PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Mancini, F; Pieroni, L; Monteleone, V; Luca, R; Fici, L; Luca, E; Urbani, A; Xiong, S; Soddu, S; Masetti, R; Lozano, G; Pontecorvi, A; Moretti, F				Mancini, F.; Pieroni, L.; Monteleone, V.; Luca, R.; Fici, L.; Luca, E.; Urbani, A.; Xiong, S.; Soddu, S.; Masetti, R.; Lozano, G.; Pontecorvi, A.; Moretti, F.			MDM4/HIPK2/p53 cytoplasmic assembly uncovers coordinated repression of molecules with anti-apoptotic activity during early DNA damage response	ONCOGENE			English	Article							CELL-CYCLE ARREST; MDM4 MDMX; GROWTH ARREST; P53 ACTIVITY; P53-DEPENDENT APOPTOSIS; TRANSCRIPTIONAL PROGRAM; DOWN-REGULATION; PROTEIN; PHOSPHORYLATION; HIPK2	The p53 inhibitor, MDM4 (MDMX) is a cytoplasmic protein with p53-activating function under DNA damage conditions. Particularly, MDM4 promotes phosphorylation of p53 at Ser46, a modification that precedes different p53 activities. We investigated the mechanism by which MDM4 promotes this p53 modification and its consequences in untransformed mammary epithelial cells and tissues. In response to severe DNA damage, MDM4 stimulates p53Ser46P by binding and stabilizing serine-threonine kinase HIPK2. Under these conditions, the p53-inhibitory complex, MDM4/MDM2, dissociates and this allows MDM4 to promote p53/HIPK2 functional interaction. Comparative proteomic analysis of DNA damage-treated cells versus - untreated cells evidenced a diffuse downregulation of proteins with anti-apoptotic activity, some of which were targets of p53Ser46P/HIPK2 repressive activity. Importantly, MDM4 depletion abolishes the downregulation of these proteins indicating the requirement of MDM4 to promote p53-mediated transcriptional repression. Consistently, MDM4-mediated HIPK2/p53 activation precedes HIPK2/p53 nuclear translocation and activity. Noteworthy, repression of these proteins was evident also in mammary glands of mice subjected to.-irradiation and was significantly enhanced in transgenic mice overexpressing MDM4. This study evidences the flexibility of MDM2/MDM4 heterodimer, which allows the development of a positive activity of cytoplasmic MDM4 towards p53-mediated transcriptional function. Noteworthy, this activity uncovers coordinated repression of molecules with shared anti-apoptotic function which precedes active cell apoptosis and that are frequently overexpressed and/or markers of tumour phenotype in human cancer.	[Mancini, F.; Monteleone, V.; Luca, R.; Fici, L.; Luca, E.; Moretti, F.] Natl Res Council Italy CNR, Inst Cell Biol & Neurobiol, I-00143 Rome, Italy; [Mancini, F.; Luca, E.; Pontecorvi, A.] Univ Cattolica Sacro Cuore, Dept Endocrinol & Metab, Rome, Italy; [Pieroni, L.; Urbani, A.] Fdn Santa Lucia, Prote & Metabol Lab, Rome, Italy; [Pieroni, L.; Urbani, A.] Univ Roma Tor Vergata, Dept Expt Med & Surg, Rome, Italy; [Fici, L.; Masetti, R.] Univ Cattolica Sacro Cuore, Dept Obstet & Gynaecol, Rome, Italy; [Xiong, S.; Lozano, G.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Soddu, S.] Regina Elena Inst Canc Res, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Cellulare e Neurobiologia (IBCN-CNR); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Santa Lucia; University of Rome Tor Vergata; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Texas System; UTMD Anderson Cancer Center; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Mancini, F (corresponding author), Natl Res Council Italy CNR, Inst Cell Biol & Neurobiol, I-00143 Rome, Italy.	francesca.mancini@ibcn.cnr.it; fabiola.moretti@cnr.it	Luca, Emilia/K-6983-2019; Moretti, Fabiola/I-5647-2013; Urbani, Andrea/AAD-1675-2022; Soddu, Silvia/K-2467-2018; Mancini, Francesca/AAZ-1672-2021; mancini, francesca/K-6062-2016; Pieroni, Luisa/Q-6315-2019; Xiong, Shunbin/AAR-5823-2021; Urbani, Andrea/B-2953-2012; Soddu, Silvia/ABH-6774-2020; Lucà, Rossella/J-5921-2018; Pieroni, Luisa/J-8651-2018	Moretti, Fabiola/0000-0002-2691-1254; Soddu, Silvia/0000-0001-8526-0044; Mancini, Francesca/0000-0002-2459-8815; mancini, francesca/0000-0002-2459-8815; Pieroni, Luisa/0000-0001-7141-1817; Soddu, Silvia/0000-0001-8526-0044; Lucà, Rossella/0000-0003-2495-7803; Pieroni, Luisa/0000-0001-7141-1817; MASETTI, Riccardo/0000-0002-7520-9111; Luca, Emilia/0000-0002-8279-067X	Associazione Italiana Ricerca sul Cancro (AIRC) [IG-8825, IG-12767]; Italian Ministry of Economy and Finance; FIRB [RBAP1153LS_007, RBAP11WCRZ_003]; Susan Komen Italia Fellowship; NATIONAL CANCER INSTITUTE [R01CA047296] Funding Source: NIH RePORTER	Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Economy and Finance; FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Susan Komen Italia Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by research grants from Associazione Italiana Ricerca sul Cancro (AIRC; IG-8825, IG-12767) and from the Italian Ministry of Economy and Finance to the CNR for the Project 'FaReBio di Qualita' to FM; by FIRB RBAP1153LS_007 to AP; by FIRB: RBAP11WCRZ_003 to AU. LP and LF were supported by Susan Komen Italia Fellowship. We are grateful to Dr JC Marine for Mdm4<SUP>-/--</SUP>p53<SUP>-/-</SUP> MEFs and lentiviral vectors, Dr L Schmith for polyclonal aHIPK2 antibody and Dr Cinzia Rinaldo for pSuper.retro-ip53 plasmid.	Barboza JA, 2008, MOL CANCER RES, V6, P947, DOI 10.1158/1541-7786.MCR-07-2079; Biderman Lynn, 2012, Genes Cancer, V3, P264, DOI 10.1177/1947601912455331; Bon G, 2009, CANCER RES, V69, P5978, DOI 10.1158/0008-5472.CAN-09-0244; Boyd KE, 1998, P NATL ACAD SCI USA, V95, P13887, DOI 10.1073/pnas.95.23.13887; Brooks CL, 2011, PROTEIN CELL, V2, P456, DOI 10.1007/s13238-011-1063-9; Calzado MA, 2007, CELL CYCLE, V6, P139, DOI 10.4161/cc.6.2.3788; Cecchinelli B, 2006, MOL CELL BIOL, V26, P4746, DOI 10.1128/MCB.00959-05; Chen LH, 2005, EMBO J, V24, P3411, DOI 10.1038/sj.emboj.7600812; Chiu CG, 2010, AM J PATHOL, V176, P2067, DOI 10.2353/ajpath.2010.090353; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Di Conza G, 2012, CELL CYCLE, V11, P749, DOI 10.4161/cc.11.4.19208; Di Stefano V, 2004, EXP CELL RES, V293, P311, DOI 10.1016/j.yexcr.2003.09.032; Drane P, 2001, ONCOGENE, V20, P430, DOI 10.1038/sj.onc.1204101; Enge M, 2009, CANCER CELL, V15, P171, DOI 10.1016/j.ccr.2009.01.019; Feng LJ, 2006, CELL CYCLE, V5, P2812, DOI 10.4161/cc.5.23.3526; Gembarska A, 2012, NAT MED, V18, P1239, DOI 10.1038/nm.2863; Giglio S, 2010, ONCOGENE, V29, P5935, DOI 10.1038/onc.2010.324; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Herold MJ, 2008, P NATL ACAD SCI USA, V105, P18507, DOI 10.1073/pnas.0806213105; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Huang L, 2011, P NATL ACAD SCI USA, V108, P12001, DOI 10.1073/pnas.1102309108; Iacovelli S, 2009, CELL PROLIFERAT, V42, P373, DOI 10.1111/j.1365-2184.2009.00601.x; Kawai H, 2007, CANCER RES, V67, P6026, DOI 10.1158/0008-5472.CAN-07-1313; Kho PS, 2004, J BIOL CHEM, V279, P21183, DOI 10.1074/jbc.M311912200; Kim YH, 1998, J BIOL CHEM, V273, P25875, DOI 10.1074/jbc.273.40.25875; Kracikova M, 2013, CELL DEATH DIFFER, V20, P576, DOI 10.1038/cdd.2012.155; Kreuzaler P, 2012, NAT REV CANCER, V12, P411, DOI 10.1038/nrc3264; Latonen L, 2001, ONCOGENE, V20, P6784, DOI 10.1038/sj.onc.1204883; Lecona E, 2008, MOL CELL BIOL, V28, P4665, DOI 10.1128/MCB.00650-07; Lenos K, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-111; Leventaki V, 2012, BRIT J HAEMATOL, V158, P763, DOI 10.1111/j.1365-2141.2012.09243.x; Li QX, 2009, NAT CELL BIOL, V11, P1128, DOI 10.1038/ncb1927; Lipscomb EA, 2005, CANCER RES, V65, P10970, DOI 10.1158/0008-5472.CAN-05-2327; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Mancini F, 2004, J BIOL CHEM, V279, P8169, DOI 10.1074/jbc.M311793200; Mancini F, 2010, INT J BIOCHEM CELL B, V42, P1080, DOI 10.1016/j.biocel.2010.04.010; Mancini F, 2009, CELL CYCLE, V8, P3854, DOI 10.4161/cc.8.23.10089; Mancini F, 2009, EMBO J, V28, P1926, DOI 10.1038/emboj.2009.154; Marchenko ND, 2010, CELL DEATH DIFFER, V17, P255, DOI 10.1038/cdd.2009.173; Mayo LD, 2005, J BIOL CHEM, V280, P25953, DOI 10.1074/jbc.M503026200; Migliorini D, 2002, J BIOL CHEM, V277, P7318, DOI 10.1074/jbc.M108795200; Migliorini D, 2002, MOL CELL BIOL, V22, P5527, DOI 10.1128/MCB.22.15.5527-5538.2002; Mirza A, 2003, ONCOGENE, V22, P3645, DOI 10.1038/sj.onc.1206477; Moller A, 2003, CANCER RES, V63, P4310; Nakahara S, 2005, APOPTOSIS, V10, P267, DOI 10.1007/s10495-005-0801-y; Nardinocchi L, 2011, AGING-US, V3, P33, DOI 10.18632/aging.100254; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Pant V, 2011, P NATL ACAD SCI USA, V108, P11995, DOI 10.1073/pnas.1102241108; Parant J, 2001, NAT GENET, V29, P92, DOI 10.1038/ng714; Pieroni L, 2011, MOL BIOSYST, V7, P630, DOI 10.1039/c0mb00135j; Puca R, 2010, ONCOGENE, V29, P4378, DOI 10.1038/onc.2010.183; Rinaldo C, 2007, MOL CELL, V25, P739, DOI 10.1016/j.molcel.2007.02.008; Rinaldo C, 2012, MOL CELL, V47, P87, DOI 10.1016/j.molcel.2012.04.029; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Silva JC, 2005, ANAL CHEM, V77, P2187, DOI 10.1021/ac048455k; Sorrentino G, 2013, CELL DEATH DIFFER, V20, P198, DOI 10.1038/cdd.2012.112; Stad R, 2001, EMBO REP, V2, P1029, DOI 10.1093/embo-reports/kve227; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Tsvetkov P, 2009, J BIOL CHEM, V284, P26234, DOI 10.1074/jbc.M109.040493; Wang CL, 2014, CARCINOGENESIS, V35, P1500, DOI 10.1093/carcin/bgu015; Wang XJ, 2011, J BIOL CHEM, V286, P23725, DOI 10.1074/jbc.M110.213868; Werner ME, 2007, J BIOL CHEM, V282, P5560, DOI 10.1074/jbc.M603669200; Xiong SB, 2010, CANCER RES, V70, P7148, DOI 10.1158/0008-5472.CAN-10-1457; Zhu Y, 2013, GENE DEV, V27, P1739, DOI 10.1101/gad.212258.112	65	30	30	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 14	2016	35	2					228	240		10.1038/onc.2015.76	http://dx.doi.org/10.1038/onc.2015.76			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DB0JH	25961923	Green Published, hybrid			2022-12-26	WOS:000368193900009
J	Liu, Y; Batchuluun, B; Ho, L; Zhu, D; Prentice, KJ; Bhattacharjee, A; Zhang, M; Pourasgari, F; Hardy, AB; Taylor, KM; Gaisano, H; Dai, FF; Wheeler, MB				Liu, Ying; Batchuluun, Battsetseg; Ho, Louisa; Zhu, Dan; Prentice, Kacey J.; Bhattacharjee, Alpana; Zhang, Ming; Pourasgari, Farzaneh; Hardy, Alexandre B.; Taylor, Kathryn M.; Gaisano, Herbert; Dai, Feihan F.; Wheeler, Michael B.			Characterization of Zinc Influx Transporters (ZIPs) in Pancreatic beta Cells ROLES IN REGULATING CYTOSOLIC ZINC HOMEOSTASIS AND INSULIN SECRETION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE-HOMEOSTASIS; OXIDATIVE STRESS; SUPEROXIDE-DISMUTASE; DIABETES-MELLITUS; ADAPTIVE RESPONSE; GENE-EXPRESSION; LIV-1 SUBFAMILY; GLP-1 RECEPTOR; CELLULAR ZINC; MICE	Zinc plays an essential role in the regulation of pancreatic beta cell function, affecting important processes including insulin biosynthesis, glucose-stimulated insulin secretion, and cell viability. Mutations in the zinc efflux transport protein ZnT8 have been linked with both type 1 and type 2 diabetes, further supporting an important role for zinc in glucose homeostasis. However, very little is known about how cytosolic zinc is controlled by zinc influx transporters (ZIPs). In this study, we examined the beta cells. Modulation of ZIP6 and ZIP7 expression significantly altered cytosolic zinc influx in pancreatic beta cells, indicating an important role for ZIP6 and ZIP7 in regulating cellular zinc homeostasis. Functionally, this dysregulated cytosolic zinc homeostasis led to impaired insulin secretion. In parallel studies, we identified both ZIP6 and ZIP7 as potential interacting proteins with GLP-1R by a membrane yeast two-hybrid assay. Knock-down of ZIP6 but not ZIP7 in MIN6 beta cells impaired the protective effects of GLP-1 on fatty acid-induced cell apoptosis, possibly via reduced activation of the p-ERK pathway. Therefore, our data suggest that ZIP6 and ZIP7 function as two important zinc influx transporters to regulate cytosolic zinc concentrations and insulin secretion in beta cells. In particular, ZIP6 is also capable of directly interacting with GLP-1R to facilitate the protective effect of GLP-1 on beta cell survival.	[Zhang, Ming; Pourasgari, Farzaneh; Hardy, Alexandre B.; Gaisano, Herbert; Dai, Feihan F.; Wheeler, Michael B.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Taylor, Kathryn M.] Cardiff Univ, Sch Pharm & Pharmaceut Sci, Breast Canc Mol Pharmacol Unit, Cardiff CF10 3NB, S Glam, Wales	University of Toronto; Cardiff University	Dai, FF (corresponding author), 1 Kings Coll Circle, Dept Physiol, Med Sci Bldg,Rm 3352, Toronto, ON M5S 1A8, Canada.	f.dai@utoronto.ca; Michael.wheeler@utoronto.ca	Taylor, Kathryn M/O-3401-2014; Liu, Ying/H-6045-2018	Taylor, Kathryn M/0000-0002-9576-9490; Liu, Ying/0000-0001-7710-0809; Wheeler, Michael B./0000-0002-7480-7267	Ontario Research Funds [19442, 30961]	Ontario Research Funds	We thank the Canadian Foundation for Innovation and Ontario Research Funds (19442 and 30961) for providing the equipment used in our study. We thank Islet Core and Clinical Islet Laboratory (University of Alberta) providing us human islets from review board-approved donors. We thank Judith A. Eversley for contributions to the manuscript. We also thank Kyle W. Sloop for the pcDNA3.1-ZIP6-HA plasmid construct.	Al-Maroof RA, 2006, SAUDI MED J, V27, P344; Anderson RA, 2001, J AM COLL NUTR, V20, P212, DOI 10.1080/07315724.2001.10719034; ATWATER I, 1979, J PHYSIOL-LONDON, V288, P575; Bao B, 2008, TRANSL RES, V152, P67, DOI 10.1016/j.trsl.2008.06.001; Basford CL, 2012, DIABETOLOGIA, V55, P358, DOI 10.1007/s00125-011-2335-x; Bayascas JR, 2002, CELL DEATH DIFFER, V9, P1078, DOI 10.1038/sj.cdd.4401075; Bellomo EA, 2011, J BIOL CHEM, V286, P25778, DOI 10.1074/jbc.M111.246082; Benters J, 1997, BIOCHEM J, V322, P793, DOI 10.1042/bj3220793; Besecker B, 2008, AM J PHYSIOL-LUNG C, V294, pL1127, DOI 10.1152/ajplung.00057.2008; Chimienti F, 2004, DIABETES, V53, P2330, DOI 10.2337/diabetes.53.9.2330; Chowanadisai W, 2008, BRAIN RES, V1199, P10, DOI 10.1016/j.brainres.2008.01.015; COFFMAN FD, 1988, BIOCHEMISTRY-US, V27, P6179, DOI 10.1021/bi00416a053; Craddock TJA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033552; CROUCH RK, 1984, EXP MOL PATHOL, V41, P377, DOI 10.1016/0014-4800(84)90026-1; CUNNINGHAM JJ, 1994, METABOLISM, V43, P1558, DOI 10.1016/0026-0495(94)90016-7; Desouki MM, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-37; Diao J, 2008, P NATL ACAD SCI USA, V105, P12057, DOI 10.1073/pnas.0710434105; Dufner-Beattie J, 2004, J BIOL CHEM, V279, P49082, DOI 10.1074/jbc.M409962200; Dufner-Beattie J, 2007, HUM MOL GENET, V16, P1391, DOI 10.1093/hmg/ddm088; Favaro E, 2012, DIABETOLOGIA, V55, P1058, DOI 10.1007/s00125-011-2423-y; FLATT PR, 1980, BIOCHEM J, V190, P361, DOI 10.1042/bj1900361; FOSTER MC, 1993, BIOPHYS J, V64, P525, DOI 10.1016/S0006-3495(93)81397-3; Foster M, 2010, ANTIOXID REDOX SIGN, V13, P1549, DOI 10.1089/ars.2010.3111; Fukada T, 2011, J BIOL INORG CHEM, V16, P1123, DOI 10.1007/s00775-011-0797-4; Gyulkhandanyan AV, 2006, J BIOL CHEM, V281, P9361, DOI 10.1074/jbc.M508542200; Hardy AB, 2012, AM J PHYSIOL-ENDOC M, V302, pE1084, DOI 10.1152/ajpendo.00448.2011; Hardy AB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119136; Hardy AB, 2009, J BIOL CHEM, V284, P30441, DOI 10.1074/jbc.M109.040659; Hashemi M, 2007, EUR J PHARMACOL, V557, P9, DOI 10.1016/j.ejphar.2006.11.010; Hennigar SR, 2012, BIOL CHEM, V393, P565, DOI 10.1515/hsz-2012-0128; Hogstrand C, 2009, TRENDS MOL MED, V15, P101, DOI 10.1016/j.molmed.2009.01.004; Hogstrand C, 2013, BIOCHEM J, V455, P229, DOI 10.1042/BJ20130483; Huang LP, 2005, J BIOL CHEM, V280, P15456, DOI 10.1074/jbc.M412188200; Huang X, 2013, MOL ENDOCRINOL, V27, P1550, DOI 10.1210/me.2013-1047; Jansen J, 2009, J NUTR BIOCHEM, V20, P399, DOI 10.1016/j.jnutbio.2009.01.009; Kahn SE, 2001, INT J CLIN PRACT, P13; Kambe T, 2004, CELL MOL LIFE SCI, V61, P49, DOI 10.1007/s00018-003-3148-y; Kitamura H, 2006, NAT IMMUNOL, V7, P971, DOI 10.1038/ni1373; Le DA, 2002, P NATL ACAD SCI USA, V99, P15188, DOI 10.1073/pnas.232473399; Lee SC, 2009, J ENDOCRINOL, V203, P33, DOI 10.1677/JOE-09-0117; Lemaire K, 2009, P NATL ACAD SCI USA, V106, P14872, DOI 10.1073/pnas.0906587106; Li YZ, 2003, J BIOL CHEM, V278, P471, DOI 10.1074/jbc.M209423200; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Lu HF, 2010, DIABETES, V59, P448, DOI 10.2337/db09-0129; Luu L, 2013, DIABETOLOGIA, V56, P2010, DOI 10.1007/s00125-013-2946-5; Maclean KH, 2001, BLOOD, V98, P3831, DOI 10.1182/blood.V98.13.3831; Makhov P, 2008, CELL DEATH DIFFER, V15, P1745, DOI 10.1038/cdd.2008.106; Maret W, 2007, MOL MED, V13, P371, DOI 10.2119/2007-00036.Maret; MCNAIR P, 1981, CLIN CHIM ACTA, V112, P343, DOI 10.1016/0009-8981(81)90457-5; Meier JJ, 2012, NAT REV ENDOCRINOL, V8, P728, DOI 10.1038/nrendo.2012.140; Mendivil-Perez M, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/313275; Myers SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079316; Nicolson TJ, 2009, DIABETES, V58, P2070, DOI 10.2337/db09-0551; Nygaard Sanne Bjorn, 2014, BMC Res Notes, V7, P84, DOI 10.1186/1756-0500-7-84; Ohly P, 2000, DIABETOLOGIA, V43, P1020, DOI 10.1007/s001250050009; Oteiza PI, 2012, FREE RADICAL BIO MED, V53, P1748, DOI 10.1016/j.freeradbiomed.2012.08.568; OTEIZA PI, 1995, J NUTR, V125, P823; Plum LM, 2010, INT J ENV RES PUB HE, V7, P1342, DOI 10.3390/ijerph7041342; Pound LD, 2009, BIOCHEM J, V421, P371, DOI 10.1042/BJ20090530; Prentice KJ, 2014, CELL METAB, V19, P653, DOI 10.1016/j.cmet.2014.03.008; QUARTERMAN J, 1966, BIOCHEM BIOPH RES CO, V25, P354, DOI 10.1016/0006-291X(66)90785-6; Quoyer J, 2010, J BIOL CHEM, V285, P1989, DOI 10.1074/jbc.M109.067207; Shuttleworth CW, 2011, TRENDS PHARMACOL SCI, V32, P480, DOI 10.1016/j.tips.2011.04.001; Slepchenko KG, 2012, EXP DIABETES RES, DOI 10.1155/2012/190309; Tamaki M, 2013, J CLIN INVEST, V123, P4513, DOI 10.1172/JCI68807; Taylor KM, 2008, ENDOCRINOLOGY, V149, P4912, DOI 10.1210/en.2008-0351; Taylor KM, 2007, MOL MED, V13, P396, DOI 10.2119/2007-00040.Taylor; Taylor KM, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002585; Taylor KM, 2003, BBA-BIOMEMBRANES, V1611, P16, DOI 10.1016/S0005-2736(03)00048-8; Trzcinska-Daneluti AM, 2009, MOL CELL PROTEOMICS, V8, P780, DOI 10.1074/mcp.M800268-MCP200; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; Wichroski MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042609; Wijesekara N, 2010, DIABETOLOGIA, V53, P1656, DOI 10.1007/s00125-010-1733-9; Williams RG, 2006, METHOD ENZYMOL, V414, P364, DOI 10.1016/S0076-6879(06)14021-5; Wolff NA, 2014, FASEB J, V28, P2134, DOI 10.1096/fj.13-240564; Wu CY, 2007, J BIOL CHEM, V282, P2184, DOI 10.1074/jbc.M606639200; Wu CY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007061; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Zhang TT, 2006, NANO LETT, V6, P800, DOI 10.1021/nl0603350; Zhao L, 2007, BIOCHEM BIOPH RES CO, V363, P82, DOI 10.1016/j.bbrc.2007.08.127; Zhu D, 2012, CELL METAB, V16, P238, DOI 10.1016/j.cmet.2012.07.001	81	49	49	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18757	18769		10.1074/jbc.M115.640524	http://dx.doi.org/10.1074/jbc.M115.640524			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	25969539	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000358512100043
J	Hatton, L; Warr, G				Hatton, Leslie; Warr, Gregory			Protein Structure and Evolution: Are They Constrained Globally by a Principle Derived from Information Theory?	PLOS ONE			English	Article							LENGTH; IDENTIFICATION; GLYCOSYLATION; CONSERVATION; ARCHAEA	That the physicochemical properties of amino acids constrain the structure, function and evolution of proteins is not in doubt. However, principles derived from information theory may also set bounds on the structure (and thus also the evolution) of proteins. Here we analyze the global properties of the full set of proteins in release 13-11 of the SwissProt database, showing by experimental test of predictions from information theory that their collective structure exhibits properties that are consistent with their being guided by a conservation principle. This principle (Conservation of Information) defines the global properties of systems composed of discrete components each of which is in turn assembled from discrete smaller pieces. In the system of proteins, each protein is a component, and each protein is assembled from amino acids. Central to this principle is the inter-relationship of the unique amino acid count and total length of a protein and its implications for both average protein length and occurrence of proteins with specific unique amino acid counts. The unique amino acid count is simply the number of distinct amino acids (including those that are post-translationally modified) that occur in a protein, and is independent of the number of times that the particular amino acid occurs in the sequence. Conservation of Information does not operate at the local level (it is independent of the physicochemical properties of the amino acids) where the influences of natural selection are manifest in the variety of protein structure and function that is well understood. Rather, this analysis implies that Conservation of Information would define the global bounds within which the whole system of proteins is constrained; thus it appears to be acting to constrain evolution at a level different from natural selection, a conclusion that appears counter-intuitive but is supported by the studies described herein.	[Hatton, Leslie] Univ Kingston, Fac Sci Engn & Comp, London, England; [Warr, Gregory] Med Univ S Carolina, Charleston, SC 29425 USA	Kingston University; Medical University of South Carolina	Hatton, L (corresponding author), Univ Kingston, Fac Sci Engn & Comp, London, England.	lesh@oakcomp.co.uk			National Science Foundation	National Science Foundation(National Science Foundation (NSF))	This material is based in part on work supported by the National Science Foundation. Any opinion, finding, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami C, 2012, ANN NY ACAD SCI, V1256, P49, DOI 10.1111/j.1749-6632.2011.06422.x; [Anonymous], 2013, SWISSPROT REL 13 11; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Baxter G, 2006, OOPSLA 06; Campbell MP, 2014, NUCLEIC ACIDS RES, V42, pD215, DOI 10.1093/nar/gkt1128; Cherry C, 1963, ON HUMAN COMMUNICATI, P56; Concas G, 2007, IEEE T SOFTWARE ENG, V33, P687, DOI [10.1109/TSE.2007.1019, 10.1109/TSE.2007.1016]; Feynman R., 1996, FEYNMAN LECT COMPUTA; Frank SA, 2009, J EVOLUTION BIOL, V22, P1563, DOI 10.1111/j.1420-9101.2009.01775.x; Gladyshev VN, 2010, NUCLEIC ACIDS MOL BI, V24, P3, DOI 10.1007/978-0-387-89382-2_1; Hahne H, 2013, J PROTEOME RES, V12, P927, DOI 10.1021/pr300967y; Hartley RVL, 1928, BELL SYST TECH J, V7, P535, DOI 10.1002/j.1538-7305.1928.tb01236.x; Hatton L, 2014, IEEE T SOFTWARE ENG, V40, P450, DOI 10.1109/TSE.2014.2316158; Hatton L, 2009, IEEE T SOFTWARE ENG, V35, P566, DOI 10.1109/TSE.2008.105; Ince DC, 2012, NATURE, V482, P485, DOI 10.1038/nature10836; Jochmann R, 2014, BBA-PROTEINS PROTEOM, V1844, P416, DOI 10.1016/j.bbapap.2013.12.002; Karev GP, 2003, BIOINFORMATICS, V19, P1889, DOI 10.1093/bioinformatics/btg351; Khoury GA, 2011, SCI REP-UK, V1, DOI 10.1038/srep00090; Koonin EV, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002173; Lipman DJ, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-20; Louridas P, 2008, ACM T SOFTW ENG METH, V18, DOI 10.1145/1391984.1391986; Manhart M, 2012, THEOR POPUL BIOL, V82, P66, DOI 10.1016/j.tpb.2012.03.007; Mitzenmacher M., 2003, INTERNET MATH, V2, P226, DOI [10.1080/15427951.2004.10129088, DOI 10.1080/15427951.2004.10129088]; Motomura K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050039; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Noether E., 1918, KLG GES WISS NACH MP, P235, DOI DOI 10.1080/00411457108231446; Pape S, 2010, PROTEINS, V78, P2322, DOI 10.1002/prot.22744; Philippe N, 2013, SCIENCE, V341, P281, DOI 10.1126/science.1239181; Prabakaran S, 2012, WIRES SYST BIOL MED, V4, P565, DOI 10.1002/wsbm.1185; Rawlings PK, 2004, PHYSICA A, V343, P643, DOI 10.1016/j.physa.2004.06.152; Reed WJ, 2003, SCI MATH JAPONICAE O, V8, P329; Sella G, 2005, P NATL ACAD SCI USA, V102, P9541, DOI 10.1073/pnas.0501865102; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; SwissProt, 2014, CONTR VOC POSTTR MOD; Thaysen-Andersen M, 2014, BBA-PROTEINS PROTEOM, V1844, P1437, DOI 10.1016/j.bbapap.2014.05.002; Tiessen Axel, 2012, BMC Res Notes, V5, P85, DOI 10.1186/1756-0500-5-85; Trinidad JC, 2013, MOL CELL PROTEOMICS, V12, P3474, DOI 10.1074/mcp.M113.030007; Trinidad JC, 2012, MOL CELL PROTEOMICS, V11, P215, DOI 10.1074/mcp.O112.018366; van der Meulen MJP, 2008, IEEE T SOFTWARE ENG, V34, P753, DOI 10.1109/TSE.2008.70; Wang DY, 2005, MOL BIOL EVOL, V22, P142, DOI 10.1093/molbev/msh263; Xu L, 2006, MOL BIOL EVOL, V23, P1107, DOI 10.1093/molbev/msk019; Zafar S, 2011, BIOINFORMATION, V6, P352, DOI 10.6026/97320630006352; Zhang JZ, 2000, TRENDS GENET, V16, P107, DOI 10.1016/S0168-9525(99)01922-8; Zipf George, 1935, PSYCHOBIOLOGY LANGUA	45	2	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0125663	10.1371/journal.pone.0125663	http://dx.doi.org/10.1371/journal.pone.0125663			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970335	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000354544200081
J	Kang, H; Corr, M; Mansson, R; Welinder, E; Hedrick, SM; Stone, EL				Kang, Hannah; Corr, Maripat; Mansson, Robert; Welinder, Eva; Hedrick, Stephen M.; Stone, Erica L.			Loss of Murine FOXO3 in Cells of the Myeloid Lineage Enhances Myelopoiesis but Protects from K/BxN-Serum Transfer-Induced Arthritis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXO3A; INFLAMMATORY ARTHRITIS; HEMATOPOIETIC STEM; IMMUNE-RESPONSES; MOUSE MODEL; NEUTROPHILS; PATHWAY; DISEASE; MICE; DIVERSIFICATION	FOXO transcription factors have a highly conserved role in regulating transcription of genes involved in differentiation, cell cycle arrest, apoptosis and DNA repair. Loss of FOXO3 in mice has previously been shown to result in a myeloproliferative disease. In agreement with this, we found that an independent Foxo3 null mouse strain, Foxo3Kca, exhibits an increase in neutrophils in the spleen, bone marrow and blood. This coincides with an expansion of myeloid progenitor cells including pre-granulocyte-macrophage progenitors (Pre-GMs) and granulocyte-macrophage progenitors (GMPs). Surprisingly, despite neutrophilia, the severity of passive serum transfer arthritis was markedly attenuated in Foxo3Kca mice. These defects appear to be at least partially intrinsic to the myeloid lineage, as deleting Foxo3 specifically from myeloid cells using LysMCre also leads to an elevated number of neutrophils and protection from K/BxN-serum transfer-induced arthritis.	[Kang, Hannah; Mansson, Robert; Welinder, Eva; Hedrick, Stephen M.] Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA; [Kang, Hannah; Hedrick, Stephen M.; Stone, Erica L.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Corr, Maripat] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; [Mansson, Robert] Karolinska Inst, Dept Lab Med, Stockholm, Sweden	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Karolinska Institutet	Stone, EL (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	elstone@ucsd.edu	Mansson, Robert/D-4372-2014; Hedrick, Stephen M/E-9171-2010	Mansson, Robert/0000-0003-0738-0328; 	NIH [R01AI073855, R21AI103772, 5R21AR062236]; Istitutional Research and Academic Career Development Award [K12]; K01 award [K01DK095008]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI103440, R21AI103772] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR062236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK095008] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Istitutional Research and Academic Career Development Award; K01 award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants R01AI073855 (S.M.H.), R21AI103772 (S.M.H.), and 5R21AR062236 (M.C.). E.L.S. was supported by an (K12) Istitutional Research and Academic Career Development Award (L. Brunton, Director) and a K01 award K01DK095008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carrette F, 2009, ADV EXP MED BIOL, V665, P3; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cortez-Retamozo V, 2012, P NATL ACAD SCI USA, V109, P2491, DOI 10.1073/pnas.1113744109; Cuenca AG, 2011, MOL MED, V17, P281, DOI 10.2119/molmed.2010.00178; Dejean AS, 2009, NAT IMMUNOL, V10, P504, DOI 10.1038/ni.1729; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Griseri T, 2012, IMMUNITY, V37, P1116, DOI 10.1016/j.immuni.2012.08.025; Hedrick SM, 2012, NAT REV IMMUNOL, V12, P649, DOI 10.1038/nri3278; Hedrick SM, 2009, NAT IMMUNOL, V10, P1057, DOI 10.1038/ni.1784; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Jonsson H, 2005, NAT MED, V11, P666, DOI 10.1038/nm1248; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; Kyburz D, 2003, SPRINGER SEMIN IMMUN, V25, P79, DOI 10.1007/s00281-003-0131-5; Lee JC, 2013, CELL, V155, P57, DOI 10.1016/j.cell.2013.08.034; Ley K, 2006, IMMUNOL RES, V34, P229, DOI 10.1385/IR:34:3:229; Liew FY, 2005, NAT MED, V11, P601, DOI 10.1038/nm0605-601; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; Maiese K, 2008, TRENDS MOL MED, V14, P219, DOI 10.1016/j.molmed.2008.03.002; Matsumoto I, 1999, SCIENCE, V286, P1732, DOI 10.1126/science.286.5445.1732; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Miyamoto K, 2008, BLOOD, V112, P4485, DOI 10.1182/blood-2008-05-159848; Monach Paul, 2007, V136, P269; Monach PA, 2010, ARTHRITIS RHEUM-US, V62, P753, DOI 10.1002/art.27238; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Puga I, 2012, NAT IMMUNOL, V13, P170, DOI 10.1038/ni.2194; Rose S, 2012, CYTOM PART A, V81A, P343, DOI 10.1002/cyto.a.22012; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Stone EL, IMMUNITY IN PRESS; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Turrel-Davin F, 2010, ANN RHEUM DIS, V69, P755, DOI 10.1136/ard.2009.109991; Wipke BT, 2001, J IMMUNOL, V167, P1601, DOI 10.4049/jimmunol.167.3.1601; Yalcin S, 2010, EMBO J, V29, P4118, DOI 10.1038/emboj.2010.292; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	37	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0126728	10.1371/journal.pone.0126728	http://dx.doi.org/10.1371/journal.pone.0126728			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25969990	Green Published, Green Submitted, gold			2022-12-26	WOS:000354544200128
J	Lindegren, S; Andrade, LNS; Back, T; Machado, CML; Horta, BB; Buchpiguel, C; Moro, AM; Okamoto, OK; Jacobsson, L; Cederkrantz, E; Washiyama, K; Aneheim, E; Palm, S; Jensen, H; Tuma, MCB; Chammas, R; Hultborn, R; Albertsson, P				Lindegren, Sture; Andrade, Luciana N. S.; Back, Tom; Machado, Camila Maria L.; Horta, Bruno Brasil; Buchpiguel, Carlos; Moro, Ana Maria; Okamoto, Oswaldo Keith; Jacobsson, Lars; Cederkrantz, Elin; Washiyama, Kohshin; Aneheim, Emma; Palm, Stig; Jensen, Holger; Tuma, Maria Carolina B.; Chammas, Roger; Hultborn, Ragnar; Albertsson, Per			Binding Affinity, Specificity and Comparative Biodistribution of the Parental Murine Monoclonal Antibody MX35 (Anti-NaPi2b) and Its Humanized Version Rebmab200	PLOS ONE			English	Article							OVARIAN-CANCER; NUDE-MICE; RADIOIMMUNOTHERAPY; EFFICACY; AT-211	The aim of this preclinical study was to evaluate the characteristics of the monoclonal antibody Rebmab200, which is a humanized version of the ovarian-specific murine antibody MX35. This investigation contributes to the foundation for future clinical alpha-radioimmunotherapy of minimal residual ovarian cancer with At-211-Rebmab200. Here, the biodistribution of 211At-Rebmab200 was evaluated, as was the utility of Tc-99m-Rebmab200 for bioimaging. Rebmab200 was directly compared with its murine counterpart MX35 in terms of its in-vitro capacity for binding the immobilized NaPi2B epitope and live cells; we also assessed its biodistribution in nude mice carrying subcutaneous OVCAR-3 tumors. Tumor antigen and cell binding were similar between Rebmab200 and murine MX35, as was biodistribution, including normal tissue uptake and in-vivo tumor binding. We also demonstrated that Tc-99m-Rebmab200 can be used for single-photon emission computed tomography of subcutaneous ovarian carcinomas in tumor-bearing mice. Taken together, our data support the further development of Rebmab200 for radioimmunotherapy and diagnostics.	[Lindegren, Sture; Back, Tom; Jacobsson, Lars; Cederkrantz, Elin; Washiyama, Kohshin; Aneheim, Emma; Palm, Stig] Univ Gothenburg, Sahlgrenska Acad, Dept Radiat Phys, Gothenburg, Sweden; [Andrade, Luciana N. S.; Horta, Bruno Brasil; Okamoto, Oswaldo Keith; Tuma, Maria Carolina B.] Recepta Biopharma, Sao Paulo, Brazil; [Andrade, Luciana N. S.; Machado, Camila Maria L.; Chammas, Roger] Univ Sao Paulo, Fac Med, Ctr Invest Translac Oncol LIM24, Inst Canc Estado Sao Paulo,Dept Radiol & Oncol, Sao Paulo, Brazil; [Machado, Camila Maria L.; Buchpiguel, Carlos] Univ Sao Paulo, Fac Med, Dept Radiol & Oncol, Lab Invest Med Radioisotopos LIM43, Sao Paulo, Brazil; [Moro, Ana Maria] Inst Butantan, Lab Biofarmacos Celulas Anim, Sao Paulo, Brazil; [Okamoto, Oswaldo Keith] Univ Sao Paulo, Inst Biociencias, Dept Genet & Biol Evolut, Sao Paulo, Brazil; [Jensen, Holger] Rigshosp, Cyclotron & PET Unit, KF 3982, Copenhagen, Denmark; [Hultborn, Ragnar; Albertsson, Per] Univ Gothenburg, Sahlgrenska Acad, Dept Oncol, Gothenburg, Sweden	University of Gothenburg; Universidade de Sao Paulo; Universidade de Sao Paulo; Instituto Butantan; Universidade de Sao Paulo; Rigshospitalet; University of Copenhagen; University of Gothenburg	Lindegren, S (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Radiat Phys, Gothenburg, Sweden.	sture.lindegren@radfys.gu.se	Moro, Ana Maria/A-5134-2012; Chammas, Roger/A-8004-2011; Tuma, Maria/P-6456-2015; Buchpiguel, Carlos A/C-3774-2012; Buchpiguel, Carlos/AAC-6237-2020; Okamoto, Oswaldo Keith/C-5593-2013; machado, camila/AAH-5488-2019	Moro, Ana Maria/0000-0002-0650-7764; Chammas, Roger/0000-0003-0342-8726; Buchpiguel, Carlos A/0000-0003-0956-2790; Buchpiguel, Carlos/0000-0003-0956-2790; Okamoto, Oswaldo Keith/0000-0002-8528-6225; Back, Tom/0000-0002-3375-9473; Albertsson, Per/0000-0002-8158-3345; Andrade, Luciana/0000-0003-2735-1217; Aneheim, Emma/0000-0003-2566-886X	King Gustaf V Jubilee Clinic Cancer Research Foundation in Gothenburg, Sweden; Swedish Cancer Society [2013-642, 2013-644]; CNPq in Brasil; FINEP, in Brasil; Recepta Biopharma; Grants-in-Aid for Scientific Research [26461848] Funding Source: KAKEN	King Gustaf V Jubilee Clinic Cancer Research Foundation in Gothenburg, Sweden; Swedish Cancer Society(Swedish Cancer Society); CNPq in Brasil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FINEP, in Brasil; Recepta Biopharma; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the King Gustaf V Jubilee Clinic Cancer Research Foundation in Gothenburg, Sweden and the Swedish Cancer Society (2013-642 and 644), and by CNPq and FINEP, in Brasil. Recepta Biopharma provided support in the form of salaries for authors Luciana N. S. Andrade, Bruno Brasil Horta, Oswaldo Keith Okamoto and Maria Carolina B. Tuma, but did not have any additional role in the study design, data	Andersson H, 2000, ACTA ONCOL, V39, P741; Andersson H, 2000, ANTICANCER RES, V20, P459; Andersson H, 2009, J NUCL MED, V50, P1153, DOI 10.2967/jnumed.109.062604; dos Santos ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070332; Elgqvist J, 2005, J NUCL MED, V46, P464; Elgqvist J, 2005, J NUCL MED, V46, P1907; Elgqvist J, 2010, J ONCOL, V2010, DOI 10.1155/2010/394913; Elgqvist J, 2006, INT J RADIAT ONCOL, V66, P1228, DOI 10.1016/j.ijrobp.2006.07.003; Flook AM, 2013, MOL PHARMACEUT, V10, P3417, DOI 10.1021/mp400248f; Gainkam LOT, 2008, J NUCL MED, V49, P788, DOI 10.2967/jnumed.107.048538; Goldenberg DM, 2012, THERANOSTICS, V2, P523, DOI 10.7150/thno.3582; HAMILTON JG, 1950, J CLIN INVEST, V29, P820; KUUSREICHEL K, 1994, CLIN DIAGN LAB IMMUN, V1, P365, DOI 10.1128/CDLI.1.4.365-372.1994; Leinster DA, 2012, J PATHOL, V227, P136, DOI 10.1002/path.4002; Lindegren S, 2001, APPL RADIAT ISOTOPES, V55, P157, DOI 10.1016/S0969-8043(01)00044-6; Lindegren S, 2008, J NUCL MED, V49, P1537, DOI 10.2967/jnumed.107.049833; LINDMO T, 1984, J IMMUNOL METHODS, V72, P77, DOI 10.1016/0022-1759(84)90435-6; MAHER VE, 1992, J IMMUNOTHER, V11, P56, DOI 10.1097/00002371-199201000-00007; Malviya G, 2012, MOL IMAGING BIOL, V14, P637, DOI 10.1007/s11307-011-0527-x; MATTES MJ, 1987, CANCER RES, V47, P6741; Mirick GR, 2004, Q J NUCL MED MOL IM, V48, P251; Vaneycken I, 2010, J NUCL MED, V51, P1099, DOI 10.2967/jnumed.109.069823; VISSER GWM, 1981, INT J APPL RADIAT IS, V32, P905, DOI 10.1016/0020-708X(81)90077-6; Wu AM, 2014, METHODS, V65, P139, DOI 10.1016/j.ymeth.2013.09.015; Yin Beatrice W T, 2008, Cancer Immun, V8, P3; Zalutsky MR, 2008, J NUCL MED, V49, P30, DOI 10.2967/jnumed.107.046938; Zalutsky MR, 2005, J NUCL MED, V46, p151S; ZALUTSKY MR, 1987, APPL RADIAT ISOTOPES, V38, P1051, DOI 10.1016/0883-2889(87)90069-4; Zalutsky MR, 2000, CURR PHARM DESIGN, V6, P1433, DOI 10.2174/1381612003399275	29	14	15	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0126298	10.1371/journal.pone.0126298	http://dx.doi.org/10.1371/journal.pone.0126298			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970341	Green Published, Green Submitted, gold			2022-12-26	WOS:000354544200101
J	Song, H; Nan, ZB				Song, Hui; Nan, Zhibiao			Origin, Divergence, and Phylogeny of Asexual Epichloe Endophyte in Elymus Species from Western China	PLOS ONE			English	Article							FUNGAL ENDOPHYTES; VERTICAL TRANSMISSION; EVOLUTIONARY ORIGINS; GRASS; ALKALOIDS; HYBRIDIZATION; GERMINATION; ACREMONIUM; DIVERSITY; INFECTION	Asexual Epichloe species are likely derived directly from sexual Epichloe species that then lost their capacity for sexual reproduction or lost sexual reproduction because of interspecific hybridization between distinct lineages of sexual Epichloe and/or asexual Epichloe species. In this study we isolated asexual Epichloe endophytes from Elymus species in western China and sequenced intron-rich regions in the genes encoding beta-tubulin (tubB) and translation elongation factor 1-alpha (tefA). Our results showed that there are no gene copies of tubB and tefA in any of the isolates. Phylogenetic analysis showed that sequences in this study formed a single clade with asexual Epichloe bromicola from Hordeum brevisubulatum, which implies asexual Epichloe endophytes that are symbionts in a western Chinese Elymus species likely share a common ancestor with asexual E. bromicola from European H. brevisubulatum. In addition, our results revealed that asexual E. bromicola isolates that are symbionts in a western Chinese Elymus species and sexual Epichloe species that are symbionts in a North American Elymus species have a different origin. Further analysis found that Epichloe species likely originated in Eurasia. In addition, the results support the hypothesis that migratory birds or humans might have aided the dispersal of these fungal endophytes to other continents.	[Song, Hui; Nan, Zhibiao] Key Lab Grassland Agroecosyst, Lanzhou 730020, Peoples R China; [Song, Hui; Nan, Zhibiao] Lanzhou Univ, Coll Pastoral Agr Sci & Technol, Lanzhou 730020, Peoples R China	Lanzhou University	Nan, ZB (corresponding author), Key Lab Grassland Agroecosyst, Lanzhou 730020, Peoples R China.	zhibiao@lzu.edu.cn			National Basic Research Program of China [2014CB138702]; Fundamental Research Funds for the Central Universities [lzujbky-2014-76, lzujbky-2014-81]	National Basic Research Program of China(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by the National Basic Research Program of China (2014CB138702) and the Fundamental Research Funds for the Central Universities (lzujbky-2014-76, lzujbky-2014-81).	Abbott LB, 2003, J RANGE MANAGE, V56, P56, DOI 10.2307/4003882; Agnew P, 1999, EVOL ECOL, V13, P67, DOI 10.1023/A:1006586131235; ARACHEVALETA M, 1989, AGRON J, V81, P83, DOI 10.2134/agronj1989.00021962008100010015x; Beyer M, 2004, J PHYTOPATHOL, V152, P92, DOI 10.1111/j.1439-0434.2003.00807.x; Bush LP, 1997, PLANT PHYSIOL, V114, P1, DOI 10.1104/pp.114.1.1; BUSH LP, 1993, AGR ECOSYST ENVIRON, V44, P81, DOI 10.1016/0167-8809(93)90040-V; Chung KR, 1997, MYCOL RES, V101, P295, DOI 10.1017/S0953756296002602; Dewey DR, 1984, GENOMIC SYSTEM CLASS; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; ELMI AA, 1995, NEW PHYTOL, V131, P61, DOI 10.1111/j.1469-8137.1995.tb03055.x; Fu YB, 2010, GENET RESOUR CROP EV, V57, P667, DOI 10.1007/s10722-009-9502-7; FU YX, 1993, GENETICS, V133, P693; Gentile A, 2005, MOL PHYLOGENET EVOL, V35, P196, DOI 10.1016/j.ympev.2005.01.008; Glenn AE, 1996, MYCOLOGIA, V88, P369, DOI 10.2307/3760878; GWINN KD, 1992, PLANT DIS, V76, P911, DOI 10.1094/PD-76-0911; Helfgott DM, 2004, SYST BOT, V29, P850, DOI 10.1600/0363644042451017; Hopkins D. M, 1967, BERING LAND BRIDGE; Iannone LJ, 2011, MYCOL PROG, V10, P9, DOI 10.1007/s11557-010-0669-2; Iannone LJ, 2009, MYCOLOGIA, V101, P340, DOI 10.3852/08-156; Jakob SS, 2006, MOL BIOL EVOL, V23, P1602, DOI 10.1093/molbev/msl018; JOHNSON MC, 1985, APPL ENVIRON MICROB, V49, P568, DOI 10.1128/AEM.49.3.568-571.1985; Kang Y, 2009, MYCOLOGIA, V101, P211, DOI 10.3852/08-018; Kannadan S, 2008, FUNCT ECOL, V22, P706, DOI 10.1111/j.1365-2435.2008.01395.x; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; LATCH GCM, 1985, ANN APPL BIOL, V107, P17, DOI 10.1111/j.1744-7348.1985.tb01543.x; Leuchtmann A, 2014, MYCOLOGIA, V106, P202, DOI 10.3852/106.2.202; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MARKS S, 1991, J APPL ECOL, V28, P194, DOI 10.2307/2404125; Moon CD, 2000, MYCOLOGIA, V92, P1103, DOI 10.2307/3761478; Moon CD, 2002, MYCOLOGIA, V94, P694, DOI 10.2307/3761720; NEILL J. C., 1940, New Zealand Journal of Science and Technology, Section A, V21, P280; NISHIKAWA K, 1980, JPN J GENET, V55, P325, DOI 10.1266/jjg.55.325; Oberhofer M, 2012, MOL ECOL, V21, P2713, DOI 10.1111/j.1365-294X.2012.05459.x; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Restif O, 2006, OIKOS, V114, P148, DOI 10.1111/j.2006.0030-1299.14611.x; Saikkonen K, 1998, ANNU REV ECOL SYST, V29, P319, DOI 10.1146/annurev.ecolsys.29.1.319; Schardl CL, 2007, PHYTOCHEMISTRY, V68, P980, DOI 10.1016/j.phytochem.2007.01.010; Schardl CL, 2010, ANN MO BOT GARD, V97, P646, DOI 10.3417/2009144; SCHARDL CL, 1994, GENETICS, V136, P1307; Selosse MA, 2007, NEW PHYTOL, V173, P452, DOI 10.1111/j.1469-8137.2007.01978.x; Spatafora JW, 2007, MOL ECOL, V16, P1701, DOI 10.1111/j.1365-294X.2007.03225.x; Stewart A., 2006, P 13 AUSTR PLANT BRE, V12, P55; Sullivan TJ, 2008, MICROB ECOL, V55, P697, DOI 10.1007/s00248-007-9312-4; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Tadych M, 2012, FUNGAL DIVERS, V54, P117, DOI 10.1007/s13225-012-0170-0; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tintjer T, 2008, NEW PHYTOL, V179, P236, DOI 10.1111/j.1469-8137.2008.02441.x; TSAI HF, 1994, P NATL ACAD SCI USA, V91, P2542, DOI 10.1073/pnas.91.7.2542; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WHITE JF, 1993, AGR ECOSYST ENVIRON, V44, P13, DOI 10.1016/0167-8809(93)90037-P; Zhang X, 2010, MICROB ECOL, V59, P744, DOI 10.1007/s00248-010-9652-3; Zhang X, 2009, FEMS MICROBIOL LETT, V301, P12, DOI 10.1111/j.1574-6968.2009.01789.x	53	15	19	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0127096	10.1371/journal.pone.0127096	http://dx.doi.org/10.1371/journal.pone.0127096			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970178	Green Submitted, gold, Green Published			2022-12-26	WOS:000354544200149
J	Sanchez, A; Russell, P				Sanchez, Arancha; Russell, Paul			Ku Stabilizes Replication Forks in the Absence of Brc1	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; DNA-REPAIR; RIBOSOMAL DNA; FISSION; YEAST; PROTEIN; COMPLEX; RECOMBINATION; MAINTENANCE; ARREST	DNA replication errors are a major source of genome instability in all organisms. In the fission yeast Schizosaccharomyces pombe, the DNA damage response protein Brc1 binds phospho-histone H2A (Upsilon H2A)-marked chromatin during S-phase, but how Brc1 protects genome integrity remains unclear. Here we report that the non-homologous end-joining (NHEJ) protein Ku becomes critical for survival of replication stress in brc1 Delta cells. Ku's protective activity in brc1 Delta cells does not involve its canonical NHEJ function or its roles in protecting telomeres or shielding DNA ends from Exo1 exonuclease. In brc1 Delta pku80 Delta cells, nuclear foci of Rad52 homologous recombination (HR) protein increase and Mus81-Eme1 Holliday junction resolvase becomes critical, indicating increased replication fork instability. Ku's localization at a ribosomal DNA replication fork barrier associated with frequent replisome- transcriptosome collisions increases in brc1 Delta cells and increased collisions correlate with an enhanced requirement for Brc1. These data indicate that Ku stabilizes replication forks in the absence of Brc1.	[Sanchez, Arancha; Russell, Paul] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Russell, P (corresponding author), Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA.	prussell@scripps.edu			NIH [GM059447, CA077325, CA117638]; NATIONAL CANCER INSTITUTE [R01CA117638, R01CA077325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059447] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by NIH grants GM059447, CA077325 and CA117638 awarded to PR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen C, 2011, J MOL CELL BIOL, V3, P4, DOI 10.1093/jmcb/mjq049; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bass KL, 2012, J CELL SCI, V125, P2753, DOI 10.1242/jcs.103119; Baumann P, 2000, MOL BIOL CELL, V11, P3265, DOI 10.1091/mbc.11.10.3265; Boddy MN, 2000, MOL CELL BIOL, V20, P8758, DOI 10.1128/MCB.20.23.8758-8766.2000; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Costes A, 2013, BIOMOLECULES, V3, P39, DOI 10.3390/biom3010039; Cotta-Ramusino C, 2005, MOL CELL, V17, P153, DOI 10.1016/j.molcel.2004.11.032; Doe CL, 2002, J BIOL CHEM, V277, P32753, DOI 10.1074/jbc.M202120200; Du LL, 2003, MOL CELL BIOL, V23, P6150, DOI 10.1128/MCB.23.17.6150-6158.2003; Ferreira MG, 2004, GENE DEV, V18, P2249, DOI 10.1101/gad.315804; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; Hills SA, 2014, CURR BIOL, V24, pR435, DOI 10.1016/j.cub.2014.04.012; Kibe T, 2003, NUCLEIC ACIDS RES, V31, P5054, DOI 10.1093/nar/gkg718; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Krings G, 2004, P NATL ACAD SCI USA, V101, P14085, DOI 10.1073/pnas.0406037101; Lambert S, 2013, CHROMOSOMA, V122, P33, DOI 10.1007/s00412-013-0398-9; Langerak P, 2011, PHILOS T R SOC B, V366, P3562, DOI 10.1098/rstb.2011.0070; Langerak P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002271; Lee SY, 2013, CELL CYCLE, V12, P1665, DOI 10.4161/cc.24900; Lee SY, 2013, MOL CELL BIOL, V33, P1410, DOI 10.1128/MCB.01654-12; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; McGlynn P, 2002, NAT REV MOL CELL BIO, V3, P859, DOI 10.1038/nrm951; Meister P, 2003, NUCLEIC ACIDS RES, V31, P5064, DOI 10.1093/nar/gkg719; Mimitou EP, 2011, DNA REPAIR, V10, P344, DOI 10.1016/j.dnarep.2010.12.004; Miyoshi T, 2009, GENES CELLS, V14, P1091, DOI 10.1111/j.1365-2443.2009.01337.x; Morikawa H, 2004, MOL CELL BIOL, V24, P9401, DOI 10.1128/MCB.24.21.9401-9413.2004; Nakamura TM, 2004, MOL CELL BIOL, V24, P6215, DOI 10.1128/MCB.24.14.6215-6230.2004; Nakamura TM, 2002, GENETICS, V161, P1437; Noguchi E, 2004, MOL CELL BIOL, V24, P8342, DOI 10.1128/MCB.24.19.8342-8355.2004; Noguchi E, 2003, MOL CELL BIOL, V23, P7861, DOI 10.1128/MCB.23.21.7861-7874.2003; Pebernard S, 2006, MOL CELL BIOL, V26, P1617, DOI 10.1128/MCB.26.5.1617-1630.2006; Pebernard S, 2004, MOL BIOL CELL, V15, P4866, DOI 10.1091/mbc.E04-05-0436; Postow L, 2011, FEBS LETT, V585, P2876, DOI 10.1016/j.febslet.2011.05.046; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Roguev A, 2007, NAT METHODS, V4, P861, DOI 10.1038/NMETH1098; Roseaulin L, 2008, EMBO J, V27, P1378, DOI 10.1038/emboj.2008.65; Rozenzhak S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001032; Sanchez A, 2012, MOL CELL BIOL, V32, P4445, DOI 10.1128/MCB.01062-12; Sanchez-Gorostiaga A, 2004, MOL CELL BIOL, V24, P398, DOI 10.1128/MCB.24.1.398-406.2004; Segurado M, 2008, GENE DEV, V22, P1816, DOI 10.1101/gad.477208; Sheedy DM, 2005, GENETICS, V171, P457, DOI 10.1534/genetics.105.044966; Tsang E, 2008, DNA REPAIR, V7, P1613, DOI 10.1016/j.dnarep.2008.06.010; Ui A, 2005, DNA REPAIR, V4, P191, DOI 10.1016/j.dnarep.2004.09.002; Verkade HM, 1999, MOL BIOL CELL, V10, P2905, DOI 10.1091/mbc.10.9.2905; Wehrkamp-Richter S, 2012, NUCLEIC ACIDS RES, V40, P9633, DOI 10.1093/nar/gks713; Williams JS, 2010, EMBO J, V29, P1136, DOI 10.1038/emboj.2009.413; Yamana Y, 2005, MOL GENET GENOMICS, V273, P167, DOI 10.1007/s00438-005-1108-y; Zaratiegui M, 2011, NATURE, V479, P135, DOI 10.1038/nature10501; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897	53	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0126598	10.1371/journal.pone.0126598	http://dx.doi.org/10.1371/journal.pone.0126598			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965521	gold, Green Submitted, Green Published			2022-12-26	WOS:000354543500069
J	Sueoka, H; Ichihara, J; Tsukimura, T; Togawa, T; Sakuraba, H				Sueoka, Hideaki; Ichihara, Junji; Tsukimura, Takahiro; Togawa, Tadayasu; Sakuraba, Hitoshi			Nano-LC-MS/MS for Quantification of Lyso-Gb3 and Its Analogues Reveals a Useful Biomarker for Fabry Disease	PLOS ONE			English	Article							MUTANT ALPHA-GALACTOSIDASE; MASS-SPECTROMETRY ANALYSIS; LIQUID-CHROMATOGRAPHY; PLASMA GLOBOTRIAOSYLSPHINGOSINE; MUTATIONS; VARIANT; GLOBOTRIAOSYLCERAMIDE; GENE	Biomarkers useful for diagnosis and evaluation of treatment for patients with Fabry disease are urgently needed. Recently, plasma globotriaosylsphingosine (lyso-Gb3) and lyso-Gb3-related analogues have attracted attention as promising biomarkers of Fabry disease. However, the plasma concentrations of lyso-Gb3 and its analogues are extremely low or below the detection limits in some Fabry patients as well as in healthy subjects. In this paper, we introduce the novel application of a nano-liquid chromatography-tandem mass spectrometry (nano-LC-MS/MS) system to the measurement of lyso-Gb3 and its analogues in plasma. Nano-LC-MS/MS requires smaller amounts of samples and is more sensitive than conventional techniques. Using this method, we measured the plasma concentrations of lyso-Gb3 and its analogues in 40 healthy subjects, 5 functional variants (males with E66Q), and various Fabry patients (9 classic Fabry males/9 mutations; 7 later-onset Fabry males/5 mutations; and 10 Fabry females/9 mutations). The results revealed that the mean lyso-Gb3 and lyso-Gb3(-2) concentrations in all the Fabry patient subgroups were statistically higher, especially in the classic Fabry males, than those in the functional variants and healthy subjects. The plasma concentrations of lyso-Gb3 and its analogues in healthy subjects, functional variants, and some Fabry patients with specific mutations (R112H and M296I) that cannot be established by conventional techniques were successfully determined by means of nano-LC-MS/MS. The lyso-Gb3 and lyso-Gb3(-2) concentrations in male patients with these mutations were lower than those in most Fabry patients having other mutations, but higher than those in the functional variants and healthy subjects. This new method is expected to be useful for sensitive determination of the plasma concentrations of lyso-Gb3 and its analogues. This study also revealed that not only lyso-Gb3 but also lyso-Gb3(-2) in plasma is a useful biomarker for the diagnosis of Fabry disease.	[Sueoka, Hideaki] Sumitomo Dainippon Pharma Co Ltd, Genom Sci Labs, Konohana ku, Osaka 5540022, Japan; [Ichihara, Junji] Sumitomo Dainippon Pharma Co Ltd, Drug Dev Res Labs, Suita, Osaka 5640053, Japan; [Tsukimura, Takahiro; Togawa, Tadayasu] Meiji Pharmaceut Univ, Dept Funct Bioanal, Kiyose, Tokyo 2048588, Japan; [Sakuraba, Hitoshi] Meiji Pharmaceut Univ, Dept Clin Genet, Kiyose, Tokyo 2048588, Japan	Dainippon Sumitomo Pharmaceutical Company; Dainippon Sumitomo Pharmaceutical Company; Meiji Pharmaceutical University; Meiji Pharmaceutical University	Sakuraba, H (corresponding author), Meiji Pharmaceut Univ, Dept Clin Genet, 2-522-1 Noshio, Kiyose, Tokyo 2048588, Japan.	sakuraba@my-pharm.ac.jp			Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation [09-15]; Program for Research on Intractable Diseases of Health and Labor Science Research; Sumitomo Dainippon Pharma Co., Ltd.	Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Program for Research on Intractable Diseases of Health and Labor Science Research; Sumitomo Dainippon Pharma Co., Ltd.	This work was supported by the Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (ID: 09-15, H. Sakuraba), and the Program for Research on Intractable Diseases of Health and Labor Science Research (H. Sakuraba) and Sumitomo Dainippon Pharma Co., Ltd. provided support in the form of salaries for two authors (H. Sueoka and J. Ichihara), but did not play any additional role in the study design, data collection or analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are given in the 'author contributions' section.	Aerts JM, 2008, P NATL ACAD SCI USA, V105, P2812, DOI 10.1073/pnas.0712309105; Auray-Blais C, 2012, ANAL CHEM, V84, P2745, DOI 10.1021/ac203433e; Boutin M, 2014, ANAL CHEM, V86, P3476, DOI 10.1021/ac404000d; Boutin M, 2012, CLIN CHIM ACTA, V414, P273, DOI 10.1016/j.cca.2012.09.026; Desnick RJ, 2001, METABOLIC MOL BASES, V8, P3733; Dupont FO, 2013, CURR MED CHEM, V20, P280, DOI 10.2174/092986713804806685; ENG CM, 1994, HUM MOL GENET, V3, P1795, DOI 10.1093/hmg/3.10.1795; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; Fedorova G, 2013, RAPID COMMUN MASS SP, V27, P1751, DOI 10.1002/rcm.6628; Gold H, 2013, CLIN CHEM, V59, P547, DOI 10.1373/clinchem.2012.192138; Gold H, 2011, EUR J ORG CHEM, V2011, P1652, DOI 10.1002/ejoc.201001690; Ishihama Y, 2005, J CHROMATOGR A, V1067, P73, DOI 10.1016/j.chroma.2004.10.107; KARLSSON KE, 1988, ANAL CHEM, V60, P1662, DOI 10.1021/ac00168a006; Karu K, 2011, CHEM PHYS LIPIDS, V164, P411, DOI 10.1016/j.chemphyslip.2011.04.011; Kruger R, 2012, J CHROMATOGR B, V883, P128, DOI 10.1016/j.jchromb.2011.11.020; Lavoie P, 2013, ANAL CHEM, V85, P1743, DOI 10.1021/ac303033v; Lee BH, 2010, J HUM GENET, V55, P512, DOI 10.1038/jhg.2010.58; Lukas J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003632; MacDermot KD, 2001, J MED GENET, V38, P769, DOI 10.1136/jmg.38.11.769; Mitobe S, 2012, MOL GENET METAB, V107, P623, DOI 10.1016/j.ymgme.2012.07.003; NAKAO S, 1995, NEW ENGL J MED, V333, P288, DOI 10.1056/NEJM199508033330504; Nance CS, 2006, ARCH NEUROL-CHICAGO, V63, P453, DOI 10.1001/archneur.63.3.453; Niemann M, 2014, CIRC-CARDIOVASC GENE, V7, P8, DOI 10.1161/CIRCGENETICS.113.000249; Rombach SM, 2010, BBA-MOL BASIS DIS, V1802, P741, DOI 10.1016/j.bbadis.2010.05.003; Schiffmann R, 2000, P NATL ACAD SCI USA, V97, P365, DOI 10.1073/pnas.97.1.365; Thomas D, 2013, TALANTA, V116, P912, DOI 10.1016/j.talanta.2013.07.057; Togawa T, 2012, MOL GENET METAB, V105, P615, DOI 10.1016/j.ymgme.2012.01.010; Togawa T, 2010, MOL GENET METAB, V100, P257, DOI 10.1016/j.ymgme.2010.03.020; Tsukimura T, 2014, MOLEC GENET METAB RE, V1, P288, DOI 10.1016/j.ymgmr.2014.07.005; van Breemen MJ, 2011, BBA-MOL BASIS DIS, V1812, P70, DOI 10.1016/j.bbadis.2010.09.007; Young E, 2005, ACTA PAEDIATR, V94, P51, DOI 10.1080/08035320510028111	31	28	28	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0127048	10.1371/journal.pone.0127048	http://dx.doi.org/10.1371/journal.pone.0127048			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965380	Green Submitted, gold, Green Published			2022-12-26	WOS:000354543500091
J	Yang, M; Yang, YR; Li, HJ; Lu, XS; Shi, YM; Liu, B; Chen, HJ; Teng, GJ; Chen, R; Herskovits, EH				Yang, Ming; Yang, Ya-ru; Li, Hui-jun; Lu, Xue-song; Shi, Yong-mei; Liu, Bin; Chen, Hua-jun; Teng, Gao-jun; Chen, Rong; Herskovits, Edward H.			Combining Diffusion Tensor Imaging and Gray Matter Volumetry to Investigate Motor Functioning in Chronic Stroke	PLOS ONE			English	Article							CHRONIC HEMIPARESIS; CAUDATE-NUCLEUS; BASAL GANGLIA; BRAIN; RECOVERY; INTEGRITY; REORGANIZATION; IMMOBILIZATION; IMPROVEMENT; DIASCHISIS	Motor impairment after stroke is related to the integrity of the corticospinal tract (CST). However, considerable variability in motor impairment remains unexplained. To increase the accuracy in evaluating long-term motor function after ischemic stroke, we tested the hypothesis that combining diffusion tensor imaging (DTI) and gray matter (GM) volumetry can better characterize long-term motor deficit than either method alone in patients with chronic stroke. We recruited 31 patients whose Medical Research Council strength grade was <= 3/5 in the extensor muscles of the affected upper extremity in the acute phase. We used the Upper Extremity Fugl-Meyer (UE-FM) assessment to evaluate motor impairment, and as the primary outcome variable. We computed the fractional anisotropy ratio of the entire CST (CSTratio) and the volume of interest ratio (VOIratio), between ipsilesional and contralesional hemispheres, to explain long-term motor impairment. The results showed that CSTratio, VOIratio of motor-related brain regions, and VOIratio in the temporal lobe were correlated with UE-FM. A multiple regression model including CSTratio and VOIratio of the caudate nucleus explained 40.7% of the variability in UE-FM. The adjusted R2 of the regression model with CSTratio as an independent variable was 29.4%, and that of using VOIratio of the caudate nucleus as an independent variable was 23.1%. These results suggest that combining DTI and GM volumetry may achieve better explanation of long-term motor deficit in stroke patients, than using either measure individually. This finding may provide guidance in determining optimal neurorehabilitative interventions.	[Yang, Ming; Yang, Ya-ru; Li, Hui-jun; Liu, Bin; Chen, Hua-jun; Teng, Gao-jun] Southeast Univ, Zhong Da Hosp, Dept Radiol, Nanjing 210009, Jiangsu, Peoples R China; [Lu, Xue-song] Southeast Univ, Zhong Da Hosp, Dept Rehabil, Nanjing 210009, Jiangsu, Peoples R China; [Shi, Yong-mei] Southeast Univ, Zhong Da Hosp, Dept Neurol, Nanjing 210009, Jiangsu, Peoples R China; [Chen, Rong; Herskovits, Edward H.] Univ Maryland, Sch Med, Dept Radiol, Baltimore, MD 21201 USA	Southeast University - China; Southeast University - China; Southeast University - China; University System of Maryland; University of Maryland Baltimore	Teng, GJ (corresponding author), Southeast Univ, Zhong Da Hosp, Dept Radiol, Nanjing 210009, Jiangsu, Peoples R China.	gjteng@vip.sina.com; ehh@ieee.org			National Key Basic Research Program of China (973 Program) [2013CB733800, 2013CB733803]; Jiangsu Provincial Special Program of Medical Science [BL2013029]; National Science Foundation of China [30970808]; Excellent Teacher Project of Jiangsu Provincial Department of Education	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); Jiangsu Provincial Special Program of Medical Science; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Excellent Teacher Project of Jiangsu Provincial Department of Education	The study was supported by National Key Basic Research Program of China (973 Program, No. 2013CB733800, 2013CB733803), Excellent Teacher Project of Jiangsu Provincial Department of Education, Jiangsu Provincial Special Program of Medical Science (BL2013029) and partly supported by the National Science Foundation of China (Grant No. 30970808). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Chakravarthy VS, 2010, BIOL CYBERN, V103, P237, DOI 10.1007/s00422-010-0401-y; Chen R, 2008, NEUROIMAGE, V40, P1633, DOI 10.1016/j.neuroimage.2008.01.014; Chen R, 2010, NEUROIMAGE, V49, P597, DOI 10.1016/j.neuroimage.2009.07.061; Chu WJ, 2002, STROKE, V33, P1243, DOI 10.1161/01.STR.0000015240.75199.BE; Cirstea CM, 2011, STROKE, V42, P1004, DOI 10.1161/STROKEAHA.110.601047; Cramer SC, 2011, BRAIN, V134, P1591, DOI 10.1093/brain/awr039; Dang C, 2013, STROKE, V44, P2795, DOI 10.1161/STROKEAHA.113.000971; Fan FM, 2013, HUM BRAIN MAPP, V34, P1872, DOI 10.1002/hbm.22034; Galderisi S, 2008, SCHIZOPHRENIA BULL, V34, P393, DOI 10.1093/schbul/sbm097; Gauthier LV, 2008, STROKE, V39, P1520, DOI 10.1161/STROKEAHA.107.502229; Gauthier LV, 2012, STROKE, V43, P453, DOI 10.1161/STROKEAHA.111.633255; Gladstone DJ, 2002, NEUROREHAB NEURAL RE, V16, P232, DOI 10.1177/154596802401105171; Grahn JA, 2009, BEHAV BRAIN RES, V199, P53, DOI 10.1016/j.bbr.2008.11.020; Grahn JA, 2008, PROG NEUROBIOL, V86, P141, DOI 10.1016/j.pneurobio.2008.09.004; Groenewegen Henk J., 2003, Neural Plasticity, V10, P107, DOI 10.1155/NP.2003.107; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Jiji S, 2013, EUR J RADIOL, V82, P1525, DOI 10.1016/j.ejrad.2013.03.012; Kou N, 2013, NEUROLOGY, V80, P2242, DOI 10.1212/WNL.0b013e318296e977; Langer N, 2012, NEUROLOGY, V78, P182, DOI 10.1212/WNL.0b013e31823fcd9c; Lindenberg R, 2010, NEUROLOGY, V74, P280, DOI 10.1212/WNL.0b013e3181ccc6d9; Lindenberg R, 2012, HUM BRAIN MAPP, V33, P1040, DOI 10.1002/hbm.21266; MURPHY DGM, 1992, ARCH NEUROL-CHICAGO, V49, P839, DOI 10.1001/archneur.1992.00530320063013; Onnink AM, 2013, EUR NEUROPSYCHOPHARM; Park CH, 2013, NEUROIMAGE-CLIN, V2, P521, DOI 10.1016/j.nicl.2013.04.002; Pennisi G, 2002, CLIN NEUROPHYSIOL, V113, P1536, DOI 10.1016/S1388-2457(02)00255-9; Puig J, 2013, STROKE, V44, P2016, DOI 10.1161/STROKEAHA.111.000382; Rebec GV, 2006, NEUROPSYCHOPHARMACOL, V31, P2341, DOI 10.1038/sj.npp.1301160; Rehme AK, 2013, J PHYSIOL-LONDON, V591, P17, DOI 10.1113/jphysiol.2012.243469; Schaechter JD, 2009, HUM BRAIN MAPP, V30, P3461, DOI 10.1002/hbm.20770; Schulz R, 2012, STROKE, V43, P2248, DOI 10.1161/STROKEAHA.112.662619; Seidman LJ, 2011, BIOL PSYCHIAT, V69, P857, DOI 10.1016/j.biopsych.2010.09.053; Seitz RJ, 1999, STROKE, V30, P1844, DOI 10.1161/01.STR.30.9.1844; Sterr A, 2003, NEUROLOGY, V61, P842, DOI 10.1212/WNL.61.6.842; Sterr A, 2014, NEUROREHAB NEURAL RE, V28, P335, DOI 10.1177/1545968313510972; Sterr A, 2013, NEUROIMAGE-CLIN, V2, P797, DOI 10.1016/j.nicl.2013.05.005; Stinear C, 2010, LANCET NEUROL, V9, P1228, DOI 10.1016/S1474-4422(10)70247-7; Swayne OBC, 2008, CEREB CORTEX, V18, P1909, DOI 10.1093/cercor/bhm218; Sztriha LK, 2012, STROKE, V43, P3124, DOI 10.1161/STROKEAHA.111.649244; Tessa C, 2014, HUM BRAIN MAPP; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Vliet P, 2012, INT J STROKE, V7, P480, DOI 10.1111/j.1747-4949.2012.00867.x; Ward N, 2011, J PHYSIOL-LONDON, V589, P5625, DOI 10.1113/jphysiol.2011.220939; Ward NS, 2006, J PHYSIOL-PARIS, V99, P425, DOI 10.1016/j.jphysparis.2006.03.002; World Health Organization, 2004, THE GLOBAL BURDEN OF; Yang M, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/370849	46	9	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0125038	10.1371/journal.pone.0125038	http://dx.doi.org/10.1371/journal.pone.0125038			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965398	Green Submitted, Green Published, gold			2022-12-26	WOS:000354543500008
J	Li, WJ; Zhang, CJ; Ren, A; Li, TN; Jin, R; Li, GH; Gu, X; Shi, RH; Zhao, YF				Li, Wenjuan; Zhang, Chunjing; Ren, Amy; Li, Teena; Jin, Rong; Li, Guohong; Gu, Xin; Shi, Runhua; Zhao, Yunfeng			Shikonin Suppresses Skin Carcinogenesis via Inhibiting Cell Proliferation	PLOS ONE			English	Article							ACTIVATING TRANSCRIPTION FACTOR-2; CANCER DRUG-RESISTANCE; INDUCED APOPTOSIS; TUMOR-GROWTH; INDUCTION; MECHANISM; MODEL; OVEREXPRESSION; ANGIOGENESIS; PROGRESSION	The M2 isoform of pyruvate kinase M2 (PKM2) has been shown to be up-regulated in human skin cancers. To test whether PKM2 may be a target for chemoprevention, shikonin, a natural product from the root of Lithospermum erythrorhizon and a specific inhibitor of PKM2, was used in a chemically-induced mouse skin carcinogenesis study. The results revealed that shikonin treatment suppressed skin tumor formation. Morphological examinations and immunohistochemical staining of the skin epidermal tissues suggested that shikonin inhibited cell proliferation without inducing apoptosis. Although shikonin alone suppressed PKM2 activity, it did not suppress tumor promoter-induced PKM2 activation in the skin epidermal tissues at the end of the skin carcinogenesis study. To reveal the potential chemopreventive mechanism of shikonin, an antibody microarray analysis was performed, and the results showed that the transcription factor ATF2 and its downstream target Cdk4 were up-regulated by chemical carcinogen treatment; whereas these up-regulations were suppressed by shikonin. In a promotable skin cell model, the nuclear levels of ATF2 were increased during tumor promotion, whereas this increase was inhibited by shikonin. Furthermore, knockdown of ATF2 decreased the expression levels of Cdk4 and Fra-1 (a key subunit of the activator protein 1. In summary, these results suggest that shikonin, rather than inhibiting PKM2 in vivo, suppresses the ATF2 pathway in skin carcinogenesis.	[Li, Wenjuan; Zhang, Chunjing; Ren, Amy; Li, Teena; Zhao, Yunfeng] LSU, Hlth Sci Ctr Shreveport, Dept Pharmacol Toxicol & Neurosci, Shreveport, LA 71115 USA; [Jin, Rong; Li, Guohong] LSU, Hlth Sci Ctr Shreveport, Dept Neurosurg, Shreveport, LA USA; [Gu, Xin] LSU, Hlth Sci Ctr Shreveport, Dept Pathol, Shreveport, LA USA; [Shi, Runhua] LSU, Hlth Sci Ctr Shreveport, Feist Weiller Canc Ctr, Shreveport, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Zhao, YF (corresponding author), LSU, Hlth Sci Ctr Shreveport, Dept Pharmacol Toxicol & Neurosci, Shreveport, LA 71115 USA.	yzhao1@lsuhsc.edu			NIH [1R03CA167689]; NATIONAL CANCER INSTITUTE [R03CA167689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS088719] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by NIH Grant Number 1R03CA167689.	Bhoumik A, 2008, CELL CYCLE, V7, P2341, DOI 10.4161/cc.6388; Bhoumik A, 2008, P NATL ACAD SCI USA, V105, P1674, DOI 10.1073/pnas.0706057105; Chen CH, 2003, PLANTA MED, V69, P1119, DOI 10.1055/s-2003-45193; Chen J, 2011, ONCOGENE, V30, P4297, DOI 10.1038/onc.2011.137; Clower CV, 2010, P NATL ACAD SCI USA, V107, P1894, DOI 10.1073/pnas.0914845107; de Marval PLM, 2004, MOL CELL BIOL, V24, P7538, DOI 10.1128/MCB.24.17.7538-7547.2004; Gaddipati JP, 2000, ANTICANCER RES, V20, P2547; Gao H, 2011, BIOL PHARM BULL, V34, P197, DOI 10.1248/bpb.34.197; Han WD, 2007, MOL CANCER THER, V6, P1641, DOI 10.1158/1535-7163.MCT-06-0511; Hsu PC, 2004, J AGR FOOD CHEM, V52, P6330, DOI 10.1021/jf0495993; Hu X, 2008, CANCER LETT, V259, P127, DOI 10.1016/j.canlet.2007.11.007; Iqbal MA, 2014, FEBS LETT, V588, P2685, DOI 10.1016/j.febslet.2014.04.011; Komi Y, 2009, CANCER SCI, V100, P269, DOI 10.1111/j.1349-7006.2008.01049.x; Lee HJ, 2008, YAKUGAKU ZASSHI, V128, P1681, DOI 10.1248/yakushi.128.1681; Li WJ, 2014, MOL CARCINOGEN, V53, P403, DOI 10.1002/mc.21988; Lim ES, 2007, ANN NY ACAD SCI, V1095, P7, DOI 10.1196/annals.1397.002; Lu L, 2011, EUR J PHARMACOL, V658, P242, DOI 10.1016/j.ejphar.2011.02.043; Papassava P, 2004, CANCER RES, V64, P8573, DOI 10.1158/0008-5472.CAN-03-0955; Pignatelli J, 2012, J BIOL CHEM, V287, P37309, DOI 10.1074/jbc.M112.385229; Robbins D., 2011, J SIGNAL TRANSDUCT, V2012, DOI 10.1155/2012/101465; Subbaramaiah K, 2001, J BIOMOL SCREEN, V6, P101; Wittwer JA, 2011, CANCER PREV RES, V4, P1476, DOI 10.1158/1940-6207.CAPR-11-0028; Woenckhaus C, 2003, J PATHOL, V201, P278, DOI 10.1002/path.1424; Wu Z, 2004, J PHARMACOL SCI, V94, P166, DOI 10.1254/jphs.94.166; Yeh CC, 2007, IN VIVO, V21, P1011; Yoon Y, 1999, PLANTA MED, V65, P532, DOI 10.1055/s-1999-14010; YOSHIMI N, 1992, JPN J CANCER RES, V83, P1273, DOI 10.1111/j.1349-7006.1992.tb02758.x; Zhao YF, 2001, CANCER RES, V61, P6082; Zhao YF, 2005, CANCER RES, V65, P1401, DOI 10.1158/0008-5472.CAN-04-3334; Zhao YF, 2002, ONCOGENE, V21, P3836, DOI 10.1038/sj.onc.1205477; Zoumpourlis V, 2000, ONCOGENE, V19, P4011, DOI 10.1038/sj.onc.1203732	31	19	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126459	10.1371/journal.pone.0126459	http://dx.doi.org/10.1371/journal.pone.0126459			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961580	Green Published, gold, Green Submitted			2022-12-26	WOS:000354542500102
J	Lipowska, M; Lipowski, M				Lipowska, Malgorzata; Lipowski, Mariusz			Narcissism as a Moderator of Satisfaction with Body Image in Young Women with Extreme Underweight and Obesity	PLOS ONE			English	Article							SELF-ESTEEM; EATING ATTITUDES; COLLEGE-WOMEN; WEIGHT; DISSATISFACTION; IDEAL; PERCEPTION; GENDER; MEDIA; SIZE	Objective Body weight and age constitute main determinants of body image in women. We analyzed the role of narcissism as a moderator of body image in young women representing various extremes of body weight. Methods The study included 325 women between 18 and 35 years, qualified into three BMI categories: obese women (BMI > 30.0, n = 72), severely underweight women who did not satisfy the remaining criteria of anorexia (BMI < 17.5, n = 85), and women with normal body weight (21.7 < "ideal BMI" > 22.7, n = 168). Satisfaction with body image was determined with Multidimensional Body-Self Relations Questionnaire and Body Esteem Scale, while narcissism was measured with Narcissistic Personality Inventory. Principal Findings We revealed that narcissism has significant impact on the body image of women who are extremely underweight or obese. Vanity and Leadership were narcissism dimensions which played significant role in slim women, as compared to Vanity and Self-Sufficiency in obese women. Conclusion The role of narcissism as a modulator of self-satisfaction with one's body varies depending on BMI level: extremely underweight women and obese individuals constitute groups in which narcissism has the strongest impact on the self-satisfaction with body.	[Lipowska, Malgorzata] Univ Gdansk, Inst Psychol, PL-80952 Gdansk, Poland; [Lipowski, Mariusz] Gdansk Univ Phys Educ & Sport, Dept Hlth Psychol, Gdansk, Poland	Fahrenheit Universities; University of Gdansk; Gdansk University of Physical Education & Sport	Lipowska, M (corresponding author), Univ Gdansk, Inst Psychol, PL-80952 Gdansk, Poland.	malgorzata.lipowska@ug.edu.pl	Lipowska, Małgorzata/R-5954-2019; Lipowski, Mariusz/AAJ-1239-2020; Lipowski, Mariusz/AAN-3033-2020	Lipowska, Małgorzata/0000-0002-7422-159X; Lipowski, Mariusz/0000-0002-8389-7006	Institute of Psychology, University of Gdansk; Gdansk University of Physical Education and Sport	Institute of Psychology, University of Gdansk; Gdansk University of Physical Education and Sport	The work was supported from statutory funds of the Institute of Psychology, University of Gdansk and the Gdansk University of Physical Education and Sport.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Annis Natasha Milkewicz, 2004, Body Image, V1, P155, DOI 10.1016/j.bodyim.2003.12.001; Anschutz DJ, 2008, HEALTH PSYCHOL, V27, P401, DOI 10.1037/0278-6133.27.4.401; Bakhshi S, 2011, EUR J PSYCHOL, V7, P374; Bazinska R, 2000, WOMENS STUDIES J, V6, P171; Bazinska R., 2000, CZASOPISMO PSYCHOL, V6, P171; Brown RP, 2009, PERS SOC PSYCHOL B, V35, P951, DOI 10.1177/0146167209335461; Brownell CA, 2007, CHILD DEV, V78, P1426, DOI 10.1111/j.1467-8624.2007.01075.x; Brytek-Matera A, 2010, PSYCHIATR POL, V44, P267; Bucchianeri MM, 2013, BODY IMAGE, V10, P1, DOI 10.1016/j.bodyim.2012.09.001; Burgess Jacqulyn N, 2012, Pediatr Nurs, V38, P147; Burgess JN, 2012, PEDIAT NURS, V38, P176; Camoes-Costa V, 2011, BRIT J DEV PSYCHOL, V29, P552, DOI 10.1348/026151010X523040; Cash T.F., 2000, MULTIDIMENSIONAL BOD; Cash T.F., 2011, BODY IMAGE HDB SCI P, P3; Cash TF, 2004, J CONSULT CLIN PSYCH, V72, P1081, DOI 10.1037/0022-006X.72.6.1081; Cella S, 2013, EAT WEIGHT DISORD-ST, V18, P115, DOI 10.1007/s40519-013-0017-z; Central Statistical Office, 2011, STAT YB REP POL; Coy AE, 2014, BODY IMAGE, V11, P282, DOI 10.1016/j.bodyim.2014.04.003; Dalle Grave R, 2008, INT J EAT DISORDER, V41, P705, DOI 10.1002/eat.20555; Dalley SE, 2013, PERS INDIV DIFFER, V55, P465, DOI 10.1016/j.paid.2013.04.006; Davis C, 1997, PERS INDIV DIFFER, V22, P309, DOI 10.1016/S0191-8869(96)00210-3; EMMONS RA, 1987, J PERS SOC PSYCHOL, V52, P11, DOI 10.1037/0022-3514.52.1.11; Fardouly J, 2015, BODY IMAGE, V13, P38, DOI 10.1016/j.bodyim.2014.12.002; Fayet F, 2012, INT J WOMENS HEALTH, V4, P405, DOI 10.2147/IJWH.S33920; Ferraro FR, 2008, J GEN PSYCHOL, V135, P379, DOI 10.3200/GENP.135.4.379-392; FRANZOI SL, 1984, J PERS ASSESS, V48, P173, DOI 10.1207/s15327752jpa4802_12; Franzoi SL., 1995, SEX ROLES, V56, P13; Franzoi SL, 2012, PSYCHOL WOMEN QUART, V36, P99, DOI 10.1177/0361684311427028; Fryar CD, 2012, PREVELANCE UNDERGRAD; Gillen MM, 2015, BODY IMAGE, V13, P67, DOI 10.1016/j.bodyim.2015.01.002; Gumble A, 2012, BODY IMAGE, V9, P101, DOI 10.1016/j.bodyim.2011.07.005; Hayes S, 2010, BRIT J DEV PSYCHOL, V28, P413, DOI 10.1348/026151009X424240; Hrabosky JI, 2009, BODY IMAGE, V6, P155, DOI 10.1016/j.bodyim.2009.03.001; Izydorczyk B, 2011, PSYCHIATR POL, V45, P653; JACKSON LA, 1992, J RES PERS, V26, P357, DOI 10.1016/0092-6566(92)90065-C; Kapka-Skrzypczak L, 2012, ANN AGR ENV MED, V19, P299; Karr TM, 2013, BODY IMAGE, V10, P70, DOI 10.1016/j.bodyim.2012.09.004; Kazmierczak M, 2011, J REPROD INFANT PSYC, V29, P334, DOI 10.1080/02646838.2011.631179; Kochan-Wojcik M., 2010, PSYCHOL ROZW, V15, P21; Korn L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058543; Krahe B, 2010, PSYCHOL WOMEN QUART, V34, P349, DOI 10.1111/j.1471-6402.2010.01580.x; Lemon SC, 2009, BODY IMAGE, V6, P90, DOI 10.1016/j.bodyim.2008.11.004; Lipowska M, 2006, WOMAN CULTURE CULTUR, P385; Lipowska M, 2013, HEALTH PSYCHOL REP, V1, P72, DOI 10.5114/hpr.2013.40471; Lipowski M, 2009, MED SCI MONITOR, V15, pCR423; Loth KA, 2011, J PEDIATR PSYCHOL, V36, P216, DOI 10.1093/jpepsy/jsq026; Macik D, 2015, HEALTH PSYCHOL REP, V3, P24, DOI 10.5114/hpr.2015.47087; Marium J, 2014, J BEHAV SCI, V24, P29; McLaren L, 2003, HEALTH PSYCHOL, V22, P370, DOI 10.1037/0278-6133.22.4.370; Mills JS, 2012, BODY IMAGE, V9, P365, DOI 10.1016/j.bodyim.2012.03.004; Mitchell SH, 2012, BODY IMAGE, V9, P431, DOI 10.1016/j.bodyim.2012.07.001; Morey LC, 2012, J CLIN PSYCHOL, V68, P908, DOI 10.1002/jclp.21895; Morf CC, 2001, PSYCHOL INQ, V12, P177, DOI 10.1207/S15327965PLI1204_1; Murray T, 2014, PSYCHOL MEN MASCULIN, V15, P40, DOI 10.1037/a0030959; Nevicka B, 2011, LEADERSHIP QUART, V22, P910, DOI 10.1016/j.leaqua.2011.07.011; Nicholls E, 2011, J SOC PSYCHOL, V151, P201, DOI 10.1080/00224540903510852; Noser A, 2014, BODY IMAGE, V11, P119, DOI 10.1016/j.bodyim.2013.11.006; Oehlhof MEW, 2009, BODY IMAGE, V6, P308, DOI 10.1016/j.bodyim.2009.05.002; Ogden Cynthia L, 2012, NCHS Data Brief, P1; Parzuchowska M, 2006, PSYCHOLOGIA ROZWOJOW, V11, P113; Pastwa-Wojciechowska B, 2005, DIAGN STAT MAN MENT, P458; Paulk A, 2014, SOCIOL SPECTRUM, V34, P442, DOI 10.1080/02732173.2014.937653; Pincus AL, 2010, ANNU REV CLIN PSYCHO, V6, P421, DOI 10.1146/annurev.clinpsy.121208.131215; Pokrajac-Bulian A, 2005, EUR EAT DISORD REV, V13, P54, DOI 10.1002/erv.606; Pontiroli AE, 2007, OBES SURG, V17, P1492, DOI 10.1007/s11695-008-9428-8; Pruis TA, 2010, J GEN PSYCHOL, V137, P225, DOI 10.1080/00221309.2010.484446; Radziwillowicz W, 2014, HEALTH PSYCHOL REP, V2, P132, DOI 10.5114/hpr.2014.43920; RASKIN R, 1988, J PERS SOC PSYCHOL, V54, P890, DOI 10.1037/0022-3514.54.5.890; RASKIN R, 1981, J PERS ASSESS, V45, P159, DOI 10.1207/s15327752jpa4502_10; Roberts A, 2010, EAT BEHAV, V11, P211, DOI 10.1016/j.eatbeh.2010.04.002; Robles DS, 2009, INT J RES REV, V2, P16; Roche MJ, 2013, J PERS ASSESS, V95, P237, DOI 10.1080/00223891.2013.770400; RUCKER CE, 1992, INT J EAT DISORDER, V12, P291, DOI 10.1002/1098-108X(199211)12:3&lt;291::AID-EAT2260120309&gt;3.0.CO;2-A; Rudd NA, 2015, INT J FASHION DESIGN, V8, P1; Schwartz Marlene B, 2004, Body Image, V1, P43, DOI 10.1016/S1740-1445(03)00007-X; Sezgin B, 2012, AESTHET SURG J, V32, P421, DOI 10.1177/1090820X12442083; Skorek M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112086; Slater A, 2014, EAT BEHAV, V15, P679, DOI 10.1016/j.eatbeh.2014.10.002; Slay HA, 1998, INT J EAT DISORDER, V23, P267, DOI 10.1002/(SICI)1098-108X(199804)23:3<267::AID-EAT4>3.0.CO;2-H; Slevec J, 2010, PSYCHOL WOMEN QUART, V34, P65, DOI 10.1111/j.1471-6402.2009.01542.x; Sorokowski P, 2010, PERCEPTION, V39, P1427, DOI 10.1068/p6621; Standley R, 2009, BODY IMAGE, V6, P56, DOI 10.1016/j.bodyim.2008.08.004; Swami V, 2013, SCAND J PSYCHOL, V54, P146, DOI 10.1111/sjop.12014; Thomaes S, 2010, CHILD DEV, V81, P811, DOI 10.1111/j.1467-8624.2010.01435.x; Tiggemann Marika, 2004, Body Image, V1, P29, DOI 10.1016/S1740-1445(03)00002-0; Tiggemann M, 2013, BODY IMAGE, V10, P624, DOI 10.1016/j.bodyim.2013.07.003; Tod D, 2013, BODY IMAGE, V10, P135, DOI 10.1016/j.bodyim.2012.08.010; Waller Glenn, 2008, Eat Behav, V9, P163, DOI 10.1016/j.eatbeh.2007.07.004; Waller G, 2007, INT J EAT DISORDER, V40, P143, DOI 10.1002/eat.20345; Watson P. J., 2005, IMAGINATION COGNITIO, V25, P253, DOI [DOI 10.2190/40AU-00RD-CV7Q-VBPB, 10.2190/40AU-00RD-CV7Q-VBPB]; World Health Organization, 2012, EHO GLOB SAT BOD MAS; Zeigler-Hill V, 2015, PSYCHOL WOMEN QUART, V39, P109, DOI 10.1177/0361684313515841; Zemojtel-Piotrowska M, 2014, CURR ISS PERSONAL PS, V2, P10, DOI 10.5114/CIPP.2014.43097; Ziebland S, 2002, INT J OBESITY, V26, P1083, DOI 10.1038/sj.ijo.0802049; Zuckerman M, 2009, EUR J SOC PSYCHOL, V39, P957, DOI 10.1002/ejsp.594	97	30	30	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126724	10.1371/journal.pone.0126724	http://dx.doi.org/10.1371/journal.pone.0126724			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI1YY	25961302	Green Published, Green Submitted, gold			2022-12-26	WOS:000354542500143
J	Roggeveen, S; van Os, J; Lousberg, R				Roggeveen, Suzanne; van Os, Jim; Lousberg, Richel			Does the Brain Detect 3G Mobile Phone Radiation Peaks? An Explorative In-Depth Analysis of an Experimental Study	PLOS ONE			English	Article							ELECTROMAGNETIC-FIELDS; HUMAN SLEEP; EXPOSURE	This study aimed to investigate whether third generation mobile phone radiation peaks result in event related potentials. Thirty-one healthy females participated. In this single-blind, cross-over design, a 15 minute mobile phone exposure was compared to two 15 minute sham phone conditions, one preceding and one following the exposure condition. Each participant was measured on two separate days, where mobile phone placement was varied between the ear and heart. EEG activity and radiofrequency radiation were recorded jointly. Epochs of 1200ms, starting 200ms before and lasting until 1000ms after the onset of a radiation peak, were extracted from the exposure condition. Control epochs were randomly selected from the two sham phone conditions. The main a-priori hypothesis to be tested concerned an increase of the area in the 240-500ms post-stimulus interval, in the exposure session with ear-placement. Using multilevel regression analyses the placement* exposure interaction effect was significant for the frontal and central cortical regions, indicating that only in the mobile phone exposure with ear-placement an enlarged cortical reactivity was found. Post-hoc analyses based on visual inspection of the ERPs showed a second significantly increased area between 500-1000ms post-stimulus for almost every EEG location measured. It was concluded that, when a dialing mobile phone is placed on the ear, its radiation, although unconsciously, is electrically detected by the brain. The question of whether or not this cortical reactivity results in a negative health outcome has to be answered in future longitudinal experiments.	[Roggeveen, Suzanne; van Os, Jim; Lousberg, Richel] Maastricht Univ, Dept Psychiat & Psychol, NL-6200 MD Maastricht, Limburg, Netherlands; [van Os, Jim] Kings Coll London, Inst Psychiat, Kings Hlth Partners, Dept Psychosis Studies, London, England	Maastricht University; University of London; King's College London	Roggeveen, S (corresponding author), Maastricht Univ, Dept Psychiat & Psychol, NL-6200 MD Maastricht, Limburg, Netherlands.	s.roggeveen@maastrichtuniversity.nl	Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; van Os, Jim/V-8884-2019; van Os, Jim/C-2113-2014	van Os, Jim/0000-0002-7245-1586; 				Adair ER, 2003, BIOELECTROMAGNETICS, pS17, DOI 10.1002/bem.10133; Ahlbom A, 1998, HEALTH PHYS, V74, P494; [Anonymous], TEN20 COND NEUR EL P; Borbely AA, 1999, NEUROSCI LETT, V275, P207, DOI 10.1016/S0304-3940(99)00770-3; Carrubba S, 2007, NEUROSCIENCE, V144, P356, DOI 10.1016/j.neuroscience.2006.08.068; Carrubba S, 2010, NEUROSCI LETT, V469, P164, DOI 10.1016/j.neulet.2009.11.068; Croft RJ, 2008, BIOELECTROMAGNETICS, V29, P1, DOI 10.1002/bem.20352; Croft RJ, 2010, BIOELECTROMAGNETICS, V31, P434, DOI 10.1002/bem.20583; Desai NR, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-114; Ferreri F, 2006, ANN NEUROL, V60, P188, DOI 10.1002/ana.20906; Gaestel M, 2010, BIOL REV, V85, P489, DOI 10.1111/j.1469-185X.2009.00112.x; Gultekin DH, 2013, P NATL ACAD SCI USA, V110, P58, DOI 10.1073/pnas.1205598109; Kesari KK, 2013, CELL BIOCHEM BIOPHYS, V65, P85, DOI 10.1007/s12013-012-9414-6; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kwon MS, 2011, BIOELECTROMAGNETICS, V32, P253, DOI 10.1002/bem.20635; Loughran SP, 2012, BIOELECTROMAGNETICS, V33, P86, DOI 10.1002/bem.20691; Lowden A, 2011, BIOELECTROMAGNETICS, V32, P4, DOI 10.1002/bem.20609; Marino AA, 2009, ELECTROMAGN BIOL MED, V28, P250, DOI [10.1080/15368370902918912, 10.3109/15368370902918912]; Parazzini M, 2007, IEEE T BIO-MED ENG, V54, P39, DOI 10.1109/TBME.2006.886613; Regel SJ, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-10; Roggeveen S, 2015, EEG CHANGES DU UNPUB; Shevrin H, 2001, INT J PSYCHOPHYSIOL, V42, P209, DOI 10.1016/S0167-8760(01)00165-9; Valentini E, 2007, BIOELECTROMAGNETICS, V28, P415, DOI 10.1002/bem.20323; Vossen CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079905	24	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0125390	10.1371/journal.pone.0125390	http://dx.doi.org/10.1371/journal.pone.0125390			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962168	Green Published, Green Submitted, gold			2022-12-26	WOS:000354542500030
J	Valot, B; Guyeux, C; Rolland, JY; Mazouzi, K; Bertrand, X; Hocquet, D				Valot, Benoit; Guyeux, Christophe; Rolland, Julien Yves; Mazouzi, Kamel; Bertrand, Xavier; Hocquet, Didier			What It Takes to Be a Pseudomonas aeruginosa? The Core Genome of the Opportunistic Pathogen Updated	PLOS ONE			English	Article							BETA-LACTAMASES; SEQUENCE; ADAPTATION; VIRULENCE; GENES	Pseudomonas aeruginosa is an opportunistic bacterial pathogen able to thrive in highly diverse ecological niches and to infect compromised patients. Its genome exhibits a mosaic structure composed of a core genome into which accessory genes are inserted en bloc at specific sites. The size and the content of the core genome are open for debate as their estimation depends on the set of genomes considered and the pipeline of gene detection and clustering. Here, we redefined the size and the content of the core genome of P. aeruginosa from fully re-analyzed genomes of 17 reference strains. After the optimization of gene detection and clustering parameters, the core genome was defined at 5,233 orthologs, which represented similar to 88% of the average genome. Extrapolation indicated that our panel was suitable to estimate the core genome that will remain constant even if new genomes are added. The core genome contained resistance determinants to the major antibiotic families as well as most metabolic, respiratory, and virulence genes. Although some virulence genes were accessory, they often related to conserved biological functions. Long-standing prophage elements were subjected to a genetic drift to eventually display a G+C content as higher as that of the core genome. This contrasts with the low G+C content of highly conserved ribosomal genes. The conservation of metabolic and respiratory genes could guarantee the ability of the species to thrive on a variety of carbon sources for energy in aerobiosis and anaerobiosis. Virtually all the strains, of environmental or clinical origin, have the complete toolkit to become resistant to the major antipseudomonal compounds and possess basic pathogenic mechanisms to infect humans. The knowledge of the genes shared by the majority of the P. aeruginosa isolates is a prerequisite for designing effective therapeutics to combat the wide variety of human infections.	[Valot, Benoit; Bertrand, Xavier; Hocquet, Didier] Univ Franche Comte, CNRS, Chrono Environm, UMR 6249, F-25030 Besancon, France; [Guyeux, Christophe] Univ Franche Comte, CNRS, Inst FEMTO ST, Dept DISC,UMR 6174, Belfort, France; [Rolland, Julien Yves] Univ Franche Comte, CNRS, Lab Math Besancon, UMR 6623, F-25030 Besancon, France; [Mazouzi, Kamel] Univ Franche Comte, Mesoctr Calculs, F-25030 Besancon, France; [Bertrand, Xavier; Hocquet, Didier] Ctr Hosp Reg Univ, Lab Hyg Hosp, Besancon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Franche-Comte; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Franche-Comte; Universite de Technologie de Belfort-Montbeliard (UTBM); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); Universite de Franche-Comte; Universite de Franche-Comte; Universite de Franche-Comte; CHU Besancon	Hocquet, D (corresponding author), Univ Franche Comte, CNRS, Chrono Environm, UMR 6249, F-25030 Besancon, France.	dhocquet@chu-besancon.fr	Bertrand, Xavier/AAK-3270-2021; Bertrand, Xavier/AAL-3809-2021; Valot, Benoit BV/G-3521-2018; Guyeux, Christophe/C-2153-2011; Hocquet, Didier/AAK-9107-2020	Bertrand, Xavier/0000-0002-8028-1396; Guyeux, Christophe/0000-0003-0195-4378; Hocquet, Didier/0000-0002-4192-7238; Rolland, Julien Yves/0000-0002-0960-6688	Mesocentre de Franche-comte	Mesocentre de Franche-comte	Mesocentre de Franche-comte (Grand Challenge 2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boissy R, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-187; Boyle B, 2012, J BACTERIOL, V194, P529, DOI 10.1128/JB.06246-11; Chan KG, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00246-14; Chen LH, 2012, NUCLEIC ACIDS RES, V40, pD641, DOI 10.1093/nar/gkr989; Cholley P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107008; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Eckweiler D, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01232-13; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Ernst RK, 2003, ENVIRON MICROBIOL, V5, P1341, DOI 10.1111/j.1462-2920.2003.00518.x; Feltman H, 2001, MICROBIOL-SGM, V147, P2659, DOI 10.1099/00221287-147-10-2659; Grocock RJ, 2002, GENE, V289, P131, DOI 10.1016/S0378-1119(02)00503-6; Grosso-Becerra MV, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-318; Henderson TA, 1997, J BACTERIOL, V179, P6112, DOI 10.1128/jb.179.19.6112-6121.1997; Hirakata Y, 2002, J EXP MED, V196, P109, DOI 10.1084/jem.20020005; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jeukens J, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00568-13; Klockgether J, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00150; Kung VL, 2010, MICROBIOL MOL BIOL R, V74, P621, DOI 10.1128/MMBR.00027-10; Kus JV, 2004, MICROBIOL-SGM, V150, P1315, DOI 10.1099/mic.0.26822-0; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; Lee DG, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r90; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Livermore DM, 2002, CLIN INFECT DIS, V34, P634, DOI 10.1086/338782; LIVERMORE DM, 1995, CLIN MICROBIOL REV, V8, P557, DOI 10.1128/CMR.8.4.557; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Mathee K, 2008, P NATL ACAD SCI USA, V105, P3100, DOI 10.1073/pnas.0711982105; Miyoshi-Akiyama T, 2011, J BACTERIOL, V193, P7010, DOI 10.1128/JB.06312-11; Ohtsubo Y, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01130-13; Ozer EA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-737; Rau MH, 2012, ENVIRON MICROBIOL, V14, P2200, DOI 10.1111/j.1462-2920.2012.02795.x; Raymond CK, 2002, J BACTERIOL, V184, P3614, DOI 10.1128/JB.184.13.3614-3622.2002; Richardson EJ, 2013, BRIEF BIOINFORM, V14, P1, DOI 10.1093/bib/bbs007; Rohmer L, 2011, TRENDS MICROBIOL, V19, P341, DOI 10.1016/j.tim.2011.04.003; Roy PH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008842; Schurek KN, 2009, ANTIMICROB AGENTS CH, V53, P4345, DOI 10.1128/AAC.01267-08; Spencer DH, 2003, J BACTERIOL, V185, P1316, DOI 10.1128/JB.185.4.1316-1325.2003; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Verma A, 2006, J BACTERIOL, V188, P4395, DOI 10.1128/JB.01642-05; Weinel C, 2002, ENVIRON MICROBIOL, V4, P809, DOI 10.1046/j.1462-2920.2002.00331.x; Winstanley C, 2009, GENOME RES, V19, P12, DOI 10.1101/gr.086082.108; Wolfgang MC, 2003, P NATL ACAD SCI USA, V100, P8484, DOI 10.1073/pnas.0832438100; Woodford N, 2011, FEMS MICROBIOL REV, V35, P736, DOI 10.1111/j.1574-6976.2011.00268.x; Wu DQ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-438	47	64	66	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126468	10.1371/journal.pone.0126468	http://dx.doi.org/10.1371/journal.pone.0126468			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961859	Green Published, Green Submitted, gold			2022-12-26	WOS:000354542500104
J	Arrat, H; Lukas, TJ; Siddique, T				Arrat, Hasan; Lukas, Thomas J.; Siddique, Teepu			ACTH (Acthar Gel) Reduces Toxic SOD1 Protein Linked to Amyotrophic Lateral Sclerosis in Transgenic Mice: A Novel Observation	PLOS ONE			English	Article							NEUROMUSCULAR FUNCTION; HEXANUCLEOTIDE REPEAT; SQSTM1 MUTATIONS; ONSET ALS; GENE; NEUROINFLAMMATION; DEGENERATION; MOUSE; REGENERATION; EXPRESSION	Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease with a complex etiology and pathology that makes the development of new therapies difficult. ACTH has neurotrophic and myotrophic effects, but has not been tested in an ALS mouse model. The G93A-SOD1 mouse model of ALS was used to test the ability of this drug to delay ALS-like symptoms. We showed that within a specific dose range, ACTH significantly postponed the disease onset and paralysis in the mouse model. To our surprise and of greater significance is that ACTH significantly reduced the levels of soluble SOD1 in the spinal cord and CNS tissues of G93A-SOD1 treated mice as well as cultured fibroblasts.	[Arrat, Hasan; Siddique, Teepu] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA; [Lukas, Thomas J.] Northwestern Univ, Feinberg Sch Med, Dept Pharmacol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Lukas, TJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Pharmacol, Chicago, IL 60611 USA.	t-lukas@northwestern.edu; t-siddique@northwestern.edu	Siddique, Teepu/AAT-8166-2021	Siddique, Teepu/0000-0001-7293-9146	Questcor Pharmaceuticals; Les Turner ALS Foundation; Les Turner Foundation/Herbert C. Wenske Professorship; Harold Post Research Professorship; Vena E. Schaff ALS Research Fund; S.W. Ranson Fund in ALS Research; Foglia Family Foundation	Questcor Pharmaceuticals; Les Turner ALS Foundation; Les Turner Foundation/Herbert C. Wenske Professorship; Harold Post Research Professorship; Vena E. Schaff ALS Research Fund; S.W. Ranson Fund in ALS Research; Foglia Family Foundation	The work was supported in part by Questcor Pharmaceuticals. Additional support was from the Les Turner ALS Foundation, the Les Turner Foundation/Herbert C. Wenske Professorship (to TS), Harold Post Research Professorship (to TS), Vena E. Schaff ALS Research Fund, the S.W. Ranson Fund in ALS Research, and the Foglia Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartolome F, 2013, NEURON; Benatar M, 2007, NEUROBIOL DIS, V26, P1, DOI 10.1016/j.nbd.2006.12.015; BESEDOVSKY H, 1986, SCIENCE, V233, P652, DOI 10.1126/science.3014662; Brod SA, 2009, BIOMED PHARMACOTHER, V63, P251, DOI 10.1016/j.biopha.2008.08.022; Chen M, 2007, BIOCHEMISTRY-US, V46, P11389, DOI 10.1021/bi700125e; Cheng B, 1998, J STEROID BIOCHEM, V66, P335, DOI 10.1016/S0960-0760(98)00062-4; Couthouis J, 2011, P NATL ACAD SCI USA, V108, P20881, DOI 10.1073/pnas.1109434108; DalCanto MC, 1997, ACTA NEUROPATHOL, V93, P537; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; DUCKERS HJ, 1993, BRAIN, V116, P1059, DOI 10.1093/brain/116.5.1059; DUCKERS HJ, 1994, BRAIN, V117, P365, DOI 10.1093/brain/117.2.365; Fecto F, 2011, ARCH NEUROL-CHICAGO, V68, P1440, DOI 10.1001/archneurol.2011.250; Gettig Jacob, 2009, P T, V34, P250; Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742; Gros-Louis F, 2004, J BIOL CHEM, V279, P45951, DOI 10.1074/jbc.M408139200; Gurney ME, 1997, J NEUROL SCI, V152, pS67, DOI 10.1016/S0022-510X(97)00247-5; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; HOOGSTRATEN MC, 1990, ACTA NEUROL SCAND, V82, P74; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kang SH, 2013, NAT NEUROSCI, V16, P571, DOI 10.1038/nn.3357; Kuo JJ, 2005, J PHYSIOL-LONDON, V563, P843, DOI 10.1113/jphysiol.2004.074138; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lukas TJ, 2014, BIOORG MED CHEM LETT, V24, P1532, DOI 10.1016/j.bmcl.2014.01.078; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Meyer T, 2005, NEUROLOGY, V65, P141, DOI 10.1212/01.wnl.0000167130.31618.0a; Mhatre M, 2004, J ALZHEIMERS DIS, V6, P147; Mosley RL, 2010, EXP NEUROL, V222, P1, DOI 10.1016/j.expneurol.2009.12.018; Niebroj-Dobosz I, 2002, ACTA NEUROL SCAND, V106, P39, DOI 10.1034/j.1600-0404.2002.00206.x; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Noh KM, 2000, NEUROBIOL DIS, V7, P375, DOI 10.1006/nbdi.2000.0297; Noh MY, 2014, NEUROSCI LETT, V574, P53, DOI 10.1016/j.neulet.2014.05.001; Pagani MR, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/497080; Parkinson N, 2006, NEUROLOGY, V67, P1074, DOI 10.1212/01.wnl.0000231510.89311.8b; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Philips T, 2011, LANCET NEUROL, V10, P253, DOI 10.1016/S1474-4422(11)70015-1; Pozza C, 2012, J ONCOL, V2012, DOI 10.1155/2012/685213; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Roy S, 2010, ENDOCRINOLOGY, V151, P660, DOI 10.1210/en.2009-0826; Rubino E, 2012, NEUROLOGY, V79, P1556, DOI 10.1212/WNL.0b013e31826e25df; Saeed M, 2009, NEUROLOGY, V72, P1634, DOI 10.1212/01.wnl.0000343509.76828.2a; SAINTCOME C, 1982, PEPTIDES, V3, P439, DOI 10.1016/0196-9781(82)90105-X; Schymick JC, 2007, J NEUROL NEUROSUR PS, V78, P754, DOI 10.1136/jnnp.2006.109553; Siddique T, 1991, Int J Neurol, V25-26, P60; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; STRAND FL, 1976, PHARMACOL BIOCHEM BE, V5, P179, DOI 10.1016/0091-3057(76)90349-X; STRAND FL, 1980, PEPTIDES, V1, P135, DOI 10.1016/0196-9781(80)90077-7; Synofzik M, 2010, J NEUROL NEUROSUR PS, V81, P764, DOI 10.1136/jnnp.2009.181719; Waldman M, 2012, J AM SOC NEPHROL; Weydt P, 2005, NEUROREPORT, V16, P527, DOI 10.1097/00001756-200504250-00001; Wu CH, 2012, NATURE, V488, P499, DOI 10.1038/nature11280; Xing YW, 2010, J MOL ENDOCRINOL, V45, P59, DOI 10.1677/JME-10-0006; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160	55	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0125638	10.1371/journal.pone.0125638	http://dx.doi.org/10.1371/journal.pone.0125638			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955410	Green Published, Green Submitted, gold			2022-12-26	WOS:000356768100063
J	Mahajan, S; Saini, A; Chandra, V; Nanduri, R; Kalra, R; Bhagyaraj, E; Khatri, N; Gupta, P				Mahajan, Sahil; Saini, Ankita; Chandra, Vemika; Nanduri, Ravikanth; Kalra, Rashi; Bhagyaraj, Ella; Khatri, Neeraj; Gupta, Pawan			Nuclear Receptor Nr4a2 Promotes Alternative Polarization of Macrophages and Confers Protection in Sepsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVITY; NGFI-B; PHOSPHATIDYLINOSITOL 3-KINASE; INNATE IMMUNITY; PROTEIN-KINASE; ARGINASE 1; T-CELLS; ACTIVATION; NURR1; EXPRESSION	The orphan nuclear receptor Nr4a2 is known to modulate both inflammatory and metabolic processes, but the mechanism by which it regulates innate inflammatory homeostasis has not been adequately addressed. This study shows that exposure to ligands for Toll-like receptors (TLRs) robustly induces Nr4a2 and that this induction is tightly regulated by the PI3K-Akt signaling axis. Interestingly, exogenous expression of Nr4a2 in macrophages leads to their alternative phenotype with induction of genes that are prototypical M2 markers. Moreover, Nr4a2 transcriptionally activates arginase 1 expression by directly binding to its promoter. Adoptive transfer experiments revealed that increased survival of animals in endotoxin-induced sepsis is Nr4a2-dependent. Thus our data identify a previously unknown role for Nr4a2 in the regulation of macrophage polarization.	[Mahajan, Sahil; Saini, Ankita; Chandra, Vemika; Nanduri, Ravikanth; Kalra, Rashi; Bhagyaraj, Ella; Khatri, Neeraj; Gupta, Pawan] CSIR, Inst Microbial Technol, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Gupta, P (corresponding author), CSIR, Inst Microbial Technol, Chandigarh 160036, India.	pawan@imtech.res.in	Ella, Bhagyaraj/X-2823-2019; Chandra, Vemika/AAK-6997-2020; NANDURI, RAVIKANTH/Q-9729-2018	Chandra, Vemika/0000-0001-5360-7875; NANDURI, RAVIKANTH/0000-0002-0031-2333	Department of Biotechnology-India [BT/01/IYBA/2009]; Council of Scientific and Industrial Research 12th Plan Network project [BSC0211, BSC0210]	Department of Biotechnology-India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research 12th Plan Network project	This work was supported by the Department of Biotechnology-India project BT/01/IYBA/2009 and Council of Scientific and Industrial Research 12th Plan Network project Bugs to Drugs and Infectious Disease (Grants BSC0211 and BSC0210) (to P. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Aherne CM, 2009, MOL IMMUNOL, V46, P3345, DOI 10.1016/j.molimm.2009.07.019; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Barish GD, 2005, MOL ENDOCRINOL, V19, P2466, DOI 10.1210/me.2004-0529; Chawla A, 2010, CIRC RES, V106, P1559, DOI 10.1161/CIRCRESAHA.110.216523; Cho DI, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2013.135; Doi Y, 2008, P NATL ACAD SCI USA, V105, P8381, DOI 10.1073/pnas.0803454105; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; Fujiwara Nagatoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P281, DOI 10.2174/1568010054022024; Gallardo-Soler A, 2008, MOL ENDOCRINOL, V22, P1394, DOI 10.1210/me.2007-0525; Han YF, 2012, WORLD J GASTROENTERO, V18, P6865, DOI 10.3748/wjg.v18.i47.6865; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Ishii KJ, 2002, J EXP MED, V196, P269, DOI 10.1084/jem.20020773; Kondo T, 2012, TRENDS IMMUNOL, V33, P449, DOI 10.1016/j.it.2012.05.002; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Le WD, 2003, NAT GENET, V33, P85, DOI 10.1038/ng1066; Li X, 2012, BIOCHEM PHARMACOL, V83, P1445, DOI 10.1016/j.bcp.2012.02.021; Liao XD, 2011, J CLIN INVEST, V121, P2736, DOI 10.1172/JCI45444; LoPiccolo J, 2008, DRUG RESIST UPDATE, V11, P32, DOI 10.1016/j.drup.2007.11.003; Mahajan S, 2012, J INFECT DIS, V206, P366, DOI 10.1093/infdis/jis354; Mahajan S, 2012, J IMMUNOL, V188, P5593, DOI 10.4049/jimmunol.1103038; Maira M, 2003, MOL CELL BIOL, V23, P763, DOI 10.1128/MCB.23.3.763-776.2003; Maira M, 1999, MOL CELL BIOL, V19, P7549; Menzies FM, 2010, CLIN EXP IMMUNOL, V160, P369, DOI 10.1111/j.1365-2249.2009.04086.x; Mix KS, 2012, ARTHRITIS RHEUM-US, V64, P2126, DOI 10.1002/art.34399; Monick MM, 2001, J IMMUNOL, V166, P4713, DOI 10.4049/jimmunol.166.7.4713; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Munder M, 2009, BRIT J PHARMACOL, V158, P638, DOI 10.1111/j.1476-5381.2009.00291.x; Murray PJ, 2012, NAT IMMUNOL, V13, P916, DOI 10.1038/ni.2391; O'Kane M, 2008, J INVEST DERMATOL, V128, P300, DOI 10.1038/sj.jid.5701023; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Ojaniemi M, 2003, EUR J IMMUNOL, V33, P597, DOI 10.1002/eji.200323376; Ordentlich P, 2003, J BIOL CHEM, V278, P24791, DOI 10.1074/jbc.M302167200; Park SJ, 2002, CELL BIOL TOXICOL, V18, P121, DOI 10.1023/A:1015384201785; Pauleau AL, 2004, J IMMUNOL, V172, P7565, DOI 10.4049/jimmunol.172.12.7565; Pei LM, 2005, J BIOL CHEM, V280, P29256, DOI 10.1074/jbc.M502606200; PERLMANN T, 1995, GENE DEV, V9, P769, DOI 10.1101/gad.9.7.769; Pirih FQ, 2004, J BIOL CHEM, V279, P53167, DOI 10.1074/jbc.M405677200; Pourcet B, 2011, CIRC RES, V109, P492, DOI 10.1161/CIRCRESAHA.111.241810; Ruse M, 2006, IMMUNOL RES, V34, P33, DOI 10.1385/IR:34:1:33; Sacchetti P, 2006, NUCLEIC ACIDS RES, V34, P5515, DOI 10.1093/nar/gkl712; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Sarkar SN, 2004, NAT STRUCT MOL BIOL, V11, P1060, DOI 10.1038/nsmb847; Sekiya T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1272; Shi YH, 2007, DRUG DISCOV TODAY, V12, P440, DOI 10.1016/j.drudis.2007.04.006; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Tugal D, 2013, ARTERIOSCL THROM VAS, V33, P1135, DOI 10.1161/ATVBAHA.113.301453; Wang ZL, 2003, NATURE, V423, P555, DOI 10.1038/nature01645; Wijnands KAP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086135; Zetterstrom RH, 1996, MOL ENDOCRINOL, V10, P1656, DOI 10.1210/me.10.12.1656	53	46	47	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18304	18314		10.1074/jbc.M115.638064	http://dx.doi.org/10.1074/jbc.M115.638064			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	25953901	Green Published, hybrid			2022-12-26	WOS:000358512100005
J	Cantlon, A; Frigerio, CS; Freir, DB; Boland, B; Jin, M; Walsh, DM				Cantlon, Adam; Frigerio, Carlo Sala; Freir, Darragh B.; Boland, Barry; Jin, Ming; Walsh, Dominic M.			The Familial British Dementia Mutation Promotes Formation of Neurotoxic Cystine Cross-linked Amyloid Bri (ABri) Oligomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE; A-BETA; DANISH DEMENTIA; MEMORY DEFICITS; SYNAPTIC PLASTICITY; PLAQUE-FORMATION; DISULFIDE BONDS; PEPTIDES; PROTEIN	Familial British dementia (FBD) is an inherited neurodegenerative disease believed to result from a mutation in the BRI2 gene. Post-translational processing of wild type BRI2 and FBD-BRI2 result in the production of a 23-residue long Bri peptide and a 34-amino acid long ABri peptide, respectively, and ABri is found deposited in the brains of individuals with FBD. Similarities in the neuropathology and clinical presentation shared by FBD and Alzheimer disease (AD) have led some to suggest that ABri and the AD-associated amyloid beta-protein (A beta) are molecular equivalents that trigger analogous pathogenic cascades. But the sequences and innate properties of ABri and A beta are quite different, notably ABri contains two cysteine residues that can form disulfide bonds. Thus we sought to determine whether ABri was neurotoxic and if this activity was regulated by oxidation and/or aggregation. Crucially, the type of oxidative cross-linking dramatically influenced both ABri aggregation and toxicity. Cyclization of Bri and ABri resulted in production of biologically inert monomers that showed no propensity to assemble, whereas reduced ABri and reduced Bri aggregated forming thioflavin T-positive amyloid fibrils that lacked significant toxic activity. ABri was more prone to form inter-molecular disulfide bonds than Bri and the formation of covalently stabilized ABri oligomers was associated with toxicity. These results suggest that extension of the C-terminal of Bri causes a shift in the type of disulfide bonds formed and that structures built from covalently cross-linked oligomers can interact with neurons and compromise their function and viability.	[Cantlon, Adam; Frigerio, Carlo Sala; Freir, Darragh B.; Boland, Barry] Natl Univ Ireland Univ Coll Dublin, Conway Inst, Sch Biomol & Biomed Sci, Lab Neurodegenerat Res, Dublin 4, Ireland; [Cantlon, Adam; Jin, Ming; Walsh, Dominic M.] Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, Lab Neurodegenerat Res, Boston, MA 02115 USA; [Cantlon, Adam; Jin, Ming; Walsh, Dominic M.] Harvard Univ, Sch Med, Boston, MA 02115 USA	University College Dublin; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Walsh, DM (corresponding author), Harvard Inst Med, Brigham & Womens Hosp, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	dwalsh3@partners.org	Boland, Barry/D-1235-2010	Boland, Barry/0000-0003-2676-4343; Sala Frigerio, Carlo/0000-0003-4038-6449	Science Foundation Ireland [08/1N.1/B2033]; Cure Alzheimer's Fund; Foundation of Neurological diseases	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Cure Alzheimer's Fund; Foundation of Neurological diseases	This work was supported by Science Foundation Ireland Grant 08/1N.1/B2033, the Cure Alzheimer's Fund, and the Foundation of Neurological diseases (to D.M.W.). The authors declare that they have no conflicts of interest with the contents of this article.	AIKAWA H, 1985, ANN NEUROL, V17, P297, DOI 10.1002/ana.410170313; Akiyama H, 2004, ACTA NEUROPATHOL, V107, P53, DOI 10.1007/s00401-003-0783-1; Andreu D, 1994, Methods Mol Biol, V35, P91; [Anonymous], 2011, NAT NEUROSCI, V14, P399, DOI 10.1038/nn0411-399; Betts V, 2008, NEUROBIOL DIS, V31, P442, DOI 10.1016/j.nbd.2008.06.001; Chen QS, 2000, J NEUROSCI RES, V60, P65, DOI 10.1002/(SICI)1097-4547(20000401)60:1<65::AID-JNR7>3.0.CO;2-Q; Choi SI, 2003, FASEB J, V17, P373, DOI 10.1096/fj.03-0730fje; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; Coomaraswamy J, 2010, P NATL ACAD SCI USA, V107, P7969, DOI 10.1073/pnas.1001056107; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; El-Agnaf O, 2004, PROTEIN PEPTIDE LETT, V11, P207, DOI 10.2174/0929866043407156; El-Agnaf OMA, 2001, J MOL BIOL, V310, P157, DOI 10.1006/jmbi.2001.4743; El-Agnaf OMA, 2001, BIOCHEMISTRY-US, V40, P3449, DOI 10.1021/bi002287i; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Ghiso J, 2006, BRAIN PATHOL, V16, P71; Ghiso JA, 2001, J BIOL CHEM, V276, P43909, DOI 10.1074/jbc.M105956200; Gibson G, 2005, BIOCHEM SOC T, V33, P1111, DOI 10.1042/BST0331111; Giliberto L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007900; Golde TE, 2011, NEURON, V69, P203, DOI 10.1016/j.neuron.2011.01.002; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hedlund Joel, 2009, BMC Res Notes, V2, P180, DOI 10.1186/1756-0500-2-180; Hellstrand E, 2010, ACS CHEM NEUROSCI, V1, P13, DOI 10.1021/cn900015v; Holton JL, 2001, AM J PATHOL, V158, P515, DOI 10.1016/S0002-9440(10)63993-4; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kim SH, 2002, J BIOL CHEM, V277, P1872, DOI 10.1074/jbc.M108739200; Kim SH, 1999, NAT NEUROSCI, V2, P984, DOI 10.1038/14783; Marcora MS, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-5; Matsuda S, 2011, J ALZHEIMERS DIS, V27, P385, DOI 10.3233/JAD-2011-110785; Mead S, 2000, BRAIN, V123, P975, DOI 10.1093/brain/123.5.975; Mesulam NM, 1999, NEURON, V24, P521, DOI 10.1016/S0896-6273(00)81109-5; Minogue AM, 2009, BRAIN RES, V1262, P89, DOI 10.1016/j.brainres.2009.01.008; Morris RGM, 2003, PHILOS T ROY SOC B, V358, P643, DOI 10.1098/rstb.2002.1230; O'Malley TT, 2014, BIOCHEM J, V461, P413, DOI 10.1042/BJ20140219; PLANT GT, 1990, BRAIN, V113, P721, DOI 10.1093/brain/113.3.721; Revesz T, 1999, ACTA NEUROPATHOL, V97, P170, DOI 10.1007/s004010050970; Rostagno A, 2005, CELL MOL LIFE SCI, V62, P1814, DOI 10.1007/s00018-005-5092-5; Rowan MJ, 2003, PHILOS T R SOC B, V358, P821, DOI 10.1098/rstb.2002.1240; Sanchez-Pulido L, 2002, TRENDS BIOCHEM SCI, V27, P329, DOI 10.1016/S0968-0004(02)02134-5; Shankar GM, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-48; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Srinivasan R, 2003, J MOL BIOL, V333, P1003, DOI 10.1016/j.jmb.2003.09.001; Tamayev R, 2012, J NEUROSCI, V32, P5481, DOI 10.1523/JNEUROSCI.5193-11.2012; Tamayev R, 2010, P NATL ACAD SCI USA, V107, P20822, DOI 10.1073/pnas.1011689107; Tamayev R, 2010, J NEUROSCI, V30, P14915, DOI 10.1523/JNEUROSCI.3917-10.2010; Tsachaki M, 2010, NEUROBIOL AGING, V31, P88, DOI 10.1016/j.neurobiolaging.2008.03.004; Vidal R, 2000, P NATL ACAD SCI USA, V97, P4920, DOI 10.1073/pnas.080076097; Vidal R, 1999, NATURE, V399, P776; Vidal R, 2009, BRAIN PATHOL, V19, P58, DOI 10.1111/j.1750-3639.2008.00164.x; Walsh Dominic M., 2003, Current Medicinal Chemistry - Immunology Endocrine & Metabolic Agents, V3, P277, DOI 10.2174/1568013033483311; Walsh DM, 2009, FEBS J, V276, P1266, DOI 10.1111/j.1742-4658.2008.06862.x; Wang QW, 2004, J NEUROSCI, V24, P3370, DOI 10.1523/JNEUROSCI.1633-03.2004; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134	53	5	5	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16502	16516		10.1074/jbc.M115.652263	http://dx.doi.org/10.1074/jbc.M115.652263			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25957407	Green Published, hybrid			2022-12-26	WOS:000357572800004
J	Ogawa, H; Wu, X; Kawamoto, K; Nishida, N; Konno, M; Koseki, J; Matsui, H; Noguchi, K; Gotoh, N; Yamamoto, T; Miyata, K; Nishiyama, N; Nagano, H; Yamamoto, H; Obika, S; Kataoka, K; Doki, Y; Mori, M; Ishii, H				Ogawa, Hisataka; Wu, Xin; Kawamoto, Koichi; Nishida, Naohiro; Konno, Masamitsu; Koseki, Jun; Matsui, Hidetoshi; Noguchi, Kozou; Gotoh, Noriko; Yamamoto, Tsuyoshi; Miyata, Kanjiro; Nishiyama, Nobuhiro; Nagano, Hiroaki; Yamamoto, Hirofumi; Obika, Satoshi; Kataoka, Kazunori; Doki, Yuichiro; Mori, Masaki; Ishii, Hideshi			MicroRNAs Induce Epigenetic Reprogramming and Suppress Malignant Phenotypes of Human Colon Cancer Cells	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; MESENCHYMAL TRANSITION; COLORECTAL-CANCER; EXPRESSION; MOUSE; GENERATION	Although cancer is a genetic disease, epigenetic alterations are involved in its initiation and progression. Previous studies have shown that reprogramming of colon cancer cells using Oct3/4, Sox2, Klf4, and cMyc reduces cancer malignancy. Therefore, cancer reprogramming may be a useful treatment for chemo- or radiotherapy-resistant cancer cells. It was also reported that the introduction of endogenous small-sized, non-coding ribonucleotides such as microRNA (miR) 302s and miR-369-3p or -5p resulted in the induction of cellular reprogramming. miRs are smaller than the genes of transcription factors, making them possibly suitable for use in clinical strategies. Therefore, we reprogrammed colon cancer cells using miR-302s and miR-369-3p or -5p. This resulted in inhibition of cell proliferation and invasion and the stimulation of the mesenchymal-to-epithelial transition phenotype in colon cancer cells. Importantly, the introduction of the ribonucleotides resulted in epigenetic reprogramming of DNA demethylation and histone modification events. Furthermore, in vivo administration of the ribonucleotides in mice elicited the induction of cancer cell apoptosis, which involves the mitochondrial Bcl2 protein family. The present study shows that the introduction of miR-302s and miR-369s could induce cellular reprogramming and modulate malignant phenotypes of human colorectal cancer, suggesting that the appropriate delivery of functional small-sized ribonucleotides may open a new avenue for therapy against human malignant tumors.	[Ogawa, Hisataka; Wu, Xin; Kawamoto, Koichi; Nishida, Naohiro; Noguchi, Kozou; Nagano, Hiroaki; Yamamoto, Hirofumi; Doki, Yuichiro; Mori, Masaki] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Suita, Osaka, Japan; [Ogawa, Hisataka; Kawamoto, Koichi; Nishida, Naohiro; Konno, Masamitsu; Noguchi, Kozou; Ishii, Hideshi] Osaka Univ, Grad Sch Med, Dept Frontier Sci Canc & Chemotherapy, Suita, Osaka, Japan; [Koseki, Jun; Ishii, Hideshi] Osaka Univ, Grad Sch Med, Dept Canc Profiling Discovery, Suita, Osaka, Japan; [Matsui, Hidetoshi] Kyushu Univ, Fac Math, Fukuoka 812, Japan; [Gotoh, Noriko] Kanazawa Univ, Canc Res Inst, Div Canc Cell Biol, Kanazawa, Ishikawa 920, Japan; [Yamamoto, Tsuyoshi; Obika, Satoshi] Osaka Univ, Grad Sch Pharmaceut Sci, Dept Bioorgan Chem, Suita, Osaka, Japan; [Miyata, Kanjiro; Nishiyama, Nobuhiro; Kataoka, Kazunori] Univ Tokyo, Dept Mat Engn, Bunkyo Ku, Tokyo, Japan; [Nishiyama, Nobuhiro] Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 227, Japan	Osaka University; Osaka University; Osaka University; Kyushu University; Kanazawa University; Osaka University; University of Tokyo; Tokyo Institute of Technology	Mori, M (corresponding author), Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Suita, Osaka, Japan.	mmori@gesurg.med.osaka-u.ac.jp; hishii@gesurg.med.osaka-u.ac.jp	Kataoka, Kazunori/K-7108-2012; GOTOH, Noriko/D-8430-2015; Koseki, Jun/ABH-7420-2020; Ishii, Hideshi/AAV-5317-2020; Matsui, Hidetoshi/AAM-1339-2020	Kataoka, Kazunori/0000-0002-8591-413X; Matsui, Hidetoshi/0000-0002-6286-5072; Yamamoto, Tsuyoshi/0000-0002-3206-2455; Gotoh, Noriko/0000-0003-3733-260X	Ministry of Education, Culture, Sports, Science, and Technology [23390199, 25112708, 25134711, 30253420, 26670604]; Ministry of Health, Labor and Welfare [H23-003]; National Institute of Biomedical Innovation [12-4]; Osaka University Drug Discovery Funds; Takeda Science and Medical Research Foundation; Princess Takamatsu Cancer Research Fund; Suzuken Memorial Foundation; Yasuda Medical Foundation; Pancreas Research Foundation; Nakatani Foundation; Nakatomi Foundation of Japan	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Osaka University Drug Discovery Funds; Takeda Science and Medical Research Foundation; Princess Takamatsu Cancer Research Fund; Suzuken Memorial Foundation; Yasuda Medical Foundation; Pancreas Research Foundation; Nakatani Foundation; Nakatomi Foundation of Japan	Institutional endowments were received partially from Taiho Pharmaceutical Co., Ltd. (http://www.taiho.co.jp/english/), Evidence Based Medical (EBM) Research Center (http://ebmrce.co.jp/index.html), Chugai Co., Ltd. (http://www.chugai-pharm.co.jp/english/index.html), Yakult Honsha Co., Ltd. (http:// www.yakult.co.jp/english/index.html), and Merck Co., Ltd. (http://www.merck.co.jp/en/index.html). This work was also supported a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (http://www.mext.go.jp/english/; #23390199, #25112708, #25134711, #30253420, #26670604; M.M, K.M, H.I); a Grant-in-Aid from the Ministry of Health, Labor and Welfare (http://www.mhlw.go.jp/english/; #H23-003; M.M., H.I.); a grant from the National Institute of Biomedical Innovation (http://www.nibio.go.jp/english/index.html; #12-4; M.M., H.I.); and a grant from the Osaka University Drug Discovery Funds (http://www.osaka-u.ac.jp/en/index.html; M.M., H.I.). Partial supports were received from Takeda Science and Medical Research Foundation (http://www.takeda-sci.or.jp/index.html; M.M., H.I.), Princess Takamatsu Cancer Research Fund (http://www.ptcrf.or.jp/english; M.M., H.I.), Suzuken Memorial Foundation (http://www.suzukenzaidan.or.jp; M.K.), Yasuda Medical Foundation (http://www.yasuda-mf.or.jp; N.N.), Pancreas Research Foundation (http://www.jprf.or.jp/shoreisho.html; K.K.), Nakatani Foundation (http://www.nakatani-foundation.jp; H.I.), and Nakatomi Foundation of Japan (https://www.nakatomi.or.jp/en/index.html; M.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Bader AG, 2010, CANCER RES, V70, P7027, DOI 10.1158/0008-5472.CAN-10-2010; Findlay VJ, 2014, CANCER GENE THER, V21, P181, DOI 10.1038/cgt.2014.15; Hossain S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060428; Hossain S, 2010, J CONTROL RELEASE, V147, P101, DOI 10.1016/j.jconrel.2010.06.024; Hu SJ, 2013, STEM CELLS, V31, P259, DOI 10.1002/stem.1278; Jackson AL, 2012, NUCLEIC ACID THER, V22, P213, DOI 10.1089/nat.2012.0356; Kennedy MT, 2004, J CLIN PATHOL, V57, P932, DOI 10.1136/jcp.2004.016964; Koga C, 2014, ANN SURG ONCOL, V21, pS591, DOI 10.1245/s10434-014-3705-7; Kong YW, 2012, LANCET ONCOL, V13, pE249, DOI 10.1016/S1470-2045(12)70073-6; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Liao BJ, 2011, J BIOL CHEM, V286, P17359, DOI 10.1074/jbc.C111.235960; Lin SL, 2008, RNA, V14, P2115, DOI 10.1261/rna.1162708; Lin SL, 2011, NUCLEIC ACIDS RES, V39, P1054, DOI 10.1093/nar/gkq850; Lin SL, 2010, CANCER RES, V70, P9473, DOI 10.1158/0008-5472.CAN-10-2746; Lipchina I, 2012, CELL CYCLE, V11, P1517, DOI 10.4161/cc.19846; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Miyazaki S, 2014, ANN SURG ONCOL; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Miyoshi N, 2010, P NATL ACAD SCI USA, V107, P40, DOI 10.1073/pnas.0912407107; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Ohnishi K, 2014, CELL, V156, P663, DOI 10.1016/j.cell.2014.01.005; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Singh U, 2012, STEM CELL REV REP, V8, P1021, DOI 10.1007/s12015-012-9359-6; Takeyama H, 2014, MOL CANCER THER, V13, P976, DOI 10.1158/1535-7163.MCT-13-0571; Tsuno S, 2014, SCI REP-UK, V4, DOI 10.1038/srep03852; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Zhang X, 2013, ONCOGENE, V32, P2249, DOI 10.1038/onc.2012.237	28	24	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0127119	10.1371/journal.pone.0127119	http://dx.doi.org/10.1371/journal.pone.0127119			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970424	Green Published, gold, Green Submitted			2022-12-26	WOS:000354544200152
J	Ezoe, K; Yabuuchi, A; Tani, T; Mori, C; Miki, T; Takayama, Y; Beyhan, Z; Kato, Y; Okuno, T; Kobayashi, T; Kato, K				Ezoe, Kenji; Yabuuchi, Akiko; Tani, Tetsuya; Mori, Chiemi; Miki, Tetsuya; Takayama, Yuko; Beyhan, Zeki; Kato, Yoko; Okuno, Takashi; Kobayashi, Tamotsu; Kato, Keiichi			Developmental Competence of Vitrified-Warmed Bovine Oocytes at the Germinal-Vesicle Stage is Improved by Cyclic Adenosine Monophosphate Modulators during In Vitro Maturation	PLOS ONE			English	Article							PHOSPHODIESTERASE ISOENZYME INHIBITORS; IMMATURE MOUSE OOCYTES; TYPE-3 INHIBITOR; CAMP MODULATORS; PROPHASE-I; CRYOPRESERVATION; MEIOSIS; VITRIFICATION; NUCLEAR; SYSTEM	Cryopreservation of mature oocytes and embryos has provided numerous benefits in reproductive medicine. Although successful cryopreservation of germinal-vesicle stage (GV) oocytes holds promise for further advances in reproductive biology and clinical embryology fields, reports regarding cryopreservation of immature oocytes are limited. Oocyte survival and maturation rates have improved since vitrification is being performed at the GV stage, but the subsequent developmental competence of GV oocytes is still low. The purpose of this study was to evaluate the effects of supplementation of the maturation medium with cyclic adenosine monophosphate (cAMP) modulators on the developmental competence of vitrified-warmed GV bovine oocytes. GV oocytes were vitrified-warmed and cultured to allow for oocyte maturation, and then parthenogenetically activated or fertilized in vitro. Our results indicate that addition of a cAMP modulator forskolin (FSK) or 3-isobutyl-1-methylxanthine (IBMX) to the maturation medium significantly improved the developmental competence of vitrified-warmed GV oocytes. We also demonstrated that vitrification of GV oocytes led to a decline in cAMP levels and maturation-promoting factor (MPF) activity in the oocytes during the initial and final phases of maturation, respectively. Nevertheless, the addition of FSK or IBMX to the maturation medium significantly elevated cAMP levels and MPF activity during IVM. Taken together, our results suggest that the cryopreservation-associated meiotic and developmental abnormalities observed in GV oocytes may be ameliorated by an artificial increase in cAMP levels during maturation culture after warming.	[Ezoe, Kenji; Yabuuchi, Akiko; Mori, Chiemi; Miki, Tetsuya; Takayama, Yuko; Okuno, Takashi; Kobayashi, Tamotsu; Kato, Keiichi] Kato Ladies Clin, Shinjuku Ku, Tokyo, Japan; [Tani, Tetsuya; Kato, Yoko] Kinki Univ, Coll Agr, Lab Anim Reprod, Nara, Japan; [Beyhan, Zeki] Sher Inst Reprod Med Las Vegas, Las Vegas, NV USA	Kindai University (Kinki University)	Yabuuchi, A (corresponding author), Kato Ladies Clin, Shinjuku Ku, Tokyo, Japan.	a-yabuuchi@towako-kato.com; k-kato@towako.net	tani, tetsuya/AAR-7581-2021	tani, tetsuya/0000-0001-5276-8941; Ezoe, Kenji/0000-0002-3778-2259; Miki, Testuya/0000-0003-0563-5358				Albuz FK, 2010, HUM REPROD, V25, P2999, DOI 10.1093/humrep/deq246; Amer Soc Reprod Med, 2013, FERTIL STERIL, V99, P37, DOI 10.1016/j.fertnstert.2012.09.028; ANDERSON E, 1976, J CELL BIOL, V71, P680, DOI 10.1083/jcb.71.2.680; BALL GD, 1983, BIOL REPROD, V28, P717, DOI 10.1095/biolreprod28.3.717; Bilodeau-Goeseels S, 2006, THERIOGENOLOGY, V66, P297, DOI 10.1016/j.theriogenology.2005.11.014; Borini A, 2010, CLIN OBSTET GYNECOL, V53, P763, DOI 10.1097/GRF.0b013e3181f96f01; Brambillasca F, 2013, J ASSIST REPROD GEN, V30, P1531, DOI 10.1007/s10815-013-0112-0; Cao YX, 2009, REPROD BIOMED ONLINE, V19, P369, DOI 10.1016/S1472-6483(10)60170-8; Chian RC, 2004, CURR OPIN OBSTET GYN, V16, P211, DOI 10.1097/00001703-200406000-00003; Chian RC, 2008, REPROD BIOMED ONLINE, V16, P608, DOI 10.1016/S1472-6483(10)60471-3; Cobo A, 2011, FERTIL STERIL, V96, P277, DOI 10.1016/j.fertnstert.2011.06.030; Conti M, 2012, MOL CELL ENDOCRINOL, V356, P65, DOI 10.1016/j.mce.2011.11.002; Cooper A, 1998, HUM REPROD, V13, P971, DOI 10.1093/humrep/13.4.971; DEKEL N, 1978, ENDOCRINOLOGY, V102, P1797, DOI 10.1210/endo-102-6-1797; DESSEV G, 1991, J CELL BIOL, V112, P523, DOI 10.1083/jcb.112.4.523; Duffy DM, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-131; Fasano G, 2012, J ASSIST REPROD GEN, V29, P507, DOI 10.1007/s10815-012-9751-9; Funahashi H, 1997, BIOL REPROD, V57, P49, DOI 10.1095/biolreprod57.1.49; Gilchrist RB, 2011, REPROD FERT DEVELOP, V23, P23, DOI 10.1071/RD10225; Guixue Z, 2001, THERIOGENOLOGY, V55, P1733, DOI 10.1016/S0093-691X(01)00516-7; Isachenko EF, 1999, HUM REPROD, V14, P400, DOI 10.1093/humrep/14.2.400; Kikuchi K, 1995, J REPROD FERTIL, V105, P325, DOI 10.1530/jrf.0.1050325; Lai D, 2015, HUM REPROD, V30, P37, DOI 10.1093/humrep/deu284; Lee JA, 2013, FERTIL STERIL, V99, P1356, DOI 10.1016/j.fertnstert.2012.11.042; Luciano AM, 2011, BIOL REPROD, V85, P1252, DOI 10.1095/biolreprod.111.092858; Luciano AM, 2004, BIOL REPROD, V70, P465, DOI 10.1095/biolreprod.103.020644; Luciano AM, 1999, MOL REPROD DEV, V54, P86, DOI 10.1002/(SICI)1098-2795(199909)54:1&lt;86::AID-MRD13&gt;3.0.CO;2-C; LUSCHER B, 1991, EMBO J, V10, P865, DOI 10.1002/j.1460-2075.1991.tb08019.x; Mehlmann LM, 2002, SCIENCE, V297, P1343, DOI 10.1126/science.1073978; MOTLIK J, 1990, MOL REPROD DEV, V27, P366, DOI 10.1002/mrd.1080270411; Nogueira D, 2003, BIOL REPROD, V69, P2045, DOI 10.1095/biolreprod.103.021105; Nogueira D, 2003, BIOL REPROD, V69, P1042, DOI 10.1095/biolreprod.103.015982; Noyes N, 2009, REPROD BIOMED ONLINE, V18, P769, DOI 10.1016/S1472-6483(10)60025-9; Richani D, 2014, MOL REPROD DEV, V81, P422, DOI 10.1002/mrd.22307; Rose RD, 2013, THERIOGENOLOGY, V79, P142, DOI 10.1016/j.theriogenology.2012.09.020; Sela-Abramovich S, 2006, ENDOCRINOLOGY, V147, P2280, DOI 10.1210/en.2005-1011; Shu YM, 2008, HUM REPROD, V23, P504, DOI 10.1093/humrep/dem344; Smitz JEJ, 2011, SEMIN REPROD MED, V29, P24, DOI 10.1055/s-0030-1268701; Solc P, 2008, DEV BIOL, V317, P260, DOI 10.1016/j.ydbio.2008.02.028; Son WY, 1996, FERTIL STERIL, V66, P995, DOI 10.1016/S0015-0282(16)58696-8; Song YN, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-547; Suo L, 2009, ZYGOTE, V17, P71, DOI 10.1017/S0967199408005091; Tani T, 2003, BIOL REPROD, V69, P1890, DOI 10.1095/biolreprod.103.018945; Thomas RE, 2004, BIOL REPROD, V71, P1142, DOI 10.1095/biolreprod.103.024828; Thomas RE, 2002, DEV BIOL, V244, P215, DOI 10.1006/dbio.2002.0609; Thouas G. A., 2001, Reprod Biomed Online, V3, P25; TOTH TL, 1994, FERTIL STERIL, V61, P1077; Vanhoutte L, 2009, HUM REPROD, V24, P1946, DOI 10.1093/humrep/dep104; Vanhoutte L, 2009, HUM REPROD, V24, P658, DOI 10.1093/humrep/den420; Zeng HT, 2013, HUM REPROD, V28, P1536, DOI 10.1093/humrep/det086; Zhou XL, 2010, CRYOBIOLOGY, V61, P66, DOI 10.1016/j.cryobiol.2010.05.002	51	29	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0126801	10.1371/journal.pone.0126801	http://dx.doi.org/10.1371/journal.pone.0126801			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965267	Green Published, gold, Green Submitted			2022-12-26	WOS:000354543500077
J	Rajalakshmy, AR; Malathi, J; Madhavan, HN				Rajalakshmy, Ayilam Ramachandran; Malathi, Jambulingam; Madhavan, Hajib Naraharirao			Hepatitis C Virus NS3 Mediated Microglial Inflammation via TLR2/TLR6 MyD88/NF-kappa B Pathway and Toll Like Receptor Ligand Treatment Furnished Immune Tolerance	PLOS ONE			English	Article							NF-KAPPA-B; INNATE IMMUNITY; CELLS; ACTIVATION; EXPRESSION; CYTOKINE; BRAIN; CORE; MACROPHAGES; AGONISTS	Background Recent evidence suggests the neurotrophic potential of hepatitis C virus (HCV). HCV NS3 protein is one of the potent antigens of this virus mediating inflammatory response in different cell types. Microglia being the immune surveillance cells in the central nervous system (CNS), the inflammatory potential of NS3 on microglia was studied. Role of toll like receptor (TLR) ligands Pam2CSK3 and Pam3CSK4 in controlling the NS3 mediated microglial inflammation was studied using microglial cell line CHME3. Methods IL (Interleukin)-8, IL-6, TNF-alpha (Tumor nicrosis factor alpha) and IL-1 beta gene expressions were measured by semi quantitative RT-PCR (reverse transcription-PCR). ELISA was performed to detect IL-8, IL-6, TNF-alpha, IL-1 beta and IL-10 secretion. FACS (Flourescent activated cell sorting) was performed to quantify TLR1, TLR2, TLR6, MyD88 (Myeloid differntiation factor 88), IkB-alpha (I kappaB alpha) and pNF-kappa B (phosphorylated nuclear factor kappaB) expression. Immunofluorescence staining was performed for MyD88, TLR6 and NF-kappa B (Nuclear factor kappaB). Student's t-test or One way analysis of variance with Bonferoni post hoc test was performed and p < 0.05 was considered significant. Results Microglia responded to NS3 by secreting IL-8, IL-6, TNF-alpha and IL-1 beta via TLR2 or TLR6 mediated MyD88/NF-kappa B pathway. Transcription factor NF-.kappa B was involved in activating the cytokine gene expression and the resultant inflammatory response was controlled by NF-kappa B inhibitor, Ro106-9920, which is known to down regulate pro-inflammatory cytokine secretion. Activation of the microglia by TLR agonists Pam3CSK4 and Pam2CSK4 induced immune tolerance against NS3. TLR ligand treatment significantly down regulated pro-inflammatory cytokine secretion in the microglia. IL-10 secretion was suggested as the possible mechanism by which TLR agonists induced immune tolerance. NS3 as such was not capable of self-inducing immune tolerance in microglia. Conclusion In conclusion, NS3 protein was capable of activatingmicroglia and the inflammatory response could be controlled via blocking the transcription factor NF-kappa B, or by treating themicroglia with TLR ligands which likely function via secreting anti-inflammatory cytokines such as IL-10. This can have therapeutic potential in controlling HCV mediated neuroinflammation.	[Rajalakshmy, Ayilam Ramachandran; Malathi, Jambulingam; Madhavan, Hajib Naraharirao] Vis Res Fdn, L&T Microbiol Res Ctr, Madras, Tamil Nadu, India; [Rajalakshmy, Ayilam Ramachandran] SASTRA Univ, Ctr Nanotechnol & Adv Biomat, Thanjavur, India	Shanmugha Arts, Science, Technology & Research Academy (SASTRA)	Malathi, J (corresponding author), Vis Res Fdn, L&T Microbiol Res Ctr, Madras, Tamil Nadu, India.	drjm@snmail.org	/AAD-1512-2020		 [BT/PR1028/med/29/303/2011];  [IF110775]	; 	This study was supported by BT/PR1028/med/29/303/2011 (http://dbtindia.nic.in/index.asp) and IF110775 (http://www.dst.gov.in/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bielefeldt-Ohmann H, 2012, INT J EXP PATHOL, V93, P24, DOI 10.1111/j.1365-2613.2011.00795.x; Burlone ME, 2009, J GEN VIROL, V90, P1055, DOI 10.1099/vir.0.008300-0; Chang S, 2007, J LEUKOCYTE BIOL, V82, P479, DOI 10.1189/jlb.0207128; Chung H, 2010, J INFECT DIS, V202, P853, DOI 10.1086/655812; Dolganiuc A, 2004, GASTROENTEROLOGY, V127, P1513, DOI 10.1053/j.gastro.2004.08.067; Fishman SL, 2008, J INFECT DIS, V197, P597, DOI 10.1086/526519; Forton DM, 2004, J VIROL, V78, P5170, DOI 10.1128/JVI.78.10.5170-5183.2004; Galluzzi L, 2012, ONCOIMMUNOLOGY, V1, P699, DOI 10.4161/onci.20696; Gomez-Nicola D, 2010, GLIA, V58, P264, DOI 10.1002/glia.20920; Gravitz L, 2011, NATURE, V474, pS2, DOI 10.1038/474S2a; Griffiths M, 2007, INT REV NEUROBIOL, V82, P29, DOI 10.1016/S0074-7742(07)82002-2; Howard CR, 2002, J GASTROEN HEPATOL, V17, pS468, DOI 10.1046/j.1440-1746.17.s4.12.x; Hu SX, 1999, J LEUKOCYTE BIOL, V65, P815, DOI 10.1002/jlb.65.6.815; Husemann J, 2002, GLIA, V40, P195, DOI 10.1002/glia.10148; Husemann J, 2001, AM J PATHOL, V158, P825, DOI 10.1016/S0002-9440(10)64030-8; Jack CS, 2005, J IMMUNOL, V175, P4320, DOI 10.4049/jimmunol.175.7.4320; JANABI N, 1995, NEUROSCI LETT, V195, P105, DOI 10.1016/0304-3940(94)11792-H; Kanzler H, 2007, NAT MED, V13, P552, DOI 10.1038/nm1589; Laskus T, 2002, J VIROL, V76, P10064, DOI 10.1128/JVI.76.19.10064-10068.2002; Letendre S, 2007, J INFECT DIS, V196, P361, DOI 10.1086/519285; Makela SM, 2009, J LEUKOCYTE BIOL, V85, P664, DOI 10.1189/jlb.0808503; Martins KAO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089735; Mifsud EJ, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00079; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Murray J, 2008, J NEUROVIROL, V14, P17, DOI 10.1080/13550280701708427; Nakao Y, 2007, J LEUKOCYTE BIOL, V174, P1566; Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049; Nomura F, 2000, J IMMUNOL, V164, P3476, DOI 10.4049/jimmunol.164.7.3476; Penin F, 2004, HEPATOLOGY, V39, P5, DOI 10.1002/hep.20032; Sillanpaa M, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-84; Swinney DC, 2002, J BIOL CHEM, V277, P23573, DOI 10.1074/jbc.M200842200; Vivithanaporn P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012856; Wang JP, 2005, J VIROL, V79, P12658, DOI 10.1128/JVI.79.20.12658-12666.2005; Wilkinson J, 2009, J VIROL, V83, P1312, DOI 10.1128/JVI.01890-08; Wu CCN, 2014, J INNATE IMMUN, V6, P315, DOI 10.1159/000355217; Yamazaki S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018833; Zhang C, 2005, J VIROL, V79, P8687, DOI 10.1128/JVI.79.14.8687-8697.2005	38	20	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0125419	10.1371/journal.pone.0125419	http://dx.doi.org/10.1371/journal.pone.0125419			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965265	Green Published, Green Submitted, gold			2022-12-26	WOS:000354543500017
J	Yu, DK; Zhang, GS; Huang, XD; Wu, C; Tan, W; Qiao, Y; Chang, J; Zhao, H; Bi, XY; Cai, JQ; Li, Y; Lin, DX				Yu, Dianke; Zhang, Guosheng; Huang, Xudong; Wu, Chen; Tan, Wen; Qiao, Yan; Chang, Jiang; Zhao, Hong; Bi, Xinyu; Cai, Jianqiang; Li, Yun; Lin, Dongxin			Relatively Small Contribution of Methylation and Genomic Copy Number Aberration to the Aberrant Expression of Inflammation-Related Genes in HBV-Related Hepatocellular Carcinoma	PLOS ONE			English	Article							LIVER-CANCER; HYPERMETHYLATION; CARCINOGENESIS; EPIDEMIOLOGY; LANDSCAPE	Background It is well known that chronic inflammation plays a pivotal role in the development of hepatitis B virus (HBV) related hepatocellular carcinoma (HCC). However, the causes behind aberrant expression of inflammation-related genes occurred in HCC remain unclear. Methods We performed array-based analyses to comprehensively investigate the contributions of DNA methylation and somatic copy number aberration (SCNA) to the aberrant expression of 1,027 inflammation-related genes in 30 HCCs and paired non-tumor tissues. The results were validated in public datasets and an additional sample set of 47 paired HCCs and non-tumor tissues. Results We identified 252 differentially expressed, 125 aberrantly methylated and 287 copy number changed inflammation-related genes. Despite reasonable statistical power, among them, only 11 genes and 56 genes whose aberrant expression was associated with DNA methylation or SCNA, respectively. DNA methylation and SCNA together contributed to less than 30% aberrant expression of inflammation-related genes. Conclusion These results suggest that molecular mechanisms other than DNA methylation and SCNA might play major role in the regulation of aberrant expression of inflammation-related gene in HBV-related HCCs.	[Yu, Dianke; Huang, Xudong; Wu, Chen; Tan, Wen; Qiao, Yan; Chang, Jiang; Lin, Dongxin] Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China; [Yu, Dianke; Huang, Xudong; Wu, Chen; Tan, Wen; Qiao, Yan; Chang, Jiang; Lin, Dongxin] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Etiol & Carcinogenesis, Beijing 100730, Peoples R China; [Yu, Dianke; Huang, Xudong; Wu, Chen; Tan, Wen; Qiao, Yan; Chang, Jiang; Zhao, Hong; Bi, Xinyu; Cai, Jianqiang; Lin, Dongxin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhang, Guosheng; Li, Yun] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Zhang, Guosheng; Li, Yun] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Zhao, Hong; Bi, Xinyu; Cai, Jianqiang] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Abdominal Surg, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS	Cai, JQ (corresponding author), Chinese Acad Med Sci, Canc Inst & Hosp, Dept Abdominal Surg, Beijing 100730, Peoples R China.	caijianqiang188@sina.com; yunli@med.unc.edu; lindx@cicams.ac.cn		Wu, Chen/0000-0003-4954-1011; Lin, Dongxin/0000-0002-8723-8868	National Natural Science Foundation of China [81030050]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (grant No. 81030050). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Ammerpohl O, 2012, INT J CANCER, V130, P1319, DOI 10.1002/ijc.26136; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hishida M, 2013, INT J ONCOL, V43, P88, DOI 10.3892/ijo.2013.1951; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Komatsu Y, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-5; Lamb JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020090; Lee Ju-Seog, 2013, Genomics & Informatics, V11, P180, DOI 10.5808/GI.2013.11.4.180; Loza MJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001035; Natoli G, 2011, GENE DEV, V25, P101, DOI 10.1101/gad.2018811; Nordlund J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034513; Ozen C, 2013, NEW BIOTECHNOL, V30, P381, DOI 10.1016/j.nbt.2013.01.007; Rogers AB, 2004, AM J PHYSIOL-GASTR L, V286, pG361, DOI 10.1152/ajpgi.00499.2003; Sutherland KD, 2004, ONCOGENE, V23, P7726, DOI 10.1038/sj.onc.1207787; Tanaka M, 2011, J EPIDEMIOL, V21, P401, DOI 10.2188/jea.JE20100190; Trevisani F, 2008, CARCINOGENESIS, V29, P1299, DOI 10.1093/carcin/bgn113; Wai PY, 2012, WORLD J CLIN ONCOL, V3, P15, DOI 10.5306/wjco.v3.i2.15; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wang K, 2013, HEPATOLOGY, V58, P706, DOI 10.1002/hep.26402; Wang TL, 2002, P NATL ACAD SCI USA, V99, P16156, DOI 10.1073/pnas.202610899; Wang WL, 2013, CANCER SCI, V104, P1523, DOI 10.1111/cas.12279; Wojdacz TK, 2008, NAT PROTOC, V3, P1903, DOI 10.1038/nprot.2008.191; Ying J, 2006, LEUKEMIA, V20, P1173, DOI 10.1038/sj.leu.2404193; Zhang ZM, 2012, NAT GENET, V44, P1075, DOI 10.1038/ng.2412; Zitvogel L, 2012, NAT IMMUNOL, V13, P343, DOI 10.1038/ni.2224	28	1	1	1	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0126836	10.1371/journal.pone.0126836	http://dx.doi.org/10.1371/journal.pone.0126836			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965583	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000354543500082
J	de la Maria, CG; Cervera, C; Pericas, JM; Castaneda, X; Armero, Y; Soy, D; Almela, M; Ninot, S; Falces, C; Mestres, CA; Gatell, JM; Moreno, A; Marco, F; Miro, JM				Garcia de la Maria, Cristina; Cervera, Carlos; Pericas, Juan M.; Castaneda, Ximena; Armero, Yolanda; Soy, Dolors; Almela, Manel; Ninot, Salvador; Falces, Carlos; Mestres, Carlos A.; Gatell, Jose M.; Moreno, Asuncion; Marco, Francesc; Miro, Jose M.		Hosp Clin Endocarditis Study Grp	Epidemiology and Prognosis of Coagulase-Negative Staphylococcal Endocarditis: Impact of Vancomycin Minimum Inhibitory Concentration	PLOS ONE			English	Article							NATIVE-VALVE ENDOCARDITIS; BLOOD-STREAM INFECTIONS; IN-VITRO ACTIVITY; METHICILLIN-RESISTANT; ANTIMICROBIAL ACTIVITY; SURVEILLANCE PROGRAM; AUREUS BACTEREMIA; LEAD ENDOCARDITIS; US HOSPITALS; DAPTOMYCIN	This study describes coagulase-negative staphylococcal (CoNS) infective endocarditis (IE) epidemiology at our institution, the antibiotic susceptibility profile, and the influence of vancomycin minimum inhibitory concentration (MIC) on patient outcomes. One hundred and three adults with definite IE admitted to an 850-bed tertiary care hospital in Barcelona from 1995-2008 were prospectively included in the cohort. We observed that CoNS IE was an important cause of community-acquired and healthcare-associated IE; one-third of patients involved native valves. Staphylococcus epidermidis was the most frequent species, methicillin-resistant in 52% of patients. CoNS frozen isolates were available in 88 patients. Vancomycin MICs of 2.0 mu g/mL were common; almost all cases were found among S. epidermidis isolates and did not increase over time. Eighty-five patients were treated either with cloxacillin or vancomycin: 38 patients (Group 1) were treated with cloxacillin, and 47 received vancomycin; of these 47, 27 had CoNS isolates with a vancomycin MIC <2.0 mu g/mL (Group 2), 20 had isolates with a vancomycin MIC >= 2.0 mu g/mL (Group 3). One-year mortality was 21%, 48%, and 65% in Groups 1, 2, and 3, respectively (P=0.003). After adjusting for confounders and taking Group 2 as a reference, methicillin-susceptibility was associated with lower 1-year mortality (OR 0.12, 95% CI 0.02-0.55), and vancomycin MIC >= 2.0 mu g/mL showed a trend to higher 1-year mortality (OR 3.7, 95% CI 0.9-15.2; P=0.069). Other independent variables associated with 1-year mortality were heart failure (OR 6.2, 95% CI 1.5-25.2) and pacemaker lead IE (OR 0.1, 95%CI 0.02-0.51). In conclusion, methicillin-resistant S. epidermidis was the leading cause of CoNS IE, and patients receiving vancomycin had higher mortality rates than those receiving cloxacillin; mortality was higher among patients having isolates with vancomycin MICs >= 2.0 mu g/mL.	[Garcia de la Maria, Cristina; Cervera, Carlos; Pericas, Juan M.; Castaneda, Ximena; Armero, Yolanda; Gatell, Jose M.; Moreno, Asuncion; Miro, Jose M.] Univ Barcelona, Sch Med, IDIBAPS, Infect Dis Serv,Hosp Clin, Barcelona, Spain; [Almela, Manel; Marco, Francesc] Univ Barcelona, Sch Med, IDIBAPS, Microbiol Serv,Hosp Clin, Barcelona, Spain; [Soy, Dolors] Univ Barcelona, Sch Med, IDIBAPS, Pharm Serv,Hosp Clin, Barcelona, Spain; [Ninot, Salvador; Mestres, Carlos A.] Univ Barcelona, Sch Med, IDIBAPS, Dept Cardiovasc Surg,Hosp Clin, Barcelona, Spain; [Falces, Carlos] Univ Barcelona, Sch Med, IDIBAPS, Cardiol Serv,Hosp Clin, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Miro, JM (corresponding author), Univ Barcelona, Sch Med, IDIBAPS, Infect Dis Serv,Hosp Clin, Barcelona, Spain.	jmmiro@ub.edu	Cervera, Carlos/U-4538-2018; Pericàs, Juan M/N-5674-2019; Gatell, Jose M/ABC-3607-2020; de la Maria, Cristina Garcia/H-7302-2017; Marco, Francesc D/K-2900-2017; Vila, Jordi/P-3613-2016	Cervera, Carlos/0000-0002-0161-1749; Pericàs, Juan M/0000-0002-3645-3293; de la Maria, Cristina Garcia/0000-0002-0585-9469; Marco, Francesc D/0000-0002-1863-6379; Vila, Jordi/0000-0002-8025-3926; Brunet, Merce/0000-0002-7154-916X; Falces, Carlos/0000-0002-3483-3786; Moreno Camacho, Asuncion/0000-0002-5850-5007; Granados Oliveros, Ulises/0000-0002-4056-6477; Pereda, Daniel/0000-0002-0526-8722; Tellez, Adrian/0000-0003-3502-5999; Quintana, Eduard/0000-0002-5386-7463	Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III (Madrid, Spain); Spanish Network for Research in Infectious Diseases [REIPI RD06/0008]; Fundacion Meximo Soriano Jimenez (Barcelona, Spain); Hospital Clinic, Barcelona (Spain); Instituto de Salud Carlos III, Madrid (Spain) [CM14/00135]; Ministerio de Economia and Competitividad, Madrid (Spain) [CM14/00135]	Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III (Madrid, Spain)(Instituto de Salud Carlos III); Spanish Network for Research in Infectious Diseases; Fundacion Meximo Soriano Jimenez (Barcelona, Spain); Hospital Clinic, Barcelona (Spain); Instituto de Salud Carlos III, Madrid (Spain)(Instituto de Salud Carlos III); Ministerio de Economia and Competitividad, Madrid (Spain)	This work was supported in part by a grant from the "Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III" (Madrid, Spain; http://www.isciii.es/), the Spanish Network for Research in Infectious Diseases (REIPI RD06/0008; http://www.reipi.org/), and the "Fundacion Meximo Soriano Jimenez" (Barcelona, Spain; http://www.fundsoriano.es/). JP received, during the period of manuscript elaboration, an "Emili Letang" Post-residency Scholarship (2013-14) from the Hospital Clinic, Barcelona (Spain) and a "Rio Hortega" Research Grant (CM14/00135; 2015-16) from the 'Instituto de Salud Carlos III' and the 'Ministerio de Economia and Competitividad', Madrid (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anguera I, 2005, HEART, V91, DOI 10.1136/hrt.2004.040659; Athan E, 2012, JAMA-J AM MED ASSOC, V307, P1727, DOI 10.1001/jama.2012.497; Baddour LM, 2005, CIRCULATION, V111, pE394, DOI 10.1161/CIRCULATIONAHA.105.165564; Benito N, 2009, ANN INTERN MED, V150, P586, DOI 10.7326/0003-4819-150-9-200905050-00004; Biavasco F, 2000, EUR J CLIN MICROBIOL, V19, P403, DOI 10.1007/s100960000299; Cervera C, 2014, CLIN INFECT DIS, V58, P1668, DOI 10.1093/cid/ciu183; Chu VH, 2009, HEART, V95, P570, DOI 10.1136/hrt.2008.152975; Chu VH, 2008, CLIN INFECT DIS, V46, P232, DOI 10.1086/524666; Cuevas O, 2008, ENFERM INFEC MICR CL, V26, P269, DOI 10.1157/13120413; Das I, 2011, EUR J CLIN MICROBIOL, V30, P807, DOI 10.1007/s10096-011-1160-y; del Rio A, 2003, CHEST, V124, P1451, DOI 10.1378/chest.124.4.1451; Dominguez-Herrera J, 2012, ANTIMICROB AGENTS CH, V56, P613, DOI 10.1128/AAC.05606-11; Duah M, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-9; Durante-Mangoni E, 2012, CLIN INFECT DIS, V54, P347, DOI 10.1093/cid/cir805; Flamm RK, 2012, CLIN INFECT DIS, V55, pS194, DOI 10.1093/cid/cis562; Friedman ND, 2002, ANN INTERN MED, V137, P791, DOI 10.7326/0003-4819-137-10-200211190-00007; Fritsche TR, 2008, DIAGN MICR INFEC DIS, V61, P86, DOI 10.1016/j.diagmicrobio.2008.02.008; Gandelman Glenn, 2007, Cardiol Rev, V15, P13, DOI 10.1097/01.crd.0000197966.53529.67; Garcia-de-la-Maria C, 2010, ANTIMICROB AGENTS CH, V54, P2781, DOI 10.1128/AAC.01011-09; Gu B, 2013, J ANTIMICROB CHEMOTH, V68, P4, DOI 10.1093/jac/dks354; Habib G, 2009, EUR HEART J, V30, P2369, DOI 10.1093/eurheartj/ehp285; Holland TL, 2011, J INFECT DIS, V204, P329, DOI 10.1093/infdis/jir275; Holmes NE, 2013, ANTIMICROB AGENTS CH, V57, P1654, DOI 10.1128/AAC.01485-12; Holmes NE, 2011, J INFECT DIS, V204, P340, DOI 10.1093/infdis/jir270; Hope R, 2013, INT J ANTIMICROB AG, V41, P213, DOI 10.1016/j.ijantimicag.2012.10.016; Huebner J, 1999, ANNU REV MED, V50, P223, DOI 10.1146/annurev.med.50.1.223; John Joseph F, 2007, Ther Clin Risk Manag, V3, P1143; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Loza E, 2008, ENFERM INFEC MICR CL, V26, P489, DOI 10.1157/13127453; Murdoch DR, 2009, ARCH INTERN MED, V169, P463, DOI 10.1001/archinternmed.2008.603; Natoli S, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-83; Picazo JJ, 2011, DIAGN MICR INFEC DIS, V70, P373, DOI 10.1016/j.diagmicrobio.2011.02.009; Rybak MJ, 2009, PHARMACOTHERAPY, V29, P1275, DOI 10.1592/phco.29.11.1275; Sader HS, 2013, ANTIMICROB AGENTS CH, V57, P3178, DOI 10.1128/AAC.00484-13; Sakoulas G, 2004, J CLIN MICROBIOL, V42, P2398, DOI 10.1128/JCM.42.6.2398-2402.2004; Soriano A, 2008, CLIN INFECT DIS, V46, P193, DOI 10.1086/524667; Stuart JI, 2011, INT J ANTIMICROB AG, V37, P248, DOI 10.1016/j.ijantimicag.2010.11.020; WILSON WR, 1995, JAMA-J AM MED ASSOC, V274, P1706, DOI 10.1001/jama.274.21.1706; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946	39	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0125818	10.1371/journal.pone.0125818	http://dx.doi.org/10.1371/journal.pone.0125818			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961578	Green Published, gold			2022-12-26	WOS:000354542500046
J	Hao, XY; Chao, W; Yang, YJ; Horvath, D				Hao, Xinyuan; Chao, Wun; Yang, Yajun; Horvath, David			Coordinated Expression of FLOWERING LOCUS T and DORMANCY ASSOCIATED MADS-BOX-Like Genes in Leafy Spurge	PLOS ONE			English	Article							PERSICA L. BATSCH; CIRCADIAN CLOCK; CARBOHYDRATE-METABOLISM; PROTEIN ACCUMULATION; BUD DORMANCY; CROWN BUDS; CONSTANS; TIME; TRANSCRIPTION; PHOTOPERIOD	Leafy spurge (Euphorbia esula L.) is a noxious perennial weed that produces underground adventitious buds, which are crucial for generating new vegetative shoots following periods of freezing temperatures or exposure to various control measures. It is also capable of flowering and producing seeds, but requires vernalization in some cases. DORMANCY ASSOCIATED MADS-BOX (DAM) genes have been proposed to play a direct role in the transition to winter-induced dormancy and maintenance through regulation of the FLOWERING LOCUS T (FT) gene, which also is likely involved in the vernalization process. To explore the regulation of FT and DAM during dormancy transitions in leafy spurge, the transcript accumulation of two previously cloned DAM splice variants and two different previously cloned FT genes was characterized. Under long-photoperiods (16 h light), both DAM and FT transcripts accumulate in a diurnal manner. Tissue specific expression patterns indicated the tissues with high DAM expression had low FT expression and vice versa. DAM expression is detected in leaves, stems, shoot tips, and crown buds. FT transcripts were detected mainly in leaves and flowers. Under dormancy inducing conditions, DAM and FT genes had an inverse expression pattern. Additionally, chromatin immunoprecipitation assays were performed using DAM-like protein specific antibodies to demonstrate that DAM or related proteins likely bind to cryptic and/or conserved CArG boxes in the promoter regions of FT genes isolated from endodormant crown buds. These results are consistent with the hypothesis that DAM proteins play a crucial role in leafy spurge dormancy transition and maintenance, potentially by negatively regulating the expression of FT.	[Hao, Xinyuan; Yang, Yajun] Chinese Acad Agr Sci, Tea Res Inst, Hangzhou 310008, Zhejiang, Peoples R China; [Hao, Xinyuan; Yang, Yajun] Minist Agr, Natl Ctr Tea Improvement, Key Lab Tea Biol & Resources Utilizat, Hangzhou 310008, Zhejiang, Peoples R China; [Hao, Xinyuan; Chao, Wun; Horvath, David] ARS, USDA, Biosci Res Lab, Fargo, ND 58105 USA; [Hao, Xinyuan] Northwest A&F Univ, Coll Hort, Yangling 712100, Shaanxi, Peoples R China	Chinese Academy of Agricultural Sciences; Tea Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; United States Department of Agriculture (USDA); Northwest A&F University - China	Horvath, D (corresponding author), ARS, USDA, Biosci Res Lab, 1605 Albrecht Blvd, Fargo, ND 58105 USA.	david.horvath@ars.usda.gov	Hao, Xinyuan/AAF-6386-2021	Hao, Xinyuan/0000-0001-8300-7491; Yang, Yajun/0000-0003-0552-5730	Novel Weed Management Solutions: a Basis in Understanding Bud and Seed Dormancy CRIS [3060-21220-026-00]; China Scholarship Council	Novel Weed Management Solutions: a Basis in Understanding Bud and Seed Dormancy CRIS; China Scholarship Council(China Scholarship Council)	The work was supported by Novel Weed Management Solutions: a Basis in Understanding Bud and Seed Dormancy CRIS#3060-21220-026-00 and a graduate scholarship from the China Scholarship Council.	Adams S, 2011, ESSAYS BIOCHEM, V49, P53, DOI 10.1042/BSE0490053; Anderson JV, 2005, PLANT CELL ENVIRON, V28, P1567, DOI 10.1111/j.1365-3040.2005.01393.x; Bielenberg DG, 2008, TREE GENET GENOMES, V4, P495, DOI 10.1007/s11295-007-0126-9; Bohlenius H, 2006, SCIENCE, V312, P1040, DOI 10.1126/science.1126038; Castillejo C, 2008, CURR BIOL, V18, P1338, DOI 10.1016/j.cub.2008.07.075; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chao WS, 2007, PLANT MOL BIOL, V63, P365, DOI 10.1007/s11103-006-9094-y; Chao WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042839; Chao WS, 2010, PLANT MOL BIOL, V73, P227, DOI 10.1007/s11103-009-9568-9; Cooke JEK, 2012, PLANT CELL ENVIRON, V35, P1707, DOI 10.1111/j.1365-3040.2012.02552.x; Danilevskaya ON, 2011, PLANT SIGNAL BEHAV, V6, P1267, DOI 10.4161/psb.6.9.16423; Dogramaci M, 2010, PLANT MOL BIOL, V73, P207, DOI 10.1007/s11103-010-9621-8; Foley ME, 2009, BOTANY, V87, P986, DOI 10.1139/B09-055; Fujiwara S, 2008, PLANT CELL, V20, P2960, DOI 10.1105/tpc.108.061531; Gregis V, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r56; Horvath D, 2009, PLANT SCI, V177, P523, DOI 10.1016/j.plantsci.2009.09.002; Horvath DP, 2013, WEED SCI, V61, P303, DOI 10.1614/WS-D-12-00175.1; Horvath DP, 2010, PLANT MOL BIOL, V73, P169, DOI 10.1007/s11103-009-9596-5; Horvath DP, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-536; Horvath DP, 2003, TRENDS PLANT SCI, V8, P534, DOI 10.1016/j.tplants.2003.09.013; Horvath DP, 1998, CAN J BOT, V76, P1227, DOI 10.1139/cjb-76-7-1227; HORVATH DP, 1993, PLANT PHYSIOL, V103, P1047, DOI 10.1104/pp.103.4.1047; Hsu CY, 2011, P NATL ACAD SCI USA, V108, P10756, DOI 10.1073/pnas.1104713108; Inigo S, 2012, PLANT J, V69, P601, DOI 10.1111/j.1365-313X.2011.04815.x; Jang S, 2009, PLANT J, V60, P614, DOI 10.1111/j.1365-313X.2009.03986.x; Jimenez S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-81; Kumar SV, 2012, NATURE, V484, P242, DOI 10.1038/nature10928; Kumimoto RW, 2010, PLANT J, V63, P379, DOI 10.1111/j.1365-313X.2010.04247.x; Lee JH, 2007, GENE DEV, V21, P397, DOI 10.1101/gad.1518407; Li D, 2008, DEV CELL, V15, P110, DOI 10.1016/j.devcel.2008.05.002; Li ZG, 2009, J EXP BOT, V60, P3521, DOI 10.1093/jxb/erp195; Liu HT, 2008, SCIENCE, V322, P1535, DOI 10.1126/science.1163927; Mathieu J, 2007, CURR BIOL, V17, P1055, DOI 10.1016/j.cub.2007.05.009; Mathieu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000148; Mouhu K, 2013, PLANT CELL, V25, P3296, DOI 10.1105/tpc.113.115055; Pin PA, 2012, PLANT CELL ENVIRON, V35, P1742, DOI 10.1111/j.1365-3040.2012.02558.x; Roden LC, 2002, P NATL ACAD SCI USA, V99, P13313, DOI 10.1073/pnas.192365599; Ruttink T, 2007, PLANT CELL, V19, P2370, DOI 10.1105/tpc.107.052811; Sasaki R, 2011, PLANT PHYSIOL, V157, P485, DOI 10.1104/pp.111.181982; Sawa M, 2011, P NATL ACAD SCI USA, V108, P11698, DOI 10.1073/pnas.1106771108; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Tang WN, 2003, J BIOL CHEM, V278, P28154, DOI 10.1074/jbc.M212976200; Tiwari SB, 2010, NEW PHYTOL, V187, P57, DOI 10.1111/j.1469-8137.2010.03251.x; Trainin T, 2013, TREE GENET GENOMES, V9, P753, DOI 10.1007/s11295-012-0590-8; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; WANG CS, 1992, AM J BOT, V79, P118, DOI 10.2307/2445097; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996	47	36	37	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126030	10.1371/journal.pone.0126030	http://dx.doi.org/10.1371/journal.pone.0126030			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961298	Green Published, gold, Green Submitted			2022-12-26	WOS:000354542500059
J	Karathanasis, N; Tsamardinos, I; Poirazi, P				Karathanasis, Nestoras; Tsamardinos, Ioannis; Poirazi, Panayiota			MiRduplexSVM: A High-Performing MiRNA-Duplex Prediction and Evaluation Methodology	PLOS ONE			English	Article							MICRORNAS; IDENTIFICATION; RECOGNITION; BIOGENESIS; CANCER; MODEL; TOOL	We address the problem of predicting the position of a miRNA duplex on a microRNA hairpin via the development and application of a novel SVM-based methodology. Our method combines a unique problem representation and an unbiased optimization protocol to learn from mirBase19.0 an accurate predictive model, termed MiRduplexSVM. This is the first model that provides precise information about all four ends of the miRNA duplex. We show that (a) our method outperforms four state-of-the-art tools, namely MaturePred, MiRPara, MatureBayes, MiRdup as well as a Simple Geometric Locator when applied on the same training datasets employed for each tool and evaluated on a common blind test set. (b) In all comparisons, MiRduplexSVM shows superior performance, achieving up to a 60% increase in prediction accuracy for mammalian hairpins and can generalize very well on plant hairpins, without any special optimization. (c) The tool has a number of important applications such as the ability to accurately predict the miRNA or the miRNA*, given the opposite strand of a duplex. Its performance on this task is superior to the 2nts overhang rule commonly used in computational studies and similar to that of a comparative genomic approach, without the need for prior knowledge or the complexity of performing multiple alignments. Finally, it is able to evaluate novel, potential miRNAs found either computationally or experimentally. In relation with recent confidence evaluation methods used in miRBase, MiRduplexSVM was successful in identifying high confidence potential miRNAs.	[Karathanasis, Nestoras] Univ Crete, Dept Biol, Iraklion, Greece; [Karathanasis, Nestoras; Poirazi, Panayiota] Fdn Res & Technol Hellas FORTH, Inst Mol Biol & Biotechnol, Iraklion, Greece; [Tsamardinos, Ioannis] Univ Crete, Dept Comp Sci, Iraklion, Greece; [Tsamardinos, Ioannis] Fdn Res & Technol Hellas FORTH, Inst Comp Sci, Iraklion, Greece	University of Crete; University of Crete	Poirazi, P (corresponding author), Fdn Res & Technol Hellas FORTH, Inst Mol Biol & Biotechnol, Iraklion, Greece.	poirazi@imbb.forth.gr		Poirazi, Panayiota/0000-0001-6152-595X	European Union (European Social Fund - ESF); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II; rpogram Investing in knowledge society through the European Social Fund; BIOSYS research project, Action KRIPIS [MIS-448301 (2013SE01380036)]; General Secretariat for Research and Technology, Ministry of Education, Greece; European Regional Development Fund/European Commission [20072013]	European Union (European Social Fund - ESF)(European Social Fund (ESF)European Commission); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II; rpogram Investing in knowledge society through the European Social Fund; BIOSYS research project, Action KRIPIS; General Secretariat for Research and Technology, Ministry of Education, Greece; European Regional Development Fund/European Commission	This work was supported by the European Union (European Social Fund - ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II and the rpogram Investing in knowledge society through the European Social Fund and the BIOSYS research project, Action KRIPIS, project No MIS-448301 (2013SE01380036) that was funded by the General Secretariat for Research and Technology, Ministry of Education, Greece and the European Regional Development Fund (Sectoral Operational Programme: Competitiveness and Entrepreneurship, NSRF 20072013)/European Commission.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Batuwita R, 2009, BIOINFORMATICS, V25, P989, DOI 10.1093/bioinformatics/btp107; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Gkirtzou K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011843; Hackenberg M, 2009, NUCLEIC ACIDS RES, V37, pW68, DOI 10.1093/nar/gkp347; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Hawkins PG, 2008, CELL CYCLE, V7, P602, DOI 10.4161/cc.7.5.5522; Helvik SA, 2007, BIOINFORMATICS, V23, P142, DOI 10.1093/bioinformatics/btl570; Karathanasis N, 2012, IEEE 12 INT C BIOINF; Karathanasis N, 2013, IEEE INT C BIOINF BI; Karathanasis N, 2014, BIOINFORMATICS, V30, P1047, DOI 10.1093/bioinformatics/btu100; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Leclercq M, 2013, NUCLEIC ACIDS RES, V41, P7200, DOI 10.1093/nar/gkt466; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Mathelier A, 2010, BIOINFORMATICS, V26, P2226, DOI 10.1093/bioinformatics/btq329; Mitchell TM, 1997, MACH LEARN, P45; Nam JW, 2005, NUCLEIC ACIDS RES, V33, P3570, DOI 10.1093/nar/gki668; Oulas A, 2012, RNA BIOL, V9, P1196, DOI 10.4161/rna.21725; Oulas A, 2009, NUCLEIC ACIDS RES, V37, P3276, DOI 10.1093/nar/gkp120; Simoneau M, 1999, ONCOGENE, V18, P157, DOI 10.1038/sj.onc.1202277; Tan YL, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-12; Terai G, 2007, RNA, V13, P2081, DOI 10.1261/rna.655107; Vermeulen A, 2005, RNA, V11, P674, DOI 10.1261/rna.7272305; Wu YG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-107; Xuan P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027422; Yousef M, 2006, BIOINFORMATICS, V22, P1325, DOI 10.1093/bioinformatics/btl094; Zarudnaya MI, 2013, J BIOMOL STRUCT DYN, V31, P1044, DOI 10.1080/07391102.2012.718530; Zeng Y, 2005, EMBO J, V24, P138, DOI 10.1038/sj.emboj.7600491	31	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126151	10.1371/journal.pone.0126151	http://dx.doi.org/10.1371/journal.pone.0126151			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961860	Green Submitted, Green Published, gold			2022-12-26	WOS:000354542500069
J	Loginov, VI; Dmitriev, AA; Senchenko, VN; Pronina, IV; Khodyrev, DS; Kudryavtseva, AV; Krasnov, GS; Gerashchenko, GV; Chashchina, LI; Kazubskaya, TP; Kondratieva, TT; Chashchina, LI; Kazubskaya, TP; Kondratieva, TT; Lerman, MI; Angeloni, D; Braga, EA; Kashuba, VI				Loginov, Vitaly I.; Dmitriev, Alexey A.; Senchenko, Vera N.; Pronina, Irina V.; Khodyrev, Dmitry S.; Kudryavtseva, Anna V.; Krasnov, George S.; Gerashchenko, Ganna V.; Chashchina, Larisa I.; Kazubskaya, Tatiana P.; Kondratieva, Tatiana T.; Chashchina, Larisa I.; Kazubskaya, Tatiana P.; Kondratieva, Tatiana T.; Lerman, Michael I.; Angeloni, Debora; Braga, Eleonora A.; Kashuba, Vladimir I.			Tumor Suppressor Function of the SEMA3B Gene in Human Lung and Renal Cancers	PLOS ONE			English	Article							HUMAN-CHROMOSOME 3P21.3; CARCINOMA CELL-LINE; SEMAPHORIN 3B; GASTRIC-CANCER; BREAST-CANCER; PROMOTER HYPERMETHYLATION; EPIGENETIC INACTIVATION; HOMOZYGOUS DELETION; ALLELE LOSS; EXPRESSION	The SEMA3B gene is located in the 3p21.3 LUCA region, which is frequently affected in different types of cancer. The objective of our study was to expand our knowledge of the SEMA3B gene as a tumor suppressor and the mechanisms of its inactivation. In this study, several experimental approaches were used: tumor growth analyses and apoptosis assays in vitro and in SCID mice, expression and methylation assays and other. With the use of the small cell lung cancer cell line U2020 we confirmed the function of SEMA3B as a tumor suppressor, and showed that the suppression can be realized through the induction of apoptosis and, possibly, associated with the inhibition of angiogenesis. In addition, for the first time, high methylation frequencies have been observed in both intronic (32-39%) and promoter (44-52%) CpG-islands in 38 non-small cell lung carcinomas, including 16 squamous cell carcinomas (SCC) and 22 adenocarcinomas (ADC), and in 83 clear cell renal cell carcinomas (ccRCC). Correlations between the methylation frequencies of the promoter and the intronic CpG-islands of SEMA3B with tumor stage and grade have been revealed for SCC, ADC and ccRCC. The association between the decrease of the SEMA3B mRNA level and hypermethylation of the promoter and the intronic CpG-islands has been estimated in renal primary tumors (P < 0.01). Using qPCR, we observed on the average 10- and 14-fold decrease of the SEMA3B mRNA level in SCC and ADC, respectively, and a 4-fold decrease in ccRCC. The frequency of this effect was high in both lung (92-95%) and renal (84%) tumor samples. Moreover, we showed a clear difference (P < 0.05) of the SEMA3B relative mRNA levels in ADC with and without lymph node metastases. We conclude that aberrant expression and methylation of SEMA3B could be suggested as markers of lung and renal cancer progression.	[Loginov, Vitaly I.; Pronina, Irina V.; Braga, Eleonora A.] Russian Acad Med Sci, Inst Gen Pathol & Pathophysiol, Lab Pathogen & Transcript, Moscow 125315, Russia; [Loginov, Vitaly I.; Pronina, Irina V.; Braga, Eleonora A.] Russian Acad Med Sci, Med Genet Res Ctr, Lab Mol Genet Complex Inherited Dis, Moscow 115478, Russia; [Dmitriev, Alexey A.; Senchenko, Vera N.; Kudryavtseva, Anna V.; Krasnov, George S.] Russian Acad Sci, Engelhardt Inst Mol Biol, Lab Struct & Funct Genom, Moscow 119991, Russia; [Dmitriev, Alexey A.; Kudryavtseva, Anna V.] Minist Healthcare Russian Federat, PA Herzen Moscow Canc Res Inst, Dept Pathomorphol, Moscow 125284, Russia; [Khodyrev, Dmitry S.] Fed Med & Biol Agcy Russia, Fed Res Clin Ctr, Genet Lab, Moscow 115682, Russia; [Krasnov, George S.] Russian Acad Med Sci, Mechnikov Res Inst Vaccines & Sera, Biotechnol Lab, Moscow 105064, Russia; [Gerashchenko, Ganna V.; Chashchina, Larisa I.; Kashuba, Vladimir I.] Natl Acad Sci Ukraine, Inst Mol Biol & Genet, Dept Mol Oncogenet, UA-03680 Kiev, Ukraine; [Kazubskaya, Tatiana P.; Kondratieva, Tatiana T.] Russian Acad Med Sci, NN Blokhin Canc Res Ctr, Res Inst Clin Oncol, Moscow 115478, Russia; [Lerman, Michael I.] Affina Biotechnol, Sci Board, Stamford, CT 06902 USA; [Angeloni, Debora] Scuola Super Sant Anna, Inst Life Sci, I-56127 Pisa, Italy; [Angeloni, Debora] CNR, Inst Clin Physiol, I-56124 Pisa, Italy; [Angeloni, Debora] Ist Toscano Tumori, I-56124 Pisa, Italy; [Braga, Eleonora A.] Russian Acad Sci, Inst Biochem Phys, Lab Post Genom Mol Genet Res, Moscow 119334, Russia; [Kashuba, Vladimir I.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, SE-17177 Stockholm, Sweden	Russian Academy of Medical Sciences; Institute of General Pathology & Pathophysiology, RAMS; Research Centre for Medical Genetics; Russian Academy of Medical Sciences; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Russian Academy of Medical Sciences; Research Institute of Vaccines and Sera Mechnikov, RAMS; National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU; N.N. Blokhin Russian Cancer Research Center; Russian Academy of Medical Sciences; Scuola Superiore Sant'Anna; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; Russian Academy of Sciences; Emanuel Institute of Biochemical Physics; Karolinska Institutet	Senchenko, VN (corresponding author), Russian Acad Sci, Engelhardt Inst Mol Biol, Lab Struct & Funct Genom, Moscow 119991, Russia.	versen@eimb.ru	Gerashchenko, Ganna/N-3797-2017; Loginov, Vytaliy/J-9738-2018; Kudryavtseva, Anna V/C-9032-2014; Braga, Eleonora A./P-5574-2016; Senchenko, Vera N/C-8992-2014; Pronina, Irina/ABD-8018-2021; Gerashchenko, Ganna/AAO-7703-2020; Krasnov, George S/Q-2591-2017; Карпухин, Александр В/J-2337-2018; Dmitriev, Alexey A./D-6109-2011; Kashuba, Vladimir/AAO-7742-2020; Krasnov, George S/E-6529-2014; Kashuba, Vladimir I/N-3732-2017; Khodyrev, Dmitriy/M-7237-2014; Pronina, Irina Valerievna/G-3951-2014	Gerashchenko, Ganna/0000-0002-4700-5736; Loginov, Vytaliy/0000-0003-2668-8096; Kudryavtseva, Anna V/0000-0002-3722-8207; Senchenko, Vera N/0000-0002-3119-515X; Pronina, Irina/0000-0002-0423-7801; Gerashchenko, Ganna/0000-0002-4700-5736; Krasnov, George S/0000-0002-6493-8378; Dmitriev, Alexey A./0000-0002-6827-9584; Krasnov, George S/0000-0002-6493-8378; Kashuba, Vladimir I/0000-0001-9416-8282; Pronina, Irina Valerievna/0000-0002-0423-7801; Angeloni, Debora/0000-0002-3850-5392; Hodyrev, Dmitrii/0000-0001-6518-8305; Braga, Eleonora/0000-0001-5188-4094	Russian Foundation for Basic Research [13-04-00828a, 13-04-02072a, 14-04-32084 mol_a]; Istituto Toscano Tumori [28.12.07-6888]; CNR-RAS Joint Projects; RAS Presidium Program "Molecular and Cellular Biology"; Ministry of Education and Science of the Russian Federation [14.604.21.0117, RFMEFI60414X0117, 14.621.21.0001, RFMEFI62114X0001]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Istituto Toscano Tumori; CNR-RAS Joint Projects; RAS Presidium Program "Molecular and Cellular Biology"; Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation)	This work was supported by grants 13-04-00828a, 13-04-02072a, and 14-04-32084 mol_a from the Russian Foundation for Basic Research; grant 28.12.07-6888 from Istituto Toscano Tumori; a grant from CNR-RAS Joint Projects 2008-2010; the grant from RAS Presidium Program "Molecular and Cellular Biology"; contracts 14.604.21.0117 (project's unique identifier RFMEFI60414X0117) and 14.621.21.0001 (project's unique identifier RFMEFI62114X0001) from the Ministry of Education and Science of the Russian Federation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimov A, 2000, ONCOGENE, V19, P1392, DOI 10.1038/sj.onc.1203449; Angeloni Debora, 2007, Briefings in Functional Genomics & Proteomics, V6, P19, DOI 10.1093/bfgp/elm007; Angeloni D, 2006, GENE CHROMOSOME CANC, V45, P676, DOI 10.1002/gcc.20332; Basile JR, 2006, P NATL ACAD SCI USA, V103, P9017, DOI 10.1073/pnas.0508825103; Bender RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061788; Bernal C, 2008, CLIN CANCER RES, V14, P6264, DOI 10.1158/1078-0432.CCR-07-4522; Bielenberg DR, 2007, CANCER METAST REV, V26, P421, DOI 10.1007/s10555-007-9097-4; Bielenberg DR, 2004, J CLIN INVEST, V114, P1260, DOI 10.1172/JCI200421378; Castro-Rivera E, 2004, P NATL ACAD SCI USA, V101, P11432, DOI 10.1073/pnas.0403969101; Castro-Rivera E, 2008, CANCER RES, V68, P8295, DOI 10.1158/0008-5472.CAN-07-6601; Chakraborty G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033633; Chen RP, 2014, ONCOL REP, V31, P1211, DOI 10.3892/or.2014.2972; De Lange R, 2003, ANTICANCER RES, V23, P187; Dorfman DM, 1998, AM J PATHOL, V153, P255, DOI 10.1016/S0002-9440(10)65566-6; Dreijerink K, 2001, P NATL ACAD SCI USA, V98, P7504, DOI 10.1073/pnas.131216298; Eble J, 2004, WHO CLASSIFICATION T; Gaur P, 2009, CLIN CANCER RES, V15, P6763, DOI 10.1158/1078-0432.CCR-09-1810; Gu CH, 2002, J BIOL CHEM, V277, P18069, DOI 10.1074/jbc.M201681200; Heppell-Parton AC, 1999, CANCER GENET CYTOGEN, V108, P110, DOI 10.1016/S0165-4608(98)00130-7; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hesson LB, 2007, ONCOGENE, V26, P7283, DOI 10.1038/sj.onc.1210547; Ito M, 2005, CANCER LETT, V225, P131, DOI 10.1016/j.canlet.2004.10.041; Janssen BJC, 2012, NAT STRUCT MOL BIOL, V19, P1293, DOI 10.1038/nsmb.2416; Ji Lin, 2005, Future Oncol, V1, P79, DOI 10.1517/14796694.1.1.79; Joseph D, 2010, MOL CANCER THER, V9, P499, DOI 10.1158/1535-7163.MCT-09-0664; Kigel B, 2011, BLOOD, V118, P4285, DOI 10.1182/blood-2011-03-341388; Klimov EA, 2013, FOLIA BIOL-PRAGUE, V59, P204; Krasnov GS, 2011, MOL BIOL+, V45, P211, DOI 10.1134/S0026893311020129; Kuroki T, 2003, CANCER RES, V63, P3352; Lerman MI, 2000, CANCER RES, V60, P6116; Li JF, 1999, FEBS LETT, V451, P289, DOI 10.1016/S0014-5793(99)00598-0; Li K, 2013, NEOPLASMA, V60, P683, DOI 10.4149/neo_2013_087; Lu TP, 2010, CANCER EPIDEM BIOMAR, V19, P2590, DOI 10.1158/1055-9965.EPI-10-0332; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Ma Y, 2008, BLOOD, V111, P2339, DOI 10.1182/blood-2007-09-112128; Miao HQ, 1999, J CELL BIOL, V146, P233, DOI 10.1083/jcb.146.1.233; Miyato H, 2012, CANCER SCI, V103, P1961, DOI 10.1111/cas.12003; MURATA Y, 1994, HUM MOL GENET, V3, P1341, DOI 10.1093/hmg/3.8.1341; Nair PN, 2007, CANCER GENET CYTOGEN, V174, P100, DOI 10.1016/j.cancergencyto.2006.11.017; Neufeld G, 2008, NAT REV CANCER, V8, P632, DOI 10.1038/nrc2404; Neufeld G, 2007, ADV EXP MED BIOL, V600, P118; Osada R, 2006, HUM PATHOL, V37, P1414, DOI 10.1016/j.humpath.2006.04.031; Pan Q, 2007, CANCER CELL, V11, P53, DOI 10.1016/j.ccr.2006.10.018; Prando ED, 2011, EPIGENETICS-US, V6, P1413, DOI 10.4161/epi.6.12.18271; Pronina IV, 2009, MOL BIOL+, V43, P403, DOI 10.1134/S002689330903008X; Protopopov AI, 2002, J GENE MED, V4, P397, DOI 10.1002/jgm.283; Rehman M, 2013, SEMIN CELL DEV BIOL, V24, P179, DOI 10.1016/j.semcdb.2012.10.005; Riquelme E, 2007, CANCER LETT, V250, P100, DOI 10.1016/j.canlet.2006.09.019; Rolny C, 2008, J EXP MED, V205, P1155, DOI 10.1084/jem.20072509; Sabag AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042912; Senchenko V, 2003, ONCOGENE, V22, P2984, DOI 10.1038/sj.onc.1206429; Senchenko VN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015612; Senchenko VN, 2004, ONCOGENE, V23, P5719, DOI 10.1038/sj.onc.1207760; Shimizu A, 2008, J BIOL CHEM, V283, P27230, DOI 10.1074/jbc.M804520200; Sobin, 2009, UICC TNM CLASSIFICAT; Tischoff I, 2005, INT J CANCER, V115, P684, DOI 10.1002/ijc.20944; Tomizawa Y, 2001, P NATL ACAD SCI USA, V98, P13954, DOI 10.1073/pnas.231490898; Travis WD, 2004, WHO CLASSIFICATION; Tse C, 2002, CANCER RES, V62, P542; Varshavsky A, 2008, CANCER RES, V68, P6922, DOI 10.1158/0008-5472.CAN-07-5408; Wang K, 2013, ONCOL REP, V29, P1175, DOI 10.3892/or.2012.2213; Wyckoff JB, 2007, CANCER RES, V67, P2649, DOI 10.1158/0008-5472.CAN-06-1823; Zabarovsky ER, 2002, ONCOGENE, V21, P6915, DOI 10.1038/sj.onc.1205835	63	32	37	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0123369	10.1371/journal.pone.0123369	http://dx.doi.org/10.1371/journal.pone.0123369			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961819	Green Published, Green Submitted, gold			2022-12-26	WOS:000354542500006
J	Oh, HS; Choi, BK; Kim, YH; Lee, DG; Hwang, S; Lee, MJ; Park, SH; Bae, YS; Kwon, BS				Oh, Ho S.; Choi, Beom K.; Kim, Young H.; Lee, Don G.; Hwang, Sunhee; Lee, Myoung J.; Park, Sang H.; Bae, Yong-Soo; Kwon, Byoung S.			4-1BB Signaling Enhances Primary and Secondary Population Expansion of CD8(+) T Cells by Maximizing Autocrine IL-2/IL-2 Receptor Signaling	PLOS ONE			English	Article							RESPONSES IN-VIVO; IMMUNE-RESPONSES; INTERLEUKIN-2; PROLIFERATION; IL-2; INDUCTION; INFECTION; COSTIMULATION; PROGRESSION; ACTIVATION	4-1BB (CD137), a member of the tumor necrosis factor receptor superfamily (TNFRSF), is primarily expressed on activated T cells and is known to enhance proliferation of T cells, prevent activation-induced cell death, and promote memory formation of CD8(+) T cells. In particular, it is well acknowledged that 4-1BB triggering preferentially enhances the expansion of CD8(+) T cells rather than CD4(+) T cells, but the underlying mechanism remains unclear. Here we found that 4-1BB triggering markedly increased IL-2R alpha (CD25) and IL-2 expressions of CD8(+) T cells but minimally for CD4(+) T cells. Proliferation of CD8(+) T cells was moderately enhanced by direct 4-1BB triggering in the absence of signaling through IL2R alpha/IL-2 interactions, but further promoted in the presence of IL-2R alpha/IL-2 interactions. Among the TNFRSF members including OX40, GITR, CD30, and CD27, 4-1BB was superior in the ability to induce IL-2Ra expression on CD8(+) T cells. When the primary and secondary expansions of CD8(+) T cells in vivowere examined by adoptively transferring OVA-specific CD8(+) T cells along with the treatment with agonistic anti-4-1BB and/or antagonistic anti-CD25 F(ab') 2 mAb, 4-1BB triggering enhanced both primary and secondary expansion of CD8(+) T cells in vivo, and the 4-1BB effects were moderately suppressed in primary expansion while completely abolished in secondary expansion of OVA-specific CD8(+) T cells by blocking IL-2R alpha. These results suggest that 4-1BB-mediated increases of IL-2R alpha and IL-2 prolong the effects of transient TCR- and 4-1BB-mediated signaling in CD8(+) T cells, and that 4-1BB triggering preferentially enhances the expansion of CD8(+) T cells through the amplification of autocrine IL-2/IL-2R signaling loop.	[Oh, Ho S.; Choi, Beom K.; Lee, Don G.; Hwang, Sunhee; Lee, Myoung J.; Park, Sang H.; Kwon, Byoung S.] Natl Canc Ctr, Div Canc Biol, Canc Immunol Branch, Goyang, Gyeonggi, South Korea; [Kim, Young H.] Natl Canc Ctr, Program Immunotherapeut Res, Immune Cell Prod Unit, Goyang, Gyeonggi, South Korea; [Bae, Yong-Soo] Sungkyunkwan Univ, Dept Biol Sci, Suwon, Gyeonggi, South Korea; [Kwon, Byoung S.] Tulane Univ, Hlth Sci Ctr, Dept Med, Sect Clin Immunol Allergy & Rheumatol, New Orleans, LA 70118 USA	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); Sungkyunkwan University (SKKU); Tulane University	Kwon, BS (corresponding author), Natl Canc Ctr, Div Canc Biol, Gyeonggi, South Korea.	bskwon@ncc.re.kr			National Cancer Center of Korea [NCC-1032160-5]; National Research Foundation of Korea [NRF-2005-0093837]	National Cancer Center of Korea; National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by National Cancer Center of Korea (NCC-1032160-5, http://ncc.re.kr) to BSK; National Research Foundation of Korea (NRF-2005-0093837, http://nrf.re.kr) to BSK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann MF, 2007, EMBO REP, V8, P1142, DOI 10.1038/sj.embor.7401099; Bachmann MF, 2007, EUR J IMMUNOL, V37, P1502, DOI 10.1002/eji.200637023; Bertram EM, 2002, J IMMUNOL, V168, P3777, DOI 10.4049/jimmunol.168.8.3777; Cheng LE, 2002, J IMMUNOL, V169, P4990, DOI 10.4049/jimmunol.169.9.4990; COUSENS LP, 1995, J IMMUNOL, V155, P5690; Deane JA, 2004, ANNU REV IMMUNOL, V22, P563, DOI 10.1146/annurev.immunol.22.012703.104721; Feau S, 2011, NAT IMMUNOL, V12, P908, DOI 10.1038/ni.2079; Gattinoni L, 2005, J EXP MED, V202, P907, DOI 10.1084/jem.20050732; Hurtado JC, 1997, J IMMUNOL, V158, P2600; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Kristensen NN, 2002, J GEN VIROL, V83, P2123, DOI 10.1099/0022-1317-83-9-2123; Lee DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069677; Lee HW, 2003, EUR J IMMUNOL, V33, P2133, DOI 10.1002/eji.200323996; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI13296; Mittler RS, 1999, J EXP MED, V190, P1535, DOI 10.1084/jem.190.10.1535; Sandau MM, 2007, J IMMUNOL, V179, P120, DOI 10.4049/jimmunol.179.1.120; Saoulli K, 1998, J EXP MED, V187, P1849, DOI 10.1084/jem.187.11.1849; Shuford WW, 1997, J EXP MED, V186, P47, DOI 10.1084/jem.186.1.47; STERN JB, 1986, SCIENCE, V233, P203, DOI 10.1126/science.3523754; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Takahashi C, 1999, J IMMUNOL, V162, P5037; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Vinay DS, 1998, SEMIN IMMUNOL, V10, P481, DOI 10.1006/smim.1998.0157; Wang C, 2009, IMMUNOL REV, V229, P192, DOI 10.1111/j.1600-065X.2009.00765.x; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Yu AX, 2003, J IMMUNOL, V170, P236, DOI 10.4049/jimmunol.170.1.236; Zimmerli SC, 2005, P NATL ACAD SCI USA, V102, P7239, DOI 10.1073/pnas.0502393102	29	27	29	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126765	10.1371/journal.pone.0126765	http://dx.doi.org/10.1371/journal.pone.0126765			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962156	Green Submitted, Green Published, gold			2022-12-26	WOS:000354542500148
J	Venneri, MA; Giannetta, E; Panio, G; De Gaetano, R; Gianfrilli, D; Pofi, R; Masciarelli, S; Fazi, F; Pellegrini, M; Lenzi, A; Naro, F; Isidori, AM				Venneri, Mary Anna; Giannetta, Elisa; Panio, Giuseppe; De Gaetano, Rita; Gianfrilli, Daniele; Pofi, Riccardo; Masciarelli, Silvia; Fazi, Francesco; Pellegrini, Manuela; Lenzi, Andrea; Naro, Fabio; Isidori, Andrea M.			Chronic Inhibition of PDE5 Limits Pro-Inflammatory Monocyte-Macrophage Polarization in Streptozotocin-Induced Diabetic Mice	PLOS ONE			English	Article							PHOSPHODIESTERASE 5 INHIBITION; PERIPHERAL-BLOOD; TIE2-EXPRESSING MONOCYTES; ENDOTHELIAL DYSFUNCTION; DISEASE; STRESS; PREVENTS; OBESITY; GROWTH; CELLS	Diabetes mellitus is characterized by changes in endothelial cells that alter monocyte recruitment, increase classic (M1-type) tissue macrophage infiltration and lead to self-sustained inflammation. Our and other groups recently showed that chronic inhibition of phosphodiesterase-5 (PDE5i) affects circulating cytokine levels in patients with diabetes; whether PDE5i also affects circulating monocytes and tissue inflammatory cell infiltration remains to be established. Using murine streptozotocin (STZ)-induced diabetes and in human vitro cell-cell adhesion models we show that chronic hyperglycemia induces changes in myeloid and endothelial cells that alter monocyte recruitment and lead to self-sustained inflammation. Continuous PDE5i with sildenafil (SILD) expanded tissue anti-inflammatory TIE2-expressing monocytes (TEMs), which are known to limit inflammation and promote tissue repair. Specifically, SILD: 1) normalizes the frequency of circulating pro-inflammatory monocytes triggered by hyperglycemia (53.7 +/- 7.9% of CD11b(+)Gr-1(+) cells in STZ vs. 30.4 +/- 8.3% in STZ+SILD and 27.1 +/- 1.6% in CTRL, P<0.01); 2) prevents STZ-induced tissue inflammatory infiltration (4-fold increase in F4/80+ macrophages in diabetic vs. control mice) by increasing renal and heart anti-inflammatory TEMs (30.9 +/- 3.6% in STZ+SILD vs. 6.9 +/- 2.7% in STZ, P <0.01, and 11.6 +/- 2.9% in CTRL mice); 3) reduces vascular inflammatory proteins (iNOS, COX2, VCAM-1) promoting tissue protection; 4) lowers monocyte adhesion to human endothelial cells in vitro through the TIE2 receptor. All these changes occurred independently from changes of glycemic status. In summary, we demonstrate that circulating renal and cardiac TEMs are defective in chronic hyperglycemia and that SILD normalizes their levels by facilitating the shift from classic (M1-like) to alternative (M2-like)/TEM macrophage polarization. Restoration of tissue TEMs with PDE5i could represent an additional pharmacological tool to prevent end-organ diabetic complications.	[Venneri, Mary Anna; Giannetta, Elisa; Panio, Giuseppe; Gianfrilli, Daniele; Pofi, Riccardo; Lenzi, Andrea; Isidori, Andrea M.] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [De Gaetano, Rita; Masciarelli, Silvia; Fazi, Francesco; Naro, Fabio] Univ Roma La Sapienza, Dept Anat Histol Forens & Orthoped Sci, I-00185 Rome, Italy; [Pellegrini, Manuela] Univ Molise, Dept Med & Hlth Sci, Campobasso, Italy	Sapienza University Rome; Sapienza University Rome; University of Molise	Venneri, MA (corresponding author), Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy.	maryanna.venneri@uniroma1.it; andrea.isidori@uniroma1.it	Isidori, Andrea/AAL-3249-2020; Pofi, Riccardo/AAE-2378-2020; Isidori, Andrea M./F-3062-2010; Giannetta, Elisa/K-4381-2018; Pellegrini, manuela/AAC-1423-2022; Fazi, Francesco/K-5304-2018; Lenzi, Andrea/I-7711-2015	Isidori, Andrea/0000-0002-9037-5417; Pofi, Riccardo/0000-0001-7808-5735; Isidori, Andrea M./0000-0002-9037-5417; Giannetta, Elisa/0000-0003-3614-6151; Fazi, Francesco/0000-0003-2910-7912; Lenzi, Andrea/0000-0002-7711-0465; pellegrini, manuela/0000-0001-6387-5187; MASCIARELLI, SILVIA/0000-0002-6738-6281; VENNERI, MARY ANNA/0000-0002-0687-8135	Ministry of Research MIUR Grant FIRB [RBAP109BLT, RBFR10URHP]	Ministry of Research MIUR Grant FIRB(Ministry of Education, Universities and Research (MIUR))	The study was supported by Ministry of Research MIUR Grant FIRB (grant numbers RBAP109BLT and RBFR10URHP). The funder played no role in the conduct of the study, collection of data, management of the study, analysis of data, interpretation of data or preparation of the manuscript.	Bannon P, 2013, DIS MODEL MECH, V6, P1434, DOI 10.1242/dmm.012237; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Capobianco A, 2011, AM J PATHOL, V179, P2651, DOI 10.1016/j.ajpath.2011.07.029; Das A, 2015, PHARMACOL THERAPEUT, V147, P12, DOI 10.1016/j.pharmthera.2014.10.003; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; Donath MY, 2011, ENDOCRINOLOGY, V152, P4005, DOI 10.1210/en.2011-1691; Eringa EC, 2013, REV ENDOCR METAB DIS, V14, P39, DOI 10.1007/s11154-013-9239-7; Fadini GP, 2013, DIABETOLOGIA, V56, P1856, DOI 10.1007/s00125-013-2918-9; Fadini GP, 2015, VASC PHARMACOL, V67-69, P21, DOI 10.1016/j.vph.2014.11.005; Fantin A, 2010, BLOOD, V116, P829, DOI 10.1182/blood-2009-12-257832; Festing Michael F W, 2002, ILAR J, V43, P244; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Giannetta E, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0185-3; Giannetta E, 2012, CIRCULATION, V125, P2323, DOI 10.1161/CIRCULATIONAHA.111.063412; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gustavsson C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012699; Hartge Martin M, 2007, Diab Vasc Dis Res, V4, P84; Jaipersad AS, 2014, J AM COLL CARDIOL, V63, P1, DOI 10.1016/j.jacc.2013.09.019; Jeong KH, 2009, AM J NEPHROL, V29, P274, DOI 10.1159/000158635; Kirpichnikov D, 2001, TRENDS ENDOCRIN MET, V12, P225, DOI 10.1016/S1043-2760(01)00391-5; Li Y, 2011, DIABETES, V60, P2985, DOI 10.2337/db10-1333; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Mazzieri R, 2011, CANCER CELL, V19, P512, DOI 10.1016/j.ccr.2011.02.005; Menniti FS, 2009, J PHARMACOL EXP THER, V331, P842, DOI 10.1124/jpet.109.156919; Min DQ, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/649083; Nangaku M, 2005, NEPHROL DIAL TRANSPL, V20, P2661, DOI 10.1093/ndt/gfi096; Paneni F, 2013, EUR HEART J, V34, P2436, DOI 10.1093/eurheartj/eht149; Patel AS, 2013, EMBO MOL MED, V5, P858, DOI 10.1002/emmm.201302752; Paulus WJ, 2013, J AM COLL CARDIOL, V62, P263, DOI 10.1016/j.jacc.2013.02.092; Pifarre P, 2014, EXP NEUROL, V251, P58, DOI 10.1016/j.expneurol.2013.10.021; Piga R, 2007, ATHEROSCLEROSIS, V193, P328, DOI 10.1016/j.atherosclerosis.2006.09.016; Pucci F, 2009, BLOOD, V114, P901, DOI 10.1182/blood-2009-01-200931; Puzzo D, 2009, J NEUROSCI, V29, P8075, DOI 10.1523/JNEUROSCI.0864-09.2009; Quilley J, 2011, AM J PHYSIOL-HEART C, V300, pH2316, DOI 10.1152/ajpheart.01259.2010; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Santi D, 2015, EUR J ENDOCRINOL, V172, pR103, DOI 10.1530/EJE-14-0700; Schaper NC, 2012, DIABETOLOGIA, V55, P18, DOI 10.1007/s00125-011-2368-1; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Stohr R, 2013, BIOCHEM J, V454, P1, DOI 10.1042/BJ20130121; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; Varma A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045243; Venneri MA, 2007, BLOOD, V109, P5276, DOI 10.1182/blood-2006-10-053504; Wang L, 2011, NEUROSCIENCE, V193, P399, DOI 10.1016/j.neuroscience.2011.07.039; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wong WT, 2013, J CARDIOVASC PHARM, V61, P204, DOI 10.1097/FJC.0b013e31827fe46e	46	44	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126580	10.1371/journal.pone.0126580	http://dx.doi.org/10.1371/journal.pone.0126580			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961566	Green Published, gold, Green Submitted			2022-12-26	WOS:000354542500116
J	Wasitthankasem, R; Vongpunsawad, S; Siripon, N; Suya, C; Chulothok, P; Chaiear, K; Rujirojindakul, P; Kanjana, S; Theamboonlers, A; Tangkijvanich, P; Poovorawan, Y				Wasitthankasem, Rujipat; Vongpunsawad, Sompong; Siripon, Nipaporn; Suya, Chutima; Chulothok, Phrutsada; Chaiear, Kasemporn; Rujirojindakul, Pairaya; Kanjana, Sawan; Theamboonlers, Apiradee; Tangkijvanich, Pisit; Poovorawan, Yong			Genotypic Distribution of Hepatitis C Virus in Thailand and Southeast Asia	PLOS ONE			English	Article							FULL-LENGTH GENOMES; BLOOD-DONORS; GENETIC DIVERSITY; DRUG-USERS; MOLECULAR EPIDEMIOLOGY; HIGH PREVALENCE; LIVER-DISEASE; HCV; SUBTYPES; VARIANTS	The majority of hepatitis C virus (HCV) infection results in chronic infection, which can lead to liver cirrhosis and hepatocellular carcinoma. Global burden of hepatitis C virus (HCV) is estimated at 150 million individuals, or 3% of the world's population. The distribution of the seven major genotypes of HCV varies with geographical regions. Since Asia has a high incidence of HCV, we assessed the distribution of HCV genotypes in Thailand and Southeast Asia. From 588 HCV-positive samples obtained throughout Thailand, we characterized the HCV 5' untranslated region, Core, and NS5B regions by nested PCR. Nucleotide sequences obtained from both the Core and NS5B of these isolates were subjected to phylogenetic analysis, and genotypes were assigned using published reference genotypes. Results were compared to the epidemiological data of HCV genotypes identified within Southeast Asian. Among the HCV subtypes characterized in the Thai samples, subtype 3a was the most predominant (36.4%), followed by 1a (19.9%), 1b (12.6%), 3b (9.7%) and 2a (0.5%). While genotype 1 was prevalent throughout Thailand (27-36%), genotype 3 was more common in the south. Genotype 6 (20.9%) constituted subtype 6f (7.8%), 6n (7.7%), 6i (3.4%), 6j and 6m (0.7% each), 6c (0.3%), 6v and 6xa (0.2% each) and its prevalence was significantly lower in southern Thailand compared to the north and northeast (p = 0.027 and p = 0.030, respectively). Within Southeast Asia, high prevalence of genotype 6 occurred in northern countries such as Myanmar, Laos, and Vietnam, while genotype 3 was prevalent in Thailand and Malaysia. Island nations of Singapore, Indonesia and Philippines demonstrated prevalence of genotype 1. This study further provides regional HCV genotype information that may be useful in fostering sound public health policy and tracking future patterns of HCV spread.	[Wasitthankasem, Rujipat; Vongpunsawad, Sompong; Siripon, Nipaporn; Theamboonlers, Apiradee; Poovorawan, Yong] Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Bangkok 10330, Thailand; [Suya, Chutima; Chulothok, Phrutsada] Chiangrai Prachanukroh Hosp, Chiang Rai, Thailand; [Chaiear, Kasemporn] Udon Thani Hosp, Udon Thani, Thailand; [Rujirojindakul, Pairaya] Prince Songkla Univ, Fac Med, Dept Pathol, Hat Yai, Thailand; [Kanjana, Sawan] Thai Red Cross Soc, Reg Blood Ctr Nakhorn Si Thammarat 11, Nakhon Si Thammarat, Thailand; [Tangkijvanich, Pisit] Chulalongkorn Univ, Fac Med, Dept Biochem, Bangkok 10330, Thailand	Chulalongkorn University; Prince of Songkla University; Chulalongkorn University	Poovorawan, Y (corresponding author), Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Bangkok 10330, Thailand.	yong.p@chula.ac.th	ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022	Poovorawan, Yong/0000-0002-2337-6807; vongpunsawad, sompong/0000-0001-7520-8728	National Research University Project, Office of Higher Education Commission [WCU001-HR-57, WCU007-HR-57]; Research Chair Grant from NSTDA; Chulalongkorn University Centenary Academic Development Project [CU56-HR01]; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University [RES560530093, RES560530155]; Outstanding Professor of the Thailand Research Fund [DPG5480002]; Siam Cement Group; MK Restaurant Company Limited; Rachadapisek Sompote Fund of Chulalongkorn University; Research Unit of Hepatitis and Liver Cancer, Chulalongkorn University	National Research University Project, Office of Higher Education Commission; Research Chair Grant from NSTDA; Chulalongkorn University Centenary Academic Development Project; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University(Chulalongkorn University); Outstanding Professor of the Thailand Research Fund; Siam Cement Group; MK Restaurant Company Limited; Rachadapisek Sompote Fund of Chulalongkorn University; Research Unit of Hepatitis and Liver Cancer, Chulalongkorn University	This work was supported by the National Research University Project, Office of Higher Education Commission (WCU001-HR-57 and WCU007-HR-57), the Research Chair Grant from NSTDA, Chulalongkorn University Centenary Academic Development Project (CU56-HR01), the Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University (RES560530093 and RES560530155), the Outstanding Professor of the Thailand Research Fund (DPG5480002), Siam Cement Group, and MK Restaurant Company Limited. This research is also supported by the Rachadapisek Sompote Fund of Chulalongkorn University for postdoctoral fellowship to Rujipat Wasitthanksem and Research Unit of Hepatitis and Liver Cancer, Chulalongkorn University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agdamag DM, 2005, J MED VIROL, V77, P221, DOI 10.1002/jmv.20439; Akkarathamrongsin S, 2013, INTERVIROLOGY, V56, P284, DOI 10.1159/000351621; Akkarathamrongsin S, 2011, INTERVIROLOGY, V54, P10, DOI 10.1159/000318884; Akkarathamrongsin S, 2010, J MED VIROL, V82, P257, DOI 10.1002/jmv.21680; Anggorowati N, 2012, J MED VIROL, V84, P857, DOI 10.1002/jmv.23293; Apichartpiyakul C, 1999, JPN J INFECT DIS, V52, P121; Barusrux S, 2014, ASIAN PAC J CANCER P, V15, P8837, DOI 10.7314/APJCP.2014.15.20.8837; Chimparlee N, 2011, SE ASIAN J TROP MED, V42, P609; Choudhary MC, 2014, INFECT GENET EVOL, V28, P87, DOI 10.1016/j.meegid.2014.09.009; Cochrane A, 2002, J INFECT DIS, V186, P1212, DOI 10.1086/344314; Dunford L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041266; Fu YSH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047324, 10.1371/journal.pone.0028006]; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; GREENE WK, 1995, J GEN VIROL, V76, P211, DOI 10.1099/0022-1317-76-1-211; Hairul Aini H, 2012, Med J Malaysia, V67, P199; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Hubschen JM, 2011, CLIN MICROBIOL INFEC, V17, pE30, DOI 10.1111/j.1469-0691.2011.03665.x; Inoue Y, 2000, AM J TROP MED HYG, V62, P92, DOI 10.4269/ajtmh.2000.62.92; Juniastuti, 2014, BIOMED REP, V2, P79, DOI 10.3892/br.2013.188; Jutavijittum P, 2009, SE ASIAN J TROP MED, V40, P471; Kageyama S, 2009, J MED VIROL, V81, P1157, DOI 10.1002/jmv.21516; Kanistanon D, 1997, J CLIN MICROBIOL, V35, P1772, DOI 10.1128/JCM.35.7.1772-1776.1997; Khan A, 2009, J MED VIROL, V81, P1189, DOI 10.1002/jmv.21466; Kumthip K, 2014, J MED VIROL, V86, P1360, DOI 10.1002/jmv.23962; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li CH, 2014, VIROLOGY, V468, P197, DOI 10.1016/j.virol.2014.07.026; Li CH, 2014, J GEN VIROL, V95, P1677, DOI 10.1099/vir.0.065128-0; Lu L, 2014, J GEN VIROL, V95, P1479, DOI 10.1099/vir.0.064980-0; Lwin AA, 2007, HEPATOL RES, V37, P337, DOI 10.1111/j.1872-034X.2007.00053.x; Magiorkinis G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000198; MELLOR J, 1995, J GEN VIROL, V76, P2493, DOI 10.1099/0022-1317-76-10-2493; Messina JP, 2015, HEPATOLOGY, V61, P77, DOI 10.1002/hep.27259; Mixson-Hayden T, 2014, AM J TROP MED HYG, V90, P1014, DOI 10.4269/ajtmh.14-0068; Mohamed NA, 2013, PAK J MED SCI, V29, P1142; Mohamed NA, 2014, J CLIN LAB ANAL, V28, P224, DOI 10.1002/jcla.21670; Murphy DG, 2007, J CLIN MICROBIOL, V45, P1102, DOI 10.1128/JCM.02366-06; Nakai K, 2001, J CLIN MICROBIOL, V39, P1536, DOI 10.1128/JCM.39.4.1536-1539.2001; Narahari S, 2009, INFECT GENET EVOL, V9, P643, DOI 10.1016/j.meegid.2009.04.001; Ng KT, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00168-12; NG WC, 1995, J VIRAL HEPATITIS, V2, P203, DOI 10.1111/j.1365-2893.1995.tb00030.x; Pawlotsky JM, 2002, GASTROENTEROLOGY, V122, P1554, DOI 10.1053/gast.2002.33428; Pham DA, 2009, ASIAN PAC J ALLERGY, V27, P153; Pham VH, 2011, JPN J INFECT DIS, V64, P537; Prasetyo AA, 2013, J INFECT DEV COUNTR, V7, P453, DOI 10.3855/jidc.2965; Pybus OG, 2003, MOL BIOL EVOL, V20, P381, DOI 10.1093/molbev/msg043; Pybus Oliver G, 2005, Infect Genet Evol, V5, P131, DOI 10.1016/j.meegid.2004.08.001; Pybus OG, 2009, J VIROL, V83, P1071, DOI 10.1128/JVI.01501-08; Rong X, 2014, ARCH VIROL, V159, P3231, DOI 10.1007/s00705-014-2185-1; Shinji T, 2004, ACTA MED OKAYAMA, V58, P135; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Do SH, 2015, HEPATOL RES, V45, P259, DOI 10.1111/hepr.12350; Sunanchaikarn S, 2007, ASIAN PAC J ALLERGY, V25, P175; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanaka Y, 2005, J HEPATOL, V42, P47, DOI 10.1016/j.jhep.2004.09.023; Tanimoto T, 2010, J MED VIROL, V82, P1355, DOI 10.1002/jmv.21787; Theamboonlers A, 2002, ACTA VIROL, V46, P169; TOKITA H, 1994, J GEN VIROL, V75, P931, DOI 10.1099/0022-1317-75-4-931; Utama A, 2010, LIVER INT, V30, P1152, DOI 10.1111/j.1478-3231.2010.02280.x; Utama A, 2008, INTERVIROLOGY, V51, P410, DOI 10.1159/000205515; Verachai Viroj, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P849; Wang YZ, 2009, J CLIN VIROL, V44, P195, DOI 10.1016/j.jcv.2008.12.009; World Health Organization, 2014, HEP C; Xia XS, 2008, J MED VIROL, V80, P1740, DOI 10.1002/jmv.21287; Yamada H, 2015, HEPATOL RES, V45, P480, DOI 10.1111/hepr.12367; Zhang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082598; Zhou XM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024889	68	55	64	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126764	10.1371/journal.pone.0126764	http://dx.doi.org/10.1371/journal.pone.0126764			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962112	Green Submitted, Green Published, gold			2022-12-26	WOS:000354542500147
J	Zetterberg, C; Richter, HO; Forsman, M				Zetterberg, Camilla; Richter, Hans O.; Forsman, Mikael			Temporal Co-Variation between Eye Lens Accommodation and Trapezius Muscle Activity during a Dynamic Near-Far Visual Task	PLOS ONE			English	Article							NECK-DISABILITY-INDEX; MUSCULOSKELETAL DISORDERS; SYMPTOMS; WORK; GAZE; POWERREFRACTOR; INTERVENTIONS; ERGONOMICS; SHOULDER; USERS	Near work is associated with increased activity in the neck and shoulder muscles, but the underlying mechanismis still unknown. This study was designed to determine whether a dynamic change in focus, alternating between a nearby and a more distant visual target, produces a direct parallel change in trapezius muscle activity. Fourteen healthy controls and 12 patients with a history of visual and neck/shoulder symptoms performed a Near-Far visual task under three different viewing conditions; one neutral condition with no trial lenses, one condition with negative trial lenses to create increased accommodation, and one condition with positive trial lenses to create decreased accommodation. Eye lens accommodation and trapeziusmuscle activity were continuously recorded. The trapezius muscle activity was significantly higher during Near than during Far focusing periods for both groups within the neutral viewing condition, and there was a significant co-variation in time between accommodation and trapezius muscle activity within the neutral and positive viewing conditions for the control group. In conclusion, these results reveal a connection between Near focusing and increased muscle activity during dynamic changes in focus between a nearby and a far target. A direct link, from the accommodation/vergence system to the trapezius muscles cannot be ruled out, but the connection may also be explained by an increased need for eye-neck (head) stabilization when focusing on a nearby target as compared to a more distant target.	[Zetterberg, Camilla; Richter, Hans O.; Forsman, Mikael] Univ Gavle, Fac Hlth & Occupat Studies, Ctr Musculoskeletal Res, Dept Occupat & Publ Hlth Sci, Gavle, Sweden; [Zetterberg, Camilla] Uppsala Univ, Dept Med Sci, Sect Occupat & Environm Med, Uppsala, Sweden; [Forsman, Mikael] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden	University of Gavle; Uppsala University; Karolinska Institutet	Zetterberg, C (corresponding author), Univ Gavle, Fac Hlth & Occupat Studies, Ctr Musculoskeletal Res, Dept Occupat & Publ Hlth Sci, Gavle, Sweden.	camilla.zetterberg@hig.se	Forsman, Mikael/AAE-5119-2020	Forsman, Mikael/0000-0001-5777-4232	University of Gavle; Swedish Research Council for Health, Working Life and Welfare [2005-0488, 2009-1761]	University of Gavle; Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	This study was funded by internal funds from the University of Gavle and by external funding from the Swedish Research Council for Health, Working Life and Welfare, http://www.forte.se/en/ [2005-0488 to HR and 2009-1761 to HR and MF]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaras A, 2001, APPL ERGON, V32, P559, DOI 10.1016/S0003-6870(01)00030-8; Adler FH, 2003, ADLERS PHYSL EYE CLI; Bendat JS, 2000, WILEY PS TX; Benjamin W.J., 1998, BORISHS CLIN REFRACT, P77; Bexander CSM, 2012, EXP BRAIN RES, V217, P67, DOI 10.1007/s00221-011-2973-8; Bexander CSM, 2005, EXP BRAIN RES, V167, P422, DOI 10.1007/s00221-005-0048-4; Blade PJ, 2006, OPTOMETRY VISION SCI, V83, P346, DOI 10.1097/01.opx.0000221402.35099.fb; Brewer S, 2006, J OCCUP REHABIL, V16, P325, DOI 10.1007/s10926-006-9031-6; Eltayeb S, 2009, J OCCUP REHABIL, V19, P315, DOI 10.1007/s10926-009-9196-x; Falla D, 2006, J ELECTROMYOGR KINES, V16, P621, DOI 10.1016/j.jelekin.2005.10.003; FINCHAM EF, 1957, J PHYSIOL-LONDON, V137, P488, DOI 10.1113/jphysiol.1957.sp005829; Horgen G, 2004, OPTOMETRY VISION SCI, V81, P341, DOI 10.1097/01.opx.0000134908.44145.49; Hunt OA, 2003, BRIT J OPHTHALMOL, V87, P1504, DOI 10.1136/bjo.87.12.1504; Huysmans MA, 2012, INT ARCH OCC ENV HEA, V85, P651, DOI 10.1007/s00420-011-0717-5; Inman V T, 1996, Clin Orthop Relat Res, P3, DOI 10.1097/00003086-199609000-00002; Jonsson P, 2011, J ELECTROMYOGR KINES, V21, P363, DOI 10.1016/j.jelekin.2010.10.007; Kapoula Z, 2006, EXP BRAIN RES, V173, P438, DOI 10.1007/s00221-006-0382-1; Kapoula Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046739; Li L, 1999, J ELECTROMYOGR KINES, V9, P385, DOI 10.1016/S1050-6411(99)00012-7; LIE I, 1987, EUR J APPL PHYSIOL, V56, P151, DOI 10.1007/BF00640638; Mathiassen SE, 1995, J ELECTROMYOGR KINES, V5, P197, DOI 10.1016/1050-6411(94)00014-X; MAYOUXBENHAMOU MA, 1994, SURG RADIOL ANAT, V16, P367, DOI 10.1007/BF01627655; NOLAN JP, 1988, SPINE, V13, P9, DOI 10.1097/00007632-198801000-00003; Nordander C, 2004, WORK RELATED MUSCULO; OHLSSON K, 1994, ERGONOMICS, V37, P891, DOI 10.1080/00140139408963698; Ranasinghe P, 2011, ENV HLTH, V10; Richter HO, 2010, VISION RES, V50, P2559, DOI 10.1016/j.visres.2010.08.021; Robertson MM, 2013, APPL ERGON, V44, P73, DOI 10.1016/j.apergo.2012.05.001; Sommerich CM, 2000, J ELECTROMYOGR KINES, V10, P377, DOI 10.1016/S1050-6411(00)00033-X; Sterner B, 2006, OPHTHAL PHYSL OPT, V26, P148, DOI 10.1111/j.1475-1313.2006.00364.x; Strom V, 2009, PAIN, V144, P147, DOI 10.1016/j.pain.2009.04.002; Treaster D, 2006, J ELECTROMYOGR KINES, V16, P115, DOI 10.1016/j.jelekin.2005.06.016; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409; Vernon H, 2008, J MANIP PHYSIOL THER, V31, P491, DOI 10.1016/j.jmpt.2008.08.006; Wahlstrom J, 2005, OCCUP MED-OXFORD, V55, P168, DOI 10.1093/occmed/kqi083; WIDROW B, 1975, P IEEE, V63, P1692, DOI 10.1109/PROC.1975.10036; Wolffsohn JS, 2002, OPHTHAL PHYSL OPT, V22, P380, DOI 10.1046/j.1475-1313.2002.00050.x; Woods V, 2005, OCCUP MED-OXFORD, V55, P121, DOI 10.1093/occmed/kqi029; Zetterberg C, 2013, J ELECTROMYOGR KINES, V23, P1190, DOI 10.1016/j.jelekin.2013.06.003; Zetterlund C., 2009, J OPTOMETRY, V2, P127, DOI [DOI 10.3921/joptom.2009.127, 10.3921/joptom.2009.127]	40	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126578	10.1371/journal.pone.0126578	http://dx.doi.org/10.1371/journal.pone.0126578			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961299	Green Published, gold, Green Submitted			2022-12-26	WOS:000354542500115
J	Catanzaro, D; Rancan, S; Orso, G; Dall'Acqua, S; Brun, P; Giron, MC; Carrara, M; Castagliuolo, I; Ragazzi, E; Caparrotta, L; Montopoli, M				Catanzaro, Daniela; Rancan, Serena; Orso, Genny; Dall'Acqua, Stefano; Brun, Paola; Giron, Maria Cecilia; Carrara, Maria; Castagliuolo, Ignazio; Ragazzi, Eugenio; Caparrotta, Laura; Montopoli, Monica			Boswellia serrata Preserves Intestinal Epithelial Barrier from Oxidative and Inflammatory Damage	PLOS ONE			English	Article							NF-KAPPA-B; BOWEL-DISEASE; IN-VITRO; IFN-GAMMA; PERMEABILITY; MECHANISMS; EXPRESSION; INDUCTION; MODELS	Aminosalicylates, corticosteroids and immunosuppressants are currently the therapeutic choices in inflammatory bowel diseases (IBD), however, with limited remission and often serious side effects. Meanwhile complementary and alternative medicine (CAM) use is increasing, particularly herbal medicine. Boswellia serrata is a traditional Ayurvedic remedy with anti-inflammatory properties, of interest for its usefulness in IBDs. The mechanism of this pharmacological potential of Boswellia serrata was investigated in colonic epithelial cell monolayers exposed to H2O2 or INF-gamma+TNF-alpha, chosen as in vitro experimental model of intestinal inflammation. The barrier function was evaluated by the transepithelial electrical resistance (TEER) and paracellular permeability assay, and by the tight junction proteins (zonula occludens-1, ZO-1 and occludin) immunofluorescence. The expression of phosphorylated NF-kappa B and reactive oxygen species (ROS) generation were determined by immunoblot and cytofluorimetric assay, respectively. Boswellia serrata oleo-gum extract (BSE) and its pure derivative acetyl-11-keto-beta-boswellic acid (AKBA), were tested at 0.1-10 mu g/ml and 0.027 mu g/ml, respectively. BSE and AKBA safety was demonstrated by no alteration of intestinal cell viability and barrier function and integrity biomarkers. H2O2 or INF-gamma+TNF-alpha treatment of Caco-2 cell monolayers significantly reduced TEER, increased paracellular permeability and caused the disassembly of tight junction proteins occludin and ZO-1. BSE and AKBA pretreatment significantly prevented functional and morphological alterations and also the NF-kappa B phosphorylation induced by the inflammatory stimuli. At the same concentrations BSE and AKBA counteracted the increase of ROS caused by H2O2 exposure. Data showed the positive correlation of the antioxidant activity with the mechanism involved in the physiologic maintenance of the integrity and function of the intestinal epithelium. This study elucidates the pharmacological mechanisms mediated by BSE, in protecting intestinal epithelial barrier from inflammatory damage and supports its use as safe adjuvant in patients affected by IBD.	[Catanzaro, Daniela; Rancan, Serena; Dall'Acqua, Stefano; Giron, Maria Cecilia; Carrara, Maria; Ragazzi, Eugenio; Caparrotta, Laura; Montopoli, Monica] Univ Padua, Dept Pharmaceut & Pharmacol Sci, I-35131 Padua, Italy; [Orso, Genny] IRCCS E Medea, Conegliano, Italy; [Brun, Paola; Castagliuolo, Ignazio] Univ Padua, Dept Mol Med, I-35121 Padua, Italy	University of Padua; IRCCS Eugenio Medea; University of Padua	Caparrotta, L (corresponding author), Univ Padua, Dept Pharmaceut & Pharmacol Sci, Largo E Meneghetti 2, I-35131 Padua, Italy.	laura.caparrotta@unipd.it; monica.montopoli@unipd.it	Giron, Maria Cecilia/K-7557-2019; Ragazzi, Eugenio/ACX-1875-2022; Giron, Maria Cecilia/AAL-4438-2021; castagliuolo, ignazio/K-9963-2016; Dall'Acqua, Stefano/C-1353-2013; Montopoli, Monica/W-9666-2019; Catanzaro, Daniela/AAB-8715-2019; Orso, Genny/C-6492-2016	Giron, Maria Cecilia/0000-0002-0825-7965; Ragazzi, Eugenio/0000-0002-0390-6823; Giron, Maria Cecilia/0000-0002-0825-7965; castagliuolo, ignazio/0000-0001-9888-7030; Catanzaro, Daniela/0000-0003-0765-3058; Orso, Genny/0000-0002-2959-8806; MONTOPOLI, MONICA/0000-0001-6182-4132	University of Padova [CPDA124517/12, CPDR134012]; University of Padova (UNIPD) [n. 60A04-0443, n.60A04-9128/14]	University of Padova; University of Padova (UNIPD)	This work was supported by grants from the University of Padova (CPDA124517/12 to MM; UNIPDex60% n. 60A04-0443 to ER, LC and MM, UNIPDex60% n.60A04-9128/14 to MCG and MM). DC fellowship was supported by the grant n. CPDR134012 from the University of Padova. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Tawab M, 2011, CLIN PHARMACOKINET, V50, P349, DOI 10.2165/11586800-000000000-00000; Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Ammon HPT, 2010, PHYTOMEDICINE, V17, P862, DOI 10.1016/j.phymed.2010.03.003; Anthoni C, 2006, AM J PHYSIOL-GASTR L, V290, pG1131, DOI 10.1152/ajpgi.00562.2005; Atreya I, 2008, J INTERN MED, V263, P591, DOI 10.1111/j.1365-2796.2008.01953.x; Balimane PV, 2005, DRUG DISCOV TODAY, V10, P335, DOI 10.1016/S1359-6446(04)03354-9; Bernstein CN, 2001, CANCER-AM CANCER SOC, V91, P854, DOI 10.1002/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z; Blau S, 1999, MOL CELL BIOCHEM, V194, P185, DOI 10.1023/A:1006994800272; Cao M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061944; Fleet JC, 2003, PHYSIOL GENOMICS, V13, P57, DOI 10.1152/physiolgenomics.00152.2002; Florean C, 2012, BIOCHEM PHARMACOL, V84, P1223, DOI 10.1016/j.bcp.2012.07.001; Frank A, 2006, J CHROMATOGR A, V1112, P255, DOI 10.1016/j.chroma.2005.11.116; Guidi L, 2011, CLIN EXP GASTROENTER, V4, P163, DOI 10.2147/CEG.S14558; Gupta I, 2001, PLANTA MED, V67, P391, DOI 10.1055/s-2001-15802; Harhaj NS, 2004, INT J BIOCHEM CELL B, V36, P1206, DOI 10.1016/j.biocel.2003.08.007; Hartmann RM, 2014, PHYTOTHER RES, V28, P1392, DOI 10.1002/ptr.5142; Hering NA, 2012, J PHYSIOL-LONDON, V590, P1035, DOI 10.1113/jphysiol.2011.224568; Huang MT, 2000, BIOFACTORS, V13, P225, DOI 10.1002/biof.5520130135; John LJ, 2011, ANTIOXID REDOX SIGN, V15, P1255, DOI 10.1089/ars.2011.3892; Ke F, 2012, SAUDI J GASTROENTERO, V18, P3, DOI 10.4103/1319-3767.91726; Kiela PR, 2005, AM J PHYSIOL-GASTR L, V288, pG798, DOI 10.1152/ajpgi.00433.2004; Konishi Y, 2002, BIOSCI BIOTECH BIOCH, V66, P2449, DOI 10.1271/bbb.66.2449; Li QR, 2008, CLIN IMMUNOL, V126, P67, DOI 10.1016/j.clim.2007.08.017; Liu H, 2012, CELL PHYSIOL BIOCHEM, V29, P799, DOI 10.1159/000188076; Ma TY, 2004, AM J PHYSIOL-GASTR L, V286, pG367, DOI 10.1152/ajpgi.00173.2003; Madisch A, 2007, INT J COLORECTAL DIS, V22, P1445, DOI 10.1007/s00384-007-0364-1; Mariadason JM, 2002, CANCER RES, V62, P4791; Montopoli M, 2009, CELL PROLIFERAT, V42, P195, DOI 10.1111/j.1365-2184.2009.00585.x; Moussaieff A, 2009, J PHARM PHARMACOL, V61, P1281, DOI [10.1211/jpp/61.10.0003, 10.1211/jpp.61.10.0003]; Mudter J, 2011, WORLD J GASTROENTERO, V17, P3177, DOI 10.3748/wjg.v17.i27.3177; Ng SC, 2013, ALIMENT PHARM THER, V38, P854, DOI 10.1111/apt.12464; Pastorelli L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00280; Pavlick KP, 2002, FREE RADICAL BIO MED, V33, P311, DOI 10.1016/S0891-5849(02)00853-5; Peloquin JM, 2013, ANAEROBE, V24, P102, DOI 10.1016/j.anaerobe.2013.04.006; Perli E, 2012, HUM MOL GENET, V21, P85, DOI 10.1093/hmg/ddr440; PETERSON MD, 1993, J CELL SCI, V105, P445; Poeckel D, 2006, CURR MED CHEM, V13, P3359, DOI 10.2174/092986706779010333; Pravda J, 2005, WORLD J GASTROENTERO, V11, P2371, DOI 10.3748/wjg.v11.i16.2371; Rahimi R, 2013, WORLD J GASTROENTERO, V19, P5738, DOI 10.3748/wjg.v19.i34.5738; Rotoli BM, 2000, CELL PHYSIOL BIOCHEM, V10, P13, DOI 10.1159/000016331; Salim SY, 2011, INFLAMM BOWEL DIS, V17, P362, DOI 10.1002/ibd.21403; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Siddiqui MZ, 2011, INDIAN J PHARM SCI, V73, P255, DOI 10.4103/0250-474X.93507; Suzuki T, 2013, CELL MOL LIFE SCI, V70, P631, DOI 10.1007/s00018-012-1070-x; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Wan P, 2014, WORLD J GASTROENTERO, V20, P14099, DOI 10.3748/wjg.v20.i39.14099; Wang FJ, 2006, GASTROENTEROLOGY, V131, P1153, DOI 10.1053/j.gastro.2006.08.022; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yapali S, 2007, ANN GASTROENTEROL, V20, P48; Youmba SB, 2012, J PEDIATR GASTR NUTR, V54, P463, DOI 10.1097/MPG.0b013e318247240d; Zhu H, 2012, EXP BIOL MED, V237, P474, DOI 10.1258/ebm.2011.011358	51	57	61	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0125375	10.1371/journal.pone.0125375	http://dx.doi.org/10.1371/journal.pone.0125375			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955295	gold, Green Published, Green Submitted			2022-12-26	WOS:000356768100051
J	Estrada-Pena, A; de la Fuente, J; Latapia, T; Ortega, C				Estrada-Pena, Agustin; de la Fuente, Jose; Latapia, Tamara; Ortega, Carmelo			The Impact of Climate Trends on a Tick Affecting Public Health: A Retrospective Modeling Approach for Hyalomma marginatum (Ixodidae)	PLOS ONE			English	Article							CONGO HEMORRHAGIC-FEVER; IXODES-RICINUS; INFECTIOUS-DISEASES; POPULATION-MODEL; MATRIX MODEL; NICHE; DYNAMICS; VECTOR; BIRDS; ACARI	The impact of climate trends during the period 1901-2009 on the life cycle of Hyalomma marginatum in Europe was modeled to assess changes in the physiological processes of this threat to public health. Monthly records of temperature and water vapour at a resolution of 0.5 degrees and equations describing the life cycle processes of the tick were used. The climate in the target region affected the rates of the life cycle processes of H. marginatum: development rates increased, mortality rates in molting stages decreased, and the survival rates of questing ticks decreased in wide territories of the Mediterranean basin. The modeling framework indicated the existence of critical areas in the Balkans, central Europe, and the western coast of France, where the physiological processes of the tick improved to extents that are consistent with the persistence of populations if introduced. A spatially explicit risk assessment was performed to detect candidate areas where active surveys should be performed to monitor changes in tick density or persistence after a hypothetical introduction. We detected areas where the critical abiotic (climate) and biotic (host density) factors overlap, including most of the Iberian peninsula, the Mediterranean coast of France, eastern Turkey, and portions of the western Black Sea region. Wild ungulate densities are unavailable for large regions of the territory, a factor that might affect the outcome of the study. The risk of successfully establishing H. marginatum populations at northern latitudes of its current colonization range seems to be still low, even if the climate has improved the performance of the tick in these areas.	[Estrada-Pena, Agustin; Latapia, Tamara; Ortega, Carmelo] Fac Vet Med, Dept Anim Pathol, Zaragoza 50013, Spain; [de la Fuente, Jose] IREC CSIC UCLM JCCM, SaBio, Inst Invest Recursos Cineget, Ciudad Real 13005, Spain; [de la Fuente, Jose] Oklahoma State Univ, Ctr Vet Hlth Sci, Dept Vet Pathobiol, Stillwater, OK 74078 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Oklahoma State University System; Oklahoma State University - Stillwater	Estrada-Pena, A (corresponding author), Fac Vet Med, Dept Anim Pathol, Miguel Servet 177, Zaragoza 50013, Spain.	aestrada@unizar.es		Estrada Pena, Agustin/0000-0001-7483-046X	EU FP7 ANTIGONE (Anticipating the Global Onset of Novel Epidemics) project [278976]	EU FP7 ANTIGONE (Anticipating the Global Onset of Novel Epidemics) project	Parts of this work were supported by EU FP7 ANTIGONE (Anticipating the Global Onset of Novel Epidemics) project number 278976. Parts of this work were conducted in the framework of the EurNegVec (European Neglected Vectors) COST Action TD1303. Climate data were obtained from the Climatic Research Unit, University of East Anglia (United Kingdom).	Altizer S, 2013, SCIENCE, V341, P514, DOI 10.1126/science.1239401; Apanaskevich DA, 2008, INT J ACAROL, V34, P13, DOI 10.1080/01647950808683704; Badeck FW, 2004, NEW PHYTOL, V162, P295, DOI 10.1111/j.1469-8137.2004.01059.x; Baltussen Rob, 2006, Cost Eff Resour Alloc, V4, P14, DOI 10.1186/1478-7547-4-14; Bente DA, 2013, ANTIVIR RES, V100, P159, DOI 10.1016/j.antiviral.2013.07.006; Bosch J, 2013, TRANSBOUND EMERG DIS, V60, P403, DOI 10.1111/j.1865-1682.2012.01358.x; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Dobson ADM, 2011, J APPL ECOL, V48, P1017, DOI 10.1111/j.1365-2664.2011.02003.x; Ellis JB, 2004, SCI TOTAL ENVIRON, V334, P251, DOI 10.1016/j.scitotenv.2004.04.066; Emelyanova N., 2005, ZURNAL MIKROBIOLOGII, V4, P115; Ergonul Onder, 2007, P3, DOI 10.1007/978-1-4020-6106-6_1; Estrada-Pena A, 2014, MED VET ENTOMOL, V28, P35, DOI 10.1111/mve.12009; Estrada-Pena A, 2013, J APPL MICROBIOL, V114, P278, DOI 10.1111/jam.12039; Estrada-Pena A, 2013, EXP APPL ACAROL, V59, P351, DOI 10.1007/s10493-012-9600-7; Estrada-Pena A, 2011, TRANSBOUND EMERG DIS, V58, P213, DOI 10.1111/j.1865-1682.2010.01198.x; Estrada-Pena A, 2007, J MED ENTOMOL, V44, P1130, DOI 10.1603/0022-2585(2007)44[1130:CNOTSI]2.0.CO;2; Estrada-Pena A, 2012, VECTOR-BORNE ZOONOT, V12, P758, DOI 10.1089/vbz.2011.0771; ESTRADAPENA A, 1992, ANN PARASIT HUM COMP, V67, P42, DOI 10.1051/parasite/199267242; Evans MEK, 2009, AM NAT, V173, P225, DOI 10.1086/595757; Gale P, 2010, J APPL MICROBIOL, V108, P1859, DOI 10.1111/j.1365-2672.2009.04638.x; Gilliams S, 2005, COMPUT ELECTRON AGR, V49, P142, DOI 10.1016/j.compag.2005.02.011; Gravel D, 2006, ECOL LETT, V9, P399, DOI 10.1111/j.1461-0248.2006.00884.x; Gray J S, 2009, Interdiscip Perspect Infect Dis, V2009, P593232, DOI 10.1155/2009/593232; Hartemink NA, 2008, AM NAT, V171, P743, DOI 10.1086/587530; Hasle G, 2009, J PARASITOL, V95, P1342, DOI 10.1645/GE-2146.1; Hongoh V, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-70; HOOGSTRAAL H, 1961, B WORLD HEALTH ORGAN, V24, P197; Hornok S, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-170; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Jaenson TGT, 2009, MED VET ENTOMOL, V23, P226, DOI 10.1111/j.1365-2915.2009.00813.x; Kiker GA, 2005, INTEGR ENVIRON ASSES, V1, P95, DOI 10.1897/IEAM_2004a-015.1; Medlock JM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-1; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Morin X, 2009, ECOLOGY, V90, P1301, DOI 10.1890/08-0134.1; Mount GA, 1997, J MED ENTOMOL, V34, P672, DOI 10.1093/jmedent/34.6.672; Mucher CA, 2010, ECOL INDIC, V10, P87, DOI 10.1016/j.ecolind.2009.03.018; Nijhof AM, 2007, VECTOR-BORNE ZOONOT, V7, P585, DOI 10.1089/vbz.2007.0130; Ogden NH, 2005, INT J PARASITOL, V35, P375, DOI 10.1016/j.ijpara.2004.12.013; Ogden NH, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-24; Ostfeld RS, 2005, TRENDS ECOL EVOL, V20, P328, DOI 10.1016/j.tree.2005.03.009; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Patz JA, 2013, CURR TOP MICROBIOL, V366, P141, DOI 10.1007/82_2012_274; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Perret JL, 2000, PARASITOL RES, V86, P554, DOI 10.1007/s004360000209; Peterson AT, 2006, EMERG INFECT DIS, V12, P1822; Peterson AT, 2005, T ROY SOC TROP MED H, V99, P647, DOI 10.1016/j.trstmh.2005.02.004; R Core Team, 2021, R LANGUAGE ENV STAT; Randolph SE, 2009, PARASITOLOGY, V136, P1403, DOI 10.1017/S0031182009005782; Randolph S, 2008, FUTURE VIROL, V3, P303, DOI 10.2217/17460794.3.4.303; Randolph SE, 2002, INT J PARASITOL, V32, P979, DOI 10.1016/S0020-7519(02)00030-9; Ruiz-Fons F, 2006, VET PARASITOL, V140, P133, DOI 10.1016/j.vetpar.2006.03.033; Schonwiese CD, 1997, CLIMATE TREND ATLAS, DOI DOI 10.1007/978-94-015-8818-8; STREY OF, 1991, J MED ENTOMOL, V28, P165, DOI 10.1093/jmedent/28.1.165; Sutherst RW, 2000, AGR ECOSYST ENVIRON, V82, P303, DOI 10.1016/S0167-8809(00)00234-6; Tabachnick WJ, 2010, J EXP BIOL, V213, P946, DOI 10.1242/jeb.037564; Tildesley MJ, 2009, J THEOR BIOL, V258, P623, DOI 10.1016/j.jtbi.2009.02.019; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; Vescio FM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1116	59	33	33	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0125760	10.1371/journal.pone.0125760	http://dx.doi.org/10.1371/journal.pone.0125760			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955315	Green Submitted, Green Published, gold			2022-12-26	WOS:000356768100073
J	Guescini, M; Canonico, B; Lucertini, F; Maggio, S; Annibalini, G; Barbieri, E; Luchetti, F; Papa, S; Stocchi, V				Guescini, Michele; Canonico, Barbara; Lucertini, Francesco; Maggio, Serena; Annibalini, Giosue; Barbieri, Elena; Luchetti, Francesca; Papa, Stefano; Stocchi, Vilberto			Muscle Releases Alpha-Sarcoglycan Positive Extracellular Vesicles Carrying miRNAs in the Bloodstream	PLOS ONE			English	Article							SKELETAL-MUSCLE; INTERCELLULAR TRANSFER; CIRCULATING MICRORNAS; GENE-EXPRESSION; CELL; EXERCISE; PROTEINS; MECHANISM; TRANSPORT; PLASMA	In the past few years, skeletal muscle has emerged as an important secretory organ producing soluble factors, called myokines, that exert either autocrine, paracrine or endocrine effects. Moreover, recent studies have shown that muscle releases microRNAs into the bloodstream in response to physical exercise. These microRNAs affect target cells, such as hormones and cytokines. The mechanisms underlying microRNA secretion are poorly characterized at present. Here, we investigated whether muscle tissue releases extracellular vesicles (EVs), which carry microRNAs in the bloodstream under physiological conditions such as physical exercise. Using density gradient separation of plasma from sedentary and physically fit young men we found EVs positive for TSG101 and alpha-sarcoglycan (SGCA), and enriched for miR-206. Cytometric analysis showed that the SGC(A+) EVs account for 1-5% of the total and that 60-65% of these EVs were also positive for the exosomal marker CD81. Furthermore, the SGCA-immuno captured sub-population of EVs exhibited higher levels of the miR-206/miR16 ratio compared to total plasma EVs. Finally, a significant positive correlation was found between the aerobic fitness and muscle-specific miRNAs and EV miR-133b and -181a-5p were significantly up-regulated after acute exercise. Thus, our study proposes EVs as a novel means of muscle communication potentially involved in muscle remodeling and homeostasis.	[Guescini, Michele; Lucertini, Francesco; Maggio, Serena; Annibalini, Giosue; Barbieri, Elena; Stocchi, Vilberto] Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, Italy; [Canonico, Barbara; Luchetti, Francesca; Papa, Stefano] Univ Urbino Carlo Bo, Dept Human Environm & Nat Sci, Urbino, Italy	University of Urbino; University of Urbino	Guescini, M (corresponding author), Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, Italy.	michele.guescini@uniurb.it	Annibalini, Giosuè/J-7701-2016; Guescini, Michele/L-1297-2019; Lucertini, Francesco/F-6603-2012	Annibalini, Giosuè/0000-0002-6914-4905; Guescini, Michele/0000-0001-9372-7038; Lucertini, Francesco/0000-0003-3134-4511; Maggio, Serena/0000-0001-8778-6576; Barbieri, Elena/0000-0002-3480-7983; Canonico, Barbara/0000-0003-3383-715X	Regione Marche - Progetto Speciale di Competenza Regionale	Regione Marche - Progetto Speciale di Competenza Regionale	This study was supported by a grant from the Regione Marche - Progetto Speciale di Competenza Regionale to VS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoi W, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00080; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Baggish AL, 2014, J APPL PHYSIOL, V116, P522, DOI 10.1152/japplphysiol.01141.2013; Baggish AL, 2011, J PHYSIOL-LONDON, V589, P3983, DOI 10.1113/jphysiol.2011.213363; Banzet S, 2013, J APPL PHYSL; Bortoluzzi S, 2006, PROTEINS, V62, P776, DOI 10.1002/prot.20803; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen X, 2012, TRENDS CELL BIOL, V22, P125, DOI 10.1016/j.tcb.2011.12.001; Choi DS, 2013, PROTEOMICS; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Davidson LE, 2011, MED SCI SPORT EXER, V43, P542, DOI 10.1249/MSS.0b013e3181ef3f07; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Forterre A, 2014, CELL CYCLE, V13, P78, DOI 10.4161/cc.26808; GOLDSTEIN M, 1961, DIABETES, V10, P232, DOI 10.2337/diab.10.3.232; Guescini M, 2012, EXP CELL RES, V318, P603, DOI 10.1016/j.yexcr.2012.01.005; Guescini M, 2010, EXP CELL RES, V316, P1977, DOI 10.1016/j.yexcr.2010.04.006; Guescini M, 2009, J NEURAL TRANSM; Guescini M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-326; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Henningsen J, 2011, MOL BIOSYST, V7, P311, DOI 10.1039/c0mb00209g; HOWLEY ET, 1995, MED SCI SPORT EXER, V27, P1292; Hudson MB, 2014, AM J PHYSIOL-CELL PH, V306, pC551, DOI 10.1152/ajpcell.00266.2013; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Lakkaraju A, 2008, TRENDS CELL BIOL, V18, P199, DOI 10.1016/j.tcb.2008.03.002; Lehmann BD, 2008, CANCER RES, V68, P7864, DOI 10.1158/0008-5472.CAN-07-6538; Li CCY, 2013, RNA BIOL, V10, P1333, DOI 10.4161/rna.25281; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Luchetti F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035766; Mathivanan S, 2012, NUCLEIC ACIDS RES, V40, pD1241, DOI 10.1093/nar/gkr828; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; McCarthy JJ, 2011, EXERC SPORT SCI REV, V39, P150, DOI 10.1097/JES.0b013e31821c01e1; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Nielsen S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087308; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Pedersen BK, 2003, J MUSCLE RES CELL M, V24, P113, DOI 10.1023/A:1026070911202; Pescatello L.S., 2014, ACSMS GUIDELINES EXE, V9; Rabinowits G, 2009, CLIN LUNG CANCER, V10, P42, DOI 10.3816/CLC.2009.n.006; Rayner KJ, 2013, J LIPID RES, V54, P1174, DOI 10.1194/jlr.R034991; Reid G, 2011, CRIT REV ONCOL HEMAT, V80, P193, DOI 10.1016/j.critrevonc.2010.11.004; Russell AP, 2013, J PHYSIOL-LONDON, V591, P4637, DOI 10.1113/jphysiol.2013.255695; Sawada S, 2013, PLOS ONE, V8; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Tauro BJ, 2012, METHODS, V56, P293, DOI 10.1016/j.ymeth.2012.01.002; Turchinovich A, 2012, TRENDS BIOCHEM SCI, V37, P460, DOI 10.1016/j.tibs.2012.08.003; Uhlemann M, 2012, EUROPEAN J PREVENTIV; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Winter E., 2007, SPORT EXERCISE PHYSL; Xin HQ, 2013, STEM CELLS, V31, P2737, DOI 10.1002/stem.1409; Xu L, 2013, J CELL PHYSIOL, V228, P1713, DOI 10.1002/jcp.24344; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010	56	100	102	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0125094	10.1371/journal.pone.0125094	http://dx.doi.org/10.1371/journal.pone.0125094			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955720	gold, Green Published, Green Submitted			2022-12-26	WOS:000356768100044
J	Tozzo, E; Bhat, G; Cheon, K; Camacho, RC				Tozzo, Effie; Bhat, Gowri; Cheon, Kyeongmi; Camacho, Raul C.			Pioglitazone Increases Whole Body Insulin Sensitivity in Obese, Insulin-Resistant Rhesus Monkeys	PLOS ONE			English	Article							DEPENDENT DIABETES-MELLITUS; HEPATIC GLUCOSE-PRODUCTION; PROTEIN-KINASE-C; SKELETAL-MUSCLE; METABOLIC SYNDROME; GLYCOGEN-SYNTHASE; ADIPOSE-TISSUE; FAT-CONTENT; LIVER FAT; TYPE-2	Hyperinsulinemic-euglycemic clamps are considered the "gold standard" for assessing whole body insulin sensitivity. When used in combination with tracer dilution techniques and physiological insulin concentrations, insulin sensitization can be dissected and attributed to hepatic and peripheral (primarily muscle) effects. Non-human primates (NHPs), such as rhesus monkeys, are the closest pre-clinical species to humans, and thus serve as an ideal model for testing of compound efficacy to support translation to human efficacy. We determined insulin infusion rates that resulted in high physiological insulin concentrations that elicited maximal pharmacodynamic responses during hyperinsulinemic-euglycemic clamps. These rates were then used with [U-C-13]-D-glucose, to assess and document the degrees of hepatic and peripheral insulin resistance between healthy and insulin-resistant, dysmetabolic NHPs. Next, dysmetabolic NHPs were treated for 28 days with pioglitazone (3 mg/kg) and again had their insulin sensitivity assessed, illustrating a significant improvement in hepatic and peripheral insulin sensitivity. This coincided with a significant increase in insulin clearance, and normalization of circulating adiponectin. In conclusion, we have determined a physiological clamp paradigm (similar to humans) for assessing glucose turnover in NHPs. We have also demonstrated that insulin-resistant, dysmetabolic NHPs respond to the established insulin sensitizer, pioglitazone, thus confirming their use as an ideal pre-clinical translational model to assess insulin sensitizing compounds.	[Tozzo, Effie] Merck Res Labs, Dept Diabet, Kenilworth, NJ USA; [Bhat, Gowri] Merck Res Labs, Dept Mol Biomarkers, Kenilworth, NJ USA; [Cheon, Kyeongmi] Merck Res Labs, Dept Biometr Res, West Point, PA USA	Merck & Company; Merck & Company; Merck & Company	Camacho, RC (corresponding author), Janssen Pharmaceut Co, Dept Cardiovasc & Metab, Spring House, PA 19002 USA.	rcamac10@its.jnj.com			Merck	Merck(Merck & Company)	This study was funded by Merck. The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aroda VR, 2009, J CLIN ENDOCR METAB, V94, P469, DOI 10.1210/jc.2008-1133; Bajaj M, 2004, J CLIN ENDOCR METAB, V89, P200, DOI 10.1210/jc.2003-031315; Bajaj M, 2003, DIABETES, V52, P1364, DOI 10.2337/diabetes.52.6.1364; BECKNIELSEN H, 1994, DIABETOLOGIA, V37, P217, DOI 10.1007/s001250050097; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; BEYLOT M, 1993, ANAL BIOCHEM, V212, P526, DOI 10.1006/abio.1993.1363; BODKIN NL, 1989, AM J PHYSIOL, V256, pE676, DOI 10.1152/ajpendo.1989.256.5.E676; BONORA E, 1984, J CLIN ENDOCR METAB, V59, P1121, DOI 10.1210/jcem-59-6-1121; CAMPBELL PJ, 1988, METABOLISM, V37, P15, DOI 10.1016/0026-0495(88)90023-6; Combs TP, 2001, J CLIN INVEST, V108, P1875, DOI 10.1172/JCI200114120; DEFRONZO RA, 1985, J CLIN INVEST, V76, P149, DOI 10.1172/JCI111938; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Ding SY, 2007, METABOLISM, V56, P1334, DOI 10.1016/j.metabol.2007.05.019; FABER OK, 1981, J CLIN ENDOCR METAB, V53, P618, DOI 10.1210/jcem-53-3-618; FIRTH R, 1987, METABOLISM, V36, P1091, DOI 10.1016/0026-0495(87)90031-X; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Gastaldelli A, 2006, DIABETES CARE, V29, P2275, DOI 10.2337/dc05-2445; GROOP LC, 1989, J CLIN INVEST, V84, P205, DOI 10.1172/JCI114142; Hansen B C, 1993, Obes Res, V1, P252; Hansen Barbara C, 2012, Methods Mol Biol, V933, P177, DOI 10.1007/978-1-62703-068-7_11; Hansen BC, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-7; Hotta K, 2001, DIABETES, V50, P1126, DOI 10.2337/diabetes.50.5.1126; Jin JY, 2006, DIABETES RES CLIN PR, V74, P233, DOI 10.1016/j.diabres.2006.04.020; KEMNITZ JW, 1994, DIABETES, V43, P204, DOI 10.2337/diabetes.43.2.204; Kotronen A, 2008, GASTROENTEROLOGY, V135, P122, DOI 10.1053/j.gastro.2008.03.021; Kotronen A, 2007, AM J PHYSIOL-ENDOC M, V293, pE1709, DOI 10.1152/ajpendo.00444.2007; Landau BR, 1998, AM J PHYSIOL-ENDOC M, V274, pE954, DOI 10.1152/ajpendo.1998.274.5.E954; Lee HW, 2011, ENDOCRINOLOGY, V152, P414, DOI 10.1210/en.2010-1164; Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976; MEISTAS MT, 1983, AM J PHYSIOL, V245, pE155, DOI 10.1152/ajpendo.1983.245.2.E155; Miyazaki Y, 2004, J CLIN ENDOCR METAB, V89, P4312, DOI 10.1210/jc.2004-0190; Miyazaki Y, 2002, J CLIN ENDOCR METAB, V87, P2784, DOI 10.1210/jc.87.6.2784; Miyazaki Y, 2001, DIABETES CARE, V24, P710, DOI 10.2337/diacare.24.4.710; Ortmeyer H K, 2000, Int J Exp Diabetes Res, V1, P195, DOI 10.1155/EDR.2000.195; Ortmeyer HK, 2011, ANTIOXID REDOX SIGN, V14, P207, DOI 10.1089/ars.2010.3234; Ortmeyer HK, 1998, AM J PHYSIOL-GASTR L, V274, pG1005, DOI 10.1152/ajpgi.1998.274.6.G1005; ORTMEYER HK, 1993, AM J PHYSIOL, V265, pR552, DOI 10.1152/ajpregu.1993.265.3.R552; Ortmeyer HK, 1997, AM J PHYSIOL-ENDOC M, V272, pE133, DOI 10.1152/ajpendo.1997.272.1.E133; POLONSKY K S, 1986, Diabetes Metabolism Reviews, V2, P315; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; ROSSELL R, 1983, J CLIN ENDOCR METAB, V56, P608, DOI 10.1210/jcem-56-3-608; Shankar SS, 2011, EARLY EFFECTS PIOGLI, pA419; Staehr P, 2001, DIABETES, V50, P1363, DOI 10.2337/diabetes.50.6.1363; Standaert ML, 2002, DIABETES, V51, P2936, DOI 10.2337/diabetes.51.10.2936; Storgaard H, 2004, J CLIN ENDOCR METAB, V89, P1301, DOI 10.1210/jc.2003-031243; Storgaard H, 2001, DIABETES, V50, P2770, DOI 10.2337/diabetes.50.12.2770; Tiikkainen M, 2004, DIABETES, V53, P2169, DOI 10.2337/diabetes.53.8.2169; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; TURK D, 1995, J CLIN INVEST, V95, P755, DOI 10.1172/JCI117723; Yaghootkar H, 2013, DIABETES, V62, P3589, DOI 10.2337/db13-0128; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Zhang XQ, 2011, CIRCULATION, V124, P77, DOI 10.1161/CIRCULATIONAHA.110.990333; Zhou R, 2007, REPROD TOXICOL, V23, P438, DOI 10.1016/j.reprotox.2006.12.009	53	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0126642	10.1371/journal.pone.0126642	http://dx.doi.org/10.1371/journal.pone.0126642			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25954816	gold, Green Submitted, Green Published			2022-12-26	WOS:000356768100134
J	Brennan, MJ; Karcz, J; Vaughn, NR; Woolwine-Cunningham, Y; DePriest, AD; Escalona, Y; Perez-Acle, T; Skerrett, IM				Brennan, Matthew J.; Karcz, Jennifer; Vaughn, Nicholas R.; Woolwine-Cunningham, Yvonne; DePriest, Adam D.; Escalona, Yerko; Perez-Acle, Tomas; Skerrett, I. Martha			Tryptophan Scanning Reveals Dense Packing of Connexin Transmembrane Domains in Gap Junction Channels Composed of Connexin32	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; ACETYLCHOLINE-RECEPTOR; HELIX INTERACTIONS; MUTAGENESIS; MUTATIONS; RESIDUES; IDENTIFICATION; TOPOLOGY; MODEL	Tryptophan was substituted for residues in all four transmembrane domains of connexin32. Function was assayed using dual cell two-electrode voltage clamp after expression in Xenopus oocytes. Tryptophan substitution was poorly tolerated in all domains, with the greatest impact in TM1 and TM4. For instance, in TM1, 15 substitutions were made, six abolished coupling and five others significantly reduced function. Only TM2 and TM3 included a distinct helical face that lacked sensitivity to tryptophan substitution. Results were visualized on a comparative model of Cx32 hemichannel. In this model, aregion midway through the membrane appears highly sensitive to tryptophan substitution and includes residues Arg-32, Ile-33, Met-34, and Val-35. In the modeled channel, pore-facing regions of TM1 and TM2 were highly sensitive to tryptophan substitution, whereas the lipid-facing regions of TM3 and TM4 were variably tolerant. Residues facing a putative intracellular water pocket ( the IC pocket) were also highly sensitive to tryptophan substitution. Although future studies will be required to separate trafficking-defective mutants from those that alter channel function, a subset of interactions important for voltage gating was identified. Interactions important for voltage gating occurred mainly in the mid-region of the channel and focused on TM1. To determine whether results could be extrapolated to other connexins, TM1 of Cx43 was scanned revealing similar but not identical sensitivity to TM1 of Cx32.	[Brennan, Matthew J.; Karcz, Jennifer; Vaughn, Nicholas R.; Skerrett, I. Martha] SUNY Coll Buffalo, Dept Biol, Buffalo, NY 14222 USA; [Woolwine-Cunningham, Yvonne] SUNY Buffalo, Clin & Translat Res Ctr, Buffalo, NY 14214 USA; [DePriest, Adam D.] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA; [Escalona, Yerko; Perez-Acle, Tomas] Fdn Ciencia & Vida, Computat Biol Lab, Santiago 7780344, Chile; [Escalona, Yerko; Perez-Acle, Tomas] Univ Valparaiso, Ctr Interdisciplinario Neurociencias Valparaiso, Valparaiso 2360102, Chile	State University of New York (SUNY) System; Buffalo State College; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute; Universidad de Valparaiso	Skerrett, IM (corresponding author), SUNY Coll Buffalo, Dept Biol, 1300 Elmwood Ave, Buffalo, NY 14222 USA.	skerreim@buffalostate.edu	Perez-Acle, Tomas/F-7176-2012	Perez-Acle, Tomas/0000-0002-3769-390X; Vaughn, Nicholas/0000-0003-0428-2909	American Heart Association National Affiliate Scientist Development grant; State University of New York Buffalo State Incentive Funding Program; Buffalo State Undergraduate Research Fellowship program; Fundacion Ciencia para la Vida [FONDECYT 1130652, ACT1107, PFB16]; ICM-Chilean Ministry of Economy [P09-022-F]	American Heart Association National Affiliate Scientist Development grant(American Heart Association); State University of New York Buffalo State Incentive Funding Program; Buffalo State Undergraduate Research Fellowship program; Fundacion Ciencia para la Vida; ICM-Chilean Ministry of Economy	This work was supported in part by an American Heart Association National Affiliate Scientist Development grant and the State University of New York Buffalo State Incentive Funding Program. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Buffalo State Undergraduate Research Fellowship program.; Supported in part by FONDECYT 1130652, ACT1107, PFB16 Fundacion Ciencia para la Vida, and Centro Interdisciplinario de Neurociencias de Valparaiso Millennium Institute that is funded by ICM-Chilean Ministry of Economy Grant P09-022-F.	Alexopoulos H, 2004, CURR BIOL, V14, pR879, DOI 10.1016/j.cub.2004.09.067; Araya-Secchi R, 2014, BIOPHYS J, V107, P599, DOI 10.1016/j.bpj.2014.05.037; Arora A, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.034108; Balice-Gordon RJ, 1998, J CELL BIOL, V142, P1095, DOI 10.1083/jcb.142.4.1095; BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; Bruzzone R, 1996, EUR J BIOCHEM, V238, P1, DOI 10.1111/j.1432-1033.1996.0001q.x; Otero-Cruz JD, 2007, J BIOL CHEM, V282, P9162, DOI 10.1074/jbc.M607492200; De Feo CJ, 2010, J MEMBRANE BIOL, V234, P113, DOI 10.1007/s00232-010-9239-4; DePriest A, 2011, BIOPHYS J, V101, P2408, DOI 10.1016/j.bpj.2011.10.004; Goodenough DA, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002576; Guzman GR, 2003, BIOCHEMISTRY-US, V42, P12243, DOI 10.1021/bi034764d; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Ishii TM, 2007, J PHYSIOL-LONDON, V579, P291, DOI 10.1113/jphysiol.2006.124297; Kleopa KA, 2012, BRAIN RES, V1487, P198, DOI 10.1016/j.brainres.2012.03.068; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Kwon T, 2011, J GEN PHYSIOL, V138, P475, DOI 10.1085/jgp.201110679; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee SP, 2000, NEUROPSYCHOPHARMACOL, V23, pS32, DOI 10.1016/S0893-133X(00)00155-X; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Mall S, 2000, BIOCHEMISTRY-US, V39, P2071, DOI 10.1021/bi992205u; Matthews EE, 2006, CELL, V127, P447, DOI 10.1016/j.cell.2006.10.016; MILKS LC, 1988, EMBO J, V7, P2967, DOI 10.1002/j.1460-2075.1988.tb03159.x; Oh S, 1997, NEURON, V19, P927, DOI 10.1016/S0896-6273(00)80973-3; Oshima A, 2007, P NATL ACAD SCI USA, V104, P10034, DOI 10.1073/pnas.0703704104; Oshima A, 2013, J BIOL CHEM, V288, P10513, DOI 10.1074/jbc.M112.428383; PERACCHIA C, 1973, J CELL BIOL, V57, P66, DOI 10.1083/jcb.57.1.66; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SHARP LL, 1995, BIOCHEMISTRY-US, V34, P9166, DOI 10.1021/bi00028a028; Shy ME, 2007, NEUROLOGY, V68, P849, DOI 10.1212/01.wnl.0000256709.08271.4d; Skerrett IM, 2004, FASEB J, V18, P860, DOI 10.1096/fj.03-0763fje; Skerrett IM, 2001, METH MOL B, V154, P225; Skerrett IM, 2002, J CELL BIOL, V159, P349, DOI 10.1083/jcb.200207060; Skerrett IM, 2000, CURR TOP MEMBR, V49, P249; Smith TD, 2012, J MEMBRANE BIOL, V245, P221, DOI 10.1007/s00232-012-9443-5; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Subbiah RN, 2005, J PHYSIOL-LONDON, V569, P367, DOI 10.1113/jphysiol.2005.097386; SUCHYNA TM, 1993, NATURE, V365, P847, DOI 10.1038/365847a0; Toloue MM, 2008, CELL COMMUN ADHES, V15, P95, DOI 10.1080/15419060802013463; Ueno S, 2000, BRIT J PHARMACOL, V131, P296, DOI 10.1038/sj.bjp.0703504; Willecke K, 2002, BIOL CHEM, V383, P725, DOI 10.1515/BC.2002.076; Zonta F, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00085	44	2	2	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2015	290	28					17074	17084		10.1074/jbc.M115.650747	http://dx.doi.org/10.1074/jbc.M115.650747			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM5MB	25969535	hybrid, Green Published			2022-12-26	WOS:000357730900003
J	Cali, T; Lopreiato, R; Shimony, J; Vineyard, M; Frizzarin, M; Zanni, G; Zanotti, G; Brini, M; Shinawi, M; Carafoli, E				Cali, Tito; Lopreiato, Raffaele; Shimony, Joshua; Vineyard, Marisa; Frizzarin, Martina; Zanni, Ginevra; Zanotti, Giuseppe; Brini, Marisa; Shinawi, Marwan; Carafoli, Ernesto			A Novel Mutation in Isoform 3 of the Plasma Membrane Ca2+ Pump Impairs Cellular Ca2+ Homeostasis in a Patient with Cerebellar Ataxia and Laminin Subunit 1 Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ataxia; calcium; calcium ATPase; enzyme mutation; laminin	CALCIUM-PUMP; CALMODULIN; CELLS; OVEREXPRESSION; EXPRESSION; ATPASES; PROTEIN; PMCA2; MOUSE; YEAST	Background: Mutations in plasma membrane Ca2+-ATPase (PMCA) isoform 3 and in laminin subunit 1 have previously been linked to ataxic phenotypes. Results: A novel PMCA3 missense mutation co-occurring with a compound heterozygous mutation in laminin subunit 1 impaired cellular Ca2+ homeostasis. Conclusion: The two mutations could work synergistically to generate the disease phenotype. Significance: A digenic mechanism could be responsible for this case of cerebellar ataxia. The particular importance of Ca2+ signaling to neurons demands its precise regulation within their cytoplasm. Isoform 3 of the plasma membrane Ca2+ ATPase (the PMCA3 pump), which is highly expressed in brain and cerebellum, plays an important role in the regulation of neuronal Ca2+. A genetic defect of the PMCA3 pump has been described in one family with X-linked congenital cerebellar ataxia. Here we describe a novel mutation in the ATP2B3 gene in a patient with global developmental delay, generalized hypotonia and cerebellar ataxia. The mutation (a R482H replacement) impairs the Ca2+ ejection function of the pump. It reduces the ability of the pump expressed in model cells to control Ca2+ transients generated by cell stimulation and impairs its Ca2+ extrusion function under conditions of low resting cytosolic Ca2+ as well. In silico analysis of the structural effect of the mutation suggests a reduced stabilization of the portion of the pump surrounding the mutated residue in the Ca2+-bound state. The patient also carries two missense mutations in LAMA1, encoding laminin subunit 1. On the basis of the family pedigree of the patient, the presence of both PMCA3 and laminin subunit 1 mutations appears to be necessary for the development of the disease. Considering the observed defect in cellular Ca2+ homeostasis and the previous finding that PMCAs act as digenic modulators in Ca2+-linked pathologies, the PMCA3 dysfunction along with LAMA1 mutations could act synergistically to cause the neurological phenotype.	[Cali, Tito; Brini, Marisa] Univ Padua, Dept Biol, I-35131 Padua, Italy; [Lopreiato, Raffaele; Frizzarin, Martina; Zanotti, Giuseppe] Univ Padua, Dept Biomed Sci, I-35131 Padua, Italy; [Shimony, Joshua] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA; [Vineyard, Marisa; Shinawi, Marwan] Washington Univ, Sch Med, Dept Pediat, Div Genet & Genom Med, St Louis, MO 63110 USA; [Zanni, Ginevra] Bambino Gesu Pediat Hosp, Dept Neurosci, Unit Mol Med Neuromuscular & Neurodegenerat Disor, IRCCS, I-00165 Rome, Italy; [Carafoli, Ernesto] VIMM, I-35131 Padua, Italy	University of Padua; University of Padua; Washington University (WUSTL); Washington University (WUSTL); IRCCS Bambino Gesu; Veneto Institute Molecular Medicine	Brini, M (corresponding author), Univ Padua, Dept Biol, I-35131 Padua, Italy.	marisa.brini@unipd.it; Shinawi_M@kids.wustl.edu; ernesto.carafoli@unipd.it	Brini, Marisa/K-5189-2016; Carafoli, Ernesto/K-5192-2016; Calì, Tito/K-5064-2016; Zanni, Ginevra/L-2869-2015	Carafoli, Ernesto/0000-0002-7826-0094; Calì, Tito/0000-0002-8901-1659; Zanni, Ginevra/0000-0002-6367-1843; Brini, Marisa/0000-0001-5141-0243; LOPREIATO, RAFFAELE/0000-0003-2368-9384; shinawi, Marwan/0000-0003-1329-4100; Andrews, Marisa/0000-0002-5448-1204	University of Padova; Progetto Giovani [GRIC128SP0]; Progetto di Ateneo [CPDA115047/11]; University of Padova [Giovani GRIC128SP0]	University of Padova; Progetto Giovani; Progetto di Ateneo; University of Padova	This work was supported by the University of Padova (local grants (to M. B.), Progetto Giovani GRIC128SP0 (to T. C.), and Progetto di Ateneo CPDA115047/11 (to R. L.)).; Supported by the University of Padova (Progetto Giovani GRIC128SP0, Bando 2012).	Aldinger KA, 2014, AM J HUM GENET, V95, P227, DOI 10.1016/j.ajhg.2014.07.007; Baekgaard L, 2006, J BIOL CHEM, V281, P1058, DOI 10.1074/jbc.M508299200; Bortolozzi M, 2010, J BIOL CHEM, V285, P37693, DOI 10.1074/jbc.M110.170092; Brini M, 2000, EMBO J, V19, P4926, DOI 10.1093/emboj/19.18.4926; BRINI M, 1995, J BIOL CHEM, V270, P9896, DOI 10.1074/jbc.270.17.9896; Brini M, 2003, J BIOL CHEM, V278, P24500, DOI 10.1074/jbc.M300784200; Brini M, 2014, CELL MOL LIFE SCI, V71, P2787, DOI 10.1007/s00018-013-1550-7; Brini M, 2013, METAL IONS LIFE SCI, V12, P119, DOI 10.1007/978-94-007-5561-1_5; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Carafoli E, 2007, N COMP BIOC, V41, P3; Chand K. K., 2014, J PHYSL, V593, P245, DOI DOI 10.1113/JPHYSIOL.2014.284133; Cox JS, 1997, MOL BIOL CELL, V8, P1805, DOI 10.1091/mbc.8.9.1805; CUNNINGHAM KW, 1994, J CELL BIOL, V124, P351, DOI 10.1083/jcb.124.3.351; Dumont RA, 2001, J NEUROSCI, V21, P5066, DOI 10.1523/JNEUROSCI.21-14-05066.2001; EAKIN TJ, 1995, MOL BRAIN RES, V29, P71, DOI 10.1016/0169-328X(94)00231-3; Empson RM, 2010, J PHYSIOL-LONDON, V588, P907, DOI 10.1113/jphysiol.2009.182196; ENYEDI A, 1989, J BIOL CHEM, V264, P12313; Ficarella R, 2007, P NATL ACAD SCI USA, V104, P1516, DOI 10.1073/pnas.0609775104; FUJIMOTO T, 1993, J CELL BIOL, V120, P1147, DOI 10.1083/jcb.120.5.1147; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Hammes A, 1998, CIRC RES, V83, P877; Heng C, 2011, CELL ADHES MIGR, V5, P480, DOI 10.4161/cam.5.6.19191; INOUE Y, 1993, NEUROSCI RES, V16, P39, DOI 10.1016/0168-0102(93)90007-D; Lopreiato R, 2014, J BIOL CHEM, V289, P10261, DOI 10.1074/jbc.O114.555565; Mao P, 2013, P NATL ACAD SCI USA, V110, P8644, DOI 10.1073/pnas.1221478110; Powell SK, 1997, INT J BIOCHEM CELL B, V29, P401, DOI 10.1016/S1357-2725(96)00110-0; Rizzuto R, 1995, METHOD ENZYMOL, V260, P417, DOI 10.1016/0076-6879(95)60155-4; Schultz JM, 2005, NEW ENGL J MED, V352, P1557, DOI 10.1056/NEJMoa043899; Ton VK, 2004, AM J PHYSIOL-CELL PH, V287, pC580, DOI 10.1152/ajpcell.00135.2004; VERMA AK, 1994, J BIOL CHEM, V269, P1687; Zanni G, 2012, P NATL ACAD SCI USA, V109, P14514, DOI 10.1073/pnas.1207488109	31	34	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16132	16141		10.1074/jbc.M115.656496	http://dx.doi.org/10.1074/jbc.M115.656496			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25953895	Green Published, hybrid			2022-12-26	WOS:000356930100018
J	Forsberg, SKG; Kierczak, M; Ljungvall, I; Merveille, AC; Gouni, V; Wiberg, M; Willesen, JL; Hanas, S; Lequarre, AS; Sorensen, LM; Tiret, L; McEntee, K; Seppala, E; Koch, J; Battaille, G; Lohi, H; Fredholm, M; Chetboul, V; Haggstrom, J; Carlborg, O; Lindblad-Toh, K; Hoglund, K				Forsberg, Simon K. G.; Kierczak, Marcin; Ljungvall, Ingrid; Merveille, Anne-Christine; Gouni, Vassiliki; Wiberg, Maria; Willesen, Jakob Lundgren; Hanas, Sofia; Lequarre, Anne-Sophie; Sorensen, Louise Mejer; Tiret, Laurent; McEntee, Kathleen; Seppala, Eija; Koch, Jorgen; Battaille, Geraldine; Lohi, Hannes; Fredholm, Merete; Chetboul, Valerie; Haggstrom, Jens; Carlborg, Orjan; Lindblad-Toh, Kerstin; Hoglund, Katja			The Shepherds' Tale: A Genome-Wide Study across 9 Dog Breeds Implicates Two Loci in the Regulation of Fructosamine Serum Concentration in Belgian Shepherds	PLOS ONE			English	Article							DIABETES-MELLITUS; RECEPTOR MUTATIONS; ASSOCIATION; LETM1; SUSCEPTIBILITY; METABOLISM; OBESITY; UPDATE	Diabetes mellitus is a serious health problem in both dogs and humans. Certain dog breeds show high prevalence of the disease, whereas other breeds are at low risk. Fructosamine and glycated haemoglobin (HbA1c) are two major biomarkers of glycaemia, where serum concentrations reflect glucose turnover over the past few weeks to months. In this study, we searched for genetic factors influencing variation in serum fructosamine concentration in healthy dogs using data from nine dog breeds. Considering all breeds together, we did not find any genome-wide significant associations to fructosamine serum concentration. However, by performing breed-specific analyses we revealed an association on chromosome 3 (rho(corrected) approximate to 1:68 x 10(-6)) in Belgian shepherd dogs of the Malinois subtype. The associated region and its close neighbourhood harbours interesting candidate genes such as LETM1 and GAPDH that are important in glucose metabolism and have previously been implicated in the aetiology of diabetes mellitus. To further explore the genetics of this breed specificity, we screened the genome for reduced heterozygosity stretches private to the Belgian shepherd breed. This revealed a region with reduced heterozygosity that shows a statistically significant interaction (rho = 0.025) with the association region on chromosome 3. This region also harbours some interesting candidate genes and regulatory regions but the exact mechanisms underlying the interaction are still unknown. Nevertheless, this finding provides a plausible explanation for breed-specific genetic effects for complex traits in dogs. Shepherd breeds are at low risk of developing diabetes mellitus. The findings in Belgian shepherds could be connected to a protective mechanism against the disease. Further insight into the regulation of glucose metabolism could improve diagnostic and therapeutic methods for diabetes mellitus.	[Forsberg, Simon K. G.; Kierczak, Marcin; Carlborg, Orjan] Swedish Univ Agr Sci, Dept Clin Sci, Computat Genet Sect, Uppsala, Sweden; [Kierczak, Marcin; Lindblad-Toh, Kerstin] Uppsala Univ, Sci Life Lab, Uppsala, Sweden; [Kierczak, Marcin; Lindblad-Toh, Kerstin] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Ljungvall, Ingrid; Hanas, Sofia; Haggstrom, Jens] Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden; [Merveille, Anne-Christine; Lequarre, Anne-Sophie; McEntee, Kathleen; Battaille, Geraldine] Univ Liege, Fac Vet Med, Dept Clin Sci, Liege, Belgium; [Gouni, Vassiliki; Chetboul, Valerie] Univ Paris Est, Ecole Natl Vet Alfort, Unite Cardiol Alfort, Ctr Hosp Univ Vet Alfort, Maisons Alfort, France; [Wiberg, Maria] Univ Helsinki, Fac Vet Med, Dept Equine & Small Anim Med, Helsinki, Finland; [Willesen, Jakob Lundgren; Sorensen, Louise Mejer; Koch, Jorgen; Fredholm, Merete] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Clin & Anim Sci, Copenhagen, Denmark; [Hanas, Sofia] Anim Clin Vasteras, Evidensia, Vasteras, Sweden; [Tiret, Laurent] INRA, Genet Fonct & Med UMR955, Maisons Alfort, France; [Tiret, Laurent] Univ Paris Est Creteil, CNM Project, Ecole Natl Vet Alfort, Maisons Alfort, France; [McEntee, Kathleen] Univ Libre Bruxelles, Fac Med, Physiol Lab, Brussels, Belgium; [Seppala, Eija; Lohi, Hannes] Univ Helsinki, Dept Vet Biosci, Res Program Mol Neurol, Res Programs Unit, Helsinki, Finland; [Seppala, Eija; Lohi, Hannes] Folkhalsan Inst Genet, Helsinki, Finland; [Seppala, Eija] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Chetboul, Valerie] Hop Henri Mondor, INSERM, U955, Equipe 03, F-94010 Creteil, France; [Lindblad-Toh, Kerstin] Broad Inst MIT & Harvard, Cambridge, MA USA; [Hoglund, Katja] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden	Swedish University of Agricultural Sciences; Uppsala University; Uppsala University; Swedish University of Agricultural Sciences; University of Liege; Ecole Nationale Veterinaire d'Alfort (ENVA); University of Helsinki; University of Copenhagen; INRAE; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Ecole Nationale Veterinaire d'Alfort (ENVA); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite Libre de Bruxelles; University of Helsinki; University of Helsinki; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Swedish University of Agricultural Sciences	Forsberg, SKG (corresponding author), Swedish Univ Agr Sci, Dept Clin Sci, Computat Genet Sect, Uppsala, Sweden.	simon.forsberg@slu.se; marcin.kierczak@imbim.uu.se; katja.hoglund@slu.se	Willesen, Jakob Lundgren/HCI-1751-2022; Tiret, Laurent/K-3877-2017; Lohi, Hannes/F-4596-2011	Tiret, Laurent/0000-0001-8573-8335; Lohi, Hannes/0000-0003-1087-5532; Kierczak, Marcin/0000-0003-2629-5655; Chetboul, Valerie/0000-0001-7891-1814; Lequarre, Anne Sophie/0000-0002-2187-4482; Haggstrom, Jens/0000-0003-3402-023X; Hoglund, Katja/0000-0002-7486-0420; Forsberg, Simon/0000-0002-7451-9222; Koch, Jorgen/0000-0001-8616-7888; Carlborg, Orjan/0000-0002-2722-5264; Hanas, Sofia/0000-0002-6758-8190; Mc Entee, Kathleen/0000-0003-3521-9232; Willesen, Jakob/0000-0002-2851-9264; Fredholm, Merete/0000-0002-3563-7648; Merveille, Anne-Christine/0000-0003-3864-6336	European Commission [GA-201370]	European Commission(European CommissionEuropean Commission Joint Research Centre)	The study was supported by the European Commission (FP7-LUPA, GA-201370). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMBRUSTER DA, 1987, CLIN CHEM, V33, P2153; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837; Belonogova NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065395; Catchpole B, 2005, DIABETOLOGIA, V48, P1948, DOI 10.1007/s00125-005-1921-1; Chan LF, 2008, HORM RES, V69, P75, DOI 10.1159/000111810; Coppo JA, 1997, VET RES COMMUN, V21, P471, DOI 10.1023/A:1005934202643; Eto K, 1999, SCIENCE, V283, P981, DOI 10.1126/science.283.5404.981; Fall T, 2007, J VET INTERN MED, V21, P1209, DOI 10.1892/07-021.1; Guptill L, 2003, VET J, V165, P240, DOI 10.1016/S1090-0233(02)00242-3; Hedrick PW, 2011, HEREDITY, V106, P712, DOI 10.1038/hdy.2010.98; Hess RS, 2000, J AM VET MED ASSOC, V216, P1414, DOI 10.2460/javma.2000.216.1414; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Hoeppner MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091172; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; JENSEN AL, 1995, VET REC, V137, P401, DOI 10.1136/vr.137.16.401; JENSEN AL, 1993, VET RES COMMUN, V17, P13, DOI 10.1007/BF01839176; Jiang DW, 2013, P NATL ACAD SCI USA, V110, pE2249, DOI 10.1073/pnas.1308558110; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; Karlsson EK, 2008, NAT REV GENET, V9, P713, DOI 10.1038/nrg2382; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Kennedy LJ, 2006, TISSUE ANTIGENS, V68, P467, DOI 10.1111/j.1399-0039.2006.00716.x; Lequarre AS, 2011, VET J, V189, P155, DOI 10.1016/j.tvjl.2011.06.013; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Liu H, 2014, BMC SYST BIOL, V8, DOI [10.1186/1752-0509-8-S3-S5, 10.1186/1752-0509-8-S1-S5]; MARMOR M, 1982, AM J VET RES, V43, P465; MCCLELLAND G, 1994, AM J PHYSIOL, V266, pR1280, DOI 10.1152/ajpregu.1994.266.4.R1280; Mencarelli M, 2011, HUM MOL GENET, V20, P392, DOI 10.1093/hmg/ddq472; Narayan KMV, 2000, DIABETES RES CLIN PR, V50, pS77; Ostrander EA, 2008, STADLER GEN, P11, DOI 10.1007/978-0-387-76723-9_2; Park J, 2014, METABOLISM, V63, P318, DOI 10.1016/j.metabol.2013.10.012; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Schmutz SM, 2003, J HERED, V94, P69, DOI 10.1093/jhered/esg014; Shin JH, 2006, J STAT SOFTWARE, V48; Sutter NB, 2004, GENOME RES, V14, P2388, DOI 10.1101/gr.3147604; Sutter NB, 2004, NAT REV GENET, V5, P900, DOI 10.1038/nrg1492; True Mark W, 2009, J Diabetes Sci Technol, V3, P743; Vaisse C, 2000, J CLIN INVEST, V106, P253, DOI 10.1172/JCI9238; Veiga APM, 2008, J VET DIAGN INVEST, V20, P224, DOI 10.1177/104063870802000214; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	40	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0123173	10.1371/journal.pone.0123173	http://dx.doi.org/10.1371/journal.pone.0123173			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970163	Green Published, Green Submitted, gold			2022-12-26	WOS:000354544200009
J	Platt, C; Calimano, M; Nemet, J; Bubenik, J; Cochrane, A				Platt, Craig; Calimano, Maria; Nemet, Josip; Bubenik, Jodi; Cochrane, Alan			Differential Effects of Tra2 beta Isoforms on HIV-1 RNA Processing and Expression	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; EXONIC SPLICING ENHANCER; PRE-MESSENGER-RNA; ON REGULATORY SYSTEM; MOTOR-NEURON SMN; GENE-EXPRESSION; MOLECULAR-CLONING; TRA2 PROTEINS; REV FUNCTION; HNRNP-G	Balanced processing of HIV-1 RNA is critical to virus replication and is regulated by host factors. In this report, we demonstrate that overexpression of either Tra2 alpha or Tra2 beta results in a marked reduction in HIV-1 Gag/Env expression, an effect associated with changes in HIV-1 RNA accumulation, altered viral splice site usage, and a block to export of HIV-1 genomic RNA. A natural isoform of Tra2 beta (Tra2 beta 3), lacking the N-terminal RS domain, also suppressed HIV-1 expression but had different effects on viral RNA processing. The functional differences between the Tra2 beta isoforms were also observed in the context of another RNA substrate indicating that these factors have distinct functions within the cell. Finally, we demonstrate that Tra2 beta depletion results in a selective reduction in HIV-1 Env expression as well as an increase in multiply spliced viral RNA. Together, the findings indicate that Tra2 alpha/beta can play important roles in regulating HIV-1 RNA metabolism and expression.	[Platt, Craig; Calimano, Maria; Nemet, Josip; Bubenik, Jodi; Cochrane, Alan] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of Toronto	Cochrane, A (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.	alan.cochrane@utoronto.ca			Ontario HIV Treatment Network (OHTN); Canadian Institutes of Health Research (CIHR); OHTN	Ontario HIV Treatment Network (OHTN); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); OHTN	Studies were supported by operating grants from the Ontario HIV Treatment Network (OHTN) and the Canadian Institutes of Health Research (CIHR). AC was supported by a Scientist award from the OHTN during the course of these studies. Neither funder had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABACIOGLU YH, 1994, AIDS RES HUM RETROV, V10, P371, DOI 10.1089/aid.1994.10.371; Anderson ES, 2012, RNA, V18, P1041, DOI 10.1261/rna.032912.112; Asai K, 2003, VIROLOGY, V314, P229, DOI 10.1016/S0042-6822(03)00400-8; Asang C, 2008, NUCLEIC ACIDS RES, V36, P1450, DOI 10.1093/nar/gkm1147; Beil B, 1997, DNA CELL BIOL, V16, P679, DOI 10.1089/dna.1997.16.679; Blencowe BJ, 1999, BIOCHEM CELL BIOL, V77, P277, DOI 10.1139/bcb-77-4-277; Caputi M, 2004, J VIROL, V78, P6517, DOI 10.1128/JVI.78.12.6517-6526.2004; Cavaloc Y, 1999, RNA, V5, P468, DOI 10.1017/S1355838299981967; Chen XH, 2003, CELL BIOL INT, V27, P491, DOI 10.1016/S1065-6995(03)00072-6; CHESEBRO B, 1992, J VIROL, V66, P6547, DOI 10.1128/JVI.66.11.6547-6554.1992; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Clery A, 2011, NAT STRUCT MOL BIOL, V18, P443, DOI 10.1038/nsmb.2001; Cramer P, 1999, MOL CELL, V4, P251, DOI 10.1016/S1097-2765(00)80372-X; Dauwalder B, 1996, P NATL ACAD SCI USA, V93, P9004, DOI 10.1073/pnas.93.17.9004; Erkelenz S, 2013, J VIROL, V87, P2721, DOI 10.1128/JVI.02756-12; Graveley BR, 1998, EMBO J, V17, P6747, DOI 10.1093/emboj/17.22.6747; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Grellscheid S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002390; Hallay H, 2006, J BIOL CHEM, V281, P37159, DOI 10.1074/jbc.M603864200; Hofmann Y, 2000, P NATL ACAD SCI USA, V97, P9618, DOI 10.1073/pnas.160181697; Hofmann Y, 2002, HUM MOL GENET, V11, P2037, DOI 10.1093/hmg/11.17.2037; Hope TJ, 1999, ARCH BIOCHEM BIOPHYS, V365, P186, DOI 10.1006/abbi.1999.1207; Huang YQ, 2005, MOL CELL, V17, P613, DOI 10.1016/j.molcel.2005.02.020; Huang YQ, 2003, MOL CELL, V11, P837, DOI 10.1016/S1097-2765(03)00089-3; Huang YQ, 2001, MOL CELL, V7, P899, DOI 10.1016/S1097-2765(01)00233-7; Iacampo S, 1996, J VIROL, V70, P8332, DOI 10.1128/JVI.70.12.8332-8339.1996; Jablonski JA, 2009, J VIROL, V83, P981, DOI 10.1128/JVI.01801-08; Jiang ZH, 2003, J BIOL CHEM, V278, P18997, DOI 10.1074/jbc.M301800200; Kriegler M., 1990, GENE TRANSFER EXPRES; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; MATSUO N, 1995, J BIOL CHEM, V270, P28216, DOI 10.1074/jbc.270.47.28216; McLaren M, 2008, FRONT BIOSCI, V13, P5693; Misteli T, 1998, CURR OPIN CELL BIOL, V10, P323, DOI 10.1016/S0955-0674(98)80007-0; Nasim MT, 2003, HUM MOL GENET, V12, P1337, DOI 10.1093/hmg/ddg136; Nayler O, 1998, GENOMICS, V53, P191, DOI 10.1006/geno.1998.5471; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pollard VW, 1998, ANNU REV MICROBIOL, V52, P491, DOI 10.1146/annurev.micro.52.1.491; Pongoski J, 2002, J VIROL, V76, P5108, DOI 10.1128/JVI.76.10.5108-5120.2002; PURCELL DFJ, 1993, J VIROL, V67, P6365, DOI 10.1128/JVI.67.11.6365-6378.1993; Ropers D, 2004, J BIOL CHEM, V279, P29963, DOI 10.1074/jbc.M404452200; Sajic R, 2007, NUCLEIC ACIDS RES, V35, P247, DOI 10.1093/nar/gkl022; Segade F, 1996, FEBS LETT, V387, P152, DOI 10.1016/0014-5793(96)00496-6; Seong JY, 2002, MOL ENDOCRINOL, V16, P2426, DOI 10.1210/me.2001-0297; Shen HH, 2007, NAT STRUCT MOL BIOL, V14, P597, DOI 10.1038/nsmb1263; Shu-Jing L, 2013, J BIOL CHEM, V288, P8898, DOI [10.1074/jbc.M113.456715, DOI 10.1074/JBC.M113.456715]; STAFFA A, 1995, MOL CELL BIOL, V15, P4597; Stoilov P, 2004, HUM MOL GENET, V13, P509, DOI 10.1093/hmg/ddh051; Stoltzfus CM, 2009, ADV VIRUS RES, V74, P1, DOI 10.1016/S0065-3527(09)74001-1; Stoltzfus CM, 2006, CURR HIV RES, V4, P43, DOI 10.2174/157016206775197655; Su ZZ, 2003, GENE, V306, P67, DOI 10.1016/S0378-1119(03)00404-9; Suh D, 2003, VIROLOGY, V310, P85, DOI 10.1016/S0042-6822(03)00073-4; Tacke R, 1999, P SOC EXP BIOL MED, V220, P59, DOI 10.1046/j.1525-1373.1999.d01-10.x; Tacke R, 1999, CURR OPIN CELL BIOL, V11, P358, DOI 10.1016/S0955-0674(99)80050-7; TACKE R, 1995, EMBO J, V14, P3540, DOI 10.1002/j.1460-2075.1995.tb07360.x; Tacke R, 1998, CELL, V93, P139, DOI 10.1016/S0092-8674(00)81153-8; Tran Q, 2003, BBA-GENE STRUCT EXPR, V1625, P141, DOI 10.1016/S0167-4781(02)00600-0; Tsuda K, 2011, NUCLEIC ACIDS RES, V39, P1538, DOI 10.1093/nar/gkq854; van Oordt WVH, 2000, NUCLEIC ACIDS RES, V28, P4822, DOI 10.1093/nar/28.24.4822; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang J, 1998, GENE DEV, V12, P2222, DOI 10.1101/gad.12.14.2222; Wong R, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-47; Wong RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003241; Young PJ, 2002, HUM MOL GENET, V11, P577, DOI 10.1093/hmg/11.5.577; Zhou X, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-82; Zhou X, 2006, J BIOL CHEM, V281, P17084, DOI 10.1074/jbc.M513400200	65	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0125315	10.1371/journal.pone.0125315	http://dx.doi.org/10.1371/journal.pone.0125315			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970345	Green Published, gold, Green Submitted			2022-12-26	WOS:000354544200071
J	Tan, A; Tan, SH; Vyas, D; Malaivijitnond, S; Gumert, MD				Tan, Amanda; Tan, Say Hoon; Vyas, Dhaval; Malaivijitnond, Suchinda; Gumert, Michael D.			There Is More than One Way to Crack an Oyster: Identifying Variation in Burmese Long-Tailed Macaque (Macaca fascicularis aurea) Stone-Tool Use	PLOS ONE			English	Article							MONKEYS CEBUS-LIBIDINOSUS; BEARDED CAPUCHIN MONKEYS; BEHAVIORAL TRADITION; HANDLING BEHAVIOR; NUT-CRACKING; CHIMPANZEES; CULTURES; STRATEGIES; PATTERNS; HAMMERS	We explored variation in patterns of percussive stone-tool use on coastal foods by Burmese long-tailed macaques (Macaca fascicularis aurea) from two islands in Laem Son National Park, Ranong, Thailand. We catalogued variation into three hammering classes and 17 action patterns, after examining 638 tool-use bouts across 90 individuals. Hammering class was based on the stone surface used for striking food, being face, point, and edge hammering. Action patterns were discriminated by tool material, hand use, posture, and striking motion. Hammering class was analyzed for associations with material and behavioural elements of tool use. Action patterns were not, owing to insufficient instances of most patterns. We collected 3077 scan samples from 109 macaques on Piak Nam Yai Island's coasts, to determine the proportion of individuals using each hammering class and action pattern. Point hammering was significantly more associated with sessile foods, smaller tools, faster striking rates, smoother recoil, unimanual use, and more varied striking direction, than were face and edge hammering, while both point and edge hammering were significantly more associated with precision gripping than face hammering. Edge hammering also showed distinct differences depending on whether such hammering was applied to sessile or unattached foods, resembling point hammering for sessile foods and face hammering for unattached foods. Point hammering and sessile edge hammering compared to prior descriptions of axe hammering, while face and unattached edge hammering compared to pound hammering. Analysis of scans showed that 80% of individuals used tools, each employing one to four different action patterns. The most common patterns were unimanual point hammering (58%), symmetrical-bimanual face hammering (47%) and unimanual face hammering (37%). Unimanual edge hammering was relatively frequent (13%), compared to the other thirteen rare action patterns (<5%). We compare our study to other stone-using primates, and discuss implications for further research.	[Tan, Amanda; Tan, Say Hoon; Gumert, Michael D.] Nanyang Technol Univ, Sch Humanities & Social Sci, Div Psychol, Singapore 637322, Singapore; [Vyas, Dhaval] Colorado State Univ, Grad Degree Program Ecol, Ft Collins, CO 80523 USA; [Malaivijitnond, Suchinda; Gumert, Michael D.] Chulalongkorn Univ, Fac Sci, Natl Primate Res Ctr Thailand, Bangkok 10330, Thailand; [Malaivijitnond, Suchinda; Gumert, Michael D.] Chulalongkorn Univ, Fac Sci, Dept Biol, Bangkok 10330, Thailand	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Colorado State University; Chulalongkorn University; Chulalongkorn University	Tan, A (corresponding author), Nanyang Technol Univ, Sch Humanities & Social Sci, Div Psychol, Singapore 637322, Singapore.	wytan5@e.ntu.edu.sg	Gumert, Michael D./N-2516-2015	Gumert, Michael D./0000-0002-7464-4525; Tan, Amanda/0000-0002-9227-4644	Thailand Research Fund [RSA/G2/2545, RMU 4880019]; Center for Excellence in Biodiversity at Chulalongkorn University; Ratchadapisek Sompoch Endowment Fund; Chulalongkorn University [Sci-Super 2014-021]; Ministry of Education (Singapore); Academic Research Fund [RG07/95]; College of Humanities, Arts, and Social Sciences (CoHASS) Incentive Grant; School of Humanities and Social Sciences, Nanyang Technological University; Leakey Foundation	Thailand Research Fund(Thailand Research Fund (TRF)); Center for Excellence in Biodiversity at Chulalongkorn University(Chulalongkorn University); Ratchadapisek Sompoch Endowment Fund; Chulalongkorn University(Chulalongkorn University); Ministry of Education (Singapore)(Ministry of Education, Singapore); Academic Research Fund(Ministry of Education, Singapore); College of Humanities, Arts, and Social Sciences (CoHASS) Incentive Grant; School of Humanities and Social Sciences, Nanyang Technological University(Nanyang Technological University); Leakey Foundation	This research was supported by the Thailand Research Fund (Grant RSA/G2/2545 and RMU 4880019), The Center for Excellence in Biodiversity at Chulalongkorn University, the Ratchadapisek Sompoch Endowment Fund (2013), Chulalongkorn University (Sci-Super 2014-021), the Ministry of Education (Singapore), Academic Research Fund (Grant RG07/95), the College of Humanities, Arts, and Social Sciences (CoHASS) Incentive Grant, School of Humanities and Social Sciences, Nanyang Technological University, and a research grant for doctoral students from The Leakey Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Bird DW, 2000, J ANTHROPOL ARCHAEOL, V19, P461, DOI 10.1006/jaar.2000.0367; Biro D, 2003, ANIM COGN, V6, P213, DOI 10.1007/s10071-003-0183-x; Biro D, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0408; Biro Dora, 2010, P141; BOESCH C, 1983, BEHAVIOUR, V83, P265, DOI 10.1163/156853983X00192; BOESCH C, 1990, FOLIA PRIMATOL, V54, P86, DOI 10.1159/000156428; Boesch C., 1993, P31; Boesch C, 2000, CHIMPANZEES TAI FORE; Canale GR, 2009, AM J PRIMATOL, V71, P366, DOI 10.1002/ajp.20648; Carvalho S, 2008, J HUM EVOL, V55, P148, DOI 10.1016/j.jhevol.2008.02.005; Carvalho S, 2009, ANIM COGN, V12, pS103, DOI 10.1007/s10071-009-0271-7; FERNANDES MEB, 1991, PRIMATES, V32, P529, DOI 10.1007/BF02381944; Ferreira RG, 2010, AM J PRIMATOL, V72, P270, DOI 10.1002/ajp.20771; Fragaszy, 2008, BIOL TRADITIONS; Fragaszy D, 2004, AM J PRIMATOL, V64, P359, DOI 10.1002/ajp.20085; Gumert MD, 2013, ORYX, V47, P535, DOI 10.1017/S0030605312000130; Gumert MD, 2012, AM J PHYS ANTHROPOL, V149, P447, DOI 10.1002/ajpa.22143; Gumert MD, 2009, AM J PRIMATOL, V71, P594, DOI 10.1002/ajp.20694; HANNAH AC, 1987, PRIMATES, V28, P31, DOI 10.1007/BF02382181; Haslam M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072872; Haslam M, 2009, NATURE, V460, P339, DOI 10.1038/nature08188; Hernandez-Aguilar RA, 2007, P NATL ACAD SCI USA, V104, P19210, DOI 10.1073/pnas.0707929104; Huffman Michael A., 2003, P267, DOI 10.1017/CBO9780511584022.011; Huffman MA, 2010, JAPANESE MACAQUES, P191, DOI 10.1007/978-4-431-53886-8_9; Humle T, 2002, AM J PRIMATOL, V58, P133, DOI 10.1002/ajp.10055; JOULIAN F, 1996, MODELLING EARLY HUMA, P173; KORTLANDT A, 1987, PRIMATES, V28, P473, DOI 10.1007/BF02380862; Krutzen M, 2011, CURR BIOL, V21, P1808, DOI 10.1016/j.cub.2011.09.017; Kyle R, 1997, BIOL CONSERV, V82, P201; Leca JB, 2007, J HUM EVOL, V53, P691, DOI 10.1016/j.jhevol.2007.05.009; Leca JB, 2008, AM J PRIMATOL, V70, P803, DOI 10.1002/ajp.20551; Leca JB, 2008, AM J PHYS ANTHROPOL, V135, P233, DOI 10.1002/ajpa.20726; Leca JB, 2007, BEHAVIOUR, V144, P251, DOI 10.1163/156853907780425712; Liu Q, 2009, AM J PHYS ANTHROPOL, V138, P210, DOI 10.1002/ajpa.20920; Luncz LV, 2012, CURR BIOL, V22, P922, DOI 10.1016/j.cub.2012.03.031; Malaivijitnond S, 2007, AM J PRIMATOL, V69, P227, DOI 10.1002/ajp.20342; Mannu M, 2009, AM J PRIMATOL, V71, P242, DOI 10.1002/ajp.20642; Meehan Betty., 1977, SUNDA SAHUL EDITORS, P493; Mercader J, 2002, SCIENCE, P1542; Mercader J, 2007, P NATL ACAD SCI USA, V104, P3043, DOI 10.1073/pnas.0607909104; Morgan BJ, 2006, CURR BIOL, V16, pR632, DOI 10.1016/j.cub.2006.07.045; Nahallage CAD, 2007, AM J PRIMATOL, V69, P1; Nahallage CAD, 2008, AM J PRIMATOL, V70, P1124, DOI 10.1002/ajp.20610; Nahallage CAD, 2007, BEHAVIOUR, V144, P1193, DOI 10.1163/156853907781890959; Nahallage CAD, 2012, PRIMATES, V53, P71, DOI 10.1007/s10329-011-0279-x; Ottoni EB, 2008, EVOL ANTHROPOL, V17, P171, DOI 10.1002/evan.20185; Panger MA, 2002, AM J PHYS ANTHROPOL, V119, P52, DOI 10.1002/ajpa.10103; Pouydebat E, 2009, J BIOMECH, V42, P266, DOI 10.1016/j.jbiomech.2008.10.026; Shumaker R. W., 2011, ANIMAL TOOL BEHAV US; SUGIYAMA Y, 1979, Primates, V20, P323, DOI 10.1007/BF02373387; Swadling P, 1981, J SOC OCEANISTES, V72-73, P159, DOI DOI 10.3406/JS0.1981.3057; van Schaik CP, 2003, SCIENCE, V299, P102, DOI 10.1126/science.1078004; Visalberghi E, 2008, AM J PRIMATOL, V70, P884, DOI 10.1002/ajp.20578; Visalberghi E, 2007, AM J PHYS ANTHROPOL, V132, P426, DOI 10.1002/ajpa.20546; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Whiten A, 2013, NATURE, V498, P303, DOI 10.1038/498303a; Whiten A, 2009, J HUM EVOL, V57, P420, DOI 10.1016/j.jhevol.2008.12.010; Whitesides G.H., 1985, Primates, V26, P91, DOI 10.1007/BF02389050	59	23	24	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0124733	10.1371/journal.pone.0124733	http://dx.doi.org/10.1371/journal.pone.0124733			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970286	Green Published, gold			2022-12-26	WOS:000354544200050
J	Chan, AWS; Jiang, J; Chen, YJ; Li, CX; Prucha, MS; Hu, YJ; Chi, T; Moran, S; Rahim, T; Li, SH; Li, XJ; Zola, SM; Testa, CM; Mao, H; Villalba, R; Smith, Y; Zhang, XD; Bachevalier, J				Chan, Anthony W. S.; Jiang, Jie; Chen, Yiju; Li, Chunxia; Prucha, Melinda S.; Hu, Yijuan; Chi, Tim; Moran, Sean; Rahim, Tayeb; Li, Shihua; Li, Xiaojiang; Zola, Stuart M.; Testa, Claudia M.; Mao, Hui; Villalba, Rosa; Smith, Yoland; Zhang, Xiaodong; Bachevalier, Jocelyne			Progressive Cognitive Deficit, Motor Impairment and Striatal Pathology in a Transgenic Huntington Disease Monkey Model from Infancy to Adulthood	PLOS ONE			English	Article							ORBITAL FRONTAL-CORTEX; RHESUS-MONKEYS; PRIMATE MODEL; NONHUMAN-PRIMATES; CAG REPEATS; LATE-ONSET; INTERMEDIATE; DYSFUNCTION; MACAQUE; BLOOD	One of the roadblocks to developing effective therapeutics for Huntington disease (HD) is the lack of animal models that develop progressive clinical traits comparable to those seen in patients. Here we report a longitudinal study that encompasses cognitive and motor assessment, and neuroimaging of a group of transgenic HD and control monkeys from infancy to adulthood. Along with progressive cognitive and motor impairment, neuroimaging revealed a progressive reduction in striatal volume. Magnetic resonance spectroscopy at 48 months of age revealed a decrease of N-acetylaspartate (NAA), further suggesting neuronal damage/loss in the striatum. Postmortem neuropathological analyses revealed significant neuronal loss in the striatum. Our results indicate that HD monkeys share similar disease patterns with HD patients, making them potentially suitable as a preclinical HD animal model.	[Chan, Anthony W. S.; Jiang, Jie; Chen, Yiju; Prucha, Melinda S.; Li, Shihua; Li, Xiaojiang] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Chan, Anthony W. S.; Jiang, Jie; Chen, Yiju; Prucha, Melinda S.; Chi, Tim; Moran, Sean; Rahim, Tayeb; Villalba, Rosa; Smith, Yoland; Zhang, Xiaodong] Emory Univ, Yerkes Natl Primate Res Ctr, Div Neuropharmacol & Neurol Dis, Atlanta, GA 30322 USA; [Li, Chunxia; Zhang, Xiaodong] Emory Univ, Yerkes Natl Primate Res Ctr, Yerkes Imaging Ctr, Atlanta, GA 30322 USA; [Hu, Yijuan] Emory Univ, Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA USA; [Zola, Stuart M.] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA USA; [Testa, Claudia M.] Virginia Commonwealth Univ, Dept Neurol, Richmond, VA USA; [Testa, Claudia M.] Virginia Commonwealth Univ, Parkinsons & Movement Disorders Ctr, Richmond, VA USA; [Mao, Hui] Emory Univ, Sch Med, Dept Radiol & Imaging Sci, Atlanta, GA USA; [Smith, Yoland] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Bachevalier, Jocelyne] Emory Univ, Sch Med, Dept Psychol, Atlanta, GA USA; [Bachevalier, Jocelyne] Emory Univ, Yerkes Natl Primate Ctr, Div Dev & Cognit Neurosci, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University; Emory University; Virginia Commonwealth University; Virginia Commonwealth University; Emory University; Emory University; Emory University; Emory University	Chan, AWS (corresponding author), Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA.	awchan@emory.edu		Moran, Sean/0000-0001-7672-242X	 [AWSC: NIH/OD010930];  [YNPRC: NIH/P51OD11132]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019206] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132, R24OD010930] Funding Source: NIH RePORTER	; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	AWSC: NIH/OD010930. YNPRC: NIH/P51OD11132. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adluru N, 2012, NEUROIMAGE, V59, P306, DOI 10.1016/j.neuroimage.2011.07.029; Aylward EH, 2012, BIOL PSYCHIAT, V71, P822, DOI 10.1016/j.biopsych.2011.07.030; Aziz NA, 2010, J NEUROL NEUROSUR PS, V81, P1233, DOI 10.1136/jnnp.2009.191833; BACHEVALIER J, 1991, NEUROBIOL AGING, V12, P99, DOI 10.1016/0197-4580(91)90048-O; Bachevalier J, 2011, ANN NY ACAD SCI, V1239, P71, DOI 10.1111/j.1749-6632.2011.06211.x; Biglan K, 2007, ARCH NEUROL-CHICAGO, V64, P783, DOI 10.1001/archneur.64.6.783; Brouillet E, 1999, PROG NEUROBIOL, V59, P427, DOI 10.1016/S0301-0082(99)00005-2; Chan AWS, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-36; Cloud LJ, 2012, MOVEMENT DISORD, V27, P1797, DOI 10.1002/mds.25237; Courtine G, 2007, NAT MED, V13, P561, DOI 10.1038/nm1595; Darling WG, 2006, J NEUROSCI METH, V154, P38, DOI 10.1016/j.jneumeth.2005.11.013; Ewing-Cobbs L, 2012, INT J DEV NEUROSCI, V30, P247, DOI 10.1016/j.ijdevneu.2011.07.004; Gaba AM, 2005, AM J CLIN NUTR, V81, P1335; Geevasinga N, 2006, J PAEDIATR CHILD H, V42, P552, DOI 10.1111/j.1440-1754.2006.00921.x; Goursaud APS, 2007, BEHAV BRAIN RES, V176, P75, DOI 10.1016/j.bbr.2006.09.020; Groen JL, 2010, J NEUROL NEUROSUR PS, V81, P228, DOI 10.1136/jnnp.2008.170902; Gundersen H. J., 1986, THOMPSON J MICROSC 1, V143, P3, DOI DOI 10.1111/J.1365-2818.1986.TB02764.X; Haga KK, 2009, NEUROBIOL AGING, V30, P353, DOI 10.1016/j.neurobiolaging.2007.07.005; Hamilton JM, 2004, J NEUROL NEUROSUR PS, V75, P209, DOI 10.1136/jnnp.2003.017822; Herndon JG, 1998, NEUROREPORT, V9, P2127, DOI 10.1097/00001756-199806220-00040; Kocerha J, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-88; Lacreuse A, 2005, NEUROBIOL AGING, V26, P543, DOI 10.1016/j.neurobiolaging.2004.05.007; Li CX, 2013, NEUROSCI LETT, V541, P58, DOI 10.1016/j.neulet.2013.02.007; McBride JL, 2011, MOL THER, V19, P2152, DOI 10.1038/mt.2011.219; Mittoux V, 2000, HUM GENE THER, V11, P1177, DOI 10.1089/10430340050015220; Padowski JM, 2014, MOVEMENT DISORD, V29, P327, DOI 10.1002/mds.25801; Palfi S, 1998, NAT MED, V4, P963, DOI 10.1038/nm0898-963; Palfi SP, 1996, J NEUROSCI, V16, P3019; Paulsen JS, 2013, J NEUROL NEUROSUR PS, V84, P1233, DOI 10.1136/jnnp-2013-305114; Paulsen JS, 2010, BRAIN RES BULL, V82, P201, DOI 10.1016/j.brainresbull.2010.04.003; Pouladi MA, 2013, NAT REV NEUROSCI, V14, P708, DOI 10.1038/nrn3570; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Putkhao K, 2013, STEM CELLS DEV, V22, P1198, DOI 10.1089/scd.2012.0469; Rice J, 2012, NATURE, V484, pS9, DOI 10.1038/nature11102; Roitberg BZ, 2002, NEUROSURGERY, V50, P137, DOI 10.1097/00006123-200201000-00022; Rubinsztein DC, 1996, AM J HUM GENET, V59, P16; Sackett GP, 2002, AM J PRIMATOL, V56, P165, DOI 10.1002/ajp.1072; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Squitieri F, 2006, MECH AGEING DEV, V127, P208, DOI 10.1016/j.mad.2005.09.012; Squitieri F, 2012, MOVEMENT DISORD, V27, P1714, DOI 10.1002/mds.25172; Tabrizi SJ, 2013, LANCET NEUROL, V12, P637, DOI 10.1016/S1474-4422(13)70088-7; Tabrizi SJ, 2011, LANCET NEUROL, V10, P31, DOI 10.1016/S1474-4422(10)70276-3; TAYLOR JR, 1990, BRAIN, V113, P617, DOI 10.1093/brain/113.3.617; Unschuld PG, 2012, MOVEMENT DISORD, V27, P895, DOI 10.1002/mds.25010; Yang SH, 2008, NATURE, V453, P921, DOI 10.1038/nature06975; Zhang ZM, 2000, J GERONTOL A-BIOL, V55, pB473, DOI 10.1093/gerona/55.10.B473	46	36	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0122335	10.1371/journal.pone.0122335	http://dx.doi.org/10.1371/journal.pone.0122335			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25966278	Green Published, gold, Green Submitted			2022-12-26	WOS:000354543500002
J	Katagiri, F; Canelon-Suarez, D; Griffin, K; Petersen, J; Meyer, RK; Siegle, M; Mase, K				Katagiri, Fumiaki; Canelon-Suarez, Dario; Griffin, Kelsey; Petersen, John; Meyer, Rachel K.; Siegle, Megan; Mase, Keisuke			Design and Construction of an Inexpensive Homemade Plant Growth Chamber	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY	Plant growth chambers produce controlled environments, which are crucial in making reproducible observations in experimental plant biology research. Commercial plant growth chambers can provide precise controls of environmental parameters, such as temperature, humidity, and light cycle, and the capability via complex programming to regulate these environmental parameters. But they are expensive. The high cost of maintaining a controlled growth environment is often a limiting factor when determining experiment size and feasibility. To overcome the limitation of commercial growth chambers, we designed and constructed an inexpensive plant growth chamber with consumer products for a material cost of $2,300. For a comparable growth space, a commercial plant growth chamber could cost $40,000 or more. Our plant growth chamber had outside dimensions of 1.5 m (W) x 1.8 m (D) x 2 m (H), providing a total growth area of 4.5 m(2) with 40-cm high clearance. The dimensions of the growth area and height can be flexibly changed. Fluorescent lights with large reflectors provided a relatively spatially uniform photosynthetically active radiation intensity of 140-250 mu moles/m(2)/sec. A portable air conditioner provided an ample cooling capacity, and a cooling water mister acted as a powerful humidifier. Temperature, relative humidity, and light cycle inside the chamber were controlled via a z-wave home automation system, which allowed the environmental parameters to be monitored and programmed through the internet. In our setting, the temperature was tightly controlled: 22.2 degrees C +/- 0.8 degrees C. The one-hour average relative humidity was maintained at 75%+/- 7% with short spikes up to +/- 15%. Using the interaction between Arabidopsis and one of its bacterial pathogens as a test experimental system, we demonstrate that experimental results produced in our chamber were highly comparable to those obtained in a commercial growth chamber. In summary, our design of an inexpensive plant growth chamber will tremendously increase research opportunities in experimental plant biology.	[Katagiri, Fumiaki; Canelon-Suarez, Dario; Griffin, Kelsey; Petersen, John; Meyer, Rachel K.; Siegle, Megan; Mase, Keisuke] Univ Minnesota, Dept Plant Biol, Microbial & Plant Genom Inst, St Paul, MN 55104 USA; [Canelon-Suarez, Dario] Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Katagiri, F (corresponding author), Univ Minnesota, Dept Plant Biol, Microbial & Plant Genom Inst, St Paul, MN 55104 USA.	katagiri@umn.edu		Katagiri, Fumiaki/0000-0001-6893-3788	National Science Foundation [IOS-1121425]; University of Minnesota	National Science Foundation(National Science Foundation (NSF)); University of Minnesota(University of Minnesota System)	This work was partly supported by a grant from the National Science Foundation (IOS-1121425) to FK and University of Minnesota. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; BROWDER LE, 1985, ANNU REV PHYTOPATHOL, V23, P201, DOI 10.1146/annurev.py.23.090185.001221; COLHOUN J, 1973, ANNU REV PHYTOPATHOL, V11, P343, DOI 10.1146/annurev.py.11.090173.002015; Kliebenstein DJ, 2002, GENETICS, V161, P1685; Nicotra AB, 2010, TRENDS PLANT SCI, V15, P684, DOI 10.1016/j.tplants.2010.09.008; Prasch CM, 2013, PLANT PHYSIOL, V162, P1849, DOI 10.1104/pp.113.221044; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0; Tsuda K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000772	8	10	10	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0126826	10.1371/journal.pone.0126826	http://dx.doi.org/10.1371/journal.pone.0126826			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965420	Green Submitted, gold, Green Published			2022-12-26	WOS:000354543500081
J	Abd-Ella, A; Stankiewicz, M; Mikulska, K; Nowak, W; Pennetier, C; Goulu, M; Fruchart-Gaillard, C; Licznar, P; Apaire-Marchais, V; List, O; Corbel, V; Servent, D; Lapied, B				Abd-Ella, Aly; Stankiewicz, Maria; Mikulska, Karolina; Nowak, Wieslaw; Pennetier, Cedric; Goulu, Mathilde; Fruchart-Gaillard, Carole; Licznar, Patricia; Apaire-Marchais, Veronique; List, Olivier; Corbel, Vincent; Servent, Denis; Lapied, Bruno			The Repellent DEET Potentiates Carbamate Effects via Insect Muscarinic Receptor Interactions: An Alternative Strategy to Control Insect Vector-Borne Diseases	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; UNPAIRED MEDIAN NEURONS; CENTRAL-NERVOUS-SYSTEM; NEUROSECRETORY-CELLS; MOSQUITO REPELLENTS; ELECTRICAL-ACTIVITY; MOLECULAR-DYNAMICS; ANOPHELES-GAMBIAE; PROTEIN-KINASE; IDENTIFICATION	Insect vector-borne diseases remain one of the principal causes of human mortality. In addition to conventional measures of insect control, repellents continue to be the mainstay for personal protection. Because of the increasing pyrethroid-resistant mosquito populations, alternative strategies to reconstitute pyrethroid repellency and knock-down effects have been proposed by mixing the repellent DEET (N,N-Diethyl-3-methylbenzamide) with non-pyrethroid insecticide to better control resistant insect vector-borne diseases. By using electrophysiological, biochemichal, in vivo toxicological techniques together with calcium imaging, binding studies and in silico docking, we have shown that DEET, at low concentrations, interacts with high affinity with insect M1/M3 mAChR allosteric site potentiating agonist effects on mAChRs coupled to phospholipase C second messenger pathway. This increases the anticholinesterase activity of the carbamate propoxur through calcium-dependent regulation of acetylcholinesterase. At high concentrations, DEET interacts with low affinity on distinct M1/M3 mAChR site, counteracting the potentiation. Similar dose-dependent dual effects of DEET have also been observed at synaptic mAChR level. Additionally, binding and in silico docking studies performed on human M1 and M3 mAChR subtypes indicate that DEET only displays a low affinity antagonist profile on these M1/M3 mAChRs. These results reveal a selective high affinity positive allosteric site for DEET in insect mAChRs. Finally, bioassays conducted on Aedes aegypti confirm the synergistic interaction between DEET and propoxur observed in vitro, resulting in a higher mortality of mosquitoes. Our findings reveal an unusual allosterically potentiating action of the repellent DEET, which involves a selective site in insect. These results open exciting research areas in public health particularly in the control of the pyrethroid-resistant insect-vector borne diseases. Mixing low doses of DEET and a non-pyrethroid insecticide will lead to improvement in the efficiency treatments thus reducing both the concentration of active ingredients and side effects for non-target organisms. The discovery of this insect specific site may pave the way for the development of new strategies essential in the management of chemical use against resistant mosquitoes.	[Abd-Ella, Aly; Goulu, Mathilde; Licznar, Patricia; Apaire-Marchais, Veronique; List, Olivier; Lapied, Bruno] Univ Angers, UFR Sci, Lab Recepteurs & Canaux Ion Membranaires RCIM, UPRES EA 2647,USC INRA 1330,QUASAV SFR 4207, Angers, France; [Stankiewicz, Maria] N Copernicus Univ, Fac Biol & Environm Protect, Torun, Poland; [Mikulska, Karolina; Nowak, Wieslaw] N Copernicus Univ, Fac Phys Astron & Informat, Inst Phys, Torun, Poland; [Pennetier, Cedric; Corbel, Vincent] Malad Infect & Vecteurs Ecol Genet Evolut & Contr, Inst Rech Dev, UMR 224, Montpellier, France; [Fruchart-Gaillard, Carole; Servent, Denis] CEA, iBiTecS, Serv Ingn Mol Proteines SIMOPRO, Lab Toxinol Mol & Biotechnol, Gif Sur Yvette, France; [Corbel, Vincent] Kasetsart Univ, Fac Agr Kamphaeng Saen, Dept Entomol, Nakhon Pathom, Thailand; [Abd-Ella, Aly] Assiut Univ, Fac Agr, Dept Plant Protect, Assiut, Egypt	INRAE; Universite d'Angers; Nicolaus Copernicus University; Nicolaus Copernicus University; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; CEA; UDICE-French Research Universities; Universite Paris Saclay; Kasetsart University; Egyptian Knowledge Bank (EKB); Assiut University	Lapied, B (corresponding author), Univ Angers, UFR Sci, Lab Recepteurs & Canaux Ion Membranaires RCIM, UPRES EA 2647,USC INRA 1330,QUASAV SFR 4207, Angers, France.	bruno.lapied@univ-angers.fr	Abd-Ella, Aly/W-7039-2019; Stankiewicz, Maria/H-6780-2014; Pennetier, Cedric/K-2010-2016; Mikulska-Ruminska, Karolina/D-2843-2015; List, Olivier/F-3049-2011; Corbel, VIncent/G-9576-2016; Mikulska-Ruminska, Karolina/AAL-1993-2021; Fruchart Gaillard, Carole/GWV-2801-2022; Nowak, Wieslaw/F-8833-2016	Abd-Ella, Aly/0000-0002-9612-5523; Mikulska-Ruminska, Karolina/0000-0001-7227-5503; List, Olivier/0000-0002-8302-8089; Mikulska-Ruminska, Karolina/0000-0001-7227-5503; Fruchart Gaillard, Carole/0000-0002-3149-4774; Nowak, Wieslaw/0000-0003-2584-1327; Maria, Stankiewicz/0000-0001-7038-0959; Servent, Denis/0000-0002-0774-1691; corbel, vincent/0000-0003-0995-3257; Lapied, Bruno/0000-0002-0354-4375; Pennetier, Cedric/0000-0002-3362-6371	Egyptian government grant; Direction Generale de l'Armement-Ministere de la Defense; Region Pays de la Loire	Egyptian government grant; Direction Generale de l'Armement-Ministere de la Defense; Region Pays de la Loire(Region Pays de la Loire)	A.A. was supported by the Egyptian government grant. M.G. was supported by a doctoral fellowship from the Direction Generale de l'Armement-Ministere de la Defense and from the Region Pays de la Loire.	Abdul-Ridha A, 2014, J BIOL CHEM, V289, P6067, DOI 10.1074/jbc.M113.539080; Badiou A, 2007, ARCH INSECT BIOCHEM, V66, P122, DOI 10.1002/arch.20204; Bae YS, 2003, MOL PHARMACOL, V63, P1043, DOI 10.1124/mol.63.5.1043; Bodereau-Dubois B, 2012, J PHARMACOL EXP THER, V341, P326, DOI 10.1124/jpet.111.188060; Bonnet J, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-17; Calas-List D, 2013, NEUROTOXICOLOGY, V37, P127, DOI 10.1016/j.neuro.2013.04.011; Corbel V, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-47; Courjaret R, 2003, EUR J NEUROSCI, V17, P2023, DOI 10.1046/j.1460-9568.2003.02644.x; Courjaret R, 2001, MOL PHARMACOL, V60, P80, DOI 10.1124/mol.60.1.80; Dickens JC, 2013, PESTIC BIOCHEM PHYS, V106, P149, DOI 10.1016/j.pestbp.2013.02.006; Ditzen M, 2008, SCIENCE, V319, P1838, DOI 10.1126/science.1153121; Dvir H, 2010, CHEM-BIOL INTERACT, V187, P10, DOI 10.1016/j.cbi.2010.01.042; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Espinoza-Fonseca LM, 2008, ARCH BIOCHEM BIOPHYS, V469, P142, DOI 10.1016/j.abb.2007.09.002; Fruchart-Gaillard C, 2006, MOL PHARMACOL, V69, P1641, DOI 10.1124/mol.105.020883; Gautier H, 2008, J PHARMACOL EXP THER, V324, P149, DOI 10.1124/jpet.107.128694; Grolleau F, 2000, J EXP BIOL, V203, P1633; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Han EH, 2009, TOXICOLOGY, V266, P38, DOI 10.1016/j.tox.2009.10.013; Hue B., 1990, P149; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kain P, 2013, NATURE, V502, P507, DOI 10.1038/nature12594; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; LAPIED B, 1989, J EXP BIOL, V144, P535; LAPIED B, 1990, BRAIN RES, V533, P132, DOI 10.1016/0006-8993(90)91805-Q; Lavialle-Defaix C, 2010, J PHARMACOL EXP THER, V333, P264, DOI 10.1124/jpet.109.163519; LECORRONC H, 1993, J EXP BIOL, V181, P257; Lee Y, 2010, NEURON, V67, P555, DOI 10.1016/j.neuron.2010.07.006; Marquer C, 2011, J BIOL CHEM, V286, P31661, DOI 10.1074/jbc.M111.261404; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Murillo L, 2011, NEUROTOXICOLOGY, V32, P828, DOI 10.1016/j.neuro.2011.05.015; Paluch G, 2010, PEST MANAG SCI, V66, P925, DOI 10.1002/ps.1974; Paulick MG, 2008, BIOCHEMISTRY-US, V47, P6991, DOI 10.1021/bi8006324; Pellegrino M, 2011, NATURE, V478, P511, DOI 10.1038/nature10438; Peng JYC, 2006, CHEMMEDCHEM, V1, P878, DOI 10.1002/cmdc.200600047; Pennetier C, 2008, EMERG INFECT DIS, V14, P1707, DOI 10.3201/eid1411.071575; Pennetier C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-38; Pennetier C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007896; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Sanford JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099924; Seals RC, 2004, ENDOCRINOLOGY, V145, P5616, DOI 10.1210/en.2003-1528; Silva APB, 2004, PARASITE VECTOR, V7, P450; Stankiewicz M, 2012, J TOXICOL, V2012, P1; Swale DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103713; Syed Z, 2008, P NATL ACAD SCI USA, V105, P13598, DOI 10.1073/pnas.0805312105; Thany SH, 2007, TRENDS PHARMACOL SCI, V28, P14, DOI 10.1016/j.tips.2006.11.006; Wicher D, 2001, PROG NEUROBIOL, V64, P431, DOI 10.1016/S0301-0082(00)00066-6; Xia YF, 2008, P NATL ACAD SCI USA, V105, P6433, DOI 10.1073/pnas.0801007105; Xu P, 2014, P NATL ACAD IN PRESS	49	28	29	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126406	10.1371/journal.pone.0126406	http://dx.doi.org/10.1371/journal.pone.0126406			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961834	Green Published, gold			2022-12-26	WOS:000354542500097
J	Beare, R; Chen, J; Phan, TG				Beare, Richard; Chen, Jian; Phan, Thanh G.		VISTA-Acute Collaboration	Googling Stroke ASPECTS to Determine Disability: Exploratory Analysis from VISTA-Acute Collaboration	PLOS ONE			English	Article							PRINCIPAL-COMPONENT ANALYSIS; COMPUTED-TOMOGRAPHY SCORE; FUNCTIONAL CONNECTIVITY; CT; REGRESSION; NETWORK; FLOW	The summed Alberta Stroke Program Early CT Score (ASPECTS) is useful for predicting stroke outcome. The anatomical information in the CT template is rarely used for this purpose because traditional regression methods are not adept at handling collinearity (relatedness) among brain regions. While penalized logistic regression (PLR) can handle collinearity, it does not provide an intuitive understanding of the interaction among network structures in a way that eigenvector method such as PageRank can (used in Google search engine). In this exploratory analysis we applied graph theoretical analysis to explore the relationship among ASPECTS regions with respect to disability outcome. The Virtual International Stroke Trials Archive (VISTA) was searched for patients who had infarct in at least one ASPECTS region (ASPECTS <= 9, ASPECTS= 10 were excluded), and disability (modified Rankin score/mRS). A directed graph was created from a cross correlation matrix (thresholded at false discovery rate of 0.01) of the ASPECTS regions and demographic variables and disability (mRS> 2). We estimated the network-based importance of each ASPECTS region by comparing PageRank and node strength measures. These results were compared with those from PLR. There were 185 subjects, average age 67.5 +/- 12.8 years (55% Males). Model 1: demographic variables having no direct connection with disability, the highest PageRank was M2 (0.225, bootstrap 95% CI 0.215-0.347). Model 2: demographic variables having direct connection with disability, the highest PageRank were M2 (0.205, bootstrap 95% CI 0.194-0.367) and M5 (0.125, bootstrap 95% CI 0.096-0.204). Both models illustrate the importance of M2 region to disability. The PageRank method reveals complex interaction among ASPECTS regions with respects to disability. This approach may help to understand the infarcted brain network involved in stroke disability.	[Beare, Richard; Chen, Jian; Phan, Thanh G.] Monash Univ, Stroke & Aging Res Grp, Stroke Unit, Melbourne, Vic 3004, Australia; [Phan, Thanh G.] Monash Univ, Monash Hlth & Stroke & Aging Res Grp, Melbourne, Vic 3004, Australia; [Beare, Richard; Chen, Jian] Royal Childrens Hosp, Murdoch Childrens Res Inst, Dev Imaging, Melbourne, Vic, Australia	Monash University; Monash University; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Phan, TG (corresponding author), Monash Univ, Stroke & Aging Res Grp, Stroke Unit, Melbourne, Vic 3004, Australia.	Thanh.Phan@monash.edu	; Davis, Stephen/L-5260-2013; Bath, Philip/F-9020-2011	Donnan, Geoffrey/0000-0001-6324-3403; Kaste, Markku/0000-0001-6557-6412; Davis, Stephen/0000-0003-0962-2300; grotta, james/0000-0002-3667-4248; Bath, Philip/0000-0003-2734-5132; Chen, Jian/0000-0002-0684-0866; Beare, Richard/0000-0002-7530-5664				Ali M, 2013, STROKE, V44, P3161, DOI 10.1161/STROKEAHA.113.001126; Ali M, 2012, INT J STROKE, V7, P133, DOI 10.1111/j.1747-4949.2011.00735.x; Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; BONACICH P, 1972, J MATH SOCIOL, V2, P113, DOI 10.1080/0022250X.1972.9989806; BONITA R, 1992, LANCET, V339, P342, DOI 10.1016/0140-6736(92)91658-U; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Choi JY, 2011, CEREBROVASC DIS, V31, P346, DOI 10.1159/000322602; Dowlatshahi D, 2011, NEUROLOGY, V76, P1238, DOI 10.1212/WNL.0b013e3182143317; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Grefkes C, 2011, BRAIN, V134, P1264, DOI 10.1093/brain/awr033; Hill MD, 2014, STROKE, V45, P444, DOI 10.1161/STROKEAHA.113.003580; Kupek Emil, 2006, BMC Med Res Methodol, V6, P13, DOI 10.1186/1471-2288-6-13; Langville AN., 2004, INTERNET MATH, V1, P335, DOI [10.1080/15427951.2004.10129091, DOI 10.1080/15427951.2004.10129091]; Leibovitch FS, 1999, HUM BRAIN MAPP, V7, P244, DOI 10.1002/(SICI)1097-0193(1999)7:4<244::AID-HBM3>3.0.CO;2-K; Liebeskind DS, 2014, STROKE, V45, P723, DOI 10.1161/STROKEAHA.113.003914; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; McIntosh AR, 1996, NEUROIMAGE, V3, P143, DOI 10.1006/nimg.1996.0016; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; Park MY, 2008, BIOSTATISTICS, V9, P30, DOI 10.1093/biostatistics/kxm010; Phan TG, 2013, CEREBROVASC DIS, V35, P560, DOI 10.1159/000351147; Phan TG, 2010, NEUROIMAGE, V49, P127, DOI 10.1016/j.neuroimage.2009.07.067; PHILLIPS CG, 1984, BRAIN, V107, P328, DOI 10.1093/brain/107.1.328; Puetz V, 2010, CEREBROVASC DIS, V29, P584, DOI 10.1159/000311079; Sehm B, 2012, J NEUROPHYSIOL, V108, P3253, DOI 10.1152/jn.00606.2012; Shi L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081388; Singhal S, 2012, NEUROIMAGE, V62, P300, DOI 10.1016/j.neuroimage.2012.04.025; Weimar C, 2009, J NEUROL, V256, P464, DOI 10.1007/s00415-009-0115-z; White S, 2003, P 9 ACM SIGKDD INT C; Zuo XN, 2012, CEREB CORTEX, V22, P1862, DOI 10.1093/cercor/bhr269	31	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0125687	10.1371/journal.pone.0125687	http://dx.doi.org/10.1371/journal.pone.0125687			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961856	Green Published, Green Submitted, gold			2022-12-26	WOS:000354542500041
J	He, D; Zhang, XL; Gao, QL; Huang, RF; Deng, ZS; Guo, CF; Guo, Q; Huang, J; Zhang, HQ				He, Dan; Zhang, Xiaolu; Gao, Qile; Huang, Rongfu; Deng, Zhansheng; Guo, Chaofeng; Guo, Qiang; Huang, Jia; Zhang, Hongqi			Correlation between Serum Level of Monocyte Chemoattractant Protein-1 and Postoperative Recurrence of Spinal Tuberculosis in the Chinese Han Population	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; IMMUNE-RESPONSES; MANAGEMENT; CHEMOKINES; POSTERIOR; DISEASE	Objective To correlate serum level of monocyte chemoattractant protein-1 (MCP-1) with postoperative recurrence of spinal tuberculosis in the Chinese Han population. Methods Patients of Han nationality with newly diagnosed spinal tuberculosis were consecutively included in this study. At different time points postoperatively, serum level of MCP-1 was determined using an enzyme linked immunosorbent assay. Recurrence of spinal tuberculosis after surgery and during the follow-up period was recorded. The correlation between serum MCP-1 level and recurrence of spinal tuberculosis was analyzed. Results A total of 169 patients with spinal tuberculosis were included in the study and followed up for an average of2.2 +/- 1.3 years (range, 1-5 years). Of these patients, 11 had postoperative recurrence of spinal tuberculosis. The patients' serum level of MCP-1 increased significantly after postoperative recurrence of spinal tuberculosis. Once the symptoms of recurrence were cured, the serum level of MCP-1 decreased significantly and it did not differ from patients without disease recurrence. Conclusion Postoperative recurrence of spinal tuberculosis is likely to increase the serumlevel of MCP-1.	[He, Dan] First Hosp Changsha, Dept Neurol, Changsha, Hunan, Peoples R China; [Zhang, Xiaolu] Fujian Med Univ, Affiliated Hosp 2, Dept Orthoped, Quanzhou, Peoples R China; [Gao, Qile; Deng, Zhansheng; Guo, Chaofeng; Guo, Qiang; Huang, Jia; Zhang, Hongqi] Cent S Univ, Xiangya Hosp, Xiangya Spinal Surg Ctr, Dept Spine Surg, Changsha 410083, Hunan, Peoples R China; [Huang, Rongfu] Fujian Med Univ, Affiliated Hosp 2, Clin Lab, Quanzhou, Peoples R China	Fujian Medical University; Central South University; Fujian Medical University	Gao, QL (corresponding author), Cent S Univ, Xiangya Hosp, Xiangya Spinal Surg Ctr, Dept Spine Surg, Changsha 410083, Hunan, Peoples R China.	Gaoql9968@163.com			National Natural Science Fund, China [81401818, 81301576]	National Natural Science Fund, China(National Natural Science Foundation of China (NSFC))	The study was supported by The National Natural Science Fund, No. 81401818 and No. 81301576, China.	Behar SM, 2011, MICROBES INFECT, V13, P749, DOI 10.1016/j.micinf.2011.03.002; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Cooper AM, 2007, TRENDS IMMUNOL, V28, P33, DOI 10.1016/j.it.2006.11.002; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Feng WX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014652; Flores-Villanueva PO, 2005, J EXP MED, V202, P1649, DOI 10.1084/jem.20050126; Ganachari M, 2012, GENES IMMUN, V13, P605, DOI 10.1038/gene.2012.39; Garg RK, 2011, J SPINAL CORD MED, V34, P440, DOI 10.1179/2045772311Y.0000000023; Guo CF, 2014, DIAGN MICR INFEC DIS, V78, P49, DOI 10.1016/j.diagmicrobio.2013.07.024; Hasan Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008459; Hussain R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025803; Huynh KK, 2011, CURR OPIN IMMUNOL, V23, P464, DOI 10.1016/j.coi.2011.06.002; Kleinnijenhuis J, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/405310; Li LT, 2012, INT ORTHOP, V36, P277, DOI 10.1007/s00264-011-1398-0; Liu P, 2011, SPINE, V36, pE1290, DOI 10.1097/BRS.0b013e31820beae3; Mendez A, 2011, TUBERCULOSIS, V91, P140, DOI 10.1016/j.tube.2010.12.008; Natarajan K, 2011, TUBERCULOSIS, V91, P427, DOI 10.1016/j.tube.2011.04.003; Shigenaga T, 2001, IMMUNOLOGY, V102, P466, DOI 10.1046/j.1365-2567.2001.01195.x; Shukla S, 2011, ANN TROP PAEDIATR, V31, P363, DOI 10.1179/1465328111Y.0000000034; Siveke JT, 1998, J IMMUNOL, V160, P550; Su WL, 2010, CLIN VACCINE IMMUNOL, V17, P223, DOI 10.1128/CVI.00381-09; Valsalan R, 2012, INDIAN J ORTHOP, V46, P138, DOI 10.4103/0019-5413.93673; Yang L, 2013, J ORTHOP SURG RES, V8, DOI 10.1186/1749-799X-8-47; Zhang HQ, 2012, ARCH ORTHOP TRAUM SU, V132, P1717, DOI 10.1007/s00402-012-1618-0; Zhang HQ, 2013, EUR SPINE J, V22, P616, DOI 10.1007/s00586-012-2470-1	25	2	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0125756	10.1371/journal.pone.0125756	http://dx.doi.org/10.1371/journal.pone.0125756			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962150	Green Published, gold, Green Submitted			2022-12-26	WOS:000354542500043
J	Kumar, R; Yadav, SK; Palomares, JA; Park, B; Joshi, SH; Ogren, JA; Macey, PM; Fonarow, GC; Harper, RM; Woo, MA				Kumar, Rajesh; Yadav, Santosh K.; Palomares, Jose A.; Park, Bumhee; Joshi, Shantanu H.; Ogren, Jennifer A.; Macey, Paul M.; Fonarow, Gregg C.; Harper, Ronald M.; Woo, Mary A.			Reduced Regional Brain Cortical Thickness in Patients with Heart Failure	PLOS ONE			English	Article							MAMMILLARY BODIES; CORTEX; METABOLISM; DEPRESSION; INVENTORY; MAGNESIUM; RESPONSES; SITES	Aims Autonomic, cognitive, and neuropsychologic deficits appear in heart failure (HF) subjects, and these compromised functions depend on cerebral cortex integrity in addition to that of subcortical and brainstem sites. Impaired autoregulation, low cardiac output, sleep-disordered-breathing, hypertension, and diabetic conditions in HF offer considerable potential to affect cortical areas by loss of neurons and glia, which would be expressed as reduced cortical thicknesses. However, except for gross descriptions of cortical volume loss/injury, regional cortical thickness integrity in HF is unknown. Our goal was to assess regional cortical thicknesses across the brain in HF, compared to control subjects. Methods and Results We examined localized cortical thicknesses in 35 HF and 61 control subjects with high-resolution T1-weighted images (3.0-Tesla MRI) using FreeSurfer software, and assessed group differences with analysis-of-covariance (covariates; age, gender; p<0.05; FDR). Significantly-reduced cortical thicknesses appeared in HF over controls in multiple areas, including the frontal, parietal, temporal, and occipital lobes, more markedly on the left side, within areas that control autonomic, cognitive, affective, language, and visual functions. Conclusion Heart failure subjects show reduced regional cortical thicknesses in sites that control autonomic, cognitive, affective, language, and visual functions that are deficient in the condition. The findings suggest chronic tissue alterations, with regional changes reflecting loss of neurons and glia, and presumably are related to earlier-described axonal changes. The pathological mechanisms contributing to reduced cortical thicknesses likely include hypoxia/ischemia, accompanying impaired cerebral perfusion from reduced cardiac output and sleep-disordered-breathing and other comorbidities in HF.	[Kumar, Rajesh; Yadav, Santosh K.; Palomares, Jose A.; Park, Bumhee] Univ Calif Los Angeles, Dept Anesthesiol, Los Angeles, CA 90024 USA; [Kumar, Rajesh] Univ Calif Los Angeles, Dept Radiol Sci, Los Angeles, CA 90024 USA; [Kumar, Rajesh] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90024 USA; [Kumar, Rajesh; Harper, Ronald M.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; [Joshi, Shantanu H.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Ogren, Jennifer A.; Macey, Paul M.; Woo, Mary A.] Univ Calif Los Angeles, Sch Nursing, Los Angeles, CA 90024 USA; [Fonarow, Gregg C.] Univ Calif Los Angeles, Div Cardiol, Los Angeles, CA 90024 USA; [Harper, Ronald M.] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Kumar, R (corresponding author), Univ Calif Los Angeles, Dept Anesthesiol, Los Angeles, CA 90024 USA.	rkumar@mednet.ucla.edu	Joshi, Sudhanshu/L-2284-2019; Fonarow, Gregg C/D-5988-2014; Yadav, Santosh/GQZ-7569-2022; Macey, Paul M./B-5037-2008	Joshi, Sudhanshu/0000-0003-4748-5001; Fonarow, Gregg C/0000-0002-3192-8093; Macey, Paul M./0000-0003-4093-7458	National Institutes of Health [R01 NR-013625, R01 NR-014669]; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR014669, R01NR013625] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This work was supported by the National Institutes of Health R01 NR-013625; R01 NR-014669 (http://www.nih.gov/).	Aggleton JP, 2005, EUR J NEUROSCI, V22, P2519, DOI 10.1111/j.1460-9568.2005.04450.x; Almeida JRC, 2005, BRAZ J MED BIOL RES, V38, P431, DOI 10.1590/S0100-879X2005000300014; Almeida OP, 2001, INTERN MED J, V31, P290, DOI 10.1046/j.1445-5994.2001.00067.x; ALTURA B M, 1985, Magnesium, V4, P245; Bauer L, 2012, EUR J CARDIOVASC NUR, V11, P223, DOI 10.1016/j.ejcnurse.2011.03.007; Bechara A, 2005, CURR OPIN NEUROL, V18, P734, DOI 10.1097/01.wco.0000194141.56429.3c; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Bohm M, 2015, CLIN CARDIOL; Carpenter JS, 1998, J PSYCHOSOM RES, V45, P5, DOI 10.1016/S0022-3999(97)00298-5; Chang EF, 2010, NAT NEUROSCI, V13, P1428, DOI 10.1038/nn.2641; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Douban S, 1996, AM HEART J, V132, P664, DOI 10.1016/S0002-8703(96)90253-7; DYCKNER T, 1984, DRUGS, V28, P161, DOI 10.2165/00003495-198400281-00016; Ferrier K, 2005, CHEST, V128, P2116, DOI 10.1378/chest.128.4.2116; Geranmayeh F, 2012, BRAIN LANG, V121, P47, DOI 10.1016/j.bandl.2012.02.005; Granek JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046619; Hazell AS, 2013, NEUROCHEM INT, V62, P796, DOI 10.1016/j.neuint.2013.01.009; Jessup M, 2009, CIRCULATION, V119, P1977, DOI 10.1161/CIRCULATIONAHA.109.192064; JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376; Kumar R, 2012, J MAGN RESON IMAGING, V35, P300, DOI 10.1002/jmri.22831; Kumar R, 2011, J NEUROL SCI, V307, P106, DOI 10.1016/j.jns.2011.04.028; Kumar R, 2011, EUR J HEART FAIL, V13, P651, DOI 10.1093/eurjhf/hfr012; Kumar R, 2011, MAGN RESON IMAGING, V29, P185, DOI 10.1016/j.mri.2010.08.006; Kumar R, 2009, NEUROBIOL DIS, V33, P236, DOI 10.1016/j.nbd.2008.10.004; Mapelli D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028313; Naismith S, 2002, AM J PSYCHIAT, V159, P2096, DOI 10.1176/appi.ajp.159.12.2096; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Ogren JA, 2012, CEREBELLUM, V11, P931, DOI 10.1007/s12311-012-0361-y; OPPENHEIMER SM, 1992, NEUROLOGY, V42, P1727, DOI 10.1212/WNL.42.9.1727; Pan A, 2013, J CARD FAIL, V19, P94, DOI 10.1016/j.cardfail.2012.12.001; Peiffer C, 2001, AM J RESP CRIT CARE, V163, P951, DOI 10.1164/ajrccm.163.4.2005057; Radford Martha J, 2005, Circulation, V112, P1888, DOI 10.1161/CIRCULATIONAHA.105.170073; Reekie YL, 2008, P NATL ACAD SCI USA, V105, P9787, DOI 10.1073/pnas.0800417105; Rumsfeld JS, 2003, J AM COLL CARDIOL, V42, P1811, DOI 10.1016/j.jacc.2003.07.013; Schoenenberger AW, 2012, CLIN RES CARDIOL, V101, P159, DOI 10.1007/s00392-011-0376-2; Shinnick M. A., 2014, WORLD C AC HEART FAI; Singleton Charles K., 2001, Current Molecular Medicine (Hilversum), V1, P197, DOI 10.2174/1566524013363870; Stoeckel C, 2009, CORTEX, V45, P1091, DOI 10.1016/j.cortex.2008.12.004; Suter P M, 2000, J Nutr Health Aging, V4, P69; Thomson AD, 2012, NEUROPSYCHOL REV, V22, P81, DOI 10.1007/s11065-012-9196-z; von Haehling S, 2007, CARDIOVASC RES, V73, P298, DOI 10.1016/j.cardiores.2006.08.018; Wong SW, 2007, NEUROIMAGE, V35, P698, DOI 10.1016/j.neuroimage.2006.12.027; Woo MA, 2005, J CARD FAIL, V11, P437, DOI 10.1016/j.cardfail.2005.02.003; Woo MA, 2003, J APPL PHYSIOL, V95, P677, DOI 10.1152/japplphysiol.00101.2003; Woo MA, 2015, EUR J HEART FAIL; Woo Mary A, 2007, Congest Heart Fail, V13, P29, DOI 10.1111/j.1527-5299.2007.05856.x; Woo MA, 2009, J CARD FAIL, V15, P214, DOI 10.1016/j.cardfail.2008.10.020	49	32	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126595	10.1371/journal.pone.0126595	http://dx.doi.org/10.1371/journal.pone.0126595			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962164	Green Published, Green Submitted, gold			2022-12-26	WOS:000354542500121
J	Oboshi, M; Naito, Y; Sawada, H; Hirotani, S; Iwasaku, T; Okuhara, Y; Morisawa, D; Eguchi, A; Nishimura, K; Fujii, K; Mano, T; Ishihara, M; Masuyama, T				Oboshi, Makiko; Naito, Yoshiro; Sawada, Hisashi; Hirotani, Shinichi; Iwasaku, Toshihiro; Okuhara, Yoshitaka; Morisawa, Daisuke; Eguchi, Akiyo; Nishimura, Koichi; Fujii, Kenichi; Mano, Toshiaki; Ishihara, Masaharu; Masuyama, Tohru			Temporary Dietary Iron Restriction Affects the Process of Thrombus Resolution in a Rat Model of Deep Vein Thrombosis	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE; DEFICIENCY ANEMIA; VENOUS THROMBOSIS; RISK; MEN; ASSOCIATIONS	Background Deep vein thrombosis (DVT) is a major cause of pulmonary thromboembolism and sudden death. Thus, it is important to consider the pathophysiology of DVT. Recently, iron has been reported to be associated with thrombotic diseases. Hence, in this study, we investigate the effects of dietary iron restriction on the process of thrombus resolution in a rat model of DVT. Methods We induced DVT in 8-week-old male Sprague-Dawley rats by performing ligations of their inferior venae cavae. The rats were then given either a normal diet (DVT group) or an iron-restricted diet (DVT + IR group). Thrombosed inferior venae cavae were harvested at 5 days after ligation. Results The iron-restricted diet reduced venous thrombus size compared to the normal diet. Intra-thrombotic collagen content was diminished in the DVT + IR group compared to the DVT group. In addition, intrathrombotic gene expression and the activity of matrix metalloproteinase-9 were increased in the DVT + IR group compared to the DVT group. Furthermore, the DVT + IR group had greater intrathrombotic neovascularization as well as higher gene expression levels of urokinase-type plasminogen activator and tissue-type plasminogen activator than the DVT group. The iron-restricted diet decreased intrathrombotic superoxide production compared to the normal diet. Conclusions These results suggest that dietary iron restriction affects the process of thrombus resolution in DVT.	[Oboshi, Makiko; Naito, Yoshiro; Sawada, Hisashi; Hirotani, Shinichi; Iwasaku, Toshihiro; Okuhara, Yoshitaka; Morisawa, Daisuke; Eguchi, Akiyo; Nishimura, Koichi; Fujii, Kenichi; Mano, Toshiaki; Masuyama, Tohru] Hyogo Coll Med, Dept Internal Med, Div Cardiovasc, Nishinomiya, Hyogo 6638501, Japan; [Ishihara, Masaharu] Hyogo Coll Med, Dept Internal Med, Div Coronary Heart Dis, Nishinomiya, Hyogo 6638501, Japan	Hyogo College of Medicine; Hyogo College of Medicine	Naito, Y (corresponding author), Hyogo Coll Med, Dept Internal Med, Div Cardiovasc, Nishinomiya, Hyogo 6638501, Japan.	ynaito@hyo-med.ac.jp			JSPS KAKENHI Grant [25460919]; Takeda Science Foundation; Hyogo Science and Technology Association; Grants-in-Aid for Scientific Research [25460919] Funding Source: KAKEN	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Hyogo Science and Technology Association; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research (C) (JSPS KAKENHI Grant No. 25460919) and grants from Takeda Science Foundation and Hyogo Science and Technology Association (to Y. Naito).	Akins PT, 1996, STROKE, V27, P1002, DOI 10.1161/01.STR.27.5.1002; ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; Basuli D, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00117; Bates SM, 2004, NEW ENGL J MED, V351, P268, DOI 10.1056/NEJMcp031676; Corti MC, 1997, ANN EPIDEMIOL, V7, P62, DOI 10.1016/S1047-2797(96)00112-3; Daniels TR, 2006, CLIN IMMUNOL, V121, P144, DOI 10.1016/j.clim.2006.06.010; Day SM, 2003, CIRCULATION, V107, P2601, DOI 10.1161/01.CIR.0000066910.02844.D0; Ekim M, 2014, BIOCHEM RES INT, V2014, DOI 10.1155/2014/703128; Frey MK, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000772; Habis A, 2010, PEDIATR EMERG CARE, V26, P848, DOI 10.1097/PEC.0b013e3181fb0def; Henke PK, 2006, J IMMUNOL, V177, P3388, DOI 10.4049/jimmunol.177.5.3388; Iqbal MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067981; Kaluza J, 2014, INT J CARDIOL, V172, P155, DOI 10.1016/j.ijcard.2013.12.176; Kaluza J, 2013, STROKE, V44, P334, DOI 10.1161/STROKEAHA.112.679662; Kessinger CW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116621; Klipstein-Grobusch K, 1999, AM J EPIDEMIOL, V149, P421, DOI 10.1093/oxfordjournals.aje.a009829; Lipinski B, 2013, CURR NEUROVASC RES, V10, P269, DOI 10.2174/15672026113109990016; Modarai B, 2005, THROMB HAEMOSTASIS, V93, P801, DOI 10.1160/TH04-09-0596; Naito Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075906; Naito Y, 2012, J HYPERTENS, V30, P2192, DOI 10.1097/HJH.0b013e3283581a64; Naito Y, 2011, HYPERTENSION, V57, P497, DOI 10.1161/HYPERTENSIONAHA.110.159681; Nielsen VG, 2014, BLOOD COAGUL FIBRIN, V25, P435, DOI 10.1097/MBC.0000000000000075; Ogata Toshiyasu, 2008, J Stroke Cerebrovasc Dis, V17, P426, DOI 10.1016/j.jstrokecerebrovasdis.2008.04.008; Ploplis VA, 1998, BLOOD, V91, P2005, DOI 10.1182/blood.V91.6.2005.2005_2005_2009; Pretorius E, 2013, MICROSC RES TECHNIQ, V76, P268, DOI 10.1002/jemt.22163; Re G, 1998, Eur J Emerg Med, V5, P9; STEWART GJ, 1993, HAEMOSTASIS, V23, P127; Sullivan JL, 2009, BBA-GEN SUBJECTS, V1790, P718, DOI 10.1016/j.bbagen.2008.06.005; Tuomainen TP, 1998, CIRCULATION, V97, P1461; Whatling C, 2004, ARTERIOSCL THROM VAS, V24, P10, DOI 10.1161/01.ATV.0000100562.63144.C1; Zhang W, 2012, J EPIDEMIOL, V22, P484, DOI 10.2188/jea.JE20120006; Zhou J, 2009, ARTERIOSCL THROM VAS, V29, P863, DOI 10.1161/ATVBAHA.109.185678	32	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126611	10.1371/journal.pone.0126611	http://dx.doi.org/10.1371/journal.pone.0126611			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962140	gold, Green Submitted, Green Published			2022-12-26	WOS:000354542500127
J	Patarrao, RS; Lautt, WW; Macedo, MP				Patarrao, Rita S.; Wayne Lautt, W.; Paula Macedo, M.			Acute Glucagon Induces Postprandial Peripheral Insulin Resistance	PLOS ONE			English	Article							HEPATIC GLUTATHIONE; PULSATILE INSULIN; NITRIC-OXIDE; GLUCOSE CLEARANCE; BETA-CELL; SENSITIVITY; SECRETION; PHOSPHODIESTERASES; HYPERGLYCEMIA; PHYSIOLOGY	Glucagon levels are often moderately elevated in diabetes. It is known that glucagon leads to a decrease in hepatic glutathione (GSH) synthesis that in turn is associated with decreased postprandial insulin sensitivity. Given that cAMP pathway controls GSH levels we tested whether insulin sensitivity decreases after intraportal (ipv) administration of a cAMP analog (DBcAMP), and investigated whether glucagon promotes insulin resistance through decreasing hepatic GSH levels. Insulin sensitivity was determined in fed male SpragueDawley rats using a modified euglycemic hyperinsulinemic clamp in the postprandial state upon ipv administration of DBcAMP as well as glucagon infusion. Glucagon effects on insulin sensitivity was assessed in the presence or absence of postprandial insulin sensitivity inhibition by administration of L-NMMA. Hepatic GSH and NO content and plasma levels of NO were measured after acute ipv glucagon infusion. Insulin sensitivity was assessed in the fed state and after ipv glucagon infusion in the presence of GSH-E. We founf that DBcAMP and glucagon produce a decrease of insulin sensitivity, in a dose-dependent manner. Glucagon-induced decrease of postprandial insulin sensitivity correlated with decreased hepatic GSH content and was restored by administration of GSH-E. Furthermore, inhibition of postprandial decrease of insulin sensitivity L-NMMA was not overcome by glucagon, but glucagon did not affect hepatic and plasma levels of NO. These results show that glucagon decreases postprandial insulin sensitivity through reducing hepatic GSH levels, an effect that is mimicked by increasing cAMP hepatic levels and requires physiological NO levels. These observations support the hypothesis that glucagon acts via adenylate cyclase to decrease hepatic GSH levels and induce insulin resistance. We suggest that the glucagon-cAMP-GSH axis is a potential therapeutic target to address insulin resistance in pathological conditions.	[Patarrao, Rita S.; Paula Macedo, M.] Univ Nova Lisboa, Fac Ciencias Med, Ctr Estudos Doencas Cron CEDOC, NOVA Med Sch, P-1200 Lisbon, Portugal; [Wayne Lautt, W.] Univ Manitoba, Fac Med, Dept Pharmacol & Therapeut, Winnipeg, MB R3E 0W3, Canada; [Paula Macedo, M.] APDP ERC Portuguese Diabet Assoc Educ & Res Ctr, Lisbon, Portugal	Universidade Nova de Lisboa; University of Manitoba	Macedo, MP (corresponding author), Univ Nova Lisboa, Fac Ciencias Med, Ctr Estudos Doencas Cron CEDOC, NOVA Med Sch, Campo Martires da Patria, P-1200 Lisbon, Portugal.	paula.macedo@fcm.unl.pt	Lautt, W. Wayne/AAC-6106-2021; Macedo, Maria Paula/Q-7827-2018; Patarrao, Rita/Q-7832-2018	Macedo, Maria Paula/0000-0002-2549-0275; Patarrao, Rita/0000-0001-8701-2917; Lautt, W. Wayne/0000-0002-7239-1798	Fundacao para a Ciencia e Tecnologia (FCT) [PIC/IC/82956/2007, PTDC/BIM-MET/0486/2012, PTDC/DTP-EPI/0207/2012]; Portuguese Diabetes Society (SPD); Fundação para a Ciência e a Tecnologia [PIC/IC/82956/2007, PTDC/DTP-EPI/0207/2012, PTDC/BIM-MET/0486/2012] Funding Source: FCT	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Portuguese Diabetes Society (SPD); Fundação para a Ciência e a Tecnologia	This study was supported by Fundacao para a Ciencia e Tecnologia (FCT) grant PIC/IC/82956/2007, PTDC/BIM-MET/0486/2012, PTDC/DTP-EPI/0207/2012 and by the Portuguese Diabetes Society (SPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 2006, DIABETOLOGIA, V49, P117, DOI 10.1007/s00125-005-0056-8; ANDERSON ME, 1989, ANAL BIOCHEM, V183, P16, DOI 10.1016/0003-2697(89)90164-4; BEAVO JA, 1995, PHYSIOL REV, V75, P725, DOI 10.1152/physrev.1995.75.4.725; BRAMAN RS, 1989, ANAL CHEM, V61, P2715, DOI 10.1021/ac00199a007; BUTLER PC, 1991, DIABETES, V40, P73, DOI 10.2337/diabetes.40.1.73; Conti M, 2000, MOL ENDOCRINOL, V14, P1317, DOI 10.1210/me.14.9.1317; Del Prato S, 2004, HORM METAB RES, V36, P775, DOI 10.1055/s-2004-826163; Dunning BE, 2007, ENDOCR REV, V28, P253, DOI 10.1210/er.2006-0026; Fernandes AB, 2011, J NEUROENDOCRINOL, V23, P1288, DOI 10.1111/j.1365-2826.2011.02226.x; Findeisen HM, 2011, OBESITY, V19, P2429, DOI 10.1038/oby.2011.298; Gilon P, 2001, ENDOCR REV, V22, P565, DOI 10.1210/er.22.5.565; GOSS PM, 1994, J NUTR, V124, P323, DOI 10.1093/jn/124.3.323; Guarino MP, 2006, BRIT J PHARMACOL, V147, P959, DOI 10.1038/sj.bjp.0706691; Guarino MP, 2004, AM J PHYSIOL-GASTR L, V287, pG527, DOI 10.1152/ajpgi.00085.2004; Guarino MP, 2003, AM J PHYSIOL-GASTR L, V284, pG588, DOI 10.1152/ajpgi.00423.2002; HIGASHI T, 1976, BIOCHEM BIOPH RES CO, V68, P1280, DOI 10.1016/0006-291X(76)90335-1; HOUSLAY MD, 1995, ADV ENZYME REGUL, V35, P303, DOI 10.1016/0065-2571(94)00012-R; HOWELL SL, 1994, DIABETOLOGIA, V37, pS30, DOI 10.1007/BF00400823; LAUTERBURG BH, 1981, J CLIN INVEST, V67, P1415, DOI 10.1172/JCI110170; Lautt WW, 1999, CAN J PHYSIOL PHARM, V77, P553, DOI 10.1139/cjpp-77-8-553; Lautt WW, 1998, CAN J PHYSIOL PHARM, V76, P1080, DOI 10.1139/cjpp-76-12-1080; Lautt WW, 2001, AM J PHYSIOL-GASTR L, V281, pG29, DOI 10.1152/ajpgi.2001.281.1.G29; Lechin F, 2006, NEUROENDOCRINOLOGY, V84, P222, DOI 10.1159/000098005; Leeuwenburgh C, 1996, J NUTR, V126, P1833; Loh K, 2009, CELL METAB, V10, P260, DOI 10.1016/j.cmet.2009.08.009; LU SC, 1991, J CLIN INVEST, V88, P260, DOI 10.1172/JCI115286; LU SC, 1990, J BIOL CHEM, V265, P16088; Meier JJ, 2006, DIABETES, V55, P1051, DOI 10.2337/diabetes.55.04.06.db05-1449; Melancon A, 2013, HORM METAB RES, V45, P716, DOI 10.1055/s-0033-1349853; Menge BA, 2011, DIABETES, V60, P2160, DOI 10.2337/db11-0251; Patarrao RS, 2008, CAN J PHYSIOL PHARM, V86, P880, DOI 10.1139/Y08-080; Porksen N, 2002, DIABETES, V51, pS245, DOI 10.2337/diabetes.51.2007.S245; Quesada I, 2008, J ENDOCRINOL, V199, P5, DOI 10.1677/JOE-08-0290; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Suckow AT, 2014, J BIOL CHEM, V289, P15751, DOI 10.1074/jbc.M114.568683; TATEISHI N, 1974, J BIOCHEM, V75, P93, DOI 10.1093/oxfordjournals.jbchem.a130387; UNGER RH, 1971, NEW ENGL J MED, V285, P443; UNGER RH, 1975, LANCET, V1, P14; VOGT BL, 1993, BIOCHEM PHARMACOL, V46, P257, DOI 10.1016/0006-2952(93)90412-P; Yang F, 1997, CLIN CHEM, V43, P657; Zhou A, 2014, DIABETOLOGIA, V57, P801, DOI 10.1007/s00125-013-3148-x	41	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0127221	10.1371/journal.pone.0127221	http://dx.doi.org/10.1371/journal.pone.0127221			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961284	Green Published, gold, Green Submitted			2022-12-26	WOS:000354542500171
J	Zhang, S; Kriza, C; Schaller, S; Kolominsky-Rabas, PL				Zhang, Shixuan; Kriza, Christine; Schaller, Sandra; Kolominsky-Rabas, Peter L.		Natl Leading-Edge Cluster Med Tech	Recalls of Cardiac Implants in the Last Decade: What Lessons Can We Learn?	PLOS ONE			English	Article							MEDICAL DEVICES; REGISTRIES	Background Due to an ageing population and demographic changes worldwide, a higher prevalence of heart disease is forecasted, which causes an even higher demand for cardiac implants in future. The increasing high incidence of clinical adverse events attributed especially to high-risk medical devices has led an advocated change from many stakeholders. This holds especially true for devices like cardiac implants, with their high-risk nature and high complication rates associated with considerable mortality, due to their frequent use in older populations with frequent co-morbidities. To ensure patients' safety, the objective of this study is to analyze different cardiac implants recall reasons and different recall systems, based on an overview of the recalls of cardiac implant medical devices in the last decade. On the basis of the results from this structured analysis, this study provides recommendations on how to avoid such recalls from a manufacturer perspective, as well as how to timely react to an adverse event from a post-surveillance system perspective. Methods and Findings A systematic search of cardiac implant recalls information has been performed in the PubMed, ScienceDirect and Scopus databases, as well as data sources in regulatory authorities from 193 UN Member States. Data has been extracted for the years 2004-2014 with the following criteria applied: cardiac implant medical device recalls and reasons for recall, associated harm or risk to patients. From the data sources described above, eleven regulatory authorities and 103 recall reports have been included in this study. The largest cardiac implant categories include ICDs 40.8%, pacemakers 14.5% and stents 14.5%. Regarding the recall reasons, the majority of reports were related to device battery problems (33.0%) and incorrect therapy delivery (31.1%). From a total of 103 recall reports, five reported death and serious injuries. Our review highlights weaknesses in the current cardiac implant recall system, including data reporting and management issues and provides recommendations for the improvement of safety information and management. Conclusion Due to the mortality associated with the nature of cardiac implants, the traceability and transparency of safety hazards information is crucial. By a structured analysis of recall reasons and their efficient management, important knowledge is gained to inform an effective safety-reporting system for monitoring the safety of cardiac implanted patients, ideally by building up cardiac implant registries worldwide in the future.	[Zhang, Shixuan; Kriza, Christine; Schaller, Sandra; Kolominsky-Rabas, Peter L.] Univ Erlangen Nurnberg, Interdisciplinary Ctr Hlth Technol Assessment HTA, D-91054 Erlangen, Bavaria, Germany; [Kriza, Christine; Kolominsky-Rabas, Peter L.] Natl Leading Edge Cluster Med Technol Med Valley, Erlangen, Bavaria, Germany	University of Erlangen Nuremberg	Kolominsky-Rabas, PL (corresponding author), Univ Erlangen Nurnberg, Interdisciplinary Ctr Hlth Technol Assessment HTA, D-91054 Erlangen, Bavaria, Germany.	Peter.Kolominsky@uk-erlangen.de		Kolominsky-Rabas, Peter/0000-0002-7168-058X	German Federal Ministry of Education and Research (BMBF), as part of the National Leading-Edge Cluster Medical Technologies 'Medical Valley EMN' [13EX1013B]	German Federal Ministry of Education and Research (BMBF), as part of the National Leading-Edge Cluster Medical Technologies 'Medical Valley EMN'(Federal Ministry of Education & Research (BMBF))	This research is supported by the German Federal Ministry of Education and Research (BMBF), project grant no. 13EX1013B, as part of the National Leading-Edge Cluster Medical Technologies 'Medical Valley EMN'.	American Heart Association, 2012, IMPL CARD DEF; American Heart Association, 2012, STENT; American Heart Association, 2012, CARD RES THER; American Heart Association, 2012, PAC; Auricchio A, 2006, EUROPACE, V8, P313, DOI 10.1093/europace/eul043; Australia Therapeutic Goods Administration, 2014, MEDTR MOS PORC AORT; Blake K, 2013, J INTERV CARD ELECTR, V36, P119, DOI 10.1007/s10840-013-9778-6; Bundesinstitut fur Arzneimittel und Medizinprodukte (BfArM), 2013, IMP SAF INF COGNIS C; Bundesinstitut fur Arzneimittel und Medizinprodukte (BfArM), 2007, FIELD SAF CORR ACT S; Campillo-Artero C, 2013, HEALTH POLICY, V113, P38, DOI 10.1016/j.healthpol.2013.03.017; da Silva KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071090; Department of Health Hong Kong, 2013, INF REC ICDS; Dhruva SS, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001277; Dutch Parliament, 2015, MED IMPL REG; EUROPEAN COMMISSION DG Health and Consumers (SANCO), 2013, GUID MED DEV VIG SYS; Gitt AK, 2010, EUR HEART J, V31, P525, DOI 10.1093/eurheartj/ehp596; Healthy Canadians, 2007, ARCH URG MED DEV INF; Irish Medicines Board, 2007, REC MEDTR SPRINT FID; Kramer DB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001519; Kramer DB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001276; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Mehrotra AK, 2011, HEART RHYTHM, V8, P1192, DOI 10.1016/j.hrthm.2011.02.039; Niederlander C, 2013, HEALTH POLICY, V113, P20, DOI 10.1016/j.healthpol.2013.08.008; Nof E, 2013, EUR HEART J, V34, P229, DOI 10.1093/eurheartj/ehs352; OECD, 2014, LIST OECD MEMB COUNT; Paxton Elizabeth W, 2012, Perm J, V16, P36; Swiss Agency for Therapeutic Products, 2008, FIELD SAF NOT URG ME; Swiss Agency for Therapeutic Products, 2007, FIELD SAF CORR ACT S; Swiss Agency for Therapeutic Products, 2013, URG MED DEV FIELD SA; Swiss Agency for Therapeutic Products, 2012, STJUDE MED ACC SR MO; The International Monetary Fund's global economy forum, 2011, BRICS MORT BUILD GRO; U.S. Food and Drug Administration, 2004, BOST SCI EXPRESS2TM; U.S. Food and Drug Administration, 2004, BOST SCI REC ADD COR; U.S. Food and Drug Administration, 2014, WHAT IS MED DEV REC; U.S. Food and Drug Administration, 2010, MED DEV REC CORR REM; U.S. Food and Drug Administration, 2013, MED DEV REP MAN; U.S. Food and Drug Administration, 2012, REC REP DEV PROBL; U.S. Food and Drug Administration, 2011, STJUDE MED RIAT RIAT; U.S. Food and Drug Administration, 2004, BOST SCI TAX EXPRESS; U.S. Food and Drug Administration. Medtronic Inc, 2007, SPRINT FID DEF LEADS; UK. Medicines and Healthcare Products Regulatory Agency (MHRA), 2004, MEDTR IMPL DEF MOD M; UK. Medicines and Healthcare Products Regulatory Agency (MHRA), 2013, MED DEV AL IMPL CARD; UK. Medicines and Healthcare Products Regulatory Agency (MHRA), 2008, MDA2007078 UK MHRA; Zhang SX, 2014, EXPERT REV MED DEVIC, V11, P527, DOI 10.1586/17434440.2014.932688	44	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0125987	10.1371/journal.pone.0125987	http://dx.doi.org/10.1371/journal.pone.0125987			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962074	Green Submitted, Green Published, gold			2022-12-26	WOS:000354542500056
J	Lu, SS; Xin, Y; Tang, XL; Yue, F; Wang, HH; Bai, YC; Niu, YG; Chen, Q				Lu, Songsong; Xin, Ying; Tang, Xiaolong; Yue, Feng; Wang, Huihui; Bai, Yucheng; Niu, Yonggang; Chen, Qiang			Differences in Hematological Traits between High- and Low-Altitude Lizards (Genus Phrynocephalus)	PLOS ONE			English	Article							HEMOGLOBIN-FUNCTION; ALLOSTERIC REGULATION; FUNCTIONAL DIVERSIFICATION; PHYSIOLOGICAL ADAPTATION; PHENOTYPIC PLASTICITY; OXYGEN-TRANSPORT; GYPS-RUEPPELLII; HYPOXIA; HEMATOCRIT; MECHANISMS	Phrynocephalus erythrurus (Lacertilia: Agamidae) is considered to be the highest living reptile in the world (about 4500-5000 m above sea level), whereas Phrynocephalus przewalskii inhabits low altitudes (about 1000-1500 m above sea level). Here, we report the differences in hematological traits between these two different Phrynocephalus species. Compared with P. przewalskii, the results indicated that P. erythrurus own higher oxygen carrying capacity by increasing red blood cell count (RBC), hemoglobin concentration ([Hb]) and hematocrit (Hct) and these elevations could promote oxygen carrying capacity without disadvantage of high viscosity. The lower partial pressure of oxygen in arterial blood (PaO2) of P. erythrurus did not cause the secondary alkalosis, which may be attributed to an efficient pulmonary system for oxygen (O-2) loading. The elevated blood-O-2 affinity in P. erythrurus may be achieved by increasing intrinsic O-2 affinity of isoHbs and balancing the independent effects of potential heterotropic ligands. We detected one alpha-globin gene and three beta-globin genes with 1 and 33 amino acid substitutions between these two species, respectively. Molecular dynamics simulation results showed that amino acids substitutions in beta-globin chains could lead to the elimination of hydrogen bonds in T-state Hb models of P. erythrurus. Based on the present data, we suggest that P. erythrurus have evolved an efficient oxygen transport system under the unremitting hypobaric hypoxia.	[Lu, Songsong; Xin, Ying; Tang, Xiaolong; Yue, Feng; Wang, Huihui; Bai, Yucheng; Niu, Yonggang; Chen, Qiang] Lanzhou Univ, Sch Life Sci, Inst Biochem & Mol Biol, Lanzhou 730000, Peoples R China	Lanzhou University	Chen, Q (corresponding author), Lanzhou Univ, Sch Life Sci, Inst Biochem & Mol Biol, Lanzhou 730000, Peoples R China.	chenq@lzu.edu.cn	wang, huimin/HDM-8421-2022; chen, qiang/HGU-5418-2022; wang, hui/GRS-4730-2022		National Natural Science Foundation of China [31272313, 31472005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Research funding was provided by the National Natural Science Foundation of China (No. 31272313 and No. 31472005 to Q Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Bouverot P., 1985, ADAPTATION ALTITUDE; Brutsaert TD, 2007, RESP PHYSIOL NEUROBI, V158, P151, DOI 10.1016/j.resp.2007.03.004; Connes P, 2006, J APPL PHYSIOL, V100, P2099, DOI 10.1152/japplphysiol.00279.2006; CROWELL JW, 1967, J APPL PHYSIOL, V22, P501, DOI 10.1152/jappl.1967.22.3.501; CROWELL JW, 1959, AM J PHYSIOL, V196, P1033, DOI 10.1152/ajplegacy.1959.196.5.1033; Damsgaard C, 2013, AM J PHYSIOL-REG I, V305, pR961, DOI 10.1152/ajpregu.00284.2013; Dickerson R.E., 1983, HEMOGLOBIN STRUCTURE; EKBLOM B, 1968, J APPL PHYSIOL, V25, P619, DOI 10.1152/jappl.1968.25.5.619; EKBLOM B, 1991, Scandinavian Journal of Medicine and Science in Sports, V1, P88; Espinosa-Aviles D, 2008, J ZOO WILDLIFE MED, V39, P21, DOI 10.1638/2006-0029.1; Freckmann Guido, 2013, J Diabetes Sci Technol, V7, P1648; Grispo MT, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.375600; GUEST GEORGE M., 1934, JOUR LAB AND CLIN MED, V19, P757; GUYTON AC, 1961, CIRC RES, V9, P157, DOI 10.1161/01.RES.9.1.157; He JZ, 2013, J EXP ZOOL PART A, V319A, P117, DOI 10.1002/jez.1776; HIEBL I, 1988, BIOL CHEM H-S, V369, P217, DOI 10.1515/bchm3.1988.369.1.217; HIRANO M, 1981, BLOOD, V57, P697; Hoffmann FG, 2010, MOL BIOL EVOL, V27, P1126, DOI 10.1093/molbev/msp325; Hsia CCW, 2005, RESP PHYSIOL NEUROBI, V147, P105, DOI 10.1016/j.resp.2005.02.001; Hsia CCW, 2007, J APPL PHYSIOL, V102, P1448, DOI 10.1152/japplphysiol.00971.2006; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jin Y, 2008, THESIS LANZHOU U LAN; Jin YT, 2013, J ZOOL, V290, P293, DOI 10.1111/jzo.12042; Jin YT, 2008, MOL ECOL, V17, P1971, DOI 10.1111/j.1365-294X.2008.03721.x; Jin YT, 2010, MOL PHYLOGENET EVOL, V54, P933, DOI 10.1016/j.ympev.2009.11.003; KANSTRUP IL, 1984, MED SCI SPORT EXER, V16, P256; Lukin JA, 2004, CHEM REV, V104, P1219, DOI 10.1021/cr940325w; LUTZ PL, 1980, AM ZOOL, V20, P187; MARKS SK, 1990, J ZOO WILDLIFE MED, V21, P342; Meir JU, 2013, J EXP BIOL, V216, P2172, DOI 10.1242/jeb.085282; MONGE C, 1991, PHYSIOL REV, V71, P1135, DOI 10.1152/physrev.1991.71.4.1135; Nagel RL, 2001, DISORDERS HEMOGLOBIN, P197; PERUTZ MF, 1982, NATURE, V299, P421, DOI 10.1038/299421a0; PERUTZ MF, 1969, NATURE, V222, P1240, DOI 10.1038/2221240a0; PETTIGREW DW, 1982, P NATL ACAD SCI-BIOL, V79, P1849, DOI 10.1073/pnas.79.6.1849; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Powell FL, 1998, RESP PHYSIOL, V112, P123, DOI 10.1016/S0034-5687(98)00026-7; Powell FL, 2007, RESP PHYSIOL NEUROBI, V157, P154, DOI 10.1016/j.resp.2007.01.009; Projecto-Garcia J, 2013, P NATL ACAD SCI USA, V110, P20669, DOI 10.1073/pnas.1315456110; Ramirez JM, 2007, ANNU REV PHYSIOL, V69, P113, DOI 10.1146/annurev.physiol.69.031905.163111; Ravikumar P, 2009, J APPL PHYSIOL, V107, P1911, DOI 10.1152/japplphysiol.00552.2009; Revsbech IG, 2013, J EXP BIOL, V216, P4264, DOI 10.1242/jeb.091397; RIGGS AF, 1988, ANNU REV PHYSIOL, V50, P181, DOI 10.1146/annurev.ph.50.030188.001145; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scott GR, 2009, CARDIO-RESPIRATORY CONTROL IN VERTEBRATES: COMPARATIVE AND EVOLUTIONARY ASPECTS, P429, DOI 10.1007/978-3-540-93985-6_17; SNYDER GK, 1971, AM J PHYSIOL, V220, P1667, DOI 10.1152/ajplegacy.1971.220.6.1667; Storz JF, 2008, HIGH ALT MED BIOL, V9, P148, DOI 10.1089/ham.2007.1079; Storz JF, 2007, J MAMMAL, V88, P24, DOI 10.1644/06-MAMM-S-199R1.1; Storz JF, 2013, MOL PHYLOGENET EVOL, V66, P469, DOI 10.1016/j.ympev.2012.07.013; Storz JF, 2011, J EXP BIOL, V214, P575, DOI 10.1242/jeb.050443; Storz JF, 2010, J EXP BIOL, V213, P4125, DOI 10.1242/jeb.048181; Tang XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071976; Troiano Juan Carlos, 2008, Comparative Clinical Pathology, V17, P93, DOI 10.1007/s00580-007-0715-x; Tufts DM, 2014, MOL BIOL EVOL; Villafuerte FC, 2004, J APPL PHYSIOL, V96, P1581, DOI 10.1152/japplphysiol.00328.2003; WEATHERS W W, 1972, Herpetologica, V28, P172; WEBER RE, 1988, BIOL CHEM H-S, V369, P233, DOI 10.1515/bchm3.1988.369.1.233; Weber RE, 2004, RESP PHYSIOL NEUROBI, V144, P141, DOI 10.1016/j.resp.2004.04.018; Weber RE, 2002, AM J PHYSIOL-REG I, V283, pR1052, DOI 10.1152/ajpregu.00292.2002; Weber RE, 2007, RESP PHYSIOL NEUROBI, V158, P132, DOI 10.1016/j.resp.2007.05.001; Weber RE, 2013, AM J PHYSIOL-REG I, V305, pR300, DOI 10.1152/ajpregu.00014.2013; Zanella-Cleon I, 2008, CLIN CHEM, V54, P1053, DOI 10.1373/clinchem.2007.097857; Zhao E-m, 1999, FAUNA SINICA REPTILI, V2, p[i, 1]	64	21	23	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0125751	10.1371/journal.pone.0125751	http://dx.doi.org/10.1371/journal.pone.0125751			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955247	Green Published, gold, Green Submitted			2022-12-26	WOS:000356768100072
J	Katara, GK; Kulshrestha, A; Jaiswal, MK; Pamarthy, S; Gilman-Sachs, A; Beaman, KD				Katara, G. K.; Kulshrestha, A.; Jaiswal, M. K.; Pamarthy, S.; Gilman-Sachs, A.; Beaman, K. D.			Inhibition of vacuolar ATPase subunit in tumor cells delays tumor growth by decreasing the essential macrophage population in the tumor microenvironment	ONCOGENE			English	Article							BREAST-CANCER CELLS; H+-ATPASE; IN-VITRO; V-ATPASE; DIFFERENTIATION; POLARIZATION; METASTASIS; EXPRESSION; ISOFORM	In cancer cells, vacuolar ATPase (V-ATPase), a multi-subunit enzyme, is expressed on the plasma as well as vesicular membranes and critically influences metastatic behavior. The soluble, cleaved N-terminal domain of V-ATPase a2 isoform is associated with in vitro induction of tumorigenic characteristics in macrophages. This activity led us to further investigate its in vivo role in cancer progression by inhibition of a2 isoform (a2V) in tumor cells and the concomitant effect on tumor microenvironment in the mouse 4T-1 breast cancer model. Results showed that macrophages cocultivated with a2V knockdown (sh-a2) 4T-1 cells produce lower amounts of tumorigenic factors in vitro and have reduced ability to suppress T-cell activation and proliferation compared with control 4T-1 cells. Data analysis showed a delayed mammary tumor growth in Balb/c mice inoculated with sh-a2 4T-1 cells compared with control. The purified CD11b(+) macrophages from sh-a2 tumors showed a reduced expression of mannose receptor-1 (CD206), interleukin-10, transforming growth factor-beta, arginase-1, matrix metalloproteinase and vascular endothelial growth factor. Flow cytometric analysis of tumor-infiltrated macrophages showed a significantly low number of F4/80(+) CD11c(+) CD206(+) macrophages in sh-a2 tumors compared with control. In sh-a2 tumors, most of the macrophages were F4/80(+) CD11c(+) (antitumor M1 macrophages) suggesting it to be the reason behind delayed tumor growth. Additionally, tumor-infiltrating macrophages from sh-a2 tumors showed a reduced expression of CD206 compared with control whereas CD11c expression was unaffected. These findings demonstrate that in the absence of a2V in tumor cells, the resident macrophage population in the tumor microenvironment is altered which affects in vivo tumor growth. We suggest that by involving the host immune system, tumor growth can be controlled through targeting of a2V on tumor cells.	[Katara, G. K.; Kulshrestha, A.; Jaiswal, M. K.; Pamarthy, S.; Gilman-Sachs, A.; Beaman, K. D.] Rosalind Franklin Univ Med & Sci, Dept Microbiol & Immunol, 3333 Green Bay Rd, N Chicago, IL 60064 USA	Rosalind Franklin University Medical & Science	Beaman, KD (corresponding author), Rosalind Franklin Univ Med & Sci, Dept Microbiol & Immunol, 3333 Green Bay Rd, N Chicago, IL 60064 USA.	kenneth.beaman@rosalindfranklin.edu		Pamarthy, Sahithi/0000-0003-2692-4829	Clinical Immunology Laboratory, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA	Clinical Immunology Laboratory, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA	We thank Robert Dickinson for technical assistance and the Rosalind Franklin University of Medicine and Science Flow Cytometry Core Facility. This work was supported by the grants from the Clinical Immunology Laboratory, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA.	Conejo-Garcia JR, 2004, NAT MED, V10, P950, DOI 10.1038/nm1097; Feng SM, 2013, INT J BIOL SCI, V9, P853, DOI 10.7150/ijbs.6030; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Granata F, 2010, J IMMUNOL, V184, P5232, DOI 10.4049/jimmunol.0902501; Hinton A, 2009, J BIOL CHEM, V284, P16400, DOI 10.1074/jbc.M901201200; Jaiswal MK, 2013, J IMMUNOL, V191, P5702, DOI 10.4049/jimmunol.1301604; Jaiswal MK, 2012, REPRODUCTION, V143, P713, DOI 10.1530/REP-12-0036; Katara GK, 2014, ONCOGENE, V33, P5649, DOI 10.1038/onc.2013.532; Kwong C, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.22978; Kwong C, 2011, J IMMUNOL, V186, P1781, DOI 10.4049/jimmunol.1002998; Lu YD, 2005, CANCER RES, V65, P6843, DOI 10.1158/0008-5472.CAN-04-3822; Luo YP, 2006, J CLIN INVEST, V116, P2132, DOI 10.1172/JCI27648; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Motz GT, 2013, IMMUNITY, V39, P61, DOI 10.1016/j.immuni.2013.07.005; Movahedi K, 2010, CANCER RES, V70, P5728, DOI 10.1158/0008-5472.CAN-09-4672; Nishisho T, 2011, MOL CANCER RES, V9, P845, DOI 10.1158/1541-7786.MCR-10-0449; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Ntrivalas E, 2007, AM J REPROD IMMUNOL, V57, P201, DOI 10.1111/j.1600-0897.2006.00463.x; Ostrand-Rosenberg S, 2010, CANCER IMMUNOL IMMUN, V59, P1593, DOI 10.1007/s00262-010-0855-8; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Sennoune SR, 2004, CELL BIOCHEM BIOPHYS, V40, P185, DOI 10.1385/CBB:40:2:185; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Torigoe T, 2002, J BIOL CHEM, V277, P36534, DOI 10.1074/jbc.M202605200; Umemura N, 2008, J LEUKOCYTE BIOL, V83, P1136, DOI 10.1189/jlb.0907611; Watkins SK, 2007, J IMMUNOL, V178, P1357, DOI 10.4049/jimmunol.178.3.1357	28	23	24	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 25	2016	35	8					1058	1065		10.1038/onc.2015.159	http://dx.doi.org/10.1038/onc.2015.159			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DE7NF	25961933				2022-12-26	WOS:000370823300011
J	Ma, X; Chen, Y; Zhang, S; Xu, W; Shao, Y; Yang, Y; Li, W; Li, M; Xue, L				Ma, X.; Chen, Y.; Zhang, S.; Xu, W.; Shao, Y.; Yang, Y.; Li, W.; Li, M.; Xue, L.			Rho1-Wnd signaling regulates loss-of-cell polarity-induced cell invasion in Drosophila	ONCOGENE			English	Article							MAP KINASE; TUMOR-SUPPRESSOR; JNK ACTIVATION; APOPTOTIC CELLS; ONCOGENIC RAS; RHO-GTPASES; CANCER; DEATH; PATHWAY; MIGRATION	Both cell polarity and c-Jun N-terminal kinase (JNK) activity are essential to the maintenance of tissue homeostasis, and disruption of either is commonly seen in cancer progression. Despite the established connection between loss-of-cell polarity and JNK activation, much less is known about the molecular mechanism by which aberrant cell polarity induces JNK-mediated cell migration and tumor invasion. Here we show results from a genetic screen using an in vivo invasion model via knocking down cell polarity gene in Drosophila wing discs, and identify Rho1-Wnd signaling as an important molecular link that mediates loss-of-cell polarity-triggered JNK activation and cell invasion. We show that Wallenda (Wnd), a protein kinase of the mitogen-activated protein kinase kinase kinase family, by forming a complex with the GTPase Rho1, is both necessary and sufficient for Rho1-induced JNK-dependent cell invasion, MMP1 activation and epithelial-mesenchymal transition. Furthermore, Wnd promotes cell proliferation and tissue growth through wingless production when apoptosis is inhibited by p35. Finally, Wnd shows oncogenic cooperation with Ras(V12) to trigger tumor growth in eye discs and causes invasion into the ventral nerve cord. Together, our data not only provides a novel mechanistic insight on how cell polarity loss contributes to cell invasion, but also highlights the value of the Drosophila model system to explore human cancer biology.	[Ma, X.; Chen, Y.; Zhang, S.; Shao, Y.; Yang, Y.; Li, W.; Li, M.; Xue, L.] Tongji Univ, Inst Intervent Vessel, Shanghai Peoples Hosp 10, Shanghai Key Lab Signaling & Dis Res,Sch Life Sci, 1239 Siping Rd, Shanghai 200092, Peoples R China; [Ma, X.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Xu, W.] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China	Tongji University; Howard Hughes Medical Institute; Johns Hopkins University; Tongji University	Li, M; Xue, L (corresponding author), Tongji Univ, Inst Intervent Vessel, Shanghai Peoples Hosp 10, Shanghai Key Lab Signaling & Dis Res,Sch Life Sci, 1239 Siping Rd, Shanghai 200092, Peoples R China.; Ma, X (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Howard Hughes Med Inst, Baltimore, MD 21205 USA.	XianjueMa@jhmi.eduor; cjr.limaoquan@vip.163.com; lei.xue@tongji.edu.cn		Ma, Xianjue/0000-0003-4360-3947	National Basic Research Program of China (973 Program) [2011CB943903]; National Natural Science Foundation of China [31071294, 31171413, 31371490]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20120072110023, 20120072120030]; Shanghai Committee of Science and Technology [09DZ2260100, 14JC1406000]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	We thank Drs Duojia Pan, Tian Xu, Helena Richardson, Aaron DiAntonio, Bloomington, VDRC and NIG stock centers for fly stocks and reagents, Dr Margaret Ho and members of Xue lab for discussion and comments, Dr Jonathan Phillips for critically reading the manuscript. This research was supported by the National Basic Research Program of China (973 Program) (2011CB943903), National Natural Science Foundation of China (31071294, 31171413, 31371490), the Specialized Research Fund for the Doctoral Program of Higher Education of China (20120072110023, 20120072120030), and Shanghai Committee of Science and Technology (09DZ2260100, 14JC1406000). Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc).	Baek SH, 2010, BIOCHEM BIOPH RES CO, V394, P488, DOI 10.1016/j.bbrc.2010.02.124; Bergstralh DT, 2012, ESSAYS BIOCHEM, V53, P129, DOI [10.1042/BSE0530129, 10.1042/bse0530129]; Billuart P, 2001, CELL, V107, P195, DOI 10.1016/S0092-8674(01)00522-0; Brumby AM, 2003, EMBO J, V22, P5769, DOI 10.1093/emboj/cdg548; Brumby AM, 2011, GENETICS, V188, P105, DOI 10.1534/genetics.111.127910; Collins CA, 2006, NEURON, V51, P57, DOI 10.1016/j.neuron.2006.05.026; Cordero JB, 2010, DEV CELL, V18, P999, DOI 10.1016/j.devcel.2010.05.014; Cuevas BD, 2007, ONCOGENE, V26, P3159, DOI 10.1038/sj.onc.1210409; Ebelt Nancy D, 2013, Genes Cancer, V4, P378, DOI 10.1177/1947601913485413; Elsum I, 2012, ESSAYS BIOCHEM, V53, P141, DOI [10.1042/bse0530141, 10.1042/BSE0530141]; Fernandez BG, 2014, ONCOGENE, V33, P2027, DOI 10.1038/onc.2013.155; Gaspar P, 2014, CURR OPIN CELL BIOL, V31, P74, DOI 10.1016/j.ceb.2014.09.003; Geuking P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007709; GLISE B, 1995, CELL, V83, P451, DOI 10.1016/0092-8674(95)90123-X; Gonzalez C, 2013, NAT REV CANCER, V13, P172, DOI 10.1038/nrc3461; Grifoni D, 2004, ONCOGENE, V23, P8688, DOI 10.1038/sj.onc.1208023; Hammarlund M, 2009, SCIENCE, V323, P802, DOI 10.1126/science.1165527; Hirai S, 2006, J NEUROSCI, V26, P11992, DOI 10.1523/JNEUROSCI.2272-06.2006; Igaki T, 2006, CURR BIOL, V16, P1139, DOI 10.1016/j.cub.2006.04.042; Itoh A, 2011, J NEUROSCI, V31, P7223, DOI 10.1523/JNEUROSCI.5947-10.2011; Khoo P, 2013, DIS MODEL MECH, V6, P661, DOI 10.1242/dmm.010066; Kulshammer E, 2013, J CELL SCI, V126, P927, DOI 10.1242/jcs.114462; Lee MH, 2008, J CELL SCI, V121, P1141, DOI 10.1242/jcs.016634; Lesch C, 2010, GENETICS, V186, P943, DOI 10.1534/genetics.110.121822; Lewcock JW, 2007, NEURON, V56, P604, DOI 10.1016/j.neuron.2007.09.009; Ma X, 2014, CELL DEATH DIFFER, V21, P407, DOI 10.1038/cdd.2013.154; Ma X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.392; Ma XJ, 2014, AIMS GENET, V1, P20, DOI 10.3934/genet.2014.1.20; Ma XJ, 2015, P NATL ACAD SCI USA, V112, P1065, DOI 10.1073/pnas.1415020112; Ma XJ, 2013, DEV BIOL, V380, P211, DOI 10.1016/j.ydbio.2013.05.013; Ma XJ, 2012, CELL RES, V22, P425, DOI 10.1038/cr.2011.135; Macara IG, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0012; Martin-Belmonte F, 2012, NAT REV CANCER, V12, P23, DOI 10.1038/nrc3169; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Miles WO, 2011, DIS MODEL MECH, V4, P753, DOI 10.1242/dmm.006908; Morata G, 2011, DEV GROWTH DIFFER, V53, P168, DOI 10.1111/j.1440-169X.2010.01225.x; Muthuswamy SK, 2012, ANNU REV CELL DEV BI, V28, P599, DOI 10.1146/annurev-cellbio-092910-154244; Neisch AL, 2010, J CELL BIOL, V189, P311, DOI 10.1083/jcb.200912010; Ohsawa S, 2012, NATURE, V490, P547, DOI 10.1038/nature11452; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Parri M, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-23; Pearson HB, 2011, J CLIN INVEST, V121, P4257, DOI 10.1172/JCI58509; Pichon S, 2004, J CELL SCI, V117, P2569, DOI 10.1242/jcs.01110; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Rauskolb C, 2014, CELL, V158, P143, DOI 10.1016/j.cell.2014.05.035; Royer C, 2011, CELL DEATH DIFFER, V18, P1470, DOI 10.1038/cdd.2011.60; Rudrapatna VA, 2014, ONCOGENE, V33, P2801, DOI 10.1038/onc.2013.232; Rudrapatna VA, 2013, EMBO REP, V14, P172, DOI 10.1038/embor.2012.217; Rudrapatna VA, 2012, DEV DYNAM, V241, P107, DOI 10.1002/dvdy.22771; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; Srivastava A, 2007, P NATL ACAD SCI USA, V104, P2721, DOI 10.1073/pnas.0611666104; Tedeschi A, 2013, EMBO REP, V14, P605, DOI 10.1038/embor.2013.64; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Uhlirova M, 2005, P NATL ACAD SCI USA, V102, P13123, DOI 10.1073/pnas.0504170102; Uhlirova M, 2006, EMBO J, V25, P5294, DOI 10.1038/sj.emboj.7601401; Vaira V, 2011, AM J PATHOL, V178, P2478, DOI 10.1016/j.ajpath.2011.02.028; Vidal M, 2006, DEV CELL, V10, P33, DOI 10.1016/j.devcel.2005.11.007; Xiong X, 2012, J NEUROSCI, V32, P610, DOI 10.1523/JNEUROSCI.3586-11.2012; Xue L, 2007, DEV CELL, V13, P446, DOI 10.1016/j.devcel.2007.07.012; Zhan LX, 2008, CELL, V135, P865, DOI 10.1016/j.cell.2008.09.045; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhang SY, 2012, TRENDS PHARMACOL SCI, V33, P122, DOI 10.1016/j.tips.2011.11.002	62	23	23	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 18	2016	35	7					846	855		10.1038/onc.2015.137	http://dx.doi.org/10.1038/onc.2015.137			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DE0RO	25961917				2022-12-26	WOS:000370332200005
J	Nemoto, K; Takemori, N; Seki, M; Shinozaki, K; Sawasaki, T				Nemoto, Keiichirou; Takemori, Nobuaki; Seki, Motoaki; Shinozaki, Kazuo; Sawasaki, Tatsuya			Members of the Plant CRK Superfamily Are Capable of Trans- and Autophosphorylation of Tyrosine Residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; BRI1 RECEPTOR KINASE; BIOCHEMICAL-CHARACTERIZATION; SYNTHESIS SYSTEM; IN-VITRO; SIGNAL-TRANSDUCTION; PHOSPHORYLATION; STRESS; EXPRESSION; GENE	Protein phosphorylation on Tyr residues is a key post-translational modification in mammals. In plants, recent studies have identified Tyr-specific protein phosphatase and Tyr-phosphorylated proteins in Arabidopsis by phosphoproteomic screenings, implying that plants have a Tyr phosphorylation signal pathway. However, little is known about the protein kinases (PKs) involved in Tyr phosphorylation in plants. Here, we demonstrate that Arabidopsis calcium-dependent protein kinase (CDPK/CPK)-related PKs (CRKs) have high Tyr-autophosphorylation activity and that they can phosphorylate Tyr residue(s) on substrate proteins in Arabidopsis. To identify PKs for Tyr phosphorylation, we examined the autophosphorylation activity of 759 PKs using an Arabidopsis protein array based on a wheat cell-free system. In total, we identified 38 PKs with Tyr-autophosphorylation activity. The CRK family was a major protein family identified. A cell-free substrate screening revealed that these CRKs phosphorylate beta-tubulin (TBB) 2, TBB7, and certain transcription factors (TFs) such as ethylene response factor 13 (ERF13). All five CRKs tested showed Tyr-auto/trans-phosphorylation activity and especially two CRKs, CRK2 and CRK3, showed a high ERF13 Tyr-phosphorylation activity. A cell-based transient expression assay revealed that Tyr(16)/Tyr(207) sites in ERF13 were phosphorylated by CRK3 and that Tyr phosphorylation of endogenous TBBs occurs in CRK2 overexpressing cells. Furthermore, crk2 and crk3 mutants showed a decrease in the Tyr phosphorylation level of TBBs. These results suggest that CRKs have Tyr kinase activity, and these might be one of the major PKs responsible for protein Tyr phosphorylation in Arabidopsis plants.	[Nemoto, Keiichirou; Takemori, Nobuaki; Sawasaki, Tatsuya] Ehime Univ, Proteosci Ctr, Matsuyama, Ehime 7908577, Japan; [Seki, Motoaki] RIKEN Ctr Sustainable Resource Sci, Plant Genom Network Res Team, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Shinozaki, Kazuo] RIKEN Ctr Sustainable Resource Sci, Gene Discovery Res Grp, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Seki, Motoaki] Japan Sci & Technol Agcy JST, CREST, Kawaguchi, Saitama 3320012, Japan	Ehime University; RIKEN; RIKEN; Japan Science & Technology Agency (JST)	Sawasaki, T (corresponding author), Ehime Univ, Proteosci Ctr, 3 Bunkyo Cho, Matsuyama, Ehime 7908577, Japan.	sawasaki@ehime-u.ac.jp	Nemoto, Keiichirou/P-2085-2015; Shinozaki, Kazuo/G-4202-2013; Takemori, Nobuaki/O-3990-2014; Seki, Motoaki/I-2854-2012; Shinozaki, Kazuo/AAB-4945-2019	Nemoto, Keiichirou/0000-0002-0344-004X; Shinozaki, Kazuo/0000-0002-6317-9867; Takemori, Nobuaki/0000-0001-6639-854X; Seki, Motoaki/0000-0001-8288-0467; Shinozaki, Kazuo/0000-0002-6317-9867; Sawasaki, Tatsuya/0000-0002-7952-0556	Ministry of Education, Culture, Sports, Science, and Technology in Japan	Ministry of Education, Culture, Sports, Science, and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research (B) (to T. S.) and the Platform for Drug Discovery, Informatics, and Structural Life Science (to T. S.) and a Grant-in-Aid for Scientific Research on Innovative Areas (to T. S.) from the Ministry of Education, Culture, Sports, Science, and Technology in Japan. The authors declare that they have no conflicts of interest with the contents of this article.	ALI N, 1994, J BIOL CHEM, V269, P31626; Blume Y, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-29; Blume Y, 2008, PLANTA, V229, P143, DOI 10.1007/s00425-008-0816-z; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Boudsocq M, 2013, TRENDS PLANT SCI, V18, P30, DOI 10.1016/j.tplants.2012.08.008; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; Das R, 2010, CURR GENOMICS, V11, P2, DOI 10.2174/138920210790217981; Du W, 2005, PLANT SCI, V168, P1181, DOI 10.1016/j.plantsci.2004.12.019; Engelsberger WR, 2012, PLANT J, V69, P978, DOI 10.1111/j.1365-313X.2011.04848.x; Fu XD, 2002, PLANT CELL, V14, P3191, DOI 10.1105/tpc.006197; Ghelis T, 2008, PLANT PHYSIOL, V148, P1668, DOI 10.1104/pp.108.124594; Ghelis T, 2011, PLANT SIGNAL BEHAV, V6, P942, DOI 10.4161/psb.6.7.15261; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Hegeman AD, 2006, PROTEOMICS, V6, P3649, DOI 10.1002/pmic.200500926; Hotta H, 1998, GENE, V213, P47, DOI 10.1016/S0378-1119(98)00207-8; Hrabak EM, 2003, PLANT PHYSIOL, V132, P666, DOI 10.1104/pp.102.011999; Hua W, 2004, J BIOL CHEM, V279, P31483, DOI 10.1074/jbc.M402861200; Hua W, 2004, PLANT SCI, V166, P1253, DOI 10.1016/j.plantsci.2004.01.003; Huang YF, 2000, PLANT PHYSIOL, V122, P1301, DOI 10.1104/pp.122.4.1301; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Kim TW, 2009, NAT CELL BIOL, V11, P1254, DOI 10.1038/ncb1970; Kudoh A, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-9; Kulik A, 2011, OMICS, V15, P859, DOI 10.1089/omi.2011.0091; Leclercq J, 2005, J EXP BOT, V56, P25, DOI 10.1093/jxb/eri003; Lee SJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-277; Li RJ, 2006, BIOCHEM BIOPH RES CO, V342, P119, DOI 10.1016/j.bbrc.2006.01.100; Lin WW, 2014, P NATL ACAD SCI USA, V111, P3632, DOI 10.1073/pnas.1318817111; Liu HT, 2008, PLANT J, V55, P760, DOI 10.1111/j.1365-313X.2008.03544.x; Liu JY, 2014, PLANT GROWTH REGUL, V74, P187, DOI 10.1007/s10725-014-9910-3; Lu YT, 1997, PLANTA, V203, pS91, DOI 10.1007/PL00008121; Ma L, 2004, PLANT PHYSIOL, V135, P1280, DOI 10.1104/pp.104.041970; Madin K, 2000, P NATL ACAD SCI USA, V97, P559, DOI 10.1073/pnas.97.2.559; MANESS PF, 1990, CIBA F SYMP, V150, P57; Masaki T, 2014, J VIROL, V88, P7541, DOI 10.1128/JVI.03170-13; Masaoka T, 2008, FEBS LETT, V582, P1795, DOI 10.1016/j.febslet.2008.04.060; MATTEN WT, 1990, J CELL BIOL, V111, P1959, DOI 10.1083/jcb.111.5.1959; Nakagami H, 2010, PLANT PHYSIOL, V153, P1161, DOI 10.1104/pp.110.157347; Nemoto K, 2011, PHYTOCHEMISTRY, V72, P1136, DOI 10.1016/j.phytochem.2011.02.029; Nozawa A, 2009, BIOSCI BIOTECH BIOCH, V73, P1661, DOI 10.1271/bbb.90026; Oh MH, 2012, FEBS LETT, V586, P4070, DOI 10.1016/j.febslet.2012.09.040; Oh MH, 2012, P NATL ACAD SCI USA, V109, P327, DOI 10.1073/pnas.1108321109; Oh MH, 2009, P NATL ACAD SCI USA, V106, P658, DOI 10.1073/pnas.0810249106; Pandey S, 2002, EUR J BIOCHEM, V269, P3193, DOI 10.1046/j.1432-1033.2002.02994.x; Rigo G, 2013, PLANT CELL, V25, P1592, DOI 10.1105/tpc.113.110452; Ritsema T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006605; Rudrabhatla P, 2006, PLANT MOL BIOL, V60, P293, DOI 10.1007/s11103-005-4109-7; Sangwan V, 2001, PLANT J, V27, P1, DOI 10.1046/j.1365-313x.2001.01052.x; Satoh R, 2004, PLANT CELL PHYSIOL, V45, P309, DOI 10.1093/pcp/pch036; Sawasaki T, 2002, P NATL ACAD SCI USA, V99, P14652, DOI 10.1073/pnas.232580399; Sawasaki T, 2002, FEBS LETT, V514, P102, DOI 10.1016/S0014-5793(02)02329-3; Sawasaki T, 2008, FEBS LETT, V582, P221, DOI 10.1016/j.febslet.2007.12.004; Sheremet YA, 2012, CYTOL GENET+, V46, P263, DOI [10.3103/S0095452712050088, 10.3103/S0095452712010112]; SMITH JA, 1993, MOL CELL BIOCHEM, V128, P51, DOI 10.1007/BF01076757; Sugiyama N, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.32; Swatek KN, 2014, BIOCHEM J, V459, P15, DOI 10.1042/BJ20130035; Takahashi H, 2012, FEBS LETT, V586, P3134, DOI 10.1016/j.febslet.2012.08.014; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; van Bentem SD, 2009, TRENDS PLANT SCI, V14, P71, DOI 10.1016/j.tplants.2008.11.003; van Wijk KJ, 2014, PLANT CELL, V26, P2367, DOI 10.1105/tpc.114.125815; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wang L, 2001, PLANTA, V213, P556, DOI 10.1007/s004250100540; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Wang XL, 2005, DEV CELL, V8, P855, DOI 10.1016/j.devcel.2005.05.001; Wang Y, 2005, CELL RES, V15, P604, DOI 10.1038/sj.cr.7290330; Wang ZX, 2002, BIOCHEM J, V368, P947, DOI 10.1042/BJ20020557; Xu Q, 1998, PLANT CELL, V10, P849, DOI 10.1105/tpc.10.5.849; Yemets A, 2008, CELL BIOL INT, V32, P630, DOI 10.1016/j.cellbi.2008.01.013; Zhang L, 2002, BIOCHEM J, V368, P145, DOI 10.1042/BJ20020780	68	35	36	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16665	16677		10.1074/jbc.M114.617274	http://dx.doi.org/10.1074/jbc.M114.617274			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25969537	hybrid, Green Published			2022-12-26	WOS:000357572800017
J	Pathak, KV; Bellamri, M; Wang, Y; Langouet, S; Turesky, RJ				Pathak, Khyatiben V.; Bellamri, Medjda; Wang, Yi; Langouet, Sophie; Turesky, Robert J.			2-Amino-9H-pyrido[2,3-b]indole (AC) Adducts and Thiol Oxidation of Serum Albumin as Potential Biomarkers of Tobacco Smoke	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carcinogenesis; Cigarette Smoke; DNA Damage; Oxidative Stress; Protein Chemical Modification	HETEROCYCLIC AROMATIC-AMINES; TANDEM MASS-SPECTROMETRY; EXPERIMENTAL CANCER-RESEARCH; PROTEIN ADDUCTS; IN-VITRO; HUMAN HEPATOCYTES; LIVER-MICROSOMES; DNA-ADDUCTS; CARCINOGENIC ARYLAMINES; EPIDEMIOLOGIC EVIDENCE	Background: The reactivity of AC, a tobacco smoke carcinogen, was investigated with DNA and albumin of human hepatocytes. Results: Hepatocytes bioactivate AC to metabolites, which adduct to DNA and albumin. Conclusion: Cys(34) and Met(329) of serum albumin are targets for AC electrophiles. Significance: AC forms macromolecular adducts and induces oxidative stress, which may be contributing factors to liver damage and cancer risk in smokers. 2-Amino-9H-pyrido[2,3-b]indole (AC) is a carcinogenic heterocyclic aromatic amine formed during the combustion of tobacco. AC undergoes bioactivation to form electrophilic N-oxidized metabolites that react with DNA to form adducts, which can lead to mutations. Many genotoxicants and toxic electrophiles react with human serum albumin (albumin); however, the chemistry of reactivity of AC with proteins has not been studied. The genotoxic metabolites, 2-hydroxyamino-9H-pyrido[2,3-b]indole (HONH-AC), 2-nitroso-9H-pyrido[2,3-b]indole (NO-AC), N-acetyloxy-2-amino-9H-pyrido[2,3-b]indole (N-acetoxy-AC), and their [C-13(6)]AC-labeled homologues were reacted with albumin. Sites of adduction of AC to albumin were identified by data-dependent scanning and targeted bottom-up proteomics approaches employing ion trap and Orbitrap MS. AC-albumin adducts were formed at Cys(34), Tyr(140), and Tyr(150) residues when albumin was reacted with HONH-AC or NO-AC. Sulfenamide, sulfinamide, and sulfonamide adduct formation occurred at Cys(34) (AC-Cys(34)). N-Acetoxy-AC also formed an adduct at Tyr(332). Albumin-AC adducts were characterized in human plasma treated with N-oxidized metabolites of AC and human hepatocytes exposed to AC. High levels of N-(deoxyguanosin-8-yl)-AC (dG-C8-AC) DNA adducts were formed in hepatocytes. The Cys(34) was the sole amino acid of albumin to form adducts with AC. Albumin also served as an antioxidant and scavenged reactive oxygen species generated by metabolites of AC in hepatocytes; there was a strong decrease in reduced Cys(34), whereas the levels of Cys(34) sulfinic acid (Cys-SO2H), Cys(34)-sulfonic acid (Cys-SO3H), and Met(329) sulfoxide were greatly increased. Cys(34) adduction products and Cys-SO2H, Cys-SO3H, and Met(329) sulfoxide may be potential biomarkers to assess exposure and oxidative stress associated with AC and other arylamine toxicants present in tobacco smoke.	[Pathak, Khyatiben V.; Wang, Yi; Turesky, Robert J.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Pathak, Khyatiben V.; Wang, Yi; Turesky, Robert J.] Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA; [Bellamri, Medjda; Langouet, Sophie] Univ Rennes 1, INSERM, IRSET, UMR 1085,UMS Biosit 3480, F-35043 Rennes, France	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes	Turesky, RJ (corresponding author), Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA.	rturesky@umn.edu	Langouet, Sophie A/I-2776-2015; Bellamri, Madjda/AAX-9938-2021	Bellamri, Madjda/0000-0002-6477-967X; PATHAK, KHYATIBEN/0000-0002-8050-0747; Langouet, Sophie/0000-0002-0016-5425	National Institutes of Health of the Family Smoking Prevention and Tobacco Control Act [RO1 CA134700, R01CA134700-03S1]; PNREST Anses, Cancer TMOI AVIESAN [2013/1/166]; NATIONAL CANCER INSTITUTE [R01CA134700] Funding Source: NIH RePORTER	National Institutes of Health of the Family Smoking Prevention and Tobacco Control Act; PNREST Anses, Cancer TMOI AVIESAN; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 CA134700 and R01CA134700-03S1 of the Family Smoking Prevention and Tobacco Control Act. This work was also supported by PNREST Anses, Cancer TMOI AVIESAN (2013/1/166). The authors declare that they have no conflicts of interest with the contents of this article.	Aldini G, 2008, J MASS SPECTROM, V43, P1470, DOI 10.1002/jms.1419; Bessette EE, 2010, CHEM RES TOXICOL, V23, P1234, DOI 10.1021/tx100098f; Bruschi M, 2008, J CHROMATOGR B, V864, P29, DOI 10.1016/j.jchromb.2008.01.035; Carballal S, 2003, BIOCHEMISTRY-US, V42, P9906, DOI 10.1021/bi027434m; Colombo G, 2012, ANTIOXID REDOX SIGN, V17, P1515, DOI 10.1089/ars.2012.4702; Colombo G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029930; Colombo G, 2010, ANTIOXID REDOX SIGN, V12, P349, DOI 10.1089/ars.2009.2806; Colzani M, 2013, J PROTEOMICS, V92, P28, DOI 10.1016/j.jprot.2013.03.030; Damsten MC, 2007, DRUG METAB DISPOS, V35, P1408, DOI 10.1124/dmd.106.014233; Eyer P., 1996, CHEM AMINO NITRO SF2, P999; Felton J. S., 2000, Food borne carcinogens: heterocyclic amines., P31; FINCH JW, 1993, ARCH BIOCHEM BIOPHYS, V305, P595, DOI 10.1006/abbi.1993.1466; Frederiksen H, 2004, CARCINOGENESIS, V25, P1525, DOI 10.1093/carcin/bgh156; Giovannucci E, 2001, CANCER EPIDEM BIOMAR, V10, P725; Goodenough AK, 2007, CHEM RES TOXICOL, V20, P263, DOI 10.1021/tx0601713; Grigoryan H, 2012, CHEM RES TOXICOL, V25, P1633, DOI 10.1021/tx300096a; Guillouzo A, 1998, ENVIRON HEALTH PERSP, V106, P511, DOI 10.2307/3433803; Hackett TL, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-180; Hecht SS, 2003, NAT REV CANCER, V3, P733, DOI 10.1038/nrc1190; Hoffmann D, 2001, CHEM RES TOXICOL, V14, P767, DOI 10.1021/tx000260u; International Agency for Research on Cancer, 1986, IARC MON EV CARC RIS, P127; International Agency for Research on Cancer, 2002, IARC MON EV CARC RIS, P1005; John H, 2010, ANAL BIOANAL CHEM, V398, P2677, DOI 10.1007/s00216-010-4076-y; Kang P, 2007, DRUG METAB DISPOS, V35, P1081, DOI 10.1124/dmd.107.014860; Kim DH, 2004, CHEM RES TOXICOL, V17, P529, DOI 10.1021/tx034267y; King RS, 2000, CARCINOGENESIS, V21, P1347, DOI 10.1093/carcin/21.7.1347; KRIEK E, 1992, J CANCER RES CLIN, V118, P481, DOI 10.1007/BF01225261; LANGOUET S, 1995, CANCER RES, V55, P5574; Lemke T. L., 2012, REV ORGANIC FUNCTION, V5th, P85; Li B, 2007, ANAL BIOCHEM, V361, P263, DOI 10.1016/j.ab.2006.11.018; Liebler DC, 2002, ENVIRON HEALTH PERSP, V110, P3, DOI 10.1289/ehp.02110s113; Luchtenborg M, 2007, CANCER EPIDEM BIOMAR, V16, P1341, DOI 10.1158/1055-9965.EPI-06-0519; Majer BJ, 2004, J CHROMATOGR B, V802, P167, DOI 10.1016/j.jchromb.2003.10.042; MILLER JA, 1970, CANCER RES, V30, P559; Murata M, 2011, FRONT BIOSCI-LANDMRK, V16, P1132, DOI 10.2741/3739; Nauwelaers G, 2013, CHEM RES TOXICOL, V26, P1367, DOI 10.1021/tx4002226; Nauwelaers G, 2011, CHEM RES TOXICOL, V24, P913, DOI 10.1021/tx200091y; Neumann HG, 2007, CRIT REV TOXICOL, V37, P211, DOI 10.1080/10408440601028603; NIWA T, 1982, MUTAT RES, V95, P159, DOI 10.1016/0027-5107(82)90254-8; Noort D, 2004, J ANAL TOXICOL, V28, P333, DOI 10.1093/jat/28.5.333; Noort D, 2003, ARCH TOXICOL, V77, P543, DOI 10.1007/s00204-003-0484-5; Noort D, 2009, ARCH TOXICOL, V83, P1031, DOI 10.1007/s00204-009-0456-5; Novak M, 2003, J ORG CHEM, V68, P9875, DOI 10.1021/jo034505u; Novak M, 2000, J AM CHEM SOC, V122, P3606, DOI 10.1021/ja993433e; Okonogi H, 1997, CANCER LETT, V111, P105, DOI 10.1016/S0304-3835(96)04505-3; Peng LJ, 2014, J PROTEOMICS, V103, P267, DOI 10.1016/j.jprot.2014.03.023; Peng LJ, 2013, ANAL CHEM, V85, P1065, DOI 10.1021/ac3028273; Peng LJ, 2012, CHEM RES TOXICOL, V25, P2179, DOI 10.1021/tx300253j; Peng LJ, 2011, CHEM RES TOXICOL, V24, P2004, DOI 10.1021/tx2003504; Rappaport SM, 2012, TOXICOL LETT, V213, P83, DOI 10.1016/j.toxlet.2011.04.002; Raza H, 1996, DRUG METAB DISPOS, V24, P395; REISTAD R, 1994, CARCINOGENESIS, V15, P2547, DOI 10.1093/carcin/15.11.2547; Rubino FM, 2009, MASS SPECTROM REV, V28, P725, DOI 10.1002/mas.20207; SAITO K, 1984, BIOCHEM BIOPH RES CO, V124, P1, DOI 10.1016/0006-291X(84)90907-0; Siraki AG, 2002, DRUG METAB REV, V34, P549, DOI 10.1081/DMR-120005657; SKIPPER PL, 1990, CARCINOGENESIS, V11, P507, DOI 10.1093/carcin/11.4.507; SNYDERWINE EG, 1988, CARCINOGENESIS, V9, P1061, DOI 10.1093/carcin/9.6.1061; Steen H, 2001, J AM SOC MASS SPECTR, V12, P228, DOI 10.1016/S1044-0305(00)00219-1; Sugimura T, 2004, CANCER SCI, V95, P290, DOI 10.1111/j.1349-7006.2004.tb03205.x; Tabb DL, 2007, J PROTEOME RES, V6, P654, DOI 10.1021/pr0604054; Tang YJ, 2013, TOXICOL SCI, V133, P248, DOI 10.1093/toxsci/kft077; Tornqvist M, 2002, J CHROMATOGR B, V778, P279, DOI 10.1016/S1570-0232(02)00172-1; Tsuneoka Y, 2003, J NATL CANCER I, V95, P1227, DOI 10.1093/jnci/djg025; TURESKY RJ, 1987, CARCINOGENESIS, V8, P1537, DOI 10.1093/carcin/8.10.1537; TURESKY RJ, 1992, CHEM RES TOXICOL, V5, P479, DOI 10.1021/tx00028a005; TURESKY RJ, 1994, CHEM RES TOXICOL, V7, P752, DOI 10.1021/tx00042a007; Turesky RJ, 2007, CANCER EPIDEM BIOMAR, V16, P1554, DOI 10.1158/1055-9965.EPI-07-0132; Turesky RJ, 2011, CHEM RES TOXICOL, V24, P1169, DOI 10.1021/tx200135s; Turesky RJ, 2009, CHEM RES TOXICOL, V22, P726, DOI 10.1021/tx800473w; Vineis P, 2004, JNCI-J NATL CANCER I, V96, P99, DOI 10.1093/jnci/djh014; Wang ZH, 2011, CHEM RES TOXICOL, V24, P54, DOI 10.1021/tx1002854; WESTRA JG, 1981, CARCINOGENESIS, V2, P355, DOI 10.1093/carcin/2.4.355; YOSHIDA D, 1980, CANCER LETT, V10, P141, DOI 10.1016/0304-3835(80)90037-3; YOSHIDA D, 1978, BIOCHEM BIOPH RES CO, V83, P915, DOI 10.1016/0006-291X(78)91482-1; Yu MC, 2002, MUTAT RES-FUND MOL M, V506, P21, DOI 10.1016/S0027-5107(02)00148-3; Zhang LQ, 2011, NICOTINE TOB RES, V13, P120, DOI 10.1093/ntr/ntq219; Zhang XB, 1996, CARCINOGENESIS, V17, P2259, DOI 10.1093/carcin/17.10.2259	77	17	17	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16304	16318		10.1074/jbc.M115.646539	http://dx.doi.org/10.1074/jbc.M115.646539			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25953894	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000356930100033
J	Tholen, M; Wolanski, J; Stolze, B; Chiabudini, M; Gajda, M; Bronsert, P; Stickeler, E; Rospert, S; Reinheckel, T				Tholen, Martina; Wolanski, Julia; Stolze, Britta; Chiabudini, Marco; Gajda, Mieczyslaw; Bronsert, Peter; Stickeler, Elmar; Rospert, Sabine; Reinheckel, Thomas			Stress-resistant Translation of Cathepsin L mRNA in Breast Cancer Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alternative splicing; breast cancer; cysteine protease; metastasis; translation control	INTERNAL RIBOSOME ENTRY; PLASMINOGEN-ACTIVATOR INHIBITOR-1; L SPLICE VARIANTS; L EXPRESSION; ENDOPLASMIC-RETICULUM; DEFICIENT MICE; CELL STRESS; STEFIN-A; HYPOXIA; GENES	Background: Translational regulation might underlie the high expression levels of the protease cathepsin L (CTSL) associated with poor breast cancer prognosis. Results: Translation of CTSL mRNA is highly stress-resistant and promotes metastasis of murine breast cancer. Conclusion: CTSL mRNA circumvents translational shutdown in cancer-associated stress conditions. Significance: High expression of a metastasis promoting protease is maintained by translational regulation. The cysteine protease cathepsin L (CTSL) is often thought to act as a tumor promoter by enhancing tumor progression and metastasis. This goes along with increased CTSL activity in various tumor entities; however, the mechanisms leading to high CTSL levels are incompletely understood. With the help of the polyoma middle T oncogene driven breast cancer mouse model expressing a human CTSL genomic transgene, we show that CTSL indeed promotes breast cancer metastasis to the lung. During tumor formation and progression high expression levels of CTSL are maintained by enduring translation of CTSL mRNA. Interestingly, human breast cancer specimens expressed the same pattern of 5 untranslated region (UTR) splice variants as the transgenic mice and the human cancer cell line MDA-MB 321. By polyribosome profiling of tumor tissues and human breast cancer cells, we observe an intrinsic resistance of CTSL to stress-induced shutdown of translation. This ability can be attributed to all 5 UTR variants of CTSL and is not dependent on a previously described internal ribosomal entry site motif. In conclusion, we provide in vivo functional evidence for overexpressed CTSL as a promoter of lung metastasis, whereas high CTSL levels are maintained during tumor progression due to stress-resistant mRNA translation.	[Tholen, Martina; Wolanski, Julia; Stolze, Britta; Reinheckel, Thomas] Univ Freiburg, Inst Mol Med & Cell Res, D-79104 Freiburg, Germany; [Tholen, Martina] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Chiabudini, Marco; Rospert, Sabine] Univ Freiburg, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; [Chiabudini, Marco; Rospert, Sabine; Reinheckel, Thomas] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany; [Gajda, Mieczyslaw] Univ Jena, Inst Pathol, D-07743 Jena, Germany; [Bronsert, Peter] Univ Med Ctr Freiburg, Inst Pathol, D-79106 Freiburg, Germany; [Bronsert, Peter; Stickeler, Elmar; Reinheckel, Thomas] German Canc Consortium DKTK, Comprehens Canc Center, D-79106 Freiburg, Germany; [Stickeler, Elmar] Univ Med Ctr Freiburg, Clin Gynecol, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Friedrich Schiller University of Jena; University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Freiburg	Reinheckel, T (corresponding author), Inst Mol Med & Cell Res, Stefan Meier Str 17, D-79104 Freiburg, Germany.	thomas.reinheckel@uniklinik-freiburg.de	Stickeler, Elmar/AHE-9022-2022; Reinheckel, Thomas/AAL-9761-2021	Reinheckel, Thomas/0000-0001-9866-9105; Rospert, Sabine/0000-0002-3089-9614	Deutsche Forschungsgemeinschaft [SFB850, RE1584/6-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB850 project B7 and RE1584/6-1 (to T.R.) and SFB850 project C8 (to E. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Abudula A, 2001, BIOL CHEM, V382, P1583, DOI 10.1515/BC.2001.193; Bengsch F, 2014, ONCOGENE, V33, P4474, DOI 10.1038/onc.2013.395; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Caserman S, 2006, BIOL CHEM, V387, P629, DOI 10.1515/BC.2006.080; Chang TH, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S2-S4; Dennemarker J, 2010, BIOL CHEM, V391, P913, DOI 10.1515/BC.2010.097; Esposito A. M., 2010, J VIS EXP, V40, P1948, DOI DOI 10.3791/1948; Foekens JA, 1998, J CLIN ONCOL, V16, P1013, DOI 10.1200/JCO.1998.16.3.1013; Gilbert WV, 2010, J BIOL CHEM, V285, P29033, DOI 10.1074/jbc.R110.150532; Gocheva V, 2006, GENE DEV, V20, P543, DOI 10.1101/gad.1407406; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Harbeck N, 2001, CLIN CANCER RES, V7, P2757; Houseweart MK, 2003, J NEUROBIOL, V56, P315, DOI 10.1002/neu.10253; Ivanov PA, 2003, EXP CELL RES, V290, P227, DOI 10.1016/S0014-4827(03)00290-8; Ivanov P, 2011, GENE DEV, V25, P2119, DOI 10.1101/gad.17838411; Jean D, 2006, ONCOGENE, V25, P1474, DOI 10.1038/sj.onc.1209196; Jean D, 2008, BIOCHEM J, V413, P125, DOI 10.1042/BJ20071255; Kozak M, 2005, NUCLEIC ACIDS RES, V33, P6593, DOI 10.1093/nar/gki958; Levicar N, 2002, CANCER DETECT PREV, V26, P42, DOI 10.1016/S0361-090X(02)00015-6; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Mason SD, 2011, TRENDS CELL BIOL, V21, P228, DOI 10.1016/j.tcb.2010.12.002; Meng XB, 2012, J BIOL CHEM, V287, P4485, DOI 10.1074/jbc.C111.291518; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mittal S, 2011, BIOL CHEM, V392, P405, DOI 10.1515/BC.2011.039; Miyamoto K, 2011, INT J ONCOL, V39, P1109, DOI 10.3892/ijo.2011.1127; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Noch E, 2011, CANCER BIOL THER, V11, P32, DOI 10.4161/cbt.11.1.13835; Nouh MA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-1; Piccirillo CA, 2014, NAT IMMUNOL, V15, P503, DOI 10.1038/ni.2891; Rafn B, 2012, MOL CELL, V45, P764, DOI 10.1016/j.molcel.2012.01.029; Reid DW, 2012, J BIOL CHEM, V287, P5518, DOI 10.1074/jbc.M111.312280; Rescheleit DK, 1996, FEBS LETT, V394, P345, DOI 10.1016/0014-5793(96)00986-6; Samaiya M, 2011, J CELL MOL MED, V15, P2189, DOI 10.1111/j.1582-4934.2010.01203.x; Sevenich L, 2006, BIOL CHEM, V387, P885, DOI 10.1515/BC.2006.112; Shatsky IN, 2010, MOL CELLS, V30, P285, DOI 10.1007/s10059-010-0149-1; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Skrzypczak M, 2012, CANCER INVEST, V30, P398, DOI 10.3109/07357907.2012.672608; Spriggs KA, 2008, BIOL CELL, V100, P27, DOI 10.1042/BC20070098; Spriggs KA, 2010, MOL CELL, V40, P228, DOI 10.1016/j.molcel.2010.09.028; Thomssen C, 1995, CLIN CANCER RES, V1, P741; Thoreen CC, 2009, AUTOPHAGY, V5, P725, DOI 10.4161/auto.5.5.8504; Unsworth H, 2010, FASEB J, V24, P3370, DOI 10.1096/fj.09-151142; Vasiljeva O, 2008, ONCOGENE, V27, P4191, DOI 10.1038/onc.2008.59; Wilkinson N, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00176; Young RM, 2008, J BIOL CHEM, V283, P16309, DOI 10.1074/jbc.M710079200; Zajc I, 2002, CANCER LETT, V187, P185, DOI 10.1016/S0304-3835(02)00452-4	47	19	19	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15758	15769		10.1074/jbc.M114.624353	http://dx.doi.org/10.1074/jbc.M114.624353			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25957406	hybrid, Green Published			2022-12-26	WOS:000356527400037
J	Gerente, VM; Schor, RR; Chaim, KT; Felix, MD; Ventura, DF; Teixeira, SH; Lottenberg, CL; Amaro, E; Paranhos, A				Gerente, Vanessa M.; Schor, Ruth R.; Chaim, Khallil T.; Felix, Marcelo de Maria; Ventura, Dora F.; Teixeira, Sergio H.; Lottenberg, Claudio L.; Amaro, Edson, Jr.; Paranhos, Augusto, Jr.			Evaluation of Glaucomatous Damage via Functional Magnetic Resonance Imaging, and Correlations Thereof with Anatomical and Psychophysical Ocular Findings	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; LATERAL GENICULATE-NUCLEUS; RETINOTOPIC ORGANIZATION; PARVOCELLULAR LAYERS; CORTICAL FUNCTION; FMRI MEASUREMENTS; FIELD; MRI; NEURONS; ATROPHY	Purpose To evaluate the functional magnetic resonance imaging (fMRI) response to binocular visual stimulation and the association thereof with structural ocular findings and psychophysical test results in patients with glaucoma, and controls. Methods Cross-sectional study. Participants underwent a complete ophthalmic examination, including Humphrey 24-2 visual field (VF) testing and optical coherence tomography. Binocular VF in each quadrant was determined using an integrated method. Patients with glaucoma were assigned to three subgroups: initial, asymmetrical and severe glaucoma. Regions of interest (ROIs) were determined anatomically. fMRI (3 T) was performed using a bilaterally presented polar angle stimulus, and the accompanying changes in blood oxygen level-dependent (BOLD) signals were obtained from the occipital poles and calcarine ROIs. We used generalized estimation equation models to compare anatomical and functional data between the groups. Results A total of 25 subjects were enrolled, of whom 17 had glaucoma and 8 were controls. Significant associations between quadrant binocular VF sensitivities and fMRI responses were found in the occipital pole ROIs (p = 0.033) and the calcarine ROIs (p = 0.045). In glaucoma severity subgroup analysis, retinal nerve fiber layer (RNFL) thickness was associated with the BOLD response of the calcarine and occipital pole ROIs (p = 0.002 and 0.026, respectively). The initial and asymmetrical glaucoma subgroups had similar binocular VF sensitivities and RNFL thicknesses, but distinct BOLD responses. Conclusions The response of the visual cortex to binocular stimulation was associated with binocular VF sensitivity. RNFL thickness was associated with the BOLD response of the calcarine and occipital pole ROIs.	[Gerente, Vanessa M.; Schor, Ruth R.; Teixeira, Sergio H.; Paranhos, Augusto, Jr.] Univ Fed Sao Paulo, Dept Ophthalmol, Sao Paulo, Brazil; [Gerente, Vanessa M.; Schor, Ruth R.; Chaim, Khallil T.; Felix, Marcelo de Maria; Lottenberg, Claudio L.; Amaro, Edson, Jr.; Paranhos, Augusto, Jr.] Hosp Israelita Albert Einstein, Sao Paulo, Brazil; [Ventura, Dora F.] Univ Sao Paulo, Inst Psychol, Dept Expt Psychol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Hospital Israelita Albert Einstein; Universidade de Sao Paulo	Gerente, VM (corresponding author), Univ Fed Sao Paulo, Dept Ophthalmol, Sao Paulo, Brazil.	vanessagerente@gmail.com	amaro, edson/GLR-7735-2022; Ventura, Dora F/B-9071-2012; Amaro, Edson/B-6653-2009; Paranhos Jr, Augusto/E-6297-2012	amaro, edson/0000-0002-5889-1382; Ventura, Dora F/0000-0002-7616-4031; Amaro, Edson/0000-0002-5889-1382; Paranhos Jr, Augusto/0000-0001-6266-6922	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2007/07339-2]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors acknowledge financial support provided by a grant from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP 2007/07339-2). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaro E, 2006, BRAIN COGNITION, V60, P220, DOI 10.1016/j.bandc.2005.11.009; Asaoka R, 2011, INVEST OPHTH VIS SCI, V52, P7007, DOI 10.1167/iovs.11-7643; Brusini P, 2007, SURV OPHTHALMOL, V52, P156, DOI 10.1016/j.survophthal.2006.12.008; Buchert M, 2002, EXP BRAIN RES, V145, P334, DOI 10.1007/s00221-002-1121-x; Chang EE, 2012, OPHTHALMOLOGY, V119, P979, DOI 10.1016/j.ophtha.2011.11.003; Chen HF, 2004, BRAIN TOPOGR, V17, P39, DOI 10.1023/B:BRAT.0000047335.00110.6a; Cheng K, 2001, NEURON, V32, P359, DOI 10.1016/S0896-6273(01)00477-9; Crabb DP, 2013, OPHTHALMOLOGY, V120, P1120, DOI 10.1016/j.ophtha.2012.11.043; Crabb DP, 1998, BRIT J OPHTHALMOL, V82, P1236, DOI 10.1136/bjo.82.11.1236; Crawford MLJ, 2001, INVEST OPHTH VIS SCI, V42, P358; Duncan RO, 2007, INVEST OPHTH VIS SCI, V48, P733, DOI 10.1167/iovs.06-0773; Duncan RO, 2007, PROG RETIN EYE RES, V26, P38, DOI 10.1016/j.preteyeres.2006.10.001; Duncan RO, 2012, VISION RES, V60, P51, DOI 10.1016/j.visres.2012.03.012; Duyn JH, 2010, MAGN RESON IMAGING, V28, P1210, DOI 10.1016/j.mri.2010.02.007; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Goense J, 2012, NEURON, V76, P629, DOI 10.1016/j.neuron.2012.09.019; Gupta N, 2006, BRIT J OPHTHALMOL, V90, P674, DOI 10.1136/bjo.2005.086769; Gupta N, 2003, EUR J OPHTHALMOL, V13, pS32; Hinds O, 2009, NEUROIMAGE, V46, P915, DOI 10.1016/j.neuroimage.2009.03.036; Horton JC, 2006, CAN J OPHTHALMOL, V41, P584, DOI 10.1016/S0008-4182(06)80027-X; Hoste A M, 2003, Bull Soc Belge Ophtalmol, P65; Kotecha A, 2012, INVEST OPHTH VIS SCI, V53, P7795, DOI 10.1167/iovs.12-10866; Lestak J, 2014, BIOMED PAP, V158, P144, DOI 10.5507/bp.2013.038; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; McGwin G, 2005, INVEST OPHTH VIS SCI, V46, P4437, DOI 10.1167/iovs.05-0750; Miki A, 1996, AM J OPHTHALMOL, V122, P404, DOI 10.1016/S0002-9394(14)72067-7; Murdoch IE, 1998, BRIT J OPHTHALMOL, V82, P971, DOI 10.1136/bjo.82.8.971; Nelson-Quigg JM, 2000, INVEST OPHTH VIS SCI, V41, P2212; Portin K, 1999, EXP BRAIN RES, V124, P287, DOI 10.1007/s002210050625; Qing GP, 2010, INVEST OPHTH VIS SCI, V51, P4627, DOI 10.1167/iovs.09-4834; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Wade Mary, 2013, Insight, V38, P21; Weber AJ, 2000, INVEST OPHTH VIS SCI, V41, P1370; Yucel YH, 2003, PROG RETIN EYE RES, V22, P465, DOI 10.1016/S1350-9462(03)00026-0; Yucel YH, 2001, INVEST OPHTH VIS SCI, V42, P3216; Yucel YH, 2000, ARCH OPHTHALMOL-CHIC, V118, P378; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	38	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0126362	10.1371/journal.pone.0126362	http://dx.doi.org/10.1371/journal.pone.0126362			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25969982	gold, Green Submitted, Green Published			2022-12-26	WOS:000354544200108
J	Chen, J; Tan, RK; Guo, XJ; Fu, ZL; Wang, Z; Zhang, ZY; Tan, XL				Chen, Jie; Tan, Ren-Ke; Guo, Xiao-Juan; Fu, Zheng-Li; Wang, Zheng; Zhang, Zhi-Yan; Tan, Xiao-Li			Transcriptome Analysis Comparison of Lipid Biosynthesis in the Leaves and Developing Seeds of Brassica napus	PLOS ONE			English	Article							LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE; CARRIER PROTEIN SYNTHASE; ACETYL-COA CARBOXYLASE; OIL CONTENT; PHOSPHATASE ENZYMES; SN-2 POSITION; OLEIC-ACID; FAD2 GENE; ARABIDOPSIS; EXPRESSION	Brassica napus seed is a lipid storage organ containing approximately 40% oil, while its leaves contain many kinds of lipids for many biological roles, but the overall amounts are less than in seeds. Thus, lipid biosynthesis in the developing seeds and the leaves is strictly regulated which results the final difference of lipids. However, there are few reports about the molecular mechanism controlling the difference in lipid biosynthesis between developing seeds and leaves. In this study, we tried to uncover this mechanism by analyzing the transcriptome data for lipid biosynthesis. The transcriptome data were de novo assembled and a total of 47216 unigenes were obtained, which had an N50 length and median of 1271 and 755 bp, respectively. Among these unigenes, 36368 (about 77.02%) were annotated and there were 109 up-regulated unigenes and 72 down-regulated unigenes in the developing seeds lipid synthetic pathway after comparing with leaves. In the oleic acid pathway, 23 unigenes were up-regulated and four unigenes were down-regulated. During triacylglycerol (TAG) synthesis, the key unigenes were all up-regulated, such as phosphatidate phosphatase and diacylglycerol O-acyltransferase. During palmitic acid, palmitoleic acid, stearic acid, linoleic acid and linolenic acid synthesis in leaves, the unigenes were nearly all up-regulated, which indicated that the biosynthesis of these particular fatty acids were more important in leaves. In the developing seeds, almost all the unigenes in the ABI3VP1, RKD, CPP, E2F-DP, GRF, JUMONJI, MYB-related, PHD and REM transcript factorfamilies were up-regulated, which helped us to discern the regulation mechanism underlying lipid biosynthesis. The differential up/down-regulation of the genes and TFs involved in lipid biosynthesis in developing seeds and leaves provided direct evidence that allowed us to map the network that regulates lipid biosynthesis, and the identification of new TFs that are up-regulated in developing seeds will help us to further elucidate the lipids biosynthesis pathway in developing seeds and leaves.	[Chen, Jie; Tan, Ren-Ke; Guo, Xiao-Juan; Fu, Zheng-Li; Wang, Zheng; Zhang, Zhi-Yan; Tan, Xiao-Li] Jiangsu Univ, Inst Life Sci, Zhenjiang, Peoples R China	Jiangsu University	Tan, XL (corresponding author), Jiangsu Univ, Inst Life Sci, Zhenjiang, Peoples R China.	xltan@ujs.edu.cn	Tan, Renke/ABF-1309-2020		National Natural Science Foundation of China [31271760, 31471527, 31071672]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was funded by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) 31271760, 31471527 to XL Tan, 31071672 to Z Wang, and the The Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions (http://202.119.175.131/pages/index.aspx) to XL Tan, Z Wang and ZY Zhang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad I, 2015, PLANT BIOTECHNOL J, V13, P540, DOI 10.1111/pbi.12278; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bates PD, 2013, CURR OPIN PLANT BIOL, V16, P358, DOI 10.1016/j.pbi.2013.02.015; Baud S, 2010, PROG LIPID RES, V49, P235, DOI 10.1016/j.plipres.2010.01.001; Beule T, 2011, TREE GENET GENOMES, V7, P169, DOI 10.1007/s11295-010-0323-9; Brown AP, 2006, J EXP BOT, V57, P1563, DOI 10.1093/jxb/erj150; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Chen X, 2014, J EXP BOT, V65, P4201, DOI 10.1093/jxb/eru199; Cheng F, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-136; Dehesh K, 2001, PLANT PHYSIOL, V125, P1103, DOI 10.1104/pp.125.2.1103; Dormann P, 2002, TRENDS PLANT SCI, V7, P112, DOI 10.1016/S1360-1385(01)02216-6; Faergeman NJ, 1997, BIOCHEM J, V323, P1; Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200; Frandsen GI, 2001, PHYSIOL PLANTARUM, V112, P301, DOI 10.1034/j.1399-3054.2001.1120301.x; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Gomez-Campo C, 1999, DEV PL GEN, V4, P33; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guimaraes PM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-387; Heilmann I, 2004, PLANT PHYSIOL, V136, P4237, DOI 10.1104/pp.104.052951; Heilmann I, 2004, P NATL ACAD SCI USA, V101, P10266, DOI 10.1073/pnas.0402200101; Hills MJ, 2004, CURR OPIN PLANT BIOL, V7, P302, DOI 10.1016/j.pbi.2004.03.003; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Hu XY, 2006, THEOR APPL GENET, V113, P497, DOI 10.1007/s00122-006-0315-1; HUANG AHC, 1992, ANNU REV PLANT PHYS, V43, P177, DOI 10.1146/annurev.pp.43.060192.001141; Jako C, 2001, PLANT PHYSIOL, V126, P861, DOI 10.1104/pp.126.2.861; JAWORSKI JG, 1989, PLANT PHYSIOL, V90, P41, DOI 10.1104/pp.90.1.41; Jha JK, 2007, PLANT PHYSIOL BIOCH, V45, P490, DOI 10.1016/j.plaphy.2007.03.001; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Knutzon DS, 1999, PLANT PHYSIOL, V120, P739, DOI 10.1104/pp.120.3.739; Konishi T, 1996, PLANT CELL PHYSIOL, V37, P117, DOI 10.1093/oxfordjournals.pcp.a028920; Kumar S, 2010, J FOOD SCI TECH MYS, V47, P690, DOI 10.1007/s13197-010-0120-3; Lardizabal K, 2008, PLANT PHYSIOL, V148, P89, DOI 10.1104/pp.108.123042; Larson TR, 2002, PLANT J, V32, P519, DOI 10.1046/j.1365-313X.2002.01440.x; Larson TR, 2001, PLANT J, V25, P115, DOI 10.1046/j.1365-313x.2001.00929.x; Li HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030987; Li YH, 2006, PHYTOCHEMISTRY, V67, P904, DOI 10.1016/j.phytochem.2006.02.015; Li-Beisson Yonghua, 2010, Arabidopsis Book, V8, pe0133, DOI [10.1199/tab.0133, 10.1199/tab.0161]; Lin LJ, 2002, PLANT PHYSIOL, V128, P1200, DOI 10.1104/pp.010928; Liu YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074441; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Loll B, 2007, BBA-BIOENERGETICS, V1767, P509, DOI 10.1016/j.bbabio.2006.12.009; Lu CF, 2009, P NATL ACAD SCI USA, V106, P18837, DOI 10.1073/pnas.0908848106; Madoka Y, 2002, PLANT CELL PHYSIOL, V43, P1518, DOI 10.1093/pcp/pcf172; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; MIQUEL M, 1992, J BIOL CHEM, V267, P1502; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MURATA N, 1992, PLANT CELL PHYSIOL, V33, P933; Naested H, 2000, PLANT MOL BIOL, V44, P463, DOI 10.1023/A:1026564411918; Natarajan P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-191; Niewitetzki O, 2010, J AGR FOOD CHEM, V58, P94, DOI 10.1021/jf9028199; Nookaew I, 2012, NUCLEIC ACIDS RES, V40, P10084, DOI 10.1093/nar/gks804; Palaniswamy SK, 2006, PLANT PHYSIOL, V140, P818, DOI 10.1104/pp.105.072280; Pidkowich MS, 2007, P NATL ACAD SCI USA, V104, P4742, DOI 10.1073/pnas.0611141104; Poxleitner M, 2006, PLANT J, V47, P917, DOI 10.1111/j.1365-313X.2006.02845.x; Reue K, 2008, J LIPID RES, V49, P2493, DOI 10.1194/jlr.R800019-JLR200; Rismani-Yazdi H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-148; Roesler K, 1997, PLANT PHYSIOL, V113, P75, DOI 10.1104/pp.113.1.75; Santos-Mendoza M, 2008, PLANT J, V54, P608, DOI 10.1111/j.1365-313X.2008.03461.x; Shimada TL, 2010, BIOL PHARM BULL, V33, P360, DOI 10.1248/bpb.33.360; Shyam Prakash, 2012, Plant Breeding Reviews, V35, P19; Stoutjesdijk PA, 2002, PLANT PHYSIOL, V129, P1723, DOI 10.1104/pp.006353; Subramaniam S, 2011, CHEM REV, V111, P6452, DOI 10.1021/cr200295k; Tasaka Y, 1996, EMBO J, V15, P6416, DOI 10.1002/j.1460-2075.1996.tb01033.x; TAYLOR DC, 1995, PLANT PHYSIOL, V109, P409, DOI 10.1104/pp.109.2.409; Trick M, 2009, PLANT BIOTECHNOL J, V7, P334, DOI 10.1111/j.1467-7652.2008.00396.x; TZEN JTC, 1993, PLANT PHYSIOL, V101, P267, DOI 10.1104/pp.101.1.267; Voelker T, 2001, ANNU REV PLANT PHYS, V52, P335, DOI 10.1146/annurev.arplant.52.1.335; Vu HS, 2014, PLANT J, V80, P728, DOI 10.1111/tpj.12659; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wang Z, 2014, MOL GENET GENOMICS, V289, P1023, DOI 10.1007/s00438-014-0853-1; Wu GZ, 2010, PLANT CELL, V22, P3726, DOI 10.1105/tpc.110.075564; Wu XL, 2014, J INTEGR PLANT BIOL, V56, P582, DOI 10.1111/jipb.12158; Xiao G, 2014, GENE, V545, P45, DOI 10.1016/j.gene.2014.05.008; Xiao S, 2011, PROG LIPID RES, V50, P141, DOI 10.1016/j.plipres.2010.11.002; Xu JY, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-4; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Yurchenko O, 2014, PLANT PHYSIOL, V165, P550, DOI 10.1104/pp.114.238071; Zheng P, 2008, NAT GENET, V40, P367, DOI 10.1038/ng.85	80	20	22	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0126250	10.1371/journal.pone.0126250	http://dx.doi.org/10.1371/journal.pone.0126250			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965272	Green Published, gold, Green Submitted			2022-12-26	WOS:000354543500053
J	Freidl, GS; Binger, T; Muller, MA; de Bruin, E; van Beek, J; Corman, VM; Rasche, A; Drexler, JF; Sylverken, A; Oppong, SK; Adu-Sarkodie, Y; Tschapka, M; Cottontail, VM; Drosten, C; Koopmans, M				Freidl, Gudrun Stephanie; Binger, Tabea; Mueller, Marcel Alexander; de Bruin, Erwin; van Beek, Janko; Corman, Victor Max; Rasche, Andrea; Drexler, Jan Felix; Sylverken, Augustina; Oppong, Samuel K.; Adu-Sarkodie, Yaw; Tschapka, Marco; Cottontail, Veronika M.; Drosten, Christian; Koopmans, Marion			Serological Evidence of Influenza A Viruses in Frugivorous Bats from Africa	PLOS ONE			English	Article							INFECTIOUS-DISEASES; ECOLOGY; ASSAYS	Bats are likely natural hosts for a range of zoonotic viruses such as Marburg, Ebola, Rabies, as well as for various Corona-and Paramyxoviruses. In 2009/10, researchers discovered RNA of two novel influenza virus subtypes - H17N10 and H18N11 - in Central and South American fruit bats. The identification of bats as possible additional reservoir for influenza A viruses raises questions about the role of this mammalian taxon in influenza A virus ecology and possible public health relevance. As molecular testing can be limited by a short time window in which the virus is present, serological testing provides information about past infections and virus spread in populations after the virus has been cleared. This study aimed at screening available sera from 100 free-ranging, frugivorous bats (Eidolon helvum) sampled in 2009/10 in Ghana, for the presence of antibodies against the complete panel of influenza A haemagglutinin (HA) types ranging from H1 to H18 by means of a protein microarray platform. This technique enables simultaneous serological testing against multiple recombinant HA-types in 5 mu l of serum. Preliminary results indicate serological evidence against avian influenza subtype H9 in about 30% of the animals screened, with low-level cross-reactivity to phylogenetically closely related subtypes H8 and H12. To our knowledge, this is the first report of serological evidence of influenza A viruses other than H17 and H18 in bats. As avian influenza subtype H9 is associated with human infections, the implications of our findings from a public health context remain to be investigated.	[Freidl, Gudrun Stephanie; de Bruin, Erwin; van Beek, Janko; Koopmans, Marion] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Res Diagnost & Screening, Dept Virol, NL-3720 BA Bilthoven, Netherlands; [Freidl, Gudrun Stephanie; de Bruin, Erwin; van Beek, Janko; Koopmans, Marion] Erasmus MC, Virosci Dept, Rotterdam, Netherlands; [Binger, Tabea; Mueller, Marcel Alexander; Corman, Victor Max; Rasche, Andrea; Drexler, Jan Felix; Drosten, Christian] Univ Bonn, Med Ctr, Inst Virol, Bonn, Germany; [Sylverken, Augustina; Oppong, Samuel K.; Adu-Sarkodie, Yaw] Kumasi Ctr Collaborat Res Trop Med, Kumasi, Ghana; [Oppong, Samuel K.; Adu-Sarkodie, Yaw] Kwame Nkrumah Univ Sci & Technol, Kumasi, Ghana; [Tschapka, Marco; Cottontail, Veronika M.] Univ Ulm, Inst Evolutionary Ecol & Conservat Genom, D-89069 Ulm, Germany; [Tschapka, Marco] Smithsonian Trop Res Inst, Balboa, Panama	Netherlands National Institute for Public Health & the Environment; Erasmus University Rotterdam; Erasmus MC; University of Bonn; Kumasi Center for Collaborative Research; Kwame Nkrumah University Science & Technology; Ulm University; Smithsonian Institution; Smithsonian Tropical Research Institute	Freidl, GS (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Res Diagnost & Screening, Dept Virol, NL-3720 BA Bilthoven, Netherlands.	gudrun.freidl@rivm.nl	Corman, Victor M/K-1319-2019; Koopmans, Marion/Y-9170-2019; Drexler, Jan Felix/GMW-5098-2022; Sylverken, Augustina Angelina/ABE-4664-2020; Müller, Marcel A./O-2425-2019	Corman, Victor M/0000-0002-3605-0136; Koopmans, Marion/0000-0002-5204-2312; Müller, Marcel A./0000-0003-2242-5117; Drexler, Jan Felix/0000-0002-3509-0232; SYLVERKEN, AUGUSTINA/0000-0002-7691-914X; Rasche, Andrea/0000-0001-6693-1180	European Commission [278976]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This project was funded by the European Commission's FP7 program under the umbrella of the Antigone project - ANTIcipating the Global onset of Novel Epidemics (project number 278976, http://antigonefp7.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1980, B WORLD HEALTH ORGAN, V58, P585; Binger T, 2015, J VIROL, V89, P4588, DOI 10.1128/JVI.02932-14; Drexler JF, 2013, P NATL ACAD SCI USA, V110, P16151, DOI 10.1073/pnas.1308049110; Drexler JF, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003438; Drexler JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1796; Eckerle I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084679; Fereidouni S, 2015, ZOONOSES PUBLIC HLTH, V62, P187, DOI 10.1111/zph.12131; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Freidl GS, 2014, EURO SURVEILL BULL E, V19; Freidl GS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108043; Fusaro A, 2011, J VIROL, V85, P8413, DOI 10.1128/JVI.00219-11; Gilbert AT, 2013, ECOHEALTH, V10, P298, DOI 10.1007/s10393-013-0856-0; Hayman DTS, 2013, ZOONOSES PUBLIC HLTH, V60, P2, DOI 10.1111/zph.12000; Kamins AO, 2011, BIOL CONSERV, V144, P3000, DOI 10.1016/j.biocon.2011.09.003; Katz JM, 2011, EXPERT REV ANTI-INFE, V9, P669, DOI [10.1586/ERI.11.51, 10.1586/eri.11.51]; Koopmans M, 2012, CLIN MICROBIOL INFEC, V18, P797, DOI 10.1111/j.1469-0691.2011.03701.x; O'Shea TJ, 2014, EMERG INFECT DIS, V20, P741, DOI 10.3201/eid2005.130539; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Ossa G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045729; Peel AJ, 2013, J VIROL METHODS, V193, P295, DOI 10.1016/j.jviromet.2013.06.030; Qi WB, 2014, PROTEIN CELL, V5, P878, DOI 10.1007/s13238-014-0084-6; Sonntag M, 2009, EMERG INFECT DIS, V15, P2052, DOI 10.3201/eid1512.090646; Tong SX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003657; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Zhou B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004420	25	29	31	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0127035	10.1371/journal.pone.0127035	http://dx.doi.org/10.1371/journal.pone.0127035			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965069	gold, Green Published, Green Submitted			2022-12-26	WOS:000354543500088
J	Wotodjo, AN; Trape, JF; Richard, V; Doucoure, S; Diagne, N; Tall, A; Ndiath, O; Faye, N; Gaudart, J; Rogier, C; Sokhna, C				Wotodjo, Amele N.; Trape, Jean-Francois; Richard, Vincent; Doucoure, Souleymane; Diagne, Nafissatou; Tall, Adama; Ndiath, Ousmane; Faye, Ngor; Gaudart, Jean; Rogier, Christophe; Sokhna, Cheikh			No Difference in the Incidence of Malaria in Human-Landing Mosquito Catch Collectors and Non-Collectors in a Senegalese Village with Endemic Malaria	PLOS ONE			English	Article							DAR-ES-SALAAM; SAMPLING METHODS; HOLOENDEMIC AREA; CLINICAL MALARIA; RICE IRRIGATION; WESTERN KENYA; RESTING BOXES; IMMUNITY; DIELMO; TRAP	Background The human landing catches is the gold standard method used to study the vectors of malaria and to estimate their aggressiveness. However, this method has raised safety concerns due to a possible increased risk of malaria or other mosquito-borne diseases among the mosquito collectors. The aim of this study was to evaluate the incidence of malaria attacks among mosquito collectors and to compare these results with those of non-collectors in a Senegalese village. Methods From July 1990 to December 2011, a longitudinal malaria study involving mosquito collectors and non-collectors was performed in Dielmo village, Senegal. During the study period, 4 drugs were successively used to treat clinical malaria, and long-lasting insecticide-treated nets were offered to all villagers in July 2008. No malaria chemoprophylaxis was given to mosquito collectors. Incidence of uncomplicated clinical malaria and asymptomatic malaria infection were analyzed among these two groups while controlling for confounding factors associated with malaria risk in random effects negative binomial and logistic regression models, respectively. Results A total of 3,812 person-trimester observations of 199 adults at least 15 years of age were analyzed. Clinical malaria attacks accounted for 6.3% both in collectors and non-collectors, and asymptomatic malaria infections accounted for 21% and 20% in collectors and non-collectors, respectively. A non-significant lower risk of malaria was observed in the collector group in comparison with the non-collector group after adjusting for other risk factors of malaria and endemicity level (Clinical malaria: adjusted incidence rate ratio = 0.89; 95% confidence interval = 0.65-1.22; p= 0.47). Conclusion Being a mosquito collector in Dielmo was not significantly associated with an increased risk of malaria both under holoendemic, mesoendemic and hypoendemic conditions of malaria epidemiology. This result supports the view that HLC, the most accurate method for evaluating malaria transmission, may be used without health concerns in Dielmo.	[Wotodjo, Amele N.; Doucoure, Souleymane; Diagne, Nafissatou; Sokhna, Cheikh] Aix Marseille Univ, INSERM 1095, Unite Rech Malad Infectieuses & Trop Emergenes, IRD,UMR 198,UM63,CNRS 7278, Dakar 18524, Senegal; [Trape, Jean-Francois] Inst Dev Res, Lab Paludol, Dakar, Senegal; [Richard, Vincent; Tall, Adama] Inst Pasteur, Unite Epidemiol, Dakar, Senegal; [Ndiath, Ousmane] Inst Pasteur, G4 Leader Grp, Inst Pasteur Int Network, Bangui, Cent Afr Republ; [Wotodjo, Amele N.; Faye, Ngor] Univ Cheikh Anta Diop Dakar, Fac Sci & Tech, Lab Parasitol, Dakar, Senegal; [Gaudart, Jean] Aix Marseille Univ, UMR 912, SESSTIM, INSERM IRD AMU, F-13005 Marseille, France; [Rogier, Christophe] Inst Pasteur Madagascar, Antananarivo, Madagascar; [Rogier, Christophe] Inst Rech Biomed Armees, Bretigny Sur Orge, France; [Rogier, Christophe] Aix Marseille Univ, Unite Rech Malad Infectieuses & Trop Mergentes, CNRS 7278, UM 63,IRD 198,INSERM 1095, F-1095 Marseille, France	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; University Cheikh Anta Diop Dakar; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Sokhna, C (corresponding author), Aix Marseille Univ, INSERM 1095, Unite Rech Malad Infectieuses & Trop Emergenes, IRD,UMR 198,UM63,CNRS 7278, Campus UCAD,BP 1386, Dakar 18524, Senegal.	cheikh.sokhna@ird.fr	wotodjo, Amélé Nyedzie/AAK-5188-2020; gaudart, jean/D-9071-2013; wotodjo, Amélé N/R-2408-2016	wotodjo, Amélé Nyedzie/0000-0001-6940-7325; gaudart, jean/0000-0001-9006-5729; wotodjo, Amélé N/0000-0001-6940-7325; Vincent, RICHARD/0000-0002-6961-1753	Institut Pasteur of Paris; Institut Pasteur of Dakar; Institut de Recherche pour le Developpement (IRD); Ministry of Cooperation; Ministry of Research (France); IRD-DPF; ADDRF	Institut Pasteur of Paris; Institut Pasteur of Dakar; Institut de Recherche pour le Developpement (IRD); Ministry of Cooperation; Ministry of Research (France)(Ministry of Research, France); IRD-DPF; ADDRF	The Dielmo project was funded by the Institut Pasteur of Paris, the Institut Pasteur of Dakar, the Institut de Recherche pour le Developpement (IRD, formerly ORSTOM) and received grants from the Ministry of Cooperation and the Ministry of Research (France). This publication was made possible through support provided by the IRD-DPF. ANW was partially supported by the ADDRF offered by the African Population and Health Research Center (APHRC) in partnership with the International Development Research Centre (IDRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JR, 1989, J AM MOSQUITO CONTR, V5, P325; Diop F, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-83; Gimnig JE, 2013, AM J TROP MED HYG, V88, P301, DOI 10.4269/ajtmh.2012.12-0209; Govella NJ, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-40; Kariuki SK, 2003, AM J TROP MED HYG, V68, P108, DOI 10.4269/ajtmh.2003.68.108; Kelly-Hope LA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-19; Kilama M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-111; Kweka EJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-149; LINDSAY SW, 1993, J MED ENTOMOL, V30, P368, DOI 10.1093/jmedent/30.2.368; Mathenge EM, 2002, MED VET ENTOMOL, V16, P67, DOI 10.1046/j.0269-283x.2002.00350.x; Mathenge EM, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-7; Mboera L E G, 2005, Tanzan Health Res Bull, V7, P117; Ndiath MO, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-270; Ndiath MO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097700; O'Meara WP, 2008, AM J TROP MED HYG, V79, P185, DOI 10.4269/ajtmh.2008.79.185; R Core Team, R LANG ENV STAT COMP; Rogier C, 1999, AM J TROP MED HYG, V60, P410, DOI 10.4269/ajtmh.1999.60.410; Roucher C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046188; SERVICE MW, 1977, B ENTOMOL RES, V67, P343, DOI 10.1017/S0007485300011184; Service MW, 1993, MOSQUITO ECOLOGY; Sikaala CH, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-91; Sikulu M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-197; Sougoufara S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-125; Trape JF, 2014, LANCET INFECT DIS, V14, P476, DOI 10.1016/S1473-3099(14)70712-1; TRAPE JF, 1994, AM J TROP MED HYG, V51, P123, DOI 10.4269/ajtmh.1994.51.123; Wong J, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-143; World Health Organization (WHO), 1975, WHO OFFS PUBL, V13	27	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0126187	10.1371/journal.pone.0126187	http://dx.doi.org/10.1371/journal.pone.0126187			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25966028	Green Published, Green Submitted, gold			2022-12-26	WOS:000354543500050
J	Crabbe, A; Liu, YL; Sarker, SF; Bonenfant, NR; Barrila, J; Borg, ZD; Lee, JJ; Weiss, DJ; Nickerson, CA				Crabbe, Aurelie; Liu, Yulong; Sarker, Shameema F.; Bonenfant, Nicholas R.; Barrila, Jennifer; Borg, Zachary D.; Lee, James J.; Weiss, Daniel J.; Nickerson, Cheryl A.			Recellularization of Decellularized Lung Scaffolds Is Enhanced by Dynamic Suspension Culture	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; HOST-PATHOGEN INTERACTIONS; ROTATING-WALL VESSEL; FLUID SHEAR-STRESS; BONE-MARROW; OSTEOGENIC DIFFERENTIATION; SIMULATED MICROGRAVITY; PULMONARY-FIBROSIS; RE-CELLULARIZATION; BIOREACTOR SYSTEM	Strategies are needed to improve repopulation of decellularized lung scaffolds with stromal and functional epithelial cells. We demonstrate that decellularized mouse lungs recellularized in a dynamic low fluid shear suspension bioreactor, termed the rotating wall vessel (RWV), contained more cells with decreased apoptosis, increased proliferation and enhanced levels of total RNA compared to static recellularization conditions. These results were observed with two relevant mouse cell types: bone marrow-derived mesenchymal stromal (stem) cells (MSCs) and alveolar type II cells (C10). In addition, MSCs cultured in decellularized lungs under static but not bioreactor conditions formed multilayered aggregates. Gene expression and immunohistochemical analyses suggested differentiation of MSCs into collagen I-producing fibroblast-like cells in the bioreactor, indicating enhanced potential for remodeling of the decellularized scaffold matrix. In conclusion, dynamic suspension culture is promising for enhancing repopulation of decellularized lungs, and could contribute to remodeling the extracellular matrix of the scaffolds with subsequent effects on differentiation and functionality of inoculated cells.	[Crabbe, Aurelie; Liu, Yulong; Sarker, Shameema F.; Barrila, Jennifer; Nickerson, Cheryl A.] Arizona State Univ, Ctr Infect Dis & Vaccinol, Biodesign Inst, Tempe, AZ 85281 USA; [Bonenfant, Nicholas R.; Borg, Zachary D.; Weiss, Daniel J.] Univ Vermont, Coll Med, Dept Med, Burlington, VT 05405 USA; [Lee, James J.] Mayo Clin Arizona, Dept Biochem & Mol Biol, Div Pulm Med, Scottsdale, AZ USA; [Nickerson, Cheryl A.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; University of Vermont; Mayo Clinic; Mayo Clinic Phoenix; Arizona State University; Arizona State University-Tempe	Nickerson, CA (corresponding author), Arizona State Univ, Ctr Infect Dis & Vaccinol, Biodesign Inst, Tempe, AZ 85281 USA.	cheryl.nickerson@asu.edu		Barrila, Jennifer/0000-0002-6597-3001; Crabbe, Aurelie/0000-0003-3084-4418; Liu, Yulong/0000-0003-0775-9258	National Institutes of Health [RC4HL106625]; NHLBI [R21HL108689, R21HL094611]; NIGMS COBRE [P30 GM103532]; National Aeronautics and Space Administration (NASA) [NNX10AO52G, NNX13AM01G]; Mayo Clinic-ASU Seed; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL108689, RC4HL106625, R21HL094611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103532] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS COBRE; National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); Mayo Clinic-ASU Seed; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institutes of Health (National Institutes of Health grants RC4HL106625 [DJW and CAN], NHLBI R21HL108689 [DJW], NHLBI R21HL094611 [DJW], NIGMS COBRE P30 GM103532 [C Irvin PI]), the National Aeronautics and Space Administration (NASA grants NNX10AO52G [CAN] and NNX13AM01G [CAN]) and by a Mayo Clinic-ASU Seed grant (AC, CAN, JJL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya PS, 2006, HUM PATHOL, V37, P352, DOI 10.1016/j.humpath.2005.11.020; Adamo L, 2011, ANTIOXID REDOX SIGN, V15, P1463, DOI 10.1089/ars.2011.3907; Barrila J, 2010, NAT REV MICROBIOL, V8, P791, DOI 10.1038/nrmicro2423; Bonenfant NR, 2013, BIOMATERIALS, V34, P3231, DOI 10.1016/j.biomaterials.2013.01.031; Bonvillain RW, 2012, TISSUE ENG A; Carterson AJ, 2005, INFECT IMMUN, V73, P1129, DOI 10.1128/IAI.73.2.1129-1140.2005; Chang J, 2013, P NATL ACAD SCI USA, V110, P9469, DOI 10.1073/pnas.1300532110; Colter DC, 2000, P NATL ACAD SCI USA, V97, P3213, DOI 10.1073/pnas.070034097; Cortiella J, 2010, TISSUE ENG PT A, V16, P2565, DOI 10.1089/ten.tea.2009.0730; Covas DT, 2008, EXP HEMATOL, V36, P642, DOI 10.1016/j.exphem.2007.12.015; Crabbe A, 2011, CELL MICROBIOL, V13, P469, DOI 10.1111/j.1462-5822.2010.01548.x; Cuiffo BG, 2012, CELL ADHES MIGR, V6, P220, DOI 10.4161/cam.20875; Daly AB, 2012, TISSUE ENG PT A, V18, P1, DOI [10.1089/ten.tea.2011.0301, 10.1089/ten.TEA.2011.0301]; David J, 2014, MICROBES INFECT, V16, P735, DOI 10.1016/j.micinf.2014.04.001; Delaine-Smith RM, 2012, EUR CELLS MATER, V24, P162, DOI 10.22203/eCM.v024a12; Fink T, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-98; Frith JE, 2010, TISSUE ENG PART C-ME, V16, P735, DOI 10.1089/ten.TEC.2009.0432; Gao H, 1997, MICROGRAVITY SCI TEC, V10, P154; Ghaedi M, 2013, BIOMATERIALS; Ghaedi M, 2013, J CLIN INVEST; Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393; Girard ED, 2013, BIOMATERIALS, V34, P10043, DOI 10.1016/j.biomaterials.2013.09.055; Gupta SK, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/651945; Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107; Kuroda Y, 2010, P NATL ACAD SCI USA, V107, P8639, DOI 10.1073/pnas.0911647107; Lawson WE, 2005, AM J RESP CRIT CARE, V171, P899, DOI 10.1164/rccm.200311-1535OC; Lecht S, 2014, BIOMATERIALS; Lelkes PI, 1997, IN VITRO CELL DEV-AN, V33, P344; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malkinson AM, 1997, TOXICOLOGY, V123, P53, DOI 10.1016/S0300-483X(97)00108-X; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Mendez JJ, 2014, TISSUE ENG PT A, V20, P1735, DOI [10.1089/ten.tea.2013.0647, 10.1089/ten.TEA.2013.0647]; Nauman EA, 2007, APPL ENVIRON MICROB, V73, P699, DOI 10.1128/AEM.02428-06; Nichols JE, 2013, TISSUE ENG PT A, V19, P2045, DOI [10.1089/ten.tea.2012.0250, 10.1089/ten.TEA.2012.0250]; Orens Jonathan B, 2009, Proc Am Thorac Soc, V6, P13, DOI 10.1513/pats.200807-072GO; Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Petersen TH, 2012, CELLS TISSUES ORGANS, V195, P222, DOI 10.1159/000324896; Price AP, 2010, TISSUE ENG PT A, V16, P2581, DOI [10.1089/ten.tea.2009.0659, 10.1089/ten.TEA.2009.0659]; Rock JR, 2011, ANNU REV CELL DEV BI, V27, P493, DOI 10.1146/annurev-cellbio-100109-104040; Samuelson L, 2013, TISSUE ENG PART C-ME, V19, DOI 10.1089/ten.tec.2012.0236; Seo CH, 2011, BIOMATERIALS, V32, P9568, DOI 10.1016/j.biomaterials.2011.08.077; Sheyn D, 2010, TISSUE ENG PT A, V16, P3403, DOI 10.1089/ten.tea.2009.0834; Shieh AC, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015012; Sikavitsas VI, 2003, P NATL ACAD SCI USA, V100, P14683, DOI 10.1073/pnas.2434367100; Siti-Ismail N, 2012, TISSUE ENG PART C-ME, V18, P263, DOI [10.1089/ten.TEC.2011.0299, 10.1089/ten.tec.2011.0299]; Sokocevic D, 2013, BIOMATERIALS, V34, P3256, DOI 10.1016/j.biomaterials.2013.01.028; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Sueblinvong V, 2008, AM J RESP CRIT CARE, V177, P701, DOI 10.1164/rccm.200706-859OC; Takahashi F, 2001, AM J RESP CELL MOL, V24, P264, DOI 10.1165/ajrcmb.24.3.4293; TSAO YMD, 1994, J SPACECRAFT ROCKETS, V31, P937, DOI 10.2514/3.26541; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veazey KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027592; Vertrees RA, 2008, CANCER BIOL THER, V7, P405, DOI 10.4161/cbt.7.3.5368; Wagner DE, 2014, BIOMATERIALS, V35, P3281, DOI 10.1016/j.biomaterials.2013.12.103; Wagner DE, 2013, RESPIROLOGY, V18, P895, DOI 10.1111/resp.12102; Wagner DE, 2014, BIOMATERIALS; Wakao S, 2011, P NATL ACAD SCI USA, V108, P9875, DOI 10.1073/pnas.1100816108; Wallis JM, 2012, TISSUE ENG PART C-ME, V18, P420, DOI [10.1089/ten.tec.2011.0567, 10.1089/ten.TEC.2011.0567]; Warstat K, 2010, STEM CELLS DEV, V19, P645, DOI 10.1089/scd.2009.0208; Wong AP, 2009, J CLIN INVEST, V119, P336, DOI 10.1172/JCI36882; Zhang D, 2013, BIOMATERIALS, V34, P3962, DOI 10.1016/j.biomaterials.2013.02.029	63	37	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126846	10.1371/journal.pone.0126846	http://dx.doi.org/10.1371/journal.pone.0126846			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962111	gold, Green Submitted, Green Published			2022-12-26	WOS:000354542500154
J	Csanadi, A; Kayser, C; Donauer, M; Gumpp, V; Aumann, K; Rawluk, J; Prasse, A; Hausen, AZ; Wiesemann, S; Werner, M; Kayser, G				Csanadi, Agnes; Kayser, Claudia; Donauer, Marcel; Gumpp, Vera; Aumann, Konrad; Rawluk, Justyna; Prasse, Antje; Hausen, Axel zur; Wiesemann, Sebastian; Werner, Martin; Kayser, Gian			Prognostic Value of Malic Enzyme and ATP-Citrate Lyase in Non-Small Cell Lung Cancer of the Young and the Elderly	PLOS ONE			English	Article							DRIVER MUTATIONS; METABOLISM; DEHYDROGENASE; EXPRESSION; LACTATE; INHIBITION; PROTEIN; GROWTH	Background Lung cancer is the leading cause of death among malignancies worldwide. Understanding its biology is therefore of pivotal importance to improve patient's prognosis. In contrast to non-neoplastic tissues, cancer cells utilize glucose mainly for production of basic cellular modules '(i.e. nucleotides, aminoacids, fatty acids). In cancer, Malic enzyme (ME) and ATP-citrate lyase (ACLY) are key enzymes linking aerobic glycolysis and fatty acid synthesis and may therefore be of biological and prognostic significance in non-small cell lung cancer (NSCLC). Material and Methods ME and ACLY expression was analyzed in 258 NSCLC in correlation with clinico-pathological parameters including patient's survival. Results Though, overall expression of both enzymes correlated positively, ACLY was associated with local tumor stage, whereas ME correlated with occurrence of mediastinal lymph node metastases. Young patients overexpressing ACLY and/or ME had a significantly longer overall survival. This proved to be an independent prognostic factor. This contrasts older NSCLC patients, in whom overexpression of ACLY and/or ME appears to predict the opposite. Conclusion In NSCLC, ME and ACLY show different enzyme expressions relating to local and mediastinal spread. Most important, we detected an inverse prognostic impact of ACLY and/or ME overexpression in young and elderly patients. It can therefore be expected, that treatment of NSCLC especially, if targeting metabolic pathways, requires different strategies in different age groups.	[Csanadi, Agnes; Kayser, Claudia; Donauer, Marcel; Aumann, Konrad; Werner, Martin; Kayser, Gian] Univ Med Ctr Freiburg, Inst Surg Pathol, Dept Pathol, D-79106 Freiburg, Germany; [Gumpp, Vera] Univ Med Ctr Freiburg, Comprehens Canc Ctr Freiburg, Clin Canc Registry, D-79106 Freiburg, Germany; [Rawluk, Justyna] Univ Med Ctr Freiburg, Dept Hematol & Oncol, D-79106 Freiburg, Germany; [Prasse, Antje] Hannover Med Sch, Dept Pneumonol, D-30625 Hannover, Germany; [Hausen, Axel zur] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Dept Pathol, NL-6200 MD Maastricht, Netherlands; [Wiesemann, Sebastian] Univ Med Ctr Freiburg, Dept Thorac Surg, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; Hannover Medical School; Maastricht University; University of Freiburg	Kayser, G (corresponding author), Univ Med Ctr Freiburg, Inst Surg Pathol, Dept Pathol, Breisacher Str 115a, D-79106 Freiburg, Germany.	gian.kayser@uniklinik-freiburg.de	Aumann, Konrad/GSN-1821-2022; Prasse, Antje/AAY-6279-2020; Prasse, Antje/AAM-7521-2021	Aumann, Konrad/0000-0001-8178-1571; Prasse, Antje/0000-0002-7336-7458	Deutsche Forschungsgemeinschaft [SFB850]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors acknowledge the support of this study by the Deutsche Forschungsgemeinschaft SFB850. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer DE, 2005, ONCOGENE, V24, P6314, DOI 10.1038/sj.onc.1208773; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Butler CA, 2006, RESP MED, V100, P1642, DOI 10.1016/j.rmed.2005.12.006; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Gentile TL, 2013, MOL CELL BIOL, V33, P3864, DOI 10.1128/MCB.01495-12; Guay C, 2007, J BIOL CHEM, V282, P35657, DOI 10.1074/jbc.M707294200; HALLIDAY KR, 1988, MAGN RESON MED, V7, P384, DOI 10.1002/mrm.1910070403; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hirschhaeuser F, 2011, CANCER RES, V71, P6921, DOI 10.1158/0008-5472.CAN-11-1457; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang P, 2013, NATURE, V493, P689, DOI 10.1038/nature11776; Kajuter H, 2014, BUNDESGESUNDHEITSBLA, V57, P52, DOI 10.1007/s00103-013-1880-5; Kayser G, 2011, PATHOLOGY, V43, P719, DOI 10.1097/PAT.0b013e32834c352b; Kayser G, 2010, DIAGN PATHOL, V5, DOI 10.1186/1746-1596-5-22; Koukourakis MI, 2005, NEOPLASIA, V7, P1, DOI 10.1593/neo.04373; Koukourakis MI, 2003, TUMOR BIOL, V24, P199, DOI 10.1159/000074430; Koukourakis MI, 2007, CANCER BIOL THER, V6, P1476, DOI 10.4161/cbt.6.9.4635; Meijer TWH, 2012, LUNG CANCER, V76, P316, DOI 10.1016/j.lungcan.2011.11.006; Migita T, 2008, CANCER RES, V68, P8547, DOI 10.1158/0008-5472.CAN-08-1235; Migita T, 2014, INT J CANCER, V135, P37, DOI 10.1002/ijc.28652; Migita T, 2013, AM J PATHOL, V182, P1800, DOI 10.1016/j.ajpath.2013.01.048; Mogi A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/583929; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Ruschoff J, 2012, MODERN PATHOL, V25, P637, DOI 10.1038/modpathol.2011.198; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Sobin L.H., 2009, INT UNION CANC UICC, V7th; Travis W, 2004, TUMOURS LUNG PLEURA; Turyn J, 2003, HORM METAB RES, V35, P565, DOI 10.1055/s-2003-43500; Varis A, 2002, CANCER RES, V62, P2625; Walenta S, 2004, SEMIN RADIAT ONCOL, V14, P267, DOI 10.1016/j.semradonc.2004.04.004; Warburg O, 1924, BIOCHEM Z, V152, P309; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Yancy Haile F, 2007, J Carcinog, V6, P8; Zhou JX, 2013, ANN ONCOL, V24, P1319, DOI 10.1093/annonc/mds626	38	25	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126357	10.1371/journal.pone.0126357	http://dx.doi.org/10.1371/journal.pone.0126357			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962060	Green Published, gold, Green Submitted			2022-12-26	WOS:000354542500091
J	Fang, YF; Liang, X; Jiang, WB; Li, JB; Xu, JF; Cai, XJ				Fang, Yifeng; Liang, Xiao; Jiang, Wenbin; Li, Jianbo; Xu, Junfen; Cai, Xiujun			Cyclin B1 Suppresses Colorectal Cancer Invasion and Metastasis by Regulating E-Cadherin	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; PROGNOSTIC-SIGNIFICANCE; MESENCHYMAL TRANSITIONS; PROTEIN EXPRESSION; BREAST-CANCER; TUMOR-GROWTH; OVEREXPRESSION; SNAIL; PROLIFERATION; STATISTICS	Cyclin B1, a mitotic cyclin, has been implicated in malignances. However, its contribution to colorectal cancer invasion and metastasis are still not well understood. Here, we demonstrated that the invasion and metastasis of colorectal cancer is regulated by Cyclin B1. Overexpression of Cyclin B1 was observed in colorectal cancer tissues, but this elevated expression was negatively associated with lymph node metastasis, distant metastasis stage, and TNM stage. The Kaplan-Meier survival analysis proved that low Cyclin B1 expression was associated with poor overall survival of patients with colorectal cancer. Inhibition of Cyclin B1 in colorectal cancer cells enhanced the cell migration and invasion of three different colorectal cancer cell lines. In studying the possible mechanism by which Cyclin B1 suppresses colorectal cancer invasion and metastasis, we observed that suppression of Cyclin B1 decreased the expression of E-cadherin protein level. Our findings suggest that Cyclin B1 could suppress the invasion and metastasis of colorectal cancer cells through regulating E-cadherin expression, which enables the development of potential intervention strategies for colorectal cancer.	[Fang, Yifeng; Liang, Xiao; Jiang, Wenbin; Li, Jianbo; Cai, Xiujun] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Gen Surg 2, Hangzhou 310016, Zhejiang, Peoples R China; [Xu, Junfen] Zhejiang Univ, Womens Hosp, Sch Med, Dept Gynecol Oncol, Hangzhou 310006, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Cai, XJ (corresponding author), Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Gen Surg 2, Hangzhou 310016, Zhejiang, Peoples R China.	cxjzu@zju.edu.cn			International Scientific and Technological Cooperation Projects of China [2012DFA30410]; National Science-technology Support Plan Projects of China [2012BAI14B06]	International Scientific and Technological Cooperation Projects of China; National Science-technology Support Plan Projects of China	This work was supported by the International Scientific and Technological Cooperation Projects of China (http://www.istcp.org.cn/) (Grant No. 2012DFA30410 to Xiujun Cai), and the National Science-technology Support Plan Projects of China (http://www.most.gov.cn/) (Grant No. 2012BAI14B06 to Xiujun Cai).	Aaltonen K, 2009, BRIT J CANCER, V100, P1055, DOI 10.1038/sj.bjc.6604874; Arias AM, 2001, CELL, V105, P425, DOI 10.1016/S0092-8674(01)00365-8; Arinaga M, 2003, ONCOL REP, V10, P1381; Begnami MD, 2010, HUM PATHOL, V41, P1120, DOI 10.1016/j.humpath.2010.01.007; Bjorck E, 2005, BLOOD, V105, P2908, DOI 10.1182/blood-2004-07-2721; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Bonnet ME, 2013, J CONTROL RELEASE, V170, P183, DOI 10.1016/j.jconrel.2013.05.015; Brabletz T, 2005, CELLS TISSUES ORGANS, V179, P56, DOI 10.1159/000084509; Chae SW, 2011, YONSEI MED J, V52, P445, DOI 10.3349/ymj.2011.52.3.445; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; David JM, 2012, CANCER RES, V72, P2917, DOI 10.1158/0008-5472.CAN-11-3498; Fang YF, 2014, CANCER BIOL THER, V15, P1268, DOI 10.4161/cbt.29691; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Grabsch H, 2004, AM J CLIN PATHOL, V122, P511, DOI 10.1309/54H4Q88A1UBBWPTE; Guaita S, 2002, J BIOL CHEM, V277, P39209, DOI 10.1074/jbc.M206400200; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070858; Hiscox S, 1997, ANTICANCER RES, V17, P1349; Hur K, 2013, GUT, V62, P1315, DOI 10.1136/gutjnl-2011-301846; Kanthan, 2012, PATHOLOG RES INT, V2012, DOI [10.1155/2012/597497, DOI 10.1155/2012/597497]; Kedinger V, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-338; Kwak JM, 2007, DIS COLON RECTUM, V50, P1873, DOI 10.1007/s10350-007-9034-1; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Li JQ, 2003, INT J ONCOL, V22, P1101; Lin T, 2010, ONCOGENE, V29, P4896, DOI 10.1038/onc.2010.234; Mani SA, 2007, P NATL ACAD SCI USA, V104, P10069, DOI 10.1073/pnas.0703900104; Mashal RD, 1996, CANCER RES, V56, P4159; Matthess Y, 2010, MOL CELL BIOL, V30, P5726, DOI 10.1128/MCB.00731-10; Murakami H, 1999, VIRCHOWS ARCH, V434, P153, DOI 10.1007/s004280050319; Murthy SRK, 2013, CANCER LETT, V341, P204, DOI 10.1016/j.canlet.2013.08.011; Nasulewicz A, 2004, BBA-MOL BASIS DIS, V1739, P26, DOI 10.1016/j.bbadis.2004.08.003; Nimeus-Malmstrom E, 2010, INT J CANCER, V127, P961, DOI 10.1002/ijc.25091; Nozoe T, 2002, CLIN CANCER RES, V8, P817; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Rosivatz E, 2004, INT J CANCER, V111, P711, DOI 10.1002/ijc.20317; Sengupta N, 2008, PATHOL RES PRACT, V204, P469, DOI 10.1016/j.prp.2008.03.003; Shin JU, 2012, TUMOR BIOL, V33, P1645, DOI 10.1007/s13277-012-0420-5; Shiozaki H, 1996, CANCER, V77, P1605, DOI 10.1002/(SICI)1097-0142(19960415)77:8+<1605::AID-CNCR4>3.3.CO;2-R; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Song YM, 2008, CARCINOGENESIS, V29, P307, DOI 10.1093/carcin/bgm269; Soria JC, 2000, CANCER RES, V60, P4000; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tsanou E, 2008, ANTICANCER RES, V28, P3815; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Vesuna F, 2008, BIOCHEM BIOPH RES CO, V367, P235, DOI 10.1016/j.bbrc.2007.11.151; Weng L, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-39; Wu WJ, 2009, NAT REV CANCER, V9, P145, DOI 10.1038/nrc2521-c1	49	38	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126875	10.1371/journal.pone.0126875	http://dx.doi.org/10.1371/journal.pone.0126875			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962181	gold, Green Published, Green Submitted			2022-12-26	WOS:000354542500156
J	Kumar, M; Dahiya, S; Sharma, P; Sharma, S; Singh, TP; Kapil, A; Kaur, P				Kumar, Manoj; Dahiya, Sushila; Sharma, Priyanka; Sharma, Sujata; Singh, Tej P.; Kapil, Arti; Kaur, Punit			Structure Based In Silico Analysis of Quinolone Resistance in Clinical Isolates of Salmonella Typhi from India	PLOS ONE			English	Article							GYRA GENE; TOPOISOMERASE-IV; DECREASED SUSCEPTIBILITIES; CIPROFLOXACIN RESISTANCE; MOLECULAR-DYNAMICS; ESCHERICHIA-COLI; DNA GYRASE; MUTATIONS; MECHANISMS; MINIMIZATION	Enteric fever is a major cause of morbidity in several parts of the Indian subcontinent. The treatment for typhoid fever majorly includes the fluoroquinolone group of antibiotics. Excessive and indiscriminate use of these antibiotics has led to development of acquired resistance in the causative organism Salmonella Typhi. The resistance towards fluoroquinolones is associated with mutations in the target gene of DNA Gyrase. We have estimated the Minimum Inhibitory Concentration (MIC) of commonly used fluoroquinolone representatives from three generations, ciprofloxacin, ofloxacin, levofloxacin and moxifloxacin, for 100 clinical isolates of Salmonella Typhi from patients in the Indian subcontinent. The MICs have been found to be in the range of 0.032 to 8 mu g/ml. The gene encoding DNA Gyrase was subsequently sequenced and point mutations were observed in DNA Gyrase in the quinolone resistance determining region comprising Ser83Phe/Tyr and Asp87Tyr/Gly. The binding ability of these four fluoroquinolones in the quinolone binding pocket of wild type as well as mutant DNA Gyrase was computationally analyzed by molecular docking to assess their differential binding behaviour. This study has revealed that mutations in DNA Gyrase alter the characteristics of the binding pocket resulting in the loss of crucial molecular interactions and consequently decrease the binding affinity of fluoroquinolones with the target protein. The present study assists in understanding the underlying molecular and structural mechanism for decreased fluoroquinolone susceptibility in clinical isolates as a consequence of mutations in DNA Gyrase.	[Kumar, Manoj; Sharma, Sujata; Singh, Tej P.; Kaur, Punit] All India Inst Med Sci, Dept Biophys, New Delhi 110029, India; [Dahiya, Sushila; Sharma, Priyanka; Kapil, Arti] All India Inst Med Sci, Dept Microbiol, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Kaur, P (corresponding author), All India Inst Med Sci, Dept Biophys, New Delhi 110029, India.	punitkaur1@hotmail.com	Dahiya, Sushila/GOG-9170-2022; KUMAR, MANOJ/HHC-0782-2022	Sharma, priyanka/0000-0002-8853-1126	 [BIC/12(04)/2013]		This work was supported by Grant No BIC/12(04)/2013 (http://icmr.nic.in/projects/projectsanc2002-2007march.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya D, 2012, JPN J INFECT DIS, V65, P264, DOI 10.7883/yoken.65.264; Aldred KJ, 2013, NUCLEIC ACIDS RES, V41, P4628, DOI 10.1093/nar/gkt124; Aldred KJ, 2012, BIOCHEMISTRY-US, V51, P370, DOI 10.1021/bi2013905; Andriole VT, 2005, CLIN INFECT DIS, V41, pS113, DOI 10.1086/428051; [Anonymous], 2007, DISC STUD 2 0 MOL MO; Ayana N, 2008, RES J MICROBIOL, V3, P654; Banks JL, 2005, J COMPUT CHEM, V26, P1752, DOI 10.1002/jcc.20292; Bast DJ, 2004, J ANTIMICROB CHEMOTH, V54, P90, DOI 10.1093/jac/dkh294; Bax BD, 2010, NATURE, V466, P935, DOI 10.1038/nature09197; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bowers K.J., 2006, SC 06 P 2006 ACM IEE; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brown JC, 1996, J ANTIMICROB CHEMOTH, V37, P351, DOI 10.1093/jac/37.2.351; Cabral JHM, 1997, NATURE, V388, P903, DOI 10.1038/42294; Chang WL, 2012, HELICOBACTER, V17, P210, DOI 10.1111/j.1523-5378.2012.00935.x; Cheng AFB, 2004, ANTIMICROB AGENTS CH, V48, P596, DOI 10.1128/AAC.48.2.596-601.2004; Clinical and Laboratory Standards Institute (CLSI), 2013, 422M100S23 CLSI; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Drlica K, 1997, MICROBIOL MOL BIOL R, V61, P377, DOI 10.1128/.61.3.377-392.1997; Drlica K, 2009, CURR TOP MED CHEM, V9, P981, DOI 10.2174/156802609789630947; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; FLETCHER R, 1964, COMPUT J, V7, P149, DOI 10.1093/comjnl/7.2.149; GELLERT M, 1976, P NATL ACAD SCI USA, V73, P3872, DOI 10.1073/pnas.73.11.3872; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hooper DC, 2000, CLIN INFECT DIS, V31, pS24, DOI 10.1086/314056; Hooper DC, 1999, DRUG RESIST UPDATE, V2, P38, DOI 10.1054/drup.1998.0068; Jones ME, 2000, ANTIMICROB AGENTS CH, V44, P462, DOI 10.1128/AAC.44.2.462-466.2000; Kapil A, 1994, Indian J Pathol Microbiol, V37, P179; Khodursky AB, 1998, J BIOL CHEM, V273, P27668, DOI 10.1074/jbc.273.42.27668; Laponogov I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011338; Laponogov I, 2009, NAT STRUCT MOL BIOL, V16, P667, DOI 10.1038/nsmb.1604; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Ling JM, 2003, ANTIMICROB AGENTS CH, V47, P3567, DOI 10.1128/AAC.47.11.3567-3573.2003; MARTYNA GJ, 1992, J CHEM PHYS, V97, P2635, DOI 10.1063/1.463940; Mitscher LA, 2005, CHEM REV, V105, P559, DOI 10.1021/cr030101q; Mohanty S, 2006, EPIDEMIOL INFECT, V134, P961, DOI 10.1017/S0950268805005844; MOMANY FA, 1992, J COMPUT CHEM, V13, P888, DOI 10.1002/jcc.540130714; Morgan-Linnell SK, 2009, ANTIMICROB AGENTS CH, V53, P235, DOI 10.1128/AAC.00665-08; Nicholas JC, 1997, GENEDOC ANAL VISUALI; Price LB, 2003, ANTIMICROB AGENTS CH, V47, P2362, DOI 10.1128/AAC.47.7.2362-2365.2003; Renuka K, 2004, MICROB DRUG RESIST, V10, P146, DOI 10.1089/1076629041310028; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schedletzky H, 1999, J ANTIMICROB CHEMOTH, V43, P31, DOI 10.1093/jac/43.suppl_2.31; Schmitz FJ, 1999, FEMS IMMUNOL MED MIC, V26, P281, DOI 10.1111/j.1574-695X.1999.tb01400.x; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Sharma V, 2013, INDIAN J MED MICROBI, V31, P374, DOI 10.4103/0255-0857.118898; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Spassov VZ, 2007, PROTEIN SCI, V16, P494, DOI 10.1110/ps.062447107; Sun Y, 2011, PLOS ONE, V8, DOI [10.1371/ journal. pone. 0023471, DOI 10.1371/J0URNAL.P0NE.0023471]; Tatavarthy A, 2012, J CLIN MICROBIOL, V50, P2631, DOI 10.1128/JCM.00593-12; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Venkatachalam CM, 2003, J MOL GRAPH MODEL, V21, P289, DOI 10.1016/S1093-3263(02)00164-X; VILA J, 1995, ANTIMICROB AGENTS CH, V39, P1201, DOI 10.1128/AAC.39.5.1201; Vlieghe ER, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001933; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Wohlkonig A, 2010, NAT STRUCT MOL BIOL, V17, P1152, DOI 10.1038/nsmb.1892; YOSHIDA H, 1988, MOL GEN GENET, V211, P1, DOI 10.1007/BF00338386; YOSHIDA H, 1990, ANTIMICROB AGENTS CH, V34, P1271, DOI 10.1128/AAC.34.6.1271	61	21	22	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126560	10.1371/journal.pone.0126560	http://dx.doi.org/10.1371/journal.pone.0126560			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962113	Green Published, Green Submitted, gold			2022-12-26	WOS:000354542500112
J	Liu, F; Hu, JJ; Xia, WJ; Hao, LL; Ma, J; Ma, D; Ma, ZX				Liu, Fei; Hu, Jiongjiong; Xia, Wenjun; Hao, Lili; Ma, Jing; Ma, Duan; Ma, Zhaoxin			Exome Sequencing Identifies a Mutation in EYA4 as a Novel Cause of Autosomal Dominant Non-Syndromic Hearing Loss	PLOS ONE			English	Article							DROSOPHILA-EYES-ABSENT; HUMAN HOMOLOG; DFNA10 LOCUS; FAMILY; PHOSPHATASES; COOPERATION; IMPAIRMENT; GENES; SIX1	Autosomal dominant non-syndromic hearing loss is highly heterogeneous, and eyes absent 4 (EYA4) is a disease-causing gene. Most EYA4 mutations founded in the Eya-homologous region, however, no deafness causative missense mutation in variable region of EYA4 have previously been found. In this study, we identified a pathogenic missense mutation located in the variable region of the EYA4 gene for the first time in a four-generation Chinese family with 57 members. Whole-exome sequencing (WES) was performed on samples from one unaffected and two affected individuals to systematically search for deafness susceptibility genes, and the candidate mutations and the co-segregation of the phenotype were verified by polymerase chain reaction amplification and by Sanger sequencing in all of the family members. Then, we identified a novel EYA4 mutation in exon 8, c.511G>C; p.G171R, which segregated with postlingual and progressive autosomal dominant sensorineural hearing loss (SNHL). This report is the first to describe a missense mutation in the variable region domain of the EYA4 gene, which is not highly conserved in many species, indicating that the potential unconserved role of 171G>R in human EYA4 function is extremely important.	[Liu, Fei; Ma, Jing; Ma, Duan] Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Dept Biochem & Mol Biol,Key Lab Metab & Mol Med,M, Shanghai 200433, Peoples R China; [Hu, Jiongjiong; Ma, Zhaoxin] Tongji Univ, Shanghai East Hosp, Dept Otorhinolaryngol, Shanghai 200092, Peoples R China; [Xia, Wenjun; Hao, Lili; Ma, Duan] Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Tongji University; Fudan University	Ma, D (corresponding author), Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Dept Biochem & Mol Biol,Key Lab Metab & Mol Med,M, Shanghai 200433, Peoples R China.	duanma@fudan.edu.cn; mzhx114@163.com	Ma, Duan/I-8330-2014		East Raising Sun Talents Program of Shanghai East Hospital, Tongji University [2013DFYY-2]; Foundation for Development of Science and Technology, Pudong new district, Shanghai [2013 PKJ2013-Y18]; National Basic Research Program of China [2011CB504502]; Basic Key Program of Shanghai Scientific and Technology Committee [14DJ1400103]; Program of Shanghai Municipal Commission of Health and Family Planning [2013ZYJB0015]	East Raising Sun Talents Program of Shanghai East Hospital, Tongji University; Foundation for Development of Science and Technology, Pudong new district, Shanghai; National Basic Research Program of China(National Basic Research Program of China); Basic Key Program of Shanghai Scientific and Technology Committee; Program of Shanghai Municipal Commission of Health and Family Planning	This study was supported by the East Raising Sun Talents Program of Shanghai East Hospital, Tongji University (2013DFYY-2), the Foundation for Development of Science and Technology, Pudong new district, Shanghai (2013 PKJ2013-Y18), National Basic Research Program of China (2011CB504502), Basic Key Program of Shanghai Scientific and Technology Committee (14DJ1400103) and Program of Shanghai Municipal Commission of Health and Family Planning (2013ZYJB0015).	Abdelhak S, 1997, NAT GENET, V15, P157, DOI 10.1038/ng0297-157; Ahmed M, 2012, DEVELOPMENT, V139, P1965, DOI 10.1242/dev.071670; Armengot M, 2010, AM J RHINOL ALLERGY, V24, P175, DOI 10.2500/ajra.2010.24.3448; Azuma N, 2000, HUM MOL GENET, V9, P363, DOI 10.1093/hmg/9.3.363; Baek JI, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-60; Borsani G, 1999, HUM MOL GENET, V8, P11, DOI 10.1093/hmg/8.1.11; CHARBONNEAU H, 1992, ANNU REV CELL BIOL, V8, P463, DOI 10.1146/annurev.cellbio.8.1.463; Depreux FFS, 2008, J CLIN INVEST, V118, P651, DOI 10.1172/JCI32899; Desplan C, 1997, CELL, V91, P861, DOI 10.1016/S0092-8674(00)80475-4; Heanue TA, 1999, GENE DEV, V13, P3231, DOI 10.1101/gad.13.24.3231; Hildebrand MS, 2007, AM J MED GENET A, V143A, P1599, DOI 10.1002/ajmg.a.31860; Makishima T, 2007, AM J MED GENET A, V143A, P1592, DOI 10.1002/ajmg.a.31793; Mehra S, 2009, OTOLARYNG HEAD NECK, V140, P461, DOI 10.1016/j.otohns.2008.12.022; O'Donoghue G, 2013, NEW ENGL J MED, V369, P1190, DOI 10.1056/NEJMp1310111; Ohto H, 1999, MOL CELL BIOL, V19, P6815; Pfister M, 2002, MOL MED, V8, P607, DOI 10.1007/BF03402171; Rayapureddi JP, 2003, NATURE, V426, P295, DOI 10.1038/nature02093; Schonberger J, 2005, NAT GENET, V37, P418, DOI 10.1038/ng1527; Tan MX, 2014, INT J MOL MED, V34, P1467, DOI 10.3892/ijmm.2014.1939; Verstreken M, 2000, AM J OTOL, V21, P675; Wang LB, 2008, DEVELOPMENT, V135, P3425, DOI 10.1242/dev.012237; Wayne S, 2001, HUM MOL GENET, V10, P195, DOI 10.1093/hmg/10.3.195; Xu PX, 1997, DEVELOPMENT, V124, P219; Xu PX, 2002, DEVELOPMENT, V129, P3033	24	16	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126602	10.1371/journal.pone.0126602	http://dx.doi.org/10.1371/journal.pone.0126602			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961296	Green Submitted, Green Published, gold			2022-12-26	WOS:000354542500122
J	Ng, L; Wan, TMH; Lam, CSC; Chow, AKM; Wong, SKM; Man, JHW; Li, HS; Cheng, NSM; Pak, RCH; Cheung, AHK; Yau, TCC; Lo, OSH; Foo, DCC; Poon, JTC; Poon, RTP; Pang, RWC; Law, WL				Ng, Lui; Wan, Timothy Ming-Hun; Lam, Colin Siu-Chi; Chow, Ariel Ka-Man; Wong, Sunny Kit-Man; Man, Johnny Hon-Wai; Li, Hung-Sing; Cheng, Nathan Shiu-Man; Pak, Ryan Chung-Hei; Cheung, Alvin Ho-Kwan; Yau, Thomas Chung-Cheung; Lo, Oswens Siu-Hung; Foo, Dominic Chi-Chung; Poon, Jensen Tung-Chung; Poon, Ronnie Tung-Ping; Pang, Roberta Wen-Chi; Law, Wai-Lun			Post-Operative Plasma Osteopontin Predicts Distant Metastasis in Human Colorectal Cancer	PLOS ONE			English	Article							CELL LUNG-CANCER; NEOPLASTIC TRANSFORMATION; BREAST-CANCER; COLON-CANCER; CARCINOMA; SURVIVAL; PROGRESSION; EXPRESSION; MARKERS; ACTIVATION	Background The overall prognosis of colorectal cancer (CRC) patients is unsatisfactory due to cancer metastasis after operation. This study aims to investigate the clinical significance of plasma osteopontin (OPN) levels as minimally invasive, predictive, and surrogate biomarkers for prognosis of CRC patients. Methods This randomized study design consists of pre-operative and post-operative plasma samples from a total of 79 patients. We determined plasma levels of OPN by ELISA and examined their correlation with the clinicopathological parameters of CRC patients. The effects of endogenous and exogenous OPN on CRC metastasis were investigated by examination of the effect on regulators of epithelial to messenchymal transition and migration assay. Results Our findings demonstrated for the first time the clinical correlation of plasma OPN with metastasis of CRC patients. High post-operative plasma OPN level (>153.02 ng/ml) associated with development of metastasis after curative resection (p<0.001). Moreover, postoperative plasma OPN level correlated with disease-free survival of CRC patients (p=0.009) and was an independent factor for predicting development of metastasis in CRC patients after curative resection (p=0.036). Our in vitro model showed that OPN ectopic expression induced DLD1 cell migration through Snail and Twist1 overexpression and E-cadherin repression, and secretory OPN level enhanced cell migration. Conclusions The results of the current study suggest that post-operative plasma OPN correlated with post-operative metastasis, suggesting that it is a potential non-invasive biomarker for the development of future metastasis in CRC patients. In addition, OPN was shown to be involved in the metastatic process and thus inhibition of OPN is a potential therapeutic approach to treat CRC patients.	[Ng, Lui; Wan, Timothy Ming-Hun; Lam, Colin Siu-Chi; Chow, Ariel Ka-Man; Wong, Sunny Kit-Man; Man, Johnny Hon-Wai; Li, Hung-Sing; Cheng, Nathan Shiu-Man; Pak, Ryan Chung-Hei; Cheung, Alvin Ho-Kwan; Yau, Thomas Chung-Cheung; Lo, Oswens Siu-Hung; Foo, Dominic Chi-Chung; Poon, Jensen Tung-Chung; Poon, Ronnie Tung-Ping; Pang, Roberta Wen-Chi; Law, Wai-Lun] Univ Hong Kong, Li Ka Shing Fac Med, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Chow, Ariel Ka-Man; Yau, Thomas Chung-Cheung; Poon, Ronnie Tung-Ping; Pang, Roberta Wen-Chi] Univ Hong Kong, Li Ka Shing Fac Med, Ctr Canc Res, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Pang, RWC (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Surg, Hong Kong, Hong Kong, Peoples R China.	robertap@hku.hk	Foo, Chi Chung/S-1508-2018; Chow, Ariel/HGF-2363-2022; Wan, Timothy/AAA-2432-2021; Ng, Lui/AAG-4397-2019; Yau, Thomas Chung Cheung/B-3429-2011	Foo, Chi Chung/0000-0001-8849-6597; Wan, Timothy/0000-0002-9235-2913; Ng, Lui/0000-0002-9010-2654; Li, Hung Sing/0000-0002-2156-8362; /0000-0003-2801-5717; Cheung, Alvin Ho-Kwan/0000-0002-3913-8117; Yau, Thomas Chung Cheung/0000-0002-7114-0305; Chow, Ariel/0000-0002-5729-5415				Abajo A, 2012, WORLD J GASTROENTERO, V18, P637, DOI 10.3748/wjg.v18.i7.637; Anborgh PH, 2011, J CELL COMMUN SIGNAL, V5, P111, DOI 10.1007/s12079-011-0130-6; Andre F, 2004, ONCOGENE, V23, P1177, DOI 10.1038/sj.onc.1207238; Armaghany Tannaz, 2012, Gastrointest Cancer Res, V5, P19; Blasberg JD, 2010, J CLIN ONCOL, V28, P936, DOI 10.1200/JCO.2009.25.5711; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Castellano G, 2008, CLIN CANCER RES, V14, P7470, DOI 10.1158/1078-0432.CCR-08-0870; Cohen Roger B, 2003, Clin Colorectal Cancer, V2, P246, DOI 10.3816/CCC.2003.n.006; Dai JX, 2010, CANCER IMMUNOL IMMUN, V59, P355, DOI 10.1007/s00262-009-0754-z; El-Tanani M, 2001, CANCER RES, V61, P5619; El-Tanani MK, 2006, CYTOKINE GROWTH F R, V17, P463, DOI 10.1016/j.cytogfr.2006.09.010; Fisher LW, 2001, BIOCHEM BIOPH RES CO, V280, P460, DOI 10.1006/bbrc.2000.4146; Giachelli CM, 2000, MATRIX BIOL, V19, P615, DOI 10.1016/S0945-053X(00)00108-6; Hotte SJ, 2002, CANCER-AM CANCER SOC, V95, P506, DOI 10.1002/cncr.10709; Huang JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047901; Hundt S, 2007, CANCER EPIDEM BIOMAR, V16, P1935, DOI 10.1158/1055-9965.EPI-06-0994; Irby R, 2004, CLIN EXP METASTAS, V21, P515, DOI 10.1007/s10585-004-2873-4; Khan MA, 2013, TUMOR BIOL, V34, P2497, DOI 10.1007/s13277-013-1002-x; Li J, 2012, EXP THER MED, V3, P621, DOI 10.3892/etm.2012.465; Li YP, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-34; Mack PC, 2008, J CLIN ONCOL, V26, P4771, DOI 10.1200/JCO.2008.17.0662; Mole DJ, 2011, BRIT J CANCER, V104, P1007, DOI 10.1038/bjc.2011.33; Murakami T, 2013, INT J CANCER, V132, P276, DOI 10.1002/ijc.27670; Ng L, 2013, CELL MOL LIFE SCI, V70, P3631, DOI 10.1007/s00018-013-1266-8; Nitsche U, 2012, ANN SURG, V256, P763, DOI 10.1097/SLA.0b013e318272de87; Ramankulov A, 2007, J CANCER RES CLIN, V133, P643, DOI 10.1007/s00432-007-0215-z; Rodrigues LR, 2007, CANCER EPIDEM BIOMAR, V16, P1087, DOI 10.1158/1055-9965.EPI-06-1008; SENGER DR, 1988, CANCER RES, V48, P5770; SENGER DR, 1989, ANTICANCER RES, V9, P1291; SHIKE M, 1990, B WORLD HEALTH ORGAN, V68, P377; Shimada Y, 2005, ONCOLOGY-BASEL, V68, P285, DOI 10.1159/000086961; SHIRAGA H, 1992, P NATL ACAD SCI USA, V89, P426, DOI 10.1073/pnas.89.1.426; Singhal H, 1997, CLIN CANCER RES, V3, P605; Steller EJA, 2013, NEOPLASIA, V15, P204, DOI 10.1593/neo.121726; Tania M, 2014, TUMOR BIOL, V35, P7335, DOI 10.1007/s13277-014-2163-y; Voorneveld PW, 2014, GASTROENTEROLOGY, V147, P196, DOI 10.1053/j.gastro.2014.03.052; Wang LK, 2011, J GASTROINTEST SURG, V15, P652, DOI 10.1007/s11605-011-1445-6; Wang LK, 2010, J GASTROINTEST SURG, V14, P74, DOI 10.1007/s11605-009-1035-z; Wang YF, 2013, CURR CANCER DRUG TAR, V13, P963, DOI 10.2174/15680096113136660102; Weber GF, 2010, BRIT J CANCER, V103, P861, DOI 10.1038/sj.bjc.6605834; Wu CY, 2007, GUT, V56, P782, DOI 10.1136/gut.2006.109868; Zhou C, 2013, ANN SURG ONCOL, V20, P929, DOI 10.1245/s10434-012-2749-9	42	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126219	10.1371/journal.pone.0126219	http://dx.doi.org/10.1371/journal.pone.0126219			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961724	Green Published, gold, Green Submitted			2022-12-26	WOS:000354542500075
J	Ramzan, M; Bilal, M				Ramzan, Muhammad; Bilal, Muhammad			Time Dependent MHD Nano-Second Grade Fluid Flow Induced by Permeable Vertical Sheet with Mixed Convection and Thermal Radiation	PLOS ONE			English	Article							STAGNATION POINT FLOW; HEAT-TRANSFER; 2ND-GRADE FLUID; MAGNETIC-FIELD; NANOFLUID; SURFACE; CONDUCTIVITY	The aim of present paper is to study the series solution of time dependent MHD second grade incompressible nanofluid towards a stretching sheet. The effects of mixed convection and thermal radiation are also taken into account. Because of nanofluid model, effects Brownian motion and thermophoresis are encountered. The resulting nonlinear momentum, heat and concentration equations are simplified using appropriate transformations. Series solutions have been obtained for velocity, temperature and nanoparticle fraction profiles using Homotopy Analysis Method (HAM). Convergence of the acquired solution is discussed critically. Behavior of velocity, temperature and concentration profiles on the prominent parameters is depicted and argued graphically. It is observed that temperature and concentration profiles show similar behavior for thermophoresis parameter Nt but opposite tendency is noted in case of Brownian motion parameter Nb. It is further analyzed that suction parameter S and Hartman number. depict decreasing behavior on velocity profile.	[Ramzan, Muhammad] Majmaah Univ, Coll Sci, Dept Math, Al Zulfi, Saudi Arabia; [Bilal, Muhammad] Mohammad Ali Jinnah Univ, Dept Math, Fac Comp, Islamabad, Pakistan	Majmaah University; Mohammad Ali Jinnah University	Ramzan, M (corresponding author), Majmaah Univ, Coll Sci, Dept Math, Al Zulfi, Saudi Arabia.	m.ramzan@mu.edu.sa	Ramzan, M./AAH-9959-2020	Ramzan, M./0000-0002-9523-5800	Deanship of Scientific Research (DSR), Majmaah University, Saudi Arabia [36-1-5]; DSR	Deanship of Scientific Research (DSR), Majmaah University, Saudi Arabia; DSR	This project is funded by the Deanship of Scientific Research (DSR), Majmaah University, Saudi Arabia under project no. 36-1-5. The author, therefore, acknowledges with thanks DSR for its financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsaedi A, 2012, COMMUN NONLINEAR SCI, V17, P4210, DOI 10.1016/j.cnsns.2012.03.008; Ashorynejad HR, 2014, J FRANKLIN I, V351, P701, DOI 10.1016/j.jfranklin.2013.04.027; Azizian R, 2014, INT J HEAT MASS TRAN, V68, P94, DOI 10.1016/j.ijheatmasstransfer.2013.09.011; Bataineh AS, 2009, COMMUN NONLINEAR SCI, V14, P430, DOI 10.1016/j.cnsns.2007.09.012; Choi S.U.S., 1995, ASME, V66, P99, DOI DOI 10.1115/1.1532008; El-Dawy HA, 2014, J NANOFLUIDS, V3, P72, DOI 10.1166/jon.2014.1077; Gorla RSR, 2014, J NANOFLUIDS, V3, P65, DOI 10.1166/jon.2014.1074; Gumgum S, 2014, J COMPUT APPL MATH, V259, P730, DOI 10.1016/j.cam.2013.05.006; Hayat T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107858; Hayat T, 2014, BRAZ J CHEM ENG, V31, P109, DOI 10.1590/S0104-66322014000100011; Hayat T, 2013, J THERMOPHYS HEAT TR, V27, P761, DOI 10.2514/1.T4059; Hayat T, 2013, HEAT TRANSF RES, V44, P687; Hayat T, 2010, COMMUN NONLINEAR SCI, V15, P2375, DOI 10.1016/j.cnsns.2009.09.013; Hayat T, 2011, THERM SCI, V15, pS253, DOI 10.2298/TSCI101014058H; Hussain T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103719; Jamil M, 2011, COMMUN NONLINEAR SCI, V16, P1959, DOI 10.1016/j.cnsns.2010.09.003; Liao S.J., 2003, PERTURBATION INTRO H; Mahian O, 2013, INT J HEAT MASS TRAN, V57, P582, DOI 10.1016/j.ijheatmasstransfer.2012.10.037; Makinde OD, 2013, INT J HEAT MASS TRAN, V62, P526, DOI 10.1016/j.ijheatmasstransfer.2013.03.049; Makinde OD, 2010, CAN J CHEM ENG, V88, P983, DOI 10.1002/cjce.20369; Ramzan M, 2013, EUR PHYS J PLUS, V128, DOI 10.1140/epjp/i2013-13049-5; Rizvi IH, 2013, HEAT MASS TRANSFER, V49, P595, DOI 10.1007/s00231-013-1117-z; Shehzad SA, 2013, BRAZ J CHEM ENG, V30, P187, DOI 10.1590/S0104-66322013000100020; Sheikholeslami M, 2013, POWDER TECHNOL, V235, P873, DOI 10.1016/j.powtec.2012.11.030; Turkyilmazoglu M, 2012, COMPUT FLUIDS, V70, P53, DOI 10.1016/j.compfluid.2012.01.009; Zheng LC, 2012, MATH COMPUT MODEL, V56, P133, DOI 10.1016/j.mcm.2011.11.080	26	47	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0124929	10.1371/journal.pone.0124929	http://dx.doi.org/10.1371/journal.pone.0124929			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962063	Green Submitted, Green Published, gold			2022-12-26	WOS:000354542500021
J	Vaca-Paniagua, F; Alvarez-Gomez, RM; Maldonado-Martinez, HA; Perez-Plasencia, C; Fragoso-Ontiveros, V; Lasa-Gonsebatt, F; Herrera, LA; Cantu, D; Bargallo-Rocha, E; Mohar, A; Durand, G; Forey, N; Voegele, C; Vallee, M; Le Calvez-Kelm, F; McKay, J; Ardin, M; Villar, S; Zavadil, J; Olivier, M				Vaca-Paniagua, Felipe; Maria Alvarez-Gomez, Rosa; Aquiles Maldonado-Martinez, Hector; Perez-Plasencia, Carlos; Fragoso-Ontiveros, Veronica; Lasa-Gonsebatt, Federico; Alonso Herrera, Luis; Cantu, David; Bargallo-Rocha, Enrique; Mohar, Alejandro; Durand, Geoffroy; Forey, Nathalie; Voegele, Catherine; Vallee, Maxime; Le Calvez-Kelm, Florence; McKay, James; Ardin, Maude; Villar, Stephanie; Zavadil, Jiri; Olivier, Magali			Revealing the Molecular Portrait of Triple Negative Breast Tumors in an Understudied Population through Omics Analysis of Formalin-Fixed and Paraffin-Embedded Tissues	PLOS ONE			English	Article							GENE-EXPRESSION; HOMOLOGOUS RECOMBINATION; MUTATIONAL PROCESSES; MICRORNA EXPRESSION; CANCER SUBTYPES; GENOME; SURVIVAL; BRCA1; P53; MUTAGENESIS	Triple negative breast cancer (TNBC), defined by the lack of expression of the estrogen receptor, progesterone receptor and human epidermal receptor 2, is an aggressive form of breast cancer that is more prevalent in certain populations, in particular in low-and middle-income regions. The detailed molecular features of TNBC in these regions remain unexplored as samples are mostly accessible as formalin-fixed paraffin embedded (FFPE) archived tissues, a challenging material for advanced genomic and transcriptomic studies. Using dedicated reagents and analysis pipelines, we performed whole exome sequencing and miRNA and mRNA profiling of 12 FFPE tumor tissues collected from pathological archives in Mexico. Sequencing analyses of the tumor tissues and their blood pairs identified TP53 and RB1 genes as the most frequently mutated genes, with a somatic mutation load of 1.7 mutations/exome Mb on average. Transcriptional analyses revealed an overexpression of growth-promoting signals (EGFR, PDGFR, VEGF, PIK3CA, FOXM1), a repression of cell cycle control pathways (TP53, RB1), a deregulation of DNA-repair pathways, and alterations in epigenetic modifiers through miRNA: mRNA network de-regulation. The molecular programs identified were typical of those described in basal-like tumors in other populations. This work demonstrates the feasibility of using archived clinical samples for advanced integrated genomics analyses. It thus opens up opportunities for investigating molecular features of tumors from regions where only FFPE tissues are available, allowing retrospective studies on the search for treatment strategies or on the exploration of the geographic diversity of breast cancer.	[Vaca-Paniagua, Felipe; Ardin, Maude; Villar, Stephanie; Zavadil, Jiri; Olivier, Magali] Int Agcy Res Canc, Grp Mol Mech & Biomarkers, F-69372 Lyon, France; [Durand, Geoffroy; Forey, Nathalie; Voegele, Catherine; Vallee, Maxime; Le Calvez-Kelm, Florence; McKay, James] Int Agcy Res Canc, Grp Genet Canc Susceptibil, F-69372 Lyon, France; [Vaca-Paniagua, Felipe; Perez-Plasencia, Carlos; Fragoso-Ontiveros, Veronica] Inst Nacl Cancerol, Subdirecc Invest Basica, Mexico City, DF, Mexico; [Vaca-Paniagua, Felipe; Perez-Plasencia, Carlos] Univ Nacl Autonoma Mexico, FES Iztacala, Unidad Biomed, Mexico City 04510, DF, Mexico; [Maria Alvarez-Gomez, Rosa; Perez-Plasencia, Carlos; Fragoso-Ontiveros, Veronica] Inst Nacl Cancerol, Unidad Genom & Secuenciac Masiva UGESEM, Mexico City, DF, Mexico; [Aquiles Maldonado-Martinez, Hector] Inst Nacl Cancerol, Dept Patol Mol, Mexico City, DF, Mexico; [Lasa-Gonsebatt, Federico; Mohar, Alejandro] Inst Nacl Cancerol, Dept Epidemiol, Mexico City, DF, Mexico; [Alonso Herrera, Luis; Cantu, David] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Inst Nacl Cancerol, Unidad Invest Biomed Canc, Mexico City 04510, DF, Mexico; [Bargallo-Rocha, Enrique] Inst Nacl Cancerol, Dept Tumores Mamarios, Mexico City, DF, Mexico	World Health Organization; International Agency for Research on Cancer (IARC); World Health Organization; International Agency for Research on Cancer (IARC); Instituto Nacional de Cancerologia (INCAN); Universidad Nacional Autonoma de Mexico; Instituto Nacional de Cancerologia (INCAN); Instituto Nacional de Cancerologia (INCAN); Instituto Nacional de Cancerologia (INCAN); Instituto Nacional de Cancerologia (INCAN); Universidad Nacional Autonoma de Mexico; Instituto Nacional de Cancerologia (INCAN)	Vaca-Paniagua, F (corresponding author), Int Agcy Res Canc, Grp Mol Mech & Biomarkers, 150 Cours Albert Thomas, F-69372 Lyon, France.	felipe.vaca@gmail.com; OlivierM@iarc.fr	Olivier, Magali/G-3728-2010; Zavadil, Jiri/ABG-1780-2020; Herrera, Luis/GOV-3311-2022; Cantu-de Leon, David/P-7930-2017	Olivier, Magali/0000-0002-8202-342X; Zavadil, Jiri/0000-0003-0640-5562; Cantu-de Leon, David/0000-0002-0229-7931; Le Calvez-Kelm, Florence/0000-0003-0063-5068; Vaca Paniagua, Felipe/0000-0002-2200-9706; Vallee, Maxime/0000-0002-3616-9508; Perez-Plasencia, Carlos/0000-0002-8593-8211	International Agency for Research on Cancer; European Commission; CONACyT [169082]	International Agency for Research on Cancer; European Commission(European CommissionEuropean Commission Joint Research Centre); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was undertaken during the tenure of a Postdoctoral Fellowship from the International Agency for Research on Cancer, partially supported by the European Commission FP7 Marie Curie Actions-People-Co-funding of regional, national and international programs (COFUND). FV was supported by CONACyT 169082.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Amirikia KC, 2011, CANCER-AM CANCER SOC, V117, P2747, DOI 10.1002/cncr.25862; April C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008162; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Burstein MD, 2014, CLIN CANC RES; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Cascione L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055910; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; Craig DW, 2013, MOL CANCER THER, V12, P104, DOI 10.1158/1535-7163.MCT-12-0781; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Garcia AI, 2011, EMBO MOL MED, V3, P279, DOI 10.1002/emmm.201100136; Goswami RS, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-47; Hall JS, 2012, BRIT J CANCER, V107, P684, DOI 10.1038/bjc.2012.294; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Holstege H, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-654; Hui ABY, 2009, LAB INVEST, V89, P597, DOI 10.1038/labinvest.2009.12; Huo DZ, 2009, J CLIN ONCOL, V27, P4515, DOI 10.1200/JCO.2008.19.6873; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lara-Medina F, 2011, CANCER-AM CANCER SOC, V117, P3658, DOI 10.1002/cncr.25961; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Lu HM, 2007, NUCLEIC ACIDS RES, V35, P7160, DOI 10.1093/nar/gkm732; Lund MJ, 2009, BREAST CANCER RES TR, V113, P357, DOI 10.1007/s10549-008-9926-3; Ly M, 2011, B CANCER, V98, P797, DOI 10.1684/bdc.2011.1392; Maia AT, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2458; Meng XB, 2007, J BIOL CHEM, V282, P1570, DOI 10.1074/jbc.M607520200; Morris JH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-436; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Podo F, 2010, MOL ONCOL, V4, P209, DOI 10.1016/j.molonc.2010.04.006; Powell SN, 2003, ONCOGENE, V22, P5784, DOI 10.1038/sj.onc.1206678; Prat A, 2013, ONCOLOGIST, V18, P123, DOI 10.1634/theoncologist.2012-0397; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Schweiger MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005548; Sfakianos GP, 2013, GYNECOL ONCOL, V129, P159, DOI 10.1016/j.ygyno.2012.12.030; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Shen H, 2013, CELL, V153, P38, DOI 10.1016/j.cell.2013.03.008; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stead LA, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2242; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Stevens KN, 2013, CANCER RES, V73, P2025, DOI 10.1158/0008-5472.CAN-12-1699; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tian S, 2010, BIOCHEM BIOPH RES CO, V396, P435, DOI 10.1016/j.bbrc.2010.04.112; Timp W, 2013, NAT REV CANCER, V13, P497, DOI 10.1038/nrc3486; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wagle N, 2012, CANCER DISCOV, V2, P82, DOI 10.1158/2159-8290.CD-11-0184; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; Xu H, 2014, CLIN CHEM, V60, P122, DOI 10.1373/clinchem.2013.207167; Yamakuchi M, 2010, P NATL ACAD SCI USA, V107, P6334, DOI 10.1073/pnas.0911082107	53	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126762	10.1371/journal.pone.0126762	http://dx.doi.org/10.1371/journal.pone.0126762			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961742	Green Published, Green Submitted, gold			2022-12-26	WOS:000354542500145
J	Zhou, YQ; Kang, J; Chen, D; Han, NN; Ma, HT				Zhou, Yingqiao; Kang, Jian; Chen, Di; Han, Ningning; Ma, Haitian			Ample Evidence: Dehydroepiandrosterone (DHEA) Conversion into Activated Steroid Hormones Occurs in Adrenal and Ovary in Female Rat	PLOS ONE			English	Article							ORAL DEHYDROEPIANDROSTERONE; S LEVELS; EXPRESSION; ENZYMES; WOMEN; AROMATASE; SULFATE; MEN; THERAPY; TISSUE	Dehydroepiandrosterone (DHEA) is important for human health, especially for women. All estrogens and practically half of androgens are synthesized from DHEA in peripheral tissues. However, the mechanism and exact target tissues of DHEA biotransformation in the female are not fully clear. The present study showed that maximal content of androstenedione (AD) and testosterone (T) were observed at 3h after DHEA administration in female rats, which was 264% and 8000% above the control, respectively. Estradiol (E2) content significantly increased at 6h after DHEA administration, which was 113% higher than that in control group. Gavage with DHEA could significantly reduce 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) mRNA level at 3-12h and 17 beta-hydroxysteroid dehydrogenase (17 beta-HSD) mRNA level at 12h in ovary, while increasing aromatase mRNA levels at 6, 24, and 48h. It is interesting that administration of DHEA caused a significant increase of 17 beta-HSD, 3 beta-HSD and aromatase mRNA levels in adrenal. The AD and T contents also markedly increased by 537% and 2737% after DHEA administration in ovariectomised rats, in company with a significant increase in 17 beta-HSD and 3 beta-HSD mRNA levels and decreased aromatase mRNA level in adrenal. However, DHEA administration did not restore the decreased E2, estrone (E1), and progesterone (P) caused by the removal of the ovaries in females. These results clearly illustrated that exogenous DHEA is preferentially converted into androgens in adrenal, while its conversion to estrogens mainly happens in the ovary through steroidogenic enzyme in female rats.	[Zhou, Yingqiao; Kang, Jian; Chen, Di; Han, Ningning; Ma, Haitian] Nanjing Agr Univ, Coll Vet Med, Key Lab Anim Physiol & Biochem, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Ma, HT (corresponding author), Nanjing Agr Univ, Coll Vet Med, Key Lab Anim Physiol & Biochem, Nanjing, Jiangsu, Peoples R China.	mahaitian@njau.edu.cn			Program for New Century Excellent Talents in University [NCET-10-0495]; Fundamental Research Funds for the Central Universities [KYZ201151]; Natural Science Foundation of Jiangsu Province [BK2011647]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the Program for New Century Excellent Talents in University (No. NCET-10-0495), the Fundamental Research Funds for the Central Universities (No. KYZ201151), the Natural Science Foundation of Jiangsu Province (No. BK2011647), and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Antonio-Rubio NR, 2011, J MOL HISTOL, V42, P535, DOI 10.1007/s10735-011-9358-y; Arlt W, 1999, J CLIN ENDOCR METAB, V84, P2170, DOI 10.1210/jc.84.6.2170; Bacsi Krisztian, 2007, Orvosi Hetilap, V148, P1273, DOI 10.1556/OH.2007.28102; Baulieu EE, 2000, P NATL ACAD SCI USA, V97, P4279, DOI 10.1073/pnas.97.8.4279; Bourguiba S, 2003, J MOL ENDOCRINOL, V31, P83, DOI 10.1677/jme.0.0310083; Buster JE, 2009, MENOPAUSE, V16, P858, DOI 10.1097/gme.0b013e3181ae1fca; Fan Y, 2005, LIFE SCI, V76, P8; Gleicher N, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-67; Hinfray N, 2006, ENVIRON TOXICOL, V21, P332, DOI 10.1002/tox.20203; Kurita H, 2013, J AFFECT DISORDERS, V146, P205, DOI 10.1016/j.jad.2012.09.004; LABRIE F, 1991, MOL CELL ENDOCRINOL, V78, pC113, DOI 10.1016/0303-7207(91)90116-A; Labrie F, 2007, J STEROID BIOCHEM, V103, P178, DOI 10.1016/j.jsbmb.2006.09.034; Labrie F, 2010, PROG BRAIN RES, V182, P97, DOI 10.1016/S0079-6123(10)82004-7; Leblanc M, 2002, J STEROID BIOCHEM, V81, P159, DOI 10.1016/S0960-0760(02)00059-6; Legrain S, 2003, DRUG AGING, V20, P949, DOI 10.2165/00002512-200320130-00001; Liu TC, 2013, EUR J APPL PHYSIOL, V113, P1783, DOI 10.1007/s00421-013-2607-x; Panjari M, 2007, HUM REPROD UPDATE, V13, P239, DOI 10.1093/humupd/dml055; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; Perret M, 2005, EXP GERONTOL, V40, P582, DOI 10.1016/j.exger.2005.05.002; Rice SPL, 2010, MOL CELL ENDOCRINOL, V320, P51, DOI 10.1016/j.mce.2010.02.017; Sato K, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-47; Savineau JP, 2013, BIOCHEM PHARMACOL, V85, P718, DOI 10.1016/j.bcp.2012.12.004; Shen XueHuai, 2013, Journal of Animal and Veterinary Advances, V12, P831; SIMPSON ER, 1994, ENDOCR REV, V15, P342, DOI 10.1210/er.15.3.342; Sivik T, 2012, HORM METAB RES, V44, P949, DOI 10.1055/s-0032-1321815; Song LJ, 2010, STEROIDS, V75, P213, DOI 10.1016/j.steroids.2009.11.007; Yamada S, 2010, GERIATR GERONTOL INT, V10, P280, DOI 10.1111/j.1447-0594.2010.00625.x	27	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0124511	10.1371/journal.pone.0124511	http://dx.doi.org/10.1371/journal.pone.0124511			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962158	Green Submitted, Green Published, gold			2022-12-26	WOS:000354542500015
J	Kuo, CL; Vsevolozhskaya, OA; Zaykin, DV				Kuo, Chia-Ling; Vsevolozhskaya, Olga A.; Zaykin, Dmitri V.			Assessing the Probability that a Finding Is Genuine for Large-Scale Genetic Association Studies	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; FALSE DISCOVERY; TRUNCATED PRODUCT; POSITIVE REPORT; P-VALUES; MICROARRAY; LOCI	Genetic association studies routinely involve massive numbers of statistical tests accompanied by P-values. Whole genome sequencing technologies increased the potential number of tested variants to tens of millions. The more tests are performed, the smaller P-value is required to be deemed significant. However, a small P-value is not equivalent to small chances of a spurious finding and significance thresholds may fail to serve as efficient filters against false results. While the Bayesian approach can provide a direct assessment of the probability that a finding is spurious, its adoption in association studies has been slow, due in part to the ubiquity of P-values and the automated way they are, as a rule, produced by software packages. Attempts to design simple ways to convert an association P-value into the probability that a finding is spurious have been met with difficulties. The False Positive Report Probability (FPRP) method has gained increasing popularity. However, FPRP is not designed to estimate the probability for a particular finding, because it is defined for an entire region of hypothetical findings with P-values at least as small as the one observed for that finding. Here we propose a method that lets researchers extract probability that a finding is spurious directly from a P-value. Considering the counterpart of that probability, we term this method POFIG: the Probability that a Finding is Genuine. Our approach shares FPRP's simplicity, but gives a valid probability that a finding is spurious given a P-value. In addition to straightforward interpretation, POFIG has desirable statistical properties. The POFIG average across a set of tentative associations provides an estimated proportion of false discoveries in that set. POFIGs are easily combined across studies and are immune to multiple testing and selection bias. We illustrate an application of POFIG method via analysis of GWAS associations with Crohn's disease.	[Kuo, Chia-Ling] Univ Connecticut, Dept Community Med & Hlth Care, Farmington, CT 06032 USA; [Vsevolozhskaya, Olga A.] Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA; [Zaykin, Dmitri V.] NIEHS, NIH, Res Triangle Pk, NC USA	University of Connecticut; Michigan State University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Zaykin, DV (corresponding author), Univ Connecticut, Dept Community Med & Hlth Care, Farmington, CT 06032 USA.	dmitri.zaykin@nih.gov	Zaykin, Dmitri/C-3752-2019; Vsevolozhskaya, Olga/AAX-5846-2020	Zaykin, Dmitri/0000-0002-9444-2859; 	Intramural Research Program of the NIH, National Institute of Environmental Health Sciences; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101866] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bowden J, 2009, GENET EPIDEMIOL, V33, P406, DOI 10.1002/gepi.20394; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P360, DOI 10.1002/gepi.10264; Dudbridge Frank, 2006, Human Genomics, V2, P310; Efron B, 2001, J AM STAT ASSOC, V96, P1151, DOI 10.1198/016214501753382129; Efron B, 2002, GENET EPIDEMIOL, V23, P70, DOI 10.1002/gepi.1124; Ioannidis JPA, 2011, EPIDEMIOLOGY, V22, P450, DOI 10.1097/EDE.0b013e31821b506e; Jager LR, 2014, BIOSTATISTICS, V15, P1, DOI 10.1093/biostatistics/kxt007; Kuo CL, 2011, GENETICS, V189, P329, DOI 10.1534/genetics.111.130542; Lee SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071494; Leek JT, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1673; Lin DY, 2010, GENET EPIDEMIOL, V34, P60, DOI 10.1002/gepi.20435; Lucke JE, 2009, GENET EPIDEMIOL, V33, P145, DOI 10.1002/gepi.20363; MORTON NE, 1955, AM J HUM GENET, V7, P277; Otto SP, 2000, GENETICS, V156, P2093; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Pounds S, 2003, BIOINFORMATICS, V19, P1236, DOI 10.1093/bioinformatics/btg148; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Senn S, 2008, AM STAT, V62, P206, DOI 10.1198/000313008X331530; Star S.A., 1949, STUDIES SOCIAL PSYCH, V1; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wacholder S, 2004, J NATL CANCER I, V96, P1722, DOI 10.1093/jnci/djh327; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wakefield J, 2007, AM J HUM GENET, V81, P208, DOI 10.1086/519024; Wakefield J, 2009, GENET EPIDEMIOL, V33, P79, DOI 10.1002/gepi.20359; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yang J, 2010, GENET EPIDEMIOL, V34, P254, DOI 10.1002/gepi.20456; Young SS, 2011, SIGNIFICANCE, V8, P116, DOI DOI 10.1111/J.1740-9713.2011.00506.X; Zaykin DV, 2011, J EVOLUTION BIOL, V24, P1836, DOI 10.1111/j.1420-9101.2011.02297.x; Zaykin DV, 2007, PHARM STAT, V6, P217, DOI 10.1002/pst.304; Zaykin DV, 2010, GENET EPIDEMIOL, V34, P725, DOI 10.1002/gepi.20536; Zaykin DV, 2002, GENET EPIDEMIOL, V22, P170, DOI 10.1002/gepi.0042; Zaykin DV, 2000, THESIS N CAROLINA ST; Zhang H, 2009, METHODS APPL STAT LI, P81	37	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0124107	10.1371/journal.pone.0124107	http://dx.doi.org/10.1371/journal.pone.0124107			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955023	Green Published, gold			2022-12-26	WOS:000356768100026
J	Lee, FFY; Chuang, HC; Chen, NY; Nagarajan, G; Chiou, PP				Lee, Frank Fang-Yao; Chuang, Hsiang-Chieh; Chen, Nai-Yu; Nagarajan, Govindarajulu; Chiou, Pinwen Peter			Toll-Like Receptor 9 Alternatively Spliced Isoform Negatively Regulates TLR9 Signaling in Teleost Fish	PLOS ONE			English	Article							EXPRESSION ANALYSIS; CUTTING EDGE; GENE FAMILY; CPG DNA; EVOLUTION; CLONING; TOLL-LIKE-RECEPTOR-9; TRANSCRIPTION; RECOGNITION; ACTIVATION	Toll-like receptor 9 (TLR9) recognizes and binds unmethylated CpG motifs in DNA, which are found in the genomes of bacteria and DNA viruses. In fish, Tlr9 is highly diverse, with the number of introns ranging from 0 to 4. A fish Tlr9 gene containing two introns has been reported to express two alternatively spliced isoforms, namely gTLR9A (full-length) and gTLR9B (with a truncated C'-terminal signal transducing domain), whose regulation and function remain unclear. Here, we report a unique regulatory mechanism of gTLR9 signaling in orange-spotted grouper (Epinephelus coioides), whose gTlr9 sequence also contains two introns. We demonstrated that the grouper gTlr9 gene indeed has the capacity to produce two gTLR9 isoforms via alternative RNA splicing. We found that gTLR9B could function as a negative regulator to suppress gTLR9 signaling as demonstrated by the suppression of downstream gene expression. Following stimulation with CpG oligodeoxy-nucleotide (ODN), gTLR9A and gTLR9B were observed to translocate into endosomes and co-localize with ODN and the adaptor protein gMyD88. Both gTLR9A and gTLR9B could interact with gMyD88; however, gTLR9B could not interact with downstream IRAK4 and TRAF6. Further analysis of the expression profile of gTlr9A and gTlr9B upon immune-stimulation revealed that the two isoforms were differentially regulated in a time-dependent manner. Overall, these data suggest that fish TLR9B functions as a negative regulator, and that its temporal expression is mediated by alternative RNA splicing. This has not been observed in mammalian TLR9s and might have been acquired relatively recently in the evolution of fish.	[Lee, Frank Fang-Yao; Chuang, Hsiang-Chieh; Chen, Nai-Yu; Nagarajan, Govindarajulu; Chiou, Pinwen Peter] Acad Sinica, Inst Cellular & Organism Biol, Marine Res Stn, Yilan 26242, Taiwan; [Lee, Frank Fang-Yao] Acad Sinica, Taiwan Int Grad Program, Mol & Biol Agr Sci, Taipei 26242, Taiwan; [Chuang, Hsiang-Chieh] Natl Taiwan Univ, Dept Life Sci, Taipei 10764, Taiwan; [Lee, Frank Fang-Yao] Natl Chung Hsing Univ, Ctr Biotechnol, Taichung 40227, Taiwan	Academia Sinica - Taiwan; National Taiwan University; National Chung Hsing University	Chiou, PP (corresponding author), Acad Sinica, Inst Cellular & Organism Biol, Marine Res Stn, 23-10 Dawen Rd, Yilan 26242, Taiwan.	ppchiou@gate.sinica.edu.tw			National Science Council [NSC97-2313-B-001-003-MY3, NSC100-2313-B-001-005-MY3]; Academia Sinica	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan)	This work was supported by National Science Council (NSC97-2313-B-001-003-MY3; NSC100-2313-B-001-005-MY3) and an Academia Sinica intramural funding to PP Chiou. The National Science Council has been restructured to Ministry of Science and Technology (MOST) since 2014. MOST website: http://www.most.gov.tw. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Chuang TH, 2000, EUR CYTOKINE NETW, V11, P372; Cuesta A, 2008, FISH SHELLFISH IMMUN, V25, P617, DOI 10.1016/j.fsi.2008.09.001; Divanovic S, 2005, NAT IMMUNOL, V6, P571, DOI 10.1038/ni1198; Du X, 2000, EUR CYTOKINE NETW, V11, P362; Dunne A, 2003, J BIOL CHEM, V278, P41443, DOI 10.1074/jbc.M301742200; Franch R, 2006, GENE, V378, P42, DOI 10.1016/j.gene.2006.04.025; Irazoqui JE, 2010, NAT REV IMMUNOL, V10, P47, DOI 10.1038/nri2689; Iwami K, 2000, J IMMUNOL, V165, P6682, DOI 10.4049/jimmunol.165.12.6682; Jaresova I, 2007, MICROBES INFECT, V9, P1359, DOI 10.1016/j.micinf.2007.06.009; Jault C, 2004, MOL IMMUNOL, V40, P759, DOI 10.1016/j.molimm.2003.10.001; Jenkins KA, 2010, CYTOKINE, V49, P237, DOI 10.1016/j.cyto.2009.01.009; Jorgensen JB, 2001, FISH SHELLFISH IMMUN, V11, P673, DOI 10.1006/fsim.2001.0344; Kongchum P, 2011, FISH SHELLFISH IMMUN, V30, P361, DOI 10.1016/j.fsi.2010.11.012; Kongchum P, 2010, FISH SHELLFISH IMMUN, V29, P356, DOI 10.1016/j.fsi.2010.04.013; Kornblihtt AR, 2013, NAT REV MOL CELL BIO, V14, P153, DOI 10.1038/nrm3525; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Meijer AH, 2004, MOL IMMUNOL, V40, P773, DOI 10.1016/j.molimm.2003.10.003; MIYAKE K, 1995, J IMMUNOL, V154, P3333; Nyman T, 2008, J BIOL CHEM, V283, P11861, DOI 10.1074/jbc.C800001200; Ortega-Villaizan M, 2009, MOL IMMUNOL, V46, P1710, DOI 10.1016/j.molimm.2009.02.006; Oshiumi H, 2003, IMMUNOGENETICS, V54, P791, DOI 10.1007/s00251-002-0519-8; Palti Y, 2011, DEV COMP IMMUNOL, V35, P1263, DOI 10.1016/j.dci.2011.03.006; Qi RS, 2010, J BIOL CHEM, V285, P36635, DOI 10.1074/jbc.M110.144402; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Sanjuan MA, 2006, J CELL BIOL, V172, P1057, DOI 10.1083/jcb.200508058; Sepulcre MP, 2009, J IMMUNOL, V182, P1836, DOI 10.4049/jimmunol.0801755; Song DH, 2012, IMMUNOL REV, V250, P216, DOI 10.1111/j.1600-065X.2012.01167.x; Star B, 2011, NATURE, V477, P207, DOI 10.1038/nature10342; Su JG, 2009, FISH SHELLFISH IMMUN, V27, P33, DOI 10.1016/j.fsi.2009.02.016; Sullivan C, 2007, J IMMUNOL, V178, P4517, DOI 10.4049/jimmunol.178.7.4517; Sullivan C, 2009, J IMMUNOL, V183, P5896, DOI 10.4049/jimmunol.0803285; Szabo G, 2007, J IMMUNOL, V178, P1243, DOI 10.4049/jimmunol.178.3.1243; Takano T, 2007, MOL IMMUNOL, V44, P1845, DOI 10.1016/j.molimm.2006.10.018; Takeshita F, 2001, J IMMUNOL, V167, P3555, DOI 10.4049/jimmunol.167.7.3555; Tsujita T, 2006, VACCINE, V24, P2193, DOI 10.1016/j.vaccine.2005.11.003; Tsujita T, 2004, J BIOL CHEM, V279, P48588, DOI 10.1074/jbc.M407634200; Wells CA, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r10; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Yang EJ, 2004, YONSEI MED J, V45, P359, DOI 10.3349/ymj.2004.45.2.359; Yao CL, 2008, FISH SHELLFISH IMMUN, V25, P648, DOI 10.1016/j.fsi.2008.07.006	43	11	12	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0126388	10.1371/journal.pone.0126388	http://dx.doi.org/10.1371/journal.pone.0126388			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955250	gold, Green Submitted, Green Published			2022-12-26	WOS:000356768100116
J	Sugita, Y; Araki, F; Chaya, T; Kawano, K; Furukawa, T; Miura, K				Sugita, Yuko; Araki, Fumiyuki; Chaya, Taro; Kawano, Kenji; Furukawa, Takahisa; Miura, Kenichiro			Role of the Mouse Retinal Photoreceptor Ribbon Synapse in Visual Motion Processing for Optokinetic Responses	PLOS ONE			English	Article							BIPOLAR CELLS; RECEPTIVE-FIELDS; EYE-MOVEMENTS; CAT RETINA; COMPONENT; PIKACHURIN	The ribbon synapse is a specialized synaptic structure in the retinal outer plexiform layer where visual signals are transmitted from photoreceptors to the bipolar and horizontal cells. This structure is considered important in high-efficiency signal transmission; however, its role in visual signal processing is unclear. In order to understand its role in visual processing, the present study utilized Pikachurin-null mutant mice that show improper formation of the photoreceptor ribbon synapse. We examined the initial and late phases of the optokinetic responses (OKRs). The initial phase was examined by measuring the open-loop eye velocity of the OKRs to sinusoidal grating patterns of various spatial frequencies moving at various temporal frequencies for 0.5 s. The mutant mice showed significant initial OKRs with a spatiotemporal frequency tuning (spatial frequency, 0.09 +/- 0.01 cycles/degrees; temporal frequency, 1.87 +/- 0.12 Hz) that was slightly different from the wild-type mice (spatial frequency, 0.11 +/- 0.01 cycles/degrees; temporal frequency, 1.66 +/- 0.12 Hz). The late phase of the OKRs was examined by measuring the slow phase eye velocity of the optokinetic nystagmus induced by the sinusoidal gratings of various spatiotemporal frequencies moving for 30 s. We found that the optimal spatial and temporal frequencies of the mutant mice (spatial frequency, 0.11 +/- 0.02 cycles/degrees; temporal frequency, 0.81 +/- 0.24 Hz) were both lower than those in the wild-type mice (spatial frequency, 0.15 +/- 0.02 cycles/degrees; temporal frequency, 1.93 +/- 0.62 Hz). These results suggest that the ribbon synapse modulates the spatiotemporal frequency tuning of visual processing along the ON pathway by which the late phase of OKRs is mediated.	[Sugita, Yuko; Kawano, Kenji; Miura, Kenichiro] Kyoto Univ, Grad Sch Med, Dept Integrat Brain Sci, Kyoto, Japan; [Sugita, Yuko; Chaya, Taro; Furukawa, Takahisa] Osaka Univ, Inst Prot Res, Lab Mol & Dev Biol, Osaka, Japan; [Sugita, Yuko; Chaya, Taro; Furukawa, Takahisa] Japan Sci & Technol Agcy, CREST, Tokyo, Japan; [Araki, Fumiyuki; Chaya, Taro; Furukawa, Takahisa] Osaka Biosci Inst, Dept Dev Biol, Osaka, Japan; [Araki, Fumiyuki] Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Tokyo, Japan	Kyoto University; Osaka University; Japan Science & Technology Agency (JST); University of Tokyo	Miura, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Integrat Brain Sci, Kyoto, Japan.	kmiura@brain.med.kyoto-u.ac.jp			JSPS KAKENHI [21240037, 23500467]; CREST; Japan Science and Technology Agency; Takeda Science Foundation; Grants-in-Aid for Scientific Research [15K18955, 24650105] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); CREST(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI, #21240037 to KK and in part by JSPS KAKENHI, #23500467 to KM. TF was supported by CREST, Japan Science and Technology Agency and the Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baden T, 2013, TRENDS NEUROSCI, V36, P480, DOI 10.1016/j.tins.2013.04.006; BAYLOR DA, 1971, J PHYSIOL-LONDON, V214, P265, DOI 10.1113/jphysiol.1971.sp009432; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Buttner Ulrich, 2007, Dev Ophthalmol, V40, P76; Cahill H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002055; COLLEWIJN H, 1969, VISION RES, V9, P117, DOI 10.1016/0042-6989(69)90035-2; Collewijn H, 1991, EYE MOVEMENTS, P45; Dacey D, 2000, VISION RES, V40, P1801, DOI 10.1016/S0042-6989(00)00039-0; Distler C, 2003, ANN NY ACAD SCI, V1004, P10, DOI 10.1196/annals.1303.002; Fahey PK, 2003, VISUAL NEUROSCI, V20, P1, DOI 10.1017/S0952523803201012; Koike C, 2010, P NATL ACAD SCI USA, V107, P332, DOI 10.1073/pnas.0912730107; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; NOMURA A, 1994, CELL, V77, P361, DOI 10.1016/0092-8674(94)90151-1; Omori Y, 2012, J NEUROSCI, V32, P6126, DOI 10.1523/JNEUROSCI.0322-12.2012; Purkinje J., 1825, NEUE BEITRAGE KENNTN, V2; Robson JG, 1996, J OPT SOC AM A, V13, P613, DOI 10.1364/JOSAA.13.000613; ROBSON JG, 1995, VISUAL NEUROSCI, V12, P837, DOI 10.1017/S0952523800009408; Sato S, 2008, NAT NEUROSCI, V11, P923, DOI 10.1038/nn.2160; Shimizu N, 2010, NEUROSCIENCE, V168, P200, DOI 10.1016/j.neuroscience.2010.03.025; SMITH RG, 1990, VISUAL NEUROSCI, V5, P453, DOI 10.1017/S0952523800000572; Stahl JS, 2004, VISION RES, V44, P3401, DOI 10.1016/j.visres.2004.09.011; Stahl JS, 2008, EYE RETINA VISUAL SY, P87; Sterling P., 2004, SYNAPTIC ORG BRAIN, P217; Sugita Y, 2013, EUR J NEUROSCI, V38, P2823, DOI 10.1111/ejn.12284; Sugita Y, 2012, NEUROSCI RES, V73, P133, DOI 10.1016/j.neures.2012.03.007; Tabata H, 2010, J VISION, V10, DOI 10.1167/10.1.13; Ter Braak J.W.G., 1936, UNTERSUCHUNGEN OPTOK, V21, P309; van Alphen AM, 2001, BRAIN RES, V890, P296, DOI 10.1016/S0006-8993(00)03180-2; van Alphen B, 2009, INVEST OPHTH VIS SCI, V50, P2451, DOI 10.1167/iovs.08-2594; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6; Zhang AJ, 2009, J NEUROSCI, V29, P789, DOI 10.1523/JNEUROSCI.4984-08.2009	31	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0124132	10.1371/journal.pone.0124132	http://dx.doi.org/10.1371/journal.pone.0124132			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955222	Green Submitted, gold, Green Published			2022-12-26	WOS:000356768100027
J	Zeng, QY; Ling, QP; Fan, LN; Li, Y; Hu, F; Chen, JW; Huang, ZR; Deng, HH; Li, QW; Qi, YW				Zeng, Qiaoying; Ling, Qiuping; Fan, Lina; Li, Yu; Hu, Fei; Chen, Jianwen; Huang, Zhenrui; Deng, Haihua; Li, Qiwei; Qi, Yongwen			Transcriptome Profiling of Sugarcane Roots in Response to Low Potassium Stress	PLOS ONE			English	Article							METABOLIC-CHANGES; PROTEIN-KINASE; TRANSPORTER; NITROGEN; PHOSPHORUS; AKT1; TOLERANCE; CHANNEL; GENE; DEPRIVATION	Sugarcane is the most important crop for supplying sugar. Due to its high biomass, sugarcane needs to absorb a large amount of potassium (K) throughout its lifecycle. In South China, a deficiency of K available in soil restricts the production of sugarcane. Increasing the tolerance of sugarcane to low-K will be an effective approach for improving survival of the crop in this area. However, there is little information regarding the mechanism of tolerance to low-K stress in sugarcane. In this study, a customized microarray was used to analyze the changes in the level of transcripts of sugarcane genes 8 h, 24 h and 72 h after exposure to low-K conditions. We identified a total of 4153 genes that were differentially expressed in at least one of the three time points. The number of genes responding to low-K stress at 72 h was almost 2-fold more than the numbers at 8 h and 24 h. Gene ontology (GO) analysis revealed that many genes involved in metabolic, developmental and biological regulatory processes displayed changes in the level of transcripts in response to low-K stress. Additionally, we detected differential expression of transcription factors, transporters, kinases, oxidative stress-related genes and genes in Ca+ and ethylene signaling pathways; these proteins might play crucial roles in improving the tolerance of sugarcane to low-K stress. The results of this study will help to better understand the molecular mechanisms of sugarcane tolerance to low-K.	[Zeng, Qiaoying; Ling, Qiuping; Fan, Lina; Li, Yu; Hu, Fei; Chen, Jianwen; Huang, Zhenrui; Deng, Haihua; Li, Qiwei; Qi, Yongwen] Guangzhou Sugarcane Ind Res Inst, Guangdong Key Lab Sugarcane Improvement & Biorefi, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Sciences; Institute of Nanfan & Seed Industry, Guangdong Academy of Sciences	Li, QW (corresponding author), Guangzhou Sugarcane Ind Res Inst, Guangdong Key Lab Sugarcane Improvement & Biorefi, Guangzhou, Guangdong, Peoples R China.	liqiwei66@163.com; yongwen2001@163.com			Earmarked Fund for China Agriculture Research System [CARS-20-1-4, CARS-20-3-1]; Science and Technology Planning Project of Guangdong Province, China [2012B020301008]	Earmarked Fund for China Agriculture Research System; Science and Technology Planning Project of Guangdong Province, China	This work was supported by the Earmarked Fund for China Agriculture Research System (CARS-20-1-4 and CARS-20-3-1), and the Science and Technology Planning Project of Guangdong Province, China (2012B020301008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves MS, 2013, INT J MOL SCI, V14, P7815, DOI 10.3390/ijms14047815; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Armengaud P, 2004, PLANT PHYSIOL, V136, P2556, DOI 10.1104/pp.104.046482; Armengaud P, 2009, PLANT PHYSIOL, V150, P772, DOI 10.1104/pp.108.133629; Ashley MK, 2006, J EXP BOT, V57, P425, DOI 10.1093/jxb/erj034; Ashraf M, 2012, ARCH AGRON SOIL SCI, V58, P385, DOI 10.1080/03650340.2010.529609; Baligar VC, 2001, COMMUN SOIL SCI PLAN, V32, P921, DOI 10.1081/CSS-100104098; Banuelos MA, 2002, PLANT PHYSIOL, V130, P784, DOI 10.1104/pp.007781; Bao S., 1999, SOIL AND AGRICULTURA; Buschmann PH, 2000, PLANT PHYSIOL, V122, P1387, DOI 10.1104/pp.122.4.1387; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; Dennison KL, 2001, PLANT PHYSIOL, V127, P1012, DOI 10.1104/pp.010193; Famoso AN, 2010, PLANT PHYSIOL, V153, P1678, DOI 10.1104/pp.110.156794; Fulgenzi FR, 2008, PLANT PHYSIOL, V147, P252, DOI 10.1104/pp.107.114546; Gierth M, 2005, PLANT PHYSIOL, V137, P1105, DOI 10.1104/pp.104.057216; Golldack D, 2011, PLANT CELL REP, V30, P1383, DOI 10.1007/s00299-011-1068-0; Gopalasundaram P, 2012, SUGAR TECH, V14, P3, DOI 10.1007/s12355-011-0097-x; Grabov A, 2007, ANN BOT-LONDON, V99, P1035, DOI 10.1093/aob/mcm066; Held K, 2011, CELL RES, V21, P1116, DOI 10.1038/cr.2011.50; Wyn Jones R. G., 1983, Inorganic plant nutrition, P528; Jung JY, 2009, PLANT CELL, V21, P607, DOI 10.1105/tpc.108.063099; Kim EJ, 1998, PLANT CELL, V10, P51, DOI 10.1105/tpc.10.1.51; Kim MJ, 2012, MOL PLANT, V5, P1042, DOI 10.1093/mp/sss003; Kim MJ, 2010, MOL PLANT, V3, P420, DOI 10.1093/mp/ssp121; Lan WZ, 2011, MOL PLANT, V4, P527, DOI 10.1093/mp/ssr031; Lian XM, 2006, PLANT MOL BIOL, V60, P617, DOI 10.1007/s11103-005-5441-7; Liu LL, 2013, PLANT PHYSIOL, V161, P266, DOI 10.1104/pp.112.206896; Ma TL, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-161; Nieves-Cordones M, 2008, PLANT MOL BIOL, V68, P521, DOI 10.1007/s11103-008-9388-3; Qi Z, 2008, J EXP BOT, V59, P595, DOI 10.1093/jxb/erm330; Santa-Maria GE, 1997, PLANT CELL, V9, P2281, DOI 10.1105/tpc.9.12.2281; Schachtman DP, 2007, ANNU REV PLANT BIOL, V58, P47, DOI 10.1146/annurev.arplant.58.032806.103750; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SCHROEDER JI, 1994, ANNU REV BIOPH BIOM, V23, P441, DOI 10.1146/annurev.bb.23.060194.002301; Shin R, 2004, P NATL ACAD SCI USA, V101, P8827, DOI 10.1073/pnas.0401707101; Shin R, 2005, PLANT CELL PHYSIOL, V46, P1350, DOI 10.1093/pcp/pci145; Smith CR, 2000, EUR J BIOCHEM, V267, P4477, DOI 10.1046/j.1432-1327.2000.01494.x; Wang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039856; Wang M, 2013, INT J MOL SCI, V14, P7370, DOI 10.3390/ijms14047370; Wang RC, 2003, PLANT PHYSIOL, V132, P556, DOI 10.1104/pp.103.021253; Wang Y, 2013, ANNU REV PLANT BIOL, V64, P451, DOI 10.1146/annurev-arplant-050312-120153; Wasaki J, 2003, PLANT CELL ENVIRON, V26, P1515, DOI 10.1046/j.1365-3040.2003.01074.x; Wasaki J, 2006, J EXP BOT, V57, P2049, DOI 10.1093/jxb/erj158; WOOD RA, 1990, FERT RES, V26, P89, DOI 10.1007/BF01048746; Xu J, 2006, CELL, V125, P1347, DOI 10.1016/j.cell.2006.06.011; Yu QY, 2014, PLANT CELL REP, V33, P203, DOI 10.1007/s00299-013-1507-1; Zeng JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100567	47	24	28	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0126306	10.1371/journal.pone.0126306	http://dx.doi.org/10.1371/journal.pone.0126306			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955765	Green Published, gold, Green Submitted			2022-12-26	WOS:000356768100110
J	Baeten, JT; Lilly, B				Baeten, Jeremy T.; Lilly, Brenda			Differential Regulation of NOTCH2 and NOTCH3 Contribute to Their Unique Functions in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; differentiation; mitogen-activated protein kinase (MAPK); Notch receptor; proliferation; vascular smooth muscle cells	SIGNALING PATHWAY; INTRACELLULAR DOMAIN; DEPENDENT PATHWAY; DOWN-REGULATION; LUNG-CANCER; CROSS-TALK; RAS-MAPK; C-FLIP; APOPTOSIS; GROWTH	Background: Notch receptors govern vascular smooth muscle phenotypes, yet their distinct mechanisms are undefined. Results: NOTCH2 and NOTCH3 are differentially regulated and uniquely control smooth muscle cell proliferation and survival. Conclusion: NOTCH2 and NOTCH3 have discrete functions in vascular smooth muscle cells that are linked to their expression. Significance: These findings highlight functional differences between the predominant Notch receptors in vascular smooth muscle cells. Notch signaling is a key regulator of vascular smooth muscle cell (VSMC) phenotypes, including differentiation, proliferation, and cell survival. However, the exact contribution of the individual Notch receptors has not been thoroughly delineated. In this study, we identify unique roles for NOTCH2 and NOTCH3 in regulating proliferation and cell survival in cultured VSMCs. Our results indicate that NOTCH2 inhibits PDGF-B-dependent proliferation and its expression is decreased by PDGF-B. In contrast, NOTCH3 promotes proliferation and receptor expression is increased by PDGF-B. Additionally, data show that NOTCH3, but not NOTCH2 protects VSMCs from apoptosis and apoptosis mediators degrade NOTCH3 protein. We identified three pro-survival genes specifically regulated by NOTCH3 in cultured VSMCs and in mouse aortas. This regulation is mediated through MAP kinase signaling, which we demonstrate can be activated by NOTCH3, but not NOTCH2. Overall, this study highlights discrete roles for NOTCH2 and NOTCH3 in VSMCs and connects these roles to specific upstream regulators that control their expression.	Ohio State Univ, Ctr Cardiovasc & Pulm Res, Columbus, OH 43205 USA; Ohio State Univ, Nationwide Childrens Hosp, Ctr Heart, Columbus, OH 43205 USA; Ohio State Univ, Dept Pediat, Columbus, OH 43205 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University	Lilly, B (corresponding author), Nationwide Childrens Hosp, Res Inst, 700 Childrens Dr, Columbus, OH 43205 USA.	brenda.lilly@nationwidechildrens.org	LILLY, BRENDA/N-6867-2015	LILLY, BRENDA/0000-0002-3125-7496	American Heart Association	American Heart Association(American Heart Association)	This study was supported by Grant-in-aid (to B. L.) from the American Heart Association.	Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Ballif BA, 2001, CELL GROWTH DIFFER, V12, P397; Bianchi S, 2006, J CELL PHYSIOL, V207, P300, DOI 10.1002/jcp.20542; Blokzijl A, 2003, J CELL BIOL, V163, P723, DOI 10.1083/jcb.200305112; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Boucher J, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00081; Boucher JM, 2013, CIRC RES, V113, P975, DOI 10.1161/CIRCRESAHA.113.301272; Boucher MJ, 2000, J CELL BIOCHEM, V79, P355, DOI 10.1002/1097-4644(20001201)79:3<355::AID-JCB20>3.3.CO;2-S; Cao HQ, 2012, APMIS, V120, P441, DOI 10.1111/j.1600-0463.2011.02825.x; Carmena A, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000066; Carvalho FLF, 2014, PROSTATE, V74, P933, DOI 10.1002/pros.22811; Doi H, 2006, J BIOL CHEM, V281, P28555, DOI 10.1074/jbc.M602749200; Domenga V, 2004, GENE DEV, V18, P2730, DOI 10.1101/gad.308904; Egan SE, 1998, CURR TOP MICROBIOL, V228, P273; Fedorov Y, 2006, RNA, V12, P1188, DOI 10.1261/rna.28106; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Havrda MC, 2006, THROMB HAEMOSTASIS, V96, P361, DOI 10.1160/TH06-04-0224; Hayward P, 2005, DEVELOPMENT, V132, P1819, DOI 10.1242/dev.01724; Henshall TL, 2015, ARTERIOSCL THROM VAS, V35, P409, DOI 10.1161/ATVBAHA.114.304849; High FA, 2008, P NATL ACAD SCI USA, V105, P1955, DOI 10.1073/pnas.0709663105; High FA, 2007, J CLIN INVEST, V117, P353, DOI 10.1172/JCI30070; Hiratochi M, 2007, NUCLEIC ACIDS RES, V35, P912, DOI 10.1093/nar/gkl1128; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Iso T, 2003, ARTERIOSCL THROM VAS, V23, P543, DOI 10.1161/01.ATV.0000060892.81529.8F; Jackson AL, 2004, TRENDS GENET, V20, P521, DOI 10.1016/j.tig.2004.08.006; Jalali S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046808; Jin S, 2008, CIRC RES, V102, P1483, DOI 10.1161/CIRCRESAHA.107.167965; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; Konishi J, 2010, ONCOGENE, V29, P589, DOI 10.1038/onc.2009.366; Krebs LT, 2003, GENESIS, V37, P139, DOI 10.1002/gene.10241; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Li XD, 2009, NAT MED, V15, P1289, DOI 10.1038/nm.2021; Li YX, 2009, CIRCULATION, V119, P2686, DOI 10.1161/CIRCULATIONAHA.108.790485; Lin CH, 2014, VASC PHARMACOL, V63, P88, DOI 10.1016/j.vph.2014.09.004; Lin CH, 2014, STEM CELLS DEV, V23, P2581, DOI 10.1089/scd.2014.0163; Lin LP, 2010, CANCER RES, V70, P632, DOI 10.1158/0008-5472.CAN-09-3293; Liu H, 2008, ANGIOGENESIS, V11, P223, DOI 10.1007/s10456-008-9102-8; Liu H, 2010, CIRC RES, V107, P860, DOI 10.1161/CIRCRESAHA.110.218271; Liu H, 2009, CIRC RES, V104, P466, DOI 10.1161/CIRCRESAHA.108.184846; Long XC, 2007, P NATL ACAD SCI USA, V104, P16570, DOI 10.1073/pnas.0708253104; Mann CD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051119; McCright B, 2006, GENESIS, V44, P29, DOI 10.1002/gene.20181; Munoz-Descalzo S, 2011, DEVELOPMENT, V138, P1501, DOI 10.1242/dev.061309; O'Neill CF, 2007, AM J PATHOL, V171, P1023, DOI 10.2353/ajpath.2007.061029; Pancewicz J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-502; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Pursglove SE, 2005, INT J BIOCHEM CELL B, V37, P2472, DOI 10.1016/j.biocel.2005.06.013; Seidelin JB, 2013, J MOL MED, V91, P839, DOI 10.1007/s00109-013-1003-7; Song GS, 2009, J BIOL CHEM, V284, P31921, DOI 10.1074/jbc.M109.046862; Sweeney C, 2004, FASEB J, V18, P1421, DOI 10.1096/fj.04-1700fje; Tang YF, 2010, J BIOL CHEM, V285, P17556, DOI 10.1074/jbc.M109.076414; Truong M, 2011, ANN SURG ONCOL, V18, P1506, DOI 10.1245/s10434-010-1488-z; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Voss OH, 2005, J BIOL CHEM, V280, P17371, DOI 10.1074/jbc.M412449200; Wang Q, 2012, IERI PROC, V3, P2, DOI 10.1016/j.ieri.2012.09.002; Wang T, 2007, CELL SIGNAL, V19, P2458, DOI 10.1016/j.cellsig.2007.07.019; Wang WL, 2002, J BIOL CHEM, V277, P21723, DOI 10.1074/jbc.M202224200; Wang XW, 2015, ONCOL REP, V33, P1402, DOI 10.3892/or.2015.3731; Ye YZ, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0595-7; Zhao XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021980	61	57	58	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16226	16237		10.1074/jbc.M115.655548	http://dx.doi.org/10.1074/jbc.M115.655548			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25957400	Green Published, hybrid			2022-12-26	WOS:000356930100026
J	Bessette, DC; Tilch, E; Seidens, T; Quinn, MCJ; Wiegmans, AP; Shi, W; Cocciardi, S; McCart-Reed, A; Saunus, JM; Simpson, PT; Grimmond, SM; Lakhani, SR; Khanna, KK; Waddell, N; Al-Ejeh, F; Chenevix-Trench, G				Bessette, Darrell C.; Tilch, Erik; Seidens, Tatjana; Quinn, Michael C. J.; Wiegmans, Adrian P.; Shi, Wei; Cocciardi, Sibylle; McCart-Reed, Amy; Saunus, Jodi M.; Simpson, Peter T.; Grimmond, Sean M.; Lakhani, Sunil R.; Khanna, Kum Kum; Waddell, Nic; Al-Ejeh, Fares; Chenevix-Trench, Georgia			Using the MCF10A/MCF10CA1a Breast Cancer Progression Cell Line Model to Investigate the Effect of Active, Mutant Forms of EGFR in Breast Cancer Development and Treatment Using Gefitinib	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; ACUTE MYELOID-LEUKEMIA; KINASE GENE-COMPLEX; BASAL-LIKE SUBTYPE; LUNG-CANCER; PROTEIN-KINASE; OPEN-LABEL; ACTIVATING MUTATIONS; 1ST-LINE TREATMENT; SOMATIC MUTATIONS	Background Basal-like and triple negative breast cancer (TNBC) share common molecular features, poor prognosis and a propensity for metastasis to the brain. Amplification of epidermal growth factor receptor (EGFR) occurs in similar to 50% of basal-like breast cancer, and mutations in the epidermal growth factor receptor (EGFR) have been reported in up to similar to 10% of Asian TNBC patients. In non-small cell lung cancer several different mutations in the EGFR tyrosine kinase domain confer sensitivity to receptor tyrosine kinase inhibitors, but the tumourigenic potential of EGFR mutations in breast cells and their potential for targeted therapy is unknown. Materials and Methods Constructs containing wild type, G719S or E746-A750 deletion mutant forms of EGFR were transfected into the MCF10A breast cells and their tumorigenic derivative, MCF10CA1a. The effects of EGFR over-expression and mutation on proliferation, migration, invasion, response to gefitinib, and tumour formation in vivo was investigated. Copy number analysis and whole exome sequencing of the MCF10A and MCF10CA1a cell lines were also performed. Results Mutant EGFR increased MCF10A and MCF10CA1a proliferation and MCF10A gefitinib sensitivity. The EGFR-E746-A750 deletion increased MCF10CA1a cell migration and invasion, and greatly increased MCF10CA1a xenograft tumour formation and growth. Compared to MCF10A cells, MCF10CA1a cells exhibited large regions of gain on chromosomes 3 and 9, deletion on chromosome 7, and mutations in many genes implicated in cancer. Conclusions Mutant EGFR enhances the oncogenic properties of MCF10A cell line, and increases sensitivity to gefitinib. Although the addition of EGFR E746-A750 renders the MCF10CA1a cells more tumourigenic in vivo it is not accompanied by increased gefitinib sensitivity, perhaps due to additional mutations, including the PIK3CA H1047R mutation, that the MCF10CA1a cell line has acquired. Screening TNBC/basal-like breast cancer for EGFR mutations may prove useful for directing therapy but, as in non-small cell lung cancer, accompanying mutations in PIK3CA may confer gefitinib resistance.	[Bessette, Darrell C.; Tilch, Erik; Seidens, Tatjana; Wiegmans, Adrian P.; Shi, Wei; Cocciardi, Sibylle; McCart-Reed, Amy; Saunus, Jodi M.; Simpson, Peter T.; Khanna, Kum Kum; Waddell, Nic; Al-Ejeh, Fares; Chenevix-Trench, Georgia] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Quinn, Michael C. J.; Grimmond, Sean M.; Waddell, Nic] Univ Queensland, Queensland Ctr Med Genom, Inst Mol Biosci, Brisbane, Qld, Australia; [McCart-Reed, Amy; Saunus, Jodi M.; Simpson, Peter T.; Lakhani, Sunil R.] Univ Queensland, UQ Ctr Clin Res, Brisbane, Qld, Australia; [Lakhani, Sunil R.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Lakhani, Sunil R.] Royal Brisbane & Womens Hosp, Pathol Queensland, Brisbane, Qld, Australia	QIMR Berghofer Medical Research Institute; University of Queensland; University of Queensland; University of Queensland; Royal Brisbane & Women's Hospital	Chenevix-Trench, G (corresponding author), QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia.	Georgia.Trench@qimrberghofer.edu.au	Lakhani, Sunil R/I-1970-2018; Reed, Amy E McCart/C-6192-2011; Wiegmans, Adrian/K-1609-2015; Waddell, Nicola/H-4929-2015; Chenevix-Trench, Georgia/AAV-2014-2020; Grimmond, Sean/K-3246-2019; Al-Ejeh, Fares/M-7032-2016; Saunus, Jodi M/C-6657-2011; Shi, Wei/AAX-6450-2021; Grimmond, Sean M/J-5304-2016; Simpson, Peter/F-1225-2010; Saunus, Jodi/AAE-5291-2020	Lakhani, Sunil R/0000-0003-4067-2760; Reed, Amy E McCart/0000-0001-5387-2791; Wiegmans, Adrian/0000-0003-4059-5988; Waddell, Nicola/0000-0002-3950-2476; Chenevix-Trench, Georgia/0000-0002-1878-2587; Grimmond, Sean/0000-0002-8102-7998; Al-Ejeh, Fares/0000-0002-1553-0077; Saunus, Jodi M/0000-0002-4604-4709; Shi, Wei/0000-0002-0378-8361; Grimmond, Sean M/0000-0002-8102-7998; Simpson, Peter/0000-0002-4816-8289; Saunus, Jodi/0000-0002-4604-4709; Khanna, Kum Kum/0000-0001-8650-5381	National Health and Medical Research Council Australia [1017028]; National Breast Cancer Foundation, Australia; Max Weber-Programm des Freistaates Bayern zur Hochbegabtenforderung nach dem Bayerischen Eliteforderungsgesetz of the State of Bavaria; Deans' Office of the faculty for chemistry and pharmacy of the Ludwig-Maximilians University	National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); National Breast Cancer Foundation, Australia; Max Weber-Programm des Freistaates Bayern zur Hochbegabtenforderung nach dem Bayerischen Eliteforderungsgesetz of the State of Bavaria; Deans' Office of the faculty for chemistry and pharmacy of the Ludwig-Maximilians University	This work was funded by the National Health and Medical Research Council Australia (Programme Grant No. 1017028). In addition, APW and PTS are funded by fellowships from the National Breast Cancer Foundation, Australia; GCT is a Senior Principal Research Fellow of the NHMRC. ET was supported by the Max Weber-Programm des Freistaates Bayern zur Hochbegabtenforderung nach dem Bayerischen Eliteforderungsgesetz of the State of Bavaria and a grant from the Deans' Office of the faculty for chemistry and pharmacy of the Ludwig-Maximilians University.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Al-Ejeh F, 2013, J NUCL MED, V54, P913, DOI 10.2967/jnumed.112.111534; Al-Ejeh F, 2011, CARCINOGENESIS, V32, P650, DOI 10.1093/carcin/bgr028; Amann J, 2005, CANCER RES, V65, P226; Banerjee S, 2006, J CLIN PATHOL, V59, P729, DOI 10.1136/jcp.2005.033043; Bergamaschi D, 2004, MOL CELL BIOL, V24, P1341, DOI 10.1128/MCB.24.3.1341-1350.2004; Borkhardt A, 2001, GENE CHROMOSOME CANC, V32, P82, DOI 10.1002/gcc.1169; BUCKLE AM, 1987, EUR J CANCER CLIN ON, V23, P663, DOI 10.1016/0277-5379(87)90261-6; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Carey LA, 2012, J CLIN ONCOL, V30, P2615, DOI 10.1200/JCO.2010.34.5579; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cheang MCU, 2008, CLIN CANCER RES, V14, P1368, DOI 10.1158/1078-0432.CCR-07-1658; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Cobleigh MA, 2005, CLIN CANCER RES, V11, P8623, DOI 10.1158/1078-0432.CCR-05-0735; Da Silva L, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2603; Dave BJ, 1999, CANCER GENET CYTOGEN, V108, P120, DOI 10.1016/S0165-4608(98)00138-1; Dawson PJ, 1996, AM J PATHOL, V148, P313; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Del Vecchio CA, 2012, CANCER RES, V72, P2657, DOI 10.1158/0008-5472.CAN-11-2656; Duan ZF, 2012, CLIN CANCER RES, V18, P4580, DOI 10.1158/1078-0432.CCR-12-1157; Engelman JA, 2006, J CLIN INVEST, V116, P2695, DOI 10.1172/JCI28656; Fidler MJ, 2011, BRIT J CANCER, V105, P1920, DOI 10.1038/bjc.2011.494; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235; Fulford LG, 2006, HISTOPATHOLOGY, V49, P22, DOI 10.1111/j.1365-2559.2006.02453.x; Fulford LG, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1636; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Glaysher Sharon, 2014, BMC Res Notes, V7, P397, DOI 10.1186/1756-0500-7-397; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HANNA N, 1980, INT J CANCER, V26, P675, DOI 10.1002/ijc.2910260521; Hohensee I, 2013, AM J PATHOL, V183, P83, DOI 10.1016/j.ajpath.2013.03.023; HOLMNIELSEN P, 1988, APMIS, V96, P48; Jacot W, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3079; Janmaat ML, 2006, J CLIN ONCOL, V24, P1612, DOI 10.1200/JCO.2005.03.4900; Janmaat ML, 2006, INT J CANCER, V118, P209, DOI 10.1002/ijc.21290; Ji W, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-606; Jia B, 2014, CANCER LETT, V342, P104, DOI 10.1016/j.canlet.2013.08.040; Kadota M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009201; Kadota M, 2009, CANCER RES, V69, P7357, DOI 10.1158/0008-5472.CAN-09-0064; Kassahn KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074380; KIDD VJ, 1991, CELL GROWTH DIFFER, V2, P85; Kinoshita M, 2001, CELL STRUCT FUNCT, V26, P667, DOI 10.1247/csf.26.667; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; LAHTI JM, 1995, MOL CELL BIOL, V15, P1; LAHTI JM, 1994, NAT GENET, V7, P370, DOI 10.1038/ng0794-370; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li SJ, 2012, ONCOL REP, V28, P133, DOI 10.3892/or.2012.1778; Livasy CA, 2006, MODERN PATHOL, V19, P264, DOI 10.1038/modpathol.3800528; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Marella NV, 2009, CANCER RES, V69, P5946, DOI 10.1158/0008-5472.CAN-09-0420; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mitsudomi T, 2007, CANCER SCI, V98, P1817, DOI 10.1111/j.1349-7006.2007.00607.x; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mitsudomi T, 2010, FEBS J, V277, P301, DOI 10.1111/j.1742-4658.2009.07448.x; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Mori S, 2004, CANCER-AM CANCER SOC, V100, P1673, DOI 10.1002/cncr.20164; Mori T, 2000, FEBS LETT, V465, P124, DOI 10.1016/S0014-5793(99)01726-3; Nelson MA, 1999, CANCER GENET CYTOGEN, V108, P91, DOI 10.1016/S0165-4608(98)00122-8; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Nonis D, 2008, CELL SIGNAL, V20, P1725, DOI 10.1016/j.cellsig.2008.05.018; Ono R, 2002, CANCER RES, V62, P333; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; PESANDO JM, 1979, BLOOD, V54, P1240; Popova T, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r128; Rakha EA, 2006, EUR J CANCER, V42, P3149, DOI 10.1016/j.ejca.2006.08.015; Rakha EA, 2009, CLIN CANCER RES, V15, P2302, DOI 10.1158/1078-0432.CCR-08-2132; RICHIE JP, 1981, SURGERY, V90, P214; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; Sgroi DC, 1999, CANCER RES, V59, P5656; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Slater DJ, 2002, ONCOGENE, V21, P4706, DOI 10.1038/sj.onc.1205572; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sos ML, 2009, CANCER RES, V69, P3256, DOI 10.1158/0008-5472.CAN-08-4055; SOULE HD, 1990, CANCER RES, V50, P6075; Sullivan A, 2007, BRIT J CANCER, V96, P196, DOI 10.1038/sj.bjc.6603525; Sun ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017490; Teng YHF, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2857; Tilch E, 2014, BREAST CANCER RES TR, V143, P385, DOI 10.1007/s10549-013-2798-1; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	96	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0125232	10.1371/journal.pone.0125232	http://dx.doi.org/10.1371/journal.pone.0125232			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25969993	Green Published, gold			2022-12-26	WOS:000354544200068
J	Lankester, F; Lugelo, A; Mnyambwa, N; Ndabigaye, A; Keyyu, J; Kazwala, R; Grant, DM; Relf, V; Haig, DM; Cleaveland, S; Russell, GC				Lankester, Felix; Lugelo, Ahmed; Mnyambwa, Nicholas; Ndabigaye, Ahab; Keyyu, Julius; Kazwala, Rudovick; Grant, Dawn M.; Relf, Valerie; Haig, David M.; Cleaveland, Sarah; Russell, George C.			Alcelaphine Herpesvirus-1 (Malignant Catarrhal Fever Virus) in Wildebeest Placenta: Genetic Variation of ORF50 and A9.5 Alleles	PLOS ONE			English	Article							NASAL SECRETIONS; OVINE HERPESVIRUS-2; CARRIER STATUS; CATTLE; GAMMAHERPESVIRUS; TRANSMISSION; IMMUNIZATION; SEQUENCE	Alcelaphine herpesvirus-1 (AlHV-1), a causative agent of malignant catarrhal fever in cattle, was detected in wildebeest (Connochaetes taurinus) placenta tissue for the first time. Although viral load was low, the finding of viral DNA in over 50% of 94 samples tested lends support to the possibility that placental tissue could play a role in disease transmission and that wildebeest calves are infected in utero. Two viral loci were sequenced to examine variation among virus samples obtained from wildebeest and cattle: the ORF50 gene, encoding the lytic cycle transactivator protein, and the A9.5 gene, encoding a novel polymorphic viral glycoprotein. ORF50 was well conserved with six newly discovered alleles differing at only one or two base positions. In contrast, while only three new A9.5 alleles were discovered, these differed by up to 13% at the nucleotide level and up to 20% at the amino acid level. Structural homology searching performed with the additional A9.5 sequences determined in this study adds power to recent analysis identifying the four-helix bundle cytokine interleukin-4 (IL4) as the major homologue. The majority of MCF virus samples obtained from Tanzanian cattle and wildebeest encoded A9.5 polypeptides identical to the previously characterized A9.5 allele present in the laboratory maintained AlHV-1 C500 strain. This supports the view that AlHV-1 C500 is suitable for the development of a vaccine for wildebeest-associated MCF.	[Lankester, Felix; Cleaveland, Sarah] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Boyd Orr Ctr Populat & Ecosyst Hlth, Glasgow G12 8QQ, Lanark, Scotland; [Lankester, Felix] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA; [Lankester, Felix; Mnyambwa, Nicholas; Ndabigaye, Ahab; Cleaveland, Sarah] Nelson Mandela African Inst Sci & Technol, Sch Life Sci & Bioengn, Arusha, Tanzania; [Lugelo, Ahmed; Kazwala, Rudovick] Sokoine Univ Agr, Fac Vet Med, Morogoro, Tanzania; [Ndabigaye, Ahab] Dar Es Salaam Inst Technol, Dept Sci & Lab Technol, Dar Es Salaam, Tanzania; [Keyyu, Julius] Tanzania Wildlife Res Inst, Arusha, Tanzania; [Grant, Dawn M.; Relf, Valerie; Russell, George C.] Moredun Res Inst, Edinburgh EH17 7JH, Midlothian, Scotland; [Haig, David M.] Univ Nottingham, Sch Vet Med & Sci, Sutton, Leics, England	University of Glasgow; Washington State University; Nelson Mandela African Institution of Science & Technology; Sokoine University of Agriculture; Moredun Research Institute; University of Nottingham	Lankester, F (corresponding author), Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Boyd Orr Ctr Populat & Ecosyst Hlth, Glasgow G12 8QQ, Lanark, Scotland.	lankesterf@vetmed.wsu.edu	Mnyambwa, Nicholaus P./AGM-9675-2022	Mnyambwa, Nicholaus P./0000-0002-8584-4477; Kayigwe, Ahab/0000-0002-0530-0737; Cleaveland, Sarah/0000-0002-0456-0959; Lankester, Felix/0000-0002-0802-0693	Scottish Government; Department for International Development; Biotechnology and Biological Sciences Research Council under the CIDLID initiative (Control of Infectious Diseases of Livestock for International Development) [BB/H009116/1, BB/H008950/1, BB/H009302/1]; University of Glasgow - Lister / Bellahouston Travelling Fellowship; consortium Afrique One "Ecosystem and Population Health: Expanding Frontiers in Health"; Wellcome Trust [WT087535MA]; BBSRC [BB/H009302/1, BB/H009035/1, BB/H009116/1, BB/H008950/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H009035/1, BB/H009302/1, BB/H009116/1, BB/H008950/1] Funding Source: researchfish	Scottish Government; Department for International Development; Biotechnology and Biological Sciences Research Council under the CIDLID initiative (Control of Infectious Diseases of Livestock for International Development)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Glasgow - Lister / Bellahouston Travelling Fellowship; consortium Afrique One "Ecosystem and Population Health: Expanding Frontiers in Health"; Wellcome Trust(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Scottish Government, the Department for International Development and the Biotechnology and Biological Sciences Research Council under the CIDLID initiative (Control of Infectious Diseases of Livestock for International Development); grants BB/H009116/1, BB/H008950/1 and BB/H009302/1. Data analysis was supported by a University of Glasgow - Lister / Bellahouston Travelling Fellowship (2014) that was awarded to FL. JK and RK were supported by the consortium Afrique One "Ecosystem and Population Health: Expanding Frontiers in Health". Afrique One is funded by the Wellcome Trust (WT087535MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNARD BJH, 1989, ONDERSTEPOORT J VET, V56, P131; BUXTON D, 1980, VET REC, V106, P243, DOI 10.1136/vr.106.11.243; Chmielewicz B, 2001, VIRUS RES, V75, P87; Cleaveland S., 2001, ASSESSING IMPACT MAL; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ensser A, 1997, J VIROL, V71, P6517, DOI 10.1128/JVI.71.9.6517-6525.1997; Flach EJ, 2002, RES VET SCI, V73, P93, DOI 10.1016/S0034-5288(02)00094-2; Georgiadis Nicholas, 1995, P473; Haig DM, 2008, VACCINE, V26, P4461, DOI 10.1016/j.vaccine.2008.06.056; Hart J, 2007, J GEN VIROL, V88, P28, DOI 10.1099/vir.0.82284-0; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kim O, 2003, VIRUS RES, V98, P117, DOI 10.1016/j.virusres.2003.09.002; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kleiboeker SB, 2002, J CLIN MICROBIOL, V40, P1311, DOI 10.1128/JCM.40.4.1311-1318.2002; Klieforth R, 2002, J CLIN MICROBIOL, V40, P3381, DOI 10.1128/JCM.40.9.3381-3390.2002; Li H, 2005, J GEN VIROL, V86, P3021, DOI 10.1099/vir.0.81238-0; Li H, 2004, J CLIN MICROBIOL, V42, P5558, DOI 10.1128/JCM.42.12.5558-5564.2004; Li H, 2000, J CLIN MICROBIOL, V38, P1313, DOI 10.1128/JCM.38.4.1313-1318.2000; Li H, 2001, J GEN VIROL, V82, P227, DOI 10.1099/0022-1317-82-1-227; McGeoch DJ, 2005, J GEN VIROL, V86, P307, DOI 10.1099/vir.0.80588-0; MUSHI EZ, 1981, J COMP PATHOL, V91, P63, DOI 10.1016/0021-9975(81)90045-1; MUSHI EZ, 1980, RES VET SCI, V29, P168, DOI 10.1016/S0034-5288(18)32659-6; Plowright W., 1984, Latent herpesvirus infections in veterinary medicine, P279; PLOWRIGHT W, 1968, J AM VET MED ASSOC, V152, P795; PLOWRIGHT W, 1975, RES VET SCI, V19, P159, DOI 10.1016/S0034-5288(18)33526-4; PLOWRIGHT W, 1965, RES VET SCI, V6, P56; Pretorius JA, 2008, J S AFR VET ASSOC, V79, P136; Roizmann B. (Corresponding Author), 1992, Archives of Virology, V123, P425, DOI 10.1007/BF01317276; ROSSITER PB, 1983, VET REC, V113, P150, DOI 10.1136/vr.113.7.150; Russell GC, 2014, VET MICROBIOL, V172, P63, DOI 10.1016/j.vetmic.2014.04.011; Russell GC, 2013, J GEN VIROL, V94, P2515, DOI 10.1099/vir.0.055673-0; Russell George C, 2012, Vet Res, V43, P51, DOI 10.1186/1297-9716-43-51; RWEYEMAMU M M, 1974, Journal of Wildlife Diseases, V10, P478; Schultheiss PC, 2000, J VET DIAGN INVEST, V12, P497, DOI 10.1177/104063870001200602; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taus NS, 2006, VET MICROBIOL, V116, P29, DOI 10.1016/j.vetmic.2006.03.005; Taus NS, 2014, VET MICROBIOL, V172, P318, DOI 10.1016/j.vetmic.2014.04.003; Traul DL, 2005, J VIROL METHODS, V129, P186, DOI 10.1016/j.jviromet.2005.05.021; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Whitaker KA, 2007, VET REC, V161, P692, DOI 10.1136/vr.161.20.692	41	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0124121	10.1371/journal.pone.0124121	http://dx.doi.org/10.1371/journal.pone.0124121			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25969987	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000354544200028
J	Mak, HW; Lee, SH; Chee, J; Tham, I; Goh, BC; Chao, SS; Ong, YK; Loh, KS; Lim, CM				Mak, Han Wen; Lee, Shan Hui; Chee, Jeremy; Tham, Ivan; Goh, Boon Cher; Chao, Siew Shuen; Ong, Yew Kwang; Loh, Kwok Seng; Lim, Chwee Ming			Clinical Outcome among Nasopharyngeal Cancer Patients in a Multi-Ethnic Society in Singapore	PLOS ONE			English	Article							PROGNOSTIC-FACTORS; LATE COMPLICATIONS; BREAST-CANCER; CARCINOMA; RADIOTHERAPY; EPIDEMIOLOGY; RISK; CHEMOTHERAPY; METAANALYSIS; EXPERIENCE	Background Nasopharyngeal cancer (NPC) is endemic among Chinese populations in Southeast Asia. However, the outcomes of non-Chinese NPC patients in Singapore are not well reported. Aim To determine if non-Chinese NPC patients have a different prognosis and examine the clinical outcomes of NPC patients in a multi-ethnic society. Methods Retrospective chart review of 558 NPC patients treated at a single academic tertiary hospital from 2002 to 2012. Survival and recurrence rates were analysed and predictive factors identified using the Kaplan-Meier method and Cox regression model. Results Our cohort comprised 409 males (73.3%) and 149 females (26.7%) with a median age of 52 years. There were 476 Chinese (85.3%), 57 Malays (10.2%), and 25 of other ethnic groups (4.5%). Non-Chinese patients were more likely to be associated with advanced nodal disease at initial presentation (p = 0.049), compared with the Chinese. However, there were no statistical differences in their overall survival (OS) or disease specific survival (DSS) (p = 0.934 and p = 0.857 respectively). The 3-year and 5-year cohort OS and DSS rates were 79.3%, 70.7%, and 83.2%, 77.4% respectively. Advanced age (p<0.001), N2 disease (p = 0.036), N3 disease (p<0.001), and metastatic disease (p<0.001) at presentation were independently associated with poor overall survival. N2 disease (p = 0.032), N3 disease (p<0.001) and metastatic disease (p<0.001) were also independently associated with poor DSS. No predictive factors were associated with loco-regional recurrence after definitive treatment. Advanced age (p = 0.044), N2 disease (p = 0.033) and N3 disease (p<0.001) were independently associated with distant relapse. Conclusion In a multi-ethnic society in Singapore, non-Chinese are more likely to present with advanced nodal disease. This however did not translate into poorer survival outcomes. Older patients with N2 or N3 disease are associated with a higher risk of distant relapse and poor overall survival.	[Mak, Han Wen; Lee, Shan Hui; Chee, Jeremy; Chao, Siew Shuen; Ong, Yew Kwang; Loh, Kwok Seng; Lim, Chwee Ming] Natl Univ Hlth Syst, Dept Otolaryngol Head & Neck Surg, Singapore, Singapore; [Tham, Ivan] Natl Univ Hlth Syst, Dept Radiat Oncol, Singapore, Singapore; [Goh, Boon Cher] Natl Univ Hlth Syst, Dept Hematol & Oncol, Singapore, Singapore	National University of Singapore; National University of Singapore; National University of Singapore	Lim, CM (corresponding author), Natl Univ Hlth Syst, Dept Otolaryngol Head & Neck Surg, Singapore, Singapore.	chwee_ming_lim@nuhs.edu.sg	Tham, Ivan WK/H-6188-2016; Loh, Thomas/GYU-2298-2022	Tham, Ivan WK/0000-0002-9476-4276; Lim, Chwee Ming/0000-0001-9528-4365	Clinician Scientist Unit, National University of Singapore	Clinician Scientist Unit, National University of Singapore	The publication is funded by the Clinician Scientist Unit, National University of Singapore. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sarraf M, 1998, J CLIN ONCOL, V16, P1310, DOI 10.1200/JCO.1998.16.4.1310; ANDERSSONANVRET M, 1977, INT J CANCER, V20, P486, DOI 10.1002/ijc.2910200403; BUELL P, 1974, CANCER RES, V34, P1189; CHAN S H, 1990, Annals Academy of Medicine Singapore, V19, P201; CHAN SH, 1985, BRIT J CANCER, V51, P389, DOI 10.1038/bjc.1985.52; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; Chen CY, 2009, BRIT J RADIOL, V82, P452, DOI 10.1259/bjr/72813246; Cheng SH, 2001, INT J RADIAT ONCOL, V50, P717, DOI 10.1016/S0360-3016(01)01509-7; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Erkal HS, 2001, RADIOTHER ONCOL, V61, P247, DOI 10.1016/S0167-8140(01)00448-0; Fong K. W., 1996, Annals Academy of Medicine Singapore, V25, P341; Hadi MA, 2010, MED PRIN PRACT, V19, P61, DOI 10.1159/000252837; Han Lu, 2010, Chin J Cancer, V29, P145; Heng DMK, 1999, CANCER-AM CANCER SOC, V86, P1912, DOI 10.1002/(SICI)1097-0142(19991115)86:10<1912::AID-CNCR6>3.0.CO;2-S; Huncharek M, 2002, AM J CLIN ONCOL-CANC, V25, P219, DOI 10.1097/00000421-200206000-00002; Jia WH, 2012, SEMIN CANCER BIOL, V22, P117, DOI 10.1016/j.semcancer.2012.01.009; Langendijk JA, 2004, J CLIN ONCOL, V22, P4604, DOI 10.1200/JCO.2004.10.074; Lee AWM, 2005, INT J RADIAT ONCOL, V61, P1107, DOI 10.1016/j.ijrobp.2004.07.702; Liu MT, 2003, JPN J CLIN ONCOL, V33, P501, DOI 10.1093/jjco/hyg092; McDermott AL, 2001, CLIN OTOLARYNGOL, V26, P82, DOI 10.1046/j.1365-2273.2001.00449.x; SHANMUGARATNAM K, 1979, CANCER, V44, P1029, DOI 10.1002/1097-0142(197909)44:3<1029::AID-CNCR2820440335>3.0.CO;2-5; Sim HL, 2009, SINGAP MED J, V50, P132; Su Sheng-Fa, 2011, Chin J Cancer, V30, P565, DOI 10.5732/cjc.010.10547; Teo MCC, 2013, JPN J CLIN ONCOL, V43, P219, DOI 10.1093/jjco/hys230; Teo P, 1996, INT J RADIAT ONCOL, V36, P291, DOI 10.1016/S0360-3016(96)00323-9; Wang H, 2004, ANN ACAD MED SINGAP, V33, P57; Wang JH, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-2; Wang Y, 2013, CANCER EPIDEMIOL, V37, P793, DOI 10.1016/j.canep.2013.08.008; Yeh SA, 2005, INT J RADIAT ONCOL, V62, P672, DOI 10.1016/j.ijrobp.2004.11.002; Yu MC, 2002, SEMIN CANCER BIOL, V12, P421, DOI 10.1016/S1044579X02000858; Zhang L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-558; Zhang L, 2011, ANN SURG ONCOL, V18, P233, DOI 10.1245/s10434-010-1292-9	32	28	29	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0126108	10.1371/journal.pone.0126108	http://dx.doi.org/10.1371/journal.pone.0126108			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965270	Green Published, gold, Green Submitted			2022-12-26	WOS:000354543500041
J	Chang, TC; Hsu, MF; Wu, KK				Chang, Tzu-Ching; Hsu, Min-Fen; Wu, Kenneth K.			High Glucose Induces Bone Marrow-Derived Mesenchymal Stem Cell Senescence by Upregulating Autophagy	PLOS ONE			English	Article							LIFE-SPAN EXTENSION; REPLICATIVE SENESCENCE; N-ACETYLCYSTEINE; DOUBLE-BLIND; C-ELEGANS	Hyperglycemia was reported to cause bone marrow hematopoietic niche dysfunction, and high glucose (HG) in the cultured medium induces MSC senescence. The underlying mechanism is unclear. Here, we investigated the role of HG-induced autophagy in bone-marrow-derived mesenchymal stem cell (BMSC) senescence. HG (25 mM) increased expression of Beclin-1, Atg 5, 7 and 12, generation of LC3-II and autophagosome formation which was correlated with development of cell senescence. Pretreatment of HG-MSC with 3-methyladenine (3-MA) prevented senescence but increased apoptosis. N-acetylcysteine (NAC) was effective in abrogating HG-induced autophagy accompanied by prevention of senescence. Diphenyleneiodonium (DPI), an inhibitor of NADPH oxidase, blocked autophagy and senescence in a manner comparable to NAC. 3-MA, NAC and DPI inhibited HG-induced interleukin-6 production in BMSCs. These results suggest that hyperglycemia induces MSC senescence and local inflammation via a novel oxidant-mediated autophagy which contributes to bone marrow niche dysfunction and hematopoietic impairment.	[Chang, Tzu-Ching; Hsu, Min-Fen; Wu, Kenneth K.] China Med Univ Hosp, Metabol Med Res Ctr, Taichung, Taiwan; [Chang, Tzu-Ching] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Wu, Kenneth K.] China Med Univ, Grad Inst Basic Med, Taichung, Taiwan; [Wu, Kenneth K.] Natl Hlth Res Inst, Zhunan, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; National Health Research Institutes - Taiwan	Wu, KK (corresponding author), China Med Univ Hosp, Metabol Med Res Ctr, Taichung, Taiwan.	kkwugo@gmail.com			National Science Council, Taiwan [NSC-102-2321-B-400-012, NSC-102-2321-B-039-009]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from National Science Council, Taiwan (Stem Cell Frontier Program grant NSC-102-2321-B-400-012 and Excellent Team Research Program grant NSC-102-2321-B-039-009). The website of the funder: (http://www.most.gov.tw). Authors who received the funding: KKW, TCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040193; Critofalo VJ, 1998, P NATL ACAD SCI USA, V95, P10614; Estrada JC, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.211; Fang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060546; Ferraro F, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002191; Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003; Grandjean EM, 2000, CLIN THER, V22, P209, DOI 10.1016/S0149-2918(00)88479-9; Han D, 2010, BIOCHEM J, V425, P541, DOI 10.1042/BJ20090429; Tse HN, 2013, CHEST, V144, P106, DOI 10.1378/chest.12-2357; Jia KL, 2007, AUTOPHAGY, V3, P597, DOI 10.4161/auto.4989; Kojima H, 2014, TRENDS ENDOCRIN MET, V25, P178, DOI 10.1016/j.tem.2014.01.002; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Moruno Felix, 2012, Cells, V1, P372, DOI 10.3390/cells1030372; Park EY, 2013, INT ORTHOP, V37, P2507, DOI 10.1007/s00264-013-2037-8; Parsch D, 2004, J MOL MED-JMM, V82, P49, DOI 10.1007/s00109-003-0506-z; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Stolzing A, 2006, REJUV RES, V9, P31, DOI 10.1089/rej.2006.9.31; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wang YH, 2012, P NATL ACAD SCI USA, V109, P13325, DOI 10.1073/pnas.1120193109; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709; Yu TZ, 2008, CARDIOVASC RES, V79, P341, DOI 10.1093/cvr/cvn104	24	84	89	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126537	10.1371/journal.pone.0126537	http://dx.doi.org/10.1371/journal.pone.0126537			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961745	Green Submitted, Green Published, gold			2022-12-26	WOS:000354542500110
J	Koss, CA; Jarlsberg, LG; den Boon, S; Cattamanchi, A; Davis, JL; Worodria, W; Ayakaka, I; Sanyu, I; Huang, L				Koss, Catherine A.; Jarlsberg, Leah G.; den Boon, Saskia; Cattamanchi, Adithya; Davis, J. Lucian; Worodria, William; Ayakaka, Irene; Sanyu, Ingvar; Huang, Laurence		Int HIV-Associated Opportunistic P	A Clinical Predictor Score for 30-Day Mortality among HIV-Infected Adults Hospitalized with Pneumonia in Uganda	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; BACTERIAL PNEUMONIA; SEVERITY; TUBERCULOSIS; VALIDATION; INDIVIDUALS; ETIOLOGY; ILLNESS	Background Pneumonia is a major cause of mortality among HIV-infected patients. Pneumonia severity scores are promising tools to assist clinicians in predicting patients' 30-day mortality, but existing scores were developed in populations infected with neither HIV nor tuberculosis ( TB) and include laboratory data that may not be available in resource-limited settings. The objective of this study was to develop a score to predict mortality in HIV-infected adults with pneumonia in TB-endemic, resource-limited settings. Methods We conducted a secondary analysis of data from a prospective study enrolling HIV-infected adults with cough >= 2 weeks and <6 months and clinically suspected pneumonia admitted to Mulago Hospital in Kampala, Uganda from September 2008 to March 2011. Patients provided two sputum specimens for mycobacteria, and those with Ziehl-Neelsen sputum smears that were negative for mycobacteria underwent bronchoscopy with inspection for Kaposi sarcoma and testing for mycobacteria and fungi, including Pneumocystis jirovecii. A multivariable best subsets regression model was developed, and one point was assigned to each variable in the model to develop a clinical predictor score for 30-day mortality. Results Overall, 835 patients were studied (mean age 34 years, 53.4% female, 30-day mortality 18.2%). A four-point clinical predictor score was identified and included heart rate >120 beats/minute, respiratory rate >30 breaths/minute, oxygen saturation <90%, and CD4 cell count <50 cells/mm(3). Patients' 30-day mortality, stratified by score, was: score 0 or 1, 12.6%, score 2 or 3, 23.4%, score 4, 53.9%. For each 1 point change in clinical predictor score, the odds of 30-day mortality increased by 65%(OR 1.65, 95% CI 1.39-1.96, p <0.001). Conclusions A simple, four-point scoring system can stratify patients by levels of risk for mortality. Rapid identification of higher risk patients combined with provision of timely and appropriate treatment may improve clinical outcomes. This predictor score should be validated in other resource-limited settings.	[Koss, Catherine A.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Jarlsberg, Leah G.; Cattamanchi, Adithya; Davis, J. Lucian; Huang, Laurence] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div Pulm & Crit Care Med, San Francisco, CA USA; [den Boon, Saskia; Cattamanchi, Adithya; Davis, J. Lucian; Worodria, William; Ayakaka, Irene; Sanyu, Ingvar; Huang, Laurence] Univ Calif San Francisco, Makerere Univ, Res Collaborat, Kampala, Uganda; [Worodria, William] Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda; [Worodria, William] Mulago Natl Referral & Teaching Hosp, Dept Med, Kampala, Uganda; [Huang, Laurence] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, Div HIV AIDS, San Francisco, CA USA	University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Makerere University; Makerere University; Mulago National Referral Hospital; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Koss, CA (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	catherine.koss@ucsf.edu	Huang, Laurence/AAZ-7120-2021; Davis, J. Lucian/AAC-8376-2019; Huang, Laurence/AAE-1590-2019	Huang, Laurence/0000-0003-3888-2195; Davis, J. Lucian/0000-0002-8629-9992; Jarlsberg, Leah/0000-0001-6548-6337	National Institutes of Health [K24 087713, R01 090335]; Mount Zion Global Health Project Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL087713, R01HL090335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mount Zion Global Health Project Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by grants from the National Institutes of Health (K24 087713, L.H. and R01 090335, L.H.) and the Mount Zion Global Health Project Fund (C.A.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arozullah AM, 2003, CHEST, V123, P1151, DOI 10.1378/chest.123.4.1151; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Chew KW, 2011, AIDS PATIENT CARE ST, V25, P273, DOI 10.1089/apc.2010.0365; Cordero E, 2000, AM J RESP CRIT CARE, V162, P2063, DOI 10.1164/ajrccm.162.6.9910104; Cox JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033685; Curran A, 2008, HIV MED, V9, P609, DOI 10.1111/j.1468-1293.2008.00603.x; Curtis AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052019; Fei MW, 2009, THORAX, V64, P1070, DOI 10.1136/thx.2009.117846; Feldman C, 1999, CHEST, V116, P107, DOI 10.1378/chest.116.1.107; FINE MJ, 1990, AM J MED, V88, pN1; FINE MJ, 1995, J GEN INTERN MED, V10, P359, DOI 10.1007/BF02599830; FINE MJ, 1993, AM J MED, V94, P153, DOI 10.1016/0002-9343(93)90177-Q; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; HIRSCHTICK RE, 1995, NEW ENGL J MED, V333, P845, DOI 10.1056/NEJM199509283331305; Hosmer Jr DW, 2004, APPL LOGISTIC REGRES; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Johnson David H, 2003, Can Respir J, V10, P265; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Manabe YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034319; Marshall CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068445; Park DR, 2001, J INFECT DIS, V184, P268, DOI 10.1086/322040; Reed C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027793; Sanders K M, 2006, Can Respir J, V13, P89; Shtatland E, 2001, PERILS STEPWISE LOGI, V26; Sogaard OS, 2008, CLIN INFECT DIS, V47, P1345, DOI 10.1086/592692; Sogaard OS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007022; Touchie C, 1996, Can J Infect Dis, V7, P253; Uganda Ministry of Health, 2008, NAT ANT TREATM CAR G; Uganda Ministry of Health, 2013, ADD NAT ANT TREATM G; Uganda Ministry of Health and ICF International, 2012, 2011 UG AIDS IND SUR; Wong EB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047542; World Health Organization, 2007, RED NUMB SMEARS DIAG; Zolopa AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005575; Zuberi FF, 2008, INT J TUBERC LUNG D, V12, P447	36	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126591	10.1371/journal.pone.0126591	http://dx.doi.org/10.1371/journal.pone.0126591			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962069	Green Published, gold			2022-12-26	WOS:000354542500119
J	Plenderleith, TL; Smith, KL; Donnellan, SC; Reina, RD; Chapple, DG				Plenderleith, T. Lynette; Smith, Katie L.; Donnellan, Stephen C.; Reina, Richard D.; Chapple, David G.			Human-Assisted Invasions of Pacific Islands by Litoria Frogs: A Case Study of the Bleating Tree Frog on Lord Howe Island	PLOS ONE			English	Article							ELEUTHERODACTYLUS-COQUI; BIOLOGICAL INVASIONS; SPECIES INVASIONS; MITOCHONDRIAL-DNA; ANURA; POPULATIONS; EVOLUTION; ORIGIN; AUREA; PHYLOGENIES	There are substantial differences among taxonomic groups in their capacity to reach remote oceanic islands via long-distance overwater dispersal from mainland regions. Due to their permeable skin and intolerance of saltwater, amphibians generally require human-assisted dispersal to reach oceanic islands. Several Litoria frog species have been introduced to remote islands throughout the Pacific Ocean region. Lord Howe Island (LHI) is an oceanic island that lies approximately 600 km east of the Australian mainland and has a diverse, endemic biota. The bleating tree frog (Litoria dentata) is native to mainland eastern Australia, but was accidentally introduced to LHI in the 1990s, yet its ecology and potential impact on LHI has remained unstudied. We used a mitochondrial phylogeographical approach to determine that L. dentata was introduced from the Ballina region in northeastern New South Wales. The founding population was likely accidentally introduced with cargo shipped from the mainland. We also completed the first detailed investigation of the distribution, ecology and habitat use of L. dentata on LHI. The species is widespread on LHI and is prevalent in human habitat, cattle pasture and undisturbed forest. We discuss the potential impact of introduced Litoria species on Pacific islands and outline what biosecurity protocols could be implemented to prevent the introduction of further amphibian species to the ecologically sensitive oceanic area.	[Plenderleith, T. Lynette; Smith, Katie L.; Reina, Richard D.; Chapple, David G.] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia; [Smith, Katie L.] Museum Victoria, Div Sci, Melbourne, Vic, Australia; [Donnellan, Stephen C.] S Australian Museum, Adelaide, SA 5000, Australia	Monash University; Museum Victoria	Plenderleith, TL (corresponding author), Monash Univ, Sch Biol Sci, Clayton, Vic, Australia.	Lynette.Plenderleith@monash.edu	Smith, Katie Elizabeth/GXH-2114-2022; Reina, Richard/AAC-7017-2019; Donnellan, Stephen/F-2442-2013; Chapple, David/B-9073-2008; Plenderleith, Lynette/C-9315-2012	Donnellan, Stephen/0000-0002-5448-3226; Chapple, David/0000-0002-7720-6280; Plenderleith, Lynette/0000-0002-1203-8095	Holsworth Wildlife Research Endowment Fund; Australian Research Council [DP0771913]; National Geographic Society [CRE8085-06]; Hermon Slade Foundation [HSF09/02]; Science Faculty Early Career Researcher Grant	Holsworth Wildlife Research Endowment Fund; Australian Research Council(Australian Research Council); National Geographic Society(National Geographic Society); Hermon Slade Foundation; Science Faculty Early Career Researcher Grant	The research was funded by the Holsworth Wildlife Research Endowment Fund (http://www.anz.com/personal/private-bank-trustees/trustees/granting/granting-programs/small-grants/ grant to TLP), a Science Faculty Early Career Researcher Grant (http://www.monash.edu/science/about to DGC), the Australian Research Council (http://www.arc.gov.au/ grant to DGC; DP0771913), the National Geographic Society (http://www.nationalgeographic.com/ grant to DGC; CRE8085-06), and the Hermon Slade Foundation (http://www.hermonslade.org.au/guidelines.html grant to DGC; HSF09/02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, LORD HOWE ISLAND PER; AREVALO E, 1994, SYST BIOL, V43, P387, DOI 10.2307/2413675; Auld TD, 2010, BIOL INVASIONS, V12, P3351, DOI 10.1007/s10530-010-9728-5; Beard KH, 2009, PAC SCI, V63, P297, DOI 10.2984/049.063.0301; Beard KH, 2005, DIVERS DISTRIB, V11, P427, DOI 10.1111/j.1366-9516.2005.00178.x; Beard KH, 2003, J TROP ECOL, V19, P607, DOI 10.1017/S0266467403006011; Bell BD, 2004, BIOL CONSERV, V120, P189, DOI 10.1016/j.biocon.2004.02.011; Blackburn TM, 2004, SCIENCE, V305, P1955, DOI 10.1126/science.1101617; Burns EL, 2006, MOL PHYLOGENET EVOL, V39, P573, DOI 10.1016/j.ympev.2005.11.017; Burns EL, 2007, CONSERV GENET, V8, P17, DOI 10.1007/s10592-006-9143-8; Chapple DG, 2011, ZOOTAXA, P1; Chapple DG, 2013, DIVERS DISTRIB, V19, P134, DOI 10.1111/j.1472-4642.2012.00919.x; Chapple DG, 2011, BMC EVOLUTIONARY BIO, V11; Choi RT, 2012, BIOL INVASIONS, V14, P939, DOI 10.1007/s10530-011-0127-3; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cogger H.G., 1983, Zoological Catalogue of Australia, V1, P1; Corin SE, 2007, DIVERS DISTRIB, V13, P510, DOI 10.1111/j.1472-4642.2007.00355.x; Cowie RH, 2008, PHILOS T R SOC B, V363, P3363, DOI 10.1098/rstb.2008.0061; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Estoup A, 2010, MOL ECOL, V19, P4113, DOI 10.1111/j.1365-294X.2010.04773.x; Ficetola GF, 2008, MOL ECOL, V17, P773, DOI 10.1111/j.1365-294X.2007.03622.x; Gillespie RG, 2002, ANNU REV ENTOMOL, V47, P595, DOI 10.1146/annurev.ento.47.091201.145244; Goebel AM, 1999, MOL PHYLOGENET EVOL, V11, P163, DOI 10.1006/mpev.1998.0538; Greer Allen E., 1998, Australian Zoologist, V30, P383; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Halliday T, 2006, ECOLOGICAL CENSUS TECHNIQUES: A HANDBOOK, 2ND EDITION, P278, DOI 10.1017/CBO9780511790508.008; Hindwood K. A., 1940, Emu Melbourne, V40, P1; Hoopes M.F., 2013, INVASION ECOLOGY, V2nd; Hutton I, 2007, ANIM CONSERV, V10, P22, DOI 10.1111/j.1469-1795.2006.00077.x; Kaiser B.A., 2006, INTERDISCIPLINARY EN, V8, P1; Kraus Fred, 2002, Biological Invasions, V4, P327, DOI 10.1023/A:1020909205908; Kraus Fred, 1999, Herpetological Review, V30, P21; Kraus Fred, 2009, V4, P1; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Lever C., 2003, NATURALIZED REPTILES; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MacArthur R.H., 1967, THEORY ISLAND BIOGEO; Mahony Michael, 2001, Records of the Australian Museum, V53, P37; MCDOUGALL I, 1981, J GEOL SOC AUST, V28, P155, DOI 10.1080/00167618108729154; McKeown S., 1998, B CHICAGO HERPETOLOG, V33; Measey GJ, 2007, J BIOGEOGR, V34, P7, DOI 10.1111/j.1365-2699.2006.01589.x; Muirhead JR, 2008, MOL ECOL, V17, P1020, DOI 10.1111/j.1365-294X.2008.03669.x; Nicholls M, 1952, HIST LORD HOWE ISLAN; PAULAY G, 1994, AM ZOOL, V34, P134; Peacock MM, 2009, MOL ECOL, V18, P3603, DOI 10.1111/j.1365-294X.2009.04308.x; Rambaut A, TRACER V1 5; Reaser JK, 2007, ENVIRON CONSERV, V34, P98, DOI 10.1017/S0376892907003815; RECHER H F, 1974, Biological Conservation, V6, P263, DOI 10.1016/0006-3207(74)90005-6; Ronquist F, 2011, MRBAYES VER IN PRESS; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Salinas FV, 2009, BREEDING BEHAV COLON; Schauble CS, 2001, BIOL J LINN SOC, V74, P157, DOI 10.1006/bijl.2001.0562; SHINE R, 2010, Q REV BIOL, V85, P253; Smith KL, 2013, MOL ECOL, V22, P1869, DOI 10.1111/mec.12176; Sugiura S, 2010, P ROY SOC B-BIOL SCI, V277, P1807, DOI 10.1098/rspb.2009.2086; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tingley R, 2015, BIOL INVASIONS, V17, P31, DOI 10.1007/s10530-014-0716-z; Tingley R, 2010, GLOBAL ECOL BIOGEOGR, V19, P496, DOI 10.1111/j.1466-8238.2010.00530.x; TYLER MJ, 1979, COPEIA, P355; Vidal N, 2008, BIOL LETTERS, V4, P115, DOI 10.1098/rsbl.2007.0531; Vitousek P.M., 1988, P181; Voros J, 2008, AUSTRAL ECOL, V33, P623, DOI 10.1111/j.1442-9993.2007.01828.x; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY, V2nd	65	2	2	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126287	10.1371/journal.pone.0126287	http://dx.doi.org/10.1371/journal.pone.0126287			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962141	Green Published, gold, Green Submitted			2022-12-26	WOS:000354542500085
J	Yoon, HE; Kim, SJ; Hwang, HS; Chung, S; Yang, CW; Shin, SJ				Yoon, Hye Eun; Kim, Sung Jun; Hwang, Hyeon Seok; Chung, Sungjin; Yang, Chul Woo; Shin, Seok Joon			Progressive Rise in Red Blood Cell Distribution Width Predicts Mortality and Cardiovascular Events in End-Stage Renal Disease Patients	PLOS ONE			English	Article							HEART-FAILURE; PROGNOSTIC MARKER; ENDOTHELIAL DYSFUNCTION; CHRONIC KIDNEY; INFLAMMATION; ERYTHROPOIESIS; HEMODIALYSIS; HEPCIDIN; ANEMIA; IRON	Red blood cell distribution width (RDW) is a robust marker of adverse clinical outcomes in various populations. However, the clinical significance of a progressive rise in RDW is undetermined in end-stage renal disease (ESRD) patients. The purpose of this study was to determine the prognostic importance of a change in RDW in ESRD patients. Three hundred twenty-six incident dialysis patients were retrospectively analyzed. Temporal changes in RDW during 12 months after dialysis initiation were assessed by calculating the coefficients by linear regression. Patients were divided into two groups: an RDW-decreased group who had negative coefficient values (n = 177) and an RDW-increased group who had positive values (n = 149). The associations between rising RDW and mortality and cardiovascular (CV) events were investigated. During a median follow-up of 2.7 years (range, 1.0-7.7 years), 75 deaths (24.0%) and 60 non-fatal CV events (18.4%) occurred. The event-free survival rate for the composite of end-points was lower in the RDW-increased group (P = 0.004). After categorizing patients according to baseline RDW, the event-free survival rate was lowest in patients with a baseline RDW>14.9% and increased RDW, and highest in patients with a baseline RDW <= 14.9% and decreased RDW (P = 0.02). In multivariate analysis, rising RDW was independently associated with the composite of end-points (hazard ratio = 1.75, P = 0.007), whereas the baseline RDW was not. This study shows that a progressive rise in RDW independently predicted mortality and CV events in ESRD patients. Rising RDW could be an additive predictor for adverse CV outcomes ESRD patients.	[Yoon, Hye Eun; Kim, Sung Jun; Hwang, Hyeon Seok; Chung, Sungjin; Yang, Chul Woo; Shin, Seok Joon] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Nephrol, Seoul, South Korea; [Yoon, Hye Eun; Kim, Sung Jun; Shin, Seok Joon] Incheon St Marys Hosp, Dept Internal Med, Inchon, South Korea	Catholic University of Korea	Shin, SJ (corresponding author), Catholic Univ Korea, Coll Med, Dept Internal Med, Div Nephrol, Seoul, South Korea.	imkidney@catholic.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning [2014R1A1A3A04050919]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and future Planning (2014R1A1A3A04050919).	Allen LA, 2010, J CARD FAIL, V16, P230, DOI 10.1016/j.cardfail.2009.11.003; Ani C, 2009, J NEUROL SCI, V277, P103, DOI 10.1016/j.jns.2008.10.024; Cauthen CA, 2012, J CARD FAIL, V18, P146, DOI 10.1016/j.cardfail.2011.10.013; CHIARI MM, 1995, J AM GERIATR SOC, V43, P767, DOI 10.1111/j.1532-5415.1995.tb07047.x; Emans ME, 2011, J CARD FAIL, V17, P626, DOI 10.1016/j.cardfail.2011.04.009; Felker GM, 2007, J AM COLL CARDIOL, V50, P40, DOI 10.1016/j.jacc.2007.02.067; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Forhecz Z, 2009, AM HEART J, V158, P659, DOI 10.1016/j.ahj.2009.07.024; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; Kalantar-Zadeh K, 2009, J AM SOC NEPHROL, V20, P479, DOI 10.1681/ASN.2007070728; KARNAD A, 1985, ARCH INTERN MED, V145, P1270, DOI 10.1001/archinte.145.7.1270; Lee P, 2005, P NATL ACAD SCI USA, V102, P1906, DOI 10.1073/pnas.0409808102; Lopez-Gomez JM, 2008, KIDNEY INT, V74, pS75, DOI 10.1038/ki.2008.523; Malandrino N, 2012, DIABETOLOGIA, V55, P226, DOI 10.1007/s00125-011-2331-1; Oh HJ, 2012, NEPHROL DIAL TRANSPL, V27, P589, DOI 10.1093/ndt/gfr307; Patel KV, 2013, ADV EXP MED BIOL, V765, P211, DOI 10.1007/978-1-4614-4989-8_29; Patel KV, 2009, ARCH INTERN MED, V169, P515, DOI 10.1001/archinternmed.2009.11; Peng F, 2014, INT J CARDIOLOGY; Perlstein TS, 2009, ARCH INTERN MED, V169, P588, DOI 10.1001/archinternmed.2009.55; Pierce CN, 2005, PERFUSION-UK, V20, P83, DOI 10.1191/0267659105pf793oa; Poggio ED, 2005, J AM SOC NEPHROL, V16, P459, DOI 10.1681/ASN.2004060447; RAINE AEG, 1992, NEPHROL DIAL TRANSPL, V7, P7; Sicaja M, 2013, CROAT MED J, V54, P25; Solak Y, 2014, AM J MED SCI, V347, P118, DOI 10.1097/MAJ.0b013e3182996a96; Tonelli M, 2008, CIRCULATION, V117, P163, DOI 10.1161/CIRCULATIONAHA.107.727545; Yang W, 2007, J AM SOC NEPHROL, V18, P3164, DOI 10.1681/ASN.2007010058; Yildiz A, 2003, AM J KIDNEY DIS, V41, P616, DOI 10.1053/ajkd.2003.50123	27	38	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126272	10.1371/journal.pone.0126272	http://dx.doi.org/10.1371/journal.pone.0126272			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961836	Green Published, Green Submitted, gold			2022-12-26	WOS:000354542500083
J	Pennati, R; Ficetola, GF; Brunetti, R; Caicci, F; Gasparini, F; Griggio, F; Sato, A; Stach, T; Kaul-Strehlow, S; Gissi, C; Manni, L				Pennati, Roberta; Ficetola, Gentile Francesco; Brunetti, Riccardo; Caicci, Federico; Gasparini, Fabio; Griggio, Francesca; Sato, Atsuko; Stach, Thomas; Kaul-Strehlow, Sabrina; Gissi, Carmela; Manni, Lucia			Morphological Differences between Larvae of the Ciona intestinalis Species Complex: Hints for a Valid Taxonomic Definition of Distinct Species	PLOS ONE			English	Article							ADHESIVE PAPILLAE; INTROGRESSION; DIVERGENCE; EVOLUTION; INSIGHTS; PLACODES; NEURONS; MODEL	The cosmopolitan ascidian Ciona intestinalis is the most common model species of Tunicata, the sister-group of Vertebrata, and widely used in developmental biology, genomics and evolutionary studies. Recently, molecular studies suggested the presence of cryptic species hidden within the C. intestinalis species, namely C. intestinalis type A and type B. So far, no substantial morphological differences have been identified between individuals belonging to the two types. Here we present morphometric, immunohistochemical, and histological analyses, as well as 3-D reconstructions, of late larvae obtained by cross-fertilization experiments of molecularly determined type A and type B adults, sampled in different seasons and in four different localities. Our data point to quantitative and qualitative differences in the trunk shape of larvae belonging to the two types. In particular, type B larvae exhibit a longer pre-oral lobe, longer and relatively narrower total body length, and a shorter ocellus-tail distance than type A larvae. All these differences were found to be statistically significant in a Discriminant Analysis. Depending on the number of analyzed parameters, the obtained discriminant function was able to correctly classify > 93% of the larvae, with the remaining misclassified larvae attributable to the existence of intra-type seasonal variability. No larval differences were observed at the level of histology and immunohistochemical localization of peripheral sensory neurons. We conclude that type A and type B are two distinct species that can be distinguished on the basis of larval morphology and molecular data. Since the identified larval differences appear to be valid diagnostic characters, we suggest to raise both types to the rank of species and to assign them distinct names.	[Pennati, Roberta; Griggio, Francesca; Gissi, Carmela] Univ Milan, Dipartimento Biosci, Milan, Italy; [Ficetola, Gentile Francesco] Univ Milano Bicocca, Dipartimento Sci Ambiente & Terr & Sci Terra, Milan, Italy; [Ficetola, Gentile Francesco] Univ Grenoble Alpes, Lab Ecol Alpine LECA, Grenoble, France; [Brunetti, Riccardo] Museo Storia Nat, Venice, Italy; [Caicci, Federico; Gasparini, Fabio; Manni, Lucia] Univ Padua, Dipartimento Biol, Padua, Italy; [Sato, Atsuko] Univ Oxford, Dept Zool, Oxford, England; [Stach, Thomas] Humboldt Univ, Inst Lebenswissensch Vergleichende Zool, D-10099 Berlin, Germany; [Kaul-Strehlow, Sabrina] Univ Vienna, Dept Integrat Zool, Vienna, Austria	University of Milan; University of Milano-Bicocca; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; University of Padua; University of Oxford; Humboldt University of Berlin; University of Vienna	Gissi, C (corresponding author), Univ Milan, Dipartimento Biosci, Milan, Italy.	carmela.gissi@unimi.it; lucia.manni@unipd.it	Ficetola, Gentile Francesco/A-2813-2008; Gasparini, Fabio/F-4485-2011	Ficetola, Gentile Francesco/0000-0003-3414-5155; Gasparini, Fabio/0000-0002-7574-0834; Manni, Lucia/0000-0003-4257-8946; Gissi, Carmela/0000-0002-2269-079X	MIUR (Ministero dell'Istruzione, Universita e Ricerca) [2009XF7TYT, 2009NWXMXX_003]; University of Padova [GRIC120LSZ]; CARIPLO Foundation [2013-0752]	MIUR (Ministero dell'Istruzione, Universita e Ricerca)(Ministry of Education, Universities and Research (MIUR)); University of Padova; CARIPLO Foundation(Fondazione Cariplo)	This work was supported by: PRIN Projects 2009 of MIUR (Ministero dell'Istruzione, Universita e Ricerca) to LM and CG (http://www.istruzione.it, grant numbers 2009XF7TYT and 2009NWXMXX_003, respectively), University of Padova Senior post-doc 2012 Project to FG (http://www.unipd.it, grant number GRIC120LSZ); and by grant n. 2013-0752 from CARIPLO Foundation to RP.	Bellas J, 2003, WATER RES, V37, P4613, DOI 10.1016/S0043-1354(03)00396-8; Berrill N. J., 1950, TUNICATA ACCOUNT BRI; Brunetti R, 2015, J ZOOLOGICA IN PRESS; Burighel P, 1997, MICROSCOPICAL ANATOM, V15, P221; Caicci F, 2010, J COMP NEUROL, V518, P547, DOI 10.1002/cne.22222; Caputi L, 2007, P NATL ACAD SCI USA, V104, P9364, DOI 10.1073/pnas.0610158104; CARLISLE DB, 1954, J MAR BIOL ASSOC UK, V33, P313, DOI 10.1017/S0025315400008341; Chiba S, 2004, ZOOL SCI, V21, P285, DOI 10.2108/zsj.21.285; Coniglio L, 1998, J EXP ZOOL, V280, P314, DOI 10.1002/(SICI)1097-010X(19980301)280:4<314::AID-JEZ5>3.0.CO;2-R; COPELLO M, 1981, Vie et Milieu, V31, P243; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Dolcemascolo G, 2009, ISJ-INVERT SURVIV J, V6, pS77; Groppelli S, 2001, INVERTEBR REPROD DEV, V40, P95, DOI 10.1080/07924259.2001.9652709; Horie T, 2008, J COMP NEUROL, V508, P249, DOI 10.1002/cne.21678; Hoshino Z., 1967, Publications of the Seto Marine Biological Laboratory, V15, P275; HOSHINO Z-I, 1985, Publications of the Seto Marine Biological Laboratory, V30, P61; Iannelli F, 2007, TRENDS GENET, V23, P419, DOI 10.1016/j.tig.2007.07.001; Imai JH, 2007, J COMP NEUROL, V501, P335, DOI 10.1002/cne.21247; JEFFERY WR, 1992, BIOESSAYS, V14, P219, DOI 10.1002/bies.950140404; KOTT P, 1990, Memoirs of the Queensland Museum, V29, P1; Kott P, 1969, ANTARCTIC RES SERIES; LAMBERT C, 1990, Vie et Milieu, V40, P293; Legendre P., 2012, NUMERICAL ECOLOGY; Manni L, 2005, J EXP ZOOL PART B, V304B, P324, DOI 10.1002/jez.b.21039; Manni L, 2004, J EXP ZOOL PART B, V302B, P483, DOI 10.1002/jez.b.21013; Marks JA, 1996, CAN J ZOOL, V74, P357, DOI 10.1139/z96-043; Millar RH, 1953, CIONA; Milne-Edwards H., 1841, MEM ACAD SCI I FR, V18, P217, DOI DOI 10.5962/BHL.TITLE.6289; MUKAI H, 1987, J MORPHOL, V193, P263, DOI 10.1002/jmor.1051930305; Nydam ML, 2007, MAR BIOL, V151, P1839, DOI 10.1007/s00227-007-0617-0; Nydam ML, 2011, EVOLUTION, V65, P429, DOI 10.1111/j.1558-5646.2010.01153.x; Nydam ML, 2010, MOL PHYLOGENET EVOL, V56, P718, DOI 10.1016/j.ympev.2010.03.042; Pfennig DW, 2012, ANN NY ACAD SCI, V1256, P89, DOI 10.1111/j.1749-6632.2011.06381.x; Pinheiro P., 2000, MIXED EFFECT MODELS; Roule L, 1884, RECHERCHES ASCIDIES; Roux C, 2013, MOL BIOL EVOL, V30, P1574, DOI 10.1093/molbev/mst066; Sasakura Y, 2009, EXP ANIM TOKYO, V58, P459, DOI 10.1538/expanim.58.459; Sato A, 2014, ZOOL SCI, V31, P369, DOI 10.2108/zs130249; Sato A, 2012, MAR BIOL, V159, P1611, DOI 10.1007/s00227-012-1898-5; Satoh N, 2003, NAT REV GENET, V4, P285, DOI 10.1038/nrg1042; Stach TG, 2009, ZOOMORPHOLOGY, V128, P97, DOI 10.1007/s00435-008-0076-2; Stuart YE, 2013, TRENDS ECOL EVOL, V28, P402, DOI 10.1016/j.tree.2013.02.014; Suzuki MM, 2005, J MOL EVOL, V61, P627, DOI 10.1007/s00239-005-0009-3; Takamura K, 1998, DEV GENES EVOL, V208, P1, DOI 10.1007/s004270050147; Turon X, 2004, MOL PHYLOGENET EVOL, V33, P309, DOI 10.1016/j.ympev.2004.06.011; Verrill A. E., 1871, AM J SCI, P443; Zhan AB, 2010, MOL ECOL, V19, P4678, DOI 10.1111/j.1365-294X.2010.04837.x	47	78	78	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0122879	10.1371/journal.pone.0122879	http://dx.doi.org/10.1371/journal.pone.0122879			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955391	Green Published, gold, Green Submitted			2022-12-26	WOS:000356768100008
J	Shen, KZ; Feng, XW; Su, R; Xie, HY; Zhou, L; Zheng, SS				Shen, Kezhen; Feng, Xiaowen; Su, Rong; Xie, Haiyang; Zhou, Lin; Zheng, Shusen			Epigallocatechin 3-Gallate Ameliorates Bile Duct Ligation Induced Liver Injury in Mice by Modulation of Mitochondrial Oxidative Stress and Inflammation	PLOS ONE			English	Article							NF-KAPPA-B; (-)EPIGALLOCATECHIN-GALLATE EGCG; OBSTRUCTIVE CHOLESTASIS; CELL-PROLIFERATION; ENERGY-METABOLISM; HEPATIC-FIBROSIS; DOWN-REGULATION; UP-REGULATION; APOPTOSIS; RATS	Cholestatic liver fibrosis was achieved by bile duct ligation (BDL) in mice. Liver injury associated with BDL for 15 days included significant reactive oxygen/nitrogen species generation, liver inflammation, cell death and fibrosis. Administration of Epigallocatechin 3-Gallate (EGCG) in animals reduced liver fibrosis involving parenchymal cells in BDL model. EGCG attenuated BDL-induced gene expression of pro-fibrotic markers (Collagen, Fibronectin, alpha 2 smooth muscle actin or SMA and connective tissue growth factor or CTGF), mitochondrial oxidative stress, cell death marker (DNA fragmentation and PARP activity), NF kappa B activity and pro-inflammatory cytokines (TNF alpha, MIP1 alpha, IL1 beta, and MIP2). EGCG also improved BDL induced damages of mitochondrial electron transport chain complexes and antioxidant defense enzymes such as glutathione peroxidase and manganese superoxide dismutase. EGCG also attenuated hydrogen peroxide induced cell death in hepatocytes in vitro and alleviate stellate cells mediated fibrosis through TIMP1, SMA, Collagen 1 and Fibronectin in vitro. In conclusion, the reactive oxygen/nitrogen species generated from mitochondria plays critical pathogenetic role in the progression of liver inflammation and fibrosis and this study indicate that EGCG might be beneficial for reducing liver inflammation and fibrosis.	[Shen, Kezhen; Feng, Xiaowen; Su, Rong; Xie, Haiyang; Zhou, Lin; Zheng, Shusen] Zhejiang Univ, Affiliated Hosp 1, Key Lab Combined Multiorgan Transplantat, Minist Publ Hlth,Coll Med, Hangzhou 310003, Zhejiang, Peoples R China; [Shen, Kezhen; Feng, Xiaowen; Su, Rong; Xie, Haiyang; Zhou, Lin; Zheng, Shusen] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China; [Zheng, Shusen] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Div Hepatobiliary & Pancreat Surg, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; Zhejiang University	Zheng, SS (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Key Lab Combined Multiorgan Transplantat, Minist Publ Hlth,Coll Med, Hangzhou 310003, Zhejiang, Peoples R China.	shusenzheng@zju.edu.cn			National ST Major Project [2012ZX10002-017]; Science and Technology Department of Zhejiang Province [2013C37053]; Education Department of Zhejiang Province [Y201326715, Y200908541]	National ST Major Project; Science and Technology Department of Zhejiang Province; Education Department of Zhejiang Province	This work was supported by grants from National S&T Major Project (No. 2012ZX10002-017), Science and Technology Department of Zhejiang Province(no. 2013C37053), Education Department of Zhejiang Province (Y201326715, Y200908541). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmegeed MA, 2013, FREE RADICAL BIO MED, V60, P211, DOI 10.1016/j.freeradbiomed.2013.02.018; Alaish SM, 2005, SHOCK, V24, P412, DOI 10.1097/01.shk.0000183392.83272.97; Alison M, 1998, CURR OPIN CELL BIOL, V10, P710, DOI 10.1016/S0955-0674(98)80111-7; Aredia F, 2014, BIOCHEM PHARMACOL, V92, P157, DOI 10.1016/j.bcp.2014.06.021; Arif IA, 2010, TOXICOL IND HEALTH, V26, P121, DOI 10.1177/0748233710362382; Bohan A, 2003, J BIOL CHEM, V278, P36688, DOI 10.1074/jbc.M304011200; Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677; Castro L, 2011, FREE RADICAL RES, V45, P37, DOI 10.3109/10715762.2010.516254; Chacko Sabu M, 2010, Chin Med, V5, P13, DOI 10.1186/1749-8546-5-13; Cui Y, 2007, HEPATOLOGY, V46, P504, DOI 10.1002/hep.21713; Czaja AJ, 2014, WORLD J GASTROENTERO, V20, P2515, DOI 10.3748/wjg.v20.i10.2515; Devika PT, 2008, PHARMACOL RES, V57, P351, DOI 10.1016/j.phrs.2008.03.008; Devika PT, 2008, CHEM-BIOL INTERACT, V172, P245, DOI 10.1016/j.cbi.2008.01.003; Dragicevic N, 2011, J ALZHEIMERS DIS, V26, P507, DOI 10.3233/JAD-2011-101629; Duarte S, 2015, MATRIX BIOL, V44-46, P147, DOI 10.1016/j.matbio.2015.01.004; Forbes SJ, 2004, GASTROENTEROLOGY, V126, P955, DOI 10.1053/j.gastro.2004.02.025; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Garcia-Ruiz I, 2014, DIS MODEL MECH, V7, P1287, DOI 10.1242/dmm.016766; Georgiev P, 2008, BRIT J SURG, V95, P646, DOI 10.1002/bjs.6050; Giakoustidis DE, 2010, J SURG RES, V159, P720, DOI 10.1016/j.jss.2008.08.038; Gujral JS, 2003, HEPATOLOGY, V38, P355, DOI 10.1053/jhep.2003.50341; Harakeh S, 2014, ASIAN PAC J CANCER P, V15, P1219, DOI 10.7314/APJCP.2014.15.3.1219; Hinson JA, 2004, DRUG METAB REV, V36, P805, DOI 10.1081/DMR-200033494; Jaeschke H, 2004, LIVER INT, V24, P85, DOI 10.1111/j.1478-3231.2004.0906.x; Jeong WI, 2006, HEPATOLOGY, V44, P1441, DOI 10.1002/hep.21419; Jiao K, 2014, SCAND J GASTROENTERO, V49, P715, DOI 10.3109/00365521.2014.899618; Kaviarasan S, 2007, BASIC CLIN PHARMACOL, V100, P151, DOI 10.1111/j.1742-7843.2006.00036.x; Kong XN, 2012, HEPATOLOGY, V56, P1150, DOI 10.1002/hep.25744; Kumar P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110405; Kuo WN, 2002, MOL CELL BIOCHEM, V233, P57, DOI 10.1023/A:1015510207489; Lambert JD, 2010, FOOD CHEM TOXICOL, V48, P409, DOI 10.1016/j.fct.2009.10.030; Lim YS, 2008, CLIN LIVER DIS, V12, P733, DOI 10.1016/j.cld.2008.07.007; Marques TG, 2012, ACTA CIR BRAS, V27, P589, DOI 10.1590/S0102-86502012000800013; Marshall A, 2013, BIOCHEM BIOPH RES CO, V430, P231, DOI 10.1016/j.bbrc.2012.10.142; Maruyama T, 2014, ONCOL REP, V31, P625, DOI 10.3892/or.2013.2925; Mielgo-Ayuso J, 2014, BRIT J NUTR, V111, P1263, DOI 10.1017/S0007114513003784; Miyoshi H, 1999, GASTROENTEROLOGY, V117, P669, DOI 10.1016/S0016-5085(99)70461-0; Mochizuki M, 2010, PHYTOTHER RES, V24, pS120, DOI 10.1002/ptr.2862; Mukhopadhyay P, 2014, HEPATOLOGY, V59, P1998, DOI 10.1002/hep.26763; Mukhopadhyay P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015705; Nagle DG, 2006, PHYTOCHEMISTRY, V67, P1849, DOI 10.1016/j.phytochem.2006.06.020; Nanji AA, 1997, ALCOHOL HEALTH RES W, V21, P325; Olynyk JK, 1998, AM J PATHOL, V152, P347; Paik YH, 2014, ANTIOXID REDOX SIGN, V20, P2854, DOI 10.1089/ars.2013.5619; Pan H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124775; Pan H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086057; Pastor A, 1997, J HEPATOL, V27, P363, DOI 10.1016/S0168-8278(97)80183-3; Peairs A, 2010, CELL MOL IMMUNOL, V7, P123, DOI 10.1038/cmi.2010.1; Puche JE, 2013, COMPR PHYSIOL, V3, P1473, DOI 10.1002/cphy.c120035; Radi R, 2002, FREE RADICAL BIO MED, V33, P1451, DOI 10.1016/S0891-5849(02)01111-5; Radi R, 2002, BIOL CHEM, V383, P401, DOI 10.1515/BC.2002.044; Ren YA, 2011, MOL BIOL REP, V38, P879, DOI 10.1007/s11033-010-0180-5; RIEDER H, 1993, HEPATOLOGY, V18, P937, DOI 10.1002/hep.1840180427; Roede JR, 2010, ENVIRON MOL MUTAGEN, V51, P380, DOI 10.1002/em.20553; Sandoval-Acuna C, 2014, ARCH BIOCHEM BIOPHYS, V559, P75, DOI 10.1016/j.abb.2014.05.017; Schaffer S, 2012, MOL NEUROBIOL, V46, P161, DOI 10.1007/s12035-012-8282-9; Schroeder EK, 2009, ANTIOXID REDOX SIGN, V11, P469, DOI [10.1089/ars.2008.2215, 10.1089/ARS.2008.2215]; Scovassi AI, 2004, BIOCHEM PHARMACOL, V68, P1041, DOI 10.1016/j.bcp.2004.04.023; Sen T, 2009, LIFE SCI, V84, P194, DOI 10.1016/j.lfs.2008.11.018; Siegelin MD, 2008, NEUROSCI LETT, V448, P161, DOI 10.1016/j.neulet.2008.10.036; Soroka CJ, 2001, HEPATOLOGY, V33, P783, DOI 10.1053/jhep.2001.23501; STARZL TE, 1989, NEW ENGL J MED, V321, P1014, DOI 10.1056/NEJM198910123211505; STIEHL A, 1990, HEPATOLOGY, V12, P492, DOI 10.1002/hep.1840120308; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tao L, 2014, MOL NUTR FOOD RES, V58, P665, DOI 10.1002/mnfr.201300427; Thomas F, 2009, PROSTATE, V69, P219, DOI 10.1002/pros.20873; Tipoe GL, 2010, TOXICOLOGY, V273, P45, DOI 10.1016/j.tox.2010.04.014; Ullmann U, 2003, J INT MED RES, V31, P88, DOI 10.1177/147323000303100205; Velayutham P, 2008, CURR MED CHEM, V15, P1840; Virag L, 2013, MOL ASPECTS MED, V34, P1153, DOI 10.1016/j.mam.2013.01.007; Wagner M, 2003, GASTROENTEROLOGY, V125, P825, DOI 10.1016/S0016-5085(03)01068-0; WANG Y, 2013, PLOS ONE, V2013; Yang J, 2013, LIFE SCI, V92, P589, DOI 10.1016/j.lfs.2013.01.025; You Hong, 2012, Zhonghua Gan Zang Bing Za Zhi, V20, P563; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200; Zhang QY, 2014, J SURG RES, V189, P152, DOI 10.1016/j.jss.2014.01.061; Zhao Y, 2014, FREE RADICAL BIO MED, V72, P55, DOI 10.1016/j.freeradbiomed.2014.03.001; Zhu W, 2014, J RADIAT RES, V55, P1056, DOI 10.1093/jrr/rru047; Zhu YP, 2014, FITOTERAPIA, V99, P243, DOI 10.1016/j.fitote.2014.08.007	79	32	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0126278	10.1371/journal.pone.0126278	http://dx.doi.org/10.1371/journal.pone.0126278			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955525	Green Published, gold, Green Submitted			2022-12-26	WOS:000356768100108
J	Yonesaka, K; Hirotani, K; Kawakami, H; Takeda, M; Kaneda, H; Sakai, K; Okamoto, I; Nishio, K; Janne, PA; Nakagawa, K				Yonesaka, K.; Hirotani, K.; Kawakami, H.; Takeda, M.; Kaneda, H.; Sakai, K.; Okamoto, I.; Nishio, K.; Jaenne, P. A.; Nakagawa, K.			Anti-HER3 monoclonal antibody patritumab sensitizes refractory non-small cell lung cancer to the epidermal growth factor receptor inhibitor erlotinib	ONCOGENE			English	Article							ADVANCED SOLID TUMORS; KINASE DOMAIN; INACTIVE HER3; EGFR; GEFITINIB; AMPLIFICATION; RESISTANCE; THERAPY; ERBB3; ACTIVATION	Human epidermal growth factor receptor (HER) 3 is aberrantly overexpressed and correlates with poor prognosis in non-small cell lung cancer (NSCLC). Patritumab is a monoclonal antibody against HER3 that has shown promising results in early-phase clinical trials, but an optimal target population for the drug has yet to be identified. In the present study, we examined whether heregulin, a HER3 ligand that is also overexpressed in a subset of NSCLC, can be used as a biomarker to predict the antitumorigenic efficacy of patritumab and whether the drug can overcome the epidermal growth factor receptor tyrosine kinase inhibitor (EGFR TKI) resistance induced by heregulin. Patritumab sensitivity was associated with heregulin expression, which, when abolished, resulted in the loss of HER3 and AKT activation and growth arrest. Furthermore, heregulin overexpression induced EGFR TKI resistance in NSCLC cells harbouring an activating EGFR mutation, while HER3 and AKT activation was maintained in the presence of erlotinib in heregulin-overexpressing, EGFR-mutant NSCLC cells. Sustained HER3-AKT activation was blocked by combining erlotinib with either anti-HER2 or anti-HER3 antibody. Notably, heregulin was upregulated in tissue samples from an NSCLC patient who had an activating EGFR mutation but was resistant to the TKI gefitinib. These results indicate that patritumab can overcome heregulin-dependent EGFR inhibitor resistance in NSCLC in vitro and in vivo and suggest that it can be used in combination with EGFR TKIs to treat a subset of heregulin-overexpressing NSCLC patients.	[Yonesaka, K.; Kawakami, H.; Takeda, M.; Kaneda, H.; Nakagawa, K.] Kinki Univ, Sch Med, Dept Med Oncol, 377-2 Ohnohigashi Osaka Sayamashi, Osaka 5898511, Japan; [Kawakami, H.] Daiichi Sankyo Pharmaceut Dev, Tokyo, Japan; [Sakai, K.; Nishio, K.] Kinki Univ, Sch Med, Dept Genome Biol, Osaka 589, Japan; [Okamoto, I.] Kyushu Univ, Ctr Clin & Translat Res, Fukuoka 812, Japan; [Jaenne, P. A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, Boston, MA 02115 USA; [Jaenne, P. A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Jaenne, P. A.] Harvard Univ, Sch Med, Brigham Womens Hosp, Dept Med, Boston, MA 02115 USA	Kindai University (Kinki University); Daiichi Sankyo Company Limited; Kindai University (Kinki University); Kyushu University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Yonesaka, K (corresponding author), Kinki Univ, Sch Med, Dept Med Oncol, 377-2 Ohnohigashi Osaka Sayamashi, Osaka 5898511, Japan.; Janne, PA (corresponding author), Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, 450 Brookline Ave,HIM223, Boston, MA 02215 USA.	yonesaka@sakai.med.kindai.ac.jp; pjanne@partners.org	Kawakami, Hisato/L-6845-2019	Kawakami, Hisato/0000-0002-3280-4850	Daiichi-Sankyo Pharmaceutical Development	Daiichi-Sankyo Pharmaceutical Development	We thank Haruka Yamaguchi, Yume Shinkai, Michiko Kitano and Mami Kitano for technical support. This work was financially funded in part by Daiichi-Sankyo Pharmaceutical Development.	Aguilar Z, 1999, ONCOGENE, V18, P6050, DOI 10.1038/sj.onc.1202993; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Cappuzzo F, 2005, BRIT J CANCER, V93, P1334, DOI 10.1038/sj.bjc.6602865; Cho BC, 2007, J CLIN ONCOL, V25, P2528, DOI 10.1200/JCO.2006.10.4166; Engelman JA, 2005, P NATL ACAD SCI USA, V102, P3788, DOI 10.1073/pnas.0409773102; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Ercan D, 2010, ONCOGENE, V29, P2346, DOI 10.1038/onc.2009.526; Garner AP, 2013, CANCER RES, V73, P6024, DOI 10.1158/0008-5472.CAN-13-1198; Guerra-Vladusic FK, 2001, ONCOL REP, V8, P1203; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Ji HB, 2006, CANCER CELL, V9, P485, DOI 10.1016/j.ccr.2006.04.022; Jura N, 2009, P NATL ACAD SCI USA, V106, P21608, DOI 10.1073/pnas.0912101106; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Lee-Hoeflich ST, 2008, CANCER RES, V68, P5878, DOI 10.1158/0008-5472.CAN-08-0380; LoRusso P, 2013, CLIN CANCER RES, V19, P3078, DOI 10.1158/1078-0432.CCR-12-3051; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mirschberger C, 2013, CANCER RES, V73, P5183, DOI 10.1158/0008-5472.CAN-13-0099; Murakami H, 2013, ANN ONCOL S9, V24; Noto A, 2013, ONCOTARGET, V4, P1253, DOI 10.18632/oncotarget.1141; Ohsaki Y, 2000, ONCOL REP, V7, P603; Okabe T, 2007, CANCER RES, V67, P2046, DOI 10.1158/0008-5472.CAN-06-3339; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Schaefer G, 2011, CANCER CELL, V20, P472, DOI 10.1016/j.ccr.2011.09.003; Schoeberl B, 2010, CANCER RES, V70, P2485, DOI 10.1158/0008-5472.CAN-09-3145; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; Takezawa K, 2012, CANCER DISCOV, V2, P922, DOI 10.1158/2159-8290.CD-12-0108; Takezawa K, 2009, CANCER RES, V69, P6515, DOI 10.1158/0008-5472.CAN-09-1076; Von Pawel J, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.8045; Wakui H, 2014, CANCER CHEMOTH PHARM, V73, P511, DOI 10.1007/s00280-014-2375-2; Wilson TR, 2011, CANCER CELL, V20, P158, DOI 10.1016/j.ccr.2011.07.011; Yi ES, 1997, MODERN PATHOL, V10, P142; Yonesaka K, 2008, CLIN CANCER RES, V14, P6963, DOI 10.1158/1078-0432.CCR-08-0957; Yonesaka K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002442; Zhang Q, 2012, P NATL ACAD SCI USA, V109, P13237, DOI 10.1073/pnas.1200105109; Zhou BBS, 2006, CANCER CELL, V10, P39, DOI 10.1016/j.ccr.2006.05.024	37	58	65	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 18	2016	35	7					878	886		10.1038/onc.2015.142	http://dx.doi.org/10.1038/onc.2015.142			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DE0RO	25961915				2022-12-26	WOS:000370332200008
J	Schuepbach-Mallepell, S; Das, D; Willen, L; Vigolo, M; Tardivel, A; Lebon, L; Kowalczyk-Quintas, C; Nys, J; Smulski, C; Zheng, TS; Maskos, K; Lammens, A; Jiang, XL; Hess, H; Tan, SL; Schneider, P				Schuepbach-Mallepell, Sonia; Das, Dolon; Willen, Laure; Vigolo, Michele; Tardivel, Aubry; Lebon, Luc; Kowalczyk-Quintas, Christine; Nys, Josquin; Smulski, Cristian; Zheng, Timothy S.; Maskos, Klaus; Lammens, Alfred; Jiang, Xuliang; Hess, Henry; Tan, Seng-Lai; Schneider, Pascal			Stoichiometry of Heteromeric BAFF and APRIL Cytokines Dictates Their Receptor Binding and Signaling Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytokine; immunology; protein engineering; receptor; signaling; APRIL; BAFF; heteromers	NECROSIS-FACTOR FAMILY; SINGLE-CHAIN TNF; CRYSTAL-STRUCTURE; B-CELLS; LYMPHOTOXIN-BETA; MEMBER; BLYS; ACTIVATION; TACI; SURVIVAL	Background: The B cell survival factors B cell activation factor (BAFF) and a proliferation-inducing ligand (APRIL) can heteromerize. Results: BAFF-APRIL(2) and APRIL-BAFF(2) heteromers have distinct receptor-binding specificities and activities. Conclusion: BAFF-APRIL(2) resembles APRIL, and APRIL-BAFF(2) resembles BAFF but poorly activates the BAFF receptor. Significance: Heteromers should be taken into account when evaluating the physiology or pharmacological inhibition of BAFF and APRIL. The closely related TNF family ligands B cell activation factor (BAFF) and a proliferation-inducing ligand (APRIL) serve in the generation and maintenance of mature B-lymphocytes. Both BAFF and APRIL assemble as homotrimers that bind and activate several receptors that they partially share. However, heteromers of BAFF and APRIL that occur in patients with autoimmune diseases are incompletely characterized. The N and C termini of adjacent BAFF or APRIL monomers are spatially close and can be linked to create single-chain homo- or hetero-ligands of defined stoichiometry. Similar to APRIL, heteromers consisting of one BAFF and two APRILs (BAA) bind to the receptors B cell maturation antigen (BCMA), transmembrane activator and CAML interactor (TACI) but not to the BAFF receptor (BAFFR). Heteromers consisting of one APRIL and two BAFF (ABB) bind to TACI and BCMA and weakly to BAFFR in accordance with the analysis of the receptor interaction sites in the crystallographic structure of ABB. Receptor binding correlated with activity in reporter cell line assays specific for BAFFR, TACI, or BCMA. Single-chain BAFF (BBB) and to a lesser extent single-chain ABB, but not APRIL or single-chain BAA, rescued BAFFR-dependent B cell maturation in BAFF-deficient mice. In conclusion, BAFF-APRIL heteromers of different stoichiometries have distinct receptor-binding properties and activities. Based on the observation that heteromers are less active than BAFF, we speculate that their physiological role might be to down-regulate BAFF activity.	[Schuepbach-Mallepell, Sonia; Das, Dolon; Willen, Laure; Vigolo, Michele; Tardivel, Aubry; Lebon, Luc; Kowalczyk-Quintas, Christine; Nys, Josquin; Smulski, Cristian; Schneider, Pascal] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Zheng, Timothy S.] Biogen, Cambridge, MA 02142 USA; [Maskos, Klaus; Lammens, Alfred] Proteros Biostruct GmbH, D-82152 Martinsried, Germany; [Jiang, Xuliang; Tan, Seng-Lai] EMD Serono Res & Dev Inst, Billerica, MA 01821 USA; [Hess, Henry] Merck KGaA, D-64293 Darmstadt, Germany	University of Lausanne; Biogen; Merck KGaA	Schneider, P (corresponding author), Univ Lausanne, Dept Biochem, Boveresses 155, CH-1066 Epalinges, Switzerland.	pascal.schneider@unil.ch	Tan, Seng-Lai/AAQ-2585-2021	Vigolo, Michele/0000-0002-4765-6598; Smulski, Cristian/0000-0003-4186-8116; Schneider, Pascal/0000-0003-0677-9409	Swiss National Science Foundation; Institute of Arthritis Research; EMD Serono	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Institute of Arthritis Research; EMD Serono	This work was supported by grants from the Swiss National Science Foundation (to P. S.), by the Institute of Arthritis Research, and by project funding from EMD Serono (to P. S.). P. S. is supported by a research grant from EMD Serono, a subsidiary of Merck, KGaA. X. J., H. H., and S. T. are employees of Merck, KGaA. T. Z. is an employee of BiogenIdec. A. L. and M. K. are employees of Proteros Biostructures GmbH. Other authors declare no competing financial interests.	Benson MJ, 2008, J IMMUNOL, V180, P3655, DOI 10.4049/jimmunol.180.6.3655; Blanc E., 2011, BUSTER VERSION 2 11; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Boschert V, 2010, CELL SIGNAL, V22, P1088, DOI 10.1016/j.cellsig.2010.02.011; Bossen C, 2008, BLOOD, V111, P1004, DOI 10.1182/blood-2007-09-110874; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Bossen C, 2006, SEMIN IMMUNOL, V18, P263, DOI 10.1016/j.smim.2006.04.006; Bossen C, 2011, EUR J IMMUNOL, V41, P787, DOI 10.1002/eji.201040591; Browning JL, 1996, J BIOL CHEM, V271, P8618, DOI 10.1074/jbc.271.15.8618; BROWNING JL, 1993, CELL, V72, P847, DOI 10.1016/0092-8674(93)90574-A; Cachero TG, 2006, BIOCHEMISTRY-US, V45, P2006, DOI 10.1021/bi051685o; Chang SK, 2006, BLOOD, V108, P2687, DOI 10.1182/blood-2005-12-017319; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Craxton A, 2003, BLOOD, V101, P4464, DOI 10.1182/blood-2002-10-3123; CROWE PD, 1994, SCIENCE, V264, P707, DOI 10.1126/science.8171323; Dillon SR, 2006, NAT REV DRUG DISCOV, V5, P235, DOI 10.1038/nrd1982; Dillon SR, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2959; ECK MJ, 1989, J BIOL CHEM, V264, P17595; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Figgett WA, 2013, IMMUNITY, V39, P573, DOI 10.1016/j.immuni.2013.05.019; Gordon NC, 2003, BIOCHEMISTRY-US, V42, P5977, DOI 10.1021/bi034017g; Holler N, 2003, MOL CELL BIOL, V23, P1428, DOI 10.1128/MCB.23.4.1428-1440.2003; Huard B, 2008, J CLIN INVEST, V118, P2887, DOI 10.1172/JCI33760; Hymowitz SG, 2005, J BIOL CHEM, V280, P7218, DOI 10.1074/jbc.M411714200; Ingold K, 2005, J EXP MED, V201, P1375, DOI 10.1084/jem.20042309; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karpusas M, 2002, J MOL BIOL, V315, P1145, DOI 10.1006/jmbi.2001.5296; Kim HM, 2003, NAT STRUCT BIOL, V10, P342, DOI 10.1038/nsb925; Kimberley FC, 2012, J BIOL CHEM, V287, P37434, DOI 10.1074/jbc.M112.406090; Krippner-Heidenreich A, 2008, J IMMUNOL, V180, P8176, DOI 10.4049/jimmunol.180.12.8176; Liu YF, 2003, NATURE, V423, P49, DOI 10.1038/nature01543; Liu YF, 2002, CELL, V108, P383, DOI 10.1016/S0092-8674(02)00631-1; Lopez-Fraga M, 2001, EMBO REP, V2, P945, DOI 10.1093/embo-reports/kve198; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; O'Connor BP, 2004, J EXP MED, V199, P91, DOI 10.1084/jem.20031330; Oren DA, 2002, NAT STRUCT BIOL, V9, P288, DOI 10.1038/nsb769; Patke A, 2006, J EXP MED, V203, P2551, DOI 10.1084/jem.20060990; Roschke V, 2002, J IMMUNOL, V169, P4314, DOI 10.4049/jimmunol.169.8.4314; Schneider P, 2000, METHOD ENZYMOL, V322, P325; Schneider P, 2014, METHOD ENZYMOL, V545, P103, DOI 10.1016/B978-0-12-801430-1.00005-6; Schneider P, 2010, CONTEMP IMMUNOL, P1, DOI 10.1007/978-1-60327-013-7_1; Shulga-Morskaya S, 2004, J IMMUNOL, V173, P2331, DOI 10.4049/jimmunol.173.4.2331; Stohl W, 2014, EXPERT OPIN THER TAR, V18, P473, DOI 10.1517/14728222.2014.888415; Sudhamsu J, 2013, P NATL ACAD SCI USA, V110, P19896, DOI 10.1073/pnas.1310838110; Swee LK, 2010, IMMUNOL LETT, V131, P40, DOI 10.1016/j.imlet.2010.03.007; Treml LS, 2007, J IMMUNOL, V178, P7531, DOI 10.4049/jimmunol.178.12.7531; von Bulow GU, 2001, IMMUNITY, V14, P573, DOI 10.1016/S1074-7613(01)00130-3; Yan MH, 2001, NAT IMMUNOL, V2, P638, DOI 10.1038/89790	51	34	36	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16330	16342		10.1074/jbc.M115.661405	http://dx.doi.org/10.1074/jbc.M115.661405			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25953898	Green Published, hybrid			2022-12-26	WOS:000356930100035
J	Garcia, JE; Girard, MB; Kasumovic, M; Petersen, P; Wilksch, PA; Dyer, AG				Garcia, Jair E.; Girard, Madeline B.; Kasumovic, Michael; Petersen, Phred; Wilksch, Philip A.; Dyer, Adrian G.			Differentiating Biological Colours with Few and Many Sensors: Spectral Reconstruction with RGB and Hyperspectral Cameras	PLOS ONE			English	Article							REFLECTANCE SPECTRA; VISUAL PIGMENTS; PRINCIPAL COMPONENTS; SURFACE REFLECTANCE; STRUCTURAL COLORS; SEXUAL-DIMORPHISM; PLUMAGE COLOR; OIL DROPLETS; VISION; EVOLUTION	Background The ability to discriminate between two similar or progressively dissimilar colours is important for many animals as it allows for accurately interpreting visual signals produced by key target stimuli or distractor information. Spectrophotometry objectively measures the spectral characteristics of these signals, but is often limited to point samples that could underestimate spectral variability within a single sample. Algorithms for RGB images and digital imaging devices with many more than three channels, hyperspectral cameras, have been recently developed to produce image spectrophotometers to recover reflectance spectra at individual pixel locations. We compare a linearised RGB and a hyperspectral camera in terms of their individual capacities to discriminate between colour targets of varying perceptual similarity for a human observer. Main Findings (1) The colour discrimination power of the RGB device is dependent on colour similarity between the samples whilst the hyperspectral device enables the reconstruction of a unique spectrum for each sampled pixel location independently from their chromatic appearance. (2) Uncertainty associated with spectral reconstruction from RGB responses results from the joint effect of metamerism and spectral variability within a single sample. Conclusion (1) RGB devices give a valuable insight into the limitations of colour discrimination with a low number of photoreceptors, as the principles involved in the interpretation of photoreceptor signals in trichromatic animals also apply to RGB camera responses. (2) The hyperspectral camera architecture provides means to explore other important aspects of colour vision like the perception of certain types of camouflage and colour constancy where multiple, narrow-band sensors increase resolution.	[Garcia, Jair E.; Petersen, Phred; Dyer, Adrian G.] RMIT Univ, Sch Media & Commun, Melbourne, Vic, Australia; [Girard, Madeline B.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Kasumovic, Michael] Univ New S Wales, Ecol & Evolut Res Ctr, Sydney, NSW, Australia; [Wilksch, Philip A.] RMIT Univ, Sch Appl Sci, Melbourne, Vic, Australia	Royal Melbourne Institute of Technology (RMIT); University of California System; University of California Berkeley; University of New South Wales Sydney; Royal Melbourne Institute of Technology (RMIT)	Garcia, JE (corresponding author), RMIT Univ, Sch Media & Commun, Melbourne, Vic, Australia.	jair.garcia@rmit.edu.au	Wilksch, Philip/I-3888-2019	Wilksch, Philip/0000-0003-1552-0263; Kasumovic, Michael/0000-0003-0158-5517; Garcia, Jair/0000-0001-8456-4759	Colfuturo (Colombia) Credito-beca [200818772]; Australian Research Council [DP0878968/DP130100015, DE120100214]	Colfuturo (Colombia) Credito-beca; Australian Research Council(Australian Research Council)	JEG was supported by Colfuturo (Colombia) (http://www.colfuturo.org) Credito-beca 200818772. AGD was supported by Australian Research Council (http://www.arc.gov.au/) DP0878968/DP130100015. MK was supported by Australian Research Council (http://www.arc.gov.au/) DE120100214. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adobe Systems Incorporated. Adobe RGB, 1998, COLOR IMAGE ENCODING, P2005; Alsam A, 2007, J OPT SOC AM A, V24, P2505, DOI 10.1364/JOSAA.24.002505; Alsam A, 2006, COMPUT IMAGING VIS, V32, P252, DOI 10.1007/1-4020-4179-9_36; Andersson S, 1998, P ROY SOC B-BIOL SCI, V265, P445, DOI 10.1098/rspb.1998.0315; ARIKAWA K, 1987, NATURWISSENSCHAFTEN, V74, P297, DOI 10.1007/BF00366422; BENNETT ATD, 1994, AM NAT, V144, P848, DOI 10.1086/285711; BERNARD GD, 1991, P NATL ACAD SCI USA, V88, P2783, DOI 10.1073/pnas.88.7.2783; Boves TJ, 2014, AUK, V131, P20, DOI 10.1642/AUK-13-191.1; BOWMAKER JK, 1977, VISION RES, V17, P1129, DOI 10.1016/0042-6989(77)90147-X; BOWMAKER JK, 1977, VISION RES, V17, P17, DOI 10.1016/0042-6989(77)90195-X; BOWMAKER JK, 1980, J PHYSIOL-LONDON, V298, P501, DOI 10.1113/jphysiol.1980.sp013097; Bradbury Jack W., 1998, pi; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; BROWN WRJ, 1957, J OPT SOC AM, V47, P137, DOI 10.1364/JOSA.47.000137; CARR DB, 1987, J AM STAT ASSOC, V82, P424, DOI 10.2307/2289444; Cheung V, 2005, J OPT SOC AM A, V22, P1231, DOI 10.1364/JOSAA.22.001231; Chiao CC, 2000, J OPT SOC AM A, V17, P218, DOI 10.1364/JOSAA.17.000218; Chiao CC, 2011, P NATL ACAD SCI USA, V108, P9148, DOI 10.1073/pnas.1019090108; CHITTKA L, 1992, J COMP PHYSIOL A, V170, P533; CHITTKA L, 1994, VISION RES, V34, P1489, DOI 10.1016/0042-6989(94)90151-1; Connah D, 2001, COLOR TECHNOL, V117, P309, DOI 10.1111/j.1478-4408.2001.tb00080.x; Conway BR, 2009, NEUROSCIENTIST, V15, P274, DOI 10.1177/1073858408331369; D'Andrade RG, 2003, P NATL ACAD SCI USA, V100, P6281, DOI 10.1073/pnas.1031827100; DAFNI A, 1984, ANNU REV ECOL SYST, V15, P259, DOI 10.1146/annurev.es.15.110184.001355; DAUMER K, 1956, Z VERGL PHYSIOL, V38, P413; de Lasarte M, 2010, J IMAGING SCI TECHN, V54, DOI 10.2352/J.ImagingSci.Technol.2010.54.3.030501; Dyer AG, 2006, ENTOMOL GEN, V28, P257; Dyer AG, 2012, P ROY SOC B-BIOL SCI, V279, P3606, DOI 10.1098/rspb.2012.0827; Dyer AG, 2011, P ROY SOC B-BIOL SCI, V278, P952, DOI 10.1098/rspb.2010.2412; Dyer AG, 2009, ISR J PLANT SCI, V57, P203, DOI 10.1560/IJPS.57.3.203; Dyer AG, 2005, J COMP PHYSIOL A, V191, P547, DOI 10.1007/s00359-005-0622-z; Dyer AG, 2004, NATURWISSENSCHAFTEN, V91, P224, DOI 10.1007/s00114-004-0508-x; Dyer AG, 1998, J COMP PHYSIOL A, V183, P203, DOI 10.1007/s003590050248; ENDLER JA, 1993, ECOL MONOGR, V63, P1, DOI 10.2307/2937121; Endler JA, 2005, EVOLUTION, V59, P1795, DOI 10.1111/j.0014-3820.2005.tb01827.x; ENDLER JA, 1990, BIOL J LINN SOC, V41, P315, DOI 10.1111/j.1095-8312.1990.tb00839.x; Endler JA, 1996, AM NAT, V148, P421, DOI 10.1086/285934; Endler JA, 2005, BIOL J LINN SOC, V86, P405, DOI 10.1111/j.1095-8312.2005.00540.x; Endler JA, 2012, BIOL J LINN SOC, V107, P233, DOI 10.1111/j.1095-8312.2012.01937.x; Evans SR, 2013, J ANIM ECOL, V82, P418, DOI 10.1111/1365-2656.12008; FARMER EW, 1980, PERCEPT PSYCHOPHYS, V27, P267, DOI 10.3758/BF03204265; Fielding AH, 2007, CLUSTER AND CLASSIFICATION TECHNIQUES FOR THE BIOSCIENCES, P1, DOI 10.2277/ 0521618002; Finlayson GD, 2005, J OPT SOC AM A, V22, P810, DOI 10.1364/JOSAA.22.000810; Fleishman LJ, 2006, ANIM BEHAV, V71, P463, DOI 10.1016/j.anbehav.2005.06.005; Foster DH, 2011, VISION RES, V51, P674, DOI 10.1016/j.visres.2010.09.006; Frisch K.v, 1914, ZOOLOGISCHE JB, V37, P1, DOI DOI 10.5962/BHL.TITLE.11736; Garcia JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096646; Garcia JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079534; Garcia JE, 2013, J EXP BIOL, V216, P4290, DOI 10.1242/jeb.094045; Gehres M, 2007, VISUAL NEUROSCI, V24, P399, DOI 10.1017/S0952523807070447; Giurfa M, 2004, NATURWISSENSCHAFTEN, V91, P228, DOI 10.1007/s00114-004-0530-z; Gonzalez R. C., 2008, DIGITAL IMAGE PROCES; Gonzalez-Miret ML, 2007, FOOD RES INT, V40, P1080, DOI 10.1016/j.foodres.2007.06.001; Haneishi H, 2000, APPL OPTICS, V39, P6621, DOI 10.1364/AO.39.006621; Hart NS, 2001, PROG RETIN EYE RES, V20, P675, DOI 10.1016/S1350-9462(01)00009-X; Heikkinen V, 2008, J OPT SOC AM A, V25, P2444, DOI 10.1364/JOSAA.25.002444; HELVERSEN OV, 1972, J COMP PHYSIOL, V80, P439, DOI 10.1007/BF00696438; Holst GC., 2007, CMOS CCD SENSORS CAM; Imai FH, 2000, J IMAGING SCI TECHN, V44, P280; Jacobs GH, 2007, SCIENCE, V315, P1723, DOI 10.1126/science.1138838; Telles FJ, 2014, J COMP PHYSIOL A, V200, P537, DOI 10.1007/s00359-014-0888-0; Johnson SD, 2003, ECOLOGY, V84, P2919, DOI 10.1890/02-0471; JUDD DB, 1964, J OPT SOC AM, V54, P1031, DOI 10.1364/JOSA.54.001031; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; Kinoshita M, 1999, J EXP BIOL, V202, P95; Kooi CJ, 2014, NEW PHYTOL; Koshitaka H, 2008, P ROY SOC B-BIOL SCI, V275, P947, DOI 10.1098/rspb.2007.1614; Kwon OS, 2007, J IMAGING SCI TECHN, V51, P166, DOI [10.2352/J.ImagingSci.Technol.(2007)51:2(166), 10.2352/J.lmagingSci.Technol.(2007)51:2(166)]; Lee H.-C., 2005, INTRO COLOR IMAGING; LENNIE P, 1988, CRIT REV NEUROBIOL, V3, P333; Lunau K., 2014, J COMP PHYSIOL A, V6, P1; Luo MR, 2006, COLOR RES APPL, V31, P320, DOI 10.1002/col.20227; MacAdam D. L., 1970, SOURCES COLOR SCI; MacAdam DL, 1943, J OPT SOC AM, V33, P18, DOI 10.1364/JOSA.33.000018; MACADAM DL, 1974, J OPT SOC AM, V64, P1691, DOI 10.1364/JOSA.64.001691; MacAdam DL, 1981, COLOR MEASUREMENT TH, V27; MALONEY LT, 1986, J OPT SOC AM A, V3, P1673, DOI 10.1364/JOSAA.3.001673; Mancuso K, 2009, NATURE, V461, P784, DOI 10.1038/nature08401; Maxwell JC, 1872, SOURCES COLOR SCI, P1872; McGraw KJ, 2004, CAN J ZOOL, V82, P734, DOI 10.1139/Z04-043; Mielke PW, 2007, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-69813-7; MORGAN MJ, 1992, P ROY SOC B-BIOL SCI, V248, P291, DOI 10.1098/rspb.1992.0074; Morovic P, 2006, J OPT SOC AM A, V23, P1814, DOI 10.1364/JOSAA.23.001814; Myers RD, 2010, COLORCHECKER PASSPOR; NAGY AL, 1990, J OPT SOC AM A, V7, P1209, DOI 10.1364/JOSAA.7.001209; NEUMEYER C, 1992, J COMP PHYSIOL A, V171, P639; NEWHALL SM, 1957, J OPT SOC AM, V47, P43, DOI 10.1364/JOSA.47.000043; Nieves JL, 2005, APPL OPTICS, V44, P5696, DOI 10.1364/AO.44.005696; Ogawa Y, 2013, J EXP BIOL, V216, P1916, DOI 10.1242/jeb.083485; Osorio D, 2008, VISION RES, V48, P2042, DOI 10.1016/j.visres.2008.06.018; Osorio D, 1997, VISION RES, V37, P3299, DOI 10.1016/S0042-6989(97)00136-3; Osorio D, 2004, AM NAT, V164, P696, DOI 10.1086/425332; Palmer G, 1777, SOURCES COLOR SCI, P1777; Parker AR, 1998, J EXP BIOL, V201, P2343; PARKKINEN JPS, 1989, J OPT SOC AM A, V6, P318, DOI 10.1364/JOSAA.6.000318; PEITSCH D, 1992, J COMP PHYSIOL A, V170, P23, DOI 10.1007/BF00190398; Pike TW, 2012, BEHAV ECOL, V23, P723, DOI 10.1093/beheco/ars018; Pike TW, 2011, BEHAV ECOL SOCIOBIOL, V65, P849, DOI 10.1007/s00265-010-1097-7; Regan BC, 2001, PHILOS T R SOC B, V356, P229, DOI 10.1098/rstb.2000.0773; Reser DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048577; Romney AK, 2008, J OPT SOC AM A, V25, P658, DOI 10.1364/JOSAA.25.000658; RUSHTON W A H, 1972, Journal of Physiology (Cambridge), V220, P1; Ryan MJ, 2013, ANNU REV ECOL EVOL S, V44, P437, DOI 10.1146/annurev-ecolsys-110512-135901; Schrodinger EV, 1970, SOURCES COLOR SCI, P1970; Shawkey MD, 2005, BIOL LETTERS, V1, P121, DOI 10.1098/rsbl.2004.0289; Shi MH, 2002, J OPT SOC AM A, V19, P645, DOI 10.1364/JOSAA.19.000645; Shimano N, 2007, J OPT SOC AM A, V24, P3211, DOI 10.1364/JOSAA.24.003211; Shimano N, 2006, IEEE T IMAGE PROCESS, V15, P1848, DOI 10.1109/TIP.2006.877069; Shimano N, 2010, J OPT SOC AM A, V27, P251, DOI 10.1364/JOSAA.27.000251; SMITH B, 1992, COLOR RES APPL, V17, P394, DOI 10.1002/col.5080170605; Solli M, 2005, IMAGE ANAL, P2005; Stavenga DG, 2006, ARTHROPOD STRUCT DEV, V35, P307, DOI 10.1016/j.asd.2006.08.011; Stevens M, 2007, BIOL J LINN SOC, V90, P211, DOI 10.1111/j.1095-8312.2007.00725.x; STOCKMAN A, 1993, J OPT SOC AM A, V10, P2491, DOI 10.1364/JOSAA.10.002491; Stockman A, 2000, VISION RES, V40, P1711, DOI 10.1016/S0042-6989(00)00021-3; Stoddard MC, 2011, BEHAV ECOL, V22, P1042, DOI 10.1093/beheco/arr088; Stojcev M, 2011, VISUAL NEUROSCI, V28, P361, DOI 10.1017/S0952523811000101; Thery M, 2002, NATURE, V415, P133, DOI 10.1038/415133a; Valero EM, 2007, COLOR RES APPL, V32, P352, DOI 10.1002/col.20339; van Trigt C, 2010, COLOR RES APPL, V35, P164, DOI 10.1002/col.20526; von Helmholtz H, 1866, SOURCES COLOR SCI, P1866; Vora PL, 2001, IEEE T IMAGE PROCESS, V10, P307, DOI 10.1109/83.902295; Vorobyev M, 1998, P ROY SOC B-BIOL SCI, V265, P351, DOI 10.1098/rspb.1998.0302; Vorobyev M, 1998, J COMP PHYSIOL A, V183, P621, DOI 10.1007/s003590050286; VRHEL MJ, 1994, COLOR RES APPL, V19, P4, DOI 10.1111/j.1520-6378.1994.tb00053.x; Vukusic P, 2009, J R SOC INTERFACE, V6, pS133, DOI 10.1098/rsif.2008.0386.focus; Vukusic P, 2003, NATURE, V424, P852, DOI 10.1038/nature01941; WALD G, 1964, SCIENCE, V145, P1007, DOI 10.1126/science.145.3636.1007; Westland S., 2012, COMPUTATIONAL COLOUR; Whitney HM, 2009, SCIENCE, V323, P130, DOI 10.1126/science.1166256; WORTHEY JA, 1986, J OPT SOC AM A, V3, P1708, DOI 10.1364/JOSAA.3.001708; WYSZECKI G, 1971, J OPT SOC AM, V61, P1135, DOI 10.1364/JOSA.61.001135; Wyszecki G., 2000, COLOR SCI CONCEPTS M, V2nd ed., P117; Yam KL, 2004, J FOOD ENG, V61, P137, DOI 10.1016/S0260-8774(03)00195-X; Young T, 1802, SOURCES COLOR SCI, P51; Zhang XD, 2008, J OPT SOC AM A, V25, P371, DOI 10.1364/JOSAA.25.000371	136	18	18	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0125817	10.1371/journal.pone.0125817	http://dx.doi.org/10.1371/journal.pone.0125817			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965264	Green Published, Green Submitted, gold			2022-12-26	WOS:000354543500029
J	Milani, N; Hettiarachchi, GM; Kirby, JK; Beak, DG; Stacey, SP; McLaughlin, MJ				Milani, Narges; Hettiarachchi, Ganga M.; Kirby, Jason K.; Beak, Douglas G.; Stacey, Samuel P.; McLaughlin, Mike J.			Fate of Zinc Oxide Nanoparticles Coated onto Macronutrient Fertilizers in an Alkaline Calcareous Soil	PLOS ONE			English	Article							ZNO NANOPARTICLES; CROP RESPONSE; DISSOLUTION; SOLUBILITY; SPECIATION; FLUID; HYDROZINCITE; PHOSPHORUS; ADSORPTION; MOBILITY	Zinc oxide (ZnO) nanoparticles may provide a more soluble and plant available source of Zn in Zn fertilizers due to their greater reactivity compared to equivalent micron-or millimetresized (bulk) particles. However, the effect of soil on solubility, spatial distribution and speciation of ZnO nanoparticles has not yet been investigated. In this study, we examined the diffusion and solid phase speciation of Zn in an alkaline calcareous soil following application of nanoparticulate and bulk ZnO coated fertilizer products (monoammonium phosphate (MAP) and urea) using laboratory-based x-ray techniques and synchrotron-based mu-x-ray fluorescence (mu-XRF) mapping and absorption fine structure spectroscopy (mu-XAFS). Mapping of the soil-fertilizer reaction zones revealed that most of the applied Zn for all treatments remained on the coated fertilizer granule or close to the point of application after five weeks of incubation in soil. Zinc precipitated mainly as scholzite (CaZn2(PO4)(2)center dot 2H(2)O) and zinc ammonium phosphate (Zn(NH4)PO4) species at the surface of MAP granules. These reactions reduced dissolution and diffusion of Zn from the MAP granules. Although Zn remained as zincite (ZnO) at the surface of urea granules, limited diffusion of Zn from ZnO-coated urea granules was also observed for both bulk and nanoparticulate ZnO treatments. This might be due to either the high pH of urea granules, which reduced solubility of Zn, or aggregation (due to high ionic strength) of released ZnO nanoparticles around the granule/point of application. The relative proportion of Zn(OH)(2) and ZnCO3 species increased for all Zn treatments with increasing distance from coated MAP and urea granules in the calcareous soil. When coated on macronutrient fertilizers, Zn from ZnO nanoparticles (without surface modifiers) was not more mobile or diffusible compared to bulk forms of ZnO. The results also suggest that risk associated with the presence of ZnO NPs in calcareous soils would be the same as bulk sources of ZnO.	[Milani, Narges; Stacey, Samuel P.; McLaughlin, Mike J.] Univ Adelaide, Sch Agr Food & Wine, Soil Sci, Glen Osmond, SA, Australia; [Hettiarachchi, Ganga M.] Kansas State Univ, Dept Agron, Throckmorton Plant Sci Ctr, Manhattan, KS 66506 USA; [Kirby, Jason K.; Beak, Douglas G.; McLaughlin, Mike J.] CSIRO, Land & Water Flagship, Environm Contaminant Mitigat & Technol Program, Adv Mat Transformat Capabil Platform Nanosafety, Glen Osmond, SA, Australia	University of Adelaide; Kansas State University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Milani, N (corresponding author), Univ Melbourne, Fac Vet & Agr Sci, Crop & Soil Sect, Melbourne, Vic, Australia.	nmilani@unimelb.edu.au	Hettiarachchi, Ganga/F-6895-2015; Milani, Narges/AAH-3618-2021; Hettiarachchi, Ganga M/GSD-8153-2022; Kirby, Jason K/F-5942-2013; McLaughlin, Michael J/N-5888-2017; McLaughlin, Mike J/F-2931-2010	Hettiarachchi, Ganga/0000-0002-6669-2885; Hettiarachchi, Ganga M/0000-0002-6669-2885; McLaughlin, Michael J/0000-0001-6796-4144; McLaughlin, Mike J/0000-0001-6796-4144; Stacey, Samuel/0000-0002-8758-746X; Kirby, Jason/0000-0001-6867-0332	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357 (http://science.energy.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloway BJ, 2009, ENVIRON GEOCHEM HLTH, V31, P537, DOI 10.1007/s10653-009-9255-4; Amrani M, 1999, J PLANT NUTR, V22, P1815, DOI 10.1080/01904169909365758; Bertrand I, 2006, NUTR CYCL AGROECOSYS, V74, P27, DOI 10.1007/s10705-005-4404-3; Borm P, 2006, TOXICOL SCI, V90, P23, DOI 10.1093/toxsci/kfj084; Brookes Phil, 2008, P247, DOI 10.1201/9781420069921.ch10; BRUMMER G, 1983, GEODERMA, V31, P337, DOI 10.1016/0016-7061(83)90045-9; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; Cornelis G, 2014, CRIT REV ENV SCI TEC, V44, P2720, DOI 10.1080/10643389.2013.829767; Degryse F, 2011, EUR J SOIL SCI, V62, P318, DOI 10.1111/j.1365-2389.2010.01332.x; FAO, 2000, LAND PLANT NUTR MAN; Franklin NM, 2007, ENVIRON SCI TECHNOL, V41, P8484, DOI 10.1021/es071445r; Gangloff WJ, 2006, COMMUN SOIL SCI PLAN, V37, P199, DOI 10.1080/00103620500403200; Gimbert LJ, 2007, ENVIRON CHEM, V4, P8, DOI 10.1071/EN06072; Harris W., 2008, METHODS SOIL ANAL 5, P81, DOI DOI 10.2136/SSSABOOKSER5.5.C4; Hettiarachchi GM, 2010, AUST J SOIL RES, V48, P238, DOI 10.1071/SR09051; Hettiarachchi GM, 2008, SOIL SCI SOC AM J, V72, P98, DOI 10.2136/sssaj2007.0058; Hettiarachchi GM, 2006, SOIL SCI SOC AM J, V70, P960, DOI 10.2136/sssaj2005.0296; Jacquat O, 2008, GEOCHIM COSMOCHIM AC, V72, P5037, DOI 10.1016/j.gca.2008.07.024; KALBASI M, 1978, SOIL SCI, V125, P55, DOI 10.1097/00010694-197801000-00009; Lombi E, 2004, SOIL SCI SOC AM J, V68, P682, DOI 10.2136/sssaj2004.0682; Lombi E, 2009, PLANT SOIL, V320, P1, DOI 10.1007/s11104-008-9876-x; Lv JT, 2012, ENVIRON SCI TECHNOL, V46, P7215, DOI 10.1021/es301027a; Ma YB, 2006, NUTR CYCL AGROECOSYS, V76, P11, DOI 10.1007/s10705-006-9036-8; McNear DH, 2005, ELEMENTS, V1, P211, DOI 10.2113/gselements.1.4.211; Milani N, 2012, J AGR FOOD CHEM, V60, P3991, DOI 10.1021/jf205191y; MORTVEDT JJ, 1992, FERT RES, V33, P249, DOI 10.1007/BF01050880; MORTVEDT JJ, 1968, J AGR FOOD CHEM, V16, P241, DOI 10.1021/jf60156a039; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Nriagu J. O., 1984, Phosphate Minerals, P318; Rashid A, 2004, J PLANT NUTR, V27, P959, DOI 10.1081/PLN-120037530; Ravel B, 2005, J SYNCHROTRON RADIAT, V12, P537, DOI 10.1107/S0909049505012719; SAEED M, 1977, SOIL SCI, V124, P199, DOI 10.1097/00010694-197710000-00002; Scheckel KG, 2010, ENVIRON SCI TECHNOL, V44, P1307, DOI 10.1021/es9032265; Soil Survey Staff, 2010, KEYS SOIL TAX; TAKKAR PN, 1993, DEV PLANT SOIL SCI, V55, P151; Vagvolgyi V, 2008, J THERM ANAL CALORIM, V92, P911, DOI 10.1007/s10973-007-8846-5; Voegelin A, 2005, ENVIRON SCI TECHNOL, V39, P6616, DOI 10.1021/es047962g; Voegelin A, 2011, ENVIRON SCI TECHNOL, V45, P255, DOI 10.1021/es101189d; Wang B, 2010, ANAL BIOANAL CHEM, V398, P667, DOI 10.1007/s00216-010-3752-2; Wigginton NS, 2007, J ENVIRON MONITOR, V9, P1306, DOI 10.1039/b712709j	40	46	48	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0126275	10.1371/journal.pone.0126275	http://dx.doi.org/10.1371/journal.pone.0126275			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965385	Green Published, Green Submitted, gold			2022-12-26	WOS:000354543500055
J	Waring, GJ; Robson, SC; Bulmer, JN; Tyson-Capper, AJ				Waring, Gareth J.; Robson, Stephen C.; Bulmer, Judith N.; Tyson-Capper, Alison J.			Inflammatory Signalling in Fetal Membranes: Increased Expression Levels of TLR 1 in the Presence of Preterm Histological Chorioamnionitis	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; CEREBRAL-PALSY; INFECTION; TERM; CONTRACTIONS; AND-4; LABOR	Histological chorioamnionitis (HCA) is an established marker of ascending infection, a major cause of preterm birth. No studies have characterised the global change in expression of genes involved in the toll-like receptor (TLR) signalling pathways in the presence of HCA in the setting of preterm birth (pHCA). Fetal membranes were collected immediately after delivery and underwent histological staging for inflammation to derive 3 groups; term spontaneous labour without HCA (n = 9), preterm birth <34 weeks gestation without HCA (n = 8) and pHCA <34 weeks (n = 12). Profiling arrays ran in triplicate for each group were used to determine the expression of 84 genes associated with TLR signalling and screen for genes of interest (fold change >2; p<0.1). Expression of identified genes was validated individually for all samples, relative to GAPDH, using RT-PCR. Expression of TLR 1, TLR 2, lymphocyte antigen 96, interleukin 8 and Interleukin-1 receptor-associated kinase-like 2 was increased in pHCA (p<0.05). Degree of expression was positively associated with histological staging of both maternal and fetal inflammation (p<0.05). The inflammatory expression profile at the maternal/fetal interface associated with pHCA, a reflection of ascending infection, is extremely heterogeneous suggesting polymicrobial involvement with activation of a common pathway. Antagonism of TLR 1 and TLR 2 signalling in this setting warrants further assessment.	[Waring, Gareth J.; Robson, Stephen C.] Newcastle Upon Tyne NHS Fdn Trust, Directorate Womens Serv, Newcastle Upon Tyne, Tyne & Wear, England; [Waring, Gareth J.; Robson, Stephen C.; Bulmer, Judith N.; Tyson-Capper, Alison J.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK	Tyson-Capper, AJ (corresponding author), Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	alison.tyson-capper@ncl.ac.uk	Waring, Gareth J/ABB-9766-2021		Wellbeing of Women [ELS064]; British Maternal and Fetal Medicine Society	Wellbeing of Women(Wellbeing of Women (WoW)); British Maternal and Fetal Medicine Society	This work was supported by grants awarded to GJW by Wellbeing of Women (ELS064) http://www.wellbeingofwomen.org.uk/ and by the British Maternal and Fetal Medicine Society http://www.bmfms.org.uk/.	Abrahams VM, 2013, AM J REPROD IMMUNOL, V69, P33, DOI 10.1111/aji.12016; Adams KM, 2007, PLACENTA, V28, P477, DOI 10.1016/j.placenta.2006.08.004; BENIRSCHKE K, 1960, AMA J DIS CHILD, V99, P714, DOI 10.1001/archpedi.1960.02070030716003; Bersani I, 2012, J MATERN-FETAL NEO M, V25, P12, DOI 10.3109/14767058.2012.663161; BLANC W A, 1953, Gynaecologia, V136, P100; BLANC WA, 1961, J PEDIATR-US, V59, P473, DOI 10.1016/S0022-3476(61)80232-1; Gillaux C, 2011, J IMMUNOL, V187, P2766, DOI 10.4049/jimmunol.1100217; Goldenberg RL, 2002, NUTR REV, V60, pS19, DOI 10.1301/00296640260130696; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gravett MG, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.03.064; Hamann L, INFECTION GENETICS E, V10, P785; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; HILLIER SL, 1988, NEW ENGL J MED, V319, P972, DOI 10.1056/NEJM198810133191503; Jones HE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008205; Kacerovsky M, J MATERNAL FETAL NEO, V25, P1699; Kim MJ, 2009, LAB INVEST, V89, P924, DOI 10.1038/labinvest.2009.49; Kim YM, 2004, AM J OBSTET GYNECOL, V191, P1346, DOI 10.1016/j.ajog.2004.07.009; Klaffenbach D, 2005, AM J REPROD IMMUNOL, V53, P77, DOI 10.1111/j.1600-0897.2004.00247.x; Lau J, 2005, AM J OBSTET GYNECOL, V193, P708, DOI 10.1016/j.ajog.2005.01.017; Marvin KW, 2002, MOL HUM REPROD, V8, P399, DOI 10.1093/molehr/8.4.399; Menon R, 2010, PLACENTA, V31, P113, DOI 10.1016/j.placenta.2009.11.012; Moco NP, 2013, EUR J OBSTET GYN R B, V171, P12, DOI 10.1016/j.ejogrb.2013.07.036; Nhan-Chang CL, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.02.045; PANKUCH GA, 1984, OBSTET GYNECOL, V64, P802; Pino-Yanes M, PLOS ONE ELECT RESOU, V5; Redline RW, 2003, PEDIATR DEVEL PATHOL, V6, P435, DOI 10.1007/s10024-003-7070-y; ROMERO R, 1992, AM J OBSTET GYNECOL, V166, P1382, DOI 10.1016/0002-9378(92)91609-E; Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773; Romero R, 2006, SEMIN FETAL NEONAT M, V11, P317, DOI 10.1016/j.siny.2006.05.001; Sadowsky DR, 2000, AM J OBSTET GYNECOL, V183, P173, DOI 10.1067/mob.2000.105968; Sadowsky DW, 2003, AM J OBSTET GYNECOL, V188, P252, DOI 10.1067/mob.2003.70; Sebire N J, 1996, J Matern Fetal Med, V5, P227; Shimizu T, 2008, MICROBIOL-SGM, V154, P1318, DOI 10.1099/mic.0.2007/016212-0; Sugimoto J, 2012, J IMMUNOL, V188, P6338, DOI 10.4049/jimmunol.1101765; Taylor BD, 2012, J INFECT DIS, V205, P603, DOI 10.1093/infdis/jir822; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Triantafilou M, 2013, PLOS ONE, V8, DOI [10.1371/annotation/1dc00176-e096-4621-9494-2d848dac8262, 10.1371/journal.pone.0061199]; Tyson-Capper AJ, REPROD SCI, V17, P420; Waldorf KMA, 2008, REPROD SCI, V15, P121, DOI 10.1177/1933719107310992; Wolfs TG, AM J PHYSL GASTROINT, V306, pG382; Wong SH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000979; Wu YW, 2000, JAMA-J AM MED ASSOC, V284, P1417, DOI 10.1001/jama.284.11.1417; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yoon BH, 2000, AM J OBSTET GYNECOL, V182, P675, DOI 10.1067/mob.2000.104207; Youssef RE, 2009, REPROD SCI, V16, P843, DOI 10.1177/1933719109336621; Yu L, 2010, J CELL MOL MED, V14, P2592, DOI 10.1111/j.1582-4934.2010.01127.x; ZHANG J, 1985, INT J GYNECOL PATHOL, V4, P1, DOI 10.1097/00004347-198501000-00001	47	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0124298	10.1371/journal.pone.0124298	http://dx.doi.org/10.1371/journal.pone.0124298			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965269	Green Published, Green Submitted, gold			2022-12-26	WOS:000354543500005
J	Du, L; Li, YP; Yao, Y; Zhang, LW				Du, Li; Li, Yongpeng; Yao, Yao; Zhang, Liwei			An Efficient Protocol for Plantlet Regeneration via Direct Organogenesis by Using Nodal Segments from Embryo-Cultured Seedlings of Cinnamomum camphora L.	PLOS ONE			English	Article							SHOOT ORGANOGENESIS; COTYLEDON EXPLANTS; GROWTH-REGULATORS; MICROPROPAGATION	A simple and efficient plantlet regeneration protocol via direct organogenesis was established for camphor tree (Cinnamomum camphora L.). Stem segments with one node (SN explants) from embryo-cultured seedlings (EC seedlings) were used as explants. Murashige and Skoog (MS) medium supplemented with 0.5 mg/L 2, 4-dichlorophenoxyacetic acid and 2.0 mg/L 6-benzyladenine was used to induce cotyledonary embryo germination. This medium was also used for EC seedlings propagation and adventitious bud induction from SN explants. Regenerated plantlets were cultured on hormone-free MS medium for elongation and root induction. The regeneration capability of SN explants was compared by using EC seedling lines established in this research. EC seedling line EL6 exhibited the highest adventitious bud induction frequency (91.7%) and the highest number of buds per responding explant (5.2), which was considered as the most efficient EC seedling line for further gene transformation research.	[Du, Li; Li, Yongpeng; Yao, Yao; Zhang, Liwei] Nanyang Normal Univ, Sch Life Sci & Technol, Nanyang City, Henan Province, Peoples R China	Nanyang Normal College	Du, L (corresponding author), Nanyang Normal Univ, Sch Life Sci & Technol, Nanyang City, Henan Province, Peoples R China.	dldldlucky@163.com			National Natural Science Foundation of China [31100511]; College Backbone Young Teachers Finance Assistance Scheme of Henan Province [2010GGJS-161]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); College Backbone Young Teachers Finance Assistance Scheme of Henan Province	This report was supported by the National Natural Science Foundation of China, Grant No. 31100511 (http://www.nsfc.gov.cn/) and the College Backbone Young Teachers Finance Assistance Scheme of Henan Province, Grant No. 2010GGJS-161 (http://www.haedu.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, FLORA CHINA; [Anonymous], 2008, FLORA CHINA; [Anonymous], 2008, FLORA CHINA; Arshad M, 2012, PLANT CELL TISS ORG, V108, P315, DOI 10.1007/s11240-011-0045-1; Arun M, 2014, PLANT CELL TISS ORG, V117, P305, DOI 10.1007/s11240-014-0431-6; Babu KN, 2003, PLANT CELL TISS ORG, V74, P179, DOI 10.1023/A:1023988110064; Bernabe-Antonio A, 2012, PLANT GROWTH REGUL, V68, P293, DOI 10.1007/s10725-012-9717-z; Curtis IS, 2012, PLANT CELL TISS ORG, V108, P345, DOI 10.1007/s11240-011-0037-1; Du L, 2005, THESIS HUAZHONG AGR; Du Li, 2006, Scientia Silvae Sinicae, V42, P37; Giovannelli A, 2004, IN VITRO CELL DEV-PL, V40, P509, DOI 10.1079/IVP2004561; Huang LC, 1998, IN VITRO CELL DEV-PL, V34, P141, DOI 10.1007/BF02822779; Jayanand B, 2003, IN VITRO CELL DEV-PL, V39, P171, DOI 10.1079/IVP2002387; Mulwa RMS, 2006, PLANT CELL REP, V25, P1281, DOI 10.1007/s00299-006-0182-x; Perez-Jimenez M, 2012, PLANT CELL TISS ORG, V108, P55, DOI 10.1007/s11240-011-0011-y; Pourhosseini L, 2013, PLANT CELL TISS ORG, V112, P101, DOI 10.1007/s11240-012-0210-1; Rani D, 2012, PLANT CELL TISS ORG, V109, P9, DOI 10.1007/s11240-011-0068-7; Shabannezhad Mamaghani M, 2008, IRANIAN RANGEL FORES, V16, P229; Shi XP, 2009, THESIS HUAZHONG AGR; Shi XP, 2010, IN VITRO CELL DEV-PL, V46, P117, DOI 10.1007/s11627-009-9272-0; Singh AK, 2002, PLANT CELL TISS ORG, V68, P203, DOI 10.1023/A:1013870803937; Stevens ME, 2012, PLANT CELL TISS ORG, V108, P129, DOI 10.1007/s11240-011-0021-9; Yang MJ, 2006, PLANT CELL TISS ORG, V85, P241, DOI 10.1007/s11240-006-9082-6; Zhu ML, 2007, IN VITRO CELL DEV-PL, V43, P449, DOI 10.1007/s11627-007-9092-z	24	3	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0127215	10.1371/journal.pone.0127215	http://dx.doi.org/10.1371/journal.pone.0127215			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962170	Green Published, gold, Green Submitted			2022-12-26	WOS:000354542500170
J	Ghag, SB; Shekhawat, UKS; Ganapathi, TR				Ghag, Siddhesh B.; Shekhawat, Upendra K. S.; Ganapathi, Thumballi R.			Small RNA Profiling of Two Important Cultivars of Banana and Overexpression of miRNA156 in Transgenic Banana Plants	PLOS ONE			English	Article							IDENTIFIES MICRORNAS; GENES; ARABIDOPSIS; EXPRESSION; RICE	Micro RNAs( miRNAs) are a class of non-coding, short RNAs having important roles in regulation of gene expression. Although plant miRNAs have been studied in detail in some model plants, less is known about these miRNAs in important fruit plants like banana. miRNAs have pivotal roles in plant growth and development, and in responses to diverse biotic and abiotic stress stimuli. Here, we have analyzed the small RNA expression profiles of two different economically significant banana cultivars by using high-throughput sequencing technology. We identified a total of 170 and 244 miRNAs in the two libraries respectively derived from cv. Grand Naine and cv. Rasthali leaves. In addition, several cultivar specific microRNAs along with their putative target transcripts were also detected in our studies. To validate our findings regarding the small RNA profiles, we also undertook overexpression of a common microRNA, MusamiRNA156 in transgenic banana plants. The transgenic plants overexpressing the stem-loop sequence derived from MusamiRNA156 gene were stunted in their growth together with peculiar changes in leaf anatomy. These results provide a foundation for further investigations into important physiological and metabolic pathways operational in banana in general and cultivar specific traits in particular.	[Ghag, Siddhesh B.; Shekhawat, Upendra K. S.; Ganapathi, Thumballi R.] Bhabha Atom Res Ctr, Nucl Agr & Biotechnol Div, Plant Cell Culture Technol Sect, Bombay 400085, Maharashtra, India	Bhabha Atomic Research Center (BARC)	Ganapathi, TR (corresponding author), Bhabha Atom Res Ctr, Nucl Agr & Biotechnol Div, Plant Cell Culture Technol Sect, Bombay 400085, Maharashtra, India.	trgana@barc.gov.in		Shekhawat, Upendra/0000-0002-4012-2614	Department of Atomic Energy, Govt. of India	Department of Atomic Energy, Govt. of India(Department of Atomic Energy (DAE))	Department of Atomic Energy, Govt. of India funded the study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; Davey MW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-683; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Ganapathi TR, 2001, PLANT CELL REP, V20, P157, DOI 10.1007/s002990000287; Ghag SB, 2014, AOB PLANTS, V6, DOI 10.1093/aobpla/plu037; Ghag SB, 2014, PLANT BIOTECHNOL J, V12, P541, DOI 10.1111/pbi.12158; Ghag SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039557; Ghosh A, 2012, J PLANT BIOCHEM BIOT, V21, P189, DOI 10.1007/s13562-011-0070-5; Gou JY, 2011, PLANT CELL, V23, P1512, DOI 10.1105/tpc.111.084525; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Huijser P, 2011, DEVELOPMENT, V138, P4117, DOI 10.1242/dev.063511; Jeong DH, 2011, PLANT CELL, V23, P4185, DOI 10.1105/tpc.111.089045; Jia L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104409; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Khraiwesh Basel, 2012, Biochim Biophys Acta, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Lescot M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-58; Liu Yong-Xin, 2014, Genomics Proteomics & Bioinformatics, V12, P64, DOI 10.1016/j.gpb.2014.04.003; Mohapatra D, 2010, J SCI IND RES INDIA, V69, P323; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; Papp I, 2003, PLANT PHYSIOL, V132, P1382, DOI 10.1104/pp.103.021980; Tee Y. K., 2011, SCI HORTIC, V129, P382; Vaucheret H, 2006, GENE DEV, V20, P759, DOI 10.1101/gad.1410506; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang LW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-154; Xie KB, 2012, PLANT PHYSIOL, V158, P1382, DOI 10.1104/pp.111.190488; Xing SP, 2010, PLANT CELL, V22, P3935, DOI 10.1105/tpc.110.079343; Yu N, 2010, PLANT CELL, V22, P2322, DOI 10.1105/tpc.109.072579; Zhang RX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057233; Zhao YT, 2012, PLANT PHYSIOL, V158, P813, DOI 10.1104/pp.111.187666; Zhou XF, 2009, GENOME RES, V19, P70, DOI 10.1101/gr.084806.108	30	14	16	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0127179	10.1371/journal.pone.0127179	http://dx.doi.org/10.1371/journal.pone.0127179			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962076	gold, Green Published, Green Submitted			2022-12-26	WOS:000354542500168
J	Lemessa, D; Hamback, PA; Hylander, K				Lemessa, Debissa; Hamback, Peter A.; Hylander, Kristoffer			Arthropod but Not Bird Predation in Ethiopian Homegardens Is Higher in Tree-Poor than in Tree-Rich Landscapes	PLOS ONE			English	Article							NATURAL PEST-CONTROL; TOP-DOWN CONTROL; BIOLOGICAL-CONTROL; COFFEE FARMS; AGRICULTURAL INTENSIFICATION; ARTIFICIAL CATERPILLARS; TROPICAL AGROECOSYSTEMS; HABITAT FRAGMENTATION; FUNCTIONAL DIVERSITY; ECOSYSTEM SERVICE	Bird and arthropod predation is often associated with natural pest control in agricultural landscapes, but the rates of predation may vary with the amount of tree cover or other environmental factors. We examined bird and arthropod predation in three tree-rich and three tree-poor landscapes across southwestern Ethiopia. Within each landscape we selected three tree-rich and three tree-poor homegardens in which we recorded the number of tree species and tree stems within 100 x 100 m surrounding the central house. To estimate predation rates, we attached plasticine caterpillars on leaves of two coffee and two avocado shrubs in each homegarden, and recorded the number of attacked caterpillars for 7-9 consecutive weeks. The overall mean daily predation rate was 1.45% for birds and 1.60% for arthropods. The rates of arthropod predation varied among landscapes and were higher in tree-poor landscapes. There was no such difference for birds. Within landscapes, predation rates from birds and arthropods did not vary between tree-rich and tree-poor homegardens in either tree-rich or tree-poor landscapes. The most surprising result was the lack of response by birds to tree cover at either spatial scale. Our results suggest that in tree-poor landscapes there are still enough non-crop habitats to support predatory arthropods and birds to deliver strong top-down effect on crop pests.	[Lemessa, Debissa] Leuphana Univ Luneburg, Luneburg, Germany; [Hamback, Peter A.; Hylander, Kristoffer] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden	Leuphana University Luneburg; Stockholm University	Lemessa, D (corresponding author), Leuphana Univ Luneburg, Scharnhorststr 1, Luneburg, Germany.	lemessa@leuphana.de	Lemessa, Debissa/AAV-7950-2020; Hambäck, Peter A/A-8194-2008	Hambäck, Peter A/0000-0001-6362-6199	Swedish International Development Cooperation Agency (SIDA) [SWE-2009-134]; Formas [229-2009-991]	Swedish International Development Cooperation Agency (SIDA); Formas(Swedish Research Council Formas)	The Swedish International Development Cooperation Agency (SIDA) (contract number: SWE-2009-134) and Formas (contract number: 229-2009-991) provided fund support [to KH]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate T, 2000, ANNU REV ENTOMOL, V45, P631, DOI 10.1146/annurev.ento.45.1.631; Abebe T, 2010, AGROFOREST SYST, V78, P309, DOI 10.1007/s10457-009-9246-6; Albuquerque UP, 2005, J ARID ENVIRON, V62, P491, DOI 10.1016/j.jaridenv.2005.01.003; Amarasekare P, 2001, AM NAT, V158, P572, DOI 10.1086/323586; Banwo O. O., 2003, Archives of Phytopathology and Plant Protection, V36, P59, DOI 10.1080/0323540031000106723; Barbaro L, 2012, LANDSCAPE ECOL, V27, P1451, DOI 10.1007/s10980-012-9800-x; Batary P, 2010, BIOL CONSERV, V143, P2020, DOI 10.1016/j.biocon.2010.05.005; Bates D., 2013, LME4 LINEAR MIXED EF; Bereczki K, 2014, FOREST ECOL MANAG, V327, P96, DOI 10.1016/j.foreco.2014.05.001; Bianchi FJJA, 2006, P ROY SOC B-BIOL SCI, V273, P1715, DOI 10.1098/rspb.2006.3530; Bianchi FJJA, 2013, AGR FOREST ENTOMOL, V15, P12, DOI 10.1111/j.1461-9563.2012.00586.x; De La Vega X, 2012, AUSTRAL ECOL, V37, P836, DOI 10.1111/j.1442-9993.2011.02345.x; Demel Teketay., 1999, WALIA J ETHIOPIAN WI, V20, P28; Engelen D, 2012, THESIS STOCKHOLM U S; Ferrante M, 2014, EUR J ENTOMOL, V111, P649, DOI 10.14411/eje.2014.082; Friis I., 2010, ATLAS POTENTIAL VEGE; Gillis H, 2012, CAN J ZOOL, V90, P694, DOI 10.1139/Z2012-035; Girma H, 2000, AGROFOREST SYST, V50, P279, DOI 10.1023/A:1006447813882; Gotelli NJ, 2013, ECOSIMR 1 00; Gove AD, 2013, J TROP ECOL, V29, P87, DOI 10.1017/S0266467413000023; Gove AD, 2008, CONSERV LETT, V1, P208, DOI 10.1111/j.1755-263X.2008.00033.x; Greenberg R, 2000, ECOLOGY, V81, P1750, DOI 10.1890/0012-9658(2000)081[1750:TIOAIO]2.0.CO;2; Gunnarsson B, 1996, J ANIM ECOL, V65, P389, DOI 10.2307/5885; Gunnarsson B, 2009, FOREST ECOL MANAG, V257, P619, DOI 10.1016/j.foreco.2008.09.055; Howe A, 2009, ENTOMOL EXP APPL, V131, P325, DOI 10.1111/j.1570-7458.2009.00860.x; Howe AG, 2015, ENTOMOL EXP APPL, V154, P161, DOI 10.1111/eea.12267; Janssen A, 2007, ECOLOGY, V88, P2713, DOI 10.1890/06-1408.1; Jobin B, 2001, AGR ECOSYST ENVIRON, V84, P131, DOI 10.1016/S0167-8809(00)00206-1; Johnson MD, 2010, ANIM CONSERV, V13, P140, DOI 10.1111/j.1469-1795.2009.00310.x; Johnson MD, 2009, AGROFOREST SYST, V76, P139, DOI 10.1007/s10457-008-9198-2; JOHNSON RJ, 1988, AGR ECOSYST ENVIRON, V22-3, P301, DOI 10.1016/0167-8809(88)90028-X; Jones GA, 2005, CONSERV BIOL, V19, P1234, DOI 10.1111/j.1523-1739.2005.00211.x; Kellermann JL, 2008, CONSERV BIOL, V22, P1177, DOI 10.1111/j.1523-1739.2008.00968.x; Koh LP, 2006, BIOTROPICA, V38, P132, DOI 10.1111/j.1744-7429.2006.00114.x; Kumar BM, 2004, AGROFOREST SYST, V61-2, P135, DOI 10.1023/B:AGFO.0000028995.13227.ca; Langellotto GA, 2004, OECOLOGIA, V139, P1, DOI 10.1007/s00442-004-1497-3; Lemessa D, 2015, LANDSCAPE ECOL, V30, P167, DOI 10.1007/s10980-014-0115-y; Lichtenberg JS, 2003, SOUTHEAST NAT, V2, P423, DOI 10.1656/1528-7092(2003)002[0423:POCOUS]2.0.CO;2; Macfadyen S, 2015, INSECT SCI, V22, P20, DOI 10.1111/1744-7917.12174; Martin EA, 2013, P NATL ACAD SCI USA, V110, P5534, DOI 10.1073/pnas.1215725110; Nair PKR, 2001, AGROFOREST SYST, V53, P239, DOI 10.1023/A:1013388806993; Nigussie A, 2012, GLOB ADV RES J AGR S, V1, P66; Nyffeler M, 1999, J ARACHNOL, V27, P317; O'Rourke ME, 2011, ECOL APPL, V21, P1782, DOI 10.1890/10-0241.1; Otieno M, 2011, BIOL CONSERV, V144, P2424, DOI 10.1016/j.biocon.2011.06.013; Patten MA, 2003, OIKOS, V101, P479, DOI 10.1034/j.1600-0706.2003.12515.x; Paulos D, 2001, NE AFRICAN STUDIES, V8, P27, DOI DOI 10.1353/nas.2005.0015; Pearce S, 2006, J APPL ECOL, V43, P128, DOI 10.1111/j.1365-2664.2005.01118.x; Perfecto I, 2004, ECOLOGY, V85, P2677, DOI 10.1890/03-3145; Philpott SM, 2009, ECOL APPL, V19, P1858, DOI 10.1890/08-1928.1; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rand TA, 2006, ECOL LETT, V9, P603, DOI 10.1111/j.1461-0248.2006.00911.x; Richards LA, 2007, OIKOS, V116, P31, DOI 10.1111/j.2006.0030-1299.15043.x; Roland J, 1997, NATURE, V386, P710, DOI 10.1038/386710a0; Ruiz-Guerra B, 2012, BIOTROPICA, V44, P228, DOI 10.1111/j.1744-7429.2011.00795.x; Rusch A, 2013, J APPL ECOL, V50, P345, DOI 10.1111/1365-2664.12055; Sekercioglu CH, 2006, TRENDS ECOL EVOL, V21, P464, DOI 10.1016/j.tree.2006.05.007; Sekercioglu CH, 2002, P NATL ACAD SCI USA, V99, P263, DOI 10.1073/pnas.012616199; Singh G. B., 1987, Agroforestry: a decade of development., P117; Soemarwoto O., 1987, Agroforestry: a decade of development., P157; Thies C, 2011, ECOL APPL, V21, P2187, DOI 10.1890/10-0929.1; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Tscharntke T, 2004, ANNU REV ENTOMOL, V49, P405, DOI 10.1146/annurev.ento.49.061802.123339; Tscharntke T, 2008, ECOLOGY, V89, P944, DOI 10.1890/07-0455.1; Tvardikova K, 2012, J TROP ECOL, V28, P331, DOI 10.1017/S0266467412000235; Van Bael SA, 2005, OECOLOGIA, V145, P658, DOI 10.1007/s00442-005-0134-0; Van Bael SA, 2008, ECOLOGY, V89, P928, DOI 10.1890/06-1976.1; Watson JEM, 2005, J BIOGEOGR, V32, P1353, DOI 10.1111/j.1365-2699.2005.01256.x; Wilby A, 2006, ECOSYSTEMS, V9, P538, DOI 10.1007/s10021-006-0131-0; Wilson JD, 1997, J APPL ECOL, V34, P1462, DOI 10.2307/2405262; With KA, 2002, ECOL APPL, V12, P52, DOI 10.1890/1051-0761(2002)012[0052:TEOLSO]2.0.CO;2; Zaviezo T, 2006, ECOL ENTOMOL, V31, P646, DOI 10.1111/j.1365-2311.2006.00830.x	72	18	18	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126639	10.1371/journal.pone.0126639	http://dx.doi.org/10.1371/journal.pone.0126639			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961306	Green Published, Green Submitted, gold			2022-12-26	WOS:000354542500129
J	Inoue, TA; Ito, T; Hagiya, H; Hata, T; Asaoka, K; Yokohari, F; Niihara, K				Inoue, Takashi A.; Ito, Tetsuo; Hagiya, Hiroshi; Hata, Tamako; Asaoka, Kiyoshi; Yokohari, Fumio; Niihara, Kinuko			K+ Excretion: The Other Purpose for Puddling Behavior in Japanese Papilio Butterflies	PLOS ONE			English	Article							SODIUM; LEPIDOPTERA; REPRODUCTION; DIURESIS; GLAUCUS; XUTHUS	To elucidate the purpose of butterfly puddling, we measured the amounts of Na+, K+, Ca2+, and Mg2+ that were absorbed or excreted during puddling by male Japanese Papilio butterflies through a urine test. All of the butterflies that sipped water with a Na+ concentration of 13 mM absorbed Na+ and excreted K+, although certain butterflies that sipped solutions with high concentrations of Na+ excreted Na+. According to the Na+ concentrations observed in naturally occurring water sources, water with a Na+ concentration of up to 10 mM appears to be optimal for the health of male Japanese Papilio butterflies. The molar ratio of K+ to Na+ observed in leaves was 43.94 and that observed in flower nectars was 10.93. The Na+ amount in 100 g of host plant leaves ranged from 2.11 to 16.40 mg, and the amount in 100 g of flower nectar ranged from 1.24 to 108.21 mg. Differences in host plants did not explain the differences in the frequency of puddling observed for different Japanese Papilio species. The amounts of Na+, K+, Ca2+, and Mg2+ in the meconium of both male and female butterflies were also measured, and both males and females excreted more K+ than the other three ions. Thus, the fluid that was excreted by butterflies at emergence also had a role in the excretion of the excessive K+ in their bodies. The quantities of Na+ and K+ observed in butterfly eggs were approximately 0.50 mu g and 4.15 mu g, respectively; thus, female butterflies required more K+ than male butterflies. Therefore, female butterflies did not puddle to excrete K+. In conclusion, the purpose of puddling for male Papilio butterflies is not only to absorb Na+ to correct deficiencies but also to excrete excessive K+.	[Inoue, Takashi A.; Hata, Tamako; Asaoka, Kiyoshi] Japanese Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058634, Japan; [Hagiya, Hiroshi; Niihara, Kinuko] Tokyo City Univ, Fac Knowledge Engn, Dept Nat Sci, Setagaya Ku, Tokyo 1588557, Japan; [Yokohari, Fumio] Fukuoka Univ, Fac Sci, Dept Earth Syst Sci, Div Biol, Fukuoka, Fukuoka 8140180, Japan	National Institute of Agrobiological Sciences - Japan; Tokyo City University; Fukuoka University	Inoue, TA (corresponding author), Japanese Natl Inst Agrobiol Sci, Owashi 1-2, Tsukuba, Ibaraki 3058634, Japan.	inoueatp@affrc.go.jp			Grants-in-Aid for Scientific Research [25650119] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		ADLER PH, 1982, CAN J ZOOL, V60, P322, DOI 10.1139/z82-043; ARMS K, 1974, SCIENCE, V185, P372, DOI 10.1126/science.185.4148.372; Beck J, 1999, OECOLOGIA, V119, P140, DOI 10.1007/s004420050770; Bergstrom J, 2002, BEHAV ECOL SOCIOBIOL, V52, P296, DOI 10.1007/s00265-002-0512-0; Boggs CL, 2004, ENVIRON ENTOMOL, V33, P1020, DOI 10.1603/0046-225X-33.4.1020; BOGGS CL, 1991, ECOL ENTOMOL, V16, P123, DOI 10.1111/j.1365-2311.1991.tb00199.x; Cribb BW, 2008, NATURWISSENSCHAFTEN, V95, P17, DOI 10.1007/s00114-007-0288-1; HIEBERT SM, 1983, ECOLOGY, V64, P399, DOI 10.2307/1937086; Inoue TA, 2013, NATURE INSECTS, V48, P13; Inoue TA, 2012, NATURWISSENSCHAFTEN, V99, P985, DOI 10.1007/s00114-012-0976-3; Inoue T, 2009, NATURWISSENSCHAFTEN, V96, P355, DOI 10.1007/s00114-008-0483-8; LEDERHOUSE RC, 1990, FUNCT ECOL, V4, P743, DOI 10.2307/2389441; Molleman F, 2004, BEHAV ECOL SOCIOBIOL, V56, P404, DOI 10.1007/s00265-004-0789-2; NICOLSON SW, 1976, J INSECT PHYSIOL, V22, P1623, DOI 10.1016/0022-1910(76)90054-8; NICOLSON SW, 1980, J INSECT PHYSIOL, V26, P841, DOI 10.1016/0022-1910(80)90101-8; PIVNICK KA, 1987, PHYSIOL ENTOMOL, V12, P461, DOI 10.1111/j.1365-3032.1987.tb00773.x; Smedley SR, 1996, P NATL ACAD SCI USA, V93, P809, DOI 10.1073/pnas.93.2.809; SMEDLEY SR, 1995, SCIENCE, V270, P1816, DOI 10.1126/science.270.5243.1816; Watanabe M, 2005, ENTOMOL SCI, V8, P161, DOI 10.1111/j.1479-8298.2005.00114.x	19	3	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0126632	10.1371/journal.pone.0126632	http://dx.doi.org/10.1371/journal.pone.0126632			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955856	gold, Green Submitted, Green Published			2022-12-26	WOS:000356768100133
J	Pan, L; Liu, Y; Wei, Q; Xiao, CW; Ji, QN; Bao, GL; Wu, XS				Pan, Lei; Liu, Yan; Wei, Qiang; Xiao, Chenwen; Ji, Quanan; Bao, Guolian; Wu, Xinsheng			Solexa-Sequencing Based Transcriptome Study of Plaice Skin Phenotype in Rex Rabbits (Oryctolagus cuniculus)	PLOS ONE			English	Article							GROWTH-ARREST; C/EBP-BETA; EXPRESSION; KERATINOCYTE	Background Fur is an important genetically-determined characteristic of domestic rabbits; rabbit furs are of great economic value. We used the Solexa sequencing technology to assess gene expression in skin tissues from full-sib Rex rabbits of different phenotypes in order to explore the molecular mechanisms associated with fur determination. Methodology/Principal Findings Transcriptome analysis included de novo assembly, gene function identification, and gene function classification and enrichment. We obtained 74,032,912 and 71,126,891 short reads of 100 nt, which were assembled into 377,618 unique sequences by Trinity strategy (N50=680 nt). Based on BLAST results with known proteins, 50,228 sequences were identified at a cut-off E-value >= 10(-5). Using Blast to Gene Ontology (GO), Clusters of Orthologous Groups (KOG) and Kyoto Encyclopedia of Genes and Genomes (KEGG), we obtained several genes with important protein functions. A total of 308 differentially expressed genes were obtained by transcriptome analysis of plaice and un-plaice phenotype animals; 209 additional differentially expressed genes were not found in any database. These genes included 49 that were only expressed in plaice skin rabbits. The novel genes may play important roles during skin growth and development. In addition, 99 known differentially expressed genes were assigned to PI3K-Akt signaling, focal adhesion, and ECM-receptor interactin, among others. Growth factors play a role in skin growth and development by regulating these signaling pathways. We confirmed the altered expression levels of seven target genes by qRT-PCR. And chosen a key gene for SNP to found the differentially between plaice and un-plaice phenotypes rabbit. Conclusions/Significance The rabbit transcriptome profiling data provide new insights in understanding the molecular mechanisms underlying rabbit skin growth and development.	[Pan, Lei; Liu, Yan; Wei, Qiang; Xiao, Chenwen; Ji, Quanan; Bao, Guolian] Zhejiang Acad Agr Sci, Anim Husb & Vet Inst, Hangzhou, Zhejiang, Peoples R China; [Wu, Xinsheng] Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou 225009, Jiangsu, Peoples R China; [Pan, Lei] Zhejiang Normal Univ, Chem & Life Sci, Jinhua, Zhejiang, Peoples R China	Zhejiang Academy of Agricultural Sciences; Yangzhou University; Zhejiang Normal University	Bao, GL (corresponding author), Zhejiang Acad Agr Sci, Anim Husb & Vet Inst, Hangzhou, Zhejiang, Peoples R China.	baoguolian@163.com; xswu@yzu.edu.cn			Important Agricultural Project of Important Science & Technology Specific Projects of Zhejiang [2012C12906-11]; China Modern Agricultural Industry Technology System Projects [nycytx-44-C-2]	Important Agricultural Project of Important Science & Technology Specific Projects of Zhejiang; China Modern Agricultural Industry Technology System Projects	This work was supported by the Important Agricultural Project of Important Science & Technology Specific Projects of Zhejiang (2012C12906-11) and the China Modern Agricultural Industry Technology System Projects (nycytx-44-C-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Castro LFC, 2012, PLOS ONE, V2; Cavalieri S, 2005, INT J IMMUNOPATH PH, V18, P223, DOI 10.1177/039463200501800205; Eckert RL, 1997, PHYSIOL REV, V77, P397, DOI 10.1152/physrev.1997.77.2.397; Fan RW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-389; Floeth M, 1999, AM J HUM GENET, V65, P1530, DOI 10.1086/302672; Fu XB, 2001, LANCET, V358, P1067, DOI 10.1016/S0140-6736(01)06202-X; Gao Bei, 2014, BMC Res Notes, V7, P490, DOI 10.1186/1756-0500-7-490; Gao YB, MODERN REHABILITATIO, V5, P50; GONUL B, 1995, BURNS, V21, P7, DOI 10.1016/0305-4179(95)90773-S; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, DOI [10.1038/nprot.2013.096, DOI 10.1038/NPROT.2013.096]; Han XW, 2009, P NATL ACAD SCI USA, V106, P12741, DOI 10.1073/pnas.0902417106; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim TH, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-36; Lehnert EM, 2014, PLANT GENETICS GENOM, V5, P1; Liu Y, 2001, MED J NATL DEFEND FO, V22, P214; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-663; Maytin EV, 1998, J INVEST DERMATOL, V110, P238, DOI 10.1046/j.1523-1747.1998.00123.x; McFie PJ, 2006, J BIOL CHEM, V281, P18069, DOI 10.1074/jbc.M512734200; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Paszkiewicz K, 2010, BRIEF BIOINFORM, V11, P457, DOI 10.1093/bib/bbq020; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Tang YH, 2004, CHIN J MED AESTH COS, V10, P53; Walsh D, 2014, GENE DEV, V28, P835, DOI 10.1101/gad.236752.113; Xu P, 2013, GENE, V525, P26, DOI 10.1016/j.gene.2013.04.066; Xu Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055496; Yamanaka K, 2010, CHEM RES TOXICOL, V23, P689, DOI 10.1021/tx900449u; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhu SY, 1999, MOL CELL BIOL, V19, P7181	34	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0124583	10.1371/journal.pone.0124583	http://dx.doi.org/10.1371/journal.pone.0124583			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955442	Green Submitted, Green Published, gold			2022-12-26	WOS:000356768100030
J	Suarez-Vega, A; Gutierrez-Gil, B; Benavides, J; Perez, V; Tosser-Klopp, G; Klopp, C; Keennel, SJ; Arranz, JJ				Suarez-Vega, Aroa; Gutierrez-Gil, Beatriz; Benavides, Julio; Perez, Valentin; Tosser-Klopp, Gwenola; Klopp, Christophe; Keennel, Stephen J.; Jose Arranz, Juan			Combining GWAS and RNA-Seq Approaches for Detection of the Causal Mutation for Hereditary Junctional Epidermolysis Bullosa in Sheep	PLOS ONE			English	Article							APLASIA-CUTIS-CONGENITA; BETA-4 INTEGRIN; PYLORIC ATRESIA; GENE; MISSENSE; HEMIDESMOSOMES; DIAGNOSIS; FRAMEWORK; SPECTRUM; DELETION	In this study, we demonstrate the use of a genome-wide association mapping together with RNA-seq in a reduced number of samples, as an efficient approach to detect the causal mutation for a Mendelian disease. Junctional epidermolysis bullosa is a recessive genodermatosis that manifests with neonatal mechanical fragility of the skin, blistering confined to the lamina lucida of the basement membrane and severe alteration of the hemidesmosomal junctions. In Spanish Churra sheep, junctional epidermolysis bullosa (JEB) has been detected in two commercial flocks. The JEB locus was mapped to Ovis aries chromosome 11 by GWAS and subsequently fine-mapped to an 868-kb homozygous segment using the identical-by-descent method. The ITGB4, which is located within this region, was identified as the best positional and functional candidate gene. The RNA-seq variant analysis enabled us to discover a 4-bp deletion within exon 33 of the ITGB4 gene (c.4412_4415del). The c.4412_4415del mutation causes a frameshift resulting in a premature stop codon at position 1472 of the integrin beta 4 protein. A functional analysis of this deletion revealed decreased levels of mRNA in JEB skin samples and the absence of integrin beta 4 labeling in immunohistochemical assays. Genotyping of c.4412_4415del showed perfect concordance with the recessive mode of the disease phenotype. Selection against this causal mutation will now be used to solve the problem of JEB in flocks of Churra sheep. Furthermore, the identification of the ITGB4 mutation means that affected sheep can be used as a large mammal animal model for the human form of epidermolysis bullosa with aplasia cutis. Our approach evidences that RNA-seq offers cost-effective alternative to identify variants in the species in which high resolution exome-sequencing is not straightforward.	[Suarez-Vega, Aroa; Gutierrez-Gil, Beatriz; Jose Arranz, Juan] Univ Leon, Fac Vet, Dept Anim Prod, E-24071 Leon, Spain; [Benavides, Julio; Perez, Valentin] Univ Leon, Fac Vet, CSIC ULE, Inst Ganaderia Montana,Dept Sanidad Anim Anat Pat, E-24071 Leon, Spain; [Tosser-Klopp, Gwenola] INRA, GenPhySE Genet Physiol & Syst Elevage UMR1388, F-31326 Castanet Tolosan, France; [Tosser-Klopp, Gwenola] Univ Toulouse, INP, ENSAT, GenPhySE Genet Physiol & Syst Elevage, F-31326 Castanet Tolosan, France; [Tosser-Klopp, Gwenola] Univ Toulouse, INP, ENVT, GenPhySE Genet Physiol & Syst Elevage, F-31076 Toulouse, France; [Klopp, Christophe] INRA, Plateforme Bioinformat Toulouse Midi Pyrenees, Biometrie & Intelligence Artificielle UR875, F-31326 Castanet Tolosan, France; [Keennel, Stephen J.] Univ Tennessee, Grad Sch Med, Knoxville, TN 37920 USA	Universidad de Leon; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-ULE - Instituto de Ganaderia de Montana (IGM); Universidad de Leon; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; INRAE; University of Tennessee System; University of Tennessee Health Science Center	Arranz, JJ (corresponding author), Univ Leon, Fac Vet, Dept Anim Prod, Campus Vegazana S-N, E-24071 Leon, Spain.	jjarrs@unileon.es	Arranz, Juan-Jose/H-1225-2015; Klopp, Christophe/J-3164-2019; Gutierrez, Beatriz/AAU-1711-2021; Perez, Valentin/A-6281-2015; Benavides, Julio/D-5299-2014	Arranz, Juan-Jose/0000-0001-9058-131X; Klopp, Christophe/0000-0001-7126-5477; Perez, Valentin/0000-0003-0075-1587; Benavides, Julio/0000-0001-9706-100X; Suarez Vega, Aroa/0000-0002-7726-4288; TOSSER-KLOPP, GWENOLA/0000-0003-0550-4673	Spanish Ministry of Economy and Competitiveness [AGL2012-34437]; FPU contract from Spanish Ministry of Education; Ramon y Cajal contract from the Spanish Ministry of Economy and Competitiveness	Spanish Ministry of Economy and Competitiveness(Spanish Government); FPU contract from Spanish Ministry of Education(German Research Foundation (DFG)); Ramon y Cajal contract from the Spanish Ministry of Economy and Competitiveness(Spanish Government)	Funded by Spanish Ministry of Economy and Competitiveness (grant AGL2012-34437 to JJA); Aroa Suarez-Vega is funded by an FPU contract from Spanish Ministry of Education. Beatriz Guterrez-Gil is funded by an Ramon y Cajal contract from the Spanish Ministry of Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aho S, 1998, BIOCHEM BIOPH RES CO, V243, P694, DOI 10.1006/bbrc.1998.8162; Alhaidari Z, 2005, VET DERMATOL, V16, P69, DOI 10.1111/j.1365-3164.2005.00420.x; Birnbaum RY, 2008, AM J MED GENET A, V146A, P1063, DOI 10.1002/ajmg.a.31903; Borradori L, 1999, J INVEST DERMATOL, V112, P411, DOI 10.1046/j.1523-1747.1999.00546.x; Canovas A, 2010, MAMM GENOME, V21, P592, DOI 10.1007/s00335-010-9297-z; Capt A, 2005, J INVEST DERMATOL, V124, P530, DOI 10.1111/j.0022-202X.2004.23584.x; CARMI R, 1982, AM J MED GENET, V11, P319, DOI 10.1002/ajmg.1320110308; Chavanas S, 1999, HUM MOL GENET, V8, P2097, DOI 10.1093/hmg/8.11.2097; Cox LA, 2012, J PHYSIOL-LONDON, V590, P2873, DOI 10.1113/jphysiol.2011.222398; Dalrymple BP, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r152; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Djari A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-307; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fine JD, 2008, J AM ACAD DERMATOL, V58, P931, DOI 10.1016/j.jaad.2008.02.004; Fine JD, 2014, J AM ACAD DERMATOL, V70, P1103, DOI 10.1016/j.jaad.2014.01.903; Graves KT, 2009, ANIM GENET, V40, P35, DOI 10.1111/j.1365-2052.2008.01795.x; Inoue M, 2000, J INVEST DERMATOL, V114, P1061, DOI 10.1046/j.1523-1747.2000.00960-3.x; Keller O, 2011, BIOINFORMATICS, V27, P757, DOI 10.1093/bioinformatics/btr010; KENNEL SJ, 1990, HYBRIDOMA, V9, P243, DOI 10.1089/hyb.1990.9.243; Kerkmann A, 2010, BERL MUNCH TIERARZTL, V123, P413, DOI 10.2376/0005-9366-123-413; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lee MY, 2015, ACTA DERM-VENEREOL, V95, P112, DOI 10.2340/00015555-1888; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Medeiros GX, 2012, J VET DIAGN INVEST, V24, P231, DOI 10.1177/1040638711425953; Milenkovic D, 2003, GENET SEL EVOL, V35, P249, DOI [10.1051/gse:2003007, 10.1186/1297-9686-35-2-249]; Momke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018943; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakano A, 2001, PEDIATR RES, V49, P618, DOI 10.1203/00006450-200105000-00003; Olivry T, 1997, VET DERMATOL, V8, P203, DOI 10.1046/j.1365-3164.1997.d01-17.x; Ostmeier M, 2012, J COMP PATHOL, V146, P338, DOI 10.1016/j.jcpa.2011.08.008; Peters M, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0366-0; Poulter JA, 2014, EUR J HUM GENET, V22, P132, DOI 10.1038/ejhg.2013.76; Pulkkinen L, 1998, AM J HUM GENET, V63, P1376, DOI 10.1086/302116; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ratnakumar Abhirami, 2010, BMC Res Notes, V3, P334, DOI 10.1186/1756-0500-3-334; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Ruzzi L, 1997, J CLIN INVEST, V99, P2826, DOI 10.1172/JCI119474; Schaapveld RQJ, 1998, J CELL BIOL, V142, P271, DOI 10.1083/jcb.142.1.271; Schumann H, 2013, BRIT J DERMATOL, V169, P115, DOI 10.1111/bjd.12317; Shariflou MR, 2013, ANIM GENET, V44, P231, DOI 10.1111/j.1365-2052.2012.02392.x; Spirito F, 2002, J INVEST DERMATOL, V119, P684, DOI 10.1046/j.1523-1747.2002.01852.x; Stanke M, 2008, BIOINFORMATICS, V24, P637, DOI 10.1093/bioinformatics/btn013; STEPP MA, 1990, P NATL ACAD SCI USA, V87, P8970, DOI 10.1073/pnas.87.22.8970; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Suarez-Vega A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081072; Takeichi T, 2015, BRIT J DERMATOL, V172, P94, DOI 10.1111/bjd.13190; Uitto J, 1997, MOL MED TODAY, V3, P457; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; vanderNeut R, 1996, NAT GENET, V13, P366, DOI 10.1038/ng0796-366; Varki R, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039685; VIDAL F, 1995, NAT GENET, V10, P229, DOI 10.1038/ng0695-229; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484	56	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0126416	10.1371/journal.pone.0126416	http://dx.doi.org/10.1371/journal.pone.0126416			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955497	Green Published, Green Submitted, gold			2022-12-26	WOS:000356768100119
J	Yin, N; Qi, X; Tsai, S; Lu, Y; Basir, Z; Oshima, K; Thomas, JP; Myers, CR; Stoner, G; Chen, G				Yin, N.; Qi, X.; Tsai, S.; Lu, Y.; Basir, Z.; Oshima, K.; Thomas, J. P.; Myers, C. R.; Stoner, G.; Chen, G.			p38 gamma MAPK is required for inflammation-associated colon tumorigenesis	ONCOGENE			English	Article							ACTIVATED PROTEIN-KINASE; RAS TRANSFORMATION; ESTROGEN-RECEPTOR; BETA-CATENIN; CANCER; STRESS; CARCINOGENESIS; PIRFENIDONE; EXPRESSION; PATHWAY	Chronic inflammation has long been considered to causatively link to colon cancer development. However, signal transduction pathways involved remain largely unidentified. Here, we report that p38 gamma mitogen-activated protein kinase mediates inflammatory signaling to promote colon tumorigenesis. Inflammation activates p38 gamma in mouse colon tissues and intestinal epithelial cell-specific p38 gamma knockout (KO) attenuates colitis and inhibits pro-inflammatory cytokine expression. Significantly, p38 gamma KO inhibits tumorigenesis in a colitis-associated mouse model. The specific p38 gamma pharmacological inhibitor pirfenidone also suppresses pro-inflammatory cytokine expression and colon tumorigenesis. The tumor-promoting activity of epithelial p38 gamma was further demonstrated by xenograft studies. In addition, p38 gamma is required for beta-catenin/Wnt activities and p38 gamma stimulates Wnt transcription by phosphorylating beta-catenin at Ser605. These results show that p38 gamma activation links inflammation and colon tumorigenesis. Targeting p38 gamma may be a novel strategy for colon cancer prevention and treatment.	[Yin, N.; Qi, X.; Myers, C. R.; Chen, G.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, 8701 Watertown Plank Rd,BSB 660, Milwaukee, WI 53226 USA; [Tsai, S.] Med Coll Wisconsin, Dept Surg, Milwaukee, WI 53226 USA; [Lu, Y.] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; [Basir, Z.; Oshima, K.] Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA; [Thomas, J. P.; Stoner, G.] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA; [Chen, G.] Med Coll Wisconsin, Zablocki Vet Affairs Med Ctr, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Chen, G (corresponding author), Med Coll Wisconsin, Dept Pharmacol & Toxicol, 8701 Watertown Plank Rd,BSB 660, Milwaukee, WI 53226 USA.	gchen@mcw.edu	Yin, Ning/AAA-7617-2020; Oshima, Kiyoko/CAF-1543-2022	Myers, Charles/0000-0001-7956-3217	Department of Veterans Affairs Merit Review [I01BX002883]; Cancer Center of Medical College of Wisconsin (the State of Wisconsin Tax Check-Off Program); Clinical & Translational Science Institute (CTSI) of Southeast Wisconsin; Veterans Affairs [I01BX002883] Funding Source: NIH RePORTER	Department of Veterans Affairs Merit Review(US Department of Veterans Affairs); Cancer Center of Medical College of Wisconsin (the State of Wisconsin Tax Check-Off Program); Clinical & Translational Science Institute (CTSI) of Southeast Wisconsin; Veterans Affairs(US Department of Veterans Affairs)	We thank Boehringer Ingelheim Pharmaceuticals Inc. and Dr Zhen Yan (University of Virginia) for providing the floxed p38 gamma mice. We also thank former lab members Drs PS Suresh for maintaining mice and conducting some preliminary experiments, and S Hou for generating the p38 gamma-depleted HCT116 cell lines. In addition, we express our gratitude to Drs D Wang (Blood Institute of Wisconsin), A Chan, R Li and J Tichelaar (Medical College of Wisconsin) for useful discussions. We also thank Drs J Han (The Scripps Research Institute), A Cuenda (National Center for Biotechnology-CSIC), NK Tonks (Cold Spring Harbor) and H Howe (South Carolina University) for providing various reagents. This work was in part supported by the grants from the Department of Veterans Affairs Merit Review (I01BX002883), the Cancer Center of Medical College of Wisconsin (the State of Wisconsin Tax Check-Off Program), and Clinical & Translational Science Institute (CTSI) of Southeast Wisconsin (to GC).	Abdollahi T, 2005, APOPTOSIS, V10, P1383, DOI 10.1007/s10495-005-2139-x; Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; Chen G, 2000, J BIOL CHEM, V275, P38973, DOI 10.1074/jbc.M002856200; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; del Reino P, 2014, CANCER RES, V74, P6150, DOI 10.1158/0008-5472.CAN-14-0870; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; Gillespie MA, 2009, J CELL BIOL, V187, P991, DOI 10.1083/jcb.200907037; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gupta J, 2014, CANCER CELL, V25, P484, DOI 10.1016/j.ccr.2014.02.019; Hou SW, 2010, CANCER RES, V70, P2901, DOI 10.1158/0008-5472.CAN-09-3229; Hou SW, 2012, J BIOL CHEM, V287, P27895, DOI 10.1074/jbc.M111.335794; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Kim C, 2008, NAT IMMUNOL, V9, P1019, DOI 10.1038/ni.1640; Korb A, 2006, ARTHRITIS RHEUM, V54, P2745, DOI 10.1002/art.22080; Kozono S, 2013, CANCER RES, V73, P2345, DOI 10.1158/0008-5472.CAN-12-3180; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Lee MH, 2009, FASEB J, V23, P3874, DOI 10.1096/fj.08-117804; Liu LX, 2003, WORLD J GASTROENTERO, V9, P683, DOI 10.3748/wjg.v9.i4.683; Loesch M, 2010, J BIOL CHEM, V285, P15149, DOI 10.1074/jbc.M110.105429; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Meng FY, 2011, NEOPLASIA, V13, P472, DOI 10.1593/neo.101748; Moran N, 2011, NAT BIOTECHNOL, V29, P301, DOI 10.1038/nbt0411-301; Neufert C, 2007, NAT PROTOC, V2, P1998, DOI 10.1038/nprot.2007.279; Noble PW, 2011, LANCET, V377, P1760, DOI 10.1016/S0140-6736(11)60405-4; Oku H, 2002, EUR J PHARMACOL, V446, P167, DOI 10.1016/S0014-2999(02)01757-0; Otsuka M, 2010, GASTROENTEROLOGY, V138, P1255, DOI 10.1053/j.gastro.2010.01.005; Ozes O, 2008, United States Patent-US, P1, Patent No. [7,407,973, 7407973, US7407973B2]; Pogozelski AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007934; Qi XM, 2007, J BIOL CHEM, V282, P31398, DOI 10.1074/jbc.M703857200; Qi XM, 2006, CANCER RES, V66, P7540, DOI 10.1158/0008-5472.CAN-05-4639; Qi XM, 2014, ONCOTARGET, V5, P4269, DOI 10.18632/oncotarget.2001; Qi XM, 2012, J BIOL CHEM, V287, P14681, DOI 10.1074/jbc.M112.349357; Qi XM, 2004, J BIOL CHEM, V279, P22138, DOI 10.1074/jbc.M313964200; Rhodes JM, 2002, TRENDS MOL MED, V8, P10, DOI 10.1016/S1471-4914(01)02194-3; Risco A, 2012, P NATL ACAD SCI USA, V109, P11200, DOI 10.1073/pnas.1207290109; Rosenthal DT, 2011, CANCER RES, V71, P6338, DOI 10.1158/0008-5472.CAN-11-1291; Sabio G, 2005, EMBO J, V24, P1134, DOI 10.1038/sj.emboj.7600578; Schreiber S, 2006, CLIN GASTROENTEROL H, V4, P325, DOI 10.1016/j.cgh.2005.11.013; Seril DN, 2003, CARCINOGENESIS, V24, P353, DOI 10.1093/carcin/24.3.353; Suzuki R, 2006, CARCINOGENESIS, V27, P162, DOI 10.1093/carcin/bgi205; Tamura K, 2000, CELL, V102, P221, DOI 10.1016/S0092-8674(00)00027-1; Tang J, 2005, J BIOL CHEM, V280, P23910, DOI 10.1074/jbc.M500699200; Tenbaum SP, 2012, NAT MED, V18, P892, DOI 10.1038/nm.2772; Tian Y, 2013, AM J PATHOL, V182, P2310, DOI 10.1016/j.ajpath.2013.02.037; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Wakeman D, 2012, SURGERY, V152, P286, DOI 10.1016/j.surg.2012.05.009; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Yang K, 2013, SCI REP-UK, V3, DOI 10.1038/srep03021	49	24	24	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 25	2016	35	8					1039	1048		10.1038/onc.2015.158	http://dx.doi.org/10.1038/onc.2015.158			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DE7NF	25961922				2022-12-26	WOS:000370823300009
J	Gustin, KM; Belser, JA; Veguilla, V; Zeng, H; Katz, JM; Tumpey, TM; Maines, TR				Gustin, Kortney M.; Belser, Jessica A.; Veguilla, Vic; Zeng, Hui; Katz, Jacqueline M.; Tumpey, Terrence M.; Maines, Taronna R.			Environmental Conditions Affect Exhalation of H3N2 Seasonal and Variant Influenza Viruses and Respiratory Droplet Transmission in Ferrets	PLOS ONE			English	Article							H5N1 VIRUSES; UNITED-STATES; PATHOGENESIS; HUMIDITY; VIRULENCE; AEROSOLS; HUMANS	The seasonality of influenza virus infections in temperate climates and the role of environmental conditions like temperature and humidity in the transmission of influenza virus through the air are not well understood. Using ferrets housed at four different environmental conditions, we evaluated the respiratory droplet transmission of two influenza viruses (a seasonal H3N2 virus and an H3N2 variant virus, the etiologic virus of a swine to human summertime infection) and concurrently characterized the aerosol shedding profiles of infected animals. Comparisons were made among the different temperature and humidity conditions and between the two viruses to determine if the H3N2 variant virus exhibited enhanced capabilities that may have contributed to the infections occurring in the summer. We report here that although increased levels of H3N2 variant virus were found in ferret nasal wash and exhaled aerosol samples compared to the seasonal H3N2 virus, enhanced respiratory droplet transmission was not observed under any of the environmental settings. However, overall environmental conditions were shown to modulate the frequency of influenza virus transmission through the air. Transmission occurred most frequently at 23 degrees C/30% RH, while the levels of infectious virus in aerosols exhaled by infected ferrets agree with these results. Improving our understanding of how environmental conditions affect influenza virus infectivity and transmission may reveal ways to better protect the public against influenza virus infections.	[Gustin, Kortney M.; Belser, Jessica A.; Veguilla, Vic; Zeng, Hui; Katz, Jacqueline M.; Tumpey, Terrence M.; Maines, Taronna R.] Natl Ctr Immunizat & Resp Dis, Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA	Maines, TR (corresponding author), Natl Ctr Immunizat & Resp Dis, Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30329 USA.	tmaines@cdc.gov						Belser JA, 2011, DIS MODEL MECH, V4, P575, DOI 10.1242/dmm.007823; Blanton L, 2014, MMWR-MORBID MORTAL W, V63, P861; Branch Alicia, 2012, Morbidity and Mortality Weekly Report, V61, P237; Cao G, 2011, J ENVIRON MONITOR, V13, P3321, DOI 10.1039/c1em10607d; Centers for Disease C, 2011, MMWR-MORBID MORTAL W, V60, P705; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P1615; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; *CTR, 2000, MMWR-MORBID MORTAL W, V49, P375; Fiegel J, 2006, DRUG DISCOV TODAY, V11, P51, DOI 10.1016/S1359-6446(05)03687-1; Fox J., 1998, BIOL DIFERRET, V2nd ed, P221; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gustin KM, 2013, J VIROL, V87, P7864, DOI 10.1128/JVI.00719-13; Gustin KM, 2012, TRENDS MICROBIOL, V20, P275, DOI 10.1016/j.tim.2012.03.006; Gustin KM, 2011, P NATL ACAD SCI USA, V108, P8432, DOI 10.1073/pnas.1100768108; Hanley BP, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-98; Hinds W.C., 1999, AEROSOL TECHNOLOGY; Houser KV, 2013, J VIROL, V87, P13480, DOI 10.1128/JVI.02434-13; Huang SSH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027512; Jhung MA, 2013, CLIN INFECT DIS, V57, P1703, DOI 10.1093/cid/cit649; Koster F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033118; Lindsley WG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015100; Lowen AC, 2008, J VIROL, V82, P5650, DOI 10.1128/JVI.00325-08; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Maines TR, 2012, J INFECT DIS, V205, P474, DOI 10.1093/infdis/jir768; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; Milton DK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003205; Mubareka S, 2009, J INFECT DIS, V199, P858, DOI 10.1086/597073; Nalluswami Kumar, 2011, Morbidity and Mortality Weekly Report, V60, P1213; Noti JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057485; Pearce MB, 2012, P NATL ACAD SCI USA, V109, P3944, DOI 10.1073/pnas.1119945109; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Skowronski DM, 2012, EUROSURVEILLANCE, V17, P2; Tamerius JD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003194; Thangavel RR, 2014, J IMMUNOL METHODS, V410, P60, DOI 10.1016/j.jim.2014.03.023; van Doremalen N, 2013, EUROSURVEILLANCE, V18, P7, DOI 10.2807/1560-7917.ES2013.18.38.20590; Weber TP, 2008, J INFECTION, V57, P361, DOI 10.1016/j.jinf.2008.08.013; Yang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046789; Yang W, 2012, APPL ENVIRON MICROB, V78, P6781, DOI 10.1128/AEM.01658-12; Zeng H, 2007, J VIROL, V81, P12439, DOI 10.1128/JVI.01134-07; Zitzow LA, 2002, J VIROL, V76, P4420, DOI 10.1128/JVI.76.9.4420-4429.2002	41	39	40	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0125874	10.1371/journal.pone.0125874	http://dx.doi.org/10.1371/journal.pone.0125874			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25969995	Green Published, Green Submitted, gold			2022-12-26	WOS:000354544200088
J	Hung, KY; Michailides, TJ; Millar, JG; Wayadande, A; Gerry, AC				Hung, Kim Y.; Michailides, Themis J.; Millar, Jocelyn G.; Wayadande, Astri; Gerry, Alec C.			House Fly (Musca domestica L.) Attraction to Insect Honeydew	PLOS ONE			English	Article							ESCHERICHIA-COLI O157H7; HORSE FLIES DIPTERA; SUGARS; MUSCIDAE; TRANSMISSION; PERFORMANCE; VOLATILES; HABITATS; SPINACH; NECTAR	House flies are of major concern as vectors of food-borne pathogens to food crops. House flies are common pests on cattle feedlots and dairies, where they develop in and feed on animal waste. By contacting animal waste, house flies can acquire human pathogenic bacteria such as Escherichia coli and Salmonella spp., in addition to other bacteria, viruses, or parasites that may infect humans and animals. The subsequent dispersal of house flies from animal facilities to nearby agricultural fields containing food crops may lead to pre-harvest food contamination with these pathogens. We hypothesized that odors from honeydew, the sugary excreta produced by sucking insects feeding on crops, or molds and fungi growing on honeydew, may attract house flies, thereby increasing the risk of food crop contamination. House fly attraction to honeydew-contaminated plant material was evaluated using a laboratory bioassay. House flies were attracted to the following plant-pest-honeydew combinations: citrus mealybug on squash fruit, pea aphid on faba bean plants, whitefly on navel orange and grapefruit leaves, and combined citrus mealybug and cottony cushion scale on mandarin orange leaves. House flies were not attracted to field-collected samples of lerp psyllids on eucalyptus plants or aphids on crepe myrtle leaves. Fungi associated with field-collected honeydews were isolated and identified for further study as possible emitters of volatiles attractive to house flies. Two fungal species, Aureobasidium pullulans and Cladosporium cladosporioides, were repeatedly isolated from field-collected honeydew samples. Both fungal species were grown in potato dextrose enrichment broth and house fly attraction to volatiles from these fungal cultures was evaluated. House flies were attracted to odors from A. pullulans cultures but not to those of C. cladosporioides. Identification of specific honeydew odors that are attractive to house flies could be valuable for the development of improved house fly baits for management of this pest species.	[Hung, Kim Y.; Millar, Jocelyn G.; Gerry, Alec C.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Wayadande, Astri] Oklahoma State Univ, Dept Entomol & Plant Pathol, Stillwater, OK 74078 USA; [Michailides, Themis J.] Kearney Agr Res Extens Ctr, Parlier, CA USA	University of California System; University of California Riverside; Oklahoma State University System; Oklahoma State University - Stillwater	Gerry, AC (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.	alec.gerry@ucr.edu	Michailides, Themis/AAI-6592-2020	Millar, Jocelyn/0000-0001-7639-9001	United States Department of Agriculture National Integrated Food Safety Initiative (USDA-NIFSI) [2009-51110-05856]; National Science Foundation Graduate Research Fellowship Program (NSF GRFP)	United States Department of Agriculture National Integrated Food Safety Initiative (USDA-NIFSI); National Science Foundation Graduate Research Fellowship Program (NSF GRFP)(National Science Foundation (NSF)NSF - Office of the Director (OD))	This project was funded by United States Department of Agriculture National Integrated Food Safety Initiative (USDA-NIFSI) # 2009-51110-05856. Support for KYH was also provided by the National Science Foundation Graduate Research Fellowship Program (NSF GRFP). USDA-NIFSI and NSF GRFP had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Beltran G, 2008, INT J FOOD MICROBIOL, V121, P169, DOI 10.1016/j.ijfoodmicro.2007.11.030; BROWN AW, 1961, J ECON ENTOMOL, V54, P670, DOI 10.1093/jee/54.4.670; Burgin SG, 1997, CAN ENTOMOL, V129, P859, DOI 10.4039/Ent129859-5; Chakrabarti S, 2010, J KANSAS ENTOMOL SOC, V83, P172, DOI 10.2317/JKES0809.15.1; Chavasse DC, 1999, LANCET, V353, P22, DOI 10.1016/S0140-6736(98)03366-2; Chen SF, 2011, PLANT PATHOL, V60, P739, DOI 10.1111/j.1365-3059.2011.02431.x; Choi MY, 2004, ENTOMOL EXP APPL, V111, P37, DOI 10.1111/j.0013-8703.2004.00151.x; COHEN D, 1991, LANCET, V337, P993, DOI 10.1016/0140-6736(91)92657-N; COOKE W. B., 1959, MYCOPATH ET MYCOL APPL, V12, P1, DOI 10.1007/BF02118435; Cosse AA, 1996, J AGR ENTOMOL, V13, P301; Davis TS, 2013, J CHEM ECOL, V39, P840, DOI 10.1007/s10886-013-0306-z; Davis TS, 2013, J CHEM ECOL, V39, P860, DOI 10.1007/s10886-013-0278-z; Davis TS, 2012, MICROB ECOL, V64, P1056, DOI 10.1007/s00248-012-0074-2; Doud CW, 2014, MICROB ECOL, V67, P380, DOI 10.1007/s00248-013-0337-6; DOWNES WL, 1987, ENVIRON ENTOMOL, V16, P847, DOI 10.1093/ee/16.4.847; El-Sayed AM, 2009, J ECON ENTOMOL, V102, P815, DOI 10.1603/029.102.0301; Elder RO, 2000, P NATL ACAD SCI USA, V97, P2999, DOI 10.1073/pnas.060024897; FOSTER WA, 1995, ANNU REV ENTOMOL, V40, P443, DOI 10.1146/annurev.en.40.010195.002303; Frishman AM, 1996, OLFACTORY RESPONSES, P89; Gould LH, 2013, MMWR SURVEILL SUMM, V62, P1; Graczyk TK, 2001, MICROBES INFECT, V3, P231, DOI 10.1016/S1286-4579(01)01371-5; Greenberg B, 1973, FLIES AND DIS, V2; Greenberg B., 1971, FLIES AND DIS, V1; Hunter FF, 1999, J MED ENTOMOL, V36, P896, DOI 10.1093/jmedent/36.6.896; Leroy PD, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1347; Leroy PD, 2010, BIOL CONTROL, V54, P181, DOI 10.1016/j.biocontrol.2010.05.006; LEVINE OS, 1991, REV INFECT DIS, V13, P688; LINDSAY DR, 1953, PUBLIC HEALTH REP, V68, P361, DOI 10.2307/4588424; LYSYK TJ, 1986, J ECON ENTOMOL, V79, P993, DOI 10.1093/jee/79.4.993; MACVICKER JAK, 1990, B ENTOMOL RES, V80, P339, DOI 10.1017/S0007485300050537; MANDEVILLE JD, 1988, CAN ENTOMOL, V120, P153, DOI 10.4039/Ent120153-2; MOORE JS, 1987, MED VET ENTOMOL, V1, P427, DOI 10.1111/j.1365-2915.1987.tb00373.x; Muller GC, 2011, ACTA TROP, V118, P45, DOI 10.1016/j.actatropica.2011.01.009; Olsen AR, 1998, REGUL TOXICOL PHARM, V28, P199, DOI 10.1006/rtph.1998.1271; Qian K, 2013, J ECON ENTOMOL, V106, P979, DOI 10.1603/EC12424; Quinn BP, 2007, J CHROMATOGR A, V1139, P279, DOI 10.1016/j.chroma.2006.11.039; Sasaki T, 2000, J MED ENTOMOL, V37, P945, DOI 10.1603/0022-2585-37.6.945; SCHUTZ SJ, 1989, J MED ENTOMOL, V26, P471, DOI 10.1093/jmedent/26.5.471; Slippers B, 2004, MYCOLOGIA, V96, P83, DOI 10.2307/3761991; Stanfield TK, 2010, CAN J ZOOL, V88, P69, DOI 10.1139/Z09-119; Talley JL, 2009, J FOOD PROTECT, V72, P1547, DOI 10.4315/0362-028X-72.7.1547; Wackers FL, 2001, J INSECT PHYSIOL, V47, P1077, DOI 10.1016/S0022-1910(01)00088-9; Wang XG, 2011, ENTOMOL EXP APPL, V139, P128, DOI 10.1111/j.1570-7458.2011.01114.x; Wang YC, 2011, J FOOD PROTECT, V74, P1012, DOI 10.4315/0362-028X.JFP-10-394; Wasala L, 2013, PHYTOPATHOLOGY, V103, P373, DOI [10.1094/PHYTO-09-12-0217-FI, 10]; WATT J, 1948, PUBLIC HEALTH REP, V63, P1319, DOI 10.2307/4586723; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wieting JOG, 1939, J ECON ENTOMOL, V32, P24, DOI 10.1093/jee/32.1.24	50	14	14	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0124746	10.1371/journal.pone.0124746	http://dx.doi.org/10.1371/journal.pone.0124746			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970333	Green Published, Green Submitted, gold			2022-12-26	WOS:000354544200051
J	Heiland, F; Yin, N				Heiland, Frank; Yin, Na			Anchoring Vignettes in the Health and Retirement Study: How Do Medical Professionals and Disability Recipients Characterize the Severity of Work Limitations?	PLOS ONE			English	Article							DYNAMICS; PROBIT; BIAS	Purpose Recent studies report systematic differences in how individuals categorize the severity of identical health and work limitation vignettes. We investigate how health professionals and disability recipients characterize the severity of work limitations and whether their reporting patterns are robust to demographic, education, and health characteristics. We use the results to illustrate the potential impact of reporting heterogeneity on the distribution of work disability estimated from self-reported categorical health and disability data. Method Nationally representative data on anchoring disability vignettes from the 2004 Health and Retirement Study (HRS) are used to investigate how respondents with an occupation background in health and Social Security disability beneficiaries categorize work limitation vignettes. Using pain, cardiovascular health, and depression vignettes, we estimate generalized ordered probit models (N = 2,660 individuals or 39,681 person-vignette observations) that allow the severity thresholds to vary by respondent characteristics. Results We find that health professionals (excluding nurses) and disability recipients tend to classify identical work limitations as more severe compared to non-health professional non-disabled respondents. For disability recipients, the differences are most pronounced and particularly visible in the tails of the work limitations distribution. For health professionals, we observe smaller differences, affecting primarily the classification of mildly and moderately severe work limitations. The patterns for health professionals (excluding nurses) are robust to demographics, education, and health conditions. The greater likelihood of viewing the vignette person as more severely work limited observed among disability recipients is mostly explained by the fact that these respondents also tend to be in poorer health which itself predicts a more inclusive scale. Conclusions Knowledge of reporting scales from health professionals and disabled individuals can benefit researchers in a broad range of applications in health and disability research. They may be useful as reference scales to evaluate disability survey data. Such knowledge may be beneficial when studying disability programs. Given the increasing availability of anchoring vignette data in surveys, this is a promising area for future evaluation research.	[Heiland, Frank; Yin, Na] CUNY, Sch Publ Affairs, Baruch Coll, New York, NY 10021 USA; [Heiland, Frank; Yin, Na] CUNY, Inst Demog Res, New York, NY 10021 USA; [Heiland, Frank; Yin, Na] CUNY, Grad Ctr, New York, NY USA	City University of New York (CUNY) System; Baruch College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System	Yin, N (corresponding author), CUNY, Sch Publ Affairs, Baruch Coll, New York, NY 10021 USA.	Na.Yin@baruch.cuny.edu						Angelini V, 2011, J R STAT SOC A STAT, V174, P621, DOI 10.1111/j.1467-985X.2011.00705.x; d'Uva TB, 2008, INT J EPIDEMIOL, V37, P1375, DOI 10.1093/ije/dyn146; BAGOZZI RP, 1994, J MARKETING, V58, P56, DOI 10.2307/1252251; Benitez-Silva H, 2004, J APPL ECONOMET, V19, P649, DOI 10.1002/jae.797; Benitez-Silva H, 2008, J HEALTH ECON, V27, P564, DOI 10.1016/j.jhealeco.2007.09.008; BENITEZSILVA H, 1999, LABOUR ECONOMICS, V0006; BOUND J, 1991, J HUM RESOUR, V26, P106, DOI 10.2307/145718; D'Uva TB, 2008, HEALTH ECON, V17, P351, DOI 10.1002/hec.1269; d'Uva TB, 2011, J HUM RESOUR, V46, P875, DOI 10.3368/jhr.46.4.875; Dwyer DS, 1999, J HEALTH ECON, V18, P173, DOI 10.1016/S0167-6296(98)00034-4; Dywer D, 2002, JOURNAL OF ECONOMIC, V28, P109; Grol-Prokopczyk H, 2011, J HEALTH SOC BEHAV, V52, P246, DOI 10.1177/0022146510396713; Gupta ND, 2010, ECON MODEL, V27, P854, DOI 10.1016/j.econmod.2009.11.007; Hulshof C, HANDBOOK OF WORK DIS, P2; Kapteyn A, 2009, RAND LABOR AND POPUL; Kapteyn A, 2007, AM ECON REV, V97, P461, DOI 10.1257/aer.97.1.461; King G, 2004, AM POLIT SCI REV, V98, P191, DOI 10.1017/S000305540400108X; Kristensen N, 2008, LABOUR ECON, V15, P96, DOI 10.1016/j.labeco.2006.11.001; Likert R., 1932, ARCH PSYCHOL, V140, P1, DOI DOI 10.1111/J.1540-5834.2010.00585.X; Mu R, 2014, HEALTH ECON, V23, P529, DOI 10.1002/hec.2929; Murray CJ, 2003, HEALTH SYSTEMS PERFO; Pudney S, 2000, J APPL ECONOM, V15, P367, DOI 10.1002/1099-1255(200007/08)15:4<367::AID-JAE563>3.0.CO;2-Z; Rice N, 2011, EUR J HEALTH ECON, V12, P141, DOI 10.1007/s10198-010-0235-5; Sadana R, 2002, GLOBAL PROGRAMME ON; Small DA, 2010, ORGAN BEHAV HUM DEC, V112, P151, DOI 10.1016/j.obhdp.2010.03.001; Social Security Administration, 2004, ANNUAL STATISTICAL R; TERZA JV, 1985, COMMUN STAT-THEOR M, V14, P1; van Soest A, 2011, J R STAT SOC A STAT, V174, P575, DOI 10.1111/j.1467-985X.2011.00694.x; Zajacova A, 2011, AM J EPIDEMIOL, V174, P977, DOI 10.1093/aje/kwr204	29	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0126218	10.1371/journal.pone.0126218	http://dx.doi.org/10.1371/journal.pone.0126218			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI1ZI	25966316	Green Published, gold			2022-12-26	WOS:000354543500051
J	Jarlais, DD; Arasteh, K; McKnight, C; Feelemyer, J; Hagan, H; Cooper, H; Campbell, A; Tross, S; Perlman, D				Jarlais, Don Des; Arasteh, Kamyar; McKnight, Courtney; Feelemyer, Jonathan; Hagan, Holly; Cooper, Hannah; Campbell, Aimee; Tross, Susan; Perlman, David			Will "Combined Prevention" Eliminate Racial/Ethnic Disparities in HIV Infection among Persons Who Inject Drugs in New York City?	PLOS ONE			English	Article							SEXUAL TRANSMISSION; USERS; RISK; SEROPREVALENCE; BEHAVIORS	It has not been determined whether implementation of combined prevention programming for persons who inject drugs reduce racial/ethnic disparities in HIV infection. We examine racial/ethnic disparities in New York City among persons who inject drugs after implementation of the New York City Condom Social Marketing Program in 2007. Quantitative interviews and HIV testing were conducted among persons who inject drugs entering Mount Sinai Beth Israel drug treatment (2007-2014). 703 persons who inject drugs who began injecting after implementation of large-scale syringe exchange were included in the analyses. Factors independently associated with being HIV seropositive were identified and a published model was used to estimate HIV infections due to sexual transmission. Overall HIV prevalence was 4%; Whites 1%, African-Americans 17%, and Hispanics 4%. Adjusted odds ratios were 21.0 (95% CI 5.7, 77.5) for African-Americans to Whites and 4.5 (95% CI 1.3, 16.3) for Hispanics to Whites. There was an overall significant trend towards reduced HIV prevalence over time (adjusted odd ratio = 0.7 per year, 95% confidence interval (0.6-0.8). An estimated 75% or more of the HIV infections were due to sexual transmission. Racial/ethnic disparities among persons who inject drugs were not significantly different from previous disparities. Reducing these persistent disparities may require new interventions (treatment as prevention, pre-exposure prophylaxis) for all racial/ethnic groups.	[Jarlais, Don Des; Arasteh, Kamyar; McKnight, Courtney; Feelemyer, Jonathan; Perlman, David] Mt Sinai Beth Israel, Baron Edmond Rothschild Chem Dependency Inst, New York, NY 10003 USA; [Hagan, Holly] NYU, Coll Nursing, New York, NY USA; [Cooper, Hannah] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Campbell, Aimee; Tross, Susan] Columbia Univ, Dept Psychiat, New York, NY USA	New York University; Emory University; Rollins School Public Health; Columbia University	Jarlais, DD (corresponding author), Mt Sinai Beth Israel, Baron Edmond Rothschild Chem Dependency Inst, New York, NY 10003 USA.	ddesjarlais@chpnet.org		McKnight, Courtney A/0000-0001-8685-5381; Feelemyer, Jonathan/0000-0001-6617-4992	National Institutes of Health [5R01DA003574]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH043520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA003574, P30DA011041] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported through Grant 5R01DA003574 from the National Institutes of Health. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the organizations and/or agencies the authors are affiliated with. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], GUID US PREEXP PROPH; Clinton H, 2011, CREATING AIDS FREE G; Crepaz N, 2006, AIDS, V20, P143, DOI 10.1097/01.aids.0000196166.48518.a0; Des Jarlais DC, 2014, AIDS BEHAV, V18, P443, DOI 10.1007/s10461-013-0664-0; Des Jarlais DC, 2013, J URBAN HEALTH, P1; Des Jarlais DC, 2012, ADDICTION; Des Jarlais DC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087993; Des Jarlais DC, 2012, DRUG ALCOHOL DEPEN, V124, P95, DOI 10.1016/j.drugalcdep.2011.12.020; DESJARLAIS DC, 1989, JAMA-J AM MED ASSOC, V261, P1008, DOI 10.1001/jama.261.7.1008; Farley T, 2011, 2011 ADVISORY 27 HLT; Friedman SR, 1999, J ACQ IMMUN DEF SYND, V22, P83, DOI 10.1097/00042560-199909010-00011; Jarlais DCD, 2009, AM J PUBLIC HEALTH, V99, pS445, DOI 10.2105/AJPH.2008.159327; Jarlais DCD, 2009, DRUG ALCOHOL DEPEN, V101, P88, DOI 10.1016/j.drugalcdep.2008.11.007; Kral AH, 2001, LANCET, V357, P1397, DOI 10.1016/S0140-6736(00)04562-1; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; New York City Department of Health and Mental Hygiene, 2007, HLTH DEP LAUNCH NAT; New York City State Department of Health, 2014, NEW YORK CIT STAT DE; STATA Corp, 2012, STAT 12; Strathdee SA, 2003, J URBAN HEALTH, V80, P7; Vickerman P, 2013, DRUG ALCOHOL DEPEN, V132, P172, DOI 10.1016/j.drugalcdep.2013.01.020	20	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0126180	10.1371/journal.pone.0126180	http://dx.doi.org/10.1371/journal.pone.0126180			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI1ZI	25965957	Green Published, Green Submitted, gold			2022-12-26	WOS:000354543500049
J	Myburgh, H; Murphy, JP; van Huyssteen, M; Foster, N; Grobbelaar, CJ; Struthers, HE; McIntyre, JA; Hurter, T; Peters, RPH				Myburgh, Hanlie; Murphy, Joshua P.; van Huyssteen, Mea; Foster, Nicola; Grobbelaar, Cornelius J.; Struthers, Helen E.; McIntyre, James A.; Hurter, Theunis; Peters, Remco P. H.			Implementation of an Electronic Monitoring and Evaluation System for the Antiretroviral Treatment Programme in the Cape Winelands District, South Africa: A Qualitative Evaluation	PLOS ONE			English	Article								Background A pragmatic three-tiered approach to monitor the world's largest antiretroviral treatment (ART) programme was adopted by the South African National Department of Health in 2010. With the rapid expansion of the programme, the limitations of the paper-based register (tier 1) were the catalyst for implementation of the stand-alone electronic register (tier 2), which offers simple digitisation of the paper-based register. This article engages with theory on implementation to identify and contextualise enabling and constraining factors for implementation of the electronic register, to describe experiences and use of the register, and to make recommendations for implementation in similar settings where standardisation of ART monitoring and evaluation has not been achieved. Methods We conducted a qualitative evaluation of the roll-out of the register. This comprised twenty in-depth interviews with a diverse sample of stakeholders at facility, sub-district, and district levels of the health system. Facility-level participants were selected across five sub-districts, including one facility per sub-district. Responses were coded and analysed using a thematic approach. An implementation science framework guided interpretation of the data. Results & Discussion We identified the following seven themes: 1) ease of implementation, 2) perceived value of an electronic M&E system, 3) importance of stakeholder engagement, 4) influence of a data champion, 5) operational and logistical factors, 6) workload and role clarity, and 7) importance of integrating the electronic register with routine facility monitoring and evaluation. Interpreting our findings through an implementation theory enabled us to construct the scaffolding for implementation across the five facility-settings. This approach illustrated that implementation was not a linear process but occurred at two nodes: at the adoption of the register for roll-out, and at implementation at facility-level. Conclusion In this study we found that relative advantage of an intervention and stakeholder engagement are critical to implementation. We suggest that without these aspects of implementation, formative and summative outcomes of implementation at both the adoption and coalface stages of implementation would be negatively affected.	[Myburgh, Hanlie; Grobbelaar, Cornelius J.; Hurter, Theunis] Anova Hlth Inst, Paarl, Western Cape Pr, South Africa; [Murphy, Joshua P.; Struthers, Helen E.; McIntyre, James A.; Peters, Remco P. H.] Anova Hlth Inst, Johannesburg, Gauteng Provinc, South Africa; [van Huyssteen, Mea] Univ Western Cape, Fac Nat Sci, Sch Pharm, ZA-7535 Bellville, Western Cape Pr, South Africa; [Foster, Nicola; McIntyre, James A.; Hurter, Theunis] Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, Western Cape Pr, South Africa	University of the Western Cape; University of Cape Town	Myburgh, H (corresponding author), Anova Hlth Inst, Paarl, Western Cape Pr, South Africa.	myburgh@anovahealth.co.za	Foster, Nicola/AAA-9040-2020	Foster, Nicola/0000-0003-4630-6243; Murphy, Joshua/0000-0001-5466-3131; Peters, Remco Petrus Hendricus/0000-0003-2124-7275	US President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID) [AID-674-A-12-00015]	US President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This article was funded by the US President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (USAID) under Cooperative Agreement number AID-674-A-12-00015 to the Anova Health Institute. The opinions expressed herein are those of the authors and do not necessarily reflect the views of USAID or PEPFAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott PA, 2014, INT J MED INFORM, V83, pE12, DOI 10.1016/j.ijmedinf.2013.10.009; Agarwal M, 2013, PUBLIC HEALTH ACTION, V3, P175, DOI 10.5588/pha.12.0096; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Kaposhi BM, 2014, HLTH POLICY PLAN, P1, DOI [10.1093/heapol/czs111, DOI 10.1093/HEAPOL/CZS111]; Kawonga M, 2012, HEALTH RES POLICY SY, V10, DOI 10.1186/1478-4505-10-2; Osler M, 2010, WORKING PAPER; Osler M, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18908; Schneider H, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-S1-S4; Shisana O, 2014, S AFRICAN NATL HIV P, DOI [10.2989/16085906.2015.1016988, DOI 10.2989/16085906.2015.1016988]	10	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0127223	10.1371/journal.pone.0127223	http://dx.doi.org/10.1371/journal.pone.0127223			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25966294	Green Submitted, Green Published, gold			2022-12-26	WOS:000354543500098
J	Rao, TD; Tian, HS; Ma, X; Yan, XJ; Thapi, S; Schultz, N; Rosales, N; Monette, S; Wang, A; Hyman, DM; Levine, DA; Solit, D; Spriggs, DR				Rao, Thapi D.; Tian, Huasong; Ma, Xun; Yan, Xiujun; Thapi, Sahityasri; Schultz, Nikolaus; Rosales, Nestor; Monette, Sebastien; Wang, Amy; Hyman, David M.; Levine, Douglas A.; Solit, David; Spriggs, David R.			Expression of the Carboxy-Terminal Portion of MUC16/CA125 Induces Transformation and Tumor Invasion	PLOS ONE			English	Article							OVARIAN-CANCER ANTIGEN; MOUSE FIBROBLAST CELLS; MOLECULAR CHARACTERIZATION; BETA-CATENIN; CARCINOMA; CA125; MUC16; MUCIN; SURFACE; MODEL	The CA125 antigen is found in the serum of many patients with serous ovarian cancer and has been widely used as a disease marker. CA125 has been shown to be an independent factor for clinical outcome in this disease. In The Cancer Genome Atlas ovarian cancer project, MUC16 expression levels are frequently increased, and the highest levels of MUC16 expression are linked to a significantly worse survival. To examine the biologic effect of the proximal portion of MUC16/CA125, NIH/3T3 (3T3) fibroblast cell lines were stably transfected with the carboxy elements of MUC16. As few as 114 amino acids from the carboxyterminal portion of MUC16 were sufficient to increase soft agar growth, promote matrigel invasion, and increase the rate of tumor growth in athymic nude mice. Transformation with carboxy elements of MUC16 was associated with activation of the AKT and ERK pathways. MUC16 transformation was associated with up-regulation of a number of metastases and invasion gene transcripts, including IL-1 beta, MMP2, and MMP9. All observed oncogenic changes were exclusively dependent on the extracellular "ectodomain" of MUC16. The biologic impact of MUC16 was also explored through the creation of a transgenic mouse model expressing 354 amino acids of the carboxy-terminal portion of MUC16 (MUC16(c354)). Under a CMV, early enhancer plus chicken beta actin promoter (CAG) MUC16(c354) was well expressed in many organs, including the brain, colon, heart, kidney, liver, lung, ovary, and spleen. MUC16(c354) transgenic animals appear to be viable, fertile, and have a normal lifespan. However, when crossed with p53-deficient mice, the MUC16(c354): p53(+/-) progeny displayed a higher frequency of spontaneous tumor development compared to p53(+/-) mice alone. We conclude that the carboxy-terminal portion of the MUC16/CA125 protein is oncogenic in NIH/3T3 cells, increases invasive tumor properties, activates the AKT and ERK pathways, and contributes to the biologic properties of ovarian cancer.	[Rao, Thapi D.; Tian, Huasong; Ma, Xun; Yan, Xiujun; Thapi, Sahityasri; Rosales, Nestor; Wang, Amy; Hyman, David M.; Solit, David; Spriggs, David R.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Rao, Thapi D.; Tian, Huasong; Ma, Xun; Yan, Xiujun; Thapi, Sahityasri; Rosales, Nestor; Wang, Amy; Solit, David; Spriggs, David R.] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Schultz, Nikolaus] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA; [Monette, Sebastien] Rockefeller Univ, Weill Cornell Med Coll, Mem Sloan Kettering Canc Ctr, Triinst Lab Comparat Pathol, New York, NY 10021 USA; [Hyman, David M.] Weill Cornell Med Coll, New York, NY USA; [Levine, Douglas A.] Mem Sloan Kettering Canc Ctr, Dept Surg, Gynecol Serv, New York, NY 10021 USA; [Levine, Douglas A.] Weill Cornell Med Coll, Dept Obstet & Gynecol, New York, NY USA	Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Rockefeller University; Cornell University; Memorial Sloan Kettering Cancer Center; Cornell University	Spriggs, DR (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.	spriggsd@mskcc.org	Solit, David B./AAC-5309-2019; Schultz, Nikolaus/ABE-6347-2020	Levine, Douglas/0000-0003-1038-8232; Solit, David/0000-0002-6614-802X; Thapi, Sahityasri/0000-0002-2273-6102	NIH Grant [PO1-CA52477-17]; NIH Core Grant [P30 CA 008748]; NATIONAL CANCER INSTITUTE [P01CA190174, P30CA008748, P01CA052477] Funding Source: NIH RePORTER	NIH Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Core Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work supported by NIH Grant # PO1-CA52477-17. This work used core facilities funded by NIH Core Grant # P30 CA 008748. The NIH played no role in any aspect of study design, data collection and analysis, or publication.	Bafna S, 2008, CANCER RES, V68, P9231, DOI 10.1158/0008-5472.CAN-08-3135; Bast RC, 2005, INT J GYNECOL CANCER, V15, P274, DOI 10.1111/j.1525-1438.2005.00441.x; BAST RC, 1983, NEW ENGL J MED, V309, P883, DOI 10.1056/NEJM198310133091503; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Cheon DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004675; Comamala M, 2011, BRIT J CANCER, V104, P989, DOI 10.1038/bjc.2011.34; Corrales RM, 2009, OPTOMETRY VISION SCI, V86, P1051, DOI 10.1097/OPX.0b013e3181b4f02e; Duraisamy S, 2006, GENE, V373, P28, DOI 10.1016/j.gene.2005.12.021; Ghosh S, 2012, J BIOL CHEM, V287, P15001, DOI 10.1074/jbc.M111.284034; Giannakouros P, 2015, INT J ONCOL, V46, P91, DOI 10.3892/ijo.2014.2707; Govindarajan B, 2010, EXP EYE RES, V90, P655, DOI 10.1016/j.exer.2010.02.014; HELLER G, 1992, BIOMETRICS, V48, P101, DOI 10.2307/2532742; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Huang L, 2005, CANCER RES, V65, P10413, DOI 10.1158/0008-5472.CAN-05-2474; KABAWAT SE, 1983, INT J CANCER, V32, P547, DOI 10.1002/ijc.2910320505; Kaneko O, 2009, J BIOL CHEM, V284, P3739, DOI 10.1074/jbc.M806776200; Li Q, 2004, BIOCHEM BIOPH RES CO, V315, P471, DOI 10.1016/j.bbrc.2004.01.075; Li YQ, 2003, ONCOGENE, V22, P6107, DOI 10.1038/sj.onc.1206732; Liu Y, 2008, CLIN IMMUNOL, V129, P471, DOI 10.1016/j.clim.2008.07.030; Lloyd KO, 2001, TUMOR BIOL, V22, P77, DOI 10.1159/000050600; Mazzoletti M, 2010, CURR MED CHEM, V17, P4433, DOI 10.2174/092986710794182999; O'Brien TJ, 2001, TUMOR BIOL, V22, P348, DOI 10.1159/000050638; Rao TD, 2011, MOL CANCER THER, V10, P1939, DOI 10.1158/1535-7163.MCT-11-0228; Rao TD, 2010, APPL IMMUNOHISTO M M, V18, P462, DOI 10.1097/PAI.0b013e3181dbfcd2; Seelenmeyer C, 2003, J CELL SCI, V116, P1305, DOI 10.1242/jcs.00312; Shinoda Y, 2008, J BIOL CHEM, V283, P24682, DOI 10.1074/jbc.M709857200; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Theriault C, 2011, GYNECOL ONCOL, V121, P434, DOI 10.1016/j.ygyno.2011.02.020; Ventura AP, 2010, APPL IMMUNOHISTO M M, V18, P499, DOI 10.1097/PAI.0b013e3181e53e1c; Xing DY, 2006, CANCER RES, V66, P8949, DOI 10.1158/0008-5472.CAN-06-1495; Xing DY, 2005, P NATL ACAD SCI USA, V102, P6936, DOI 10.1073/pnas.0502256102; Yin BWT, 2002, INT J CANCER, V98, P737, DOI 10.1002/ijc.10250; Yin BWT, 2001, J BIOL CHEM, V276, P27371, DOI 10.1074/jbc.M103554200; Zorn KK, 2009, CANCER-AM CANCER SOC, V115, P1028, DOI 10.1002/cncr.24084	35	26	30	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0126633	10.1371/journal.pone.0126633	http://dx.doi.org/10.1371/journal.pone.0126633			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965947	Green Published, Green Submitted, gold			2022-12-26	WOS:000354543500072
J	Rodriguez-Dominguez, M; Gonzalez-Alba, JM; Puerta, T; Menendez, B; Sanchez-Diaz, AM; Canton, R; del Romero, J; Galan, JC				Rodriguez-Dominguez, Mario; Gonzalez-Alba, Jose Maria; Puerta, Teresa; Menendez, Blanca; Sanchez-Diaz, Ana Maria; Canton, Rafael; del Romero, Jorge; Galan, Juan Carlos			High Prevalence of Co-Infections by Invasive and Non-Invasive Chlamydia trachomatis Genotypes during the Lymphogranuloma Venereum Outbreak in Spain	PLOS ONE			English	Article							L-SEROVARS; SEX; MEN; STRAINS; INFECTIONS; RECOMBINATION; VARIANTS; EPIDEMIC; TROPISM; SWEDEN	The evolution of Chlamydia trachomatis is mainly driven by recombination events. This fact can be fuelled by the coincidence in several European regions of the high prevalence of non-invasive urogenital genotypes and lymphogranuloma venereum (LGV) outbreaks. This scenario could modify the local epidemiology and favor the selection of new C. trachomatis variants. Quantifying the prevalence of co-infection could help to predict the potential risk in the selection of new variants with unpredictable results in pathogenesis or transmissibility. In the 2009-2013 period, 287 clinical samples with demonstrated presence of C. trachomatis were selected. They were divided in two groups. The first group was constituted by 137 samples with C. trachomatis of the LGV genotypes, and the second by the remaining 150 samples in which the presence of LGV genotypes was previously excluded. They were analyzed to detect the simultaneous presence of non-LGV genotypes based on pmpH and ompA genes. In the first group, co-infections were detected in 10.9% of the cases whereas in the second group the prevalence was 14.6%, which is the highest percentage ever described among European countries. Moreover, bioinformatic analyses suggested the presence among men who have sex with men of a pmpH-recombinant variant, similar to strains described in Seattle in 2002. This variant was the result of genetic exchange between genotypes belonging to LGV and members of G-genotype. Sequencing of other genes, phylogenetically related to pathotype, confirmed that the putative recombinant found in Madrid could have a common origin with the strains described in Seattle. Countries with a high prevalence of co-infections and high migration flows should enhance surveillance programs in at least their vulnerable population.	[Rodriguez-Dominguez, Mario; Gonzalez-Alba, Jose Maria; Sanchez-Diaz, Ana Maria; Canton, Rafael; Galan, Juan Carlos] Hosp Univ Raman y Cajal, Microbiol Serv, Madrid, Spain; [Rodriguez-Dominguez, Mario; Gonzalez-Alba, Jose Maria; Sanchez-Diaz, Ana Maria; Canton, Rafael; Galan, Juan Carlos] Inst Raman y Cajal Invest Sanitaria IRYCIS, Madrid, Spain; [Rodriguez-Dominguez, Mario; Canton, Rafael] REIPI, Madrid, Spain; [Gonzalez-Alba, Jose Maria; Galan, Juan Carlos] CIBERESP, Madrid, Spain; [Puerta, Teresa; del Romero, Jorge] Ctr Sanitario Sandoval, Madrid, Spain; [Puerta, Teresa; Menendez, Blanca; del Romero, Jorge] Hosp Clin San Carlos, Inst Invest Sanitaria, Madrid, Spain; [Menendez, Blanca] Ctr Sandoval, Microbiol Lab, Madrid, Spain; [Galan, Juan Carlos] CSIC, Unidad Resistencia A Antibiot & Virulencia Bacter, RYC, Madrid, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital Clinico San Carlos; Consejo Superior de Investigaciones Cientificas (CSIC)	Galan, JC (corresponding author), Hosp Univ Raman y Cajal, Microbiol Serv, Madrid, Spain.	juancarlos.galan@salud.madrid.org	Cantón, Rafael/AAP-8669-2021; CANTON, RAFAEL/ABF-6353-2020; Rodriguez-Dominguez, Mario/J-4431-2015	Rodriguez-Dominguez, Mario/0000-0002-1783-9318; Canton, Rafael/0000-0003-1675-3173; Sanchez-Diaz, Ana Maria/0000-0001-5625-6900	Spanish Network Research Infectious Disease (REIPI); Ministry of Economy and Competitiveness; Instituto de Salud Carlos III; European Development Regional Fund "A way to achieve Europe" (ERDF)	Spanish Network Research Infectious Disease (REIPI); Ministry of Economy and Competitiveness; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Development Regional Fund "A way to achieve Europe" (ERDF)(European Commission)	MRD's work is supported by a contract of the Spanish Network Research Infectious Disease (REIPI), Ministry of Economy and Competitiveness, Instituto de Salud Carlos III, and cofinanced by the European Development Regional Fund "A way to achieve Europe" (ERDF).	Almeida F, 2012, J BACTERIOL, V194, P6574, DOI 10.1128/JB.01428-12; Bandea CI, 2001, SEX TRANSM INFECT, V77, P419, DOI 10.1136/sti.77.6.419; Batteiger BE, 2010, J INFECT DIS, V201, P42, DOI 10.1086/648734; Bax CJ, 2011, SEX TRANSM INFECT, V87, P503, DOI 10.1136/sti.2010.048173; Bom RJM, 2013, J INFECT DIS, V208, P969, DOI 10.1093/infdis/jit275; Centers for Disease Control and Prevention, 2009, SEX TRANSM DIS SURV; Centers for Disease Control and Prevention, 2012, SEX TRANSM DIS SURV; de Vrieze NHN, 2013, SEX TRANSM DIS, V40, P607, DOI 10.1097/01.OLQ.0000431359.26583.13; European Centre for Disease Prevention and Control, 2011, SEX TRANSM INF EUR 1, DOI [10.2900/52553, DOI 10.2900/52553]; Gharsallah H, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-333; Gomes JP, 2007, GENOME RES, V17, P50, DOI 10.1101/gr.5674706; Gravningen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034452; Haar K, 2013, EUROSURVEILLANCE, V22, P18; Harris SR, 2012, NAT GENET, V44, P413, DOI 10.1038/ng.2214; Hughes G, 2013, SEX TRANSM INFECT, V89, P542, DOI 10.1136/sextrans-2013-051051; International Organization of Migration, 2010, WORLD MIGR REP FUT M; Jeffrey BM, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-142; Jeffrey BM, 2010, INFECT IMMUN, V78, P2544, DOI 10.1128/IAI.01324-09; Joseph SJ, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-28; Jurstrand M, 2001, J CLIN MICROBIOL, V39, P3915, DOI 10.1128/JCM.39.11.3915-3919.2001; Kendall BA, 2014, SEX TRANSM INFECT, V90, DOI 10.1136/sextrans-2013-051478; Klint M, 2006, J CLIN MICROBIOL, V44, P4066, DOI 10.1128/JCM.00574-06; Koper NE, 2013, EURO SURVEILL, V18; Lee G, 2006, J INFECTION, V52, P451, DOI 10.1016/j.jinf.2005.08.019; Mejuto P, 2013, BMJ OPEN, V20, P3; Molano M, 2005, J INFECT DIS, V191, P907, DOI 10.1086/428287; Nunes A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r153; Quint KD, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-63; Rodriguez-Dominguez M, 2014, CLIN MICROBIOL INFEC, V20, P219, DOI 10.1111/1469-0691.12256; Schaeffer A, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-56; Somboonna N, 2011, MBIO, V2, DOI 10.1128/mBio.00045-11; Suchland RJ, 2009, ANTIMICROB AGENTS CH, V53, P4604, DOI 10.1128/AAC.00477-09; Twin J, 2011, SEX TRANSM DIS, V38, P279, DOI 10.1097/OLQ.0b013e3181fc6944; Van de Laar M, 2007, EUROSURVEILLANCE, V12, P304; van Duynhoven YTHP, 1998, CLIN INFECT DIS, V26, P314, DOI 10.1086/516291; Wang YB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016971; Zhang JJ, 2012, SEX TRANSM INFECT, V88, P272, DOI 10.1136/sextrans-2011-050163	37	11	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0126145	10.1371/journal.pone.0126145	http://dx.doi.org/10.1371/journal.pone.0126145			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965545	Green Submitted, gold, Green Published			2022-12-26	WOS:000354543500046
J	Yu, JW; Hoffman, S; Beal, AM; Dykon, A; Ringenberg, MA; Hughes, AC; Dare, L; Anderson, AD; Finger, J; Kasparcova, V; Rickard, D; Berger, SB; Ramanjulu, J; Emery, JG; Gough, PJ; Bertin, J; Foley, KP				Yu, Jong W.; Hoffman, Sandy; Beal, Allison M.; Dykon, Angela; Ringenberg, Michael A.; Hughes, Anna C.; Dare, Lauren; Anderson, Amber D.; Finger, Joshua; Kasparcova, Viera; Rickard, David; Berger, Scott B.; Ramanjulu, Joshi; Emery, John G.; Gough, Peter J.; Bertin, John; Foley, Kevin P.			MALT1 Protease Activity Is Required for Innate and Adaptive Immune Responses	PLOS ONE			English	Article							NF-KAPPA-B; T-CELL-ACTIVATION; CYTOKINE PRODUCTION; LYMPHOMA; PARACASPASE; BCL10; CLEAVAGE; COMPLEX; CARMA1; UBIQUITINATION	CARMA-BCL10-MALT1 signalosomes play important roles in antigen receptor signaling and other pathways. Previous studies have suggested that as part of this complex, MALT1 functions as both a scaffolding protein to activate NF-kappa B through recruitment of ubiquitin ligases, and as a protease to cleave and inactivate downstream inhibitory signaling proteins. However, our understanding of the relative importance of these two distinct MALT1 activities has been hampered by a lack of selective MALT1 protease inhibitors with suitable pharmacologic properties. To fully investigate the role of MALT1 protease activity, we generated mice homozygous for a protease-dead mutation in MALT1. We found that some, but not all, MALT1 functions in immune cells were dependent upon its protease activity. Protease-dead mice had defects in the generation of splenic marginal zone and peritoneal B1 B cells. CD4(+) and CD8(+) T cells displayed decreased T cell receptor-stimulated proliferation and IL-2 production while B cell receptor-stimulated proliferation was partially dependent on protease activity. In dendritic cells, stimulation of cytokine production through the Dectin-1, Dectin-2, and Mincle C-type lectin receptors was also found to be partially dependent upon protease activity. In vivo, protease-dead mice had reduced basal immunoglobulin levels, and showed defective responses to immunization with T-dependent and T-independent antigens. Surprisingly, despite these decreased responses, MALT1 protease-dead mice, but not MALT1 null mice, developed mixed inflammatory cell infiltrates in multiple organs, suggesting MALT1 protease activity plays a role in immune homeostasis. These findings highlight the importance of MALT1 protease activity in multiple immune cell types, and in integrating immune responses in vivo.	[Yu, Jong W.; Hoffman, Sandy; Beal, Allison M.; Dykon, Angela; Dare, Lauren; Finger, Joshua; Kasparcova, Viera; Rickard, David; Berger, Scott B.; Ramanjulu, Joshi; Emery, John G.; Gough, Peter J.; Bertin, John; Foley, Kevin P.] GlaxoSmithKline, Pattern Recognit Receptor Discovery Performance U, Immunoinflammat Therapeut Area, Collegeville, PA USA; [Ringenberg, Michael A.; Hughes, Anna C.] GlaxoSmithKline, Dept Safety Assessment, King Of Prussia, PA USA; [Anderson, Amber D.] GlaxoSmithKline, Quantitat Sci, Collegeville, PA USA	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Bertin, J (corresponding author), GlaxoSmithKline, Pattern Recognit Receptor Discovery Performance U, Immunoinflammat Therapeut Area, Collegeville, PA USA.	john.j.bertin@gsk.com	Foley, Kevin/ABC-1041-2020	Foley, Kevin/0000-0001-5148-7689	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	GlaxoSmithKline provided support in the form of salaries for authors JWY, SH, AMB, AD, MAR, ACH, LD, ADA, JF, VK, DR, SBB, JR, JGE, PJG, JB, and KPF but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertin J, 2000, J BIOL CHEM, V275, P41082, DOI 10.1074/jbc.C000726200; Brustle A, 2012, J CLIN INVEST, V122, P4698, DOI 10.1172/JCI63528; Coornaert B, 2008, NAT IMMUNOL, V9, P263, DOI 10.1038/ni1561; Duwel M, 2009, J IMMUNOL, V182, P7718, DOI 10.4049/jimmunol.0803313; Ferch U, 2007, NAT IMMUNOL, V8, P984, DOI 10.1038/ni1493; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Gewies A, 2014, CELL REP, V9, P1292, DOI 10.1016/j.celrep.2014.10.044; Gringhuis SI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001259; Gross O, 2008, BLOOD, V112, P2421, DOI 10.1182/blood-2007-11-123513; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Hailfinger S, 2011, P NATL ACAD SCI USA, V108, P14596, DOI 10.1073/pnas.1105020108; Hailfinger S, 2009, P NATL ACAD SCI USA, V106, P19946, DOI 10.1073/pnas.0907511106; Hailfinger S, 2009, IMMUNOL REV, V232, P334, DOI 10.1111/j.1600-065X.2009.00830.x; Jaworski M, 2014, EMBO J, V33, P2765, DOI 10.15252/embj.201488987; Jost PJ, 2007, J IMMUNOL, V178, P953, DOI 10.4049/jimmunol.178.2.953; KANTOR AB, 1993, ANNU REV IMMUNOL, V11, P501, DOI 10.1146/annurev.immunol.11.1.501; Kingeter LM, 2008, J IMMUNOL, V181, P6244, DOI 10.4049/jimmunol.181.9.6244; Klemm S, 2006, J EXP MED, V203, P337, DOI 10.1084/jem.20051982; Klemm S, 2007, P NATL ACAD SCI USA, V104, P134, DOI 10.1073/pnas.0608388103; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Mc GC, 2013, J IMMUNOL, V190, P2896, DOI [10.4049/jimmunol.1201351, DOI 10.4049/JIMMUNOL.1201351]; McAllister-Lucas LM, 2011, CLIN CANCER RES, V17, P6623, DOI 10.1158/1078-0432.CCR-11-0467; Oeckinghaus A, 2007, EMBO J, V26, P4634, DOI 10.1038/sj.emboj.7601897; Pomerantz JL, 2002, EMBO J, V21, P5184, DOI 10.1093/emboj/cdf505; Rebeaud F, 2008, NAT IMMUNOL, V9, P272, DOI 10.1038/ni1568; Rosebeck S, 2011, CELL CYCLE, V10, P2485, DOI 10.4161/cc.10.15.16923; Ruefli-Brasse AA, 2003, SCIENCE, V302, P1581, DOI 10.1126/science.1090769; Ruland J, 2003, IMMUNITY, V19, P749, DOI 10.1016/S1074-7613(03)00293-0; Staal J, 2011, EMBO J, V30, P1742, DOI 10.1038/emboj.2011.85; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Thome M, 2008, NAT REV IMMUNOL, V8, P495, DOI 10.1038/nri2338; Uehata T, 2013, CELL, V153, P1036, DOI 10.1016/j.cell.2013.04.034; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Vautier S, 2010, CYTOKINE GROWTH F R, V21, P405, DOI 10.1016/j.cytogfr.2010.10.001; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; Wiesmann C, 2012, J MOL BIOL, V419, P4, DOI 10.1016/j.jmb.2012.02.018; Wu CJ, 2008, P NATL ACAD SCI USA, V105, P3023, DOI 10.1073/pnas.0712313105; Yu JW, 2011, P NATL ACAD SCI USA, V108, P21004, DOI 10.1073/pnas.1111708108; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	40	63	64	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0127083	10.1371/journal.pone.0127083	http://dx.doi.org/10.1371/journal.pone.0127083			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965667	Green Submitted, gold, Green Published			2022-12-26	WOS:000354543500094
J	Campagnolo, P; Hong, XC; Di Bernardini, E; Smyrnias, I; Hu, YH; Xu, QB				Campagnolo, Paola; Hong, Xuechong; Di Bernardini, Elisabetta; Smyrnias, Ioannis; Hu, Yanhua; Xu, Qingbo			Resveratrol-Induced Vascular Progenitor Differentiation towards Endothelial Lineage via MiR-21/Akt/beta-Catenin Is Protective in Vessel Graft Models	PLOS ONE			English	Article							STEM-CELLS; E-DEFICIENT; IN-VITRO; APOPTOSIS; MICE; PHOSPHORYLATION; CAPACITY; ALCOHOL; CATENIN; NUMBER	Background and Purpose Vessel graft failure is typically associated with arteriosclerosis, in which endothelial dysfunction/ damage is a key event. Resveratrol has been shown to possess cardioprotective capacity and to reduce atherosclerosis. We aimed to study the influence of resveratrol on the behavior of resident stem cells that may contribute to graft arteriosclerosis. Experimental Approach Vascular resident progenitor cells and embryonic stem cells were treated with resveratrol under differentiating conditions and endothelial markers expression was evaluated. Expression of miR-21 and beta-catenin was also tested and exogenously modified. Effects of resveratrol treatment in an ex vivo re-endothelialization model and on mice undergone vascular graft were evaluated. Key Results Resveratrol induced expression of endothelial markers such as CD31, VE-cadherin and eNOS in both progenitor and stem cells. We demonstrated that resveratrol significantly reduced miR-21 expression, which in turn reduced Akt phosphorylation. This signal cascade diminished the amount of nuclear beta-catenin, inducing endothelial marker expression and increasing tube-like formation by progenitor cells. Both the inhibition of miR-21 and the knockdown of beta-catenin were able to recapitulate the effect of resveratrol application. Ex vivo, progenitor cells treated with resveratrol produced better endothelialization of the decellularized vessel. Finally, in a mouse model of vessel graft, a resveratrol-enhanced diet was able to reduce lesion formation. Conclusions and Implications We provide the first evidence that oral administration of resveratrol can reduce neointimal formation in a model of vascular graft and elucidated the underpinning miR-21/Akt/beta-catenin dependent mechanism. These findings may support the beneficial effect of resveratrol supplementation for graft failure prevention.	[Campagnolo, Paola; Hong, Xuechong; Di Bernardini, Elisabetta; Smyrnias, Ioannis; Hu, Yanhua; Xu, Qingbo] Kings Coll London, Div Cardiovasc, BHF Ctr, London, England	University of London; King's College London	Campagnolo, P (corresponding author), Kings Coll London, Div Cardiovasc, BHF Ctr, London, England.	campagnolo.p@gmail.com; qingbo.xu@kcl.ac.uk	Campagnolo, Paola/F-7149-2015	Campagnolo, Paola/0000-0002-8957-3969; Smyrnias, Ioannis/0000-0001-6422-938X	British Heart Foundation grant [RG/09/004]	British Heart Foundation grant	This work was supported by British Heart Foundation grant [RG/09/004], http://www.bhf.org.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breen DM, 2012, ATHEROSCLEROSIS, V222, P375, DOI 10.1016/j.atherosclerosis.2012.03.021; Chen HJ, 2012, BIOCHEM PHARMACOL, V84, P1143, DOI 10.1016/j.bcp.2012.08.011; Do GM, 2008, BIOCHEM BIOPH RES CO, V374, P55, DOI 10.1016/j.bbrc.2008.06.113; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Fukao H, 2004, BLOOD COAGUL FIBRIN, V15, P441, DOI 10.1097/00001721-200408000-00001; Gan L, 2009, HYPERTENS RES, V32, P542, DOI 10.1038/hr.2009.67; Gantner BN, 2012, J IMMUNOL, V189, P3104, DOI 10.4049/jimmunol.1201669; Garvin S, 2006, CANCER LETT, V231, P113, DOI 10.1016/j.canlet.2005.01.031; Huang PH, 2010, ARTERIOSCL THROM VAS, V30, P869, DOI 10.1161/ATVBAHA.109.200618; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Kaneko H, 2011, ATHEROSCLEROSIS, V217, P350, DOI 10.1016/j.atherosclerosis.2011.03.042; Karamariti E, 2013, CIRC RES, V112, P1433, DOI 10.1161/CIRCRESAHA.111.300415; Kumarswamy R, 2012, ARTERIOSCL THROM VAS, V32, P361, DOI 10.1161/ATVBAHA.111.234286; Liu LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019139; Liu P, 2013, CLIN TRANSL ONCOL; Mayr U, 2006, CIRC RES, V98, P412, DOI 10.1161/01.RES.0000201957.09227.6d; McDonald RA, 2013, EUR HEART J, V34, P1636, DOI 10.1093/eurheartj/eht105; Nakazawa G, 2008, CIRCULATION, V118, P1138, DOI 10.1161/CIRCULATIONAHA.107.762047; RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F; Renaud SC, 1998, EPIDEMIOLOGY, V9, P184, DOI 10.1097/00001648-199803000-00014; Sabatel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016979; Sheth S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051655; Tang ZY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1867; Tigges U, 2012, JOURNAL OF VASCULAR; Trapp V, 2010, ANGIOGENESIS, V13, P305, DOI 10.1007/s10456-010-9187-8; Tsai TN, 2012, AM J PATHOL, V181, P362, DOI 10.1016/j.ajpath.2012.03.021; Vittet D, 1996, BLOOD, V88, P3424, DOI 10.1182/blood.V88.9.3424.bloodjournal8893424; Wang H, 2010, BIOCHEM PHARMACOL, V80, P1386, DOI 10.1016/j.bcp.2010.07.034; Wang XB, 2007, CLIN EXP PHARMACOL P, V34, P1109, DOI 10.1111/j.1440-1681.2007.04667.x; Wong MM, 2013, SIROLIMUS STIMULATES; Xia L, 2008, BRIT J PHARMACOL, V155, P387, DOI 10.1038/bjp.2008.272; Zeng LF, 2009, P NATL ACAD SCI USA, V106, P8326, DOI 10.1073/pnas.0903197106; Zhang L, 2012, APOPTOSIS, V17, P25, DOI 10.1007/s10495-011-0653-6; Zou YP, 1998, AM J PATHOL, V153, P1301, DOI 10.1016/S0002-9440(10)65675-1	34	24	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0125122	10.1371/journal.pone.0125122	http://dx.doi.org/10.1371/journal.pone.0125122			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961718	Green Published, gold, Green Submitted			2022-12-26	WOS:000354542500026
J	Chen, ZY; Lou, X; Liu, MQ; Huang, DH; Wei, SH; Yu, SY; Ma, L				Chen, Zhiye; Lou, Xin; Liu, Mengqi; Huang, Dehui; Wei, Shihui; Yu, Shengyuan; Ma, Lin			Assessment of Optic Nerve Impairment in Patients with Neuromyelitis Optica by MR Diffusion Tensor Imaging	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; WHOLE-BRAIN DIFFUSION; MULTIPLE-SCLEROSIS; COGNITIVE IMPAIRMENT; CORTICOSPINAL TRACT; CORD DAMAGE; NEURITIS; INTEGRITY; DISEASE	Background Diffusion tensor imaging (DTI) has been used for the evaluation of the white matter integrity. In this study, we evaluated optic nerve impairment in patients with neuromyelitis optica (NMO) using DTI. Methodology/Principal Findings Optic nerve DTI were performed on 28 NMO patients and 38 normal controls. Fractional anisotropy (FA) values were measured in the anterior, middle, and posterior parts of the intraorbital optic nerve segment. For the posterior intraorbital optic nerve, FA values of BI (0.20 +/- 0.07), MI (0.24 +/- 0.16), and NA (0.25 +/- 0.14) decreased significantly compared with that of NC (0.43 +/- 0.07) (P<0.05), and ROC analysis demonstrated that the area under the curve (AUC) measurements for BI vs. NC, MI vs. NC, NA vs. NC, and NMO (including BI, MI, and NA) vs. NC were 0.99, 0.93, 0.88, and 0.96, respectively. The corresponding diagnostic sensitivities of ROC analysis were 100%, 80%, 80%, and 91%; and the specificities were 93%, 97%, 91%, and 93%. Conclusions/Significance Decreased FA value in the intraorbital optic nerve, especially in the posterior part of the nerve, was demonstrated as a characteristic MR feature for NMO-related optic nerve impairment.	[Chen, Zhiye; Lou, Xin; Liu, Mengqi; Ma, Lin] Chinese Peoples Liberat Army Gen Hosp, Dept Radiol, Beijing 100853, Peoples R China; [Chen, Zhiye; Huang, Dehui; Yu, Shengyuan] Chinese Peoples Liberat Army Gen Hosp, Dept Neurol, Beijing 100853, Peoples R China; [Wei, Shihui] Chinese Peoples Liberat Army Gen Hosp, Dept Ophthalmol, Beijing 100853, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Yu, SY (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Neurol, Beijing 100853, Peoples R China.	yusy1963@126.com; cjr.malin@vip.163.com	Chen, Zhiye/T-6256-2018; Ma, Lin/AAF-8728-2019; Lou, Xin/CAI-1998-2022; Lou, Xin/ABD-0868-2022	Lou, Xin/0000-0003-2980-5171; 	Special Financial Grant from the China Postdoctoral Science Foundation [2014T70960]; Nursery fund of Chinese PLA General Hospital [13KMM41]	Special Financial Grant from the China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Nursery fund of Chinese PLA General Hospital	This work was supported by a Special Financial Grant from the China Postdoctoral Science Foundation (2014T70960). This funder had a role in decision to publish. This work was also supported by Nursery fund of Chinese PLA General Hospital (13KMM41). This funder had a role in data collection and analysis.	Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Benedetti B, 2006, NEUROLOGY, V67, P161, DOI 10.1212/01.wnl.0000223637.65208.7c; de Seze J, 2003, MULT SCLER J, V9, P521, DOI 10.1191/1352458503ms947oa; Grigis A, 2011, LECT NOTES COMPUT SC, V6892, P1, DOI 10.1007/978-3-642-23629-7_1; Hao YH, 2006, NEUROREPORT, V17, P23, DOI 10.1097/01.wnr.0000195664.15090.46; He DA, 2011, BRAIN COGNITION, V77, P80, DOI 10.1016/j.bandc.2011.05.007; Jeffrey AR, 1996, J PEDIATR OPHTHALMOL, V33, P223; Khanna S, 2012, J NEURO-OPHTHALMOL, V32, P216, DOI 10.1097/WNO.0b013e318254c62d; Kolbe S, 2009, NEUROIMAGE, V45, P679, DOI 10.1016/j.neuroimage.2008.12.047; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Li J, 2014, ACTA RADIOL, V55, P855, DOI 10.1177/0284185113506900; Li M, 2011, BRIT J RADIOL, V84, P304, DOI 10.1259/bjr/93494520; Lin FC, 2006, NEUROIMAGE, V33, P154, DOI 10.1016/j.neuroimage.2006.03.055; Matsui H, 2007, ACTA NEUROL SCAND, V116, P177, DOI 10.1111/j.1600-0404.2007.00838.x; Odom JV, 2004, DOC OPHTHALMOL, V108, P115, DOI 10.1023/B:DOOP.0000036790.67234.22; Qian WS, 2011, J MAGN RESON IMAGING, V33, P1312, DOI 10.1002/jmri.22575; Schimrigk SK, 2007, AM J NEURORADIOL, V28, P724; Wang S, 2006, AM J NEURORADIOL, V27, P1234; Wheeler-Kingshott CAM, 2006, MAGN RESON MED, V56, P446, DOI 10.1002/mrm.20964; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Wingerchuk DM, 1999, NEUROLOGY, V53, P1107, DOI 10.1212/WNL.53.5.1107; Yu CS, 2006, AM J NEURORADIOL, V27, P1009; Yu CS, 2007, RADIOLOGY, V244, P249, DOI 10.1148/radiol.2441060930; Yu CS, 2008, NEUROIMAGE, V40, P1533, DOI 10.1016/j.neuroimage.2008.01.063; Zhou Y, 2008, J NEUROL SCI, V268, P60, DOI 10.1016/j.jns.2007.11.005	26	4	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126574	10.1371/journal.pone.0126574	http://dx.doi.org/10.1371/journal.pone.0126574			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962183	Green Published, gold, Green Submitted			2022-12-26	WOS:000354542500114
J	Hagag, IT; Mansour, SMG; Zhang, ZR; Ali, AAH; Ismaiel, EBM; Salama, AA; Cardona, CJ; Collins, J; Xing, Z				Hagag, Ibrahim Thabet; Mansour, Shimaa M. G.; Zhang, Zerui; Ali, Ahmed A. H.; Ismaiel, El-Bakry M.; Salama, Ali A.; Cardona, Carol J.; Collins, James; Xing, Zheng			Pathogenicity of Highly Pathogenic Avian Influenza Virus H5N1 in Naturally Infected Poultry in Egypt	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE PCR; BLOOD-BRAIN-BARRIER; HONG-KONG; SUBTYPE H5N1; A VIRUS; DUCKS; MICE; TRANSMISSION; OUTBREAKS; FERRETS	Highly pathogenic avian influenza virus (HPAIV) H5N1 has been endemic in Egypt since 2006, and there is increasing concern for its potential to become highly transmissible among humans. Infection by HPAIV H5N1 has been described in experimentally challenged birds. However, the pathogenicity of the H5N1 isolated in Egypt has never been reported in naturally infected chickens and ducks. Here we report a 2013 outbreak of HPAIV H5N1 in commercial poultry farms and backyards in Sharkia Province, Egypt. The main symptoms were ecchymosis on the shanks and feet, cyanosis of the comb and wattles, subcutaneous edema of the head and neck for chickens, and nervous signs (torticollis) for ducks. Within 48-72 hrs of the onset of illness, the average mortality rates were 22.8-30% and 28.5-40% in vaccinated chickens and non-vaccinated ducks, respectively. Tissue samples of chickens and ducks were collected for analyses with cross-section immunohistochemistry and real-time RT-PCR for specific viral RNA transcripts. While viral RNA was detected in nearly all tissues and sera collected, viral nucleoprotein was detected almost ubiquitously in all tissues, including testis. Interestingly, viral antigen was also observed in endothelial cells of most organs in chickens, and clearly detected in the trachea and brain in particular. Viral nucleoprotein was also detected in mononuclear cells of various organs, especially pulmonary tissue. We performed phylogenetic analyses and compared the genomic sequences of the hemagglutinin (HA) and nonstructural proteins (NS) among the isolated viruses, the HPAIV circulated in Egypt in the past and currently, and some available vaccine strains. Further analysis of deduced amino acids of both HA and NS1 revealed that our isolates carried molecular determinants of HPAIV, including the multibasic amino acids (PQGERRRK/KR*GLF) in the cleavage site in HA and glutamate at position 92 (D92E) in NS1. This is the first report of the pathogenicity of the HPAIVH5N1 strain currently circulating in naturally infected poultry in Egypt, which may provide unique insights into the viral pathogenesis in HPAIV-infected chickens and ducks.	[Hagag, Ibrahim Thabet; Mansour, Shimaa M. G.; Ali, Ahmed A. H.; Ismaiel, El-Bakry M.; Salama, Ali A.] Zagazig Univ, Fac Vet Med, Dept Virol, Zagazig, Egypt; [Hagag, Ibrahim Thabet; Cardona, Carol J.; Xing, Zheng] Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Collins, James] Univ Minnesota, Coll Vet Med, Vet Diagnost Lab, St Paul, MN 55108 USA; [Zhang, Zerui; Xing, Zheng] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China; [Zhang, Zerui; Xing, Zheng] Nanjing Univ, Sch Med, Nanjing 210008, Jiangsu, Peoples R China	Egyptian Knowledge Bank (EKB); Zagazig University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Nanjing University; Nanjing University	Xing, Z (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, St Paul, MN 55108 USA.	zxing@umn.edu	Hagag, Ibrahim T./AAX-8048-2021; Xing, Zheng/O-3137-2015; Xing, Zheng/G-8366-2011	Hagag, Ibrahim T./0000-0002-5639-9618; Xing, Zheng/0000-0002-7288-0268; Xing, Zheng/0000-0002-7288-0268; Collins, James/0000-0003-3212-5927	Minnesota Rapid Agricultural Response Fund (RARF); State Key Laboratory of Pharmaceutical Biotechnology of Nanjing University [(grant KF-GN-201407]	Minnesota Rapid Agricultural Response Fund (RARF); State Key Laboratory of Pharmaceutical Biotechnology of Nanjing University	ZX was supported by the Minnesota Rapid Agricultural Response Fund (RARF) and the State Key Laboratory of Pharmaceutical Biotechnology of Nanjing University (grant KF-GN-201407). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwhab EM, 2011, EPIDEMIOL INFECT, V139, P647, DOI 10.1017/S0950268810003122; Abdelwhab EM, 2010, AVIAN DIS, V54, P911, DOI 10.1637/9099-100809-RESNOTE.1; Aly MM, 2008, AVIAN DIS, V52, P269, DOI 10.1637/8166-103007-Reg.1; Brojer C, 2009, J VET DIAGN INVEST, V21, P579, DOI 10.1177/104063870902100501; Brown JD, 2009, J VET DIAGN INVEST, V21, P437, DOI 10.1177/104063870902100404; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Enserink M, 2006, SCIENCE, V311, P932; Freiji M., 2008, LOHMANN INFORM, V43, P4; Goletic T, 2010, AVIAN DIS, V54, P496, DOI 10.1637/8705-031609-ResNote.1; Grund C, 2011, VACCINE, V29, P5567, DOI 10.1016/j.vaccine.2011.01.006; Hafez MH, 2010, POULTRY SCI, V89, P1609, DOI 10.3382/ps.2010-00708; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Jackson D, 2008, P NATL ACAD SCI USA, V105, P4381, DOI 10.1073/pnas.0800482105; Keawcharoen J, 2008, EMERG INFECT DIS, V14, P600, DOI 10.3201/eid1404.071016; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; Liu NQ, 2002, J VIROL, V76, P6689, DOI 10.1128/JVI.76.13.6689-6700.2002; Lossinsky AS, 2004, HISTOL HISTOPATHOL, V19, P535, DOI 10.14670/HH-19.535; Lu G, 2007, NUCLEIC ACIDS RES, V35, pW275, DOI 10.1093/nar/gkm365; Majde JA, 2007, J NEUROVIROL, V13, P399, DOI 10.1080/13550280701427069; Matsuda K, 2004, VET PATHOL, V41, P101, DOI 10.1354/vp.41-2-101; MORI I, 1995, MICROB PATHOGENESIS, V19, P237, DOI 10.1016/S0882-4010(95)90290-2; Neumann G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002932; Njoum R, 2008, VET MICROBIOL, V130, P380, DOI 10.1016/j.vetmic.2008.02.006; Pantin-Jackwood MJ, 2009, REV SCI TECH OIE, V28, P113, DOI 10.20506/rst.28.1.1869; Pfeiffer J, 2009, VIRUS RES, V142, P108, DOI 10.1016/j.virusres.2009.01.019; Sims LD, 2003, AVIAN DIS, V47, P832, DOI 10.1637/0005-2086-47.s3.832; Sims LD, 2005, VET REC, V157, P159, DOI 10.1136/vr.157.6.159; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Tanaka H, 2003, VET MICROBIOL, V95, P1, DOI 10.1016/S0378-1135(03)00132-9; Tang YH, 2009, AVIAN PATHOL, V38, P457, DOI 10.1080/03079450903349147; Tsukamoto K, 2009, J CLIN MICROBIOL, V47, P2301, DOI 10.1128/JCM.02366-08; Verma S, 2009, VIROLOGY, V385, P425, DOI 10.1016/j.virol.2008.11.047; Wasilenko JL, 2011, ARCH VIROL, V156, P37, DOI 10.1007/s00705-010-0813-y; WHO/GIP, 2003, CUM NUMB CONF HUM CA; World Health Organization, 2011, H5N1 AV INFL TIM MAJ; Xu XY, 1999, VIROLOGY, V261, P15, DOI 10.1006/viro.1999.9820	39	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0120061	10.1371/journal.pone.0120061	http://dx.doi.org/10.1371/journal.pone.0120061			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962145	Green Published, gold, Green Submitted			2022-12-26	WOS:000354542500001
J	Jin, Y; Luo, B; Su, YY; Wang, XX; Chen, L; Wang, M; Wang, WW; Chen, L				Jin, Yan; Luo, Bin; Su, Yan-Yan; Wang, Xin-Xing; Chen, Liang; Wang, Ming; Wang, Wei-Wen; Chen, Lin			Sodium Salicylate Suppresses GABAergic Inhibitory Activity in Neurons of Rodent Dorsal Raphe Nucleus	PLOS ONE			English	Article							RAT INFERIOR COLLICULUS; GAMMA-AMINOBUTYRIC-ACID; SEROTONIN NEURONS; POSTSYNAPTIC CURRENTS; ASPIRIN METABOLITE; BRAIN; RECEPTORS; INNERVATION; CELLS; GABA	Sodium salicylate (NaSal), a tinnitus inducing agent, can activate serotonergic (5-HTergic) neurons in the dorsal raphe nucleus (DRN) and can increase serotonin (5-HT) level in the inferior colliculus and the auditory cortex in rodents. To explore the underlying neural mechanisms, we first examined effects of NaSal on neuronal intrinsic properties and the inhibitory synaptic transmissions in DRN slices of rats by using whole-cell patch-clamp technique. We found that NaSal hyperpolarized the resting membrane potential, decreased the input resistance, and suppressed spontaneous and current-evoked firing in GABAergic neurons, but not in 5-HTergic neurons. In addition, NaSal reduced GABAergic spontaneous and miniature inhibitory postsynaptic currents in 5-HTergic neurons. We next examined whether the observed depression of GABAergic activity would cause an increase in the excitability of 5-HTergic neurons using optogenetic technique in DRN slices of the transgenic mouse with channelrhodopsin-2 expressed in GABAergic neurons. When the GABAergic inhibition was enhanced by optical stimulation to GABAergic neurons in mouse DRN, NaSal significantly depolarized the resting membrane potential, increased the input resistance and increased current-evoked firing of 5-HTergic neurons. However, NaSal would fail to increase the excitability of 5-HTergic neurons when the GABAergic synaptic transmission was blocked by picrotoxin, a GABA receptor antagonist. Our results indicate that NaSal suppresses the GABAergic activities to raise the excitability of local 5-HTergic neural circuits in the DRN, which may contribute to the elevated 5-HT level by NaSal in the brain.	[Jin, Yan; Chen, Lin] Univ Sci & Technol China, Sch Life Sci, CAS Key Lab Brain Funct & Dis, Hefei 230027, Peoples R China; [Luo, Bin] Anhui Prov Hosp, Dept Otolaryngol Head & Neck Surg, Hefei 230001, Peoples R China; [Su, Yan-Yan] Anhui Med Univ, Dept Anat, Hefei 230032, Peoples R China; [Wang, Xin-Xing; Chen, Liang; Wang, Ming; Chen, Lin] Univ Sci & Technol China, Auditory Res Lab, Hefei 230027, Peoples R China; [Wang, Wei-Wen] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Anhui Medical University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Institute of Psychology, CAS	Wang, WW (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China.	wangww@psych.ac.cn; linchen@ustc.edu.cn	Chen, Lin/N-8327-2013; Wang, Xinxing/AAU-6356-2021	Chen, Lin/0000-0002-5847-2989; Wang, Xinxing/0000-0002-1581-4846	National Basic Research Program of China [2011CB504506, 2012CB932502]; National Natural Science Foundation of China [81371503, 31170965, 81200741]; Fundamental Research Funds for Central Universities [WK2070000041]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Basic Research Program of China (Grants 2011CB504506 and 2012CB932502), the National Natural Science Foundation of China (Grants 81371503, 31170965, and 81200741) and the Fundamental Research Funds for Central Universities (WK2070000041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allers KA, 2003, NEUROSCIENCE, V122, P193, DOI 10.1016/S0306-4522(03)00518-9; AMIN AH, 1954, J PHYSIOL-LONDON, V126, P596, DOI 10.1113/jphysiol.1954.sp005229; ANDORN AC, 1989, PSYCHOPHARMACOLOGY, V99, P520, DOI 10.1007/BF00589902; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; AZMITIA EC, 1978, J COMP NEUROL, V179, P641, DOI 10.1002/cne.901790311; BARABAN JM, 1981, BRAIN RES, V204, P1, DOI 10.1016/0006-8993(81)90646-6; BARABAN JM, 1978, EUR J PHARMACOL, V52, P27, DOI 10.1016/0014-2999(78)90018-3; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; BELIN MF, 1979, BRAIN RES, V170, P279, DOI 10.1016/0006-8993(79)90107-0; Brown RE, 2008, EUR J NEUROSCI, V27, P352, DOI 10.1111/j.1460-9568.2008.06024.x; Calizo LH, 2011, NEUROPHARMACOLOGY, V61, P524, DOI 10.1016/j.neuropharm.2011.04.008; Caperton KK, 2011, OTOL NEUROTOL, V32, P301, DOI 10.1097/MAO.0b013e3182009d46; Charara A, 1998, J CHEM NEUROANAT, V15, P111, DOI 10.1016/S0891-0618(98)00036-2; Dascal N, 1997, CELL SIGNAL, V9, P551, DOI 10.1016/S0898-6568(97)00095-8; Day HEW, 2004, J COMP NEUROL, V474, P364, DOI 10.1002/cne.20138; DEER BC, 1982, J OTOLARYNGOL, V11, P260; DESCARRIES L, 1982, J COMP NEUROL, V207, P239, DOI 10.1002/cne.902070305; Fu WY, 2010, J COMP NEUROL, V518, P3464, DOI 10.1002/cne.22407; Galindo-Charles L, 2008, SYNAPSE, V62, P601, DOI 10.1002/syn.20526; GALLAGER DW, 1976, EUR J PHARMACOL, V39, P341, DOI 10.1016/0014-2999(76)90144-8; Gocho Y, 2013, J PHYSIOL SCI, V63, P147, DOI 10.1007/s12576-012-0250-7; Gong N, 2008, NEUROPHARMACOLOGY, V54, P454, DOI 10.1016/j.neuropharm.2007.10.017; GROENEWEGEN HJ, 1984, NEUROSCI LETT, V51, P19, DOI 10.1016/0304-3940(84)90256-8; Grove G, 1997, J NEUROPSYCH CLIN N, V9, P198; Guitton MJ, 2005, EUR J NEUROSCI, V22, P2675, DOI 10.1111/j.1460-9568.2005.04436.x; Hallam RS, 1996, SCAND AUDIOL, V25, P263, DOI 10.3109/01050399609074965; HARANDI M, 1987, NEUROSCIENCE, V21, P237, DOI 10.1016/0306-4522(87)90336-8; Hornung JP, 2003, J CHEM NEUROANAT, V26, P331, DOI 10.1016/j.jchemneu.2003.10.002; Horrobin DF, 1999, PROSTAG LEUKOTR ESS, V60, P141, DOI 10.1054/plef.1999.0027; Hurley LM, 2002, HEARING RES, V168, P1, DOI 10.1016/S0378-5955(02)00365-9; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; JASTREBOFF PJ, 1986, ARCH OTOLARYNGOL, V112, P1050; Johnson RG, 1998, J PHARMACOL EXP THER, V285, P643; Kim DK, 2014, EUR ARCH OTO-RHINO-L, V271, P2915, DOI 10.1007/s00405-013-2785-5; Kirby LG, 2003, NEUROSCIENCE, V116, P669, DOI 10.1016/S0306-4522(02)00584-5; KLEPPER A, 1991, BRAIN RES, V557, P190, DOI 10.1016/0006-8993(91)90134-H; KOSOFSKY BE, 1987, SYNAPSE, V1, P153, DOI 10.1002/syn.890010204; Li YQ, 2001, BRAIN RES, V900, P110, DOI 10.1016/S0006-8993(01)02272-7; LIDOV HGW, 1982, BRAIN RES BULL, V8, P389, DOI 10.1016/0361-9230(82)90077-6; Liu JX, 2003, HEARING RES, V175, P45, DOI 10.1016/S0378-5955(02)00708-6; Liu YX, 2005, HEARING RES, V205, P271, DOI 10.1016/j.heares.2005.03.028; Lu YG, 2009, BRIT J PHARMACOL, V157, P1514, DOI 10.1111/j.1476-5381.2009.00321.x; MAGOUL R, 1986, J HISTOCHEM CYTOCHEM, V34, P735, DOI 10.1177/34.6.2422252; Marinelli S, 2004, J NEUROPHYSIOL, V92, P3532, DOI 10.1152/jn.00437.2004; MELO LL, 1995, PHARMACOL BIOCHEM BE, V51, P317, DOI 10.1016/0091-3057(94)00387-X; ORMSBEE HS, 1985, P SOC EXP BIOL MED, V178, P333; Pineyro G, 1999, PHARMACOL REV, V51, P533; Ravindran R, 2005, J PHARMACOL SCI, V98, P354, DOI 10.1254/jphs.FP0050127; Sachanska T, 1999, Int Tinnitus J, V5, P24; Shikanai H, 2012, J NEUROSCI, V32, P14415, DOI 10.1523/JNEUROSCI.5929-11.2012; Sodickson DL, 1996, J NEUROSCI, V16, P6374; STAMP JA, 1995, BRAIN RES, V677, P39, DOI 10.1016/0006-8993(95)00119-B; Su YY, 2009, HEARING RES, V253, P60, DOI 10.1016/j.heares.2009.03.007; Sun H, 2009, NEUROSCIENCE, V160, P198, DOI 10.1016/j.neuroscience.2009.02.011; Thompson AM, 2004, NEUROSCI LETT, V356, P179, DOI 10.1016/j.neulet.2003.11.052; THOMPSON GC, 1994, OTOLARYNG HEAD NECK, V110, P93, DOI 10.1016/S0194-5998(94)70797-9; TWAROG BM, 1953, AM J PHYSIOL, V175, P157, DOI 10.1152/ajplegacy.1953.175.1.157; VANDERMAELEN CP, 1983, BRAIN RES, V289, P109, DOI 10.1016/0006-8993(83)90011-2; Varga V, 2001, NEUROSCIENCE, V106, P783, DOI 10.1016/S0306-4522(01)00294-9; VLADIMIROVA IA, 1986, FIZIOL ZH SSSR, V32, P671; WALLACE JA, 1982, BRAIN RES BULL, V9, P117, DOI 10.1016/0361-9230(82)90127-7; WallhausserFranke E, 1997, NEUROREPORT, V8, P725, DOI 10.1097/00001756-199702100-00029; Wang HT, 2008, HEARING RES, V236, P42, DOI 10.1016/j.heares.2007.11.015; Wang HT, 2006, HEARING RES, V215, P77, DOI 10.1016/j.heares.2006.03.004; WANG QP, 1992, BRAIN RES BULL, V29, P943; Wang W, 1996, NEUROLOGY, V46, P1404, DOI 10.1212/WNL.46.5.1404; Wang X-X, 2015, ABSTR ASSOC RES OTOL, pPS; Woods CI, 1999, BRAIN RES, V836, P9, DOI 10.1016/S0006-8993(99)01541-3; Xu H, 2005, NEUROREPORT, V16, P813, DOI 10.1097/00001756-200505310-00007	69	34	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126956	10.1371/journal.pone.0126956	http://dx.doi.org/10.1371/journal.pone.0126956			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962147	gold, Green Published, Green Submitted			2022-12-26	WOS:000354542500162
J	Beck, BH; Kim, H; O'Brien, R; Jadus, MR; Gillespie, GY; Cloud, GA; Hoa, NT; Langford, CP; Lopez, RD; Harkins, LE; Lamb, LS				Beck, Benjamin H.; Kim, Hyunggoon; O'Brien, Rebecca; Jadus, Martin R.; Gillespie, G. Yancey; Cloud, Gretchen A.; Hoa, Neil T.; Langford, Catherine P.; Lopez, Richard D.; Harkins, Lualhati E.; Lamb, Lawrence S., Jr.			Dynamics of Circulating gamma delta T Cell Activity in an Immunocompetent Mouse Model of High-Grade Glioma	PLOS ONE			English	Article							PERIPHERAL-BLOOD; ANTITUMOR-ACTIVITY; TUMOR-IMMUNITY; EXPRESSION; LYMPHOCYTES; RECEPTOR; ANTIGEN; GROWTH; RECOGNITION; ACTIVATION	Human gamma delta T cells are potent effectors against glioma cell lines in vitro and in human/mouse xenograft models of glioblastoma, however, this effect has not been investigated in an immunocompetent mouse model. In this report, we established GL261 intracranial gliomas in syngeneicWT C57BL/6 mice and measured circulating gamma delta T cell count, phenotype, V gamma/gamma delta repertoire, tumor histopathology, NKG2D ligands expression, and T cell invasion at day 10-12 post-injection and at end stage. Circulating gamma delta T cells transiently increased and upregulated Annexin V expression at post-tumor day 10-12 followed by a dramatic decline in gamma delta T cell count at end stage. T cell receptor repertoire showed no changes in V gamma 1, V gamma 4, V gamma 7 or V delta 1 subsets from controls at post-tumor day 10-12 or at end stage except for an end-stage increase in the V delta 4 population. Approximately 12% of gamma delta T cells produced IFN-gamma. IL-17 and IL-4 producing gamma delta T cells were not detected. Tumor progression was the same in TCR delta(-/-)C57BL/6 mice as that observed in WT mice, suggesting that gamma delta T cells exerted neither a regulatory nor a sustainable cytotoxic effect on the tumor. WT mice that received an intracranial injection of gamma delta T cells 15m following tumor placement showed evidence of local tumor growth inhibition but this was insufficient to confer a survival advantage over untreated controls. Taken together, our findings suggest that an early nonspecific proliferation of gamma delta T cells followed by their depletion occurs in mice implanted with syngeneic GL261 gliomas. The mechanism by which gamma delta T cell expansion occurs remains a subject for further investigation of the mechanisms responsible for this immune response in the setting of high-grade glioma.	[Beck, Benjamin H.; Kim, Hyunggoon; Lopez, Richard D.; Harkins, Lualhati E.; Lamb, Lawrence S., Jr.] Univ Alabama Birmingham, Sch Med, Dept Med, Birmingham, AL 35294 USA; [Beck, Benjamin H.] Univ Alabama Birmingham, Med Sch Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [O'Brien, Rebecca] Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO USA; [Jadus, Martin R.; Hoa, Neil T.] Univ Calif Irvine, Dept Pathol, Vet Affairs Med Ctr, Irvine, CA 92697 USA; [Gillespie, G. Yancey; Langford, Catherine P.] Univ Alabama Birmingham, Med Sch Birmingham, Dept Neurosurg, Birmingham, AL 35294 USA; [Cloud, Gretchen A.] Univ Alabama Birmingham, Med Sch Birmingham, UAB Comprehens Canc Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; National Jewish Health; University of California System; University of California Irvine; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Lamb, LS (corresponding author), Univ Alabama Birmingham, Sch Med, Dept Med, Birmingham, AL 35294 USA.	lslamb@uabmc.edu		Gillespie, George/0000-0001-6436-9542; Beck, Benjamin/0000-0002-9611-826X; Lamb, Lawrence/0000-0001-7180-0994	National Institute for Neurologic Diseases and Stroke [R21 NS057431-01A1]; Elsa U Pardee Foundation; Samuel Gerson Research Chair of the National Brain Tumor Society; National Cancer Institute Specialized Centers of Research Excellence in Neurologic Cancer [P50 CA 097247, P20 CA 151129]; VA Merit Review; NATIONAL CANCER INSTITUTE [P50CA097247, P20CA151129] Funding Source: NIH RePORTER	National Institute for Neurologic Diseases and Stroke; Elsa U Pardee Foundation; Samuel Gerson Research Chair of the National Brain Tumor Society; National Cancer Institute Specialized Centers of Research Excellence in Neurologic Cancer; VA Merit Review(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for these studies was made possible by the National Institute for Neurologic Diseases and Stroke (R21 NS057431-01A1, LSL), the Elsa U Pardee Foundation (LSL), the Samuel Gerson Research Chair of the National Brain Tumor Society (LSL), the National Cancer Institute Specialized Centers of Research Excellence in Neurologic Cancer (P50 CA 097247; P20 CA 151129, GYG), and the VA Merit Review (MRJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar AN, 2011, NAT REV IMMUNOL, V11, P289, DOI 10.1038/nri2959; Argentati K, 2003, J INVEST DERMATOL, V120, P829, DOI 10.1046/j.1523-1747.2003.12141.x; BAGOT M, 1985, BRIT J DERMATOL, V113, P55, DOI 10.1111/j.1365-2133.1985.tb15626.x; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Beck BH, 2010, BREAST CANCER RES TR, V122, P135, DOI 10.1007/s10549-009-0527-6; BRENNER MB, 1986, NATURE, V322, P145, DOI 10.1038/322145a0; Bryant NA, 2011, VET MICROBIOL, V147, P19, DOI 10.1016/j.vetmic.2010.05.040; Bryant NL, 2011, J NEURO-ONCOL, V101, P179, DOI 10.1007/s11060-010-0245-2; Bryant NL, 2009, NEURO-ONCOLOGY, V11, P357, DOI 10.1215/15228517-2008-111; BUKOWSKI JF, 1995, J IMMUNOL, V154, P998; CHOUDHARY A, 1995, J IMMUNOL, V154, P3932; Dieli F, 2007, CANCER RES, V67, P7450, DOI 10.1158/0008-5472.CAN-07-0199; Do JS, 2012, IMMUNOL CELL BIOL, V90, P396, DOI 10.1038/icb.2011.50; Eisele G, 2006, BRAIN, V129, P2416, DOI 10.1093/brain/awl205; FERRARINI M, 1995, J IMMUNOL, V154, P3704; Ferrarini M, 2002, TRENDS IMMUNOL, V23, P14, DOI 10.1016/S1471-4906(01)02110-X; FERRARINI M, 1994, INT J CANCER, V57, P486, DOI 10.1002/ijc.2910570408; FISCH P, 1990, SCIENCE, V250, P1269, DOI 10.1126/science.1978758; Friese MA, 2003, CANCER RES, V63, P8996; Fujimiya Y, 1997, CLIN CANCER RES, V3, P633; Gao YF, 2003, J EXP MED, V198, P433, DOI 10.1084/jem.20030584; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Godder KT, 2007, BONE MARROW TRANSPL, V39, P751, DOI 10.1038/sj.bmt.1705650; Hao JL, 2011, J IMMUNOL, V187, P4979, DOI 10.4049/jimmunol.1101389; Hayday A, 2003, NAT REV IMMUNOL, V3, P233, DOI 10.1038/nri1030; He WF, 2010, J IMMUNOL, V185, P126, DOI 10.4049/jimmunol.0903767; Hoa N, 2010, J IMMUNOL; INGE TH, 1992, J IMMUNOL, V148, P3847; JACHIMCZAK P, 1993, J NEUROSURG, V78, P944, DOI 10.3171/jns.1993.78.6.0944; Kabelitz D, 2007, CANCER RES, V67, P5, DOI 10.1158/0008-5472.CAN-06-3069; Ksendzovsky A, 2009, J NEURO-ONCOL, V93, P107, DOI 10.1007/s11060-009-9884-6; Lamb L S Jr, 1996, J Hematother, V5, P503, DOI 10.1089/scd.1.1996.5.503; Lamb LS, 2005, BIOL BLOOD MARROW TR, V11, P161, DOI 10.1016/j.bbmt.2004.11.015; Lamb LS, 1999, CYTOTHERAPY, V1, P7, DOI 10.1080/0032472031000141295; LECA G, 1994, CELL IMMUNOL, V156, P230, DOI 10.1006/cimm.1994.1167; Li A, 2010, CURR BIOL, V20, P339, DOI 10.1016/j.cub.2009.12.035; Liu ZY, 2008, J IMMUNOL, V180, P6044, DOI 10.4049/jimmunol.180.9.6044; Machesky Laura M, 2010, Commun Integr Biol, V3, P263; Malarkannan S, 1998, J IMMUNOL, V161, P3501; Meeh PF, 2006, CANCER IMMUNOL IMMUN, V55, P1072, DOI 10.1007/s00262-005-0094-6; Peng G, 2007, IMMUNITY, V27, P334, DOI 10.1016/j.immuni.2007.05.020; Pennington DJ, 2005, ADV IMMUNOL, V87, P27, DOI 10.1016/S0065-2776(05)87002-6; Roark CL, 2013, IMMUNOL RES, V55, P217, DOI 10.1007/s12026-012-8364-9; Rutka JT, 2008, NEOPLASIA, V10, P149, DOI 10.1593/neo.07909; Schilbach K, 2008, J IMMUNOTHER, V31, P896, DOI 10.1097/CJI.0b013e31818955ad; Schilbach KE, 2000, J IMMUNOTHER, V23, P536, DOI 10.1097/00002371-200009000-00004; Shin S, 2005, SCIENCE, V308, P252, DOI 10.1126/science.1106480; SMYTH MJ, 1991, J IMMUNOL, V146, P3289; Wrobel P, 2007, SCAND J IMMUNOL, V66, P320, DOI 10.1111/j.1365-3083.2007.01963.x; Wu AH, 2007, J NEURO-ONCOL, V83, P121, DOI 10.1007/s11060-006-9265-3; Yamaguchi T, 1998, CANCER IMMUNOL IMMUN, V47, P97, DOI 10.1007/s002620050509; Yamaguchi T, 1997, J IMMUNOL METHODS, V205, P19, DOI 10.1016/S0022-1759(97)00062-8; ZHAO X, 1995, IMMUNOL INVEST, V24, P607, DOI 10.3109/08820139509066861	53	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0122387	10.1371/journal.pone.0122387	http://dx.doi.org/10.1371/journal.pone.0122387			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955158	Green Submitted, Green Published, gold			2022-12-26	WOS:000356768100005
J	Gorshkov, V; Blenau, W; Koeniger, G; Roopp, A; Vilcinskas, A; Spengler, B				Gorshkov, Vladimir; Blenau, Wolfgang; Koeniger, Gudrun; Roempp, Andreas; Vilcinskas, Andreas; Spengler, Bernhard			Protein and Peptide Composition of Male Accessory Glands of Apis mellifera Drones Investigated by Mass Spectrometry	PLOS ONE			English	Article							SEMINAL FLUID PROTEINS; HONEY-BEE; SPERM STORAGE; SPERMATHECA; SECRETION; ORGAN; SEMEN; SIGN	In honeybees, reproductive females usually mate early in their life with more than 10 males in free flight, often within 10 minutes, and then store male gametes for up to five years. Because of the extreme polyandry and mating in free flight special adaptations in males are most likely. We present here the results of an investigation of the protein content of four types of male reproductive glands from the Western honeybee (Apis mellifera) drone, namely seminal vesicles (secretion in ejaculate), as well as bulbus, cornua and mucus glands (secretions for the mating plug). Using high resolution and accuracy mass spectrometry and a combination of database searching and de novo sequencing techniques it was possible to identify 50 different proteins in total, inside all mentioned glands, except in the mucus gland. Most of the proteins are unique for a specific gland type, only one of them (H9KEY1/ATP synthase subunit O) was found in three glands, and 7 proteins were found in two types of glands. The identified proteins represent a wide variety of biological functions and can be assigned to several physiological classes, such as protection, energy generation, maintaining optimal conditions, associated mainly with vesicula seminalis; signaling, cuticle proteins, icarpin and apolipoproteins located mainly in the bulbus and cornua glands; and some other classes. Most of the discovered proteins were not found earlier during investigation of semen, seminal fluid and tissue of reproductive glands of the bee drone. Moreover, we provide here the origin of each protein. Thus, the presented data might shed light on the role of each reproductive gland.	[Gorshkov, Vladimir; Roempp, Andreas; Spengler, Bernhard] Univ Giessen, Inst Inorgan & Analyt Chem, D-35390 Giessen, Germany; [Blenau, Wolfgang] Univ Cologne, Inst Zool, D-50931 Cologne, Germany; [Koeniger, Gudrun] Goethe Univ Frankfurt, Bee Res Inst, D-60054 Frankfurt, Germany; [Vilcinskas, Andreas] Univ Giessen, Inst Phytopathol & Appl Zool, D-35390 Giessen, Germany	Justus Liebig University Giessen; University of Cologne; Goethe University Frankfurt; Justus Liebig University Giessen	Spengler, B (corresponding author), Univ Giessen, Inst Inorgan & Analyt Chem, D-35390 Giessen, Germany.	Bernhard.Spengler@anorg.Chemie.uni-giessen.de	Roempp, Andreas/C-3922-2011; Spengler, Bernhard/A-9497-2012; Blenau, Wolfgang/A-4304-2010; Gorshkov, Vladimir/I-5633-2015	Blenau, Wolfgang/0000-0002-6874-4730; Gorshkov, Vladimir/0000-0003-0170-5785; Spengler, Bernhard/0000-0003-0179-5653	Deutsche Forschungsgemeinschaft [Sp314/12-1]; State of Hesse (LOEWE focus insect biotechnology)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); State of Hesse (LOEWE focus insect biotechnology)	Financial support by the Deutsche Forschungsgemeinschaft, www.dfg.de, (project Sp314/12-1) and by the State of Hesse (LOEWE focus insect biotechnology), https://wissenschaft.hessen.de/loewe, is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila FW, 2011, ANNU REV ENTOMOL, V56, P21, DOI 10.1146/annurev-ento-120709-144823; Baer B, 2005, APIDOLOGIE, V36, P187, DOI 10.1051/apido:2005013; Baer B, 2008, BEHAV ECOLOGY; Baer B, 2012, J PROTEOMICS, V75, P5646, DOI 10.1016/j.jprot.2012.08.002; Baer B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r67; Baer B, 2009, PROTEOMICS, V9, P2085, DOI 10.1002/pmic.200800708; Chan QWT, 2013, GENOME RES, V23, P1951, DOI 10.1101/gr.155994.113; Chapman T, 2004, PEPTIDES, V25, P1477, DOI 10.1016/j.peptides.2003.10.023; Collins AM, 2006, INSECT MOL BIOL, V15, P541, DOI 10.1111/j.1365-2583.2006.00674.x; Collins AM, 2004, INSECT MOL BIOL, V13, P141, DOI 10.1111/j.0962-1075.2004.00469.x; Colonello NA, 2003, APIDOLOGIE, V34, P257, DOI 10.1051/apido:2003019; den Boer SPA, 2010, SCIENCE, V327, P1506, DOI 10.1126/science.1184709; den Boer SPA, 2009, J INSECT PHYSIOL, V55, P538, DOI 10.1016/j.jinsphys.2009.01.012; DZIERZON J, 1845, EICHSTADTER BIENENZE, V1, P119; Dzierzon J, 1845, EICHSTADTER BIENENZE, V1, P109; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Gobin B, 2006, CELL TISSUE RES, V326, P169, DOI 10.1007/s00441-006-0232-2; Goloborodko AA, 2013, J AM SOC MASS SPECTR, V24, P301, DOI 10.1007/s13361-012-0516-6; King M, 2011, J INSECT PHYSIOL, V57, P409, DOI 10.1016/j.jinsphys.2010.12.011; KOENIGER G, 1990, APIDOLOGIE, V21, P185, DOI 10.1051/apido:19900303; Koeniger G, 1996, APIDOLOGIE, V27, P145, DOI 10.1051/apido:19960303; KOENIGER G, 1986, BEE WORLD, V67, P141, DOI 10.1080/0005772X.1986.11098892; KOENIGER G, 1990, ANIM BEHAV, V39, P444, DOI 10.1016/S0003-3472(05)80407-5; Koeniger N, 2000, APIDOLOGIE, V31, P313, DOI 10.1051/apido:2000125; Kubli E, 2003, CELL MOL LIFE SCI, V60, P1689, DOI 10.1007/s00018-003-3052; Landim CD, 2005, GENET MOL RES, V4, P473; Moors L, 2012, APIDOLOGIE, V43, P201, DOI 10.1007/s13592-011-0094-9; Moors L, 2009, APIDOLOGIE, V40, P600, DOI 10.1051/apido/2009033; Peiren N, 2008, TOXICON, V52, P72, DOI 10.1016/j.toxicon.2008.05.003; Ram KR, 2007, INTEGR COMP BIOL, V47, P427, DOI 10.1093/icb/icm046; TABER S, 1960, SCIENCE, V131, P1734, DOI 10.1126/science.131.3415.1734; Tarpy DR, 2004, INSECT SOC, V51, P203, DOI 10.1007/s00040-004-0734-4; VERMA LR, 1973, J INSECT PHYSIOL, V19, P97, DOI 10.1016/0022-1910(73)90225-4; VERMA LR, 1973, COMP BIOCHEM PHYSIOL, V44, P1325, DOI 10.1016/0300-9629(73)90272-7; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wegener J, 2013, J INSECT PHYSL; Weirich GF, 2002, APIDOLOGIE, V33, P3, DOI 10.1051/apido:2001001; Woyke R, 1958, BEE WORLD, V39, P3	39	16	16	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0125068	10.1371/journal.pone.0125068	http://dx.doi.org/10.1371/journal.pone.0125068			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955586	Green Submitted, gold, Green Published			2022-12-26	WOS:000356768100043
J	Lin, CY; Shuhaiber, JH; Loyola, H; Liu, H; del Nido, P; DiNardo, JA; Pigula, FA				Lin, Chih-Yuan; Shuhaiber, Jeffery H.; Loyola, Hugo; Liu, Hua; del Nido, Pedro; DiNardo, James A.; Pigula, Frank A.			The Safety and Efficacy of Antifibrinolytic Therapy in Neonatal Cardiac Surgery	PLOS ONE			English	Article							EPSILON-AMINOCAPROIC ACID; HIGH-DOSE APROTININ; CARDIOPULMONARY BYPASS; TRANEXAMIC ACID; BLOOD-TRANSFUSION; RENAL DYSFUNCTION; DOUBLE-BLIND; INFLAMMATORY RESPONSE; CONTROLLED-TRIAL; RISK	Background Neonates undergoing open-heart surgery are particularly at risk of postoperative bleeding requiring blood transfusion. Aprotinin has attained high efficacy in reducing the requirement for a blood transfusion following a cardiopulmonary bypass, but is seldom studied in the neonatal age group. The aim of this study was to compare the efficacy and adverse effects of aprotinin and tranexamic acid in neonates undergoing open-heart surgery at a single centre. Methods Between October 2003 and March 2008, perioperative data of 552 consecutive neonatal patients undergoing open-heart surgery in Children's Hospital Boston were reviewed. Among them, 177 did not receive antifibrinolytic therapy (Group A); 100 were treated with tranexamic acid only (Group B); and 275 patients received aprotinin with or without tranexamic acid (Group C). Except for antifibrinolytic therapy, the anaesthesiological and surgical protocols remained identical. Postoperative complications and in-hospital mortality were the primary study endpoints. Results Body weight and Risk Adjustment for Congenital Heart Surgery (RACHS-1) scores were statistically comparable among the three groups. No statistically significant differences were observed between the duration of hospitalization, chest tube drainage, reexploration for bleeding, and kidney function impairment. In Group C, less blood was transfused within 24 hours than in GroupB. Operative mortality was similar among the three groups. Conclusion No further risk and kidney injury were observed in the use of aprotinin in neonatal cardiac surgery, aprotinin demonstrated a reduced requirement for blood transfusion compared with tranexamic acid. Our data provide reasonable evidence that aprotinin and tranexamic acid are safe and efficacious as antifibrinolytic modalities in neonatal patients undergoing cardiac surgery.	[Lin, Chih-Yuan; Shuhaiber, Jeffery H.; Loyola, Hugo; Liu, Hua; del Nido, Pedro; Pigula, Frank A.] Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Cardiac Surg, Boston, MA 02114 USA; [DiNardo, James A.] Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Anaesthesia, Boston, MA USA; [Lin, Chih-Yuan] Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Surg, Div Cardiovasc Surg, Taipei, Taiwan	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; National Defense Medical Center; Tri-Service General Hospital	Pigula, FA (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Cardiac Surg, Boston, MA 02114 USA.	frank.pigula@cardio.chboston.org						Arnold DM, 2006, ANESTH ANALG, V102, P731, DOI 10.1213/01.ane.0000194954.64293.61; Backer CL, 2007, J THORAC CARDIOV SUR, V134, P1421, DOI 10.1016/j.jtcvs.2007.08.006; BAHNSON HT, 1950, SURG GYNECOL OBSTET, V90, P60; Bennett-Guerrero E, 2010, J CARDIOTHOR VASC AN, V24, P814, DOI 10.1053/j.jvca.2010.06.003; Breuer T, 2009, EUR J CARDIO-THORAC, V35, P167, DOI 10.1016/j.ejcts.2008.09.038; Brown JR, 2007, CIRCULATION, V115, P2801, DOI 10.1161/CIRCULATIONAHA.106.671222; Brown Jeremiah R, 2009, J Extra Corpor Technol, V41, P79; Carrel TP, 1998, ANN THORAC SURG, V66, P153, DOI 10.1016/S0003-4975(98)00396-8; D'Errico CC, 1999, J CARDIOTHOR VASC AN, V13, P782, DOI 10.1016/S1053-0770(99)90136-2; Davies MJ, 1997, ANN THORAC SURG, V63, P497; Dietrich W, 1996, J CARDIOVASC PHARM, V27, pS50; Dorman BH, 2008, J CARDIOVASC PHARM, V51, P418, DOI 10.1097/FJC.0b013e318168400a; European Medicines Agency, EUR MED AG REC LIFT; Fergusson DA, 2008, NEW ENGL J MED, V358, P2319, DOI 10.1056/NEJMoa0802395; Ferraris VA, 2007, ANN THORAC SURG, V83, P27, DOI 10.1016/j.athoracsur.2007.02.099; Furnary AP, 2007, CIRCULATION, V116, pI127, DOI 10.1161/CIRCULATIONAHA.106.681395; GILL JC, 1986, BLOOD, V67, P758; Greilich PE, 2003, J THORAC CARDIOV SUR, V126, P1498, DOI 10.1016/S0022-5223(03)00946-2; Greilich PE, 2001, CIRCULATION, V104, pI265; Guzzetta NA, 2009, ANESTH ANALG, V108, P448, DOI 10.1213/ane.0b013e318194007a; Habermann E, 1973, Med Welt, V24, P1163; Horl WH, 2000, BRIT J ANAESTH, V84, P3; Hsia TY, 2010, ANN THORAC SURG, V89, P1843, DOI 10.1016/j.athoracsur.2010.02.069; Jenkins KJ, 2002, J THORAC CARDIOV SUR, V123, P110, DOI 10.1067/mtc.2002.119064; Karkouti K, 2006, TRANSFUSION, V46, P327, DOI 10.1111/j.1537-2995.2006.00724.x; KERN FH, 1992, ANN THORAC SURG, V54, P541, DOI 10.1016/0003-4975(92)90451-9; Kuhle S, 2003, SEMIN THROMB HEMOST, V29, P329; Later AFL, 2013, CYTOKINE, V61, P438, DOI 10.1016/j.cyto.2012.10.033; Later AFL, 2013, J THORAC CARDIOV SUR, V145, P1611, DOI 10.1016/j.jtcvs.2012.11.042; Levy JH, 2003, ANN THORAC SURG, V75, pS715, DOI 10.1016/S0003-4975(02)04701-X; LEVY JH, 1995, CIRCULATION, V92, P2236, DOI 10.1161/01.CIR.92.8.2236; Leyvi G, 2011, J CARDIOTHOR VASC AN, V25, P402, DOI 10.1053/j.jvca.2011.01.015; Mangano DT, 2007, JAMA-J AM MED ASSOC, V297, P471, DOI 10.1001/jama.297.5.471; Mangano DT, 2006, NEW ENGL J MED, V354, P353, DOI 10.1056/NEJMoa051379; Manrique A, 2009, ANESTH ANALG, V109, P45, DOI 10.1213/ane.0b013e3181a7f00a; McMullan V, 2010, J CARDIOTHOR VASC AN, V24, P418, DOI 10.1053/j.jvca.2009.10.028; Miller BE, 1998, ANN THORAC SURG, V66, P535, DOI 10.1016/S0003-4975(98)00469-X; Mojcik CF, 2001, ANN THORAC SURG, V71, P745, DOI 10.1016/S0003-4975(00)02218-9; Mossinger H, 2003, ANN THORAC SURG, V75, P430, DOI 10.1016/S0003-4975(02)04412-0; Paparella D, 2004, INTENS CARE MED, V30, P1873, DOI 10.1007/s00134-004-2388-0; Pasquali SK, 2010, ANN THORAC SURG, V90, P14, DOI 10.1016/j.athoracsur.2010.02.073; PETAJA J, 1995, J THORAC CARDIOV SUR, V109, P524, DOI 10.1016/S0022-5223(95)70284-9; ROYSTON D, 1987, LANCET, V2, P1289; Schindler E, 2011, EUR J CARDIO-THORAC, V39, P495, DOI 10.1016/j.ejcts.2010.07.026; Sedrakyan A, 2004, J THORAC CARDIOV SUR, V128, P442, DOI 10.1016/j.jtcvs.2004.03.041; Shen I, 2003, ANN THORAC SURG, V75, pS729, DOI 10.1016/S0003-4975(02)04697-0; Siegel S., 1988, NONPARAMETRIC STAT B; Sniecinski RM, 2010, J CARDIOTHOR VASC AN, V24, P959, DOI 10.1053/j.jvca.2010.02.018; Stammers AH, 2000, PERFUSION-UK, V15, P161, DOI 10.1177/026765910001500212; Strouch ZY, 2009, J CLIN ANESTH, V21, P502, DOI 10.1016/j.jclinane.2008.12.021; Szekely A, 2008, PEDIATR ANESTH, V18, P151, DOI 10.1111/j.1460-9592.2007.02398.x; Tweddell JS, 1996, ANN THORAC SURG, V62, P1329, DOI 10.1016/0003-4975(96)00670-4; U.S. Food and Drug Administration, 2010, INF HEALTHC PROF APR; VANOEVEREN W, 1990, J THORAC CARDIOV SUR, V99, P788; Wagener G, 2008, AM J NEPHROL, V28, P576, DOI 10.1159/000115973; Wilder NS, 2011, ANN THORAC SURG, V92, P958, DOI 10.1016/j.athoracsur.2011.04.094; Williams GD, 2008, PEDIATR ANESTH, V18, P812, DOI 10.1111/j.1460-9592.2008.02678.x	57	10	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0126514	10.1371/journal.pone.0126514	http://dx.doi.org/10.1371/journal.pone.0126514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25954976	Green Submitted, Green Published, gold			2022-12-26	WOS:000356768100124
J	Mombach, JCM; Vendrusculo, B; Bugs, CA				Mombach, Jose C. M.; Vendrusculo, Bruno; Bugs, Cristhian A.			A Model for p38MAPK-Induced Astrocyte Senescence	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CELLULAR SENESCENCE; REGULATORY NETWORKS; OXIDATIVE STRESS; TUMOR-SUPPRESSOR; GROWTH ARREST; CHECKPOINT; P53; APOPTOSIS; PHOSPHATASE	Experimental evidence indicates that aging leads to accumulation of senescent cells in tissues and they develop a secretory phenotype (also known as SASP, for senescence-associated secretory phenotype) that can contribute to chronic inflammation and diseases. Recent results have showed that markers of senescence in astrocytes from aged brains are increased in brains with Alzheimer's disease. These studies strongly involved the stress kinase p38MAPK in the regulation of the secretory phenotype of astrocytes, yet the molecular mechanisms underlying the onset of senescence and SASP activation remain unclear. In this work, we propose a discrete logical model for astrocyte senescence determined by the level of DNA damage (reparable or irreparable DNA strand breaks) where the kinase p38MAPK plays a central role in the regulation of senescence and SASP. The model produces four alternative stable states: proliferation, transient cycle arrest, apoptosis and senescence (and SASP) computed from its inputs representing DNA damages. Perturbations of the model were performed through gene gain or loss of functions and compared with results concerning cultures of normal and mutant astrocytes showing agreement in most cases. Moreover, the model allows some predictions that remain to be tested experimentally.	[Mombach, Jose C. M.; Vendrusculo, Bruno] Univ Fed Santa Maria, BR-97119900 Santa Maria, RS, Brazil; [Bugs, Cristhian A.] Univ Fed Pampa, Sao Gabriel, RS, Brazil	Universidade Federal de Santa Maria (UFSM); Universidade Federal do Pampa	Mombach, JCM (corresponding author), Univ Fed Santa Maria, BR-97119900 Santa Maria, RS, Brazil.	jcmombach@ufsm.br	Bugs, Cristhian Augusto/AAB-2996-2020; Mombach, Jose C. M./L-1484-2013	Mombach, Jose C. M./0000-0002-6602-3905	Conselho Nacional de Pesquisa Cientifica [304805/2012-2, 402547/2012-8]	Conselho Nacional de Pesquisa Cientifica	JCMM received financial support from Conselho Nacional de Pesquisa Cientifica (304805/2012-2, 402547/2012-8).	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Bhat R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045069; Bitto A, 2010, EXP CELL RES, V316, P2961, DOI 10.1016/j.yexcr.2010.06.021; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; Bulavin DV, 2001, NATURE, V411, P102, DOI 10.1038/35075107; Calzone L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000702; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Chaouiya C, 2003, LECT NOTES CONTR INF, V294, P119; Chen CR, 2005, CANCER RES, V65, P6017, DOI 10.1158/0008-5472.CAN-05-0677; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Coppe JP, 2011, J BIOL CHEM, V286, P36396, DOI 10.1074/jbc.M111.257071; de Lange T, 2009, SCIENCE, V326, P948, DOI 10.1126/science.1170633; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; Fanton CP, 2001, J BIOL CHEM, V276, P18871, DOI 10.1074/jbc.M011514200; Faure A, 2006, BIOINFORMATICS, V22, pE124, DOI 10.1093/bioinformatics/btl210; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Gosink EC, 1999, CANCER RES, V59, P5294; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; Hemmati PG, 2005, ONCOGENE, V24, P4114, DOI 10.1038/sj.onc.1208579; Holland EC, 1998, GENE DEV, V12, P3644, DOI 10.1101/gad.12.23.3644; Kracikova M, 2013, CELL DEATH DIFFER, V20, P576, DOI 10.1038/cdd.2012.155; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560; Lafarga V, 2009, MOL CELL BIOL, V29, P4341, DOI 10.1128/MCB.00210-09; Lanigan F, 2011, ONCOGENE, V30, P2901, DOI 10.1038/onc.2011.34; Lee Y, 2012, EMBO J, V31, P1177, DOI 10.1038/emboj.2011.493; Liu N, 2005, LAB INVEST, V85, P1471, DOI 10.1038/labinvest.3700354; Medema RH, 2012, ONCOGENE, V31, P2601, DOI 10.1038/onc.2011.451; Mombach JCM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S7-S7; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; Naldi A, 2009, BIOSYSTEMS, V97, P134, DOI 10.1016/j.biosystems.2009.04.008; Ray D, 2008, CANCER RES, V68, P1251, DOI 10.1158/0008-5472.CAN-07-5983; Reinhardt HC, 2009, CURR OPIN CELL BIOL, V21, P245, DOI 10.1016/j.ceb.2009.01.018; Salminen A, 2011, EUR J NEUROSCI, V34, P3, DOI 10.1111/j.1460-9568.2011.07738.x; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Simpson JE, 2010, NEUROPATH APPL NEURO, V36, P25, DOI 10.1111/j.1365-2990.2009.01030.x; Sorensen CS, 2003, CANCER CELL, V3, P247, DOI 10.1016/S1535-6108(03)00048-5; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Taneja P, 2011, CLIN MED INSIGHTS-ON, V5, P235, DOI 10.4137/CMO.S7516; THOMAS R, 1995, B MATH BIOL, V57, P247, DOI 10.1007/BF02460618; Thomas R., 1990, BIOL FEEDBACK; Thornton TM, 2009, INT J BIOL SCI, V5, P44, DOI 10.7150/ijbs.5.44; Timmers C, 2007, MOL CELL BIOL, V27, P65, DOI 10.1128/MCB.02147-06; van den Heuvel S, 2008, NAT REV MOL CELL BIO, V9, P713, DOI 10.1038/nrm2469; Wang WP, 2002, MOL CELL BIOL, V22, P3389, DOI 10.1128/MCB.22.10.3389-3403.2002; Yap DBS, 1999, ONCOGENE, V18, P7681, DOI 10.1038/sj.onc.1202954; Zhan H, 2010, J BIOL CHEM, V285, P29662, DOI 10.1074/jbc.M110.125138	48	30	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0125217	10.1371/journal.pone.0125217	http://dx.doi.org/10.1371/journal.pone.0125217			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25954815	gold, Green Published, Green Submitted			2022-12-26	WOS:000356768100046
J	Morikawa, A; Takeuchi, T; Kito, Y; Saigo, C; Sakuratani, T; Futamura, M; Yoshida, K				Morikawa, Akemi; Takeuchi, Tamotsu; Kito, Yusuke; Saigo, Chiemi; Sakuratani, Takuji; Futamura, Manabu; Yoshida, Kazuhiro			Expression of Beclin-1 in the Microenvironment of Invasive Ductal Carcinoma of the Breast: Correlation with Prognosis and the Cancer-Stromal Interaction	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; TUMOR MICROENVIRONMENT; PLEURAL EFFUSION; AUTOPHAGY; REGULATOR; DISEASE; LINE	We examined the pathobiological properties of beclin-1, which is a key regulator of autophagosome formation in invasive ductal carcinoma of the breast, with a particular focus on the cancer microenvironment. Immunohistochemistry demonstrated that cancer cells and stromal mesenchymal cells expressed beclin-1 in 68 and 38 of 115 invasive ductal cancers, respectively. Expression of beclin-1 in cancer or stromal cells alone did not correlate with patient prognosis. In contrast, loss of beclin-1 in cancer cells and overexpression in stromal mesenchymal cells was associated with local cancer recurrence, postoperative lymph node metastasis, and a poor disease-free survival rate. A comprehensive gene expression analysis was performed on a co-culture of breast cancer cells and mesenchymal stromal cells, that latter of which either expressed beclin-1 or was depleted of beclin-1 by siRNA. Notably, siRNA-mediated downregulation of beclin-1 in mesenchymal cells co-cultured with breast cancer cells decreased the levels of various pro-inflammatory cytokines, their receptors, and collagen receptors. Quantitative reverse transcription polymerase chain reaction analysis confirmed that reduction of stromal beclin-1 expression decreased the expression of IL-1 beta and collagen receptor discoidin domain receptor 2 (DDR2). Microenvironmental IL-1 beta is believed to play an important role in tumor invasion. Recent work has also indicated that overexpression of DDR2 contributes to breast cancer invasion and lymph node metastasis. Taken together, these findings indicate beclin-1 expression in the stroma might be important for shaping the breast cancer microenvironment and thus could be a potent molecular target in patients with invasive ductal carcinoma of the breast.	[Morikawa, Akemi; Sakuratani, Takuji; Futamura, Manabu; Yoshida, Kazuhiro] Gifu Univ, Grad Sch Med, Dept Surg Oncol, Gifu, Japan; [Morikawa, Akemi] Gifu Univ, Grad Sch Med, Dept Frontier Sci Surg Oncol, Gifu, Japan; [Takeuchi, Tamotsu; Kito, Yusuke; Saigo, Chiemi] Gifu Univ, Grad Sch Med, Dept Pathol & Translat Res, Gifu, Japan; [Futamura, Manabu] Gifu Univ, Grad Sch Med, Dept Breast & Mol Oncol, Gifu, Japan	Gifu University; Gifu University; Gifu University; Gifu University	Takeuchi, T (corresponding author), Gifu Univ, Grad Sch Med, Dept Pathol & Translat Res, Gifu, Japan.	takeutit08@gmail.com			Ministry of Education of Japan [KAKEN 24590384, 25860267]; Yakult Honsha Co., Ltd., Tokyo	Ministry of Education of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yakult Honsha Co., Ltd., Tokyo	This work was supported by Ministry of Education of Japan (KAKEN 24590384 and 25860267), and Yakult Honsha Co., Ltd., Tokyo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]; Dong M, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0355-0; Gong C, 2013, ONCOGENE, V32, P2261, DOI 10.1038/onc.2012.252; He YY, 2014, TUMOR BIOL, V35, P7317, DOI 10.1007/s13277-014-2060-4; Jin L, 1997, CANCER-AM CANCER SOC, V80, P421, DOI 10.1002/(SICI)1097-0142(19970801)80:3<421::AID-CNCR10>3.0.CO;2-Z; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kurtova AV, 2009, BLOOD, V114, P4441, DOI 10.1182/blood-2009-07-233718; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li ZD, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-98; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorin S, 2013, SEMIN CANCER BIOL, V23, P361, DOI 10.1016/j.semcancer.2013.06.007; Maes H, 2013, TRENDS MOL MED, V19, P428, DOI 10.1016/j.molmed.2013.04.005; Martinez-Outschoorn U, 2014, SEMIN ONCOL, V41, P195, DOI 10.1053/j.seminoncol.2014.03.002; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nishimura K, 2012, PATHOBIOLOGY, V79, P290, DOI 10.1159/000337296; Ren TT, 2014, J PATHOL, V234, P526, DOI 10.1002/path.4415; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Takeuchi T, 2006, ONCOGENE, V25, P7059, DOI 10.1038/sj.onc.1209688; Takeuchi T, 2000, J NEUROCHEM, V74, P1489, DOI 10.1046/j.1471-4159.2000.0741489.x; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Won KY, 2010, HUM PATHOL, V41, P107, DOI 10.1016/j.humpath.2009.07.006; YOUNG RK, 1974, IN VITRO CELL DEV B, V9, P239; Zhang K, 2013, NAT CELL BIOL, V15, P677, DOI 10.1038/ncb2743	25	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0125762	10.1371/journal.pone.0125762	http://dx.doi.org/10.1371/journal.pone.0125762			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955408	gold, Green Published, Green Submitted			2022-12-26	WOS:000356768100074
J	Greineder, CF; Brenza, JB; Carnemolla, R; Zaitsev, S; Hood, ED; Pan, DC; Ding, BS; Esmon, CT; Chacko, AM; Muzykantov, VR				Greineder, Colin F.; Brenza, Jacob B.; Carnemolla, Ronald; Zaitsev, Sergei; Hood, Elizabeth D.; Pan, Daniel C.; Ding, Bi-Sen; Esmon, Charles T.; Chacko, Ann Marie; Muzykantov, Vladimir R.			Dual targeting of therapeutics to endothelial cells: collaborative enhancement of delivery and effect	FASEB JOURNAL			English	Article						drug delivery; PECAM-1; thrombomodulin; EPCR	PROTEIN-C RECEPTOR; SOLUBLE THROMBOMODULIN ART-123; SEVERE SEPSIS; IN-VITRO; ESCHERICHIA-COLI; DRUG-DELIVERY; ACTIVATION; MODEL; COAGULATION; RELEASE	Anchoring pharmacologic agents to the vascular lumen has the potential to modulate critical processes at the blood-tissue interface, avoiding many of the off-target effects of systemically circulating agents. We report a novel strategy for endothelial dual targeting of therapeutics, which both enhances drug delivery and enables targeted agents to partner enzymatically to generate enhanced biologic effect. Based on the recent discovery that paired antibodies directed to adjacent epitopes of platelet endothelial cell adhesion molecule (PECAM)-1 stimulate each other's binding, we fused single-chain fragments (scFv) of paired anti-mouse PECAM-1 antibodies to recombinant murine thrombomodulin (TM) and endothelial protein C receptor (EPCR), endothelial membrane proteins that partner in activation of protein C (PC). scFv/TM and scFv/EPCR bound to mouse endothelial PECAM-1 with high affinity (EC50 1.5 and 3.8 nM, respectively), and codelivery induced a 5-fold increase in PC activation not seen when TM and EPCR are anchored to distinct cell adhesion molecules. In a mouse model of acute lung injury, dual targeting reduces both the expression of lung inflammatory markers and trans-endothelial protein leak by as much as 40%, as compared to either agent alone. These findings provide proof of principle for endothelial dual targeting, an approach with numerous potential biomedical applications.-Greineder, C. F., Brenza, J. B., Carnemolla, R., Zaitsev, S., Hood, E. D., Pan, D. C., Ding, B.-S., Esmon, C. T., Chacko, A. M., Muzykantov, V. R. Dual targeting of therapeutics to endothelial cells: collaborative enhancement of delivery and effect.	[Greineder, Colin F.; Carnemolla, Ronald; Zaitsev, Sergei; Hood, Elizabeth D.; Pan, Daniel C.; Muzykantov, Vladimir R.] Univ Penn, Perelman Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Greineder, Colin F.; Brenza, Jacob B.; Carnemolla, Ronald; Zaitsev, Sergei; Hood, Elizabeth D.; Pan, Daniel C.; Chacko, Ann Marie; Muzykantov, Vladimir R.] Univ Penn, Inst Translat Med & Therapeut, Ctr Targeted Therapeut & Translat Nanomed, Perelman Sch Med, Philadelphia, PA 19104 USA; [Chacko, Ann Marie] Univ Penn, Perelman Sch Med, Dept Radiol, Philadelphia, PA 19104 USA; [Greineder, Colin F.] Univ Penn, Perelman Sch Med, Dept Emergency Med, Philadelphia, PA 19104 USA; [Ding, Bi-Sen] Weill Cornell Med Coll, Howard Hughes Med Inst, Dept Med Genet, New York, NY USA; [Esmon, Charles T.] Howard Hughes Med Inst, Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Cornell University; Howard Hughes Medical Institute; Howard Hughes Medical Institute; Oklahoma Medical Research Foundation	Muzykantov, VR (corresponding author), Univ Penn, Inst Translat Med & Therapeut, Translat Res Ctr, Perelman Sch Med, TRC 10-125,3400 Civ Ctr Blvd,Bldg 421, Philadelphia, PA 19104 USA.	muzykant@mail.med.upenn.edu		Greineder, Colin/0000-0001-9740-7672	Institute of Translational Medicine and Therapeutics at the University of Pennsylvania; American Heart Association Fellow-to-Faculty Grant [10FTF4150053]; U. S. National Institutes of Health Grant from the National Heart, Lung, and Blood Institute [R01-HL091950]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091950, P01HL110860, T32HL007915, T32HL007439] Funding Source: NIH RePORTER	Institute of Translational Medicine and Therapeutics at the University of Pennsylvania; American Heart Association Fellow-to-Faculty Grant; U. S. National Institutes of Health Grant from the National Heart, Lung, and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Dr. Annunciata Vecchi (Mario Negri Institute of Pharmacology Research, Milan, Italy) for her generous gift of Mec13 hybridoma lysate. This work was supported by a Junior Investigator Preliminary/Feasibility Grant Program grant from the Institute of Translational Medicine and Therapeutics at the University of Pennsylvania (to C.F.G.), as well as an American Heart Association Fellow-to-Faculty Grant 10FTF4150053 (to C.F.G.), and a U. S. National Institutes of Health Grant R01-HL091950 from the National Heart, Lung, and Blood Institute (to V.R.M.).	Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Boehme MWJ, 1996, IMMUNOLOGY, V87, P134; Carnemolla R, 2012, J IMMUNOL METHODS, V384, P21, DOI 10.1016/j.jim.2012.06.012; Carnemolla R, 2010, SEMIN THROMB HEMOST, V36, P332, DOI 10.1055/s-0030-1253455; Chacko AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034958; Ding BS, 2009, AM J RESP CRIT CARE, V180, P247, DOI 10.1164/rccm.200809-1433OC; DUBEL S, 1994, J IMMUNOL METHODS, V175, P89, DOI 10.1016/0022-1759(94)90334-4; Duncan R, 2003, NAT REV DRUG DISCOV, V2, P347, DOI 10.1038/nrd1088; Esmon CT, 2001, CRIT CARE, V5, pS7, DOI 10.1186/cc1333; ESMON CT, 1995, FASEB J, V9, P946, DOI 10.1096/fasebj.9.10.7615164; ESMON CT, 1989, J BIOL CHEM, V264, P4743; Faust SN, 2001, NEW ENGL J MED, V345, P408, DOI 10.1056/NEJM200108093450603; Feistritzer C, 2006, J BIOL CHEM, V281, P20077, DOI 10.1074/jbc.M600506200; Greineder CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080110; Greineder CF, 2013, BLOOD, V122, P1565, DOI 10.1182/blood-2013-03-453498; Gu JM, 2000, BLOOD, V95, P1687, DOI 10.1182/blood.V95.5.1687.005k08_1687_1693; Han HS, 2001, J BIOMAT SCI-POLYM E, V12, P1075, DOI 10.1163/15685620152691869; Kador KE, 2011, ACTA BIOMATER, V7, P2508, DOI 10.1016/j.actbio.2011.03.015; Kearon C, 2005, J THROMB HAEMOST, V3, P962, DOI 10.1111/j.1538-7836.2005.01251.x; Kerschen EJ, 2007, J EXP MED, V204, P2439, DOI 10.1084/jem.20070404; KISHIDA A, 1994, BIOMATERIALS, V15, P848, DOI 10.1016/0142-9612(94)90041-8; Koren E, 2011, IUBMB LIFE, V63, P586, DOI 10.1002/iub.496; Kurosawa S, 1998, BLOOD, V91, P725, DOI 10.1182/blood.V91.2.725; Li W, 2005, J THROMB HAEMOST, V3, P1351, DOI 10.1111/j.1538-7836.2005.01385.x; Maniatis NA, 2008, CURR OPIN CRIT CARE, V14, P22, DOI 10.1097/MCC.0b013e3282f269b9; Muro S, 2005, CURR PHARM DESIGN, V11, P2383, DOI 10.2174/1381612054367274; Muzykantov Vladimir R, 2005, Expert Opin Drug Deliv, V2, P909, DOI 10.1517/17425247.2.5.909; Muzykantov VR, 2013, ISRN VASC MED, V2013, DOI [10.1155/2013/916254, DOI 10.1155/2013/916254]; Newman PJ, 1997, J CLIN INVEST, V99, P3, DOI 10.1172/JCI119129; Opal SM, 2013, AM J RESP CRIT CARE, V187, P1041, DOI 10.1164/rccm.201303-0505ED; REDL H, 1995, J INFECT DIS, V171, P1522, DOI 10.1093/infdis/171.6.1522; Saito H, 2007, J THROMB HAEMOST, V5, P31, DOI 10.1111/j.1538-7836.2006.02267.x; Schouten M, 2014, THROMB HAEMOSTASIS, V111, P970, DOI 10.1160/TH13-10-0859; SOLIS MM, 1991, J VASC SURG, V14, P599; Sperling C, 2004, BIOMATERIALS, V25, P5101, DOI 10.1016/j.biomaterials.2003.12.014; StearnsKurosawa DJ, 1996, P NATL ACAD SCI USA, V93, P10212, DOI 10.1073/pnas.93.19.10212; Su EJ, 2011, J THROMB HAEMOST, V9, P1174, DOI 10.1111/j.1538-7836.2011.04269.x; Sun J, 2000, J CELL SCI, V113, P1459; TAYLOR FB, 1987, J CLIN INVEST, V79, P918, DOI 10.1172/JCI112902; Thorpe PE, 2004, CLIN CANCER RES, V10, P415, DOI 10.1158/1078-0432.CCR-0642-03; Torchilin VP, 2006, ANNU REV BIOMED ENG, V8, P343, DOI 10.1146/annurev.bioeng.8.061505.095735; Tseng PY, 2006, BIOMATERIALS, V27, P2768, DOI 10.1016/j.biomaterials.2005.11.032; Wang J, 2010, AAPS J, V12, P492, DOI 10.1208/s12248-010-9210-4; Xu J, 2000, J BIOL CHEM, V275, P6038, DOI 10.1074/jbc.275.8.6038; Zhang HL, 2013, BIOCONJUGATE CHEM, V24, P550, DOI 10.1021/bc300399f	46	22	22	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3483	3492		10.1096/fj.15-271213	http://dx.doi.org/10.1096/fj.15-271213			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25953848	Green Published			2022-12-26	WOS:000358796900034
J	Angel-Chavez, LI; Acosta-Gomez, EI; Morales-Avalos, M; Castro, E; Cruzblanca, H				Angel-Chavez, Luis I.; Acosta-Gomez, Eduardo I.; Morales-Avalos, Mario; Castro, Elena; Cruzblanca, Humberto			Forskolin Suppresses Delayed-Rectifier K+ Currents and Enhances Spike Frequency-Dependent Adaptation of Sympathetic Neurons	PLOS ONE			English	Article							SUPERIOR CERVICAL-GANGLION; POTASSIUM CURRENTS; HIPPOCAMPAL-NEURONS; ADENYLATE-CYCLASE; CHANNELS; KV2.1; MODULATION; CELLS; PHOSPHORYLATION; PATHWAYS	In signal transduction research natural or synthetic molecules are commonly used to target a great variety of signaling proteins. For instance, forskolin, a diterpene activator of adenylate cyclase, has been widely used in cellular preparations to increase the intracellular cAMP level. However, it has been shown that forskolin directly inhibits some cloned K+ channels, which in excitable cells set up the resting membrane potential, the shape of action potential and regulate repetitive firing. Despite the growing evidence indicating that K+ channels are blocked by forskolin, there are no studies yet assessing the impact of this mechanism of action on neuron excitability and firing patterns. In sympathetic neurons, we find that forskolin and its derivative 1,9-Dideoxyforskolin, reversibly suppress the delayed rectifier K+ current (I-KV). Besides, forskolin reduced the spike afterhyperpolarization and enhanced the spike frequency-dependent adaptation. Given that I-KV is mostly generated by Kv2.1 channels, HEK293 cells were transfected with cDNA encoding for the Kv2.1 alpha subunit, to characterize the mechanism of forskolin action. Both drugs reversible suppressed the Kv2.1-mediated K+ currents. Forskolin inhibited Kv2.1 currents and I-KV with an IC50 of similar to 32 mu M and similar to 24 mu M, respectively. Besides, the drug induced an apparent current inactivation and slowed-down current deactivation. We suggest that forskolin reduces the excitability of sympathetic neurons by enhancing the spike frequency-dependent adaptation, partially through a direct block of their native Kv2.1 channels.	[Angel-Chavez, Luis I.; Acosta-Gomez, Eduardo I.] Univ Autonoma Ciudad Juarez, Inst Ciencias Biomed, Dept Ciencias Salud, Ciudad Juarez 32310, Chih, Mexico; [Morales-Avalos, Mario; Castro, Elena; Cruzblanca, Humberto] Univ Colima, Ctr Univ Invest Biomed, Colima 28045, Col, Mexico	Universidad Autonoma de Ciudad Juarez; Universidad de Colima	Cruzblanca, H (corresponding author), Univ Colima, Ctr Univ Invest Biomed, Colima 28045, Col, Mexico.	cruzblan@ucol.mx		Angel-Chavez, Luis Ignacio/0000-0002-9471-0489; Acosta Gomez, Eduardo Ivan/0000-0003-4502-1860	Consejo Nacional de Ciencia y Tecnologia [61954, 102863]; Secretaria de Educacion Publica [103.5-08-3334]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Secretaria de Educacion Publica	Consejo Nacional de Ciencia y Tecnologia (www.conacyt.gob.mx) grants 61954 and 102863 to HC. Secretaria de Educacion Publica (http://dsa.sep.gob.mx/prodep.html) grant 103.5-08-3334 to EIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta E, 2007, J NEUROPHYSIOL, V98, P79, DOI 10.1152/jn.01103.2006; Atkinson SE, 2011, J BIOL RHYTHM, V26, P210, DOI 10.1177/0748730411402810; Ballard ST, 2006, AM J PHYSIOL-LUNG C, V290, pL97, DOI 10.1152/ajplung.00159.2005; Baranauskas G, 1999, J NEUROSCI, V19, P6394; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Cao JL, 2010, P NATL ACAD SCI USA, V107, P17011, DOI 10.1073/pnas.1010077107; Cruzblanca H, 2006, BRIT J PHARMACOL, V149, P441, DOI 10.1038/sj.bjp.0706874; Czirjak G, 2010, J BIOL CHEM, V285, P14549, DOI 10.1074/jbc.M110.102020; Davies PJ, 1996, J PHYSIOL-LONDON, V495, P353, DOI 10.1113/jphysiol.1996.sp021599; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; Du J, 2000, J PHYSIOL-LONDON, V522, P19, DOI 10.1111/j.1469-7793.2000.t01-2-00019.xm; GARBER SS, 1990, J NEUROSCI, V10, P3361; Gu N, 2007, J PHYSIOL-LONDON, V580, P859, DOI 10.1113/jphysiol.2006.126367; Guan D, 2007, J PHYSIOL-LONDON, V581, P941, DOI 10.1113/jphysiol.2007.128454; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HOSHI T, 1988, SCIENCE, V240, P1652, DOI 10.1126/science.2454506; Jia ZF, 2008, J GEN PHYSIOL, V131, P575, DOI 10.1085/jgp.200709924; Jiao S, 2007, J NEUROCHEM, V100, P979, DOI 10.1111/j.1471-4159.2006.04261.x; Kuo CC, 1998, BIOPHYS J, V75, P2845, DOI 10.1016/S0006-3495(98)77727-6; Malin SA, 2002, J NEUROSCI, V22, P10094; Malin SA, 2000, J NEUROSCI, V20, P5191, DOI 10.1523/JNEUROSCI.20-14-05191.2000; MARSH SJ, 1991, NEUROSCI LETT, V133, P298, DOI 10.1016/0304-3940(91)90593-I; Matthias K, 2002, NEUROPHARMACOLOGY, V43, P444, DOI 10.1016/S0028-3908(02)00115-6; Mohapatra DP, 2006, J NEUROSCI, V26, P685, DOI 10.1523/JNEUROSCI.4620-05.2006; Murakoshi H, 1999, J NEUROSCI, V19, P1728; Murakoshi H, 1997, MOL PHARMACOL, V52, P821, DOI 10.1124/mol.52.5.821; Nahorski SR, 2006, BRIT J PHARMACOL, V147, pS38, DOI 10.1038/sj.bjp.0706468; Nuwer MO, 2009, NEUROPHARMACOLOGY, V57, P219, DOI 10.1016/j.neuropharm.2009.06.006; SCHOFIELD GG, 1989, BRAIN RES, V485, P205, DOI 10.1016/0006-8993(89)90563-5; SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363; Sokolova IV, 2006, J NEUROPHYSIOL, V95, P2570, DOI 10.1152/jn.00617.2005; Tytgat J, 1997, BRIT J PHARMACOL, V122, P1417, DOI 10.1038/sj.bjp.0701545; WAGONER PK, 1988, SCIENCE, V240, P1655, DOI 10.1126/science.2454507; WANG HS, 1995, J PHYSIOL-LONDON, V485, P319, DOI 10.1113/jphysiol.1995.sp020732; Yue CY, 2004, J NEUROSCI, V24, P4614, DOI 10.1523/JNEUROSCI.0765-04.2004	35	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126365	10.1371/journal.pone.0126365	http://dx.doi.org/10.1371/journal.pone.0126365			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962132	Green Submitted, Green Published, gold			2022-12-26	WOS:000354542500092
J	Brown, AR; Ettefagh, KA; Todd, D; Cole, PS; Egan, JM; Foil, DH; Graf, TN; Schindler, BD; Kaatz, GW; Cech, NB				Brown, Adam R.; Ettefagh, Keivan A.; Todd, Daniel; Cole, Patrick S.; Egan, Joseph M.; Foil, Daniel H.; Graf, Tyler N.; Schindler, Bryan D.; Kaatz, Glenn W.; Cech, Nadja B.			A Mass Spectrometry-Based Assay for Improved Quantitative Measurements of Efflux Pump Inhibition	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; MULTIDRUG-RESISTANCE; ETHIDIUM-BROMIDE; PLANT; NORA; DERIVATIVES; GENTAMICIN; VANCOMYCIN; FLAVONOIDS; MECHANISM	Bacterial efflux pumps are active transport proteins responsible for resistance to selected biocides and antibiotics. It has been shown that production of efflux pumps is up-regulated in a number of highly pathogenic bacteria, including methicillin resistant Staphylococcus aureus. Thus, the identification of new bacterial efflux pump inhibitors is a topic of great interest. Existing assays to evaluate efflux pump inhibitory activity rely on fluorescence by an efflux pump substrate. When employing these assays to evaluate efflux pump inhibitory activity of plant extracts and some purified compounds, we observed severe optical interference that gave rise to false negative results. To circumvent this problem, a new mass spectrometry-based method was developed for the quantitative measurement of bacterial efflux pump inhibition. The assay was employed to evaluate efflux pump inhibitory activity of a crude extract of the botanical Hydrastis Canadensis, and to compare the efflux pump inhibitory activity of several pure flavonoids. The flavonoid quercetin, which appeared to be completely inactive with a fluorescence-based method, showed an IC50 value of 75 mu g/mL with the new method. The other flavonoids evaluated (apigenin, kaempferol, rhamnetin, luteolin, myricetin), were also active, with IC50 values ranging from 19 mu g/mL to 75 mu g/mL. The assay described herein could be useful in future screening efforts to identify efflux pump inhibitors, particularly in situations where optical interference precludes the application of methods that rely on fluorescence.	[Brown, Adam R.; Ettefagh, Keivan A.; Todd, Daniel; Cole, Patrick S.; Egan, Joseph M.; Foil, Daniel H.; Graf, Tyler N.; Cech, Nadja B.] Univ N Carolina, Dept Chem Biochem, Greensboro, NC 27412 USA; [Schindler, Bryan D.; Kaatz, Glenn W.] Wayne State Univ, Sch Med, John Dingell Dept Veteran Affairs Med Ctr, Div Infect Dis, Detroit, MI USA; [Schindler, Bryan D.; Kaatz, Glenn W.] Wayne State Univ, Sch Med, Dept Internal Med, Detroit, MI USA	University of North Carolina; University of North Carolina Greensboro; Wayne State University; Wayne State University	Cech, NB (corresponding author), Univ N Carolina, Dept Chem Biochem, Greensboro, NC 27412 USA.	nadja_cech@uncg.edu	Foil, Daniel/AAJ-1809-2021	Foil, Daniel/0000-0003-0512-8997; Egan, Joseph/0000-0002-6836-2361; Graf, Tyler/0000-0003-4145-2815; Todd, Daniel/0000-0003-2199-1029	National Center for Complementary and Alternative Medicine (NCCAM), a component of the National Institutes of Health (NIH) [1 R01 AT006860]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R15AT005005] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT006860] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicine (NCCAM), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by Grant Number 1 R01 AT006860 from the National Center for Complementary and Alternative Medicine (NCCAM), a component of the National Institutes of Health (NIH).	BAER GR, 1982, PLANT PHYSIOL, V70, P999, DOI 10.1104/pp.70.4.999; Brenwald NP, 1998, ANTIMICROB AGENTS CH, V42, P2032, DOI 10.1128/AAC.42.8.2032; Ettefagh KA, 2011, PLANTA MED, V77, P835, DOI 10.1055/s-0030-1250606; Gibbons S, 2004, NAT PROD REP, V21, P263, DOI 10.1039/b212695h; Gibbons Simon, 2005, Phytochemistry Reviews, V4, P63, DOI 10.1007/s11101-005-2494-9; Gu JQ, 2004, J NAT PROD, V67, P1156, DOI 10.1021/np040027m; Guz NR, 2001, J MED CHEM, V44, P261, DOI 10.1021/jm0004190; Hamilton-Miller JMT, 2000, J ANTIMICROB CHEMOTH, V46, P852, DOI 10.1093/jac/46.5.852; Hollman PCH, 1999, FOOD CHEM TOXICOL, V37, P937, DOI 10.1016/S0278-6915(99)00079-4; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hudson SA, 2009, FEBS J, V276, P5960, DOI 10.1111/j.1742-4658.2009.07307.x; Iwashina T, 2000, J PLANT RES, V113, P287, DOI 10.1007/PL00013940; Junio HA, 2011, J NAT PROD, V74, P1621, DOI 10.1021/np200336g; Kaatz GW, 2000, ANTIMICROB AGENTS CH, V44, P1404, DOI 10.1128/AAC.44.5.1404-1406.2000; Khan IA, 2006, ANTIMICROB AGENTS CH, V50, P810, DOI 10.1128/AAC.50.2.810-812.2006; LaPlante KL, 2004, ANTIMICROB AGENTS CH, V48, P4665, DOI 10.1128/AAC.48.12.4665-4672.2004; Lechner D, 2008, J ANTIMICROB CHEMOTH, V62, P345, DOI 10.1093/jac/dkn178; Mahamoud A, 2006, CURR DRUG TARGETS, V7, P843, DOI 10.2174/138945006777709557; Matsuura N, 2002, J HEALTH SCI, V48, P520, DOI 10.1248/jhs.48.520; Mulazimoglu L, 1996, ANTIMICROB AGENTS CH, V40, P1534, DOI 10.1128/AAC.40.6.1534; Nargotra A, 2009, EUR J MED CHEM, V44, P4128, DOI 10.1016/j.ejmech.2009.05.004; NEWTON BA, 1957, J GEN MICROBIOL, V17, P718, DOI 10.1099/00221287-17-3-718; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; OLMSTED J, 1977, BIOCHEMISTRY-US, V16, P3647, DOI 10.1021/bi00635a022; Pereda-Miranda R, 2006, J NAT PROD, V69, P406, DOI 10.1021/np050227d; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Piddock LJV, 2006, CLIN MICROBIOL REV, V19, P382, DOI 10.1128/CMR.19.2.382-402.2006; Remans T, 1999, PLANT MOL BIOL REP, V17, P385, DOI 10.1023/A:1007654318401; Sabatini S, 2008, J MED CHEM, V51, P4321, DOI 10.1021/jm701623q; Saidijam M, 2006, CURR DRUG TARGETS, V7, P793, DOI 10.2174/138945006777709575; Schindler BD, 2013, J BACTERIOL, V195, P3651, DOI 10.1128/JB.00565-13; Simoes M, 2009, NAT PROD REP, V26, P746, DOI 10.1039/b821648g; Stavri M, 2007, J ANTIMICROB CHEMOTH, V59, P1247, DOI 10.1093/jac/dkl460; Stermitz FR, 2001, BIOCHEM SYST ECOL, V29, P793, DOI 10.1016/S0305-1978(01)00025-4; Stermitz FR, 2000, J NAT PROD, V63, P1146, DOI 10.1021/np990639k; Stermitz FR, 2000, P NATL ACAD SCI USA, V97, P1433, DOI 10.1073/pnas.030540597; Stermitz FR, 2002, PLANTA MED, V68, P1140, DOI 10.1055/s-2002-36347; Tegos G, 2002, ANTIMICROB AGENTS CH, V46, P3133, DOI 10.1128/AAC.46.10.3133-3141.2002; Turner RJ, 2005, ASSAY DRUG DEV TECHN, V3, P525, DOI 10.1089/adt.2005.3.525; Van Bambeke F, 2000, BIOCHEM PHARMACOL, V60, P457, DOI 10.1016/S0006-2952(00)00291-4; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; WARING MJ, 1965, J MOL BIOL, V13, P269, DOI 10.1016/S0022-2836(65)80096-1; Wikler M.A., 2006, CLIN LAB STAND I, V26; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629	44	36	38	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0124814	10.1371/journal.pone.0124814	http://dx.doi.org/10.1371/journal.pone.0124814			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961825	gold, Green Submitted, Green Published			2022-12-26	WOS:000354542500020
J	Gu, YQ				Gu, Yuqiao			Modeling the Cellular Mechanisms and Olfactory Input Underlying the Triphasic Response of Moth Pheromone-Sensitive Projection Neurons	PLOS ONE			English	Article							ANTENNAL-LOBE NEURONS; MANDUCA-SEXTA; SPHINX MOTH; NETWORK MECHANISMS; UPWIND FLIGHT; CURRENTS; ODORS; REPRESENTATION; STIMULATION; MORPHOLOGY	In the antennal lobe of the noctuid moth Agrotis ipsilon, most pheromone-sensitive projection neurons (PNs) exhibit a triphasic firing pattern of excitation (E-1)-inhibition (I)-excitation (E-2) in response to a pulse of the sex pheromone. To understand the mechanisms underlying this stereotypical discharge, we developed a biophysical model of a PN receiving inputs from olfactory receptor neurons (ORNs) via nicotinic cholinergic synapses. The ORN is modeled as an inhomogeneous Poisson process whose firing rate is a function of time and is fitted to extracellular data recorded in response to pheromone stimulations at various concentrations and durations. The PN model is based on the Hodgkin-Huxley formalism with realistic ionic currents whose parameters were derived from previous studies. Simulations revealed that the inhibitory phase I can be produced by a SK current (Ca2+-gated small conductance K+ current) and that the excitatory phase E-2 can result from the long-lasting response of the ORNs. Parameter analysis further revealed that the ending time of E-1 depends on some parameters of SK, Ca2+, nACh and Na+ currents; I duration mainly depends on the time constant of intracellular Ca2+ dynamics, conductance of Ca2+ currents and some parameters of nACh currents; The mean firing frequency of E-1 and E-2 depends differentially on the interaction of various currents. Thus it is likely that the interplay between PN intrinsic currents and feedforward synaptic currents are sufficient to generate the triphasic firing patterns observed in the noctuid moth A. ipsilon.	[Gu, Yuqiao] Natl Inst Agr Res, UMR iEES Paris 1392, Versailles, France; [Gu, Yuqiao] Scuola Int Super Studi Avanzati, Cognit Neurosci, Trieste, Italy	INRAE; UDICE-French Research Universities; Sorbonne Universite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); International School for Advanced Studies (SISSA)	Gu, YQ (corresponding author), Natl Inst Agr Res, UMR iEES Paris 1392, Versailles, France.	alice63_gu@hotmail.com			Agence Nationale de la Recherche within the French-British ANR BBSRC SysBio "Pherosys" initiative [006 01]; European FP7-ICT STREP Bio-ICT convergence "Neurochem"; state program "Investissements d'avenir" [ANR-10-BINF-05 "Pherotaxis"]	Agence Nationale de la Recherche within the French-British ANR BBSRC SysBio "Pherosys" initiative(French National Research Agency (ANR)); European FP7-ICT STREP Bio-ICT convergence "Neurochem"; state program "Investissements d'avenir"(French National Research Agency (ANR))	This work was funded by the Agence Nationale de la Recherche within the French-British ANR BBSRC SysBio 006 01 "Pherosys" initiative, the European FP7-ICT 2007 STREP Bio-ICT convergence "Neurochem" and the state program "Investissements d'avenir" managed by the Agence Nationale de la Recherche (grant ANR-10-BINF-05 "Pherotaxis"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton Sylvia, 1999, P97; Assisi C, 2011, NEURON, V69, P373, DOI 10.1016/j.neuron.2010.12.019; ATEMA J, 1995, P NATL ACAD SCI USA, V92, P62, DOI 10.1073/pnas.92.1.62; AVRON E, 1995, BIOSYSTEMS, V36, P101, DOI 10.1016/0303-2647(95)01531-O; AVRON E, 1994, J MATH BIOL, V33, P71, DOI 10.1007/BF00160174; Bazhenov M, 2001, NEURON, V30, P553, DOI 10.1016/S0896-6273(01)00284-7; Bazhenov M, 2001, NEURON, V30, P569, DOI 10.1016/S0896-6273(01)00286-0; Belmabrouk H, 2011, P NATL ACAD SCI USA, V108, P19790, DOI 10.1073/pnas.1112367108; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Brown SL, 2005, NAT NEUROSCI, V8, P1568, DOI 10.1038/nn1559; Buckley CL, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.238109; Christensen TA, 1996, J NEUROBIOL, V30, P82, DOI 10.1002/(SICI)1097-4695(199605)30:1<82::AID-NEU8>3.0.CO;2-C; Christensen TA, 1998, J NEUROSCI, V18, P5999; CHRISTENSEN TA, 1993, J COMP PHYSIOL A, V173, P385, DOI 10.1007/BF00193512; Defaix C, 2014, 11 NEUR COD INT WORK; Destexhe A, 1994, J Comput Neurosci, V1, P195, DOI 10.1007/BF00961734; Gu YQ, 2007, BIOSYSTEMS, V89, P236, DOI 10.1016/j.biosystems.2006.04.021; HAMILTON KA, 1989, J NEUROPHYSIOL, V62, P609, DOI 10.1152/jn.1989.62.3.609; Hansson BS, 2000, ANNU REV ENTOMOL, V45, P203, DOI 10.1146/annurev.ento.45.1.203; Husch A, 2009, J NEUROSCI, V29, P716, DOI 10.1523/JNEUROSCI.3677-08.2009; Jarriault D, 2010, CHEM SENSES, V35, P705, DOI 10.1093/chemse/bjq069; KANZAKI R, 1989, J COMP PHYSIOL A, V165, P427, DOI 10.1007/BF00611233; Kloppenburg P, 1999, J NEUROSCI, V19, P8172; LAPIED B, 1990, J EXP BIOL, V151, P387; Laurent G, 1996, TRENDS NEUROSCI, V19, P489, DOI 10.1016/S0166-2236(96)10054-0; MAFRANETO A, 1994, NATURE, V369, P142, DOI 10.1038/369142a0; Martinez D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061220; Mercer AR, 2002, J NEUROPHYSIOL, V87, P2664, DOI 10.1152/jn.2002.87.6.2664; MERCER AR, 1995, J EXP BIOL, V198, P613; MOORE PA, 1994, CHEM SENSES, V19, P71, DOI 10.1093/chemse/19.1.71; MORI K, 1995, PROG NEUROBIOL, V45, P585, DOI 10.1016/0301-0082(94)00058-P; Roper P, 2003, J COMPUT NEUROSCI, V15, P367, DOI 10.1023/A:1027424128972; Rospars JP, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003975; Sivan E, 2006, J COMPUT NEUROSCI, V20, P85, DOI 10.1007/s10827-006-4087-z; VICKERS NJ, 1992, J INSECT BEHAV, V5, P669, DOI 10.1007/BF01047979; VICKERS NJ, 1994, P NATL ACAD SCI USA, V91, P5756, DOI 10.1073/pnas.91.13.5756; WELLIS DP, 1989, J NEUROPHYSIOL, V61, P1161, DOI 10.1152/jn.1989.61.6.1161; WILLIS MA, 1984, PHYSIOL ENTOMOL, V9, P341, DOI 10.1111/j.1365-3032.1984.tb00715.x; YOUNGENTOB SL, 1987, PHYSIOL BEHAV, V41, P59, DOI 10.1016/0031-9384(87)90131-4; [No title captured]	41	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126305	10.1371/journal.pone.0126305	http://dx.doi.org/10.1371/journal.pone.0126305			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962173	Green Published, Green Submitted, gold			2022-12-26	WOS:000354542500086
J	Maity, AK; Chaudhury, P; Banik, SK				Maity, Alok Kumar; Chaudhury, Pinaki; Banik, Suman K.			Role of Relaxation Time Scale in Noisy Signal Transduction	PLOS ONE			English	Article							STOCHASTIC GENE-EXPRESSION; NETWORK MOTIFS; FEEDFORWARD LOOP; TRANSCRIPTIONAL REGULATION; FLUCTUATIONS; RECONSTRUCTION; ATTENUATION; PROPAGATION; SPECIFICITY; FEEDBACK	Intra-cellular fluctuations, mainly triggered by gene expression, are an inevitable phenomenon observed in living cells. It influences generation of phenotypic diversity in genetically identical cells. Such variation of cellular components is beneficial in some contexts but detrimental in others. To quantify the fluctuations in a gene product, we undertake an analytical scheme for studying few naturally abundant linear as well as branched chain network motifs. We solve the Langevin equations associated with each motif under the purview of linear noise approximation and derive the expressions for Fano factor and mutual information in close analytical form. Both quantifiable expressions exclusively depend on the relaxation time (decay rate constant) and steady state population of the network components. We investigate the effect of relaxation time constraints on Fano factor and mutual information to indentify a time scale domain where a network can recognize the fluctuations associated with the input signal more reliably. We also show how input population affects both quantities. We extend our calculation to long chain linear motif and show that with increasing chain length, the Fano factor value increases but the mutual information processing capability decreases. In this type of motif, the intermediate components act as a noise filter that tune up input fluctuations and maintain optimum fluctuations in the output. For branched chain motifs, both quantities vary within a large scale due to their network architecture and facilitate survival of living system in diverse environmental conditions.	[Maity, Alok Kumar; Chaudhury, Pinaki] Univ Calcutta, Dept Chem, Kolkata, India; [Banik, Suman K.] Bose Inst, Dept Chem, Kolkata, India	University of Calcutta; Department of Science & Technology (India); Bose Institute	Banik, SK (corresponding author), Bose Inst, Dept Chem, Kolkata, India.	skbanik@jcbose.ac.in			University Grants Commission, New Delhi [UGC/776/JRF(Sc), 42-301/2013(SR)]; Bose Institute, Kolkata, India through Institutional Programme VI -Development of Systems Biology	University Grants Commission, New Delhi(University Grants Commission, India); Bose Institute, Kolkata, India through Institutional Programme VI -Development of Systems Biology	University Grants Commission, New Delhi (UGC/776/JRF(Sc)) for a research fellowship to AKM, University Grants Commission, New Delhi (42-301/2013(SR)) for funding a major research project to PC, and the Bose Institute, Kolkata, India through Institutional Programme VI -Development of Systems Biology to SKB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U., 2006, INTRO SYSTEMS BIOL D; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Armitage JP, 1999, ADV MICROB PHYSIOL, V41, P229, DOI 10.1016/S0065-2911(08)60168-X; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Becskei A, 2005, NAT GENET, V37, P937, DOI 10.1038/ng1616; Bialek W, 2005, P NATL ACAD SCI USA, V102, P10040, DOI 10.1073/pnas.0504321102; Blais A, 2005, GENE DEV, V19, P1499, DOI 10.1101/gad.1325605; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; Bowsher CG, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002965; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bruggeman FJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000506; Charlebois DA, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.052708; Charlebois DA, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.218101; Cheong R, 2011, SCIENCE, V334, P354, DOI 10.1126/science.1204553; Cover TM, 1991, ELEMENTS OF INFORMAT; de Ronde WH, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.021913; de Ronde WH, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.031914; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Elf J, 2003, GENOME RES, V13, P2475, DOI 10.1101/gr.1196503; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; FANO U, 1947, PHYS REV, V72, P26, DOI 10.1103/PhysRev.72.26; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; Gardiner C., 2009, STOCHASTIC METHODS; Ghosh B, 2005, PHYS BIOL, V2, P36, DOI 10.1088/1478-3967/2/1/005; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Goentoro L, 2009, MOL CELL, V36, P894, DOI 10.1016/j.molcel.2009.11.018; Grima R, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3625958; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hayot F, 2005, J THEOR BIOL, V234, P133, DOI 10.1016/j.jtbi.2004.11.010; Heinrich R, 2002, MOL CELL, V9, P957, DOI 10.1016/S1097-2765(02)00528-2; Hilfinger A, 2011, P NATL ACAD SCI USA, V108, P12167, DOI 10.1073/pnas.1018832108; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Hynes NE, 2013, NAT REV MOL CELL BIO, V14, P393, DOI 10.1038/nrm3581; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kittisopikul M, 2010, P NATL ACAD SCI USA, V107, P13300, DOI 10.1073/pnas.1003975107; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mehta P, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.79; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Munsky B, 2012, SCIENCE, V336, P183, DOI 10.1126/science.1216379; Murugan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041027; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paninski L, 2003, NEURAL COMPUT, V15, P1191, DOI 10.1162/089976603321780272; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Paulsson J, 2005, PHYS LIFE REV, V2, P157, DOI 10.1016/j.plrev.2005.03.003; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Pedraza JM, 2008, SCIENCE, V319, P339, DOI 10.1126/science.1144331; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Ray JCJ, 2011, NAT REV MICROBIOL, V9, P817, DOI 10.1038/nrmicro2667; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Rotem E, 2010, P NATL ACAD SCI USA, V107, P12541, DOI 10.1073/pnas.1004333107; Scott M, 2006, CHAOS, V16, DOI 10.1063/1.2211787; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Silva-Rocha R, 2010, ANNU REV MICROBIOL, V64, P257, DOI 10.1146/annurev.micro.091208.073229; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Sureka K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001771; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Swain PS, 2004, J MOL BIOL, V344, P965, DOI 10.1016/j.jmb.2004.09.073; Tanase-Nicola S, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.068102; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Thattai M, 2002, BIOPHYS J, V82, P2943, DOI 10.1016/S0006-3495(02)75635-X; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; Thomas P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S4-S5; Thomas P, 2013, J THEOR BIOL, V335, P222, DOI 10.1016/j.jtbi.2013.06.021; Tkacik G, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/15/153102; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; VanKampen NG, 2007, NORTH-HOLL PERS LIBR, P1; Zhang LJ, 2007, BIOTECHNIQUES, V42, P446, DOI 10.2144/000112453	81	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0123242	10.1371/journal.pone.0123242	http://dx.doi.org/10.1371/journal.pone.0123242			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955500	Green Published, Green Submitted, gold			2022-12-26	WOS:000356768100009
J	Teng, Y; Radde, BN; Litchfield, LM; Ivanova, MM; Prough, RA; Clark, BJ; Doll, MA; Hein, DW; Klinge, CM				Teng, Yun; Radde, Brandie N.; Litchfield, Lacey M.; Ivanova, Margarita M.; Prough, Russell A.; Clark, Barbara J.; Doll, Mark A.; Hein, David W.; Klinge, Carolyn M.			Dehydroepiandrosterone Activation of G-protein-coupled Estrogen Receptor Rapidly Stimulates MicroRNA-21 Transcription in Human Hepatocellular Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						estrogen receptor; G-protein-coupled receptor (GPCR); gene transcription; microRNA (miRNA); microRNA biogenesis; hormones	BREAST-CANCER CELLS; METHYL-BETA-CYCLODEXTRIN; EPIDERMAL-GROWTH-FACTOR; GENE-EXPRESSION; VARIANT ER-ALPHA-36; PROSTATE-CANCER; UP-REGULATION; GPR30; MIGRATION; PROLIFERATION	Background: MicroRNA-21 (miR-21) is an oncomiR in human hepatocellular carcinoma and is highly expressed in liver, but its regulation is uncharacterized. Results: Dehydroepiandrosterone (DHEA) rapidly increases miR-21 transcription in HepG2 cells by activating G-protein-coupled estrogen receptor (GPER). Conclusion: miR-21 transcription is regulated by DHEA through GPER. Significance: GPER may be among the activators of miR-21 expression in human hepatocellular carcinoma. Little is known about the regulation of the oncomiR miR-21 in liver. Dehydroepiandrosterone (DHEA) regulates gene expression as a ligand for a G-protein-coupled receptor and as a precursor for steroids that activate nuclear receptor signaling. We report that 10 nm DHEA increases primary miR-21 (pri-miR-21) transcription and mature miR-21 expression in HepG2 cells in a biphasic manner with an initial peak at 1 h followed by a second, sustained response from 3-12 h. DHEA also increased miR-21 in primary human hepatocytes and Hep3B cells. siRNA, antibody, and inhibitor studies suggest that the rapid DHEA-mediated increase in miR-21 involves a G-protein-coupled estrogen receptor (GPER/GPR30), estrogen receptor -36 (ER36), epidermal growth factor receptor-dependent, pertussis toxin-sensitive pathway requiring activation of c-Src, ERK1/2, and PI3K. GPER antagonist G-15 attenuated DHEA- and BSA-conjugated DHEA-stimulated pri-miR-21 transcription. Like DHEA, GPER agonists G-1 and fulvestrant increased pri-miR-21 in a GPER- and ER36-dependent manner. DHEA, like G-1, increased GPER and ER36 mRNA and protein levels. DHEA increased ERK1/2 and c-Src phosphorylation in a GPER-responsive manner. DHEA increased c-Jun, but not c-Fos, protein expression after 2 h. DHEA increased androgen receptor, c-Fos, and c-Jun recruitment to the miR-21 promoter. These results suggest that physiological concentrations of DHEA activate a GPER intracellular signaling cascade that increases pri-miR-21 transcription mediated at least in part by AP-1 and androgen receptor miR-21 promoter interaction.	[Teng, Yun; Radde, Brandie N.; Litchfield, Lacey M.; Ivanova, Margarita M.; Prough, Russell A.; Clark, Barbara J.; Klinge, Carolyn M.] Univ Louisville, Sch Med, Ctr Genet & Mol Med, Dept Biochem & Mol Genet, Louisville, KY 40292 USA; [Doll, Mark A.; Hein, David W.] Univ Louisville, Sch Med, Ctr Genet & Mol Med, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA	University of Louisville; University of Louisville	Klinge, CM (corresponding author), Univ Louisville, Sch Med, Ctr Genet & Mol Med, Dept Biochem & Mol Genet, Louisville, KY 40292 USA.	carolyn.klinge@louisville.edu	Regan, Clinton/E-6250-2012; Ivanova, Margarita/AAM-4510-2021; Russell A, Prough/AAH-5907-2020; Hein, David W/A-9707-2008	Ivanova, Margarita/0000-0002-6197-8606; Prough, Russell/0000-0001-8901-8490; Clark, Barbara/0000-0003-1558-1904; Hein, David/0000-0003-3261-9775	National Institutes of Health [R01 CA138410]; NIEHS, National Institutes of Health [T32 ES011564]; NATIONAL CANCER INSTITUTE [R01CA138410] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES011564] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA138410 (to C. M. K.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by NIEHS, National Institutes of Health Grant T32 ES011564.	Anagnostopoulou V, 2013, ENDOCRINOLOGY, V154, P2446, DOI 10.1210/en.2012-2249; Androsavich JR, 2012, RNA, V18, P1510, DOI 10.1261/rna.033308.112; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Borel F, 2012, J HEPATOL, V56, P1371, DOI 10.1016/j.jhep.2011.11.026; Bourdeau V, 2008, NUCLEIC ACIDS RES, V36, P76, DOI 10.1093/nar/gkm945; Cermelli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023937; Chan QKY, 2010, CELL DEATH DIFFER, V17, P1511, DOI 10.1038/cdd.2010.20; Charalampopoulos I, 2006, FASEB J, V20, P577, DOI 10.1096/fj.05-5078fje; Chaudhri RA, 2012, J BIOL CHEM, V287, P7169, DOI 10.1074/jbc.M111.292946; Chen JL, 2009, ENDOCRINOLOGY, V150, P4583, DOI 10.1210/en.2009-0455; Deng H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088034; Dennis MK, 2009, NAT CHEM BIOL, V5, P421, DOI 10.1038/nchembio.168; Dey P, 2013, J MOL ENDOCRINOL, V51, pT61, DOI 10.1530/JME-13-0150; Dinneen JL, 2004, TRAFFIC, V5, P606, DOI 10.1111/j.1398-9219.2004.00204.x; Dong B, 2011, BBA-GEN SUBJECTS, V1810, P427, DOI 10.1016/j.bbagen.2010.11.007; Dorak M. Tevfik, 2012, Frontiers in Genetics, V3, P268, DOI 10.3389/fgene.2012.00268; Dowman JK, 2013, ENDOCRINOLOGY, V154, P4536, DOI 10.1210/en.2013-1592; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Filardo EJ, 2012, ENDOCRINOLOGY, V153, P2953, DOI 10.1210/en.2012-1061; Fox EM, 2008, MOL ENDOCRINOL, V22, P1781, DOI 10.1210/me.2007-0419; Francis H, 2014, J BIOL CHEM, V289, P27526, DOI 10.1074/jbc.M114.602383; Fujita S, 2008, J MOL BIOL, V378, P492, DOI 10.1016/j.jmb.2008.03.015; Girgert R, 2012, BREAST CANCER RES TR, V134, P199, DOI 10.1007/s10549-012-1968-x; Ho HY, 2008, INT J ONCOL, V33, P969, DOI 10.3892/ijo_00000084; Huang YH, 2013, CANCER RES, V73, P2505, DOI 10.1158/0008-5472.CAN-12-2218; Ikeda Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040465; Jiang RQ, 2011, CLIN CANCER RES, V17, P5593, DOI 10.1158/1078-0432.CCR-10-1734; Jin SH, 2008, ARCH DERMATOL RES, V300, P451, DOI 10.1007/s00403-008-0864-z; Joel PB, 1998, J BIOL CHEM, V273, P13317, DOI 10.1074/jbc.273.21.13317; Kang LG, 2010, MOL ENDOCRINOL, V24, P709, DOI 10.1210/me.2009-0317; Labrie F, 1997, J CLIN ENDOCR METAB, V82, P2396, DOI 10.1210/jc.82.8.2396; Li Z, 2012, CELL, V148, P72, DOI 10.1016/j.cell.2011.11.026; Lin F, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-58; Liu DM, 2004, STEROIDS, V69, P279, DOI 10.1016/j.steroids.2004.02.004; Lobenhofer EK, 2000, CELL GROWTH DIFFER, V11, P99; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Madeo A, 2010, CANCER RES, V70, P6036, DOI 10.1158/0008-5472.CAN-10-0408; Mattingly KA, 2008, MOL ENDOCRINOL, V22, P609, DOI 10.1210/me.2007-0029; Mayer D, 2004, INT J ONCOL, V25, P1021; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Miceli V, 2011, OMICS, V15, P313, DOI 10.1089/omi.2010.0108; Moriguchi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060863; Mudduluru G, 2011, BIOSCIENCE REP, V31, P185, DOI 10.1042/BSR20100065; Nie HZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061678; Niro S, 2012, STEROIDS, V77, P542, DOI 10.1016/j.steroids.2012.01.019; Notas G, 2012, STEROIDS, V77, P943, DOI 10.1016/j.steroids.2011.11.005; Pinthus JH, 2007, NEOPLASIA, V9, P68, DOI 10.1593/neo.06739; Prossnitz ER, 2014, MOL CELL ENDOCRINOL, V389, P71, DOI 10.1016/j.mce.2014.02.002; Prossnitz ER, 2011, NAT REV ENDOCRINOL, V7, P715, DOI 10.1038/nrendo.2011.122; Prossnitz ER, 2009, MOL CELL ENDOCRINOL, V308, P32, DOI 10.1016/j.mce.2009.03.026; Qu KZ, 2011, J CLIN GASTROENTEROL, V45, P355, DOI 10.1097/MCG.0b013e3181f18ac2; Rege J, 2013, J CLIN ENDOCR METAB, V98, P1182, DOI 10.1210/jc.2012-2912; Riggs KA, 2006, CANCER RES, V66, P10188, DOI 10.1158/0008-5472.CAN-05-3937; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Samaras N, 2013, REJUV RES, V16, P285, DOI 10.1089/rej.2013.1425; Santolla MF, 2012, J BIOL CHEM, V287, P43234, DOI 10.1074/jbc.M112.417303; Simoncini T, 2006, MOL ENDOCRINOL, V20, P1756, DOI 10.1210/me.2005-0259; Teng Y, 2014, MOL CELL ENDOCRINOL, V392, P23, DOI 10.1016/j.mce.2014.05.007; Terao M, 2011, J BIOL CHEM, V286, P4027, DOI 10.1074/jbc.M110.184994; Tiwary R, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3063; Traish AM, 2011, J SEX MED, V8, P2960, DOI 10.1111/j.1743-6109.2011.02523.x; Turato C, 2014, LIFE SCI, V100, P9, DOI 10.1016/j.lfs.2014.01.073; Vivar OI, 2010, J BIOL CHEM, V285, P22059, DOI 10.1074/jbc.M110.114116; Wallacides A, 2012, MOL CELL ENDOCRINOL, V350, P61, DOI 10.1016/j.mce.2011.11.021; Wang YP, 1999, HEPATOLOGY, V30, P682, DOI 10.1002/hep.510300318; Webb SJ, 2006, DRUG METAB REV, V38, P89, DOI 10.1080/03602530600569877; Wu MH, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001143; Yang WW, 2012, J BIOL CHEM, V287, P40140, DOI 10.1074/jbc.M112.348763; Zhang H, 2006, ONCOGENE, V25, P6101, DOI 10.1038/sj.onc.1209634; Zhu Q, 2012, ONCOL REP, V27, P1660, DOI 10.3892/or.2012.1682; Zou Y, 2009, FEBS LETT, V583, P1368, DOI 10.1016/j.febslet.2009.03.047	71	40	41	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15799	15811		10.1074/jbc.M115.641167	http://dx.doi.org/10.1074/jbc.M115.641167			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25969534	hybrid, Green Published			2022-12-26	WOS:000356527400040
J	Christiansen, F; Lynas, NM; Lusseau, D; Tscherter, U				Christiansen, Fredrik; Lynas, Ned M.; Lusseau, David; Tscherter, Ursula			Structure and Dynamics of Minke Whale Surfacing Patterns in the Gulf of St. Lawrence, Canada	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; ENERGY-EXPENDITURE; FORAGING BEHAVIOR; DIVING BEHAVIOR; BALAENOPTERA-ACUTOROSTRATA; OPTIMAL ALLOCATION; DIVE DURATION; WEDDELL SEALS; BODY-SIZE; TIME	Animal behavioral patterns can help us understand physiological and ecological constraints on animals and its influence on fitness. The surfacing patterns of aquatic air-breathing mammals constitute a behavioral pattern that has evolved as a trade-off between the need to replenish oxygen stores at the surface and the need to conduct other activities underwater. This study aims to better understand the surfacing pattern of a marine top predator, the minke whale (Balaenoptera acutorostrata), by investigating how their dive duration and surfacing pattern changes across their activity range. Activities were classified into resting, traveling, surface feeding and foraging at depth. For each activity, we classified dives into short and long dives and then estimated the temporal dependence between dive types. We found that minke whales modified their surfacing pattern in an activity-specific manner, both by changing the expression of their dives (i.e. density distribution) and the temporal dependence (transition probability) between dive types. As the depth of the prey layer increased between activities, the surfacing pattern of foraging whales became increasingly structured, going from a pattern dominated by long dives, when feeding at the surface, to a pattern where isolated long dives were followed by an increasing number of breaths (i.e. short dives), when the whale was foraging at depth. A similar shift in surfacing pattern occurred when prey handling time (inferred from surface corralling maneuvers) increased for surface feeding whales. The surfacing pattern also differed between feeding and non-feeding whales. Resting whales did not structure their surfacing pattern, while traveling whales did, possibly as a way to minimize cost of transport. Our results also suggest that minke whales might balance their oxygen level over multiple, rather than single, dive cycles.	[Christiansen, Fredrik] Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Warrnambool, Vic, Australia; [Christiansen, Fredrik; Lynas, Ned M.; Tscherter, Ursula] Fdn Marine Environm Res ORES, Basel, Switzerland; [Lynas, Ned M.; Tscherter, Ursula] ORES, Les Bergeronnes, PQ, Canada; [Lusseau, David] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland; [Lusseau, David] Univ Aberdeen, Inst Marine Alliance Sci & Technol, Aberdeen, Scotland	Deakin University; University of Aberdeen; University of Aberdeen	Christiansen, F (corresponding author), Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Warrnambool, Vic, Australia.	f.christiansen@live.se	Christiansen, Fredrik/O-3655-2017; Lusseau, David/AAV-9295-2021	Christiansen, Fredrik/0000-0001-9090-8458; Lusseau, David/0000-0003-1245-3747	Foundation for Marine Environment Research (ORES), Switzerland; Ocean Care, Switzerland	Foundation for Marine Environment Research (ORES), Switzerland; Ocean Care, Switzerland	This work was supported by the Foundation for Marine Environment Research (ORES), Switzerland and Ocean Care, Switzerland.	Acevedo-Gutierrez A, 2002, J EXP BIOL, V205, P1747; Anthony LL, 2000, BIOL CONSERV, V95, P303, DOI 10.1016/S0006-3207(00)00037-9; BLAKE RW, 1983, J MAR BIOL ASSOC UK, V63, P61, DOI 10.1017/S0025315400049808; Buckland S. T., 1993, Distance sampling: estimating abundance of biological populations.; Carbone C, 1996, ANIM BEHAV, V51, P1247, DOI 10.1006/anbe.1996.0129; CARBONE C, 1994, ANIM BEHAV, V48, P457, DOI 10.1006/anbe.1994.1259; Caswell, 2000, MATRIX POPULATION MO; Christiansen F., 2014, WHALE WATCHING SUSTA, P177, DOI [10.1017/CBO9781139018166.016, DOI 10.1017/CBO9781139018166.016]; Christiansen F, 2011, SC63RMP6 INT WHAL CO; Christiansen F, 2014, J EXP MAR BIOL ECOL, V459, P96, DOI 10.1016/j.jembe.2014.05.014; Christiansen F, 2013, BEHAV ECOL, V24, P1415, DOI 10.1093/beheco/art086; Christiansen F, 2013, MAR ECOL PROG SER, V478, P239, DOI 10.3354/meps10163; Christiansen Fredrik, 2010, Endangered Species Research, V11, P91, DOI 10.3354/esr00265; Costa DP, 2004, INT CONGR SER, V1275, P359, DOI 10.1016/j.ics.2004.08.058; Croll DA, 2001, COMP BIOCHEM PHYS A, V129, P797, DOI 10.1016/S1095-6433(01)00348-8; de Vos A, 2013, J EXP MAR BIOL ECOL, V449, P149, DOI 10.1016/j.jembe.2013.09.010; DORSEY EM, 1983, CAN J ZOOL, V61, P174, DOI 10.1139/z83-022; EMLEN JM, 1966, AM NAT, V100, P611, DOI 10.1086/282455; Fahlman A, 2008, J EXP BIOL, V211, P3573, DOI 10.1242/jeb.023655; FOLKOW LP, 1992, ACTA PHYSIOL SCAND, V146, P141, DOI 10.1111/j.1748-1716.1992.tb09402.x; Fortin D, 2005, ECOLOGY, V86, P1320, DOI 10.1890/04-0953; Friedlaender AS, 2014, J EXP BIOL, V217, P2851, DOI 10.1242/jeb.106682; Goldbogen JA, 2011, J EXP BIOL, V214, P131, DOI 10.1242/jeb.048157; Goldbogen JA, 2006, J EXP BIOL, V209, P1231, DOI 10.1242/jeb.02135; Goldbogen JA, 2008, J EXP BIOL, V211, P3712, DOI 10.1242/jeb.023366; Goldbogen JA, 2007, MAR ECOL PROG SER, V349, P289, DOI 10.3354/meps07066; Goldbogen JA, 2012, FUNCT ECOL, V26, P216, DOI 10.1111/j.1365-2435.2011.01905.x; Hanuise N, 2013, J ZOOL, V290, P181, DOI 10.1111/jzo.12026; Heithaus MR, 2003, J THEOR BIOL, V223, P79, DOI 10.1016/S0022-5193(03)00073-0; HIBY AR, 1989, REP INT WHALING COMM, V11, P47; HINDELL MA, 1992, CAN J ZOOL, V70, P370, DOI 10.1139/z92-055; HOELZEL AR, 1989, ANIM BEHAV, V38, P786, DOI 10.1016/S0003-3472(89)80111-3; Horning M, 2012, FRONT PHYSIOL, V3, P1, DOI [10.3389/fphys.2012.00001, DOI 10.3389/FPHYS.2012.00001]; Horwood J., 1990, BIOL EXPLOITATION MI; HOUSTON AI, 1992, BEHAV ECOL, V3, P255, DOI 10.1093/beheco/3.3.255; Irvine LG, 2000, J ZOOL, V251, P463, DOI 10.1017/S0952836900008062; Kooyman G. L., 1989, DIVERSE DIVERS; Kooyman GL, 1998, ANNU REV PHYSIOL, V60, P19, DOI 10.1146/annurev.physiol.60.1.19; KOOYMAN GL, 1980, J COMP PHYSIOL, V138, P335, DOI 10.1007/BF00691568; KOOYMAN GL, 1971, RESP PHYSIOL, V12, P271, DOI 10.1016/0034-5687(71)90069-7; KRAMER DL, 1988, CAN J ZOOL, V66, P89, DOI 10.1139/z88-012; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lusseau D, 2003, CONSERV BIOL, V17, P1785, DOI 10.1111/j.1523-1739.2003.00054.x; LYNAS E M, 1988, Aquatic Mammals, V14, P21; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; McFarland D, 1999, ANIMAL BEHAV PSYCHOB; Nowacek DP, 2001, P ROY SOC B-BIOL SCI, V268, P1811, DOI 10.1098/rspb.2001.1730; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Patterson TA, 2009, J ANIM ECOL, V78, P1113, DOI 10.1111/j.1365-2656.2009.01583.x; R Core Team, 2013, R LANG ENV STAT COMP, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; Scholander PF, 1942, J BIOL CHEM, V142, P431; Schreer JF, 1997, CAN J ZOOL, V75, P339, DOI 10.1139/z97-044; SIBLY R, 1976, AM NAT, V110, P601, DOI 10.1086/283093; Sumich J. L., 2001, Aquatic Mammals, V27, P279; Sutherland WJ, 2013, J ECOL, V101, P58, DOI 10.1111/1365-2745.12025; Sutherland WJ, 1998, ANIM BEHAV, V56, P801, DOI 10.1006/anbe.1998.0896; THOMPSON D, 1993, J EXP BIOL, V174, P139; Thompson D, 2001, ANIM BEHAV, V61, P287, DOI 10.1006/anbe.2000.1539; Watwood SL, 2006, J ANIM ECOL, V75, P814, DOI 10.1111/j.1365-2656.2006.01101.x; Williams R, 2009, MAR MAMMAL SCI, V25, P327, DOI 10.1111/j.1748-7692.2008.00255.x; Williams TM, 1999, PHILOS T R SOC B, V354, P193, DOI 10.1098/rstb.1999.0371; Williams TM, 2000, SCIENCE, V288, P133, DOI 10.1126/science.288.5463.133; Wilson RP, 2003, MAR ECOL PROG SER, V249, P305, DOI 10.3354/meps249305; Yazdi P, 1999, MAR BIOL, V134, P601, DOI 10.1007/s002270050575; Zucchini W, 2008, BIOMETRICS, V64, P807, DOI 10.1111/j.1541-0420.2007.00939.x; Zuur Alain F., 2009, P1	66	3	3	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0126396	10.1371/journal.pone.0126396	http://dx.doi.org/10.1371/journal.pone.0126396			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970425	Green Published, Green Submitted, gold			2022-12-26	WOS:000354544200112
J	Kawahara, T; Yamashita, M; Ikegami, K; Nakamura, T; Yanagita, M; Yamada, S; Kitamura, M; Murakami, S				Kawahara, Takanobu; Yamashita, Motozo; Ikegami, Kuniko; Nakamura, Tomomi; Yanagita, Manabu; Yamada, Satoru; Kitamura, Masahiro; Murakami, Shinya			TGF-Beta Negatively Regulates the BMP2-Dependent Early Commitment of Periodontal Ligament Cells into Hard Tissue Forming Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; I RECEPTOR KINASE; STEM-CELLS; INHIBITOR; EXPRESSION; DIFFERENTIATION; FIBROBLASTS; POTENT; SMAD7; ALK5	Transforming growth factor beta (TGF-beta) is a multi-functional growth factor expressed in many tissues and organs. Genetic animal models have revealed the critical functions of TGF-beta in craniofacial development, including the teeth and periodontal tissue. However, the physiological function of TGF-beta in the periodontal ligament (PDL) has not been fully elucidated. In this study, we examined the roles of TGF-beta in the cytodifferentiation of PDL cells using a TGF-beta receptor kinase inhibitor, SB431542. Mouse PDL cell clones (MPDL22) were cultured in calcification-inducing medium with or without SB431542 in the presence or absence of various growth factors, such as bone morphogenetic protein (BMP)-2, TGF-beta and fibroblast growth factor (FGF)-2. SB431542 dramatically enhanced the BMP-2-dependent calcification of MPDL22 cells and accelerated the expression of ossification genes alkaline phosphatase (ALPase) and Runt-related transcription factor (Runx) 2 during early osteoblastic differentiation. SB431542 did not promote MPDL22 calcification without BMP-2 stimulation. The cell growth rate and collagen synthesis during the late stage of MPDL22 culture were retarded by SB431542. Quantitative reverse transcription polymerase chain reaction analysis revealed that the expressions of Smurf1 and Smad6, which are negative feedback components in the TGF-beta/BMP signaling pathway, were downregulated in MPDL22 cells with SB431542 treatment. These results suggest that an endogenous signal from TGF-beta negatively regulates the early commitment and cytodifferentiation of PDL cells into hard tissue-forming cells. A synthetic drug that regulates endogenous TGF-beta signals may be efficacious for developing periodontal regenerative therapies.	[Kawahara, Takanobu; Yamashita, Motozo; Ikegami, Kuniko; Nakamura, Tomomi; Yanagita, Manabu; Yamada, Satoru; Kitamura, Masahiro; Murakami, Shinya] Osaka Univ, Grad Sch Dent, Dept Periodontol, Suita, Osaka 5650871, Japan	Osaka University	Yamashita, M (corresponding author), Osaka Univ, Grad Sch Dent, Dept Periodontol, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	yamashim@dent.osaka-u.ac.jp		Murakami, Shinya/0000-0002-5230-452X	Japan Society for the Promotion of Science [21689053, 23659976, 24390466]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by KAKENHI Grants-in-Aid for Scientific Research 21689053, 23659976 and 24390466 to Motozo Yamashita from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atilla G, 2006, CLIN BIOCHEM, V39, P929, DOI 10.1016/j.clinbiochem.2006.05.013; BESSEY OA, 1946, J BIOL CHEM, V164, P321; DAHL LK, 1952, P SOC EXP BIOL MED, V80, P474, DOI 10.3181/00379727-80-19661; DASCH JR, 1989, J IMMUNOL, V142, P1536; de Gorter DJJ, 2011, J BONE MINER RES, V26, P1178, DOI 10.1002/jbmr.313; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Derynck Rik, 2008, P29; Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200; Finnson KW, 2008, J BONE MINER RES, V23, P896, DOI 10.1359/JBMR.080209; Gellibert FO, 2004, J MED CHEM, V47, P4494, DOI 10.1021/jm0400247; Giannelli G, 2014, CANCER RES, V74, P1890, DOI 10.1158/0008-5472.CAN-14-0243; Goto K, 2007, J BIOL CHEM, V282, P20603, DOI 10.1074/jbc.M702100200; Gueorguieva I, 2014, BRIT J CLIN PHARMACO, V77, P796, DOI 10.1111/bcp.12256; Horiki M, 2004, J CELL BIOL, V165, P433, DOI 10.1083/jcb.200311015; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Kamiya Y, 2010, J BIOL CHEM, V285, P30804, DOI 10.1074/jbc.M110.166140; Kao RT, 2009, PERIODONTOL 2000, V50, P127, DOI 10.1111/j.1600-0757.2008.00287.x; Kitamura M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002611; Liu YL, 2011, STEM CELLS, V29, P1804, DOI 10.1002/stem.728; Maeda S, 2004, EMBO J, V23, P552, DOI 10.1038/sj.emboj.7600067; Miyazono K, 2000, ADV IMMUNOL, V75, P115, DOI 10.1016/S0065-2776(00)75003-6; Mohammad KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005275; Mori Y, 2004, ARTHRITIS RHEUM-US, V50, P4008, DOI 10.1002/art.20658; Nevins M, 2005, J PERIODONTOL, V76, P2205, DOI 10.1902/jop.2005.76.12.2205; Oka M, 2008, BLOOD, V111, P4571, DOI 10.1182/blood-2007-10-120337; Remst DFG, 2014, CELL TISSUE RES, V355, P163, DOI 10.1007/s00441-013-1740-5; Sawyer JS, 2003, J MED CHEM, V46, P3953, DOI 10.1021/jm0205705; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SOMERMAN MJ, 1988, J DENT RES, V67, P66, DOI 10.1177/00220345880670011301; Tomokiyo A, 2012, J CELL PHYSIOL, V227, P2040, DOI 10.1002/jcp.22933; Watabe T, 2003, J CELL BIOL, V163, P1303, DOI 10.1083/jcb.200305147; Xu X, 2003, INT J DEV BIOL, V47, P31; Yamada S, 2007, J BIOL CHEM, V282, P23070, DOI 10.1074/jbc.M611181200; Ye P, 2003, PATHOLOGY, V35, P384, DOI 10.1080/00313020310001602585; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P974, DOI 10.1073/pnas.98.3.974; Zhu QW, 2013, J CELL BIOL, V202, P937, DOI 10.1083/jcb.201208113	39	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0125590	10.1371/journal.pone.0125590	http://dx.doi.org/10.1371/journal.pone.0125590			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970290	Green Submitted, Green Published, gold			2022-12-26	WOS:000354544200080
J	Nguyen, DT; Louwen, R; Elberse, K; van Amerongen, G; Yuksel, S; Luijendijk, A; Osterhaus, ADME; Duprex, WP; de Swart, RL				Nguyen, D. Tien; Louwen, Rogier; Elberse, Karin; van Amerongen, Geert; Yuksel, Selma; Luijendijk, Ad; Osterhaus, Albert D. M. E.; Duprex, W. Paul; de Swart, Rik L.			Streptococcus pneumoniae Enhances Human Respiratory Syncytial Virus Infection In Vitro and In Vivo	PLOS ONE			English	Article							PULMONARY BACTERIAL COINFECTION; HUMAN EPITHELIAL-CELLS; PNEUMOCOCCAL DISEASE; INFLUENZA; CHILDREN; COLONIZATION; ASSOCIATION; ADHERENCE; CARRIAGE	Human respiratory syncytial virus (HRSV) and Streptococcus pneumoniae are important causative agents of respiratory tract infections. Both pathogens are associated with seasonal disease outbreaks in the pediatric population, and can often be detected simultaneously in infants hospitalized with bronchiolitis or pneumonia. It has been described that respiratory virus infections may predispose for bacterial superinfections, resulting in severe disease. However, studies on the influence of bacterial colonization of the upper respiratory tract on the pathogenesis of subsequent respiratory virus infections are scarce. Here, we have investigated whether pneumococcal colonization enhances subsequent HRSV infection. We used a newly generated recombinant subgroup B HRSV strain that expresses enhanced green fluorescent protein and pneumococcal isolates obtained from healthy children in disease-relevant in vitro and in vivo model systems. Three pneumococcal strains specifically enhanced in vitro HRSV infection of primary well-differentiated normal human bronchial epithelial cells grown at air-liquid interface, whereas two other strains did not. Since previous studies reported that bacterial neuraminidase enhanced HRSV infection in vitro, we measured pneumococcal neuraminidase activity in these cultures but found no correlation with the observed infection enhancement in our model. Subsequently, a selection of pneumococcal strains was used to induce nasal colonization of cotton rats, the best available small animal model for HRSV. Intranasal HRSV infection three days later resulted in strain-specific enhancement of HRSV replication in vivo. One S. pneumoniae strain enhanced HRSV both in vitro and in vivo, and was also associated with enhanced syncytium formation in vivo. However, neither pneumococci nor HRSV were found to spread from the upper to the lower respiratory tract, and neither pathogen was transmitted to naive cage mates by direct contact. These results demonstrate that pneumococcal colonization can enhance subsequent HRSV infection, and provide tools for additional mechanistic and intervention studies.	[Nguyen, D. Tien; van Amerongen, Geert; Yuksel, Selma; Osterhaus, Albert D. M. E.; de Swart, Rik L.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [Louwen, Rogier; Luijendijk, Ad] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands; [Elberse, Karin] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; [Duprex, W. Paul] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Netherlands National Institute for Public Health & the Environment; Boston University	de Swart, RL (corresponding author), Erasmus MC, Dept Virosci, Rotterdam, Netherlands.	r.deswart@erasmusmc.nl	de Swart, Rik L./E-6508-2011	de Swart, Rik L./0000-0003-3599-8969; Louwen, Dr. Rogier/0000-0003-2537-4941	VIRGO consortium, an innovative cluster; Dutch Government [BSIK03012]; ZonMw [91208012]	VIRGO consortium, an innovative cluster; Dutch Government; ZonMw(Netherlands Organization for Health Research and Development)	This work was supported by the VIRGO consortium, an innovative cluster approved by the Netherlands Genomics Initiative and partially funded by the Dutch Government (grant #BSIK03012) and ZonMw (grant #91208012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. A.D.M.E. Osterhaus co-founded and is a consultant of ViroClinics Biosciences B.V., a contract research organisation established in collaboration with Erasmus University. ViroClinics Biosciences B.V. had no role in funding, study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the author contributions' sections. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Avadhanula V, 2007, J MED MICROBIOL, V56, P1133, DOI 10.1099/jmm.0.47086-0; Barretto N, 2003, VIROLOGY, V313, P33, DOI 10.1016/S0042-6822(03)00288-5; BEEM M, 1960, NEW ENGL J MED, V263, P523, DOI 10.1056/NEJM196009152631101; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Bosch AATM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003057; Brundage JF, 2008, EMERG INFECT DIS, V14, P1193, DOI 10.3201/eid1408.071313; Chu HY, 2013, CURR TOP MICROBIOL, V372, P235, DOI 10.1007/978-3-642-38919-1_12; Cohen M, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-321; Collins P.L., 2013, FIELDS VIROLOGY, P1086; CONVERSE GM, 1977, J CLIN MICROBIOL, V5, P293; de Swart RL, 2007, PLOS PATHOG, V3, P1771, DOI 10.1371/journal.ppat.0030178; Diavatopoulos DA, 2010, FASEB J, V24, P1789, DOI 10.1096/fj.09-146779; Duttweiler L, 2004, ARCH DIS CHILD, V89, P1155, DOI 10.1136/adc.2004.049551; Elberse K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025018; Elberse KEM, 2012, VACCINE, V30, P7644, DOI 10.1016/j.vaccine.2012.04.021; Feikin DR, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001517; Gabryszewski SJ, 2011, J IMMUNOL, V186, P1151, DOI 10.4049/jimmunol.1001751; Graham BS, 2011, IMMUNOL REV, V239, P149, DOI 10.1111/j.1600-065X.2010.00972.x; Hall CB, 2013, CURR TOP MICROBIOL, V372, P39, DOI 10.1007/978-3-642-38919-1_2; Hament JM, 2005, PEDIATR RES, V58, P1198, DOI 10.1203/01.pdr.0000188699.55279.1b; Hament JM, 2004, PEDIATR RES, V55, P972, DOI 10.1203/01.PDR.0000127431.11750.D9; Hoti F, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-102; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kuss SK, 2011, SCIENCE, V334, P249, DOI 10.1126/science.1211057; Lemon K, 2015, J VIROL, V89, P2849, DOI 10.1128/JVI.03587-14; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Madhi SA, 2004, NAT MED, V10, P811, DOI 10.1038/nm1077; Martner A, 2009, INFECT IMMUN, V77, P3826, DOI 10.1128/IAI.00290-09; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; Miller MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031359; Nguyen DT, 2013, J VIROL METHODS, V193, P159, DOI 10.1016/j.jviromet.2013.06.016; Nguyen DT, 2012, VACCINE, V30, P5073, DOI 10.1016/j.vaccine.2012.05.079; Nguyen DT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001049; Palacios G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008540; Paunio M, 1998, AM J EPIDEMIOL, V148, P1103, DOI 10.1093/oxfordjournals.aje.a009588; Pittet LF, 2012, CLIN MICROBIOL INFEC, V18, P25, DOI 10.1111/j.1469-0691.2012.03938.x; Poolman JT, 2013, EXPERT REV VACCINES, V12, P1379, DOI 10.1586/14760584.2013.852475; Rietveld E, 2010, ARCH DIS CHILD, V95, P493, DOI 10.1136/adc.2008.155556; Sajjan US, 2006, FASEB J, V20, P2121, DOI 10.1096/fj.06-5806fje; SCANLON KL, 1989, ENZYME, V41, P143, DOI 10.1159/000469069; Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]; Simoes EAF, 1999, LANCET, V354, P847, DOI 10.1016/S0140-6736(99)80040-3; Talbot TR, 2005, AM J MED, V118, P285, DOI 10.1016/j.amjmed.2004.09.016; Thorburn K, 2006, THORAX, V61, P611, DOI 10.1136/thx.2005.048397; Thorburn K, 2007, INTENS CARE MED, V33, P565, DOI 10.1007/s00134-006-0486-x; TIMMONS OD, 1987, PEDIATR INFECT DIS J, V6, P1134; Tomosada Y, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-40; Verkaik NJ, 2011, CLIN MICROBIOL INFEC, V17, P1840, DOI 10.1111/j.1469-0691.2011.03480.x; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; WANG XJ, 2011, J INEQUAL APPL, DOI DOI 10.1155/2011/; Weinberger DM, 2014, CLIN INFECT DIS, V58, P188, DOI 10.1093/cid/cit721; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Widjojoatmodjo MN, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-114	54	31	31	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0127098	10.1371/journal.pone.0127098	http://dx.doi.org/10.1371/journal.pone.0127098			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970287	Green Published, gold, Green Submitted			2022-12-26	WOS:000354544200150
J	Toral, GM; Baouab, RE; Martinez-Haro, M; Sanchez-Barbudo, IS; Broggi, J; Martinez-de La Puente, J; Viana, D; Mateo, R; Figuerola, J				Toral, Gregorio M.; Baouab, Riad E.; Martinez-Haro, Monica; Sanchez-Barbudo, Ines S.; Broggi, Juli; Martinez-de la Puente, Josue; Viana, Duarte; Mateo, Rafael; Figuerola, Jordi			Effects of Agricultural Management Policies on the Exposure of Black-Winged Stilts (Himantopus himantopus) Chicks to Cholinesterase-Inhibiting Pesticides in Rice Fields	PLOS ONE			English	Article							MONITORING EXPOSURE; BIRDS; WATERBIRDS; WETLANDS; CAMARGUE; FARMS; HAWKS	Levels of exposure to pesticides in rice fields can be significant depending on the environmental policies practiced. The aim of European Union integrated management policy is to reduce pesticide use and impact on environment. Rice fields provide an alternative breeding habitat for many waterbirds that are exposed to the pesticides used and therefore can be valuable indicators of their risk for wildlife. To evaluate integrated management success we examined exposure of Black-winged Stilts (Himantopus himantopus) to cholinesterase-inhibiting pesticides in rice fields under different types of management by measuring plasma cholinesterase activity. Cholinesterase activity was lower in birds sampled in (a) 2008 after a period of intense pesticide application, than in (b) 2005-2007 and 2011 in rice fields subject to integrated management in Donana (SW Spain) and (c) in control natural wetlands in Spain and Morocco. During 2009 and 2010, cholinesterase activity was lower in rice fields in Donana than in rice fields in Larache and Sidi Allal Tazi (NW Morocco). Our results suggest that integrated management successfully reduced the exposure of Black-winged Stilts to pesticides in most of the years. Care should be taken to implement mosquito and pest crop controls on time and with environmentally friendly products in order to reduce its impact on wildlife.	[Toral, Gregorio M.; Broggi, Juli; Martinez-de la Puente, Josue; Viana, Duarte; Figuerola, Jordi] CSIC, Dept Wetland Ecol, Estn Biol Donana, E-41080 Seville, Spain; [Baouab, Riad E.] Univ Mohammed 5, Rabat, Morocco; [Martinez-Haro, Monica; Sanchez-Barbudo, Ines S.; Mateo, Rafael] CSIC, IREC, Dept Sanidad Anim, Ciudad Real, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Mohammed V University in Rabat; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC)	Figuerola, J (corresponding author), CSIC, Dept Wetland Ecol, Estn Biol Donana, E-41080 Seville, Spain.	jordi@ebd.csic.es	la Puente, Josué Martínez-de/E-8597-2011; Broggi, Juli/AAB-1796-2020; Martinez-Haro, Mónica/B-8363-2015; Figuerola, Jordi/B-7917-2008; Mateo, Rafael/AAU-1480-2020; Viana, Duarte/AAA-1482-2020; Mateo, Rafael/A-3117-2011	la Puente, Josué Martínez-de/0000-0001-8055-4115; Martinez-Haro, Mónica/0000-0002-4326-5805; Figuerola, Jordi/0000-0002-4664-9011; Mateo, Rafael/0000-0003-1307-9152; Viana, Duarte/0000-0002-7864-0871; Mateo, Rafael/0000-0003-1307-9152; Broggi, Juli/0000-0002-1706-4014	Junta de Andalucia; I3P-CSIC grant; Marie Curie Intra-European Fellowship for Career Development within the 7th Framework Programme (FP7) of the European Commission [PIEF-GA-2011-299747]; INRA administration; CNRST-CSIC collaboration program [P2007MA01, P2009MA01]	Junta de Andalucia(Junta de Andalucia); I3P-CSIC grant; Marie Curie Intra-European Fellowship for Career Development within the 7th Framework Programme (FP7) of the European Commission; INRA administration; CNRST-CSIC collaboration program	The Junta de Andalucia funded this study through the project "Las aves acuaticas de Donana y el cultivo del arroz: la interaccion entre la agricultura y la conservacion de las zonas humedas". This study was possible thanks to the INRA administration and CNRST-CSIC collaboration program (P2007MA01 and P2009MA01). GMT was funded by an I3P-CSIC grant for the formation of Researchers. MMH is supported by a Marie Curie Intra-European Fellowship for Career Development (PIEF-GA-2011-299747) within the 7th Framework Programme (FP7 2007-2013) of the European Commission.	Aparicio S, 2008, ANO 2007; Baouab Riad Essolh, 2008, Bulletin de l'Institut Scientifique Section Sciences de la Vie - Rabat, V30, P37; Beecher NA, 2002, CONSERV BIOL, V16, P1620, DOI 10.1046/j.1523-1739.2002.01228.x; Berny PJ, 1999, J LIQ CHROMATOGR R T, V22, P1547, DOI 10.1081/JLC-100101750; Czech HA, 2002, WATERBIRDS, V25, P56; Dempster J. P., 1987, Rational pesticide use: proceedings of the ninth Long Ashton Symposium., P17; Elphick CS, 2003, AGR ECOSYST ENVIRON, V94, P17, DOI 10.1016/S0167-8809(02)00022-1; Fasola M, 1996, COLON WATERBIRD, V19, P122, DOI 10.2307/1521955; Ferrero A., 2004, INT C SUST RIC SYST; Figuerola J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000539; FLICKINGER EL, 1986, WILDLIFE SOC B, V14, P59; Freemark KE, 2001, BIOL CONSERV, V101, P337, DOI 10.1016/S0006-3207(01)00079-9; Gard Nicholas W., 1995, P294; Genghini M, 2006, BIODIVERS CONSERV, V15, P3077, DOI 10.1007/s10531-005-5400-2; Glaser LC., 1999, FIELD MANUAL WILDLIF, P287; Goldstein MI, 1999, ECOTOXICOLOGY, V8, P215, DOI 10.1023/A:1026448415467; Grue C.E., 1991, Chemicals in Agriculture, V2, P151; Grue CE, 1997, AM ZOOL, V37, P369; HILL E F, 1982, Environmental Toxicology and Chemistry, V1, P27, DOI 10.1897/1552-8618(1982)1[27:APOBFM]2.0.CO;2; HOOPER MJ, 1989, B ENVIRON CONTAM TOX, V42, P651, DOI 10.1007/BF01700383; Kogan M, 1998, ANNU REV ENTOMOL, V43, P243, DOI 10.1146/annurev.ento.43.1.243; Lawler SP, 2001, ISR J ZOOL, V47, P513, DOI 10.1560/X7K3-9JG8-MH2J-XGX1; Lopez-Antia A, 2013, ECOTOXICOLOGY, V22, P125, DOI 10.1007/s10646-012-1009-x; Ludke J L, 1975, Arch Environ Contam Toxicol, V3, P1; Manosa S, 2001, ENVIRON MONIT ASSESS, V71, P187, DOI 10.1023/A:1017545932219; Martinez-Haro M, 2007, ENVIRON TOXICOL PHAR, V23, P347, DOI 10.1016/j.etap.2006.11.011; Matsumura F., 1975, TOXICOLOGY INSECTICI; Maul JD, 2005, ENVIRON TOXICOL CHEM, V24, P1721, DOI 10.1897/04-385R.1; McInnes PF, 1996, ENVIRON TOXICOL CHEM, V15, P544, DOI [10.1897/1551-5028(1996)015&lt;0544:MEONST&gt;2.3.CO;2, 10.1002/etc.5620150420]; Parsons KC, 2010, WATERBIRDS, V33, P193, DOI 10.1675/063.033.s115; Parsons KC, 2000, ENVIRON TOXICOL CHEM, V19, P1317, DOI 10.1002/etc.5620190514; Pimentel D, 1991, CRC HDB PEST MANAGEM, P741; Rendon MA, 2008, BIOL CONSERV, V141, P1371, DOI 10.1016/j.biocon.2008.03.006; SAS Institute Inc, 2010, USING JMP 9; Smith GJ, 1987, RESOURCE PUBLICATION, V170; Strum KM, 2008, ORNITOL NEOTROP, V19, P641; Strum KM, 2010, CONDOR, V112, P15, DOI 10.1525/cond.2010.090026; Sutherland WJ, 2006, J APPL ECOL, V43, P617, DOI 10.1111/j.1365-2664.2006.01188.x; Toral GM, 2010, BIODIVERS CONSERV, V19, P3459, DOI 10.1007/s10531-010-9907-9; Tourenq C, 2004, AUK, V121, P192, DOI 10.1642/0004-8038(2004)121[0192:SRBTHC]2.0.CO;2; Tourenq C, 2003, AGR ECOSYST ENVIRON, V95, P543, DOI 10.1016/S0167-8809(02)00203-7; Woese K, 1997, J SCI FOOD AGR, V74, P281, DOI [10.1002/(SICI)1097-0010(199707)74:3&lt;281::AID-JSFA794&gt;3.0.CO;2-Z, 10.1002/(SICI)1097-0010(199707)74:3<281::AID-JSFA794>3.3.CO;2-Q]	42	2	2	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0126738	10.1371/journal.pone.0126738	http://dx.doi.org/10.1371/journal.pone.0126738			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970170	Green Published, gold, Green Submitted			2022-12-26	WOS:000354544200129
J	Gorfine, M; Goldstein, B; Fishman, A; Heller, R; Heller, Y; Lamm, AT				Gorfine, Malka; Goldstein, Boaz; Fishman, Alla; Heller, Ruth; Heller, Yair; Lamm, Ayelet T.			Function of Cancer Associated Genes Revealed by Modern Univariate and Multivariate Association Tests	PLOS ONE			English	Article							COPY-NUMBER VARIATION; COMPUTATIONAL METHODS; SPHINGOSINE KINASE-1; RESISTANCE; CATENIN; PROTEIN; CELLS	Copy number variation (CNV) plays a role in pathogenesis of many human diseases, especially cancer. Several whole genome CNV association studies have been performed for the purpose of identifying cancer associated CNVs. Here we undertook a novel approach to whole genome CNV analysis, with the goal being identification of associations between CNV of different genes (CNV-CNV) across 60 human cancer cell lines. We hypothesize that these associations point to the roles of the associated genes in cancer, and can be indicators of their position in gene networks of cancer-driving processes. Recent studies show that gene associations are often non-linear and non-monotone. In order to obtain a more complete picture of all CNV associations, we performed omnibus univariate analysis by utilizing dCov, MIC, and HHG association tests, which are capable of detecting any type of association, including non-monotone relationships. For comparison we used Spearman and Pearson association tests, which detect only linear or monotone relationships. Application of dCov, MIC and HHG tests resulted in identification of twice as many associations compared to those found by Spearman and Pearson alone. Interestingly, most of the new associations were detected by the HHG test. Next, we utilized dCov's and HHG's ability to perform multivariate analysis. We tested for association between genes of unknown function and known cancer-related pathways. Our results indicate that multivariate analysis is much more effective than univariate analysis for the purpose of ascribing biological roles to genes of unknown function. We conclude that a combination of multivariate and univariate omnibus association tests can reveal significant information about gene networks of disease-driving processes. These methods can be applied to any large gene or pathway dataset, allowing more comprehensive analysis of biological processes.	[Goldstein, Boaz; Fishman, Alla; Lamm, Ayelet T.] Technion Israel Inst Technol, Fac Biol, IL-3200003 Haifa, Israel; [Gorfine, Malka] Technion Israel Inst Technol, Fac Ind Engn & Management, IL-3200003 Haifa, Israel; [Heller, Ruth] Tel Aviv Univ, Dept Stat & Operat Res, IL-6997801 Tel Aviv, Israel	Technion Israel Institute of Technology; Technion Israel Institute of Technology; Tel Aviv University	Gorfine, M (corresponding author), Technion Israel Inst Technol, Fac Ind Engn & Management, IL-3200003 Haifa, Israel.	gorfinm@ie.technion.ac.il; ayeletla@tx.technion.ac.il	Gorfine, Malka/AAV-1242-2021; Gorfine, Malka/AAD-1468-2022	Lamm, Ayelet/0000-0002-5973-5218	National Institutes of Health [P01CA53996]; Israeli Centers of Research Excellence (I-CORE) program [1796/12]; Israel Science Foundation [644/13]; Taub Foundation; NATIONAL CANCER INSTITUTE [P01CA053996] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israeli Centers of Research Excellence (I-CORE) program; Israel Science Foundation(Israel Science Foundation); Taub Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by National Institutes of Health (grant P01CA53996 to MG), The Israeli Centers of Research Excellence (I-CORE) program, (Center No. 1796/12 to ATL), The Israel Science Foundation (grant No. 644/13 to ATL). ATL is a Taub fellow - supported by the Taub Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel HJ, 2013, CANCER GENET-NY, V206, P432, DOI 10.1016/j.cancergen.2013.11.002; Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bussey KJ, 2006, MOL CANCER THER, V5, P853, DOI 10.1158/1535-7163.MCT-05-0155; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Carter NP, 2007, NAT GENET, V39, pS16, DOI 10.1038/ng2028; EDWARDS AL, 1976, INTRO LINEAR REGRESS, P33; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Franchitto A, 2003, ONCOGENE, V22, P2110, DOI 10.1038/sj.onc.1206254; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Grabocka E, 2014, CANCER CELL, V25, P243, DOI 10.1016/j.ccr.2014.01.005; Guo XB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087446; Heller R, 2014, RXIV14106758STAT; Heller R, 2013, BIOMETRIKA, V100, P503, DOI 10.1093/biomet/ass070; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Karakas B, 2006, BRIT J CANCER, V94, P455, DOI 10.1038/sj.bjc.6602970; Kumari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050411; Lehmann E. L., 1998, NONPARAMETRICS STAT, p[292, 300, 323]; Liu BA, 2013, ONCOTARGET, V4, P1868, DOI 10.18632/oncotarget.1537; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Massion PP, 2002, CANCER RES, V62, P3636; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; Ong CC, 2011, ONCOTARGET, V2, P491; Perry JM, 2011, GENE DEV, V25, P1928, DOI 10.1101/gad.17421911; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Saijilafu, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3690; Santos SD, 2014, BRIEF BIOINFORM, V15, P906, DOI 10.1093/bib/bbt051; Sedaghat N, 2014, CANCER INFORM, V13, P55, DOI 10.4137/CIN.S13781; Stamoulis C, 2011, BIOINFORMATICS, V27, P2338, DOI 10.1093/bioinformatics/btr402; Szekely GJ, 2007, ANN STAT, V35, P2769, DOI 10.1214/009053607000000505; Szekely GJ, 2009, ANN APPL STAT, V3, P1236, DOI 10.1214/09-AOAS312; Taha TA, 2005, J BIOL CHEM, V280, P17196, DOI 10.1074/jbc.M413744200; Taha TA, 2006, FEBS LETT, V580, P6047, DOI 10.1016/j.febslet.2006.09.070; Tenbaum SP, 2012, NAT MED, V18, P892, DOI 10.1038/nm.2772; Urtz N, 2004, MOL CELL BIOL, V24, P8765, DOI 10.1128/MCB.24.19.8765-8777.2004; Valsesia Armand, 2013, Frontiers in Genetics, V4, P92, DOI 10.3389/fgene.2013.00092; Vizan P, 2009, INT J CANCER, V124, P2789, DOI 10.1002/ijc.24262; Wang J, 2007, MOL CANCER THER, V6, P1143, DOI 10.1158/1535-7163.MCT-06-0555	40	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0126544	10.1371/journal.pone.0126544	http://dx.doi.org/10.1371/journal.pone.0126544			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965968	gold, Green Submitted, Green Published			2022-12-26	WOS:000354543500060
J	Hess, AK; Saffert, P; Liebeton, K; Ignatova, Z				Hess, Anne-Katrin; Saffert, Paul; Liebeton, Klaus; Ignatova, Zoya			Optimization of Translation Profiles Enhances Protein Expression and Solubility	PLOS ONE			English	Article							TRANSFER-RNA GENES; CODON USAGE; EPOXIDE HYDROLASES; ESCHERICHIA-COLI; MESSENGER-RNA; SEQUENCE; RIBOSOME; MECHANISM; MEMBRANE; BIAS	mRNA is translated with a non-uniform speed that actively coordinates co-translational folding of protein domains. Using structure-based homology we identified the structural domains in epoxide hydrolases (EHs) and introduced slow-translating codons to delineate the translation of single domains. These changes in translation speed dramatically improved the solubility of two EHs of metagenomic origin in Escherichia coli. Conversely, the importance of transient attenuation for the folding, and consequently solubility, of EH was evidenced with a member of the EH family from Agrobacterium radiobacter, which partitions in the soluble fraction when expressed in E. coli. Synonymous substitutions of codons shaping the slow-transiting regions to fast-translating codons render this protein insoluble. Furthermore, we show that low protein yield can be enhanced by decreasing the free folding energy of the initial 5'-coding region, which can disrupt mRNA secondary structure and enhance ribosomal loading. This study provides direct experimental evidence that mRNA is not a mere messenger for translation of codons into amino acids but bears an additional layer of information for folding, solubility and expression level of the encoded protein. Furthermore, it provides a general frame on how to modulate and fine-tune gene expression of a target protein.	[Hess, Anne-Katrin; Saffert, Paul; Ignatova, Zoya] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Liebeton, Klaus] BRAIN, Zwingenberg, Germany; [Ignatova, Zoya] Univ Hamburg, Dept Chem & Biochem, Biochem, Hamburg, Germany	University of Potsdam; University of Hamburg	Liebeton, K (corresponding author), BRAIN, Zwingenberg, Germany.	zoya.ignatova@uni-hamburg.de; kl@brain-biotech.de		Ignatova, Zoya/0000-0002-9478-8825				Angov E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002189; Arand M, 2005, METHOD ENZYMOL, V400, P569, DOI 10.1016/S0076-6879(05)00032-7; Barth S, 2004, BIOINFORMATICS, V20, P2845, DOI 10.1093/bioinformatics/bth284; Barth S, 2004, PROTEINS, V55, P846, DOI 10.1002/prot.20013; Bartoszewski RA, 2010, J BIOL CHEM, V285, P28741, DOI 10.1074/jbc.M110.154575; Belasco JG, 2010, NAT REV MOL CELL BIO, V11, P467, DOI 10.1038/nrm2917; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bentele K, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.32; Bevilacqua A, 2003, J CELL PHYSIOL, V195, P356, DOI 10.1002/jcp.10272; Buchan JR, 2007, BIOL CELL, V99, P475, DOI 10.1042/BC20070037; Ciandrini L, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002866; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; Elf J, 2003, SCIENCE, V300, P1718, DOI 10.1126/science.1083811; Fedyunin I, 2012, FEBS LETT, V586, P3336, DOI 10.1016/j.febslet.2012.07.012; Fluitt A, 2007, COMPUT BIOL CHEM, V31, P335, DOI 10.1016/j.compbiolchem.2007.07.003; Gingold H, 2014, CELL, V158, P1281, DOI 10.1016/j.cell.2014.08.011; Goodman DB, 2013, SCIENCE, V342, P475, DOI 10.1126/science.1241934; Gorgoni B, 2014, BIOCHEM SOC T, V42, P160, DOI 10.1042/BST20130132; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; Hershey JWB, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011528; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ito K, 2010, BIOCHEM BIOPH RES CO, V393, P1, DOI 10.1016/j.bbrc.2010.01.073; Jansen R, 2003, NUCLEIC ACIDS RES, V31, P2242, DOI 10.1093/nar/gkg306; Kanaya S, 1999, GENE, V238, P143, DOI 10.1016/S0378-1119(99)00225-5; Komar AA, 1999, FEBS LETT, V462, P387, DOI 10.1016/S0014-5793(99)01566-5; Komar AA, 2009, TRENDS BIOCHEM SCI, V34, P16, DOI 10.1016/j.tibs.2008.10.002; Komili S, 2008, NAT REV GENET, V9, P38, DOI 10.1038/nrg2223; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Lorenz P, 2002, CURR OPIN BIOTECH, V13, P572, DOI 10.1016/S0958-1669(02)00345-2; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Marshall E, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0589; Novoa EM, 2012, CELL, V149, P202, DOI 10.1016/j.cell.2012.01.050; Pei JM, 2007, BIOINFORMATICS, V23, P802, DOI 10.1093/bioinformatics/btm017; Puri P, 2014, MOL MICROBIOL, V93, P944, DOI 10.1111/mmi.12710; Rink R, 1997, J BIOL CHEM, V272, P14650, DOI 10.1074/jbc.272.23.14650; Rosano GL, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-41; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Rouskin S, 2014, NATURE, V505, P701, DOI 10.1038/nature12894; Siller E, 2010, J MOL BIOL, V396, P1310, DOI 10.1016/j.jmb.2009.12.042; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spencer PS, 2012, J MOL BIOL, V422, P328, DOI 10.1016/j.jmb.2012.06.010; Subramaniam AR, 2014, CELL, V159, P1200, DOI 10.1016/j.cell.2014.10.043; Supek F, 2010, GENETICS, V185, P1129, DOI 10.1534/genetics.110.115477; Supek F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001004; Tuller Tamir, 2011, Mob Genet Elements, V1, P75; Turner M, 2011, ADV EXP MED BIOL, V780, P1, DOI 10.1007/978-1-4419-5632-3_1; Wagner S, 2008, P NATL ACAD SCI USA, V105, P14371, DOI 10.1073/pnas.0804090105; Welch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007002; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; Xia XH, 1998, GENETICS, V149, P37; Xu Y, 2013, NATURE, V495, P116, DOI 10.1038/nature11942; Yang JR, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001910; Zaborske JM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002015; Zhang G, 2011, NUCLEIC ACIDS RES, V39, P3331, DOI 10.1093/nar/gkq1257; Zhang G, 2011, CURR OPIN STRUC BIOL, V21, P25, DOI 10.1016/j.sbi.2010.10.008; Zhang G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005036; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554	59	23	24	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0127039	10.1371/journal.pone.0127039	http://dx.doi.org/10.1371/journal.pone.0127039			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965266	Green Published, Green Submitted, gold			2022-12-26	WOS:000354543500089
J	Kjaer, TN; Thorsen, K; Jessen, N; Stenderup, K; Pedersen, SB				Kjaer, Thomas Nordstrom; Thorsen, Kasper; Jessen, Niels; Stenderup, Karin; Pedersen, Steen Bonlokke			Resveratrol Ameliorates Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice	PLOS ONE			English	Article							KERATINOCYTE GROWTH-FACTOR; HUMAN ADIPOSE-TISSUE; NF-KAPPA-B; PHOSPHOENOLPYRUVATE CARBOXYKINASE; EXPRESSION; TRANSCRIPTION; BRODALUMAB; SUPPLEMENTATION; GLUCONEOGENESIS; METABOLISM	Background The polyphenol resveratrol has anti-inflammatory effects in various cells, tissues, animals and human settings of low-grade inflammation. Psoriasis is a disease of both localized and systemic low-grade inflammation. The Sirtuin1 enzyme thought to mediate the effects of resveratrol is present in skin and resveratrol is known to down regulate NF-kappa B; an important contributor in the development of psoriasis. Consequently we investigated whether resveratrol has an effect on an Imiquimod induced psoriasis-like skin inflammation in mice and sought to identify candidate genes, pathways and interleukins mediating the effects. Methods The study consisted of three treatment groups: A control group, an Imiquimod group and an Imiquimod+ resveratrol group. Psoriasis severity was assessed using elements of the Psoriasis Area Severity Index, skin thickness measurements, and histological examination. We performed an RNA microarray from lesional skin and afterwards Ingenuity pathway analysis to identify affected signalling pathways. Our microarray was compared to a previously deposited microarray to determine if gene changes were psoriasis-like, and to a human microarray to determine if findings could be relevant in a human setting. Results Imiquimod treatment induced a psoriasis-like skin inflammation. Resveratrol significantly diminished the severity of the psoriasis-like skin inflammation. The RNA microarray revealed a psoriasis-like gene expression-profile in the Imiquimod treated group, and highlighted several resveratrol dependent changes in relevant genes, such as increased expression of genes associated with retinoic acid stimulation and reduced expression of genes involved in IL-17 dependent pathways. Quantitative PCR confirmed a resveratrol dependent decrease in mRNA levels of IL-17A and IL-19; both central in developing psoriasis. Conclusions Resveratrol ameliorates psoriasis, and changes expression of retinoic acid stimulated genes, IL-17 signalling pathways, IL-17A and IL-19 mRNA levels in a beneficial manner, which suggests resveratrol, might have a role in the treatment of psoriasis and should be explored further in a human setting.	[Kjaer, Thomas Nordstrom; Pedersen, Steen Bonlokke] Aarhus Univ Hosp, Dept Endocrinol & Internal Med, DK-8000 Aarhus, Denmark; [Kjaer, Thomas Nordstrom; Thorsen, Kasper; Jessen, Niels; Stenderup, Karin; Pedersen, Steen Bonlokke] Aarhus Univ, Dept Clin Med, Aarhus, Denmark; [Thorsen, Kasper; Jessen, Niels] Aarhus Univ Hosp, Dept Mol Med, DK-8000 Aarhus, Denmark; [Stenderup, Karin] Aarhus Univ Hosp, Dept Dermatol, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University	Kjaer, TN (corresponding author), Aarhus Univ Hosp, Dept Endocrinol & Internal Med, DK-8000 Aarhus, Denmark.	Thomas.kjaer@clin.au.dk	Pedersen, Steen B./AAB-3331-2019; Jessen, Niels/E-1731-2011	Pedersen, Steen B./0000-0002-7838-8063; Jessen, Niels/0000-0001-5613-7274	Elvira and Rasmus Riisfort Foundation; Ejnar Danielsens Foundation; AP Moller Maersk Foundation; Danish Council for Strategic Research [10-093499]	Elvira and Rasmus Riisfort Foundation; Ejnar Danielsens Foundation; AP Moller Maersk Foundation; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	This work was supported by grants from the Elvira and Rasmus Riisfort Foundation, the Ejnar Danielsens Foundation and the AP Moller Maersk Foundation. This study is also part of the LIRMOI Research Center (www.LIRMOI.com) research program, which is supported by the Danish Council for Strategic Research (Grant 10-093499). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; Biedasek K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016674; Blander G, 2009, J INVEST DERMATOL, V129, P41, DOI 10.1038/jid.2008.179; Boocock DJ, 2007, CANCER EPIDEM BIOMAR, V16, P1246, DOI 10.1158/1055-9965.EPI-07-0022; Cadoudal T, 2008, J NUTR, V138, P1004, DOI 10.1093/jn/138.6.1004; Chakravarty K, 2005, CRIT REV BIOCHEM MOL, V40, P129, DOI 10.1080/10409230590935479; Choi W, 2010, J INVEST DERMATOL, V130, P1685, DOI 10.1038/jid.2010.5; Cohen AD, 2008, DERMATOLOGY, V216, P152, DOI 10.1159/000111512; Cullberg KB, 2013, EUR J PHARM SCI; Finch PW, 1997, AM J PATHOL, V151, P1619; Gallagher G, 2010, CYTOKINE GROWTH F R, V21, P345, DOI 10.1016/j.cytogfr.2010.08.005; Goldminz AM, 2013, J DERMATOL SCI, V69, P89, DOI 10.1016/j.jdermsci.2012.11.002; Gottlieb AB, 2013, J RHEUMATOL, V40, P1428, DOI 10.3899/jrheum.130456; Gudjonsson JE, 2010, J INVEST DERMATOL, V130, P1829, DOI 10.1038/jid.2010.36; Gustafson CJ, 2013, AM J CLIN DERMATOL, V14, P9, DOI 10.1007/s40257-012-0003-7; Jiang WQ, 2011, MOL CELL, V43, P33, DOI 10.1016/j.molcel.2011.04.028; Korecka JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063862; Leiherer A, 2013, VASC PHARMACOL, V58, P3, DOI 10.1016/j.vph.2012.09.002; Li HH, 2005, BRIT J DERMATOL, V153, P591, DOI 10.1111/j.1365-2133.2005.06665.x; Naldi Luigi, 2004, Current Drug Targets - Inflammation and Allergy, V3, P121, DOI 10.2174/1568010043343958; Neimann AL, 2006, J AM ACAD DERMATOL, V55, P829, DOI 10.1016/j.jaad.2006.08.040; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Olholm J, 2010, INT J OBESITY, V34, P1546, DOI 10.1038/ijo.2010.98; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Pedersen SB, 2008, INT J OBESITY, V32, P1250, DOI 10.1038/ijo.2008.78; Perera GK, 2012, ANNU REV PATHOL-MECH, V7, P385, DOI 10.1146/annurev-pathol-011811-132448; Potapovich AI, 2011, TOXICOL APPL PHARM, V255, P138, DOI 10.1016/j.taap.2011.06.007; Poulsen MM, 2013, DIABETES, V62, P1186, DOI 10.2337/db12-0975; Russell CB, 2014, J IMMUNOL, V192, P3828, DOI 10.4049/jimmunol.1301737; Shin DJ, 2012, NUCLEIC ACIDS RES, V40, P11499, DOI 10.1093/nar/gks932; Sin TK, 2014, J PHYSIOL; Spuls PI, 2012, BRIT J DERMATOL, V167, P710, DOI 10.1111/bjd.12025; Swindell WR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018266; Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002; Van Belle AB, 2012, J IMMUNOL, V188, P462, DOI 10.4049/jimmunol.1102224; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Vinter H, 2015, BRIT J DERMATOL, V172, P345, DOI 10.1111/bjd.13236; Wang AP, 2011, J BIOL CHEM, V286, P60, DOI 10.1074/jbc.M110.188144; Wang F, 2012, BRIT J DERMATOL, V167, P92, DOI 10.1111/j.1365-2133.2012.10961.x; Witte E, 2014, J INVEST DERMATOL, V134, P2757, DOI 10.1038/jid.2014.308; Yang JQ, 2009, J BIOL CHEM, V284, P27042, DOI 10.1074/jbc.M109.047340; Zhang Y, 2011, MOL CELL BIOCHEM, V355, P1, DOI 10.1007/s11010-011-0831-4	42	60	60	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0126599	10.1371/journal.pone.0126599	http://dx.doi.org/10.1371/journal.pone.0126599			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965695	Green Published, gold, Green Submitted			2022-12-26	WOS:000354543500070
J	Moazen, M; Peskett, E; Babbs, C; Pauws, E; Fagan, MJ				Moazen, Mehran; Peskett, Emma; Babbs, Christian; Pauws, Erwin; Fagan, Michael J.			Mechanical Properties of Calvarial Bones in a Mouse Model for Craniosynostosis	PLOS ONE			English	Article							SAETHRE-CHOTZEN SYNDROME; CRANIAL SUTURES; SYNDROMIC CRANIOSYNOSTOSIS; NANOMECHANICAL PROPERTIES; SKULL VAULT; NANOINDENTATION; LOAD; INDENTATION; GROWTH; TISSUE	The mammalian cranial vault largely consists of five flat bones that are joined together along their edges by soft fibrous tissues called sutures. Premature closure of the cranial sutures, craniosynostosis, can lead to serious clinical pathology unless there is surgical intervention. Research into the genetic basis of the disease has led to the development of various animal models that display this condition, e.g. mutant type Fgfr2(C342Y/+) mice which display early fusion of the coronal suture (joining the parietal and frontal bones). However, whether the biomechanical properties of the mutant and wild type bones are affected has not been investigated before. Therefore, nanoindentation was used to compare the elastic modulus of cranial bone and sutures in wild type (WT) and Fgfr2(C342Y/+) mutant type (MT) mice during their postnatal development. Further, the variations in properties with indentation position and plane were assessed. No difference was observed in the elastic modulus of parietal bone between the WT and MT mice at postnatal (P) day 10 and 20. However, the modulus of frontal bone in the MT group was lower than the WT group at both P10 (1.39 +/- 0.30 vs. 5.32 +/- 0.68 GPa; p<0.05) and P20 (5.57 +/- 0.33 vs. 7.14 +/- 0.79 GPa; p<0.05). A wide range of values was measured along the coronal sutures for both the WT and MT samples, with no significant difference between the two groups. Findings of this study suggest that the inherent mechanical properties of the frontal bone in the mutant mice were different to the wild type mice from the same genetic background. These differences may reflect variations in the degree of biomechanical adaptation during skull growth, which could have implications for the surgical management of craniosynostosis patients.	[Moazen, Mehran; Fagan, Michael J.] Univ Hull, Sch Engn, Med & Biol Engn, Kingston Upon Hull HU6 7RX, N Humberside, England; [Peskett, Emma; Pauws, Erwin] UCL Inst Child Hlth, London, England; [Babbs, Christian] Univ Oxford, Weatherall Inst Mol Med, Oxford, England	University of Hull; University of London; University College London; University of Oxford	Moazen, M (corresponding author), Univ Hull, Sch Engn, Med & Biol Engn, Kingston Upon Hull HU6 7RX, N Humberside, England.	M.Moazen@hull.ac.uk	Pauws, Erwin/J-4848-2019; Moazen, Mehran/F-8393-2011; Babbs, Christian/AAA-5917-2022	Pauws, Erwin/0000-0003-1751-0317; Moazen, Mehran/0000-0002-9951-2975; Babbs, Christian/0000-0002-1898-5878; Peskett, Emma/0000-0002-0978-5401	Royal Academy of Engineering Research Fellowship; Great Ormond Street Hospital Childrens Charity [W0908] Funding Source: researchfish; BBSRC [BB/E014259/1, BB/H011668/1] Funding Source: UKRI	Royal Academy of Engineering Research Fellowship(Royal Academy of Engineering - UK); Great Ormond Street Hospital Childrens Charity; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Royal Academy of Engineering Research Fellowship (MM).	Boulet SL, 2008, AM J MED GENET A, V146A, P984, DOI 10.1002/ajmg.a.32208; CHEN ZF, 1995, GENE DEV, V9, P686, DOI 10.1101/gad.9.6.686; Cohen MM, 2005, AM J MED GENET A, V136A, P313, DOI 10.1002/ajmg.a.30757; Currey J.D., 2001, BONE MECH HDB; Donnelly E, 2006, J BIOMED MATER RES A, V77A, P426, DOI 10.1002/jbm.a.30633; Ebenstein DM, 2011, HDB NANOINDENTATION, P279; Ebenstein DM, 2006, NANO TODAY, V1, P26, DOI 10.1016/S1748-0132(06)70077-9; Eswarakumar VP, 2004, P NATL ACAD SCI USA, V101, P12555, DOI 10.1073/pnas.0405031101; Franke O, 2007, ACTA BIOMATER, V3, P873, DOI 10.1016/j.actbio.2007.04.005; Grau N, 2006, J CRANIOFAC SURG, V17, P91, DOI 10.1097/01.scs.0000179754.52154.42; Grova M, 2012, J CRANIOFAC SURG, V23, P1954, DOI 10.1097/SCS.0b013e318258ba53; Henderson JH, 2005, J BIOMECH, V38, P2294, DOI 10.1016/j.jbiomech.2004.07.037; Henderson JH, 2004, BONE, V34, P271, DOI 10.1016/j.bone.2003.10.007; Hermann CD, 2012, CALCIFIED TISSUE INT, V91, P255, DOI 10.1007/s00223-012-9632-3; Herring Susan W., 2008, V12, P41, DOI 10.1159/000115031; Heuze Y, 2014, BONE, V63, P101, DOI 10.1016/j.bone.2014.03.003; Holmes G, 2012, CHILD NERV SYST, V28, P1471, DOI 10.1007/s00381-012-1844-3; Holmes G, 2012, DEV BIOL, V368, P283, DOI 10.1016/j.ydbio.2012.05.026; JASLOW CR, 1990, J BIOMECH, V23, P313, DOI 10.1016/0021-9290(90)90059-C; Jiang XB, 2002, DEV BIOL, V241, P106, DOI 10.1006/dbio.2001.0487; Jin J, 2013, SIMULATION, V90, P3; Johnson D, 2011, EUR J HUM GENET, V19, P369, DOI 10.1038/ejhg.2010.235; Leong PL, 2008, ACTA BIOMATER, V4, P1569, DOI 10.1016/j.actbio.2008.02.030; Liu J, 2013, CALCIFIED TISSUE INT, V92, P451, DOI 10.1007/s00223-013-9701-2; Maloul A, 2013, J BIOMECH, V46, P912, DOI 10.1016/j.jbiomech.2012.12.016; Margulies SS, 2000, J BIOMECH ENG-T ASME, V122, P364, DOI 10.1115/1.1287160; Martinez-Abadias N, 2013, DEV DYNAM, V242, P80, DOI 10.1002/dvdy.23903; MCELHANEY JH, 1970, J BIOMECH, V3, P495, DOI 10.1016/0021-9290(70)90059-X; McLaughlin E, 2000, CLEFT PALATE-CRAN J, V37, P590, DOI 10.1597/1545-1569(2000)037<0590:TLDCON>2.0.CO;2; MCPHERSON GK, 1980, J BIOMECH, V13, P17, DOI 10.1016/0021-9290(80)90004-4; Mehta VA, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10204; Mooney MP, 1998, CHILD NERV SYST, V14, P236, DOI 10.1007/s003810050219; Morriss-Kay GM, 2005, J ANAT, V207, P637, DOI 10.1111/j.1469-7580.2005.00475.x; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Opperman LA, 2000, DEV DYNAM, V219, P472, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1073>3.0.CO;2-F; Perlyn CA, 2006, CLEFT PALATE-CRAN J, V43, P740, DOI 10.1597/05-212; Pollack IF, 1996, PEDIATR NEUROSURG, V24, P202, DOI 10.1159/000121038; Popowics TE, 2007, J BIOMECH, V40, P837, DOI 10.1016/j.jbiomech.2006.03.011; Radhakrishnan P, 2004, J DENT RES, V83, P470, DOI 10.1177/154405910408300607; Rodriguez-Florez N, 2013, J MECH BEHAV BIOMED, V18, P90, DOI 10.1016/j.jmbbm.2012.11.005; Wang JW, 2014, MED SCI MONITOR, V20, P1808, DOI 10.12659/MSM.892278; Wilkie AOM, 1997, HUM MOL GENET, V6, P1647, DOI 10.1093/hmg/6.10.1647; Wolanski W, 2013, INT J NUMER METH BIO, V29, P916, DOI 10.1002/cnm.2506; Wolfram U, 2010, BONE, V46, P348, DOI 10.1016/j.bone.2009.09.035; Woods RH, 2009, PLAST RECONSTR SURG, V123, P1801, DOI 10.1097/PRS.0b013e3181a3f391; Zysset PK, 2009, OSTEOPOROSIS INT, V20, P1049, DOI 10.1007/s00198-009-0854-9	46	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0125757	10.1371/journal.pone.0125757	http://dx.doi.org/10.1371/journal.pone.0125757			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25966306	Green Published, gold, Green Submitted			2022-12-26	WOS:000354543500027
J	Anderson, KW; Chen, JJ; Wang, MY; Mast, N; Pikuleva, IA; Turko, IV				Anderson, Kyle W.; Chen, Junjun; Wang, Meiyao; Mast, Natalia; Pikuleva, Irina A.; Turko, Illarion V.			Quantification of Histone Deacetylase Isoforms in Human Frontal Cortex, Human Retina, and Mouse Brain	PLOS ONE			English	Article							MASS-SPECTROMETRY QUANTIFICATION; ALZHEIMERS-DISEASE; MACULAR DEGENERATION; MEMORY; ACETYLATION; EXPRESSION; QCONCATS; HDAC6	Histone deacetylase (HDAC) inhibition has promise as a therapy for Alzheimer's disease (AD) and other neurodegenerative diseases. Currently, therapeutic HDAC inhibitors target many HDAC isoforms, a particularly detrimental approach when HDAC isoforms are known to have different and specialized functions. We have developed a multiple reaction monitoring (MRM) mass spectrometry assay using stable isotope-labeled QconCATs as internal standards to quantify HDAC isoforms. We further determined a quantitative pattern of specific HDACs expressed in various human and mouse neural tissues. In human AD frontal cortex, HDAC1,2 decreased 32%, HDAC5 increased 47%, and HDAC6 increased 31% in comparison to age-matched controls. Human neural retina concentrations of HDAC1, 2, HDAC5, HDAC6, and HDAC7 decreased in age-related macular degeneration (AMD)-affected donors and exhibited a greater decrease in AD-affected donors in comparison to age-matched control neural retinas. Additionally, HDAC concentrations were measured in whole hemisphere of brain of 5XFAD mice, a model of beta-amyloid deposition, to assess similarity to AD in human frontal cortex. HDAC profiles of human frontal cortex and mouse hemisphere had noticeable differences and relatively high concentrations of HDAC3 and HDAC4 in mice, which were undetectable in humans. Our method for quantification of HDAC isoforms is a practical and efficient technique to quantify isoforms in various tissues and diseases. Changes in HDAC concentrations reported herein contribute to the understanding of the pathology of neurodegeneration.	[Anderson, Kyle W.; Chen, Junjun; Wang, Meiyao; Turko, Illarion V.] Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA; [Anderson, Kyle W.; Chen, Junjun; Wang, Meiyao; Turko, Illarion V.] NIST, Biomol Measurement Div, Gaithersburg, MD 20899 USA; [Anderson, Kyle W.] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA; [Mast, Natalia; Pikuleva, Irina A.] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA	National Institute of Standards & Technology (NIST) - USA; University System of Maryland; University of Maryland College Park; Case Western Reserve University	Turko, IV (corresponding author), Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA.	iturko@umd.edu		Pikuleva, Irina/0000-0001-9742-6232; Anderson, Kyle/0000-0002-2808-3026	National Institutes of Health [P50 AG005681, EY018383, GM062882, EY011373]; Institute for Bioscience and Biotechnology Research; National Institute of Standards and Technology; Case Western Reserve University; NATIONAL EYE INSTITUTE [P30EY011373, R01EY018383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005681] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Bioscience and Biotechnology Research; National Institute of Standards and Technology(National Institute of Standards & Technology (NIST) - USA); Case Western Reserve University; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	External funding for this work was provided by: National Institutes of Health grant P50 AG005681 to the Washington University School of Medicine Alzheimer's Disease Research Center; National Institutes of Health grants EY018383 and GM062882 (to IAP); and National Institutes of Health grant EY011373 to Case Western Reserve University (P30 Core grant). The external funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All additional funding was provided internally by the Institute for Bioscience and Biotechnology Research, the National Institute of Standards and Technology, and Case Western Reserve University.	Agis-Balboa RC, 2013, J ALZHEIMERS DIS, V33, P35, DOI 10.3233/JAD-2012-121009; Alzheimers Assoc, 2012, ALZHEIMERS DEMENT, V8, P131, DOI 10.1016/j.jalz.2012.02.001; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Broide RS, 2007, J MOL NEUROSCI, V31, P47, DOI 10.1007/BF02686117; Castello MA, 2014, AGEING RES REV, V13, P10, DOI 10.1016/j.arr.2013.10.001; Chen JJ, 2014, TRAC-TREND ANAL CHEM, V57, P1, DOI 10.1016/j.trac.2013.12.013; Chen J, 2013, ANAL BIOCHEM, V442, P253, DOI 10.1016/j.ab.2013.08.005; Chen JJ, 2013, ANAL CHEM, V85, P6011, DOI 10.1021/ac400831z; Chen JJ, 2013, ANAL CHEM, V85, P303, DOI 10.1021/ac3033239; Chen JJ, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-41; Cook C, 2012, HUM MOL GENET, V21, P2936, DOI 10.1093/hmg/dds125; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Fitzsimons CP, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-25; Gonzalez-Zuniga M, 2014, MOL CELL, V56, P163, DOI 10.1016/j.molcel.2014.08.013; Graff J, 2012, NATURE, V483, P222, DOI 10.1038/nature10849; Izzo A, 2010, BRIEF FUNCT GENOMICS, V9, P429, DOI 10.1093/bfgp/elq024; Jakovcevski M, 2013, BIOL PSYCHIAT, V74, P696, DOI 10.1016/j.biopsych.2013.03.020; Kaarniranta K, 2011, J ALZHEIMERS DIS, V24, P615, DOI 10.3233/JAD-2011-101908; Kawabata Tomoko, 2010, Arthritis Res Ther, V12, pR133, DOI 10.1186/ar3071; Kilgore M, 2010, NEUROPSYCHOPHARMACOL, V35, P870, DOI 10.1038/npp.2009.197; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Li GY, 2011, J NEUROL SCI, V304, P1, DOI 10.1016/j.jns.2011.02.017; Lucio-Eterovic AK, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-243; MacLean B, 2010, ANAL CHEM, V82, P10116, DOI 10.1021/ac102179j; Millan MJ, 2014, DIALOGUES CLIN NEURO, V16, P373; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; OBRIEN JS, 1965, J LIPID RES, V6, P537; Ohno-Matsui K, 2011, PROG RETIN EYE RES, V30, P217, DOI 10.1016/j.preteyeres.2011.02.004; Sananbenesi F, 2009, BIOL CHEM, V390, P1145, DOI 10.1515/BC.2009.131; Sando R, 2012, CELL, V151, P821, DOI 10.1016/j.cell.2012.09.037; Simoes-Pires C, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-7; Simpson DM, 2012, ANAL BIOANAL CHEM, V404, P977, DOI 10.1007/s00216-012-6230-1; Stilling RM, 2011, NEUROBIOL LEARN MEM, V96, P19, DOI 10.1016/j.nlm.2011.04.002; Tiwari S, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-30; Wang MY, 2012, ANAL CHEM, V84, P8340, DOI 10.1021/ac3018873; Wang YJ, 2013, EPIGENETICS-US, V8, P756, DOI 10.4161/epi.25202; Xu K, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/143269; Yeh HH, 2013, NEUROIMAGE, V64, P630, DOI 10.1016/j.neuroimage.2012.09.019; Zhang L, 2013, J ALZHEIMERS DIS, V33, P283, DOI 10.3233/JAD-2012-120727; Zheng WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037926	40	27	28	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126592	10.1371/journal.pone.0126592	http://dx.doi.org/10.1371/journal.pone.0126592			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962138	Green Published, gold, Green Submitted			2022-12-26	WOS:000354542500120
J	Lai, WF; Lin, MC				Lai, Wing-Fu; Lin, Marie C.			Chemotherapeutic Drugs Interfere with Gene Delivery Mediated by Chitosan-Graft-Poly(ethylenimine)	PLOS ONE			English	Article							CISPLATIN CHEMOTHERAPY; THERAPY; CHITOSAN; RESISTANCE; DNA; PHARMACOKINETICS; GROWTH; TUMORS	Combined chemo-gene therapy is one of the treatment modalities that have attracted extensive research interests; however, there is little information regarding the influence of drug application on gene transfer. This study bridges this gap by examining how chemotherapeutic drugs (teniposide, cis-diamminedichloroplatinum(II) and temozolomide) interfere with polyplex formation and transfection of chitosan-graft-poly(ethylenimine). Our results indicate that the degree of drug interference varies with the mechanism of drug action, with the transgene expression being severely suppressed when the plasmid is co-delivered with cis-diamminedichloroplatinum(II) or teniposide but not temozolomide. In addition, the interference with transfection by drugs varies with different gene/drug co-formulations. This is the first study to evidence that, though combined chemo-gene therapy has therapeutic potential, some chemotherapeutic drugs may reduce the treatment efficiency of gene therapy.	[Lai, Wing-Fu; Lin, Marie C.] Shenzhen Univ, Sch Med, Shenzhen, Peoples R China; [Lai, Wing-Fu] Univ Hong Kong, Dept Mech Engn, Hong Kong, Hong Kong, Peoples R China	Shenzhen University; University of Hong Kong	Lin, MC (corresponding author), Shenzhen Univ, Sch Med, Shenzhen, Peoples R China.	mcmlin@163.com	Lai, Wing-Fu/J-3170-2015	Lai, Wing-Fu/0000-0003-0585-6396	Key Lab Project of Shenzhen [ZDSY20130392101130496]; National Natural Science Foundation of China [NSFC 81272549]	Key Lab Project of Shenzhen; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the Key Lab Project of Shenzhen (ZDSY20130392101130496) and National Natural Science Foundation of China (NSFC 81272549). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basile KJ, 2012, ADV PHARMACOL, V65, P315, DOI 10.1016/B978-0-12-397927-8.00010-5; BELLON SF, 1991, BIOCHEMISTRY-US, V30, P8026, DOI 10.1021/bi00246a021; CHU G, 1994, J BIOL CHEM, V269, P787; EASTMAN A, 1986, BIOCHEMISTRY-US, V25, P3912, DOI 10.1021/bi00361a026; FICHTINGERSCHEPMAN AMJ, 1985, BIOCHEMISTRY-US, V24, P707, DOI 10.1021/bi00324a025; Gao JQ, 2010, INT J PHARMACEUT, V387, P286, DOI 10.1016/j.ijpharm.2009.12.033; Gao ZN, 2007, ORAL ONCOL, V43, P477, DOI 10.1016/j.oraloncology.2006.05.009; Gu JL, 2014, CANCER LETT, V343, P200, DOI 10.1016/j.canlet.2013.10.011; Hohenforst-Schmidt W, 2014, J CANCER, V5, P344, DOI 10.7150/jca.9021; Jiang G, 2011, INT J CANCER, V129, P263, DOI 10.1002/ijc.25948; Lai WF, 2010, J MAT SCI ENG, V4, P34; Lai WF, 2014, BIOMATERIALS, V35, P401, DOI 10.1016/j.biomaterials.2013.09.061; Lai WF, 2009, J CONTROL RELEASE, V134, P158, DOI 10.1016/j.jconrel.2008.11.021; LONG BH, 1985, CANCER RES, V45, P3106; Mao SR, 2004, INT J PHARMACEUT, V281, P45, DOI 10.1016/j.ijpharm.2004.05.019; Mitrus I, 2006, ACTA BIOCHIM POL, V53, P357; ODWYER PJ, 1984, CANCER TREAT REP, V68, P1455; Patel M, 2003, J NEURO-ONCOL, V61, P203, DOI 10.1023/A:1022592913323; STEVENS MFG, 1987, CANCER RES, V47, P5846; Ta HT, 2009, BIOMATERIALS, V30, P4815, DOI 10.1016/j.biomaterials.2009.05.035; Tang GP, 2006, J GENE MED, V8, P736, DOI 10.1002/jgm.874; Torrero Marina, 2008, V423, P339, DOI 10.1007/978-1-59745-194-9_26; Vadlapatla RK, 2013, CURR PHARM DESIGN, V19, P7126, DOI 10.2174/13816128113199990493; Warfel NA, 2014, CURR MED CHEM; Wu A, 2013, P NATL ACAD SCI USA, V110, P16103, DOI 10.1073/pnas.1314385110; Xu QX, 2013, BIOMATERIALS, V34, P5149, DOI 10.1016/j.biomaterials.2013.03.044; Yardley DA, 2013, INT J BREAST CANCER, V2013, DOI 10.1155/2013/137414; Zheng WE, 2012, J BUON, V17, P284	28	14	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126367	10.1371/journal.pone.0126367	http://dx.doi.org/10.1371/journal.pone.0126367			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961282	Green Published, Green Submitted, gold			2022-12-26	WOS:000354542500094
J	Liu, XX; Wu, Y; Huang, Q; Zou, DH; Qin, WH; Chen, Z				Liu, Xixia; Wu, Yuan; Huang, Qi; Zou, Donghua; Qin, Weihan; Chen, Zhen			Grouping Pentylenetetrazol-Induced Epileptic Rats According to Memory Impairment and MicroRNA Expression Profiles in the Hippocampus	PLOS ONE			English	Article							REMOTE MEMORY; KAINIC ACID; SEIZURES	Previous studies have demonstrated a close relationship between abnormal regulation of microRNA (miRNA) and various types of diseases, including epilepsy and other neurological disorders of memory. However, the role of miRNA in the memory impairment observed in epilepsy remains unknown. In this study, a model of temporal lobe epilepsy (TLE) was induced via pentylenetetrazol (PTZ) kindling in Sprague-Dawley rats. First, the TLE rats were subjected to Morris water maze to identify those with memory impairment (TLE-MI) compared with TLE control rats (TLE-C), which presented normal memory. Both groups were analyzed to detect dysregulated miRNAs in the hippocampus; four up-regulated miRNAs (miR-34c, miR-374, miR-181a, and miR-let-7c-1) and seven down-regulated miRNAs (miR1188, miR-770-5p, miR-127-5p, miR-375, miR-331, miR-873-5p, and miR-328a) were found. Some of the dysregulated miRNAs (miR-34c, miR-1188a, miR-328a, and miR-331) were confirmed using qRT-PCR, and their blood expression patterns were identical to those of their counterparts in the rat hippocampus. The targets of these dysregulated miRNAs and other potentially enriched biological signaling pathways were analyzed using bioinformatics. Following these results, the MAPK, apoptosis and hippocampal signaling pathways might be involved in the molecular mechanisms underlying the memory disorders of TLE.	[Liu, Xixia; Wu, Yuan; Huang, Qi; Zou, Donghua; Qin, Weihan; Chen, Zhen] Guangxi Med Univ, Affiliated Hosp 1, Dept Neurol, Nanning, Guangxi, Peoples R China	Guangxi Medical University	Wu, Y (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Neurol, Nanning, Guangxi, Peoples R China.	wuyuan90@126.com		Zou, Donghua/0000-0002-3891-9472; Wu, Yuan/0000-0001-5016-1660; Wu, Yuan/0000-0003-3267-8388	National Natural Science Foundation of China (NSFC) [81360201]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (NSFC); Grant number: 81360201.	Aikia M, 2001, EPILEPSY BEHAV, V2, P20, DOI 10.1006/ebeh.2000.0140; Austin JK, 2002, PROG BRAIN RES, V135, P419; BENARI Y, 1981, NEUROSCIENCE, V6, P1361, DOI 10.1016/0306-4522(81)90193-7; Bergin PS, 2000, EPILEPSIA, V41, P231, DOI 10.1111/j.1528-1157.2000.tb00145.x; Bhatnagar S, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00002; Bohbot VD, 2007, HIPPOCAMPUS, V17, P863, DOI 10.1002/hipo.20313; Boissonneault V, 2009, J BIOL CHEM, V284, P1971, DOI 10.1074/jbc.M807530200; Butler CR, 2008, BRAIN, V131, P2243, DOI 10.1093/brain/awn127; Choudhary KM, 2013, EUR J PHARMACOL, V704, P33, DOI 10.1016/j.ejphar.2013.02.012; Dhir A., 2012, CURR PROT NEUROSCI, V58, p9.37.1, DOI [DOI 10.1002/0471142301.NS0937S58, 10.1002/0471142301.ns0937s58]; Dudek FE, 2002, PROG BRAIN RES, V135, P53; Dutta R, 2013, ANN NEUROL, V73, P637, DOI 10.1002/ana.23860; Eacker SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025068; Fiore R, 2008, BBA-GENE REGUL MECH, V1779, P471, DOI 10.1016/j.bbagrm.2007.12.006; Fischbach SJ, 2009, NEURON, V63, P714, DOI 10.1016/j.neuron.2009.09.007; Fisher RS, 2000, EPILEPSY RES, V41, P39, DOI 10.1016/S0920-1211(00)00126-1; Hansen KF, 2013, BRAIN STRUCT FUNCT, V218, P817, DOI 10.1007/s00429-012-0431-4; Helmstaedter C, 2009, BRAIN, V132, P2822, DOI 10.1093/brain/awp182; Helmstaedter C, 2007, EPILEPSIA, V48, P85, DOI 10.1111/j.1528-1167.2007.01360.x; Hermann B, 2010, EPILEPSY BEHAV, V17, P1, DOI 10.1016/j.yebeh.2009.10.019; Holmes GL, 2006, EPILEPSY BEHAV, V8, P504, DOI 10.1016/j.yebeh.2005.11.014; Hu K, 2011, NEUROSCI LETT, V488, P252, DOI 10.1016/j.neulet.2010.11.040; Inostroza M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022372; Jimenez-Mateos EM, 2011, AM J PATHOL, V179, P2519, DOI 10.1016/j.ajpath.2011.07.036; Kleen JK, 2012, JASPERS BASIC MECHAN; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Li MM, 2014, SCI REP-UK, V4, DOI 10.1038/srep04734; Liu DZ, 2010, J CEREBR BLOOD F MET, V30, P92, DOI 10.1038/jcbfm.2009.186; Lu Yu, 2014, Zhonghua Yi Xue Za Zhi, V94, P3020; Lusardi TA, 2010, J CEREBR BLOOD F MET, V30, P744, DOI 10.1038/jcbfm.2009.253; Majak K, 2004, EPILEPSY BEHAV, V5, pS35, DOI 10.1016/j.yebeh.2003.11.012; McKiernan RC, 2012, EXP NEUROL, V237, P346, DOI 10.1016/j.expneurol.2012.06.029; Meador KJ, 2006, EPILEPSY RES, V68, P63, DOI 10.1016/j.eplepsyres.2005.09.023; Nadiminty N, 2012, J BIOL CHEM, V287, P1527, DOI 10.1074/jbc.M111.278705; Nelson PT, 2008, BRAIN PATHOL, V18, P130, DOI 10.1111/j.1750-3639.2007.00120.x; Nelson PT, 2010, J ALZHEIMERS DIS, V21, P75, DOI 10.3233/JAD-2010-091603; Packer AN, 2008, J NEUROSCI, V28, P14341, DOI 10.1523/JNEUROSCI.2390-08.2008; Pahuja M, 2013, NEUROCHEM RES, V38, P547, DOI 10.1007/s11064-012-0947-2; Pichardo-Casas I, 2012, BRAIN RES, V1436, P20, DOI 10.1016/j.brainres.2011.12.001; RACINE R, 1972, ELECTROEN CLIN NEURO, V32, P295, DOI 10.1016/0013-4694(72)90178-2; Sayin U, 2004, EPILEPSIA, V45, P1539, DOI 10.1111/j.0013-9580.2004.54903.x; Schratt G, 2009, NAT REV NEUROSCI, V10, P842, DOI 10.1038/nrn2763; Schwarcz R, 2002, EPILEPSY RES, V50, P161, DOI 10.1016/S0920-1211(02)00077-3; TURSKI WA, 1983, BEHAV BRAIN RES, V9, P315, DOI 10.1016/0166-4328(83)90136-5; Wang RY, 2013, HIPPOCAMPUS, V23, P625, DOI 10.1002/hipo.22123; Zeng Q, 2012, BEHAVIOURAL PHARMACO, V23, P669, DOI [10.1097/FBP.0b013e3283585923, DOI 10.1097/FBP.0B013E3283585923]; Zhang FX, 2014, CELL MOL NEUROBIOL, V34, P813, DOI 10.1007/s10571-014-0068-3	47	31	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126123	10.1371/journal.pone.0126123	http://dx.doi.org/10.1371/journal.pone.0126123			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962166	Green Published, Green Submitted, gold			2022-12-26	WOS:000354542500065
J	Carbonell-Estrany, X; Perez-Yarza, EG; Garcia, LS; Cabanas, JMG; Boria, EV; Atienza, BB				Carbonell-Estrany, Xavier; Perez-Yarza, Eduardo G.; Garcia, Laura Sanchez; Cabanas, Juana M. Guzman; Boria, Elena Villarrubia; Atienza, Belen Bernardo		IRIS Infeccion Respiratoria Infan	Long-Term Burden and Respiratory Effects of Respiratory Syncytial Virus Hospitalization in Preterm Infants-The SPRING Study	PLOS ONE			English	Article							INFECTION REQUIRING HOSPITALIZATION; 1ST 6 YEARS; LUNG-FUNCTION; RISK-FACTORS; PREMATURE-INFANTS; RSV BRONCHIOLITIS; PALIVIZUMAB PROPHYLAXIS; GESTATIONAL-AGE; SPANISH VERSION; ASTHMA	The health status of premature infants born 32(1)-35(0) weeks' gestational age (wGA) hospitalized for RSV infection in the first year of life (cases; n = 125) was compared to that of premature infants not hospitalized for RSV (controls; n = 362) through 6 years. The primary endpoints were the percentage of children with wheezing between 2-6 years and lung function at 6 years of age. Secondary endpoints included quality of life, healthcare resource use, and allergic sensitization. A significantly higher proportion of cases than controls experienced recurrent wheezing through 6 years of age (46.7% vs. 27.4%; p = 0.001). The vast majority of lung function tests appeared normal at 6 years of age in both cohorts. In children with pulmonary function in the lower limit of normality (FEV1 Z-score [-2; -1]), wheezing was increased, particularly for cases vs. controls (72.7% vs. 18.9%, p = 0.002). Multivariate analysis revealed the most important factor for wheezing was RSV hospitalization. Quality of life on the respiratory subscale of the TAPQOL was significantly lower (p = 0.001) and healthcare resource utilization was significantly higher (p<0.001) in cases than controls. This study confirms RSV disease is associated with wheezing in 32-35 wGA infants through 6 years of age.	[Carbonell-Estrany, Xavier] Hosp Clin Barcelona, Serv Neonatol, Inst Invest Biomed August Pi Suner IDIBAPS, Barcelona, Spain; [Perez-Yarza, Eduardo G.] Hosp Univ Donostia, Div Pediat Resp Med, Inst Biodonostia, San Sebastian, Spain; [Perez-Yarza, Eduardo G.] Biomed Res Ctr Network Resp Dis CIBERES, San Sebastian, Spain; [Perez-Yarza, Eduardo G.] Univ Basque Country, Dept Pediat, UPV EHU, San Sebastian, Spain; [Garcia, Laura Sanchez] Hosp Univ La Paz, Neonatol Unit, Madrid, Spain; [Cabanas, Juana M. Guzman] Hosp Univ Reina Sofia, Serv Neonatol, Cordoba, Spain; [Boria, Elena Villarrubia] 3D Hlth Res, Hlth Outcomes Res Dept, Barcelona, Spain; [Atienza, Belen Bernardo] Hosp Gen Univ Gregorio Maranon, Div Neonatol, Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Instituto de Investigacion Sanitaria Biodonostia; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; CIBERESP; University of Basque Country; Hospital Universitario La Paz; General University Gregorio Maranon Hospital	Carbonell-Estrany, X (corresponding author), Hosp Clin Barcelona, Serv Neonatol, Inst Invest Biomed August Pi Suner IDIBAPS, Barcelona, Spain.	carbonell@comb.cat	Sanchez Luna, Manuel/H-2165-2014; Centeno, Fernando/R-5056-2017	Sanchez Luna, Manuel/0000-0001-9543-7392; Centeno, Fernando/0000-0002-4816-7649; Perez-Yarza, Eduardo G./0000-0002-8004-7110; Perez-Frias, Javier/0000-0002-5515-3034; sardon, olaia/0000-0002-1567-9824; Corcuera, Paula/0000-0001-8661-7033	AbbVie Farmaceutica S.L.U. Madrid, Spain	AbbVie Farmaceutica S.L.U. Madrid, Spain(AbbVie)	This study was funded by AbbVie Farmaceutica S.L.U. Madrid, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose CS, 2014, PEDIATR INFECT DIS J, V33, P576, DOI 10.1097/INF.0000000000000219; Bacharier LB, 2012, J ALLERGY CLIN IMMUN, V130, P91, DOI 10.1016/j.jaci.2012.02.010; Blanken MO, 2013, NEW ENGL J MED, V368, P1791, DOI 10.1056/NEJMoa1211917; Bont L, 2004, PEDIATR INFECT DIS J, V23, P414, DOI 10.1097/01.inf.0000122604.32137.29; Carroll KN, 2009, J ALLERGY CLIN IMMUN, V123, P964, DOI 10.1016/j.jaci.2008.12.011; Colin AA, 2010, PEDIATRICS, V126, P115, DOI 10.1542/peds.2009-1381; Collins SA, 2013, PEDIATR PULM, V48, P683, DOI 10.1002/ppul.22766; Drysdale SB, 2014, EUR J PEDIATR, V173, P905, DOI 10.1007/s00431-014-2263-0; Escobar GJ, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-97; Escobar GJ, 2010, ARCH PEDIAT ADOL MED, V164, P915, DOI 10.1001/archpediatrics.2010.177; Fekkes M, 2000, QUAL LIFE RES, V9, P961, DOI 10.1023/A:1008981603178; Figueras-Aloy J, 2004, PEDIATR INFECT DIS J, V23, P815, DOI 10.1097/01.inf.0000136869.21397.6b; Figueras-Aloy J, 2008, PEDIATR INFECT DIS J, V27, P788, DOI 10.1097/INF.0b013e3181710990; Friedrich L, 2006, AM J RESP CRIT CARE, V173, P442, DOI 10.1164/rccm.200503-444OC; Friedrich L, 2007, AM J RESP CRIT CARE, V176, P1269, DOI 10.1164/rccm.200703-476OC; Greenough A, 2005, ARCH DIS CHILD-FETAL, V90, pF320, DOI 10.1136/adc.2004.062018; Greenough A, 2009, THORAX, V64, P490, DOI 10.1136/thx.2008.095547; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Henderson J, 2005, PEDIAT ALLERG IMM-UK, V16, P386, DOI 10.1111/j.1399-3038.2005.00298.x; Horn SD, 2003, J PEDIATR-US, V143, pS133, DOI 10.1067/S0022-3476(03)00509-2; Host A, 2003, ALLERGY, V58, P559, DOI 10.1034/j.1398-9995.2003.00238.x; Kneyber M, 2000, ACTA PAEDIATR, V89, P654, DOI 10.1080/080352500750043945; Kotecha SJ, 2013, THORAX, V68, P760, DOI 10.1136/thoraxjnl-2012-203079; Law BJ, 2004, PEDIATR INFECT DIS J, V23, P806, DOI 10.1097/01.inf.0000137568.71589.bd; Liese JG, 2003, EUR J PEDIATR, V162, P230, DOI 10.1007/s00431-002-1105-7; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Oppenheimer J, 2006, ANN ALLERG ASTHMA IM, V96, pS6, DOI 10.1016/S1081-1206(10)60895-2; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Rajmil L, 2011, INT J NURS STUD, V48, P549, DOI 10.1016/j.ijnurstu.2010.09.004; Regnier SA, 2013, PEDIATR INFECT DIS J, V32, P820, DOI 10.1097/INF.0b013e31829061e8; Sardon Prado O, 2008, An Pediatr (Barc), V68, P420; Shefali-Patel D, 2012, EUR J PEDIATR, V171, P1055, DOI 10.1007/s00431-012-1673-0; Sigurs N, 2005, AM J RESP CRIT CARE, V171, P137, DOI 10.1164/rccm.200406-730OC; SIGURS N, 1995, PEDIATRICS, V95, P500; Sigurs N, 2001, AM J RESP CRIT CARE, V163, pS2, DOI 10.1164/ajrccm.163.supplement_1.2011109; Sigurs N, 2010, THORAX, V65, P1045, DOI 10.1136/thx.2009.121582; Simoes EAF, 1999, LANCET, V354, P847, DOI 10.1016/S0140-6736(99)80040-3; Simoes EAF, 2002, RESP RES, V3, DOI 10.1186/rr187; Simoes EAF, 2007, J PEDIATR-US, V151, P34, DOI 10.1016/j.jpeds.2007.02.032; Simoes EAF, 2010, J ALLERGY CLIN IMMUN, V126, P256, DOI 10.1016/j.jaci.2010.05.026; Stein R, 1999, LANCET, V354, P541, DOI 10.1016/S0140-6736(98)10321-5; Stensballe LG, 2009, J ALLERGY CLIN IMMUN, V123, P131, DOI 10.1016/j.jaci.2008.10.042; Szabo Shelagh M, 2013, Paediatr Respir Rev, V13 Suppl 2, pS9, DOI 10.1016/S1526-0542(12)70161-6; Takeyama A, 2014, EUR J PEDIATR, V173, P959, DOI 10.1007/s00431-014-2277-7; Tapia LI, 2013, INFECT GENET EVOL, V16, P54, DOI 10.1016/j.meegid.2012.12.030; Yoshihara S, 2013, PEDIATRICS, V132, P811, DOI 10.1542/peds.2013-0982; Zomer-Kooijker K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087162	49	44	45	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0125422	10.1371/journal.pone.0125422	http://dx.doi.org/10.1371/journal.pone.0125422			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955487	Green Published, gold			2022-12-26	WOS:000356768100053
J	Lees, AC; Moura, NG; de Almeida, AS; Vieira, ICG				Lees, Alexander C.; Moura, Nargila G.; de Almeida, Arlete Silva; Vieira, Ima C. G.			Poor Prospects for Avian Biodiversity in Amazonian Oil Palm	PLOS ONE			English	Article							CONSERVATION VALUE; FOREST; PLANTATIONS; SECONDARY; BIRDS; AGRICULTURE; LANDSCAPES; BIODIESEL; HABITATS; STATE	Expansion of oil palm plantations across the humid tropics has precipitated massive loss of tropical forest habitats and their associated speciose biotas. Oil palm plantation monocultures have been identified as an emerging threat to Amazonian biodiversity, but there are no quantitative studies exploring the impact of these plantations on the biome's biota. Understanding these impacts is extremely important given the rapid projected expansion of oil palm cultivation in the basin. Here we investigate the biodiversity value of oil palm plantations in comparison with other dominant regional land-uses in Eastern Amazonia. We carried out bird surveys in oil palm plantations of varying ages, primary and secondary forests, and cattle pastures. We found that oil palm plantations retained impoverished avian communities with a similar species composition to pastures and agrarian land-uses and did not offer habitat for most forest-associated species, including restricted range species and species of conservation concern. On the other hand, the forests that the oil palm companies are legally obliged to protect hosted a relatively species-rich community including several globally-threatened bird species. We consider oil palm to be no less detrimental to regional biodiversity than other agricultural land-uses and that political pressure exerted by large landowners to allow oil palm to count as a substitute for native forest vegetation in private landholdings with forest restoration deficits would have dire consequences for regional biodiversity.	[Lees, Alexander C.; Moura, Nargila G.; de Almeida, Arlete Silva; Vieira, Ima C. G.] Museu Paraense Emilio Goeldi, Belem, Para, Brazil; [de Almeida, Arlete Silva; Vieira, Ima C. G.] Fed Univ Para, Museu Paraense Emilio Goeldi, Programa Posgrad Ciencias Ambientais, BR-66059 Belem, Para, Brazil	Museu Paraense Emilio Goeldi; Museu Paraense Emilio Goeldi; Universidade Federal do Para	Lees, AC (corresponding author), Museu Paraense Emilio Goeldi, Belem, Para, Brazil.	alexanderlees@btopenworld.com	Vieira, Ima C.G./H-6897-2012; Lees, Alexander Charles/S-2443-2019	Vieira, Ima C.G./0000-0003-1233-318X; Lees, Alexander Charles/0000-0001-7603-9081	Instituto Nacional de Ciencia e Tecnologia, Biodiversidade e Uso da Terra na Amazonia (CNPq) [574008/2008-0]; CNPq [CNPq 306368/2013-7]	Instituto Nacional de Ciencia e Tecnologia, Biodiversidade e Uso da Terra na Amazonia (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	We are grateful to the Instituto Nacional de Ciencia e Tecnologia, Biodiversidade e Uso da Terra na Amazonia (CNPq grant 574008/2008-0), for financial support; CNPq for the Science without Borders Program's Fellowship to ACL and for a postdoctoral fellowship grant to NGM, as well as a CNPq for Research Productivity grant (CNPq 306368/2013-7) to ICGV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandratos N, 1999, P NATL ACAD SCI USA, V96, P5908, DOI 10.1073/pnas.96.11.5908; Almeida Arlete Silva de, 2014, Rev. Ambient. Água, V9, P476, DOI 10.4136/ambi-agua.1410; Aratrakorn S, 2006, BIRD CONSERV INT, V16, P71, DOI 10.1017/S0959270906000062; Barlow J, 2007, P NATL ACAD SCI USA, V104, P18555, DOI 10.1073/pnas.0703333104; Basiron Y, 2009, COMMUNICATION; Bastos TX, 2001, REV BRAS AGROMET, V9, P564; Bhagwat SA, 2008, CONSERV BIOL, V22, P1368, DOI 10.1111/j.1523-1739.2008.01026.x; Bird JP, 2012, DIVERS DISTRIB, V18, P273, DOI 10.1111/j.1472-4642.2011.00843.x; BirdLife International, 2014, IUCN RED LIST THREAT; Brockerhoff EG, 2008, BIODIVERS CONSERV, V17, P925, DOI 10.1007/s10531-008-9380-x; Burnham K P, 2003, MODEL SELECT MULTIMO; Butler RA, 2009, TROP CONSERV SCI, V2, P1, DOI 10.1177/194008290900200102; CBRO-Comite Brasileiro de Registros Ornitologicos, 2014, LIST AV BRAS, V11th; Cerqueira PV, 2012, WIKI AVES ENCICLOPED; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; CLARKE KR, 1988, MAR ECOL PROG SER, V46, P213, DOI 10.3354/meps046213; Clarke KR, 2006, PRIMER VER 6 USER MA; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Corley R., 2003, OIL PALM; Corley RHV, 2009, ENVIRON SCI POLICY, V12, P134, DOI 10.1016/j.envsci.2008.10.011; Danielsen F, 2009, CONSERV BIOL, V23, P348, DOI 10.1111/j.1523-1739.2008.01096.x; Droulers M, 2010, CONFINS, V10, DOI [10.4000/confins.6867, DOI 10.4000/CONFINS.6867]; Edwards DP, 2014, ECOL APPL, V24, P2029, DOI 10.1890/14-0010.1; Edwards DP, 2012, CONSERV LETT, V5, P20, DOI 10.1111/j.1755-263X.2011.00209.x; Edwards DP, 2011, P ROY SOC B-BIOL SCI, V278, P82, DOI 10.1098/rspb.2010.1062; Edwards DP, 2010, CONSERV LETT, V3, P236, DOI 10.1111/j.1755-263X.2010.00107.x; (EPE) Ministerio de Minas e Energia and Empresa de Pesquisa Energetica, 2006, DEC PLAN EL EN EXP 2; Falesi IC, 1964, B TECNICO, V44; FERREIRA L. V, 2010, ZONEAMENTO ECOLOGICO, V2, P25; Fitzherbert EB, 2008, TRENDS ECOL EVOL, V23, P538, DOI 10.1016/j.tree.2008.06.012; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Foster WA, 2011, PHILOS T R SOC B, V366, P3277, DOI 10.1098/rstb.2011.0041; Gardner TA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0166; Gibbs HK, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/3/034001; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Gilroy JJ, 2015, GLOBAL CHANGE BIOL, V21, P1531, DOI 10.1111/gcb.12696; Vieira ICG, 2014, FORESTS, V5, P1737, DOI 10.3390/f5071737; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Henriques Luiza Magalli Pinto, 2003, Ornitologia Neotropical, V14, P307; INPE, 2014, MONITORAMENTO DA FLO; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Koh LP, 2008, BIOL CONSERV, V141, P2450, DOI 10.1016/j.biocon.2008.08.005; Koh LP, 2008, J APPL ECOL, V45, P1002, DOI 10.1111/j.1365-2664.2008.01491.x; Koh LP, 2009, TRENDS ECOL EVOL, V24, P431, DOI 10.1016/j.tree.2009.03.012; Koh LP, 2009, TRENDS ECOL EVOL, V24, P67, DOI 10.1016/j.tree.2008.09.006; Koh LP, 2007, CONSERV BIOL, V21, P1373, DOI 10.1111/j.1523-1739.2007.00771.x; Lees AC, 1826, PTEROGLOSSUS BITORQU; Lees AC, 2008, CONSERV BIOL, V22, P439, DOI 10.1111/j.1523-1739.2007.00870.x; Lees Alexander C., 2014, BULLETIN OF THE BRITISH ORNITHOLOGISTS CLUB, V134, P247; Lees Alexander C., 2013, BULLETIN OF THE BRITISH ORNITHOLOGISTS CLUB, V133, P178; Lees AC, 2012, REV BRAS ORNITOL, V20, P93; Lees AC, 2013, NATURE, V497, P188, DOI 10.1038/497188c; Lucey JM, 2014, BIOL CONSERV, V169, P268, DOI 10.1016/j.biocon.2013.11.014; Mahood SP, 2012, BIODIVERS CONSERV, V21, P385, DOI 10.1007/s10531-011-0188-8; MONSERUD RA, 1992, ECOL MODEL, V62, P275, DOI 10.1016/0304-3800(92)90003-W; Moraes Bergson Cavalcanti de, 2005, Acta Amaz., V35, P207, DOI 10.1590/S0044-59672005000200010; Moura NG, 2014, CONSERV BIOL, V28, P1271, DOI 10.1111/cobi.12300; Moura NG, 2013, BIOL CONSERV, V167, P339, DOI 10.1016/j.biocon.2013.08.023; Nelson BW, 1999, FOREST ECOL MANAG, V117, P149, DOI 10.1016/S0378-1127(98)00475-7; Oliveira E. C. P., 2006, Revista Brasileira de Plantas Medicinais, V8, P14; Peh KSH, 2006, DIVERS DISTRIB, V12, P572, DOI 10.1111/j.1366-9516.2006.00257.x; Pousa GPAG, 2007, ENERG POLICY, V35, P5393, DOI 10.1016/j.enpol.2007.05.010; Powell LL, 2013, AUK, V130, P459, DOI 10.1525/auk.2013.12202; PROJETO Terraclass, 2012, MAP US COB TERR AM L; Putz FE, 2010, BIOTROPICA, V42, P10, DOI 10.1111/j.1744-7429.2009.00567.x; R Development Core Team, R LANG ENV STAT COMP; Remsen J.V. Jr, 2003, P162; RSPO, 2007, ROUNDT SUST PALM OIL; Sachs JD, 2009, SCIENCE, V325, P1502, DOI 10.1126/science.1175035; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; SEMA, 2014, DEF CRIT DISP LIC AM; Silva JMD, 2005, CONSERV BIOL, V19, P89; Silveira LF, 2006, DIVERSITY BIREDS MON; Snow D.W., 2004, HDB BIRDS WORLD VOLU, P110; Soares BS, 2006, NATURE, V440, P520, DOI 10.1038/nature04389; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Strassburg BBN, 2014, GLOBAL ENVIRON CHANG, V28, P84, DOI 10.1016/j.gloenvcha.2014.06.001; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; USDA, 2010, IND RIS GLOB DEM FUE; Villela AA, 2014, BIOMASS BIOENERG, V67, P270, DOI 10.1016/j.biombioe.2014.05.005; Zimmer K.J., 2003, P448	81	55	56	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0122432	10.1371/journal.pone.0122432	http://dx.doi.org/10.1371/journal.pone.0122432			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955243	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000356768100006
J	Nightingale, TE; Walhin, JP; Thompson, D; Bilzon, JLJ				Nightingale, Tom Edward; Walhin, Jean-Philippe; Thompson, Dylan; Bilzon, James Lee John			Influence of Accelerometer Type and Placement on Physical Activity Energy Expenditure Prediction in Manual Wheelchair Users	PLOS ONE			English	Article							ACTIVITY MONITORS; ADULTS; VALIDATION; PARTICIPATION; ACTIGRAPH; VALIDITY; PEOPLE; SENSOR	Purpose To assess the validity of two accelerometer devices, at two different anatomical locations, for the prediction of physical activity energy expenditure (PAEE) in manual wheelchair users (MWUs). Methods Seventeen MWUs (36 +/- 10 yrs, 72 +/- 11 kg) completed ten activities; resting, folding clothes, propulsion on a 1% gradient (3,4,5,6 and 7 km.hr(-1)) and propulsion at 4km.hr(-1)(with an additional 8% body mass, 2% and 3% gradient) on a motorised wheelchair treadmill. GT3X+ and GENEActiv accelerometers were worn on the right wrist (W) and upper arm (UA). Linear regression analysis was conducted between outputs from each accelerometer and criterion PAEE, measured using indirect calorimetry. Subsequent error statistics were calculated for the derived regression equations for all four device/location combinations, using a leave-one-out cross-validation analysis. Results Accelerometer outputs at each anatomical location were significantly (p < .01) associated with PAEE (GT3X+-UA; r = 0.68 and GT3X+-W; r = 0.82. GENEActiv-UA; r = 0.87 and GENE-Activ-W; r = 0.88). Mean +/- SD PAEE estimation errors for all activities combined were 15 +/- 45%, 14 +/- 50%, 3 +/- 25% and 4 +/- 26% for GT3X+-UA, GT3X+-W, GENEActiv-UA and GENEActiv-W, respectively. Absolute PAEE estimation errors for devices varied, 19 to 66% for GT3X+-UA, 17 to 122% for GT3X+-W, 15 to 26% for GENEActiv-UA and from 17.0 to 32% for the GENEActiv-W. Conclusion The results indicate that the GENEActiv device worn on either the upper arm or wrist provides the most valid prediction of PAEE in MWUs. Variation in error statistics between the two devices is a result of inherent differences in internal components, on-board filtering processes and outputs of each device.	[Nightingale, Tom Edward; Walhin, Jean-Philippe; Thompson, Dylan; Bilzon, James Lee John] Univ Bath, Dept Hlth, Ctr DisAbil Sport & Hlth DASH, Bath BA2 7AY, Somerset, England	University of Bath	Bilzon, JLJ (corresponding author), Univ Bath, Dept Hlth, Ctr DisAbil Sport & Hlth DASH, Bath BA2 7AY, Somerset, England.	J.Bilzon@bath.ac.uk	Nightingale, Tom E/Q-8525-2019	Nightingale, Tom E/0000-0003-2947-4931; Bilzon, James/0000-0002-6701-7603				Atkin AJ, 2012, INT J EPIDEMIOL, V41, P1460, DOI 10.1093/ije/dys118; Bailey RR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103135; Bassett DR, 2012, MED SCI SPORT EXER, V44, pS32, DOI 10.1249/MSS.0b013e3182399cf7; Bassett DR, 2000, MED SCI SPORT EXER, V32, pS471, DOI 10.1097/00005768-200009001-00006; Biolo G, 2005, J RENAL NUTR, V15, P49, DOI 10.1053/j.jrn.2004.09.009; Blacker S.D., 2009, MED SPORT, V13, P116, DOI DOI 10.2478/v10036-009-0018-1; Bland JM, 2010, INT J NURS STUD, V47, P931, DOI 10.1016/j.ijnurstu.2009.10.001; Bouten CVC, 1997, MED BIOL ENG COMPUT, V35, P50, DOI 10.1007/BF02510392; Buchholz AC, 2004, CURR OPIN CLIN NUTR, V7, P635, DOI 10.1097/00075197-200411000-00008; Buchholz AC, 2009, APPL PHYSIOL NUTR ME, V34, P640, DOI 10.1139/H09-050; Cardenas D, 2006, TOP SPINAL CORD INJ, V11, P12, DOI DOI 10.1310/FAEH-YGYJ-Q4LF-0X6W; Chen KY, 2005, MED SCI SPORT EXER, V37, pS490, DOI 10.1249/01.mss.0000185571.49104.82; Clasey JL, 2007, TOP SPINAL CORD INJ, V12, P8, DOI DOI 10.1310/SCI1204-8; Compher C, 2006, J AM DIET ASSOC, V106, P881, DOI 10.1016/j.jada.2006.02.009; Conger SA, 2015, J PHYS ACT IN PRESS; Conger SA, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2014-093540; Coulter EH, 2011, SPINAL CORD, V49, P445, DOI 10.1038/sc.2010.126; Davis GM, 2010, MED SCI SPORT EXER, V42, P335, DOI 10.1249/01.MSS.0000384600.02816.fc; Esliger DW, 2011, MED SCI SPORT EXER, V43, P1085, DOI 10.1249/MSS.0b013e31820513be; Garcia-Masso X, 2013, SPINAL CORD, V51, P898, DOI 10.1038/sc.2013.85; Ginis KAM, 2011, SPINAL CORD, V49, P1088, DOI 10.1038/sc.2011.63; Ginis KAM, 2005, MED SCI SPORT EXER, V37, P1099, DOI 10.1249/01.mss.0000170127.54394.eb; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hastie Y., 2009, ELEMENTS STAT LEARNI; Hetz SP, 2009, ARCH PHYS MED REHAB, V90, P1755, DOI 10.1016/j.apmr.2009.04.021; Hiremath SV, 2012, ARCH PHYS MED REHAB, V93, P1937, DOI 10.1016/j.apmr.2012.05.004; Hiremath SV, 2011, J SPINAL CORD MED, V34, P110, DOI 10.1179/107902610X12911165975142; Hiremath SV, 2009, IEEE ENG MED BIO, P835, DOI 10.1109/IEMBS.2009.5333626; Hiremath SV, 2011, REGRESSION EQUATIONS; Intille SS, 2012, MED SCI SPORT EXER, V44, pS24, DOI 10.1249/MSS.0b013e3182399c7d; John D, 2012, MED SCI SPORT EXER, V44, pS86, DOI 10.1249/MSS.0b013e3182399f5e; Nightingale TE, 2014, MED SCI SPORT EXER, V46, P1849, DOI 10.1249/MSS.0000000000000291; Parvataneni L, 2009, CLIN BIOMECH, V24, P95, DOI 10.1016/j.clinbiomech.2008.07.002; Ried-Larsen M, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-113; Sagawa Y, 2010, ARCH PHYS MED REHAB, V91, P1248, DOI 10.1016/j.apmr.2010.05.011; Sallis JF, 2000, RES Q EXERCISE SPORT, V71, pS1, DOI 10.1080/02701367.2000.11082780; Staudenmayer J, 2012, MED SCI SPORT EXER, V44, pS61, DOI 10.1249/MSS.0b013e3182399e0f; Tanhoffer RA, 2015, J PHYS ACT HEALTH, V12, P163, DOI 10.1123/jpah.2013-0190; Ullrich PM, 2012, J REHABIL RES DEV, V49, P155, DOI 10.1682/JRRD.2010.06.0108; Washburn RA, 1999, ADAPT PHYS ACT Q, V16, P290, DOI 10.1123/apaq.16.3.290	40	25	25	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0126086	10.1371/journal.pone.0126086	http://dx.doi.org/10.1371/journal.pone.0126086			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955304	Green Submitted, Green Published, gold			2022-12-26	WOS:000356768100095
J	Wang, AP; Ling, ZX; Yang, ZX; Kiela, PR; Wang, T; Wang, C; Cao, L; Geng, F; Shen, MQ; Ran, XZ; Su, YP; Cheng, TM; Wang, JP				Wang, Aiping; Ling, Zongxin; Yang, Zhixiang; Kiela, Pawel R.; Wang, Tao; Wang, Cheng; Cao, Le; Geng, Fang; Shen, Mingqiang; Ran, Xinze; Su, Yongping; Cheng, Tianmin; Wang, Junping			Gut Microbial Dysbiosis May Predict Diarrhea and Fatigue in Patients Undergoing Pelvic Cancer Radiotherapy: A Pilot Study	PLOS ONE			English	Article							PLASMA CITRULLINE CONCENTRATION; BOWEL FUNCTION; RADIATION; DIVERSITY; DISEASE; MARKER; TOOL	Fatigue and diarrhea are the most frequent adverse effects of pelvic radiotherapy, while their etiologies are largely unknown. The aim of this study is to investigate the correlations between fatigue, diarrhea, and alterations in gut microbiota induced by pelvic radiotherapy. During the 5-week treatment of pelvic radiotherapy in 11 cancer patients, the general fatigue score significantly increased and was more prominent in the patients with diarrhea. The fatigue score was closely correlated with the decrease of serum citrulline (an indicator of the functional enterocyte mass) and the increases of systemic inflammatory proteins, including haptoglobin, orosomuoid, alpha(1)-antitrypsin and TNF-alpha. Serum level of lipopolysaccharide (LPS) was also elevated, especially in the patients with diarrhea indicating epithelial barrier breach and endotoxemia. Pyrosequencing analysis of 16S rRNA gene revealed that microbial diversity, richness, and the Firmicutes/Bacteroidetes ratio were significantly altered prior to radiotherapy in patients who later developed diarrhea. Pelvic radiotherapy induced further changes in fecal microbial ecology, some of which were specific to the patients with or without diarrhea. Our results indicate that gut microbial dysbiosis prior to radiation therapy may be exploited to predict development of diarrhea and to guide preventive treatment options. Radiation-induced dysbiosis may contribute to pelvic radiation disease, including mucositis, diarrhea, systemic inflammatory response, and pelvic radiotherapy-associated fatigue in cancer patients.	[Wang, Aiping; Wang, Tao; Wang, Cheng; Cao, Le; Geng, Fang; Shen, Mingqiang; Ran, Xinze; Su, Yongping; Cheng, Tianmin; Wang, Junping] Third Mil Med Univ, Coll Prevent Med, State Key Lab Trauma Burns & Combined Injury, Chongqing Engn Res Ctr Nanomed,Inst Combined Inju, Chongqing, Peoples R China; [Ling, Zongxin] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Yang, Zhixiang] Chongqing Zhongshan Hosp, Dept Oncol, Chongqing, Peoples R China; [Kiela, Pawel R.] Univ Arizona, Coll Med, Dept Pediat, Tucson, AZ USA; [Kiela, Pawel R.] Univ Arizona, Coll Med, Dept Immunobiol, Tucson, AZ USA	Army Medical University; Zhejiang University; University of Arizona; University of Arizona	Wang, JP (corresponding author), Third Mil Med Univ, Coll Prevent Med, State Key Lab Trauma Burns & Combined Injury, Chongqing Engn Res Ctr Nanomed,Inst Combined Inju, Chongqing, Peoples R China.	wangjunping@tmmu.edu.cn	Ling, Zongxin/AAM-4059-2021; Wang, Cheng/AAK-7457-2021; Kiela, Pawel/AAF-5320-2020; Ling, Zongxin/M-1657-2018	Wang, Cheng/0000-0002-6690-6433; Ling, Zongxin/0000-0001-9662-099X; Kiela, Pawel/0000-0002-0014-3517; Wang, Cheng/0000-0001-5850-4533	National Natural Science Foundation of China grants (NSFC) [81172600, 81272101]; NSFC grant [81000831, 81271898]; National medical science "The Twelfth Five-year Plan" key project of China grant [BWS11J009]; Independent Research Grants of the State Key Laboratory of Trauma, Burn and Combined Injury [SKLZZ201114, SKLZZ201021, SKLZZ201202]; NIH grant [5R01-DK041274]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041274] Funding Source: NIH RePORTER	National Natural Science Foundation of China grants (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC grant(National Natural Science Foundation of China (NSFC)); National medical science "The Twelfth Five-year Plan" key project of China grant; Independent Research Grants of the State Key Laboratory of Trauma, Burn and Combined Injury; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Natural Science Foundation of China grants (NSFC) 81172600, 81272101 to Aiping Wang, NSFC grant 81000831, 81271898 to Junping Wang, National medical science "The Twelfth Five-year Plan" key project of China grant BWS11J009 to Junping Wang, Independent Research Grants of the State Key Laboratory of Trauma, Burn and Combined Injury SKLZZ201114, SKLZZ201021, SKLZZ201202 to Aiping Wang, the NIH grant 5R01-DK041274 to Pawel R. Kiela. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abayomi J, 2005, J HUM NUTR DIET, V18, P353, DOI 10.1111/j.1365-277X.2005.00633.x; Ahlberg K, 2005, INT J NURS STUD, V42, P377, DOI 10.1016/j.ijnurstu.2004.07.008; Andreyev HJN, 2010, LANCET ONCOL, V11, P310, DOI 10.1016/S1470-2045(10)70026-7; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atherton PJ, 2013, SUPPORT CARE CANCER, V21, P1193, DOI 10.1007/s00520-012-1648-8; Crawford PA, 2005, P NATL ACAD SCI USA, V102, P13254, DOI 10.1073/pnas.0504830102; Crenn P, 2000, GASTROENTEROLOGY, V119, P1496, DOI 10.1053/gast.2000.20227; Delia P, 2002, AM J GASTROENTEROL, V97, P2150; Ferreira MR, 2014, LANCET ONCOL, V15, pE139, DOI 10.1016/S1470-2045(13)70504-7; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Fuccio Lorenzo, 2015, World J Gastrointest Pharmacol Ther, V6, P1, DOI 10.4292/wjgpt.v6.i1.1; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Haddock MG, 2007, J CLIN ONCOL, V25, P1255, DOI 10.1200/JCO.2006.09.0001; Hagelin CL, 2007, ACTA ONCOL, V46, P97, DOI 10.1080/02841860601009430; Hauer-Jensen M, 2014, NAT REV GASTRO HEPAT, V11, P470, DOI 10.1038/nrgastro.2014.46; Hogan NM, 2013, CURR PROB SURG, V50, P395, DOI 10.1067/j.cpsurg.2013.04.004; Jakobsson S, 2010, ONCOLOGIST, V15, P1009, DOI 10.1634/theoncologist.2010-0097; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kim YS, 2015, ANAEROBE, V33, P1, DOI 10.1016/j.anaerobe.2015.01.004; Ling ZX, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-390; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Lutgens LCHW, 2004, INT J RADIAT ONCOL, V60, P275, DOI 10.1016/j.ijrobp.2004.02.052; Manichanh C, 2008, AM J GASTROENTEROL, V103, P1754, DOI 10.1111/j.1572-0241.2008.01868.x; Mayer EA, 2014, J NEUROSCI, V34, P15490, DOI 10.1523/JNEUROSCI.3299-14.2014; Miquel S, 2013, CURR OPIN MICROBIOL, V16, P255, DOI 10.1016/j.mib.2013.06.003; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rosen GL, 2011, BIOINFORMATICS, V27, P127, DOI 10.1093/bioinformatics/btq619; Ryan JL, 2007, ONCOLOGIST, V12, P22, DOI 10.1634/theoncologist.12-S1-22; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schubert C, 2007, BRAIN BEHAV IMMUN, V21, P413, DOI 10.1016/j.bbi.2006.11.004; Touchefeu Y, 2014, ALIMENT PHARM THER, V40, P409, DOI 10.1111/apt.12878; Trotti A, 2000, INT J RADIAT ONCOL, V47, P13, DOI 10.1016/S0360-3016(99)00559-3; Urbancsek H, 2001, EUR J GASTROEN HEPAT, V13, P391, DOI 10.1097/00042737-200104000-00015; Wedlake L, 2008, ALIMENT PHARM THER, V27, P980, DOI 10.1111/j.1365-2036.2008.03663.x	34	110	116	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0126312	10.1371/journal.pone.0126312	http://dx.doi.org/10.1371/journal.pone.0126312			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955845	gold, Green Published, Green Submitted			2022-12-26	WOS:000356768100111
J	Wang, L; Yang, H; Lei, Z; Zhao, J; Chen, Y; Chen, P; Li, C; Zeng, Y; Liu, Z; Liu, X; Zhang, HT				Wang, L.; Yang, H.; Lei, Z.; Zhao, J.; Chen, Y.; Chen, P.; Li, C.; Zeng, Y.; Liu, Z.; Liu, X.; Zhang, H-T			Repression of TIF gamma by SOX2 promotes TGF-beta-induced epithelial-mesenchymal transition in non-small-cell lung cancer	ONCOGENE			English	Article							TUMOR-SUPPRESSOR; TRANSCRIPTION FACTORS; MULTIPLE ROLES; GROWTH; METASTASIS; EXPRESSION; TIF1-GAMMA; SMAD4; PROGRESSION; SURVIVAL	TIF1 gamma is a novel regulator of transforming growth factor (TGF)-beta/Smad signaling. Our previous studies show that dysregulated expression of transcriptional intermediary factor 1 gamma (TIF1 gamma) and abnormal TGF-beta/Smad signaling are implicated in non-small-cell lung cancer (NSCLC) separately. However, how TIF1 gamma contributes to NSCLC by controlling TGF-beta/Smad signaling is poorly understood. Here, we investigated the mechanistic role of TIF1 gamma in TGF-beta-induced epithelial-mesenchymal transition (EMT), as well as a link between TIF1 gamma and SOX2 in NSCLC. We show that TIF1 gamma is a downstream target of SOX2 in NSCLC cells. SOX2 overexpression negatively regulated TIF1 gamma promoter activity and thereby attenuated TIF1 gamma mRNA and protein expression levels; SOX2 knockdown significantly enhanced TIF1 gamma promoter activity and augmented TIF1 gamma expression. Moreover, TIF1 gamma mRNA expression was downregulated in human NSCLC tissues and negatively correlated with SOX2 protein, which was upregulated in NSCLC tissues. Importantly, knockdown of TIF1 gamma or SOX2 overexpression augmented SMAD4 (human Mad (mothers against decapentaplegic)-related homologous protein 4)-dependent transcriptional responses, and enhanced TGF-beta-induced EMT and human NSCLC cell invasion; knockdown of SOX2 impaired TGF-beta-induced EMT and NSCLC cell invasion. In an in vivo model of metastasis, knockdown of TIF1 gamma promotes NSCLC cell metastasis. In addition, our data suggested that TIF1 gamma inhibited TGF-beta-induced EMT through competing with SMAD4 in NSCLC cells. Taken together, our findings reveal a new mechanism by which SOX2-mediated transcription repression of TIF1 gamma promotes TGF-beta-induced EMT in NSCLC.	[Wang, L.; Yang, H.; Lei, Z.; Liu, X.; Zhang, H-T] Soochow Univ, Coll Med, Lab Canc Mol Genet, 199 Renai Rd,Sinosingapore Ind Pk, Suzhou 215123, Peoples R China; [Wang, L.; Yang, H.; Lei, Z.; Zhao, J.; Li, C.; Zeng, Y.; Liu, Z.; Liu, X.; Zhang, H-T] Suzhou Key Lab Mol Canc Genet, Suzhou, Peoples R China; [Zhao, J.; Li, C.; Zeng, Y.; Liu, Z.] Soochow Univ, Dept Thorac & Cardiovasc Surg, Affiliated Hosp 1, Coll Med, Suzhou, Peoples R China; [Chen, Y.] Soochow Univ, Coll Med, Affiliated Hosp 2, Dept Thorac & Cardiovasc Surg, Suzhou, Peoples R China; [Chen, P.] Genome Scale Biol, Res Programs Unit, Syst Biol Lab, Haartmaninkatu 8, Helsinki, Finland; [Chen, P.] Univ Helsinki, Fac Med, Inst Biomed Biochem & Dev Biol, Haartmaninkatu 8, Helsinki, Finland	Soochow University - China; Soochow University - China; Soochow University - China; University of Helsinki	Zhang, HT (corresponding author), Soochow Univ, Coll Med, Lab Canc Mol Genet, 199 Renai Rd,Sinosingapore Ind Pk, Suzhou 215123, Peoples R China.	htzhang@suda.edu.cn	Chen, Ping/AAL-8264-2020; Lei, Zhe/AGZ-4963-2022; Zhang, Hong-Tao/P-9661-2017	Chen, Ping/0000-0002-8068-1891; Zhang, Hong-Tao/0000-0003-4182-421X	National Natural Science Foundation of China [81372277, 81171894, 81201575]; Jiangsu Province's Key Provincial Talents Program [RC2011106]; '333' Project of Jiangsu Province Government; Graduate Innovation Project of Jiangsu Province [CXZZ13_0830]; Soochow Scholar Project of Soochow University; Suzhou Key Laboratory for Molecular Cancer Genetics [SZS201209]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province's Key Provincial Talents Program; '333' Project of Jiangsu Province Government; Graduate Innovation Project of Jiangsu Province; Soochow Scholar Project of Soochow University; Suzhou Key Laboratory for Molecular Cancer Genetics; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	We are grateful for participation and cooperation from the patients with NSCLC. This work was supported in part by the grants from National Natural Science Foundation of China (81372277, 81171894 and 81201575), Jiangsu Province's Key Provincial Talents Program (RC2011106), '333' Project of Jiangsu Province Government, Graduate Innovation Project of Jiangsu Province (CXZZ13_0830), Soochow Scholar Project of Soochow University, Suzhou Key Laboratory for Molecular Cancer Genetics (SZS201209) and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Akhurst RJ, 1999, J PATHOL, V187, P82, DOI 10.1002/(SICI)1096-9896(199901)187:1<82::AID-PATH248>3.0.CO;2-8; Asselin-Paturel C, 1998, INT J CANCER, V77, P7, DOI 10.1002/(SICI)1097-0215(19980703)77:1<7::AID-IJC2>3.0.CO;2-Y; Aucagne R, 2011, J CLIN INVEST, V121, P2361, DOI 10.1172/JCI45213; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bennett WP, 1998, CLIN CANCER RES, V4, P1499; Deckers M, 2006, CANCER RES, V66, P2202, DOI 10.1158/0008-5472.CAN-05-3560; Dupont S, 2005, CELL, V121, P87, DOI 10.1016/j.cell.2005.01.033; Fang WT, 2014, INT J CANCER, V135, P809, DOI 10.1002/ijc.28734; Fattet L, 2013, J CELL SCI, V126, P3713, DOI 10.1242/jcs.126748; Feng J, 2012, AM J CLIN PATHOL, V138, P230, DOI 10.1309/AJCPDHQFNYJZ01YG; Gontan C, 2008, DEV BIOL, V317, P296, DOI 10.1016/j.ydbio.2008.02.035; Gregory PA, 2011, MOL BIOL CELL, V22, P1686, DOI 10.1091/mbc.E11-02-0103; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Han G, 2005, J CLIN INVEST, V115, P1714, DOI 10.1172/JCI24399; Han X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041335; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Hesling C, 2011, EMBO REP, V12, P665, DOI 10.1038/embor.2011.78; Jeon HS, 2010, J THORAC ONCOL, V5, P417, DOI 10.1097/JTO.0b013e3181ce3afd; Justilien V, 2014, CANCER CELL, V25, P139, DOI 10.1016/j.ccr.2014.01.008; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Lei Z, 2014, FASEB J, V28, P2696, DOI 10.1096/fj.13-247288; Lei Z, 2009, CANCER RES, V69, P7046, DOI 10.1158/0008-5472.CAN-08-4602; Li XF, 2013, CANCER LETT, V336, P379, DOI 10.1016/j.canlet.2013.03.027; Liu KC, 2013, CELL SIGNAL, V25, P1264, DOI 10.1016/j.cellsig.2013.02.013; Liu RY, 2014, INT J ONCOL, V44, P1643, DOI 10.3892/ijo.2014.2310; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Meulmeester E, 2011, J PATHOL, V223, P205, DOI 10.1002/path.2785; Nakatsugawa M, 2011, LAB INVEST, V91, P1796, DOI 10.1038/labinvest.2011.140; Park C, 2002, LUNG CANCER-J IASLC, V38, P143, DOI 10.1016/S0169-5002(02)00182-4; Pirozzi G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021548; Principe DR, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt369; Qian Q, 2014, INT J ONCOL, V44, P874, DOI 10.3892/ijo.2014.2255; Que JW, 2009, DEVELOPMENT, V136, P1899, DOI 10.1242/dev.034629; Szymanowska-Narloch A, 2013, ADV MED SCI-POLAND, V58, P196, DOI 10.2478/ams-2013-0025; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Venturini L, 1999, ONCOGENE, V18, P1209, DOI 10.1038/sj.onc.1202655; Vincent DF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000575; Wang Longqiang, 2013, Zhongguo Fei Ai Za Zhi, V16, P227, DOI 10.3779/j.issn.1009-3419.2013.05.02; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Xu Wei, 2013, Zhongguo Fei Ai Za Zhi, V16, P591, DOI 10.3779/j.issn.1009-3419.2013.11.05; Xue JF, 2014, J CLIN INVEST, V124, P564, DOI 10.1172/JCI71104; Zhang HT, 2004, CLIN CANCER RES, V10, P2359, DOI 10.1158/1078-0432.CCR-0959-3; Zhao J, 2008, J CANCER RES CLIN, V134, P919, DOI 10.1007/s00432-008-0392-4; Zhou CH, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-18	47	51	58	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 18	2016	35	7					867	877		10.1038/onc.2015.141	http://dx.doi.org/10.1038/onc.2015.141			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DE0RO	25961934				2022-12-26	WOS:000370332200007
J	Mortusewicz, O; Evers, B; Helleday, T				Mortusewicz, O.; Evers, B.; Helleday, T.			PC4 promotes genome stability and DNA repair through binding of ssDNA at DNA damage sites	ONCOGENE			English	Article							DOUBLE-STRAND BREAKS; TRANSCRIPTIONAL COACTIVATOR PC4; ONCOGENE-INDUCED SENESCENCE; MAMMALIAN-CELLS; HOMOLOGOUS RECOMBINATION; REPLICATION FORKS; FRAGILE SITES; COFACTOR PC4; RPA; ACTIVATION	The transcriptional cofactor PC4 is an ancient single-strand DNA (ssDNA)-binding protein that has a homologue in bacteriophage TS where it is likely the elusive replicative ssDNA-binding protein. We hypothesize that human PC4 has retained functions in ssDNA binding to stabilize replication forks and prevent genome instability in mammalian cells, Here we demonstrate that PC4 is recruited to hydroxyurea (HU)-stalled replication forks, which is dependent on active transcription and its ssDNA-binding ability. Interestingly, we demonstrate that ssDNA binding by PC4 is critical to suppress spontaneous DNA damage and promote cellular survival. PC4 accumulation co-localizes with replication protein A (RPA) at stalled forks and is increased upon RPA depletion, demonstrating compensatory functions in ssDNA binding. Depletion of PC4 not only results in defective resolution of HU-induced DNA damage but also significantly reduces homologous recombination repair efficiency. Altogether, our results indicate that PC4 has similar functions to RPA in binding ssDNA to promote genome stability, especially at sites of replication transcription collisions,	[Mortusewicz, O.; Evers, B.; Helleday, T.] Karolinska Inst, Dept Med Biochem & Biophys, Div Translat Med & Chem Biol, Sci Life Lab, Box 1031, S-17121 Stockholm, Sweden; [Evers, B.] Netherlands Canc Inst, Div Mol Carcinogenesis, Amsterdam, Netherlands	Karolinska Institutet; Netherlands Cancer Institute	Mortusewicz, O; Helleday, T (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Translat Med & Chem Biol, Sci Life Lab, Box 1031, S-17121 Stockholm, Sweden.	oliver.mortusewicz@scilifelab.se; thomas.helleday@scilifelab.se		Helleday, Thomas/0000-0002-7384-092X	Swedish Research Council; Swedish Cancer Society; EMBO LTF [O.M. 451-2010]; Dutch Cancer Society (BE); Torsten and Ragnar Soderberg Foundation; AXA foundation; Goran Gustafsson Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); EMBO LTF(European Molecular Biology Organization (EMBO)); Dutch Cancer Society (BE); Torsten and Ragnar Soderberg Foundation; AXA foundation; Goran Gustafsson Foundation	We would like to express our gratitude to Annette Medhurst and Songmin Ying for help with the fibre assay, Guy Kingham for assistance on the DR-GFP assay and to Mick Woodcock for support with the FACS analysis. This project was supported by the Swedish Research Council, Swedish Cancer Society, EMBO LTF (O.M. 451-2010), Dutch Cancer Society (BE), the Torsten and Ragnar Soderberg Foundation, AXA foundation and the Goran Gustafsson Foundation.	Alabert C, 2014, NAT CELL BIOL, V16, P281, DOI 10.1038/ncb2918; Arnaudeau C, 2001, J MOL BIOL, V307, P1235, DOI 10.1006/jmbi.2001.4564; Aymard F, 2014, NAT STRUCT MOL BIOL, V21, P366, DOI 10.1038/nsmb.2796; Barlow JH, 2013, CELL, V152, P620, DOI 10.1016/j.cell.2013.01.006; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Batta K, 2009, J MOL BIOL, V385, P788, DOI 10.1016/j.jmb.2008.11.008; Brandsen J, 1997, NAT STRUCT BIOL, V4, P900, DOI 10.1038/nsb1197-900; Das C, 2006, MOL CELL BIOL, V26, P8303, DOI 10.1128/MCB.00887-06; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Feijoo C, 2001, J CELL BIOL, V154, P913, DOI 10.1083/jcb.200104099; GE H, 1994, CELL, V78, P513, DOI 10.1016/0092-8674(94)90428-6; KAISER K, 1995, EMBO J, V14, P3520, DOI 10.1002/j.1460-2075.1995.tb07358.x; KRETZSCHMAR M, 1994, CELL, V78, P525, DOI 10.1016/0092-8674(94)90429-4; Lundin C, 2003, J MOL BIOL, V328, P521, DOI 10.1016/S0022-2836(03)00313-9; Mortusewicz O, 2013, EMBO J, V32, P493, DOI 10.1038/emboj.2013.20; Mortusewicz O, 2008, J CELL BIOL, V183, P769, DOI 10.1083/jcb.200808097; Pan ZQ, 1996, J BIOL CHEM, V271, P22111, DOI 10.1074/jbc.271.36.22111; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Sakaguchi K, 2009, FEBS J, V276, P943, DOI 10.1111/j.1742-4658.2008.06841.x; Steigemann B, 2013, J MOL BIOL, V425, P4125, DOI 10.1016/j.jmb.2013.09.001; Suzuki K, 2011, NAT PROTOC, V6, P134, DOI 10.1038/nprot.2010.183; Toledo LI, 2013, CELL, V155, P1088, DOI 10.1016/j.cell.2013.10.043; Vassin VM, 2009, J CELL SCI, V122, P4070, DOI 10.1242/jcs.053702; Wang JY, 2004, MOL CELL BIOL, V24, P6084, DOI 10.1128/MCB.24.13.6084-6093.2004; Werten S, 2006, NAT STRUCT MOL BIOL, V13, P181, DOI 10.1038/nsmb1044; Werten S, 1998, EMBO J, V17, P5103, DOI 10.1093/emboj/17.17.5103; Yu LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058015; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	29	31	31	4	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 11	2016	35	6					761	770		10.1038/onc.2015.135	http://dx.doi.org/10.1038/onc.2015.135			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DE0RF	25961912				2022-12-26	WOS:000370331300009
J	Pang, MF; Georgoudaki, AM; Lambut, L; Johansson, J; Tabor, V; Hagikura, K; Jin, Y; Jansson, M; Alexander, JS; Nelson, CM; Jakobsson, L; Betsholtz, C; Sunds, M; Karlsson, MCI; Fuxe, J				Pang, M-F; Georgoudaki, A-M; Lambut, L.; Johansson, J.; Tabor, V.; Hagikura, K.; Jin, Y.; Jansson, M.; Alexander, J. S.; Nelson, C. M.; Jakobsson, L.; Betsholtz, C.; Sunds, M.; Karlsson, M. C. I.; Fuxe, J.			TGF-beta 1-induced EMT promotes targeted migration of breast cancer cells through the lymphatic system by the activation of CCR7/CCL21-mediated chemotaxis	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CHEMOKINE RECEPTOR 7; NF-KAPPA-B; TGF-BETA; ENDOTHELIAL-CELLS; NODE METASTASIS; VESSEL INVASION; STEM-CELLS; INFLAMMATION; EXPRESSION	Tumor cells frequently disseminate through the lymphatic system during metastatic spread of breast cancer and many other types of cancer. Yet it is not clear how tumor cells make their way into the lymphatic system and how they choose between lymphatic and blood vessels for migration. Here we report that mammary tumor cells undergoing epithelial-mesenchymal transition (EMT) in response to transforming growth factor-beta (TGF-beta 1) become activated for targeted migration through the lymphatic system, similar to dendritic cells (DCs) during inflammation. EMT cells preferentially migrated toward lymphatic vessels compared with blood vessels, both in vivo and in 3D cultures. A mechanism of this targeted migration was traced to the capacity of TGF-beta 1 to promote CCR7/CCL21-mediated crosstalk between tumor cells and lymphatic endothelial cells. On one hand, TGF-beta 1 promoted CCR7 expression in EMT cells through p38 MAP kinase-mediated activation of the JunB transcription factor. Blockade of CCR7, or treatment with a p38 MAP kinase inhibitor, reduced lymphatic dissemination of EMT cells in syngeneic mice. On the other hand, TGF-beta 1 promoted CCL21 expression in lymphatic endothelial cells. CCL21 acted in a paracrine fashion to mediate chemotactic migration of EMT cells toward lymphatic endothelial cells. The results identify TGF-beta 1-induced EMT as a mechanism, which activates tumor cells for targeted, DC-like migration through the lymphatic system. Furthermore, it suggests that p38 MAP kinase inhibition may be a useful strategy to inhibit EMT and lymphogenic spread of tumor cells.	[Pang, M-F; Lambut, L.; Johansson, J.; Tabor, V.; Hagikura, K.; Jin, Y.; Jakobsson, L.; Betsholtz, C.; Fuxe, J.] Karolinska Inst, Dept Med Biochem & Biophys, Div Vasc Biol, SE-17177 Stockholm, Sweden; [Pang, M-F; Nelson, C. M.] Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA; [Georgoudaki, A-M; Karlsson, M. C. I.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, SE-17177 Stockholm, Sweden; [Hagikura, K.] Nihon Univ, Sch Med, Div Cell Regenerat & Transplantat, Dept Funct Morphol, Tokyo, Japan; [Jansson, M.; Sunds, M.] Umea Univ, Dept Surg & Perioperat Sci Surg, Umea, Sweden; [Alexander, J. S.] Louisiana State Univ, Dept Mol & Cellular Physiol, Hlth Sci Ctr, Shreveport, LA 71105 USA	Karolinska Institutet; Princeton University; Karolinska Institutet; Nihon University; Umea University; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Fuxe, J (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Vasc Biol, SE-17177 Stockholm, Sweden.	jonas.fuxe@ki.se	Georgoudaki, Anna-Maria/AAM-9829-2020; Fuxe, Jonas/T-4433-2017; Jakobsson, Lars/B-4200-2011; Nelson, Celeste/AAT-7612-2021	Fuxe, Jonas/0000-0003-4576-9377; Jakobsson, Lars/0000-0001-7956-587X; Nelson, Celeste/0000-0001-9973-8870; Jin, Yi/0000-0001-9704-973X	Swedish Research Council; Swedish Cancer Society; Strategic Cancer Programme at Karolinska Institutet; Nordic Cancer Foundation; Swedish Childhood Cancer Foundation; Stockholm County Council/Karolinska Institutet; Nilsson-Ehle donation; Robert Lundberg foundation; Swedish Society for Medical Research (SSMF); Swedish Medical Society; Magnus Bergvall foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Strategic Cancer Programme at Karolinska Institutet; Nordic Cancer Foundation; Swedish Childhood Cancer Foundation(European Commission); Stockholm County Council/Karolinska Institutet(Stockholm County Council); Nilsson-Ehle donation; Robert Lundberg foundation; Swedish Society for Medical Research (SSMF); Swedish Medical Society; Magnus Bergvall foundation	We thank Drs Carl-Henrik Heldin and Marene Landstrom at the Ludwig Institute for Cancer Research (Uppsala, Sweden) and Dr Lars Holmgren at the Karolinska Institutet (Stockholm, Sweden) for valuable input on the results. We thank Dr Lena Claesson-Welsh at Uppsala University and Dr Jonathan S Alexander (Louisiana State University Health Sciences Center, Shreveport, Louisiana) for providing the lymphatic endothelial cells. We also thank Dr Seonghyang SOHN (Department of Microbiology School of Medicine, Suwon, Korea) for providing the CCL21 construct. JF was supported by project grants from the Swedish Research Council, the Swedish Cancer Society, The Strategic Cancer Programme at Karolinska Institutet, the Nordic Cancer Foundation and the Swedish Childhood Cancer Foundation. M-FP was supported by a PhD fellowship (KID-funding) from Stockholm County Council/Karolinska Institutet, by the Nilsson-Ehle donation, The Robert Lundberg foundation and the Swedish Society for Medical Research (SSMF). MCIK was supported by the Swedish Research Council, the Swedish Cancer Society, the Swedish Medical Society and the Magnus Bergvall foundation. VT was supported by the Swedish Cancer Society.	Baluk P, 2007, J EXP MED, V204, P2349, DOI 10.1084/jem.20062596; Ben-Baruch A, 2003, BREAST CANCER RES, V5, P31, DOI 10.1186/bcr554; Biswas S, 2014, BREAST CANCER RES TR, V143, P265, DOI 10.1007/s10549-013-2811-8; Chladkova B, 2011, J CELL MOL MED, V15, P938, DOI 10.1111/j.1582-4934.2010.01066.x; Chod J, 2008, EUR J GYNAECOL ONCOL, V29, P613; Choi B, 2013, IMMUNOBIOLOGY, V218, P579, DOI 10.1016/j.imbio.2012.07.003; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Cote SC, 2009, MOL IMMUNOL, V46, P2682, DOI 10.1016/j.molimm.2008.08.269; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cunningham HD, 2010, TRANSL ONCOL, V3, P354, DOI 10.1593/tlo.10178; DALAL BI, 1993, AM J PATHOL, V143, P381; Davidson B, 2006, GYNECOL ONCOL, V102, P453, DOI 10.1016/j.ygyno.2006.01.034; Davies M, 2005, J CELL BIOCHEM, V95, P918, DOI 10.1002/jcb.20458; Esteva FJ, 2004, CANCER-AM CANCER SOC, V100, P499, DOI 10.1002/cncr.11940; FISHER B, 1983, CANCER-AM CANCER SOC, V52, P1551, DOI 10.1002/1097-0142(19831101)52:9<1551::AID-CNCR2820520902>3.0.CO;2-3; Fuxe J, 2012, SEMIN CANCER BIOL, V22, P455, DOI 10.1016/j.semcancer.2012.05.004; Fuxe J, 2010, CELL CYCLE, V9, P2363, DOI 10.4161/cc.9.12.12050; Giampieri S, 2009, NAT CELL BIOL, V11, P1287, DOI 10.1038/ncb1973; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Issa A, 2009, CANCER RES, V69, P349, DOI 10.1158/0008-5472.CAN-08-1875; Johansson J, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00003; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kriehuber E, 2001, J EXP MED, V194, P797, DOI 10.1084/jem.194.6.797; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lappin MB, 1999, IMMUNOLOGY, V98, P181; LAURIA R, 1995, CANCER-AM CANCER SOC, V76, P1772, DOI 10.1002/1097-0142(19951115)76:10<1772::AID-CNCR2820761014>3.0.CO;2-O; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mathas S, 2002, EMBO J, V21, P4104, DOI 10.1093/emboj/cdf389; Mburu YK, 2012, J BIOL CHEM, V287, P3581, DOI 10.1074/jbc.M111.294876; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Lopez-Novoa JM, 2009, EMBO MOL MED, V1, P303, DOI 10.1002/emmm.200900043; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nakatsu MN, 2003, MICROVASC RES, V66, P102, DOI 10.1016/S0026-2862(03)00045-1; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; Shields JD, 2007, CANCER CELL, V11, P526, DOI 10.1016/j.ccr.2007.04.020; Sundqvist A, 2013, ONCOGENE, V32, P3606, DOI 10.1038/onc.2012.370; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Van den Eynden GG, 2006, BRIT J CANCER, V94, P1643, DOI 10.1038/sj.bjc.6603152; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; Weaver DL, 2011, NEW ENGL J MED, V364, P412, DOI 10.1056/NEJMoa1008108; Wiley HE, 2001, J NATL CANCER I, V93, P1638, DOI 10.1093/jnci/93.21.1638; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5	47	206	212	0	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 11	2016	35	6					748	760		10.1038/onc.2015.133	http://dx.doi.org/10.1038/onc.2015.133			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DE0RF	25961925	Green Published, hybrid			2022-12-26	WOS:000370331300008
J	Wang, G; Fu, Y; Yang, X; Luo, X; Wang, J; Gong, J; Hu, J				Wang, G.; Fu, Y.; Yang, X.; Luo, X.; Wang, J.; Gong, J.; Hu, J.			Brg-1 targeting of novel miR550a-5p/RNF43/Wnt signaling axis regulates colorectal cancer metastasis	ONCOGENE			English	Article							NUCLEOSOME-REMODELING COMPLEXES; SWI/SNF COMPLEX; HEPATOCELLULAR-CARCINOMA; UBIQUITIN LIGASE; CELL; RNF43; EXPRESSION; MUTATIONS; COMPONENT; FAMILY	Metastasis is one of the main causes of death in patients with colorectal cancer (CRC). Brg-1 is a central component of the SWItch/Sucrose NonFermentable chromatin-remodeling complex, which features a bromodomain and helicase/ATPase activity. The gene encoding Brg-1 is frequently mutated or silenced in human cancers. Several reports have proposed Brg-1 as a tumor suppressor; however, little is known about its role in oncogenesis and metastasis. Here we demonstrated that decreased Brg-1 regulates a novel miR-550a-5p/RNF43/Wnt/beta-catenin signaling pathway, to promote CRC metastasis in vitro and in vivo. In particular, we used high-throughput RNA-sequencing analysis to show that Brg-1 negatively regulates miR-550a-5p in CRC cells. We further found that Brg-1 inhibits the transcriptional activity of miR-550a-5p promoter, and that decreased Brg-1 expression increased miR-550a-5p expression. We also identified ring finger 43 (RNF43), an inhibitor of Wnt/beta-catenin signaling, as a target of miR-550a-5p. Knockdown of Brg-1 by small interfering RNA led to decreased RNF43 expression, increased Wnt signaling and increased CRC cell migration and invasion. This novel pathway defines a new function for Brg-1 and provides potential targets for the treatment of Brg-1 mutant and loss-of-function tumors.	[Wang, G.; Fu, Y.; Yang, X.; Luo, X.; Hu, J.] Huazhong Univ Sci & Technol, Tongji Med Coll, Canc Res Inst, 1095 Jiefang Rd, Wuhan 430030, Peoples R China; [Wang, J.] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Immunol, 1095 Jiefang Rd, Wuhan 430030, Peoples R China; [Gong, J.] Huazhong Univ Sci & Technol, Tongji Hosp, Mol Med Ctr, 1095 Jiefang Rd, Wuhan 430030, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Hu, J (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Canc Res Inst, 1095 Jiefang Rd, Wuhan 430030, Peoples R China.; Hu, J (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Canc Res Inst, 1095 Jiefang Rd, Wuhan 430030, Peoples R China.	jbhu@tjh.tjmu.edu.cn	Wang, Guihua/AAX-3130-2021		National Natural Science foundation [81300411, 81372662]; Fundamental Research Funds for the Central Universities [2015QN144]	National Natural Science foundation(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the National Natural Science foundation (Number. 81300411 and Number. 81372662) and the Fundamental Research Funds for the Central Universities (Number 2015QN144).	Anson M, 2012, J CLIN INVEST, V122, P586, DOI 10.1172/JCI43937; Bai J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059772; Bultman SJ, 2008, ONCOGENE, V27, P460, DOI 10.1038/sj.onc.1210664; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Dai Y, 2008, CARCINOGENESIS, V29, P1725, DOI 10.1093/carcin/bgn117; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Griffin CT, 2008, DEVELOPMENT, V135, P493, DOI 10.1242/dev.010090; Han D, 2008, DEV BIOL, V315, P136, DOI 10.1016/j.ydbio.2007.12.024; Jiang XM, 2013, P NATL ACAD SCI USA, V110, P12649, DOI 10.1073/pnas.1307218110; Katoh H, 2005, J HEPATOL, V43, P863, DOI 10.1016/j.jhep.2005.05.033; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Klochendler-Yeivin A, 2002, CURR OPIN GENET DEV, V12, P73, DOI 10.1016/S0959-437X(01)00267-2; Koizumi Y, 1997, CLIN CANCER RES, V3, P1067; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Lin H, 2010, BRIT J DERMATOL, V163, P502, DOI 10.1111/j.1365-2133.2010.09851.x; Liu K, 2004, GENE DEV, V18, P673, DOI 10.1101/gad.1180204; Marignani PA, 2001, J BIOL CHEM, V276, P32415, DOI 10.1074/jbc.C100207200; Martens JA, 2003, CURR OPIN GENET DEV, V13, P136, DOI 10.1016/S0959-437X(03)00022-4; MCNUTT NS, 1981, LAB INVEST, V44, P309; Medina PP, 2008, HUM MUTAT, V29, P617, DOI 10.1002/humu.20730; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Sanchez-Tillo E, 2011, P NATL ACAD SCI USA, V108, P19204, DOI 10.1073/pnas.1108977108; Sentani K, 2001, PATHOBIOLOGY, V69, P315, DOI 10.1159/000064638; Shinada K, 2011, BIOCHEM BIOPH RES CO, V404, P143, DOI 10.1016/j.bbrc.2010.11.082; STRAGAND JJ, 1980, CANCER RES, V40, P2846; Sudarsanam P, 2000, TRENDS GENET, V16, P345, DOI 10.1016/S0168-9525(00)02060-6; Sugiura T, 2008, EXP CELL RES, V314, P1519, DOI 10.1016/j.yexcr.2008.01.013; Sun A, 2007, PROSTATE, V67, P203, DOI 10.1002/pros.20521; Tian Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048958; Trotter K., 2008, NUCL RECEPT SIGNAL, V6, P1, DOI DOI 10.1621/NRS.06004; Valdman A, 2003, INT J ONCOL, V22, P1003; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Van Rechem C, 2009, BIOCHEM BIOPH RES CO, V385, P586, DOI 10.1016/j.bbrc.2009.05.115; von Figura G, 2014, NAT CELL BIOL, V16, P255, DOI 10.1038/ncb2916; Wang G, 2015, ONCOGENE, V34, P912, DOI 10.1038/onc.2014.30; Wang G, 2012, CELL DEATH DIFFER, V19, P1870, DOI 10.1038/cdd.2012.70; Wang GH, 2013, ANGIOGENESIS, V16, P561, DOI 10.1007/s10456-013-9336-y; Whitehouse I, 1999, NATURE, V400, P784, DOI 10.1038/23506; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wong AKC, 2000, CANCER RES, V60, P6171; Xu Y, 2007, J BIOL CHEM, V282, P37429, DOI 10.1074/jbc.M706039200; Yen CC, 2003, INT J ONCOL, V23, P871; Zebisch M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3787; Zou Y, 2013, GENE, V531, P112, DOI 10.1016/j.gene.2013.08.054	45	47	48	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 4	2016	35	5					651	661		10.1038/onc.2015.124	http://dx.doi.org/10.1038/onc.2015.124			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DC9NR	25961913				2022-12-26	WOS:000369548800012
J	Chi, T; Kim, MS; Lang, S; Bose, N; Kahn, A; Flechner, L; Blaschko, SD; Zee, T; Muteliefu, G; Bond, N; Kolipinski, M; Fakra, SC; Mandel, N; Miller, J; Ramanathan, A; Killilea, DW; Bruckner, K; Kapahi, P; Stoller, ML				Chi, Thomas; Kim, Man Su; Lang, Sven; Bose, Neelanjan; Kahn, Arnold; Flechner, Lawrence; Blaschko, Sarah D.; Zee, Tiffany; Muteliefu, Gulinuer; Bond, Nichole; Kolipinski, Marysia; Fakra, Sirine C.; Mandel, Neil; Miller, Joe; Ramanathan, Arvind; Killilea, David W.; Brueckner, Katja; Kapahi, Pankaj; Stoller, Marshall L.			A Drosophila Model Identifies a Critical Role for Zinc in Mineralization for Kidney Stone Disease	PLOS ONE			English	Article							XANTHINE OXIDOREDUCTASE; MEDICAL-MANAGEMENT; MALPIGHIAN TUBULES; CALCIUM; PLAQUE; RISK; CALCIFICATION; NANOBACTERIA; INSIGHTS; GROWTH	Ectopic calcification is a driving force for a variety of diseases, including kidney stones and atherosclerosis, but initiating factors remain largely unknown. Given its importance in seemingly divergent disease processes, identifying fundamental principal actors for ectopic calcification may have broad translational significance. Here we establish a Drosophila melanogaster model for ectopic calcification by inhibiting xanthine dehydrogenase whose deficiency leads to kidney stones in humans and dogs. Micro X-ray absorption near edge spectroscopy (mu XANES) synchrotron analyses revealed high enrichment of zinc in the Drosophila equivalent of kidney stones, which was also observed in human kidney stones and Randall's plaques (early calcifications seen in human kidneys thought to be the precursor for renal stones). To further test the role of zinc in driving mineralization, we inhibited zinc transporter genes in the ZnT family and observed suppression of Drosophila stone formation. Taken together, genetic, dietary, and pharmacologic interventions to lower zinc confirm a critical role for zinc in driving the process of heterogeneous nucleation that eventually leads to stone formation. Our findings open a novel perspective on the etiology of urinary stones and related diseases, which may lead to the identification of new preventive and therapeutic approaches.	[Chi, Thomas; Flechner, Lawrence; Blaschko, Sarah D.; Miller, Joe; Stoller, Marshall L.] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA; [Kim, Man Su] Inje Univ, Coll Pharm, Gimhae, South Korea; [Kim, Man Su; Lang, Sven; Bose, Neelanjan; Kahn, Arnold; Zee, Tiffany; Muteliefu, Gulinuer; Bond, Nichole; Kolipinski, Marysia; Ramanathan, Arvind; Kapahi, Pankaj] Buck Inst Res Aging, Novato, CA 94945 USA; [Fakra, Sirine C.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA 94720 USA; [Mandel, Neil] Med Coll Wisconsin, Zablocki VA Med Ctr, Dept Med, Div Nephrol, Milwaukee, WI 53226 USA; [Killilea, David W.] Childrens Hosp, Oakland Res Inst, Nutr & Metab Ctr, Oakland, CA 94609 USA; [Brueckner, Katja] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Brueckner, Katja] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; [Brueckner, Katja] Univ Calif San Francisco, Inst Cardiovasc Res, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Inje University; Buck Institute for Research on Aging; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Medical College of Wisconsin; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kapahi, P (corresponding author), Buck Inst Res Aging, Novato, CA 94945 USA.	pkapahi@buckinstitute.org	Bose, Neelanjan/B-8054-2017	Bose, Neelanjan/0000-0002-3817-4757; Killilea, David/0000-0002-8929-6527	American Federation for Aging Research; California Urology Foundation; National Institutes of Health [R01 AG038012, RO1 AG038688, R21 DK091727, P20 DK100863-01]; AUA Foundation Research Scholars Program; Boston Scientific Corporation; Endourological Society; Friends of Joe; Multidisciplinary K12 Urologic Research Career Development Program [K12-DK-07-006]; FOOD AND DRUG ADMINISTRATION [R01FD005716] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P20DK100863, K12DK083021, R21DK091727, T32DK007006, F32DK098865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG038012, R01AG038688, R01AG045835] Funding Source: NIH RePORTER	American Federation for Aging Research; California Urology Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AUA Foundation Research Scholars Program; Boston Scientific Corporation(Boston Scientific); Endourological Society; Friends of Joe; Multidisciplinary K12 Urologic Research Career Development Program; FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by grants from the American Federation for Aging Research, the California Urology Foundation, and the National Institutes of Health (R01 AG038012, RO1 AG038688, and R21 DK091727 (P. K.); P20 DK100863-01 (M. L. S., P. K., D.K., T. C.); K12-DK-07-006: Multidisciplinary K12 Urologic Research Career Development Program (T. C.)). This work was also supported in part by a grant from the AUA Foundation Research Scholars Program and Boston Scientific Corporation, The Endourological Society, and the "Friends of Joe" (T. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams HM, 2003, CURR OPIN UROL, V13, P63, DOI 10.1097/00042307-200301000-00011; Arikyants N, 2007, PEDIATR NEPHROL, V22, P310, DOI 10.1007/s00467-006-0267-3; Bagga HS, 2013, UROL CLIN N AM, V40, P1, DOI 10.1016/j.ucl.2012.09.006; Bazin D, 2007, UROL RES, V35, P179, DOI 10.1007/s00240-007-0099-z; Bobryshev YV, 2008, J CELL MOL MED, V12, P2073, DOI 10.1111/j.1582-4934.2008.00230.x; Bonner AM, 2013, P NATL ACAD SCI USA, V110, pE1222, DOI 10.1073/pnas.1301690110; BONSE A, 1967, Z NATURFORSCH PT B, VB 22, P1027; Cejkova J, 2002, HISTOL HISTOPATHOL, V17, P755, DOI 10.14670/HH-17.755; Chen LY, 2006, CURR BIOL, V16, P1183, DOI 10.1016/j.cub.2006.05.050; Chen YH, 2011, KIDNEY INT, V80, P369, DOI 10.1038/ki.2011.80; Cochat P, 2010, PEDIATR NEPHROL, V25, P415, DOI 10.1007/s00467-008-1085-6; Curhan GC, 2004, ARCH INTERN MED, V164, P885, DOI 10.1001/archinte.164.8.885; Dansinger ML, 2005, JAMA-J AM MED ASSOC, V293, P43, DOI 10.1001/jama.293.1.43; Dorozhkin SV, 2010, ACTA BIOMATER, V6, P715, DOI 10.1016/j.actbio.2009.10.031; Dow JAT, 2010, AM J PHYSIOL-RENAL, V299, pF1237, DOI 10.1152/ajprenal.00521.2010; Dow JAT, 2009, J EXP BIOL, V212, P435, DOI 10.1242/jeb.024224; Dube KA, 2000, ARCH INSECT BIOCHEM, V44, P27, DOI 10.1002/(SICI)1520-6327(200005)44:1&lt;27::AID-ARCH4&gt;3.0.CO;2-I; Duer MJ, 2008, ARTERIOSCL THROM VAS, V28, P2030, DOI 10.1161/ATVBAHA.108.172387; Evan AP, 2008, SEMIN NEPHROL, V28, P111, DOI 10.1016/j.semnephrol.2008.01.004; Evan AP, 2010, PEDIATR NEPHROL, V25, P831, DOI 10.1007/s00467-009-1116-y; Evan AP, 2005, UROL RES, V33, P383, DOI 10.1007/s00240-005-0488-0; Fink HA, 2009, EUR UROL, V56, P72, DOI 10.1016/j.eururo.2009.03.031; Giachelli CM, 1999, AM J PATHOL, V154, P671, DOI 10.1016/S0002-9440(10)65313-8; Golub EE, 2011, SEMIN IMMUNOPATHOL, V33, P409, DOI 10.1007/s00281-010-0230-z; Hirata T, 2012, AM J PHYSIOL-RENAL, V303, pF1555, DOI 10.1152/ajprenal.00074.2012; Jacinto AML, 2013, J SMALL ANIM PRACT, V54, P395, DOI 10.1111/jsap.12106; Jiang ZR, 2006, NAT GENET, V38, P474, DOI 10.1038/ng1762; JOHNSON O, 1994, ETHIOPIAN MED J, V32, P231; Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21; Kajander EO, 1998, P NATL ACAD SCI USA, V95, P8274, DOI 10.1073/pnas.95.14.8274; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kaplon DM, 2010, J ENDOUROL, V24, P355, DOI 10.1089/end.2009.0202; Kemner KM, 2001, J SYNCHROTRON RADIAT, V8, P949, DOI 10.1107/S0909049500021026; Knauf F, 2011, KIDNEY INT, V80, P327, DOI 10.1038/ki.2011.166; LEE CS, 1987, GENETICS, V116, P55; Linnes MP, 2013, KIDNEY INT, V84, P818, DOI 10.1038/ki.2013.189; Liuzzi JP, 2004, ANNU REV NUTR, V24, P151, DOI 10.1146/annurev.nutr.24.012003.132402; Lye JC, 2012, J EXP BIOL, V215, P3254, DOI 10.1242/jeb.069260; Ma GB, 2011, J NANOSCI NANOTECHNO, V11, P5199, DOI 10.1166/jnn.2011.4187; Martel J, 2008, P NATL ACAD SCI USA, V105, P5549, DOI 10.1073/pnas.0711744105; Miller J, 2013, J UROLOGY, V190, P1648, DOI 10.1016/j.juro.2013.03.010; Nikdin H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031525; PAK CYC, 1971, P NATL ACAD SCI USA, V68, P1456, DOI 10.1073/pnas.68.7.1456; Park S, 2007, EXPERT OPIN PHARMACO, V8, P1117, DOI 10.1517/14656566.8.8.1117; Pearle MS, 2005, J UROLOGY, V173, P848, DOI 10.1097/01.ju.0000152082.14384.d7; PRASAD AS, 1977, NEW ENGL J MED, V297, P1124; Pritsos CA, 2000, CHEM-BIOL INTERACT, V129, P195, DOI 10.1016/S0009-2797(00)00203-9; Qin QH, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-101; Quintana C, 2010, BBA-GEN SUBJECTS, V1800, P770, DOI 10.1016/j.bbagen.2010.04.012; Randall A, 1937, ANN SURG, V105, P1009, DOI 10.1097/00000658-193706000-00014; RECKER RR, 1992, JAMA-J AM MED ASSOC, V268, P2403, DOI 10.1001/jama.268.17.2403; Robbins JB, 2011, CURR BIOL, V21, P243, DOI 10.1016/j.cub.2011.01.008; Roh HC, 2012, CELL METAB, V15, P88, DOI 10.1016/j.cmet.2011.12.003; Roijers RB, 2011, AM J PATHOL, V178, P2879, DOI 10.1016/j.ajpath.2011.02.004; Rule AD, 2009, CLIN J AM SOC NEPHRO, V4, P804, DOI 10.2215/CJN.05811108; Ryall RL, 2008, UROL RES, V36, P77, DOI 10.1007/s00240-007-0131-3; Tang J, 2012, AM J NEPHROL, V36, P549, DOI 10.1159/000345550; Tracy CR, 2009, CURR OPIN UROL, V19, P200, DOI 10.1097/MOU.0b013e328323a81d; Tryselius Y, 1997, INSECT MOL BIOL, V6, P173, DOI 10.1111/j.1365-2583.1997.tb00085.x; Vupputuri S, 2004, ANN EPIDEMIOL, V14, P222, DOI 10.1016/S1047-2797(03)00126-1; Wang XZ, 2009, STUD FUZZ SOFT COMP, V245, P1; WESSING A, 1992, J INSECT PHYSIOL, V38, P543, DOI 10.1016/0022-1910(92)90080-W; Wessing A, 1999, J INSECT PHYSIOL, V45, P39, DOI 10.1016/S0022-1910(98)00097-3; White A, 2001, CURR BIOL, V11, pR589, DOI 10.1016/S0960-9822(01)00359-1; Yepiskoposyan H, 2006, NUCLEIC ACIDS RES, V34, P4866, DOI 10.1093/nar/gkl606; Yuan Q, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002726	66	56	58	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0124150	10.1371/journal.pone.0124150	http://dx.doi.org/10.1371/journal.pone.0124150			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970330	Green Published, gold, Green Submitted			2022-12-26	WOS:000354544200031
J	Gonzalez-Maya, JF; Vquez-R, LR; Belant, JL; Ceballos, G				Gonzalez-Maya, Jose F.; Vquez-R, Luis R.; Belant, Jerrold L.; Ceballos, Gerardo			Effectiveness of Protected Areas for Representing Species and Populations of Terrestrial Mammals in Costa Rica	PLOS ONE			English	Article							CONSERVATION PRIORITIES; MEGADIVERSE MEXICO; BIODIVERSITY; DIVERSITY; CONNECTIVITY; RICHNESS; PATTERNS; FORESTS; SYSTEM	Costa Rica has one of the greatest percentages (26%) of protected land in the world. The National Protected Areas System (NPAS) of Costa Rica was established in 1976 and currently includes >190 protected areas within seven different protection categories. The effectiveness of the NPAS to represent species, populations, and areas with high species richness has not been properly evaluated. Such evaluations are fundamental to understand what is necessary to strengthen the NPAS and better protect biodiversity. We present a novel assessment of NPAS effectiveness in protecting mammal species. We compiled the geographical ranges of all terrestrial Costa Rican mammals then determined species lists for all protected areas and the estimated proportion of each species' geographic range protected. We also classified mammal species according to their conservation status using the IUCN Red List of Threatened Species. We found almost complete representation of mammal species (98.5%) in protected areas, but low relative coverage (28.3% on average) of their geographic ranges in Costa Rica and 25% of the species were classified as underprotected according to a priori representation targets. Interestingly, many species-rich areas are not protected, and at least 43% of cells covering the entire country are not included in protected areas. Though protected areas in Costa Rica represent species richness well, strategic planning for future protected areas to improve species complementarity and range protection is necessary. Our results can help to define sites where new protected areas can have a greater impact on mammal conservation, both in terms of species richness and range protection.	[Gonzalez-Maya, Jose F.; Vquez-R, Luis R.; Ceballos, Gerardo] Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City 04318, DF, Mexico; [Gonzalez-Maya, Jose F.] ProCAT Colombia Int, Proyecto Conservac Aguas & Tierras, Bogota, Colombia; [Belant, Jerrold L.] Mississippi State Univ, Forest & Wildlife Res Ctr, Carnivore Ecol Lab, Starkville, MS USA	Universidad Nacional Autonoma de Mexico; Mississippi State University	Gonzalez-Maya, JF (corresponding author), Univ Nacl Autonoma Mexico, Inst Ecol, Ciudad Univ, Mexico City 04318, DF, Mexico.	jfgonzalezmaya@gmail.com	Viquez-R, Luis R/O-4723-2015; González-Maya, José F./B-6913-2011; Viquez-R, Luis/Q-3887-2019; Belant, Jerrold/HDM-7749-2022	Viquez-R, Luis R/0000-0002-5865-2461; González-Maya, José F./0000-0002-8942-5157; Viquez-R, Luis/0000-0002-5865-2461; Ceballos, Gerardo/0000-0001-8374-2656	National Council of Science and Technology (CONACyT); Universidad Nacional Autonoma de Mexico [255983]	National Council of Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico)	JFGM received a scholarship from National Council of Science and Technology (CONACyT), and Universidad Nacional Autonoma de Mexico (scholarship 255983). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias Alzate A, 2012, REVISTA DE BIODIVERS, V2, P69; Arponen A, 2012, CONSERV BIOL, V26, P294, DOI 10.1111/j.1523-1739.2011.01814.x; Balmford A, 1996, P ROY SOC B-BIOL SCI, V263, P1267, DOI 10.1098/rspb.1996.0186; Boron V, 2013, PLAN CONSERVACION FE, P165, DOI [10.1371/journal.pone.0088459, DOI 10.1371/JOURNAL.PONE.0088459]; BOZA MA, 1993, CONSERV BIOL, V7, P239, DOI 10.1046/j.1523-1739.1993.07020239.x; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Calvo-Alvarado J, 2009, FOREST ECOL MANAG, V258, P931, DOI 10.1016/j.foreco.2008.10.035; Canet-Desanti L, 2009, DIAGNOSTICO SOBRE LA; Cantu-Salazar L, 2013, BIODIVERS CONSERV, V22, P1033, DOI 10.1007/s10531-013-0467-7; Carwardine J, 2007, BIODIVERS CONSERV, V16, P245, DOI 10.1007/s10531-006-9055-4; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Ceballos G, 1998, ECOL APPL, V8, P8, DOI 10.1890/1051-0761(1998)008[0008:ACPIMM]2.0.CO;2; Ceballos G., 2010, J COSMOL, V8, P1821; Ceballos G, 2007, ECOL APPL, V17, P569, DOI 10.1890/06-0134; Chape S, 2005, PHILOS T R SOC B, V360, P443, DOI 10.1098/rstb.2004.1592; Cody S, 2010, ECOGRAPHY, V33, P326, DOI 10.1111/j.1600-0587.2010.06327.x; Convention on Biological Diversity, 2006, GLOBAL BIODIVERSITY; Crooks K. R., 2006, CONNECTIVITY CONSERV; Crooks KR, 2011, PHILOS T R SOC B, V366, P2642, DOI 10.1098/rstb.2011.0120; Daily GC, 2003, CONSERV BIOL, V17, P1814, DOI 10.1111/j.1523-1739.2003.00298.x; Di Rienzo J.A., 2011, INFOSTAT; Dudley N., 2008, GUIDELINES FOR APPLY; Dudley N, 2006, CLOSING THE GAP CREA; Elbers J, 2011, LAS AREAS PROTEGIDAS; Environmental Systems Research Institute, 2013, ARCGIS 10 2 1; Gaston KJ, 2008, ANNU REV ECOL EVOL S, V39, P93, DOI 10.1146/annurev.ecolsys.39.110707.173529; Gonzalez-Maya J. F., 2011, Revista Latinoamericana de Conservacion, V2, P1; Gonzalez-Maya JF, EL JAGUAR EN EL SIGL; Gonzalez-Maya Jose F., 2012, Revista Biodiversidad Neotropical, V2, P5; Gonzalez-Maya JF, 2012, INTEGR ZOOL, V7, P381, DOI 10.1111/j.1749-4877.2012.00324.x; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Instituto Tecnologico de Costa Rica, 2008, ATLAS DIGITAL DE COS; International Union for Conservation of Nature, 2012, IUCN RED LIST CATEGO; IUCN, 2012, IUCN RED LIST OF THR; Magurran A.E., 2004, MEASURING BIOL DIVER; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Martinez-Estevez L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075229; Obando V, 2008, BIODIVERSIDAD DE COS; Olden JD, 2006, GLOBAL ECOL BIOGEOGR, V15, P113, DOI 10.1111/j.1466-822x.2006.00214.x; Pfab MF, 2011, BIODIVERS CONSERV, V20, P1001, DOI 10.1007/s10531-011-0009-0; Powell GVN, 2000, BIOL CONSERV, V93, P35, DOI 10.1016/S0006-3207(99)00115-9; Powers JS, 2009, FOREST ECOL MANAG, V258, P959, DOI 10.1016/j.foreco.2008.10.036; Rodrigues ASL, 2007, ANNU REV ECOL EVOL S, V38, P713, DOI 10.1146/annurev.ecolsys.38.091206.095737; Rodrigues ASL, 2004, BIOSCIENCE, V54, P1092, DOI 10.1641/0006-3568(2004)054[1092:GGAPRF]2.0.CO;2; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Rodriguez-H B, 2002, REV MEXICANA MASTOZO, V6, P21; RODRIGUEZ-HERRERA B, 2005, BRENESIA, V63-64, P89; Rodriguez-Herrera B., 2012, IMPORTANT BIRD AREAS, P31; Rondinini C, 2011, PHILOS T R SOC B, V366, P2633, DOI 10.1098/rstb.2011.0113; Sanchez-Azofeifa G, 2001, BIOTROPICA, V33, P378, DOI 10.1111/j.1744-7429.2001.tb00192.x; Sanchez-Azofeifa GA, 1999, CONSERV BIOL, V13, P407, DOI 10.1046/j.1523-1739.1999.013002407.x; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Silveira L, 2014, LANDSCAPE ECOL, V29, P1213, DOI 10.1007/s10980-014-0057-4; SINAC MINAET, 2010, POLITICAS PARA LAS A; Sinclair A. R. E., 2003, Alces, V39, P161; Sinclair ARE, 2003, PHILOS T R SOC B, V358, P1729, DOI 10.1098/rstb.2003.1359; Sistema Nacional de Areas de Conservacion, 2007, PROGRAMA DE MONITORE; Sistema Nacional de Areas de Conservacion Ministerio de Ambientey Energia., 2007, ANALISIS DE VACIOS E, V1; UNEP IUCN, 2009, WORLD DATABASE ON PR; Watson JEM, 2011, CONSERV BIOL, V25, P324, DOI 10.1111/j.1523-1739.2010.01587.x; WEBB SD, 1991, PALEOBIOLOGY, V17, P266, DOI 10.1017/S0094837300010605	62	33	34	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0124480	10.1371/journal.pone.0124480	http://dx.doi.org/10.1371/journal.pone.0124480			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970293	Green Published, gold, Green Submitted			2022-12-26	WOS:000354544200040
J	Mograbi, PJ; Erasmus, BFN; Witkowski, ETF; Asner, GP; Wessels, KJ; Mathieu, R; Knapp, DE; Martin, RE; Main, R				Mograbi, Penelope J.; Erasmus, Barend F. N.; Witkowski, E. T. F.; Asner, Gregory P.; Wessels, Konrad J.; Mathieu, Renaud; Knapp, David E.; Martin, Roberta E.; Main, Russell			Biomass Increases Go under Cover: Woody Vegetation Dynamics in South African Rangelands	PLOS ONE			English	Article							TROPICAL RAIN-FOREST; SUPPLY-AND-DEMAND; LAND-USE; ABOVEGROUND BIOMASS; CHARCOAL PRODUCTION; BUSHBUCKRIDGE LOWVELD; BUSH ENCROACHMENT; MIOMBO WOODLANDS; SEMIARID SAVANNA; PROTECTED AREA	Woody biomass dynamics are an expression of ecosystem function, yet biomass estimates do not provide information on the spatial distribution of woody vegetation within the vertical vegetation subcanopy. We demonstrate the ability of airborne light detection and ranging (LiDAR) to measure aboveground biomass and subcanopy structure, as an explanatory tool to unravel vegetation dynamics in structurally heterogeneous landscapes. We sampled three communal rangelands in Bushbuckridge, South Africa, utilised by rural communities for fuelwood harvesting. Woody biomass estimates ranged between 9 Mg ha(-1) on gabbro geology sites to 27 Mg ha(-1) on granitic geology sites. Despite predictions of woodland depletion due to unsustainable fuelwood extraction in previous studies, biomass in all the communal rangelands increased between 2008 and 2012. Annual biomass productivity estimates (10-14% p.a.) were higher than previous estimates of 4% and likely a significant contributor to the previous underestimations of modelled biomass supply. We show that biomass increases are attributable to growth of vegetation <5 m in height, and that, in the high wood extraction rangeland, 79% of the changes in the vertical vegetation subcanopy are gains in the 1-3m height class. The higher the wood extraction pressure on the rangelands, the greater the biomass increases in the low height classes within the subcanopy, likely a strong resprouting response to intensive harvesting. Yet, fuelwood shortages are still occurring, as evidenced by the losses in the tall tree height class in the high extraction rangeland. Loss of large trees and gain in subcanopy shrubs could result in a structurally simple landscape with reduced functional capacity. This research demonstrates that intensive harvesting can, paradoxically, increase biomass and this has implications for the sustainability of ecosystem service provision. The structural implications of biomass increases in communal rangelands could be misinterpreted as woodland recovery in the absence of three-dimensional, subcanopy information.	[Mograbi, Penelope J.; Witkowski, E. T. F.] Univ Witwatersrand, Restorat & Conservat Biol Res Grp, Sch Anim Plant & Environm Sci, Johannesburg, South Africa; [Mograbi, Penelope J.] Univ Witwatersrand, Ctr African Ecol, Sch Anim Plant & Environm Sci, Johannesburg, South Africa; [Erasmus, Barend F. N.] Univ Witwatersrand, Global Change & Sustainabil Res Inst, Johannesburg, South Africa; [Asner, Gregory P.; Knapp, David E.; Martin, Roberta E.] Carnegie Inst Sci, Dept Global Ecol, Stanford, CA USA; [Wessels, Konrad J.] CSIR, Remote Sensing Res Unit, Meraka Inst, ZA-0001 Pretoria, South Africa; [Mathieu, Renaud; Main, Russell] CSIR, Ecosyst Earth Observat Nat Resources & Environm, ZA-0001 Pretoria, South Africa; [Wessels, Konrad J.; Mathieu, Renaud] Univ Pretoria, Dept Geog Geomat & Meteorol, ZA-0002 Pretoria, South Africa	University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; Carnegie Institution for Science; Council for Scientific & Industrial Research (CSIR) - South Africa; Council for Scientific & Industrial Research (CSIR) - South Africa; University of Pretoria	Mograbi, PJ (corresponding author), Univ Witwatersrand, Restorat & Conservat Biol Res Grp, Sch Anim Plant & Environm Sci, Johannesburg, South Africa.	penny.mograbi@gmail.com	Mograbi, Penelope/J-8495-2019; Main, Russell/AAQ-5673-2021; Erasmus, Barend/G-3411-2012; Witkowski, Edward/AAW-6252-2021; Asner, Gregory/G-9268-2013; Martin, Roberta/A-5073-2015	Mograbi, Penelope/0000-0001-8437-7021; Main, Russell/0000-0003-1967-1122; Erasmus, Barend/0000-0003-1869-8091; Asner, Gregory/0000-0001-7893-6421; Witkowski, Edward/0000-0001-5453-1390; Martin, Roberta/0000-0003-3509-8530; Mathieu, Renaud/0000-0001-8520-7358	South African Department of Science and Technology [DST/CON 0119/2010]; European Union [282621]; National Research Foundation [NRF: * *SFH1207203615]; Exxaro	South African Department of Science and Technology; European Union(European Commission); National Research Foundation; Exxaro	The Carnegie Airborne Observatory (CAO) is made possible by the Avatar Alliance Foundation, Margaret A. Cargill Foundation, John D. and Catherine T. MacArthur Foundation, Grantham Foundation for the Protection of the Environment, W. M. Keck Foundation, Gordon and Betty Moore Foundation, Mary Anne Nyburg Baker and G. Leonard Baker, Jr., and William R. Hearst III. Application of the CAO data in South Africa is made possible through the Andrew Mellon Foundation and the endowment of the Carnegie Institution for Science, the Council for Scientific and Industrial Research (CSIR), and the South African Department of Science and Technology (grant agreement DST/CON 0119/2010, Earth Observation Application Development in Support of SAEOS). CSIR coauthors are supported by the European Union's Seventh Framework Programme (FP7/2007-2013, grant agreement no 282621, AGRICAB). PJM acknowledges funding from the National Research Foundation (NRF: * *SFH1207203615). Additionally, PJM and ETFW acknowledge the DST-NRF Centre of Excellence in Tree Health Biotechnology (CTHB) and, PJM and BFNE, the Applied Centre for Climate and Earth Systems Science (ACCESS). BFNE acknowledges financial support from Exxaro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbot JIO, 1999, J APPL ECOL, V36, P422, DOI 10.1046/j.1365-2664.1999.00413.x; Abbot PG, 1999, FOREST ECOL MANAG, V119, P111, DOI 10.1016/S0378-1127(98)00516-7; Anderson J, 2006, REMOTE SENS ENVIRON, V105, P248, DOI 10.1016/j.rse.2006.07.001; ARCHER S, 1989, AM NAT, V134, P545, DOI 10.1086/284996; ARCHER S, 1995, CLIMATIC CHANGE, V29, P91, DOI 10.1007/BF01091640; Archibald S, 2009, GLOBAL CHANGE BIOL, V15, P613, DOI 10.1111/j.1365-2486.2008.01754.x; Arnold M., 2003, FUELWOOD REVISITED W; Asner GP, 2007, J APPL REMOTE SENS, V1, DOI 10.1117/1.2794018; Asner GP, 2014, REMOTE SENS ENVIRON, V140, P614, DOI 10.1016/j.rse.2013.09.023; Asner GP, 2012, ECOL LETT, V15, P1211, DOI 10.1111/j.1461-0248.2012.01842.x; Asner GP, 2012, REMOTE SENS ENVIRON, V124, P454, DOI 10.1016/j.rse.2012.06.012; Asner GP, 2012, OECOLOGIA, V168, P1147, DOI 10.1007/s00442-011-2165-z; Asner GP, 2009, ECOSYSTEMS, V12, P261, DOI 10.1007/s10021-008-9221-5; Banks DI, 1996, BIOMASS BIOENERG, V11, P319, DOI 10.1016/0961-9534(96)00031-1; Beg N, 2002, CLIM POLICY, V2, P129, DOI 10.1016/S1469-3062(02)00028-1; Bond WJ, 2012, PHILOS T R SOC B, V367, P601, DOI 10.1098/rstb.2011.0182; Bond WJ, 2008, ANNU REV ECOL EVOL S, V39, P641, DOI 10.1146/annurev.ecolsys.39.110707.173411; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Buitenwerf R, 2012, GLOBAL CHANGE BIOL, V18, P675, DOI 10.1111/j.1365-2486.2011.02561.x; Butz RJ, 2013, ENERGY SUSTAIN DEV, V17, P138, DOI 10.1016/j.esd.2012.11.001; Caspersen JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028660; Chambers JQ, 2004, OECOLOGIA, V141, P596, DOI 10.1007/s00442-004-1676-2; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Coetzer KL, 2013, ENVIRON MANAGE, V52, P595, DOI 10.1007/s00267-013-0094-9; Coetzer KL, 2010, S AFR J SCI, V106, P26, DOI 10.4102/sajs.v106i7/8.221; Colgan MS, 2012, BIOGEOSCIENCES, V9, P1809, DOI 10.5194/bg-9-1809-2012; Colgan MS, 2013, ECOL APPL, V23, P1170, DOI 10.1890/12-0922.1; Dahlin KM, 2012, ECOL APPL, V22, P104, DOI 10.1890/11-1401.1; de Castilho CV, 2006, FOREST ECOL MANAG, V234, P85, DOI 10.1016/j.foreco.2006.06.024; De Castro EA, 1998, J TROP ECOL, V14, P263, DOI 10.1017/S0266467498000212; De Montalembert MR, 1983, 42 FAO US; Denman KL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P499; Dovie D., 2004, GEOJOURNAL, V60, P123, DOI DOI 10.1023/B:GEJ0.0000033597.34013.9F; Drake JB, 2002, REMOTE SENS ENVIRON, V79, P305, DOI 10.1016/S0034-4257(01)00281-4; Fischer J, 2006, FRONT ECOL ENVIRON, V4, P80, DOI 10.1890/1540-9295(2006)004[0080:BEFART]2.0.CO;2; Fisher JT, 2012, ENVIRON CONSERV, V39, P72, DOI 10.1017/S0376892911000592; Fisher JT, 2015, APPL VEG SCI, V18, P528, DOI 10.1111/avsc.12160; Fisher JT, 2014, APPL VEG SCI, V17, P172, DOI 10.1111/avsc.12048; Frolking S, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000911; Furukawa T, 2011, FOREST ECOL MANAG, V262, P962, DOI 10.1016/j.foreco.2011.05.030; Gaugris JY, 2010, S AFR J BOT, V76, P289, DOI 10.1016/j.sajb.2009.11.007; Giannecchini M, 2007, GEOGR J, V173, P26, DOI 10.1111/j.1475-4959.2007.00227.x; Goatley CHR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027307; Halaj J, 2000, OIKOS, V90, P139, DOI 10.1034/j.1600-0706.2000.900114.x; Hall FG, 2011, REMOTE SENS ENVIRON, V115, P2753, DOI 10.1016/j.rse.2011.01.024; HARRINGTON RA, 1995, J APPL ECOL, V32, P1, DOI 10.2307/2404410; Herremans M, 1995, ECOGRAPHY, V18, P440, DOI 10.1111/j.1600-0587.1995.tb00147.x; Higgins SI, 2000, J ECOL, V88, P213, DOI 10.1046/j.1365-2745.2000.00435.x; Higgins SI, 1999, J BIOGEOGR, V26, P619, DOI 10.1046/j.1365-2699.1999.t01-1-00317.x; Kalema Vettes Neckemiah, 2012, International Journal of Biodiversity Science Ecosystem Services & Management, V8, P231, DOI 10.1080/21513732.2012.681070; Kaschula SA, 2005, ENVIRON CONSERV, V32, P76, DOI 10.1017/S0376892905001980; Kaschula SA, 2005, HUM ECOL, V33, P387, DOI 10.1007/s10745-005-4144-7; Kennedy AD, 1998, AFR J ECOL, V36, P148; Kgope BS, 2010, AUSTRAL ECOL, V35, P451, DOI 10.1111/j.1442-9993.2009.02046.x; Kirkland T, 2007, SOC NATUR RESOUR, V20, P337, DOI 10.1080/08941920601161353; Lefsky MA, 2002, BIOSCIENCE, V52, P19, DOI 10.1641/0006-3568(2002)052[0019:LRSFES]2.0.CO;2; Lefsky MA, 2002, GLOBAL ECOL BIOGEOGR, V11, P393, DOI 10.1046/j.1466-822x.2002.00303.x; Lumsden LF, 2005, BIOL CONSERV, V122, P205, DOI 10.1016/j.biocon.2004.07.006; Luoga EJ, 2000, ECOL ECON, V35, P243, DOI 10.1016/S0921-8009(00)00196-8; Luoga EJ, 2004, FOREST ECOL MANAG, V189, P23, DOI 10.1016/j.foreco.2003.02.001; Luoga EJ, 2002, FOREST ECOL MANAG, V164, P15, DOI 10.1016/S0378-1127(01)00604-1; Madubansi M, 2007, J ENVIRON MANAGE, V83, P416, DOI 10.1016/j.jenvman.2006.03.014; Masera O, 2006, BIOMASS BIOENERG, V30, P618, DOI 10.1016/j.biombioe.2006.01.006; Matsika R, 2013, ENERG POLICY, V52, P716, DOI 10.1016/j.enpol.2012.10.030; Matsika R, ENV CONSERV, V40, P71; MILLER RF, 1994, BIOSCIENCE, V44, P465, DOI 10.2307/1312298; Moleele NM, 2002, J ENVIRON MANAGE, V64, P3, DOI 10.1006/jema.2001.0486; Mortimore MJ, 2001, GLOBAL ENVIRON CHANG, V11, P49, DOI 10.1016/S0959-3780(00)00044-3; Moyo H, 2014, TREES; Mucina L., 2006, VEGETATION S AFRICA, V19, P439; Mwavu EN, 2008, FOREST ECOL MANAG, V255, P982, DOI 10.1016/j.foreco.2007.10.018; Neke KS, 2006, FOREST ECOL MANAG, V232, P114, DOI 10.1016/j.foreco.2006.05.051; Nickless A, 2011, S AFR J SCI, V107, P86, DOI 10.4102/sajs.v107i5/6.356; Okello BD, 2001, FOREST ECOL MANAG, V142, P143, DOI 10.1016/S0378-1127(00)00346-7; Parresol BR, 1999, FOREST SCI, V45, P573; Patenaude G, 2004, REMOTE SENS ENVIRON, V93, P368, DOI 10.1016/j.rse.2004.07.016; Pollard S, 2011, KOEDOE, V53, DOI 10.4102/koedoe.v53i2.1011; Popescu SC, 2007, BIOMASS BIOENERG, V31, P646, DOI 10.1016/j.biombioe.2007.06.022; Poulter B, 2014, NATURE; Rutherford M. C., 1978, Biogeography and ecology of Southern Africa. Vol.1., P621; Ryu Y, 2012, REMOTE SENS ENVIRON, V126, P116, DOI 10.1016/j.rse.2012.08.027; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; Sankaran M, 2008, GLOBAL ECOL BIOGEOGR, V17, P236, DOI 10.1111/j.1466-8238.2007.00360.x; Schneider SH, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P779; Scholes R.J., 2004, COUNC SCI IND RES; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; Shackleton CM, 2006, INT J SUST DEV WORLD, V13, P481, DOI 10.1080/13504500609469697; Shackleton C. M., 2003, Forests, Trees and Livelihoods, V13, P217; Shackleton CM, 2011, S AFR J BOT, V77, P184, DOI 10.1016/j.sajb.2010.07.014; Shackleton C. M., 2000, Koedoe, V43, P75; Shackleton CM, 2000, S AFR J BOT, V66, P124, DOI 10.1016/S0254-6299(15)31074-7; SHACKLETON CM, 1993, BIOL CONSERV, V63, P247, DOI 10.1016/0006-3207(93)90720-L; Shackleton CM, 2005, LAND DEGRAD DEV, V16, P273, DOI 10.1002/ldr.652; Shackleton CM, 2000, BIOL CONSERV, V94, P273, DOI 10.1016/S0006-3207(00)00001-X; Shackleton CM, 2001, BIOMASS BIOENERG, V20, P261, DOI 10.1016/S0961-9534(00)00086-6; Smit IPJ, 2010, ECOL APPL, V20, P1865, DOI 10.1890/09-0929.1; Staver AC, 2011, ECOLOGY, V92, P1063, DOI 10.1890/i0012-9658-92-5-1063; Staver AC, 2009, ECOL APPL, V19, P1909, DOI 10.1890/08-1907.1; Stringer LC, 2007, LAND DEGRAD DEV, V18, P99, DOI 10.1002/ldr.760; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Thomas DSG, 2005, GLOBAL ENVIRON CHANG, V15, P115, DOI 10.1016/j.gloenvcha.2004.10.001; Thornton R., 2002, HUMAN RIGHTS ENV CON, P219; Top N, 2004, FOREST ECOL MANAG, V194, P369, DOI 10.1016/j.foreco.2004.02.028; Twine W, 2003, S AFR J SCI, V99, P467; Twine W, 2003, INT J SUST DEV WORLD, V10, P263, DOI 10.1080/13504500309469804; Twine W. C., 2005, African Journal of Range & Forage Science, V22, P93, DOI 10.2989/10220110509485866; Vasconcelos MJP, 2002, APPL GEOGR, V22, P139, DOI 10.1016/S0143-6228(02)00005-X; Weishampel JF, 2000, INT J REMOTE SENS, V21, P409, DOI 10.1080/014311600210939; Wessels KJ, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/014007; Wessels KJ, 2011, FOREST ECOL MANAG, V261, P19, DOI 10.1016/j.foreco.2010.09.012; Wigley BJ, 2009, AFR J ECOL, V47, P62, DOI 10.1111/j.1365-2028.2008.01051.x; Williams Christopher A, 2007, Carbon Balance Manag, V2, P3, DOI 10.1186/1750-0680-2-3	112	27	27	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0127093	10.1371/journal.pone.0127093	http://dx.doi.org/10.1371/journal.pone.0127093			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25969985	gold, Green Published			2022-12-26	WOS:000354544200148
J	Toth, GB; Larsson, AI; Jonsson, PR; Appelqvist, C				Toth, Gunilla B.; Larsson, Ann I.; Jonsson, Per R.; Appelqvist, Christin			Natural Populations of Shipworm Larvae Are Attracted to Wood by Waterborne Chemical Cues	PLOS ONE			English	Article							CORAL-REEFS; SWIMMING BEHAVIOR; TEREDO-BARTSCHI; SETTLEMENT CUE; FLOW; HYDRODYNAMICS; TURBULENT; BARNACLE; BIVALVIA; RECRUITMENT	The life cycle of many sessile marine invertebrates includes a dispersive planktonic larval stage whose ability to find a suitable habitat in which to settle and transform into benthic adults is crucial to maximize fitness. To facilitate this process, invertebrate larvae commonly respond to habitat-related chemical cues to guide the search for an appropriate environment. Furthermore, small-scale hydrodynamic conditions affect dispersal of chemical cues, as well as swimming behavior of invertebrate larvae and encounter with potential habitats. Shipworms within the family Teredinidae are dependent on terrestrially derived wood in order to complete their life cycle, but very little is known about the cues and processes that promote settlement. We investigated the potential for remote detection of settling substrate via waterborne chemical cues in teredinid larvae through a combination of empirical field and laboratory flume experiments. Natural populations of teredinid larvae were significantly more abundant close to wooden structures enclosed in plankton net compared to empty control nets, clearly showing that shipworm larvae can sense and respond to chemical cues associated with suitable settling substrate in the field. However, the flume experiments, using ecologically relevant flow velocities, showed that the boundary layer around experimental wooden panels was thin and that the mean flow velocity exceeded larval swimming velocity approximately 5 mm (approximate to 25 larval body lengths) from the panel surface. Therefore, we conclude that the scope for remote detection of waterborne cues is limited and that the likely explanation for the higher abundance of shipworm larvae associated with the wooden panels in the field is a response to a cue during or after attachment on, or very near, the substrate. Waterborne cues probably guide the larva in its decision to remain attached and settle, or to detach and continue swimming and drifting until the next encounter with a solid substrate.	[Toth, Gunilla B.; Larsson, Ann I.; Jonsson, Per R.; Appelqvist, Christin] Univ Gothenburg, Dept Biol & Environm Sci Tjarno, Stromstad, Sweden	University of Gothenburg	Toth, GB (corresponding author), Univ Gothenburg, Dept Biol & Environm Sci Tjarno, Stromstad, Sweden.	gunilla.toth@bioenv.gu.se	Toth, Gunilla B/E-8737-2013	Toth, Gunilla/0000-0002-1225-7773; Jonsson, Per/0000-0002-1793-5473	aculty of Natural Sciences at the University of Gothenburg through the Center for Marine Chemical Ecology; Department of Biological and Environmental Sciences; Swedish Research Council Formas [215-2012-1134]	aculty of Natural Sciences at the University of Gothenburg through the Center for Marine Chemical Ecology; Department of Biological and Environmental Sciences; Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	This work was supported by the Faculty of Natural Sciences at the University of Gothenburg through the Center for Marine Chemical Ecology (http://cemace.science.gu.se/) to GBT, AIL and PRJ; the Department of Biological and Environmental Sciences (http://bioenv.gu.se/) to CA; and the Swedish Research Council Formas (contract 215-2012-1134) (http://www.formas.se/en/) to AIL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson A, 1997, ECOLOGY, V78, P160; Appelqvist C, 2015, J MAR BIOL ASSOC UK, V95, P783, DOI 10.1017/S0025315414001830; Borges LMS, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-13; BUTMAN CA, 1988, NATURE, V333, P771, DOI 10.1038/333771a0; BUTMAN CA, 1987, OCEANOGR MAR BIOL, V25, P113; Calloway C.B., 1988, P215; Carlton J.T., 1995, NONINDIGENOUS AQUATI; Chan KYK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082764; CHANLEY P, 1971, Malacologia, V11, P45; Clare AS, 2011, CHEMICAL COMMUNICATION IN CRUSTACEANS, P431, DOI 10.1007/978-0-387-77101-4_22; Coe WR, 1933, BIOL BULL, V65, P293; COLMAN JOHN, 1933, JOUR MARINE BIOL ASSOC UNITED KINGDOM, V18, P435; Cragg SM, 2009, J EXP MAR BIOL ECOL, V375, P99, DOI 10.1016/j.jembe.2009.05.014; Crimaldi JP, 2002, LIMNOL OCEANOGR, V47, P1137, DOI 10.4319/lo.2002.47.4.1137; Crisp D.J., 1984, P103; CRISP DJ, 1955, J EXP BIOL, V32, P569; CULLINEY JL, 1975, MAR BIOL, V29, P245, DOI 10.1007/BF00391850; Distel DL, 2011, MOL PHYLOGENET EVOL, V61, P245, DOI 10.1016/j.ympev.2011.05.019; ECKMAN JE, 1994, DEEP-SEA RES PT II, V41, P185, DOI 10.1016/0967-0645(94)90067-1; Fuchs HL, 2004, LIMNOL OCEANOGR, V49, P1937, DOI 10.4319/lo.2004.49.6.1937; Fulford RS, 2011, ESTUAR COAST, V34, P618, DOI 10.1007/s12237-010-9360-8; Gara RI, 1997, ESTUARIES, V20, P441, DOI 10.2307/1352356; Gaylord B, 2013, P NATL ACAD SCI USA, V110, P6901, DOI 10.1073/pnas.1220680110; Hadfield MG, 2001, CRC MAR SCI, P431; Hadfield MG, 1998, BIOFOULING, V12, P9, DOI 10.1080/08927019809378343; Harington CR, 1921, BIOCHEM J, V15, P736, DOI 10.1042/bj0150736; Harrington L, 2004, ECOLOGY, V85, P3428, DOI 10.1890/04-0298; Hendriks IE, 2005, J SEA RES, V54, P151, DOI 10.1016/j.seares.2005.03.001; HOAGLAND KE, 1986, AM MALACOL BULL, V4, P89; Jonsson PR, 1997, J EXP MAR BIOL ECOL, V215, P135, DOI 10.1016/S0022-0981(97)00031-2; JONSSON PR, 1991, MAR ECOL PROG SER, V79, P67, DOI 10.3354/meps079067; Kingsford MJ, 2002, B MAR SCI, V70, P309; Koehl MAR, 2007, EXP FLUIDS, V43, P755, DOI 10.1007/S00348-007-0371-6; Koehl MAR, 2007, BIOFOULING, V23, P357, DOI 10.1080/08927010701492250; Koehl MAR, 2007, MAR ECOL PROG SER, V335, P1, DOI 10.3354/meps335001; Koehl MAR, 2010, INTEGR COMP BIOL, V50, P539, DOI 10.1093/icb/icq101; Koehl MAR, 2004, J MARINE SYST, V49, P75, DOI 10.1016/j.jmarsys.2003.06.003; Larsson AI, 2006, ECOLOGY, V87, P1960, DOI 10.1890/0012-9658(2006)87[1960:BLASFE]2.0.CO;2; Leonel RMV, 2002, J MAR BIOL ASSOC UK, V82, P1039, DOI 10.1017/S002531540200663X; Lillis A, 2014, MAR ECOL PROG SER, V509, P57, DOI 10.3354/meps10917; MacIntosh H, 2014, J EXP MAR BIOL ECOL, V459, P80, DOI 10.1016/j.jembe.2014.05.015; MacIntosh H, 2012, MAR ECOL PROG SER, V461, P95, DOI 10.3354/meps09823; Marshall DJ, 2012, ANNU REV ECOL EVOL S, V43, P97, DOI 10.1146/annurev-ecolsys-102710-145004; MCKOY JL, 1980, NEW ZEAL J MAR FRESH, V14, P263, DOI 10.1080/00288330.1980.9515869; MULLINEAUX LS, 1991, MAR BIOL, V110, P93, DOI 10.1007/BF01313096; NAIR N. BALAKRISHNAN, 1962, SARSIA, V8, P1; NAIR NB, 1971, ADV MAR BIOL, V9, P335, DOI 10.1016/S0065-2881(08)60345-4; NORMAN E, 1977, OPHELIA, V16, P233, DOI 10.1080/00785326.1977.10425473; Paalvast P, 2011, INT BIODETER BIODEGR, V65, P379, DOI 10.1016/j.ibiod.2010.11.016; PAWLIK JR, 1992, OCEANOGR MAR BIOL, V30, P273; PAWLIK JR, 1993, LIMNOL OCEANOGR, V38, P1730, DOI 10.4319/lo.1993.38.8.1730; PAWLIK JR, 1991, SCIENCE, V251, P421, DOI 10.1126/science.251.4992.421; Pineda J, 2010, J EXP MAR BIOL ECOL, V392, P9, DOI 10.1016/j.jembe.2010.04.008; Qian PY, 2000, MAR ECOL PROG SER, V207, P109, DOI 10.3354/meps207109; Reidenbach MA, 2009, LIMNOL OCEANOGR, V54, P318, DOI 10.4319/lo.2009.54.1.0318; ROONEY P, 1991, CAN J FISH AQUAT SCI, V48, P1944, DOI 10.1139/f91-231; SINGH HR, 1994, HYDROBIOLOGIA, V285, P111, DOI 10.1007/BF00005659; Sporman LA, 2006, VELIGER, V48, P105; Tamburri MN, 1996, BIOL BULL, V191, P367, DOI 10.2307/1543009; THORSON G, 1950, BIOL REV, V25, P1, DOI 10.1111/j.1469-185X.1950.tb00585.x; Troost K, 2008, J EXP MAR BIOL ECOL, V358, P185, DOI 10.1016/j.jembe.2008.02.009; Tuente U, 2002, HELGOLAND MAR RES, V56, P87, DOI 10.1007/s10152-002-0101-7; TURNER EJ, 1994, LIMNOL OCEANOGR, V39, P1579, DOI 10.4319/lo.1994.39.7.1579; Turner RD, 1966, SPECIAL PUBLICATION; Zilman G, 2013, J EXP BIOL, V216, P2789, DOI 10.1242/jeb.083352	65	8	8	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0124950	10.1371/journal.pone.0124950	http://dx.doi.org/10.1371/journal.pone.0124950			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970270	Green Published, Green Submitted, gold			2022-12-26	WOS:000354544200060
J	Kanungo, S; Bhowmik, K; Mahapatra, T; Mahapatra, S; Bhadra, UK; Sarkar, K				Kanungo, Suman; Bhowmik, Kalyan; Mahapatra, Tanmay; Mahapatra, Sanchita; Bhadra, Uchhal K.; Sarkar, Kamalesh			Perceived Morbidity, Healthcare-Seeking Behavior and Their Determinants in a Poor-Resource Setting: Observation from India	PLOS ONE			English	Article							SELF-REPORTED ILLNESS; NONCOMMUNICABLE DISEASES; DEVELOPING-COUNTRIES; GENDER-DIFFERENCES; ANTIBIOTIC MISUSE; RURAL BANGLADESH; URBAN SLUMS; CHILDREN; BURDEN; HYPERTENSION	Background To control the double burden of communicable and non-communicable diseases (NCDs), in the developing world, understanding the patterns of morbidity and healthcare-seeking is critical. The objective of this cross-sectional study was to determine the distribution, predictors and inter-relationship of perceived morbidity and related healthcare-seeking behavior in a poor-resource setting. Methods Between October 2013 and July 2014, 43999 consenting subjects were recruited from 10107 households in Malda district of West Bengal state in India, through multistage random sampling, using probability proportional-to-size. Information on socio-demographics, behaviors, recent ailments, perceived severity and healthcare-seeking were analyzed in SAS-9.3.2. Results Recent illnesses were reported by 55.91% (n=24600) participants. Among diagnosed ailments (n=23626), 50.92% (n=12031) were NCDs. Respiratory (17.28%, n=7605)), gastrointestinal (13.48%, n=5929) and musculoskeletal (6.25%, n=2749) problems were predominant. Non-qualified practitioners treated 53.16% (n=13074) episodes. Older children/adolescents [adjusted odds ratio for private healthcare providers(AOR(Pri))=0.76, 95% confidence interval=0.71-0.83) and for Govt. healthcare provider(AOR(Govt))=0.80(0.68-0.95)], females [AOR(Govt)=0.80(0.73-0.88)], Muslims [AOR(Pri)=0.85(0.69-0.76) and AOR(Govt)=0.92(0.87-0.96)], backward castes [AOR(Govt)=0.93(0.91-0.96)] and rural residents [AOR(Pri)=0.82(0.75-0.89) and AOR(Govt)=0.72(0.64-0.81)] had lower odds of visiting qualified practitioners. Apparently less severe NCDs [acid-peptic disorders: AOR(Pri)=0.41(0.37-0.46) & AOR(Govt)=0.41(0.37-0.46), osteoarthritis: AOR(Pri)=0.72(0.59-0.68) & AOR(Govt)=0.58(0.43-0.78)], gastrointestinal [AOR(Pri)=0.28(0.24-0.33) & AOR(Govt)=0.69(0.58-0.81)], respiratory [AOR(Pri)=0.35(0.32-0.39) & AOR(Govt)=0.46(0.41-0.52)] and skin infections [AOR(Pri)=0.65 (0.55-0.77)] were also less often treated by qualified practitioners. Better education [AOR(Pri)=1.91(1.65-2.22) for >= graduation], sanitation [AOR(Pri)=1.58(1.42-1.75)] and access to safe water [AOR(Pri)=1.33(1.05-1.67)] were associated with healthcare-seeking from qualified private practitioners. Longstanding NCDs [chronic obstructive pulmonary diseases: AOR(Pri)=1.80(1.46-2.23), hypertension: AOR(Pri)=1.94(1.60-2.36), diabetes: AOR(Pri)=4.94 (3.55-6.87)] and serious infections [typhoid: AOR(Pri)=2.86(2.04-4.03)] were also more commonly treated by qualified private practitioners. Potential limitations included temporal ambiguity, reverse causation, generalizability issues and misclassification. Conclusion In this poor-resource setting with high morbidity, ailments and their perceived severity were important predictors for healthcare-seeking. Interventions to improve awareness and healthcare-seeking among under-privileged and vulnerable population with efforts to improve the knowledge and practice of non-qualified practitioners probably required urgently.	[Kanungo, Suman; Bhowmik, Kalyan; Mahapatra, Tanmay; Mahapatra, Sanchita; Sarkar, Kamalesh] Natl Inst Cholera & Enter Dis, Kolkata 700010, W Bengal, India; [Bhadra, Uchhal K.] Coll Med, Malda 732101, W Bengal, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Sarkar, K (corresponding author), Natl Inst Cholera & Enter Dis, Kolkata 700010, W Bengal, India.	kamalesh.sarkar@gmail.com	Kanungo, Sloka/HHM-7508-2022; Sarkar, Kamalesh/AAE-1127-2022; Sarkar, Kamalesh/AAD-8836-2022	Sarkar, Kamalesh/0000-0002-9193-0849; Kanungo, Suman/0000-0003-4441-4443	Indian Council of Medical Research [65/56/2012-13ECD-II]	Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	The study was funded by the Indian Council of Medical Research (http://icmr.nic.in/Grants/Grants.html) with Grant No. 65/56/2012-13ECD-II. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SM, 2005, B WORLD HEALTH ORGAN, V83, P109; Ahmed SM, 2000, SOC SCI MED, V51, P361, DOI 10.1016/S0277-9536(99)00461-X; Ahmed SM, 2007, HEALTH POLICY, V84, P332, DOI 10.1016/j.healthpol.2007.05.011; [Anonymous], 2011, HLTH MARCH 2010 2011; [Anonymous], 2013, NONC DIS; [Anonymous], 2014, HLTH TRANS TRAD FOR; [Anonymous], 2005, PREV CHRON DIS VIT I; Ansah EK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-853; BAPNA JS, 1992, EUR J CLIN PHARMACOL, V43, P413, DOI 10.1007/BF02220618; Barnett S, 2001, J EPIDEMIOL COMMUN H, V55, P44, DOI 10.1136/jech.55.1.44; Basu S, 2008, NIGER J CLIN PRACT, V11, P52; Basu S, 2013, HYPERTENSION, V62, P18, DOI 10.1161/HYPERTENSIONAHA.113.01374; Binnendijk E, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-23; BOJALIL R, 1994, J CLIN EPIDEMIOL, V47, P147, DOI 10.1016/0895-4356(94)90019-1; Boutayeb A, 2006, T ROY SOC TROP MED H, V100, P191, DOI 10.1016/j.trstmh.2005.07.021; Chaturvedi HK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-301; Daar AS, 2007, NATURE, V450, P494, DOI 10.1038/450494a; Giang KB, 2003, SCAND J PUBLIC HEALT, V31, P52, DOI 10.1080/14034950310015112; González-López José Rafael, 2014, Invest. educ. enferm, V32, P347, DOI 10.17533/udea.iee.v32n2a17; Gupta R, 2012, J HUM HYPERTENS, V26, P585, DOI 10.1038/jhh.2011.79; HAUSFELD RG, 1973, MED J AUSTRALIA, V2, P975, DOI 10.5694/j.1326-5377.1973.tb129866.x; Ir P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010930; John TJ, 2011, LANCET, V377, P252, DOI 10.1016/S0140-6736(10)61265-2; Joshi A, 2013, J COMMUN HEALTH, V38, P320, DOI 10.1007/s10900-012-9617-1; Kanungo S, 2014, EPIDEMIOL INFECT, V142, P314, DOI 10.1017/S0950268813001076; Kwak C, 2002, NURS RES, V51, P406, DOI 10.1097/00006199-200211000-00009; Lopez AD, 2006, ANN TROP MED PARASIT, V100, P481, DOI 10.1179/136485906X97417; Manna B, 2013, AM J TROP MED HYG, V89, P56, DOI 10.4269/ajtmh.12-0756; Organization WH, 2016, GLOBAL STATUS REPORT; Pandey A, 2002, J HEALTH POPUL NUTR, V20, P306; Picavet HSJ, 2003, ANN RHEUM DIS, V62, P644, DOI 10.1136/ard.62.7.644; Pillai R, 2003, SOC SCI MED, V57, P783, DOI 10.1016/S0277-9536(02)00448-3; Pokhrel S, 2004, HEALTH POLICY PLANN, V19, P218, DOI 10.1093/heapol/czh027; Quigley MA, 2006, INT J EPIDEMIOL, V35, P1530, DOI 10.1093/ije/dyl244; Rahman MM, 2013, B WORLD HEALTH ORGAN, V91, P449, DOI 10.2471/BLT.12.115428; Ramirez AL, 2011, J PUBLIC HEALTH-UK, V33, P579, DOI 10.1093/pubmed/fdr014; Reddy KS, 2005, LANCET, V366, P1744, DOI [10.1016/s0140-6736(05)67343-6, 10.1016/S0140-6736(05)67343-6]; Sharma K., 2013, INT J MED SCI PUBLIC, V2, P7, DOI DOI 10.5455/IJMSPH.2013.2.7-11; Sreeramareddy Chandrashekhar T, 2006, BMC Int Health Hum Rights, V6, P7, DOI 10.1186/1472-698X-6-7; Steinhardt LC, 2009, HEALTH POLICY PLANN, V24, P1, DOI 10.1093/heapol/czn043; Taffa N, 2005, TROP MED INT HEALTH, V10, P240, DOI 10.1111/j.1365-3156.2004.01381.x; WAGNER EH, 1984, J CHRON DIS, V37, P943, DOI 10.1016/0021-9681(84)90071-7; Willis JR, 2009, J HEALTH POPUL NUTR, V27, P62; World Health Organization, 2014, NONC DIS COUNTR PROF; World Health Organization (WHO), 2014, DET HLTH	45	27	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0125865	10.1371/journal.pone.0125865	http://dx.doi.org/10.1371/journal.pone.0125865			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI1ZI	25965382	Green Submitted, gold, Green Published			2022-12-26	WOS:000354543500031
J	Lebreton, F; Cayzac, S; Pietropaolo, S; Jeantet, Y; Cho, YH				Lebreton, Fanny; Cayzac, Sebastien; Pietropaolo, Susanna; Jeantet, Yannick; Cho, Yoon H.			Sleep Physiology Alterations Precede Plethoric Phenotypic Changes in R6/1 Huntington's Disease Mice	PLOS ONE			English	Article							TRANSGENIC MOUSE MODEL; ENVIRONMENTAL ENRICHMENT; NOCTURNAL SLEEP; MEMORY CONSOLIDATION; GENE; DISTURBANCES; DEFICITS; ELECTROENCEPHALOGRAM; ABNORMALITIES; NEUROGENESIS	In hereditary neurodegenerative Huntington's disease (HD), there exists a growing consideration that sleep and circadian dysregulations may be important symptoms. It is not known, however, whether sleep abnormalities contribute to other behavioral deficits in HD patients and mouse models. To determine the precise chronology for sleep physiology alterations and other sensory, motor, psychiatric and cognitive symptoms of HD, the same R6/1 HD transgenics and their wild-type littermates were recorded monthly for sleep electroencephalogram (EEG) together with a wide range of behavioral tests according to a longitudinal plan. We found an early and progressive deterioration of both sleep architecture and EEG brain rhythms in R6/1 mice, which are correlated timely with their spatial working memory impairments. Sleep fragmentation and memory impairments were accompanied by the loss of delta (1-4Hz) power in the transgenic mice, the magnitude of which increased with age and disease progression. These precocious sleep and cognitive impairments were followed by deficits in social behavior, sensory and motor abilities. Our data confirm the existence and importance of sleep physiology alterations in the widely used R6/1 mouse line and highlight their precedence over other plethoric phenotypic changes. The brainwave abnormalities, may represent a novel biomarker and point to innovative therapeutic interventions against HD.	[Lebreton, Fanny; Cayzac, Sebastien; Pietropaolo, Susanna; Jeantet, Yannick; Cho, Yoon H.] CNRS, Inst Neurosci Cognit & Integrat Aquitaine, UMR 5287, F-33405 Talence, France; [Lebreton, Fanny; Cayzac, Sebastien; Pietropaolo, Susanna; Jeantet, Yannick; Cho, Yoon H.] Univ Bordeaux, F-33405 Talence, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Cho, YH (corresponding author), CNRS, Inst Neurosci Cognit & Integrat Aquitaine, UMR 5287, Bat B2 Ave Fac, F-33405 Talence, France.	yoon.cho@u-bordeaux1.fr	Lebreton, Fanny/K-1969-2012; Lebreton, Fanny/AAC-4053-2020; Lebreton, Fanny/AGY-7906-2022	Lebreton, Fanny/0000-0002-3175-0205; Lebreton, Fanny/0000-0002-3175-0205; pietropaolo, susanna/0000-0002-8993-1922	University of Bordeaux 1 (BQR); Agence National de la Recherche [ANR-08-MNPS-019-01]; Hereditary Disease Foundation	University of Bordeaux 1 (BQR); Agence National de la Recherche(French National Research Agency (ANR)); Hereditary Disease Foundation	The work was supported by University of Bordeaux 1 (BQR), Agence National de la Recherche [ANR-08-MNPS-019-01] and the Hereditary Disease Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainge JA, 2007, HIPPOCAMPUS, V17, P988, DOI 10.1002/hipo.20301; Arnulf I, 2008, ARCH NEUROL-CHICAGO, V65, P482, DOI 10.1001/archneur.65.4.482; Aron AR, 2003, BRAIN, V126, P713, DOI 10.1093/brain/awg067; Cayzac S, 2011, P NATL ACAD SCI USA, V108, P9280, DOI 10.1073/pnas.1016190108; Cha JHJ, 1999, PHILOS T R SOC B, V354, P981, DOI 10.1098/rstb.1999.0449; Cha JHJ, 1998, P NATL ACAD SCI USA, V95, P6480, DOI 10.1073/pnas.95.11.6480; Duff K, 2007, BIOL PSYCHIAT, V62, P1341, DOI 10.1016/j.biopsych.2006.11.034; EMSER W, 1988, J NEUROL, V235, P177, DOI 10.1007/BF00314313; Eschenko O, 2006, J NEUROSCI, V26, P12914, DOI 10.1523/JNEUROSCI.3175-06.2006; Fisher SP, 2013, BRAIN, V136, P2159, DOI 10.1093/brain/awt132; Goodman AOG, 2011, CURR NEUROL NEUROSCI, V11, P211, DOI 10.1007/s11910-010-0163-x; Goodman AOG, 2010, J NEUROL, V257, P882, DOI 10.1007/s00415-010-5517-4; HANSOTIA P, 1985, NEUROLOGY, V35, P1672, DOI 10.1212/WNL.35.11.1672; Hobbs NZ, 2010, AM J NEURORADIOL, V31, P1036, DOI 10.3174/ajnr.A2018; Hockly E, 2002, ANN NEUROL, V51, P235, DOI 10.1002/ana.10094; Jeantet Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079509; Kantor S, 2013, BRAIN, V136, P2147, DOI 10.1093/brain/awt128; Kassubek J, 2005, CEREB CORTEX, V15, P846, DOI 10.1093/cercor/bhh185; Kemp J, 2013, CORTEX, V49, P559, DOI 10.1016/j.cortex.2012.01.004; Kudo T, 2011, EXP NEUROL, V228, P80, DOI 10.1016/j.expneurol.2010.12.011; Lawrence AD, 1998, BRAIN, V121, P1329, DOI 10.1093/brain/121.7.1329; Lazic SE, 2006, EUR J NEUROSCI, V23, P1829, DOI 10.1111/j.1460-9568.2006.04715.x; Lazic SE, 2007, BRAIN RES, V1151, P219, DOI 10.1016/j.brainres.2007.03.018; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Marshall U, 2007, TRENDS COGN SCI, V11, P442, DOI 10.1016/j.tics.2007.09.001; Moberg PJ, 1997, INT J NEUROSCI, V89, P133, DOI 10.3109/00207459708988468; MOBERG PJ, 1987, J CLIN EXP NEUROPSYC, V9, P650, DOI 10.1080/01688638708405208; Molle M, 2004, P NATL ACAD SCI USA, V101, P13963, DOI 10.1073/pnas.0402820101; Morton AJ, 2005, J NEUROSCI, V25, P157, DOI 10.1523/JNEUROSCI.3842-04.2005; Nordin S, 1995, J Int Neuropsychol Soc, V1, P281; Pallier PN, 2007, J NEUROSCI, V27, P7869, DOI 10.1523/JNEUROSCI.0649-07.2007; Parmentier R, 2002, J NEUROSCI, V22, P7695; Petersen A, 2006, EUR J NEUROSCI, V24, P961, DOI 10.1111/j.1460-9568.2006.04985.x; Phillips W, 2005, J NEUROSCI, V25, P11564, DOI 10.1523/JNEUROSCI.3796-05.2005; Pietropaolo S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.09.012; Pietropaolo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019965; Pignatelli M, 2012, NEUROBIOL DIS, V48, P409, DOI 10.1016/j.nbd.2012.07.015; Roos RAC, 2007, PARKINSONISM RELAT D, V13, pS387, DOI 10.1016/S1353-8020(08)70035-X; Rudenko O, 2009, BEHAV BRAIN RES, V203, P188, DOI 10.1016/j.bbr.2009.04.034; SILVESTRI R, 1995, NEUROPHYSIOL CLIN, V25, P66, DOI 10.1016/0987-7053(96)81034-3; Spires TL, 2004, J NEUROSCI, V24, P2270, DOI 10.1523/JNEUROSCI.1658-03.2004; Steele AD, 2007, P NATL ACAD SCI USA, V104, P1983, DOI 10.1073/pnas.0610779104; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Taylor N, 1997, BRIT J PSYCHIAT, V171, P393, DOI 10.1192/bjp.171.4.393c; van Dellen A, 2000, NATURE, V404, P721, DOI 10.1038/35008142; Videnovic A, 2009, PARKINSONISM RELAT D, V15, P471, DOI 10.1016/j.parkreldis.2008.10.002; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; WIEGAND M, 1991, EUR ARCH PSY CLIN N, V240, P148, DOI 10.1007/BF02190755; WIEGAND M, 1991, J NEUROL, V238, P203, DOI 10.1007/BF00314781; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Yang Mu, 2011, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0826s56	53	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0126972	10.1371/journal.pone.0126972	http://dx.doi.org/10.1371/journal.pone.0126972			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25966356	gold, Green Published, Green Submitted			2022-12-26	WOS:000354543500087
J	Huberlant, S; Fernandez, H; Vieille, P; Khrouf, M; Ulrich, D; deTayrac, R; Letouzey, V				Huberlant, Stephanie; Fernandez, Herve; Vieille, Pierre; Khrouf, Mohamed; Ulrich, Daniela; deTayrac, Renaud; Letouzey, Vincent			Application of a Hyaluronic Acid Gel after Intrauterine Surgery May Improve Spontaneous Fertility: A Randomized Controlled Trial in New Zealand White Rabbits	PLOS ONE			English	Article							HYSTEROSCOPIC SURGERY; ADHESION FORMATION; PREVENTION; MODEL; EFFICACY; SYNECHIA; AGENTS	Objective Intrauterine adhesions (IUAs) are the most common complication after hysteroscopy in patients of reproductive age. Intra-abdominal anti-adhesion gel reduces the incidence of adhesions, but effects on fertility after uterine surgery are not known. The objective of our work was to evaluate the effect of intrauterine anti-adhesion gel on spontaneous fertility after repeated intrauterine surgery with induced experimental synechiae in the rabbit model. Materials and Methods Twenty New Zealand White rabbits underwent a double uterine curettage 10 days apart and were randomized into two groups. Each rabbit served as its own control: one uterine tube was the treatment group (A), the second uterine tube was the control group (B) to avoid bias through other causes of infertility. Group A received a post curettage intrauterine instillation of anti-adhesion gel whereas group B, the control group, underwent curettage without instillation of the gel. After a recovery period, the rabbits were mated. An abdominal ultrasound performed 21 days after mating allowed us to diagnose pregnancy and quantify the number of viable fetuses. Results There was a significant difference in total fetuses in favor of group A, with an average of 3.7 (range, 0-9) total fetuses per tube against 2.1 (0-7) in group B (p = .04). The number of viable fetuses shows a trend in favor of group A, with an average of 3.4 (0-7) viable fetuses per tube against 1.9 (0-6) viable fetuses per tube in group B (p = .05). Conclusion The use of immediate postoperative anti-adhesion gel improved fertility in an animal model after intrauterine surgery likely to cause uterine synechiae. This experimental model will permit comparison of different anti-adhesion solutions, including assessment of their tolerance and potential mucosal toxicity on embryonic development.	[Huberlant, Stephanie; Vieille, Pierre; Ulrich, Daniela; deTayrac, Renaud; Letouzey, Vincent] Univ Nimes Hosp, Dept Obstet & Gynaecol, F-30006 Nimes, France; [Fernandez, Herve; Khrouf, Mohamed] Hop Bicetre, AP HP, Dept Obstet & Gynaecol, Le Kremlin Bicetre, Paris, France	Universite de Montpellier; CHU de Nimes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Ulrich, D (corresponding author), Graz Univ Hosp, Dept Obstet & Gynaecol, Graz, Austria.	daniela.ulrich@medunigraz.at	KHROUF, Mohamed/AGV-7714-2022; Gold, Daniela/ABE-4818-2020	Gold, Daniela/0000-0002-7196-454X; FERNANDEZ, Herve/0000-0002-6463-1018				Acunzo G, 2003, HUM REPROD, V18, P1918, DOI 10.1093/humrep/deg368; Binda MM, 2010, BJOG-INT J OBSTET GY, V117, P331, DOI 10.1111/j.1471-0528.2009.02370.x; De Iaco PA, 1998, FERTIL STERIL, V69, P318; Deans R, 2010, J MINIM INVAS GYN, V17, P555, DOI 10.1016/j.jmig.2010.04.016; Fischer B, 2012, REPRODUCTION, V144, P1, DOI 10.1530/REP-12-0091; Guida M, 2004, HUM REPROD, V19, P1461, DOI 10.1093/humrep/deh238; Huberlant S, 2014, J GYNECOL SURG, V30, P347, DOI 10.1089/gyn.2013.0138; Hwang HJ, 2013, INT J COLORECTAL DIS, V28, P1117, DOI 10.1007/s00384-013-1679-8; Kaya C, 2014, EUR J OBSTET GYN R B, V176, P44, DOI 10.1016/j.ejogrb.2014.02.033; Khrouf Mohamed, 2012, J Hum Reprod Sci, V5, P175, DOI 10.4103/0974-1208.101017; Kodaman PH, 2007, CURR OPIN OBSTET GYN, V19, P207, DOI 10.1097/GCO.0b013e32814a6473; Kumar S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005080.pub2; Kupesic S, 2007, EUR J OBSTET GYN R B, V133, P64, DOI 10.1016/j.ejogrb.2006.10.010; Pellicano M, 2005, FERTIL STERIL, V83, P498, DOI 10.1016/j.fertnstert.2004.09.019; Pucciarelli S, 2003, BRIT J SURG, V90, P66, DOI 10.1002/bjs.4006; Rathat G, 2011, FERTIL STERIL, V95, P405, DOI 10.1016/j.fertnstert.2010.08.055; Revaux A, 2008, GYNECOL OBSTET FERTI, V36, P311, DOI 10.1016/j.gyobfe.2007.11.014; Robinson JK, 2008, FERTIL STERIL, V90, P409, DOI 10.1016/j.fertnstert.2007.06.034; Salzani A, 2007, SAO PAULO MED J, V125, P261, DOI 10.1590/S1516-31802007000500002; Sardo AD, 2011, J MINIM INVAS GYN, V18, P462, DOI 10.1016/j.jmig.2011.04.007; Shamiyeh A, 2007, HEPATO-GASTROENTEROL, V54, P1121; Tao T, 2000, HUM REPROD, V15, P881, DOI 10.1093/humrep/15.4.881; Taskin O, 2000, J AM ASSOC GYN LAP, V7, P351, DOI 10.1016/S1074-3804(05)60478-1; Thomson AJM, 2009, CURR OPIN OBSTET GYN, V21, P335, DOI 10.1097/GCO.0b013e32832e07fc; Touboul C, 2009, FERTIL STERIL, V92, P1690, DOI 10.1016/j.fertnstert.2008.08.108; Yu D, 2008, FERTIL STERIL, V89, P759, DOI 10.1016/j.fertnstert.2008.02.096	26	23	29	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0125610	10.1371/journal.pone.0125610	http://dx.doi.org/10.1371/journal.pone.0125610			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961307	Green Published, Green Submitted, gold			2022-12-26	WOS:000354542500038
J	Kato, M; Tani, T; Terahara, N; Tsuda, T				Kato, Masaki; Tani, Tsubasa; Terahara, Norihiko; Tsuda, Takanori			The Anthocyanin Delphinidin 3-Rutinoside Stimulates Glucagon-Like Peptide-1 Secretion in Murine GLUTag Cell Line via the Ca2+/Calmodulin-Dependent Kinase II Pathway	PLOS ONE			English	Article							EXTRACT AMELIORATES HYPERGLYCEMIA; DIPEPTIDYL PEPTIDASE-4 INHIBITOR; ACTIVATED PROTEIN-KINASE; FATTY-ACIDS; ENTEROENDOCRINE CELLS; INSULIN SENSITIVITY; POTENT STIMULATOR; GLUCOSE-TOLERANCE; GLP-1 SECRETION; BETA-CELLS	Glucagon-like peptide-1 (GLP-1) is an incretin hormone secreted from enteroendocrine Lcells. Although several nutrients induce GLP-1 secretion, there is little evidence to suggest that non-nutritive compounds directly increase GLP-1 secretion. Here, we hypothesized that anthocyanins induce GLP-1 secretion and thereby significantly contribute to the prevention and treatment of diabetes. Delphinidin 3-rutinoside (D3R) was shown to increase GLP-1 secretion in GLUTag L cells. The results suggested that three hydroxyl or two methoxyl moieties on the aromatic ring are essential for the stimulation of GLP-1 secretion. Notably, the rutinose moiety was shown to be a potent enhancer of GLP-1 secretion, but only in conjunction with three hydroxyl moieties on the aromatic ring (D3R). Receptor antagonist studies revealed that D3R-stimulates GLP-1 secretion involving inositol 1,4,5-trisphosphate receptor-mediated intracellular Ca2+ mobilization. Treatment of GLUTag cells with a Ca2+/calmodulin-dependent kinaseII (CaMKII) inhibitor (KN-93) abolished D3R-stimulated GLP-1 secretion. In addition, treatment of GLUTag cells with D3R resulted in activation of CaMKII. Pre-treatment of cells with a G protein-coupled receptor (GPR) 40/120 antagonist (GW1100) also significantly decreased D3R-stimulated GLP-1 secretion. These observations suggest that D3R stimulates GLP-1 secretion in GLUTag cells, and that stimulation of GLP-1 secretion by D3R is mediated via Ca2+-CaMKII pathway, which may possibly be mediated by GPR40/120. These findings provide a possible molecular mechanism of GLP-1 secretion in intestinal L-cells mediated by foods or drugs and demonstrate a novel biological function of anthocyanins in regards to GLP-1 secretion.	[Kato, Masaki; Tani, Tsubasa; Tsuda, Takanori] Chubu Univ, Coll Biosci & Biotechnol, Kasugai, Aichi 487, Japan; [Terahara, Norihiko] Minami Kyushu Univ, Dept Food Sci & Technol, Miyazaki, Japan	Chubu University	Tsuda, T (corresponding author), Chubu Univ, Coll Biosci & Biotechnol, Kasugai, Aichi 487, Japan.	tsudat@isc.chubu.ac.jp		Kato, Masaki/0000-0003-0756-8881	Japan Society for Promotion of Science [26450168, 26850088]	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by Grants-in-Aid for Scientific Research (Nos. 26450168 for TAT, and 26850088 for MK) from the Japan Society for Promotion of Science.	Alvarez-Suarez JM, 2014, J NUTR BIOCHEM, V25, P289, DOI 10.1016/j.jnutbio.2013.11.002; Buteau J, 2003, DIABETES, V52, P124, DOI 10.2337/diabetes.52.1.124; Choi SE, 2007, J ETHNOPHARMACOL, V110, P49, DOI 10.1016/j.jep.2006.09.001; Clemmensen C, 2013, ENDOCRINOLOGY, V154, P3978, DOI 10.1210/en.2013-1529; Cordier-Bussat M, 1998, DIABETES, V47, P1038, DOI 10.2337/diabetes.47.7.1038; DEACON CF, 1995, DIABETES, V44, P1126, DOI 10.2337/diabetes.44.9.1126; DRUCKER DJ, 1994, MOL ENDOCRINOL, V8, P1646, DOI 10.1210/me.8.12.1646; Edfalk S, 2008, DIABETES, V57, P2280, DOI 10.2337/db08-0307; Herman GA, 2006, J CLIN ENDOCR METAB, V91, P4612, DOI 10.1210/jc.2006-1009; Higuchi N, ENDOCRINOLOGY, V15, P3089; Hira T, 2009, AM J PHYSIOL-GASTR L, V297, pG663, DOI 10.1152/ajpgi.90635.2008; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Iakoubov R, 2007, ENDOCRINOLOGY, V148, P1089, DOI 10.1210/en.2006-1403; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Janssen S, 2013, TRENDS ENDOCRIN MET, V24, P92, DOI 10.1016/j.tem.2012.11.006; KIEFFER TJ, 1995, ENDOCRINOLOGY, V136, P3585, DOI 10.1210/en.136.8.3585; KREYMANN B, 1987, LANCET, V2, P1300; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lan H, 2012, BRIT J PHARMACOL, V165, P2799, DOI 10.1111/j.1476-5381.2011.01754.x; Lauffer LM, 2009, DIABETES, V58, P1058, DOI 10.2337/db08-1237; Lee SJ, 2009, MOL CELLS, V28, P167, DOI 10.1007/s10059-009-0119-7; Li SK, 2014, DIABETOLOGIA, V57, P809, DOI 10.1007/s00125-013-3143-2; Lim GE, 2009, ENDOCRINOLOGY, V150, P5249, DOI 10.1210/en.2009-0508; Lim GE, 2009, ENDOCRINOLOGY, V150, P580, DOI 10.1210/en.2008-0726; Mahadev K, 2001, J BIOL CHEM, V276, P48662, DOI 10.1074/jbc.M105061200; MOJSOV S, 1987, J CLIN INVEST, V79, P616, DOI 10.1172/JCI112855; Ohyama A, 2002, J NEUROSCI, V22, P3342; Parker HE, 2012, BRIT J PHARMACOL, V165, P414, DOI 10.1111/j.1476-5381.2011.01561.x; Reimann F, 2004, DIABETOLOGIA, V47, P1592, DOI 10.1007/s00125-004-1498-0; Reimann F, 2006, DIABETES, V55, pS78, DOI 10.2337/db06-S010; Reimann F, 2008, CELL METAB, V8, P532, DOI 10.1016/j.cmet.2008.11.002; Reimer RA, 2006, J ENDOCRINOL, V191, P159, DOI 10.1677/joe.1.06557; ROCCA AS, 1995, ENDOCRINOLOGY, V136, P5593, DOI 10.1210/en.136.12.5593; Rocca AS, 2001, ENDOCRINOLOGY, V142, P1148, DOI 10.1210/en.142.3.1148; Rorsman P, 2012, CELL CALCIUM, V51, P300, DOI 10.1016/j.ceca.2011.11.006; Rosenstock J, 2008, DIABETES OBES METAB, V10, P376, DOI 10.1111/j.1463-1326.2008.00876.x; Sangle GV, 2012, ENDOCRINOLOGY, V153, P564, DOI 10.1210/en.2011-1732; Symonds EL, 2015, GUT, V64, P618, DOI 10.1136/gutjnl-2014-306834; Takikawa M, 2010, J NUTR, V140, P527, DOI 10.3945/jn.109.118216; Takikawa M, 2013, BIOCHEM BIOPH RES CO, V435, P165, DOI 10.1016/j.bbrc.2013.04.092; Thomsen C, 1999, AM J CLIN NUTR, V69, P1135; Tolhurst G, 2011, ENDOCRINOLOGY, V152, P405, DOI 10.1210/en.2010-0956; Tsuda T, 2012, FOOD SCI TECHNOL RES, V18, P315, DOI 10.3136/fstr.18.315; Tsuda T, 2012, MOL NUTR FOOD RES, V56, P159, DOI 10.1002/mnfr.201100526; Vilsboll T, 2008, DIABETIC MED, V25, P152, DOI 10.1111/j.1464-5491.2007.02333.x; Wedick NM, 2012, AM J CLIN NUTR, V95, P925, DOI 10.3945/ajcn.111.028894; Williamson G, 2005, AM J CLIN NUTR, V81, p243S, DOI [10.1093/ajcn/81.1.243S, 10.1093/ajcn/81.1.230S]; Zander M, 2002, LANCET, V359, P824, DOI 10.1016/S0140-6736(02)07952-7	50	50	53	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126157	10.1371/journal.pone.0126157	http://dx.doi.org/10.1371/journal.pone.0126157			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962102	Green Submitted, Green Published, gold			2022-12-26	WOS:000354542500070
J	Lago, C; Landoni, M; Cassani, E; Cantaluppi, E; Doria, E; Nielsen, E; Giorgi, A; Pilu, R				Lago, Chiara; Landoni, Michela; Cassani, Elena; Cantaluppi, Enrico; Doria, Enrico; Nielsen, Erik; Giorgi, Annamaria; Pilu, Roberto			Study and Characterization of an Ancient European Flint White Maize Rich in Anthocyanins: Millo Corvo from Galicia	PLOS ONE			English	Article							ZEA-MAYS L.; VITAMIN-A-DEFICIENCY; BALSAS RIVER VALLEY; R-R COMPLEX; PHENOLIC-COMPOUNDS; ANTIOXIDANT CAPACITY; PURPLE CORN; GENE; MEXICO; DOMESTICATION	In the second half of the last century, the American dent hybrids began to be widely grown, leading to the disappearance or marginalization of the less productive traditional varieties. Nowadays the characterization of traditional landraces can help breeders to discover precious alleles that could be useful for modern genetic improvement and allow a correct conservation of these open pollinated varieties (opv(s)). In this work we characterized the ancient coloured cultivar "Millo Corvo" typical of the Spanish region of Galicia. We showed that this cultivar accumulates high amounts of anthocyanins (83.4 mg/100g flour), and by TLC (Thin Layer Chromatography) and HPLC (High Pressure Liquid Chromatography) analysis, we demonstrated that they mainly consisted of cyanidin. Mapping and sequencing data demonstrate that anthocyanin pigmentation is due to the presence of the red color1 gene(r1), a transcription factor driving the accumulation of this pigment in the aleurone layer. Further chemical analysis showed that the kernels are lacking in carotenoids, as confirmed by genetic study. Finally a DPPH (2,2-diphenyl-1-picrylhydrazyl) radical scavenging ability test showed that Millo Corvo, even though lacking carotenoids, has a high antioxidant ability, and could be considered as a functional food due to the presence of anthocyanins.	[Lago, Chiara; Cassani, Elena; Cantaluppi, Enrico; Giorgi, Annamaria; Pilu, Roberto] Univ Milan, Dipartimento Sci Agr & Ambientali Prod Terr Agroe, I-20133 Milan, Italy; [Landoni, Michela] Univ Milan, Dipartimento Biosci, I-20133 Milan, Italy; [Doria, Enrico; Nielsen, Erik] Univ Pavia, Dipartimento Biol & Biotecnol, I-27100 Pavia, Italy; [Giorgi, Annamaria] Univ Milan, Ctr Appl Studies Sustainable Management & Protect, Brescia, Italy	University of Milan; University of Milan; University of Pavia; University of Milan	Pilu, R (corresponding author), Univ Milan, Dipartimento Sci Agr & Ambientali Prod Terr Agroe, Via Celoria 2, I-20133 Milan, Italy.	salvatore.pilu@unimi.it	Doria, Enrico/Q-3244-2018; Cantaluppi, Enrico/HGC-4418-2022	Doria, Enrico/0000-0002-6805-0202; PILU, SALVATORE ROBERTO/0000-0003-0181-2169; Landoni, Marco/0000-0001-5570-5081; giorgi, annamaria/0000-0001-5386-7378	"Accordo di Programma, affermazione in Edolo del Centro di Eccellenza Universita della Montagna" MIUR-Universita degli Studi di Milano [386 1293-05/08/2011]; Fondazione della Comunita Bresciana-Onlus	"Accordo di Programma, affermazione in Edolo del Centro di Eccellenza Universita della Montagna" MIUR-Universita degli Studi di Milano; Fondazione della Comunita Bresciana-Onlus	This study was partly supported by "Accordo di Programma, affermazione in Edolo del Centro di Eccellenza Universita della Montagna" MIUR-Universita degli Studi di Milano, prot. no. 386 1293-05/08/2011, and by Fondazione della Comunita Bresciana-Onlus.	Astadi IR, 2009, FOOD CHEM, V112, P659, DOI 10.1016/j.foodchem.2008.06.034; Berardo N., 2004, Innovative Food Science & Emerging Technologies, V5, P393, DOI 10.1016/j.ifset.2004.03.001; Brandolini A, 2009, MAYDICA, V54, P233; Buckner B, 1996, GENETICS, V143, P479; Camus-Kulandaivelu L, 2006, GENETICS, V172, P2449, DOI 10.1534/genetics.105.048603; Cevallos-Casals BA, 2003, J AGR FOOD CHEM, V51, P3313, DOI 10.1021/jf034109c; Chander S, 2008, THEOR APPL GENET, V116, P223, DOI 10.1007/s00122-007-0661-7; Consonni G, 1997, MOL GEN GENET, V256, P265, DOI 10.1007/s004380050569; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; DOONER HK, 1971, GENETICS, V67, P427; DOONER HK, 1991, ANNU REV GENET, V25, P173, DOI 10.1146/annurev.ge.25.120191.001133; Doria E, 2009, J EXP BOT, V60, P967, DOI 10.1093/jxb/ern345; Dubreuil P, 2006, MAYDICA, V51, P281; Eschholz TW, 2010, GENET RESOUR CROP EV, V57, P71, DOI 10.1007/s10722-009-9452-0; Grobman A, 1982, MAYS ZEA MAYS PRECER, P157; Grotewold E, 2000, P NATL ACAD SCI USA, V97, P13579, DOI 10.1073/pnas.250379897; Hallauer A.R., 1988, CORN CORN IMPROVEMEN, V18, P463; Kirk J., 1978, PLASTIDS THEIR CHEM, P217; Kurilich AC, 1999, J AGR FOOD CHEM, V47, P1948, DOI 10.1021/jf981029d; Lago C, 2014, PLANT BREEDING, V133, P210, DOI 10.1111/pbr.12153; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Lopez-Martinez LX, 2009, LWT-FOOD SCI TECHNOL, V42, P1187, DOI 10.1016/j.lwt.2008.10.010; Matsuoka Y, 2002, P NATL ACAD SCI USA, V99, P6080, DOI 10.1073/pnas.052125199; Mir C, 2013, THEOR APPL GENET, V126, P2671, DOI 10.1007/s00122-013-2164-z; Montilla EC, 2011, J AGR FOOD CHEM, V59, P7068, DOI 10.1021/jf201061x; PAZARES J, 1987, EMBO J, V6, P3553, DOI 10.1002/j.1460-2075.1987.tb02684.x; Pearsall DM, 2004, J ARCHAEOL SCI, V31, P423, DOI 10.1016/j.jas.2003.09.010; Petroni K, 2010, J NUTRIGENET NUTRIGE, V3, P76; Pilu R, 2003, PLANT J, V36, P510, DOI 10.1046/j.1365-313X.2003.01898.x; Pilu R, 2012, MOL BREEDING, V30, P799, DOI 10.1007/s11032-011-9664-9; Piperno DR, 2009, P NATL ACAD SCI USA, V106, P5019, DOI 10.1073/pnas.0812525106; Piperno DR, 2000, NATURE, V407, P894, DOI 10.1038/35038055; Piperno DR, 2006, PHYTOLITH ANAL COMPR; Pohl MED, 2007, P NATL ACAD SCI USA, V104, P6870, DOI 10.1073/pnas.0701425104; Prasanna BM, 2012, J BIOSCIENCES, V37, P843, DOI 10.1007/s12038-012-9227-1; Ranere AJ, 2009, P NATL ACAD SCI USA, V106, P5014, DOI 10.1073/pnas.0812590106; ROBBINS TP, 1991, GENETICS, V129, P271; Rodriguez VM, 2013, EUPHYTICA, V193, P339, DOI 10.1007/s10681-013-0924-0; Shen LY, 2006, MOL BREEDING, V18, P57, DOI 10.1007/s11032-006-9018-1; Sommer A, 2002, J NUTR, V132, p2845S, DOI 10.1093/jn/132.9.2845S; Toufektsian MC, 2008, J NUTR, V138, P747, DOI 10.1093/jn/138.4.747; Tsuda T, 2012, MOL NUTR FOOD RES, V56, P159, DOI 10.1002/mnfr.201100526; Tukaj Z, 2003, PLANT PHYSIOL BIOCH, V41, P337, DOI 10.1016/S0981-9428(03)00028-7; van Heerwaarden J, 2011, P NATL ACAD SCI USA, V108, P1088, DOI 10.1073/pnas.1013011108; WALKER EL, 1995, EMBO J, V14, P2350, DOI 10.1002/j.1460-2075.1995.tb07230.x; West CE, 2002, J NUTR, V132, p2920S, DOI 10.1093/jn/132.9.2920S; WHO, 2002, RED RISKS PROM HLTH; Wurtzel ET, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00029; Zarrillo S, 2008, P NATL ACAD SCI USA, V105, P5006, DOI 10.1073/pnas.0800894105; Zilic S, 2012, J AGR FOOD CHEM, V60, P1224, DOI 10.1021/jf204367z	50	18	18	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126521	10.1371/journal.pone.0126521	http://dx.doi.org/10.1371/journal.pone.0126521			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961304	Green Submitted, Green Published, gold			2022-12-26	WOS:000354542500108
J	Liu, B; Li, YG				Liu, Bo; Li, YiGang			Impact of Conditional miRNA126 Overexpression on Apoptosis-Resistant Endothelial Cell Production	PLOS ONE			English	Article							PULMONARY-HYPERTENSION; EXPRESSION; MICRORNA; PROTEIN; PROLIFERATION; ANGIOGENESIS; INFLAMMATION; INHIBITOR; GENE	The activation of endothelial cells is essential to repair damage caused by atherosclerosis via endothelial cell proliferation and migration. Overexpression of VEGF (vascular endothelial growth factor) and the downstream gene, B-cell lymphoma-2 (BCL-2) could result in apoptosis-resistant endothelial cells, which are responsible for aggravated hyperplasia and instable plaques generation. Previous studies have shown that miRNA126 could regulate the expression of VEGF. Here, we verified the existence of a miRNA126 binding site in VEGF's 3'UTR. Additionally, VEGF regulated BCL-2 expression via AP1 (Activator Protein 1) binding site in BCL-2' s promoter. Next, we established an apoptosis-resistant endothelial cell line and constructed a lentiviral vector to express miRNA126 under the control of the BCL-2 promoter to investigate whether conditional expression of miRNA126 could modulate VEGF and BCL-2 expression in apoptosis-resistant endothelial cells. This lentiviral system specifically expressed miRNA126 in cells with high BCL-2 levels, downregulated VEGF expression, inhibited MAPK pathway activation and downregulated BCL-2 expression via suppression of AP1, and as a whole, reduced apoptosis-resistant endothelial cells, while the effects of miRNA126 on normal endothelial cells were relatively small. Our results demonstrate that conditional miRNA126 overexpression under the control of the downstream BCL-2 promoter provides a flexible regulatory strategy for reducing the apoptosis-resistant endothelial cells without having a significant impact on normal endothelial cells.	[Liu, Bo; Li, YiGang] Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Dept Cardiol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Li, YG (corresponding author), Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Dept Cardiol, Shanghai 200030, Peoples R China.	drliyigang@outlook.com			National Natural Science Foundation of China [81200110]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Grants from the Young Project of National Natural Science Foundation of China (No. 81200110).	Arciniegas E, 2003, ANAT REC PART A, V274A, P942, DOI 10.1002/ar.a.10105; Bagci EZ, 2006, BIOPHYS J, V90, P1546, DOI 10.1529/biophysj.105.068122; Derwall M, 2012, ARTERIOSCL THROM VAS, V32, P613, DOI 10.1161/ATVBAHA.111.242594; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Fang CC, 2013, CARDIOVASC RES, V99, P146, DOI 10.1093/cvr/cvt060; Frazier WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050071; Guerard P, 2006, N-S ARCH PHARMACOL, V373, P401, DOI 10.1007/s00210-006-0082-1; Huang PY, 2010, PROTEIN CELL, V1, P218, DOI 10.1007/s13238-010-0019-9; Keglowich L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089875; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Kuhnert F, 2008, DEVELOPMENT, V135, P3989, DOI 10.1242/dev.029736; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Lavoie JR, 2014, CIRCULATION, V129, P2125, DOI 10.1161/CIRCULATIONAHA.114.008777; Levy M, 2007, J AM COLL CARDIOL, V49, P803, DOI 10.1016/j.jacc.2006.09.049; Levy M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065114; Levy M, 2013, EUR RESPIR J, V41, P236, DOI 10.1183/09031936.00114212; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Masri FA, 2007, AM J PHYSIOL-LUNG C, V293, pL548, DOI 10.1152/ajplung.00428.2006; Moore AD, 2014, HEART, V100, pA111, DOI 10.1136/heartjnl-2014-306118.203; Mostafavi Nasser, 2015, Adv Biomed Res, V4, P25, DOI 10.4103/2277-9175.150393; Musiyenko A, 2008, J MOL MED, V86, P313, DOI 10.1007/s00109-007-0296-9; Peng Y, 2005, CARDIOVASC RES NATUR, V436, P214; Poliseno L, 2006, BLOOD, V108, P3068, DOI 10.1182/blood-2006-01-012369; Procko E, 2014, CELL, V157, P1644, DOI 10.1016/j.cell.2014.04.034; Rao J, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-71; Sakai Y, 2009, WORLD J UROL, V27, P659, DOI 10.1007/s00345-009-0422-0; Sakao S, 2005, FASEB J, V19, P1178, DOI 10.1096/fj.04-3261fje; Weber SU, 2008, CRIT CARE, V12, DOI 10.1186/cc7088; Xu Wei-li, 2011, Zhonghua Zheng Xing Wai Ke Za Zhi, V27, P182; Yao YC, 2013, CIRC RES, V113, P495, DOI 10.1161/CIRCRESAHA.113.301792; Yao YC, 2009, CIRC RES, V105, P575, DOI 10.1161/CIRCRESAHA.109.202333; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	33	2	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126661	10.1371/journal.pone.0126661	http://dx.doi.org/10.1371/journal.pone.0126661			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961846	Green Submitted, gold, Green Published			2022-12-26	WOS:000354542500132
J	Wong, PT; Leroueil, PR; Smith, DM; Ciotti, S; Bielinska, AU; Janczak, KW; Mullen, CH; Groom, JV; Taylor, EM; Passmore, C; Makidon, PE; O'Konek, JJ; Myc, A; Hamouda, T; Baker, JR				Wong, Pamela T.; Leroueil, Pascale R.; Smith, Douglas M.; Ciotti, Susan; Bielinska, Anna U.; Janczak, Katarzyna W.; Mullen, Catherine H.; Groom, Jeffrey V., II; Taylor, Erin M.; Passmore, Crystal; Makidon, Paul E.; O'Konek, Jessica J.; Myc, Andrzej; Hamouda, Tarek; Baker, James R., Jr.			Formulation, High Throughput In Vitro Screening and In Vivo Functional Characterization of Nanoemulsion-Based Intranasal Vaccine Adjuvants	PLOS ONE			English	Article							INFLUENZA-A VIRUS; CATIONIC LIPOSOMES; TRIMETHYL CHITOSAN; IMMUNE-RESPONSE; CELL-DEATH; NASAL VACCINATION; MUCOSAL IMMUNITY; INNATE IMMUNITY; CORD FACTOR; ANTIGEN	Vaccine adjuvants have been reported to induce both mucosal and systemic immunity when applied to mucosal surfaces and this dual response appears important for protection against certain pathogens. Despite the potential advantages, however, no mucosal adjuvants are currently approved for human use. Evaluating compounds as mucosal adjuvants is a slow and costly process due to the need for lengthy animal immunogenicity studies. We have constructed a library of 112 intranasal adjuvant candidate formulations consisting of oil-in-water nanoemulsions that contain various cationic and nonionic surfactants. To facilitate adjuvant development we first evaluated this library in a series of high-throughput, in vitro assays for activities associated with innate and adaptive immune activation in vivo. These in vitro assays screened for the ability of the adjuvant to bind to mucin, induce cytotoxicity, facilitate antigen uptake in epithelial and dendritic cells, and activate cellular pathways. We then sought to determine how these parameters related to adjuvant activity in vivo. While the in vitro assays alone were not enough to predict the in vivo adjuvant activity completely, several interesting relationships were found with immune responses in mice. Furthermore, by varying the physicochemical properties of the surfactant components (charge, surfactant polar head size and hydrophobicity) and the surfactant blend ratio of the formulations, the strength and type of the immune response generated (T(H)1, T(H)2, T(H)17) could be modulated. These findings suggest the possibility of using high-throughput screens to aid in the design of custom adjuvants with unique immunological profiles to match specific mucosal vaccine applications.	[Wong, Pamela T.; Leroueil, Pascale R.; Smith, Douglas M.; Bielinska, Anna U.; Janczak, Katarzyna W.; Mullen, Catherine H.; Groom, Jeffrey V., II; Taylor, Erin M.; Passmore, Crystal; Makidon, Paul E.; O'Konek, Jessica J.; Myc, Andrzej; Baker, James R., Jr.] Univ Michigan, Sch Med, Michigan Nanotechnol Inst Med & Biol Sci, Ann Arbor, MI 48109 USA; [Wong, Pamela T.; Leroueil, Pascale R.; Smith, Douglas M.; Bielinska, Anna U.; Janczak, Katarzyna W.; Mullen, Catherine H.; Groom, Jeffrey V., II; Taylor, Erin M.; Passmore, Crystal; Makidon, Paul E.; O'Konek, Jessica J.; Myc, Andrzej; Baker, James R., Jr.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Ciotti, Susan; Hamouda, Tarek] NanoBio Corp, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Baker, JR (corresponding author), Univ Michigan, Sch Med, Michigan Nanotechnol Inst Med & Biol Sci, Ann Arbor, MI 48109 USA.	jbakerjr@umich.edu			Federal funds from the National Institute for Allergy and Infectious Disease; Department of Health and Human Services [HHSN272200900031C]; National Institutes of Health	Federal funds from the National Institute for Allergy and Infectious Disease; Department of Health and Human Services; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project has been funded by Federal funds from the National Institute for Allergy and Infectious Disease, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN272200900031C. The funders provided critical insights, but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NanoBio Corp. provided support in the form of salaries for authors SC & TH, but had no role in the study design of the work performed at UM, the data collection and analysis, the decision to publish, or the preparation of the manuscript unless such manuscript is clearly collaborative. The specific roles of these authors are articulated in the 'author contributions' section.	Aramaki Y, 1999, FEBS LETT, V460, P472, DOI 10.1016/S0014-5793(99)01386-1; Aramaki Y, 2000, PHARM RES-DORDR, V17, P515, DOI 10.1023/A:1007552529280; Bielinska AU, 2008, CLIN VACCINE IMMUNOL, V15, P348, DOI 10.1128/CVI.00440-07; Bielinska AU, 2008, AIDS RES HUM RETROV, V24, P271, DOI 10.1089/aid.2007.0148; Bielinska AU, 2007, INFECT IMMUN, V75, P4020, DOI 10.1128/IAI.00070-07; Bielinska AU, 2014, J IMMUNOL, V192, P2722, DOI 10.4049/jimmunol.1301424; Bielinska AU, 2010, CRIT REV IMMUNOL, V30, P189, DOI 10.1615/CritRevImmunol.v30.i2.60; Champion CI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005409; Christensen D, 2012, J CONTROL RELEASE, V160, P468, DOI 10.1016/j.jconrel.2012.03.016; Christensen D, 2011, EXPERT REV VACCINES, V10, P513, DOI [10.1586/erv.11.17, 10.1586/ERV.11.17]; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Das SC, 2012, VACCINE, V30, P6871, DOI 10.1016/j.vaccine.2012.09.007; Davidsen J, 2005, BBA-BIOMEMBRANES, V1718, P22, DOI 10.1016/j.bbamem.2005.10.011; De Gregorio E, 2009, CURR OPIN IMMUNOL, V21, P339, DOI 10.1016/j.coi.2009.05.003; Dombu CY, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/35/355102; Donovan BW, 2000, ANTIVIR CHEM CHEMOTH, V11, P41, DOI 10.1177/095632020001100104; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545; Hamouda T, 1999, J INFECT DIS, V180, P1939, DOI 10.1086/315124; Hamouda T, 2010, HUM VACCINES, V6, P585, DOI 10.4161/hv.6.7.11818; Henriksen-Lacey M, 2011, J CONTROL RELEASE, V154, P131, DOI 10.1016/j.jconrel.2011.05.019; Henriksen-Lacey M, 2010, J CONTROL RELEASE, V145, P102, DOI 10.1016/j.jconrel.2010.03.027; Henriksen-Lacey M, 2010, J CONTROL RELEASE, V142, P180, DOI 10.1016/j.jconrel.2009.10.022; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Holten-Andersen L, 2004, INFECT IMMUN, V72, P1608, DOI 10.1128/IAI.72.3.1608-1617.2004; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Levitz SM, 2012, CELL, V148, P1284, DOI 10.1016/j.cell.2012.02.012; Lohmann C, 2009, J IMMUNOL, V182, P4538, DOI 10.4049/jimmunol.0803989; Lonez C, 2014, NANOMED-NANOTECHNOL, V10, P775, DOI 10.1016/j.nano.2013.12.003; Lonez C, 2012, ADV DRUG DELIVER REV, V64, P1749, DOI 10.1016/j.addr.2012.05.009; Makidon PE, 2010, MED MICROBIOL IMMUN, V199, P81, DOI 10.1007/s00430-009-0137-2; Makidon PE, 2012, EUR J IMMUNOL, V42, P2073, DOI 10.1002/eji.201142346; Makidon PE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002954; Mangal S, 2011, VACCINE, V29, P4953, DOI 10.1016/j.vaccine.2011.04.112; Myc A, 2003, VACCINE, V21, P3801, DOI 10.1016/S0264-410X(03)00381-5; Myc A, 2002, MYCOPATHOLOGIA, V155, P195, DOI 10.1023/A:1021129710316; Myc A, 2013, VACCINE, V31, P1072, DOI 10.1016/j.vaccine.2012.12.033; Nembrini C, 2011, P NATL ACAD SCI USA, V108, pE989, DOI 10.1073/pnas.1104264108; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049; Nochi T, 2010, NAT MATER, V9, P572, DOI [10.1038/NMAT2784, 10.1038/nmat2784]; Oda K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100057; Passmore C, 2013, HUMAN VACCINES IMMUN, V10; Pawar D, 2013, EUR J PHARM BIOPHARM, V85, P550, DOI 10.1016/j.ejpb.2013.06.017; Rock KL, 2005, IMMUNOL REV, V207, P166, DOI 10.1111/j.0105-2896.2005.00301.x; Ryan EJ, 2001, TRENDS BIOTECHNOL, V19, P293, DOI 10.1016/S0167-7799(01)01670-5; Samadikhah HR, 2011, INT J NANOMED, V6, P2275, DOI 10.2147/IJN.S23074; Savina A, 2007, IMMUNOL REV, V219, P143, DOI 10.1111/j.1600-065X.2007.00552.x; Shen SS, 2012, VACCINE, V30, P1560, DOI 10.1016/j.vaccine.2011.12.120; Slutter B, 2010, VACCINE, V28, P6282, DOI 10.1016/j.vaccine.2010.06.121; Slutter B, 2010, J CONTROL RELEASE, V143, P207, DOI 10.1016/j.jconrel.2010.01.007; Smith DM, 2013, NAT REV IMMUNOL, V13, P592, DOI 10.1038/nri3488; Tafaghodi M, 2012, VACCINE, V30, P5341, DOI 10.1016/j.vaccine.2012.06.035; Takano S, 2003, PHARMACEUT RES, V20, P962, DOI 10.1023/A:1024441702398; Wong PT, 2014, MOL PHARMACEUT, V11, P531, DOI 10.1021/mp4005029; Yang YW, 2004, VACCINE, V22, P1524, DOI 10.1016/j.vaccine.2003.08.048	56	30	31	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126120	10.1371/journal.pone.0126120	http://dx.doi.org/10.1371/journal.pone.0126120			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962136	Green Published, Green Submitted, gold			2022-12-26	WOS:000354542500064
J	Zhang, TY; Wang, HS				Zhang, Tianyi; Wang, Hesong			Trend Patterns of Vegetative Coverage and Their Underlying Causes in the Deserts of Northwest China over 1982-2008	PLOS ONE			English	Article							CLIMATE-CHANGE; LAND-USE; DESERTIFICATION; VARIABLES	We identified the spatiotemporal patterns of the Normalized Difference Vegetation Index (NDVI) for the years 1982-2008 in the desert areas of Northwest China and quantified the impacts of climate and non-climate factors on NDVI changes. The results indicate that although the mean NDVI has improved in 24.7% of the study region; 16.3% among the region has been stagnating in recent years and only 8.4% had a significantly increasing trend. Additionally, 45.3% of the region has maintained a stable trend over the study period and 30.0% has declined. A multiple regression model suggests that a wetter climate (quantified by the Palmer Drought Severity Index, PDSI) is associated with higher NDVI in most areas (18.1% of significance) but these historical changes in PDSI only caused an average improvement of approximately 0.4% over the study region. Contrasting the regression results under different trend patterns, no significant differences in PDSI impacts were detected among the four trend patterns. Therefore, we conclude that climate is not the primary driver for vegetative coverage in Northwest China. Future studies will be required to identify the impacts of specific non-climatic factors on vegetative coverage based on high-resolution data, which will be beneficial in creating an effective strategy to combat the recent desertification trend in China.	[Zhang, Tianyi] Chinese Acad Sci, Inst Atmospher Phys, State Key Lab Atmospher Boundary Layer Phys & Atm, Beijing, Peoples R China; [Wang, Hesong] Beijing Forestry Univ, Coll Forestry, Minist Educ, Key Lab Silviculture & Conservat, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Atmospheric Physics, CAS; Beijing Forestry University	Wang, HS (corresponding author), Beijing Forestry Univ, Coll Forestry, Minist Educ, Key Lab Silviculture & Conservat, Beijing, Peoples R China.	wanghs119@126.com	LAPC, IAP/AAI-6991-2020; Zhang, Tianyi/AAJ-6909-2020	LAPC, IAP/0000-0002-0025-3484; Zhang, Tianyi/0000-0002-9266-6082	Chinese National Basic Research Program [2014CB954204]; National Natural Science Foundation of China [41301044, 31370707, 41105076]	Chinese National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was financially supported by the Chinese National Basic Research Program (2014CB954204) and the National Natural Science Foundation of China (41301044, 31370707, and 41105076). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Bhatt US, 2010, EARTH INTERACT, V14, DOI 10.1175/2010EI315.1; Chen Y, 2005, LAND DEGRAD DEV, V16, P367, DOI 10.1002/ldr.667; Chen YaNing, 2013, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V21, P134; Dai AG, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015541; Ge XD, 2013, J ENVIRON MANAGE, V123, P34, DOI 10.1016/j.jenvman.2013.02.033; Hellden U, 2008, GLOBAL PLANET CHANGE, V64, P169, DOI 10.1016/j.gloplacha.2008.10.006; Herrmann SM, 2005, GLOBAL ENVIRON CHANG, V15, P394, DOI 10.1016/j.gloenvcha.2005.08.004; Jeong SJ, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD014633; Liu B, 2010, ENVIRON EARTH SCI, V59, P1235, DOI 10.1007/s12665-009-0112-7; Miao CY, 2012, LAND DEGRAD DEV, V23, P62, DOI 10.1002/ldr.1050; Ostwald M, 2007, GEOGR ANN A, V89A, P223, DOI 10.1111/j.1468-0459.2007.00322.x; Palmer W.C., 1965, METEOROLOGICAL DROUG; Peters DPC, 2012, GLOBAL CHANGE BIOL, V18, P151, DOI 10.1111/j.1365-2486.2011.02498.x; Piao SL, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021764; Rotzer T, 2001, CLIM RES, V18, P249, DOI 10.3354/cr018249; Sheffield J, 2012, NATURE, V491, P435, DOI 10.1038/nature11575; Shi X., 2002, P 17 WORLD C SOIL SC, P1; Slayback DA, 2003, GLOBAL CHANGE BIOL, V9, P1, DOI 10.1046/j.1365-2486.2003.00507.x; Sop TK, 2013, LAND DEGRAD DEV, V24, P511, DOI 10.1002/ldr.1144; Spinoni J, 2013, GEOPHYS RES ABSTRACT, V15; Teuling AJ, 2013, GEOPHYS RES LETT, V40, P2071, DOI 10.1002/grl.50495; Thornthwaite CW, 1948, GEOGR REV, V38, P55, DOI 10.2307/210739; Thornton PE, 1997, J HYDROL, V190, P214, DOI 10.1016/S0022-1694(96)03128-9; Wang T, 2013, LAND DEGRAD DEV, V24, P422, DOI 10.1002/ldr.1138; Wang XM, 2008, EARTH-SCI REV, V88, P188, DOI 10.1016/j.earscirev.2008.02.001; Wu JP, 2013, LAND DEGRAD DEV, V24, P400, DOI 10.1002/ldr.2161; Xu QX, 2012, LAND DEGRAD DEV, V23, P34, DOI 10.1002/ldr.1045; Zhang F, 2013, ENVIRON EARTH SCI, V70, P249, DOI 10.1007/s12665-012-2120-2; Zhang TY, 2013, INT J CLIMATOL, V33, P699, DOI 10.1002/joc.3463; Zhou W, 2013, J ARID LAND, V5, P465, DOI 10.1007/s40333-013-0181-z; 2011, CHINA ENV YB	33	4	4	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126044	10.1371/journal.pone.0126044	http://dx.doi.org/10.1371/journal.pone.0126044			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961563	Green Published, gold, Green Submitted			2022-12-26	WOS:000354542500060
J	Cheng, JC; Chang, HM; Fang, LL; Sun, YP; Leung, PCK				Cheng, Jung-Chien; Chang, Hsun-Ming; Fang, Lanlan; Sun, Ying-Pu; Leung, Peter C. K.			TGF-beta 1 Up-Regulates Connective Tissue Growth Factor Expression in Human Granulosa Cells through Smad and ERK1/2 Signaling Pathways	PLOS ONE			English	Article							BETA SUPERFAMILY MEMBERS; OVARIAN FOLLICULAR-FLUID; MESSENGER RIBONUCLEIC-ACIDS; FACTOR GENE-EXPRESSION; TGF-BETA; IN-VITRO; PROGESTERONE PRODUCTION; STIMULATING-HORMONE; CTGF EXPRESSION; CCN FAMILY	Connective tissue growth factor (CTGF), which is also called CCN2, is a secreted matricellular protein. CTGF regulates various important cellular functions by interacting with multiple molecules in the microenvironment. In the ovary, CTGF is mainly expressed in granulosa cells and involved in the regulation of follicular development, ovulation and luteinization. TGF-beta 1 has been shown to up-regulate CTGF expression in rat and hen granulosa cells. However, the underlying molecular mechanisms of this up-regulation remain undefined. More importantly, whether the stimulatory effect of TGF-beta 1 on CTGF expression can be observed in human granulosa cells remains unknown. In the present study, our results demonstrated that TGF-beta 1 treatment up-regulates CTGF expression in both immortalized human granulosa cells and primary human granulosa cells. Using a siRNA-mediated knockdown approach and a pharmacological inhibitor, we demonstrated that the inhibition of Smad2, Smad3 or ERK1/2 attenuates the TGF-beta 1-induced up-regulation of CTGF. This study provides important insights into the molecular mechanisms that mediate TGF-beta 1-up-regulated CTGF expression in human granulosa cells.	[Cheng, Jung-Chien; Chang, Hsun-Ming; Fang, Lanlan; Leung, Peter C. K.] Univ British Columbia, Child & Family Res Inst, Dept Obstet & Gynaecol, Vancouver, BC V5Z 4H4, Canada; [Fang, Lanlan; Sun, Ying-Pu] Zhengzhou Univ, Affiliated Hosp 1, Reprod Med Ctr, Zhengzhou 450052, Peoples R China	Child & Family Research Institute; University of British Columbia; Zhengzhou University	Leung, PCK (corresponding author), Univ British Columbia, Child & Family Res Inst, Dept Obstet & Gynaecol, Vancouver, BC V5Z 4H4, Canada.	peter.leung@ubc.ca	Cheng, Jung-Chien/T-4258-2019; Chang, Hsun-Ming/M-8584-2018	Cheng, Jung-Chien/0000-0002-5399-9327; Fang, Lanlan/0000-0001-8725-895X	Canadian Institutes of Health Research; National Natural Science Foundation of China [31271605]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by an operating grant from the Canadian Institutes of Health Research to P.C.K.L. and an operating grant from the National Natural Science Foundation of China (31271605) to Y.P.S.	Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7; BRADHAM DM, 1991, J CELL BIOL, V114, P1285, DOI 10.1083/jcb.114.6.1285; Brigstock DR, 1999, ENDOCR REV, V20, P189, DOI 10.1210/er.20.2.189; Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Chang HM, 2014, J CLIN ENDOCR METAB, V99, pE1922, DOI 10.1210/jc.2014-1223; Chang HM, 2013, MOL ENDOCRINOL, V27, P2093, DOI 10.1210/me.2013-1233; Chang HM, 2013, FERTIL STERIL, V100, P585, DOI 10.1016/j.fertnstert.2013.04.019; CHEGINI N, 1992, J CLIN ENDOCR METAB, V74, P973, DOI 10.1210/jc.74.5.973; CHEGINI N, 1992, ENDOCRINOLOGY, V130, P1707, DOI 10.1210/en.130.3.1707; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Chen YJ, 2002, KIDNEY INT, V62, P1149, DOI 10.1111/j.1523-1755.2002.kid567.x; Ding ZY, 2013, CELL SIGNAL, V25, P1981, DOI 10.1016/j.cellsig.2013.05.027; Duncan WC, 2005, J CLIN ENDOCR METAB, V90, P5366, DOI 10.1210/jc.2005-0014; Fang LL, 2014, J CLIN ENDOCR METAB, V99, pE1217, DOI 10.1210/jc.2013-4100; Fang LL, 2014, J CLIN ENDOCR METAB, V99, pE2234, DOI 10.1210/jc.2014-1930; Fried G, 1998, HUM REPROD, V13, P656, DOI 10.1093/humrep/13.3.656; Fried G, 1998, FERTIL STERIL, V70, P129, DOI 10.1016/S0015-0282(98)00105-8; Harlow CR, 2007, J ENDOCRINOL, V192, P41, DOI 10.1677/joe.1.06689; Harlow CR, 2002, MOL CELL ENDOCRINOL, V187, P23, DOI 10.1016/S0303-7207(01)00702-X; Harlow CR, 2002, ENDOCRINOLOGY, V143, P3316, DOI 10.1210/en.2001-211389; Holbourn KP, 2008, TRENDS BIOCHEM SCI, V33, P461, DOI 10.1016/j.tibs.2008.07.006; Holmes A, 2001, J BIOL CHEM, V276, P10594, DOI 10.1074/jbc.M010149200; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Knight PG, 2003, ANIM REPROD SCI, V78, P165, DOI 10.1016/S0378-4320(03)00089-7; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; Kubota S, 2015, CLIN SCI, V128, P181, DOI 10.1042/CS20140264; Lee SJ, 2013, BIOCHEM J, V456, P109, DOI 10.1042/BJ20130744; Lie BL, 1996, MOL CELL ENDOCRINOL, V120, P169, DOI 10.1016/0303-7207(96)03835-X; Liu Y, 2013, J BIOL CHEM, V288, P30708, DOI 10.1074/jbc.M113.478685; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Nagashima T, 2011, MOL ENDOCRINOL, V25, P1740, DOI 10.1210/me.2011-1045; Ohyama Y, 2012, J ATHEROSCLER THROMB, V19, P23, DOI 10.5551/jat.9753; Phan B, 2006, MOL REPROD DEV, V73, P878, DOI 10.1002/mrd.20465; Quinn MCJ, 2006, REPROD FERT DEVELOP, V18, P501, DOI 10.1071/RD05051; Roy SK, 1998, MOL HUM REPROD, V4, P207, DOI 10.1093/molehr/4.3.207; RYSECK RP, 1991, CELL GROWTH DIFFER, V2, P225; Slee RB, 2001, ENDOCRINOLOGY, V142, P1082, DOI 10.1210/en.142.3.1082; Tran CM, 2010, ARTHRITIS RHEUM-US, V62, P1983, DOI 10.1002/art.27445; Wandji SA, 2000, ENDOCRINOLOGY, V141, P2648, DOI 10.1210/en.141.7.2648; Winterhager E, 2014, CELL MOL LIFE SCI, V71, P2299, DOI 10.1007/s00018-014-1556-9; Yang DH, 1998, J CLIN ENDOCR METAB, V83, P2593, DOI 10.1210/jc.83.7.2593; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhu GY, 2012, GEN COMP ENDOCR, V178, P314, DOI 10.1016/j.ygcen.2012.06.018	44	19	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0126532	10.1371/journal.pone.0126532	http://dx.doi.org/10.1371/journal.pone.0126532			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955392	Green Published, Green Submitted, gold			2022-12-26	WOS:000356768100128
J	Letourneau, A; Cobellis, G; Fort, A; Santoni, F; Garieri, M; Falconnet, E; Ribaux, P; Vannier, A; Guipponi, M; Carninci, P; Borel, C; Antonarakis, SE				Letourneau, Audrey; Cobellis, Gilda; Fort, Alexandre; Santoni, Federico; Garieri, Marco; Falconnet, Emilie; Ribaux, Pascale; Vannier, Anne; Guipponi, Michel; Carninci, Piero; Borel, Christelle; Antonarakis, Stylianos E.			HSA21 Single-Minded 2 (Sim2) Binding Sites Co-Localize with Super-Enhancers and Pioneer Transcription Factors in Pluripotent Mouse ES Cells	PLOS ONE			English	Article							CHROMATIN-REMODELING COMPLEX; DOWN-SYNDROME; CNS MIDLINE; GENE-EXPRESSION; MURINE HOMOLOG; DROSOPHILA; CHROMOSOME; MUTATIONS; PROTEIN; OTX2	The HSA21 encoded Single-minded 2 (SIM2) transcription factor has key neurological functions and is a good candidate to be involved in the cognitive impairment of Down syndrome. We aimed to explore the functional capacity of SIM2 by mapping its DNA binding sites in mouse embryonic stem cells. ChIP-sequencing revealed 1229 high-confidence SIM2-binding sites. Analysis of the SIM2 target genes confirmed the importance of SIM2 in developmental and neuronal processes and indicated that SIM2 may be a master transcription regulator. Indeed, SIM2 DNA binding sites share sequence specificity and overlapping domains of occupancy with master transcription factors such as SOX2, OCT4 (Pou5f1), NANOG or KLF4. The association between SIM2 and these pioneer factors is supported by co-immunoprecipitation of SIM2 with SOX2, OCT4, NANOG or KLF4. Furthermore, the binding of SIM2 marks a particular sub-category of enhancers known as super-enhancers. These regions are characterized by typical DNA modifications and Mediator co-occupancy (MED1 and MED12). Altogether, we provide evidence that SIM2 binds a specific set of enhancer elements thus explaining how SIM2 can regulate its gene network in neuronal features.	[Letourneau, Audrey; Santoni, Federico; Garieri, Marco; Falconnet, Emilie; Ribaux, Pascale; Vannier, Anne; Guipponi, Michel; Borel, Christelle; Antonarakis, Stylianos E.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Cobellis, Gilda] Univ Naples 2, Dept Biophys Biochem & Gen Pathol, Naples, Italy; [Fort, Alexandre; Carninci, Piero] RIKEN, Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa, Japan; [Vannier, Anne; Guipponi, Michel; Antonarakis, Stylianos E.] Univ Hosp Geneva, Geneva, Switzerland; [Antonarakis, Stylianos E.] iGE3 Inst Genet & Genom Geneva, Geneva, Switzerland	University of Geneva; Universita della Campania Vanvitelli; RIKEN; University of Geneva	Borel, C (corresponding author), Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland.	christelle.borel@unige.ch; stylianos.antonarakis@unige.ch	borel, christelle/AAC-9645-2019; Carninci, Piero/K-1568-2014; Antonarakis, Stylianos E/N-8866-2014	Carninci, Piero/0000-0001-7202-7243; Antonarakis, Stylianos E/0000-0001-8907-5823; Cobellis, Gilda/0000-0003-2687-2272; Santoni, Federico/0000-0002-3258-4747	Swiss National Science Foundation; European ERC; Lejeune Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European ERC(European Research Council (ERC)); Lejeune Foundation	This work was supported by grants from the Swiss National Science Foundation, and the European ERC to SEA, and the Lejeune Foundation to CB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman MJ, 2005, P NATL ACAD SCI USA, V102, P12765, DOI 10.1073/pnas.0505484102; Antonarakis SE, 2004, NAT REV GENET, V5, P725, DOI 10.1038/nrg1448; Beby F, 2013, EXP EYE RES, V111, P9, DOI 10.1016/j.exer.2013.03.007; Bergsland M, 2011, GENE DEV, V25, P2453, DOI 10.1101/gad.176008.111; Chassaing N, 2012, J MED GENET, V49, P373, DOI 10.1136/jmedgenet-2012-100892; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chrast R, 1997, GENOME RES, V7, P615, DOI 10.1101/gr.7.6.615; Chrast R, 2000, HUM MOL GENET, V9, P1853, DOI 10.1093/hmg/9.12.1853; Crews ST, 1998, GENE DEV, V12, P607, DOI 10.1101/gad.12.5.607; DAHMANE N, 1995, P NATL ACAD SCI USA, V92, P9191, DOI 10.1073/pnas.92.20.9191; De Cegli R, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r64; Deyoung MP, 2002, ANTICANCER RES, V22, P3149; Ema M, 1999, HUM MOL GENET, V8, P1409, DOI 10.1093/hmg/8.8.1409; Ema M, 1996, BIOCHEM BIOPH RES CO, V218, P588, DOI 10.1006/bbrc.1996.0104; Estes P, 2001, DEV BIOL, V232, P157, DOI 10.1006/dbio.2001.0174; Fan CM, 1996, MOL CELL NEUROSCI, V7, P519, DOI 10.1006/mcne.1996.0037; Fullwood Melissa J, 2010, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2115s89; Gardiner K, 2006, BEHAV GENET, V36, P439, DOI 10.1007/s10519-006-9051-1; Goshu E, 2002, MOL CELL BIOL, V22, P4147, DOI 10.1128/MCB.22.12.4147-4157.2002; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hoyer J, 2012, AM J HUM GENET, V90, P565, DOI 10.1016/j.ajhg.2012.02.007; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang Y, 2010, CANCER BIOL THER, V9, P204, DOI 10.4161/cbt.9.3.10960; Hubbard Kyle S, 2013, F1000Res, V2, P35, DOI 10.12688/f1000research.2-35.v1; Janz R, 1999, NEURON, V24, P687, DOI 10.1016/S0896-6273(00)81122-8; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; Kwak HI, 2007, CARCINOGENESIS, V28, P259, DOI 10.1093/carcin/bgl122; Li G, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r22; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liber D, 2010, CELL STEM CELL, V7, P114, DOI 10.1016/j.stem.2010.05.020; Lin MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023356; Lu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028837; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Ma Y, 2000, J NEUROSCI, V20, P4596, DOI 10.1523/JNEUROSCI.20-12-04596.2000; Magnani L, 2011, TRENDS GENET, V27, P465, DOI 10.1016/j.tig.2011.07.002; Masui S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni043; MATSUO I, 1995, GENE DEV, V9, P2646, DOI 10.1101/gad.9.21.2646; Meng XF, 2006, CELL BIOL INT, V30, P841, DOI 10.1016/j.cellbi.2006.07.003; Moffett P, 1996, GENOMICS, V35, P144, DOI 10.1006/geno.1996.0333; NAMBU JR, 1991, CELL, V67, P1157, DOI 10.1016/0092-8674(91)90292-7; NAMBU JR, 1990, CELL, V63, P63, DOI 10.1016/0092-8674(90)90288-P; Nishiyama A, 2009, CELL STEM CELL, V5, P420, DOI 10.1016/j.stem.2009.07.012; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Rachidi M, 2005, INT J DEV NEUROSCI, V23, P475, DOI 10.1016/j.ijdevneu.2005.05.004; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Santen GWE, 2012, NAT GENET, V44, P379, DOI 10.1038/ng.2217; Santoni FA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001008; Schilter KF, 2011, CLIN GENET, V79, P158, DOI 10.1111/j.1399-0004.2010.01450.x; Serandour AA, 2011, GENOME RES, V21, P555, DOI 10.1101/gr.111534.110; Shamblott MJ, 2002, DEV DYNAM, V224, P373, DOI 10.1002/dvdy.10116; Sonnenfeld M, 1997, DEVELOPMENT, V124, P4571; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; THOMAS JB, 1988, CELL, V52, P133, DOI 10.1016/0092-8674(88)90537-5; Tsurusaki Y, 2012, NAT GENET, V44, P376, DOI 10.1038/ng.2219; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wu JQ, 2010, P NATL ACAD SCI USA, V107, P5254, DOI 10.1073/pnas.0914114107; Xiao H, 1996, MECH DEVELOP, V58, P65, DOI 10.1016/S0925-4773(96)00559-X; Yamaki A, 1996, GENOMICS, V35, P136, DOI 10.1006/geno.1996.0332; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zhang YB, 2013, NATURE, V504, P306, DOI 10.1038/nature12716	63	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0126475	10.1371/journal.pone.0126475	http://dx.doi.org/10.1371/journal.pone.0126475			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955728	Green Published, gold, Green Submitted			2022-12-26	WOS:000356768100121
J	Potgieser, ARE; van der Hoorn, A; de Jong, BM				Potgieser, Adriaan R. E.; van der Hoorn, Anouk; de Jong, Bauke M.			Cerebral Activations Related to Writing and Drawing with Each Hand	PLOS ONE			English	Article							SUPERIOR PARIETAL CORTEX; INFERIOR TEMPORAL CORTEX; WORD FORM AREA; PREMOTOR CORTEX; MOTOR AREAS; CORTICAL ORGANIZATION; CEREBELLAR LOOPS; SPOKEN LANGUAGE; PURE AGRAPHIA; BRAIN	Background Writing is a sequential motor action based on sensorimotor integration in visuospatial and linguistic functional domains. To test the hypothesis of lateralized circuitry concerning spatial and language components involved in such action, we employed an fMRI paradigm including writing and drawing with each hand. In this way, writing-related contributions of dorsal and ventral premotor regions in each hemisphere were assessed, together with effects in wider distributed circuitry. Given a right-hemisphere dominance for spatial action, right dorsal premotor cortex dominance was expected in left-hand writing while dominance of the left ventral premotor cortex was expected during right-hand writing. Methods Sixteen healthy right-handed subjects were scanned during audition-guided writing of short sentences and simple figure drawing without visual feedback. Tapping with a pencil served as a basic control task for the two higher-order motor conditions. Activation differences were assessed with Statistical Parametric Mapping (SPM). Results Writing and drawing showed parietal-premotor and posterior inferior temporal activations in both hemispheres when compared to tapping. Drawing activations were rather symmetrical for each hand. Activations in left-and right-hand writing were left-hemisphere dominant, while right dorsal premotor activation only occurred in left-hand writing, supporting a spatial motor contribution of particularly the right hemisphere. Writing contrasted to drawing revealed left-sided activations in the dorsal and ventral premotor cortex, Broca's area, pre-Supplementary Motor Area and posterior middle and inferior temporal gyri, without parietal activation. Discussion The audition-driven postero-inferior temporal activations indicated retrieval of virtual visual form characteristics in writing and drawing, with additional activation concerning word form in the left hemisphere. Similar parietal processing in writing and drawing pointed at a common mechanism by which such visually formatted information is used for subsequent sensorimotor integration along a dorsal visuomotor pathway. In this, the left posterior middle temporal gyrus subserves phonological-orthographical conversion, dissociating dorsal parietal-premotor circuitry from perisylvian circuitry including Broca's area.	[Potgieser, Adriaan R. E.; van der Hoorn, Anouk; de Jong, Bauke M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Potgieser, Adriaan R. E.; van der Hoorn, Anouk; de Jong, Bauke M.] Univ Groningen, Univ Med Ctr Groningen, Neuroimaging Ctr, Groningen, Netherlands; [Potgieser, Adriaan R. E.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosurg, Groningen, Netherlands; [van der Hoorn, Anouk] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	de Jong, BM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands.	b.m.de.jong@umcg.nl	van der Hoon, Anouk/AAX-8298-2021	de Jong, Bauke M./0000-0002-6568-5739; van der Hoorn, Anouk/0000-0003-4649-327X	University of Groningen	University of Groningen	AREP and AH received a JSM grant from the University of Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; ANDERSON SW, 1990, BRAIN, V113, P749, DOI 10.1093/brain/113.3.749; AUERBACH SH, 1981, J NEUROL NEUROSUR PS, V44, P430, DOI 10.1136/jnnp.44.5.430; BARBAS H, 1987, J COMP NEUROL, V256, P211, DOI 10.1002/cne.902560203; Beeson PM, 2003, APHASIOLOGY, V17, P647, DOI 10.1080/02687030344000067; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Binkofski F, 2004, BRAIN LANG, V89, P362, DOI 10.1016/S0093-934X(03)00358-4; Binkofski F, 1999, EUR J NEUROSCI, V11, P3276, DOI 10.1046/j.1460-9568.1999.00753.x; Brownsett SLE, 2010, CEREB CORTEX, V20, P517, DOI 10.1093/cercor/bhp120; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Callaert DV, 2011, HUM BRAIN MAPP, V32, P1311, DOI 10.1002/hbm.21110; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Chambon V, 2013, CEREB CORTEX, V23, P1031, DOI 10.1093/cercor/bhs059; Chouinard PA, 2006, NEUROSCIENTIST, V12, P143, DOI 10.1177/1073858405284255; Clavagnier S, 2007, NEUROSCIENTIST, V13, P22, DOI 10.1177/1073858406295688; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; Corballis MC, 1997, BRAIN LANG, V57, P100, DOI 10.1006/brln.1997.1835; Corballis PM, 2003, BRAIN COGNITION, V53, P171, DOI 10.1016/S0278-2626(03)00103-9; de Jong BM, 2002, CEREB CORTEX, V12, P1213, DOI 10.1093/cercor/12.11.1213; de Jong BM, 2001, NEUROIMAGE, V14, P1128, DOI 10.1006/nimg.2001.0911; de Jong BM, 1999, NEUROIMAGE, V9, P290, DOI 10.1006/nimg.1998.0410; Dehaene S, 2005, TRENDS COGN SCI, V9, P335, DOI 10.1016/j.tics.2005.05.004; Dehaene S, 2011, TRENDS COGN SCI, V15, P254, DOI 10.1016/j.tics.2011.04.003; deJong BM, 1996, EXP BRAIN RES, V109, P136, DOI 10.1007/BF00228634; Dien J, 2013, CORTEX, V49, P2307, DOI 10.1016/j.cortex.2013.03.008; Exner S., 1881, UNTERSUCHUNGEN LOKAL; Feder KP, 2007, DEV MED CHILD NEUROL, V49, P312, DOI 10.1111/j.1469-8749.2007.00312.x; Fedorenko E, 2013, P NATL ACAD SCI USA, V110, P16616, DOI 10.1073/pnas.1315235110; Friederici AD, 2003, CEREB CORTEX, V13, P170, DOI 10.1093/cercor/13.2.170; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; GEORGOPOULOS AP, 1991, ANNU REV NEUROSCI, V14, P361, DOI 10.1146/annurev.ne.14.030191.002045; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Gordinier HS, 1899, AM J MED SCI, P526; Gow DW, 2012, BRAIN LANG, V121, P273, DOI 10.1016/j.bandl.2012.03.005; Grezes J, 1999, BRAIN, V122, P1875, DOI 10.1093/brain/122.10.1875; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; HE SQ, 1993, J NEUROSCI, V13, P952; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Hillis Argye E, 2008, Handb Clin Neurol, V88, P311, DOI 10.1016/S0072-9752(07)88015-8; Jameson Leslie C, 2006, Anesthesiol Clin, V24, P777, DOI 10.1016/j.atc.2006.08.002; Jancke L, 2001, CEREB CORTEX, V11, P114, DOI 10.1093/cercor/11.2.114; Jefferies E, 2013, CORTEX, V49, P611, DOI 10.1016/j.cortex.2012.10.008; Jobard G, 2007, NEUROIMAGE, V34, P784, DOI 10.1016/j.neuroimage.2006.06.067; Johnson-Frey SH, 2005, CEREB CORTEX, V15, P681, DOI 10.1093/cercor/bhh169; Katanoda K, 2001, HUM BRAIN MAPP, V13, P34, DOI 10.1002/hbm.1023; Kelly RM, 2003, J NEUROSCI, V23, P8432; Knecht S, 2000, BRAIN, V123, P2512, DOI 10.1093/brain/123.12.2512; Longcamp M, 2003, NEUROIMAGE, V19, P1492, DOI 10.1016/S1053-8119(03)00088-0; MacFie Campbell C., 2004, REV NEUROLOGY PSYCHI, P287; MACK L, 1993, BRAIN COGNITION, V21, P80, DOI 10.1006/brcg.1993.1006; Makris N, 2009, BRAIN STRUCT FUNCT, V213, P343, DOI 10.1007/s00429-008-0199-8; Mano QR, 2013, CEREB CORTEX, V23, P988, DOI 10.1093/cercor/bhs093; Marcus H., 1937, ACTA PSYCHOL, P431; Mayka MA, 2006, NEUROIMAGE, V31, P1453, DOI 10.1016/j.neuroimage.2006.02.004; McConnel JW, 1905, U PENNSYLVANIA MED B, P156; Menon V, 2001, COGNITIVE BRAIN RES, V12, P337, DOI 10.1016/S0926-6410(01)00063-5; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Nakamura K, 2000, BRAIN, V123, P954, DOI 10.1093/brain/123.5.954; Ohno T, 2000, NEUROLOGY, V54, P2336, DOI 10.1212/WNL.54.12.2336; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Osawa A, 2013, CASE REP NEUROL, V5, P74, DOI 10.1159/000350713; Paillard J., 1993, USE TOOLS HUMAN NONH, P36; PASSINGHAM R, 1978, BRAIN RES, V145, P410, DOI 10.1016/0006-8993(78)90878-8; Penfield W, 1950, CEREBRAL CORTEX MAN; PETRIDES M, 1997, HDB NEUROPSYCHOLOGY, P17; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Pisella L, 2011, PHILOS T R SOC B, V366, P572, DOI 10.1098/rstb.2010.0258; Planton S., 2013, CORTEX; Potgieser ARE, 2011, HUM MOVEMENT SCI, V30, P1072, DOI 10.1016/j.humov.2011.02.005; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Price CJ, 2003, NEUROIMAGE, V19, P473, DOI 10.1016/S1053-8119(03)00084-3; Rapcsak SZ, 2004, NEUROLOGY, V62, P2221, DOI 10.1212/01.WNL.0000130169.60752.C5; Richardson FM, 2011, J NEUROSCI, V31, P8239, DOI 10.1523/JNEUROSCI.6519-10.2011; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Roeltgen David P, 2010, Continuum (Minneap Minn), V16, P59, DOI 10.1212/01.CON.0000368260.15544.35; Roux FE, 2010, CORTEX, V46, P1204, DOI 10.1016/j.cortex.2010.03.001; Roux FE, 2009, ANN NEUROL, V66, P537, DOI 10.1002/ana.21804; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Sakata H, 1997, TRENDS NEUROSCI, V20, P350, DOI 10.1016/S0166-2236(97)01067-9; Sakreida K, 2005, J NEUROSCI, V25, P1335, DOI 10.1523/JNEUROSCI.4170-04.2005; Sakurai Y, 1997, NEUROLOGY, V49, P946, DOI 10.1212/WNL.49.4.946; Sakurai Y, 2011, J NEUROL, V258, P1528, DOI 10.1007/s00415-011-5981-5; Schubotz RI, 2010, NEUROIMAGE, V50, P396, DOI 10.1016/j.neuroimage.2009.12.069; Segal E, 2012, EUR J NEUROSCI, V35, P309, DOI 10.1111/j.1460-9568.2011.07937.x; Seitz RJ, 1997, EUR J NEUROSCI, V9, P378, DOI 10.1111/j.1460-9568.1997.tb01407.x; Shimazu H, 2004, J NEUROSCI, V24, P1200, DOI 10.1523/JNEUROSCI.4731-03.2004; Shipp S, 1998, EUR J NEUROSCI, V10, P3171, DOI 10.1046/j.1460-9568.1998.00327.x; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Strick PL, 2009, ANNU REV NEUROSCI, V32, P413, DOI 10.1146/annurev.neuro.31.060407.125606; Sugihara G, 2006, NEUROIMAGE, V32, P1837, DOI 10.1016/j.neuroimage.2006.05.035; Sugishita M, 1996, NEUROREPORT, V7, P1917, DOI 10.1097/00001756-199608120-00009; Tanaka K, 2003, CEREB CORTEX, V13, P90, DOI 10.1093/cercor/13.1.90; Tanji J, 2001, ANNU REV NEUROSCI, V24, P631, DOI 10.1146/annurev.neuro.24.1.631; TOHGI H, 1995, J NEUROL NEUROSUR PS, V58, P629, DOI 10.1136/jnnp.58.5.629; van der Hoorn A, 2014, EUR J NEUROSCI, V40, P2980, DOI 10.1111/ejn.12656; Vinckier F, 2007, NEURON, V55, P143, DOI 10.1016/j.neuron.2007.05.031; Vogel JJ, 2003, BRAIN COGNITION, V52, P197, DOI 10.1016/S0278-2626(03)00056-3; Wise SP, 1997, ANNU REV NEUROSCI, V20, P25, DOI 10.1146/annurev.neuro.20.1.25; WISE SP, 1985, ANNU REV NEUROSCI, V8, P1, DOI 10.1146/annurev.ne.08.030185.000245	101	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0126723	10.1371/journal.pone.0126723	http://dx.doi.org/10.1371/journal.pone.0126723			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL2IX	25955655	Green Published, Green Submitted, gold			2022-12-26	WOS:000356768100142
J	Rempe, CS; Burris, KP; Woo, HL; Goodrich, B; Gosnell, DK; Tschaplinski, TJ; Stewart, CN				Rempe, Caroline S.; Burris, Kellie P.; Woo, Hannah L.; Goodrich, Benjamin; Gosnell, Denise Koessler; Tschaplinski, Timothy J.; Stewart, C. Neal, Jr.			Computational Ranking of Yerba Mate Small Molecules Based on Their Predicted Contribution to Antibacterial Activity against Methicillin-Resistant Staphylococcus aureus	PLOS ONE			English	Article							ESCHERICHIA-COLI O157/H7; ANTIMICROBIAL ACTIVITY; ILEX-PARAGUARIENSIS; AQUEOUS EXTRACTS; MICROBIOLOGICAL MEDIUM; PHENOLIC-COMPOUNDS; MASS-SPECTROMETRY; XCMS	The aqueous extract of yerba mate, a South American tea beverage made from Ilex paraguariensis leaves, has demonstrated bactericidal and inhibitory activity against bacterial pathogens, including methicillin-resistant Staphylococcus aureus (MRSA). The gas chromatography-mass spectrometry (GC-MS) analysis of two unique fractions of yerba mate aqueous extract revealed 8 identifiable small molecules in those fractions with antimicrobial activity. For a more comprehensive analysis, a data analysis pipeline was assembled to prioritize compounds for antimicrobial testing against both MRSA and methicillin-sensitive S. aureus using forty-two unique fractions of the tea extract that were generated in duplicate, assayed for activity, and analyzed with GC-MS. As validation of our automated analysis, we checked our predicted active compounds for activity in literature references and used authentic standards to test for antimicrobial activity. 3,4-dihydroxybenzaldehyde showed the most antibacterial activity against MRSA at low concentrations in our bioassays. In addition, quinic acid and quercetin were identified using random forests analysis and 5-hydroxy pipecolic acid was identified using linear discriminant analysis. We also generated a ranked list of unidentified compounds that may contribute to the antimicrobial activity of yerba mate against MRSA. Here we utilized GC-MS data to implement an automated analysis that resulted in a ranked list of compounds that likely contribute to the antimicrobial activity of aqueous yerba mate extract against MRSA.	[Rempe, Caroline S.; Tschaplinski, Timothy J.; Stewart, C. Neal, Jr.] Univ Tennessee, UT ORNL Grad Sch Genome Sci & Technol, Knoxville, TN 37996 USA; [Rempe, Caroline S.; Burris, Kellie P.; Stewart, C. Neal, Jr.] Univ Tennessee, Dept Plant Sci, Knoxville, TN 37996 USA; [Woo, Hannah L.] Univ Tennessee, Dept Civil & Environm Engn, Knoxville, TN 37996 USA; [Goodrich, Benjamin; Gosnell, Denise Koessler] Univ Tennessee, Dept Elect Engn & Comp Sci, Knoxville, TN 37996 USA; [Tschaplinski, Timothy J.] Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory	Stewart, CN (corresponding author), Univ Tennessee, UT ORNL Grad Sch Genome Sci & Technol, Knoxville, TN 37996 USA.	nealstewart@utk.edu	Tschaplinski, Timothy/D-6382-2018	Tschaplinski, Timothy/0000-0002-9540-6622; Rempe, Caroline/0000-0002-8326-6423	NSF-IGERT program SCALE-IT; Ivan Racheff Chair of Excellence endowment; Tennessee Agricultural Experiment Station; Genomic Science Program (project 'Plant-Microbe Interactions'), U.S. Department of Energy, Office of Science, Biological and Environmental Research [DE-AC05-00OR22725]	NSF-IGERT program SCALE-IT; Ivan Racheff Chair of Excellence endowment; Tennessee Agricultural Experiment Station; Genomic Science Program (project 'Plant-Microbe Interactions'), U.S. Department of Energy, Office of Science, Biological and Environmental Research(United States Department of Energy (DOE))	This research was supported by an internal research grant through the NSF-IGERT program SCALE-IT, the Ivan Racheff Chair of Excellence endowment, and the Tennessee Agricultural Experiment Station. TJT was supported by the Genomic Science Program (project 'Plant-Microbe Interactions'), U.S. Department of Energy, Office of Science, Biological and Environmental Research under the contract DE-AC05-00OR22725. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R, 2013, PYTHON FUNCTION; Allison KR, 2011, NATURE, V473, P216, DOI 10.1038/nature10069; Alves MJ, 2013, J APPL MICROBIOL, V115, P346, DOI 10.1111/jam.12196; Burris KP, 2015, FOOD CONTROL, V50, P748, DOI 10.1016/j.foodcont.2014.10.021; Burris KP, 2012, J FOOD PROTECT, V75, P753, DOI 10.4315/0362-028X.JFP-11-214; Burris KP, 2011, J FOOD SCI, V76, pM456, DOI 10.1111/j.1750-3841.2011.02255.x; Chen Tianlu, 2013, Evid Based Complement Alternat Med, V2013, P298183, DOI 10.1155/2013/298183; Covington JA, 2013, SENSORS-BASEL, V13, P11899, DOI 10.3390/s130911899; Cowan MM, 1999, CLIN MICROBIOL REV, V12, P564, DOI 10.1128/CMR.12.4.564; Ettre LS, 2003, CHROMATOGRAPHIA, V58, P491, DOI 10.1365/s10337-003-0075-x; Fattouch S, 2007, J AGR FOOD CHEM, V55, P963, DOI 10.1021/jf062614e; Gowda H, 2014, ANAL CHEM, V86, P6931, DOI 10.1021/ac500734c; Hazni H, 2008, PLANTA MED, V74, P1802, DOI 10.1055/s-0028-1088340; Heck CI, 2007, J FOOD SCI, V72, pR138, DOI 10.1111/j.1750-3841.2007.00535.x; Hirai I, 2010, INT J FOOD SCI TECH, V45, P1250, DOI 10.1111/j.1365-2621.2010.02267.x; Hoffmann N, 2012, METABOLOMICS, P73; Hummel J, 2010, METABOLOMICS, V6, P322, DOI 10.1007/s11306-010-0198-7; Luis A, 2014, BIOFOULING, V30, P69, DOI 10.1080/08927014.2013.845878; Nagoba BS, 2008, J MED MICROBIOL, V57, P681, DOI 10.1099/jmm.0.47647-0; Ozcelik B, 2011, PHARM BIOL, V49, P396, DOI 10.3109/13880209.2010.519390; Martin JGP, 2013, REV ARGENT MICROBIOL, V45, P93, DOI 10.1016/S0325-7541(13)70006-3; Vaquero MJR, 2007, FOOD CONTROL, V18, P93, DOI 10.1016/j.foodcont.2005.08.010; Saleem M, 2010, NAT PROD REP, V27, P238, DOI 10.1039/b916096e; Santos VS, 2014, FOOD CHEM, V153, P334, DOI 10.1016/j.foodchem.2013.12.057; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Su YC, 2014, INT J MOL SCI, V15, P2738, DOI 10.3390/ijms15022738; Tautenhahn R, 2012, ANAL CHEM, V84, P5035, DOI 10.1021/ac300698c; Tegos G, 2002, ANTIMICROB AGENTS CH, V46, P3133, DOI 10.1128/AAC.46.10.3133-3141.2002; Varmuza K, 2003, J DATA SCI, V1, P391, DOI DOI 10.6339/JDS.2003.01(4).173; Webber W, 2010, ACM T INFORM SYST, V28, DOI 10.1145/1852102.1852106; WHO-World Health Organization, 2014, ANTIMICROBIAL RESIST; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374	32	10	10	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0123925	10.1371/journal.pone.0123925	http://dx.doi.org/10.1371/journal.pone.0123925			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955847	Green Submitted, gold, Green Published			2022-12-26	WOS:000356768100023
J	Tanaka, R; Tomosugi, M; Horinaka, M; Sowa, Y; Sakai, T				Tanaka, Ryoichi; Tomosugi, Mitsuhiro; Horinaka, Mano; Sowa, Yoshihiro; Sakai, Toshiyuki			Metformin Causes G1-Phase Arrest via Down-Regulation of MiR-221 and Enhances TRAIL Sensitivity through DR5 Up-Regulation in Pancreatic Cancer Cells	PLOS ONE			English	Article							INDUCED APOPTOSIS; TUMOR-SUPPRESSOR; STEM-CELLS; INHIBITION; EXPRESSION; RESISTANCE; MICRORNAS; RECEPTOR; PROLIFERATION; GEMCITABINE	Although many chemotherapeutic strategies against cancer have been developed, pancreatic cancer is one of the most aggressive and intractable types of malignancies. Therefore, new strategies and anti-cancer agents are necessary to treat this disease. Metformin is a widely used drug for type-2 diabetes, and is also known as a promising candidate anti-cancer agent from recent studies in vitro and in vivo. However, the mechanisms of metformin's anti-cancer effects have not been elucidated. We demonstrated that metformin suppressed the expression of miR-221, one of the most well-known oncogenic microRNAs, in human pancreatic cancer PANC-1 cells. Moreover, we showed that the down-regulation of miR-221 by metformin caused G1-phase arrest via the up-regulation of p27, one of the direct targets of miR-221. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is also a promising agent for cancer treatment. While recent studies showed that treatment with only TRAIL was not effective against pancreatic cancer cells, the present data showed that metformin sensitized p53-mutated pancreatic cancer cells to TRAIL. Metformin induced the expressions of death receptor 5 (DR5), a receptor for TRAIL, and Bim with a pro-apoptotic function in the downstream of TRAIL-DR5 pathway. We suggest that the up-regulation of these proteins may contribute to sensitization of TRAIL-induced apoptosis. The combination therapy of metformin and TRAIL could therefore be effective in the treatment of pancreatic cancer.	[Tanaka, Ryoichi; Tomosugi, Mitsuhiro; Horinaka, Mano; Sowa, Yoshihiro; Sakai, Toshiyuki] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Targeting Canc Prevent, Kyoto, Japan	Kyoto Prefectural University of Medicine	Horinaka, M (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Targeting Canc Prevent, Kyoto, Japan.	m-hori@koto.kpu-m.ac.jp			JSPS KAKENHI [24689031]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI (http://www.jsps.go.jp/english/e-grants/index.html) Grant Number 24689031. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abayasiriwardana KS, 2007, MOL CANCER THER, V6, P2766, DOI 10.1158/1535-7163.MCT-07-0278; Acunzo M, 2012, ONCOGENE, V31, P634, DOI 10.1038/onc.2011.260; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Bao B, 2012, CANCER PREV RES, V5, P355, DOI 10.1158/1940-6207.CAPR-11-0299; Bednar F, 2012, CANCER PREV RES, V5, P351, DOI 10.1158/1940-6207.CAPR-12-0026; Ben Sahra I, 2008, ONCOGENE, V27, P3576, DOI 10.1038/sj.onc.1211024; Bennett WL, 2011, ANN INTERN MED, V154, P602, DOI 10.7326/0003-4819-154-9-201105030-00336; Choi YK, 2013, MOL CELLS, V36, P279, DOI 10.1007/s10059-013-0169-8; Coleman CB, 2013, MOL CELL ENDOCRINOL, V374, P125, DOI 10.1016/j.mce.2013.04.019; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Esteva FJ, 2013, CANCER CHEMOTH PHARM, V71, P63, DOI 10.1007/s00280-012-1977-9; Garofalo M, 2008, ONCOGENE, V27, P3845, DOI 10.1038/onc.2008.6; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Gonzalez-Angulo AM, 2010, CLIN CANCER RES, V16, P1695, DOI 10.1158/1078-0432.CCR-09-1805; GOTTLIEB B, 1962, BRIT MED J, P680, DOI 10.1136/bmj.1.5279.680; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Gritti M, 2014, ONCOTARGET, V5, P11252, DOI 10.18632/oncotarget.2617; Herbst RS, 2010, J CLIN ONCOL, V28, P2839, DOI 10.1200/JCO.2009.25.1991; Khanbolooki S, 2006, MOL CANCER THER, V5, P2251, DOI 10.1158/1535-7163.MCT-06-0075; Kleger A, 2014, ANN ONCOL, V25, P1260, DOI 10.1093/annonc/mdu013; Lawrence D, 2001, NAT MED, V7, P383, DOI 10.1038/86397; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li WG, 2012, DIABETES RES CLIN PR, V96, P187, DOI 10.1016/j.diabres.2011.12.028; Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175; Lu T, 2013, CANCER GENE THER, V20, P33, DOI 10.1038/cgt.2012.81; MacKenzie MJ, 2012, INVEST NEW DRUG, V30, P647, DOI 10.1007/s10637-010-9570-8; Ozawa F, 2001, CANCER LETT, V163, P71, DOI 10.1016/S0304-3835(00)00660-1; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Park JK, 2009, PANCREAS, V38, pE190, DOI 10.1097/MPA.0b013e3181ba82e1; Sarkar S, 2013, AM J CANCER RES, V3, P465; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sikka A, 2012, CELL CYCLE, V11, P1374, DOI 10.4161/cc.19798; Truong Do M, 2014, FREE RADIC BIOL MED, V74, P21, DOI DOI 10.1016/J.FREERADBIOMED.2014.06.010; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; Wang HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099067; Yang ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057528	42	39	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0125779	10.1371/journal.pone.0125779	http://dx.doi.org/10.1371/journal.pone.0125779			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955843	Green Published, Green Submitted, gold			2022-12-26	WOS:000356768100078
J	Vitacolonna, M; Belharazem, D; Maier, P; Hohenberger, P; Roessner, ED				Vitacolonna, Mario; Belharazem, Djeda; Maier, Patrick; Hohenberger, Peter; Roessner, Eric Dominic			In vivo Quantification of the Effects of Radiation and Presence of Hair Follicle Pores on the Proliferation of Fibroblasts in an Acellular Human Dermis in a Dorsal Skinfold Chamber: Relevance for Tissue Reconstruction following Neoadjuvant Therapy	PLOS ONE			English	Article							LENTIVIRAL VECTOR; EXTRACELLULAR-MATRIX; SCAFFOLD; CELLS; SUBSTITUTES; VIABILITY; DELIVERY; DAMAGE	Introduction In neoadjuvant therapy, irradiation has a deleterious effect on neoangiogenesis. The aim of this study was to examine the post-implantation effects of neoadjuvant irradiation on the survival and proliferation of autologous cells seeded onto an acellular human dermis (hAD; Epiflex). Additionally, we examined the influence of dermal hair follicle pores on viability and proliferation. We used dorsal skinfold chambers implanted in rats and in-situ microscopy to quantify cell numbers over 9 days. Methods 24 rats received a skinfold chamber and were divided into 2 main groups; irradiated and un-irradiated. In the irradiated groups 20Gy were applied epicutaneously at the dorsum. Epiflex pieces were cut to size 5x5mm such that each piece had either one or more visible hair follicle pores, or no such visible pores. Fibroblasts were transduced lentiviral with a fluorescent protein for cell tracking. Matrices were seeded statically with 2.5x10(4) fluorescent fibroblasts and implanted into the chambers. In each of the two main groups, half of the rats received Epiflex with hair follicle pores and half received Epiflex without pores. Scaffolds were examined in-situ at 0, 3, 6 and 9 days after transplantation. Visible cells on the surface were quantified using ImageJ. Results In all groups cell numbers were decreased on day 3. A treatment-dependent increase in cell numbers was observed at subsequent time points. Irradiation had an adverse effect on cell survival and proliferation. The number of cells detected in both irradiated and non-irradiated subjects was increased in those subjects that received transplants with hair follicle pores. Discussion This in-vivo study confirms that radiation negatively affects the survival and proliferation of fibroblasts seeded onto a human dermis transplant. The presence of hair follicle pores in the dermis transplants is shown to have a positive effect on cell survival and proliferation even in irradiated subjects.	[Vitacolonna, Mario; Hohenberger, Peter; Roessner, Eric Dominic] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Surg, Div Surg Oncol & Thorac Surg, D-69115 Heidelberg, Germany; [Belharazem, Djeda] Heidelberg Univ, Univ Med Ctr Mannheim, Inst Pathol, D-69115 Heidelberg, Germany; [Maier, Patrick] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Radiat Oncol, D-69115 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Roessner, ED (corresponding author), Heidelberg Univ, Univ Med Ctr Mannheim, Dept Surg, Div Surg Oncol & Thorac Surg, Bergheimer Str 58, D-69115 Heidelberg, Germany.	eric.roessner@medma.uni-heidelberg.de		Roessner, Eric Dominic/0000-0003-1173-1098				Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016; Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013; Bellincampi LD, 1998, J ORTHOP RES, V16, P414, DOI 10.1002/jor.1100160404; Bergmeister H, 2005, J BIOMED MATER RES B, V74B, P495, DOI 10.1002/jbm.b.30228; Brown BN, 2010, BIOMATERIALS, V31, P428, DOI 10.1016/j.biomaterials.2009.09.061; Brown JM, 2013, SEMIN RADIAT ONCOL, V23, P281, DOI 10.1016/j.semradonc.2013.05.002; Chen F, 1999, UROLOGY, V54, P407, DOI 10.1016/S0090-4295(99)00179-X; CLOWES AW, 1986, AM J PATHOL, V123, P220; Coulomb B, 1998, PLAST RECONSTR SURG, V101, P1891, DOI 10.1097/00006534-199806000-00018; Dai WD, 2009, BIOSCI TRENDS, V3, P216; Dellgren G, 1999, SCAND CARDIOVASC J, V33, P259; Demaison C, 2002, HUM GENE THER, V13, P803, DOI 10.1089/10430340252898984; Grabenwoger M, 1998, ANN THORAC SURG, V66, pS110, DOI 10.1016/S0003-4975(98)00982-5; Harper C, 2001, HOSP MED, V62, P90, DOI 10.12968/hosp.2001.62.2.2379; Hasegawa T, 2010, J DENT RES, V89, P854, DOI 10.1177/0022034510370022; Jhaveri HM, 2010, J PERIODONTOL, V81, P616, DOI 10.1902/jop.2009.090530; Kasyanov VA, 2009, J MATER SCI-MATER M, V20, P329, DOI 10.1007/s10856-008-3590-3; Kesler CT, 2014, ANGIOGENESIS, V17, P419, DOI 10.1007/s10456-013-9400-7; Kolker AR, 2005, ANN PLAS SURG, V55, P36, DOI 10.1097/01.sap.0000168248.83197.d4; Lamme EN, 1998, J INVEST DERMATOL, V111, P989, DOI 10.1046/j.1523-1747.1998.00459.x; Laschke MW, 2006, TISSUE ENG, V12, P2093, DOI 10.1089/ten.2006.12.2093; Lee MS, 2004, ORTHOPEDICS, V27, pS151; LEHR HA, 1993, AM J PATHOL, V143, P1055; Maier P, 2012, CANCER GENE THER, V19, P802, DOI 10.1038/cgt.2012.67; Maier P, 2010, RADIAT RES, V173, P612, DOI 10.1667/RR1952.1; Mandoli C, 2010, MACROMOL BIOSCI, V10, P127, DOI 10.1002/mabi.200900323; Mao XW, 2006, TECHNOL CANCER RES T, V5, P127, DOI 10.1177/153303460600500206; Morimoto N, 2005, J SURG RES, V125, P56, DOI 10.1016/j.jss.2004.11.012; Nie CL, 2009, MED HYPOTHESES, V72, P679, DOI 10.1016/j.mehy.2008.10.033; Nolte SV, 2008, CELLS TISSUES ORGANS, V187, P165, DOI 10.1159/000111805; Novaes AB, 2007, J PERIODONTOL, V78, P296, DOI 10.1902/jop.2007.060060; Orbay H, 2011, AESTHET PLAST SURG, V35, P756, DOI 10.1007/s00266-011-9683-2; Phelps EA, 2010, CURR OPIN BIOTECH, V21, P704, DOI 10.1016/j.copbio.2010.06.005; REINHOLD HS, 1990, INT J RADIAT ONCOL, V18, P37, DOI 10.1016/0360-3016(90)90264-K; Rodrigues Annelissa Zorzeto, 2010, Braz. Dent. J., V21, P179, DOI 10.1590/S0103-64402010000300001; Rossner E, 2011, CELL TISSUE BANK, V12, P209, DOI 10.1007/s10561-010-9187-3; Roessner E, 2013, ANN SURG ONCOL, V20, pS709, DOI 10.1245/s10434-013-3209-x; Roessner ED, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045991; Roessner ED, 2011, J BIOMATER APPL, V25, P413, DOI 10.1177/0885328209347961; Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Suzuki S, 2000, BRIT J PLAST SURG, V53, P659, DOI 10.1054/bjps.2000.3426; Vitacolonna M, 2014, BMC SURG, V14, DOI 10.1186/1471-2482-14-7; Vitacolonna M, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-55; Zhong SP, 2010, WIRES NANOMED NANOBI, V2, P510, DOI 10.1002/wnan.100; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	46	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0125689	10.1371/journal.pone.0125689	http://dx.doi.org/10.1371/journal.pone.0125689			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955842	Green Published, Green Submitted, gold			2022-12-26	WOS:000356768100067
J	Margolin, DA; Myers, T; Zhang, X; Bertoni, DM; Reuter, BA; Obokhare, I; Borgovan, T; Grimes, C; Green, H; Driscoll, T; Lee, CG; Davis, NK; Li, L				Margolin, David A.; Myers, Tamara; Zhang, Xin; Bertoni, Danielle M.; Reuter, Brian A.; Obokhare, Izi; Borgovan, Theodor; Grimes, Chelsea; Green, Heather; Driscoll, Tiffany; Lee, Chung-Gi; Davis, Nancy K.; Li, Li			The critical roles of tumor-initiating cells and the lymph node stromal microenvironment in human colorectal cancer extranodal metastasis using a unique humanized orthotopic mouse model	FASEB JOURNAL			English	Article						cancer stem cell; intrarectal injection; xenograft; HK cell	FOLLICULAR DENDRITIC CELLS; HUMAN-COLON-CANCER; ACID INHIBITS GROWTH; STEM-CELLS; NUDE-MOUSE; SCID MICE; CHEMOSENSITIVITY; PROLIFERATION; REQUIREMENT; EXPRESSION	Colorectal cancer (CRC) is the second-most common cause of cancer-related mortality. The most important prognostic factors are lymph node (LN) involvement and extranodal metastasis. Our objective is to investigate the interactions between CD133(+)CXCR4(+) (CXC receptor 4) colorectal cancer tumor-initiating cells (Co-TICs) and the LN stromal microenvironment in human CRC extranodal metastasis. We established a unique humanized orthotopic xenograft model. Luciferase-tagged CRC cell lines and human cancer cells were injected intrarectally into nonobese diabetic/SCID mice. Mesenteric LN stromal cells, stromal cell line HK, or CXCL12 knockdownHK (HK-KD-A3) cells were coinoculated with CRC cells. Tumor growth and metastasis were monitored by bioluminescent imaging and immunohistochemistry. We found that this model mimics the human CRC metastatic pattern with CRC cell lines or patient specimens. Adding LN stromal cells promotes CRC tumor growth and extranodal metastasis (P < 0.001). Knocking down CXCL12 impaired HK cell support of CRC tumor formation and extranodal metastasis. When HK cells were added, sorted CD133(+)CXCR4(+) Co-TICs showed increased tumor formation and extranodal metastasis capacities compared to unseparated and non-Co-TIC populations. In conclusion, both Co-TIC and LN stromal factors play crucial roles in CRC metastasis through the CXCL12/CXCR4 axis. Blocking Co-TIC/LN-stromal interactions may lead to effective therapy to prevent extranodal metastasis.	[Margolin, David A.; Myers, Tamara; Bertoni, Danielle M.; Obokhare, Izi; Green, Heather] Ochsner Hlth Syst, Dept Colon Rectal Surg, New Orleans, LA USA; [Davis, Nancy K.] Ochsner Hlth Syst, Dept Pathol, New Orleans, LA USA; [Zhang, Xin; Reuter, Brian A.; Borgovan, Theodor; Grimes, Chelsea; Driscoll, Tiffany; Lee, Chung-Gi; Li, Li] Ochsner Hlth Syst, Lab Translat Canc Res, New Orleans, LA USA; [Margolin, David A.; Li, Li] Univ Queensland, Sch Med, Ochsner Clin Sch, Brisbane, Qld, Australia	Ochsner Health System; Ochsner Health System; Ochsner Health System; University of Queensland	Li, L (corresponding author), Ochsner Clin Fdn, Lab Translat Canc Res, 1514 Jefferson Highway, New Orleans, LA 70121 USA.	lli@ochsner.org	Lee, Chung-Gi/AAT-4964-2020; Margolin, David/A-6017-2011	Lee, Chung-Gi/0000-0003-3821-1316; 	Ochsner Translational Medicine Research Initiative Grant	Ochsner Translational Medicine Research Initiative Grant	The authors thank Yong Sung Choi and David Beck for scientific discussion, Grace Maresh, Linh Hellmers, and Peter Miller for excellent technical assistance, and Kim Darensbourg for pathology expertise. This study is partially supported by Ochsner Translational Medicine Research Initiative Grant 2014. The authors declare no conflicts of interest.	Abedini Fatemeh, 2011, Cancer Manag Res, V3, P301, DOI 10.2147/CMR.S11678; Bellizzi A, 2013, J CELL PHYSIOL, V228, P408, DOI 10.1002/jcp.24145; BRESALIER RS, 1987, INT J CANCER, V39, P625, DOI 10.1002/ijc.2910390514; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Dallas NA, 2009, CANCER RES, V69, P1951, DOI 10.1158/0008-5472.CAN-08-2023; Donigan M, 2009, J SURG RES, V154, P299, DOI 10.1016/j.jss.2008.05.028; Fan F, 2015, BRIT J CANCER, V112, P539, DOI 10.1038/bjc.2014.620; FU XY, 1992, ANTICANCER RES, V12, P1395; Gerger A, 2011, CLIN CANCER RES, V17, P6934, DOI 10.1158/1078-0432.CCR-11-1180; GIAVAZZI R, 1986, CANCER RES, V46, P1928; Gout S, 2008, CANCER MICROENVIRON, V1, P69, DOI 10.1007/s12307-008-0007-2; Heckmann D, 2014, CLIN CANCER RES, V20, P604, DOI 10.1158/1078-0432.CCR-13-0582; Heijstek MW, 2005, DIGEST SURG, V22, P16, DOI 10.1159/000085342; Kashtan H, 1992, Surg Oncol, V1, P251, DOI 10.1016/0960-7404(92)90072-S; KIM HS, 1995, J IMMUNOL, V155, P1101; KIM HS, 1994, J IMMUNOL, V153, P2951; Kojima M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088018; KUBOTA T, 1994, J CELL BIOCHEM, V56, P4, DOI 10.1002/jcb.240560103; Kucia M, 2005, STEM CELLS, V23, P879, DOI 10.1634/stemcells.2004-0342; KUO TH, 1993, ANTICANCER RES, V13, P627; Lee CG, 2012, BRIT J HAEMATOL, V158, P79, DOI 10.1111/j.1365-2141.2012.09123.x; Lee IY, 2005, J IMMUNOL, V175, P1658, DOI 10.4049/jimmunol.175.3.1658; Li L, 2004, BLOOD, V104, P815, DOI 10.1182/blood-2004-01-0292; Lim SH, 2014, J GASTROINTEST ONCOL, V5, P447, DOI 10.3978/j.issn.2078-6891.2014.071; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Margolin DA, 2011, NEOPLASIA, V13, P874, DOI 10.1593/neo.11324; Meads MB, 2009, NAT REV CANCER, V9, P665, DOI 10.1038/nrc2714; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Moore N, 2011, J ONCOL, V2011, DOI 10.1155/2011/396076; Mueller SN, 2008, IMMUNOL REV, V224, P284, DOI 10.1111/j.1600-065X.2008.00657.x; Munoz-Fernandez R, 2006, J IMMUNOL, V177, P280, DOI 10.4049/jimmunol.177.1.280; National Cancer Institute, 2014, SEER STAT FACT SHEET; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Otranto M, 2012, CELL ADHES MIGR, V6, P203, DOI 10.4161/cam.20377; Overdevest JB, 2011, CANCER RES, V71, P3802, DOI 10.1158/0008-5472.CAN-11-0519; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001; Pocard M, 1996, IN VIVO, V10, P463; Prasad S, 2012, CLIN CANCER RES, V18, P4942, DOI 10.1158/1078-0432.CCR-11-2805; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rosenberg DW, 2009, CARCINOGENESIS, V30, P183, DOI 10.1093/carcin/bgn267; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Silinsky J, 2013, J SURG RES, V185, P113, DOI 10.1016/j.jss.2013.05.049; Sundlisxter E, 2007, INT J CANCER, V121, P1401, DOI 10.1002/ijc.22996; Touil Y, 2014, CLIN CANCER RES, V20, P837, DOI 10.1158/1078-0432.CCR-13-1854; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang XM, 2011, J EXP MED, V208, P2497, DOI 10.1084/jem.20111449; Went P, 2006, BRIT J CANCER, V94, P128, DOI 10.1038/sj.bjc.6602924; Yadav VR, 2012, INT J CANCER, V130, P2176, DOI 10.1002/ijc.26251; Zhang SS, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-85	51	18	19	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3571	3581		10.1096/fj.14-268938	http://dx.doi.org/10.1096/fj.14-268938			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25962655				2022-12-26	WOS:000358796900042
J	Hofer, P; Boeszoermenyi, A; Jaeger, D; Feiler, U; Arthanari, H; Mayer, N; Zehender, F; Rechberger, G; Oberer, M; Zimmermann, R; Lass, A; Haemmerle, G; Breinbauer, R; Zechner, R; Preiss-Landl, K				Hofer, Peter; Boeszoermenyi, Andras; Jaeger, Doris; Feiler, Ursula; Arthanari, Haribabu; Mayer, Nicole; Zehender, Fabian; Rechberger, Gerald; Oberer, Monika; Zimmermann, Robert; Lass, Achim; Haemmerle, Guenter; Breinbauer, Rolf; Zechner, Rudolf; Preiss-Landl, Karina			Fatty Acid-binding Proteins Interact with Comparative Gene Identification-58 Linking Lipolysis with Lipid Ligand Shuttling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; ADIPOSE TRIGLYCERIDE LIPASE; PROLIFERATOR-ACTIVATED RECEPTORS; NMR-SPECTROSCOPY; STRUCTURAL BASIS; PPAR-GAMMA; CGI-58; ALPHA; ATGL; RECONSTRUCTION	The coordinated breakdown of intracellular triglyceride (TG) stores requires the exquisitely regulated interaction of lipolytic enzymes with regulatory, accessory, and scaffolding proteins. Together they form a dynamic multiprotein network designated as the "lipolysome." Adipose triglyceride lipase (Atgl) catalyzes the initiating step of TG hydrolysis and requires comparative gene identification-58 (Cgi-58) as a potent activator of enzyme activity. Here, we identify adipocyte-type fatty acid-binding protein (A-Fabp) and other members of the fatty acid-binding protein (Fabp) family as interaction partners of Cgi-58. Co-immunoprecipitation, microscale thermophoresis, and solid phase assays proved direct protein/protein interaction between A-Fabp and Cgi-58. Using nuclear magnetic resonance titration experiments and site-directed mutagenesis, we located a potential contact region on A-Fabp. In functional terms, A-Fabp stimulates Atgl-catalyzed TG hydrolysis in a Cgi-58-dependent manner. Additionally, transcriptional transactivation assays with a luciferase reporter system revealed that Fabps enhance the ability of Atgl/Cgi-58-mediated lipolysis to induce the activity of peroxisome proliferator-activated receptors. Our studies identify Fabps as crucial structural and functional components of the lipolysome.	[Hofer, Peter; Boeszoermenyi, Andras; Jaeger, Doris; Feiler, Ursula; Rechberger, Gerald; Oberer, Monika; Zimmermann, Robert; Lass, Achim; Haemmerle, Guenter; Zechner, Rudolf; Preiss-Landl, Karina] Graz Univ, Inst Mol Biosci, NAWI Graz, A-8010 Graz, Austria; [Arthanari, Haribabu] Harvard Univ, Dept Biol Chem & Mol Pharmacol, Sch Med, Boston, MA 02115 USA; [Mayer, Nicole; Breinbauer, Rolf] Graz Univ Technol, Inst Organ Chem, A-8010 Graz, Austria; [Zehender, Fabian] NanoTemper Technol GmbH, D-81369 Munich, Germany	University of Graz; Harvard University; Harvard Medical School; Graz University of Technology	Zechner, R (corresponding author), Graz Univ, Inst Mol Biosci, Heinrichstr 31-2, A-8010 Graz, Austria.	rudolf.zechner@uni-graz.at; karina.landl@uni-graz.at	Lass, Achim/C-3332-2008; Breinbauer, Rolf/AAK-1750-2020; Boeszoermenyi, Andras/AAD-9808-2020	Lass, Achim/0000-0002-8190-7151; Breinbauer, Rolf/0000-0001-6009-7359; Boeszoermenyi, Andras/0000-0001-9810-7241; Hofer, Peter/0000-0002-0788-7519; Arthanari, Haribabu/0000-0002-7281-1289; Haemmerle, Guenter/0000-0001-9900-5896; Oberer, Monika/0000-0003-2525-9513; Zimmermann, Robert/0000-0002-7354-870X; Rechberger, Gerald N./0000-0002-0071-317X; Zechner, Rudolf/0000-0001-5483-1182	Austrian Fonds zur Forderung der Wissenschaftlichen Forschung [SFB LIPOTOX F30, P22170]; DK Molecular Enzymology [W09]; Wittgenstein Award - Austrian Fonds zur Forderung der Wissenschaftlichen Forschung [Z136]; Foundation Leduq [TNT 12CVD04]; Austrian Science Fund (FWF) [P 22170, Z 136, W 901, F 3002] Funding Source: researchfish	Austrian Fonds zur Forderung der Wissenschaftlichen Forschung(Austrian Science Fund (FWF)); DK Molecular Enzymology(Austrian Science Fund (FWF)); Wittgenstein Award - Austrian Fonds zur Forderung der Wissenschaftlichen Forschung(Austrian Science Fund (FWF)); Foundation Leduq; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Fonds zur Forderung der Wissenschaftlichen Forschung Grants SFB LIPOTOX F30 and P22170, DK Molecular Enzymology W09, Wittgenstein Award Z136 funded by the Austrian Fonds zur Forderung der Wissenschaftlichen Forschung, and Foundation Leduq TNT 12CVD04. The authors declare that they have no conflicts of interest with the contents of this article.	Adida A, 2006, BBA-MOL CELL BIOL L, V1761, P172, DOI 10.1016/j.bbalip.2006.02.006; Armstrong EH, 2014, J BIOL CHEM, V289, P14941, DOI 10.1074/jbc.M113.514646; Ayers SD, 2007, BIOCHEMISTRY-US, V46, P6744, DOI 10.1021/bi700047a; Birner-Gruenberger R, 2005, MOL CELL PROTEOMICS, V4, P1710, DOI 10.1074/mcp.M500062-MCP200; Borg ML, 2011, DIABETES, V60, P1458, DOI 10.2337/db10-0845; Cao HM, 2013, CELL METAB, V17, P768, DOI 10.1016/j.cmet.2013.04.012; Cerk IK, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.602599; Chung C, 2008, J HEPATOL, V48, P471, DOI 10.1016/j.jhep.2007.10.012; Coe NR, 1999, J LIPID RES, V40, P967; Dai ZY, 2013, INT J BIOCHEM CELL B, V45, P2076, DOI 10.1016/j.biocel.2013.07.008; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; EGLOFF MP, 1995, PROTEIN SCI, V4, P44; Ellong EN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021889; Ferentz AE, 2000, Q REV BIOPHYS, V33, P29, DOI 10.1017/S0033583500003589; Filleur S, 2009, J CELL BIOCHEM, V106, P769, DOI 10.1002/jcb.22072; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Garin-Shkolnik T, 2014, DIABETES, V63, P900, DOI 10.2337/db13-0436; Gillilan RE, 2007, J MOL BIOL, V372, P1246, DOI 10.1016/j.jmb.2007.07.040; Goeritzer M, 2014, J LIPID RES, V55, P2562, DOI 10.1194/jlr.M052613; Granneman JG, 2011, J BIOL CHEM, V286, P5126, DOI 10.1074/jbc.M110.180711; Granneman JG, 2009, J BIOL CHEM, V284, P3049, DOI 10.1074/jbc.M808251200; Gruber A, 2010, J BIOL CHEM, V285, P12289, DOI 10.1074/jbc.M109.064469; Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439; Haunerland NH, 2004, PROG LIPID RES, V43, P328, DOI 10.1016/j.plipres.2004.05.001; Heckmann BL, 2013, BBA-MOL CELL BIOL L, V1831, P276, DOI 10.1016/j.bbalip.2012.09.016; Hostetler HA, 2009, J LIPID RES, V50, P1663, DOI 10.1194/jlr.M900058-JLR200; Hyberts SG, 2012, J BIOMOL NMR, V52, P315, DOI 10.1007/s10858-012-9611-z; Hyberts SG, 2010, J AM CHEM SOC, V132, P2145, DOI 10.1021/ja908004w; Jenkins-Kruchten AE, 2003, J BIOL CHEM, V278, P47636, DOI 10.1074/jbc.M307680200; Kioka H, 2014, P NATL ACAD SCI USA, V111, P273, DOI 10.1073/pnas.1318547111; Lass A, 2011, PROG LIPID RES, V50, P14, DOI 10.1016/j.plipres.2010.10.004; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lefevre C, 2001, AM J HUM GENET, V69, P1002, DOI 10.1086/324121; MacPhee CE, 2000, BIOCHEMISTRY-US, V39, P3433, DOI 10.1021/bi992523t; MacPherson REK, 2013, AM J PHYSIOL-REG I, V304, pR644, DOI 10.1152/ajpregu.00418.2012; Marcelino AMC, 2006, PROTEINS, V63, P373, DOI 10.1002/prot.20860; Mayer N, 2013, NAT CHEM BIOL, V9, P785, DOI [10.1038/NCHEMBIO.1359, 10.1038/nchembio.1359]; Nagy HM, 2014, BBA-MOL CELL BIOL L, V1841, P588, DOI 10.1016/j.bbalip.2014.01.005; Nooren IMA, 2003, EMBO J, V22, P3486, DOI 10.1093/emboj/cdg359; Oberer M, 2011, CURR OPIN LIPIDOL, V22, P149, DOI 10.1097/MOL.0b013e328346230e; Olzmann JA, 2013, P NATL ACAD SCI USA, V110, P1345, DOI 10.1073/pnas.1213738110; Ozbabacan SEA, 2011, PROTEIN ENG DES SEL, V24, P635, DOI 10.1093/protein/gzr025; Park S, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.27723; Sahu-Osen A, 2015, J LIPID RES, V56, P109, DOI 10.1194/jlr.M055004; Schupp M, 2010, J BIOL CHEM, V285, P40409, DOI 10.1074/jbc.R110.182451; Schweiger M, 2012, J LIPID RES, V53, P2307, DOI 10.1194/jlr.M027409; Schweiger M, 2009, AM J PHYSIOL-ENDOC M, V297, pE289, DOI 10.1152/ajpendo.00099.2009; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Shen WJ, 1999, P NATL ACAD SCI USA, V96, P5528, DOI 10.1073/pnas.96.10.5528; Shen WJ, 2001, J BIOL CHEM, V276, P49443, DOI 10.1074/jbc.M104095200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Smith AJ, 2004, J BIOL CHEM, V279, P52399, DOI 10.1074/jbc.M410301200; Smith AJ, 2007, J BIOL CHEM, V282, P32424, DOI 10.1074/jbc.M703730200; Smith AJ, 2008, J BIOL CHEM, V283, P33536, DOI 10.1074/jbc.M806732200; Storch J, 2008, ANNU REV NUTR, V28, P73, DOI 10.1146/annurev.nutr.27.061406.093710; Sulsky R, 2007, BIOORG MED CHEM LETT, V17, P3511, DOI 10.1016/j.bmcl.2006.12.044; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Velkov T, 2013, PPAR RES, V2013, DOI 10.1155/2013/938401; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wolfrum C, 2001, P NATL ACAD SCI USA, V98, P2323, DOI 10.1073/pnas.051619898; Yamaguchi T, 2007, J LIPID RES, V48, P1078, DOI 10.1194/jlr.M600493-JLR200; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200; Zhang J, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.573857; Zierler KA, 2014, CURR OPIN LIPIDOL, V25, P102, DOI 10.1097/MOL.0000000000000058	65	36	37	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18438	18453		10.1074/jbc.M114.628958	http://dx.doi.org/10.1074/jbc.M114.628958			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	25953897	Green Published, hybrid			2022-12-26	WOS:000358512100016
J	Gowda, ASP; Moldovan, GL; Spratt, TE				Gowda, A. S. Prakasha; Moldovan, George-Lucian; Spratt, Thomas E.			Human DNA Polymerase Catalyzes Correct and Incorrect DNA Synthesis with High Catalytic Efficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA polymerase; DNA repair; DNA replication; enzyme kinetics; enzyme mechanism	I KLENOW FRAGMENT; UNIQUE ERROR SIGNATURE; KINETIC MECHANISM; NUCLEOTIDE INCORPORATION; REPLICATION FIDELITY; ESCHERICHIA-COLI; INCORPORATION OPPOSITE; PRIMER TERMINUS; MINOR-GROOVE; CROSS-LINKS	Background: DNA polymerase is a low fidelity polymerase with an unknown function. Results: The kinetic mechanism of correct and incorrect base pair formation was determined. Conclusion: Phosphodiester bond formation is rapid for both correct and mispair formation. Significance: The presence of a mispair does not induce the polymerase to adopt a low catalytic conformation. DNA polymerase (pol ) is a low fidelity A-family polymerase with a putative role in interstrand cross-link repair and homologous recombination. We carried out pre-steady-state kinetic analysis to elucidate the kinetic mechanism of this enzyme. We found that the mechanism consists of seven steps, similar that of other A-family polymerases. pol binds to DNA with a K-d for DNA of 9.2 nm, with an off-rate constant of 0.013 s(-1)and an on-rate constant of 14 m(-1) s(-1). dNTP binding is rapid with K-d values of 20 and 476 m for the correct and incorrect dNTP, respectively. Pyrophosphorylation occurs with a K-d value for PPi of 3.7 mm and a maximal rate constant of 11 s(-1). Pre-steady-state kinetics, examination of the elemental effect using dNTPS, and pulse-chase experiments indicate that a rapid phosphodiester bond formation step is flanked by slow conformational changes for both correct and incorrect base pair formation. These experiments in combination with computer simulations indicate that the first conformational change occurs with rate constants of 75 and 20 s(-1); rapid phosphodiester bond formation occurs with a K-eq of 2.2 and 1.7, and the second conformational change occurs with rate constants of 2.1 and 0.5 s(-1), for correct and incorrect base pair formation, respectively. The presence of a mispair does not induce the polymerase to adopt a low catalytic conformation. pol catalyzes both correct and mispair formation with high catalytic efficiency.	[Gowda, A. S. Prakasha; Moldovan, George-Lucian; Spratt, Thomas E.] Penn State Univ, Milton S Hershey Med Ctr, Dept Biochem & Mol Biol, Coll Med, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Spratt, TE (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, H171,500 Univ Dr, Hershey, PA 17033 USA.	tes13@psu.edu		George-Lucian, Moldovan/0000-0003-3825-149X; Spratt, Thomas/0000-0002-6805-3729	Pennsylvania Department of Health using Tobacco Settlement Funds; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021762] Funding Source: NIH RePORTER	Pennsylvania Department of Health using Tobacco Settlement Funds; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The oligodeoxynucleotide synthesis and MS analysis were performed in the Macromolecular Core facility at the Pennsylvania State University College of Medicine. Core Facility services and instruments used in this project were funded, in part, under a grant with the Pennsylvania Department of Health using Tobacco Settlement Funds.	Arana ME, 2007, DNA REPAIR, V6, P213, DOI 10.1016/j.dnarep.2006.09.012; Arana ME, 2011, BIOCHEMISTRY-US, V50, P10126, DOI 10.1021/bi201197p; Beckman JW, 2008, J BIOL CHEM, V283, P36711, DOI 10.1074/jbc.M806785200; Bevington P. R., 1969, DATA REDUCTION ERROR, P56; BOYD JB, 1990, GENETICS, V125, P813; Carlson KD, 2006, P NATL ACAD SCI USA, V103, P15776, DOI 10.1073/pnas.0605785103; Carlson KD, 2005, MOL CELL BIOL, V25, P2169, DOI 10.1128/MCB.25.6.2169-2176.2005; CARROLL SS, 1991, BIOCHEMISTRY-US, V30, P804, DOI 10.1021/bi00217a034; DAHLBERG ME, 1991, BIOCHEMISTRY-US, V30, P4835, DOI 10.1021/bi00234a002; DONLIN MJ, 1994, BIOCHEMISTRY-US, V33, P14908, DOI 10.1021/bi00253a030; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Dunn D. B., 1986, HDB BIOCH MOL BIOL, P65; ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.biochem.60.1.477; EGER BT, 1992, BIOCHEMISTRY-US, V31, P9227, DOI 10.1021/bi00153a016; EGER BT, 1991, BIOCHEMISTRY-US, V30, P1441, DOI 10.1021/bi00219a039; Furge LL, 1999, BIOCHEMISTRY-US, V38, P4818, DOI 10.1021/bi982163u; Graziewicz MA, 2006, CHEM REV, V106, P383, DOI 10.1021/cr040463d; Hobza P, 1999, CHEM REV, V99, P3247, DOI 10.1021/cr9800255; Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041; Irimia A, 2009, J BIOL CHEM, V284, P22467, DOI 10.1074/jbc.M109.003905; Johnson AA, 2001, J BIOL CHEM, V276, P38090; Johnson SJ, 2004, CELL, V116, P803, DOI 10.1016/S0092-8674(04)00252-1; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; Kool ET, 2002, ANNU REV BIOCHEM, V71, P191, DOI 10.1146/annurev.biochem.71.110601.135453; KUCHTA RD, 1987, BIOCHEMISTRY-US, V26, P8410, DOI 10.1021/bi00399a057; KUCHTA RD, 1988, BIOCHEMISTRY-US, V27, P6716, DOI 10.1021/bi00418a012; Kunkel TA, 2004, J BIOL CHEM, V279, P16895, DOI 10.1074/jbc.R400006200; Kuzmic P, 2009, METHOD ENZYMOL, V467, P247, DOI 10.1016/S0076-6879(09)67010-5; Lee YS, 2015, NAT STRUCT MOL BIOL, V22, P298, DOI 10.1038/nsmb.2985; Lee YS, 2010, J BIOL CHEM, V285, P28105, DOI 10.1074/jbc.M110.122283; Longley MJ, 2001, J BIOL CHEM, V276, P38555, DOI 10.1074/jbc.M105230200; Marini F, 2003, J BIOL CHEM, V278, P32014, DOI 10.1074/jbc.M305646200; McCain MD, 2005, BIOCHEMISTRY-US, V44, P5647, DOI 10.1021/bi047460f; Meyer AS, 2004, J BIOL CHEM, V279, P33043, DOI 10.1074/jbc.C400232200; MIZRAHI V, 1985, BIOCHEMISTRY-US, V24, P4010, DOI 10.1021/bi00336a031; Moldovan GL, 2010, MOL CELL BIOL, V30, P1088, DOI 10.1128/MCB.01124-09; Pang M, 2005, DNA REPAIR, V4, P971, DOI 10.1016/j.dnarep.2005.04.020; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Patra A, 2015, J BIOL CHEM, V290, P8028, DOI 10.1074/jbc.M115.637561; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Rothwell PJ, 2005, MOL CELL, V19, P345, DOI 10.1016/j.molcel.2005.06.032; Sherrer SM, 2012, CHEM RES TOXICOL, V25, P730, DOI 10.1021/tx200531y; Spratt TE, 1997, BIOCHEMISTRY-US, V36, P13292, DOI 10.1021/bi971253g; Spratt TE, 2001, BIOCHEMISTRY-US, V40, P2647, DOI 10.1021/bi002641c; Spratt TE, 1997, NUCLEIC ACIDS RES, V25, P3354, DOI 10.1093/nar/25.16.3354; Takata K, 2006, J BIOL CHEM, V281, P23445, DOI 10.1074/jbc.M604317200; Takata K, 2010, NUCLEIC ACIDS RES, V38, P3233, DOI 10.1093/nar/gkq048; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; Wang WJ, 2011, APPL CATAL B-ENVIRON, V108, P108, DOI 10.1016/j.apcatb.2011.08.015; Washington MT, 2003, MOL CELL BIOL, V23, P8316, DOI 10.1128/MCB.23.22.8316-8322.2003; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; WONG I, 1991, BIOCHEMISTRY-US, V30, P526, DOI 10.1021/bi00216a030; Woodside AM, 2002, BIOCHEMISTRY-US, V41, P1039, DOI 10.1021/bi011496f; Wu EY, 2011, J BIOL CHEM, V286, P19758, DOI 10.1074/jbc.M110.191130; Xia SL, 2013, J AM CHEM SOC, V135, P193, DOI 10.1021/ja3079048; Yamanaka K, 2010, CHEM RES TOXICOL, V23, P689, DOI 10.1021/tx900449u; Zhao LL, 2014, FEBS J, V281, P4394, DOI 10.1111/febs.12947; Zietlow L, 2009, BIOCHEMISTRY-US, V48, P11817, DOI 10.1021/bi9015346	59	8	8	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16292	16303		10.1074/jbc.M115.653287	http://dx.doi.org/10.1074/jbc.M115.653287			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25963146	Green Published, hybrid			2022-12-26	WOS:000356930100032
J	Kang, ZZ; Chen, JL; Wang, BQ				Kang, Zhizhong; Chen, Jinlei; Wang, Baoqian			Global Registration of Subway Tunnel Point Clouds Using an Augmented Extended Kalman Filter and Central-Axis Constraint	PLOS ONE			English	Article							MULTIVIEW REGISTRATION; ERROR	Because tunnels generally have tubular shapes, the distribution of tie points between adjacent scans is usually limited to a narrow region, which makes the problem of registration error accumulation inevitable. In this paper, a global registration method is proposed based on an augmented extended Kalman filter and a central-axis constraint. The point cloud registration is regarded as a stochastic system, and the global registration is considered to be a process that recursively estimates the rigid transformation parameters between each pair of adjacent scans. Therefore, the augmented extended Kalman filter (AEKF) is used to accurately estimate the rigid transformation parameters by eliminating the error accumulation caused by the pair-wise registration. Moreover, because the scanning range of a terrestrial laser scanner can reach hundreds of meters, a single scan can cover a tunnel segment with a length of more than one hundred meters, which means that the central axis extracted from the scan can be employed to control the registration of multiple scans. Therefore, the central axis of the subway tunnel is first determined through the 2D projection of the tunnel point cloud and curve fitting using the RANSAC (RANdom SAmple Consensus) algorithm. Because the extraction of the central axis by quadratic curve fitting may suffer from noise in the tunnel points and from variations in the tunnel, we present a global extraction algorithm that is based on segment-wise quadratic curve fitting. We then derive the central-axis constraint as an additional observation model of AEKF to optimize the registration parameters between each pair of adjacent scans. The proposed approach is tested on terrestrial point clouds that were acquired in a subway tunnel. The results show that the proposed algorithm is capable of improving the accuracy of aligning multiple scans by 48%.	[Kang, Zhizhong; Chen, Jinlei] China Univ Geosci, Sch Land Sci & Technol, Beijing, Peoples R China; [Wang, Baoqian] Beijing Siwei Spatial Data Technol Co Ltd, Beijing, Peoples R China	China University of Geosciences	Kang, ZZ (corresponding author), China Univ Geosci, Sch Land Sci & Technol, Beijing, Peoples R China.	zzkang@cugb.edu.cn			Natural Science Foundation of China [41171358]; Fundamental Research Funds for the Central Universities [2652012103]; Beijing Siwei Spatial Data Technology Co., Ltd	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Beijing Siwei Spatial Data Technology Co., Ltd	This work was supported by the Natural Science Foundation of China under grant No. 41171358 and the Fundamental Research Funds for the Central Universities under grant No. 2652012103. Beijing Siwei Spatial Data Technology Co., Ltd provided support in the form of salaries for author BW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjemaa R, 1999, IMAGE VISION COMPUT, V17, P113, DOI 10.1016/S0262-8856(98)00115-2; Bergevin R, 1996, IEEE T PATTERN ANAL, V18, P540, DOI 10.1109/34.494643; Eggert DW, 1998, COMPUT VIS IMAGE UND, V69, P253, DOI 10.1006/cviu.1998.0667; FISCHLER MA, 1981, COMMUN ACM, V24, P381, DOI 10.1145/358669.358692; Hu SX, 2006, INFORMATION VISUALIZATION-BOOK, P725; Julier SJ, 2004, P IEEE, V92, P401, DOI 10.1109/JPROC.2003.823141; Kang ZZ, 2009, SENSORS-BASEL, V9, P2621, DOI 10.3390/s90402621; Ma B, 2004, LECT NOTES COMPUT SC, V3216, P566; Moghari MH, 2007, IEEE T MED IMAGING, V26, P1708, DOI 10.1109/TMI.2007.901984; Neugebauer P. J., 1997, International Journal of Shape Modeling, V3, P71, DOI 10.1142/S0218654397000070; Sharp GC, 2004, IEEE T PATTERN ANAL, V26, P1037, DOI 10.1109/TPAMI.2004.49; Stoddart A. J., 1996, Proceedings of the 13th International Conference on Pattern Recognition, P40, DOI 10.1109/ICPR.1996.546720; Van der Merwe R, 2000, 380 CUEDFINFENGTR; Welch G, 1995, INTRO CALMAN FILTER; Williams J, 2000, IEICE T INF SYST, VE83D, P1662	15	1	1	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0126862	10.1371/journal.pone.0126862	http://dx.doi.org/10.1371/journal.pone.0126862			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965807	Green Submitted, gold, Green Published			2022-12-26	WOS:000354543500083
J	Worwa, G; Wheeler, SS; Brault, AC; Reisen, WK				Worwa, Gabriella; Wheeler, Sarah S.; Brault, Aaron C.; Reisen, William K.			Comparing Competitive Fitness of West Nile Virus Strains in Avian and Mosquito Hosts	PLOS ONE			English	Article							EXPERIMENTAL-INFECTION; DIPTERA-CULICIDAE; VECTOR COMPETENCE; CULEX-TARSALIS; AMERICAN CROWS; UNITED-STATES; NEW-YORK; IN-VIVO; CALIFORNIA; TRANSMISSION	Enzootic transmission of West Nile virus (WNV; Flaviviridae, Flavivirus) involves various species of birds and ornithophilic mosquitoes. Single nucleotide substitutions in the WNV genome may impact viral fitness necessary for WNV adaptation and evolution as previously shown for the WN02 genotype. In an effort to study phenotypic change, we developed an in vivo fitness competition model in two biologically relevant hosts for WNV. The House Finch (HOFI; Haemorhous mexicanus) and Culex tarsalis mosquitoes represent moderately susceptible hosts for WNV, are highly abundant in Western North America and frequently are infected with WNV in nature. Herein, we inoculated HOFIs and Culex tarsalis competitively (dually) and singly with infectious-clone derived viruses of the founding California isolate COAV997-2003 (COAV997-IC), the founding North American isolate NY99 (NY99-IC), and a 2004 field isolate from California (CA-04), and compared the replicative capacities (fitness) of these viruses to a genetically marked virus of COAV997 (COAV997-5nt) by measuring RNA copy numbers. COAV997 and COAV997-5nt exhibited neutral fitness in HOFIs and Culex tarsalis, and the temperature-sensitive phenotype of COAV997 did not affect replication in HOFIs as none of the infected birds became febrile. The NY99 and CA-04 isolates demonstrated elevated fitness in HOFIs compared to COAV997-5nt, whereas all viruses replicated to similar titers and RNA copies in Culex tarsalis, and the only fitness differences were related to infection rates. Our data demonstrated that competitive replication allows for the sensitive comparison of fitness differences among two genetically closely related viruses using relevant hosts of WNV while eliminating host-to-host differences. In conclusion, our approach may be helpful in understanding the extent of phenotypic change in fitness associated with genetic changes in WNV.	[Worwa, Gabriella; Wheeler, Sarah S.; Reisen, William K.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Ctr Vectorborne Dis, Davis, CA 95616 USA; [Brault, Aaron C.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA	University of California System; University of California Davis; Centers for Disease Control & Prevention - USA	Reisen, WK (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Ctr Vectorborne Dis, Davis, CA 95616 USA.	wkreisen@ucdavis.edu			Swiss National Science Foundation [PBBEP3_128345]; Swiss Foundation for Grants in Biology and Medicine [PASMP3_137034]; US National Institutes of Health Allergy and Infectious Diseases [RO1-AI55607]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055607] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Foundation for Grants in Biology and Medicine; US National Institutes of Health Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	G. Worwa was supported by the Swiss National Science Foundation through grant PBBEP3_128345 and the Swiss Foundation for Grants in Biology and Medicine through grant PASMP3_137034. Funding for these studies also was provided, in part, by US National Institutes of Health Allergy and Infectious Diseases Grant RO1-AI55607. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade CC, 2011, J GEN VIROL, V92, P2523, DOI 10.1099/vir.0.032318-0; Beaty BC., 1995, VIRAL RICKETTSIAL CH, P189; Brault AC, 2007, NAT GENET, V39, P1162, DOI 10.1038/ng2097; Brault AC, 2004, EMERG INFECT DIS, V10, P2161, DOI 10.3201/eid1012.040486; Chiles RE, 1998, J VECTOR ECOL, V23, P123; Coffey LL, 2008, P NATL ACAD SCI USA, V105, P6970, DOI 10.1073/pnas.0712130105; Colton L, 2006, J AM MOSQUITO CONTR, V22, P57, DOI 10.2987/8756-971X(2006)22[57:QOWNVI]2.0.CO;2; Davis CT, 2005, VIROLOGY, V342, P252, DOI 10.1016/j.virol.2005.07.022; Deardorff E, 2006, EMERG INFECT DIS, V12, P314, DOI 10.3201/eid1202.050871; Deardorff ER, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002335; Duggal NK, 2013, AM J TROP MED HYG, V89, P205, DOI 10.4269/ajtmh.13-0140; Ebel GD, 2004, AM J TROP MED HYG, V71, P493, DOI 10.4269/ajtmh.2004.71.493; Ebel GD, 2011, J VIROL, V85, P12605, DOI 10.1128/JVI.05637-11; Goddard LB, 2002, EMERG INFECT DIS, V8, P1385, DOI 10.3201/eid0812.020536; Hom A, 2005, PROC PAP ANNU CONF C, P66; Kilpatrick AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000092; Kinney RM, 2006, J GEN VIROL, V87, P3611, DOI 10.1099/vir.0.82299-0; Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628; Kwan JL, 2010, AM J TROP MED HYG, V83, P400, DOI 10.4269/ajtmh.2010.10-0076; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; Langevin SA, 2005, AM J TROP MED HYG, V72, P99, DOI 10.4269/ajtmh.2005.72.99; Moudy RM, 2007, AM J TROP MED HYG, V77, P365, DOI 10.4269/ajtmh.2007.77.365; Reisen W, 2004, EMERG INFECT DIS, V10, P1369, DOI 10.3201/eid1008.040077; Reisen WK, 2009, J MED ENTOMOL, V46, P139, DOI 10.1603/033.046.0118; Reisen WK, 2005, J MED ENTOMOL, V42, P367, DOI 10.1603/0022-2585(2005)042[0367:AHAMDC]2.0.CO;2; Reisen WK, 2006, J MED ENTOMOL, V43, P309, DOI 10.1603/0022-2585(2006)043[0309:EOTOTT]2.0.CO;2; Rozen-Gagnon K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003877; Snapinn KW, 2007, J VIROL, V81, P2531, DOI 10.1128/JVI.02169-06; Thiemann TC, 2012, J MED ENTOMOL, V49, P903, DOI 10.1603/ME11272; Wheeler SS, 2012, AM J TROP MED HYG, V87, P559, DOI 10.4269/ajtmh.2012.11-0654; Wheeler SS, 2012, J MED ENTOMOL, V49, P895, DOI 10.1603/ME11286; Wheeler SS, 2011, VECTOR-BORNE ZOONOT, V11, P1069, DOI 10.1089/vbz.2010.0173; Worwa G, 2014, J VIROL METHODS, V195, P76, DOI 10.1016/j.jviromet.2013.09.014	33	3	3	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0125668	10.1371/journal.pone.0125668	http://dx.doi.org/10.1371/journal.pone.0125668			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965850	gold, Green Published, Green Submitted			2022-12-26	WOS:000354543500024
J	Degaspari, S; Tzanno-Martins, CB; Fujihara, CK; Zatz, R; Branco-Martins, JP; Viel, TA; Buck, HD; Orellana, AMM; Bohmer, AE; Lima, LD; Andreotti, DZ; Munhoz, CD; Scavone, C; Kawamoto, EM				Degaspari, Sabrina; Tzanno-Martins, Carmen Branco; Fujihara, Clarice Kazue; Zatz, Roberto; Branco-Martins, Joao Paulo; Viel, Tania Araujo; Buck, Hudson de Souza; Marques Orellana, Ana Maria; Boehmer, Ana Elisa; Lima, Larissa de Sa; Andreotti, Diana Zukas; Munhoz, Carolina Demarchi; Scavone, Cristoforo; Kawamoto, Elisa Mitiko			Altered KLOTHO and NF-kappa B-TNF-alpha Signaling Are Correlated with Nephrectomy-Induced Cognitive Impairment in Rats	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; NITRIC-OXIDE; KIDNEY; BRAIN; MICE; INTERLEUKIN-10; EXPRESSION; PROTEIN; STRESS; CELLS	Renal insufficiency can have a negative impact on cognitive function. Neuroinflammation and changes in klotho levels associate with chronic kidney disease (CKD) and may play a role in the development of cognitive impairment (CI). The present study evaluates the correlation of cognitive deficits with neuroinflammation and soluble KLOTHO in the cerebral spinal fluid (CSF) and brain tissue of nephrectomized rats (Nx), with 5/6 renal mass ablation. Nx and sham Munich Wistar rats were tested over 4 months for locomotor activity, as well as inhibitory avoidance or novel object recognition, which started 30 days after the surgery. EMSA for Nuclear factor-kappa B and MILLIPLEXMAP or ELISA kit were used to evaluate cytokines, glucocorticoid and KLOTHO levels. Nx animals that showed a loss in aversive-related memory and attention were included in the CI group (Nx-CI) (n=14) and compared to animals with intact learning (Nx-M n=12 and Sham n=20 groups). CSF and tissue samples were collected 24 hours after the last behavioral test. The results show that the Nx-groups have increased NF-kappa B binding activity and tumor necrosis factor-alpha (TNF-alpha) levels in the hippocampus and frontal cortex, with these changes more pronounced in the Nx-CI group frontal cortex. In addition, the Nx-CI group showed significantly increased CSF glucocorticoid levels and TNF-alpha / IL-10 ratio compared to the Sham group. Klotho levels were decreased in Nx-CI frontal cortex but not in hippocampus, when compared to Nx-M and Sham groups. Overall, these results suggest that neuroinflammation mediated by frontal cortex NF-kappa B, TNF-alpha and KLOTHO signaling may contribute to Nx-induced CI in rats.	[Degaspari, Sabrina; Marques Orellana, Ana Maria; Boehmer, Ana Elisa; Lima, Larissa de Sa; Andreotti, Diana Zukas; Munhoz, Carolina Demarchi; Scavone, Cristoforo; Kawamoto, Elisa Mitiko] Univ Sao Paulo, Dept Pharmacol, Mol Neuropharmacol Lab, Inst Biomed Sci, Sao Paulo, Brazil; [Tzanno-Martins, Carmen Branco; Zatz, Roberto; Branco-Martins, Joao Paulo] Ctr Integrado Nefrol, Sao Paulo, Brazil; [Fujihara, Clarice Kazue; Zatz, Roberto] Univ Sao Paulo, Fac Med, Div Renal, Dept Clin Med, Sao Paulo, Brazil; [Viel, Tania Araujo] Univ Sao Paulo, Sch Arts Sci & Humanities, Sao Paulo, Brazil; [Buck, Hudson de Souza] Santa Casa Sao Paulo Med Sch, Dept Physiol Sci, BR-01221020 Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Scavone, C (corresponding author), Univ Sao Paulo, Dept Pharmacol, Mol Neuropharmacol Lab, Inst Biomed Sci, Sao Paulo, Brazil.	criscavone@usp.br	Buck, Hudson/E-7664-2013; Kawamoto, Elisa Mitiko/E-3485-2012; Scavone, Cristoforo/AFK-9950-2022; Scavone, Cristoforo/C-1580-2012; Orellana, Ana Maria Marques/AAR-2226-2020; Viel, Tania/K-2909-2016; Orellana, Ana Maria M/B-9446-2014; Munhoz, Carolina Demarchi/N-7219-2014; Scavone, Cristoforo/ABB-8279-2021	Buck, Hudson/0000-0002-1867-2441; Kawamoto, Elisa Mitiko/0000-0001-8637-414X; Scavone, Cristoforo/0000-0002-1206-0882; Scavone, Cristoforo/0000-0002-1206-0882; Viel, Tania/0000-0002-4015-785X; Munhoz, Carolina Demarchi/0000-0002-8656-5234; Scavone, Cristoforo/0000-0002-1206-0882; de Sa Lima, Larissa/0000-0001-9321-9834; Orellana, Ana Maria/0000-0003-1309-3608; Bohmer Morschbacher, Ana Elisa/0000-0002-4364-0767	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP [2011/50596-1]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Universidade de Sao Paulo [2011.1.9333.1.3]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Universidade de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	EMK and AEB are supported by postdoc fellowships from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP and R.A. from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); ARV and SD are Ph.D student research fellowship from FAPESP and CAPES respectively, and LSL is supported by grants from Universidade de Sao Paulo and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq. This research was supported by grants from FAPESP (2011/50596-1), CNPq and partially funded by the University of Sao Paulo (Grant#2011.1.9333.1.3, NAPNA). CS, RZ, CDM, TAV and HSB, are research fellows of CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albensi BC, 2000, SYNAPSE, V35, P151; Anderson G, 2013, PHARMACOL REP, V65, P1647, DOI 10.1016/S1734-1140(13)71526-3; Bautovich A., 2014, AUST NZ J PSYCHIAT; Ben Menachem-Zidon O, 2008, NEUROPSYCHOPHARMACOL, V33, P2251, DOI 10.1038/sj.npp.1301606; Bladh LG, 2005, MOL ENDOCRINOL, V19, P632, DOI 10.1210/me.2004-0294; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Camandola S, 2007, EXPERT OPIN THER TAR, V11, P123, DOI 10.1517/14728222.11.2.123; Casadesus G, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-2; Chiavegatto S, 1998, NEUROREPORT, V9, P571, DOI 10.1097/00001756-199803090-00002; Dahbour SS, 2009, HEMODIAL INT, V13, P80, DOI 10.1111/j.1542-4758.2009.00343.x; Diaz-Delfin J, 2012, ENDOCRINOLOGY, V153, P4238, DOI 10.1210/en.2012-1193; Dubal DB, 2014, CELL REP, V7, P1065, DOI 10.1016/j.celrep.2014.03.076; Fiore M, 2000, BEHAV BRAIN RES, V112, P165, DOI 10.1016/S0166-4328(00)00180-7; Fontaine V, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-07-j0001.2002; Frank MG, 2007, BRAIN BEHAV IMMUN, V21, P47, DOI 10.1016/j.bbi.2006.03.005; Freitas JJS, 2001, J NEUROCHEM, V77, P655, DOI 10.1046/j.1471-4159.2001.00280.x; Gava Agata L, 2012, Int J Physiol Pathophysiol Pharmacol, V4, P167; German D, 2012, NEUROBIOL AGING, V33, P1; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Giunta B, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-51; Glezer I, 2003, NEUROPHARMACOLOGY, V45, P1120, DOI 10.1016/S0028-3908(03)00279-X; GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611; Griva K, 2010, AM J KIDNEY DIS, V56, P693, DOI 10.1053/j.ajkd.2010.07.003; Hein AM, 2010, BRAIN BEHAV IMMUN, V24, P243, DOI 10.1016/j.bbi.2009.10.002; Heyser CJ, 1997, P NATL ACAD SCI USA, V94, P1500, DOI 10.1073/pnas.94.4.1500; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hsu SC, 2014, INT J BIOCHEM CELL B, V53, P361, DOI 10.1016/j.biocel.2014.06.002; Huang XY, 2014, KIDNEY INT, V85, P507, DOI 10.1038/ki.2013.438; Izquierdo I, 1999, BEHAV BRAIN RES, V103, P1, DOI 10.1016/S0166-4328(99)00036-4; JARVIK ME, 1967, PSYCHOL REP, V21, P221, DOI 10.2466/pr0.1967.21.1.221; Kaltschmidt B, 2005, BBA-MOL CELL RES, V1745, P287, DOI 10.1016/j.bbamcr.2005.05.009; Kawamoto EM, 2013, NEUROSIGNALS, V21, P75, DOI 10.1159/000336074; Kawamoto EM, 2013, AGE, V35, P331, DOI 10.1007/s11357-011-9365-7; Koh N, 2001, BIOCHEM BIOPH RES CO, V280, P1015, DOI 10.1006/bbrc.2000.4226; KOLESNIKOV YA, 1992, EUR J PHARMACOL, V221, P399, DOI 10.1016/0014-2999(92)90732-J; Ksontini R, 1998, ARCH SURG-CHICAGO, V133, P558, DOI 10.1001/archsurg.133.5.558; Kuro-o M, 2009, BBA-GEN SUBJECTS, V1790, P1049, DOI 10.1016/j.bbagen.2009.02.005; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Li SA, 2004, CELL STRUCT FUNCT, V29, P91, DOI 10.1247/csf.29.91; Liu X, 2012, NEUROSCIENCE, V216, P133, DOI 10.1016/j.neuroscience.2012.04.050; Madero M, 2008, SEMIN DIALYSIS, V21, P29, DOI 10.1111/j.1525-139X.2007.00384.x; Maekawa Y, 2009, ENDOCRINE, V35, P341, DOI 10.1007/s12020-009-9181-3; Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837; McAfoose J, 2009, NEUROSCI BIOBEHAV R, V33, P355, DOI 10.1016/j.neubiorev.2008.10.005; MCKEE M, 1994, P NATL ACAD SCI USA, V91, P12056, DOI 10.1073/pnas.91.25.12056; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Montine TJ, 1999, NEUROLOGY, V53, P1495, DOI 10.1212/WNL.53.7.1495; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Mortega L, 2010, INT J INTERFERON CYT, V2, P49; Motulsky H.J., 2003, FITTING MODELS BIOL, V1st ed., P13; Munhoz CD, 2006, J NEUROSCI, V26, P3813, DOI 10.1523/JNEUROSCI.4398-05.2006; Murray AM, 2008, ADV CHRONIC KIDNEY D, V15, P123, DOI 10.1053/j.ackd.2008.01.010; Nagai Taku, 2003, FASEB Journal, V17, P50; Ohyama Y, 1998, BIOCHEM BIOPH RES CO, V251, P920, DOI 10.1006/bbrc.1998.9576; Park SJ, 2013, NEUROPSYCHOPHARMACOL, V38, P1426, DOI 10.1038/npp.2013.39; Richwine AF, 2009, BRAIN BEHAV IMMUN, V23, P794, DOI 10.1016/j.bbi.2009.02.020; Rong YQ, 1996, J NEUROCHEM, V67, P662; Saito Y, 2000, BIOCHEM BIOPH RES CO, V276, P767, DOI 10.1006/bbrc.2000.3470; Saito Y, 1998, BIOCHEM BIOPH RES CO, V248, P324, DOI 10.1006/bbrc.1998.8943; Sallee M, 2014, TOXINS, V6, P934, DOI 10.3390/toxins6030934; Schottelius AJG, 1999, J BIOL CHEM, V274, P31868, DOI 10.1074/jbc.274.45.31868; Seguin JA, 2009, NEUROPSYCH DIS TREAT, V5, P5; Shaftel SS, 2007, J CLIN INVEST, V117, P1595, DOI 10.1172/JCI31450; Sorrells SF, 2009, NEURON, V64, P33, DOI 10.1016/j.neuron.2009.09.032; Strle K, 2001, CRIT REV IMMUNOL, V21, P427; Thomson LM, 2005, BRAIN RES BULL, V67, P24, DOI 10.1016/j.brainresbull.2005.05.024; Wang F, 2010, AM J NEPHROL, V32, P117, DOI 10.1159/000315618; Ye JM, 2013, NEUROSCI LETT, V553, P72, DOI 10.1016/j.neulet.2013.08.020; Yirmiya R, 2011, BRAIN BEHAV IMMUN, V25, P181, DOI 10.1016/j.bbi.2010.10.015; Zeldich E, 2014, J BIOL CHEM, V289, P24700, DOI 10.1074/jbc.M114.567321; Zhang R, 2012, J ALZHEIMERS DIS, V31, P801, DOI 10.3233/JAD-2012-120151; Zhao YH, 2011, DIABETES, V60, P1907, DOI 10.2337/db10-1262	73	35	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0125271	10.1371/journal.pone.0125271	http://dx.doi.org/10.1371/journal.pone.0125271			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961830	Green Published, gold			2022-12-26	WOS:000354542500027
J	Gibson, JL; Lombardo, MJ; Aponyi, I; Cruz, DV; Ray, MP; Rosenberg, SM				Gibson, Janet L.; Lombardo, Mary-Jane; Aponyi, Ildiko; Cruz, Diana Vera; Ray, Mellanie P.; Rosenberg, Susan M.			Atypical Role for PhoU in Mutagenic Break Repair under Stress in Escherichia coli	PLOS ONE			English	Article							RESPONSE REGULATOR RSSB; STATIONARY-PHASE; ADAPTIVE MUTATION; MISMATCH REPAIR; DNA BREAKS; FRAMESHIFT MUTATION; PHOSPHATE REGULON; RPOS TRANSLATION; SOS RESPONSE; EVOLUTION	Mechanisms of mutagenesis activated by stress responses drive pathogen/host adaptation, antibiotic and anti-fungal-drug resistance, and perhaps much of evolution generally. In Escherichia coli, repair of double-strand breaks (DSBs) by homologous recombination is high fidelity in unstressed cells, but switches to a mutagenic mode using error-prone DNA polymerases when the both the SOS and general (sS) stress responses are activated. Additionally, the sE response promotes spontaneous DNA breakage that leads to mutagenic break repair (MBR). We identified the regulatory protein PhoU in a genetic screen for functions required for MBR. PhoU negatively regulates the phosphate-transport and utilization (Pho) regulon when phosphate is in excess, including the PstB and PstC subunits of the phosphate-specific ABC transporter PstSCAB. Here, we characterize the PhoU mutationpromoting role. First, some mutations that affect phosphate transport and Pho transcriptional regulation decrease mutagenesis. Second, the mutagenesis and regulon-expression phenotypes do not correspond, revealing an apparent new function(s) for PhoU. Third, the PhoU mutagenic role is not via activation of the sS, SOS or sE responses, because mutations (or DSBs) that restore mutagenesis to cells defective in these stress responses do not restore mutagenesis to phoU cells. Fourth, the mutagenesis defect in phoU-mutant cells is partially restored by deletion of arcA, a gene normally repressed by PhoU, implying that a gene(s) repressed by ArcA promotes mutagenic break repair. The data show a new role for PhoU in regulation, and a new regulatory branch of the stress-response signaling web that activates mutagenic break repair in E. coli.	[Gibson, Janet L.; Lombardo, Mary-Jane; Aponyi, Ildiko; Cruz, Diana Vera; Ray, Mellanie P.; Rosenberg, Susan M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Gibson, Janet L.; Lombardo, Mary-Jane; Aponyi, Ildiko; Cruz, Diana Vera; Ray, Mellanie P.; Rosenberg, Susan M.] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Gibson, Janet L.; Lombardo, Mary-Jane; Aponyi, Ildiko; Cruz, Diana Vera; Ray, Mellanie P.; Rosenberg, Susan M.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Gibson, Janet L.; Lombardo, Mary-Jane; Aponyi, Ildiko; Cruz, Diana Vera; Ray, Mellanie P.; Rosenberg, Susan M.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Rosenberg, SM (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	smr@bcm.edu		Vera Cruz, Diana/0000-0002-8754-7724; Rosenberg, Susan M./0000-0003-1444-473X	Alberta Heritage Foundation for Medical Research postdoctoral fellowship; National Institutes of Health (NIH) postdoctoral fellowship [F32-GM19909]; NIH [R01-GM53158]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM019909, R01GM053158] Funding Source: NIH RePORTER	Alberta Heritage Foundation for Medical Research postdoctoral fellowship; National Institutes of Health (NIH) postdoctoral fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an Alberta Heritage Foundation for Medical Research postdoctoral fellowship (M-JL), and National Institutes of Health (NIH) postdoctoral fellowship F32-GM19909 (M-JL) and NIH grant R01-GM53158 (SMR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Mamun AM, 2012, SCIENCE, V338, P1344, DOI 10.1126/science.1226683; Becker G, 1999, P NATL ACAD SCI USA, V96, P6439, DOI 10.1073/pnas.96.11.6439; Bindra RS, 2007, CANCER METAST REV, V26, P249, DOI 10.1007/s10555-007-9061-3; CAIRNS J, 1991, GENETICS, V128, P695; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Cirz RT, 2007, CRIT REV BIOCHEM MOL, V42, P341, DOI 10.1080/10409230701597741; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Forche A, 2011, MBIO, V2, DOI 10.1128/mBio.00129-11; Foster PL, 2007, CRIT REV BIOCHEM MOL, V42, P373, DOI 10.1080/10409230701648494; FOSTER PL, 1994, SCIENCE, V265, P407, DOI 10.1126/science.8023164; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Galhardo RS, 2009, GENETICS, V182, P55, DOI 10.1534/genetics.109.100735; Gardner SG, 2014, J BACTERIOL, V196, P1741, DOI 10.1128/JB.00029-14; Gibson JL, 2010, MOL MICROBIOL, V77, P415, DOI 10.1111/j.1365-2958.2010.07213.x; GUNSALUS RP, 1994, RES MICROBIOL, V145, P437, DOI 10.1016/0923-2508(94)90092-2; Gutierrez A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2607; Haldimann A, 1998, J BACTERIOL, V180, P1277, DOI 10.1128/JB.180.5.1277-1286.1998; Harris RS, 1999, MUTAT RES-REV MUTAT, V437, P51; Harris RS, 1996, GENETICS, V142, P681; HARRIS RS, 1994, SCIENCE, V264, P258, DOI 10.1126/science.8146657; Harris RS, 1997, GENE DEV, V11, P2426, DOI 10.1101/gad.11.18.2426; Harris RS, 1997, THESIS U ALBERTA EDM; Hastings PJ, 2007, CRIT REV BIOCHEM MOL, V42, P271, DOI 10.1080/10409230701507757; Hastings PJ, 2000, CELL, V103, P723, DOI 10.1016/S0092-8674(00)00176-8; Hengge R, 2008, ADV EXP MED BIOL, V631, P40, DOI 10.1007/978-0-387-78885-2_4; Hsieh YJ, 2010, CURR OPIN MICROBIOL, V13, P198, DOI 10.1016/j.mib.2010.01.014; KATO J, 1993, APPL ENVIRON MICROB, V59, P3744, DOI 10.1128/AEM.59.11.3744-3749.1993; Klauck E, 2001, MOL MICROBIOL, V40, P1381, DOI 10.1046/j.1365-2958.2001.02482.x; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; Li YF, 2007, ANTIMICROB AGENTS CH, V51, P2092, DOI 10.1128/AAC.00052-07; Lombardo MJ, 2004, GENETICS, V166, P669, DOI 10.1534/genetics.166.2.669; Longerich S, 1995, P NATL ACAD SCI USA, V92, P12017, DOI 10.1073/pnas.92.26.12017; McKenzie GJ, 1998, GENETICS, V149, P1163; McKenzie GJ, 2000, P NATL ACAD SCI USA, V97, P6646, DOI 10.1073/pnas.120161797; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Morohoshi T, 2002, APPL ENVIRON MICROB, V68, P4107, DOI 10.1128/AEM.68.8.4107-4110.2002; Ponder RG, 2005, MOL CELL, V19, P791, DOI 10.1016/j.molcel.2005.07.025; Ram Y, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1025; Ram Y, 2012, EVOLUTION, V66, P2315, DOI 10.1111/j.1558-5646.2012.01576.x; Robleto EA, 2007, CRIT REV BIOCHEM MOL, V42, P327, DOI 10.1080/10409230701597717; ROSENBERG SM, 1994, SCIENCE, V265, P405, DOI 10.1126/science.8023163; Rosenberg SM, 2001, NAT REV GENET, V2, P504, DOI 10.1038/35080556; Rosenberg SM, 1998, GENETICS, V148, P1559; Rosenberg SM, 2014, SCIENCE, V343, P1088, DOI 10.1126/science.1247472; Rosenberg SM, 2012, BIOESSAYS, V34, P885, DOI 10.1002/bies.201200050; Ruiz N, 2003, J BACTERIOL, V185, P5984, DOI 10.1128/JB.185.20.5984-5992.2003; Saint-Ruf C, 2007, CRIT REV BIOCHEM MOL, V42, P259, DOI 10.1080/10409230701495599; Schurdell MS, 2007, J BACTERIOL, V189, P1150, DOI 10.1128/JB.01482-06; Shee C, 2012, CELL REP, V2, P714, DOI 10.1016/j.celrep.2012.08.033; Shee C, 2011, P NATL ACAD SCI USA, V108, P13659, DOI 10.1073/pnas.1104681108; Shor E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003680; STEED PM, 1993, J BACTERIOL, V175, P6797, DOI 10.1128/jb.175.21.6797-6809.1993; Stumpf JD, 2005, MOL MICROBIOL, V57, P751, DOI 10.1111/j.1365-2958.2005.04724.x; TORRIANI A, 1961, J BACTERIOL, V81, P835, DOI 10.1128/JB.81.5.835-836.1961; Von Borstel R C, 1978, Methods Cell Biol, V20, P1, DOI 10.1016/S0091-679X(08)62005-1; WANNER BL, 1992, J BACTERIOL, V174, P2124, DOI 10.1128/JB.174.7.2124-2130.1992; Wanner BL, 1996, ESCHERICHIA COLI SAL, P1357, DOI DOI 10.1007/978-3-642-75969-7_16; Wimberly H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3115; YAMADA M, 1989, J BACTERIOL, V171, P5601, DOI 10.1128/jb.171.10.5601-5606.1989; Zhou YN, 2001, GENE DEV, V15, P627, DOI 10.1101/gad.864401	60	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0123315	10.1371/journal.pone.0123315	http://dx.doi.org/10.1371/journal.pone.0123315			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961709	gold, Green Submitted, Green Published			2022-12-26	WOS:000354542500005
J	Howng, SYB; Huang, Y; Ptacek, L; Fu, YH				Howng, Shen-Yi Bruce; Huang, Yong; Ptacek, Louis; Fu, Ying-Hui			Understanding the Role of Dicer in Astrocyte Development	PLOS ONE			English	Article							STEM-CELL; PROLIFERATION; NEUROGENESIS; NEURONS; DIFFERENTIATION; GLIOGENESIS; MICRORNAS; DELETION; MIRNAS	The Dicer1 allele is used to show that microRNAs (miRNAs) play important roles in astrocyte development and functions. While it is known that astrocytes that lack miRNAs are dysregulated, the in vivo phenotypes of these astrocytes are not well understood. In this study, we use Aldh1l1-EGFP transgene, a marker of astrocytes, to characterize mouse models with conditional Dicer1 ablation (via either human or mouse GFAP-Cre). This transgene revealed novel features of the defective astrocytes from the absence of miRNA. Although astrocyte miRNAs were depleted in both lines, we found histological and molecular differences in the Aldh1l1-EGFP cells between the two Cre lines. Aldh1l1-EGFP cells from hGFAP-Cre mutant lines displayed up-regulation of Aldh1l1-EGFP with increased proliferation and a genomic profile that acquired many features of wildtype primary astrocyte cultures. In the young mGFAP-Cre mutant lines we found that Aldh1l1-EGFP cells were disorganized and hyperproliferative in the developing cerebellum. Using the Aldh1l1-EGFP transgene, our work provides new insights into the roles of miRNAs in astrocyte development and the features of astrocytes in these two mouse models.	[Howng, Shen-Yi Bruce; Huang, Yong; Ptacek, Louis; Fu, Ying-Hui] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Huang, Yong; Ptacek, Louis] Howard Hughes Med Inst, Sch Med, San Francisco, CA USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute	Fu, YH (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	ying-hui.fu@ucsf.edu			National Multiple Sclerosis Society; NIH [NS062733]; Sandler Neurogenetics Fund	National Multiple Sclerosis Society(National Multiple Sclerosis Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Neurogenetics Fund	This work was supported by National Multiple Sclerosis Society postdoctoral fellowship to SBH, NIH grant NS062733 to YHF, and Sandler Neurogenetics Fund to YHF and LP. LP is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013453; Anthony TE, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-30; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhalala OG, 2012, J NEUROSCI, V32, P17935, DOI 10.1523/JNEUROSCI.3860-12.2012; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Glasgow SM, 2013, J NEUROSCI, V33, P13560, DOI 10.1523/JNEUROSCI.0321-13.2013; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Hutchison ER, 2013, GLIA, V61, P1018, DOI 10.1002/glia.22483; Iyer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044789; Jovicic A, 2013, J NEUROSCI, V33, P5127, DOI 10.1523/JNEUROSCI.0600-12.2013; Kawase-Koga Y, 2009, DEV DYNAM, V238, P2800, DOI 10.1002/dvdy.22109; Kuang Y, 2012, GLIA, V60, P1734, DOI 10.1002/glia.22392; Laywell ED, 2000, P NATL ACAD SCI USA, V97, P13883, DOI 10.1073/pnas.250471697; Li Q, 2011, QUANTUM INF PROCESS, V10, P13, DOI 10.1007/s11128-010-0169-y; McLoughlin HS, 2012, NEUROSCIENCE, V223, P285, DOI 10.1016/j.neuroscience.2012.08.009; Molofsky AV, 2013, GLIA, V61, P1518, DOI 10.1002/glia.22538; Nigro A, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.98; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Ouyang YB, 2011, MITOCHONDRION, V11, P279, DOI 10.1016/j.mito.2011.09.001; Pfrieger FW, 2011, PROG LIPID RES, V50, P357, DOI 10.1016/j.plipres.2011.06.002; Pogue AI, 2010, NEUROSCI LETT, V476, P18, DOI 10.1016/j.neulet.2010.03.054; Saurat N, 2013, NEURAL DEV, V8, DOI 10.1186/1749-8104-8-14; Sirko S, 2013, CELL STEM CELL, V12, P426, DOI 10.1016/j.stem.2013.01.019; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Tao JF, 2011, J NEUROSCI, V31, P8306, DOI 10.1523/JNEUROSCI.0567-11.2011; Tien AC, 2012, DEVELOPMENT, V139, P2477, DOI 10.1242/dev.077214; Tonelli DD, 2008, DEVELOPMENT, V135, P3911, DOI 10.1242/dev.025080; Tsai HH, 2012, SCIENCE, V337, P358, DOI 10.1126/science.1222381; Volvert ML, 2012, CELL DEATH DIFFER, V19, P1573, DOI 10.1038/cdd.2012.96; Yang Y, 2010, ADV TOP SCI TECH CHI, P1, DOI 10.1007/978-3-642-05012-1_1; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zheng K, 2012, NEUROSCIENTIST, V18, P114, DOI 10.1177/1073858411398322; Zheng K, 2010, J NEUROSCI, V30, P8245, DOI 10.1523/JNEUROSCI.1169-10.2010	33	14	14	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126667	10.1371/journal.pone.0126667	http://dx.doi.org/10.1371/journal.pone.0126667			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962146	Green Published, Green Submitted, gold			2022-12-26	WOS:000354542500134
J	Nora, A; Renvall, H; Kim, JY; Salmelin, R				Nora, Anni; Renvall, Hanna; Kim, Jeong-Young; Salmelin, Riitta		Elisabet Serv	Distinct Effects of Memory Retrieval and Articulatory Preparation when Learning and Accessing New Word Forms	PLOS ONE			English	Article							SHORT-TERM-MEMORY; FOREIGN-LANGUAGE VOCABULARY; SURFACE-BASED ANALYSIS; PREMOTOR CORTEX; TOP-DOWN; MOTOR TRANSFORMATIONS; PHONOLOGICAL ANALYSIS; PREFRONTAL CORTEX; SPEECH-PERCEPTION; BRAIN RESPONSES	Temporal and frontal activations have been implicated in learning of novel word forms, but their specific roles remain poorly understood. The present magnetoencephalography (MEG) study examines the roles of these areas in processing newly-established word form representations. The cortical effects related to acquiring new phonological word forms during incidental learning were localized. Participants listened to and repeated back new word form stimuli that adhered to native phonology (Finnish pseudowords) or were foreign (Korean words), with a subset of the stimuli recurring four times. Subsequently, a modified 1-back task and a recognition task addressed whether the activations modulated by learning were related to planning for overt articulation, while parametrically added noise probed reliance on developing memory representations during effortful perception. Learning resulted in decreased left superior temporal and increased bilateral frontal premotor activation for familiar compared to new items. The left temporal learning effect persisted in all tasks and was strongest when stimuli were embedded in intermediate noise. In the noisy conditions, native phonotactics evoked overall enhanced left temporal activation. In contrast, the frontal learning effects were present only in conditions requiring overt repetition and were more pronounced for the foreign language. The results indicate a functional dissociation between temporal and frontal activations in learning new phonological word forms: the left superior temporal responses reflect activation of newlyestablished word-form representations, also during degraded sensory input, whereas the frontal premotor effects are related to planning for articulation and are not preserved in noise.	[Nora, Anni; Renvall, Hanna; Salmelin, Riitta] Aalto Univ, Dept Neurosci & Biomed Engn, Espoo, Finland; [Nora, Anni; Renvall, Hanna; Salmelin, Riitta] Aalto Univ, Aalto NeuroImaging, Espoo, Finland; [Renvall, Hanna] Univ Helsinki, Cent Hosp, Dept Neurol, Helsinki, Finland; [Kim, Jeong-Young] Univ Helsinki, Dept World Cultures, Helsinki, Finland; McMaster Univ, Dept Linguist & Languages, Hamilton, ON, Canada; [Elisabet Serv] Univ Helsinki, Inst Behav Sci, Div Cognit & Neuropsychol, Helsinki, Finland	Aalto University; Aalto University; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; McMaster University; University of Helsinki	Nora, A (corresponding author), Aalto Univ, Dept Neurosci & Biomed Engn, Espoo, Finland.	anni.nora@aalto.fi	Renvall, Hanna/I-4210-2016; Salmelin, Riitta H/I-7044-2012; Service, Elisabet/M-7686-2015	Salmelin, Riitta H/0000-0003-2499-193X; Service, Elisabet/0000-0002-7698-1189; Jeong-Young, jeong-young.kim@helsinki.fi/0000-0002-0169-3596	Academy of Finland [255349, 256459, 283071, 127401]; Doctoral Program Brain and Mind; Sigrid Juselius Foundation; National Sciences and Engineering Research Council of Canada (NSERC) [245327]	Academy of Finland(Academy of Finland); Doctoral Program Brain and Mind; Sigrid Juselius Foundation(Sigrid Juselius Foundation); National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Academy of Finland (grants #255349, #256459 and #283071 to RS, #127401 to HR), the Doctoral Program Brain and Mind (AN), the Sigrid Juselius Foundation (RS), and the National Sciences and Engineering Research Council of Canada (NSERC; grant #245327 to ES).	Alho J, 2012, NEUROIMAGE, V60, P1937, DOI 10.1016/j.neuroimage.2012.02.011; Baumgaertner A, 2013, HUM BRAIN MAPP, V34, P1293, DOI 10.1002/hbm.21512; Binder JR, 2004, NAT NEUROSCI, V7, P295, DOI 10.1038/nn1198; Boersma P., 1993, P I PHONETIC SCI, V17, P97; Bohland JW, 2006, NEUROIMAGE, V32, P821, DOI 10.1016/j.neuroimage.2006.04.173; Bonte M, 2006, CEREB CORTEX, V16, P115, DOI 10.1093/cercor/bhi091; Buchsbaum BR, 2011, J COGNITIVE NEUROSCI, V23, P978, DOI 10.1162/jocn.2010.21496; Burton MW, 2009, CLIN LINGUIST PHONET, V23, P180, DOI 10.1080/02699200802394963; Burton MW, 2000, J COGNITIVE NEUROSCI, V12, P679, DOI 10.1162/089892900562309; Calabrese A, 2012, J NEUROLINGUIST, V25, P355, DOI 10.1016/j.jneuroling.2011.03.005; Callan D, 2010, NEUROIMAGE, V51, P844, DOI 10.1016/j.neuroimage.2010.02.027; Callan DE, 2004, NEUROIMAGE, V22, P1182, DOI 10.1016/j.neuroimage.2004.03.006; Chee MWL, 2001, NEUROIMAGE, V13, P1155, DOI 10.1006/nimg.2001.0781; Clark D, 2003, NEUROPSYCHOLOGIA, V41, P304, DOI 10.1016/S0028-3932(02)00163-X; Cogan GB, 2014, NATURE, V507, P94, DOI 10.1038/nature12935; CONNOLLY JF, 1994, J COGNITIVE NEUROSCI, V6, P256, DOI 10.1162/jocn.1994.6.3.256; Cunillera T, 2009, NEUROIMAGE, V48, P541, DOI 10.1016/j.neuroimage.2009.06.069; D'Ausilio A, 2012, J NEUROLINGUIST, V25, P328, DOI 10.1016/j.jneuroling.2010.02.003; Dale AM, 2000, NEURON, V26, P55, DOI 10.1016/S0896-6273(00)81138-1; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Davachi L, 2001, J COGNITIVE NEUROSCI, V13, P1059, DOI 10.1162/089892901753294356; Davis MH, 2007, HEARING RES, V229, P132, DOI 10.1016/j.heares.2007.01.014; Davis MH, 2003, J NEUROSCI, V23, P3423; Davis MH, 2008, J ACOUST SOC AM, V123, P3580; ELLIS N, 1993, Q J EXP PSYCHOL-A, V46, P533, DOI 10.1080/14640749308401062; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; French L., 2006, PHONOLOGICAL WORKING; Friederici AD, 2012, TRENDS COGN SCI, V16, P262, DOI 10.1016/j.tics.2012.04.001; Friedrich M, 2005, J COGNITIVE NEUROSCI, V17, P1785, DOI 10.1162/089892905774589172; Gagnepain P, 2012, CURR BIOL, V22, P615, DOI 10.1016/j.cub.2012.02.015; GATHERCOLE SE, 1989, J MEM LANG, V28, P200, DOI 10.1016/0749-596X(89)90044-2; Giraud AL, 2004, CEREB CORTEX, V14, P247, DOI 10.1093/cercor/bhg124; Gramfort A, 2014, NEUROIMAGE, V86, P446, DOI 10.1016/j.neuroimage.2013.10.027; Graves WW, 2008, J COGNITIVE NEUROSCI, V20, P1698, DOI 10.1162/jocn.2008.20113; Guediche S, 2014, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00126; Guenther FH, 2006, J COMMUN DISORD, V39, P350, DOI 10.1016/j.jcomdis.2006.06.013; Guenther FH, 2012, J NEUROLINGUIST, V25, P408, DOI 10.1016/j.jneuroling.2009.08.006; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; HARI R, 1990, ELECTROEN CLIN NEURO, P3; Herman AB, 2013, J NEUROSCI, V33, P5439, DOI 10.1523/JNEUROSCI.1472-12.2013; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Hickok G, 2014, LANG COGN NEUROSCI, V29, P2, DOI 10.1080/01690965.2013.834370; Hickok G, 2011, NEURON, V69, P407, DOI 10.1016/j.neuron.2011.01.019; Holcomb PJ, 2002, J COGNITIVE NEUROSCI, V14, P938, DOI 10.1162/089892902760191153; Hope TMH, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00246; Hulten A, 2010, J NEUROSCI, V30, P15160, DOI 10.1523/JNEUROSCI.1278-10.2010; Hulten A, 2009, HUM BRAIN MAPP, V30, P976, DOI 10.1002/hbm.20561; Iacoboni M, 2008, J PHYSIOL-PARIS, V102, P31, DOI 10.1016/j.jphysparis.2008.03.003; Indefrey P, 2004, COGNITION, V92, P101, DOI 10.1016/j.cognition.2002.06.001; Karuza EA, 2013, BRAIN LANG, V127, P46, DOI 10.1016/j.bandl.2012.11.007; Kim KHS, 1997, NATURE, V388, P171, DOI 10.1038/40623; Kovacs G, 2008, LANG LEARN, V58, P597, DOI 10.1111/j.1467-9922.2008.00451.x; Krieger-Redwood K, 2013, J COGNITIVE NEUROSCI, V25, P2179, DOI 10.1162/jocn_a_00463; Kuhl PK, 2014, P NATL ACAD SCI USA, V111, P11238, DOI 10.1073/pnas.1410963111; Kujala A, 2004, COGNITIVE BRAIN RES, V21, P106, DOI 10.1016/j.cogbrainres.2004.05.011; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Liljestrom M, 2009, HUM BRAIN MAPP, V30, P1845, DOI 10.1002/hbm.20785; Lin FH, 2006, NEUROIMAGE, V31, P160, DOI 10.1016/j.neuroimage.2005.11.054; Lonnrot E., 1874, FINSKT SVENSKT LEXIC; Lopez-Barroso D, 2015, NEUROIMAGE, V110, P182, DOI 10.1016/j.neuroimage.2014.12.085; Lopez-Barroso D, 2013, P NATL ACAD SCI USA, V110, P13168, DOI 10.1073/pnas.1301696110; Majerus S, 2005, BRAIN LANG, V92, P320, DOI 10.1016/j.bandl.2004.07.003; Majerus S, 2004, J MEM LANG, V51, P297, DOI 10.1016/j.jml.2004.05.002; Majerus S, 2013, J EXP CHILD PSYCHOL, V116, P811, DOI 10.1016/j.jecp.2013.07.014; Majerus S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00357; Makela J P, 1990, Adv Neurol, V54, P177; Mattys SL, 2012, LANG COGNITIVE PROC, V27, P953, DOI 10.1080/01690965.2012.705006; McDermott KB, 2000, J COGNITIVE NEUROSCI, V12, P965, DOI 10.1162/08989290051137503; McNealy K, 2006, J NEUROSCI, V26, P7629, DOI 10.1523/JNEUROSCI.5501-05.2006; Meister IG, 2007, CURR BIOL, V17, P1692, DOI 10.1016/j.cub.2007.08.064; Moser D, 2009, NEUROIMAGE, V46, P549, DOI 10.1016/j.neuroimage.2009.01.015; Mottonen R, 2009, J NEUROSCI, V29, P9819, DOI 10.1523/JNEUROSCI.6018-08.2009; Nora A, 2012, NEUROIMAGE, V63, P789, DOI 10.1016/j.neuroimage.2012.07.026; Norris D, 2008, PSYCHOL REV, V115, P357, DOI 10.1037/0033-295X.115.2.357; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Osnes B, 2011, NEUROIMAGE, V54, P2437, DOI 10.1016/j.neuroimage.2010.09.078; PAPAGNO C, 1991, J MEM LANG, V30, P331, DOI 10.1016/0749-596X(91)90040-Q; Pulvermuller F, 2012, CORTEX, V48, P871, DOI 10.1016/j.cortex.2011.02.006; Rauschecker AM, 2008, HUM BRAIN MAPP, V29, P1231, DOI 10.1002/hbm.20460; Rauschecker JP, 2009, NAT NEUROSCI, V12, P718, DOI 10.1038/nn.2331; Renvall H, 2012, CEREB CORTEX, V22, P132, DOI 10.1093/cercor/bhr095; Rodriguez-Fornells A, 2009, PHILOS T R SOC B, V364, P3711, DOI 10.1098/rstb.2009.0130; Roland PE, 1996, NEUROIMAGE, V4, pS39, DOI 10.1006/nimg.1996.0050; Rossi S, 2013, BRAIN LANG, V127, P404, DOI 10.1016/j.bandl.2013.02.009; Rossi S, 2011, J COGNITIVE NEUROSCI, V23, P1752, DOI 10.1162/jocn.2010.21547; Sato M, 2009, BRAIN LANG, V111, P1, DOI 10.1016/j.bandl.2009.03.002; Schomers MR, 2014, CEREB CORTEX, P1, DOI [10.1093/cercor/bhu274, DOI 10.1093/CERCOR/BHU274]; Schwartz JL, 2012, J NEUROLINGUIST, V25, P336, DOI 10.1016/j.jneuroling.2009.12.004; Scott SK, 2009, NAT REV NEUROSCI, V10, P295, DOI 10.1038/nrn2603; SERVICE E, 1995, APPL PSYCHOLINGUIST, V16, P155, DOI 10.1017/S0142716400007062; SERVICE E, 1992, Q J EXP PSYCHOL-A, V45, P21, DOI 10.1080/14640749208401314; Sohoglu E, 2012, J NEUROSCI, V32, P8443, DOI 10.1523/JNEUROSCI.5069-11.2012; Sollmann N, 2014, NEUROIMAGE, V102, P776, DOI 10.1016/j.neuroimage.2014.09.002; Strand F, 2008, BRAIN RES, V1212, P48, DOI 10.1016/j.brainres.2008.02.097; Talairach J., 1988, COPLANAR STEREOTAXIC; Tremblay P, 2011, NEUROIMAGE, V57, P1561, DOI 10.1016/j.neuroimage.2011.05.067; Uusvuori J, 2008, CEREB CORTEX, V18, P456, DOI 10.1093/cercor/bhm076; Vigneau M, 2011, NEUROIMAGE, V54, P577, DOI 10.1016/j.neuroimage.2010.07.036; Vihla M, 2006, NEUROIMAGE, V33, P732, DOI 10.1016/j.neuroimage.2006.06.040; Warker JA, 2009, COGNITION, V112, P81, DOI 10.1016/j.cognition.2009.03.009; Warren JE, 2005, TRENDS NEUROSCI, V28, P636, DOI 10.1016/j.tins.2005.09.010; Wilson SM, 2004, NAT NEUROSCI, V7, P701, DOI 10.1038/nn1263; Wilson SM, 2006, NEUROIMAGE, V33, P316, DOI 10.1016/j.neuroimage.2006.05.032; Yuen I, 2010, P NATL ACAD SCI USA, V107, P592, DOI 10.1073/pnas.0904774107; Zatorre RJ, 1996, CEREB CORTEX, V6, P21, DOI 10.1093/cercor/6.1.21; Zekveld AA, 2006, NEUROIMAGE, V32, P1826, DOI 10.1016/j.neuroimage.2006.04.199; Zhuang J, 2014, CEREB CORTEX, V24, P908, DOI 10.1093/cercor/bhs366	109	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126652	10.1371/journal.pone.0126652	http://dx.doi.org/10.1371/journal.pone.0126652			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI1YY	25961571	Green Published, Green Submitted, gold			2022-12-26	WOS:000354542500130
J	Imbir, KK; Jarymowicz, MT; Spustek, T; Kus, R; Zygierewicz, J				Imbir, Kamil Konrad; Jarymowicz, Maria Teresa; Spustek, Tomasz; Kus, Rafal; Zygierewicz, Jaroslaw			Origin of Emotion Effects on ERP Correlates of Emotional Word Processing: The Emotion Duality Approach	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; BRAIN POTENTIALS; AROUSAL; CONCRETENESS; ADJECTIVES; VALENCE; MODULATION; ATTENTION	We distinguish two evaluative systems which evoke automatic and reflective emotions. Automatic emotions are direct reactions to stimuli whereas reflective emotions are always based on verbalized (and often abstract) criteria of evaluation. We conducted an electroencephalography (EEG) study in which 25 women were required to read and respond to emotional words which engaged either the automatic or reflective system. Stimulus words were emotional (positive or negative) and neutral. We found an effect of valence on an early response with dipolar fronto-occipital topography; positive words evoked a higher amplitude response than negative words. We also found that topographically specific differences in the amplitude of the late positive complex were related to the system involved in processing. Emotional stimuli engaging the automatic system were associated with significantly higher amplitudes in the left-parietal region; the response to neutral words was similar regardless of the system engaged. A different pattern of effects was observed in the central region, neutral stimuli engaging the reflective system evoked a higher amplitudes response whereas there was no system effect for emotional stimuli. These differences could not be reduced to effects of differences between the arousing properties and concreteness of the words used as stimuli.	[Imbir, Kamil Konrad] Maria Grzegorzewska Univ, Fac Appl Social Sci, Warsaw, Poland; [Jarymowicz, Maria Teresa] Univ Warsaw, Fac Psychol, Warsaw, Poland; [Spustek, Tomasz; Kus, Rafal; Zygierewicz, Jaroslaw] Univ Warsaw, Fac Phys, Warsaw, Poland	The Maria Grzegorzewska University; University of Warsaw; University of Warsaw	Imbir, KK (corresponding author), Maria Grzegorzewska Univ, Fac Appl Social Sci, Warsaw, Poland.	kamil.imbir@gmail.com		Zygierewicz, Jaroslaw/0000-0002-7536-0735; Imbir, Kamil/0000-0002-3630-5602	National Science Center grant [DEC-2013/09/B/HS6/00303]; Polish funds for science	National Science Center grant; Polish funds for science	K. Imbir and J. Zygierewicz were supported by the National Science Center grant allocated on the basis of decision DEC-2013/09/B/HS6/00303, the other authors were supported by Polish funds for science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber HA, 2013, BRAIN LANG, V125, P47, DOI 10.1016/j.bandl.2013.01.005; Bartholow B. D., 2009, METHODS SOCIAL NEURO, P198; Bayer M, 2010, INT J PSYCHOPHYSIOL, V78, P299, DOI 10.1016/j.ijpsycho.2010.09.004; Bernat E, 2001, INT J PSYCHOPHYSIOL, V42, P11, DOI 10.1016/S0167-8760(01)00133-7; Berridge KC, 2003, SER AFFECTIVE SCI, P25; Bradley MM, 1999, AFFECTIVE NORMS FOR; Cacioppo JT, 1999, ANNU REV PSYCHOL, V50, P191, DOI 10.1146/annurev.psych.50.1.191; Carretie L, 2008, PSYCHOPHYSIOLOGY, V45, P188, DOI 10.1111/j.1469-8986.2007.00617.x; Citron FMM, 2012, BRAIN LANG, V122, P211, DOI 10.1016/j.bandl.2011.12.007; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; Damasio Antonio, 2010, SELF COMES TO MIND C; Dillon DG, 2006, BRAIN COGNITION, V62, P43, DOI 10.1016/j.bandc.2006.03.008; Fischler I, 2006, PROG BRAIN RES, V156, P185, DOI 10.1016/S0079-6123(06)56009-1; Gawronski B., 2013, OXFORD HDB SOCIAL CO, P282, DOI DOI 10.1093/OXFORDHB/9780199730018.013.0014; Gazzaniga MS, 2011, WHO IS IN CHARGE; Gibbons H, 2009, CONSCIOUS COGN, V18, P383, DOI 10.1016/j.concog.2009.02.007; Gootjes L, 2011, INT J PSYCHOPHYSIOL, V79, P356, DOI 10.1016/j.ijpsycho.2010.12.003; Grandjean D, 2008, EMOTION, V8, P341, DOI 10.1037/1528-3542.8.3.341; Hajcak G., 2012, OXFORD HDB EVENT REL, P441, DOI 10.1093/oxfordhb/9780195374148.013.0222; Herbert C, 2008, PSYCHOPHYSIOLOGY, V45, P487, DOI 10.1111/j.1469-8986.2007.00638.x; Herbert C, 2006, PSYCHOPHYSIOLOGY, V43, P197, DOI 10.1111/j.1469-8986.2006.00385.x; Herbert C, 2011, SOC COGN AFFECT NEUR, V6, P653, DOI 10.1093/scan/nsq082; Herbert C, 2011, SOC NEUROSCI-UK, V6, P277, DOI 10.1080/17470919.2010.523543; Hinojosa JA, 2010, PSYCHOPHYSIOLOGY, V47, P748, DOI 10.1111/j.1469-8986.2010.00982.x; Hofmann MJ, 2009, COGN AFFECT BEHAV NE, V9, P389, DOI 10.3758/9.4.389; Imbir K.K., 2013, POLISH PSYCHOL B, V44, P137, DOI [https://doi.org/10.2478/ppb-2013-0016, DOI 10.2478/PPB-2013-0016, 10.2478/ppb-2013-0016]; Imbir KK, 2015, BEHAV RES METHODS, V47, P860, DOI 10.3758/s13428-014-0509-4; Imbir KK, AFFECTIVE NORMS FOR; Imbir KK, 2014, STUDIA PSYCHOLOGICZN, V52, P33, DOI DOI 10.2478/V10167-010-0082-7; Imbir KK, 2013, ANN PSYCHOL, V16, P109; Jarymowicz MT, 2015, EMOT REV, V7, P183, DOI 10.1177/1754073914555923; Junghofer M, 2001, PSYCHOPHYSIOLOGY, V38, P175, DOI 10.1017/S0048577201000762; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; Kahneman D., 2011, THINKING FAST AND SL; Kaltwasser L, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00168; Kanske P, 2007, BRAIN RES, V1148, P138, DOI 10.1016/j.brainres.2007.02.044; Kazojc J., 2011, SLOWNIK FREKWENCYJNY; Kissler J, 2007, PSYCHOL SCI, V18, P475, DOI 10.1111/j.1467-9280.2007.01924.x; Kissler J, 2009, BIOL PSYCHOL, V80, P75, DOI 10.1016/j.biopsycho.2008.03.004; LeDoux J. E., 1996, EMOTIONAL BRAIN; LeDoux J, 2012, NEURON, V73, P653, DOI 10.1016/j.neuron.2012.02.004; Lee TW, 1999, NEURAL COMPUT, V11, P417, DOI 10.1162/089976699300016719; Lieberman M.D., 2003, SOCIAL JUDGMENTS IMP, P44; Luck S, 2005, AN INTRODUCTION TO T; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Naumann E, 1997, J PSYCHOPHYSIOL, V11, P158; Nunez P, 2005, ELECTRIC FIELDS OF T; Ortigue S, 2004, NEUROIMAGE, V21, P1242, DOI 10.1016/j.neuroimage.2003.11.007; Palazova M, 2013, BRAIN LANG, V125, P264, DOI 10.1016/j.bandl.2013.02.008; Panksepp J, 2007, COGNITION EMOTION, V21, P1819, DOI 10.1080/02699930701334302; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Potts GF, 2004, BRAIN COGNITION, V56, P5, DOI 10.1016/j.bandc.2004.03.006; Reykowski J., 1989, SOCIAL MORAL VALUES, P23; Rolls ET, 2000, BEHAV BRAIN SCI, V23, P177, DOI 10.1017/S0140525X00002429; Rozenkrants B, 2008, CLIN NEUROPHYSIOL, V119, P2260, DOI 10.1016/j.clinph.2008.07.213; Russell JA, 2003, PSYCHOL REV, V110, P145, DOI 10.1037/0033-295X.110.1.145; Schacht A, 2009, BRAIN COGNITION, V69, P538, DOI 10.1016/j.bandc.2008.11.005; Schacht A, 2009, COGN AFFECT BEHAV NE, V9, P28, DOI 10.3758/CABN.9.1.28; Scherer KR, 2005, SOC SCI INFORM, V44, P695, DOI 10.1177/0539018405058216; Schupp HT, 2004, COGNITION EMOTION, V18, P593, DOI 10.1080/02699930341000239; Schupp HT, 2000, PSYCHOPHYSIOLOGY, V37, P257, DOI 10.1017/S0048577200001530; Scott GG, 2009, BIOL PSYCHOL, V80, P95, DOI 10.1016/j.biopsycho.2008.03.010; Smith NK, 2006, J PERS SOC PSYCHOL, V90, P210, DOI 10.1037/0022-3514.90.2.210; ZAJONC RB, 1980, AM PSYCHOL, V35, P151, DOI 10.1037/0003-066X.35.2.151	64	16	17	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0126129	10.1371/journal.pone.0126129	http://dx.doi.org/10.1371/journal.pone.0126129			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL2IX	25955719	Green Published, gold, Green Submitted			2022-12-26	WOS:000356768100099
J	Jalasvuori, M; Mattila, S; Hoikkala, V				Jalasvuori, Matti; Mattila, Sari; Hoikkala, Ville			Chasing the Origin of Viruses: Capsid-Forming Genes as a Life-Saving Preadaptation within a Community of Early Replicators	PLOS ONE			English	Article							THERMOPHILIC BACTERIA; EVOLUTION; RNA; SELECTION; VESICLES; TRAGEDY; DOMAINS; REVEAL; MODELS; WORLD	Virus capsids mediate the transfer of viral genetic information from one cell to another, thus the origin of the first viruses arguably coincides with the origin of the viral capsid. Capsid genes are evolutionarily ancient and their emergence potentially predated even the origin of first free-living cells. But does the origin of the capsid coincide with the origin of viruses, or is it possible that capsid-like functionalities emerged before the appearance of true viral entities? We set to investigate this question by using a computational simulator comprising primitive replicators and replication parasites within a compartment matrix. We observe that systems with no horizontal gene transfer between compartments collapse due to the rapidly emerging replication parasites. However, introduction of capsid-like genes that induce the movement of randomly selected genes from one compartment to another rescues life by providing the non-parasitic replicators a mean to escape their current compartments before the emergence of replication parasites. Capsid-forming genes can mediate the establishment of a stable meta-population where parasites cause only local tragedies but cannot overtake the whole community. The long-term survival of replicators is dependent on the frequency of horizontal transfer events, as systems with either too much or too little genetic exchange are doomed to succumb to replication-parasites. This study provides a possible scenario for explaining the origin of viral capsids before the emergence of genuine viruses: in the absence of other means of horizontal gene transfer between compartments, evolution of capsid-like functionalities may have been necessary for early life to prevail.	[Jalasvuori, Matti; Mattila, Sari; Hoikkala, Ville] Univ Jyvaskyla, Ctr Excellence Biol Interact, Dept Biol & Environm Sci, Jyvaskyla, Finland	University of Jyvaskyla	Jalasvuori, M (corresponding author), Univ Jyvaskyla, Ctr Excellence Biol Interact, Dept Biol & Environm Sci, Jyvaskyla, Finland.	matti.jalasvuori@jyu.fi		Hoikkala, Ville/0000-0003-3995-3215; Jalasvuori, Matti/0000-0003-3499-5248	Academy of Finland [251013]	Academy of Finland(Academy of Finland)	This study was supported by Academy of Finland grant 251013 (www.aka.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrescia NGA, 2012, ANNU REV BIOCHEM, V81, P795, DOI 10.1146/annurev-biochem-060910-095130; Bansho Y, 2012, CHEM BIOL, V19, P478, DOI 10.1016/j.chembiol.2012.01.019; Biller SJ, 2014, SCIENCE, V343, P183, DOI 10.1126/science.1243457; Chen IA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002170; EIGEN M, 1991, BIOCHEMISTRY-US, V30, P11005, DOI 10.1021/bi00110a001; Flores R, 2014, ANNU REV MICROBIOL, V68, P395, DOI 10.1146/annurev-micro-091313-103416; Forterre P, 2012, VIRUSES ESSENTIAL AG, P43, DOI DOI 10.1007/978-94-007-4899-6; Forterre P, 2014, TRENDS MICROBIOL, V22, P554, DOI 10.1016/j.tim.2014.07.004; Forterre P, 2009, RES MICROBIOL, V160, P466, DOI 10.1016/j.resmic.2009.07.008; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; FRANK SA, 1994, P ROY SOC B-BIOL SCI, V258, P153, DOI 10.1098/rspb.1994.0156; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Higgins MK, 2002, TRENDS BIOCHEM SCI, V27, P257, DOI 10.1016/S0968-0004(02)02089-3; Hogeweg P, 2003, ORIGINS LIFE EVOL B, V33, P375, DOI 10.1023/A:1025754907141; Jalasvuori M, 2012, VIRUSES ESSENTIAL AG, P1; Jalasvuori M, 2008, ORIGINS LIFE EVOL B, V38, P165, DOI 10.1007/s11084-008-9121-x; Jalasvuori M, 2015, ANN NY ACAD SCI, V1341, P96, DOI 10.1111/nyas.12696; Jalasvuori Matti, 2012, Int J Evol Biol, V2012, P874153, DOI 10.1155/2012/874153; Jalasvuori M, 2010, ORIGINS LIFE EVOL B, V40, P319, DOI 10.1007/s11084-009-9187-0; Jalasvuori M, 2009, J VIROL, V83, P9388, DOI 10.1128/JVI.00869-09; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Kerr B, 2006, NATURE, V442, P75, DOI 10.1038/nature04864; Konnyu B, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-204; Konnyu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020931; Konnyu B, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-267; Koonin EV, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-29; Koonin EV, 2015, NAT REV GENET, V16, P184, DOI 10.1038/nrg3859; Koonin EV, 2014, MICROBIOL MOL BIOL R, V78, P278, DOI 10.1128/MMBR.00049-13; Koonin EV, 2014, RNA BIOL, V11, P197, DOI 10.4161/rna.27673; Koonin EV, 2013, CURR OPIN VIROL, V3, P546, DOI 10.1016/j.coviro.2013.06.008; Koonin EV, 2005, TRENDS GENET, V21, P647, DOI 10.1016/j.tig.2005.09.006; Krupovic M, 2008, NAT REV MICROBIOL, V6, P941, DOI 10.1038/nrmicro2033; Krupovic M, 2010, J VIROL, V84, P12476, DOI 10.1128/JVI.01489-10; Martin W, 2008, NAT REV MICROBIOL, V6, P805, DOI 10.1038/nrmicro1991; Matsuura T, 2002, P NATL ACAD SCI USA, V99, P7514, DOI 10.1073/pnas.062710399; Pawlowski A, 2014, ARCH VIROL, V159, P1541, DOI 10.1007/s00705-013-1970-6; Rissanen I, 2013, STRUCTURE, V21, P718, DOI 10.1016/j.str.2013.02.026; Russell MJ, 2010, GEOBIOLOGY, V8, P355, DOI 10.1111/j.1472-4669.2010.00249.x; Shaw AK, 2014, OIKOS, V123, P1003, DOI 10.1111/oik.01229; Soler N, 2015, ISME J, V9, P793, DOI 10.1038/ismej.2014.184; Szabo P, 2002, NATURE, V420, P340, DOI 10.1038/nature01187; SZATHMARY E, 1987, J THEOR BIOL, V128, P463, DOI 10.1016/S0022-5193(87)80191-1; Szathmary E, 2006, PHILOS T R SOC B, V361, P1761, DOI 10.1098/rstb.2006.1912; Szostak JW, 2001, NATURE, V409, P387, DOI 10.1038/35053176; Takeuchi N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000542; Villarreal LP, 2010, J THEOR BIOL, V262, P698, DOI 10.1016/j.jtbi.2009.10.014; Woese CR, 2002, P NATL ACAD SCI USA, V99, P8742, DOI 10.1073/pnas.132266999	47	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0126094	10.1371/journal.pone.0126094	http://dx.doi.org/10.1371/journal.pone.0126094			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955384	Green Submitted, Green Published, gold			2022-12-26	WOS:000356768100096
J	Kulkarni, P; Kenkel, W; Finklestein, SP; Barchet, TM; Ren, JM; Davenport, M; Shenton, ME; Kikinis, Z; Nedelman, M; Ferris, CF				Kulkarni, Praveen; Kenkel, William; Finklestein, Seth P.; Barchet, Thomas M.; Ren, JingMei; Davenport, Mathew; Shenton, Martha E.; Kikinis, Zora; Nedelman, Mark; Ferris, Craig F.			Use of Anisotropy, 3D Segmented Atlas, and Computational Analysis to Identify Gray Matter Subcortical Lesions Common to Concussive Injury from Different Sites on the Cortex	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; IMAGING FINDINGS; C-FOS; RAT; AGGRESSION; BEHAVIOR; AMYGDALA; ATROPHY; MODEL; HIPPOCAMPUS	Traumatic brain injury (TBI) can occur anywhere along the cortical mantel. While the cortical contusions may be random and disparate in their locations, the clinical outcomes are often similar and difficult to explain. Thus a question that arises is, do concussions at different sites on the cortex affect similar subcortical brain regions? To address this question we used a fluid percussion model to concuss the right caudal or rostral cortices in rats. Five days later, diffusion tensor MRI data were acquired for indices of anisotropy (IA) for use in a novel method of analysis to detect changes in gray matter microarchitecture. IA values from over 20,000 voxels were registered into a 3D segmented, annotated rat atlas covering 150 brain areas. Comparisons between left and right hemispheres revealed a small population of subcortical sites with altered IA values. Rostral and caudal concussions were of striking similarity in the impacted subcortical locations, particularly the central nucleus of the amygdala, laterodorsal thalamus, and hippocampal complex. Subsequent immunohistochemical analysis of these sites showed significant neuroinflammation. This study presents three significant findings that advance our understanding and evaluation of TBI: 1) the introduction of a new method to identify highly localized disturbances in discrete gray matter, subcortical brain nuclei without postmortem histology, 2) the use of this method to demonstrate that separate injuries to the rostral and caudal cortex produce the same subcortical, disturbances, and 3) the central nucleus of the amygdala, critical in the regulation of emotion, is vulnerable to concussion.	[Kulkarni, Praveen; Kenkel, William; Barchet, Thomas M.; Ferris, Craig F.] Northeastern Univ, Boston, MA 02115 USA; [Finklestein, Seth P.; Ren, JingMei; Davenport, Mathew] Biotrofix, Waltham, MA USA; [Shenton, Martha E.; Kikinis, Zora] Brigham & Womens Hosp, Boston, MA 02115 USA; [Nedelman, Mark] Ekam Imaging, Boston, MA USA	Northeastern University; Harvard University; Brigham & Women's Hospital	Ferris, CF (corresponding author), Northeastern Univ, Boston, MA 02115 USA.	c.ferris@neu.edu	Kenkel, William/T-5695-2019; Shenton, Martha/V-8780-2019	Kenkel, William/0000-0002-0271-1071; Kulkarni, Praveen/0000-0002-8876-4544	Ekam Imaging; Biotrofix	Ekam Imaging; Biotrofix	The work was supported by funding from Ekam Imaging and Biotrofix. The funders provided support in the form of salaries for authors MN, MD, SF & MR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abrous DN, 1999, BRAIN RES, V826, P181, DOI 10.1016/S0006-8993(99)01259-7; Anderson CV, 1995, J CLIN EXP NEUROPSYC, V17, P900, DOI 10.1080/01688639508402438; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Bouix S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066205; Bozzali M, 2002, AM J NEURORADIOL, V23, P985; Brezova V, 2014, NEUROIMAGE-CLIN, V5, P128, DOI 10.1016/j.nicl.2014.03.012; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Coccaro EF, 1997, NEUROPSYCHOPHARMACOL, V16, P211, DOI 10.1016/S0893-133X(96)00194-7; Coccaro EF, 1997, BIOL PSYCHIAT, V41, P273, DOI 10.1016/S0006-3223(96)00257-0; Conti AC, 1998, J NEUROSCI, V18, P5663; Das M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-148; Geary EK, 2010, J INT NEUROPSYCH SOC, V16, P506, DOI 10.1017/S135561771000010X; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Gussin HA, 2010, BIOCONJUGATE CHEM, V21, P1455, DOI 10.1021/bc100050s; HAYES RL, 1995, J NEUROTRAUM, V12, P779, DOI 10.1089/neu.1995.12.779; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hill SJ, 1996, J NEUROPATH EXP NEUR, V55, P1221, DOI 10.1097/00005072-199612000-00005; Himanen L, 2005, BRAIN INJURY, V19, P93, DOI 10.1080/02699050410001720031; Hogg S, 1998, BEHAV BRAIN RES, V93, P143, DOI 10.1016/S0166-4328(97)00146-0; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; Hylin MJ, 2013, J NEUROTRAUM, V30, P702, DOI 10.1089/neu.2012.2630; Ishikawa A, 2006, J NEUROPHYSIOL, V96, P2134, DOI 10.1152/jn.00069.2006; Johnsen EL, 2009, INT J PSYCHOPHYSIOL, V72, P24, DOI 10.1016/j.ijpsycho.2008.03.011; Kao C, 2012, J NEUROSURG, V117, P316, DOI 10.3171/2012.4.JNS111170; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Liu YR, 2010, J NUCL MED, V51, P1788, DOI 10.2967/jnumed.110.078626; Lull N, 2010, BRAIN INJURY, V24, P1098, DOI 10.3109/02699052.2010.494592; Maller JJ, 2010, BRAIN RES REV, V64, P213, DOI 10.1016/j.brainresrev.2010.04.003; McCloskey MS, 2008, PSYCHIAT RES, V158, P248, DOI 10.1016/j.psychres.2007.09.011; McCloskey MS, 2008, AGGRESSIVE BEHAV, V34, P51, DOI 10.1002/ab.20216; McCloskey M, 2009, PSYCHOPHARMACOLOGY, V203, P53, DOI 10.1007/s00213-008-1374-6; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; MOSELEY ME, 1991, MAGNET RESON MED, V19, P321, DOI 10.1002/mrm.1910190222; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Pasternak O, 2015, SCHIZOPHR RES, V161, P113, DOI 10.1016/j.schres.2014.07.031; Raghupathi R, 1996, MOL BRAIN RES, V37, P134, DOI 10.1016/0169-328X(95)00289-5; Rao VLR, 2000, EXP NEUROL, V161, P102, DOI 10.1006/exnr.1999.7269; Rathi Y, 2014, HUM BRAIN MAPP, V35, P3841, DOI 10.1002/hbm.22441; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Rodgers KM, 2012, J NEUROTRAUM, V29, P1886, DOI 10.1089/neu.2011.2273; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Silverstein SM, 2010, NEUROPSYCHOLOGIA, V48, P2886, DOI 10.1016/j.neuropsychologia.2010.05.030; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Strangman GE, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00182; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7; Wang L, 2008, BIOL PSYCHIAT, V64, P1060, DOI 10.1016/j.biopsych.2008.08.007; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Yount R, 2002, J NEUROPSYCH CLIN N, V14, P416, DOI 10.1176/appi.neuropsych.14.4.416; Yu I, 2010, J NEUROTRAUM, V27, P1463, DOI 10.1089/neu.2009.1196	64	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0125748	10.1371/journal.pone.0125748	http://dx.doi.org/10.1371/journal.pone.0125748			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955025	Green Published, Green Submitted, gold			2022-12-26	WOS:000356768100070
J	Robriquet, F; Lardenois, A; Babarit, C; Larcher, T; Dubreil, L; Leroux, I; Zuber, C; Ledevin, M; Deschamps, JY; Fromes, Y; Cherel, Y; Guevel, L; Rouger, K				Robriquet, Florence; Lardenois, Aurelie; Babarit, Candice; Larcher, Thibaut; Dubreil, Laurence; Leroux, Isabelle; Zuber, Celine; Ledevin, Mireille; Deschamps, Jack-Yves; Fromes, Yves; Cherel, Yan; Guevel, Laetitia; Rouger, Karl			Differential Gene Expression Profiling of Dystrophic Dog Muscle after MuStem Cell Transplantation	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; HUMAN SKELETAL-MUSCLE; HINDLIMB MUSCLES; SATELLITE CELLS; ANIMAL-MODELS; IN-VIVO; ADIPONECTIN; IDENTIFICATION; REGENERATION; OSTEOPONTIN	Background Several adult stem cell populations exhibit myogenic regenerative potential, thus representing attractive candidates for therapeutic approaches of neuromuscular diseases such as Duchenne Muscular Dystrophy (DMD). We have recently shown that systemic delivery of MuStem cells, skeletal muscle-resident stem cells isolated in healthy dog, generates the remodelling of muscle tissue and gives rise to striking clinical benefits in Golden Retriever Muscular Dystrophy (GRMD) dog. This global effect, which is observed in the clinically relevant DMD animal model, leads us to question here the molecular pathways that are impacted by MuStem cell transplantation. To address this issue, we compare the global gene expression profile between healthy, GRMD and MuStem cell treated GRMD dog muscle, four months after allogenic MuStem cell transplantation. Results In the dystrophic context of the GRMD dog, disease-related deregulation is observed in the case of 282 genes related to various processes such as inflammatory response, regeneration, calcium ion binding, extracellular matrix organization, metabolism and apoptosis regulation. Importantly, we reveal the impact of MuStem cell transplantation on several molecular and cellular pathways based on a selection of 31 genes displaying signals specifically modulated by the treatment. Concomitant with a diffuse dystrophin expression, a histological remodelling and a stabilization of GRMD dog clinical status, we show that cell delivery is associated with an up-regulation of genes reflecting a sustained enhancement of muscle regeneration. We also identify a decreased mRNA expression of a set of genes having metabolic functions associated with lipid homeostasis and energy. Interestingly, ubiquitin-mediated protein degradation is highly enhanced in GRMD dog muscle after systemic delivery of MuStem cells. Conclusions Overall, our results provide the first high-throughput characterization of GRMD dog muscle and throw new light on the complex molecular/cellular effects associated with muscle repair and the clinical efficacy of MuStem cell-based therapy.	[Robriquet, Florence; Lardenois, Aurelie; Babarit, Candice; Larcher, Thibaut; Dubreil, Laurence; Leroux, Isabelle; Zuber, Celine; Ledevin, Mireille; Deschamps, Jack-Yves; Cherel, Yan; Guevel, Laetitia; Rouger, Karl] INRA, PAnTher, UMR703, F-44026 Nantes, France; [Robriquet, Florence; Lardenois, Aurelie; Babarit, Candice; Larcher, Thibaut; Dubreil, Laurence; Leroux, Isabelle; Zuber, Celine; Ledevin, Mireille; Deschamps, Jack-Yves; Fromes, Yves; Cherel, Yan; Guevel, Laetitia; Rouger, Karl] LUNAM Univ, Oniris, Ecole Natl Vet Agroalimentaire & Nantes Atlantiq, Nantes, France; [Robriquet, Florence; Guevel, Laetitia] Univ Nantes, Nantes, France; [Fromes, Yves] Hop La Pitie Salpetriere, Inst Myol, Lab RMN AIM CEA, Paris, France	Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; INRAE; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Nantes Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; CEA; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay	Guevel, L (corresponding author), INRA, PAnTher, UMR703, F-44026 Nantes, France.	laetitia.guevel@univ-nantes.fr	Lardenois, Aurélie/AAA-8961-2020; Larcher, Thibaut/X-8500-2019; Robriquet, Florence/L-4018-2015; FROMES, Yves/AAB-9267-2020; Larcher, Thibaut/M-9160-2013	Guevel, Laetitia/0000-0002-0320-2615; Larcher, Thibaut/0000-0002-0396-3190	Association Francaise contre les Myopathies (AFM) [14379]; FEDER (Fonds Europeen de Developpement Regional) [37085]; French government [ANR-10-IBHU-005]; Nantes Metropole; Pays de la Loire Region	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); FEDER (Fonds Europeen de Developpement Regional)(European Commission); French government; Nantes Metropole(Region Pays de la Loire); Pays de la Loire Region(Region Pays de la Loire)	This research was supported by grants from the Association Francaise contre les Myopathies (AFM No 14379) and the FEDER (Fonds Europeen de Developpement Regional No 37085). It was carried out in the context of the IHU-Cesti project that received French government financial support managed by the National Research Agency via the investment of the future programme ANR-10-IBHU-005. The IHU-Cesti project is also supported by Nantes Metropole and the Pays de la Loire Region. All these grants were received by KR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acland A, 2014, NUCLEIC ACIDS RES, V42, pD7, DOI 10.1093/nar/gkt1146; Allamand V, 2000, HUM MOL GENET, V9, P2459, DOI 10.1093/hmg/9.16.2459; Ambrosio CE, 2009, GENET MOL RES, V8, P389, DOI 10.4238/vol8-2gmr581; Baban D, 2008, NEUROMUSCULAR DISORD, V18, P239, DOI 10.1016/j.nmd.2007.11.011; Bakay M, 2002, NEUROMUSCULAR DISORD, V12, pS125, DOI 10.1016/S0960-8966(02)00093-7; Barthelemy I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048478; Blake JA, 2013, NUCLEIC ACIDS RES, V41, pD530, DOI 10.1093/nar/gks1050; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; BONILLA E, 1988, CELL, V54, P447, DOI 10.1016/0092-8674(88)90065-7; Chalmel F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-86; Chen R, 2007, NAT METHODS, V4, P879, DOI 10.1038/nmeth1107-879; Chen YW, 2000, J CELL BIOL, V151, P1321, DOI 10.1083/jcb.151.6.1321; Chirieleison SM, 2012, TISSUE ENG PT A, V18, P232, DOI [10.1089/ten.tea.2010.0553, 10.1089/ten.TEA.2010.0553]; COOPER BJ, 1988, NATURE, V334, P154, DOI 10.1038/334154a0; Cotten SW, 2014, AM J TRANSL RES, V6, P43; Guzman ODC, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/485376; Delaigle AM, 2006, DIABETOLOGIA, V49, P1311, DOI 10.1007/s00125-006-0210-y; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; Fareed M, 2006, AM J PHYSIOL-REG I, V02215, P1589; Feron M, 2009, AM J PATHOL, V174, P1459, DOI 10.2353/ajpath.2009.080460; Govoni A, 2013, CELL MOL LIFE SCI, V70, P4585, DOI 10.1007/s00018-013-1396-z; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; Guerre-Millo M, 2008, DIABETES METAB, V34, P12, DOI 10.1016/j.diabet.2007.08.002; Guevel L, 2011, J PROTEOME RES, V10, P2465, DOI 10.1021/pr2001385; Haslett JN, 2003, NEUROGENETICS, V4, P163, DOI 10.1007/s10048-003-0148-x; Haslett JN, 2002, P NATL ACAD SCI USA, V99, P15000, DOI 10.1073/pnas.192571199; Hirata A, 2003, AM J PATHOL, V163, P203, DOI 10.1016/S0002-9440(10)63644-9; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Honeyman K, 1999, AM J VET RES, V60, P734; Humm A, 1997, EMBO J, V16, P3373, DOI 10.1093/emboj/16.12.3373; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Jensen JH, 2012, EXP PHYSIOL, V97, P833, DOI 10.1113/expphysiol.2011.063727; Jortay J, 2012, AM J PATHOL, V181, P245, DOI 10.1016/j.ajpath.2012.03.035; Kazi AA, 2011, MOL MED, V17, P925, DOI 10.2119/molmed.2011.00070; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kornegay JN, 2012, MAMM GENOME, V23, P85, DOI 10.1007/s00335-011-9382-y; Krause MP, 2013, ACTA PHYSIOL, V208, P180, DOI 10.1111/apha.12099; Kunkel SD, 2011, CELL METAB, V13, P627, DOI 10.1016/j.cmet.2011.03.020; Kuznetsov AV, 1998, MOL CELL BIOCHEM, V183, P87, DOI 10.1023/A:1006868130002; Lavasani Mitra, 2013, Methods Mol Biol, V976, P53, DOI 10.1007/978-1-62703-317-6_5; Lewis FC, 2014, STEM CELL TRANSL MED, V3, P702, DOI 10.5966/sctm.2013-0174; Liu C, 2010, AM J PHYSIOL-CELL PH, V298, pC1100, DOI 10.1152/ajpcell.00553.2009; Liu JMK, 2004, MUSCLE NERVE, V30, P767, DOI 10.1002/mus.20154; Liu Y, 2014, BEST PRACT RES CL EN, V28, P33, DOI 10.1016/j.beem.2013.08.003; Liu Y, 2009, AM J PHYSIOL-ENDOC M, V297, pE657, DOI 10.1152/ajpendo.00186.2009; Marotta M, 2009, PHYSIOL GENOMICS, V37, P119, DOI 10.1152/physiolgenomics.90370.2008; Masiero E, 2010, AUTOPHAGY, V6, P307, DOI 10.4161/auto.6.2.11137; McClure WC, 2007, NEUROMUSCULAR DISORD, V17, P639, DOI 10.1016/j.nmd.2007.04.008; Meng JH, 2014, MOL THER, V22, P1008, DOI 10.1038/mt.2014.26; Mori R, 2008, J EXP MED, V205, P43, DOI 10.1084/jem.20071412; Nakamura A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02183; Nghiem PP, 2013, AM J PATHOL, V183, P1411, DOI 10.1016/j.ajpath.2013.07.013; O'Regan A, 2000, INT J EXP PATHOL, V81, P373, DOI 10.1046/j.1365-2613.2000.00163.x; Park JJ, 2006, PHYSIOL GENOMICS, V27, P114, DOI 10.1152/physiolgenomics.00045.2006; Pescatori M, 2007, FASEB J, V21, P1210, DOI 10.1096/fj.06-7285com; Porter JD, 2004, HUM MOL GENET, V13, P257, DOI 10.1093/hmg/ddh033; Porter JD, 2003, HUM MOL GENET, V12, P1813, DOI 10.1093/hmg/ddg197; Qu ZQ, 1998, J CELL BIOL, V142, P1257, DOI 10.1083/jcb.142.5.1257; Rayavarapu S, 2013, MOL CELL PROTEOMICS, V12, P1061, DOI 10.1074/mcp.M112.023127; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Rouger K, 2002, AM J PHYSIOL-CELL PH, V283, pC773, DOI 10.1152/ajpcell.00112.2002; Rouger K, 2011, AM J PATHOL, V179, P2501, DOI 10.1016/j.ajpath.2011.07.022; Rustici G, 2013, NUCLEIC ACIDS RES, V41, pD987, DOI 10.1093/nar/gks1174; Sampaolesi M, 2006, NATURE, V444, P574, DOI 10.1038/nature05282; Sandri M, 2013, J CELL SCI, V126, P5325, DOI 10.1242/jcs.114041; Shabbir A, 2009, TRANSPLANTATION, V87, P1275, DOI 10.1097/TP.0b013e3181a1719b; SHARP NJH, 1992, GENOMICS, V13, P115, DOI 10.1016/0888-7543(92)90210-J; Skuk D, 2007, NEUROMUSCULAR DISORD, V17, P38, DOI 10.1016/j.nmd.2006.10.003; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stapleton DI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091514; t' Hoen PAC, 2006, PHARMACOGENOMICS, V7, P281, DOI 10.2217/14622416.7.3.281; Tagami S, 2002, J BIOL CHEM, V277, P3085, DOI 10.1074/jbc.M103705200; Thibaud JL, 2007, NEUROMUSCULAR DISORD, V17, P575, DOI 10.1016/j.nmd.2007.03.013; Tkatchenko AV, 2000, BBA-MOL BASIS DIS, V1500, P17, DOI 10.1016/S0925-4439(99)00084-8; Uaesoontrachoon K, 2008, INT J BIOCHEM CELL B, V40, P2303, DOI 10.1016/j.biocel.2008.03.020; VALENTINE BA, 1990, J NEUROL SCI, V97, P1, DOI 10.1016/0022-510X(90)90095-5; VALENTINE BA, 1988, J NEUROL SCI, V88, P69, DOI 10.1016/0022-510X(88)90206-7; Vella JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029226; WAKAI S, 1988, J NEUROL SCI, V84, P167, DOI 10.1016/0022-510X(88)90122-0; WATKINS SC, 1987, J NEUROL SCI, V82, P181, DOI 10.1016/0022-510X(87)90017-7; Willis MS, 2014, J MOL CELL CARDIOL, V71, P43, DOI 10.1016/j.yjmcc.2013.11.008	83	11	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0123336	10.1371/journal.pone.0123336	http://dx.doi.org/10.1371/journal.pone.0123336			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955839	Green Submitted, Green Published, gold			2022-12-26	WOS:000356768100012
J	Streb, J; Kammer, T; Spitzer, M; Hille, K				Streb, Judith; Kammer, Thomas; Spitzer, Manfred; Hille, Katrin			Extremely Reduced Motion in Front of Screens: Investigating Real-World Physical Activity of Adolescents by Accelerometry and Electronic Diary	PLOS ONE			English	Article							CHILDREN; YOUTH; METAANALYSIS; BEHAVIOR; TRENDS; RISK	This paper reports accelerometer and electronic dairy data on typical daily activities of 139 school students from grade six and nine. Recordings covered a typical school day for each student and lasted on average for 23 h. Screen activities (watching television and using the computer) are compared to several other activities performed while sitting (e.g., playing, eating, sitting in school, and doing homework). Body movement was continuously recorded by four accelerometers and transformed into a motion sore. Our results show that extremely low motion scores, as if subjects were freezing, emerge to a greater extent in front of screens compared to other investigated activities. Given the substantial amount of time young people spend in front of screens and the rising obesity epidemic, our data suggest a mechanism for the association of screen time and obesity.	[Streb, Judith; Spitzer, Manfred; Hille, Katrin] Univ Ulm, ZNL Transferctr Neurosci & Learning, D-89069 Ulm, Germany; [Kammer, Thomas; Spitzer, Manfred] Univ Ulm, Dept Psychiat, D-89069 Ulm, Germany	Ulm University; Ulm University	Hille, K (corresponding author), Univ Ulm, ZNL Transferctr Neurosci & Learning, D-89069 Ulm, Germany.	katrin.hille@znl-ulm.de	Kammer, Thomas/K-2168-2012	Kammer, Thomas/0000-0002-2769-5645				Bucksch J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-351; DIETZ WH, 1994, AM J CLIN NUTR, V59, P556, DOI 10.1093/ajcn/59.3.556; DURANT RH, 1994, PEDIATRICS, V94, P449; Eisenmann JC, 2002, OBES RES, V10, P379, DOI 10.1038/oby.2002.52; Ekelund U, 2006, PLOS MED, V3, P2449, DOI 10.1371/journal.pmed.0030488; Levine JA, 2005, SCIENCE, V307, P584, DOI 10.1126/science.1106561; Marshall SJ, 2004, INT J OBESITY, V28, P1238, DOI 10.1038/sj.ijo.0802706; Myrtek M, 2001, FREIBURGER MONITORIN; Pearson N, 2014, OBES REV, V15, P666, DOI 10.1111/obr.12188; Samdal O, 2007, EUR J PUBLIC HEALTH, V17, P242, DOI 10.1093/eurpub/ckl245; Serrano-Sanchez JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024453	11	3	3	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0126722	10.1371/journal.pone.0126722	http://dx.doi.org/10.1371/journal.pone.0126722			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955531	Green Published, Green Submitted, gold			2022-12-26	WOS:000356768100141
J	Xu, SW; Stratton, R; Nikitorowicz-Buniak, J; Ahmed-Abdi, B; Ponticos, M; Denton, C; Abraham, D; Takahashi, A; Suki, B; Layne, MD; Lafyatis, R; Smith, BD				Xu Shiwen; Stratton, Richard; Nikitorowicz-Buniak, Joanna; Ahmed-Abdi, Bahja; Ponticos, Markella; Denton, Christopher; Abraham, David; Takahashi, Ayuko; Suki, Bela; Layne, Matthew D.; Lafyatis, Robert; Smith, Barbara D.			A Role of Myocardin Related Transcription Factor-A (MRTF-A) in Scleroderma Related Fibrosis	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITION; NECROSIS-FACTOR-ALPHA; SMOOTH-MUSCLE-CELLS; SYSTEMIC-SCLEROSIS; MYOFIBROBLAST DIFFERENTIATION; EXTRACELLULAR-MATRIX; GENE-TRANSCRIPTION; ACTIN DYNAMICS; EXPRESSION	In scleroderma (systemic sclerosis, SSc), persistent activation of myofibroblast leads to severe skin and organ fibrosis resistant to therapy. Increased mechanical stiffness in the involved fibrotic tissues is a hallmark clinical feature and a cause of disabling symptoms. Myocardin Related Transcription Factor-A (MRTF-A) is a transcriptional co-activator that is sequestered in the cytoplasm and translocates to the nucleus under mechanical stress or growth factor stimulation. Our objective was to determine if MRTF-A is activated in the disease microenvironment to produce more extracellular matrix in progressive SSc. Immunohistochemistry studies demonstrate that nuclear translocation of MRTF-A in scleroderma tissues occurs in keratinocytes, endothelial cells, infiltrating inflammatory cells, and dermal fibroblasts, consistent with enhanced signaling in multiple cell lineages exposed to the stiff extracellular matrix. Inhibition of MRTF-A nuclear translocation or knockdown of MRTF-A synthesis abolishes the SSc myofibroblast enhanced basal contractility and synthesis of type I collagen and inhibits the matricellular profibrotic protein, connective tissue growth factor (CCN2/CTGF). In MRTF-A null mice, basal skin and lung stiffness was abnormally reduced and associated with altered fibrillar collagen. MRTF-A has a role in SSc fibrosis acting as a central regulator linking mechanical cues to adverse remodeling of the extracellular matrix.	[Xu Shiwen; Stratton, Richard; Nikitorowicz-Buniak, Joanna; Ahmed-Abdi, Bahja; Ponticos, Markella; Denton, Christopher; Abraham, David] UCL, Ctr Rheumatol & Connect Tissue Dis, London, England; [Takahashi, Ayuko; Suki, Bela] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Layne, Matthew D.; Smith, Barbara D.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Lafyatis, Robert] Boston Univ, Sch Med, Dept Rheumatol, Boston, MA 02215 USA	University of London; University College London; Boston University; Boston University; Boston University	Smith, BD (corresponding author), Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA.	bdsmith@bu.edu		Nikitorowicz-Buniak, Joanna/0000-0002-7510-3843; Ponticos, Markella/0000-0001-5957-5851	Scleroderma foundation, USA; Arthritis Research, UK; Raynauds and Scleroderma Association, UK; Scleroderma Society, UK; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051089, P30AR061271] Funding Source: NIH RePORTER; Medical Research Council [G0801052] Funding Source: researchfish; Rosetrees Trust [M429] Funding Source: researchfish; MRC [G0801052] Funding Source: UKRI	Scleroderma foundation, USA; Arthritis Research, UK(Versus Arthritis); Raynauds and Scleroderma Association, UK; Scleroderma Society, UK; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Rosetrees Trust(Rosetrees Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Support was provided by Scleroderma foundation, USA to BDS, and by the Arthritis Research, UK, the Raynauds and Scleroderma Association, UK, the Scleroderma Society, UK to RS CD DA.	Abraham DJ, 2000, J BIOL CHEM, V275, P15220, DOI 10.1074/jbc.275.20.15220; Aden N, 2008, RHEUMATOLOGY, V47, P1754, DOI 10.1093/rheumatology/ken370; Aden N, 2010, J INVEST DERMATOL; Annes JP, 2004, J CELL BIOL, V165, P723, DOI 10.1083/jcb.200312172; Asparuhova MB, 2009, SCAND J MED SCI SPOR, V19, P490, DOI 10.1111/j.1600-0838.2009.00928.x; Balbir-Gurman A, 2002, ANN RHEUM DIS, V61, P237, DOI 10.1136/ard.61.3.237; Becvar R, 2005, ANN NY ACAD SCI, V1051, P404, DOI 10.1196/annals.1361.082; Bradshaw AD, 2003, J INVEST DERMATOL, V120, P949, DOI 10.1046/j.1523-1747.2003.12241.x; Chan MWC, 2010, J BIOL CHEM, V285, P9273, DOI 10.1074/jbc.M109.075218; Chen YL, 2006, ARTHRITIS RHEUM-US, V54, P1309, DOI 10.1002/art.21725; Chen YL, 2005, AM J PATHOL, V167, P1699, DOI 10.1016/S0002-9440(10)61252-7; Connelly JT, 2010, NAT CELL BIOL, V12, P711, DOI 10.1038/ncb2074; Crider BJ, 2011, J INVEST DERMATOL, V131, P2378, DOI 10.1038/jid.2011.219; Dacic S, 2001, J BONE MINER RES, V16, P1228, DOI 10.1359/jbmr.2001.16.7.1228; Driskell RR, 2013, NATURE, V504, P277, DOI 10.1038/nature12783; Du KL, 2004, J BIOL CHEM, V279, P17578, DOI 10.1074/jbc.M400961200; Evelyn CR, 2007, MOL CANCER THER, V6, P2249, DOI 10.1158/1535-7163.MCT-06-0782; Evelyn CR, 2010, BIOORG MED CHEM LETT, V20, P665, DOI 10.1016/j.bmcl.2009.11.056; Fang F, 2011, CIRC RES, V108, P797, DOI 10.1161/CIRCRESAHA.111.240655; Fintha A, 2013, AM J PATHOL, V182, P388, DOI 10.1016/j.ajpath.2012.10.009; FLEISCHMAJER R, 1981, P NATL ACAD SCI-BIOL, V78, P7360, DOI 10.1073/pnas.78.12.7360; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gieni RS, 2008, J CELL BIOCHEM, V104, P1964, DOI 10.1002/jcb.21364; Gilbane AJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4230; Gomez EW, 2010, J CELL BIOCHEM, V110, P44, DOI 10.1002/jcb.22545; Gupta Madhuja, 2013, Mol Vis, V19, P1017; Haak AJ, 2014, J PHARMACOL EXP THER, V349, P480, DOI 10.1124/jpet.114.213520; Hayashi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089016; Higashi-Kuwata N, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3066; Hinkel R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4970; Holmes A, 2001, J BIOL CHEM, V276, P10594, DOI 10.1074/jbc.M010149200; Huang DP, 2009, CHINESE MED J-PEKING, V122, P2700, DOI 10.3760/cma.j.issn.0366-6999.2009.22.005; Huang XW, 2012, AM J RESP CELL MOL, V47, P340, DOI 10.1165/rcmb.2012-0050OC; Janmey PA, 2013, DIFFERENTIATION, V86, P112, DOI 10.1016/j.diff.2013.07.004; Jimenez Sergio A, 2013, ISRN Rheumatol, V2013, P835948, DOI 10.1155/2013/835948; Johnson LA, 2014, INFLAMM BOWEL DIS, V20, P154, DOI 10.1097/01.MIB.0000437615.98881.31; Kendall RT, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00123; Kissin EY, 2006, ARTHRITIS RHEUM-US, V54, P3655, DOI 10.1002/art.22186; Kuwahara K, 2005, MOL CELL BIOL, V25, P3173, DOI 10.1128/MCB.25.8.3173-3181.2005; Lafyatis R, 2014, NAT REV RHEUMATOL, V10, P706, DOI 10.1038/nrrheum.2014.137; Lagna G, 2007, J BIOL CHEM, V282, P37244, DOI 10.1074/jbc.M708137200; LEROY EC, 1988, J RHEUMATOL, V15, P202; Li SJ, 2006, MOL CELL BIOL, V26, P5797, DOI 10.1128/MCB.00211-06; Liu F, 2010, J CELL BIOL, V190, P693, DOI 10.1083/jcb.201004082; Liu SX, 2008, ARTHRITIS RHEUM-US, V58, P2189, DOI 10.1002/art.23595; Liu SX, 2009, AM J PATHOL, V174, P1847, DOI 10.2353/ajpath.2009.080779; Luchsinger LL, 2011, J BIOL CHEM, V286, P44116, DOI 10.1074/jbc.M111.276931; McGee KM, 2011, EMBO REP, V12, P963, DOI 10.1038/embor.2011.141; Mihira H, 2012, J BIOCHEM, V151, P145, DOI 10.1093/jb/mvr121; Minami T, 2012, EMBO J, V31, P4428, DOI 10.1038/emboj.2012.296; Moinzadeh P, 2012, J EUR ACAD DERMATOL, V26, P267, DOI 10.1111/j.1468-3083.2011.04206.x; Morita T, 2007, J CELL BIOL, V179, P1027, DOI 10.1083/jcb.200708174; NEEDLEMAN BW, 1992, ARTHRITIS RHEUM, V35, P67, DOI 10.1002/art.1780350111; Ni JX, 2013, FREE RADICAL BIO MED, V61, P26, DOI 10.1016/j.freeradbiomed.2013.03.012; Nikitorowicz-Buniak J, 2014, J INVEST DERMATOL, V134, P2693, DOI 10.1038/jid.2014.253; O'Connor JW, 2015, J CELL PHYSIOL, V230, P1829, DOI 10.1002/jcp.24895; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; PERLISH JS, 1988, J INVEST DERMATOL, V90, P48, DOI 10.1111/1523-1747.ep12462561; Poormoghim H, 2000, ARTHRITIS RHEUM, V43, P444, DOI 10.1002/1529-0131(200002)43:2<444::AID-ANR27>3.0.CO;2-G; Rabquer BJ, 2009, RHEUMATOLOGY, V48, P734, DOI 10.1093/rheumatology/kep091; Sackson I, 2013, ARTHRITIS AND RHEUMA, V65; Sakai N, 2013, FASEB J, V27, P1830, DOI 10.1096/fj.12-219378; Sazonova OV, 2011, BIOPHYS J, V101, P622, DOI 10.1016/j.bpj.2011.06.051; Shi-wen X, 2009, ARTHRITIS RHEUM-US, V60, P234, DOI 10.1002/art.24223; Silver RM, 2014, ARTHRITIS RHEUMATOL, V66, P485, DOI 10.1002/art.38287; Small EM, 2010, CIRC RES, V107, P294, DOI 10.1161/CIRCRESAHA.110.223172; Suki B, 2005, J APPL PHYSIOL, V98, P1892, DOI 10.1152/japplphysiol.01087.2004; Talwar S, 2014, BIOMATERIALS, V35, P2411, DOI 10.1016/j.biomaterials.2013.12.010; Tan KY, 2013, INTEGR BIOL-UK, V5, P899, DOI 10.1039/c3ib40026c; Tian WF, 2015, J HEPATOL, V62, P165, DOI 10.1016/j.jhep.2014.07.029; Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/nmat3339, 10.1038/NMAT3339]; Tumelty KE, 2014, J BIOL CHEM, V289, P2526, DOI 10.1074/jbc.M113.502617; Varga JA, 2008, RHEUM DIS CLIN N AM, V34, P115, DOI 10.1016/j.rdc.2007.11.002; Velasquez LS, 2013, P NATL ACAD SCI USA, V110, P16850, DOI 10.1073/pnas.1316764110; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Watt FM, 2013, NAT REV MOL CELL BIO, V14, P467, DOI 10.1038/nrm3620; Wei J, 2011, AUTOIMMUN REV, V10, P267, DOI 10.1016/j.autrev.2010.09.015; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Xie L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-301; Xu HH, 2015, J AM SOC NEPHROL, V26, P1648, DOI 10.1681/ASN.2014070678; Xu J, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00167; Xu SW, 2007, ARTHRITIS RHEUM-US, V56, P4189, DOI 10.1002/art.23134; Xu SW, 1997, ARTHRITIS RHEUM-US, V40, P1237; Yang YY, 2013, NUCLEIC ACIDS RES, V41, P6005, DOI 10.1093/nar/gkt311; Yu LM, 2014, J CELL SCI, V127, P4645, DOI 10.1242/jcs.152314; Yuan HC, 2000, J APPL PHYSIOL, V89, P3, DOI 10.1152/jappl.2000.89.1.3; Yuan ZB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083895; Zhao XH, 2007, J CELL SCI; Zhou Y, 2013, J CLIN INVEST, V123, P1096, DOI 10.1172/JCI66700	90	62	62	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0126015	10.1371/journal.pone.0126015	http://dx.doi.org/10.1371/journal.pone.0126015			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955164	Green Published, gold			2022-12-26	WOS:000356768100093
J	Sartorius, T; Peter, A; Heni, M; Maetzler, W; Fritsche, A; Haring, HU; Hennige, AM				Sartorius, Tina; Peter, Andreas; Heni, Martin; Maetzler, Walter; Fritsche, Andreas; Haering, Hans-Ulrich; Hennige, Anita M.			The Brain Response to Peripheral Insulin Declines with Age: A Contribution of the Blood-Brain Barrier?	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; TEMPORAL-LOBE; IN-VIVO; TRANSPORT; RESISTANCE; OBESITY; SENSITIVITY; DEMENTIA; LEPTIN	Objectives It is a matter of debate whether impaired insulin action originates from a defect at the neural level or impaired transport of the hormone into the brain. In this study, we aimed to investigate the effect of aging on insulin concentrations in the periphery and the central nervous system as well as its impact on insulin-dependent brain activity. Methods Insulin, glucose and albumin concentrations were determined in 160 paired human serum and cerebrospinal fluid (CSF) samples. Additionally, insulin was applied in young and aged mice by subcutaneous injection or intracerebroventricularly to circumvent the blood-brain barrier. Insulin action and cortical activity were assessed by Western blotting and electrocorticography radiotelemetric measurements. Results In humans, CSF glucose and insulin concentrations were tightly correlated with the respective serum/plasma concentrations. The CSF/serum ratio for insulin was reduced in older subjects while the CSF/serum ratio for albumin increased with age like for most other proteins. Western blot analysis in murine whole brain lysates revealed impaired phosphorylation of AKT (P-AKT) in aged mice following peripheral insulin stimulation whereas P-AKT was comparable to levels in young mice after intracerebroventricular insulin application. As readout for insulin action in the brain, insulin-mediated cortical brain activity instantly increased in young mice subcutaneously injected with insulin but was significantly reduced and delayed in aged mice during the treatment period. When insulin was applied intracerebroventricularly into aged animals, brain activity was readily improved. Conclusions This study discloses age-dependent changes in insulin CSF/serum ratios in humans. In the elderly, cerebral insulin resistance might be partially attributed to an impaired transport of insulin into the central nervous system.	[Sartorius, Tina; Peter, Andreas; Heni, Martin; Fritsche, Andreas; Haering, Hans-Ulrich] Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Vasc Dis Nephrol & Clin C, Tubingen, Germany; [Sartorius, Tina; Peter, Andreas; Heni, Martin; Fritsche, Andreas; Haering, Hans-Ulrich; Hennige, Anita M.] German Ctr Diabet Res DZD, Tubingen, Germany; [Sartorius, Tina; Peter, Andreas; Heni, Martin; Fritsche, Andreas; Haering, Hans-Ulrich; Hennige, Anita M.] Univ Tuebingen IDM, Helmholtz Ctr Munich, Inst Diabet Res & Metab Dis, Tubingen, Germany; [Maetzler, Walter] Univ Tubingen, Dept Neurodegenerat Dis, Tubingen, Germany; [Maetzler, Walter] Univ Tubingen, Hertie Inst Clin Brain Res, Tubingen, Germany; [Maetzler, Walter] German Ctr Neurodegenerat Dis DZNE, Tubingen, Germany	Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Eberhard Karls University of Tubingen; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Sartorius, T (corresponding author), Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Vasc Dis Nephrol & Clin C, Tubingen, Germany.	tina.sartorius@med.uni-tuebingen.de	Maetzler, Walter/A-6796-2011; Maetzler, Walter/AAE-5831-2020	Maetzler, Walter/0000-0002-5945-4694; Maetzler, Walter/0000-0002-5945-4694; Heni, Martin/0000-0002-8462-3832	Deutsche Forschungsgemeinschaft [HE 3653/3-1]; German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.) [DLR01GI0925]; Open Access Publishing Fund of Tuebingen University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.); Open Access Publishing Fund of Tuebingen University	This study was supported by grants from the Deutsche Forschungsgemeinschaft (HE 3653/3-1), and the German Federal Ministry of Education and Research (BMBF, DLR01GI0925) to the German Center for Diabetes Research (DZD e.V.). We further acknowledge support by Open Access Publishing Fund of Tuebingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DD, 1999, NEUROSCI LETT, V277, P198, DOI 10.1016/S0304-3940(99)00869-1; Alquier T, 2003, J NEUROENDOCRINOL, V15, P75, DOI 10.1046/j.1365-2826.2003.00961.x; Alves MG, 2012, CURR DIABETES REV, V8, P401, DOI 10.2174/157339912803529896; Banks WA, 1997, PEPTIDES, V18, P1423, DOI 10.1016/S0196-9781(97)00231-3; Banks WA, 2004, DIABETES, V53, P1253, DOI 10.2337/diabetes.53.5.1253; BANKS WA, 1985, BRAIN RES BULL, V15, P287, DOI 10.1016/0361-9230(85)90153-4; BAURA GD, 1993, J CLIN INVEST, V92, P1824, DOI 10.1172/JCI116773; Bayer-Carter JL, 2011, ARCH NEUROL-CHICAGO, V68, P743, DOI 10.1001/archneurol.2011.125; Benedict C, 2012, DIABETES CARE, V35, P488, DOI 10.2337/dc11-2075; Chechlacz M, 2009, DIABETOLOGIA, V52, P524, DOI 10.1007/s00125-008-1253-z; Cholerton B, 2011, DIABETIC MED, V28, P1463, DOI 10.1111/j.1464-5491.2011.03464.x; Clark CR, 2004, INT J PSYCHOPHYSIOL, V53, P1, DOI 10.1016/j.ijpsycho.2003.12.011; COHEN BM, 1995, JAMA-J AM MED ASSOC, V274, P902, DOI 10.1001/jama.274.11.902; Cole GM, 2007, EXP GERONTOL, V42, P10, DOI 10.1016/j.exger.2006.08.009; Craft S, 1998, NEUROLOGY, V50, P164, DOI 10.1212/WNL.50.1.164; Craft S, 2009, ARCH NEUROL-CHICAGO, V66, P300, DOI 10.1001/archneurol.2009.27; De Felice FG, 2013, J CLIN INVEST, V123, P531, DOI 10.1172/JCI64595; DUFFY KR, 1987, BRAIN RES, V420, P32, DOI 10.1016/0006-8993(87)90236-8; Fujita N, 2003, EXP BIOL MED, V228, P1156, DOI 10.1177/153537020322801009; Guthoff M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019482; Guthoff M, 2010, J CLIN ENDOCR METAB, V95, P748, DOI 10.1210/jc.2009-1677; HACHIYA HL, 1988, AM J PHYSIOL, V255, pC459, DOI 10.1152/ajpcell.1988.255.4.C459; Heni M, 2014, DIABETES, V63, P4083, DOI 10.2337/db14-0477; Heni M, 2014, ACTA DIABETOL, V51, P679, DOI 10.1007/s00592-013-0546-y; Hennige AM, 2009, DIABETOLOGIA, V52, P2416, DOI 10.1007/s00125-009-1522-5; Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134; Kaiyala KJ, 2000, DIABETES, V49, P1525, DOI 10.2337/diabetes.49.9.1525; Ketterer C, 2014, OBESITY, V22, P925, DOI 10.1002/oby.20573; Ketterer C, 2011, DIABETES RES CLIN PR, V93, pS47, DOI 10.1016/S0168-8227(11)70013-4; KING GL, 1985, SCIENCE, V227, P1583, DOI 10.1126/science.3883490; Kloet DEA, 2011, BBA-MOL CELL RES, V1813, P1926, DOI 10.1016/j.bbamcr.2011.04.003; Leirer VM, 2011, BRAIN IMAGING BEHAV, V5, P222, DOI 10.1007/s11682-011-9126-3; Li L, 2007, BRAIN RES REV, V56, P384, DOI 10.1016/j.brainresrev.2007.09.001; Nerad L, 2005, J NEUROPHYSIOL, V93, P1246, DOI 10.1152/jn.00199.2004; Nolan JJ, 2010, DIABETOLOGIA, V53, P2273, DOI 10.1007/s00125-010-1890-x; Ott V, 2012, DIABETES OBES METAB, V14, P214, DOI 10.1111/j.1463-1326.2011.01490.x; Park CR, 2000, PHYSIOL BEHAV, V68, P509, DOI 10.1016/S0031-9384(99)00220-6; Persidsky Y, 2006, J NEUROIMMUNE PHARM, V1, P223, DOI 10.1007/s11481-006-9025-3; Reiber H, 2003, RESTOR NEUROL NEUROS, V21, P79; Ribeiro RT, 2008, J GERONTOL A-BIOL, V63, P560, DOI 10.1093/gerona/63.6.560; Rotte M, 2005, NEUROENDOCRINOLOGY, V81, P49, DOI 10.1159/000084874; Sartorius T, 2012, DIABETES, V61, P1669, DOI 10.2337/db11-1521; Sartorius T, 2012, FASEB J, V26, P1799, DOI 10.1096/fj.11-191023; SCHWARTZ MW, 1990, PEPTIDES, V11, P467, DOI 10.1016/0196-9781(90)90044-6; Seaquist ER, 2007, J CEREBR BLOOD F MET, V27, P154, DOI 10.1038/sj.jcbfm.9600316; Shah GN, 1997, EXP GERONTOL, V32, P501, DOI 10.1016/S0531-5565(96)00158-1; Tschritter O, 2007, DIABETOLOGIA, V50, P2602, DOI 10.1007/s00125-007-0839-1; Tschritter O, 2012, DIABETOLOGIA, V55, P175, DOI 10.1007/s00125-011-2309-z; Tschritter O, 2009, DIABETOLOGIA, V52, P169, DOI 10.1007/s00125-008-1187-5; Tschritter O, 2006, P NATL ACAD SCI USA, V103, P12103, DOI 10.1073/pnas.0604404103; Tschritter O, 2011, J OBES, V2011, DOI 10.1155/2011/283153; Tschritter O, 2009, J CLIN ENDOCR METAB, V94, P4600, DOI 10.1210/jc.2009-0469; Tucsek Z, 2014, J GERONTOL A-BIOL, V69, P1339, DOI 10.1093/gerona/glu080; Urayama A, 2008, ENDOCRINOLOGY, V149, P3592, DOI 10.1210/en.2008-0008; Wardlaw JM, 2003, STROKE, V34, P806, DOI 10.1161/01.STR.0000058480.77236.B3; Woods SC, 2003, CURR PHARM DESIGN, V9, P795, DOI 10.2174/1381612033455323; Zeevi N, 2010, J AM GERIATR SOC, V58, P1749, DOI 10.1111/j.1532-5415.2010.03011.x	57	61	62	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0126804	10.1371/journal.pone.0126804	http://dx.doi.org/10.1371/journal.pone.0126804			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965336	gold, Green Published, Green Submitted			2022-12-26	WOS:000354543500078
J	Kimura, K; Sato, C; Koganezawa, M; Yamamoto, D				Kimura, Ken-ichi; Sato, Chiaki; Koganezawa, Masayuki; Yamamoto, Daisuke			Drosophila Ovipositor Extension in Mating Behavior and Egg Deposition Involves Distinct Sets of Brain Interneurons	PLOS ONE			English	Article							SEXUAL RECEPTIVITY; FEMALE RECEPTIVITY; NEURONS; MELANOGASTER; REJECTION; SYSTEM; GENE	Oviposition is a female-specific behavior that directly affects fecundity, and therefore fitness. If a fertilized female encounters another male that she has evaluated to be of better quality than her previous mate, it would be beneficial for her to remate with this male rather than depositing her eggs. Females who decided not to remate exhibited rejection behavior toward a courting male and engaged in oviposition. Although recent studies of Drosophila melanogaster identified sensory neurons and putative second-order ascending interneurons that mediate uterine afferents affecting female reproductive behavior, little is known about the brain circuitry that selectively activates rejection versus oviposition behaviors. We identified the sexually dimorphic pC2l and female-specific pMN2 neurons, two distinct classes of doublesex (dsx)-expressing neurons that can initiate ovipositor extension associated with rejection and oviposition behavior, respectively. pC2l interneurons, which induce ovipositor extrusion for rejection in females, have homologues that control courtship behavior in males. Activation of these two classes of neurons appears to be mutually exclusive and each governs hierarchical control of the motor program in the VNC either for rejection or oviposition, contributing centrally to the switching on or off of the alternative motor programs.	[Kimura, Ken-ichi; Sato, Chiaki] Hokkaido Univ, Biol Lab, Sapporo, Hokkaido, Japan; [Koganezawa, Masayuki; Yamamoto, Daisuke] Tohoku Univ, Grad Sch Life Sci, Div Neurogenet, Sendai, Miyagi 980, Japan	Hokkaido University; Tohoku University	Kimura, K (corresponding author), Hokkaido Univ, Biol Lab, Sapporo Campus, Sapporo, Hokkaido, Japan.	kimura.kenichi@s.hokkyodai.ac.jp	Koganezawa, Masayuki/X-7284-2018	Koganezawa, Masayuki/0000-0002-8009-0450; , Daisuke/0000-0002-4623-0106	Japanese Government Ministry of Education, Culture, Sports, Science and Technology (MEXT) [23220007, 1802012, 24113502, 24570081]; Strategic Japanese-French Cooperative Program from the Japan Science and Technology Agency (JST); Takeda Science Foundation; Sumitomo Foundation; Grants-in-Aid for Scientific Research [23220007, 15K07141] Funding Source: KAKEN	Japanese Government Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Strategic Japanese-French Cooperative Program from the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Sumitomo Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research (23220007, 1802012 to K.-I.K. and D.Y.; 24113502 to D.Y.; 24570081 to K.-I.K.) from the Japanese Government Ministry of Education, Culture, Sports, Science and Technology (MEXT), a grant from the Strategic Japanese-French Cooperative Program from the Japan Science and Technology Agency (JST) to D.Y., a Life Science Grant from the Takeda Science Foundation to D.Y., and a grant from the Sumitomo Foundation to K.-I.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIGAKI T, 1991, NEURON, V7, P557, DOI 10.1016/0896-6273(91)90368-A; Asahina K, 2014, CELL, V156, P221, DOI 10.1016/j.cell.2013.11.045; Ayali A, 2010, J INSECT PHYSIOL, V56, P834, DOI 10.1016/j.jinsphys.2010.03.015; BOULETREAUMERLE J, 1976, J INSECT PHYSIOL, V22, P933, DOI 10.1016/0022-1910(76)90074-3; Bussell JJ, 2014, CURR BIOL, V24, P1584, DOI 10.1016/j.cub.2014.06.011; CONNOLLY K, 1973, BEHAVIOUR, V44, P142, DOI 10.1163/156853973X00364; DAVID J, 1974, Archives de Zoologie Experimentale et Generale, V115, P263; Feng K, 2014, NEURON, V83, P135, DOI 10.1016/j.neuron.2014.05.017; Ferveur JF, 2010, CURR OPIN NEUROBIOL, V20, P764, DOI 10.1016/j.conb.2010.09.007; GROSSFIELD J, 1972, J INSECT PHYSIOL, V18, P237, DOI 10.1016/0022-1910(72)90124-2; Hasemeyer M, 2009, NEURON, V61, P511, DOI 10.1016/j.neuron.2009.01.009; Kandel E.R., 2012, PRINCIPLES NEURAL SC; Kimura K, 2008, NEURON, V59, P759, DOI 10.1016/j.neuron.2008.06.007; Kimura K, 2015, J NEUROGENET, V29, P18, DOI 10.3109/01677063.2014.968278; King R. C., 1970, OVARIAN DEV DROSOPHI; Kohatsu S, 2011, NEURON, V69, P498, DOI 10.1016/j.neuron.2010.12.017; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; OBARA Y, 1975, Zoological Magazine (Tokyo), V84, P71; Obara Y, 2011, NATURWISSENSCHAFTEN, V98, P989, DOI 10.1007/s00114-011-0847-3; Ogawa H, 2011, J INSECT PHYSIOL, V57, P326, DOI 10.1016/j.jinsphys.2010.11.021; Pan YF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021144; Rezaval C, 2014, CURR BIOL, V24, P725, DOI 10.1016/j.cub.2013.12.051; Rezaval C, 2012, CURR BIOL, V22, P1155, DOI 10.1016/j.cub.2012.04.062; Rideout EJ, 2010, NAT NEUROSCI, V13, P458, DOI 10.1038/nn.2515; Robinett CC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000365; Sakurai A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2837; Schinaman JM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001964; SZABAD J, 1982, GENETICS, V100, P61; TOMPKINS L, 1983, GENETICS, V103, P179; Venken KJT, 2011, NEURON, V72, P202, DOI 10.1016/j.neuron.2011.09.021; von Philipsborn AC, 2011, NEURON, V69, P509, DOI 10.1016/j.neuron.2011.01.011; Von Schilcher F., 1976, Animal Behav, V24, P18, DOI 10.1016/S0003-3472(76)80095-4; Yang CH, 2008, SCIENCE, V319, P1679, DOI 10.1126/science.1151842; Yang CH, 2009, NEURON, V61, P519, DOI 10.1016/j.neuron.2008.12.021; Zhou C, 2014, NEURON, V83, P149, DOI 10.1016/j.neuron.2014.05.038	35	35	35	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0126445	10.1371/journal.pone.0126445	http://dx.doi.org/10.1371/journal.pone.0126445			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955600	Green Published, gold, Green Submitted			2022-12-26	WOS:000356768100120
J	Naav, A; Erlandsson, L; Axelsson, J; Larsson, I; Johansson, M; Wester-Rosenlof, L; Morgelin, M; Casslen, V; Gram, M; Akerstrom, B; Hansson, SR				Naav, Asa; Erlandsson, Lena; Axelsson, Josefin; Larsson, Irene; Johansson, Martin; Wester-Rosenlof, Lena; Morgelin, Matthias; Casslen, Vera; Gram, Magnus; Akerstrom, Bo; Hansson, Stefan R.			A1M Ameliorates Preeclampsia-Like Symptoms in Placenta and Kidney Induced by Cell-Free Fetal Hemoglobin in Rabbit	PLOS ONE			English	Article							LIPOCALIN ALPHA(1)-MICROGLOBULIN; SCAVENGER ALPHA(1)-MICROGLOBULIN; GLOMERULAR-PERMEABILITY; HEME; MODEL; PREGNANCY; HYPERTENSION; BINDING; STRESS	Preeclampsia is one of the most serious pregnancy-related diseases and clinically manifests as hypertension and proteinuria after 20 gestational weeks. The worldwide prevalence is 3-8% of pregnancies, making it the most common cause of maternal and fetal morbidity and mortality. Preeclampsia lacks an effective therapy, and the only "cure" is delivery. We have previously shown that increased synthesis and accumulation of cell-free fetal hemoglobin (HbF) in the placenta is important in the pathophysiology of preeclampsia. Extracellular hemoglobin (Hb) and its metabolites induce oxidative stress, which may lead to acute renal failure and vascular dysfunction seen in preeclampsia. The human endogenous protein, alpha(1)-microglobulin (A1M), removes cell-free heme-groups and induces natural tissue repair mechanisms. Exogenously administered A1M has been shown to alleviate the effects of Hb-induced oxidative stress in rat kidneys. Here we attempted to establish an animal model mimicking the human symptoms at stage two of preeclampsia by administering species-specific cell-free HbF starting mid-gestation until term, and evaluated the therapeutic effect of A1M on the induced symptoms. Female pregnant rabbits received HbF infusions i. v. with or without A1M every second day from gestational day 20. The HbF-infused animals developed proteinuria and a significantly increased glomerular sieving coefficient in kidney that was ameliorated by co-administration of A1M. Transmission electron microscopy analysis of kidney and placenta showed both intracellular and extracellular tissue damages after HbF-treatment, while A1M co-administration resulted in a significant reduction of the structural and cellular changes. Neither of the HbF-treated animals displayed any changes in blood pressure during pregnancy. In conclusion, infusion of cell-free HbF in the pregnant rabbits induced tissue damage and organ failure similar to those seen in preeclampsia, and was restored by co-administration of A1M. This study provides preclinical evidence supporting further examination of A1M as a potential new therapy for preeclampsia.	[Naav, Asa; Erlandsson, Lena; Larsson, Irene; Casslen, Vera; Hansson, Stefan R.] Lund Univ, Dept Clin Sci Lund, Obstet & Gynecol, Lund, Sweden; [Axelsson, Josefin] Lund Univ, Dept Clin Sci Lund, Nephrol, Lund, Sweden; [Johansson, Martin] Lund Univ, Dept Lab Med, Clin Pathol, Malmo, Sweden; [Wester-Rosenlof, Lena; Morgelin, Matthias; Gram, Magnus; Akerstrom, Bo] Lund Univ, Dept Clin Sci Lund, Infect Med, Lund, Sweden	Lund University; Lund University; Lund University; Lund University	Naav, A (corresponding author), Lund Univ, Dept Clin Sci Lund, Obstet & Gynecol, Lund, Sweden.	asa.naav@med.lu.se	Gram, Magnus/AAM-4825-2021	Gram, Magnus/0000-0002-5880-2925; Erlandsson, Lena/0000-0003-4350-5909; Naav, Asa/0000-0001-7186-674X	Swedish Medical Research Council [D0631001, B0387801]; Government ALF research grant from Lund University; Government ALF research grant from Lund University Hospital; Royal Physiographic Society in Lund; Greta and Johan Kock Foundation; Alfred Osterlund Foundation; Blood and Defence Network, Lund University; Crafoord Foundation; Marianne and Marcus Wallenberg Foundation; Torsten Soderberg Foundation; Maggie Stephens Foundation	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Government ALF research grant from Lund University; Government ALF research grant from Lund University Hospital; Royal Physiographic Society in Lund; Greta and Johan Kock Foundation; Alfred Osterlund Foundation; Blood and Defence Network, Lund University; Crafoord Foundation; Marianne and Marcus Wallenberg Foundation; Torsten Soderberg Foundation; Maggie Stephens Foundation	This work was supported by the Swedish Medical Research Council - SH (D0631001, B0387801) (www.vr.se), Government ALF research grants from Lund University and Lund University Hospital - SH (www.med.lu.se/alf), The Royal Physiographic Society in Lund - BA (www.fysiografen.se), The Greta and Johan Kock Foundation - BA (www.kockskastiftelsen.se), The Alfred Osterlund Foundation - BA (http://www.alfredosterlundsstiftelse.se/), The Blood and Defence Network, Lund University - BA (www.med.lu.se/blooddefence/),The Crafoord Foundation - BA (www.crafoord.se) A1M Pharma AB-SH & BA (www.a1m.se), the Marianne and Marcus Wallenberg Foundation - SH (www.wallenberg.com/mmw), the Torsten Soderberg Foundation - SH (www.torstensoderbergsstiftelse.se), and the Maggie Stephens Foundation - SH (www.med.lu.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerstrom B, 2007, J BIOL CHEM, V282, P31493, DOI 10.1074/jbc.M702624200; Akerstrom B, 2014, FREE RADICAL BIO MED, V74, P274, DOI 10.1016/j.freeradbiomed.2014.06.025; Allhorn M, 2002, BLOOD, V99, P1894, DOI 10.1182/blood.V99.6.1894; Asgeirsson D, 2006, AM J PHYSIOL-RENAL, V291, pF1083, DOI 10.1152/ajprenal.00488.2005; Axelsson J, 2013, AM J PHYSIOL-RENAL, V305, pF237, DOI 10.1152/ajprenal.00154.2013; Axelsson J, 2012, AM J PHYSIOL-RENAL, V303, pF790, DOI 10.1152/ajprenal.00153.2012; Brosens JJ, 2002, AM J OBSTET GYNECOL, V187, P1416, DOI 10.1067/mob.2002.127305; Brunori ID, 2005, EUR J OBSTET GYN R B, V118, P182, DOI 10.1016/j.ejogrb.2004.04.024; Buchmiller-Crair TL, 2001, PEDIATR RES, V50, P520, DOI 10.1203/00006450-200110000-00016; Buehler PW, 2010, ANTIOXID REDOX SIGN, V12, P275, DOI 10.1089/ars.2009.2799; CARLEMALM E, 1990, J STRUCT BIOL, V104, P189, DOI 10.1016/1047-8477(90)90075-N; Carter AM, 2007, PLACENTA, V28, pS41, DOI 10.1016/j.placenta.2006.11.002; Centlow M, 2009, Z Geburtshilfe Neonatol, V213, P89, DOI 10.1055/s-0029-1224196; Centlow M, 2008, FERTIL STERIL, V90, P1834, DOI 10.1016/j.fertnstert.2007.09.030; Cronqvist T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090020; Derrick M, 2004, J NEUROSCI, V24, P24, DOI 10.1523/JNEUROSCI.2816-03.2004; DONKER AJM, 1983, HYPERTENSION, V5, P514, DOI 10.1161/01.HYP.5.4.514; Jarad G, 2009, CURR OPIN NEPHROL HY, V18, P226, DOI 10.1097/MNH.0b013e3283296044; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; Kwasek A, 2007, PROTEIN EXPRES PURIF, V53, P145, DOI 10.1016/j.pep.2006.10.023; Lafayette RA, 1998, KIDNEY INT, V54, P1240, DOI 10.1046/j.1523-1755.1998.00097.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacKay AP, 2001, OBSTET GYNECOL, V97, P533, DOI 10.1016/S0029-7844(00)01223-0; May K, 2011, PLACENTA, V32, P323, DOI 10.1016/j.placenta.2011.01.017; Olsson MG, 2008, FREE RADICAL RES, V42, P725, DOI 10.1080/10715760802337265; Olsson MG, 2007, FREE RADICAL BIO MED, V42, P842, DOI 10.1016/j.freeradbiomed.2006.12.017; Olsson MG, 2013, ANTIOXID REDOX SIGN, V18, P2017, DOI 10.1089/ars.2012.4658; Olsson MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027505; Olsson MG, 2010, RADIAT RES, V174, P590, DOI 10.1667/RR2213.1; Olsson MG, 2010, FREE RADICAL BIO MED, V48, P284, DOI 10.1016/j.freeradbiomed.2009.10.052; Redman CWG, 2011, HEART, V97, P1967, DOI 10.1136/heartjnl-2011-300949; Redman CWG, 2009, PLACENTA, V30, pS38, DOI 10.1016/j.placenta.2008.11.021; Roberts JM, 2009, PLACENTA, V30, pS32, DOI 10.1016/j.placenta.2008.11.009; Roberts JM, 2001, LANCET, V357, P53, DOI 10.1016/S0140-6736(00)03577-7; ROBERTS JM, 1989, AM J OBSTET GYNECOL, V161, P1200, DOI 10.1016/0002-9378(89)90665-0; Rutardottir S, 2013, FREE RADICAL RES, V47, P541, DOI 10.3109/10715762.2013.801555; Shmueli A, 2012, PRENATAL DIAG, V32, P29, DOI 10.1002/pd.2871; Stillman IE, 2007, J AM SOC NEPHROL, V18, P2281, DOI 10.1681/ASN.2007020255; Sveinsdottir S, 2012, ULTRASOUND MED BIOL, V38, P423, DOI 10.1016/j.ultrasmedbio.2011.12.003; Sverrisson K, 2014, AM J PHYSIOL-RENAL, V306, pF442, DOI 10.1152/ajprenal.00502.2013; Talosi G, 1997, BIOCHEM MOL MED, V62, P58, DOI 10.1006/bmme.1997.2602; Tan S, 2005, J CHILD NEUROL, V20, P972, DOI 10.1177/08830738050200120801; TEJLER L, 1978, BIOCHIM BIOPHYS ACTA, V542, P506, DOI 10.1016/0304-4165(78)90380-X; Tjoa ML, 2006, AM J PATHOL, V169, P400, DOI 10.2353/ajpath.2006.060161; Wester-Rosenlof L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086353	45	31	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0125499	10.1371/journal.pone.0125499	http://dx.doi.org/10.1371/journal.pone.0125499			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955715	Green Submitted, gold, Green Published			2022-12-26	WOS:000356768100055
J	Vermeij, EA; Koenders, MI; Bennink, MB; Crowe, LA; Maurizi, L; Vallee, JP; Hofmann, H; van den Berg, WB; van Lent, PLEM; van de Loo, FAJ				Vermeij, Eline A.; Koenders, Marije I.; Bennink, Miranda B.; Crowe, Lindsey A.; Maurizi, Lionel; Vallee, Jean-Paul; Hofmann, Heinrich; van den Berg, Wim B.; van Lent, Peter L. E. M.; van de Loo, Fons A. J.			The In-Vivo Use of Superparamagnetic Iron Oxide Nanoparticles to Detect Inflammation Elicits a Cytokine Response but Does Not Aggravate Experimental Arthritis	PLOS ONE			English	Article							MODEL; MOUSE; VISUALIZATION; MACROPHAGES; EXPRESSION; TOXICITY; CELLS; MRI	Background Superparamagnetic Iron Oxide Nanoparticles (SPION) are used in diagnostic imaging of a variety of different diseases. For such in-vivo application, an additional coating with a polymer, for example polyvinyl alcohol (PVA), is needed to stabilize the SPION and prevent aggregation. As the particles are foreign to the body, reaction against the SPION could occur. In this study we investigated the effects that SPION may have on experimental arthritis after intra-articular (i.a.) or intravenous (i.v.) injection. Methods PVA-coated SPION were injected either i.a. (6 or 24 mu g iron) or i.v. (100 mu g or 1 mg iron) into naive Toll-like receptor-4 deficient (TLR4-/-) or wild-type C57Bl/6 mice, or C57Bl/6 mice with antigen-induced arthritis. As control, some mice were injected with PVA or PBS. MR imaging was performed at 1 and 7 days after injection. Mice were sacrificed 2 hours and 1, 2, 7, 10 and 14 days after injection of the SPION, and RNA from synovium and liver was isolated for pro-inflammatory gene expression analysis. Serum cytokine measurements and whole knee joint histology were also performed. Results Injection of a high dose of SPION or PVA into naive knee joints resulted in an immediate upregulation of pro-inflammatory gene expression in the synovium. A similar gene expression profile was observed after SPION or PVA injection into knee joints of TLR4-/-mice, indicating that this effect is not due to LPS contamination. Histological analysis of the knee joints also revealed synovial inflammation after SPION injection. Two hours after i.v. injection of SPION or PVA into naive mice, an upregulation of pro-inflammatory gene expression was detected in the liver. Administration of SPION or PVA into arthritic mice via i.a. injection did not result in an upregulation in gene expression and also no additional effects were observed on histology. MR imaging and histology showed long-term retention of SPION in the inflamed joint. However, 14 days after the injections no long-term effects were evident for gene expression, histology or serum cytokine concentrations. Conclusions Injection of SPION, either locally or systemically, gives an acute inflammatory response. In the long term, up to 14 days after the injection, while the SPION reside in the joint, no further activating effects of SPION were observed. Hence, we conclude that SPION do not aggravate arthritis and can therefore be used safely to detect joint inflammation by MR imaging.	[Vermeij, Eline A.; Koenders, Marije I.; Bennink, Miranda B.; van den Berg, Wim B.; van Lent, Peter L. E. M.; van de Loo, Fons A. J.] Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, Expt Rheumatol, NL-6525 ED Nijmegen, Netherlands; [Crowe, Lindsey A.; Vallee, Jean-Paul] Univ Geneva, Univ Hosp Geneva, Fac Med, Div Radiol, Geneva, Switzerland; [Maurizi, Lionel; Hofmann, Heinrich] Ecole Polytech Fed Lausanne, Lab Powder Technol, Lausanne, Switzerland	Radboud University Nijmegen; University of Geneva; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	van de Loo, FAJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, Expt Rheumatol, NL-6525 ED Nijmegen, Netherlands.	Fons.vandeloo@radboudumc.nl	van de Loo, Fons AJ/A-3425-2014; Koenders, Marije I/A-1341-2012; van Lent, Peter/A-4047-2014; Maurizi, Lionel/E-3606-2016; van den Berg, W.B./H-8010-2014	van de Loo, Fons AJ/0000-0002-5851-099X; Koenders, Marije I/0000-0001-5845-8362; Maurizi, Lionel/0000-0002-6346-7623; Vallee, Jean-Paul/0000-0001-7546-2013	European Union [228929]; Innovative Medicines Initiative Joint Undertaking funded project BTCure [115142-2]	European Union(European Commission); Innovative Medicines Initiative Joint Undertaking funded project BTCure	The research leading to these results received funding from the European Union Seventh Framework Programme NMP-2008-4.0-1, grant agreement # 228929, project NanoDiaRA and from the Innovative Medicines Initiative Joint Undertaking funded project BTCure (grant number: agreement 115142-2). WBvdB received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi-Roodsaz S, 2007, ARTHRITIS RHEUM, V56, P2957, DOI 10.1002/art.22848; Allen MJ, 2004, SPINE, V29, P515, DOI 10.1097/01.BRS.0000113871.67305.38; Beckmann N, 2003, MAGNET RESON MED, V49, P1047, DOI [10.1002/mrm.10480, 10.1002/mrm10480]; Berry CC, 2004, BIOMATERIALS, V25, P5405, DOI 10.1016/j.biomaterials.2003.12.046; Blank F, 2011, NANOTOXICOLOGY, V5, P606, DOI 10.3109/17435390.2010.541293; Cengelli F, 2006, J PHARMACOL EXP THER, V318, P108, DOI 10.1124/jpet.106.101915; Chastellain A, 2004, J COLLOID INTERF SCI, V278, P353, DOI 10.1016/j.jcis.2004.06.025; Cho WS, 2009, TOXICOL APPL PHARM, V239, P106, DOI 10.1016/j.taap.2009.05.026; Dardzinski BJ, 2001, MAGN RESON IMAGING, V19, P1209, DOI 10.1016/S0730-725X(01)00448-9; Farrell BT, 2013, NEUROLOGY, V81, P256, DOI 10.1212/WNL.0b013e31829bfd8f; Frericks BB, 2009, INVEST RADIOL, V44, P23, DOI 10.1097/RLI.0b013e3181899025; Galuppo LQ, 2006, J NANOSCI NANOTECHNO, V6, P2841, DOI 10.1166/jnn.2006.481; Gramoun A, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4588; Kievit FM, 2012, ACS NANO, V6, P2591, DOI 10.1021/nn205070h; Kobayashi M, 2005, BIOMATERIALS, V26, P3243, DOI 10.1016/j.biomaterials.2004.08.028; Kodali V, 2013, ACS NANO, V7, P6997, DOI 10.1021/nn402145t; Laskar A, 2013, BIOCHEM BIOPH RES CO, V441, P737, DOI 10.1016/j.bbrc.2013.10.115; Laurent S, 2008, CHEM REV, V108, P2064, DOI 10.1021/cr068445e; Lutz AM, 2006, J MAGN RESON IMAGING, V24, P657, DOI 10.1002/jmri.20667; Mahmoudi M, 2009, J COLLOID INTERF SCI, V336, P510, DOI 10.1016/j.jcis.2009.04.046; Maurizi L, 2014, ANALYST, V139, P1184, DOI 10.1039/c3an02153j; Michalska M, 2012, ARTERIOSCL THROM VAS, V32, P2350, DOI 10.1161/ATVBAHA.112.255224; Moghimi SM, 2001, PHARMACOL REV, V53, P283; Murray AR, 2013, CELL BIOCHEM BIOPHYS, V67, P461, DOI 10.1007/s12013-012-9367-9; Naqvi S, 2010, INT J NANOMED, V5, P983, DOI 10.2147/IJN.S13244; Petri-Fink A, 2008, EUR J PHARM BIOPHARM, V68, P129, DOI 10.1016/j.ejpb.2007.02.024; Roohi F, 2012, INT J NANOMED, V7, P4447, DOI 10.2147/IJN.S33120; Smulders S, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-41; van den Brand BT, 2013, ANN RHEUM DIS, V72, P1407, DOI 10.1136/annrheumdis-2012-202467; van Lent PLEM, 2007, ANN RHEUM DIS, V66, P334, DOI 10.1136/ard.2006.057471; Wu HY, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-46; Wu YW, 2014, RADIOLOGY, V271, P400, DOI 10.1148/radiol.13122254; Yu MK, 2011, SMALL, V7, P2241, DOI 10.1002/smll.201100472; Zhu MT, 2011, TOXICOL LETT, V203, P162, DOI 10.1016/j.toxlet.2011.03.021	34	26	26	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0126687	10.1371/journal.pone.0126687	http://dx.doi.org/10.1371/journal.pone.0126687			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955417	Green Published, Green Submitted, gold			2022-12-26	WOS:000356768100140
J	Rousseau, M; Naika, GS; Perron, J; Jacques, F; Gelb, MH; Boilard, E				Rousseau, Matthieu; Naika, Gajendra S.; Perron, Jean; Jacques, Frederic; Gelb, Michael H.; Boilard, Eric			Study of the Role of Cytosolic Phospholipase A(2) Alpha in Eicosanoid Generation and Thymocyte Maturation in the Thymus	PLOS ONE			English	Article							T-CELL DEVELOPMENT; PROSTAGLANDIN E-2; IMMUNE-RESPONSES; ARACHIDONIC-ACID; THROMBOXANE-A2 RECEPTOR; APOPTOTIC NEUTROPHILS; CENTRAL TOLERANCE; LEUKOTRIENE B-4; EXPRESSION; INFLAMMATION	The thymus is a primary lymphoid organ, home of maturation and selection of thymocytes for generation of functional T-cells. Multiple factors are involved throughout the different stages of the maturation process to tightly regulate T-cell production. The metabolism of arachidonic acid by cyclooxygenases, lipoxygenases and specific isomerases generates eicosanoids, lipid mediators capable of triggering cellular responses. In this study, we determined the profile of expression of the eicosanoids present in the mouse thymus at different stages of thymocyte development. As the group IVA cytosolic phospholipase A(2) (cPLA(2)alpha) catalyzes the hydrolysis of phospholipids, thereby generating arachidonic acid, we further verified its contribution by including cPLA2 alpha deficient mice to our investigations. We found that a vast array of eicosanoids is expressed in the thymus, which expression is substantially modulated through thymocyte development. The cPLA2 alpha was dispensable in the generation of most eicosanoids in the thymus and consistently, the ablation of the cPLA2 alpha gene in mouse thymus and the culture of thymuses from human newborns in presence of the cPLA2 alpha inhibitor pyrrophenone did not impact thymocyte maturation. This study provides information on the eicosanoid repertoire present during thymocyte development and suggests that thymocyte maturation can occur independently of cPLA2 alpha.	[Rousseau, Matthieu; Boilard, Eric] Univ Laval, Univ Quebec, Fac Med, Ctr Hosp,Ctr Res,Ctr Rech Rhumatol & Immunol, Quebec City, PQ, Canada; [Naika, Gajendra S.; Gelb, Michael H.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Perron, Jean; Jacques, Frederic] Univ Laval, Univ Quebec, Ctr Hosp, Ctr Rech, Quebec City, PQ, Canada	Laval University; University of Quebec; University of Washington; University of Washington Seattle; Laval University; University of Quebec	Boilard, E (corresponding author), Univ Laval, Univ Quebec, Fac Med, Ctr Hosp,Ctr Res,Ctr Rech Rhumatol & Immunol, Quebec City, PQ, Canada.	eric.boilard@crchuq.ulaval.ca	Rousseau, Matthieu/AAA-5385-2022	Rousseau, Matthieu/0000-0002-2895-2957; gelb, michael/0000-0001-7000-5219	National Sciences and Engineering Research Council; National Institutes of Health [R37 HL36235]; Fonds Quebecois de Recherche en Sante (FQRS); Canadian Institutes of Health Research New Investigator; Faculte de Medecine (Universite Laval); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL036235] Funding Source: NIH RePORTER	National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds Quebecois de Recherche en Sante (FQRS); Canadian Institutes of Health Research New Investigator(Canadian Institutes of Health Research (CIHR)); Faculte de Medecine (Universite Laval); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by an operating discovery grant from the National Sciences and Engineering Research Council awarded to EB and by National Institutes of Health grants R37 HL36235 awarded to MHG. EB is recipient of awards from the Fonds Quebecois de Recherche en Sante (FQRS) and is a Canadian Institutes of Health Research New Investigator. MR is recipient of a fellowship from the Faculte de Medecine (Universite Laval). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai ZB, 2013, J IMMUNOL, V190, P2036, DOI 10.4049/jimmunol.1202025; BETZ M, 1991, J IMMUNOL, V146, P108; Bezzine S, 2000, J BIOL CHEM, V275, P3179, DOI 10.1074/jbc.275.5.3179; Bollinger JG, 2010, ANAL CHEM, V82, P6790, DOI 10.1021/ac100720p; Boniface K, 2009, J EXP MED, V206, P535, DOI 10.1084/jem.20082293; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Bryn T, 2008, INT IMMUNOL, V20, P235, DOI 10.1093/intimm/dxm134; Chizzolini C, 2008, BLOOD, V112, P3696, DOI 10.1182/blood-2008-05-155408; Chuang SS, 2004, J BIOL CHEM, V279, P6305, DOI 10.1074/jbc.M311830200; Cupillard L, 1997, J BIOL CHEM, V272, P15745, DOI 10.1074/jbc.272.25.15745; Demeure CE, 1997, EUR J IMMUNOL, V27, P3526, DOI 10.1002/eji.1830271254; Eerola LI, 2006, BBA-MOL CELL BIOL L, V1761, P745, DOI 10.1016/j.bbalip.2006.04.002; Fedyk ER, 1996, P NATL ACAD SCI USA, V93, P10978, DOI 10.1073/pnas.93.20.10978; Gilbert JJ, 1996, J IMMUNOL, V156, P2054; Godson C, 2000, J IMMUNOL, V164, P1663, DOI 10.4049/jimmunol.164.4.1663; Han C, 2002, AM J PHYSIOL-GASTR L, V282, pG586, DOI 10.1152/ajpgi.00305.2001; Hegen M, 2003, J EXP MED, V197, P1297, DOI 10.1084/jem.20030016; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; HONDA A, 1993, J BIOL CHEM, V268, P7759; HOSTEIN I, 1992, THYMUS, V20, P101; JENKINSON EJ, 1994, CURR OPIN IMMUNOL, V6, P293, DOI 10.1016/0952-7915(94)90104-X; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; KISIELOW P, 1984, J IMMUNOL, V133, P1117; KRAAN TCTMV, 1995, J EXP MED, V181, P775, DOI 10.1084/jem.181.2.775; Kunikata T, 2005, NAT IMMUNOL, V6, P524, DOI 10.1038/ni1188; Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601; Mahic M, 2006, J IMMUNOL, V177, P246, DOI 10.4049/jimmunol.177.1.246; Mitchell S, 2002, J AM SOC NEPHROL, V13, P2497, DOI 10.1097/01.ASN.0000032417.73640.72; Miyaura C, 2003, J EXP MED, V197, P1303, DOI 10.1084/jem.20030015; Morioka Y, 2000, ARCH BIOCHEM BIOPHYS, V381, P31, DOI 10.1006/abbi.2000.1977; Murakami M, 2002, J BIOCHEM, V131, P285, DOI 10.1093/oxfordjournals.jbchem.a003101; NAMBA T, 1992, BIOCHEM BIOPH RES CO, V184, P1197, DOI 10.1016/S0006-291X(05)80009-9; Napolitani G, 2009, EUR J IMMUNOL, V39, P1301, DOI 10.1002/eji.200838969; NEEDLEMAN P, 1986, ANNU REV BIOCHEM, V55, P69, DOI 10.1146/annurev.biochem.55.1.69; NUSING R, 1990, EICOSANOIDS, V3, P53; Ono T, 2002, BIOCHEM J, V363, P727, DOI 10.1042/0264-6021:3630727; Pawliczak R, 2002, J BIOL CHEM, V277, P33153, DOI 10.1074/jbc.M200246200; Rocca B, 1999, J CLIN INVEST, V103, P1469, DOI 10.1172/JCI6400; Rocca B, 2002, EUR J IMMUNOL, V32, P1482, DOI 10.1002/1521-4141(200205)32:5<1482::AID-IMMU1482>3.0.CO;2-O; ROPER RL, 1995, J IMMUNOL, V154, P162; Sharma S, 2005, CANCER RES, V65, P5211, DOI 10.1158/0008-5472.CAN-05-0141; Shortman K, 1990, Semin Immunol, V2, P3; SMITH MJH, 1980, J PHARM PHARMACOL, V32, P517, DOI 10.1111/j.2042-7158.1980.tb12985.x; Song H, 2002, DEVELOPMENT, V129, P2879; SUGIMOTO Y, 1992, J BIOL CHEM, V267, P6463; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; Takahama Y, 2006, NAT REV IMMUNOL, V6, P127, DOI 10.1038/nri1781; Tilley SL, 2001, J CLIN INVEST, V108, P15, DOI 10.1172/JCI200113416; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; USHIKUBI F, 1993, J EXP MED, V178, P1825, DOI 10.1084/jem.178.5.1825; Valentin E, 1999, J BIOL CHEM, V274, P19152, DOI 10.1074/jbc.274.27.19152; Wu CY, 1998, J IMMUNOL, V161, P2723; Wu T, 2002, HEPATOLOGY, V36, P363, DOI 10.1053/jhep.2002.34743; Xu H, 2001, CELL IMMUNOL, V214, P184, DOI 10.1006/cimm.2001.1891; Yao CC, 2009, NAT MED, V15, P633, DOI 10.1038/nm.1968; Yarilin AA, 2004, CURR MED CHEM, V11, P447, DOI 10.2174/0929867043455972; Yokomizo T, 2000, J EXP MED, V192, P421, DOI 10.1084/jem.192.3.421; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506; Yun B, 2014, J BIOL CHEM, V289, P1491, DOI 10.1074/jbc.M113.497651	59	3	3	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0126204	10.1371/journal.pone.0126204	http://dx.doi.org/10.1371/journal.pone.0126204			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25969996	Green Published, gold, Green Submitted			2022-12-26	WOS:000354544200098
J	Li, HH; Cui, DM; Zhao, F; Huo, LJ; Hu, JM; Zeng, JW				Li, Honghui; Cui, Dongmei; Zhao, Feng; Huo, Lijun; Hu, Jianmin; Zeng, Junwen			BMP-2 Is Involved in Scleral Remodeling in Myopia Development	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-2; GENE-EXPRESSION SIGNATURES; LENS-INDUCED MYOPIA; GROWTH-FACTOR-BETA; TREE SHREW SCLERA; CHONDROGENIC DIFFERENTIATION; COLLAGEN GENE; IN-VITRO; CARTILAGE; RECOVERY	The development of myopia is associated with scleral remodeling, but it is unclear which factors regulate this process. This study investigated bone morphogenetic protein-2 (BMP-2) expression in the sclera of guinea pigs with lens-induced myopia (LIM) and after recovery from myopia and evaluated the effect of BMP-2 on extracellular matrix (ECM) synthesis in human scleral fibroblasts (HSFs) cultured in vitro. Lens-induced myopia was brought about in two groups of guinea pigs (the lens-induced myopia and myopia recovery groups) by placing -4.00 D lenses on the right eye for three weeks. The left eye served as a contralateral control. In the recovery group, the lenses were removed after one week. The refractive power and axial length of the eyes were measured, and the BMP-2 expression levels in the sclera were measured. After three weeks, the lens-induced eyes acquired relative myopia in both groups of guinea pigs. Immunostaining of the eyeballs revealed significantly decreased BMP-2 expression in the posterior sclera of the myopic eyes compared to the contralateral eyes. One week after lens removal, BMP-2 expression recovered, and no differences were observed between the experimental and contralateral eyes in the recovery group. HSFs were cultured with BMP-2 or transforming growth factor-beta 1 (TGF-beta 1). Type I and type III collagen synthesis was significantly up-regulated following BMP-2 treatment in culture after one and two weeks, but the ratio of type III to type I collagen mRNA was not increased. Biosynthesis of glycosaminoglycan (GAG) and aggrecan was increased in HSFs treated with BMP-2. Some chondrogenesis-associated genes expression increased in HSFs treated with BMP-2. From this study, we concluded that BMP-2 is involved in scleral remodeling in the development and recovery of lens-induced myopia.	[Li, Honghui; Cui, Dongmei; Zhao, Feng; Zeng, Junwen] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510060, Guangdong, Peoples R China; [Huo, Lijun] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou 510080, Guangdong, Peoples R China; [Hu, Jianmin] Fujian Med Univ, Affiliated Hosp 2, Quanzhou 362000, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Fujian Medical University	Zeng, JW (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, 54 South Xianlie Rd, Guangzhou 510060, Guangdong, Peoples R China.	cier72@163.com			National Natural Science Foundation in China [30572005]; Province Science Foundation of China [10251008901000025]	National Natural Science Foundation in China(National Natural Science Foundation of China (NSFC)); Province Science Foundation of China	The authors' research was supported by grant 30572005 from the National Natural Science Foundation in China and the Province Science Foundation of China (No. 10251008901000025).	Arokoski JPA, 1999, J BIOMED MATER RES, V48, P99; AVETISOV ES, 1983, METAB PEDIATR SYST O, V7, P183; Birk DE, 1997, EUR J CELL BIOL, V72, P352; BUSCHMANN MD, 1995, J BIOMECH ENG-T ASME, V117, P179, DOI 10.1115/1.2796000; Campbell IC, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026286; FUNATA M, 1990, GRAEF ARCH CLIN EXP, V228, P174, DOI 10.1007/BF02764314; Gao ZY, 2012, INT J OPHTHALMOL-CHI, V5, P661, DOI 10.3980/j.issn.2222-3959.2012.06.02; Gentle A, 2003, J BIOL CHEM, V278, P16587, DOI 10.1074/jbc.M300970200; Gentle A, 2002, CYTOKINE, V18, P344, DOI 10.1006/cyto.2002.1046; Gentle A, 2001, CURR EYE RES, V23, P179, DOI 10.1076/ceyr.23.3.179.5466; GOH WSH, 1994, OPHTHAL PHYSL OPT, V14, P378, DOI 10.1111/j.1475-1313.1994.tb00128.x; GREY RHB, 1989, BRIT J OPHTHALMOL, V73, P88, DOI 10.1136/bjo.73.2.88; Guggenheim JA, 1996, INVEST OPHTH VIS SCI, V37, P1380; He L, 2014, VISION RES, V102, P52, DOI 10.1016/j.visres.2014.07.005; He L, 2014, EXP EYE RES, V123, P56, DOI 10.1016/j.exer.2014.04.005; Hu JM, 2008, MOL VIS, V14, P2373; HYAMS S, 1991, AM J OPHTHALMOL, V112, P356, DOI 10.1016/S0002-9394(14)76751-0; Ikeda T, 2004, ARTHRITIS RHEUM-US, V50, P3561, DOI 10.1002/art.20611; Jobling AI, 2004, J BIOL CHEM, V279, P18121, DOI 10.1074/jbc.M400381200; Jobling AI, 2009, EXP EYE RES, V88, P458, DOI 10.1016/j.exer.2008.10.022; Kim SW, 2008, OTOLARYNG HEAD NECK, V139, P143, DOI 10.1016/j.otohns.2008.04.015; Kramer J, 2000, MECH DEVELOP, V92, P193, DOI 10.1016/S0925-4773(99)00339-1; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Leng YX, 2010, SCI CHINA LIFE SCI, V53, P1433, DOI 10.1007/s11427-010-4099-9; Lin LLK, 1999, OPTOMETRY VISION SCI, V76, P275, DOI 10.1097/00006324-199905000-00013; McBrien NA, 2000, INVEST OPHTH VIS SCI, V41, P3713; McBrien NA, 2003, PROG RETIN EYE RES, V22, P307, DOI 10.1016/S1350-9462(02)00063-0; McBrien NA, 2001, INVEST OPHTH VIS SCI, V42, P2179; McBrien NA, 2013, EXP EYE RES, V114, P128, DOI 10.1016/j.exer.2013.01.014; Miller DG, 2001, CURR OPIN OPHTHALMOL, V12, P222, DOI 10.1097/00055735-200106000-00014; Moring AG, 2007, INVEST OPHTH VIS SCI, V48, P2947, DOI 10.1167/iovs.06-0906; MUIR H, 1983, BIOCHEM SOC T, V11, P613, DOI 10.1042/bst0110613; NORTON TT, 1995, VISION RES, V35, P1271, DOI 10.1016/0042-6989(94)00243-F; Phillips JR, 2000, INVEST OPHTH VIS SCI, V41, P2028; Rada JAS, 2006, EXP EYE RES, V82, P185, DOI 10.1016/j.exer.2005.08.009; Seko Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003709; Shea CM, 2003, J CELL BIOCHEM, V90, P1112, DOI 10.1002/jcb.10734; Siegwart JT, 2007, MOL VIS, V13, P1878; Siegwart JT, 1999, VISION RES, V39, P387, DOI 10.1016/S0042-6989(98)00150-3; Singh M, 2011, J BIOMED MATER RES A, V98A, P412, DOI 10.1002/jbm.a.33129; Smith N, 2005, J CELL PHYSIOL, V203, P133, DOI 10.1002/jcp.20210; SPERDUTO RD, 1983, ARCH OPHTHALMOL-CHIC, V101, P405, DOI 10.1001/archopht.1983.01040010405011; Verhoeven VJM, 2013, NAT GENET, V45, P314, DOI 10.1038/ng.2554; Wang Q, 2011, MOL VIS, V17, P647; Wordinger RJ, 2007, EXP BIOL MED, V232, P979, DOI 10.3181/0510-MR-345; Yoshikawa M, 2014, INVEST OPHTH VIS SCI, V55, P7343, DOI 10.1167/iovs.14-15105; Zadnik K, 1997, OPTOMETRY VISION SCI, V74, P603, DOI 10.1097/00006324-199708000-00021; Zhang Y, 2012, INVEST OPHTH VIS SCI, V53, P6072, DOI 10.1167/iovs.12-9917	48	21	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0125219	10.1371/journal.pone.0125219	http://dx.doi.org/10.1371/journal.pone.0125219			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965995	gold, Green Published, Green Submitted			2022-12-26	WOS:000354543500013
J	Mohni, KN; Thompson, PS; Luzwick, JW; Glick, GG; Pendleton, CS; Lehmann, BD; Pietenpol, JA; Cortez, D				Mohni, Kareem N.; Thompson, Petria S.; Luzwick, Jessica W.; Glick, Gloria G.; Pendleton, Christopher S.; Lehmann, Brian D.; Pietenpol, Jennifer A.; Cortez, David			A Synthetic Lethal Screen Identifies DNA Repair Pathways that Sensitize Cancer Cells to Combined ATR Inhibition and Cisplatin Treatments	PLOS ONE			English	Article							NEGATIVE BREAST-CANCER; POLY(ADP-RIBOSE) POLYMERASE; HOMOLOGOUS RECOMBINATION; REPLICATION FORK; MISMATCH REPAIR; PARP INHIBITOR; PROTEIN-KINASE; TUMOR-CELLS; DEFICIENCY; DAMAGE	The DNA damage response kinase ATR may be a useful cancer therapeutic target. ATR inhibition synergizes with loss of ERCC1, ATM, XRCC1 and DNA damaging chemotherapy agents. Clinical trials have begun using ATR inhibitors in combination with cisplatin. Here we report the first synthetic lethality screen with a combination treatment of an ATR inhibitor (ATRi) and cisplatin. Combination treatment with ATRi/cisplatin is synthetically lethal with loss of the TLS polymerase zeta and 53BP1. Other DNA repair pathways including homologous recombination and mismatch repair do not exhibit synthetic lethal interactions with ATRi/cisplatin, even though loss of some of these repair pathways sensitizes cells to cisplatin as a single-agent. We also report that ATRi strongly synergizes with PARP inhibition, even in homologous recombination-proficient backgrounds. Lastly, ATR inhibitors were able to resensitize cisplatin-resistant cell lines to cisplatin. These data provide a comprehensive analysis of DNA repair pathways that exhibit synthetic lethality with ATR inhibitors when combined with cisplatin chemotherapy, and will help guide patient selection strategies as ATR inhibitors progress into the cancer clinic.	[Mohni, Kareem N.; Thompson, Petria S.; Luzwick, Jessica W.; Glick, Gloria G.; Pendleton, Christopher S.; Lehmann, Brian D.; Pietenpol, Jennifer A.; Cortez, David] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA	Vanderbilt University	Cortez, D (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA.	david.cortez@vanderbilt.edu	Lehmann, Brian D./H-8464-2019	Lehmann, Brian D./0000-0003-0407-5248; Thompson, Petria/0000-0002-3839-4303	National Institutes of Health [CA102792, T32CA093240, CA95131, SAC110030, PDF14302198]; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE [T32CA009582, R01CA102729, R01CA102792, T32CA093240] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Institutes of Health [CA102792 to D.C., T32CA093240 to K.N.M., CA95131 to J.A.P], Susan G. Komen [SAC110030 to J.A.P., PDF14302198 to K.N.M.] and the Breast Cancer Research Foundation [D.C.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Anders CK, 2010, CLIN CANCER RES, V16, P4702, DOI 10.1158/1078-0432.CCR-10-0939; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bhat A, 2013, NUCLEIC ACIDS RES, V41, P2328, DOI 10.1093/nar/gks1442; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Charrier JD, 2011, J MED CHEM, V54, P2320, DOI 10.1021/jm101488z; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Couch FB, 2013, GENE DEV, V27, P1610, DOI 10.1101/gad.214080.113; Cufer T, 2013, EUR J CANCER, V49, P1216, DOI 10.1016/j.ejca.2012.11.021; Di Cosimo S, 2010, NAT REV CLIN ONCOL, V7, P139, DOI 10.1038/nrclinonc.2009.234; ELION GB, 1954, J BIOL CHEM, V208, P477; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fokas E, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.181; Foote KM, 2013, J MED CHEM, V56, P2125, DOI 10.1021/jm301859s; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; GRECO WR, 1995, PHARMACOL REV, V47, P331; Guler G, 2011, BREAST CANCER RES TR, V129, P421, DOI 10.1007/s10549-010-1248-6; Hall AB, 2014, ONCOTARGET, V5, P5674, DOI 10.18632/oncotarget.2158; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Harrigan JA, 2011, J CELL BIOL, V193, P97, DOI 10.1083/jcb.201011083; Heacock ML, 2010, DNA REPAIR, V9, P929, DOI 10.1016/j.dnarep.2010.05.007; Horton JK, 2005, J BIOL CHEM, V280, P15773, DOI 10.1074/jbc.M413841200; Hudis CA, 2011, ONCOLOGIST, V16, P1, DOI 10.1634/theoncologist.2011-S1-01; Huntoon CJ, 2013, CANCER RES, V73, P3683, DOI 10.1158/0008-5472.CAN-13-0110; Kedar PS, 2012, MOL CANCER RES, V10, P360, DOI 10.1158/1541-7786.MCR-11-0477; Knobel PA, 2011, CANCER CELL INT, V11, DOI 10.1186/1475-2867-11-39; Knobel PA, 2011, NEOPLASIA, V13, P961, DOI 10.1593/neo.11828; KOI M, 1994, CANCER RES, V54, P4308; Kotov IN, 2014, MOL ONCOL, V8, P1747, DOI 10.1016/j.molonc.2014.07.008; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; Mohni KN, 2014, CANCER RES, V74, P2835, DOI 10.1158/0008-5472.CAN-13-3229; Morelli C, 2002, ONCOGENE, V21, P7266, DOI 10.1038/sj.onc.1205573; Murai J, 2014, MOL CANCER THER, V13, P433, DOI 10.1158/1535-7163.MCT-13-0803; Murai J, 2012, CANCER RES, V72, P5588, DOI 10.1158/0008-5472.CAN-12-2753; Neboori HJR, 2012, INT J RADIAT ONCOL, V83, pE677, DOI 10.1016/j.ijrobp.2012.01.089; Patel AG, 2011, P NATL ACAD SCI USA, V108, P3406, DOI 10.1073/pnas.1013715108; Postel-Vinay S, 2012, NAT REV CLIN ONCOL, V9, P144, DOI 10.1038/nrclinonc.2012.3; PRICHARD MN, 1990, ANTIVIR RES, V14, P181, DOI 10.1016/0166-3542(90)90001-N; Reaper PM, 2011, NAT CHEM BIOL, V7, P428, DOI [10.1038/NCHEMBIO.573, 10.1038/nchembio.573]; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Shen YQ, 2013, CLIN CANCER RES, V19, P5003, DOI 10.1158/1078-0432.CCR-13-1391; Sultana R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057098; Telli ML, 2010, CLIN BREAST CANCER, V10, pE16, DOI 10.3816/CBC.2010.s.003; Toledo LI, 2011, NAT STRUCT MOL BIOL, V18, P721, DOI 10.1038/nsmb.2076; Turner NC, 2008, EMBO J, V27, P1368, DOI 10.1038/emboj.2008.61; Umar A, 1997, CANCER RES, V57, P3949; Wang HY, 2004, CANCER RES, V64, P7139, DOI 10.1158/0008-5472.CAN-04-1289	52	71	75	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0125482	10.1371/journal.pone.0125482	http://dx.doi.org/10.1371/journal.pone.0125482			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965342	Green Published, gold, Green Submitted			2022-12-26	WOS:000354543500018
J	Brouard, C; Le Strat, Y; Larsen, C; Jauffret-Roustide, M; Lot, F; Pillonel, J				Brouard, Cecile; Le Strat, Yann; Larsen, Christine; Jauffret-Roustide, Marie; Lot, Florence; Pillonel, Josiane			The Undiagnosed Chronically-Infected HCV Population in France. Implications for Expanded Testing Recommendations in 2014	PLOS ONE			English	Article							HEPATITIS-C VIRUS; DRUG-USERS; INJECT DRUGS; PREVALENCE; COHORT; RISK; PREVENTION; PEOPLE; EPIDEMIOLOGY; THERAPY	Background Recent HCV therapeutic advances make effective screening crucial for potential HCV eradication. To identify the target population for a possible population-based screening strategy to complement current risk-based testing in France, we aimed to estimate the number of adults with undiagnosed chronic HCV infection and age and gender distribution at two time points: 2004 and 2014. Methods A model taking into account mortality, HCV incidence and diagnosis rates was applied to the 2004 national seroprevalence survey. Results In 2014, an estimated 74,102 individuals aged 18 to 80 were undiagnosed for chronic HCV infection (plausible interval: 64,920-83,283) compared with 100,868 [95% CI: 58,534-143,202] in 2004. Men aged 18-59 represented approximately half of the undiagnosed population in 2014. The proportion of undiagnosed individuals in 2004 (43%) varied from 21.9% to 74.1% in the 1945-1965 and 1924-1944 birth cohorts. Consequently, age and gender distributions between the chronically-infected (diagnosed and undiagnosed) and undiagnosed HCV populations were different, the 1945-1965 birth cohort representing 48.9% and 24.7%, respectively. Conclusions Many individuals were still undiagnosed in 2014 despite a marked reduction with respect to 2004. The present work contributed to the 2014 recommendation of a new French complementary screening strategy, consisting in one-time simultaneous HCV, HBV and HIV testing in men aged 18-60. Further studies are needed to assess the cost-effectiveness and feasibility of such a strategy. We also demonstrated that data on the undiagnosed HCV population are crucial to help adapt testing strategies, as the features of the chronically-infected HCV population are very distinct.	[Brouard, Cecile; Le Strat, Yann; Larsen, Christine; Jauffret-Roustide, Marie; Lot, Florence; Pillonel, Josiane] French Inst Publ Hlth Surveillance InVS, Dept Infect Dis, St Maurice, France; [Jauffret-Roustide, Marie] Univ Paris 05, CNRS, INSERM, Cermes3,U988,UMR8211, Paris, France	Institute of Public Health Surveillance; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Brouard, C (corresponding author), French Inst Publ Hlth Surveillance InVS, Dept Infect Dis, St Maurice, France.	c.brouard@invs.sante.fr	Le Strat, Yann/C-9848-2013; Jauffret-Roustide, Marie/AAF-4983-2021	Le Strat, Yann/0000-0002-6180-4200; Jauffret-Roustide, Marie/0000-0001-8563-5395				Afdhal NH, 2013, J VIRAL HEPATITIS, V20, P745, DOI 10.1111/jvh.12173; Agence nationale d'accreditation et d'evaluation en sante, 2001, DEP HEP C POP DEP MO; Albers C, 2013, HEPATOLOGY, V58, p917A; Amin J, 2006, EPIDEMIOL INFECT, P1; [Anonymous], 2014, PRIS CHARG PERS INF; Backus LI, 2014, AM J PUBLIC HEALTH, V104, pS555, DOI 10.2105/AJPH.2014.302090; Brant LJ, 2008, J VIRAL HEPATITIS, V15, P871, DOI 10.1111/j.1365-2893.2008.01009.x; Brouard C, 2014, J HEPATOL, P60; Brouard C, 2009, B EPIDEMIOL HEBD, V20-21, P199, DOI [10.3945/jn.111.146258, DOI 10.3945/JN.111.146258]; Bruggmann P, 2014, J VIRAL HEPATITIS, V21, P5, DOI 10.1111/jvh.12247; Cazein F, 2012, JAIDS-J ACQ IMM DEF, V60, pE114, DOI 10.1097/QAI.0b013e318256b3fd; Costes JM, 2009, PREVALENCE USAGE PRO; Cousien A, 2014, J HEPATOL, P60; Craine N, 2009, EPIDEMIOL INFECT, V137, P1255, DOI 10.1017/S095026880900212X; Delarocque-Astagneau E, 2010, J VIRAL HEPATITIS, V17, P435, DOI 10.1111/j.1365-2893.2009.01196.x; Denniston MM, 2012, HEPATOLOGY, V55, P1652, DOI 10.1002/hep.25556; Deuffic-Burban S, 2012, GASTROENTEROLOGY, V143, P974, DOI 10.1053/j.gastro.2012.05.054; European Association for the Study of the Liver, 2014, Journal of Hepatology, V60, P392, DOI 10.1016/j.jhep.2013.11.003; Geboy A, 2013, HEPATOLOGY, V58, p1290A; Grebely J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097726; Grebely J, 2013, CAN J GASTROENTEROL, V27, P627, DOI 10.1155/2013/242405; Grebely J, 2013, CLIN INFECT DIS, V57, P1014, DOI 10.1093/cid/cit377; Hagan H, 2010, J INFECT DIS, V201, P378, DOI 10.1086/649783; Health consumer powerhouse, 2012, EUR IND REP; Hellard M, 2014, HEPATOLOGY, V59, P366, DOI 10.1002/hep.26623; Hoofnagle JH, 2014, NEW ENGL J MED, V370, P1552, DOI 10.1056/NEJMe1401508; Hope VD, 2011, J VIRAL HEPATITIS, V18, P262, DOI 10.1111/j.1365-2893.2010.01297.x; Hopkins DR, 2013, NEW ENGL J MED, V368, P54, DOI 10.1056/NEJMra1200391; Janssen E, 2013, USAGE PROBLEMATIQUE; Jauffret RM, 2013, B EPIDEMIOL HEBD, P504; Jauffret-Roustide M, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-113; Kielland KB, 2013, J HEPATOL, V58, P31, DOI 10.1016/j.jhep.2012.08.024; Laperche S., 2012, Bulletin Epidemiologique Hebdomadaire, P447; Lopez D, 2004, MORTALITE LIEE DROGU; Lucidarme D, 2004, EPIDEMIOL INFECT, V132, P699, DOI 10.1017/S095026880400247X; Martin NK, 2013, HEPATOLOGY, V58, P1598, DOI 10.1002/hep.26431; Meffre C, 2010, J MED VIROL, V82, P546, DOI 10.1002/jmv.21734; Page-Shafer K, 2008, J CLIN MICROBIOL, V46, P499, DOI 10.1128/JCM.01229-07; Pillonel J, 2005, Euro Surveill, V10, P5; Plan national de lutte contre les hepatites B et C, 2009, PLAN NAT LUTT HEP B; Shivkumar S, 2012, ANN INTERN MED, V157, P558, DOI 10.7326/0003-4819-157-8-201210160-00006; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Stockman LJ, 2014, MMWR-MORBID MORTAL W, V63; Supervie V, 2014, AIDS, V28, P1797, DOI 10.1097/QAD.0000000000000270; Valdiserri R, 2014, AM J PUBLIC HEALTH, V104, P816, DOI 10.2105/AJPH.2013.301812; van den Berg CHSB, 2007, EUR J EPIDEMIOL, V22, P183, DOI 10.1007/s10654-006-9089-7; Wandeler G, 2012, CLIN INFECT DIS, V55, P1408, DOI 10.1093/cid/cis694; Wedemeyer H, 2014, J VIRAL HEPATITIS, V21, P60, DOI 10.1111/jvh.12249; WHO (World Health Organization), 2002, WKLY EPIDEMIOL REC, V77, P41; Yazdanpanah Y, 2014, AIDS, V28, P1831, DOI 10.1097/QAD.0000000000000271	50	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126920	10.1371/journal.pone.0126920	http://dx.doi.org/10.1371/journal.pone.0126920			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961575	Green Published, gold, Green Submitted			2022-12-26	WOS:000354542500158
J	Huan, YJ; Zhu, J; Huang, B; Mu, YS; Kong, QR; Liu, ZH				Huan, Yanjun; Zhu, Jiang; Huang, Bo; Mu, Yanshuang; Kong, Qingran; Liu, Zhonghua			Trichostatin A Rescues the Disrupted Imprinting Induced by Somatic Cell Nuclear Transfer in Pigs	PLOS ONE			English	Article							ASSISTED REPRODUCTIVE TECHNOLOGIES; PORCINE CLONED EMBRYOS; SCNT EMBRYOS; METHYLATION; EXPRESSION; ANIMALS; MODEL; MICE	Imprinting disorders induced by somatic cell nuclear transfer (SCNT) usually lead to the abnormalities of cloned animals and low cloning efficiency. Histone deacetylase inhibitors have been shown to improve gene expression, genomic methylation reprogramming and the development of cloned embryos, however, the imprinting statuses in these treated embryos and during their subsequent development remain poorly studied. In this study, we investigated the dynamics of H19/Igf2 methylation and transcription in porcine cloned embryos treated with trichostatin A (TSA), and examined H19/Igf2 imprinting patterns in cloned fetuses and piglets. Our results showed that compared with the maintenance of H19/Igf2 methylation in fertilized embryos, cloned embryos displayed aberrant H19/Igf2 methylation and lower H19/Igf2 transcripts. When TSA enhanced the development of cloned embryos, the disrupted H19/Igf2 imprinting was largely rescued in these treated embryos, more similar to those detected in fertilized counterparts. Further studies displayed that TSA effectively rescued the disrupted imprinting of H19/Igf2 in cloned fetuses and piglets, prevented the occurrence of cloned fetus and piglet abnormalities, and enhanced the full-term development of cloned embryos. In conclusion, our results demonstrated that aberrant imprinting induced by SCNT led to the abnormalities of cloned fetuses and piglets and low cloning efficiency, and TSA rescued the disrupted imprinting in cloned embryos, fetuses and piglets, and prevented the occurrence of cloned fetus and piglet abnormalities, thereby improving the development of cloned embryos. This study would have important implications in improving cloning efficiency and the health of cloned animals.	[Huan, Yanjun; Zhu, Jiang; Huang, Bo; Mu, Yanshuang; Kong, Qingran; Liu, Zhonghua] Northeast Agr Univ, Coll Life Sci, Harbin, Heilongjiang Pr, Peoples R China; [Huan, Yanjun] Shandong Acad Agr Sci, Dairy Cattle Res Ctr, Jinan, Shandong, Peoples R China	Northeast Agricultural University - China; Shandong Academy of Agricultural Sciences	Liu, ZH (corresponding author), Northeast Agr Univ, Coll Life Sci, Harbin, Heilongjiang Pr, Peoples R China.	liu086@126.com	Liu, Zhunghua/F-2485-2010; Liu, Zhonghua/AAO-3590-2021	Liu, Zhunghua/0000-0002-9199-6493; Liu, Zhonghua/0000-0002-9199-6493; , Yanjun/0000-0001-7334-4582	National Basic Research Program of China [2011CB944202]; National Natural Science Foundation of China, NSFC [31101035]; China Postdoctoral Science Foundation [2014M551943]; Special Foundation of Postdoctoral Innovation Project in Shandong Province of China [201402044]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China, NSFC(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Special Foundation of Postdoctoral Innovation Project in Shandong Province of China	This work was supported by the National Basic Research Program of China, Program 973 (2011CB944202) to ZHL, http://www.most.gov.cn/; National Natural Science Foundation of China, NSFC (31101035) to ZHL, http://www.nsfc.gov.cn/; China Postdoctoral Science Foundation (2014M551943) to YJH, http://bg.chinapostdoctor.org.cn/; The Special Foundation of Postdoctoral Innovation Project in Shandong Province of China (201402044) to YJH, http://www.sdhrss.gov.cn/cm/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzi S, 2013, CURR OPIN ENDOCRINOL, V5, P5; Barlow DP, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018382; Bohrer RC, 2014, CELL CYCLE, V13, P2138, DOI 10.4161/cc.29215; Cervera RP, 2009, THERIOGENOLOGY, V72, P1097, DOI 10.1016/j.theriogenology.2009.06.030; Chen ZY, 2013, EPIGENETICS-US, V8, P591, DOI 10.4161/epi.24655; Delaval K, 2007, EMBO J, V26, P720, DOI 10.1038/sj.emboj.7601513; Denomme MM, 2012, REPRODUCTION, V144, P393, DOI 10.1530/REP-12-0237; Gabory A, 2009, DEVELOPMENT, V136, P3413, DOI 10.1242/dev.036061; Galli C, 2012, REPROD DOMEST ANIM, V47, P2, DOI 10.1111/j.1439-0531.2012.02045.x; Gu T, 2013, ANIM GENET, V22, P12074; Hill JR, 2014, ANNU REV ANIM BIOSCI, V2, P307, DOI 10.1146/annurev-animal-022513-114109; Hiura Hitoshi, 2014, Reproductive Medicine and Biology, V13, P193, DOI 10.1007/s12522-014-0183-3; Huan YJ, 2014, J REPROD DEVELOP, V60, P377, DOI 10.1262/jrd.2014-062; Huan YJ, 2013, J REPROD DEVELOP, V59, P442, DOI 10.1262/jrd.2013-026; Kohda T, 2012, CELL REPROGRAM, V14, P45, DOI 10.1089/cell.2011.0062; Kong Qing-Ran, 2011, Yichuan, V33, P749, DOI 10.3724/SP.J.1005.2011.00749; Lee KiHo, 2013, Animal Frontiers, V3, P56, DOI 10.2527/af.2013-0034; LI GL, 2014, BMC GENOMICS S12, V15, DOI DOI 10.1186/1471-; Liu ZH, 2008, CHINESE SCI BULL, V53, P1035, DOI 10.1007/s11434-008-0168-x; Ma Xin, 2014, Yichuan, V36, P959, DOI 10.3724/SP.J.1005.2014.0959; Mann MRW, 2003, BIOL REPROD, V69, P902, DOI 10.1095/biolreprod.103.017293; Nordin M, 2014, CELL PROLIFERAT, V47, P189, DOI 10.1111/cpr.12106; Okae H, 2014, HUM MOL GENET, V23, P992, DOI 10.1093/hmg/ddt495; Peat JR, 2012, NAT GENET, V44, P965, DOI 10.1038/ng.2393; Shen CJ, 2013, CELL REPROGRAM, V15, P413, DOI 10.1089/cell.2013.0012; Suzuki J, 2011, BIOL REPROD, V84, P947, DOI 10.1095/biolreprod.110.087833; Tian X, 2014, ANNU REV ANIM BIOSCI, V2, P23, DOI 10.1146/annurev-animal-022513-114144; Uyar A, 2014, CURR OPIN OBSTET GYN, V26, P210, DOI 10.1097/GCO.0000000000000071; Wang D, 2014, BIOTECHNOL LETT, V15, P15; Wei YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020154; Xu WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064705; Zhao MT, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.104471	32	10	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126607	10.1371/journal.pone.0126607	http://dx.doi.org/10.1371/journal.pone.0126607			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962071	Green Published, gold, Green Submitted			2022-12-26	WOS:000354542500126
J	Ma, F; Zhang, MD; Gong, W; Weng, MZ; Quan, ZW				Ma, Fei; Zhang, Mingdi; Gong, Wei; Weng, Mingzhe; Quan, Zhiwei			MiR-138 Suppresses Cell Proliferation by Targeting Bag-1 in Gallbladder Carcinoma	PLOS ONE			English	Article							LUNG-CANCER CELLS; IN-VIVO; RESISTANCE; MICRORNAS; SURVIVAL; GROWTH; TUMOR; OVEREXPRESSION; MIR-26A; PATHWAY	Background MiR-138 is frequently downregulated in different cancer types and is thought to be involved in the progression of tumorigenesis. However, the molecular mechanism of miR-138 involvement in gallbladder carcinoma still remains unknown. Methods The expression of miR-138 in 49 gallbladder carcinoma samples and paired normal gallbladder samples was analyzed using quantitative reverse transcription-polymerase chain reaction. The biological functions of miR-138 and Bag-1 (Bcl-2-associated athanogene-1) on cell proliferation were examined using 3-(4, 5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide and apoptosis assays. Targets of miR-138 were predicted using bioinformatics and validated using luciferase reporter and Western blot analyses. The in vivo effects of miR-138 were examined using subcutaneous inoculation of gallbladder carcinoma cells in Balb/c nude mice. Results Compared with their paired normal gallbladder samples, the gallbladder carcinoma samples had decreased expression of miR-138 and increased expression of Bag-1. Overexpression of miR-138 inhibited the proliferation of gallbladder carcinoma cells. Bag-1 was defined as a novel target of miR-138. Both the inhibition of Bag-1 by miR-138 and the silencing of Bag-1 by siRNA led to alterations of apoptosis-related proteins such as Bcl-2 and Bax. Restoring expression of Bag-1 eliminates the effects of miR-138 on cell proliferation and apoptosis. Furthermore, overexpression of miR-138 markedly inhibited the growth of tumors in the gallbladder carcinoma xenograft model in nude mice. Conclusions Expression of miR-138 is frequently reduced in gallbladder carcinoma when compared to normal cells. Overexpression of miR-138 inhibited cell proliferation by directly suppressing the expression of Bag-1. These results suggest that miR-138 plays an important role in inhibiting the growth of gallbladder carcinoma.	[Ma, Fei] Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Dept Oncol, Shanghai 200030, Peoples R China; [Zhang, Mingdi; Gong, Wei; Weng, Mingzhe; Quan, Zhiwei] Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Dept Surg, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Quan, ZW (corresponding author), Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Dept Surg, Shanghai 200030, Peoples R China.	zhiwquan@163.com			Medical School of Shanghai Jiaotong University Fund	Medical School of Shanghai Jiaotong University Fund	This work was supported by Medical School of Shanghai Jiaotong University Fund.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chakrabarti M, 2013, EXP CELL RES, V319, P1575, DOI 10.1016/j.yexcr.2013.02.025; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Clemo NK, 2008, CARCINOGENESIS, V29, P849, DOI 10.1093/carcin/bgn004; Dutta U, 2012, J GASTROEN HEPATOL, V27, P642, DOI 10.1111/j.1440-1746.2011.07048.x; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gao Y, 2014, BIOCHEM BIOPH RES CO, V446, P179, DOI 10.1016/j.bbrc.2014.02.073; Hirata H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051056; Hundal R, 2014, CLIN EPIDEMIOL, V6, P99, DOI 10.2147/CLEP.S37357; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Konstantinidis IT, 2009, ARCH SURG-CHICAGO, V144, P441, DOI 10.1001/archsurg.2009.46; Lahtz C, 2011, J MOL CELL BIOL, V3, P51, DOI 10.1093/jmcb/mjq053; Lezina L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.483; Liu BN, 2012, BBA-MOL BASIS DIS, V1822, P1692, DOI 10.1016/j.bbadis.2012.07.019; Liu X, 2012, CELL CYCLE, V11, P2495, DOI 10.4161/cc.20898; Ma YH, 2010, CANCER LETT, V298, P150, DOI 10.1016/j.canlet.2010.06.012; Mitomo S, 2008, CANCER SCI, V99, P280, DOI 10.1111/j.1349-7006.2007.00666.x; Naishiro Y, 1999, ONCOGENE, V18, P3244, DOI 10.1038/sj.onc.1202661; Ni WK, 2013, J CELL BIOCHEM, V114, P2120, DOI 10.1002/jcb.24560; Scheibner KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050895; Stinton LM, 2012, GUT LIVER, V6, P172, DOI 10.5009/gnl.2012.6.2.172; Townsend PA, 2003, CANCER RES, V63, P4150; Townsend PA, 2003, BBA-REV CANCER, V1603, P83, DOI 10.1016/S0304-419X(03)00002-7; Wang Hui, 2013, Asian Journal of Animal and Veterinary Advances, V8, P1; Wistuba II, 2004, NAT REV CANCER, V4, P695, DOI 10.1038/nrc1429; Xu WY, 2013, INT J ONCOL, V42, P757, DOI 10.3892/ijo.2012.1742; Yang XL, 1999, CLIN CANCER RES, V5, P1816; Zhao XH, 2010, LEUKEMIA RES, V34, P1078, DOI 10.1016/j.leukres.2009.10.002	30	42	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126499	10.1371/journal.pone.0126499	http://dx.doi.org/10.1371/journal.pone.0126499			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962180	gold, Green Published, Green Submitted			2022-12-26	WOS:000354542500107
J	Meyer, D; Schmeiser, S; Postel, A; Becher, P				Meyer, Denise; Schmeiser, Stefanie; Postel, Alexander; Becher, Paul			Transfection of RNA from Organ Samples of Infected Animals Represents a Highly Sensitive Method for Virus Detection and Recovery of Classical Swine Fever Virus	PLOS ONE			English	Article							MOUTH-DISEASE VIRUS; ORAL IMMUNIZATION; RT-PCR; REPLICATION; CP7-E2ALF; SEQUENCE; ELEMENTS; DATABASE; STRAINS; RESCUE	Translation and replication of positive stranded RNA viruses are directly initiated in the cellular cytoplasm after uncoating of the viral genome. Accordingly, infectious virus can be generated by transfection of RNA genomes into susceptible cells. In the present study, efficiency of conventional virus isolation after inoculation of cells with infectious sample material was compared to virus recovery after transfection of total RNA derived from organ samples of pigs infected with Classical swine fever virus (CSFV). Compared to the conventional method of virus isolation applied in three different porcine cell lines used in routine diagnosis of CSF, RNA transfection showed a similar efficiency for virus rescue. For two samples, recovery of infectious virus was only possible by RNA transfection, but not by the classical approach of virus isolation. Therefore, RNA transfection represents a valuable alternative to conventional virus isolation in particular when virus isolation is not possible, sample material is not suitable for virus isolation or when infectious material is not available. To estimate the potential risk of RNA prepared from sample material for infection of pigs, five domestic pigs were oronasally inoculated with RNA that was tested positive for virus rescue after RNA transfection. This exposure did not result in viral infection or clinical disease of the animals. In consequence, shipment of CSFV RNA can be regarded as a safe alternative to transportation of infectious virus and thereby facilitates the exchange of virus isolates among authorized laboratories with appropriate containment facilities.	[Meyer, Denise; Schmeiser, Stefanie; Postel, Alexander; Becher, Paul] Univ Vet Med Hannover, Inst Virol, Dept Infect Dis, EU & OIE Reference Lab Class Swine Fever, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation	Becher, P (corresponding author), Univ Vet Med Hannover, Inst Virol, Dept Infect Dis, EU & OIE Reference Lab Class Swine Fever, Hannover, Germany.	paul.becher@tiho-hannover.de		Postel, Alexander/0000-0002-1187-1069; Becher, Paul/0000-0001-7857-1354	DG Sanco of the European Commission; Deutsche Forschungsgemeinschaft [BE2333/1-1, BE2333/1-2]	DG Sanco of the European Commission(European CommissionEuropean Commission Joint Research Centre); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was part of the activities of the EURL and was supported by DG Sanco of the European Commission. P.B. was supported by a Heisenberg professorship (BE2333/1-1 and-/1-2) from the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, EU DIAGNOSTIC MANUAL; [Anonymous], 2002, OFFICIAL J EUROPEAN, P39; Austermann-Busch S, 2012, J VIROL, V86, P7393, DOI 10.1128/JVI.00864-12; Belsham GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014621; Bisht P, 2014, J VIROL METHODS, V196, P65, DOI 10.1016/j.jviromet.2013.10.041; Blome S, 2014, VET MICROBIOL, V169, P8, DOI 10.1016/j.vetmic.2013.12.002; Blome S, 2012, VET MICROBIOL, V158, P42, DOI 10.1016/j.vetmic.2012.02.015; DAHLE J, 1995, WIEN TIERARZTL MONAT, V82, P232; Dreier S, 2007, J VIROL METHODS, V140, P95, DOI 10.1016/j.jviromet.2006.11.013; Edwards S, 2000, VET MICROBIOL, V73, P103, DOI 10.1016/S0378-1135(00)00138-3; Fowler VL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109322; Gallei A, 2008, J VIROL, V82, P9717, DOI 10.1128/JVI.00782-08; Gould E., 2011, VIRUS TAXONOMY, P1003, DOI DOI 10.1016/J.BJID.2014.12.003; Greiser-Wilke I, 1998, J VIROL METHODS, V75, P141, DOI 10.1016/S0166-0934(98)00109-8; Greiser-Wilke I, 2000, VET MICROBIOL, V73, P131, DOI 10.1016/S0378-1135(00)00140-1; GREISERWILKE I, 1992, J GEN VIROL, V73, P47, DOI 10.1099/0022-1317-73-1-47; Grummer B, 2006, DEUT TIERARZTL WOCH, V113, P138; Hoffmann B, 2005, J VIROL METHODS, V130, P36, DOI 10.1016/j.jviromet.2005.05.030; Hofmann MA, 2000, J VIROL METHODS, V87, P29, DOI 10.1016/S0166-0934(00)00154-3; Kaden V, 2008, VET MICROBIOL, V130, P20, DOI 10.1016/j.vetmic.2007.12.022; Kaden V, 2001, VET MICROBIOL, V82, P301, DOI 10.1016/S0378-1135(01)00400-X; Kaden V, 2001, ACTA VIROL, V45, P23; KASZA L, 1972, RES VET SCI, V13, P46; Lamp B, 2011, J VIROL, V85, P3607, DOI 10.1128/JVI.02206-10; Meyers G, 1996, J VIROL, V70, P8606, DOI 10.1128/JVI.70.12.8606-8613.1996; Meyers G, 1996, J VIROL, V70, P1588, DOI 10.1128/JVI.70.3.1588-1595.1996; Mittelholzer C, 2000, VET MICROBIOL, V74, P293, DOI 10.1016/S0378-1135(00)00195-4; Pankraz A, 2005, J VIROL, V79, P9119, DOI 10.1128/JVI.79.14.9119-9127.2005; POOLE TL, 1995, VIROLOGY, V206, P750, DOI 10.1016/S0042-6822(95)80003-4; Postel A, 2013, BERL MUNCH TIERARZTL, V126, P468, DOI 10.2376/0005-9366-126-468; Postel A, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-50; Reimann I, 2010, VET MICROBIOL, V142, P45, DOI 10.1016/j.vetmic.2009.09.042; Rijnbrand R, 1997, J VIROL, V71, P451, DOI 10.1128/JVI.71.1.451-457.1997; Ruggli N, 1996, J VIROL, V70, P3478, DOI 10.1128/JVI.70.6.3478-3487.1996; Vandeputte J, 1999, REV SCI TECH OIE, V18, P638, DOI 10.20506/rst.18.3.1192; Weesendorp E, 2009, VET RES, V40, DOI 10.1051/vetres/2009041	36	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126806	10.1371/journal.pone.0126806	http://dx.doi.org/10.1371/journal.pone.0126806			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961582	Green Published, gold, Green Submitted			2022-12-26	WOS:000354542500151
J	Schreglmann, SR; Regensburger, M; Rockenstein, E; Masliah, E; Xiang, W; Winkler, J; Winner, B				Schreglmann, Sebastian R.; Regensburger, Martin; Rockenstein, Edward; Masliah, Eliezer; Xiang, Wei; Winkler, Juergen; Winner, Beate			The Temporal Expression Pattern of Alpha-Synuclein Modulates Olfactory Neurogenesis in Transgenic Mice	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; PARKINSONS-DISEASE; ADULT NEUROGENESIS; HIPPOCAMPAL NEUROGENESIS; BULB NEUROGENESIS; NEWBORN NEURONS; GROWTH-FACTOR; MOUSE MODEL; STEM-CELLS; INCREASES	Background Adult neurogenesis mirrors the brain's endogenous capacity to generate new neurons throughout life. In the subventricular zone/olfactory bulb system adult neurogenesis is linked to physiological olfactory function and has been shown to be impaired in murine models of neuronal alpha-Synuclein overexpression. We analyzed the degree and temporospatial dynamics of adult olfactory bulb neurogenesis in transgenic mice expressing human wild-type alpha-Synuclein (WTS) under the murine Thy1 (mThy1) promoter, a model known to have a particularly high tg expression associated with impaired olfaction. Results Survival of newly generated neurons (NeuN-positive) in the olfactory bulb was unchanged in mThy1 transgenic animals. Due to decreased dopaminergic differentiation a reduction in new dopaminergic neurons within the olfactory bulb glomerular layer was present. This is in contrast to our previously published data on transgenic animals that express WTS under the control of the human platelet-derived growth factor beta (PDGF) promoter, that display a widespread decrease in survival of newly generated neurons in regions of adult neurogenesis, resulting in a much more pronounced neurogenesis deficit. Temporal and quantitative expression analysis using immunofluorescence co-localization analysis and Western blots revealed that in comparison to PDGF transgenic animals, in mThy1 transgenic animals WTS is expressed from later stages of neuronal maturation only but at significantly higher levels both in the olfactory bulb and cortex. Conclusions The dissociation between higher absolute expression levels of alpha-Synuclein but less severe impact on adult olfactory neurogenesis in mThy1 transgenic mice highlights the importance of temporal expression characteristics of alpha-Synuclein on the maturation of newborn neurons.	[Schreglmann, Sebastian R.] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; [Regensburger, Martin; Winner, Beate] FAU Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, Interdisciplinary Ctr Clin Res, IZKF Jr Res Grp 3, Erlangen, Germany; [Regensburger, Martin; Winner, Beate] FAU Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, Interdisciplinary Ctr Clin Res, BMBF Res Grp Neurosci, Erlangen, Germany; [Regensburger, Martin] FAU Erlangen Nurnberg, Dept Neurol, Erlangen, Germany; [Rockenstein, Edward; Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Rockenstein, Edward; Masliah, Eliezer] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Xiang, Wei] FAU Erlangen Nurnberg, Emil Fischer Zentrum, Inst Biochem, Erlangen, Germany; [Winkler, Juergen] FAU Erlangen Nurnberg, Dept Mol Neurol, Erlangen, Germany	University of Zurich; University Zurich Hospital; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Winner, B (corresponding author), FAU Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, Interdisciplinary Ctr Clin Res, IZKF Jr Res Grp 3, Erlangen, Germany.	beate.winner@med.uni-erlangen.de	Winner, Beate/K-3730-2012; Xiang, Wei/Y-3171-2019; Regensburger, Martin/AAI-2311-2020; Winner, Beate/O-8213-2019	Winner, Beate/0000-0002-6909-0564; Regensburger, Martin/0000-0002-2172-7386; Winner, Beate/0000-0002-6909-0564; Winkler, Jurgen/0000-0003-0630-9204; Schreglmann, Sebastian/0000-0002-4129-5808	German Federal Ministry of Education and Research [01GQ113]; Independent Research Program (School of Medicine, University of Regensburg); German Research Society (Deutsche Forschungsgemeinschaft) [INST 410/45-1 FUGG]; Studienstiftung des Deutschen Volkes; Interdisciplinary Center of Clinical Research [IZKF N3, E11, E12]; ELAN [NL-14-03-12-1]; Bavarian Ministry of Education and Culture, Science and the Arts; NATIONAL INSTITUTE ON AGING [P50AG005131] Funding Source: NIH RePORTER	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Independent Research Program (School of Medicine, University of Regensburg); German Research Society (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Studienstiftung des Deutschen Volkes; Interdisciplinary Center of Clinical Research; ELAN; Bavarian Ministry of Education and Culture, Science and the Arts; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the Interdisciplinary Center of Clinical Research (IZKF N3 to BW, E11 to WX, E12 to JW), ELAN NL-14-03-12-1 to MR, the Bavarian Ministry of Education and Culture, Science and the Arts in the framework of the Bavarian Molecular Biosystems Reseach Network BioSysNet and ForIPS, the German Federal Ministry of Education and Research (Grant 01GQ113 to BW), the Independent Research Program (School of Medicine, University of Regensburg, to SRS & MR), the German Research Society (Deutsche Forschungsgemeinschaft) grant No. INST 410/45-1 FUGG, and a scholarship by the Studienstiftung des Deutschen Volkes to SRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso M, 2006, J NEUROSCI, V26, P10508, DOI 10.1523/JNEUROSCI.2633-06.2006; ALTMAN J, 1965, NATURE, V207, P953, DOI 10.1038/207953a0; Aponso PM, 2008, NEUROSCIENCE, V151, P1142, DOI 10.1016/j.neuroscience.2007.11.036; Bendor JT, 2013, NEURON, V79, P1044, DOI 10.1016/j.neuron.2013.09.004; Breton-Provencher V, 2012, BEHAV BRAIN RES, V227, P480, DOI 10.1016/j.bbr.2011.08.001; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chesselet MF, 2012, NEUROTHERAPEUTICS, V9, P297, DOI 10.1007/s13311-012-0104-2; Crews L, 2008, J NEUROSCI, V28, P4250, DOI 10.1523/JNEUROSCI.0066-08.2008; Enwere E, 2004, J NEUROSCI, V24, P8354, DOI 10.1523/JNEUROSCI.2751-04.2004; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fleming SM, 2008, EUR J NEUROSCI, V28, P247, DOI 10.1111/j.1460-9568.2008.06346.x; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Gheusi C, 2000, P NATL ACAD SCI USA, V97, P1823, DOI 10.1073/pnas.97.4.1823; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Hashimoto M, 2003, ANN NY ACAD SCI, V991, P171; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Kohl Z, 2012, EUR J NEUROSCI, V35, P10, DOI 10.1111/j.1460-9568.2011.07933.x; Lam HA, 2011, J NEUROSCI RES, V89, P1091, DOI 10.1002/jnr.22611; Lazarini F, 2014, J NEUROSCI, V34, P14430, DOI 10.1523/JNEUROSCI.5366-13.2014; Lledo PM, 2005, TRENDS NEUROSCI, V28, P248, DOI 10.1016/j.tins.2005.03.005; Luthi A, 1997, J NEUROSCI, V17, P4688; Marxreiter F, 2013, CELL MOL LIFE SCI, V70, P459, DOI 10.1007/s00018-012-1062-x; Marxreiter F, 2009, EUR J NEUROSCI, V29, P879, DOI 10.1111/j.1460-9568.2009.06641.x; May VEL, 2012, NEUROSCIENCE, V222, P343, DOI 10.1016/j.neuroscience.2012.07.001; May VEL, 2014, NEUROBIOL AGING, V35, P2357, DOI 10.1016/j.neurobiolaging.2014.02.028; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Mouret A, 2009, J NEUROSCI, V29, P12302, DOI 10.1523/JNEUROSCI.3383-09.2009; Nuber S, 2008, J NEUROSCI, V28, P2471, DOI 10.1523/JNEUROSCI.3040-07.2008; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Prediger RDS, 2011, J NEURAL TRANSM, V118, P1215, DOI 10.1007/s00702-010-0568-3; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Rockenstein E, 2002, J NEUROSCI RES, V68, P568, DOI 10.1002/jnr.10231; SASAHARA M, 1991, CELL, V64, P217, DOI 10.1016/0092-8674(91)90223-L; Schneider BL, 2007, HUM MOL GENET, V16, P651, DOI 10.1093/hmg/ddm008; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; Tani M, 2010, J NEUROCHEM, V115, P854, DOI 10.1111/j.1471-4159.2010.06727.x; Thiel Gerald, 2013, Biochem J, V450, pe1, DOI 10.1042/BJ20130176; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Winner B, 2006, EXP NEUROL, V197, P113, DOI 10.1016/j.expneurol.2005.08.028; Winner B, 2004, J NEUROPATH EXP NEUR, V63, P1155, DOI 10.1093/jnen/63.11.1155; Winner B, 2008, NEUROBIOL AGING, V29, P913, DOI 10.1016/j.neurobiolaging.2006.12.016; Winner B, 2012, J NEUROSCI, V32, P16906, DOI 10.1523/JNEUROSCI.2723-12.2012; Winner B, 2011, EUR J NEUROSCI, V33, P1139, DOI 10.1111/j.1460-9568.2011.07613.x; Yamashita H, 2006, J NEUROCHEM, V98, P45, DOI 10.1111/j.1471-4159.2006.03815.x; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhou W, 2008, J BIOL CHEM, V283, P9863, DOI 10.1074/jbc.M710232200	48	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126261	10.1371/journal.pone.0126261	http://dx.doi.org/10.1371/journal.pone.0126261			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961568	Green Published, gold, Green Submitted			2022-12-26	WOS:000354542500081
J	Gebregergs, GB; Alemu, WG				Gebregergs, Gebremedhin Berhe; Alemu, Wondmu Gebeyehu			Household Contact Screening Adherence among Tuberculosis Patients in Northern Ethiopia	PLOS ONE			English	Article							KNOWLEDGE	Background Household contacts of active tuberculosis cases are at high risk of getting tuberculosis disease. Tuberculosis detection rate among contacts of household members is high. Hence, this study investigated household contact screening adherence and associated factors among tuberculosis patients in Amhara region, Ethiopia. Methods A cross-sectional study was conducted from April 10 -June 30, 2013 in five urban districts of Amhara region, where 418 patients receiving treatment at tuberculosis clinic were interviewed. All patients were interviewed using structured and pre-tested questionnaire. Bringing at least one household contact to TB clinic was regarded as adherent to household contacts screening. Bivariate and multiple logistic regressions were used to investigate association. Results The overall adherence to household contact screening in Amhara region was 33.7%. Adherence was higher among Muslims than Christians. Adherence was high if patient took health education from Health Care Worker [AOR: 3.22, 95% CI: 1.88 to 5.51] and 2.17 times higher if patient had sufficient knowledge on tuberculosis [AOR: 2.17, 95% CI: 1.29 to 3.67] during interview. Relationship with contact was a significant [AOR: 0.4, 95% CI: 0.2 to 0.9] social related factor. Conclusion One third of tuberculosis patients adhered to household contact screening in health facilities during their treatment course. Promoting knowledge of tuberculosis in the community and continuous health education to tuberculosis patients are recommended.	[Gebregergs, Gebremedhin Berhe] Bahirdar Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Bahir Dar, Ethiopia; [Alemu, Wondmu Gebeyehu] Amhara Natl Reg State Hlth Bur, Hlth Res & Technol Transfer Core Proc, Bahir Dar, Ethiopia	Bahir Dar University	Gebregergs, GB (corresponding author), Bahirdar Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Bahir Dar, Ethiopia.	bgebrish04@gmail.com			PEPFAR; American people through USAID (Ethiopia mission) [RFA: 663-11-000005]; MSH led consortium of international and Ethiopian organizations	PEPFAR; American people through USAID (Ethiopia mission)(United States Agency for International Development (USAID)); MSH led consortium of international and Ethiopian organizations	United States Agency for International Development (USAID) ENHAT-CS program, which is funded by PEPFAR and implemented by an MSH led consortium of international and Ethiopian organizations, financially supported this research. This study was made possible by the generous support of the American people through USAID (Ethiopia mission) under RFA: 663-11-000005. The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government.	BanuRekha VV, INT J TUBERC LUNG DI, V13, P1507; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Chakravorty S, 2012, TUBERCULOSIS DIAGNOS; Claessens NJM, 2002, INT J TUBERC LUNG D, V6, P362; Federal Ministry of Health of Ethiopia, 2012, COMPR TRAIN MAN CLIN, P16; Fox GJ, 2013, EUR RESPIR J, V41, P140, DOI 10.1183/09031936.00070812; Gazetta CE, 2008, REV LAT-AM ENFERM, V16, P306, DOI 10.1590/S0104-11692008000200021; Hoa NP, 2003, SCAND J PUBLIC HEALT, V31, P59, DOI 10.1080/14034950310015121; Kaona FAD, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-68; Long NH, 1999, INT J TUBERC LUNG D, V3, P388; Mesfin MM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-53; Navio JLP, 2002, INT J TUBERC LUNG D, V6, P301; Okuonghae D, 2010, GLOBAL J HLTH SCI, V2; Robertson BD, 2012, TUBERCULOSIS, V92, P447, DOI 10.1016/j.tube.2012.06.004; Sekandi JN, 2009, INT J TUBERC LUNG D, V13, P508; Tornee S, 2005, S E ASIAN J TROP MED, V369; World Health Organization, 2013, WHOHTMTB201311	17	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0125767	10.1371/journal.pone.0125767	http://dx.doi.org/10.1371/journal.pone.0125767			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955517	Green Submitted, gold, Green Published			2022-12-26	WOS:000356768100075
J	Herndon, MK; Nilson, JH				Herndon, Maria K.; Nilson, John H.			Maximal Expression of Foxl2 in Pituitary Gonadotropes Requires Ovarian Hormones	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; BETA-SUBUNIT GENE; RIBONUCLEIC-ACID LEVELS; RAT ESTROUS-CYCLE; LUTEINIZING-HORMONE; MESSENGER-RNA; ACTIVIN-A; FSH-BETA; FORKHEAD TRANSCRIPTION; PROXIMAL PROMOTER	Gonadotropin-releasing hormone (GnRH) and activin regulate synthesis of FSH and ultimately fertility. Recent in vivo studies cast SMAD4 and FOXL2 as master transcriptional mediators of activin signaling that act together and independently of GnRH to regulate Fshb gene expression and female fertility. Ovarian hormones regulate GnRH and its receptor (GNRHR) through negative and positive feedback loops. In contrast, the role of ovarian hormones in regulating activin, activin receptors, and components of the activin signaling pathway, including SMAD4 and FOXL2, remains understudied. The widespread distribution of activin and many of its signaling intermediates complicates analysis of the effects of ovarian hormones on their synthesis in gonadotropes, one of five pituitary cell types. We circumvented this complication by using a transgenic model that allows isolation of polyribosomes selectively from gonadotropes of intact females and ovariectomized females treated with or without a GnRH antagonist. This paradigm allows assessment of ovarian hormonal feedback and distinguishes responses that are either independent or dependent on GnRH. Surprisingly, our results indicate that Foxl2 levels in gonadotropes decline significantly in the absence of ovarian input and independently of GnRH. Expression of the genes encoding other members of the activin signaling pathway are unaffected by loss of ovarian hormonal feedback, highlighting their selective effect on Foxl2. Expression of Gnrhr, a known target of FOXL2, also declines upon ovariectomy consistent with reduced expression of Foxl2 and loss of ovarian hormones. In contrast, Fshb mRNA increases dramatically post-ovariectomy due to increased compensatory input from GnRH. Together these data suggest that ovarian hormones regulate expression of Foxl2 thereby expanding the number of genes controlled by the hypothalamic-pituitary-gonadal axis that ultimately dictate reproductive fitness.	[Herndon, Maria K.; Nilson, John H.] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA	Washington State University	Nilson, JH (corresponding author), Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA.	jhn@wsu.edu			National Institutes of Health [5R01HD055776]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a grant from the National Institutes of Health 5R01HD055776 awarded to JHN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron D, 2004, J MOL ENDOCRINOL, V33, P705, DOI 10.1677/jme.1.01566; Benayoun BA, 2011, HUM MOL GENET, V20, P1673, DOI 10.1093/hmg/ddr042; Bernard DJ, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-52; Bernard DJ, 2004, MOL ENDOCRINOL, V18, P606, DOI 10.1210/me.2003-0264; Besecke LM, 1997, ENDOCRINOLOGY, V138, P2841, DOI 10.1210/en.138.7.2841; Bilezikjian LM, 1996, ENDOCRINOLOGY, V137, P4277, DOI 10.1210/en.137.10.4277; Bilezikjian LM, 2006, REPRODUCTION, V132, P207, DOI 10.1530/rep.1.01073; Bilezikjian LM, 2012, MOL CELL ENDOCRINOL, V359, P43, DOI 10.1016/j.mce.2012.01.025; Bliss SP, 2010, FRONT NEUROENDOCRIN, V31, P322, DOI 10.1016/j.yfrne.2010.04.002; Blount AL, 2009, J BIOL CHEM, V284, P7631, DOI 10.1074/jbc.M806676200; Burger LL, 2001, ENDOCRINOLOGY, V142, P3435, DOI 10.1210/en.142.8.3435; Charles MA, 2008, GENESIS, V46, P507, DOI 10.1002/dvg.20398; CHILDS GV, 1987, MOL ENDOCRINOL, V1, P926, DOI 10.1210/mend-1-12-926; Ciccone NA, 2009, CURR OPIN ENDOCRINOL, V16, P321, DOI 10.1097/MED.0b013e32832d88fb; CLAYTON RN, 1985, J STEROID BIOCHEM, V23, P691, DOI 10.1016/S0022-4731(85)80004-2; Cocquet J, 2002, J MED GENET, V39, P916, DOI 10.1136/jmg.39.12.916; Corpuz PS, 2010, MOL ENDOCRINOL, V24, P1037, DOI 10.1210/me.2009-0425; CORRIGAN AZ, 1991, ENDOCRINOLOGY, V128, P1682, DOI 10.1210/endo-128-3-1682; Coss D, 2005, MOL ENDOCRINOL, V19, P2610, DOI 10.1210/me.2005-0047; Coss D, 2010, TRENDS ENDOCRIN MET, V21, P562, DOI 10.1016/j.tem.2010.05.006; Couse JF, 2003, MOL ENDOCRINOL, V17, P1039, DOI 10.1210/me.2002-0398; DALKIN AC, 1989, ENDOCRINOLOGY, V125, P917, DOI 10.1210/endo-125-2-917; DEPAOLO LV, 1992, ENDOCRINOLOGY, V130, P1741, DOI 10.1210/en.130.3.1741; DEPAOLO LV, 1991, ENDOCRINOLOGY, V128, P1731, DOI 10.1210/endo-128-4-1731; Ellsworth BS, 2003, MOL CELL ENDOCRINOL, V206, P93, DOI 10.1016/S0303-7207(03)00235-1; Ellsworth BS, 2006, MOL ENDOCRINOL, V20, P2796, DOI 10.1210/me.2005-0303; ELSKUS AA, 1995, NEUROENDOCRINOLOGY, V61, P301, DOI 10.1159/000126852; Eozenou C, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.101584; FALLEST PC, 1995, BIOL REPROD, V53, P103, DOI 10.1095/biolreprod53.1.103; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Ferris HA, 2006, BIOL REPROD, V74, P993, DOI 10.1095/biolreprod.105.049049; Fortin J, 2014, FASEB J, V28, P3396, DOI 10.1096/fj.14-249532; GHARIB SD, 1990, ENDOCR REV, V11, P177, DOI 10.1210/edrv-11-1-177; Ghochani Y, 2012, ENDOCRINOLOGY, V153, P2023, DOI 10.1210/en.2011-1763; Glidewell-Kenney C, 2008, ENDOCRINOLOGY, V149, P4168, DOI 10.1210/en.2007-1807; Gore AJ, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-73; HAISENLEDER DJ, 1990, LIFE SCI, V47, P1769, DOI 10.1016/0024-3205(90)90351-Q; Hunzicker-Dunn M, 2014, PHYSL REPROD, V4; IBRAHIM SN, 1986, ENDOCRINOLOGY, V119, P629, DOI 10.1210/endo-119-2-629; Jiang WB, 2011, COMP BIOCHEM PHYS B, V160, P187, DOI 10.1016/j.cbpb.2011.08.005; Jorgensen JS, 2004, ENDOCR REV, V25, P521, DOI 10.1210/er.2003-0029; KERI RA, 1994, MOL ENDOCRINOL, V8, P1807, DOI 10.1210/me.8.12.1807; Lamba P, 2006, J MOL ENDOCRINOL, V36, P201, DOI 10.1677/jme.1.01961; Lamba P, 2009, MOL ENDOCRINOL, V23, P1001, DOI 10.1210/me.2008-0324; Le Tissier PR, 2012, FRONT NEUROENDOCRIN, V33, P252, DOI 10.1016/j.yfrne.2012.08.002; Liu ZH, 2007, J ENDOCRINOL, V194, P223, DOI 10.1677/JOE-07-0135; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUDERER U, 1991, BIOL REPROD, V45, P918, DOI 10.1095/biolreprod45.6.918; Meinhardt UJ, 2006, CLIN ENDOCRINOL, V65, P413, DOI 10.1111/j.1365-2265.2006.02676.x; MEUNIER H, 1988, P NATL ACAD SCI USA, V85, P247, DOI 10.1073/pnas.85.1.247; Moumne L, 2008, HUM MOL GENET, V17, P1010, DOI 10.1093/hmg/ddm373; NAIK SI, 1985, J REPROD FERTIL, V74, P615, DOI 10.1530/jrf.0.0740615; NAIK SI, 1985, J REPROD FERTIL, V74, P605, DOI 10.1530/jrf.0.0740605; Pannetier M, 2005, GENOMICS, V85, P715, DOI 10.1016/j.ygeno.2005.02.011; ROBERTS V, 1989, ENDOCRINOLOGY, V124, P552, DOI 10.1210/endo-124-1-552; Roybal LL, 2014, MOL ENDOCRINOL, V28, P1640, DOI 10.1210/me.2014-1008; SAADE G, 1989, J MOL ENDOCRINOL, V2, P213, DOI 10.1677/jme.0.0020213; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Suszko MI, 2005, MOL ENDOCRINOL, V19, P1849, DOI 10.1210/me.2004-0475; Thackray VG, 2010, MOL CELL ENDOCRINOL, V314, P192, DOI 10.1016/j.mce.2009.09.003; Tran S, 2013, MOL ENDOCRINOL, V27, P407, DOI 10.1210/me.2012-1286; Tran S, 2011, MOL ENDOCRINOL, V25, P1170, DOI 10.1210/me.2010-0480; Wang Y, 2008, ENDOCRINOLOGY, V149, P5577, DOI 10.1210/en.2008-0220; WEISS J, 1992, ENDOCRINOLOGY, V131, P1403, DOI 10.1210/en.131.3.1403; Wen S, 2008, ENDOCRINOLOGY, V149, P2701, DOI 10.1210/en.2007-1502	65	6	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0126527	10.1371/journal.pone.0126527	http://dx.doi.org/10.1371/journal.pone.0126527			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955311	Green Published, gold, Green Submitted			2022-12-26	WOS:000356768100127
J	Leuchtenberger, C; Magnusson, WE; Mourao, G				Leuchtenberger, Caroline; Magnusson, William E.; Mourao, Guilherme			Territoriality of Giant Otter Groups in an Area with Seasonal Flooding	PLOS ONE			English	Article							HOME-RANGE SIZE; SCENT-MARKING; SETTLEMENT TACTICS; VULPES-VULPES; LUTRA-LUTRA; RED FOXES; ORGANIZATION; MUSTELIDAE; CARNIVORA; PATTERNS	Territoriality carries costs and benefits, which are commonly affected by the spatial and temporal abundance and predictability of food, and by intruder pressure. Giant otters (Pteronura brasiliensis) live in groups that defend territories along river channels during the dry season using chemical signals, loud vocalizations and agonistic encounters. However, little is known about the territoriality of giant otters during the rainy season, when groups leave their dry season territories and follow fish dispersing into flooded areas. The objective of this study was to analyze long-term territoriality of giant otter groups in a seasonal environment. The linear extensions of the territories of 10 giant otter groups were determined based on locations of active dens, latrines and scent marks in each season. Some groups overlapped the limits of neighboring territories. The total territory extent of giant otters was correlated with group size in both seasons. The extent of exclusive territories of giant otter groups was negatively related to the number of adults present in adjacent groups. Territory fidelity ranged from 0 to 100% between seasons. Some groups maintained their territory for long periods, which demanded constant effort in marking and re-establishing their territories during the wet season. These results indicate that the defense capacity of groups had an important role in the maintenance of giant otter territories across seasons, which may also affect the reproductive success of alpha pairs.	[Leuchtenberger, Caroline; Magnusson, William E.] INPA, Grad Program Ecol, Manaus, Amazonas, Brazil; [Leuchtenberger, Caroline; Mourao, Guilherme] Embrapa Pantanal, Lab Vida Selvagem, Corumba, Brazil	Institute Nacional de Pesquisas da Amazonia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Leuchtenberger, C (corresponding author), INPA, Grad Program Ecol, Manaus, Amazonas, Brazil.	caroleucht@gmail.com	Mourão, Guilherme M/C-3319-2013	Mourão, Guilherme M/0000-0002-8300-4191	National Council for Scientific and Technological Development-CNPq [520056/98-1, 476939/2008-9]; Rufford Small Grants Foundation [88.08.09]; Mohamed bin Zayed Species Conservation Fund [10051040]; IDEA Wild	National Council for Scientific and Technological Development-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Rufford Small Grants Foundation; Mohamed bin Zayed Species Conservation Fund; IDEA Wild	This study was supported by the National Council for Scientific and Technological Development-CNPq (grants 520056/98-1 and 476939/2008-9, http://www.cnpq.br/), the Rufford Small Grants Foundation (grant 88.08.09, http://www.rufford.org/), the Mohamed bin Zayed Species Conservation Fund (project 10051040, http://www.speciesconservation.org/) and IDEA Wild (http://www.ideawild.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS ES, 1994, AM NAT, V143, P939, DOI 10.1086/285642; Adams ES, 2001, ANNU REV ECOL SYST, V32, P277, DOI 10.1146/annurev.ecolsys.32.081501.114034; Brennan PA, 2006, PHILOS T R SOC B, V361, P2061, DOI 10.1098/rstb.2006.1931; Brown J.L., 1970, ANNU REV ECOL SYST, V1, P239; BROWN JL, 1982, J THEOR BIOL, V95, P793, DOI 10.1016/0022-5193(82)90354-X; Carter SK, 1997, MAMMAL REV, V27, P1, DOI 10.1111/j.1365-2907.1997.tb00370.x; DONCASTER CP, 1992, J THEOR BIOL, V159, P189, DOI 10.1016/S0022-5193(05)80701-5; Duplaix N, 1980, REV ECOL-TERRE VIE, V34, P495, DOI DOI 10.1016/J.ENCEP.2013.04.017; ERLINGE S, 1968, OIKOS, V19, P81, DOI 10.2307/3564733; Evangelista E, 2011, IUCN OTTER SPEC GR, V28, P31; GITTLEMAN JL, 1982, BEHAV ECOL SOCIOBIOL, V10, P57, DOI 10.1007/BF00296396; Gosling L.M., 2001, Animal Behaviour Forum, V62, pF7, DOI 10.1006/anbe.2001.1802; GOSLING LM, 1982, Z TIERPSYCHOL, V60, P89; GRANT JWA, 1992, BEHAV ECOL SOCIOBIOL, V31, P149; Groenendijk J., 2005, HABITAT, V16, P1; Hamilton SK, 1996, ARCH HYDROBIOL, V137, P1; Herr J, 2004, J ZOOL, V262, P257, DOI 10.1017/S0952836903004606; Johnson DDP, 2001, OIKOS, V95, P265, DOI 10.1034/j.1600-0706.2001.950208.x; Kernohan Brian J., 2001, P125, DOI 10.1016/B978-012497781-5/50006-2; KRUUK H, 1984, ANIM BEHAV, V32, P899, DOI 10.1016/S0003-3472(84)80168-2; Kruuk H., 1985, P521; KRUUK H, 1992, BEHAV ECOL, V3, P133, DOI 10.1093/beheco/3.2.133; Laidler L., 1984, THESIS U CAMBRIDGE; Leuchtenberger C, 2014, ETHOL ECOL EVOL, V26, P19, DOI 10.1080/03949370.2013.821673; Leuchtenberger C, 2008, SOCIOBIOLOGY, V52, P257; Leuchtenberger C, 2014, J ACOUST SOC AM, V136, P2861, DOI 10.1121/1.4896518; Leuchtenberger C, 2013, J MAMMAL, V94, P320, DOI 10.1644/12-MAMM-A-210.1; Leuchtenberger C, 2009, ETHOLOGY, V115, P210, DOI 10.1111/j.1439-0310.2008.01607.x; MACDONALD DW, 1983, NATURE, V301, P379, DOI 10.1038/301379a0; Maher CR, 2000, AM MIDL NAT, V143, P1, DOI 10.1674/0003-0031(2000)143[0001:AROEDO]2.0.CO;2; Mares R, 2012, P ROY SOC B-BIOL SCI, V279, P3989, DOI 10.1098/rspb.2012.1071; Mourao G, 2001, MAMMALIA, V65, P225; Potts JR, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0231; Powell RA, 2000, METH C CONS, P65; Revilla E, 2002, J ANIM ECOL, V71, P497, DOI 10.1046/j.1365-2656.2002.00617.x; Ribas C, 2012, THESIS I NACL PESQUI; Ribas C, 2004, THESIS FEDERAL U MAT; Ribas Carolina, 2004, IUCN Otter Specialist Group Bulletin, V21, P89; Ribas C, 2012, STUD NEOTROP FAUNA E, V47, P19, DOI 10.1080/01650521.2012.662795; Rostain RR, 2004, ANIM BEHAV, V68, P703, DOI 10.1016/j.anbehav.2003.10.027; SCHENCK C, 1999, LOBO RIO PTERONURA B; Schweizer J, 1992, ARIRANHAS PANTANAL E; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Sillero-Zubiri C, 1998, J ZOOL, V245, P351, DOI 10.1111/j.1469-7998.1998.tb00110.x; Silveira L, 2011, AQUAT MAMM, V37, P208, DOI 10.1578/AM.37.2.2011.208; Staib E., 2005, THESIS SOC ZOOLOGICA; STAMPS J, 1995, AM NAT, V146, P41, DOI 10.1086/285786; Stamps JA, 1999, Q REV BIOL, V74, P291, DOI 10.1086/393163; STAMPS JA, 1990, AM NAT, V135, P527, DOI 10.1086/285060; STAMPS JA, 1990, AM NAT, V135, P614, DOI 10.1086/285065; Tallents LA, 2012, J ANIM ECOL, V81, P24, DOI 10.1111/j.1365-2656.2011.01911.x; Tomas W, 2000, 3 S REC NAT SOC PANT; WHITE PCL, 1994, J ANIM ECOL, V63, P315, DOI 10.2307/5550; WILKINSON L, 2004, SYSTAT SYSTEMS STAT; WOLFF JO, 1993, OIKOS, V68, P364, DOI 10.2307/3544853; Zub K, 2003, BEHAVIOUR, V140, P635, DOI 10.1163/156853903322149478	56	13	13	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0126073	10.1371/journal.pone.0126073	http://dx.doi.org/10.1371/journal.pone.0126073			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955248	Green Published, gold, Green Submitted			2022-12-26	WOS:000356768100094
J	Nasirudin, RA; Mei, K; Panchev, P; Fehringer, A; Pfeiffer, F; Rummeny, EJ; Fiebich, M; Noel, PB				Nasirudin, Radin A.; Mei, Kai; Panchev, Petar; Fehringer, Andreas; Pfeiffer, Franz; Rummeny, Ernst J.; Fiebich, Martin; Noel, Peter B.			Reduction of Metal Artifact in Single Photon-Counting Computed Tomography by Spectral-Driven Iterative Reconstruction Technique	PLOS ONE			English	Article							CT	Purpose The exciting prospect of Spectral CT (SCT) using photon-counting detectors (PCD) will lead to new techniques in computed tomography (CT) that take advantage of the additional spectral information provided. We introduce a method to reduce metal artifact in X-ray tomography by incorporating knowledge obtained from SCT into a statistical iterative reconstruction scheme. We call our method Spectral-driven Iterative Reconstruction (SPIR). Method The proposed algorithm consists of two main components: material decomposition and penalized maximum likelihood iterative reconstruction. In this study, the spectral data acquisitions with an energy-resolving PCD were simulated using a Monte-Carlo simulator based on EGSnrc C++ class library. A jaw phantom with a dental implant made of gold was used as an object in this study. A total of three dental implant shapes were simulated separately to test the influence of prior knowledge on the overall performance of the algorithm. The generated projection data was first decomposed into three basis functions: photoelectric absorption, Compton scattering and attenuation of gold. A pseudo-monochromatic sinogram was calculated and used as input in the reconstruction, while the spatial information of the gold implant was used as a prior. The results from the algorithm were assessed and bench-marked with state-of-the-art reconstruction methods. Results Decomposition results illustrate that gold implant of any shape can be distinguished from other components of the phantom. Additionally, the result from the penalized maximum likelihood iterative reconstruction shows that artifacts are significantly reduced in SPIR reconstructed slices in comparison to other known techniques, while at the same time details around the implant are preserved. Quantitatively, the SPIR algorithm best reflects the true attenuation value in comparison to other algorithms. Conclusion It is demonstrated that the combination of the additional information from Spectral CT and statistical reconstruction can significantly improve image quality, especially streaking artifacts caused by the presence of materials with high atomic numbers.	[Nasirudin, Radin A.; Mei, Kai; Rummeny, Ernst J.; Noel, Peter B.] Tech Univ Munich, Dept Diagnost & Intervent Radiol, D-81675 Munich, Germany; [Panchev, Petar; Fiebich, Martin] Tech Hsch Mittelhessen, Inst Med Phys & Strahlenschutz, D-35390 Giessen, Germany; [Fehringer, Andreas; Pfeiffer, Franz] Tech Univ Munich, Chair Biomed Phys, D-85748 Garching, Germany; [Fehringer, Andreas; Pfeiffer, Franz] Tech Univ Munich, Inst Med Engn, D-85748 Garching, Germany	Technical University of Munich; Technical University of Munich; Technical University of Munich	Nasirudin, RA (corresponding author), Tech Univ Munich, Dept Diagnost & Intervent Radiol, Ismaninger Str 22, D-81675 Munich, Germany.	radin.nasirudin@tum.de		Noel, Peter/0000-0002-9671-6171	German Department of Education and Research (BMBF) [01EX1021D]; DFG Cluster of Excellence Munich-Centre for Advanced Photonics; DFG Gottfried Wilhelm Leibniz program	German Department of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); DFG Cluster of Excellence Munich-Centre for Advanced Photonics(German Research Foundation (DFG)); DFG Gottfried Wilhelm Leibniz program(German Research Foundation (DFG))	The work was supported by German Department of Education and Research (BMBF) under grant 01EX1021D, DFG Cluster of Excellence Munich-Centre for Advanced Photonics and the DFG Gottfried Wilhelm Leibniz program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ RE, 1976, PHYS MED BIOL, V21, P733, DOI 10.1088/0031-9155/21/5/002; Barrett JF, 2004, RADIOGRAPHICS, V24, P1679, DOI 10.1148/rg.246045065; Berger Martin J., 1987, XCOM PHOTON CROSS SE; BROOKS RA, 1976, PHYS MED BIOL, V21, P390, DOI 10.1088/0031-9155/21/3/004; Cormode DP, 2010, RADIOLOGY, V256, P774, DOI 10.1148/radiol.10092473; De Man B., 1998, 1998 IEEE Nuclear Science Symposium Conference Record. 1998 IEEE Nuclear Science Symposium and Medical Imaging Conference (Cat. No.98CH36255), P1860, DOI 10.1109/NSSMIC.1998.773898; De Man B, 2000, IEEE T NUCL SCI, V47, P977, DOI 10.1109/23.856534; Engel KJ, 2008, MED PHYS, V35, P318, DOI 10.1118/1.2820901; Erdogan H, 1999, PHYS MED BIOL, V44, P2835, DOI 10.1088/0031-9155/44/11/311; Fehringer A, 2014, SPIE MED IMAGING; FESSLER JA, 2000, HDB MED IMAGING, V2; Feuerlein S, 2008, RADIOLOGY, V249, P1010, DOI 10.1148/radiol.2492080560; Fischer P, 2000, IEEE T NUCL SCI, V47, P881, DOI 10.1109/23.856711; GLOVER GH, 1981, MED PHYS, V8, P799, DOI 10.1118/1.595032; Hsieh Jiang, 2009, COMPUTED TOMOGRAPHY; Johnson TRC, 2007, EUR RADIOL, V17, P1510, DOI 10.1007/s00330-006-0517-6; KALENDER WA, 1987, RADIOLOGY, V164, P576, DOI 10.1148/radiology.164.2.3602406; Kawrakow I., 2013, EGSNRC CODE SYSTEM M; Kawrakow I, 2009, PIRS898 NRC; Koehler T, 2011, THE INTERNATIONAL CO; LANGE K, 1990, IEEE T MED IMAGING, V9, P439, DOI 10.1109/42.61759; Ljungberg M, 2013, SER MED PHYS BIOMED, P1; Meyer E, 2012, MED PHYS, V39, P1904, DOI 10.1118/1.3691902; Meyer E, 2010, MED PHYS, V37, P5482, DOI 10.1118/1.3484090; Noeel P, 2011, MED PHYS, V38, P3811, DOI [10.1118/1.3613350, DOI 10.1118/1.3613350]; Noel PB, 2010, COMPUT METH PROG BIO, V98, P271, DOI 10.1016/j.cmpb.2009.08.006; Robertson DD, 1997, J COMPUT ASSIST TOMO, V21, P293, DOI 10.1097/00004728-199703000-00024; Roessl E, 2007, PHYS MED BIOL, V52, P4679, DOI 10.1088/0031-9155/52/15/020; Roessl E, 2011, NUCL INSTRUM METH A, V648, pS259, DOI 10.1016/j.nima.2010.11.072; Schlomka JP, 2008, PHYS MED BIOL, V53, P4031, DOI 10.1088/0031-9155/53/15/002; Shikhaliev PM, 2008, PHYS MED BIOL, V53, P5595, DOI 10.1088/0031-9155/53/20/002; Shikhaliev PM, 2008, PHYS MED BIOL, V53, P1475, DOI 10.1088/0031-9155/53/5/020; Stayman JW, 2012, IEEE T MED IMAGING, V31, P1837, DOI 10.1109/TMI.2012.2199763; Watzke O, 2004, EUR RADIOL, V14, P849, DOI 10.1007/s00330-004-2263-y	35	26	26	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0124831	10.1371/journal.pone.0124831	http://dx.doi.org/10.1371/journal.pone.0124831			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955019	Green Submitted, gold, Green Published			2022-12-26	WOS:000356768100037
J	Sharma, K; Kathait, A; Jain, A; Kujur, K; Raghuwanshi, S; Bharti, AC; Saklani, AC; Das, BC				Sharma, Kirti; Kathait, Atul; Jain, Asha; Kujur, Karmila; Raghuwanshi, Shirish; Bharti, Alok Chandra; Saklani, Asha Chandola; Das, Bhudev Chandra			Higher Prevalence of Human Papillomavirus Infection in Adolescent and Young Adult Girls Belonging to Different Indian Tribes with Varied Socio-Sexual Lifestyle	PLOS ONE			English	Article							CERVICAL-CANCER; HPV INFECTION; DNA DETECTION; RISK-FACTORS; WOMEN; URINE; TRANSMISSION; FEMALES; SAMPLES; SMEAR	Background Despite high prevalence of human papillomavirus (HPV) infection and cervical cancer in Indian women, no study has been done in tribal populations whose socio-sexual lifestyle is different. Therefore, HPV screening has been carried out in pre-adolescent, adolescent and young adult tribal girls using self-collected urine samples. Methods 20-35 ml self-collected midstream urine samples were obtained from a total of 2278 healthy tribal girls (9-25 years) comprising pre-adolescent, adolescent and young adults from three Indian states: Madhya Pradesh, Jharkhand and Chhattisgarh. beta-globin positive 2034 samples were employed for HPV detection and genotyping. Results The overall prevalence of HPV infection in tribal girls was 12.9% (262/2034). More than 65% (172/262) of them were infected with HR-HPV types of which HPV16 was the most predominant type (54%). Young adult girls aged 18-25 years showed a significantly higher prevalence of HPV infection (19.2%; OR = 3.36; 95% CI 2.97-6.34, P<0.001) as compared to that in adolescent (11.4%; OR = 1.82; 95% CI 1.20-2.76, P<0.01) or pre-adolescent girls (6.6%). Conclusion This is a first study showing significantly a very high prevalence of HPV infection in adolescent and young adult tribal girls possibly due to different socio-sexual behavior, indicating a serious health concern for Indian tribal women.	[Sharma, Kirti; Das, Bhudev Chandra] Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India; [Sharma, Kirti; Kathait, Atul; Saklani, Asha Chandola] ApeejayStya Univ, Sch Biosci & Clin Res, Sohna, Gurgaon, India; [Jain, Asha] Sri MaaSardaArogyaDham, Raipur, Chhattisgarh, India; [Kujur, Karmila] MGM Med Coll & Hosp, Dept Obstet & Gynaecol, Jamshedpur, Jharkhand, India; [Raghuwanshi, Shirish] Dist Hosp, Dept Obstet & Gynaecol, Hoshangabad, Madhya Pradesh, India; [Bharti, Alok Chandra] Inst Cytol & Prevent Oncol ICMR, Div Mol Oncol, Noida, India	University of Delhi; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cancer Prevention & Research (NICPR)	Das, BC (corresponding author), Amity Univ, AIMMSCR, Noida, Uttar Pradesh, India.	bcdas48@hotmail.com	Sharma, Kirti/GQQ-4921-2022; Bharti, Prof. AC/AGL-5994-2022; Kathait, Atul/AAE-5010-2021	Kathait, Atul/0000-0002-1930-1087	Indian Council of Medical Research [3/2/2/91/2011/NCD-III (OPA-15762)]	Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	This work was supported by the Indian Council of Medical Research, Grant no. 3/2/2/91/2011/NCD-III (OPA-15762), www.icmr.nic.in. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bharti A.C., 2010, EXPERT REV OBSTET GY, V5, P329, DOI DOI 10.1586/EOG.10.23; Bhatla N, 2008, VACCINE, V26, P2811, DOI 10.1016/j.vaccine.2008.03.047; Bianchi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079719; Brito EB, 2002, EPIDEMIOL INFECT, V128, P485, DOI 10.1017/S0950268802006908; Castellsague X, 2002, NEW ENGL J MED, V346, P1105, DOI 10.1056/NEJMoa011688; D'Hauwers K, 2007, ASIAN J ANDROL, V9, P705, DOI 10.1111/j.1745-7262.2007.00287.x; DAS BC, 1992, LANCET, V340, P1417, DOI 10.1016/0140-6736(92)92612-J; Das BC, 2008, VACCINE, V26, P2669, DOI 10.1016/j.vaccine.2008.03.056; Dunne EF, 2007, JAMA-J AM MED ASSOC, V297, P813, DOI 10.1001/jama.297.8.813; Franceschi S, 2003, INT J CANCER, V107, P127, DOI 10.1002/ijc.11350; Gupta A, 2006, J CLIN VIROL, V37, P190, DOI 10.1016/j.jcv.2006.07.007; GUTMAN LT, 1993, PEDIATRICS, V91, P31; Hildesheim A, 2007, J INFECT DIS, V196, P1431, DOI 10.1086/522869; Houlihan CF, 2014, J INFECT DIS, V210, P837, DOI 10.1093/infdis/jiu202; Hussain S, 2012, J MED VIROL, V84, P298, DOI 10.1002/jmv.22261; Jayasinghe Y, 2006, ARCH DIS CHILD, V91, P696, DOI 10.1136/adc.2005.092080; Kailash U, 2002, J MED MICROBIOL, V51, P606, DOI 10.1099/0022-1317-51-7-606; Kerkar SC, 2011, SEX REPROD HEALTHC, V2, P7, DOI 10.1016/j.srhc.2010.11.001; Lee SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066368; Manhart LE, 2006, SEX TRANSM DIS, V33, P502, DOI 10.1097/01.olq.0000204545.89516.0a; Mishra S, 2008, J PUBLIC HEALTH-HEID, V16, P331, DOI 10.1007/s10389-007-0176-3; Mollers M, 2012, CANCER EPIDEMIOL, V36, P519, DOI 10.1016/j.canep.2012.07.006; Moscicki AB, 2001, JAMA-J AM MED ASSOC, V285, P2995, DOI 10.1001/jama.285.23.2995; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Naik Eknath, 2005, BMC Int Health Hum Rights, V5, P1, DOI 10.1186/1472-698X-5-1; O'Leary MC, 2011, BRIT J CANCER, V104, P1221, DOI 10.1038/bjc.2011.30; Pillai RM, 2010, INT J GYNECOL CANCER, V20, P1046, DOI 10.1111/IGC.0b013e3181e02fe0; Prusty BK, 2005, INT J GYNECOL OBSTET, V90, P223, DOI 10.1016/j.ijgo.2005.06.004; Rombaldi RL, 2009, VIROL J, V6, P83, DOI DOI 10.1186/1743-422X-6-83; Shew ML, 2013, J INFECT DIS, V207, P1012, DOI 10.1093/infdis/jis775; Shigehara K, 2010, INT J UROL, V17, P563, DOI 10.1111/j.1442-2042.2010.02521.x; Shukla S, 2014, INDIAN J MED RES, V139, P531; Song ES, 2007, J KOREAN MED SCI, V22, P99, DOI 10.3346/jkms.2007.22.1.99; Thilagavathi A, 2012, ARCH GYNECOL OBSTET, V286, P1483, DOI 10.1007/s00404-012-2500-6; Vorsters A, 2012, EUR J CLIN MICROBIOL, V31, P627, DOI 10.1007/s10096-011-1358-z; Widdice LE, 2012, ARCH PEDIAT ADOL MED, V166, P774, DOI 10.1001/archpediatrics.2012.586; Winer RL, 2010, CANCER EPIDEM BIOMAR, V19, P1682, DOI 10.1158/1055-9965.EPI-10-0226; Winer RL, 2003, AM J EPIDEMIOL, V157, P218, DOI 10.1093/aje/kwf180; World Health Organization, 2010, HUM PAP LAB MAN, P35	39	17	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0125693	10.1371/journal.pone.0125693	http://dx.doi.org/10.1371/journal.pone.0125693			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25954813	Green Published, Green Submitted, gold			2022-12-26	WOS:000356768100068
J	Wu, CC; Huang, YS; Chen, JS; Huang, CF; Su, SL; Lu, KC; Lin, YF; Chu, PL; Lin, SH; Sytwu, HK				Wu, Chia-Chao; Huang, Yen-Sung; Chen, Jin-Shuen; Huang, Ching-Feng; Su, Sui-Lung; Lu, Kuo-Cheng; Lin, Yuh-Feng; Chu, Pauling; Lin, Shih-Hua; Sytwu, Huey-Kang			Resveratrol Ameliorates Renal Damage, Increases Expression of Heme Oxygenase-1, and Has Anti-Complement, Anti-Oxidative, and Anti-Apoptotic Effects in a Murine Model of Membranous Nephropathy	PLOS ONE			English	Article							BOVINE SERUM-ALBUMIN; FRENCH PARADOX; BIOAVAILABILITY; PATHOGENESIS; MICE	Background Idiopathic membranous nephropathy (MN) is an autoimmune-mediated glomerulonephritis and a common cause of nephrotic syndrome in adults. There are limited available treatments for MN. We assessed the efficacy of resveratrol (RSV) therapy for treatment of MN in a murine model of this disease. Methods Murine MN was experimentally induced by daily subcutaneous administration of cationic bovine serum albumin, with phosphate-buffered saline used in control mice. MN mice were untreated or given RSV. Disease severity and pathogenesis was assessed by determination of metabolic and histopathology profiles, lymphocyte subsets, immunoglobulin production, oxidative stress, apoptosis, and production of heme oxygenase-1 (HO1). Results MN mice given RSV had significantly reduced proteinuria and a marked amelioration of glomerular lesions. RSV also significantly attenuated immunofluorescent staining of C3, although there were no changes of serum immunoglobulin levels or immunocomplex deposition in the kidneys. RSV treatment of MN mice also reduced the production of reactive oxygen species (ROS), reduced cell apoptosis, and upregulated heme oxygenase 1 (HO1). Inhibition of HO1 with tin protoporphyrin IX partially reversed the renoprotective effects of RSV. The HO1 induced by RSV maybe via Nrf2 signaling. Conclusion Our results show that RSV increased the expression of HO1 and ameliorated the effects of membranous nephropathy in a mouse model due to its anti-complement, anti-oxidative, and anti-apoptotic effects. RSV appears to have potential as a treatment for MN.	[Wu, Chia-Chao; Chen, Jin-Shuen; Chu, Pauling; Lin, Shih-Hua] Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Med, Div Nephrol, Taipei, Taiwan; [Wu, Chia-Chao; Sytwu, Huey-Kang] Natl Def Med Ctr, Grad Inst Microbiol & Immunol, Taipei, Taiwan; [Huang, Yen-Sung] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Huang, Ching-Feng] Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Pediat, Taipei, Taiwan; [Su, Sui-Lung] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Lu, Kuo-Cheng] Fu Jen Catholic Univ, Cardinal Tien Hosp, Sch Med, Dept Med, New Taipei City, Taiwan; [Lin, Yuh-Feng] Taipei Med Univ, Shuang Ho Hosp, Dept Med, Div Nephrol, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Academia Sinica - Taiwan; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Cardinal Tien Hospital; Fu Jen Catholic University; Taipei Medical University; Shuang Ho Hospital	Wu, CC (corresponding author), Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Med, Div Nephrol, Taipei, Taiwan.	wucc@ndmctsgh.edu.tw	Huang, Yen-Sung/E-9086-2013	Huang, Yen-Sung/0000-0002-1219-0724; Wu, Chia-Chao/0000-0002-8772-011X; Su, Sui-Lung/0000-0003-3122-1116	National Science Council [NSC 101-2314-B-016-061-MY3]; Ministry of National Defense [MBA-05]; Tri-Service General Hospital, Taiwan [TSGH-C104-008-S03]; Cardinal Tien Hospital [CTH-C101-S05]	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of National Defense; Tri-Service General Hospital, Taiwan; Cardinal Tien Hospital	This study was supported by research grants from the National Science Council (NSC 101-2314-B-016-061-MY3), Ministry of National Defense (MBA-05) and the Tri-Service General Hospital (TSGH-C104-008-S03), Taiwan to CC Wu and grants from the Cardinal Tien Hospital (CTH-C101-S05) to KC Lu. We declare that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bertelli A, 1998, DRUG EXP CLIN RES, V24, P133; Bertelli AAA, 2009, J CARDIOVASC PHARM, V54, P468, DOI 10.1097/FJC.0b013e3181bfaff3; Bhat KPL, 2001, CANCER RES, V61, P7456; Borriello A, 2014, CANCER TREAT RES, V159, P167, DOI 10.1007/978-3-642-38007-5_10; Catalgol B, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00141; Cattran D, 2005, J AM SOC NEPHROL, V16, P1188, DOI 10.1681/ASN.2005010028; Cattran DC, 2001, KIDNEY INT, V59, P1983, DOI 10.1046/j.1523-1755.2001.0590051983.x; Chen JS, 2004, NEPHROL DIAL TRANSPL, V19, P2721, DOI 10.1093/ndt/gfh419; Cottart CH, 2010, MOL NUTR FOOD RES, V54, P7, DOI 10.1002/mnfr.200900437; COUSER WG, 1988, ANNU REV MED, V39, P517; Csiszar A, 2011, ANN NY ACAD SCI, V1215, P117, DOI 10.1111/j.1749-6632.2010.05848.x; Cybulsky AV, 2005, AM J PHYSIOL-RENAL, V289, pF660, DOI 10.1152/ajprenal.00437.2004; de la Lastra CA, 2005, MOL NUTR FOOD RES, V49, P405; du Buf-Vereijken PWG, 2005, AM J KIDNEY DIS, V46, P1012, DOI 10.1053/j.ajkd.2005.08.020; Glassock RJ, 2004, AM J KIDNEY DIS, V44, P562, DOI 10.1053/j.ajkd.2004.06.003; Glassock RJ, 2003, SEMIN NEPHROL, V23, P324, DOI 10.1016/S0270-9295(03)00049-4; He S, 2013, CURR MED CHEM, V20, P1005; Huang YS, 2014, BIOCHEM BIOPH RES CO, V452, P415, DOI 10.1016/j.bbrc.2014.08.077; Issuree PDA, 2009, FASEB J, V23, P2412, DOI 10.1096/fj.09-130542; Kitada M, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/568093; Kovacic P, 2010, OXID MED CELL LONGEV, V3, P86, DOI 10.4161/oxim.3.2.11147; Nangaku M, 2005, J AM SOC NEPHROL, V16, P1195, DOI 10.1681/ASN.2004121098; Nihei T, 2001, LIFE SCI, V68, P2845, DOI 10.1016/S0024-3205(01)01061-X; Oh SR, 1998, ARCH PHARM RES, V21, P703, DOI 10.1007/BF02976761; Palsamy P, 2011, BBA-MOL BASIS DIS, V1812, P719, DOI 10.1016/j.bbadis.2011.03.008; RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F; Ronco P, 2006, CURR OPIN NEPHROL HY, V15, P258, DOI 10.1097/01.mnh.0000222692.99711.02; Signorelli P, 2005, J NUTR BIOCHEM, V16, P449, DOI 10.1016/j.jnutbio.2005.01.017; Son Y, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/639541; Walle T, 2004, DRUG METAB DISPOS, V32, P1377, DOI 10.1124/dmd.104.000885; Whitlock NC, 2012, NUTR CANCER, V64, P493, DOI 10.1080/01635581.2012.667862; Wood LG, 2010, ANTIOXID REDOX SIGN, V13, P1535, DOI 10.1089/ars.2009.3064; Wu CC, 2007, KIDNEY INT, V72, P831, DOI 10.1038/sj.ki.5002426; Wu CC, 2008, NEPHROL DIAL TRANSPL, V23, P3082, DOI 10.1093/ndt/gfn247; Wu CC, 2008, LAB ANIM-UK, V42, P350, DOI 10.1258/la.2007.06016e; Wu CC, 2012, J CLIN IMMUNOL, V32, P138, DOI 10.1007/s10875-011-9614-7; Wu CC, 2007, PLANTA MED, V73, P439, DOI 10.1055/s-2007-967173; Wu JM, 2011, ANN NY ACAD SCI, V1215, P16, DOI 10.1111/j.1749-6632.2010.05854.x	39	53	56	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0125726	10.1371/journal.pone.0125726	http://dx.doi.org/10.1371/journal.pone.0125726			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25954969	Green Submitted, Green Published, gold			2022-12-26	WOS:000356768100069
J	Kim, H; Youn, SJ; Kim, SO; Ko, J; Lee, JO; Choi, BS				Kim, Henna; Youn, Suk-Jun; Kim, Seong Ok; Ko, Junsang; Lee, Jie-Oh; Choi, Byong-Seok			Structural Studies of Potassium Transport Protein KtrA Regulator of Conductance of K+ (RCK) C Domain in Complex with Cyclic Diadenosine Monophosphate (c-di-AMP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial signal transduction; crystal structure; cyclic diadenosine monophosphate (c-di-AMP); isothermal titration calorimetry (ITC); potassium transport; Staphylococcus aureus (S; aureus)	BACILLUS-SUBTILIS; SIGNAL-TRANSDUCTION; DNA INTEGRITY; GMP; REVEALS; BINDING; SYSTEM; IDENTIFICATION; RECOGNITION; RESISTANCE	Background: Cyclic di-AMP inactivates the potassium transport activity of KtrA. Results: Cyclic di-AMP binding to KrtA induced conformational changes. Conclusion: Cyclic di-AMP selectively binds to the KtrA RCK_C domain and signals the inactivation of potassium transport. Significance: The molecular basis for the role of cyclic di-AMP in potassium channel activity was investigated. Although it was only recently identified as a second messenger, c-di-AMP was found to have fundamental importance in numerous bacterial functions such as ion transport. The potassium transporter protein, KtrA, was identified as a c-di-AMP receptor. However, the co-crystallization of c-di-AMP with the protein has not been studied. Here, we determined the crystal structure of the KtrA RCK_C domain in complex with c-di-AMP. The c-di-AMP nucleotide, which adopts a U-shaped conformation, is bound at the dimer interface of RCK_C close to helices 3 and 4. c-di-AMP interacts with KtrA RCK_C mainly by forming hydrogen bonds and hydrophobic interactions. c-di-AMP binding induces the contraction of the dimer, bringing the two monomers of KtrA RCK_C into close proximity. The KtrA RCK_C was able to interact with only c-di-AMP, but not with c-di-GMP, 3,3-cGAMP, ATP, and ADP. The structure of the KtrA RCK_C domain and c-di-AMP complex would expand our understanding about the mechanism of inactivation in Ktr transporters governed by c-di-AMP.	[Kim, Henna; Youn, Suk-Jun; Kim, Seong Ok; Ko, Junsang; Lee, Jie-Oh; Choi, Byong-Seok] Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST)	Lee, JO (corresponding author), Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea.	jieoh@kaist.ac.kr; byongseok.choi@kaist.ac.kr	Choi, Byong-Seok/C-1937-2011; Lee, Jie-Oh/AAG-4302-2020	Lee, Jie-Oh/0000-0001-6519-6049	National Research Foundation of Korea [2011-0020322]; High Risk High Return project by KAIST; Intelligent Synthetic Biology Center of Global Frontier Project - Ministry of Science, ICT and Future Planning Grant [20110031955]	National Research Foundation of Korea(National Research Foundation of Korea); High Risk High Return project by KAIST; Intelligent Synthetic Biology Center of Global Frontier Project - Ministry of Science, ICT and Future Planning Grant	This work was supported by the National Research Foundation of Korea Grant 2011-0020322 and High Risk High Return project by KAIST (to B-S. C.) and the Intelligent Synthetic Biology Center of Global Frontier Project funded by the Ministry of Science, ICT and Future Planning Grant 20110031955 (to J. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Albright RA, 2006, CELL, V126, P1147, DOI 10.1016/j.cell.2006.08.028; Bai YL, 2014, J BACTERIOL, V196, P614, DOI 10.1128/JB.01041-13; Barker JR, 2013, MBIO, V4, DOI 10.1128/mBio.00018-13; Benach J, 2007, EMBO J, V26, P5153, DOI 10.1038/sj.emboj.7601918; Berry S, 2003, FEBS LETT, V548, P53, DOI 10.1016/S0014-5793(03)00729-4; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Campeotto I, 2015, J BIOL CHEM, V290, P2888, DOI 10.1074/jbc.M114.621789; Campos SS, 2014, J BACTERIOL, V196, P568, DOI 10.1128/JB.01259-13; Corrigan RM, 2013, NAT REV MICROBIOL, V11, P513, DOI 10.1038/nrmicro3069; Corrigan RM, 2013, P NATL ACAD SCI USA, V110, P9084, DOI 10.1073/pnas.1300595110; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; Davies BW, 2012, CELL, V149, P358, DOI 10.1016/j.cell.2012.01.053; Dvir H, 2010, J STRUCT BIOL, V171, P231, DOI 10.1016/j.jsb.2010.03.020; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gundlach J, 2015, J BIOL CHEM, V290, P3069, DOI 10.1074/jbc.M114.619619; Hanelt I, 2011, EUR J CELL BIOL, V90, P696, DOI 10.1016/j.ejcb.2011.04.010; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Holtmann G, 2003, J BACTERIOL, V185, P1289, DOI 10.1128/JB.185.4.1289-1298.2003; Horrigan FT, 2005, J GEN PHYSIOL, V126, P7, DOI 10.1085/jgp.200509262; Huang YH, 2012, NAT STRUCT MOL BIOL, V19, P728, DOI 10.1038/nsmb.2333; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Luo Y, 2012, MOL MICROBIOL, V83, P623, DOI 10.1111/j.1365-2958.2011.07953.x; Matsuda N, 2004, J BIOL CHEM, V279, P54952, DOI 10.1074/jbc.M407268200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mehne FMP, 2013, J BIOL CHEM, V288, P2004, DOI 10.1074/jbc.M112.395491; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Oppenheimer-Shaanan Y, 2011, EMBO REP, V12, P594, DOI 10.1038/embor.2011.77; Ouyang SY, 2012, IMMUNITY, V36, P1073, DOI 10.1016/j.immuni.2012.03.019; Parvatiyar K, 2012, NAT IMMUNOL, V13, P1155, DOI 10.1038/ni.2460; Pozzi C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002626; Rao F, 2010, J BIOL CHEM, V285, P473, DOI 10.1074/jbc.M109.040238; Shang GJ, 2012, NAT STRUCT MOL BIOL, V19, P725, DOI 10.1038/nsmb.2332; Shu C, 2012, NAT STRUCT MOL BIOL, V19, P722, DOI 10.1038/nsmb.2331; Smith FJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3621; Smith WM, 2012, APPL ENVIRON MICROB, V78, P7753, DOI 10.1128/AEM.02316-12; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sureka K, 2014, CELL, V158, P1389, DOI 10.1016/j.cell.2014.07.046; Terwilliger TC, 2006, ACTA CRYSTALLOGR D, V62, P915, DOI 10.1107/S0907444906017161; Vieira-Pires RS, 2013, NATURE, V496, P323, DOI 10.1038/nature12055; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Yang J, 2014, MOL MICROBIOL, V93, P65, DOI 10.1111/mmi.12641; Yin Q, 2012, MOL CELL, V46, P735, DOI 10.1016/j.molcel.2012.05.029; Zhang L, 2013, J BIOL CHEM, V288, P3085, DOI 10.1074/jbc.M112.428110	48	54	58	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16393	16402		10.1074/jbc.M115.641340	http://dx.doi.org/10.1074/jbc.M115.641340			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25957408	Green Published, hybrid			2022-12-26	WOS:000356930100040
J	Paczolt, KA; Jones, AG				Paczolt, Kimberly A.; Jones, Adam G.			The Effects of Food Limitation on Life History Tradeoffs in Pregnant Male Gulf Pipefish	PLOS ONE			English	Article							FILIAL CANNIBALISM; RESOURCE-ALLOCATION; BROOD SIZE; CARE; REPRODUCTION; COSTS; AVAILABILITY; SELECTION; BEHAVIOR; SUCCESS	Syngnathid fishes (pipefishes, seahorses and seadragons) are characterized by a unique mode of paternal care in which embryos develop on or in the male's body, often within a structure known as a brood pouch. Evidence suggests that this pouch plays a role in mediating postcopulatory sexual selection and that males have some control over the events occurring within the pouch during the pregnancy. These observations lead to the prediction that males should invest differently in broods depending on the availability of food. Here, we use the Gulf pipefish to test this prediction by monitoring growth rate and offspring survivorship during the pregnancies of males under low- or high-food conditions. Our results show that pregnant males grow less rapidly on average than non-pregnant males, and pregnant males under low- food conditions grow less than pregnant males under high-food conditions. Offspring survivorship, on the other hand, does not differ between food treatments, suggesting that male Gulf pipefish sacrifice investment in somatic growth, and thus indirectly sacrifice future reproduction, in favor of current reproduction. However, a positive relationship between number of failed eggs and male growth rate in our low-food treatments suggests that undeveloped eggs reduce the pregnancy's overall cost to the male compared to broods containing only viable offspring.	[Paczolt, Kimberly A.; Jones, Adam G.] Texas A&M Univ, Dept Biol, TAMU 3258, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Paczolt, KA (corresponding author), Texas A&M Univ, Dept Biol, TAMU 3258, College Stn, TX 77843 USA.	kpaczolt@umd.edu		Jones, Adam/0000-0003-0228-7124	National Science Foundation Doctoral Dissertation Improvement Grant [IOS-1011468]; National Science Foundation [DEB-1119261]	National Science Foundation Doctoral Dissertation Improvement Grant(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF))	This work was supported by a National Science Foundation Doctoral Dissertation Improvement Grant (IOS-1011468) to KAP, and a National Science Foundation grant to AGJ (DEB-1119261). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHNESJO I, 1992, FUNCT ECOL, V6, P274, DOI 10.2307/2389517; AZZARELLO MY, 1991, B MAR SCI, V49, P741; Baron JP, 2013, FUNCT ECOL, V27, P173, DOI 10.1111/1365-2435.12023; BERGLUND A, 1990, BEHAV ECOL SOCIOBIOL, V27, P129, DOI 10.1007/BF00168456; Brown JD, 1972, COMP LIFE HIST STUDY; CARLISLE TR, 1982, ANIM BEHAV, V30, P824, DOI 10.1016/S0003-3472(82)80156-5; Hamel S, 2010, ECOLOGY, V91, P2034, DOI 10.1890/09-1311.1; HARESIGN TW, 1981, COMP BIOCHEM PHYS A, V69, P603, DOI 10.1016/0300-9629(81)93030-9; Ji X, 2007, BIOL J LINN SOC, V91, P315, DOI 10.1111/j.1095-8312.2007.00791.x; Jones AG, 1997, MOL ECOL, V6, P203, DOI 10.1046/j.1365-294X.1997.00173.x; Jones AG, 2001, P ROY SOC B-BIOL SCI, V268, P2531, DOI 10.1098/rspb.2001.1841; Klug H, 2009, ANIM BEHAV, V77, P1313, DOI 10.1016/j.anbehav.2009.01.035; Lindstrom K, 1997, BEHAV ECOL SOCIOBIOL, V40, P107, DOI 10.1007/s002650050322; Lindstrom K, 1998, BEHAV ECOL SOCIOBIOL, V42, P101, DOI 10.1007/s002650050417; Manica A, 2003, J FISH BIOL, V63, P37, DOI 10.1046/j.1095-8649.2003.00113.x; Manica A, 2002, BIOL REV, V77, P261, DOI 10.1017/S1464793101005905; Mehlis M, 2009, NATURWISSENSCHAFTEN, V96, P399, DOI 10.1007/s00114-008-0485-6; Neff BD, 2003, BEHAV ECOL SOCIOBIOL, V54, P377, DOI 10.1007/s00265-003-0645-9; Okuda N, 2004, BEHAVIOUR, V141, P279, DOI 10.1163/156853904322981851; Paczolt KA, 2010, NATURE, V464, P401, DOI 10.1038/nature08861; Partridge C, 2007, COMP BIOCHEM PHYS A, V147, P556, DOI 10.1016/j.cbpa.2007.02.007; Partridge C, 2013, ETHOLOGY, V119, P692, DOI 10.1111/eth.12110; QUAST WD, 1980, COMP BIOCHEM PHYS A, V67, P675, DOI 10.1016/0300-9629(80)90259-5; Ripley JL, 2009, COMP BIOCHEM PHYS A, V154, P98, DOI 10.1016/j.cbpa.2009.05.003; Ripley JL, 2009, J COMP PHYSIOL B, V179, P325, DOI 10.1007/s00360-008-0316-2; Roff Derek A., 1992; Rose E, 2013, AM NAT, V182, P410, DOI 10.1086/671233; Roth O, 2012, AM NAT, V180, P802, DOI 10.1086/668081; Sagebakken G, 2010, P ROY SOC B-BIOL SCI, V277, P971, DOI 10.1098/rspb.2009.1767; Sargent RC, 1992, CANNIBALISM ECOL EVO, V38, P62; Scobell SK, 2009, ANIM BEHAV, V78, P747, DOI 10.1016/j.anbehav.2009.05.036; Stearns S.C., 1992, pi; SVENSSON I, 1988, J ANIM ECOL, V57, P929, DOI 10.2307/5102; Therrien JF, 2007, BEHAV ECOL SOCIOBIOL, V62, P193, DOI 10.1007/s00265-007-0453-8; Thomas LK, 2003, ANIM BEHAV, V66, P205, DOI 10.1006/anbe.2003.2202; Velando A, 2003, J ANIM ECOL, V72, P846, DOI 10.1046/j.1365-2656.2003.00756.x; Yurewicz KL, 2004, COPEIA, P28, DOI 10.1643/0045-8511(2004)004[0028:RAACOR]2.0.CO;2	37	7	7	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0124147	10.1371/journal.pone.0124147	http://dx.doi.org/10.1371/journal.pone.0124147			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970284	gold, Green Submitted, Green Published			2022-12-26	WOS:000354544200030
J	Singh, N; Mishra, AK; Chand, SK; Bharti, PK; Singh, MP; Nanda, N; Singh, OP; Sodagiri, K; Udhyakumar, V				Singh, Neeru; Mishra, Ashok K.; Chand, Sunil K.; Bharti, Praveen K.; Singh, Mrigendra P.; Nanda, Nutan; Singh, Om P.; Sodagiri, Kranti; Udhyakumar, Venkatachalam			Relative Abundance and Plasmodium Infection Rates of Malaria Vectors in and around Jabalpur, a Malaria Endemic Region in Madhya Pradesh State, Central India	PLOS ONE			English	Article							ANOPHELES-CULICIFACIES; RIBOSOMAL DNA; MEMBERS; IDENTIFICATION; FLUVIATILIS; DYNAMICS; COMPLEX; DIFFERENTIATION; TRANSMISSION; SPOROZOITES	Background This study was undertaken in two Primary Health Centers (PHCs) of malaria endemic district Jabalpur in Madhya Pradesh (Central India). Methods In this study we had investigated the relative frequencies of the different anopheline species collected within the study areas by using indoor resting catches, CDC light trap and human landing methods. Sibling species of malaria vectors were identified by cytogenetic and molecular techniques. The role of each vector and its sibling species in the transmission of the different Plasmodium species was ascertained by using sporozoite ELISA. Results A total of 52,857 specimens comprising of 17 anopheline species were collected by three different methods (39,964 by indoor resting collections, 1059 by human landing and 11,834 by CDC light trap). Anopheles culicifacies was most predominant species in all collections (55, 71 and 32% in indoor resting, human landing and light trap collections respectively) followed by An. subpictus and An. annularis. All five sibling species of An. culicifacies viz. species A, B, C, D and E were found while only species T and S of An. fluviatilis were collected. The overall sporozoite rate in An. culicifacies and An. fluviatilis were 0.42% (0.25% for P. falciparum and 0.17% for P. vivax) and 0.90% (0.45% for P. falciparum and 0.45% for P. vivax) respectively. An. culicifacies and An. fluviatilis were found harbouring both P. vivax variants VK-210 and VK-247, and P. falciparum. An. culicifacies sibling species C and D were incriminated as vectors during most part of the year while sibling species T of An. fluviatilis was identified as potential vector in monsoon and post monsoon season. Conclusions An. culicifacies species C (59%) was the most abundant species followed by An. culicifacies D (24%), B (8.7%), E (6.7%) and A (1.5%). Among An. fluviatilis sibling species, species T was common (99%) and only few specimens of S were found. Our study provides crucial information on the prevalence of An. culicifacies and An. fluviatilis sibling species and their potential in malaria transmission which will assist in developing strategic control measures against these vectors.	[Singh, Neeru; Bharti, Praveen K.; Sodagiri, Kranti] Reg Med Res Ctr Tribals, Natl Inst Res Tribal Hlth, Jabalpur, Madhya Pradesh, India; [Mishra, Ashok K.; Chand, Sunil K.; Singh, Mrigendra P.] ICMR, Natl Inst Malaria Res, Field Stn, Jabalpur, Madhya Pradesh, India; [Nanda, Nutan; Singh, Om P.] Natl Inst Malaria Res, New Delhi, India; [Udhyakumar, Venkatachalam] CDC, Genet & Immunol Lab, Malaria Branch, DPD,NCZVED,CCID, Atlanta, GA USA	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tribal Health (NIRTH); Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Centers for Disease Control & Prevention - USA	Singh, N (corresponding author), Reg Med Res Ctr Tribals, Natl Inst Res Tribal Hlth, Nagpur Rd, Jabalpur, Madhya Pradesh, India.	neeru.singh@gmail.com	Singh, Om/B-7958-2011	Singh, Om/0000-0001-5135-6654; Singh, Mrigendra/0000-0003-4336-4413	Indian Council of Medical Research, New Delhi, India (ICMR Task Force Grant)	Indian Council of Medical Research, New Delhi, India (ICMR Task Force Grant)	The study was funded by Indian Council of Medical Research, New Delhi, India (ICMR Task Force Grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barik TK, 2009, ACTA TROP, V109, P87, DOI 10.1016/j.actatropica.2008.09.017; Chand G, 2015, IND J MED R IN PRESS; Christopher S. R., 1933, FAUNA BRIT INDIA INC, VIV; COEN E, 1982, J MOL BIOL, V158, P17, DOI 10.1016/0022-2836(82)90448-X; Das M, 2013, TROP MED INT HEALTH, V18, P810, DOI 10.1111/tmi.12112; Goswami G, 2005, ACTA TROP, V95, P92, DOI 10.1016/j.actatropica.2005.04.018; Goswami G, 2006, AM J TROP MED HYG, V75, P454, DOI 10.4269/ajtmh.2006.75.454; GREEN CA, 1980, GENETICA, V51, P187, DOI 10.1007/BF00121610; Gunasekaran K, 2005, TROP MED INT HEALTH, V10, P160, DOI 10.1111/j.1365-3156.2004.01369.x; KULKARNI S M, 1987, Indian Journal of Malariology, V24, P163; Nanda N, 2000, J AM MOSQUITO CONTR, V16, P199; Nanda N, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-215; Puri IM, 1955, HLTH B, V10; Rao TR, 1984, ANOPHELINES INDIA RE; REISEN WK, 1978, B ENTOMOL RES, V68, P313, DOI 10.1017/S0007485300007392; Singh N, 1996, J AM MOSQUITO CONTR, V12, P225; Singh N, 2004, TROP MED INT HEALTH, V9, P364, DOI 10.1046/j.1365-3156.2003.01181.x; Singh N, 1999, J AM MOSQUITO CONTR, V15, P283; Singh N, 2003, AM J TROP MED HYG, V68, P602, DOI 10.4269/ajtmh.2003.68.602; Singh N, 2006, TROP MED INT HEALTH, V11, P1512, DOI 10.1111/j.1365-3156.2006.01703.x; Singh N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073730; Singh N, 2011, T ROY SOC TROP MED H, V105, P133, DOI 10.1016/j.trstmh.2010.11.002; Singh OP, 2004, J BIOSCIENCES, V29, P275, DOI 10.1007/BF02702609; Singh OP, 2004, AM J TROP MED HYG, V70, P27, DOI 10.4269/ajtmh.2004.70.27; Subbarao S.K., 1988, Systematics Association Special Volume Series, P25; SUBBARAO SK, 1992, T ROY SOC TROP MED H, V86, P613, DOI 10.1016/0035-9203(92)90149-7; SUBBARAO SK, 1988, J AM MOSQUITO CONTR, V4, P29; Subbarao SK, 2007, ANOPHELINE SPECIES C, V57; Surendran SN, 2006, MED VET ENTOMOL, V20, P153, DOI 10.1111/j.1365-2915.2006.00601.x; Vaid B. K., 1974, Journal of Communicable Diseases, V6, P270; WHITE R. Senior., 1946, Journal of the Malaria Institute of India, V6, P417; WHO, 1975, MAN PRACT ENT MAL; WIRTZ RA, 1987, B WORLD HEALTH ORGAN, V65, P39; WIRTZ RA, 1985, AM J TROP MED HYG, V34, P1048, DOI 10.4269/ajtmh.1985.34.1048	34	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0126932	10.1371/journal.pone.0126932	http://dx.doi.org/10.1371/journal.pone.0126932			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970291	Green Published, gold, Green Submitted			2022-12-26	WOS:000354544200140
J	Chiuso-Minicucci, F; Ishikawa, LLW; Mimura, LAN; Fraga-Silva, TFD; Franca, TGD; Zorzella-Pezavento, SFG; Marques, C; Ikoma, MRV; Sartori, A				Chiuso-Minicucci, Fernanda; Watanabe Ishikawa, Larissa Lumi; Nishiyama Mimura, Luiza Ayumi; de Campos Fraga-Silva, Thais Fernanda; Donega Franca, Thais Graziela; Fernanda Goncalves Zorzella-Pezavento, Sofia; Marques, Camila; Valerio Ikoma, Maura Rosane; Sartori, Alexandrina			Treatment with Vitamin D/MOG Association Suppresses Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							MYELIN BASIC-PROTEIN; DENDRITIC CELLS; MULTIPLE-SCLEROSIS; T-CELLS; IMMUNE-SYSTEM; INDUCTION; MODULATION; ACTIVATION; TOLERANCE; ADJUVANT	Experimental autoimmune encephalomyelitis (EAE) is an animal model to study multiple sclerosis (MS). Considering the tolerogenic effects of active vitamin D, we evaluated the therapeutic effect of myelin oligodendrocyte glycoprotein (MOG) associated with active vitamin D in EAE development. EAE was induced in female C57BL/6 mice by immunization with MOG emulsified with Complete Freund's Adjuvant plus Mycobacterium tuberculosis. Animals also received two intraperitoneal doses of Bordetella pertussis toxin. One day after immunization, mice were treated with 0,1 mu g of 1 alpha,25-dihydroxyvitamin D3 (1,25(OH)(2)D-3) every other day during 15 days (on days 1, 3, 5, 7, 9, 11, 13 and 15). MOG (150 mu g) was coadministered on days 3 and 11. The administration of 1,25(OH)(2)D-3 or MOG determined significant reduction in EAE incidence and in clinical scores. When MOG was associated with 1,25(OH)(2)D-3 the animals did not develop EAE. Spleen and central nervous system (CNS) cell cultures from this group produced less IL-6 and IL-17 upon stimulation with MOG in comparison to the EAE control group. In addition, this treatment inhibited dendritic cells maturation in the spleen and reduced inflammatory infiltration in the CNS. The association of MOG with 1,25(OH)(2)D-3 was able to control EAE development.	[Chiuso-Minicucci, Fernanda; Watanabe Ishikawa, Larissa Lumi; Nishiyama Mimura, Luiza Ayumi; de Campos Fraga-Silva, Thais Fernanda; Donega Franca, Thais Graziela; Fernanda Goncalves Zorzella-Pezavento, Sofia; Sartori, Alexandrina] Univ Estadual Paulista UNESP, Biosci Inst, Dept Microbiol & Immunol, Botucatu, SP, Brazil; [Marques, Camila; Valerio Ikoma, Maura Rosane] Fundacao Dr Amaral Carvalho, Lab Citometria Fluxo, Jau, SP, Brazil	Universidade Estadual Paulista	Sartori, A (corresponding author), Univ Estadual Paulista UNESP, Biosci Inst, Dept Microbiol & Immunol, Botucatu, SP, Brazil.	sartori@ibb.unesp.br	Ishikawa, Larissa LW/I-5104-2014; Fraga-Silva, Thais Fernanda de Campos/D-3962-2016; Sartori, Alexandrina/AAA-6191-2020; Sartori, Alexandrina/B-2951-2013; Zorzella-Pezavento, Sofia Fernanda Gonçalves/B-2568-2013; Minicucci, Fernanda C/A-9220-2015; Mimura, Luiza/D-6034-2017	Ishikawa, Larissa LW/0000-0003-3481-2181; Fraga-Silva, Thais Fernanda de Campos/0000-0002-2053-8938; Sartori, Alexandrina/0000-0003-4557-3331; Sartori, Alexandrina/0000-0003-4557-3331; Zorzella-Pezavento, Sofia Fernanda Gonçalves/0000-0001-9030-0768; Minicucci, Fernanda C/0000-0002-4155-6414; Mimura, Luiza/0000-0001-6173-0523	National Counsel of Technological and Scientific Development (CNPq) [301770/2009-3]; Sao Paulo Research Foundation (FAPESP) grant [2011/00465-8]	National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sao Paulo Research Foundation (FAPESP) grant(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by National Counsel of Technological and Scientific Development (CNPq) grant number 301770/2009-3 to AS. Sao Paulo Research Foundation (FAPESP) grant # 2011/00465-8 to FCM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorini L, 2004, SEMIN IMMUNOL, V16, P127, DOI 10.1016/j.smim.2003.12.008; Barazany HL, 2014, EXP NEUROL, V255, P63, DOI 10.1016/j.expneurol.2014.02.010; Bynoe MS, 2003, IMMUNITY, V19, P317, DOI 10.1016/S1074-7613(03)00239-5; Carlberg C, 1998, CRIT REV EUKAR GENE, V8, P19, DOI 10.1615/CritRevEukarGeneExpr.v8.i1.20; Chambers ES, 2011, CURR ALLERGY ASTHM R, V11, P29, DOI 10.1007/s11882-010-0161-8; Chang JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012925; Chen SJ, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/970789; Dimeloe S, 2010, J STEROID BIOCHEM, V120, P86, DOI 10.1016/j.jsbmb.2010.02.029; Divekar RD, 2011, J IMMUNOL, V187, P3979, DOI 10.4049/jimmunol.1100531; Domingues HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015531; Farias AS, 2013, CNS NEUROSCI THER, V19, P269, DOI 10.1111/cns.12071; Fissolo N, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-139; Fletcher JM, 2010, CLIN EXP IMMUNOL, V162, P1, DOI 10.1111/j.1365-2249.2010.04143.x; Zorzella-Pezavento SFG, 2014, J NEUROIMMUNOL, V268, P35, DOI 10.1016/j.jneuroim.2013.12.015; Zorzella-Pezavento SFG, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/519627; Gordon JR, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00007; Gregori S, 2002, DIABETES, V51, P1367, DOI 10.2337/diabetes.51.5.1367; Hackstein H, 2004, NAT REV IMMUNOL, V4, P24, DOI 10.1038/nri1256; Hart PH, 2011, NAT REV IMMUNOL, V11, P584, DOI 10.1038/nri3045; HIGGINS PJ, 1988, J IMMUNOL, V140, P440; Hilliard B, 1999, MULT SCLER, V5, P2; Ishikawa LLW, 2014, LUPUS, V23, P577, DOI 10.1177/0961203314527369; Ishizu T, 2005, BRAIN, V128, P988, DOI 10.1093/brain/awh453; Kang YM, 2008, J IMMUNOL, V180, P5172, DOI 10.4049/jimmunol.180.8.5172; Kang YM, 2009, J GENE MED, V11, P1064, DOI 10.1002/jgm.1387; Li B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058808; Loleit V, 2014, CURR PHARM BIOTECHNO, V15, P276, DOI 10.2174/1389201015666140617104332; Martinelli V, 2014, MULT SCLER J, V20, P147, DOI 10.1177/1352458513494959; Mathieu C, 2011, IBMS BONEKEY, V8, P178, DOI DOI 10.1138/20110505; Mitchell KM, 2007, MULT SCLER J, V13, P1118, DOI 10.1177/1352458507078916; Nikolic T, 2013, FRONT IMMUNOL, V14, P4; Pedersen AW, 2011, VITAM HORM, V86, P63, DOI 10.1016/B978-0-12-386960-9.00003-4; Penna G, 2000, J IMMUNOL, V164, P2405, DOI 10.4049/jimmunol.164.5.2405; Petkovic F, 2013, J NEUROIMMUNOL, V259, P55, DOI 10.1016/j.jneuroim.2013.03.010; Spach KM, 2006, J IMMUNOL, V177, P6030, DOI 10.4049/jimmunol.177.9.6030; Tang J, 2009, J IMMUNOL, V182, P4624, DOI 10.4049/jimmunol.0801543; Tian Y, 2012, INVEST OPHTH VIS SCI, V53, P6434, DOI 10.1167/iovs.12-10398; van Halteren AGS, 2004, J AUTOIMMUN, V23, P233, DOI 10.1016/j.jaut.2004.06.004; Walczak A, 2013, JAMA NEUROL, V70, P1105, DOI 10.1001/jamaneurol.2013.3022; Yang CY, 2013, CLIN REV ALLERG IMMU, V45, P217, DOI 10.1007/s12016-013-8361-3	40	34	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0125836	10.1371/journal.pone.0125836	http://dx.doi.org/10.1371/journal.pone.0125836			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965341	Green Published, gold, Green Submitted			2022-12-26	WOS:000354543500030
J	Niu, LL; Zhang, SJ; Wu, JH; Chen, L; Wang, Y				Niu, Liangliang; Zhang, Shujie; Wu, Jihong; Chen, Ling; Wang, Yan			Upregulation of NLRP3 Inflammasome in the Tears and Ocular Surface of Dry Eye Patients	PLOS ONE			English	Article							SJOGRENS-SYNDROME; MACULAR DEGENERATION; DISEASE; EXPRESSION; MECHANISMS; CYTOKINES; CLASSIFICATION; DISORDER; COMPLEX; BETA	Purpose To evaluate the mRNA and protein expressions of NLRP3 inflammasome and its downstream inflammatory factors in human dry eye. Methods We recruited 54 patients with Sjogren's syndrome dry eye (SSDE), 50 patients with non-Sjogren's syndrome dry eye (NSSDE), and 46 healthy controls. Tear film breakup time (TBUT), Schirmer I test, and fluorescein staining (FL) were performed on all subjects. Tear samples were obtained to analyze the inflammatory cytokine levels of IL-1 beta and IL-18 via enzyme-linked immunosorbent (ELISA). Conjunctival impression cytology (CIC) specimens were collected to detect the mRNA expression of NLRP3, caspase-1, IL-1 beta, and IL-18 using quantitative RT-PCR, and the protein expression of NLRP3 and caspase-1 by Western blotting. Results NLRP3 mRNA expression showed higher levels in both dry eye groups compared with controls, with a comparably significant elevation in the SSDE group (relative 2.47-fold upregulation, p<0.05). NLRP3 protein expression was also increased in SSDE group (relative1.94-fold upregulation) compared with the controls. mRNA expression of caspase-1 was significantly upregulated in both SSDE (relative 1.44-fold upregulation, p<0.05) and NSSDE (relative 1.32-fold upregulation, p<0.05). Procaspase-1 protein level was increased in SSDE (relative 1.84-fold upregulation) and NSSDE (relative 1.12-fold upregulation) versus controls; and caspase-1 protein expression was also increased in SSDE (relative 1.49-fold upregulation) and NSSDE (relative 1.17-fold upregulation) compared with the controls. The patients with SSDE and NSSDE had higher IL-1 beta and IL-18 mRNA values and protein expressions than the controls did. The relative mRNA expression of IL-1 beta upregulated 3.59-fold (p<0.001) in SSDE and 2.13-fold (p<0.01) in NSSDE compared with the controls. IL-1 beta protein level also showed significant upregulation in SSDE (p=0.01; vs. controls groups). IL-18 mRNA expression levels were significantly upregulated in the SSDE (relative 2.97-fold upregulation, p=0.001) and NSSDE (relative 2.05-fold upregulation, p=0.001) groups compared with the controls; tear IL-18 concentrations were also significantly increased in the SSDE (p<0.001) and NSSDE (p<0.05) groups. Conclusions In the current study, we found that mRNA and protein expressions of NLRP3 inflammasome were upregulated in human dry eyes, especially in SSDE; the downstream inflammatory factors caspase-1, IL-1 beta, and IL-18 were also elevated in dry eye patients. These observations suggest the involvement of NLRP3 inflammasome in the onset and development of the inflammation in dry eye.	[Niu, Liangliang; Chen, Ling; Wang, Yan] Fudan Univ, Eye & ENT Hosp, Dept Ophthalmol, Shanghai 200433, Peoples R China; [Zhang, Shujie; Wu, Jihong] Fudan Univ, Eye & ENT Hosp, Expt Res Ctr, Shanghai 200433, Peoples R China; [Chen, Ling] Univ Hong Kong, Dept Ophthalmol, Hong Kong, Hong Kong, Peoples R China	Fudan University; Fudan University; University of Hong Kong	Wang, Y (corresponding author), Fudan Univ, Eye & ENT Hosp, Dept Ophthalmol, Shanghai 200433, Peoples R China.	wangyandoc@163.com	Chen, Ling/AAM-1821-2021	Wang, Yan/0000-0001-9385-044X	National Science Foundation for Young Scientists of China [81100636]; Shanghai Rising-Star program [12QH1400500]; fund for the development of talents in Shanghai City [2012049]; National Natural Science Foundation of China [81371042]	National Science Foundation for Young Scientists of China; Shanghai Rising-Star program; fund for the development of talents in Shanghai City; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Science Foundation for Young Scientists of China (No. 81100636), the Shanghai Rising-Star program (No. 12QH1400500), the fund for the development of talents in Shanghai City (No. 2012049), and the National Natural Science Foundation of China (No. 81371042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Andersen K, 2014, KIDNEY INT, V86, P965, DOI 10.1038/ki.2014.161; Baldini C, 2013, J INTERN MED, V274, P480, DOI 10.1111/joim.12115; Barabino S, 2012, PROG RETIN EYE RES, V31, P271, DOI 10.1016/j.preteyeres.2012.02.003; Benetti E, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/678627; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Brignole F, 2000, INVEST OPHTH VIS SCI, V41, P1356; Caffery B, 2008, MOL VIS, V14, P2547; Caffery B, 2010, MOL VIS, V16, P1720; Campbell M, 2013, J MOL MED, V91, P1059, DOI 10.1007/s00109-013-1050-0; Cassel SL, 2010, EUR J IMMUNOL, V40, P607, DOI 10.1002/eji.200940207; Choi W, 2012, CURR EYE RES, V37, P12, DOI 10.3109/02713683.2011.622852; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Doyle SL, 2012, NAT MED, V18, P791, DOI 10.1038/nm.2717; Epstein SP, 2013, EXP EYE RES, V111, P95, DOI 10.1016/j.exer.2013.03.018; Hoffman HM, 2010, CURR ALLERGY ASTHM R, V10, P229, DOI 10.1007/s11882-010-0109-z; Im H, 2014, CLIN EXP ALLERGY, V44, P160, DOI 10.1111/cea.12206; Jankovic D, 2013, J EXP MED, V210, P1899, DOI 10.1084/jem.20130084; Kahlenberg JM, 2014, CURR OPIN RHEUMATOL, V26, P475, DOI 10.1097/BOR.0000000000000088; Kimura-Shimmyo A, 2002, J IMMUNOTHER, V25, pS42, DOI 10.1097/00002371-200203001-00007; Lam H, 2009, AM J OPHTHALMOL, V147, P198, DOI 10.1016/j.ajo.2008.08.032; Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745; Lamkanfi M, 2011, NAT REV IMMUNOL, V11, P213, DOI 10.1038/nri2936; Lee SY, 2013, AM J OPHTHALMOL, V156, P247, DOI 10.1016/j.ajo.2013.04.003; Lemp MA, 2007, OCUL SURF, V5, P75; Marneros AG, 2013, CELL REP, V4, P945, DOI 10.1016/j.celrep.2013.08.002; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Massingale ML, 2009, CORNEA, V28, P1023, DOI 10.1097/ICO.0b013e3181a16578; Rock KL, 2013, NAT REV RHEUMATOL, V9, P13, DOI 10.1038/nrrheum.2012.143; Roescher N, 2010, ANN RHEUM DIS, V69, P945, DOI 10.1136/ard.2009.115378; Stern ME, 2013, INT REV IMMUNOL, V32, P19, DOI 10.3109/08830185.2012.748052; Stevenson W, 2012, ARCH OPHTHALMOL-CHIC, V130, P90, DOI 10.1001/archophthalmol.2011.364; TODA I, 1993, CORNEA, V12, P366, DOI 10.1097/00003226-199307000-00015; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Wang Y, 2007, AM J OPHTHALMOL, V144, P930, DOI 10.1016/j.ajo.2007.07.037; Yoon KC, 2010, INVEST OPHTH VIS SCI, V51, P643, DOI 10.1167/iovs.09-3425; Zheng QX, 2014, EXP EYE RES, V125, P1, DOI 10.1016/j.exer.2014.05.001; Zoukhri D, 2002, INVEST OPHTH VIS SCI, V43, P1429	38	60	65	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126277	10.1371/journal.pone.0126277	http://dx.doi.org/10.1371/journal.pone.0126277			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962072	Green Published, gold, Green Submitted			2022-12-26	WOS:000354542500084
J	Perez-Kohler, B; Garcia-Moreno, F; Bayon, Y; Pascual, G; Bellon, JM				Perez-Koehler, Barbara; Garcia-Moreno, Francisca; Bayon, Yves; Pascual, Gemma; Manuel Bellon, Juan			Inhibition of Staphylococcus aureus Adhesion to the Surface of a Reticular Heavyweight Polypropylene Mesh Soaked in a Combination of Chlorhexidine and Allicin: An In vitro Study	PLOS ONE			English	Article							HERNIA REPAIR; WOUND-INFECTION; RELEASE; EPIDERMIDIS; PREVENTION; IMPLANTS; BIOFILM; EXTRACT; RISK	Introduction Presoaking meshes for hernia repair with antiseptics prior to implantation could decrease the adhesion of microorganisms to the material surface and reduce the risk of antibiotic resistances. In this work, we evaluate chlorhexidine and allicin (natural antiseptic not yet tested for these purposes) against vancomycin as antiseptics to be used in the pretreatment of a heavyweight polypropylene mesh using an in vitro model of bacterial contamination. Methods Solutions of saline, vancomycin (40 mu g/mL), allicin (1,000 mu g/mL), chlorhexidine (2%-0.05%) and the combination allicin-chlorhexidine (900 mu g/mL-0.05%) were analyzed with agar diffusion tests in the presence of 10(6) CFU Staphylococcus aureus ATCC25923. Additionally, sterile fragments of Surgipro (1 cm(2)) were soaked with the solutions and cultured onto contaminated agar plates for 24/48/72 h. The antimicrobial material DualMesh Plus was utilized as positive control. At every time, the inhibition zones were measured and the bacterial adhesion to the mesh surface quantified (sonication, scanning electron microscopy). Cytotoxicity of the treatments was examined (alamarBlue) using rabbit skin fibroblasts. Results The largest zones of inhibition were created by allicin-chlorhexidine. Chlorhexidine was more effective than vancomycin, and allicin lost its effectiveness after 24 h. No bacteria adhered to the surface of the DualMesh Plus or the meshes soaked with vancomycin, chlorhexidine andallicin-chlorhexidine. On the contrary, saline and allicin allowed adherence of high loads of bacteria. Vancomycin had no toxic effects on fibroblasts, while allicin and chlorhexidine exerted high toxicity. Cytotoxicity was significantly reduced with the allicin-chlorhexidine combination. Conclusions The use of antiseptics such as chlorhexidine, alone or combined with others like allicin, could represent an adequate prophylactic strategy to be used for hernia repair materials because soaking with these agents provides the mesh with similar antibacterial properties to those observed after soaking with vancomycin, similar to the effect of DualMesh Plus.	[Perez-Koehler, Barbara; Garcia-Moreno, Francisca; Manuel Bellon, Juan] Univ Alcala, Fac Med & Hlth Sci, Dept Surg Med & Social Sci, Madrid, Spain; [Bayon, Yves] Covidien Sofradim Prod, Trevoux, France; [Pascual, Gemma] Univ Alcala, Fac Med & Hlth Sci, Dept Med & Med Specialties, Madrid, Spain; [Perez-Koehler, Barbara; Garcia-Moreno, Francisca; Pascual, Gemma; Manuel Bellon, Juan] Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Madrid, Spain	Universidad de Alcala; Covidien; Universidad de Alcala; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN	Bellon, JM (corresponding author), Univ Alcala, Fac Med & Hlth Sci, Dept Surg Med & Social Sci, Madrid, Spain.	juanm.bellon@uah.es	Köhler, Bárbara Pérez/M-1858-2019; nisa, francisca f garcia-moreno/J-3906-2015; PASCUAL, GEMMA/M-6564-2016	Köhler, Bárbara Pérez/0000-0002-5061-1526; nisa, francisca f garcia-moreno/0000-0001-5360-0577; garcia-moreno nisa, francisca/0000-0002-2194-4647; BELLON, JUAN M./0000-0002-6071-5011; PASCUAL, GEMMA/0000-0002-1623-4384	Covidien-Sofradim Production	Covidien-Sofradim Production	Covidien-Sofradim Production provided support in the form of a financial research grant, but the funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankri S, 1999, MICROBES INFECT, V1, P125, DOI 10.1016/S1286-4579(99)80003-3; Aufenacker TJ, 2004, ANN SURG, V240, P955, DOI 10.1097/01.sla.0000145926.74300.42; Bellon JM, 2004, BRIT J SURG, V91, P489, DOI 10.1002/bjs.4451; Bondar VM, 2000, ARCH SURG-CHICAGO, V135, P309, DOI 10.1001/archsurg.135.3.309; Chevrel JP, 1990, 92 C FRANC CHIR, DOI [10.1016/j.psychres.2009.03.029, DOI 10.1016/J.PSYCHRES.2009.03.029]; Cobb WS, 2009, AM SURGEON, V75, P762; Corzo-Martinez M, 2007, TRENDS FOOD SCI TECH, V18, P609, DOI 10.1016/j.tifs.2007.07.011; Costerton JW, 2005, INT J ARTIF ORGANS, V28, P1062, DOI 10.1177/039139880502801103; Cruz-Villalon G, 2011, J APPL MICROBIOL, V110, P723, DOI 10.1111/j.1365-2672.2010.04929.x; Cutler RR, 2009, J ANTIMICROB CHEMOTH, V63, P151, DOI 10.1093/jac/dkn457; Cutler RR, 2004, BRIT J BIOMED SCI, V61, P71, DOI 10.1080/09674845.2004.11732646; Deysine M, 2006, Hernia, V10, P25, DOI 10.1007/s10029-005-0028-4; Deysine M, 2010, HERNIA REPAIR SEQUELAE, P135, DOI 10.1007/978-3-642-11541-7_18; Ehrlich GD, 2004, ASM NEWS, V70, P127; Engelsman AF, 2008, BRIT J SURG, V95, P1051, DOI 10.1002/bjs.6154; Engelsman AF, 2010, ANN SURG, V251, P133, DOI 10.1097/SLA.0b013e3181b61d9a; Fernandez ICS, 2010, ACTA BIOMATER, V6, P1119, DOI 10.1016/j.actbio.2009.08.040; Fernandez-Gutierrez M, 2013, ACTA BIOMATER, V9, P6006, DOI 10.1016/j.actbio.2012.12.012; GRISTINA A G, 1988, Medical Progress Through Technology, V14, P205; GRISTINA AG, 1989, MED PROG TECHNOL, V14, P205; Guillaume O, 2012, J CONTROL RELEASE, V162, P492, DOI 10.1016/j.jconrel.2012.08.003; Guillaume O, 2011, ACTA BIOMATER, V7, P3390, DOI 10.1016/j.actbio.2011.05.009; Harrell A G, 2006, Hernia, V10, P120, DOI 10.1007/s10029-005-0056-0; Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b; Holmes NE, 2015, SEMIN RESP CRIT CARE, V36, P17, DOI 10.1055/s-0034-1397040; Katsikogianni M, 2004, Eur Cell Mater, V8, P37; LICHTENSTEIN IL, 1989, AM J SURG, V157, P188, DOI 10.1016/0002-9610(89)90526-6; Perez-Giraldo C, 2003, J APPL MICROBIOL, V95, P709, DOI 10.1046/j.1365-2672.2003.02030.x; Robinson TN, 2005, SURG ENDOSC, V19, P1556, DOI 10.1007/s00464-005-0120-y; Lessa FCR, 2010, J APPL ORAL SCI, V18, P50, DOI 10.1590/S1678-77572010000100010; Rutkow IM, 2003, SURG CLIN N AM, V83, P1045, DOI 10.1016/S0039-6109(03)00132-4; Sadava EE, 2013, J GASTROINTEST SURG, V17, P562, DOI 10.1007/s11605-012-2099-8; Sanchez VM, 2011, SURG INFECT, V12, P205, DOI 10.1089/sur.2011.033; Sanchez-Manuel FJ, 2004, COCHRANE DB SYST REV, V4; Sanders DL, 2013, SURG ENDOSC, V27, P978, DOI 10.1007/s00464-012-2545-4; Saygun O, 2006, J SURG RES, V131, P73, DOI 10.1016/j.jss.2005.06.020; Sharifi-Rad J, 2014, ANN MED HEALTH SCI R, V4, P863, DOI 10.4103/2141-9248.144883; Teixeira K, 2014, DRUG DELIV; von Eiff C, 2005, DRUGS, V65, P179, DOI 10.2165/00003495-200565020-00003; Wiegering A, 2014, HERNIA, V18, P691, DOI 10.1007/s10029-014-1293-x; Yabanoglu H, 2015, INT SURG; Zhai HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102760	42	23	23	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126711	10.1371/journal.pone.0126711	http://dx.doi.org/10.1371/journal.pone.0126711			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962163	Green Published, gold, Green Submitted			2022-12-26	WOS:000354542500142
J	Pun, NT; Subedi, A; Kim, MJ; Park, PH				Pun, Nirmala Tilija; Subedi, Amit; Kim, Mi Jin; Park, Pil-Hoon			Globular Adiponectin Causes Tolerance to LPS-Induced TNF-alpha Expression via Autophagy Induction in RAW 264.7 Macrophages: Involvement of SIRT1/FoxO3A Axis	PLOS ONE			English	Article							OXIDATIVE STRESS; CELL-SURVIVAL; NADPH OXIDASE; HEPG2 CELLS; ACTIVATION; LIVER; APOPTOSIS; INFLAMMATION; MECHANISMS; P38	Adiponectin, an adipokine predominantly produced from adipose tissue, exhibited potent anti-inflammatory properties. In particular, it inhibits production of pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-alpha), in macrophages. Autophagy, an intracellular self-digestion process, has been recently shown to regulate inflammatory responses. In the present study, we investigated the role of autophagy induction in the suppression of Lipopolysaccharide (LPS) -induced TNF-alpha expression by globular adiponectin (gAcrp) and its potential mechanisms. Herein, we found that gAcrp treatment increased expression of genes related with autophagy, including Atg5 and microtubule-associated protein light chain (LC3B), induced autophagosome formation and autophagy flux in RAW 264.7 macrophages. Similar results were observed in primary macrophages isolated peritoneum of mice. Interestingly, inhibition of autophagy by pretreatment with Bafilomycin A1 or knocking down of LC3B gene restored suppression of TNF-alpha expression, tumor necrosis factor receptor- associated factor 6 (TRAF6) expression and p38MAPK phosphorylation by gAcrp, implying a critical role of autophagy induction in the development of tolerance to LPS-induced TNF-alpha expression by gAcrp. We also found that knocking-down of FoxO3A, a forkhead box O member of transcription factor, blocked gAcrp-induced expression of LC3II and Atg5. Moreover, gene silencing of Silent information regulator 1 (SIRT1) blocked both gAcrp-induced nuclear translocation of FoxO3A and LC3II expression. Finally, pretreatment with ROS inhibitors, prevented gAcrp-induced SIRT1 expression and further generated inhibitory effects on gAcrp-induced autophagy, indicating a role of ROS production in gAcrp-induced SIRT1 expression and subsequent autophagy induction. Taken together, these findings indicate that globular adiponectin suppresses LPS-induced TNF-alpha expression, at least in part, via autophagy activation. Furthermore, SIRT1-FoxO3A axis plays a crucial role in gAcrp-induced autophagy in macrophages.	[Pun, Nirmala Tilija; Subedi, Amit; Kim, Mi Jin; Park, Pil-Hoon] Yeungnam Univ, Coll Pharm, Kyongsan 712749, Gyeongsangbuk D, South Korea	Yeungnam University	Park, PH (corresponding author), Yeungnam Univ, Coll Pharm, Kyongsan 712749, Gyeongsangbuk D, South Korea.	parkp@yu.ac.kr	Kim, Mi Jin/GXH-9639-2022	Subedi, Amit/0000-0003-4216-9819	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2013R1A1A4A01011110]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2013R1A1A4A01011110). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akifusa S, 2010, J CELL BIOCHEM, V111, P597, DOI 10.1002/jcb.22745; Akifusa S, 2009, FREE RADICAL BIO MED, V46, P1308, DOI 10.1016/j.freeradbiomed.2009.02.014; Alvarez-Arellano Lourdes, 2014, World J Gastrointest Pathophysiol, V5, P400, DOI 10.4291/wjgp.v5.i4.400; Brenner C, 2013, J HEPATOL, V59, P583, DOI 10.1016/j.jhep.2013.03.033; Buchholz BM, 2010, NEUROGASTROENT MOTIL, V22, P232, DOI 10.1111/j.1365-2982.2009.01464.x; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Canto C, 2012, PHARMACOL REV, V64, P166, DOI 10.1124/pr.110.003905; Cao JJ, 2011, J ORTHOP SURG RES, V6, DOI 10.1186/1749-799X-6-30; Chiacchiera F, 2010, CELL CYCLE, V9, P1091, DOI 10.4161/cc.9.6.11035; Christou GA, 2014, J ENDOCRINOL, V221, pR49, DOI 10.1530/JOE-13-0578; Chung KW, 2014, J GERONTOL A; Fang J, 2012, BLOOD, V120, P858, DOI 10.1182/blood-2012-02-407999; Francois A, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0056-z; Fujishima Y, 2011, ARCH BIOCHEM BIOPHYS, V506, P223, DOI 10.1016/j.abb.2010.12.009; Fujita KI, 2011, P NATL ACAD SCI USA, V108, P1427, DOI 10.1073/pnas.1014156108; Fukada H, 2012, HEPATOL RES, V42, P1112, DOI 10.1111/j.1872-034X.2012.01024.x; Gukovsky I, 2012, J GASTROEN HEPATOL, V27, P27, DOI 10.1111/j.1440-1746.2011.07004.x; Guo LJ, 2012, INT J MOL SCI, V13, P3563, DOI 10.3390/ijms13033563; Habeeb BS, 2011, CANCER SCI, V102, P999, DOI 10.1111/j.1349-7006.2011.01902.x; Hagiwara S, 2010, BIOMED RES-TOKYO, V31, P263, DOI 10.2220/biomedres.31.263; Heath RJ, 2009, CURR OPIN GASTROEN, V25, P512, DOI 10.1097/MOG.0b013e32833104f1; Hori YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073875; Howell GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069520; Huang BQ, 2014, ONCOTARGET, V5, P4732, DOI 10.18632/oncotarget.1963; Huang H, 2008, J GASTROEN HEPATOL, V23, pS50, DOI 10.1111/j.1440-1746.2007.05284.x; Huang J, 2009, P NATL ACAD SCI USA, V106, P6226, DOI 10.1073/pnas.0811045106; Jagani Z, 2008, BBA-REV CANCER, V1785, P63, DOI 10.1016/j.bbcan.2007.10.003; Jiang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070746; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kim MJ, 2014, MOL PHARMACOL, V86, P284, DOI 10.1124/mol.114.093039; Kim MJ, 2013, TOXICOL APPL PHARM, V273, P77, DOI 10.1016/j.taap.2013.08.005; Kyriazi E, 2011, HORM METAB RES, V43, P537, DOI 10.1055/s-0031-1277227; Liu P, 2014, BIOSCI BIOTECH BIOCH, V78, P1504, DOI 10.1080/09168451.2014.923295; Mandal P, 2011, J BIOL CHEM, V286, P13460, DOI 10.1074/jbc.M110.204644; Manzanero Silvia, 2011, Exp Transl Stroke Med, V3, P8, DOI 10.1186/2040-7378-3-8; Mukherjee S, 2010, CAN J PHYSIOL PHARM, V88, P1017, DOI [10.1139/Y10-082, 10.1139/y10-082]; Nagelkerke A., 2014, SEMIN CANC BIOL; Nahid MA, 2011, CELL MOL IMMUNOL, V8, P388, DOI 10.1038/cmi.2011.26; Nepal S, 2013, BBA-MOL CELL RES, V1833, P2111, DOI 10.1016/j.bbamcr.2013.05.013; Nho Richard Seonghun, 2014, World J Biol Chem, V5, P346, DOI 10.4331/wjbc.v5.i3.346; Ohashi K, 2010, J BIOL CHEM, V285, P6153, DOI 10.1074/jbc.M109.088708; Ou X, 2014, STEM CELLS, V32, P1183, DOI 10.1002/stem.1641; Park PH, 2007, J BIOL CHEM, V282, P21695, DOI 10.1074/jbc.M701419200; Petrovski G, 2007, AUTOPHAGY, V3, P509; Qi GM, 2014, ENDOCRINOLOGY, V155, P2254, DOI 10.1210/en.2013-2011; Qiang L, 2013, J BIOL CHEM, V288, P1603, DOI 10.1074/jbc.M112.415224; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Sengupta A, 2011, J BIOL CHEM, V286, P7468, DOI 10.1074/jbc.M110.179242; Seo G, 2011, FREE RADICAL RES, V45, P389, DOI 10.3109/10715762.2010.535530; Shen Z, 2010, AM J PHYSIOL-GASTR L, V298, pG364, DOI 10.1152/ajpgi.00456.2009; Subedi A, 2013, FEBS LETT, V587, P1556, DOI 10.1016/j.febslet.2013.03.040; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Wang KK, 2011, J MOL CELL BIOL, V3, P360, DOI 10.1093/jmcb/mjr021; Wang ZH, 2014, SCI WORLD J, DOI 10.1155/2014/189168; Williams-Bey Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097957; Wolf AM, 2004, BIOCHEM BIOPH RES CO, V323, P630, DOI 10.1016/j.bbrc.2004.08.145; Wu DF, 2013, REDOX BIOL, V1, P552, DOI 10.1016/j.redox.2013.10.008; Wu PF, 2013, J NUTR BIOCHEM, V24, P1070, DOI 10.1016/j.jnutbio.2012.08.005; Wulster-Radcliffe MC, 2004, BIOCHEM BIOPH RES CO, V316, P924, DOI 10.1016/j.bbrc.2004.02.130; Xu Y, 2006, J BIOL CHEM, V281, P19179, DOI 10.1074/jbc.M513377200; Yokota T, 2000, BLOOD, V96, P1723, DOI 10.1182/blood.V96.5.1723; Zacharioudaki V, 2009, J IMMUNOL, V182, P6444, DOI 10.4049/jimmunol.0803694; Zhang L, 2014, TOXICOL LETT, V228, P248, DOI 10.1016/j.toxlet.2014.05.015; Zhang Y, 2014, AM J PHYSIOL-LUNG C, V307, pL173, DOI 10.1152/ajplung.00083.2014; Zhou CH, 2012, ACTA BIOCH BIOPH SIN, V44, P815, DOI 10.1093/abbs/gms064; Zhou HY, 2014, ONCOTARGET, V5, P10140, DOI 10.18632/oncotarget.2471	66	38	38	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0124636	10.1371/journal.pone.0124636	http://dx.doi.org/10.1371/journal.pone.0124636			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961287	gold, Green Published, Green Submitted			2022-12-26	WOS:000354542500017
J	Wen, JP; Yang, JG; Shi, YJ; Liang, YB; Wang, FH; Duan, XR; Lu, XL; Tao, QS; Lu, XX; Tian, YP; Wang, NL				Wen, Jiangping; Yang, Jingang; Shi, Yujie; Liang, Yuanbo; Wang, Fenghua; Duan, Xinrong; Lu, Xilin; Tao, Qiushan; Lu, Xinxin; Tian, Yaping; Wang, Ningli			Comparisons of Different Metabolic Syndrome Definitions and Associations with Coronary Heart Disease, Stroke, and Peripheral Arterial Disease in a Rural Chinese Population	PLOS ONE			English	Article							INTERNATIONAL-DIABETES-FEDERATION; INCIDENT CARDIOVASCULAR EVENTS; PREVALENCE; ADULTS; RISK; METAANALYSIS; HEALTH; MANAGEMENT; MORTALITY; STATEMENT	Objectives We estimated the prevalence of metabolic syndrome (MetS) and compared associations of different MetS definitions with coronary heart disease (CHD), stroke, and peripheral arterial disease (PAD) in a rural Chinese population. Methods Among 4,748 residents (2,145 men and 2,603 women) aged 30+ years in rural China from 2006 to 2007, the prevalence of MetS was estimated by using five different definitions: modified World Health Organization (WHO), Chinese Diabetes Society (CDS), the updated National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP III) for Asian-Americans, International Diabetes Federation (IDF), and Joint Interim Statement (JIS). Multivariable logistic regression analyses were implemented to estimate the association between MetS and the prevalence of CHD, stroke and PAD, respectively. Results Prevalence of MetS in men was 11.5% (WHO), 14.8% (CDS), 32.4% (NCEP-ATP III), 27.5% (IDF) and 39.7%(JIS) and in women was 15.7%(WHO), 20.7%(CDS), 54.2% NCEP-ATP III), 51.5%(IDF) and 54.2% (JIS), respectively. Respective ORs (95% CI) for associating MetS with CHD in men were 1.79 (1.02-3.17), 1.25 (0.69-2.26), 1.61 (1.01-2.58), 1.84 (1.14-2.96), and 1.53 (0.96-2.43). Corresponding ORs (95% CI) for stroke in men were 2.18 (95% CI 1.20 to 3.97), 2.20 (95% CI 1.25 to 3.89), 1.71 (95% CI 1.02 to 2.84), 1.30 (95% CI 0.77 to 2.23), and 1.61 (95% CI 0.97 to 2.68), respectively. In women, CHD and stroke were significantly associated with MetS using all five definitions of MetS. In addition, PAD was associated with all five MetS definitions in men, but not in women. Only hyperglycemia and BMI were significantly associated with PAD in women. Conclusions In this rural Chinese population, the JIS, IDF and CDS criteria may not be more suitable than WHO and updated NCEP-ATPIII definitions for screening high-risk individuals and estimating the risk of CHD and stroke from MetS, especially in men.	[Wen, Jiangping; Tian, Yaping] Chinese Peoples Liberat Army Gen Hosp, Dept Clin Biochem, Beijing 100853, Peoples R China; [Wen, Jiangping; Lu, Xinxin] Capital Med Univ, Beijing Tongren Hosp, Dept Lab Med, Beijing, Peoples R China; [Yang, Jingang] Chinese Acad Med Sci, Fuwai Hosp, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China; [Yang, Jingang] Peking Union Med Coll, Beijing 100021, Peoples R China; [Shi, Yujie] Beijing Mil Area Command Gen Hosp, Cardiovasc Dis Inst, Beijing, Peoples R China; [Liang, Yuanbo] Wenzhou Med Univ, Affiliated Eye Hosp, Clin & Epidemiol Res Ctr, Wenzhou, Zhejiang, Peoples R China; [Wang, Fenghua; Duan, Xinrong; Wang, Ningli] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Ophthalmol & Visual Sci Key Lab, Beijing, Peoples R China; [Lu, Xilin] Handan 3rd Hosp, Dept Lab Med, Handan, Hebei Province, Peoples R China; [Tao, Qiushan] Peking Univ, Sch Publ Hlth, Beijing 100871, Peoples R China	Chinese People's Liberation Army General Hospital; Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Wenzhou Medical University; Capital Medical University; Peking University	Tian, YP (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Clin Biochem, Beijing 100853, Peoples R China.	tianyp61@gmail.com; wningli@vip.163.com		liang, Yuanbo/0000-0001-9685-7356	National Basic Research Program of China (973 Program); Ministry of Science and Technology of China [2007CB512201]; Foundation of Beijing Tongren Hospital	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Foundation of Beijing Tongren Hospital	This study was financially supported by the National Basic Research Program of China (973 Program), the Ministry of Science and Technology of China (Grant 2007CB512201). Additional support was provided by the Foundation of Beijing Tongren Hospital (Grant 2005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Conen D, 2009, CIRCULATION, V120, P1041, DOI 10.1161/CIRCULATIONAHA.109.863092; Galassi A, 2006, AM J MED, V119, P812, DOI 10.1016/j.amjmed.2006.02.031; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Garg PK, 2014, HYPERTENSION, V63, P413, DOI 10.1161/HYPERTENSIONAHA.113.01925; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Gu DF, 2005, LANCET, V365, P1398, DOI 10.1016/S0140-6736(05)66375-1; He Y, 2006, J AM COLL CARDIOL, V47, P1588, DOI 10.1016/j.jacc.2005.11.074; Hu DS, 2008, DIABETES RES CLIN PR, V81, P250, DOI 10.1016/j.diabres.2008.04.008; Kassi E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-48; Lahoz C, 2006, DIABETES CARE, V29, P148, DOI 10.2337/diacare.29.1.148; Lawlor DA, 2006, DIABETOLOGIA, V49, P41, DOI 10.1007/s00125-005-0040-3; Lian ZP, 2014, CHINESE MED J-PEKING, V127, P777, DOI 10.3760/cma.j.issn.0366-6999.20131054; Liang YB, 2009, OPHTHAL EPIDEMIOL, V16, P115, DOI 10.1080/09286580902738159; Liu J, 2004, JAMA-J AM MED ASSOC, V291, P2591, DOI 10.1001/jama.291.21.2591; Liu M, 2013, PLOS ONE, V8; Lu Yan-hui, 2006, Zhonghua Yi Xue Za Zhi, V86, P386; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Nilsson PM, 2007, DIABETIC MED, V24, P464, DOI 10.1111/j.1464-5491.2007.02142.x; Qiao Q, 2006, DIABETOLOGIA, V49, P2837, DOI 10.1007/s00125-006-0438-6; Qiao Q, 2009, STROKE, V40, P337, DOI 10.1161/STROKEAHA.108.518878; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Rooke TW, 2011, J AM COLL CARDIOL, V58, P2020, DOI 10.1016/j.jacc.2011.08.023; Tanomsup S, 2007, DIABETES CARE, V30, P2138, DOI 10.2337/dc07-0388; Vinluan CM, 2012, METABOLISM, V61, P302, DOI 10.1016/j.metabol.2011.07.002; Wen JP, 2010, CLIN CHIM ACTA, V411, P198, DOI 10.1016/j.cca.2009.11.002; Wen JP, 2009, CLIN BIOCHEM, V42, P976, DOI 10.1016/j.clinbiochem.2009.03.026; Weng X, 2007, PUBLIC HEALTH NUTR, V10, P131, DOI 10.1017/S1368980007226023; Xi B, 2013, PREV MED, V57, P867, DOI 10.1016/j.ypmed.2013.09.023; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yang WJ, 2007, AM J MED SCI, V334, P184, DOI 10.1097/MAJ.0b013e3180a6ed66; Yang WY, 2012, CIRCULATION, V125, P2212, DOI 10.1161/CIRCULATIONAHA.111.065904	36	19	24	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126832	10.1371/journal.pone.0126832	http://dx.doi.org/10.1371/journal.pone.0126832			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961739	Green Published, Green Submitted, gold			2022-12-26	WOS:000354542500152
J	Meijer, K; Zemel, H; Chiba, S; Smit, C; Beukeboom, LW; Schilthuizen, M				Meijer, Kim; Zemel, Hidde; Chiba, Satoshi; Smit, Christian; Beukeboom, Leo W.; Schilthuizen, Menno			Phytophagous Insects on Native and Non-Native Host Plants: Combining the Community Approach and the Biogeographical Approach	PLOS ONE			English	Article							ENEMY RELEASE; INVASIONS; RICHNESS; SUCCESS	During the past centuries, humans have introduced many plant species in areas where they do not naturally occur. Some of these species establish populations and in some cases become invasive, causing economic and ecological damage. Which factors determine the success of non-native plants is still incompletely understood, but the absence of natural enemies in the invaded area (Enemy Release Hypothesis; ERH) is one of the most popular explanations. One of the predictions of the ERH, a reduced herbivore load on non-native plants compared with native ones, has been repeatedly tested. However, many studies have either used a community approach (sampling from native and non-native species in the same community) or a biogeographical approach (sampling from the same plant species in areas where it is native and where it is non-native). Either method can sometimes lead to inconclusive results. To resolve this, we here add to the small number of studies that combine both approaches. We do so in a single study of insect herbivory on 47 woody plant species (trees, shrubs, and vines) in the Netherlands and Japan. We find higher herbivore diversity, higher herbivore load and more herbivory on native plants than on non-native plants, generating support for the enemy release hypothesis.	[Meijer, Kim; Zemel, Hidde; Smit, Christian; Beukeboom, Leo W.; Schilthuizen, Menno] Univ Groningen, Groningen Inst Evolutionary Life Sci GELIFES, Groningen, Netherlands; [Meijer, Kim] Altenburg Wymenga Ecol Consultants, Veenwouden, Netherlands; [Chiba, Satoshi] Tohoku Univ, Grad Sch Life Sci, Ecol & Evolutionary Biol, Sendai, Miyagi 980, Japan; [Schilthuizen, Menno] Nat Biodivers Ctr, Leiden, Netherlands	University of Groningen; Tohoku University; Naturalis Biodiversity Center	Schilthuizen, M (corresponding author), Univ Groningen, Groningen Inst Evolutionary Life Sci GELIFES, Groningen, Netherlands.	menno.schilthuizen@naturalis.nl	smit, christian/B-9817-2008	smit, christian/0000-0002-4044-9473; Chiba, Satoshi/0000-0001-9273-0307	Altenburg & Wymenga Ecological Consultants	Altenburg & Wymenga Ecological Consultants	Altenburg & Wymenga Ecological Consultants provided support in the form of salaries for authors KM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2005, ECOLOGY, V86, P2979, DOI 10.1890/05-0219; Agrawal AA, 2003, ECOL LETT, V6, P712, DOI 10.1046/j.1461-0248.2003.00498.x; [Anonymous], 2010, R LANG ENV STAT COMP; BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425; Colautti RI, 2004, ECOL LETT, V7, P721, DOI 10.1111/j.1461-0248.2004.00616.x; Gerber E, 2008, BIOL CONSERV, V141, P646, DOI 10.1016/j.biocon.2007.12.009; Heywood VH, 1989, BIOL INVASIONS GLOBA, V37, P31; Hierro JL, 2005, J ECOL, V93, P5, DOI 10.1111/j.0022-0477.2004.00953.x; JONES CG, 1991, J ANIM ECOL, V60, P767, DOI 10.2307/5413; Joshi J, 2005, ECOL LETT, V8, P704, DOI 10.1111/j.1461-0248.2005.00769.x; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; KENNEDY CEJ, 1984, J ANIM ECOL, V53, P455, DOI 10.2307/4528; Lehsten V, 2005, THESIS C VONOSSIETZK; Liu H, 2006, FLA ENTOMOL, V89, P475, DOI 10.1653/0015-4040(2006)89[475:IHFDAI]2.0.CO;2; Mitchell CE, 2003, NATURE, V421, P625, DOI 10.1038/nature01317; Norghauer JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018790; Pimentel D., 2001, PESTIC YOU, V21, P10; SOUTHWOOD TRE, 1982, J ANIM ECOL, V51, P635, DOI 10.2307/3988; Torchin ME, 2003, NATURE, V421, P628, DOI 10.1038/nature01346; van der Weijden W., 2007, BIOL GLOBALISATION B; Visser ME, 2005, P ROY SOC B-BIOL SCI, V272, P2561, DOI 10.1098/rspb.2005.3356; Williamson M., 1996, BIOL INVASIONS	22	8	8	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0125607	10.1371/journal.pone.0125607	http://dx.doi.org/10.1371/journal.pone.0125607			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955254	Green Published, Green Submitted, gold			2022-12-26	WOS:000356768100061
J	Nazir, S; Kumar, A; Chatterjee, I; Anbazhagan, AN; Gujral, T; Priyamvada, S; Saksena, S; Alrefai, WA; Dudeja, PK; Gill, RK				Nazir, Saad; Kumar, Anoop; Chatterjee, Ishita; Anbazhagan, Arivarasu N.; Gujral, Tarunmeet; Priyamvada, Shubha; Saksena, Seema; Alrefai, Waddah A.; Dudeja, Pradeep K.; Gill, Ravinder K.			Mechanisms of Intestinal Serotonin Transporter (SERT) Upregulation by TGF-beta 1 Induced Non-Smad Pathways	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; INFLAMMATORY-BOWEL-DISEASE; NA+/H+ EXCHANGER-3 NHE3; EPITHELIAL-CELLS; SYNTAXIN 1A; TGF-BETA; ULCERATIVE-COLITIS; EXOCYTOSIS; EXPRESSION; 5-HYDROXYTRYPTAMINE	TGF-beta 1 is an important multifunctional cytokine with numerous protective effects on intestinal mucosa. The influence of TGF-beta 1 on serotonin transporter (SERT) activity, the critical mechanism regulating the extracellular availability of serotonin (5-HT), is not known. Current studies were designed to examine acute effects of TGF-beta 1 on SERT. Model human intestinal Caco-2 cells grown as monolayer's or as cysts in 3D culture and ex vivo mouse model were utilized. Treatment of Caco-2 cells with TGF-beta 1 (10 ng/ml, 60 min) stimulated SERT activity (similar to 2 fold, P<0.005). This stimulation of SERT function was dependent upon activation of TGF-beta 1 receptor (TGFRI) as SB-431542, a specific TGF-beta RI inhibitor blocked the SERT stimulation. SERT activation in response to TGF-beta 1 was attenuated by inhibition of PI3K and occurred via enhanced recruitment of SERT-GFP to apical surface in a PI3K dependent manner. The exocytosis inhibitor brefeldin A (2.5 mu M) attenuated the TGF-beta 1-mediated increase in SERT function. TGF-beta 1 increased the association of SERT with the soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) syntaxin 3 (STX3) and promoted exocytosis of SERT. Caco-2 cells grown as cysts in 3D culture recapitulated the effects of TGF-beta 1 showing increased luminal staining of SERT. Ussing chamber studies revealed increase in H-3-5-HT uptake in mouse ileum treated ex vivo with TGF-beta 1 (10 ng/ml, 1h). These data demonstrate a novel mechanism rapidly regulating intestinal SERT via PI3K and STX3. Since decreased SERT is implicated in various gastro-intestinal disorders e.g IBD, IBS and diarrhea, understanding mechanisms stimulating SERT function by TGF-beta 1 offers a novel therapeutic strategy to treat GI disorders.	[Nazir, Saad; Kumar, Anoop; Chatterjee, Ishita; Anbazhagan, Arivarasu N.; Gujral, Tarunmeet; Priyamvada, Shubha; Saksena, Seema; Alrefai, Waddah A.; Dudeja, Pradeep K.; Gill, Ravinder K.] Univ Illinois, Div Gastroenterol & Hepatol, Dept Med, Chicago, IL 60607 USA; [Alrefai, Waddah A.; Dudeja, Pradeep K.] Jesse Brown VA Med Ctr, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Gill, RK (corresponding author), Univ Illinois, Div Gastroenterol & Hepatol, Dept Med, Chicago, IL 60607 USA.	rgill@uic.edu		Priyamvada, Shubha/0000-0002-7241-569X; Gill, Ravinder/0000-0002-5337-2567	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01 DK098170, R03 DK096258, R01 DK54016, R01 DK81858, R01DK92441, R21 DK96245, R01 DK71596]; Department of Veterans Affairs [BX 002011, BX000152]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071596, R01DK054016, R01DK098170, R01DK081858, R03DK096258, R01DK092441, R21DK096254] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002011, I01BX000152] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	These studies were supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grants [R01 DK098170, R03 DK096258 (RKG)], [R01 DK54016, R01 DK81858, R01DK92441 (PKD)], [R21 DK96245 (SS)], [R01 DK71596 (WAA)] and [The Department of Veterans Affairs BX 002011 (PKD) and BX000152 (WAA)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammar DA, 2002, AM J PHYSIOL-GASTR L, V282, pG23, DOI 10.1152/ajpgi.00277.2002; Bobulescu IA, 2005, AM J PHYSIOL-RENAL, V289, pF685, DOI 10.1152/ajprenal.00447.2004; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chatterjee I, 2014, GASTROENTEROLOGY, V146, pS654; Chen JJ, 2001, J NEUROSCI, V21, P6348, DOI 10.1523/JNEUROSCI.21-16-06348.2001; Ciccone MA, 2008, NEUROPHARMACOLOGY, V55, P763, DOI 10.1016/j.neuropharm.2008.06.018; Coates MD, 2006, NEUROGASTROENT MOTIL, V18, P464, DOI 10.1111/j.1365-2982.2006.00792.x; Coates MD, 2004, GASTROENTEROLOGY, V126, P1657, DOI 10.1053/j.gastro.2004.03.013; Collaco A, 2010, AM J PHYSIOL-CELL PH, V299, pC1450, DOI 10.1152/ajpcell.00029.2010; Delgrossi MH, 1997, J CELL SCI, V110, P2207; Donnet-Hughes A, 2000, IMMUNOL CELL BIOL, V78, P74, DOI 10.1046/j.1440-1711.2000.00882.x; du Cheyron D, 2003, KIDNEY INT, V64, P939, DOI 10.1046/j.1523-1755.2003.00189.x; Esmaili A, 2009, GASTROENTEROLOGY, V137, P2074, DOI 10.1053/j.gastro.2009.09.002; Farrell RJ, 2003, NEW ENGL J MED, V349, P395, DOI 10.1056/NEJMe030075; Faure C, 2010, GASTROENTEROLOGY, V139, P249, DOI 10.1053/j.gastro.2010.03.032; Foley KF, 2007, AM J PHYSIOL-GASTR L, V292, pG779, DOI 10.1152/ajpgi.00470.2006; Ghia JE, 2009, GASTROENTEROLOGY, V137, P1649, DOI 10.1053/j.gastro.2009.08.041; Gill RK, 2008, AM J PHYSIOL-GASTR L, V294, pG254, DOI 10.1152/ajpgi.00354.2007; Gill RK, 2007, J CLIN INVEST, V117, P428, DOI 10.1172/JCI29625; Gill RK, 2011, AM J PHYSIOL-GASTR L, V300, pG627, DOI 10.1152/ajpgi.00563.2010; Guo JP, 2011, J BIOL CHEM, V286, P37389, DOI 10.1074/jbc.M111.287433; Hahm KB, 2001, GUT, V49, P190, DOI 10.1136/gut.49.2.190; Horbelt D, 2012, INT J BIOCHEM CELL B, V44, P469, DOI 10.1016/j.biocel.2011.12.013; Kitani A, 2000, J EXP MED, V192, P41, DOI 10.1084/jem.192.1.41; KULKARNI AB, 1995, AM J PATHOL, V146, P264; Lee-Kwon W, 2003, J BIOL CHEM, V278, P16494, DOI 10.1074/jbc.M300580200; Linden DR, 2003, AM J PHYSIOL-GASTR L, V285, pG207, DOI 10.1152/ajpgi.00488.2002; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Magro F, 2006, DIGEST DIS SCI, V51, P495, DOI 10.1007/s10620-006-3161-8; Magro F, 2002, DIGEST DIS SCI, V47, P216, DOI 10.1023/A:1013256629600; Martel F, 2003, J PHARMACOL EXP THER, V306, P355, DOI 10.1124/jpet.103.049668; Mendoza C, 2009, INNATE IMMUN-LONDON, V15, P243, DOI 10.1177/1753425909104781; Meunier FA, 2005, MOL BIOL CELL, V16, P4841, DOI 10.1091/mbc.E05-02-0171; MIYAZONO K, 1988, J BIOL CHEM, V263, P6407; Monteleone G, 2001, J CLIN INVEST, V108, P601, DOI 10.1172/JCI200112821; Motavallian A, BIOIMPACTS, V3, P169, DOI [10.5681/bi.2013.021, DOI 10.5681/BI.2013.021]; Naren AP, 2000, J CLIN INVEST, V105, P377, DOI 10.1172/JCI8631; Quick MW, 2002, INT J DEV NEUROSCI, V20, P219, DOI 10.1016/S0736-5748(02)00021-7; Rowe J, 2001, J CELL SCI, V114, P3323; Schink KO, 2013, BIOESSAYS, V35, P900, DOI 10.1002/bies.201300064; Steiner JA, 2008, TRAFFIC, V9, P1393, DOI 10.1111/j.1600-0854.2008.00757.x; Strober W, 2001, ACTA ODONTOL SCAND, V59, P244, DOI 10.1080/00016350152509274; Thong FSL, 2005, PHYSIOLOGY, V20, P271, DOI 10.1152/physiol.00017.2005; Vallance BA, 2005, AM J PHYSIOL-GASTR L, V289, pG116, DOI 10.1152/ajpgi.00051.2005; Vasudevan KM, 2009, CANCER CELL, V16, P21, DOI 10.1016/j.ccr.2009.04.012; Walia B, 2003, FASEB J, V17, P2130, DOI 10.1096/fj.02-1211fje; Wharton K, 2009, DEVELOPMENT, V136, P3691, DOI 10.1242/dev.040584; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	49	18	20	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0120447	10.1371/journal.pone.0120447	http://dx.doi.org/10.1371/journal.pone.0120447			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25954931	Green Published, gold, Green Submitted			2022-12-26	WOS:000356768100003
J	Wilske, B; Eccard, JA; Zistl-Schlingmann, M; Hohmann, M; Methler, A; Herde, A; Liesenjohann, T; Dannenmann, M; Butterbach-Bahl, K; Breuer, L				Wilske, Burkhard; Eccard, Jana A.; Zistl-Schlingmann, Marcus; Hohmann, Maximilian; Methler, Annabel; Herde, Antje; Liesenjohann, Thilo; Dannenmann, Michael; Butterbach-Bahl, Klaus; Breuer, Lutz			Effects of Short Term Bioturbation by Common Voles on Biogeochemical Soil Variables	PLOS ONE			English	Article							SMALL MAMMALIAN HERBIVORES; POCKET GOPHERS; FIELD VOLES; ECOSYSTEM SERVICES; MICROTUS-AGRESTIS; ORGANIC-CARBON; NITROGEN; POPULATION; LANDSCAPE; ARVALIS	Bioturbation contributes to soil formation and ecosystem functioning. With respect to the active transport of matter by voles, bioturbation may be considered as a very dynamic process among those shaping soil formation and biogeochemistry. The present study aimed at characterizing and quantifying the effects of bioturbation by voles on soil water relations and carbon and nitrogen stocks. Bioturbation effects were examined based on a field set up in a luvic arenosol comprising of eight 50 x 50 m enclosures with greatly different numbers of common vole (Microtus arvalis L., ca. 35-150 individuals ha(-1) mth(-1)). Eleven key soil variables were analyzed: bulk density, infiltration rate, saturated hydraulic conductivity, water holding capacity, contents of soil organic carbon (SOC) and total nitrogen (N), CO2 emission potential, C/N ratio, the stable isotopic signatures of C-13 and N-15, and pH. The highest vole densities were hypothesized to cause significant changes in some variables within 21 months. Results showed that land history had still a major influence, as eight key variables displayed an additional or sole influence of topography. However, the delta N-15 at depths of 10-20 and 20-30 cm decreased and increased with increasing vole numbers, respectively. Also the CO2 emission potential from soil collected at a depth of 15-30 cm decreased and the C/N ratio at 5-10 cm depth narrowed with increasing vole numbers. These variables indicated the first influence of voles on the respective mineralization processes in some soil layers. Tendencies of vole activity homogenizing SOC and N contents across layers were not significant. The results of the other seven key variables did not confirm significant effects of voles. Thus overall, we found mainly a first response of variables that are indicative for changes in biogeochemical dynamics but not yet of those representing changes in pools.	[Wilske, Burkhard; Hohmann, Maximilian; Methler, Annabel; Breuer, Lutz] Univ Giessen, Dept Landscape Water & Biogeochem Cycles, Inst Landscape Ecol & Resources Management ILR, Res Ctr Bio Syst Land Use & Nutr IFZ, D-35390 Giessen, Germany; [Eccard, Jana A.; Herde, Antje; Liesenjohann, Thilo] Univ Potsdam, Inst Anim Ecol, Potsdam, Germany; [Zistl-Schlingmann, Marcus; Dannenmann, Michael; Butterbach-Bahl, Klaus] KIT IMK IFU, Garmisch Partenkirchen, Germany; [Butterbach-Bahl, Klaus] Int Livestock Res Inst, Nairobi, Kenya	Justus Liebig University Giessen; University of Potsdam; CGIAR; International Livestock Research Institute (ILRI)	Wilske, B (corresponding author), Univ Giessen, Dept Landscape Water & Biogeochem Cycles, Inst Landscape Ecol & Resources Management ILR, Res Ctr Bio Syst Land Use & Nutr IFZ, D-35390 Giessen, Germany.	brkwils@yahoo.com	Dannenmann, Michael/A-7278-2013; Wilske, Burkhard/ABG-5441-2020; Breuer, Lutz/C-6652-2013; Butterbach-Bahl, Klaus/A-8081-2013	Breuer, Lutz/0000-0001-9720-1076; Butterbach-Bahl, Klaus/0000-0001-9499-6598; Dannenmann, Michael/0000-0001-5924-7612				AMOOZEGAR A, 1992, SSSA SPEC PUBL, V30, P31; [Anonymous], 1997, 196827 DIN; Bagchi S, 2006, BIOL CONSERV, V127, P438, DOI 10.1016/j.biocon.2005.09.003; Bai M, 2013, PLANT SOIL, V372, P375, DOI 10.1007/s11104-013-1745-6; Bai M, 2011, RAPID COMMUN MASS SP, V25, P3683, DOI 10.1002/rcm.5280; BAKER JA, 1981, CONDOR, V83, P42, DOI 10.2307/1367598; Bakker ES, 2004, OECOLOGIA, V138, P91, DOI 10.1007/s00442-003-1402-5; Barrios E, 2007, ECOL ECON, V64, P269, DOI 10.1016/j.ecolecon.2007.03.004; Batjes NH, 2002, SOIL USE MANAGE, V18, P324, DOI 10.1079/SUM2002138; Bedard-Haughn A, 2003, J HYDROL, V272, P175, DOI 10.1016/S0022-1694(02)00263-9; Boeken B, 1995, ECOGRAPHY, V18, P410, DOI 10.1111/j.1600-0587.1995.tb00144.x; BRADSHAW RH, 1992, MAMMALIA, V56, P292; Brugger A, 2010, MAMMALIA, V74, P311, DOI 10.1515/MAMM.2010.035; Buisson R., 2001, BRIT WILDLIFE, V12, P272; Butterbach-Bahl K, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0122; Butterbach-Bahl K, 2011, CURR OPIN ENV SUST, V3, P389, DOI 10.1016/j.cosust.2011.08.004; Carleton M.D., 1984, P289; Cassel D. K., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P901; CHITTY D, 1966, J ANIM ECOL, V35, P313, DOI 10.2307/2398; Clark JE, 2005, OECOLOGIA, V144, P447, DOI 10.1007/s00442-005-0004-9; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; de Bello F, 2010, BIODIVERS CONSERV, V19, P2873, DOI 10.1007/s10531-010-9850-9; Eccard JA, 2013, ANN ZOOL FENN, V50, P371, DOI 10.5735/086.050.0602; Eccard JA, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-43; Eldridge DJ, 2012, GEOMORPHOLOGY, V157, P131, DOI 10.1016/j.geomorph.2011.04.041; Forbes KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091113; Fung I, 1997, GLOBAL BIOGEOCHEM CY, V11, P507, DOI 10.1029/97GB01751; Gervais JA, 2010, NORTHWEST SCI, V84, P159, DOI 10.3955/046.084.0205; Harte J., 2005, Global change and mountain regions: an overview of current knowledge, P421; Huitu O, 2003, OECOLOGIA, V135, P209, DOI 10.1007/s00442-002-1171-6; Imholt C, 2011, WILDLIFE RES, V38, P551, DOI 10.1071/WR10196; Jaarola M, 2002, MOL ECOL, V11, P2613, DOI 10.1046/j.1365-294X.2002.01639.x; Jackson DM, 2001, J ANIM ECOL, V70, P633, DOI 10.1046/j.1365-2656.2001.00518.x; James AI, 2009, ECOGRAPHY, V32, P723, DOI 10.1111/j.1600-0587.2009.05450.x; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Korpimaki E, 2002, P ROY SOC B-BIOL SCI, V269, P991, DOI 10.1098/rspb.2002.1972; Kremen C, 2005, ECOL LETT, V8, P468, DOI 10.1111/j.1461-0248.2005.00751.x; Kuzyakov Y, 2010, SOIL BIOL BIOCHEM, V42, P1363, DOI 10.1016/j.soilbio.2010.04.003; Lantova P, 2009, ECOL RES, V24, P831, DOI 10.1007/s11284-008-0556-3; LAUNDRE JW, 1993, OECOLOGIA, V94, P43, DOI 10.1007/BF00317299; Litaor MI, 1996, GEODERMA, V70, P37, DOI 10.1016/0016-7061(95)00069-0; Manaeva ES, 2014, BIOL BULL+, V41, P80, DOI 10.1134/S1062359013040110; Mapelli FJ, 2009, LANDSCAPE ECOL, V24, P723, DOI 10.1007/s10980-009-9352-x; Massey FP, 2006, P R SOC B, V273, P2299, DOI 10.1098/rspb.2006.3586; Migula P., 1969, Acta Theriologica, V14, P167, DOI 10.4098/AT.arch.69-13; MYERS JH, 1974, SCI AM, V230, P38, DOI 10.1038/scientificamerican0674-38; Niethammer J, 1982, HDB SAUGETIERE EUROP, DOI [10.1080/0964704X.2013.774246, DOI 10.1080/0964704X.2013.774246]; Olofsson J, 2004, OIKOS, V106, P324, DOI 10.1111/j.0030-1299.2004.13224.x; Olofsson J, 2012, NAT CLIM CHANGE, V2, P880, DOI 10.1038/NCLIMATE1537; Pastor J, 1996, ECOGRAPHY, V19, P52, DOI 10.1111/j.1600-0587.1996.tb00154.x; Paton T.R., 1995, SOILS NEW GLOBAL VIE; PUSENIUS J, 1993, ANN ZOOL FENN, V30, P143; Reichman OJ, 2002, TRENDS ECOL EVOL, V17, P44, DOI 10.1016/S0169-5347(01)02329-1; RYDEN JC, 1984, NATURE, V311, P50, DOI 10.1038/311050a0; Salamolard M, 2000, ECOLOGY, V81, P2428, DOI 10.1890/0012-9658(2000)081[2428:ROAAPT]2.0.CO;2; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; Sherrod SK, 2001, BIOGEOCHEMISTRY, V55, P195, DOI 10.1023/A:1010621102330; Sirotnak JM, 2000, ECOLOGY, V81, P78, DOI 10.1890/0012-9658(2000)081[0078:DAIEOH]2.0.CO;2; Smallwood KS, 1999, SOUTHWEST NAT, V44, P173; Tasser E., 2005, ADV GLOB CHANGE RES, P409, DOI 10.1007/1-4020-3508-X_41; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Villarreal D, 2008, J MAMMAL, V89, P700, DOI 10.1644/07-MAMM-A-025R1.1; Walthert L, 2010, J PLANT NUTR SOIL SC, V173, P207, DOI 10.1002/jpln.200900158; Whitford WG, 1999, J ARID ENVIRON, V41, P203, DOI 10.1006/jare.1998.0482; Wilkinson MT, 2009, EARTH-SCI REV, V97, P257, DOI 10.1016/j.earscirev.2009.09.005; Wilske B, 2014, ENVIRON SCI POLLUT R, V21, P9453, DOI 10.1007/s11356-013-2103-1; WOODMANSEE RG, 1978, BIOSCIENCE, V28, P448, DOI 10.2307/1307227; Yoo K, 2006, GEODERMA, V130, P47, DOI 10.1016/j.geoderma.2005.01.008; Yoo K, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001304; Zaitlin B, 2007, APPL SOIL ECOL, V37, P88, DOI 10.1016/j.apsoil.2007.04.003; Zaitlin B, 2012, GEOMORPHOLOGY, V157, P142, DOI 10.1016/j.geomorph.2011.07.029; Zangerle A, 2011, GEODERMA, V167-68, P303, DOI 10.1016/j.geoderma.2011.09.004	72	13	13	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0126011	10.1371/journal.pone.0126011	http://dx.doi.org/10.1371/journal.pone.0126011			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25954967	Green Published, gold, Green Submitted			2022-12-26	WOS:000356768100091
J	Woods, LT; Camden, JM; El-Sayed, FG; Khalafalla, MG; Petris, MJ; Erb, L; Weisman, GA				Woods, Lucas T.; Camden, Jean M.; El-Sayed, Farid G.; Khalafalla, Mahmoud G.; Petris, Michael J.; Erb, Laurie; Weisman, Gary A.			Increased Expression of TGF-beta Signaling Components in a Mouse Model of Fibrosis Induced by Submandibular Gland Duct Ligation	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION FACTOR SNAIL; E-CADHERIN; SALIVARY-GLANDS; LIVER FIBROSIS; SJOGRENS-SYNDROME; RENAL FIBROSIS; IN-VIVO; FIBROBLASTS DERIVE	Transforming growth factor-beta (TGF-beta) is a multi-functional cytokine with a well-described role in the regulation of tissue fibrosis and regeneration in the liver, kidney and lung. Submandibular gland (SMG) duct ligation and subsequent deligation in rodents is a classical model for studying salivary gland damage and regeneration. While previous studies suggest that TGF-beta may contribute to salivary gland fibrosis, the expression of TGF-beta signaling components has not been investigated in relation to mouse SMG duct ligation-induced fibrosis and regeneration following ductal deligation. Following a 7 day SMG duct ligation, TGF-beta 1 and TGF-beta 3 were significantly upregulated in the SMG, as were TGF-beta receptor 1 and downstream Smad family transcription factors in salivary acinar cells, but not in ductal cells. In acinar cells, duct ligation also led to upregulation of snail, a Smad-activated E-cadherin repressor and regulator of epithelial-mesenchymal transition, whereas in ductal cells upregulation of E-cadherin was observed while snail expression was unchanged. Upregulation of these TGF-beta signaling components correlated with upregulation of fibrosis markers collagen 1 and fibronectin, responses that were inhibited by administration of the TGF-beta receptor 1 inhibitors SB431542 or GW788388. After SMG regeneration following a 28 day duct deligation, TGF-beta signaling components and epithelial-mesenchymal transition markers returned to levels similar to non-ligated controls. The results from this study indicate that increased TGF-beta signaling contributes to duct ligation-induced changes in salivary epithelium that correlate with glandular fibrosis. Furthermore, the reversibility of enhanced TGF-beta signaling in acinar cells of duct-ligated mouse SMG after deligation indicates that this is an ideal model for studying TGF-beta signaling mechanisms in salivary epithelium as well as mechanisms of fibrosis initiation and their resolution.	[Woods, Lucas T.; Camden, Jean M.; El-Sayed, Farid G.; Khalafalla, Mahmoud G.; Petris, Michael J.; Erb, Laurie; Weisman, Gary A.] Univ Missouri, Dept Biochem, Columbia, MO 65201 USA; [Woods, Lucas T.; Camden, Jean M.; El-Sayed, Farid G.; Khalafalla, Mahmoud G.; Petris, Michael J.; Erb, Laurie; Weisman, Gary A.] Univ Missouri, Christopher S Bond Life Sci Ctr, Columbia, MO USA; [Petris, Michael J.] Univ Missouri, Dept Nutrit Sci & Exercise Physiol, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Weisman, GA (corresponding author), Univ Missouri, Dept Biochem, Columbia, MO 65201 USA.	weismang@missouri.edu	Khalafalla, Farid/Q-9788-2019	Khalafalla, Farid/0000-0003-3907-9716; Khalafalla, Mahmoud/0000-0002-7171-8162; Erb, Laurie/0000-0001-6372-3378	National Institutes of Health (NIH) from the National Institute of Dental & Craniofacial Research (NIDCR) [R01DE007389, R01DE0223342]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023342, R01DE007389] Funding Source: NIH RePORTER	National Institutes of Health (NIH) from the National Institute of Dental & Craniofacial Research (NIDCR); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The study described was supported by National Institutes of Health (NIH) grants R01DE007389 and R01DE0223342 from the National Institute of Dental & Craniofacial Research (NIDCR) to GAW. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the NIDCR. The NIDCR had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JS, 2000, AM J PHYSIOL-CELL PH, V279, pC286, DOI 10.1152/ajpcell.2000.279.2.C286; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Arany S, 2011, DEV BIOL, V353, P186, DOI 10.1016/j.ydbio.2011.02.025; Atkinson Jane C, 2005, Dent Clin North Am, V49, P309, DOI 10.1016/j.cden.2004.10.002; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Boland S, 1996, J CELL SCI, V109, P2207; Bonniaud P, 2005, AM J RESP CRIT CARE, V171, P889, DOI 10.1164/rccm.200405-612OC; Boussadia O, 2002, MECH DEVELOP, V115, P53, DOI 10.1016/S0925-4773(02)00090-4; Brandl M, 2010, J CELL SCI, V123, P4231, DOI 10.1242/jcs.071100; Brito-Zeron P, 2013, EXPERT OPIN PHARMACO, V14, P279, DOI 10.1517/14656566.2013.767333; Burgess KL, 1998, ORAL SURG ORAL MED O, V85, P699; Callahan JF, 2002, J MED CHEM, V45, P999, DOI 10.1021/jm010493y; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; CAULI A, 1995, ANN RHEUM DIS, V54, P209, DOI 10.1136/ard.54.3.209; Chen SJ, 1999, J INVEST DERMATOL, V112, P49, DOI 10.1046/j.1523-1747.1999.00477.x; Cho HJ, 2007, BIOCHEM BIOPH RES CO, V353, P337, DOI 10.1016/j.bbrc.2006.12.035; CHRIST M, 1994, J IMMUNOL, V153, P1936; COOPER JS, 1995, INT J RADIAT ONCOL, V31, P1141, DOI 10.1016/0360-3016(94)00421-G; Cotroneo E, 2008, CELL TISSUE RES, V332, P227, DOI 10.1007/s00441-008-0588-6; Cotroneo E, 2010, DIFFERENTIATION, V79, P120, DOI 10.1016/j.diff.2009.11.005; DANG H, 1995, J IMMUNOL, V155, P3205; Day ML, 1999, J BIOL CHEM, V274, P9656, DOI 10.1074/jbc.274.14.9656; Docherty NG, 2009, KIDNEY INT, V75, P205, DOI 10.1038/ki.2008.482; Farris AB, 2012, CURR OPIN NEPHROL HY, V21, P289, DOI 10.1097/MNH.0b013e3283521cfa; Fox PC, 1998, ANN NY ACAD SCI, V842, P132, DOI 10.1111/j.1749-6632.1998.tb09641.x; Fragiadaki M, 2011, INT J EXP PATHOL, V92, P143, DOI 10.1111/j.1365-2613.2011.00775.x; Gallagher DT, 2009, J BIOL CHEM, V284, P8228, DOI 10.1074/jbc.C800215200; Gardner A, 2012, AM J PATHOL, V180, P2293, DOI 10.1016/j.ajpath.2012.02.022; Gellibert F, 2006, J MED CHEM, V49, P2210, DOI 10.1021/jm0509905; Gershengorn MC, 2004, SCIENCE, V306, P2261, DOI 10.1126/science.1101968; Grundmann O, 2009, J DENT RES, V88, P894, DOI 10.1177/0022034509343143; Hagimoto N, 2002, J IMMUNOL, V168, P6470, DOI 10.4049/jimmunol.168.12.6470; Hakim SG, 2011, RADIOTHER ONCOL, V101, P93, DOI 10.1016/j.radonc.2011.07.032; Hall BE, 2010, LAB INVEST, V90, P543, DOI 10.1038/labinvest.2010.5; Harrison JD, 1998, ULTRASTRUCT PATHOL, V22, P431, DOI 10.3109/01913129809032278; Hoffman MP, 1996, J CELL SCI, V109, P2013; Hoot KE, 2008, J CLIN INVEST, V118, P2722, DOI 10.1172/JCI33713; Huang XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096860; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; JANEBODIN K, 2013, BIOMED RES INT, V2013, DOI DOI 10.1155/2013/815895; JASKOLL T, 1994, J CRAN GENET DEV BIO, V14, P217; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Khan SQ, 2014, FRONT MED, V1, DOI 10.3389/fmed.2014.00045; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kizu Y, 1996, J CLIN PATHOL, V49, P728, DOI 10.1136/jcp.49.9.728; Kriz W, 2011, J CLIN INVEST, V121, P468, DOI 10.1172/JCI44595; Li JH, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000014252.37680.E4; Liu XD, 2013, J NEUROSURG-SPINE, V19, P2; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Lombaert IMA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002063; Mallat A, 2013, AM J PHYSIOL-CELL PH, V305, pC789, DOI 10.1152/ajpcell.00230.2013; Man YG, 2001, ANAT REC, V263, P202, DOI 10.1002/ar.1098; Martin M, 2000, INT J RADIAT ONCOL, V47, P277, DOI 10.1016/S0360-3016(00)00435-1; Mason GI, 2003, J CLIN PATHOL-MOL PA, V56, P52, DOI 10.1136/mp.56.1.52; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; McCartneyFrancis NL, 1996, J IMMUNOL, V157, P1306; Medici D, 2008, MOL BIOL CELL, V19, P4875, DOI 10.1091/mbc.E08-05-0506; Meng XM, 2012, J PATHOL, V227, P175, DOI 10.1002/path.3976; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Minami K, 2005, P NATL ACAD SCI USA, V102, P15116, DOI 10.1073/pnas.0507567102; MOSES HL, 1992, MOL REPROD DEV, V32, P179, DOI 10.1002/mrd.1080320215; Moustakas A, 2001, J CELL SCI, V114, P4359; Mu YB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1332; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Muraoka-Cook RS, 2006, ONCOGENE, V25, P3408, DOI 10.1038/sj.onc.1208964; Murphy-Ullrich JE, 2000, CYTOKINE GROWTH F R, V11, P59, DOI 10.1016/S1359-6101(99)00029-5; Nakaya Y, 2008, DEV GROWTH DIFFER, V50, P755, DOI 10.1111/j.1440-169X.2008.01070.x; Nandula SR, 2007, ARTHRITIS RHEUM-US, V56, P1798, DOI 10.1002/art.22715; Ogawa M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3498; Pedersen AM, 2002, ORAL DIS, V8, P117, DOI 10.1034/j.1601-0825.2002.02851.x; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Petersen M, 2008, KIDNEY INT, V73, P705, DOI 10.1038/sj.ki.5002717; Rastaldi MP, 2002, KIDNEY INT, V62, P137, DOI 10.1046/j.1523-1755.2002.00430.x; Redman RS, 2008, BIOTECH HISTOCHEM, V83, P103, DOI 10.1080/10520290802374683; Rees JRE, 2006, CANCER RES, V66, P9583, DOI 10.1158/0008-5472.CAN-06-1842; Rezaie A, 2007, ANN NY ACAD SCI, V1095, P305, DOI 10.1196/annals.1397.034; Sampson VB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102041; Sanjabi S, 2009, CURR OPIN PHARMACOL, V9, P447, DOI 10.1016/j.coph.2009.04.008; Scott J, 1999, J DENT RES, V78, P1711, DOI 10.1177/00220345990780110801; Segawa S, 2010, CLIN EXP IMMUNOL, V160, P394, DOI 10.1111/j.1365-2249.2010.04094.x; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Silver N, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.12; Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Strippoli R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031492; Takahashi S, 1998, INT J EXP PATHOL, V79, P293, DOI 10.1046/j.1365-2613.1998.710405.x; Takahashi S, 2000, TISSUE CELL, V32, P457, DOI 10.1016/S0040-8166(00)80002-6; TAMARIN A, 1979, J ORAL PATHOL MED, V8, P293, DOI 10.1111/j.1600-0714.1979.tb01831.x; TAMARIN A, 1971, J ULTRA MOL STRUCT R, V34, P276, DOI 10.1016/S0022-5320(71)80072-2; Tarin D, 2005, CANCER RES, V65, P5996, DOI 10.1158/0008-5472.CAN-05-0699; Tatler Amanda L, 2012, Proc Am Thorac Soc, V9, P130, DOI 10.1513/pats.201201-003AW; Teymoortash A, 2003, ARCH ORAL BIOL, V48, P111, DOI 10.1016/S0003-9969(02)00168-1; Thenappan A, 2010, HEPATOLOGY, V51, P1373, DOI 10.1002/hep.23449; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tirino V, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.144; Vissink A, 2010, INT J RADIAT ONCOL, V78, P983, DOI 10.1016/j.ijrobp.2010.06.052; Vitsky A, 2009, AM J PATHOL, V174, P2137, DOI 10.2353/ajpath.2009.080723; Wang YF, 2013, CURR CANCER DRUG TAR, V13, P963, DOI 10.2174/15680096113136660102; Wong AP, 2009, J CLIN INVEST, V119, P336, DOI 10.1172/JCI36882; Woods LT, 2012, AM J PHYSIOL-CELL PH, V303, pC790, DOI 10.1152/ajpcell.00072.2012; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Xia JL, 2006, AM J PATHOL, V168, P1500, DOI 10.2353/ajpath.2006.050747; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Xue ZF, 2013, WORLD J GASTROENTERO, V19, P1380, DOI 10.3748/wjg.v19.i9.1380; Yang L, 2013, GASTROENTEROLOGY, V144, P1042, DOI 10.1053/j.gastro.2013.01.056; Yoshiji H, 2002, HEPATOLOGY, V36, P850, DOI 10.1053/jhep.2002.35625; You S, 2012, INVEST OPHTH VIS SCI, V53, P126, DOI 10.1167/iovs.11-7893; Yu Q, 2000, GENE DEV, V14, P163; Zaia AA, 1996, EUR J ORAL SCI, V104, P627, DOI 10.1111/j.1600-0722.1996.tb00153.x; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200; Zhou XY, 2004, LIVER INT, V24, P492, DOI 10.1111/j.1478-3231.2004.0946.x	115	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0123641	10.1371/journal.pone.0123641	http://dx.doi.org/10.1371/journal.pone.0123641			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955532	gold, Green Published, Green Submitted			2022-12-26	WOS:000356768100020
J	Garant, KA; Shmulevitz, M; Pan, L; Daigle, RM; Ahn, DG; Gujar, SA; Lee, PWK				Garant, K. A.; Shmulevitz, M.; Pan, L.; Daigle, R. M.; Ahn, D-G; Gujar, S. A.; Lee, P. W. K.			Oncolytic reovirus induces intracellular redistribution of Ras to promote apoptosis and progeny virus release	ONCOGENE			English	Article							GOLGI-COMPLEX; H-RAS; FRAGMENTATION; LOCALIZATION; INHIBITION; CANCER; TRAFFICKING; APPARATUS; PROTEINS; REQUIRES	Reovirus is a naturally oncolytic virus that preferentially replicates in Ras-transformed cells and is currently undergoing clinical trials as a cancer therapeutic. Ras transformation promotes reovirus oncolysis by enhancing virion disassembly during entry, viral progeny production, and virus release through apoptosis; however, the mechanism behind the latter is not well understood. Here, we show that reovirus alters the intracellular location of oncogenic Ras to induce apoptosis of H-RasV12-transformed fibroblasts. Reovirus infection decreases Ras palmitoylation levels and causes accumulation of Ras in the Golgi through Golgi fragmentation. With the Golgi being the site of Ras palmitoylation, treatment of target cells with the palmitoylation inhibitor, 2-bromopalmitate (2BP), prompts a greater accumulation of H-RasV12 in the Golgi, and a dose-dependent increase in progeny virus release and subsequent spread. Conversely, tethering H-RasV12 to the plasma membrane (thereby preventing its movement to the Golgi) allows for efficient virus production, but results in basal levels of reovirus-induced cell death. Analysis of Ras downstream signaling reveals that cells expressing cycling H-RasV12 have elevated levels of phosphorylated JNK (c-Jun N-terminal kinase), and that Ras retained at the Golgi body by 28P increases activation of the MEKK1/MKK4/JNK signaling pathway to promote cell death. Collectively, our data suggest that reovirus induces Golgi fragmentation of target cells, and the subsequent accumulation of oncogenic Ras in the Golgi body initiates apoptotic signaling events required for virus release and spread.	[Garant, K. A.; Ahn, D-G; Gujar, S. A.; Lee, P. W. K.] Dalhousie Univ, Dept Microbiol & Immunol, 5850 Coll St,7P Sir Charles Tupper Med Bldg, Halifax, NS B3H 1X5, Canada; [Shmulevitz, M.] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada; [Pan, L.] Toronto Western Res Inst, Div Fundamental Neurobiol, Toronto, ON, Canada; [Daigle, R. M.] Dalhousie Univ, Dept Oceanog, Halifax, NS B3H 1X5, Canada; [Gujar, S. A.] IWK Hlth Ctr, Strategy & Org Performance, Halifax, NS, Canada; [Lee, P. W. K.] Dalhousie Univ, Dept Pathol, Halifax, NS B3H 1X5, Canada	Dalhousie University; University of Alberta; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Dalhousie University; Dalhousie University; Dalhousie University	Gujar, SA; Lee, PWK (corresponding author), Dalhousie Univ, Dept Microbiol & Immunol, 5850 Coll St,7P Sir Charles Tupper Med Bldg, Halifax, NS B3H 1X5, Canada.	shashi.gujar@dal.ca; patrick.lee@dal.ca	Daigle, Remi M/H-3160-2019; Ahn, Dae-Gyun/L-7106-2015	Daigle, Remi M/0000-0001-8832-4189; Shmulevitz, Maya/0000-0002-8627-068X; Ahn, Dae-Gyun/0000-0001-8251-8820; Gujar, Shashi/0000-0002-5427-0829	Canadian Institutes for Health Research [130574]; Terry Fox Research Institute (TFRI) New Frontiers Program in Cancer Research; National Sciences and Engineering Research Council of Canada; Killam Trusts; Nova Scotia Health Research Foundation; Canadian Institute of Health Research (CIHR)-Cancer Research Training Program; Beatrice Hunter Cancer Research Institute (BHCRI); CIHR postdoctoral fellowship	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Terry Fox Research Institute (TFRI) New Frontiers Program in Cancer Research; National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Killam Trusts; Nova Scotia Health Research Foundation; Canadian Institute of Health Research (CIHR)-Cancer Research Training Program(Canadian Institutes of Health Research (CIHR)); Beatrice Hunter Cancer Research Institute (BHCRI); CIHR postdoctoral fellowship(Canadian Institutes of Health Research (CIHR))	This work was supported by the research grants from the Canadian Institutes for Health Research (Grant FRN # 130574) and the Terry Fox Research Institute (TFRI) New Frontiers Program in Cancer Research (through Canadian Oncolytic Virus Consortium (COVCo)) to PWKL and SAG. Funding for KA Garant was awarded through the National Sciences and Engineering Research Council of Canada, the Killam Trusts and the Nova Scotia Health Research Foundation. Plasma membrane-tethered CD8-H-RasV12xx in pCEFL was a gift from Dr Piero Crespo (University of Cantabria, Cantabria, Spain). D-G Ahn was supported by the Canadian Institute of Health Research (CIHR)-Cancer Research Training Program and the Beatrice Hunter Cancer Research Institute (BHCRI). SG was supported by CIHR postdoctoral fellowship.	Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; Ahearn IM, 2011, MOL CELL, V41, P173, DOI 10.1016/j.molcel.2011.01.001; AVITABILE E, 1995, J VIROL, V69, P7472, DOI 10.1128/JVI.69.12.7472-7482.1995; Baines AT, 2011, FUTURE MED CHEM, V3, P1787, DOI [10.4155/FMC.11.121, 10.4155/fmc.11.121]; BOS JL, 1989, CANCER RES, V49, P4682; Boyartchuk VL, 1997, SCIENCE, V275, P1796, DOI 10.1126/science.275.5307.1796; Calvo F, 2010, BIOESSAYS, V32, P412, DOI 10.1002/bies.200900155; CASEY PJ, 1989, P NATL ACAD SCI USA, V86, P8323, DOI 10.1073/pnas.86.21.8323; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Clarke P, 2004, J VIROL, V78, P13132, DOI 10.1128/JVI.78.23.13132-13138.2004; Coffey MC, 1998, SCIENCE, V282, P1332, DOI 10.1126/science.282.5392.1332; Colanzi A, 2003, CURR OPIN CELL BIOL, V15, P462, DOI 10.1016/S0955-0674(03)00067-X; Dai Q, 1998, J BIOL CHEM, V273, P15030, DOI 10.1074/jbc.273.24.15030; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; DER CJ, 1982, P NATL ACAD SCI-BIOL, V79, P3637, DOI 10.1073/pnas.79.11.3637; Drisdel RC, 2006, METHODS, V40, P127, DOI 10.1016/j.ymeth.2006.04.015; Duncan JA, 1998, J BIOL CHEM, V273, P15830, DOI 10.1074/jbc.273.25.15830; Goodwin JS, 2005, J CELL BIOL, V170, P261, DOI 10.1083/jcb.200502063; Grabocka E, 2014, CANCER CELL, V25, P243, DOI 10.1016/j.ccr.2014.01.005; GUTIERREZ L, 1989, EMBO J, V8, P1093, DOI 10.1002/j.1460-2075.1989.tb03478.x; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; Heinemann L, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-221; Hirasawa K, 2002, CANCER RES, V62, P1696; Ilkow CS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003836; Kominsky DJ, 2002, CELL DEATH DIFFER, V9, P926, DOI 10.1038/sj.cdd.4401045; Kominsky DJ, 2002, J VIROL, V76, P11414, DOI 10.1128/JVI.76.22.11414-11424.2002; Marcato P, 2007, MOL THER, V15, P1522, DOI 10.1038/sj.mt.6300179; Matallanas D, 2006, MOL CELL BIOL, V26, P100, DOI 10.1128/MCB.26.1.100-116.2006; Mendez II, 2000, J VIROL METHODS, V90, P59, DOI 10.1016/S0166-0934(00)00217-2; Mukherjee S, 2007, TRAFFIC, V8, P369, DOI 10.1111/j.1600-0854.2007.00542.x; Norman KL, 2002, HUM GENE THER, V13, P641, DOI 10.1089/10430340252837233; Nozawa K, 2002, ARTHRITIS RES, V4, DOI 10.1186/ar422; Parker JSL, 2002, J VIROL, V76, P4483, DOI 10.1128/JVI.76.9.4483-4496.2002; Resh MD, 2006, METHODS, V40, P191, DOI 10.1016/j.ymeth.2006.04.013; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Roy S, 2005, MOL CELL BIOL, V25, P6722, DOI 10.1128/MCB.25.15.6722-6733.2005; RUSSELL M, 1995, J BIOL CHEM, V270, P11757, DOI 10.1074/jbc.270.20.11757; SHAHINIAN S, 1995, BIOCHEMISTRY-US, V34, P3813, DOI 10.1021/bi00011a039; SHARPE AH, 1982, VIROLOGY, V120, P399, DOI 10.1016/0042-6822(82)90040-X; SHIMIZU K, 1983, P NATL ACAD SCI-BIOL, V80, P383, DOI 10.1073/pnas.80.2.383; Shmulevitz M, 2010, CANCER RES, V70, P4912, DOI 10.1158/0008-5472.CAN-09-4676; Stickney JT, 2001, METHOD ENZYMOL, V332, P64; Strong JE, 1998, EMBO J, V17, P3351, DOI 10.1093/emboj/17.12.3351; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Swarthout JT, 2005, J BIOL CHEM, V280, P31141, DOI 10.1074/jbc.M504113200; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261	48	25	25	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 11	2016	35	6					771	782		10.1038/onc.2015.136	http://dx.doi.org/10.1038/onc.2015.136			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DE0RF	25961930				2022-12-26	WOS:000370331300010
J	Fuerstenau-Sharp, M; Zimmermann, ME; Stark, K; Jentsch, N; Klingenstein, M; Drzymalski, M; Wagner, S; Maier, LS; Hehr, U; Baessler, A; Fischer, M; Hengstenberg, C				Fuerstenau-Sharp, Maya; Zimmermann, Martina E.; Stark, Klaus; Jentsch, Nico; Klingenstein, Melanie; Drzymalski, Marzena; Wagner, Stefan; Maier, Lars S.; Hehr, Ute; Baessler, Andrea; Fischer, Marcus; Hengstenberg, Christian			Generation of Highly Purified Human Cardiomyocytes from Peripheral Blood Mononuclear Cell-Derived Induced Pluripotent Stem Cells	PLOS ONE			English	Article							ACTION-POTENTIALS; PROGENITOR CELLS; MOUSE; CONTRACTION; DIFFERENTIATION; PURIFICATION; MODELS	Induced pluripotent stem (iPS) cells have an enormous potential for physiological studies. A novel protocol was developed combining the derivation of iPS from peripheral blood with an optimized directed differentiation to cardiomyocytes and a subsequent metabolic selection. The human iPS cells were retrovirally dedifferentiated from activated T cells. The subsequent optimized directed differentiation protocol yielded 30-45% cardiomyocytes at day 16 of differentiation. The derived cardiomyocytes expressed appropriate structural markers like cardiac troponin T, alpha-actinin and myosin light chain 2 (MLC2V). In a subsequent metabolic selection with lactate, the cardiomyocytes content could be increased to more than 90%. Loss of cardiomyocytes during metabolic selection were less than 50%, whereas alternative surface antibody-based selection procedures resulted in loss of up to 80% of cardiomyocytes. Electrophysiological characterization confirmed the typical cardiac features and the presence of ventricular, atrial and nodal-like action potentials within the derived cardio-myocyte population. Our combined and optimized protocol is highly robust and applicable for scalable cardiac differentiation. It provides a simple and cost-efficient method without expensive equipment for generating large numbers of highly purified, functional cardiomyocytes. It will further enhance the applicability of iPS cell-derived cardiomyocytes for disease modeling, drug discovery, and regenerative medicine.	[Fuerstenau-Sharp, Maya; Zimmermann, Martina E.; Jentsch, Nico; Klingenstein, Melanie; Drzymalski, Marzena; Wagner, Stefan; Maier, Lars S.; Baessler, Andrea; Fischer, Marcus; Hengstenberg, Christian] Univ Hosp Regensburg, Clin Internal Med 2, Regensburg, Germany; [Stark, Klaus] Univ Regensburg, Inst Epidemiol & Prevent Med, Dept Genet Epidemiol, D-93053 Regensburg, Germany; [Hehr, Ute] Univ Regensburg, Ctr & Dept Human Genet, D-93053 Regensburg, Germany	University of Regensburg; University of Regensburg; University of Regensburg	Hengstenberg, C (corresponding author), Tech Univ Munich, Deutsch Herzzentrum Munchen, D-80290 Munich, Germany.	Christian.hengstenberg@gmail.com	Zimmermann, Martina/AAL-2990-2021; Stark, Klaus/L-7367-2013; Maier, Lars/AAQ-8313-2021; Hengstenberg, Christian/U-5485-2019	Zimmermann, Martina/0000-0002-6916-4404; Stark, Klaus/0000-0002-7832-1942; Maier, Lars/0000-0001-9915-4429; Wagner, Stefan/0000-0002-9471-1166	National Genome Network (NGFNplus Atherogenomics) [01GS0831]; European Union 6th Framework Program Cardiogenics [LSH-2006-037593]; Deutsche Forschungsgemeinschaft (DFG) through an International Research Training Group [GRK 1816]; Fondation Leducq Transatlantic Network on "Redox and Nitrosative Regulation of Cardiac Remodeling"	National Genome Network (NGFNplus Atherogenomics); European Union 6th Framework Program Cardiogenics; Deutsche Forschungsgemeinschaft (DFG) through an International Research Training Group(German Research Foundation (DFG)); Fondation Leducq Transatlantic Network on "Redox and Nitrosative Regulation of Cardiac Remodeling"	This work was supported by the National Genome Network (NGFNplus Atherogenomics, 01GS0831) (CH, MFS), and the European Union 6th Framework Program Cardiogenics (LSH-2006-037593) (CH). SW and LSM are funded by Deutsche Forschungsgemeinschaft (DFG) through an International Research Training Group GRK 1816. LSM is funded by the Fondation Leducq Transatlantic Network on "Redox and Nitrosative Regulation of Cardiac Remodeling".	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Anderson D, 2007, MOL THER, V15, P2027, DOI 10.1038/sj.mt.6300303; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Brown ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011373; Carvajal-Vergara X, 2010, NATURE, V465, P808, DOI 10.1038/nature09005; Chen A, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt401; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; Dubois NC, 2011, NAT BIOTECHNOL, V29, P1011, DOI 10.1038/nbt.2005; Dybkova N, 2014, CARDIOVASC RES, V103, P168, DOI 10.1093/cvr/cvu120; Eminli S, 2008, STEM CELLS, V26, P2467, DOI 10.1634/stemcells.2008-0317; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; Guan K, 2007, CIRC RES, V100, P1615, DOI 10.1161/01.RES.0000269182.22798.d9; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; HARRISON SM, 1995, J PHYSIOL-LONDON, V482, P555, DOI 10.1113/jphysiol.1995.sp020539; Hemmi N, 2014, STEM CELL TRANSL MED, V3, P1473, DOI 10.5966/sctm.2014-0072; Itzhaki I, 2011, NATURE, V471, P225, DOI 10.1038/nature09747; Jung CB, 2012, EMBO MOL MED, V4, P180, DOI 10.1002/emmm.201100194; JURKIEWICZ NK, 1993, CIRC RES, V72, P75, DOI 10.1161/01.RES.72.1.75; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lahti AL, 2012, DIS MODEL MECH, V5, P220, DOI 10.1242/dmm.008409; Loh YH, 2010, CELL STEM CELL, V7, P15, DOI 10.1016/j.stem.2010.06.004; Ma JY, 2011, AM J PHYSIOL-HEART C, V301, pH2006, DOI 10.1152/ajpheart.00694.2011; MACERA MJ, 1992, GENOMICS, V13, P829, DOI 10.1016/0888-7543(92)90161-K; Matsuura K, 2012, BIOCHEM BIOPH RES CO, V425, P321, DOI 10.1016/j.bbrc.2012.07.089; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; Mummery C, 2002, J ANAT, V200, P233, DOI 10.1046/j.1469-7580.2002.00031.x; Navarrete EG, 2013, CIRCULATION, V128, pS3, DOI 10.1161/CIRCULATIONAHA.112.000570; Park SJ, 2013, CARDIOLOGY, V124, P139, DOI 10.1159/000346390; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Rajala K, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/383709; Riedel M, 2014, STEM CELL REP, V3, DOI 10.1016/j.stemcr.2014.04.017; Seki T, 2010, CELL STEM CELL, V7, P11, DOI 10.1016/j.stem.2010.06.003; Sirenko O, 2013, J BIOMOL SCREEN, V18, P39, DOI 10.1177/1087057112457590; Staerk J, 2010, CELL STEM CELL, V7, P20, DOI 10.1016/j.stem.2010.06.002; Stankewicz C, 2013, INVENTORSCARDIOMYOCY; Sun N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003552; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tohyama S, 2013, CELL STEM CELL, V12, P127, DOI 10.1016/j.stem.2012.09.013; Uosaki H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023657; WADE MH, 1986, SCIENCE, V232, P525, DOI 10.1126/science.3961495; Wagner S, 2006, J CLIN INVEST, V116, P3127, DOI 10.1172/JCI26620; Wagner S, 2011, CIRC RES, V108, P555, DOI 10.1161/CIRCRESAHA.110.221911; Wagner S, 2009, CIRC-ARRHYTHMIA ELEC, V2, P285, DOI 10.1161/CIRCEP.108.842799; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yazawa M, 2011, NATURE, V471, P230, DOI 10.1038/nature09855; Zhou T, 2012, NAT PROTOC, V7, P2080, DOI 10.1038/nprot.2012.115	50	37	40	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0126596	10.1371/journal.pone.0126596	http://dx.doi.org/10.1371/journal.pone.0126596			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970162	Green Submitted, Green Published, gold			2022-12-26	WOS:000354544200119
J	Larsen, SB; Grove, EL; Pareek, M; Kristensen, SD; Hvas, AM				Larsen, Sanne Bojet; Grove, Erik Lerkevang; Pareek, Manan; Kristensen, Steen Dalby; Hvas, Anne-Mette			Calprotectin and Platelet Aggregation in Patients with Stable Coronary Artery Disease	PLOS ONE			English	Article							MYELOID-RELATED PROTEIN-14; TRADITIONAL RISK-FACTORS; C-REACTIVE PROTEIN; MYOCARDIAL-INFARCTION; S100A8/A9 COMPLEX; ASPIRIN; SERUM; INFLAMMATION; EXPRESSION; RECEPTOR	Background Recent studies suggest that the inflammation-associated protein calprotectin may be implicated in the pathogenesis of coronary artery disease (CAD). However, the impact of calprotectin levels on platelet aggregation in CAD patients has never been investigated. Objectives We investigated the association between calprotectin levels and platelet aggregation in stable, high-risk CAD patients receiving aspirin as mono antiplatelet therapy. Furthermore, we aimed to investigate independent clinical and laboratory determinants of calprotectin levels. Methods We performed a cross-sectional study including 581 stable, high-risk CAD patients. All patients received 75 mg aspirin daily as mono antiplatelet therapy. Platelet aggregation was assessed by 1) impedance aggregometry (Multiplate Analyzer) using arachidonic acid (AA) and collagen as agonists and by 2) the VerifyNow Aspirin Assay. Low-grade inflammation was evaluated by calprotectin, high-sensitive C-reactive-protein (hs-CRP) and interleukin-6. Platelet activation was assessed by soluble P-selectin, and cyclooxygenase-1 inhibition was evaluated by serum thromboxane B-2, both measured by ELISA. Results Calprotectin levels correlated positively with platelet aggregation according to Multiplate Analyzer (r=0.12, p=0.01). Additionally, calprotectin was positively associated with leukocytes (r=0.33, p<0.0001), hs-CRP (r=0.31, p<0.0001), interleukin-6 (r=0.28, p<0.0001), soluble P-selectin (r=0.10, p=0.02) and serum thromboxane B-2 (r=0.10, p=0.02). Type 2 diabetes mellitus was an independent predictor of increased calprotectin levels (p=0.004), and trends were seen for body mass index (p=0.06) and smoking (p=0.07). Compliance with aspirin was confirmed by low serum thromboxane B-2 levels in all patients (median [25%; 75%]: 1.07 [0.52; 1.87]ng/mL). Conclusion Calprotectin levels correlated positively, though weakly, with platelet aggregation and activation as well as serum thromboxane B-2 in high-risk, stable CAD patients treated with aspirin.	[Larsen, Sanne Bojet; Grove, Erik Lerkevang; Pareek, Manan; Kristensen, Steen Dalby] Aarhus Univ Hosp, Dept Cardiol, DK-8200 Aarhus, Denmark; [Kristensen, Steen Dalby; Hvas, Anne-Mette] Aarhus Univ, Fac Hlth Sci, DK-8200 Aarhus, Denmark; [Hvas, Anne-Mette] Aarhus Univ Hosp, Dept Clin Biochem, DK-8200 Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Hvas, AM (corresponding author), Aarhus Univ, Fac Hlth Sci, DK-8200 Aarhus, Denmark.	am.hvas@dadlnet.dk	Pareek, Manan/ABF-2534-2020	Pareek, Manan/0000-0002-0867-5825; Grove, Erik/0000-0002-1466-0865	Danish Agency for Science, Technology and Innovation [2101-05-0052]; Faculty of Health Sciences, Aarhus University, Denmark; Danish Heart Foundation; Department of Clinical Medicine, Aarhus University Hospital, Denmark; Eva and Henry Fraenkel's Foundation; Aase and Ejnar Danielsen's Foundation; Sophus Jacobsen and Spouse Astrid Jacobsen's Foundation; Korning Foundation; Physician's assurance association [anno 1891]; Fabrikant Karl G. Andersen's Foundation; Novo Nordisk Fonden [NNF14OC0008817] Funding Source: researchfish	Danish Agency for Science, Technology and Innovation; Faculty of Health Sciences, Aarhus University, Denmark; Danish Heart Foundation; Department of Clinical Medicine, Aarhus University Hospital, Denmark; Eva and Henry Fraenkel's Foundation; Aase and Ejnar Danielsen's Foundation; Sophus Jacobsen and Spouse Astrid Jacobsen's Foundation; Korning Foundation(National Research Foundation of Korea); Physician's assurance association; Fabrikant Karl G. Andersen's Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation)	The study was financially supported by the Danish Agency for Science, Technology and Innovation (grant no. 2101-05-0052); the Faculty of Health Sciences, Aarhus University, Denmark; The Danish Heart Foundation; Department of Clinical Medicine, Aarhus University Hospital, Denmark; Eva and Henry Fraenkel's Foundation; Aase and Ejnar Danielsen's Foundation; Sophus Jacobsen and Spouse Astrid Jacobsen's Foundation; The Korning Foundation; The Physician's assurance association anno 1891 and Fabrikant Karl G. Andersen's Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altwegg LA, 2007, EUR HEART J, V28, P941, DOI 10.1093/eurheartj/ehm078; Averill MM, 2012, ARTERIOSCL THROM VAS, V32, P223, DOI 10.1161/ATVBAHA.111.236927; Bernlochner I, 2010, THROMB HAEMOSTASIS, V104, P1193, DOI 10.1160/TH10-05-0266; Boyd JH, 2008, CIRC RES, V102, P1239, DOI 10.1161/CIRCRESAHA.107.167544; Catalan V, 2011, MOL MED, V17, P1157, DOI 10.2119/molmed.2011.00144; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Cotoi OS, 2014, ARTERIOSCL THROM VAS, V34, P202, DOI 10.1161/ATVBAHA.113.302432; de SD, 2008, CLIN CHEM, V54, P1066, DOI [10.1373/clinchem.2007.099549, DOI 10.1373/CLINCHEM.2007.099549]; EDGEWORTH J, 1991, J BIOL CHEM, V266, P7706; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Falk E, 2013, EUR HEART J, V34, P719, DOI 10.1093/eurheartj/ehs411; Grant PJ, 2007, J INTERN MED, V262, P157, DOI 10.1111/j.1365-2796.2007.01824.x; Gremmel T, 2013, J ATHEROSCLER THROMB, V20, P630, DOI 10.5551/jat.17665; Grove EL, 2012, CURR VASC PHARMACOL, V10, P494; Grove EL, 2010, THROMB HAEMOSTASIS, V103, P1245, DOI 10.1160/TH09-08-0527; Hanriot D, 2008, THROMB HAEMOSTASIS, V99, P558, DOI 10.1160/TH07-06-0410; Healy AM, 2006, CIRCULATION, V113, P2278, DOI 10.1161/CIRCULATIONAHA.105.607333; HESSIAN PA, 1993, J LEUKOCYTE BIOL, V53, P197, DOI 10.1002/jlb.53.2.197; Hirata A, 2012, DIABETES RES CLIN PR, V97, P82, DOI 10.1016/j.diabres.2012.01.026; Ho GT, 2009, AM J GASTROENTEROL, V104, P673, DOI 10.1038/ajg.2008.119; Ionita MG, 2009, ARTERIOSCL THROM VAS, V29, P1220, DOI 10.1161/ATVBAHA.109.190314; Jensen LJN, 2010, J INTERV CARDIOL, V23, P123, DOI 10.1111/j.1540-8183.2010.00532.x; Katashima T, 2010, CIRC J, V74, P741, DOI 10.1253/circj.CJ-09-0564; Kruzliak P, 2014, CYTOKINE GROWTH F R, V25, P67, DOI 10.1016/j.cytogfr.2014.01.005; Kuzniatsova N, 2012, ANN MED, V44, P773, DOI 10.3109/07853890.2011.605388; Larsen SB, 2013, THROMB HAEMOSTASIS, V109, P920, DOI 10.1160/TH12-09-0666; Larsen SB, 2012, THROMB HAEMOSTASIS, V108, P140, DOI 10.1160/TH12-01-0026; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; McCormick MM, 2005, J BIOL CHEM, V280, P41521, DOI 10.1074/jbc.M509442200; Morrow DA, 2008, AM HEART J, V155, P49, DOI 10.1016/j.ahj.2007.08.018; Mortensen OH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007419; Muller K, 2010, ATHEROSCLEROSIS, V213, P256, DOI 10.1016/j.atherosclerosis.2010.07.023; Nakagomi A, 2000, CIRCULATION, V101, P1785, DOI 10.1161/01.CIR.101.15.1785; Neergaard-Petersen S, 2014, THROMB HAEMOSTASIS, V112, P1142, DOI 10.1160/TH14-05-0468; Ortega FJ, 2012, EUR J ENDOCRINOL, V167, P569, DOI 10.1530/EJE-12-0374; Peng WH, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-41; Schiopu A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/828354; Schmidt Morten, 2010, Clin Epidemiol, V2, P137; Sekimoto R, 2012, BIOCHEM BIOPH RES CO, V419, P782, DOI 10.1016/j.bbrc.2012.02.102; Siller-Matula JM, 2013, INT J CARDIOL, V167, P430, DOI 10.1016/j.ijcard.2012.01.016; Viemann D, 2005, BLOOD, V105, P2955, DOI 10.1182/blood-2004-07-2520; Wang YM, 2014, J CLIN INVEST, V124, P2160, DOI 10.1172/JCI70966; Wurtz M, 2012, CURR PHARM DESIGN, V18, P5344, DOI 10.2174/138161212803251925	43	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0125992	10.1371/journal.pone.0125992	http://dx.doi.org/10.1371/journal.pone.0125992			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970343	gold, Green Submitted, Green Published			2022-12-26	WOS:000354544200091
J	Bates, R; Blyuss, O; Alsaedi, A; Zaikin, A				Bates, Russell; Blyuss, Oleg; Alsaedi, Ahmed; Zaikin, Alexey			Effect of Noise in Intelligent Cellular Decision Making	PLOS ONE			English	Article							STOCHASTIC RESONANCE; IMPLEMENTATION; EVOLUTION; NETWORK	Similar to intelligent multicellular neural networks controlling human brains, even single cells, surprisingly, are able to make intelligent decisions to classify several external stimuli or to associate them. This happens because of the fact that gene regulatory networks can perform as perceptrons, simple intelligent schemes known from studies on Artificial Intelligence. We study the role of genetic noise in intelligent decision making at the genetic level and show that noise can play a constructive role helping cells to make a proper decision. We show this using the example of a simple genetic classifier able to classify two external stimuli.	[Bates, Russell; Zaikin, Alexey] UCL, Dept Math, London, England; [Blyuss, Oleg; Zaikin, Alexey] UCL, Inst Womens Hlth, London, England; [Alsaedi, Ahmed] King AbdulAziz Univ, Dept Math, Jeddah, Saudi Arabia; [Zaikin, Alexey] Lobachevsky State Univ Nizhniy Novgorod, Nizhnii Novgorod, Russia	University of London; University College London; University of London; University College London; King Abdulaziz University; Lobachevsky State University of Nizhni Novgorod	Zaikin, A (corresponding author), UCL, Dept Math, London, England.	alexey.zaikin@ucl.ac.uk	Zaikin, Alexey/T-7171-2019; Blyuss, Oleg/O-3370-2015; Blyuss, Oleg/AAC-3430-2022; Alsaedi, Ahmed/A-2094-2013; Zaikin, Alexey/K-6581-2017	Zaikin, Alexey/0000-0001-7540-1130; Blyuss, Oleg/0000-0002-0194-6389; Blyuss, Oleg/0000-0002-0194-6389; Alsaedi, Ahmed/0000-0003-3452-8922; Zaikin, Alexey/0000-0001-7540-1130	Deanship of Scientific Research (DSR), King Abdulaziz University (KAU), Jeddah [86-130-35-RG]; Russian Foundation for Basic Research [14-02-01202, 3-02-00918]; Ministry of education and science of the Russian Federation [N 02.B.49.21.0003]; Lobachevsky State University of Nizhni Novgorod [N 02.B.49.21.0003]; CR-UK; Eve Appeal; Cancer Research UK [12677] Funding Source: researchfish	Deanship of Scientific Research (DSR), King Abdulaziz University (KAU), Jeddah; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Ministry of education and science of the Russian Federation(Ministry of Education and Science, Russian Federation); Lobachevsky State University of Nizhni Novgorod; CR-UK(Cancer Research UK); Eve Appeal; Cancer Research UK(Cancer Research UK)	The authors acknowledge support from the Deanship of Scientific Research (DSR), King Abdulaziz University (KAU), Jeddah, under grant No. (86-130-35-RG), CR-UK and Eve Appeal funded project PROMISE-2016, Russian Foundation for Basic Research (14-02-01202, 3-02-00918), and partly by the grant (the agreement of August 27, 2013 N 02.B.49.21.0003 between The Ministry of education and science of the Russian Federation and Lobachevsky State University of Nizhni Novgorod).	Alberts B, 2008, MOL BIOL CELL; Bates R, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.032716; BENZI R, 1981, J PHYS A-MATH GEN, V14, pL453, DOI 10.1088/0305-4470/14/11/006; BRAY D, 1994, BIOPHYS J, V66, P972, DOI 10.1016/S0006-3495(94)80878-1; Cohen M, 2010, DEV CELL, V19, P78, DOI 10.1016/j.devcel.2010.06.006; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Fernando CT, 2009, J R SOC INTERFACE, V6, P463, DOI 10.1098/rsif.2008.0344; Gandhi N, 2007, J THEOR BIOL, V249, P58, DOI 10.1016/j.jtbi.2007.07.004; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; HJELMFELT A, 1995, PHYSICA D, V84, P180, DOI 10.1016/0167-2789(95)00014-U; HJELMFELT A, 1991, P NATL ACAD SCI USA, V88, P10983, DOI 10.1073/pnas.88.24.10983; Jones B, 2006, IEEE SYMP ART LIFE, P187; Lu TK, 2009, NAT BIOTECHNOL, V27, P1139, DOI 10.1038/nbt.1591; McAdams HH, 1999, TRENDS GENET, V15, P65, DOI 10.1016/S0168-9525(98)01659-X; Mori T, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.218101; PARTRIDGE L, 1994, EVOLUTION, V48, P1269, DOI 10.1111/j.1558-5646.1994.tb05311.x; Priplata AA, 2003, LANCET, V362, P1123, DOI 10.1016/S0140-6736(03)14470-4; Qian L, 2011, NATURE, V475, P368, DOI 10.1038/nature10262; Russell DF, 1999, NATURE, V402, P291, DOI 10.1038/46279; Sadooghi-Alvandi SM, 2009, STAT PAP, V50, P171, DOI 10.1007/s00362-007-0049-4; Saigusa T, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.018101; Suzuki N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027232; Weiss JN, 1997, FASEB J, V11, P835, DOI 10.1096/fasebj.11.11.9285481	24	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0125079	10.1371/journal.pone.0125079	http://dx.doi.org/10.1371/journal.pone.0125079			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965584	Green Published, gold, Green Submitted			2022-12-26	WOS:000354543500010
J	Decleyre, H; Heylen, K; Sabbe, K; Tytgat, B; Deforce, D; Van Nieuwerburgh, F; Van Colen, C; Willems, A				Decleyre, Helen; Heylen, Kim; Sabbe, Koen; Tytgat, Bjorn; Deforce, Dieter; Van Nieuwerburgh, Filip; Van Colen, Carl; Willems, Anne			A Doubling of Microphytobenthos Biomass Coincides with a Tenfold Increase in Denitrifier and Total Bacterial Abundances in Intertidal Sediments of a Temperate Estuary	PLOS ONE			English	Article							REDUCTASE GENES NIRS; NITROGEN-CYCLE; COMMUNITY COMPOSITION; CULTIVATED DENITRIFIERS; MICROBIAL DIVERSITY; NITRATE REDUCTION; MARINE ECOSYSTEMS; ACTIVATED-SLUDGE; UNITED-KINGDOM; RARE BIOSPHERE	Surface sediments are important systems for the removal of anthropogenically derived inorganic nitrogen in estuaries. They are often characterized by the presence of a microphytobenthos (MPB) biofilm, which can impact bacterial communities in underlying sediments for example by secretion of extracellular polymeric substances (EPS) and competition for nutrients (including nitrogen). Pyrosequencing and qPCR was performed on two intertidal surface sediments of the Westerschelde estuary characterized by a two-fold difference in MPB biomass but no difference in MPB composition. Doubling of MPB biomass was accompanied by a disproportionately (ten-fold) increase in total bacterial abundances while, unexpectedly, no difference in general community structure was observed, despite significantly lower bacterial richness and distinct community membership, mostly for non-abundant taxa. Denitrifier abundances corresponded likewise while community structure, both for nirS and nirK denitrifiers, remained unchanged, suggesting that competition with diatoms for nitrate is negligible at concentrations in the investigated sediments (appr. 1 mg/l NO3-). This study indicates that MPB biomass increase has a general, significantly positive effect on total bacterial and denitrifier abundances, with stimulation or inhibition of specific bacterial groups that however do not result in a re-structured community.	[Decleyre, Helen; Heylen, Kim; Tytgat, Bjorn; Willems, Anne] Univ Ghent, Dept Biochem & Microbiol, Lab Microbiol LM UGent, B-9000 Ghent, Belgium; [Sabbe, Koen] Univ Ghent, Dept Biol, Lab Protistol & Aquat Ecol, B-9000 Ghent, Belgium; [Deforce, Dieter; Van Nieuwerburgh, Filip] Univ Ghent, Fac Pharmaceut Sci, Lab Pharmaceut Biotechnol, B-9000 Ghent, Belgium; [Van Colen, Carl] Univ Ghent, Dept Biol, Marine Biol Res Grp, B-9000 Ghent, Belgium	Ghent University; Ghent University; Ghent University; Ghent University	Heylen, K (corresponding author), Univ Ghent, Dept Biochem & Microbiol, Lab Microbiol LM UGent, B-9000 Ghent, Belgium.	Kim.Heylen@ugent.be	Willems, Anne/B-2872-2010; Van Nieuwerburgh, Filip/H-9697-2015	Willems, Anne/0000-0002-8421-2881; Van Nieuwerburgh, Filip/0000-0001-8815-5485	Special Research Fund Ghent University (BOF-UGent) [01G01911, 0J28410]; Belgian Science Policy Office (BelSPO) project CCAMBIO; Fund for Scientific Research (FWO), Flanders [FWO- 12BO812N, FWO-1.2.380.11.N.00]	Special Research Fund Ghent University (BOF-UGent); Belgian Science Policy Office (BelSPO) project CCAMBIO; Fund for Scientific Research (FWO), Flanders(FWO)	This work was supported by the Special Research Fund Ghent University (BOF-UGent projects 01G01911 and 0J28410) and Belgian Science Policy Office (BelSPO) project CCAMBIO. KH and CVC are funded by the Fund for Scientific Research (FWO), Flanders for a position as postdoctoral research fellows (FWO- 12BO812N; FWO-1.2.380.11.N.00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell GCJ, 2010, ISME J, V4, P286, DOI 10.1038/ismej.2009.105; Amin SA, 2012, MICROBIOL MOL BIOL R, V76, P667, DOI 10.1128/MMBR.00007-12; Anderson DM, 2002, ESTUARIES, V25, P704, DOI 10.1007/BF02804901; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Barta J, 2010, BIOGEOCHEMISTRY, V101, P123, DOI 10.1007/s10533-010-9430-9; Bartoli M, 2012, J EXP MAR BIOL ECOL, V438, P41, DOI 10.1016/j.jembe.2012.09.011; Bellinger BJ, 2009, AQUAT MICROB ECOL, V55, P169, DOI 10.3354/ame01287; Belzile C, 2008, J MARINE SYST, V74, P946, DOI 10.1016/j.jmarsys.2007.12.010; Berry D, 2011, APPL ENVIRON MICROB, V77, P7846, DOI 10.1128/AEM.05220-11; Bodelier PLE, 2013, ISME J, V7, P2214, DOI 10.1038/ismej.2013.99; Boon N, 2000, APPL ENVIRON MICROB, V66, P2906, DOI 10.1128/AEM.66.7.2906-2913.2000; Bowen JL, 2012, ISME J, V6, P2014, DOI 10.1038/ismej.2012.47; Brito A, 2009, ESTUAR COAST SHELF S, V83, P67, DOI 10.1016/j.ecss.2009.03.023; BuffanDubau E, 1996, MAR ECOL PROG SER, V137, P71, DOI 10.3354/meps137071; Campbell BJ, 2011, P NATL ACAD SCI USA, V108, P12776, DOI 10.1073/pnas.1101405108; Canfield DE, 2010, SCIENCE, V330, P192, DOI 10.1126/science.1186120; Fonseca ALD, 2013, BRAZ J OCEANOGR, V61, P83, DOI 10.1590/S1679-87592013000200001; Dahnke K, 2012, BIOGEOSCIENCES, V9, P4059, DOI 10.5194/bg-9-4059-2012; Dale OR, 2009, ENVIRON MICROBIOL, V11, P1194, DOI 10.1111/j.1462-2920.2008.01850.x; Dang HY, 2009, MICROB ECOL, V58, P161, DOI 10.1007/s00248-008-9469-5; Depkat-Jakob PS, 2013, FEMS MICROBIOL ECOL, V83, P375, DOI 10.1111/j.1574-6941.2012.01476.x; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Dong LF, 2011, LIMNOL OCEANOGR, V56, P279, DOI 10.4319/lo.2011.56.1.0279; Dong LF, 2009, APPL ENVIRON MICROB, V75, P3171, DOI 10.1128/AEM.02511-08; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Francis CA, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00237; Gardner WS, 2009, BIOGEOCHEMISTRY, V95, P185, DOI 10.1007/s10533-009-9329-5; Giblin AE, 2013, OCEANOGRAPHY, V26, P124, DOI 10.5670/oceanog.2013.54; Graf DRH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114118; Green SJ, 2010, APPL ENVIRON MICROB, V76, P3244, DOI 10.1128/AEM.03069-09; Gurung Tek Bahadur, 2001, Limnology, V2, P19, DOI 10.1007/s102010170012; Hallin S, 1999, APPL ENVIRON MICROB, V65, P1652; Hallin S, 2006, APPL ENVIRON MICROB, V72, P5445, DOI 10.1128/AEM.00809-06; Hanlon ARM, 2006, LIMNOL OCEANOGR, V51, P79, DOI 10.4319/lo.2006.51.1.0079; Hannig M, 2006, FEMS MICROBIOL ECOL, V57, P260, DOI 10.1111/j.1574-6941.2006.00116.x; Hashimoto T, 2009, SOIL SCI PLANT NUTR, V55, P647, DOI 10.1111/j.1747-0765.2009.00404.x; Haynes K, 2007, APPL ENVIRON MICROB, V73, P6112, DOI 10.1128/AEM.00551-07; Heylen K, 2007, ENVIRON MICROBIOL, V9, P1072, DOI 10.1111/j.1462-2920.2006.01194.x; Heylen K, 2006, ENVIRON MICROBIOL, V8, P2012, DOI 10.1111/j.1462-2920.2006.01081.x; Hochard S, 2010, ECOL MODEL, V221, P1687, DOI 10.1016/j.ecolmodel.2010.04.002; Hunt DE, 2013, APPL ENVIRON MICROB, V79, P177, DOI 10.1128/AEM.02155-12; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Ianora A, 2010, ECOTOXICOLOGY, V19, P493, DOI 10.1007/s10646-009-0434-y; Jayakumar DA, 2004, AQUAT MICROB ECOL, V34, P69, DOI 10.3354/ame034069; Jeffrey S.W., 1997, PHYTOPLANKTON PIGMEN; Jesus B, 2005, ESTUAR COAST SHELF S, V65, P30, DOI 10.1016/j.ecss.2005.05.005; Jesus B, 2009, CONT SHELF RES, V29, P1624, DOI 10.1016/j.csr.2009.05.006; Jones CM, 2010, ISME J, V4, P633, DOI 10.1038/ismej.2009.152; Jones SE, 2010, P NATL ACAD SCI USA, V107, P5881, DOI 10.1073/pnas.0912765107; Kamp A, 2011, P NATL ACAD SCI USA, V108, P5649, DOI 10.1073/pnas.1015744108; Kandeler E, 2006, APPL ENVIRON MICROB, V72, P5957, DOI 10.1128/AEM.00439-06; Koort J, 2005, APPL ENVIRON MICROB, V71, P4400, DOI 10.1128/AEM.71.8.4400-4406.2005; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; Liu XD, 2003, APPL ENVIRON MICROB, V69, P3549, DOI 10.1128/AEM.69.6.3549-3560.2003; Lomas MW, 2000, J PHYCOL, V36, P903, DOI 10.1046/j.1529-8817.2000.99029.x; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Lubarsky HV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013794; Martin-Jezequel V, 2000, J PHYCOL, V36, P821, DOI 10.1046/j.1529-8817.2000.00019.x; McKew BA, 2013, FEMS MICROBIOL ECOL, V84, P495, DOI 10.1111/1574-6941.12077; Michotey V, 2000, APPL ENVIRON MICROB, V66, P1564, DOI 10.1128/AEM.66.4.1564-1571.2000; Middelburg JJ, 2000, LIMNOL OCEANOGR, V45, P1224, DOI 10.4319/lo.2000.45.6.1224; Mizrahi-Man O DE, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053608, DOI 10.1371/JOURNAL.PONE.0053608]; Moens T, 1999, MAR ECOL PROG SER, V176, P165, DOI 10.3354/meps176165; Moens T, 1997, J MAR BIOL ASSOC UK, V77, P211, DOI 10.1017/S0025315400033889; Mosier AC, 2010, ENV MICROBIOL REP, V2, P667, DOI 10.1111/j.1758-2229.2010.00156.x; Nemergut DR, 2013, MICROBIOL MOL BIOL R, V77, P342, DOI 10.1128/MMBR.00051-12; Nogales B, 2002, APPL ENVIRON MICROB, V68, P5017, DOI 10.1128/AEM.68.10.5017-5025.2002; Orellana LH, 2014, MBIO, V5, DOI 10.1128/mBio.01193-14; Orvain F, 2014, J SEA RES, V92, P6, DOI 10.1016/j.seares.2014.02.018; Ott M, 2010, 2007 ACM/IEEE SC07 CONFERENCE, P466; Paerl HW, 2006, LIMNOL OCEANOGR, V51, P448, DOI 10.4319/lo.2006.51.1_part_2.0448; Palmer K, 2012, ISME J, V6, P1058, DOI 10.1038/ismej.2011.172; Penton CR, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00279; Philippot L, 2005, CURR OPIN MICROBIOL, V8, P234, DOI 10.1016/j.mib.2005.04.003; Prosser JI, 2010, ENVIRON MICROBIOL, V12, P1806, DOI 10.1111/j.1462-2920.2010.02201.x; Ribalet F, 2008, AQUAT TOXICOL, V86, P249, DOI 10.1016/j.aquatox.2007.11.005; Rich JJ, 2008, MICROB ECOL, V55, P311, DOI 10.1007/s00248-007-9277-3; Risgaard-Petersen N, 2003, LIMNOL OCEANOGR, V48, P93; Santoro AE, 2006, APPL ENVIRON MICROB, V72, P2102, DOI 10.1128/AEM.72.3.2102-2109.2006; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SEITZINGER SP, 1988, LIMNOL OCEANOGR, V33, P702, DOI 10.4319/lo.1988.33.4_part_2.0702; Seuront L, 2002, PHYSICA A, V313, P513, DOI 10.1016/S0378-4371(02)00989-5; Smith CJ, 2007, APPL ENVIRON MICROB, V73, P3612, DOI 10.1128/AEM.02894-06; Smith JM, 2008, APPL ENVIRON MICROB, V74, P5615, DOI 10.1128/AEM.00349-08; SOETAERT K, 1995, HYDROBIOLOGIA, V311, P225, DOI 10.1007/BF00008583; Soetaert K, 2006, LIMNOL OCEANOGR, V51, P409, DOI 10.4319/lo.2006.51.1_part_2.0409; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Sokoll S, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00395; Stal LJ, 2010, ECOL ENG, V36, P236, DOI 10.1016/j.ecoleng.2008.12.032; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stief P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073257; Sundback K, 2000, AQUAT MICROB ECOL, V22, P291, DOI 10.3354/ame022291; Taroncher-Oldenburg G, 2003, APPL ENVIRON MICROB, V69, P1159, DOI 10.1128/AEM.69.2.1159-1171.2003; Taylor JD, 2013, LIMNOL OCEANOGR, V58, P1463, DOI 10.4319/lo.2013.58.4.1463; Throback IN, 2004, FEMS MICROBIOL ECOL, V49, P401, DOI 10.1016/j.femsec.2004.04.011; Tiedje J.M., 1988, ENV MICROBIOLOGY ANA, V717, P179; Trimmer M, 2003, APPL ENVIRON MICROB, V69, P6447, DOI 10.1128/AEM.69.11.6447-6454.2003; Turner RE, 2003, BIOSCIENCE, V53, P563, DOI 10.1641/0006-3568(2003)053[0563:LLAWQI]2.0.CO;2; Van Colen C, 2014, J SEA RES, V92, P2, DOI 10.1016/j.seares.2014.07.003; Van Colen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049795; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Weisman D, 2013, BIOINFORMATICS, V29, P1212, DOI 10.1093/bioinformatics/btt123; Wright SW, 1997, PHYTOPLANKTON PIGMEN, P343; Yallop ML, 2000, MICROB ECOL, V39, P116, DOI 10.1007/s002489900186; Yu ZT, 2004, APPL ENVIRON MICROB, V70, P4800, DOI 10.1128/AEM.70.8.4800-4806.2004; Zaprasis A, 2010, APPL ENVIRON MICROB, V76, P119, DOI 10.1128/AEM.01727-09; Zhang Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-198; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	110	20	21	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126583	10.1371/journal.pone.0126583	http://dx.doi.org/10.1371/journal.pone.0126583			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961719	Green Published, gold			2022-12-26	WOS:000354542500117
J	Ficarra, FA; Garofalo, CG; Gottig, N; Ottado, J				Ficarra, Florencia A.; Garofalo, Cecilia G.; Gottig, Natalia; Ottado, Jorgelina			The Amino Acid Arginine 210 of the Response Regulator HrpG of Xanthomonas citri subsp citri Is Required for HrpG Function in Virulence	PLOS ONE			English	Article							CAMPESTRIS PV VESICATORIA; ANTIBIOTIC-RESISTANCE CASSETTES; EFFECTOR PROTEINS; ESCHERICHIA-COLI; EXPRESSION; OMPR; PATHOGENICITY; GENE; CANKER; CLUSTER	Xanthomonas citri subsp. citri colonizes its hosts through the trafficking of effector proteins to the plant cell by the type III protein secretion system. In X. citri subsp. citri, as in other plant pathogens, the hrp cluster encodes the type III protein secretion system and is regulated by the transcription factors HrpG and HrpX. HrpG belongs to the OmpR family's response regulator of EnvZ/OmpR two-component signal transduction system. Here, we show that the arginine 210 residue is crucial for the transcriptional activity of HrpG revealed by the absence of disease in host plants and hypersensitive response in non-host plants when a strain carrying this point mutation is used in plant infiltration assays. Also, this strain showed decreased expression levels of hrp genes in bacteria grown in culture or when they were recovered from citrus leaves. Moreover, we show for the first time that HrpG binds to both hrpX and its own promoter, and the change of the arginine 210 by a cysteine does not prevent the binding to both promoters. Nevertheless, in vitro hrpX transcription was observed only with HrpG whereas no transcription was detected with the R210C mutant. HrpG was able to interact with itself as well as with the mutant R210C suggesting that it functions as a dimer. The mutant protein R210C showed altered protease sensitivity, suggesting that Arg210 is essential for protein active conformation and thus for transcriptional activity. Our results indicate that arginine 210 in HrpG, as it may occur with this conserved residue in other members of this family of response regulators, is not required for DNA binding whereas is essential for hrp genes transcription and therefore for pathogenicity and HR induction.	[Ficarra, Florencia A.; Garofalo, Cecilia G.; Gottig, Natalia; Ottado, Jorgelina] IBR CONICET, Consejo Nacl Invest Cient & Tecn, Inst Biol Mol & Celular Rosario, RA-2000 Rosario, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Ottado, J (corresponding author), IBR CONICET, Consejo Nacl Invest Cient & Tecn, Inst Biol Mol & Celular Rosario, RA-2000 Rosario, Argentina.	ottado@ibr-conicet.gov.ar			Argentine Federal Government: ANPCyT [PICT2013-055, PICT2013-0625]; CONICET [PIP2010-2012]; Fundacion Josefina Prats	Argentine Federal Government: ANPCyT(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Fundacion Josefina Prats	This work was supported by grants from the Argentine Federal Government: ANPCyT (PICT2013-055 to NG and PICT2013-0625 to JO) and CONICET (PIP2010-2012 to JO and NG), the Fundacion Josefina Prats to FAF and CGG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegria MC, 2004, J BACTERIOL, V186, P6186, DOI 10.1128/JB.186.18.6186-6197.2004; Alphen W V, 1977, J Bacteriol, V131, P623; Andrade MO, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003945; Brunings AM, 2003, MOL PLANT PATHOL, V4, P141, DOI 10.1046/j.1364-3703.2003.00163.x; Buttner D, 2002, EMBO J, V21, P5313, DOI 10.1093/emboj/cdf536; Dunger G, 2005, PLANT PATHOL, V54, P781, DOI 10.1111/j.1365-3059.2005.01284.x; Dunger G, 2007, ARCH MICROBIOL, V188, P127, DOI 10.1007/s00203-007-0227-8; Dunger G, 2012, MOL PLANT PATHOL, V13, P865, DOI 10.1111/j.1364-3703.2012.00797.x; Fenselau S, 1995, MOL PLANT MICROBE IN, V8, P845, DOI 10.1094/MPMI-8-0845; Gottig N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004358; Graham JH, 2004, MOL PLANT PATHOL, V5, P1, DOI 10.1046/j.1364-3703.2004.00197.x; Guo YP, 2011, MOL PLANT MICROBE IN, V24, P649, DOI 10.1094/MPMI-09-10-0209; Hu Y, 2014, P NATL ACAD SCI USA, V111, pE521, DOI 10.1073/pnas.1313271111; Huang DL, 2009, MOL PLANT MICROBE IN, V22, P321, DOI 10.1094/MPMI-22-3-0321; Jacob TR, 2011, BIOTECHNOL LETT, V33, P1177, DOI 10.1007/s10529-011-0552-5; Katzen F, 1999, APPL ENVIRON MICROB, V65, P278; Kim JG, 2003, J BACTERIOL, V185, P3155, DOI 10.1128/JB.185.10.3155-3166.2003; Koebnik R, 2006, J BACTERIOL, V188, P7652, DOI 10.1128/JB.00795-06; Kondo H, 1997, NAT STRUCT BIOL, V4, P28, DOI 10.1038/nsb0197-28; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Li RF, 2014, ENVIRON MICROBIOL, V16, P2053, DOI 10.1111/1462-2920.12207; LILJESTROM P, 1987, J BACTERIOL, V169, P438, DOI 10.1128/jb.169.1.438-441.1987; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MartinezHackert E, 1997, J MOL BIOL, V269, P301, DOI 10.1006/jmbi.1997.1065; MartinezHackert E, 1997, STRUCTURE, V5, P109, DOI 10.1016/S0969-2126(97)00170-6; Miller WG, 2000, MOL PLANT MICROBE IN, V13, P1243, DOI 10.1094/MPMI.2000.13.11.1243; Noel L, 2001, MOL MICROBIOL, V41, P1271, DOI 10.1046/j.1365-2958.2001.02567.x; Pereira ALA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-157; PRATT LA, 1994, J MOL BIOL, V243, P579, DOI 10.1016/0022-2836(94)90033-7; REECE KS, 1995, GENE, V165, P141, DOI 10.1016/0378-1119(95)00529-F; Rhee JE, 2008, J BIOL CHEM, V283, P8664, DOI 10.1074/jbc.M705550200; RUSSO FD, 1993, J MOL BIOL, V231, P261, DOI 10.1006/jmbi.1993.1281; SCHULTE R, 1992, J BACTERIOL, V174, P815, DOI 10.1128/jb.174.3.815-823.1992; Sgro GG, 2012, MOL PLANT PATHOL, V13, P1047, DOI 10.1111/j.1364-3703.2012.00814.x; Tsuge S, 2005, J BACTERIOL, V187, P2308, DOI 10.1128/JB.187.7.2308-2314.2005; Wengelnik K, 1999, J BACTERIOL, V181, P6828, DOI 10.1128/JB.181.21.6828-6831.1999; Wengelnik K, 1996, MOL PLANT MICROBE IN, V9, P704, DOI 10.1094/MPMI-9-0704; Wengelnik K, 1996, J BACTERIOL, V178, P1061, DOI 10.1128/jb.178.4.1061-1069.1996; Wengelnik K, 1996, J BACTERIOL, V178, P3462, DOI 10.1128/jb.178.12.3462-3469.1996; Zimaro T, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-96	40	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0125516	10.1371/journal.pone.0125516	http://dx.doi.org/10.1371/journal.pone.0125516			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961560	Green Published, Green Submitted, gold			2022-12-26	WOS:000354542500032
J	Lhoumeau, AC; Martinez, S; Boher, JM; Monges, G; Castellano, R; Goubard, A; Doremus, M; Poizat, F; Lelong, B; de Chaisemartin, C; Bardin, F; Viens, P; Raoul, JL; Prebet, T; Aurrand-Lions, M; Borg, JP; Goncalves, A				Lhoumeau, Anne-Catherine; Martinez, Sebastien; Boher, Jean-Marie; Monges, Genevieve; Castellano, Remy; Goubard, Armelle; Doremus, Marie; Poizat, Flora; Lelong, Bernard; de Chaisemartin, Cecile; Bardin, Florence; Viens, Patrice; Raoul, Jean-Luc; Prebet, Thomas; Aurrand-Lions, Michel; Borg, Jean-Paul; Goncalves, Anthony			Overexpression of the Promigratory and Prometastatic PTK7 Receptor Is Associated with an Adverse Clinical Outcome in Colorectal Cancer	PLOS ONE			English	Article							TYROSINE KINASE 7; III COLON-CANCER; CELL POLARITY; DNA MICROARRAYS; STAGE-II; FLUOROURACIL; LEUCOVORIN; OXALIPLATIN; EXPRESSION; SURVIVAL	Biomarkers and novel therapeutic targets are urgently needed in colorectal cancer (CRC). The pseudo tyrosine kinase receptor 7 (PTK7) is involved in planar cell polarity and it is deregulated in various malignancies, including CRC. Yet, little is known about its protein expression in human CRC, or about a possible correlation of its expression with clinical endpoints. Using a clinically annotated Tissue MicroArray (TMA) produced from from 192 consecutive CRC patients treated by initial surgery, we examined PTK7 expression by immunohistochemistry in tumoral tissue and matched normal mucosae, and correlated its expression with clinico-pathological features and patient outcome. PTK7 depletion by specific shRNA in HCT116 and HCT15 CRC cell lines was found to affect cell proliferation, resistance to drugs and cell migration. Tumor growth and metastatic phenotype were investigated in vivo using a xenograft mouse model of CRC cells with modulated expression of PTK7 levels. PTK7 was significantly up-regulated in CRC tissue as compared to matched healthy mucosae, and significant overexpression was found in 34% of patients. PTK7 overexpression was significantly associated with a reduced metastasis-free survival in non-metastatic patients. In HCT116 and HCT15 cells, shRNA PTK7 reduced migration but did not affect cell proliferation and resistance to drugs. In a xenograft mouse of HCT15 cells, downregulation of PTK7 led to reduced tumor growth, whereas its overexpression in PTK7-negative cancer cells led to increased metastatic events. PTK7 expression thus represents a potential prognostic biomarker and a novel therapeutic target in CRC.	[Lhoumeau, Anne-Catherine; Martinez, Sebastien; Castellano, Remy; Goubard, Armelle; Doremus, Marie; Bardin, Florence; Viens, Patrice; Raoul, Jean-Luc; Prebet, Thomas; Aurrand-Lions, Michel; Borg, Jean-Paul; Goncalves, Anthony] INSERM, CRCM, Cell Signalling & Canc Equipe Labellisee Ligue Co, Team Cell Polar,U1068, F-13009 Marseille, France; [Lhoumeau, Anne-Catherine; Martinez, Sebastien; Boher, Jean-Marie; Monges, Genevieve; Castellano, Remy; Goubard, Armelle; Doremus, Marie; Poizat, Flora; Lelong, Bernard; de Chaisemartin, Cecile; Bardin, Florence; Viens, Patrice; Raoul, Jean-Luc; Prebet, Thomas; Aurrand-Lions, Michel; Borg, Jean-Paul; Goncalves, Anthony] Inst Paoli Calmettes, F-13009 Marseille, France; [Lhoumeau, Anne-Catherine; Martinez, Sebastien; Castellano, Remy; Goubard, Armelle; Doremus, Marie; Bardin, Florence; Viens, Patrice; Raoul, Jean-Luc; Prebet, Thomas; Aurrand-Lions, Michel; Borg, Jean-Paul; Goncalves, Anthony] Aix Marseille Univ, F-13284 Marseille, France; [Lhoumeau, Anne-Catherine; Martinez, Sebastien; Castellano, Remy; Goubard, Armelle; Doremus, Marie; Bardin, Florence; Viens, Patrice; Raoul, Jean-Luc; Prebet, Thomas; Aurrand-Lions, Michel; Borg, Jean-Paul; Goncalves, Anthony] CNRS, UMR7258, F-13009 Marseille, France; [Boher, Jean-Marie] Inst Paoli Calmettes, Dept Biostat, Marseille, France; [Lhoumeau, Anne-Catherine; Monges, Genevieve; Poizat, Flora] Inst Paoli Calmettes, Dept Biopathol, Marseille, France; [Lelong, Bernard; de Chaisemartin, Cecile] Inst Paoli Calmettes, Dept Surg Oncol, Marseille, France; [Viens, Patrice; Raoul, Jean-Luc; Goncalves, Anthony] Inst Paoli Calmettes, Dept Med Oncol, Marseille, France; [Prebet, Thomas] Inst Paoli Calmettes, Dept Hematol, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Institut Paoli-Calmette (IPC)	Goncalves, A (corresponding author), INSERM, CRCM, Cell Signalling & Canc Equipe Labellisee Ligue Co, Team Cell Polar,U1068, F-13009 Marseille, France.	goncalvesa@ipc.unicancer.fr	Borg, Jean-Paul/AAX-8096-2020; Viens, Patrice/Q-8499-2018; Prebet, Thomas/Y-7847-2019; Aurrand-Lions, Michel/O-9953-2016	Borg, Jean-Paul/0000-0001-8418-3382; Viens, Patrice/0000-0003-1511-1048; Prebet, Thomas/0000-0002-6872-625X; Aurrand-Lions, Michel/0000-0002-8361-3034; BOHER, Jean-Marie/0000-0002-5395-839X; lelong, bernard/0000-0003-1642-2913; Raoul, Jean-Luc/0000-0001-6305-8953	La Ligue Nationale Contre le Cancer; Fondation pour la Recherche Medicale; Region PACA; SIRIC (INCa-DGOS-Inserm) [6038]	La Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Region PACA(Region Provence-Alpes-Cote d'Azur); SIRIC (INCa-DGOS-Inserm)	This work was supported by La Ligue Nationale Contre le Cancer (Label Ligue JPB) http://www.ligue-cancer.net/, Fondation pour la Recherche Medicale (ACL) http://www.frm.org/, Region PACA (SM) http://www.regionpaca.fr/, SIRIC (INCa-DGOS-Inserm 6038) http://www.oncopaca.org/fr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts SR, 2012, JAMA-J AM MED ASSOC, V307, P1383, DOI 10.1001/jama.2012.385; Allegra CJ, 2011, J CLIN ONCOL, V29, P11, DOI 10.1200/JCO.2010.30.0855; Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Andre T, 2003, J CLIN ONCOL, V21, P2896, DOI 10.1200/JCO.2003.10.065; Arcangeli ML, 2012, FEBS LETT, V586, P4046, DOI 10.1016/j.febslet.2012.10.005; Ataseven B, 2013, ANTICANCER RES, V33, P3759; Benson AB, 2004, J CLIN ONCOL, V22, P3408, DOI 10.1200/JCO.2004.05.063; Bertucci F, 2004, ONCOGENE, V23, P1377, DOI 10.1038/sj.onc.1207262; Bin-Nun N, 2014, DEVELOPMENT, V141, P410, DOI 10.1242/dev.095984; Chen R, 2014, CANCER RES, V74, P2892, DOI 10.1158/0008-5472.CAN-13-2775; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Endoh H, 2004, J CLIN ONCOL, V22, P811, DOI 10.1200/JCO.2004.04.109; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Gartner S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084472; Ginestier C, 2002, AM J PATHOL, V161, P1223, DOI 10.1016/S0002-9440(10)64399-4; Gobble RM, 2011, CANCER RES, V71, P2697, DOI 10.1158/0008-5472.CAN-10-3588; Golubkov VS, 2014, J BIOL CHEM, V289, P24238, DOI 10.1074/jbc.M114.574459; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jiang GH, 2012, LEUKEMIA RES, V36, P1347, DOI 10.1016/j.leukres.2012.07.004; Jin J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090247; Lambaudie E, 2014, ANTICANCER RES, V34, P177; LEE ST, 1993, ONCOGENE, V8, P3403; Lhoumeau AC, 2011, CELL CYCLE, V10, P1233, DOI 10.4161/cc.10.8.15368; Lin Y, 2012, J SURG ONCOL, V106, P880, DOI 10.1002/jso.23154; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; McShane L. M., 2006, Experimental Oncology, V28, P99; Meng L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014018; MOSSIE K, 1995, ONCOGENE, V11, P2179; Na HW, 2012, J BIOL CHEM, V287, P25001, DOI 10.1074/jbc.M112.348904; Prebet T, 2010, BLOOD, V116, P2315, DOI 10.1182/blood-2010-01-262352; Puppo F, 2011, EMBO REP, V12, P43, DOI 10.1038/embor.2010.185; Shin WS, 2008, BIOCHEM BIOPH RES CO, V371, P793, DOI 10.1016/j.bbrc.2008.04.168; Shin WS, 2013, CANCER SCI, V104, P1120, DOI 10.1111/cas.12194; Shnitsar I, 2008, DEVELOPMENT, V135, P4015, DOI 10.1242/dev.023556; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Van Cutsem E, 2012, J CLIN ONCOL, V30, P3499, DOI 10.1200/JCO.2012.42.8201; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Wang YQ, 2009, MOL CANCER THER, V8, P2103, DOI 10.1158/1535-7163.MCT-09-0282; Zallen JA, 2007, CELL, V129, P1051, DOI 10.1016/j.cell.2007.05.050; Zhou HX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086195	42	36	36	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0123768	10.1371/journal.pone.0123768	http://dx.doi.org/10.1371/journal.pone.0123768			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962058	Green Published, Green Submitted, gold			2022-12-26	WOS:000354542500007
J	Marshall, DC; Lyman, SK; McCauley, S; Kovalenko, M; Spangler, R; Liu, C; Lee, M; O'Sullivan, C; Barry-Hamilton, V; Ghermazien, H; Mikels-Vigdal, A; Garcia, CA; Jorgensen, B; Velayo, AC; Wang, R; Adamkewicz, JI; Smith, V				Marshall, Derek C.; Lyman, Susan K.; McCauley, Scott; Kovalenko, Maria; Spangler, Rhyannon; Liu, Chian; Lee, Michael; O'Sullivan, Christopher; Barry-Hamilton, Vivian; Ghermazien, Haben; Mikels-Vigdal, Amanda; Garcia, Carlos A.; Jorgensen, Brett; Velayo, Arleene C.; Wang, Ruth; Adamkewicz, Joanne I.; Smith, Victoria			Selective Allosteric Inhibition of MMP9 Is Efficacious in Preclinical Models of Ulcerative Colitis and Colorectal Cancer	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE INHIBITORS; MATRIX-METALLOPROTEINASE-9 MESSENGER-RNA; INFLAMMATORY-BOWEL-DISEASE; GELATINASE-B; GENE-EXPRESSION; DOWN-REGULATION; TUMOR INVASION; TNF-ALPHA; CELLS; GROWTH	Expression of matrix metalloproteinase 9 (MMP9) is elevated in a variety of inflammatory and oncology indications, including ulcerative colitis and colorectal cancer. MMP9 is a downstream effector and an upstream mediator of pathways involved in growth and inflammation, and has long been viewed as a promising therapeutic target. However, previous efforts to target matrix metalloproteinases (MMPs), including MMP9, have utilized broad-spectrum or semi-selective inhibitors. While some of these drugs showed signs of efficacy in patients, all MMP-targeted inhibitors have been hampered by dose-limiting toxicity or insufficient clinical benefit, likely due to their lack of specificity. Here, we show that selective inhibition of MMP9 did not induce musculoskeletal syndrome (a characteristic toxicity of pan-MMP inhibitors) in a rat model, but did reduce disease severity in a dextran sodium sulfate-induced mouse model of ulcerative colitis. We also found that MMP9 inhibition decreased tumor growth and metastases incidence in a surgical orthotopic xenograft model of colorectal carcinoma, and that inhibition of either tumor-or stroma-derived MMP9 was sufficient to reduce primary tumor growth. Collectively, these data suggest that selective MMP9 inhibition is a promising therapeutic strategy for treatment of inflammatory and oncology indications in which MMP9 is upregulated and is associated with disease pathology, such as ulcerative colitis and colorectal cancer. In addition, we report the development of a potent and highly selective allosteric MMP9 inhibitor, the humanized monoclonal antibody GS-5745, which can be used to evaluate the therapeutic potential of MMP9 inhibition in patients.	[Marshall, Derek C.; Lyman, Susan K.; McCauley, Scott; Kovalenko, Maria; Spangler, Rhyannon; Liu, Chian; Lee, Michael; O'Sullivan, Christopher; Barry-Hamilton, Vivian; Ghermazien, Haben; Mikels-Vigdal, Amanda; Jorgensen, Brett; Wang, Ruth; Adamkewicz, Joanne I.; Smith, Victoria] Gilead Sci Inc, Dept Biol, Foster City, CA 94404 USA; [Garcia, Carlos A.; Velayo, Arleene C.] Gilead Sci Inc, Dept Proc Dev, Oceanside, CA USA	Gilead Sciences; Gilead Sciences	Smith, V (corresponding author), Gilead Sci Inc, Dept Biol, 353 Lakeside Dr, Foster City, CA 94404 USA.	victoria.smith@gilead.com		McCauley, Scott/0000-0003-4549-5599	Gilead Sciences	Gilead Sciences(Gilead Sciences)	All authors and acknowledged persons are current or former employees of Gilead Sciences. Gilead Sciences funded all research reported in this study and was solely involved in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Acuff HB, 2006, CANCER RES, V66, P259, DOI 10.1158/0008-5472.CAN-05-2502; Ahn GO, 2008, CANCER CELL, V13, P193, DOI 10.1016/j.ccr.2007.11.032; Ahrens D, 1996, ARTHRITIS RHEUM, V39, P1576, DOI 10.1002/art.1780390919; Al-Batran SE, 2012, ANN ONCOL, V23, P1699, DOI 10.1093/annonc/mdr552; Ali T, 2013, DRUG HEALTHC PATIENT, V5, P79, DOI 10.2147/DHPS.S28801; Allen M, 2011, J PATHOL, V223, P162, DOI 10.1002/path.2803; ALVAREZ OA, 1990, J NATL CANCER I, V82, P589, DOI 10.1093/jnci/82.7.589; Annahazi A, 2013, INFLAMM BOWEL DIS, V19, P316, DOI 10.1002/ibd.22996; Ardi VC, 2007, P NATL ACAD SCI USA, V104, P20262, DOI 10.1073/pnas.0706438104; Ardi VC, 2009, J BIOL CHEM, V284, P25854, DOI 10.1074/jbc.M109.033472; Baay M, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/565187; Bauvois B, 2012, BBA-REV CANCER, V1825, P29, DOI 10.1016/j.bbcan.2011.10.001; Beliveau A, 2010, GENE DEV, V24, P2800, DOI 10.1101/gad.1990410; Ben David D, 2008, HISTOCHEM CELL BIOL, V129, P589, DOI 10.1007/s00418-008-0391-1; Ben-David D, 2012, INFLAMM RES, V61, P673, DOI 10.1007/s00011-012-0461-7; Bendardaf R, 2010, CANCER INVEST, V28, P38, DOI 10.3109/07357900802672761; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bezzio C, 2014, EXPERT OPINION PHARM, P1, DOI [10.1517/14656566.2015.980724, DOI 10.1517/14656566.2015.980724]; Buhmeida Abdelbaset, 2009, J Gastrointest Cancer, V40, P91, DOI 10.1007/s12029-009-9091-x; Castaneda FE, 2005, GASTROENTEROLOGY, V129, P1991, DOI 10.1053/j.gastro.2005.09.017; Chang YH, 2008, CLIN BIOCHEM, V41, P955, DOI 10.1016/j.clinbiochem.2008.04.012; Chetty C, 2010, MOL CANCER THER, V9, P2605, DOI 10.1158/1535-7163.MCT-10-0245; Chu DK, 2012, ANN SURG ONCOL, V19, P318, DOI 10.1245/s10434-011-1686-3; Coffelt SB, 2009, BBA-REV CANCER, V1796, P11, DOI 10.1016/j.bbcan.2009.02.004; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Copeland RA, 2013, EVALUATION OF ENZYME INHIBITORS IN DRUG DISCOVERY: A GUIDE FOR MEDICINAL CHEMISTS AND PHARMACOLOGISTS, 2ND EDITION, P1, DOI 10.1002/9781118540398; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Crampton SP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007841; D'Haese A, 2000, J INTERF CYTOK RES, V20, P667, DOI 10.1089/107999000414853; Delclaux C, 1996, AM J RESP CELL MOL, V14, P288, DOI 10.1165/ajrcmb.14.3.8845180; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Deryugina EI, 2010, BBA-MOL CELL RES, V1803, P103, DOI 10.1016/j.bbamcr.2009.09.017; Devy L, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/191670; Drygiannakis I, 2013, J CROHNS COLITIS, V7, P286, DOI 10.1016/j.crohns.2012.04.008; Elkins PA, 2002, ACTA CRYSTALLOGR D, V58, P1182, DOI 10.1107/S0907444902007849; Fanjul-Fernandez M, 2010, BBA-MOL CELL RES, V1803, P3, DOI 10.1016/j.bbamcr.2009.07.004; Fukuyama R, 2007, MOL CARCINOGEN, V46, P402, DOI 10.1002/mc.20288; Gao Q, 2005, DIGEST LIVER DIS, V37, P584, DOI 10.1016/j.dld.2005.02.011; Garg P, 2009, AM J PHYSIOL-GASTR L, V296, pG175, DOI 10.1152/ajpgi.90454.2008; GEARING AJH, 1994, NATURE, V370, P555, DOI 10.1038/370555a0; Geboes K., 2003, INFLAMM BOWEL DIS, V18, P255; Genersch E, 2000, J CELL SCI, V113, P4319; Gerg M, 2008, MOL CANCER RES, V6, P341, DOI 10.1158/1541-7786.MCR-07-2032; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Goetzl EJ, 1996, J IMMUNOL, V156, P1; Gooz M, 2010, CRIT REV BIOCHEM MOL, V45, P146, DOI 10.3109/10409231003628015; Grossmann J, 2002, APOPTOSIS, V7, P247, DOI 10.1023/A:1015312119693; Guo YB, 2013, ADV MECH ENG, DOI 10.1155/2013/942580; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hawinkels LJAC, 2008, EUR J CANCER, V44, P1904, DOI 10.1016/j.ejca.2008.06.031; Hidalgo M, 2001, JNCI-J NATL CANCER I, V93, P178, DOI 10.1093/jnci/93.3.178; Holvoet S, 2003, EXP CELL RES, V290, P108, DOI 10.1016/S0014-4827(03)00293-3; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Iniesta P, 2007, ONCOL REP, V17, P217; Itoh T, 2002, J IMMUNOL, V169, P2643, DOI 10.4049/jimmunol.169.5.2643; Jawad N, 2011, RECENT RESULTS CANC, V185, P99, DOI 10.1007/978-3-642-03503-6_6; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Klein T, 2011, AMINO ACIDS, V41, P271, DOI 10.1007/s00726-010-0689-x; KNIGHT CG, 1992, FEBS LETT, V296, P263, DOI 10.1016/0014-5793(92)80300-6; Koboziev I, 2011, INFLAMM BOWEL DIS, V17, P1229, DOI 10.1002/ibd.21557; Krueger A, 2009, BIOL CHEM, V390, P91, DOI 10.1515/BC.2009.015; Kuniyasu H, 1999, CLIN CANCER RES, V5, P25; Labrijn AF, 2009, NAT BIOTECHNOL, V27, P767, DOI 10.1038/nbt.1553; Lakatos G, 2012, PATHOL ONCOL RES, V18, P85, DOI 10.1007/s12253-011-9420-9; Lakka SS, 2002, ONCOGENE, V21, P5601, DOI 10.1038/sj.onc.1205646; Li J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021816; Lukaszewicz-Zajac M, 2011, CLIN CHIM ACTA, V412, P1725, DOI 10.1016/j.cca.2011.06.003; Lyng G, 2009, INFLAMM BOWEL DIS, V15, pS48, DOI 10.1097/00054725-200912002-00149; Maatta M, 2000, CLIN CANCER RES, V6, P2726; Martin MD, 2008, CANCER RES, V68, P6251, DOI 10.1158/0008-5472.CAN-08-0537; MOHLER KM, 1993, J IMMUNOL, V151, P1548; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Naito Yuji, 2005, Molecular Aspects of Medicine, V26, P379; Nakamura T, 2007, NEOPLASIA, V9, P979, DOI 10.1593/neo.07742; Nalla AK, 2010, CANCER GENE THER, V17, P599, DOI 10.1038/cgt.2010.16; Neumann H, 2011, WORLD J GASTROENTERO, V17, P3184, DOI 10.3748/wjg.v17.i27.3184; Ogata Y, 2006, CANCER CHEMOTH PHARM, V57, P577, DOI 10.1007/s00280-005-0081-9; OGATA Y, 1995, J BIOL CHEM, V270, P18506, DOI 10.1074/jbc.270.31.18506; Okayasu I, 2002, J GASTROEN HEPATOL, V17, P1078, DOI 10.1046/j.1440-1746.2002.02853.x; Opdenakker G, 2001, J LEUKOCYTE BIOL, V69, P851; Opdenakker G, 2001, TRENDS IMMUNOL, V22, P571, DOI 10.1016/S1471-4906(01)02023-3; Ordas I, 2012, LANCET, V380, P1606, DOI 10.1016/S0140-6736(12)60150-0; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Paemen L, 1995, EUR J BIOCHEM, V234, P759, DOI 10.1111/j.1432-1033.1995.759_a.x; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Pedersen G, 2009, CLIN EXP IMMUNOL, V155, P257, DOI 10.1111/j.1365-2249.2008.03836.x; Perng DW, 2011, LIFE SCI, V89, P204, DOI 10.1016/j.lfs.2011.06.008; Peterson JT, 2006, CARDIOVASC RES, V69, P677, DOI 10.1016/j.cardiores.2005.11.032; Ram M, 2006, J CLIN IMMUNOL, V26, P299, DOI 10.1007/s10875-006-9022-6; Renkiewicz R, 2003, ARTHRITIS RHEUM, V48, P1742, DOI 10.1002/art.11030; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; Roy R, 2009, J CLIN ONCOL, V27, P5287, DOI 10.1200/JCO.2009.23.5556; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Salfeld JG, 2007, NAT BIOTECHNOL, V25, P1369, DOI 10.1038/nbt1207-1369; Santana A, 2006, WORLD J GASTROENTERO, V12, P6464, DOI 10.3748/wjg.v12.i40.6464; Schonbeck U, 1998, J IMMUNOL, V161, P3340; Sela-Passwell NA, 2012, NAT MED, V18, P143, DOI 10.1038/nm.2582; Shao WL, 2011, J SURG ONCOL, V104, P841, DOI 10.1002/jso.22001; Shih JY, 2006, J CANC MOL, V2, P101; Silva LCR, 2010, IMMUNOTHERAPY-UK, V2, P817, DOI [10.2217/imt.10.67, 10.2217/IMT.10.67]; Simi L, 2004, LUNG CANCER, V45, P171, DOI 10.1016/j.lungcan.2004.01.014; Solomon L., 2010, COMP CLIN PATHOL, V19, DOI [10.1007/s00580-010-0979-4, DOI 10.1007/S00580-010-0979-4]; STETLERSTEVENSON WG, 1990, CANCER METAST REV, V9, P289, DOI 10.1007/BF00049520; Svagzdys S, 2011, TOHOKU J EXP MED, V223, P67, DOI 10.1620/tjem.223.67; Thorsteinsdottir S, 2011, NAT REV GASTRO HEPAT, V8, P395, DOI 10.1038/nrgastro.2011.96; Ullman TA, 2011, GASTROENTEROLOGY, V140, P1807, DOI 10.1053/j.gastro.2011.01.057; Vaid M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023000; Van den Steen PE, 2000, BLOOD, V96, P2673, DOI 10.1182/blood.V96.8.2673.h8002673_2673_2681; Vandooren J, 2013, CRIT REV BIOCHEM MOL, V48, P222, DOI 10.3109/10409238.2013.770819; Vihinen P, 2005, CURR CANCER DRUG TAR, V5, P203, DOI 10.2174/1568009053765799; Wang X, 2011, CURR DRUG METAB, V12, P395, DOI 10.2174/138920011795202901; Williams JW, 2005, SURGERY, V23, P346; Woo J, 2011, MESENCYHME EPITHELIA; Yang QO, 2010, ANAT REC, V293, P2012, DOI 10.1002/ar.21071; Yoon SO, 2006, MOL CANCER THER, V5, P2666, DOI 10.1158/1535-7163.MCT-06-0321; Yu Q, 2000, GENE DEV, V14, P163	116	128	132	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0127063	10.1371/journal.pone.0127063	http://dx.doi.org/10.1371/journal.pone.0127063			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961845	gold, Green Submitted, Green Published			2022-12-26	WOS:000354542500167
J	Valverde, G; Zhou, H; Lippold, S; de Filippo, C; Tang, K; Herraez, DL; Li, J; Stoneking, M				Valverde, Guido; Zhou, Hang; Lippold, Sebastian; de Filippo, Cesare; Tang, Kun; Herraez, David Lopez; Li, Jing; Stoneking, Mark			A Novel Candidate Region for Genetic Adaptation to High Altitude in Andean Populations	PLOS ONE			English	Article							SURFACTANT PROTEIN-D; CHRONIC MOUNTAIN-SICKNESS; ANGIOTENSIN-CONVERTING ENZYME; GENOME-WIDE ASSOCIATION; OXIDE SYNTHASE GENE; NITRIC-OXIDE; POSITIVE SELECTION; NATIVE POPULATION; PERUVIAN QUECHUA; HEMOGLOBIN CONCENTRATION	Humans living at high altitude (>= 2,500 meters above sea level) have acquired unique abilities to survive the associated extreme environmental conditions, including hypoxia, cold temperature, limited food availability and high levels of free radicals and oxidants. Longterm inhabitants of the most elevated regions of the world have undergone extensive physiological and/or genetic changes, particularly in the regulation of respiration and circulation, when compared to lowland populations. Genome scans have identified candidate genes involved in altitude adaption in the Tibetan Plateau and the Ethiopian highlands, in contrast to populations from the Andes, which have not been as intensively investigated. In the present study, we focused on three indigenous populations from Bolivia: two groups of Andean natives, Aymara and Quechua, and the low-altitude control group of Guarani from the Gran Chaco lowlands. Using pooled samples, we identified a number of SNPs exhibiting large allele frequency differences over 900,000 genotyped SNPs. A region in chromosome 10 (within the cytogenetic bands q22.3 and q23.1) was significantly differentiated between highland and lowland groups. We resequenced similar to 1.5 Mb surrounding the candidate region and identified strong signals of positive selection in the highland populations. A composite of multiple signals like test localized the signal to FAM213A and a related enhancer; the product of this gene acts as an antioxidant to lower oxidative stress and may help to maintain bone mass. The results suggest that positive selection on the enhancer might increase the expression of this antioxidant, and thereby prevent oxidative damage. In addition, the most significant signal in a relative extended haplotype homozygosity analysis was localized to the SFTPD gene, which encodes a surfactant pulmonary-associated protein involved in normal respiration and innate host defense. Our study thus identifies two novel candidate genes and associated pathways that may be involved in high-altitude adaptation in Andean populations.	[Valverde, Guido] Univ Adelaide, Sch Earth & Environm Sci, Australian Ctr Ancient DNA, Adelaide, SA, Australia; [Zhou, Hang; Tang, Kun; Li, Jing] Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Dept Computat Regulatory Genom, Shanghai, Peoples R China; [Lippold, Sebastian; de Filippo, Cesare; Stoneking, Mark] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Leipzig, Germany; [Herraez, David Lopez] UFZ Helmholtz Ctr Environm Res, Dept Effect Directed Anal, Leipzig, Germany	University of Adelaide; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Max Planck Society; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Herraez, DL (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Effect Directed Anal, Leipzig, Germany.	david.lopez-herraez@ufz.de; lijing@picb.ac.cn; stonekg@eva.mpg.de	Valverde, Guido/ABF-1641-2020; Tang, Kun/GSD-3218-2022; Zhou, Hang/N-4483-2018	Zhou, Hang/0000-0002-7694-6391; Valverde, Guido/0000-0001-6201-6030	DAAD (German Academic Exchange Service) [414 / PKZ: A/07/97245]; Max-Planck-Gesellschaft; National Science Foundation of China [31371267]	DAAD (German Academic Exchange Service)(Deutscher Akademischer Austausch Dienst (DAAD)); Max-Planck-Gesellschaft(Max Planck Society); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	Guido Valverde acknowledges the DAAD (German Academic Exchange Service) Scholarship (Forschungsstipendium Referat: 414 / PKZ: A/07/97245). Kun Tang acknowledges the support by the Max-Planck-Gesellschaft www.mpg.de Partner Group Grant and the National Science Foundation of China (31371267). This research was supported by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Rached L, 2011, SCIENCE, V334, P89, DOI 10.1126/science.1209202; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aldenderfer MS, 2003, AM SCI, V91, P542; Alkorta-Aranburu G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003110; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Beall CM, 2006, INTEGR COMP BIOL, V46, P18, DOI 10.1093/icb/icj004; Beall CM, 2002, P NATL ACAD SCI USA, V99, P17215, DOI 10.1073/pnas.252649199; Beall CM, 1998, AM J PHYS ANTHROPOL, V106, P385, DOI 10.1002/(SICI)1096-8644(199807)106:3<385::AID-AJPA10>3.3.CO;2-6; Beall CM, 2001, NATURE, V414, P411, DOI 10.1038/35106641; Beall CM, 2007, P NATL ACAD SCI USA, V104, P8655, DOI 10.1073/pnas.0701985104; Beall CM, 2013, AM J HUM BIOL, V25, P141, DOI 10.1002/ajhb.22355; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Bigham A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001116; Bigham AW, 2008, HIGH ALT MED BIOL, V9, P167, DOI 10.1089/ham.2007.1066; Bigham Abigail W., 2009, Human Genomics, V4, P79; Brutsaert TD, 2007, RESP PHYSIOL NEUROBI, V158, P151, DOI 10.1016/j.resp.2007.03.004; Cassinell CM, 2003, RETO FISIOLOGICO VIV; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Chen H, 2010, GENOME RES, V20, P393, DOI 10.1101/gr.100545.109; Choi EH, 2006, PEDIATR PULM, V41, P255, DOI 10.1002/ppul.20361; de Filippo C, 2011, MOL BIOL EVOL, V28, P1255, DOI 10.1093/molbev/msq312; Docherty SJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-214; Droma Y, 2006, HIGH ALT MED BIOL, V7, P209, DOI 10.1089/ham.2006.7.209; Eichstaedt CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093314; ERGUETA J, 1971, RESPIRATION, V28, P485, DOI 10.1159/000192835; Ewing G, 2010, BIOINFORMATICS, V26, P2064, DOI 10.1093/bioinformatics/btq322; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; Fay JC, 2000, GENETICS, V155, P1405; Ferrer-Admetlla A, 2014, MOL BIOL EVOL, V31, P1275, DOI 10.1093/molbev/msu077; Frisancho AR, 2013, AM J HUM BIOL, V25, P151, DOI 10.1002/ajhb.22367; FRISANCHO AR, 1969, HUM BIOL, V41, P365; Gaya-Vidal M, 2011, AM J PHYS ANTHROPOL, V145, P215, DOI 10.1002/ajpa.21487; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; Herraez DL, 2008, ANAL BIOCHEM, V383, P329, DOI 10.1016/j.ab.2008.08.015; Herrera-Ramos E, 2014, CRIT CARE, V18, DOI 10.1186/cc13934; Hodges E, 2009, NAT PROTOC, V4, P960, DOI 10.1038/nprot.2009.68; Hofmann S, 2008, NAT GENET, V40, P1103, DOI 10.1038/ng.198; Hoit BD, 2005, J APPL PHYSIOL, V99, P1796, DOI 10.1152/japplphysiol.00205.2005; Huerta-Sanchez E, 2014, NATURE, V512, P194, DOI 10.1038/nature13408; Huerta-Sanchez E, 2013, MOL BIOL EVOL, V30, P1877, DOI 10.1093/molbev/mst089; Hurtado A, 1932, AM J PHYS ANTHROPOL, V17, P137, DOI 10.1002/ajpa.1330170212; Ishii T, 2012, EUR J HUM GENET, V20, P230, DOI 10.1038/ejhg.2011.183; Jack DL, 2006, CLIN INFECT DIS, V43, P1426, DOI 10.1086/508775; Jawaid A, 2009, ANN HUM GENET, V73, P118, DOI 10.1111/j.1469-1809.2008.00486.x; Julian CG, 2009, AM J HUM BIOL, V21, P614, DOI 10.1002/ajhb.20900; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Kim DK, 2012, AM J RESP CRIT CARE, V186, P1238, DOI 10.1164/rccm.201206-1013OC; Kirov G, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-27; Komura D, 2006, GENOME RES, V16, P1575, DOI 10.1101/gr.5629106; Lahti M, 2002, PEDIATR RES, V51, P696, DOI [10.1203/00006450-200206000-00006, 10.1023/01.PDR.0000015911.65104.93]; Leon-Velarde F, 2003, HIGH ALT MED BIOL, V4, P256, DOI 10.1089/152702903322022857; Leth-Larsen R, 2005, J IMMUNOL, V174, P1532, DOI 10.4049/jimmunol.174.3.1532; Levin AM, 2013, GENES IMMUN, V14, P13, DOI 10.1038/gene.2012.48; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Luisi P, 2012, MOL BIOL EVOL, V29, P1379, DOI 10.1093/molbev/msr298; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meer K, 1995, EUR J PEDIATR, V154, P263; Mejia OM, 2005, HAEMATOLOGICA, V90, P13; Meyer M., 2010, COLD SPRING HARB PRO, V2010, P5448; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; MONGE CARLOS, 1942, SCIENCE, V95, P79, DOI 10.1126/science.95.2456.79; Moore LG, 1998, YEARB PHYS ANTHROPOL, V41, P25; Morais A, 2013, TISSUE ANTIGENS, V82, P186, DOI 10.1111/tan.12188; O'Rourke DH, 2010, CURR BIOL, V20, pR202, DOI 10.1016/j.cub.2009.11.051; Padhy G, 2013, HIGH ALT MED BIOL, V14, P289, DOI 10.1089/ham.2012.1095; Pagani L, 2012, HUM GENET, V131, P423, DOI 10.1007/s00439-011-1084-8; Peng Y, 2011, MOL BIOL EVOL, V28, P1075, DOI 10.1093/molbev/msq290; Priyanka Pandey, 2014, Advances in Genomics and Genetics, V4, P29; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Quinque D, 2006, ANAL BIOCHEM, V353, P272, DOI 10.1016/j.ab.2006.03.021; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Rothhammer F, 2009, ANN HUM GENET, V73, P540, DOI 10.1111/j.1469-1809.2009.00537.x; Rupert JL, 2001, HIGH ALT MED BIOL, V2, P235, DOI 10.1089/152702901750265332; Rupert JL, 1999, AM J PHYS ANTHROPOL, V109, P181, DOI 10.1002/(SICI)1096-8644(199906)109:2<181::AID-AJPA4>3.3.CO;2-P; Rupert JL, 2000, ANN HUM GENET, V64, P135, DOI 10.1017/S0003480000008009; Ryckman KK, 2012, J PERINATOL, V32, P349, DOI 10.1038/jp.2011.104; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Salzano FM, 1988, S AM INDIANS CASE ST; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; Scheinfeldt LB, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r1; Scheinfeldt LB, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-133; Schmidt MC, 2002, WILD ENVIRON MED, V13, P94, DOI 10.1580/1080-6032(2002)013[0094:OSIHTI]2.0.CO;2; Shriver MD, 2006, ADV EXP MED BIOL, V588, P89; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Sinha S, 2009, RESP PHYSIOL NEUROBI, V167, P255, DOI 10.1016/j.resp.2009.05.003; TAJIMA F, 1989, GENETICS, V123, P585; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Vernot B, 2014, SCIENCE, V343, P1017, DOI 10.1126/science.1245938; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang P, 2010, HIGH ALT MED BIOL, V11, P27, DOI 10.1089/ham.2009.1054; Weir B.S., 1984, EVOLUTION, P38; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; West JB., 2007, HIGH ALTITUDE MED PH; Wilkening S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-77; Xing GQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002342; Xu SH, 2011, MOL BIOL EVOL, V28, P1003, DOI 10.1093/molbev/msq277; Xu Y, 2010, ANTIOXID REDOX SIGN, V13, P27, DOI 10.1089/ars.2009.2886; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Zaykin DV, 2007, PHARM STAT, V6, P217, DOI 10.1002/pst.304; Zhao M, 2009, P NATL ACAD SCI USA, V106, P21230, DOI 10.1073/pnas.0907844106; ZHUANG J, 1993, J APPL PHYSIOL, V74, P303, DOI 10.1152/jappl.1993.74.1.303	106	33	33	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0125444	10.1371/journal.pone.0125444	http://dx.doi.org/10.1371/journal.pone.0125444			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961286	gold, Green Published, Green Submitted			2022-12-26	WOS:000354542500031
J	Vieira, J; Campelo, F; Rossi, S; Carvalho, A; Freitas, H; Nabais, C				Vieira, Joana; Campelo, Filipe; Rossi, Sergio; Carvalho, Ana; Freitas, Helena; Nabais, Cristina			Adjustment Capacity of Maritime Pine Cambial Activity in Drought-Prone Environments	PLOS ONE			English	Article							INTRAANNUAL DENSITY-FLUCTUATIONS; TREE-RING WIDTH; LOCALLY HEATED STEMS; WOOD FORMATION; CLIMATIC SIGNIFICANCE; XYLEM PHENOLOGY; SILVER-FIR; PINASTER; GROWTH; XYLOGENESIS	Intra-annual density fluctuations (IADFs) are anatomical features formed in response to changes in the environmental conditions within the growing season. These anatomical features are commonly observed in Mediterranean pines, being more frequent in younger and wider tree rings. However, the process behind IADF formation is still unknown. Weekly monitoring of cambial activity and wood formation would fill this void. Although studies describing cambial activity and wood formation have become frequent, this knowledge is still fragmentary in the Mediterranean region. Here we present data from the monitoring of cambial activity and wood formation in two diameter classes of maritime pine (Pinus pinaster Ait.), over two years, in order to test: (i) whether the differences in stem diameter in an even-aged stand were due to timings and/or rates of xylogenesis; (ii) if IADFs were more common in large trees; and (iii) if their formation is triggered by cambial resumption after the summer drought. Larger trees showed higher rates of cell production and longer growing seasons, due to an earlier start and later end of xylogenesis. When a drier winter occurs, larger trees were more affected, probably limiting xylogenesis in the summer months. In both diameter classes a latewood IADF was formed in 2012 in response to late-September precipitation, confirming that the timing of the precipitation event after the summer drought is crucial in determining the resumption of cambial activity and whether or not an IADF is formed. It was the first time that the formation of a latewood IADF was monitored at a weekly time scale in maritime pine. The capacity of maritime pine to adjust cambial activity to the current environmental conditions represents a valuable strategy under the future climate change conditions.	[Vieira, Joana; Campelo, Filipe; Carvalho, Ana; Freitas, Helena; Nabais, Cristina] Univ Coimbra, Dept Life Sci, Ctr Funct Ecol, Coimbra, Portugal; [Rossi, Sergio] Univ Quebec Chicoutimi, Dept Sci Fondamentales, Chicoutimi, PQ, Canada; [Rossi, Sergio] Chinese Acad Sci, Prov Key Lab Appl Bot South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China	Universidade de Coimbra; University of Quebec; University of Quebec Chicoutimi; Chinese Academy of Sciences; South China Botanical Garden, CAS	Vieira, J (corresponding author), Univ Coimbra, Dept Life Sci, Ctr Funct Ecol, Coimbra, Portugal.	joana.vieira@uc.pt	Campelo, Filipe/D-6931-2011; Carvalho, Ana/AAF-3487-2021; Freitas, Helena/ABE-6998-2020; Vieira, Joana/M-6152-2013; Freitas, Helena/A-2803-2010; Carvalho, Ana L P/L-2564-2016	Campelo, Filipe/0000-0001-6022-9948; Carvalho, Ana/0000-0002-9316-9571; Vieira, Joana/0000-0003-1021-4101; Freitas, Helena/0000-0002-1907-9615; Carvalho, Ana L P/0000-0002-9316-9571; Nabais, Cristina/0000-0001-6901-8776	Fundacao para a Ciencia e a Tecnologia, Ministerio da Educacao e Ciencia (FCT) - Compete [PTDC/AAC-AMB/111675/2009, EXPL/AAG-GLO/1885/2013]; CFE strategic program [UI0134-UID/BIA/04004/2013]; FCT [SFRH/BD/48089/2008, SFRH/BPD/47822/2008]; POPH (Portuguese Operational Human Potential Program); QREN Portugal (Portuguese National Strategic Reference Framework); FPS COST Action STReESS [FP1106]	Fundacao para a Ciencia e a Tecnologia, Ministerio da Educacao e Ciencia (FCT) - Compete; CFE strategic program; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); POPH (Portuguese Operational Human Potential Program); QREN Portugal (Portuguese National Strategic Reference Framework); FPS COST Action STReESS	This study was supported by the Fundacao para a Ciencia e a Tecnologia, Ministerio da Educacao e Ciencia (FCT) co-financed by Compete, through the projects PTDC/AAC-AMB/111675/2009 and EXPL/AAG-GLO/1885/2013, and CFE strategic program UI0134-UID/BIA/04004/2013. Joana Vieira was supported by a Ph.D. grant (SFRH/BD/48089/2008) and Filipe Campelo by a postdoctoral research grant (SFRH/BPD/47822/2008), both grants from FCT with funds from POPH (Portuguese Operational Human Potential Program) and QREN Portugal (Portuguese National Strategic Reference Framework). This research also benefited from the support of the FPS COST Action STReESS (FP1106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2003, TREE PHYSIOL, V23, P859, DOI 10.1093/treephys/23.12.859; Begum S, 2007, ANN BOT-LONDON, V100, P439, DOI 10.1093/aob/mcm130; Begum S, 2013, PHYSIOL PLANTARUM, V147, P46, DOI 10.1111/j.1399-3054.2012.01663.x; Begum S, 2010, TREES-STRUCT FUNCT, V24, P43, DOI 10.1007/s00468-009-0377-1; Campelo F, 2007, CAN J FOREST RES, V37, P1915, DOI 10.1139/X07-050; Campelo F, 2007, ANN FOREST SCI, V64, P229, DOI 10.1051/forest:2006107; Campelo F, 2015, TREES-STRUCT FUNCT, V29, P237, DOI 10.1007/s00468-014-1108-9; Campelo F, 2013, TREES-STRUCT FUNCT, V27, P763, DOI 10.1007/s00468-012-0831-3; Linares JC, 2010, J ECOL, V98, P592, DOI 10.1111/j.1365-2745.2010.01645.x; Linares JC, 2009, TREE PHYSIOL, V29, P1525, DOI 10.1093/treephys/tpp084; Cherubini P, 2003, BIOL REV, V78, P119, DOI 10.1017/S1464793102006000; CRU Netherlands Royal Meteorological Institute, 2011, 31 CRU TS; Cuny HE, 2014, NEW PHYTOL, V203, P1231, DOI 10.1111/nph.12871; de Luis M, 2011, FOREST ECOL MANAG, V262, P1630, DOI 10.1016/j.foreco.2011.07.013; de Luis M, 2011, DENDROCHRONOLOGIA, V29, P163, DOI 10.1016/j.dendro.2011.01.005; De Micco V, 2007, IAWA J, V28, P61, DOI 10.1163/22941932-90001619; Delzon S, 2004, PLANT CELL ENVIRON, V27, P1077, DOI 10.1111/j.1365-3040.2004.01213.x; DENNE MP, 1989, IAWA BULL, V10, P59, DOI 10.1163/22941932-90001112; DeSoto L, 2012, EUR J FOREST RES, V131, P905, DOI 10.1007/s10342-011-0564-7; Dyer T.G.J., 2006, TREE RINGS CLIMATE, DOI 10.2307/2402947; Gricar J, 2005, ANN BOT-LONDON, V95, P959, DOI 10.1093/aob/mci112; Gruber Andreas, 2009, Ann For Sci, V66, DOI 10.1051/forest/2009038; Hertig E, 2008, INT J CLIMATOL, V28, P1025, DOI 10.1002/joc.1597; Irvine J, 1997, PLANTA, V202, P455, DOI 10.1007/s004250050149; Camarero JJ, 2010, NEW PHYTOL, V185, P471, DOI 10.1111/j.1469-8137.2009.03073.x; Larson PR., 1994, VASCULAR CAMBIUM DEV, DOI [10.1007/978-3-642-78466-8, DOI 10.1007/978-3-642-78466-8]; Lionello P, 2006, DEV EARTH ENV SCI, V4, P1, DOI 10.1016/s1571-9197(06)80003-0; LIPHSCHITZ N, 1986, IAWA BULL, V7, P145, DOI 10.1163/22941932-90000978; LITTLE CHA, 1974, CAN J BOT, V52, P1723, DOI 10.1139/b74-224; Loustau D, 1996, OECOLOGIA, V107, P33, DOI 10.1007/BF00582232; Lupi C, 2014, TREE PHYSIOL, V34, P87, DOI 10.1093/treephys/tpt108; Lupi C, 2010, PLANT CELL ENVIRON, V33, P1721, DOI 10.1111/j.1365-3040.2010.02176.x; Martinez-Vilalta J, 2007, FUNCT ECOL, V21, P1072, DOI 10.1111/j.1365-2435.2007.01332.x; Masiokas M, 2004, TREES-STRUCT FUNCT, V18, P696, DOI 10.1007/s00468-004-0355-6; Nabais C, 2014, FORESTRY, V87, P598, DOI 10.1093/forestry/cpu021; Novak K, 2013, TREES-STRUCT FUNCT, V27, P927, DOI 10.1007/s00468-013-0845-5; Oberhuber W, 2010, TREES-STRUCT FUNCT, V24, P887, DOI 10.1007/s00468-010-0458-1; Oribe Y, 2003, TREES-STRUCT FUNCT, V17, P185, DOI 10.1007/s00468-002-0231-1; Oribe Y, 2001, PLANTA, V212, P684, DOI 10.1007/s004250000430; Phillips NG, 2003, TREE PHYSIOL, V23, P237, DOI 10.1093/treephys/23.4.237; Rathgeber CBK, 2011, ANN BOT-LONDON, V108, P429, DOI 10.1093/aob/mcr168; Rensing KH, 2004, TREES-STRUCT FUNCT, V18, P373, DOI 10.1007/s00468-003-0314-7; RIDING RT, 1984, CAN J BOT, V62, P2570, DOI 10.1139/b84-349; Rigling A, 2001, CAN J FOREST RES, V31, P18, DOI 10.1139/cjfr-31-1-18; Rossi S, 2006, IAWA J, V27, P89, DOI 10.1163/22941932-90000139; Rossi S, 2008, GLOBAL ECOL BIOGEOGR, V17, P696, DOI 10.1111/j.1466-8238.2008.00417.x; Rossi S, 2008, NEW PHYTOL, V177, P199, DOI 10.1111/j.1469-8137.2007.02235.x; Rossi S, 2015, ANN FOREST SCI, V72, P77, DOI [10.1007/s13595-014-0399-8, 10.1007/s13595-013-0341-5]; Rossi S, 2013, ANN BOT-LONDON, V112, P1911, DOI 10.1093/aob/mct243; Rossi S, 2012, J EXP BOT, V63, P2117, DOI 10.1093/jxb/err423; Rozas V, 2011, TREES-STRUCT FUNCT, V25, P443, DOI 10.1007/s00468-010-0519-5; Sarris D, 2013, AGR FOREST METEOROL, V168, P59, DOI 10.1016/j.agrformet.2012.08.007; Vieira J, 2014, EUR J FOREST RES, V133, P41, DOI 10.1007/s10342-013-0734-x; Vieira J, 2013, AGR FOREST METEOROL, V180, P173, DOI 10.1016/j.agrformet.2013.06.009; Vieira J, 2010, CAN J FOREST RES, V40, P1567, DOI 10.1139/X10-096; Vieira J, 2009, TREES-STRUCT FUNCT, V23, P257, DOI 10.1007/s00468-008-0273-0; Wimmer R, 2000, CAN J FOREST RES, V30, P1691, DOI 10.1139/cjfr-30-11-1691; Zweifel R, 2006, J EXP BOT, V57, P1445, DOI 10.1093/jxb/erj125	58	53	61	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126223	10.1371/journal.pone.0126223	http://dx.doi.org/10.1371/journal.pone.0126223			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961843	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000354542500076
J	Carreon-Martinez, LB; Walter, RP; Johnson, TB; Ludsin, SA; Heath, DD				Carreon-Martinez, Lucia B.; Walter, Ryan P.; Johnson, Timothy B.; Ludsin, Stuart A.; Heath, Daniel D.			Benefits of Turbid River Plume Habitat for Lake Erie Yellow Perch (Perca flavescens) Recruitment Determined by Juvenile to Larval Genotype Assignment	PLOS ONE			English	Article							BOTTOM-UP; GENETIC DIFFERENTIATION; POPULATION-STRUCTURE; MICROSATELLITE DNA; LARGE-SCALE; FISH; ABUNDANCE; PATTERNS; BARRIERS; WALLEYE	Nutrient-rich, turbid river plumes that are common to large lakes and coastal marine ecosystems have been hypothesized to benefit survival of fish during early life stages by increasing food availability and (or) reducing vulnerability to visual predators. However, evidence that river plumes truly benefit the recruitment process remains meager for both freshwater and marine fishes. Here, we use genotype assignment between juvenile and larval yellow perch (Perca flavescens) from western Lake Erie to estimate and compare recruitment to the age-0 juvenile stage for larvae residing inside the highly turbid, south-shore Maumee River plume versus those occupying the less turbid, more northerly Detroit River plume. Bayesian genotype assignment of a mixed assemblage of juvenile (age-0) yellow perch to putative larval source populations established that recruitment of larvae was higher from the turbid Maumee River plume than for the less turbid Detroit River plume during 2006 and 2007, but not in 2008. Our findings add to the growing evidence that turbid river plumes can indeed enhance survival of fish larvae to recruited life stages, and also demonstrate how novel population genetic analyses of early life stages can contribute to determining critical early life stage processes in the fish recruitment process.	[Carreon-Martinez, Lucia B.; Walter, Ryan P.; Heath, Daniel D.] Univ Windsor, Great Lakes Inst Environm Res, Windsor, ON N9B 3P4, Canada; [Walter, Ryan P.] Calif State Univ Fullerton, Dept Biol Sci, Fullerton, CA 92831 USA; [Johnson, Timothy B.] Ontario Minist Nat Resources, Glenora Fisheries Stn, Picton, ON K0K 2T0, Canada; [Ludsin, Stuart A.] Ohio State Univ, Aquat Ecol Lab, Dept Evolut Ecol & Organismal Biol, Columbus, OH 43212 USA	University of Windsor; California State University System; California State University Fullerton; Ministry of Natural Resources & Forestry; Ohio State University	Heath, DD (corresponding author), Univ Windsor, Great Lakes Inst Environm Res, Windsor, ON N9B 3P4, Canada.	dheath@uwindsor.ca	Carreon Martinez, Lucia/B-9214-2017		Great Lakes Fishery Commission's Fisheries (GLFC) Research Program [00012267]; Natural Sciences and Engineering Research Council (NSERC) of Canada [814014]; Ontario Ministry of Natural Resources (OMNR)	Great Lakes Fishery Commission's Fisheries (GLFC) Research Program; Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Ministry of Natural Resources (OMNR)	Funding for this research was provided by 1) Great Lakes Fishery Commission's Fisheries (GLFC) Research Program (http://www.glfc.org/research/FisheryDesc.php), grant #00012267: no individuals employed or contracted by the GLFC played any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; 2) Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery Grant #814014 (http://www.nserc-crsng.gc.ca/index_eng.asp): no individuals employed or contracted by the NSERC played any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; and 3) Ontario Ministry of Natural Resources (OMNR) base funds (https://www.ontario.ca/environment-and-energy/aquatic-research): no individuals employed or contracted by the OMNR (other than co-author T.B. Johnson) played any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams M, 1997, BEHAV ECOL SOCIOBIOL, V40, P169, DOI 10.1007/s002650050330; [Anonymous], 1997, TFPGA TOOLS POPULATI; Auer NA, 1982, SPECIAL PUBLICATION, DOI [10.1038/gim.2015.39, DOI 10.1038/GIM.2015.39]; Beletsky D, 1999, J GREAT LAKES RES, V25, P78, DOI 10.1016/S0380-1330(99)70718-5; Beneteau CL, 2009, CONSERV GENET, V10, P477, DOI 10.1007/s10592-008-9627-9; Bergek S, 2007, EVOLUTION, V61, P2035, DOI 10.1111/j.1558-5646.2007.00163.x; Bergek S, 2009, EVOL ECOL RES, V11, P827; BODALY RA, 1989, J FISH BIOL, V34, P965, DOI 10.1111/j.1095-8649.1989.tb03380.x; Campana SE, 1999, MAR ECOL PROG SER, V188, P263, DOI 10.3354/meps188263; Campana SE, 2001, CAN J FISH AQUAT SCI, V58, P30, DOI 10.1139/f00-177; CARPENTER SR, 1985, BIOSCIENCE, V35, P634, DOI 10.2307/1309989; Carreon-Martinez L B, 2014, MOL ECOL IN PRESS; Chassot E, 2007, MAR ECOL PROG SER, V343, P45, DOI 10.3354/meps06919; Christie MR, 2010, MOL ECOL, V19, P1042, DOI 10.1111/j.1365-294X.2010.04524.x; De Robertis A, 2005, MAR ECOL PROG SER, V299, P33, DOI 10.3354/meps299033; De Robertis A, 2003, CAN J FISH AQUAT SCI, V60, P1517, DOI 10.1139/F03-123; Elphinstone MS, 2003, MOL ECOL NOTES, V3, P317, DOI 10.1046/j.1471-8286.2003.00397.x; Elsdon TS, 2008, OCEANOGR MAR BIOL, V46, P297, DOI 10.1201/9781420065756.ch7; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fuller K, 1995, GREAT LAKES ENV ATLA; GASCON D, 1977, J FISH RES BOARD CAN, V34, P1105, DOI 10.1139/f77-167; Goodyear CS, 1982, ATLAS SPAWNING NURSI, V9; Grimes CB, 1996, MAR FRESHWATER RES, V47, P191, DOI 10.1071/MF9960191; GRIMES CB, 1991, MAR ECOL PROG SER, V75, P109, DOI 10.3354/meps075109; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Hauser L, 1998, J FISH BIOL, V53, P413, DOI 10.1006/jfbi.1998.0826; Hedgecock D, 2010, MOL ECOL, V19, P845, DOI 10.1111/j.1365-294X.2010.04525.x; Hogan JD, 2012, OECOLOGIA, V168, P61, DOI 10.1007/s00442-011-2058-1; HOUDE ED, 1969, J FISH RES BOARD CAN, V26, P1647, DOI 10.1139/f69-148; Houde Edward D., 2009, P91, DOI 10.1002/9781444312133.ch3; HUNTER MD, 1992, ECOLOGY, V73, P724; John MA, 1992, FISH OCEAN, V1, P153, DOI DOI 10.1111/J.1365-2419.1992.TB000; Kocovsky PM, 2013, J FISH BIOL, V82, P2015, DOI 10.1111/jfb.12129; Le Pape O, 2003, J SEA RES, V50, P177, DOI 10.1016/S1385-1101(03)00061-3; Lecomte F, 2004, EVOL ECOL RES, V6, P631; Li L, 2007, MOL ECOL NOTES, V7, P600, DOI 10.1111/j.1471-8286.2006.01645.x; Litz MN, 2013, ICES J MAR SCI; Ludsin SA, 2014, CAN J FISH AQUAT SCI, V71, P775, DOI 10.1139/cjfas-2013-0512; MCQUEEN DJ, 1989, ECOL MONOGR, V59, P289, DOI 10.2307/1942603; Miller LM, 2003, T AM FISH SOC, V132, P503, DOI 10.1577/1548-8659(2003)132&lt;0503:MDLRGS&gt;2.0.CO;2; MORTIMER CH, 1987, J GREAT LAKES RES, V13, P407, DOI 10.1016/S0380-1330(87)71664-5; OConnell M, 1997, REV FISH BIOL FISHER, V7, P331, DOI 10.1023/A:1018443912945; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Pangle K., 2011, RIVER DISCHARGE PRED; Pangle KL, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00224.1; Parker AD, 2009, T AM FISH SOC, V138, P899, DOI 10.1577/T08-093.1; Pekcan-Hekim Z, 2006, NATURWISSENSCHAFTEN, V93, P356, DOI 10.1007/s00114-006-0114-1; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Porta D, 2005, J GREAT LAKES RES, V31, P63, DOI 10.1016/S0380-1330(05)70305-1; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Reichert JM, 2010, CAN J FISH AQUAT SCI, V67, P987, DOI 10.1139/F10-036; Roseman EF, 2005, J GREAT LAKES RES, V31, P28, DOI 10.1016/S0380-1330(05)70288-4; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Saenz-Agudelo P, 2011, P ROYAL SOC B; Salen-Picard C, 2002, OECOLOGIA, V133, P380, DOI 10.1007/s00442-002-1032-3; SAYLOR JH, 1987, J GREAT LAKES RES, V13, P487, DOI 10.1016/S0380-1330(87)71668-2; Sepulveda-Villet OJ, 2011, CAN J FISH AQUAT SCI, V68, P1435, DOI 10.1139/F2011-077; Sepulveda-Villet OJ, 2009, J GREAT LAKES RES, V35, P107, DOI 10.1016/j.jglr.2008.11.009; Shrimpton JM, 2003, MOL ECOL, V12, P2571, DOI 10.1046/j.1365-294X.2003.01932.x; Sinclair M, 1988, MARINE POPULATIONS E; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Strange RM, 2007, CAN J FISH AQUAT SCI, V64, P437, DOI 10.1139/F07-022; Swenson WA, 1978, EPA600378067; Thorrold SR, 2002, B MAR SCI, V70, P291; Utne-Palm AC, 2002, MAR FRESHW BEHAV PHY, V35, P111, DOI 10.1080/10236240290025644; Ward RD, 2000, HYDROBIOLOGIA, V420, P191, DOI 10.1023/A:1003928327503; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Yellow Perch Task Group, 2010, REP LAK ER YELL PERC	71	11	11	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0125234	10.1371/journal.pone.0125234	http://dx.doi.org/10.1371/journal.pone.0125234			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25954968	gold, Green Submitted, Green Published			2022-12-26	WOS:000356768100047
J	Hsiao, FY; Peng, LN; Wen, YW; Liang, CK; Wang, PN; Chen, LK				Hsiao, Fei-Yuan; Peng, Li-Ning; Wen, Yu-Wen; Liang, Chih-Kuang; Wang, Pei-Ning; Chen, Liang-Kung			Care Needs and Clinical Outcomes of Older People with Dementia: A Population-Based Propensity Score-Matched Cohort Study	PLOS ONE			English	Article							POTENTIALLY INAPPROPRIATE MEDICATIONS; ALZHEIMERS-DISEASE; HOSPITAL DEMENTIA; MANAGED CARE; RISK-FACTORS; SERVICES; ALENDRONATE; PREVALENCE; FRACTURES; HYPNOTICS	Objective To explore the healthcare resource utilization, psychotropic drug use and mortality of older people with dementia. Design A nationwide propensity score-matched cohort study. Setting National Health Insurance Research database. Participants A total of 32,649 elderly people with dementia and their propensity-score matched controls (n = 32,649). Measurements Outpatient visits, inpatient care, psychotropic drug use, in-hospital mortality and all-cause mortality at 90 and 365 days. Results Compared to the non-dementia group, a higher proportion of patients with dementia used inpatient services (1 year after index date: 20.91% vs. 9.55%), and the dementia group had more outpatient visits (median [standard deviation]: 7.00 [8.87] vs. 3.00 [8.30]). Furthermore, dementia cases with acute admission had the highest psychotropic drug utilization both at baseline and at the post-index dates (difference-in-differences: all <0.001). Dementia was associated with an increased risk of all-cause mortality (90 days, Odds ratio (OR) =1.85 [95% CI 1.67-2.05], p<0.001; 365 days, OR=1.59 [1.50-1.69], p<0.001) and in-hospital mortality (90 days, OR=1.97 [1.71-2.27], p<0.001; 365 days, OR=1.82 [1.61-2.05], p<0.001) compared to matched controls. Conclusions When older people with dementia are admitted for acute illnesses, they may increase their use of psychotropic agents and their risk of death, particularly in-hospital mortality.	[Hsiao, Fei-Yuan] Natl Taiwan Univ, Coll Med, Grad Inst Clin Pharm, Taipei 10764, Taiwan; [Hsiao, Fei-Yuan] Natl Taiwan Univ, Coll Med, Sch Pharm, Taipei, Taiwan; [Hsiao, Fei-Yuan] Natl Taiwan Univ Hosp, Dept Pharm, Taipei, Taiwan; [Peng, Li-Ning; Liang, Chih-Kuang; Wang, Pei-Ning; Chen, Liang-Kung] Natl Yang Ming Univ, Aging & Hlth Res Ctr, Taipei 112, Taiwan; [Peng, Li-Ning; Chen, Liang-Kung] Taipei Vet Gen Hosp, Ctr Geriatr & Gerontol, Taipei, Taiwan; [Wen, Yu-Wen] Chang Gung Univ, Clin Informat & Med Stat Res Ctr, Taoyuan, Taiwan; [Liang, Chih-Kuang] Kaohsiung Vet Gen Hosp, Geriatr Med Ctr, Kaohsiung, Taiwan; [Wang, Pei-Ning] Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Chang Gung University; Kaohsiung Veterans General Hospital; Taipei Veterans General Hospital	Hsiao, FY (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Clin Pharm, Taipei 10764, Taiwan.	fyshsiao@ntu.edu.tw; lkchen2@vghtpe.gov.tw	Liang, Chih-Kuang/AAJ-5235-2020; wen, yu/AAJ-7482-2021	Liang, Chih-Kuang/0000-0003-1604-1600; HSIAO, FEI-YUAN/0000-0003-1660-9120; Chen, Liang-Kung/0000-0002-2387-8508	National Science Council, Taiwan [NSC102-2410-H-002-058-MY2]; Food and Drug Administration, Taiwan [DOH102-FDA-41100]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Food and Drug Administration, Taiwan	FYH received a part-time research assistantship from a research grant (NSC102-2410-H-002-058-MY2), which was sponsored by the National Science Council, Taiwan, and a research grant sponsored by the Food and Drug Administration, Taiwan (DOH102-FDA-41100).	Albert SM, 1999, J GERONTOL A-BIOL, V54, pM267, DOI 10.1093/gerona/54.5.M267; Alzheimer's Society, 2009, COUNT COST CAR PEOPL; Austin PC, 2008, J CLIN EPIDEMIOL, V61, P537, DOI 10.1016/j.jclinepi.2007.07.011; Austin PC, 2007, STAT MED, V26, P734, DOI 10.1002/sim.2580; Austin PC, 2007, STAT MED, V26, P754, DOI 10.1002/sim.2618; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Bail K, 2013, AUST J RURAL HEALTH, V21, P208, DOI 10.1111/ajr.12041; Banerjee S., 2009, USE ANTIPSYCHOTIC ME; Bradshaw LE, 2013, AGE AGEING, V42, P582, DOI 10.1093/ageing/aft074; Chang CM, 2011, INT J GERIATR PSYCH, V26, P602, DOI 10.1002/gps.2569; Chen YM, 2011, J AM GERIATR SOC, V59, P2379, DOI 10.1111/j.1532-5415.2011.03693.x; Dewing J, 2014, LIT REV DEMENTIA LON; Donald SG, 2007, REV ECON STAT, V89, P221, DOI 10.1162/rest.89.2.221; Draper B, 2013, AUSTRALAS J AGEING; Draper B, 2011, INT PSYCHOGERIATR, V23, P1649, DOI 10.1017/S1041610211001694; Finkle WD, 2011, J AM GERIATR SOC, V59, P1883, DOI 10.1111/j.1532-5415.2011.03591.x; Goldberg SE, 2014, INT J NURS STUD; Gustavsen I, 2008, SLEEP MED, V9, P818, DOI 10.1016/j.sleep.2007.11.011; Hsiao FY, 2007, J FOOD DRUG ANAL, V15, P99; Hsiao FY, 2014, J AM MED DIR ASSOC, V15, P509, DOI 10.1016/j.jamda.2014.02.009; Hsiao FY, 2011, CLIN THER, V33, P1659, DOI 10.1016/j.clinthera.2011.09.006; Huang WF, 2010, MENOPAUSE, V17, P57, DOI 10.1097/gme.0b013e3181b34749; Imfeld P, 2013, NEUROLOGY, V81, P910, DOI 10.1212/WNL.0b013e3182a35151; Jurgens FJ, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-57; Kang Dong-Yoon, 2012, J Prev Med Public Health, V45, P219, DOI 10.3961/jpmph.2012.45.4.219; Koyama A, 2014, J GERONTOL A-BIOL, V69, P423, DOI 10.1093/gerona/glt192; Koyama A, 2013, J AM GERIATR SOC, V61, P258, DOI 10.1111/jgs.12093; Kurrle SE, 2006, MED J AUSTRALIA, V184, P427, DOI 10.5694/j.1326-5377.2006.tb00310.x; Leibson C, 1999, J AM GERIATR SOC, V47, P864, DOI 10.1111/j.1532-5415.1999.tb03846.x; Lin CF, 2012, DRUG AGING, V29, P819, DOI 10.1007/s40266-012-0011-6; Liu ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061771; Lu JH, 2013, J CLIN GERONTOL GERI, V4, P115, DOI 10.1016/j.jcgg.2013.06.001; Lyketsos CG, 2002, JAMA-J AM MED ASSOC, V288, P1475, DOI 10.1001/jama.288.12.1475; Miu DKY, 2012, J CLIN GERONTOL GERI, V3, P105, DOI 10.1016/j.jcgg.2012.04.008; Moyle W, 2011, J CLIN NURS, V20, P420, DOI 10.1111/j.1365-2702.2010.03521.x; Natalwala A, 2008, DEMENT GERIATR COGN, V26, P499, DOI 10.1159/000171044; Orriols L, 2011, CLIN PHARMACOL THER, V89, P595, DOI 10.1038/clpt.2011.3; Panneman MJM, 2003, DRUG AGING, V20, P833, DOI 10.2165/00002512-200320110-00004; Phelan EA, 2012, JAMA-J AM MED ASSOC, V307, P165, DOI 10.1001/jama.2011.1964; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Richards KM, 2000, CLIN THER, V22, P775, DOI 10.1016/S0149-2918(00)90011-0; Rojas-Fernandez C H, 1999, Can J Clin Pharmacol, V6, P149; Saver BG, 2014, EUR J PUBLIC HEALTH, V24, P66, DOI 10.1093/eurpub/ckt019; van der Ploeg ES, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-51; Verhoeven V, 2014, J CLIN GERONTOLOGY G; Weiner M, 1998, J AM GERIATR SOC, V46, P762, DOI 10.1111/j.1532-5415.1998.tb03814.x; World Health Organization, 2011, INT CLASS DIS NINTH; Yeh KP, 2014, J CLIN GERONTOL GERI, V5, P13, DOI 10.1016/j.jcgg.2013.08.001; Zhao Y, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-108; Zuliani G, 2012, INT J GERIATR PSYCH, V27, P313, DOI 10.1002/gps.2722	50	29	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0124973	10.1371/journal.pone.0124973	http://dx.doi.org/10.1371/journal.pone.0124973			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL2IX	25955163	gold, Green Submitted, Green Published			2022-12-26	WOS:000356768100038
J	Jensen, JB; Lysaght, AC; Liberman, MC; Qvortrup, K; Stankovic, KM				Jensen, Jane Bjerg; Lysaght, Andrew C.; Liberman, M. Charles; Qvortrup, Klaus; Stankovic, Konstantina M.			Immediate and Delayed Cochlear Neuropathy after Noise Exposure in Pubescent Mice	PLOS ONE			English	Article							PRODUCT OTOACOUSTIC EMISSIONS; HEARING-LOSS; TRANSMITTER RELEASE; SPIRAL GANGLION; SYNAPTIC VESICLE; CAT COCHLEA; AGE; NEURONS; INJURY; YOUNG	Moderate acoustic overexposure in adult rodents is known to cause acute loss of synapses on sensory inner hair cells (IHCs) and delayed degeneration of the auditory nerve, despite the completely reversible temporary threshold shift (TTS) and morphologically intact hair cells. Our objective was to determine whether a cochlear synaptopathy followed by neuropathy occurs after noise exposure in pubescence, and to define neuropathic versus non-neuropathic noise levels for pubescent mice. While exposing 6 week old CBA/CaJ mice to 8-16 kHz bandpass noise for 2 hrs, we defined 97 dB sound pressure level (SPL) as the threshold for this particular type of neuropathic exposure associated with TTS, and 94 dB SPL as the highest non-neuropathic noise level associated with TTS. Exposure to 100 dB SPL caused permanent threshold shift although exposure of 16 week old mice to the same noise is reported to cause only TTS. Amplitude of wave I of the auditory brainstem response, which reflects the summed activity of the cochlear nerve, was complemented by synaptic ribbon counts in IHCs using confocal microscopy, and by stereological counts of peripheral axons and cell bodies of the cochlear nerve from 24 hours to 16 months post exposure. Mice exposed to neuropathic noise demonstrated immediate cochlear synaptopathy by 24 hours post exposure, and delayed neurodegeneration characterized by axonal retraction at 8 months, and spiral ganglion cell loss at 8-16 months post exposure. Although the damage was initially limited to the cochlear base, it progressed to also involve the cochlear apex by 8 months post exposure. Our data demonstrate a fine line between neuropathic and non-neuropathic noise levels associated with TTS in the pubescent cochlea.	[Jensen, Jane Bjerg; Lysaght, Andrew C.; Liberman, M. Charles; Stankovic, Konstantina M.] Massachusetts Eye & Ear Infirm, Eaton Peabody Labs, Boston, MA 02114 USA; [Jensen, Jane Bjerg; Lysaght, Andrew C.; Liberman, M. Charles; Stankovic, Konstantina M.] Massachusetts Eye & Ear Infirm, Dept Otolaryngol, Boston, MA 02114 USA; [Jensen, Jane Bjerg; Lysaght, Andrew C.; Liberman, M. Charles; Stankovic, Konstantina M.] Harvard Univ, Sch Med, Dept Otol & Laryngol, Boston, MA 02115 USA; [Lysaght, Andrew C.; Liberman, M. Charles; Stankovic, Konstantina M.] Harvard & Massachusetts Inst Technol, Div Hlth Sci & Technol, Program Speech & Hearing Biosci & Technol, Boston, MA 02139 USA; [Jensen, Jane Bjerg; Qvortrup, Klaus] Univ Copenhagen, CFIM, Dept Biomed Sci, DK-2200 Copenhagen N, Denmark	Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Copenhagen	Stankovic, KM (corresponding author), Massachusetts Eye & Ear Infirm, Eaton Peabody Labs, Boston, MA 02114 USA.	konstantina_stankovic@meei.harvard.edu		Qvortrup, Klaus/0000-0001-8811-0260; bjerg groth, jane/0000-0002-7315-003X	National Institute on Deafness and Other Communicative Disorders [K08DC010419, R01 DC00188, P30 05209, T32 DC00038]; Bertarelli Foundation; Aase and Ejnar Danielsens Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000188, K08DC010419, T32DC000038] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communicative Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Bertarelli Foundation; Aase and Ejnar Danielsens Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by grants from the National Institute on Deafness and Other Communicative Disorders: K08DC010419 (KMS), R01 DC00188 (MCL), P30 05209 (MCL) and T32 DC00038 (ACL, KMS); The Bertarelli Foundation (KMS); and The Aase and Ejnar Danielsens Foundation (JBJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandt A, 2005, J NEUROSCI, V25, P11577, DOI 10.1523/JNEUROSCI.3411-05.2005; Castellano-Munoz M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00162; Chen ZQ, 2009, J NEUROPHYSIOL, V102, P1152, DOI 10.1152/jn.00288.2009; Cho YS, 2004, MOL BRAIN RES, V130, P134, DOI 10.1016/j.molbrainres.2004.07.017; CHOI DW, 1987, J NEUROSCI, V7, P369; Epp B, 2012, J ACOUST SOC AM, V132, pEL196, DOI 10.1121/1.4740462; FALK SA, 1974, LARYNGOSCOPE, V84, P444, DOI 10.1288/00005537-197403000-00008; Furman AC, 2013, J NEUROPHYSIOL, V110, P577, DOI 10.1152/jn.00164.2013; Gates GA, 2000, HEARING RES, V141, P220, DOI 10.1016/S0378-5955(99)00223-3; Glowatzki E, 2002, NAT NEUROSCI, V5, P147, DOI 10.1038/nn796; Goutman JD, 2007, P NATL ACAD SCI USA, V104, P16341, DOI 10.1073/pnas.0705756104; Gu JW, 2012, JARO-J ASSOC RES OTO, V13, P819, DOI 10.1007/s10162-012-0344-1; Han SK, 2005, J NEUROSCI, V25, P11349, DOI 10.1523/JNEUROSCI.3328-05.2005; Han Y, 2012, GENE, V499, P318, DOI 10.1016/j.gene.2012.02.042; HENRY KR, 1982, BEHAV GENET, V12, P563, DOI 10.1007/BF01070410; HENRY KR, 1984, BEHAV NEUROSCI, V98, P1073, DOI 10.1037/0735-7044.98.6.1073; HENRY KR, 1980, AUDIOLOGY, V19, P369; Hickox AE, 2014, J NEUROPHYSIOL, V111, P552, DOI 10.1152/jn.00184.2013; Khimich D, 2005, NATURE, V434, P889, DOI 10.1038/nature03418; Konrad-Martin D, 2012, J AM ACAD AUDIOL, V23, P18, DOI 10.3766/jaaa.23.1.3; Kujawa SG, 2006, J NEUROSCI, V26, P2115, DOI 10.1523/JNEUROSCI.4985-05.2006; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Larsen JO, 1998, J NEUROSCI METH, V85, P107, DOI 10.1016/S0165-0270(98)00129-0; Le Prell CG, 2012, EAR HEARING, V33, pE44, DOI 10.1097/AUD.0b013e31825f9d89; Leigh J, 1999, EPIDEMIOLOGY, V10, P626, DOI 10.1097/00001648-199909000-00032; LIBERMAN MC, 1980, HEARING RES, V3, P45, DOI 10.1016/0378-5955(80)90007-6; LIBERMAN MC, 1990, J COMP NEUROL, V301, P443, DOI 10.1002/cne.903010309; LIBERMAN MC, 1984, HEARING RES, V16, P55, DOI 10.1016/0378-5955(84)90025-X; Liberman MC, 2014, J ACOUST SOC AM, V135, P2311, DOI DOI 10.1523/JNEUROSCI.2845-09.2009; Lin HW, 2011, JARO-J ASSOC RES OTO, V12, P605, DOI 10.1007/s10162-011-0277-0; MerchanPerez A, 1996, J COMP NEUROL, V371, P208, DOI 10.1002/(SICI)1096-9861(19960722)371:2<208::AID-CNE2>3.0.CO;2-6; Meyer AC, 2009, NAT NEUROSCI, V12, P444, DOI 10.1038/nn.2293; Morata TC, 2007, INT J AUDIOL, V46, P111, DOI 10.1080/14992020601103079; Moser T, 2006, J PHYSIOL-LONDON, V576, P55, DOI 10.1113/jphysiol.2006.114835; NADOL JB, 1990, HEARING RES, V49, P141, DOI 10.1016/0378-5955(90)90101-T; Ohlemiller KK, 2000, HEARING RES, V149, P239, DOI 10.1016/S0378-5955(00)00191-X; OTA CY, 1980, ACTA OTO-LARYNGOL, V89, P53, DOI 10.3109/00016488009127108; Parham K, 1999, HEARING RES, V134, P29, DOI 10.1016/S0378-5955(99)00059-3; Patel M, 2013, NEUROSCIENCE, V248, P1, DOI 10.1016/j.neuroscience.2013.05.038; Plack CJ, 2014, TRENDS HEAR, V18, DOI 10.1177/2331216514550621; Portnuff CDF, 2011, J AM ACAD AUDIOL, V22, P663, DOI 10.3766/jaaa.22.10.5; PRICE GR, 1976, J ACOUST SOC AM, V60, P886, DOI 10.1121/1.381169; PUEL JL, 1995, CR ACAD SCI III-VIE, V318, P67; PUEL JL, 1994, J COMP NEUROL, V341, P241, DOI 10.1002/cne.903410209; PUEL JL, 1991, NEUROSCIENCE, V45, P63, DOI 10.1016/0306-4522(91)90103-U; Puel JL, 1998, NEUROREPORT, V9, P2109, DOI 10.1097/00001756-199806220-00037; PUJOL R, 1985, HEARING RES, V18, P145, DOI 10.1016/0378-5955(85)90006-1; PUJOL R, 1993, ACTA OTO-LARYNGOL, V113, P330, DOI 10.3109/00016489309135819; RANDALL RD, 1992, J NEUROSCI, V12, P1882; Rattay F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079256; ROBERTSON D, 1982, HEARING RES, V7, P55, DOI 10.1016/0378-5955(82)90081-8; ROBERTSON D, 1983, HEARING RES, V9, P263, DOI 10.1016/0378-5955(83)90031-X; SAUNDERS JC, 1982, ENVIRON HEALTH PERSP, V44, P63, DOI 10.2307/3429477; Schaette R, 2011, J NEUROSCI, V31, P13452, DOI 10.1523/JNEUROSCI.2156-11.2011; Sergeyenko Y, 2013, J NEUROSCI, V33, P13686, DOI 10.1523/JNEUROSCI.1783-13.2013; Skinner LJ, 2003, J NEUROPHYSIOL, V90, P320, DOI 10.1152/jn.01155.2002; SPOENDLIN H, 1971, ACTA OTO-LARYNGOL, V71, P166, DOI 10.3109/00016487109125346; Stamataki S, 2006, HEARING RES, V221, P104, DOI 10.1016/j.heares.2006.07.014; Stamper GC, 2015, EAR HEARING, V36, P172, DOI 10.1097/AUD.0000000000000107; Subramanian J, 2011, J NEUROSCI, V31, P4755, DOI 10.1523/JNEUROSCI.6594-10.2011; Varghese GI, 2005, HEARING RES, V209, P60, DOI 10.1016/j.heares.2005.06.006; Verbeek JH, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006396.pub3; Wang Y, 2002, JARO, V3, P248, DOI 10.1007/s101620020028; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Yang X, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.3.031104; Zhang SY, 1999, J NEUROPHYSIOL, V82, P3307, DOI 10.1152/jn.1999.82.6.3307	66	59	62	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0125160	10.1371/journal.pone.0125160	http://dx.doi.org/10.1371/journal.pone.0125160			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955832	Green Submitted, gold, Green Published			2022-12-26	WOS:000356768100045
J	Lee, SH; Kim, YJ; Lee, HJ; Kim, HY; Kang, YA; Park, MS; Kim, YS; Kim, SK; Chang, J; Jung, JY				Lee, Sang Hoon; Kim, Young Jae; Lee, Hye Jeong; Kim, Hee Yeong; Kang, Young Ae; Park, Moo Suk; Kim, Young Sam; Kim, Se Kyu; Chang, Joon; Jung, Ji Ye			Comparison of CT-Determined Pulmonary Artery Diameter, Aortic Diameter, and Their Ratio in Healthy and Diverse Clinical Conditions	PLOS ONE			English	Article							CARDIAC COMPUTED-TOMOGRAPHY; REFERENCE VALUES; HYPERTENSION; ENLARGEMENT; AGE	Background The main pulmonary artery diameter (mPA), aortic diameter (Ao), and the mPA/Ao ratio, easily measured using chest computed tomography (CT), provide information that enables the diagnosis and evaluation of cardiopulmonary diseases. Here, we used CT to determine the sex-and age-specific distribution of normal reference values for mPA, Ao, and mPA/Ao ratio in an adult Korean population. Methods Data from non-contrast, ECG-gated, coronary-calcium-scoring CT images of 2,547 individuals who visited the Health Screening Center of the Severance Hospital were analyzed. Healthy individuals (n = 813) included those who do not have hypertension, diabetes, asthma, obstructive lung disease, ischemic heart disease, stroke, smoking, obesity, and abnormal CT findings. Both mPA and Ao were measured at the level of bifurcation of the main pulmonary artery. Results The mean mPA and Ao were 25.9 mm and 30.0 mm in healthy participants, respectively, while the mean mPA/Ao ratio was 0.87. Medical conditions associated with a larger mPA were male, obesity, smoking history, hypertension, and diabetes. A larger mPA/Ao ratio was associated with female, the obese, non-smoker, normotensive, and normal serum level of lipids, while a smaller mPA/Ao ratio was associated with older age. In healthy individuals, the 90th percentile sex-specific mPA, Ao, and mPA/Ao ratio were, 31.3 mm (95% CI 29.9-32.2), 36.8 mm (95% CI 35.7-37.5), and 1.05 (95% CI 0.99-1.07) in males, and 29.6 mm (95% CI 29.1-30.2), 34.5 mm (95% CI 34.1-34.9), and 1.03 (95% CI 1.02-1.06) in females, respectively. Conclusion In the Korean population, the mean mPA reference values in male and female were 26.5 mm and 25.8 mm, respectively, while the mean mPA/Ao ratio was 0.87. These values were influenced by a variety of underlying medical conditions.	[Lee, Sang Hoon; Kim, Young Jae; Kang, Young Ae; Park, Moo Suk; Kim, Young Sam; Kim, Se Kyu; Chang, Joon; Jung, Ji Ye] Yonsei Univ, Coll Med, Severance Hosp, Inst Chest Dis,Dept Internal Med,Div Pulmonol, Seoul, South Korea; [Lee, Hye Jeong] Yonsei Univ, Coll Med, Severance Hosp, Dept Radiol, Seoul, South Korea; [Kim, Hee Yeong] Hallym Univ, Kangnam Sacred Heart Hosp, Coll Med, Dept Radiol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Hallym University	Jung, JY (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Inst Chest Dis,Dept Internal Med,Div Pulmonol, Seoul, South Korea.	stopyes@yuhs.ac	Jung, Ji Ye/AAB-4993-2021	Kim, Young Sam/0000-0001-9656-8482; Lee, Hye-Jeong/0000-0003-4349-9174; Chang, Joon/0000-0003-4542-6841; Park, Moo Suk/0000-0003-0820-7615; Kang, Young Ae/0000-0002-7783-5271; Jung, Ji Ye/0000-0003-1589-4142				Blum A, 2014, EUR J INTERN MED, V25, P370, DOI 10.1016/j.ejim.2013.03.017; Chaouat A, 2008, EUR RESPIR J, V32, P1371, DOI 10.1183/09031936.00015608; Edwards PD, 1998, BRIT J RADIOL, V71, P1018, DOI 10.1259/bjr.71.850.10211060; Iyer AS, 2014, CHEST, V145, P824, DOI 10.1378/chest.13-1422; Karazincir S, 2008, DIAGN INTERV RADIOL, V14, P72; KURIYAMA K, 1984, INVEST RADIOL, V19, P16, DOI 10.1097/00004424-198401000-00005; Lange TJ, 2013, PULM CIRC, V3, P363, DOI 10.4103/2045-8932.113175; Lin FY, 2009, ACAD RADIOL, V16, P981, DOI 10.1016/j.acra.2009.02.013; Mahammedi A, 2013, J THORAC IMAG, V28, P96, DOI 10.1097/RTI.0b013e318271c2eb; Mao SS, 2008, ACAD RADIOL, V15, P827, DOI 10.1016/j.acra.2008.02.001; Matsushita S, 2014, CLIN IMAG, V38, P454, DOI 10.1016/j.clinimag.2014.02.004; Nakanishi R, 2013, AM J CARDIOL, V111, P1259, DOI 10.1016/j.amjcard.2013.01.266; Ng CS, 1999, J THORAC IMAG, V14, P270, DOI 10.1097/00005382-199910000-00007; Rogers IS, 2013, AM J CARDIOL, V111, P1510, DOI 10.1016/j.amjcard.2013.01.306; Tan RT, 1998, CHEST, V113, P1250, DOI 10.1378/chest.113.5.1250; Truong QA, 2012, CIRC-CARDIOVASC IMAG, V5, P147, DOI 10.1161/CIRCIMAGING.111.968610; Wells JM, 2012, NEW ENGL J MED, V367, P913, DOI 10.1056/NEJMoa1203830; Wolak A, 2008, JACC-CARDIOVASC IMAG, V1, P200, DOI 10.1016/j.jcmg.2007.11.005	18	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0126646	10.1371/journal.pone.0126646	http://dx.doi.org/10.1371/journal.pone.0126646			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955036	gold, Green Published, Green Submitted			2022-12-26	WOS:000356768100136
J	Nishioka, C; Ikezoe, T; Yang, J; Yokoyama, A				Nishioka, Chie; Ikezoe, Takayuki; Yang, Jing; Yokoyama, Akihito			Tetraspanin Family Member, CD82, Regulates Expression of EZH2 via Inactivation of p38 MAPK Signaling in Leukemia Cells	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASE EZH2; CPG ISLAND HYPERMETHYLATION; STEM-CELLS; SOMATIC MUTATIONS; MYELOID-LEUKEMIA; TUMOR-SUPPRESSOR; OXIDATIVE STRESS; GENE EZH2; LYSINE 27; INHIBITION	Purpose We recently found that the tetraspanin family member, CD82, which is aberrantly expressed in chemotherapy-resistant CD34(+)/CD38(-) acute myelogenous leukemia ( AML) cells, negatively regulates matrix metalloproteinase 9, and plays an important role in enabling CD34(+)/CD38(-) AML cells to adhere to the bone marrow microenvironment. This study explored novel functions of CD82 that contribute to AML progression. Materials and Methods We employed microarray analysis comparing the gene expression profiles between CD34+/ CD38(-) AML cells transduced with CD82 shRNA and CD34(+)/CD38(-) AML cells transduced with control shRNA. Real-time RT-PCR and western blot analysis were performed to examine the effect of CD82 knockdown on the expression of the polycomb group member, enhancer of zeste homolog 2 (EZH2), in leukemia cells. A chromatin immunoprecipitation assay was performed to examine the effect of CD82 expression on the amount of EZH2 bound to the promoter regions of tumor suppressor genes in leukemia cells. We also utilized methylation-specific PCR to examine whether CD82 expression influences the methylation status of the tumor suppressor gene promoter regions in leukemia cells. Results Microarray analysis revealed that levels of EZH2 decreased after shRNA-mediated depletion of CD82 in CD34(+)/CD38(-) AML cells. Moreover, the antibody-mediated blockade of CD82 in leukemia cells lowered EZH2 expression via activation of p38 MAPK signaling, decreased the amount of EZH2 bound to the promoter regions of the tumor suppressor genes, and inhibited histone H3 lysine 27 trimethylation in these promoter regions, resulting in upregulation of the tumor suppressors at both the mRNA and protein levels.	[Nishioka, Chie; Ikezoe, Takayuki; Yokoyama, Akihito] Kochi Univ, Kochi Med Sch, Dept Hematol & Resp Med immunol, Nankoku, Kochi 7838505, Japan; [Yang, Jing] Kochi Univ, Kochi Med Sch, Dept Immunol, Nankoku, Kochi 7838505, Japan	Kochi University; Kochi University	Ikezoe, T (corresponding author), Kochi Univ, Kochi Med Sch, Dept Hematol & Resp Med immunol, Nankoku, Kochi 7838505, Japan.	ikezoet@kochi-u.ac.jp			Takeda Science Foundation; JSPS KAKENHI [14446690]	Takeda Science Foundation(Takeda Science Foundation (TSF)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant from the Takeda Science Foundation (http://www.takeda-sci.or.jp/ to CN) and JSPS KAKENHI Grant Number 14446690 (http://www.jsps.go.jp/j-grantsinaid/ CN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg T, 2014, BLOOD, V123, P3914, DOI 10.1182/blood-2012-12-473439; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Cakouros D, 2012, MOL CELL BIOL, V32, P1433, DOI 10.1128/MCB.06315-11; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chen SA, 2010, NAT CELL BIOL, V12, P1108, DOI 10.1038/ncb2116; Cheong JW, 2013, BRIT J HAEMATOL, V122, P454; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Delgado-Olguin P, 2014, DEVELOPMENT, V141, P4610, DOI 10.1242/dev.112607; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Duarte S, 2012, AM J TRANSPLANT, V12, P2689, DOI 10.1111/j.1600-6143.2012.04161.x; Esteller M, 2001, CANCER RES, V61, P3225; Geest CR, 2009, J LEUKOCYTE BIOL, V86, P237, DOI 10.1189/jlb.0209097; Hemler ME, 2001, J CELL BIOL, V155, P1103, DOI 10.1083/jcb.200108061; Hua WF, 2010, EUR J PHARMACOL, V637, P16, DOI 10.1016/j.ejphar.2010.03.051; Ikezoe T, 2004, BLOOD, V104, P237, DOI 10.1182/blood-2003-07-2203; Ikezoe T, 2011, INT J CANCER, V128, P2317, DOI 10.1002/ijc.25806; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Jacamo R, 2014, BLOOD, V123, P2691, DOI 10.1182/blood-2013-06-511527; Jankowska AM, 2011, BLOOD, V118, P3932, DOI 10.1182/blood-2010-10-311019; Khan SN, 2013, LEUKEMIA, V27, P1301, DOI 10.1038/leu.2013.80; Konuma T, 2010, DEV GROWTH DIFFER, V52, P505, DOI 10.1111/j.1440-169X.2010.01191.x; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Kwong J, 2009, J BIOL CHEM, V284, P11237, DOI 10.1074/jbc.M808327200; Lee S, 2004, LAB INVEST, V84, P884, DOI 10.1038/labinvest.3700108; Liggett WH, 1998, J CLIN ONCOL, V16, P1197, DOI 10.1200/JCO.1998.16.3.1197; Lind GE, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-28; Maecker HT, 1997, FASEB J, V11, P428, DOI 10.1096/fasebj.11.6.9194523; Matsuo Y, 1997, LEUKEMIA, V11, P1469, DOI 10.1038/sj.leu.2400768; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Nakayama K, 2012, INT J MOL SCI, V13, P11705, DOI 10.3390/ijms130911705; Nikoloski G, 2010, NAT GENET, V42, P665, DOI 10.1038/ng.620; Nishioka C, 2011, BLOOD CANCER J, V1, DOI 10.1038/bcj.2011.33; Nishioka C, 2010, LEUKEMIA, V24, P1631, DOI 10.1038/leu.2010.145; Nishioka C, 2014, INT J CANCER, V134, P55, DOI 10.1002/ijc.28348; Nishioka C, 2013, INT J CANCER, V132, P2006, DOI 10.1002/ijc.27904; Ohtani Naoko, 2004, J Med Invest, V51, P146, DOI 10.2152/jmi.51.146; Peng C, 2010, BLOOD, V115, P626, DOI 10.1182/blood-2009-06-228130; Sahasrabuddhe AA, 2015, ONCOGENE, V34, P445, DOI 10.1038/onc.2013.571; Sneeringer CJ, 2010, P NATL ACAD SCI USA, V107, P20980, DOI 10.1073/pnas.1012525107; Stipp CS, 2003, TRENDS BIOCHEM SCI, V28, P106, DOI 10.1016/S0968-0004(02)00014-2; Su YC, 2012, HEMATOLOGY, V17, P41, DOI 10.1179/102453312X13221316477624; Tam WF, 2013, CANCER RES, V73, P373, DOI 10.1158/0008-5472.CAN-12-0255; Tanaka S, 2012, BLOOD, V120, P1107, DOI 10.1182/blood-2011-11-394932; Ueda K, 2014, CANCER SCI, V105, P512, DOI 10.1111/cas.12386; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Wang XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061341; Wang Y, 2011, RADIAT RES, V176, P743, DOI 10.1667/RR2727.1; Xiao Y, 2012, J HUAZHONG U SCI-MED, V32, P328, DOI 10.1007/s11596-012-0057-z; Xu F, 2012, EXPERT REV HEMATOL, V5, P177, DOI [10.1586/EHM.12.5, 10.1586/ehm.12.5]; Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zhang YM, 2009, FASEB J, V23, P1358, DOI 10.1096/fj.08-110296; Zou J, 2012, ANN HEMATOL, V91, P813, DOI 10.1007/s00277-011-1397-7	56	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0125017	10.1371/journal.pone.0125017	http://dx.doi.org/10.1371/journal.pone.0125017			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955299	Green Submitted, Green Published, gold			2022-12-26	WOS:000356768100040
J	Winkelmann, A; You, XT; Grunewald, N; Haussler, U; Krestel, H; Haas, CA; Schwarz, G; Chen, W; Meier, JC				Winkelmann, Aline; You, Xiantian; Gruenewald, Nora; Haeussler, Ute; Krestel, Heinz; Haas, Carola A.; Schwarz, Guenter; Chen, Wei; Meier, Jochen C.			Identification of a New Genomic Hot Spot of Evolutionary Diversification of Protein Function	PLOS ONE			English	Article							GLYCINE RECEPTOR ALPHA-3; DIRECT BINDING; INHIBITORY SYNAPSES; GEPHYRIN; GENE; ACCUMULATION; ALIGNMENT; SUBUNITS	Establishment of phylogenetic relationships remains a challenging task because it is based on computational analysis of genomic hot spots that display species-specific sequence variations. Here, we identify a species-specific thymine-to-guanine sequence variation in the Glrb gene which gives rise to species-specific splice donor sites in the Glrb genes of mouse and bushbaby. The resulting splice insert in the receptor for the inhibitory neurotransmitter glycine (GlyR) conveys synaptic receptor clustering and specific association with a particular synaptic plasticity-related splice variant of the postsynaptic scaffold protein gephyrin. This study identifies a new genomic hot spot which contributes to phylogenetic diversification of protein function and advances our understanding of phylogenetic relationships.	[Winkelmann, Aline; Meier, Jochen C.] Max Delbruck Ctr Mol Med, RNA Editing & Hyperexcitabil Disorders Grp, Berlin, Germany; [You, Xiantian; Chen, Wei] Max Delbruck Ctr Mol Med, Lab Funct & Med Genom, Berlin, Germany; [Gruenewald, Nora; Schwarz, Guenter] Univ Cologne, Dept Biochem, D-50931 Cologne, Germany; [Gruenewald, Nora; Schwarz, Guenter] Ctr Mol Med, Cologne, Germany; [Haeussler, Ute; Haas, Carola A.] Univ Freiburg, Dept Neurosurg, D-79106 Freiburg, Germany; [Krestel, Heinz] Univ Hosp Bern, Dept Neurol, CH-3010 Bern, Switzerland; [Meier, Jochen C.] TU Braunschweig, Div Cell Physiol, Inst Zool, Dept Life Sci, Braunschweig, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Cologne; University of Cologne; University of Freiburg; University of Bern; University Hospital of Bern; Braunschweig University of Technology	Meier, JC (corresponding author), Max Delbruck Ctr Mol Med, RNA Editing & Hyperexcitabil Disorders Grp, Berlin, Germany.	jochen.meier@mdc-berlin.de	Häussler, Ute/GPF-8944-2022; Schwarz, Guenter/ABE-9643-2021	Schwarz, Guenter/0000-0002-2118-9338; Haussler, Ute/0000-0001-5601-9833; Meier, Jochen/0000-0001-5574-3336; Krestel, Heinz Eric/0000-0001-8742-0232; YOU, Xintian/0000-0002-1684-7084	Bundesministerium fur Bildung und Forschung BMBF [CIPRESS]; Helmholtz Association [VH-NG-246]	Bundesministerium fur Bildung und Forschung BMBF(Federal Ministry of Education & Research (BMBF)); Helmholtz Association(Helmholtz Association)	This work was funded by Bundesministerium fur Bildung und Forschung BMBF, grant No. CIPRESS (http://www.neuron-eranet.eu/en/317.php); and Helmholtz Association, grant No. VH-NG-246 (http://www.helmholtz.de/en/home). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedet C, 2006, J BIOL CHEM, V281, P30046, DOI 10.1074/jbc.M602155200; BREWER GJ, 1989, BRAIN RES, V494, P65, DOI 10.1016/0006-8993(89)90144-3; Buzsaki G, 2001, NEUROCHEM RES, V26, P899, DOI 10.1023/A:1012324231897; Callister RJ, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/fnmol.2010.00013; Dillman AA, 2013, NAT NEUROSCI, V16, P499, DOI 10.1038/nn.3332; Dugladze T, 2013, P NATL ACAD SCI USA, V110, P15073, DOI 10.1073/pnas.1313505110; Eichler SA, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.002.2008; Eichler SA, 2009, EUR J NEUROSCI, V30, P1077, DOI 10.1111/j.1460-9568.2009.06903.x; Forstera B, 2014, J CELL SCI, V127, P3687, DOI 10.1242/jcs.146662; Forstera B, 2010, BRAIN, V133, P3778, DOI 10.1093/brain/awq298; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kowalczyk S, 2013, EUR J NEUROSCI, V37, P544, DOI 10.1111/ejn.12078; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Meier J, 2000, MOL CELL NEUROSCI, V16, P566, DOI 10.1006/mcne.2000.0899; Meier J, 2000, J CELL SCI, V113, P2783; Meier J, 2004, J PHYSIOL-LONDON, V559, P355, DOI 10.1113/jphysiol.2004.066233; Meier J, 2004, J NEUROSCI, V24, P1398, DOI 10.1523/JNEUROSCI.4260-03.2004; Meier J, 2001, NAT NEUROSCI, V4, P253, DOI 10.1038/85099; Meier J, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00164; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; Miller W, 2007, GENOME RES, V17, P1797, DOI 10.1101/gr.6761107; Mukherjee J, 2011, J NEUROSCI, V31, P14677, DOI 10.1523/JNEUROSCI.2001-11.2011; Notelaers K, 2014, HISTOCHEM CELL BIOL, V142, P79, DOI 10.1007/s00418-014-1197-y; Notelaers K, 2014, BBA-MOL CELL RES, V1843, P544, DOI 10.1016/j.bbamcr.2013.11.019; Notelaers K, 2012, BBA-BIOMEMBRANES, V1818, P3131, DOI 10.1016/j.bbamem.2012.08.010; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Smolinsky B, 2008, J BIOL CHEM, V283, P17370, DOI 10.1074/jbc.M800985200; Tamura K, 2002, MOL BIOL EVOL, V19, P1727, DOI 10.1093/oxfordjournals.molbev.a003995; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tretter V, 2008, J NEUROSCI, V28, P1356, DOI 10.1523/JNEUROSCI.5050-07.2008; Tretter V, 2011, J BIOL CHEM, V286, P37702, DOI 10.1074/jbc.M111.291336; Tyagarajan SK, 2014, NAT REV NEUROSCI, V15, P141, DOI 10.1038/nrn3670; Winkelmann A, 2014, J CLIN INVEST, V124, P696, DOI 10.1172/JCI71472; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418	37	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0125413	10.1371/journal.pone.0125413	http://dx.doi.org/10.1371/journal.pone.0125413			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955356	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000356768100052
J	Tatsumi, N; Hojo, N; Yamada, O; Ogawa, M; Katsura, Y; Kawata, S; Morii, E; Sakamoto, H; Inaba, R; Tsuda, A; Fukuda, I; Moriguchi, N; Hasuwa, H; Okabe, M; Fujiki, F; Nishida, S; Nakajima, H; Tsuboi, A; Oka, Y; Hosen, N; Sugiyama, H; Oji, Y				Tatsumi, N.; Hojo, N.; Yamada, O.; Ogawa, M.; Katsura, Y.; Kawata, S.; Morii, E.; Sakamoto, H.; Inaba, R.; Tsuda, A.; Fukuda, I.; Moriguchi, N.; Hasuwa, H.; Okabe, M.; Fujiki, F.; Nishida, S.; Nakajima, H.; Tsuboi, A.; Oka, Y.; Hosen, N.; Sugiyama, H.; Oji, Y.			Deficiency in WT1-targeting microRNA-125a leads to myeloid malignancies and urogenital abnormalities	ONCOGENE			English	Article							WILMS-TUMOR GENE; SUPPRESSOR GENE; LEUKEMIC-CELLS; TRANSCRIPTION FACTOR; PROGENITOR CELLS; BINDING-SITES; SOLID TUMORS; WT1 PROTEIN; EXPRESSION; OVEREXPRESSION	The Wilms' tumor gene WT1 is overexpressed in leukemia and solid tumors and has an oncogenic role in leukemogenesis and tumorigenesis. However, precise regulatory mechanisms of WT1 overexpression remain undetermined. In the present study, microRNA-125a (miR-125a) was identified as a miRNA that suppressed WT1 expression via binding to the WT1-3'UTR. MiR-125a knockout mice overexpressed WT1, developed myeloproliferative disorder (MPD) characterized by expansion of myeloid cells in bone marrow (BM), spleen and peripheral blood, and displayed urogenital abnormalities. Silencing of WT1 expression in hematopoietic stem/progenitor cells of miR-125a knockout MPD mice by short-hairpin RNA inhibited myeloid colony formation in vitro. Furthermore, the incidence and severity of MPD were lower in miR-125a (-/-) mice than in miR-125a (+/-) mice, indicating the operation of compensatory mechanisms for the complete loss of miR-125a. To elucidate the compensatory mechanisms, miRNA array was performed. MiR-486 was occasionally induced in compete loss of miR-125a and inhibited WT1 expression instead of miR-125a, resulting in the cancellation of MPD occurrence. These results showed for the first time the post-transcriptional regulatory mechanisms of WT1 by both miR-125a and miR-486 and should contribute to the elucidation of mechanisms of normal hematopoiesis and kidney development.	[Tatsumi, N.; Hojo, N.; Yamada, O.; Ogawa, M.; Katsura, Y.; Kawata, S.; Sakamoto, H.; Inaba, R.; Tsuda, A.; Fukuda, I.; Moriguchi, N.; Sugiyama, H.] Osaka Univ, Grad Sch Med, Dept Funct Diagnost Sci, Yamada Oka 1-7, Suita, Osaka 5650871, Japan; [Morii, E.] Osaka Univ, Grad Sch Med, Dept Pathol, Suita, Osaka 5650871, Japan; [Hasuwa, H.; Okabe, M.] Osaka Univ, Res Inst Microbial Dis, Suita, Osaka 5650871, Japan; [Fujiki, F.; Nakajima, H.; Oka, Y.] Osaka Univ, Grad Sch Med, Dept Canc Immunol, Suita, Osaka 5650871, Japan; [Nishida, S.] Osaka Univ, Grad Sch Med, Dept Resp Med Immunol & Allergy, Suita, Osaka 5650871, Japan; [Tsuboi, A.] Osaka Univ, Grad Sch Med, Dept Canc Immunotherapy, Suita, Osaka 5650871, Japan; [Hosen, N.; Oji, Y.] Osaka Univ, Grad Sch Med, Dept Canc Stem Cell Biol, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University; Osaka University; Osaka University; Osaka University; Osaka University	Tatsumi, N (corresponding author), Osaka Univ, Grad Sch Med, Dept Funct Diagnost Sci, Yamada Oka 1-7, Suita, Osaka 5650871, Japan.	tatsumi@cit.med.osaka-u.ac.jp			Ministry of Education, Science, Sports, Culture and Technology, Japan; Ministry of Health, Labour, and Welfare, Japan	Ministry of Education, Science, Sports, Culture and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by a Grant-in-Aid from the Ministry of Education, Science, Sports, Culture and Technology, Japan, and the Ministry of Health, Labour, and Welfare, Japan. We thank Yoko Esaki and Saki Nishioka of NPO Biotechnology Research and Development for technical assistance.	Alberta JA, 2003, BLOOD, V101, P2570, DOI 10.1182/blood-2002-06-1656; Alemdehy MF, 2012, CELL CYCLE, V11, P2799, DOI 10.4161/cc.21077; Algar EM, 1996, ONCOGENE, V12, P1005; Bao JQ, 2012, J BIOL CHEM, V287, P21686, DOI 10.1074/jbc.M111.328054; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; Chau YY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002404; Cohen HT, 1997, J BIOL CHEM, V272, P2901, DOI 10.1074/jbc.272.5.2901; Dehbi M, 1996, ONCOGENE, V13, P447; Dehbi M, 1996, EMBO J, V15, P4297, DOI 10.1002/j.1460-2075.1996.tb00804.x; Discenza MT, 2004, FEBS LETT, V560, P183, DOI 10.1016/S0014-5793(04)00104-8; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; Downing JR, 2003, CURR OPIN GENET DEV, V13, P48, DOI 10.1016/S0959-437X(02)00018-7; Funakoshi-Tago M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052844; Gao F, 2006, P NATL ACAD SCI USA, V103, P11987, DOI 10.1073/pnas.0600994103; Gao SM, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-110; Gebeshuber CA, 2013, NAT MED, V19, P481, DOI 10.1038/nm.3142; Guo SQ, 2010, P NATL ACAD SCI USA, V107, P14229, DOI 10.1073/pnas.0913574107; Han YQ, 2004, ONCOGENE, V23, P6933, DOI 10.1038/sj.onc.1207609; Harada Y, 1999, MOL UROL, V3, P357; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Hosen N, 2002, BRIT J HAEMATOL, V116, P409, DOI 10.1046/j.1365-2141.2002.03261.x; INOUE K, 1994, BLOOD, V84, P3071, DOI 10.1182/blood.V84.9.3071.3071; Ito K, 2006, ONCOGENE, V25, P4217, DOI 10.1038/sj.onc.1209455; Jomgeow T, 2006, CANCER SCI, V97, P259, DOI 10.1111/j.1349-7006.2006.00169.x; Kanato K, 2005, BIOCHEM BIOPH RES CO, V326, P836, DOI 10.1016/j.bbrc.2004.11.107; Klein U, 2010, CANCER CELL, V17, P28, DOI 10.1016/j.ccr.2009.11.019; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Loeb DM, 2001, CANCER RES, V61, P921; Manikandan M, 2014, OMICS, V18, P142, DOI 10.1089/omi.2013.0098; Martinez-Estrada OM, 2010, NAT GENET, V42, P89, DOI 10.1038/ng.494; Mayo MW, 1999, EMBO J, V18, P3990, DOI 10.1093/emboj/18.14.3990; Miyoshi Y, 2002, CLIN CANCER RES, V8, P1167; Moore AW, 1999, DEVELOPMENT, V126, P1845; Moshier JA, 1996, NUCLEIC ACIDS RES, V24, P1149, DOI 10.1093/nar/24.6.1149; Nishida S, 2006, BLOOD, V107, P3303, DOI 10.1182/blood-2005-04-1656; Oji Y, 1999, JPN J CANCER RES, V90, P194, DOI 10.1111/j.1349-7006.1999.tb00733.x; Oji Y, 2002, INT J CANCER, V100, P297, DOI 10.1002/ijc.10476; Oji Y, 2004, CANCER SCI, V95, P822, DOI 10.1111/j.1349-7006.2004.tb02188.x; Oji Y, 2004, ANTICANCER RES, V24, P3103; Oji Y, 2004, CANCER SCI, V95, P583, DOI 10.1111/j.1349-7006.2004.tb02490.x; Oji Y, 2003, CANCER SCI, V94, P712, DOI 10.1111/j.1349-7006.2003.tb01507.x; Oji Y, 2003, CANCER SCI, V94, P606, DOI 10.1111/j.1349-7006.2003.tb01490.x; Oji Y, 2003, CANCER SCI, V94, P523, DOI 10.1111/j.1349-7006.2003.tb01477.x; Perez-Pomares JM, 2002, DEV BIOL, V247, P307, DOI 10.1006/dbio.2002.0706; Preskill Carina, 2013, Critical Reviews in Oncogenesis, V18, P327; Reavie L, 2013, CANCER CELL, V23, P362, DOI 10.1016/j.ccr.2013.01.025; Roberts SGE, 2005, CURR OPIN GENET DEV, V15, P542, DOI 10.1016/j.gde.2005.08.004; Scharnhorst V, 2001, GENE, V273, P141, DOI 10.1016/S0378-1119(01)00593-5; SHARMA PM, 1994, GENE DEV, V8, P720, DOI 10.1101/gad.8.6.720; Sotobori T, 2006, CANCER-AM CANCER SOC, V106, P2233, DOI 10.1002/cncr.21861; Tatsumi N, 2008, INT J ONCOL, V32, P701; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Vidovic K, 2010, LEUKEMIA, V24, P992, DOI 10.1038/leu.2010.33; Wagner KD, 2002, EMBO J, V21, P1398, DOI 10.1093/emboj/21.6.1398; Wu S, 2010, ONCOGENE, V29, P2302, DOI 10.1038/onc.2010.34; Yamagami T, 1998, LEUKEMIA RES, V22, P383, DOI 10.1016/S0145-2126(97)00176-8; Zhang XH, 1997, J BIOL CHEM, V272, P29272, DOI 10.1074/jbc.272.46.29272; Zhao X, 2010, ARTHRITIS RHEUM-US, V62, P3425, DOI 10.1002/art.27632	59	12	13	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 25	2016	35	8					1003	1014		10.1038/onc.2015.154	http://dx.doi.org/10.1038/onc.2015.154			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DE7NF	25961914				2022-12-26	WOS:000370823300006
J	Trono, P; Di Modugno, F; Circo, R; Spada, S; Di Benedetto, A; Melchionna, R; Palermo, B; Matteoni, S; Soddu, S; Mottolese, M; De Maria, R; Nistio, P				Trono, P.; Di Modugno, F.; Circo, R.; Spada, S.; Di Benedetto, A.; Melchionna, R.; Palermo, B.; Matteoni, S.; Soddu, S.; Mottolese, M.; De Maria, R.; Nistio, P.			hMENA(11a) contributes to HER3-mediated resistance to PI3K inhibitors in HER2-overexpressing breast cancer cells	ONCOGENE			English	Article							UP-REGULATION; TUMOR CELLS; MENA; GROWTH; PROTEIN; EXPRESSION; 3-KINASE; ACTIN; ENAH; BIM	Human Mena (hMENA), an actin regulatory protein of the ENA/VASP family, cooperates with ErbB receptor family signaling in breast cancer. It is overexpressed in high-risk preneoplastic lesions and in primary breast tumors where it correlates with HER2 overexpression and an activated status of AKT and MAPK. The concomitant overexpression of hMENA and HER2 in breast cancer patients is indicative of a worse prognosis. hMENA is expressed along with alternatively expressed isoforms, hMENA(11a) and hMENA Delta v6 with opposite functions. A novel role for the epithelial-associated hMENA(11a) isoform in sustaining HER3 activation and pro-survival pathways in HER2-overexpressing breast cancer cells has been identified by reverse phase protein array and validated in vivo in a series of breast cancer tissues. As HER3 activation is crucial in mechanisms of cell resistance to PI3K inhibitors, we explored whether hMENA(11a) is involved in these resistance mechanisms. The specific hMENA(11a) depletion switched off the HER3r-elated pathway activated by PI3K inhibitors and impaired the nuclear accumulation of HER3 transcription factor FOXO3a induced by PI3K inhibitors, whereas PI3K inhibitors activated hMENA(11a) phosphorylation and affected its localization. At the functional level, we found that hMENA(11a) sustains cell proliferation and survival in response to PI3K inhibitor treatment, whereas hMENA(11a) silencing increases molecules involved in cancer cell apoptosis. As shown in three-dimensional cultures, hMENA(11a) contributes to resistance to PI3K inhibition because its depletion drastically reduced cell viability upon treatment with PI3K inhibitor BEZ235. Altogether, these results indicate that hMENA(11a) in HER2-overexpressing breast cancer cells sustains HER3/AKT axis activation and contributes to HER3-mediated resistance mechanisms to PI3K inhibitors. Thus, hMENA(11a) expression can be proposed as a marker of HER3 activation and resistance to PI3K inhibition therapies, to select patients who may benefit from these combined targeted treatments. hMENA(11a) activity could represent a new target for antiproliferative therapies in breast cancer.	[Trono, P.; Di Modugno, F.; Spada, S.; Melchionna, R.; Palermo, B.; Nistio, P.] Regina Elena Inst Canc Res, Lab Immunol, Expt Oncol, Rome, Italy; [Circo, R.] Ist Super Sanita, Dept Hematol Oncol & Mol Med, Viale Regina Elena 299, I-00161 Rome, Italy; [Spada, S.; Palermo, B.] Univ Rome, Dept Mol Med, Rome, Italy; [Di Benedetto, A.; Mottolese, M.] Regina Elena Inst Canc Res, Dept Pathol, Rome, Italy; [Matteoni, S.; Soddu, S.] Regina Elena Inst Canc Res, Expt Oncol, Rome, Italy; [De Maria, R.] Regina Elena Inst Canc Res, Sci Direct, Rome, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Istituto Superiore di Sanita (ISS); Sapienza University Rome; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Nistio, P (corresponding author), Regina Elena Inst Canc Res, Immunol Lab, Via Elio Chianesi 53, I-00144 Rome, Italy.	nistico@ifo.it	Spada, Sheila/AAN-1520-2020; Nisticò, Paola/B-2862-2018; Matteoni, Silvia/U-7578-2017; Melchionna, Roberta/AAZ-4111-2021; De Maria, Ruggero/S-6385-2019; Di Modugno, Francesca/B-2865-2018; Di Modugno, Francesca/ABH-9406-2020; Soddu, Silvia/K-2467-2018; Soddu, Silvia/ABH-6774-2020	Nisticò, Paola/0000-0003-4409-2261; Matteoni, Silvia/0000-0001-6926-6593; Melchionna, Roberta/0000-0002-8410-9681; De Maria, Ruggero/0000-0003-2255-0583; Di Modugno, Francesca/0000-0003-1427-1883; Di Modugno, Francesca/0000-0003-1427-1883; Soddu, Silvia/0000-0001-8526-0044; Soddu, Silvia/0000-0001-8526-0044; Palermo, Belinda/0000-0001-6293-0113; Trono, Paola/0000-0002-2053-6334; Di Benedetto, Anna/0000-0002-9853-8671	Associazione Italiana per la Ricerca sul Cancro (AIRC) [12182, 9979]; IG [11631]	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); IG	We thank Dr C Rinaldo for her helpful suggestions, Dr M Panetta for her support, Dr I Terrenato for statistical analysis of data, Mrs G Falasca for technical support and Mrs MV Sarcone for secretarial assistance. This work was supported by the Associazione Italiana per la Ricerca sul Cancro (AIRC) 5x1000 Grants 12182 and 9979 and IG 11631 (to PN).	Amin DN, 2012, BIOCHEM J, V447, P417, DOI 10.1042/BJ20120724; Amin DN, 2010, SEMIN CELL DEV BIOL, V21, P944, DOI 10.1016/j.semcdb.2010.08.007; Amin DN, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000389; Andersen JN, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001065; Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; Bean GR, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003483; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; Boudreau A, 2013, P NATL ACAD SCI USA, V110, pE3937, DOI 10.1073/pnas.1315022110; Chakrabarty A, 2012, P NATL ACAD SCI USA, V109, P2718, DOI 10.1073/pnas.1018001108; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Desouza Melissa, 2012, Bioarchitecture, V2, P75; Di Modugno F, 2006, CLIN CANCER RES, V12, P1470, DOI 10.1158/1078-0432.CCR-05-2027; Di Modugno F, 2004, INT J CANCER, V109, P909, DOI 10.1002/ijc.20094; Di Modugno F, 2007, CANCER RES, V67, P2657, DOI 10.1158/0008-5472.CAN-06-1997; Di Modugno F, 2012, P NATL ACAD SCI USA, V109, P19280, DOI 10.1073/pnas.1214394109; Di Modugno F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015852; Dinkel H, 2012, NUCLEIC ACIDS RES, V40, pD242, DOI 10.1093/nar/gkr1064; Faber AC, 2011, CANCER DISCOV, V1, P352, DOI 10.1158/2159-8290.CD-11-0106; Federici G, 2013, MOL CANCER RES, V11, P676, DOI 10.1158/1541-7786.MCR-12-0690; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Gala K, 2014, CLIN CANCER RES, V20, P1410, DOI 10.1158/1078-0432.CCR-13-1549; Garrett JT, 2011, P NATL ACAD SCI USA, V108, P5021, DOI 10.1073/pnas.1016140108; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; Goswami S, 2009, CLIN EXP METASTAS, V26, P153, DOI 10.1007/s10585-008-9225-8; Hellyer NJ, 2001, J BIOL CHEM, V276, P42153, DOI 10.1074/jbc.M102079200; Hellyer NJ, 1998, BIOCHEM J, V333, P757, DOI 10.1042/bj3330757; Howes AL, 2007, MOL CANCER THER, V6, P2505, DOI 10.1158/1535-7163.MCT-06-0698; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Knowlden JM, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3018; Polo ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010786; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Morrison MM, 2013, J CLIN INVEST, V123, P4329, DOI 10.1172/JCI66764; Muranen T, 2012, CANCER CELL, V21, P227, DOI 10.1016/j.ccr.2011.12.024; NISTICO P, 1994, J CLIN INVEST, V94, P1426, DOI 10.1172/JCI117479; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Pinto Mauricio P, 2011, Front Endocrinol (Lausanne), V2, P15, DOI 10.3389/fendo.2011.00015; Rexer BN, 2013, CANCER RES, V73, P3817, DOI 10.1158/0008-5472.CAN-13-0687; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Serra V, 2011, ONCOGENE, V30, P2547, DOI 10.1038/onc.2010.626; Serra V, 2008, CANCER RES, V68, P8022, DOI 10.1158/0008-5472.CAN-08-1385; Shapiro GI, 2014, CLIN CANCER RES, V20, P233, DOI 10.1158/1078-0432.CCR-13-1777; Singh A, 2010, MOL BIOL CELL, V21, P1140, DOI 10.1091/mbc.E09-09-0795; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; Tani K, 2003, J BIOL CHEM, V278, P21685, DOI 10.1074/jbc.M301447200; Urbanelli L, 2006, BBA-GENE STRUCT EXPR, V1759, P99, DOI 10.1016/j.bbaexp.2006.01.001; Vehlow A, 2013, EMBO J, V32, P2722, DOI 10.1038/emboj.2013.212; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Weigelt B, 2014, ADV DRUG DELIVER REV, V69, P42, DOI 10.1016/j.addr.2014.01.001	50	8	8	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 18	2016	35	7					887	896		10.1038/onc.2015.143	http://dx.doi.org/10.1038/onc.2015.143			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DE0RO	25961924	Green Published			2022-12-26	WOS:000370332200009
J	Bermudez, R; Feng, YY; Roleda, MY; Tatters, AO; Hutchins, DA; Larsen, T; Boyd, PW; Hurd, CL; Riebesell, U; Winder, M				Bermudez, Rafael; Feng, Yuanyuan; Roleda, Michael Y.; Tatters, Avery O.; Hutchins, David A.; Larsen, Thomas; Boyd, Philip W.; Hurd, Catriona L.; Riebesell, Ulf; Winder, Monika			Long-Term Conditioning to Elevated pCO(2) and Warming Influences the Fatty and Amino Acid Composition of the Diatom Cylindrotheca fusiformis	PLOS ONE			English	Article							CO2 CONCENTRATION; OCEAN ACIDIFICATION; CARBON-DIOXIDE; BIOCHEMICAL-COMPOSITION; DIFFERENT TEMPERATURE; MARINE DIATOMS; CLIMATE-CHANGE; FOOD QUALITY; PHYTOPLANKTON; GROWTH	The unabated rise in anthropogenic CO2 emissions is predicted to strongly influence the ocean's environment, increasing the mean sea-surface temperature by 4 degrees C and causing a pH decline of 0.3 units by the year 2100. These changes are likely to affect the nutritional value of marine food sources since temperature and CO2 can influence the fatty (FA) and amino acid (AA) composition of marine primary producers. Here, essential amino (EA) and polyunsaturated fatty (PUFA) acids are of particular importance due to their nutritional value to higher trophic levels. In order to determine the interactive effects of CO2 and temperature on the nutritional quality of a primary producer, we analyzed the relative PUFA and EA composition of the diatom Cylindrotheca fusiformis cultured under a factorial matrix of 2 temperatures (14 and 19 degrees C) and 3 partial pressures of CO2 (180, 380, 750 mu atm) for >250 generations. Our results show a decay of similar to 3% and similar to 6% in PUFA and EA content in algae kept at a pCO(2) of 750 mu atm (high) compared to the 380 mu atm (intermediate) CO2 treatments at 14 degrees C. Cultures kept at 19 degrees C displayed a similar to 3% lower PUFA content under high compared to intermediate pCO(2), while EA did not show differences between treatments. Algae grown at a pCO(2) of 180 mu atm (low) had a lower PUFA and AA content in relation to those at intermediate and high CO2 levels at 14 degrees C, but there were no differences in EA at 19 degrees C for any CO2 treatment. This study is the first to report adverse effects of warming and acidification on the EA of a primary producer, and corroborates previous observations of negative effects of these stressors on PUFA. Considering that only similar to 20% of essential biomolecules such as PUFA (and possibly EA) are incorporated into new biomass at the next trophic level, the potential impacts of adverse effects of ocean warming and acidification at the base of the food web may be amplified towards higher trophic levels, which rely on them as source of essential biomolecules	[Bermudez, Rafael; Riebesell, Ulf] GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany; [Bermudez, Rafael] Escuela Super Politecn Litoral, Fac Ingn Maritima Ciencias Biol Ocean & Recursos, Guayaquil, Ecuador; [Feng, Yuanyuan; Roleda, Michael Y.; Hurd, Catriona L.] Univ Otago, Dept Bot, Dunedin, New Zealand; [Roleda, Michael Y.] Bioforsk Norwegian Inst Agr & Environm Res, Bodo, Norway; [Tatters, Avery O.; Hutchins, David A.] Univ So Calif, Marine & Environm Biol, Los Angeles, CA USA; [Larsen, Thomas] Univ Kiel, Leibniz Lab Radiometr Dating & Stable Isotope Res, Kiel, Germany; [Boyd, Philip W.; Hurd, Catriona L.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Winder, Monika] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Escuela Superior Politecnica del Litoral; University of Otago; Bioforsk; University of Southern California; University of Kiel; University of Tasmania; Stockholm University	Bermudez, R (corresponding author), GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany.	jrbermud@espol.edu.ec	Larsen, Thomas/D-3105-2012; Hurd, Catriona/J-2411-2013; Hutchins, David A/D-3301-2013; /AAL-3738-2021; Riebesell, Ulf/AAC-9717-2020; Tatters, Avery/V-7723-2019; Boyd, Philip W/J-7624-2014; Roleda, Michael/AAA-3820-2022; Roleda, Michael Y./H-9645-2019; Feng, Yuanyuan/K-5983-2012	Larsen, Thomas/0000-0002-0311-9707; Hurd, Catriona/0000-0001-9965-4917; Hutchins, David A/0000-0002-6637-756X; Boyd, Philip W/0000-0001-7850-1911; Roleda, Michael Y./0000-0003-0568-9081; Feng, Yuanyuan/0000-0002-4565-8717; Bermudez, Jorge Rafael/0000-0002-8109-5819; Tatters, Avery/0000-0002-5616-1044; Riebesell, Ulf/0000-0002-9442-452X	Royal Society of New Zealand Marsden grant [UOO0914]; United States National Science Foundation grant [ANT1043748]; Integrate School of Ocean Sciences (ISOS) Kiel, PhD Miniproposals scheme [D20/97.1]; Marie Curie IRG grant [276917]; German Federal Ministry of Education and Research through the 'BIOACID' programme; Directorate For Geosciences [1043748] Funding Source: National Science Foundation; Division Of Ocean Sciences [1260490] Funding Source: National Science Foundation	Royal Society of New Zealand Marsden grant(Royal Society of New ZealandMarsden Fund (NZ)); United States National Science Foundation grant; Integrate School of Ocean Sciences (ISOS) Kiel, PhD Miniproposals scheme; Marie Curie IRG grant(European Commission); German Federal Ministry of Education and Research through the 'BIOACID' programme; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Grant support was provided by the Royal Society of New Zealand Marsden grant (UOO0914) to CLH and United States National Science Foundation grant ANT1043748 to DAH. This work was partly funded by the Integrate School of Ocean Sciences (ISOS) Kiel, PhD Miniproposals scheme, project D20/97.1 to RB, Marie Curie IRG grant No 276917 to MW, and the German Federal Ministry of Education and Research through the 'BIOACID' programme to UR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo SD, 2005, AQUACULTURE, V246, P405, DOI 10.1016/j.aquaculture.2005.02.051; Arts MT, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P1, DOI 10.1007/978-0-387-89366-2; Auguie B, 2017, GRIDEXTRA MISCELLANE; Badawy AAB, 2008, AMINO ACIDS, V34, P587, DOI 10.1007/s00726-007-0012-7; Belitz D, 2009, FOOD CHEM, V34, P8; Breteler WCMK, 1999, MAR BIOL, V135, P191, DOI 10.1007/s002270050616; Burkhardt S, 2001, LIMNOL OCEANOGR, V46, P1378, DOI 10.4319/lo.2001.46.6.1378; Collins S, 2006, ECOL LETT, V9, P129, DOI 10.1111/j.1461-0248.2005.00854.x; Currie KI, 2011, BIOGEOCHEMISTRY, V104, P23, DOI 10.1007/s10533-009-9355-3; Dickson AG, 2003, MAR CHEM, V80, P185, DOI 10.1016/S0304-4203(02)00133-0; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; DUNSTAN GA, 1992, J EXP MAR BIOL ECOL, V161, P115, DOI 10.1016/0022-0981(92)90193-E; Fabry VJ, 2008, SCIENCE, V320, P1020, DOI 10.1126/science.1157130; Fink P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028498; Fiorini S, 2010, J EXP MAR BIOL ECOL, V394, P74, DOI 10.1016/j.jembe.2010.07.020; Food Agricultural Organization of the United Nations, 2010, STAT WORLD FISH AQ 2; FRASER AJ, 1989, MAR CHEM, V27, P1, DOI 10.1016/0304-4203(89)90024-8; FRASER AJ, 1989, J EXP MAR BIOL ECOL, V130, P81, DOI 10.1016/0022-0981(89)90020-8; Giordano M, 1997, PLANT PHYSIOL, V115, P1049, DOI 10.1104/pp.115.3.1049; Gladyshev MI, 2011, OECOLOGIA, V165, P521, DOI 10.1007/s00442-010-1843-6; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hare CE, 2007, MAR ECOL PROG SER, V352, P9, DOI 10.3354/meps07182; HARRISON P J, 1990, Journal of Applied Phycology, V2, P45, DOI 10.1007/BF02179768; Helland S, 2003, MAR BIOL, V142, P1141, DOI 10.1007/s00227-003-1045-4; Izquierdo MS, 2001, AQUACULTURE, V197, P25, DOI 10.1016/S0044-8486(01)00581-6; JAMES CM, 1989, AQUACULTURE, V77, P337, DOI 10.1016/0044-8486(89)90218-4; John MAS, 2001, ICES J MAR SCI, V58, P1106, DOI 10.1006/jmsc.2001.1089; Jonasdottir SH, 2009, MAR ECOL PROG SER, V382, P139, DOI 10.3354/meps07985; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; LANE AE, 1981, PLANT PHYSIOL, V68, P439, DOI 10.1104/pp.68.2.439; Lewis E., 1998, PROGRAM DEV CO2 SYST; Lohbeck KT, 2012, NAT GEOSCI, V5, P346, DOI [10.1038/ngeo1441, 10.1038/NGEO1441]; McGraw CM, 2010, LIMNOL OCEANOGR-METH, V8, P686, DOI 10.4319/lom.2010.8.686; Mouritsen OG, 2005, FRONT COLLECT, P1, DOI 10.1007/b138577; Muller-Navarra DC, 2004, NATURE, V427, P69, DOI 10.1038/nature02210; Muller-Navarra DC, 2000, NATURE, V403, P74, DOI 10.1038/47469; REITAN KI, 1994, J PHYCOL, V30, P972, DOI 10.1111/j.0022-3646.1994.00972.x; Renberg L, 2010, PLANT PHYSIOL, V154, P187, DOI 10.1104/pp.110.157651; Reusch TBH, 2014, EVOL APPL, V7, P104, DOI 10.1111/eva.12109; Reusch TBH, 2013, EVOLUTION, V67, P1849, DOI 10.1111/evo.12035; Rhein M, 2013, CLIMATE CHANGE 2013, DOI DOI 10.1017/CBO9781107415324.010; Riebesell U, 2000, GEOCHIM COSMOCHIM AC, V64, P4179, DOI 10.1016/S0016-7037(00)00474-9; Roleda MY, 2013, BIORESOURCE TECHNOL, V129, P439, DOI 10.1016/j.biortech.2012.11.043; Rossoll D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034737; Rousch JM, 2003, J EXP MAR BIOL ECOL, V295, P145, DOI 10.1016/S0022-0981(03)00293-4; SATO N, 1989, PLANT SCI, V61, P17, DOI 10.1016/0168-9452(89)90113-1; Sato N, 2003, BBA-MOL CELL BIOL L, V1633, P35, DOI 10.1016/S1388-1981(03)00070-2; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Suffrian K, 2011, NEW PHYTOL, V190, P595, DOI 10.1111/j.1469-8137.2010.03633.x; Tatters AO, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0437; TSUZUKI M, 1990, PLANT PHYSIOL, V93, P851, DOI 10.1104/pp.93.3.851; Van Wagenen J, 2012, ENERGIES, V5, P731, DOI 10.3390/en5030731; VISO AC, 1993, PHYTOCHEMISTRY, V34, P1521, DOI 10.1016/S0031-9422(00)90839-2; Winder M, 2004, ECOLOGY, V85, P2100, DOI 10.1890/04-0151; Winder M, 2012, HYDROBIOLOGIA, V698, P5, DOI 10.1007/s10750-012-1149-2; Wynn-Edwards C, 2014, WATER-SUI, V6, P1840, DOI 10.3390/w6061840; YOUNG VR, 1994, J NUTR, V124, pS1517, DOI 10.1093/jn/124.suppl_8.1517S; ZHUKOVA NV, 1995, PHYTOCHEMISTRY, V39, P351, DOI 10.1016/0031-9422(94)00913-E	58	43	45	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0123945	10.1371/journal.pone.0123945	http://dx.doi.org/10.1371/journal.pone.0123945			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970340	Green Published, Green Accepted, gold			2022-12-26	WOS:000354544200021
J	Casanova-Salas, I; Masia, E; Arminan, A; Calatrava, A; Mancarella, C; Rubio-Briones, J; Scotlandi, K; Vicent, MJ; Lopez-Guerrero, JA				Casanova-Salas, Irene; Masia, Esther; Arminan, Ana; Calatrava, Ana; Mancarella, Caterina; Rubio-Briones, Jose; Scotlandi, Katia; Vicent, Maria Jesus; Lopez-Guerrero, Jose Antonio			MiR-187 Targets the Androgen-Regulated Gene ALDH1A3 in Prostate Cancer	PLOS ONE			English	Article							IDENTIFICATION; CELLS	miRNAs are predicted to control the activity of approximately 60% of all protein-coding genes participating in the regulation of several cellular processes and diseases, including cancer. Recently, we have demonstrated that miR-187 is significantly downregulated in prostate cancer (PCa) and here we propose a proteomic approach to identify its potential targets. For this purpose, PC-3 cells were transiently transfected with miR-187 precursor and miRNA mimic negative control. Proteins were analyzed by a two-dimensional difference gel electrophoresis (2D-DIGE) and defined as differentially regulated if the observed fold change was +/- 1.06. Then, MALDI-TOF MS analysis was performed after protein digestion and low abundance proteins were identified by LC-MS/MS. Peptides were identified by searching against the Expasy SWISS PROT database, and target validation was performed both in vitro by western blot and qRT-PCR and in clinical samples by qRT-PCR, immunohistochemistry and ELISA. DIGE analysis showed 9 differentially expressed spots (p<0.05) and 7 showed a down-regulated expression upon miR-187 re-introduction. Among these targets we identified aldehyde dehydrogenase 1A3 (ALDH1A3). ALDH1A3 expression was significantly downregulated in PC3, LNCaP and DU-145 cells after miR-187 re-introduction. Supporting these data, the expression of ALDH1A3 was found significantly (p<0.0001) up-regulated in PCa samples and inversely correlated (p<0.0001) with miR-187 expression, its expression being directly associated with Gleason score (p = 0.05). The expression of ALDH1A3 was measured in urine samples to evaluate the predictive capability of this biomarker for the presence of PCa and, at a signification level of 10%, PSA and also ALDH1A3 were significantly associated with a positive biopsy of PCa. In conclusion, our data illustrate for the first time the role of ALDH1A3 as a miR-187 target in PCa and provide insights in the utility of using this protein as a new biomarker for PCa.	[Casanova-Salas, Irene; Lopez-Guerrero, Jose Antonio] Fdn Inst Valenciano Oncol, Mol Biol Lab, Valencia, Spain; [Masia, Esther; Arminan, Ana; Vicent, Maria Jesus] Ctr Invest Principe Felipe, Polymer Therapeut Lab, Valencia, Spain; [Calatrava, Ana] Fdn Inst Valenciano Oncol, Dept Pathol, Valencia, Spain; [Mancarella, Caterina; Scotlandi, Katia] Ist Ortoped Rizzoli, Expt Oncol Lab, Bologna, Italy; [Rubio-Briones, Jose] Fdn Inst Valenciano Oncol, Dept Urol, Valencia, Spain	Instituto Valenciano De Oncologia; Prince Felipe Research Center; Instituto Valenciano De Oncologia; IRCCS Istituto Ortopedico Rizzoli; Instituto Valenciano De Oncologia	Lopez-Guerrero, JA (corresponding author), Fdn Inst Valenciano Oncol, Mol Biol Lab, Valencia, Spain.	jalopez@fivo.org	Armiñán, Ana/AAY-9712-2021; Sanchis, Esther Masiá/AAB-6989-2019; Guerrero, Jose Antonio Lopez/Z-2413-2019; Vicent, Maria J./A-9690-2014; scotlandi, katia/J-9009-2016; Mancarella, Caterina/C-7463-2019	Sanchis, Esther Masiá/0000-0003-2293-0359; Guerrero, Jose Antonio Lopez/0000-0002-7369-8388; Vicent, Maria J./0000-0001-7771-3373; Casanova-Salas, Irene/0000-0002-0499-1038; scotlandi, katia/0000-0001-6114-9499; Arminan, Ana/0000-0003-2821-8477; Mancarella, Caterina/0000-0002-5778-4251	Instituto de Salud Carlos III [PI10/01206, FPI11/00505]; Madrid, FPI from Spanish Ministry of Science and Education [CTQ2007-60601, CTQ2011-18195]; Italian Ministry of Research and Instruction (F.I.R.B.) [RBAP11884 M_005]; Italian Association for Cancer Research (Katia Scotlandi-AIRC Project) [14049]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Madrid, FPI from Spanish Ministry of Science and Education(German Research Foundation (DFG)); Italian Ministry of Research and Instruction (F.I.R.B.); Italian Association for Cancer Research (Katia Scotlandi-AIRC Project)(Fondazione AIRC per la ricerca sul cancro)	This study was supported by grants from the Instituto de Salud Carlos III PI10/01206, FPI11/00505, Madrid, FPI (CTQ2007-60601; CTQ2011-18195) from Spanish Ministry of Science and Education, and from the Italian Ministry of Research and Instruction (F.I.R.B. project number: RBAP11884 M_005), the Italian Association for Cancer Research (Katia Scotlandi-AIRC Project N.14049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboseif SR, 1997, PROSTATE, V31, P161; Casanova-Salas I, 2014, J UROLOGY, V192, P252, DOI 10.1016/j.juro.2014.01.107; Casanova-Salas I, 2012, CLIN TRANSL ONCOL, V14, P803, DOI 10.1007/s12094-012-0877-0; DINSE GE, 1982, BIOMETRICS, V38, P921, DOI 10.2307/2529872; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kwak PB, 2010, CANCER SCI, V101, P2309, DOI 10.1111/j.1349-7006.2010.01683.x; Lin He XH, 2006, NATURE REV, V7, P4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo YC, 2012, STEM CELLS, V30, P2100, DOI 10.1002/stem.1193; Marcato P, 2011, STEM CELLS, V29, P32, DOI 10.1002/stem.563; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Razak SRA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073532; Sakr WA, 1996, EUR UROL, V30, P138; Schramedei K, 2011, ONCOGENE, V30, P2975, DOI 10.1038/onc.2011.15; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Sophos NA, 2001, CHEM-BIOL INTERACT, V130, P323, DOI 10.1016/S0009-2797(00)00275-1; Thompson IM, 2006, J NATL CANCER I, V98, P529, DOI 10.1093/jnci/djj131; Trasino SE, 2007, EXP BIOL MED, V232, P762; van den Hoogen C, 2010, CANCER RES, V70, P5163, DOI 10.1158/0008-5472.CAN-09-3806; Yang Y, 2009, PROTEOMICS, V9, P1374, DOI 10.1002/pmic.200800551	22	44	45	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0125576	10.1371/journal.pone.0125576	http://dx.doi.org/10.1371/journal.pone.0125576			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25969992	Green Submitted, Green Published, gold			2022-12-26	WOS:000354544200078
J	Lim, SM; Choi, DP; Rhee, Y; Kim, HC				Lim, Sun Min; Choi, Dong Phil; Rhee, Yumie; Kim, Hyeon Chang			Association between Obesity Indices and Insulin Resistance among Healthy Korean Adolescents: The JS High School Study	PLOS ONE			English	Article							HOMEOSTASIS MODEL ASSESSMENT; IMPAIRED GLUCOSE-TOLERANCE; CARDIOVASCULAR RISK; CHILDREN; SENSITIVITY; POPULATION; PREVALENCE; CHILDHOOD; RATIO	Objective To investigate whether indices of obesity are associated with insulin resistance in Korean adolescents. Methods This study was conducted as a cross-sectional analysis of 817 healthy adolescents aged 15-16 years without diabetes. Percentiles group of weight-for-height, body mass index (BMI)-for-age, waist circumference (WC)-for-age, and skin fold thickness (SFT)-for-age were based on the 2007 Korean National Growth Charts. Percentiles of waist-to-hip ratio (WHR), waist-to-height ratio (WHtR), and percent body fat were calculated for the study population. Insulin resistance was estimated by homeostatic model assessment (HOMAIR). Logistic regression models were used to estimate odds ratio for insulin resistance according to seven obesity indices. Generalized linear models were used to assess the associations between obesity indices and continuous HOMA-IR levels. Results Sex and age-adjusted odds ratios (95% confidence interval) for insulin resistance, defined as HOMA-IR>2.50, of the 75-94th and >= 95th percentiles of weight-for-height were 3.87 (2.38-6.30) and 11.37 (5.87-22.02), compared to the <50th percentile. Corresponding odds ratios were 3.27 (2.02-5.28) and 11.72 (6.05-22.73) for BMI-for-age, 4.72 (2.82-7.88) and 13.22 (6.42-27.23) for WC-for-age, 3.67 (2.27-5.94) and 13.58 (6.71-27.48) for WHR, 4.78 (2.99-7.67) and 12.84 (6.23-26.46) for WHtR, 2.62 (1.61-4.26) and 6.68 (3.46-12.90) for SFT-for-age, and 2.29 (1.33-4.26) and 10.06 (4.39-23.06) for body fat. These associations were more prominent when insulin resistance was defined as HOMA-IR>3.16 and were stronger in males than in females. Continuous measure of HOMA-IR was significantly associated with body weight, BMI, WC, WHR, WHtR, and SFT in both sexes (p<0.001), and with percent body fat in males only (p<0.001). Conclusion Our findings suggest that obesity indices are positively associated with insulin resistance in apparently healthy adolescents.	[Lim, Sun Min; Rhee, Yumie] Yonsei Univ, Coll Med, Dept Internal Med, Seoul 120749, South Korea; [Choi, Dong Phil; Kim, Hyeon Chang] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul 120749, South Korea; [Kim, Hyeon Chang] Yonsei Univ, Coll Med, Severance Inst Vasc & Metab Res, Seoul 120749, South Korea; [Choi, Dong Phil; Kim, Hyeon Chang] Yonsei Univ, Coll Med, Cardiovasc & Metab Dis Etiol Res Ctr, Seoul 120749, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, HC (corresponding author), Yonsei Univ, Coll Med, Dept Prevent Med, Seoul 120749, South Korea.	hckim@yuhs.ac	Sánchez-Margalet, Victor/AAB-9986-2021; Rhee, Yumie/L-8020-2019; Kim, Hyeon Chang/F-8796-2019	Sánchez-Margalet, Victor/0000-0001-8638-8680; Rhee, Yumie/0000-0003-4227-5638; Kim, Hyeon Chang/0000-0001-7867-1240	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2010-0007860, 2011-0005131]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (Grant No. 2010-0007860, 2011-0005131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atabek ME, 2007, DIABETES OBES METAB, V9, P304, DOI 10.1111/j.1463-1326.2006.00601.x; BONADONNA RC, 1990, METABOLISM, V39, P452, DOI 10.1016/0026-0495(90)90002-T; Chinn S, 2001, BRIT MED J, V322, P24, DOI 10.1136/bmj.322.7277.24; Cho H, 1997, KOREAN CIRC J, V27, P1087; Franks PW, 2007, DIABETES, V56, P2964, DOI 10.2337/db06-1639; Godsland IF, 2005, DIABETOLOGIA, V48, P2213, DOI 10.1007/s00125-005-1930-0; GoGel RJ, PREVALENCE IMPAIRED; Guercio G, 2003, J CLIN ENDOCR METAB, V88, P1389, DOI 10.1210/jc.2002-020979; He Q, 2004, OBES RES, V12, P725, DOI 10.1038/oby.2004.85; Herder C, 2007, J CLIN ENDOCR METAB, V92, P4569, DOI 10.1210/jc.2007-0955; Hillier TA, 2001, DIABETES CARE, V24, P1522, DOI 10.2337/diacare.24.9.1522; Hoffman RP, 2000, PEDIATR RES, V48, P384, DOI 10.1203/00006450-200009000-00022; Kahn HS, 2005, J PEDIATR-US, V146, P482, DOI 10.1016/j.jpeds.2004.12.028; Keskin M, 2005, PEDIATRICS, V115, pE500, DOI 10.1542/peds.2004-1921; Lee HJ, 1999, KOREAN CIRC J, V29, P673, DOI DOI 10.4070/KCJ.1999.29.7.673; Manios Y, 2008, ACTA PAEDIATR, V97, P494, DOI 10.1111/j.1651-2227.2008.00729.x; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Moon JS, 2007, KOREAN J PEDIAT, V1, P1, DOI DOI 10.3345/KJP.2008.51.1.1; Moran A, 1999, DIABETES, V48, P2039, DOI 10.2337/diabetes.48.10.2039; Moran A, 2008, CIRCULATION, V117, P2361, DOI 10.1161/CIRCULATIONAHA.107.704569; Nguyen QM, 2008, DIABETES CARE, V31, P2044, DOI 10.2337/dc08-0898; PinhasHamiel O, 1996, J PEDIATR-US, V128, P608, DOI 10.1016/S0022-3476(96)80124-7; Shalitin S, 2005, INT J OBESITY, V29, P571, DOI 10.1038/sj.ijo.0802919; Sinha R, 2002, NEW ENGL J MED, V346, P802, DOI 10.1056/NEJMoa012578; Yoon SJ, 2008, METABOLISM, V57, P853, DOI 10.1016/j.metabol.2008.01.031; 이순영, 2008, Clinical and Experimental Pediatrics, V51, P26	26	36	36	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0125238	10.1371/journal.pone.0125238	http://dx.doi.org/10.1371/journal.pone.0125238			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970186	Green Published, gold, Green Submitted			2022-12-26	WOS:000354544200069
J	Przytulska, A; Bartosiewicz, M; Rautio, M; Dufresne, F; Vincent, WF				Przytulska, Anna; Bartosiewicz, Maciej; Rautio, Milla; Dufresne, France; Vincent, Warwick F.			Climate Effects on High Latitude Daphnia via Food Quality and Thresholds	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; COMMUNITY STRUCTURE; ARCTIC ECOSYSTEMS; GENOME SIZE; BODY-SIZE; TEMPERATURE; CYANOBACTERIUM; WATER; GROWTH; POLYPLOIDY	Climate change is proceeding rapidly at high northern latitudes and may have a variety of direct and indirect effects on aquatic food webs. One predicted effect is the potential shift in phytoplankton community structure towards increased cyanobacterial abundance. Given that cyanobacteria are known to be a nutritionally poor food source, we hypothesized that such a shift would reduce the efficiency of feeding and growth of northern zooplankton. To test this hypothesis, we first isolated a clone of Daphnia pulex from a permafrost thaw pond in subarctic Quebec, and confirmed that it was triploid but otherwise genetically similar to a diploid, reference clone of the same species isolated from a freshwater pond in southern Quebec. We used a controlled flow-through system to investigate the direct effect of temperature and indirect effect of subarctic picocyanobacteria (Synechococcus) on threshold food concentrations and growth rate of the high latitude clone. We also compared the direct effect of temperature on both Daphnia clones feeding on eukaryotic picoplankton (Nannochloropsis). The high latitude clone had a significantly lower food threshold for growth than the temperate clone at both 18 and 26 degrees C, implying adaptation to lower food availability even under warmer conditions. Polyunsaturated fatty acids were present in the picoeukaryote but not the cyanobacterium, confirming the large difference in food quality. The food threshold for growth of the high latitude Daphnia was 3.7 (18 degrees C) to 4.2 (26 degrees C) times higher when fed Synechococcus versus Nannochloropsis, and there was also a significant negative effect of increased temperature and cyanobacterial food on zooplankton fatty acid content and composition. The combined effect of temperature and food quality on the performance of the high latitude Daphnia was greater than their effects added separately, further indicating the potentially strong indirect effects of climate warming on aquatic food web processes.	[Przytulska, Anna; Bartosiewicz, Maciej; Rautio, Milla; Vincent, Warwick F.] Univ Laval, CEN, Quebec City, PQ, Canada; [Przytulska, Anna; Vincent, Warwick F.] Univ Laval, Dept Biol, Quebec City, PQ G1K 7P4, Canada; [Bartosiewicz, Maciej] Inst Natl Rech Sci, Ctr Eau Terre Environm, Quebec City, PQ, Canada; [Rautio, Milla] Univ Quebec Chicoutimi, Dept Fundamental Sci, Chicoutimi, PQ, Canada; [Dufresne, France] Univ Quebec, Biol Chem & Geog Dept, Rimouski, PQ G5L 3A1, Canada	Laval University; Laval University; University of Quebec; Institut national de la recherche scientifique (INRS); University of Quebec; University of Quebec Chicoutimi; University of Quebec	Przytulska, A (corresponding author), Univ Laval, CEN, Quebec City, PQ, Canada.	anna.przytulska.1@ulaval.ca	Vincent, Warwick/AAH-6152-2019	Vincent, Warwick/0000-0001-9055-1938	Natural Sciences and Engineering Research Council of Canada; ArcticNet; Fonds de recherche du Quebec-Nature et technologies; Centre d'etudes nordiques; Natural Sciences and Engineering Research Council of Canada Interdisciplinary Fellowship	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); ArcticNet; Fonds de recherche du Quebec-Nature et technologies; Centre d'etudes nordiques; Natural Sciences and Engineering Research Council of Canada Interdisciplinary Fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by Natural Sciences and Engineering Research Council of Canada (2011; http://www.nserc-crsng.gc.ca/index_eng.asp), ArcticNet (2011; http://www.arcticnet.ulaval.ca), Fonds de recherche du Quebec-Nature et technologies (2011; http://www.frqnt.gouv.qc.ca/en/), Centre d'etudes nordiques (2011; http://www.cen.ulaval.ca/en/page.aspx?lien = index) to WFV and by an Natural Sciences and Engineering Research Council of Canada Interdisciplinary Fellowship to AP (EnviroNorth 2013; http://environord-environorth.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach L, 1997, OIKOS, V79, P469, DOI 10.2307/3546889; Beaugrand G, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3350; Bennett MD, 2003, ANN BOT-LONDON, V91, P547, DOI 10.1093/aob/mcg057; Brett MT, 2006, LIMNOL OCEANOGR, V51, P2428, DOI 10.4319/lo.2006.51.5.2428; Charvet S, 2014, FEMS MICROBIOL ECOL, V88, P550, DOI 10.1111/1574-6941.12324; Cole PC, 2002, FRESHWATER BIOL, V47, P2113, DOI 10.1046/j.1365-2427.2002.00955.x; Comeau AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027492; Crevecoeur S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00192; De Senerpont Domis LN, 2013, FRESHWATER BIOL, V58, P560, DOI 10.1111/fwb.12076; DeMott WR, 1997, FRESHWATER BIOL, V38, P649, DOI 10.1046/j.1365-2427.1997.00222.x; DeMott WR, 1998, ECOLOGY, V79, P2463, DOI 10.2307/176836; Dinh Van K, 2013, GLOBAL CHANGE BIOL, V19, P2625, DOI 10.1111/gcb.12243; Dufresne F, 1998, ECOSCIENCE, V5, P433, DOI 10.1080/11956860.1998.11682481; Dufresne F, 1997, P ROY SOC B-BIOL SCI, V264, P201, DOI 10.1098/rspb.1997.0028; DUFRESNE F, 1994, P ROY SOC B-BIOL SCI, V258, P141, DOI 10.1098/rspb.1994.0154; Dzialowski AR, 2004, FRESHWATER BIOL, V49, P1103, DOI 10.1111/j.1365-2427.2004.01250.x; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; GLIWICZ ZM, 1990, ECOLOGY, V71, P691, DOI 10.2307/1940323; GLIWICZ ZM, 1990, NATURE, V343, P638, DOI 10.1038/343638a0; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Haag CR, 2004, ANN ZOOL FENN, V41, P539; Iwabuchi T, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00098.1; Jose C, 2010, EVOL ECOL, V24, P413, DOI 10.1007/s10682-009-9314-4; Kaplan JO, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002559; Kirchman DL, 2009, NAT REV MICROBIOL, V7, P451, DOI 10.1038/nrmicro2115; Kleinteich J, 2012, NAT CLIM CHANGE, V2, P356, DOI [10.1038/nclimate1418, 10.1038/NCLIMATE1418]; Kosten S, 2012, GLOBAL CHANGE BIOL, V18, P118, DOI 10.1111/j.1365-2486.2011.02488.x; Kotai J, 1972, NIVA REPORTS NORWE B, V11, P69; Kozlowski J, 2003, P NATL ACAD SCI USA, V100, P14080, DOI 10.1073/pnas.2334605100; Lampert W, 2006, POL J ECOL, V54, P607; Laurion I, 2010, LIMNOL OCEANOGR, V55, P115, DOI 10.4319/lo.2010.55.1.0115; Little TJ, 1997, P ROY SOC B-BIOL SCI, V264, P1363, DOI 10.1098/rspb.1997.0189; Mable BK, 2004, BIOL J LINN SOC, V82, P453, DOI 10.1111/j.1095-8312.2004.00332.x; Mariash HL, 2014, LIMNOL OCEANOGR, V59, P733, DOI 10.4319/lo.2014.59.3.0733; Masclaux H, 2009, LIMNOL OCEANOGR, V54, P1323, DOI 10.4319/lo.2009.54.4.1323; Maszczyk P, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00146.1; MOORE M, 1993, TRENDS ECOL EVOL, V8, P178, DOI 10.1016/0169-5347(93)90144-E; Paerl HW, 2009, ENV MICROBIOL REP, V1, P27, DOI 10.1111/j.1758-2229.2008.00004.x; Quinlan R, 2005, GLOBAL CHANGE BIOL, V11, P1381, DOI 10.1111/j.1365-2486.2005.00981.x; Rae R, 1998, FRESHWATER BIOL, V40, P747, DOI 10.1046/j.1365-2427.1998.00361.x; Rautio M, 2011, ECOSCIENCE, V18, P204, DOI 10.2980/18-3-3463; Schlechtriem C, 2006, LIPIDS, V41, P397, DOI 10.1007/s11745-006-5111-9; Smol JP, 2007, FRONT ECOL ENVIRON, V5, P466, DOI 10.1890/060162; STEBBINS GL, 1984, BOT HELV, V94, P1; STICH HB, 1984, OECOLOGIA, V61, P192, DOI 10.1007/BF00396759; Taipale SJ, 2011, OIKOS, V120, P1674, DOI 10.1111/j.1600-0706.2011.19415.x; Veillette J, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2008JG000730; Vergilino R, 2009, BIOL J LINN SOC, V97, P68, DOI 10.1111/j.1095-8312.2008.01185.x; Vincent W. F., 2013, CLIMATIC CHANGE GLOB, P27, DOI DOI 10.1002/9781118470596.CH2; VINCENT WF, 2000, MICROBIAL BIOSYSTEMS; von Elert E, 2003, P ROY SOC B-BIOL SCI, V270, P1209, DOI 10.1098/rspb.2003.2357; WADA H, 1990, PLANT PHYSIOL, V92, P1062, DOI 10.1104/pp.92.4.1062; WADA H, 1990, NATURE, V347, P200, DOI 10.1038/347200a0; Wilson AE, 2005, APPL ENVIRON MICROB, V71, P6126, DOI 10.1128/AEM.71.10.6126-6133.2005; Wrona FJ, 2006, AMBIO, V35, P359, DOI 10.1579/0044-7447(2006)35[359:CCEOAB]2.0.CO;2; Yurista PM, 1999, FRESHWATER BIOL, V42, P21, DOI 10.1046/j.1365-2427.1999.00446.x	56	16	16	5	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0126231	10.1371/journal.pone.0126231	http://dx.doi.org/10.1371/journal.pone.0126231			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970289	Green Published, gold, Green Accepted			2022-12-26	WOS:000354544200100
J	Sakry, D; Yigit, H; Dimou, L; Trotter, J				Sakry, Dominik; Yigit, Hatice; Dimou, Leda; Trotter, Jacqueline			Oligodendrocyte Precursor Cells Synthesize Neuromodulatory Factors	PLOS ONE			English	Article							PROSTAGLANDIN-D SYNTHASE; GLIAL PROGENITOR CELLS; MEMBRANE-SPANNING PROTEOGLYCAN; NG2 PROTEOGLYCAN; AMPA RECEPTORS; DEMYELINATING DISEASE; EXCITATORY SYNAPSES; CEREBRAL-CORTEX; WHITE-MATTER; IN-VITRO	NG2 protein-expressing oligodendrocyte progenitor cells (OPC) are a persisting and major glial cell population in the adult mammalian brain. Direct synaptic innervation of OPC by neurons throughout the brain together with their ability to sense neuronal network activity raises the question of additional physiological roles of OPC, supplementary to generating myelinating oligodendrocytes. In this study we investigated whether OPC express neuromodulatory factors, typically synthesized by other CNS cell types. Our results show that OPC express two well-characterized neuromodulatory proteins: Prostaglandin D2 synthase (PTGDS) and neuronal Pentraxin 2 (Nptx2/Narp). Expression levels of the enzyme PTGDS are influenced in cultured OPC by the NG2 intracellular region which can be released by cleavage and localizes to glial nuclei upon transfection. Furthermore PTGDS mRNA levels are reduced in OPC from NG2-KO mouse brain compared to WT cells after isolation by cell sorting and direct analysis. These results show that OPC can contribute to the expression of these proteins within the CNS and suggest PTGDS expression as a downstream target of NG2 signaling.	[Sakry, Dominik; Yigit, Hatice; Trotter, Jacqueline] Johannes Gutenberg Univ Mainz, Dept Biol, Mol Cell Biol, D-55122 Mainz, Germany; [Dimou, Leda] Univ Munich, Biomed Ctr, Physiol Genom, D-80336 Munich, Germany	Johannes Gutenberg University of Mainz; University of Munich	Sakry, D (corresponding author), Johannes Gutenberg Univ Mainz, Dept Biol, Mol Cell Biol, D-55122 Mainz, Germany.	sakryd@uni-mainz.de; trotter@uni-mainz.de	Dimou, Leda/E-7968-2012	Sakry, Dominik/0000-0002-7144-7243	Deutsche Forschungsgemeinschaft [TR 1008/1-1, TR1008/2-1, CRC TRR 128/1, GRK1044/2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was financed by the Deutsche Forschungsgemeinschaft (TR 1008/1-1, TR1008/2-1, CRC TRR 128/1, and GRK1044/2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asher RA, 2005, MOL CELL NEUROSCI, V29, P82, DOI 10.1016/j.mcn.2005.02.001; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Barritt DS, 2000, J CELL BIOCHEM, V79, P213, DOI 10.1002/1097-4644(20001101)79:2<213::AID-JCB50>3.0.CO;2-G; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; Bergles DE, 2010, BRAIN RES REV, V63, P130, DOI 10.1016/j.brainresrev.2009.12.003; Biname F, 2013, J NEUROSCI, V33, P10858, DOI 10.1523/JNEUROSCI.5010-12.2013; Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; Cajigas IJ, 2012, NEURON, V74, P453, DOI 10.1016/j.neuron.2012.02.036; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Chang MC, 2010, NAT NEUROSCI, V13, P1090, DOI 10.1038/nn.2621; Chatterjee N, 2008, J BIOL CHEM, V283, P8310, DOI 10.1074/jbc.M706074200; Chittajallu R, 2004, J PHYSIOL-LONDON, V561, P109, DOI 10.1113/jphysiol.2004.074252; Clarke LE, 2012, J NEUROSCI, V32, P8173, DOI 10.1523/JNEUROSCI.0928-12.2012; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Dehn D, 2006, GLIA, V53, P491, DOI 10.1002/glia.20307; Diers-Fenger M, 2001, GLIA, V34, P213, DOI 10.1002/glia.1055; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; FORSTERMANN U, 1983, PSYCHOPHARMACOLOGY, V80, P365, DOI 10.1007/BF00432122; Franklin RJM, 2014, GLIA, V62, P1905, DOI 10.1002/glia.22622; Hernandez MR, 2002, GLIA, V38, P45, DOI 10.1002/glia.10051; Jones LL, 2002, J NEUROSCI, V22, P2792, DOI 10.1523/JNEUROSCI.22-07-02792.2002; JUNG M, 1995, EUR J NEUROSCI, V7, P1245, DOI 10.1111/j.1460-9568.1995.tb01115.x; Kagitani-Shimono K, 2006, NEUROPATH APPL NEURO, V32, P64, DOI 10.1111/j.1365-2990.2005.00690.x; Kaji N, 2003, J BIOL CHEM, V278, P33450, DOI 10.1074/jbc.M305802200; Kandachar V, 2012, CURR OPIN CELL BIOL, V24, P534, DOI 10.1016/j.ceb.2012.06.006; Kang SH, 2013, NAT NEUROSCI, V16, P571, DOI 10.1038/nn.3357; Karram K, 2008, GENESIS, V46, P743, DOI 10.1002/dvg.20440; Kim JH, 2012, MED SCI MONITOR, V18, pBR450, DOI 10.12659/MSM.883538; Kucharova K, 2010, NEUROSCIENCE, V166, P185, DOI 10.1016/j.neuroscience.2009.12.014; Kukley M, 2008, FASEB J, V22, P2957, DOI 10.1096/fj.07-090985; Kukley M, 2007, NAT NEUROSCI, V10, P311, DOI 10.1038/nn1850; LEVINE JM, 1993, GLIA, V7, P307, DOI 10.1002/glia.440070406; Lin SC, 2005, NEURON, V46, P773, DOI 10.1016/j.neuron.2005.04.025; Lin SC, 2004, NAT NEUROSCI, V7, P24, DOI 10.1038/nn1162; Makagiansar IT, 2007, J CELL BIOL, V178, P155, DOI 10.1083/jcb.200612084; Mangin JM, 2012, NAT NEUROSCI, V15, P1192, DOI 10.1038/nn.3190; Niehaus A, 1999, J NEUROSCI, V19, P4948; NISHIYAMA A, 1995, MOL BIOL CELL, V6, P1819, DOI 10.1091/mbc.6.12.1819; NISHIYAMA A, 1991, J CELL BIOL, V114, P359, DOI 10.1083/jcb.114.2.359; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; O'Brien R, 2002, J NEUROSCI, V22, P4487, DOI 10.1523/JNEUROSCI.22-11-04487.2002; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; Pan DJ, 1997, CELL, V90, P271, DOI 10.1016/S0092-8674(00)80335-9; Robins SC, 2013, GLIA, V61, P1735, DOI 10.1002/glia.22554; Sakry D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001993; Sakry D, 2011, J ANAT, V219, P2, DOI 10.1111/j.1469-7580.2011.01359.x; Schmid B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-274; Simon C, 2011, GLIA, V59, P869, DOI 10.1002/glia.21156; Stegmuller J, 2002, J NEUROCYTOL, V31, P497, DOI 10.1023/A:1025743731306; Stegmuller J, 2003, J BIOL CHEM, V278, P3590, DOI 10.1074/jbc.M210010200; Sudol M, 2001, FEBS LETT, V490, P190, DOI 10.1016/S0014-5793(01)02122-6; Taniike M, 2002, J NEUROSCI, V22, P4885, DOI 10.1523/JNEUROSCI.22-12-04885.2002; Trimarco A, 2014, NAT NEUROSCI, V17, P1682, DOI 10.1038/nn.3857; Tripathi RB, 2010, J NEUROSCI, V30, P16383, DOI 10.1523/JNEUROSCI.3411-10.2010; Trotter J, 2010, BRAIN RES REV, V63, P72, DOI 10.1016/j.brainresrev.2009.12.006; Tsui CC, 1996, J NEUROSCI, V16, P2463; URADE Y, 1993, P NATL ACAD SCI USA, V90, P9070, DOI 10.1073/pnas.90.19.9070; Velez-Fort M, 2010, J NEUROSCI, V30, P6921, DOI 10.1523/JNEUROSCI.0238-10.2010; Vigano F, 2013, NAT NEUROSCI, V16, P1370, DOI 10.1038/nn.3503; Wake H, 2011, SCIENCE, V333, P1647, DOI 10.1126/science.1206998; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895	62	24	24	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0127222	10.1371/journal.pone.0127222	http://dx.doi.org/10.1371/journal.pone.0127222			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25966014	Green Published, gold, Green Submitted			2022-12-26	WOS:000354543500097
J	Fukuda, Y; Manolis, C; Saalfeld, K; Zuur, A				Fukuda, Yusuke; Manolis, Charlie; Saalfeld, Keith; Zuur, Alain			Dead or Alive? Factors Affecting the Survival of Victims during Attacks by Saltwater Crocodiles (Crocodylus porosus) in Australia	PLOS ONE			English	Article							HUMAN-WILDLIFE CONFLICT; NORTHERN-TERRITORY; MANAGEMENT; RECOVERY; FLORIDA; HUMANS	Conflicts between humans and crocodilians are a widespread conservation challenge and the number of crocodile attacks is increasing worldwide. We identified the factors that most effectively decide whether a victim is injured or killed in a crocodile attack by fitting generalized linear models to a 42-year dataset of 87 attacks (27 fatal and 60 non-fatal) by saltwater crocodiles (Crocodylus porosus) in Australia. The models showed that the most influential factors were the difference in body mass between crocodile and victim, and the position of victim in relation to the water at the time of an attack. In-water position (for diving, swimming, and wading) had a higher risk than on-water (boating) or on-land (fishing, and hunting near the water's edge) positions. In the in-water position a 75 kg person would have a relatively high probability of survival (0.81) if attacked by a 300 cm crocodile, but the probability becomes much lower (0.17) with a 400 cm crocodile. If attacked by a crocodile larger than 450 cm, the survival probability would be extremely low (<0.05) regardless of the victim's size. These results indicate that the main cause of death during a crocodile attack is drowning and larger crocodiles can drag a victim more easily into deeper water. A higher risk associated with a larger crocodile in relation to victim's size is highlighted by children's vulnerability to fatal attacks. Since the first recently recorded fatal attack involving a child in 2006, six out of nine fatal attacks (66.7%) involved children, and the average body size of crocodiles responsible for these fatal attacks was considerably smaller (384 cm, 223 kg) than that of crocodiles that killed adults (450 cm, 324 kg) during the same period (2006-2014). These results suggest that culling programs targeting larger crocodiles may not be an effective management option to improve safety for children.	[Fukuda, Yusuke; Saalfeld, Keith] Northern Terr Dept Land Resource Management, Palmerston, NT, Australia; [Manolis, Charlie] Wildlife Management Int Pty Ltd, Karama, NT, Australia; [Zuur, Alain] Highland Stat Ltd, Newburgh, NY USA		Fukuda, Y (corresponding author), Northern Terr Dept Land Resource Management, Palmerston, NT, Australia.	yusuke.fukuda@nt.gov.au	Fukuda, Yusuke/AAN-4676-2020	Fukuda, Yusuke/0000-0002-8675-318X	Wildlife Management International Pty. Limited; Highland Statistics Limited	Wildlife Management International Pty. Limited; Highland Statistics Limited	Wildlife Management International Pty. Limited and Highland Statistics Limited provided support in the form of salaries for authors CM and AZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allison P. D., 2004, NUMERICAL ISSUES STA, DOI [DOI 10.1002/0471475769.CH10, 10.1002/0471475769.ch10]; Aust P, 2009, S AFR J WILDL RES, V39, P57, DOI 10.3957/056.039.0107; Australian Bureau of Statistics, 2012, 4364 0 055 001 AUSTR; Brien ML, 2008, WILDLIFE RES, V35, P140, DOI 10.1071/WR06116; Brien ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080872; Britton A, 2014, THE CONVERSATION; Britton Adam R. C., 2012, Herpetological Review, V43, P541; Bureau of Meteorology, 2014, CLIM DAT ONL; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Caldicott DGE, 2005, WILD ENVIRON MED, V16, P143, DOI 10.1580/1080-6032(2005)16[143:CAIAAA]2.0.CO;2; Campbell H, 2013, CONVERSATION; Campbell HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062127; Campbell HA, 2010, J ANIM ECOL, V79, P955, DOI 10.1111/j.1365-2656.2010.01709.x; Cavanagh G., 2004, NTMC 09; Charles Darwin University Big Gecko, 2014, CROCB WORLDW CROC AT; Conover Michael R., 1997, Herpetological Review, V28, P120; Crawley MJ, 2005, STAT INTRO USING R; Department of Infrastructure and Regional Development Australian Government, 2014, AUSTR ROAD DEATHS DA; Dickman AJ, 2010, ANIM CONSERV, V13, P458, DOI 10.1111/j.1469-1795.2010.00368.x; Dunham KM, 2010, ORYX, V44, P185, DOI 10.1017/S003060530999086X; Elsey RM, 2010, CROCODILES STATUS SU, P1; Fukuda Y, 2007, WILDLIFE RES, V34, P167, DOI 10.1071/WR06110; Fukuda Y, 2014, J WILDLIFE MANAGE, V78, P1239, DOI 10.1002/jwmg.767; Fukuda Y, 2011, J WILDLIFE MANAGE, V75, P1253, DOI 10.1002/jwmg.191; Gopi GV, 2009, CURR SCI INDIA, V96, P459; Gruen RL, 2009, WORLD J SURG, V33, P1554, DOI 10.1007/s00268-009-0103-6; Harding BE, 2006, J FORENSIC SCI, V51, P674, DOI 10.1111/j.1556-4029.2006.00135.x; KAR SK, 1983, BIOL CONSERV, V25, P377, DOI 10.1016/0006-3207(83)90071-X; Langley RL, 2010, WILD ENVIRON MED, V21, P156, DOI 10.1016/j.wem.2010.02.002; Leach GJ, 2009, MANAGEMENT PROGRAM S; Manolis SC, 2013, CROCODILES, P97; Martin S, 2008, HYDROBIOLOGIA, V595, P587, DOI 10.1007/s10750-007-9030-4; Mazzotti FJ, 2007, J HERPETOL, V41, P122, DOI 10.1670/0022-1511(2007)41[122:ACCAIF]2.0.CO;2; MEKISIC AP, 1992, MED J AUSTRALIA, V157, P751; Natural Resource Management Ministerial Council (NRMMC), 2009, COD PRACT HUM TREAT; Platt SG, 2000, BIOL CONSERV, V96, P21, DOI 10.1016/S0006-3207(00)00039-2; Sideleau B, 2012, CROCODILES, P111; Stevenson, 2010, CROCODILES STATUS SU, P99; Thapaliya BP, 2010, CROCODILES STATUS SU, P3, DOI [10.3126/init.v3i0.2422, DOI 10.3126/INIT.V3I0.2422]; Thorbjarnarson J, 2002, BIOL CONSERV, V103, P93, DOI 10.1016/S0006-3207(01)00128-8; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Treves Adrian, 2006, Human Dimensions of Wildlife, V11, P383, DOI 10.1080/10871200600984265; van Weerd M, 2010, CROCODILES STATUS SU, P71; Wamisho BL, 2009, MALAWI MED J, V21, P29; Webb G., 1989, CROCODILES AUSTR; Webb G., 2012, CONVERSATION; Webb G.J.W., 1991, P125; WEBB GJW, 1978, AUST J ZOOL, V26, P1; Woolgar JD, 2001, CONVERSATION, P50; World Health Organization, 2006, GROWTH REF DAT 5 19; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	51	21	21	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126778	10.1371/journal.pone.0126778	http://dx.doi.org/10.1371/journal.pone.0126778			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961294	gold, Green Published, Green Submitted			2022-12-26	WOS:000354542500150
J	Glaser, G; Weroha, SJ; Becker, MA; Hou, XN; Enderica-Gonzalez, S; Harrington, SC; Haluska, P				Glaser, Gretchen; Weroha, S. John; Becker, Marc A.; Hou, Xiaonan; Enderica-Gonzalez, Sergio; Harrington, Sean C.; Haluska, Paul			Conventional Chemotherapy and Oncogenic Pathway Targeting in Ovarian Carcinosarcoma Using a Patient-Derived Tumorgraft	PLOS ONE			English	Article							MIXED MESODERMAL TUMORS; IN-VIVO; PLATINUM RESPONSE; MULLERIAN TUMORS; CANCER; XENOGRAFTS; INHIBITOR; CARCINOMA; IFOSFAMIDE; PACLITAXEL	Ovarian carcinosarcoma is a rare subtype of ovarian cancer with poor clinical outcomes. The low incidence of this disease makes accrual to large clinical trials challenging. However, studies have shown that treatment responses in patient-derived xenograft (PDX) models correlate with matched-patient responses in the clinic, supporting their use for preclinical testing of standard and novel therapies. An ovarian carcinosarcoma PDX is presented herein and showed resistance to carboplatin and paclitaxel (similar to the patient) but exhibited significant sensitivity to ifosfamide and paclitaxel. The PDX demonstrated overexpression of EGFR mRNA and gene amplification by array comparative genomic hybridization (log2 ratio 0.399). EGFR phosphorylation was also detected. Angiogensis and insulin-like growth factor pathways were also implicated by overexpression of VEGFC and IRS1. In order to improve response to chemotherapy, the PDX was treated with carboplatin/paclitaxel with or without a pan-HER and VEGF inhibitor (BMS-690514) but there was no tumor growth inhibition or improved animal survival, which may be explained by a KRAS mutation. Resistance was also observed when the IGF-1R inhibitor BMS-754807 was combined with carboplatin/paclitaxel. Because poly (ADP-ribose) polymerase inhibitors have activity in ovarian cancer patients, with and without BRCA mutations, ABT-888 was also tested but found to have no activity. Pathogenic mutations were also detected in TP53 and PIK3CA. In conclusion, ifosfamide/paclitaxel was superior to carboplatin/paclitaxel in this ovarian carcinosarcoma PDX and gene overexpression or amplification alone was not sufficient to predict response to targeted therapy. Better predictive markers of response are needed.	[Glaser, Gretchen] Mayo Clin, Div Gynecol Surg, Rochester, MN USA; [Weroha, S. John; Becker, Marc A.; Hou, Xiaonan; Enderica-Gonzalez, Sergio; Harrington, Sean C.; Haluska, Paul] Mayo Clin, Dept Oncol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Weroha, SJ (corresponding author), Mayo Clin, Dept Oncol, Rochester, MN 55905 USA.	weroha.saravut@mayo.edu		Haluska, Paul/0000-0003-3283-4512	Mayo Clinic SPORE in Ovarian Cancer [CA136393]; National Institutes of Health [DK07352]; NATIONAL CANCER INSTITUTE [P50CA136393] Funding Source: NIH RePORTER	Mayo Clinic SPORE in Ovarian Cancer; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	For all funding sources, they had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding provided by Mayo Clinic SPORE in Ovarian Cancer CA136393 provided to PH to support the research effort in the lab. National Institutes of Health T32 Training Grant, DK07352 to support MAB and his effort. The Petersen Family, private donation to support general lab efforts.	Audeh MW, 2010, LANCET, V376, P245, DOI 10.1016/S0140-6736(10)60893-8; Banerji U, 2008, CANCER CHEMOTH PHARM, V62, P769, DOI 10.1007/s00280-007-0662-x; Bankert RB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024420; Becker MA, 2013, MOL CANCER THER, V12, P2909, DOI 10.1158/1535-7163.MCT-13-0547; Burger RA, 2011, NEW ENGL J MED, V365, P2473, DOI 10.1056/NEJMoa1104390; Cimbaluk D, 2007, GYNECOL ONCOL, V105, P138, DOI 10.1016/j.ygyno.2006.11.001; Conway T, 2012, BIOINFORMATICS, V28, pI172, DOI 10.1093/bioinformatics/bts236; Crotzer DR, 2007, GYNECOL ONCOL, V105, P399, DOI 10.1016/j.ygyno.2006.12.023; Duska LR, 2002, GYNECOL ONCOL, V85, P459, DOI 10.1006/gyno.2002.6645; Elkas JC, 2002, GYNECOL ONCOL, V87, P200, DOI 10.1006/gyno.2002.6819; Gamba S, 2015, ANTI-CANCER DRUG, V26, P371, DOI 10.1097/CAD.0000000000000196; Gelmon KA, 2011, LANCET ONCOL, V12, P852, DOI 10.1016/S1470-2045(11)70214-5; Haluska P, 2008, MOL CANCER THER, V7, P2589, DOI 10.1158/1535-7163.MCT-08-0493; Hidalgo M, 2011, MOL CANCER THER, V10, P1311, DOI 10.1158/1535-7163.MCT-11-0233; Hou XN, 2011, CANCER RES, V71, P7597, DOI 10.1158/0008-5472.CAN-11-1080; Inthasorn P, 2003, AUST NZ J OBSTET GYN, V43, P61, DOI 10.1046/j.0004-8666.2003.00003.x; Jernigan AM, 2013, OBSTET GYNECOL INT, V2013, DOI 10.1155/2013/490508; Jones S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6006; Karachaliou N, 2013, CLIN LUNG CANCER, V14, P205, DOI 10.1016/j.cllc.2012.09.007; Kodaz H, 2015, MOL CLIN ONCOL, V3, P179, DOI 10.3892/mco.2014.448; Kortmann U, 2011, CLIN CANCER RES, V17, P783, DOI 10.1158/1078-0432.CCR-10-1382; Lee CH, 2005, GYNECOL ONCOL, V96, P48, DOI 10.1016/j.ygyno.2004.09.025; Leiser AL, 2007, GYNECOL ONCOL, V105, P657, DOI 10.1016/j.ygyno.2007.01.037; Li H., 2013, ARXIV 13033997 Q BIO; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Livasy CA, 2006, GYNECOL ONCOL, V100, P101, DOI 10.1016/j.ygyno.2005.07.124; Loizzi V, 2011, ONCOLOGY-BASEL, V80, P102, DOI 10.1159/000328794; Nemati F, 2000, CLIN CANCER RES, V6, P2075; Paine GD, 1996, SEMIN ONCOL, V23, P35; Palma JP, 2009, CLIN CANCER RES, V15, P7277, DOI 10.1158/1078-0432.CCR-09-1245; Paster EV, 2009, COMPARATIVE MED, V59, P234; Pennington KP, 2014, CLIN CANCER RES, V20, P764, DOI 10.1158/1078-0432.CCR-13-2287; Perren TJ, 2011, NEW ENGL J MED, V365, P2484, DOI 10.1056/NEJMoa1103799; Piura J, 1998, EUR J GYNAECOL ONCOL, V19, P257; Press JZ, 2008, GYNECOL ONCOL, V110, P256, DOI 10.1016/j.ygyno.2008.03.011; Rauh-Hain JA, 2011, GYNECOL ONCOL, V121, P477, DOI 10.1016/j.ygyno.2011.02.023; Rigakos G, 2012, ONCOLOGIST, V17, P956, DOI 10.1634/theoncologist.2012-0028; Roy RN, 2000, CANCER LETT, V153, P67, DOI 10.1016/S0304-3835(00)00347-5; Rutledge TL, 2006, GYNECOL ONCOL, V100, P128, DOI 10.1016/j.ygyno.2005.07.119; Sandhu SK, 2013, LANCET ONCOL, V14, P882, DOI 10.1016/S1470-2045(13)70240-7; Sawada M, 2003, CANCER SCI, V94, P986, DOI 10.1111/j.1349-7006.2003.tb01389.x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sit ASY, 2000, GYNECOL ONCOL, V79, P196, DOI 10.1006/gyno.2000.5956; Sopo M, 2012, INT J CANCER, V131, P2394, DOI 10.1002/ijc.27495; STORER BE, 1989, BIOMETRICS, V45, P925, DOI 10.2307/2531693; SUTTON GP, 1994, GYNECOL ONCOL, V53, P24, DOI 10.1006/gyno.1994.1081; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; Topp MD, 2014, MOL ONCOL, V8, P656, DOI 10.1016/j.molonc.2014.01.008; VANHAAFTENDAY C, 1988, IN VITRO CELL DEV B, V24, P965; Weroha SJ, 2014, CLIN CANCER RES, V20, P1288, DOI 10.1158/1078-0432.CCR-13-2611; Weroha S, 2008, J MAMMARY GLAND BIOL, V13, P471, DOI 10.1007/s10911-008-9104-6; Xu Y, 1999, GYNECOL ONCOL, V72, P161, DOI 10.1006/gyno.1998.5238	52	14	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126867	10.1371/journal.pone.0126867	http://dx.doi.org/10.1371/journal.pone.0126867			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962155	Green Published, gold, Green Submitted			2022-12-26	WOS:000354542500155
J	Kesorn, K; Ongruk, P; Chompoosri, J; Phumee, A; Thavara, U; Tawatsin, A; Siriyasatien, P				Kesorn, Kraisak; Ongruk, Phatsavee; Chompoosri, Jakkrawarn; Phumee, Atchara; Thavara, Usavadee; Tawatsin, Apiwat; Siriyasatien, Padet			Morbidity Rate Prediction of Dengue Hemorrhagic Fever (DHF) Using the Support Vector Machine and the Aedes aegypti Infection Rate in Similar Climates and Geographical Areas	PLOS ONE			English	Article							VIRUS; SURVEILLANCE; CULICIDAE; DIPTERA; MODELS	Background In the past few decades, several researchers have proposed highly accurate prediction models that have typically relied on climate parameters. However, climate factors can be unreliable and can lower the effectiveness of prediction when they are applied in locations where climate factors do not differ significantly. The purpose of this study was to improve a dengue surveillance system in areas with similar climate by exploiting the infection rate in the Aedes aegypti mosquito and using the support vector machine (SVM) technique for forecasting the dengue morbidity rate. Methods and Findings Areas with high incidence of dengue outbreaks in central Thailand were studied. The proposed framework consisted of the following three major parts: 1) data integration, 2) model construction, and 3) model evaluation. We discovered that the Ae. aegypti female and larvae mosquito infection rates were significantly positively associated with the morbidity rate. Thus, the increasing infection rate of female mosquitoes and larvae led to a higher number of dengue cases, and the prediction performance increased when those predictors were integrated into a predictive model. In this research, we applied the SVM with the radial basis function (RBF) kernel to forecast the high morbidity rate and take precautions to prevent the development of pervasive dengue epidemics. The experimental results showed that the introduced parameters significantly increased the prediction accuracy to 88.37% when used on the test set data, and these parameters led to the highest performance compared to state-of-the-art forecasting models. Conclusions The infection rates of the Ae. aegypti female mosquitoes and larvae improved the morbidity rate forecasting efficiency better than the climate parameters used in classical frameworks. We demonstrated that the SVM-R-based model has high generalization performance and obtained the highest prediction performance compared to classical models as measured by the accuracy, sensitivity, specificity, and mean absolute error (MAE).	[Kesorn, Kraisak; Ongruk, Phatsavee] Naresuan Univ, Fac Sci, Comp Sci & Informat Technol Dept, Phitsanulok, Thailand; [Chompoosri, Jakkrawarn; Thavara, Usavadee; Tawatsin, Apiwat] Natl Inst Hlth, Dept Med Sci, Minist Publ Hlth, Nonthaburi, Thailand; [Phumee, Atchara; Siriyasatien, Padet] Chulalongkorn Univ, Fac Med, Dept Parasitol, Bangkok 10330, Thailand; [Siriyasatien, Padet] King Chulalongkorn Mem Hosp, Excellence Ctr Emerging Infect Dis, Thai Red Cross Soc, Bangkok, Thailand	Naresuan University; Ministry of Public Health - Thailand; Chulalongkorn University; Chulalongkorn University; Thai Red Cross Society	Kesorn, K (corresponding author), Naresuan Univ, Fac Sci, Comp Sci & Informat Technol Dept, Phitsanulok, Thailand.	kraisakk@nu.ac.th	PHUMEE, ATCHARA/AAG-4881-2020; Kesorn, Kraisak/AAU-2475-2020; Kesorn, Kraisak/AAE-8562-2020; siriyasatien, padet/F-3936-2012	PHUMEE, ATCHARA/0000-0001-8243-7406; Kesorn, Kraisak/0000-0002-5195-8038; Siriyasatien, Padet/0000-0002-9248-1678	National Research Council in Thailand [Phor Khor/2555-125]; National Science and Technology Development Agency (Thailand)	National Research Council in Thailand; National Science and Technology Development Agency (Thailand)	This research was supported by the National Research Council in Thailand, Project no: Phor Khor/2555-125 and the National Science and Technology Development Agency (Thailand) for a Research Chair Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althouse BM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001258; [Anonymous], 2003, PRACTICAL GUIDE SUPP; Arcari P, 2007, SINGAPORE J TROP GEO, V28, P251, DOI 10.1111/j.1467-9493.2007.00300.x; Campbell-Lendrum D, 2007, J URBAN HEALTH, V84, pI109, DOI 10.1007/s11524-007-9170-x; Cao LJ, 2003, IEEE T NEURAL NETWOR, V14, P1506, DOI 10.1109/TNN.2003.820556; Chen CF, 2010, VECTOR-BORNE ZOONOT, V10, P1017, DOI 10.1089/vbz.2008.0069; Chompoosri J, 2012, THAI J VET MED, V42, P185; Choudhury MAHZ., 2008, DENGUE BULL, V32, P29; Descloux E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001470; Evgeniou T, 2000, INT J COMPUT VISION, V38, P9, DOI 10.1023/A:1008110632619; Faisal T, 2012, J MED SYST, V36, P661, DOI 10.1007/s10916-010-9532-x; Fathima S, 2011, COMPARISON OF CLASSI, P538; Focks DA, 1997, AM J TROP MED HYG, V56, P159, DOI 10.4269/ajtmh.1997.56.159; FOCKS DA, 1995, AM J TROP MED HYG, V53, P489, DOI 10.4269/ajtmh.1995.53.489; Gharbi M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-166; Gibbons RV, 2002, BMJ-BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563; Goh K. T., 1997, Annals Academy of Medicine Singapore, V26, P664; Halide H, 2008, INT J ENVIRON HEAL R, V18, P253, DOI 10.1080/09603120801966043; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hearst MA, 1998, IEEE INTELL SYST APP, V13, P18, DOI 10.1109/5254.708428; Hii YL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001908; Huang XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081887; Husin NA, 2008, INTERNATIONAL SYMPOSIUM OF INFORMATION TECHNOLOGY 2008, VOLS 1-4, PROCEEDINGS, P1796; Ibrahim F, 2010, MED BIOL ENG COMPUT, V48, P1141, DOI 10.1007/s11517-010-0669-z; Johansson MA, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000168; Luz PM, 2008, AM J TROP MED HYG, V79, P933, DOI 10.4269/ajtmh.2008.79.933; Mitchell T.M, 2003, MACH LEARN; Mourya DT, 2001, ACTA VIROL, V45, P67; Nakhapakorn Kanchana, 2005, Int J Health Geogr, V4, P13; Racloz V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001648; Schmidt WP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001082; Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89; Stewart-Ibarra AM, 2013, AM J TROP MED HYG, V88, P971, DOI 10.4269/ajtmh.12-0478; Thammapalo Suwich, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P191; Thu Hlaing Myat, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P280; Urdaneta Ludmel, 2005, Infection Genetics and Evolution, V5, P177, DOI 10.1016/j.meegid.2004.09.004; VAPNIK V, 1995, THE NATURE OF STATIS; Wangroongsarb Y., 1997, Dengue Bulletin, V21, P52; Xie Y, 2008, C IND ELECT APPL, P2228, DOI 10.1109/ICIEA.2008.4582913; Yusof Y., 2011, INT J COMPUT THEORY, V3, P489, DOI [DOI 10.7763/IJCTE.2011.V3.355, 10.7763/IJCTE.2011.V3.355]	41	29	29	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0125049	10.1371/journal.pone.0125049	http://dx.doi.org/10.1371/journal.pone.0125049			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961289	gold, Green Submitted, Green Published			2022-12-26	WOS:000354542500024
J	Wylie, GR; Freeman, K; Thomas, A; Shpaner, M; OKeefe, M; Watts, R; Naylor, MR				Wylie, Glenn R.; Freeman, Kalev; Thomas, Alex; Shpaner, Marina; OKeefe, Michael; Watts, Richard; Naylor, Magdalena R.			Cognitive Improvement after Mild Traumatic Brain Injury Measured with Functional Neuroimaging during the Acute Period	PLOS ONE			English	Article							WORKING-MEMORY LOAD; HEAD-INJURY; NETWORK; CONNECTIVITY; SYMPTOMS; RECOVERY; RETURN; TBI; ABNORMALITIES; RECRUITMENT	Functional neuroimaging studies in mild traumatic brain injury (mTBI) have been largely limited to patients with persistent post-concussive symptoms, utilizing images obtained months to years after the actual head trauma. We sought to distinguish acute and delayed effects of mild traumatic brain injury on working memory functional brain activation patterns < 72 hours after mild traumatic brain injury (mTBI) and again one-week later. We hypothesized that clinical and fMRI measures of working memory would be abnormal in symptomatic mTBI patients assessed < 72 hours after injury, with most patients showing clinical recovery (i.e., improvement in these measures) within 1 week after the initial assessment. We also hypothesized that increased memory workload at 1 week following injury would expose different cortical activation patterns in mTBI patients with persistent post-concussive symptoms, compared to those with full clinical recovery. We performed a prospective, cohort study of working memory in emergency department patients with isolated head injury and clinical diagnosis of concussion, compared to control subjects (both uninjured volunteers and emergency department patients with extremity injuries and no head trauma). The primary outcome of cognitive recovery was defined as resolution of reported cognitive impairment and quantified by scoring the subject's reported cognitive post-concussive symptoms at 1 week. Secondary outcomes included additional post-concussive symptoms and neurocognitive testing results. We enrolled 46 subjects: 27 with mild TBI and 19 controls. The time of initial neuroimaging was 48 (22 S.D.) hours after injury (time 1). At follow up (8.7, + 1.2 S.D., days after injury, time 2), 18 of mTBI subjects (64%) reported moderate to complete cognitive recovery, 8 of whom fully recovered between initial and follow-up imaging. fMRI changes from time 1 to time 2 showed an increase in posterior cingulate activation in the mTBI subjects compared to controls. Increases in activation were greater in those mTBI subjects without cognitive recovery. As workload increased in mTBI subjects, activation increased in cortical regions in the right hemisphere. In summary, we found neuroimaging evidence for working memory deficits during the first week following mild	[Wylie, Glenn R.] Kessler Fdn, Rocco Ortenzio Neuroimaging Ctr, W Orange, NJ USA; [Wylie, Glenn R.] Rutgers State Univ, Sch Med, Dept Phys Med & Rehabil, Newark, NJ 07102 USA; [Wylie, Glenn R.] War Related Illness & Injury Study Ctr, Dept Vet Affairs, E Orange, NJ USA; [Freeman, Kalev; Thomas, Alex; Shpaner, Marina; OKeefe, Michael; Watts, Richard; Naylor, Magdalena R.] Univ Vermont, Dept Psychiat, Burlington, VT 05405 USA	Kessler Institute for Rehabilitation; Rutgers State University Newark; Rutgers State University New Brunswick; University of Vermont	Naylor, MR (corresponding author), Univ Vermont, Dept Psychiat, Burlington, VT 05405 USA.	magdalena.naylor@uvm.edu			Department of Surgery at UVM; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM098795] Funding Source: NIH RePORTER	Department of Surgery at UVM; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an internal grant from the Department of Surgery at UVM to Dr. Freeman.	Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Bryer EJ, 2013, J INT NEUROPSYCH SOC, V19, P751, DOI 10.1017/S1355617713000490; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Chen JK, 2008, CLIN J SPORT MED, V18, P241, DOI 10.1097/JSM.0b013e318170b59d; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Das A, 2012, NEUROLOGY, V79, P2146, DOI 10.1212/WNL.0b013e3182752cdb; EDNA TH, 1987, ACTA NEUROCHIR, V86, P12, DOI 10.1007/BF01419498; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Gosselin N, 2011, J NEUROTRAUM, V28, P329, DOI 10.1089/neu.2010.1493; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hillary FG, 2011, BRAIN, V134, P1555, DOI 10.1093/brain/awr043; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Kasahara M, 2011, BRAIN INJURY, V25, P1170, DOI 10.3109/02699052.2011.608210; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Mayer AR, 2009, HUM BRAIN MAPP, V30, P4152, DOI 10.1002/hbm.20836; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; Newsome MR, 2007, CORTEX, V43, P95, DOI 10.1016/S0010-9452(08)70448-9; Palacios EM, 2012, NEUROLOGY, V78, P852, DOI 10.1212/WNL.0b013e31824c465a; Pardini JE, 2010, NEUROSURGERY, V67, P1020, DOI 10.1227/NEU.0b013e3181ee33e2; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; Ricker JH, 2001, J HEAD TRAUMA REHAB, V16, P191, DOI 10.1097/00001199-200104000-00007; Sanchez-Carrion R, 2008, NEUROIMAGE, V43, P421, DOI 10.1016/j.neuroimage.2008.08.003; Singh KD, 2008, NEUROIMAGE, V41, P100, DOI 10.1016/j.neuroimage.2008.01.051; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Turner GR, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00009; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Wilde EA, 2011, INT J PSYCHOPHYSIOL, V82, P86, DOI 10.1016/j.ijpsycho.2011.04.006	38	30	32	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126110	10.1371/journal.pone.0126110	http://dx.doi.org/10.1371/journal.pone.0126110			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962067	Green Published, gold, Green Submitted			2022-12-26	WOS:000354542500063
J	del Rey, M; Benito, R; Fontanillo, C; Campos-Laborie, FJ; Janusz, K; Velasco-Hernandez, T; Abaigar, M; Hernandez, M; Cuello, R; Borrego, D; Martin-Zanca, D; Rivas, JDL; Mills, KI; Hernandez-Rivas, JM				del Rey, Monica; Benito, Rocio; Fontanillo, Celia; Campos-Laborie, Francisco J.; Janusz, Kamila; Velasco-Hernandez, Talia; Abaigar, Maria; Hernandez, Maria; Cuello, Rebeca; Borrego, Daniel; Martin-Zanca, Dionisio; Rivas, Javier De Las; Mills, Ken I.; Hernandez-Rivas, Jesus M.			Deregulation of Genes Related to Iron and Mitochondrial Metabolism in Refractory Anemia with Ring Sideroblasts	PLOS ONE			English	Article							WORLD-HEALTH-ORGANIZATION; MYELODYSPLASTIC SYNDROMES; SF3B1 MUTATIONS; EXPRESSION; TRANSPORTER; ATAXIA; ABCB7; CLASSIFICATION; IDENTIFICATION; MITOFERRIN	The presence of SF3B1 gene mutations is a hallmark of refractory anemia with ring sideroblasts (RARS). However, the mechanisms responsible for iron accumulation that characterize the Myelodysplastic Syndrome with ring sideroblasts (MDS-RS) are not completely understood. In order to gain insight in the molecular basis of MDS-RS, an integrative study of the expression and mutational status of genes related to iron and mitochondrial metabolism was carried out. A total of 231 low-risk MDS patients and 81 controls were studied. Gene expression analysis revealed that iron metabolism and mitochondrial function had the highest number of genes deregulated in RARS patients compared to controls and the refractory cytopenias with unilineage dysplasia (RCUD). Thus mitochondrial transporters SLC25 (SLC25A37 and SLC25A38) and ALAD genes were over-expressed in RARS. Moreover, significant differences were observed between patients with SF3B1 mutations and patients without the mutations. The deregulation of genes involved in iron and mitochondrial metabolism provides new insights in our knowledge of MDS-RS. New variants that could be involved in the pathogenesis of these diseases have been identified.	[del Rey, Monica; Benito, Rocio; Fontanillo, Celia; Campos-Laborie, Francisco J.; Janusz, Kamila; Abaigar, Maria; Hernandez, Maria; Rivas, Javier De Las; Hernandez-Rivas, Jesus M.] Univ Salamanca, CSIC, CIC, IBMCC, E-37008 Salamanca, Spain; [del Rey, Monica; Benito, Rocio; Fontanillo, Celia; Campos-Laborie, Francisco J.; Janusz, Kamila; Abaigar, Maria; Hernandez, Maria; Rivas, Javier De Las; Hernandez-Rivas, Jesus M.] Inst Invest Biomed Salamanca, IBSAL, Salamanca, Spain; [Velasco-Hernandez, Talia; Martin-Zanca, Dionisio] Univ Salamanca, CSIC, Inst Biol Func & Genom, E-37008 Salamanca, Spain; [Cuello, Rebeca; Borrego, Daniel] Hosp Clin Valladolid, Serv Hematol, Valladolid, Spain; [Mills, Ken I.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland; [Hernandez-Rivas, Jesus M.] Hosp Univ Salamanca, Serv Hematol, Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca; Queens University Belfast; University of Salamanca	Hernandez-Rivas, JM (corresponding author), Univ Salamanca, CSIC, CIC, IBMCC, E-37008 Salamanca, Spain.	jmhr@usal.es	Velasco-Hernández, Talía/AAD-9753-2019; Campos-Laborie, Francisco Jose/AAK-5744-2020; Alvarado, María Abáigar/V-9309-2017; BENITO, ROCIO/B-4271-2017; Hernandez Rivas, Jesus Maria/B-5459-2017; De Las Rivas, Javier/G-5936-2014; Mills, Ken/A-8556-2012	Velasco-Hernández, Talía/0000-0003-2183-7443; Campos-Laborie, Francisco Jose/0000-0002-1213-0457; Alvarado, María Abáigar/0000-0002-5716-6242; BENITO, ROCIO/0000-0001-9781-4198; Hernandez Rivas, Jesus Maria/0000-0002-9661-9371; De Las Rivas, Javier/0000-0002-0984-9946; Mills, Ken/0000-0002-6362-4481; Fontanillo, Celia/0000-0002-3631-7881	Spanish Fondo de Investigaciones Sanitarias [PI14/1971, PI12/00281]; Proyectos de Investigacion del SACYL [BIO/SA52/14, BIO/SA10/14, BIO/SA31/13, GRS 994/A/14]; Consejeria Educacion, Junta Castilla y Leon [HUS272U13]; COST Action "EuGESMA" [BM0801]; Red Tematica de Investigacion Cooperativa en Cancer (RTICC); Instituto de Salud Carlos III (ISCIII); Spanish Ministry of Economy and Competitiveness & European Regional Development Fund (ERDF) [RD12/0036/0069, RD12/0036/0029, RD12/0036/0044]; European Union [306242- NGS-PTL]; Fundacion Espanola de Hematologia y Hemoterapia; Spanish Consejo Superior de Investigaciones Cientificas, Junta para la Ampliacion de Estudios (JAE Predoctoral) [09-02402]; "Ayuda predoctoral de la Junta de Castilla y Leon" from "European Regional Development Fund"; Spanish Ministry of Science and Innovation [PI082025]; Junta de Castilla y Leon [CSI224A11-2, SAN/103/2011]; Leukaemia & Lymphoma NI [R2536CNR, R2029HAE, R2043HAE] Funding Source: researchfish	Spanish Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Proyectos de Investigacion del SACYL; Consejeria Educacion, Junta Castilla y Leon; COST Action "EuGESMA"(European Cooperation in Science and Technology (COST)); Red Tematica de Investigacion Cooperativa en Cancer (RTICC)(European Commission); Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Spanish Ministry of Economy and Competitiveness & European Regional Development Fund (ERDF)(Spanish Government); European Union(European Commission); Fundacion Espanola de Hematologia y Hemoterapia; Spanish Consejo Superior de Investigaciones Cientificas, Junta para la Ampliacion de Estudios (JAE Predoctoral); "Ayuda predoctoral de la Junta de Castilla y Leon" from "European Regional Development Fund"(Junta de Castilla y Leon); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon); Leukaemia & Lymphoma NI	This work was partially supported by grants from: the Spanish Fondo de Investigaciones Sanitarias (PI14/1971, PI12/00281); Proyectos de Investigacion del SACYL (BIO/SA52/14, BIO/SA10/14, BIO/SA31/13, GRS 994/A/14); Consejeria Educacion, Junta Castilla y Leon (HUS272U13); COST Action "EuGESMA" (BM0801); Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Instituto de Salud Carlos III (ISCIII), Spanish Ministry of Economy and Competitiveness & European Regional Development Fund (ERDF) "Una manera de hacer Europa" (Innocampus) (RD12/0036/0069, RD12/0036/0029, RD12/0036/0044); European Union's Seventh Framework Programme (FP7/2007-2013 no 306242- NGS-PTL). MDR is fully supported by a "Grant from Fundacion Espanola de Hematologia y Hemoterapia". MA was fully supported by a "Grant from the Spanish Consejo Superior de Investigaciones Cientificas, Junta para la Ampliacion de Estudios (JAE Predoctoral) [09-02402]". MH is fully suported by an "Ayuda predoctoral de la Junta de Castilla y Leon" from "European Regional Development Fund". DMZ was funded by the Spanish Ministry of Science and Innovation (PI082025) and Junta de Castilla y Leon (CSI224A11-2, SAN/103/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allikmets R, 1999, HUM MOL GENET, V8, P743, DOI 10.1093/hmg/8.5.743; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], LEUKEMIA; Bekri S, 2000, BLOOD, V96, P3256; Boultwood J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001970; Cavadini P, 2007, BLOOD, V109, P3552, DOI 10.1182/blood-2006-08-041632; Cazzola M, 2005, NEW ENGL J MED, V352, P536, DOI 10.1056/NEJMp048266; COTTER PD, 1994, BLOOD, V84, P3915, DOI 10.1182/blood.V84.11.3915.bloodjournal84113915; Cuijpers MLH, 2010, BRIT J HAEMATOL, V149, P322, DOI 10.1111/j.1365-2141.2009.08051.x; Damm F, 2012, LEUKEMIA, V26, P1137, DOI 10.1038/leu.2011.321; del Rey M, 2013, LEUKEMIA, V27, P610, DOI 10.1038/leu.2012.253; del Rey M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053624; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Guernsey DL, 2009, NAT GENET, V41, P651, DOI 10.1038/ng.359; Haferlach T, 2010, J CLIN ONCOL, V28, P2529, DOI 10.1200/JCO.2009.23.4732; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Krishnamurthy P, 2007, PHARMACOL THERAPEUT, V114, P345, DOI 10.1016/j.pharmthera.2007.02.001; Krishnamurthy PC, 2006, NATURE, V443, P586, DOI 10.1038/nature05125; Lakhal S, 2009, BLOOD, V113, P1555, DOI 10.1182/blood-2008-07-170431; Malcovati L, 2011, BLOOD, V118, P6239, DOI 10.1182/blood-2011-09-377275; Martin-Guerrero I, 2011, GENE CHROMOSOME CANC, V50, P887, DOI 10.1002/gcc.20912; Mills KI, 2009, BLOOD, V114, P1063, DOI 10.1182/blood-2008-10-187203; Nikpour M, 2010, BRIT J HAEMATOL, V149, P844, DOI 10.1111/j.1365-2141.2010.08174.x; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Paradkar PN, 2009, MOL CELL BIOL, V29, P1007, DOI 10.1128/MCB.01685-08; Patnaik MM, 2012, BLOOD, V119, P569, DOI 10.1182/blood-2011-09-377994; Pellagatti A, 2010, LEUKEMIA, V24, P756, DOI 10.1038/leu.2010.31; Pellagatti A, 2006, BLOOD, V108, P337, DOI 10.1182/blood-2005-12-4769; Pondarre C, 2007, BLOOD, V109, P3567, DOI 10.1182/blood-2006-04-015768; Ramirez JM, 2009, BRIT J HAEMATOL, V144, P251, DOI 10.1111/j.1365-2141.2008.07441.x; Risueno A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-221; Rousseau J, 2011, BLOOD, V118, P5883, DOI 10.1182/blood-2011-05-355560; SASSA S, 1982, ENZYME, V28, P133, DOI 10.1159/000459097; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Steensma DP, 2007, LEUKEMIA RES, V31, P623, DOI 10.1016/j.leukres.2006.06.005; Tanno T, 2007, NAT MED, V13, P1096, DOI 10.1038/nm1629; Theilgaard-Monch K, 2011, LEUKEMIA, V25, P909, DOI 10.1038/leu.2011.48; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Vardiman JW, 2002, BLOOD, V100, P2292, DOI 10.1182/blood-2002-04-1199; Visconte V, 2012, LEUKEMIA, V26, P542, DOI 10.1038/leu.2011.232; Visconte V, 2012, BLOOD, V120, P3173, DOI 10.1182/blood-2012-05-430876; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496	45	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0126555	10.1371/journal.pone.0126555	http://dx.doi.org/10.1371/journal.pone.0126555			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955609	Green Published, Green Submitted, gold			2022-12-26	WOS:000356768100130
J	Takeshita, N; Wernet, V; Tsuizaki, M; Grun, N; Hoshi, H; Ohta, A; Fischer, R; Horiuchi, H				Takeshita, Norio; Wernet, Valentin; Tsuizaki, Makusu; Gruen, Nathalie; Hoshi, Hiro-omi; Ohta, Akinori; Fischer, Reinhard; Horiuchi, Hiroyuki			Transportation of Aspergillus nidulans Class III and V Chitin Synthases to the Hyphal Tips Depends on Conventional Kinesin	PLOS ONE			English	Article							MOTOR-LIKE DOMAIN; RETROGRADE ENDOSOME MOTILITY; LONG-DISTANCE MOVEMENT; SACCHAROMYCES-CEREVISIAE; ACTIN CYTOSKELETON; POLARIZED GROWTH; DYNEIN; GENE; LOCALIZATION; CSMA	Cell wall formation and maintenance are crucial for hyphal morphogenesis. In many filamentous fungi, chitin is one of the main structural components of the cell wall. Aspergillus nidulans ChsB, a chitin synthase, and CsmA, a chitin synthase with a myosin motor-like domain (MMD) at its N-terminus, both localize predominantly at the hyphal tip regions and at forming septa. ChsB and CsmA play crucial roles in polarized hyphal growth in A. nidulans. In this study, we investigated the mechanism by which CsmA and ChsB accumulate at the hyphal tip in living hyphae. Deletion of kinA, a gene encoding conventional kinesin (kinesin-1), impaired the localization of GFP-CsmA and GFP-ChsB at the hyphal tips. The transport frequency of GFP-CsmA and GFP-ChsB in both anterograde and retrograde direction appeared lower in the kinA-deletion strain compared to wild type, although the velocities of the movements were comparable. Co-localization of GFP-ChsB and GFP-CsmA with mRFP1-KinA(rigor), a KinA mutant that binds to microtubules but does not move along them, was observed in the posterior of the hyphal tip regions. KinA co-immunoprecipitated with ChsB and CsmA. Co-localization and association of CsmA with KinA did not depend on the MMD. These findings indicate that ChsB and CsmA are transported along microtubules to the subapical region by KinA.	[Takeshita, Norio; Wernet, Valentin; Gruen, Nathalie; Fischer, Reinhard] Karlsruhe Inst Technol, Dept Microbiol, Inst Appl Biosci, D-76021 Karlsruhe, Germany; [Tsuizaki, Makusu; Hoshi, Hiro-omi; Ohta, Akinori; Horiuchi, Hiroyuki] Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo, Japan; [Takeshita, Norio] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan	Helmholtz Association; Karlsruhe Institute of Technology; University of Tokyo; University of Tsukuba	Takeshita, N (corresponding author), Karlsruhe Inst Technol, Dept Microbiol, Inst Appl Biosci, D-76021 Karlsruhe, Germany.	norio.takeshita@kit.edu; ahhoriu@mail.ecc.u-tokyo.ac.jp	Fischer, Reinhard/I-1220-2016	Fischer, Reinhard/0000-0002-6704-2569; Wernet, Valentin/0000-0002-3747-6171; Takeshita, Norio/0000-0003-2666-4991	German Research Foundation (DFG) [TA819/2-1]; Baden-Wurttemberg Stiftung, Eliteprogramm fur Postdocs; German Research Foundation Grant [FOR1334];  [10J03260]	German Research Foundation (DFG)(German Research Foundation (DFG)); Baden-Wurttemberg Stiftung, Eliteprogramm fur Postdocs; German Research Foundation Grant; 	NT was supported by German Research Foundation (DFG; http://www.dfg.de/) Grant No. TA819/2-1 and by the Baden-Wurttemberg Stiftung, Eliteprogramm fur Postdocs (http://www.bwstiftung.de/startseite/). RF was supported by German Research Foundation Grant No. FOR1334. MT was supported by Grant-in-Aid for Japan Society for the Promotion of Science Grant No. 10J03260. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abenza JF, 2010, MOL BIOL CELL, V21, P2756, DOI 10.1091/mbc.E10-02-0119; Abenza JF, 2009, TRAFFIC, V10, P57, DOI 10.1111/j.1600-0854.2008.00848.x; Penalva MA, 2010, CURR OPIN MICROBIOL, V13, P684, DOI 10.1016/j.mib.2010.09.005; Araujo-Bazan L, 2008, MOL MICROBIOL, V67, P891, DOI 10.1111/j.1365-2958.2007.06102.x; AufauvreBrown A, 1997, FUNGAL GENET BIOL, V21, P141, DOI 10.1006/fgbi.1997.0959; Banks IR, 2005, EUKARYOT CELL, V4, P1902, DOI 10.1128/EC.4.11.1902-1912.2005; Bartnicki-Garcia S, 2006, FEMS YEAST RES, V6, P957, DOI 10.1111/j.1567-1364.2006.00158.x; Baumann S, 2012, J CELL SCI, V125, P2740, DOI 10.1242/jcs.101212; Chigira Y, 2002, CURR GENET, V41, P261, DOI 10.1007/s00294-002-0305-z; Choquer M, 2004, EUR J BIOCHEM, V271, P2153, DOI 10.1111/j.1432-1033.2004.04135.x; Egan MJ, 2012, J CELL BIOL, V197, P971, DOI 10.1083/jcb.201112101; Fischer R, 2008, MOL MICROBIOL, V68, P813, DOI 10.1111/j.1365-2958.2008.06193.x; Fujiwara M, 1997, BIOCHEM BIOPH RES CO, V236, P75, DOI 10.1006/bbrc.1997.6907; Fukuda K, 2009, EUKARYOT CELL, V8, P945, DOI 10.1128/EC.00326-08; Harris SD, 2009, MOL MICROBIOL, V73, P733, DOI 10.1111/j.1365-2958.2009.06803.x; Hervas-Aguilar A, 2010, EUKARYOT CELL, V9, P1504, DOI 10.1128/EC.00119-10; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Horiuchi H, 1999, J BACTERIOL, V181, P3721, DOI 10.1128/JB.181.12.3721-3729.1999; Ichinomiya M, 2005, EUKARYOT CELL, V4, P1125, DOI 10.1128/EC.4.6.1125-1136.2005; Ichinomiya M, 2002, MICROBIOL-SGM, V148, P1335, DOI 10.1099/00221287-148-5-1335; Kim JE, 2009, CURR GENET, V55, P449, DOI 10.1007/s00294-009-0258-6; Kong LA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002526; Konzack S, 2005, MOL BIOL CELL, V16, P497, DOI 10.1091/mbc.E04-02-0083; Larson TM, 2011, CURR GENET, V57, P177, DOI 10.1007/s00294-011-0334-6; Lenardon MD, 2010, CURR OPIN MICROBIOL, V13, P416, DOI 10.1016/j.mib.2010.05.002; Lenz JH, 2006, EMBO J, V25, P2275, DOI 10.1038/sj.emboj.7601119; Liu HB, 2004, EUKARYOT CELL, V3, P40, DOI 10.1128/EC.3.1.40-51.2004; May G., 1992, APPL MOL GENETICS FI, P1; MCGOLDRICK CA, 1995, J CELL BIOL, V128, P577, DOI 10.1083/jcb.128.4.577; Mellado E, 1996, MOL MICROBIOL, V20, P667, DOI 10.1046/j.1365-2958.1996.5571084.x; MOTOYAMA T, 1994, BIOSCI BIOTECH BIOCH, V58, P2254, DOI 10.1271/bbb.58.2254; Motoyama T, 1996, MOL GEN GENET, V251, P442, DOI 10.1007/BF02172373; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Pareja-Jaime Y, 2010, MOL PLANT PATHOL, V11, P479, DOI [10.1111/j.1364-3703.2010.00624.x, 10.1111/J.1364-3703.2010.00624.X]; Penalva Miguel A, 2012, Cell Logist, V2, P2; Requena N, 2001, MOL MICROBIOL, V42, P121, DOI 10.1046/j.1365-2958.2001.02609.x; RIEDER SE, 2001, CURR PROTOC CELL BIO; Riquelme M, 2007, EUKARYOT CELL, V6, P1853, DOI 10.1128/EC.00088-07; Rittenour William R., 2009, Fungal Biology Reviews, V23, P20, DOI 10.1016/j.fbr.2009.08.001; Rogg LE, 2012, MED MYCOL, V50, P2, DOI 10.3109/13693786.2011.577104; ROWLANDS RT, 1973, MOL GEN GENET, V126, P201, DOI 10.1007/BF00267531; Sambrook J., 2001, MOL CLONING LAB MANU; Sanchez-Leon E, 2011, EUKARYOT CELL, V10, P683, DOI 10.1128/EC.00280-10; Schoch CL, 2003, FUNGAL GENET BIOL, V39, P1, DOI 10.1016/S1087-1845(03)00022-7; Schuchardt I, 2005, MOL BIOL CELL, V16, P5191, DOI 10.1091/mbc.E05-04-0272; Schuster M, 2012, EMBO J, V31, P214, DOI 10.1038/emboj.2011.361; Schuster M, 2011, MOL BIOL CELL, V22, P3645, DOI [10.1091/E11-03-0217, 10.1091/mbc.E11-03-0217]; Schuster M, 2011, EMBO J, V30, P652, DOI 10.1038/emboj.2010.360; Seidel C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030976; Seiler S, 1999, CURR BIOL, V9, P779, DOI 10.1016/S0960-9822(99)80360-1; Sheng W, 2013, BIOSCI BIOTECH BIOCH, V77, P1275, DOI 10.1271/bbb.130111; Soulie MC, 2006, CELL MICROBIOL, V8, P1310, DOI 10.1111/j.1462-5822.2006.00711.x; Steinberg G, 2014, CURR OPIN MICROBIOL, V20, P10, DOI 10.1016/j.mib.2014.04.001; Steinberg G, 2011, CURR OPIN MICROBIOL, V14, P660, DOI 10.1016/j.mib.2011.09.013; Sudbery Peter E., 2008, Fungal Biology Reviews, V22, P44, DOI 10.1016/j.fbr.2008.07.001; Taheri-Talesh N, 2008, MOL BIOL CELL, V19, P1439, DOI 10.1091/mbc.E07-05-0464; Taheri-Talesh N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031218; Takeshita N, 2006, MOL MICROBIOL, V59, P1380, DOI 10.1111/j.1365-2958.2006.05030.x; Takeshita N, 2005, MOL BIOL CELL, V16, P1961, DOI 10.1091/mbc.E04-09-0761; Takeshita N, 2002, BIOCHEM BIOPH RES CO, V298, P103, DOI 10.1016/S0006-291X(02)02418-X; Takeshita N, 2014, CURR OPIN MICROBIOL, V20, P34, DOI 10.1016/j.mib.2014.04.005; Treitschke S, 2010, PLANT CELL, V22, P2476, DOI 10.1105/tpc.110.075028; Tsuizaki M, 2013, BIOSCI BIOTECH BIOCH, V77, P369, DOI 10.1271/bbb.120822; Tsuizaki M, 2009, BIOSCI BIOTECH BIOCH, V73, P1163, DOI 10.1271/bbb.90074; Upadhyay S, 2008, MOL MICROBIOL, V68, P690, DOI 10.1111/j.1365-2958.2008.06178.x; Werner S, 2007, MOL PLANT MICROBE IN, V20, P1555, DOI 10.1094/MPMI-20-12-1555; Yabe T, 1998, EUR J BIOCHEM, V258, P941, DOI 10.1046/j.1432-1327.1998.2580941.x; YANAI K, 1994, BIOSCI BIOTECH BIOCH, V58, P1828, DOI 10.1271/bbb.58.1828; Yao XL, 2012, TRAFFIC, V13, P375, DOI 10.1111/j.1600-0854.2011.01312.x; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Zekert N, 2009, MOL BIOL CELL, V20, P673, DOI 10.1091/mbc.E08-07-0685; Zhang J, 2003, MOL BIOL CELL, V14, P1479, DOI 10.1091/mbc.E02-08-0516; Zhang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028575; Zhang J, 2010, J CELL SCI, V123, P3596, DOI 10.1242/jcs.075259	74	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0125937	10.1371/journal.pone.0125937	http://dx.doi.org/10.1371/journal.pone.0125937			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955346	Green Published, gold			2022-12-26	WOS:000356768100084
J	Witek, B; El Wakil, A; Nord, C; Ahlgren, U; Eriksson, M; Vernersson-Lindahl, E; Helland, A; Alexeyev, OA; Hallberg, B; Palmer, RH				Witek, Barbara; El Wakil, Abeer; Nord, Christoffer; Ahlgren, Ulf; Eriksson, Maria; Vernersson-Lindahl, Emma; Helland, Aslaug; Alexeyev, Oleg A.; Hallberg, Bengt; Palmer, Ruth H.			Targeted Disruption of ALK Reveals a Potential Role in Hypogonadotropic Hypogonadism	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; ANAPLASTIC LYMPHOMA KINASE; HORMONE-RELEASING HORMONE; OPTICAL PROJECTION TOMOGRAPHY; ACTIVATING MUTATIONS; MESSENGER-RNA; CELL; GENE; MICE; CRIZOTINIB	Mice lacking ALK activity have previously been reported to exhibit subtle behavioral phenotypes. In this study of ALK of loss of function mice we present data supporting a role for ALK in hypogonadotropic hypogonadism in male mice. We observed lower level of serum testosterone at P40 in ALK knock-out males, accompanied by mild disorganization of seminiferous tubules exhibiting decreased numbers of GATA4 expressing cells. These observations highlight a role for ALK in testis function and are further supported by experiments in which chemical inhibition of ALK activity with the ALK TKI crizotinib was employed. Oral administration of crizotinib resulted in a decrease of serum testosterone levels in adult wild type male mice, which reverted to normal levels after cessation of treatment. Analysis of GnRH expression in neurons of the hypothalamus revealed a significant decrease in the number of GnRH positive neurons in ALK knock-out mice at P40 when compared with control littermates. Thus, ALK appears to be involved in hypogonadotropic hypogonadism by regulating the timing of pubertal onset and testis function at the upper levels of the hypothalamic-pituitary gonadal axis.	[Hallberg, Bengt] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med Biochem & Cell Biol, Gothenburg, Sweden; [Witek, Barbara; El Wakil, Abeer; Palmer, Ruth H.] Umea Univ, Dept Mol Biol, Umea, Sweden; [Nord, Christoffer; Ahlgren, Ulf; Eriksson, Maria] Umea Univ, Umea Ctr Mol Med, Umea, Sweden; [Vernersson-Lindahl, Emma; Alexeyev, Oleg A.] Umea Univ, Inst Med Biosci Pathol, Umea, Sweden; [Helland, Aslaug] Oslo Univ Hosp, Radiumhosp, Dept Oncol, Oslo, Norway	University of Gothenburg; Umea University; Umea University; Umea University; University of Oslo	Hallberg, B (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med Biochem & Cell Biol, Gothenburg, Sweden.	bengt.hallberg@gu.se; ruth.palmer@gu.se	Helland, Åslaug/H-3910-2015; Wakil, Abeer El/AAD-4693-2019	Helland, Åslaug/0000-0002-5520-0275; Wakil, Abeer El/0000-0003-2117-0677; Ahlgren, Ulf/0000-0001-5923-8572	Swedish Cancer Society [12-0722, 12-0796]; Children's Cancer Foundation [11/020, 13/0049]; Swedish Research Council [621-2011-5181, 521-2012-2831]; Lions Cancer Society, Umea [12-1946]; JC Kempe Foundation; FP-People-IAPP	Swedish Cancer Society(Swedish Cancer Society); Children's Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Lions Cancer Society, Umea; JC Kempe Foundation; FP-People-IAPP	Work in the author's laboratories has been supported by grants from the Swedish Cancer Society (BH 12-0722, RHP 12-0796), the Children's Cancer Foundation (BH 11/020, RHP 13/0049), the Swedish Research Council (RHP 621-2011-5181, BH 521-2012-2831), Lions Cancer Society, Umea (BH and RHP LP 12-1946), the JC Kempe Foundation (BH and RHP) and FP-People-2011-IAPP (BH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanentalo T, 2007, NAT METHODS, V4, P31, DOI 10.1038/NMETH985; Anjamrooz Sayed Hadi, 2007, Iran Biomed J, V11, P15; Arantes-Rodrigues R, 2012, LAB ANIMAL, V41, P129, DOI 10.1038/laban0512-129; Awad Mark M, 2014, Clin Adv Hematol Oncol, V12, P429; Bilsland JG, 2008, NEUROPSYCHOPHARMACOL, V33, P685, DOI 10.1038/sj.npp.1301446; Caren H, 2008, BIOCHEM J, V416, P153, DOI 10.1042/BJ20081834; Charlton H, 2004, REPRODUCTION, V127, P3, DOI 10.1530/rep.1.00066; Cheddad A, 2012, IEEE T MED IMAGING, V31, P1, DOI 10.1109/TMI.2011.2161590; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Cheng Y, 2007, MOL CELL BIOL, V27, P2582, DOI 10.1128/MCB.01722-06; Christensen JG, 2007, MOL CANCER THER, V6, P3314, DOI 10.1158/1535-7163.MCT-07-0365; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Ebling FJP, 2000, NEUROREPORT, V11, pR23, DOI 10.1097/00001756-200011090-00002; Eriksson AU, 2013, JOVE-J VIS EXP, DOI 10.3791/50238; Friboulet L, 2014, CANCER DISCOV, V4, P662, DOI 10.1158/2159-8290.CD-13-0846; FRISCH RE, 1975, P NATL ACAD SCI USA, V72, P4172, DOI 10.1073/pnas.72.10.4172; Galkin AV, 2007, P NATL ACAD SCI USA, V104, P270, DOI 10.1073/pnas.0609412103; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Golde WT, 2005, LAB ANIMAL, V34, P39, DOI 10.1038/laban1005-39; Hallberg B, 2013, NAT REV CANCER, V13, P685, DOI 10.1038/nrc3580; Hornblad A, 2011, ISLETS, V3, P204, DOI 10.4161/isl.3.4.16417; Huhtaniemi I, 2006, MOL CELL ENDOCRINOL, V254, P84, DOI 10.1016/j.mce.2006.04.015; Irwig MS, 2004, NEUROENDOCRINOLOGY, V80, P264, DOI 10.1159/000083140; Iwahara T, 1997, ONCOGENE, V14, P439, DOI 10.1038/sj.onc.1200849; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; KORENBROT CC, 1977, BIOL REPROD, V17, P298, DOI 10.1095/biolreprod17.2.298; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Kyronlahti A, 2011, MOL CELL ENDOCRINOL, V333, P85, DOI 10.1016/j.mce.2010.12.019; Lasek AW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022636; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Morris SW, 1997, ONCOGENE, V14, P2175, DOI 10.1038/sj.onc.1201062; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Mosse YP, 2013, LANCET ONCOL, V14, P472, DOI 10.1016/S1470-2045(13)70095-0; Ou SHI, 2012, ONCOLOGIST, V17, P1351, DOI 10.1634/theoncologist.2012-0311; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Thompson IR, 2014, MOL CELL ENDOCRINOL, V385, P28, DOI 10.1016/j.mce.2013.09.012; Tobet SA, 2001, MOL CELL ENDOCRINOL, V185, P173, DOI 10.1016/S0303-7207(01)00616-5; Vernersson E, 2006, GENE EXPR PATTERNS, V6, P448, DOI 10.1016/j.modgep.2005.11.006; Weickhardt AJ, 2012, CANCER-AM CANCER SOC, V118, P5302, DOI 10.1002/cncr.27450; Weiss JB, 2012, PHARMACOL BIOCHEM BE, V100, P566, DOI 10.1016/j.pbb.2011.10.024; WRAY S, 1989, P NATL ACAD SCI USA, V86, P8132, DOI 10.1073/pnas.86.20.8132; Wray S, 2002, CHEM SENSES, V27, P569, DOI 10.1093/chemse/27.6.569; Wray S, 2001, J NEUROENDOCRINOL, V13, P3, DOI 10.1046/j.1365-2826.2001.00609.x; WRAY S, 1989, DEV BRAIN RES, V46, P309, DOI 10.1016/0165-3806(89)90295-2; Zaneveld LJ., 1977, COLLECTION PHYS EXAM, P147	46	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0123542	10.1371/journal.pone.0123542	http://dx.doi.org/10.1371/journal.pone.0123542			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955180	Green Published, gold, Green Submitted			2022-12-26	WOS:000356768100016
J	Zhang, LL; Xu, PJ; Xiao, HJ; Lu, YH; Liang, GM; Zhang, YJ; Wu, KM				Zhang, Lili; Xu, Pengjun; Xiao, Haijun; Lu, Yanhui; Liang, Gemei; Zhang, Yongjun; Wu, Kongming			Molecular Characterization and Expression Profiles of Polygalacturonase Genes in Apolygus lucorum (Hemiptera: Miridae)	PLOS ONE			English	Article							TARNISHED PLANT BUG; SALIVARY PROTEINS; BT COTTON; LYGUS; IDENTIFICATION; HETEROPTERA; PHYSIOLOGY; CLONING; DAMAGE; PCR	Polygalacturonase (PG) is an enzyme in the salivary glands of piercing-sucking mirid bugs (Hemiptera: Miridae) that plays a key role in plant feeding and injury. By constructing a full-length cDNA library, we cloned and characterized 14 PG genes from the salivary glands of Apolygus lucorum, a pestiferous mirid bug in cotton, fruit trees and other crops in China. BLAST search analysis showed that the amino acid sequences deduced from transcripts of the PG genes were closely related to PGs from other mirid bugs. Phylogenetic analysis showed that the PGs of mirid bugs had six main branches, PG1-PG6 (Genbank accession numbers: KF881899 similar to KF881912). We investigated the mRNA expression patterns of the A. lucorum PG genes using real-time PCR. All 14 PGs were expressed significantly higher in the salivary glands than in other tissues (head, thorax, abdomen, leg and wing). For eggs and nymphs, the expression levels of these PGs were much higher in the 5th instar stage than in the egg, and 1st and 3rd instar stages. The PG expression levels in 1-day-old adults were very low, and increased in 5, 20 and 30-day-old adults. Additionally, PG expression levels were generally similar between males and females. The possible physiological functions of PGs in A. lucorum were discussed.	[Zhang, Lili; Xu, Pengjun; Xiao, Haijun; Lu, Yanhui; Liang, Gemei; Zhang, Yongjun; Wu, Kongming] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Lu, YH (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	yhlu@ippcaas.cn	XIAO, Haijun/AAJ-5321-2021; Xiao, Haijun/HGE-3088-2022	XIAO, Haijun/0000-0002-0832-0493; Xiao, Haijun/0000-0002-0832-0493; Lu, Yanhui/0000-0002-6552-0248	National Natural Science Foundation of China [31171859, 31321004]; National Basic Research Program of China [2012CB114104]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (31171859 and 31321004), and National Basic Research Program of China (2012CB114104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGBLOR A, 1994, FOOD RES INT, V27, P321, DOI 10.1016/0963-9969(94)90187-2; Allen ML, 2007, GENET MOL RES, V6, P206; Allen ML, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.2701; Celorio-Mancera MD, 2009, ARCH INSECT BIOCHEM, V70, P122, DOI 10.1002/arch.20282; Celorio-Mancera MD, 2008, ARTHROPOD-PLANT INTE, V2, P215, DOI 10.1007/s11829-008-9050-7; Dong JW, 2013, ARTHROPOD-PLANT INTE, V7, P83, DOI 10.1007/s11829-012-9222-3; Frati F, 2006, EUR J ENTOMOL, V103, P515, DOI 10.14411/eje.2006.067; Fuller RC, 2011, MOL ECOL, V20, P3321, DOI 10.1111/j.1365-294X.2011.05180.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu YH, 2008, CROP PROT, V27, P465, DOI 10.1016/j.cropro.2007.07.017; Lu Y H, 2008, ACTA PHYTOPHYLACICA, V35, P251, DOI [DOI 10.3866/PKU.WHXB201803163, DOI 10.1016/S1673-8527(08)60035-1]; Lu YanHui, 2011, Outlooks on Pest Management, V22, P248, DOI 10.1564/22dec02; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; Lu YH, 2008, BIOLOGY AND CONTROL; Miles P.W., 1972, Advances Insect Physiol, V9, P183, DOI 10.1016/S0065-2806(08)60277-5; Pan HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068980; Shackel KA, 2005, ARCH INSECT BIOCHEM, V58, P69, DOI 10.1002/arch.20033; Sharma A, 2014, B ENTOMOL RES, V104, P117, DOI 10.1017/S0007485313000618; STRONG FE, 1968, J INSECT PHYSIOL, V14, P1113, DOI 10.1016/0022-1910(68)90050-4; STRONG FE, 1970, J ECON ENTOMOL, V63, P808, DOI 10.1093/jee/63.3.808; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TAYLOR GS, 1994, ENTOMOL EXP APPL, V73, P265, DOI 10.1007/BF02382478; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Walker WB, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14133; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Zhang LL, 2013, ENTOMOL EXP APPL, V149, P292, DOI 10.1111/eea.12125	26	13	14	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0126391	10.1371/journal.pone.0126391	http://dx.doi.org/10.1371/journal.pone.0126391			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955307	Green Published, Green Submitted, gold			2022-12-26	WOS:000356768100117
J	Scala, F; Brighenti, E; Govoni, M; Imbrogno, E; Fornari, F; Trere, D; Montanaro, L; Derenzini, M				Scala, F.; Brighenti, E.; Govoni, M.; Imbrogno, E.; Fornari, F.; Trere, D.; Montanaro, L.; Derenzini, M.			Direct relationship between the level of p53 stabilization induced by rRNA synthesis-inhibiting drugs and the cell ribosome biogenesis rate	ONCOGENE			English	Article							POLYMERASE I; PROTEIN L11; DNA-DAMAGE; ACTIVATION; APOPTOSIS; CANCER; MDM2; PATHWAY; VIVO; 5-FLUOROURACIL	Many drugs currently used in chemotherapy work by hindering the process of ribosome biogenesis. In tumors with functional p53, the inhibition of ribosome biogenesis may contribute to the efficacy of this treatment by inducing p53 stabilization. As the level of stabilized p53 is critical for the induction of cytotoxic effects, it seems useful to highlight those cancer cell characteristics that can predict the degree of p53 stabilization following the treatment with inhibitors of ribosome biogenesis. In the present study we exposed a series of p53 wild-type human cancer cell lines to drugs such as actinomycin D (ActD), doxorubicin, 5-fluorouracil and CX-5461, which hinder ribosomal RNA (rRNA) synthesis. We found that the amount of stabilized p53 was directly related to the level of ribosome biogenesis in cells before the drug treatment. This was due to different levels of inactivation of the ribosomal proteins-MDM2 pathway of p53 digestion. Inhibition of rRNA synthesis always caused cell cycle arrest, independent of the ribosome biogenesis rate of the cells, whereas apoptosis occurred only in cells with a high rDNA transcription rate. The level of p53 stabilization induced by drugs acting in different ways from the inhibition of ribosome biogenesis, such as hydroxyurea (HU) and nutlin-3, was independent of the level of ribosome biogenesis in cells and always lower than that occurring after the inhibition of rRNA synthesis. Interestingly, in cells with a low ribosome biogenesis rate, the combined treatment with ActD and HU exerted an additive effect on p53 stabilization. These results indicated that (i) drugs inhibiting ribosome biogenesis may be highly effective in p53 wild-type cancers with a high ribosome biogenesis rate, as they induce apoptotic cell death, and (ii) the combination of drugs capable of stabilizing p53 through different mechanisms may be useful for treating cancers with a low ribosome biogenesis rate.	[Scala, F.; Brighenti, E.; Govoni, M.; Imbrogno, E.; Trere, D.; Montanaro, L.; Derenzini, M.] Univ Bologna, Dept Expt Diagnost & Specialty Med, Via Massarenti 9, I-40138 Bologna, Italy; [Fornari, F.] Azienda Osped Univ Bologna, Policlin S Orsola Malpighi, Biomed & Appl Res Ctr, Bologna, Italy	University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna	Derenzini, M (corresponding author), Univ Bologna, Dept Expt Diagnost & Specialty Med, Via Massarenti 9, I-40138 Bologna, Italy.	massimo.derenzini@unibo.it	imbrogno, enrica/AAL-2342-2020; Montanaro, Lorenzo/I-4236-2019; Trere', Davide/AAC-4725-2021; Fornari, Francesca/K-6748-2016	Montanaro, Lorenzo/0000-0001-9776-9518; Trere', Davide/0000-0003-1127-1052; Fornari, Francesca/0000-0002-4302-4411; govoni, marzia/0000-0003-1673-0107; IMBROGNO, ENRICA/0000-0002-6375-9343	Roberto and Cornelia Pallotti's Legacy for Cancer Research; Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG13480]	Roberto and Cornelia Pallotti's Legacy for Cancer Research; Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the Roberto and Cornelia Pallotti's Legacy for Cancer Research and Associazione Italiana per la Ricerca sul Cancro (AIRC, grant number IG13480).	Bhat KP, 2004, EMBO J, V23, P2402, DOI 10.1038/sj.emboj.7600247; Bland JM, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3985; Burger K, 2010, J BIOL CHEM, V285, P12416, DOI 10.1074/jbc.M109.074211; Burns TF, 1999, J CELL PHYSIOL, V181, P231, DOI 10.1002/(SICI)1097-4652(199911)181:2<231::AID-JCP5>3.0.CO;2-L; Bywater MJ, 2012, CANCER CELL, V22, P51, DOI 10.1016/j.ccr.2012.05.019; Chen XB, 1996, GENE DEV, V10, P2438, DOI 10.1101/gad.10.19.2438; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Deisenroth C, 2010, ONCOGENE, V29, P4253, DOI 10.1038/onc.2010.189; Derenzini M, 2005, J CELL PHYSIOL, V202, P483, DOI 10.1002/jcp.20144; Derenzini M, 2000, MICRON, V31, P117, DOI 10.1016/S0968-4328(99)00067-0; Derenzini M, 2009, HISTOPATHOLOGY, V54, P753, DOI 10.1111/j.1365-2559.2008.03168.x; Donati G, 2011, ONCOGENE, V30, P3274, DOI 10.1038/onc.2011.48; Drygin D, 2011, CANCER RES, V71, P1418, DOI 10.1158/0008-5472.CAN-10-1728; Drygin D, 2010, ANNU REV PHARMACOL, V50, P131, DOI 10.1146/annurev.pharmtox.010909.105844; Drygin D, 2009, CANCER RES, V69, P7653, DOI 10.1158/0008-5472.CAN-09-1304; ELLEDGE SJ, 1992, TRENDS BIOCHEM SCI, V17, P119, DOI 10.1016/0968-0004(92)90249-9; Gajjar M, 2012, CANCER CELL, V21, P25, DOI 10.1016/j.ccr.2011.11.016; Gottifredi V, 2001, P NATL ACAD SCI USA, V98, P1036, DOI 10.1073/pnas.021282898; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hu Wenwei, 2012, Genes Cancer, V3, P199, DOI 10.1177/1947601912454734; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Kapoor M, 2000, ONCOGENE, V19, P358, DOI 10.1038/sj.onc.1203300; KAUFMANN SH, 1993, CANCER RES, V53, P3976; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Lowe SW, 1999, ENDOCR-RELAT CANCER, V6, P45, DOI 10.1677/erc.0.0060045; Maggi LB, 2005, CANCER INVEST, V23, P599, DOI 10.1080/07357900500283085; Mayer C, 2005, CELL CYCLE, V4, P1036, DOI 10.4161/cc.4.8.1925; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Montanaro L, 2008, AM J PATHOL, V173, P301, DOI 10.2353/ajpath.2008.070752; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Oskarsson T, 2005, NAT CELL BIOL, V7, P215, DOI 10.1038/ncb0305-215; PERRY RP, 1970, J CELL PHYSIOL, V76, P127, DOI 10.1002/jcp.1040760202; Poortinga G, 2015, ONCOGENE, V34, P403, DOI 10.1038/onc.2014.13; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Sax Joanna K, 2003, Methods Mol Biol, V234, P65; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Sun XX, 2008, J BIOL CHEM, V283, P12387, DOI 10.1074/jbc.M801387200; Sun XX, 2007, J BIOL CHEM, V282, P8052, DOI 10.1074/jbc.M610621200; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Yin CY, 1997, NATURE, V385, P637, DOI 10.1038/385637a0; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45; Yuan XJ, 2005, MOL CELL, V19, P77, DOI 10.1016/j.molcel.2005.05.023; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003	55	34	36	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 25	2016	35	8					977	989		10.1038/onc.2015.147	http://dx.doi.org/10.1038/onc.2015.147			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DE7NF	25961931				2022-12-26	WOS:000370823300004
J	Hou, L; Chen, XM; Wang, MN; See, DR; Chao, SM; Bulli, P; Jing, JX				Hou, Lu; Chen, Xianming; Wang, Meinan; See, Deven R.; Chao, Shiaoman; Bulli, Peter; Jing, Jinxue			Mapping a Large Number of QTL for Durable Resistance to Stripe Rust in Winter Wheat Druchamp Using SSR and SNP Markers	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ADULT-PLANT RESISTANCE; F-SP TRITICI; ALL-STAGE RESISTANCE; NORTH-AMERICAN RACES; PUCCINIA-STRIIFORMIS; HIGH-TEMPERATURE; YELLOW RUST; LEAF RUST; VIRULENCE CHARACTERIZATION	Winter wheat Druchamp has both high-temperature adult-plant (HTAP) resistance and all-stage resistance to stripe rust caused by Puccinia striiformisf. sp. tritici (Pst). The HTAP resistance in Druchamp is durable as the variety has been resistant in adult-plant stage since it was introduced from France to the United States in late 1940s. To map the quantitative trait loci (QTL) for stripe rust resistance, an F8 recombinant inbred line (RIL) population from cross Druchamp x Michigan Amber was phenotyped for stripe rust response in multiple years in fields under natural infection and with selected Pst races under controlled greenhouse conditions, and genotyped with simple sequence repeat (SSR) and single nucleotide polymorphism (SNP) markers. Composite interval mapping (CIM) identified eight HTAP resistance QTL and three all-stage resistance QTL. Among the eight HTAP resistance QTL, QYrdr.wgp-1BL.2 (explaining 2.36-31.04% variation), QYrdr.wgp-2BL (2.81-15.65%), QYrdr.wgp-5AL(2.27-17.22%) and QYrdr.wgp-5BL.2 (2.42-15.13%) were significant in all tests; and QYrdr.wgp-1BL.1 (1.94-10.19%), QYrdr.wgp-1DS (2.04-27.24%), QYrdr.wgp-3AL (1.78-13.85%) and QYrdr.wgp-6BL. 2 (1.69-33.71%) were significant in some of the tests. The three all-stage resistance QTL, QYrdr.wgp-5BL.1 (5.47-36.04%), QYrdr.wgp-5DL (9.27-11.94%) and QYrdr.wgp-6BL.1(13.07-20.36%), were detected based on reactions in the seedlings tested with certain Pstraces. Among the eleven QTL detected in Druchamp, at least three (QYrdr.wgp-5DL for race-specific all-stage resistance and QYrdr.wgp-3AL and QYrdr.wgp-6BL.2 for race non-specific HTAP resistance) are new. All these QTL, especially those for durable HTAP resistance, and their closely linked molecular markers could be useful for developing wheat cultivars with durable resistance to stripe rust.	[Hou, Lu] Qinghai Acad Agr & Forestry Sci, Inst Plant Protect, Key Lab Agr Integrated Pest Management, Xining, Qinghai, Peoples R China; [Hou, Lu; Chen, Xianming; Wang, Meinan; See, Deven R.] Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA; [Hou, Lu; Jing, Jinxue] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Hou, Lu; Jing, Jinxue] Northwest A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China; [Chen, Xianming; See, Deven R.] USDA ARS, Wheat Genet Qual Physiol & Dis Res Unit, Pullman, WA USA; [Chao, Shiaoman] USDA ARS, Cereal Crops Res, Fargo, ND USA; [Bulli, Peter] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA	Qinghai University; Washington State University; Northwest A&F University - China; Northwest A&F University - China; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Washington State University	Chen, XM (corresponding author), Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA.	xianming@wsu.edu	Bulli, Peter/H-6637-2019	Bulli, Peter/0000-0002-7223-7838	US Department of Agriculture, Agricultural Research Service [5348-22000-015-00D]; Washington State University, PPNS [13C-3061-5665, 13Z-3061-6665, 0670]; Department of Plant Pathology, College of Agricultural, Human, and Natural Resource Sciences, Agricultural Research Center, HATCH, Washington State University, Pullman, WA, USA [WNP00663]; Northwest A;F University Plant Pathology; "973" project [2013CB127700]; "111" Project [B07049]; China Scholarship Council scholarship	US Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Washington State University, PPNS; Department of Plant Pathology, College of Agricultural, Human, and Natural Resource Sciences, Agricultural Research Center, HATCH, Washington State University, Pullman, WA, USA; Northwest A;F University Plant Pathology; "973" project(National Basic Research Program of China); "111" Project(Ministry of Education, China - 111 Project); China Scholarship Council scholarship(China Scholarship Council)	This research was supported by the US Department of Agriculture, Agricultural Research Service (Project No. 5348-22000-015-00D) and Washington State University (Project No. 13C-3061-5665 and 13Z-3061-6665) PPNS No. 0670, Department of Plant Pathology, College of Agricultural, Human, and Natural Resource Sciences, Agricultural Research Center, HATCH Project Number WNP00663, Washington State University, Pullman, WA, 99164-6430, USA. The research is also part of the Northwest A & F University Plant Pathology, the "973" project (2013CB127700) and "111" Project (B07049). The China Scholarship Council scholarship to the first author is greatly appreciated.	Bariana HS, 2010, EUPHYTICA, V176, P251, DOI 10.1007/s10681-010-0240-x; Bariana HS, 2006, THEOR APPL GENET, V112, P1143, DOI 10.1007/s00122-006-0216-3; Boukhatem N, 2002, THEOR APPL GENET, V104, P111, DOI 10.1007/s001220200013; Cao XH, 2012, J INTEGR PLANT BIOL, V54, P330, DOI 10.1111/j.1744-7909.2012.01111.x; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Chen XM, 2014, CAN J PLANT PATHOL, V36, P311, DOI 10.1080/07060661.2014.924560; Chen X. M., 2013, American Journal of Plant Sciences, V4, P608; Chen XM, 2013, CURR GENOMICS, V14, P111, DOI 10.2174/1389202911314020004; Chen XM, 2010, CAN J PLANT PATHOL, V32, P315, DOI 10.1080/07060661.2010.499271; Chen XM, 2005, CAN J PLANT PATHOL, V27, P314; CHEN XM, 1992, PHYTOPATHOLOGY, V82, P1428, DOI 10.1094/Phyto-82-1428; Chen XM, 2002, PLANT DIS, V86, P39, DOI 10.1094/PDIS.2002.86.1.39; CHEN XM, 1995, PHYTOPATHOLOGY, V85, P573, DOI 10.1094/Phyto-85-573; CHEN XM, 1992, PHYTOPATHOLOGY, V82, P633, DOI 10.1094/Phyto-82-633; Chen XM, 1996, PHYTOPATHOLOGY, V86, P1228, DOI 10.1094/Phyto-86-1228; CHEN XM, 1995, PHYTOPATHOLOGY, V85, P1362, DOI 10.1094/Phyto-85-1362; CHEN XM, 1995, PHYTOPATHOLOGY, V85, P567, DOI 10.1094/Phyto-85-567; Chhuneja P, 2008, THEOR APPL GENET, V116, P313, DOI 10.1007/s00122-007-0668-0; Christiansen MJ, 2006, THEOR APPL GENET, V112, P581, DOI 10.1007/s00122-005-0128-7; CHURCHILL GA, 1994, GENETICS, V138, P963; Clarke JD, 2002, ARABIDOPSIS A LABORA; Dadkhodaie NA, 2011, THEOR APPL GENET, V122, P479, DOI 10.1007/s00122-010-1462-y; Dedryver F, 2009, PHYTOPATHOLOGY, V99, P968, DOI 10.1094/PHYTO-99-8-0968; Guo Q, 2008, PHYTOPATHOLOGY, V98, P803, DOI 10.1094/PHYTO-98-7-0803; Hou L, 2013, J INTEGR AGR, V12, P2197, DOI 10.1016/S2095-3119(13)60293-2; Jagger LJ, 2011, THEOR APPL GENET, V122, P723, DOI 10.1007/s00122-010-1481-8; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Lan CX, 2010, PHYTOPATHOLOGY, V100, P313, DOI 10.1094/PHYTO-100-4-0313; Li QA, 2010, CAN J PLANT SCI, V90, P529, DOI 10.4141/CJPS09076; Lillemo M, 2008, THEOR APPL GENET, V116, P1155, DOI 10.1007/s00122-008-0743-1; Lin F, 2008, THEOR APPL GENET, V116, P797, DOI 10.1007/s00122-008-0713-7; Lin F, 2007, THEOR APPL GENET, V114, P1277, DOI 10.1007/s00122-007-0518-0; Lin F, 2009, THEOR APPL GENET, V118, P631, DOI 10.1007/s00122-008-0894-0; Line RF, 2002, ANNU REV PHYTOPATHOL, V40, P75, DOI 10.1146/annurev.phyto.40.020102.111645; LINE RF, 1995, PLANT DIS, V79, P1254; Line RF, 1992, US DEPARTMENT OF AGR, P44; Liu Fanghui, 2007, Journal of Genetics and Genomics, V34, P1123, DOI 10.1016/S1673-8527(07)60128-3; Lowe I, 2011, THEOR APPL GENET, V123, P143, DOI 10.1007/s00122-011-1573-0; Lu YM, 2009, THEOR APPL GENET, V119, P1349, DOI 10.1007/s00122-009-1139-6; Mallard S, 2005, THEOR APPL GENET, V110, P1401, DOI 10.1007/s00122-005-1954-3; Maniatis TA, 1982, COLD SPRING HARB SYM; McIntosh RA, 2013, 12TH INT WHEAT GENET; Melichar JPE, 2008, THEOR APPL GENET, V117, P391, DOI 10.1007/s00122-008-0783-6; QAYOUM A, 1985, PHYTOPATHOLOGY, V75, P1121, DOI 10.1094/Phyto-75-1121; Ren Y, 2012, THEOR APPL GENET, V125, P1211, DOI 10.1007/s00122-012-1907-6; Rosewarne GM, 2008, THEOR APPL GENET, V116, P1027, DOI 10.1007/s00122-008-0736-0; Rosewarne GM, 2013, THEOR APPL GENET, V126, P2427, DOI 10.1007/s00122-013-2159-9; Rosewarne GM, 2012, THEOR APPL GENET, V124, P1283, DOI 10.1007/s00122-012-1786-x; Rosewarne GM, 2006, THEOR APPL GENET, V112, P500, DOI 10.1007/s00122-005-0153-6; Santra DK, 2008, THEOR APPL GENET, V117, P793, DOI 10.1007/s00122-008-0820-5; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Sharma-Poudyal D, 2013, PLANT DIS, V97, P379, DOI 10.1094/PDIS-01-12-0078-RE; Sharma-Poudyal D, 2014, INT J BIOMETEOROL, V58, P987, DOI 10.1007/s00484-013-0683-6; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Sourdille Pierre, 2004, Functional & Integrative Genomics, V4, P12, DOI 10.1007/s10142-004-0106-1; Stubbs R. W., 1985, CEREAL RUSTS, V2, P61, DOI 10.1016/B978-0-12-148402-6.50011-0; Suenaga K, 2003, PHYTOPATHOLOGY, V93, P881, DOI 10.1094/PHYTO.2003.93.7.881; Tang SX, 2006, CROP SCI, V46, P721, DOI 10.2135/cropsci2005.0006-7; Uauy C, 2005, THEOR APPL GENET, V112, P97, DOI 10.1007/s00122-005-0109-x; Van Ooijen J. W, 2006, JOINMAP 4 SOFTWARE F; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wan AM, 2014, PLANT DIS, V98, P1534, DOI 10.1094/PDIS-01-14-0071-RE; Wan AM, 2012, PLANT DIS, V96, P67, DOI 10.1094/PDIS-02-11-0119; Wang S, 2007, WINDOWS QTL CARTOGRA; Wellings CR, 2011, EUPHYTICA, V179, P129, DOI 10.1007/s10681-011-0360-y; William HM, 2006, GENOME, V49, P977, DOI 10.1139/G06-052; Worland AJ, 1988, 1987 ANNUAL REPORT, P8; Yang MinNa, 2008, Scientia Agricultura Sinica, V41, P2931; ZENG ZB, 1994, GENETICS, V136, P1457; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972	70	50	53	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0126794	10.1371/journal.pone.0126794	http://dx.doi.org/10.1371/journal.pone.0126794			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970329	Green Published, Green Submitted, gold			2022-12-26	WOS:000354544200131
J	Wyatt, C; Lucas, RM; Hurst, C; Kimlin, MG				Wyatt, Candy; Lucas, Robyn M.; Hurst, Cameron; Kimlin, Michael G.			Vitamin D Deficiency at Melanoma Diagnosis Is Associated with Higher Breslow Thickness	PLOS ONE			English	Article							PRIMARY CUTANEOUS MELANOMA; AMERICAN JOINT COMMITTEE; 25-HYDROXYVITAMIN D; SUN EXPOSURE; AUSTRALIAN ADULTS; MITOTIC RATE; PROGRESSION; RISK; STAGE; EXPRESSION	Background Epidemiological evidence shows that people with thicker, or higher stage, melanomas have lower vitamin D status compared to those with thinner tumours. Evidence from experimental studies is inconsistent, but some suggest that administration of vitamin D metabolites can decrease tumour aggressiveness. Objectives Determine the relationship between vitamin D status at diagnosis and melanoma thickness (as an indicator of prognosis), in a subtropical setting with high melanoma incidence. Methods We recruited 100 melanoma patients in Brisbane, Australia within days of their diagnosis. Data on factors previously associated with melanoma risk or prognosis were collected by questionnaire and physical examination. Serum for 25-hydroxyvitamin D3 [25(OH)D] levels was collected prior to wider excision biopsy; histological indicators of prognosis were obtained from pathology reports. We used multivariable logistic regression models to analyse the association between Breslow thickness (>= 0.75 mm compared to <0.75 mm), Clark level (2-5 compared to 1) and presence of mitoses, and vitamin D status. Results Serum 25(OH)D <50 nmol/L (versus >= 50 nmol/L) was associated with a nearly four-fold increase in risk of having a thicker tumour (Adjusted OR = 3.82, 95% CI: 1.03, 14.14; p = 0.04, adjusted for age, sex, skin phototype, body mass index and season at diagnosis). There was no significant association with Clark level or presence of mitosis. Serum 25(OH) D levels in the highest quartile (>= 69.8 nmol/L) were not associated with a more favourable prognosis. Conclusions Vitamin D deficiency at the time of melanoma diagnosis is associated with thicker tumours that are likely to have a poorer prognosis. Ensuring vitamin D levels of 50 nmol/L or higher in this population could potentially result in 18% of melanomas having Breslow thickness of <0.75 mm rather than >= 0.75 mm.	[Wyatt, Candy; Kimlin, Michael G.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, AusSun Res Lab, Brisbane, Qld 4001, Australia; [Lucas, Robyn M.] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Lucas, Robyn M.] Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia; [Hurst, Cameron] Khon Kaen Univ, Fac Publ Hlth, Khon Kaen, Thailand	Queensland University of Technology (QUT); Australian National University; Telethon Kids Institute; University of Western Australia; Khon Kaen University	Wyatt, C (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, AusSun Res Lab, Brisbane, Qld 4001, Australia.	candy.wyatt@gmail.com	Hurst, Cameron/AAD-5753-2019; Hurst, Cameron P/P-5175-2017	Hurst, Cameron/0000-0002-4577-8962; Hurst, Cameron P/0000-0002-4577-8962; Kimlin, Michael/0000-0002-9536-8646; Lucas, Robyn/0000-0003-2736-3541	Queensland University of Technology Women's Re-entry Ph.D scholarship; AusSun Research Laboratory	Queensland University of Technology Women's Re-entry Ph.D scholarship; AusSun Research Laboratory	CW was funded through a Queensland University of Technology Women's Re-entry Ph.D scholarship. AusSun Research Laboratory provided funding for serum analyses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG BK, 1993, MELANOMA RES, V3, P395, DOI 10.1097/00008390-199311000-00002; Australian Bureau of Statistics, 2014, AUSTR HLTH SURV BIOM; Azzola MF, 2003, CANCER-AM CANCER SOC, V97, P1488, DOI 10.1002/cncr.11196; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Balch CM, 2004, CA-CANCER J CLIN, V54, P131, DOI 10.3322/canjclin.54.3.131; Balch CM, 2001, J CLIN ONCOL, V19, P3622, DOI 10.1200/JCO.2001.19.16.3622; Berwick M, 2005, J NATL CANCER I, V97, P195, DOI 10.1093/jnci/dji019; BRESLOW A, 1970, ANN SURG, V172, P902, DOI 10.1097/00000658-197011000-00017; Brozyna AA, 2013, HUM PATHOL, V44, P374, DOI 10.1016/j.humpath.2012.03.031; Brozyna AA, 2014, INT J MOL SCI, V15, P19000, DOI 10.3390/ijms151019000; Brozyna AA, 2014, ANTICANCER RES, V34, P2735; Brozyna AA, 2013, HUM PATHOL, V44, P2071, DOI 10.1016/j.humpath.2013.02.022; Cancer Council Queensland, 2009, CAN QUEENSL INC MORT; Chang YM, 2009, INT J EPIDEMIOL, V38, P814, DOI 10.1093/ije/dyp166; CLARK WH, 1969, CANCER RES, V29, P705; EISMAN JA, 1987, CANCER RES, V47, P21; Erdmann F, 2013, INT J CANCER, V132, P385, DOI 10.1002/ijc.27616; Gambichler T, 2013, BRIT J DERMATOL, V168, P625, DOI 10.1111/j.1365-2133.2012.11212.x; Gilbert R, 2012, INT J CANCER, V131, P1187, DOI 10.1002/ijc.27327; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; International Agency for Research on Cancer (IARC). World Health Organization. Globocan, 2012, GLOB 2012 EST CANC I; IOM, 2011, DIETARY REFERENCE IN; Kimlin MG, 2014, AM J EPIDEMIOL, V179, P864, DOI 10.1093/aje/kwt446; Labrousse AL, 2004, CRIT REV ONCOL HEMAT, V49, P269, DOI 10.1016/j.critrevonc.2003.10.007; LANCASTER H. O., 1956, MED JOUR AUSTRALIA I, V43, P1082; Lehmann B, 2005, PHOTOCHEM PHOTOBIOL, V81, P1246, DOI 10.1562/2005-02-02-IR-430; Lucas RM, 2011, NEUROLOGY, V76, P540, DOI 10.1212/WNL.0b013e31820af93d; Lucas RM, 2013, J STEROID BIOCHEM, V136, P300, DOI 10.1016/j.jsbmb.2013.01.011; McCullough ML, 2010, AM J EPIDEMIOL, V172, P21, DOI 10.1093/aje/kwq113; McGOVERN V J, 1952, Med J Aust, V1, P139; Mocellin S, 2008, CANCER-AM CANCER SOC, V113, P2398, DOI 10.1002/cncr.23867; Newton-Bishop JA, 2009, J CLIN ONCOL, V27, P5439, DOI 10.1200/JCO.2009.22.1135; Nurnberg B, 2009, ANTICANCER RES, V29, P3669; Olbryt M, 2013, POSTEP HIG MED DOSW, V67, P413, DOI 10.5604/17322693.1049286; Peppone LJ, 2012, ANN SURG ONCOL, V19, P2590, DOI 10.1245/s10434-012-2297-3; Pludowski P, 2013, ENDOKRYNOL POL, V64, P319, DOI 10.5603/EP.2013.0012; Queensland Government, 2012, MEL QUEENSL OV 2012; Rebel H, 2015, INT J CANCER, V136, P271, DOI 10.1002/ijc.29002; Reichrath J, 2007, CANCER BIOL THER, V6, P48, DOI 10.4161/cbt.6.1.3493; Ren C, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-16; Seifert M, 2004, J STEROID BIOCHEM, V89-90, P375, DOI 10.1016/j.jsbmb.2004.03.002; Thompson JF, 2011, J CLIN ONCOL, V29, P2199, DOI 10.1200/JCO.2010.31.5812; U.S. Cancer Statistics Working Group, 2010, US CANC STAT 1999 20; Youl PH, 2013, BRIT J DERMATOL, V168, P136, DOI 10.1111/j.1365-2133.2012.11064.x	44	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0126394	10.1371/journal.pone.0126394	http://dx.doi.org/10.1371/journal.pone.0126394			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970336	Green Submitted, Green Published, gold			2022-12-26	WOS:000354544200111
J	Harma, V; Haavikko, R; Virtanen, J; Ahonen, I; Schukov, HP; Alakurtti, S; Purev, E; Rischer, H; Yli-Kauhaluoma, J; Moreira, VM; Nees, M; Oksman-Caldentey, KM				Harma, Ville; Haavikko, Raisa; Virtanen, Johannes; Ahonen, Ilmari; Schukov, Hannu-Pekka; Alakurtti, Sami; Purev, Enkhee; Rischer, Heiko; Yli-Kauhaluoma, Jari; Moreira, Vania M.; Nees, Matthias; Oksman-Caldentey, Kirsi-Marja			Optimization of Invasion-Specific Effects of Betulin Derivatives on Prostate Cancer Cells through Lead Development	PLOS ONE			English	Article							TUMOR SPHEROIDS; ACID; CULTURE; 3RD-DIMENSION; PLASTICITY; ASSAY	The anti-invasive and anti-proliferative effects of betulins and abietane derivatives was systematically tested using an organotypic model system of advanced, castration-resistant prostate cancers. A preliminary screen of the initial set of 93 compounds was performed in two-dimensional (2D) growth conditions using non-transformed prostate epithelial cells (EP156T), an androgen-sensitive prostate cancer cell line (LNCaP), and the castration-resistant, highly invasive cell line PC-3. The 25 most promising compounds were all betulin derivatives. These were selected for a focused secondary screen in three-dimensional (3D) growth conditions, with the goal to identify the most effective and specific anti-invasive compounds. Additional sensitivity and cytotoxicity tests were then performed using an extended cell line panel. The effects of these compounds on cell cycle progression, mitosis, proliferation and unspecific cytotoxicity, versus their ability to specifically interfere with cell motility and tumor cell invasion was addressed. To identify potential mechanisms of action and likely compound targets, multiplex profiling of compound effects on a panel of 43 human protein kinases was performed. These target de-convolution studies, combined with the phenotypic analyses of multicellular organoids in 3D models, revealed specific inhibition of AKT signaling linked to effects on the organization of the actin cytoskeleton as the most likely driver of altered cell morphology and motility.	[Harma, Ville; Virtanen, Johannes; Purev, Enkhee; Nees, Matthias] VTT Tech Res Ctr Finland Ltd, Ind Biotechnol, Turku, Finland; [Haavikko, Raisa; Yli-Kauhaluoma, Jari; Moreira, Vania M.] Univ Helsinki, Fac Pharm, Div Pharmaceut Chem & Technol, Helsinki, Finland; [Ahonen, Ilmari; Nees, Matthias] Univ Turku, Turku Ctr Biotechnol BTK, Turku, Finland; [Schukov, Hannu-Pekka] Univ Turku, Fac Med, Inst Biomed, Turku, Finland; [Alakurtti, Sami] VTT Tech Res Ctr Finland Ltd, Proc Chem & Environm Engn, Espoo, Finland; [Purev, Enkhee] Natl Univ Mongolia, Ulanbataar, Mongolia, Mongolia; [Rischer, Heiko; Oksman-Caldentey, Kirsi-Marja] VTT Tech Res Ctr Finland Ltd, Ind Biotechnol, Espoo, Finland	VTT Technical Research Center Finland; University of Helsinki; University of Turku; University of Turku; VTT Technical Research Center Finland; National University of Mongolia; VTT Technical Research Center Finland	Nees, M (corresponding author), VTT Tech Res Ctr Finland Ltd, Ind Biotechnol, Turku, Finland.	mattnees@btk.fi; kirsi-marja.oksman@vtt.fi	Moreira, Vânia M/C-8237-2013; Rischer, Heiko/ABB-4681-2020; Nees, Matthias/W-6596-2018; Nees, Matthias/AAT-5577-2020	Moreira, Vânia M/0000-0001-6169-5035; Rischer, Heiko/0000-0002-8004-4526; Nees, Matthias/0000-0002-9034-301X; Haavikko, Raisa/0000-0002-2445-503X; Oksman-Caldentey, Kirsi-Marja/0000-0003-2830-165X; Harma, Ville/0000-0001-5767-5226; Yli-Kauhaluoma, Jari/0000-0003-0370-7653	(BARC Betulins, abietans and resins as novel lead compounds for cancer) from theAcademy of Finland [252308]; Tumor Microenvironment & Metastasis in Castration-Resistant Prostate Cancer [267326]	(BARC Betulins, abietans and resins as novel lead compounds for cancer) from theAcademy of Finland; Tumor Microenvironment & Metastasis in Castration-Resistant Prostate Cancer	The authors kindly acknowledge the financial support (Project number 252308; BARC Betulins, abietans and resins as novel lead compounds for cancer) from the Academy of Finland (to KMOC), and Tumor Microenvironment & Metastasis in Castration-Resistant Prostate Cancer (project number 267326) to MN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alakurtti S, 2006, EUR J PHARM SCI, V29, P1, DOI 10.1016/j.ejps.2006.04.006; Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509; Celli JP, 2014, SCI REP-UK, V4, DOI 10.1038/srep03751; Clardy J, 2004, NATURE, V432, P829, DOI 10.1038/nature03194; ECKERMAN C, 1985, PAP PUU-PAP TIM, V67, P100; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Gough A, 2014, ANONYMOUS MOL BASIS; Haavikko R, 2014, MEDCHEMCOMM, V5, P445, DOI 10.1039/c3md00282a; Harma V, 2012, ONCOGENE, V31, P2075, DOI 10.1038/onc.2011.396; Harma V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096426; Harma V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010431; Hongisto V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077232; Hsiao AY, 2012, BIOTECHNOL BIOENG, V109, P1293, DOI 10.1002/bit.24399; Ivascu A, 2006, J BIOMOL SCREEN, V11, P922, DOI 10.1177/1087057106292763; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Krausz E, 2013, J BIOMOL SCREEN, V18, P54, DOI 10.1177/1087057112456874; Lovitt Carrie J, 2014, Biology (Basel), V3, P345, DOI 10.3390/biology3020345; Lovitt CJ, 2013, ASSAY DRUG DEV TECHN, V11, P435, DOI 10.1089/adt.2012.483; Mehta G, 2012, J CONTROL RELEASE, V164, P192, DOI 10.1016/j.jconrel.2012.04.045; Moreira VM, 2008, CURR MED CHEM, V15, P868, DOI 10.2174/092986708783955428; Moreira VMA, 2007, STEROIDS, V72, P939, DOI 10.1016/j.steroids.2007.08.004; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Park B, 2011, INT J CANCER, V129, P23, DOI 10.1002/ijc.25966; PISHA E, 1995, NAT MED, V1, P1046, DOI 10.1038/nm1095-1046; Rimann M, 2012, CURR OPIN BIOTECH, V23, P803, DOI 10.1016/j.copbio.2012.01.011; Rzeski W, 2009, BASIC CLIN PHARMACOL, V105, P425, DOI 10.1111/j.1742-7843.2009.00471.x; Salvador JAR, 2010, CANCER ETIOL DIAGN T, P1; Salvador JAR, 2011, ADV SYNTH CATAL, V353, P2637, DOI 10.1002/adsc.201100155; Shanmugam MK, 2011, INT J CANCER, V129, P1552, DOI 10.1002/ijc.26120; Sheng HM, 2011, NAT PROD REP, V28, P543, DOI 10.1039/c0np00059k; Silhar P, 2011, BIOORG MED CHEM LETT, V21, P2229, DOI 10.1016/j.bmcl.2011.02.115; Thierbach R, 2009, ANAL BIOCHEM, V387, P318, DOI 10.1016/j.ab.2009.01.029; Tran K, 2012, CANCER PREV RES, V5, P726, DOI 10.1158/1940-6207.CAPR-11-0404; Yadav VR, 2010, J MOL MED, V88, P1243, DOI 10.1007/s00109-010-0669-3; Yoon JJ, 2010, J CELL BIOCHEM, V111, P1501, DOI 10.1002/jcb.22880	38	19	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0126111	10.1371/journal.pone.0126111	http://dx.doi.org/10.1371/journal.pone.0126111			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965345	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000354543500042
J	Spruijt, S; Jongsma, MLA; van der Kamp, J; Steenbergen, B				Spruijt, Steffie; Jongsma, Marijtje L. A.; van der Kamp, John; Steenbergen, Bert			Predictive Models to Determine Imagery Strategies Employed by Children to Judge Hand Laterality	PLOS ONE			English	Article							DEVELOPMENTAL-COORDINATION-DISORDER; MENTAL ROTATION TASK; MOTOR IMAGERY; VISUAL-IMAGERY; BODY PARTS; TRANSFORMATIONS; REPRESENTATION; MECHANISMS; LINK	A commonly used paradigm to study motor imagery is the hand laterality judgment task. The present study aimed to determine which strategies young children employ to successfully perform this task. Children of 5 to 8 years old (N = 92) judged laterality of back and palm view hand pictures in different rotation angles. Response accuracy and response duration were registered. Response durations of the trials with a correct judgment were fitted to a-priori defined predictive sinusoid models, representing different strategies to successfully perform the hand laterality judgment task. The first model predicted systematic changes in response duration as a function of rotation angle of the displayed hand. The second model predicted that response durations are affected by biomechanical constraints of hand rotation. If observed data could be best described by the first model, this would argue for a mental imagery strategy that does not involve motor processes to solve the task. The second model reflects a motor imagery strategy to solve the task. In line with previous research, we showed an age-related increase in response accuracy and decrease in response duration in children. Observed data for both back and palm view showed that motor imagery strategies were used to perform hand laterality judgments, but that not all the children use these strategies (appropriately) at all times. A direct comparison of response duration patterns across age sheds new light on age-related differences in the strategies employed to solve the task. Importantly, the employment of the motor imagery strategy for successful task performance did not change with age.	[Spruijt, Steffie; Jongsma, Marijtje L. A.; Steenbergen, Bert] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands; [van der Kamp, John] Vrije Univ Amsterdam, Res Inst Move, Amsterdam, Netherlands; [van der Kamp, John] Univ Hong Kong, Inst Human Performance, Hong Kong, Hong Kong, Peoples R China; [Steenbergen, Bert] Australian Catholic Univ, Sch Psychol, Melbourne, Vic, Australia	Radboud University Nijmegen; Vrije Universiteit Amsterdam; University of Hong Kong; Australian Catholic University	Spruijt, S (corresponding author), Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands.	s.spruijt@pwo.ru.nl		Steenbergen, Bert/0000-0001-8863-2624; van der Kamp, John/0000-0002-3826-1973	Netherlands Organization for Scientific Research (NWO) [433-09-215]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research was supported by a grant awarded by The Netherlands Organization for Scientific Research (NWO, project number: 433-09-215) to BS MJ, and SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brady N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023316; Butson ML, 2014, HUM MOVEMENT SCI, V35, P50, DOI 10.1016/j.humov.2014.03.013; Caeyenberghs K, 2009, DEV NEUROPSYCHOL, V34, P103, DOI 10.1080/87565640802499183; Conson M, 2012, NEUROSCI LETT, V530, P35, DOI 10.1016/j.neulet.2012.09.051; Dalecki M, 2012, HUM MOVEMENT SCI, V31, P1151, DOI 10.1016/j.humov.2011.12.001; de Lange FP, 2006, NEUROIMAGE, V33, P609, DOI 10.1016/j.neuroimage.2006.07.017; Decety J, 1999, TRENDS COGN SCI, V3, P172, DOI 10.1016/S1364-6613(99)01312-1; Deconinck FJA, 2009, J CLIN EXP NEUROPSYC, V31, P720, DOI 10.1080/13803390802484805; Funk M, 2005, DEVELOPMENTAL SCI, V8, P402, DOI 10.1111/j.1467-7687.2005.00428.x; JEANNEROD M, 1994, BEHAV BRAIN SCI, V17, P187, DOI 10.1017/S0140525X00034026; Jonkman K, 2008, TECHNISCHE HANDLEIDI; Kruger M, 2009, J COGN DEV, V10, P239, DOI 10.1080/15248370903389341; Lust JM, 2006, CHILD CARE HLTH DEV, V32, P649, DOI 10.1111/j.1365-2214.2006.00683.x; PARSONS LM, 1994, J EXP PSYCHOL HUMAN, V20, P709, DOI 10.1037/0096-1523.20.4.709; PARSONS LM, 1987, COGNITIVE PSYCHOL, V19, P178, DOI 10.1016/0010-0285(87)90011-9; Petit LS, 2003, BRAIN COGNITION, V51, P95, DOI 10.1016/S0278-2626(02)00526-2; SEKIYAMA K, 1982, PERCEPT PSYCHOPHYS, V32, P89, DOI 10.3758/BF03204268; Sharma N, 2006, STROKE, V37, P1941, DOI 10.1161/01.STR.0000226902.43357.fc; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; Sirigu A, 2001, J COGNITIVE NEUROSCI, V13, P910, DOI 10.1162/089892901753165827; Steenbergen B, 2007, NEUROPSYCHOLOGIA, V45, P3324, DOI 10.1016/j.neuropsychologia.2007.07.002; ter Horst AC, 2010, EXP BRAIN RES, V203, P347, DOI 10.1007/s00221-010-2235-1; Tomasino B, 2004, J COGNITIVE NEUROSCI, V16, P878, DOI 10.1162/089892904970753; Toussaint L, 2013, EXP BRAIN RES, V231, P331, DOI 10.1007/s00221-013-3698-7; Wechsler D., 2008, WECHSLER NONVERBAL S; Williams J, 2006, CHILD CARE HLTH DEV, V32, P633, DOI 10.1111/j.1365-2214.2006.00688.x; Williams J, 2008, HUM MOVEMENT SCI, V27, P270, DOI 10.1016/j.humov.2008.02.008; Williams J, 2013, HUM MOVEMENT SCI, V32, P121, DOI 10.1016/j.humov.2012.08.003; Williams J, 2011, RES DEV DISABIL, V32, P740, DOI 10.1016/j.ridd.2010.11.006; Williams J, 2011, J CLIN EXP NEUROPSYC, V33, P273, DOI 10.1080/13803395.2010.509714; Wilson PH, 2004, DEV MED CHILD NEUROL, V46, P754, DOI 10.1017/S001216220400129X	31	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0126568	10.1371/journal.pone.0126568	http://dx.doi.org/10.1371/journal.pone.0126568			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI1ZI	25965271	Green Published, Green Submitted, gold			2022-12-26	WOS:000354543500065
J	Kurt, R; Chandra, PK; Aboulnasr, F; Panigrahi, R; Ferraris, P; Aydin, Y; Reiss, K; Wu, T; Balart, LA; Dash, S				Kurt, Ramazan; Chandra, Partha K.; Aboulnasr, Fatma; Panigrahi, Rajesh; Ferraris, Pauline; Aydin, Yucel; Reiss, Krzysztof; Wu, Tong; Balart, Luis A.; Dash, Srikanta			Chaperone-Mediated Autophagy Targets IFNAR1 for Lysosomal Degradation in Free Fatty Acid Treated HCV Cell Culture	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; IN-VITRO MODEL; VIRUS-REPLICATION; PEPTIDE SEQUENCES; TRIPLE THERAPY; STEATOSIS; GENOTYPE; PROTEINS; PHOSPHORYLATION; PROGRESSION	Background Hepatic steatosis is a risk factor for both liver disease progression and an impaired response to interferon alpha (IFN-alpha)-based combination therapy in chronic hepatitis C virus (HCV) infection. Previously, we reported that free fatty acid (FFA)-treated HCV cell culture induces hepatocellular steatosis and impairs the expression of interferon alpha receptor-1 (IFNAR1), which is why the antiviral activity of IFN-alpha against HCV is impaired. Aim To investigate the molecular mechanism by which IFNAR1 expression is impaired in HCV cell culture with or without free fatty acid-treatment. Method HCV-infected Huh 7.5 cells were cultured with or without a mixture of saturated (palmitate) and unsaturated (oleate) long-chain free fatty acids (FFA). Intracytoplasmic fat accumulation in HCV-infected culture was visualized by oil red staining. Clearance of HCV in FFA cell culture treated with type I IFN (IFN-alpha) and Type III IFN (IFN-lambda) was determined by Renilla luciferase activity, and the expression of HCV core was determined by immunostaining. Activation of Jak-Stat signaling in the FFA-treated HCV culture by IFN-alpha alone and IFN-lambda alone was examined by Western blot analysis and confocal microscopy. Lysosomal degradation of IFNAR1 by chaperone-mediated autophagy (CMA) in the FFA-treated HCV cell culture model was investigated. Results FFA treatment induced dose-dependent hepatocellular steatosis and lipid droplet accumulation in HCV-infected Huh-7.5 cells. FFA treatment of infected culture increased HCV replication in a concentration-dependent manner. Intracellular lipid accumulation led to reduced Stat phosphorylation and nuclear translocation, causing an impaired IFN-alpha antiviral response and HCV clearance. Type III IFN (IFN-lambda), which binds to a separate receptor, induces Stat phosphorylation, and nuclear translocation as well as antiviral clearance in FFA-treated HCV cell culture. We show here that the HCV-induced autophagy response is increased in FFA-treated cell culture. Pharmacological inhibitors of lysosomal degradation, such as ammonium chloride and bafilomycin, prevented IFNAR1 degradation in FFA-treated HCV cell culture. Activators of chaperone-mediated autophagy, including 6-aminonicotinamide and nutrient starvation, decreased IFNAR1 levels in Huh-7.5 cells. Co-immunoprecipitation, colocalization and siRNA knockdown experiments revealed that IFNAR1 but not IFNLR1 interacts with HSC70 and LAMP2A, which are core components of chaperone-mediated autophagy (CMA). Conclusion Our study presents evidence indicating that chaperone-mediated autophagy targets IFNAR1 degradation in the lysosome in FFA-treated HCV cell culture. These results provide a mechanism for why HCV induced autophagy response selectively degrades type I but not the type III IFNAR1.	[Kurt, Ramazan; Aydin, Yucel; Wu, Tong; Balart, Luis A.; Dash, Srikanta] Tulane Univ, Sch Med, Div Gastroenterol & Hepatol, Dept Med, New Orleans, LA 70118 USA; [Chandra, Partha K.; Aboulnasr, Fatma; Panigrahi, Rajesh; Ferraris, Pauline; Dash, Srikanta] Tulane Univ, Sch Med, Pathol & Lab Med, New Orleans, LA 70118 USA; [Reiss, Krzysztof] LSU Hlth Sci Ctr, Stanley S Scott Canc Ctr, Neurol Canc Res, New Orleans, LA USA	Tulane University; Tulane University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Dash, S (corresponding author), Tulane Univ, Sch Med, Div Gastroenterol & Hepatol, Dept Med, New Orleans, LA 70118 USA.	sdash@tulane.edu	AYDIN, YUCEL/AAA-8522-2019; Ferraris, Pauline/F-9077-2017	AYDIN, YUCEL/0000-0001-6727-6296; Ferraris, Pauline/0000-0002-8796-3074; Panigrahi, Rajesh/0000-0002-6704-0029	NIH [CA127481, CA089121, AI103106]; Tulane University Health Sciences Center; NATIONAL CANCER INSTITUTE [R01CA089121, R01CA127481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI103106] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tulane University Health Sciences Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants CA127481, CA089121, and AI103106, as well as bridge funding received from Tulane University Health Sciences Center.	Abid K, 2005, J HEPATOL, V42, P744, DOI 10.1016/j.jhep.2004.12.034; Adinolfi LE, 2001, HEPATOLOGY, V33, P1358, DOI 10.1053/jhep.2001.24432; Araya J, 2004, CLIN SCI, V106, P635, DOI 10.1042/CS20030326; Aronsohn A, 2014, SEMIN LIVER DIS, V34, P30, DOI 10.1055/s-0034-1371008; Asselah T, 2012, BEST PRACT RES CL GA, V26, P455, DOI 10.1016/j.bpg.2012.09.003; Asselah T, 2010, LIVER INT, V30, P1259, DOI 10.1111/j.1478-3231.2010.02283.x; Bao LL, 2014, EXP MOL PATHOL, V96, P149, DOI 10.1016/j.yexmp.2013.12.002; Barba G, 1997, P NATL ACAD SCI USA, V94, P1200, DOI 10.1073/pnas.94.4.1200; Bressler BL, 2003, HEPATOLOGY, V38, P639, DOI 10.1053/jhep.2003.50350; Brunt EM, 2001, SEMIN LIVER DIS, V21, P3, DOI 10.1055/s-2001-12925; Burt AD, 1998, SEMIN DIAGN PATHOL, V15, P246; Chandra PK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108616; Chandra PK, 2014, AM J PATHOL, V184, P214, DOI 10.1016/j.ajpath.2013.10.005; CHIANG HL, 1988, J BIOL CHEM, V263, P6797; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; DICE JF, 1990, TRENDS BIOCHEM SCI, V15, P305, DOI 10.1016/0968-0004(90)90019-8; Dickensheets H, 2013, J LEUKOCYTE BIOL, V93, P377, DOI 10.1189/jlb.0812395; Finn PE, 2005, AUTOPHAGY, V1, P141, DOI 10.4161/auto.1.3.2000; Forestier N, 2012, LIVER INT, V32, P44, DOI 10.1111/j.1478-3231.2011.02720.x; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Gomez-Lechon MJ, 2007, CHEM-BIOL INTERACT, V165, P106, DOI 10.1016/j.cbi.2006.11.004; Gunduz F, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-143; Henriques CM, 2010, BLOOD, V115, P3269, DOI 10.1182/blood-2009-10-246876; Herker E, 2011, TRENDS ENDOCRIN MET, V22, P241, DOI 10.1016/j.tem.2011.03.004; Kumar KGS, 2004, J BIOL CHEM, V279, P46614, DOI 10.1074/jbc.M407082200; Kumar KGS, 2003, EMBO J, V22, P5480; Lambert JE, 2013, HEPATOLOGY, V57, P1697, DOI 10.1002/hep.25990; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; LING LE, 1995, J INTERF CYTOK RES, V15, P55, DOI 10.1089/jir.1995.15.55; Liu JH, 2009, CELL HOST MICROBE, V5, P72, DOI 10.1016/j.chom.2008.11.008; Liu SH, 2011, ANTIVIR RES, V89, P54, DOI 10.1016/j.antiviral.2010.11.004; Masserdotti C, 2006, VET CLIN PATH, V35, P37, DOI 10.1111/j.1939-165X.2006.tb00086.x; Monto A, 2002, HEPATOLOGY, V36, P729, DOI 10.1053/jhep.2002.35064; Moriya K, 1997, J GEN VIROL, V78, P1527, DOI 10.1099/0022-1317-78-7-1527; Negro F, 2009, J VIRAL HEPATITIS, V16, P681, DOI 10.1111/j.1365-2893.2009.01186.x; Negro F, 2010, GUT, V59, P1279, DOI 10.1136/gut.2009.192732; Panigrahi R, 2015, J VIROL, V89, P626, DOI 10.1128/JVI.02492-14; Patton HM, 2004, J HEPATOL, V40, P484, DOI 10.1016/j.jhep.2003.11.004; Poynard T, 2003, HEPATOLOGY, V38, P75, DOI 10.1053/jhep.2003.50267; Puri P, 2006, CLIN LIVER DIS, V10, P703; Quintavalle C, 2014, J CELL PHYSIOL, V229, P1359, DOI 10.1002/jcp.24569; Restivo L, 2012, J VIRAL HEPATITIS, V19, P346, DOI 10.1111/j.1365-2893.2011.01555.x; Ripoli M, 2011, EXPERT REV ANTI-INFE, V9, P747, DOI [10.1586/ERI.11.94, 10.1586/eri.11.94]; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Syed GH, 2010, TRENDS ENDOCRIN MET, V21, P33, DOI 10.1016/j.tem.2009.07.005; Garcia-Mediavilla MV, 2012, LAB INVEST, V92, P1191, DOI 10.1038/labinvest.2012.88; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086; Zhang LL, 2011, J HEPATOL, V55, P289, DOI 10.1016/j.jhep.2010.11.019	48	18	19	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0125962	10.1371/journal.pone.0125962	http://dx.doi.org/10.1371/journal.pone.0125962			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961570	gold, Green Submitted, Green Published			2022-12-26	WOS:000354542500053
J	Parente, DB; Paiva, FF; Neto, JAO; Machado-Silva, L; Figueiredo, FAF; Lanzoni, V; Campos, CFF; do Brasil, PEAA; Gomes, MD; Perez, RD; Rodrigues, RS				Parente, Daniella Braz; Paiva, Fernando Fernandes; Oliveira Neto, Jaime Araujo; Machado-Silva, Lilian; Ferreira Figueiredo, Fatima Aparecida; Lanzoni, Valeria; Ferreira Campos, Carlos Frederico; Alvarenga Americano do Brasil, Pedro Emmanuel; Gomes, Marilia de Brito; Perez, Renata de Mello; Rodrigues, Rosana Souza			Intravoxel Incoherent Motion Diffusion Weighted MR Imaging at 3.0 T: Assessment of Steatohepatitis and Fibrosis Compared with Liver Biopsy in Type 2 Diabetic Patients	PLOS ONE			English	Article							NONALCOHOLIC STEATOHEPATITIS; HEPATIC STEATOSIS; SCORING SYSTEM; B-VALUES; DISEASE; DIAGNOSIS; IVIM; ASSOCIATION; PREVALENCE; VALIDATION	Objective To evaluate the capability of intravoxel incoherent motion (IVIM) diffusion-weighted imaging (DWI) to assess steatohepatitis and fibrosis determined by histopathology in type 2 diabetic patients. Methods Fifty-nine type 2 diabetic patients (49 women, 10 men; mean age, 54 +/- 9 years) were submitted to liver biopsy for the evaluation of non-alcoholic fatty liver disease (NAFLD) and underwent DWI on a 3.0T MR system using 10 b values. Institutional approval and patient consent were obtained. Pure molecular-based (D), perfusion-related (D*), and vascular fraction (f) were calculated using a double exponential model and least squares curve fitting. D, D*, and f were compared between patients with and without steatohepatitis and between patients with and without fibrosis. The variables were compared by using the Ranksum test and Student t-test. Results Steatohepatitis was observed in 22 patients and fibrosis in 16 patients. A lower D median (0.70 s/mm(2) vs. 0.83 s/mm(2), p< 0.05) and a lower D* median (34.39 s/mm(2) vs. 45.23 s/mm2, p< 0.05) were observed among those with steatohepatitis. A lower D median (0.70 s/mm(2) vs. 0.82 s/mm(2), p< 0.05) and a lower D* median (35.01 s/mm(2) vs. 44.76 s/mm(2), p= 0.05) were also observed among those with fibrosis. Conclusion IVIM-DWI has the potential to aid in the characterization of steatohepatitis and fibrosis.	[Parente, Daniella Braz; Paiva, Fernando Fernandes; Oliveira Neto, Jaime Araujo; Alvarenga Americano do Brasil, Pedro Emmanuel; Perez, Renata de Mello; Rodrigues, Rosana Souza] DOr Inst Res & Educ, Rio De Janeiro, Brazil; [Parente, Daniella Braz; Ferreira Figueiredo, Fatima Aparecida; Perez, Renata de Mello; Rodrigues, Rosana Souza] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil; [Machado-Silva, Lilian; Ferreira Figueiredo, Fatima Aparecida; Ferreira Campos, Carlos Frederico; Gomes, Marilia de Brito; Perez, Renata de Mello] Univ Estado Rio De Janeiro, Rio De Janeiro, Brazil; [Paiva, Fernando Fernandes] Univ Sao Paulo, Inst Phys Sao Carlos, BR-13560 Sao Carlos, SP, Brazil; [Lanzoni, Valeria] Univ Fed Sao Paulo, Sao Paulo, Brazil	IDOR - Instituto D'Or de Ensino e Pesquisa; Universidade Federal do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Parente, DB (corresponding author), DOr Inst Res & Educ, Rio De Janeiro, Brazil.	daniella.parente@gmail.com	Parente, Daniella/AAP-7677-2020; Paiva, Fernando F/C-1429-2012; Rodrigues, Rosana Souza/N-9866-2013; Brasil, Pedro E A A/B-4357-2008	Parente, Daniella/0000-0003-0031-5785; Paiva, Fernando F/0000-0002-8989-9707; Rodrigues, Rosana Souza/0000-0002-9952-3834; Brasil, Pedro E A A/0000-0002-6700-2268	D'Or Institute for Research and Education; FAPERJ (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro)	D'Or Institute for Research and Education; FAPERJ (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by the D'Or Institute for Research and Education and by FAPERJ (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Annet L, 2007, J MAGN RESON IMAGING, V25, P122, DOI 10.1002/jmri.20771; Arun J, 2007, OBES SURG, V17, P155, DOI 10.1007/s11695-007-9041-2; Brunt EM, 2010, WORLD J GASTROENTERO, V16, P5286, DOI 10.3748/wjg.v16.i42.5286; Callot V, 2003, MAGN RESON MED, V50, P531, DOI 10.1002/mrm.10568; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Chow AM, 2012, J MAGN RESON IMAGING, V36, P159, DOI 10.1002/jmri.23607; Cusi K, 2009, CURR OPIN ENDOCRINOL, V16, P141, DOI 10.1097/MED.0b013e3283293015; Dyvorne HA, 2013, RADIOLOGY, V266, P920, DOI 10.1148/radiol.12120686; Fracanzani AL, 2008, HEPATOLOGY, V48, P792, DOI 10.1002/hep.22429; Girometti R, 2008, J MAGN RESON IMAGING, V28, P411, DOI 10.1002/jmri.21461; Guiu B, 2012, RADIOLOGY; Gupte P, 2004, J GASTROEN HEPATOL, V19, P854, DOI 10.1111/j.1440-1746.2004.03312.x; Harrison SA, 2008, GUT, V57, P1441, DOI 10.1136/gut.2007.146019; Joo I, 2014, RADIOLOGY, V270, P131, DOI 10.1148/radiol.13122506; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Koinuma M, 2005, J MAGN RESON IMAGING, V22, P80, DOI 10.1002/jmri.20344; Kwok R, 2014, ALIMENT PHARM THER, V39, P254, DOI 10.1111/apt.12569; Lazo M, 2008, SEMIN LIVER DIS, V28, P339, DOI 10.1055/s-0028-1091978; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; LEBIHAN D, 1989, MAGNET RESON MED, V10, P324; Lee JT, 2012, MAGN RESON IMAGING, V30, P572, DOI 10.1016/j.mri.2011.12.013; Leitao HS, 2013, EUR RADIOL, V23, P461, DOI 10.1007/s00330-012-2626-8; Lewin M, 2007, HEPATOLOGY, V46, P658, DOI 10.1002/hep.21747; Loomba R, 2012, HEPATOLOGY; Luciani A, 2008, RADIOLOGY, V249, P891, DOI 10.1148/radiol.2493080080; McCullough AJ, 2006, J CLIN GASTROENTEROL, V40, pS17; Morling JR, 2014, J HEPATOL, V60, P384, DOI 10.1016/j.jhep.2013.10.017; Moteki T, 2006, J MAGN RESON IMAGING, V24, P637, DOI 10.1002/jmri.20682; Murphy P, 2014, J MAGN RESON IMAGING; Nettschwander-Tetri BA, 2010, HEPATOLOGY, V52, P913, DOI 10.1002/hep.23784; Patel J, 2010, J MAGN RESON IMAGING, V31, P589, DOI 10.1002/jmri.22081; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Sandrasegaran K, 2009, AM J ROENTGENOL, V193, P1556, DOI 10.2214/AJR.09.2436; Szczepaniak LS, 2005, AM J PHYSIOL-ENDOC M, V288, pE462, DOI 10.1152/ajpendo.00064.2004; Taouli B, 2008, J MAGN RESON IMAGING, V28, P89, DOI 10.1002/jmri.21227; Taouli B, 2007, AM J ROENTGENOL, V189, P799, DOI 10.2214/AJR.07.2086; Targher G, 2007, DIABETES CARE, V30, P1212, DOI 10.2337/dc06-2247; Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132; Van Beers BE, 2014, RADIOLOGY, V270, P1, DOI 10.1148/radiol.13132294; Wang YF, 2008, OBESITY, V16, P2323, DOI 10.1038/oby.2008.351; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; XIE Q, 2014, PLOS COMPUT BIOL, V10, P92772, DOI DOI 10.1371/JOURNAL.PONE.0092772; Zhang Y, 2013, MAGN RESON IMAGING, V31, P1017, DOI 10.1016/j.mri.2013.03.007	44	27	28	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0125653	10.1371/journal.pone.0125653	http://dx.doi.org/10.1371/journal.pone.0125653			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961735	gold, Green Published, Green Submitted			2022-12-26	WOS:000354542500040
J	Su, BY; Kabinejadian, F; Phang, HQ; Kumar, GP; Cui, FS; Kim, S; Tan, RS; Hon, JKF; Allen, JC; Leo, HL; Zhong, L				Su, Boyang; Kabinejadian, Foad; Phang, Hui Qun; Kumar, Gideon Praveen; Cui, Fangsen; Kim, Sangho; Tan, Ru San; Hon, Jimmy Kim Fatt; Allen, John Carson; Leo, Hwa Liang; Zhong, Liang			Numerical Modeling of Intraventricular Flow during Diastole after Implantation of BMHV	PLOS ONE			English	Article							FLUID-STRUCTURE INTERACTION; MECHANICAL HEART-VALVES; LEFT-VENTRICULAR FLOW; PARTICLE IMAGE VELOCIMETRY; OF-THE-ART; IN-VIVO; BLOOD-FLOW; DYNAMICS; SIMULATION; RESTORATION	This work presents a numerical simulation of intraventricular flow after the implantation of a bileaflet mechanical heart valve at the mitral position. The left ventricle was simplified conceptually as a truncated prolate spheroid and its motion was prescribed based on that of a healthy subject. The rigid leaflet rotation was driven by the transmitral flow and hence the leaflet dynamics were solved using fluid-structure interaction approach. The simulation results showed that the bileaflet mechanical heart valve at the mitral position behaved similarly to that at the aortic position. Sudden area expansion near the aortic root initiated a clockwise anterior vortex, and the continuous injection of flow through the orifice resulted in further growth of the anterior vortex during diastole, which dominated the intraventricular flow. This flow feature is beneficial to preserving the flow momentum and redirecting the blood flow towards the aortic valve. To the best of our knowledge, this is the first attempt to numerically model intraventricular flow with the mechanical heart valve incorporated at the mitral position using a fluid-structure interaction approach. This study facilitates future patient-specific studies.	[Su, Boyang; Tan, Ru San; Zhong, Liang] Natl Heart Ctr Singapore, Natl Heart Res Inst Singapore, Singapore, Singapore; [Kabinejadian, Foad; Kim, Sangho; Leo, Hwa Liang] Natl Univ Singapore, Dept Biomed Engn, Singapore 117548, Singapore; [Phang, Hui Qun; Hon, Jimmy Kim Fatt] Natl Univ Singapore, Dept Surg, Singapore 117548, Singapore; [Kumar, Gideon Praveen; Cui, Fangsen] ASTAR, Inst High Performance Comp, Singapore, Singapore; [Allen, John Carson; Zhong, Liang] Duke NUS Grad Med Sch, Singapore, Singapore	National Heart Centre Singapore; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of High Performance Computing (IHPC); National University of Singapore	Zhong, L (corresponding author), Natl Heart Ctr Singapore, Natl Heart Res Inst Singapore, Singapore, Singapore.	zhong.liang@nhcs.com.sg	Hon, Jimmy/B-5445-2012; Kabinejadian, Foad/A-9829-2015; Cui, Fangsen/C-2025-2009; Kim, Sangho/I-7032-2012; Leo, Hwa Liang/B-6946-2011	Kabinejadian, Foad/0000-0002-4125-5064; Cui, Fangsen/0000-0001-6682-9768; Tan, Ru San/0000-0003-2086-6517; ZHONG, LIANG/0000-0003-3608-4173; Kim, Sangho/0000-0002-1045-5928; Leo, Hwa Liang/0000-0003-0592-6470	A*STAR BEP Program (SERC) [103 149 0004]; National Research Foundation, Singapore [NMRC/EDG/1037/2011]; Goh Cardiovascular Research Award [Duke-NUSGCR/2013/0009]	A*STAR BEP Program (SERC)(Agency for Science Technology & Research (A*STAR)); National Research Foundation, Singapore(National Research Foundation, Singapore); Goh Cardiovascular Research Award	This work was supported by A*STAR BEP Program (SERC Grant number 103 149 0004) to HLL and JKFH http://www.a-star.edu.sg/Research/Funding-Opportunities/Grants-Sponsorship/SERCBiomedical-Engineering-Programme-BEP.aspx; National Research Foundation, Singapore under its Cooperative Basic Research Grant and administered by the Singapore Ministry of Health's National Medical Research Council (NMRC/EDG/1037/2011) (LZ) http://www.nmrc.gov.sg/content/nmrc_internet/home/grant/compgrants/grantedg.html; and Goh Cardiovascular Research Award (Duke-NUSGCR/2013/0009) (LZ) http://www.academic-medicine.edu.sg/amri/content/awarded-grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annerel S, 2012, COMPUT METHOD BIOMEC, V15, P1281, DOI 10.1080/10255842.2011.586946; Annerel S, 2012, INT J NUMER METH BIO, V28, P745, DOI 10.1002/cnm.2470; Aoyagi S, 2006, ANN THORAC SURG, V82, P853, DOI 10.1016/j.athoracsur.2006.04.088; Baccani B, 2002, J BIOMECH, V35, P665, DOI 10.1016/S0021-9290(02)00005-2; Borazjani I, 2008, J COMPUT PHYS, V227, P7587, DOI 10.1016/j.jcp.2008.04.028; Borazjani I, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4002491; Borazjani I, 2010, ANN BIOMED ENG, V38, P326, DOI 10.1007/s10439-009-9807-x; Cheng YG, 2005, ANN BIOMED ENG, V33, P567, DOI 10.1007/s10439-005-4388-9; Choi YJ, 2014, ANN BIOMED ENG, V42, P1668, DOI 10.1007/s10439-014-1018-4; Dahl SK, 2012, COMPUT METHOD BIOMEC, V15, P121, DOI 10.1080/10255842.2010.517200; Dasi LP, 2007, PHYS FLUIDS, V19, DOI 10.1063/1.2743261; Dumont K., 2004, Computer Methods in Biomechanics and Biomedical Engineering, V7, P139, DOI 10.1080/10255840410001715222; Dumont K, 2007, J BIOMECH ENG-T ASME, V129, P558, DOI 10.1115/1.2746378; Espa S, 2012, EUR J MECH B-FLUID, V35, P9, DOI 10.1016/j.euromechflu.2012.01.015; Faludi R, 2010, J THORAC CARDIOV SUR, V139, P1501, DOI 10.1016/j.jtcvs.2009.07.060; Forsythe N, 2008, INT J COMPUT FLUID D, V22, P541, DOI 10.1080/10618560802336962; Ge L, 2005, J BIOMECH ENG-T ASME, V127, P782, DOI 10.1115/1.1993665; Ge L, 2003, J BIOMECH ENG-T ASME, V125, P709, DOI 10.1115/1.1614817; Ge L, 2007, J COMPUT PHYS, V225, P1782, DOI 10.1016/j.jcp.2007.02.017; Guivier-Curien C, 2009, MED ENG PHYS, V31, P986, DOI 10.1016/j.medengphy.2009.05.012; Khalafvand SS, 2014, INT J NUMER METH BIO, V30, P1044, DOI 10.1002/cnm.2643; Khalafvand SS, 2012, COMPUT BIOL MED, V42, P863, DOI 10.1016/j.compbiomed.2012.06.010; Kheradvar A, 2009, ANN BIOMED ENG, V37, P1, DOI 10.1007/s10439-008-9588-7; Le TB, 2012, EUR J MECH B-FLUID, V35, P20, DOI 10.1016/j.euromechflu.2012.01.013; Li CP, 2012, J ARTIF ORGANS, V15, P364, DOI 10.1007/s10047-012-0650-8; Lim CW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093747; Machler H, 2004, EUR J CARDIO-THORAC, V26, P747, DOI 10.1016/j.ejcts.2004.06.019; Manning KB, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2927356; McCormick M, 2013, J COMPUT PHYS, V244, P80, DOI 10.1016/j.jcp.2012.08.008; Merrifield R, 2004, LECT NOTES COMPUT SC, V3150, P229; Nakamura M, 2003, BIOMECH MODEL MECHAN, V2, P59, DOI [10.1007/s10237-003-0028-1, 10.1007/S10237-003-0028-1]; Nakamura M, 2006, ANN BIOMED ENG, V34, P927, DOI 10.1007/s10439-006-9127-3; Nguyen V.-T., 2012, CARDIOVASC ENG TECHN, V3, P88, DOI DOI 10.1007/S13239-011-0077-Z; Nobili M, 2008, J BIOMECH, V41, P2539, DOI 10.1016/j.jbiomech.2008.05.004; Pierrakos O, 2004, J BIOMECH ENG-T ASME, V126, P714, DOI 10.1115/1.1824124; Pierrakos O, 2006, J BIOMECH ENG-T ASME, V128, P527, DOI 10.1115/1.2205863; Querzoli G, 2010, PHYS FLUIDS, V22, DOI 10.1063/1.3371720; Saber NR, 2001, ANN BIOMED ENG, V29, P275, DOI 10.1114/1.1359452; Schenkel T, 2009, ANN BIOMED ENG, V37, P503, DOI 10.1007/s10439-008-9627-4; Simon HA, 2010, ANN BIOMED ENG, V38, P3295, DOI 10.1007/s10439-010-0086-3; Simon HA, 2010, ANN BIOMED ENG, V38, P841, DOI 10.1007/s10439-009-9857-0; Smadi O, 2010, J BIOMECH, V43, P1565, DOI 10.1016/j.jbiomech.2010.01.029; Sotiropoulos F, 2009, MED BIOL ENG COMPUT, V47, P245, DOI 10.1007/s11517-009-0438-z; Su BY, 2014, COMPUT METH PROG BIO, V113, P474, DOI 10.1016/j.cmpb.2013.11.009; Su BY, 2012, ARTIF ORGANS, V36, P359, DOI 10.1111/j.1525-1594.2011.01362.x; Tay WB, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-52; Taylor CA, 2009, ANNU REV BIOMED ENG, V11, P109, DOI 10.1146/annurev.bioeng.10.061807.160521; Vierendeels JA, 2000, J BIOMECH ENG-T ASME, V122, P667, DOI 10.1115/1.1318941; Votta E, 2013, J BIOMECH, V46, P217, DOI 10.1016/j.jbiomech.2012.10.026; Vukicevic M, 2012, EUR J MECH B-FLUID, V35, P54, DOI 10.1016/j.euromechflu.2012.01.014; Watanabe H, 2004, BIOPHYS J, V87, P2074, DOI 10.1529/biophysj.103.035840; Yoganathan AP, 2004, ANNU REV BIOMED ENG, V6, P331, DOI 10.1146/annurev.bioeng.6.040803.140111; Zhong L, 2011, AM J PHYSIOL-HEART C, V300, pH1653, DOI 10.1152/ajpheart.00021.2011	53	17	17	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126315	10.1371/journal.pone.0126315	http://dx.doi.org/10.1371/journal.pone.0126315			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961285	Green Published, Green Submitted, gold			2022-12-26	WOS:000354542500087
J	Wu, HZ; Guan, S; Sun, ML; Yu, ZJ; Zhao, L; He, M; Zhao, HS; Yao, WF; Wang, EH; Jin, F; Xiao, QH; Wei, MJ				Wu, Huizhe; Guan, Shu; Sun, Mingli; Yu, Zhaojin; Zhao, Lin; He, Miao; Zhao, Haishan; Yao, Weifan; Wang, Enhua; Jin, Feng; Xiao, Qinghuan; Wei, Minjie			Ano1/TMEM16A Overexpression Is Associated with Good Prognosis in PR-Positive or HER2-Negative Breast Cancer Patients following Tamoxifen Treatment	PLOS ONE			English	Article							CA2+-ACTIVATED CL-CHANNEL; CHLORIDE CHANNEL; PROGESTERONE-RECEPTOR; DOWN-REGULATION; ANO1 TMEM16A; CALCIUM; EXPRESSION; INHIBITION; THERAPY; AMPLIFICATION	The calcium-activated chloride channel Ano1 (TMEM16A) is overexpressed in many tumors. Although Ano1 overexpression is found in breast cancer due to 11q13 amplification, it remains unclear whether signaling pathways are involved in Ano1 overexpression during breast cancer tumorigenesis in vivo. Estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) have been known to contribute to breast cancer progression. It is unclear whether Ano1 is associated with clinical outcomes in breast cancer patients with different ER, PR and HER2 status. In the present study, we investigated the Ano1 expression in 431 patients with invasive ductal breast carcinoma and 46 patients with fibroadenoma, using immunohistochemistry, and analyzed the association between Ano1 expression and clinical characteristics and outcomes of breast cancer patients with different ER, PR, and HER2 status. Ano1 was overexpressed in breast cancer compared with fibroadenoma. Ano1 was significantly more associated with breast cancer with the lower clinical stage (stage I or II), or triple-negative status. Mostly importantly, Ano1 overexpression was associated with good prognosis in patients with the PR-positive or HER2-negative status, and in patients following tamoxifen treatment. Multivariate Cox regression analysis showed that Ano1 overexpression was a prognostic factor for longer overall survival in PR-positive or HER2-negative patients, and a predictive factor for longer overall survival in patients following tamoxifen treatment. Our findings suggest that Ano1 may be a potential marker for good prognosis in PR-positive or HER2-negative patients following tamoxifen treatment. The PR and HER2 status defines a subtype of breast cancer in which Ano1 overexpression is associated with good prognosis following tamoxifen treatment.	[Wu, Huizhe; Sun, Mingli; Yu, Zhaojin; Zhao, Lin; He, Miao; Zhao, Haishan; Yao, Weifan; Wei, Minjie] China Med Univ, Sch Pharm, Dept Pharmacol, Shenyang 110001, Liaoning, Peoples R China; [Guan, Shu; Jin, Feng] China Med Univ, Hosp 1, Dept Breast Surg, Shenyang 110001, Liaoning, Peoples R China; [Wang, Enhua] China Med Univ, Hosp 1, Inst Pathol & Pathophysiol, Shenyang 110001, Liaoning, Peoples R China; [Wang, Enhua] China Med Univ, Coll Basic Med Sci, Shenyang 110001, Liaoning, Peoples R China; [Xiao, Qinghuan] China Med Univ, Sch Pharm, Dept Ion Channel Pharmacol, Shenyang 110001, Liaoning, Peoples R China	China Medical University; China Medical University; China Medical University; China Medical University; China Medical University	Jin, F (corresponding author), China Med Univ, Hosp 1, Dept Breast Surg, Shenyang 110001, Liaoning, Peoples R China.	jinfeng66cn@hotmail.com; qinghuanxiao@gmail.com; mjweicmu@hotmail.com	Xiao, Qinghuan/L-1114-2019		National Natural Science Foundation of the People's Republic of China [81373427, 31371145]; Program for Liaoning Innovative Research Team in University [LNIRT LT2014016]; Educational Commission of Liaoning Province, China [L2014315]; Research Fund for the Doctoral Program of Higher Education of Liaoning Province, China [20141032]; open foundation of State Key Laboratory of oncology in Southern China [HN2014-03]	National Natural Science Foundation of the People's Republic of China(National Natural Science Foundation of China (NSFC)); Program for Liaoning Innovative Research Team in University; Educational Commission of Liaoning Province, China; Research Fund for the Doctoral Program of Higher Education of Liaoning Province, China; open foundation of State Key Laboratory of oncology in Southern China	This work was supported by grants from National Natural Science Foundation of the People's Republic of China (No. 81373427, No. 31371145), Program for Liaoning Innovative Research Team in University (LNIRT LT2014016), Educational Commission of Liaoning Province, China (L2014315), Research Fund for the Doctoral Program of Higher Education of Liaoning Province, China (20141032), and the open foundation of State Key Laboratory of oncology in Southern China (HN2014-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Ahn ER, 2012, BREAST CANCER RES TR, V131, P371, DOI 10.1007/s10549-011-1781-y; Akpalo H, 2012, HISTOPATHOLOGY, V60, P1099, DOI 10.1111/j.1365-2559.2011.04152.x; Ayoub C, 2010, BRIT J CANCER, V103, P715, DOI 10.1038/sj.bjc.6605823; Bicaku E, 2008, CANCER RES, V68, P1513, DOI 10.1158/0008-5472.CAN-07-2822; Britschgi A, 2013, P NATL ACAD SCI USA, V110, pE1026, DOI 10.1073/pnas.1217072110; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Carles A, 2006, ONCOGENE, V25, P1821, DOI 10.1038/sj.onc.1209203; Carneiro A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-98; Chen W, 2009, VALUE HEALTH, V12, pS82, DOI 10.1111/j.1524-4733.2009.00634.x; Coates AS, 2007, J CLIN ONCOL, V25, P486, DOI 10.1200/JCO.2006.08.8617; DICKSON C, 1995, CANCER LETT, V90, P43, DOI 10.1016/0304-3835(94)03676-A; Dowsett M, 2006, ANN ONCOL, V17, P818, DOI 10.1093/annonc/mdl016; Duran C, 2011, ACTA PHARMACOL SIN, V32, P685, DOI 10.1038/aps.2011.48; Duran C, 2010, ANNU REV PHYSIOL, V72, P95, DOI 10.1146/annurev-physiol-021909-135811; Duvvuri U, 2012, CANCER RES, V72, P3270, DOI 10.1158/0008-5472.CAN-12-0475-T; Ellmann S, 2009, CELL MOL LIFE SCI, V66, P2405, DOI 10.1007/s00018-009-0017-3; Fang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062558; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Hartzell HC, 2009, J PHYSIOL-LONDON, V587, P2127, DOI 10.1113/jphysiol.2008.163709; Huang F, 2012, PHARMACOL REV, V64, P1, DOI 10.1124/pr.111.005009; Jung J, 2013, P NATL ACAD SCI USA, V110, P360, DOI 10.1073/pnas.1211594110; Katoh M, 2003, INT J ONCOL, V22, P1375; Lambrechts D, 2012, HUM MUTAT, V33, P1123, DOI 10.1002/humu.22089; Liu W, 2012, CANCER LETT, V326, P41, DOI 10.1016/j.canlet.2012.07.015; Matsuba S, 2014, J PHARMACOL EXP THER, V351, P510, DOI 10.1124/jpet.114.217315; Pedemonte N, 2014, PHYSIOL REV, V94, P419, DOI 10.1152/physrev.00039.2011; Perez-Cornejo P, 2012, P NATL ACAD SCI USA, V109, P10376, DOI 10.1073/pnas.1200174109; Phillis JW, 1998, BRAIN RES, V780, P352, DOI 10.1016/S0006-8993(97)01352-8; Qu ZQ, 2014, CANCER MED-US, V3, P453, DOI 10.1002/cam4.232; Rimawi MF, 2010, CANCER-AM CANCER SOC, V116, P1234, DOI 10.1002/cncr.24816; Ruiz C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043265; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Schuetz F, 2011, BREAST CARE, V6, P179, DOI 10.1159/000329336; Ubby I, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-75; Vocke K, 2013, J GEN PHYSIOL, V142, P381, DOI 10.1085/jgp.201311015; Wang M, 2012, CIRCULATION, V125, P697, DOI 10.1161/CIRCULATIONAHA.111.041806; Wanitchakool P, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0096; Weigel MT, 2010, ENDOCR-RELAT CANCER, V17, pR245, DOI 10.1677/ERC-10-0136; West RB, 2004, AM J PATHOL, V165, P107, DOI 10.1016/S0002-9440(10)63279-8; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Xiao QH, 2011, P NATL ACAD SCI USA, V108, P8891, DOI 10.1073/pnas.1102147108; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Yu K, 2014, J GEN PHYSIOL, V143, P253, DOI 10.1085/jgp.201311047; ZHANG JJ, 1994, J CLIN INVEST, V94, P1690, DOI 10.1172/JCI117514; Zhu W, 2012, GUT, V61, P562, DOI 10.1136/gutjnl-2011-300207	46	27	33	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126128	10.1371/journal.pone.0126128	http://dx.doi.org/10.1371/journal.pone.0126128			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961581	gold, Green Published, Green Submitted			2022-12-26	WOS:000354542500067
J	Campia, I; Buondonno, I; Castella, B; Rolando, B; Kopecka, J; Gazzano, E; Ghigo, D; Riganti, C				Campia, Ivana; Buondonno, Ilaria; Castella, Barbara; Rolando, Barbara; Kopecka, Joanna; Gazzano, Elena; Ghigo, Dario; Riganti, Chiara			An Autocrine Cytokine/JAK/STAT-Signaling Induces Kynurenine Synthesis in Multidrug Resistant Human Cancer Cells	PLOS ONE			English	Article							INDOLEAMINE 2,3-DIOXYGENASE EXPRESSION; DENDRITIC CELLS; NITRIC-OXIDE; LUNG-CANCER; TRYPTOPHAN; INHIBITION; DISEASE; IDO; MECHANISM; STAT3	Background Multidrug resistant cancer cells are hard to eradicate for the inefficacy of conventional anticancer drugs. Besides escaping the cytotoxic effects of chemotherapy, they also bypass the pro-immunogenic effects induced by anticancer drugs: indeed they are not well recognized by host dendritic cells and do not elicit a durable anti-tumor immunity. It has not yet been investigated whether multidrug resistant cells have a different ability to induce immunosuppression than chemosensitive ones. We addressed this issue in human and murine chemosensitive and multidrug resistant cancer cells. Results We found that the activity and expression of indoleamine 2,3-dioxygenase 1 (IDO1), which catalyzes the conversion of tryptophan into the immunosuppressive metabolite kynurenine, was higher in all the multidrug resistant cells analyzed and that IDO1 inhibition reduced the growth of drug-resistant tumors in immunocompetent animals. In chemoresistant cells the basal activity of JAK1/STAT1 and JAK1/STAT3 signaling was higher, the STAT3 inhibitor PIAS3 was down-regulated, and the autocrine production of STAT3-target and IDO1-inducers cytokines IL-6, IL-4, IL-1 beta, IL-13, TNF-alpha and CD40L, was increased. The disruption of the JAK/STAT signaling lowered the IDO1 activity and reversed the kynurenine-induced pro-immunosuppressive effects, as revealed by the restored proliferation of T-lymphocytes in STAT-silenced chemoresistant cells. Conclusions Our work shows that multidrug resistant cells have a stronger immunosuppressive attitude than chemosensitive cells, due to the constitutive activation of the JAK/STAT/IDO1 axis, thus resulting chemo-and immune-evasive. Disrupting this axis may significantly improve the efficacy of chemo-immunotherapy protocols against resistant tumors.	[Campia, Ivana; Buondonno, Ilaria; Kopecka, Joanna; Gazzano, Elena; Ghigo, Dario; Riganti, Chiara] Univ Turin, Dept Oncol, Turin, Italy; [Castella, Barbara; Ghigo, Dario; Riganti, Chiara] Univ Turin, Ctr Expt Res & Med Studies CeRMS, Turin, Italy; [Castella, Barbara] Univ Turin, Div Hematol, Turin, Italy; [Rolando, Barbara] Univ Turin, Dept Drug Sci & Technol, Turin, Italy	University of Turin; University of Turin; University of Turin; University of Turin	Ghigo, D (corresponding author), Univ Turin, Dept Oncol, Turin, Italy.	dario.ghigo@unito.it		Rolando, Barbara/0000-0001-6138-1503; CASTELLA, Barbara/0000-0002-5880-2263; KOPECKA, JOANNA/0000-0003-3612-3953	Italian Association for Cancer Research (AIRC) [MFAG 11475]; Italian Ministry of University and Research ("Future in Research program" FIRB) [RBFR12SOQ1]	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of University and Research ("Future in Research program" FIRB)	This work was supported by grants from the Italian Association for Cancer Research (AIRC; grant MFAG 11475; www.airc.it), the Italian Ministry of University and Research ("Future in Research program" FIRB 2012, grant RBFR12SOQ1; www.istruzione.it). JK is fellow of the Italian Foundation for Cancer Research (FIRC; www.fondazionefirc.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001888; Banerjee T, 2008, ONCOGENE, V27, P2851, DOI 10.1038/sj.onc.1210939; Brandacher G, 2006, CLIN CANCER RES, V12, P1144, DOI 10.1158/1078-0432.CCR-05-1966; Burkholder B, 2014, BBA-REV CANCER, V1845, P182, DOI 10.1016/j.bbcan.2014.01.004; Cacciotti P, 2001, P NATL ACAD SCI USA, V98, P12032, DOI 10.1073/pnas.211026798; Creelan B, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23428; De Boo S, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-108; Ferguson PJ, 2014, ONCOTARGET, V5, P2778; Gajewski TF, 2006, IMMUNOL REV, V213, P131, DOI 10.1111/j.1600-065X.2006.00442.x; Gariboldi MB, 2007, CANCER LETT, V258, P181, DOI 10.1016/j.canlet.2007.08.019; Gelsomino G, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-137; Godin-Ethier J, 2011, CLIN CANCER RES, V17, P6985, DOI 10.1158/1078-0432.CCR-11-1331; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Gough DJ, 2008, CYTOKINE GROWTH F R, V19, P383, DOI 10.1016/j.cytogfr.2008.08.004; Harden JL, 2012, IMMUNOL INVEST, V41, P738, DOI 10.3109/08820139.2012.676122; Hou DY, 2007, CANCER RES, V67, P792, DOI 10.1158/0008-5472.CAN-06-2925; Hwu P, 2000, J IMMUNOL, V164, P3596, DOI 10.4049/jimmunol.164.7.3596; Ino K, 2012, J CANC SCI THER, V13; Iversen TZ, 2014, CLIN CANCER RES, V20, P221, DOI 10.1158/1078-0432.CCR-13-1560; Kopecka J, 2011, J CELL MOL MED, V15, P1492, DOI 10.1111/j.1582-4934.2010.01137.x; Krausse-Opatz B, 2009, MICROB PATHOGENESIS, V46, P289, DOI 10.1016/j.micpath.2009.03.001; Lawrence S, 2015, ENVIRON TOXICOL, V30, P559, DOI 10.1002/tox.21932; Lee BD, 2003, ONCOL RES, V14, P49, DOI 10.3727/000000003108748603; Litzenburger UM, 2014, ONCOTARGET, V5, P1038, DOI 10.18632/oncotarget.1637; Liu WL, 2014, J VIROL, V88, P6660, DOI 10.1128/JVI.03678-13; Lu B, 2008, CELL DEATH DIFFER, V15, P70, DOI 10.1038/sj.cdd.4402274; Metz R, 2007, CANCER RES, V67, P7082, DOI 10.1158/0008-5472.CAN-07-1872; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Okamoto A, 2005, CLIN CANCER RES, V11, P6030, DOI 10.1158/1078-0432.CCR-04-2671; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Orabona C, 2011, METHODS MOL BIOL, V677, P269, DOI 10.1007/978-1-60761-869-0_19; Orabona C, 2008, P NATL ACAD SCI USA, V105, P20828, DOI 10.1073/pnas.0810278105; OZAKI Y, 1988, P NATL ACAD SCI USA, V85, P1242, DOI 10.1073/pnas.85.4.1242; Prendergast GC, 2011, NATURE, V478, P192, DOI 10.1038/478192a; Qian F, 2009, CANCER RES, V69, P5498, DOI 10.1158/0008-5472.CAN-08-2106; Riganti C, 2008, TOXICOL APPL PHARM, V228, P277, DOI 10.1016/j.taap.2007.12.013; Riganti C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060975; Russell MA, 2013, ISLETS, V5, P95, DOI 10.4161/isl.24249; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Smith C, 2012, CANCER DISCOV, V2, P722, DOI 10.1158/2159-8290.CD-12-0014; Song LX, 2011, MOL CANCER THER, V10, P481, DOI 10.1158/1535-7163.MCT-10-0502; Sun YP, 2009, J IMMUNOL, V182, P5899, DOI 10.4049/jimmunol.0804388; Suzuki Y, 2010, LUNG CANCER, V67, P361, DOI 10.1016/j.lungcan.2009.05.001; Thomas SR, 2007, J BIOL CHEM, V282, P23778, DOI 10.1074/jbc.M700669200; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Yadav MC, 2007, GLIA, V55, P1385, DOI 10.1002/glia.20544; Yoshida N, 2008, CLIN CANCER RES, V14, P7251, DOI 10.1158/1078-0432.CCR-08-0991; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Zhang XQ, 2009, J CHROMATOGR B, V877, P1678, DOI 10.1016/j.jchromb.2009.04.013; Zunszain PA, 2012, NEUROPSYCHOPHARMACOL, V37, P939, DOI 10.1038/npp.2011.277	52	22	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0126159	10.1371/journal.pone.0126159	http://dx.doi.org/10.1371/journal.pone.0126159			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955018	gold, Green Published, Green Submitted			2022-12-26	WOS:000356768100103
J	Dik, JWH; Hendrix, R; Friedrich, AW; Luttjeboer, J; Panday, PN; Wilting, KR; Lo-Ten-Foe, JR; Postma, MJ; Sinha, B				Dik, Jan-Willem H.; Hendrix, Ron; Friedrich, Alex W.; Luttjeboer, Jos; Panday, Prashant Nannan; Wilting, Kasper R.; Lo-Ten-Foe, Jerome R.; Postma, Maarten J.; Sinha, Bhanu			Cost-Minimization Model of a Multidisciplinary Antibiotic Stewardship Team Based on a Successful Implementation on a Urology Ward of an Academic Hospital	PLOS ONE			English	Article							ANTIMICROBIAL STEWARDSHIP; HEALTH-CARE; OUTCOMES; PROGRAM; INTERVENTION; INFECTIONS; PREVENTION; MANAGEMENT; RESISTANCE; SAVINGS	Background In order to stimulate appropriate antimicrobial use and thereby lower the chances of resistance development, an Antibiotic Stewardship Team (A-Team) has been implemented at the University Medical Center Groningen, the Netherlands. Focus of the A-Team was a pro-active day 2 case-audit, which was financially evaluated here to calculate the return on investment from a hospital perspective. Methods Effects were evaluated by comparing audited patients with a historic cohort with the same diagnosis-related groups. Based upon this evaluation a cost-minimization model was created that can be used to predict the financial effects of a day 2 case-audit. Sensitivity analyses were performed to deal with uncertainties. Finally, the model was used to financially evaluate the A-Team. Results One whole year including 114 patients was evaluated. Implementation costs were calculated to be (sic)17,732, which represent total costs spent to implement this A-Team. For this specific patient group admitted to a urology ward and consulted on day 2 by the A-Team, the model estimated total savings of (sic)60,306 after one year for this single department, leading to a return on investment of 5.9. Conclusions The implemented multi-disciplinary A-Team performing a day 2 case-audit in the hospital had a positive return on investment caused by a reduced length of stay due to a more appropriate antibiotic therapy. Based on the extensive data analysis, a model of this intervention could be constructed. This model could be used by other institutions, using their own data to estimate the effects of a day 2 case-audit in their hospital.	[Dik, Jan-Willem H.; Hendrix, Ron; Friedrich, Alex W.; Wilting, Kasper R.; Lo-Ten-Foe, Jerome R.; Sinha, Bhanu] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, NL-9713 AV Groningen, Netherlands; [Hendrix, Ron] Certe Lab Infect Dis, Groningen, Netherlands; [Luttjeboer, Jos; Postma, Maarten J.] Univ Groningen, Dept Pharm, Unit PharmacoEpidemiol & PharmacoEcon, Groningen, Netherlands; [Panday, Prashant Nannan] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, NL-9713 AV Groningen, Netherlands; [Postma, Maarten J.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, NL-9713 AV Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	Friedrich, AW (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, NL-9713 AV Groningen, Netherlands.	alex.friedrich@umcg.nl	Friedrich, Alex/ABG-9823-2020	Postma, Maarten/0000-0002-6306-3653; Dik, Jan-Willem/0000-0003-3258-8817; Sinha, Bhanu/0000-0003-1634-0010	European Union; German state of North Rhine-Westphalia; German state of Lower Saxony; Dutch province Overijssel; Dutch province Gelderland; Dutch province Limburg via the EurSafety Health-net project [Interreg IVa III-1-01=073]	European Union(European Commission); German state of North Rhine-Westphalia; German state of Lower Saxony; Dutch province Overijssel; Dutch province Gelderland; Dutch province Limburg via the EurSafety Health-net project	This work was supported by the European Union, the German states of North Rhine-Westphalia and Lower Saxony, and the Dutch provinces Overijssel, Gelderland, and Limburg via the EurSafety Health-net project [Interreg IVa III-1-01=073] (AWF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken LH, 2002, NURS OUTLOOK, V50, P187, DOI 10.1067/mno.2002.126696; Ansari F, 2003, J ANTIMICROB CHEMOTH, V52, P842, DOI 10.1093/jac/dkg459; Ciccolini M, 2013, INT J MED MICROBIOL, V303, P380, DOI 10.1016/j.ijmm.2013.02.003; Clements A, 2008, LANCET INFECT DIS, V8, P427, DOI 10.1016/S1473-3099(08)70151-8; Cosgrove SE, 2006, CLIN INFECT DIS, V42, pS82, DOI 10.1086/499406; Davey P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003543.pub3; De Angelis G, 2010, CLIN MICROBIOL INFEC, V16, P1729, DOI 10.1111/j.1469-0691.2010.03332.x; de Kraker MEA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001104; Dellit TH, 2007, CLIN INFECT DIS, V44, P159, DOI 10.1086/510393; DIK JWH, 2015, FRONT MICROBIOL, V6, DOI DOI 10.3389/FMICB; Donker T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035002; Drummond M.F., 2005, METHODS EC EVALUATIO, V3d, P55; ECDC/EMEA Joint Working Group, EMEA5761762009 ECDCE, P13; Goff DA, 2012, CLIN INFECT DIS, V55, P587, DOI 10.1093/cid/cis494; Gray A, 2012, J ANTIMICROB CHEMOTH, V67, P2297, DOI 10.1093/jac/dks194; Gross R, 2001, CLIN INFECT DIS, V33, P289, DOI 10.1086/321880; Hakkaart-van Roijen L, 2010, GUIDELINES PHARMACOE; Hamblin S, 2012, J TRAUMA ACUTE CARE, V73, P1484, DOI 10.1097/TA.0b013e318267cd80; Handoko K B, 2004, Ned Tijdschr Geneeskd, V148, P222; Jonsson B, 2009, EUR J HEALTH ECON, V10, P357, DOI 10.1007/s10198-009-0173-2; Lo-Ten-Foe Jerome R, 2014, Ned Tijdschr Geneeskd, V158, pA6795; Morgan D, 2014, OECD HLTH WORKING PA, V68, P25; Niwa T, 2012, INT J CLIN PRACT, V66, P999, DOI 10.1111/j.1742-1241.2012.02999.x; Nowak MA, 2012, AM J HEALTH-SYST PH, V69, P1500, DOI 10.2146/ajhp110603; Perez KK, 2013, ARCH PATHOL LAB MED, V137, P1247, DOI 10.5858/arpa.2012-0651-OA; Roberts RR, 2009, CLIN INFECT DIS, V49, P1175, DOI 10.1086/605630; Rudholm N, 2002, J HEALTH ECON, V21, P1071, DOI 10.1016/S0167-6296(02)00053-X; Ruttimann S, 2004, CLIN INFECT DIS, V38, P348, DOI 10.1086/380964; Scheetz MH, 2009, J ANTIMICROB CHEMOTH, V63, P816, DOI 10.1093/jac/dkp004; SMITH R, 2013, BMJ-BRIT MED J, V346, DOI DOI 10.1136/BMJ.F1493; Tice AD, 2007, AM J HEALTH-SYST PH, V64, P1080, DOI 10.1093/ajhp/64.10.1080; van Cleef BAGL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042787; van Zanten ARH, 2003, CRIT CARE, V7, pR184, DOI 10.1186/cc2388; WHO, 2012, EVOLVING THREAT OF ANTIMICROBIAL RESISTANCE: OPTIONS FOR ACTION, P1; With de K., 2013, S3 LEITLINIE STRATEG; World Health Organization, 2014, HLTH SYST TIM GLOB E, V1, P27	36	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0126106	10.1371/journal.pone.0126106	http://dx.doi.org/10.1371/journal.pone.0126106			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955494	Green Published, gold, Green Submitted			2022-12-26	WOS:000356768100097
J	Rentzsch, J; Shen, C; Jockers-Scherubl, MC; Gallinat, J; Neuhaus, AH				Rentzsch, Johannes; Shen, Christina; Jockers-Scheruebl, Maria C.; Gallinat, Juergen; Neuhaus, Andres H.			Auditory Mismatch Negativity and Repetition Suppression Deficits in Schizophrenia Explained by Irregular Computation of Prediction Error	PLOS ONE			English	Article							P50 SUPPRESSION; RISK; N100; MMN; HALLUCINATIONS; ABNORMALITIES; METAANALYSIS; POTENTIALS; PSYCHOSIS; STIMULI	Background The predictive coding model is rapidly gaining attention in schizophrenia research. It posits the neuronal computation of residual variance ('prediction error') between sensory information and top-down expectation through multiple hierarchical levels. Event-related potentials (ERP) reflect cortical processing stages that are increasingly interpreted in the light of the predictive coding hypothesis. Both mismatch negativity (MMN) and repetition suppression (RS) measures are considered a prediction error correlates based on error detection and error minimization, respectively. Methods Twenty-five schizophrenia patients and 25 healthy controls completed auditory tasks designed to elicit MMN and RS responses that were investigated using repeated measures models and strong spatio-temporal a priori hypothesis based on previous research. Separate correlations were performed for controls and schizophrenia patients, using age and clinical variables as covariates. Results MMN and RS deficits were largely replicated in our sample of schizophrenia patients. Moreover, MMN and RS measures were strongly correlated in healthy controls, while no correlation was found in schizophrenia patients. Single-trial analyses indicated significantly lower signal-to-noise ratio during prediction error computation in schizophrenia. Conclusions This study provides evidence that auditory ERP components relevant for schizophrenia research can be reconciled in the light of the predictive coding framework. The lack of any correlation between the investigated measures in schizophrenia patients suggests a disruption of predictive coding mechanisms in general. More specifically, these results suggest that schizophrenia is associated with an irregular computation of residual variance between sensory input and top-down models, i.e. prediction error.	[Rentzsch, Johannes; Shen, Christina; Jockers-Scheruebl, Maria C.; Gallinat, Juergen; Neuhaus, Andres H.] Charite, Dept Psychiat, D-13353 Berlin, Germany; [Jockers-Scheruebl, Maria C.] Oberhavel Hosp, Dept Psychiat, Hennigsdorf, Germany; [Gallinat, Juergen] Univ Hosp Eppendorf, Dept Psychiat, Hamburg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf	Neuhaus, AH (corresponding author), Charite, Dept Psychiat, D-13353 Berlin, Germany.	andres.neuhaus@charite.de	Neuhaus, Andres H./H-4500-2019; Rentzsch, Johannes/T-9114-2017	Neuhaus, Andres H./0000-0003-2644-610X; Rentzsch, Johannes/0000-0002-3192-2417				Adams Rick A, 2013, Front Psychiatry, V4, P47, DOI 10.3389/fpsyt.2013.00047; ADLER LE, 1982, BIOL PSYCHIAT, V17, P639; Adler LE, 2004, AM J PSYCHIAT, V161, P1822, DOI 10.1176/appi.ajp.161.10.1822; Baldeweg T, 2004, SCHIZOPHR RES, V69, P203, DOI 10.1016/j.schres.2003.09.009; Blakemore SJ, 2000, PSYCHOL MED, V30, P1131, DOI 10.1017/S0033291799002676; Bodatsch M, 2011, BIOL PSYCHIAT, V69, P959, DOI 10.1016/j.biopsych.2010.09.057; Boutros NN, 2009, SCHIZOPHR RES, V113, P339, DOI 10.1016/j.schres.2009.05.019; Bramon E, 2004, SCHIZOPHR RES, V70, P315, DOI 10.1016/j.schres.2004.01.004; Brenner CA, 2009, SCHIZOPHR RES, V113, P332, DOI 10.1016/j.schres.2009.06.012; Brockhaus-Dumke A, 2008, BIOL PSYCHIAT, V64, P376, DOI 10.1016/j.biopsych.2008.02.006; Butler PD, 2012, SCHIZOPHRENIA BULL, V38, P81, DOI 10.1093/schbul/sbr106; Cadenhead KS, 2005, BIOL PSYCHIAT, V57, P1504, DOI 10.1016/j.biopsych.2005.03.003; Camchong J, 2011, SCHIZOPHRENIA BULL, V37, P640, DOI 10.1093/schbul/sbp131; Corlett PR, 2007, BRAIN, V130, P2387, DOI 10.1093/brain/awm173; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Fisher DJ, 2012, SCHIZOPHR RES, V139, P237, DOI 10.1016/j.schres.2012.06.004; Ford JM, 2014, SCHIZOPHRENIA BULL, V40, P804, DOI 10.1093/schbul/sbt072; Freedman R, 1996, ARCH GEN PSYCHIAT, V53, P1114; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Garrido MI, 2008, NEUROIMAGE, V42, P936, DOI 10.1016/j.neuroimage.2008.05.018; Gjini K, 2010, SCHIZOPHR RES, V121, P139, DOI 10.1016/j.schres.2010.04.020; Gradin VB, 2011, BRAIN, V134, P1751, DOI 10.1093/brain/awr059; Jacobsen T, 2001, PSYCHOPHYSIOLOGY, V38, P723, DOI 10.1017/S0048577201000993; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kisley MA, 2004, PSYCHOPHYSIOLOGY, V41, P604, DOI 10.1111/j.1469-8986.2004.00191.x; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Krober HL, 1998, RECHTSMEDIZIN, V8, P41; Lakatos P, 2013, J NEUROSCI, V33, P11692, DOI 10.1523/JNEUROSCI.0010-13.2013; Light GA, 2000, AM J PSYCHIAT, V157, P767, DOI 10.1176/appi.ajp.157.5.767; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Minzenberg MJ, 2009, ARCH GEN PSYCHIAT, V66, P811, DOI 10.1001/archgenpsychiatry.2009.91; Murray GK, 2008, MOL PSYCHIATR, V13, P267, DOI 10.1038/sj.mp.4002058; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Neuhaus AH, 2013, SCHIZOPHR RES, V147, P326, DOI 10.1016/j.schres.2013.04.004; Perez VB, 2014, BIOL PSYCHIAT, V75, P459, DOI 10.1016/j.biopsych.2013.07.038; Rentzsch J, 2008, INT J PSYCHOPHYSIOL, V67, P81, DOI 10.1016/j.ijpsycho.2007.10.006; Repovs G, 2011, BIOL PSYCHIAT, V69, P967, DOI 10.1016/j.biopsych.2010.11.009; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Shaikh M, 2012, SCHIZOPHR RES, V134, P42, DOI 10.1016/j.schres.2011.09.022; Shergill SS, 2014, JAMA PSYCHIAT, V71, P28, DOI 10.1001/jamapsychiatry.2013.2974; Steinberg EE, 2013, NAT NEUROSCI, V16, P966, DOI 10.1038/nn.3413; Stephan KE, 2006, BIOL PSYCHIAT, V59, P929, DOI 10.1016/j.biopsych.2005.10.005; Umbricht D, 2005, SCHIZOPHR RES, V76, P1, DOI 10.1016/j.schres.2004.12.002; Voss M, 2010, BRAIN, V133, P3104, DOI 10.1093/brain/awq152; Wacongne C, 2012, J NEUROSCI, V32, P3665, DOI 10.1523/JNEUROSCI.5003-11.2012	46	28	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0126775	10.1371/journal.pone.0126775	http://dx.doi.org/10.1371/journal.pone.0126775			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955846	Green Published, Green Submitted, gold			2022-12-26	WOS:000356768100144
J	Volckmar, AL; Song, JY; Jarick, I; Putter, C; Gobel, M; Horn, L; Struve, C; Haas, K; Knoll, N; Grallert, H; Illig, T; Reinehr, T; Wang, HJ; Hebebrand, J; Hinney, A				Volckmar, Anna-Lena; Song, Jie-Yun; Jarick, Ivonne; Puetter, Carolin; Goebel, Maria; Horn, Lucie; Struve, Christoph; Haas, Katharina; Knoll, Nadja; Grallert, Harald; Illig, Thomas; Reinehr, Thomas; Wang, Hai-Jun; Hebebrand, Johannes; Hinney, Anke			Fine Mapping of a GWAS-Derived Obesity Candidate Region on Chromosome 16p11.2	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PERFORMANCE LIQUID-CHROMATOGRAPHY; ONSET EXTREME OBESITY; APOLIPOPROTEIN B48; ADULT OBESITY; RECEPTOR GENE; LOCI; SEQUENCE; SH2B1; VARIANTS	Introduction Large-scale genome-wide association studies (GWASs) have identified 97 chromosomal loci associated with increased body mass index in population-based studies on adults. One of these SNPs, rs7359397, tags a large region (approx. 1MB) with high linkage disequilibrium (r(2)>0.7), which comprises five genes (SH2B1, APOBR, sulfotransferases: SULT1A1 and SULT1A2, TUFM). We had previously described a rare mutation in SH2B1 solely identified in extremely obese individuals but not in lean controls. Methods The coding regions of the genes APOBR, SULT1A1, SULT1A2, and TUFM were screened for mutations (dHPLC, SSCP, Sanger re-sequencing) in 95 extremely obese children and adolescents. Detected non-synonymous variants were genotyped (TaqMan SNP Genotyping, MALDI TOF, PCR-RFLP) in independent large study groups (up to 3,210 extremely obese/overweight cases, 485 lean controls and 615 obesity trios). In silico tools were used for the prediction of potential functional effects of detected variants. Results Except for TUFM we detected non-synonymous variants in all screened genes. Two polymorphisms rs180743 (APOBR p.Pro428Ala) and rs3833080 (APOBR p.Gly369_Asp370-del9) showed nominal association to (extreme) obesity (uncorrected p = 0.003 and p = 0.002, respectively). In silico analyses predicted a functional implication for rs180743 (APOBR p. Pro428Ala). Both APOBR variants are located in the repetitive region with unknown function. Conclusion Variants in APOBR contributed as strongly as variants in SH2B1 to the association with extreme obesity in the chromosomal region chr16p11.2. In silico analyses implied no functional effect of several of the detected variants. Further in vitro or in vivo analyses on the functional implications of the obesity associated variants are warranted.	[Volckmar, Anna-Lena; Goebel, Maria; Horn, Lucie; Struve, Christoph; Haas, Katharina; Knoll, Nadja; Hebebrand, Johannes; Hinney, Anke] Univ Duisburg Essen, Univ Hosp Essen, Dept Child & Adolescent Psychiat, Essen, Germany; [Song, Jie-Yun; Wang, Hai-Jun] Peking Univ, Sch Publ Hlth, Inst Child & Adolescent Hlth, Beijing 100871, Peoples R China; [Jarick, Ivonne] Univ Marburg, Inst Med Biometry & Epidemiol, Marburg, Germany; [Grallert, Harald; Illig, Thomas] Helmholtz Zentrum Munich, Inst Epidemiol, Munich, Germany; [Illig, Thomas] Hannover Med Sch, Hannover Unified Biobank, Hannover, Germany; [Puetter, Carolin; Illig, Thomas] Hannover Med Sch, Inst Human Genet, Hannover, Germany; [Reinehr, Thomas] Univ Witten Herdecke, Vest Hosp, Clin Children & Adolescents Med, Witten, Germany	University of Duisburg Essen; Peking University; Philipps University Marburg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Hannover Medical School; Hannover Medical School; Witten Herdecke University	Hinney, A (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Dept Child & Adolescent Psychiat, Essen, Germany.	anke.hinney@uni-due.de	Hinney, Anke/D-6953-2011; Wang, Haijun/AAD-1302-2021; Grallert, Harald/B-3424-2013; Volckmar, Anna-Lena/ABE-3676-2021	Hinney, Anke/0000-0001-5659-0706; Wang, Haijun/0000-0003-0849-2903; 	Deutsche Forschungsgemeinschaft (DFG) [HI 865/2-1]; Bundesministerium fuer Bildung und Forschung Germany [NGFN 01GS0820]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bundesministerium fuer Bildung und Forschung Germany	Deutsche Forschungsgemeinschaft (DFG; HI 865/2-1) and Bundesministerium fuer Bildung und Forschung Germany (NGFN 01GS0820). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attia J, 2009, JAMA-J AM MED ASSOC, V301, P74, DOI 10.1001/jama.2008.901; Bachmann-Gagescu R, 2010, GENET MED, V12, P641, DOI 10.1097/GIM.0b013e3181ef4286; Beckers S, 2011, OBESITY FACTS, V4, P473, DOI 10.1159/000335305; Bochukova EG, 2010, NATURE, V463, P666, DOI 10.1038/nature08689; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Brown ML, 2000, P NATL ACAD SCI USA, V97, P7488, DOI 10.1073/pnas.120184097; Brown ML, 2002, J LIPID RES, V43, P1181, DOI 10.1194/jlr.M100395-JLR200; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Choi YH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039927, 10.1371/journal.pone.0046688]; DANIEL TO, 1983, J BIOL CHEM, V258, P4606; Doche ME, 2012, J CLIN INVEST, V122, P4732, DOI 10.1172/JCI62696; Egger JIM, 2014, NEUROPSYCH DIS TREAT, V10, P513, DOI 10.2147/NDT.S58684; Elks CE, 2012, AM J CLIN NUTR, V95, P1150, DOI 10.3945/ajcn.111.027870; Emaus A, 2008, HUM REPROD, V23, P919, DOI 10.1093/humrep/dem432; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Ferrer-Costa C, 2004, PROTEINS, V57, P811, DOI 10.1002/prot.20252; Fujita Y, 2005, J HUM GENET, V50, P203, DOI 10.1007/s10038-005-0240-1; Ghose R, 2011, LIFE SCI, V89, P57, DOI 10.1016/j.lfs.2011.05.005; Glatt H, 2001, MUTAT RES-FUND MOL M, V482, P27, DOI 10.1016/S0027-5107(01)00207-X; GLATT H, 1994, MUTAGENESIS, V9, P553, DOI 10.1093/mutage/9.6.553; Glatt H, 2004, N-S ARCH PHARMACOL, V369, P55, DOI 10.1007/s00210-003-0826-0; Goren A, 2006, MOL CELL, V22, P769, DOI 10.1016/j.molcel.2006.05.008; Graff M, 2013, HUM MOL GENET, V22, P3597, DOI 10.1093/hmg/ddt205; Guo YR, 2013, HUM MOL GENET, V22, P184, DOI 10.1093/hmg/dds396; Gutierrez-Aguilar R, 2012, OBESITY, V20, P306, DOI 10.1038/oby.2011.236; Haraguchi G, 2003, J LIPID RES, V44, P1224, DOI 10.1194/jlr.M300077-JLR200; Harris RM, 2000, J BIOL CHEM, V275, P159, DOI 10.1074/jbc.275.1.159; HAYASHI K, 1993, HUM MUTAT, V2, P338, DOI 10.1002/humu.1380020503; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hester JM, 2012, INT J OBESITY, V36, P465, DOI 10.1038/ijo.2011.131; Hinney A, 2003, J CLIN ENDOCR METAB, V88, P4258, DOI 10.1210/jc.2003-030233; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Hinney A, 2014, BEST PRACT RES CL EN, V28, P635, DOI 10.1016/j.beem.2014.04.007; Holzapfel C, 2010, INT J OBESITY, V34, P1538, DOI 10.1038/ijo.2010.79; Huan TX, 2015, HUM GENET, V134, P343, DOI 10.1007/s00439-014-1524-3; Jacquemont S, 2011, NATURE, V478, P97, DOI 10.1038/nature10406; Jarick I, 2011, HUM MOL GENET, V20, P840, DOI 10.1093/hmg/ddq518; Jones AC, 1999, CLIN CHEM, V45, P1133; Knoll N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055884; Kurelac I, 2012, BIOTECHNOL ADV, V30, P363, DOI 10.1016/j.biotechadv.2011.06.001; Ling MF, 1997, GENE, V197, P325, DOI 10.1016/S0378-1119(97)00279-5; Liu JL, 1997, J CHROMATOGR B, V700, P175, DOI 10.1016/S0378-4347(97)00324-1; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Mahabir S, 2006, AM J CLIN NUTR, V84, P230, DOI 10.1093/ajcn/84.1.230; Meinl W, 2002, PHARMACOGENETICS, V12, P677, DOI 10.1097/00008571-200212000-00002; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Morris DL, 2009, AM J PHYSIOL-ENDOC M, V297, pE1247, DOI 10.1152/ajpendo.00274.2009; O'Donovan MC, 1998, GENOMICS, V52, P44, DOI 10.1006/geno.1998.5411; Pearce LR, 2014, ENDOCRINOLOGY, V155, P3219, DOI 10.1210/en.2014-1264; Perrone Laura, 2010, Ital J Pediatr, V36, P43, DOI 10.1186/1824-7288-36-43; Poveda A, 2014, AM J HUM BIOL, V26, P660, DOI 10.1002/ajhb.22576; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2014, R A LANGUAGE AND ENV; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Reinehr T, 2007, J PEDIATR-US, V150, P618, DOI 10.1016/j.jpeds.2007.01.042; Ren DC, 2007, J CLIN INVEST, V117, P397, DOI 10.1172/JCI29417; Renstrom F, 2009, HUM MOL GENET, V18, P1489, DOI 10.1093/hmg/ddp041; Robiou-du-Pont S, 2013, INT J OBESITY, V37, P980, DOI 10.1038/ijo.2012.175; Rodriguez-Moran M, 2010, PEDIATR DIABETES, V11, P331, DOI 10.1111/j.1399-5448.2009.00590.x; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Santos ARA, 2008, J NEUROSCI RES, V86, P3684, DOI 10.1002/jnr.21796; Scherag A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013967; Scherag A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000916; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shi JJ, 2010, AM J EPIDEMIOL, V172, P244, DOI 10.1093/aje/kwq129; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Takeuchi F, 2011, DIABETOLOGIA, V54, P1350, DOI 10.1007/s00125-011-2086-8; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Varela LM, 2013, J NUTR BIOCHEM, V24, P2031, DOI 10.1016/j.jnutbio.2013.07.004; Varela LM, 2011, AM J CLIN NUTR, V93, P918, DOI 10.3945/ajcn.110.007765; Volckmar AL, 2013, EXP CLIN ENDOCRINOL, V121, P1, DOI [10.1055/s-0031-1297992, DOI 10.1055/S-0031-1297992]; Volckmar AL, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-65; Walters RG, 2010, NATURE, V463, P671, DOI 10.1038/nature08727; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Yoganathan P, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-65; Zheng ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067039	78	4	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0125660	10.1371/journal.pone.0125660	http://dx.doi.org/10.1371/journal.pone.0125660			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955518	Green Published, Green Submitted, gold			2022-12-26	WOS:000356768100064
J	Khongkow, P; Gomes, AR; Gong, C; Man, EPS; Tsang, JWH; Zhao, F; Monteiro, LJ; Coombes, RC; Medema, RH; Khoo, US; Lam, EWF				Khongkow, P.; Gomes, A. R.; Gong, C.; Man, E. P. S.; Tsang, J. W-H; Zhao, F.; Monteiro, L. J.; Coombes, R. C.; Medema, R. H.; Khoo, U. S.; Lam, E. W-F			Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance	ONCOGENE			English	Article							EPIRUBICIN RESISTANCE; MICROTUBULE MOTORS; KINESIN; PROTEINS; CYTOKINESIS; EXPRESSION; FOXO3A; CELLS; INHIBITION; MECHANISMS	FOXM1 has been implicated in taxane resistance, but the molecular mechanism involved remains elusive. In here, we show that FOXM1 depletion can sensitize breast cancer cells and mouse embryonic fibroblasts into entering paclitaxel-induced senescence, with the loss of clonogenic ability, and the induction of senescence-associated beta-galactosidase activity and flat cell morphology. We also demonstrate that FOXM1 regulates the expression of the microtubulin-associated kinesin KIF20A at the transcriptional level directly through a Forkhead response element (FHRE) in its promoter. Similar to FOXM1, KIF20A expression is downregulated by paclitaxel in the sensitive MCF-7 breast cancer cells and deregulated in the paclitaxel-resistant MCF-7Tax(R) cells. KIF20A depletion also renders MCF-7 and MCF-7Tax(R) cells more sensitive to paclitaxel-induced cellular senescence. Crucially, resembling paclitaxel treatment, silencing of FOXM1 and KIF20A similarly promotes abnormal mitotic spindle morphology and chromosome alignment, which have been shown to induce mitotic catastrophe-dependent senescence. The physiological relevance of the regulation of KIF20A by FOXM1 is further highlighted by the strong and significant correlations between FOXM1 and KIF20A expression in breast cancer patient samples. Statistical analysis reveals that both FOXM1 and KIF20A protein and mRNA expression significantly associates with poor survival, consistent with a role of FOXM1 and KIF20A in paclitaxel action and resistance. Collectively, our findings suggest that paclitaxel targets the FOXM1-KIF20A axis to drive abnormal mitotic spindle formation and mitotic catastrophe and that deregulated FOXM1 and KIF20A expression may confer paclitaxel resistance. These findings provide insights into the underlying mechanisms of paclitaxel resistance and have implications for the development of predictive biomarkers and novel chemotherapeutic strategies for paclitaxel resistance.	[Khongkow, P.; Gomes, A. R.; Gong, C.; Zhao, F.; Monteiro, L. J.; Coombes, R. C.; Lam, E. W-F] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Hammersmith Hosp Campus, London W12 0NN, England; [Gong, C.; Man, E. P. S.; Zhao, F.; Khoo, U. S.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Tsang, J. W-H] Univ Hong Kong, Li Ka Shing Fac Med, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Medema, R. H.] Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands	Imperial College London; University of Hong Kong; University of Hong Kong; Netherlands Cancer Institute	Lam, EWF (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Hammersmith Hosp Campus,Du Cane Rd, London W12 0NN, England.	eric.lam@imperial.ac.uk	Khoo, Ui Soon/C-1345-2014; Khoo, Ui Soon/K-2041-2019; Khoo, Ui Soon/C-4293-2009; Lam, Eric W-F/AAW-8566-2020; Monteiro, Lara J/AAU-8518-2020	Khoo, Ui Soon/0000-0003-2200-7505; Khoo, Ui Soon/0000-0003-2200-7505; Lam, Eric W-F/0000-0003-1274-3576; Khongkow, Pasarat/0000-0003-3068-2412; Coombes, Raoul Charles/0000-0002-4811-1100; Medema, Rene/0000-0002-6754-0381	Cancer Research UK; Breast Cancer Campaign; Royal Thai Government Scholarships; Committee on Research and Conference Grants from the University of Hong Kong (CRCG) [201007176118]; MRC [MR/N012097/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/B/03785] Funding Source: researchfish; Cancer Research UK [12011] Funding Source: researchfish; Engineering and Physical Sciences Research Council [1234732] Funding Source: researchfish; Medical Research Council [MR/N012097/1] Funding Source: researchfish; Breast Cancer Campaign [2012MayPR070, 2012NovPhD016] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Breast Cancer Campaign; Royal Thai Government Scholarships; Committee on Research and Conference Grants from the University of Hong Kong (CRCG); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Breast Cancer Campaign	EW-F Lam, AR Gomes and RC Coombes were supported by grants from Cancer Research UK; EW-F Lam by grants from Breast Cancer Campaign; P Khongkow, from the Royal Thai Government Scholarships. US Khoo received funding from Committee on Research and Conference Grants from the University of Hong Kong (CRCG) (201007176118). We also thank Muhammad Zaini, Marios Poullas and Laura Bella for help with this work.	Chen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012293; Coley HM, 2008, CANCER TREAT REV, V34, P378, DOI 10.1016/j.ctrv.2008.01.007; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Cortes J, 2007, ONCOLOGIST, V12, P271, DOI 10.1634/theoncologist.12-3-271; Dean-Colomb W, 2008, SEMIN ONCOL, V35, pS31, DOI 10.1053/j.seminoncol.2008.02.008; Exertier P, 2013, ONCOTARGET, V4, P2302, DOI 10.18632/oncotarget.1490; Francis RE, 2009, INT J ONCOL, V35, P57, DOI 10.3892/ijo_00000313; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Gonzalez-Angulo AM, 2007, ADV EXP MED BIOL, V608, P1; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hirokawa N, 1998, CURR OPIN CELL BIOL, V10, P60, DOI 10.1016/S0955-0674(98)80087-2; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Karadedou CT, 2012, ONCOGENE, V31, P1845, DOI 10.1038/onc.2011.368; Khongkow M, 2013, CARCINOGENESIS, V34, P1476, DOI 10.1093/carcin/bgt098; Khongkow P, 2014, ONCOGENE, V33, P4144, DOI 10.1038/onc.2013.457; Kitagawa M, 2014, CELL REP, V7, P166, DOI 10.1016/j.celrep.2014.02.034; Kline-Smith SL, 2004, MOL CELL, V15, P317, DOI 10.1016/j.molcel.2004.07.012; Kwok JMM, 2010, MOL CANCER RES, V8, P24, DOI 10.1158/1541-7786.MCR-09-0432; Kwok JMM, 2008, MOL CANCER THER, V7, P2022, DOI 10.1158/1535-7163.MCT-08-0188; Lam EWF, 2013, NAT REV CANCER, V13, P482, DOI 10.1038/nrc3539; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Liu J, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-117; Misiukiewicz K, 2014, ANTI-CANCER DRUG, V25, P561, DOI 10.1097/CAD.0000000000000086; Monteiro LJ, 2013, ONCOGENE, V32, P4634, DOI 10.1038/onc.2012.491; Myatt SS, 2014, ONCOGENE, V33, P4316, DOI 10.1038/onc.2013.546; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Neef R, 2005, METHOD ENZYMOL, V403, P618, DOI 10.1016/S0076-6879(05)03054-5; Nguyen PA, 2014, SCIENCE, V346, P244, DOI 10.1126/science.1256773; Nitta M, 2004, ONCOGENE, V23, P6548, DOI 10.1038/sj.onc.1207873; Okuyama R, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.27010; Rohena CC, 2014, NAT PROD REP, V31, P335, DOI 10.1039/c3np70092e; SAWIN KE, 1993, BIOESSAYS, V15, P399, DOI 10.1002/bies.950150606; Schuller U, 2007, MOL CELL BIOL, V27, P8259, DOI 10.1128/MCB.00707-07; Sharp DJ, 2000, NATURE, V407, P41, DOI 10.1038/35024000; Sunters A, 2006, CANCER RES, V66, P212, DOI 10.1158/0008-5472.CAN-05-1997; Sunters A, 2003, J BIOL CHEM, V278, P49795, DOI 10.1074/jbc.M309523200; Tcherniuk S, 2010, ANGEW CHEM INT EDIT, V49, P8228, DOI 10.1002/anie.201003254; Verhey KJ, 2009, NAT REV MOL CELL BIO, V10, P765, DOI 10.1038/nrm2782; Vitale I, 2011, NAT REV MOL CELL BIO, V12, P384, DOI 10.1038/nrm3115; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059	41	138	143	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 25	2016	35	8					990	1002		10.1038/onc.2015.152	http://dx.doi.org/10.1038/onc.2015.152			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DE7NF	25961928	Green Published, hybrid, Green Accepted, Green Submitted			2022-12-26	WOS:000370823300005
J	Wei, AC; Liu, T; O'Rourke, B				Wei, An-Chi; Liu, Ting; O'Rourke, Brian			Dual Effect of Phosphate Transport on Mitochondrial Ca2+ Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP; bioenergetics; calcium; metabolism; mitochondrial transport; calcium buffer; calcium uniporter; phosphate carrier	RAT-KIDNEY MITOCHONDRIA; LIVER-MITOCHONDRIA; CALCIUM UNIPORTER; PERMEABILITY TRANSITION; ADENINE-NUCLEOTIDES; INORGANIC-PHOSPHATE; ESSENTIAL COMPONENT; INNER MEMBRANE; P-31 NMR; CARRIER	Background: Inorganic phosphate (P-i) buffers matrix Ca2+, but its impact on mitochondrial Ca2+ handling is often overlooked. Results: Mitochondrial Ca2+ uptake and buffering strictly depend on anion transport rates; ATP accelerates P-i-independent Ca2+ uptake. Conclusion: Maximal Ca2+ uniporter rate and Ca2+ buffering are anion transport limited; ATP alters influx without being hydrolyzed. Significance: P-i transport is fundamentally important in controlling mitochondrial Ca2+ signals. The large inner membrane electrochemical driving force and restricted volume of the matrix confer unique constraints on mitochondrial ion transport. Cation uptake along with anion and water movement induces swelling if not compensated by other processes. For mitochondrial Ca2+ uptake, these include activation of countertransporters (Na+/Ca2+ exchanger and Na+/H+ exchanger) coupled to the proton gradient, ultimately maintained by the proton pumps of the respiratory chain, and Ca2+ binding to matrix buffers. Inorganic phosphate (P-i) is known to affect both the Ca2+ uptake rate and the buffering reaction, but the role of anion transport in determining mitochondrial Ca2+ dynamics is poorly understood. Here we simultaneously monitor extra- and intra-mitochondrial Ca2+ and mitochondrial membrane potential ((m)) to examine the effects of anion transport on mitochondrial Ca2+ flux and buffering in P-i-depleted guinea pig cardiac mitochondria. Mitochondrial Ca2+ uptake proceeded slowly in the absence of P-i but matrix free Ca2+ ([Ca2+](mito)) still rose to approximate to 50 m. P-i (0.001-1 mm) accelerated Ca2+ uptake but decreased [Ca2+](mito) by almost 50% while restoring (m). P-i-dependent effects on Ca2+ were blocked by inhibiting the phosphate carrier. Mitochondrial Ca2+ uptake rate was also increased by vanadate (V-i), acetate, ATP, or a non-hydrolyzable ATP analog (AMP-PNP), with differential effects on matrix Ca2+ buffering and (m) recovery. Interestingly, ATP or AMP-PNP prevented the effects of P-i on Ca2+ uptake. The results show that anion transport imposes an upper limit on mitochondrial Ca2+ uptake and modifies the [Ca2+](mito) response in a complex manner.	[Wei, An-Chi; Liu, Ting; O'Rourke, Brian] Johns Hopkins Univ, Div Cardiol, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University	O'Rourke, B (corresponding author), Johns Hopkins Univ, Div Cardiol, Dept Med, 720 Rutland Ave,1060 Ross Bldg, Baltimore, MD 21205 USA.	bor@jhmi.edu	Regan, Clinton/E-6250-2012	Liu, Ting/0000-0002-8304-5751; Wei, An-Chi/0000-0001-7927-1636; O'Rourke, Brian/0000-0002-5548-4853	National Institutes of Health [R01HL101235, R01HL108917]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101235, R01HL108917] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants R01HL101235 and R01HL108917. The authors declare that they have no conflicts of interest with the contents of this article.	Balaban RS, 2003, AM J PHYSIOL-CELL PH, V284, pC285, DOI 10.1152/ajpcell.00129.2002; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Buntinas L, 2001, BBA-BIOENERGETICS, V1504, P248, DOI 10.1016/S0005-2728(00)00254-1; CARAFOLI E, 1965, J BIOL CHEM, V240, P2254; Carafoli E, 2010, BBA-BIOENERGETICS, V1797, P595, DOI 10.1016/j.bbabio.2010.03.024; Chalmers S, 2003, J BIOL CHEM, V278, P19062, DOI 10.1074/jbc.M212661200; CHANCE B, 1965, J BIOL CHEM, V240, P2729; Chaudhuri D, 2013, ELIFE, V2, DOI 10.7554/eLife.00704; Csordas G, 2013, CELL METAB, V17, P976, DOI 10.1016/j.cmet.2013.04.020; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; DELUCA HF, 1961, P NATL ACAD SCI USA, V47, P1744, DOI 10.1073/pnas.47.11.1744; DEMASTER EG, 1973, BIOCHEMISTRY-US, V12, P3616, DOI 10.1021/bi00743a007; Fiermonte G, 2004, J BIOL CHEM, V279, P30722, DOI 10.1074/jbc.M400445200; GARLICK PB, 1983, J MOL CELL CARDIOL, V15, P855, DOI 10.1016/0022-2828(83)90347-4; GARLICK PB, 1992, NMR BIOMED, V5, P29, DOI 10.1002/nbm.1940050106; HARRIS EJ, 1977, FEBS LETT, V79, P284, DOI 10.1016/0014-5793(77)80804-1; Hoffman NE, 2014, MOL BIOL CELL, V25, P936, DOI 10.1091/mbc.E13-08-0502; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Kramer R, 1996, KIDNEY INT, V49, P947, DOI 10.1038/ki.1996.133; Kwong JQ, 2014, CELL DEATH DIFFER, V21, P1209, DOI 10.1038/cdd.2014.36; LANGER GA, 1980, AM J PHYSIOL, V239, pH769, DOI 10.1152/ajpheart.1980.239.6.H769; LEHNINGER AL, 1974, P NATL ACAD SCI USA, V71, P1520, DOI 10.1073/pnas.71.4.1520; Leung AWC, 2008, J BIOL CHEM, V283, P26312, DOI 10.1074/jbc.M805235200; Litsky ML, 1997, BIOCHEMISTRY-US, V36, P7071, DOI 10.1021/bi970180y; Liu T, 2009, J BIOENERG BIOMEMBR, V41, P127, DOI 10.1007/s10863-009-9216-8; Mallilankaraman K, 2012, NAT CELL BIOL, V14, P1336, DOI 10.1038/ncb2622; Nicholls DG, 2004, J BIOENERG BIOMEMBR, V36, P277, DOI 10.1023/B:JOBB.0000041753.52832.f3; NICHOLLS DG, 2013, BIOENERGETICS; PAPA S, 1973, FEBS LETT, V36, P9, DOI 10.1016/0014-5793(73)80325-4; PARADIES G, 1991, ARCH BIOCHEM BIOPHYS, V284, P332, DOI 10.1016/0003-9861(91)90304-2; Patron M, 2014, MOL CELL, V53, P726, DOI 10.1016/j.molcel.2014.01.013; Plovanich M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055785; Raffaello A, 2013, EMBO J, V32, P2362, DOI 10.1038/emboj.2013.157; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Sancak Y, 2013, SCIENCE, V342, P1379, DOI 10.1126/science.1242993; SPARAGNA GC, 1995, J BIOL CHEM, V270, P27510, DOI 10.1074/jbc.270.46.27510; TYLER DD, 1969, BIOCHEM J, V111, P665, DOI 10.1042/bj1110665; VASINGTON FD, 1962, J BIOL CHEM, V237, P2670; Wei AC, 2012, J GEN PHYSIOL, V139, P465, DOI 10.1085/jgp.201210784; Wei AC, 2011, BIOPHYS J, V100, P2894, DOI 10.1016/j.bpj.2011.05.027; Wei AC, 2011, BBA-MOL CELL RES, V1813, P1373, DOI 10.1016/j.bbamcr.2011.02.012; WEINBACH EC, 1967, BIOCHIM BIOPHYS ACTA, V148, P256, DOI 10.1016/0304-4165(67)90301-7; WOHLRAB H, 1986, BIOCHIM BIOPHYS ACTA, V853, P115, DOI 10.1016/0304-4173(86)90007-8; ZOCCARATO F, 1982, EUR J BIOCHEM, V127, P333, DOI 10.1111/j.1432-1033.1982.tb06875.x	44	16	16	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16088	16098		10.1074/jbc.M114.628446	http://dx.doi.org/10.1074/jbc.M114.628446			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25963147	hybrid, Green Published			2022-12-26	WOS:000356930100015
J	Hendriks, IA; Schimmel, J; Eifler, K; Olsen, JV; Vertegaal, ACO				Hendriks, Ivo A.; Schimmel, Joost; Eifler, Karolin; Olsen, Jesper V.; Vertegaal, Alfred C. O.			Ubiquitin-specific Protease 11 (USP11) Deubiquitinates Hybrid Small Ubiquitin-like Modifier (SUMO)-Ubiquitin Chains to Counteract RING Finger Protein 4 (RNF4)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						deubiquitylation (deubiquitination); DNA damage response; proteasome; RING finger protein 4 (RNF4); small ubiquitin-like modifier (SUMO); sumoylation; ubiquitin; ubiquitin-dependent protease; ubiquitylation (ubiquitination); USP11	PML NUCLEAR-BODIES; DNA-DAMAGE; IN-VIVO; E3 LIGASE; SUMO; SUMOYLATION; IDENTIFICATION; TARGETS; CELLS; MOTIF	Background: RNF4 is a ubiquitin ligase targeted to SUMOylated proteins. Results: USP11 co-purified with RNF4 and can remove ubiquitin polymers attached to SUMO chains. Conclusion: USP11 is a ubiquitin protease with the ability to counteract RNF4 in the DNA damage response. Significance: Identification of a ubiquitin protease to balance the activity of a SUMO-targeted ubiquitin ligase. Ring finger protein 4 (RNF4) is a SUMO-targeted ubiquitin E3 ligase with a pivotal function in the DNA damage response (DDR). SUMO interaction motifs (SIMs) in the N-terminal part of RNF4 tightly bind to SUMO polymers, and RNF4 can ubiquitinate these polymers in vitro. Using a proteomic approach, we identified the deubiquitinating enzyme ubiquitin-specific protease 11 (USP11), a known DDR-component, as a functional interactor of RNF4. USP11 can deubiquitinate hybrid SUMO-ubiquitin chains to counteract RNF4. SUMO-enriched nuclear bodies are stabilized by USP11, which functions downstream of RNF4 as a counterbalancing factor. In response to DNA damage induced by methyl methanesulfonate, USP11 could counteract RNF4 to inhibit the dissolution of nuclear bodies. Thus, we provide novel insight into cross-talk between ubiquitin and SUMO and uncover USP11 and RNF4 as a balanced SUMO-targeted ubiquitin ligase/protease pair with a role in the DDR.	[Hendriks, Ivo A.; Schimmel, Joost; Eifler, Karolin; Vertegaal, Alfred C. O.] Leiden Univ, Med Ctr, Dept Mol Cell Biol, NL-2333 ZA Leiden, Netherlands; [Olsen, Jesper V.] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen, Denmark	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Copenhagen	Vertegaal, ACO (corresponding author), Leiden Univ, Med Ctr, Dept Mol Cell Biol, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands.	vertegaal@lumc.nl	Vertegaal, Alfred/ABG-8141-2021; Vertegaal, Alfred CO/Y-3875-2018; Olsen, Jesper/ABH-4638-2020	Vertegaal, Alfred/0000-0002-7989-0493; Vertegaal, Alfred CO/0000-0002-7989-0493; Olsen, Jesper/0000-0002-4747-4938; Hendriks, Ivo/0000-0002-1439-3701; Schimmel, Joost/0000-0002-2620-4349	Netherlands Organization for Scientific Research (NWO); ZonMW; European Research Council; Danish Research Council	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); ZonMW(Netherlands Organization for Health Research and Development); European Research Council(European Research Council (ERC)European Commission); Danish Research Council(Det Frie Forskningsrad (DFF))	This work was supported by the Netherlands Organization for Scientific Research (NWO) (to A. C. O. V.), ZonMW (to A. C. O. V.), the European Research Council (to A. C. O. V.), and the research career program FSS Sapere Aude (to J. V. O.) from the Danish Research Council. The authors declare that they have no conflicts of interest with the contents of this article.	Becker J, 2013, NAT STRUCT MOL BIOL, V20, P525, DOI 10.1038/nsmb.2526; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Brouwer AK, 2009, MOL BIOL CELL, V20, P4804, DOI 10.1091/mbc.E09-04-0309; Bruderer R, 2011, EMBO REP, V12, P142, DOI 10.1038/embor.2010.206; Burkhart RA, 2013, MOL CANCER RES, V11, P901, DOI 10.1158/1541-7786.MCR-12-0699; Conlan LA, 2004, ONCOGENE, V23, P307, DOI 10.1038/sj.onc.1207119; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Danielsen JR, 2012, J CELL BIOL, V197, P179, DOI 10.1083/jcb.201106152; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Galanty Y, 2012, GENE DEV, V26, P1179, DOI 10.1101/gad.188284.112; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Guo A, 2000, NAT CELL BIOL, V2, P730, DOI 10.1038/35036365; Hay RT, 2007, TRENDS CELL BIOL, V17, P370, DOI 10.1016/j.tcb.2007.08.002; Heideker J, 2009, DNA REPAIR, V8, P517, DOI 10.1016/j.dnarep.2009.01.010; Hendriks IA, 2015, CELL REP, V10, P1778, DOI 10.1016/j.celrep.2015.02.033; Hendriks IA, 2014, NAT STRUCT MOL BIOL, V21, P927, DOI 10.1038/nsmb.2890; Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478; Hu XYV, 2010, P NATL ACAD SCI USA, V107, P15087, DOI 10.1073/pnas.1009025107; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Hunter T, 2009, ERNST SCHERING FOUND, V1, P1, DOI 10.1007/2789_2008_098; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Luo KT, 2012, EMBO J, V31, P3008, DOI 10.1038/emboj.2012.158; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; Matic I, 2010, MOL CELL, V39, P641, DOI 10.1016/j.molcel.2010.07.026; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Poulsen SL, 2013, J CELL BIOL, V201, P797, DOI 10.1083/jcb.201212075; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Schimmel J, 2008, MOL CELL PROTEOMICS, V7, P2107, DOI 10.1074/mcp.M800025-MCP200; Schimmel J, 2014, MOL CELL, V53, P1053, DOI 10.1016/j.molcel.2014.02.001; Schimmel J, 2010, J PROTEOMICS, V73, P1523, DOI 10.1016/j.jprot.2010.03.008; Schoenfeld AR, 2004, MOL CELL BIOL, V24, P7444, DOI 10.1128/MCB.24.17.7444-7455.2004; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Smeenk G, 2010, J CELL BIOL, V190, P741, DOI 10.1083/jcb.201001048; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; STUURMAN N, 1992, J CELL SCI, V101, P773; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Sun HY, 2012, J BIOL CHEM, V287, P42071, DOI 10.1074/jbc.M112.410985; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Tatham MH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001484; Ulrich HD, 2005, TRENDS CELL BIOL, V15, P525, DOI 10.1016/j.tcb.2005.08.002; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; van Hagen M, 2010, NUCLEIC ACIDS RES, V38, P1922, DOI 10.1093/nar/gkp1157; Vertegaal ACO, 2007, BIOCHEM SOC T, V35, P1422, DOI 10.1042/BST0351422; Vertegaal ACO, 2004, J BIOL CHEM, V279, P33791, DOI 10.1074/jbc.M404201200; Vertegaal ACO, 2006, MOL CELL PROTEOMICS, V5, P2298, DOI 10.1074/mcp.M600212-MCP200; Vertegaal ACO, 2011, CHEM REV, V111, P7923, DOI 10.1021/cr200187e; Vertegaal ACO, 2010, BIOCHEM SOC T, V38, P46, DOI 10.1042/BST0380046; Vyas R, 2013, CELL DEATH DIFFER, V20, P490, DOI 10.1038/cdd.2012.145; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; Weisshaar SR, 2008, FEBS LETT, V582, P3174, DOI 10.1016/j.febslet.2008.08.008; Wiltshire TD, 2010, J BIOL CHEM, V285, P14565, DOI 10.1074/jbc.M110.104745; Wu HC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4214; Yin YL, 2012, GENE DEV, V26, P1196, DOI 10.1101/gad.189274.112	63	29	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15526	15537		10.1074/jbc.M114.618132	http://dx.doi.org/10.1074/jbc.M114.618132			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25969536	Green Accepted, hybrid, Green Published			2022-12-26	WOS:000356527400018
J	Gu, J; Fu, CY; Ng, BK; Liu, LB; Lim-Tan, SK; Lee, CGL				Gu, Jun; Fu, Chit Yaw; Ng, Beng Koon; Liu, Lin Bo; Lim-Tan, Soo Kim; Lee, Caroline Guat Lay			Enhancement of Early Cervical Cancer Diagnosis with Epithelial Layer Analysis of Fluorescence Lifetime Images	PLOS ONE			English	Article							IN-VIVO DETECTION; SPECTROSCOPY; INFORMATION	This work reports the use of layer analysis to aid the fluorescence lifetime diagnosis of cervical intraepithelial neoplasia (CIN) from H&E stained cervical tissue sections. The mean and standard deviation of lifetimes in single region of interest (ROI) of cervical epithelium were previously shown to correlate to the gold standard histopathological classification of early cervical cancer. These previously defined single ROIs were evenly divided into layers for analysis. A 10-layer model revealed a steady increase in fluorescence lifetime from the inner to the outer epithelial layers of healthy tissue sections, suggesting a close association with cellular maturity. The shorter lifetime and minimal lifetime increase towards the epithelial surface of CIN-affected regions are in good agreement with the absence of cellular maturation in CIN. Mean layer lifetimes in the top-half cervical epithelium were used as feature vectors for extreme learning machine (ELM) classifier discriminations. It was found that the proposed layer analysis technique greatly improves the sensitivity and specificity to 94.6% and 84.3%, respectively, which can better supplement the traditional gold standard cervical histopathological examinations.	[Gu, Jun; Fu, Chit Yaw; Ng, Beng Koon; Liu, Lin Bo] Nanyang Technol Univ, Sch Elect & Elect Engn, Photon Ctr Excellence, Optimus, Singapore 639798, Singapore; [Lim-Tan, Soo Kim] KK Womens & Childrens Hosp, Singapore, Singapore; [Lee, Caroline Guat Lay] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Lee, Caroline Guat Lay] Natl Canc Ctr, Singapore, Singapore; [Lee, Caroline Guat Lay] Duke NUS Grad Med Sch, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; KK Women's & Children's Hospital; National University of Singapore; National Cancer Centre Singapore (NCCS); National University of Singapore	Ng, BK (corresponding author), Nanyang Technol Univ, Sch Elect & Elect Engn, Photon Ctr Excellence, Optimus, Singapore 639798, Singapore.	ebkng@ntu.edu.sg	Liu, Linbo/O-2572-2018; Ng, BK/B-8202-2008	Liu, Linbo/0000-0001-6691-9253; Ng, Beng Koon/0000-0003-0086-6982; Lee, Caroline/0000-0002-4323-3635	internal start-up grant from Nanyang Technological University [SUG/NBK/2014]	internal start-up grant from Nanyang Technological University(Nanyang Technological University)	The authors declare that this work is supported by an internal start-up grant (SUG/NBK/2014) from Nanyang Technological University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Aal RE, 2005, J BIOMED INFORM, V38, P456, DOI 10.1016/j.jbi.2005.03.003; Becker W, 2005, ADV TIME CORRELATED; Becker W., 2012, BH TCSPC HDB; Benavides JM, 2003, OPT EXPRESS, V11, P1223, DOI 10.1364/OE.11.001223; Berezin MY, 2010, CHEM REV, V110, P2641, DOI 10.1021/cr900343z; Boone CW, 1997, J CELL BIOCHEM, P1; BUCKLEY CH, 1982, J CLIN PATHOL, V35, P1, DOI 10.1136/jcp.35.1.1; Chang SK, 2004, J BIOMED OPT, V9, P511, DOI 10.1117/1.1695559; Chow TWS, 2005, IEEE T NEURAL NETWOR, V16, P213, DOI 10.1109/TNN.2004.841414; Conklin MW, 2009, CELL BIOCHEM BIOPHYS, V53, P145, DOI 10.1007/s12013-009-9046-7; DeMay RM, 1997, ARCH PATHOL LAB MED, V121, P229; Denkceken T, 2013, IEEE T BIO-MED ENG, V60, P123, DOI 10.1109/TBME.2012.2225429; Drezek RA, 2003, CANCER-AM CANCER SOC, V98, P2015, DOI 10.1002/cncr.11678; Elson D, 2004, PHOTOCH PHOTOBIO SCI, V3, P795, DOI 10.1039/b316456j; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Fausett LV, 2006, FUNDAMENTALS NEURAL; Fu C, 2006, BIOM PHARM ENG 2006; Gu J, 2013, J BIOPHOTONICS; Hild KE, 2006, IEEE T PATTERN ANAL, V28, P1385, DOI 10.1109/TPAMI.2006.186; Huang GB, 2006, NEUROCOMPUTING, V70, P489, DOI 10.1016/j.neucom.2005.12.126; Huang GB, 2011, INT J MACH LEARN CYB, V2, P107, DOI 10.1007/s13042-011-0019-y; Jansen KU, 2004, EXPERT OPIN BIOL TH, V4, P1803, DOI 10.1517/14712598.4.11.1803; Joseph RL, 1999, PRINCIPLES FLUORESCE, P11; Jun WJ, 2009, GLOB LIB WOMENS MED; Kalof AN, 2007, J CLIN PATHOL, V60, P449, DOI 10.1136/jcp.2005.036426; Kelley C.T., 1999, ITERATIVE METHODS OP; KEMNITZ K, 1990, J PHYS CHEM-US, V94, P3099, DOI 10.1021/j100370a065; Kocjan G., 2010, DIAGN CYTOPATHOL, V27; Kumar V, 2007, BASIC PATHOLOGY ROBB; Leiva-Murillo JM, 2007, IEEE T NEURAL NETWOR, V18, P1433, DOI 10.1109/TNN.2007.891630; Mirabal YN, 2002, J BIOMED OPT, V7, P587, DOI 10.1117/1.1502675; Mycek M.-A., 2003, HDB BIOMEDICAL FLUOR; Myers K, 2009, EUR J OBSTET GYN R B, V144, pS82, DOI 10.1016/j.ejogrb.2009.02.008; NHS Cervical Screening Programme FH, HIST REP CERV SCREEN; NUCCI MR, 2009, GYNECOLOGIC PATHOLOG; Park SY, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2830654; Park SY, 2010, SEM COMP ICSC 2010 I; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Pretty Mary D, 2012, COMP EL EL TECHN ICC; RAMANUJAM N, 1994, GYNECOL ONCOL, V52, P31, DOI 10.1006/gyno.1994.1007; Reichert RA, 2012, DIAGNOSTIC GYNECOLOG; RESNICK RM, 1990, JNCI-J NATL CANCER I, V82, P1477, DOI 10.1093/jnci/82.18.1477; Rohan TE, 2004, CERCIVAL CANC ETIOLO; Sell S, 2010, AM J PATHOL, V176, P2584, DOI 10.2353/ajpath.2010.091064; Shambayati B, 2011, CYTOPATHOLOGY; Thekkek N, 2008, NAT REV CANCER, V8, P725, DOI 10.1038/nrc2462; Tuer A, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3382908; Walker DC, 2003, PHYSIOL MEAS, V24, P121, DOI 10.1088/0967-3334/24/1/309; Wood BR, 2004, GYNECOL ONCOL, V93, P59, DOI 10.1016/j.ygyno.2003.12.028; Young B., 2013, WHEATERS FUNCTIONAL	50	10	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0125706	10.1371/journal.pone.0125706	http://dx.doi.org/10.1371/journal.pone.0125706			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25966026	Green Published, gold			2022-12-26	WOS:000354543500026
J	Pawar, K; Egan, G; Zhang, JX				Pawar, Kamlesh; Egan, Gary; Zhang, Jingxin			Multichannel Compressive Sensing MRI Using Noiselet Encoding	PLOS ONE			English	Article							SIGNAL RECOVERY; PULSE DESIGN; RECONSTRUCTION; EXCITATION	The incoherence between measurement and sparsifying transform matrices and the restricted isometry property (RIP) of measurement matrix are two of the key factors in determining the performance of compressive sensing (CS). In CS-MRI, the randomly under-sampled Fourier matrix is used as the measurement matrix and the wavelet transform is usually used as sparsifying transform matrix. However, the incoherence between the randomly under-sampled Fourier matrix and the wavelet matrix is not optimal, which can deteriorate the performance of CS-MRI. Using the mathematical result that noiselets are maximally incoherent with wavelets, this paper introduces the noiselet unitary bases as the measurement matrix to improve the incoherence and RIP in CS-MRI. Based on an empirical RIP analysis that compares the multichannel noiselet and multichannel Fourier measurement matrices in CS-MRI, we propose a multichannel compressive sensing (MCS) framework to take the advantage of multichannel data acquisition used in MRI scanners. Simulations are presented in the MCS framework to compare the performance of noiselet encoding reconstructions and Fourier encoding reconstructions at different acceleration factors. The comparisons indicate that multichannel noiselet measurement matrix has better RIP than that of its Fourier counterpart, and that noiselet encoded MCS-MRI outperforms Fourier encoded MCS-MRI in preserving image resolution and can achieve higher acceleration factors. To demonstrate the feasibility of the proposed noiselet encoding scheme, a pulse sequences with tailored spatially selective RF excitation pulses was designed and implemented on a 3T scanner to acquire the data in the noiselet domain from a phantom and a human brain. The results indicate that noislet encoding preserves image resolution better than Fouirer encoding.	[Pawar, Kamlesh; Zhang, Jingxin] Monash Univ, Dept Elect & Comp Syst Engn, Melbourne, Vic 3004, Australia; [Pawar, Kamlesh] Indian Inst Technol, Bombay 400076, Maharashtra, India; [Pawar, Kamlesh] IITB Monash Res Acad, Bombay, Maharashtra, India; [Egan, Gary] Monash Univ, Monash Biomed Imaging, Melbourne, Vic 3004, Australia; [Zhang, Jingxin] Swinburne Univ Technol, Sch Software & Elect Engn, Melbourne, Vic, Australia	Monash University; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Monash University; Swinburne University of Technology	Zhang, JX (corresponding author), Monash Univ, Dept Elect & Comp Syst Engn, Melbourne, Vic 3004, Australia.	jingxinzhang@swin.edu.au	Egan, Gary F./A-1381-2013	Pawar, Kamlesh/0000-0001-6199-2312; Egan, Gary/0000-0002-3186-4026				Applebaum L, 2009, APPL COMPUT HARMON A, V26, P283, DOI 10.1016/j.acha.2008.08.002; Bayati M., 2012, Proceedings of the 2012 IEEE International Symposium on Information Theory - ISIT, P1643, DOI 10.1109/ISIT.2012.6283554; Blanchard JD, 2013, P NATL ACAD SCI USA, P1147; Candes E, 2005, PROC SPIE, V5674, P76, DOI 10.1117/12.600722; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P489, DOI 10.1109/TIT.2005.862083; Candes EJ, 2005, IEEE T INFORM THEORY, V51, P4203, DOI 10.1109/TIT.2005.858979; Candes E, 2007, INVERSE PROBL, V23, P969, DOI 10.1088/0266-5611/23/3/008; Candes EJ, 2008, CR MATH, V346, P589, DOI 10.1016/j.crma.2008.03.014; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P5406, DOI 10.1109/TIT.2006.885507; Coifman R, 2001, APPL COMPUT HARMON A, V10, P27, DOI 10.1006/acha.2000.0313; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Elad M, 2010, SPARSE AND REDUNDANT REPRESENTATIONS, P3, DOI 10.1007/978-1-4419-7011-4_1; Grissom WA, 2009, IEEE T MED IMAGING, V28, P1548, DOI 10.1109/TMI.2009.2020064; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Haldar JP, 2011, IEEE T MED IMAGING, V30, P893, DOI 10.1109/TMI.2010.2085084; Ji JX, 2008, IEEE ENG MED BIO, P1671, DOI 10.1109/IEMBS.2008.4649496; Jung H, 2010, INT J IMAG SYST TECH, V20, P81, DOI 10.1002/ima.20231; Jung H, 2009, MAGN RESON MED, V61, P103, DOI 10.1002/mrm.21757; Kim Y, 2008, P INT SOC MAG RES ME, P1267; Liang D, 2009, MAGN RESON MED, V62, P1574, DOI 10.1002/mrm.22161; Liang D, 2009, I S BIOMED IMAGING, P270, DOI 10.1109/ISBI.2009.5193036; Liang D, 2008, IEEE ENG MED BIO, P1667, DOI 10.1109/IEMBS.2008.4649495; Lustig M., 2006, P INT SOC MAG RESON, V14, P2420; Lustig M, 2008, IEEE SIGNAL PROC MAG, V25, P72, DOI 10.1109/MSP.2007.914728; Lustig M, 2007, MAGN RESON MED, V58, P1182, DOI 10.1002/mrm.21391; Lustig M, 2010, MAGN RESON MED, V64, P457, DOI 10.1002/mrm.22428; Ma S., 2008, P IEEE C COMP VIS PA, P1, DOI DOI 10.1109/CVPR.2008.4587391; Margosian PM, 1996, EMAGRES; MCGIBNEY G, 1993, MAGNET RESON MED, V30, P51, DOI 10.1002/mrm.1910300109; Mitsouras D, 2004, MAGNET RESON MED, V52, P321, DOI 10.1002/mrm.20172; Ni K., 2013, APPL MATH, V4, P183, DOI [10.4236/am.2013.41A029, DOI 10.4236/AM.2013.41A029]; Ni K, 2011, SIAM J IMAGING SCI, V4, P931, DOI 10.1137/100808794; Nishimura D. G., 2010, PRINCIPLES MAGNETIC; Otazo R, 2010, MAGN RESON MED, V64, P767, DOI 10.1002/mrm.22463; Otazo Ricardo SD, 2009, P INT SOC MAGN RES M, P378; Panych LP, 1998, JMRI-J MAGN RESON IM, V8, P1135, DOI 10.1002/jmri.1880080520; Panych LP, 1999, INT J IMAG SYST TECH, V10, P143, DOI 10.1002/(SICI)1098-1098(1999)10:2<143::AID-IMA5>3.0.CO;2-W; Panych LP, 1996, MAGNET RESON MED, V35, P554, DOI 10.1002/mrm.1910350415; PAULY J, 1991, IEEE T MED IMAGING, V10, P53, DOI 10.1109/42.75611; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Puy G, 2012, IEEE T MED IMAGING, V31, P586, DOI 10.1109/TMI.2011.2173698; Qiu CL, 2009, INT CONF ACOUST SPEE, P393, DOI 10.1109/ICASSP.2009.4959603; Qu X., 2013, ARXIV13015451; Sebert F., 2008, P ISMRM, P3151; Sodickson DK, 1997, MAGNET RESON MED, V38, P591, DOI 10.1002/mrm.1910380414; Tillmann AM, 2012, ARXIV12052081; Tuma T., 2009, SAMPTA 09; Wang H, 2012, INT SOC MAGN RES MED, P73; Wang HF, 2012, 2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), P398, DOI 10.1109/ISBI.2012.6235568; Wang H, 2009, WINT SIMUL C PROC, P2669; Xu D, 2008, MAGN RESON MED, V59, P547, DOI 10.1002/mrm.21485; Zheng Liu, 2012, Proceedings of the 2012 IEEE Southwest Symposium on Image Analysis & Interpretation (SSIAI 2012), P137, DOI 10.1109/SSIAI.2012.6202472	52	16	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0126386	10.1371/journal.pone.0126386	http://dx.doi.org/10.1371/journal.pone.0126386			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965548	gold, Green Published, Green Submitted			2022-12-26	WOS:000354543500057
J	Schuster, CF; Mechler, L; Nolle, N; Krismer, B; Zelder, ME; Gotz, F; Bertram, R				Schuster, Christopher F.; Mechler, Lukas; Nolle, Nicoletta; Krismer, Bernhard; Zelder, Marc-Eric; Goetz, Friedrich; Bertram, Ralph			The MazEF Toxin-Antitoxin System Alters the beta-Lactam Susceptibility of Staphylococcus aureus	PLOS ONE			English	Article							ESCHERICHIA-COLI; PLASMID R1; F-PLASMID; RNA-SEQ; GENE; ENDORIBONUCLEASE; PERSISTENCE; MAZF(SA); BIOFILM; CELLS	Toxin-antitoxin (TA) systems are genetic elements of prokaryotes which encode a stable toxin and an unstable antitoxin that can counteract toxicity. TA systems residing on plasmids are often involved in episomal maintenance whereas those on chromosomes can have multiple functions. The opportunistic pathogen Staphylococcus aureus possesses at least four different families of TA systems but their physiological roles are elusive. The chromosomal mazEF system encodes the RNase toxin MazF and the antitoxin MazE. In the light of ambiguity regarding the cleavage activity, we here verify that MazF specifically targets UACAU sequences in S. aureus in vivo. In a native strain background and under non-stress conditions, cleavage was observed in the absence or presence of mazE. Transcripts of spa (staphylococcal protein A) and rsbW (anti-sB factor) were cut, but translational reporter fusions indicated that protein levels of the encoded products were unaffected. Despite a comparable growth rate as the wild-type, an S. aureus mazEF deletion mutant was more susceptible to beta-lactam antibiotics, which suggests that further genes, putatively involved in the antibiotic stress response or cell wall synthesis or turnover, are controlled by this TA system.	[Schuster, Christopher F.; Mechler, Lukas; Nolle, Nicoletta; Zelder, Marc-Eric; Goetz, Friedrich; Bertram, Ralph] Univ Tubingen, Dept Microbial Genet, Fac Sci, Interfac Inst Microbiol & Infect Med Tubingen IM, Tubingen, Germany; [Krismer, Bernhard] Univ Tubingen, Cellular & Mol Microbiol, IMIT, German Ctr Infect Res DZIF, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; German Center for Infection Research	Bertram, R (corresponding author), Klinikum Numberg Med Sch GmbH, Nurnberg, Germany.	rbertram@gmx.de	Krismer, Bernhard/O-3741-2019; Schuster, Christopher/J-9904-2015; Krismer, Bernhard/V-1380-2017	Krismer, Bernhard/0000-0002-9505-8285; Schuster, Christopher/0000-0002-4566-7226; 	Deutsche Forschungsgemeinschaft [BE4038/2, BE4038/5]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Support was provided by Deutsche Forschungsgemeinschaft, BE4038/2 and BE4038/5 to RB. www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruckner R, 1997, FEMS MICROBIOL LETT, V151, P1; Bukowski M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3012; Chevalier C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000809; Conlon BP, 2014, BIOESSAYS, V36, P991, DOI 10.1002/bies.201400080; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Donegan NP, 2010, J BACTERIOL, V192, P1416, DOI 10.1128/JB.00233-09; Donegan NP, 2009, J BACTERIOL, V191, P2795, DOI 10.1128/JB.01713-08; Edelheit O, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-61; Fey PD, 2013, MBIO, V4, DOI 10.1128/mBio.00537-12; Fu ZB, 2007, J BACTERIOL, V189, P8871, DOI 10.1128/JB.01272-07; Fu ZB, 2009, J BACTERIOL, V191, P2051, DOI 10.1128/JB.00907-08; Gao JX, 2004, J BACTERIOL, V186, P3738, DOI 10.1128/JB.186.12.3738-3748.2004; GERDES K, 1986, P NATL ACAD SCI USA, V83, P3116, DOI 10.1073/pnas.83.10.3116; GERDES K, 1985, J BACTERIOL, V161, P292, DOI 10.1128/JB.161.1.292-298.1985; GERDES K, 1986, EMBO J, V5, P2023, DOI 10.1002/j.1460-2075.1986.tb04459.x; Gertz S, 1999, MOL GEN GENET, V261, P558, DOI 10.1007/s004380051001; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Grady R, 2003, MOL MICROBIOL, V47, P1419, DOI 10.1046/j.1365-2958.2003.03387.x; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Helle L, 2011, MICROBIOL-SGM, V157, P3314, DOI 10.1099/mic.0.052548-0; Herbert S, 2010, INFECT IMMUN, V78, P2877, DOI 10.1128/IAI.00088-10; Huntzinger E, 2005, EMBO J, V24, P824, DOI 10.1038/sj.emboj.7600572; JAFFE A, 1985, J BACTERIOL, V163, P841; Lechner S, 2012, J MOL MICROB BIOTECH, V22, P235, DOI 10.1159/000342449; Leibig M, 2008, APPL ENVIRON MICROB, V74, P1316, DOI 10.1128/AEM.02424-07; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Magnuson RD, 2007, J BACTERIOL, V189, P6089, DOI 10.1128/JB.00958-07; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; Markovski M, 2013, MOL CELL, V52, P611, DOI 10.1016/j.molcel.2013.11.018; Monk IR, 2012, MBIO, V3, DOI 10.1128/mBio.00277-11; MOYED HS, 1983, J BACTERIOL, V155, P768, DOI 10.1128/JB.155.2.768-775.1983; Nolle N, 2013, MICROBIOL-SGM, V159, P1575, DOI 10.1099/mic.0.068049-0; OGURA T, 1983, P NATL ACAD SCI-BIOL, V80, P4784, DOI 10.1073/pnas.80.15.4784; Otto M, 2013, INT J MED MICROBIOL, V303, P324, DOI 10.1016/j.ijmm.2013.02.007; Pane-Farre J, 2006, INT J MED MICROBIOL, V296, P237, DOI 10.1016/j.ijmm.2005.11.011; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pinel-Marie ML, 2014, CELL REP, V7, P424, DOI 10.1016/j.celrep.2014.03.012; Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384; Sayed N, 2012, NAT STRUCT MOL BIOL, V19, P105, DOI 10.1038/nsmb.2193; Schifano JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4538; Schuster CF, 2014, JOVE-J VIS EXP, DOI 10.3791/52134; Schuster CF, 2013, FEMS MICROBIOL LETT, V340, P73, DOI 10.1111/1574-6968.12074; Schuster CF, 2013, J BACTERIOL, V195, P115, DOI 10.1128/JB.00400-12; Senn MM, 2005, J BACTERIOL, V187, P8006, DOI 10.1128/JB.187.23.8006-8019.2005; Sharma CM, 2014, CURR OPIN MICROBIOL, V19, P97, DOI 10.1016/j.mib.2014.06.010; Tuchscherr L, 2011, EMBO MOL MED, V3, P129, DOI 10.1002/emmm.201000115; Van Acker H, 2014, PATHOG DIS, V71, P326, DOI 10.1111/2049-632X.12177; Wang NR, 2007, ANAL BIOCHEM, V371, P173, DOI 10.1016/j.ab.2007.07.017; Wang XX, 2011, APPL ENVIRON MICROB, V77, P5577, DOI 10.1128/AEM.05068-11; Williams JJ, 2012, TRENDS MICROBIOL, V20, P291, DOI 10.1016/j.tim.2012.02.005; Yoshizumi S, 2009, J BACTERIOL, V191, P5868, DOI 10.1128/JB.00623-09; Yu WQ, 2012, PLOS ONE, V7, P384, DOI 10.1371/journal.pone.0030076; Zhu L, 2009, J BACTERIOL, V191, P3248, DOI 10.1128/JB.01815-08	54	41	41	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0126118	10.1371/journal.pone.0126118	http://dx.doi.org/10.1371/journal.pone.0126118			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965381	Green Published, gold			2022-12-26	WOS:000354543500043
J	Uziela, K; Honkela, A				Uziela, Karolis; Honkela, Antti			Probe Region Expression Estimation for RNA-Seq Data for Improved Microarray Comparability	PLOS ONE			English	Article							DIFFERENTIAL GENE-EXPRESSION; ARRAYS; TRANSCRIPTOMICS; REPOSITORY; RETRIEVAL; CANCER; LEVEL	Rapidly growing public gene expression databases contain a wealth of data for building an unprecedentedly detailed picture of human biology and disease. This data comes from many diverse measurement platforms that make integrating it all difficult. Although RNA-sequencing (RNA-seq) is attracting the most attention, at present, the rate of new microarray studies submitted to public databases far exceeds the rate of new RNA-seq studies. There is clearly a need for methods that make it easier to combine data from different technologies. In this paper, we propose a new method for processing RNA-seq data that yields gene expression estimates that are much more similar to corresponding estimates from microarray data, hence greatly improving cross-platform comparability. The method we call PREBS is based on estimating the expression from RNA-seq reads overlapping the microarray probe regions, and processing these estimates with standard microarray summarisation algorithms. Using paired microarray and RNA-seq samples from TCGA LAML data set we show that PREBS expression estimates derived from RNA-seq are more similar to microarray-based expression estimates than those from other RNA-seq processing methods. In an experiment to retrieve paired microarray samples from a database using an RNA-seq query sample, gene signatures defined based on PREBS expression estimates were found to be much more accurate than those from other methods. PREBS also allows new ways of using RNA-seq data, such as expression estimation for microarray probe sets. An implementation of the proposed method is available in the Bioconductor package "prebs."	[Uziela, Karolis; Honkela, Antti] Univ Helsinki, Dept Comp Sci, HIIT, SF-00510 Helsinki, Finland; [Uziela, Karolis] Stockholm Univ, Sci Life Lab, Dept Biochem & Biophys, S-17121 Solna, Sweden	Aalto University; University of Helsinki; Stockholm University	Honkela, A (corresponding author), Univ Helsinki, Dept Comp Sci, HIIT, Teollisuuskatu 23, SF-00510 Helsinki, Finland.	antti.honkela@hiit.fi			Academy of Finland [259440]	Academy of Finland(Academy of Finland)	This work was supported by the Academy of Finland (grant number 259440 to AH, URL: http://www.aka.fi/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affymetrix, 2002, STAT ALG DESCR DOC; Arino J, 2013, OMICS, V17, P53, DOI 10.1089/omi.2011.0065; Beane J, 2011, CANCER PREV RES, V4, P803, DOI 10.1158/1940-6207.CAPR-11-0212; Bottomly D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017820; Bradford JR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-282; Brazma A, 2003, NUCLEIC ACIDS RES, V31, P68, DOI 10.1093/nar/gkg091; Caldas J, 2012, BIOINFORMATICS, V28, P246, DOI 10.1093/bioinformatics/btr634; Caldas J, 2009, BIOINFORMATICS, V25, pI145, DOI 10.1093/bioinformatics/btp215; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fu X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-161; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glaus P, 2012, BIOINFORMATICS, V28, P1721, DOI 10.1093/bioinformatics/bts260; Huang HY, 2010, P NATL ACAD SCI USA, V107, P6823, DOI 10.1073/pnas.0912043107; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Katz S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-464; Lahti L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt229; Lahti L, 2011, IEEE ACM T COMPUT BI, V8, P217, DOI 10.1109/TCBB.2009.38; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; Malone JH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-34; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nookaew I, 2012, NUCLEIC ACIDS RES, V40, P10084, DOI 10.1093/nar/gks804; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Schmid PR, 2012, P NATL ACAD SCI USA, V109, P5594, DOI 10.1073/pnas.1118792109; Shi M, 2011, BIOINFORMATICS, V27, P3017, DOI 10.1093/bioinformatics/btr502; Su ZQ, 2011, CHEM RES TOXICOL, V24, P1486, DOI 10.1021/tx200103b; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Turro E, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r13; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484	36	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0126545	10.1371/journal.pone.0126545	http://dx.doi.org/10.1371/journal.pone.0126545			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25966034	Green Published, Green Submitted, gold			2022-12-26	WOS:000354543500061
J	Adjemian, MK; Volpe, RJ; Adjemian, J				Adjemian, Michael K.; Volpe, Richard J.; Adjemian, Jennifer			Relationships between Diet, Alcohol Preference, and Heart Disease and Type 2 Diabetes among Americans	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; LIFE-STYLE; INSULIN SENSITIVITY; HEMOSTATIC FACTORS; CROSSOVER TRIAL; SOCIAL-STATUS; US ADULTS; RED WINE; CONSUMPTION; MORTALITY	Although excessive alcohol consumption is a recognized cause of morbidity and mortality, many studies have linked moderate alcohol consumption to improved cardiovascular health and a lower risk of Type 2 Diabetes (T2D). Self-reported alcohol and diet data used to generate these results suffer from measurement error due to recall bias. We estimate the effects of diet, alcohol, and lifestyle choices on the prevalence and incidence of cardiovascular disease and T2D among U.S. adults using a nationally representative cohort of households with scanner data representing their food-at-home, alcohol, and tobacco purchases from 2007-2010, and self-reported health surveys for the same study participants from 2010-2012. Multivariate regression models were used to identify significant associations among purchase data and lifestyle/demographic factors with disease prevalence in 2010, and with incidence of new disease from 2011-2012. After controlling for important confounders, respondents who purchased moderate levels of wine were 25% less likely than non-drinkers to report heart disease in 2010. However, no alcohol-related expenditure variables significantly affected the likelihood of reporting incident heart disease from 2011-2012. In contrast, many types of alcohol-related purchases were associated with a lower prevalence of T2D, and respondents who purchased the greatest volumes of wine or beer-but not liquor-were less likely to report being diagnosed with T2D in 2011-2012 than non-drinkers.	[Adjemian, Michael K.] USDA, Econ Res Serv, Washington, DC 20024 USA; [Volpe, Richard J.] Calif Polytech State Univ San Luis Obispo, Coll Agr Food & Environm Sci, Agribusiness Dept, San Luis Obispo, CA 93407 USA; [Adjemian, Jennifer] NIAID, Epidemiol Unit, Lab Clin Infect Dis, Bethesda, MD 20892 USA; [Adjemian, Jennifer] US Publ Hlth Serv Commissioned Corps, Rockville, MD USA	United States Department of Agriculture (USDA); California State University System; California Polytechnic State University San Luis Obispo; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); United States Public Health Service	Adjemian, MK (corresponding author), USDA, Econ Res Serv, Washington, DC 20024 USA.	MAdjemian@ers.usda.gov	Adjemian, Michael/X-3833-2019	Adjemian, Michael/0000-0003-4111-8526	National Institute of Allergy and Infectious Diseases, National Institutes of Health	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported in part by the intramural research program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N., 2006, IFS WORKING PAPERS; [Anonymous], 2010, DATA NATL HLT HSRUV; Beulens JWJ, 2008, EUR J CLIN NUTR, V62, P1098, DOI 10.1038/sj.ejcn.1602821; Bureau of Labor Statistics and U.S. Census Bureau, 2012, CURR POP SURV 2011 H; Center for Disease Control and Prevention, FACT SHEETS ALC US H; Centers for Disease Control and Prevention, 2013, ALC PUBL HLTH FREQ A; Corrao G, 2004, PREV MED, V38, P613, DOI 10.1016/j.ypmed.2003.11.027; Djousse L, 2009, CIRCULATION, V120, P237, DOI 10.1161/CIRCULATIONAHA.108.832360; Ebbert JO, 2005, J GEN INTERN MED, V20, P14, DOI 10.1111/j.1525-1497.2005.40129.x; Ekholm O, 2004, EUR J CLIN NUTR, V58, P60, DOI 10.1038/sj.ejcn.1601746; Estruch R, 2004, ATHEROSCLEROSIS, V175, P117, DOI 10.1016/j.atherosclerosis.2004.03.006; FUCHS CS, 1995, NEW ENGL J MED, V332, P1245, DOI 10.1056/NEJM199505113321901; Gell L, 2012, DRUG ALCOHOL REV, V31, P422, DOI 10.1111/j.1465-3362.2011.00330.x; Gronbaek M, 2000, ANN INTERN MED, V133, P411, DOI 10.7326/0003-4819-133-6-200009190-00008; GRONBAEK M, 1995, BRIT MED J, V310, P1165, DOI 10.1136/bmj.310.6988.1165; Hansel B, 2010, EUR J CLIN NUTR, V64, P561, DOI 10.1038/ejcn.2010.61; Hansen AS, 2005, EUR J CLIN NUTR, V59, P449, DOI 10.1038/sj.ejcn.1602107; Harriss LR, 2007, ADDICTION, V102, P1574, DOI 10.1111/j.1360-0443.2007.01947.x; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Howden LM, 2010, AGE SEX COMPOSITION; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Johansen D, 2006, BMJ-BRIT MED J, V332, P519, DOI 10.1136/bmj.38694.568981.80; Joosten MM, 2008, DIABETOLOGIA, V51, P1375, DOI 10.1007/s00125-008-1031-y; Klatsky AL, 2003, AM J EPIDEMIOL, V158, P585, DOI 10.1093/aje/kwg184; KLATSKY AL, 1990, BRIT J ADDICT, V85, P1279; Knoops KTB, 2004, JAMA-J AM MED ASSOC, V292, P1433, DOI 10.1001/jama.292.12.1433; Koppes LLJ, 2005, DIABETES CARE, V28, P719, DOI 10.2337/diacare.28.3.719; Mortensen EL, 2001, ARCH INTERN MED, V161, P1844, DOI 10.1001/archinte.161.15.1844; Mukamal KJ, 2010, JAMA-J AM MED ASSOC, V303, P2065, DOI 10.1001/jama.2010.550; Mukamal KJ, 2003, NEW ENGL J MED, V348, P109, DOI 10.1056/NEJMoa022095; Naimi TS, 2005, AM J PREV MED, V28, P369, DOI 10.1016/j.amepre.2005.01.011; Narhinen M, 1999, PUBLIC HEALTH NUTR, V2, P277, DOI 10.1017/S1368980099000373; National Center for Health Statistics, 2013, HLTH US 2012 SPEC FE; Paschall M, 2005, DRUG ALCOHOL DEPEN, V78, P339, DOI 10.1016/j.drugalcdep.2004.12.004; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; Ronksley PE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d671; Ruidavets JB, 2004, EUR HEART J, V25, P1153, DOI 10.1016/j.ehj.2003.12.022; StataCorp, 2021, STATA STAT SOFTWARE; Thun MJ, 1997, NEW ENGL J MED, V337, P1705, DOI 10.1056/NEJM199712113372401; Tolstrup J, 2006, BMJ-BRIT MED J, V332, P1244, DOI 10.1136/bmj.38831.503113.7C; U.S. Census Bureau, 2011, SUMM FIL 1 DAT SF 1; US Department of Agriculture and US Department of Health and Human Services, 2010, AM J AGR EC; Volpe R, 2013, AM J AGR ECON, V95, P1; Volpe R, 2012, ASSESSING HEALTHFULN	44	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0124351	10.1371/journal.pone.0124351	http://dx.doi.org/10.1371/journal.pone.0124351			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI1YY	25961601	Green Published, Green Submitted, gold			2022-12-26	WOS:000354542500011
J	Akimoto, M; Iizuka, M; Kanematsu, R; Yoshida, M; Takenaga, K				Akimoto, Miho; Iizuka, Mari; Kanematsu, Rie; Yoshida, Masato; Takenaga, Keizo			Anticancer Effect of Ginger Extract against Pancreatic Cancer Cells Mainly through Reactive Oxygen Species-Mediated Autotic Cell Death	PLOS ONE			English	Article							AUTOPHAGY; APOPTOSIS; HYPOXIA; ROS; ACTIVATION; INDUCTION; MITOCHONDRIA; ANTIOXIDANT; METASTASIS; EXPRESSION	The extract of ginger (Zingiber officinale Roscoe) and its major pungent components, [6]-shogaol and [6]-gingerol, have been shown to have an anti-proliferative effect on several tumor cell lines. However, the anticancer activity of the ginger extract in pancreatic cancer is poorly understood. Here, we demonstrate that the ethanol-extracted materials of ginger suppressed cell cycle progression and consequently induced the death of human pancreatic cancer cell lines, including Panc-1 cells. The underlying mechanism entailed autosis, a recently characterized form of cell death, but not apoptosis or necroptosis. The extract markedly increased the LC3-II/LC3-I ratio, decreased SQSTM1/p62 protein, and enhanced vacuolization of the cytoplasm in Panc-1 cells. It activated AMPK, a positive regulator of autophagy, and inhibited mTOR, a negative autophagic regulator. The autophagy inhibitors 3-methyladenine and chloroquine partially prevented cell death. Morphologically, however, focal membrane rupture, nuclear shrinkage, focal swelling of the perinuclear space and electron dense mitochondria, which are unique morphological features of autosis, were observed. The extract enhanced reactive oxygen species (ROS) generation, and the antioxidant N-acetylcystein attenuated cell death. Our study revealed that daily intraperitoneal administration of the extract significantly prolonged survival (P = 0.0069) in a peritoneal dissemination model and suppressed tumor growth in an orthotopic model of pancreatic cancer (P < 0.01) without serious adverse effects. Although [6]-shogaol but not [6]-gingerol showed similar effects, chromatographic analyses suggested the presence of other constituent(s) as active substances. Together, these results show that ginger extract has potent anticancer activity against pancreatic cancer cells by inducing ROS-mediated autosis and warrants further investigation in order to develop an efficacious candidate drug.	[Akimoto, Miho; Kanematsu, Rie; Takenaga, Keizo] Shimane Univ, Fac Med, Dept Life Sci, Lab Tumor Biol, Izumo, Shimane, Japan; [Iizuka, Mari; Yoshida, Masato] Shimane Univ, Fac Med, Dept Life Sci, Lab Mol Sci, Izumo, Shimane, Japan	Shimane University; Shimane University	Takenaga, K (corresponding author), Shimane Univ, Fac Med, Dept Life Sci, Lab Tumor Biol, Izumo, Shimane, Japan.	biokeizo@med.shimane-u.ac.jp			Shimane University "SUIGANN" Project; Ministry of Education, Culture, Sports, Science, and Technology, Japan [25430110]; Japan Arteriosclerosis Research Foundation; Support for Super Science High Schools from Japan Science and Technology Agency	Shimane University "SUIGANN" Project; Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Arteriosclerosis Research Foundation; Support for Super Science High Schools from Japan Science and Technology Agency	This work was supported in part by Grants-in-Aid from: Shimane University "SUIGANN" Project (http://www.shimane-u.ac.jp) (to KT); Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (http://www.mext.go.jp) (no. 25430110 to KT); and Japan Arteriosclerosis Research Foundation (to KT). This work was also supported by the Support for Super Science High Schools from Japan Science and Technology Agency to Izumo High School (http://rikai.jst.go.jp) (to KT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto M., 2013, WORLD J MED GENET, V3, P41, DOI [10.5496/wjmg.v3.i4.41, DOI 10.5496/WJMG.V3.I4.41]; Chen Y, 2009, CELL DEATH DIFFER, V16, P1040, DOI 10.1038/cdd.2009.49; Citronberg J, 2013, CANCER PREV RES, V6, P271, DOI 10.1158/1940-6207.CAPR-12-0327; CORBETT TH, 1984, CANCER RES, V44, P717; Dewaele M, 2010, AUTOPHAGY, V6, P838, DOI 10.4161/auto.6.7.12113; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Filomeni G, 2015, CELL DEATH DIFFER, V22, P377, DOI 10.1038/cdd.2014.150; Filomeni G, 2010, AUTOPHAGY, V6, P999, DOI 10.4161/auto.6.7.12754; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; HONMA Y, 1989, CANCER RES, V49, P331; Hu R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039664; HYUGA S, 1994, CANCER RES, V54, P3611; Imanishi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023401; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Ito S, 2007, INT J ONCOL, V31, P261; Karna P, 2012, BRIT J NUTR, V107, P473, DOI 10.1017/S0007114511003308; Kim MO, 2014, CARCINOGENESIS, V35, P683, DOI 10.1093/carcin/bgt365; Kirkland RA, 2002, NEUROSCIENCE, V115, P587, DOI 10.1016/S0306-4522(02)00512-2; Koong AC, 2000, INT J RADIAT ONCOL, V48, P919, DOI 10.1016/S0360-3016(00)00803-8; Lee DH, 2014, TOXICOL APPL PHARM, V279, P253, DOI 10.1016/j.taap.2014.06.030; Li F, 2012, FOOD CHEM, V135, P332, DOI 10.1016/j.foodchem.2012.04.145; Liu Q, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-135; Liu Q, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/278652; Liu Y, 2015, CELL DEATH DIFFER, V22, P367, DOI 10.1038/cdd.2014.143; Liu Y, 2013, P NATL ACAD SCI USA, V110, P20364, DOI 10.1073/pnas.1319661110; Loc WS, 2014, WORLD J GASTROENTERO, V20, P14717, DOI 10.3748/wjg.v20.i40.14717; Lu DL, 2014, FOOD CHEM, V165, P191, DOI 10.1016/j.foodchem.2014.05.077; Mizumura K, 2014, J CLIN INVEST, V124, P3987, DOI 10.1172/JCI74985; Monma H, 2013, MOL CANCER THER, V12, P341, DOI 10.1158/1535-7163.MCT-12-0954; Morikane K, 2001, INT IMMUNOL, V13, P233, DOI 10.1093/intimm/13.2.233; NAKATANI H, 1986, JPN J CANCER RES, V77, P849; OGAWA H, 1995, P NATL ACAD SCI USA, V92, P11899, DOI 10.1073/pnas.92.25.11899; Ozaki T, 1999, CANCER RES, V59, P5902; Park EJ, 2002, CANCER METAST REV, V21, P231, DOI 10.1023/A:1021254725842; Partensky C, 2013, PANCREAS, V42, P729, DOI 10.1097/MPA.0b013e318288107a; Radhakrishnan EK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104401; Rastogi N, 2014, FREE RADICAL BIO MED, V68, P288, DOI 10.1016/j.freeradbiomed.2013.12.016; Sawai H, 2011, BIOCHEM BIOPH RES CO, V411, P569, DOI 10.1016/j.bbrc.2011.06.186; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Scherz-Shouval R, 2007, AUTOPHAGY, V3, P371, DOI 10.4161/auto.4214; Shimojo Y, 2013, CLIN EXP METASTAS, V30, P143, DOI 10.1007/s10585-012-9519-8; Shukla Y, 2007, FOOD CHEM TOXICOL, V45, P683, DOI 10.1016/j.fct.2006.11.002; SRIVASTAVA KC, 1992, MED HYPOTHESES, V39, P342, DOI 10.1016/0306-9877(92)90059-L; Stoner GD, 2013, CANCER PREV RES, V6, P257, DOI 10.1158/1940-6207.CAPR-13-0055; Takenaga K, 1997, CLIN CANCER RES, V3, P2309; Tan BS, 2013, CANCER LETT, V336, P127, DOI 10.1016/j.canlet.2013.04.014; WILLIAMS CJ, 1990, TUMOR BIOL, V11, P145, DOI 10.1159/000217649; Yokoi K, 2004, CLIN CANCER RES, V10, P2299, DOI 10.1158/1078-0432.CCR-03-0488; Yoshida K, 2008, ONCOGENE, V27, P1183, DOI 10.1038/sj.onc.1210722; Zhang C, 2013, CANCER LETT, V340, P51, DOI 10.1016/j.canlet.2013.06.021; Zhu YD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054677; Zick SM, 2015, MOL CARCINOGEN, V54, P908, DOI 10.1002/mc.22163; Zick SM, 2009, SUPPORT CARE CANCER, V17, P563, DOI 10.1007/s00520-008-0528-8	54	94	99	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126605	10.1371/journal.pone.0126605	http://dx.doi.org/10.1371/journal.pone.0126605			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961833	Green Submitted, gold, Green Published			2022-12-26	WOS:000354542500125
J	Giovannoni, F; Damonte, EB; Garcia, CC				Giovannoni, Federico; Damonte, Elsa B.; Garcia, Cybele C.			Cellular Promyelocytic Leukemia Protein Is an Important Dengue Virus Restriction Factor	PLOS ONE			English	Article							PML NUCLEAR-BODIES; ND10; EXPRESSION; INFECTION; SCREEN; REPLICATION; COMPONENTS; RESISTANCE; INSIGHTS; GENE	The intrinsic antiviral defense is based on cellular restriction factors that are constitutively expressed and, thus, active even before a pathogen enters the cell. The promyelocytic leukemia (PML) nuclear bodies (NBs) are discrete nuclear foci that contain several cellular proteins involved in intrinsic antiviral responses against a number of viruses. Accumulating reports have shown the importance of PML as a DNA virus restriction factor and how these pathogens evade this antiviral activity. However, very little information is available regarding the antiviral role of PML against RNA viruses. Dengue virus (DENV) is an RNA emerging mosquito-borne human pathogen affecting millions of individuals each year by causing severe and potentially fatal syndromes. Since no licensed antiviral drug against DENV infection is currently available, it is of great importance to understand the factors mediating intrinsic immunity that may lead to the development of new pharmacological agents that can boost their potency and thereby lead to treatments for this viral disease. In the present study, we investigated the in vitro antiviral role of PML in DENV-2 A549 infected cells.	[Giovannoni, Federico; Damonte, Elsa B.; Garcia, Cybele C.] Univ Buenos Aires, IQUIBICEN, CONICET, Sch Sci,Biochem Dept,Lab Antiviral Strategies, RA-1428 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Garcia, CC (corresponding author), Univ Buenos Aires, IQUIBICEN, CONICET, Sch Sci,Biochem Dept,Lab Antiviral Strategies, RA-1428 Buenos Aires, DF, Argentina.	cygarcia@qb.fcen.uba.ar		garcia, cybele/0000-0002-6431-7176	Agencia Nacional de Promocion Cientifica y Tecnologica PICT [166, 517]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad de Buenos Aires (UBA), Argentina	Agencia Nacional de Promocion Cientifica y Tecnologica PICT(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires (UBA), Argentina(University of Buenos Aires)	Research was supported by grants from Agencia Nacional de Promocion Cientifica y Tecnologica PICT 166 and 517, Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) and Universidad de Buenos Aires (UBA), Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta EG, 2014, ADV VIRUS RES, V88, P1, DOI 10.1016/B978-0-12-800098-4.00001-5; Ahn JH, 2000, VIROLOGY, V274, P39, DOI 10.1006/viro.2000.0448; Bernardi R, 2003, ONCOGENE, V22, P9048, DOI 10.1038/sj.onc.1207106; Bischof O, 2002, EMBO J, V21, P3358, DOI 10.1093/emboj/cdf341; Blondel D, 2010, J VIROL, V84, P10719, DOI 10.1128/JVI.01286-10; Bonilla WV, 2002, J VIROL, V76, P3810, DOI 10.1128/JVI.76.8.3810-3818.2002; Borden KLB, 2009, FRONT BIOSCI-LANDMRK, V14, P497, DOI 10.2741/3258; Borden KLB, 2002, MOL CELL BIOL, V22, P5259, DOI 10.1128/MCB.22.15.5259-5269.2002; Chee AV, 2003, J VIROL, V77, P7101, DOI 10.1128/JVI.77.12.7101-7105.2003; de THE, 1960, Bull Assoc Fr Etud Cancer, V47, P570; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; Djavani M, 2001, J VIROL, V75, P6204, DOI 10.1128/JVI.75.13.6204-6208.2001; Doucas V, 1996, GENE DEV, V10, P196, DOI 10.1101/gad.10.2.196; El Asmi F, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003975; Everett RD, 2007, BIOCHIMIE, V89, P819, DOI 10.1016/j.biochi.2007.01.004; Everett RD, 2006, J VIROL, V80, P7995, DOI 10.1128/JVI.00734-06; Garcia CC, 2010, BIOCHEM BIOPH RES CO, V393, P625, DOI 10.1016/j.bbrc.2010.02.040; Geoffroy MC, 2011, J INTERF CYTOK RES, V31, P145, DOI 10.1089/jir.2010.0111; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; GULDNER HH, 1992, J IMMUNOL, V149, P4067; Harris RS, 2012, J BIOL CHEM, V287, P40875, DOI 10.1074/jbc.R112.416925; Jensen K, 2001, ONCOGENE, V20, P7223, DOI 10.1038/sj.onc.1204765; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Kyratsous CA, 2009, J VIROL, V83, P4262, DOI 10.1128/JVI.00021-09; Lang M, 2010, J CELL SCI, V123, P392, DOI 10.1242/jcs.053496; LAVAU C, 1995, ONCOGENE, V11, P871; Le Sommer C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001820; Li QS, 2009, P NATL ACAD SCI USA, V106, P16410, DOI 10.1073/pnas.0907439106; Li WZ, 2009, BIOCHEM BIOPH RES CO, V389, P84, DOI 10.1016/j.bbrc.2009.08.091; Lusic M, 2013, CELL HOST MICROBE, V13, P665, DOI 10.1016/j.chom.2013.05.006; Maroui MA, 2014, M S-MED SCI, V30, P765, DOI 10.1051/medsci/20143008014; Maroui MA, 2011, J VIROL, V85, P13164, DOI 10.1128/JVI.05808-11; Maul GG, 2000, J STRUCT BIOL, V129, P278, DOI 10.1006/jsbi.2000.4239; Maul GG, 1995, J CELL BIOCHEM, V59, P498, DOI 10.1002/jcb.240590410; Netsawang J, 2014, BIOCHEM BIOPH RES CO, V450, P1485, DOI 10.1016/j.bbrc.2014.07.016; Nisole S, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00125; Pillai SK, 2012, P NATL ACAD SCI USA, V109, P3035, DOI 10.1073/pnas.1111573109; Raposo RAS, 2014, J VIROL, V88, P11624, DOI 10.1128/JVI.01771-14; Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7; Saffert RT, 2008, FUTURE VIROL, V3, P265, DOI 10.2217/17460794.3.3.265; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967; Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001; Takahashi Y, 2004, ONCOGENE, V23, P2819, DOI 10.1038/sj.onc.1207533; Tavalai N, 2008, BBA-MOL CELL RES, V1783, P2207, DOI 10.1016/j.bbamcr.2008.08.004; Tavalai N, 2008, J VIROL, V82, P126, DOI 10.1128/JVI.01685-07; Tavalai N, 2006, J VIROL, V80, P8006, DOI 10.1128/JVI.00743-06; Zhong S, 2000, NAT CELL BIOL, V2, pE85, DOI 10.1038/35010583; Zuo XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084748	49	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0125690	10.1371/journal.pone.0125690	http://dx.doi.org/10.1371/journal.pone.0125690			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962098	Green Submitted, gold, Green Published			2022-12-26	WOS:000354542500042
J	Grassmann, F; Fleckenstein, M; Chew, EY; Strunz, T; Schmitz-Valckenberg, S; Gobel, AP; Klein, ML; Ratnapriya, R; Swaroop, A; Holz, FG; Weber, BHF				Grassmann, Felix; Fleckenstein, Monika; Chew, Emily Y.; Strunz, Tobias; Schmitz-Valckenberg, Steffen; Goebel, Arno P.; Klein, Michael L.; Ratnapriya, Rinki; Swaroop, Anand; Holz, Frank G.; Weber, Bernhard H. F.			Clinical and Genetic Factors Associated with Progression of Geographic Atrophy Lesions in Age-Related Macular Degeneration	PLOS ONE			English	Article							DISEASE PROGRESSION; NATURAL-HISTORY; MESSENGER-RNA; EYE DISEASE; FACTOR-H; COMPLEMENT; RISK; AMD; ARMS2; NEUROGENESIS	Worldwide, age-related macular degeneration (AMD) is a serious threat to vision loss in individuals over 50 years of age with a pooled prevalence of approximately 9%. For 2020, the number of people afflicted with this condition is estimated to reach 200 million. While AMD lesions presenting as geographic atrophy (GA) show high inter-individual variability, only little is known about prognostic factors. Here, we aimed to elucidate the contribution of clinical, demographic and genetic factors on GA progression. Analyzing the currently largest dataset on GA lesion growth (N = 388), our findings suggest a significant and independent contribution of three factors on GA lesion growth including at least two genetic factors (ARMS2_rs10490924 [P < 0.00088] and C3_rs2230199 [P < 0.00015]) as well as one clinical component (presence of GA in the fellow eye [P < 0.00023]). These correlations jointly explain up to 7.2% of the observed inter-individual variance in GA lesion progression and should be considered in strategy planning of interventional clinical trials aimed at evaluating novel treatment options in advanced GA due to AMD.	[Grassmann, Felix; Strunz, Tobias; Weber, Bernhard H. F.] Univ Regensburg, Inst Human Genet, D-93053 Regensburg, Germany; [Fleckenstein, Monika; Schmitz-Valckenberg, Steffen; Goebel, Arno P.; Holz, Frank G.] Univ Bonn, Dept Ophthalmol, D-53127 Bonn, Germany; [Chew, Emily Y.; Ratnapriya, Rinki; Swaroop, Anand] NEI, NIH, Bethesda, MD 20892 USA; [Klein, Michael L.] Oregon Hlth & Sci Univ, Macular Degenerat Ctr, Casey Eye Inst, Portland, OR 97239 USA; [Klein, Michael L.] Devers Eye Inst, Portland, OR 97239 USA	University of Regensburg; University of Bonn; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Oregon Health & Science University; Devers Eye Institute	Weber, BHF (corresponding author), Univ Regensburg, Inst Human Genet, D-93053 Regensburg, Germany.	bweb@klinik.uni-regensburg.de	Mitchell, Paul/P-1498-2014; Strunz, Tobias/ABD-9798-2021; Strunz, Tobias/ABB-6300-2020	Strunz, Tobias/0000-0002-3744-9595; Swaroop, Anand/0000-0002-1975-1141; Ratnapriya, Rinki/0000-0002-0469-4631; Weber, Bernhard H.F./0000-0002-8808-7723; Grassmann, Felix/0000-0003-1390-7528; Fleckenstein, Monika/0000-0001-8321-8037	Deutsche Forschungsgemeinschaft [WE 1259/19-2]; Alcon Research Institute; Intramural Research program of the National Eye Institute; National Eye Institute, National Institutes of Health, Bethesda, MD [R01-EY021532]; NATIONAL EYE INSTITUTE [ZIAEY000489, ZIAEY000485, ZIAEY000546, R01EY021532] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Alcon Research Institute(Novartis); Intramural Research program of the National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Eye Institute, National Institutes of Health, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported in parts by the Deutsche Forschungsgemeinschaft (WE 1259/19-2 to BHFW), the Alcon Research Institute (to BHFW, EYC, and AS), the Intramural Research program of the National Eye Institute (EYC and AS), and by grants from the National Eye Institute, National Institutes of Health, Bethesda, MD (R01-EY021532 to MLK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelsalam A, 1999, SURV OPHTHALMOL, V44, P1, DOI 10.1016/S0039-6257(99)00072-7; [Anonymous], 2010, R LANG ENV STAT COMP; Augood CA, 2006, ARCH OPHTHALMOL-CHIC, V124, P529, DOI 10.1001/archopht.124.4.529; Caire J, 2014, JAMA OPHTHALMOL; Dreyhaupt J, 2005, OPHTHAL EPIDEMIOL, V12, P353, DOI 10.1080/09286580591005723; Feuer WJ, 2013, JAMA OPHTHALMOL, V131, P110, DOI 10.1001/jamaophthalmol.2013.572; Fleckenstein M, 2011, INVEST OPHTH VIS SCI, V52, P6552, DOI 10.1167/iovs.11-7298; Fleckenstein M, 2010, INVEST OPHTH VIS SCI, V51, P637, DOI 10.1167/iovs.09-3547; Friedrich U, 2011, HUM MOL GENET, V20, P1387, DOI 10.1093/hmg/ddr020; Fritsche LG, 2008, NAT GENET, V40, P892, DOI 10.1038/ng.170; Fritsche LG, 2014, ANNU REV GENOM HUM G, V15, P151, DOI 10.1146/annurev-genom-090413-025610; Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578; Fritsche LG, 2012, INVEST OPHTH VIS SCI, V53, P2112, DOI 10.1167/iovs.11-8785; Grassmann F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037979; Griffiths MR, 2009, J IMMUNOL, V182, P4368, DOI 10.4049/jimmunol.0800205; Heurich M, 2011, P NATL ACAD SCI USA, V108, P8761, DOI 10.1073/pnas.1019338108; Holz FG, 2007, AM J OPHTHALMOL, V143, P463, DOI 10.1016/j.ajo.2006.11.041; Kinnunen K, 2012, ACTA OPHTHALMOL, V90, P299, DOI 10.1111/j.1755-3768.2011.02179.x; Klein ML, 2008, OPHTHALMOLOGY, V115, P1019, DOI 10.1016/j.ophtha.2008.01.036; Klein ML, 2011, ARCH OPHTHALMOL-CHIC, V129, P1543, DOI 10.1001/archophthalmol.2011.216; Klein ML, 2010, OPHTHALMOLOGY, V117, P1554, DOI 10.1016/j.ophtha.2009.12.012; Klein R, 2008, AM J OPHTHALMOL, V146, P692, DOI 10.1016/j.ajo.2008.05.050; Klein R, 2007, OPHTHALMOLOGY, V114, P253, DOI 10.1016/j.ophtha.2006.10.040; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Lindblad AS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1168, DOI 10.1001/archophthalmol.2009.198; Pekny M, 2007, INT REV NEUROBIOL, V82, P95, DOI 10.1016/S0074-7742(07)82005-8; Rahpeymai Y, 2006, EMBO J, V25, P1364, DOI 10.1038/sj.emboj.7601004; Ramaglia V, 2012, P NATL ACAD SCI USA, V109, P965, DOI 10.1073/pnas.1111924109; Sallo FB, 2009, CURR EYE RES, V34, P238, DOI 10.1080/02713680802714058; Schmidt-Erfurth U, 2014, BRIT J OPHTHALMOL, V98, P1144, DOI 10.1136/bjophthalmol-2014-305702; Scholl HPN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007418; Seddon JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087047; Smailhodzic D, 2011, INVEST OPHTH VIS SCI, V52, P8908, DOI 10.1167/iovs.11-7926; Steiner B, 2006, REGEN MED, V1, P15, DOI 10.2217/17460751.1.1.15; Steiner T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092404; Sunness JS, 2007, OPHTHALMOLOGY, V114, P271, DOI 10.1016/j.ophtha.2006.09.016; Sunness JS, 1999, OPHTHALMOLOGY, V106, P1768, DOI 10.1016/S0161-6420(99)90340-8; van Beek J, 2001, NEUROREPORT, V12, P289, DOI 10.1097/00001756-200102120-00022; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1	41	51	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126636	10.1371/journal.pone.0126636	http://dx.doi.org/10.1371/journal.pone.0126636			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962167	gold, Green Published, Green Submitted			2022-12-26	WOS:000354542500128
J	Han, SM; Hwang, B; Park, TG; Kim, DI; Rhee, MY; Lee, BK; Ahn, YK; Cho, BR; Woo, J; Hur, SH; Jeong, JO; Park, S; Jang, Y; Lee, MG; Bang, D; Lee, JH; Lee, SH				Han, Soo Min; Hwang, Byungjin; Park, Tae-Gun; Kim, Do-Il; Rhee, Moo-Yong; Lee, Byoung-Kwon; Ahn, Young Keun; Cho, Byung Ryul; Woo, Jeongtaek; Hur, Seung-Ho; Jeong, Jin-Ok; Park, Sungha; Jang, Yangsoo; Lee, Min Goo; Bang, Duhee; Lee, Ji Hyun; Lee, Sang-Hak			Genetic Testing of Korean Familial Hypercholesterolemia Using Whole-Exome Sequencing	PLOS ONE			English	Article							LIPOPROTEIN RECEPTOR GENE; CLINICAL-DIAGNOSIS; MUTATIONS; PCSK9; UK; FRAMEWORK; SPECTRUM; VARIANT; UPDATE	Familial hypercholesterolemia (FH) is a genetic disorder with an increased risk of early-onset coronary artery disease. Although some clinically diagnosed FH cases are caused by mutations in LDLR, APOB, or PCSK9, mutation detection rates and profiles can vary across ethnic groups. In this study, we aimed to provide insight into the spectrum of FH-causing mutations in Koreans. Among 136 patients referred for FH, 69 who met Simon Broome criteria with definite family history were enrolled. By whole-exome sequencing (WES) analysis, we confirmed that the 3 known FH-related genes accounted for genetic causes in 23 patients (33.3%). A substantial portion of the mutations (19 of 23 patients, 82.6%) resulted from 17 mutations and 2 copy number deletions in LDLR gene. Two mutations each in the APOB and PCSK9 genes were verified. Of these anomalies, two frameshift deletions in LDLR and one mutation in PCSK9were identified as novel causative mutations. In particular, one novel mutation and copy number deletion were validated by co-segregation in their relatives. This study confirmed the utility of genetic diagnosis of FH through WES.	[Han, Soo Min] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Dept Pharmacol,Brain Korea PLUS Project Med Sci 2, Seoul 120749, South Korea; [Hwang, Byungjin; Park, Tae-Gun] Yonsei Univ, Dept Chem, Seoul 120749, South Korea; [Kim, Do-Il] Inje Univ, Haeundae Paik Hosp, Coll Med, Dept Internal Med,Cardiol Div, Busan, South Korea; [Rhee, Moo-Yong] Dongguk Univ, Ilsan Hosp, Cardiovasc Ctr, Goyang, South Korea; [Lee, Byoung-Kwon] Yonsei Univ, Gangnam Severance Hosp, Coll Med, Dept Internal Med,Cardiol Div, Seoul 120749, South Korea; [Ahn, Young Keun] Chonnam Natl Univ Hosp, Ctr Heart, Gwangju, South Korea; [Cho, Byung Ryul] Kangwon Natl Univ, Kangwon Natl Univ Hosp, Coll Med, Dept Internal Med,Cardiol Div, Chunchon, South Korea; [Woo, Jeongtaek] Kyung Hee Univ, Sch Med, Dept Internal Med, Div Endocrinol, Seoul, South Korea; [Hur, Seung-Ho] Keimyung Univ, Dongsan Med Ctr, Dept Internal Med, Div Cardiol, Daegu, South Korea; [Jeong, Jin-Ok] Chungnam Natl Univ, Chungnam Natl Univ Hosp, Sch Med, Dept Internal Med,Cardiol Div, Daejeon, South Korea; [Park, Sungha; Jang, Yangsoo; Lee, Sang-Hak] Severance Cardiovascular Hosp, Dept Internal Med, Div Cardiol, Seoul, South Korea; [Park, Sungha; Jang, Yangsoo; Lee, Sang-Hak] Yonsei Univ, Cardiovasc Res Inst, Seoul 120749, South Korea; [Park, Sungha; Jang, Yangsoo; Lee, Sang-Hak] Yonsei Univ, Cardiovasc Genome Ctr, Hlth Syst, Seoul 120749, South Korea; [Lee, Ji Hyun] Yonsei Univ, Coll Dent, Dept Oral Biol, Seoul 120749, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Inje University; Dongguk University; NHIS Ilsan Hospital; Yonsei University; Yonsei University Health System; Chonnam National University; Chonnam National University Hospital; Kangwon National University; Kangwon National University Hospital; Kyung Hee University; Keimyung University; Chungnam National University; Chungnam National University Hospital; Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Bang, D (corresponding author), Yonsei Univ, Dept Chem, Seoul 120749, South Korea.	duheebang@yonsei.ac.kr; jihyni@yuhs.ac; shl1106@yuhs.ac	Lee, Min Goo/AAS-4636-2020; Lee, Min Goo/D-5635-2012	Lee, Min Goo/0000-0001-7436-012X; Lee, Min Goo/0000-0001-7436-012X; Park, Sungha/0000-0001-5362-478X; Jang, Yangsoo/0000-0002-2169-3112; Woo, Jeong-Taek/0000-0001-9201-0713; Jeong, Jin-Ok/0000-0003-0763-4754; Lee, Byoung Kwon/0000-0001-9259-2776; Seong, In-Whan/0000-0003-4628-0258	Basic Science Research Program through the National Research Foundation of Korea; Creative Allied Project (Korean Research Council of Fundamental Science and Technology, SH Lee); Korea Health Technology R&D Project (Korea Health Industry Development Institute, Ministry of Health Welfare) [HI14C0070, HI13C2163]	Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Creative Allied Project (Korean Research Council of Fundamental Science and Technology, SH Lee); Korea Health Technology R&D Project (Korea Health Industry Development Institute, Ministry of Health Welfare)	Financial support was provided by the Basic Science Research Program through the National Research Foundation of Korea, which was funded by the Ministry of Education, Science, and Technology (2012R1A1A2039828, 2012R1A4A1029061, SH Lee). Funding was also provided by the Creative Allied Project (Korean Research Council of Fundamental Science and Technology, SH Lee) and Korea Health Technology R&D Project (Korea Health Industry Development Institute, Ministry of Health & Welfare; HI14C0070, JH Lee; HI13C2163, D Bang).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Awan Z, 2013, ATHEROSCLEROSIS, V231, P218, DOI 10.1016/j.atherosclerosis.2013.09.007; Brice P, 2013, ATHEROSCLEROSIS, V231, P223, DOI 10.1016/j.atherosclerosis.2013.09.019; Bujo Hideaki, 2004, J Atheroscler Thromb, V11, P146; Cameron J, 2008, J INTERN MED, V263, P420, DOI 10.1111/j.1365-2796.2007.01915.x; Chiou KR, 2010, AM J CARDIOL, V105, P1752, DOI 10.1016/j.amjcard.2010.01.356; Civeira F, 2008, AM J CARDIOL, V102, P1187, DOI 10.1016/j.amjcard.2008.06.056; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Fouchier SW, 2014, CIRC RES, V115, P552, DOI 10.1161/CIRCRESAHA.115.304660; Futema M, 2014, J MED GENET, V51, P537, DOI 10.1136/jmedgenet-2014-102405; Futema M, 2013, ATHEROSCLEROSIS, V229, P161, DOI 10.1016/j.atherosclerosis.2013.04.011; Futema M, 2012, J MED GENET, V49, P644, DOI 10.1136/jmedgenet-2012-101189; Garcia-Rios A, 2010, ATHEROSCLEROSIS, V210, P486, DOI 10.1016/j.atherosclerosis.2010.01.010; Hu M, 2013, INT J CARDIOL, V167, P762, DOI 10.1016/j.ijcard.2012.03.048; Humphries SE, 2006, J MED GENET, V43, P943, DOI 10.1136/jmg.2006.038356; Krumm N, 2012, GENOME RES, V22, P1525, DOI 10.1101/gr.138115.112; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lee YH, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000650; Mabuchi H, 2014, ATHEROSCLEROSIS, V236, P54, DOI 10.1016/j.atherosclerosis.2014.06.005; Maglio C, 2014, J INTERN MED, V276, P396, DOI 10.1111/joim.12263; Marks D, 2003, ATHEROSCLEROSIS, V168, P1, DOI 10.1016/S0021-9150(02)00330-1; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miyake Y, 2009, ATHEROSCLEROSIS, V203, P153, DOI 10.1016/j.atherosclerosis.2008.07.005; Motazacker MM, 2012, EUR HEART J, V33, P1360, DOI 10.1093/eurheartj/ehs010; Noguchi T, 2010, ATHEROSCLEROSIS, V210, P166, DOI 10.1016/j.atherosclerosis.2009.11.018; Rader DJ, 2003, J CLIN INVEST, V111, P1795, DOI 10.1172/JCI200318925; Sharma P, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16170; Talmud PJ, 2013, LANCET, V381, P1293, DOI 10.1016/S0140-6736(12)62127-8; Taylor A, 2010, CLIN GENET, V77, P572, DOI 10.1111/j.1399-0004.2009.01356.x; Umans-Eckenhausen MAW, 2001, LANCET, V357, P165, DOI 10.1016/S0140-6736(00)03587-X; Usifo E, 2012, ANN HUM GENET, V76, P387, DOI 10.1111/j.1469-1809.2012.00724.x; Vandrovcova J, 2013, GENET MED, V15, P948, DOI 10.1038/gim.2013.55; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; WILLIAMS RR, 1993, AM J CARDIOL, V72, P171, DOI 10.1016/0002-9149(93)90155-6	35	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126706	10.1371/journal.pone.0126706	http://dx.doi.org/10.1371/journal.pone.0126706			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962062	Green Submitted, gold, Green Published			2022-12-26	WOS:000354542500140
J	Stepkowski, D; Wozniak, G; Studnicki, M				Stepkowski, Dariusz; Wozniak, Grazyna; Studnicki, Marcin			Correlation of Alzheimer's Disease Death Rates with Historical Per Capita Personal Income in the USA	PLOS ONE			English	Article							MEDITERRANEAN DIET; COGNITIVE DECLINE; PHYSICAL-ACTIVITY; RISK-FACTORS; LATER LIFE; DEMENTIA; MIDLIFE; EPIGENETICS; IMPAIRMENT; PREVALENCE	Alzheimer's disease (AD) is a progressive degenerating disease of complex etiology. A variety of risk factors contribute to the chance of developing AD. Lifestyle factors, such as physical, mental and social activity, education, and diet all affect the susceptibility to developing AD. These factors are in turn related to the level of personal income. Lower income usually coincides with lower level of education, lesser mental, leisure-social and physical activity, and poorer diet. In the present paper, we have analyzed the correlation of historical (1929-2011) per capita personal income (PCPI) for all states of the USA with corresponding age-adjusted AD death rates (AADR) for years 2000, 2005 and 2008. We found negative correlations in all cases, the highest one (R approximate to -0.65) for the PCPIs in the year 1970 correlated against the AADRs in 2005. From 1929 to 2005 the R value varies in an oscillatory manner, with the strongest correlations in 1929, 1970, 1990 and the weakest in 1950, 1980, 1998. Further analysis indicated that this oscillatory behavior of R is not artificially related to the economic factors but rather to delayed biological consequences associated with personal income. We conclude that the influence of the income level on the AD mortality in 2005 was the highest in the early years of life of the AD victims. Overall, the income had a significant, lifelong, albeit constantly decreasing, influence on the risk of developing AD. We postulate that the susceptibility of a population to late-onset AD (LOAD) is determined to a large extent by the history of income-related modifiable lifestyle risk factors. Among these risk factors, inappropriate diet has a significant contribution.	[Stepkowski, Dariusz; Wozniak, Grazyna] Nencki Inst Expt Biol, Lab Mol Basis Cell Motil, Warsaw, Poland; [Studnicki, Marcin] Warsaw Univ Life Sci SGGW, Dept Expt Design & Bioinformat, Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Warsaw University of Life Sciences	Stepkowski, D (corresponding author), Nencki Inst Expt Biol, Lab Mol Basis Cell Motil, Warsaw, Poland.	d.stepkowski@nencki.gov.pl	Stępkowski, Dariusz/R-4134-2016; Studnicki, Marcin/J-4927-2019	Stępkowski, Dariusz/0000-0002-9926-3542; Studnicki, Marcin/0000-0001-9773-7313				Al Hazzouri AZ, 2014, J GERONTOL A-BIOL, V69, P595, DOI 10.1093/gerona/glt139; Alegra-Torres JA, 2011, EPIGENOMICS-UK, V3, P267, DOI [10.2217/EPI.11.22, 10.2217/epi.11.22]; Altmann S, 2012, EPIGENETICS-US, V7, P239, DOI 10.4161/epi.7.3.19183; Balazs R, 2011, NEUROBIOL AGING, V32, P1181, DOI 10.1016/j.neurobiolaging.2011.02.024; Ballard C, 2013, NAT REV NEUROL, V9, P605, DOI 10.1038/nrneurol.2013.215; Barnes DE, 2013, JAMA INTERN MED, V173, P797, DOI 10.1001/jamainternmed.2013.189; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Breunig JJ, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00026; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Brookmeyer R, 2011, ALZHEIMERS DEMENT, V7, P61, DOI 10.1016/j.jalz.2010.11.007; Chin AL, 2011, ALZ DIS ASSOC DIS, V25, P187, DOI 10.1097/WAD.0b013e318211c6c9; Crane PK, 2013, NEW ENGL J MED, V369, P540, DOI [10.1056/NEJMoa1215740, 10.1056/NEJMc1311765]; Daviglus ML, 2010, ANN INTERN MED, V153, P176, DOI 10.7326/0003-4819-153-3-201008030-00260; De Felice FG, 2013, EXPERT REV NEUROTHER, V13, P1297, DOI 10.1586/14737175.2013.864824; Exalto LG, 2014, ALZHEIMERS DEMENT, V10, P562, DOI 10.1016/j.jalz.2013.05.1772; Feart C, 2009, JAMA-J AM MED ASSOC, V302, P638, DOI 10.1001/jama.2009.1146; Fischer C, 2009, INT PSYCHOGERIATR, V21, P1096, DOI 10.1017/S1041610209990846; Fratiglioni L, 2000, BEHAV BRAIN RES, V113, P117, DOI 10.1016/S0166-4328(00)00206-0; Glymour MM, 2012, AM J EPIDEMIOL, V175, P750, DOI 10.1093/aje/kwr509; Glymour MM, 2011, ALZ DIS ASSOC DIS, V25, P196, DOI 10.1097/WAD.0b013e31820905e7; Grant WB, 2014, J ALZHEIMERS DIS, V38, P611, DOI 10.3233/JAD-130719; Gray SG, 2011, EPIGENOMICS-UK, V3, P431, DOI [10.2217/EPI.11.67, 10.2217/epi.11.67]; HEBERT LE, 1995, JAMA-J AM MED ASSOC, V273, P1354, DOI 10.1001/jama.273.17.1354; Kim M, 2012, J ENVIRON SCI HEAL C, V30, P323, DOI 10.1080/10590501.2012.731959; Kivipelto M, 2001, BMJ-BRIT MED J, V322, P1447, DOI 10.1136/bmj.322.7300.1447; Kwok JBJ, 2010, EPIGENOMICS-UK, V2, P671, DOI 10.2217/EPI.10.43; Sosa-Ortiz AL, 2012, ARCH MED RES, V43, P600, DOI 10.1016/j.arcmed.2012.11.003; Mangialasche F, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt104; Mckay JA, 2011, ACTA PHYSIOL, V202, P103, DOI 10.1111/j.1748-1716.2011.02278.x; Middleton LE, 2010, J AM GERIATR SOC, V58, P1322, DOI 10.1111/j.1532-5415.2010.02903.x; Moceri VM, 2000, NEUROLOGY, V54, P415, DOI 10.1212/WNL.54.2.415; Moceri VM, 2001, EPIDEMIOLOGY, V12, P383, DOI 10.1097/00001648-200107000-00007; Panza F, 2007, EXP GERONTOL, V42, P6, DOI 10.1016/j.exger.2006.09.011; Richardson JR, 2014, JAMA NEUROL, V71, P284, DOI 10.1001/jamaneurol.2013.6030; Rizzuto D, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5568; Rogers MAM, 2009, J GERIATR PSYCH NEUR, V22, P71, DOI 10.1177/0891988708328220; Roseboom TJ, 2001, MOL CELL ENDOCRINOL, V185, P93, DOI 10.1016/S0303-7207(01)00721-3; Scarmeas N, 2009, JAMA-J AM MED ASSOC, V302, P627, DOI 10.1001/jama.2009.1144; Thies W, 2013, ALZHEIMERS DEMENT, V9, P208, DOI 10.1016/j.jalz.2013.02.003; Tolppanen AM, 2014, J ALZHEIMERS DIS, V38, P201, DOI 10.3233/JAD-130698; Verghese J, 2003, NEW ENGL J MED, V348, P2508, DOI 10.1056/NEJMoa022252; Wengreen H, 2013, AM J CLIN NUTR, V98, P1263, DOI 10.3945/ajcn.112.051276	42	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126139	10.1371/journal.pone.0126139	http://dx.doi.org/10.1371/journal.pone.0126139			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961738	Green Submitted, gold, Green Published			2022-12-26	WOS:000354542500068
J	Anderson, WC; Boyd, MB; Aguilar, J; Pickell, B; Laysang, A; Pysz, MA; Bheddah, S; Ramoth, J; Slingerland, BC; Dylla, SJ; Rubio, ER				Anderson, Wade C.; Boyd, Michael B.; Aguilar, Jorge; Pickell, Brett; Laysang, Amy; Pysz, Marybeth A.; Bheddah, Sheila; Ramoth, Johanna; Slingerland, Brian C.; Dylla, Scott J.; Rubio, Edmundo R.			Initiation and Characterization of Small Cell Lung Cancer Patient-Derived Xenografts from Ultrasound-Guided Transbronchial Needle Aspirates	PLOS ONE			English	Article							TUMOR; CLASSIFICATION; CHEMOTHERAPY; EXPRESSION; TOPOTECAN; CULTURE; MODEL	Small cell lung cancer (SCLC) is a devastating disease with limited treatment options. Due to its early metastatic nature and rapid growth, surgical resection is rare. Standard of care treatment regimens remain largely unchanged since the 1980's, and five-year survival lingers near 5%. Patient-derived xenograft (PDX) models have been established for other tumor types, amplifying material for research and serving as models for preclinical experimentation; however, limited availability of primary tissue has curtailed development of these models for SCLC. The objective of this study was to establish PDX models from commonly collected fine needle aspirate biopsies of primary SCLC tumors, and to assess their utility as research models of primary SCLC tumors. These transbronchial needle aspirates efficiently engrafted as xenografts, and tumor histomorphology was similar to primary tumors. Resulting tumors were further characterized by H&E and immunohistochemistry, cryopreserved, and used to propagate tumor-bearing mice for the evaluation of standard of care chemotherapy regimens, to assess their utility as models for tumors in SCLC patients. When treated with Cisplatin and Etoposide, tumor-bearing mice responded similarly to patients from whom the tumors originated. Here, we demonstrate that PDX tumor models can be efficiently established from primary SCLC transbronchial needle aspirates, even after overnight shipping, and that resulting xenograft tumors are similar to matched primary tumors in cancer patients by both histology and chemo-sensitivity. This method enables physicians at non-research institutions to collaboratively contribute to the rapid establishment of extensive PDX collections of SCLC, enabling experimentation with clinically relevant tissues and development of improved therapies for SCLC patients.	[Boyd, Michael B.; Rubio, Edmundo R.] Caril Clin, Virginia Tech Caril Sch Med, Sect Pulm Crit Care Environm & Sleep Med, Roanoke, VA 24013 USA; [Anderson, Wade C.; Aguilar, Jorge; Pickell, Brett; Laysang, Amy; Pysz, Marybeth A.; Bheddah, Sheila; Ramoth, Johanna; Slingerland, Brian C.; Dylla, Scott J.] Stemcentrx Inc, San Francisco, CA USA		Rubio, ER (corresponding author), Caril Clin, Virginia Tech Caril Sch Med, Sect Pulm Crit Care Environm & Sleep Med, Roanoke, VA 24013 USA.	errubio@carilionclinic.org			Stem CentRx, Inc.	Stem CentRx, Inc.	WCA, JA, BP, AL, MAP, SB, JR, BCS, and SJD are employees of Stem CentRx, Inc., a biotechnology company focused on therapeutic targeting of Cancer Stem Cells. The funder provided support in the form of salaries for authors WCA, JA, BP, AL, MAP, SB, JR, BCS, and SJD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bradley JD, 2004, J CLIN ONCOL, V22, P3248, DOI 10.1200/JCO.2004.11.089; Brambilla E, 2001, EUR RESPIR J, V18, P1059, DOI 10.1183/09031936.01.00275301; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Daniel VC, 2009, CANCER RES, V69, P3364, DOI 10.1158/0008-5472.CAN-08-4210; Dong X, 2010, CLIN CANCER RES, V16, P1442, DOI 10.1158/1078-0432.CCR-09-2878; Dylla SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002428; Grigorova M, 2005, CANCER GENET CYTOGEN, V162, P1, DOI 10.1016/j.cancergencyto.2005.03.007; Hamer PCDW, 2008, ONCOGENE, V27, P2091, DOI 10.1038/sj.onc.1210850; Herth FJF, 2006, THORAX, V61, P795, DOI 10.1136/thx.2005.047829; Hodgkinson CL, 2014, NAT MED, V20, P897, DOI 10.1038/nm.3600; Jin KT, 2010, CLIN TRANSL ONCOL, V12, P473, DOI 10.1007/s12094-010-0540-6; Lally BE, 2007, ONCOLOGIST, V12, P1096, DOI 10.1634/theoncologist.12-9-1096; Leong TL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106862; LITTLE CD, 1983, NATURE, V306, P194, DOI 10.1038/306194a0; Marangoni E, 2007, CLIN CANCER RES, V13, P3989, DOI 10.1158/1078-0432.CCR-07-0078; O'Brien MER, 2006, J CLIN ONCOL, V24, P5441, DOI 10.1200/JCO.2006.06.5821; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Owonikoko TK, 2012, J THORAC ONCOL, V7, P866, DOI 10.1097/JTO.0b013e31824c7f4b; Pandita A, 2004, GENE CHROMOSOME CANC, V39, P29, DOI 10.1002/gcc.10300; Park SH, 2008, CANCER CHEMOTH PHARM, V62, P1009, DOI 10.1007/s00280-008-0690-1; POUPON MF, 1993, J NATL CANCER I, V85, P2023, DOI 10.1093/jnci/85.24.2023; Reyal F, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3095; Roschke AV, 2003, CANCER RES, V63, P8634; Sasai K, 2006, CANCER RES, V66, P4215, DOI 10.1158/0008-5472.CAN-05-4505; Shepherd FA, 2007, J THORAC ONCOL, V2, P1067, DOI 10.1097/JTO.0b013e31815bdc0d; Tarver T, 2012, J CONS HLTH INTERNET, V16, P366, DOI 10.1080/15398285.2012.701177; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Williams SA, 2013, LAB INVEST, V93, P970, DOI 10.1038/labinvest.2013.92	29	34	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0125255	10.1371/journal.pone.0125255	http://dx.doi.org/10.1371/journal.pone.0125255			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955027	Green Published, Green Submitted, gold			2022-12-26	WOS:000356768100048
J	Mackie, SL; Hughes, R; Walsh, M; Day, J; Newton, M; Pease, C; Kirwan, J; Morris, M				Mackie, Sarah Louise; Hughes, Rodney; Walsh, Margaret; Day, John; Newton, Marion; Pease, Colin; Kirwan, John; Morris, Marianne			"An Impediment to Living Life": Why and How Should We Measure Stiffness in Polymyalgia Rheumatica?	PLOS ONE			English	Article							EUROPEAN LEAGUE; OUTCOMES; GUIDELINES; CRITERIA	Objectives To explore patients' concepts of stiffness in polymyalgia rheumatica (PMR), and how they think stiffness should be measured. Methods Eight focus groups were held at three centres involving 50 patients with current/previous PMR. Each group had at least one facilitator and one rapporteur making field notes. An interview schedule was used to stimulate discussion. Interviews were recorded, transcribed and analysed using an inductive thematic approach. Results Major themes identified were: symptoms: pain, stiffness and fatigue; functional impact; impact on daily schedule; and approaches to measurement. The common subtheme for the experience of stiffness was "difficulty in moving", and usually considered as distinct from the experience of pain, albeit with a variable overlap. Some participants felt stiffness was the "overwhelming" symptom, in that it prevented them carrying out "fundamental activities" and "generally living life". Diurnal variation in stiffness was generally described in relation to the daily schedule but was not the same as stiffness severity. Some participants suggested measuring stiffness using a numeric rating scale or a Likert scale, while others felt that it was more relevant and straightforward to measure difficulty in performing everyday activities rather than about stiffness itself. Conclusions A conceptual model of stiffness in PMR is presented where stiffness is an important part of the patient experience and impacts on their ability to live their lives. Stiffness is closely related to function and often regarded as interchangeable with pain. From the patients' perspective, visual analogue scales measuring pain and stiffness were not the most useful method for reporting stiffness; participants preferred numerical rating scales, or assessments of function to reflect how stiffness impacts on their daily lives. Assessing function may be a pragmatic solution to difficulties in quantifying stiffness.	[Mackie, Sarah Louise] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England; [Mackie, Sarah Louise] NIHR, Leeds Musculoskeletal Biomed Res Unit, Leeds, W Yorkshire, England; [Hughes, Rodney; Walsh, Margaret] Ashford & St Peters NHS Fdn Trust, Dept Rheumatol, Chertsey, England; [Day, John; Newton, Marion] PMRGCAuk, Surrey, Chertsey, England; [Pease, Colin] Leeds Teaching Hosp NHS Trust, Dept Rheumatol, Leeds, W Yorkshire, England; [Kirwan, John] Univ Bristol, Dept Rheumatol, Bristol, Avon, England; [Morris, Marianne] Univ W England, Bristol BS16 1QY, Avon, England	University of Leeds; University of Leeds; University of Bristol; University of West England	Mackie, SL (corresponding author), Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England.	s.l.mackie@leeds.ac.uk		Kirwan, John/0000-0002-6617-3217	Department of Health [NIHR-CS-012-016] Funding Source: Medline; National Institute for Health Research [CL-2009-02-002, NIHR-CS-012-016] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		Boers M, 2014, J RHEUMATOL, V41, P1025, DOI 10.3899/jrheum.131314; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Carpenter J, 2008, RES NURS HEALTH, V31, P274, DOI 10.1002/nur.20253; Creswell J. W., 2007, QUALITATIVE INQUIRY; Dasgupta B, 2012, ANN RHEUM DIS, V71, P484, DOI 10.1136/annrheumdis-2011-200329; Dasgupta B, 2010, RHEUMATOLOGY, V49, P186, DOI 10.1093/rheumatology/kep303a; de Wit MPT, 2011, ANN RHEUM DIS, V70, P722, DOI 10.1136/ard.2010.135129; Flury C, 2012, THESIS U W ENGLAND; Gabriel SE, 1997, ARTHRITIS RHEUM, V40, P1873, DOI 10.1002/art.1780401022; HAZES JMW, 1993, J RHEUMATOL, V20, P1138; Hewlett S, 2012, RHEUMATOLOGY, V51, P69, DOI 10.1093/rheumatology/keq455; Hutchings A, 2007, ARTHRIT RHEUM-ARTHR, V57, P803, DOI 10.1002/art.22777; Kalke S, 2000, RHEUMATOLOGY, V39, P883, DOI 10.1093/rheumatology/39.8.883; Kirwan JR, 2011, J RHEUMATOL, V38, P1711, DOI 10.3899/jrheum.110391; Leeb BF, 2004, ANN RHEUM DIS, V63, P1279, DOI 10.1136/ard.2003.011379; Mackie SL, 2014, J RHEUMATOL, V41, P819, DOI 10.3899/jrheum.131254; Mackie SL, 2010, RHEUMATOLOGY, V49, P716, DOI 10.1093/rheumatology/kep395; Matteson EL, 2012, J RHEUMATOL, V39, P795, DOI 10.3899/jrheum.110977; Ruff CC, 2005, NURS OUTLOOK, V53, P134, DOI 10.1016/j.outlook.2005.03.010; Spiera R, 2012, ANN RHEUM DIS, V71, P475, DOI 10.1136/annrheumdis-2011-201111; Vlieland TPMV, 1997, J CLIN EPIDEMIOL, V50, P757, DOI 10.1016/S0895-4356(97)00051-6; WHO, 2001, WHO INT CLASS FUNCT; Wilkinson S, 1998, INT J SOC RES METHOD, V1, P181, DOI DOI 10.1080/13645579.1998.10846874	23	18	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0126758	10.1371/journal.pone.0126758	http://dx.doi.org/10.1371/journal.pone.0126758			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955770	Green Published, gold			2022-12-26	WOS:000356768100143
J	Schurger, A; Kim, MS; Cohen, JD				Schurger, Aaron; Kim, Min-Soo; Cohen, Jonathan D.			Paradoxical Interaction between Ocular Activity, Perception, and Decision Confidence at the Threshold of Vision	PLOS ONE			English	Article							FIXATIONAL EYE-MOVEMENTS; SUPPRESSION; PATHWAY; DISCRIMINATION; METACOGNITION; MICROSACCADES; ACCURACY; CHILDREN; IMPACT; AUTISM	In humans and some other species perceptual decision-making is complemented by the ability to make confidence judgements about the certainty of sensory evidence. While both forms of decision process have been studied empirically, the precise relationship between them remains poorly understood. We performed an experiment that combined a perceptual decision-making task (identifying the category of a faint visual stimulus) with a confidence-judgement task (wagering on the accuracy of each perceptual decision). The visual stimulation paradigm required steady fixation, so we used eye-tracking to control for stray eye movements. Our data analyses revealed an unexpected and counterintuitive interaction between the steadiness of fixation (prior to and during stimulation), perceptual decision making, and post-decision wagering: greater variability in gaze direction during fixation was associated with significantly increased visual-perceptual sensitivity, but significantly decreased reliability of confidence judgements. The latter effect could not be explained by a simple change in overall confidence (i.e. a criterion artifact), but rather was tied to a change in the degree to which high wagers predicted correct decisions (i.e. the sensitivity of the confidence judgement). We found no evidence of a differential change in pupil diameter that could account for the effect and thus our results are consistent with fixational eye movements being the relevant covariate. However, we note that small changes in pupil diameter can sometimes cause artefactual fluctuations in measured gaze direction and this possibility could not be fully ruled out. In either case, our results suggest that perceptual decisions and confidence judgements can be processed independently and point toward a new avenue of research into the relationship between them.	[Schurger, Aaron; Kim, Min-Soo; Cohen, Jonathan D.] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Schurger, Aaron; Cohen, Jonathan D.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Schurger, Aaron] CEA Saclay, INSERM, U992, NeuroSpin, F-91191 Gif Sur Yvette, France	Princeton University; Princeton University; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Schurger, A (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA.	schurger@princeton.edu	Schurger, Aaron/Y-4459-2018	Schurger, Aaron/0000-0003-2985-3253	Ruth L. Kirschstein National Research Service Award (NRSA) from the US National Institutes of Health (NIH) [1 F31 MH075342-01A1]; Mind Science Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH075342] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award (NRSA) from the US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mind Science Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	AS was supported by a Ruth L. Kirschstein National Research Service Award (NRSA) from the US National Institutes of Health (NIH), award number 1 F31 MH075342-01A1 (www.nih.gov) and by a grant from the Mind Science Foundation (www.mindscience.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzopardi P, 1997, P NATL ACAD SCI USA, V94, P14190, DOI 10.1073/pnas.94.25.14190; BURR DC, 1994, NATURE, V371, P511, DOI 10.1038/371511a0; Call J., 2001, ANIM COGN, V3, P207, DOI [10.1007/s100710100078, DOI 10.1007/S100710100078]; Chua EF, 2004, J COGNITIVE NEUROSCI, V16, P1131, DOI 10.1162/0898929041920568; Clifford CWG, 2008, TRENDS COGN SCI, V12, P54, DOI 10.1016/j.tics.2007.11.009; Del Cul A, 2009, BRAIN, V132, P2531, DOI 10.1093/brain/awp111; Fleming SM, 2012, J NEUROSCI, V32, P6117, DOI 10.1523/JNEUROSCI.6489-11.2012; Fleming SM, 2010, SCIENCE, V329, P1541, DOI 10.1126/science.1191883; Galvin SJ, 2003, PSYCHON B REV, V10, P843, DOI 10.3758/BF03196546; Gilzenrat MS, 2010, COGN AFFECT BEHAV NE, V10, P252, DOI 10.3758/CABN.10.2.252; Gitelman DR, 2002, BEHAV RES METH INS C, V34, P605, DOI 10.3758/BF03195488; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Gori S, 2015, CEREB CORTEX, V25, P1685, DOI 10.1093/cercor/bhu234; Gori S, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00460; Gori S, 2014, VISION RES, V99, P78, DOI 10.1016/j.visres.2013.11.011; Greenaway R, 2013, NEUROPSYCHOLOGIA, V51, P592, DOI 10.1016/j.neuropsychologia.2013.01.005; Hafed ZM, 2010, J NEUROSCI, V30, P9542, DOI 10.1523/JNEUROSCI.1137-10.2010; HOVIS JK, 1989, OPTOMETRY VISION SCI, V66, P181, DOI 10.1097/00006324-198903000-00010; Ives HE, 1912, PHILOS MAG, V24, P149, DOI 10.1080/14786440708637317; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; Kiani R, 2009, SCIENCE, V324, P759, DOI 10.1126/science.1169405; King JR, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0204; Lau HC, 2008, PROG BRAIN RES, V168, P35, DOI 10.1016/S0079-6123(07)68004-2; Maniscalco B, 2012, CONSCIOUS COGN, V21, P422, DOI 10.1016/j.concog.2011.09.021; Martinez-Conde S, 2006, NEURON, V49, P297, DOI 10.1016/j.neuron.2005.11.033; Martinez-Conde S, 2004, NAT REV NEUROSCI, V5, P229, DOI 10.1038/nrn1348; Martinez-Conde S, 2013, NAT REV NEUROSCI, V14, P83, DOI 10.1038/nrn3405; McCamy MB, 2014, J PHYSIOL-LONDON, V592, P4381, DOI 10.1113/jphysiol.2014.279059; Metcalfe J, 2008, HDB METAMEMORY MEMOR, P29; Miller J, 1996, PERCEPT PSYCHOPHYS, V58, P65, DOI 10.3758/BF03205476; Milne E, 2002, J CHILD PSYCHOL PSYC, V43, P255, DOI 10.1111/1469-7610.00018; Moutoussis K, 2002, P NATL ACAD SCI USA, V99, P9527, DOI 10.1073/pnas.142305699; Persaud N, 2007, NAT NEUROSCI, V10, P257, DOI 10.1038/nn1840; Rahnev D, 2011, NAT NEUROSCI, V14, P1513, DOI 10.1038/nn.2948; RIGGS LA, 1953, J OPT SOC AM, V43, P495, DOI 10.1364/JOSA.43.000495; Ronconi L, 2013, BRAIN COGNITION, V82, P213, DOI 10.1016/j.bandc.2013.04.006; Ronconi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049019; Ross J, 1996, BEHAV BRAIN RES, V80, P1, DOI 10.1016/0166-4328(96)00012-5; Rucci M, 2007, NATURE, V447, P851, DOI 10.1038/nature05866; Schutz AC, 2008, NAT NEUROSCI, V11, P1211, DOI 10.1038/nn.2194; Schurger A, 2008, TRENDS COGN SCI, V12, P209, DOI 10.1016/j.tics.2008.02.012; Schurger A, 2010, SCIENCE, V327, P97, DOI 10.1126/science.1180029; Schurger A, 2009, J NEUROSCI METH, V177, P199, DOI 10.1016/j.jneumeth.2008.09.028; Smith JD, 2005, CURR DIR PSYCHOL SCI, V14, P19, DOI 10.1111/j.0963-7214.2005.00327.x; Smith JD, 2003, BEHAV BRAIN SCI, V26, P317; STEINMAN RM, 1973, SCIENCE, V181, P810, DOI 10.1126/science.181.4102.810; Sutherland A, 2010, BRAIN, V133, P2089, DOI 10.1093/brain/awq122; Troxler D., 1804, OPHTHALMOLOGISCHE BI, V2, P1; Wilimzig C, 2008, J VISION, V8, DOI 10.1167/8.5.7; ZUBER BL, 1966, EXP NEUROL, V16, P65, DOI 10.1016/0014-4886(66)90087-2	51	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0125278	10.1371/journal.pone.0125278	http://dx.doi.org/10.1371/journal.pone.0125278			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL2IX	25955162	Green Published, gold, Green Submitted			2022-12-26	WOS:000356768100049
J	Strommenger, B; Layer, F; Klare, I; Werner, G				Strommenger, Birgit; Layer, Franziska; Klare, Ingo; Werner, Guido			Pre-Use Susceptibility to Ceftaroline in Clinical Staphylococcus aureus Isolates from Germany: Is There a Non-Susceptible Pool to be Selected?	PLOS ONE			English	Article							SOFT-TISSUE INFECTIONS; METHICILLIN-RESISTANT; SKIN; MRSA; SURVEILLANCE; REPLACEMENT; SPECTRUM; HOMOLOG; CLONES; TRENDS	Ceftaroline is a new cephalosporin active against Methicillin-resistant Staphylococcus aureus (MRSA). Based on a representative collection of clinical S. aureus isolates from Germany, supplemented with isolates of clonal lineages ST228 and ST239, we demonstrate the in-vitro susceptibility towards ceftaroline prior to its introduction into clinical use for a total of 219 isolates. Susceptibility testing was performed by broth microdilution, disc diffusion and Etest, respectively. Results were interpreted according to EUCAST guidelines and showed considerable variance in dependence on clonal affiliation of the isolates tested. Among isolates of widespread hospital-associated lineages we found a high proportion of clinical isolates with MICs close to the EUCAST breakpoint (MIC50/90 1.0/1.5 mg/L); currently, interpretation of these "borderline" MICs is complicated by a lack of concordant susceptibility testing methods and reasonable breakpoint determination. Isolates of clonal lineages ST228 and ST239 demonstrated increased MIC50/90 values of 2.5/3.33 mg/L. Sequencing of mecA revealed no association of resistance to a specific mecA polymorphism, but rather reveals two regions in the non-penicillin-binding domain of PbP2a which displayed different combinations of mutations putatively involved in resistance development. This study provides national baseline data to (i) adjust susceptibility testing methods and current breakpoints to clinical and epidemiological requirements, (ii) evaluate current breakpoints with respect to therapeutic outcome and (iii) monitor further resistance evolution.	[Strommenger, Birgit; Layer, Franziska; Klare, Ingo; Werner, Guido] Robert Koch Inst, Natl Reference Ctr Staphylococci & Enterococci, Wernigerode Branch, Wernigerode, Germany	Robert Koch Institute	Strommenger, B (corresponding author), Robert Koch Inst, Natl Reference Ctr Staphylococci & Enterococci, Wernigerode Branch, Wernigerode, Germany.	strommengerb@rki.de		Layer, Franziska/0000-0002-4613-6478	Robert Koch Institute; German Ministry of Health	Robert Koch Institute; German Ministry of Health	The current study was supported by the Robert Koch Institute and German Ministry of Health. Ceftaroline was donated by AstraZeneca (Wedel, Germany) for scientific purposes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm R, 2013, ECCMID EUROPEAN CONG; Alm RA, 2014, J ANTIMICROB CHEMOTH, V69, P2065, DOI 10.1093/jac/dku114; Alp E, 2009, J INFECTION, V58, P433, DOI 10.1016/j.jinf.2009.04.006; Baneriee R, 2008, ANTIMICROB AGENTS CH, V52, P2089, DOI 10.1128/AAC.01403-07; Bush K, 2012, CURR OPIN PHARMACOL, V12, P527, DOI 10.1016/j.coph.2012.06.003; Bush K, 2011, NAT REV MICROBIOL, V9, P894, DOI 10.1038/nrmicro2693; Campanile F, 2009, ANN CLIN MICROB ANTI, V8, DOI 10.1186/1476-0711-8-22; Canton Moreno R, 2013, ECCMID EUROPEAN CONG; Clinical and Laboratory Standards Institute (CLSI), 2013, PERFORMANCE STANDARD; Conceicao T, 2007, CLIN MICROBIOL INFEC, V13, P971, DOI 10.1111/j.1469-0691.2007.01794.x; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; European Committee on Antimicrobial Susceptibility Testing (EUCAST), 2014, CLINICAL BREAKPOINTS; European Committee on Antimicrobial Susceptibility Testing (EUCAST), 2013, CLINICAL BREAKPOINTS; Farrell DJ, 2013, INT J ANTIMICROB AG, V41, P337, DOI 10.1016/j.ijantimicag.2012.12.013; Garcia-Alvarez L, 2011, LANCET INFECT DIS, V11, P595, DOI 10.1016/S1473-3099(11)70126-8; Katayama Y, 2004, ANTIMICROB AGENTS CH, V48, P453, DOI 10.1128/AAC.48.2.453-459.2004; Kim C, 2012, J BIOL CHEM, V287, P36854, DOI 10.1074/jbc.M112.395962; Kock R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055040; Krziwanek K, 2008, CLIN MICROBIOL INFEC, V14, P250, DOI 10.1111/j.1469-0691.2007.01896.x; Layer F, 2012, BUNDESGESUNDHEITSBLA, V55, P1377, DOI 10.1007/s00103-012-1560-x; Leopold SR, 2014, J CLIN MICROBIOL, V52, P2365, DOI 10.1128/JCM.00262-14; MacGowan AP, 2013, ANTIMICROB AGENTS CH, V57, P2451, DOI 10.1128/AAC.01386-12; Mendes RE, 2012, J ANTIMICROB CHEMOTH, V67, P1321, DOI 10.1093/jac/dks069; Mick V, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-68; Moisan H, 2010, J ANTIMICROB CHEMOTH, V65, P713, DOI 10.1093/jac/dkp503; Nickerson EK, 2009, LANCET INFECT DIS, V9, P130, DOI 10.1016/S1473-3099(09)70022-2; Nimmo GR, 2013, J INFECTION, V67, P439, DOI 10.1016/j.jinf.2013.07.020; Richter SS, 2011, ANTIMICROB AGENTS CH, V55, P4154, DOI 10.1128/AAC.00315-11; Sader HS, 2012, CLIN INFECT DIS, V55, pS181, DOI 10.1093/cid/cis560; Sader HS, 2013, DIAGN MICR INFEC DIS, V76, P61, DOI 10.1016/j.diagmicrobio.2013.01.005; Schaumburg F, 2012, J CLIN MICROBIOL, V50, P3186, DOI 10.1128/JCM.01174-12; Strommenger B, 2008, J CLIN MICROBIOL, V46, P574, DOI 10.1128/JCM.01599-07; Strommenger B, 2014, J ANTIMICROB CHEMOTH, V69, P616, DOI 10.1093/jac/dkt413; Uhlemann AC, 2014, INFECT GENET EVOL, V21, P563, DOI 10.1016/j.meegid.2013.04.030; Vogel V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038969; Xiao M, 2013, J CLIN MICROBIOL, V51, P3638, DOI 10.1128/JCM.01375-13; Zhanel GG, 2009, DRUGS, V69, P809, DOI 10.2165/00003495-200969070-00003; Zhang H, 2013, J MED MICROBIOL, V62, P496, DOI 10.1099/jmm.0.052522-0	38	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0125864	10.1371/journal.pone.0125864	http://dx.doi.org/10.1371/journal.pone.0125864			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955221	gold, Green Published			2022-12-26	WOS:000356768100082
J	Zitella, LM; Xiao, Y; Teplitzky, BA; Kastl, DJ; Duchin, Y; Baker, KB; Vitek, JL; Adriany, G; Yacoub, E; Harel, N; Johnson, MD				Zitella, Laura M.; Xiao, YiZi; Teplitzky, Benjamin A.; Kastl, Daniel J.; Duchin, Yuval; Baker, Kenneth B.; Vitek, Jerrold L.; Adriany, Gregor; Yacoub, Essa; Harel, Noam; Johnson, Matthew D.			In Vivo 7T MRI of the Non-Human Primate Brainstem	PLOS ONE			English	Article							HUMAN PEDUNCULOPONTINE NUCLEUS; AUDITORY MIDBRAIN IMPLANT; HIGH-RESOLUTION MRI; ELECTRICAL-STIMULATION; SUBTHALAMIC NUCLEUS; TEGMENTAL NUCLEUS; ATLAS; VISUALIZATION; ROBUST; TRACTOGRAPHY	Structural brain imaging provides a critical framework for performing stereotactic and intraoperative MRI-guided surgical procedures, with procedural efficacy often dependent upon visualization of the target with which to operate. Here, we describe tools for in vivo, subject-specific visualization and demarcation of regions within the brainstem. High-field 7T susceptibility-weighted imaging and diffusion-weighted imaging of the brain were collected using a customized head coil from eight rhesus macaques. Fiber tracts including the superior cerebellar peduncle, medial lemniscus, and lateral lemniscus were identified using high-resolution probabilistic diffusion tractography, which resulted in three-dimensional fiber tract reconstructions that were comparable to those extracted from sequential application of a two-dimensional nonlinear brain atlas warping algorithm. In the susceptibility-weighted imaging, white matter tracts within the brainstem were also identified as hypointense regions, and the degree of hypointensity was age-dependent. This combination of imaging modalities also enabled identifying the location and extent of several brainstem nuclei, including the periaqueductal gray, pedunculopontine nucleus, and inferior colliculus. These clinically-relevant high-field imaging approaches have potential to enable more accurate and comprehensive subject-specific visualization of the brainstem and to ultimately improve patient-specific neurosurgical targeting procedures, including deep brain stimulation lead implantation.	[Zitella, Laura M.; Xiao, YiZi; Teplitzky, Benjamin A.; Kastl, Daniel J.; Johnson, Matthew D.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA; [Duchin, Yuval; Adriany, Gregor; Yacoub, Essa; Harel, Noam] Univ Minnesota, Ctr Magnet Resonance Res, Minneapolis, MN USA; [Baker, Kenneth B.; Vitek, Jerrold L.] Univ Minnesota, Dept Neurol, Minneapolis, MN USA; [Johnson, Matthew D.] Univ Minnesota, Inst Translat Neurosci, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Johnson, MD (corresponding author), Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA.	john5101@umn.edu	Yacoub, Essa/AAS-7757-2021; Adriany, Gregor/AAK-1323-2020; Adriany, Gregor/R-6656-2016; Harel, Noam/R-7391-2018	Harel, Noam/0000-0002-6034-3801; Zitella Verbick, Laura/0000-0003-1359-9916; Baker, Kenneth/0000-0002-4435-7015; Adriany, Gregor/0000-0002-6428-9005	National Institutes of Health [R01NS081118, R01-NS085188, P41-EB015894, P30-076408, U54-MH091657]; National Science Foundation [IGERT DGE-1069104, GFRP 00006595]; Michael J. Fox Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH091657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085188, R01NS081118] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Michael J. Fox Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Institutes of Health (R01NS081118, R01-NS085188, P41-EB015894, P30-076408, Human Connectome Project U54-MH091657), the National Science Foundation (IGERT DGE-1069104 to LZ and GFRP 00006595 to BT), and the Michael J. Fox Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abosch A, 2010, NEUROSURGERY, V67, P1745, DOI 10.1227/NEU.0b013e3181f74105; Adriany G., 2010, P 18 ANN M ISMRM STO; Aggarwal M, 2013, NEUROIMAGE, V74, P117, DOI 10.1016/j.neuroimage.2013.01.061; Alvarez-Linera J, 2010, SEMIN ULTRASOUND CT, V31, P230, DOI 10.1053/j.sult.2010.03.003; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Aravamuthan BR, 2009, J CLIN NEUROSCI, V16, P413, DOI 10.1016/j.jocn.2008.03.018; Ashkan K, 2007, BRIT J NEUROSURG, V21, P197, DOI 10.1080/02688690701272240; BOHM C, 1983, AM J NEURORADIOL, V4, P731; Butson CR, 2008, BRAIN STIMUL, V1, P7, DOI 10.1016/j.brs.2007.08.004; Chaturvedi A, 2012, BRAIN STIMUL, V5, P369, DOI 10.1016/j.brs.2011.05.002; Dann R., 1988, Proceedings of the SPIE - The International Society for Optical Engineering, V914, P600; Deistung A, 2013, FRONT HUM NEUROSCI, V7, P1; Deistung A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00710; Diedrichsen J, 2011, NEUROIMAGE, V54, P1786, DOI 10.1016/j.neuroimage.2010.10.035; Duarte-Carvajalino JM, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00041; Duchin Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037328; Duvernoy HM, 1978, HUMAN BRAINSTEM VESS, DOI 10.1007/978-3-662-02299-3; Eapen M, 2011, AM J NEURORADIOL, V32, P688, DOI 10.3174/ajnr.A2355; EVANS AC, 1988, J CEREBR BLOOD F MET, V8, P513, DOI 10.1038/jcbfm.1988.92; Ferraye MU, 2010, BRAIN, V133, P205, DOI 10.1093/brain/awp229; Foltynie T, 2011, J NEUROL NEUROSUR PS, V82, P358, DOI 10.1136/jnnp.2010.205542; Ganser KA, 2004, MED IMAGE ANAL, V8, P3, DOI 10.1016/j.media.2003.06.001; GEE JC, 1991, P SOC PHOTO-OPT INS, V1445, P226, DOI 10.1117/12.45220; Giller CA, 1998, NEUROSURGERY, V42, P56, DOI 10.1097/00006123-199801000-00011; Gizewski ER, 2014, NEURORADIOLOGY, V56, P177, DOI 10.1007/s00234-013-1312-0; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Habas C, 2007, NEURORADIOLOGY, V49, P849, DOI 10.1007/s00234-007-0267-4; Hamani C, 2006, PAIN, V125, P188, DOI 10.1016/j.pain.2006.05.019; HOSOBUCHI Y, 1987, PACE, V10, P213, DOI 10.1111/j.1540-8159.1987.tb05951.x; Janssens T, 2013, NMR BIOMED, V26, P1431, DOI 10.1002/nbm.2970; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jenkinson N, 2004, NEUROREPORT, V15, P2621, DOI 10.1097/00001756-200412030-00012; Johnson MD, 2008, J NEUROPHYSIOL, V100, P2549, DOI 10.1152/jn.90372.2008; Johnson MD, 2012, J NEUROPHYSIOL, V108, P567, DOI 10.1152/jn.00039.2012; Keane M, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/046005; Keuken MC, 2014, NEUROIMAGE, V94, P40, DOI 10.1016/j.neuroimage.2014.03.032; Keuken MC, 2013, J NEUROSCI, V33, P4896, DOI 10.1523/JNEUROSCI.3241-12.2013; Kojima J, 1997, NEUROSCI LETT, V226, P111, DOI 10.1016/S0304-3940(97)00254-1; Lenarz T, 2006, OTOL NEUROTOL, V27, P838, DOI 10.1097/01.mao.0000232010.01116.e9; Lenglet C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029153; Lim HH, 2008, HEARING RES, V242, P74, DOI 10.1016/j.heares.2008.02.003; Markovitz CD, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00039; Marques JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069294; Matsumura M, 2001, STEREOT FUNCT NEUROS, V77, P108, DOI 10.1159/000064614; MAYER DJ, 1974, BRAIN RES, V68, P73, DOI 10.1016/0006-8993(74)90534-4; MAYER DJ, 1971, SCIENCE, V174, P1351, DOI 10.1126/science.174.4016.1351; Mazzone P, 2005, NEUROREPORT, V16, P1877, DOI 10.1097/01.wnr.0000187629.38010.12; Miocinovic S, 2007, J NEUROSCI METH, V162, P32, DOI 10.1016/j.jneumeth.2006.12.007; Miocinovic S, 2006, J NEUROPHYSIOL, V96, P1569, DOI 10.1152/jn.00305.2006; Moro E, 2010, BRAIN, V133, P215, DOI 10.1093/brain/awp261; Muthusamy KA, 2007, J NEUROSURG, V107, P814, DOI 10.3171/JNS-07/10/0814; Nagae-Poetscher LM, 2004, AM J NEURORADIOL, V25, P1325; Nolte IS, 2012, ACTA NEUROCHIR, V154, P481, DOI 10.1007/s00701-011-1242-8; Novak P, 2001, J COMPUT ASSIST TOMO, V25, P242, DOI 10.1097/00004728-200103000-00016; Paxinos G., 2000, RHESUS MONKEY BRAIN; Paxinos G., 2009, STEREOTAXIC COORDINA, DOI [10.1007/s12021-008-9039-5, DOI 10.1007/S12021-008-9039-5]; Perrini P., 2012, NEUROSURGICAL REV, P1; Plaha P, 2005, NEUROREPORT, V16, P1883, DOI 10.1097/01.wnr.0000187637.20771.a0; Polders DL, 2011, J MAGN RESON IMAGING, V33, P1456, DOI 10.1002/jmri.22554; Sadikot AF, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00071; Sakaie K, 2014, NEUROLOGY, V82, P182, DOI 10.1212/WNL.0000000000000016; Sandor S, 1994, IEEE INT C 13 16 NOV; Schaefer S, 2006, ACM T GRAPHIC, V25, P533, DOI 10.1145/1141911.1141920; Seehaus AK, 2013, CEREB CORTEX, V23, P442, DOI 10.1093/cercor/bhs036; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Soria G, 2011, ANAT REC, V294, P1035, DOI 10.1002/ar.21383; St-Jean P, 1998, IEEE T MED IMAGING, V17, P672, DOI 10.1109/42.736017; Stefani A, 2007, BRAIN, V130, P1596, DOI 10.1093/brain/awl346; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Stieltjes B, 2001, NEUROIMAGE, V14, P723, DOI 10.1006/nimg.2001.0861; Sweet JA, 2014, J NEUROSURG, V120, P988, DOI 10.3171/2013.12.JNS131537; Tani N, 2011, NEUROIMAGE, V58, P60, DOI 10.1016/j.neuroimage.2011.06.019; Tiddeman B, 2001, COMPUT GRAPH-UK, V25, P59, DOI 10.1016/S0097-8493(00)00107-2; Wang H, 2014, NEUROIMAGE, V100, P395, DOI 10.1016/j.neuroimage.2014.06.032; Weinberger M, 2008, EXP BRAIN RES, V188, P165, DOI 10.1007/s00221-008-1349-1; Weiss M, 2014, BRAIN STRUCT FUNCT; Wilcox RA, 2011, J NEUROL NEUROSUR PS, V82, P1256, DOI 10.1136/jnnp.2010.213462; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Xu WD, 2011, EXP NEUROL, V228, P294, DOI 10.1016/j.expneurol.2010.08.007; Yang DS, 2009, NEUROSCI LETT, V459, P19, DOI 10.1016/j.neulet.2009.04.058; Zhan L, 2013, BRAIN CONNECT, V3, P72, DOI 10.1089/brain.2012.0114; Ziegler E, 2014, NEUROIMAGE, V99, P498, DOI 10.1016/j.neuroimage.2014.06.033; Zitella LM, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/4/045005; Zrinzo L, 2008, BRAIN, V131, P1588, DOI 10.1093/brain/awn075	87	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0127049	10.1371/journal.pone.0127049	http://dx.doi.org/10.1371/journal.pone.0127049			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965401	gold, Green Published, Green Submitted			2022-12-26	WOS:000354543500092
J	Cappellesso, R; Millioni, R; Arrigoni, G; Simonato, F; Caroccia, B; Iori, E; Guzzardo, V; Ventura, L; Tessari, P; Fassina, A				Cappellesso, Rocco; Millioni, Renato; Arrigoni, Giorgio; Simonato, Francesca; Caroccia, Brasilina; Iori, Elisabetta; Guzzardo, Vincenza; Ventura, Laura; Tessari, Paolo; Fassina, Ambrogio			Lumican Is Overexpressed in Lung Adenocarcinoma Pleural Effusions	PLOS ONE			English	Article							HUMAN PLASMA PROTEOME; EXPRESSION; PROTEOGLYCANS; BIOLOGY; CELLS	Adenocarcinoma (AdC) is the most common lung cancer subtype and is often associated with pleural effusion (PE). Its poor prognosis is attributable to diagnostic delay and lack of effective treatments and there is a pressing need in discovering new biomarkers for early diagnosis or targeted therapies. To date, little is known about lung AdC proteome. We investigated protein expression of lung AdC in PE using the isobaric Tags for Relative and Absolute Quantification (iTRAQ) approach to identify possible novel diagnostic/prognostic biomarkers. This provided the identification of 109 of lung AdC-related proteins. We further analyzed lumican, one of the overexpressed proteins, in 88 resected lung AdCs and in 23 malignant PE cell-blocks (13 lung AdCs and 10 non-lung cancers) using immunohistochemistry. In AdC surgical samples, lumican expression was low in cancer cells, whereas it was strong and diffuse in the stroma surrounding the tumor. However, lumican expression was not associated with tumor grade, stage, and vascular/pleural invasion. None of the lung cancer cell-blocks showed lumican immunoreaction, whereas those of all the other tumors were strongly positive. Finally, immunoblotting analysis showed lumican expression in both cell lysate and conditioned medium of a fibroblast culture but not in those of A549 lung cancer cell line. PE is a valid source of information for proteomic analysis without many of the restrictions of plasma. The high lumican levels characterizing AdC PEs are probably due to its release by the fibroblasts surrounding the tumor. Despite the role of lumican in lung AdC is still elusive, it could be of diagnostic value.	[Cappellesso, Rocco; Simonato, Francesca; Guzzardo, Vincenza; Fassina, Ambrogio] Univ Padua, Dept Med, Surg Pathol & Cytopathol Unit, Padua, PD, Italy; [Millioni, Renato] Univ Padua, Dept Med, Padua, PD, Italy; [Millioni, Renato; Arrigoni, Giorgio] Univ Padua, Prote Ctr, Padua, PD, Italy; [Arrigoni, Giorgio] Univ Padua, Dept Biomed Sci, Padua, PD, Italy; [Caroccia, Brasilina] Univ Padua, Dept Med, Internal Med 4, Padua, PD, Italy; [Iori, Elisabetta; Tessari, Paolo] Univ Padua, Dept Med, Div Metab, Padua, PD, Italy; [Ventura, Laura] Univ Padua, Dept Stat Sci, Padua, PD, Italy	University of Padua; University of Padua; University of Padua; University of Padua; University of Padua; University of Padua; University of Padua	Fassina, A (corresponding author), Univ Padua, Dept Med, Surg Pathol & Cytopathol Unit, Padua, PD, Italy.	ambrogio.fassina@unipd.it	Millioni, Renato/ABG-1799-2020; Arrigoni, Giorgio/A-3535-2014; Cappellesso, Rocco/L-5463-2016	Arrigoni, Giorgio/0000-0002-4103-2733; Cappellesso, Rocco/0000-0002-0480-3412; Tessari, Paolo/0000-0002-4570-9238; Caroccia, Brasilina/0000-0002-3775-0011	University of Padua (Progetti di Ricerca di Ateneo) [CPDA103851/10]	University of Padua (Progetti di Ricerca di Ateneo)	University of Padua provided financial support) for reagents and consumables for this study (Progetti di Ricerca di Ateneo, grant No. CPDA103851/10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albig Allan R., 2007, Angiogenesis, V10, P197, DOI 10.1007/s10456-007-9075-z; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Brezillon S, 2013, FEBS J, V280, P2369, DOI 10.1111/febs.12210; Cappellesso R, 2014, CANCER CYTOPATHOL, V122, P685, DOI 10.1002/cncy.21442; Dolhnikoff M, 1998, AM J RESP CELL MOL, V19, P582, DOI 10.1165/ajrcmb.19.4.2979; Donnem TP, 2015, CLIN CANC R IN PRESS; Gauci S, 2008, PROTEOMICS, V8, P4898, DOI 10.1002/pmic.200800295; Iori E, 2008, BBA-MOL BASIS DIS, V1782, P627, DOI 10.1016/j.bbadis.2008.08.012; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; LIGHT RW, 1972, ANN INTERN MED, V77, P507, DOI 10.7326/0003-4819-77-4-507; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Marioni G, 2013, OTOL NEUROTOL, V34, P1476, DOI 10.1097/MAO.0b013e3182a036c9; Matsuda Y, 2008, INT J ONCOL, V33, P1177, DOI 10.3892/ijo_00000107; McEwan PA, 2006, J STRUCT BIOL, V155, P294, DOI 10.1016/j.jsb.2006.01.016; Menegazzo L, 2013, FASEB J, V27, P4355, DOI 10.1096/fj.12-223719; Millioni R, 2012, AMINO ACIDS, V43, P2199, DOI 10.1007/s00726-012-1267-1; Millioni R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019603; Morgensztern D, 2012, J THORAC ONCOL, V7, P1485, DOI 10.1097/JTO.0b013e318267223a; Nikitovic D, 2014, MATRIX BIOL, V35, P206, DOI 10.1016/j.matbio.2013.09.003; Pastor MD, 2013, CLIN TRANSL ONCOL, V15, P671, DOI 10.1007/s12094-013-1034-0; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Rifai N, 2006, NAT BIOTECHNOL, V24, P971, DOI 10.1038/nbt1235; Rosato A, 2013, LUNG CANCER, V79, P180, DOI 10.1016/j.lungcan.2012.11.004; Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Stamov DR, 2013, J STRUCT BIOL, V183, P394, DOI 10.1016/j.jsb.2013.05.022; Travis W, 2004, WHO CLASSIFICATION T; Vij N, 2005, INVEST OPHTH VIS SCI, V46, P88, DOI 10.1167/iovs.04-0833; Vuillermoz B, 2004, EXP CELL RES, V296, P294, DOI 10.1016/j.yexcr.2004.02.005; Weston AD, 2004, J PROTEOME RES, V3, P179, DOI 10.1021/pr0499693	30	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126458	10.1371/journal.pone.0126458	http://dx.doi.org/10.1371/journal.pone.0126458			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961303	Green Published, gold, Green Submitted			2022-12-26	WOS:000354542500101
J	MacGlashan, D				MacGlashan, Donald, Jr.			Expression Profiling of Human Basophils: Modulation by Cytokines and Secretagogues	PLOS ONE			English	Article							FC-EPSILON-RI; HIGH SPONTANEOUS RELEASE; HISTAMINE-RELEASE; IL-3; IGE; LEUKOCYTES; ACTIVATION; GROWTH; CELL; PHOSPHORYLATION	Human basophils are an accessible participant of the human allergic reaction. There is natural variation in various functional endpoints and in signaling molecule expression but there has been only a limited effort to place this information in the context of mRNA expression profiles. This study examined the hypothesis that unique mRNA signatures could be identified during the response of human basophils to several known forms of stimulation. Highly purified human basophils were cultured in vitro and exposed to IL-3, IL-5, NGF, IL-33, IL-2, anti-IgE Ab, or FMLP and the mRNA profiles examined by microarrays. The response to IL-3 and anti-IgE Ab were examined on 2-3 time frames and the response to IL-3 examined at several concentrations. In addition, the mRNA signatures of 3 different potential phenotypes were examined. These included basophils with the so-called non-releaser phenotype, and basophils from atopic and non-atopic subjects. Given the role of IL-3 in basophil maturation and the known profound effects on mature basophil function, it was not surprising that IL-3 showed the greatest influence on the basophil transcriptome. However, it also became apparent that the act of isolating and culturing basophils was sufficient to induce a large number of changes in the transcriptome, despite high viability and recovery. These "culture-effect" changes dominated the changes in mRNA profiles induced by other stimuli. Unique signatures for anti-IgE antibody and IL-33 could be identified although the number of gene transcripts (6-30) that were unique to these two stimuli was very limited. There were no apparent unique profiles for IL-5, NGF, IL-2 or FMLP. Therefore, a potential tool for screening basophil phenotypes was limited to changes that could be induced by IL-3 (or no IL-3), IL-33 and anti-IgE Ab.	Johns Hopkins Asthma & Allergy Ctr, Baltimore, MD 21224 USA	Johns Hopkins University; Johns Hopkins Medicine	MacGlashan, D (corresponding author), Johns Hopkins Asthma & Allergy Ctr, Baltimore, MD 21224 USA.	dmacglas@jhmi.edu			National Institutes of Health [AI099036]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI099036, U01AI100952, R56AI100952] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by National Institutes of Health grant number AI099036. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker R, 2008, ANN ALLERG ASTHMA IM, V100, P244, DOI 10.1016/S1081-1206(10)60449-8; Burgi B, 1996, J IMMUNOL, V157, P5582; Causton H. C., 2003, MICROARRAY GENE EXPR; DENBURG JA, 1989, CLIN EXP ALLERGY, V19, P249, DOI 10.1111/j.1365-2222.1989.tb02379.x; Didichenko SA, 2008, BLOOD, V112, P3949, DOI 10.1182/blood-2008-04-149419; FINDLAY SR, 1980, AM REV RESPIR DIS, V122, P53; GILBERT HS, 1975, BLOOD, V46, P279; Ishmael S, 2009, J LEUKOCYTE BIOL, V86, P313, DOI 10.1189/jlb.1208724; Ishmael SS, 2010, J LEUKOCYTE BIOL, V87, P291, DOI 10.1189/jlb.0509336; Kepley CL, 1998, J LEUKOCYTE BIOL, V64, P474, DOI 10.1002/jlb.64.4.474; KERN F, 1976, J CLIN INVEST, V57, P1369, DOI 10.1172/JCI108405; Kim S, 2010, J IMMUNOL, V184, P1143, DOI 10.4049/jimmunol.0902447; KNOL EF, 1991, EUR J IMMUNOL, V21, P881, DOI 10.1002/eji.1830210404; KURIMOTO Y, 1991, EUR J IMMUNOL, V21, P361, DOI 10.1002/eji.1830210217; KURIMOTO Y, 1989, J EXP MED, V170, P467, DOI 10.1084/jem.170.2.467; Lavens-Phillips SE, 2000, AM J RESP CELL MOL, V23, P566, DOI 10.1165/ajrcmb.23.4.4123; Laviolette M, 2013, J ALLERGY CLIN IMMUN, V132, P1086, DOI 10.1016/j.jaci.2013.05.020; LICHTENSTEIN LM, 1986, J ALLERGY CLIN IMMUN, V77, P291, DOI 10.1016/S0091-6749(86)80106-3; Luquin E, 2005, CLIN EXP ALLERGY, V35, P456, DOI 10.1111/j.1365-2222.2005.02212.x; MacGlashan D, 2014, CLIN EXP ALLERGY, V44, P713, DOI 10.1111/cea.12155; MacGlashan D, 2006, J IMMUNOL, V177, P1040, DOI 10.4049/jimmunol.177.2.1040; MacGlashan D, 2012, J IMMUNOL METHODS, V385, P51, DOI 10.1016/j.jim.2012.08.006; MacGlashan DW, 2007, J LEUKOCYTE BIOL, V82, P1003, DOI 10.1189/jlb.0207103; MacGlashan DW, 2007, J ALLERGY CLIN IMMUN, V119, P626, DOI 10.1016/j.jaci.2006.09.040; MASSEY W, 1993, J IMMUNOL, V150, P1084; MAY CD, 1982, CLIN ALLERGY, V12, P229, DOI 10.1111/j.1365-2222.1982.tb02523.x; MAY CD, 1976, J ALLERGY CLIN IMMUN, V58, P432, DOI 10.1016/0091-6749(76)90124-X; Miura K, 2000, J IMMUNOL, V164, P3026, DOI 10.4049/jimmunol.164.6.3026; Miura K, 1998, J ALLERGY CLIN IMMUN, V102, P512, DOI 10.1016/S0091-6749(98)70142-3; Miura K, 2001, J IMMUNOL, V167, P2282, DOI 10.4049/jimmunol.167.4.2282; NGUYEN KL, 1990, J ALLERGY CLIN IMMUN, V85, P1020, DOI 10.1016/0091-6749(90)90046-7; Pecaric-Petkovic T, 2009, BLOOD, V113, P1526, DOI 10.1182/blood-2008-05-157818; PETERS SP, 1985, INT ARCH ALLER A IMM, V76, P344, DOI 10.1159/000233719; Plaut M, 1986, J ALLERGY CLIN IMMUN; Saini SS, 2000, J ALLERGY CLIN IMMUN, V106, P514, DOI 10.1067/mai.2000.108431; Schroeder JT, 2009, J IMMUNOL, V182, P2432, DOI 10.4049/jimmunol.0801782; Shen T, 2008, INT IMMUNOL, V20, P1201, DOI 10.1093/intimm/dxn077; TUNG R, 1982, J IMMUNOL, V128, P2067; Vasagar K, 2006, CLIN EXP ALLERGY, V36, P770, DOI 10.1111/j.1365-2222.2006.02494.x; Vilarino N, 2005, J IMMUNOL, V175, P3006, DOI 10.4049/jimmunol.175.5.3006; Vonakis BM, 2007, J ALLERGY CLIN IMMUN, V119, P441, DOI 10.1016/j.jaci.2006.09.035; Vonakis BM, 2005, CURR ALLERGY ASTHM R, V5, P270, DOI 10.1007/s11882-005-0066-0; Yamaguchi M, 1996, J ALLERGY CLIN IMMUN, V97, P1279, DOI 10.1016/S0091-6749(96)70196-3; YAMAGUCHI M, 1992, INT ARCH ALLERGY IMM, V97, P322, DOI 10.1159/000236140; Youssef LA, 2007, J IMMUNOL, V178, P4584, DOI 10.4049/jimmunol.178.7.4584; Zaidi AK, 2011, INT ARCH ALLERGY IMM, V154, P15, DOI 10.1159/000319204; Zaidi AK, 2010, J ALLERGY CLIN IMMUN, V125, P902, DOI 10.1016/j.jaci.2009.12.996; Zaidi AK, 2010, J IMMUNOL, V184, P1463, DOI 10.4049/jimmunol.0901865	48	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126435	10.1371/journal.pone.0126435	http://dx.doi.org/10.1371/journal.pone.0126435			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962139	Green Published, gold, Green Submitted			2022-12-26	WOS:000354542500099
J	Pinto, SWL; Mastroianni-Kirsztajn, G; Sesso, R				Pinto, Sergio Wyton L.; Mastroianni-Kirsztajn, Gianna; Sesso, Ricardo			Ten-Year Follow-up of Patients with Epidemic Post Infectious Glomerulonephritis	PLOS ONE			English	Article							ACUTE POSTSTREPTOCOCCAL GLOMERULONEPHRITIS; LONG-TERM PROGNOSIS; STREPTOCOCCUS-ZOOEPIDEMICUS; NOVA-SERRANA; CHILDREN; DISEASE; AUSTRALIA; BRAZIL	Background Scarce information on outcomes of epidemic post infectious glomerulonephritis is available. This is a 10-year follow-up of the patients that developed acute glomerulonephritis in an epidemic outbreak caused by group C Streptococcus zooepidemicus in Brazil in 1998, that were also previously evaluated 2 and 5 years after the acute episode. Methods In this prospective study 60 cases (out of 134 in 1998) were reevaluated after 10 years, as well as community controls matched by gender and age. They underwent clinical and renal function evaluation, including serum creatinine and cystatin C, estimated glomerular filtration rate (eGFR), albuminuria and hematuria. Results Comparisons of clinical and renal function aspects of 60 patients and 48 community controls have not shown significant differences (eGFR <60 ml/min/1.73m(2) and/or albuminuria >30mg/g creatinine: 13.8% vs. 12.2%, respectively, p = 0.817) except for a higher frequency of hypertension in the cases (45.0% vs. 20.8%, p = 0.009). Comparing the same patients affected in the acute episode, 2, 5 and 10 years later, it was observed an improvement of median eGFR levels at 2 years and a trend toward subsequent stabilization in these levels, associated with decrease in albuminuria and increased hypertension rates in the last survey. At 10 years it was not observed additional reduction of renal function using serum creatinine, eGFR and cystatin C. Conclusions During the acute episode of epidemic GN a considerable proportion of patients presented hypertension and reduced renal function; after 2 years and particularly at this 10-year follow-up survey there was no worsening of renal function parameters, except for persistent higher frequency of hypertension. Nevertheless, a longer follow up is necessary to confirm that progressive loss of renal function will not occur.	[Pinto, Sergio Wyton L.] Hosp Sao Joao Deus, Div Nephrol, Divinopolis, MG, Brazil; [Mastroianni-Kirsztajn, Gianna; Sesso, Ricardo] Univ Fed Sao Paulo, Div Nephrol, Sao Paulo, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP)	Mastroianni-Kirsztajn, G (corresponding author), Univ Fed Sao Paulo, Div Nephrol, Sao Paulo, SP, Brazil.	gm.kirsztajn@unifesp.br	Mastroianni Kirsztajn, Gianna/D-9596-2013	Mastroianni Kirsztajn, Gianna/0000-0003-1317-4109; Sesso, Ricardo/0000-0002-1062-0073	Brazilian Research Council (CNPq)	Brazilian Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Dr. R. Sesso and Dr. G. Mastroianni Kirsztajn receive research grants from the Brazilian Research Council (CNPq).	BALDWIN DS, 1974, ANN INTERN MED, V80, P342, DOI 10.7326/0003-4819-80-3-342; Balter S, 2000, LANCET, V355, P1776, DOI 10.1016/S0140-6736(00)02265-0; Barham M, 1983, LANCET, V1, P945; DODGE WF, 1972, NEW ENGL J MED, V286, P273, DOI 10.1056/NEJM197202102860601; DUCA E, 1969, J HYG-CAMB, V67, P691, DOI 10.1017/S0022172400042145; EDWARDS AT, 1988, EPIDEMIOL INFECT, V101, P43, DOI 10.1017/S0950268800029204; FRANCIS AJ, 1993, J INFECTION, V27, P317, DOI 10.1016/0163-4453(93)92358-4; GARCIA R, 1981, CLIN NEPHROL, V15, P291; Hoy WE, 2012, KIDNEY INT, V81, P1026, DOI 10.1038/ki.2011.478; Kanjanabuch T, 2009, NAT REV NEPHROL, V5, P259, DOI 10.1038/nrneph.2009.44; Lopes MB, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-265; Marshall CS, 2011, AM J TROP MED HYG, V85, P703, DOI 10.4269/ajtmh.2011.11-0185; Perlman LV, 1965, JAMA-J AM MED ASSOC, V194, P175; Pinto SWL, 2001, AM J KIDNEY DIS, V38, P249, DOI 10.1053/ajkd.2001.26083; POTTER EV, 1982, NEW ENGL J MED, V307, P725, DOI 10.1056/NEJM198209163071205; Rodriguez-Iturbe B, 1976, Clin Nephrol, V5, P197; RODRIGUEZITURBE B, 1984, KIDNEY INT, V25, P129, DOI 10.1038/ki.1984.19; SCHACHT RG, 1976, NEW ENGL J MED, V295, P977, DOI 10.1056/NEJM197610282951803; Sesso R, 2005, NEPHROL DIAL TRANSPL, V20, P1808, DOI 10.1093/ndt/gfh904; Sesso R, 2005, KIDNEY INT, V68, pS132, DOI 10.1111/j.1523-1755.2005.09722.x; Stratta P, 2014, J NEPHROL, V27, P229, DOI 10.1007/s40620-013-0018-z; VOGL W, 1986, NEPHRON, V44, P58, DOI 10.1159/000183913; Wong W, 2013, J PAEDIATR CHILD H, V49, P850, DOI 10.1111/jpc.12295; WOOLCOCK JB, 1975, RES VET SCI, V18, P113, DOI 10.1016/S0034-5288(18)33642-7	24	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0125313	10.1371/journal.pone.0125313	http://dx.doi.org/10.1371/journal.pone.0125313			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962068	Green Published, Green Submitted, gold			2022-12-26	WOS:000354542500028
J	Braga, RM; Roze, E; Ball, G; Merchant, N; Tusor, N; Arichi, T; Edwards, D; Rueckert, D; Counsell, SJ				Braga, Rodrigo M.; Roze, Elise; Ball, Gareth; Merchant, Nazakat; Tusor, Nora; Arichi, Tomoki; Edwards, David; Rueckert, Daniel; Counsell, Serena J.			Development of the Corticospinal and Callosal Tracts from Extremely Premature Birth up to 2 Years of Age	PLOS ONE			English	Article							WHITE-MATTER ABNORMALITIES; PRETERM INFANTS; SPATIAL STATISTICS; MICROSTRUCTURAL DEVELOPMENT; FIBER TRACTOGRAPHY; CORPUS-CALLOSUM; DIFFUSION; BRAIN; INJURY; QUANTITATION	White matter tracts mature asymmetrically during development, and this development can be studied using diffusion magnetic resonance imaging. The aims of this study were i. to generate dynamic population-averaged white matter registration templates covering in detail the period from 25 weeks gestational age to term, and extending to 2 years of age based on DTI and fractional anisotropy, ii. to produce tract-specific probability maps of the corticospinal tracts, forceps major and forceps minor using probabilistic tractography, and iii. to assess the development of these tracts throughout this critical period of neurodevelopment. We found evidence for asymmetric development across the fiber bundles studied, with the corticospinal tracts showing earlier maturation (as measured by fractional anisotropy) but slower volumetric growth compared to the callosal fibers. We also found evidence for an anterior to posterior gradient in white matter microstructure development (as measured by mean diffusivity) in the callosal fibers, with the posterior forceps major developing at a faster rate than the anterior forceps minor in this age range. Finally, we report a protocol for delineating callosal and corticospinal fibers in extremely premature cohorts, and make available population-averaged registration templates and a probabilistic tract atlas which we hope will be useful for future neonatal and infant white-matter imaging studies.	Univ London Imperial Coll Sci Technol & Med, Div Brain Sci, Computat Cognit & Clin Neuroimaging Lab, London, England; Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Braga, Rodrigo M.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Dept Radiol, Charlestown, MA USA; [Braga, Rodrigo M.] Harvard Univ, Sch Med, Charlestown, MA USA; [Roze, Elise] Univ Utrecht, Wilhelmina Childrens Hosp, Univ Med Ctr Utrecht, NL-3508 TC Utrecht, Netherlands; [Ball, Gareth; Merchant, Nazakat; Tusor, Nora; Arichi, Tomoki; Edwards, David; Counsell, Serena J.] Kings Coll London, Ctr Developing Brain, Div Imaging Sci & Biomed Engn, London SE1 7EH, England; [Rueckert, Daniel] Univ London Imperial Coll Sci Technol & Med, Dept Comp, London, England	Imperial College London; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; University of London; King's College London; Imperial College London	Counsell, SJ (corresponding author), Kings Coll London, Ctr Developing Brain, Div Imaging Sci & Biomed Engn, London SE1 7EH, England.	serena.counsell@kcl.ac.uk	Merchant, Nazakat/AAT-4322-2020; Arichi, Tomoki/AFR-9798-2022	Arichi, Tomoki/0000-0002-3550-1644; Merchant, Nazakat/0000-0001-7520-3169; Tusor, Nora/0000-0002-3664-7397; Counsell, Serena/0000-0002-8033-5673; Braga, Rodrigo M./0000-0003-2671-7096; Edwards, Anthony David/0000-0003-4801-7066; Ball, Gareth/0000-0003-3509-1435	National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London; Imperial College London; EPSRC; Garfield Weston Foundation; MRC; Medical Research Council [MR/L011530/1] Funding Source: researchfish; National Institute for Health Research [CL-2012-17-006] Funding Source: researchfish; MRC [MR/K006355/1, MR/L011530/1] Funding Source: UKRI	National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London; Imperial College London(General Electric); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Garfield Weston Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by the National Institute for Health Research (NIHR) Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, and at Imperial College London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health. Funding for the research was supplied by MRC, EPSRC, and the Garfield Weston Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MC, 2008, CURR OPIN NEUROL, V21, P123, DOI 10.1097/WCO.0b013e3282f88bb4; Anjari M, 2007, NEUROIMAGE, V35, P1021, DOI 10.1016/j.neuroimage.2007.01.035; Arzoumanian Y, 2003, AM J NEURORADIOL, V24, P1646; Ball G, 2010, NEUROIMAGE, V53, P94, DOI 10.1016/j.neuroimage.2010.05.055; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Bayley N., 1936, CALIFORNIA INFANT SC; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Berman JI, 2005, NEUROIMAGE, V27, P862, DOI 10.1016/j.neuroimage.2005.05.018; Costeloe KL, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7976; DOBBING J, 1973, ARCH DIS CHILD, V48, P757, DOI 10.1136/adc.48.10.757; Dudink J, 2008, EARLY HUM DEV, V84, P777, DOI 10.1016/j.earlhumdev.2008.09.004; Gilles FH, 1983, DEV HUMAN BRAIN GROW; Gilmore JH, 2007, J NEUROSCI, V27, P1255, DOI 10.1523/JNEUROSCI.3339-06.2007; GRIFFITHS R, 1954, ABILITIES BABIES; Hasegawa T, 2011, PEDIATR RES, V69, P249, DOI 10.1203/PDR.0b013e3182084e54; Hermoye L, 2006, NEUROIMAGE, V29, P493, DOI 10.1016/j.neuroimage.2005.08.017; Huppi PS, 1998, PEDIATR RES, V44, P584; Iams JD, 2008, LANCET, V371, P164, DOI 10.1016/S0140-6736(08)60108-7; Johansen-Berg H, 2009, ANNU REV NEUROSCI, V32, P75, DOI 10.1146/annurev.neuro.051508.135735; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lee JD, 2011, BRAIN, V134, P1199, DOI 10.1093/brain/awr021; Martin JA, 2005, PEDIATRICS, V115, P619, DOI 10.1542/peds.2004-2695; Mathur A, 2009, J COMMUN DISORD, V42, P248, DOI 10.1016/j.jcomdis.2009.03.007; McGraw P, 2002, AM J ROENTGENOL, V179, P1515, DOI 10.2214/ajr.179.6.1791515; Miller SP, 2003, AM J NEURORADIOL, V24, P1661; Mukherjee P, 2008, AM J NEURORADIOL, V29, P632, DOI 10.3174/ajnr.A1051; Murakami A, 2008, PEDIATRICS, V122, P500, DOI 10.1542/peds.2007-2816; Nagy Z, 2003, PEDIATR RES, V54, P672, DOI 10.1203/01.PDR.0000084083.71422.16; Nagy Z, 2009, PEDIATRICS, V124, pE964, DOI 10.1542/peds.2008-3801; Neil JJ, 1998, RADIOLOGY, V209, P57, DOI 10.1148/radiology.209.1.9769812; Oishi K, 2013, INT J DEV NEUROSCI, V31, P512, DOI 10.1016/j.ijdevneu.2013.06.004; Oishi K, 2011, NEUROIMAGE, V56, P8, DOI 10.1016/j.neuroimage.2011.01.051; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Partridge SC, 2004, NEUROIMAGE, V22, P1302, DOI 10.1016/j.neuroimage.2004.02.038; Partridge SC, 2005, J MAGN RESON IMAGING, V22, P467, DOI 10.1002/jmri.20410; Rose J, 2014, NEUROIMAGE, V86, P244, DOI 10.1016/j.neuroimage.2013.09.053; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Schneider JFL, 2004, NEURORADIOLOGY, V46, P258, DOI 10.1007/s00234-003-1154-2; Skranes J, 2009, NEUROREPORT, V20, P263, DOI 10.1097/WNR.0b013e32832027fe; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Snook L, 2005, NEUROIMAGE, V26, P1164, DOI 10.1016/j.neuroimage.2005.03.016; Tanner SF, 2000, AM J ROENTGENOL, V174, P1643, DOI 10.2214/ajr.174.6.1741643; Thompson DK, 2012, NEUROIMAGE, V59, P3571, DOI 10.1016/j.neuroimage.2011.11.057; Tzarouchi LC, 2009, NEUROIMAGE, V47, P1148, DOI 10.1016/j.neuroimage.2009.03.072; Verhoeven JS, 2010, HUM BRAIN MAPP, V31, P470, DOI 10.1002/hbm.20880; Volpe J.J., 2008, NEUROLOGY NEWBORN; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049	50	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0125681	10.1371/journal.pone.0125681	http://dx.doi.org/10.1371/journal.pone.0125681			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955638	Green Published, gold			2022-12-26	WOS:000356768100065
J	Hu, CJ; Huang, W; Chen, H; Song, G; Li, P; Shan, Q; Zhang, X; Zhang, FC; Zhu, H; Wu, L; Li, YZ				Hu, Chaojun; Huang, Wei; Chen, Hua; Song, Guang; Li, Ping; Shan, Qiang; Zhang, Xuan; Zhang, Fengchun; Zhu, Heng; Wu, Lin; Li, Yongzhe			Autoantibody Profiling on Human Proteome Microarray for Biomarker Discovery in Cerebrospinal Fluid and Sera of Neuropsychiatric Lupus	PLOS ONE			English	Article							ANTICARDIOLIPIN ANTIBODIES; GLUTAMATE-RECEPTOR; ERYTHEMATOSUS; IMMUNOGLOBULINS; DIAGNOSIS; TARGET; DAMAGE	Autoantibodies in cerebrospinal fluid (CSF) from patients with neuropsychiatric systemic lupus erythematosus (NPSLE) may be potential biomarkers for prediction, diagnosis, or prognosis of NPSLE. We used a human proteome microarray with similar to 17,000 unique full-length human proteins to investigate autoantibodies associated with NPSLE. Twenty-nine CSF specimens from 12 NPSLE, 7 non-NPSLE, and 10 control (non-systemic lupus erythematosus) patients were screened for NPSLE-associated autoantibodies with proteome microarrays. A focused autoantigen microarray of candidate NPSLE autoantigens was applied to profile a larger cohort of CSF with patient-matched sera. We identified 137 autoantigens associated with NPSLE. Ingenuity Pathway Analysis revealed that these autoantigens were enriched for functions involved in neurological diseases (score = 43). Anti-proliferating cell nuclear antigen (PCNA) was found in the CSF of NPSLE and non-NPSLE patients. The positive rates of 4 autoantibodies in CSF specimens were significantly different between the SLE (i.e., NPSLE and non-NPSLE) and control groups: anti-ribosomal protein RPLP0, anti-RPLP1, anti-RPLP2, and anti-TROVE2 (also known as anti-Ro/SS-A). The positive rate for anti-SS-A associated with NPSLE was higher than that for non-NPSLE (31.11% cf. 10.71%; P = 0.045). Further analysis showed that anti-SS-A in CSF specimens was related to neuropsychiatric syndromes of the central nervous systemin SLE (P = 0.009). Analysis with Spearman's rank correlation coefficient indicated that the titers of anti-RPLP2 and anti-SS-A in paired CSF and serum specimens significantly correlated. Human proteome microarrays offer a powerful platform to discover novel autoantibodies in CSF samples. Anti-SS-A autoantibodies may be potential CSF markers for NPSLE.	[Hu, Chaojun; Chen, Hua; Li, Ping; Zhang, Xuan; Zhang, Fengchun; Li, Yongzhe] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol & Clin Immunol, Beijing 100730, Peoples R China; [Hu, Chaojun; Chen, Hua; Li, Ping; Zhang, Xuan; Zhang, Fengchun; Li, Yongzhe] Peking Union Med Coll, Key Lab Rheumatol & Clin Immunol, Minist Educ, Beijing 100021, Peoples R China; [Huang, Wei; Song, Guang; Shan, Qiang; Wu, Lin] Chinese Acad Sci, Beijing Inst Gen, Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Zhu, Heng] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Johns Hopkins University	Zhu, H (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	hzhu4@jhmi.edu; wul@big.ac.cn; yongzhelipumch@126.com	zhang, xu/GRX-9733-2022; zhang, xuan/GQO-8953-2022; zhang, xuan/AAN-9914-2020; Song, guang/I-6224-2019	zhang, xuan/0000-0001-8775-1699; zhang, xuan/0000-0001-8775-1699; Song, guang/0000-0002-7630-716X	National Science Technology Pillar Program [2014BAI07B00]; Research Special Fund for Public Welfare Industry of Health [201202004]; Chinese National High Technology Research and Development Program, Ministry of Science and Technology [2011AA02A113]; National Natural Science Foundation of China [81072486, 81373188, 81172857, 81302610, 81302590, 81172084]	National Science Technology Pillar Program; Research Special Fund for Public Welfare Industry of Health; Chinese National High Technology Research and Development Program, Ministry of Science and Technology(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by 2014BAI07B00 to Yongzhe Li, National Science Technology Pillar Program in the 12nd Five-year Plan, sponsoring materials; 201202004 to Fengchun Zhang, Research Special Fund for Public Welfare Industry of Health, sponsoring materials; 2011AA02A113 to Yongzhe Li, Chinese National High Technology Research and Development Program, Ministry of Science and Technology Grants, sponsoring materials; 81072486, 81373188, and 81172857 to Yongzhe Li, 81302610 to Chaojun Hu, 81302590 to Hua Chen, and 81172084 to Lin Wu, National Natural Science Foundation of China Grants, sponsoring data collection and analysis.	Bhattacharyya S, 2009, NEUROPSYCHOPHARMACOL, V34, P2489, DOI 10.1038/npp.2009.77; BLUESTEIN HG, 1981, AM J MED, V70, P240, DOI 10.1016/0002-9343(81)90756-7; BOULOUKOS A, 1980, CLIN CHEM, V26, P115; Briani C, 2009, J AUTOIMMUN, V32, P79, DOI 10.1016/j.jaut.2008.12.002; Butte AJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000497; Chiba Y, 2013, NEUROSCI LETT, V534, P217, DOI 10.1016/j.neulet.2012.10.060; Choi J, 2012, CURR OPIN IMMUNOL, V24, P651, DOI 10.1016/j.coi.2012.10.004; DeGiorgio LA, 2001, NAT MED, V7, P1189, DOI 10.1038/nm1101-1189; Fragoso-Loyo H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003347; Gonzalez-Quintela A, 2008, CLIN EXP IMMUNOL, V151, P42, DOI 10.1111/j.1365-2249.2007.03545.x; Hanly JG, 2014, NAT REV RHEUMATOL, V10, P338, DOI 10.1038/nrrheum.2014.15; Hirohata S, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2184; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hu CJ, 2012, MOL CELL PROTEOMICS, V11, P669, DOI 10.1074/mcp.M111.015529; Hu SH, 2013, ELIFE, V2, DOI 10.7554/eLife.00726; Huang W, 2012, BIOCHEM BIOPH RES CO, V418, P241, DOI 10.1016/j.bbrc.2012.01.001; Jeong JS, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.016253; Kiss E, 2007, CLIN REV ALLERG IMMU, V32, P37, DOI 10.1007/BF02686080; Lai NS, 2000, LUPUS, V9, P353, DOI 10.1191/096120300678828415; Li RF, 2011, CELL HOST MICROBE, V10, P390, DOI 10.1016/j.chom.2011.08.013; Liang MH, 1999, ARTHRITIS RHEUM-US, V42, P599; Lu JY, 2011, CELL, V146, P968, DOI 10.1016/j.cell.2011.07.044; Lu KY, 2012, MOL CELL PROTEOMICS, V11, P1177, DOI 10.1074/mcp.M112.017426; Lu XY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011124; Mahler M, 2012, AUTOIMMUN REV, V11, P771, DOI 10.1016/j.autrev.2012.02.012; Martinez-Cordero E, 1997, J INVEST ALLERG CLIN, V7, P596; Matus S, 2007, J EXP MED, V204, P3221, DOI 10.1084/jem.20071285; MEVORACH D, 1994, LUPUS, V3, P117, DOI 10.1177/096120339400300211; Newman RH, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.12; PEREIRA RMR, 1992, LUPUS, V1, P175; Querol L, 2013, NEUROLOGY, V81, P956, DOI 10.1212/WNL.0b013e3182a43b48; Quintana FJ, 2012, NEUROLOGY, V78, P532, DOI 10.1212/WNL.0b013e318247f9f3; Roche S, 2008, J IMMUNOL METHODS, V338, P75, DOI 10.1016/j.jim.2008.07.002; Sasajima T, 2006, J NEUROIMMUNOL, V181, P150, DOI 10.1016/j.jneuroim.2006.09.003; Song QF, 2010, J PROTEOME RES, V9, P30, DOI 10.1021/pr900131e; Tobon GJ, 2013, AUTOIMMUN DIS, V2013, DOI 10.1155/2013/827254; Trysberg E, 2003, ARTHRITIS RHEUM, V48, P2881, DOI 10.1002/art.11279; Zhang L, 2009, PROTEIN EXPRES PURIF, V64, P55, DOI 10.1016/j.pep.2008.10.007; Zhu H, 2003, CURR OPIN CHEM BIOL, V7, P55, DOI 10.1016/S1367-5931(02)00005-4	39	19	23	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0126643	10.1371/journal.pone.0126643	http://dx.doi.org/10.1371/journal.pone.0126643			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25954975	Green Submitted, gold, Green Published			2022-12-26	WOS:000356768100135
J	Lemkul, JA; Lewis, SN; Bassaganya-Riera, J; Bevan, DR				Lemkul, Justin A.; Lewis, Stephanie N.; Bassaganya-Riera, Josep; Bevan, David R.			Phosphorylation of PPAR gamma Affects the Collective Motions of the PPAR gamma-RXR alpha-DNA Complex	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; PARTICLE MESH EWALD; MOLECULAR SIMULATION; LIGAND-BINDING; PROTEIN STRUCTURES; PARTIAL AGONISTS; FORCE-FIELD; MECHANISM; DYNAMICS; MACROMOLECULES	Peroxisome-proliferator activated receptor-gamma (PPAR gamma) is a nuclear hormone receptor that forms a heterodimeric complex with retinoid X receptor-alpha (RXR alpha) to regulate transcription of genes involved in fatty acid storage and glucose metabolism. PPAR gamma is a target for pharmaceutical intervention in type 2 diabetes, and insight into interactions between PPAR gamma, RXR alpha, and DNA is of interest in understanding the function and regulation of this complex. Phosphorylation of PPAR gamma by cyclin-dependent kinase 5 (Cdk5) has been shown to dysregulate the expression of metabolic regulation genes, an effect that is counteracted by PPAR gamma ligands. We applied molecular dynamics (MD) simulations to study the relationship between the ligand-binding domains of PPAR gamma and RXR alpha with their respective DNA-binding domains. Our results reveal that phosphorylation alters collective motions within the PPAR gamma-RXR alpha complex that affect the LBD-LBD dimerization interface and the AF-2 coactivator binding region of PPAR gamma.	[Lemkul, Justin A.; Lewis, Stephanie N.; Bevan, David R.] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA; [Lewis, Stephanie N.; Bassaganya-Riera, Josep] Virginia Tech, Nutrit Immunol & Mol Med Lab, Virginia Bioinformat Inst, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Bevan, DR (corresponding author), Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA.	drbevan@vt.edu	Lemkul, Justin A./I-5346-2019	Lemkul, Justin A./0000-0001-6661-8653; Lewis, Stephanie/0000-0001-8724-2069; Bevan, David/0000-0001-9974-1105	Virginia Tech College of Agriculture and Life Sciences Biodesign and Bioprocessing Research Center; National Science Foundation [CNS-0960081]	Virginia Tech College of Agriculture and Life Sciences Biodesign and Bioprocessing Research Center; National Science Foundation(National Science Foundation (NSF))	The work was supported by the following: Virginia Tech College of Agriculture and Life Sciences Biodesign and Bioprocessing Research Center; and National Science Foundation Grant CNS-0960081. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; Bain DL, 2007, ANNU REV PHYSIOL, V69, P201, DOI 10.1146/annurev.physiol.69.031905.160308; Bernardes A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031852; Berrabah W, 2011, FEBS LETT, V585, P1640, DOI 10.1016/j.febslet.2011.03.066; Bruning JB, 2007, STRUCTURE, V15, P1258, DOI 10.1016/j.str.2007.07.014; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Chebaro Y, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003012; Choi JH, 2011, NATURE, V477, P477, DOI 10.1038/nature10383; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dudev T, 2002, J AM CHEM SOC, V124, P6759, DOI 10.1021/ja012620l; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Farce A, 2009, CURR MED CHEM, V16, P1768, DOI 10.2174/092986709788186165; Fidelak J, 2010, EUR BIOPHYS J BIOPHY, V39, P1503, DOI 10.1007/s00249-010-0608-9; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Gampe RT, 2000, GENE DEV, V14, P2229, DOI 10.1101/gad.802300; Gelman L, 2007, BBA-MOL CELL BIOL L, V1771, P1094, DOI 10.1016/j.bbalip.2007.03.004; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Hughes TS, 2012, STRUCTURE, V20, P139, DOI 10.1016/j.str.2011.10.018; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Li M, 2000, MOL CELL BIOL, V20, P4699, DOI 10.1128/MCB.20.13.4699-4707.2000; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lu IL, 2006, J MED CHEM, V49, P2703, DOI 10.1021/jm051129s; Malapaka RRV, 2012, J BIOL CHEM, V287, P183, DOI 10.1074/jbc.M111.294785; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Myers J, 2006, PROTEINS, V63, P928, DOI 10.1002/prot.20922; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Olefsky JM, 2000, J CLIN INVEST, V106, P467, DOI 10.1172/JCI10843; Osz J, 2012, PPAR RES, V2012, DOI 10.1155/2012/701412; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Phillips KJ, 2006, J AM CHEM SOC, V128, P11298, DOI 10.1021/ja0635985; Pochetti G, 2007, J BIOL CHEM, V282, P17314, DOI 10.1074/jbc.M702316200; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Rochel N, 2011, NAT STRUCT MOL BIOL, V18, P564, DOI 10.1038/nsmb.2054; Shao DL, 1998, NATURE, V396, P377, DOI 10.1038/24634; TONTONOZ P, 1995, MOL CELL BIOL, V15, P351, DOI 10.1128/MCB.15.1.351; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; VERLET L, 1967, PHYS REV, V159, P98, DOI 10.1103/PhysRev.159.98; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Zhang J, 2011, NAT STRUCT MOL BIOL, V18, P556, DOI 10.1038/nsmb.2046	47	12	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0123984	10.1371/journal.pone.0123984	http://dx.doi.org/10.1371/journal.pone.0123984			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25954810	gold, Green Published, Green Submitted			2022-12-26	WOS:000356768100024
J	Pahlman, S; Lund, LR; Jogi, A				Pahlman, Sven; Lund, Leif R.; Jogi, Annika			Differential HIF-1 alpha and HIF-2 alpha Expression in Mammary Epithelial Cells during Fat Pad Invasion, Lactation, and Involution	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1; GLAND DEVELOPMENT; MOUSE; NEUROBLASTOMA; PROMOTES; GROWTH; GENES; HIF-1; TRANSCRIPTION; MACROPHAGES	The development and functional cycle of the mammary gland involves a number of processes that are caricatured by breast cancer cells during invasion and metastasis. Expression of the hypoxia-inducible transcription factors HIF-1 and HIF-2 has been associated with metastatic, poor prognosis, and high-grade breast cancers. Since hypoxia affects normal epithelial differentiation, we hypothesise that HIFs are important for normal breast epithelial development and regeneration as well as cancer initiation and progression. Here, we investigated the expression of the oxygen-sensitive HIF-alpha subunits during mouse mammary gland development, lactation, and involution. In breast epithelial cells, HIF-1 alpha was expressed during early development, prior to cell polarisation. In contrast, expression of HIF-2 alpha occurred later and was restricted to a subpopulation of luminal epithelial cells in the lactating gland. Mammary gland involution is a developmental stage that involves extensive tissue remodelling with cell death but survival of tissue stem/progenitor cells. At this stage, HIF-2 alpha, but little HIF-1 alpha, was expressed in CK14-positive epithelial cells. The temporal but differential expression of the HIF-alpha subunits during the mammary gland life cycle indicates that their expression is controlled by additional factors to hypoxia. Further functional studies of the roles of these proteins in the mammary gland and breast cancer are warranted.	[Pahlman, Sven; Jogi, Annika] Lund Univ, Dept Lab Med Lund, Canc Ctr Medicon Village, Translat Canc Res, Lund, Sweden; [Lund, Leif R.] Univ Copenhagen, Fac Hlth Sci, Dept Cellular & Mol Med, Copenhagen, Denmark	Lund University; University of Copenhagen	Jogi, A (corresponding author), Lund Univ, Dept Lab Med Lund, Canc Ctr Medicon Village, Translat Canc Res, Lund, Sweden.	annika.jogi@med.lu.se		Jogi, Annika/0000-0003-1697-8030	Swedish Research Council; Crafoord foundation; Swedish cancer research campaign; Hans von Kantzow's Research foundation; Percy Falk's foundation, c/o Tomas Kramar Solna, Stockholm, Sweden; Royal physiographic society Lund; Gunnar Nilsson's CS	Swedish Research Council(Swedish Research CouncilEuropean Commission); Crafoord foundation; Swedish cancer research campaign; Hans von Kantzow's Research foundation; Percy Falk's foundation, c/o Tomas Kramar Solna, Stockholm, Sweden; Royal physiographic society Lund; Gunnar Nilsson's CS	Funding: The Swedish Research Council http://www.vr.se, Crafoord foundation http://www.crafoord.se, Swedish cancer research campaign www.cancerfonden.se, Hans von Kantzow's Research foundation, Percy Falk's foundation, c/o Tomas Kramar 17173 Solna, Stockholm, Sweden, The Royal physiographic society Lund, www.fysiografen.se, Gunnar Nilsson's CS www.cancerstiftelsen.com. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bos R, 2001, JNCI-J NATL CANCER I, V93, P309, DOI 10.1093/jnci/93.4.309; Callihan EB, 2013, BREAST CANCER RES TR, V138, P549, DOI 10.1007/s10549-013-2437-x; Cardiff RD, 1999, J MAMMARY GLAND BIOL, V4, P105, DOI 10.1023/A:1018712905244; Gouon-Evans V, 2000, DEVELOPMENT, V127, P2269; Green KA, 2005, BIOESSAYS, V27, P894, DOI 10.1002/bies.20281; Helczynska K, 2003, CANCER RES, V63, P1441; Helczynska K, 2008, CANCER RES, V68, P9212, DOI 10.1158/0008-5472.CAN-08-1135; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Jiang BH, 1997, CANCER RES, V57, P5328; Jogi A, 2002, P NATL ACAD SCI USA, V99, P7021, DOI 10.1073/pnas.102660199; Liao D, 2007, CANCER RES, V67, P563, DOI 10.1158/0008-5472.CAN-06-2701; Lund LR, 1996, DEVELOPMENT, V122, P181; Nilsson H, 2005, EXP CELL RES, V303, P447, DOI 10.1016/j.yexcr.2004.10.003; O'Brien J, 2012, DEVELOPMENT, V139, P269, DOI 10.1242/dev.071696; Rehbinder C, 1996, LAB ANIM, V30, P193, DOI 10.1258/002367796780684881; Schwab LP, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3087; Seagroves TN, 2010, AM J PATHOL, V176, P2269, DOI 10.2353/ajpath.2010.090310; Seagroves TN, 2003, DEVELOPMENT, V130, P1713, DOI 10.1242/dev.00403; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; STRANGE R, 1992, DEVELOPMENT, V115, P49; Thomasset N, 1998, AM J PATHOL, V153, P457, DOI 10.1016/S0002-9440(10)65589-7; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; Uniacke J, 2012, NATURE, V486, P126, DOI 10.1038/nature11055; Vaapil M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046543; Watson CJ, 2008, DEVELOPMENT, V135, P995, DOI 10.1242/dev.005439; Watson Christine J., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000196; Watson CJ, 2011, INT J DEV BIOL, V55, P757, DOI 10.1387/ijdb.113414cw; Watson CJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1401; Williams KJ, 2002, ONCOGENE, V21, P282, DOI 10.1038/sj.onc.1205047; Zhong H, 2000, CANCER RES, V60, P1541	33	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0125771	10.1371/journal.pone.0125771	http://dx.doi.org/10.1371/journal.pone.0125771			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955753	Green Published, Green Submitted, gold			2022-12-26	WOS:000356768100077
J	Spatz, JM; Wein, MN; Gooi, JH; Qu, YL; Garr, JL; Liu, S; Barry, KJ; Uda, Y; Lai, F; Dedic, C; Balcells-Camps, M; Kronenberg, HM; Babij, P; Pajevic, PD				Spatz, Jordan M.; Wein, Marc N.; Gooi, Jonathan H.; Qu, Yili; Garr, Jenna L.; Liu, Shawn; Barry, Kevin J.; Uda, Yuhei; Lai, Forest; Dedic, Christopher; Balcells-Camps, Mercedes; Kronenberg, Henry M.; Babij, Philip; Pajevic, Paola Divieti			The Wnt Inhibitor Sclerostin Is Up-regulated by Mechanical Unloading in Osteocytes in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOST DOWN-REGULATION; SPINAL-CORD-INJURY; PARATHYROID-HORMONE; BONE-FORMATION; BED REST; TARGETED ABLATION; SERUM SCLEROSTIN; RANKL EXPRESSION; GENE-EXPRESSION; SPACE-FLIGHT	Although bone responds to its mechanical environment, the cellular and molecular mechanisms underlying the response of the skeleton to mechanical unloading are not completely understood. Osteocytes are the most abundant but least understood cells in bones and are thought to be responsible for sensing stresses and strains in bone. Sclerostin, a product of the SOST gene, is produced postnatally primarily by osteocytes and is a negative regulator of bone formation. Recent studies show that SOST is mechanically regulated at both the mRNA and protein levels. During prolonged bed rest and immobilization, circulating sclerostin increases both in humans and in animal models, and its increase is associated with a decrease in parathyroid hormone. To investigate whether SOST/sclerostin up-regulation in mechanical unloading is a cell-autonomous response or a hormonal response to decreased parathyroid hormone levels, we subjected osteocytes to an in vitro unloading environment achieved by the NASA rotating wall vessel system. To perform these studies, we generated a novel osteocytic cell line (Ocy454) that produces high levels of SOST/sclerostin at early time points and in the absence of differentiation factors. Importantly, these osteocytes recapitulated the in vivo response to mechanical unloading with increased expression of SOST (3.4 +/- 1.9-fold, p< 0.001), sclerostin (4.7 +/- 0.1-fold, p< 0.001), and the receptor activator of nuclear factor kappa B ligand (RANKL)/osteoprotegerin (OPG) (2.5 +/- 0.7-fold, p < 0.001) ratio. These data demonstrate for the first time a cell-autonomous increase in SOST/sclerostin and RANKL/OPG ratio in the setting of unloading. Thus, targeted osteocyte therapies could hold promise as novel osteoporosis and disuse-induced bone loss treatments by directly modulating the mechanosensing cells in bone.	[Spatz, Jordan M.; Wein, Marc N.; Qu, Yili; Garr, Jenna L.; Liu, Shawn; Barry, Kevin J.; Uda, Yuhei; Lai, Forest; Dedic, Christopher; Kronenberg, Henry M.; Pajevic, Paola Divieti] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Spatz, Jordan M.; Wein, Marc N.; Qu, Yili; Garr, Jenna L.; Liu, Shawn; Barry, Kevin J.; Uda, Yuhei; Lai, Forest; Dedic, Christopher; Kronenberg, Henry M.; Pajevic, Paola Divieti] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Spatz, Jordan M.; Balcells-Camps, Mercedes] MIT, Harvard MIT Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Balcells-Camps, Mercedes] Ramon Llull Univ, Inst Quim Sarria, Bioengn Dept, Barcelona 08017, Spain; [Gooi, Jonathan H.] Univ Melbourne, NorthWest Acad Ctr, St Albans, Vic 3065, Australia; [Babij, Philip] Amgen Inc, Thousand Oaks, CA 91320 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Universitat Ramon Llull; Institut Quimic de Sarria; University of Melbourne; Amgen	Pajevic, PD (corresponding author), Boston Univ, Goldman Sch Dent Med, Mol & Cell Biol, 700 Albany St, Boston, MA 02118 USA.	pdivieti@bu.edu	Uda, Yuhei/AAZ-4978-2021; Pajevic, Paola Divieti/M-3236-2019; Gooi, Jonathan/AAS-7982-2020; Gooi, Jonathan/M-2407-2016	Uda, Yuhei/0000-0003-4705-6215; Gooi, Jonathan/0000-0002-8839-1602; Divieti Pajevic, Paola/0000-0001-9853-9837; Aronson, Jenna/0000-0002-7376-8622; Spatz, Jordan/0000-0002-6732-7353	National Institutes of Health from the NIAMS [AR059655]; National Institutes of Health from NIDDK [DK011794, DK100215]; Northrop Grumman Aerospace Systems Ph.D. training fellowship; Massachusetts Institute of Technology Hugh Hampton Young fellowship; National Space Biomedical Research Institute through NASA [NCC 9-58]; United States Army Institute for Environmental Medicine Oak Ridge Science Institute for Science and Education fellowship program; Spain's Ministerio de Economia e Innovacion [SAF2013-43302-R]; Posimat; Fundacio Empreses Institut Quimic de Sarria; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060221, UH2AR059655, UH3AR059655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK011794, F32DK100215] Funding Source: NIH RePORTER	National Institutes of Health from the NIAMS; National Institutes of Health from NIDDK; Northrop Grumman Aerospace Systems Ph.D. training fellowship; Massachusetts Institute of Technology Hugh Hampton Young fellowship; National Space Biomedical Research Institute through NASA; United States Army Institute for Environmental Medicine Oak Ridge Science Institute for Science and Education fellowship program; Spain's Ministerio de Economia e Innovacion; Posimat; Fundacio Empreses Institut Quimic de Sarria; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants AR059655 from the NIAMS (to P. D. P.) and DK011794 (to H. M. K.) and DK100215 (to M. N. W.) from the NIDDK. P. Babij was employed by Amgen Inc. and received Amgen stock.; Supported by a Northrop Grumman Aerospace Systems Ph.D. training fellowship, a Massachusetts Institute of Technology Hugh Hampton Young fellowship, the National Space Biomedical Research Institute through NASA Grant NCC 9-58, and the United States Army Institute for Environmental Medicine Oak Ridge Science Institute for Science and Education fellowship program.; Supported by Spain's Ministerio de Economia e Innovacion (Grant SAF2013-43302-R), Posimat, and Fundacio Empreses Institut Quimic de Sarria.	Armamento-Villareal R, 2012, J BONE MINER RES, V27, P1215, DOI 10.1002/jbmr.1560; Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; Bellido T, 2005, ENDOCRINOLOGY, V146, P4577, DOI 10.1210/en.2005-0239; Bishop KA, 2011, J BIOL CHEM, V286, P20880, DOI 10.1074/jbc.M111.231548; Bonewald LF, 1999, J BONE MINER METAB, V17, P61, DOI 10.1007/s007740050066; Bonnet N, 2012, P NATL ACAD SCI USA, V109, P15048, DOI 10.1073/pnas.1203085109; Bonnet N, 2009, J BIOL CHEM, V284, P35939, DOI 10.1074/jbc.M109.060335; Boukhechba F, 2009, J BONE MINER RES, V24, P1927, DOI [10.1359/JBMR.090517, 10.1359/jbmr.090517]; Capulli M, 2009, J CELL BIOCHEM, V107, P240, DOI 10.1002/jcb.22120; Chen JH, 2010, J BIOMECH, V43, P108, DOI 10.1016/j.jbiomech.2009.09.016; Cherian PP, 2003, J BIOL CHEM, V278, P43146, DOI 10.1074/jbc.M302993200; Cohen-Kfir E, 2011, ENDOCRINOLOGY, V152, P4514, DOI 10.1210/en.2011-1128; Costa AG, 2011, J CLIN ENDOCR METAB, V96, P3804, DOI 10.1210/jc.2011-0566; Fulzele K, 2013, BLOOD, V121, P930, DOI 10.1182/blood-2012-06-437160; Galea GL, 2011, FEBS LETT, V585, P2450, DOI 10.1016/j.febslet.2011.06.019; Gaudio A, 2010, J CLIN ENDOCR METAB, V95, P2248, DOI 10.1210/jc.2010-0067; Genetos DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017772; Hammond TG, 2001, AM J PHYSIOL-RENAL, V281, pF12, DOI 10.1152/ajprenal.2001.281.1.F12; Holdsworth G, 2012, J BIOL CHEM, V287, P26464, DOI 10.1074/jbc.M112.350108; Honma M, 2015, J BONE MINER METAB, V33, P73, DOI 10.1007/s00774-013-0555-5; Hughes JM, 2010, J MUSCULOSKEL NEURON, V10, P128; Hughes-Fulford M, 2001, J Gravit Physiol, V8, pP1; Igwe JC, 2011, CONNECT TISSUE RES, V52, P401, DOI 10.3109/03008207.2010.546536; Inniss AM, 2009, AVIAT SPACE ENVIR MD, V80, pA9, DOI 10.3357/ASEM.BR04.2009; Ito Takayasu, 1996, Environmental Medicine (Nagoya), V40, P43; Jami A, 2013, MOL CELLS, V35, P305, DOI 10.1007/s10059-013-2310-0; Kalajzic I, 2004, BONE, V35, P74, DOI 10.1016/j.bone.2004.03.006; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kramer I, 2010, J BONE MINER RES, V25, P178, DOI 10.1359/jbmr.090730; LeBlanc A. D., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P33; Leupin O, 2007, J BONE MINER RES, V22, P1957, DOI 10.1359/JBMR.070804; Li J, 2012, J BIOMECH, V45, P247, DOI 10.1016/j.jbiomech.2011.10.037; Lin CW, 2009, J BONE MINER RES, V24, P1651, DOI [10.1359/JBMR.090411, 10.1359/jbmr.090411]; Loots GG, 2012, BONE, V50, P663, DOI 10.1016/j.bone.2011.11.016; Macias BR, 2013, BONE, V53, P515, DOI 10.1016/j.bone.2013.01.018; Massagli TL, 1999, ARCH PHYS MED REHAB, V80, P998, DOI 10.1016/S0003-9993(99)90050-3; Morse LR, 2012, J BONE MINER RES, V27, P352, DOI 10.1002/jbmr.546; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Nguyen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053813; O'Brien CA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002942; Paic F, 2009, BONE, V45, P682, DOI 10.1016/j.bone.2009.06.010; Papanicolaou SE, 2009, BIORHEOLOGY, V46, P389, DOI 10.3233/BIR-2009-0550; Paszty C, 2010, J BONE MINER RES, V25, P1897, DOI 10.1002/jbmr.161; Powell WF, 2011, J ENDOCRINOL, V209, P21, DOI 10.1530/JOE-10-0308; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Rodionova NV, 2002, ADV SPACE RES, V30, P765, DOI 10.1016/S0273-1177(02)00393-9; Santos A, 2009, J ORTHOP RES, V27, P1280, DOI 10.1002/jor.20888; Semenov M., 2005, J BIOL CHEM, V280, P26770; Sevetson B, 2004, J BIOL CHEM, V279, P13849, DOI 10.1074/jbc.M306249200; Sinha NN, 2011, PHYS WORLD, V24, P25; Smith SM, 2012, NUTRIENTS, V4, P2047, DOI 10.3390/nu4122047; Song KD, 2013, CELL STRESS CHAPERON, V18, P193, DOI 10.1007/s12192-012-0370-2; Spatz JM, 2012, J CLIN ENDOCR METAB, V97, pE1736, DOI 10.1210/jc.2012-1579; Spatz JM, 2013, J BONE MINER RES, V28, P865, DOI 10.1002/jbmr.1807; Spector ER, 2009, AVIAT SPACE ENVIR MD, V80, pA23, DOI 10.3357/ASEM.BR02.2009; Stein EM, 2013, J CLIN ENDOCR METAB, V98, P541, DOI 10.1210/jc.2012-2394; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Tu XL, 2012, BONE, V50, P209, DOI 10.1016/j.bone.2011.10.025; Vilarrasa N, 2011, OBES SURG, V21, P465, DOI 10.1007/s11695-010-0338-1; Wein Marc N, 2015, J Bone Miner Res, V30, P400, DOI 10.1002/jbmr.2381; Woo SM, 2011, J BONE MINER RES, V26, P2634, DOI 10.1002/jbmr.465; Wu JY, 2011, J CLIN INVEST, V121, P3492, DOI 10.1172/JCI46406; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yang F, 2010, BIOCHEM BIOPH RES CO, V400, P684, DOI 10.1016/j.bbrc.2010.08.128; Yu EW, 2011, J CLIN ENDOCR METAB, V96, P2011; Yu LC, 2011, BONE, V49, P1131, DOI 10.1016/j.bone.2011.08.016; Zhang KQ, 2006, MOL CELL BIOL, V26, P4539, DOI 10.1128/MCB.02120-05; Zhu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050099	68	172	180	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16744	16758		10.1074/jbc.M114.628313	http://dx.doi.org/10.1074/jbc.M114.628313			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25953900	Green Published, hybrid			2022-12-26	WOS:000357572800022
J	Holmes, K; Shepherd, DA; Ashcroft, AE; Whelan, M; Rowlands, DJ; Stonehouse, NJ				Holmes, Kris; Shepherd, Dale A.; Ashcroft, Alison E.; Whelan, Mike; Rowlands, David J.; Stonehouse, Nicola J.			Assembly Pathway of Hepatitis B Core Virus-like Particles from Genetically Fused Dimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hepatitis virus; mass spectrometry (MS); protein assembly; protein self-assembly; virus assembly; capsid; fused dimer; tandem core	SPECTROMETRY-MASS SPECTROMETRY; CAPSID PROTEIN; C-TERMINUS; RNA; STABILITY; INTERMEDIATE	Background: We studied assembly of HBV capsids using a genetically-fused dimer. Results: Assembly intermediates composed of two, three and five copies of a fused dimer have been isolated. Conclusion: Capsid assembly could progress using dimeric, trimeric, and pentameric intermediates. Significance: The low abundance and transient nature of assembly intermediates make analysis challenging, however, the stability of the intermediates described here has overcome this. Macromolecular complexes are responsible for many key biological processes. However, in most cases details of the assembly/disassembly of such complexes are unknown at the molecular level, as the low abundance and transient nature of assembly intermediates make analysis challenging. The assembly of virus capsids is an example of such a process. The hepatitis B virus capsid (core) can be composed of either 90 or 120 dimers of coat protein. Previous studies have proposed a trimer of dimers as an important intermediate species in assembly, acting to nucleate further assembly by dimer addition. Using novel genetically-fused coat protein dimers, we have been able to trap higher-order assembly intermediates and to demonstrate for the first time that both dimeric and trimeric complexes are on pathway to virus-like particle (capsid) formation.	[Holmes, Kris; Shepherd, Dale A.; Ashcroft, Alison E.; Rowlands, David J.; Stonehouse, Nicola J.] Univ Leeds, Sch Mol & Cellular Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England; [Holmes, Kris; Shepherd, Dale A.; Ashcroft, Alison E.; Rowlands, David J.; Stonehouse, Nicola J.] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; [Whelan, Mike] IQur Ltd, London Biosci Innovat Ctr, London NW1 0NH, England	University of Leeds; University of Leeds; University of London; University of London Royal Veterinary College	Stonehouse, NJ (corresponding author), Univ Leeds, Sch Mol & Cellular Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England.	n.j.stonehouse@leeds.ac.uk		Stonehouse, Nicola/0000-0003-1146-5519; Cooper-Shepherd, Dale/0000-0001-9301-1777	Biotechnology and Biological Sciences Research Council through its Research Equipment Initiative scheme [BB/E012558/1]	Biotechnology and Biological Sciences Research Council through its Research Equipment Initiative scheme(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank all members of the Ashcroft and Stonehouse groups (especially Sam Stephen and Joe Ward) for helpful discussions and colleagues at the University of Leeds for useful suggestions on the manuscript. The Synapt HDMS mass spectrometer was purchased with funds from the Biotechnology and Biological Sciences Research Council through its Research Equipment Initiative scheme (BB/E012558/1).	BIRNBAUM F, 1990, J VIROL, V64, P3319, DOI 10.1128/JVI.64.7.3319-3330.1990; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; Bourne CR, 2009, BIOCHEMISTRY-US, V48, P1736, DOI 10.1021/bi801814y; Ceres P, 2004, J VIROL, V78, P9538, DOI 10.1128/JVI.78.17.9538-9543.2004; Ceres P, 2002, BIOCHEMISTRY-US, V41, P11525, DOI 10.1021/bi0261645; Hernandez H, 2007, NAT PROTOC, V2, P715, DOI 10.1038/nprot.2007.73; Hilton GR, 2012, J R SOC INTERFACE, V9, P801, DOI 10.1098/rsif.2011.0823; Knapman TW, 2010, RAPID COMMUN MASS SP, V24, P3033, DOI 10.1002/rcm.4732; Packianathan C, 2010, J VIROL, V84, P1607, DOI 10.1128/JVI.02033-09; Peng T, 2012, BIOMACROMOLECULES, V13, P699, DOI 10.1021/bm201587q; Peyret H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120751; Pierson EE, 2014, J AM CHEM SOC, V136, P3536, DOI 10.1021/ja411460w; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; Selzer L, 2014, BIOCHEMISTRY-US, V53, P5496, DOI 10.1021/bi500732b; Shepherd DA, 2013, BIOPHYS J, V105, P1258, DOI 10.1016/j.bpj.2013.07.028; Singh S, 2003, J BIOL CHEM, V278, P18249, DOI 10.1074/jbc.M211408200; Stockley PG, 2007, J MOL BIOL, V369, P541, DOI 10.1016/j.jmb.2007.03.020; STONEHOUSE NJ, 1993, FEBS LETT, V334, P355, DOI 10.1016/0014-5793(93)80711-3; Stray SJ, 2004, BIOCHEMISTRY-US, V43, P9989, DOI 10.1021/bi049571k; SUMMERS J, 1982, CELL, V29, P403, DOI 10.1016/0092-8674(82)90157-X; Tsiang M, 2012, BIOCHEMISTRY-US, V51, P4416, DOI 10.1021/bi300052h; Uetrecht C, 2008, P NATL ACAD SCI USA, V105, P9216, DOI 10.1073/pnas.0800406105; Uetrecht C, 2011, NAT CHEM, V3, P126, DOI 10.1038/NCHEM.947; WINGFIELD PT, 1995, BIOCHEMISTRY-US, V34, P4919, DOI 10.1021/bi00015a003; Wynne SA, 1999, MOL CELL, V3, P771, DOI 10.1016/S1097-2765(01)80009-5; Zlotnick A, 1997, P NATL ACAD SCI USA, V94, P9556, DOI 10.1073/pnas.94.18.9556; Zlotnick A, 1999, BIOCHEMISTRY-US, V38, P14644, DOI 10.1021/bi991611a; Zlotnick A, 1996, BIOCHEMISTRY-US, V35, P7412, DOI 10.1021/bi9604800; Zlotnick A, 2007, NAT PROTOC, V2, P490, DOI 10.1038/nprot.2007.60	29	20	21	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16238	16245		10.1074/jbc.M114.622035	http://dx.doi.org/10.1074/jbc.M114.622035			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25953902	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000356930100027
J	Zhong, L; Chen, XF; Zhang, ZL; Wang, Z; Shi, XZ; Xu, K; Zhang, YW; Xu, HX; Bu, GJ				Zhong, Li; Chen, Xiao-Fen; Zhang, Zhen-Lian; Wang, Zhe; Shi, Xin-Zhen; Xu, Kai; Zhang, Yun-Wu; Xu, Huaxi; Bu, Guojun			DAP12 Stabilizes the C-terminal Fragment of the Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) and Protects against LPS-induced Pro-inflammatory Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; cytokine; inflammation; lipopolysaccharide (LPS); microglia; -secretase; DAP12; TREM-CTF; TREM2	AMYLOID PRECURSOR PROTEIN; GENOME-WIDE ASSOCIATION; CUTTING EDGE; AMPLIFIES INFLAMMATION; RISK-FACTOR; DISEASE; TRAFFICKING; VARIANTS; PHAGOCYTOSIS; ACTIVATION	Triggering receptor expressed on myeloid cells 2 (TREM2) is a DAP12-associated receptor expressed in microglia, macrophages, and other myeloid-derived cells. Previous studies have suggested that TREM2/DAP12 signaling pathway reduces inflammatory responses and promotes phagocytosis of apoptotic neurons. Recently, TREM2 has been identified as a risk gene for Alzheimer disease (AD). Here, we show that DAP12 stabilizes the C-terminal fragment of TREM2 (TREM2-CTF), a substrate for -secretase. Co-expression of DAP12 with TREM2 selectively increased the level of TREM2-CTF with little effects on that of full-length TREM2. The interaction between DAP12 and TREM2 is essential for TREM2-CTF stabilization as a mutant form of DAP12 with disrupted interaction with TREM2 failed to exhibit such an effect. Silencing of either Trem2 or Dap12 gene significantly exacerbated pro-inflammatory responses induced by lipopolysaccharides (LPS). Importantly, overexpression of either full-length TREM2 or TREM2-CTF reduced LPS-induced inflammatory responses. Taken together, our results support a role of DAP12 in stabilizing TREM2-CTF, thereby protecting against excessive pro-inflammatory responses.	[Zhong, Li; Chen, Xiao-Fen; Zhang, Zhen-Lian; Wang, Zhe; Shi, Xin-Zhen; Xu, Kai; Zhang, Yun-Wu; Xu, Huaxi; Bu, Guojun] Xiamen Univ, Coll Med, Inst Neurosci, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Xiamen 361102, Peoples R China; [Xu, Huaxi] Sanford Burnham Med Res Inst, Ctr Neurosci Aging & Stem Cell Res, Degenerat Dis Res Program, La Jolla, CA 92037 USA; [Bu, Guojun] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA	Xiamen University; Sanford Burnham Prebys Medical Discovery Institute; Mayo Clinic	Chen, XF (corresponding author), Xiamen Univ, Coll Med, Inst Neurosci, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Xiamen 361102, Peoples R China.	chenxf@xmu.edu.cn; bu.guojun@mayo.edu	Regan, Clinton/E-6250-2012; Xu, Huaxi/AAV-7177-2021	Zhong, Li/0000-0003-3815-6484; Zhang, Yun-wu/0000-0002-7152-7630	National Institutes of Health [R01AG027924, R01AG035355, R01AG046205]; National Natural Science Foundation of China [81370459, 31400914]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS074969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027924, P50AG016574, R01AG046205, P01AG030128, RF1AG046205, R01AG035355] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants R01AG027924, R01AG035355, R01AG046205 (to G. B.) and Grants (81370459, 31400914) from the National Natural Science Foundation of China (to X. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Benitez BA, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.12.018; Bertram L, 2008, AM J HUM GENET, V83, P623, DOI 10.1016/j.ajhg.2008.10.008; BOCCHINI V, 1992, J NEUROSCI RES, V31, P616, DOI 10.1002/jnr.490310405; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; BUXBAUM JD, 1990, P NATL ACAD SCI USA, V87, P6003, DOI 10.1073/pnas.87.15.6003; Cady J, 2014, JAMA NEUROL, V71, P449, DOI 10.1001/jamaneurol.2013.6237; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; Cuyvers E, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.09.009; Eikelenboom P, 2010, NEURODEGENER DIS, V7, P38, DOI 10.1159/000283480; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Hamerman JA, 2005, NAT IMMUNOL, V6, P579, DOI 10.1038/ni1204; Hamerman JA, 2006, J IMMUNOL, V177, P2051, DOI 10.4049/jimmunol.177.4.2051; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Hsieh CL, 2009, J NEUROCHEM, V109, P1144, DOI 10.1111/j.1471-4159.2009.06042.x; Ito H, 2012, EUR J IMMUNOL, V42, P176, DOI 10.1002/eji.201141679; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kleinberger G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009093; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Landel V, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-33; Lanier LL, 2009, IMMUNOL REV, V227, P150, DOI 10.1111/j.1600-065X.2008.00720.x; Lanier LL, 2000, IMMUNOL TODAY, V21, P611, DOI 10.1016/S0167-5699(00)01745-X; Lanier LL, 1998, NATURE, V391, P703, DOI 10.1038/35642; Lemere CA, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-36; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; Lucin KM, 2013, NEURON, V79, P873, DOI 10.1016/j.neuron.2013.06.046; Muller T, 2008, PROG NEUROBIOL, V85, P393, DOI 10.1016/j.pneurobio.2008.05.002; Nakayama K, 2011, CELL MOL NEUROBIOL, V31, P887, DOI 10.1007/s10571-011-9688-z; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Paloneva J, 2001, NEUROLOGY, V56, P1552, DOI 10.1212/WNL.56.11.1552; Pottier C, 2013, J ALZHEIMERS DIS, V35, P45, DOI 10.3233/JAD-122311; Prada I, 2006, NEUROSCIENCE, V140, P1139, DOI 10.1016/j.neuroscience.2006.03.058; Rayaprolu S, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-19; Schmid CD, 2002, J NEUROCHEM, V83, P1309, DOI 10.1046/j.1471-4159.2002.01243.x; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Sessa G, 2004, EUR J NEUROSCI, V20, P2617, DOI 10.1111/j.1460-9568.2004.03729.x; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Takahashi K, 2007, PLOS MED, V4, P675, DOI 10.1371/journal.pmed.0040124; Turnbull IR, 2005, J EXP MED, V202, P363, DOI 10.1084/jem.20050986; Turnbull IR, 2006, J IMMUNOL, V177, P3520, DOI 10.4049/jimmunol.177.6.3520; Wang H, 2004, J BIOL CHEM, V279, P40560, DOI 10.1074/jbc.M404345200; Wunderlich P, 2013, J BIOL CHEM, V288, P33027, DOI 10.1074/jbc.M113.517540; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zhang YW, 2007, P NATL ACAD SCI USA, V104, P10613, DOI 10.1073/pnas.0703903104	45	83	84	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15866	15877		10.1074/jbc.M115.645986	http://dx.doi.org/10.1074/jbc.M115.645986			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25957402	Green Published, hybrid			2022-12-26	WOS:000356527400045
J	de Boer, R; Smith, RL; De Vos, WH; Manders, EMM; Brul, S; van der Spek, H				de Boer, Richard; Smith, Ruben L.; De Vos, Winnok H.; Manders, Erik M. M.; Brul, Stanley; van der Spek, Hans			Caenorhabditis elegans as a Model System for Studying Drug Induced Mitochondrial Toxicity	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; ANTIVIRAL NUCLEOSIDE ANALOGS; ENERGY-METABOLISM; DNA; HIV; NEMATODE; THERAPY; GROWTH; DAMAGE	Today HIV-1 infection is recognized as a chronic disease with obligatory lifelong treatment to keep viral titers below detectable levels. The continuous intake of antiretroviral drugs however, leads to severe and even life-threatening side effects, supposedly by the deleterious impact of nucleoside-analogue type compounds on the functioning of the mitochondrial DNA polymerase. For detailed investigation of the yet partially understood underlying mechanisms, the availability of a versatile model system is crucial. We therefore set out to develop the use of Caenorhabditis elegansto study drug induced mitochondrial toxicity. Using a combination of molecular-biological and functional assays, combined with a quantitative analysis of mitochondrial network morphology, we conclude that anti-retroviral drugs with similar working mechanisms can be classified into distinct groups based on their effects on mitochondrial morphology and biochemistry. Additionally we show that mitochondrial toxicity of antiretroviral drugs cannot be exclusively attributed to interference with the mitochondrial DNA polymerase.	[de Boer, Richard; Smith, Ruben L.; Brul, Stanley; van der Spek, Hans] Univ Amsterdam, Fac Sci FNWI, SILS, Mol Biol & Microbial Food Safety, NL-1098 XH Amsterdam, Netherlands; [De Vos, Winnok H.] Univ Antwerp, Dept Vet Sci, Cell Biol & Histol Grp, B-2020 Antwerp, Belgium; [De Vos, Winnok H.] Univ Ghent, Dept Mol Biotechnol, Cell Syst & Imaging Res Grp, B-9000 Ghent, Belgium; [Manders, Erik M. M.] Univ Amsterdam, Fac Sci FNWI, SILS, Van Leeuwenhoek Ctr Adv Microscopy, NL-1098 XH Amsterdam, Netherlands	University of Amsterdam; Vrije Universiteit Amsterdam; University of Antwerp; Ghent University; University of Amsterdam; Vrije Universiteit Amsterdam	van der Spek, H (corresponding author), Univ Amsterdam, Fac Sci FNWI, SILS, Mol Biol & Microbial Food Safety, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands.	j.c.vanderspek@uva.nl	de vos, winnok/A-6445-2012	de vos, winnok/0000-0003-0960-6781; de Boer, Richard/0000-0003-2746-4596	Hercules Foundation [AUGE/013]; Belgian Research Fund [B/11599/17]	Hercules Foundation; Belgian Research Fund	The financial support of the Hercules Foundation (AUGE/013) and the Belgian Research Fund (B/11599/17) are gratefully acknowledged.	Addo MG, 2010, BBA-MOL BASIS DIS, V1802, P765, DOI 10.1016/j.bbadis.2010.05.007; Apostolova N, 2011, TRENDS PHARMACOL SCI, V32, P715, DOI 10.1016/j.tips.2011.07.007; Bess AS, 2012, NUCLEIC ACIDS RES, V40, P7916, DOI 10.1093/nar/gks532; Braeckman BP, 2002, MECH AGEING DEV, V123, P1447, DOI 10.1016/S0047-6374(02)00085-4; Bratic I, 2010, BBA-BIOENERGETICS, V1797, P961, DOI 10.1016/j.bbabio.2010.01.004; Bratic I, 2009, NUCLEIC ACIDS RES, V37, P1817, DOI 10.1093/nar/gkp018; Brinkman K, 1999, LANCET, V354, P1112, DOI 10.1016/S0140-6736(99)06102-4; Brinkman K, 1998, AIDS, V12, P1735, DOI 10.1097/00002030-199814000-00004; Carr A, 2000, LANCET, V356, P1423, DOI 10.1016/S0140-6736(00)02854-3; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Chen XL, 2011, GENET MED, V13, P794, DOI 10.1097/GIM.0b013e31821afca5; Cihlar T, 2010, ANTIVIR RES, V85, P39, DOI 10.1016/j.antiviral.2009.09.014; Cote HCF, 2002, NEW ENGL J MED, V346, P811, DOI 10.1056/NEJMoa012035; Culetto E, 2000, HUM MOL GENET, V9, P869, DOI 10.1093/hmg/9.6.869; Davidson I, 2010, ANTIVIR RES, V86, P227, DOI 10.1016/j.antiviral.2010.03.001; De Vos WH, 2010, CYTOM PART A, V77A, P64, DOI 10.1002/cyto.a.20807; Doleans-Jordheim A, 2011, EUR J CLIN MICROBIOL, V30, P1249, DOI 10.1007/s10096-011-1220-3; Dykens JA, 2008, DRUG INDUCED MITOCHO, DOI [10.1002/9780470372531, DOI 10.1002/9780470372531]; Golden TR, 2007, AGING CELL, V6, P179, DOI 10.1111/j.1474-9726.2007.00273.x; Grad LI, 2005, P NATL ACAD SCI USA, V102, P18367, DOI 10.1073/pnas.0506939102; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Johnson AA, 2001, J BIOL CHEM, V276, P40847, DOI 10.1074/jbc.M106743200; Jonassen T, 2001, P NATL ACAD SCI USA, V98, P421, DOI 10.1073/pnas.021337498; Kakuda TN, 2000, CLIN THER, V22, P685, DOI 10.1016/S0149-2918(00)90004-3; Koczor CA, 2010, EXPERT OPIN DRUG MET, V6, P1493, DOI 10.1517/17425255.2010.526602; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Lewis W, 2006, AIDS, V20, P675, DOI 10.1097/01.aids.0000216367.23325.58; LEWIS W, 1995, NAT MED, V1, P417, DOI 10.1038/nm0595-417; Li J, 2009, PROTEOMICS, V9, P4539, DOI 10.1002/pmic.200900101; Lund KC, 2008, TOXICOL APPL PHARM, V226, P94, DOI 10.1016/j.taap.2007.08.015; Maagaard A, 2009, SCAND J INFECT DIS, V41, P808, DOI 10.3109/00365540903186181; Markaki M, 2010, BIOTECHNOL J, V5, P1261, DOI 10.1002/biot.201000183; MARTIN JL, 1994, ANTIMICROB AGENTS CH, V38, P2743, DOI 10.1128/AAC.38.12.2743; May MT, 2011, SEX HEALTH, V8, P526, DOI 10.1071/SH11046; MITCHELL DH, 1979, J GERONTOL, V34, P28, DOI 10.1093/geronj/34.1.28; Neustadt J, 2008, MOL NUTR FOOD RES, V52, P780, DOI 10.1002/mnfr.200700075; O'Rourke EJ, 2009, CELL METAB, V10, P430, DOI 10.1016/j.cmet.2009.10.002; PEZESHKPOUR G, 1991, HUM PATHOL, V22, P1281, DOI 10.1016/0046-8177(91)90112-3; Sanz MA, 2003, J BIOL CHEM, V278, P32091, DOI 10.1074/jbc.M304877200; Schapira AHV, 2012, LANCET, V379, P1825, DOI 10.1016/S0140-6736(11)61305-6; Skovgaard T, 2012, FEBS J, V279, P1777, DOI 10.1111/j.1742-4658.2012.08554.x; Smith Reuben L, 2015, Methods Mol Biol, V1265, P367, DOI 10.1007/978-1-4939-2288-8_26; Smith Reuben L., 2013, Frontiers in Genetics, V3, P328, DOI 10.3389/fgene.2012.00328; Suntres ZE, 2002, TOXICOLOGY, V180, P65, DOI 10.1016/S0300-483X(02)00382-7; Tsang WY, 2003, BBA-MOL BASIS DIS, V1638, P91, DOI 10.1016/S0925-4439(03)00079-6; Tsang WY, 2002, BIOCHEM BIOPH RES CO, V291, P8, DOI 10.1006/bbrc.2002.6394; Vasta V, 2011, MITOCHONDRION, V11, P136, DOI 10.1016/j.mito.2010.09.002; Zeldin RK, 2004, J ANTIMICROB CHEMOTH, V53, P4, DOI 10.1093/jac/dkh029; Zeviani M, 2007, CURR OPIN NEUROL, V20, P564, DOI 10.1097/WCO.0b013e3282ef58cd; Zubovych IO, 2010, MOL BIOL CELL, V21, P956, DOI 10.1091/mbc.E09-08-0673	50	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0126220	10.1371/journal.pone.0126220	http://dx.doi.org/10.1371/journal.pone.0126220			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970180	Green Published, Green Submitted, gold			2022-12-26	WOS:000354544200099
J	Li, X; Xu, SL; He, PN; Liu, YX				Li, Xiang; Xu, Sulei; He, Pingnian; Liu, Yuxin			In Vitro Recapitulation of Functional Microvessels for the Study of Endothelial Shear Response, Nitric Oxide and [Ca2+](i)	PLOS ONE			English	Article							INTRACELLULAR CALCIUM; CYTOPLASMIC CALCIUM; EXTRACELLULAR ATP; NO PRODUCTION; PERMEABILITY; CELLS; INCREASES; CYTOSKELETON; ADHESION; STRESS	Microfluidic technologies enable in vitro studies to closely simulate in vivo microvessel environment with complexity. Such method overcomes certain constrains of the statically cultured endothelial monolayers and enables the cells grow under physiological range of shear flow with geometry similar to microvessels in vivo. However, there are still existing knowledge gaps and lack of convincing evidence to demonstrate and quantify key biological features of the microfluidic microvessels. In this paper, using advanced micromanufacturing and microfluidic technologies, we presented an engineered microvessel model that mimicked the dimensions and network structures of in vivo microvessels with a long-term and continuous perfusion capability, as well as high-resolution and real-time imaging capability. Through direct comparisons with studies conducted in intact microvessels, our results demonstrated that the cultured microvessels formed under perfused conditions recapitulated certain key features of the microvessels in vivo. In particular, primary human umbilical vein endothelial cells were successfully cultured the entire inner surfaces of the microchannel network with well-developed junctions indicated by VE-cadherin staining. The morphological and proliferative responses of endothelial cells to shear stresses were quantified under different flow conditions which was simulated with three-dimensional shear dependent numerical flow model. Furthermore, we successfully measured agonist-induced changes in intracellular Ca2+ concentration and nitric oxide production at individual endothelial cell levels using fluorescence imaging. The results were comparable to those derived from individually perfused intact venules. With in vivo validation of its functionalities, our microfluidic model demonstrates a great potential for biological applications and bridges the gaps between in vitro and in vivo microvascular research.	[Li, Xiang; Xu, Sulei; He, Pingnian] Penn State Univ, Sch Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Liu, Yuxin] W Virginia Univ, Lane Dept Comp Sci & Elect Engn, Morgantown, WV 26506 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; West Virginia University	He, PN (corresponding author), Penn State Univ, Sch Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA.	pinghe@hmc.psu.edu; yuxin.liu@mail.wvu.edu	liu, yuxin/GRY-3592-2022; Liu, Yuxin/AAN-4165-2020; Li, Xiang/I-1349-2019	HE, Pingnian/0000-0001-7346-7419; Li, Xiang/0000-0002-4916-524X	National Science Foundation [NSF-1227359]; WV EPSCoR program - National Science Foundation [EPS-1003907]; National Heart, Lung, and Blood Institute [HL56237, HL084338]; American Heart Association Great Rivers Affiliate [12PRE11470010]; Directorate For Engineering [1227359] Funding Source: National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056237, R01HL084338, R29HL056237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097391] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); WV EPSCoR program - National Science Foundation(National Science Foundation (NSF)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association Great Rivers Affiliate(American Heart Association); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Science Foundation (NSF-1227359) and by WV EPSCoR program (EPS-1003907) funded by the National Science Foundation (Liu, Y.); and by National Heart, Lung, and Blood Institute grants HL56237 and HL084338 (He, P.) and American Heart Association Great Rivers Affiliate 12PRE11470010 pre-doctoral fellowship (Xu, S.).	ANDO J, 1987, MICROVASC RES, V33, P62, DOI 10.1016/0026-2862(87)90007-0; Berthier E, 2012, LAB CHIP, V12, P1224, DOI 10.1039/c2lc20982a; Bischel LL, 2013, BIOMATERIALS, V34, P1471, DOI 10.1016/j.biomaterials.2012.11.005; CARTER TD, 1988, BRIT J PHARMACOL, V95, P1181, DOI 10.1111/j.1476-5381.1988.tb11754.x; CURRY FE, 1992, FASEB J, V6, P2456, DOI 10.1096/fasebj.6.7.1563597; DUBYAK GR, 1993, AM J PHYSIOL, V265, pC577, DOI 10.1152/ajpcell.1993.265.3.C577; Feugier P, 2005, BIOMATERIALS, V26, P1457, DOI 10.1016/j.biomaterials.2004.04.050; Hamdollah Zadeh MA, 2008, MICROCIRCULATION, V15, P605, DOI 10.1080/10739680802220323; HE P, 1991, AM J PHYSIOL, V261, pH1246, DOI 10.1152/ajpheart.1991.261.4.H1246; HE P, 1990, AM J PHYSIOL, V258, pH1366; HE P, 1994, J APPL PHYSIOL, V76, P2288, DOI 10.1152/jappl.1994.76.6.2288; He P, 1996, AM J PHYSIOL-HEART C, V271, pH2377, DOI 10.1152/ajpheart.1996.271.6.H2377; HE P, 1993, AM J PHYSIOL, V265, pH1019, DOI 10.1152/ajpheart.1993.265.3.H1019; HOBSON B, 1984, BRIT J CANCER, V49, P405, DOI 10.1038/bjc.1984.66; Huang ZC, 2012, BIOMED MICRODEVICES, V14, P873, DOI 10.1007/s10544-012-9667-2; Keller H E, 2006, HDB BIOL CONFOCAL MI, P145, DOI DOI 10.1007/978-0-387-45524-2_7; Kim S, 2013, LAB CHIP, V13, P1489, DOI 10.1039/c3lc41320a; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Kou SZ, 2011, BIOCHEM BIOPH RES CO, V408, P350, DOI 10.1016/j.bbrc.2011.04.044; Lamberti G, 2014, ANAL CHEM, V86, P8344, DOI 10.1021/ac5018716; LANGILLE BL, 1991, ARTERIOSCLER THROMB, V11, P1814, DOI 10.1161/01.ATV.11.6.1814; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Li X, 2013, JOVE-J VIS EXP, DOI 10.3791/50771; LIPOWSKY HH, 1978, CIRC RES, V43, P738, DOI 10.1161/01.RES.43.5.738; MANNIX RJ, 1993, AM J PHYSIOL, V265, pH675, DOI 10.1152/ajpheart.1993.265.2.H675; Morawietz H, 2000, J PHYSIOL-LONDON, V525, P761, DOI 10.1111/j.1469-7793.2000.00761.x; Munaron L, 2006, RECENT PAT ANTI-CANC, V1, P105, DOI 10.2174/157489206775246502; NAGEL T, 1994, J CLIN INVEST, V94, P885, DOI 10.1172/JCI117410; Oblak TD, 2006, ANAL CHEM, V78, P3193, DOI 10.1021/ac052066o; Price GM, 2010, BIOMATERIALS, V31, P6182, DOI 10.1016/j.biomaterials.2010.04.041; Sackmann EK, 2014, NATURE, V507, P181, DOI 10.1038/nature13118; Sato M, 2005, BIORHEOLOGY, V42, P421; Sprague RS, 2003, AM J PHYSIOL-HEART C, V285, pH693, DOI 10.1152/ajpheart.01026.2002; Tsai M, 2012, J CLIN INVEST, V122, P408, DOI 10.1172/JCI58753; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Ukropec JA, 2002, EXP CELL RES, V273, P240, DOI 10.1006/excr.2001.5453; Xu SL, 2013, AM J PHYSIOL-HEART C, V305, pH1484, DOI 10.1152/ajpheart.00382.2013; Xu T, 2013, LAB CHIP, V13, P1060, DOI 10.1039/c3lc40880a; Yuan D, 2014, AM J PHYSIOL-HEART C, V307, pH44, DOI 10.1152/ajpheart.00929.2013; Yuan D, 2012, J APPL PHYSIOL, V113, P1110, DOI 10.1152/japplphysiol.00102.2012; Zakrzewicz A, 2002, NEWS PHYSIOL SCI, V17, P197, DOI 10.1152/nips.01395.2001; Zheng Y, 2012, P NATL ACAD SCI USA, V109, P9342, DOI 10.1073/pnas.1201240109; Zhou XP, 2013, AM J PHYSIOL-HEART C, V304, pH82, DOI 10.1152/ajpheart.00300.2012; Zhou XP, 2011, AM J PHYSIOL-HEART C, V301, pH1788, DOI 10.1152/ajpheart.00599.2011; Zhou XP, 2011, AM J PHYSIOL-HEART C, V301, pH108, DOI 10.1152/ajpheart.00195.2011; Zhou XP, 2010, CARDIOVASC RES, V87, P340, DOI 10.1093/cvr/cvq006; Zhu LK, 2005, AM J PHYSIOL-HEART C, V288, pH2869, DOI 10.1152/ajpheart.01080.2004	47	16	17	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0126797	10.1371/journal.pone.0126797	http://dx.doi.org/10.1371/journal.pone.0126797			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965067	Green Published, gold, Green Submitted			2022-12-26	WOS:000354543500076
J	Minias, AE; Brzostek, AM; Korycka-Machala, M; Dziadek, B; Minias, P; Rajagopalan, M; Madiraju, M; Dziadek, J				Minias, Alina E.; Brzostek, Anna M.; Korycka-Machala, Malgorzata; Dziadek, Bozena; Minias, Piotr; Rajagopalan, Malini; Madiraju, Murty; Dziadek, Jaroslaw			RNase HI Is Essential for Survival of Mycobacterium smegmatis	PLOS ONE			English	Article							STABLE DNA-REPLICATION; COMPLETE GENOME SEQUENCE; ESCHERICHIA-COLI; R-LOOPS; POLYMERASE-I; SUBSTRATE-SPECIFICITY; DEFECTIVE-MUTANTS; POTENTIAL TARGET; RIBONUCLEASE H; TRANSCRIPTION	RNases H are involved in the removal of RNA from RNA/DNA hybrids. Type I RNases H are thought to recognize and cleave the RNA/DNA duplex when at least four ribonucleotides are present. Here we investigated the importance of RNase H type I encoding genes for model organism Mycobacterium smegmatis. By performing gene replacement through homologous recombination, we demonstrate that each of the two presumable RNase H type I encoding genes, rnhA and MSMEG4305, can be removed from M. smegmatis genome without affecting the growth rate of the mutant. Further, we demonstrate that deletion of both RNases H type I encoding genes in M. smegmatis leads to synthetic lethality. Finally, we question the possibility of existence of RNase HI related alternative mode of initiation of DNA replication in M. smegmatis, the process initially discovered in Escherichia coli. We suspect that synthetic lethality of double mutant lacking RNases H type I is caused by formation of R-loops leading to collapse of replication forks. We report Mycobacterium smegmatis as the first bacterial species, where function of RNase H type I has been found essential.	[Minias, Alina E.; Brzostek, Anna M.; Korycka-Machala, Malgorzata; Dziadek, Jaroslaw] Polish Acad Sci, Inst Med Biol, Lodz, Poland; [Dziadek, Bozena] Univ Lodz, Dept Immunoparasitol, PL-90131 Lodz, Poland; [Minias, Piotr] Univ Lodz, Dept Teacher Training & Biodivers Studies, PL-90131 Lodz, Poland; [Rajagopalan, Malini; Madiraju, Murty] Univ Texas Tyler, Dept Microbiol, Ctr Hlth, Tyler, TX 75799 USA	Polish Academy of Sciences; Institute of Medical Biology of the Polish Academy of Sciences; University of Lodz; University of Lodz; University of Texas System; University of Texas at Tyler	Minias, AE (corresponding author), Polish Acad Sci, Inst Med Biol, Lodz, Poland.	alinagorna@gmail.pl; jdziadek@cbm.pan.pl		Minias, Piotr/0000-0002-7742-6750; Minias, Alina/0000-0002-3210-6737; Dziadek, Jaroslaw/0000-0003-1427-884X; Dziadek, Bozena/0000-0002-4942-7385	Innovative Economy Operational Programme, "Studies of the molecular mechanisms at the interface the human organism - the pathogen - environmental factors" [POIG.01.01.02-10-107/09]; Polish National Center of Science [2011/01/N/NZ6/04186]	Innovative Economy Operational Programme, "Studies of the molecular mechanisms at the interface the human organism - the pathogen - environmental factors"; Polish National Center of Science	The study was supported by POIG.01.01.02-10-107/09 project implemented under Innovative Economy Operational Programme, years 2007-2013 "Studies of the molecular mechanisms at the interface the human organism - the pathogen - environmental factors" and by grant of Polish National Center of Science 2011/01/N/NZ6/04186 "Identification of a novel mechanism of initiation of DNA replication in Mycobacterium smegmatis".	Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Amin AG, 2008, MICROBIOL-SGM, V154, P240, DOI 10.1099/mic.0.2007/012153-0; Anupama K, 2011, MOL MICROBIOL, V82, P1330, DOI 10.1111/j.1365-2958.2011.07895.x; Arudchandran A, 2000, GENES CELLS, V5, P789, DOI 10.1046/j.1365-2443.2000.00373.x; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Baharoglu Z, 2010, MOL MICROBIOL, V77, P324, DOI 10.1111/j.1365-2958.2010.07208.x; Balk B, 2013, NAT STRUCT MOL BIOL, V20, P1199, DOI 10.1038/nsmb.2662; Bayliss CD, 2005, NUCLEIC ACIDS RES, V33, P400, DOI 10.1093/nar/gki180; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Boubakri H, 2010, EMBO J, V29, P145, DOI 10.1038/emboj.2009.308; Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x; Chon H, 2013, NUCLEIC ACIDS RES, V41, P3130, DOI 10.1093/nar/gkt027; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Davis CA, 2011, VIROLOGY, V419, P64, DOI 10.1016/j.virol.2011.08.010; DAWES SS, 1995, GENE, V165, P71, DOI 10.1016/0378-1119(95)00523-9; DEMASSY B, 1984, J MOL BIOL, V178, P227, DOI 10.1016/0022-2836(84)90141-4; Dziadek J, 2002, J BACTERIOL, V184, P3848, DOI 10.1128/JB.184.14.3848-3855.2002; EDER PS, 1993, BIOCHIMIE, V75, P123, DOI 10.1016/0300-9084(93)90033-O; Fukushima S, 2007, J BACTERIOL, V189, P8575, DOI 10.1128/JB.00653-07; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Ginno PA, 2013, GENOME RES, V23, P1590, DOI 10.1101/gr.158436.113; Greendyke R, 2002, MICROBIOL-SGM, V148, P3887, DOI 10.1099/00221287-148-12-3887; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Hiller B, 2012, J EXP MED, V209, P1419, DOI 10.1084/jem.20120876; HONG XK, 1995, EMBO J, V14, P2385, DOI 10.1002/j.1460-2075.1995.tb07233.x; HORIUCHI T, 1984, MOL GEN GENET, V195, P17, DOI 10.1007/BF00332717; Howard JAL, 2011, BIOCHEM J, V439, P85, DOI 10.1042/BJ20110901; Ilina Tatiana, 2012, Biology (Basel), V1, P521, DOI 10.3390/biology1030521; Itaya M, 1999, J BACTERIOL, V181, P2118, DOI 10.1128/JB.181.7.2118-2123.1999; ITAYA M, 1991, MOL GEN GENET, V227, P424, DOI 10.1007/BF00273933; ITOH T, 1980, P NATL ACAD SCI-BIOL, V77, P2450, DOI 10.1073/pnas.77.5.2450; KANAYA S, 1984, P NATL ACAD SCI-BIOL, V81, P3447, DOI 10.1073/pnas.81.11.3447; Kochiwa H, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-128; KOGOMA T, 1983, EMBO J, V2, P463, DOI 10.1002/j.1460-2075.1983.tb01445.x; Kogoma T, 1997, MICROBIOL MOL BIOL R, V61, P212, DOI 10.1128/.61.2.212-238.1997; KOGOMA T, 1994, MOL GEN GENET, V244, P557, DOI 10.1007/BF00583907; Kogoma T, 1997, J BACTERIOL, V179, P2109, DOI 10.1128/jb.179.7.2109-2115.1997; Korycka-Machala M, 2006, FEMS MICROBIOL LETT, V258, P83, DOI 10.1111/j.1574-6968.2006.00199.x; Korycka-Machala M, 2007, ANTIMICROB AGENTS CH, V51, P2888, DOI 10.1128/AAC.00254-07; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Kuron A, 2014, ANTIMICROB AGENTS CH, V58, P1699, DOI 10.1128/AAC.01721-13; Lee DY, 1998, J BIOL CHEM, V273, P30614, DOI 10.1074/jbc.273.46.30614; Leela JK, 2013, P NATL ACAD SCI USA, V110, P258, DOI 10.1073/pnas.1213123110; Lima WF, 2007, MOL PHARMACOL, V71, P83, DOI 10.1124/mol.106.025015; Lima WF, 2007, MOL PHARMACOL, V71, P73, DOI 10.1124/mol.106.025429; Mahdi AA, 2006, GENE DEV, V20, P2135, DOI 10.1101/gad.382306; Murante RS, 1998, P NATL ACAD SCI USA, V95, P2244, DOI 10.1073/pnas.95.5.2244; Murdeshwar MS, 2012, J BACTERIOL, V194, P4003, DOI 10.1128/JB.00258-12; Nossal NG, 2001, MOL CELL, V7, P31, DOI 10.1016/S1097-2765(01)00152-6; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; OGAWA T, 1984, MOL GEN GENET, V193, P231, DOI 10.1007/BF00330673; OGAWA T, 1984, P NATL ACAD SCI-BIOL, V81, P1040, DOI 10.1073/pnas.81.4.1040; OKAZAKI R, 1971, P NATL ACAD SCI USA, V68, P2954, DOI 10.1073/pnas.68.12.2954; OLIVERA BM, 1974, NATURE, V250, P513, DOI 10.1038/250513a0; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Petrov DA, 2000, J HERED, V91, P221, DOI 10.1093/jhered/91.3.221; Pfeiffer V, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002747; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Sandler SJ, 2000, GENETICS, V155, P487; Sandler SJ, 2005, GENETICS, V169, P1799, DOI 10.1534/genetics.104.036962; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Seigneur M, 1998, CELL, V95, P419, DOI 10.1016/S0092-8674(00)81772-9; Shen Y, 2012, NAT STRUCT MOL BIOL, V19, P98, DOI 10.1038/nsmb.2176; Skourti-Stathaki K, 2014, GENE DEV, V28, P1384, DOI 10.1101/gad.242990.114; TORREY TA, 1984, MOL GEN GENET, V196, P350, DOI 10.1007/BF00328070; Watkins HA, 2010, J BACTERIOL, V192, P2878, DOI 10.1128/JB.01615-09; Williams A, 2011, J BACTERIOL, V193, P4487, DOI 10.1128/JB.00302-11; Yao NY, 2013, P NATL ACAD SCI USA, V110, P12942, DOI 10.1073/pnas.1309506110; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	71	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0126260	10.1371/journal.pone.0126260	http://dx.doi.org/10.1371/journal.pone.0126260			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965344	Green Published, gold, Green Submitted			2022-12-26	WOS:000354543500054
J	Monaco, C; Whitfield, J; Jain, SS; Spriet, LL; Bonen, A; Holloway, GP				Monaco, Cynthia; Whitfield, Jamie; Jain, Swati S.; Spriet, Lawrence L.; Bonen, Arend; Holloway, Graham P.			Activation of AMPK alpha 2 Is Not Required for Mitochondrial FAT/CD36 Accumulation during Exercise	PLOS ONE			English	Article							FATTY-ACID OXIDATION; HUMAN SKELETAL-MUSCLE; PROTEIN-KINASE; GLUCOSE-TRANSPORT; PALMITATE OXIDATION; LIPID-METABOLISM; FUEL SELECTION; RAT-LIVER; CPT-I; MEMBRANE	Exercise has been shown to induce the translocation of fatty acid translocase (FAT/CD36), a fatty acid transport protein, to both plasma and mitochondrial membranes. While previous studies have examined signals involved in the induction of FAT/CD36 translocation to sarcolemmal membranes, to date the signaling events responsible for FAT/CD36 accumulation on mitochondrial membranes have not been investigated. In the current study muscle contraction rapidly increased FAT/CD36 on plasma membranes (7.5 minutes), while in contrast, FAT/CD36 only increased on mitochondrial membranes after 22.5 minutes of muscle contraction, a response that was exercise-intensity dependent. Considering that previous research has shown that AMP activated protein kinase (AMPK) alpha 2 is not required for FAT/CD36 translocation to the plasma membrane, we investigated whether AMPK alpha 2 signaling is necessary for mitochondrial FAT/CD36 accumulation. Administration of 5-Aminoimidazole-4-carboxamide ribonucleotide (AICAR) induced AMPK phosphorylation, and resulted in FAT/CD36 accumulation on SS mitochondria, suggesting AMPK signaling may mediate this response. However, SS mitochondrial FAT/CD36 increased following acute treadmill running in both wild-type (WT) and AMPK alpha 2 kinase dead (KD) mice. These data suggest that AMPK signaling is not required for SS mitochondrial FAT/CD36 accumulation. The current data also implicates alternative signaling pathways that are exercise-intensity dependent, as IMF mitochondrial FAT/CD36 content only occurred at a higher power output. Taken altogether the current data suggests that activation of AMPK signaling is sufficient but not required for exercise-induced accumulation in mitochondrial FAT/CD36.	[Monaco, Cynthia; Whitfield, Jamie; Jain, Swati S.; Spriet, Lawrence L.; Bonen, Arend; Holloway, Graham P.] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada	University of Guelph	Holloway, GP (corresponding author), Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada.	ghollowa@uoguelph.ca	Whitfield, Jamie/J-1570-2018	Whitfield, Jamie/0000-0002-8961-8872	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by Dr Bonen's and Holloway's operating grants from the Natural Sciences and Engineering Research Council of Canada.	ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665; Aoi W, 2008, BIOCHEM BIOPH RES CO, V366, P892, DOI 10.1016/j.bbrc.2007.12.019; Benton CR, 2004, BIOCHEM BIOPH RES CO, V323, P249, DOI 10.1016/j.bbrc.2004.08.084; Bezaire V, 2006, AM J PHYSIOL-ENDOC M, V290, pE509, DOI 10.1152/ajpendo.00312.2005; Bonen A, 2000, J BIOL CHEM, V275, P14501, DOI 10.1074/jbc.275.19.14501; Bonen A, 2007, AM J PHYSIOL-ENDOC M, V292, pE1740, DOI 10.1152/ajpendo.00579.2006; Bradley NS, 2012, AM J PHYSIOL-ENDOC M, V302, pE183, DOI 10.1152/ajpendo.00254.2011; Campbell SE, 2004, J BIOL CHEM, V279, P36235, DOI 10.1074/jbc.M400566200; Chen HC, 2002, J BIOL CHEM, V277, P23554, DOI 10.1074/jbc.M201152200; Distler AM, 2006, ANAL BIOCHEM, V356, P18, DOI 10.1016/j.ab.2006.03.053; Dzamko N, 2008, J PHYSIOL-LONDON, V586, P5819, DOI 10.1113/jphysiol.2008.159814; Fentz J, 2015, FASEB J, V29, P1725, DOI 10.1096/fj.14-266650; Fujii N, 2000, BIOCHEM BIOPH RES CO, V273, P1150, DOI 10.1006/bbrc.2000.3073; Gimeno RE, 2003, J BIOL CHEM, V278, P16039, DOI 10.1074/jbc.M211412200; Glatz JFC, 2010, PHYSIOL REV, V90, P367, DOI 10.1152/physrev.00003.2009; Hayashi T, 2000, DIABETES, V49, P527, DOI 10.2337/diabetes.49.4.527; Hirsch D, 1998, P NATL ACAD SCI USA, V95, P8625, DOI 10.1073/pnas.95.15.8625; Holloway GP, 2006, J PHYSIOL-LONDON, V571, P201, DOI 10.1113/jphysiol.2005.102178; Holloway GP, 2007, J PHYSIOL-LONDON, V582, P393, DOI 10.1113/jphysiol.2007.135301; Holloway GP, 2007, AM J PHYSIOL-ENDOC M, V292, pE1782, DOI 10.1152/ajpendo.00639.2006; Holloway GP, 2009, AM J PHYSIOL-REG I, V297, pR960, DOI 10.1152/ajpregu.91021.2008; Jain SS, 2009, FEBS LETT, V583, P2294, DOI 10.1016/j.febslet.2009.06.020; Jeppesen J, 2011, J LIPID RES, V52, P699, DOI 10.1194/jlr.M007138; Jeppesen J, 2013, DIABETES, V62, P1490, DOI 10.2337/db12-1160; Jeppesen J, 2010, J LIPID RES, V51, P1504, DOI 10.1194/jlr.M003756; King KL, 2007, ARCH BIOCHEM BIOPHYS, V467, P234, DOI 10.1016/j.abb.2007.08.020; Lally JSV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055660; Luiken JJFP, 2003, DIABETES, V52, P1627, DOI 10.2337/diabetes.52.7.1627; McFarlan JT, 2012, J BIOL CHEM, V287, P23502, DOI 10.1074/jbc.M111.315358; Miura S, 2013, AM J PHYSIOL-ENDOC M, V305, pE213, DOI 10.1152/ajpendo.00114.2013; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Nickerson JG, 2009, J BIOL CHEM, V284, P16522, DOI 10.1074/jbc.M109.004788; O'Neill HM, 2013, MOL CELL ENDOCRINOL, V366, P135, DOI 10.1016/j.mce.2012.06.019; POTTER BJ, 1987, BIOCHEM BIOPH RES CO, V148, P1370, DOI 10.1016/S0006-291X(87)80283-8; RANDLE PJ, 1986, BIOCHEM SOC T, V14, P799, DOI 10.1042/bst0140799; RANDLE PJ, 1964, BIOCHEM J, V93, P652, DOI 10.1042/bj0930652; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; Schenk S, 2006, AM J PHYSIOL-ENDOC M, V291, pE254, DOI 10.1152/ajpendo.00051.2006; Sebastian D, 2009, J LIPID RES, V50, P1789, DOI 10.1194/jlr.M800535-JLR200; Smith BK, 2011, BIOCHEM J, V437, P125, DOI 10.1042/BJ20101861; STUMP DD, 1993, AM J PHYSIOL, V265, pG894, DOI 10.1152/ajpgi.1993.265.5.G894; Turcotte LP, 2005, ACTA PHYSIOL SCAND, V184, P131, DOI 10.1111/j.1365-201X.2005.01445.x; van Loon LJC, 2001, J PHYSIOL-LONDON, V536, P295, DOI 10.1111/j.1469-7793.2001.00295.x	43	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0126122	10.1371/journal.pone.0126122	http://dx.doi.org/10.1371/journal.pone.0126122			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965390	gold, Green Published, Green Submitted			2022-12-26	WOS:000354543500044
J	Paiva, EG; Salgado-Kent, C; Gagnon, MM; Parnum, I; McCauley, R				Paiva, Estenio Guimaraes; Salgado-Kent, Chandra; Gagnon, Marthe Monique; Parnum, Iain; McCauley, Robert			An Assessment of the Effectiveness of High Definition Cameras as Remote Monitoring Tools for Dolphin Ecology Studies	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; MAMMALS; TRAPS; DENSITY; WHALE; FIELD; SEA	Research involving marine mammals often requires costly field programs. This paper assessed whether the benefits of using cameras outweighs the implications of having personnel performing marine mammal detection in the field. The efficacy of video and still cameras to detect Indo-Pacific bottlenose dolphins (Tursiops aduncus) in the Fremantle Harbour (Western Australia) was evaluated, with consideration on how environmental conditions affect detectability. The cameras were set on a tower in the Fremantle Port channel and videos were perused at 1.75 times the normal speed. Images from the cameras were used to estimate position of dolphins at the water's surface. Dolphin detections ranged from 5.6 m to 463.3 m for the video camera, and from 10.8 m to 347.8 m for the still camera. Detection range showed to be satisfactory when compared to distances at which dolphins would be detected by field observers. The relative effect of environmental conditions on detectability was considered by fitting a Generalised Estimation Equations (GEEs) model with Beaufort, level of glare and their interactions as predictors and a temporal auto-correlation structure. The best fit model indicated level of glare had an effect, with more intense periods of glare corresponding to lower occurrences of observed dolphins. However this effect was not large (-0.264) and the parameter estimate was associated with a large standard error (0.113). The limited field of view was the main restraint in that cameras can be only applied to detections of animals observed rather than counts of individuals. However, the use of cameras was effective for long term monitoring of occurrence of dolphins, outweighing the costs and reducing the health and safety risks to field personal. This study showed that cameras could be effectively implemented onshore for research such as studying changes in habitat use in response to development and construction activities.	[Paiva, Estenio Guimaraes; Salgado-Kent, Chandra; Parnum, Iain; McCauley, Robert] Curtin Univ, Ctr Marine Sci & Technol, Perth, WA 6845, Australia; [Paiva, Estenio Guimaraes; Gagnon, Marthe Monique] Curtin Univ, Dept Environm & Agr, Perth, WA 6845, Australia	Curtin University; Curtin University	Paiva, EG (corresponding author), Curtin Univ, Ctr Marine Sci & Technol, Perth, WA 6845, Australia.	esteniopaiva@gmail.com	Salgado Kent, Chandra/B-9872-2015; Salgado Kent, Chandra/HHZ-2367-2022; GAGNON, Marthe Monique/P-6078-2014	Salgado Kent, Chandra/0000-0002-3460-609X; Salgado Kent, Chandra/0000-0002-3460-609X; GAGNON, Marthe Monique/0000-0002-3190-5094; Parnum, Iain/0000-0003-4491-3445	Centre for Marine Science and Technology, Department of Environment and Agriculture from Curtin University; Fremantle Ports	Centre for Marine Science and Technology, Department of Environment and Agriculture from Curtin University; Fremantle Ports	This research was supported by the Centre for Marine Science and Technology (http://cmst.curtin.edu.au), Department of Environment and Agriculture (http://environmentagriculture.curtin.edu. au) from Curtin University and the data collection funded by Fremantle Ports (http://www.fremantleports.com.au) through a subcontract to BMT Oceanica (http://www.bmtoceanica.com.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MATLAB 6 1; [Anonymous], 1996, VLC MEDIA PLAYER VER; Aragones Lemnuel V., 1997, Asian Marine Biology, V14, P15; Barco SG, 1999, MAR MAMMAL SCI, V15, P394, DOI 10.1111/j.1748-7692.1999.tb00809.x; Brager S, 1999, HELGOLAND MAR RES, V53, P122, DOI 10.1007/s101520050015; Brown J., 2009, BASICS USING REMOTE; Carbone C, 2001, ANIM CONSERV, V4, P75, DOI 10.1017/S1367943001001081; Chabanne Delphine, 2012, Pacific Conservation Biology, V18, P247; Cutler TL, 1999, WILDLIFE SOC B, V27, P571; Denardo C, 2001, J APPL ECOL, V38, P888, DOI 10.1046/j.1365-2664.2001.00639.x; Double MC, 2013, IWC SCI COMM JUN 201, P1; Environmental Systems Research Institute, ARCGIS DESKT REL 10; Evans R, 2011, 221 DEP FISH, P20; Finn Hugh C., 2008, Western Australian Naturalist, V26, P157; Frederick PC, 2003, J FIELD ORNITHOL, V74, P281, DOI 10.1648/0273-8570-74.3.281; Gordon J, 2001, J APPL ECOL, V38, P879, DOI 10.1046/j.1365-2664.2001.00615.x; Halekoh U, 2006, J STAT SOFTW, V15, P1, DOI 10.18637/jss.v015.i02; Harrell FE, 2001, REGRESSION MODELING; Hodgson AB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059561, 10.1371/journal.pone.0079556]; HOjsgaard S., 2013, DOBY DOBY GROUPWISE; Holyoake C., 2011, TOXICANT EXPOSURE PO; Hooker SK, 2002, MAR MAMMAL SCI, V18, P680, DOI 10.1111/j.1748-7692.2002.tb01066.x; Jiménez Carlos F., 2010, Rev. peru biol., V17, P191; Lyra-Jorge MC, 2008, EUR J WILDLIFE RES, V54, P739, DOI 10.1007/s10344-008-0205-8; Maniscalco JM, 2007, MAR MAMMAL SCI, V23, P306, DOI 10.1111/j.1748-7692.2007.00103.x; Meek P, 2012, INTRO CAMERA TRAPPIN; Mellinger DK, 2007, OCEANOGRAPHY, V20, P36, DOI 10.5670/oceanog.2007.03; Mesnick SL, 2002, REPORT LJ 02 30; Nieukirk SL, 2004, J ACOUST SOC AM, V115, P1832, DOI 10.1121/1.1675816; O'Brien TG, 2008, BIRD CONSERV INT, V18, pS144, DOI 10.1017/S0959270908000348; R Core Team, 2021, R LANGUAGE ENV STAT; Ridoux V, 1997, MAR MAMMAL SCI, V13, P196, DOI 10.1111/j.1748-7692.1997.tb00627.x; Rowcliffe JM, 2008, J APPL ECOL, V45, P1228, DOI 10.1111/j.1365-2664.2008.01473.x; Shek Chung-tong, 2007, Hong Kong Biodiversity, V15, P1; Silveira L, 2003, BIOL CONSERV, V114, P351, DOI 10.1016/S0006-3207(03)00063-6; Slooten E, 2006, NEW ZEAL J MAR FRESH, V40, P333, DOI 10.1080/00288330.2006.9517425; Soisalo MK, 2006, BIOL CONSERV, V129, P487, DOI 10.1016/j.biocon.2005.11.023; Srbek-Araujo AC, 2005, J TROP ECOL, V21, P121, DOI 10.1017/S0266467404001956; Srbek-Araujo AC, 2007, REV BRAS ZOOL, V24, P647, DOI 10.1590/S0101-81752007000300016; Stanistreet JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061263; Trolle M, 2005, MAMMALIA, V69, P409, DOI 10.1515/mamm.2005.032; Wickham H., 2012, STRINGR MAKE IT EASI; Yan J, 2004, STAT MED, V23, P859, DOI 10.1002/sim.1650; Yan J., 2002, R NEWS, V2, P12; Zuur A.F., 2007, ANAL ECOLOGICAL DATA; Zuur Alain F., 2009, P1	46	5	5	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0126165	10.1371/journal.pone.0126165	http://dx.doi.org/10.1371/journal.pone.0126165			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965856	gold, Green Published, Green Submitted			2022-12-26	WOS:000354543500048
J	Pladys, A; Couchoud, C; LeGuillou, A; Siebert, M; Vigneau, C; Bayat, S				Pladys, Adelaide; Couchoud, Cecile; LeGuillou, Aurelie; Siebert, Muriel; Vigneau, Cecile; Bayat, Sahar			Type 1 and Type 2 Diabetes and Cancer Mortality in the 2002-2009 Cohort of 39 811 French Dialyzed Patients	PLOS ONE			English	Article							STAGE RENAL-DISEASE; ASSOCIATION; INSULIN; RISK; DIALYSIS; MELLITUS; ALBUMINURIA; NEPHROPATHY; CARCINOMA; KIDNEY	End-stage renal disease is a chronic and progressive pathology associated with several comorbidities, particularly diabetes. Indeed, diabetes is the first cause of end-stage renal disease and, in France, 42% of incident patients had diabetes in 2012. In the general population, diabetes is associated with increased cancer risk. The aim of this study was to examine the association between risk of cancer death and diabetes in a large French cohort of patients with end-stage renal disease. Data on all patients with end-stage renal disease who initiated dialysis in France between 2002 and 2009 were extracted from the Renal Epidemiology Information Network registry. The risk of dying by cancer was studied using the Fine and Gray model to take into account the competing risk of death by other causes. We analyzed 39 811 patients with end-stage renal disease. Their mean age was 67.7 +/- 15 years, 39.4% had diabetes and 55.3% at least one cardiovascular disease. Compared with the non-diabetic group, patients with diabetes were older and had more cardiovascular and respiratory comorbidities when they started dialysis. Conversely, fewer diabetic patients had also a tumor at the beginning of the renal replacement therapy. Cancer was indicated as the cause of death for 6.7% of diabetic and 13.4% of non-diabetic patients. The Fine and Gray multivariate analyses indicated that diabetes (HR=0.72 95% CI: [0.68-0.95], p<0.001) and also female gender, peritoneal dialysis, cardio-vascular disease and kidney transplantation were associated with decreased risk of death by cancer. In this French cohort of patients with end-stage renal disease, diabetes was not associated with a significant increased risk of dying from cancer. Studies on the incidence of cancer in patients with ESRD are now needed to evaluate the potential association between diabetes and specific malignancies in this population.	[Pladys, Adelaide; Bayat, Sahar] Dept Epidemiol & Biostat EHESP, Rennes, France; [Couchoud, Cecile] Agence Biomed, Registre REIN, La Plaine St Denis, France; [LeGuillou, Aurelie; Siebert, Muriel; Vigneau, Cecile] CHU Pontchaillou, Serv Nephrol, Rennes, France; [Pladys, Adelaide; Vigneau, Cecile] Univ Rennes 1, UMR CNRS 6290, Rennes, France; [Bayat, Sahar] EA MOS EHESP, Rennes, France	CHU Rennes; Universite de Rennes	Pladys, A (corresponding author), Dept Epidemiol & Biostat EHESP, Rennes, France.	adelaide.pladys@ehesp.fr	vigneau, cecile/I-3178-2015	Pladys, Adelaide/0000-0002-4500-7869	French Biomedicine Agency	French Biomedicine Agency	This study was supported by grants from the French Biomedicine Agency. The funder participated in the study design and data collection.	Arcidiacono B, 2012, EXP DIABETES RES, DOI 10.1155/2012/789174; Ayav C, 2012, REIN RAPPORT ANNUEL; Biesenbach G, 2003, DIABETIC MED, V20, P642, DOI 10.1046/j.1464-5491.2003.01025.x; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Caro JJ, 2001, CANCER-AM CANCER SOC, V91, P2214, DOI 10.1002/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.0.CO;2-P; Chung CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044675; Couchoud C, 2006, NEPHROL DIAL TRANSPL, V21, P411, DOI 10.1093/ndt/gfi198; Coughlin SS, 2004, AM J EPIDEMIOL, V159, P1160, DOI 10.1093/aje/kwh161; Denton MD, 2002, KIDNEY INT, V61, P2201, DOI 10.1046/j.1523-1755.2002.00374.x; Donadon V, 2008, WORLD J GASTROENTERO, V14, P5695, DOI 10.3748/wjg.14.5695; Hannedouche T, 2012, REIN RAPPORT ANNUEL; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Huang CC, 2011, AM J CARDIOL, V107, P1028, DOI 10.1016/j.amjcard.2010.11.026; Iglesias P, 2008, DIABETES OBES METAB, V10, P811, DOI 10.1111/j.1463-1326.2007.00802.x; Institut National du Cancer, 2008, ATL MORT CANC FRANC, P1; Kolko A, 2012, REIN RAPPORT ANNUEL; LAVECCHIA C, 1994, BRIT J CANCER, V70, P950, DOI 10.1038/bjc.1994.427; Lee JE, 2009, J KOREAN MED SCI, V24, pS95, DOI 10.3346/jkms.2009.24.S1.S95; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Liang JA, 2011, JPN J CLIN ONCOL, V41, P752, DOI 10.1093/jjco/hyr051; Lin YS, 2010, CANCER EPIDEM BIOMAR, V19, P2950, DOI 10.1158/1055-9965.EPI-10-0617; MACAULAY VM, 1992, BRIT J CANCER, V65, P311, DOI 10.1038/bjc.1992.65; Maisonneuve P, 1999, LANCET, V354, P93, DOI 10.1016/S0140-6736(99)06154-1; Neuzillet Y, 2011, EUR UROL, V60, P366, DOI 10.1016/j.eururo.2011.02.035; Newstead CG, 1999, LANCET, V354, P90, DOI 10.1016/S0140-6736(99)00207-X; Peces Ramon, 2003, Saudi J Kidney Dis Transpl, V14, P5; Stewart JH, 2003, J AM SOC NEPHROL, V14, P197, DOI 10.1097/01.ASN.0000039608.81046.81; U.S. Renal Data System, 2012, USRDS 2012 ANN DAT R, DOI [10.1053/j.ajkd.2011.11.015, DOI 10.1053/J.AJKD.2011.11.015]; Vamvakas S, 1998, AM J NEPHROL, V18, P89, DOI 10.1159/000013314; Verhoest G, 2014, PROG UROL, V24, P73, DOI 10.1016/j.purol.2013.09.010; Villar E, 2007, J AM SOC NEPHROL, V18, P2125, DOI 10.1681/ASN.2006091048; Wong G, 2012, NEPHROL DIAL TRANSPL, V27, P3337, DOI 10.1093/ndt/gfs022; Wong G, 2009, J AM SOC NEPHROL, V20, P1341, DOI 10.1681/ASN.2008090998; Yang X, RENIN ANGIOTENSIN SY, DOI [10.1002/dmrr.2504, DOI 10.1002/DMRR.2504]	35	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0125089	10.1371/journal.pone.0125089	http://dx.doi.org/10.1371/journal.pone.0125089			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965806	Green Submitted, Green Published, gold			2022-12-26	WOS:000354543500011
J	Melo, JIF; Chojniak, R; Silva, DHC; Oliveira, JC; Bitencourt, AGV; Silva, DH; Guimaraes, MD; Silva, HCS; Dias, DGT; Rodrigues, WC; Brancucci, EL; Cruz, BMS; Schiavon, BN; Argenton, JLP; Camporini, MA; Zocchio, A				Fortalesa Melo, Joao Italo; Chojniak, Rubens; Costa Silva, Debora Helena; Oliveira Junior, Jose Carlos; Vieira Bitencourt, Almir Galvao; Silva, Diego Holanda; Guimaraes, Marcos Duarte; Souza Silva, Hernandes Cerqueira; Teixeira Dias, Denis Guilherme; Rodrigues, Winglison Carli; Brancucci, Ellen Luzia; Soares Cruz, Barbara Martins; Schiavon, Beatriz Nunes; Passos Argenton, Juliana Luz; Camporini, Margareth Arrivabene; Zocchio, Adriana			Use of Cystatin C and Serum Creatinine for the Diagnosis of Contrast-Induced Nephropathy in Patients Undergoing Contrast-Enhanced Computed Tomography at an Oncology Centre	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; CHRONIC KIDNEY-DISEASE; ACUTE-RENAL-FAILURE; INSUFFICIENCY; MARKER; CANCER; NEPHROTOXICITY; PREDICTION; GUIDELINES; VALUES	Objective Our aim was to assess renal function using as laboratory measurements serum creatinine and cystatin C concentrations before and after administration of low-osmolarity (nonionic) iodinated contrast medium in patients with cancer undergoing computed tomography (CT). Methods This prospective study included 400 oncologic outpatients. Serum creatinine and cystatin C concentrations were measured before and 72 h after contrast administration. Glomerular filtration rates (GFRs) were estimated using serum creatinine-based [Modification of Diet in Renal Disease (MDRD) and Cockroft-Gault and cystatin C based (Larsson) equations. Exploratory data analysis was performed. The nonparametric Wilcoxon test was used to compare pre and post contrast of test results and estimated clearance. The confidence interval used in the analysis was 95%. Results Compared with the pre-contrast values, the mean serum creatinine concentration was significantly higher and average GFRs estimated using MDRD and Cockcroft-Gault equations were significantly lower after the administration of contrast (p < 0.001). It was also observed a significant increase after contrast in the concentration of Cystatin C (p = 0.015). In addition, a decrease in GFR estimated using the average Larsson (p = 0.021) was observed between time points. However, none of the patients presented clinically significant nephropathy. Conclusions Assessment using serum creatinine and cystatin C concentrations showed changes in renal function among patients with cancer undergoing contrast-enhanced CT examination in this study. No significant renal damage related to the use of low-osmolarity iodinated contrast medium of the type and dosage employed in this study was observed. This contrast medium is thus safe for use in patients with cancer.	[Fortalesa Melo, Joao Italo; Chojniak, Rubens; Costa Silva, Debora Helena; Oliveira Junior, Jose Carlos; Vieira Bitencourt, Almir Galvao; Silva, Diego Holanda; Guimaraes, Marcos Duarte; Souza Silva, Hernandes Cerqueira; Teixeira Dias, Denis Guilherme; Rodrigues, Winglison Carli; Brancucci, Ellen Luzia; Camporini, Margareth Arrivabene; Zocchio, Adriana] AC Camargo Canc Ctr, Dept Imaging, Sao Paulo, Brazil; [Soares Cruz, Barbara Martins; Schiavon, Beatriz Nunes] AC Camargo Canc Ctr, Dept Clin Pathol, Sao Paulo, Brazil; [Passos Argenton, Juliana Luz] Univ Estadual Campinas, Sch Med, Stat Nucleos, Campinas, SP, Brazil	A.C.Camargo Cancer Center; A.C.Camargo Cancer Center; Universidade Estadual de Campinas	Melo, JIF (corresponding author), AC Camargo Canc Ctr, Dept Imaging, Sao Paulo, Brazil.	italo_me@outlook.com	Bitencourt, Almir/D-6437-2013; Guimaraes, Marcos/N-8412-2013; Chojniak, Rubens/L-3770-2013; Bitencourt, Almir/W-9536-2019	Bitencourt, Almir/0000-0003-0192-9885; Guimaraes, Marcos/0000-0002-4662-5845; Chojniak, Rubens/0000-0002-8096-252X; Bitencourt, Almir/0000-0003-0192-9885; Fortaleza de Melo, Joao Italo/0000-0002-7384-9502; Schiavon, Beatriz/0000-0002-1323-1161	Sao Paulo Research Foundation; AC Camargo Cancer Center	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); AC Camargo Cancer Center	When the study was conducted the authors received financial support from Sao Paulo Research Foundation, which is an agency of the government. It has a role in Brazil to support research with public money, and the authors submitted the project and benefited from the financial support. The funder's role was only financial support, without any interaction with the project, its execution or publication. Today the research is to be published and the authors have the support of this foundation. The authors also have the financial support of the institution where the study was conducted, the AC Camargo Cancer Center, which also had no influence on the conduct of the study.	Ando H, 2012, J CARDIOVASC COMPUT, V6, P31, DOI 10.1016/j.jcct.2011.10.017; Balta S, 2015, CARDIOLOGY, V130, P1, DOI 10.1159/000368300; Berg KJ, 2000, SCAND J UROL NEPHROL, V34, P317, DOI 10.1080/003655900750048341; Briguori C, 2010, CIRCULATION, V121, P2117, DOI 10.1161/CIRCULATIONAHA.109.919639; Bruce RJ, 2009, AM J ROENTGENOL, V192, P711, DOI 10.2214/AJR.08.1413; Cengiz Kuddusi, 2002, International Urology and Nephrology, V33, P121; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; COHAN RH, 1987, AM J ROENTGENOL, V149, P665, DOI 10.2214/ajr.149.4.665; CRAMER BC, 1985, ARCH INTERN MED, V145, P87, DOI 10.1001/archinte.145.1.87; Detrenis S, 2005, NEPHROL DIAL TRANSPL, V20, P1542, DOI 10.1093/ndt/gfh868; Dharnidharka VR, 2002, AM J KIDNEY DIS, V40, P221, DOI 10.1053/ajkd.2002.34487; DiPaola Robert S, 2003, Med Sci Monit, V9, pPI5; Fidanci MK, 2014, ANGIOLOGY, V65, P224, DOI 10.1177/0003319713482356; Gleeson TG, 2004, AM J ROENTGENOL, V183, P1673, DOI 10.2214/ajr.183.6.01831673; Gross JL, 2006, NEW ENGL J MED, V354, P1853; Heiken Jay P, 2008, Cancer Imaging, V8 Spec No A, pS124, DOI 10.1102/1470-7330.2008.9018; Itoh Y, 2005, J PHARMACOL SCI, V97, P473, DOI 10.1254/jphs.CRJ05002X; Janus N, 2010, BRIT J CANCER, V103, P1815, DOI 10.1038/sj.bjc.6605979; Kato K, 2008, CIRC J, V72, P1499, DOI 10.1253/circj.CJ-07-1006; Ko C, 2002, J SURG RES, V105, P53, DOI 10.1006/jsre.2002.6449; Lameire NH, 2011, KIDNEY INT, V79, P1047, DOI 10.1038/ki.2011.21; Larsson A, 2004, SCAND J CLIN LAB INV, V64, P25, DOI 10.1080/00365510410003723; Launay-Vacher V, 2004, MED SCI MONITOR, V10, pCR209; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; McCullough PA, 2008, J AM COLL CARDIOL, V51, P1419, DOI 10.1016/j.jacc.2007.12.035; McDougal W Scott, 2005, J Urol, V174, P1024; Nash K, 2002, AM J KIDNEY DIS, V39, P930, DOI 10.1053/ajkd.2002.32766; Newhouse JH, 2008, AM J ROENTGENOL, V191, P376, DOI 10.2214/AJR.07.3280; NEWMAN DJ, 1995, KIDNEY INT, V47, P312, DOI 10.1038/ki.1995.40; PARFREY PS, 1989, NEW ENGL J MED, V320, P143, DOI 10.1056/NEJM198901193200303; PERRONE RD, 1992, CLIN CHEM, V38, P1933; Persson PB, 2006, KIDNEY INT, V69, pS8, DOI 10.1038/sj.ki.5000367; Persson PB, 2005, KIDNEY INT, V68, P14, DOI 10.1111/j.1523-1755.2005.00377.x; Rickli H, 2004, CLIN NEPHROL, V61, P98; Roos JF, 2007, CLIN BIOCHEM, V40, P383, DOI 10.1016/j.clinbiochem.2006.10.026; Rudnick MR, 2008, AM HEART J, V156, P776, DOI 10.1016/j.ahj.2008.05.023; SHEMESH O, 1985, KIDNEY INT, V28, P830, DOI 10.1038/ki.1985.205; Stacul F, 2011, EUR RADIOL, V21, P2527, DOI 10.1007/s00330-011-2225-0; Takeuchi T, 2011, CYSTATIN C A POSSIBL, P17, DOI [10.1097/RCT.0b013e31820a9465.Cystatin, DOI 10.1097/RCT.0B013E31820A9465]; Tepel M, 2006, CIRCULATION, V113, P1799, DOI 10.1161/CIRCULATIONAHA.105.595090; Thomsen HS, 2005, NEPHROL DIAL TRANSPL, V20, pI18, DOI 10.1093/ndt/gfh1070; Tublin ME, 1998, AM J ROENTGENOL, V171, P933, DOI 10.2214/ajr.171.4.9762972; Van Biesen W, 2006, CLIN J AM SOC NEPHRO, V1, P1314, DOI 10.2215/CJN.02070606; White CA, 2011, CLIN J AM SOC NEPHRO, V6, P2150, DOI 10.2215/CJN.00130111	46	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0122877	10.1371/journal.pone.0122877	http://dx.doi.org/10.1371/journal.pone.0122877			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961558	gold, Green Published, Green Submitted			2022-12-26	WOS:000354542500004
J	Ji, HS; Ding, YJ; Liu, XY; Li, LQ; Zhang, DX; Li, ZC; Sun, JL; Lashari, MS; Joseph, S; Meng, YD; Kuzyakov, Y; Pan, GX				Ji, Haishi; Ding, Yuanjun; Liu, Xiaoyu; Li, Lianqing; Zhang, Dengxiao; Li, Zichuan; Sun, Jingling; Lashari, Muhammad Siddique; Joseph, Stephen; Meng, Yuanduo; Kuzyakov, Yakov; Pan, Genxing			Root-Derived Short-Chain Suberin Diacids from Rice and Rape Seed in a Paddy Soil under Rice Cultivar Treatments	PLOS ONE			English	Article							TOPSOIL ORGANIC-CARBON; LIQUID-CHROMATOGRAPHY; MATTER; SEQUESTRATION; EXTRACTION; BIOMARKERS; SEPARATION; CUTIN; CHINA; DEGRADATION	Suberin-derived substituted fatty acids have been shown to be potential biomarkers for plant-derived carbon (C) in soils across ecosystems. Analyzing root derived suberin compounds bound in soil could help to understand the root input into a soil organic carbon pool. In this study, bound lipids were extracted and identified in root and topsoil samples. Shortchain suberin diacids were quantified under rice (Oryza sativa L.) and rape (Brassica campestris) rotations with different cultivar combinations in a Chinese rice paddy. After removal of free lipids with sequential extraction, the residual bound lipids were obtained with saponification and derivatization before analysis using gas chromatography-mass spectrometry (GC-MS). Diacids C16 and C18 in bound lipids were detected both in rice and rape root samples, while diacids C20 and C22 were detected only in rape root samples. Accordingly, diacids were quantified in both rhizosphere and bulk soil (0-15 cm). The amount of total root-derived diacids in bulk soil varied in a range of 5.6-9.6 mg/kg across growth stages and crop seasons. After one year-round rice-rape rotation, root-derived suberin diacids were maintained at a level of 7-9 mg/kg in bulk soil; this was higher under a super rice cultivar LY than under a hybrid cultivar IIY. While concentrations of the analyzed diacids were generally higher in rhizosphere than in bulk soil, the total diacid (DA) concentration was higher at the time of rape harvest than at rice harvest, suggesting that rape roots made a major contribution to the preservation of diacids in the paddy. Moreover, the net change in the concentration and the ratios of C-16:0 DA to C-18:1 DA, and of C-16:0 DA to C-18:0 DA, over a whole growing season, were greater under LY than under IIY, though there was no difference between cultivars within a single growth stage. Overall, total concentration of root-derived suberin diacids was found to be positively correlated to soil organic carbon concentration both for bulk soil and rhizosphere. However, the turnover and preservation of the root suberin biomolecules with soil property and field conditions deserve further field studies.	[Ji, Haishi; Ding, Yuanjun; Liu, Xiaoyu; Li, Lianqing; Zhang, Dengxiao; Li, Zichuan; Sun, Jingling; Lashari, Muhammad Siddique; Joseph, Stephen; Pan, Genxing] Nanjing Agr Univ, Inst Resource Ecosyst & Environm Agr, Nanjing 210095, Jiangsu, Peoples R China; [Joseph, Stephen] Univ Newcastle, Discipline Chem, Callaghan, NSW 2308, Australia; [Meng, Yuanduo] Natl Agr Tech Extens & Serv Ctr, Beijing 100026, Peoples R China; [Kuzyakov, Yakov] Univ Gottingen, Dept Soil Sci Temperate Ecosyst, D-37077 Gottingen, Germany; [Kuzyakov, Yakov] Univ Gottingen, Dept Agr Soil Sci, D-37077 Gottingen, Germany; [Kuzyakov, Yakov] Kazan Fed Univ, Inst Environm Sci, Kazan 420049, Russia; [Pan, Genxing] Zhejiang Agroforestry Univ, Res Ctr Terr Ecosyst Carbon Sink & Land Remediat, Hangzhou 311300, Zhejiang, Peoples R China	Nanjing Agricultural University; University of Newcastle; University of Gottingen; University of Gottingen; Kazan Federal University	Pan, GX (corresponding author), Nanjing Agr Univ, Inst Resource Ecosyst & Environm Agr, Nanjing 210095, Jiangsu, Peoples R China.	pangenxing@aliyun.com	Pan, Genxing/AAH-8501-2019; Kuzyakov, Yakov/D-1605-2010	Kuzyakov, Yakov/0000-0002-9863-8461; Li, Lianqing/0000-0002-0022-1108	China Natural Science Foundation [40830528]	China Natural Science Foundation(National Natural Science Foundation of China (NSFC))	The present research was funded by the China Natural Science Foundation under grant numbers 40830528. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernards MA, 2002, CAN J BOT, V80, P227, DOI [10.1139/B02-017, 10.1139/b02-017]; Butler JL, 2003, APPL ENVIRON MICROB, V69, P6793, DOI 10.1128/AEM.69.11.6793-6800.2003; CAMBARDELLA CA, 1992, SOIL SCI SOC AM J, V56, P777, DOI 10.2136/sssaj1992.03615995005600030017x; Cheng S., 1998, CHINA RICE, V1, P3; Cheng SH, 2007, J INTEGR PLANT BIOL, V49, P805, DOI [10.1111/j.1744-7909.2007.00514.x, 10.1111/j.1672-9072.2007.00514.x]; Crow SE, 2009, GLOBAL CHANGE BIOL, V15, P2003, DOI 10.1111/j.1365-2486.2009.01850.x; Dinel H., 1990, Soil biochemistry. Volume 6., P397; FAO, 2014, WORLD SOIL RESOURCES; FAO, 2006, FAOSTAT; Feng XJ, 2007, ORG GEOCHEM, V38, P1558, DOI 10.1016/j.orggeochem.2007.05.001; Fiorentino G, 2006, TALANTA, V68, P1135, DOI 10.1016/j.talanta.2005.07.037; Franke R, 2005, PHYTOCHEMISTRY, V66, P2643, DOI 10.1016/j.phytochem.2005.09.027; Gandini A, 2006, PROG POLYM SCI, V31, P878, DOI 10.1016/j.progpolymsci.2006.07.004; Gregorich EG, 1996, SOIL SCI, V161, P680, DOI 10.1097/00010694-199610000-00005; Hamer U, 2012, EUR J SOIL SCI, V63, P808, DOI 10.1111/j.1365-2389.2012.01476.x; Hu BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044122; Huang Z., 1998, SW CHINA J AGR SCI, V11, P27; Hussain Q, 2011, FEMS MICROBIOL ECOL, V78, P116, DOI 10.1111/j.1574-6941.2011.01128.x; Kolattukudy PE, 2001, ADV BIOCHEM ENG BIOT, V71, P1; KOLATTUKUDY PE, 1975, PLANT PHYSIOL, V55, P567, DOI 10.1104/pp.55.3.567; Kuzyakov Y, 2006, SOIL BIOL BIOCHEM, V38, P747, DOI 10.1016/j.soilbio.2005.06.025; Kuzyakov Y, 2000, J PLANT NUTR SOIL SC, V163, P421, DOI 10.1002/1522-2624(200008)163:4<421::AID-JPLN421>3.0.CO;2-R; Liu D., 2011, BIOGEOSCI DISCUSS, V8, P1529, DOI DOI 10.5194/BGD-8-1529-2011; Lu RK., 2000, METHODS SOIL AGROCHE, p[2, 10, 13]; Mendez-Millan M, 2010, ORG GEOCHEM, V41, P187, DOI 10.1016/j.orggeochem.2009.10.008; Mendez-Millan M, 2010, SOIL BIOL BIOCHEM, V42, P169, DOI 10.1016/j.soilbio.2009.10.010; Meng YuanDuo, 2011, Journal of Agro-Environment Science, V30, P1822; Molina I, 2006, PHYTOCHEMISTRY, V67, P2597, DOI 10.1016/j.phytochem.2006.09.011; Nebbioso A, 2011, BIOMACROMOLECULES, V12, P1187, DOI 10.1021/bm101488e; Nierop KGJ, 2003, ORG GEOCHEM, V34, P719, DOI 10.1016/S0146-6380(03)00042-1; [潘根兴 Pan Genxing], 2005, [地球科学进展, Advance in Earth Sciences], V20, P384; [潘根兴 PAN GenXing], 2006, [生态学报, Acta Ecologica Sinica], V26, P3704; Pan GX, 2004, GLOBAL CHANGE BIOL, V10, P79, DOI 10.1111/j.1365-2486.2003.00717.x; PAN GX, 2003, GLOBAL CHANGE BIOL, V10, P79, DOI DOI 10.1046/J.1529-8817.2003.00717.X; Piccolo A, 2004, CLIMATIC CHANGE, V67, P329, DOI 10.1007/s10584-004-1822-1; Quenea K, 2006, ORG GEOCHEM, V37, P20, DOI 10.1016/j.orggeochem.2005.08.021; Rasse DP, 2005, PLANT SOIL, V269, P341, DOI 10.1007/s11104-004-0907-y; RAY AK, 1995, PHYTOCHEMISTRY, V38, P1361, DOI 10.1016/0031-9422(94)00627-6; Schreiber L, 2005, J EXP BOT, V56, P1427, DOI 10.1093/jxb/eri144; Smith P., 2007, CONTRIBUTION WORKING; Song X, 2011, GEOPH RES EGU GEN AS; Spaccini R, 2009, SOIL BIOL BIOCHEM, V41, P1164, DOI 10.1016/j.soilbio.2009.02.026; Spielvogel S, 2010, SOIL SOL CHANG WORLD; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wiesenberg GLB, 2004, EUR J SOIL SCI, V55, P349, DOI 10.1111/j.1351-0754.2004.00601.x; Wiesenberg GLB, 2006, ORG GEOCHEM, V37, P1973, DOI 10.1016/j.orggeochem.2006.07.020; Wiesenberg GLB, 2010, ORG GEOCHEM, V41, P1049, DOI 10.1016/j.orggeochem.2009.12.007; Wissing L, 2011, CATENA, V87, P376, DOI 10.1016/j.catena.2011.07.007; Zhang XH, 2007, J ENVIRON SCI, V19, P319, DOI 10.1016/S1001-0742(07)60052-7; Zheng JF, 2011, CHINESE SCI BULL, V56, P3748, DOI 10.1007/s11434-011-4693-7; Zhou Ping, 2006, Plant Nutrition and Fertilizer Science, V12, P765; Zhou Ping, 2009, Scientia Agricultura Sinica, V42, P4260; Zhou P, 2009, GEODERMA, V153, P52, DOI 10.1016/j.geoderma.2009.07.018	53	9	10	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0127474	10.1371/journal.pone.0127474	http://dx.doi.org/10.1371/journal.pone.0127474			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961557	Green Published, gold, Green Submitted			2022-12-26	WOS:000354542500172
J	Fabbi, P; Spallarossa, P; Garibaldi, S; Barisione, C; Mura, M; Altieri, P; Rebesco, B; Monti, MG; Canepa, M; Ghigliotti, G; Brunelli, C; Ameri, P				Fabbi, Patrizia; Spallarossa, Paolo; Garibaldi, Silvano; Barisione, Chiara; Mura, Marzia; Altieri, Paola; Rebesco, Barbara; Monti, Maria Gaia; Canepa, Marco; Ghigliotti, Giorgio; Brunelli, Claudio; Ameri, Pietro			Doxorubicin Impairs the Insulin-Like Growth Factor-1 System and Causes Insulin-Like Growth Factor-1 Resistance in Cardiomyocytes	PLOS ONE			English	Article							CARDIAC STEM-CELLS; INDUCED CARDIOTOXICITY; INDUCED CARDIOMYOPATHY; BINDING PROTEIN-3; MYOCARDIAL-INFARCTION; FACTOR-RECEPTOR; APOPTOSIS; HEART; P53; MICE	Background Insulin-like growth factor-1 (IGF-1) promotes the survival of cardiomyocytes by activating type 1 IGF receptor (IGF-1R). Within the myocardium, IGF-1 action is modulated by IGF binding protein-3 (IGFBP-3), which sequesters IGF-1 away from IGF-1R. Since cardiomyocyte apoptosis is implicated in anthracycline cardiotoxicity, we investigated the effects of the anthracycline, doxorubicin, on the IGF-1 system in H9c2 cardiomyocytes. Methods and Results Besides inducing apoptosis, concentrations of doxorubicin comparable to those observed in patients after bolus infusion (0.1-1 mu M) caused a progressive decrease in IGF-1R and increase in IGFBP-3 expression. Exogenous IGF-1 was capable to rescue cardiomyocytes from apoptosis triggered by 0.1 and 0.5 mu M, but not 1 mu M doxorubicin. The loss of response to IGF-1 was paralleled by a significant reduction in IGF-1 availability and signaling, as assessed by free hormone levels in conditioned media and Akt phosphorylation in cell lysates, respectively. Doxorubicin also dose-dependently induced p53, which is known to repress the transcription of IGF1R and induce that of IGFBP3. Pre-treatment with the p53 inhibitor, pifithrin-alpha, prevented apoptosis and the changes in IGF-1R and IGFBP-3 elicited by doxorubicin. The decrease in IGF-1R and increase in IGFBP-3, as well as apoptosis, were also antagonized by pre-treatment with the antioxidant agents, N-acetylcysteine, dexrazoxane, and carvedilol. Conclusions Doxorubicin down-regulates IGF-1R and up-regulates IGFBP-3 via p53 and oxidative stress in H9c2 cells. This leads to resistance to IGF-1 that may contribute to doxorubicin-initiated apoptosis. Further studies are needed to confirm these findings in human cardiomyocytes and explore the possibility of manipulating the IGF-1 axis to protect against anthracycline cardiotoxicity.	[Fabbi, Patrizia; Spallarossa, Paolo; Garibaldi, Silvano; Barisione, Chiara; Mura, Marzia; Altieri, Paola; Canepa, Marco; Ghigliotti, Giorgio; Brunelli, Claudio; Ameri, Pietro] Univ Genoa, Res Ctr Cardiovasc Biol, Dept Internal Med, Genoa, Italy; [Rebesco, Barbara] IRCCS AOU San Martino IST, Antiblast Drug Unit, Genoa, Italy; [Monti, Maria Gaia] Univ Naples Federico II, Dept Med Translat Sci, Naples, Italy	University of Genoa; University of Genoa; IRCCS AOU San Martino IST; University of Naples Federico II	Ameri, P (corresponding author), Univ Genoa, Res Ctr Cardiovasc Biol, Dept Internal Med, Genoa, Italy.	pietroameri@unige.it	Spallarossa, Paolo/AAC-8981-2019; Canepa, Marco/K-3850-2018; Monti, Maria Gaia/I-8472-2012; Ameri, Pietro/K-8556-2016	Monti, Maria Gaia/0000-0002-3795-5762; Ameri, Pietro/0000-0001-7167-7287; Ghigliotti, Giorgio/0000-0001-8484-542X; CANEPA, MARCO/0000-0001-9063-5576				BUCKBINDER L, 1995, NATURE, V377, P646, DOI 10.1038/377646a0; D'Amario D, 2011, CIRC RES, V108, P1467, DOI 10.1161/CIRCRESAHA.111.240648; De Angelis A, 2010, CIRCULATION, V121, P276, DOI 10.1161/CIRCULATIONAHA.109.895771; Dean R, 1999, J HISTOCHEM CYTOCHEM, V47, P649, DOI 10.1177/002215549904700507; Dean RG, 2003, J HISTOCHEM CYTOCHEM, V51, P831, DOI 10.1177/002215540305100614; DERCOLE AJ, 1984, P NATL ACAD SCI-BIOL, V81, P935, DOI 10.1073/pnas.81.3.935; Esaki M, 2008, AM J PHYSIOL-HEART C, V294, pH1048, DOI 10.1152/ajpheart.01102.2007; Granata R, 2003, J ENDOCRINOL INVEST, V26, P1231, DOI 10.1007/BF03349163; HESCHELER J, 1991, CIRC RES, V69, P1476, DOI 10.1161/01.RES.69.6.1476; Holly J, 2006, NEUROENDOCRINOLOGY, V83, P154, DOI 10.1159/000095523; Horio T, 2005, REGUL PEPTIDES, V124, P65, DOI 10.1016/j.regpep.2004.06.029; Hu BS, 2007, AM J PHYSIOL-HEART C, V293, pH677, DOI 10.1152/ajpheart.01413.2006; Ikeda Y, 2010, MOL ENDOCRINOL, V24, P1338, DOI 10.1210/me.2009-0402; Jogie-Brahim S, 2009, ENDOCR REV, V30, P417, DOI 10.1210/er.2008-0028; Li Q, 1997, J CLIN INVEST, V100, P1991, DOI 10.1172/JCI119730; Lotrionte M, 2013, AM J CARDIOL, V112, P1980, DOI 10.1016/j.amjcard.2013.08.026; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Morales MP, 2000, BIOCHEM BIOPH RES CO, V270, P1029, DOI 10.1006/bbrc.2000.2550; Nakamura T, 2000, CIRCULATION, V102, P572; Nithipongvanitch R, 2007, ANTIOXID REDOX SIGN, V9, P1001, DOI 10.1089/ars.2007.1632; Octavia Y, 2012, J MOL CELL CARDIOL, V52, P1213, DOI 10.1016/j.yjmcc.2012.03.006; Oikonomopoulos A, 2011, CIRC RES, V109, P1363, DOI 10.1161/CIRCRESAHA.111.250282; Piegari E, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0334-4; Ren J, 1999, J MOL CELL CARDIOL, V31, P2049, DOI 10.1006/jmcc.1999.1036; Shizukuda Y, 2005, MOL CELL BIOCHEM, V273, P25, DOI 10.1007/s11010-005-5905-8; Spallarossa P, 2004, J MOL CELL CARDIOL, V37, P837, DOI 10.1016/j.yjmcc.2004.05.024; Takeda N, 2010, J CLIN INVEST, V120, P254, DOI 10.1172/JCI40295; Troncoso R, 2014, TRENDS ENDOCRIN MET, V25, P128, DOI 10.1016/j.tem.2013.12.002; Urbanek K, 2005, CIRC RES, V97, P663, DOI 10.1161/01.RES.0000183733.53101.11; Vejpongsa P, 2014, J AM COLL CARDIOL, V64, P938, DOI 10.1016/j.jacc.2014.06.1167; Wang L, 1998, CIRC RES, V83, P516, DOI 10.1161/01.RES.83.5.516; Werner H, 1996, P NATL ACAD SCI USA, V93, P8318, DOI 10.1073/pnas.93.16.8318; Wu WH, 2000, J BIOL CHEM, V275, P40113, DOI 10.1074/jbc.M004108200; Yoshida M, 2009, J MOL CELL CARDIOL, V47, P698, DOI 10.1016/j.yjmcc.2009.07.024; Yu XY, 2010, EXP CELL RES, V316, P2903, DOI 10.1016/j.yexcr.2010.07.004; Zhang S, 2012, NAT MED, V18, P1639, DOI 10.1038/nm.2919	36	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0124643	10.1371/journal.pone.0124643	http://dx.doi.org/10.1371/journal.pone.0124643			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955698	Green Published, Green Submitted, gold			2022-12-26	WOS:000356768100032
J	Hu, JL; Tan, ZM; Ren, DF; Zhang, X; He, YL; Bao, CJ; Liu, DP; Yi, QH; Qian, WJ; Yin, J; Xu, Z; Yu, CX; Wang, SJ; Wu, B; Yang, HY; Yue, M; Zhang, Y; Liu, WD; Zhu, YF; Zhou, MH; Tang, FY				Hu, Jianli; Tan, Zhongming; Ren, Dafei; Zhang, Xiang; He, Yilin; Bao, Changjun; Liu, Dapeng; Yi, Qianhua; Qian, Weijuan; Yin, Jun; Xu, Zhen; Yu, Chunxia; Wang, Shenjiao; Wu, Bin; Yang, Haiyu; Yue, Ming; Zhang, Yun; Liu, Wendong; Zhu, Yefei; Zhou, Minghao; Tang, Fenyang			Clinical Characteristics and Risk Factors of an Outbreak with Scrub Typhus in Previously Unrecognized Areas, Jiangsu Province, China 2013	PLOS ONE			English	Article							ORIENTIA-TSUTSUGAMUSHI; STRAINS	Scrub typhus, caused by Orientia tsutsugamushi, has emerged recently in Jingjiang City, China where the disease had not been known to exist. We analyzed epidemiological data, clinical characteristics and risk factors of scrub typhus outbreak in Jingjiang City, 2013. The 271 clinically diagnosed patients were predominantly farmers 50 to 69 years old and the peak of onset was early to mid-November. For the 187 laboratory-confirmed cases, the major clinical manifestations of the patients were fever (100%), eschar (88.2%), rash (87.7%), chills (87.7%), and headache (66.8%). A community-based case-control study was carried out to investigate the risk factors of the scrub typhus outbreak. Bundling or moving waste straw (OR=9.0, 95% CI 4.6-17.8) and living at the edge of village (OR=0.6, 95% CI 0.4-0.9) posed the highest risks through single-and multi-variable conditional logistic regression. Phylogenetic analysis of the 56-kDa TSA gene showed that the new cluster (GB-C2) and the previously reported cluster (GB-C1) of O. tsutsugamushi were associated with this outbreak. These findings are useful for the establishment of a detailed control strategy for scrub typhus infection in previously unrecognized areas of Jiangsu Province, China.	[Hu, Jianli; Tan, Zhongming; Bao, Changjun; Liu, Dapeng; Wang, Shenjiao; Wu, Bin; Liu, Wendong; Zhu, Yefei; Zhou, Minghao; Tang, Fenyang] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Ren, Dafei] Tongren Municipal Ctr Dis Control & Prevent, Tongren, Peoples R China; [Zhang, Xiang; He, Yilin; Yi, Qianhua; Yu, Chunxia; Yang, Haiyu] Taizhou Municipal Ctr Dis Control & Prevent, Taizhou, Peoples R China; [Qian, Weijuan; Yin, Jun; Xu, Zhen] Jingjiang Cty Ctr Dis Control & Prevent, Jingjiang, Peoples R China; [Yue, Ming] Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Zhang, Yun] Huadong Res Inst Med & Biotech, Nanjing, Jiangsu, Peoples R China	Jiangsu Provincial Center for Disease Control & Prevention; Nanjing Medical University	Tang, FY (corresponding author), Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China.	tfyepi@163.com	岳, 明/AAX-5776-2021; zhou, minghao/GZA-7244-2022	岳, 明/0000-0002-7677-0832; 	Innovation Plat-form for Public Health Emergency Preparedness and Response [ZX201109]; Natural Science Foundation of China [81472932]	Innovation Plat-form for Public Health Emergency Preparedness and Response; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by the Innovation Plat-form for Public Health Emergency Preparedness and Response (No. ZX201109) and Natural Science Foundation of China (No. 81472932). The Innovation Plat-form for Public Health Emergency Preparedness and Response had a role in study design. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Chattopadhyay S, 2007, HUM VACCINES, V3, P73, DOI 10.4161/hv.3.3.4009; Chinese Center for Disease Control and Prevention, 2009, SCRUB TYPH CONTR PRE; Coleman RE, 2002, AM J TROP MED HYG, V67, P497, DOI 10.4269/ajtmh.2002.67.497; Enatsu T, 1999, FEMS MICROBIOL LETT, V180, P163, DOI 10.1111/j.1574-6968.1999.tb08791.x; Guo HB, 1994, CHIN J EPIDEMIOL, V1, P27; Kamarasu K, 2007, INDIAN J MED RES, V126, P128; Kelly DJ, 2009, CLIN INFECT DIS, V48, pS203, DOI 10.1086/596576; Kelly DJ, 2002, CLIN INFECT DIS, V34, pS145, DOI 10.1086/339908; Kim DM, 2006, AM J TROP MED HYG, V75, P542, DOI 10.4269/ajtmh.2006.75.542; Kweon SS, 2009, AM J TROP MED HYG, V80, P442, DOI 10.4269/ajtmh.2009.80.442; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Watt G, 2003, CURR OPIN INFECT DIS, V16, P429, DOI 10.1097/00001432-200310000-00009; Wu GH, 2000, CHIN J INFECT DIS, V18, P142; Zhang Lijuan, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P482; Zhang M, 2012, AM J TROP MED HYG, V87, P1099, DOI 10.4269/ajtmh.2012.12-0306; Zhang Meng, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P419; Zhang SY, 2010, J CLIN MICROBIOL, V48, P1241, DOI 10.1128/JCM.01784-09	17	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0125999	10.1371/journal.pone.0125999	http://dx.doi.org/10.1371/journal.pone.0125999			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25954814	Green Submitted, Green Published, gold			2022-12-26	WOS:000356768100090
J	Jain, A; Lim, C; Gan, EM; Ng, DZ; Ng, QS; Ang, MK; Takano, A; Chan, KS; Tan, WM; Kanesvaran, R; Toh, CK; Loo, CM; Hsu, AAL; Devanand, A; Lim, CH; Koong, HN; Koh, T; Fong, KW; Yap, SP; Kim, SW; Chowbay, B; Oon, L; Lim, KH; Lim, WT; Tan, EH; Tan, DSW				Jain, Amit; Lim, Cindy; Gan, Eugene MingJin; Ng, David Zhihao; Ng, Quan Sing; Ang, Mei Kim; Takano, Angela; Chan, Kian Sing; Tan, Wu Meng; Kanesvaran, Ravindran; Toh, Chee Keong; Loo, Chian Min; Hsu, Anne Ann Ling; Devanand, Anantham; Lim, Chong Hee; Koong, Heng Nung; Koh, Tina; Fong, Kam Weng; Yap, Swee Peng; Kim, Su Woon; Chowbay, Balram; Oon, Lynette; Lim, Kiat Hon; Lim, Wan Teck; Tan, Eng Huat; Tan, Daniel Shao Weng			Impact of Smoking and Brain Metastasis on Outcomes of Advanced EGFR Mutation Lung Adenocarcinoma Patients Treated with First Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors	PLOS ONE			English	Article							1ST-LINE TREATMENT; OPEN-LABEL; EXON 19; CANCER; GEFITINIB; ERLOTINIB; CHEMOTHERAPY; SURVIVAL; MULTICENTER; SMOKERS	Objectives This purpose of this study was to examine clinical-pathologic factors - particularly smoking and brain metastases - in EGFR mutation positive (M+) lung adenocarcinoma (ADC) to determine their impact on survival in patients treated with first line EGFR TKI. Methods A retrospective review of EGFR mutation reflex testing experience for all ADC diagnosed at a tertiary Asian cancer centre from January 2009 to April 2013. Amongst this cohort, patients with advanced EGFR M+ ADC treated with first line EGFR TKI were identified to determine factors that influence progression free and overall survival. Results 444/742 (59.8%) ADC reflex tested for EGFR mutations were EGFR M+. Amongst never-smokers (n=468), EGFR M+ were found in 74.5% of females and 76.3% of males, and amongst ever smokers (n=283), in 53.3% of females and 35.6% of males. Exon 20 mutations were found more commonly amongst heavy smokers (> 50 pack years and > 20 pack years, Pearson's chi square p=0.044, and p=0.038 respectively). 211 patients treated with palliative first line TKI had a median PFS and OS of 9.2 and 19.6 months respectively. 26% of patients had brain metastasis at diagnosis. This was significantly detrimental to overall survival (HR 1.85, CI 1.09-3.16, p=0.024) on multivariate analysis. There was no evidence that smoking status had a significant impact on survival. Conclusions The high prevalence of EGFR M+ in our patient population warrants reflex testing regardless of gender and smoking status. Smoking status and dosage did not impact progression free or overall survival in patients treated with first line EGFR TKI. The presence of brain metastasis at diagnosis negatively impacts overall survival.	[Jain, Amit; Ng, Quan Sing; Ang, Mei Kim; Tan, Wu Meng; Kanesvaran, Ravindran; Toh, Chee Keong; Lim, Wan Teck; Tan, Eng Huat; Tan, Daniel Shao Weng] Natl Canc Ctr Singapore, Div Med Oncol, Singapore, Singapore; [Lim, Cindy] Natl Canc Ctr Singapore, Clin Trials & Epidemiol Sci, Singapore, Singapore; [Gan, Eugene MingJin] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117548, Singapore; [Takano, Angela; Chan, Kian Sing; Oon, Lynette; Lim, Kiat Hon] Singapore Gen Hosp, Dept Pathol, Singapore, Singapore; [Loo, Chian Min; Hsu, Anne Ann Ling; Devanand, Anantham] Singapore Gen Hosp, Resp & Crit Care Med, Singapore, Singapore; [Lim, Chong Hee] Natl Heart Ctr Singapore, Dept Cardiothorac Surg, Singapore, Singapore; [Koong, Heng Nung; Koh, Tina] Natl Canc Ctr Singapore, Div Surg Oncol, Singapore, Singapore; [Fong, Kam Weng; Yap, Swee Peng; Kim, Su Woon] Natl Canc Ctr Singapore, Div Radiat Oncol, Singapore, Singapore; [Chowbay, Balram] Natl Canc Ctr Singapore, Div Med Sci, Clin Pharmacol Lab, Singapore, Singapore; [Tan, Daniel Shao Weng] Natl Canc Ctr Singapore, Div Med Sci, Canc Therapeut Res Lab, Singapore, Singapore; [Tan, Daniel Shao Weng] Genome Inst Singapore, Canc Stem Cell Biol, Singapore, Singapore	National Cancer Centre Singapore (NCCS); National Cancer Centre Singapore (NCCS); National University of Singapore; Singapore General Hospital; Singapore General Hospital; National Heart Centre Singapore; National Cancer Centre Singapore (NCCS); National Cancer Centre Singapore (NCCS); National Cancer Centre Singapore (NCCS); National Cancer Centre Singapore (NCCS); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Tan, DSW (corresponding author), Natl Canc Ctr Singapore, Div Med Oncol, Singapore, Singapore.	daniel.tan.s.w@nccs.com.sg	Lim, Darren Wan-Teck/V-8435-2019; Lim, Darren Wan Teck/L-2007-2016; Toh, Chee-Keong/AAC-9610-2020	Lim, Darren Wan-Teck/0000-0002-4655-0206; Lim, Darren Wan Teck/0000-0002-4655-0206; Kanesvaran, Ravindran/0000-0002-2351-881X; Toh, Chee-Keong/0000-0002-5691-6144; Lim, Cindy/0000-0002-8036-4554	National Medical Research Council [NMRC/1224/2009]; National Cancer Centre Research Fund [NRFMP10111-10112]	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Cancer Centre Research Fund	This work is supported in part by a National Medical Research Council Grant (NMRC/1224/2009), National Cancer Centre Research Fund (NRFMP10111-10112). We are also grateful to the Trailblazer Foundation Ltd. and Singapore Millennium Foundation Ltd for their instrumental support to the Lung Cancer Consortium Singapore (NRFTB11122). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dearden S, 2013, ANN ONCOL, V24, P2371, DOI 10.1093/annonc/mdt205; Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Grommes C, 2011, NEURO-ONCOLOGY, V13, P1364, DOI 10.1093/neuonc/nor121; Heon S, 2012, CLIN CANCER RES, V18, P4406, DOI 10.1158/1078-0432.CCR-12-0357; Jamal-Hanjani M, 2012, CLIN CANCER RES, V18, P938, DOI 10.1158/1078-0432.CCR-11-2529; Kim MH, 2014, ACCEPTED MANUSCRIPT, P1; Lee VHF, 2013, J THORAC ONCOL, V8, P1148, DOI 10.1097/JTO.0b013e31829f684a; Lim SH, 2014, J THORAC ONCOL, V9, P506, DOI 10.1097/JTO.0000000000000095; Lopes GD, 2012, CANCER-AM CANCER SOC, V118, P1032, DOI 10.1002/cncr.26372; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Mitchell P, 2012, CLIN LUNG CANCER, V13, P239, DOI 10.1016/j.cllc.2011.08.003; Mitsudomi T, 2011, LANCET ONCOL, V12, P710, DOI 10.1016/S1470-2045(11)70194-2; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Morita S, 2009, CLIN CANCER RES, V15, P4493, DOI 10.1158/1078-0432.CCR-09-0391; Paik PK, 2012, CANCER-AM CANCER SOC, V118, P5840, DOI 10.1002/cncr.27637; Park SJ, 2012, LUNG CANCER, V77, P556, DOI 10.1016/j.lungcan.2012.05.092; Porta R, 2011, EUR RESPIR J, V37, P624, DOI 10.1183/09031936.00195609; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Sequist LV, 2013, JOURNAL OF CLINICAL; Shin DY, 2014, J THORAC ONCOL, V9, P195, DOI 10.1097/JTO.0000000000000069; Stanic K, 2014, RADIOL ONCOL, V48, P173, DOI 10.2478/raon-2014-0016; Tan DSW, 2014, INT J CANCER; Togashi Y, 2012, CANCER CHEMOTH PHARM, V70, P399, DOI 10.1007/s00280-012-1929-4; Wu YL, 2013, ANN ONCOL, V24, P993, DOI 10.1093/annonc/mds529; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	27	22	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0123587	10.1371/journal.pone.0123587	http://dx.doi.org/10.1371/journal.pone.0123587			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955322	Green Submitted, gold, Green Published			2022-12-26	WOS:000356768100018
J	Kamomae, T; Monzen, H; Nakayama, S; Mizote, R; Oonishi, Y; Kaneshige, S; Sakamoto, T				Kamomae, Takeshi; Monzen, Hajime; Nakayama, Shinichi; Mizote, Rika; Oonishi, Yuuichi; Kaneshige, Soichiro; Sakamoto, Takashi			Accuracy of Image Guidance Using Free-Breathing Cone-Beam Computed Tomography for Stereotactic Lung Radiotherapy	PLOS ONE			English	Article							X-RAY HEAD; GUIDED RADIOTHERAPY; RADIATION-THERAPY; QUALITY-ASSURANCE; GEOMETRIC ACCURACY; CT; SYSTEM; MOTION; PHANTOM; CANCER	Movement of the target object during cone-beam computed tomography (CBCT) leads to motion blurring artifacts. The accuracy of manual image matching in image-guided radiotherapy depends on the image quality. We aimed to assess the accuracy of target position localization using free-breathing CBCT during stereotactic lung radiotherapy. The Vero4DRT linear accelerator device was used for the examinations. Reference point discrepancies between the MV X-ray beam and the CBCT system were calculated using a phantom device with a centrally mounted steel ball. The precision of manual image matching between the CBCT and the averaged intensity (AI) images restructured from four-dimensional CT (4DCT) was estimated with a respiratory motion phantom, as determined in evaluations by five independent operators. Reference point discrepancies between the MV X-ray beam and the CBCT image-guidance systems, categorized as left-right (LR), anterior-posterior (AP), and superior-inferior (SI), were 0.33 +/- 0.09, 0.16 +/- 0.07, and 0.05 +/- 0.04 mm, respectively. The LR, AP, and SI values for residual errors from manual image matching were -0.03 +/- 0.22, 0.07 +/- 0.25, and -0.79 +/- 0.68 mm, respectively. The accuracy of target position localization using the Vero4DRT system in our center was 1.07 +/- 1.23 mm (2 SD). This study experimentally demonstrated the sufficient level of geometric accuracy using the free-breathing CBCT and the image-guidance system mounted on the Vero4DRT. However, the inter-observer variation and systematic localization error of image matching substantially affected the overall geometric accuracy. Therefore, when using the free-breathing CBCT images, careful consideration of image matching is especially important.	[Kamomae, Takeshi] Nagoya Univ, Dept Therapeut Radiol, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Kamomae, Takeshi; Kaneshige, Soichiro; Sakamoto, Takashi] Okayama Cent Hosp, Dept Radiat Oncol, Okayama, Japan; [Monzen, Hajime] Kinki Univ, Grad Sch Med Sci, Dept Radiat Oncol, Higashiosaka, Osaka 577, Japan; [Nakayama, Shinichi; Mizote, Rika; Oonishi, Yuuichi] Okayama Cent Hosp, Div Clin, Serv Radiol, Okayama, Japan	Nagoya University; Kindai University (Kinki University)	Monzen, H (corresponding author), Kinki Univ, Grad Sch Med Sci, Dept Radiat Oncol, Higashiosaka, Osaka 577, Japan.	hmon@med.kindai.ac.jp	Kamomae, Takeshi/I-7525-2014		Foundation for Promotion of Cancer Research in Japan	Foundation for Promotion of Cancer Research in Japan	This work was supported by the Foundation for Promotion of Cancer Research in Japan (http://www.fpcr.or.jp). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional funding was received for this study.	Benedict SH, 2010, MED PHYS, V37, P4078, DOI 10.1118/1.3438081; BIPM IEC IFCC ILAC ISO IUPAC IUPA OIML, 2008, EV MEAS DAT GUID EXP; Bissonnette JP, 2008, INT J RADIAT ONCOL, V71, pS57, DOI 10.1016/j.ijrobp.2007.06.086; Bissonnette JP, 2012, MED PHYS, V39, P1946, DOI 10.1118/1.3690466; Bissonnette JP, 2009, INT J RADIAT ONCOL, V73, P927, DOI 10.1016/j.ijrobp.2008.08.059; Clements N, 2013, MED PHYS, V40, DOI 10.1118/1.4773310; Depuydt T, 2011, RADIOTHER ONCOL, V98, P365, DOI 10.1016/j.radonc.2011.01.015; Du WL, 2010, MED PHYS, V37, P2256, DOI 10.1118/1.3397452; Dzyubak O, 2014, MED PHYS, V41, DOI 10.1118/1.4896101; Glide-Hurst C, 2013, MED PHYS, V40, DOI 10.1118/1.4790563; Hugo GD, 2007, INT J RADIAT ONCOL, V69, P1634, DOI 10.1016/j.ijrobp.2007.08.023; Jiang B, 2012, MED DOSIM, V37, P47, DOI 10.1016/j.meddos.2011.01.001; Jr REK, 2013, MED PHYS, V40, DOI [10.1118/1.4795336, DOI 10.1118/1.4795336]; Kamino Y, 2007, MED PHYS, V34, P1797, DOI 10.1118/1.2723878; Kamino Y, 2006, INT J RADIAT ONCOL, V66, P271, DOI 10.1016/j.ijrobp.2006.04.044; Keall PJ, 2004, PHYS MED BIOL, V49, P2053, DOI 10.1088/0031-9155/49/10/015; Klein EE, 2009, MED PHYS, V36, P4197, DOI 10.1118/1.3190392; LAX I, 1994, ACTA ONCOL, V33, P677, DOI 10.3109/02841869409121782; Lujan AE, 1999, MED PHYS, V26, P715, DOI 10.1118/1.598577; Miyabe Y, 2011, MED PHYS, V38, P2535, DOI 10.1118/1.3578607; Mukumoto N, 2012, MED PHYS, V39, P6287, DOI 10.1118/1.4754592; Nagata Y, 2002, INT J RADIAT ONCOL, V52, P1041, DOI 10.1016/S0360-3016(01)02731-6; Nakamura M, 2012, MED DOSIM, V37, P20, DOI 10.1016/j.meddos.2010.12.007; Ploquin N, 2008, MED PHYS, V35, P5303, DOI 10.1118/1.3005482; Sonke JJ, 2005, MED PHYS, V32, P1176, DOI 10.1118/1.1869074; Takakura T, 2010, PHYS MED BIOL, V55, P1, DOI 10.1088/0031-9155/55/1/001; Wulf J, 2004, INT J RADIAT ONCOL, V60, P186, DOI 10.1016/j.ijrobp.2004.02.060; Yoo S, 2009, INT J RADIAT ONCOL, V73, P296, DOI 10.1016/j.ijrobp.2008.09.006; Zhang QH, 2007, MED PHYS, V34, P4772, DOI 10.1118/1.2804576; Zhang QH, 2010, MED PHYS, V37, P2901, DOI 10.1118/1.3397460	30	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0126152	10.1371/journal.pone.0126152	http://dx.doi.org/10.1371/journal.pone.0126152			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25954809	Green Published, gold, Green Submitted			2022-12-26	WOS:000356768100101
J	Miljkovic, M; Strahinic, I; Tolinacki, M; Zivkovic, M; Kojic, S; Golic, N; Kojic, M				Miljkovic, Marija; Strahinic, Ivana; Tolinacki, Maja; Zivkovic, Milica; Kojic, Snezana; Golic, Natasa; Kojic, Milan			AggLb Is the Largest Cell-Aggregation Factor from Lactobacillus paracasei Subsp paracasei BGNJ1-64, Functions in Collagen Adhesion, and Pathogen Exclusion In Vitro	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; BINDING PROTEINS; SURFACE-PROTEINS; PROMOTING FACTOR; PLASMID DNA; LACTOCOCCUS; STRAINS; TRANSFORMATION; COAGGREGATION	Eleven Lactobacillus strains with strong aggregation abilities were selected from a laboratory collection. In two of the strains, genes associated with aggregation capability were plasmid located and found to strongly correlate with collagen binding. The gene encoding the auto-aggregation-promoting protein (AggLb) of Lactobacillus paracasei subsp. paracasei BGNJ1-64 was cloned using a novel, wide-range-host shuttle cloning vector, pAZILSJ. The clone pALb35, containing a 11377-bp DNA fragment, was selected from the SacI plasmid library for its ability to provide carriers with the aggregation phenotype. The complete fragment was sequenced and four potential ORFs were detected, including the aggLb gene and three surrounding transposase genes. AggLb is the largest known cell-surface protein in lactobacilli, consisting of 2998 aa (318,611 Da). AggLb belongs to the collagen-binding superfamily and its C-terminal region contains 20 successive repeats that are identical even at the nucleotide level. Deletion of aggLb causes a loss of the capacity to form cell aggregates, whereas overexpression increases cellular aggregation, hydrophobicity and collagen-binding potential. PCR screening performed with three sets of primers based on the aggLb gene of BGNJ1-64 enabled detection of the same type of aggLb gene in five of eleven selected aggregation-positive Lactobacillus strains. Heterologous expression of aggLb confirmed the crucial role of the AggLb protein in cell aggregation and specific collagen binding, indicating that AggLb has a useful probiotic function in effective colonization of host tissue and prevention of pathogen colonization.	[Miljkovic, Marija; Strahinic, Ivana; Tolinacki, Maja; Zivkovic, Milica; Golic, Natasa; Kojic, Milan] Univ Belgrade, Mol Microbiol Lab, Inst Mol Genet & Genet Engn, Belgrade 11010, Serbia; [Kojic, Snezana] Univ Belgrade, Mol Biol Lab, Inst Mol Genet & Genet Engn, Belgrade 11010, Serbia	University of Belgrade; University of Belgrade	Kojic, M (corresponding author), Univ Belgrade, Mol Microbiol Lab, Inst Mol Genet & Genet Engn, Vojvode Stepe 444-A,POB 23, Belgrade 11010, Serbia.	mkojic@imgge.bg.ac.rs	Kojic, Milan/I-4528-2019; Kojic, Snezana/AAF-4873-2019	Kojic, Milan/0000-0001-5645-750X; Zivkovic, Milica/0000-0003-1022-5767; Kojic, Snezana/0000-0001-5090-1278	Ministry of Education, Science and Technological Development, Republic of Serbia [OI 173019]	Ministry of Education, Science and Technological Development, Republic of Serbia	This work was supported by OI 173019, Ministry of Education, Science and Technological Development, Republic of Serbia, www.mpn.gov.rs, to MK.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDERSON DG, 1983, APPL ENVIRON MICROB, V46, P549, DOI 10.1128/AEM.46.3.549-552.1983; Bailey T.L., 1994, P 2 INT C INT SYST M; Barlow S, 2007, EFSA J, V5, DOI 10.2903/j.efsa.2007.587; Boris S, 1997, J APPL MICROBIOL, V83, P413, DOI 10.1046/j.1365-2672.1997.00250.x; Chen XY, 2007, INT J FOOD MICROBIOL, V115, P307, DOI 10.1016/j.ijfoodmicro.2006.11.007; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; Cucarella C, 2004, INFECT IMMUN, V72, P2177, DOI 10.1128/IAI.72.4.2177-2185.2004; Deivanayagam CCS, 2000, STRUCTURE, V8, P67, DOI 10.1016/S0969-2126(00)00081-2; Dubreuil JD, 2002, MICROBIOL MOL BIOL R, V66, P617, DOI 10.1128/MMBR.66.4.617-629.2002; Fimereli Danai K., 2012, Artificial Intelligence: Theories and Applications. Proceedings 7th Hellenic Conference on AI, SETN 2012, P285, DOI 10.1007/978-3-642-30448-4_36; Flock JI, 1999, MOL MED TODAY, V5, P532, DOI 10.1016/S1357-4310(99)01597-X; Food and Agriculture Organization of the United nations/World Health Organization (FAO/WHO), 2006, 85 FAOWHO; Garcia-Cayuela T, 2014, FOOD RES INT, V57, P44, DOI 10.1016/j.foodres.2014.01.010; Goh YJ, 2010, APPL ENVIRON MICROB, V76, P5005, DOI 10.1128/AEM.00030-10; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Holo H, 1995, Methods Mol Biol, V47, P195; Hopwood D. A., 1985, GENETIC MANIPULATION; Howard JC, 2000, APPL ENVIRON MICROB, V66, P4396, DOI 10.1128/AEM.66.10.4396-4400.2000; Jankovic I, 2003, J BACTERIOL, V185, P3288, DOI 10.1128/JB.185.11.3288-3296.2003; Kojic M, 2006, CAN J MICROBIOL, V52, P1110, DOI 10.1139/W06-072; Kojic M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-265; Kojic M, 2010, INT J FOOD MICROBIOL, V140, P117, DOI 10.1016/j.ijfoodmicro.2010.04.010; Kos B, 2003, J APPL MICROBIOL, V94, P981, DOI 10.1046/j.1365-2672.2003.01915.x; Lorca G, 2002, FEMS MICROBIOL LETT, V206, P31, DOI 10.1111/j.1574-6968.2002.tb10982.x; Lozo J, 2007, CURR MICROBIOL, V55, P266, DOI 10.1007/s00284-007-0159-1; Nikolic M, 2010, EUR FOOD RES TECHNOL, V231, P925, DOI 10.1007/s00217-010-1344-1; OSULLIVAN DJ, 1993, APPL ENVIRON MICROB, V59, P2730, DOI 10.1128/AEM.59.8.2730-2733.1993; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; Pelletier C, 1997, APPL ENVIRON MICROB, V63, P1725, DOI 10.1128/AEM.63.5.1725-1731.1997; Peter A, 2013, INT J BIOPHARM, V4, P140; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Prince T, 2012, APPL ENVIRON MICROB, V78, P5119, DOI 10.1128/AEM.00595-12; REID G, 1990, CURR MICROBIOL, V20, P47, DOI 10.1007/BF02094024; RENIERO R, 1992, J GEN MICROBIOL, V138, P763, DOI 10.1099/00221287-138-4-763; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Valenzuela AS, 2009, FOOD CONTROL, V20, P381, DOI 10.1016/j.foodcont.2008.06.004; Schachtsiek M, 2004, APPL ENVIRON MICROB, V70, P7078, DOI 10.1128/AEM.70.12.7078-7085.2004; Sillanpaa J, 2000, J BACTERIOL, V182, P6440, DOI 10.1128/JB.182.22.6440-6450.2000; SWITALSKI LM, 1993, MOL MICROBIOL, V7, P99, DOI 10.1111/j.1365-2958.1993.tb01101.x; Ton-That H, 1999, P NATL ACAD SCI USA, V96, P12424, DOI 10.1073/pnas.96.22.12424; Turpin W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057711; Turpin W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038034; Veljovic K, 2007, J APPL MICROBIOL, V103, P2142, DOI 10.1111/j.1365-2672.2007.03450.x; Vitetta L, 2013, PATHOGENS, V2, P606, DOI 10.3390/pathogens2040606; Walencka E, 2008, FOLIA MICROBIOL, V53, P61, DOI 10.1007/s12223-008-0009-y; Wasko A, 2014, ANAEROBE, V30, P161, DOI 10.1016/j.anaerobe.2014.10.002; Yadav AK, 2013, MICROBIOL RES, V168, P639, DOI 10.1016/j.micres.2013.05.003; Younes JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036917; Z?rate G., 2007, INFECT DIS OBSTET GY, V2007, P1, DOI DOI 10.1155/2007/48358	50	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0126387	10.1371/journal.pone.0126387	http://dx.doi.org/10.1371/journal.pone.0126387			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955159	Green Submitted, gold, Green Published			2022-12-26	WOS:000356768100115
J	Saavedra, K; Valbuena, J; Olivares, W; Marchant, MJ; Rodriguez, A; Torres-Estay, V; Carrasco-Avino, G; Guzman, L; Aguayo, F; Roa, JC; Corvalan, AH				Saavedra, Kathleen; Valbuena, Jose; Olivares, Wilda; Marchant, Maria Jose; Rodriguez, Andres; Torres-Estay, Veronica; Carrasco-Avino, Gonzalo; Guzman, Leda; Aguayo, Francisco; Roa, Juan Carlos; Corvalan, Alejandro H.			Loss of Expression of Reprimo, a p53-induced Cell Cycle Arrest Gene, Correlates with Invasive Stage of Tumor Progression and p73 Expression in Gastric Cancer	PLOS ONE			English	Article							SUPPRESSOR; HYPERMETHYLATION; METHYLATION; RISK	Reprimo (RPRM), a downstream effector of p53-induced cell cycle arrest at G2/M, has been proposed as a putative tumor suppressor gene (TSG) and as a potential biomarker for non-invasive detection of gastric cancer (GC). The aim of this study was to evaluate the epigenetic silencing of RPRM gene by promoter methylation and its tumor suppressor function in GC cell lines. Furthermore, clinical significance of RPRM protein product and its association with p53/p73 tumor suppressor protein family was explored. Epigenetic silencing of RPRM gene by promoter methylation was evaluated in four GC cell lines. Protein expression of RPRM was evaluated in 20 tumor and non-tumor matched cases. The clinical significance of RPRM association with p53/p73 tumor suppressor protein family was assessed in 114 GC cases. Tumor suppressor function was examined through functional assays. RPRM gene expression was negatively correlated with promoter methylation (Spearman rank r = -1; p = 0.042). RPRM overexpression inhibited colony formation and anchorage-independent growth. In clinical samples, RPRM gene protein expression was detected in 75% (15/20) of non-tumor adjacent mucosa, but only in 25% (5/20) of gastric tumor tissues (p = 0.001). Clinicopathological correlations of loss of RPRM expression were significantly associated with invasive stage of GC (stage I to II-IV, p = 0.02) and a positive association between RPRM and p73 gene protein product expression was found (p<0.0001 and kappa value = 0.363). In conclusion, epigenetic silencing of RPRM gene by promoter methylation is associated with loss of RPRM expression. Functional assays suggest that RPRM behaves as a TSG. Loss of expression of RPRM gene protein product is associated with the invasive stage of GC. Positive association between RPRM and p73 expression suggest that other members of the p53 gene family may participate in the regulation of RPRM expression.	[Saavedra, Kathleen; Olivares, Wilda; Rodriguez, Andres; Torres-Estay, Veronica; Roa, Juan Carlos; Corvalan, Alejandro H.] Pontificia Univ Catolica Chile, Adv Ctr Chron Dis ACCDiS, Santiago, Chile; [Saavedra, Kathleen; Olivares, Wilda; Rodriguez, Andres; Roa, Juan Carlos; Corvalan, Alejandro H.] Pontificia Univ Catolica Chile, UC Ctr Invest Oncol CITO, Santiago, Chile; [Saavedra, Kathleen] Univ La Frontera, Sci & Technol Bioresource Nucleus BIOREN, Ctr Estudios Genet & Inmunol CEGIN, Temuco, Chile; [Saavedra, Kathleen] Univ La Frontera, Dept Pathol, Temuco, Chile; [Valbuena, Jose; Roa, Juan Carlos] Pontificia Univ Catolica Chile, Dept Pathol, Santiago, Chile; [Marchant, Maria Jose; Guzman, Leda] Pontificia Univ Catolica Valparaiso, Inst Quim, Valparaiso, Chile; [Carrasco-Avino, Gonzalo] Univ Chile, Dept Pathol, Santiago, Chile; [Carrasco-Avino, Gonzalo] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA; [Aguayo, Francisco] Univ Chile, Inst Biomed Sci, Fac Med, Virol Program, Santiago, Chile; [Corvalan, Alejandro H.] Pontificia Univ Catolica Chile, Fac Med, Dept Hematol Oncol, Santiago, Chile	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Universidad de La Frontera; Universidad de La Frontera; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Valparaiso; Universidad de Chile; Icahn School of Medicine at Mount Sinai; Universidad de Chile; Pontificia Universidad Catolica de Chile	Corvalan, AH (corresponding author), Pontificia Univ Catolica Chile, Adv Ctr Chron Dis ACCDiS, Alameda 340, Santiago, Chile.	corvalan@med.puc.cl	Guzmán, Leda/AAF-5330-2020; Roa, Juan C./K-4749-2014; Torres, Veronica/AAT-2005-2021; Saavedra, Kathleen/GNH-6255-2022; Aguayo, Francisco/I-2851-2013	Roa, Juan C./0000-0001-8313-8774; Corvalan, Alejandro/0000-0001-5492-3853; Saavedra, Kathleen/0000-0001-5729-8854; Torres, Veronica/0000-0002-1882-8805	CONICYT-FONDECYT from the Government of Chile [1111014]; CONICYT-FONDAP from the Government of Chile [15130011]	CONICYT-FONDECYT from the Government of Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT-FONDAP from the Government of Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP)	This works was supported by grants CONICYT-FONDECYT#1111014 (AHC) and CONICYT-FONDAP#15130011 (AHC and JCR) from the Government of Chile.	Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Bernal C, 2008, CLIN CANCER RES, V14, P6264, DOI 10.1158/1078-0432.CCR-07-4522; Bernal C, 2008, BIOL RES, V41, P303, DOI [10.4067/S0716-97602008000300007, /S0716-97602008000300007]; Carrasco G, 2010, CLIN CANCER RES, V16, P3253, DOI 10.1158/1078-0432.CCR-09-2491; Forman D, 2013, CANC INCIDENCE 5 CON, VX; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Kovalev S, 1998, CELL GROWTH DIFFER, V9, P897; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LLORENS P, 1991, SEMIN SURG ONCOL, V7, P339, DOI 10.1002/ssu.2980070604; Marabese M, 2007, EUR J CANCER, V43, P1361, DOI 10.1016/j.ejca.2007.01.042; McLean MIH, 2014, NAT REV GASTRO HEPAT, V11, P664, DOI 10.1038/nrgastro.2014.143; Morris MR, 2010, ONCOGENE, V29, P2104, DOI 10.1038/onc.2009.493; Ohki R, 2000, J BIOL CHEM, V275, P22627, DOI 10.1074/jbc.C000235200; Ooki A, 2013, MOL CANCER RES, V11, P1362, DOI 10.1158/1541-7786.MCR-13-0091; Pasechnikov V, 2014, WORLD J GASTROENTERO, V20, P13842, DOI 10.3748/wjg.v20.i38.13842; Pflaumf J, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00285; Sapari NS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036275; Schneider BG, 2010, INT J CANCER, V127, P2588, DOI 10.1002/ijc.25274; VanLandingham JW, 2005, NEUROMOL MED, V7, P311, DOI 10.1385/NMM:7:4:311; Xu M, 2012, ENDOCRINOLOGY, V153, P2963, DOI 10.1210/en.2011-2021	22	30	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0125834	10.1371/journal.pone.0125834	http://dx.doi.org/10.1371/journal.pone.0125834			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25954972	gold, Green Submitted, Green Published			2022-12-26	WOS:000356768100080
J	Williams, AV; Boykin, LM; Howell, KA; Nevill, PG; Small, I				Williams, Anna V.; Boykin, Laura M.; Howell, Katharine A.; Nevill, Paul G.; Small, Ian			The Complete Sequence of the Acacia ligulata Chloroplast Genome Reveals a Highly Divergent clpP1 Gene	PLOS ONE			English	Article							PLASTID GENOME; AUSTRALIAN ACACIAS; DNA-SEQUENCES; LEGUMINOSAE; LEGUME; CONSERVATION; EVOLUTIONARY; MIMOSOIDEAE; PHYLOGENY; ALIGNMENT	Legumes are a highly diverse angiosperm family that include many agriculturally important species. To date, 21 complete chloroplast genomes have been sequenced from legume crops confined to the Papilionoideae subfamily. Here we report the first chloroplast genome from the Mimosoideae, Acacia ligulata, and compare it to the previously sequenced legume genomes. The A. ligulata chloroplast genome is 158,724 bp in size, comprising inverted repeats of 25,925 bp and single-copy regions of 88,576 bp and 18,298 bp. Acacia ligulata lacks the inversion present in many of the Papilionoideae, but is not otherwise significantly different in terms of gene and repeat content. The key feature is its highly divergent clpP1 gene, normally considered essential in chloroplast genomes. In A. ligulata, although transcribed and spliced, it probably encodes a catalytically inactive protein. This study provides a significant resource for further genetic research into Acacia and the Mimosoideae. The divergent clpP1 gene suggests that Acacia will provide an interesting source of information on the evolution and functional diversity of the chloroplast Clp protease complex.	[Williams, Anna V.; Boykin, Laura M.; Howell, Katharine A.; Small, Ian] Univ Western Australia, Australian Res Council Ctr Excellence Plant Energ, Crawley, WA, Australia; [Williams, Anna V.; Nevill, Paul G.] Kings Pk & Bot Gardens, Bot Gardens & Pk Author, Kings Pk, WA, Australia; [Williams, Anna V.; Nevill, Paul G.] Univ Western Australia, Sch Plant Biol, Crawley, WA, Australia; [Boykin, Laura M.; Small, Ian] Univ Western Australia, Ctr Excellence Computat Syst Biol, Crawley, WA, Australia	University of Western Australia; University of Western Australia; University of Western Australia	Small, I (corresponding author), Univ Western Australia, Australian Res Council Ctr Excellence Plant Energ, Crawley, WA, Australia.	ian.small@uwa.edu.au	Howell, Katharine A/A-4973-2010; Boykin, Laura/H-8876-2014; Williams, Anna/H-6211-2013; Small, Ian D/C-1168-2008; Small, Ian/AAR-5506-2021	Howell, Katharine A/0000-0002-5044-0034; Boykin, Laura/0000-0002-6101-1921; Williams, Anna/0000-0002-5691-5934; Small, Ian D/0000-0001-5300-1216; Small, Ian/0000-0001-5300-1216; Nevill, Paul/0000-0001-8238-0534	Australian Research Council [DE120101117]; Centre of Excellence grant [CE140100008]; Karara Mining Limited	Australian Research Council(Australian Research Council); Centre of Excellence grant; Karara Mining Limited	This work was supported by the Australian Research Council (http://www.arc.gov.au) through an Australian Postgraduate Award to AVW, a Discovery Early Career Researcher Award (DE120101117) to KAH and Centre of Excellence grant CE140100008 to IS. Funding was also provided by Karara Mining Limited (http://www.kararamining.com.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf FW, 2010, NAT REV GENET, V11, P697, DOI 10.1038/nrg2844; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angeloni F, 2012, EVOL APPL, V5, P130, DOI 10.1111/j.1752-4571.2011.00217.x; Avise JC, 2010, CONSERV GENET, V11, P665, DOI 10.1007/s10592-009-0006-y; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bayly MJ, 2013, MOL PHYLOGENET EVOL, V69, P704, DOI 10.1016/j.ympev.2013.07.006; Broadhurst LM, 2006, CONSERV GENET, V7, P49, DOI 10.1007/s10592-005-7855-9; Brown GK, 2008, SYST BOT, V33, P739, DOI 10.1600/036364408786500136; Brown GK, 2006, AUST SYST BOT, V19, P315, DOI 10.1071/SB05039; BRUNEAU A, 1990, SYST BOT, V15, P378, DOI 10.2307/2419351; Bruneau A, 2013, TAXON, V62, P217, DOI 10.12705/622.8; Bui EN, 2014, PLANT SOIL, V381, P161, DOI 10.1007/s11104-014-2113-x; Butcher P., 2004, Forest Genetics, V11, P303; Butcher PA, 1998, HEREDITY, V81, P205, DOI 10.1046/j.1365-2540.1998.00392.x; Butcher PA, 2002, THEOR APPL GENET, V104, P1185, DOI 10.1007/s00122-001-0820-1; Byrne M, 2002, J EVOLUTION BIOL, V15, P576, DOI 10.1046/j.1420-9101.2002.00429.x; Cai ZQ, 2008, J MOL EVOL, V67, P696, DOI 10.1007/s00239-008-9180-7; Cognat V, 2013, NUCLEIC ACIDS RES, V41, pD273, DOI 10.1093/nar/gks935; Delannoy E, 2011, MOL BIOL EVOL, V28, P2077, DOI 10.1093/molbev/msr028; Doyle JJ, 1996, MOL PHYLOGENET EVOL, V5, P429, DOI 10.1006/mpev.1996.0038; DOYLE JJ, 1995, SYST BOT, V20, P272, DOI 10.2307/2419496; Funk HT, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-45; Gallagher RV, 2011, DIVERS DISTRIB, V17, P884, DOI 10.1111/j.1472-4642.2011.00805.x; GANTT JS, 1991, EMBO J, V10, P3073, DOI 10.1002/j.1460-2075.1991.tb07859.x; Goremykin VV, 2005, MOL BIOL EVOL, V22, P1813, DOI 10.1093/molbev/msi173; Griffin AR, 2011, DIVERS DISTRIB, V17, P837, DOI 10.1111/j.1472-4642.2011.00814.x; Guo XW, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-228; Helaers R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-379; HNATIUK RJ, 1988, AUST J BOT, V36, P361, DOI 10.1071/BT9880361c; HUANG CZ, 1994, MOL GEN GENET, V244, P151, DOI 10.1007/BF00283516; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jansen RK, 2012, ADV PHOTOSYNTHESIS R, P103, DOI DOI 10.1007/978-94-007-2920-9_5; Jansen RK, 2008, MOL PHYLOGENET EVOL, V48, P1204, DOI 10.1016/j.ympev.2008.06.013; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Jansen RK, 2011, MOL BIOL EVOL, V28, P835, DOI 10.1093/molbev/msq261; Kane N, 2012, AM J BOT, V99, P320, DOI 10.3732/ajb.1100570; Kato T, 2000, DNA RES, V7, P323, DOI 10.1093/dnares/7.6.323; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kazakoff SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051687; Kim JS, 2006, PLANT CELL REP, V25, P334, DOI 10.1007/s00299-005-0097-y; Kuroda H, 2003, NATURE, V425, P86, DOI 10.1038/nature01909; Kuroda H, 2007, PLANT CELL PHYSIOL, V48, P1374, DOI 10.1093/pcp/pcm097; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LAVIN M, 1990, EVOLUTION, V44, P390, DOI 10.1111/j.1558-5646.1990.tb05207.x; Lohse M, 2013, NUCLEIC ACIDS RES, V41, pW575, DOI 10.1093/nar/gkt289; Magee AM, 2010, GENOME RES, V20, P1700, DOI 10.1101/gr.111955.110; Martin GE, 2014, ANN BOT-LONDON, V113, P1197, DOI 10.1093/aob/mcu050; Martinez-Alberola F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079685; MAURIZI MR, 1990, J BIOL CHEM, V265, P12546; McNeal JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005982; Miller JT, 2012, AUST SYST BOT, V25, P217, DOI 10.1071/SB11042; Miller JT, 2011, DIVERS DISTRIB, V17, P848, DOI 10.1111/j.1472-4642.2011.00780.x; Miller JT, 2001, AM J BOT, V88, P697, DOI 10.2307/2657071; Milne I, 2013, BRIEF BIOINFORM, V14, P193, DOI 10.1093/bib/bbs012; Mishler BD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5473; Murphy DJ, 2003, AUST SYST BOT, V16, P19, DOI 10.1071/SB01042; Nevill PG, 2013, MOL ECOL RESOUR, V13, P1033, DOI 10.1111/1755-0998.12060; Newmaster SG, 2009, MOL ECOL RESOUR, V9, P172, DOI 10.1111/j.1755-0998.2009.02642.x; Nishimura K, 2015, BBA-BIOENERGETICS, V1847, P915, DOI 10.1016/j.bbabio.2014.11.012; Nock CJ, 2011, PLANT BIOTECHNOL J, V9, P328, DOI 10.1111/j.1467-7652.2010.00558.x; Olinares PDB, 2011, PLANT CELL, V23, P2348, DOI 10.1105/tpc.111.086454; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, TRACER WEBSITE; Raubeson LA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-174; Ravi V, 2007, TREE GENET GENOMES, V3, P49, DOI 10.1007/s11295-006-0051-3; Reverdatto S, 1995, PLANT PHYSIOL, V109, P338; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Saski C, 2005, PLANT MOL BIOL, V59, P309, DOI 10.1007/s11103-005-8882-0; Shikanai T, 2001, PLANT CELL PHYSIOL, V42, P264, DOI 10.1093/pcp/pce031; Svensson O, 2006, PLOS COMPUT BIOL, V2, P358, DOI 10.1371/journal.pcbi.0020046; Tangphatsornruang S, 2010, DNA RES, V17, P11, DOI 10.1093/dnares/dsp025; Terakami S, 2012, TREE GENET GENOMES, V8, P841, DOI 10.1007/s11295-012-0469-8; Williams AV, 2014, TRENDS PLANT SCI, V19, P529, DOI 10.1016/j.tplants.2014.03.011; Wojciechowski MF, 2004, AM J BOT, V91, P1846, DOI 10.3732/ajb.91.11.1846; WOLFE KH, 1992, P NATL ACAD SCI USA, V89, P10648, DOI 10.1073/pnas.89.22.10648; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zeiler E, 2013, P NATL ACAD SCI USA, V110, P11302, DOI 10.1073/pnas.1219125110	78	75	76	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0125768	10.1371/journal.pone.0125768	http://dx.doi.org/10.1371/journal.pone.0125768			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955637	Green Submitted, gold, Green Published			2022-12-26	WOS:000356768100076
J	Zhao, M; Liu, BM; Wu, K; Ye, YF; Huang, SX; Wang, SS; Wang, Y; Han, RX; Liu, Q; Fu, XD; Wu, YJ				Zhao, Meng; Liu, Binmei; Wu, Kun; Ye, Yafeng; Huang, Shixia; Wang, Shuansuo; Wang, Yi; Han, Ruixi; Liu, Qian; Fu, Xiangdong; Wu, Yuejin			Regulation of OsmiR156h through Alternative Polyadenylation Improves Grain Yield in Rice	PLOS ONE			English	Article							GREEN-REVOLUTION; ARABIDOPSIS-THALIANA; SPL GENES; OSSPL14; ARCHITECTURE; EXPRESSION; MICRORNAS; PLANTS; MIR156	Substantial increases in grain yield of cereal crops are required to feed a growing human population. Here we show that a natural variant of SEMIDWARF AND HIGH-TILLERING (SDT) increases harvest index and grain productivity in rice. Gain-of-function sdt mutation has a shortened polyadenylation tail on the OsmiR156h microRNA precursor, which cause the up-regulation of OsmiR156h. The plants carrying the semidominant sdt allele exhibit reduced plant height, enhanced lodging resistance, increased tiller numbers per plant, and resulting in an increased grain yield. We also show that combining the sdt allele with the OsSPL14(WFP) allele can be effective in simultaneously improving tillering capacity and panicle branching, thereby leading to higher harvest index and grain yield. Most importantly, pyramiding of the sdt allele and the green revolution gene sd1 enhances grain yield by about 20% in hybrid rice breeding. Our results suggest that the manipulation of the polyadenylation status of OsmiR156 represents a novel strategy for improving the yield potential of rice over what is currently achievable.	[Zhao, Meng; Liu, Binmei; Wu, Kun; Ye, Yafeng; Huang, Shixia; Wu, Yuejin] Chinese Acad Sci, Hefei Inst Phys Sci, Inst Tech Biol & Agr Engn, Hefei, Peoples R China; [Zhao, Meng; Wu, Kun; Wang, Shuansuo; Wang, Yi; Han, Ruixi; Liu, Qian; Fu, Xiangdong] Chinese Acad Sci, State Key Lab Plant Cell & Chromosome Engn, Inst Genet & Dev Biol, Beijing, Peoples R China	Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Fu, XD (corresponding author), Chinese Acad Sci, State Key Lab Plant Cell & Chromosome Engn, Inst Genet & Dev Biol, Beijing, Peoples R China.	xdfu@genetics.ac.cn; yjwu@ipp.ac.cn	Binmei, Liu/ABB-8384-2020		National Natural Science Foundation of China [31130070, 91335207, 31301297]; Ministry of Science and Technology of China [2012AA10A301]; Chinese Academy of Sciences [KSCX2-EW-N01, KJCX2-EW-N05, KJCX2-YW-N34]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by grants from National Natural Science Foundation of China (31130070, 91335207 and 31301297), the Ministry of Science and Technology of China (2012AA10A301) and Chinese Academy of Sciences (KSCX2-EW-N01, KJCX2-EW-N05 and KJCX2-YW-N34).	Arazi T, 2005, PLANT J, V43, P837, DOI 10.1111/j.1365-313X.2005.02499.x; Heal G, 2004, RESOUR ENERGY ECON, V26, P175, DOI 10.1016/j.reseneeco.2003.11.006; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hornyik C, 2010, DEV CELL, V18, P203, DOI 10.1016/j.devcel.2009.12.009; Huang XZ, 2009, NAT GENET, V41, P494, DOI 10.1038/ng.352; Ikeda-Kawakatsu K, 2009, PLANT PHYSIOL, V150, P736, DOI 10.1104/pp.109.136739; Islam MS, 2007, FIELD CROP RES, V101, P240, DOI 10.1016/j.fcr.2006.12.002; Jiang CF, 2007, PLANT PHYSIOL, V145, P1460, DOI 10.1104/pp.107.103788; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kantar M, 2011, PLANTA, V233, P471, DOI 10.1007/s00425-010-1309-4; Khush GS, 1999, GENOME, V42, P646, DOI 10.1139/gen-42-4-646; Liu FQ, 2010, SCIENCE, V327, P94, DOI 10.1126/science.1180278; Luo L, 2012, PLANT CELL PHYSIOL, V53, P1793, DOI 10.1093/pcp/pcs122; McCouch S, 2013, NATURE, V499, P23, DOI 10.1038/499023a; Miura K, 2010, NAT GENET, V42, P545, DOI 10.1038/ng.592; Nagano H, 2005, GENES GENET SYST, V80, P351, DOI 10.1266/ggs.80.351; Ookawa T, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1132; Porkka M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082714; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Sakamoto T, 2008, CURR OPIN PLANT BIOL, V11, P209, DOI 10.1016/j.pbi.2008.01.009; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Spielmeyer W, 2002, P NATL ACAD SCI USA, V99, P9043, DOI 10.1073/pnas.132266399; Squicciarini MP, 2013, NATURE, V501, P492, DOI 10.1038/501492d; Tian XJ, 2006, PLANT PHYSIOL, V140, P401, DOI 10.1104/pp.105.070060; Wang JW, 2008, PLANT CELL, V20, P1231, DOI 10.1105/tpc.108.058180; Wang JW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002012; Wang S, 2010, NAT GENET, V44, P950; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Xie KB, 2006, PLANT PHYSIOL, V142, P280, DOI 10.1104/pp.106.084475; Yu N, 2010, PLANT CELL, V22, P2322, DOI 10.1105/tpc.109.072579; Yuan L.P., 1997, HYBRID RICE, V12, P1, DOI DOI 10.16267/J.CNKI.1005-3956.1997.06.001	33	17	23	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0126154	10.1371/journal.pone.0126154	http://dx.doi.org/10.1371/journal.pone.0126154			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25954944	gold, Green Published, Green Submitted			2022-12-26	WOS:000356768100102
J	Elliott, DR; Caporn, SJM; Nwaishi, F; Nilsson, RH; Sen, R				Elliott, David R.; Caporn, Simon J. M.; Nwaishi, Felix; Nilsson, R. Henrik; Sen, Robin			Bacterial and Fungal Communities in a Degraded Ombrotrophic Peatland Undergoing Natural and Managed Re-Vegetation	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; CARBON; IDENTIFICATION; DIVERSITY; SEQUENCES; MOORLAND; DATABASE; BOREAL	The UK hosts 15-19% of global upland ombrotrophic (rain fed) peatlands that are estimated to store 3.2 billion tonnes of carbon and represent a critical upland habitat with regard to bio-diversity and ecosystem services provision. Net production is dependent on an imbalance between growth of peat-forming Sphagnum mosses and microbial decomposition by microorganisms that are limited by cold, acidic, and anaerobic conditions. In the Southern Pennines, land-use change, drainage, and over 200 years of anthropogenic N and heavy metal deposition have contributed to severe peatland degradation manifested as a loss of vegetation leaving bare peat susceptible to erosion and deep gullying. A restoration programme designed to regain peat hydrology, stability and functionality has involved re-vegetation through nurse grass, dwarf shrub and Sphagnum re-introduction. Our aim was to characterise bacterial and fungal communities, via high-throughput rRNA gene sequencing, in the surface acrotelm/mesotelm of degraded bare peat, long-term stable vegetated peat, and natural and managed restorations. Compared to long-term vegetated areas the bare peat microbiome had significantly higher levels of oligotrophic marker phyla (Acidobacteria, Verrucomicrobia, TM6) and lower Bacteroidetes and Actinobacteria, together with much higher ligninolytic Basidiomycota. Fewer distinct microbial sequences and significantly fewer cultivable microbes were detected in bare peat compared to other areas. Microbial community structure was linked to restoration activity and correlated with soil edaphic variables (e.g. moisture and heavy metals). Although rapid community changes were evident following restoration activity, restored bare peat did not approach a similar microbial community structure to non-eroded areas even after 25 years, which may be related to the stabilisation of historic deposited heavy metals pollution in long-term stable areas. These primary findings are discussed in relation to bare peat oligotrophy, re-vegetation recalcitrance, rhizosphere-microbe-soil interactions, C, N and P cycling, trajectory of restoration, and ecosystem service implications for peatland restoration.	[Elliott, David R.; Caporn, Simon J. M.; Sen, Robin] Manchester Metropolitan Univ, Div Biol & Conservat Ecol, Manchester M1 5GD, Lancs, England; [Nwaishi, Felix] Wilfrid Laurier Univ, Cold Reg Res Ctr, Waterloo, ON 2NL 3C5, Canada; [Nilsson, R. Henrik] Univ Gothenburg, Dept Biol & Environm Sci, S-40530 Gothenburg, Sweden	Manchester Metropolitan University; Wilfrid Laurier University; University of Gothenburg	Elliott, DR (corresponding author), Manchester Metropolitan Univ, Div Biol & Conservat Ecol, Manchester M1 5GD, Lancs, England.	d.elliott@mmu.ac.uk	Nilsson, R. Henrik/A-6062-2009; Elliott, David/E-2816-2010; Elliott, David/H-7868-2019; Sen, Robin/G-3263-2011	Nilsson, R. Henrik/0000-0002-8052-0107; Elliott, David/0000-0001-9837-7890; Elliott, David/0000-0001-9837-7890; Sen, Robin/0000-0002-1914-2178; Nwaishi, Felix/0000-0003-1191-015X	Moors for the Future; Manchester Metropolitan University	Moors for the Future; Manchester Metropolitan University	This work was funded by Moors for the Future (http://www.moorsforthefuture.org.uk) and Manchester Metropolitan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Adams RI, 2013, PLOS ONE, V8, P78866, DOI DOI 10.1371/journal.pone.0078866; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersen R, 2013, SOIL BIOL BIOCHEM, V57, P979, DOI 10.1016/j.soilbio.2012.10.003; Andersen R, 2006, SOIL BIOL BIOCHEM, V38, P1375, DOI 10.1016/j.soilbio.2005.10.012; Anderson P, 2010, MOORLAND RESTORATION; Artz RRE, 2007, MICROB ECOL, V54, P508, DOI 10.1007/s00248-007-9220-7; Artz RRE, 2009, GEOPHYS MONOGR SER, V184, P111, DOI 10.1029/2008GM000806; Bengtsson-Palme J, 2013, METHODS ECOL EVOL, V4, P914, DOI 10.1111/2041-210X.12073; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beswick KM, 2003, ATMOS ENVIRON, V37, P1927, DOI 10.1016/S1352-2310(03)00046-3; Billett MF, 2010, CLIM RES, V45, P13, DOI 10.3354/cr00903; Bonn A., 2009, DRIVERS ENV CHANGE U, P34; Bulluck LR, 2002, PHYTOPATHOLOGY, V92, P181, DOI 10.1094/PHYTO.2002.92.2.181; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporn S, 2007, RESEARCH REPORT TO M; Charman D, 2002, PEATLANDS AND ENVIRO; Churchland C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00261; Clarke D, 2010, STRATEGY FOR RESPONS; Clymo RS, 2008, GEOCHIM COSMOCHIM AC, V72, P2048, DOI 10.1016/j.gca.2008.01.032; Croft M, 2001, APPL SOIL ECOL, V18, P1, DOI 10.1016/S0929-1393(01)00154-8; Dedysh SN, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00184; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Evans M, 2010, EARTH SURF PROC LAND, V35, P876, DOI 10.1002/esp.1918; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Freeman C, 2004, SOIL BIOL BIOCHEM, V36, P1663, DOI 10.1016/j.soilbio.2004.07.012; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gimingham C. H., 1972, ECOLOGY OF HEATHLAND; Griffiths RI, 2011, ENVIRON MICROBIOL, V13, P1642, DOI 10.1111/j.1462-2920.2011.02480.x; Hartmann M, 2010, J MICROBIOL METH, V83, P250, DOI 10.1016/j.mimet.2010.08.008; Holden J, 2007, EARTH-SCI REV, V82, P75, DOI 10.1016/j.earscirev.2007.01.003; Joosten H, 2012, MITIGATION FOR CLIMA, V5; Kardol P, 2010, TRENDS ECOL EVOL, V25, P670, DOI 10.1016/j.tree.2010.09.001; Lappalainen Eino, 1996, P53; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Lin XJ, 2014, APPL ENVIRON MICROB, V80, P3518, DOI 10.1128/AEM.00205-14; Lin X, 2014, APPL ENVIRON MICROB, V80, P3531, DOI 10.1128/AEM.00206-14; Lindahl BD, 2013, NEW PHYTOL, V199, P288, DOI 10.1111/nph.12243; Lindsay RA, 1988, THE FLOW COUNTRY THE; Linton PE, 2007, WATER AIR SOIL POLL, V186, P97, DOI 10.1007/s11270-007-9468-z; Littlewood N.A., 2010, PEATLAND BIODIVERSIT; Lundin D, 2012, ENV MICROBIOL REP, V4, P367, DOI 10.1111/j.1758-2229.2012.00345.x; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Millennium Ecosystem Assessment, 2005, ECOSYSTEMS AND HUMAN; Moors for the Future Partnership, 2008, COMP UK PEAT REST MA; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Muyzer G, 1998, MOLECULAR MICROBIAL; Nwaishi F., 2011, THESIS, DOI [10.6084/m9.figshare.11929012011, DOI 10.6084/M9.FIGSHARE.1192901]; Oksanen J., **DATA OBJECT**; Paivanen J, 2012, PEATLAND ECOLOGY AND; Parry LE, 2014, J ENVIRON MANAGE, V133, P193, DOI 10.1016/j.jenvman.2013.11.033; Prashar P, 2014, REV ENVIRON SCI BIO, V13, P63, DOI 10.1007/s11157-013-9317-z; Puspita ID, 2012, MICROBES ENVIRON, V27, P356, DOI 10.1264/jsme2.ME12092; R Core Team (n.d.), R A LANGUAGE AND ENV; Rodwell JS, 1991, BRITISH PLANT COMMUN, V2; Rothwell J.J., 2006, WATER AIR SOIL POLLU, V6, P669, DOI [DOI 10.1007/S11267-006-9052-3, 10.1007/s11267-006-9052-3]; Rowell D. L., 1994, SOIL SCIENCE METHODS; Rydin H., 2013, THE BIOLOGY OF PEATL; Serkebaeva YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063994; Shumway M, 2010, NUCLEIC ACIDS RES, V38, pD870, DOI 10.1093/nar/gkp1078; Shuttleworth EL, 2014, EARTH SURFACE PROCES, DOI 101002/esp3645; Tallis J.H., 1997, BLANKET MIRE DEGRADA, P7; THOMPSON DBA, 1995, BIOL CONSERV, V71, P163, DOI 10.1016/0006-3207(94)00043-P; Turunen J, 2002, HOLOCENE, V12, P69, DOI 10.1191/0959683602hl522rp; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Vandenkoornhuyse P, 2007, P NATL ACAD SCI USA, V104, P16970, DOI 10.1073/pnas.0705902104; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Worrall F, 2009, SCI TOTAL ENVIRON, V407, P4084, DOI 10.1016/j.scitotenv.2009.03.008; Yan W, 2008, SOIL BIOL BIOCHEM, V40, P544, DOI 10.1016/j.soilbio.2007.09.001	73	38	41	10	152	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0124726	10.1371/journal.pone.0124726	http://dx.doi.org/10.1371/journal.pone.0124726			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25969988	Green Published, Green Submitted, gold			2022-12-26	WOS:000354544200048
J	Speir, RW; Stallings, JD; Andrews, JM; Gelnett, MS; Brand, TC; Salgar, SK				Speir, Ryan W.; Stallings, Jonathan D.; Andrews, Jared M.; Gelnett, Mary S.; Brand, Timothy C.; Salgar, Shashikumar K.			Effects of Valproic Acid and Dexamethasone Administration on Early Bio-Markers and Gene Expression Profile in Acute Kidney Ischemia-Reperfusion Injury in the Rat	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; GELATINASE-ASSOCIATED LIPOCALIN; ACUTE LUNG INJURY; ISCHEMIA/REPERFUSION INJURY; OSTEOPONTIN EXPRESSION; EPITHELIAL-CELLS; 2-HIT MODEL; BIOMARKERS; MOLECULE-1; INDUCTION	Renal ischemia-reperfusion (IR) causes acute kidney injury (AKI) with high mortality and morbidity. The objective of this investigation was to ameliorate kidney IR injury and identify novel biomarkers for kidney injury and repair. Under general anesthesia, left renal ischemia was induced in Wister rats by occluding renal artery for 45 minutes, followed by reperfusion and right nephrectomy. Thirty minutes prior to ischemia, rats (n = 8/group) received Valproic Acid (150 mg/kg; VPA), Dexamethasone (3 mg/kg; Dex) or Vehicle (saline) intraperitoneally. Animals were sacrificed at 3, 24 or 120 h post-IR. Plasma creatinine (mg/dL) at 24 h was reduced (P<0.05) in VPA (2.7 +/- 1.8) and Dex (2.3 +/- 1.2) compared to Vehicle (3.8 +/- 0.5) group. At 3 h, urine albumin (mg/mL) was higher in Vehicle (1.47 +/- 0.10), VPA (0.84 +/- 0.62) and Dex (1.04 +/- 0.73) compared to naive (uninjured/untreated control) (0.14 +/- 0.26) group. At 24 h post-IR urine lipocalin-2 (mu g/mL) was higher (P<0.05) in VPA, Dex and Vehicle groups (9.61-11.36) compared to naive group (0.67 +/- 0.29); also, kidney injury molecule-1 (KIM-1; ng/mL) was higher (P<0.05) in VPA, Dex and Vehicle groups (13.7-18.7) compared to naive group (1.7 +/- 1.9). Histopathology demonstrated reduced (P<0.05) ischemic injury in the renal cortex in VPA (Grade 1.6 +/- 1.5) compared to Vehicle (Grade 2.9 +/- 1.1). Inflammatory cytokines IL1 beta and IL6 were downregulated and anti-apoptotic molecule BCL2 was upregulated in VPA group. Furthermore, kidney DNA microarray demonstrated reduced injury, stress, and apoptosis related gene expression in the VPA administered rats. VPA appears to ameliorate kidney IR injury via reduced inflammatory cytokine, apoptosis/stress related gene expression, and improved regeneration. KIM-1, lipocalin-2 and albumin appear to be promising early urine biomarkers for the diagnosis of AKI.	[Speir, Ryan W.; Brand, Timothy C.] Madigan Army Med Ctr, Dept Surg, Ft Lewis, WA USA; [Stallings, Jonathan D.] US Army Ctr Environm Hlth Res, Environm Hlth Program, Ft Detrick, MD USA; [Andrews, Jared M.; Gelnett, Mary S.] Madigan Army Med Ctr, Dept Pathol, Ft Lewis, WA USA; [Salgar, Shashikumar K.] Madigan Army Med Ctr, Dept Clin Investigat, Ft Lewis, WA 98431 USA	Madigan Army Medical Center; Madigan Army Medical Center; Madigan Army Medical Center	Salgar, SK (corresponding author), Madigan Army Med Ctr, Dept Clin Investigat, Ft Lewis, WA 98431 USA.	Shashikumar.k.salgar.civ@mail.mil	Stallings, Jonathan D/H-7779-2013	Stallings, Jonathan D/0000-0002-6430-5888	Graduate Medical Education Program; Department of Clinical Investigation, Madigan Army Medical Center	Graduate Medical Education Program; Department of Clinical Investigation, Madigan Army Medical Center	This work was supported by funds from the Graduate Medical Education Program and Department of Clinical Investigation, Madigan Army Medical Center.	AbdulHameed MDM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112193; An SX, 2013, RENAL FAILURE, V35, P143, DOI 10.3109/0886022X.2012.741877; Basile DP, 2012, COMPR PHYSIOL, V2, P1303, DOI 10.1002/cphy.c110041; Basile DP, 2004, KIDNEY INT, V65, P2201, DOI 10.1111/j.1523-1755.2004.00637.x; Basireddy M, 2006, AM J PHYSIOL-RENAL, V290, pF779, DOI 10.1152/ajprenal.00334.2005; Bates EEM, 1999, J IMMUNOL, V163, P1973; BONVENTRE JV, 1993, KIDNEY INT, V43, P1160, DOI 10.1038/ki.1993.163; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Butt MU, 2009, J SURG RES, V156, P290, DOI 10.1016/j.jss.2009.04.012; Causey MW, 2012, J VASC SURG, V55, P1096, DOI 10.1016/j.jvs.2011.08.060; Charlton JR, 2014, NEPHROL DIAL TRANSPL, V29, P1301, DOI 10.1093/ndt/gft510; Chatterjee PK, 2001, KIDNEY INT, V59, P2073, DOI 10.1046/j.1523-1755.2001.00722.x; Choi HM, 2013, BIOCHEM BIOPH RES CO, V435, P678, DOI 10.1016/j.bbrc.2013.05.042; Csiszar K, 2001, PROG NUCLEIC ACID RE, V70, P1, DOI 10.1016/S0079-6603(01)70012-8; Delbridge MS, 2007, TRANSPLANTATION, V84, P187, DOI 10.1097/01.tp.0000269794.74990.da; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dobashi K, 2000, MOL CELL BIOCHEM, V205, P1, DOI 10.1023/A:1007047505107; Essaghir A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq149; Fukudome EY, 2012, SURGERY, V152, P254, DOI 10.1016/j.surg.2012.03.013; Godet C, 2006, SHOCK, V25, P384, DOI 10.1097/01.shk.0000209528.35743.54; Ha KCH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-519; Han WK, 2002, KIDNEY INT, V62, P237, DOI 10.1046/j.1523-1755.2002.00433.x; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hudkins KL, 2000, KIDNEY INT, V57, P105, DOI 10.1046/j.1523-1755.2000.00813.x; JABLONSKI P, 1983, TRANSPLANTATION, V35, P198, DOI 10.1097/00007890-198303000-00002; Kim HJ, 2007, J PHARMACOL EXP THER, V321, P892, DOI 10.1124/jpet.107.120188; Kim K, 2012, RESUSCITATION, V83, P243, DOI 10.1016/j.resuscitation.2011.07.029; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; Kumar S, 2009, J AM SOC NEPHROL, V20, P2412, DOI 10.1681/ASN.2008080868; Lim AI, 2013, J CELL PHYSIOL, V228, P917, DOI 10.1002/jcp.24267; Liu ZC, 2014, SHOCK, V41, P104, DOI 10.1097/SHK.0000000000000074; Liu ZC, 2013, J TRAUMA ACUTE CARE, V74, P991, DOI 10.1097/TA.0b013e31828583e3; Mishra J, 2004, J AM SOC NEPHROL, V15, P3073, DOI 10.1097/01.ASN.0000145013.44578.45; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Miyaji T, 2001, J AM SOC NEPHROL, V12, P900, DOI 10.1681/ASN.V125900; MORAN SM, 1985, KIDNEY INT, V27, P928, DOI 10.1038/ki.1985.101; Nielsen BS, 1996, GUT, V38, P414, DOI 10.1136/gut.38.3.414; Okada H, 2000, AM J KIDNEY DIS, V36, P498, DOI 10.1053/ajkd.2000.9790; Paragas N, 2011, NAT MED, V17, P216, DOI 10.1038/nm.2290; Persy VP, 1999, KIDNEY INT, V56, P601, DOI 10.1046/j.1523-1755.1999.00581.x; Qu Y, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-211; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Russo LM, 2007, KIDNEY INT, V71, P504, DOI 10.1038/sj.ki.5002041; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schiffl H, 2012, MOL DIAGN THER, V16, P199, DOI 10.2165/11634310-000000000-00000; Sear JW, 2005, BRIT J ANAESTH, V95, P20, DOI 10.1093/bja/aei018; Shang Y, 2010, CHINESE MED J-PEKING, V123, P2682, DOI 10.3760/cma.j.issn.0366-6999.2010.19.012; Slocum JL, 2012, TRANSL RES, V159, P277, DOI 10.1016/j.trsl.2012.01.014; Stallings JD, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1058; Tawa GJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107230; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Vaidya VS, 2008, ANNU REV PHARMACOL, V48, P463, DOI 10.1146/annurev.pharmtox.48.113006.094615; Vaidya VS, 2010, NAT BIOTECHNOL, V28, P478, DOI 10.1038/nbt.1623; Vaidya VS, 2006, AM J PHYSIOL-RENAL, V290, pF517, DOI 10.1152/ajprenal.00291.2005; Van Beneden K, 2011, J AM SOC NEPHROL, V22, P1863, DOI 10.1681/ASN.2010111196; Vlasakova K, 2014, TOXICOL SCI, V138, P3, DOI 10.1093/toxsci/kft330; Ware LB, 2011, AM J PHYSIOL-RENAL, V300, pF628, DOI 10.1152/ajprenal.00654.2010; Wunnapuk K, 2014, TOXICOL LETT, V225, P467, DOI 10.1016/j.toxlet.2014.01.018; Xie YS, 2001, KIDNEY INT, V60, P1645, DOI 10.1046/j.1523-1755.2001.00032.x; Zacharias M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003590.pub3; Zacharias N, 2011, RESUSCITATION, V82, P105, DOI 10.1016/j.resuscitation.2010.09.469; Zhang PL, 2008, KIDNEY INT, V73, P608, DOI 10.1038/sj.ki.5002697; Zhang ZZ, 2012, CURR EYE RES, V37, P429, DOI 10.3109/02713683.2011.653616; Zhou H, 2003, PFLUG ARCH EUR J PHY, V446, P116, DOI 10.1007/s00424-002-0996-5; Zhou Y, 2008, TOXICOL SCI, V101, P159, DOI 10.1093/toxsci/kfm260	65	28	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0126622	10.1371/journal.pone.0126622	http://dx.doi.org/10.1371/journal.pone.0126622			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970334	Green Submitted, Green Published, gold			2022-12-26	WOS:000354544200121
J	Yin, DX; Liu, W; Zhai, NN; Feng, YZ; Yang, GH; Wang, XJ; Han, XH				Yin, Dongxue; Liu, Wei; Zhai, Ningning; Feng, Yongzhong; Yang, Gaihe; Wang, Xiaojiao; Han, Xinhui			Production of Bio-Energy from Pig Manure: A Focus on the Dynamics Change of Four Parameters under Sunlight-Dark Conditions	PLOS ONE			English	Article							ANAEROBIC CO-DIGESTION; VOLATILE FATTY-ACIDS; BIOHYDROGEN PRODUCTION; FEEDING COMPOSITION; METHANE PRODUCTION; DAIRY MANURE; SWINE MANURE; WASTE-WATER; HYDROGEN; FERMENTATION	This study investigated the effect of sunlight-dark conditions on volatile fatty acids (VFAs), total ammonium nitrogen (TAN), total alkalinity (TA) and pH during pig manure (PM) digestion and then the subsequent influence on biogas yield of PM. PM1 and PM2 were performed in a transparent reactor and a non-transparent reactor, respectively. Two sets of experiments were conducted with a temperature of 35.0 +/- 2.0 degrees C and a total solid concentration of 8.0% to the digestion material. The dynamic change of the four parameters in response to sunlight-dark conditions resulted in variations of the physiological properties in the digester and affected the cumulative biogas production (CBP). PM1 obtained higher CBP (15020.0 mL) with a more stable pH and a lower TAN concentration (1414.5 mg/L) compared to PM2 (2675.0 mL and 1670.0 mg/L, respectively). The direct path coefficients and indirect path coefficients between the four parameters and CBP were also analyzed.	[Yin, Dongxue; Liu, Wei] Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China; [Yin, Dongxue; Liu, Wei; Zhai, Ningning; Feng, Yongzhong; Yang, Gaihe; Wang, Xiaojiao; Han, Xinhui] Northwest A&F Univ, Res Ctr Recycle Agr Engn & Technol Shaanxi Prov, Yangling, Shaanxi, Peoples R China; [Zhai, Ningning; Feng, Yongzhong; Yang, Gaihe; Wang, Xiaojiao; Han, Xinhui] Northwest A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Northwest A&F University - China	Yang, GH (corresponding author), Northwest A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China.	ygh@nwsuaf.edu.cn	Feng, Yongzhong/F-5090-2012	Feng, Yongzhong/0000-0002-5202-4368	Science and Technology Support Projects from Ministry of Science and Technology Department of the People's Republic of China [2011 BAD15B03]; Basic Scientific Fund of Northwest AF University [QM2012002]	Science and Technology Support Projects from Ministry of Science and Technology Department of the People's Republic of China; Basic Scientific Fund of Northwest AF University	The work was supported by Science and Technology Support Projects (2011 BAD15B03) from Ministry of Science and Technology Department of the People's Republic of China and the Basic Scientific Fund of Northwest A&F University (QM2012002).	AHRING BK, 1995, APPL MICROBIOL BIOT, V43, P559, DOI 10.1007/BF00218466; Alcaraz-Gonzalez V, 2013, CLEAN-SOIL AIR WATER, V41, P1157, DOI 10.1002/clen.201100736; ANGELIDAKI I, 1994, WATER RES, V28, P727, DOI 10.1016/0043-1354(94)90153-8; Angelidaki I, 2000, WATER SCI TECHNOL, V41, P189, DOI 10.2166/wst.2000.0071; Apha A, 1995, WPCF STANDARD METHOD; Argun H, 2010, INT J HYDROGEN ENERG, V35, P1604, DOI 10.1016/j.ijhydene.2009.12.033; Astals S, 2012, BIORESOURCE TECHNOL, V110, P63, DOI 10.1016/j.biortech.2012.01.080; Azwar MY, 2014, RENEW SUST ENERG REV, V31, P158, DOI 10.1016/j.rser.2013.11.022; Bjornsson L, 2000, APPL MICROBIOL BIOT, V54, P844, DOI 10.1007/s002530000471; Bonmati A, 2001, WATER SCI TECHNOL, V44, P109, DOI 10.2166/wst.2001.0193; Calli B, 2005, PROCESS BIOCHEM, V40, P1285, DOI 10.1016/j.procbio.2004.05.008; Chandra R, 2014, INT J HYDROGEN ENERG, V39, P7604, DOI 10.1016/j.ijhydene.2014.01.196; Danesh S, 1997, WATER ENVIRON RES, V69, P1106, DOI 10.2175/106143097X125830; Fernandez N, 2008, RENEW ENERG, V33, P2458, DOI 10.1016/j.renene.2008.02.002; Ghimire A, 2015, APPL ENERG, V144, P73, DOI 10.1016/j.apenergy.2015.01.045; Hansen KH, 1999, WATER RES, V33, P1805, DOI 10.1016/S0043-1354(98)00410-2; HARPER SR, 1986, BIOTECHNOL BIOENG, V28, P585, DOI 10.1002/bit.260280416; Cuetos MJ, 2011, BIOTECHNOL BIOPROC E, V16, P1044, DOI 10.1007/s12257-011-0117-4; KUS F, 1995, WATER RES, V29, P1437, DOI 10.1016/0043-1354(94)00285-F; Lay JJ, 1997, WATER RES, V31, P1518, DOI 10.1016/S0043-1354(96)00413-7; Levin DB, 2007, BIORESOURCE TECHNOL, V98, P654, DOI 10.1016/j.biortech.2006.02.027; Lins P, 2012, FOLIA MICROBIOL, V57, P313, DOI 10.1007/s12223-012-0132-7; Mo H., 1983, J JIANGSU AGR COLL, V4, P45; Motte JC, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-164; Munch E, 1998, WATER RES, V32, P2431; Page LH, 2014, BIOSYST ENG, V118, P16, DOI 10.1016/j.biosystemseng.2013.11.004; Rittmann S, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-115; Shi JC, 2011, ANIM FEED SCI TECH, V166-67, P457, DOI 10.1016/j.anifeedsci.2011.04.033; Song M, 2010, BIORESOURCE TECHNOL, V101, pS23, DOI 10.1016/j.biortech.2009.03.054; Walker M, 2011, CHEM ENG J, V178, P138, DOI 10.1016/j.cej.2011.10.027; Wang QH, 1999, BIOMASS BIOENERG, V16, P407, DOI 10.1016/S0961-9534(99)00016-1; Wang XJ, 2013, BIORESOURCE TECHNOL, V131, P172, DOI 10.1016/j.biortech.2012.12.174; Wang XJ, 2012, BIORESOURCE TECHNOL, V120, P78, DOI 10.1016/j.biortech.2012.06.058; Ward AJ, 2011, BIORESOURCE TECHNOL, V102, P4083, DOI 10.1016/j.biortech.2010.12.046; Yenigun O, 2013, PROCESS BIOCHEM, V48, P901, DOI 10.1016/j.procbio.2013.04.012; Yin DX, 2014, BIORESOURCE TECHNOL, V166, P373, DOI 10.1016/j.biortech.2014.05.037; Yuan Zhifa, 2002, MULTIVARIATE STAT AN; Zhang DD, 2011, J ENVIRON SCI-CHINA, V23, P497, DOI 10.1016/S1001-0742(10)60434-2	38	3	3	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0126616	10.1371/journal.pone.0126616	http://dx.doi.org/10.1371/journal.pone.0126616			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970266	gold, Green Submitted, Green Published			2022-12-26	WOS:000354544200120
J	March, MI; Geahchan, C; Wenger, J; Raghuraman, N; Berg, A; Haddow, H; Mckeon, BA; Narcisse, R; David, JL; Scott, J; Thadhani, R; Karumanchi, SA; Rana, S				March, Melissa I.; Geahchan, Carl; Wenger, Julia; Raghuraman, Nandini; Berg, Anders; Haddow, Hamish; Mckeon, Bri Ann; Narcisse, Rulx; David, Jean Louis; Scott, Jennifer; Thadhani, Ravi; Karumanchi, S. Ananth; Rana, Sarosh			Circulating Angiogenic Factors and the Risk of Adverse Outcomes among Haitian Women with Preeclampsia	PLOS ONE			English	Article							MATERNAL PLASMA-CONCENTRATIONS; PLACENTAL GROWTH-FACTOR; SOLUBLE ENDOGLIN; PREGNANCY	Objective Angiogenic factors are strongly associated with adverse maternal and fetal outcomes among women with preterm preeclampsia (PE) in developed countries. We evaluated the role of angiogenic factors and their relationship to adverse outcomes among Haitian women with PE. Material and Methods We measured plasma antiangiogenic soluble fms-like tyrosine kinase 1 (sFlt1) and proangiogenic placental growth factor (PlGF) levels in women with PE (n=35) compared to controls with no hypertensive disorders (NHD) (n=43) among subjects with singleton pregnancies that delivered at Hospital Albert Schweitzer (HAS) in Haiti. We divided the preeclamptic women into two groups, early onset (similar to 34 weeks) and late onset (>34 weeks) and examined relationships between sFlt1/PlGF ratios on admission and adverse outcomes (abruption, respiratory complications, stroke, renal insufficiency, eclampsia, maternal death, birth weight <2500 grams, or fetal/neonatal death) in women with PE subgroups as compared to NHD groups separated by week of admission. Data are presented as median (25th-75th centile), n (%), and proportions. Results Among patients with PE, most (24/35) were admitted at term. Adverse outcome rates in PE were much higher among the early onset group compared to the late onset group (100.0% vs. 54.2%, P=0.007). Plasma angiogenic factors were dramatically altered in both subtypes of PE. Angiogenic factors also correlated with adverse outcomes in both subtypes of PE. The median sFlt1/PlGF ratios for subjects with early onset PE with any adverse outcome vs. NHD <=34 weeks with no adverse outcome were 703.1 (146.6, 1614.9) and 9.6 (3.5, 58.6); P<0.001). Among late onset group the median sFlt1/PlGF ratio for women with any adverse outcome was 130.7 (56.1, 242.6) versus 22.4 (10.2, 58.7; P=0.005) in NHD >34 weeks with no adverse outcome. Conclusion PE-related adverse outcomes are common in women in Haiti and are associated with profound angiogenic imbalance regardless of gestational age at presentation.	[March, Melissa I.; Raghuraman, Nandini; Mckeon, Bri Ann; Scott, Jennifer; Karumanchi, S. Ananth; Rana, Sarosh] Beth Israel Deaconess Med Ctr, Dept Obstet & Gynecol, Boston, MA 02215 USA; [March, Melissa I.; Karumanchi, S. Ananth; Rana, Sarosh] Beth Israel Deaconess Med Ctr, Dept Obstet & Gynecol, Div Maternal Fetal Med, Boston, MA 02215 USA; [March, Melissa I.; Wenger, Julia; Berg, Anders; Thadhani, Ravi; Karumanchi, S. Ananth; Rana, Sarosh] Harvard Univ, Sch Med, Boston, MA USA; [Geahchan, Carl; Karumanchi, S. Ananth] Beth Israel Deaconess Med Ctr, Ctr Vasc Biol & Res, Boston, MA 02215 USA; [Wenger, Julia; Thadhani, Ravi] Massachusetts Gen Hosp, Dept Med, Div Nephrol, Boston, MA 02114 USA; [Berg, Anders] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Haddow, Hamish] Savjani Inst Hlth Res, Windham, ME USA; [Narcisse, Rulx; David, Jean Louis] Hosp Albert Schweitzer, Dept Obstet & Gynecol, Deshapelles, Haiti; [Scott, Jennifer] Brigham & Womens Hosp, Dept Med, Div Womens Hlth, Boston, MA 02115 USA; [Karumanchi, S. Ananth] Beth Israel Deaconess Med Ctr, Dept Med, Div Nephrol, Boston, MA 02215 USA; [Karumanchi, S. Ananth] Howard Hughes Med Inst, Boston, MA 02115 USA; [Rana, Sarosh] Univ Chicago, Dept Obstet & Gynecol, Maternal Fetal Med, Chicago, IL 60637 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Howard Hughes Medical Institute; University of Chicago	Rana, S (corresponding author), Beth Israel Deaconess Med Ctr, Dept Obstet & Gynecol, Boston, MA 02215 USA.	srana2@bsd.uchicago.edu	Karumanchi, Subbian Ananth/AAI-1694-2021	Raghuraman, Nandini/0000-0003-2747-5113	Aggamin Therapeutics; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER	Aggamin Therapeutics; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	S.A.K. is a co-inventor on patents related to preeclampsia biomarkers and is a consultant to Siemens and has financial interest in Aggamin Therapeutics. R.T. has patents in preeclampsia prediction markers, is a consultant to Roche and has a financial interest in Aggamin Therapeutics. All other authors report no conflicts. S.A.K. is co-inventor on multiple patents (USPTO #7,740,849, #7,407,658, #7,335,362, #7,344,892) related to the use of angiogenic markers for the diagnosis, prediction and therapy of preeclampsia. R.T. is a co-inventor on a patent (USPTO #7,344,892) related to the use of angiogenic proteins for the prediction of preeclampsia. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	[Anonymous], 2002, OBSTET GYNECOL, V99, P159; Bilano VL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091198; Chaiworapongsa T, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.01.016; Chaiworapongsa T, 2011, J MATERN-FETAL NEO M, V24, P1187, DOI 10.3109/14767058.2011.589932; Chappell LC, 2013, CIRCULATION, V128, P2121, DOI 10.1161/CIRCULATIONAHA.113.003215; Firoz T, 2011, BEST PRACT RES CL OB, V25, P537, DOI 10.1016/j.bpobgyn.2011.04.002; Goldenberg RL, 2015, ACTA OBSTET GYN SCAN, V94, P148, DOI 10.1111/aogs.12533; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Kusanovic JP, 2009, J MATERN-FETAL NEO M, V22, P1021, DOI 10.3109/14767050902994754; Larroca SGT, 2014, FETAL DIAGN THER, V36, P9, DOI 10.1159/000362518; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Moore AG, 2012, J MATERN-FETAL NEO M, V25, P2651, DOI 10.3109/14767058.2012.713055; Morisaki N, 2014, BJOG-INT J OBSTET GY, V121, P101, DOI 10.1111/1471-0528.12631; Noori M, 2010, CIRCULATION, V122, P478, DOI 10.1161/CIRCULATIONAHA.109.895458; Organization WH, 2005, WORLD HEALTH REPORT; Raghuraman N, 2014, PREGNANCY HYPERTENS, V4, P279, DOI 10.1016/j.preghy.2014.09.002; Rana S, 2014, HYPERTENSION, V63, P198, DOI 10.1161/HYPERTENSIONAHA.113.02293; Rana S, 2012, CIRCULATION, V125, P911, DOI 10.1161/CIRCULATIONAHA.111.054361; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Romero R, 2008, J MATERN-FETAL NEO M, V21, P9, DOI 10.1080/14767050701830480; Romero R, 2013, J CLIN INVEST, V123, P2775, DOI 10.1172/JCI70431; Verlohren S, 2014, HYPERTENSION, V63, P346, DOI 10.1161/HYPERTENSIONAHA.113.01787; Verlohren S, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.09.016	25	40	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0126815	10.1371/journal.pone.0126815	http://dx.doi.org/10.1371/journal.pone.0126815			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965397	Green Published, gold, Green Submitted			2022-12-26	WOS:000354543500080
J	Asada, M; Yahata, K; Hakimi, H; Yokoyama, N; Igarashi, I; Kaneko, O; Suarez, CE; Kawazu, S				Asada, Masahito; Yahata, Kazuhide; Hakimi, Hassan; Yokoyama, Naoaki; Igarashi, Ikuo; Kaneko, Osamu; Suarez, Carlos E.; Kawazu, Shin-ichiro			Transfection of Babesia bovis by Double Selection with WR99210 and Blasticidin-S and Its Application for Functional Analysis of Thioredoxin Peroxidase-1	PLOS ONE			English	Article							STABLE EXPRESSION; GENE-EXPRESSION; DISRUPTION; TRANSIENT; PARASITES; SEQUENCE; PROTEIN; LOCUS	Genetic manipulation is an essential technique to analyze gene function; however, limited methods are available for Babesia bovis, a causative pathogen of the globally important cattle disease, bovine babesiosis. To date, two stable transfection systems have been developed for B. bovis, using selectable markers blasticidin-S deaminase (bsd) or human dihydrofolate reductase (hdhfr). In this work, we combine these two selectable markers in a sequential transfection system. Specifically, a parent transgenic B. bovis line which episomally expresses green fluorescent protein (GFP) and human dihydrofolate reductase (hDHFR), was transfected with a plasmid encoding a fusion protein consisting of red fluorescent protein (RFP) and blasticidin-S deaminase (BSD). Selection with WR99210 and blasticidin-S resulted in the emergence of parasites double positive for GFP and RFP. We then applied this method to complement gene function in a parasite line in which thioredoxin peroxidase-1 (Bbtpx-1) gene was knocked out using hDHFR as a selectable marker. A plasmid was constructed harboring both RFP-BSD and Bbtpx-1 expression cassettes, and transfected into a Bbtpx-1 knockout (KO) parasite. Transfectants were independently obtained by two transfection methods, episomal transfection and genome integration. Complementation of Bbtpx-1 resulted in full recovery of resistance to nitrosative stress, via the nitric oxide donor sodium nitroprusside, which was impaired in the Bbtpx-1 KO parasites. In conclusion, we developed a sequential transfection method in B. bovis and subsequently applied this technique in a gene complementation study. This method will enable broader genetic manipulation of Babesia toward enhancing our understanding of the biology of this parasite.	[Asada, Masahito; Yahata, Kazuhide; Hakimi, Hassan; Kaneko, Osamu] Nagasaki Univ, Inst Trop Med NEKKEN, Dept Protozool, Nagasaki 852, Japan; [Asada, Masahito; Hakimi, Hassan; Yokoyama, Naoaki; Igarashi, Ikuo; Kawazu, Shin-ichiro] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 080, Japan; [Suarez, Carlos E.] Washington State Univ, Dept Vet Microbiol & Pathol, Program Vector Borne Dis, Pullman, WA 99164 USA; [Suarez, Carlos E.] ARS, USDA, Anim Dis Res Unit, Pullman, WA USA	Nagasaki University; Obihiro University of Agriculture & Veterinary Medicine; Washington State University; United States Department of Agriculture (USDA)	Suarez, CE (corresponding author), Washington State Univ, Dept Vet Microbiol & Pathol, Program Vector Borne Dis, Pullman, WA 99164 USA.	ces@vetmed.wsu.edu; skawazu@obihiro.ac.jp	Hakimi, Hassan/AAL-2181-2021; Hakimi, Hassan/AAF-2726-2020	Hakimi, Hassan/0000-0001-6678-7393; Asada, Masahito/0000-0003-0042-6856	NRCPD-OUAVM Joint Research Grant of NRCPD, Obihiro University of Agriculture and Veterinary Medicine [24-11]; Cooperative Research Grant of NEKKEN, Nagasaki University [26-A-1]; JSPS KAKENHI, Japan society for the promotion of science [25850199]	NRCPD-OUAVM Joint Research Grant of NRCPD, Obihiro University of Agriculture and Veterinary Medicine; Cooperative Research Grant of NEKKEN, Nagasaki University; JSPS KAKENHI, Japan society for the promotion of science	This work was supported by a NRCPD-OUAVM Joint Research Grant of NRCPD, Obihiro University of Agriculture and Veterinary Medicine (http://www.obihiro.ac.jp/similar to protozoa/eng/index-eng.html), to CES (No. 24-11), Cooperative Research Grant of NEKKEN, Nagasaki University (http://www.tm.nagasaki-u.ac.jp/nekken/english/index.html) to S-IK (No. 26-A-1) and JSPS KAKENHI, Japan society for the promotion of science (http://www.jsps.go.jp/english/index.html) to MA (No. 25850199). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khedery B, 2006, MOL MICROBIOL, V59, P402, DOI 10.1111/j.1365-2958.2005.04993.x; Asada M, 2012, MOL BIOCHEM PARASIT, V181, P162, DOI 10.1016/j.molbiopara.2011.11.001; Bork S, 2005, PARASITOLOGY, V130, P489, DOI 10.1017/S0031182004006821; Brayton KA, 2007, PLOS PATHOG, V3, P1401, DOI 10.1371/journal.ppat.0030148; Clarebout G, 1998, PARASITOL RES, V84, P75, DOI 10.1007/s004360050360; de Koning-Ward TF, 2000, MOL BIOCHEM PARASIT, V106, P199, DOI 10.1016/S0166-6851(99)00189-9; de Waal DT, 2006, VET PARASITOL, V138, P88, DOI 10.1016/j.vetpar.2006.01.042; Ghorbal M, 2014, NAT BIOTECHNOL, V32, P819, DOI 10.1038/nbt.2925; Gohil S, 2013, INT J PARASITOL, V43, P125, DOI 10.1016/j.ijpara.2012.09.008; Kawazu SI, 2008, PARASITOL INT, V57, P1, DOI 10.1016/j.parint.2007.08.001; Khan SM, 2012, CURR OPIN BIOTECH, V23, P908, DOI 10.1016/j.copbio.2012.04.003; Komaki-Yasuda K, 2003, FEBS LETT, V547, P140, DOI 10.1016/S0014-5793(03)00694-X; Lacroix C, 2011, NAT PROTOC, V6, P1412, DOI 10.1038/nprot.2011.363; Laughery JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097890; Pino P, 2012, CELL HOST MICROBE, V12, P824, DOI 10.1016/j.chom.2012.10.016; Sakura T, 2013, PARASITOL INT, V62, P157, DOI 10.1016/j.parint.2012.12.002; Suarez CE, 2008, EXP PARASITOL, V118, P498, DOI 10.1016/j.exppara.2007.10.013; Suarez CE, 2006, INT J PARASITOL, V36, P965, DOI 10.1016/j.ijpara.2006.02.022; Suarez CE, 2012, MOL BIOCHEM PARASIT, V185, P52, DOI 10.1016/j.molbiopara.2012.05.003; Suarez CE, 2011, VET PARASITOL, V180, P109, DOI 10.1016/j.vetpar.2011.05.032; Suarez CE, 2010, VET PARASITOL, V167, P205, DOI 10.1016/j.vetpar.2009.09.022; Suarez CE, 2009, INT J PARASITOL, V39, P289, DOI 10.1016/j.ijpara.2008.08.006; Suarez CE, 2004, INT J PARASITOL, V34, P1177, DOI 10.1016/j.ijpara.2004.07.001; Tanaka M, 2009, PARASITOL RES, V105, P1473, DOI 10.1007/s00436-009-1587-6; UILENBERG G, 1995, VET PARASITOL, V57, P19, DOI 10.1016/0304-4017(94)03107-8; Uilenberg G, 2006, VET PARASITOL, V138, P3, DOI 10.1016/j.vetpar.2006.01.035	26	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0125993	10.1371/journal.pone.0125993	http://dx.doi.org/10.1371/journal.pone.0125993			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962142	gold, Green Submitted, Green Published			2022-12-26	WOS:000354542500057
J	Fragkiadaki, P; Soulitzis, N; Sifakis, S; Koutroulakis, D; Gourvas, V; Vrachnis, N; Spandidos, DA				Fragkiadaki, Persefoni; Soulitzis, Nikolaos; Sifakis, Stavros; Koutroulakis, Demetrios; Gourvas, Victor; Vrachnis, Nikolaos; Spandidos, Demetrios A.			Downregulation of Notch Signaling Pathway in Late Preterm and Term Placentas from Pregnancies Complicated by Preeclampsia	PLOS ONE			English	Article							PROTEIN MEMBERS; EXPRESSION; PATHOGENESIS; RECEPTORS; SMOKING	Preeclampsia (PE) is a major cause of maternal mortality and morbidity, affecting 3-5% of all pregnancies. The Notch signaling pathway plays an important role during placental development, activating several target genes. Defects in the Notch pathway have adverse effect on placentation. The aim of this study was to investigate the expression of receptors NOTCH1,-2,-3,-4, ligands DLL1,-3,-4, JAG1,-2 and target genes HEY1,-2 in placental tissue samples from 20 late preterm or term pregnancies complicated by PE versus 20 normal pregnancies. mRNA levels of the studied molecules were measured by quantitative Real-Time PCR (qRT-PCR), while the protein expression of the intracellular domain of NOTCH2 (NICD2) and NOTCH3 (NICD3) was measured by Western Blot (WB). qRT-PCR analysis revealed that NOTCH1, NOTCH4 and DLL1 were not expressed in the placenta. On the contrary, NOTCH2, NOTCH3, DLL3, DLL4, JAG1, JAG2, HEY1 and HEY2 mRNA levels were downregulated in PE samples vs. controls (p<0.01). WB confirmed that NICD2 (p = 0.014) and NICD3 (p<0.001) protein levels were also lower in PE specimens. Statistical analysis revealed several significant associations: of NOTCH3 mRNA expression with smoking during pregnancy (p = 0.029), of NICD3 protein levels (p = 0.028) and DLL3 mRNA levels (p = 0.041) with birth weight centile, and of HEY2 transcript levels with parity (p = 0.034) and mode of delivery (p = 0.028). Our results suggest that Notch pathway downregulation is associated with PE. Further studies are required in order to determine the role of these molecules in PE pathogenesis and to evaluate their potential use for the early detection and treatment of PE.	[Fragkiadaki, Persefoni; Soulitzis, Nikolaos; Gourvas, Victor; Spandidos, Demetrios A.] Univ Crete, Sch Med, Lab Clin Virol, Iraklion, Greece; [Sifakis, Stavros; Koutroulakis, Demetrios] Univ Hosp Heraklion, Dept Obstet & Gynecol, Iraklion, Greece; [Vrachnis, Nikolaos] Natl & Kapodistrian Univ Athens, Aretaieion Hosp, Dept Obstet & Gynaecol 2, Athens 11528, Greece	University of Crete; University Hospital of Heraklion; National & Kapodistrian University of Athens	Spandidos, DA (corresponding author), Univ Crete, Sch Med, Lab Clin Virol, Iraklion, Greece.	spandidos@spandidos.gr		Spandidos, Demetrios/0000-0002-1146-931X				ACOG Committee on Practice Bulletins--Obstetrics, 2002, Obstet Gynecol, V99, P159; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Borggrefe T, 2009, CELL MOL LIFE SCI, V66, P1631, DOI 10.1007/s00018-009-8668-7; Cobellis L, 2007, CELL TISSUE RES, V330, P527, DOI 10.1007/s00441-007-0511-6; De Falco M, 2007, PLACENTA, V28, P118, DOI 10.1016/j.placenta.2006.03.010; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; Fleming RJ, 1998, SEMIN CELL DEV BIOL, V9, P599, DOI 10.1006/scdb.1998.0260; Gasperowicz M, 2008, PLACENTA, V29, P651, DOI 10.1016/j.placenta.2008.06.004; Gourvas V, 2010, BJOG-INT J OBSTET GY, V117, P1635, DOI 10.1111/j.1471-0528.2010.02735.x; Herr F, 2011, PLACENTA, V32, P554, DOI 10.1016/j.placenta.2011.04.018; High FA, 2008, NAT REV GENET, V9, P49, DOI 10.1038/nrg2279; Hunkapiller NM, 2011, DEVELOPMENT, V138, P2987, DOI 10.1242/dev.066589; Ji L, 2013, MOL ASPECTS MED, V34, P981, DOI 10.1016/j.mam.2012.12.008; Kume T, 2012, ADV EXP MED BIOL, V727, P210, DOI 10.1007/978-1-4614-0899-4_16; Ness RB, 2008, AM J EPIDEMIOL, V168, P427, DOI 10.1093/aje/kwn140; Roberts JM, 2001, LANCET, V357, P53, DOI 10.1016/S0140-6736(00)03577-7; Sahin Z, 2011, ACTA HISTOCHEM, V113, P270, DOI 10.1016/j.acthis.2009.10.006; Tilley AE, 2009, AM J RESP CRIT CARE, V179, P457, DOI 10.1164/rccm.200705-795OC; Wolf M, 2005, AM J OBSTET GYNECOL, V193, P16, DOI 10.1016/j.ajog.2005.03.016; Young BC, 2010, ANNU REV PATHOL-MECH, V5, P173, DOI 10.1146/annurev-pathol-121808-102149; Zhao WX, 2014, REPROD SCI, V21, P716, DOI 10.1177/1933719113512530; Zhao WX, 2012, INT J MED SCI, V9, P447, DOI 10.7150/ijms.4593	22	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126163	10.1371/journal.pone.0126163	http://dx.doi.org/10.1371/journal.pone.0126163			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962154	Green Submitted, Green Published, gold			2022-12-26	WOS:000354542500071
J	Lei, YT; Xiong, YF; Zhang, L; Yan, H; Li, ZY; Cao, L; Huang, JY; Gu, AP; Ni, ZH; Qian, JQ; Fang, W				Lei, Yutian; Xiong, Yifan; Zhang, Lin; Yan, Hao; Li, Zhenyuan; Cao, Liou; Huang, Jiaying; Gu, Aiping; Ni, Zhaohui; Qian, Jiaqi; Fang, Wei			Comparison of Long-Term Outcomes between Peritoneal Dialysis Patients with Diabetes as a Primary Renal Disease or as a Comorbid Condition	PLOS ONE			English	Article							C-REACTIVE PROTEIN; MORBID CONDITION; SURVIVAL; TIME; INFLAMMATION; ASSOCIATION; TRANSPORT; GLUCOSE; FAILURE	Objective To investigate the long-term outcomes of peritoneal dialysis (PD) patients with diabetes as primary renal disease and patients with diabetes as a comorbid condition. Methods All diabetic patients who commenced PD between January 1, 1995 and June 30, 2012 at Ren Ji Hospital, China were included. Patients were divided into diabetic nephropathy group (DN group) and non-diabetic nephropathy group (NDN group) according to their diagnosis of primary renal disease at the initiation of PD. They were followed until death, cessation of PD, transferred to other centers or to the end of study (June 30, 2013). Outcomes were analyzed by Kaplan-Meier method and Cox regression models. Results A total of 163 diabetic patients were enrolled in the study, including 121 (74.2%) in DN group and 42 (25.8%) in NDN group. The 1-, 2-, 3- and 5-year patient survival rates were 89%, 78%, 66% and 51% for DN group, and 85%, 63%, 53% and 25% for NDN group, respectively. Kaplan-Meier analysis showed that patients in NDN group had a worse patient survival compared with DN group (log rank 4.830, P=0.028). Patients in NDN group had a marginally shorter peritonitis-free period (log rank 3.297, P=0.069), however, there was no significant difference in technique survival (log rank 0.040, P=0.841). Multivariate Cox regression analysis showed that older age (HR 1.047, 95% CI 1.022-1.073, p<0.001), cardiovascular disease comorbidity (HR 2.200, 95% CI 0.1.269-3.814, P=0.005) and diabetes as a comorbidity condition (HR 1.806, 95% CI 1.003-3.158, P=0.038) were the independent predictors of increased mortality. Conclusions PD patients with diabetes as a comorbidity had an inferior patient survival compared to those with diabetic nephropathy, and closer monitoring and extra attention in the former subgroup of patients are therefore warranted.	[Lei, Yutian; Xiong, Yifan; Zhang, Lin; Yan, Hao; Li, Zhenyuan; Cao, Liou; Huang, Jiaying; Gu, Aiping; Ni, Zhaohui; Qian, Jiaqi; Fang, Wei] Shanghai Jiao Tong Univ, Ren Ji Hosp, Ctr Peritoneal Dialysis Res, Sch Med,Dept Nephrol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Fang, W (corresponding author), Shanghai Jiao Tong Univ, Ren Ji Hosp, Ctr Peritoneal Dialysis Res, Sch Med,Dept Nephrol, Shanghai 200030, Peoples R China.	fangwei_sh@126.com	Xiong, Yifan/GSD-4318-2022		National Nature Science Foundation Grant of China [81370864]; Science and Technology Commission of Shanghai Municipality [114119a900]	National Nature Science Foundation Grant of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the National Nature Science Foundation Grant of China (81370864), grant from Science and Technology Commission of Shanghai Municipality (114119a900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG VW, 1985, NEPHRON, V39, P141, DOI 10.1159/000183358; BODNAR DM, 1993, ADV PERIT D, V9, P114; Catalano C, 1996, NEPHROL DIAL TRANSPL, V11, P1124; Chang YT, 2014, DIABETES CARE, V37, P277, DOI 10.2337/dc13-0781; Chung SH, 2003, NEPHROL DIAL TRANSPL, V18, P590, DOI 10.1093/ndt/18.3.590; Chung SH, 2001, NEPHROL DIAL TRANSPL, V16, P2240, DOI 10.1093/ndt/16.11.2240; Davies SJ, 2001, J AM SOC NEPHROL, V12, P1046, DOI 10.1681/ASN.V1251046; Ducloux D, 2002, KIDNEY INT, V62, P1417, DOI 10.1111/j.1523-1755.2002.kid562.x; Herzig KA, 2001, J AM SOC NEPHROL, V12, P814, DOI 10.1681/ASN.V124814; Liao CT, 2009, NEPHROL DIAL TRANSPL, V24, P2909, DOI 10.1093/ndt/gfp056; Moist LM, 2000, J AM SOC NEPHROL, V11, P556, DOI 10.1681/ASN.V113556; Perl J, 2012, CLIN J AM SOC NEPHRO, V7, P1145, DOI 10.2215/CJN.01480212; Schroijen MA, 2013, DIABETOLOGIA, V56, P1949, DOI 10.1007/s00125-013-2966-1; Schroijen MA, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-69; Schwenger V, 2001, DEUT MED WOCHENSCHR, V126, P1322, DOI 10.1055/s-2001-18564; Snaedal S, 2009, AM J KIDNEY DIS, V53, P1024, DOI 10.1053/j.ajkd.2009.02.008; Sorensen VR, 2007, DIABETOLOGIA, V50, P922, DOI 10.1007/s00125-007-0612-5; Su YJ, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-185; Van Dijk PCW, 2005, KIDNEY INT, V67, P1489, DOI 10.1111/j.1523-1755.2005.00227.x; Wang AYM, 2003, J AM SOC NEPHROL, V14, P1871, DOI 10.1097/01.ASN.0000070071.57901.B3; Wener MH, 2000, J RHEUMATOL, V27, P2351; Yeun JY, 1997, AM J KIDNEY DIS, V30, P923, DOI 10.1016/S0272-6386(97)90105-0	22	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126549	10.1371/journal.pone.0126549	http://dx.doi.org/10.1371/journal.pone.0126549			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961883	Green Submitted, gold, Green Published			2022-12-26	WOS:000354542500111
J	Santini, B; Zanoni, I; Marzi, R; Cigni, C; Bedoni, M; Gramatica, F; Palugan, L; Corsi, F; Granucci, F; Colombo, M				Santini, Benedetta; Zanoni, Ivan; Marzi, Roberta; Cigni, Clara; Bedoni, Marzia; Gramatica, Furio; Palugan, Luca; Corsi, Fabio; Granucci, Francesca; Colombo, Miriam			Cream Formulation Impact on Topical Administration of Engineered Colloidal Nanoparticles	PLOS ONE			English	Article							SKIN; PENETRATION; CELLS	In order to minimize the impact of systemic toxicity of drugs in the treatment of local acute and chronic inflammatory reactions, the achievement of reliable and efficient delivery of therapeutics in/through the skin is highly recommended. While the use of nanoparticles is now an established practice for drug intravenous targeted delivery, their transdermal penetration is still poorly understood and this important administration route remains almost unexplored. In the present study, we have synthesized magnetic (iron oxide) nanoparticles (MNP) coated with an amphiphilic polymer, developed a water-in-oil emulsion formulation for their topical administration and compared the skin penetration routes with the same nanoparticles deposited as a colloidal suspension. Transmission and scanning electron microscopies provided ultrastructural evidence that the amphiphilic nanoparticles (PMNP) cream formulation allowed the efficient penetration through all the skin layers with a controllable kinetics compared to suspension formulation. In addition to the preferential follicular pathway, also the intracellular and intercellular routes were involved. PMNP that crossed all skin layers were quantified by inductively coupled plasma mass spectrometry. The obtained data suggests that combining PMNP amphiphilic character with cream formulation improves the intradermal penetration of nanoparticles. While PMNP administration in living mice via aqueous suspension resulted in preferential nanoparticle capture by phagocytes and migration to draining lymph nodes, cream formulation favored uptake by all the analyzed dermis cell types, including hematopoietic and non-hematopoietic. Unlike aqueous suspension, cream formulation also favored the maintenance of nanoparticles in the dermal architecture avoiding their dispersion and migration to draining lymph nodes via afferent lymphatics.	[Santini, Benedetta; Zanoni, Ivan; Marzi, Roberta; Cigni, Clara; Granucci, Francesca; Colombo, Miriam] Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, NanoBioLab, Milan, Italy; [Zanoni, Ivan] Harvard Univ, Boston Childrens Hosp, Div Gastroenterol, Boston, MA 02115 USA; [Bedoni, Marzia; Gramatica, Furio] Fdn Don Carlo Gnocchi ONLUS, La Nanomed & Biofoton Clin, Milan, Italy; [Palugan, Luca] Univ Milan, Dipartimento Sci Farmaceut, Milan, Italy; [Corsi, Fabio] Univ Milan, Dipartimento Sci Biomed & Clin Luigi Sacco, Milan, Italy; [Zanoni, Ivan; Granucci, Francesca] Humanitas Clin & Res Ctr, Unit Cell Signalling & Innate Immun, Milan, Italy	University of Milano-Bicocca; Harvard University; Boston Children's Hospital; IRCCS Fondazione Don Carlo Gnocchi Onlus; University of Milan; University of Milan; Luigi Sacco Hospital	Colombo, M (corresponding author), Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, NanoBioLab, Milan, Italy.	miriam.colombo@unimib.it	Corsi, Fabio/ABH-9554-2020; Bedoni, Marzia/AAA-7674-2020; GRANUCCI, Francesca/K-6150-2019; Corsi, Fabio/E-9204-2017	Corsi, Fabio/0000-0002-6469-4086; Bedoni, Marzia/0000-0003-2618-3661; Corsi, Fabio/0000-0002-6469-4086; Zanoni, Ivan/0000-0002-3423-7474; Gramatica, Furio/0000-0002-2826-031X; COLOMBO, MIRIAM/0000-0003-3428-5668; granucci, francesca/0000-0002-7046-4914	Fondazione Regionale per la Ricerca Biomedica (FRRB); NanoMeDia Project (A.O. "L. Sacco"); Cariplo Foundation [2011-2096, 2010-0678]; Associazione Italiana per la Ricerca sul Cancro (MFAG) [13235]; NanoMeDia Project (Regione Lombardia); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854] Funding Source: NIH RePORTER	Fondazione Regionale per la Ricerca Biomedica (FRRB)(Regione Lombardia); NanoMeDia Project (A.O. "L. Sacco"); Cariplo Foundation(Fondazione Cariplo); Associazione Italiana per la Ricerca sul Cancro (MFAG)(Fondazione AIRC per la ricerca sul cancro); NanoMeDia Project (Regione Lombardia)(Regione Lombardia); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the following sources: Fondazione Regionale per la Ricerca Biomedica (FRRB), NanoMeDia Project (A.O. "L. Sacco" and Regione Lombardia); the Cariplo Foundation (Grant 2011-2096 and Grant 2010-0678), Associazione Italiana per la Ricerca sul Cancro (MFAG, Rif.13235).	Avvakumova S, 2014, TRENDS BIOTECHNOL, V32, P11, DOI 10.1016/j.tibtech.2013.09.006; Baroli B, 2007, J INVEST DERMATOL, V127, P1701, DOI 10.1038/sj.jid.5700733; Bolzinger MA, 2012, CURR OPIN COLLOID IN, V17, P156, DOI 10.1016/j.cocis.2012.02.001; Colombo M, 2012, CHEM SOC REV, V41, P4306, DOI 10.1039/c2cs15337h; DeLouise LA, 2012, J INVEST DERMATOL, V132, P964, DOI 10.1038/jid.2011.425; Desai P, 2010, MOL MEMBR BIOL, V27, P247, DOI 10.3109/09687688.2010.522203; Dufort S, 2012, ADV DRUG DELIVER REV, V64, P179, DOI 10.1016/j.addr.2011.09.009; Duncan R, 2011, MOL PHARMACEUT, V8, P2101, DOI 10.1021/mp200394t; Elias PM, 2005, EXP DERMATOL, V14, P719, DOI 10.1111/j.1600-0625.2005.00363.x; Gratieri T, 2010, J BIOMED NANOTECHNOL, V6, P586, DOI 10.1166/jbn.2010.1155; Harisinghani MG, 2003, NEW ENGL J MED, V348, P2491, DOI 10.1056/NEJMoa022749; Haun JB, 2010, NAT NANOTECHNOL, V5, P660, DOI [10.1038/NNANO.2010.148, 10.1038/nnano.2010.148]; Jain K, 2014, CURR OPIN PHARMACOL, V15, P97, DOI 10.1016/j.coph.2014.01.006; Klein K., 2003, COSMET TOILETRIES, V118, P24; Labouta HI, 2013, NANOMED-NANOTECHNOL, V9, P39, DOI 10.1016/j.nano.2012.04.004; Labouta HI, 2011, NANOSCALE, V3, P4989, DOI 10.1039/c1nr11109d; Mathias NR, 2010, J PHARM SCI-US, V99, P1, DOI 10.1002/jps.21793; Park J, 2004, NAT MATER, V3, P891, DOI 10.1038/nmat1251; Pellegrino T, 2004, NANO LETT, V4, P703, DOI 10.1021/nl035172j; Prapainop K, 2012, J AM CHEM SOC, V134, P4100, DOI 10.1021/ja300537u; Rosenblum MD, 2011, NATURE, V480, P538, DOI 10.1038/nature10664; Schroeder A, 2012, NAT REV CANCER, V12, P39, DOI 10.1038/nrc3180; Sonavane G, 2008, COLLOID SURFACE B, V65, P1, DOI 10.1016/j.colsurfb.2008.02.013; Verderio P, 2014, ADV HEALTHC MATER, V3, P957, DOI 10.1002/adhm.201300602; Vogt A, 2006, J INVEST DERMATOL, V126, P1316, DOI 10.1038/sj.jid.5700226; Zanoni I, 2012, J CLIN INVEST, V122, P1747, DOI 10.1172/JCI60688	26	20	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126366	10.1371/journal.pone.0126366	http://dx.doi.org/10.1371/journal.pone.0126366			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962161	Green Published, gold			2022-12-26	WOS:000354542500093
J	Wang, Y; Tan, LB; Fu, YC; Zhu, ZF; Liu, FX; Sun, CQ; Cai, HW				Wang, Yan; Tan, Lubin; Fu, Yongcai; Zhu, Zuofeng; Liu, Fengxia; Sun, Chuanqing; Cai, Hongwei			Molecular Evolution of the Sorghum Maturity Gene Ma(3)	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PHOTOPERIOD SENSITIVITY; QUANTITATIVE RESISTANCE; MAIZE DOMESTICATION; SELECTIVE SWEEP; LEAF-BLIGHT; BICOLOR; TRAITS; PLANT; ARCHITECTURE	Time to maturity is a critical trait in sorghum (Sorghum bicolor) breeding, as it determines whether a variety can be grown in a particular cropping system or ecosystem. Understanding the nucleotide variation and the mechanisms of molecular evolution of the maturity genes would be helpful for breeding programs. In this study, we analyzed the nucleotide diversity of Ma(3), an important maturity gene in sorghum, using 252 cultivated and wild sorghum materials from all over the world. The nucleotide variation and diversity were analyzed based both on race-and usage-based groups. We also sequenced 12 genes around the Ma(3) gene in 185 of these materials to search for a selective sweep and found that purifying selection was the strongest force on Ma(3), as low nucleotide diversity and low-frequency amino acid variants were observed. However, a very special mutation, described as ma(3)(R), seemed to be under positive selection, as indicated by dramatically reduced nucleotide variation not only at the loci but also in the surrounding regions among individuals carrying the mutations. In addition, in an association study using the Ma(3) nucleotide variations, we detected 3 significant SNPs for the heading date at a high-latitude environment (Beijing) and 17 at a low-latitude environment (Hainan). The results of this study increases our understanding of the evolutionary mechanisms of the maturity genes in sorghum and will be useful in sorghum breeding.	[Wang, Yan; Tan, Lubin; Fu, Yongcai; Zhu, Zuofeng; Liu, Fengxia; Sun, Chuanqing; Cai, Hongwei] China Agr Univ, Coll Agron & Biotechnol, Dept Plant Genet & Breeding, Beijing 100094, Peoples R China; [Wang, Yan; Tan, Lubin; Fu, Yongcai; Zhu, Zuofeng; Liu, Fengxia; Sun, Chuanqing; Cai, Hongwei] Minist Agr, Beijing Key Lab Crop Genet Improvement & Genome, Beijing, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs	Cai, HW (corresponding author), China Agr Univ, Coll Agron & Biotechnol, Dept Plant Genet & Breeding, Beijing 100094, Peoples R China.	caihw@cau.edu.cn	Tan, Lubin/H-9270-2017	Tan, Lubin/0000-0003-3775-7720				Alba R, 2000, MOL BIOL EVOL, V17, P362, DOI 10.1093/oxfordjournals.molbev.a026316; [Anonymous], 1974, SORGHUM IMPROVEMENT; Berenji J, 2011, ECON BOT, V65, P190, DOI 10.1007/s12231-011-9155-2; Bhosale SU, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-32; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Casa AM, 2006, CROP SCI, V46, pS27, DOI 10.2135/cropsci2006.0001tpg; CHILDS KL, 1995, PLANT PHYSIOL, V108, P345, DOI 10.1104/pp.108.1.345; Childs KL, 1997, PLANT PHYSIOL, V113, P611, DOI 10.1104/pp.113.2.611; Clark RM, 2004, P NATL ACAD SCI USA, V101, P700, DOI 10.1073/pnas.2237049100; Defelice MS, 2006, WEED TECHNOL, V20, P1076, DOI 10.1614/WT-06-051.1; Doggett H., 1988, ECON BOT, V2nd ed.; FOSTER KR, 1994, PLANT PHYSIOL, V105, P941, DOI 10.1104/pp.105.3.941; Garner WW, 1923, J AGRIC RES, V23, P0871; Hamblin MT, 2006, GENETICS, V173, P953, DOI 10.1534/genetics.105.054312; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; KAPLAN NL, 1989, GENETICS, V123, P887; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Kump KL, 2011, NAT GENET, V43, P163, DOI 10.1038/ng.747; Lin ZW, 2012, NAT GENET, V44, P720, DOI 10.1038/ng.2281; Mace ES, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3320; Mann JA, 1983, B B TEXAS AGR EXP ST, V1454, P21; Morgan PW, 2002, CROP SCI, V42, P1791, DOI 10.2135/cropsci2002.1791; Morris GP, 2013, P NATL ACAD SCI USA, V110, P453, DOI 10.1073/pnas.1215985110; Mullet J.E., 2012, US Patent, Patent No. [8,309,793., 8309793]; Mullet JE, 2013, US Patent App, Patent No. [13/886,130, 13886130]; Murphy RL, 2011, P NATL ACAD SCI USA, V108, P16469, DOI 10.1073/pnas.1106212108; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Olsen KM, 2006, GENETICS, V173, P975, DOI 10.1534/genetics.106.056473; PAO CI, 1986, PLANT PHYSIOL, V82, P575, DOI 10.1104/pp.82.2.575; Poehlman J. M., 1994, BREEDING FIELD CROPS, P508; Poland JA, 2011, P NATL ACAD SCI USA, V108, P6893, DOI 10.1073/pnas.1010894108; QUINBY J. R., 1967, Advanc. Agron., V19, P267, DOI 10.1016/S0065-2113(08)60737-3; QUINBY JR, 1945, J AM SOC AGRON, V37, P916; QUINBY JR, 1966, CROP SCI, V6, P516, DOI 10.2135/cropsci1966.0011183X000600060005x; Rooney WL, 1999, CROP SCI, V39, P397, DOI 10.2135/cropsci1999.0011183X0039000200016x; Rozas J, 1995, COMPUT APPL BIOSCI, V11, P621; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; STEMLER ABL, 1975, J AFR HIST, V16, P161, DOI 10.1017/S0021853700001109; Sweeney MT, 2007, PLOS GENET, V3, P1418, DOI 10.1371/journal.pgen.0030133; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Tian F, 2009, P NATL ACAD SCI USA, V106, P9979, DOI 10.1073/pnas.0901122106; Upadhyaya HD, 2012, GENOME, V55, P471, DOI [10.1139/G2012-034, 10.1139/g2012-034]; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435; Wang YH, 2013, G3-GENES GENOM GENET, V3, P783, DOI 10.1534/g3.112.004861; Weibel DE, 1970, SORGHUM PRODUCTION A; White GM, 2004, MOL BIOL EVOL, V21, P716, DOI 10.1093/molbev/msh067; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Zhu ZF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3200	51	2	4	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0124435	10.1371/journal.pone.0124435	http://dx.doi.org/10.1371/journal.pone.0124435			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961888	gold, Green Submitted, Green Published			2022-12-26	WOS:000354542500013
J	Wu, JD; Hillier, C; Komenda, P; de Faria, RL; Levin, D; Zhang, M; Lin, F				Wu, Jiandong; Hillier, Craig; Komenda, Paul; de Faria, Ricardo Lobato; Levin, David; Zhang, Michael; Lin, Francis			A Microfluidic Platform for Evaluating Neutrophil Chemotaxis Induced by Sputum from COPD Patients	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CHEMOATTRACTANT GRADIENTS; CELL CHEMOTAXIS; LEUKOTRIENE B-4; INTERLEUKIN-8; MIGRATION; BLOOD; PATHOGENESIS; EXPRESSION; GENERATION	Chronic Obstructive Pulmonary Disease (COPD) is a common lung disease characterized by breathing difficulty as a consequence of narrowed airways. Previous studies have shown that COPD is correlated with neutrophil infiltration into the airways through chemotactic migration. However, whether neutrophil chemotaxis can be used to characterize and diagnose COPD is not well established. In the present study, we developed a microfluidic platform for evaluating neutrophil chemotaxis to sputum samples from COPD patients. Our results show increased neutrophil chemotaxis to COPD sputum compared to control sputum from healthy individuals. The level of COPD sputum induced neutrophil chemotaxis was correlated with the patient's spirometry data. The cell morphology of neutrophils in a COPD sputum gradient is similar to the morphology displayed by neutrophils exposed to an IL-8 gradient, but not a fMLP gradient. In competing gradients of COPD sputum and fMLP, neutrophils chemotaxis and cell morphology are dominated by fMLP.	[Wu, Jiandong; Lin, Francis] Univ Manitoba, Dept Phys & Astron, Winnipeg, MB R3T 2N2, Canada; [Wu, Jiandong; Levin, David; Lin, Francis] Univ Manitoba, Dept Biosyst Engn, Winnipeg, MB R3T 2N2, Canada; [Lin, Francis] Univ Manitoba, Dept Biol Sci, Winnipeg, MB R3T 2N2, Canada; [Lin, Francis] Univ Manitoba, Dept Immunol, Winnipeg, MB R3E 0T5, Canada; [Hillier, Craig; Komenda, Paul; de Faria, Ricardo Lobato; Zhang, Michael] Seven Oaks Gen Hosp, Winnipeg, MB R2V 3M3, Canada; [Zhang, Michael] Rizhao Hosp Tradit Chinese Med, Rizhao, Peoples R China	University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba	Lin, F (corresponding author), Univ Manitoba, Dept Phys & Astron, Winnipeg, MB R3T 2N2, Canada.	flin@physics.umanitoba.ca		Wu, Jiandong/0000-0003-1153-3120; Lin, Francis/0000-0003-1736-193X	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2014-04789, RGPIN-371474-2009]; Canada Foundation for Innovation (CFI) (CFI-LOF-N: Infrastructure for Analyzing Immune Cell Trafficking in vitro and in vivo); Winnipeg Rh Institute Foundation; University of Manitoba; Research Manitoba (previously the Manitoba Health Research Council)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (CFI) (CFI-LOF-N: Infrastructure for Analyzing Immune Cell Trafficking in vitro and in vivo); Winnipeg Rh Institute Foundation; University of Manitoba; Research Manitoba (previously the Manitoba Health Research Council)	F.L. acknowledges the support of Discovery Grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) (RGPIN-2014-04789 and RGPIN-371474-2009) and Canada Foundation for Innovation (CFI) (CFI-LOF-N: Infrastructure for Analyzing Immune Cell Trafficking in vitro and in vivo). F.L. thanks the Winnipeg Rh Institute Foundation and the University of Manitoba for a Rh Award; J.W. thanks Research Manitoba (previously the Manitoba Health Research Council) for graduate fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhyankar VV, 2006, LAB CHIP, V6, P389, DOI 10.1039/b514133h; Adams DH, 1997, LANCET, V349, P490, DOI 10.1016/S0140-6736(96)07524-1; Agrawal N, 2008, LAB CHIP, V8, P2054, DOI 10.1039/b813588f; Ahmed T, 2010, NANO LETT, V10, P3379, DOI 10.1021/nl101204e; Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Beeh KM, 2003, CHEST, V123, P1240, DOI 10.1378/chest.123.4.1240; BURNETT D, 1987, LANCET, V2, P1043; Butler KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011921; Foxman EF, 1997, J CELL BIOL, V139, P1349, DOI 10.1083/jcb.139.5.1349; Gao YD, 2012, MICROFLUID NANOFLUID, V12, P887, DOI 10.1007/s10404-011-0908-0; GOLD, 2011, GLOB STRAT DIAGN MAN; Heinzelmann M, 1999, AM J KIDNEY DIS, V34, P384, DOI 10.1016/S0272-6386(99)70375-6; Heit B, 2002, J CELL BIOL, V159, P91, DOI 10.1083/jcb.200202114; Irimia D, 2006, LAB CHIP, V6, P191, DOI 10.1039/b511877h; Jeon NL, 2002, NAT BIOTECHNOL, V20, P826, DOI 10.1038/nbt712; Kim S, 2010, INTEGR BIOL-UK, V2, P584, DOI 10.1039/c0ib00055h; Kumar V, 2010, INT IMMUNOPHARMACOL, V10, P1325, DOI 10.1016/j.intimp.2010.08.012; Lin F, 2005, ANN BIOMED ENG, V33, P475, DOI 10.1007/s10439-005-2503-6; Lin F, 2004, BIOCHEM BIOPH RES CO, V319, P576, DOI 10.1016/j.bbrc.2004.05.029; Lin F, 2006, LAB CHIP, V6, P1462, DOI 10.1039/b607071j; Lin F, 2009, METHOD ENZYMOL, V461, P333, DOI 10.1016/S0076-6879(09)05415-9; MANOUCHEHRPOUR M, 1981, J DENT RES, V60, P729, DOI 10.1177/00220345810600031101; METZGER WJ, 1986, J ALLERGY CLIN IMMUN, V78, P282; NAKAMURA H, 1991, J BIOL CHEM, V266, P19611; Quint JK, 2007, J ALLERGY CLIN IMMUN, V119, P1065, DOI 10.1016/j.jaci.2006.12.640; Reddy RC, 2010, CURR OPIN HEMATOL, V17, P18, DOI 10.1097/MOH.0b013e32833338f3; RICHMANEISENSTAT JBY, 1993, AM J PHYSIOL, V264, pL413, DOI 10.1152/ajplung.1993.264.4.L413; Saadi W, 2007, BIOMED MICRODEVICES, V9, P627, DOI 10.1007/s10544-007-9051-9; Saadi W, 2006, BIOMED MICRODEVICES, V8, P109, DOI 10.1007/s10544-006-7706-6; Sackmann EK, 2014, NATURE, V507, P181, DOI 10.1038/nature13118; Sackmann EK, 2012, BLOOD, V120, pE45, DOI 10.1182/blood-2012-03-416453; Sackmann EKH, 2014, P NATL ACAD SCI USA, V111, P5813, DOI 10.1073/pnas.1324043111; Stockley RA, 2002, CHEST, V121, p151S, DOI 10.1378/chest.121.5_suppl.151S; Tharp WG, 2006, J LEUKOCYTE BIOL, V79, P539, DOI 10.1189/jlb.0905516; Turato G, 2001, RESPIRATION, V68, P117, DOI 10.1159/000050478; Warner EA, 2011, LAB INVEST, V91, P1787, DOI 10.1038/labinvest.2011.94; Woolhouse IS, 2002, THORAX, V57, P709, DOI 10.1136/thorax.57.8.709; World Health Organization, BURD OF COPD; Wu J., 2014, BIOM IJCB 2014 IEEE, P1; Wu J, 2014, EMBC2014 CHIC US; Wu JD, 2013, LAB CHIP, V13, P2484, DOI [10.1039/c3lc50415h, 10.1039/c31c50415h]; Yamamoto C, 1997, CHEST, V112, P505, DOI 10.1378/chest.112.2.505; Yamauchi A, 2014, J IMMUNOL METHODS, V404, P59, DOI 10.1016/j.jim.2013.12.005; Yoshikawa T, 2007, AM J RESP CRIT CARE, V175, P473, DOI 10.1164/rccm.200507-1152OC	44	25	26	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126523	10.1371/journal.pone.0126523	http://dx.doi.org/10.1371/journal.pone.0126523			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961597	Green Published, gold, Green Submitted			2022-12-26	WOS:000354542500109
J	Yoshino, R; Yasuo, N; Inaoka, DK; Hagiwara, Y; Ohno, K; Orita, M; Inoue, M; Shiba, T; Harada, S; Honma, T; Balogun, EO; da Rocha, JR; Montanari, CA; Kita, K; Sekijima, M				Yoshino, Ryunosuke; Yasuo, Nobuaki; Inaoka, Daniel Ken; Hagiwara, Yohsuke; Ohno, Kazuki; Orita, Masaya; Inoue, Masayuki; Shiba, Tomoo; Harada, Shigeharu; Honma, Teruki; Balogun, Emmanuel Oluwadare; da Rocha, Josmar Rodrigues; Montanari, Carlos Alberto; Kita, Kiyoshi; Sekijima, Masakazu			Pharmacophore Modeling for Anti-Chagas Drug Design Using the Fragment Molecular Orbital Method	PLOS ONE			English	Article							DIHYDROOROTATE DEHYDROGENASE INHIBITORS; TRYPANOSOMA-CRUZI; IDENTIFICATION; INSIGHTS	Background Chagas disease, caused by the parasite Trypanosoma cruzi, is a neglected tropical disease that causes severe human health problems. To develop a new chemotherapeutic agent for the treatment of Chagas disease, we predicted a pharmacophore model for T. cruzi dihydroorotate dehydrogenase (TcDHODH) by fragment molecular orbital (FMO) calculation for orotate, oxonate, and 43 orotate derivatives. Methodology/Principal Findings Intermolecular interactions in the complexes of TcDHODH with orotate, oxonate, and 43 orotate derivatives were analyzed by FMO calculation at the MP2/6-31G level. The results indicated that the orotate moiety, which is the base fragment of these compounds, interacts with the Lys43, Asn67, and Asn194 residues of TcDHODH and the cofactor flavin mononucleotide (FMN), whereas functional groups introduced at the orotate 5-position strongly interact with the Lys214 residue. Conclusions/Significance FMO-based interaction energy analyses revealed a pharmacophore model for TcDHODH inhibitor. Hydrogen bond acceptor pharmacophores correspond to Lys43 and Lys214, hydrogen bond donor and acceptor pharmacophores correspond to Asn67 and Asn194, and the aromatic ring pharmacophore corresponds to FMN, which shows important characteristics of compounds that inhibit TcDHODH. In addition, the Lys214 residue is not conserved between TcDHODH and human DHODH. Our analysis suggests that these orotate derivatives should preferentially bind to TcDHODH, increasing their selectivity. Our results obtained by pharmacophore modeling provides insight into the structural requirements for the design of TcDHODH inhibitors and their development as new anti-Chagas drugs.	[Yoshino, Ryunosuke; Orita, Masaya; Sekijima, Masakazu] Tokyo Inst Technol, Global Sci Informat & Comp Ctr, Meguro Ku, Tokyo 1528550, Japan; [Yoshino, Ryunosuke] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Yasuo, Nobuaki; Sekijima, Masakazu] Tokyo Inst Technol, Dept Comp Sci, Meguro Ku, Tokyo 1528550, Japan; [Inaoka, Daniel Ken; Honma, Teruki; Balogun, Emmanuel Oluwadare; Kita, Kiyoshi] Univ Tokyo, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; [Hagiwara, Yohsuke; Ohno, Kazuki; Orita, Masaya] Astellas Pharma Inc, Chem Res Labs, Drug Discovery Res, Tsukuba, Ibaraki 3058585, Japan; [Inoue, Masayuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Shiba, Tomoo; Harada, Shigeharu] Kyoto Inst Technol, Grad Sch Sci & Technol, Sakyo Ku, Kyoto 6068585, Japan; [Balogun, Emmanuel Oluwadare] Ahmadu Bello Univ, Dept Biochem, Zaria 2222, Nigeria; [da Rocha, Josmar Rodrigues; Montanari, Carlos Alberto] Univ Sao Paulo, Inst Quim Sao Carlos, BR-13566590 Sao Carlos, SP, Brazil	Tokyo Institute of Technology; University of Tokyo; Tokyo Institute of Technology; University of Tokyo; Astellas Pharmaceuticals; University of Tokyo; Kyoto Institute of Technology; Ahmadu Bello University; Universidade de Sao Paulo	Sekijima, M (corresponding author), Tokyo Inst Technol, Global Sci Informat & Comp Ctr, Meguro Ku, Tokyo 1528550, Japan.	sekijima@gsic.titech.ac.jp	Inaoka, Daniel Ken/GMX-4344-2022; Balogun, Emmanuel Oluwadare/AAF-3352-2020; Montanari, Carlos A/C-2799-2012	Inaoka, Daniel Ken/0000-0002-9791-927X; Montanari, Carlos A/0000-0002-4963-0316; Kita, Kiyoshi/0000-0002-0426-4308; Balogun, Emmanuel/0000-0002-2092-0045; Sekijima, Masakazu/0000-0002-3806-9535; Oluwadare, Emmanuel/0000-0002-7528-1877	Japanese Society for the Promotion of Science (JSPS) KAKENHI Grant [25870222, 24240044]; Creative Scientific Research Grant [18GS0314]; JSPS [18073004, 26253025, 26870119]; Japanese Ministry of Education, Science, Culture, Sports and Technology (MEXT); Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry; JST/JICA, SATREPS (Science and Technology Research Partnership for Sustainable Development) [10000284]; Astellas Pharma Inc. [YZ1005]	Japanese Society for the Promotion of Science (JSPS) KAKENHI Grant; Creative Scientific Research Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Ministry of Education, Science, Culture, Sports and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry; JST/JICA, SATREPS (Science and Technology Research Partnership for Sustainable Development); Astellas Pharma Inc.(Astellas Pharmaceuticals)	This research was partially supported by Japanese Society for the Promotion of Science (JSPS) KAKENHI Grant Numbers 25870222 and 24240044 (to M.S.). This work was supported in part by Creative Scientific Research Grant 18GS0314 (to K.K.), Grant-in-aid for Scientific Research 18073004 and 26253025 (to K.K.) and 26870119 (to D.K.I.) from the JSPS, and Targeted Proteins Research Program (to K.K. and S.H.) from the Japanese Ministry of Education, Science, Culture, Sports and Technology (MEXT). The authors also acknowledge the support from Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry (to K.K. and S.H.) and JST/JICA, SATREPS (Science and Technology Research Partnership for Sustainable Development) (10000284) to K.K. Astellas Pharma Inc. provided support in the form of salaries for authors YH, KO and MO (YZ1005).	Annoura T, 2005, J MOL EVOL, V60, P113, DOI 10.1007/s00239-004-0078-8; Bjornberg O, 2001, ARCH BIOCHEM BIOPHYS, V391, P286, DOI 10.1006/abbi.2001.2409; Buckner Frederick S, 2010, Curr Opin Infect Dis, V23, P609, DOI 10.1097/QCO.0b013e3283402956; Chagas C, 1909, MEM I OSWALDO CRUZ, V1, P159, DOI DOI 10.1590/S0074-02761909000200008; Copeland RA, 2000, J BIOL CHEM, V275, P33373, DOI 10.1074/jbc.M004451200; Coteron JM, 2011, J MED CHEM, V54, P5540, DOI 10.1021/jm200592f; David AC, 2010, AMBER 11; Davies M, 2009, J MED CHEM, V52, P2683, DOI 10.1021/jm800963t; Davis JP, 1996, BIOCHEMISTRY-US, V35, P1270, DOI 10.1021/bi952168g; Diao YY, 2012, J MED CHEM, V55, P8341, DOI 10.1021/jm300630p; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fedorov DG, 2007, J COMPUT CHEM, V28, P222, DOI 10.1002/jcc.20496; Fujimura K, 2010, CHEMMEDCHEM, V5, P1254, DOI 10.1002/cmdc.201000174; Hugo VDB, 1978, NATURE, V273, P626; Ichihara O, 2011, MOL INFORM, V30, P298, DOI 10.1002/minf.201000174; Inaoka DK, 2008, BIOCHEMISTRY-US, V47, P10881, DOI 10.1021/bi800413r; Jensen KF, 1998, PATHS PYRIMIDINES, V6, P20; Kirchhoff LV, 1996, GASTROENTEROL CLIN N, V25, P517, DOI 10.1016/S0889-8553(05)70261-2; Kitaura K, 1999, CHEM PHYS LETT, V312, P319, DOI 10.1016/S0009-2614(99)00937-9; Linares GEG, 2006, CURR MED CHEM, V13, P335, DOI 10.2174/092986706775476043; Lingling J, 2015, J PHYS CHEM B, V119, P1083, DOI [10.1021/jp506555w.Epub.2014.10.10, DOI 10.1021/JP506555W.EPUB.2014.10.10]; Liu SP, 2000, STRUCT FOLD DES, V8, P25, DOI 10.1016/S0969-2126(00)00077-0; Lockman JW, 2005, CURR MED CHEM, V12, P945, DOI 10.2174/0929867053507289; Marcet PL, 2006, PARASITOLOGY, V132, P57, DOI 10.1017/S0031182005008772; Marwaha A, 2012, J MED CHEM, V55, P7425, DOI 10.1021/jm300351w; Maya JD, 2007, COMP BIOCHEM PHYS A, V146, P601, DOI 10.1016/j.cbpa.2006.03.004; Mazanetz MP, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-2; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ohno K, 2011, CURR MED CHEM, V18, P220, DOI 10.2174/092986711794088335; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ozawa T, 2011, J COMPUT CHEM, V32, P2774, DOI 10.1002/jcc.21857; Ozawa T, 2008, BIOORGAN MED CHEM, V16, P10311, DOI 10.1016/j.bmc.2008.10.041; Phillips Margaret A., 2010, Infectious Disorders - Drug Targets, V10, P226; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Roellig DM, 2008, EMERG INFECT DIS, V14, P1123, DOI 10.3201/eid1407.080175; ROSSI MA, 1995, CARDIOLOGY, V86, P1, DOI 10.1159/000176822; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003; Tomonaga O, 2008, BIOORGANIC AND MEDIC, V16, P10311, DOI [10.1016/j.bmc.2008.10.041, DOI 10.1016/J.BMC.2008.10.041]; Tomonaga O, 2011, BIOORGANIC AND MEDIC, V19, P5231, DOI [10.1016/j.bmc.2011.07.004, DOI 10.1016/J.BMC.2011.07.004]; Tomonaga O, 2008, JOURNAL OF COMPUTATI, V29, P2656, DOI [10.1002/jcc.20998, DOI 10.1002/JCC.20998]; Watanabe C, 2013, J MOL GRAPH MODEL, V41, P31, DOI 10.1016/j.jmgm.2013.01.006; Wermuth G, 1998, PURE APPL CHEM, V70, P1129, DOI 10.1351/pac199870051129	43	27	28	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0125829	10.1371/journal.pone.0125829	http://dx.doi.org/10.1371/journal.pone.0125829			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961853	Green Published, gold, Green Submitted			2022-12-26	WOS:000354542500048
J	Brandt, J; Doig, G; Tsafnat, N				Brandt, Joshua; Doig, Graham; Tsafnat, Naomi			Computational Aerodynamic Analysis of a Micro-CT Based Bio-Realistic Fruit Fly Wing	PLOS ONE			English	Article							INSECT FLIGHT; HOVERING FLIGHT; FLAPPING FLIGHT; AIR VEHICLES; DROSOPHILA; DEFORMATION; CORRUGATION; PERFORMANCE; SPHERE; FORCES	The aerodynamic features of a bio-realistic 3D fruit fly wing in steady state ?(snapshot) flight conditions were analyzed numerically. The wing geometry was created from high resolution micro-computed tomography (micro-CT) of the fruit fly Drosophila virilis. Computational fluid dynamics (CFD) analyses of the wing were conducted at ultra-low Reynolds numbers ranging from 71 to 200, and at angles of attack ranging from -10 degrees to +30 degrees. It was found that in the 3D bio-realistc model, the corrugations of the wing created localized circulation regions in the flow field, most notably at higher angles of attack near the wing tip. Analyses of a simplified flat wing geometry showed higher lift to drag performance values for any given angle of attack at these Reynolds numbers, though very similar performance is noted at -10 degrees. Results have indicated that the simplified flat wing can successfully be used to approximate high-level properties such as aerodynamic coefficients and overall performance trends as well as large flow-field structures. However, local pressure peaks and near-wing flow features induced by the corrugations are unable to be replicated by the simple wing. We therefore recommend that accurate 3D bio-realistic geometries be used when modelling insect wings where such information is useful.	[Brandt, Joshua; Doig, Graham; Tsafnat, Naomi] UNSW Australia, Sch Mech & Mfg Engn, Sydney, NSW, Australia; [Doig, Graham] Calif Polytech State Univ San Luis Obispo, Dept Aerosp Engn, San Luis Obispo, CA 93407 USA	University of New South Wales Sydney; California State University System; California Polytechnic State University San Luis Obispo	Brandt, J (corresponding author), UNSW Australia, Sch Mech & Mfg Engn, Sydney, NSW, Australia.	joshua.brandt@unsw.edu.au			School of Mechanical and Manufacturing Engineering, University of New South Wales	School of Mechanical and Manufacturing Engineering, University of New South Wales	Micro-CT scanning was funded by an internal grant from the School of Mechanical and Manufacturing Engineering, University of New South Wales, 2012.	Ananda S, 2006, J ELECTRON MICROSC, V55, P151, DOI [10.1093/jmicro/dfl015, 10.1093/jmicro/df1015]; Ansari SA, 2006, PROG AEROSP SCI, V42, P129, DOI 10.1016/j.paerosci.2006.07.001; Ansari SA, 2009, EXP FLUIDS, V46, P777, DOI 10.1007/s00348-009-0661-2; Aono H, 2008, J EXP BIOL, V211, P239, DOI 10.1242/jeb.008649; Birch JM, 2003, J EXP BIOL, V206, P2257, DOI 10.1242/jeb.00381; Bomphrey RJ, 2012, EVOL BIOL, V39, P1, DOI 10.1007/s11692-011-9134-7; Card G, 2008, J EXP BIOL, V211, P341, DOI 10.1242/jeb.012682; Combes S. A., 2010, ENCY AEROSPACE ENG; DAVID CT, 1978, PHYSIOL ENTOMOL, V3, P191, DOI 10.1111/j.1365-3032.1978.tb00148.x; Dickinson MH, 1999, SCIENCE, V284, P1954, DOI 10.1126/science.284.5422.1954; Du G, 2012, J THEOR BIOL, V300, P19, DOI 10.1016/j.jtbi.2012.01.010; ELLINGTON CP, 1984, PHILOS T ROY SOC B, V305, P79, DOI 10.1098/rstb.1984.0052; Faraj KA, 2009, TISSUE ENG PART C-ME, V15, P493, DOI 10.1089/ten.tec.2008.0436; Fry SN, 2005, J EXP BIOL, V208, P2303, DOI 10.1242/jeb.01612; Hord K, 2012, J AIRCRAFT, V49, P749, DOI 10.2514/1.C031135; Houle D, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-25; Jongerius SR, 2010, EXP MECH, V50, P1323, DOI 10.1007/s11340-010-9411-x; Kesel AB, 2000, J EXP BIOL, V203, P3125; Koehler C, 2012, J EXP BIOL, V215, P3018, DOI 10.1242/jeb.069005; LECLAIR BP, 1970, J ATMOS SCI, V27, P308, DOI 10.1175/1520-0469(1970)027<0308:ANSOTD>2.0.CO;2; Lentink D, 2009, J EXP BIOL, V212, P2705, DOI 10.1242/jeb.022269; Marxen M, 2004, MED PHYS, V31, P305, DOI 10.1118/1.1637971; Meng XG, 2013, PHYS FLUIDS, V25, DOI 10.1063/1.4813804; Meng XG, 2011, J EXP BIOL, V214, P432, DOI 10.1242/jeb.046375; Mizutani R, 2012, MICRON, V43, P104, DOI 10.1016/j.micron.2011.10.002; Mizutani R, 2008, TISSUE ENG PART C-ME, V14, P359, DOI 10.1089/ten.tec.2008.0274; Sane SP, 2003, J EXP BIOL, V206, P4191, DOI 10.1242/jeb.00663; Schambach SJ, 2010, METHODS, V50, P2, DOI 10.1016/j.ymeth.2009.08.007; Sun M, 2002, J EXP BIOL, V205, P55; Sunada S, 2002, J AIRCRAFT, V39, P331, DOI 10.2514/2.2931; Tanaka H., 2011, INTEGR COMP BIOL; Tsafnat N, 2011, J ANAT, V218, P40, DOI 10.1111/j.1469-7580.2010.01289.x; Vargas A, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/2/026004; VOGEL S, 1967, J EXP BIOL, V46, P383; VOGEL S, 1967, J EXP BIOL, V46, P431; Wang ZJ, 2005, ANNU REV FLUID MECH, V37, P183, DOI 10.1146/annurev.fluid.36.050802.121940; Williams JC, 2002, AIAA J, V40, P576, DOI 10.2514/2.1685; Wu JH, 2004, J EXP BIOL, V207, P1137, DOI 10.1242/jeb.00868	38	9	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0124824	10.1371/journal.pone.0124824	http://dx.doi.org/10.1371/journal.pone.0124824			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25954946	Green Published, Green Submitted, gold			2022-12-26	WOS:000356768100036
J	Iwamoto, H; Matsuhisa, K; Saito, A; Kanemoto, S; Asada, R; Hino, K; Takai, T; Cui, M; Cui, X; Kaneko, M; Arihiro, K; Sugiyama, K; Kurisu, K; Matsubara, A; Imaizumi, K				Iwamoto, Hideo; Matsuhisa, Koji; Saito, Atsushi; Kanemoto, Soshi; Asada, Rie; Hino, Kenta; Takai, Tomoko; Cui, Min; Cui, Xiang; Kaneko, Masayuki; Arihiro, Koji; Sugiyama, Kazuhiko; Kurisu, Kaoru; Matsubara, Akio; Imaizumi, Kazunori			Promotion of Cancer Cell Proliferation by Cleaved and Secreted Luminal Domains of ER Stress Transducer BBF2H7	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; BZIP TRANSCRIPTION FACTOR; ENDOPLASMIC-RETICULUM; GENE-EXPRESSION; HEDGEHOG PATHWAY; TRANSLATION; ACTIVATION; MECHANISMS; BINDING; OASIS	BBF2H7 is an endoplasmic reticulum (ER)-resident transmembrane basic leucine zipper (bZIP) transcription factor that is cleaved at the transmembrane domain by regulated intra-membrane proteolysis in response to ER stress. The cleaved cytoplasmic N-terminus containing transcription activation and bZIP domains translocates into the nucleus to promote the expression of target genes. In chondrocytes, the cleaved luminal C-terminus is extra-cellularly secreted and facilitates proliferation of neighboring cells through activation of Hedgehog signaling. In the present study, we found that Bbf2h7 expression levels significantly increased by 1.070-2.567-fold in several tumor types including glioblastoma compared with those in respective normal tissues, using the ONCOMINE Cancer Profiling Database. In some Hedgehog ligand-dependent cancer cell lines including glioblastoma U251MG cells, the BBF2H7 C-terminus was secreted from cells into the culture media and promoted cancer cell proliferation through activation of Hedgehog signaling. Knockdown of Bbf2h7 expression suppressed the proliferation of U251MG cells by downregulating Hedgehog signaling. The impaired cell proliferation and Hedgehog signaling were recovered by addition of BBF2H7 C-terminus to the culture medium of Bbf2h7-knockdown U251MG cells. These data suggest that the secreted luminal BBF2H7 C-terminus is involved in Hedgehog ligand-dependent cancer cell proliferation through activation of Hedgehog signaling. Thus, the BBF2H7 C-terminus may be a novel target for the development of anticancer drugs.	[Iwamoto, Hideo; Matsuhisa, Koji; Saito, Atsushi; Kanemoto, Soshi; Asada, Rie; Hino, Kenta; Takai, Tomoko; Cui, Min; Cui, Xiang; Kaneko, Masayuki; Imaizumi, Kazunori] Hiroshima Univ, Dept Biochem, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan; [Arihiro, Koji] Hiroshima Univ Hosp, Dept Anat Pathol, Hiroshima, Japan; [Sugiyama, Kazuhiko] Hiroshima Univ Hosp, Canc Treatment Ctr, Dept Clin Oncol, Hiroshima, Japan; [Sugiyama, Kazuhiko] Hiroshima Univ Hosp, Canc Treatment Ctr, Neurooncol Program, Hiroshima, Japan; [Kurisu, Kaoru] Hiroshima Univ, Dept Neurosurg, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan; [Matsubara, Akio] Hiroshima Univ, Dept Urol, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan	Hiroshima University; Hiroshima University; Hiroshima University; Hiroshima University; Hiroshima University; Hiroshima University	Imaizumi, K (corresponding author), Hiroshima Univ, Dept Biochem, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan.	imaizumi@hiroshima-u.ac.jp	Kaneko, Masayuki/F-9302-2011	Kaneko, Masayuki/0000-0002-0477-0171; Kitamura, Rie/0000-0001-8347-6909; Matsuhisa, Koji/0000-0003-0707-9025	Takeda Science Foundation; YASUDA Medical Foundation; Nakajima Foundation; Tokyo Biochemical Research Foundation; Kobayashi International Scholarship Foundation; NAGASE Science Technology Foundation; Mitsubishi Foundation; SEI Group CSR Foundation; Japan Society for the Promotion of Science KAKENHI [25/677, 25251014, 25650069, 25861324, 24300135, 26460099]	Takeda Science Foundation(Takeda Science Foundation (TSF)); YASUDA Medical Foundation; Nakajima Foundation; Tokyo Biochemical Research Foundation; Kobayashi International Scholarship Foundation; NAGASE Science Technology Foundation; Mitsubishi Foundation; SEI Group CSR Foundation; Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from Takeda Science Foundation, The YASUDA Medical Foundation, The Nakajima Foundation, The Tokyo Biochemical Research Foundation, Kobayashi International Scholarship Foundation, NAGASE Science Technology Foundation, The Mitsubishi Foundation, SEI Group CSR Foundation and The Japan Society for the Promotion of Science KAKENHI(25/677, 25251014, 25650069, 25861324, 24300135, 26460099). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaba ARI, 1998, DEVELOPMENT, V125, P2203; Biewenga P, 2008, GYNECOL ONCOL, V108, P520, DOI 10.1016/j.ygyno.2007.11.024; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; DenBoer LM, 2005, BIOCHEM BIOPH RES CO, V331, P113, DOI 10.1016/j.bbrc.2005.03.141; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hetz C, 2013, NAT REV DRUG DISCOV, V12, P703, DOI 10.1038/nrd3976; Hino K, 2014, J BIOL CHEM, V289, P13810, DOI 10.1074/jbc.M113.543322; Imaizumi K, 1997, J BIOL CHEM, V272, P18842, DOI 10.1074/jbc.272.30.18842; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Izzi L, 2011, DEV CELL, V20, P788, DOI 10.1016/j.devcel.2011.04.017; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Katoh Y, 2009, CURR MOL MED, V9, P873, DOI 10.2174/156652409789105570; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kondo S, 2005, NAT CELL BIOL, V7, P186, DOI 10.1038/ncb1213; Kondo S, 2007, MOL CELL BIOL, V27, P1716, DOI 10.1128/MCB.01552-06; Kubota K, 2006, J NEUROCHEM, V97, P1259, DOI 10.1111/j.1471-4159.2006.03782.x; Kurashina K, 2008, CANCER SCI, V99, P1835, DOI 10.1111/j.1349-7006.2008.00881.x; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Moller E, 2011, CLIN CANCER RES, V17, P2646, DOI 10.1158/1078-0432.CCR-11-0145; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Pritchett J, 2011, TRENDS MOL MED, V17, P166, DOI 10.1016/j.molmed.2010.12.001; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Saito A, 2014, MOL CELL, V53, P127, DOI 10.1016/j.molcel.2013.11.008; Saito A, 2009, NAT CELL BIOL, V11, P1197, DOI 10.1038/ncb1962; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Sinha S, 2006, NAT CHEM BIOL, V2, P29, DOI 10.1038/nchembio753; Stirling J, 2006, MOL BIOL CELL, V17, P413, DOI 10.1091/mbc.E05-06-0500; Storlazzi CT, 2003, HUM MOL GENET, V12, P2349, DOI 10.1093/hmg/ddg237; Swartling FJ, 2009, ONCOGENE, V28, P3121, DOI 10.1038/onc.2009.168; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	41	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0125982	10.1371/journal.pone.0125982	http://dx.doi.org/10.1371/journal.pone.0125982			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955804	Green Published, Green Submitted, gold			2022-12-26	WOS:000356768100088
J	Lu, D; Liu, S; Shang, SZ; Wu, FF; Wen, X; Li, ZY; Li, Y; Hu, XX; Zhao, YF; Li, QY; Li, N				Lu, Dan; Liu, Shen; Shang, Shengzhe; Wu, Fangfang; Wen, Xiao; Li, Zhiyuan; Li, Yan; Hu, Xiaoxiang; Zhao, Yaofeng; Li, Qiuyan; Li, Ning			Production of Transgenic-Cloned Pigs Expressing Large Quantities of Recombinant Human Lysozyme in Milk	PLOS ONE			English	Article							ANTIMICROBIAL PROPERTIES; MAMMARY-GLAND; LACTOFERRIN; GOATS; ABSORPTION; PROTEIN; GENE; MICE; CONSUMPTION; BACTERIA	Human lysozyme is a natural non-specific immune factor in human milk that plays an important role in the defense of breastfed infants against pathogen infection. Although lysozyme is abundant in human milk, there is only trace quantities in pig milk. Here, we successfully generated transgenic cloned pigs with the expression vector pBAC-hLF-hLZ-Neo and their first generation hybrids (F1). The highest concentration of recombinant human lysozyme (rhLZ) with in vitro bioactivity was 2759.6 +/- 265.0 mg/L in the milk of F0 sows. Compared with wild-type milk, rhLZ milk inhibited growth of Escherichia coli K88 during the exponential growth phase. Moreover, rhLZ in milk from transgenic sows was directly absorbed by the intestine of piglets with no observable anaphylactic reaction. Our strategy may provide a powerful tool for large-scale production of this important human protein in pigs to improve resistance to pathogen infection.	[Lu, Dan; Liu, Shen; Shang, Shengzhe; Hu, Xiaoxiang; Zhao, Yaofeng; Li, Qiuyan; Li, Ning] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Wu, Fangfang] Yunnan Agr Univ, Coll Anim Sci & Technol, Kunming, Peoples R China; [Wen, Xiao; Li, Zhiyuan; Li, Yan] Beijing Genfucare Biotechnol Co, Beijing, Peoples R China	China Agricultural University; Yunnan Agricultural University	Li, QY (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	liqiuyan-yuan@163.com; ninglcau@cau.edu.cn	li, zhiyuan/HGD-9581-2022		National Transgenic Breeding Program of China [2013ZX08006001, 2014ZX08006006]; '948' project [2012G(1)]; Beijing Genfucare Biotechnology Company	National Transgenic Breeding Program of China; '948' project(Ministry of Agriculture & Rural Affairs); Beijing Genfucare Biotechnology Company	This work was supported by National Transgenic Breeding Program of China (No. 2013ZX08006001; No. 2014ZX08006006) and '948' project (No.2012G(1)). Beijing Genfucare Biotechnology Company provided support in the form of salaries for authors XW, ZL, and WL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bi MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042335; CAPPUCCINO JG, 1962, CANCER RES, V22, P850; CHANDAN RC, 1968, J DAIRY SCI, V51, P606, DOI 10.3168/jds.S0022-0302(68)87036-5; Cooper CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058409; Cooper CA, 2011, TRANSGENIC RES, V20, P1235, DOI 10.1007/s11248-011-9489-7; Ding JY, 2004, J AGR FOOD CHEM, V52, P3372, DOI 10.1021/jf049915d; ELLISON RT, 1991, J CLIN INVEST, V88, P1080, DOI 10.1172/JCI115407; Fujiwara Y, 1999, MOL REPROD DEV, V52, P414, DOI 10.1002/(SICI)1098-2795(199904)52:4&lt;414::AID-MRD10&gt;3.0.CO;2-S; Hashida S, 2002, CLIN EXP PHARMACOL P, V29, P79, DOI 10.1046/j.1440-1681.2002.03605.x; HENNART PF, 1991, AM J CLIN NUTR, V53, P32, DOI 10.1093/ajcn/53.1.32; HIRAI Y, 1990, J NUTR SCI VITAMINOL, V36, P531, DOI 10.3177/jnsv.36.531; Humphrey BD, 2002, J NUTR, V132, P1214, DOI 10.1093/jn/132.6.1214; Ibrahim HR, 2001, FEBS LETT, V506, P27, DOI 10.1016/S0014-5793(01)02872-1; Ibrahim HR, 2001, J BIOL CHEM, V276, P43767, DOI 10.1074/jbc.M106317200; LEMARBRE P, 1981, BLOOD, V58, P994, DOI 10.1182/blood.V58.5.994.994; LEVAY PF, 1995, HAEMATOLOGICA, V80, P252; Li QY, 2009, PROG NAT SCI-MATER, V19, P699, DOI 10.1016/j.pnsc.2008.04.021; Li XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040666; Liu S, 2012, TRANSGENIC RES, V21, P407, DOI 10.1007/s11248-011-9536-4; Liu X, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3368; Liu ZL, 2004, ANIM BIOTECHNOL, V15, P21, DOI 10.1081/ABIO-120029810; Lu D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089130; Maga EA, 1998, J FOOD PROTECT, V61, P52, DOI 10.4315/0362-028X-61.1.52; Maga EA, 2006, J DAIRY SCI, V89, P518, DOI 10.3168/jds.S0022-0302(06)72114-2; Maga EA, 2006, FOODBORNE PATHOG DIS, V3, P384, DOI 10.1089/fpd.2006.3.384; Maga EA, 2006, TRANSGENIC RES, V15, P515, DOI 10.1007/s11248-006-0014-3; Maga EA, 2012, APPL ENVIRON MICROB, V78, P6153, DOI 10.1128/AEM.00956-12; Masschalck B, 2003, CRIT REV MICROBIOL, V29, P191, DOI 10.1080/713610448; May KD, 2012, J ANIM SCI, V90, P1118, DOI 10.2527/jas.2011-4297; Montagne P, 2001, ADV EXP MED BIOL, V501, P241; Nash JA, 2006, J IMMUNOL, V177, P519, DOI 10.4049/jimmunol.177.1.519; Nishikawa M, 2002, AM J PHYSIOL-GASTR L, V282, pG711, DOI 10.1152/ajpgi.00358.2001; Oliver WT, 2013, J ANIM SCI; Rival-Gervier S, 2002, MOL REPROD DEV, V63, P161, DOI 10.1002/mrd.90007; SAVA G, 1989, ANTICANCER RES, V9, P583; SHUGAR D, 1952, BIOCHIM BIOPHYS ACTA, V8, P302, DOI 10.1016/0006-3002(52)90045-0; Takano M, 2004, EUR J PHARMACOL, V502, P149, DOI 10.1016/j.ejphar.2004.08.041; Tong J, 2011, TRANSGENIC RES, V20, P417, DOI 10.1007/s11248-010-9409-2; Wei HX, 2008, PROG NAT SCI-MATER, V18, P1583, DOI 10.1016/j.pnsc.2008.05.018; Wu XJ, 2014, BIOTECHNOL LETT, V36, P1197, DOI 10.1007/s10529-014-1476-7; Yang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017593; Yang PH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003453; Yokooji T, 2013, BIOCHEM BIOPH RES CO, V438, P61, DOI 10.1016/j.bbrc.2013.07.024; Zhang YH, 2006, SCI CHINA SER C, V49, P164, DOI 10.1007/s11427-006-0164-9	44	15	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0123551	10.1371/journal.pone.0123551	http://dx.doi.org/10.1371/journal.pone.0123551			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955256	Green Published, Green Submitted, gold			2022-12-26	WOS:000356768100017
J	Zhang, KF; Randelovic, A; Aguiar, LM; Page, D; McCarthy, DT; Deletic, A				Zhang, Kefeng; Randelovic, Anja; Aguiar, Larissa M.; Page, Declan; McCarthy, David T.; Deletic, Ana			Methodologies for Pre-Validation of Biofilters and Wetlands for Stormwater Treatment	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; TIDAL ANACOSTIA RIVER; RUNOFF WATER; POLYCHLORINATED-BIPHENYLS; REMOVAL PERFORMANCE; PRIORITY POLLUTANTS; ORGANIC-CHEMICALS; ESCHERICHIA-COLI; SEDIMENT REMOVAL; ROOF RUNOFF	Background Water Sensitive Urban Design (WSUD) systems are frequently used as part of a stormwater harvesting treatment trains (e.g. biofilters (bio-retentions and rain-gardens) and wetlands). However, validation frameworks for such systems do not exist, limiting their adoption for end-uses such as drinking water. The first stage in the validation framework is pre-validation, which prepares information for further validation monitoring. Objectives A pre-validation roadmap, consisting of five steps, is suggested in this paper. Detailed methods for investigating target micropollutants in stormwater, and determining challenge conditions for biofilters and wetlands, are provided. Methods A literature review was undertaken to identify and quantify micropollutants in stormwater. MUSIC V5.1 was utilized to simulate the behaviour of the systems based on 30-year rainfall data in three distinct climate zones; outputs were evaluated to identify the threshold of operational variables, including length of dry periods (LDPs) and volume of water treated per event. Results The paper highlights that a number of micropollutants were found in stormwater at levels above various worldwide drinking water guidelines (eight pesticides, benzene, benzo(a) pyrene, pentachlorophenol, di-(2-ethylhexyl)-phthalate and a total of polychlorinated biphenyls). The 95th percentile LDPs was exponentially related to system design area while the 5th percentile length of dry periods remained within short durations (i.e. 2-8 hours). 95th percentile volume of water treated per event was exponentially related to system design area as a percentage of an impervious catchment area. Conclusions The out-comings of this study show that pre-validation could be completed through a roadmap consisting of a series of steps; this will help in the validation of stormwater treatment systems.	[Zhang, Kefeng; Aguiar, Larissa M.; McCarthy, David T.; Deletic, Ana] Monash Univ, Dept Civil Engn, Monash Water Liveabil, Melbourne, Vic 3004, Australia; [Zhang, Kefeng; Aguiar, Larissa M.; McCarthy, David T.; Deletic, Ana] CRC Water Sensit Cities, Melbourne, Vic, Australia; [Randelovic, Anja] Univ Belgrade, Fac Civil Engn, Belgrade, Serbia; [Page, Declan] CSIRO, Waite Labs, Land & Water Res Flagship, Adelaide, SA, Australia; [McCarthy, David T.] Monash Univ, Dept Civil Engn, Environm & Publ Hlth Microbiol Lab, Melbourne, Vic 3004, Australia	Monash University; University of Belgrade; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Monash University	Zhang, KF (corresponding author), Monash Univ, Dept Civil Engn, Monash Water Liveabil, Melbourne, Vic 3004, Australia.	kefeng.zhang@monash.edu	Deletic, Ana/CAG-2385-2022; Page, Declan/AAH-5087-2020; Zhang, Kefeng/M-1594-2019; Page, Declan W/F-2566-2011	Deletic, Ana/0000-0002-3535-7451; Zhang, Kefeng/0000-0003-0956-2977; Page, Declan W/0000-0002-4902-3911; McCarthy, David/0000-0001-8845-6501; Randelovic, Anja/0000-0002-0804-8928	Cooperative Research Centre for Water Sensitive Cities [E04105]; Chinese Scholarship Council [2011609012]	Cooperative Research Centre for Water Sensitive Cities(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Chinese Scholarship Council(China Scholarship Council)	This research was funded by The Cooperative Research Centre for Water Sensitive Cities (E04105)(http://watersensitivecities.org.au/). Zhang is also supported by Chinese Scholarship Council (No. 2011609012)(http://www.csc.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abira MA, 2005, WATER SCI TECHNOL, V51, P173, DOI 10.2166/wst.2005.0312; Allison R, 2005, WSUD ENGINEERING PRO; Alvord HH, 1996, ECOL MODEL, V90, P97, DOI 10.1016/0304-3800(95)00150-6; [Anonymous], GUIDELINES FOR DRINK; ANZECEPH&ARMCANZ, 2000, AUSTRALIAN AND NEW Z; Becouze C, 2009, SYSTEM, V2, P3, DOI [10.1101/pdb.prot5156, DOI 10.1101/PDB.PROT5156]; Birch H, 2011, WATER SCI TECHNOL, V64, P485, DOI 10.2166/wst.2011.687; Bjorklund K, 2009, SCI TOTAL ENVIRON, V407, P4665, DOI 10.1016/j.scitotenv.2009.04.040; Blecken GT, 2010, J HYDROL, V394, P507, DOI 10.1016/j.jhydrol.2010.10.010; Borden RC, 2002, ENVIRON POLLUT, V118, P141, DOI 10.1016/S0269-7491(01)00204-4; Bressy A, 2012, WATER RES, V46, P6799, DOI 10.1016/j.watres.2011.12.017; Bressy A, 2011, WATER SCI TECHNOL, V63, P671, DOI 10.2166/wst.2011.121; Bucheli TD, 1998, ENVIRON SCI TECHNOL, V32, P3457, DOI 10.1021/es980317n; Chandrasena GI, 2012, WATER SCI TECHNOL, V66, P1132, DOI 10.2166/wst.2012.283; Clara M, 2010, CHEMOSPHERE, V78, P1078, DOI 10.1016/j.chemosphere.2009.12.052; COLE RH, 1984, J WATER POLLUT CON F, V56, P898; Cottin N, 2008, CHEMOSPHERE, V73, P711, DOI 10.1016/j.chemosphere.2008.06.060; Davis AP, 2009, J ENVIRON ENG, V135, P109, DOI 10.1061/(ASCE)0733-9372(2009)135:3(109); Delzer GC, 1996, OCCURRENCE OF THE GA; DHV, 2013, GUIDELINES FOR VALID; Diblasi CJ, 2009, ENVIRON SCI TECHNOL, V43, P494, DOI 10.1021/es802090g; Dickenson ERV, 2009, ENVIRON SCI TECHNOL, V43, P6242, DOI 10.1021/es803696y; Domagalski J, 1996, WATER RESOUR BULL, V32, P953; Drapper D, 2000, J ENVIRON ENG-ASCE, V126, P313, DOI 10.1061/(ASCE)0733-9372(2000)126:4(313); Drewes JE, 2008, INDICATOR AND SURROG; Dugan GL, 1983, WATER QUALITY OF AIR; Duncan H.P., 1999, DATABASE URBAN STORM; ENRC, 2009, INQUIRY INTO MELBOUR; EU, 1998, EUS DRINK WAT STAND; eWater, 2012, MODEL FOR URBAN STOR; Facility for Advancing Water Biofiltration (FAWB), 2009, ADOPTION GUIDELINES; Fries E, 2004, ATMOS ENVIRON, V38, P2013, DOI 10.1016/j.atmosenv.2004.01.013; Gerrity D, 2012, WATER RES, V46, P6257, DOI 10.1016/j.watres.2012.08.037; Gobel P, 2007, J CONTAM HYDROL, V91, P26, DOI 10.1016/j.jconhyd.2006.08.008; Grynkiewicz M, 2002, POL J ENVIRON STUD, V11, P85; Hamdan SM, 2009, WATER SCI TECHNOL, V60, P1327, DOI 10.2166/wst.2009.396; Hatt BE, 2006, J ENVIRON MANAGE, V79, P102, DOI 10.1016/j.jenvman.2005.06.003; Hatt BE, 2008, ENVIRON SCI TECHNOL, V42, P2535, DOI 10.1021/es071264p; HEC, 2007, UNTREATED HIGHWAY RU; Hinch J., 2009, STORMWATER REUSE INF; Huang XJ, 2004, ENVIRON SCI TECHNOL, V38, P3263, DOI 10.1021/es034847h; Hudak PF, 2006, URBAN WATER J, V3, P43, DOI 10.1080/15730620600578678; Hwang HM, 2006, ENVIRON POLLUT, V140, P416, DOI 10.1016/j.envpol.2005.08.003; Hwang HM, 2008, J ENVIRON SCI HEAL A, V43, P567, DOI 10.1080/10934520801893527; Imfeld G, 2009, CHEMOSPHERE, V74, P349, DOI 10.1016/j.chemosphere.2008.09.062; James RR, 2010, B ENVIRON CONTAM TOX, V85, P32, DOI 10.1007/s00128-010-0016-y; Kao CM, 2002, WATER SCI TECHNOL, V46, P199, DOI 10.2166/wst.2002.0680; Kim LH, 2005, SCI TOTAL ENVIRON, V348, P1, DOI 10.1016/j.scitotenv.2004.12.063; Kumata H, 2000, POLYCYCL AROMAT COMP, V20, P39, DOI 10.1080/10406630008034774; Lamprea K, 2008, 11TH INTERNATIONAL C; Lamprea K, 2011, ENVIRON TECHNOL, V32, P1141, DOI 10.1080/09593330.2010.528045; Larsen L, 2001, CHEMOSPHERE, V44, P231, DOI 10.1016/S0045-6535(00)00174-0; Li Y, 2007, J HYDROL, V338, P285, DOI 10.1016/j.jhydrol.2007.03.001; Li YL, 2012, ECOL ENG, V49, P137, DOI 10.1016/j.ecoleng.2012.08.007; Lopes TJ, 2000, J ENVIRON ENG, V126, P1137, DOI 10.1061/(ASCE)0733-9372(2000)126:12(1137); Lopes TJ, 1998, REV SEMIVOLATILE VOL; Mackay D., 2006, HANDBOOK OF PHYSICAL; Mahler BJ, 2005, ENVIRON SCI TECHNOL, V39, P5560, DOI 10.1021/es0501565; MAKEPEACE DK, 1995, CRIT REV ENV SCI TEC, V25, P93, DOI 10.1080/10643389509388476; Menzie CA, 2002, ESTUARIES, V25, P165, DOI 10.1007/BF02691305; NHMRC-NRMMC, 2011, AUSTRALIAN DRINKING; Norton DE., 1990, CHEMICAL CONTAMINANT; NRMMC-EPHC-NHMRC, 2009, AUSTRALIAN GUIDELINE; NRMMC-EPHC-NHMRC, 2006, NATIONAL GUIDELINES, DOI [10.2166/wst.2010.380, DOI 10.2166/WST.2010.380]; NRMMC-EPHC-NHMRC, 2009, NAT GUID WAT REC MAN; Page D, 2010, WATER SCI TECHNOL, V62, P2009, DOI 10.2166/wst.2010.539; Park D, 2012, WATER RES, V46, P6881, DOI 10.1016/j.watres.2012.04.023; Pavelic P, 2006, ENVIRON SCI TECHNOL, V40, P501, DOI 10.1021/es050768p; Payne EGI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090890; Philp M, 2008, REVIEW OF STORMWATER; Polkowska Z, 2009, URBAN WATER J, V6, P441, DOI 10.1080/15730620902972405; Polkowska Z, 2001, POL J ENVIRON STUD, V10, P351; Popov VH, 2006, AGR ECOSYST ENVIRON, V114, P351, DOI 10.1016/j.agee.2005.11.010; Revitt D.M., 2002, URBAN WATER, V4, P13; Rossi L, 2004, SCI TOTAL ENVIRON, V322, P179, DOI 10.1016/S0048-9697(03)00361-9; Rossman L. A., 2010, STORM WATER MANAGEME; Rule KL, 2006, CHEMOSPHERE, V63, P581, DOI 10.1016/j.chemosphere.2005.08.016; SCV, 2006, URBAN STORMWATER BES; Soller J, 2005, J ENVIRON MANAGE, V76, P309, DOI 10.1016/j.jenvman.2004.12.007; Steffen J, 2013, J AM WATER RESOUR AS, V49, P810, DOI 10.1111/jawr.12038; Stein ED, 2006, ENVIRON TOXICOL CHEM, V25, P373, DOI 10.1897/05-285R.1; Svensson T, 2007, BIOGEOCHEMISTRY, V82, P139, DOI 10.1007/s10533-006-9059-x; Torres C., 2010, CHARACTERIZATION AND; Tsui MTK, 2008, CHEMOSPHERE, V71, P439, DOI 10.1016/j.chemosphere.2007.10.059; USEPA, 2009, NATIONAL PRIMARY DRI; USEPA, 2005, MEMBRANE FILTRATION; Watts AW, 2010, ENVIRON SCI TECHNOL, V44, P8849, DOI 10.1021/es102059r; Wert EC, 2009, ENVIRON SCI TECHNOL, V43, P4858, DOI 10.1021/es803524a; Weston DP, 2009, ENVIRON POLLUT, V157, P287, DOI 10.1016/j.envpol.2008.06.037; Woltemade CJ, 2008, J AM WATER RESOUR AS, V44, P222, DOI 10.1111/j.1752-1688.2007.00149.x; Zgheib S, 2011, WATER SCI TECHNOL, V64, P1450, DOI 10.2166/wst.2011.770; Zgheib S, 2012, WATER RES, V46, P6683, DOI 10.1016/j.watres.2011.12.012; Zgheib S, 2011, WATER RES, V45, P913, DOI 10.1016/j.watres.2010.09.032; Zhang KF, 2014, ECOL ENG, V67, P1, DOI 10.1016/j.ecoleng.2014.03.004; Zhang SH, 2014, WATER RESOUR MANAG, V28, P149, DOI 10.1007/s11269-013-0477-y; Zhao WY, 2004, WETLANDS, V24, P202, DOI 10.1672/0277-5212(2004)024[0202:RODPBA]2.0.CO;2	96	15	15	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0125979	10.1371/journal.pone.0125979	http://dx.doi.org/10.1371/journal.pone.0125979			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955688	Green Published, gold, Green Submitted			2022-12-26	WOS:000356768100087
J	Friedmann-Morvinski, D; Bhargava, V; Gupta, S; Verma, IM; Subramaniam, S				Friedmann-Morvinski, D.; Bhargava, V.; Gupta, S.; Verma, I. M.; Subramaniam, S.			Identification of therapeutic targets for glioblastoma by network analysis	ONCOGENE			English	Article							PLURIPOTENT STEM-CELLS; GENE-EXPRESSION; TUMOR-GROWTH; OSTEOPONTIN; CANCER; MICE; DEDIFFERENTIATION; PROGNOSIS; SURVIVAL; TISSUE	Glioblastoma can originate from terminally differentiated astrocytes and neurons, which can dedifferentiate to a stem cell-like state upon transformation. In this study, we confirmed that transformed dedifferentiated astrocytes and neurons acquired a stem/progenitor cell state, although they still retained gene expression memory from their parental cell. Transcriptional network analysis on these cells identified upregulated genes in three main pathways: Wnt signaling, cell cycle and focal adhesion with the gene Spp1, also known as osteopontin (OPN) serving as a key common node connecting these three pathways. Inhibition of OPN blocked the formation of neurospheres, affected the proliferative capacity of transformed neurons and reduced the expression levels of neural stem cell markers. Specific inhibition of OPN in both murine and human glioma tumors prolonged mice survival. We conclude that OPN is an important player in dedifferentiation of cells during tumor formation, hence its inhibition can be a therapeutic target for glioblastoma.	[Friedmann-Morvinski, D.; Verma, I. M.] Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Friedmann-Morvinski, D.] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem & Mol Biol, IL-69978 Tel Aviv, Israel; [Bhargava, V.; Subramaniam, S.] Univ Calif San Diego, Bioinformat & Syst Biol Grad Program, San Diego, CA 92103 USA; [Gupta, S.; Subramaniam, S.] Univ Calif San Diego, Dept Bioengn, San Diego, CA 92103 USA; [Subramaniam, S.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Subramaniam, S.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	Salk Institute; Tel Aviv University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Verma, IM (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.; Subramaniam, S (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.; Subramaniam, S (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, Dept Bioengn, La Jolla, CA 92093 USA.	verma@salk.edu; shankar@ucsd.edu			NIH [HL053670]; Cancer Center Core Grant [P30 CA014195-38]; H.N. and Frances C. Berger Foundation; Leona M. and Harry B. Helmsley Charitable Trust grant [2012-PG-MED002]; National Institutes of Health (NIH) National Heart, Lung and Blood Institute [HL087375, HL106579, HL108735]; National Science Foundation (NSF) [DBI-0835541, STC-0939370]; California Institute for Regenerative Medicine (CIRM) Graduate Fellowship [T1-00003, TG2-01154]; NATIONAL CANCER INSTITUTE [P30CA023100, P30CA014195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108735, R33HL087375, R01HL106579, R01HL053670] Funding Source: NIH RePORTER; Direct For Biological Sciences [0835541] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Core Grant; H.N. and Frances C. Berger Foundation; Leona M. and Harry B. Helmsley Charitable Trust grant; National Institutes of Health (NIH) National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Science Foundation (NSF)(National Science Foundation (NSF)); California Institute for Regenerative Medicine (CIRM) Graduate Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank Gabriela Estepa for her technical help and Ruben Alvarez Rodriguez for designing the inducible miRNA lentivector. IMV is an American Cancer Society Professor of Molecular Biology, and holds the Irwin and Joan Jacobs Chair in Exemplary Life Science. This work was supported in part by grants from the NIH (HL053670) (to IM Verma and D Friedmann-Morvinski), Cancer Center Core Grant (P30 CA014195-38), the H.N. and Frances C. Berger Foundation, and the Leona M. and Harry B. Helmsley Charitable Trust grant #2012-PG-MED002 (to IM Verma). S Subramaniam is supported by National Institutes of Health (NIH) National Heart, Lung and Blood Institute Grant HL087375, HL106579, HL108735, the National Science Foundation (NSF) grants DBI-0835541 and STC-0939370. V Bhargava was the recipient of a California Institute for Regenerative Medicine (CIRM) Graduate Fellowship (T1-00003 and TG2-01154, Interdisciplinary Stem Cell Training Program at UCSD). Accession Code. Gene Expression Omnibus: GSE64411 (sequencing read data).	Atai NA, 2011, IMMUNOLOGY, V132, P39, DOI 10.1111/j.1365-2567.2010.03335.x; Bache M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-132; Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bhargava V, 2014, SCI REP-UK, V4, DOI 10.1038/srep03678; Bhargava V, 2013, SCI REP-UK, V3, DOI 10.1038/srep01740; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chaffer CL, 2013, CELL, V154, P61, DOI 10.1016/j.cell.2013.06.005; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Friedmann-Morvinski D, 2014, EMBO REP, V15, P244, DOI 10.1002/embr.201338254; Friedmann-Morvinski D, 2012, SCIENCE, V338, P1080, DOI 10.1126/science.1226929; Ghosh Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008975; Holland JD, 2013, CURR OPIN CELL BIOL, V25, P254, DOI 10.1016/j.ceb.2013.01.004; Ikawa M, 2003, MOL THER, V8, P666, DOI 10.1016/S1525-0016(03)00240-5; Ischenko I, 2013, P NATL ACAD SCI USA, V110, P3937, DOI 10.1073/pnas.1219592110; Jain N, 2003, BIOINFORMATICS, V19, P1945, DOI 10.1093/bioinformatics/btg264; Jan HJ, 2010, NEURO-ONCOLOGY, V12, P58, DOI 10.1093/neuonc/nop013; Katagiri YU, 1999, CANCER RES, V59, P219; Lamour V, 2010, INT J CANCER, V126, P1797, DOI 10.1002/ijc.24751; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Marchetto MCN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007076; Mason CK, 2008, MOL CANCER THER, V7, P548, DOI 10.1158/1535-7163.MCT-07-2251; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pietras A, 2014, CELL STEM CELL, V14, P357, DOI 10.1016/j.stem.2014.01.005; Polakis P, 2000, GENE DEV, V14, P1837; Polakis P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008052; Rangaswami H, 2006, TRENDS CELL BIOL, V16, P79, DOI 10.1016/j.tcb.2005.12.005; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sreekanthreddy P, 2010, CANCER EPIDEM BIOMAR, V19, P1409, DOI 10.1158/1055-9965.EPI-09-1077; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wai PY, 2004, J SURG RES, V121, P228, DOI 10.1016/j.jss.2004.03.028; Wang DD, 2008, PROG NEUROBIOL, V86, P342, DOI 10.1016/j.pneurobio.2008.09.015; Weber GF, 2001, BBA-REV CANCER, V1552, P61, DOI 10.1016/S0304-419X(01)00037-3; Weber GF, 1996, SCIENCE, V271, P509, DOI 10.1126/science.271.5248.509; Yamaguchi Y, 2013, J BIOL CHEM, V288, P3097, DOI 10.1074/jbc.M112.362954; Zhao WX, 2012, MOLECULES, V17, P6196, DOI 10.3390/molecules17066196; Zuber J, 2011, NAT BIOTECHNOL, V29, P79, DOI 10.1038/nbt.1720	48	16	16	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 4	2016	35	5					608	620		10.1038/onc.2015.119	http://dx.doi.org/10.1038/onc.2015.119			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DC9NR	25961929	Green Accepted			2022-12-26	WOS:000369548800008
J	Benros, ME; Sorensen, HJ; Nielsen, PR; Nordentoft, M; Mortensen, PB; Petersen, L				Benros, Michael Eriksen; Sorensen, Holger Jelling; Nielsen, Philip Rising; Nordentoft, Merete; Mortensen, Preben Bo; Petersen, Liselotte			The Association between Infections and General Cognitive Ability in Young Men - A Nationwide Study	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; EARLY-LIFE INFECTION; AUTOIMMUNE-DISEASES; RISK-FACTORS; IMMUNE-SYSTEM; DANISH; SCHIZOPHRENIA; IMPAIRMENT; INTELLIGENCE; INFLAMMATION	Background Infections and activated immune responses can affect the brain through several pathways that might also affect cognition. However, no large-scale study has previously investigated the effect of infections on the general cognitive ability in the general population. Methods Danish nationwide registers were linked to establish a cohort of all 161,696 male conscripts during the years 2006-2012 who were tested for cognitive ability, which was based on logical, verbal, numerical and spatial reasoning at a mean age of 19.4 years. Test scores were converted to a mean of 100.00 and with a standard deviation (SD) of 15. Data were analyzed as a cohort study with severe infections requiring hospitalization as exposure using linear regression. Results Adjusted effect sizes were calculated with non-exposure to severe infections as reference, ranging from 0.12 SD to 0.63 SD on general cognitive ability. A prior infection was associated with significantly lower cognitive ability by a mean of 1.76 (95% CI: -1.92 to -1.61; corresponding to 0.12 SD). The cognitive ability was affected the most by the temporal proximity of the last infection (P<0.001) and by the severity of infection measured by days of admission (P<0.001). The number of infections were associated with decreased cognitive ability in a dose-response relationship, and highest mean differences were found for >= 10 hospital contacts for infections (Mean: -5.54; 95% CI: -7.20 to -3.89; corresponding to 0.37 SD), and for >= 5 different types of infections (Mean: -9.44; 95% CI: -13.2 to -5.69; corresponding to 0.63 SD). Hospital contacts with infections had occurred in 35% of the individuals prior to conscription. Conclusions Independent of a wide range of possible confounders, significant associations between infections and cognitive ability were observed. Infections or related immune responses might directly affect the cognitive ability; however, associated heritable and environmental factors might also account for the lowered cognitive ability.	[Benros, Michael Eriksen; Sorensen, Holger Jelling; Nordentoft, Merete] Univ Copenhagen, Fac Hlth Sci, Mental Hlth Ctr Copenhagen, DK-2400 Copenhagen NV, Denmark; [Benros, Michael Eriksen; Nielsen, Philip Rising; Mortensen, Preben Bo; Petersen, Liselotte] Aarhus Univ, Natl Ctr Register Based Res, DK-8210 Aarhus V, Denmark; [Sorensen, Holger Jelling; Nordentoft, Merete; Mortensen, Preben Bo] Lundbeck Fdn Initiat Integrat Psychiat Res, iPSYCH, Aarhus, Denmark	University of Copenhagen; Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH)	Benros, ME (corresponding author), Univ Copenhagen, Fac Hlth Sci, Mental Hlth Ctr Copenhagen, Bispebjerg Bakke 23, DK-2400 Copenhagen NV, Denmark.	Benros@dadlnet.dk	Mortensen, Preben B/D-2358-2015; Sorensen, Holger Jelling/D-7644-2011; Nordentoft, Merete/AAH-3253-2019; Benros, Michael Eriksen/N-5868-2016	Mortensen, Preben B/0000-0002-5230-9865; Sorensen, Holger Jelling/0000-0003-2268-1735; Benros, Michael Eriksen/0000-0003-4939-9465; Petersen, Liselotte Vogdrup/0000-0002-0479-5379	Stanley Medical Research Institute; ERC [294838]; Lundbeck Foundation; Lundbeck Foundation [R155-2014-1724] Funding Source: researchfish	Stanley Medical Research Institute; ERC(European Research Council (ERC)European Commission); Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden)	The study was supported financially by grants from the Stanley Medical Research Institute, ERC Advanced Grant Project no. 294838 and an unrestricted grant from The Lundbeck Foundation. All researchers had full independence from the funders and declare no conflict of interest.	Adams-Chapman I, 2006, CURR OPIN INFECT DIS, V19, P290, DOI 10.1097/01.qco.0000224825.57976.87; Andersen TF, 1999, DAN MED BULL, V46, P263; Benros ME, 2013, JAMA PSYCHIAT, V70, P812, DOI 10.1001/jamapsychiatry.2013.1111; Benros ME, 2012, ANN NY ACAD SCI, V1262, P56, DOI 10.1111/j.1749-6632.2012.06638.x; Benros ME, 2011, AM J PSYCHIAT, V168, P1303, DOI 10.1176/appi.ajp.2011.11030516; Bilbo SD, 2010, NEUROBIOL LEARN MEM, V94, P57, DOI 10.1016/j.nlm.2010.04.001; Bland ST, 2010, BRAIN BEHAV IMMUN, V24, P329, DOI 10.1016/j.bbi.2009.09.012; Chang L, 2007, NEW ENGL J MED, V356, P1226, DOI 10.1056/NEJMoa065954; Chen J, 2008, BRAIN BEHAV IMMUN, V22, P301, DOI 10.1016/j.bbi.2007.08.014; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Dickerson F, 2012, SCHIZOPHR RES, V134, P83, DOI 10.1016/j.schres.2011.10.003; Ellman LM, 2009, BIOL PSYCHIAT, V65, P1040, DOI 10.1016/j.biopsych.2008.12.015; Gimeno D, 2008, PSYCHONEUROENDOCRINO, V33, P1322, DOI 10.1016/j.psyneuen.2008.07.006; Green A, 1996, DAN MED BULL, V43, P464; Holtze M, 2008, J NEUROSCI RES, V86, P3674, DOI 10.1002/jnr.21799; Khandaker GM, 2011, JAMA-J AM MED ASSOC, V305, P673, DOI 10.1001/jama.2011.142; Knudsen LB, 1998, DAN MED BULL, V45, P320; McGrath JJ, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.60; McGrath J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077444; Meyer U, 2014, BIOL PSYCHIAT, V75, P307, DOI 10.1016/j.biopsych.2013.07.011; Meyer U, 2013, PROG NEURO-PSYCHOPH, V42, P20, DOI 10.1016/j.pnpbp.2011.11.003; Meyer U, 2009, SCHIZOPHRENIA BULL, V35, P959, DOI 10.1093/schbul/sbn022; Mors O, 2011, SCAND J PUBLIC HEALT, V39, P54, DOI 10.1177/1403494810395825; Mortensen EL, 2002, JAMA-J AM MED ASSOC, V287, P2365, DOI 10.1001/jama.287.18.2365; Mortensen EL, 1989, SCAND J PSYCHOL, V30, P3115; Nie K, 2013, NEUROSCI LETT, V541, P111, DOI 10.1016/j.neulet.2013.02.024; O'Shea TM, 2013, BRAIN BEHAV IMMUN, V29, P104, DOI 10.1016/j.bbi.2012.12.012; Osler M, 2007, SCHIZOPHR RES, V92, P132, DOI 10.1016/j.schres.2007.01.009; Pandharipande PP, 2014, NEW ENGL J MED, V370, P185, DOI 10.1056/NEJMc1313886; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Perry VH, 2007, NAT REV IMMUNOL, V7, P161, DOI 10.1038/nri2015; Pop VJ, 1999, CLIN ENDOCRINOL, V50, P149, DOI 10.1046/j.1365-2265.1999.00639.x; Reichenberg A, 2001, ARCH GEN PSYCHIAT, V58, P445, DOI 10.1001/archpsyc.58.5.445; Rodgers JL, 2000, AM PSYCHOL, V55, P599, DOI 10.1037//0003-066X.55.6.599; Rose G., 2008, ROSES STRATEGY PREVE; Sorensen HT, 1997, BRIT MED J, V315, P401, DOI 10.1136/bmj.315.7105.401; Statistik Danmark (Statistics Denmark), 1991, INT DAT LONG LAB MAR; Talge NM, 2007, J CHILD PSYCHOL PSYC, V48, P245, DOI 10.1111/j.1469-7610.2006.01714.x; Teasdale TW, 2011, SCAND J PSYCHOL, V52, P126, DOI 10.1111/j.1467-9450.2010.00862.x; Teasdale TW, 2009, SCAND J PSYCHOL, V50, P633, DOI 10.1111/j.1467-9450.2009.00789.x; Teasdale TW, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002321; Thomas P, 2013, J PSYCHIATR RES, V47, P1680, DOI 10.1016/j.jpsychires.2013.07.010; van der Ree M, 2011, EARLY HUM DEV, V87, P821, DOI 10.1016/j.earlhumdev.2011.06.008; Vuillermot S, 2012, J NEUROSCI, V32, P436, DOI 10.1523/JNEUROSCI.4831-11.2012; Whitehouse AJO, 2012, PEDIATRICS, V129, P485, DOI 10.1542/peds.2011-2644; Williamson LL, 2011, J NEUROSCI, V31, P15511, DOI 10.1523/JNEUROSCI.3688-11.2011	46	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0124005	10.1371/journal.pone.0124005	http://dx.doi.org/10.1371/journal.pone.0124005			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI1ZP	25970427	Green Published, Green Submitted, gold			2022-12-26	WOS:000354544200022
J	Colman, RE; Schupp, JM; Hicks, ND; Smith, DE; Buchhagen, JL; Valafar, F; Crudu, V; Romancenco, E; Noroc, E; Jackson, L; Catanzaro, DG; Rodwell, TC; Catanzaro, A; Keim, P; Engelthaler, DM				Colman, Rebecca E.; Schupp, James M.; Hicks, Nathan D.; Smith, David E.; Buchhagen, Jordan L.; Valafar, Faramarz; Crudu, Valeriu; Romancenco, Elena; Noroc, Ecaterina; Jackson, Lynn; Catanzaro, Donald G.; Rodwell, Timothy C.; Catanzaro, Antonino; Keim, Paul; Engelthaler, David M.			Detection of Low-Level Mixed-Population Drug Resistance in Mycobacterium tuberculosis Using High Fidelity Amplicon Sequencing	PLOS ONE			English	Article							HETERORESISTANCE; RIFAMPIN; FLUOROQUINOLONE; MUTATIONS	Undetected and untreated, low-levels of drug resistant (DR) subpopulations in clinical Mycobacterium tuberculosis (Mtb) infections may lead to development of DR-tuberculosis, potentially resulting in treatment failure. Current phenotypic DR susceptibility testing has a theoretical potential for 1% sensitivity, is not quantitative, and requires several weeks to complete. The use of "single molecule-overlapping reads" (SMOR) analysis with next generation DNA sequencing for determination of ultra-rare target alleles in complex mixtures provides increased sensitivity over standard DNA sequencing. Ligation free amplicon sequencing with SMOR analysis enables the detection of resistant allele subpopulations at >= 0.1% of the total Mtb population in near real-time analysis. We describe the method using standardized mixtures of DNA from resistant and susceptible Mtb isolates and the assay's performance for detecting ultra-rare DR subpopulations in DNA extracted directly from clinical sputum samples. SMOR analysis enables rapid near real-time detection and tracking of previously undetectable DR sub-populations in clinical samples allowing for the evaluation of the clinical relevance of low-level DR subpopulations. This will provide insights into interventions aimed at suppressing minor DR subpopulations before they become clinically significant.	[Colman, Rebecca E.; Schupp, James M.; Hicks, Nathan D.; Smith, David E.; Buchhagen, Jordan L.; Keim, Paul; Engelthaler, David M.] Translat Genom Res Inst, Flagstaff, AZ 85004 USA; [Valafar, Faramarz] San Diego State Univ, San Diego, CA 92182 USA; [Crudu, Valeriu; Noroc, Ecaterina] Phthisiopneumol Inst PPI, Kishinev, Moldova; [Romancenco, Elena; Jackson, Lynn; Rodwell, Timothy C.; Catanzaro, Antonino] Univ Calif San Diego, San Diego, CA 92103 USA; [Catanzaro, Donald G.] Univ Arkansas, Coll Educ & Hlth Profess, Fayetteville, AR 72701 USA; [Keim, Paul] No Arizona Univ, Ctr Microbial Genet & Genom, Flagstaff, AZ 86011 USA	Translational Genomics Research Institute; California State University System; San Diego State University; University of California System; University of California San Diego; University of Arkansas System; University of Arkansas Fayetteville; Northern Arizona University	Engelthaler, DM (corresponding author), Translat Genom Res Inst, Flagstaff, AZ 85004 USA.	dengelthaler@tgen.org	Catanzaro, Donald/AAA-4932-2019; Colman, Rebecca/AAI-2112-2019	Catanzaro, Donald/0000-0003-1760-0574; Colman, Rebecca/0000-0002-6854-2100; Romancenco, Elena/0000-0001-6078-3383; Valafar, Faramarz/0000-0002-3648-9384	Global Consortium for Drug-resistant TB Diagnostics ([GCDD]) - National Institutes of Health [U01-AI082229, R01AI105185]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI105185, U01AI082229, P30AI036214, R01AI111435] Funding Source: NIH RePORTER	Global Consortium for Drug-resistant TB Diagnostics ([GCDD]) - National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Specimens, data and funding for this project were provided by the Global Consortium for Drug-resistant TB Diagnostics ([GCDD] website: http://gcdd.ucsd.edu) funded by the National Institutes of Health: #U01-AI082229 (PI: Antonino Catanzaro) and #R01AI105185 (PI: Faramarz Valafar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajbani K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049433; Bashford-Rogers RJM, 2014, BMC IMMUNOL, V15, DOI 10.1186/s12865-014-0029-0; Blakemore R, 2010, J CLIN MICROBIOL, V48, P2495, DOI 10.1128/JCM.00128-10; Campbell PJ, 2011, ANTIMICROB AGENTS CH, V55, P2032, DOI 10.1128/AAC.01550-10; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Chakravorty S, 2011, J CLIN MICROBIOL, V49, P932, DOI 10.1128/JCM.02271-10; Chen-Harris H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-96; Duwe S, 2008, J VIROL METHODS, V153, P134, DOI 10.1016/j.jviromet.2008.07.017; Eldholm V, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0490-3; Folkvardsen DB, 2013, J CLIN MICROBIOL, V51, P4220, DOI 10.1128/JCM.01602-13; Garfein RS, INT J TUBERCUL UNPUB; Georghiou SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033275; Hedskog C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011345; Hillery N, CONT CLIN TRIA UNPUB; Hofmann-Thiel S, 2009, EUR RESPIR J, V33, P368, DOI 10.1183/09031936.00089808; Homs M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112306; Johnson R, 2008, J INFECT DEV COUNTR, V2, P40; Kim BJ, 2001, J CLIN MICROBIOL, V39, P2610, DOI 10.1128/JCM.39.7.2610-2617.2001; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Koser CU, 2013, NEW ENGL J MED, V369, P290, DOI 10.1056/NEJMc1215305; Kozarewa I, 2011, METHODS MOL BIOL, V733, P279, DOI 10.1007/978-1-61779-089-8_20; Lin SYG, 2014, J CLIN MICROBIOL, V52, P475, DOI 10.1128/JCM.01821-13; Lin SYG, 2009, J CLIN MICROBIOL, V47, P3630, DOI 10.1128/JCM.00803-09; Liu CM, 2012, BMC MICROBIOL, V12, DOI [10.1186/1471-2180-12-56, 10.1186/1471-2180-12-255]; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Lou DI, 2013, P NATL ACAD SCI USA, V110, P19872, DOI 10.1073/pnas.1319590110; Macalalad AR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002417; Maruri F, 2012, J ANTIMICROB CHEMOTH, V67, P819, DOI 10.1093/jac/dkr566; McElroy K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-501; Menzel U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096727; Mild M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022741; Neonakis IK, 2008, J MICROBIOL METH, V75, P1, DOI 10.1016/j.mimet.2008.05.023; Pholwat S, 2015, MBIO, V6, DOI 10.1128/mBio.02273-14; Pholwat S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057238; Piatek AS, 2000, ANTIMICROB AGENTS CH, V44, P103, DOI 10.1128/AAC.44.1.103-110.2000; Rinder H, 2001, INT J TUBERC LUNG D, V5, P339; Rodrigues C, 2008, INT J TUBERC LUNG D, V12, P1449; Rodwell TC, 2014, J CLIN MICROBIOL, V52, P781, DOI 10.1128/JCM.02701-13; Sandgren A, 2009, PLOS MED, V6, P132, DOI 10.1371/journal.pmed.1000002; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; Telenti A, 1997, J CLIN MICROBIOL, V35, P719, DOI 10.1128/JCM.35.3.719-723.1997; Tolani MP, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-9; Watson SJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0205; (WHO) WHO, 2013, WHOHTMTB201311 WHO; World Health Organization, 2008, WHOHTMTB2008392; Wu NC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097505; Zagordi O, 2010, NUCLEIC ACIDS RES, V38, P7400, DOI 10.1093/nar/gkq655; Zhang XB, 2012, J CLIN MICROBIOL, V50, P1471, DOI 10.1128/JCM.05793-11; Zhou XF, 2014, MOL ECOL, V23, P1679, DOI 10.1111/mec.12680	49	56	60	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0126626	10.1371/journal.pone.0126626	http://dx.doi.org/10.1371/journal.pone.0126626			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970423	Green Published, gold, Green Submitted			2022-12-26	WOS:000354544200122
J	Lengagne, T; Gomez, D; Josserand, R; Voituron, Y				Lengagne, Thierry; Gomez, Doris; Josserand, Remy; Voituron, Yann			Long Recording Sequences: How to Track the Intra-Individual Variability of Acoustic Signals	PLOS ONE			English	Article							TREEFROGS HYLA-ARBOREA; FEMALE MATE CHOICE; MALE GREEN FROGS; AUSTRALIAN FROG; BODY-SIZE; INDIVIDUAL VARIATION; ADVERTISEMENT CALLS; RANA-CLAMITANS; MALE QUALITY; TREE FROG	Recently developed acoustic technologies - like automatic recording units - allow the recording of long sequences in natural environments. These devices are used for biodiversity survey but they could also help researchers to estimate global signal variability at various (individual, population, species) scales. While sexually-selected signals are expected to show a low intra-individual variability at relatively short time scale, this variability has never been estimated so far. Yet, measuring signal variability in controlled conditions should prove useful to understand sexual selection processes and should help design acoustic sampling schedules and to analyse long call recordings. We here use the overall call production of 36 male treefrogs (Hyla arborea) during one night to evaluate within-individual variability in call dominant frequency and to test the efficiency of different sampling methods at capturing such variability. Our results confirm that using low number of calls underestimates call dominant frequency variation of about 35% in the tree frog and suggest that the assessment of this variability is better by using 2 or 3 short and well-distributed records than by using samples made of consecutive calls. Hence, 3 well-distributed 2-minutes records (beginning, middle and end of the calling period) are sufficient to capture on average all the nightly variability, whereas a sample of 10 000 consecutive calls captures only 86% of it. From a biological point of view, the call dominant frequency variability observed in H. arborea (116Hz on average but up to 470 Hz of variability during the course of the night for one male) challenge about its reliability in mate quality assessment. Automatic acoustic recording units will provide long call sequences in the near future and it will be then possible to confirm such results on large samples recorded in more complex field conditions.	[Lengagne, Thierry; Josserand, Remy; Voituron, Yann] Univ Lyon 1, CNRS, ENTPE, Ecol Hydrosyst Nat & Anthropises UMR5023, F-69622 Villeurbanne, France; [Gomez, Doris] Natl Museum Nat Hist, UMR CNRS 7179, Brunoy, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Museum National d'Histoire Naturelle (MNHN)	Lengagne, T (corresponding author), Univ Lyon 1, CNRS, ENTPE, Ecol Hydrosyst Nat & Anthropises UMR5023, 6 Rue Raphael Dubois, F-69622 Villeurbanne, France.	thierry.lengagne@univ-lyon1.fr	Gomez, Doris/ABA-6361-2021	Gomez, Doris/0000-0002-9144-3426; Voituron, Yann/0000-0003-0572-7199				Anderson M, 1994, SEXUAL SELECTION; Bee MA, 2001, ANIM BEHAV, V62, P1129, DOI 10.1006/anbe.2001.1851; Bee MA, 2001, ETHOLOGY, V107, P65, DOI 10.1046/j.1439-0310.2001.00640.x; BEECHER MD, 1986, EXP BIOL, V45, P179; BEECHER MD, 1982, AM ZOOL, V22, P477; Bentsen CL, 2006, AM NAT, V167, pE102, DOI 10.1086/501376; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brepson L, 2013, BEHAV ECOL, V24, P488, DOI 10.1093/beheco/ars189; BRETAGNOLLE V, 1991, CAN J ZOOL, V69, P1669, DOI 10.1139/z91-231; Briggs VS, 2010, HERPETOLOGICA, V66, P241, DOI 10.1655/HERPETOLOGICA-D-09-00011.1; Castellano S, 1998, BIOL J LINN SOC, V63, P257, DOI 10.1006/bijl.1997.0189; Castellano S, 2002, ETHOLOGY, V108, P75, DOI 10.1046/j.1439-0310.2002.00761.x; Christie PJ, 2004, BEHAV ECOL SOCIOBIOL, V55, P341, DOI 10.1007/s00265-003-0711-3; DAVIES NB, 1978, NATURE, V274, P683, DOI 10.1038/274683a0; Farina A, 2011, ECOL INFORM, V6, P354, DOI 10.1016/j.ecoinf.2011.07.004; Feng AS, 2009, ETHOLOGY, V115, P1015, DOI 10.1111/j.1439-0310.2009.01692.x; Friedl TWP, 2002, BEHAVIOUR, V139, P113, DOI 10.1163/15685390252902319; Gasser H, 2009, ETHOLOGY, V115, P596, DOI 10.1111/j.1439-0310.2009.01639.x; GERHARDT HC, 1991, ANIM BEHAV, V42, P615, DOI 10.1016/S0003-3472(05)80245-3; GERHARDT HC, 1994, ANNU REV ECOL SYST, V25, P293, DOI 10.1146/annurev.es.25.110194.001453; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; Gomez D, 2011, BEHAV ECOL, V22, P889, DOI 10.1093/beheco/arr039; Gomez D, 2010, BEHAVIOUR, V147, P1753, DOI 10.1163/000579510X534227; Gomez D, 2009, P ROY SOC B-BIOL SCI, V276, P2351, DOI 10.1098/rspb.2009.0168; Hoskin CJ, 2009, J ZOOL, V278, P36, DOI 10.1111/j.1469-7998.2009.00550.x; Howard RD, 1998, ANIM BEHAV, V55, P1165, DOI 10.1006/anbe.1997.0683; Humfeld SC, 2008, ANIM BEHAV, V75, P205, DOI 10.1016/j.anbehav.2007.05.015; Lengagne T, 2002, P ROY SOC B-BIOL SCI, V269, P2121, DOI 10.1098/rspb.2002.2115; Lengagne T, 1999, P ROY SOC B-BIOL SCI, V266, P1623, DOI 10.1098/rspb.1999.0824; Marquez R, 1990, HERPETOLOGICA, V46, P172; MARTIN WF, 1971, J EXP ZOOL, V176, P273, DOI 10.1002/jez.1401760304; Murphy CG, 2002, BEHAV ECOL, V13, P472, DOI 10.1093/beheco/13.4.472; Owen PC, 2005, BEHAV ECOL SOCIOBIOL, V58, P446, DOI 10.1007/S00265-005-0961-3; Pieretti N, 2011, ECOL INDIC, V11, P868, DOI 10.1016/j.ecolind.2010.11.005; Pinheiro J, 2009, TRC NLME LINEAR NONL; PRESTWICH KN, 1989, J EXP BIOL, V144, P53; Richardson C, 2008, ANIM BEHAV, V76, P1487, DOI 10.1016/j.anbehav.2008.06.019; Richardson C, 2010, BEHAVIOUR, V147, P1737, DOI 10.1163/000579510X530221; Richardson C, 2010, P ROY SOC B-BIOL SCI, V277, P1247, DOI 10.1098/rspb.2009.1836; ROBERTSON JGM, 1986, ANIM BEHAV, V34, P763, DOI 10.1016/S0003-3472(86)80060-4; ROBERTSON JGM, 1990, ANIM BEHAV, V39, P639, DOI 10.1016/S0003-3472(05)80374-4; Rosso A, 2006, ETHOLOGY, V112, P599, DOI 10.1111/j.1439-0310.2005.01186.x; RYAN MJ, 1983, EVOLUTION, V37, P261, DOI 10.1111/j.1558-5646.1983.tb05536.x; RYAN MJ, 1985, AM NAT, V126, P87, DOI 10.1086/284398; Skowronski MD, 2006, J ACOUST SOC AM, V119, P1817, DOI 10.1121/1.2166948; Smith JM, 1995, J THEOR BIOL, V177, P305; Sueur J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004065; Tarano Z, 2001, COPEIA, P1064, DOI 10.1643/0045-8511(2001)001[1064:VIMACI]2.0.CO;2; Troianowski M, 2015, BEHAVIOUR IN PRESS, V152; Vannoni E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003113; WAGNER WE, 1989, BEHAV ECOL SOCIOBIOL, V25, P429, DOI 10.1007/BF00300189; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; Wollerman L, 1998, ANIM BEHAV, V55, P1619, DOI 10.1006/anbe.1997.0697; Wong BBM, 2004, AUSTRAL ECOL, V29, P209, DOI 10.1111/j.1442-9993.2004.01338.x	54	2	2	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0123828	10.1371/journal.pone.0123828	http://dx.doi.org/10.1371/journal.pone.0123828			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970183	Green Submitted, Green Published, gold			2022-12-26	WOS:000354544200019
J	Rimmer, J; Santos, C; Yli-Panula, E; Noronha, V; Viander, M				Rimmer, Janet; Santos, Conceicao; Yli-Panula, Eija; Noronha, Virginia; Viander, Markku			Clinical and Laboratory Studies of the Fate of Intranasal Allergen	PLOS ONE			English	Article							DUST MITE ALLERGEN; PROTEASE-ACTIVATED RECEPTOR-2; EPITHELIAL BARRIER FUNCTION; AIRWAY EPITHELIUM; DENDRITIC CELLS; NASAL-MUCOSA; BRONCHIAL EPITHELIUM; UP-REGULATION; RESPONSES; ASTHMA	Background The precise way in which allergen is handled by the nose is unknown. The objective of this study was to determine recovery of Der p 1 allergen following nasal administration and to determine whether Der p 1 can be detected in nasal biopsies after natural exposure and nasal challenge to allergen. Methods (1) 20 nonatopic non-rhinitics were challenged with Der p 1 and recovery was measured by ELISA in the nasal wash, nasal mucus and induced sputum up to 30 minutes. Particulate charcoal (<40 mu m) served as control. (2) In 8 subjects (5 atopics), 30 to 60 minutes after challenge histological localisation of Der p 1 in the nasal mucosal epithelium, subepithelial mucous glands and lamina propria was performed. Co-localisation of Der p 1 with macrophages and IgE-positive cells was undertaken. Results (1) Less than 25% of total allergen was retrievable after aqueous or particulate challenge, most from the nasal mucus during 1-5 min after the challenge. The median of carbon particles recovered was 9%. (2) Prechallenge Der p 1 staining was associated with the epithelium and subepithelial mucous glands. After challenge there was a trend for greater Der p 1 deposition in atopics, but both atopics and nonatopics showed increases in the number of Der p 1 stained cells and stained tissue compartments. In atopics, increased eosinophils, macrophages and IgE positive cells co-localized with Der p 1 staining. Conclusions Der p 1 allergen is detected in nasal tissue independent of atopic status after natural exposure. After challenge the nose effectively retains allergen, which remains mucosally associated; in atopics there is greater Der p 1 deposition and inflammatory response than in nonatopics. These results support the hypothesis that nasal mucus and tissue act as a reservoir for the inhaled Der p 1 allergen leading to a persistent allergic inflammatory response in susceptible individuals.	[Rimmer, Janet; Santos, Conceicao; Yli-Panula, Eija; Noronha, Virginia; Viander, Markku] Woolcock Inst Med Res, Allergen Grp, Sydney, NSW, Australia; [Rimmer, Janet; Santos, Conceicao; Yli-Panula, Eija; Noronha, Virginia; Viander, Markku] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Yli-Panula, Eija] Univ Turku, Dept Teacher Educ, Turku, Finland; [Viander, Markku] Univ Turku, Dept Med Microbiol & Immunol, Turku, Finland	University of Sydney; Woolcock Institute of Medical Research; University of Sydney; University of Turku; University of Turku	Rimmer, J (corresponding author), Woolcock Inst Med Res, Allergen Grp, Sydney, NSW, Australia.	jrimmer@optusnet.com.au		Yli-Panula, Eija/0000-0001-8774-6566	Garnett Passe; Asthma Foundation of NSW; Rodney Williams Memorial Foundation Scholarship grant	Garnett Passe; Asthma Foundation of NSW; Rodney Williams Memorial Foundation Scholarship grant	This work was supported by Garnett Passe, Asthma Foundation of NSW, and Rodney Williams Memorial Foundation Scholarship grant (to JR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ghouleh A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033929; ALLEN MH, 1991, AM J DERMATOPATH, V13, P221, DOI 10.1097/00000372-199106000-00002; ANDERSSON M, 1995, ACTA OTO-LARYNGOL, V115, P705, DOI 10.3109/00016489509139391; Asokananthan N, 2002, J IMMUNOL, V168, P3577, DOI 10.4049/jimmunol.168.7.3577; Bagnasco M, 1997, J ALLERGY CLIN IMMUN, V100, P122, DOI 10.1016/S0091-6749(97)70203-3; Blume C, 2009, J INVEST DERMATOL, V129, P1935, DOI 10.1038/jid.2008.459; Brown SJ, 2011, J ALLERGY CLIN IMMUN, V127, P661, DOI 10.1016/j.jaci.2011.01.031; BUCKLE FG, 1975, J ALLERGY CLIN IMMUN, V55, P213, DOI 10.1016/0091-6749(75)90139-6; Bufe A, 1998, AM J RESP CRIT CARE, V157, P1269, DOI 10.1164/ajrccm.157.4.9709040; CHUA KY, 1988, J EXP MED, V167, P175, DOI 10.1084/jem.167.1.175; Dinh QT, 2006, CLIN EXP ALLERGY, V36, P1039, DOI 10.1111/j.1365-2222.2006.02537.x; Efthimiadis A, 2002, EUR RESPIR J, V20, p19S, DOI 10.1183/09031936.02.00001902; Ekman AK, 2011, INT ARCH ALLERGY IMM, V155, P234, DOI 10.1159/000320480; Gangl K, 2009, ALLERGY, V64, P398, DOI 10.1111/j.1398-9995.2008.01861.x; Georas SN, 2014, J ALLERGY CLIN IMMUN, V134, P509, DOI 10.1016/j.jaci.2014.05.049; Godthelp T, 1996, CLIN EXP ALLERGY, V26, P677, DOI 10.1046/j.1365-2222.1996.1072451.x; Golebski K, 2013, ALLERGY, V68, P152, DOI 10.1111/all.12080; Greiff L, 2002, CLIN PHYSIOL FUNCT I, V22, P55, DOI 10.1046/j.1365-2281.2002.00401.x; Hammad H, 2008, NAT REV IMMUNOL, V8, P193, DOI 10.1038/nri2275; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; He R, 2010, ANN NY ACAD SCI, V1183, P13, DOI 10.1111/j.1749-6632.2009.05128.x; Heijink IH, 2010, AM J RESP CELL MOL, V42, P69, DOI 10.1165/rcmb.2008-0449OC; Hens G, 2007, J ALLERGY CLIN IMMUN, V120, P472, DOI 10.1016/j.jaci.2007.03.047; HERBERT CA, 1995, AM J RESP CELL MOL, V12, P369, DOI 10.1165/ajrcmb.12.4.7695916; Holgate ST, 1999, CLIN EXP ALLERGY, V29, P90, DOI 10.1046/j.1365-2222.1999.00016.x; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Jacquet A, 2011, CLIN EXP ALLERGY, V41, P305, DOI 10.1111/j.1365-2222.2010.03661.x; Jacquet A, 2013, ISRN ALLERGY, V2013, DOI [10.1155/2013/735031, DOI 10.1155/2013/735031]; Joenvaara S, 2009, J ALLERGY CLIN IMMUN, V124, P135, DOI 10.1016/j.jaci.2008.11.048; Kelly MM, 2002, EUR RESPIR J, V20, p24S, DOI 10.1183/09031936.02.00002402; Kirtsreesakul V, 2009, LARYNGOSCOPE, V119, P1458, DOI 10.1002/lary.20146; KleinJan A, 1997, J ALLERGY CLIN IMMUN, V99, P515, DOI 10.1016/S0091-6749(97)70079-4; Knight DA, 2003, RESPIROLOGY, V8, P432, DOI 10.1046/j.1440-1843.2003.00493.x; Knight DA, 2001, J ALLERGY CLIN IMMUN, V108, P797, DOI 10.1067/mai.2001.119025; Lambrecht BN, 2014, J ALLERGY CLIN IMMUN, V134, P499, DOI 10.1016/j.jaci.2014.06.036; Lee HM, 2007, ANN OTO RHINOL LARYN, V116, P554, DOI 10.1177/000348940711600712; LUCZYNSKA CM, 1989, J IMMUNOL METHODS, V118, P227, DOI 10.1016/0022-1759(89)90010-0; Mattila Pirkko, 2011, Clin Transl Allergy, V1, P5, DOI 10.1186/2045-7022-1-5; Mygind N, 1979, NASAL ALLERGY, P199; Mygind N, 1978, NASAL ALLERGY; Ordonez CL, 2001, AM J RESP CRIT CARE, V163, P517, DOI 10.1164/ajrccm.163.2.2004039; Osterlund C, 2011, INT ARCH ALLERGY IMM, V155, P111, DOI 10.1159/000318743; Passalacqua G, 2005, CLIN EXP ALLERGY, V35, P880, DOI 10.1111/j.1365-2222.2005.2226.x; PIN I, 1992, THORAX, V47, P25, DOI 10.1136/thx.47.1.25; Rondon C, 2012, J ALLERGY CLIN IMMUN, V129, P1460, DOI 10.1016/j.jaci.2012.02.032; Runswick S, 2007, RESPIROLOGY, V12, P834, DOI 10.1111/j.1440-1843.2007.01175.x; Ryu JH, 2013, J ALLERGY CLIN IMMUN, V131, P549, DOI 10.1016/j.jaci.2012.07.050; Saitoh T, 2009, RHINOLOGY, V47, P273, DOI [10.4193/Rhin.08.109, 10.4193/Rhin08.109]; SALVAGGIO JE, 1964, J ALLERGY, V35, P62, DOI 10.1016/0021-8707(64)90050-4; Santos eFonseca CMC, 2002, RESPIROLOGY SUPPL, V7, pA24; SCHNEEBERGER EE, 1992, AM J PHYSIOL, V262, pL647, DOI 10.1152/ajplung.1992.262.6.L647; Soyka MB, 2012, J ALLERGY CLIN IMMUN, V130, P1087, DOI 10.1016/j.jaci.2012.05.052; STEWART GA, 1992, IMMUNOLOGY, V75, P29; Thompson P. J., 2001, Clinical and Experimental Allergy Reviews, V1, P107, DOI 10.1046/j.1472-9725.2001.00018.x; TOVEY ER, 1981, NATURE, V289, P592, DOI 10.1038/289592a0; Turvey SE, 2010, J ALLERGY CLIN IMMUN, V125, pS24, DOI 10.1016/j.jaci.2009.07.016; Vermaelen KY, 2001, J EXP MED, V193, P51, DOI 10.1084/jem.193.1.51; Voynow JA, 2009, CHEST, V135, P505, DOI 10.1378/chest.08-0412; Vroling AB, 2008, ALLERGY, V63, P1110, DOI 10.1111/j.1398-9995.2008.01785.x; Vroling AB, 2008, AM J RESP CELL MOL, V38, P293, DOI 10.1165/rcmb.2007-0278OC; Wan H, 2000, EUR RESPIR J, V15, P1058, DOI 10.1034/j.1399-3003.2000.01514.x; Wan H, 1999, J CLIN INVEST, V104, P123, DOI 10.1172/JCI5844; Xepapadaki P, 2007, IMMUNOBIOLOGY, V212, P453, DOI 10.1016/j.imbio.2007.03.008; Xiao C, 2011, J ALLERGY CLIN IMMUN, V128, P549, DOI 10.1016/j.jaci.2011.05.038; Yli-Panula E, 2003, ALLERGY SUPPL, V58, P74	66	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0127477	10.1371/journal.pone.0127477	http://dx.doi.org/10.1371/journal.pone.0127477			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25969994	gold, Green Published, Green Submitted			2022-12-26	WOS:000354544200158
J	Schaming, TD				Schaming, Taza D.			Population-Wide Failure to Breed in the Clark's Nutcracker (Nucifraga columbiana)	PLOS ONE			English	Article							LIFE-HISTORY TACTICS; ANTARCTIC SEABIRD; BODY CONDITION; PINE; SELECTION; REPRODUCTION; PRODUCTIVITY; VARIABILITY; RESIDUALS; DISPERSAL	In highly variable environments, conditions can be so stressful in some years that entire populations forgo reproduction in favor of higher likelihood of surviving to breed in future years. In two out of five years, Clark's nutcrackers (Nucifraga Columbiana) in the Greater Yellowstone Ecosystem exhibited population-wide failure to breed. Clark's nutcrackers at the study site experienced substantial interannual differences in food availability and weather conditions, and the two nonbreeding years corresponded with low whitebark pine (Pinus albicaulis) cone crops the previous autumn (<= an average of 8 +/- 2 cones per tree versus >= an average of 20 +/- 2 cones per tree during breeding years) and high snowpack in early spring (>= 61.2 +/- 5.5 cm versus <= 51.9 +/- 4.4 cm during breeding years). The average adult body condition index during the breeding season was significantly lower in 2011 (-1.5 +/- 1.1), a nonbreeding year, as compared to 2012 (6.2 +/- 2.0), a breeding year. The environmental cues available to the birds prior to breeding, specifically availability of cached whitebark pine seeds, may have allowed them to predict that breeding conditions would be poor, leading to the decision to skip breeding. Alternatively, the Clark's nutcrackers may have had such low body energy stores that they chose not to or were unable to breed. Breeding plasticity would allow Clark's nutcrackers to exploit an unpredictable environment. However, if large-scale mortality of whitebark pines is leading to an increase in the number of nonbreeding years, there could be serious population-level and ecosystem-wide consequences.	Cornell Univ, Dept Nat Resources, Cornell Lab Ornithol, Ithaca, NY 14853 USA	Cornell University	Schaming, TD (corresponding author), Cornell Univ, Dept Nat Resources, Cornell Lab Ornithol, Fernow Hall, Ithaca, NY 14853 USA.	tds55@cornell.edu			Athena Fund of the Cornell Lab of Ornithology; Meg and Bert Raynes Wildlife Fund Research Grant; Cornell Lab of Ornithology; NASA [NNX10AU20A]; Cornell University; Andrew W. Mellon Student Research Grant; American Ornithologists' Union; Mazamas Graduate Student Research Grant; Conservation and Research Foundation; Western Bird Banding Association; Wyoming Wildlife - The Foundation; Wyoming Community Foundation [20120167]; American Philosophical Society Lewis and Clark Fund; Garden Club of America Frances M. Peacock Scholarship; Charles Redd Center for Western Studies; Wilson Ornithological Society; Explorers Club Exploration Fund; Fischer Equipment Grant; Havahart Equipment Grant	Athena Fund of the Cornell Lab of Ornithology; Meg and Bert Raynes Wildlife Fund Research Grant; Cornell Lab of Ornithology; NASA(National Aeronautics & Space Administration (NASA)); Cornell University; Andrew W. Mellon Student Research Grant; American Ornithologists' Union; Mazamas Graduate Student Research Grant; Conservation and Research Foundation; Western Bird Banding Association; Wyoming Wildlife - The Foundation; Wyoming Community Foundation; American Philosophical Society Lewis and Clark Fund; Garden Club of America Frances M. Peacock Scholarship; Charles Redd Center for Western Studies; Wilson Ornithological Society; Explorers Club Exploration Fund; Fischer Equipment Grant; Havahart Equipment Grant	This study was generously funded by the Athena Fund of the Cornell Lab of Ornithology (www.birds.cornell.edu), Meg and Bert Raynes Wildlife Fund Research Grant (www.rayneswildlifefund.org)*, Cornell Lab of Ornithology (www.birds.cornell.edu), NASA Harriett G. Jenkins Pre-doctoral Fellowship (#NNX10AU20A, www.nasa.gov), Cornell Lab of Ornithology Kramer Graduate Fellowship (www.birds.cornell.edu), Cornell Lab of Ornithology Halberstadt Graduate Fellowship (www.birds.cornell.edu), Cornell University Research Travel Grant (www.cornell.edu), Cornell University Sigma Xi Grants-in-Aid of Research (www.sigmaxi.org), Cornell Lab of Ornithology Samuel and Linda Kramer Award (www.cornell.edu), Andrew W. Mellon Student Research Grant (www.mellon.org), American Ornithologists' Union (www.aou.org), Mazamas Graduate Student Research Grant (www.mazamas.org), Conservation and Research Foundation Research Grant (http://conservationresearch.wordpress.com), Western Bird Banding Association Research Grant (www.westernbirdbanding.org), Wyoming Wildlife - The Foundation, Wyoming Community Foundation, Research Grant (# 20120167; www.wyomingwildlifefoundation.org)*, American Philosophical Society Lewis and Clark Fund (http://www.amphilsoc.org), The Garden Club of America Frances M. Peacock Scholarship (www.gcamerica.org), Charles Redd Center for Western Studies Summer Award for Upper Division and Graduate Students, (https://reddcenter.byu.edu), Wilson Ornithological Society Paul A. Stewart Research Award (www.wilsonsociety.org), Explorers Club Exploration Fund (www.explorers.org), Fischer Equipment Grant (www.fischersports.com), and Havahart Equipment Grant (www.havahart.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, with the exception of Cornell University and Cornell Lab of Ornithology students, professors, researchers and statisticians who provided feedback throughout the study design process, answered analyses questions and encouraged the decision to publish. TDS received all funding, with the exception of the two grants starred above (*). TDS wrote the two grants, and used the funding for her research only; however, per Cornell University policy, Janis Dickinson, TDS's advisor was the P.I.	Ainley D. G., 1990, SEABIRDS FARALLON IS; Anderson ED, 2012, WILDLIFE BIOL, V18, P153, DOI 10.2981/11-048; [Anonymous], 2011, FED REG, V76, P42631; BALDA RP, 1992, ANIM BEHAV, V44, P761, DOI 10.1016/S0003-3472(05)80302-1; Barringer LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037663; BENKMAN CW, 1990, AUK, V107, P376, DOI 10.2307/4087622; BOEKELHEIDE RJ, 1989, AUK, V106, P389; Bolger DT, 2005, OECOLOGIA, V142, P398, DOI 10.1007/s00442-004-1734-9; Campbell R.W., 1997, BIRDS BRIT COLUMBIA, V3; CHASTEL O, 1993, OECOLOGIA, V94, P278, DOI 10.1007/BF00341328; Christman BJ, 2002, AUK, V119, P1149, DOI 10.1642/0004-8038(2002)119[1149:EBYVIP]2.0.CO;2; COHEN D, 1967, J THEOR BIOL, V16, P1, DOI 10.1016/0022-5193(67)90050-1; Cubaynes S, 2011, BIOL LETTERS, V7, P303, DOI 10.1098/rsbl.2010.0778; Davis J., 1957, Condor, V59, P297, DOI 10.2307/1364965; Davis J., 1964, Wilson Bulletin, V76, P10; DIMMICK CR, 1993, THESIS NO ARIZONA U; DIXON JAMES B., 1934, CONDOR, V36, P229, DOI 10.2307/1363815; DUFFY DC, 1983, BIOL CONSERV, V26, P227, DOI 10.1016/0006-3207(83)90075-7; DWERNYCHUK LW, 1972, CAN J ZOOLOG, V50, P559, DOI 10.1139/z72-076; Ellison AM, 2005, FRONT ECOL ENVIRON, V3, P479, DOI 10.1890/1540-9295(2005)003[0479:LOFSCF]2.0.CO;2; Grant PR, 2000, ECOLOGY, V81, P2442, DOI 10.2307/177466; Greater Yellowstone Coordinating Committee Whitebark Pine Subcommi.ttee, 2011, WHIT PIN STRAT GREAT; Green AJ, 2001, ECOLOGY, V82, P1473, DOI 10.2307/2680003; Haroldson MA, 2013, WHITEBANK PINE CONE; HUTCHINS HE, 1982, OECOLOGIA, V55, P192, DOI 10.1007/BF00384487; Jenouvrier S, 2005, ECOLOGY, V86, P2889, DOI 10.1890/05-0514; Kellam JS, 2004, HORM BEHAV, V46, P703, DOI 10.1016/j.yhbeh.2004.06.014; Kendall K.C., WHITEBARK PINE COMMU, P221; KENNARD JH, 1975, BIRD BANDING, V46, P55, DOI 10.2307/4512096; Kubel JE, 2007, J FIELD ORNITHOL, V78, P195, DOI 10.1111/j.1557-9263.2006.00094.x; LIGON JD, 1978, ECOL MONOGR, V48, P111, DOI 10.2307/2937295; Lorenz T., 2009, FINAL REPORT CLARKS; Lorenz TJ, 2011, AUK, V128, P237, DOI 10.1525/auk.2011.10101; Lorenz TJ, 2009, CONDOR, V111, P326, DOI 10.1525/cond.2009.080070; Macfarlane WW, 2013, ECOL APPL, V23, P421, DOI 10.1890/11-1982.1; Macfarlane WW, 2010, USING LANDSCAPE ASSE; MEWALDT L. RICHARD, 1956, CONDOR, V58, P3, DOI 10.2307/1365043; Mewaldt LR, 1952, CONDOR, V54, P2307; Mitton JB, 2012, AM NAT, V179, pE163, DOI 10.1086/665007; Nevoux M, 2010, ECOLOGY, V91, P2416, DOI 10.1890/09-0143.1; Pereyra ME, 2011, AUK, V128, P746, DOI 10.1525/auk.2011.10144; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Ruf T, 2006, ECOLOGY, V87, P372, DOI 10.1890/05-0672; Sauer J. R., 2014, N AM BREEDING BIRD S, P3; SCHAFFER WM, 1974, AM NAT, V108, P783, DOI 10.1086/282954; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; Schulte-Hostedde AI, 2000, CAN J ZOOL, V78, P728, DOI 10.1139/cjz-78-5-728; Sepp T, 2010, PHYSIOL BIOCHEM ZOOL, V83, P276, DOI 10.1086/648580; SMITH CC, 1970, ECOL MONOGR, V40, P349, DOI 10.2307/1942287; Solomon S., 2007, CLIMATE CHANGE 2007; Solonen T., 2011, INT SCH RES NOT; Stearns S.C., 1992, pi; STEARNS SC, 1976, Q REV BIOL, V51, P3, DOI 10.1086/409052; TOMBACK D F, 1977, Living Bird, V16, P123; Tomback D. F., 1998, BIRDS N AM ONLINE; TOMBACK DF, 1976, WILSON BULL, V88, P499; TOMBACK DF, 1982, J ANIM ECOL, V51, P451, DOI 10.2307/3976; United States Department of Agriculture Natural Resources Conservation Service, TOGW PASS SNOTEL STA; USGS, NAT GAP AN PROGR GAP; VANDERWALL SB, 1977, ECOL MONOGR, V47, P89, DOI 10.2307/1942225; VANDERWALL SB, 1981, CONDOR, V83, P162; VANDERWALL SB, 1983, CAN FIELD NAT, V97, P208; Wilbur HM, 2006, AM NAT, V168, P398, DOI 10.1086/506258; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; YEZERINAC SM, 1992, SYST BIOL, V41, P471, DOI 10.2307/2992588	65	8	8	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0123917	10.1371/journal.pone.0123917	http://dx.doi.org/10.1371/journal.pone.0123917			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970294	Green Published, Green Submitted, gold			2022-12-26	WOS:000354544200020
J	Shao, Q; Guo, Q; Xu, WP; Li, ZD; Zhao, TT				Shao, Qiang; Guo, Qiang; Xu, Wen Ping; Li, Zandong; Zhao, Tong Tong			Specific Inhibitory Effect of kappa-Carrageenan Polysaccharide on Swine Pandemic 2009 H1N1 Influenza Virus	PLOS ONE			English	Article							MOLECULAR-WEIGHT CARRAGEENANS; IMPUDICUM STRAIN KG03; ANTI-HIV ACTIVITY; A VIRUS; ANTIVIRAL ACTIVITY; INFECTION; VIRULENCE; GENE; MICE	The 2009 influenza A H1N1 pandemic placed unprecedented demands on antiviral drug resources and the vaccine industry. Carrageenan, an extractive of red algae, has been proven to inhibit infection and multiplication of various enveloped viruses. The aim of this study was to examine the ability of kappa-carrageenan to inhibit swine pandemic 2009 H1N1 influenza virus to gain an understanding of antiviral ability of kappa-carrageenan. It was here demonstrated that kappa-carrageenan had no cytotoxicity at concentrations below 1000 mu g/ml. Hemagglutination, 50% tissue culture infectious dose (TCID50) and cytopathic effect (CPE) inhibition assays showed that kappa-carrageenan inhibited A/Swine/Shandong/731/2009 H1N1 (SW731) and A/California/04/2009 H1N1 (CA04) replication in a dose-dependent fashion. Mechanism studies show that the inhibition of SW731 multiplication and mRNA expression was maximized when kappa-carrageenan was added before or during adsorption. The result of Hemagglutination inhibition assay indicate that kappa-carrageenan specifically targeted HA of SW731 and CA04, both of which are pandemic H1N/2009 viruses, without effect on A/Pureto Rico/8/34 H1N1 (PR8), A/WSN/1933 H1N1 (WSN), A/Swine/Beijing/26/2008 H1N1 (SW26), A/Chicken/Shandong/LY/2008 H9N2 (LY08), and A/Chicken/Shandong/ZB/2007 H9N2 (ZB07) viruses. Immunofluorescence assay and Western blot showed that kappa-carrageenan also inhibited SW731 protein expression after its internalization into cells. These results suggest that kappa-carrageenan can significantly inhibit SW731 replication by interfering with a few replication steps in the SW731 life cycles, including adsorption, transcription, and viral protein expression, especially interactions between HA and cells. In this way, kappa-carrageenan might be a suitable alternative approach to therapy meant to address anti-IAV, which contains an HA homologous to that of SW731.	[Shao, Qiang; Guo, Qiang; Xu, Wen Ping; Li, Zandong; Zhao, Tong Tong] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China	China Agricultural University	Li, ZD (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, 2 Yuan Ming Yuan West Rd, Beijing 100193, Peoples R China.	lzdws@cau.edu.cn	Rui, Core/AAW-5603-2021; Shao, Eric Qiang/I-1359-2019	Shao, Eric Qiang/0000-0001-5307-8264	National Basic Research Program (973 Program) [2013CB945000]	National Basic Research Program (973 Program)(National Basic Research Program of China)	This work was supported by National Basic Research Program (973 Program, number 2013CB945000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae SY, 2006, INT IMMUNOPHARMACOL, V6, P473, DOI 10.1016/j.intimp.2005.09.009; Buck CB, 2006, PLOS PATHOG, V2, P671, DOI 10.1371/journal.ppat.0020069; Carlucci MJ, 2004, ANTIVIR RES, V64, P137, DOI 10.1016/j.antiviral.2004.07.001; Chen CJ, 2010, J VIROL, V84, P10051, DOI 10.1128/JVI.00592-10; Chiu YH, 2012, ANTIVIR RES, V95, P128, DOI 10.1016/j.antiviral.2012.05.009; Control CfD Prevention, 2009, PLAST SURG NURSING O, V29, P271, DOI [10.1097/PSN.0b013e3181c63dcd, DOI 10.1097/PSN.0B013E3181C63DCD]; Damonte EB, 2004, CURR MED CHEM, V11, P2399, DOI 10.2174/0929867043364504; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; DESHPANDE KL, 1987, P NATL ACAD SCI USA, V84, P36, DOI 10.1073/pnas.84.1.36; GIROND S, 1991, RES VIROLOGY, V142, P261, DOI 10.1016/0923-2516(91)90011-Q; Grassauer A, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-107; GUNTHER I, 1993, VIRUS RES, V27, P147, DOI 10.1016/0168-1702(93)90078-2; Harden EA, 2009, ANTIVIR RES, V83, P282, DOI 10.1016/j.antiviral.2009.06.007; Kim M, 2012, ANTIVIR RES, V93, P253, DOI 10.1016/j.antiviral.2011.12.006; Leibbrandt A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014320; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; POTIER M, 1979, ANAL BIOCHEM, V94, P287, DOI 10.1016/0003-2697(79)90362-2; Pujol CA, 2006, PLANTA MED, V72, P121, DOI 10.1055/s-2005-373168; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sun YP, 2014, J VIROL, V88, P4600, DOI 10.1128/JVI.03158-13; Talarico LB, 2007, VIROLOGY, V363, P473, DOI 10.1016/j.virol.2007.01.043; Wang W, 2012, MAR DRUGS, V10, P2795, DOI 10.3390/md10122795; Wang W, 2011, ANTIVIR RES, V92, P237, DOI 10.1016/j.antiviral.2011.08.010; Yamada T, 1997, CARBOHYD POLYM, V32, P51, DOI 10.1016/S0144-8617(96)00128-2; Yamada T, 2000, CARBOHYD POLYM, V41, P115, DOI 10.1016/S0144-8617(99)00083-1; Yim JH, 2005, MAR BIOTECHNOL, V7, P331, DOI 10.1007/s10126-004-0404-6; Zhou G-f, 2010, MAR SCI, V8	28	25	25	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0126577	10.1371/journal.pone.0126577	http://dx.doi.org/10.1371/journal.pone.0126577			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25969984	Green Published, gold, Green Submitted			2022-12-26	WOS:000354544200118
J	Topaz, CM; Ziegelmeier, L; Halverson, T				Topaz, Chad M.; Ziegelmeier, Lori; Halverson, Tom			Topological Data Analysis of Biological Aggregation Models	PLOS ONE			English	Article							PERSISTENCE; COMPLEXITY; STABILITY; NETWORKS; PATTERNS; BEHAVIOR; PRIMER	We apply tools from topological data analysis to two mathematical models inspired by biological aggregations such as bird flocks, fish schools, and insect swarms. Our data consists of numerical simulation output from the models of Vicsek and D'Orsogna. These models are dynamical systems describing the movement of agents who interact via alignment, attraction, and/or repulsion. Each simulation time frame is a point cloud in position-velocity space. We analyze the topological structure of these point clouds, interpreting the persistent homology by calculating the first few Betti numbers. These Betti numbers count connected components, topological circles, and trapped volumes present in the data. To interpret our results, we introduce a visualization that displays Betti numbers over simulation time and topological persistence scale. We compare our topological results to order parameters typically used to quantify the global behavior of aggregations, such as polarization and angular momentum. The topological calculations reveal events and structure not captured by the order parameters.	[Topaz, Chad M.; Ziegelmeier, Lori; Halverson, Tom] Macalester Coll, Dept Math Stat & Comp Sci, St Paul, MN 55105 USA	Macalester College	Topaz, CM (corresponding author), Macalester Coll, Dept Math Stat & Comp Sci, St Paul, MN 55105 USA.	ctopaz@macalester.edu		Topaz, Chad/0000-0001-9977-3414	National Science Foundation [DMS-1412674, DMS-1009633]; Simons Foundation [283311]; Division Of Mathematical Sciences [1412674] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Simons Foundation; Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by National Science Foundation grant DMS-1412674, www.nsf.gov, to CT; National Science Foundation grant DMS-1009633, www.nsf.gov, to CT; and Simons Foundation Grant 283311, www.simonsfoundation.org, to TH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2013, IEEE I CONF COMP VIS, P1097, DOI 10.1109/ICCV.2013.140; Allshouse MR, 2012, PHYSICA D, V241, P95, DOI 10.1016/j.physd.2011.10.002; Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; Bauer Ulrich, 2014, Mathematical Software - ICMS 2014. 4th International Congress. Proceedings. LNCS: 8592, P137, DOI 10.1007/978-3-662-44199-2_24; Bazazi S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002498; Bernoff AJ, 2013, SIAM REV, V55, P709, DOI 10.1137/130925669; Bernoff AJ, 2011, SIAM J APPL DYN SYST, V10, P212, DOI 10.1137/100804504; BREDER CM, 1954, ECOLOGY, V35, P361, DOI 10.2307/1930099; Camazine S, 2001, SELF ORG B OLOGICAL; Carlsson G, 2008, INT J COMPUT VISION, V76, P1, DOI 10.1007/s11263-007-0056-x; Carlsson G, 2009, DISCRETE COMPUT GEOM, V42, P71, DOI 10.1007/s00454-009-9176-0; Carlsson G, 2009, B AM MATH SOC, V46, P255, DOI 10.1090/S0273-0979-09-01249-X; Chuang YL, 2007, PHYSICA D, V232, P33, DOI 10.1016/j.physd.2007.05.007; Cohen-Steiner D, 2007, DISCRETE COMPUT GEOM, V37, P103, DOI 10.1007/s00454-006-1276-5; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; Crossley M.D., 2006, ESSENTIAL TOPOLOGY; D'Orsogna MR, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.104302; de Silva V, 2007, ALGEBR GEOM TOPOL, V7, P339, DOI 10.2140/agt.2007.7.339; de Silva Vin, 2004, P S POINT BAS GRAPH, DOI DOI 10.2312/SPBG/SPBG04/157-166; Edelsbrunner H, 2002, DISCRETE COMPUT GEOM, V28, P511, DOI 10.1007/s00454-002-2885-2; Edelsbrunner H, 2008, CONTEMP MATH, V453, P257; Eftimie R, 2007, P NATL ACAD SCI USA, V104, P6974, DOI 10.1073/pnas.0611483104; Freedman D, 2009, ALGEBRAIC TOPOLOGY C; Ghrist R, 2008, B AM MATH SOC, V45, P61, DOI 10.1090/s0273-0979-07-01191-3; Hatcher A., 2005, ALGEBRAIC TOPOLOGY; Huepe C, 2008, PHYSICA A, V387, P2809, DOI 10.1016/j.physa.2008.01.081; Kaczynski T., 2004, APPL MATH SCI, V157; Kasson PM, 2007, BIOINFORMATICS, V23, P1753, DOI 10.1093/bioinformatics/btm250; Levine H, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.017101; Lukeman R, 2010, P NATL ACAD SCI USA, V107, P12576, DOI 10.1073/pnas.1001763107; Mogilner A, 1999, J MATH BIOL, V38, P534, DOI 10.1007/s002850050158; Nilsen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083343; Okubo A., 2001, DIFFUSION ECOLOGICAL, P10; Okubo Akira, 2001, P197; Olfati-Saber R, 2004, IEEE T AUTOMAT CONTR, V49, P1520, DOI 10.1109/TAC.2004.834113; Parrish J., 1997, ANIMAL GROUPS 3 DIME; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; Passino K., 2005, BIOMIMICRY OPTIMIZAT; Perea JA, 2013, FOUND COMPUT MATH, P1; Potts JR, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0333; Singh G, 2008, J VISION, V8, DOI 10.1167/8.8.11; Sumpter D. J., 2010, COLLECTIVE ANIMAL BE, DOI [10.1515/9781400837106, DOI 10.1515/9781400837106]; Tausz A., 2011, PHOM PERSISTENT HOMO; Tunstrom K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002915; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Vicsek T, 2012, PHYS REP, V517, P71, DOI 10.1016/j.physrep.2012.03.004; Zhu Xiaojin, 2013, P 23 INT JOINT C ART; Zomorodian A, 2005, DISCRETE COMPUT GEOM, V33, P249, DOI 10.1007/s00454-004-1146-y	50	70	70	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0126383	10.1371/journal.pone.0126383	http://dx.doi.org/10.1371/journal.pone.0126383			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970184	Green Published, gold, Green Submitted			2022-12-26	WOS:000354544200109
J	Muranova, LK; Weeks, SD; Strelkov, SV; Gusev, NB				Muranova, Lydia K.; Weeks, Stephen D.; Strelkov, Sergei V.; Gusev, Nikolai B.			Characterization of Mutants of Human Small Heat Shock Protein HspB1 Carrying Replacements in the N-Terminal Domain and Associated with Hereditary Motor Neuron Diseases	PLOS ONE			English	Article							ALPHA-B-CRYSTALLIN; MULTIPLE SEQUENCE ALIGNMENT; CHAPERONE ACTIVITY; HSP27 HSPB1; HETEROOLIGOMERIC COMPLEXES; PHOSPHORYLATION; DETERMINANTS; NEUROPATHY; MUTATIONS; POLYDISPERSITY	Physico-chemical properties of the mutations G34R, P39L and E41K in the N-terminal domain of human heat shock protein B1 (HspB1), which have been associated with hereditary motor neuron neuropathy, were analyzed. Heat-induced aggregation of all mutants started at lower temperatures than for the wild type protein. All mutations decreased susceptibility of the N- and C-terminal parts of HspB1 to chymotrypsinolysis. All mutants formed stable homooligomers with a slightly larger apparent molecular weight compared to the wild type protein. All mutations analyzed decreased or completely prevented phosphorylation-induced dissociation of HspB1 oligomers. When mixed with HspB6 and heated, all mutants yielded heterooligomers with apparent molecular weights close to similar to 400 kDa. Finally, the three HspB1 mutants possessed lower chaperone-like activity towards model substrates (lysozyme, malate dehydrogenase and insulin) compared to the wild type protein, conversely the environmental probe bis-ANS yielded higher fluorescence with the mutants than with the wild type protein. Thus, in vitro the analyzed N-terminal mutations increase stability of large HspB1 homooligomers, prevent their phosphorylation-dependent dissociation, modulate their interaction with HspB6 and decrease their chaperoning capacity, preventing normal functioning of HspB1.	[Muranova, Lydia K.; Gusev, Nikolai B.] Moscow MV Lomonosov State Univ, Sch Biol, Dept Biochem, Moscow 119991, Russia; [Weeks, Stephen D.; Strelkov, Sergei V.] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Lab Biocrystallog, B-3000 Leuven, Belgium	Lomonosov Moscow State University; KU Leuven	Gusev, NB (corresponding author), Moscow MV Lomonosov State Univ, Sch Biol, Dept Biochem, Moscow 119991, Russia.	NBGusev@mail.ru	Weeks, Stephen D/G-6150-2017; Weeks, Stephen/N-4813-2019; Muranova, Lidia K/R-1343-2018	Weeks, Stephen D/0000-0002-1360-0852; Weeks, Stephen/0000-0002-1360-0852; Muranova, Lidia K/0000-0003-4170-3071	Russian Science Foundation (RSF) [14-35-00026]; Flanders Research Foundation [G.06978.08]; Russian Science Foundation [14-35-00026] Funding Source: Russian Science Foundation	Russian Science Foundation (RSF)(Russian Science Foundation (RSF)); Flanders Research Foundation(FWO); Russian Science Foundation(Russian Science Foundation (RSF))	Investigation of physico-chemical properties of isolated mutants performed by LKM and NBG was supported by Russian Science Foundation (RSF) (grant No 14-35-00026). Protein-protein interaction and bioinformatic analysis performed by SDW and SVS were supported by Flanders Research Foundation (grant G.06978.08 to SVS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acunzo J, 2012, INT J BIOCHEM CELL B, V44, P1622, DOI 10.1016/j.biocel.2012.04.002; Almeida-Souza L, 2010, J BIOL CHEM, V285, P12778, DOI 10.1074/jbc.M109.082644; Arrigo AP, 2013, FEBS LETT, V587, P1959, DOI 10.1016/j.febslet.2013.05.011; Bagneris C, 2009, J MOL BIOL, V392, P1242, DOI 10.1016/j.jmb.2009.07.069; Baranova EV, 2011, J MOL BIOL, V411, P110, DOI 10.1016/j.jmb.2011.05.024; Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Benndorf R, 2014, MUTAT RES-REV MUTAT, V761, P15, DOI 10.1016/j.mrrev.2014.02.004; Bukach OV, 2009, BBA-PROTEINS PROTEOM, V1794, P486, DOI 10.1016/j.bbapap.2008.11.010; Bukach OV, 2004, EUR J BIOCHEM, V271, P291, DOI 10.1046/j.1432-1033.2003.03928.x; Capponi S, 2011, J PERIPHER NERV SYST, V16, P287, DOI 10.1111/j.1529-8027.2011.00361.x; Carra S, 2012, PROG NEUROBIOL, V97, P83, DOI 10.1016/j.pneurobio.2011.09.009; Chalova AS, 2014, BBA-PROTEINS PROTEOM, V1844, P2116, DOI 10.1016/j.bbapap.2014.09.005; Chalova AS, 2014, CELL STRESS CHAPERON, V19, P963, DOI 10.1007/s12192-014-0520-9; Cox D, 2014, BBA-MOL BASIS DIS, V1842, P1830, DOI 10.1016/j.bbadis.2014.06.024; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Datskevich PN, 2012, BIOCHEMISTRY-MOSCOW+, V77, P1500, DOI 10.1134/S0006297912130081; Datskevich PN, 2012, PROTEIN EXPRES PURIF, V82, P45, DOI 10.1016/j.pep.2011.11.004; Delbecq SP, 2012, EMBO J, V31, P4587, DOI 10.1038/emboj.2012.318; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ehrnsperger M, 1999, J BIOL CHEM, V274, P14867, DOI 10.1074/jbc.274.21.14867; Elliott JL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0375; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; Fontaine JM, 2003, CELL STRESS CHAPERON, V8, P62, DOI 10.1379/1466-1268(2003)8<62:TSODFP>2.0.CO;2; Ghosh JG, 2005, BIOCHEMISTRY-US, V44, P14854, DOI 10.1021/bi0503910; Ghosh JG, 2006, BIOCHEMISTRY-US, V45, P13847, DOI 10.1021/bi061471m; Haslbeck M, 2015, J MOL BIOL, V427, P1537, DOI 10.1016/j.jmb.2015.02.002; Hayes D, 2009, J BIOL CHEM, V284, P18801, DOI 10.1074/jbc.M109.011353; Heirbaut M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105892; Hochberg GKA, 2014, PROG BIOPHYS MOL BIO, V115, P11, DOI 10.1016/j.pbiomolbio.2014.03.003; Houlden H, 2008, NEUROLOGY, V71, P1660, DOI 10.1212/01.wnl.0000319696.14225.67; Jackson SE, 2013, TOP CURR CHEM, V328, P69, DOI 10.1007/128_2012_324; Jehle S, 2011, P NATL ACAD SCI USA, V108, P6409, DOI 10.1073/pnas.1014656108; Kappe G, 2003, CELL STRESS CHAPERON, V8, P53, DOI 10.1379/1466-1268(2003)8<53:THGECS>2.0.CO;2; Kappe G, 2010, CELL STRESS CHAPERON, V15, P457, DOI 10.1007/s12192-009-0155-4; Kelley PB, 2003, MOL CELL BIOCHEM, V252, P273, DOI 10.1023/A:1025568417000; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laganowsky A, 2010, PROTEIN SCI, V19, P1031, DOI 10.1002/pro.380; Maaroufi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081207; McDonald ET, 2012, BIOCHEMISTRY-US, V51, P1257, DOI 10.1021/bi2017624; Mchaourab HS, 2009, BIOCHEMISTRY-US, V48, P3828, DOI 10.1021/bi900212j; MEDVEDEVA MV, 1995, FEBS LETT, V360, P89, DOI 10.1016/0014-5793(95)00058-H; Mymrikov EV, 2012, CELL STRESS CHAPERON, V17, P157, DOI 10.1007/s12192-011-0296-0; Mymrikov EV, 2011, PHYSIOL REV, V91, P1123, DOI 10.1152/physrev.00023.2010; Mymrikov EV, 2010, CELL STRESS CHAPERON, V15, P365, DOI 10.1007/s12192-009-0151-8; Nefedova VV, 2013, ARCH BIOCHEM BIOPHYS, V538, P16, DOI 10.1016/j.abb.2013.07.028; Nefedova VV, 2013, BIOCHIMIE, V95, P1582, DOI 10.1016/j.biochi.2013.04.014; Paul C, 2010, EXP CELL RES, V316, P1535, DOI 10.1016/j.yexcr.2010.03.006; PERRIE WT, 1970, BIOCHEM J, V119, P31, DOI 10.1042/bj1190031; Rogalla T, 1999, J BIOL CHEM, V274, P18947, DOI 10.1074/jbc.274.27.18947; Shi J, 2006, J BIOL CHEM, V281, P40420, DOI 10.1074/jbc.M608322200; STOKOE D, 1992, FEBS LETT, V313, P307, DOI 10.1016/0014-5793(92)81216-9; Taylor RP, 2005, J MOL CELL CARDIOL, V38, P433, DOI 10.1016/j.yjmcc.2004.12.014; Theriault JR, 2004, J BIOL CHEM, V279, P23463, DOI 10.1074/jbc.M402325200; Treweek TM, 2015, CELL MOL LIFE SCI, V72, P429, DOI 10.1007/s00018-014-1754-5; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weeks SD, 2014, J STRUCT BIOL, V185, P342, DOI 10.1016/j.jsb.2013.12.009; Wettstein G, 2012, INT J BIOCHEM CELL B, V44, P1680, DOI 10.1016/j.biocel.2012.05.024; Yang CW, 2006, CANCER RES, V66, P11649, DOI 10.1158/0008-5472.CAN-06-1645	58	32	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0126248	10.1371/journal.pone.0126248	http://dx.doi.org/10.1371/journal.pone.0126248			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965061	gold, Green Published, Green Submitted			2022-12-26	WOS:000354543500052
J	Pozveh, EZ; Seif, A; Ghalayani, P; Maleki, A; Mottaghi, A				Pozveh, Elham Zamani; Seif, Ahmad; Ghalayani, Parichehr; Maleki, Abbas; Mottaghi, Ahmad			The Effect of Mustard Gas on Salivary Trace Metals (Zn, Mn, Cu, Mg, Mo, Sr, Cd, Ca, Pb, Rb)	PLOS ONE			English	Article							BIOMARKERS; EXPOSURE; ZINC	We have determined and compared trace metals concentration in saliva taken from chemical warfare injures who were under the exposure of mustard gas and healthy subjects by means of inductively coupled plasma optical emission spectroscopy (ICP-OES) for the first time. The influence of preliminary operations on the accuracy of ICP-OES analysis, blood contamination, the number of restored teeth in the mouth, salivary flow rate, and daily variations in trace metals concentration in saliva were also considered. Unstimulated saliva was collected at 10:00-11:00 a.m. from 45 subjects in three equal groups. The first group was composed of 15 healthy subjects (group 1); the second group consisted of 15 subjects who, upon chemical warfare injuries, did not use Salbutamol spray, which they would have normally used on a regular basis (group 2); and the third group contained the same number of patients as the second group, but they had taken their regular medicine (Salbutamol spray; group 3). Our results showed that the concentration of Cu in saliva was significantly increased in the chemical warfare injures compared to healthy subjects, as follows: healthy subjects 15.3 +/- 5.45(p.p.b.), patients (group 2) 45.77 +/- 13.65, and patients (Salbutamol spray; group 3) 29 +/- 8.51 (P < 0.02). In contrast, zinc was significantly decreased in the patients, as follows: healthy subjects 37 +/- 9.03(p.p.b.), patients (group 2) 12.2 +/- 3.56, and patients (Salbutamol spray; group 3) 20.6 +/- 10.01 (P < 0.01). It is important to note that direct dilution of saliva samples with ultrapure nitric acid showed the optimum ICP-OES outputs.	[Pozveh, Elham Zamani] Islamic Azad Univ, Dent Sch Fac, Dept Oral Med, Khorasgan Isfahan Branch, Esfahan, Iran; [Seif, Ahmad; Maleki, Abbas] Islamic Azad Univ, Boroujerd Branch, Dept Chem, Boroujerd, Lorestan, Iran; [Ghalayani, Parichehr] Isfahan Univ Med Sci, Dept Oral Med, Esfahan, Iran; [Mottaghi, Ahmad] Islamic Azad Univ, Dept Oral & Maxillofacial Surg, Dent Sch Fac, Khorasgan Isfahan Branch, Esfahan, Iran	Islamic Azad University; Islamic Azad University; Isfahan University Medical Science; Islamic Azad University	Seif, A (corresponding author), Islamic Azad Univ, Boroujerd Branch, Dept Chem, Boroujerd, Lorestan, Iran.	Ahmaseif@yahoo.com	Ghalayani, Parichehr/W-4196-2017	Ghalayani, Parichehr/0000-0002-4269-0906; Seif, Ahmad/0000-0002-4172-6073	Boroujerd University	Boroujerd University	This work was supported by Boroujerd University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelsson P., 2000, DIAGNOSIS RISK PREDI, V2; Balali MM, 2005, J BIRJAND U MED SCI, V12, P9; BALALIMOOD M, 2005, J MED CHEM BIOL RADI, V3, P1; Barbosa F, 2005, ENVIRON HEALTH PERSP, V113, P1669, DOI 10.1289/ehp.7917; BRUNE D, 1986, BIOMATERIALS, V7, P163, DOI 10.1016/0142-9612(86)90097-9; BRYAN J, 2007, PHARM J, V279, P404; Chasapis CT, 2012, ARCH TOXICOL, V86, P521, DOI 10.1007/s00204-011-0775-1; Delvigna P, 2008, J CONT DENT PRACTICE, V9, P1; Duchovic RJ, 2007, J CHEM EDUC, V84, P944, DOI 10.1021/ed084p944; Grandjean P, 1987, TRACE ELEMENTS DIS; HENKIN RI, 1975, P NATL ACAD SCI USA, V72, P488, DOI 10.1073/pnas.72.2.488; Humphrey SP, 2001, J PROSTHET DENT, V85, P162, DOI 10.1067/mpr.2001.113778; KLEVAY LM, 2000, CLIN NUTR ESSENTIAL; Koh DSQ, 2007, OCCUP ENVIRON MED, V64, P202, DOI 10.1136/oem.2006.026567; Koji W, 2009, J TRACE ELEMENTS MED, V23, P93, DOI [10.1016/j.jtemb.2009.01.003, DOI 10.1016/J.JTEMB.2009.01.003]; Lopez-Alias JF, 2006, DENT MATER, V22, P832, DOI 10.1016/j.dental.2005.11.011; Mamoru W, 2005, CHEM SENSES, V30, P121; Mottaghi Ahmad, 2012, Indian J Dent Res, V23, P506, DOI 10.4103/0970-9290.104959; Nagler RM, 2005, ARCH ORAL BIOL, V50, P7, DOI 10.1016/j.archoralbio.2004.07.012; ROSE J, 1983, TRACE ELEMENTS HLTH; Tabak L A, 2001, J Dent Educ, V65, P1335; Ten Cate AR, 1998, ORAL HISTOLOGY DEV S, VFifth; VAUGHAN MA, 1991, CLIN CHEM, V37, P210; Williamson MA, 2012, WALLACHS INTERPRETAT; Yarmohammadi ME, 2013, INT IMMUNOPHARMACOL, V17, P952, DOI 10.1016/j.intimp.2012.12.021; YOUNG JA, 1981, AUST J EXP BIOL MED, V59, P1, DOI 10.1038/icb.1981.1	26	2	2	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0126162	10.1371/journal.pone.0126162	http://dx.doi.org/10.1371/journal.pone.0126162			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965704	gold, Green Submitted, Green Published			2022-12-26	WOS:000354543500047
J	Abeln, V; MacDonald-Nethercott, E; Piacentini, MF; Meeusen, R; Kleinert, J; Strueder, HK; Schneider, S				Abeln, Vera; MacDonald-Nethercott, Eoin; Piacentini, Maria Francesca; Meeusen, Romain; Kleinert, Jens; Strueder, Heiko K.; Schneider, Stefan			Exercise in Isolation-A Countermeasure for Electrocortical, Mental and Cognitive Impairments	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; OLDER-PEOPLE; PERFORMANCE; INTERVENTIONS; ENVIRONMENTS; FLIGHT; POLAR; STATE; MOOD; EEG	Introduction Mental impairments, including deterioration of mood and cognitive performance, are known to occur during isolation and space missions, but have been insufficiently investigated. Appropriate countermeasures are required, such as exercise, which is known to prevent mood disorders for prolonged space and isolation missions. Based on the interaction of brain activity, mood and cognitive performance, this study aims to investigate the effect of long-term isolation and confinement and the long-term effect of exercise on these parameters. Methods Eight male volunteers were isolated and confined for about eight month during the winter period at the Antarctic Concordia Station. Every six weeks electroencephalographic measurements were recorded under rest conditions, and cognitive tests and a mood questionnaire were executed. Based individual training logs, subjects were afterwards separated into an active (> 2500 arbitrary training units/interval) or inactive (< 2500 arbitrary training units/interval) group. Results A long-term effect of exercise was observed for brain activity and mood. Regularly active people showed a decreased brain activity (alpha and beta) in the course of isolation, and steady mood. Inactive people instead first increased and than remained at high brain activity accompanied with a deterioration of mood. No effect of exercise and isolation was found for cognitive performance. Conclusion The findings point out the positive effect of regularly performed voluntary exercise, supporting subjective mental well-being of long-term isolated people. The choice to be regularly active seems to support mental health, which is not only of interest for future isolation and space missions.	[Abeln, Vera; Strueder, Heiko K.; Schneider, Stefan] German Sport Univ Cologne, Inst Movement & Neurosci, Cologne, Germany; [MacDonald-Nethercott, Eoin] Univ Cambridge, Hosp NHS Trust, Cambridge, England; [MacDonald-Nethercott, Eoin] Inst Paul Emile Victor, Brest, France; [Piacentini, Maria Francesca] Univ Rome Foro Ital, Rome, Italy; [Piacentini, Maria Francesca; Meeusen, Romain] Fac Phys Educ & Physiotherapy, Dept Human Physiol, Brussels, Belgium; [Meeusen, Romain] James Cook Univ, Sch Publ Hlth, Trop Med & Rehabil Sci, Townsville, Qld 4811, Australia; [Kleinert, Jens] German Sport Univ Cologne, Inst Psychol, Dept Hlth & Social Psychol, Cologne, Germany; [Schneider, Stefan] Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Maroochydore, Qld, Australia	German Sport University Cologne; University of Cambridge; Foro Italico University of Rome; James Cook University; German Sport University Cologne; University of the Sunshine Coast	Abeln, V (corresponding author), German Sport Univ Cologne, Inst Movement & Neurosci, Cologne, Germany.	v.abeln@dshs-koeln.de	Schneider, Stefan/AAH-7418-2020	Schneider, Stefan/0000-0002-4563-9890	German Space Agency [50WB0819]	German Space Agency(Helmholtz AssociationGerman Aerospace Centre (DLR))	The study was founded by German Space Agency (DLR) grant 50WB0819 (http://www.dlr.de/dlr/en/desktopdefault.aspx/tabid-10002/). Funders were involved in funding and managing the isolation (winter-over) expedition.	Alsuwaidan MT, 2009, NEUROMOL MED, V11, P328, DOI 10.1007/s12017-009-8079-9; Bechtel R.B., 1991, ANTARCTICA OUTER SPA, P261, DOI DOI 10.1007/978-1-4612-3012-0_24; Blake H, 2009, CLIN REHABIL, V23, P873, DOI 10.1177/0269215509337449; Brummer V, 2011, MED SCI SPORT EXER, V43, P1863, DOI 10.1249/MSS.0b013e3182172a6f; Crabbe JB, 2004, PSYCHOPHYSIOLOGY, V41, P563, DOI 10.1111/j.1469-8986.2004.00176.x; Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01; DEFAYOLLE M, 1985, J HUM STRESS, V11, P157, DOI 10.1080/0097840X.1985.9936753; DORVAL M, 1986, PERCEPT MOTOR SKILL, V62, P159, DOI 10.2466/pms.1986.62.1.159; Ekkekakis P, 2009, SPORTS MED, V39, P857, DOI 10.2165/11315210-000000000-00000; Foster C, 1998, MED SCI SPORT EXER, V30, P1164, DOI 10.1097/00005768-199807000-00023; Heuer H, 2003, ERGONOMICS, V46, P920, DOI 10.1080/0014013031000107559; Johannes B, 2003, Aviakosm Ekolog Med, V37, P6; Kanas N, 1998, ACTA ASTRONAUT, V42, P339, DOI 10.1016/S0094-5765(98)00130-1; Kleinert J, 2006, Z SPORTPSYCHOL, V13, P156, DOI 10.1026/1612-5010.13.4.156; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; LeScanff C, 1997, AVIAT SPACE ENVIR MD, V68, P1144; Lindsley D. B., 1960, HDB PHYSIOLOGY, V3, P1553; Martinsen EW, 2008, NORD J PSYCHIAT, V62, P25, DOI 10.1080/08039480802315640; Mazzeo RS, 1998, MED SCI SPORT EXER, V30, P992, DOI 10.1097/00005768-199806000-00033; Meeusen Romain, 2005, Ann Transplant, V10, P49; Nitsch J, 1974, EIGENZUSTANDSSKALA E; Palinkas LA, 2003, AM PSYCHOL, V58, P353, DOI 10.1037/0003-066X.58.5.353; Palinkas LA, 2008, LANCET, V371, P153, DOI 10.1016/S0140-6736(07)61056-3; Ratey JJ, 2011, REV NEUROSCIENCE, V22, P171, DOI 10.1515/RNS.2011.017; Sandal G. M., 2006, Reviews in Environmental Science and Bio/Technology, V5, P281, DOI 10.1007/s11157-006-9000-8; Schaefer PD, 1998, PERCEPT MOTOR SKILL, V87, P56, DOI 10.2466/pms.1998.87.1.56; Schneider S, 2013, BEHAV BRAIN RES, V236, P1, DOI 10.1016/j.bbr.2012.08.022; Schneider S, 2010, BEHAV BRAIN RES, V211, P208, DOI 10.1016/j.bbr.2010.03.034; Schneider S, 2009, PHYSIOL BEHAV, V98, P447, DOI 10.1016/j.physbeh.2009.07.010; Schneider S, 2009, STRESS, V12, P336, DOI 10.1080/10253890802499175; Schneider S, 2009, PHYSIOL BEHAV, V96, P709, DOI 10.1016/j.physbeh.2009.01.007; Struder HK, 2001, INT J SPORTS MED, V22, P467, DOI 10.1055/s-2001-17605; Teri L, 2008, J NUTR HEALTH AGING, V12, P391, DOI 10.1007/BF02982672; Tseng CN, 2011, J NURS RES, V19, P119, DOI 10.1097/JNR.0b013e3182198837; van Praag H, 2008, NEUROMOL MED, V10, P128, DOI 10.1007/s12017-008-8028-z; Voss MW, 2011, J APPL PHYSIOL, V111, P1505, DOI 10.1152/japplphysiol.00210.2011; Whitmore M, 1998, Hum Perf Extrem Environ, V3, P64; Yeung RR, 1996, J PSYCHOSOM RES, V40, P123, DOI 10.1016/0022-3999(95)00554-4; Zuckerman M., 1991, PSYCHOBIOLOGY PERSON	39	18	19	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126356	10.1371/journal.pone.0126356	http://dx.doi.org/10.1371/journal.pone.0126356			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI1YY	25961821	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000354542500090
J	Konno, A; Shiba, K; Cai, C; Inaba, K				Konno, Alu; Shiba, Kogiku; Cai, Chunhua; Inaba, Kazuo			Branchial Cilia and Sperm Flagella Recruit Distinct Axonemal Components	PLOS ONE			English	Article							OUTER ARM DYNEIN; MOLECULAR CHARACTERIZATION; BETA-TUBULIN; CIONA-INTESTINALIS; PROTEOMIC ANALYSIS; DOCKING COMPLEX; PROTEIN; MOTILITY; ACTIN; HYPERACTIVATION	Eukaryotic cilia and flagella have highly conserved 9 + 2 structures. They are functionally diverged to play cell-type-specific roles even in a multicellular organism. Although their structural components are therefore believed to be common, few studies have investigated the molecular diversity of the protein components of the cilia and flagella in a single organism. Here we carried out a proteomic analysis and compared protein components between branchial cilia and sperm flagella in a marine invertebrate chordate, Ciona intestinalis. Distinct feature of protein recruitment in branchial cilia and sperm flagella has been clarified; (1) Isoforms of alpha- and beta-tubulins as well as those of actins are distinctly used in branchial cilia or sperm flagella. (2) Structural components, such as dynein docking complex, tektins and an outer dense fiber protein, are used differently by the cilia and flagella. (3) Sperm flagella are specialized for the cAMP- and Ca2+-dependent regulation of outer arm dynein and for energy metabolism by glycolytic enzymes. Our present study clearly demonstrates that flagellar or ciliary proteins are properly recruited according to their function and stability, despite their apparent structural resemblance and conservation.	[Konno, Alu; Shiba, Kogiku; Cai, Chunhua; Inaba, Kazuo] Univ Tsukuba, Shimoda Marine Res Ctr, Shizuoka 4150025, Japan	University of Tsukuba	Inaba, K (corresponding author), Univ Tsukuba, Shimoda Marine Res Ctr, Shimoda 5-10-1, Shizuoka 4150025, Japan.	kinaba@kurofune.shimoda.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [21112004, 15H01201, 22370023, 25291069]; Grants-in-Aid for Scientific Research [12J06986] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid #21112004 and 15H01201 for Scientific Research on Innovative Areas, #22370023 and 25291069 for Scientific Research (B) to KI from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT).	Afzelius BA, 2004, J PATHOL, V204, P470, DOI 10.1002/path.1652; AITKEN RJ, 1986, J ANDROL, V7, P3; Amos LA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-229; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Baccetti B, 1976, Monogr Dev Biol, P1; BERNSTEIN M, 1994, J CELL BIOL, V125, P1313, DOI 10.1083/jcb.125.6.1313; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; Cao WL, 2006, MOL CELL PROTEOMICS, V5, P801, DOI 10.1074/mcp.M500322-MCP200; de Carvalho CE, 2002, BIOL REPROD, V66, P785, DOI 10.1095/biolreprod66.3.785; Del Bigio MR, 2010, ACTA NEUROPATHOL, V119, P55, DOI 10.1007/s00401-009-0624-y; FAWCETT DW, 1975, DEV BIOL, V44, P394, DOI 10.1016/0012-1606(75)90411-X; Franzen A, 1976, COMP SPERMATOLOGY, P29; GIBBONS BH, 1973, J CELL SCI, V13, P337; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Ho HC, 2001, REPRODUCTION, V122, P519, DOI 10.1530/rep.0.1220519; Hozumi A, 2008, CELL MOTIL CYTOSKEL, V65, P249, DOI 10.1002/cm.20258; Hozumi A, 2006, CELL MOTIL CYTOSKEL, V63, P591, DOI 10.1002/cm.20146; Hurd DD, 2010, GENETICS, V185, P883, DOI 10.1534/genetics.110.116996; Inaba K, 2003, ZOOL SCI, V20, P1043, DOI 10.2108/zsj.20.1043; Inaba K, 1999, BIOCHEM BIOPH RES CO, V256, P177, DOI 10.1006/bbrc.1999.0309; Inaba K, 2002, MOL REPROD DEV, V62, P431, DOI 10.1002/mrd.10131; Inaba K, 2011, MOL HUM REPROD, V17, P524, DOI 10.1093/molehr/gar034; Itoh A, 2003, BIOCHEM BIOPH RES CO, V305, P855, DOI 10.1016/S0006-291X(03)00840-4; KatoMinoura T, 1997, J CELL BIOL, V137, P649, DOI 10.1083/jcb.137.3.649; Konno A, 2012, INT REV CEL MOL BIO, V294, P133, DOI 10.1016/B978-0-12-394305-7.00003-3; Konno A, 2010, ZOOL SCI, V27, P204, DOI 10.2108/zsj.27.204; Konno A, 2010, DEV BIOL, V337, P42, DOI 10.1016/j.ydbio.2009.10.012; Krisfalusi M, 2006, BIOL REPROD, V75, P270, DOI 10.1095/biolreprod.105.049684; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMBERT CC, 1984, DEV BIOL, V106, P307, DOI 10.1016/0012-1606(84)90229-X; LINCK RW, 1973, J CELL SCI, V12, P951; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; Malnic B, 2010, NEUROBIOLOGY OLFACTI; Marshall WF, 2008, J CELL BIOL, V180, P17, DOI 10.1083/jcb.200710085; Marshall WF, 2001, J CELL BIOL, V155, P405, DOI 10.1083/jcb.200106141; Mayer U, 2009, PROTEOMICS, V9, P322, DOI 10.1002/pmic.200800149; Mizuno K, 2012, P NATL ACAD SCI USA, V109, P20497, DOI 10.1073/pnas.1217018109; Mizuno K, 2009, BIOL CELL, V101, P91, DOI 10.1042/BC20080032; Mukai C, 2004, BIOL REPROD, V71, P540, DOI 10.1095/biolreprod.103.026054; MUNRO NC, 1994, THORAX, V49, P684, DOI 10.1136/thx.49.7.684; Nakachi M, 2011, MOL REPROD DEV, V78, P529, DOI 10.1002/mrd.21341; Nielsen MG, 2002, EVOL DEV, V4, P303, DOI 10.1046/j.1525-142X.2002.02015.x; Nielsen MG, 2001, CURR BIOL, V11, P529, DOI 10.1016/S0960-9822(01)00150-6; Ogawa K, 2006, BIOCHEM BIOPH RES CO, V343, P385, DOI 10.1016/j.bbrc.2006.02.157; Ostrowski LE, 2002, MOL CELL PROTEOMICS, V1, P451, DOI 10.1074/mcp.M200037-MCP200; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; PIPERNO G, 1979, J BIOL CHEM, V254, P2187; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Ross AJ, 2007, AM J RESP CELL MOL, V37, P169, DOI 10.1165/rcmb.2006-0466OC; ROTH Y, 1985, BRAIN RES, V330, P291, DOI 10.1016/0006-8993(85)90688-2; Roy A, 2004, MOL REPROD DEV, V67, P295, DOI 10.1002/mrd.20025; Satouh Y, 2005, MOL BIOL CELL, V16, P626, DOI 10.1091/mbc.e04-09-0784; Satouh Y, 2009, FEBS LETT, V583, P2201, DOI 10.1016/j.febslet.2009.06.016; Smith JC, 2005, J PROTEOME RES, V4, P909, DOI 10.1021/pr050013h; STEPHENS RE, 1992, J CELL SCI, V103, P999; Stolc V, 2005, P NATL ACAD SCI USA, V102, P3703, DOI 10.1073/pnas.0408358102; Suarez SS, 2008, HUM REPROD UPDATE, V14, P647, DOI 10.1093/humupd/dmn029; Ushimaru Y, 2006, ZOOL SCI, V23, P679, DOI 10.2108/zsj.23.679; WOOLLACOTT RM, 1977, J MORPHOL, V152, P77, DOI 10.1002/jmor.1051520105	59	20	21	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126005	10.1371/journal.pone.0126005	http://dx.doi.org/10.1371/journal.pone.0126005			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962172	gold, Green Submitted, Green Published			2022-12-26	WOS:000354542500058
J	Kunze, A; Steel, D; Dahlenborg, K; Sartipy, P; Svedhem, S				Kunze, Angelika; Steel, Daniella; Dahlenborg, Kerstin; Sartipy, Peter; Svedhem, Sofia			Non-Invasive Acoustical sensing of Drug-Induced Effects on the Contractile Machinery of Human Cardiomyocyte Clusters	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; IN-VITRO; SAFETY PHARMACOLOGY	There is an urgent need for improved models for cardiotoxicity testing. Here we propose acoustic sensing applied to beating human cardiomyocyte clusters for non-invasive, surrogate measuring of the QT interval and other characteristics of the contractile machinery. In experiments with the acoustic method quartz crystal microbalance with dissipation monitoring (QCM-D), the shape of the recorded signals was very similar to the extracellular field potential detected in electrochemical experiments, and the expected changes of the QT interval in response to addition of conventional drugs (E-4031 or nifedipine) were observed. Additionally, changes in the dissipation signal upon addition of cytochalasin D were in good agreement with the known, corresponding shortening of the contraction-relaxation time. These findings suggest that QCM-D has great potential as a tool for cardiotoxicological screening, where effects of compounds on the cardiomyocyte contractile machinery can be detected independently of whether the extracellular field potential is altered or not.	[Kunze, Angelika; Svedhem, Sofia] Chalmers Univ Technol, Dept Appl Phys, S-41296 Gothenburg, Sweden; [Steel, Daniella; Dahlenborg, Kerstin; Sartipy, Peter] Cellectis AB, Gothenburg, Sweden; [Sartipy, Peter] Univ Skovde, Sch Biosci, Syst Biol Res Ctr, Skovde, Sweden	Chalmers University of Technology; University of Skovde	Svedhem, S (corresponding author), Chalmers Univ Technol, Dept Appl Phys, S-41296 Gothenburg, Sweden.	sofia.svedhem@chalmers.se	Svedhem, Sofia/AAC-8727-2020		Swedish Research Council (VR) through the Linneaus program SUPRA [2007-125, 2012-4217]; Systems Biology Research Centre (University of Skovde, Sweden) under grants from Knowledge Foundation [2011/0295, 2013/89]; Kristina Stenborgs stiftelse; Cellectis AB	Swedish Research Council (VR) through the Linneaus program SUPRA; Systems Biology Research Centre (University of Skovde, Sweden) under grants from Knowledge Foundation; Kristina Stenborgs stiftelse; Cellectis AB	Support was provided to the following authors: SS: Kristina Stenborgs stiftelse; Swedish Research Council (VR) through the Linneaus program SUPRA [*2007-125] and grant no 2012-4217; PS: the Systems Biology Research Centre (University of Skovde, Sweden) under grants from the Knowledge Foundation [2011/0295 and 2013/89]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-authors Daniella Steel, Kerstin Dahlenborg and Peter Sartipy were employed by Cellectis AB. Cellectis AB provided support in the form of salaries for authors DS, KD and PS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Co-author Sofia Svedhem was part time employed by Biolin Scientific/Q-Sense. Biolin Scientific/Q-Sense provided application support, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abassi YA, 2012, BRIT J PHARMACOL, V165, P1424, DOI 10.1111/j.1476-5381.2011.01623.x; Cans AS, 2001, ANAL CHEM, V73, P5805, DOI 10.1021/ac010777q; Fatisson J, 2011, BIOSENS BIOELECTRON, V26, P3207, DOI 10.1016/j.bios.2010.12.027; Fredriksson C, 1998, J MATER SCI-MATER M, V9, P785, DOI 10.1023/A:1008927624337; Frost R, 2013, ANAL BIOCHEM, V435, P10, DOI 10.1016/j.ab.2012.12.004; Harmer AR, 2012, TOXICOL APPL PHARM, V260, P162, DOI 10.1016/j.taap.2012.02.007; Hihara T, 2014, PHARM PHARM, V5, P364; Howarth FC, 1998, PFLUG ARCH EUR J PHY, V436, P804, DOI 10.1007/s004240050706; Jahnke HG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068971; Jonsson MKB, 2012, J MOL CELL CARDIOL, V52, P998, DOI 10.1016/j.yjmcc.2012.02.002; Jonsson MKB, 2011, ASSAY DRUG DEV TECHN, V9, P589, DOI 10.1089/adt.2011.0396; Jonsson MKB, 2010, STEM CELL RES, V4, P189, DOI 10.1016/j.scr.2010.02.001; Jonsson MKB, 2009, EXPERT OPIN DRUG DIS, V4, P357, DOI 10.1517/17460440902794912; Kaneko T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04670; Kunze A, 2014, COLLOID SURFACE B, V116, P446, DOI 10.1016/j.colsurfb.2014.01.025; Laverty HG, 2011, BRIT J PHARMACOL, V163, P675, DOI 10.1111/j.1476-5381.2011.01255.x; Malan D, 2011, CIRC RES, V109, P841, DOI 10.1161/CIRCRESAHA.111.243139; Mandenius CF, 2011, J APPL TOXICOL, V31, P191, DOI 10.1002/jat.1663; Meyer T, 2004, DRUG SAFETY, V27, P763, DOI 10.2165/00002018-200427110-00002; Nguemo F, 2012, CELL PHYSIOL BIOCHEM, V29, P819, DOI 10.1159/000188069; Norstrom A, 2006, EXP BIOL MED, V231, P1753, DOI 10.1177/153537020623101113; Pax M, 2005, ANALYST, V130, P1474, DOI 10.1039/b504302f; Saitakis M, 2012, CELL MOL LIFE SCI, V69, P357, DOI 10.1007/s00018-011-0854-8; Sapper A, 2006, LANGMUIR, V22, P10869, DOI 10.1021/la061470v; Sartipy P, 2007, DRUG DISCOV TODAY, V12, P688, DOI 10.1016/j.drudis.2007.07.005; Steel D, 2009, CURR OPIN DRUG DISC, V12, P133; Synnergren J, 2008, STEM CELLS, V26, P1831, DOI 10.1634/stemcells.2007-1033; Tarantola M, 2011, CHEM RES TOXICOL, V24, P1494, DOI 10.1021/tx200115q; Tymchenko N, 2013, BIOCHEM BIOPH RES CO, V435, P520, DOI 10.1016/j.bbrc.2013.04.070; Tymchenko N, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0043-9; Vidarsson H, 2010, STEM CELL REV REP, V6, P108, DOI 10.1007/s12015-010-9113-x; Voinova MV, 2002, BIOSENS BIOELECTRON, V17, P835, DOI 10.1016/S0956-5663(02)00050-7; Wegener J, 2001, CELL BIOCHEM BIOPHYS, V34, P121, DOI 10.1385/CBB:34:1:121; Wu X, 2010, AM J PHYSIOL-HEART C, V298, pH2071, DOI 10.1152/ajpheart.01156.2009; Yamazaki K, 2012, TOXICOL IN VITRO, V26, P335, DOI 10.1016/j.tiv.2011.12.005; Yokoo N, 2009, BIOCHEM BIOPH RES CO, V387, P482, DOI 10.1016/j.bbrc.2009.07.052; Zwi-Dantsis L, 2011, TISSUE ENG PT A, V17, P1027, DOI 10.1089/ten.TEA.2010.0235	37	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0125540	10.1371/journal.pone.0125540	http://dx.doi.org/10.1371/journal.pone.0125540			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961711	Green Submitted, Green Published, gold			2022-12-26	WOS:000354542500033
J	Paolillo, R; Spinello, I; Quaranta, MT; Pasquini, L; Pelosi, E; Lo Coco, F; Testa, U; Labbaye, C				Paolillo, Rosa; Spinello, Isabella; Quaranta, Maria Teresa; Pasquini, Luca; Pelosi, Elvira; Lo Coco, Francesco; Testa, Ugo; Labbaye, Catherine			Human TM9SF4 Is a New Gene Down-Regulated by Hypoxia and Involved in Cell Adhesion of Leukemic Cells	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; BONE-MARROW; NICHE; IDENTIFICATION; CANNIBALISM; AUTOPHAGY; YEAST	Background The transmembrane 9 superfamily protein member 4, TM9SF4, belongs to the TM9SF family of proteins highly conserved through evolution. TM9SF4 homologs, previously identified in many different species, were mainly involved in cellular adhesion, innate immunity and phagocytosis. In human, the function and biological significance of TM9SF4 are currently under investigation. However, TM9SF4 was found overexpressed in human metastatic melanoma and in a small subset of acute myeloid leukemia (AMLs) and myelodysplastic syndromes, consistent with an oncogenic function of this gene. Purpose and Results In this study, we first analyzed the expression and regulation of TM9SF4 in normal and leukemic cells and identified TM9SF4 as a gene highly expressed in human quiescent CD34(+) hematopoietic progenitor cells (HPCs), regulated during monocytic and granulocytic differentiation of HPCs, both lineages giving rise to mature myeloid cells involved in adhesion, phagocytosis and immunity. Then, we found that TM9SF4 is markedly overexpressed in leukemic cells and in AMLs, particularly in M2, M3 and M4 AMLs (i.e., in AMLs characterized by the presence of a more or less differentiated granulocytic progeny), as compared to normal CD34+ HPCs. Proliferation and differentiation of HPCs occurs in hypoxia, a physiological condition in bone marrow, but also a crucial component of cancer microenvironment. Here, we investigated the impact of hypoxia on TM9SF4 expression in leukemic cells and identified TM9SF4 as a direct target of HIF-1 alpha, downregulated in these cells by hypoxia. Then, we found that the hypoxia-mediated downregulation of TM9SF4 expression is associated with a decrease of cell adhesion of leukemic cells to fibronectin, thus demonstrating that human TM9SF4 is a new molecule involved in leukemic cell adhesion. Conclusions Altogether, our study reports for the first time the expression of TM9SF4 at the level of normal and leukemic hematopoietic cells and its marked expression at the level of AMLs displaying granulocytic differentiation.	[Paolillo, Rosa; Spinello, Isabella; Quaranta, Maria Teresa; Pasquini, Luca; Pelosi, Elvira; Testa, Ugo; Labbaye, Catherine] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; [Lo Coco, Francesco] Univ Roma Tor Vergata, Dept Biomed & Prevent, Rome, Italy; [Lo Coco, Francesco] Fdn Santa Lucia, Rome, Italy	Istituto Superiore di Sanita (ISS); University of Rome Tor Vergata; IRCCS Santa Lucia	Labbaye, C (corresponding author), Ist Super Sanita, Dept Hematol Oncol & Mol Med, Viale Regina Elena 299, I-00161 Rome, Italy.	catherine.labbaye@iss.it	Labbaye, Catherine/J-9930-2016; Testa, Ugo/J-6472-2016; SPINELLO, ISABELLA/J-8779-2016; Quaranta, Maria Teresa/AAC-2134-2019; pelosi, elvira/J-7298-2016; pasquini, luca/J-8319-2016	Testa, Ugo/0000-0001-7900-8942; Quaranta, Maria Teresa/0000-0002-5886-507X; pelosi, elvira/0000-0002-3043-6249; pasquini, luca/0000-0002-3484-6288; Labbaye, Catherine/0000-0003-1255-4396	Italian Ministry of Health [RF-2010-2312222]; Lady Tata Memorial Trust Foundation	Italian Ministry of Health(Ministry of Health, Italy); Lady Tata Memorial Trust Foundation	This study was supported by institutional grant from the Italian Ministry of Health to C.L (RF-2010-2312222). R.P was supported by fellowship from the Lady Tata Memorial Trust Foundation (2012-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benghezal M, 2003, MOL BIOL CELL, V14, P2890, DOI 10.1091/mbc.E02-11-0724; Bergeret E, 2008, J CELL SCI, V121, P3325, DOI 10.1242/jcs.030163; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Brahimi-Horn MC, 2009, J CELL SCI, V122, P1055, DOI 10.1242/jcs.035022; Chen Y, 2012, BLOOD, V119, P4971, DOI 10.1182/blood-2011-11-389957; Chluba-de Tapia J, 1997, GENE, V197, P195, DOI 10.1016/S0378-1119(97)00263-1; Cornillon S, 2000, J BIOL CHEM, V275, P34287, DOI 10.1074/jbc.M006725200; Ding H, 2014, INT J BIOL SCI, V10, P746, DOI 10.7150/ijbs.8535; Fais S, 2007, CANCER LETT, V258, P155, DOI 10.1016/j.canlet.2007.09.014; Felli N, 2009, HAEMATOL-HEMATOL J, V94, P479, DOI 10.3324/haematol.2008.002345; Fiegl M, 2009, BLOOD, V113, P1504, DOI 10.1182/blood-2008-06-161539; Fontana L, 2007, NAT CELL BIOL, V9, P775, DOI 10.1038/ncb1613; Froquet R, 2008, J BIOL CHEM, V283, P6764, DOI 10.1074/jbc.M704484200; Froquet R, 2012, MOL BIOL CELL, V23, P679, DOI 10.1091/mbc.E11-04-0338; Gezer D, 2014, STEM CELLS, V32, P1390, DOI 10.1002/stem.1657; He PF, 2009, AUTOPHAGY, V5, P52, DOI 10.4161/auto.5.1.7247; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Hughes PJ, 2010, LEUKEMIA RES, V34, P553, DOI 10.1016/j.leukres.2009.09.010; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Irving P, 2005, CELL MICROBIOL, V7, P335, DOI 10.1111/j.1462-5822.2004.00462.x; Jian P, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-20; Jing DH, 2012, HAEMATOL-HEMATOL J, V97, P331, DOI 10.3324/haematol.2011.050815; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Klamer S, 2014, CELL ADHES MIGR, V8, P563, DOI 10.4161/19336918.2014.968501; Konopleva MY, 2011, J CLIN ONCOL, V29, P591, DOI 10.1200/JCO.2010.31.0904; Labbaye C, 2008, NAT CELL BIOL, V10, P788, DOI 10.1038/ncb1741; Lane SW, 2011, BLOOD, V118, P2849, DOI 10.1182/blood-2011-03-345165; Lane SW, 2009, BLOOD, V114, P1150, DOI 10.1182/blood-2009-01-202606; Lozupone F, 2015, ONCOGENE, V34, P5163, DOI 10.1038/onc.2014.437; Lozupone F, 2009, EMBO REP, V10, P1348, DOI 10.1038/embor.2009.236; Lugini L, 2006, CANCER RES, V66, P3629, DOI 10.1158/0008-5472.CAN-05-3204; Lulli V, 2010, HAEMATOLOGICA, V95, P1663; MacKinnon RN, 2010, GENE CHROMOSOME CANC, V49, P998, DOI 10.1002/gcc.20806; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Mendelson A, 2014, NAT MED, V20, P833, DOI 10.1038/nm.3647; Osawa T, 2013, CELL CYCLE, V12, P2519, DOI 10.4161/cc.25729; Park D, 2012, FRONT BIOSCI-LANDMRK, V17, P30, DOI 10.2741/3913; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Pollard PJ, 2010, CELL STEM CELL, V7, P276, DOI 10.1016/j.stem.2010.08.006; Pollard PJ, 2008, BIOCHEM J, V416, P387, DOI 10.1042/BJ20081238; Pruvot B, 2010, IMMUNOGENETICS, V62, P681, DOI 10.1007/s00251-010-0472-x; Sahin AO, 2012, CELL ADHES MIGR, V6, P39, DOI 10.4161/cam.18975; Semenza GL, 1997, KIDNEY INT, V51, P553, DOI 10.1038/ki.1997.77; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; SINGERKRUGER B, 1993, J BIOL CHEM, V268, P14376; Spinello I, 2011, BLOOD CANCER J, V1, DOI 10.1038/bcj.2011.24; Spinello I, 2009, ONCOGENE, V28, P2276, DOI 10.1038/onc.2009.87; Sugasawa T, 2001, GENE, V273, P227, DOI 10.1016/S0378-1119(01)00587-X; Wheaton WW, 2011, AM J PHYSIOL-CELL PH, V300, pC385, DOI 10.1152/ajpcell.00485.2010; Williams MJ, 2005, GENES CELLS, V10, P813, DOI 10.1111/j.1365-2443.2005.00883.x; Zhuang S, 2008, DEV COMP IMMUNOL, V32, P365, DOI 10.1016/j.dci.2007.07.007	51	11	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126968	10.1371/journal.pone.0126968	http://dx.doi.org/10.1371/journal.pone.0126968			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961573	gold, Green Published, Green Submitted			2022-12-26	WOS:000354542500165
J	Airoldi, CA; Mckay, M; Davies, B				Airoldi, Chiara A.; Mckay, Mary; Davies, Brendan			MAF2 Is Regulated by Temperature-Dependent Splicing and Represses Flowering at Low Temperatures in Parallel with FLM	PLOS ONE			English	Article							SERINE/ARGININE-RICH PROTEINS; ARABIDOPSIS-THALIANA; CIRCADIAN CLOCK; AMBIENT-TEMPERATURE; MESSENGER-RNAS; GENE FAMILY; TIME; TRANSCRIPTION; RESPONSES; EXPRESSION	Plants enter their reproductive phase when the environmental conditions are favourable for the successful production of progeny. The transition from vegetative to reproductive phase is influenced by several environmental factors including ambient temperature. In the model plant Arabidopsis thaliana, SHORT VEGETATIVE PHASE (SVP) is critical for this pathway; svp mutants cannot modify their flowering time in response to ambient temperature. SVP encodes a MADS-box transcription factor that directly represses genes that promote flowering. SVP binds DNA in complexes with other MADS-box transcription factors, including FLOWERING LOCUS M (FLM), which acts with SVP to repress the floral transition at low temperatures. Small temperature changes post-transcriptionally regulate FLM through temperature- dependent alternative splicing (TD-AS). As ambient temperature increases, the predominant FLM splice isoform shifts to encode a protein incapable of exerting a repressive effect on flowering. Here we characterize a closely related MADS-box transcription factor, MADS AFFECTING FLOWERING2 (MAF2), which has independently evolved TD-AS. At low temperatures the most abundant MAF2 splice variant encodes a protein that interacts with SVP to repress flowering. At increased temperature the relative abundance of splice isoforms shifts in favour of an intron-retaining variant that introduces a premature termination codon. We show that this isoform encodes a protein that cannot interact with SVP or repress flowering. At lower temperatures MAF2 and SVP repress flowering in parallel with FLM and SVP, providing an additional input to sense ambient temperature for the control of flowering.	[Airoldi, Chiara A.; Mckay, Mary; Davies, Brendan] Univ Leeds, Ctr Plant Sci, Leeds, W Yorkshire, England	University of Leeds	Davies, B (corresponding author), Univ Leeds, Ctr Plant Sci, Leeds, W Yorkshire, England.	b.h.davies@leeds.ac.uk		Airoldi, Chiara/0000-0003-3749-0974; Davies, Brendan/0000-0002-9282-3789	BBSRC/ERA-CAPS award (BLOOMNET) [BB/G024995/1]; BBSRC [BB/M000338/1, BB/G024995/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G024995/1, BB/M000338/1] Funding Source: researchfish	BBSRC/ERA-CAPS award (BLOOMNET); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by a BBSRC/ERA-CAPS award to BD (BLOOMNET, BB/G024995/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali GS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000471; Arciga-Reyes L, 2006, PLANT J, V47, P480, DOI 10.1111/j.1365-313X.2006.02802.x; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Balasubramanian S, 2006, PLOS GENET, V2, P980, DOI 10.1371/journal.pgen.0020106; Bensmihen S, 2004, FEBS LETT, V561, P127, DOI 10.1016/S0014-5793(04)00148-6; Blazquez MA, 2003, NAT GENET, V33, P168, DOI 10.1038/ng1085; Choi K, 2011, PLANT CELL, V23, P289, DOI 10.1105/tpc.110.075911; de Folter S, 2005, PLANT CELL, V17, P1424, DOI 10.1105/tpc.105.031831; de Montaigu A, 2010, TRENDS GENET, V26, P296, DOI 10.1016/j.tig.2010.04.003; Fornara F, 2010, CELL, V141, DOI 10.1016/j.cell.2010.04.024; Fung RWM, 2006, J PLANT PHYSIOL, V163, P1049, DOI 10.1016/j.jplph.2005.11.003; Gazzani S, 2003, PLANT PHYSIOL, V132, P1107, DOI 10.1104/pp.103.021212; Geraldo N, 2009, PLANT PHYSIOL, V150, P1611, DOI 10.1104/pp.109.137448; Gu XF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2947; Helliwell CA, 2006, PLANT J, V46, P183, DOI 10.1111/j.1365-313X.2006.02686.x; James AB, 2012, PLANT SIGNAL BEHAV, V7, P1219, DOI 10.4161/psb.21491; James AB, 2012, PLANT CELL, V24, P961, DOI 10.1105/tpc.111.093948; Jeon J, 2011, MOL CELLS, V32, P227, DOI 10.1007/s10059-011-1022-6; Jung JH, 2007, PLANT CELL, V19, P2736, DOI 10.1105/tpc.107.054528; Jung JH, 2012, J BIOL CHEM, V287, P16007, DOI 10.1074/jbc.M111.337485; Kumar SV, 2012, NATURE, V484, P242, DOI 10.1038/nature10928; Kumar SV, 2010, CELL, V140, P136, DOI 10.1016/j.cell.2009.11.006; Lazar G, 2000, PLANT MOL BIOL, V42, P571, DOI 10.1023/A:1006394207479; Lee H, 2010, NUCLEIC ACIDS RES, V38, P3081, DOI 10.1093/nar/gkp1240; Lee JH, 2007, GENE DEV, V21, P397, DOI 10.1101/gad.1518407; Lee JH, 2013, SCIENCE, V342, P628, DOI 10.1126/science.1241097; Lempe J, 2005, PLOS GENET, V1, P109, DOI 10.1371/journal.pgen.0010006; Li D, 2008, DEV CELL, V15, P110, DOI 10.1016/j.devcel.2008.05.002; Lopato S, 1999, GENE DEV, V13, P987, DOI 10.1101/gad.13.8.987; MA H, 1991, GENE DEV, V5, P484, DOI 10.1101/gad.5.3.484; Mathieu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000148; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Palusa SG, 2007, PLANT J, V49, P1091, DOI 10.1111/j.1365-313X.2006.03020.x; Park MJ, 2012, PLANT SIGNAL BEHAV, V7, P1194, DOI 10.4161/psb.21300; Pose D, 2013, NATURE, V503, P414, DOI 10.1038/nature12633; Quesada V, 2003, EMBO J, V22, P3142, DOI 10.1093/emboj/cdg305; Rataj K, 2014, J EXP BOT, V65, P353, DOI 10.1093/jxb/ert439; Ratcliffe OJ, 2003, PLANT CELL, V15, P1159, DOI 10.1105/tpc.009506; Rayson S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031917; Reddy ASN, 2011, WIRES RNA, V2, P875, DOI 10.1002/wrna.98; Rosloski SM, 2013, PLANT MOL BIOL, V81, P57, DOI 10.1007/s11103-012-9982-2; Rosloski SM, 2010, GENETICS, V186, P263, DOI 10.1534/genetics.110.116392; Salome PA, 2011, GENETICS, V188, P421, DOI 10.1534/genetics.111.126607; Scortecci K, 2003, PLANT MOL BIOL, V52, P915, DOI 10.1023/A:1025426920923; Seo PJ, 2013, PLANTA, V237, P1415, DOI 10.1007/s00425-013-1882-4; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Simpson GG, 2003, CELL, V113, P777, DOI 10.1016/S0092-8674(03)00425-2; Smaczniak C, 2012, P NATL ACAD SCI USA, V109, P1560, DOI 10.1073/pnas.1112871109; Song J, 2013, CURR BIOL, V23, pR807, DOI 10.1016/j.cub.2013.07.027; Srikanth A, 2011, CELL MOL LIFE SCI, V68, P2013, DOI 10.1007/s00018-011-0673-y; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Tanabe N, 2007, PLANT CELL PHYSIOL, V48, P1036, DOI 10.1093/pcp/pcm069; Verhage L, 2014, TRENDS PLANT SCI, V19, P583, DOI 10.1016/j.tplants.2014.03.009; Yang YZ, 2004, PLANT MOL BIOL, V55, P45, DOI 10.1007/s11103-004-0416-7; Yoo SK, 2005, PLANT PHYSIOL, V139, P770, DOI 10.1104/pp.105.066928	55	54	61	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0126516	10.1371/journal.pone.0126516	http://dx.doi.org/10.1371/journal.pone.0126516			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955034	gold, Green Published			2022-12-26	WOS:000356768100125
J	Banerjee, S; Khajanchi, S; Chaudhuri, S				Banerjee, Sandip; Khajanchi, Subhas; Chaudhuri, Swapna			A Mathematical Model to Elucidate Brain Tumor Abrogation by Immunotherapy with T11 Target Structure	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; CD8(+) T-CELLS; ADJUVANT TEMOZOLOMIDE; GLIOMA GROWTH; GLIOBLASTOMA; RADIOTHERAPY; IMMUNOSUPPRESSION; CLASSIFICATION; CHEMOTHERAPY; LYMPHOCYTES	T11 Target structure (T11TS), a membrane glycoprotein isolated from sheep erythrocytes, reverses the immune suppressed state of brain tumor induced animals by boosting the functional status of the immune cells. This study aims at aiding in the design of more efficacious brain tumor therapies with T11 target structure. We propose a mathematical model for brain tumor (glioma) and the immune system interactions, which aims in designing efficacious brain tumor therapy. The model encompasses considerations of the interactive dynamics of glioma cells, macrophages, cytotoxic T-lymphocytes (CD8+ T-cells), TGF-beta, IFN-gamma and the T11TS. The system undergoes sensitivity analysis, that determines which state variables are sensitive to the given parameters and the parameters are estimated from the published data. Computer simulations were used for model verification and validation, which highlight the importance of T11 target structure in brain tumor therapy.	[Banerjee, Sandip; Khajanchi, Subhas] Indian Inst Technol, Dept Math, Roorkee 247667, Uttar Pradesh, India; [Chaudhuri, Swapna] Sch Trop Med, Dept Lab Med, Kolkata 700073, W Bengal, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee; Calcutta School of Tropical Medicine (CSTM)	Banerjee, S (corresponding author), Indian Inst Technol, Dept Math, Roorkee 247667, Uttar Pradesh, India.	sandofma@iitr.ac.in	Chaudhuri, Swapna/AAH-4210-2020; Chaudhuri, Swapna/AFK-9403-2022; Khajanchi, Subhas/X-1271-2019	Chaudhuri, Swapna/0000-0002-8924-8066; Chaudhuri, Swapna/0000-0002-8924-8066; Khajanchi, Subhas/0000-0002-6533-1121	Department of Science and Technology (DST) India [SR/S4/MS:627/09-1]	Department of Science and Technology (DST) India(Department of Science & Technology (India))	This work is financially supported by Department of Science and Technology (DST) India (grant no. SR/S4/MS:627/09-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandara S, 2007, CHEM ENG RES DES, V85, P1065, DOI 10.1205/cherd06238; BODMER S, 1989, J IMMUNOL, V143, P3222; Burgess PK, 1997, J NEUROPATH EXP NEUR, V56, P704; Chakrabarty SP, 2009, MATH BIOSCI, V219, P129, DOI 10.1016/j.mbs.2009.03.005; COFFEY RJ, 1987, J CLIN INVEST, V80, P750, DOI 10.1172/JCI113130; Eikenberry SE, 2009, CELL PROLIFERAT, V42, P511, DOI 10.1111/j.1365-2184.2009.00613.x; Fink M., 2006, MYAD FAST AUTOMATIC; Gomez GG, 2007, J IMMUNOTHER, V30, P261, DOI 10.1097/01.cji.0000211339.81211.25; Gutierrez M, 1999, VET IMMUNOL IMMUNOP, V71, P321, DOI 10.1016/S0165-2427(99)00106-3; Hickey WF, 2001, GLIA, V36, P118, DOI 10.1002/glia.1101; Kansal AR, 2000, J THEOR BIOL, V203, P367, DOI 10.1006/jtbi.2000.2000; Kim JJ, 1998, J CLIN INVEST, V102, P1112, DOI 10.1172/JCI3986; Kim Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028293; Kirkby NF, 2007, J THEOR BIOL, V245, P112, DOI 10.1016/j.jtbi.2006.09.007; KLEIHUES P, 1995, GLIA, V15, P211, DOI 10.1002/glia.440150303; Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215; Kronik N, 2008, CANCER IMMUNOL IMMUN, V57, P425, DOI 10.1007/s00262-007-0387-z; Laperriere N, 2002, RADIOTHER ONCOL, V64, P259, DOI 10.1016/S0167-8140(02)00078-6; Mansury Yuri, 2006, P573; Mukherjee Joydeep, 2002, Asian Pac J Cancer Prev, V3, P325; Paillard F, 2000, HUM GENE THER, V11, P657, DOI 10.1089/10430340050015554; PETERSON PK, 1992, AM J MED, V92, P262, DOI 10.1016/0002-9343(92)90075-M; Rosenberg SA, 2005, J IMMUNOL, V175, P6169, DOI 10.4049/jimmunol.175.9.6169; Sarkar S, 2004, CANCER BIOL THER, V3, P1121, DOI 10.4161/cbt.3.11.1214; Schmitz JE, 2002, COMPUT MATH METHOD M, V4, P223, DOI [DOI 10.1080/1027366031000086674, 10.1080/1027366031000086674]; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Sud D, 2006, J IMMUNOL, V176, P4296, DOI 10.4049/jimmunol.176.7.4296; Swanson KR, 2000, CELL PROLIFERAT, V33, P317, DOI 10.1046/j.1365-2184.2000.00177.x; Swanson KR, 2004, DISCRETE CONT DYN-B, V4, P289; Swanson KR, 2003, MATH COMPUT MODEL, V37, P1177, DOI 10.1016/S0895-7177(03)00129-8; Swanson KR, 2002, ACTA BIOTHEOR, V50, P223, DOI 10.1023/A:1022644031905; Swanson KR, 2002, BRIT J CANCER, V86, P14, DOI 10.1038/sj.bjc.6600021; Taylor GP, 1999, J VIROL, V73, P10289, DOI 10.1128/JVI.73.12.10289-10295.1999; Toma A, 2013, CURR MED IMAGING, V9, P145, DOI 10.2174/1573405611309020010; TRACQUI P, 1995, CELL PROLIFERAT, V28, P17, DOI 10.1111/j.1365-2184.1995.tb00036.x; Turner PK, 2004, CANCER CHEMOTH PHARM, V53, P253, DOI 10.1007/s00280-003-0723-8; Visser KE, 1999, LEUKEMIA, V13, P1188, DOI [DOI 10.1038/SJ.LEU.2401477, 10.1038/sj.leu.2401477]; Walker WL, 1996, B MATH BIOL, V58, P1047; Wick WD, 2005, J VIROL, V79, P13579, DOI 10.1128/JVI.79.21.13579-13586.2005; Woodward DE, 1996, CELL PROLIFERAT, V29, P269, DOI 10.1111/j.1365-2184.1996.tb01580.x; WURZEL M, 2005, J THEOR MED, V6, P21, DOI DOI 10.1080/1027366042000334144	42	48	50	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0123611	10.1371/journal.pone.0123611	http://dx.doi.org/10.1371/journal.pone.0123611			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955428	Green Published, Green Submitted, gold			2022-12-26	WOS:000356768100019
J	Tang, QY; Larry, T; Hendra, K; Yamamoto, E; Bell, J; Cui, M; Logothetis, DE; Boland, LM				Tang, Qiong-Yao; Larry, Trevor; Hendra, Kalen; Yamamoto, Erica; Bell, Jessica; Cui, Meng; Logothetis, Diomedes E.; Boland, Linda M.			Mutations in Nature Conferred a High Affinity Phosphatidylinositol 4,5-Bisphosphate-binding Site in Vertebrate Inwardly Rectifying Potassium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIP2 REGULATION; AMPHIMEDON-QUEENSLANDICA; STRUCTURAL DETERMINANTS; KIR CHANNELS; K+ CHANNELS; EVOLUTION; GENOME; MODULATION; SPONGE; GENES	All vertebrate inwardly rectifying potassium (Kir) channels are activated by phosphatidylinositol 4,5-bisphosphate (PIP2) (Logothetis, D. E., Petrou, V. I., Zhang, M., Mahajan, R., Meng, X. Y., Adney, S. K., Cui, M., and Baki, L. (2015) Annu. Rev. Physiol. 77, 81-104; Furst, O., Mondou, B., and D'Avanzo, N. (2014) Front. Physiol. 4, 404-404). Structural components of a PIP2-binding site are conserved in vertebrate Kir channels but not in distantly related animals such as sponges and sea anemones. To expand our understanding of the structure-function relationships of PIP2 regulation of Kir channels, we studied AqKir, which was cloned from the marine sponge Amphimedon queenslandica, an animal that represents the phylogenetically oldest metazoans. A requirement for PIP2 in the maintenance of AqKir activity was examined in intact oocytes by activation of a co-expressed voltage-sensing phosphatase, application of wortmannin (at micromolar concentrations), and activation of a co-expressed muscarinic acetylcholine receptor. All three mechanisms to reduce the availability of PIP2 resulted in inhibition of AqKir current. However, time-dependent rundown of AqKir currents in inside-out patches could not be re-activated by direct application to the inside membrane surface of water-soluble dioctanoyl PIP2, and the current was incompletely re-activated by the more hydrophobic arachidonyl stearyl PIP2. When we introduced mutations to AqKir to restore two positive charges within the vertebrate PIP2-binding site, both forms of PIP2 strongly re-activated the mutant sponge channels in inside-out patches. Molecular dynamics simulations validate the additional hydrogen bonding potential of the sponge channel mutants. Thus, nature's mutations conferred a high affinity activation of vertebrate Kir channels by PIP2, and this is a more recent evolutionary development than the structures that explain ion channel selectivity and inward rectification.	[Tang, Qiong-Yao; Cui, Meng; Logothetis, Diomedes E.] Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Richmond, VA 23298 USA; [Tang, Qiong-Yao; Cui, Meng; Logothetis, Diomedes E.] XuZhou Med Coll, Jiangsu Prov Key Lab Anesthesiol, Xuzhou 221004, Jiangsu, Peoples R China; [Tang, Qiong-Yao; Cui, Meng; Logothetis, Diomedes E.] XuZhou Med Coll, Jiangsu Prov Key Lab Anesthesia & Analgesia Appli, Xuzhou 221004, Jiangsu, Peoples R China; [Bell, Jessica] Univ San Diego, Dept Chem & Biochem, San Diego, CA 92110 USA; [Larry, Trevor; Hendra, Kalen; Yamamoto, Erica; Boland, Linda M.] Univ Richmond, Dept Biol, Richmond, VA 23173 USA	Virginia Commonwealth University; Xuzhou Medical University; Xuzhou Medical University; University of San Diego; University of Richmond	Boland, LM (corresponding author), Univ Richmond, Dept Biol, B-100 Gottwald Sci Ctr, Richmond, VA 23173 USA.	lboland@richmond.edu		Hendra, Kalen/0000-0001-7625-8102; Boland, Linda/0000-0002-6172-1704	National Institutes of Health from NCCR [R15-GM096142, HL059949, HL090882, S10RR027411]; Jiangsu Specially Appointed Professor Program [53051117]; University of Richmond School of Arts and Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027411] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059949, R01HL090882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM096142] Funding Source: NIH RePORTER	National Institutes of Health from NCCR; Jiangsu Specially Appointed Professor Program; University of Richmond School of Arts and Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R15-GM096142 (to L.M. B.), HL059949 and HL090882 (to D. E. L.), and S10RR027411 from NCCR (to M. C.). This work was also supported by Grant 53051117 from the Jiangsu Specially Appointed Professor Program (to Q. Y. T.), undergraduate summer fellowships from the University of Richmond School of Arts and Sciences (to K. H. and E. Y.), and an undergraduate research grant from the University of Richmond School of Arts and Sciences (to E. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Boland LM, 2008, CELL BIOCHEM BIOPHYS, V52, P59, DOI 10.1007/s12013-008-9027-2; D'Avanzo N, 2010, J BIOL CHEM, V285, P37129, DOI 10.1074/jbc.C110.186692; D'Avanzo N, 2010, CHANNELS, V4, P139, DOI 10.4161/chan.4.3.12129; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Du XO, 2004, J BIOL CHEM, V279, P37271, DOI 10.1074/jbc.M403413200; Enkvetchakul D, 2005, J BIOL CHEM, V280, P35785, DOI 10.1074/jbc.C500355200; Falkenburger BH, 2010, J PHYSIOL-LONDON, V588, P3179, DOI 10.1113/jphysiol.2010.192153; Furst O, 2014, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00404; Halaszovich CR, 2009, J BIOL CHEM, V284, P2106, DOI 10.1074/jbc.M803543200; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JEGLA T, 1994, SOC GEN PHY, V49, P213; Jegla TJ, 2009, COMB CHEM HIGH T SCR, V12, P2, DOI 10.2174/138620709787047957; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Knoll AH, 2011, ANNU REV EARTH PL SC, V39, P217, DOI 10.1146/annurev.earth.031208.100209; Koyanagi M, 1998, FEBS LETT, V439, P66, DOI 10.1016/S0014-5793(98)01339-8; Larroux C, 2011, M S-MED SCI, V27, P138, DOI 10.1051/medsci/2011272138; Liu LJ, 2012, NAT STRUCT MOL BIOL, V19, P633, DOI 10.1038/nsmb.2289; Logothetis DE, 2007, PFLUG ARCH EUR J PHY, V455, P83, DOI 10.1007/s00424-007-0276-5; Logothetis DE, 2007, PFLUG ARCH EUR J PHY, V455, P1, DOI 10.1007/s00424-007-0311-6; Logothetis DE, 2007, J PHYSIOL-LONDON, V582, P953, DOI 10.1113/jphysiol.2007.133157; Logothetis DE, 2015, ANNU REV PHYSIOL, V77, P81, DOI 10.1146/annurev-physiol-021113-170358; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Meng XY, 2012, BIOPHYS J, V102, P2049, DOI 10.1016/j.bpj.2012.03.050; Muller WEG, 2001, GENE, V276, P161, DOI 10.1016/S0378-1119(01)00669-2; Murata Y, 2007, J PHYSIOL-LONDON, V583, P875, DOI 10.1113/jphysiol.2007.134775; NAKANISHI S, 1995, P NATL ACAD SCI USA, V92, P5317, DOI 10.1073/pnas.92.12.5317; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Pian P, 2006, J GEN PHYSIOL, V128, P593, DOI 10.1085/jgp.200609648; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Rohacs T, 2002, METHOD ENZYMOL, V345, P71; Rohacs T, 1999, J BIOL CHEM, V274, P36065, DOI 10.1074/jbc.274.51.36065; Sakarya O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000506; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Schulze D, 2003, J BIOL CHEM, V278, P10500, DOI 10.1074/jbc.M208413200; Shyng SL, 2000, J GEN PHYSIOL, V116, P599, DOI 10.1085/jgp.116.5.599; Soom M, 2001, FEBS LETT, V490, P49, DOI 10.1016/S0014-5793(01)02136-6; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Suh BC, 2007, J GEN PHYSIOL, V130, P241, DOI 10.1085/jgp.200709821; Suh BC, 2012, P NATL ACAD SCI USA, V109, P3161, DOI 10.1073/pnas.1121434109; Tang QY, 2014, J BIOL CHEM, V289, P18860, DOI 10.1074/jbc.M113.538033; Tang QY, 2010, J BIOL CHEM, V285, P19259, DOI 10.1074/jbc.M109.100156; Tang QY, 2009, J GEN PHYSIOL, V134, P409, DOI 10.1085/jgp.200910251; Telezhkin V, 2012, J BIOL CHEM, V287, P10001, DOI 10.1074/jbc.M111.322552; Tompkins-MacDonald GJ, 2009, J EXP BIOL, V212, P761, DOI 10.1242/jeb.026971; Wang SZ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1625; Wells GD, 2012, J EXP BIOL, V215, P2435, DOI 10.1242/jeb.066233; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046	52	12	12	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16517	16529		10.1074/jbc.M115.640409	http://dx.doi.org/10.1074/jbc.M115.640409			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25957411	Green Published, hybrid			2022-12-26	WOS:000357572800005
J	Zeng, LQ; Wei, HF; Liu, YJ; Zhang, W; Pan, Y; Zhang, W; Zhang, CQ; Zeng, BF; Chen, YF				Zeng, Langqing; Wei, Haifeng; Liu, Yanjie; Zhang, Wen; Pan, Yao; Zhang, Wei; Zhang, Changqing; Zeng, Bingfang; Chen, Yunfeng			Titanium Elastic Nail (TEN) versus Reconstruction Plate Repair of Midshaft Clavicular Fractures: A Finite Element Study	PLOS ONE			English	Article							MIDCLAVICULAR FRACTURES; BIOMECHANICAL ANALYSIS; FIXATION; COMPLICATIONS; STABILITY	Background The biomechanical characteristics of midshaft clavicular fractures treated with titanium elastic nail (TEN) is unclear. This study aimed to present a biomechanical finite element analysis of biomechanical characteristics involved in TEN fixation and reconstruction plate fixation for midshaft clavicular fractures. Methods Finite element models of the intact clavicle and of midshaft clavicular fractures fixed with TEN and with a reconstruction plate were built. The distal clavicle displacement, peak stress, and stress distribution on the 3 finite element models were calculated under the axial compression and cantilever bending. Results In both loading configurations, TEN generated the highest displacement of the distal clavicle, followed by the intact clavicle and the reconstruction plate. TEN showed higher peak bone and implant stresses, and is more likely to fail in both loading configurations compared with the reconstruction plate. TEN led to a stress distribution similar to that of the intact clavicle in both loading configurations, whereas the stress distribution with the reconstruction plate was nonphysiological in cantilever bending. Conclusions TEN is generally preferable for treating simple displaced fractures of the midshaft clavicle, because it showed a stress distribution similar to the intact clavicle. However, TEN provides less stability, and excessive exercise of and weight bearing on the ipsilateral shoulder should be avoided in the early postoperative period. Fixation with a reconstruction plate was more stable but showed obvious stress shielding. Therefore, for patients with a demand for early return to activity, reconstruction plate fixation may be preferred.	[Zeng, Langqing] Jinan Univ, Affiliated Zhuhai Hosp, Zhuhai Peoples Hosp, Dept Orthopaed, Guangzhou, Guangdong, Peoples R China; [Wei, Haifeng; Zhang, Wen; Pan, Yao; Zhang, Wei; Zhang, Changqing; Zeng, Bingfang; Chen, Yunfeng] Shanghai Jiao Tong Univ, Dept Orthopaed Surg, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China; [Liu, Yanjie] First Peoples Hosp Foshan, Dept Orthopaed, Guangzhou, Guangdong, Peoples R China	Jinan University; Shanghai Jiao Tong University	Chen, YF (corresponding author), Shanghai Jiao Tong Univ, Dept Orthopaed Surg, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China.	chenyunfeng1969@163.com						Andermahr J, 2007, CLIN ANAT, V20, P48, DOI 10.1002/ca.20269; Assobhi JEH, 2011, J ORTHOP TRAUMATOL, V12, P185, DOI 10.1007/s10195-011-0158-7; Brouwer Kim M, 2009, J Shoulder Elbow Surg, V18, pe22, DOI 10.1016/j.jse.2008.05.042; Canadian Orthopaedic Trauma Society, 2007, J BONE JOINT SURG AM, V89, P1, DOI DOI 10.2106/JBJS.F.00020; Celestre P, 2008, J ORTHOP TRAUMA, V22, P241, DOI 10.1097/BOT.0b013e31816c7bac; Chen YF, 2012, J SHOULDER ELB SURG, V21, P495, DOI 10.1016/j.jse.2011.03.007; Chen YF, 2010, CAN J SURG, V53, P379; Drosdowech DS, 2011, J ORTHOP TRAUMA, V25, P39, DOI 10.1097/BOT.0b013e3181d8893a; Favre P, 2011, J ORTHOP TRAUMA, V25, P661, DOI 10.1097/BOT.0b013e3182143e06; Frigg A, 2009, AM J SPORT MED, V37, P352, DOI 10.1177/0363546508328103; Golish S Raymond, 2008, J Orthop Surg Res, V3, P28, DOI 10.1186/1749-799X-3-28; HARRINGTON MA, 1993, J BIOMECH, V26, P417, DOI 10.1016/0021-9290(93)90005-Y; Houwert RM, 2012, INT ORTHOP, V36, P579, DOI 10.1007/s00264-011-1422-4; Hubner EJ, 2011, ACTA CHIR ORTHOP TR, V78, P288; Kabak S, 2004, J SHOULDER ELB SURG, V13, P396, DOI 10.1016/j.jse.2004.01.033; Kleweno CP, 2011, J SHOULDER ELB SURG, V20, P1114, DOI 10.1016/j.jse.2011.03.022; Kontautas E, 2012, MEDICINA-LITHUANIA, V48, P80, DOI 10.3390/medicina48020012; Little KJ, 2012, INJURY, V43, P921, DOI 10.1016/j.injury.2012.02.007; Liu PC, 2010, J ORTHOP TRAUMA, V24, P217, DOI 10.1097/BOT.0b013e3181b8ba33; NORDQVIST A, 1994, CLIN ORTHOP RELAT R, P127; Postacchini F, 2002, J SHOULDER ELB SURG, V11, P452, DOI 10.1067/mse.2002.126613; Robertson C, 2009, J SHOULDER ELB SURG, V18, P204, DOI 10.1016/j.jse.2008.10.002; Smith SD, 2014, KNEE SURG SPORT TR A, V22, P448, DOI 10.1007/s00167-013-2411-5; STANLEY D, 1988, J BONE JOINT SURG BR, V70, P461, DOI 10.1302/0301-620X.70B3.3372571; Stepanskiy L, 2007, J BIOMECH, V40, P1813, DOI 10.1016/j.jbiomech.2006.07.002; Tupis TM, 2012, CLIN BIOMECH, V27, P354, DOI 10.1016/j.clinbiomech.2011.11.002; van der Meijden OA, 2012, J SHOULDER ELB SURG, V21, P423, DOI 10.1016/j.jse.2011.08.053; Verborgt Olivier, 2005, Acta Orthop Belg, V71, P17; Werner CML, 2007, PLAST RECONSTR SURG, V120, P173, DOI 10.1097/01.prs.0000263537.57701.8b; Wijdicks FJG, 2012, ARCH ORTHOP TRAUM SU, V132, P617, DOI 10.1007/s00402-011-1456-5; Zlowodzki M, 2005, J ORTHOP TRAUMA, V19, P504, DOI 10.1097/01.bot.0000172287.44278.ef	31	17	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0126131	10.1371/journal.pone.0126131	http://dx.doi.org/10.1371/journal.pone.0126131			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965409	Green Published, Green Submitted, gold			2022-12-26	WOS:000354543500045
J	Zhang, YF; Kecskes, A; Copmans, D; Langlois, M; Crawford, AD; Ceulemans, B; Lagae, L; de Witte, PAM; Esguerra, CV				Zhang, Yifan; Kecskes, Angela; Copmans, Danielle; Langlois, Melanie; Crawford, Alexander D.; Ceulemans, Berten; Lagae, Lieven; de Witte, Peter A. M.; Esguerra, Camila V.			Pharmacological Characterization of an Antisense Knockdown Zebrafish Model of Dravet Syndrome: Inhibition of Epileptic Seizures by the Serotonin Agonist Fenfluramine	PLOS ONE			English	Article							SEVERE MYOCLONIC EPILEPSY; FEBRILE SEIZURES; MOUSE MODEL; INFANCY; STIRIPENTOL; INTERNEURONS; EXPRESSION; CHILDREN; CHANNELS; THERAPY	Dravet syndrome (DS) is one of the most pharmacoresistant and devastating forms of childhood epilepsy syndromes. Distinct de novo mutations in the SCN1A gene are responsible for over 80% of DS cases. While DS is largely resistant to treatment with existing anti-epileptic drugs, promising results have been obtained in clinical trials with human patients treated with the serotonin agonist fenfluramine as an add-on therapeutic. We developed a zebrafish model of DS using morpholino antisense oligomers (MOs) targeting scn1Lab, the zebrafish ortholog of SCN1A. Zebrafish larvae with an antisense knockdown of scn1Lab (scn1Lab morphants) were characterized by automated behavioral tracking and high-resolution video imaging, in addition to measuring brain activity through local field potential recordings. Our findings reveal that scn1Lab morphants display hyperactivity, convulsive seizure-like behavior, loss of posture, repetitive jerking and a myoclonic seizure-like pattern. The occurrence of spontaneous seizures was confirmed by local field potential recordings of the forebrain, measuring epileptiform discharges. Furthermore, we show that these larvae are remarkably sensitive to hyperthermia, similar to what has been described for mouse models of DS, as well as for human DS patients. Pharmacological evaluation revealed that sodium valproate and fenfluramine significantly reduce epileptiform discharges in scn1Lab morphants. Our findings for this zebrafish model of DS are in accordance with clinical data for human DS patients. To our knowledge, this is the first study demonstrating effective seizure inhibition of fenfluramine in an animal model of Dravet syndrome. Moreover, these results provide a basis for identifying novel analogs with improved activity and significantly milder or no side effects.	[Zhang, Yifan; Kecskes, Angela; Copmans, Danielle; Crawford, Alexander D.; de Witte, Peter A. M.; Esguerra, Camila V.] Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Lab Mol Biodiscovery, Leuven, Belgium; [Langlois, Melanie; Crawford, Alexander D.] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Esch Sur Alzette, Luxembourg; [Ceulemans, Berten] Univ Antwerp Hosp, Dept Neurol Child Neurol, Antwerp, Belgium; [Ceulemans, Berten] Univ Antwerp, B-2020 Antwerp, Belgium; [Lagae, Lieven] Univ Hosp Leuven, Dept Paediat Neurol, Leuven, Belgium	KU Leuven; University of Luxembourg; University of Antwerp; University of Antwerp; KU Leuven; University Hospital Leuven	de Witte, PAM (corresponding author), Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Lab Mol Biodiscovery, Leuven, Belgium.	peter.dewitte@pharm.kuleuven.be	Esguerra, Camila/N-6159-2015; Copmans, Daniëlle/K-7571-2018	Esguerra, Camila/0000-0002-2271-8094; Copmans, Daniëlle/0000-0002-9804-8410; de Witte, Peter/0000-0002-9989-9567; Zhang, Yifan/0000-0003-0916-1073; Ceulemans, Berten/0000-0001-7818-0679	Agency for Innovation by Science and Technology (IWT, Flanders) [111200]; LCSB KT program	Agency for Innovation by Science and Technology (IWT, Flanders)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); LCSB KT program	A.K. is a recipient of a PhD fellowship from the Agency for Innovation by Science and Technology (project nr 111200, IWT, Flanders). M.L. was supported by the LCSB KT program. C.V.E. is an Industrial Research Fund mandate holder of the KU Leuven. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrikanova T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054166; Baraban SC, 2005, NEUROSCIENCE, V131, P759, DOI 10.1016/j.neuroscience.2004.11.031; Baraban SC, 2013, JOVE-J VIS EXP, DOI 10.3791/50104; Baraban SC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3410; Bialer M, 2010, NAT REV DRUG DISCOV, V9, P68, DOI 10.1038/nrd2997; Ceulemans B, 2012, EPILEPSIA, V53, P1131, DOI 10.1111/j.1528-1167.2012.03495.x; Chiron C, 2000, LANCET, V356, P1638, DOI 10.1016/S0140-6736(00)03157-3; Chiron C, 2013, CNS DRUGS, V27, P185, DOI 10.1007/s40263-012-0035-9; Chiron C, 2011, DEV MED CHILD NEUROL, V53, P16, DOI 10.1111/j.1469-8749.2011.03967.x; Chiron C, 2011, EPILEPSIA, V52, P72, DOI 10.1111/j.1528-1167.2011.03007.x; Choy M, 2014, EPILEPSY CURR, V14, P15, DOI 10.5698/1535-7511-14.s2.15; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; Dravet C, 2011, EPILEPSIA, V52, P3, DOI 10.1111/j.1528-1167.2011.02994.x; Dube CM, 2007, TRENDS NEUROSCI, V30, P490, DOI 10.1016/j.tins.2007.07.006; Elangbam CS, 2010, TOXICOL PATHOL, V38, P837, DOI 10.1177/0192623310378027; Guerrini Renzo, 2012, Eur J Paediatr Neurol, V16 Suppl 1, pS1, DOI 10.1016/j.ejpn.2012.04.006; Hunt RF, 2012, EXP NEUROL, V237, P199, DOI 10.1016/j.expneurol.2012.06.013; Inoue Y, 2014, EPILEPSY RES, V108, P725, DOI 10.1016/j.eplepsyres.2014.02.008; Kim YO, 2014, DEV MED CHILD NEUROL, V56, P85, DOI 10.1111/dmcn.12322; Lindsey BW, 2010, ZEBRAFISH, V7, P85, DOI 10.1089/zeb.2009.0616; Marini C, 2011, EPILEPSIA, V52, P24, DOI 10.1111/j.1528-1167.2011.02997.x; Marsh ED, 2013, EXP NEUROL, V240, P108, DOI 10.1016/j.expneurol.2012.11.016; Novak AE, 2006, J MOL EVOL, V63, P208, DOI 10.1007/s00239-005-0287-9; Novak AE, 2006, DEV DYNAM, V235, P1962, DOI 10.1002/dvdy.20811; Oakley JC, 2011, EPILEPSIA, V52, P59, DOI 10.1111/j.1528-1167.2011.03004.x; Oakley JC, 2009, P NATL ACAD SCI USA, V106, P3994, DOI 10.1073/pnas.0813330106; Ogiwara I, 2007, J NEUROSCI, V27, P5903, DOI 10.1523/JNEUROSCI.5270-06.2007; Oguni H, 2001, BRAIN DEV-JPN, V23, P736, DOI 10.1016/S0387-7604(01)00276-5; Oguni Hirokazu, 2005, Adv Neurol, V95, P103; Patterson KP, 2014, NEUROTHERAPEUTICS, V11, P242, DOI 10.1007/s13311-014-0263-4; Perez J, 1999, EPILEPSIA, V40, P1618, DOI 10.1111/j.1528-1157.1999.tb02048.x; Rothman RB, 2008, EXP CLIN PSYCHOPHARM, V16, P458, DOI 10.1037/a0014103; Scheffer Ingrid E, 2012, Eur J Paediatr Neurol, V16 Suppl 1, pS5, DOI 10.1016/j.ejpn.2012.04.007; Schoonheim PJ, 2010, J NEUROSCI, V30, P7111, DOI 10.1523/JNEUROSCI.5193-09.2010; Schulte-Merker S, 2014, DEVELOPMENT, V141, P3103, DOI 10.1242/dev.112003; Smith BM, 2006, EXPERT OPIN INV DRUG, V15, P257, DOI 10.1517/13543784.15.3.257; Wilmshurst JM, 2014, NAT REV NEUROL, V10, P249, DOI 10.1038/nrneurol.2014.58; Yu FH, 2006, NAT NEUROSCI, V9, P1142, DOI 10.1038/nn1754	38	65	65	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0125898	10.1371/journal.pone.0125898	http://dx.doi.org/10.1371/journal.pone.0125898			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965391	Green Published, Green Submitted, gold			2022-12-26	WOS:000354543500032
J	Berthelier, V; Harris, JB; Estenson, KN; Baudry, J				Berthelier, Valerie; Harris, Jason Brett; Estenson, Kasey Noel; Baudry, Jerome			Discovery of an Inhibitor of Z-Alpha1 Antitrypsin Polymerization	PLOS ONE			English	Article							PREVENT CONFORMATIONAL DISEASE; ALPHA-1-ANTITRYPSIN DEFICIENCY; ALPHA(1)-ANTITRYPSIN DEFICIENCY; MOLECULAR-BASIS; LIVER-DISEASE; DRUG DESIGN; MECHANISM; POLYMERS; EMPHYSEMA; REVEALS	Polymerization of the Z variant alpha-1-antitrypsin (Z-alpha 1AT) results in the most common and severe form of alpha 1AT deficiency (alpha 1ATD), a debilitating genetic disorder whose clinical manifestations range from asymptomatic to fatal liver and/or lung disease. As the altered conformation of Z-alpha 1AT and its attendant aggregation are responsible for pathogenesis, the polymerization process per se has become a major target for the development of therapeutics. Based on the ability of Z-alpha 1AT to aggregate by recruiting the reactive center loop (RCL) of another Z-alpha 1AT into its s4A cavity, we developed a high-throughput screening assay that uses a modified 6-mer peptide mimicking the RCL to screen for inhibitors of Z-alpha 1AT polymer growth. A subset of compounds from the Library of Pharmacologically Active Compounds (LOPAC) with molecular weights ranging from 300 to 700 Da, was used to evaluate the assay's capabilities. The inhibitor S-(4-nitrobenzyl)-6-thioguanosine was identified as a lead compound and its ability to prevent Z-alpha 1AT polymerization confirmed by secondary assays. To further investigate the binding location of S-(4-nitrobenzyl)-6-thioguanosine, an in silico strategy was pursued and the intermediate alpha 1AT M* state modeled to allow molecular docking simulations and explore various potential binding sites. Docking results predict that S-(4-nitrobenzyl)-6-thioguanosine can bind at the s4A cavity and at the edge of beta-sheet A. The former binding site would directly block RCL insertion whereas the latter site would prevent beta-sheet A from expanding between s3A/s5A, and thus indirectly impede RCL insertion. Altogether, our investigations have revealed a novel compound that inhibits the formation of Z-alpha 1AT polymers, as well as in vitro and in silico strategies for identifying and characterizing additional blocking molecules of Z-alpha 1AT polymerization.	[Berthelier, Valerie; Estenson, Kasey Noel] Univ Tennessee, Dept Med, Hlth Sci Ctr, Grad Sch Med, Knoxville, TN 37996 USA; [Berthelier, Valerie; Harris, Jason Brett; Estenson, Kasey Noel; Baudry, Jerome] Univ Tennessee, UT ORNL Grad Sch Genome Sci & Technol, Knoxville, TN USA; [Baudry, Jerome] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN USA; [Harris, Jason Brett; Baudry, Jerome] Oak Ridge Natl Lab, UT ORNL Ctr Mol Biophys, Oak Ridge, TN USA	University of Tennessee System; University of Tennessee Health Science Center; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville	Berthelier, V (corresponding author), Univ Tennessee, Dept Med, Hlth Sci Ctr, Grad Sch Med, Knoxville, TN 37996 USA.	vberthel@utmck.edu; jbaudry@utk.edu	Harris, Jason/ABF-2684-2020	Harris, Jason/0000-0003-3642-5126	Alpha-1 Foundation's grant; Physicians' Medical Education and Research Foundation	Alpha-1 Foundation's grant; Physicians' Medical Education and Research Foundation	This work was supported by an Alpha-1 Foundation's grant [http://www.alpha1portal.org] to VB, and a grant from The Physicians' Medical Education and Research Foundation [http://www.utmedicalcenter.org/for-health-professionals/resources/physicians-medical-education-and-research-foundation/] to VB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam S, 2012, J HEPATOL, V57, P116, DOI 10.1016/j.jhep.2012.02.025; An JK, 2005, HEPATOLOGY, V41, P160, DOI 10.1002/hep.20508; [Anonymous], 2011, PLOS COMP; BRANTLY M, 1988, AM J MED, V84, P13; Burrows JAJ, 2000, P NATL ACAD SCI USA, V97, P1796, DOI 10.1073/pnas.97.4.1796; Cheng LS, 2008, J MED CHEM, V51, P3878, DOI 10.1021/jm8001197; Dafforn TR, 1999, J BIOL CHEM, V274, P9548, DOI 10.1074/jbc.274.14.9548; de Serres FJ, 2012, THER ADV RESPIR DIS, V6, P277, DOI 10.1177/1753465812457113; Devlin GL, 2001, AM J RESP CELL MOL, V24, P727, DOI 10.1165/ajrcmb.24.6.4407; Ekeowa UI, 2010, P NATL ACAD SCI USA, V107, P17146, DOI 10.1073/pnas.1004785107; Elliott PR, 2000, PROTEIN SCI, V9, P1274, DOI 10.1110/ps.9.7.1274; Elliott PR, 1998, AM J RESP CELL MOL, V18, P670, DOI 10.1165/ajrcmb.18.5.3065; ERIKSSON S, 1986, NEW ENGL J MED, V314, P736, DOI 10.1056/NEJM198603203141202; Gooptu B, 2000, P NATL ACAD SCI USA, V97, P67, DOI 10.1073/pnas.97.1.67; Gooptu B, 2014, TRENDS MOL MED, V20, P116, DOI 10.1016/j.molmed.2013.10.007; Gooptu B, 2009, J MOL BIOL, V387, P857, DOI 10.1016/j.jmb.2009.01.069; Gotzsche PC, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007851.pub2; Halgren TA, 1999, J COMPUT CHEM, V20, P720, DOI 10.1002/(SICI)1096-987X(199905)20:7<720::AID-JCC7>3.0.CO;2-X; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; HUSSAIN M, 1991, J INHERIT METAB DIS, V14, P497, DOI 10.1007/BF01797920; Labute P, 2008, J COMPUT CHEM, V29, P1693, DOI 10.1002/jcc.20933; Labute P, 2009, PROTEINS, V75, P187, DOI 10.1002/prot.22234; Leeson P, 2012, NATURE, V481, P455, DOI 10.1038/481455a; LOMAS DA, 1993, BIOCHEMISTRY-US, V32, P500, DOI 10.1021/bi00053a014; Lomas DA, 2002, NAT REV GENET, V3, P759, DOI 10.1038/nrg907; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; Lomas DA, 2000, RESP MED, V94, pS3, DOI 10.1053/rmed.2000.0850; Mahadeva R, 2002, J BIOL CHEM, V277, P6771, DOI 10.1074/jbc.C100722200; Mahadeva R, 2005, AM J PATHOL, V166, P377, DOI 10.1016/S0002-9440(10)62261-4; Makarananda K, 1992, Methods Mol Biol, V10, P267, DOI 10.1385/0-89603-204-3:267; Mallyat M, 2007, J MED CHEM, V50, P5357, DOI 10.1021/jm070687z; Miranda E, 2010, HEPATOLOGY, V52, P1078, DOI 10.1002/hep.23760; OGUSHI F, 1987, J CLIN INVEST, V80, P1366, DOI 10.1172/JCI113214; Parfrey H, 2003, J BIOL CHEM, V278, P33060, DOI 10.1074/jbc.M302646200; Parmar JS, 2002, AM J RESP CELL MOL, V26, P723, DOI 10.1165/ajrcmb.26.6.4739; Pearce MC, 2008, PROTEIN SCI, V17, P2127, DOI 10.1110/ps.037234.108; Perlmutter DH, 2011, ANNU REV MED, V62, P333, DOI 10.1146/annurev-med-042409-151920; Purkayastha P, 2005, BIOCHEMISTRY-US, V44, P2642, DOI 10.1021/bi048662e; Ramirez-Alvarado M, 2010, PROTEIN MISFOLDING D, P403; Teckman JH, 2004, J PEDIATR GASTR NUTR, V39, P34, DOI 10.1097/00005176-200407000-00007; Whisstock JC, 2006, CURR OPIN STRUC BIOL, V16, P761, DOI 10.1016/j.sbi.2006.10.005; Yamasaki M, 2008, NATURE, V455, P1255, DOI 10.1038/nature07394; Yamasaki M, 2011, EMBO REP, V12, P1011, DOI 10.1038/embor.2011.171	43	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126256	10.1371/journal.pone.0126256	http://dx.doi.org/10.1371/journal.pone.0126256			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961288	Green Submitted, gold, Green Published			2022-12-26	WOS:000354542500080
J	Hu, B; Simon, J; Gunthardt-Goerg, MS; Arend, M; Kuster, TM; Rennenberg, H				Hu, Bin; Simon, Judy; Guenthardt-Goerg, Madeleine S.; Arend, Matthias; Kuster, Thomas M.; Rennenberg, Heinz			Changes in the Dynamics of Foliar N Metabolites in Oak Saplings by Drought and Air Warming Depend on Species and Soil Type	PLOS ONE			English	Article							BEECH FAGUS-SYLVATICA; WATER RELATIONS; LEAF-NITROGEN; AMINO-ACIDS; SOLUTE ACCUMULATION; OSMOTIC ADJUSTMENT; PLANT-RESPONSES; EUROPEAN OAKS; GAS-EXCHANGE; FOREST SOILS	Climate change poses direct or indirect influences on physiological mechanisms in plants. In particular, long living plants like trees have to cope with the predicted climate changes (i.e. drought and air warming) during their life span. The present study aimed to quantify the consequences of simulated climate change for foliar N metabolites over a drought-rewetting-drought course. Saplings of three Central European oak species (i.e. Quercus robur, Q. petraea, Q. pubescens) were tested on two different soil types (i.e. acidic and calcareous). Consecutive drought periods increased foliar amino acid-N and soluble protein-N concentrations at the expense of structural N in all three oak species. In addition, transient effects on foliar metabolite dynamics were observed over the drought-rewetting-drought course. The lowest levels of foliar soluble protein-N, amino acid-N and potassium cation with a minor response to drought and air warming were found in the oak species originating from the driest/warmest habitat (Q. pubescens) compared to Q. robur and Q. petraea. Higher foliar osmolyte-N and potassium under drought and air warming were observed in all oak species when grown on calcareous versus acidic soil. These results indicate that species-specific differences in physiological mechanisms to compensate drought and elevated temperature are modified by soil acidity.	[Hu, Bin] Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China; [Hu, Bin; Simon, Judy; Rennenberg, Heinz] Univ Freiburg, Inst Forest Sci, D-79106 Freiburg, Germany; [Guenthardt-Goerg, Madeleine S.; Arend, Matthias; Kuster, Thomas M.] Snow & Landscape Res WSL, Swiss Fed Inst Forest, Birmensdorf, Switzerland	Northwest A&F University - China; University of Freiburg; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research	Hu, B (corresponding author), Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China.	hubjoe@126.com	Arend, Matthias/L-7795-2013; Simon, Judy/C-7875-2011	Arend, Matthias/0000-0003-4514-0667; Simon, Judy/0000-0002-8879-2449	Velux foundation [489]	Velux foundation(Velux Fonden)	BH was financially supported by the fellowship of GRK 1305 - International Graduate School of Signal Systems in Plant Model Organisms, funded by the Deutsche Forschungsgemeinschaft (DFG), Germany, and the basic research funds for the Talents with Foreign Doctorate funded by central government, Shaanxi province and Northwest A&F University, China, respectively; JS was funded by the Ministry of Science, Research and the Arts Baden-Wurttemberg, Germany, and the European Social Fund. The authors are also gratefully indebted to the Velux foundation for funding (project number: 489, www.veluxstiftung.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS MD, 1990, TREE PHYSIOL, V6, P305, DOI 10.1093/treephys/6.3.305; ABRAMS MD, 1990, TREE PHYSIOL, V7, P227, DOI 10.1093/treephys/7.1-2-3-4.227; An YA, 2005, GLOBAL CHANGE BIOL, V11, P1733, DOI 10.1111/j.1365-2486.2005.01030.x; Arend M, 2013, PLANT BIOLOGY, V15, P169, DOI 10.1111/j.1438-8677.2012.00625.x; Arend M, 2011, TREE PHYSIOL, V31, P287, DOI 10.1093/treephys/tpr004; Backes K, 2000, CAN J FOREST RES, V30, P335, DOI 10.1139/cjfr-30-3-335; Bongarten BC, 1986, TREE PHYSIOL, V1, P265, DOI 10.1093/treephys/1.3.265; Borken W, 2009, GLOBAL CHANGE BIOL, V15, P808, DOI 10.1111/j.1365-2486.2008.01681.x; Borowitzka L. J., 1981, The physiology and biochemistry of drought resistance in plants., P97; CH2011, 2011, SWISS CLIM CHANG SCE; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Clifford SC, 1998, J EXP BOT, V49, P967, DOI 10.1093/jexbot/49.323.967; Contran N, 2013, PLANT BIOLOGY, V15, P157, DOI 10.1111/j.1438-8677.2012.00627.x; Cushman JC, 2000, CURR OPIN PLANT BIOL, V3, P117, DOI 10.1016/S1369-5266(99)00052-7; De Diego N, 2013, TREE PHYSIOL, V33, P69, DOI 10.1093/treephys/tps125; Dury SJ, 1998, GLOBAL CHANGE BIOL, V4, P55, DOI 10.1046/j.1365-2486.1998.00102.x; Ellenberg H, 1998, VEGETATION ECOLOGY C; Fotelli MN, 2002, PLANT BIOLOGY, V4, P311, DOI 10.1055/s-2002-32334; Gessler A, 2005, TREES-STRUCT FUNCT, V19, P510, DOI [10.1007/s00468-005-0422-7, 10.1007/s00468-005-0423-6]; Gessler A, 2007, TREES-STRUCT FUNCT, V21, P1, DOI 10.1007/s00468-006-0107-x; Gieger T, 2005, TREES-STRUCT FUNCT, V19, P607, DOI 10.1007/s00468-005-0424-5; Gu MM, 2007, HORTSCIENCE, V42, P1383, DOI 10.21273/HORTSCI.42.6.1383; Gunthardt-Goerg MS, 2013, PLANT BIOLOGY, V15, P185, DOI 10.1111/j.1438-8677.2012.00665.x; Hu B, 2013, PLANT BIOLOGY, V15, P198, DOI 10.1111/j.1438-8677.2012.00658.x; Hu B, 2013, TREE PHYSIOL, V33, P489, DOI 10.1093/treephys/tpt025; JONES MM, 1980, AUST J PLANT PHYSIOL, V7, P193, DOI 10.1071/PP9800193; Korner C, 1999, ALPINE PLANT LIFE FU; Kramer P.J., 1995, WATER RELATIONS PLAN; Kuster TM, 2013, PLANT BIOLOGY, V15, P220, DOI 10.1111/j.1438-8677.2012.00686.x; Kuster TM, 2013, PLANT BIOLOGY, V15, P138, DOI 10.1111/j.1438-8677.2011.00552.x; Kuster TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089724; Kuster TM, 2013, PLANT SOIL, V369, P61, DOI 10.1007/s11104-012-1541-8; Landolt E., 2010, FLORA INDICATIVA; Larsen KS, 2011, GLOBAL CHANGE BIOL, V17, P1884, DOI 10.1111/j.1365-2486.2010.02351.x; Li CY, 2000, AUST J PLANT PHYSIOL, V27, P231; Li MH, 2013, PLANT BIOLOGY, V15, P177, DOI 10.1111/j.1438-8677.2012.00579.x; Luo YQ, 2008, GLOBAL CHANGE BIOL, V14, P1986, DOI 10.1111/j.1365-2486.2008.01629.x; Luo ZB, 2009, PLANT PHYSIOL, V151, P1902, DOI 10.1104/pp.109.143735; Mansour MMF, 2000, BIOL PLANTARUM, V43, P491, DOI 10.1023/A:1002873531707; Medrano H, 2002, ANN BOT-LONDON, V89, P895, DOI 10.1093/aob/mcf079; MORGAN JM, 1984, ANNU REV PLANT PHYS, V35, P299, DOI 10.1146/annurev.pp.35.060184.001503; PARKER WC, 1985, PHYSIOL PLANTARUM, V64, P105, DOI 10.1111/j.1399-3054.1985.tb01219.x; Patakas A, 2002, PLANT SCI, V163, P361, DOI 10.1016/S0168-9452(02)00140-1; Peuke A, 2004, TREES-STRUCT FUNCT, V18, P639, DOI 10.1007/s00468-004-0335-x; QUICK WP, 1992, PLANT CELL ENVIRON, V15, P25, DOI 10.1111/j.1365-3040.1992.tb01455.x; Rai VK, 2002, BIOL PLANTARUM, V45, P481, DOI 10.1023/A:1022308229759; Reddy AR, 2004, J PLANT PHYSIOL, V161, P1189, DOI 10.1016/j.jplph.2004.01.013; Reich PB, 2004, P NATL ACAD SCI USA, V101, P11001, DOI 10.1073/pnas.0403588101; Rennenberg H, 2006, PLANT BIOLOGY, V8, P556, DOI 10.1055/s-2006-924084; Rennenberg H, 2004, ALLG FORST JAGDZTG, V175, P210; Rennenberg H, 2010, PLANT BIOLOGY, V12, P275, DOI 10.1111/j.1438-8677.2009.00309.x; Rennenberg H, 2009, PLANT BIOLOGY, V11, P4, DOI 10.1111/j.1438-8677.2009.00241.x; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Saxe H, 2001, NEW PHYTOL, V149, P369, DOI 10.1046/j.1469-8137.2001.00057.x; Schmidli J, 2005, INT J CLIMATOL, V25, P753, DOI 10.1002/joc.1179; Schneider S, 1996, NEW PHYTOL, V134, P103, DOI 10.1111/j.1469-8137.1996.tb01150.x; Simon J, 2010, PLANT BIOLOGY, V12, P453, DOI 10.1111/j.1438-8677.2009.00225.x; Steinbrecher R, 2013, PLANT BIOLOGY, V15, P148, DOI 10.1111/j.1438-8677.2012.00688.x; Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1, DOI 10.1017/cbo9781107415324; Tjoelker MG, 1999, PLANT CELL ENVIRON, V22, P767, DOI 10.1046/j.1365-3040.1999.00435.x; Turner N. C., 1980, Adaptation of plants to water and high temperature stress., P87; TURNER NC, 1986, AUST J PLANT PHYSIOL, V13, P175, DOI 10.1071/PP9860175; VIVIN P, 1993, ANN SCI FOREST, V50, P221, DOI 10.1051/forest:19930301; Wallnofer S, 2008, BOT HELV, V118, P21, DOI 10.1007/s00035-008-0827-1; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Warren CR, 2011, PLANT CELL ENVIRON, V34, P1609, DOI 10.1111/j.1365-3040.2011.02357.x; Way DA, 2010, TREE PHYSIOL, V30, P669, DOI 10.1093/treephys/tpq015; Weih M, 2001, NEW PHYTOL, V150, P147, DOI 10.1046/j.1469-8137.2001.00078.x; Wildhagen H, 2010, TREE PHYSIOL, V30, P1096, DOI 10.1093/treephys/tpq018; WINTER H, 1992, PLANT PHYSIOL, V99, P996, DOI 10.1104/pp.99.3.996; Woods HA, 2003, FUNCT ECOL, V17, P237, DOI 10.1046/j.1365-2435.2003.00724.x; Zhu JK, 1997, CRIT REV PLANT SCI, V16, P253, DOI 10.1080/713608147; Zimmermann NE, 2006, WALD KLIMAWANDEL FOR, V2006, P63	74	13	13	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126701	10.1371/journal.pone.0126701	http://dx.doi.org/10.1371/journal.pone.0126701			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961713	Green Submitted, Green Published, gold			2022-12-26	WOS:000354542500138
J	Hussein, RM; Benjamin, IJ; Kampinga, HH				Hussein, Rasha M.; Benjamin, Ivor J.; Kampinga, Harm H.			Rescue of alpha B Crystallin (HSPB5) Mutants Associated Protein Aggregation by Co-Expression of HSPB5 Partners	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; DESMIN-RELATED MYOPATHY; MOLECULAR CHAPERONE; MAMMALIAN-CELLS; HSP70; R120G; HETEROPOLYMER; MUTATIONS; DISEASES; FIBRILS	HSPB5 (also called alpha B-crystallin) is a ubiquitously expressed small heat shock protein. Mutations in HSPB5 have been found to cause cataract, but are also associated with a subgroup of myofibrillar myopathies. Cells expressing each of these HSPB5 mutants are characterized by the appearance of protein aggregates of primarily the mutant HSPB5. Like several members of the HSPB family, HSPB5 can form both homo-oligomeric and hetero-oligomeric complexes. Previous studies showed that co-expression of HSPB1 and HSPB8 can prevent the aggregation associated with the HSPB5 (R120G) mutant in cardiomyocytes and in transgenic mice. In this study, we systematically compared the effect of co-expression of each of the members of the human HSPB family (HSPB1-10) on the aggregation of three different HSPB5 mutants (R120G, 450. A, 464. CT). Of all members, co-expression of HSPB1, HSPB4 and HSPB5 itself, most effectively prevent the aggregation of these 3 HSPB5 mutants. HSPB6 and HSPB8 were also active but less, whilst the other 5 HSPB members were ineffective. Co-expression of Hsp70 did not reduce the aggregation of the HSPB5 mutants, suggesting that aggregate formation is most likely not related to a toxic gain of function of the mutants per se, but rather related to a loss of chaperone function of the oligomeric complexes containing the HSPB5 mutants (dominant negative effects). Our data suggest that the rescue of aggregation associated with the HSPB5 mutants is due to competitive incorporation of its partners into hetero-oligomers hereby negating the dominant negative effects of the mutant on the functioning of the hetero-oligomer.	[Hussein, Rasha M.; Kampinga, Harm H.] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, NL-9713 AV Groningen, Netherlands; [Hussein, Rasha M.] Beni Suef Univ, Fac Pharm, Dept Biochem, Bani Suwayf 62511, Egypt; [Benjamin, Ivor J.] Med Coll Wisconsin, Ctr Cardiovasc, Milwaukee, WI 53226 USA	University of Groningen; Egyptian Knowledge Bank (EKB); Beni Suef University; Medical College of Wisconsin	Kampinga, HH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, NL-9713 AV Groningen, Netherlands.	h.h.kampinga@umcg.nl		Hussein, Rasha/0000-0002-0198-3067; Kampinga, Harm/0000-0002-8966-8466	Ministry of Higher Education and Scientific Research of Egypt; IOP genomic grant from Senter Novem [IOP-IGE07004]; NIH [5DP1OD006438-03]; Leducq Transatlantic Network;  [2 R01 HL063834-06];  [5R01HL074370-03]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074370, R01HL063834] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006438] Funding Source: NIH RePORTER	Ministry of Higher Education and Scientific Research of Egypt(Ministry of Higher Education & Scientific Research (MHESR)); IOP genomic grant from Senter Novem; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leducq Transatlantic Network(Leducq Foundation); ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The Ministry of Higher Education and Scientific Research of Egypt is acknowledged for financially supporting R.H. The work was also financed by an IOP genomic grant (IOP-IGE07004) from Senter Novem awarded to H.H.K. This work was supported by 2 R01 HL063834-06, 5R01HL074370-03, and NIH 5DP1OD006438-03 to I.J.B. and Leducq Transatlantic Network "Redox and Nitrosative Regulation of Cardiac Remodeling: Novel Therapeutic Approaches for Heart Failure."	Andley UP, 2007, PROG RETIN EYE RES, V26, P78, DOI 10.1016/j.preteyeres.2006.10.003; Arrigo AP, 2013, INT J HYPERTHER, V29, P409, DOI 10.3109/02656736.2013.792956; Arrigo AP, 2013, FEBS LETT, V587, P1959, DOI 10.1016/j.febslet.2013.05.011; Augusteyn Robert C, 2004, Clin Exp Optom, V87, P356; Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Berry V, 2001, AM J HUM GENET, V69, P1141, DOI 10.1086/324158; Boelens WC, 2014, PROG BIOPHYS MOL BIO, V115, P3, DOI 10.1016/j.pbiomolbio.2014.02.005; Boncoraglio A, 2012, INT J BIOCHEM CELL B, V44, P1657, DOI 10.1016/j.biocel.2012.03.011; Bova MP, 1999, P NATL ACAD SCI USA, V96, P6137, DOI 10.1073/pnas.96.11.6137; Carra S, 2008, J BIOL CHEM, V283, P1437, DOI 10.1074/jbc.M706304200; Clark AR, 2012, INT J BIOCHEM CELL B, V44, P1687, DOI 10.1016/j.biocel.2012.02.015; Datskevich PN, 2012, BIOCHEMISTRY-MOSCOW+, V77, P1500, DOI 10.1134/S0006297912130081; de Jong WW, 1998, INT J BIOL MACROMOL, V22, P151, DOI 10.1016/S0141-8130(98)00013-0; Escobedo J, 2003, BIOTECHNIQUES, V35, P936, DOI 10.2144/03355bm06; Ferrer Isidre, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000793; Garrido C, 2012, INT J BIOCHEM CELL B, V44, P1588, DOI 10.1016/j.biocel.2012.02.022; Graw J, 2009, EXP EYE RES, V88, P173, DOI 10.1016/j.exer.2008.10.011; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; Ito H, 2003, CELL MOL LIFE SCI, V60, P1217, DOI 10.1007/s00018-003-3024-9; Kannan R, 2012, PROG RETIN EYE RES, V31, P576, DOI 10.1016/j.preteyeres.2012.06.001; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Michels AA, 1997, J BIOL CHEM, V272, P33283, DOI 10.1074/jbc.272.52.33283; Minoia M, 2014, MOL CELL BIOL, V34, P3570, DOI 10.1128/MCB.00698-14; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Nollen EAA, 1999, MOL CELL BIOL, V19, P2069; Rajaraman K, 2001, FEBS LETT, V497, P118, DOI 10.1016/S0014-5793(01)02451-6; Raju I, 2013, BIOCHEM BIOPH RES CO, V430, P107, DOI 10.1016/j.bbrc.2012.11.051; Raman B, 2005, BIOCHEM J, V392, P573, DOI 10.1042/BJ20050339; RAMAN B, 1995, J BIOL CHEM, V270, P19888, DOI 10.1074/jbc.270.34.19888; Sanbe A, 2004, P NATL ACAD SCI USA, V101, P10132, DOI 10.1073/pnas.0401900101; Sanbe A, 2007, J BIOL CHEM, V282, P555, DOI 10.1074/jbc.M605481200; Sanbe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005351; Selcen D, 2003, ANN NEUROL, V54, P804, DOI 10.1002/ana.10767; Selcen D, 2011, NEUROMUSCULAR DISORD, V21, P161, DOI 10.1016/j.nmd.2010.12.007; Shammas SL, 2011, BIOPHYS J, V101, P1681, DOI 10.1016/j.bpj.2011.07.056; Simon S, 2007, BIOCHEMISTRY-US, V46, P9605, DOI 10.1021/bi7003125; Simon S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070545; Srinivas PNBS, 2008, BIOCHEM J, V414, P453, DOI 10.1042/BJ20080544; Srinivas P, 2010, IUBMB LIFE, V62, P693, DOI 10.1002/iub.373; STEGE GJJ, 1994, INT J HYPERTHER, V10, P659, DOI 10.3109/02656739409022446; Treweek TM, 2005, FEBS J, V272, P711, DOI 10.1111/j.1742-4658.2004.04507.x; Vos MJ, 2010, HUM MOL GENET, V19, P4677, DOI 10.1093/hmg/ddq398; Vos MJ, 2009, BBA-MOL CELL RES, V1793, P1343, DOI 10.1016/j.bbamcr.2009.05.005; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Zhang HL, 2010, J MOL CELL CARDIOL, V49, P918, DOI 10.1016/j.yjmcc.2010.09.004; Zobel ATC, 2003, HUM MOL GENET, V12, P1609, DOI 10.1093/hmg/ddg173	47	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126761	10.1371/journal.pone.0126761	http://dx.doi.org/10.1371/journal.pone.0126761			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961584	Green Submitted, gold, Green Published			2022-12-26	WOS:000354542500144
J	Lowe, SR; Sampson, L; Gruebner, O; Galea, S				Lowe, Sarah R.; Sampson, Laura; Gruebner, Oliver; Galea, Sandro			Psychological Resilience after Hurricane Sandy: The Influence of Individual- and Community-Level Factors on Mental Health after a Large-Scale Natural Disaster	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; TRAJECTORIES; DEPRESSION; EXPOSURE; PTSD	Several individual-level factors are known to promote psychological resilience in the aftermath of disasters. Far less is known about the role of community-level factors in shaping postdisaster mental health. The purpose of this study was to explore the influence of both individual- and community-level factors on resilience after Hurricane Sandy. A representative sample of household residents (N = 418) from 293 New York City census tracts that were most heavily affected by the storm completed telephone interviews approximately 13-16 months postdisaster. Multilevel multivariable models explored the independent and interactive contributions of individual-and community-level factors to posttraumatic stress and depression symptoms. At the individual-level, having experienced or witnessed any lifetime traumatic event was significantly associated with higher depression and posttraumatic stress, whereas demographic characteristics (e.g., older age, non-Hispanic Black race) and more disaster-related stressors were significantly associated with higher posttraumatic stress only. At the community-level, living in an area with higher social capital was significantly associated with higher posttraumatic stress. Additionally, higher community economic development was associated with lower risk of depression only among participants who did not experience any disaster-related stressors. These results provide evidence that individual- and community-level resources and exposure operate in tandem to shape postdisaster resilience.	[Lowe, Sarah R.; Gruebner, Oliver] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA; [Sampson, Laura; Galea, Sandro] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02215 USA	Columbia University; Boston University	Lowe, SR (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA.	srl2143@columbia.edu	Sampson, Laura/T-7477-2019; Galea, Sandro/GLR-6066-2022; Gruebner, Oliver/G-5126-2010; Gruebner, Oliver/X-2675-2019; Gruebner, Oliver/H-7947-2019	Sampson, Laura/0000-0002-1715-2081; Gruebner, Oliver/0000-0001-9783-4770; Gruebner, Oliver/0000-0001-9783-4770; Gruebner, Oliver/0000-0001-9783-4770; Galea, Sandro/0000-0002-7534-0945	Assistant Secretary of Preparedness and Response of the US Department of Health and Human Services [HITEP130003-01-00]; National Institute for Mental Health [T32-MH-13043]; German Research Foundation (DFG) [GR 4302/1-1]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH013043] Funding Source: NIH RePORTER	Assistant Secretary of Preparedness and Response of the US Department of Health and Human Services; National Institute for Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); German Research Foundation (DFG)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the Assistant Secretary of Preparedness and Response of the US Department of Health and Human Services, Grant HITEP130003-01-00 (to SG), the National Institute for Mental Health (T32-MH-13043 to SRL), and the German Research Foundation (DFG, GR 4302/1-1 to OG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAPOR, 2016, STAND DEF FIN DISP C; Aber J. L., 2004, APPL DEV SCI, V8, P111, DOI [10.1207/s1532480xads0803_2, DOI 10.1207/S1532480XADS0803_2]; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bonanno GA, 2013, J CHILD PSYCHOL PSYC, V54, P378, DOI 10.1111/jcpp.12021; Frankenberg E, 2012, J HEALTH SOC BEHAV, V53, P498, DOI 10.1177/0022146512456207; Galea S, 2008, J TRAUMA STRESS, V21, P357, DOI 10.1002/jts.20355; Galea S, 2007, ARCH GEN PSYCHIAT, V64, P1427, DOI 10.1001/archpsyc.64.12.1427; Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013; Goldmann E, 2011, J TRAUMA STRESS, V24, P747, DOI 10.1002/jts.20705; Goldstein W., 2014, ONE CITY REBUILDING; IBM Corp, 2013, IBM SPSS STAT WINDOW; Infoshare Online/Community Studies of New York Inc, 2014, AR COMP TABL DAT FIL; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Masten AS, 2007, DEV PSYCHOPATHOL, V19, P921, DOI 10.1017/S0954579407000442; Muthen LK, 1998, MPLUS USERS GUIDE, DOI [10.1037/met0000028, DOI 10.1037/MET0000028]; New York City Community Development Block Grant-Disaster Recovery [NYC CDBG-DR], 2013, PART ACT PLAN A; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; Norris FH, 2008, AM J COMMUN PSYCHOL, V41, P127, DOI 10.1007/s10464-007-9156-6; Norris FH, 2009, SOC SCI MED, V68, P2190, DOI 10.1016/j.socscimed.2009.03.043; Osypuk T.L., 2007, MACROSOCIAL DETERMIN, P399, DOI 10.1007/978-0-387-70812-6_19; Phongsavan P, 2006, SOC SCI MED, V63, P2546, DOI 10.1016/j.socscimed.2006.06.021; Tracy M, 2011, DEPRESS ANXIETY, V28, P666, DOI 10.1002/da.20838; Ursano RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088467; Weathers F.W., 2013, PTSD CHECKLIST DSM 5, DOI DOI 10.1037/T02622-000; Wind TR, 2012, SOC SCI MED, V75, P1715, DOI 10.1016/j.socscimed.2012.06.032	27	91	95	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0125761	10.1371/journal.pone.0125761	http://dx.doi.org/10.1371/journal.pone.0125761			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI1YY	25962178	Green Published, Green Submitted, gold			2022-12-26	WOS:000354542500044
J	Peters, U; Frenzel, K; Brettschneider, R; Oldenburg, M; Bittner, C				Peters, Ulrike; Frenzel, Karsten; Brettschneider, Reinhold; Oldenburg, Marcus; Bittner, Cordula			Identification of Two Metallothioneins as Novel Inhalative Coffee Allergens Cof a 2 and Cof a 3	PLOS ONE			English	Article							GREEN COFFEE; SENSITIZATION; DIAGNOSTICS; WORKERS	Background Dust of green coffee beans is known to be a relevant cause for occupational allergic disorders in coffee industry workers. Recently, we described the first coffee allergen (Cof a 1) establishing an allergenic potential of green coffee dust. Objective Our aim was to identify allergenic components of green coffee in order to enhance inhalative coffee allergy diagnosis. Methods A Coffea arabica pJuFo cDNA phage display library was created and screened for IgE binding with sera from allergic coffee workers. Two further coffee allergens were identified by sequence analysis, expressed in E. coli, and evaluated by Western blots. The prevalence of sensitization to recombinant Cof a 1, Cof a 2, and Cof a 3 and to commercially available extract was investigated by ELISA (enzyme-linked immunosorbent assay) respectively CAP (capacity test) screening in 18 sera of symptomatic coffee workers. Results In addition to the previously described chitinase Cof a 1, two Coffea arabica cysteine-rich metallothioneins of 9 and 7 kDa were identified and included in the IUIS Allergen Nomenclature as Cof a 2 and Cof a 3. Serum IgE antibodies to at least one of the recombinant allergens were found in 8 out of 18 symptomatic coffee workers (44%). Only 2 of the analysed sera (11%) had reacted previously to the commercial allergy test. Conclusions In addition to the previously described Cof a 1 we have identified two further coffee proteins to be type I coffee allergens (Cof a 2 and Cof a 3) which may have a relevant potential for the specific diagnosis and/or therapy of coffee allergy.	[Peters, Ulrike; Frenzel, Karsten; Brettschneider, Reinhold] Univ Hamburg, Bioctr Klein Flottbek & Bot Garden, Hamburg, Germany; [Oldenburg, Marcus; Bittner, Cordula] Univ Med Ctr Hamburg Eppendorf, Inst Occupat Med & Maritime Med ZfAM, Hamburg, Germany	University of Hamburg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Bittner, C (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Occupat Med & Maritime Med ZfAM, Hamburg, Germany.	cordula.bittner@bgv.hamburg.de						Bittner C, 2008, J ALLERGY CLIN IMMUN, V121, P744, DOI 10.1016/j.jaci.2007.09.051; Breiteneder H, 2005, BIOTECHNOL ADV, V23, P395, DOI 10.1016/j.biotechadv.2005.05.004; DEZOTTI R, 1988, INT ARCH OCC ENV HEA, V61, P7, DOI 10.1007/BF00381601; Ferreira F, 2014, YONSEI MED J, V55, P839, DOI 10.3349/ymj.2014.55.4.839; FIGLEY KD, 1950, J ALLERGY, V21, P545, DOI 10.1016/0021-8707(50)90106-7; Guzzo SD, 2009, J PHYTOPATHOL, V157, P625, DOI 10.1111/j.1439-0434.2008.01538.x; Islam SA, 2012, NAT MED, V18, P705, DOI 10.1038/nm.2760; Manavski N, 2012, INT ARCH ALLERGY IMM, V159, P235, DOI 10.1159/000337461; MOISYADI S, 1995, PLANT PHYSIOL, V107, P295, DOI 10.1104/pp.107.1.295; Oldenburg M, 2009, CHEST, V136, P536, DOI 10.1378/chest.08-1965; Petersen A, 1998, CLIN EXP ALLERGY, V28, P315; ROMANO C, 1995, CLIN EXP ALLERGY, V25, P643, DOI 10.1111/j.1365-2222.1995.tb01112.x; Steckelbroeck S, 2008, J ALLERGY CLIN IMMUN, V121, P1323, DOI 10.1016/j.jaci.2008.04.008; United States Department of Agriculture (USDA), COFF WORLD MARK TRAD; Valenta R, 1999, CLIN EXP ALLERGY, V29, P896	15	9	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126455	10.1371/journal.pone.0126455	http://dx.doi.org/10.1371/journal.pone.0126455			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962169	Green Submitted, gold, Green Published			2022-12-26	WOS:000354542500100
J	Jiao, J; Wang, YC; Selvaraj, JN; Xing, FG; Liu, Y				Jiao, Jian; Wang, Yichun; Selvaraj, Jonathan Nimal; Xing, Fuguo; Liu, Yang			Barley Stripe Mosaic Virus (BSMV) Induced MicroRNA Silencing in Common Wheat (Triticum aestivum L.)	PLOS ONE			English	Article							SMALL RNAS; DRAFT GENOME; RT-PCR; PLANT; EXPRESSION; QUANTIFICATION; MECHANISM; GENES	MicroRNAs (miRNAs) play important roles in growth, development, and response to environmental changes in plants. Based on the whole-genome shotgun sequencing strategy, more and more wheat miRNAs have been annotated. Now, there is a need for an effective technology to analyse endogenous miRNAs function in wheat. We report here that the modified barley stripe mosaic virus (BSMV)-induced miRNAs silencing system can be utilized to silence miRNAs in wheat. BSMV-based miRNA silencing system is performed through BSMV-based expression of miRNA target mimics to suppress miR159a and miR3134a. The relative expression levels of mature miR159a and miR3134a decrease with increasing transcript levels of their target genes in wheat plants. In summary, the developed approach is effective in silencing endogenous miRNAs, thereby providing a powerful tool for biological function analyses of miRNA molecules in common wheat.	[Jiao, Jian; Wang, Yichun; Selvaraj, Jonathan Nimal; Xing, Fuguo; Liu, Yang] Chinese Acad Agr Sci, Inst Agroprod Proc Sci & Technol, Key Lab Agroprod Proc, Minist Agr, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Liu, Y (corresponding author), Chinese Acad Agr Sci, Inst Agroprod Proc Sci & Technol, Key Lab Agroprod Proc, Minist Agr, Beijing 100193, Peoples R China.	liuyang01@caas.cn	Xing, Fuguo/HGD-3209-2022		National Basic Research Program of China (973 program) [2013CB127805]; Special Fund for Agro-scientific Research in the Public Interest [201203037]; China Postdoctoral Science Foundation	National Basic Research Program of China (973 program)(National Basic Research Program of China); Special Fund for Agro-scientific Research in the Public Interest; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	The authors gratefully acknowledge the financial support of National Basic Research Program of China (973 program) (2013CB127805), Special Fund for Agro-scientific Research in the Public Interest (201203037), China Postdoctoral Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai SW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002752; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; Eamens AL, 2011, MOL PLANT, V4, P157, DOI 10.1093/mp/ssq061; Feng H, 2013, PLANT PHYSIOL BIOCH, V68, P90, DOI 10.1016/j.plaphy.2013.04.008; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hefferon KL, 2012, VIROLOGY, V433, P1, DOI 10.1016/j.virol.2012.06.012; Hein I, 2005, PLANT PHYSIOL, V138, P2155, DOI 10.1104/pp.105.062810; Holzberg S, 2002, PLANT J, V30, P315, DOI 10.1046/j.1365-313X.2002.01291.x; Jackson AO, 2009, ANNU REV PHYTOPATHOL, V47, P385, DOI 10.1146/annurev-phyto-080508-081733; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Jin HL, 2008, FEBS LETT, V582, P2679, DOI 10.1016/j.febslet.2008.06.053; Lacomme C, 2003, PLANT J, V34, P543, DOI 10.1046/j.1365-313X.2003.01733.x; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Lu R, 2003, METHODS, V30, P296, DOI 10.1016/S1046-2023(03)00037-9; Lu SF, 2008, PLANT J, V55, P131, DOI 10.1111/j.1365-313X.2008.03497.x; Nobuta K, 2010, METHODS MOL BIOL, V592, P89, DOI 10.1007/978-1-60327-005-2_7; Phillips JR, 2007, FEBS LETT, V581, P3592, DOI 10.1016/j.febslet.2007.04.007; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Senthil-Kumar M, 2011, TRENDS PLANT SCI, V16, P656, DOI 10.1016/j.tplants.2011.08.006; Sha AH, 2014, PLANT PHYSIOL, V164, P36, DOI 10.1104/pp.113.231100; Sun FL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-142; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Tang Y, 2010, PLANT PHYSIOL, V153, P632, DOI 10.1104/pp.110.155796; Till BJ, 2003, GENOME RES, V13, P524, DOI 10.1101/gr.977903; Vaistij FE, 2010, PLANT MOL BIOL, V73, P391, DOI 10.1007/s11103-010-9625-4; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Warthmann N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001829; Yan J, 2012, PLANT CELL, V24, P415, DOI 10.1105/tpc.111.094144; Yuan C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026468; Zhang BH, 2006, DEV BIOL, V289, P3, DOI 10.1016/j.ydbio.2005.10.036; Zhou HB, 2007, PLANT J, V52, P420, DOI 10.1111/j.1365-313X.2007.03246.x	40	17	19	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0126621	10.1371/journal.pone.0126621	http://dx.doi.org/10.1371/journal.pone.0126621			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955840	Green Published, gold, Green Submitted			2022-12-26	WOS:000356768100132
J	Garcia, PL; Miller, AL; Kreitzburg, KM; Council, LN; Gamblin, TL; Christein, JD; Heslin, MJ; Arnoletti, JP; Richardson, JH; Chen, D; Hanna, CA; Cramer, SL; Yang, ES; Qi, J; Bradner, JE; Yoon, KJ				Garcia, P. L.; Miller, A. L.; Kreitzburg, K. M.; Council, L. N.; Gamblin, T. L.; Christein, J. D.; Heslin, M. J.; Arnoletti, J. P.; Richardson, J. H.; Chen, D.; Hanna, C. A.; Cramer, S. L.; Yang, E. S.; Qi, J.; Bradner, J. E.; Yoon, K. J.			The BET bromodomain inhibitor JQ1 suppresses growth of pancreatic ductal adenocarcinoma in patient-derived xenograft models	ONCOGENE			English	Article							SALMONELLA-TYPHIMURIUM A1-R; C-MYC; CELL-CYCLE; SELECTIVE-INHIBITION; CLINICAL BENEFIT; GENE-EXPRESSION; CANCER-CELLS; THERAPY; CDC25B; TARGET	The primary aim of this study was to evaluate the antitumor efficacy of the bromodomain inhibitor JQ1 in pancreatic ductal adenocarcinoma (PDAC) patient-derived xenograft (tumorgraft) models. A secondary aim of the study was to evaluate whether JQ1 decreases expression of the oncogene c-Myc in PDAC tumors, as has been reported for other tumor types. We used five PDAC tumorgraft models that retain specific characteristics of tumors of origin to evaluate the antitumor efficacy of JQ1. Tumor-bearing mice were treated with JQ1 (50 mg/kg daily for 21 or 28 days). Expression analyses were performed with tumors harvested from host mice after treatment with JQ1 or vehicle control. An nCounter PanCancer Pathways Panel (NanoString Technologies) of 230 cancer-related genes was used to identify gene products affected by JQ1. Quantitative RT-PCR, immunohistochemistry and immunoblots were carried out to confirm that changes in RNA expression reflected changes in protein expression. JQ1 inhibited the growth of all five tumorgraft models (P < 0.05), each of which harbors a KRAS mutation; but induced no consistent change in expression of c-Myc protein. Expression profiling identified CDC25B, a regulator of cell cycle progression, as one of the three RNA species (TIMP3, LMO2 and CDC25B) downregulated by JQ1 (P < 0.05). Inhibition of tumor progression was more closely related to decreased expression of nuclear CDC25B than to changes in c-Myc expression. JQ1 and other agents that inhibit the function of proteins with bromodomains merit further investigation for treating PDAC tumors. Work is ongoing in our laboratory to identify effective drug combinations that include JQ1.	[Garcia, P. L.; Miller, A. L.; Kreitzburg, K. M.; Gamblin, T. L.; Yoon, K. J.] Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Birmingham, AL 35294 USA; [Hanna, C. A.] Univ Alabama Birmingham, Div Anat Pathol, Dept Pathol, Birmingham, AL USA; [Christein, J. D.; Heslin, M. J.; Arnoletti, J. P.; Richardson, J. H.] Univ Alabama Birmingham, Div Gen Surg Gastrointestinal Surg Surg Oncol, Dept Surg, Birmingham, AL USA; [Chen, D.] Univ Alabama Birmingham, Div Prevent Med, Dept Med, Birmingham, AL USA; [Cramer, S. L.] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL USA; [Yang, E. S.] Univ Alabama Birmingham, Dept Radiat Oncol, Birmingham, AL USA; [Qi, J.; Bradner, J. E.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Harvard University; Dana-Farber Cancer Institute	Yoon, KJ (corresponding author), Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Birmingham, AL 35294 USA.	kyoon@uab.edu			UAB/UMN SPORE in pancreatic cancer [P50 CA101955]; NATIONAL CANCER INSTITUTE [P30CA013148, P50CA101955] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008111] Funding Source: NIH RePORTER	UAB/UMN SPORE in pancreatic cancer(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs Donald J Buchsbaum, William E Grizzle, Mary-Ann Bjornsti and Christopher Klug for their insightful guidance and helpful discussions. This research was supported in part by UAB/UMN SPORE in pancreatic cancer (P50 CA101955).	American Cancer Society, 2014, CANC FACTS FIG 2014; Asangani IA, 2014, NATURE, V510, P278, DOI 10.1038/nature13229; Bandopadhayay P, 2014, CLIN CANCER RES, V20, P912, DOI 10.1158/1078-0432.CCR-13-2281; BORN TL, 1994, MOL CELL BIOL, V14, P5710, DOI 10.1128/MCB.14.9.5710; Briasoulis E, 1998, ANTICANCER RES, V18, P1907; Bryant KL, 2014, TRENDS BIOCHEM SCI, V39, P91, DOI 10.1016/j.tibs.2013.12.004; Burris H, 1997, EUR J CANCER, V33, pS18, DOI 10.1016/S0959-8049(96)00324-3; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Chandra S, 2013, J CELL SCI, V126, P3782, DOI 10.1242/jcs.124719; Chen YH, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-246; Cheng ZX, 2013, CLIN CANCER RES, V19, P1748, DOI 10.1158/1078-0432.CCR-12-3066; Da Costa D, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.24; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Feng Q, 2014, CELL RES, V24, P809, DOI 10.1038/cr.2014.71; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Fowler T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087003; FU XY, 1992, P NATL ACAD SCI USA, V89, P5645, DOI 10.1073/pnas.89.12.5645; Gabrielli BG, 1996, J CELL SCI, V109, P1081; Galaktionov K, 1996, NATURE, V382, P511, DOI 10.1038/382511a0; GALAKTIONOV K, 1995, SCIENCE, V269, P1575, DOI 10.1126/science.7667636; Garcia PL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078183; Gartel AL, 2001, P NATL ACAD SCI USA, V98, P4510, DOI 10.1073/pnas.081074898; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; GERDES J, 1984, J IMMUNOL, V133, P1710; Gillen S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000267; Guerra L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008924; Guo JC, 2004, ONCOGENE, V23, P71, DOI 10.1038/sj.onc.1206926; Hermeking H, 2000, P NATL ACAD SCI USA, V97, P2229, DOI 10.1073/pnas.050586197; Hiroshima Y, 2014, ONCOTARGET, V5, P12346, DOI 10.18632/oncotarget.2641; Hiroshima Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114310; Hiroshima Y, 2014, J CELL BIOCHEM, V115, P1254, DOI 10.1002/jcb.24769; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Knoechel B, 2014, NAT GENET, V46, P364, DOI 10.1038/ng.2913; Koshiji M, 2005, MOL CELL, V17, P793, DOI 10.1016/j.molcel.2005.02.015; Kulkarni MV, 2011, MOL ONCOL, V5, P24, DOI 10.1016/j.molonc.2010.10.004; LI LH, 1994, EMBO J, V13, P4070, DOI 10.1002/j.1460-2075.1994.tb06724.x; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Lin WC, 2013, CANCER RES, V73, P1821, DOI 10.1158/0008-5472.CAN-12-2067; Lindqvist A, 2004, J CELL SCI, V117, P4979, DOI 10.1242/jcs.01395; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lockwood WW, 2012, P NATL ACAD SCI USA, V109, P19408, DOI 10.1073/pnas.1216363109; Loosveld M, 2014, ONCOTARGET, V5, P3168, DOI 10.18632/oncotarget.1873; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Matsumura I, 2003, CELL CYCLE, V2, P333, DOI 10.4161/cc.2.4.428; Matzuk MM, 2012, CELL, V150, P673, DOI 10.1016/j.cell.2012.06.045; Menssen A, 2002, P NATL ACAD SCI USA, V99, P6274, DOI 10.1073/pnas.082005599; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Morton JP, 2010, P NATL ACAD SCI USA, V107, P246, DOI 10.1073/pnas.0908428107; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Ott CJ, 2012, BLOOD, V120, P2843, DOI 10.1182/blood-2012-02-413021; PHILIPP A, 1994, MOL CELL BIOL, V14, P4032, DOI 10.1128/MCB.14.6.4032; Puissant A, 2013, CANCER DISCOV, V3, P308, DOI 10.1158/2159-8290.CD-12-0418; Qi Y, 2004, NATURE, V431, P712, DOI 10.1038/nature02958; Roderick JE, 2014, BLOOD, V123, P1040, DOI 10.1182/blood-2013-08-522698; Rozenblum E, 1997, CANCER RES, V57, P1731; Sahai V, 2014, MOL CANCER THER, V13, P1907, DOI 10.1158/1535-7163.MCT-13-0925; Schleger C, 2002, MODERN PATHOL, V15, P462, DOI 10.1038/modpathol.3880547; Schuldiner O, 2001, ONCOGENE, V20, P4984, DOI 10.1038/sj.onc.1204459; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Shimamura T, 2013, CLIN CANCER RES, V19, P6183, DOI 10.1158/1078-0432.CCR-12-3904; Sibani S, 2005, J CELL SCI, V118, P3247, DOI 10.1242/jcs.02427; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Suetsugu A, 2012, ANTICANCER RES, V32, P3063; Suetsugu A, 2012, J CELL BIOCHEM, V113, P2290, DOI 10.1002/jcb.24099; Suetsugu A, 2012, ANTICANCER RES, V32, P1175; Trabucco SE, 2015, CLIN CANCER RES, V21, P113, DOI 10.1158/1078-0432.CCR-13-3346; Wang WJ, 2013, CANCER RES, V73, P1219, DOI 10.1158/0008-5472.CAN-12-1408; Yu XY, 2012, ASIAN PAC J CANCER P, V13, P931, DOI 10.7314/APJCP.2012.13.3.931	69	100	102	1	24	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 18	2016	35	7					833	845		10.1038/onc.2015.126	http://dx.doi.org/10.1038/onc.2015.126			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DE0RO	25961927	Green Accepted			2022-12-26	WOS:000370332200004
J	Murthy, S; Larson-Casey, JL; Ryan, AJ; He, C; Kobzik, L; Carter, AB				Murthy, Shubha; Larson-Casey, Jennifer L.; Ryan, Alan J.; He, Chao; Kobzik, Lester; Carter, A. Brent			Alternative activation of macrophages and pulmonary fibrosis are modulated by scavenger receptor, macrophage receptor with collagenous structure	FASEB JOURNAL			English	Article						MARCO; mitochondria; asbestos	ALVEOLAR MACROPHAGES; CHRYSOTILE ASBESTOS; BINDING-RECEPTOR; SURFACE-CHARGE; SR-AI/II; MARCO; PARTICLES; BACTERIA; INFLAMMATION; DOMAIN	Alternative activation of alveolar macrophages is linked to fibrosis following exposure to asbestos. The scavenger receptor, macrophage receptor with collagenous structure (MARCO), provides innate immune defense against inhaled particles and pathogens; however, a receptor for asbestos has not been identified. We hypothesized that MARCO acts as an initial signaling receptor for asbestos, polarizes macrophages to a profibrotic M2 phenotype, and is required for the development of asbestos-induced fibrosis. Compared with normal subjects, alveolar macrophages isolated from patients with asbestosis express higher amounts of MARCO and have greater profibrotic polarization. Arginase 1 (40-fold) and IL-10 (265-fold) were higher in patients. In vivo, the genetic deletion of MARCO attenuated the profibrotic environment and pulmonary fibrosis in mice exposed to chrysotile. Moreover, alveolar macrophages from MARCO(-/-) mice polarize to an M1 phenotype, whereas wild-type mice have higher Ym1 (>3.0-fold) and nearly 7-fold more active TGF-beta 1 in bronchoalveolar lavage (BAL) fluid (BALF). Arg(432) and Arg(434) in domain V of MARCO are required for the polarization of macrophages to a profibrotic phenotype as mutation of these residues reduced FIZZ1 expression (17-fold) compared with cells expressing MARCO. These observations demonstrate that a macrophage membrane protein regulates the fibrotic response to lung injury and suggest a novel target for therapeutic intervention.-Murthy, S., Larson-Casey, J. L., Ryan, A. J., He, C., Kobzik, L., Carter, A. B. Alternative activation of macrophages and pulmonary fibrosis are modulated by scavenger receptor, macrophage receptor with collagenous structure.	[Murthy, Shubha; Ryan, Alan J.; Carter, A. Brent] Carver Coll Med, Dept Internal Med, Iowa City, IA USA; [He, Chao; Carter, A. Brent] Carver Coll Med, Dept Radiat Oncol, Iowa City, IA USA; [He, Chao; Carter, A. Brent] Carver Coll Med, Grad Program Free Radical & Radiat Biol, Iowa City, IA USA; [Kobzik, Lester] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Carter, A. Brent] Univ Iowa, Coll Publ Hlth, Human Toxicol, Iowa City, IA USA; [Carter, A. Brent] Iowa City Vet Affairs Hlth Care Syst, Iowa City, IA USA; [Larson-Casey, Jennifer L.; Carter, A. Brent] Univ Alabama Birmingham, Birmingham, AL 35294 USA	Harvard University; Harvard T.H. Chan School of Public Health; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Alabama System; University of Alabama Birmingham	Carter, AB (corresponding author), Univ Alabama Birmingham, 404 MCLM,1918 Univ Blvd, Birmingham, AL 35294 USA.	bcarter1@uab.edu	Casey, Jennifer/N-8385-2019	Casey, Jennifer/0000-0001-7238-7986	U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences Grant [2R01ES015981-07]; U.S. Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biological Laboratory Research and Development Merit Review Grant [1BX001135-03]; NIH Grant [University of Alabama at Birmingham (UAB) O'Brien Acute Kidney Injury Center] [P30 DK079337]; UAB Lung Health Center; UAB Center for Free Radical Biology; NATIONAL CANCER INSTITUTE [T32CA078586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015981] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001135] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences Grant; U.S. Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biological Laboratory Research and Development Merit Review Grant; NIH Grant [University of Alabama at Birmingham (UAB) O'Brien Acute Kidney Injury Center]; UAB Lung Health Center; UAB Center for Free Radical Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences Grant 2R01ES015981-07 (to A.B.C.) and the U.S. Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biological Laboratory Research and Development Merit Review Grant 1BX001135-03 (to A.B.C.). For the GSH and GSSG analysis, the authors thank the Targeted Metabolomics and Proteonomics Laboratory supported by NIH Grant P30 DK079337 [University of Alabama at Birmingham (UAB) O'Brien Acute Kidney Injury Center], the UAB Lung Health Center, and the UAB Center for Free Radical Biology.	Arredouani MS, 2006, AM J RESP CELL MOL, V35, P474, DOI 10.1165/rcmb.2006-0128OC; Arredouani MS, 2004, CELL MOL BIOL, V50, P657; Arredouani MS, 2005, J IMMUNOL, V175, P6058, DOI 10.4049/jimmunol.175.9.6058; BALES RC, 1985, ENVIRON SCI TECHNOL, V19, P1213, DOI 10.1021/es00142a013; Brannstrom A, 2002, BIOCHEM BIOPH RES CO, V290, P1462, DOI 10.1006/bbrc.2002.6378; Brown JM, 2007, AM J RESP CELL MOL, V36, P43, DOI 10.1165/rcmb.2006-0197OC; Chen YY, 2006, J BIOL CHEM, V281, P12767, DOI 10.1074/jbc.M513628200; Dahl M, 2007, J CLIN INVEST, V117, P757, DOI 10.1172/JCI29968; ELOMAA O, 1995, CELL, V80, P603, DOI 10.1016/0092-8674(95)90514-6; Ghosh S, 2011, AM J RESP CELL MOL, V45, P1036, DOI 10.1165/rcmb.2010-0349OC; Gibbons MA, 2011, AM J RESP CRIT CARE, V184, P569, DOI 10.1164/rccm.201010-1719OC; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gough PJ, 2000, MICROBES INFECT, V2, P305, DOI 10.1016/S1286-4579(00)00297-5; Guidotti TL, 2004, AM J RESP CRIT CARE, V170, P691, DOI 10.1164/rccm.200310-1436ST; Hamilton RF, 2006, J BIOL CHEM, V281, P34218, DOI 10.1074/jbc.M605229200; Harraz MM, 2008, J CLIN INVEST, V118, P659, DOI 10.1172/JCI34060; He C, 2013, J BIOL CHEM, V288, P20745, DOI 10.1074/jbc.M112.410720; He C, 2011, J BIOL CHEM, V286, P15597, DOI 10.1074/jbc.M110.187377; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Jain M, 2013, J BIOL CHEM, V288, P770, DOI 10.1074/jbc.M112.431973; Karo-Atar D, 2013, AM J RESP CELL MOL, V48, P456, DOI 10.1165/rcmb.2012-0329OC; LIGHT WG, 1977, NATURE, V265, P537, DOI 10.1038/265537a0; Magnan A, 1998, ALLERGY, V53, P1092, DOI 10.1111/j.1398-9995.1998.tb03821.x; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Moreira AP, 2011, J INTERF CYTOK RES, V31, P485, DOI 10.1089/jir.2011.0027; Mukhopadhyay S, 2006, EUR J IMMUNOL, V36, P940, DOI 10.1002/eji.200535389; Murthy S, 2010, J BIOL CHEM, V285, P25062, DOI 10.1074/jbc.M109.099655; Murthy S, 2009, AM J PHYSIOL-LUNG C, V297, pL846, DOI 10.1152/ajplung.90590.2008; Nair MG, 2009, J EXP MED, V206, P937, DOI 10.1084/jem.20082048; Ojala JRM, 2007, J BIOL CHEM, V282, P16654, DOI 10.1074/jbc.M701750200; Osborn-Heaford HL, 2012, J BIOL CHEM, V287, P3301, DOI 10.1074/jbc.M111.308387; Palecanda A, 1999, J EXP MED, V189, P1497, DOI 10.1084/jem.189.9.1497; RESNICK D, 1993, J BIOL CHEM, V268, P3538; SCHEULE RK, 1989, AM J RESP CELL MOL, V1, P313, DOI 10.1165/ajrcmb/1.4.313; SCHWARTZ DA, 1993, AM REV RESPIR DIS, V148, P68, DOI 10.1164/ajrccm/148.1.68; SESHAN K, 1983, ENVIRON HEALTH PERSP, V53, P143, DOI 10.2307/3429625; Tao B, 2014, J IMMUNOL, V193, P2801, DOI 10.4049/jimmunol.1303463; Thakur SA, 2009, TOXICOL SCI, V108, P462, DOI 10.1093/toxsci/kfp011; Thakur SA, 2009, TOXICOL SCI, V107, P238, DOI 10.1093/toxsci/kfn210; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; van der Laan LJW, 1999, J IMMUNOL, V162, P939; WRIGHT A, 1983, ENVIRON HEALTH PERSP, V51, P147, DOI 10.1289/ehp.8351147	43	70	75	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3527	3536		10.1096/fj.15-271304	http://dx.doi.org/10.1096/fj.15-271304			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25953850	Green Published			2022-12-26	WOS:000358796900038
J	LeMaster, DM; Mustafi, SM; Brecher, M; Zhang, J; Heroux, A; Li, HM; Hernandez, G				LeMaster, David M.; Mustafi, Sourajit M.; Brecher, Matthew; Zhang, Jing; Heroux, Annie; Li, Hongmin; Hernandez, Griselda			Coupling of Conformational Transitions in the N-terminal Domain of the 51-kDa FK506-binding Protein (FKBP51) Near Its Site of Interaction with the Steroid Receptor Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; conformational change; nuclear magnetic resonance (NMR); prolyl isomerase; x-ray crystallography	GLUCOCORTICOID-RECEPTOR; PROGESTERONE-RECEPTOR; CHEMICAL-EXCHANGE; ACTIVE-SITE; GR-ALPHA; DYNAMICS; BINDING; HSP90; RELAXATION; ASSOCIATION	Background: FK506-binding protein 51 (FKBP51) inhibits and FKBP52 stimulates transcription by various steroid receptors. Exchange of a single residue largely reverses this pattern of regulation. Results: Unlike FKBP52, FKBP51 has two distinct coupled conformational transitions surrounding this mutation site. Conclusion: Structural analysis of FKBP51 transient states can inform inhibitor design by conformational selection. Significance: The differential plasticity of the FKBP domains may underlie their differential regulation. Interchanging Leu-119 for Pro-119 at the tip of the (4)-(5) loop in the first FK506 binding domain (FK1) of the FKBP51 and FKBP52 proteins, respectively, has been reported to largely reverse the inhibitory (FKBP51) or stimulatory (FKBP52) effects of these co-chaperones on the transcriptional activity of glucocorticoid and androgen receptor-protein complexes. Previous NMR relaxation studies have identified exchange line broadening, indicative of submillisecond conformational motion, throughout the (4)-(5) loop in the FK1 domain of FKBP51, which are suppressed by the FKBP52-like L119P substitution. This substitution also attenuates exchange line broadening in the underlying (2) and (3a) strands that is centered near a bifurcated main chain hydrogen bond interaction between these two strands. The present study demonstrates that these exchange line broadening effects arise from two distinct coupled conformational transitions, and the transition within the (2) and (3a) strands samples a transient conformation that resembles the crystal structures of the selectively inhibited FK1 domain of FKBP51 recently reported. Although the crystal structures for their series of inhibitors were interpreted as evidence for an induced fit mechanism of association, the presence of a similar conformation being significantly populated in the unliganded FKBP51 domain is more consistent with a conformational selection binding process. The contrastingly reduced conformational plasticity of the corresponding FK1 domain of FKBP52 is consistent with the current model in which FKBP51 binds to both the apo- and hormone-bound forms of the steroid receptor to modulate its affinity for ligand, whereas FKBP52 binds selectively to the latter state.	[LeMaster, David M.; Mustafi, Sourajit M.; Brecher, Matthew; Zhang, Jing; Li, Hongmin; Hernandez, Griselda] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA; [LeMaster, David M.; Li, Hongmin; Hernandez, Griselda] SUNY Albany, Dept Biomed Sci, Sch Publ Hlth, Albany, NY 12201 USA; [Heroux, Annie] Brookhaven Natl Lab, Upton, NY 11973 USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; United States Department of Energy (DOE); Brookhaven National Laboratory	Hernandez, G (corresponding author), Empire State Plaza, Albany, NY 12201 USA.	griselda.hernandez@health.ny.gov	Li, Hongmin/ABI-2439-2020; Regan, Clinton/E-6250-2012	Li, Hongmin/0000-0002-8684-5308; Brecher, Matthew/0000-0003-1151-2290	National Institutes of Health [GM 088214]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088214] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 088214 (to G. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anderson JS, 2014, BIOPHYS CHEM, V192, P41, DOI 10.1016/j.bpc.2014.06.004; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Barent RL, 1998, MOL ENDOCRINOL, V12, P342, DOI 10.1210/me.12.3.342; Baughman G, 1997, BIOCHEM BIOPH RES CO, V232, P437, DOI 10.1006/bbrc.1997.6307; Binder EB, 2004, NAT GENET, V36, P1319, DOI 10.1038/ng1479; Blackburn EA, 2011, CURR OPIN PHARMACOL, V11, P365, DOI 10.1016/j.coph.2011.04.007; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Bracher A, 2013, J MOL BIOL, V425, P4134, DOI 10.1016/j.jmb.2013.07.041; Bracher A, 2011, ACTA CRYSTALLOGR D, V67, P549, DOI 10.1107/S0907444911013862; Brath U, 2006, J AM CHEM SOC, V128, P5718, DOI 10.1021/ja0570279; Brath U, 2009, J MOL BIOL, V387, P233, DOI 10.1016/j.jmb.2009.01.047; Case DA, 1995, J BIOMOL NMR, V6, P341; Chen H, 2014, ACTA CRYSTALLOGR D, V70, P636, DOI 10.1107/S1399004713032112; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; Davies TH, 2002, J BIOL CHEM, V277, P4597, DOI 10.1074/jbc.C100531200; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Denny WB, 2000, ENDOCRINOLOGY, V141, P4107, DOI 10.1210/en.141.11.4107; Egeler EL, 2011, J BIOL CHEM, V286, P31328, DOI 10.1074/jbc.M111.264101; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fabian AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057508; Feng HP, 2001, BLOOD, V97, P3505, DOI 10.1182/blood.V97.11.3505; Gaali S, 2015, NAT CHEM BIOL, V11, P33, DOI 10.1038/nchembio.1699; Galat A, 2008, J CHEM INF MODEL, V48, P1118, DOI 10.1021/ci700429n; Galigniana NM, 2012, J NEUROCHEM, V122, P4, DOI 10.1111/j.1471-4159.2012.07775.x; Gkika D, 2006, AM J PHYSIOL-RENAL, V290, pF1253, DOI 10.1152/ajprenal.00298.2005; HAIGH CW, 1979, PROG NUCL MAG RES SP, V13, P303, DOI 10.1016/0079-6565(79)80010-2; Han B, 2011, J BIOMOL NMR, V50, P43, DOI 10.1007/s10858-011-9478-4; Jiang W, 2008, NEOPLASIA, V10, P235, DOI 10.1593/neo.07929; Kirschke E, 2014, CELL, V157, P1685, DOI 10.1016/j.cell.2014.04.038; Kohlhoff KJ, 2009, J AM CHEM SOC, V131, P13894, DOI 10.1021/ja903772t; Lakomek NA, 2012, J BIOMOL NMR, V53, P209, DOI 10.1007/s10858-012-9626-5; Li PY, 2003, ACTA CRYSTALLOGR D, V59, P16, DOI 10.1107/S0907444902017523; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Mandel AM, 1996, BIOCHEMISTRY-US, V35, P16009, DOI 10.1021/bi962089k; Millet O, 2000, J AM CHEM SOC, V122, P2867, DOI 10.1021/ja993511y; Moon S, 2007, J BIOMOL NMR, V38, P139, DOI 10.1007/s10858-007-9156-8; Mustafi SM, 2014, BIOCHEM J, V461, P115, DOI 10.1042/BJ20140232; Mustafi SM, 2014, BIOCHEM J, V458, P525, DOI 10.1042/BJ20131429; Mustafi SM, 2013, BIOCHEM J, V453, P371, DOI 10.1042/BJ20130276; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palmer AG, 2014, J MAGN RESON, V241, P3, DOI 10.1016/j.jmr.2014.01.008; Pei HD, 2009, CANCER CELL, V16, P259, DOI 10.1016/j.ccr.2009.07.016; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfaff SJ, 2010, J BIOL CHEM, V285, P15256, DOI 10.1074/jbc.M110.108118; Riggs DL, 2007, MOL CELL BIOL, V27, P8658, DOI 10.1128/MCB.00985-07; Riggs DL, 2003, EMBO J, V22, P1158, DOI 10.1093/emboj/cdg108; SANCHEZ ER, 1990, J BIOL CHEM, V265, P22067; Sapienza PJ, 2011, J MOL BIOL, V405, P378, DOI 10.1016/j.jmb.2010.10.037; Sekhar A, 2013, P NATL ACAD SCI USA, V110, P12867, DOI 10.1073/pnas.1305688110; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Shen Y, 2010, J BIOMOL NMR, V48, P13, DOI 10.1007/s10858-010-9433-9; Shim S, 2009, NEURON, V64, P471, DOI 10.1016/j.neuron.2009.09.025; Silverstein AM, 1999, J BIOL CHEM, V274, P36980, DOI 10.1074/jbc.274.52.36980; SMITH DF, 1990, J BIOL CHEM, V265, P3996; Stechschulte LA, 2014, MOL ENDOCRINOL, V28, P1254, DOI 10.1210/me.2014-1023; Stechschulte LA, 2014, MOL ENDOCRINOL, V28, P1265, DOI 10.1210/me.2014-1022; TAI PKK, 1986, BIOCHEMISTRY-US, V25, P5269, DOI 10.1021/bi00366a043; Tang SS, 2011, J BIOMOL NMR, V51, P303, DOI 10.1007/s10858-011-9556-7; Trebble PJ, 2013, J CELL SCI, V126, P3159, DOI 10.1242/jcs.124784; Wochnik GM, 2005, J BIOL CHEM, V280, P4609, DOI 10.1074/jbc.M407498200; Wu BL, 2004, P NATL ACAD SCI USA, V101, P8348, DOI 10.1073/pnas.0305969101; Yang W, 2000, J MED CHEM, V43, P1135, DOI 10.1021/jm9904396	63	11	11	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2015	290	25					15746	15757		10.1074/jbc.M115.650655	http://dx.doi.org/10.1074/jbc.M115.650655			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK8YW	25953903	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000356527400036
J	Kim, S; Park, J; Kim, HJ; Lee, JJ; Choi, G; Choi, S; Kim, S; Kim, SY; Moon, HB; Kim, S; Choi, K				Kim, Sunmi; Park, Jeongim; Kim, Hai-Joong; Lee, Jeong Jae; Choi, Gyuyeon; Choi, Sooran; Kim, Sungjoo; Kim, Su Young; Moon, Hyo-Bang; Kim, Sungkyoon; Choi, Kyungho			Association between Several Persistent Organic Pollutants and Thyroid Hormone Levels in Cord Blood Serum and Bloodspot of the Newborn Infants of Korea	PLOS ONE			English	Article							POLYBROMINATED DIPHENYL ETHERS; POLYCHLORINATED-BIPHENYLS PCBS; ENDOCRINE-DISRUPTING CHEMICALS; BROMINATED FLAME RETARDANTS; TIME-COURSE VARIATION; SPRAGUE-DAWLEY RATS; HUMAN BREAST-MILK; STIMULATING HORMONE; ORGANOCHLORINE COMPOUNDS; PRENATAL EXPOSURE	Current knowledge on adverse endocrine disruption effects of persistent organic pollutants (POPs) among newborn infants is limited and often controversial. To investigate the associations between prenatal exposure to major POPs and thyroid hormone levels among newborn infants, both cord serum or maternal serum concentrations of polychlorinated biphenyls (PCBs), polybrominated diphenyl ethers (PBDEs), and organochlorine pesticides (OCPs) were compared with five thyroid hormones in cord serum of newborn infants as well as TSH in bloodspot collected at 2 day after birth (n= 104). Since cord serum thyroid hormones could be affected by those of mothers, thyroid hormone concentrations of the matching mothers at delivery were adjusted. In cord serum, BDE-47, -99, and Sigma chlordane (CHD) showed significant positive associations with cord or bloodspot TSH. At the same time, p, p'-dichlorodiphenyldichloroethylene (p, p'-DDE) and hexachlorbenzene (HCB) showed negative associations with total T3 and total T4 in cord serum, respectively. Maternal exposure to beta-hexachlorhexane (beta-HCH), SCHD, SDDT, or p, p'-DDE were also associated with neonatal thyroid hormones. Although the sample size is small and the thyroid hormone levels of the subjects were within the reference range, our observation supports thyroid disrupting potential of several POPs among newborn infants, at the levels occurring in the general population. Considering the importance of thyroid hormones during gestation and early life stages, health implication of thyroid hormone effects by low level POPs exposure deserves further follow up investigations.	[Kim, Sunmi; Kim, Sungkyoon; Choi, Kyungho] Seoul Natl Univ, Sch Publ Hlth, Seoul, South Korea; [Park, Jeongim] Soonchunhyang Univ, Coll Nat Sci, Asan, Chungcheong, South Korea; [Kim, Hai-Joong] Korea Univ, Coll Med, Seoul 136705, South Korea; [Lee, Jeong Jae; Choi, Gyuyeon] Soonchunhyang Univ, Coll Med, Seoul, South Korea; [Choi, Sooran] Inha Univ, Coll Med, Inchon, South Korea; [Kim, Sungjoo] Hallym Univ, Coll Med, Seoul, South Korea; [Kim, Su Young] Jeju Natl Univ, Coll Med, Jeju, South Korea; [Moon, Hyo-Bang] Hanyang Univ, Coll Sci & Technol, Ansan, Gyeonggi, South Korea	Seoul National University (SNU); Soonchunhyang University; Korea University; Korea University Medicine (KU Medicine); Soonchunhyang University; Inha University; Hallym University; Jeju National University; Hanyang University	Choi, K (corresponding author), Seoul Natl Univ, Sch Publ Hlth, Seoul, South Korea.	kyungho@snu.ac.kr	Choi, Soo Ran/HGU-9143-2022; Moon, Hyo-Bang/M-7676-2017; choi, kyungho/D-5732-2012; Kim, Sunmi/G-8114-2015	Moon, Hyo-Bang/0000-0001-6618-2036; choi, kyungho/0000-0001-7460-792X; Kim, Sunmi/0000-0001-9699-6532; Kim, Sungkyoon/0000-0002-1378-8795	Ministry of Food and Drug Safety of Korea [11162MFDS722]; National Research Foundation of Korea [2012R1A2A2A01015236]; BK 21 Plus program of National Research Foundation of Korea	Ministry of Food and Drug Safety of Korea(Ministry of Food & Drug Safety (MFDS), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); BK 21 Plus program of National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by a grant (11162MFDS722) from the Ministry of Food and Drug Safety of Korea(http://rnd.mfds.go.kr) in 2011 and the National Research Foundation of Korea (Project 2012R1A2A2A01015236, http://www.nrf.re.kr/nrf_eng_cms). S. M. Kim is supported by BK 21 Plus program of National Research Foundation of Korea (https://bkplus.nrf.re.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelouahab N, 2013, AM J EPIDEMIOL, V178, P701, DOI 10.1093/aje/kwt141; Abdelouahab N, 2009, NEONATOLOGY, V96, P120, DOI 10.1159/000209316; Alvarez L, 2005, TOXICOLOGY, V207, P349, DOI 10.1016/j.tox.2004.10.006; Alvarez-Pedrerol M, 2009, ENVIRON SCI TECHNOL, V43, P7909, DOI 10.1021/es9007273; Asawasinsopon R, 2006, ENVIRON INT, V32, P554, DOI 10.1016/j.envint.2006.01.001; Benhadi N, 2009, EUR J ENDOCRINOL, V160, P985, DOI 10.1530/EJE-08-0953; Berbel P, 2009, THYROID, V19, P511, DOI 10.1089/thy.2008.0341; Bergman A, 2012, STATE OF THE SCIENCE; Bernert JT, 2007, CHEMOSPHERE, V68, P824, DOI 10.1016/j.chemosphere.2007.02.043; Boas M, 2006, EUR J ENDOCRINOL, V154, P599, DOI 10.1530/eje.1.02128; Bourcigaux N, 2010, ANN ENDOCRINOL-PARIS, V71, P519, DOI 10.1016/j.ando.2010.08.004; Chevrier J, 2008, AM J EPIDEMIOL, V168, P298, DOI 10.1093/aje/kwn136; Chevrier J, 2007, ENVIRON HEALTH PERSP, V115, P1490, DOI 10.1289/ehp.9843; Chevrier J, 2011, AM J EPIDEMIOL, V174, P1166, DOI 10.1093/aje/kwr223; Choi G, 2014, SCI TOTAL ENVIRON, V491, P219, DOI 10.1016/j.scitotenv.2014.02.071; CONTEMPRE B, 1993, J CLIN ENDOCR METAB, V77, P1719, DOI 10.1210/jc.77.6.1719; Dallaire R, 2008, ENVIRON RES, V108, P387, DOI 10.1016/j.envres.2008.08.004; Darras VM, 2008, CEREBELLUM, V7, P26, DOI 10.1007/s12311-008-0004-5; Dencker L, 1998, FOOD ADDIT CONTAM, V15, P37, DOI 10.1080/02652039809374613; Donahue DA, 2004, TOXICOLOGY, V203, P99, DOI 10.1016/j.tox.2004.06.011; Eggesbo M, 2011, ENVIRON RES, V111, P737, DOI 10.1016/j.envres.2011.05.004; Eriksson P, 2001, ENVIRON HEALTH PERSP, V109, P903, DOI 10.2307/3454990; Eriksson P, 2000, NEUROTOXICOLOGY, V21, P37; Fisher DA, 1997, CLIN OBSTET GYNECOL, V40, P16, DOI 10.1097/00003081-199703000-00005; Forhead AJ, 2014, J ENDOCRINOL, V221, pR87, DOI 10.1530/JOE-14-0025; FOSTER WG, 1993, J APPL TOXICOL, V13, P79, DOI 10.1002/jat.2550130203; FRANKLIN RC, 1985, ARCH DIS CHILD, V60, P141, DOI 10.1136/adc.60.2.141; Fujii Y, 2011, CHEMOSPHERE, V82, P25, DOI 10.1016/j.chemosphere.2010.10.036; Gascon M, 2011, ENVIRON INT, V37, P605, DOI 10.1016/j.envint.2010.12.005; Gauger KJ, 2004, ENVIRON HEALTH PERSP, V112, P516, DOI 10.1289/ehp.6672; Glinoer D, 1997, ENDOCR REV, V18, P404, DOI 10.1210/er.18.3.404; GLINOER D, 1992, J CLIN ENDOCR METAB, V75, P800, DOI 10.1210/jc.75.3.800; Goldner WS, 2010, AM J EPIDEMIOL, V171, P455, DOI 10.1093/aje/kwp404; Gomara B, 2007, ENVIRON SCI TECHNOL, V41, P6961, DOI 10.1021/es0714484; Hallgren S, 2002, TOXICOLOGY, V177, P227, DOI 10.1016/S0300-483X(02)00222-6; Hallgren S, 2001, ARCH TOXICOL, V75, P200, DOI 10.1007/s002040000208; Hardy JD, 2008, J PEDIATR ENDOCR MET, V21, P245; Herbstman J, 2008, THYROID, V18, P67, DOI 10.1089/thy.2007.0180; Herbstman JB, 2008, ENVIRON HEALTH PERSP, V116, P1376, DOI 10.1289/ehp.11379; Hisada A, 2014, INT J HYG ENVIR HEAL, V217, P546, DOI 10.1016/j.ijheh.2013.10.004; Hornung RW, 1990, APPL OCCUP ENVIRON H, V5, P46, DOI [10.1080/1047322X.1990.10389587, DOI 10.1080/1047322X.1990.10389587]; Idris I, 2005, CLIN ENDOCRINOL, V63, P560, DOI 10.1111/j.1365-2265.2005.02382.x; Kapelari Klaus, 2008, BMC Endocr Disord, V8, P15, DOI 10.1186/1472-6823-8-15; Kim SS, 2005, ANN PEDIATR ENDOCRIN, V10, P147; Kim S, 2013, ENVIRON INT, V59, P442, DOI 10.1016/j.envint.2013.07.009; Kim TH, 2009, J TOXICOL ENV HEAL A, V72, P1296, DOI 10.1080/15287390903320742; Kim UJ, 2011, CHEMOSPHERE, V85, P487, DOI 10.1016/j.chemosphere.2011.08.008; Kodavanti PRS, 2010, TOXICOL SCI, V116, P297, DOI 10.1093/toxsci/kfq105; Lee S, 2013, CHEMOSPHERE, V93, P1578, DOI 10.1016/j.chemosphere.2013.08.011; Lee S, 2013, ENVIRON RES, V126, P76, DOI 10.1016/j.envres.2013.08.004; Lin SM, 2011, INT J HYG ENVIR HEAL, V214, P115, DOI 10.1016/j.ijheh.2010.10.002; Longnecker MP, 2000, EPIDEMIOLOGY, V11, P249, DOI 10.1097/00001648-200005000-00004; Maervoet J, 2007, ENVIRON HEALTH PERSP, V115, P1780, DOI 10.1289/ehp.10486; Makri A, 2004, J TOXICOL ENV HEAL B, V7, P417, DOI 10.1080/10937400490512465; Martin L, 2010, TOXICOL SCI, V117, P36, DOI 10.1093/toxsci/kfq187; Meeker JD, 2007, ENVIRON RES, V104, P296, DOI 10.1016/j.envres.2006.11.007; Ribas-Fito N, 2003, OCCUP ENVIRON MED, V60, P301, DOI 10.1136/oem.60.4.301; Richardson VM, 2008, TOXICOL APPL PHARM, V226, P244, DOI 10.1016/j.taap.2007.09.015; Sahu MT, 2010, ARCH GYNECOL OBSTET, V281, P215, DOI 10.1007/s00404-009-1105-1; Santini F, 2003, J ENDOCRINOL INVEST, V26, P950, DOI 10.1007/BF03348190; Schug TT, 2011, J STEROID BIOCHEM, V127, P204, DOI 10.1016/j.jsbmb.2011.08.007; Scollon EJ, 2004, COMP BIOCHEM PHYS C, V137, P179, DOI 10.1016/j.cca.2004.01.004; Shimada N, 2004, J ENDOCRINOL, V183, P627, DOI 10.1677/joe.1.05893; Siddiqi Muhammad Akmal, 2003, Clin Med Res, V1, P281; Skinner MK, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-228; Smith D, 1999, INT J EPIDEMIOL, V28, P179, DOI 10.1093/ije/28.2.179; Spencer CA, 2013, ASSAY OF THYROID HOR; Stagnaro-Green A, 2005, THYROID, V15, P351, DOI 10.1089/thy.2005.15.351; Stapleton HM, 2011, ENVIRON HEALTH PERSP, V119, P1454, DOI 10.1289/ehp.1003235; Takser L, 2005, ENVIRON HEALTH PERSP, V113, P1039, DOI 10.1289/ehp.7685; THORPEBEESTON JG, 1991, AM J OBSTET GYNECOL, V164, P1244, DOI 10.1016/0002-9378(91)90692-K; Torremante P, 2011, J THROID RES, V2011, DOI 10.4061/2011/905734; UCLA: Statistical Consulting Group, HOW DO I INTERPRET A; US EPA, 2009, PERSISTENT ORGANIC P; Vesselinovitch S D, 1979, Natl Cancer Inst Monogr, P239; Vizcaino E, 2014, ENVIRON INT, V65, P107, DOI 10.1016/j.envint.2014.01.004; Zhang JQ, 2010, ENVIRON SCI TECHNOL, V44, P3956, DOI 10.1021/es902883a; Zhou T, 2001, TOXICOL SCI, V61, P76, DOI 10.1093/toxsci/61.1.76; Zoeller RT, 2000, ENDOCRINOLOGY, V141, P181, DOI 10.1210/en.141.1.181	79	62	64	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0125213	10.1371/journal.pone.0125213	http://dx.doi.org/10.1371/journal.pone.0125213			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965908	Green Published, gold, Green Submitted			2022-12-26	WOS:000354543500012
J	Wood, DLA; Nones, K; Steptoe, A; Christ, A; Harliwong, I; Newell, F; Bruxner, TJC; Miller, D; Cloonan, N; Grimmond, SM				Wood, David L. A.; Nones, Katia; Steptoe, Anita; Christ, Angelika; Harliwong, Ivon; Newell, Felicity; Bruxner, Timothy J. C.; Miller, David; Cloonan, Nicole; Grimmond, Sean M.			Recommendations for Accurate Resolution of Gene and Isoform Allele-Specific Expression in RNA-Seq Data	PLOS ONE			English	Article							HUMAN GENOME; TRANSCRIPTOME; HUMANS; METHYLATION; IMBALANCE; SEQUENCE; DISEASE; READS; RISK	Genetic variation modulates gene expression transcriptionally or post-transcriptionally, and can profoundly alter an individual's phenotype. Measuring allelic differential expression at heterozygous loci within an individual, a phenomenon called allele-specific expression (ASE), can assist in identifying such factors. Massively parallel DNA and RNA sequencing and advances in bioinformatic methodologies provide an outstanding opportunity to measure ASE genome-wide. In this study, matched DNA and RNA sequencing, genotyping arrays and computationally phased haplotypes were integrated to comprehensively and conservatively quantify ASE in a single human brain and liver tissue sample. We describe a methodological evaluation and assessment of common bioinformatic steps for ASE quantification, and recommend a robust approach to accurately measure SNP, gene and isoform ASE through the use of personalized haplotype genome alignment, strict alignment quality control and intragenic SNP aggregation. Our results indicate that accurate ASE quantification requires careful bioinformatic analyses and is adversely affected by sample specific alignment confounders and random sampling even at moderate sequence depths. We identified multiple known and several novel ASE genes in liver, including WDR72, DSP and UBD, as well as genes that contained ASE SNPs with imbalance direction discordant with haplotype phase, explainable by annotated transcript structure, suggesting isoform derived ASE. The methods evaluated in this study will be of use to researchers performing highly conservative quantification of ASE, and the genes and isoforms identified as ASE of interest to researchers studying those loci.	[Wood, David L. A.; Nones, Katia; Steptoe, Anita; Christ, Angelika; Harliwong, Ivon; Newell, Felicity; Bruxner, Timothy J. C.; Miller, David; Grimmond, Sean M.] Univ Queensland, Queensland Ctr Med Genom, Brisbane, Qld, Australia; [Cloonan, Nicole] QIMR Berghofer Med Res Inst, Herston, Qld 4006, Australia; [Grimmond, Sean M.] Univ Glasgow, Translat Res Ctr, Glasgow, Lanark, Scotland	University of Queensland; QIMR Berghofer Medical Research Institute; University of Glasgow	Wood, DLA (corresponding author), Univ Queensland, Queensland Ctr Med Genom, Brisbane, Qld, Australia.	d.wood@imb.uq.edu.au	Cloonan, Nicole/B-5272-2008; Nones, Katia/AAX-6453-2021; Newell, Felicity/AAN-1253-2020; Grimmond, Sean M/J-5304-2016; Grimmond, Sean/K-3246-2019	Cloonan, Nicole/0000-0001-7802-6647; Nones, Katia/0000-0003-1925-5196; Grimmond, Sean M/0000-0002-8102-7998; Grimmond, Sean/0000-0002-8102-7998; Wood, David/0000-0002-1001-2019; Bruxner, Timothy/0000-0002-8088-316X; Christ, Angelika/0000-0002-8680-2367	Australian Research Council (ARC) [DP0988754]; Australian Government; ARC [DP0988754, FT120100453]	Australian Research Council (ARC)(Australian Research Council); Australian Government(Australian GovernmentCGIAR); ARC(Australian Research Council)	This research was funded under an Australian Research Council (ARC) discovery project grant (DP0988754). DW was supported by an Australian Postgraduate Award funded by the Australian Government. NC was supported by ARC grant (DP0988754 and FT120100453). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassi C, 2009, TRENDS CELL BIOL, V19, P465, DOI 10.1016/j.tcb.2009.06.001; Andres AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001157; Augui S, 2011, NAT REV GENET, V12, P429, DOI 10.1038/nrg2987; Battle A, 2014, GENOME RES, V24, P14, DOI 10.1101/gr.155192.113; Castellanos-Rubio A, 2010, HUM IMMUNOL, V71, P96, DOI 10.1016/j.humimm.2009.09.359; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Coles BF, 2001, PHARMACOGENETICS, V11, P663, DOI 10.1097/00008571-200111000-00004; Degner JF, 2009, BIOINFORMATICS, V25, P3207, DOI 10.1093/bioinformatics/btp579; Derrien T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030377; DeVeale B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002600; El-Sayed W, 2009, AM J HUM GENET, V85, P699, DOI 10.1016/j.ajhg.2009.09.014; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Ferguson-Smith AC, 2011, NAT REV GENET, V12, P565, DOI 10.1038/nrg3032; Fraser HB, 2009, GENOME RES, V19, P567, DOI 10.1101/gr.083477.108; Fritsche LG, 2010, HUM MOL GENET, V19, P4694, DOI 10.1093/hmg/ddq399; Heap GA, 2010, HUM MOL GENET, V19, P122, DOI 10.1093/hmg/ddp473; Jing-ru B, 2013, CHIN MED J, V126, P4238, DOI [10.3760/cma.j.issn.0366, DOI 10.3760/CMA.J.ISSN.0366]; Kadota M, 2007, PLOS GENET, V3, P768, DOI 10.1371/journal.pgen.0030081; Kasowski M, 2013, SCIENCE, V342, P750, DOI 10.1126/science.1242510; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Kassahn KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074380; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Koehler R, 2010, BIOINFORMATICS OXFOR, P1, DOI [10.1093/bioinformatics/btq640, DOI 10.1093/BIOINFORMATICS/BTQ640]; Kwan T, 2007, GENOME RES, V17, P1210, DOI 10.1101/gr.6281007; Lalonde E, 2011, GENOME RES, V21, P545, DOI 10.1101/gr.111211.110; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Le Cao KA, 2009, BIOINFORMATICS, V25, P2855, DOI 10.1093/bioinformatics/btp515; Li G, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks280; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Majewski J, 2011, TRENDS GENET, V27, P72, DOI 10.1016/j.tig.2010.10.006; Markowitz S, 2001, NAT GENET, V1756, P2001, DOI [10.1038/ng799, DOI 10.1038/NG799]; Meyer KB, 2008, PLOS BIOL, V6, P1098, DOI 10.1371/journal.pbio.0060108; Milani L, 2009, GENOME RES, V19, P1, DOI 10.1101/gr.083931.108; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ng HK, 2010, PLACENTA, V31, P259, DOI 10.1016/j.placenta.2010.01.009; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Powell JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035430; Rozowsky J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.54; Satya RV, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks425; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Shoemaker R, 2010, GENOME RES, V20, P883, DOI 10.1101/gr.104695.109; Singh P, 2011, MOL CELL BIOL, V31, P1757, DOI 10.1128/MCB.00961-10; Skelly DA, 2011, GENOME RES, V21, P1728, DOI 10.1101/gr.119784.110; Stevenson KR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-536; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Turro E, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r13; Whittock NV, 2002, J INVEST DERMATOL, V118, P232, DOI 10.1046/j.0022-202x.2001.01664.x; Wilkinson LS, 2007, NAT REV NEUROSCI, V8, P832, DOI 10.1038/nrn2235; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394	55	14	15	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0126911	10.1371/journal.pone.0126911	http://dx.doi.org/10.1371/journal.pone.0126911			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965996	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000354543500085
J	Gong, LC; Zhou, X; Ouyang, ZC				Gong, Linchen; Zhou, Xin; Ouyang, Zhongcan			Systematically Constructing Kinetic Transition Network in Polypeptide from Top to Down: Trajectory Mapping	PLOS ONE			English	Article							ENERGY LANDSCAPES; DYNAMICS; PROTEINS; ENSEMBLE; BEHAVIOR; MODELS	Molecular dynamics (MD) simulation is an important tool for understanding bio-molecules in microscopic temporal/spatial scales. Besides the demand in improving simulation techniques to approach experimental scales, it becomes more and more crucial to develop robust methodology for precisely and objectively interpreting massive MD simulation data. In our previous work [J Phys Chem B 114, 10266 (2010)], the trajectory mapping (TM) method was presented to analyze simulation trajectories then to construct a kinetic transition network of metastable states. In this work, we further present a top-down implementation of TM to systematically detect complicate features of conformational space. We first look at longer MD trajectory pieces to get a coarse picture of transition network at larger time scale, and then we gradually cut the trajectory pieces in shorter for more details. A robust clustering algorithm is designed to more effectively identify the metastable states and transition events. We applied this TM method to detect the hierarchical structure in the conformational space of alanine-dodeca-peptide from microsecond to nanosecond time scales. The results show a downhill folding process of the peptide through multiple pathways. Even in this simple system, we found that single common-used order parameter is not sufficient either in distinguishing the metastable states or predicting the transition kinetics among these states.	[Gong, Linchen; Ouyang, Zhongcan] Tsinghua Univ, Inst Adv Study, Beijing 100080, Peoples R China; [Zhou, Xin] Univ Chinese Acad Sci, Sch Phys, Beijing 100049, Peoples R China; [Ouyang, Zhongcan] Chinese Acad Sci, Inst Theoret Phys, Beijing 100190, Peoples R China	Tsinghua University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Theoretical Physics, CAS	Zhou, X (corresponding author), Univ Chinese Acad Sci, Sch Phys, Beijing 100049, Peoples R China.	xzhou@ucas.ac.cn	Zhou, Xin/AAH-1238-2020		National Science Foundation of China [11175250]; Hundred of Talents Program in Chinese Academy of Sciences	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hundred of Talents Program in Chinese Academy of Sciences	XZ: Grant No. 11175250 of National Science Foundation of China, http://www.nsfc.gov.cn/ and XZ: the Hundred of Talents Program in Chinese Academy of Sciences, http://www.cas.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett AI, 2009, NAT STRUCT MOL BIOL, V16, P582, DOI 10.1038/nsmb.1592; Best RB, 2013, P NATL ACAD SCI USA, V110, P17874, DOI 10.1073/pnas.1311599110; Bowman GR, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4812768; Bowman GR, 2010, P NATL ACAD SCI USA, V107, P10890, DOI 10.1073/pnas.1003962107; Bowman GR, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3216567; Brockwell DJ, 2007, CURR OPIN STRUC BIOL, V17, P30, DOI 10.1016/j.sbi.2007.01.003; Buchete NV, 2008, J PHYS CHEM B, V112, P6057, DOI 10.1021/jp0761665; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Chodera JD, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2714538; Coifman RR, 2006, APPL COMPUT HARMON A, V21, P5, DOI 10.1016/j.acha.2006.04.006; Das P, 2006, P NATL ACAD SCI USA, V103, P9885, DOI 10.1073/pnas.0603553103; Deng NJ, 2013, J PHYS CHEM B, V117, P12787, DOI 10.1021/jp401962k; Deuflhard P, 2000, LINEAR ALGEBRA APPL, V315, P39, DOI 10.1016/S0024-3795(00)00095-1; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Fersht AR, 2008, NAT REV MOL CELL BIO, V9, P650, DOI 10.1038/nrm2446; Gfeller D, 2007, P NATL ACAD SCI USA, V104, P1817, DOI 10.1073/pnas.0608099104; Gong LC, 2010, J PHYS CHEM B, V114, P10266, DOI 10.1021/jp100737g; Gong LC, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026707; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hovmoller S, 2002, ACTA CRYSTALLOGR D, V58, P768, DOI 10.1107/S0907444902003359; Jayachandran G, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2186317; Kohn JE, 2004, P NATL ACAD SCI USA, V101, P12491, DOI 10.1073/pnas.0403643101; Krivov SV, 2004, P NATL ACAD SCI USA, V101, P14766, DOI 10.1073/pnas.0406234101; Lee KCB, 2001, BIOPHYS J, V81, P1265, DOI 10.1016/S0006-3495(01)75784-0; Levy Y, 2001, P NATL ACAD SCI USA, V98, P2188, DOI 10.1073/pnas.041611998; Lindorff-Larsen K, 2012, J AM CHEM SOC, V134, P3787, DOI 10.1021/ja209931w; Lu SJ, 2015, COMMUN THEOR PHYS, V63, P10, DOI 10.1088/0253-6102/63/1/03; Maisuradze GG, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.238102; Marsh JA, 2007, J MOL BIOL, V367, P1494, DOI 10.1016/j.jmb.2007.01.038; McGibbon RT, 2015, J CHEM PHYS, V142, DOI 10.1063/1.4916292; Mu YG, 2005, PROTEINS, V58, P45, DOI 10.1002/prot.20310; Nadler B, 2006, APPL COMPUT HARMON A, V21, P113, DOI 10.1016/j.acha.2005.07.004; Naritomi Y, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3554380; Noe F, 2008, CURR OPIN STRUC BIOL, V18, P154, DOI 10.1016/j.sbi.2008.01.008; Noe F, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2714539; Noe F, 2009, P NATL ACAD SCI USA, V106, P19011, DOI 10.1073/pnas.0905466106; Nuske F, 2014, J CHEM THEORY COMPUT, V10, P1739, DOI 10.1021/ct4009156; Pande VS, 2010, METHODS, V52, P99, DOI 10.1016/j.ymeth.2010.06.002; Prada-Gracia D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000415; Qiu D, 1997, J PHYS CHEM A, V101, P3005, DOI 10.1021/jp961992r; Rao F, 2004, J MOL BIOL, V342, P299, DOI 10.1016/j.jmb.2004.06.063; Rao F, 2010, P NATL ACAD SCI USA, V107, P9152, DOI 10.1073/pnas.0915087107; Schuler B, 2008, CURR OPIN STRUC BIOL, V18, P16, DOI 10.1016/j.sbi.2007.12.003; Schwantes CR, 2013, J CHEM THEORY COMPUT, V9, P2000, DOI 10.1021/ct300878a; Shao JY, 2007, J CHEM THEORY COMPUT, V3, P2312, DOI 10.1021/ct700119m; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Shea JE, 2001, ANNU REV PHYS CHEM, V52, P499, DOI 10.1146/annurev.physchem.52.1.499; Sims GE, 2005, P NATL ACAD SCI USA, V102, P618, DOI 10.1073/pnas.0408746102; TORDA AE, 1994, J COMPUT CHEM, V15, P1331, DOI 10.1002/jcc.540151203; Voelz VA, 2010, J AM CHEM SOC, V132, P1526, DOI 10.1021/ja9090353; Wales DJ, 2005, PHYS BIOL, V2, pS86, DOI 10.1088/1478-3975/2/4/S02; Weber JK, 2013, J AM CHEM SOC, V135, P5501, DOI 10.1021/ja4002663; Weber M, 2003, ZIB REP, V03-04, P1	53	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0125932	10.1371/journal.pone.0125932	http://dx.doi.org/10.1371/journal.pone.0125932			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962177	Green Published, gold, Green Submitted			2022-12-26	WOS:000354542500051
J	Khan, L; Makhdoomi, MA; Kumar, S; Nair, A; Andrabi, R; Clark, BE; Auyeung, K; Bhattacharya, J; Vajpayee, M; Wig, N; Pantophlet, R; Luthra, K				Khan, Lubina; Makhdoomi, Muzamil Ashraf; Kumar, Sanjeev; Nair, Ambili; Andrabi, Raiees; Clark, Brenda E.; Auyeung, Kate; Bhattacharya, Jayanta; Vajpayee, Madhu; Wig, Naveet; Pantophlet, Ralph; Luthra, Kalpana			Identification of CD4-Binding Site Dependent Plasma Neutralizing Antibodies in an HIV-1 Infected Indian Individual	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODIES; PROXIMAL EXTERNAL REGION; POTENT NEUTRALIZATION; HIV-1 NEUTRALIZATION; TYPE-1 ENVELOPE; VIRUS; BROAD; EPITOPE; GP120; GP41	Dissecting antibody specificities in the plasma of HIV-1 infected individuals that develop broadly neutralizing antibodies (bNAbs) is likely to provide useful information for refining target epitopes for vaccine design. Several studies have reported CD4-binding site (CD4bs) antibodies as neutralization determinants in the plasma of subtype B-infected individuals; however there is little information on the prevalence of CD4bs specificities in HIV-infected individuals in India. Here, we report on the presence of CD4bs antibodies and their contribution to virus neutralization in the plasma from a cohort of HIV-1 infected Indian individuals. Plasma from 11 of the 140 HIV-1 infected individuals (7.9%) studied here exhibited crossneutralization activity against a panel of subtype B and C viruses. Analyses of these 11 plasma samples for the presence of CD4bs antibodies using two CD4bs-selective probes (antigenically resurfaced HXB2gp120 core protein RSC3 and hyperglycosylated JRFLgp120 mutant Delta N2mCHO) revealed that five (AIIMS 617, 619, 627, 642, 660) contained RSC3-reactive plasma antibodies and only one (AIIMS 660) contained Delta N2mCHO-reactive antibodies. Plasma antibody depletion and competition experiments confirmed that the neutralizing activity in the AIIMS 660 plasma was dependent on CD4bs antibodies. To the best of our knowledge, this is the first study to report specifically on the presence of CD4bs antibodies in the plasma of a cohort of HIV-1 infected Indian donors. The identification of CD4bs dependent neutralizing antibodies in an HIV-1 infected Indian donor is a salient finding of this study and is supportive of ongoing efforts to induce similar antibodies by immunization.	[Khan, Lubina; Makhdoomi, Muzamil Ashraf; Kumar, Sanjeev; Nair, Ambili; Andrabi, Raiees; Luthra, Kalpana] All India Inst Med Sci, Dept Biochem, New Delhi 110029, India; [Clark, Brenda E.; Auyeung, Kate; Pantophlet, Ralph] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Bhattacharya, Jayanta; Pantophlet, Ralph] Translat Hlth Sci & Technol Inst, THSTI IAVI HIV Vaccine Design Program, HIV Vaccine Translat Res Lab, Gurgaon, Haryana, India; [Vajpayee, Madhu] All India Inst Med Sci, Dept Microbiol, New Delhi 110029, India; [Wig, Naveet] All India Inst Med Sci, Dept Med, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Simon Fraser University; Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI); International AIDS Vaccine Initiative; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Luthra, K (corresponding author), All India Inst Med Sci, Dept Biochem, New Delhi 110029, India.	kalpanaluthra@gmail.com	Kumar, Sanjeev/AAV-4246-2021	Kumar, Sanjeev/0000-0002-8181-3999	Department of Science and Technology Indo-South Africa project [DST/INT/SAFR/Mega-P (4)/2011]; Council of Scientific and Industrial Research (CSIR); Canadian Institutes of Health Research [200100, 212115]; Michael Smith Foundation for Health Research [5268]	Department of Science and Technology Indo-South Africa project; Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This work was funded by the Department of Science and Technology Indo-South Africa project (DST/INT/SAFR/Mega-P (4)/2011) (http://www.dst.gov.in/). L.K. is supported by a Senior Research fellowship from the Council of Scientific and Industrial Research (CSIR). Work involving the JRFL gp120 and Delta N2mCHO proteins was supported by the Canadian Institutes of Health Research (research grant 200100 and New Investigator Award 212115 to R.P.) and the Michael Smith Foundation for Health Research (Career Scholar Award 5268 to R.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed FK, 2012, VACCINE, V30, P922, DOI 10.1016/j.vaccine.2011.11.089; Andrabi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043704; BARBAS CF, 1992, P NATL ACAD SCI USA, V89, P9339, DOI 10.1073/pnas.89.19.9339; Bell CH, 2008, J MOL BIOL, V375, P969, DOI 10.1016/j.jmb.2007.11.013; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Doria-Rose NA, 2009, J VIROL, V83, P188, DOI 10.1128/JVI.01583-08; Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009; Gach JS, 2010, J BIOL CHEM, V285, P1122, DOI 10.1074/jbc.M109.058792; Gray ES, 2009, J VIROL, V83, P8925, DOI 10.1128/JVI.00758-09; Hraber P, 2014, AIDS, V28, P163, DOI 10.1097/QAD.0000000000000106; Huang JH, 2014, NATURE, V515, P138, DOI 10.1038/nature13601; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Lakhashe SK, 2007, VIROLOGY, V359, P295, DOI 10.1016/j.virol.2006.09.019; Li A, 1997, AIDS RES HUM RETROV, V13, P647, DOI 10.1089/aid.1997.13.647; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Lynch RM, 2012, J VIROL, V86, P7588, DOI 10.1128/JVI.00734-12; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; MODROW S, 1987, J VIROL, V61, P570, DOI 10.1128/JVI.61.2.570-578.1987; Montefiori DC, 2012, J INFECT DIS, V206, P431, DOI 10.1093/infdis/jis367; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Moore PL, 2008, J VIROL, V82, P1860, DOI 10.1128/JVI.02187-07; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; National AIDS Control Organization, ANNUAL REPORT 2013 2; Nelson JD, 2007, J VIROL, V81, P4033, DOI 10.1128/JVI.02588-06; O'Connell RJ, 2013, CURR HIV RES, V11, P450, DOI 10.2174/1570162X113116660052; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Pantophlet R, 2004, PROTEIN ENG DES SEL, V17, P749, DOI 10.1093/protein/gzh085; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Parren P W, 1997, Immunol Lett, V58, P125, DOI 10.1016/S0165-2478(97)00109-0; Parren PWHI, 1997, IMMUNOL LETT, V57, P105, DOI 10.1016/S0165-2478(97)00043-6; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Rong R, 2007, J VIROL, V81, P5658, DOI 10.1128/JVI.00257-07; Sather DN, 2010, VACCINE, V28, pB8, DOI 10.1016/j.vaccine.2009.07.085; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Shankarappa R, 2001, J VIROL, V75, P10479, DOI 10.1128/JVI.75.21.10479-10487.2001; Song LK, 2009, P NATL ACAD SCI USA, V106, P9057, DOI 10.1073/pnas.0901474106; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; West AP, 2014, CELL, V156, P633, DOI 10.1016/j.cell.2014.01.052; WILLEY RL, 1986, P NATL ACAD SCI USA, V83, P5038, DOI 10.1073/pnas.83.14.5038; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	54	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0125575	10.1371/journal.pone.0125575	http://dx.doi.org/10.1371/journal.pone.0125575			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962059	Green Published, Green Submitted, gold			2022-12-26	WOS:000354542500035
J	Memarnejadian, A; Menbari, S; Mansouri, SA; Sadeghi, L; Vahabpour, R; Aghasadeghi, MR; Mostafavi, E; Abdi, M				Memarnejadian, Arash; Menbari, Shahoo; Mansouri, Seyed Ali; Sadeghi, Leila; Vahabpour, Rouhollah; Aghasadeghi, Mohammad Reza; Mostafavi, Ehsan; Abdi, Mohammad			Transmitted Drug Resistance Mutations in Antiretroviral-Naive Injection Drug Users with Chronic HIV-1 Infection in Iran	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LOW-PREVALENCE; SURVEILLANCE; RECOMMENDATIONS; TRANSMISSION; INDIVIDUALS	The growing incidence and transmission of drug resistant HIV-1 strains due to widespread use of antiretroviral therapy (ART) can jeopardize the success of first-line ART. While there is a known moderate prevalence of transmitted drug resistance (TDR) among newly infected Iranians, no data exist about the rate of these primary resistance mutations among the ART-naive, chronically infected individuals who are, in fact, the main candidates for ART initiation. To address this issue, we collected blood samples from 40 ART-naive injection drug-users (IDUs) with chronic HIV-1 infection (seroconversion time ranging from 2 to 9 years) living in Sanandaj, Iran, followed by sequencing of the protease and reverse-transcriptase regions from their HIV-1 genome. Phylogenetic analyses of the sequenced regions revealed that all samples were CRF35_AD. Transmitted resistance mutations were interpreted as surveillance drug-resistant mutations (SDRMs) based on the world health organization (WHO) algorithm. The frequency of SDRMs to any class of antiretroviral drugs was 15%, which included mutations to nucleoside reverse transcriptase inhibitors (NRTIs, 10%), with M41L and M184V as the most common (5%), and non-nucleoside reverse transcriptase inhibitors (NNRTIs, 5%), with K103N as the only detected mutation (5%). Although not in the WHO SDRMs list, several minor protease inhibitor resistant mutations listed in the International Antiviral Society-USA panel were identified, of which M36I, H69K, L89M/V/I (each one 100%) and K20R/T (92.5%) can be considered as polymorphic signatures for CRF35_AD. The relatively high rate of TDR mutations in our study raises concerns about the risk of treatment failure in chronically infected IDUs of Sanandaj city. These results suggest that routine resistance testing should be considered before the therapy initiation in this area. Additional surveillance studies are required to generalize this deduction to other cities of Iran.	[Memarnejadian, Arash] Pasteur Inst Iran, Dept Hepatitis & AIDS, Tehran, Iran; [Menbari, Shahoo; Abdi, Mohammad] Kurdistan Univ Med Sci, Fac Paramed, Dept Pathol & Med Lab Sci, Sanandaj, Iran; [Mansouri, Seyed Ali] Islamic Azad Univ, Fac Sci, Dept Microbiol, Qom, Iran; [Sadeghi, Leila] Islamic Azad Univ, Fac Sci, Dept Microbiol, Karaj, Iran; [Vahabpour, Rouhollah] Univ Tehran Med Sci, Fac Publ Hlth, Dept Virol, Tehran, Iran; [Mostafavi, Ehsan] Pasteur Inst Iran, Dept Epidemiol, Tehran, Iran	Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Kurdistan University of Medical Sciences; Islamic Azad University; Islamic Azad University; Tehran University of Medical Sciences; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran	Memarnejadian, A (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Microbiol & Immunol, London, ON, Canada.	memarnejadian@gmail.com; shahoo1020@gmail.com	Mostafavi, Ehsan/A-7627-2011; menbari, shaho/P-4347-2015; aghasadeghi, mohammad reza/K-9497-2017; Abdi, Mohammad/O-5331-2019; Abdi, Mohammad/O-3278-2015; Memarnejadian, Arash/I-3979-2019	Mostafavi, Ehsan/0000-0002-1997-517X; menbari, shaho/0000-0002-6948-2920; aghasadeghi, mohammad reza/0000-0003-2186-0774; Abdi, Mohammad/0000-0002-4766-0423; Memarnejadian, Arash/0000-0003-4005-8787	Pasteur Institute of Iran [570]; Ministry of health and Medical education of Iran	Pasteur Institute of Iran; Ministry of health and Medical education of Iran	This study was partially supported by Pasteur Institute of Iran grant No. 570 to AM. Parts of this work was also supported by the Ministry of health and Medical education of Iran grant to EM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, GUIDELINES USE ANTIR, P1; Baesi K, 2014, J MED VIROL, V86, P1093, DOI 10.1002/jmv.23898; Bakhouch K, 2009, J INFECT DEV COUNTR, V3, P380, DOI 10.3855/jidc.247; Bennett DE, 2008, ANTIVIR THER, V13, P25; Bennett DE, 2008, ANTIVIR THER, V13, P1; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Hamkar R, 2010, AIDS, V24, pS85, DOI 10.1097/01.aids.0000386738.32919.67; Jahanbakhsh F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061864; Khajehkazemi R, 2013, SEX TRANSM INFECT, V89, P29, DOI 10.1136/sextrans-2013-051204; Kiertiburanakul S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062057; Liu L, 2008, AIDS, V22, P835, DOI 10.1097/QAD.0b013e3282f5ff71; Manosuthi W, 2013, J MED VIROL, V85, P194, DOI 10.1002/jmv.23452; Mousavi SM, 2010, ARCH VIROL, V155, P329, DOI 10.1007/s00705-009-0583-6; Mumtaz G, 2011, SEX TRANSM INFECT, V87, P101, DOI 10.1136/sti.2010.043711; National AIDS Committee Secretariat MoHaME, 2014, UN GEN ASS SPEC SESS; Novak RM, 2005, CLIN INFECT DIS, V40, P468, DOI 10.1086/427212; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Perno CF, 2002, AIDS, V16, P619, DOI 10.1097/00002030-200203080-00014; Pineda-Pena AC, 2013, INFECT GENET EVOL, V19, P337, DOI 10.1016/j.meegid.2013.04.032; Re M C, 2001, BMC Microbiol, V1, P30, DOI 10.1186/1471-2180-1-30; Re MC, 2004, INT J ANTIMICROB AG, V23, P164, DOI 10.1016/j.ijantimicag.2003.06.005; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Salomon H, 2000, AIDS, V14, pF17, DOI 10.1097/00002030-200001280-00003; Sanders-Buell E, 2007, AIDS RES HUM RETROV, V23, P834, DOI 10.1089/aid.2006.0299; Shah S, 2011, AIDS RES HUM RETROV, V27, P1278, DOI 10.1089/aid.2010.0324; Sugiura W, 1999, JPN J INFECT DIS, V52, P21; Sullivan PS, 2002, INT J STD AIDS, V13, P554, DOI 10.1258/095646202760159684; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Toni TD, 2007, AIDS RES HUM RETROV, V23, P1155, DOI 10.1089/aid.2007.0072; Vandamme AM, 2011, AIDS REV, V13, P77; Wensing AMJ, 2005, J INFECT DIS, V192, P958, DOI 10.1086/432916	32	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126955	10.1371/journal.pone.0126955	http://dx.doi.org/10.1371/journal.pone.0126955			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962088	gold, Green Published, Green Submitted			2022-12-26	WOS:000354542500161
J	Tang, WM; Mahapatra, T; Liu, FY; Fu, GF; Yang, B; Tucker, JD; Zhao, JK; Detels, R				Tang, Weiming; Mahapatra, Tanmay; Liu, Fengying; Fu, Gengfeng; Yang, Bin; Tucker, Joseph D.; Zhao, Jinkou; Detels, Roger			Burden of HIV and Syphilis: A Comparative Evaluation between Male Sex Workers and Non-Sex-Worker Men Who Have Sex with Men in Urban China	PLOS ONE			English	Article							RISK BEHAVIORS; PREVALENCE; INFECTION; CITIES	Background The increasing burden of sexually transmitted infections (STIs) including HIV and syphilis among male sex workers (MSWs) is a major global concern. The aim of our study was to evaluate the difference between MSWs and non-commercial MSMs in China. Methods During 2008-09, in a cross-sectional study, 2618 adult MSM were recruited through respondent-driven and snowball sampling from seven cities of China. Information regarding socio-demographics, risk behaviors, HIV-related knowledge and STI-related symptoms were collected and participants were tested for HIV and syphilis. Results Among 2618 participating MSM, 9.97% sold sex to males. HIV prevalence was 7.45% (6.13% among MSWs and 7.59% among non-MSW MSM) and syphilis prevalence was 14.32% (10.73% for MSWs and 14.72% for non-MSW MSM). Compared to non-MSW MSM, MSWs were more likely to be younger (adjusted odds ratio: aOR = 0.91, 95% confidence interval: 95% CI=0.88-0.93), never married (aOR = 4.38, 95% CI = 2.38-6.80), less educated, heterosexual (aOR = 13.04, 95% CI = 6.08-27.95), less knowledgeable regarding HIV (aOR = 0.70, 95% CI= 0.51-0.96), experiencing symptoms of STI (aOR = 2.16, 95% CI = 1.47-3.19), engaging in condomless vaginal intercourse (aOR = 2.16, 95% CI = 1.47-3.19) and less likely to engage in condomless anal intercourse (aOR = 0.62, 95% CI = 0.46-0.85). Conclusions High HIV and syphilis prevalence warranted urgent intervention targeting MSWs as a separate sentinel group for efficient surveillance owing to their different distribution from non-MSW MSM. Although male sex workers and non-commercial homosexuals have similar rates of HIV and syphilis, MSWs have different characteristics which should be considered in designing intervention programs targeting them.	[Tang, Weiming; Liu, Fengying; Yang, Bin] Guangdong Prov Ctr Skin Dis & STIs Control, Guangzhou 510085, Guangdong, Peoples R China; [Tang, Weiming; Tucker, Joseph D.] Univ North Carolina Project China, Guangzhou 510085, Guangdong, Peoples R China; [Mahapatra, Tanmay; Detels, Roger] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA; [Fu, Gengfeng] Jiangsu Prov Cent Dis Prevent & Control, Nanjing, Jiangsu, Peoples R China; [Zhao, Jinkou] Global Fund Fight AIDS TB & Malaria, Monitoring & Evaluat Unit, Geneva, Switzerland	University of California System; University of California Los Angeles	Tang, WM (corresponding author), Guangdong Prov Ctr Skin Dis & STIs Control, 2 Lujing Rd, Guangzhou 510085, Guangdong, Peoples R China.	weimingtangscience@gmail.com; Button.Zhao@gmail.com		Tucker, Joseph/0000-0003-2804-1181; Tang, Weiming/0000-0002-9026-707X; Zhao, Jinkou/0000-0001-9184-3385	NIH program [1D43TW009532-01]; NIH Fogarty International Center [5R25TW009340]; FOGARTY INTERNATIONAL CENTER [R25TW009340, D43TW009532] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI114310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH058107] Funding Source: NIH RePORTER	NIH program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by NIH program (1D43TW009532-01) and NIH Fogarty International Center (5R25TW009340). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, SAS SYST WIND; Baral SD, 2014, LANCET; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Bruus M., 2003, EPIDATA VERSION 3 CO; Chow EPF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089959; Chow EPF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048025; Estcourt CS, 2000, SEX TRANSM INFECT, V76, P294, DOI 10.1136/sti.76.4.294; GOODMAN LA, 1961, ANN MATH STAT, V32, P148, DOI 10.1214/aoms/1177705148; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Huan XP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069740; Mi GD, 2007, AIDS, V21, pS67, DOI 10.1097/01.aids.0000304699.85379.32; Newcomb ME, 2011, ARCH SEX BEHAV, V40, P189, DOI 10.1007/s10508-009-9573-8; Pisani E, 2004, SEX TRANSM INFECT, V80, P536, DOI 10.1136/sti.2003.007500; Tang WM, 2013, AIDS BEHAV, V17, P1415, DOI 10.1007/s10461-013-0413-4; Wu ZY, 2013, CLIN INFECT DIS, V57, P298, DOI 10.1093/cid/cit210; Yang H-T, 2014, CLIN INFECT DIS; Zhang L, 2013, LANCET INFECT DIS, V13, P955, DOI 10.1016/S1473-3099(13)70245-7; Zhao J, 2011, AIDS BEHAV, V15, P635, DOI 10.1007/s10461-010-9786-9	18	17	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126604	10.1371/journal.pone.0126604	http://dx.doi.org/10.1371/journal.pone.0126604			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI1YY	25961721	Green Published, gold			2022-12-26	WOS:000354542500124
J	Yirdaw, KD; Hattingh, S				Yirdaw, Kesetebirhan Delele; Hattingh, Susan			Prevalence and Predictors of Immunological Failure among HIV Patients on HAART in Southern Ethiopia	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; ADHERENCE; TUBERCULOSIS; CARE; SETTINGS; HIV/AIDS; CRITERIA	Immunological monitoring is part of the standard of care for patients on antiretroviral treatment. Yet, little is known about the routine implementation of immunological laboratory monitoring and utilization in clinical care in Ethiopia. This study assessed the pattern of immunological monitoring, immunological response, level of immunological treatment failure and factors related to it among patients on antiretroviral therapy in selected hospitals in southern Ethiopia. A retrospective longitudinal analytic study was conducted using documents of patients started on antiretroviral therapy. Adequacy of timely immunological monitoring was assessed every six months the first year and every one year thereafter. Immunological response was assessed every six months at cohort level. Immunological failure was based on the criteria: fall of follow-up CD4 cell count to baseline (or below), or CD4 levels persisting below 100 cells/mm(3), or 50% fall from on-treatment peak value. A total of 1,321 documents of patients reviewed revealed timely immunological monitoring were inadequate. There was adequate immunological response, with pediatric patients, females, those with less advanced illness (baseline WHO Stage I or II) and those with higher base-line CD4 cell count found to have better immunological recovery. Thirty-nine patients (3%) were not evaluated for immunological failure because they had frequent treatment interruption. Despite overall adequate immunological response at group level, the prevalence of those who ever experienced immunological failure was 17.6% (n=226), while after subsequent re-evaluation it dropped to 11.5%(n=147). Having WHO Stage III/IV of the disease or a higher CD4 cell count at baseline was identified as a risk for immunological failure. Few patients with confirmed failure were switched to second line therapy. These findings highlight the magnitude of the problem of immunological failure and the gap in management. Prioritizing care for high risk patients may help in effective utilization of meager resources.	[Yirdaw, Kesetebirhan Delele] Univ S Africa, Dept Hlth Studies, Addis Ababa, Ethiopia; [Hattingh, Susan] King Saud bin Abdulaziz Univ Hlth Sci, Coll Nursing Al Ahsa, Natl Guard Hlth Affairs, Dean Off, Riyadh, Eastern Region, Saudi Arabia	King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; Ministry of National Guard - Health Affairs; National Guard Health Affairs - Saudi Arabia	Yirdaw, KD (corresponding author), Univ S Africa, Dept Hlth Studies, Addis Ababa, Ethiopia.	kcgp2005@yahoo.com						ALEMU A, 2010, DETERMINANTS OF SURV, V29, P3; Anude CJ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-113; Assefa A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-468; Assefa Y, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-81; Azmeraw Daniel, 2012, Ethiop Med J, V50, P115; Azzoni L, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001207; Bacha T, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-197; Barnighausen T, 2011, LANCET INFECT DIS, V11, P942, DOI 10.1016/S1473-3099(11)70181-5; Belec L, 2011, FUTURE MICROBIOL, V6, P1251, DOI [10.2217/fmb.11.121, 10.2217/FMB.11.121]; Berhan Yifru, 2011, Ethiop Med J, V49, P199; Beyene KA, 2009, PHARMACOEPIDEM DR S, V18, P1007, DOI 10.1002/pds.1814; Central Statistical Agency, 2013, POPULATION PROJECTIO, P2007; Chalker JC, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-43; Chernick M, 2011, THE ESSENTIALS OF BI; Collet D., 2003, MODELLING SURVIVAL D; Crawford KW, 2015, HIV MED, V16, P95, DOI 10.1111/hiv.12177; Dagnew YW, 2009, FACTORS INFLUENCING; Department of Health and Human Services [USA], 2013, GUIDELINES FOR THE U; El-Khatib Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017518; Ethiopian Health and Nutrition Research Institute, 2012, HIV RELATED ESTIMATE; Federal HIV/AIDS Prevention and Control Office, 2014, COUNTRY PROGRESS REP; Federal HIV/AIDS Prevention and Control Office & Federal Ministry of Health, 2008, GUIDELINE FOR ANTIRE; Federal Ministry of Health, 2010, HEALTH MANAGEMENT IN; Federal Ministry of Health, 2013, TECHNICAL UPDATES ON; Giday Araya, 2010, Ethiop Med J, V48, P187; Hosmer D., 2008, APPLIED SURVIVAL ANA; Jaka H, 2009, TANZANIA MEDICAL JOU, V24; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2013, GLOBAL REPORT UNAIDS; Kassa D, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-18; Kebede A, 2012, N AM J MED SCI, V4, P67, DOI 10.4103/1947-2714.93376; Keiser O, 2010, TROP MED INT HEALTH, V15, P251, DOI 10.1111/j.1365-3156.2009.02445.x; Keiser O, 2009, TROP MED INT HEALTH, V14, P1220, DOI 10.1111/j.1365-3156.2009.02338.x; Machin D., 2006, SURVIVAL ANALYSIS A; Mulu A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-28; Palchaudhuri S, 2014, MALAWI MED J, V26, P42; Palladino C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082718; Rawizza HE, 2011, CLIN INFECT DIS, V53, P1283, DOI 10.1093/cid/cir729; Reda AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058595; Reynolds SJ, 2009, AIDS, V23, P697, DOI 10.1097/QAD.0b013e3283262a78; Tiyou A, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-39; Tsegaye E, 2011, ETHIOP J HEALTH DEV, V25, P102; Turner BJ, 2002, J INFECT DIS, V185, pS143, DOI 10.1086/340197; Were MC, 2011, J AM MED INFORM ASSN, V18, P150, DOI 10.1136/jamia.2010.005520; WHO, 2013, CONSOLIDATED GUIDELI; Workneh N., 2009, ETHIOP J HEALTH SCI, V19, DOI DOI 10.4314/EJHS.V19I2.69419; World Health Organisation, 2003, ADHERENCE TO LONG TE; World Health Organisation, 2010, ANTIRETROVIRAL THERA; Zachariah R, 2011, TROP MED INT HEALTH, V16, P37, DOI 10.1111/j.1365-3156.2010.02669.x	48	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0125826	10.1371/journal.pone.0125826	http://dx.doi.org/10.1371/journal.pone.0125826			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961732	gold, Green Submitted, Green Published			2022-12-26	WOS:000354542500047
J	Chonpathompikunlert, P; Yoshitomi, T; Vong, LB; Imaizumi, N; Ozaki, Y; Nagasaki, Y				Chonpathompikunlert, Pennapa; Yoshitomi, Toru; Vong, Long Binh; Imaizumi, Natsuka; Ozaki, Yuki; Nagasaki, Yukio			Recovery of Cognitive Dysfunction via Orally Administered Redox-Polymer Nanotherapeutics in SAMP8 Mice	PLOS ONE			English	Article							RADICAL-CONTAINING NANOPARTICLES; ALZHEIMER-DISEASE; OXIDATIVE STRESS; VITAMIN-E; MOUSE; MODEL; PHARMACOKINETICS; BIODISTRIBUTION; DELIVERY; NANOMEDICINE	Excessively generated reactive oxygen species are associated with age-related neurodegenerative diseases. We investigated whether scavenging of reactive oxygen species in the brain by orally administered redox nanoparticles, prepared by self-assembly of redox polymers possessing antioxidant nitroxide radicals, facilitates the recovery of cognition in 17-week-old senescence-accelerated prone (SAMP8) mice. The redox polymer was delivered to the brain after oral administration of redox nanoparticles via a disintegration of the nanoparticles in the stomach and absorption of the redox polymer at small intestine to the blood. After treatment for one month, levels of oxidative stress in the brain of SAMP8 mice were remarkably reduced by treatment with redox nanoparticles, compared to that observed with low-molecular-weight nitroxide radicals, resulting in the amelioration of cognitive impairment with increased numbers of surviving neurons. Additionally, treatment by redox nanoparticles did not show any detectable toxicity. These findings indicate the potential of redox polymer nanotherapeutics for treatment of the neurodegenerative diseases.	[Chonpathompikunlert, Pennapa; Yoshitomi, Toru; Vong, Long Binh; Imaizumi, Natsuka; Ozaki, Yuki; Nagasaki, Yukio] Univ Tsukuba, Dept Mat Sci, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan; [Nagasaki, Yukio] Univ Tsukuba, Masters Sch Med Sci, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058573, Japan; [Nagasaki, Yukio] Univ Tsukuba, NIMS, Int Ctr Mat Nanoarchitechton WPI MANA, Satellite Lab, Tsukuba, Ibaraki 3058573, Japan	University of Tsukuba; University of Tsukuba; National Institute for Materials Science; University of Tsukuba	Nagasaki, Y (corresponding author), Univ Tsukuba, Dept Mat Sci, Grad Sch Pure & Appl Sci, Tennoudai 1-1-1, Tsukuba, Ibaraki 3058573, Japan.	yukio@nagalabo.jp	Vong, Long/ABC-3046-2021; Yoshitomi, Toru/Q-4274-2018	Vong, Long/0000-0002-2117-4312; Yoshitomi, Toru/0000-0003-3847-1812; Chonpathompikunlert, Pennapa/0000-0003-2764-0465	 [25220203];  [24659014]; Grants-in-Aid for Scientific Research [13J00906] Funding Source: KAKEN	; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Grant-in-Aid for Scientific Research S (No. 25220203) to Y.N. Grant-in-Aid for Exploratory Research (24659014) to T.Y.	Bae Y, 2003, ANGEW CHEM INT EDIT, V42, P4640, DOI 10.1002/anie.200250653; Bhavna, 2014, DRUG DEV IND PHARM, V40, P278, DOI 10.3109/03639045.2012.758130; Chonpathompikunlert P, 2012, NANOMEDICINE-UK, V7, P1029, DOI [10.2217/nnm.12.2, 10.2217/NNM.12.2]; Chonpathompikunlert P, 2011, BIOMATERIALS, V32, P8605, DOI 10.1016/j.biomaterials.2011.07.024; Dysken MW, 2014, JAMA-J AM MED ASSOC, V311, P33, DOI 10.1001/jama.2013.282834; Estevez AY, 2011, FREE RADICAL BIO MED, V51, P1155, DOI 10.1016/j.freeradbiomed.2011.06.006; Fodale V, 2006, BRIT J ANAESTH, V97, P445, DOI 10.1093/bja/ael233; Gao XL, 2006, BIOMATERIALS, V27, P3482, DOI 10.1016/j.biomaterials.2006.01.038; Grundman M, 2000, AM J CLIN NUTR, V71, p630S; Han LM, 2006, ACTA PHARMACOL SIN, V27, P747, DOI 10.1111/j.1745-7254.2006.00340.x; Jose S, 2014, INT J PHARMACEUT, V474, P6, DOI 10.1016/j.ijpharm.2014.08.003; Kim BYS, 2010, NEW ENGL J MED, V363, P2434, DOI 10.1056/NEJMra0912273; Vong LB, 2012, GASTROENTEROLOGY, V143, P1027, DOI 10.1053/j.gastro.2012.06.043; Marushima A, 2011, NEUROSURGERY, V68, P1418, DOI 10.1227/NEU.0b013e31820c02d9; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Monti E, 2001, J CELL BIOCHEM, V82, P271, DOI 10.1002/jcb.1160; Morley JE, 2002, BIOGERONTOLOGY, V3, P57, DOI 10.1023/A:1015207429786; Morley JE, 2012, BBA-MOL BASIS DIS, V1822, P650, DOI 10.1016/j.bbadis.2011.11.015; Nagasaki Y, 2012, THER DELIV, V3, P164, DOI 10.4155/TDE.11.153; Oishi M, 2007, J MATER CHEM, V17, P3720, DOI 10.1039/b706973a; Okatani Y, 2002, NEUROBIOL AGING, V23, P639, DOI 10.1016/S0197-4580(02)00005-2; Pelegri C, 2007, MECH AGEING DEV, V128, P522, DOI 10.1016/j.mad.2007.07.002; Sha S, 2013, BIOMATERIALS, V34, P8393, DOI 10.1016/j.biomaterials.2013.06.032; Shimizu M, 2014, J CLIN BIOCHEM NUTR, V54, P166, DOI 10.3164/jcbn.13-85; Takeda T, 2009, NEUROCHEM RES, V34, P639, DOI 10.1007/s11064-009-9922-y; Vong LB, 2015, BIOMATERIALS IN PRES; Wang YZ, 2008, YAKUGAKU ZASSHI, V128, P941, DOI 10.1248/yakushi.128.941; Ye X, 2004, HISTOL HISTOPATHOL, V19, P1141, DOI 10.14670/HH-19.1141; Yoshitomi T, 2011, BIOMATERIALS, V32, P8021, DOI 10.1016/j.biomaterials.2011.07.014; Yoshitomi T, 2011, NANOMEDICINE-UK, V6, P509, DOI [10.2217/nnm.11.13, 10.2217/NNM.11.13]; Yoshitomi T, 2009, BIOCONJUGATE CHEM, V20, P1792, DOI 10.1021/bc900214f; Yoshitomi T, 2009, BIOMACROMOLECULES, V10, P596, DOI 10.1021/bm801278n; Zhang GH, 2008, EXP ANIM TOKYO, V57, P413, DOI 10.1538/expanim.57.413; Zhu PZ, 2005, BIOPHYS J, V89, pL37, DOI 10.1529/biophysj.105.071027	34	30	30	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0126013	10.1371/journal.pone.0126013	http://dx.doi.org/10.1371/journal.pone.0126013			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955022	gold, Green Published, Green Submitted			2022-12-26	WOS:000356768100092
J	Diesner, SC; Schultz, C; Ackaert, C; Oostingh, GJ; Ondracek, A; Stremnitzer, C; Singer, J; Heiden, D; Roth-Walter, F; Fazekas, J; Assmann, VE; Jensen-Jarolim, E; Stutz, H; Duschl, A; Untersmayr, E				Diesner, Susanne C.; Schultz, Cornelia; Ackaert, Chloe; Oostingh, Gertie J.; Ondracek, Anna; Stremnitzer, Caroline; Singer, Josef; Heiden, Denise; Roth-Walter, Franziska; Fazekas, Judit; Assmann, Vera E.; Jensen-Jarolim, Erika; Stutz, Hanno; Duschl, Albert; Untersmayr, Eva			Nitration of beta-Lactoglobulin but Not of Ovomucoid Enhances Anaphylactic Responses in Food Allergic Mice	PLOS ONE			English	Article							SECONDARY STRUCTURE ANALYSES; BIRCH POLLEN ALLERGEN; IN-VIVO; TYROSINE NITRATION; PROTEIN; SENSITIZATION; EPIDEMIOLOGY; DIAGNOSIS; EPITOPES; RELEASE	Background We revealed in previous studies that nitration of food proteins reduces the risk of de novo sensitization in a murine food allergy model. In contrast, in situations with preformed specific IgE antibodies, in vitro experiments suggested an increased capacity of effector cell activation by nitrated food proteins. Objective The aim of this study was to investigate the influence of protein nitration on the effector phase of food allergy. Design BALB/c mice were immunized intraperitoneally (i.p.) with the milk allergen beta-lactoglobulin (BLG) or the egg allergen ovomucoid (OVM), followed by intragastric (i.g.) gavages to induce a strong local inflammatory response and allergen-specific antibodies. Subsequently, naive and allergic mice were intravenously (i.v.) challenged with untreated, sham-nitrated or nitrated BLG or OVM. Anaphylaxis was monitored by measuring core body temperature and determination of mouse mast cell protease-1 (mMCP-1) levels in blood. Results A significant drop of body temperature accompanied with significantly elevated concentrations of the anaphylaxis marker mMCP-1 were only observed in BLG allergic animals challenged with nitrated BLG and not in OVM allergic mice challenged with nitrated OVM. SDS-PAGE and circular dichroism analysis of the differentially modified allergens revealed an effect of nitration on the secondary protein structure exclusively for BLG together with enhanced protein aggregation. Conclusion Our data suggest that nitration affects differently the food allergens BLG and OVM. In the case of BLG, structural changes favored dimerization possibly explaining the increased anaphylactic reactivity in BLG allergic animals.	[Diesner, Susanne C.; Schultz, Cornelia; Ondracek, Anna; Stremnitzer, Caroline; Singer, Josef; Heiden, Denise; Roth-Walter, Franziska; Fazekas, Judit; Assmann, Vera E.; Jensen-Jarolim, Erika; Untersmayr, Eva] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Dept Pathophysiol & Allergy Res, Vienna, Austria; [Diesner, Susanne C.] Med Univ Vienna, Dept Pediat & Adolescent Med, Vienna, Austria; [Ackaert, Chloe; Stutz, Hanno; Duschl, Albert] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria; [Oostingh, Gertie J.] Salzburg Univ Appl Sci, Biomed Sci, Puch Salzburg, Austria; [Roth-Walter, Franziska; Jensen-Jarolim, Erika] Med Univ Vienna, Univ Vet Med Vienna, Messerli Res Inst, Comparat Med, Vienna, Austria; [Roth-Walter, Franziska; Jensen-Jarolim, Erika] Univ Vienna, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Salzburg University; Medical University of Vienna; University of Veterinary Medicine Vienna; University of Vienna	Untersmayr, E (corresponding author), Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Dept Pathophysiol & Allergy Res, Vienna, Austria.	eva.untersmayr@meduniwien.ac.at	Jensen-Jarolim, Erika/C-5120-2018; Oostingh, Gertie Janneke/HHC-1098-2022; Stutz, Hanno/L-4152-2015; Duschl, Albert/E-5872-2011; Roth-Walter, Franziska/V-4651-2017; Untersmayr, Eva/GRY-4470-2022; Fazekas-Singer, Judit/R-4349-2017	Jensen-Jarolim, Erika/0000-0003-4019-5765; Stutz, Hanno/0000-0001-8456-4943; Duschl, Albert/0000-0002-7034-9860; Roth-Walter, Franziska/0000-0001-5005-9228; Oostingh, Gertie Janneke/0000-0001-5083-217X; Untersmayr, Eva/0000-0002-1963-499X; Fazekas-Singer, Judit/0000-0002-8777-3502; Diesner-Treiber, Susanne/0000-0001-8955-4752	Austrian Science Fund FWF (Fonds zur Foerderung der wissenschaftlichen Forschung) [P21577-B11, P22236-B13, KLI284]; Award of the Viennese Economic Chamber; FWF [CCHD W1205-B09]; Fonds zur Foerderung der wissenschaftlichen Forschung [SFB F4606-B19]; Austrian Science Fund (FWF) [P 21577] Funding Source: researchfish	Austrian Science Fund FWF (Fonds zur Foerderung der wissenschaftlichen Forschung)(Austrian Science Fund (FWF)); Award of the Viennese Economic Chamber; FWF(Austrian Science Fund (FWF)); Fonds zur Foerderung der wissenschaftlichen Forschung(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by P21577-B11 (to EU), P22236-B13 (to GJO) and KLI284 (to EU) of the Austrian Science Fund FWF (Fonds zur Foerderung der wissenschaftlichen Forschung; www. fwf.ac.at) and the Award of the Viennese Economic Chamber 2014 (to EU, https://www.wko.at/Content.Node/Interessenvertretung/Aus-und-Weiterbildung/w/ Wirtschaftskammerpreis_2014.html). JS, CaS, and JF were supported by FWF grants CCHD W1205-B09 and EJJ additionally by SFB F4606-B19 (Fonds zur Foerderung der wissenschaftlichen Forschung; www.fwf.ac.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackaert C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104520; Aulak KS, 2001, P NATL ACAD SCI USA, V98, P12056, DOI 10.1073/pnas.221269198; BARSUMIAN EL, 1981, EUR J IMMUNOL, V11, P317, DOI 10.1002/eji.1830110410; Brandt EB, 2003, J CLIN INVEST, V112, P1666, DOI 10.1172/JCI19785; Brownlow S, 1997, STRUCTURE, V5, P481, DOI 10.1016/S0969-2126(97)00205-0; Cong YJ, 2012, J DAIRY SCI, V95, P6307, DOI 10.3168/jds.2012-5543; Cooke SK, 1997, J IMMUNOL, V159, P2026; Davis PJ, 2001, ALLERGY, V56, P56, DOI 10.1034/j.1398-9995.2001.00918.x; Diesner SC, 2008, IMMUNOL LETT, V121, P45, DOI 10.1016/j.imlet.2008.08.006; Diesner SC, 2012, IMMUNOL LETT, V141, P210, DOI 10.1016/j.imlet.2011.10.006; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; Franze T, 2005, ENVIRON SCI TECHNOL, V39, P1673, DOI 10.1021/es0488737; Gruijthuijsen YK, 2006, INT ARCH ALLERGY IMM, V141, P265, DOI 10.1159/000095296; Gusenkov S, 2013, ELECTROPHORESIS, V34, P2695, DOI 10.1002/elps.201300151; Harrer A, 2010, MOL NUTR FOOD RES, V54, P93, DOI 10.1002/mnfr.200900096; Hoffmann A, 1999, ALLERGY, V54, P446, DOI 10.1034/j.1398-9995.1999.00917.x; Jaervinen KM, 2007, ALLERGY, V62, P758, DOI 10.1111/j.1398-9995.2007.01332.x; Karle AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031483; Kondo M, 2008, PEDIATR ALLERGY IMMU, V19, P592, DOI 10.1111/j.1399-3038.2007.00704.x; Kontopidis G, 2004, J DAIRY SCI, V87, P785, DOI 10.3168/jds.S0022-0302(04)73222-1; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Mills ENC, 2009, MOL NUTR FOOD RES, V53, P963, DOI 10.1002/mnfr.200800236; Mizumachi K, 2003, BIOSCI BIOTECH BIOCH, V67, P712, DOI 10.1271/bbb.67.712; Nwaru BI, 2014, ALLERGY, V69, P992, DOI 10.1111/all.12423; Nwaru BI, 2014, ALLERGY, V69, P62, DOI 10.1111/all.12305; Oldreive C, 2001, FREE RADICAL RES, V35, P215, DOI 10.1080/10715760100300761; PAPIZ MZ, 1986, NATURE, V324, P383, DOI 10.1038/324383a0; Pfeiffer S, 2000, J BIOL CHEM, V275, P6346, DOI 10.1074/jbc.275.9.6346; Rocha BS, 2012, FREE RADICAL BIO MED, V52, P693, DOI 10.1016/j.freeradbiomed.2011.11.011; Roth-Walter F, 2008, ALLERGY, V63, P882, DOI 10.1111/j.1398-9995.2008.01673.x; Roth-Walter F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104803; Roth-Walter F, 2013, MOL NUTR FOOD RES, V57, P536, DOI 10.1002/mnfr.201200612; Sampson HA, 2012, J ALLERGY CLIN IMMUN, V130, P1260, DOI 10.1016/j.jaci.2012.10.017; Scholl I, 2005, J IMMUNOL, V175, P6645, DOI 10.4049/jimmunol.175.10.6645; Sharov VS, 2006, EXP GERONTOL, V41, P407, DOI 10.1016/j.exger.2006.02.012; Sicherer SH, 2014, J ALLERGY CLIN IMMUN, V133, P291, DOI 10.1016/j.jaci.2013.11.020; Souza JM, 2000, ARCH BIOCHEM BIOPHYS, V380, P360, DOI 10.1006/abbi.2000.1940; Strait RT, 2011, J ALLERGY CLIN IMMUN, V127, P982, DOI 10.1016/j.jaci.2011.01.034; Swoboda I, 2002, J IMMUNOL, V168, P4576, DOI 10.4049/jimmunol.168.9.4576; Untersmayr E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014210; Villaverde A, 2014, J FOOD SCI, V79, pC1331, DOI 10.1111/1750-3841.12481; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Yeo W. S., 2014, MASS SPECTROM REV; Yeo WS, 2008, BMB REP, V41, P194, DOI 10.5483/BMBRep.2008.41.3.194	45	10	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0126279	10.1371/journal.pone.0126279	http://dx.doi.org/10.1371/journal.pone.0126279			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955653	Green Published, Green Submitted, gold			2022-12-26	WOS:000356768100109
J	Gnanasambandam, R; Bae, C; Gottlieb, PA; Sachs, F				Gnanasambandam, Radhakrishnan; Bae, Chilman; Gottlieb, Philip A.; Sachs, Frederick			Ionic Selectivity and Permeation Properties of Human PIEZO1 Channels	PLOS ONE			English	Article							OF-FUNCTION MUTATIONS; MONO-VALENT; K+ CHANNELS; DIVALENT; PERMEABILITY; RECEPTOR; MEMBRANE; KINETICS; CATIONS; VOLTAGE	Members of the eukaryotic PIEZO family (the human orthologs are noted hPIEZO1 and hPIEZO2) form cation-selective mechanically-gated channels. We characterized the selectivity of human PIEZO1 (hPIEZO1) for alkali ions: K+, Na+, Cs+ and Li+; organic cations: TMA and TEA, and divalents: Ba2+, Ca2+, Mg2+ and Mn2+. All monovalent ions permeated the channel. At a membrane potential of -100 mV, Cs+, Na+ and K+ had chord conductances in the range of 35-55 pS with the exception of Li+, which had a significantly lower conductance of similar to 23 pS. The divalents decreased the single-channel permeability of K+, presumably because the divalents permeated slowly and occupied the open channel for a significant fraction of the time. In cell-attached mode, 90 mM extracellular divalents had a conductance for inward currents carried by the divalents of: 25 pS for Ba2+ and 15 pS for Ca2+ at -80 mV and 10 pS for Mg2+ at -50 mV. The organic cations, TMA and TEA, permeated slowly and attenuated K+ currents much like the divalents. As expected, the channel K+ conductance increased with K+ concentration saturating at similar to 45 pS and the K-D of K+ for the channel was 32 mM. Pure divalent ion currents were of lower amplitude than those with alkali ions and the channel opening rate was lower in the presence of divalents than in the presence of monovalents. Exposing cells to the actin disrupting reagent cytochalasin D increased the frequency of openings in cell-attached patches probably by reducing mechanoprotection.	[Gnanasambandam, Radhakrishnan; Bae, Chilman; Gottlieb, Philip A.; Sachs, Frederick] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Gnanasambandam, R (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14260 USA.	rg35@buffalo.edu	Gottlieb, Philip/C-3113-2019	Gottlieb, Philip/0000-0003-3764-9885	National Institutes of Health [R01HL054887]; United States Department of Defense [DM102091]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054887] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Defense(United States Department of Defense); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding was provided to FS by the National Institutes of Health (http://www.nih.gov/) GRANT# R01HL054887 and the United States Department of Defense (www.defense.gov) GRANT# DM102091. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS DJ, 1980, J GEN PHYSIOL, V75, P493, DOI 10.1085/jgp.75.5.493; Akk G, 1996, BIOPHYS J, V70, P2652, DOI 10.1016/S0006-3495(96)79834-X; Albuisson J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2899; Archer NM, 2014, AM J HEMATOL, V89, P1142, DOI 10.1002/ajh.23799; Bae C, 2013, P NATL ACAD SCI USA, V110, pE1162, DOI 10.1073/pnas.1219777110; Bae C, 2011, BIOCHEMISTRY-US, V50, P6295, DOI 10.1021/bi200770q; Besch SR, 2002, PFLUG ARCH EUR J PHY, V445, P161, DOI 10.1007/s00424-002-0903-0; Bruni F, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3684633; Burgess J., 1988, IONS SOLUTION BASIC; BURNASHEV N, 1995, J PHYSIOL-LONDON, V485, P403, DOI 10.1113/jphysiol.1995.sp020738; Coste B, 2013, P NATL ACAD SCI USA, V110, P4667, DOI 10.1073/pnas.1221400110; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; DECKER ER, 1990, J NEUROSCI, V10, P3413; Ding S, 1999, J MEMBRANE BIOL, V172, P215, DOI 10.1007/s002329900598; Dubin AE, 2012, CELL REP, V2, P511, DOI 10.1016/j.celrep.2012.07.014; Evans RJ, 1996, J PHYSIOL-LONDON, V497, P413, DOI 10.1113/jphysiol.1996.sp021777; GOLOWASCH J, 1986, J EXP BIOL, V124, P5; Gottlieb PA, 2012, CHANNELS, V6, P282, DOI 10.4161/chan.21064; HESS P, 1986, J GEN PHYSIOL, V88, P293, DOI 10.1085/jgp.88.3.293; Hill, 2001, ION CHANNELS EXCITAB, P441; HOYER J, 1994, P NATL ACAD SCI USA, V91, P2367, DOI 10.1073/pnas.91.6.2367; Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801; Kutluay E, 2005, BIOPHYS J, V88, P1018, DOI 10.1529/biophysj.104.052043; Li J, 2014, NATURE, V515, P279, DOI 10.1038/nature13701; MARCUS Y, 1991, J CHEM SOC FARADAY T, V87, P2995, DOI 10.1039/ft9918702995; McCarter GC, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-28; MCLAUGHLIN SG, 1971, J GEN PHYSIOL, V58, P667, DOI 10.1085/jgp.58.6.667; McMillin MJ, 2014, AM J HUM GENET, V94, P734, DOI 10.1016/j.ajhg.2014.03.015; Morris CE, 2001, CELL MOL BIOL LETT, V6, P703; Ranade SS, 2014, P NATL ACAD SCI USA, V111, P10347, DOI 10.1073/pnas.1409233111; SIGURDSON W, 1992, AM J PHYSIOL, V262, pH1110, DOI 10.1152/ajpheart.1992.262.4.H1110; Suchyna TM, 2009, BIOPHYS J, V97, P738, DOI 10.1016/j.bpj.2009.05.018; VILLARROEL A, 1995, BIOPHYS J, V68, P866, DOI 10.1016/S0006-3495(95)80263-8; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; Zhang PC, 2001, NATURE, V413, P428, DOI 10.1038/35096578	37	76	89	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0125503	10.1371/journal.pone.0125503	http://dx.doi.org/10.1371/journal.pone.0125503			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955826	Green Published, Green Submitted, gold			2022-12-26	WOS:000356768100056
J	Lee, YJ; Jonsson, HO; Nordstrom, K				Lee, Yu-Jen; Jonsson, H. Olof; Nordstrom, Karin			Spatio-Temporal Dynamics of Impulse Responses to Figure Motion in Optic Flow Neurons	PLOS ONE			English	Article							FLY VISUAL-SYSTEM; GROUND DISCRIMINATION BEHAVIOR; DRAGONFLY MEDIAN OCELLUS; SENSITIVE NEURONS; RECEPTIVE-FIELDS; ADAPTATION; DROSOPHILA; OBJECT; INTERNEURONS; FLIES	White noise techniques have been used widely to investigate sensory systems in both vertebrates and invertebrates. White noise stimuli are powerful in their ability to rapidly generate data that help the experimenter decipher the spatio-temporal dynamics of neural and behavioral responses. One type of white noise stimuli, maximal length shift register sequences (m-sequences), have recently become particularly popular for extracting response kernels in insect motion vision. We here use such m-sequences to extract the impulse responses to figure motion in hoverfly lobula plate tangential cells (LPTCs). Figure motion is behaviorally important and many visually guided animals orient towards salient features in the surround. We show that LPTCs respond robustly to figure motion in the receptive field. The impulse response is scaled down in amplitude when the figure size is reduced, but its time course remains unaltered. However, a low contrast stimulus generates a slower response with a significantly longer time-to-peak and half-width. Impulse responses in females have a slower time-to-peak than males, but are otherwise similar. Finally we show that the shapes of the impulse response to a figure and a widefield stimulus are very similar, suggesting that the figure response could be coded by the same input as the widefield response.	[Lee, Yu-Jen; Jonsson, H. Olof; Nordstrom, Karin] Uppsala Univ, Dept Neurosci, S-75124 Uppsala, Sweden	Uppsala University	Nordstrom, K (corresponding author), Uppsala Univ, Dept Neurosci, Box 593, S-75124 Uppsala, Sweden.	Karin.nordstrom@neuro.uu.se	Jönsson, H Olof/O-8664-2017; Nordstrom, Karin/H-1673-2011	Jönsson, H Olof/0000-0002-2076-0918; Nordstrom, Karin/0000-0002-6020-6348	Swedish Research Council (VR) [2008-2933, 2012-4740]; US Air Force Research Laboratory (AFRL) [FA9550-11-1-0349]	Swedish Research Council (VR)(Swedish Research Council); US Air Force Research Laboratory (AFRL)(United States Department of DefenseUS Air Force Research Laboratory)	This work was funded by the Swedish Research Council (VR, 2008-2933, 2012-4740) and US Air Force Research Laboratory (AFRL, FA9550-11-1-0349).	Aptekar JW, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00130; Aptekar JW, 2012, CURR BIOL, V22, P482, DOI 10.1016/j.cub.2012.01.044; Barnett PD, 2010, CURR BIOL, V20, P994, DOI 10.1016/j.cub.2010.03.072; Behnia R, 2014, NATURE, V512, P427, DOI 10.1038/nature13427; Berry R, 2006, J COMP PHYSIOL A, V192, P1105, DOI 10.1007/s00359-006-0142-5; Boeddeker N, 2005, J COMP PHYSIOL A, V191, P1143, DOI 10.1007/s00359-005-0038-9; Boeddeker N, 2003, P ROY SOC B-BIOL SCI, V270, P393, DOI 10.1098/rspb.2002.2240; Borji A, 2013, VISION RES, V91, P62, DOI 10.1016/j.visres.2013.07.016; Borst A, 2010, ANNU REV NEUROSCI, V33, P49, DOI 10.1146/annurev-neuro-060909-153155; BUCHNER E, 1984, BRAIN RES, V305, P384, DOI 10.1016/0006-8993(84)90448-7; Buschbeck EK, 1996, J NEUROSCI, V16, P4563; Buschbeck EK, 1997, J COMP NEUROL, V383, P282; COLLETT TS, 1978, J COMP PHYSIOL, V125, P191, DOI 10.1007/BF00656597; de Haan R, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00055; de Vries SEJ, 2012, CURR BIOL, V22, P353, DOI 10.1016/j.cub.2012.01.007; EGELHAAF M, 1985, BIOL CYBERN, V52, P195; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Fenk LM, 2014, CURR BIOL, V24, DOI 10.1016/j.cub.2014.10.042; Fox JL, 2014, J EXP BIOL, V217, P570, DOI 10.1242/jeb.080192; Fox JL, 2014, J EXP BIOL, V217, P558, DOI 10.1242/jeb.097220; Franz MO, 2000, BIOL CYBERN, V83, P185, DOI 10.1007/s004220000163; Gauthier JL, 2009, PLOS BIOL, V7, P747, DOI 10.1371/journal.pbio.1000063; Geurten BRH, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00011; Geurten BRH, 2010, J EXP BIOL, V213, P2461, DOI 10.1242/jeb.036079; Harris RA, 1999, VISION RES, V39, P2603, DOI 10.1016/S0042-6989(98)00297-1; Hausen K., 1989, P391; Hausen K., 1984, PHOTORECEPTION VISIO, V74, P523; James AC, 1996, J COMP PHYSIOL A, V178, P183, DOI 10.1007/BF00188161; Jung SN, 2011, J NEUROSCI, V31, P9231, DOI 10.1523/JNEUROSCI.1138-11.2011; Kalb J, 2008, J NEUROSCI, V28, P9183, DOI 10.1523/JNEUROSCI.1936-08.2008; Karmeier K, 2006, J NEUROPHYSIOL, V96, P1602, DOI 10.1152/jn.00023.2006; Kimmerle B, 2000, J NEUROSCI, V20, P6256, DOI 10.1523/JNEUROSCI.20-16-06256.2000; Krapp HG, 2001, J NEUROPHYSIOL, V85, P724, DOI 10.1152/jn.2001.85.2.724; Kurtz R, 2009, P ROY SOC B-BIOL SCI, V276, P3711, DOI 10.1098/rspb.2009.0596; LAND MF, 1974, J COMP PHYSIOL, V89, P331, DOI 10.1007/BF00695351; Lee YJ, 2012, P NATL ACAD SCI USA, V109, P8758, DOI 10.1073/pnas.1203081109; Liang P, 2008, J NEUROSCI, V28, P11328, DOI 10.1523/JNEUROSCI.0203-08.2008; Liang P, 2012, J NEUROPHYSIOL, V107, P3446, DOI 10.1152/jn.00530.2011; MADDESS T, 1985, PROC R SOC SER B-BIO, V225, P251, DOI 10.1098/rspb.1985.0061; Niven JE, 2004, J NEUROPHYSIOL, V91, P2696, DOI 10.1152/jn.01163.2003; Nordstrom K, 2008, CURR BIOL, V18, P661, DOI 10.1016/j.cub.2008.03.061; Nordstrom K, 2011, J EXP BIOL, V214, P4000, DOI 10.1242/jeb.057539; O'Carroll DC, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00074; O'Carroll DC, 2011, J VISION, V11, DOI 10.1167/11.14.20; OCARROLL DC, 1992, J COMP PHYSIOL A, V171, P447, DOI 10.1007/BF00194577; OSORIO D, 1991, VISUAL NEUROSCI, V7, P345, DOI 10.1017/S0952523800004831; PIERANTONI R, 1976, CELL TISSUE RES, V171, P101; REICHARDT W, 1976, Q REV BIOPHYS, V9, P311, DOI 10.1017/S0033583500002523; REICHARDT W, 1979, BIOL CYBERN, V35, P81, DOI 10.1007/BF00337434; Ringach D, 2004, COGNITIVE SCI, V28, P147, DOI 10.1016/j.cogsci.2003.11.003; Ringach DL, 2004, J PHYSIOL-LONDON, V558, P717, DOI 10.1113/jphysiol.2004.065771; Robie AA, 2010, J EXP BIOL, V213, P2494, DOI 10.1242/jeb.041749; Schnell B, 2010, J NEUROPHYSIOL, V103, P1646, DOI 10.1152/jn.00950.2009; Schnell B, 2014, P NATL ACAD SCI USA, V111, P5700, DOI 10.1073/pnas.1400698111; Single S, 1997, J NEUROSCI, V17, P6023; SRINIVASAN MV, 1983, VISION RES, V23, P659, DOI 10.1016/0042-6989(83)90073-1; Straw AD, 2006, J EXP BIOL, V209, P4339, DOI 10.1242/jeb.02517; Tatler B, 2000, J COMP PHYSIOL A, V186, P399, DOI 10.1007/s003590050439; Theobald JC, 2010, J EXP BIOL, V213, P1366, DOI 10.1242/jeb.037945; Theobald JC, 2008, CURR BIOL, V18, pR464, DOI 10.1016/j.cub.2008.03.050; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; van Kleef J, 2005, J GEN PHYSIOL, V126, P481, DOI 10.1085/jgp.200509319; van Kleef J, 2008, J NEUROSCI, V28, P2845, DOI 10.1523/JNEUROSCI.5556-07.2008; Warzecha AK, 2000, VISION RES, V40, P2973, DOI 10.1016/S0042-6989(00)00147-4; Weber F, 2010, NEURON, V67, P629, DOI 10.1016/j.neuron.2010.07.017; WEHRHAHN C, 1982, BIOL CYBERN, V45, P123, DOI 10.1007/BF00335239; WELLINGTON WG, 1981, CAN ENTOMOL, V113, P695, DOI 10.4039/Ent113695-8; Zeil J, 1986, BEHAV ECOL SOCIOBIOL, V19, P312	69	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0126265	10.1371/journal.pone.0126265	http://dx.doi.org/10.1371/journal.pone.0126265			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955416	Green Published, gold, Green Submitted			2022-12-26	WOS:000356768100107
J	Li, ZP; Wright, ADG; Liu, HL; Fan, ZY; Yang, FH; Zhang, ZG; Li, GY				Li, Zhipeng; Wright, Andre-Denis G.; Liu, Hanlu; Fan, Zhongyuan; Yang, Fuhe; Zhang, Zhigang; Li, Guangyu			Response of the Rumen Microbiota of Sika Deer (Cervus nippon) Fed Different Concentrations of Tannin Rich Plants	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; CONDENSED TANNINS; GASTROINTESTINAL-TRACT; GENE DATABASE; BOVINE RUMEN; DAIRY-COWS; SP NOV.; FERMENTATION; METHANOGENS; DIVERSITY	High throughput sequencing was used to examine the rumen microbiota of sika deer fed high (OLH) and low concentration (OLL) of tannin rich oak leaves. The results showed that Prevotella spp. were the most dominant bacteria. The most predominant methanogens were the members of the order Methanoplasmatales. The dominant rumen protozoa were Entodinium longinucleatum, Eudiplodinium maggii, and Epidinium caudatum, and the fungal communities were mostly represented by Piromyces spp. Moreover, the relative abundance of Pseudobutyrivibrio spp. (P=0.026), unidentified bacteria (P=0.028), and Prevotella spp. (P=0.022) was lower in the OLH group than in the OLL group. The concentration of propionate in the OLH group was greater than in the OLL group (P=0.006). Patterns of relationships showed that methanogens belonging to the order Methanoplasmatales were negatively correlated with Treponema spp., Ent. Longinucleatum, and acetate. Methanosphaera stadtmanae was positively correlated to propionate, while Methanobrevibacter ruminantium was negatively associated with Methanobrevibacter thaueri and Methanobrevibacter millerae. Tannins altered the rumen microbes and fermentation patterns. However, the response of the entire rumen microbiota and the relationship between rumen microorganisms and the fermentation parameters were not fully understood.	[Li, Zhipeng; Liu, Hanlu; Fan, Zhongyuan; Yang, Fuhe; Li, Guangyu] Chinese Acad Agr Sci, Inst Special Anim & Plant Sci, Jilin Prov Key Lab Mol Biol Special Econ Anim, Changchun, Jilin, Peoples R China; [Zhang, Zhigang] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China; [Wright, Andre-Denis G.] Univ Arizona, Sch Anim & Comparat Biomed Sci, Tucson, AZ USA	Chinese Academy of Agricultural Sciences; Institute of Special Animal & Plant Sciences, CAAS; Chinese Academy of Sciences; Kunming Institute of Zoology; University of Arizona	Zhang, ZG (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China.	zhangzhigang@mail.kiz.ac.cn; tcslgy@126.com	WRIGHT, ANDRE-DENIS/ABI-2584-2020		Jilin province [20140203018NY, 20121810]; Foundation of the State Key Laboratory of Genetic Resources and Evolution Kunming Institute of Zoology Chinese Academy of Sciences [GREKF14-14]; National Natural Science Foundation of China [31471201]; Yunnan Province High-end Scientific and Technological Talents Program [2013HA020]	Jilin province; Foundation of the State Key Laboratory of Genetic Resources and Evolution Kunming Institute of Zoology Chinese Academy of Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Province High-end Scientific and Technological Talents Program	This work is supported by the Leading Talent and Creative Team Project (20121810) and Major Scientific Research Project (20140203018NY) from Jilin province, the Foundation of the State Key Laboratory of Genetic Resources and Evolution Kunming Institute of Zoology Chinese Academy of Sciences (GREKF14-14), the National Natural Science Foundation of China (31471201), and the Yunnan Province High-end Scientific and Technological Talents Program (2013HA020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bekele AZ, 2010, FEMS MICROBIOL LETT, V305, P49, DOI 10.1111/j.1574-6968.2010.01911.x; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carberry CA, 2012, APPL ENVIRON MICROB, V78, P4949, DOI 10.1128/AEM.07759-11; Cieslak A, 2013, ANIMAL, V7, P253, DOI 10.1017/S1751731113000852; Danielsson R, 2012, APPL ENVIRON MICROB, V78, P6172, DOI 10.1128/AEM.00675-12; Dehority BA, 1999, J EUKARYOT MICROBIOL, V46, P125, DOI 10.1111/j.1550-7408.1999.tb04595.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; EADIE JM, 1962, J GEN MICROBIOL, V29, P579, DOI 10.1099/00221287-29-4-579; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Gruninger RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089682; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Ishaq SL, 2014, APPL ENVIRON MICROB, V80, P5515, DOI 10.1128/AEM.01644-14; Ishaq SL, 2014, MICROB ECOL, V68, P185, DOI 10.1007/s00248-014-0399-0; Jayanegara A, 2012, J ANIM PHYSIOL AN N, V96, P365, DOI 10.1111/j.1439-0396.2011.01172.x; Kang DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068322; King EE, 2011, APPL ENVIRON MICROB, V77, P5682, DOI 10.1128/AEM.05130-11; Kittelmann S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0047879; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Leadbetter JR, 1999, SCIENCE, V283, P686, DOI 10.1126/science.283.5402.686; Leahy SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008926; Li ZP, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-151; Li ZP, 2015, MICROB ECOL, V69, P307, DOI 10.1007/s00248-014-0497-z; MAKKAR HPS, 1995, J SCI FOOD AGR, V69, P481, DOI 10.1002/jsfa.2740690413; Mao SY, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-237; McSweeney CS, 2001, ANIM FEED SCI TECH, V91, P83, DOI 10.1016/S0377-8401(01)00232-2; Michalowski T, 2003, J ANIM FEED SCI, V12, P45; Miller TL, 2002, INT J SYST EVOL MICR, V52, P819, DOI 10.1099/ijs.0.02022-0; Min BR, 2005, ANIM FEED SCI TECH, V121, P45, DOI 10.1016/j.anifeedsci.2005.02.007; Min BR, 2003, ANIM FEED SCI TECH, V106, P3, DOI 10.1016/S0377-8401(03)00041-5; Min Byeng R, 2014, Int J Microbiol, V2014, P141909, DOI 10.1155/2014/141909; Paul SS, 2010, J SCI FOOD AGR, V90, P1218, DOI 10.1002/jsfa.3952; Poulsen M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2432; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rea S, 2007, INT J SYST EVOL MICR, V57, P450, DOI 10.1099/ijs.0.63984-0; Reichardt N, 2014, ISME J, V8, P1323, DOI 10.1038/ismej.2014.14; Ross EM, 2013, J DAIRY SCI, V96, P6030, DOI 10.3168/jds.2013-6766; Russell JB, 2001, SCIENCE, V292, P1119, DOI 10.1126/science.1058830; Samuel BS, 2007, P NATL ACAD SCI USA, V104, P10643, DOI 10.1073/pnas.0704189104; Schnorr SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4654; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sundset MA, 2007, MICROB ECOL, V54, P424, DOI 10.1007/s00248-007-9254-x; Tan HY, 2011, ANIM FEED SCI TECH, V169, P185, DOI 10.1016/j.anifeedsci.2011.07.004; Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x; Tymensen LD, 2012, MICROBIOL-SGM, V158, P1808, DOI 10.1099/mic.0.057984-0; de Oliveira MNV, 2013, VET MICROBIOL, V164, P307, DOI 10.1016/j.vetmic.2013.02.013; Williams A.G., 1992, RUMEN PROTOZOA; Wright ADG, 2003, J MICROBIOL METH, V55, P337, DOI 10.1016/S0167-7012(03)00169-6; Zhang ZG, 2014, ISME J, V8, P881, DOI 10.1038/ismej.2013.185	53	23	27	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0123481	10.1371/journal.pone.0123481	http://dx.doi.org/10.1371/journal.pone.0123481			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955033	Green Published, gold, Green Submitted			2022-12-26	WOS:000356768100015
J	Mollgaard, A; Mathiesen, J				Mollgaard, Anders; Mathiesen, Joachim			Emergent User Behavior on Twitter Modelled by a Stochastic Differential Equation	PLOS ONE			English	Article							1/F NOISE	Data from the social-media site, Twitter, is used to study the fluctuations in tweet rates of brand names. The tweet rates are the result of a strongly correlated user behavior, which leads to bursty collective dynamics with a characteristic 1/f noise. Here we use the aggregated "user interest" in a brand name to model collective human dynamics by a stochastic differential equation with multiplicative noise. The model is supported by a detailed analysis of the tweet rate fluctuations and it reproduces both the exact bursty dynamics found in the data and the 1/f noise.	[Mollgaard, Anders; Mathiesen, Joachim] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark	University of Copenhagen; Niels Bohr Institute	Mathiesen, J (corresponding author), Univ Copenhagen, Niels Bohr Inst, Blegdamsvej 17, DK-2100 Copenhagen, Denmark.	mathies@nbi.dk		Mathiesen, Joachim/0000-0002-5621-5487	UCPH Excellence Programme for Interdisciplinary Research	UCPH Excellence Programme for Interdisciplinary Research	The study received funding through the UCPH 2016 Excellence Programme for Interdisciplinary Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alstott J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085777; Asur S, 2010, CORR; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; BENSOUSSAN A, 1992, APPL MATH OPT, V25, P81, DOI 10.1007/BF01184157; Bollen Johan, 2010, CORR; Garas A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00402; Gardiner C., 2009, SPRINGER SERIES IN S; Hermida A, 2014, J COMPUT-MEDIAT COMM, V19, P479, DOI 10.1111/jcc4.12074; Horvath DX, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/7/073037; King G, 2011, SCIENCE, V331, P719, DOI 10.1126/science.1197872; KOBAYASHI M, 1982, IEEE T BIO-MED ENG, V29, P456, DOI 10.1109/TBME.1982.324972; Kwak H., 2010, PROC 19 INT C WORLD, P591, DOI 10.1145/1772690.1772751; Mathiesen J, 2013, P NATL ACAD SCI USA, V110, P17259, DOI 10.1073/pnas.1304179110; Myers SA, 2014, WWW'14 COMPANION: PROCEEDINGS OF THE 23RD INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P493, DOI 10.1145/2567948.2576939; Osborne M, 2014, PROCEEDINGS OF THE I; Ruseckas J, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.031105; Sakaki T., 2010, P 19 INT C WORLD WID, P851, DOI [10.1145/1772690.1772777, DOI 10.1145/1772690.1772777, 10.1145/1772690.1772777.]; Siegert S, 1998, PHYS LETT A, V243, P275, DOI 10.1016/S0375-9601(98)00283-7; VOSS RF, 1992, PHYS REV LETT, V68, P3805, DOI 10.1103/PhysRevLett.68.3805; WEISSMAN MB, 1988, REV MOD PHYS, V60, P537, DOI 10.1103/RevModPhys.60.537	21	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0123876	10.1371/journal.pone.0123876	http://dx.doi.org/10.1371/journal.pone.0123876			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955783	gold, Green Published, Green Submitted			2022-12-26	WOS:000356768100022
J	Li, T; Tian, Y; Li, Q; Chen, HY; Lv, HH; Xie, W; Han, JH				Li, Tao; Tian, Yao; Li, Qian; Chen, Huiying; Lv, Huihui; Xie, Wei; Han, Junhai			The Neurexin/N-Ethylmaleimide-sensitive Factor (NSF) Interaction Regulates Short Term Synaptic Depression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUSION PROTEIN; ALPHA-NEUREXINS; MEMBRANE-FUSION; TRANSSYNAPTIC INTERACTION; NEUROMUSCULAR-JUNCTION; VESICLE DOCKING; BETA-NEUREXINS; CA2+ CHANNELS; DROSOPHILA; DOMAIN	Although Neurexins, which are cell adhesion molecules localized predominantly to the presynaptic terminals, are known to regulate synapse formation and synaptic transmission, their roles in the regulation of synaptic vesicle release during repetitive nerve stimulation are unknown. Here, we show that nrx mutant synapses exhibit rapid short term synaptic depression upon tetanic nerve stimulation. Moreover, we demonstrate that the intracellular region of NRX is essential for synaptic vesicle release upon tetanic nerve stimulation. Using a yeast two-hybrid screen, we find that the intracellular region of NRX interacts with N-ethylmaleimide-sensitive factor (NSF), an enzyme that mediates soluble NSF attachment protein receptor (SNARE) complex disassembly and plays an important role in synaptic vesicle release. We further map the binding sites of each molecule and demonstrate that the NRX/NSF interaction is critical for both the distribution of NSF at the presynaptic terminals and SNARE complex disassembly. Our results reveal a previously unknown role of NRX in the regulation of short term synaptic depression upon tetanic nerve stimulation and provide new mechanistic insights into the role of NRX in synaptic vesicle release.	[Li, Tao; Tian, Yao; Li, Qian; Chen, Huiying; Lv, Huihui; Xie, Wei; Han, Junhai] Southeast Univ, Inst Life Sci, Key Lab Dev Genes & Human Dis, Nanjing 210096, Jiangsu, Peoples R China; [Xie, Wei; Han, Junhai] Nantong Univ, Coinnovat Ctr Neuroregenerat, Nantong 226001, JS, Peoples R China	Southeast University - China; Nantong University	Han, JH (corresponding author), Southeast Univ, Inst Life Sci, 2 Sipailou Rd, Nanjing 210096, Jiangsu, Peoples R China.	junhaihan@seu.edu.cn		Tian, Yao/0000-0002-0367-6239	Ministry of Science and Technology [2014CB942803, 2012CB517903]; Chinese Ministry of Education [113028A]; Excellent Youth Foundation of Jiangsu Province of China [BK20140024]; National Natural Science Foundation of China [30930051]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Chinese Ministry of Education(Ministry of Education, China); Excellent Youth Foundation of Jiangsu Province of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Ministry of Science and Technology Grants 2014CB942803 and 2012CB517903, Research Project of Chinese Ministry of Education Grant 113028A, Excellent Youth Foundation of Jiangsu Province of China Grant BK20140024 (to J. H.), and National Natural Science Foundation of China Key Program 30930051 (to W. X.). The authors declare that they have no conflicts of interest with the contents of this article.	Aoto J, 2013, CELL, V154, P75, DOI 10.1016/j.cell.2013.05.060; Atasoy D, 2007, P NATL ACAD SCI USA, V104, P2525, DOI 10.1073/pnas.0611003104; Biederer T, 2001, J BIOL CHEM, V276, P47869, DOI 10.1074/jbc.M105287200; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Choi YB, 2011, NEURON, V70, P468, DOI 10.1016/j.neuron.2011.03.020; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; Delgado R, 2000, NEURON, V28, P941, DOI 10.1016/S0896-6273(00)00165-3; Fairless R, 2008, J NEUROSCI, V28, P12969, DOI 10.1523/JNEUROSCI.5294-07.2008; Fleming KG, 1998, J BIOL CHEM, V273, P15675, DOI 10.1074/jbc.273.25.15675; Gokce O, 2013, J NEUROSCI, V33, P14617, DOI 10.1523/JNEUROSCI.1232-13.2013; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; HATA Y, 1993, NEURON, V10, P307, DOI 10.1016/0896-6273(93)90320-Q; Hata Y, 1996, J NEUROSCI, V16, P2488; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Ho A, 2006, J NEUROSCI, V26, P13089, DOI 10.1523/JNEUROSCI.2855-06.2006; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; Kawasaki F, 2009, P NATL ACAD SCI USA, V106, P14658, DOI 10.1073/pnas.0907144106; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Lenzen CU, 1998, CELL, V94, P525, DOI 10.1016/S0092-8674(00)81593-7; Li J, 2007, NEURON, V55, P741, DOI 10.1016/j.neuron.2007.08.002; Li Y, 2013, J NEUROSCI, V33, P15545, DOI 10.1523/JNEUROSCI.0819-13.2013; Littleton JT, 2001, P NATL ACAD SCI USA, V98, P12233, DOI 10.1073/pnas.221450198; Littleton JT, 1998, NEURON, V21, P401, DOI 10.1016/S0896-6273(00)80549-8; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Missler M, 1998, J NEUROSCI, V18, P3630; Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3; Missler M, 1998, J BIOL CHEM, V273, P34716, DOI 10.1074/jbc.273.52.34716; NAGIEC EE, 1995, J BIOL CHEM, V270, P29182, DOI 10.1074/jbc.270.49.29182; Owald D, 2012, NAT NEUROSCI, V15, P1219, DOI 10.1038/nn.3183; Petrenko AG, 1996, J NEUROSCI, V16, P4360; Rowen L, 2002, GENOMICS, V79, P587, DOI 10.1006/geno.2002.6734; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Sudhof T. C., 2011, CSH PERSPECT BIOL, V3, P3, DOI DOI 10.1101/CSHPERSPECT.A005637; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; SUMIDA M, 1994, J BIOL CHEM, V269, P20636; Sun MK, 2011, J NEUROSCI, V31, P687, DOI 10.1523/JNEUROSCI.3854-10.2011; TAGAYA M, 1993, J BIOL CHEM, V268, P2662; Tian Y, 2013, NEURON, V77, P311, DOI 10.1016/j.neuron.2012.11.012; Tolar LA, 1998, J NEUROSCI, V18, P10250; Uemura T, 2010, CELL, V141, P1068, DOI 10.1016/j.cell.2010.04.035; VANDEGOOR J, 1995, P NATL ACAD SCI USA, V92, P5739, DOI 10.1073/pnas.92.12.5739; Wang DY, 2006, BBA-GEN SUBJECTS, V1760, P1428, DOI 10.1016/j.bbagen.2006.05.011; WHITEHEART SW, 1994, J CELL BIOL, V126, P945, DOI 10.1083/jcb.126.4.945; Wojcik SM, 2007, NEURON, V55, P11, DOI 10.1016/j.neuron.2007.06.013; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Yu RC, 1998, NAT STRUCT BIOL, V5, P803, DOI 10.1038/1843; Yu WH, 2011, MOL CELL NEUROSCI, V47, P19, DOI 10.1016/j.mcn.2011.02.002; Zeng XK, 2007, FEBS LETT, V581, P2509, DOI 10.1016/j.febslet.2007.04.068; Zhang WQ, 2005, J NEUROSCI, V25, P4330, DOI 10.1523/JNEUROSCI.0497-05.2005	55	16	16	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17656	17667		10.1074/jbc.M115.644583	http://dx.doi.org/10.1074/jbc.M115.644583			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	25953899	Green Published, hybrid			2022-12-26	WOS:000358511700002
J	Bradley, EW; Carpio, LR; Newton, AC; Westendorf, JJ				Bradley, Elizabeth W.; Carpio, Lomeli R.; Newton, Alexandra C.; Westendorf, Jennifer J.			Deletion of the PH-domain and Leucine-rich Repeat Protein Phosphatase 1 (Phlpp1) Increases Fibroblast Growth Factor (Fgf) 18 Expression and Promotes Chondrocyte Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; cartilage; fibroblast growth factor (FGF); fibroblast growth factor receptor (FGFR); FOXO; osteoarthritis	FACTOR RECEPTOR-3; SIGNALING PATHWAYS; MICE LACKING; MURINE CHONDROCYTES; BONE-DEVELOPMENT; TUMOR-GROWTH; RAT MODEL; KINASE B; AKT; CARTILAGE	Background: Phlpp1 is a tumor suppressor that represses Akt2 and other signaling pathways. Results: Chondrocyte proliferation, matrix production, Akt2 phosphorylation, and Fgf18/Erk1/2 signaling were increased in Phlpp1(-/-) mice, but levels of the transcription factor FoxO1 were reduced. Conclusion: Phlpp1 deficiency increases Akt2 activity, which diminishes FoxO1 levels and induces Fgf18 expression to stimulate Erk1/2 activity and chondrocyte proliferation. Significance: Phlpp1 inhibition may promote cartilage regeneration. Endochondral ossification orchestrates formation of the vertebrate skeleton and is often induced during disease and repair processes of the musculoskeletal system. Here we show that the protein phosphatase Phlpp1 regulates endochondral ossification. Phlpp1 null mice exhibit decreased bone mass and notable changes in the growth plate, including increased BrdU incorporation and matrix production. Phosphorylation of known Phlpp1 substrates, Akt2, PKC, and p70 S6 kinase, were enhanced in ex vivo cultured Phlpp1(-/-) chondrocytes. Furthermore, Phlpp1 deficiency diminished FoxO1 levels leading to increased expression of Fgf18, Mek/Erk activity, and chondrocyte metabolic activity. Phlpp inhibitors also increased matrix content, Fgf18 production and Erk1/2 phosphorylation. Chemical inhibition of Fgfr-signaling abrogated elevated Erk1/2 phosphorylation and metabolic activity in Phlpp1-null cultures. These results demonstrate that Phlpp1 controls chondrogenesis via multiple mechanisms and that Phlpp1 inhibition could be a strategy to promote cartilage regeneration and repair.	[Bradley, Elizabeth W.; Westendorf, Jennifer J.] Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA; [Carpio, Lomeli R.] Mayo Clin, Mayo Grad Sch, Rochester, MN 55905 USA; [Westendorf, Jennifer J.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Newton, Alexandra C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; University of California System; University of California San Diego	Westendorf, JJ (corresponding author), Mayo Clin, Dept Orthoped Surg, 200 First St SW, Rochester, MN 55905 USA.	westendorf.jennifer@mayo.edu	Regan, Clinton/E-6250-2012	Bradley, Elizabeth/0000-0002-8814-5524; Shull, Lomeli/0000-0001-7537-8516	National Institutes of Health [AR056950, AR61873, AR65397, AR68103, GM055252, GM067946]; Mayo Clinic; Mayo Graduate School; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR061873, K01AR065397, R01AR068103, T32AR056950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067946, R25GM055252] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic; Mayo Graduate School; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants AR056950, AR61873, AR65397, AR68103, GM055252, and GM067946, the Mayo Clinic, and Mayo Graduate School.	Beier F, 2010, J CELL BIOCHEM, V110, P573, DOI 10.1002/jcb.22604; Bradley EW, 2013, J BIOL CHEM, V288, P9572, DOI 10.1074/jbc.M112.423723; Brognard J, 2008, TRENDS ENDOCRIN MET, V19, P223, DOI 10.1016/j.tem.2008.04.001; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; BROWN JH, 1992, AM FAM PHYSICIAN, V46, P1180; Colvin JS, 1996, NAT GENET, V12, P390, DOI 10.1038/ng0496-390; Davidson D, 2005, J BIOL CHEM, V280, P20509, DOI 10.1074/jbc.M410148200; Ellsworth JL, 2002, OSTEOARTHR CARTILAGE, V10, P308, DOI 10.1053/joca.2002.0514; Ericson K, 2010, P NATL ACAD SCI USA, V107, P2598, DOI 10.1073/pnas.0914018107; Fayard E, 2005, J CELL SCI, V118, P5675, DOI 10.1242/jcs.02724; Fukai A, 2010, ARTHRITIS RHEUM-US, V62, P826, DOI 10.1002/art.27296; Gao T, 2008, J BIOL CHEM, V283, P6300, DOI 10.1074/jbc.M707319200; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Govoni KE, 2007, PHYSIOL GENOMICS, V30, P354, DOI 10.1152/physiolgenomics.00022.2007; Guntur AR, 2011, DEVELOPMENT, V138, P1433, DOI 10.1242/dev.058016; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Haque T, 2007, HISTOL HISTOPATHOL, V22, P97, DOI 10.14670/HH-22.97; Ikegami D, 2011, DEVELOPMENT, V138, P1507, DOI 10.1242/dev.057802; Iwata T, 2000, HUM MOL GENET, V9, P1603, DOI 10.1093/hmg/9.11.1603; Jin EJ, 2007, J CELL BIOCHEM, V102, P252, DOI 10.1002/jcb.21430; Jones DC, 2010, P NATL ACAD SCI USA, V107, P8254, DOI 10.1073/pnas.1003727107; Kita K, 2008, GENES CELLS, V13, P839, DOI 10.1111/j.1365-2443.2008.01209.x; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lazarus JE, 2007, BONE, V40, P577, DOI 10.1016/j.bone.2006.10.013; Liu ZH, 2002, GENE DEV, V16, P859, DOI 10.1101/gad.965602; Lohmander LS, 2014, ARTHRITIS RHEUMATOL, V66, P1820, DOI 10.1002/art.38614; Masubuchi S, 2010, P NATL ACAD SCI USA, V107, P1642, DOI 10.1073/pnas.0910292107; Mikic B, 2004, J ORTHOPAED RES, V22, P552, DOI 10.1016/j.orthres.2003.09.002; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; Moore EE, 2005, OSTEOARTHR CARTILAGE, V13, P623, DOI 10.1016/j.joca.2005.03.003; Mugniery E, 2012, HUM MOL GENET, V21, P2503, DOI 10.1093/hmg/dds065; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Naski MC, 1998, DEVELOPMENT, V125, P4977; Ohbayashi N, 2002, GENE DEV, V16, P870, DOI 10.1101/gad.965702; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; Panda DK, 2012, AM J PHYSIOL-ENDOC M, V303, pE1489, DOI 10.1152/ajpendo.00254.2012; Pardo OE, 2009, CANCER RES, V69, P8645, DOI 10.1158/0008-5472.CAN-09-1576; Power J, 2014, J ORTHOP RES, V32, P669, DOI 10.1002/jor.22580; Price J, 2010, J CELL PHYSIOL, V222, P502, DOI 10.1002/jcp.22001; Priore R, 2006, J CELL PHYSIOL, V207, P800, DOI 10.1002/jcp.20620; Razidlo D. F., PLOS ONE, V5; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Rimoin DL, 2007, ANN NY ACAD SCI, V1117, P302, DOI 10.1196/annals.1402.072; Rokutanda S, 2009, DEV BIOL, V328, P78, DOI 10.1016/j.ydbio.2009.01.009; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; Schipani E, 2001, GENE DEV, V15, P2865; Shung CY, 2012, HUM MOL GENET, V21, P4628, DOI 10.1093/hmg/dds305; Sierecki E, 2010, J MED CHEM, V53, P6899, DOI 10.1021/jm100331d; Staines KA, 2013, J ENDOCRINOL, V219, pR1, DOI 10.1530/JOE-13-0276; Ulici V, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-40; Valverde-Franco G, 2006, HUM MOL GENET, V15, P1783, DOI 10.1093/hmg/ddl100; Yamaoka H, 2010, CELL PROLIFERAT, V43, P67, DOI 10.1111/j.1365-2184.2009.00655.x; Zeng GQ, 2014, INT J MOL SCI, V15, P13236, DOI 10.3390/ijms150813236; Zhao HH, 2014, J CELL MOL MED, V18, P283, DOI 10.1111/jcmm.12186	57	32	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16272	16280		10.1074/jbc.M114.612937	http://dx.doi.org/10.1074/jbc.M114.612937			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25953896	Green Published, hybrid			2022-12-26	WOS:000356930100030
J	Bavik, C; Henry, SH; Zhang, Y; Mitts, K; McGinn, T; Budzynski, E; Pashko, A; Lieu, KL; Zhong, S; Blumberg, B; Kuksa, V; Orme, M; Scott, I; Fawzi, A; Kubota, R				Bavik, Claes; Henry, Susan Hayes; Zhang, Yan; Mitts, Kyoko; McGinn, Tim; Budzynski, Ewa; Pashko, Andriy; Lieu, Kuo Lee; Zhong, Sheng; Blumberg, Bruce; Kuksa, Vladimir; Orme, Mark; Scott, Ian; Fawzi, Ahmad; Kubota, Ryo			Visual Cycle Modulation as an Approach toward Preservation of Retinal Integrity	PLOS ONE			English	Article							LIGHT-INDUCED DAMAGE; MACULAR DEGENERATION; PIGMENT EPITHELIUM; DARK-ADAPTATION; LIPOFUSCIN ACCUMULATION; INDUCED RETINOPATHY; OXYGEN DISTRIBUTION; MOUSE MODEL; A2E; MICE	Increased exposure to blue or visible light, fluctuations in oxygen tension, and the excessive accumulation of toxic retinoid byproducts places a tremendous amount of stress on the retina. Reduction of visual chromophore biosynthesis may be an effective method to reduce the impact of these stressors and preserve retinal integrity. A class of non-retinoid, small molecule compounds that target key proteins of the visual cycle have been developed. The first candidate in this class of compounds, referred to as visual cycle modulators, is emixustat hydrochloride (emixustat). Here, we describe the effects of emixustat, an inhibitor of the visual cycle isomerase (RPE65), on visual cycle function and preservation of retinal integrity in animal models. Emixustat potently inhibited isomerase activity in vitro (IC50 = 4.4 nM) and was found to reduce the production of visual chromophore (11-cis retinal) in wild-typemice following a single oral dose (ED50 = 0.18mg/kg). Measure of drug effect on the retina by electroretinography revealed a dose-dependent slowing of rod photoreceptor recovery (ED50 = 0.21mg/kg) that was consistent with the pattern of visual chromophore reduction. In albino mice, emixustat was shown to be effective in preventing photoreceptor cell death caused by intense light exposure. Pre-treatment with a single dose of emixustat (0.3 mg/kg) provided a similar to 50% protective effect against light-induced photoreceptor cell loss, while higher doses (1-3 mg/kg) were nearly 100% effective. In Abca4(-/-) mice, an animal model of excessive lipofuscin and retinoid toxin (A2E) accumulation, chronic (3 month) emixustat treatmentmarkedly reduced lipofuscin auto-fluorescence and reduced A2E levels by similar to 60%(ED50 = 0.47 mg/kg). Finally, in the retinopathy of prematurity rodentmodel, treatment with emixustat during the period of ischemia and reperfusion injury produced a similar to 30% reduction in retinal neovascularization (ED50 = 0.46mg/kg). These data demonstrate the ability of emixustat to modulate visual cycle activity and reduce pathology associated with various biochemical and environmental stressors in animal models. Other attributes of emixustat, such as oral bioavailability and target specificity make it an attractive candidate for clinical development in the treatment of retinal disease.	[Bavik, Claes; Henry, Susan Hayes; Zhang, Yan; Mitts, Kyoko; McGinn, Tim; Budzynski, Ewa; Pashko, Andriy; Lieu, Kuo Lee; Zhong, Sheng; Kuksa, Vladimir; Orme, Mark; Scott, Ian; Fawzi, Ahmad; Kubota, Ryo] Acucela Inc, Seattle, WA 98101 USA; [Blumberg, Bruce] Univ Calif Irvine, Sch Biol Sci, Irvine, CA 92697 USA	University of California System; University of California Irvine	Kubota, R (corresponding author), Acucela Inc, 1301 2nd Ave,Suite 1900, Seattle, WA 98101 USA.	rkubota@acucela.com			Acucela Inc.; Otsuka	Acucela Inc.; Otsuka(Otsuka Pharmaceutical)	This work was funded through a joint collaboration between Acucela Inc. and Otsuka. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Otsuka did review the manuscript and had no comments. The granted funds were used to support costs of the research and salaries for authors CB, SHH, YZ, KM, TM, EB, AP, KLL, SZ, VK, MO, IS, AF and RK. The specific roles of these authors are articulated in the "author contributions" section.	Arden GB, 2011, EYE, V25, P1546, DOI 10.1038/eye.2011.264; Arden GB, 2005, BRIT J OPHTHALMOL, V89, P764, DOI 10.1136/bjo.2004.062547; Arden GB, 1998, VISION RES, V38, P1723, DOI 10.1016/S0042-6989(98)00004-2; Bermann M, 2001, EXP EYE RES, V72, P191; Bhosale P, 2009, ARCH BIOCHEM BIOPHYS, V483, P175, DOI 10.1016/j.abb.2008.09.012; Birol G, 2007, AM J PHYSIOL-HEART C, V293, pH1696, DOI 10.1152/ajpheart.00221.2007; Boyer NP, 2012, J BIOL CHEM, V287, P22276, DOI 10.1074/jbc.M111.329235; Chen Y, 2012, J BIOL CHEM, V287, P5059, DOI 10.1074/jbc.M111.315432; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Fain GL, 2001, PHYSIOL REV, V81, P117, DOI 10.1152/physrev.2001.81.1.117; Fan J, 2005, J PHYSIOL-LONDON, V568, P83, DOI 10.1113/jphysiol.2005.091942; Finnemann SC, 2002, P NATL ACAD SCI USA, V99, P3842, DOI 10.1073/pnas.052025899; Golczak M, 2005, P NATL ACAD SCI USA, V102, P8162, DOI 10.1073/pnas.0503318102; Golczak M, 2008, J BIOL CHEM, V283, P9543, DOI 10.1074/jbc.M708982200; Grimm C, 2000, NAT GENET, V25, P63, DOI 10.1038/75614; Hardarson SH, 2009, INVEST OPHTH VIS SCI, V50, P2308, DOI 10.1167/iovs.08-2576; Harper WS, 2001, PHOTOCHEM PHOTOBIOL, V73, P71, DOI 10.1562/0031-8655(2001)073<0071:SOATRA>2.0.CO;2; Iriyama A, 2009, J CELL PHYSIOL, V220, P469, DOI 10.1002/jcp.21792; Lamb LE, 2004, PHOTOCHEM PHOTOBIOL, V79, P127, DOI 10.1562/0031-8655(2004)079<0127:AACOOL>2.0.CO;2; Liu JH, 2000, J BIOL CHEM, V275, P29354, DOI 10.1074/jbc.M910191199; Loginova MY, 2008, BIOCHEMISTRY-MOSCOW+, V73, P130, DOI 10.1134/S000629790802003X; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda A, 2006, MOL PHARMACOL, V70, P1220, DOI 10.1124/mol.106.026823; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; Mata NL, 2001, INVEST OPHTH VIS SCI, V42, P1685; Okawa H, 2008, CURR BIOL, V18, P1917, DOI 10.1016/j.cub.2008.10.029; Organisciak DT, 2010, PROG RETIN EYE RES, V29, P113, DOI 10.1016/j.preteyeres.2009.11.004; Radu RA, 2005, INVEST OPHTH VIS SCI, V46, P4393, DOI 10.1167/iovs.05-0820; Radu RA, 2003, P NATL ACAD SCI USA, V100, P4742, DOI 10.1073/pnas.0737855100; Radu RA, 2011, J BIOL CHEM, V286, P18593, DOI 10.1074/jbc.M110.191866; Rozanowska M, 2005, PHOTOCHEM PHOTOBIOL, V81, P1305, DOI 10.1562/2004-11-13-IR-371; Rozanowska M, 2012, PHOTOCHEM PHOTOBIOL, V88, P1362, DOI 10.1111/j.1751-1097.2012.01161.x; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; Sparrow JR, 2003, VISION RES, V43, P2983, DOI 10.1016/S0042-6989(03)00475-9; Sparrow JR, 2002, INVEST OPHTH VIS SCI, V43, P1222; Suter M, 2000, J BIOL CHEM, V275, P39625, DOI 10.1074/jbc.M007049200; Tanito M, 2007, INVEST OPHTH VIS SCI, V48, P1864, DOI 10.1167/iovs.06-1065; Thompson DA, 2003, PROG RETIN EYE RES, V22, P683, DOI 10.1016/S1350-9462(03)00051-X; Weymouth AE, 2008, PROG RETIN EYE RES, V27, P1, DOI 10.1016/j.preteyeres.2007.09.003; Woodruff ML, 2003, NAT GENET, V35, P158, DOI 10.1038/ng1246; Wu ZP, 2004, J BIOL CHEM, V279, P27357, DOI 10.1074/jbc.M401960200; Yu DY, 2005, INVEST OPHTH VIS SCI, V46, P4728, DOI 10.1167/iovs.05-0694; Yu DY, 2005, EXP EYE RES, V80, P745, DOI 10.1016/j.exer.2005.01.018	43	45	45	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0124940	10.1371/journal.pone.0124940	http://dx.doi.org/10.1371/journal.pone.0124940			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970164	Green Published, gold			2022-12-26	WOS:000354544200059
J	Graz, MB; Tolsa, JF; Fumeaux, CJF				Graz, Myriam Bickle; Tolsa, Jean-Francois; Fumeaux, Celine Julie Fischer			Being Small for Gestational Age: Does it Matter for the Neurodevelopment of Premature Infants? A Cohort Study	PLOS ONE			English	Article							INTRAUTERINE GROWTH RESTRICTION; CHILDREN BORN SMALL; BIRTH-WEIGHT; PRETERM INFANTS; CEREBRAL-PALSY; OUTCOMES; DISORDER; NEWBORNS	Background Whether being small for gestational age (SGA) increases the risk of adverse neurodevelopmental outcome in premature infants remains controversial. Objective to study the impact of SGA (birthweight < percentile 10) on cognition, behavior, neurodevelopmental impairment and use of therapy at 5 years old. Methods This population-based prospective cohort included infants born before 32 weeks of gestation. Cognition was evaluated with the K-ABC, and behavior with the Strengths and Difficulties Questionnaire (SDQ). Primary outcomes were cognitive and behavioral scores, as well as neurodevelopmental impairment (cognitive score < 2SD, hearing loss, blindness, or cerebral palsy). The need of therapy, an indirect indicator of neurodevelopmental impairment, was a secondary outcome. Linear and logistic regression models were used to analyze the association of SGA with neurodevelopment. Results 342/515 (76%) premature infants were assessed. SGA was significantly associated with hyperactivity scores of the SDQ (coefficient 0.81, p < 0.04), but not with cognitive scores, neurodevelopmental impairment or the need of therapy. Gestational age, socio-economic status, and major brain lesions were associated with cognitive outcome in the univariate and multivariate model, whereas asphyxia, sepsis and bronchopulmonary dysplasia were associated in the univariate model only. Severe impairment was associated with fetal tobacco exposition, asphyxia, gestational age and major brain lesions. Different neonatal factors were associated with the use of single or multiple therapies: children with one therapy were more likely to have suffered birth asphyxia or necrotizing enterocolitis, whereas the need for several therapies was predicted by major brain lesions. Discussion In this large cohort of premature infants, assessed at 5 years old with a complete panel of tests, SGA was associated with hyperactive behavior, but not with cognition, neurodevelopmental impairment or use of therapy. Birthweight <10th percentile alone does not appear to be an independent risk factor of neurodevelopmental adverse outcome in preterm children.	[Graz, Myriam Bickle] Univ Lausanne Hosp, Dept Pediat & Pediat Surg, Clin Neonatol & Dev Unit, Lausanne, Switzerland; Univ Lausanne, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne	Graz, MB (corresponding author), Univ Lausanne Hosp, Dept Pediat & Pediat Surg, Clin Neonatol & Dev Unit, Lausanne, Switzerland.	Myriam.Bickle-Graz@chuv.ch	Graz, Myriam Bickle/AAI-8796-2020	Graz, Myriam Bickle/0000-0003-2733-3588				Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Cans C, 2000, DEV MED CHILD NEUROL, V42, P816, DOI 10.1111/j.1469-8749.2000.tb00695.x; Cornelius MD, 2011, NEUROTOXICOL TERATOL, V33, P137, DOI 10.1016/j.ntt.2010.08.006; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Guellec I, 2011, PEDIATRICS, V127, pE883, DOI 10.1542/peds.2010-2442; Gutbrod T, 2000, ARCH DIS CHILD-FETAL, V82, pF208, DOI 10.1136/fn.82.3.F208; Heinonen K, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-91; Kaufman A. S., 1993, KAUFMAN ASSESSMENT B; Kok JH, 1998, BRIT J OBSTET GYNAEC, V105, P162, DOI 10.1111/j.1471-0528.1998.tb10046.x; LARGO RH, 1989, DEV MED CHILD NEUROL, V31, P440, DOI 10.1111/j.1469-8749.1989.tb04022.x; Latal-Hajnal B, 2003, J PEDIATR-US, V143, P163, DOI 10.1067/S0022-3476(03)00243-9; Lee ACC, 2013, LANCET GLOB HEALTH, V1, pE26, DOI 10.1016/S2214-109X(13)70006-8; Lee PA, 2003, PEDIATRICS, V111, P1253, DOI 10.1542/peds.111.6.1253; Mamelle N, 2006, EUR J PEDIATR, V165, P717, DOI 10.1007/s00431-005-0045-4; Marret S, 2009, ARCH PEDIATRIE, V16, pS17, DOI 10.1016/S0929-693X(09)75297-2; McCarthy D., 1972, MANUAL MCCARTHY SCAL; MCCARTHY D, 1976, ECHELLES APTITUDES E; McCarthy S, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-78; McCarton CM, 1996, PEDIATRICS, V98, P1167; McCowan L, 2009, BEST PRACT RES CL OB, V23, P779, DOI 10.1016/j.bpobgyn.2009.06.003; Mu Shu-Chi, 2008, Pediatr Neonatol, V49, P13, DOI 10.1016/S1875-9572(08)60005-4; Padilla N, 2011, BRAIN RES, V1382, P98, DOI 10.1016/j.brainres.2011.01.032; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Qiu XM, 2012, AM J PERINAT, V29, P87, DOI 10.1055/s-0031-1295647; Regev RH, 2003, J PEDIATR-US, V143, P186, DOI 10.1067/S0022-3476(03)00181-1; Schlotz W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096715; Sharkey P, 2011, AM J SOCIOL, V116, P1934, DOI 10.1086/660009; Sharma Puneet, 2004, BMC Pediatr, V4, P9, DOI 10.1186/1471-2431-4-9; Shojaei T, 2009, SOC PSYCH PSYCH EPID, V44, P740, DOI 10.1007/s00127-008-0489-8; Streimish IG, 2012, EARLY HUM DEV, V88, P765, DOI 10.1016/j.earlhumdev.2012.04.004; Tolsa CB, 2004, PEDIATR RES, V56, P132, DOI 10.1203/01.PDR.0000128983.54614.7E; Torrance HL, 2010, ULTRASOUND OBST GYN, V36, P171, DOI 10.1002/uog.7627; van den Berg G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037002; Van Haastert IC, 2012, DEV MED CHILD NEUROL, V54, P538, DOI 10.1111/j.1469-8749.2012.04259.x; Voigt M, 2006, GEBURTSH FRAUENHEILK, V66, P956, DOI 10.1055/s-2006-924458; von Ehrenstein OS, 2009, AM J EPIDEMIOL, V170, P1388, DOI 10.1093/aje/kwp296; Weisglas-Kuperus N, 2009, ARCH DIS CHILD-FETAL, V94, pF196, DOI 10.1136/adc.2007.135095; WHO, 2012, BORN TOO SOON GLOBAL, DOI [10.1186/1742-4755-10-S1-S1, DOI 10.1186/1742-4755-10-S1-S1]; Wolke D, 1999, DEV MED CHILD NEUROL, V41, P94, DOI 10.1017/S0012162299000201	40	30	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0125769	10.1371/journal.pone.0125769	http://dx.doi.org/10.1371/journal.pone.0125769			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965063	Green Published, gold, Green Submitted			2022-12-26	WOS:000354543500028
J	Guo, Z; Zhang, J; Jiang, JH; Li, LQ; Xiang, BD				Guo, Zhe; Zhang, Jun; Jiang, Jing-Hang; Li, Le-Qun; Xiang, Bang-De			Obesity Does Not Influence Outcomes in Hepatocellular Carcinoma Patients following Curative Hepatectomy	PLOS ONE			English	Article							BODY-MASS INDEX; HEPATIC RESECTION; CIRRHOTIC-PATIENTS; SURVIVAL; RISK; DYSFUNCTION; OVERWEIGHT; MORBIDITY; SAFETY; TERM	Background Whether obesity affects surgical outcomes in patients with hepatocellular carcinoma (HCC) is controversial. Here we retrospectively evaluated the impact of obesity on outcomes in HCC patients after curative hepatectomy. Methods Patients with Child-Pugh A liver function who underwent curative hepatectomy between 2006 and 2010 were categorized as obese (BMI >= 25 kg/m(2), n = 68) and non-obese (<25 kg/m(2), n = 242). To reduce interference from baseline differences between the two groups, propensity score-matched analysis was performed in the ratio 1:2 using a caliper width of 0.1. Surgical outcomes were compared for 61 obese and 115 non-obese patients. Results Obese patients had higher levels of albumin and aspartate aminotransferase, and more solitary tumors compared to the non-obese patients (all P<0.05). In the propensity-matched cohort, baseline characteristics did not differ between the two groups (all P>0.05). Obese and non-obese patients had comparable 30-day mortality (1.6% vs. 2.6%, P = 1.000), 90-day mortality (3.3% vs. 4.3%, P = 1.000), and incidence of postoperative complications (19.7% vs. 18.3%, P = 0.819). Overall survival at 1, 3, and 5 years was similar for obese patients (83.6%, 63.6%, 41.6%) as for non-obese patients (80.9%, 65.9%, 49.1%; P = 0.358). Disease-free survival at 1, 3, and 5 years was also similar for obese patients (71.5%, 36.3%, 24.3%) as for non-obese ones (60.2%, 43.7%, 27.7%; P = 0.969). Conclusion Our propensity score-matched analysis strengthens the case that obesity does not adversely affect surgical outcomes of HCC patients undergoing curative hepatectomy.	[Guo, Zhe; Jiang, Jing-Hang; Li, Le-Qun; Xiang, Bang-De] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Hepatobiliary Surg, Nanning, Peoples R China; [Guo, Zhe] Cent Hosp Wuhan, Dept Thyroid & Breast Surg, Wuhan, Peoples R China; [Zhang, Jun] Wuhan 1 Hosp, Dept Ultrasound, Wuhan, Peoples R China; [Guo, Zhe] Second Peoples Hosp Jing Men, Dept Gen Surg, Jingmen, Peoples R China	Guangxi Medical University	Li, LQ (corresponding author), Guangxi Med Univ, Affiliated Tumor Hosp, Dept Hepatobiliary Surg, Nanning, Peoples R China.	xiaopushu-213@163.com; zheguophd@163.com	LI, LI/GVS-5344-2022; Li, Li/AEM-3636-2022; li, li/HII-4157-2022; LI, LI QING/GRR-8855-2022		National Natural Science Foundation of China [81160262, 81260331]; National Science and Technology Major Project of the Ministry of Science and Technology of China [2012ZX10002010001009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project of the Ministry of Science and Technology of China	National Natural Science Foundation of China (grant 81160262) and National Science and Technology Major Project of the Ministry of Science and Technology of China (grant 2012ZX10002010001009) to LQL. National Natural Science Foundation of China (grant 81260331) to BDX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardeshiri Maryam, 2014, Anesth Pain Med, V4, pe18884, DOI 10.5812/aapm.18884; Austin PC, 2014, STAT MED, V33, P1242, DOI 10.1002/sim.5984; Balzan S, 2010, WORLD J SURG, V34, P2960, DOI 10.1007/s00268-010-0756-1; Berentzen TL, 2014, J HEPATOL, V60, P325, DOI 10.1016/j.jhep.2013.09.015; Bhaskaran K, 2014, LANCET, V384, P755, DOI 10.1016/S0140-6736(14)60892-8; Blom R, 2012, ANN SURG ONCOL, V19, P766, DOI 10.1245/s10434-011-2103-7; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Cucchetti A, 2011, BRIT J SURG, V98, P1147, DOI 10.1002/bjs.7516; Dahiya D, 2010, SURGERY, V147, P676, DOI 10.1016/j.surg.2009.10.043; Dindo D, 2003, LANCET, V361, P2032, DOI 10.1016/S0140-6736(03)13640-9; Guo Z, 2014, ANN SURG ONCOL, V21, P3069, DOI 10.1245/s10434-014-3704-8; Hsieh CB, 2006, EJSO-EUR J SURG ONC, V32, P72, DOI 10.1016/j.ejso.2005.09.003; Itoh S, 2012, J SURG RES, V178, P640, DOI 10.1016/j.jss.2012.05.063; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Koch M, 2011, SURGERY, V149, P680, DOI 10.1016/j.surg.2010.12.002; Llovet JM, 2003, J HEPATOL, V38, pS136, DOI 10.1016/S0168-8278(02)00432-4; Mathur A, 2013, HPB, V15, P504, DOI 10.1111/j.1477-2574.2012.00602.x; Mathur AK, 2010, J GASTROINTEST SURG, V14, P1285, DOI 10.1007/s11605-010-1232-9; Mathur AK, 2010, J GASTROINTEST SURG, V14, P849, DOI 10.1007/s11605-010-1163-5; Melis M, 2011, ANN SURG ONCOL, V18, P824, DOI 10.1245/s10434-010-1336-1; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; Nishikawa H, 2013, J GASTROINTEST LIVER, V22, P173; Ohki T, 2007, LIVER INT, V27, P360, DOI 10.1111/j.1478-3231.2006.01420.x; Okamura Y, 2012, J HEPATO-BIL-PAN SCI, V19, P449, DOI 10.1007/s00534-011-0461-y; Pan W, 2006, ANESTHESIOLOGY, V104, P441, DOI 10.1097/00000542-200603000-00010; Pol B, 1999, EUR J SURG, V165, P446; Poon RTP, 2009, ANN SURG ONCOL, V16, P792, DOI 10.1245/s10434-009-0330-y; Potts M, 2006, BRIT MED J, V333, P361, DOI 10.1136/bmj.38938.412593.80; Powell BD, 2006, AM J CARDIOL, V98, P116, DOI 10.1016/j.amjcard.2006.01.063; Rahbari NN, 2011, HPB, V13, P528, DOI 10.1111/j.1477-2574.2011.00319.x; Santamaria F, 2012, OBES REV, V13, P822, DOI 10.1111/j.1467-789X.2012.01008.x; Sartori S, 2014, J CHILD NEUROL, V29, P421, DOI 10.1177/0883073812469050; Saunders JK, 2012, ARCH SURG-CHICAGO, V147, P331, DOI 10.1001/archsurg.2011.1404; Siegel AB, 2012, TRANSPLANTATION, V94, P539, DOI 10.1097/TP.0b013e31825c58ea; Utsunomiya T, 2008, WORLD J GASTROENTERO, V14, P1553, DOI 10.3748/wjg.14.1553; Wagner BD, 2007, ANN THORAC SURG, V84, P10, DOI 10.1016/j.athoracsur.2007.03.017; Wang HQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099281; WHO, 2004, LANCET, V363, P902; Wise Jacqui, 2014, BMJ, V348, pg3582, DOI 10.1136/bmj.g3582; Wu JC, 2009, J HEPATOL, V51, P890, DOI 10.1016/j.jhep.2009.07.009	40	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0125649	10.1371/journal.pone.0125649	http://dx.doi.org/10.1371/journal.pone.0125649			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965529	Green Published, Green Submitted, gold			2022-12-26	WOS:000354543500022
J	Nori, J; Loyola, R				Nori, Javier; Loyola, Rafael			On the Worrying Fate of Data Deficient Amphibians	PLOS ONE			English	Article							CONSERVATION	The 'Data Deficient' (DD) category of the IUCN Red List assembles species that cannot be placed in another category due to insufficient information. This process generates uncertainty about whether these species are safe or actually in danger. Here, we give a global overview on the current situation of DD amphibian species (almost a quarter of living amphibians) considering land-use change through habitat modification, the degree of protection of each species and the socio-political context of each country harboring DD species. We found that DD amphibians have, on average, 81% of their ranges totally outside protected areas. Worryingly, more than half of DD species have less than 1% of their distribution represented in protected areas. Furthermore, the percentage of overlap between species' range and human-modified landscapes is high, at approximately 58%. Many countries harboring a large number of DD species show a worrying socio-political trend illustrated by substantial, recent incremental increases in the Human Development Index and lower incremental increases in the establishment of protected areas. Most of these are African countries, which are located mainly in the central and southern regions of the continent. Other countries with similar socio-political trends are in southeastern Asia, Central America, and in the northern region of South America. This situation is concerning, but it also creates a huge opportunity for considering DD amphibians in future conservation assessments, planning, and policy at different levels of government administration.	[Nori, Javier] Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, Ctr Zool Aplicada, RA-5000 Cordoba, Cordoba, Argentina; [Nori, Javier] Consejo Nacl Invest Cient & Tecn, Inst Diversidad & Ecol Animal, Cordoba, Cordoba, Argentina; [Nori, Javier] Univ Nacl Cordoba, RA-5000 Cordoba, Cordoba, Argentina; [Loyola, Rafael] Univ Fed Goias, Dept Ecol, Lab Biogeog Conservacao, BR-74001970 Goiania, Go, Brazil	National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Universidade Federal de Goias	Loyola, R (corresponding author), Univ Fed Goias, Dept Ecol, Lab Biogeog Conservacao, CP 131, BR-74001970 Goiania, Go, Brazil.	loyola@ufg.br	Loyola, Rafael/S-3978-2019; Loyola, Rafael/A-4425-2008	Loyola, Rafael/0000-0001-5323-2735; Loyola, Rafael/0000-0001-5323-2735; Nori, Javier/0000-0002-7127-7934	"Escala Docente" of the Asociacion de Universidades Grupo Montevideo (AUGM); Pro-secretary of International Relations of National University of Cordoba (UNC); Coordination Office of International Affairs of Federal University of Goias (UFG); Ministerio de Ciencia, Tecnologia e Innovacion Productiva (MINCyT) [000113/2011]; Fondo para la Investigacion Cientifica y Tecnologica (FONCYT) [PICT-2013-1607]; CNPq [308532/2014-7, 479959/2013-7, 407094/2013-0, 563621/2010-9]; Conservation International Brazil; National Center for the Conservation of Flora (CNCFlora); O Boticario Group Foundation [PROG_0008_2013]	"Escala Docente" of the Asociacion de Universidades Grupo Montevideo (AUGM); Pro-secretary of International Relations of National University of Cordoba (UNC); Coordination Office of International Affairs of Federal University of Goias (UFG); Ministerio de Ciencia, Tecnologia e Innovacion Productiva (MINCyT); Fondo para la Investigacion Cientifica y Tecnologica (FONCYT)(FONCyT); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Conservation International Brazil; National Center for the Conservation of Flora (CNCFlora); O Boticario Group Foundation	This work was supported by "Escala Docente" of the Asociacion de Universidades Grupo Montevideo (AUGM) together with the Pro-secretary of International Relations of National University of Cordoba (UNC) and the Coordination Office of International Affairs of Federal University of Goias (UFG). JN is a Ph.D student at UNC. JN's research has been funded by Ministerio de Ciencia, Tecnologia e Innovacion Productiva (MINCyT, PID 2010, proyecto #000113/2011), Fondo para la Investigacion Cientifica y Tecnologica (FONCYT, PICT-2013-1607). RL's research has been constantly funded by CNPq (grants #308532/2014-7, 479959/2013-7, 407094/2013-0, 563621/2010-9), Conservation International Brazil, the National Center for the Conservation of Flora (CNCFlora), and the O Boticario Group Foundation for the Protection of Nature (PROG_0008_2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, IUCN RED LIST CAT CR; Bertzky B., 2012, PROTECTED PLANET REP; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Brum FT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060742; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Butchart SHM, 2010, BIOL CONSERV, V143, P239, DOI 10.1016/j.biocon.2009.10.008; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; Ficetola GF, 2013, J BIOGEOGR, V40, P1202, DOI [10.1111/jbi.12060, 10.1111/jbi.12206]; Frost DR, 2013, AMPHIBIAN SPECIES WO; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Howard SD, 2014, DIVERS DISTRIB, V20, P837, DOI 10.1111/ddi.12218; IUCN, 2013, IUCN RED LIST THREAT; IUCN UNEP, 2013, THE WORLD DATABASE O; Joppa LN, 2013, SCIENCE, V341, P1100, DOI 10.1126/science.1241706; Le Saout S, 2013, SCIENCE, V342, P803, DOI 10.1126/science.1239268; Machado N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072283; Morais AR, 2013, BIOL CONSERV, V166, P98, DOI 10.1016/j.biocon.2013.06.010; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Rodrigues ASL, 2004, BIOSCIENCE, V54, P1092, DOI 10.1641/0006-3568(2004)054[1092:GGAPRF]2.0.CO;2; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Trindade J, 2012, BIODIVERS CONSERV, V21, P2709, DOI 10.1007/s10531-012-0326-y; Venter O, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001891	24	29	31	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0125055	10.1371/journal.pone.0125055	http://dx.doi.org/10.1371/journal.pone.0125055			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965422	Green Submitted, Green Published, gold			2022-12-26	WOS:000354543500009
J	Ramasamy, S; Chin, SP; Sukumaran, SD; James, M; Buckle, C; Kiew, LV; Chung, LY				Ramasamy, Seetha; Chin, Sek Peng; Sukumaran, Sri Devi; James, Michael; Buckle, Christopher; Kiew, Lik Voon; Chung, Lip Yong			In Silico and In Vitro Analysis of Bacoside A Aglycones and Its Derivatives as the Constituents Responsible for the Cognitive Effects of Bacopa monnieri	PLOS ONE			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTOR; TRANSMEMBRANE DOMAIN; 5-HYDROXYTRYPTAMINE(2A) RECEPTOR; ALLOSTERIC MODULATION; SCANNING MUTAGENESIS; NEURITE OUTGROWTH; LIGAND-BINDING; GINKGO-BILOBA; SEROTONIN; AGONIST	Bacopa monnieri has been used in Ayurvedic medicine to improve memory and cognition. The active constituent responsible for its pharmacological effects is bacoside A, a mixture of dammarane-type triterpenoid saponins containing sugar chains linked to a steroid aglycone skeleton. Triterpenoid saponins have been reported to be transformed in vivo to metabolites that give better biological activity and pharmacokinetic characteristics. Thus, the activities of the parent compounds (bacosides), aglycones (jujubogenin and pseudojujubogenin) and their derivatives (ebelin lactone and bacogenin A(1)) were compared using a combination of in silico and in vitro screening methods. The compounds were docked into 5-HT1A, 5-HT2A, D-1, D-2, M-1 receptors and acetylcholinesterase (AChE) using AutoDock and their central nervous system (CNS) drug-like properties were determined using Discovery Studio molecular properties and ADMET descriptors. The compounds were screened in vitro using radioligand receptor binding and AChE inhibition assays. In silico studies showed that the parent bacosides were not able to dock into the chosen CNS targets and had poor molecular properties as a CNS drug. In contrast, the aglycones and their derivatives showed better binding affinity and good CNS drug-like properties, were well absorbed through the intestines and had good blood brain barrier (BBB) penetration. Among the compounds tested in vitro, ebelin lactone showed binding affinity towards M-1 (K-i = 0.45 mu M) and 5-HT2A (4.21 mu M) receptors. Bacoside A and bacopaside X (9.06 mu M) showed binding affinity towards the D-1 receptor. None of the compounds showed any inhibitory activity against AChE. Since the stimulation of M-1 and 5-HT2A receptors has been implicated in memory and cognition and ebelin lactone was shown to have the strongest binding energy, highest BBB penetration and binding affinity towards M-1 and 5-HT2A receptors, we suggest that B. monnieri constituents may be transformed in vivo to the active form before exerting their pharmacological activity.	[Ramasamy, Seetha; Chin, Sek Peng; Sukumaran, Sri Devi; James, Michael; Buckle, Christopher; Chung, Lip Yong] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur 50603, Malaysia; [Kiew, Lik Voon] Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia; [Chung, Lip Yong] Univ Malaya, Ctr Nat Prod & Drug Res CENAR, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Chung, LY (corresponding author), Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur 50603, Malaysia.	chungly@um.edu.my	DEVI, SRI/AAL-2122-2020; Chin, Sek Peng/O-1186-2016; Buckle, Michael/B-5233-2010; KIEW, LIK VOON/B-8789-2010; Chin, Sek Peng/AHE-3964-2022; devi, sri/GWQ-8417-2022; CHUNG, LIP YONG/B-7764-2010	Chin, Sek Peng/0000-0001-5555-0729; Buckle, Michael/0000-0003-2438-2376; KIEW, LIK VOON/0000-0002-6855-9631; CHUNG, LIP YONG/0000-0002-3596-768X; Devi, Sri/0000-0002-1561-3331	University of Malaya [RG032/10BIO]; High Impact Research Grants HIR-MOHE - Ministry of Higher Education, Malaysia [UM.C/625/1/HIR/MOHE/MED/17, UM.C/625/1/HIR/MOHE/MED/33]	University of Malaya(Universiti Malaya); High Impact Research Grants HIR-MOHE - Ministry of Higher Education, Malaysia	The authors wish to acknowledge the grants RG032/10BIO provided by the University of Malaya, and High Impact Research Grants HIR-MOHE (UM.C/625/1/HIR/MOHE/MED/17 and UM.C/625/1/HIR/MOHE/MED/33) provided by the Ministry of Higher Education, Malaysia, for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajanian GK, 2000, BRAIN RES REV, V31, P302, DOI 10.1016/S0165-0173(99)00046-6; Aguiar S, 2013, REJUV RES, V16, P313, DOI 10.1089/rej.2013.1431; Ahirwar S., 2012, Asian Journal of Experimental Sciences, V26, P65; Allman K, 2000, MOL PHARMACOL, V58, P175, DOI 10.1124/mol.58.1.175; Almaula N, 1996, J BIOL CHEM, V271, P14672, DOI 10.1074/jbc.271.25.14672; Anelli T, 2007, BIOCHEM BIOPH RES CO, V362, P269, DOI 10.1016/j.bbrc.2007.07.093; Barbhaiya H. C., 2008, Journal of Pharmacology and Toxicology, V3, P425; Bhattacharya SK, 1999, RES COMMUN PHARM TOX, V4, P1; BLUML K, 1994, J BIOL CHEM, V269, P18870; Braden MR, 2007, MOL PHARMACOL, V72, P1200, DOI 10.1124/mol.107.039255; Charles PD, 2011, J ETHNOPHARMACOL, V134, P55, DOI 10.1016/j.jep.2010.11.045; Chen CYC, 2009, J TAIWAN INST CHEM E, V40, P36, DOI 10.1016/j.jtice.2008.07.011; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chin SP, 2014, J MOL GRAPH MODEL, V49, P91, DOI 10.1016/j.jmgm.2014.02.002; Chung LY, 2009, PHYTOTHER RES, V23, P330, DOI 10.1002/ptr.2627; Chung LY, 2005, PHARM BIOL, V43, P280, DOI 10.1080/13880200590928889; Clader JW, 2005, CURR PHARM DESIGN, V11, P3353, DOI 10.2174/138161205774370762; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Das A, 2002, PHARMACOL BIOCHEM BE, V73, P893, DOI 10.1016/S0091-3057(02)00940-1; Day AJ, 2000, FEBS LETT, V468, P166, DOI 10.1016/S0014-5793(00)01211-4; De Jaco A, 2002, NEUROSCIENCE, V113, P331, DOI 10.1016/S0306-4522(02)00179-3; Deepak M, 2005, PHYTOCHEM ANALYSIS, V16, P24, DOI 10.1002/pca.805; Dhawan BN, 1996, EUR NEUROPSYCHOPHARM, V3, P144; Egan WJ, 2000, J MED CHEM, V43, P3867, DOI 10.1021/jm000292e; Egan WJ, 2002, ADV DRUG DELIVER REV, V54, P273, DOI 10.1016/S0169-409X(02)00004-2; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Fisher A, 2008, NEUROTHERAPEUTICS, V5, P433, DOI 10.1016/j.nurt.2008.05.002; HANSCH C, 1987, J PHARM SCI, V76, P663, DOI 10.1002/jps.2600760902; Harvey JA, 2003, LEARN MEMORY, V10, P355, DOI 10.1101/lm.60803; Hollman PCH, 2004, PHARM BIOL, V42, P74, DOI 10.3109/13880200490893492; Huang XP, 1999, BRIT J PHARMACOL, V126, P735, DOI 10.1038/sj.bjp.0702301; Indian Drug Manufacturers Association (IDMA), 2002, IND HERB PHARM; Jager AK, 2011, MOLECULES, V16, P1471, DOI 10.3390/molecules16021471; Jakab RL, 1998, P NATL ACAD SCI USA, V95, P735, DOI 10.1073/pnas.95.2.735; Keov P, 2011, NEUROPHARMACOLOGY, V60, P24, DOI 10.1016/j.neuropharm.2010.07.010; Kongkeaw C, 2014, J ETHNOPHARMACOL, V151, P528, DOI 10.1016/j.jep.2013.11.008; Kren V, 2001, CURR MED CHEM, V8, P1303, DOI 10.2174/0929867013372193; Kristiansen K, 2000, J PHARMACOL EXP THER, V293, P735; Kruse AC, 2014, NAT REV DRUG DISCOV, V13, P549, DOI 10.1038/nrd4295; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; KULSHRESHTHA DK, 1973, PHYTOCHEMISTRY, V12, P2074, DOI 10.1016/S0031-9422(00)91552-8; Lefkowitz R. J., 1990, PHARMACOL BASIS THER, P84; Leung Kar Wah, 2010, Chin Med, V5, P20, DOI 10.1186/1749-8546-5-20; LEVEY AI, 1995, J NEUROSCI, V15, P4077; Lu ZL, 2001, J BIOL CHEM, V276, P34098, DOI 10.1074/jbc.M104217200; Lu ZL, 1999, J BIOL CHEM, V274, P7309, DOI 10.1074/jbc.274.11.7309; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Mercado E, 2008, PSYCHOL BULL, V134, P109, DOI 10.1037/0033-2909.134.1.109; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Nemeth K, 2003, EUR J NUTR, V42, P29, DOI 10.1007/s00394-003-0397-3; Pajouhesh Hassan, 2005, NeuroRx, V2, P541, DOI 10.1602/neurorx.2.4.541; Pravina K, 2007, PHYTOMEDICINE, V14, P301, DOI 10.1016/j.phymed.2007.03.010; QUIRION R, 1985, BRAIN RES, V333, P345, DOI 10.1016/0006-8993(85)91590-2; Rajani M., 2008, P175, DOI 10.1007/978-3-540-74603-4_9; Ramasamy S, 2014, MOLECULES, V19, P2588, DOI 10.3390/molecules19022588; Rangel-Ordonez L, 2010, PLANTA MED, V76, P1683, DOI 10.1055/s-0030-1249962; Rastogi M, 2012, BIOGERONTOLOGY, V13, P183, DOI 10.1007/s10522-011-9367-y; Roth BL, 1997, MOL PHARMACOL, V52, P259, DOI 10.1124/mol.52.2.259; Ruan JQ, 2010, J AGR FOOD CHEM, V58, P5770, DOI 10.1021/jf1005885; Russo A, 2005, PHYTOMEDICINE, V12, P305, DOI 10.1016/j.phymed.2003.12.008; Saraf MK, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/neq038; SHAPIRO G, 1992, J MED CHEM, V35, P15, DOI 10.1021/jm00079a002; Sharma RJ, 2012, NEUROSCI RES LETT, V3, P35; Sheikh N, 2007, J ETHNOPHARMACOL, V111, P671, DOI 10.1016/j.jep.2007.01.025; Shen H, 2013, CHIN MED-UK, V8, DOI 10.1186/1749-8546-8-22; Singh H., 1988, PHYTOTHER RES, V2, P70, DOI DOI 10.1002/PTR.2650020205; Singh H. K., 1997, Indian Journal of Pharmacology, V29, pS359; Singh RR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068036, 10.1371/journal.pone.0072517]; Sivaramakrishna C, 2005, PHYTOCHEMISTRY, V66, P2719, DOI 10.1016/j.phytochem.2005.09.016; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Srivastava A, 2014, NATURE, V513, P124, DOI 10.1038/nature13494; Swaminathan M, 2014, MOLECULES, V19, P8933, DOI 10.3390/molecules19078933; Tabuchi M, 2012, CELL MOL NEUROBIOL, V32, P1139, DOI 10.1007/s10571-012-9839-x; Tawab MA, 2003, DRUG METAB DISPOS, V31, P1065, DOI 10.1124/dmd.31.8.1065; VanderZee EA, 1997, HIPPOCAMPUS, V7, P271, DOI 10.1002/(SICI)1098-1063(1997)7:3<271::AID-HIPO3>3.0.CO;2-O; Vollala VR, 2011, CLINICS, V66, P663, DOI 10.1590/S1807-59322011000400023; WANG CD, 1993, MOL PHARMACOL, V43, P931; Ward SDC, 1999, MOL PHARMACOL, V56, P1031, DOI 10.1124/mol.56.5.1031; Weiss C, 2000, J NEUROSCI, V20, P783, DOI 10.1523/JNEUROSCI.20-02-00783.2000; Le XT, 2013, NEUROCHEM RES, V38, P2201, DOI 10.1007/s11064-013-1129-6; Yamasaki M, 2010, J NEUROSCI, V30, P4408, DOI 10.1523/JNEUROSCI.5719-09.2010; Yap BK, 2012, J MOL MODEL, V18, P3639, DOI 10.1007/s00894-012-1368-5; Zhang Y, 2014, INT J FOOD PROP, V17, P1841, DOI 10.1080/10942912.2012.749410	85	42	43	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0126565	10.1371/journal.pone.0126565	http://dx.doi.org/10.1371/journal.pone.0126565			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965066	Green Submitted, gold, Green Published			2022-12-26	WOS:000354543500064
J	Sutherland, AJ; Beck, EC; Dennis, SC; Converse, GL; Hopkins, RA; Berkland, CJ; Detamore, MS				Sutherland, Amanda J.; Beck, Emily C.; Dennis, S. Connor; Converse, Gabriel L.; Hopkins, Richard A.; Berkland, Cory J.; Detamore, Michael S.			Decellularized Cartilage May Be a Chondroinductive Material for Osteochondral Tissue Engineering	PLOS ONE			English	Article							INTERPENETRATING NETWORK HYDROGELS; WOVEN SCAFFOLDS; RAW-MATERIALS; MATRIX; BONE; DIFFERENTIATION; REPAIR; DEFECT; CELLS	Extracellular matrix (ECM)-based materials are attractive for regenerative medicine in their ability to potentially aid in stem cell recruitment, infiltration, and differentiation without added biological factors. In musculoskeletal tissue engineering, demineralized bone matrix is widely used, but recently cartilage matrix has been attracting attention as a potentially chondroinductive material. The aim of this study was thus to establish a chemical decellularization method for use with articular cartilage to quantify removal of cells and analyze the cartilage biochemical content at various stages during the decellularization process, which included a physically devitalization step. To study the cellular response to the cartilage matrix, rat bone marrow-derived mesenchymal stem cells (rBMSCs) were cultured in cell pellets containing cells only (control), chondrogenic differentiation medium (TGF-beta), chemically decellularized cartilage particles (DCC), or physically devitalized cartilage particles (DVC). The chemical decellularization process removed the vast majority of DNA and about half of the glycosaminoglycans (GAG) within the matrix, but had no significant effect on the amount of hydroxyproline. Most notably, the DCC group significantly outperformed TGF-beta in chondroinduction of rBMSCs, with collagen II gene expression an order of magnitude or more higher. While DVC did not exhibit a chondrogenic response to the extent that DCC did, DVC had a greater down regulation of collagen I, collagen X and Runx2. A new protocol has been introduced for cartilage devitalization and decellularization in the current study, with evidence of chondroinductivity. Such bioactivity along with providing the 'raw material' building blocks of regenerating cartilage may suggest a promising role for DCC in biomaterials that rely on recruiting endogenous cell recruitment and differentiation for cartilage regeneration.	[Sutherland, Amanda J.] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA; [Beck, Emily C.; Detamore, Michael S.] Univ Kansas, Bioengn Grad Program, Lawrence, KS 66045 USA; [Dennis, S. Connor] Orbis Biosci, Kansas City, KS USA; [Converse, Gabriel L.; Hopkins, Richard A.] Childrens Mercy Hosp, Cardiac Surg Res Lab, Ward Family Ctr Congenital Heart Dis, Kansas City, MO 64108 USA; [Berkland, Cory J.; Detamore, Michael S.] Univ Kansas, Dept Chem & Petr Engn, Lawrence, KS 66045 USA; [Berkland, Cory J.] Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66045 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; Children's Mercy Hospital; University of Kansas; University of Kansas	Detamore, MS (corresponding author), Univ Kansas, Bioengn Grad Program, Lawrence, KS 66045 USA.	detamore@ku.edu	Hopkins, Richard/AAI-5007-2020		State of Kansas [R01 AR056347]; National Institutes of Health [R01 DE022472]; National Science Foundation Graduate Research Fellowship [NSF0064451]; NIGMS Pre-doctoral Biotechnology Training Grant Program [T32 GM-08359]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008359] Funding Source: NIH RePORTER	State of Kansas; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NIGMS Pre-doctoral Biotechnology Training Grant Program; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the State of Kansas (R01 AR056347), the National Institutes of Health (R01 DE022472), a National Science Foundation Graduate Research Fellowship (NSF0064451) (ECB), and the NIGMS Pre-doctoral Biotechnology Training Grant Program (T32 GM-08359) (SCD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasiou KA, 2013, ARTICULAR CARTILAGE, P1; Benders KEM, 2013, TRENDS BIOTECHNOL, V31, P169, DOI 10.1016/j.tibtech.2012.12.004; Blum MM, 2013, MAT SCI ENG C-MATER, V33, P4377, DOI 10.1016/j.msec.2013.06.035; Burdick JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3003997; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cha MH, 2013, TISSUE ENG PT A, V19, P978, DOI [10.1089/ten.TEA.2012.0358, 10.1089/ten.tea.2012.0358]; Cheng NC, 2013, TISSUE ENG PT A, V19, P484, DOI [10.1089/ten.tea.2012.0384, 10.1089/ten.TEA.2012.0384]; Converse GL, 2012, ACTA BIOMATER, V8, P2722, DOI 10.1016/j.actbio.2012.03.047; Darling EM, 2005, TISSUE ENG, V11, P395, DOI 10.1089/ten.2005.11.395; Decaris ML, 2012, TISSUE ENG PT A, V18, P2148, DOI [10.1089/ten.tea.2011.0677, 10.1089/ten.TEA.2011.0677]; Dormer NH, 2012, TISSUE ENG PT A, V18, P757, DOI [10.1089/ten.tea.2011.0176, 10.1089/ten.TEA.2011.0176]; Garrigues NW, 2014, J BIOMED MATER RES A, V102, P3998, DOI 10.1002/jbm.a.35068; Ghanavi P, 2012, CELL TISSUE RES, V347, P643, DOI 10.1007/s00441-012-1323-x; Gong YY, 2011, BIOMATERIALS, V32, P2265, DOI 10.1016/j.biomaterials.2010.11.078; Huey DJ, 2012, SCIENCE, V338, P917, DOI 10.1126/science.1222454; Ingavle GC, 2013, TISSUE ENG PT A, V19, P1349, DOI [10.1089/ten.tea.2012.0160, 10.1089/ten.TEA.2012.0160]; Kang HJ, 2014, J TISSUE ENG REGEN M, V8, P442, DOI 10.1002/term.1538; Karlen Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-131; Kheir E, 2011, J BIOMED MATER RES A, V99A, P283, DOI 10.1002/jbm.a.33171; Liao IC, 2013, ADV FUNCT MATER, V23, P5833, DOI 10.1002/adfm.201300483; Mohan N, 2014, BIOTECHNOL BIOENG, V111, P829, DOI 10.1002/bit.25145; Moutos FT, 2010, MACROMOL BIOSCI, V10, P1355, DOI 10.1002/mabi.201000124; Renth AN, 2012, TISSUE ENG PART B-RE, V18, P341, DOI 10.1089/ten.teb.2012.0080; Rowland CR, 2013, BIOMATERIALS, V34, P5802, DOI 10.1016/j.biomaterials.2013.04.027; Schwarz S, 2012, J TISSUE ENG REGENER; Schwarz S, 2012, TISSUE ENG PT A, V18, P2195, DOI [10.1089/ten.tea.2011.0705, 10.1089/ten.TEA.2011.0705]; Singh M, 2008, TISSUE ENG PART C-ME, V14, P299, DOI 10.1089/ten.tec.2008.0167; Xiao YH, 2013, TISSUE ENG PART B-RE, V19, P403, DOI [10.1089/ten.TEB.2012.0461, 10.1089/ten.teb.2012.0461]; Yang Q, 2011, CHINESE MED J-PEKING, V124, P3930, DOI 10.3760/cma.j.issn.0366-6999.2011.23.018; Yang ZQ, 2010, TISSUE ENG PART C-ME, V16, P865, DOI [10.1089/ten.tec.2009.0444, 10.1089/ten.TEC.2009.0444]; Zhao YH, 2013, CHINESE MED J-PEKING, V126, P3130, DOI 10.3760/cma.j.issn.0366-6999.20130212; Zheng XF, 2011, BIOTECHNOL BIOPROC E, V16, P593, DOI [10.1007/s12257-010-0348-9, 10.1007/S12257-010-0348-9]	32	102	103	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0121966	10.1371/journal.pone.0121966	http://dx.doi.org/10.1371/journal.pone.0121966			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965981	Green Published, Green Submitted, gold			2022-12-26	WOS:000354543500001
J	Arkhipova, OV; Meer, MV; Mikoulinskaia, GV; Zakharova, MV; Galushko, AS; Akimenko, VK; Kondrashov, FA				Arkhipova, Oksana V.; Meer, Margarita V.; Mikoulinskaia, Galina V.; Zakharova, Marina V.; Galushko, Alexander S.; Akimenko, Vasilii K.; Kondrashov, Fyodor A.			Recent Origin of the Methacrylate Redox System in Geobacter sulfurreducens AM-1 through Horizontal Gene Transfer	PLOS ONE			English	Article							FUMARATE REDUCTASE; FLAVOCYTOCHROME-C; SP-NOV; QUINONE OXIDOREDUCTASES; WOLINELLA-SUCCINOGENES; SIGNAL PEPTIDES; CYTOCHROMES-C; STRAIN SZ; IDENTIFICATION; GENOME	The origin and evolution of novel biochemical functions remains one of the key questions in molecular evolution. We study recently emerged methacrylate reductase function that is thought to have emerged in the last century and reported in Geobacter sulfurreducens strain AM-1. We report the sequence and study the evolution of the operon coding for the flavin-containing methacrylate reductase (Mrd) and tetraheme cytochrome. (Mcc) in the genome of G. sulfurreducens AM-1. Different types of signal peptides in functionally interlinked proteins Mrd and Mcc suggest a possible complex mechanism of biogenesis for chromoproteids of the methacrylate redox system. The homologs of the Mrd and Mcc sequence found in delta-Proteobacteria and Deferribacteres are also organized into an operon and their phylogenetic distribution suggested that these two genes tend to be horizontally transferred together. Specifically, the mrd and mcc genes from G. sulfurreducens AM-1 are not monophyletic with any of the homologs found in other Geobacter genomes. The acquisition of methacrylate reductase function by G. sulfurreducens AM-1 appears linked to a horizontal gene transfer event. However, the new function of the products of mrd and mcc may have evolved either prior or subsequent to their acquisition by G. sulfurreducens AM-1.	[Arkhipova, Oksana V.; Zakharova, Marina V.] Scryabins Inst Biochem & Physiol Microorganisms, Pushchino 142290, Russia; [Meer, Margarita V.; Kondrashov, Fyodor A.] CRG, Bioinformat & Genom Programme, Barcelona 08003, Spain; [Meer, Margarita V.; Kondrashov, Fyodor A.] UPF, Barcelona 08003, Spain; [Mikoulinskaia, Galina V.] Branch Shemyakin & Ovchinnikovs Inst Bioorgan Che, Pushchino 142290, Russia; [Galushko, Alexander S.] RAS, Agrophys Res Inst, St Petersburg 195220, Russia; [Galushko, Alexander S.] Tomsk State Univ, Tomsk 634050, Russia; [Kondrashov, Fyodor A.] ICREA, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Agrophysics Research Institute; Russian Academy of Sciences; Perm Federal Research Center, Ural Branch, RAS; Perm Agricultural Research Institute; Tomsk State University; ICREA	Arkhipova, OV (corresponding author), Scryabins Inst Biochem & Physiol Microorganisms, Pushchino 142290, Russia.	aroksan@gmail.com	Kondrashov, Fyodor Alexeevich/H-6331-2015; Zakharova, Marina/ABB-6411-2020; Galushko, Alexander/I-4980-2015; Mikoulinskaia, Galina/J-9632-2018	Kondrashov, Fyodor Alexeevich/0000-0001-8243-4694; Zakharova, Marina/0000-0003-0158-7088; Galushko, Alexander/0000-0002-0387-7997; Mikoulinskaia, Galina/0000-0003-0596-0003	HHMI International Early Career Scientist Program [55007424]; Spanish Ministry of Economy and Competitiveness as part of the EMBO YIP program [EUI-EURYIP-2011-4320]; Spanish Ministry of Economy and Competitiveness, "Centro de Excelencia Severo Ochoa" [Sev-2012-0208]; European Union; European Research Council [335980_EinME]; Spanish Ministry of Economy and Competitiveness [BFU2012-31329]; ICREA Funding Source: Custom	HHMI International Early Career Scientist Program; Spanish Ministry of Economy and Competitiveness as part of the EMBO YIP program; Spanish Ministry of Economy and Competitiveness, "Centro de Excelencia Severo Ochoa"(Spanish Government); European Union(European Commission); European Research Council(European Research Council (ERC)European Commission); Spanish Ministry of Economy and Competitiveness(Spanish Government); ICREA(ICREA)	The work has been supported by a grant of the HHMI International Early Career Scientist Program (55007424), the Spanish Ministry of Economy and Competitiveness (EUI-EURYIP-2011-4320) as part of the EMBO YIP program, two grants from the Spanish Ministry of Economy and Competitiveness, "Centro de Excelencia Severo Ochoa 2013-2017 (Sev-2012-0208)" and (BFU2012-31329), the European Union and the European Research Council under grant agreement 335980_EinME. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aklujkar M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-490; Aklujkar M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-109; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amos BK, 2007, APPL ENVIRON MICROB, V73, P6898, DOI 10.1128/AEM.01218-07; Arkhipova OV, 2012, MICROBIOLOGY+, V81, P555, DOI 10.1134/S0026261712050049; Arkhipova OV, 2009, MICROBIOLOGY+, V78, P296, DOI 10.1134/S0026261709030060; Arkhipova OV, 2005, MICROBIOLOGY+, V74, P629, DOI 10.1007/s11021-005-0116-6; Bagos PG, 2010, BIOINFORMATICS, V26, P2811, DOI 10.1093/bioinformatics/btq530; Bamford V, 1999, NAT STRUCT BIOL, V6, P1104; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Boetzer M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r56; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Bogachev AV, 2012, MOL MICROBIOL, V86, P1452, DOI 10.1111/mmi.12067; Butler JE, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-471; Butler JE, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-40; Butler JE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-103; CACCAVO F, 1994, APPL ENVIRON MICROB, V60, P3752, DOI 10.1128/AEM.60.10.3752-3759.1994; Curson ARJ, 2011, NAT REV MICROBIOL, V9, P849, DOI 10.1038/nrmicro2653; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Dobbin PS, 1999, BIOCHEM J, V342, P439, DOI 10.1042/0264-6021:3420439; Doherty MK, 2000, BIOCHEMISTRY-US, V39, P10695, DOI 10.1021/bi000871l; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EGGINK G, 1990, J MOL BIOL, V212, P135, DOI 10.1016/0022-2836(90)90310-I; Eschenbrenner M, 2001, BIOCHEMISTRY-US, V40, P5352, DOI 10.1021/bi010101p; Galouchko AS, 1996, MICROBIOLOGY+, V65, P432; Galushko AS, 2000, ARCH MICROBIOL, V174, P314, DOI 10.1007/s002030000208; Galushko AS, 1994, DOKL AKAD NAUK, V335, P122; Gordon EHJ, 1998, MICROBIOL-SGM, V144, P937, DOI 10.1099/00221287-144-4-937; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Hagerhall C, 1997, BBA-BIOENERGETICS, V1320, P107, DOI 10.1016/S0005-2728(97)00019-4; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Iverson TM, 2013, BBA-BIOENERGETICS, V1827, P648, DOI 10.1016/j.bbabio.2012.09.008; KROGER A, 1992, ARCH MICROBIOL, V158, P311, DOI 10.1007/BF00245358; Kroger A, 2002, BBA-BIOENERGETICS, V1553, P23, DOI 10.1016/S0005-2728(01)00234-1; Kroger A, 1980, BACTERIAL ELECT TRAN, P1; Lemos RS, 2002, BBA-BIOENERGETICS, V1553, P158, DOI 10.1016/S0005-2728(01)00239-0; Leys D, 1999, NAT STRUCT BIOL, V6, P1113; Li GQ, 2004, BRIEF BIOINFORM, V5, P378, DOI 10.1093/bib/5.4.378; Li T, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-13; Lovley DR, 2011, ENV MICROBIOL REP, V3, P27, DOI 10.1111/j.1758-2229.2010.00211.x; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Maier TM, 2003, J BASIC MICROB, V43, P312, DOI 10.1002/jobm.200390034; Methe BA, 2003, SCIENCE, V302, P1967, DOI 10.1126/science.1088727; Mikoulinskaia O, 1999, EUR J BIOCHEM, V263, P346, DOI 10.1046/j.1432-1327.1999.00489.x; MORRIS CJ, 1994, BIOCHEM J, V302, P587, DOI 10.1042/bj3020587; Myers CR, 1997, LETT APPL MICROBIOL, V25, P162, DOI 10.1046/j.1472-765X.1997.00196.x; Nagarajan H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010922; Nevin KP, 2005, INT J SYST EVOL MICR, V55, P1667, DOI 10.1099/ijs.0.63417-0; PEALING SL, 1992, BIOCHEMISTRY-US, V31, P12132, DOI 10.1021/bi00163a023; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Simon J, 1998, ARCH MICROBIOL, V169, P424, DOI 10.1007/s002030050593; Sung Y, 2006, APPL ENVIRON MICROB, V72, P2775, DOI 10.1128/AEM.72.4.2775-2782.2006; THONYMEYER L, 1994, MOL MICROBIOL, V12, P1, DOI 10.1111/j.1365-2958.1994.tb00988.x; Tsapin AI, 2001, APPL ENVIRON MICROB, V67, P3236, DOI 10.1128/AEM.67.7.3236-3244.2001; vanderMaarel MJEC, 1996, ARCH MICROBIOL, V166, P109, DOI 10.1007/s002030050363; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	57	3	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0125888	10.1371/journal.pone.0125888	http://dx.doi.org/10.1371/journal.pone.0125888			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962149	Green Published, gold, Green Submitted			2022-12-26	WOS:000354542500050
J	Caldwell, M; Hapuarachchi, T; Highton, D; Elwell, C; Smith, M; Tachtsidis, I				Caldwell, Matthew; Hapuarachchi, Tharindi; Highton, David; Elwell, Clare; Smith, Martin; Tachtsidis, Ilias			BrainSignals Revisited: Simplifying a Computational Model of Cerebral Physiology	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; TRAUMATIC BRAIN-INJURY; MAGNETIC-RESONANCE; OXYGEN-SATURATION; METABOLIC-RATE; BLOOD-FLOW; INTRACRANIAL-PRESSURE; SENSITIVITY-ANALYSIS; CYTOCHROME-OXIDASE; SYSTEMS BIOLOGY	Multimodal monitoring of brain state is important both for the investigation of healthy cerebral physiology and to inform clinical decision making in conditions of injury and disease. Near-infrared spectroscopy is an instrument modality that allows non-invasive measurement of several physiological variables of clinical interest, notably haemoglobin oxygenation and the redox state of the metabolic enzyme cytochrome c oxidase. Interpreting such measurements requires the integration of multiple signals from different sources to try to understand the physiological states giving rise to them. We have previously published several computational models to assist with such interpretation. Like many models in the realm of Systems Biology, these are complex and dependent on many parameters that can be difficult or impossible to measure precisely. Taking one such model, BrainSignals, as a starting point, we have developed several variant models in which specific regions of complexity are substituted with much simpler linear approximations. We demonstrate that model behaviour can be maintained whilst achieving a significant reduction in complexity, provided that the linearity assumptions hold. The simplified models have been tested for applicability with simulated data and experimental data from healthy adults undergoing a hypercapnia challenge, but relevance to different physiological and pathophysiological conditions will require specific testing. In conditions where the simplified models are applicable, their greater efficiency has potential to allow their use at the bedside to help interpret clinical data in near real-time.	[Caldwell, Matthew; Hapuarachchi, Tharindi; Elwell, Clare; Tachtsidis, Ilias] UCL, Dept Med Phys & Biomed Engn, London, England; [Hapuarachchi, Tharindi] UCL, Ctr Math & Phys Life Sci & Expt Biol, London, England; [Highton, David; Smith, Martin] Univ Coll London Hosp, Neurocrit Care Unit, London, England	University of London; University College London; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London	Tachtsidis, I (corresponding author), UCL, Dept Med Phys & Biomed Engn, London, England.	i.tachtsidis@ucl.ac.uk	Tachtsidis, Ilias/N-2747-2018; Highton, David/K-9544-2017	Tachtsidis, Ilias/0000-0002-8125-0313; Highton, David/0000-0002-4608-4081; Caldwell, Matthew/0000-0002-9578-1676; Elwell, Clare/0000-0002-7281-7234	Engineering and Physical Sciences Research Council [EP/K020315/1]; Wellcome Trust [089914]; Central and East London Comprehensive Local Research Network [45-09-FSF]; Medical Research Council [17803]; UCLH/UCL National institute for Health Research Biomedical Research Centre; EPSRC [EP/K020315/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome Trust(Wellcome Trust); Central and East London Comprehensive Local Research Network; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UCLH/UCL National institute for Health Research Biomedical Research Centre; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by the following grants: Engineering and Physical Sciences Research Council (http://www.epsrc.ac.uk), EP/K020315/1 (CE MS IT MC DH); Wellcome Trust (http://www.wellcome.ac.uk), 089914 (CE MS); Central and East London Comprehensive Local Research Network, 45-09-FSF (MS CE); and Medical Research Council (http://www.mrc.ac.uk), 17803 (CE MS). MS is partially funded by the UCLH/UCL National institute for Health Research Biomedical Research Centre (http://www.uclhospitals.brc.nihr.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderliesten T, 2014, NEUROIMAGE, V85, P255, DOI 10.1016/j.neuroimage.2013.07.015; An Hongyu, 2014, Curr Radiol Rep, V2, P39; An HY, 2000, J CEREBR BLOOD F MET, V20, P1225, DOI 10.1097/00004647-200008000-00008; Bainbridge A, 2014, NEUROIMAGE, V102, P173, DOI 10.1016/j.neuroimage.2013.08.016; Bale G, 2014, BIOMED OPT EXPRESS, V5, P3450, DOI 10.1364/BOE.5.003450; Banaji M, 2005, MATH BIOSCI, V194, P125, DOI 10.1016/j.mbs.2004.10.005; Banaji M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000212; Baxter SM, 2006, PLOS COMPUT BIOL, V2, P975, DOI 10.1371/journal.pcbi.0020087; Brown KS, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.021904; Campolongo F, 2007, ENVIRON MODELL SOFTW, V22, P1509, DOI 10.1016/j.envsoft.2006.10.004; Christen T, 2014, J CEREBR BLOOD F MET, V34, P1550, DOI 10.1038/jcbfm.2014.116; Cooper CE, 1997, PHILOS T R SOC B, V352, P669, DOI 10.1098/rstb.1997.0048; Cooper CE, 2009, ADV EXP MED BIOL, V645, P123, DOI 10.1007/978-0-387-85998-9_19; Cooper RJ, 2012, NEUROIMAGE, V59, P3128, DOI 10.1016/j.neuroimage.2011.11.028; CUKIER RI, 1973, J CHEM PHYS, V59, P3873, DOI 10.1063/1.1680571; De Georgia MA, 2005, NEUROLOGIST, V11, P45, DOI 10.1097/01.nrl.0000149993.99956.09; De Georgia MA, 2015, J INTENSIVE CARE MED, V30, P473, DOI 10.1177/0885066614529254; Dehaes M, 2014, J CEREBR BLOOD F MET, V34, P87, DOI 10.1038/jcbfm.2013.165; Delpy DT, 1997, PHILOS T R SOC B, V352, P649, DOI 10.1098/rstb.1997.0046; Diop M, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3123347; Diringer MN, 2007, J NEUROSURG, V106, P526, DOI 10.3171/jns.2007.106.4.526; Edvinsson L, 1992, CEREBRAL BLOOD FLOW; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; Gansner ER, 2000, SOFTWARE PRACT EXPER, V30, P1203, DOI 10.1002/1097-024X(200009)30:11<1203::AID-SPE338>3.0.CO;2-N; Gehricke JG, 2013, PHARMACOL BIOCHEM BE, V112, P78, DOI 10.1016/j.pbb.2013.10.001; Goodman JC, 2009, CURR OPIN CRIT CARE, V15, P110, DOI 10.1097/MCC.0b013e328325d142; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Hairer E, 1996, SPRINGER SERIES COMP; Hapuarachchi T, 2013, ADV EXP MED BIOL, V789, P331, DOI 10.1007/978-1-4614-7411-1_44; Highton D, 2014, ADV EXP MED BIOL, V812, P195, DOI 10.1007/978-1-4939-0620-8_26; Highton D, 2013, ADV EXP MED BIOL, V765, P87, DOI 10.1007/978-1-4614-4989-8_13; Iwata S, 2014, INT J DEV NEUROSCI, V37, P1, DOI 10.1016/j.ijdevneu.2014.05.010; Jelfs B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038297; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; Kakihana Y, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2940583; Kirkpatrick PJ, 1996, J NEUROL NEUROSUR PS, V60, P131, DOI 10.1136/jnnp.60.2.131; Kirkpatrick PJ, 1997, PHILOS T ROY SOC B, V352, P701, DOI 10.1098/rstb.1997.0052; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kolyva C, 2014, NEUROIMAGE, V85, P234, DOI 10.1016/j.neuroimage.2013.05.070; Kolyva C, 2012, BIOMED OPT EXPRESS, V3, P2550, DOI 10.1364/BOE.3.002550; Lee JM, 2003, ANN NEUROL, V53, P227, DOI 10.1002/ana.10433; Lynch JM, 2014, ACAD RADIOL, V21, P162, DOI 10.1016/j.acra.2013.10.013; Moroz T, 2012, J R SOC INTERFACE, V9, P1499, DOI 10.1098/rsif.2011.0766; Moroz T, 2012, ADV EXP MED BIOL, V737, P293, DOI 10.1007/978-1-4614-1566-4_43; MORRIS MD, 1991, TECHNOMETRICS, V33, P161, DOI 10.2307/1269043; Muehlschlegel S, 2009, NEUROCRIT CARE, V11, P288, DOI 10.1007/s12028-009-9254-4; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Naulaers G, 2007, NEONATOLOGY, V92, P120, DOI 10.1159/000101063; Neal ML, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003849; Obrig H, 2014, NEUROIMAGE, V85, P535, DOI 10.1016/j.neuroimage.2013.03.045; Oddo M, 2014, NEUROCRIT CARE, V21, P103, DOI 10.1007/s12028-014-0024-6; Papademetriou MD, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.6.067008; Petersen BK, 2014, BMC SYST BIOL, V8, DOI 10.1186/s12918-014-0095-1; R Core Team, 2021, R LANGUAGE ENV STAT; Roche-Labarbe N, 2014, NEUROIMAGE, V85, P279, DOI 10.1016/j.neuroimage.2013.01.035; Roche-Labarbe N, 2012, J CEREBR BLOOD F MET, V32, P481, DOI 10.1038/jcbfm.2011.145; Roche-Labarbe N, 2010, HUM BRAIN MAPP, V31, P341, DOI 10.1002/hbm.20868; Saltelli A, 1999, TECHNOMETRICS, V41, P39, DOI 10.2307/1270993; Saltelli A, 2010, ENVIRON MODELL SOFTW, V25, P1508, DOI 10.1016/j.envsoft.2010.04.012; Smith M, 2011, PHILOS T R SOC A, V369, P4452, DOI 10.1098/rsta.2011.0242; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Suarez JI, 2006, CRIT CARE MED, V34, pS232, DOI 10.1097/01.CCM.0000231881.29040.25; Tibshirani R., 2009, SPRINGER SERIES STAT, DOI [10.1007/978-0-387-84858-7, DOI 10.1007/978-0-387-84858-7]; Tichauer KM, 2010, J APPL PHYSIOL, V109, P878, DOI 10.1152/japplphysiol.01432.2009; Tisdall MM, 2007, BRIT J ANAESTH, V99, P61, DOI 10.1093/bja/aem143; Tisdall MM, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2718541; Transtrum MK, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036701; Transtrum MK, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.060201; Ursino M, 1998, AM J PHYSIOL-HEART C, V274, pH1715, DOI 10.1152/ajpheart.1998.274.5.H1715; Ursino M, 1997, J APPL PHYSIOL, V82, P1256, DOI 10.1152/jappl.1997.82.4.1256; Verdecchia K, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.2.027007; Vermeij A, 2014, NEUROIMAGE, V85, P608, DOI 10.1016/j.neuroimage.2013.04.107; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Wilcox T, 2012, NEUROIMAGE, V62, P1833, DOI 10.1016/j.neuroimage.2012.05.039; Wintermark P, 2014, NEUROIMAGE, V85, P287, DOI 10.1016/j.neuroimage.2013.04.072; Wolf M, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2804899; Wolff CB, 2013, ADV EXP MED BIOL, V789, P37, DOI 10.1007/978-1-4614-7411-1_6	77	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126695	10.1371/journal.pone.0126695	http://dx.doi.org/10.1371/journal.pone.0126695			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961297	Green Published, Green Submitted, gold			2022-12-26	WOS:000354542500136
J	Hakre, S; Mydlarz, DG; Dawson, P; Danaher, PJ; Gould, PL; Witkop, CT; Michael, NL; Peel, SA; Scott, PT; Okulicz, JF				Hakre, Shilpa; Mydlarz, Dariusz G.; Dawson, Peter; Danaher, Patrick J.; Gould, Philip L.; Witkop, Catherine T.; Michael, Nelson L.; Peel, Sheila A.; Scott, Paul T.; Okulicz, Jason F.			Epidemiology of HIV among US Air Force Military Personnel, 1996-2011	PLOS ONE			English	Article							UNITED-STATES; INFECTION; AFGHANISTAN; MOBILITY; AFRICA; TRENDS; IMPACT; ARMY; IRAQ; CARE	Objective The objectives of this study were to describe the epidemiology of HIV in the United States Air Force (USAF) from 1996 through 2011 and to assess whether socio-demographic characteristics and service-related mobility, including military deployments, were associated with HIV infection. Methods We conducted a retrospective cohort analysis of USAF personnel who were HIV-infected during the study period January 1, 1996 through December 31, 2011 and a matched case-control study. Cases were USAF personnel newly-diagnosed with HIV during the study period. Five randomly-selected HIV-uninfected controls were matched to each case by age, length of service, sex, race, service, component, and HIV test collection date. Socio-demographic and service-related mobility factors and HIV diagnosis were assessed using conditional logistic regression. Results During the study period, the USAF had 541 newly diagnosed HIV-infected cases. HIV incidence rate (per 100,000 person-years) among 473 active duty members was highest in 2007 (16.78), among black/African-American USAF members (26.60) and those aged 25 to 29 years (10.84). In unadjusted analysis restricted to personnel on active duty, 10 characteristics were identified and considered for final multivariate analysis. Of these single (adjusted odds ratio [aOR], 8.15, 95% confidence interval [CI] 5.71-11.6) or other marital status (aOR 4.60, 95% CI 2.72-7.75), communications/intelligence (aOR 2.57, 95% CI 1.84-3.60) or healthcare (aOR 2.07, 95% CI 1.28-3.35) occupations, and having no deployment in the past 2 years before diagnosis (aOR 2.02, 95% CI 1.47-2.78) conferred higher odds of HIV infection in adjusted analysis. Conclusion The highest risk of HIV infection in the USAF was among young unmarried deployment-naive males, especially those in higher risk occupation groups. In an era when worldwide military operations have increased, these analyses identified potential areas where targeted HIV prevention efforts may be beneficial in reducing HIV incidence in the USAF military population.	[Hakre, Shilpa] Henry M Jackson Fdn Adv Mil Med, United States Mil HIV Res Program, Bethesda, MD 20817 USA; [Mydlarz, Dariusz G.] Natl Guard Bur, Prevent & Occupat Med Branch, Arlington, VA USA; [Dawson, Peter] EMMES Corp, Biostat, Rockville, MD USA; [Danaher, Patrick J.; Okulicz, Jason F.] San Antonio Mil Med Ctr, Infect Dis Serv, San Antonio, TX USA; [Gould, Philip L.; Witkop, Catherine T.] Air Force Med Support Agcy, Def Hlth Headquarters, Falls Church, VA USA; [Michael, Nelson L.; Scott, Paul T.] Walter Reed Army Inst Res, United States Mil HIV Res Program, Bethesda, MD USA; [Peel, Sheila A.] Walter Reed Army Inst Res, United States Mil HIV Res Program, HIV Diagnost & Reference Lab, Silver Spring, MD USA	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Walter Reed Army Institute of Research (WRAIR); Emmes Corporation; San Antonio Military Medical Center; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Hakre, S (corresponding author), Henry M Jackson Fdn Adv Mil Med, United States Mil HIV Res Program, Bethesda, MD 20817 USA.	shakre@hivresearch.org			Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) [W81XWH-07-2-0067]; U.S. Department of Defense (DoD) [W81XWH-07-2-0067]; HJF	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF); U.S. Department of Defense (DoD)(United States Department of Defense); HJF	This work was supported by a cooperative agreement (W81XWH-07-2-0067) between The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF), and the U.S. Department of Defense (DoD). The views expressed are those of the authors and should not be construed to represent the positions of the DoD. Co-author Peter Dawson is employed by Biostatistics, The EMMES Corporation. The HJF contracted the EMMES Corporation to provide data management and analysis support for this body of work; this contract was funded by the cooperative agreement between HJF and the DoD. The EMMES Corporation provided support in the form of salary for author PD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Aldous WK, 2011, MIL MED, V176, P705, DOI 10.7205/MILMED-D-10-00218; Anastario MP, 2013, CULT MED PSYCHIAT, V37, P737, DOI 10.1007/s11013-013-9335-x; [Anonymous], 2014, MSMR, V21, P16; [Anonymous], INT GUID DEV EP PROF; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Brett-Major DM, 2012, MIL MED, V177, P1328, DOI 10.7205/MILMED-D-12-00299; Coffee M, 2007, AIDS, V21, P343, DOI 10.1097/QAD.0b013e328011dac9; Cutler DM, 2010, J HEALTH ECON, V29, P1, DOI 10.1016/j.jhealeco.2009.10.003; Department of Defense, 2003, MEM HUM IMM VIR INT; Department of Defense, 2006, HUM IMM VIR; Dia A, 2012, OCCUP MED-OXFORD, V62, P141, DOI 10.1093/occmed/kqr179; DUPONT WD, 1988, BIOMETRICS, V44, P1157, DOI 10.2307/2531743; El-Bassel N, 2011, AM J PUBLIC HEALTH, V101, P1075, DOI 10.2105/AJPH.2010.300085; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; HYAMS KC, 1993, SEX TRANSM DIS, V20, P36, DOI 10.1097/00007435-199301000-00007; Johnson AS, 2014, JAMA-J AM MED ASSOC, V312, P432, DOI 10.1001/jama.2014.8534; MALONE JD, 1993, SEX TRANSM DIS, V20, P294, DOI 10.1097/00007435-199309000-00011; Matthews P, 2014, INT J STD AIDS; Mugavero MJ, 2013, CLIN INFECT DIS, V57, P1164, DOI 10.1093/cid/cit420; Okulicz JF, 2015, JAMA INTERN MED, V175, P88, DOI 10.1001/jamainternmed.2014.4010; Orroth KK, 2007, SEX TRANSM INFECT, V83, pI5, DOI 10.1136/sti.2006.023531; Patterson Shane B, 2014, MSMR, V21, P7; RAND Corporation, 2010, SEX OR US MIL PERS P; RAND corporation, 2013, MEAS ARM DEV; Rasnake Mark S, 2005, Mil Med, V170, P61; Rubertone MV, 2002, AM J PUBLIC HEALTH, V92, P1900, DOI 10.2105/AJPH.92.12.1900; Scott PT, 2012, AIDS RES HUM RETROV, V28, P1308, DOI 10.1089/aid.2011.0363; Singer DE, 2010, AIDS RES HUM RETROV, V26, P889, DOI 10.1089/aid.2009.0289; Spiegel PB, 2004, DISASTERS, V28, P322, DOI 10.1111/j.0361-3666.2004.00261.x; Under Secretary of Defense, 2011, MEM SUBJ REP DONT AS; Van Der Ploeg CPB, 1998, STDSIM MICROSIMULATI; Vissers DCJ, 2011, EPIDEMIOL INFECT, V139, P1845, DOI 10.1017/S0950268811000069; Wang HB, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-198; WARNER RD, 1993, VACCINE, V11, P534, DOI 10.1016/0264-410X(93)90225-M	34	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126700	10.1371/journal.pone.0126700	http://dx.doi.org/10.1371/journal.pone.0126700			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI1YY	25961564	Green Published, Green Submitted, gold			2022-12-26	WOS:000354542500137
J	Ismail, MA; Deris, S; Mohamad, MS; Abdullah, A				Ismail, Mohd Arfian; Deris, Safaai; Mohamad, Mohd Saberi; Abdullah, Afnizanfaizal			A Newton Cooperative Genetic Algorithm Method for In Silico Optimization of Metabolic Pathway Production	PLOS ONE			English	Article							STEADY-STATE OPTIMIZATION; BIOCHEMICAL SYSTEMS; HYBRID	This paper presents an in silico optimization method of metabolic pathway production. The metabolic pathway can be represented by a mathematical model known as the generalized mass action model, which leads to a complex nonlinear equations system. The optimization process becomes difficult when steady state and the constraints of the components in the metabolic pathway are involved. To deal with this situation, this paper presents an in silico optimization method, namely the Newton Cooperative Genetic Algorithm (NCGA). The NCGA used Newton method in dealing with the metabolic pathway, and then integrated genetic algorithm and cooperative co-evolutionary algorithm. The proposed method was experimentally applied on the benchmark metabolic pathways, and the results showed that the NCGA achieved better results compared to the existing methods.	[Ismail, Mohd Arfian] Univ Malaysia Pahang, Fac Comp Syst & Software Engn, Gambang, Kuantan, Malaysia; [Ismail, Mohd Arfian; Deris, Safaai; Mohamad, Mohd Saberi; Abdullah, Afnizanfaizal] Univ Teknol Malaysia, Fac Comp, Artificial Intelligence & Bioinformat Grp, Dept Software Engn, Johor Baharu, Malaysia	Universiti Malaysia Pahang; Universiti Teknologi Malaysia	Deris, S (corresponding author), Univ Teknol Malaysia, Fac Comp, Artificial Intelligence & Bioinformat Grp, Dept Software Engn, Johor Baharu, Malaysia.	safaai@utm.my; afnizanfaizal@utm.my	MOHAMAD, MOHD SABERI/AAA-1929-2022; Mohamad, Mohd Saberi/J-3201-2014; Abdullah, Afnizanfaizal/E-8709-2013; bin Ismail, Mohd Arfian/I-2842-2018	MOHAMAD, MOHD SABERI/0000-0002-1079-4559; Mohamad, Mohd Saberi/0000-0002-1079-4559; Abdullah, Afnizanfaizal/0000-0002-0280-565X; Ismail, Mohd Arfian/0000-0001-8312-2289	Malaysia Ministry of Science, Technology and Innovation (MOSTI), Fellowship scheme under Universiti Malaysia Pahang (UMP); Malaysia Ministry of Education (KPM)	Malaysia Ministry of Science, Technology and Innovation (MOSTI), Fellowship scheme under Universiti Malaysia Pahang (UMP); Malaysia Ministry of Education (KPM)	This research was supported by a grant from Malaysia Ministry of Science, Technology and Innovation (MOSTI), Fellowship scheme under Universiti Malaysia Pahang (UMP) and Malaysia Ministry of Education (KPM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babaei M, 2013, APPL SOFT COMPUT, V13, P3354, DOI 10.1016/j.asoc.2013.02.005; Balsa-Canto E, 2012, ADV EXP MED BIOL, V736, P409, DOI 10.1007/978-1-4419-7210-1_24; Durillo JJ, 2011, ADV ENG SOFTW, V42, P760, DOI 10.1016/j.advengsoft.2011.05.014; GALAZZO JL, 1990, ENZYME MICROB TECH, V12, P162, DOI 10.1016/0141-0229(90)90033-M; Grosan C, 2008, IEEE T SYST MAN CY A, V38, P698, DOI 10.1109/TSMCA.2008.918599; Gu JW, 2010, COMPUT OPER RES, V37, P927, DOI 10.1016/j.cor.2009.07.002; Hicklin J., 2012, JAMA JAVA MATRIX PAC; Ismail M. A., 2014, LIFE SCI J, V11, P409; Ismail MA, 2011, J COMPUTING, V3, P81; Link H, 2008, COMPUT CHEM ENG, V32, P1707, DOI 10.1016/j.compchemeng.2007.08.009; Luo YZ, 2008, APPL SOFT COMPUT, V8, P1068, DOI 10.1016/j.asoc.2007.05.013; Ma W, 2012, INVERSE PROBL, V28, DOI 10.1088/0266-5611/28/12/125001; Mariano AP, 2009, APPL BIOCHEM BIOTECH, V159, P366, DOI 10.1007/s12010-008-8450-6; Marin-Sanguino A, 2003, MATH BIOSCI, V184, P187, DOI 10.1016/S0025-5564(03)00046-4; Marin-Sanguino A, 2000, BIOTECHNOL PROGR, V16, P133, DOI 10.1021/bp990144l; Marin-Sanguino A, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-38; Rodriguez-Acosta F, 1999, J BIOTECHNOL, V68, P15, DOI 10.1016/S0168-1656(98)00178-3; Savageau M, 1976, BIOCH SYSTEMS ANAL S; Vera J, 2010, COMPUT OPER RES, V37, P1427, DOI 10.1016/j.cor.2009.02.021; Voit E. O., 2013, ISRN BIOMATH, V2013, P53, DOI [10.1155/2013/897658, DOI 10.1155/2013/897658]; Xiu ZL, 1997, J BIOTECHNOL, V58, P125, DOI 10.1016/S0168-1656(97)00143-0; Xu GX, 2013, EUR J OPER RES, V225, P12, DOI 10.1016/j.ejor.2012.07.026; Xu GX, 2012, APPL MATH COMPUT, V218, P7562, DOI 10.1016/j.amc.2012.01.023; Yang Y, 2007, IEEE T IND ELECTRON, V54, P1311, DOI 10.1109/TIE.2007.893063	24	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126199	10.1371/journal.pone.0126199	http://dx.doi.org/10.1371/journal.pone.0126199			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961295	gold, Green Published, Green Submitted			2022-12-26	WOS:000354542500073
J	Yue, RC; Li, X; Chen, BY; Zhao, J; He, WW; Yuan, H; Yuan, X; Gao, N; Wu, GZ; Jin, HZ; Shan, L; Zhang, WD				Yue, Rongcai; Li, Xia; Chen, Bingyang; Zhao, Jing; He, Weiwei; Yuan, Hu; Yuan, Xing; Gao, Na; Wu, Guozhen; Jin, Huizi; Shan, Lei; Zhang, Weidong			Astragaloside IV Attenuates Glutamate-Induced Neurotoxicity in PC12 Cells through Raf-MEK-ERK Pathway	PLOS ONE			English	Article							SPECTROMETRY-BASED PROTEOMICS; IN-VITRO; CEREBRAL-ISCHEMIA; REHMANNIAE RADIX; NATURAL-PRODUCTS; DRUG DISCOVERY; HERBAL FORMULA; BRAIN; RATS; VIVO	Astragaloside IV (AGS-IV) is a main active ingredient of Astragalus membranaceus Bunge, a medicinal herb prescribed as an immunostimulant, hepatoprotective, antiperspirant, a diuretic or a tonic as documented in Chinese Materia Medica. In the present study, we employed a high-throughput comparative proteomic approach based on 2D-nano-LC-MS/MS to investigate the possible mechanism of action involved in the neuroprotective effect of AGS-IV against glutamate-induced neurotoxicity in PC12 cells. Differential proteins were identified, among which 13 proteins survived the stringent filter criteria and were further included for functional discussion. Two proteins (vimentin and Gap43) were randomly selected, and their expression levels were further confirmed by western blots analysis. The results matched well with those of proteomics. Furthermore, network analysis of protein-protein interactions (PPI) and pathways enrichment with AGS-IV associated proteins were carried out to illustrate its underlying molecular mechanism. Proteins associated with signal transduction, immune system, signaling molecules and interaction, and energy metabolism play important roles in neuroprotective effect of AGS-IV and Raf-MEK-ERK pathway was involved in the neuroprotective effect of AGS-IV against glutamate-induced neurotoxicity in PC12 cells. This study demonstrates that comparative proteomics based on shotgun approach is a valuable tool for molecular mechanism studies, since it allows the simultaneously evaluate the global proteins alterations.	[Yue, Rongcai; Li, Xia; Chen, Bingyang; Yuan, Xing; Gao, Na; Wu, Guozhen; Shan, Lei; Zhang, Weidong] Second Mil Med Univ, Sch Pharm, Shanghai, Peoples R China; [Yue, Rongcai; Yuan, Hu; Jin, Huizi; Zhang, Weidong] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200030, Peoples R China; [Zhao, Jing] Logist Engn Univ, Dept Math, Chongqing, Peoples R China; [He, Weiwei] E China Univ Sci & Technol, Sch Pharm, Shanghai 200237, Peoples R China	Naval Medical University; Shanghai Jiao Tong University; East China University of Science & Technology	Shan, L (corresponding author), Second Mil Med Univ, Sch Pharm, Shanghai, Peoples R China.	shanleish@yahoo.com.cn; wdzhangy@hotmail.com	Zhao, Jing/S-3581-2019	Zhao, Jing/0000-0002-2439-2876	National Natural Science Foundation of China [81230090, 1302658]; Shanghai Leading Academic Discipline Project [B906]; Shanghai Engineering Research Center for the Preparation of Bioactive Natural Products [10DZ2251300]; Scientific Foundation of Shanghai China [12401900801, 13401900101]; National Key Technology R&D Program of China [2012BAI29B06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Shanghai Engineering Research Center for the Preparation of Bioactive Natural Products; Scientific Foundation of Shanghai China; National Key Technology R&D Program of China(National Key Technology R&D Program)	The work was supported by the following programs: National Natural Science Foundation of China (81230090, 1302658), Shanghai Leading Academic Discipline Project (B906), Shanghai Engineering Research Center for the Preparation of Bioactive Natural Products (10DZ2251300), the Scientific Foundation of Shanghai China (12401900801, 13401900101) and the National Key Technology R&D Program of China (2012BAI29B06).	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Atlante A, 2001, FEBS LETT, V497, P1, DOI 10.1016/S0014-5793(01)02437-1; Bensimon A, 2012, ANNU REV BIOCHEM, V81, P379, DOI 10.1146/annurev-biochem-072909-100424; Bleich S, 2003, INT J GERIATR PSYCH, V18, pS33, DOI 10.1002/gps.933; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen X, 2012, J ETHNOPHARMACOL, V139, P721, DOI 10.1016/j.jep.2011.11.035; Cheung Eric C C, 2004, Sci STKE, V2004, pPE45; Chiang YM, 2011, CURR OPIN CHEM BIOL, V15, P137, DOI 10.1016/j.cbpa.2010.10.011; Choudhary C, 2010, NAT REV MOL CELL BIO, V11, P427, DOI 10.1038/nrm2900; Colucci-D'Amato L, 2003, BIOESSAYS, V25, P1085, DOI 10.1002/bies.10355; Conn PJ, 2003, ANN NY ACAD SCI, V1003, P12, DOI 10.1196/annals.1300.002; Csermely P, 2005, TRENDS PHARMACOL SCI, V26, P178, DOI 10.1016/j.tips.2005.02.007; Du CYQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078622; Gerwick WH, 2012, CHEM BIOL, V19, P85, DOI 10.1016/j.chembiol.2011.12.014; Gubbens J, 2014, CHEM BIOL, V21, P707, DOI 10.1016/j.chembiol.2014.03.011; Gui DK, 2013, APOPTOSIS, V18, P409, DOI 10.1007/s10495-013-0801-2; Gui DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039824; Hanash S, 2003, NATURE, V422, P226, DOI 10.1038/nature01514; HIROTANI M, 1994, PHYTOCHEMISTRY, V37, P1403, DOI 10.1016/S0031-9422(00)90420-5; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; KLEIN P, 1995, J ALGORITHM, V19, P104, DOI 10.1006/jagm.1995.1029; Lau KM, 2012, J ETHNOPHARMACOL, V141, P250, DOI 10.1016/j.jep.2012.02.025; Li M, 2012, NEUROCHEM INT, V60, P458, DOI 10.1016/j.neuint.2012.01.026; Luo YM, 2004, NEUROSCI LETT, V363, P218, DOI 10.1016/j.neulet.2004.03.036; Lv L, 2010, PHYTOTHER RES, V24, P219, DOI 10.1002/ptr.2915; Ma XQ, 2002, J AGR FOOD CHEM, V50, P4861, DOI 10.1021/jf0202279; Mielke K, 1999, NEUROSCIENCE, V91, P471, DOI 10.1016/S0306-4522(98)00667-8; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Popoli M, 2012, NAT REV NEUROSCI, V13, P22, DOI 10.1038/nrn3138; Qu YZ, 2009, EUR J PHARMACOL, V606, P137, DOI 10.1016/j.ejphar.2009.01.022; Robert SM, 2014, NEUROCHEM INT, V73, P181, DOI 10.1016/j.neuint.2014.01.001; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Seyfried J, 2000, EUR J PHARMACOL, V400, P155, DOI 10.1016/S0014-2999(00)00397-6; Sinclair S, 1998, Altern Med Rev, V3, P338; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Wang C, 2010, J PROTEOME RES, V9, P3225, DOI 10.1021/pr1001274; Xu F, 2006, DRUG METAB DISPOS, V34, P913, DOI 10.1124/dmd.105.008300; You HZ, 2011, J ETHNOPHARMACOL, V134, P176, DOI 10.1016/j.jep.2010.11.064; Yu DH, 2005, J ETHNOPHARMACOL, V98, P89, DOI 10.1016/j.jep.2004.12.027; Yue RC, 2012, J NEUROCHEM, V121, P451, DOI 10.1111/j.1471-4159.2012.07682.x; Zhang C, 2007, CLIN EXP PHARMACOL P, V34, P387, DOI 10.1111/j.1440-1681.2007.04564.x; Zhang K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092917; Zhang L, 2011, J PHARMACOL EXP THER, V338, P485, DOI 10.1124/jpet.111.180992; Zhang Q, 2012, PHYTOMEDICINE, V20, P9, DOI 10.1016/j.phymed.2012.09.006; Zhang WD, 2006, PLANTA MED, V72, P4, DOI 10.1055/s-2005-873126; Zhang WD, 2006, LIFE SCI, V79, P808, DOI 10.1016/j.lfs.2006.02.032; Zhang WD, 2006, PLANTA MED, V72, P621, DOI 10.1055/s-2006-931572; Zhang WJ, 2003, THROMB HAEMOSTASIS, V90, P904, DOI 10.1160/TH03-03-0136; Zhang ZG, 2012, MOL CELL BIOCHEM, V364, P209, DOI 10.1007/s11010-011-1219-1; Zhao J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044938	51	19	22	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126603	10.1371/journal.pone.0126603	http://dx.doi.org/10.1371/journal.pone.0126603			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961569	gold, Green Published, Green Submitted			2022-12-26	WOS:000354542500123
J	Arvidsson, A; Johnsdotter, S; Essen, B				Arvidsson, Anna; Johnsdotter, Sara; Essen, Birgitta			Views of Swedish Commissioning Parents Relating to the Exploitation Discourse in Using Transnational Surrogacy	PLOS ONE			English	Article							COMMERCIAL SURROGACY; GESTATIONAL-SURROGACY; INDIA; ETHICS; AUTONOMY; LAW	Transnational surrogacy, when people travel abroad for reproduction with the help of a surrogate mother, is a heavily debated phenomenon. One of the most salient discourses on surrogacy is the one affirming that Westerners, in their quest for having a child, exploit poor women in countries such as India. As surrogacy within the Swedish health care system is not permitted, Swedish commissioning parents have used transnational surrogacy, and the majority has turned to India. This interview study aimed to explore how commissioning parents negotiate the present discourses on surrogacy. Findings from the study suggest that the commissioning parents' views on using surrogacy are influenced by competing discourses on surrogacy represented by media and surrogacy agencies. The use of this reproductive method resulted, then, in some ambiguity. Although commissioning parents defy the exploitation discourse by referring to what they have learnt about the surrogate mother's life situation and by pointing at the significant benefits for her, they still had a request for regulation of surrogacy in Sweden, to better protect all parties involved. This study, then, gives a complex view on surrogacy, where the commissioning parents simultaneously argue against the exploitation discourse but at the same time are uncertain if the surrogate mothers are well protected in the surrogacy arrangements. Their responses to the situation endorse the need for regulation both in Sweden and India.	[Arvidsson, Anna; Essen, Birgitta] Uppsala Univ, Univ Uppsala Hosp, Dept Womens & Childrens Hlth Int Maternal & Child, Uppsala, Sweden; [Johnsdotter, Sara] Malmo Univ, Dept Hlth & Welf Studies, Malmo, Sweden	Uppsala University; Uppsala University Hospital; Malmo University	Arvidsson, A (corresponding author), Uppsala Univ, Univ Uppsala Hosp, Dept Womens & Childrens Hlth Int Maternal & Child, Uppsala, Sweden.	anna.arvidsson@kbh.uu.se		Essen, Birgitta/0000-0002-2900-2849	Faculty of Medicine, Uppsala University	Faculty of Medicine, Uppsala University	This study was supported by the Faculty of Medicine, Uppsala University.	[Anonymous], 2013, EMORY INT LAW REV; Bailey A, 2011, HYPATIA, V26, P715, DOI 10.1111/j.1527-2001.2011.01168.x; Banerjee A, 2010, PLURALIST, V5, P107, DOI 10.1353/plu.2010.0014; Bank World, 2003, INV MAT HLTH LEARN M; Becker G., 2000, ELUSIVE EMBRYO WOMEN; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brunet Laurence, 2013, COMP STUDY REGIME SU; Culley L, 2011, HUM REPROD, V26, P2373, DOI 10.1093/humrep/der191; Damelio J, 2008, BIOETHICS, V22, P269, DOI 10.1111/j.1467-8519.2008.00629.x; Daunt Felicia, 1991, SASKATCHEWAN LAW REV, V55, P415; Davies T., 2010, FERTIL STERIL, V94, P20, DOI [10.1016/j.fertnstert.2009.01.164, DOI 10.1016/J.FERTNSTERT.2009.01.164]; Deomampo D, 2013, FRONTIERS, V34, P167; Ekman K.E., 2010, VARAT VARAN PROSTITU; Everingham SG, 2014, MED J AUSTRALIA, V201, P270, DOI 10.5694/mja13.11311; Ferraretti AP, 2010, REPROD BIOMED ONLINE, V20, P261, DOI 10.1016/j.rbmo.2009.11.009; FIGO Committee for Ethical Aspects of Human Reproduction and Women's Health, 2008, Int J Gynaecol Obstet, V102, P312, DOI 10.1016/j.ijgo.2008.04.016; Fixmer-Oraiz N, 2013, FRONTIERS, V34, P126; Greil AL, 2010, SOCIOL HEALTH ILL, V32, P140, DOI 10.1111/j.1467-9566.2009.01213.x; Gupta JA, 2012, INT J FEM APPROACHES, V5, P25; Jaiswal S, 2012, GEND TECHNOL DEV, V16, P1, DOI 10.1177/097185241101600101; Kerian C L, 1997, Wis Womens Law J, V12, P113; Kirby J, 2014, AM J BIOETHICS, V14, P24, DOI 10.1080/15265161.2014.892169; Krolokke CH, 2012, NORA, V20, P233, DOI 10.1080/08038740.2012.729535; Langdridge D, 2005, J REPROD INFANT PSYC, V23, P121, DOI 10.1080/02646830500129438; Markens S, 2007, SURROGATE MOTHERHOOD AND THE POLITICS OF REPRODUCTION, P1, DOI 10.1525/california/9780520252035.001.0001; Markens S, 2012, SOC SCI MED, V74, P1745, DOI 10.1016/j.socscimed.2011.09.013; Mohapatra Seema, 2012, ANN HLTH LAW, V21, P191; Pande A, 2010, FEMINIST STUD, V36, P292; Pande A, 2010, SIGNS, V35, P969, DOI 10.1086/651043; Pande A, 2009, QUAL SOCIOL, V32, P379, DOI 10.1007/s11133-009-9138-0; Pande A, 2009, INDIAN J GEND STUD, V16, P141, DOI 10.1177/097152150901600201; Pande Amrita, 2014, WOMBS LABOR TRANSNAT; Panitch V, 2013, HYPATIA, V28, P274, DOI 10.1111/hypa.12005; Parks JA, 2010, BIOETHICS, V24, P333, DOI 10.1111/j.1467-8519.2010.01831.x; Qadeer Imrana, 2010, Indian J Med Ethics, V7, P209; Ramskold LAH, 2013, J MED ETHICS, V39, P397, DOI 10.1136/medethics-2012-100527; Rotabi KS, 2012, AFFILIA J WOM SOC WO, V27, P129, DOI 10.1177/0886109912444102; Rudrappa S., 2012, CONTEXTS, V11, P22, DOI [DOI 10.1177/1536504212446456, 10.1177/1536504212446456]; Sarabhai S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053441; Sarojini N B, 2009, Indian J Med Ethics, V6, P36; Shenfield F, 2005, HUM REPROD, V20, P2705, DOI 10.1093/humrep/dei147; Shetty P, 2012, LANCET, V380, P1633, DOI 10.1016/S0140-6736(12)61933-3; Singh R, 2012, HUM REPROD S2, V27, DOI [10.1093/humrep/27.s2.74, DOI 10.1093/HUMREP/27.S2.74]; Smerdon Usha Rengachary, 2008, CUMBERLAND LAW R, V39, P15; Tanderup M, 2015, ACTA OBSTET GYN SCAN, V94, P465, DOI 10.1111/aogs.12576; Teman E, 2010, BIRTHING A MOTHER: THE SURROGATE BODY AND THE PREGNANT SELF, P1, DOI 10.1525/california/9780520259638.001.0001; Twine FW, 2011, OUTSOURCING WOMB RAC; VANBALEN F, 1995, J PSYCHOSOM OBST GYN, V16, P137, DOI 10.3109/01674829509024462; Vora K, 2013, CURR ANTHROPOL, V54, pS97, DOI 10.1086/671018	49	19	19	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0126518	10.1371/journal.pone.0126518	http://dx.doi.org/10.1371/journal.pone.0126518			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL2IX	25955178	Green Published, gold, Green Submitted			2022-12-26	WOS:000356768100126
J	Fang, HY; Yue, RC; Ga, Y; Zhang, Y; Shan, L; Zhao, J				Fang, Haiyang; Yue, Rongcai; Ga, Yang; Zhang, Yi; Shan, Lei; Zhao, Jing			Analysis of Cynandione A's Anti-Ischemic Stroke Effects from Pathways and Protein-Protein Interactome	PLOS ONE			English	Article							CULTURED CORTICAL-NEURONS; ACUTE ISCHEMIC-STROKE; PLASMINOGEN-ACTIVATOR; PLATELET-ADHESION; FIBRINOLYSIS; COAGULATION; GLUTAMATE; KNOWLEDGEBASE; HYPOTHERMIA; AGGREGATION	Ischemic stroke is the third leading cause of death in the world. Our previous study found that cynandione A (CYNA), the main component from the root of Cynanchum bungei, exhibits anti-ischemic stroke activity. In this work, we investigated the therapeutic mechanisms of CYNA to ischemic stroke at protein network level. First, PC12 cells and cerebellar granule neurons were prepared to validate the effects of CYNA against glutamate injury. Our experiments suggested that CYNA could dose-dependently mitigate glutamate-induced neurons neurotoxicity and inhibit glutamate-induced upregulation of KHSRP and HMGB1, further confirming the neuroprotective effects of CYNA in vivo. Then, on the pathway sub-networks, which present biological processes that can be impacted directly or in periphery nodes by drugs via their targets, we found that CYNA regulates 11 pathways associated with the biological process of thrombotic or embolic occlusion of a cerebral artery. Meanwhile, by defining a network-based anti-ischemic stroke effect score, we showed that CYNA has a significantly higher effect score than random counterparts, which suggests a synergistic effect of CYNA to ischemic stroke. This study may shed new lights on the study of network based pharmacology.	[Fang, Haiyang; Zhao, Jing] Logist Engn Univ, Dept Math, Chongqing, Peoples R China; [Yue, Rongcai; Shan, Lei; Zhao, Jing] Second Mil Med Univ, Dept Nat Med Chem, Shanghai, Peoples R China; [Yue, Rongcai] Shanghai Jiao Tong Univ, Shanghai 200030, Peoples R China; [Ga, Yang] Tibet Tradit Med Coll, Lhasa, Peoples R China; [Zhang, Yi] Chengdu Univ TCM, Natl Med Coll, Chengdu, Peoples R China	Naval Medical University; Shanghai Jiao Tong University; Chengdu University of Traditional Chinese Medicine	Shan, L (corresponding author), Second Mil Med Univ, Dept Nat Med Chem, Shanghai, Peoples R China.	shanleicn@126.com; zhaojanne@gmail.com	Zhao, Jing/S-3581-2019	Zhao, Jing/0000-0002-2439-2876	National Natural Science Foundation of China [61372194, 81260672, 81230090]; FP7-PEOPLE-IRSES (TCMCANCER Project) [230232]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); FP7-PEOPLE-IRSES (TCMCANCER Project)	This research was supported by the National Natural Science Foundation of China (61372194, 81260672, and 81230090) and FP7-PEOPLE-IRSES-2008 (TCMCANCER Project 230232).	Adams HP, 2007, CIRCULATION, V115, pE478, DOI 10.1161/CIRCULATIONAHA.107.181486; Ay H, 2005, ANN NEUROL, V58, P688, DOI 10.1002/ana.20617; BAUMGARTNER HR, 1976, THROMB HAEMOSTASIS, V35, P124, DOI 10.1055/s-0038-1647919; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Burkard TR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001001; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Carter LL, 2002, EUR J IMMUNOL, V32, P634, DOI 10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9; Chao JR, 1998, MOL CELL BIOL, V18, P4883, DOI 10.1128/MCB.18.8.4883; Chen X, 2002, NUCLEIC ACIDS RES, V30, P412, DOI 10.1093/nar/30.1.412; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; Clark WM, 1999, JAMA-J AM MED ASSOC, V282, P2019, DOI 10.1001/jama.282.21.2019; CONRAD ME, 1993, AM J HEMATOL, V42, P67, DOI 10.1002/ajh.2830420114; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; DELZOPPO GJ, 1992, ANN NEUROL, V32, P78, DOI 10.1002/ana.410320113; Dubinsky R, 2006, NEUROLOGY, V66, P1742, DOI 10.1212/01.wnl.0000218306.35681.38; Egan RW, 1996, ALLERGY, V51, P71, DOI 10.1111/j.1398-9995.1996.tb00038.x; Erten M. S., 2009, NETWORK BASED PRIORI; Fang H, 2013, EVID-BASED COMPL ALT, V2013, DOI [10.1155/2013/590718, DOI 10.1155/2013/590718]; Flint AC, 2007, STROKE, V38, P1274, DOI 10.1161/01.STR.0000260187.33864.a7; Gailani D, 2007, J THROMB HAEMOST, V5, P1106, DOI 10.1111/j.1538-7836.2007.02446.x; Hackam DG, 2007, STROKE, V38, P1881, DOI 10.1161/STROKEAHA.106.475525; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hankey GJ, 2006, LANCET NEUROL, V5, P287, DOI 10.1016/S1474-4422(06)70387-8; Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Jang YP, 2002, J NEUROSCI RES, V68, P233, DOI 10.1002/jnr.10204; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kasirer-Friede A, 2007, IMMUNOL REV, V218, P247, DOI 10.1111/j.1600-065X.2007.00532.x; Krieger DW, 2001, STROKE, V32, P1847, DOI 10.1161/01.STR.32.8.1847; Lee KR, 1996, ACTA NEUROCHIR, V138, P396, DOI 10.1007/BF01420301; Lee MK, 2000, J PHARM PHARMACOL, V52, P341, DOI 10.1211/0022357001773896; Lee MK, 2000, J NEUROSCI RES, V59, P259, DOI 10.1002/(SICI)1097-4547(20000115)59:2<259::AID-JNR12>3.0.CO;2-3; Li S, 2013, CHIN J NAT MEDICINES, V11, P110, DOI [10.3724/SP.J.1009.2013.00110, 10.1016/S1875-5364(13)60037-0]; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Mondino A, 2004, TRENDS IMMUNOL, V25, P450, DOI 10.1016/j.it.2004.06.004; Nishimura D, 2001, BIOTECH SOFTWARE INT, V2, P117, DOI DOI 10.1089/152791601750294344; OTOOLE TE, 1991, SCIENCE, V254, P845, DOI 10.1126/science.1948065; PACKHAM MA, 1984, PROG HEMOST THROMB, V7, P211; Parise LV, 1999, CURR OPIN CELL BIOL, V11, P597, DOI 10.1016/S0955-0674(99)00018-6; PLOW EF, 1975, J CLIN INVEST, V56, P30, DOI 10.1172/JCI108076; Schwab S, 1998, STROKE, V29, P2461, DOI 10.1161/01.STR.29.12.2461; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Shuaib A, 2007, NEW ENGL J MED, V357, P562, DOI 10.1056/NEJMoa070240; SMITH JB, 1973, J CLIN INVEST, V52, P965, DOI 10.1172/JCI107262; Smith WS, 2005, STROKE, V36, P1432, DOI 10.1161/01.STR.0000171066.25248.1d; Tong HH, 2008, KNOWL INF SYST, V14, P327, DOI 10.1007/s10115-007-0094-2; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Watson SP, 2005, J THROMB HAEMOST, V3, P1752, DOI 10.1111/j.1538-7836.2005.01429.x; World Health O, 1989, RELATION, V20, P1407; Xiong XX, 2014, NEUROCHEM RES, V39, P216, DOI 10.1007/s11064-013-1212-z; Yue RC, 2012, J NEUROCHEM, V121, P451, DOI 10.1111/j.1471-4159.2012.07682.x; ZACHARSKI LR, 1992, SEMIN THROMB HEMOST, V18, P104, DOI 10.1055/s-2007-1002415; Zhang ZQ, 2007, J NEUROTRAUM, V24, P460, DOI 10.1089/neu.2006.0078; Zhao J, 2012, BRIEF BIOINFORM, V11, P417; Zhao J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044938	57	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0124632	10.1371/journal.pone.0124632	http://dx.doi.org/10.1371/journal.pone.0124632			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955557	Green Published, Green Submitted, gold			2022-12-26	WOS:000356768100031
J	Li, L; Li, D; Liu, L; Li, SJ; Feng, YP; Peng, XL; Gong, YZ				Li, Ling; Li, Dan; Liu, Li; Li, Shijun; Feng, Yanping; Peng, Xiuli; Gong, Yanzhang			Endothelin Receptor B2 (EDNRB2) Gene Is Associated with Spot Plumage Pattern in Domestic Ducks (Anas platyrhynchos)	PLOS ONE			English	Article							TRANSMEMBRANE DOMAIN; PIGMENTATION; EVOLUTION; MELANOCYTE; EXPRESSION; GENOME; COLOR; MICE; MC1R; SPECIFICATION	Endothelin receptor B subtype 2 (EDNRB2) is a seven-transmembrane G-protein coupled receptor. In this study, we investigated EDNRB2 gene as a candidate gene for duck spot plumage pattern according to studies of chicken and Japanese quail. The entire coding region was cloned by the reverse transcription polymerase chain reaction (RT-PCR). Sequence analysis showed that duck EDNRB2 cDNA contained a 1311bp open reading frame and encoded a putative protein of 436 amino acids residues. The transcript shared 89%-90% identity with the counterparts in other avian species. A phylogenetic tree based on amino acid sequences showed that duck EDNRB2 was evolutionary conserved in avian clade. The entire coding region of EDNRB2 were sequenced in 20 spot and 20 non-spot ducks, and 13 SNPs were identified. Two of them (c.940G>A and c.995G>A) were non-synonymous substitutions, and were genotyped in 647 ducks representing non-spot and spot phenotypes. The c.995G>A mutation, which results in the amino acid substitution of Arg332His, was completely associated with the spot phenotype: all 152 spot ducks were carriers of the AA genotype and the other 495 individuals with non-spot phenotype were carriers of GA or GG genotype, respectively. Segregation in 17 GAxGG and 22 GAxGA testing combinations confirmed this association since the segregation ratios and genotypes of the offspring were in agreement with the hypothesis. In order to investigate the underlying mechanism of the spot phenotype, MITF gene was used as cell type marker of melanocyte progenitor cells while TYR and TYRP1 gene were used as cell type markers of mature melanocytes. Transcripts of MITF, TYR and TYRP1 gene with expected size were identified in all pigmented skin tissues while PCR products were not obtained from non-pigmented skin tissues. It was inferred that melanocytes are absent in non-pigmented skin tissues of spot ducks.	[Li, Ling; Li, Dan; Liu, Li; Li, Shijun; Feng, Yanping; Peng, Xiuli; Gong, Yanzhang] Huazhong Agr Univ, Coll Anim Sci & Technol, Key Lab Agr Anim Genet Breeding & Reprod, Minist Educ, Wuhan, Peoples R China	Huazhong Agricultural University	Gong, YZ (corresponding author), Huazhong Agr Univ, Coll Anim Sci & Technol, Key Lab Agr Anim Genet Breeding & Reprod, Minist Educ, Wuhan, Peoples R China.	poultry@mail.hzau.edu.cn			Hubei Provincial Scientific Research & Development Project [2011BBB096]	Hubei Provincial Scientific Research & Development Project	This research was supported by the Hubei Provincial Scientific Research & Development Project (2011BBB096). The funder's website (http://www.hbstd.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baiao PC, 2012, J HERED, V103, P322, DOI 10.1093/jhered/esr151; Baxter LL, 2004, PIGM CELL RES, V17, P215, DOI 10.1111/j.1600-0749.2004.00147.x; Benned-Jensen T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024644; Bennett DC, 2003, PIGM CELL RES, V16, P333, DOI 10.1034/j.1600-0749.2003.00067.x; Braasch I, 2009, MOL BIOL EVOL, V26, P783, DOI 10.1093/molbev/msp015; Chen M, 2009, BIOCHEM PHARMACOL, V77, P114, DOI 10.1016/j.bcp.2008.09.023; de Bellard Maria Elena, 2004, V294, P247; Dorshorst B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002412; Ellegren H, 2010, TRENDS ECOL EVOL, V25, P283, DOI 10.1016/j.tree.2009.12.004; Emaresi G, 2013, MOL ECOL, V22, P4915, DOI 10.1111/mec.12438; Fontanesi L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093750; Fontanesi L, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-59; Gao JS, 2011, ANIM SCI J, V82, P729, DOI 10.1111/j.1740-0929.2011.00905.x; Goncalves GL, 2013, GENET MOL RES, V12, P3230, DOI 10.4238/2013.February.28.24; Gong Y, 2010, ANIM GENET, V41, P105, DOI 10.1111/j.1365-2052.2009.01967.x; Griswold SL, 2012, JOVE-J VIS EXP, DOI 10.3791/3622; Harris ML, 2007, DEV DYNAM, V236, P1, DOI 10.1002/dvdy.20919; Harris ML, 2008, DEVELOPMENT, V135, P4113, DOI 10.1242/dev.023119; Hauswirth R, 2012, PLOS GENET, V8, P404, DOI 10.1371/journal.pgen.1002653; Huang YH, 2013, NAT GENET, V45, P776, DOI 10.1038/ng.2657; Hubbard JK, 2010, TRENDS GENET, V26, P231, DOI 10.1016/j.tig.2010.02.002; Jackling FC, 2014, J HERED, V105, P847, DOI 10.1093/jhered/ess093; Kaelin CB, 2012, SCIENCE, V337, P1536, DOI 10.1126/science.1220893; Kawasaki-Nishihara A, 2011, DEV DYNAM, V240, P1454, DOI 10.1002/dvdy.22649; Kinoshita K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086361; Krispin S, 2010, DEVELOPMENT, V137, P585, DOI 10.1242/dev.041509; Lecoin L, 1998, P NATL ACAD SCI USA, V95, P3024, DOI 10.1073/pnas.95.6.3024; Li SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036592; Lin SJ, 2013, SCIENCE, V340, P1442, DOI 10.1126/science.1230374; Manceau M, 2010, PHILOS T R SOC B, V365, P2439, DOI 10.1098/rstb.2010.0104; Martin SS, 2007, MOL PHARMACOL, V72, P182, DOI 10.1124/mol.106.033670; Mills MG, 2009, SEMIN CELL DEV BIOL, V20, P72, DOI 10.1016/j.semcdb.2008.11.012; Miwa M, 2007, ANIM GENET, V38, P103, DOI 10.1111/j.1365-2052.2007.01568.x; Nadeau NJ, 2007, ANIM GENET, V38, P609, DOI 10.1111/j.1365-2052.2007.01667.x; Nadeau NJ, 2006, ANIM GENET, V37, P287, DOI 10.1111/j.1365-2052.2006.01442.x; Nitzan E, 2013, DEVELOPMENT, V140, P2269, DOI 10.1242/dev.093294; Osawa M, 2009, MELANOCYTE STEM CELL, DOI [10.3824/stembook.1.46.1, DOI 10.3824/STEMBOOK.1.46.1]; Pla P, 2005, PIGM CELL RES, V18, P181, DOI 10.1111/j.1600-0749.2005.00230.x; Poynter Greg, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.emo112; Roulin A, 2013, SEMIN CELL DEV BIOL, V24, P594, DOI 10.1016/j.semcdb.2013.05.005; Sambrook J., 2001, MOL CLONING LAB MANU; Santschi EM, 1998, MAMM GENOME, V9, P306, DOI 10.1007/s003359900754; Sasaki T, 2009, J AM GERIATR SOC, V57, P1453, DOI 10.1111/j.1532-5415.2009.02349.x; Schmutz SM, 2007, ANIM GENET, V38, P539, DOI 10.1111/j.1365-2052.2007.01664.x; Suzuki H, 2013, GENES GENET SYST, V88, P155, DOI 10.1266/ggs.88.155; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomas AJ, 2008, PIGM CELL MELANOMA R, V21, P598, DOI 10.1111/j.1755-148X.2008.00506.x; TSUDZUKI M, 1993, J HERED, V84, P225, DOI 10.1093/oxfordjournals.jhered.a111325; Umanah GKE, 2011, BIOCHEMISTRY-US, V50, P6841, DOI 10.1021/bi200254h; VIJAYASARADHI S, 1995, J INVEST DERMATOL, V105, P113, DOI 10.1111/1523-1747.ep12313414; Wang C, 2012, MOL BIOL REP, V39, P9239, DOI 10.1007/s11033-012-1797-3; Wang C, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-29; Yamada T, 2006, J BIOL CHEM, V281, P10799, DOI 10.1074/jbc.M512618200; Zhang GJ, 2014, SCIENCE, V346, P1311, DOI 10.1126/science.1251385; Zhang WX, 2013, J EXP BIOL, V216, P1786, DOI 10.1242/jeb.072843	55	23	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0125883	10.1371/journal.pone.0125883	http://dx.doi.org/10.1371/journal.pone.0125883			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955279	Green Published, gold, Green Submitted			2022-12-26	WOS:000356768100083
J	Lin, SY; Chang, HH; Lai, YH; Lin, CH; Chen, MH; Chang, GC; Tsai, MF; Chen, JJW				Lin, Sheng-Yi; Chang, Hsiu-Hui; Lai, Yi-Hua; Lin, Ching-Hsiung; Chen, Min-Hsuan; Chang, Gee-Chen; Tsai, Meng-Feng; Chen, Jeremy J. W.			Digoxin Suppresses Tumor Malignancy through Inhibiting Multiple Src-Related Signaling Pathways in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; RESISTANCE; KINASE; GEFITINIB; PHOSPHORYLATION; EXPRESSION; PROGRESSION; ACTIVATION; DASATINIB; MECHANISM	Non-small cell lung cancer is the predominant type of lung cancer, resulting in high mortality worldwide. Digoxin, a cardiac glycoside, has recently been suggested to be a novel chemotherapeutic agent. Src is an oncogene that plays an important role in cancer progression and is therefore a potential target for cancer therapy. Here, we investigated whether digoxin could suppress lung cancer progression through the inhibition of Src activity. The effects of digoxin on lung cancer cell functions were investigated using colony formation, migration and invasion assays. Western blotting and qPCR assays were used to analyze the mRNA and protein expression levels of Src and its downstream proteins, and a cell viability assay was used to measure cellular cytotoxicity effects. The results of the cell function assays revealed that digoxin inhibited the proliferation, invasion, migration, and colony formation of A549 lung cancer cells. Similar effects of digoxin were also observed in other lung cancer cell lines. Furthermore, we found that digoxin significantly suppressed Src activity and its protein expression in a dose-and time-dependent manner as well as reduced EGFR and STAT3 activity. Our data suggest that digoxin is a potential anticancer agent that may suppress lung cancer progression through inhibiting Src and the activity of related proteins.	[Lin, Sheng-Yi; Chang, Hsiu-Hui; Chen, Min-Hsuan; Chen, Jeremy J. W.] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan; [Lin, Sheng-Yi; Chen, Jeremy J. W.] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 40227, Taiwan; [Chang, Hsiu-Hui; Lin, Ching-Hsiung] Changhua Christian Hosp, Dept Internal Med, Div Chest Med, Changhua, Taiwan; [Lai, Yi-Hua; Chang, Gee-Chen] Taichung Vet Gen Hosp, Dept Internal Med, Div Chest Med, Taichung, Taiwan; [Tsai, Meng-Feng] Dayeh Univ, Dept Mol Biotechnol, Changhua, Taiwan	National Chung Hsing University; National Chung Hsing University; Changhua Christian Hospital; Taichung Veterans General Hospital; Da Yeh University	Tsai, MF (corresponding author), Dayeh Univ, Dept Mol Biotechnol, Changhua, Taiwan.	tsaimf@mail.dyu.edu.tw; jwchen@dragon.nchu.edu.tw		Lin, Ching-Hsiung/0000-0001-9407-8578; Chen, Jeremy J.W./0000-0003-1049-3825	Ministry of Science and Technology, Taiwan, R.O.C [NSC 101-2325-B-005-001, NSC 102-2325-B-005-001, MOST 103-2314-B-005-001-MY3]; National Chung-Hsing University, Taiwan [TCVGH-NCHU-1037605]; Ministry of Education, Taiwan, R.O.C.; Taichung Veterans General Hospital	Ministry of Science and Technology, Taiwan, R.O.C(Ministry of Science and Technology, Taiwan); National Chung-Hsing University, Taiwan; Ministry of Education, Taiwan, R.O.C.(Ministry of Education, Taiwan); Taichung Veterans General Hospital	This work was supported by grants from the Ministry of Science and Technology, Taiwan, R.O.C. (NSC 101-2325-B-005-001, NSC 102-2325-B-005-001, and MOST 103-2314-B-005-001-MY3) and Taichung Veterans General Hospital and National Chung-Hsing University (TCVGH-NCHU-1037605), Taiwan. Additonal funding came from the Ministry of Education, Taiwan, R.O.C. under the ATU plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Boerner JL, 2004, MOL CELL BIOL, V24, P7059, DOI 10.1128/MCB.24.16.7059-7071.2004; Byers LA, 2009, CLIN CANCER RES, V15, P6852, DOI 10.1158/1078-0432.CCR-09-0767; Chang TH, 2011, AM J RESP CRIT CARE, V183, P1071, DOI 10.1164/rccm.201009-1440OC; Chang TP, 2010, CANCER RES, V70, P1656, DOI 10.1158/0008-5472.CAN-09-2453; Chen DL, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-277; Go SI, 2014, LUNG CANCER, V84, P79, DOI 10.1016/j.lungcan.2014.01.014; Haura EB, 2010, J CLIN ONCOL, V28, P1387, DOI 10.1200/JCO.2009.25.4029; Hsu KW, 2012, CARCINOGENESIS, V33, P1459, DOI 10.1093/carcin/bgs165; Huang CP, 2013, CANCER LETT, V328, P144, DOI 10.1016/j.canlet.2012.08.021; Ibrahim SRM, 2014, NAT PROD RES, V28, P1322, DOI 10.1080/14786419.2014.901323; Ishibashi K, 2013, J CELL SCI, V126, P625, DOI 10.1242/jcs.116277; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kim HJ, 2014, ANTICANCER RES, V34, P3189; Lee DH, 2014, ANTI-CANCER DRUG, V25, P44, DOI 10.1097/CAD.0000000000000015; Leibowitz MS, 2013, CLIN CANCER RES, V19, P798, DOI 10.1158/1078-0432.CCR-12-1517; Leung ELH, 2009, MOL CANCER RES, V7, P923, DOI 10.1158/1541-7786.MCR-09-0003; Li P, 2012, EUR J PHARM SCI, V47, P506, DOI 10.1016/j.ejps.2012.07.008; Lim SH, 2014, J THORAC ONCOL, V9, P506, DOI 10.1097/JTO.0000000000000095; Lin SY, 2010, NUCLEIC ACIDS RES, V38, P6148, DOI 10.1093/nar/gkq412; Liu ZL, 2014, INT J ONCOL, V44, P1571, DOI 10.3892/ijo.2014.2322; Mukohara T, 2005, JNCI-J NATL CANCER I, V97, P1185, DOI 10.1093/jnci/dji238; Ochi N, 2014, EXP CELL RES, V322, P168, DOI 10.1016/j.yexcr.2014.01.007; Pan YR, 2013, J CELL SCI, V126, P5670, DOI 10.1242/jcs.134361; Pao W, 2011, J PATHOL, V223, P230, DOI 10.1002/path.2788; Pitini V, 2013, LUNG CANCER, V82, P171, DOI 10.1016/j.lungcan.2013.07.004; Prassas I, 2008, NAT REV DRUG DISCOV, V7, P926, DOI 10.1038/nrd2682; Prassas I, 2011, MOL CANCER THER, V10, P2083, DOI 10.1158/1535-7163.MCT-11-0421; Ren SX, 2014, INT J CANCER, V135, P2962, DOI 10.1002/ijc.28925; Rothschild SI, 2010, CLIN LUNG CANCER, V11, P238, DOI 10.3816/CLC.2010.n.030; Sausgruber N, 2015, ONCOGENE, V34, P2272, DOI 10.1038/onc.2014.170; Song J, 2014, NUTR CANCER, V66, P682, DOI 10.1080/01635581.2014.895392; Suda K, 2014, LUNG CANCER, V85, P147, DOI 10.1016/j.lungcan.2014.05.018; Summy JM, 2006, CLIN CANCER RES, V12, P1398, DOI 10.1158/1078-0432.CCR-05-2692; Sutton P, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-76; Valeri N, 2014, CANCER CELL, V25, P469, DOI 10.1016/j.ccr.2014.03.006; Van Slambrouck S, 2007, INT J ONCOL, V31, P1501; Walsh CA, 2014, CANCER RES, V74, P2533, DOI 10.1158/0008-5472.CAN-13-2133; Wang CY, 2014, J THORAC ONCOL, V9, P488, DOI 10.1097/JTO.0000000000000107; Wang CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033772; Wang Y, 2012, INT J BIOCHEM CELL B, V44, P1813, DOI 10.1016/j.biocel.2012.06.028; Wang Z, 2009, CANCER RES, V69, P6556, DOI 10.1158/0008-5472.CAN-09-0891; Wei D, 2013, INT J MOL SCI, V14, P7273, DOI 10.3390/ijms14047273; Yoshida T, 2014, CLIN CANCER RES, V20, P4059, DOI 10.1158/1078-0432.CCR-13-1559; Zhang H, 2012, ONCOGENE, V31, P1757, DOI 10.1038/onc.2011.365	45	44	46	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0123305	10.1371/journal.pone.0123305	http://dx.doi.org/10.1371/journal.pone.0123305			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955608	Green Published, gold, Green Submitted			2022-12-26	WOS:000356768100010
J	Liu, Y; Wu, HY; Xie, Q; Bu, WJ				Liu, Yang; Wu, Haoyang; Xie, Qiang; Bu, Wenjun			Novel Detection of Insecticide Resistance Related P450 Genes and Transcriptome Analysis of the Hemimetabolous Pest Erthesina fullo (Thunberg) (Hemiptera: Heteroptera)	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PEACH-POTATO APHID; EVOLUTION; ANNOTATION; MECHANISMS; BLAST2GO; INSIGHT; MUSCLE; TOOL	Erthesina fullo (Thunberg, 1783) is an economically important heteropteran species in China. Since only three nucleotide sequences of this species (COI, 16S rRNA, and 18S rRNA) appear in the GenBank database so far, no analysis of the molecular mechanisms underlying E. fullo's resistance to insecticide and environmental stress has been accomplished. We reported a de novo assembled and annotated transcriptome for adult E. fullo using the Illumina sequence system. A total of 53,359,458 clean reads of 4.8 billion nucleotides (nt) were assembled into 27,488 unigenes with an average length of 750 bp, of which 17,743 (64.55%) were annotated. In the present study, we identified 88 putative cytochrome P450 sequences and analyzed the evolution of cytochrome P450 superfamilies, genes of the CYP3 clan related to metabolizing xenobiotics and plant natural compounds, in E. fullo, increasing the candidate genes for the molecular mechanisms of insecticide resistance in P450. The sequenced transcriptome greatly expands the available genomic information and could allow a better understanding of the mechanisms of insecticide resistance at the systems biology level.	[Liu, Yang; Wu, Haoyang; Xie, Qiang; Bu, Wenjun] Nankai Univ, Inst Entomol, Coll Life Sci, Tianjin 300071, Peoples R China	Nankai University	Xie, Q (corresponding author), Nankai Univ, Inst Entomol, Coll Life Sci, Tianjin 300071, Peoples R China.	qiangxie@nankai.edu.cn; wenjunbu@nankai.edu.cn		Liu, Yang/0000-0002-4938-6456	National Natural Science Foundation of China [31222051, 31372240, J1210005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (31222051, 31372240, J1210005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, INSECT RESIST MANAG; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Bao J, 2013, MOL BIOL EVOL, V30, P1471, DOI 10.1093/molbev/mst043; Bass C, 2014, INSECT BIOCHEM MOLEC, V51, P41, DOI 10.1016/j.ibmb.2014.05.003; Bass C, 2011, PEST MANAG SCI, V67, P886, DOI 10.1002/ps.2189; Berenbaum MR, 2002, J CHEM ECOL, V28, P873, DOI 10.1023/A:1015260931034; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Daane KM, 2010, ANNU REV ENTOMOL, V55, P151, DOI 10.1146/annurev.ento.54.110807.090553; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Devonshire AL, 1998, PHILOS T R SOC B, V353, P1677, DOI 10.1098/rstb.1998.0318; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; Feyereisen R., 2005, P1; Feyereisen R, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P236, DOI 10.1016/B978-0-12-384747-8.10008-X; Gotz S, 2011, BIOINFORMATICS, V27, P919, DOI 10.1093/bioinformatics/btr059; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Itokawa K, 2010, INSECT BIOCHEM MOLEC, V40, P631, DOI 10.1016/j.ibmb.2010.06.001; Jones RT, 2010, PEST MANAG SCI, V66, P1106, DOI 10.1002/ps.1986; Kasai S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002948; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Li Q, 1998, PLANT DOCTOR, V11, P17; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Lottaz C, 2003, BIOINFORMATICS, V19, pII103, DOI 10.1093/bioinformatics/btg1067; Oakeshott J.G., 2005, COMPREHENSIVE MOL IN, P309, DOI [10.1016/B0-44-451924-6/00073-9, DOI 10.1016/B0-44-451924-6/00073-9]; Pattengale ND, 2010, J COMPUT BIOL, V17, P337, DOI 10.1089/cmb.2009.0179; Puinean AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000999; Ranson H., 2005, P383; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Ribeiro JMC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002594; Ribeiro JMC, 2012, J MED ENTOMOL, V49, P563, DOI 10.1603/ME11243; Schuler MA, 2011, BBA-PROTEINS PROTEOM, V1814, P36, DOI 10.1016/j.bbapap.2010.09.012; Sparks ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111646; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Wasmuth JD, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-187; Werck-Reichhart D, 2000, GENOME BIOL, V6, P1, DOI [10.1186/GB-2000-1-6-REVIEWS3003, DOI 10.1186/GB-2000-1-6-REVIEWS3003]; Wondji CS, 2009, GENOME RES, V19, P452, DOI 10.1101/gr.087916.108; Xue J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0521-0; Yang Z, 2006, OXFORD SERIES IN ECO, P102; You MS, 2013, NAT GENET, V45, P220, DOI 10.1038/ng.2524; Zhang Y, 2010, MODERN RURAL TECHNOL, V13, P23, DOI [10.1002/yd.371, DOI 10.1002/YD.371]; Zhu F, 2013, SCI REP-UK, V3, DOI 10.1038/srep01456; Zou DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060881	48	0	0	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0125970	10.1371/journal.pone.0125970	http://dx.doi.org/10.1371/journal.pone.0125970			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955554	Green Published, gold, Green Submitted			2022-12-26	WOS:000356768100086
J	Luo, SX; Li, S; Zhang, XH; Zhang, JJ; Long, GH; Dong, GF; Su, W; Deng, Y; Liu, Y; Zhao, JM; Qin, X				Luo, Shi-Xing; Li, Shan; Zhang, Xue-Hui; Zhang, Jun-Jing; Long, Guang-Hua; Dong, Gui-Fu; Su, Wei; Deng, Yan; Liu, Yanqiong; Zhao, Jin-Min; Qin, Xue			Genetic Polymorphisms of Interleukin-16 and Risk of Knee Osteoarthritis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCUS; SEX-HORMONES; DISEASE; INFLAMMATION; CARCINOMA; VARIANTS; CYTOKINES; ARTHRITIS; CARTILAGE	Background Interleukin-16 (IL-16), a pleiotropic cytokine, plays a fundamental role in inflammatory diseases. This study investigates the association between IL-16 polymorphisms and the risk of knee osteoarthritis (OA) in a Chinese population. Methods The IL-16 rs11556218, rs4072111, and rs4778889 polymorphisms were determined in 150 knee OA cases and 147 healthy controls through polymerase chain reaction-restriction fragment length polymorphism. Results The results suggested that the variants in IL-16 gene rs11556218 site were associated with a decreased knee OA risk after adjusting for age, sex, BMI, and smoking and drinking status (TG vs. TT: OR, 0.69; 95% CI, 0.53-0.89; P = 0.006; GG vs. TT: OR, 0.64; 95% CI, 0.45-0.90; P = 0.042; dominant model: OR, 0.68; 95% CI, 0.29-0.87; P = 0.002; G vs. T allele: OR, 0.77; 95% CI, 0.66-0.90; P = 0.003). Similarly, subjects bearing the rs4072111 variant genotypes and alleles also had a lower susceptibility to knee OA compared with those bearing the wild-type (CT vs. CC: OR, 0.66; 95% CI, 0.53-0.83; P = 0.002; TT vs. CC: OR, 0.57; 95% CI, 0.40-0.82; P = 0.027; dominant model: OR, 0.65; 95%, CI 0.52-0.80; P < 0.001; T vs. C allele: OR, 0.69; 95% CI, 0.58-0.81; P < 0.001). Further, the C allele and the combined genotype (CC+CT) of rs4778889 were associated with a slightly decreased risk of knee OA. In addition, we found two high-risk haplotypes: TTT (OR, 3.70) and GCC (OR, 6.22). Finally, serum IL-16 levels of knee OA patients were significantly higher than those of controls (P = 0.001). Conclusions Despite the small sample size, this is the first study suggesting IL-16 gene polymorphisms to be associated with the risk of knee OA.	[Luo, Shi-Xing; Su, Wei; Zhao, Jin-Min] Guangxi Med Univ, Affiliated Hosp 1, Dept Orthoped Trauma & Hand Surg, Nanning, Guangxi, Peoples R China; [Luo, Shi-Xing; Zhang, Jun-Jing; Long, Guang-Hua; Dong, Gui-Fu] Guangxi Med Univ, Affiliated Hosp 9, Dept Trauma Orthoped, Beihai, Guangxi, Peoples R China; [Li, Shan; Deng, Yan; Liu, Yanqiong; Qin, Xue] Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi, Peoples R China; [Zhang, Xue-Hui] Guangxi Med Univ, Affiliated Hosp 9, Dept Nucl Med, Beihai, Guangxi, Peoples R China; [Zhang, Xue-Hui] Guangxi Med Univ, Grad Sch, Nanning, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University	Zhao, JM (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Orthoped Trauma & Hand Surg, Nanning, Guangxi, Peoples R China.	zhaojinmin919@163.com; qinxue919@126.com		Zhao, Jinmin/0000-0002-1047-8820	National Natural Science Foundation of China [81460345]; National Natural Science Youth Foundation of Guangxi [2012GXNSFBA053124]; Health Department Self-raised Foundation of Guangxi [Z2011064]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Youth Foundation of Guangxi; Health Department Self-raised Foundation of Guangxi	This research was supported by National Natural Science Foundation of China (No. 81460345); National Natural Science Youth Foundation of Guangxi (2012GXNSFBA053124); Health Department Self-raised Foundation of Guangxi (Z2011064). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Azimzadeh P, 2011, J GASTROINTEST LIVER, V20, P371; Baier M, 1997, P NATL ACAD SCI USA, V94, P5273, DOI 10.1073/pnas.94.10.5273; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bierma-Zeinstra SMA, 2007, NAT CLIN PRACT RHEUM, V3, P78, DOI 10.1038/ncprheum0423; Brooks P, 2003, B WORLD HEALTH ORGAN, V81, P689; Center DM, 1996, IMMUNOL TODAY, V17, P476, DOI 10.1016/0167-5699(96)10052-I; CRUIKSHANK WW, 1994, P NATL ACAD SCI USA, V91, P5109, DOI 10.1073/pnas.91.11.5109; Day-Williams AG, 2011, AM J HUM GENET, V89, P446, DOI 10.1016/j.ajhg.2011.08.001; Evangelou E, 2011, ANN RHEUM DIS, V70, P349, DOI 10.1136/ard.2010.132787; Goldring SR, 2004, CLIN ORTHOP RELAT R, pS27, DOI 10.1097/01.blo.0000144854.66565.8f; Han L, 2014, GENE, V533, P119, DOI 10.1016/j.gene.2013.09.113; Honsawek S, 2011, GENET MOL RES, V10, P1674, DOI 10.4238/vol10-3gmr1161; Huang H, 2013, CLIN BIOCHEM, V46, P241, DOI 10.1016/j.clinbiochem.2012.11.009; Hulin-Curtis SL, 2012, INT J IMMUNOGENET, V39, P106, DOI 10.1111/j.1744-313X.2011.01060.x; Ji B, 2013, INT ORTHOP, V37, P2061, DOI 10.1007/s00264-013-1931-4; Jiang LY, 2012, JOINT BONE SPINE, V79, P291, DOI 10.1016/j.jbspin.2011.05.015; Jochems C, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-284; Kaarvatn MH, 2013, SCAND J IMMUNOL, V77, P151, DOI 10.1111/sji.12016; Kai H, 2005, ANTICANCER RES, V25, P709; Kerkhof HJM, 2010, ARTHRITIS RHEUM-US, V62, P499, DOI 10.1002/art.27184; Kim HS, 1999, CYTOGENET CELL GENET, V84, P93, DOI 10.1159/000015224; Li S, 2011, INFECT GENET EVOL, V11, P2083, DOI 10.1016/j.meegid.2011.09.025; Linn S, 2012, PM&R, V4, pS169, DOI 10.1016/j.pmrj.2012.01.013; Liu XL, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/564750; Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-0261; Ma HL, 2007, OSTEOARTHR CARTILAGE, V15, P695, DOI 10.1016/j.joca.2006.11.005; Meulenbelt I, 2009, HUM MOL GENET, V18, P1518, DOI 10.1093/hmg/ddp053; Miyamoto Y, 2008, NAT GENET, V40, P994, DOI 10.1038/ng.176; Moss SF, 2005, NAT CLIN PRACT ONCOL, V2, P90, DOI 10.1038/ncponc0081; Nakajima M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009723; Nakayama EE, 2000, GENES IMMUN, V1, P293, DOI 10.1038/sj.gene.6363672; Pelletier JP, 2001, ARTHRITIS RHEUM-US, V44, P1237, DOI 10.1002/1529-0131(200106)44:6<1237::AID-ART214>3.0.CO;2-F; Qin X, 2014, TUMOR BIOL, V35, P1917, DOI 10.1007/s13277-013-1257-2; Sandell LJ, 2001, ARTHRITIS RES, V3, P107, DOI 10.1186/ar148; Scott D, 2008, AM FAM PHYSICIAN, V77, P1149; Seng KC, 2008, EUR J HUM GENET, V16, P554, DOI 10.1038/ejhg.2008.12; Shanmugham LN, 2006, J EXP CLIN CANC RES, V25, P529; Smith AJP, 2009, CYTOKINE GROWTH F R, V20, P43, DOI 10.1016/j.cytogfr.2008.11.006; Sowers M, 2001, CURR OPIN RHEUMATOL, V13, P447, DOI 10.1097/00002281-200109000-00018; Tan HF, 2013, PAK J MED SCI, V29, P1033, DOI 10.12669/pjms.294.3650; Tong ZC, 2013, J INT MED RES, V41, P1049, DOI 10.1177/0300060513483405; Tsai KH, 2014, CHINESE J PHYSIOL, V57, P69, DOI 10.4077/CJP.2014.BAB150; Yigit S, 2014, GENE, V537, P6, DOI 10.1016/j.gene.2013.12.060; Zeggini E, 2012, LANCET, V380, P815, DOI 10.1016/S0140-6736(12)60681-3; Zhang T, 2013, ASIAN PAC J CANCER P, V14, P5269, DOI 10.7314/APJCP.2013.14.9.5269; Zhang YJ, 1998, J BIOL CHEM, V273, P1144, DOI 10.1074/jbc.273.2.1144; Zhu JA, 2010, INT J UROL, V17, P700, DOI 10.1111/j.1442-2042.2010.02559.x	48	17	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0123442	10.1371/journal.pone.0123442	http://dx.doi.org/10.1371/journal.pone.0123442			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25954818	gold, Green Published, Green Submitted			2022-12-26	WOS:000356768100013
J	Morro, A; Canals, V; Oliver, A; Alomar, ML; Rossello, JL				Morro, Antoni; Canals, Vincent; Oliver, Antoni; Alomar, Miquel L.; Rossello, Josep L.			Ultra-Fast Data-Mining Hardware Architecture Based on Stochastic Computing	PLOS ONE			English	Article							IMAGE	Minimal hardware implementations able to cope with the processing of large amounts of data in reasonable times are highly desired in our information-driven society. In this work we review the application of stochastic computing to probabilistic-based pattern-recognition analysis of huge database sets. The proposed technique consists in the hardware implementation of a parallel architecture implementing a similarity search of data with respect to different pre-stored categories. We design pulse-based stochastic-logic blocks to obtain an efficient pattern recognition system. The proposed architecture speeds up the screening process of huge databases by a factor of 7 when compared to a conventional digital implementation using the same hardware area.	[Morro, Antoni; Canals, Vincent; Oliver, Antoni; Alomar, Miquel L.; Rossello, Josep L.] Univ Illes Balears, Dept Phys, Elect Engn Grp, Palma de Mallorca, Spain	Universitat de les Illes Balears	Rossello, JL (corresponding author), Univ Illes Balears, Dept Phys, Elect Engn Grp, Palma de Mallorca, Spain.	j.rossello@uib.es	Canals, Vincent/M-1237-2014; Rossello, Josep/K-4427-2014; Gelabert, Antonio Oliver/AAL-4894-2020; Oliver, Antonio/P-1227-2015	Canals, Vincent/0000-0002-8394-4159; Rossello, Josep/0000-0001-5390-2276; Oliver, Antonio/0000-0001-8571-2733; Gomila, Morro/0000-0002-7394-8180	Spanish Ministry of Economy and Competitiveness (MINECO); Regional European Development Funds (FEDER); Comunitat Autonoma de les Illes Balears [TEC2011-23113, TEC2014-56244-R, AAEE018/2012]; European Social Fund (ESF) [FPI/1513/2012]; Govern de les Illes Balears (Conselleria d'Educacio, Cultura i Universitats)	Spanish Ministry of Economy and Competitiveness (MINECO); Regional European Development Funds (FEDER)(European Commission); Comunitat Autonoma de les Illes Balears; European Social Fund (ESF)(European Social Fund (ESF)); Govern de les Illes Balears (Conselleria d'Educacio, Cultura i Universitats)	This work has been partially supported by the Spanish Ministry of Economy and Competitiveness (MINECO) the Regional European Development Funds (FEDER) and the Comunitat Autonoma de les Illes Balears under grant contracts TEC2011-23113, TEC2014-56244-R and AAEE018/2012 and a fellowship (FPI/1513/2012) financed by the European Social Fund (ESF) and the Govern de les Illes Balears (Conselleria d'Educacio, Cultura i Universitats). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal CC, 2005, DATA MIN KNOWL DISC, V10, P251, DOI 10.1007/s10618-005-0645-7; Alaghi A, 2013, 2013 IEEE 31ST INTERNATIONAL CONFERENCE ON COMPUTER DESIGN (ICCD), P39, DOI 10.1109/ICCD.2013.6657023; Ballester PJ, 2007, P R SOC A, V463, P1307, DOI 10.1098/rspa.2007.1823; Bayardo R.J., 2007, P 16 INT C WORLD WID, DOI DOI 10.1145/1242572.1242591; Bishop C. M, 2006, PATTERN RECOGNITION; Canals V, 2010, PATTERN RECOGN LETT, V31, P2353, DOI 10.1016/j.patrec.2010.07.008; Fayos J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000210; Gaines B.R., 1969, ADV INFORM SYSTEMS S, P37, DOI [10.1007/978-1-4899-5841-9_2, DOI 10.1007/978-1-4899-5841-9_2]; GAINES BR, 1975, ELECTRON LETT, V11, P188, DOI 10.1049/el:19750144; Grossman RL, 2008, P 14 ACM SIGKDD INT, P920, DOI DOI 10.1145/1401890.1402000; Gullo F, 2009, PATTERN RECOGN, V42, P2998, DOI 10.1016/j.patcog.2009.03.030; Hori M, 2006, JPN J APPL PHYS 1, V45, P3301, DOI 10.1143/JJAP.45.3301; Kaznadzey A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058505; KIM YC, 1995, IEEE T NEURAL NETWOR, V6, P220, DOI 10.1109/72.363434; Kitsos P, 2001, ICECS 2001: 8TH IEEE INTERNATIONAL CONFERENCE ON ELECTRONICS, CIRCUITS AND SYSTEMS, VOLS I-III, CONFERENCE PROCEEDINGS, P991, DOI 10.1109/ICECS.2001.957640; Kontos D, 2005, PATTERN RECOGN, V38, P1831, DOI 10.1016/j.patcog.2005.04.020; Koren Yehuda, 2008, KDD, P426, DOI DOI 10.1145/1401890.1401944; Korn G, 1966, RANDOM PROCESS SIMUL; Li H, 2012, P ACM SIGKDD INT C K; Li P, 2014, IEEE T VLSI SYST, V22, P449, DOI 10.1109/TVLSI.2013.2247429; Pan F, 2005, FIFTH IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P338; Peterson W. W., 1961, ERROR CORRECTING COD; Rakthanmanon Thanawin, 2012, KDD, V2012, P262, DOI 10.1145/2339530.2339576; Rossello JL, 2012, P INT JOINT C NEUR N; Rossello JL, 2012, SISTEMA DIGITAL PROB; Stegmayer G, 2012, IEEE COMPUT INTELL M, V7, P22, DOI 10.1109/MCI.2012.2215122; Szalay A, 2006, NATURE, V440, P413, DOI 10.1038/440413a; Wang XZ, 2006, DATA MIN KNOWL DISC, V13, P335, DOI 10.1007/s10618-005-0039-x; Zhen Y, 2013, DATA MIN KNOWL DISC, V26, P255, DOI 10.1007/s10618-012-0249-y; Zhou P., 2011, J COMPUTATIONAL INFO, V7, P5956; Zhu QA, 2011, DATA MIN KNOWL DISC, V23, P91, DOI 10.1007/s10618-010-0200-z; Zou Jinming, 2008, V458, P15	32	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0124176	10.1371/journal.pone.0124176	http://dx.doi.org/10.1371/journal.pone.0124176			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955274	Green Published, gold, Green Submitted			2022-12-26	WOS:000356768100028
J	Niewiadonski, VDT; Bianchi, JVDS; de Almeida-Neto, C; Gaburo, N; Sabino, EC				Niewiadonski, Vivian Dionisio Tavares; Bianchi, Juliana Vieira dos Santos; de Almeida-Neto, Cesar; Gaburo, Nelson, Jr.; Sabino, Ester Cerdeira			Evaluation of a High Throughput Method for the Detection of Mutations Associated with Thrombosis and Hereditary Hemochromatosis in Brazilian Blood Donors	PLOS ONE			English	Article							FACTOR-V-LEIDEN; HFE GENE-MUTATIONS; METHYLENETETRAHYDROFOLATE REDUCTASE; VENOUS THROMBOEMBOLISM; ORAL-CONTRACEPTIVES; INCREASED RISK; POLYMORPHISMS; MTHFR; PREECLAMPSIA; POPULATION	Background The aim of this study was to evaluate the OpenArray platform for genetic testing of blood donors and to assess the genotype frequencies of nucleotide-polymorphisms (SNPs) associated with venous thrombosis (G1691A and G20210A), hyperhomocysteinemia (C677T, A1298C), and hereditary hemochromatosis (C282Y, H63D and S65C) in blood donors from Sao Paulo, Brazil. Methods We examined 400 blood donor samples collected from October to November 2011. The SNPs were detected using OpenArray technology. The blood samples were also examined using a real-time PCR-FRET system to compare the results and determine the accuracy of the OpenArray method. Results We observed 100% agreement in all assays tested, except HFE C282Y, which showed 99.75% agreement. The HFE C282Y assay was further confirmed through direct sequencing, and the results showed that OpenArray analysis was accurate. The calculated frequencies of each SNP were FV G1691A 98.8% (G/G), 1.2% (G/A); FII G2021A 99.5% (G/G), 0.5% (G/A); MTHFR C677T 45.5%(C/C), 44.8% (C/T), 9.8% (T/T); MTHFR A1298C 60.3% (A/A), 33.6% (A/C), 6.1% (C/C); HFE C282Y 96%(G/G), 4%(G/A), HFE H63D 78.1%(C/C), 20.3% (C/G), 1.6% (G/G); and HFE S65C 98.1%(A/A), 1.9% (A/T). Conclusion Taken together, these results describe the frequencies of SNPs associated with diseases and are important to enhance our current knowledge of the genetic profiles of Brazilian blood donors, although a larger study is needed for a more accurate determination of the frequency of the alleles. Furthermore, the OpenArray platform showed a high concordance rate with standard FRET RT-PCR.	[Niewiadonski, Vivian Dionisio Tavares; Bianchi, Juliana Vieira dos Santos; Sabino, Ester Cerdeira] Univ Sao Paulo, Inst Trop Med, Sao Paulo, Brazil; [Niewiadonski, Vivian Dionisio Tavares; Gaburo, Nelson, Jr.] DASA, Dept Mol Diagnost, Sao Paulo, Brazil; [Sabino, Ester Cerdeira] Univ Sao Paulo, Dept Infect Dis, Sao Paulo, Brazil; [de Almeida-Neto, Cesar] Fdn Pro Sangue Hemocentro Sao Paulo, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Niewiadonski, VDT (corresponding author), Univ Sao Paulo, Inst Trop Med, Sao Paulo, Brazil.	vivian.tavares@usp.br	de Almeida-Neto, Cesar/O-9224-2014; Sabino, Ester C/F-7750-2010	de Almeida-Neto, Cesar/0000-0002-8490-4634; Sabino, Ester C/0000-0003-2623-5126	Conselho Nacional de Desenvolvimento Cientifico e Tecnlogico (CNPq) [302202/2011-0]; Coordenacao de aperfeicoamento pessoal de nivel superior (CAPES); Fundacao Pro-Sangue Hemocentro de Sao Paulo; Fundacao Faculdade de Medicina	Conselho Nacional de Desenvolvimento Cientifico e Tecnlogico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de aperfeicoamento pessoal de nivel superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Pro-Sangue Hemocentro de Sao Paulo; Fundacao Faculdade de Medicina	ECS was supported through funding from Conselho Nacional de Desenvolvimento Cientifico e Tecnlogico (CNPq) grant number 302202/2011-0, and JV was supported through Coordenacao de aperfeicoamento pessoal de nivel superior (CAPES). This work was also supported through the Fundacao Pro-Sangue Hemocentro de Sao Paulo and the Fundacao Faculdade de Medicina. VDTN, CAN, and NG received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessio ACM, 2004, AM J MED GENET A, V128A, P256, DOI 10.1002/ajmg.a.30108; Alexander J, 2009, GENET MED, V11, P307, DOI 10.1097/GIM.0b013e31819d30f2; Anstee DJ, 2009, BLOOD, V114, P248, DOI 10.1182/blood-2008-11-146860; Aznar J, 2013, AM J OBSTET GYNECOL, V209, P156, DOI 10.1016/j.ajog.2013.02.036; Bauduer F, 2005, MOL GENET METAB, V86, P91, DOI 10.1016/j.ymgme.2005.04.002; Bernard PS, 1998, AM J PATHOL, V153, P1055, DOI 10.1016/S0002-9440(10)65650-7; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Beutler E, 2002, LANCET, V359, P211, DOI 10.1016/S0140-6736(02)07447-0; Bezemer ID, 2008, JAMA-J AM MED ASSOC, V299, P1306, DOI 10.1001/jama.299.11.1306; Cooper DN, 2013, HUM GENET, V132, P1077, DOI 10.1007/s00439-013-1331-2; da Silva IL, 2011, ARQ NEURO-PSIQUIAT, V69, P431, DOI 10.1590/S0004-282X2011000400004; Dalmaz CA, 2006, BLOOD CELL MOL DIS, V37, P107, DOI 10.1016/j.bcmd.2006.07.005; Davis CF, 2010, ANN HEMATOL, V89, P375, DOI 10.1007/s00277-009-0839-y; De Stefano V, 1999, NEW ENGL J MED, V341, P801, DOI 10.1056/NEJM199909093411104; De Stefano V, 2013, THROMB HAEMOSTASIS, V110, P697, DOI 10.1160/TH13-01-0011; Delluc A, 2010, THROMB HAEMOSTASIS, V103, P1161, DOI 10.1160/TH09-07-0430; Eldibany MM, 2007, ARCH PATHOL LAB MED, V131, P872; Endler G, 2003, CLIN CHIM ACTA, V330, P31, DOI 10.1016/S0009-8981(03)00022-6; Goette L, 2009, TRANSFUSION, V49, P524, DOI 10.1111/j.1537-2995.2008.02007.x; Jacques PF, 1996, CIRCULATION, V93, P7, DOI 10.1161/01.CIR.93.1.7; Kvasnicka Jan, 2012, Cas Lek Cesk, V151, P76; Lee DH, 1996, CAN MED ASSOC J, V155, P285; Leitman SF, 2013, HEMATOL-AM SOC HEMAT, P645, DOI 10.1182/asheducation-2013.1.645; Lenhard MJ, 2013, TRANSFUSION, V53, P2776, DOI 10.1111/trf.12135; Lima MBPLV, 2009, GENET MOL BIOL, V32, P264, DOI 10.1590/S1415-47572009000200010; Madjunkova S, 2012, GENET TEST MOL BIOMA, V16, P259, DOI 10.1089/gtmb.2011.0173; Mira Y, 2000, CLIN APPL THROMB-HEM, V6, P162, DOI 10.1177/107602960000600308; Morrison T, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl639; Pena SDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017063; Pennings G, 2005, J MED ETHICS, V31, P69, DOI 10.1136/jme.2002.001271; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; Ramos Catarina Paula da Silva, 2008, J. Bras. Patol. Med. Lab., V44, P79, DOI 10.1590/S1676-24442008000200003; Ramos Catarina P. S., 2006, Rev. Bras. Hematol. Hemoter., V28, P131, DOI 10.1590/S1516-84842006000200013; Sabino AD, 2007, J THROMB THROMBOLYS, V24, P261, DOI 10.1007/s11239-007-0024-x; Dusse LMS, 2007, EUR J OBSTET GYN R B, V134, P20, DOI 10.1016/j.ejogrb.2006.09.006; Santos PCJL, 2010, BRAZ J MED BIOL RES, V43, P107, DOI 10.1590/S0100-879X2009007500031; Santos PCJL, 2012, INT J MOL SCI, V13, P1497, DOI 10.3390/ijms13021497; Santos RV, 2009, CURR ANTHROPOL, V50, P787, DOI 10.1086/644532; Sazci A, 2006, BRAIN RES BULL, V71, P45, DOI 10.1016/j.brainresbull.2006.07.014; Sottilotta G, 2009, CLIN APPL THROMB-HEM, V15, P356, DOI 10.1177/1076029607310218; Spinola C, 2011, ANN HEMATOL, V90, P29, DOI 10.1007/s00277-010-1034-x; Stur E, 2012, GENET TEST MOL BIOMA, V16, P219, DOI 10.1089/gtmb.2011.0163; Terada CT, 2009, TRANSFUSION MED, V19, P245, DOI 10.1111/j.1365-3148.2009.00944.x; van den Bergh FAJTM, 2000, CLIN CHEM, V46, P1191; Vares M, 2010, AM J MED GENET B, V153B, P610, DOI 10.1002/ajmg.b.31030; Westhoff CM, 2006, CURR OPIN HEMATOL, V13, P471, DOI 10.1097/01.moh.0000245695.77758.3d; Zappacosta B, 2014, CELL BIOCHEM FUNCT, V32, P1, DOI 10.1002/cbf.3019	48	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0125460	10.1371/journal.pone.0125460	http://dx.doi.org/10.1371/journal.pone.0125460			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955572	Green Published, gold, Green Submitted			2022-12-26	WOS:000356768100054
J	Zhang, ZY; Zhang, X; Hu, ZB; Wang, SF; Zhang, JB; Wang, XJ; Wang, QL; Zhang, BH				Zhang, Zhiyong; Zhang, Xin; Hu, Zebing; Wang, Sufang; Zhang, Jinbao; Wang, Xiaojing; Wang, Qinglian; Zhang, Baohong			Lack of K-Dependent Oxidative Stress in Cotton Roots Following Coronatine-Induced ROS Accumulation	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; ANTIOXIDANT RESPONSES; PHYTOTOXIN CORONATINE; POTASSIUM-DEFICIENCY; METHYL JASMONATE; ACTIVE OXYGEN; WATER-STRESS; L.; SEEDLINGS; PLANTS	Coronatine [COR] is a novel type of plant growth regulator with similarities in structure and property to jasmonate. The objective of this study was to examine the relationship between increased root vitality induced by 10nM COR and reactive oxygen species scavenging under potassium (K)-replete (2.5mM) and K-deficient (0.05mM) conditions in hydroponic cultured cotton seedlings. K-replete and K-deficient conditions increased root vitality by 2.7-and 3.5-fold, respectively. COR treatment significantly decreased lipid peroxidation in cotton seedlings determined by reduction in MDA levels. These results suggest that COR improves the functioning of both enzymatic and non-enzymatic antioxidant systems. Under K-replete and K-deficient conditions, COR significantly increased the activities of antioxidant enzymes SOD (only for K-repletion), CAT, GPX, and APX comparing; COR also significantly increased DPPH-radical scavenging activity. However, COR led to 1.6-and 1.7-fold increases in superoxide anion (O-2(center dot-)) concentrations, and 5.7-and 2.1-fold increases in hydrogen peroxide (H2O2) levels, respectively. Additionally, COR intensified the DAB staining of H2O2 and the NBT staining of O-2(center dot-). Therefore, our results reveal that COR-induced ROS accumulation stimulates the activities of most antioxidant enzymes but does not induce oxidative stress in cotton roots.	[Zhang, Zhiyong; Zhang, Xin; Hu, Zebing; Wang, Sufang; Zhang, Jinbao; Wang, Xiaojing; Wang, Qinglian; Zhang, Baohong] Henan Inst Sci & Technol, Henan Collaborat Innovat Ctr Modern Biol Breeding, Xinxiang 453003, Peoples R China; [Zhang, Baohong] E Carolina Univ, Dept Biol, Greenville, NC 27858 USA	Henan Institute of Science & Technology; University of North Carolina; East Carolina University	Wang, QL (corresponding author), Henan Inst Sci & Technol, Henan Collaborat Innovat Ctr Modern Biol Breeding, Xinxiang 453003, Peoples R China.	wangql985@163.com	Zhang, Xin/ABI-7149-2020; Zhang, Baohong/O-4948-2016		National Natural Science Foundation of China [31271648, 31170263]; Science and Technology Innovation Talents Project of Henan Province of China [114100510008]; State Key Laboratory of Plant Physiology and Biochemistry of China [SKLPPBKF09004]; National High-tech R and D Program of China (863 Program) [2011AA10A102]; Industry Technology System of Cotton in Henan China [S2013-07]; National Genetically Modified Organisms Breeding Technology Major Projects of China [2014ZX08005-002]; Project of National Scientific and Technological Achievements Transformation of China [2012GB2D000280]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Innovation Talents Project of Henan Province of China; State Key Laboratory of Plant Physiology and Biochemistry of China; National High-tech R and D Program of China (863 Program)(National High Technology Research and Development Program of China); Industry Technology System of Cotton in Henan China; National Genetically Modified Organisms Breeding Technology Major Projects of China; Project of National Scientific and Technological Achievements Transformation of China	This research was supported by the National Natural Science Foundation of China (31271648, 31170263), Science and Technology Innovation Talents Project of Henan Province of China (114100510008), and the Open Fund Project of the State Key Laboratory of Plant Physiology and Biochemistry of China (SKLPPBKF09004), also by National High-tech R and D Program of China (863 Program) (2011AA10A102), The Industry Technology System of Cotton in Henan China (S2013-07), National Genetically Modified Organisms Breeding Technology Major Projects of China (2014ZX08005-002), and the Project of National Scientific and Technological Achievements Transformation of China (2012GB2D000280). We thank Centre of Crop Chemical Control, China Agricultural University for providing the concentrated pure coronatine solution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 1998, BIOSCI BIOTECH BIOCH, V62, P661, DOI 10.1271/bbb.62.661; Aftab T, 2011, PROTOPLASMA, V248, P601, DOI 10.1007/s00709-010-0218-5; Ai L, 2008, J AGRON CROP SCI, V194, P360, DOI 10.1111/j.1439-037X.2008.00325.x; Akcay UC, 2010, PLANT GROWTH REGUL, V61, P21, DOI 10.1007/s10725-010-9445-1; Alscher RG, 1997, PHYSIOL PLANTARUM, V100, P224, DOI 10.1034/j.1399-3054.1997.1000203.x; Armengaud P, 2004, PLANT PHYSIOL, V136, P2556, DOI 10.1104/pp.104.046482; ASADA K, 1984, METHOD ENZYMOL, V105, P422; Ashraf M, 2009, BIOTECHNOL ADV, V27, P84, DOI 10.1016/j.biotechadv.2008.09.003; Cakmak I, 2005, J PLANT NUTR SOIL SC, V168, P521, DOI 10.1002/jpln.200420485; CAKMAK I, 1988, J EXP BOT, V39, P1449, DOI 10.1093/jxb/39.10.1449; Cervilla LM, 2007, ANN BOT-LONDON, V100, P747, DOI 10.1093/aob/mcm156; Cheeseman JM, 2006, J EXP BOT, V57, P2435, DOI 10.1093/jxb/erl004; Comas LH, 2000, NEW PHYTOL, V147, P171, DOI 10.1046/j.1469-8137.2000.00679.x; Dat J, 2000, CELL MOL LIFE SCI, V57, P779, DOI 10.1007/s000180050041; Soares Alexandra Martins dos Santos, 2010, Braz. J. Plant Physiol., V22, P151, DOI 10.1590/S1677-04202010000300001; ELSTNER EF, 1976, ARCH BIOCHEM BIOPHYS, V173, P623, DOI 10.1016/0003-9861(76)90299-X; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Gifford ML, 2008, P NATL ACAD SCI USA, V105, P803, DOI 10.1073/pnas.0709559105; Gong HJ, 2005, PLANT SCI, V169, P313, DOI 10.1016/j.plantsci.2005.02.023; Gong XL, 2011, PLANT SOIL, V340, P443, DOI 10.1007/s11104-010-0616-7; Gunes A, 2006, SCI HORTIC-AMSTERDAM, V110, P279, DOI 10.1016/j.scienta.2006.07.014; Hafsi C, 2014, ACTA PHYSIOL PLANT, V36, P1055, DOI 10.1007/s11738-014-1491-2; Hartley DP, 1999, TOXICOL APPL PHARM, V161, P23, DOI 10.1006/taap.1999.8788; Hernandez M, 2012, J PLANT PHYSIOL, V169, P1366, DOI 10.1016/j.jplph.2012.05.015; Ishiga Y, 2009, NEW PHYTOL, V181, P147, DOI 10.1111/j.1469-8137.2008.02639.x; Jambunathan N, 2010, METHODS MOL BIOL, V639, P291, DOI 10.1007/978-1-60761-702-0_18; Karabal E, 2003, PLANT SCI, V164, P925, DOI 10.1016/S0168-9452(03)00067-0; Li XiangWen, 2010, Journal of Triticeae Crops, V30, P676; Mellersh DG, 2002, PLANT J, V29, P257, DOI 10.1046/j.0960-7412.2001.01215.x; Merewitz EB, 2011, J EXP BOT, V62, P383, DOI 10.1093/jxb/erq285; Miao BH, 2010, ANN BOT-LONDON, V105, P967, DOI 10.1093/aob/mcq063; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Molassiotis A, 2006, ENVIRON EXP BOT, V56, P54, DOI 10.1016/j.envexpbot.2005.01.002; Orozco-Cardenas M, 1999, P NATL ACAD SCI USA, V96, P6553, DOI 10.1073/pnas.96.11.6553; Pellinen R, 1999, PLANT J, V20, P349, DOI 10.1046/j.1365-313X.1999.00613.x; POLLE A, 1994, PLANT PHYSIOL, V106, P53, DOI 10.1104/pp.106.1.53; Rao MV, 1996, PLANT PHYSIOL, V110, P125, DOI 10.1104/pp.110.1.125; SCANDALIOS JG, 1993, PLANT PHYSIOL, V101, P7, DOI 10.1104/pp.101.1.7; Shen WY, 2000, PLANT PHYSIOL, V124, P431, DOI 10.1104/pp.124.1.431; Shin R, 2004, P NATL ACAD SCI USA, V101, P8827, DOI 10.1073/pnas.0401707101; Shin R, 2005, PLANT CELL PHYSIOL, V46, P1350, DOI 10.1093/pcp/pci145; STEPONKUS PL, 1967, PLANT PHYSIOL, V42, P1423, DOI 10.1104/pp.42.10.1423; Sudhakar C, 2001, PLANT SCI, V161, P613, DOI 10.1016/S0168-9452(01)00450-2; Tewari RK, 2007, J INTEGR PLANT BIOL, V49, P313, DOI 10.1111/j.1744-7909.2007.00358.x; Tewari RK, 2006, SCI HORTIC-AMSTERDAM, V108, P7, DOI 10.1016/j.scienta.2005.12.006; Triantaphylides C, 2008, PLANT PHYSIOL, V148, P960, DOI 10.1104/pp.108.125690; Uppalapati SR, 2005, PLANT J, V42, P201, DOI 10.1111/j.1365-313X.2005.02366.x; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Xie ZX, 2008, J PLANT PHYSIOL, V165, P375, DOI 10.1016/j.jplph.2007.06.001; Xie ZhiXia, 2012, Cotton Science, V24, P511; Yamauchi T, 2014, J EXP BOT, V65, P261, DOI 10.1093/jxb/ert371; Zhang BH, 2015, J EXPT BOT, DOI [10.1093/jxb/erv1013, DOI 10.1093/JXB/ERV1013]; Zhang X, 2005, J RESIDUALS SCI TECH, V2, P173; Zhang ZY, 2007, J PLANT NUTR, V30, P659, DOI 10.1080/01904160701289206; Zhang ZY, 2009, J PLANT NUTR SOIL SC, V172, P435, DOI 10.1002/jpln.200800116	56	12	13	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0126476	10.1371/journal.pone.0126476	http://dx.doi.org/10.1371/journal.pone.0126476			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955838	Green Published, gold, Green Submitted			2022-12-26	WOS:000356768100122
J	Olcina, MM; Leszczynska, KB; Senra, JM; Isa, NF; Harada, H; Hammond, EM				Olcina, M. M.; Leszczynska, K. B.; Senra, J. M.; Isa, N. F.; Harada, H.; Hammond, E. M.			H3K9me3 facilitates hypoxia-induced p53-dependent apoptosis through repression of APAK	ONCOGENE			English	Article							CHROMATIN-STRUCTURE; ATM ACTIVATION; SOLID TUMORS; HUMAN GENOME; HISTONE H3; STRESS; P53; HETEROCHROMATIN; METHYLTRANSFERASE; REPLICATION	Regions of hypoxia occur in most solid tumors, and they are associated with a poor prognostic outcome. Despite the absence of detectable DNA damage, severe hypoxia (<0.1% O-2) induces a DNA damage response, including the activation of p53 and subsequent induction of p53-dependent apoptosis. Factors affecting hypoxia-induced p53-dependent apoptosis are unclear. Here we asked whether H3K9me3, through mediating gene repression, could regulate hypoxia-induced p53-dependent apoptosis. Under hypoxic conditions, increases in H3K9me3 occur in an oxygen-dependent but HIF-1-independent manner. We demonstrate that under hypoxic conditions, which induce p53 activity, the negative regulator of p53, APAK, is repressed by increases in H3K9me3 along the APAK loci. APAK repression in hypoxia is mediated by the methyltransferase SETDB1 but not Suv39h1 or G9a. Interestingly, increasing hypoxia-induced H3K9me3 through pharmacological inhibition of JMJD2 family members leads to an increase in apoptosis and decreased clonogenic survival and again correlates with APAK expression. The relevance of understanding the mechanisms of APAK expression regulation to human disease was suggested by analysis of patients with colorectal cancer, which demonstrates that high APAK expression correlates with poor prognosis. Together, these data demonstrate the functional importance of H3K9me3 in hypoxia, and they provide a novel mechanistic link between H3K9me3, p53 and apoptosis in physiologically relevant conditions of hypoxia.	[Olcina, M. M.; Leszczynska, K. B.; Senra, J. M.; Isa, N. F.; Hammond, E. M.] Univ Oxford, Dept Oncol, CR UK & MRC Oxford Inst Radiat Oncol, Oxford, England; [Harada, H.] Kyoto Univ, Grad Sch Med, Dept Radiat Oncol & Image Applied Therapy, Kyoto, Japan	University of Oxford; Kyoto University	Hammond, EM (corresponding author), Univ Oxford, CR UK & MRC Oxford Inst Radiat Oncol, Dept Oncol, ORCRB, Off Roosevelt Dr, Oxford OX3 7DQ, England.	Ester.Hammond@oncology.ox.ac.uk	isa, nur firdaus/HGU-0902-2022; Leszczynska, Katarzyna/AAK-9655-2020; Isa, Nur Firdaus/AAV-2880-2021	Leszczynska, Katarzyna/0000-0002-3504-1553; Isa, Nur Firdaus/0000-0003-3476-6306; Hammond, Ester/0000-0002-2335-3146	Cancer Research UK grant; MRC; MRC Centenary award; Cancer Research UK [19276] Funding Source: researchfish; Medical Research Council [891635] Funding Source: researchfish	Cancer Research UK grant(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Centenary award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to Chunyan Tian for the APAK constructs and Amato Giaccia and Laura Castellini for helpful discussions. KBL, JMS and EMH are supported by a Cancer Research UK grant (awarded to EMH). MO is supported by the MRC with an additional MRC Centenary award (awarded to MMO).	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bencokova Z, 2009, MOL CELL BIOL, V29, P526, DOI 10.1128/MCB.01301-08; Brown JM, 1998, CANCER RES, V58, P1408; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Hammond EM, 2006, MOL CELL BIOL, V26, P3492, DOI 10.1128/MCB.26.9.3492-3504.2006; Hammond EM, 2002, MOL CELL BIOL, V22, P1834, DOI 10.1128/MCB.22.6.1834-1843.2002; Jenuwein T, 1998, CELL MOL LIFE SCI, V54, P80, DOI 10.1007/s000180050127; Johnson AB, 2007, MUTAT RES-FUND MOL M, V618, P149, DOI 10.1016/j.mrfmmm.2006.10.007; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Loyola A, 2009, EMBO REP, V10, P769, DOI 10.1038/embor.2009.90; Lu YH, 2014, CELL REP, V8, P500, DOI 10.1016/j.celrep.2014.06.035; Lu YH, 2011, MOL CELL BIOL, V31, P3339, DOI 10.1128/MCB.01121-10; Mizuno H, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-18; Mungamuri SK, 2012, NAT STRUCT MOL BIOL, V19, P478, DOI 10.1038/nsmb.2271; Olcina MM, 2013, MOL CELL, V52, P758, DOI 10.1016/j.molcel.2013.10.019; Rai G, 2010, PROBE REPORTS NIH MO; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Squatrito M, 2010, CANCER CELL, V18, P619, DOI 10.1016/j.ccr.2010.10.034; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tian C, 2009, NAT CELL BIOL, V11, P580, DOI 10.1038/ncb1864; Vaupel P, 2004, METHOD ENZYMOL, V381, P335; Wang S, 2010, FEBS LETT, V584, P3909, DOI 10.1016/j.febslet.2010.08.015; Yuan L, 2012, EMBO REP, V13, P363, DOI 10.1038/embor.2012.10	29	41	45	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 11	2016	35	6					793	799		10.1038/onc.2015.134	http://dx.doi.org/10.1038/onc.2015.134			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DE0RF	25961932	Green Published, hybrid			2022-12-26	WOS:000370331300012
J	Jaijyan, DK; Singh, H; Singh, AP				Jaijyan, Dabbu Kumar; Singh, Himanshu; Singh, Agam Prasad			A Sporozoite- and Liver Stage-expressed Tryptophan-rich Protein Plays an Auxiliary Role in Plasmodium Liver Stage Development and Is a Potential Vaccine Candidate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCUMSPOROZOITE PROTEIN; MALARIA PARASITE; PROTECTIVE IMMUNITY; T-CELLS; IMMUNIZATION; INFECTION; ANTIGEN; BERGHEI; FALCIPARUM; MOSQUITO	The liver stages of the malaria parasite are clinically silent and constitute ideal targets for causal prophylactic drugs and vaccines. Cellular and molecular events responsible for liver stage development are poorly characterized. Here, we show that sporozoite, liver stage tryptophan-rich protein (SLTRiP) forms large multimers. Mice immunized with a purified recombinant SLTRiP protein gave high antibody titers in both inbred and outbred mice. Immunized mice showed highly significant levels of protection upon challenge with sporozoites and exhibited 10,000-fold fewer parasite 18S-rRNA copy numbers in their livers. The protection offered by immunization with SLTRiP came mainly from T-cells, and antibodies had little role to play despite their high titers. Immunofluorescence assays showed that SLTRiP is expressed in the sporozoite and early to late liver stages of malaria parasites. SLTRiP protein is exported to the cytosol of infected host cells during the early hours of parasite infection. Parasites deficient in SLTRiP were moderately defective in liver stage parasite development. A transcriptome profile of SLTRiP-deficient parasite-infected hepatocytes highlighted that SLTRiP interferes with multiple pathways in the host cell. We have demonstrated a role for SLTRiP in sporozoites and the liver stage of malaria parasites.	[Jaijyan, Dabbu Kumar; Singh, Himanshu; Singh, Agam Prasad] Natl Inst Immunol, Infect Dis Lab, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Singh, AP (corresponding author), Natl Inst Immunol, Infect Dis Lab, Aruna Asaf Ali Marg, New Delhi 110067, India.	singhap@nii.res.in	singh, Agam prasad/F-2532-2012; Singh, Agam/AAH-2031-2020	singh, Agam prasad/0000-0003-4262-2556; Singh, Agam/0000-0003-4262-2556	Department of Biotechnology, Government of India [BT/HRD/35/02/13/2008]; NII core grant	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); NII core grant	This work was supported in part by Ramalingaswami Fellowship Grant BT/HRD/35/02/13/2008 from the Department of Biotechnology, Government of India, conferred (to A. P. S.) and generous funding from an NII core grant. The authors declare that they have no conflicts of interest with the contents of this article.	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Albuquerque SS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-270; Aly ASI, 2009, ANNU REV MICROBIOL, V63, P195, DOI 10.1146/annurev.micro.091208.073403; Amino R, 2006, NAT MED, V12, P220, DOI 10.1038/nm1350; Arndt Claudia, 2012, Methods Mol Biol, V869, P49, DOI 10.1007/978-1-61779-821-4_5; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Broer R, 2006, J VIROL, V80, P1302, DOI 10.1128/JVI.80.3.1302-1310.2006; Burns JM, 1999, INFECT IMMUN, V67, P675, DOI 10.1128/IAI.67.2.675-680.1999; CLYDE DF, 1975, AM J TROP MED HYG, V24, P397, DOI 10.4269/ajtmh.1975.24.397; de Chassey B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003440; Frevert U, 2005, PLOS BIOL, V3, P1034, DOI 10.1371/journal.pbio.0030192; Garg S, 2008, MICROBES INFECT, V10, P1097, DOI 10.1016/j.micinf.2008.05.008; Gruner AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001371; Hill AVS, 2010, HUM VACCINES, V6, P78, DOI 10.4161/hv.6.1.10116; Hoffman SL, 2000, NAT MED, V6, P1218, DOI 10.1038/81315; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Ingmundson A, 2012, MOL MICROBIOL, V83, P1229, DOI 10.1111/j.1365-2958.2012.08004.x; Ishino T, 2005, CELL MICROBIOL, V7, P199, DOI 10.1111/j.1462-5822.2004.00447.x; Ishino T, 2004, PLOS BIOL, V2, P77, DOI 10.1371/journal.pbio.0020004; Jalah R, 2005, MOL BIOCHEM PARASIT, V142, P158, DOI 10.1016/j.molbiopara.2005.01.020; Jensen KDC, 2013, INFECT IMMUN, V81, P2156, DOI 10.1128/IAI.01185-12; Jobe O, 2007, J INFECT DIS, V196, P599, DOI 10.1086/519743; Kappe SHI, 2011, SCIENCE, V334, P460, DOI 10.1126/science.1213934; KHAN ZM, 1992, INFECT IMMUN, V60, P264, DOI 10.1128/IAI.60.1.264-270.1992; Kitagawa Y, 2011, J VIROL, V85, P4606, DOI 10.1128/JVI.02012-10; Komla-Soukha I, 2006, J VIROL, V80, P4648, DOI 10.1128/JVI.80.10.4648-4655.2006; Kumar KA, 2004, J IMMUNOL METHODS, V292, P157, DOI 10.1016/j.jim.2004.06.017; Kumar KA, 2006, NATURE, V444, P937, DOI 10.1038/nature05361; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; MELLOUK S, 1990, LANCET, V335, P721, DOI 10.1016/0140-6736(90)90832-P; Mikolajczak SA, 2007, INT J PARASITOL, V37, P483, DOI 10.1016/j.ijpara.2007.01.002; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; Mueller AK, 2005, P NATL ACAD SCI USA, V102, P3022, DOI 10.1073/pnas.0408442102; Olotu A, 2011, LANCET INFECT DIS, V11, P102, DOI 10.1016/S1473-3099(10)70262-0; Orito Y, 2013, MOL MICROBIOL, V87, P66, DOI 10.1111/mmi.12083; Pinzon-Charry A, 2008, EXPERT OPIN BIOL TH, V8, P441, DOI [10.1517/14712598.8.4.441, 10.1517/14712598.8.4.441 ]; Plassmeyer ML, 2009, J BIOL CHEM, V284, P26951, DOI 10.1074/jbc.M109.013706; Prudencio M, 2006, NAT REV MICROBIOL, V4, P849, DOI 10.1038/nrmicro1529; Sacarlal J, 2009, J INFECT DIS, V200, P329, DOI 10.1086/600119; Silvie O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000086; Singh AP, 2007, CELL, V131, P492, DOI 10.1016/j.cell.2007.09.013; Skariah S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046621; Sturm A, 2006, SCIENCE, V313, P1287, DOI 10.1126/science.1129720; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; Tsuji M, 2003, TRENDS PARASITOL, V19, P88, DOI 10.1016/S1471-4922(02)00053-3; van Dijk MR, 2005, P NATL ACAD SCI USA, V102, P12194, DOI 10.1073/pnas.0500925102; Vaughan AM, 2012, CURR OPIN IMMUNOL, V24, P324, DOI 10.1016/j.coi.2012.03.009; WEISS WR, 1988, P NATL ACAD SCI USA, V85, P573, DOI 10.1073/pnas.85.2.573	51	11	11	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19496	19511		10.1074/jbc.M114.588129	http://dx.doi.org/10.1074/jbc.M114.588129			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	25960542	hybrid, Green Published			2022-12-26	WOS:000359364600011
J	Imai, N; Suzuki, M; Hayashi, K; Ishigami, M; Hirooka, Y; Abe, T; Shioi, G; Goto, H; Fujimoto, T				Imai, Norihiro; Suzuki, Michitaka; Hayashi, Kazuhiko; Ishigami, Masatoshi; Hirooka, Yoshiki; Abe, Takaya; Shioi, Go; Goto, Hidemi; Fujimoto, Toyoshi			Hepatocyte-Specific Depletion of UBXD8 Induces Periportal Steatosis in Mice Fed a High-Fat Diet	PLOS ONE			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; LIVER CELL-CULTURE; LIPID DROPLETS; SECRETION; MOUSE; VLDL; STEATOHEPATITIS; DEGRADATION; CHOLESTEROL; DEFICIENCY	We showed previously that UBXD8 plays a key role in proteasomal degradation of lipidated ApoB in hepatocarcinoma cell lines. In the present study, we aimed to investigate the functions of UBXD8 in liver in vivo. For this purpose, hepatocyte-specific UBXD8 knockout (UBXD8-LKO) mice were generated. They were fed with a normal or high-fat diet, and the phenotypes were compared with those of littermate control mice. Hepatocytes obtained from UBXD8-LKO and control mice were analyzed in culture. After 26 wk of a high-fat diet, UBXD8-LKO mice exhibited macrovesicular steatosis in the periportal area and microvesicular steatosis in the perivenular area, whereas control mice exhibited steatosis only in the perivenular area. Furthermore, UBXD8-LKO mice on a high-fat diet had significantly lower concentrations of serum triglyceride and VLDL than control mice. A Triton WR-1339 injection study revealed that VLDL secretion from hepatocytes was reduced in UBXD8-LKO mice. The decrease of ApoB secretion upon UBXD8 depletion was recapitulated in cultured primary hepatocytes. Accumulation of lipidated ApoB in lipid droplets was observed only in UBXD8-null hepatocytes. The results showed that depletion of UBXD8 in hepatocytes suppresses VLDL secretion, and could lead to periportal steatosis when mice are fed a high-fat diet. This is the first demonstration that an abnormality in the intracellular ApoB degradation mechanism can cause steatosis, and provides a useful model for periportal steatosis, which occurs in several human diseases.	[Imai, Norihiro; Suzuki, Michitaka; Fujimoto, Toyoshi] Nagoya Univ, Grad Sch Med, Dept Anat & Mol Cell Biol, Nagoya, Aichi 4648601, Japan; [Imai, Norihiro; Hayashi, Kazuhiko; Ishigami, Masatoshi; Hirooka, Yoshiki; Goto, Hidemi] Nagoya Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Nagoya, Aichi 4648601, Japan; [Abe, Takaya; Shioi, Go] RIKEN Ctr Dev Biol, Lab Anim Resources & Genet Engn, Kobe, Hyogo, Japan	Nagoya University; Nagoya University; RIKEN	Fujimoto, T (corresponding author), Nagoya Univ, Grad Sch Med, Dept Anat & Mol Cell Biol, Nagoya, Aichi 4648601, Japan.	tfujimot@med.nagoya-u.ac.jp	Fujimoto, Toyoshi/ABH-9058-2020; Hayashi, Kazuhiko/I-7382-2014; Hirooka, Yoshiki/I-7351-2014	Fujimoto, Toyoshi/0000-0002-3601-7977; Hayashi, Kazuhiko/0000-0002-7919-6071; Hirooka, Yoshiki/0000-0001-9639-7425	Ministry of Education, Culture, Sports, Science, and Technology of the Japanese Government [26860131, 24390045, 25126710]; Grants-in-Aid for Scientific Research [15H05897] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of the Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research of the Ministry of Education, Culture, Sports, Science, and Technology of the Japanese Government (to MS [26860131] and TF [24390045, 25126710]). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspichueta P, 2005, J LIPID RES, V46, P1017, DOI 10.1194/jlr.M500003-JLR200; Braeuning A, 2006, FEBS J, V273, P5051, DOI 10.1111/j.1742-4658.2006.05503.x; Brodsky JL, 2008, TRENDS ENDOCRIN MET, V19, P254, DOI 10.1016/j.tem.2008.07.002; Brunt EM, 2007, MODERN PATHOL, V20, pS40, DOI 10.1038/modpathol.3800680; Cano A, 2011, HEPATOLOGY, V54, P1975, DOI 10.1002/hep.24607; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Cole LK, 2012, BBA-MOL CELL BIOL L, V1821, P754, DOI 10.1016/j.bbalip.2011.09.009; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Fisher EA, 2012, BBA-MOL CELL BIOL L, V1821, P778, DOI 10.1016/j.bbalip.2012.02.001; FOLCH J, 1957, J BIOL CHEM, V226, P497; Ganz M, 2014, WORLD J GASTROENTERO, V20, P8525, DOI 10.3748/wjg.v20.i26.8525; Geller SA, 2012, BIOPSY INTERPRETATIO; Gibbons GF, 2000, BBA-MOL CELL BIOL L, V1483, P37, DOI 10.1016/S1388-1981(99)00182-1; Guo F, 2013, J LIPID RES, V54, P2109, DOI 10.1194/jlr.M035519; Hebbard L, 2011, NAT REV GASTRO HEPAT, V8, P34, DOI 10.1038/nrgastro.2010.191; Hussain MM, 2003, J LIPID RES, V44, P22, DOI 10.1194/jlr.R200014-JLR200; Imajo K, 2013, INT J MOL SCI, V14, P21833, DOI 10.3390/ijms141121833; JUNGERMANN K, 1989, PHYSIOL REV, V69, P708, DOI 10.1152/physrev.1989.69.3.708; Kang S, 2000, BBA-MOL CELL BIOL L, V1529, P223, DOI 10.1016/S1388-1981(00)00151-7; Kimura F., 2013, J BIOL MACROMOL, V13, P21; KLAUNIG JE, 1981, IN VITRO CELL DEV B, V17, P913; KLAUNIG JE, 1981, IN VITRO CELL DEV B, V17, P926; Larter CZ, 2008, J HEPATOL, V49, P407, DOI 10.1016/j.jhep.2008.03.026; Lee JN, 2010, P NATL ACAD SCI USA, V107, P21424, DOI 10.1073/pnas.1011859107; Li XH, 1996, J LIPID RES, V37, P210; Lin XB, 2005, AM J PHYSIOL-GASTR L, V289, pG146, DOI 10.1152/ajpgi.00309.2004; Martinez-Una M, 2015, J HEPATOL, V62, P673, DOI 10.1016/j.jhep.2014.10.019; Meex SJR, 2011, J LIPID RES, V52, P152, DOI 10.1194/jlr.D008888; Musso G, 2009, PROG LIPID RES, V48, P1, DOI 10.1016/j.plipres.2008.08.001; Ohsaki Y, 2008, J CELL SCI, V121, P2415, DOI 10.1242/jcs.025452; Ohsaki Y, 2006, MOL BIOL CELL, V17, P2674, DOI 10.1091/mbc.E05-07-0659; Ohsaki Y, 2014, CHEM BIOL, V21, P86, DOI 10.1016/j.chembiol.2013.08.009; Olofsson SO, 2012, ARTERIOSCL THROM VAS, V32, P1334, DOI 10.1161/ATVBAHA.112.251116; Raabe M, 1999, J CLIN INVEST, V103, P1287, DOI 10.1172/JCI6576; Schonfeld G, 2003, J LIPID RES, V44, P470, DOI 10.1194/jlr.M200342-JLR200; Smith BW, 2011, CRIT REV CL LAB SCI, V48, P97, DOI 10.3109/10408363.2011.596521; Spitzer M, 2014, NAT METHODS, V11, P121, DOI 10.1038/nmeth.2811; Suzuki M, 2012, MOL BIOL CELL, V23, P800, DOI 10.1091/mbc.E11-11-0950; Tiwari S, 2012, ARTERIOSCL THROM VAS, V32, P1079, DOI 10.1161/ATVBAHA.111.241471; Usui S, 2002, J LIPID RES, V43, P805; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Weston SR, 2005, HEPATOLOGY, V41, P372, DOI 10.1002/hep.20554; Wu JW, 2011, HEPATOLOGY, V54, P122, DOI 10.1002/hep.24338; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018	44	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0127114	10.1371/journal.pone.0127114	http://dx.doi.org/10.1371/journal.pone.0127114			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970332	Green Published, gold, Green Submitted			2022-12-26	WOS:000354544200151
J	Satomura, A; Kuroda, K; Ueda, M				Satomura, Atsushi; Kuroda, Kouichi; Ueda, Mitsuyoshi			Generation of a Functionally Distinct Rhizopus oryzae Lipase through Protein Folding Memory	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; INTRAMOLECULAR CHAPERONES; TRIGLYCERIDE LIPASE; EXPRESSION; STABILIZATION; PROSEQUENCE; REQUIREMENT; MUTAGENESIS; SUBTILISIN; SEQUENCE	Rhizopus oryzae lipase (ROL) has a propeptide at its N-terminus that functions as an intramolecular chaperone and facilitates the folding of mature ROL (mROL). In this study, we successfully generated a functionally distinct imprinted mROL (mROL(imp)) through protein folding memory using a mutated propeptide. The mutated propeptide left its structural memory on mROL and produced mROLimp that exhibited different substrate specificities compared with mROL(WT) (prepared from the wild type propeptide), although the amino acid sequences of both mROLs were the same. mROL(imp) showed a preference for substrates with medium chain-length acyl groups and, noticeably, recognized a peptidase-specific substrate. In addition, ROLimp was more stable than mROL(WT). These results strongly suggest that proteins with identical amino acid sequences can fold into different conformations and that mutations in intramolecular chaperones can dynamically induce changes in enzymatic activity.	[Satomura, Atsushi; Kuroda, Kouichi; Ueda, Mitsuyoshi] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto, Japan; [Satomura, Atsushi] Japan Soc Promot Sci, Sakyo Ku, Kyoto, Japan	Kyoto University; Japan Society for the Promotion of Science	Ueda, M (corresponding author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto, Japan.	miueda@kais.kyoto-u.ac.jp	Kuroda, Kouichi/AAQ-3678-2021	Kuroda, Kouichi/0000-0002-9249-0486	Japan Society for the Promotion of Science [26-1413]; Core Research for Evolutional Science and Technology, Japan Science and Technology Agency [26-1413];  [25289293]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Core Research for Evolutional Science and Technology, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); 	This work was supported by a research fellowship from the Japan Society for the Promotion of Science for Young Scientists (grant 26-1413, http://www.jsps.go.jp/j-pd/index.html); Core Research for Evolutional Science and Technology, Japan Science and Technology Agency (http://www.jst.go.jp/kisoken/crest/); and a Grant-in-Aid for Scientific Research (B) (grant 25289293, http://www.jsps.go.jp/english/egrants/grants01.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander PA, 2007, P NATL ACAD SCI USA, V104, P11963, DOI 10.1073/pnas.0700922104; ANFINSEN CB, 1972, BIOCHEM J, V128, P737, DOI 10.1042/bj1280737; Barnita Ghosh, 2011, Journal of Applied Sciences, V11, P2470, DOI 10.3923/jas.2011.2470.2486; Beer HD, 1996, BIOCHEM J, V319, P351, DOI 10.1042/bj3190351; BOEL E, 1988, LIPIDS, V23, P701, DOI 10.1007/BF02535672; Brady L, 1990, SERINE PROTEASE TRIA; BRZOZOWSKI AM, 1991, NATURE, V351, P491, DOI 10.1038/351491a0; Dalal S, 1997, NAT STRUCT BIOL, V4, P548, DOI 10.1038/nsb0797-548; DEREWENDA U, 1992, BIOCHEMISTRY-US, V31, P1532, DOI 10.1021/bi00120a034; DEREWENDA ZS, 1992, J MOL BIOL, V227, P818, DOI 10.1016/0022-2836(92)90225-9; EMMERICH J, 1992, J BIOL CHEM, V267, P4161; Ghozlane A, 2009, BIOINFORMATION, V3, P367, DOI 10.6026/97320630003367; HAAS MJ, 1991, GENE, V109, P107, DOI 10.1016/0378-1119(91)90594-2; Haas MJ, 1999, FETT-LIPID, V101, P364, DOI 10.1002/(SICI)1521-4133(199910)101:10<364::AID-LIPI364>3.0.CO;2-0; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; IKEMURA H, 1987, J BIOL CHEM, V262, P7859; INOUYE M, 1991, ENZYME, V45, P314, DOI 10.1159/000468904; Kuroda K, 2013, BIOMOLECULES, V3, DOI 10.3390/biom3030632; Mezei M, 1998, PROTEIN ENG, V11, P411, DOI 10.1093/protein/11.6.411; Minning S, 1998, J BIOTECHNOL, V66, P147, DOI 10.1016/S0168-1656(98)00142-4; Nagayama M, 2012, BIOCHEMISTRY-US, V51, P3547, DOI 10.1021/bi3001159; RAMOS C, 1994, J BIOL CHEM, V269, P7006; ROBERTUS JD, 1972, BIOCHEMISTRY-US, V11, P4293, DOI 10.1021/bi00773a016; Shibamoto H, 2004, J MOL CATAL B-ENZYM, V28, P235, DOI 10.1016/j.molcatb.2003.11.021; Shinde U, 1999, J BIOL CHEM, V274, P15615, DOI 10.1074/jbc.274.22.15615; Shinde UP, 1997, NATURE, V389, P520, DOI 10.1038/39097; Shiraga S, 2005, APPL MICROBIOL BIOT, V68, P779, DOI 10.1007/s00253-005-1935-0; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Susanne OS, 1994, EUR J BIOCHEM, V220, P19; Takahashi S, 1998, J FERMENT BIOENG, V86, P164, DOI 10.1016/S0922-338X(98)80055-X; Takahashi S, 2001, APPL MICROBIOL BIOT, V55, P454, DOI 10.1007/s002530000537; Takahashi S, 1999, APPL MICROBIOL BIOT, V52, P534, DOI 10.1007/s002530051556; Ueda M, 2002, J MOL CATAL B-ENZYM, V17, P113, DOI 10.1016/S1381-1177(02)00018-8	33	12	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0124545	10.1371/journal.pone.0124545	http://dx.doi.org/10.1371/journal.pone.0124545			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970342	gold, Green Published, Green Submitted			2022-12-26	WOS:000354544200041
J	Konno, S; Suzuki, S; Masuda, M; Nagane, Y; Tsuda, E; Murai, H; Imai, T; Fujioka, T; Suzuki, N; Utsugisawa, K				Konno, Shingo; Suzuki, Shigeaki; Masuda, Masayuki; Nagane, Yuriko; Tsuda, Emiko; Murai, Hiroyuki; Imai, Tomihiro; Fujioka, Toshiki; Suzuki, Norihiro; Utsugisawa, Kimiaki			Association between Glucocorticoid-Induced Osteoporosis and Myasthenia Gravis: A Cross-Sectional Study	PLOS ONE			English	Article							DENSITY	Purpose To investigate the association between glucocorticoid-induced osteoporosis and myasthenia gravis (MG) using a cross-sectional survey in Japan. Methods We studied 363 patients with MG (female 68%; mean age, 57 +/- 16 years) who were followed at six Japanese centers between April and July 2012. We evaluated the clinical information of MG and fractures, bone markers, and radiological assessment. Quality of life was measured using an MG-specific battery, MG-QOL15. Results Glucocorticoids were administered in 283 (78%) of 363 MG patients. Eighteen (6%) of 283 MG patients treated with prednisolone had a history of osteoporotic fractures. The duration of glucocorticoid therapy, but not the dose of prednisolone, was associated with the osteoporotic fractures in MG patients. Bone mineral density was significantly decreased in the MG patients with fractures. The multivariate analyses showed that the total quantitative MG score was the only independent factor associated with osteoporotic fractures (OR = 1.30, 95% CI 1.02-1.67, p = 0.03). MG patients who had experienced fractures reported more severe difficulties in activities of daily living. Conclusion Glucocorticoid-induced osteoporosis aggravates quality of life in patients with MG.	[Konno, Shingo; Fujioka, Toshiki] Toho Univ, Ohashi Med Ctr, Dept Neurol, Tokyo, Japan; [Suzuki, Shigeaki] Keio Univ, Sch Med, Dept Neurol, Tokyo, Japan; [Masuda, Masayuki] Tokyo Med Univ, Dept Neurol, Tokyo 1608402, Japan; [Nagane, Yuriko; Utsugisawa, Kimiaki] Hanamaki Gen Hosp, Dept Neurol, Hanamaki, Iwate, Japan; [Tsuda, Emiko; Imai, Tomihiro] Sapporo Med Univ, Dept Neurol, Sapporo, Hokkaido, Japan; [Murai, Hiroyuki] Kyushu Univ, Grad Sch Med Sci, Neurol Inst, Dept Neurol, Fukuoka 812, Japan	Toho University; Keio University; Tokyo Medical University; Sapporo Medical University; Kyushu University	Suzuki, S (corresponding author), Keio Univ, Sch Med, Dept Neurol, Tokyo, Japan.	sgsuzuki@z3.keio.jp	Suzuki, Shigeaki/N-9555-2013; Suzuki, Norihiro/J-5125-2013	Suzuki, Norihiro/0000-0002-0399-6590	Japanese Ministry of Education, Science, Sports and Culture [26461298]; Health and Labor Sciences Research Grant on Intractable Diseases (Neuroimmunological Diseases) from the Ministry of Health, Labor and Welfare of Japan	Japanese Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health and Labor Sciences Research Grant on Intractable Diseases (Neuroimmunological Diseases) from the Ministry of Health, Labor and Welfare of Japan	Support was received in the form of a grant from the Japanese Ministry of Education, Science, Sports and Culture (no. 26461298); and a Health and Labor Sciences Research Grant on Intractable Diseases (Neuroimmunological Diseases) from the Ministry of Health, Labor and Welfare of Japan.	Jacobs J, 2013, OSTEOPOROSIS INT, V24, P1827, DOI 10.1007/s00198-012-2157-9; Jaretzki A, 2000, NEUROLOGY, V55, P16, DOI 10.1212/WNL.55.1.16; Kanis JA, 2011, OSTEOPOROSIS INT, V22, P809, DOI 10.1007/s00198-010-1524-7; Lee YH, 2008, J INVEST MED, V56, P1011, DOI 10.2310/JIM.0b013e31818e82d7; Masuda M, 2012, MUSCLE NERVE, V46, P166, DOI 10.1002/mus.23398; Meriggioli MN, 2009, LANCET NEUROL, V8, P475, DOI 10.1016/S1474-4422(09)70063-8; Pouwels S, 2013, OSTEOPOROSIS INT, V24, P467, DOI 10.1007/s00198-012-1970-5; Wakata N, 2004, CLIN NEUROL NEUROSUR, V106, P139, DOI 10.1016/j.clineuro.2003.12.001; Weinstein RS, 2011, NEW ENGL J MED, V365, P62, DOI 10.1056/NEJMcp1012926; Yeh JH, 2014, NEUROLOGY, V83, P1075, DOI 10.1212/WNL.0000000000000804	10	11	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0126579	10.1371/journal.pone.0126579	http://dx.doi.org/10.1371/journal.pone.0126579			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965387	Green Published, gold, Green Submitted			2022-12-26	WOS:000354543500067
J	Mueller, KAL; Mueller, II; Eppler, D; Zuern, CS; Seizer, P; Kramer, U; Koetter, I; Roecken, M; Kandolf, R; Gawaz, M; Geisler, T; Henes, JC; Klingel, K				Mueller, Karin A. L.; Mueller, Iris I.; Eppler, David; Zuern, Christine S.; Seizer, Peter; Kramer, Ulrich; Koetter, Ina; Roecken, Martin; Kandolf, Reinhard; Gawaz, Meinrad; Geisler, Tobias; Henes, Joerg C.; Klingel, Karin			Clinical and Histopathological Features of Patients with Systemic Sclerosis Undergoing Endomyocardial Biopsy	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; SCLERODERMA RENAL CRISIS; BONE-MARROW-TRANSPLANTATION; AMERICAN-HEART-ASSOCIATION; HIGH-DOSE CYCLOPHOSPHAMIDE; LONG-TERM OUTCOMES; ENTEROVIRUS MYOCARDITIS; IMMUNOSUPPRESSIVE THERAPY; PULSE CYCLOPHOSPHAMIDE; SUSPECTED MYOCARDITIS	Background Cardiac involvement in systemic sclerosis (SSc) is associated with a variable phenotype including heart failure, arrhythmias and pulmonary hypertension. The aim of the present study was to evaluate clinical characteristics, histopathological findings and outcome of patients with SSc and a clinical phenotype suggesting cardiac involvement. Methods and Results 25 patients with SSc and clinical signs of cardiac involvement were included between June 2007 and December 2010. They underwent routine clinical work-up including laboratory testing, echocardiography, left and right heart catheterization, holter recordings and endo-myocardial biopsy. Primary endpoint (EP) was defined as the combination of cardiovascular death, arrhythmic endpoints (defined as appropriate discharge of implantable cardioverter defibrillator (ICD)) or rehospitalization due to heart failure. The majority of patients presented with slightly impaired left ventricular function (mean LVEF 54.1 +/- 9.0%, determined by echocardiography). Endomyocardial biopsies detected cardiac fibrosis in all patients with a variable area percentage of 8% to 32%. Cardiac inflammation was diagnosed as follows: No inflammation in 3.8%, isolated inflammatory cells in 38.5%, a few foci of inflammation in 30.8%, several foci of inflammation in 15.4%, and pronounced inflammation in 7.7% of patients. During follow up (FU) (22.5 months), seven (28%) patients reached the primary EP. Patients with subsequent events showed a higher degree of fibrosis and inflammation in the myocardium by trend. While patients with an inflammation grade 0 or 1 showed an event rate of 18.2%, the subgroup of patients with an inflammation grade 2 presented with an event rate of 25% versus an event rate of 50% in the subgroup of patients with an inflammation grade 3 and 4, respectively (p=0.193). Furthermore, the subgroup of patients with fibrosis grade 1 showed an event rate of 11%, patients with fibrosis grade 2 and 3 presented with an event rate of 33% and 42% respectively (p = 0.160). Conclusions Patients with SSc and clinical signs of cardiac involvement presented with mildly impaired LVEF. Prognosis was poor with an event rate of 28% within 22.5 months FU and was associated with the degree of cardiac inflammation and fibrosis.	[Mueller, Karin A. L.; Mueller, Iris I.; Eppler, David; Zuern, Christine S.; Seizer, Peter; Gawaz, Meinrad; Geisler, Tobias] Eberhard Karls Univ Klinikum Tuebingen, Med Klin 3, Kardiol & Kreislauferkrankungen, Tubingen, Germany; [Kramer, Ulrich] Eberhard Karls Univ Klinikum Tuebingen, Inst Radiol, Tubingen, Germany; [Koetter, Ina; Henes, Joerg C.] Eberhard Karls Univ Hosp Tuebingen, Ctr Interdisciplinary Clin Immunol Rheumatol & Au, Tubingen, Germany; [Koetter, Ina; Henes, Joerg C.] Eberhard Karls Univ Hosp Tuebingen, Dept Internal Med Oncol Haematol Immunol Rheumato, Tubingen, Germany; [Roecken, Martin] Eberhard Karls Univ Klinikum Tuebingen, Hautklin, Tubingen, Germany; [Kandolf, Reinhard; Klingel, Karin] Eberhard Karls Univ Klinikum Tuebingen, Abt Mol Pathol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Geisler, T (corresponding author), Eberhard Karls Univ Klinikum Tuebingen, Med Klin 3, Kardiol & Kreislauferkrankungen, Tubingen, Germany.	tobias.geisler@med.uni-tuebingen.de	Koetter, Ina/O-3121-2019; Geisler, Tobias/AAO-4472-2020	Koetter, Ina/0000-0002-9262-005X; Zuern, Christine/0000-0001-6625-284X; Rocken, Martin/0000-0003-3795-7001	Deutsche Forschungsgemeinschaft [SFB TR19]; Klinische Forschergruppe [KFO 274]; Eberhard Karls - University Tuebingen	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Klinische Forschergruppe; Eberhard Karls - University Tuebingen	This study was supported by the Deutsche Forschungsgemeinschaft (SFB TR19 "Inflammatory Cardiomyopathy"), the Klinische Forschergruppe (KFO 274 "Platelets-Molecular Mechanisms and Translational Implications"), and the Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of the Eberhard Karls - University Tuebingen.	Altorok N, 2014, RHEUMATOLOGY OXFORD; APPELBAUM FR, 1976, LANCET, V1, P58; AYASH LJ, 1992, J CLIN ONCOL, V10, P995, DOI 10.1200/JCO.1992.10.6.995; Bashandy HG, 2006, SOUTH MED J, V99, P870, DOI 10.1097/01.smj.0000229871.68911.67; Basso C, 2013, HEART FAIL REV, V18, P673, DOI 10.1007/s10741-012-9355-6; Beranek JT, 2001, INT J CARDIOL, V80, P261, DOI 10.1016/S0167-5273(01)00490-9; Bernardo P, 2011, J RHEUMATOL, V38, P1617, DOI 10.3899/jrheum.100480; Bock C, 2010, NEW ENGL J MED, V362, P1248, DOI 10.1056/NEJMc0911362; BULKLEY BH, 1976, CIRCULATION, V53, P483, DOI 10.1161/01.CIR.53.3.483; Burt RK, 2013, LANCET, V381, P1116, DOI 10.1016/S0140-6736(12)62114-X; Burt RK, 2012, J RHEUMATOL, V39, P206, DOI 10.3899/jrheum.111302; Burt RK, 2011, LANCET, V378, P498, DOI 10.1016/S0140-6736(11)60982-3; CARETTE S, 1985, J RHEUMATOL, V12, P997; CHEN TL, 1995, CANCER RES, V55, P810; CLEMSON BS, 1992, CHEST, V101, P872, DOI 10.1378/chest.101.3.872; Coghlan JG, 2001, CURR OPIN RHEUMATOL, V13, P495, DOI 10.1097/00002281-200111000-00008; Cooper LT, 2007, CIRCULATION, V116, P2216, DOI 10.1161/CIRCULATIONAHA.107.186093; Czirjak L, 2008, ANN RHEUM DIS, V67, P59, DOI 10.1136/ard.2006.066340; DANGELO WA, 1969, AM J MED, V46, P428, DOI 10.1016/0002-9343(69)90044-8; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Diez Javier, 2007, J Clin Hypertens (Greenwich), V9, P546, DOI 10.1111/j.1524-6175.2007.06626.x; Elhai M, 2014, ANN RHEUM DIS; Elhai M, 2012, RHEUMATOLOGY, V51, P1017, DOI 10.1093/rheumatology/ker269; Elliott P, 2008, EUR HEART J, V29, P270, DOI 10.1093/eurheartj/ehm342; Farge D, 2010, HAEMATOL-HEMATOL J, V95, P284, DOI 10.3324/haematol.2009.013458; Fernandes F, 2003, J CARD FAIL, V9, P311, DOI 10.1054/jcaf.2003.51; Ferri C, 2002, MEDICINE, V81, P139, DOI 10.1097/00005792-200203000-00004; Fisher MR, 2009, AM J RESP CRIT CARE, V179, P615, DOI 10.1164/rccm.200811-1691OC; FOLLANSBEE WP, 1990, J RHEUMATOL, V17, P656; Goh NSL, 2008, AM J RESP CRIT CARE, V177, P1248, DOI 10.1164/rccm.200706-877OC; GOLDBERG MA, 1986, BLOOD, V68, P1114; GOTTDIENER JS, 1981, ARCH INTERN MED, V141, P758, DOI 10.1001/archinte.141.6.758; GROGAN M, 1995, J AM COLL CARDIOL, V26, P80, DOI 10.1016/0735-1097(95)00148-S; Hachulla AL, 2009, ANN RHEUM DIS, V68, P1878, DOI 10.1136/ard.2008.095836; Haviv YS, 1998, RENAL FAILURE, V20, P733, DOI 10.3109/08860229809045170; HELFRICH DJ, 1989, ARTHRITIS RHEUM, V32, P1128, DOI 10.1002/anr.1780320911; Henes JC, 2014, RHEUMATOLOGY, V53, P919, DOI 10.1093/rheumatology/ket464; Henes JC, 2012, J RHEUMATOL, V39, P269, DOI 10.3899/jrheum.110868; Ioannidis JPA, 2005, AM J MED, V118, P2, DOI 10.1016/j.amjmed.2004.04.031; Jiang L, 1997, ECHOCARDIOGR-J CARD, V14, P189, DOI 10.1111/j.1540-8175.1997.tb00711.x; Kahan A, 2006, RHEUMATOLOGY, V45, P14, DOI 10.1093/rheumatology/kel312; KERR LD, 1993, CLIN CARDIOL, V16, P895, DOI 10.1002/clc.4960161212; Kindermann I, 2008, CIRCULATION, V118, P639, DOI 10.1161/CIRCULATIONAHA.108.769489; Klingel K, 1996, J VIROL, V70, P8888, DOI 10.1128/JVI.70.12.8888-8895.1996; Kobayashi H, 2009, J RHEUMATOL, V36, P106, DOI 10.3899/jrheum.080377; Kohno K, 2000, CLIN NEPHROL, V53, P479; Lang C, 2008, J MOL MED-JMM, V86, P49, DOI 10.1007/s00109-007-0249-3; Leone O, 2012, CARDIOVASC PATHOL, V21, P245, DOI 10.1016/j.carpath.2011.10.001; Liangos O, 2000, RHEUMATOLOGY, V39, P674, DOI 10.1093/rheumatology/39.6.674; Mahrholdt H, 2004, CIRCULATION, V109, P1250, DOI 10.1161/01.CIR.0000118493.13323.81; Mahrholdt H, 2006, CIRCULATION, V114, P1581, DOI 10.1161/CIRCULATIONAHA.105.606509; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; MEDSGER TA, 1973, J CHRON DIS, V26, P647, DOI 10.1016/0021-9681(73)90054-4; Murata I, 1998, AM HEART J, V135, P960, DOI 10.1016/S0002-8703(98)70060-2; Murdych T, 2001, BONE MARROW TRANSPL, V28, P283, DOI 10.1038/sj.bmt.1703133; Naraghi K, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0326-2; Nash RA, 2007, BLOOD, V110, P1388, DOI 10.1182/blood-2007-02-072389; Pauschinger M, 2006, CLIN RES CARDIOL, V95, P569, DOI 10.1007/s00392-006-0427-2; Penn H, 2007, QJM-INT J MED, V100, P485, DOI 10.1093/qjmed/hcm052; Perera A, 2007, ARTHRITIS RHEUM, V56, P2740, DOI 10.1002/art.22747; PICKERING JG, 1990, CIRCULATION, V81, P949, DOI 10.1161/01.CIR.81.3.949; Pieroni M, 2014, SEMIN ARTHRITIS RHEU, V43, P526, DOI 10.1016/j.semarthrit.2013.07.006; Rosen O, 2001, BONE MARROW TRANSPL, V27, P657, DOI 10.1038/sj.bmt.1702829; Saccardi R, 2004, Bone Marrow Transplant, V34, P877, DOI 10.1038/sj.bmt.1704656; Salazar GA, 2014, SEMIN ARTHRITIS RHEU; Schanz S, 2013, EUR RADIOL, V23, P212, DOI 10.1007/s00330-012-2584-1; Seizer P, 2011, INT J CARDIOL; Steen VD, 2000, ANN INTERN MED, V133, P600, DOI 10.7326/0003-4819-133-8-200010170-00010; Steen VD, 2000, ARTHRITIS RHEUM-US, V43, P2437, DOI 10.1002/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U; Steen VD, 2007, ANN RHEUM DIS, V66, P940, DOI 10.1136/ard.2006.066068; Szalay G, 2006, AM J PATHOL, V169, P2085, DOI 10.2353/ajpath.2006.060350; Szalay G, 2009, CIRC RES, V104, P851, DOI 10.1161/CIRCRESAHA.109.193805; Tamborini G, 2009, EUR J ECHOCARDIOGR, V10, P630, DOI 10.1093/ejechocard/jep015; Tyndall AJ, 2010, ANN RHEUM DIS, V69, P1809, DOI 10.1136/ard.2009.114264; Tzelepis GE, 2007, ARTHRITIS RHEUM-US, V56, P3827, DOI 10.1002/art.22971; van den Hoogen F, 2013, ARTHRITIS RHEUM-US, V65, P2737, DOI 10.1002/art.38098; van Laar JM, 2014, JAMA-J AM MED ASSOC, V311, P2490, DOI 10.1001/jama.2014.6368; van Laar JM, 2005, ANN RHEUM DIS, V64, P1515, DOI 10.1136/ard.2005.043240; Wielosz E, 2010, POL ARCH MED WEWN, V120, P132, DOI 10.20452/pamw.907; Zuern CS, 2012, EUR J HEART FAIL; Zver S, 2007, INT J HEMATOL, V85, P408, DOI 10.1532/IJH97.E0620	81	50	51	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0126707	10.1371/journal.pone.0126707	http://dx.doi.org/10.1371/journal.pone.0126707			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25966025	Green Submitted, Green Published, gold			2022-12-26	WOS:000354543500073
J	Ponce, D; Buffarah, MB; Goes, C; Balbi, A				Ponce, Daniela; Buffarah, Marina Berbel; Goes, Cassiana; Balbi, Andre			Peritoneal Dialysis in Acute Kidney Injury: Trends in the Outcome across Time Periods	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; CRITICALLY-ILL PATIENTS; AKI; MORTALITY; SURVIVAL; ADEQUATE	Peritoneal dialysis (PD) should be considered a suitable method of renal replacement therapy in acute kidney injury (AKI) patients. This study is the largest cohort providing patient characteristics, clinical practice, patterns and their relationship to outcomes in a developing country. Its objective was to describe the main determinants of patient and technique survival, including trends over time of PD treatment in AKI patients. This was a Brazilian prospective cohort study in which all adult AKI patients on PD were studied from January/2004 to January/2014. For comparison purposes, patients were divided into 2 groups according to the year of treatment: 2004-2008 and 2009-2014. Patient survival and technique failure (TF) were analyzed using the competing risk model of Fine and Gray. A total of 301 patients were included, 51 were transferred to hemodialysis (16.9%) during the study period. The main cause of TF was mechanical complication (47%) followed by peritonitis (41.2%). There was change in TF during the study period: compared to 2004-2008, patients treated at 2009-2014 had relative risk (RR) reduction of 0.86 (95% CI 0.77-0.96) and three independent risk factors were identified: period of treatment at 2009 and 2014, sepsis and age>65 years. There were 180 deaths (59.8%) during the study. Death was the leading cause of dropout (77.9% of all cases) mainly by sepsis (58.3%), followed cardiovascular disease (36.1%). The overall patient survival was 41% at 30 days. Patient survival improved along study periods: compared to 2004-2008, patients treated at 2009-2014 had a RR reduction of 0.87 (95% CI 0.79-0.98). The independent risk factors for mortality were sepsis, age>70 years, ATN-ISS > 0.65 and positive fluid balance. As conclusion, we observed an improvement in patient survival and TF along the years even after correction for several confounders and using a competing risk approach.	[Ponce, Daniela; Buffarah, Marina Berbel; Goes, Cassiana; Balbi, Andre] Univ Sao Paulo State UNESP, Botucatu, SP, Brazil	Universidade Estadual Paulista	Ponce, D (corresponding author), Univ Sao Paulo State UNESP, Botucatu, SP, Brazil.	dponce@fmb.unesp.br	Goes, Cassiana/AFQ-6502-2022; Ponce, Daniela/Q-4221-2019; Balbi, André Luis/O-9278-2016; Balbi, Andre/AAD-9859-2019; Ponce, Daniela/M-8271-2015	Ponce, Daniela/0000-0002-6178-6938; Balbi, André Luis/0000-0001-8366-5064; Balbi, Andre/0000-0001-8366-5064; Ponce, Daniela/0000-0002-6178-6938; Goes, Cassiana/0000-0003-1166-637X				Brown EA, 2003, J AM SOC NEPHROL, V14, P2948, DOI 10.1097/01.ASN.0000092146.67909.E2; Chionh CY, 2013, CLIN J AM SOC NEPHRO, V8, P1649, DOI 10.2215/CJN.01540213; Chionh CY, 2010, NEPHROL DIAL TRANSPL, V25, P3155, DOI 10.1093/ndt/gfq178; Chitalia VC, 2002, KIDNEY INT, V61, P747, DOI 10.1046/j.1523-1755.2002.00177.x; CHUMLEA WC, 1985, J AM GERIATR SOC, V33, P116, DOI 10.1111/j.1532-5415.1985.tb02276.x; Cullis B, 2014, PERITON DIALYSIS INT, V34, P494, DOI 10.3747/pdi.2013.00222; Druml W., 1998, Handbook of nutrition and the kidney., P213; DuBois D, 1915, ARCH INTERN MED, V15, P868; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gabriel DP, 2008, KIDNEY INT, V73, pS87, DOI 10.1038/sj.ki.5002608; Gabriel DP, 2007, PERITON DIALYSIS INT, V27, P277; Gabriel DP, 2006, RENAL FAILURE, V28, P451, DOI 10.1080/0886022060081245; George J, 2011, PERITON DIALYSIS INT, V31, P422, DOI 10.3747/pdi.2009.00231; Honore PM, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-32; KATIRTZOGLOU A, 1983, PERITON DIALYSIS B, V3, P178; Kilonzo KG, 2012, PERITON DIALYSIS INT, V32, P261, DOI 10.3747/pdi.2012.00083; Korbet MS, 2001, HDB DIALYSIS, P333; Levy MM, 2005, CRIT CARE MED, V33, P2194, DOI 10.1097/01.CCM.0000182798.39709.84; LIANO F, 1993, NEPHRON, V63, P21, DOI 10.1159/000187139; Liborio AB, 2015, CLIN J AM SOC NEPHRO, V10, P21, DOI 10.2215/CJN.04750514; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Nolph KD, 1988, ACUTE RENAL FAILURE, P809; Passadakis Ploumis S, 2007, Adv Perit Dial, V23, P7; Phu NH, 2002, NEW ENGL J MED, V347, P895, DOI 10.1056/NEJMoa020074; Ponce D, 2012, BLOOD PURIFICAT, V34, P107, DOI 10.1159/000341648; Ponce D, 2012, CLIN J AM SOC NEPHRO, V7, P887, DOI 10.2215/CJN.11131111; Ponce Daniela, 2011, Adv Perit Dial, V27, P118; Ponce D, 2011, PERITON DIALYSIS INT, V31, P387, DOI 10.3747/pdi.2011.00312; Rao P, 2003, PERITON DIALYSIS INT, V23, P320; Ricci Z, 2006, NEPHROL DIAL TRANSPL, V21, P690, DOI 10.1093/ndt/gfi296; Ronco C, 2007, PERITON DIALYSIS INT, V27, P251; Ronco C, 2006, CONTRIB NEPHROL, V150, P1, DOI 10.1159/000093441; SCHRIER RW, 1979, KIDNEY INT, V15, P205, DOI 10.1038/ki.1979.26; Silversides JA, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0624-8; STEINER RW, 1989, PERITON DIALYSIS INT, V9, P5; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1143, DOI 10.1681/ASN.2005091017; WATSON PE, 1980, AM J CLIN NUTR, V33, P27, DOI 10.1093/ajcn/33.1.27	38	30	32	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0126436	10.1371/journal.pone.0126436	http://dx.doi.org/10.1371/journal.pone.0126436			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965868	gold, Green Published, Green Submitted			2022-12-26	WOS:000354543500059
J	Kim, N; Lee, H; Shin, J; Nam, YS; Im, KI; Lim, JY; Lee, ES; Kang, YN; Park, SH; Cho, SG				Kim, Nayoun; Lee, Hyunji; Shin, Junghoon; Nam, Young-Sun; Im, Keon-Il; Lim, Jung-Yeon; Lee, Eun-Sol; Kang, Young-Nam; Park, Se-Ho; Cho, Seok-Goo			Immune Reconstitution Kinetics following Intentionally Induced Mixed Chimerism by Nonmyeloablative Transplantation	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; DONOR LIVER-TRANSPLANTATION; RENAL-ALLOGRAFT RECIPIENTS; TOTAL-BODY IRRADIATION; T-CELL; LYMPHOHEMATOPOIETIC CHIMERISM; TOLERANCE INDUCTION; MULTIPLE-MYELOMA; KIDNEY ALLOGRAFT	Establishing mixed chimerism is a promising approach for inducing donor-specific transplant tolerance. The establishment and maintenance of mixed chimerism may enable long-term engraftment of organ transplants while minimizing the use of immunosuppressants. Several protocols for inducing mixed chimerism have been reported; however, the exact mechanism underlying the development of immune tolerance remains to be elucidated. Therefore, understanding the kinetics of engraftment during early post-transplant period may provide insight into establishing long-term mixed chimerism and permanent transplant tolerance. In this study, we intentionally induced allogeneic mixed chimerism using a nonmyeloablative regimen by host natural killer (NK) cell depletion and T cell-depleted bone marrow (BM) grafts in a major histocompatibility complex (MHC)-mismatched murine model and analyzed the kinetics of donor (C57BL/6) and recipient (BALB/c) engraftment in the weeks following transplantation. Donor BM cells were well engrafted and stabilized without graft-versus-host disease (GVHD) as early as one week post-bone marrow transplantation (BMT). Donor-derived thymic T cells were reconstituted four weeks after BMT; however, the emergence of newly developed T cells was more obvious at the periphery as early as two weeks after BMT. Also, the emergence and changes in ratio of recipient-and donor-derived NKT cells and antigen presenting cells (APCs) including dendritic cells (DCs) and B cells were noted after BMT. Here, we report a longitudinal analysis of the development of donor- and recipient-originated hematopoietic cells in various lymphatic tissues of intentionally induced mixed chimerism mouse model during early post-transplant period. Through the understanding of immune reconstitution at early time points after nonmyeloablative BMT, we suggest guidelines on intentionally inducing durable mixed chimerism.	[Kim, Nayoun; Nam, Young-Sun; Im, Keon-Il; Lim, Jung-Yeon; Lee, Eun-Sol; Cho, Seok-Goo] Convergent Res Consortium Immunol Dis, Lab Immune Regulat, Seoul, South Korea; [Kim, Nayoun; Nam, Young-Sun; Im, Keon-Il; Lim, Jung-Yeon; Lee, Eun-Sol; Cho, Seok-Goo] Catholic Univ Korea, Coll Med, Inst Translat Res & Mol Imaging, Seoul, South Korea; [Lee, Hyunji; Shin, Junghoon; Park, Se-Ho] Korea Univ, Sch Life Sci & Biotechnol, Seoul, South Korea; [Kang, Young-Nam] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Radiat Oncol, Seoul, South Korea; [Cho, Seok-Goo] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Catholic Blood & Marrow Transplantat Ctr, Seoul, South Korea	Catholic University of Korea; Korea University; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital	Cho, SG (corresponding author), Convergent Res Consortium Immunol Dis, Lab Immune Regulat, Seoul, South Korea.	chosg@catholic.ac.kr		Cho, Seok-Goo/0000-0002-5429-4839	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare, and Family Affairs, Republic of Korea [HI12C071801]	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare, and Family Affairs, Republic of Korea	This study was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare, and Family Affairs, Republic of Korea (HI12C071801). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barao I, 2003, BIOL BLOOD MARROW TR, V9, P727, DOI 10.1016/j.bbmt.2003.09.002; Buhler LH, 2002, TRANSPLANTATION, V74, P1405, DOI 10.1097/01.TP.0000034627.37442.A4; Cho SG, 2006, ARTHRITIS RHEUM-US, V54, P1878, DOI 10.1002/art.21888; Cho SG, 2004, EXP HEMATOL, V32, P1246, DOI 10.1016/j.exphem.2004.08.008; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; Donckier V, 2004, TRANSPL IMMUNOL, V13, P139, DOI 10.1016/j.trim.2004.05.004; Donckier V, 2006, LIVER TRANSPLANT, V12, P1523, DOI 10.1002/lt.20872; Fazekas de St Groth B, 1998, IMMUNOL TODAY, V19, P448; FERRARA JLM, 1987, TRANSPLANTATION, V44, P495, DOI 10.1097/00007890-198710000-00007; Haddad E, 1998, BLOOD, V91, P3646; Hamawi K, 2003, AM J TRANSPLANT, V3, P301, DOI 10.1034/j.1600-6143.2003.00015.x; Haraguchi K, 2004, BONE MARROW TRANSPL, V34, P595, DOI 10.1038/sj.bmt.1704582; HELG C, 1994, TRANSPLANTATION, V58, P1420; JACOBSEN N, 1994, LANCET, V343, P800, DOI 10.1016/S0140-6736(94)91881-3; Jimenez M, 2007, LEUKEMIA, V21, P1628, DOI 10.1038/sj.leu.2404681; Kadry Z, 2003, TRANSPLANTATION, V76, P1003, DOI 10.1097/01.TP.0000083981.82522.13; Kawai T, 2008, NEW ENGL J MED, V358, P353, DOI 10.1056/NEJMoa071074; Luznik L, 2001, BLOOD, V98, P3456, DOI 10.1182/blood.V98.12.3456; Manilay JO, 1998, TRANSPLANTATION, V66, P96, DOI 10.1097/00007890-199807150-00015; Millan TLT, 2002, TRANSPLANTATION, V73, P1386, DOI 10.1097/00007890-200205150-00005; Novitzky N, 2002, TRANSPLANTATION, V74, P1551, DOI 10.1097/00007890-200212150-00012; Park SH, 2001, J EXP MED, V193, P893, DOI 10.1084/jem.193.8.893; Petersen SL, 2003, BONE MARROW TRANSPL, V32, P65, DOI 10.1038/sj.bmt.1704084; Pillai AB, 2007, J IMMUNOL, V178, P6242, DOI 10.4049/jimmunol.178.10.6242; Pree I, 2007, INT ARCH ALLERGY IMM, V144, P254, DOI 10.1159/000104740; Prigozhina TB, 2002, EXP HEMATOL, V30, P89, DOI 10.1016/S0301-472X(01)00759-7; SAYEGH MH, 1991, ANN INTERN MED, V114, P954, DOI 10.7326/0003-4819-114-11-954; Scandling JD, 2008, NEW ENGL J MED, V358, P362, DOI 10.1056/NEJMoa074191; Schulenburg A, 2005, LEUKEMIA LYMPHOMA, V46, P1755, DOI 10.1080/10428190500264496; Sellers MT, 2001, TRANSPLANTATION, V71, P1681, DOI 10.1097/00007890-200106150-00031; SHARABI Y, 1989, J EXP MED, V169, P493, DOI 10.1084/jem.169.2.493; Slavin S, 1998, BLOOD, V91, P756, DOI 10.1182/blood.V91.3.756.756_756_763; SOROF JM, 1995, TRANSPLANTATION, V59, P1633; Spitzer T R, 2000, Oncologist, V5, P215, DOI 10.1634/theoncologist.5-3-215; Spitzer TR, 1999, TRANSPLANTATION, V68, P480, DOI 10.1097/00007890-199908270-00006; SVENDSEN UG, 1995, EUR RESPIR J, V8, P334, DOI 10.1183/09031936.95.08020334; Sykes M, 2005, TRANSPLANTATION, V79, pS28, DOI 10.1097/01.TP.0000153296.80385.E7; Sykes M, 1999, LANCET, V353, P1755, DOI 10.1016/S0140-6736(98)11135-2; Trivedi HL, 2005, TRANSPL P, V37, P737, DOI 10.1016/j.transproceed.2005.01.028; Trivedi HL, 2004, NEPHROL DIAL TRANSPL, V19, P2374, DOI 10.1093/ndt/gfh274; Werkele T, 2000, NAT MED, V6, P464, DOI 10.1038/74731; Yi TS, 2009, BLOOD, V114, P3101, DOI 10.1182/blood-2009-05-219402	42	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126318	10.1371/journal.pone.0126318	http://dx.doi.org/10.1371/journal.pone.0126318			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961559	Green Published, gold, Green Submitted			2022-12-26	WOS:000354542500088
J	Kolchinsky, A; Lourenco, A; Wu, HY; Li, L; Rocha, LM				Kolchinsky, Artemy; Lourenco, Analia; Wu, Heng-Yi; Li, Lang; Rocha, Luis M.			Extraction of Pharmacokinetic Evidence of Drug-Drug Interactions from the Literature	PLOS ONE			English	Article							TEXT; CLASSIFICATION; PREDICTION	Drug-drug interaction (DDI) is a major cause of morbidity and mortality and a subject of intense scientific interest. Biomedical literature mining can aid DDI research by extracting evidence for large numbers of potential interactions from published literature and clinical databases. Though DDI is investigated in domains ranging in scale from intracellular biochemistry to human populations, literature mining has not been used to extract specific types of experimental evidence, which are reported differently for distinct experimental goals. We focus on pharmacokinetic evidence for DDI, essential for identifying causal mechanisms of putative interactions and as input for further pharmacological and pharmacoepidemiology investigations. We used manually curated corpora of PubMed abstracts and annotated sentences to evaluate the efficacy of literature mining on two tasks: first, identifying PubMed abstracts containing pharmacokinetic evidence of DDIs; second, extracting sentences containing such evidence from abstracts. We implemented a text mining pipeline and evaluated it using several linear classifiers and a variety of feature transforms. The most important textual features in the abstract and sentence classification tasks were analyzed. We also investigated the performance benefits of using features derived from PubMed metadata fields, various publicly available named entity recognizers, and pharmacokinetic dictionaries. Several classifiers performed very well in distinguishing relevant and irrelevant abstracts (reaching F1 approximate to 0.93, MCC approximate to 0.74, iAUC approximate to 0.99) and sentences (F1 approximate to 0.76, MCC approximate to 0.65, iAUC approximate to 0.83). We found that word bigram features were important for achieving optimal classifier performance and that features derived from Medical Subject Headings (MeSH) terms significantly improved abstract classification. We also found that some drugrelated named entity recognition tools and dictionaries led to slight but significant improvements, especially in classification of evidence sentences. Based on our thorough analysis of classifiers and feature transforms and the high classification performance achieved, we demonstrate that literature mining can aid DDI discovery by supporting automatic extraction of specific types of experimental evidence.	[Kolchinsky, Artemy; Rocha, Luis M.] Indiana Univ, Sch Informat & Comp, Bloomington, IN 47405 USA; [Kolchinsky, Artemy; Rocha, Luis M.] Oeiras, Inst Gulbenkian Ciencia, Lisbon, Portugal; [Lourenco, Analia] Univ Vigo, ESEI Escuela Super Ingn Informat, Orense 32004, Spain; [Lourenco, Analia] Univ Minho, CEB Ctr Biol Engn, P-4710057 Braga, Portugal; [Wu, Heng-Yi; Li, Lang] Indiana Univ Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN 46202 USA; [Wu, Heng-Yi; Li, Lang] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Instituto Gulbenkian de Ciencia; Universidade de Vigo; Universidade do Minho; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Rocha, LM (corresponding author), Indiana Univ, Sch Informat & Comp, Bloomington, IN 47405 USA.	rocha@indiana.edu	Lourenço, Anália/Y-9447-2019; Lourenço, Anália/G-8879-2013	Lourenço, Anália/0000-0001-8401-5362; Lourenço, Anália/0000-0001-8401-5362; Rocha, Luis/0000-0001-9402-887X; Kolchinsky, Artemy/0000-0002-3518-9208	National Institutes of Health, National Library of Medicine Program [01LM011945-01]; Indiana University Collaborative Research Program, "Drug-Drug Interaction Prediction from Large-scale Mining of Literature and Patient Records"; Fundacao Luso-Americana para o Desenvolvimento (Portugal); National Science Foundation (USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104483] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM011945] Funding Source: NIH RePORTER	National Institutes of Health, National Library of Medicine Program; Indiana University Collaborative Research Program, "Drug-Drug Interaction Prediction from Large-scale Mining of Literature and Patient Records"; Fundacao Luso-Americana para o Desenvolvimento (Portugal); National Science Foundation (USA)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by a grant from the National Institutes of Health, National Library of Medicine Program, grant 01LM011945-01 "BLR: Evidence-based Drug-Interaction Discovery: In-Vivo, In-Vitro and Clinical," a grant from the Indiana University Collaborative Research Program 2013, "Drug-Drug Interaction Prediction from Large-scale Mining of Literature and Patient Records," as well as a grant from the joint program between the Fundacao Luso-Americana para o Desenvolvimento (Portugal) and National Science Foundation (USA), 2012-2014, "Network Mining For Gene Regulation And Biochemical Signaling." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Haidar A, 2008, GENOME BIOL, V9, DOI [10.1186/gb-2008-9-s2-s11, 10.1186/gb-2008-9-S2-S11]; Agresti A, 2007, INTRO CATEGORICAL DA, V423; [Anonymous], 2014, PAHARMACOKINETIC COR; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Becker ML, 2007, PHARMACOEPIDEM DR S, V16, P641, DOI 10.1002/pds.1351; Bickel PJ, 2004, BERNOULLI, V10, P989, DOI 10.3150/bj/1106314847; Bishop Christopher M., 2006, PATTERN RECOGNITION; Boyce R, 2009, J BIOMED INFORM, V42, P990, DOI 10.1016/j.jbi.2009.05.010; Boyce R, 2009, J BIOMED INFORM, V42, P979, DOI 10.1016/j.jbi.2009.05.001; Cheng FX, 2014, J AM MED INFORM ASSN, V21, pE278, DOI 10.1136/amiajnl-2013-002512; Cohen KB, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040020; Davis J, 2006, P 23 INT C MACH LEAR, P233, DOI [DOI 10.1145/1143844.1143874, 10.1145/1143844.1143874]; Duke JD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002614; El-Shishiny Hisham, 2008, 2008 IEEE Symposium on Computers and Communications (ISCC), P175, DOI 10.1109/ISCC.2008.4625615; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Gonzalez G, 2012, PAC S BIOC PAC S BIO, P368; Gonzalez G, 2013, PAC S BIOC PAC S BIO, V19, P312; Hajjar Emily R, 2007, Am J Geriatr Pharmacother, V5, P345, DOI 10.1016/j.amjopharm.2007.12.002; Hall MJ, 2010, NATL HLTH STAT REPOR, p[1, 24], DOI DOI 10.3886/ICPSR28162.V1; Hennessy S, 2012, CLIN PHARMACOL THER, V91, P771, DOI 10.1038/clpt.2012.39; Herrero-Zazo M, 2013, J BIOMED INFORM, V46, P914, DOI 10.1016/j.jbi.2013.07.011; Hirschman L, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S1; Huang ML, 2011, J AM MED INFORM ASSN, V18, P660, DOI 10.1136/amiajnl-2010-000055; JANKEL CA, 1993, DRUG SAFETY, V9, P51, DOI 10.2165/00002018-199309010-00005; Jensen LJ, 2006, NAT REV GENET, V7, P119, DOI 10.1038/nrg1768; Jessop DM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-41; Kolchinsky A, 2013, Pac Symp Biocomput, P409; Kolchinsky A, 2010, IEEE ACM T COMPUT BI, V7, P400, DOI 10.1109/TCBB.2010.55; KRALLINGER M, 2008, GENOME BIOL S2, V9, DOI DOI 10.1186/GB-; Krallinger M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S8-S3; LEAPE LL, 1995, JAMA-J AM MED ASSOC, V274, P35, DOI 10.1001/jama.1995.03530010049034; Leitner F, 2010, NAT BIOTECHNOL, V28, P897, DOI 10.1038/nbt0910-897; Leopold E, 2002, MACH LEARN, V46, P423, DOI 10.1023/A:1012491419635; Lin FPY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-112; Lourenco A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S8-S12; Mao Y, 2013, P 4 BIOCREATIVE CHAL, V1, P119; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; McDonald RT, 2004, BIOINFORMATICS, V20, P3249, DOI 10.1093/bioinformatics/bth350; Niska Richard, 2010, Natl Health Stat Report, P1; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Percha B, 2013, TRENDS PHARMACOL SCI, V34, P178, DOI 10.1016/j.tips.2013.01.006; Percha B, 2012, BIOCOMPUT-PAC SYM, P410; Porter MF, 2006, PROGRAM-ELECTRON LIB, V40, P211, DOI 10.1108/eb046814; Rechtsteiner A, 2006, JOINT BIOLINK BIOONT; Segura-Bedmar I., 2011, CHALLENGE TASK DRUG, P1; Segura-Bedmar I, 2014, J BIOMED INFORM, V51, P152, DOI 10.1016/j.jbi.2014.05.007; Segura-Bedmar I, 2011, J BIOMED INFORM, V44, P789, DOI 10.1016/j.jbi.2011.04.005; Segura-Bedmar I, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S2-S1; Segura-Bedmar I, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S2-S1; Settles B, 2005, BIOINFORMATICS, V21, P3191, DOI 10.1093/bioinformatics/bti475; Shatkay H, 2003, J COMPUT BIOL, V10, P821, DOI 10.1089/106652703322756104; Tari L, 2010, BIOINFORMATICS, V26, pi547, DOI 10.1093/bioinformatics/btq382; Tatonetti NP, 2011, CLIN PHARMACOL THER, V90, P133, DOI 10.1038/clpt.2011.83; Tatonetti NP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003377; Wall ME, 2003, PRACTICAL APPROACH M, P91, DOI DOI 10.1007/0-306-47815-3_5; Wang ZP, 2009, J BIOMED INFORM, V42, P726, DOI 10.1016/j.jbi.2009.03.010; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Wu H, 2013, BMC BIOINFO IN PRESS; Ye J., 2006, P 15 ACM INT C INF K, P532, DOI DOI 10.1145/1183614.1183691	60	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0122199	10.1371/journal.pone.0122199	http://dx.doi.org/10.1371/journal.pone.0122199			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961290	Green Published, gold, Green Submitted			2022-12-26	WOS:000354542500003
J	Nguyen, TV; Melville, A; Nath, S; Story, C; Howell, S; Sutton, R; Zannettino, A; Revesz, T				Nguyen, Tuong-Vi; Melville, Anna; Nath, Shriram; Story, Colin; Howell, Stuart; Sutton, Rosemary; Zannettino, Andrew; Revesz, Tamas			Bone Marrow Recovery by Morphometry during Induction Chemotherapy for Acute Lymphoblastic Leukemia in Children	PLOS ONE			English	Article							MINIMAL RESIDUAL DISEASE; FIBROSIS; NICHE; PAIN	Bone marrow architecture is grossly distorted at the diagnosis of ALL and details of the morphological changes that accompany response to Induction chemotherapy have not been reported before. While marrow aspirates are widely used to assess initial response to ALL therapy and provide some indications, we have enumerated marrow components using morphometric analysis of trephine samples with the aim of achieving a greater understanding of changes in bone marrow niches. Morphometric analyses were carried out in the bone marrow trephine samples of 44 children with ALL, using a NanoZoomer HT digital scanner. Diagnostic samples were compared to those of 32 control patients with solid tumors but without marrow involvement. Samples from patients with ALL had significantly increased fibrosis and the area occupied by bony trabeculae was lower than in controls. Cellularity was higher in ALL samples due to leukemic infiltration while the percentage of normal elements such as megakaryocytes, adipocytes, osteoblasts and osteoclasts were all significantly lower. During the course of Induction therapy, there was a decrease in the cellularity of ALL samples at day 15 of therapy with a further decrease at the end of Induction and an increase in the area occupied by adipocytes and the width of sinusoids. Reticulin fibrosis decreased throughout Induction. Megakaryocytes increased, osteoblasts and osteoclasts remained unchanged. No correlation was found between clinical presentation, early response to treatment and morphological changes. Our results provide a morphological background to further studies of bone marrow stroma in ALL.	[Nguyen, Tuong-Vi] Erasmus Univ, Rotterdam, Netherlands; [Nguyen, Tuong-Vi; Story, Colin; Revesz, Tamas] SA Pathol Womens & Childrens Hosp, Adelaide, SA, Australia; [Melville, Anna] Womens & Childrens Res Inst, Adelaide, SA, Australia; [Nath, Shriram] SA Pathol, Adelaide, SA, Australia; [Howell, Stuart] Univ Adelaide, Discipline Publ Hlth, Data Management & Anal Ctr, Adelaide, SA, Australia; [Sutton, Rosemary] UNSW, Lowy Canc Res Ctr, Childrens Canc Inst Australia, Randwick, NSW, Australia; [Zannettino, Andrew; Revesz, Tamas] Univ Adelaide, Fac Hlth Sci, Adelaide, SA, Australia; [Zannettino, Andrew] SA Pathol, Ctr Canc Biol, Adelaide, SA, Australia	Erasmus University Rotterdam; SA Pathology; SA Pathology; University of Adelaide; Children's Cancer Institute; University of New South Wales Sydney; University of Adelaide; Centre for Cancer Biology; SA Pathology	Revesz, T (corresponding author), SA Pathol Womens & Childrens Hosp, Adelaide, SA, Australia.	tom.revesz@health.sa.gov.au	nath, shriram/ABI-3571-2020; Sutton, Rosemary/J-3784-2014	Sutton, Rosemary/0000-0002-0188-6005; Zannettino, Andrew/0000-0002-6646-6167; Howell, Stuart/0000-0002-8158-3273; Nath, Shriram/0000-0002-9622-939X	Joan Norris Fellowship Fund; National Health and Medical Research Council Australia	Joan Norris Fellowship Fund; National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia)	The work was supported by a grant from the benevolent Joan Norris Fellowship Fund and the National Health and Medical Research Council Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bharos A, 2010, LEUKEMIA, V24, P1537, DOI 10.1038/leu.2010.134; Caers J, 2007, LEUKEMIA, V21, P1580, DOI 10.1038/sj.leu.2404658; Jayanthan A, 2010, PEDIATR HEMAT ONCOL, V27, P212, DOI 10.3109/08880011003663382; JONSSON OG, 1990, J PEDIATR-US, V117, P233, DOI 10.1016/S0022-3476(05)80535-9; Kopp HG, 2009, ANN NY ACAD SCI, V1176, P47, DOI 10.1111/j.1749-6632.2009.04964.x; Krevvata M, 2014, BLOOD, V124, P2834, DOI 10.1182/blood-2013-07-517219; Leeuw JA, 2003, PEDIATR RES, V54, P814, DOI 10.1203/01.PDR.0000090929.16450.DE; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Levesque JP, 2010, LEUKEMIA, V24, P1979, DOI 10.1038/leu.2010.214; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Nakamura Y, 2010, BLOOD, V116, P1422, DOI 10.1182/blood-2009-08-239194; Nath SV, 2011, MED HYPOTHESES, V77, P333, DOI 10.1016/j.mehy.2011.05.007; Noren-Nystrom U, 2008, LEUKEMIA, V22, P504, DOI 10.1038/sj.leu.2405072; Schultz KR, 2007, BLOOD, V109, P926, DOI 10.1182/blood-2006-01-024729; Sison EAR, 2014, ONCOTARGET, V5, P8947, DOI 10.18632/oncotarget.2407; Sutton R, 2009, BRIT J HAEMATOL, V146, P292, DOI 10.1111/j.1365-2141.2009.07744.x; Szaloki N, 2013, CYTOM PART A, V83, P818, DOI 10.1002/cyto.a.22315; Tabe Y, 2014, BRIT J HAEMATOL, V164, P767, DOI 10.1111/bjh.12725; van der Have N, 2012, LEUKEMIA RES, V36, P521, DOI 10.1016/j.leukres.2012.01.001; van der Velden VHJ, 2007, LEUKEMIA, V21, P706, DOI 10.1038/sj.leu.2404535; Yu HM, 2011, TRENDS CELL BIOL, V21, P47, DOI 10.1016/j.tcb.2010.08.015	21	12	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126233	10.1371/journal.pone.0126233	http://dx.doi.org/10.1371/journal.pone.0126233			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962143	Green Published, gold			2022-12-26	WOS:000354542500078
J	Woo, KS; Kim, BG; Choi, JL; Kim, BR; Kim, KH				Woo, Kwang-Sook; Kim, Byoung-Gwon; Choi, Jae-Lim; Kim, Bo-Ram; Kim, Kyeong-Hee			Neutrophil-to-Lymphocyte Ratio Is Associated with Impaired Interferon-Gamma Release to Phytohemagglutinin	PLOS ONE			English	Article							ASSAY; TUBERCULOSIS; INFLAMMATION; MORTALITY; DISEASE; AGE	Objective The neutrophil-to-lymphocyte ratio (NLR) has been shown to predict adverse outcomes in several pathologic conditions. The majority of indeterminate interferon (IFN)-gamma release assays were due to inadequate IFN-gamma response to the phytohemagglutinin. We sought to study the value of NLR to predict an indeterminate result of QuantiFERON-TB Gold In-Tube (QFT-GIT) performed in routine laboratory practice. Methods Results from 2,773 QFT-GIT assays were analyzed. Data collection included demographic data, the level of IFN-gamma to nil, mitogen, and TB antigen of QFT-GIT, total WBC, and a differential count. We calculated the absolute neutrophil count, lymphocyte count, and NLR. Results Of the total, 224 (8.1%) indeterminate results were observed. Twelve (1.8%) showed indeterminate results in the NLR range from 1.71 to 2.84, but 132 (19.2%) had indeterminate results in NLR >= 5.18 (p< 0.0001). The likelihood ratio for indeterminate results were 2.70 (95% CI, 2.36-3.08) in NLR >= 5.18 and 1.93 (95% CI, 1.64-2.27) in lymphocyte count <= 1050/mu L. NLR and neutrophil count were independent predictors for indeterminate QFT-GIT result in multiple regression analysis. The IFN-gamma response to PHA was negatively associated with NLR (r=-0.33, p< 0.001). Conclusion We showed that the NLR is an independent predictor of indeterminate QFT-GIT result. Low frequency of indeterminate results in group with normal NLR may imply the importance of a balance between two cellular compartments in physiological and pathological conditions.	[Woo, Kwang-Sook; Choi, Jae-Lim; Kim, Bo-Ram; Kim, Kyeong-Hee] Dong A Univ, Coll Med, Dept Lab Med, Busan, South Korea; [Kim, Byoung-Gwon] Dong A Univ, Coll Med, Dept Prevent Med, Busan, South Korea	Dong A University; Dong A University	Kim, KH (corresponding author), Dong A Univ, Coll Med, Dept Lab Med, Busan, South Korea.	progreen@dau.ac.kr			Dong-A University research fund	Dong-A University research fund	This work was supported by the Dong-A University research fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichelburg MC, 2012, J CLIN MICROBIOL, V50, P2767, DOI 10.1128/JCM.01054-12; Arrieta O, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-50; Calabrese C, 2015, ARTHRIT CARE RES, V67, P1063, DOI 10.1002/acr.22454; Cellestis Limited, 2010, QUANTIFERON TB GOLD; Don BR, 2004, SEMIN DIALYSIS, V17, P432, DOI 10.1111/j.0894-0959.2004.17603.x; Guthrie GJK, 2013, CRIT REV ONCOL HEMAT, V88, P218, DOI 10.1016/j.critrevonc.2013.03.010; Halazun KJ, 2013, TRANSPL P, V45, P3254, DOI 10.1016/j.transproceed.2013.07.065; Herrera V, 2010, J CLIN MICROBIOL, V48, P2672, DOI 10.1128/JCM.00482-10; Hradsky O, 2014, J PEDIATR GASTR NUTR, V58, P320, DOI 10.1097/MPG.0000000000000205; Jung HJ, 2014, RHEUMATOL INT, V34, P1711, DOI 10.1007/s00296-014-3033-z; Kim EY, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-207; Kobashi Y, 2009, EUR RESPIR J, V33, P812, DOI 10.1183/09031936.00075008; Kuyumcu ME, 2012, DEMENT GERIATR COGN, V34, P69, DOI 10.1159/000341583; Lange B, 2010, EUR RESPIR J, V35, P1179, DOI 10.1183/09031936.00122109; Li J, 2015, J CLIN LAB ANAL, V29, P437, DOI 10.1002/jcla.21791; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; MISHLER JM, 1977, BRIT J HAEMATOL, V36, P249, DOI 10.1111/j.1365-2141.1977.tb00646.x; Mocsai A, 2013, J EXP MED, V210, P1283, DOI 10.1084/jem.20122220; Nakagawa M, 1998, CIRCULATION, V98, P2307, DOI 10.1161/01.CIR.98.21.2307; Nunez J, 2008, AM J CARDIOL, V101, P747, DOI 10.1016/j.amjcard.2007.11.004; Papa A, 2008, CLIN CHIM ACTA, V395, P27, DOI 10.1016/j.cca.2008.04.019; Pillay J, 2012, J CLIN INVEST, V122, P327, DOI 10.1172/JCI57990; Rembach A, 2014, J NEUROIMMUNOL, V273, P65, DOI 10.1016/j.jneuroim.2014.05.005; Scapini P, 2014, BLOOD, V124, P710, DOI 10.1182/blood-2014-03-453217; Semiz M, 2014, PSYCHIAT DANUB, V26, P220; Shah N, 2014, INT J CARDIOL, V171, P390, DOI 10.1016/j.ijcard.2013.12.019; Tamhane UU, 2008, AM J CARDIOL, V102, P653, DOI 10.1016/j.amjcard.2008.05.006; Tebruegge M, 2014, J CLIN MICROBIOL, V52, P2694, DOI 10.1128/JCM.00814-14; Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju124; Yoon NB, 2013, ANN LAB MED, V33, P105, DOI 10.3343/alm.2013.33.2.105; Yun JW, 2014, J CLIN MICROBIOL, V52, P90, DOI 10.1128/JCM.01547-13	31	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0125794	10.1371/journal.pone.0125794	http://dx.doi.org/10.1371/journal.pone.0125794			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961292	Green Submitted, Green Published, gold			2022-12-26	WOS:000354542500045
J	Ajemian, MJ; Wetz, JJ; Shipley-Lozano, B; Shively, JD; Stunz, GW				Ajemian, Matthew J.; Wetz, Jennifer J.; Shipley-Lozano, Brooke; Shively, J. Dale; Stunz, Gregory W.			An Analysis of Artificial Reef Fish Community Structure along the Northwestern Gulf of Mexico Shelf: Potential Impacts of "Rigs-to-Reefs" Programs	PLOS ONE			English	Article							OFFSHORE PETROLEUM PLATFORMS; NATIONAL MARINE SANCTUARY; RED SNAPPER; NORTHERN GULF; OIL PLATFORMS; SPATIAL VARIATION; HERBIVOROUS FISH; HABITAT; ASSEMBLAGES; MANAGEMENT	Artificial structures are the dominant complex marine habitat type along the northwestern Gulf of Mexico (GOM) shelf. These habitats can consist of a variety of materials, but in this region are primarily comprised of active and reefed oil and gas platforms. Despite being established for several decades, the fish communities inhabiting these structures remain poorly investigated. Between 2012 and 2013 we assessed fish communities at 15 sites using remotely operated vehicles (ROVs). Fish assemblages were quantified from standing platforms and an array of artificial reef types (Liberty Ships and partially removed or toppled platforms) distributed over the Texas continental shelf. The depth gradient covered by the surveys (30-84 m) and variability in structure density and relief also permitted analyses of the effects of these characteristics on fish richness, diversity, and assemblage composition. ROVs captured a variety of species inhabiting these reefs from large transient piscivores to small herbivorous reef fishes. While structure type and relief were shown to influence species richness and community structure, major trends in species composition were largely explained by the bottom depth where these structures occurred. We observed a shift in fish communities and relatively high diversity at approximately 60 m bottom depth, confirming trends observed in previous studies of standing platforms. This depth was also correlated with some of the largest Red Snapper captured on supplementary vertical longline surveys. Our work indicates that managers of artificial reefing programs (e.g., Rigs-to-Reefs) in the GOM should carefully consider the ambient environmental conditions when designing reef sites. For the Texas continental shelf, reefing materials at a 50-60 m bottom depth can serve a dual purpose of enhancing diving experiences and providing the best potential habitat for relatively large Red Snapper.	[Ajemian, Matthew J.; Wetz, Jennifer J.; Stunz, Gregory W.] Texas A&M Univ, Harte Res Inst Gulf Mexico Studies, Corpus Christi, TX USA; [Shipley-Lozano, Brooke; Shively, J. Dale] Texas Parks & Wildlife Dept, Artificial Reef Program, Austin, TX 78744 USA	Texas A&M University System	Ajemian, MJ (corresponding author), Texas A&M Univ, Harte Res Inst Gulf Mexico Studies, Corpus Christi, TX USA.	Matt.Ajemian@tamucc.edu			Texas Parks and Wildlife Department's Artificial Reef Program (TPWD) [415254]	Texas Parks and Wildlife Department's Artificial Reef Program (TPWD)	This work was funded by a contract with Texas Parks and Wildlife Department's Artificial Reef Program (TPWD #415254) to GWS. Program website: http://tpwd.texas.gov/landwater/water/habitats/artificial_reef/index.phtml No individuals employed or contracted by the funding agency (other than the named authors) played any role in: study design, data collection and analysis, decision to publish, or preparation of the manuscript. BSL JDS provided essential logistical support and guidance on artificial reef sites during the study design phase.	Ajemian MJ, 2015, FISH RES, V167, P143, DOI 10.1016/j.fishres.2015.02.011; Baine M, 2003, REV FISH BIOL FISHER, V13, P187, DOI 10.1023/B:RFBF.0000019480.95010.67; Baine M, 2001, OCEAN COAST MANAGE, V44, P241, DOI 10.1016/S0964-5691(01)00048-5; BELL JD, 1983, J APPL ECOL, V20, P357, DOI 10.2307/2403513; Claisse JT, 2014, P NATL ACAD SCI USA, V111, P15462, DOI 10.1073/pnas.1411477111; Cresson P, 2014, MAR ECOL PROG SER, V509, P15, DOI 10.3354/meps10866; Dauterive L., 2000, RIGS REEFS POLICY PR; DENNIS GD, 1988, B MAR SCI, V43, P280; Ditton RB, 2002, ICES J MAR SCI, V59, pS186, DOI 10.1006/jmsc.2002.1188; Dokken QR, TAMUCC007CCS; Downie RA, 2013, MAR ECOL PROG SER, V482, P217, DOI 10.3354/meps10250; Dupont JM, 2008, COAST MANAGE, V36, P495, DOI 10.1080/08920750802395558; ELLIS DM, 1995, FISH B-NOAA, V93, P67; Fechhelm JD., 1998, FISHES GULF MEXICO, V2; Gallaway BJ, 2009, REV FISH SCI, V17, P48, DOI 10.1080/10641260802160717; Gallaway BJ, 1999, T AM FISH SOC, V128, P713, DOI 10.1577/1548-8659(1999)128<0713:DOEHFJ>2.0.CO;2; Gallaway BJ, 1979, ECOLOGICAL INVESTIGA; Gallaway BJ, 1981, ECOLOGICAL INVESTIGA, V2; Gallaway BJ, 1982, FWSOBS8227 OFF BIOL; Garcia-Sais JR, 2010, CORAL REEFS, V29, P277, DOI 10.1007/s00338-009-0582-9; Goodsell PJ, 2009, ECOL STUD-ANAL SYNTH, V206, P333, DOI 10.1007/978-3-540-92704-4_24; Gorley C.K., 2006, GETTING STARTED PRIM; Gregalis KC, 2012, T AM FISH SOC, V141, P1453, DOI 10.1080/00028487.2012.703154; Grossman GD, 1997, FISHERIES, V22, P17, DOI 10.1577/1548-8446(1997)022<0017:DARIRF>2.0.CO;2; Hanisko D, 2012, GULF MEXICO DATA ATL; Jorgensen D, 2012, FRONT ECOL ENVIRON, V10, P178, DOI 10.1890/12.WB.012; Jorgensen D, 2012, OCEAN COAST MANAGE, V58, P57, DOI 10.1016/j.ocecoaman.2011.12.012; Jorgensen D, 2009, HIST TECHNOL, V25, P343, DOI 10.1080/07341510903313030; Kaiser MJ, 2006, MAR POLICY, V30, P605, DOI 10.1016/j.marpol.2005.04.005; Lindquist DC, 2005, ESTUAR COAST SHELF S, V62, P655, DOI 10.1016/j.ecss.2004.10.001; Love MS, 2006, FISH B-NOAA, V104, P542; Love MS, 2006, FISH B-NOAA, V104, P383; Love MS, 2005, B MAR SCI, V77, P397; Love MS, 2003, 2003032 US DEP INT U; Macreadie PI, 2011, FRONT ECOL ENVIRON, V9, P455, DOI 10.1890/100112; Macreadie PI, 2012, FRONT ECOL ENVIRON, DOI [10.1890/12.WB.012.2012, DOI 10.1890/12.WB.012.2012]; Silvano RAM, 2006, BRAZ ARCH BIOL TECHN, V49, P623, DOI 10.1590/S1516-89132006000500012; McClatchie S, 1997, DEEP-SEA RES PT I, V44, P647, DOI 10.1016/S0967-0637(96)00096-9; Merritt D, 2011, FISH B-NOAA, V109, P56; Michael PJ, 2013, MAR ECOL PROG SER, V482, P227, DOI 10.3354/meps10262; Mitchell Karen M., 2004, Gulf of Mexico Science, V22, P164; Moore D., 1962, Fishery Bulletin United States, V61, P451; Mudrak PA, 2012, T AM FISH SOC, V141, P487, DOI 10.1080/00028487.2012.667045; Oh CO, 2008, SOC NATUR RESOUR, V21, P455, DOI 10.1080/08941920701681953; PARKER RO, 1994, FISH B-NOAA, V92, P787; Pitcher TJ, 2000, FISH FISH, V1, P73, DOI 10.1046/j.1467-2979.2000.00010.x; POLOVINA JJ, 1991, ARTIFICIAL HABITATS, P153; Pulsipher A. G., 2001, FORECASTING NUMBER O; RANDALL JOHN E., 1963, CARIBBEAN J SCI, V3, P31; Reubens JT, 2013, FISH RES, V139, P28, DOI 10.1016/j.fishres.2012.10.011; REZAK R, 1990, AM ZOOL, V30, P23; Rilov G, 2000, MAR BIOL, V136, P931, DOI 10.1007/s002279900250; Rooker JR, 1997, CORAL REEFS, V16, P83, DOI 10.1007/s003380050062; Schroepfer RL, 2006, B MAR SCI, V78, P93; Sherman RL, 1999, J APPL ICHTHYOL, V15, P116; Shipp RL, 2009, REV FISH SCI, V17, P41, DOI 10.1080/10641260802104244; Simmons CM, 2011, T AM FISH SOC, V140, P14, DOI 10.1080/00028487.2011.545002; Stanley DR, 1996, ICES J MAR SCI, V53, P473, DOI 10.1006/jmsc.1996.0067; Stanley DR, 1997, CAN J FISH AQUAT SCI, V54, P1166, DOI 10.1139/cjfas-54-5-1166; STANLEY DR, 1991, FISH B-NOAA, V89, P149; Stanley DR, 2000, FISH RES, V47, P161, DOI 10.1016/S0165-7836(00)00167-3; Steimle FW., 2000, US NMFS MAR FISH REV, V62, P24; Strelcheck AJ, 2005, B MAR SCI, V77, P425; SZEDLMAYER ST, 1994, B MAR SCI, V55, P887; Szedlmayer ST, 2005, T AM FISH SOC, V134, P315, DOI 10.1577/T04-070.1; U. S. Minerals Management Service, 2009, RIGS TO REEFS POL AD; Watson DL, 2005, MAR BIOL, V148, P415, DOI 10.1007/s00227-005-0090-6; Willis TJ, 2000, MAR ECOL PROG SER, V198, P249, DOI 10.3354/meps198249; Wilson C. A., 2003, RIGS REEFS COMP FISH; Wilson C.A., 2006, EFFECTS DEPTH LOCATI; Zalmon IR, 2002, ICES J MAR SCI, V59, pS83, DOI 10.1006/jmsc.2002.1273; Zintzen V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048522	72	86	90	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0126354	10.1371/journal.pone.0126354	http://dx.doi.org/10.1371/journal.pone.0126354			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25954943	gold, Green Submitted, Green Published			2022-12-26	WOS:000356768100113
J	Hou, QY; Zhao, CW; Guo, SQ; Mao, F; Zhang, Y				Hou, Qingyu; Zhao, Chunwang; Guo, Shaoqiang; Mao, Fei; Zhang, Yue			Effect on Electron Structure and Magneto-Optic Property of Heavy W-Doped Anatase TiO2	PLOS ONE			English	Article							PHOTOCATALYTIC ACTIVITY; MAGNETIC-PROPERTIES; PERFORMANCE; ENERGY; PURE	The spin or nonspin state of electrons in W-doped anatase TiO2 is very difficult to judge experimentally because of characterization method limitations. Hence, the effect on the microscopic mechanism underlying the visible-light effect of W-doped anatase TiO2 through the consideration of electronic spin or no-spin states is still unknown. To solve this problem, we establish supercell models of W-doped anatase TiO2 at different concentrations, followed by geometry optimization and energy calculation based on the first-principle planewave norm conserving pseudo-potential method of the density functional theory. Calculation results showed that under the condition of nonspin the doping concentration of W becomes heavier, the formation energy becomes greater, and doping becomes more difficult. Meanwhile, the total energy increases, the covalent weakens and ionic bonds strengthens, the stability of the W-doped anatase TiO2 decreases, the band gap increases, and the blue-shift becomes more significant with the increase of W doping concentration. However, under the condition of spin, after the band gap correction by the GGA+U method, it is found that the semimetal diluted magnetic semiconductors can be formed by heavy W-doped anatase TiO2. Especially, a conduction electron polarizability of as high as near 100% has been found for the first time in high concentration W-doped anatase TiO2. It will be able to be a promising new type of dilute magnetic semiconductor. And the heavy W-doped anatase TiO2 make the band gap becomes narrower and absorption spectrum red-shift.	[Hou, Qingyu; Zhao, Chunwang; Guo, Shaoqiang; Mao, Fei] Inner Mongolia Univ Technol, Coll Sci, Hohhot, Peoples R China; [Zhao, Chunwang] Shanghai Maritime Univ, Coll Arts & Sci, Shanghai, Peoples R China; [Zhang, Yue] Beihang Univ, Sch Mat Sci & Engn, Beijing 100191, Peoples R China	Inner Mongolia University of Technology; Shanghai Maritime University; Beihang University	Zhao, CW (corresponding author), Inner Mongolia Univ Technol, Coll Sci, Hohhot, Peoples R China.	cwzhao@aliyun.com	Zhao, Chunwang/E-5204-2013		National Natural Science Foundation of China [61366008, 11272142]; Program for New Century Excellent Talents in University [NCET-10-0909]; Ministry of Education of China; College Science Research Project of Inner Mongolia Autonomous Region [NJZZ13099]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Ministry of Education of China(Ministry of Education, China); College Science Research Project of Inner Mongolia Autonomous Region	The National Natural Science Foundation of China (Grant nos. 61366008, 11272142), the Program for New Century Excellent Talents in University (Grant no. NCET-10-0909), the "Spring Sunshine" Project of Ministry of Education of China, and the College Science Research Project of Inner Mongolia Autonomous Region (Grant no. NJZZ13099).	Chen DM, 2010, J APPL PHYS, V107, DOI 10.1063/1.3326940; CHOI WY, 1994, J PHYS CHEM-US, V98, P13669, DOI 10.1021/j100102a038; Couselo N, 2008, J PHYS CHEM C, V112, P1094, DOI 10.1021/jp0769781; Cui XY, 2005, PHYS REV LETT, V95, P25604; Gong JY, 2014, APPL CATAL B-ENVIRON, V152, P73, DOI 10.1016/j.apcatb.2014.01.028; IHM J, 1979, J PHYS C SOLID STATE, V12, P4409, DOI 10.1088/0022-3719/12/21/009; Jiang HQ, 2013, CHEM ENG J, V215, P348, DOI 10.1016/j.cej.2012.10.082; Kafizas A, 2011, J AM CHEM SOC, V133, P20458, DOI 10.1021/ja208633g; Kim DS, 2009, CRYSTENGCOMM, V11, P1621, DOI 10.1039/b901957j; KUBO R, 1962, J PHYS SOC JPN, V17, P975, DOI 10.1143/JPSJ.17.975; Li M, 2012, CHEM PHYS LETT, V527, P63, DOI 10.1016/j.cplett.2012.01.009; Li N, 2011, J APPL PHYS, V110; Li X, 2012, CATAL COMMUN, V24, P20, DOI 10.1016/j.catcom.2012.03.009; Long R, 2011, PHYS CHEM CHEM PHYS, V13, P13698, DOI 10.1039/c1cp21454c; Long R, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3114608; Lu JT, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2397028; Matsushima S, 2007, J PHYS CHEM SOLIDS, V68, P206, DOI 10.1016/j.jpcs.2006.10.011; Mohamed MM, 2012, CATAL COMMUN, V28, P58, DOI 10.1016/j.catcom.2012.08.012; Patel SKS, 2012, MATER CHEM PHYS, V132, P175, DOI 10.1016/j.matchemphys.2011.11.020; PERDEW JP, 1983, PHYS REV LETT, V51, P1884, DOI 10.1103/PhysRevLett.51.1884; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Riley MJ, 2012, J APPL PHYS, V111, DOI 10.1063/1.3699370; Segall MD, 2002, J PHYS-CONDENS MAT, V14, P2717, DOI 10.1088/0953-8984/14/11/301; Siraji AA, 2014, J ELECTRON MATER, V43, P1443, DOI 10.1007/s11664-014-3096-3; Stengl V, 2011, ACS APPL MATER INTER, V3, P4014, DOI 10.1021/am2008757; Tian ZM, 2008, J MAGN MAGN MATER, V320, pL5, DOI 10.1016/j.jmmm.2007.05.009; Tobaldi DM, 2013, CHEM ENG J, V214, P364, DOI 10.1016/j.cej.2012.11.018; Wang XL, 2012, APPL SURF SCI, V258, P5863, DOI 10.1016/j.apsusc.2012.02.117; Yang Y, 2009, MATER LETT, V63, P331, DOI 10.1016/j.matlet.2008.10.037	29	6	7	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0122620	10.1371/journal.pone.0122620	http://dx.doi.org/10.1371/journal.pone.0122620			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955308	Green Published, gold, Green Submitted			2022-12-26	WOS:000356768100007
J	Liu, X; Ji, Q; Ye, NJ; Sui, H; Zhou, LH; Zhu, HR; Fan, ZZ; Cai, JF; Li, Q				Liu, Xuan; Ji, Qing; Ye, Naijing; Sui, Hua; Zhou, Lihong; Zhu, Huirong; Fan, Zhongze; Cai, Jianfeng; Li, Qi			Berberine Inhibits Invasion and Metastasis of Colorectal Cancer Cells via COX-2/PGE(2) Mediated JAK2/STAT3 Signaling Pathway	PLOS ONE			English	Article							STAT3 ACTIVATION; PROSTAGLANDIN E-2; EXPRESSION; GROWTH; APOPTOSIS; INTERLEUKIN-6; MIGRATION; AZD1480; ASPIRIN; RISK	Berberin, extracted from Chinese herbal medicine Coptis chinensis, has been found to have anti-tumor activities. However, the underlying mechanisms have not been fully elucidated. Our current study demonstrated that berberin inhibited the in vitro and in vivo growth, migration/invasion of CRC cells, via attenuating the expression levels of COX-2/PGE(2), following by reducing the phosphorylation of JAK2 and STAT3, as well as the MMP-2/-9 expression. We further clarified that an increase of COX-2/PGE2 expression offset the repressive activity of Berberin on JAK2/STAT3 signaling, and a JAK2 inhibitor AZD1480 blocked the effect of COX-2/PGE(2) on MMP-2/-9 expression. In summary, Berberin inhibited CRC invasion and metastasis via down-regulation of COX-2/PGE(2)-JAK2/STAT3 signaling pathway.	[Liu, Xuan; Ji, Qing; Ye, Naijing; Sui, Hua; Zhou, Lihong; Zhu, Huirong; Li, Qi] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Dept Med Oncol, Shanghai, Peoples R China; [Fan, Zhongze] Shanghai Univ Tradit Chinese Med, Intervent Canc Inst, Shanghai, Peoples R China; [Cai, Jianfeng] Univ S Florida, Dept Chem, Tampa, FL 33620 USA	Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine; State University System of Florida; University of South Florida	Li, Q (corresponding author), Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Dept Med Oncol, Shanghai, Peoples R China.	Lzwf@hotmail.com		Ji, Qing/0000-0002-1899-0204	National Natural Science Foundation of China [81303103, 81473478, 81303102]; Science and Technology Commission of Shanghai Municipality [13ZR1461000, 14140901402]; Program of Shanghai Municipal Education Commission [13CG47, 13YZ045]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Program of Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	This work was supported by the National Natural Science Foundation of China (81303103, 81473478, 81303102), Science and Technology Commission of Shanghai Municipality (13ZR1461000, 14140901402) and Program of Shanghai Municipal Education Commission (13CG47, 13YZ045). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson AB, 2011, J NATL COMPR CANC NE, V9, P1238, DOI 10.6004/jnccn.2011.0104; Berishaj M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1680; Chan AT, 2008, GASTROENTEROLOGY, V134, P21, DOI 10.1053/j.gastro.2007.09.035; Chan AT, 2007, NEW ENGL J MED, V356, P2131, DOI 10.1056/NEJMoa067208; Cui GL, 2009, J BIOL CHEM, V284, P28420, DOI 10.1074/jbc.M109.012674; Dalwadi H, 2005, CLIN CANCER RES, V11, P7674, DOI 10.1158/1078-0432.CCR-05-1205; Derosa G, 2014, CURR TOP MED CHEM, V14, P200, DOI 10.2174/1568026613666131213155252; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; Hamsa TP, 2012, PHYTOTHER RES, V26, P568, DOI 10.1002/ptr.3586; Han C, 2006, J BIOL CHEM, V281, P24831, DOI 10.1074/jbc.M602201200; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; Hur JM, 2010, TOXICOL RES-GER, V26, P109, DOI 10.5487/TR.2010.26.2.109; Ioannidis S, 2011, J MED CHEM, V54, P262, DOI 10.1021/jm1011319; Ji Q, 2014, BRIT J CANCER, V111, P736, DOI 10.1038/bjc.2014.383; Ji Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078700; Katiyar SK, 2009, MOL CARCINOGEN, V48, P24, DOI 10.1002/mc.20453; Kim S, 2013, CELL PHYSIOL BIOCHEM, V32, P1541, DOI 10.1159/000356591; Kuo HP, 2012, J AGR FOOD CHEM, V60, P9649, DOI 10.1021/jf302832n; Li Q, 2009, CANCER LETT, V278, P97, DOI 10.1016/j.canlet.2008.12.032; Liu XH, 2002, BIOCHEM BIOPH RES CO, V290, P249, DOI 10.1006/bbrc.2001.6188; Okazaki H, 2011, BIOCHEM BIOPH RES CO, V412, P441, DOI 10.1016/j.bbrc.2011.07.111; Sai K, 2012, J NEURO-ONCOL, V107, P487, DOI 10.1007/s11060-011-0786-z; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singh IP, 2013, EXPERT OPIN THER PAT, V23, P215, DOI 10.1517/13543776.2013.746314; Singh T, 2011, CARCINOGENESIS, V32, P86, DOI 10.1093/carcin/bgq215; Slattery ML, 2013, MOL CARCINOGEN, V52, P155, DOI 10.1002/mc.21841; Song YH, 2008, MOL IMMUNOL, V45, P137, DOI 10.1016/j.molimm.2007.04.031; Sui H, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/957078; Sui H, 2011, CARCINOGENESIS, V32, P667, DOI 10.1093/carcin/bgr016; Tan KY, 2008, TECH COLOPROCTOL, V12, P1, DOI 10.1007/s10151-008-0392-z; Tsang CM, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-619; Vuddanda PR, 2010, EXPERT OPIN INV DRUG, V19, P1297, DOI 10.1517/13543784.2010.517745; Wang D, 2006, GUT, V55, P115, DOI 10.1136/gut.2004.047100; Wang D, 2010, ONCOGENE, V29, P781, DOI 10.1038/onc.2009.421; Wang LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056666; Xie TX, 2004, ONCOGENE, V23, P3550, DOI 10.1038/sj.onc.1207383; Yamaguchi Y, 2013, DIGEST ENDOSC, V25, P26, DOI 10.1111/den.12116; Yang J, 2013, NEOPLASMA, V60, P364, DOI 10.4149/neo_2013_048; Yang XL, 2013, MOL MED REP, V8, P505, DOI 10.3892/mmr.2013.1506; Zhang L, 2013, CANCER SCI, V104, P604, DOI 10.1111/cas.12120	40	110	127	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0123478	10.1371/journal.pone.0123478	http://dx.doi.org/10.1371/journal.pone.0123478			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25954974	gold, Green Published, Green Submitted			2022-12-26	WOS:000356768100014
J	Wang, DY; Yu, QW; Zhang, Y				Wang, Dongyun; Yu, Qiwei; Zhang, Yu			Research on Laser Marking Speed Optimization by Using Genetic Algorithm	PLOS ONE			English	Article								Laser Marking Machine is the most common coding equipment on product packaging lines. However, the speed of laser marking has become a bottleneck of production. In order to remove this bottleneck, a new method based on a genetic algorithm is designed. On the basis of this algorithm, a controller was designed and simulations and experiments were performed. The results show that using this algorithm could effectively improve laser marking efficiency by 25%.	[Wang, Dongyun; Yu, Qiwei; Zhang, Yu] Zhejiang Normal Univ, Sch Engn, Hangzhou, Zhejiang, Peoples R China	Zhejiang Normal University	Wang, DY (corresponding author), Zhejiang Normal Univ, Sch Engn, Hangzhou, Zhejiang, Peoples R China.	zsdwdy@zjnu.edu.cn			National Natural Science Foundation [51205368]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation, Grant Number: 51205368 (www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari R., 2011, INT JO INDUSTR ENG C, V2, P419, DOI DOI 10.5267/J.IJIEC.2010.03.002; Chen MF, 2008, OPT LASER ENG, V46, P410, DOI 10.1016/j.optlaseng.2007.11.010; Dongyun W, 2014, SCI WORLD J, V2014, P1; Larranaga P, ARTIFICIAL INTELL RE, V13, P129; Li Ni-ni, 2010, Computer Engineering and Applications, V46, P234, DOI 10.3778/j.issn.1002-8331.2010.02.069; Mohammad T, CENTRAL EUROPEAN J E, V3, P36; Panos M, 2002, POPULATION HEURISTIC, P138; Qiwei Yu, 2012, Advanced Materials Research, V571, P411, DOI 10.4028/www.scientific.net/AMR.571.411; Ray SS, 2007, APPL INTELL, V26, P183, DOI 10.1007/s10489-006-0018-y; Rego C, 2011, EUR J OPER RES, V211, P427, DOI 10.1016/j.ejor.2010.09.010; Wang DY, 2014, OPT LASER TECHNOL, V57, P52, DOI 10.1016/j.optlastec.2013.09.033; Xin S, 2012, THESIS HUAZHONG U SC	12	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0126141	10.1371/journal.pone.0126141	http://dx.doi.org/10.1371/journal.pone.0126141			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955831	Green Submitted, Green Published, gold			2022-12-26	WOS:000356768100100
J	Saitoh, M; Endo, K; Furuya, S; Minami, M; Fukasawa, A; Imamura, T; Miyazawa, K				Saitoh, M.; Endo, K.; Furuya, S.; Minami, M.; Fukasawa, A.; Imamura, T.; Miyazawa, K.			STAT3 integrates cooperative Ras and TGF-beta signals that induce Snail expression	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; SMAD TRANSCRIPTIONAL ACTIVITY; PROTEIN INHIBITOR; ACTIVATOR; PATHWAY; GROWTH; CELLS; IL-6; EMT; TRANSDUCER	The epithelial-mesenchymal transition (EMT) is a crucial morphological event that occurs during the progression of epithelial tumors. EMT can be induced by transforming growth factor beta (TGF-beta) in certain kinds of cancer cells through the induction of Snail, a key regulator of EMT. We have previously found that TGF-beta remarkably induces Snail expression in cooperation with Ras signals; however, the underlying mechanism of this synergism has not yet been determined. Here, we demonstrate that signal transducer and activator of transcription 3 (STAT3) acts as a mediator that synergizes TGF-beta and Ras signals. The overexpression of STAT3 enhanced Snail induction, whereas siRNA-mediated knockdown of STAT3 inhibited it. The STAT3-gamma F mutant, which has Tyr 705 substituted with Phe, did not enhance Snail induction. Several STAT3 mutants lacking transcriptional activity also failed to enhance it; however, the putative STAT3-binding elements in the Snail promoter regions were not required for STAT3-mediated Snail induction. Protein inhibitor of activated STAT3 (PIAS3) inhibited the enhanced Snail promoter activity induced by TGF-beta and Ras. The interaction between PIAS3 and STAT3 was reduced by TGF-beta in cells harboring oncogenic Ras, whereas TGF-beta promoted the binding of PIAS3 to Smad3, a crucial mediator of TGF-beta signaling. Therefore, these findings suggest that STAT3 enhances Snail induction when it is dissociated from PIAS3 by TGF-beta in cooperation with Ras signals.	[Saitoh, M.; Endo, K.; Furuya, S.; Minami, M.; Fukasawa, A.; Miyazawa, K.] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Biochem, 1110 Shimokato, Chuo, Yamanashi 4093898, Japan; [Furuya, S.; Minami, M.] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Res Training Program Undergrad, Chuo, Yamanashi 4093898, Japan; [Imamura, T.] Ehime Univ, Grad Sch Med, Dept Mol Med Pathogenesis, Matsuyama, Ehime 790, Japan	University of Yamanashi; University of Yamanashi; Ehime University	Saitoh, M (corresponding author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Biochem, 1110 Shimokato, Chuo, Yamanashi 4093898, Japan.	msaitoh-ind@umin.ac.jp			JSPS KAKENHI [24390419]; JSPS; Ministry of Education, Culture, Sports, Science and Technology of Japan; Astellas Foundation for Research on Metabolic Disorders; Fugaku Trust for Medicinal Research; Mitsubishi Foundation; Terumo Life Science Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Astellas Foundation for Research on Metabolic Disorders; Fugaku Trust for Medicinal Research; Mitsubishi Foundation; Terumo Life Science Foundation(Terumo Life Science Foundation)	We would like to thank M Myogahara for her excellent secretarial assistance. We also thank Dr T Shirakihara, Dr K Horiguchi, Dr D Koinuma, Dr S Ehata, Dr H Suzuki, and Dr K Miyazono for their helpful advice. This work was supported by JSPS KAKENHI Grant Number 24390419, the JSPS Core-to-Core Program 'Cooperative International Framework in TGF-beta Family Signaling', and a research program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. This work was also supported by Astellas Foundation for Research on Metabolic Disorders (to MS) and research grants from the Fugaku Trust for Medicinal Research, the Mitsubishi Foundation, and Terumo Life Science Foundation (to KM). This work was supported by JSPS KAKENHI Grant Number 24390419, the JSPS Core-to-Core Program 'Cooperative International Framework in TGF-beta Family Signaling', and a research program of the Project for the Development of Innovative Research on Cancer Therapeutics (P-Direct) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. This work was also supported by Astellas Foundation for Research on Metabolic Disorders (to MS) and research grants from the Fugaku Trust for Medicinal Research, the Mitsubishi Foundation and Terumo Life Science Foundation (to KM).	Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Fu XT, 2015, INT J ONCOL, V46, P587, DOI 10.3892/ijo.2014.2761; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Horiguchi K, 2012, ONCOGENE, V31, P3190, DOI 10.1038/onc.2011.493; Horiguchi K, 2009, J BIOL CHEM, V284, P245, DOI 10.1074/jbc.M804777200; Huang C, 2011, NEOPLASMA, V58, P396, DOI 10.4149/neo_2011_05_396; Inman GJ, 2011, CURR OPIN GENET DEV, V21, P93, DOI 10.1016/j.gde.2010.12.004; Kamran MZ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/421821; Kohsaka S, 2012, MOL CANCER THER, V11, P1289, DOI 10.1158/1535-7163.MCT-11-0801; Lee J, 2012, J BIOL CHEM, V287, P18182, DOI 10.1074/jbc.M111.328831; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Liu RY, 2014, INT J ONCOL, V44, P1643, DOI 10.3892/ijo.2014.2310; Liu Y, 2013, J BIOL CHEM, V288, P30708, DOI 10.1074/jbc.M113.478685; Long JY, 2004, P NATL ACAD SCI USA, V101, P99, DOI 10.1073/pnas.0307598100; Long JY, 2003, P NATL ACAD SCI USA, V100, P9791, DOI 10.1073/pnas.1733973100; Minegishi Y, 2007, NATURE, V448, P1058, DOI 10.1038/nature06096; Miyazawa K, 2002, GENES CELLS, V7, P1191, DOI 10.1046/j.1365-2443.2002.00599.x; Miyazono K, 2000, CYTOKINE GROWTH F R, V11, P15, DOI 10.1016/S1359-6101(99)00025-8; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Mulder KM, 2000, CYTOKINE GROWTH F R, V11, P23, DOI 10.1016/S1359-6101(99)00026-X; Ozawa Y, 2008, J BIOL CHEM, V283, P24561, DOI 10.1074/jbc.M802238200; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Rokavec M, 2014, J CLIN INVEST, V124, P1853, DOI 10.1172/JCI73531; Saitoh M, 2012, J BIOCHEM, V151, P563, DOI 10.1093/jb/mvs040; Sasse J, 1997, MOL CELL BIOL, V17, P4677, DOI 10.1128/MCB.17.8.4677; Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004; Shirakihara T, 2011, EMBO J, V30, P783, DOI 10.1038/emboj.2010.351; Subramaniam A, 2013, BBA-REV CANCER, V1835, P46, DOI 10.1016/j.bbcan.2012.10.002; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Yadav A, 2011, MOL CANCER RES, V9, P1658, DOI 10.1158/1541-7786.MCR-11-0271; Yagil Z, 2010, TRENDS IMMUNOL, V31, P199, DOI 10.1016/j.it.2010.01.005; Yamamoto T, 2001, FEBS LETT, V492, P247, DOI 10.1016/S0014-5793(01)02258-X; Zhang QF, 2013, J BIOL CHEM, V288, P31280, DOI 10.1074/jbc.M113.505057	35	72	73	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 25	2016	35	8					1049	1057		10.1038/onc.2015.161	http://dx.doi.org/10.1038/onc.2015.161			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DE7NF	25961936				2022-12-26	WOS:000370823300010
J	Arnold, P; Schmidt, F; Prox, J; Zunke, F; Pietrzik, C; Lucius, R; Becker-Pauly, C				Arnold, Philipp; Schmidt, Frederike; Prox, Johannes; Zunke, Friederike; Pietrzik, Claus; Lucius, Ralph; Becker-Pauly, Christoph			Calcium negatively regulates meprin beta activity and attenuates substrate cleavage	FASEB JOURNAL			English	Article						protease; APP; amyloid beta; protein folding	AMYOTROPHIC-LATERAL-SCLEROSIS; METALLOPROTEASE MEPRIN; ALPHA-SUBUNIT; IN-VIVO; PEPTIDE; ACTIVATION; INHIBITORS; MEMBRANE; PROTEASE; BINDING	The meprin beta metalloproteinase is an important enzyme in extracellular matrix turnover, inflammation, and neurodegeneration in humans and mice. Previous studies showed a diminished cleavage of certain meprin beta substrates in the presence of calcium, although the mechanism was not clear. With the help of a specific fluorogenic peptide assay and the human amyloid precursor protein as substrate, we demonstrated that the influence of calcium is most likely a direct effect on human meprin beta itself. Analyzing the crystal structures of pro- and mature meprin b helped to identify a cluster of negatively charged amino acids forming a potential calcium binding site. Mutation of 2 of these residues (D204A and D245A) led to severe differences in proteolytic activity and cellular localization of meprin beta. D245A was almost completely inactive and largely stored into intracellular vesicles, indicating severe misfolding of the protein. Astonishingly, D204A was not transported to the cell surface, but exhibited strong beta-secretase activity, resulting in massive accumulation of A beta-peptides. This could be explained by constitutive maturation of this meprin beta mutant already in the early secretory pathway. We hypothesize that lacking D204 abrogates the capability of binding calcium in the catalytic domain, an important step for proper folding of the propeptide and subsequent inhibition of the protease. This is supported by the inhibition constant of calcium for meprin beta (inhibitory constant 50 = 11 mM), which resembles the physiologic concentrations found in the endoplasmic reticulum. For instance, it was shown for amyotrophic lateral sclerosis that a loss of calcium in the endoplasmic reticulum leads to the misfolding of calcium-dependent proteins, which might also be relevant for proper function of meprin beta.-Arnold, P., Schmidt, F., Prox, J., Zunke, F., Pietrzik, C., Lucius, R., Becker-Pauly, C. Calcium negatively regulates meprin beta activity and attenuates substrate cleavage.	[Arnold, Philipp; Lucius, Ralph] Univ Kiel, Inst Anat, Kiel, Germany; [Schmidt, Frederike; Prox, Johannes; Zunke, Friederike; Becker-Pauly, Christoph] Univ Kiel, Inst Biochem, Kiel, Germany; [Pietrzik, Claus] Johannes Gutenberg Univ Mainz, Inst Pathobiochem, Univ Med Ctr, D-55122 Mainz, Germany	University of Kiel; University of Kiel; Johannes Gutenberg University of Mainz	Arnold, P (corresponding author), Christian Albrechts Univ Kiel CAU, Inst Anat, Otto Hahn Pl 8, D-24118 Kiel, Germany.	p.arnold@anat.uni-kiel.de	Lucius, Ralph/B-1614-2010; Becker-Pauly, Christoph/B-7569-2011	Zunke, Friederike/0000-0002-0408-6388	German Research Foundation (DFG) [SFB877, BE 4086/2-1, PI 379/6-1]; medical faculty of the Christian-Albrecht's University (Kiel, Germany)	German Research Foundation (DFG)(German Research Foundation (DFG)); medical faculty of the Christian-Albrecht's University (Kiel, Germany)	The authors thank Xavier Gomis-Ruth (Barcelona, Spain) for the pdb file of membrane-bound dimeric meprin beta and Michael Schwake (Bielefeld, Germany) for providing the Limp-2 antibody. This work was supported by the German Research Foundation (DFG) Grant SFB877 "Proteolysis as a Regulatory Event in Pathophysiology" (project A9), Grant BE 4086/2-1 (to C.B.-P.), Grant PI 379/6-1 (to C.U.P.), and by a young research investigator grant of the medical faculty of the Christian-Albrecht's University (Kiel, Germany) (to P.A.).	Arolas JL, 2012, P NATL ACAD SCI USA, V109, P16131, DOI 10.1073/pnas.1211076109; Becker C, 2003, BIOL CHEM, V384, P825, DOI 10.1515/BC.2003.092; Becker-Pauly C, 2007, J INVEST DERMATOL, V127, P1115, DOI 10.1038/sj.jid.5700675; Becker-Pauly C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009233; BEYNON RJ, 1981, BIOCHEM J, V199, P591, DOI 10.1042/bj1990591; Bien J, 2012, J BIOL CHEM, V287, P33304, DOI 10.1074/jbc.M112.395608; Brini M, 2013, METAL IONS LIFE SCI, V12, P119, DOI 10.1007/978-94-007-5561-1_5; Broder C, 2013, P NATL ACAD SCI USA, V110, P14219, DOI 10.1073/pnas.1305464110; Broder C, 2013, BIOCHEM J, V450, P253, DOI 10.1042/BJ20121751; Chen DZ, 2000, BIOCHEMISTRY-US, V39, P1256, DOI 10.1021/bi992245y; Grosskreutz J, 2010, CELL CALCIUM, V47, P165, DOI 10.1016/j.ceca.2009.12.002; Hahn D, 2003, J BIOL CHEM, V278, P42829, DOI 10.1074/jbc.M211169200; Hedrich J, 2010, BIOCHEMISTRY-US, V49, P8599, DOI 10.1021/bi1004238; Jefferson T, 2013, CELL MOL LIFE SCI, V70, P309, DOI 10.1007/s00018-012-1106-2; Jefferson T, 2011, J BIOL CHEM, V286, P27741, DOI 10.1074/jbc.M111.252718; Kato YS, 2013, BIOL CHEM, V394, P55, DOI 10.1515/hsz-2012-0152; Kruse MN, 2004, BIOCHEM J, V378, P383, DOI 10.1042/BJ20031163; Millar AW, 1998, BRIT J CLIN PHARMACO, V45, P21, DOI 10.1046/j.1365-2125.1998.00639.x; Ohler A, 2010, BIOL CHEM, V391, P455, DOI 10.1515/BC.2010.023; Prell T, 2013, CELL CALCIUM, V54, P132, DOI 10.1016/j.ceca.2013.05.007; Prox J, 2015, MATRIX BIOL, V44-46, P7, DOI 10.1016/j.matbio.2015.01.010; Prox J, 2012, CELL MOL LIFE SCI, V69, P2919, DOI 10.1007/s00018-012-0960-2; Schutte A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008835; Schutte A, 2014, P NATL ACAD SCI USA, V111, P12396, DOI 10.1073/pnas.1407597111; Siedlecka M, 1999, P NATL ACAD SCI USA, V96, P903, DOI 10.1073/pnas.96.3.903; SOMLYO AP, 1985, NATURE, V314, P622, DOI 10.1038/314622a0; STERCHI EE, 1982, CLIN SCI, V62, P557, DOI 10.1042/cs0620557; STOCKER W, 1988, BIOCHEMISTRY-US, V27, P5026; Tsuchiya S, 2011, J BONE MINER RES, V26, P220, DOI 10.1002/jbmr.202; Wang LL, 2014, EMBO J, V33, P594, DOI 10.1002/embj.201386523; Zachos C, 2012, TRAFFIC, V13, P1113, DOI 10.1111/j.1600-0854.2012.01372.x	31	16	16	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3549	3557		10.1096/fj.15-272310	http://dx.doi.org/10.1096/fj.15-272310			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25957281				2022-12-26	WOS:000358796900040
J	Schwalm, C; Jamart, C; Benoit, N; Naslain, D; Premont, C; Prevet, J; Van Thienen, R; Deldicque, L; Francaux, M				Schwalm, Celine; Jamart, Cecile; Benoit, Nicolas; Naslain, Damien; Premont, Christophe; Prevet, Jeremy; Van Thienen, Ruud; Deldicque, Louise; Francaux, Marc			Activation of autophagy in human skeletal muscle is dependent on exercise intensity and AMPK activation	FASEB JOURNAL			English	Article						cathepsin; cycling; fasting; LC3b; p62/SQSTM1	REGULATE AUTOPHAGY; PROTEIN-KINASE; MESSENGER-RNA; DEGRADATION; DENERVATION; ADAPTATIONS; MECHANISMS; PATHWAYS; MICE	In humans, nutrient deprivation and extreme endurance exercise both activate autophagy. We hypothesized that cumulating fasting and cycling exercise would potentiate activation of autophagy in skeletal muscle. Well-trained athletes were divided into control (n = 8), low-intensity (LI, n = 8), and high-intensity (HI, n = 7) exercise groups and submitted to fed and fasting sessions. Muscle biopsy samples were obtained from the vastus lateralis before, at the end, and 1 h after a 2 h LI or HI bout of exercise. Phosphorylation of ULK1(Ser317) was higher after exercise (P < 0.001). In both the fed and the fasted states, LC3bII protein level and LC3bII/I were decreased after LI and HI (P < 0.05), while p62/SQSTM1 was decreased only 1 h after HI (P < 0.05), indicating an increased autophagic flux after HI. The autophagic transcriptional program was also activated, as evidenced by the increased level of LC3b, p62/SQSTM1, GabarapL1, and Cathepsin L mRNAs observed after HI but not after LI. The increased autophagic flux after HI exercise could be due to increased AMP-activated protein kinase alpha (AMPK alpha) activity, as both AMPK alpha(Thr172) and ACC(Ser79) had a higher phosphorylation state after HI (P < 0.001). In summary, the most effective strategy to activate autophagy in human skeletal muscle seems to rely on exercise intensity more than diet.-Schwalm, C., Jamart, C., Benoit, N., Naslain, D., Premont, C., Prevet, J., Van Thienen, R., Deldicque, L., Francaux, M. Activation of autophagy in human skeletal muscle is dependent on exercise intensity and AMPK activation.	[Schwalm, Celine; Jamart, Cecile; Benoit, Nicolas; Naslain, Damien; Premont, Christophe; Prevet, Jeremy; Francaux, Marc] Catholic Univ Louvain, Inst Neurosci, B-1348 Louvain La Neuve, Belgium; [Van Thienen, Ruud; Deldicque, Louise] Katholieke Univ Leuven, Dept Kinesiol, Exercise Physiol Res Grp, Leuven, Belgium	Universite Catholique Louvain; KU Leuven	Francaux, M (corresponding author), Catholic Univ Louvain, Pl Pierre Coubertin,1 Bte L8 10-01, B-1348 Louvain La Neuve, Belgium.	marc.francaux@uclouvain.be		Deldicque, Louise/0000-0003-3393-5278; Francaux, Marc/0000-0001-8182-1588	Delhaize Chair of the Louvain Foundation	Delhaize Chair of the Louvain Foundation	The authors thank C. Bugli (Louvain School of Statistics, Biostatistics and Actuarial Sciences, Louvain-la-Neuve, Belgium) for her assistance in the statistical analyses. This research was supported by a grant from the Delhaize Chair of the Louvain Foundation.	Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Bertaggia E, 2012, AM J PHYSIOL-CELL PH, V302, pC587, DOI 10.1152/ajpcell.00142.2011; Booth FW, 2000, J APPL PHYSIOL, V88, P774, DOI 10.1152/jappl.2000.88.2.774; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Egan B, 2010, J PHYSIOL-LONDON, V588, P1779, DOI 10.1113/jphysiol.2010.188011; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Gonzalez AA, 2004, AM J PHYSIOL-ENDOC M, V287, pE1032, DOI 10.1152/ajpendo.00172.2004; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Grumati Paolo, 2012, Cells, V1, P325, DOI 10.3390/cells1030325; Grumati P, 2011, AUTOPHAGY, V7, P1415, DOI 10.4161/auto.7.12.17877; He CC, 2012, NATURE, V481, P511, DOI 10.1038/nature10758; JACKSON AS, 1978, BRIT J NUTR, V40, P497, DOI 10.1079/BJN19780152; Jamart C, 2013, AM J PHYSIOL-ENDOC M, V305, pE964, DOI 10.1152/ajpendo.00270.2013; Jamart C, 2012, EUR J APPL PHYSIOL, V112, P3173, DOI 10.1007/s00421-011-2287-3; Jamart C, 2012, J APPL PHYSIOL, V112, P1529, DOI 10.1152/japplphysiol.00952.2011; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim YA, 2012, J PHYSIOL BIOCHEM, V68, P229, DOI 10.1007/s13105-011-0135-x; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Lira VA, 2013, FASEB J, V27, P4184, DOI 10.1096/fj.13-228486; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; McClung JM, 2010, AM J PHYSIOL-CELL PH, V298, pC542, DOI 10.1152/ajpcell.00192.2009; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mofarrahi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047265; Moresi V, 2012, P NATL ACAD SCI USA, V109, P1649, DOI 10.1073/pnas.1121159109; O'Leary MFN, 2012, AM J PHYSIOL-CELL PH, V303, pC447, DOI 10.1152/ajpcell.00451.2011; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Rockl KSC, 2008, IUBMB LIFE, V60, P145, DOI 10.1002/iub.21; Sanchez AMJ, 2012, J CELL BIOCHEM, V113, P695, DOI 10.1002/jcb.23399; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Sandri M, 2010, FEBS LETT, V584, P1411, DOI 10.1016/j.febslet.2010.01.056; SCHIAFFINO S, 1972, J ULTRA MOL STRUCT R, V39, P1, DOI 10.1016/S0022-5320(72)80002-9; Schiaffino S, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-4; Tadaishi M, 2011, AM J PHYSIOL-ENDOC M, V300, pE341, DOI 10.1152/ajpendo.00400.2010; Van Thienen R, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.286; Wang XX, 2005, GENE DEV, V19, P1715, DOI 10.1101/gad.1318305; Weidberg H, 2011, ANNU REV BIOCHEM, V80, P125, DOI 10.1146/annurev-biochem-052709-094552; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	43	99	105	1	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3515	3526		10.1096/fj.14-267187	http://dx.doi.org/10.1096/fj.14-267187			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25957282				2022-12-26	WOS:000358796900037
J	Hirasawa, K; Shoji, N; Isono, K; Tsuchiya, M				Hirasawa, Kazunori; Shoji, Nobuyuki; Isono, Karen; Tsuchiya, Manami			Effects of Different Levels of Intraocular Stray Light on Kinetic Perimetry Findings	PLOS ONE			English	Article							CATARACT-EXTRACTION; REACTION-TIME; VISUAL-FIELD; MOVEMENT; LENS	Purpose To evaluate the effect of different levels of intraocular stray light on kinetic perimetry findings. Methods Twenty-five eyes of 25 healthy young participants were examined by automated kinetic perimetry (Octopus 900) using Goldmann stimuli III4e, I4e, I3e, I2e, and I1e. Each stimulus was presented with a velocity of 3 degrees/s at 24 meridians with 15 degrees intervals. Four levels of intraocular stray light were induced using non-white opacity filter (WOF) filters and WOFs applied to the clear plastic eye covers of the participants. The visual acuity, pupil diameter, isopter area, and kinetic sensitivity of each meridian were analyzed for each WOF density. Results Visual acuity deteriorated with increasing WOF densities (p < 0.01). With a visual acuity of 0.1 LogMAR units, the isopter areas for III4e, I4e, I3e, I2e, and I1e decreased by -32.7 degree(2) (-0.2%), -255.7 degree(2) (-2.6%), -381.2 degree(2) (-6.2%), -314.8 degree(2) (-12.8%), and -59.2 degree(2) (-15.2%), respectively; kinetic sensitivity for those stimuli decreased by -0.1 degree (-0.1%), -0.8 degree (-1.4%), -1.6 degree (-3.7%), -2.7 degree (-9.7%), and -1.7 degree (-16.2%), respectively. The pupil diameter with each WOF density was not significantly different. Conclusion Kinetic perimetry measurements with a high-intensity stimulus (i.e., III4e) were unaffected by intraocular stray light. In contrast, measurements with the I4e, I3e, I2e, and I1e stimuli, especially I2e and I1e, were affected. Changes in the shape of the isopter resulting from opacity must be monitored, especially in cases of smaller and lower-intensity stimuli.	[Hirasawa, Kazunori; Shoji, Nobuyuki; Isono, Karen; Tsuchiya, Manami] Kitasato Univ, Sch Allied Hlth Sci, Dept Rehabil, Orthopt & Visual Sci, Kanagawa, Japan	Kitasato University	Hirasawa, K (corresponding author), Kitasato Univ, Sch Allied Hlth Sci, Dept Rehabil, Orthopt & Visual Sci, Kanagawa, Japan.	hirasawa@kitasato-u.ac.jp		Hirasawa, Kazunori/0000-0001-5100-005X				Anderson RS, 2009, INVEST OPHTH VIS SCI, V50, P4022, DOI 10.1167/iovs.08-2934; Artal P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016823; Becker ST, 2005, INVEST OPHTH VIS SCI, V46, P2633, DOI 10.1167/iovs.04-1413; Bergin C, 2011, INVEST OPHTH VIS SCI, V52, P3676, DOI 10.1167/iovs.10-6642; Carrillo MM, 2005, ARCH OPHTHALMOL-CHIC, V123, P929, DOI 10.1001/archopht.123.7.929; Chen PP, 1998, AM J OPHTHALMOL, V125, P325, DOI 10.1016/S0002-9394(99)80142-1; Cohen J.E., 1988, STAT POWER ANAL BEHA; Freeman M, 2003, EYE OPTICAL INSTRUME; GOLDMANN H, 1945, OPHTHALMOLOGICA, V109, P71, DOI 10.1159/000300225; GOLDMANN H, 1945, OPHTHALMOLOGICA, V109, P57, DOI 10.1159/000300224; GOLDMANN H, 1946, OPHTHALMOLOGICA, V111, P187, DOI 10.1159/000300322; Hirasawa K, 2014, CURR EYE RES, P1; Hirasawa K, 2014, CURR EYE RES, V39, P928, DOI 10.3109/02713683.2014.888450; Hirasawa K, 2014, VISION RES, V98, P83, DOI 10.1016/j.visres.2014.03.010; Jang SY, 2010, AM J OPHTHALMOL, V150, P243, DOI 10.1016/j.ajo.2010.02.023; JOHNSON CA, 1988, J OPT SOC AM A, V5, P2131, DOI 10.1364/JOSAA.5.002131; JOHNSON CA, 1987, ARCH OPHTHALMOL-CHIC, V105, P73; Kook MS, 2004, AM J OPHTHALMOL, V138, P85, DOI 10.1016/j.ajo.2004.03.020; Lyne A J, 1969, Br J Ophthalmol, V53, P119, DOI 10.1136/bjo.53.2.119; Nowomiejska K, 2012, OPHTHALMOLOGICA, V227, P166, DOI 10.1159/000333821; Nowomiejska K, 2010, ACTA OPHTHALMOL, V88, P65, DOI 10.1111/j.1755-3768.2008.01407.x; Odell NV, 2008, J AAPOS, V12, P555, DOI 10.1016/j.jaapos.2008.04.012; Oleszczuk JD, 2012, INVEST OPHTH VIS SCI, V53, P1219, DOI 10.1167/iovs.11-8659; Perez GM, 2010, INVEST OPHTH VIS SCI, V51, P609, DOI 10.1167/iovs.09-3726; RADIUS RL, 1978, ARCH OPHTHALMOL-CHIC, V96, P1574; SAMPLE PA, 1988, INVEST OPHTH VIS SCI, V29, P1306; Schiefer U, 2004, PERIMETRY UPDATE 2002/2003, P233; Schiefer U, 2001, PERIMETRY UPDATE 2000/2001, P131; Schiefer U, 2001, VISION RES, V41, P2157, DOI 10.1016/S0042-6989(01)00088-8; Siddiqui MAR, 2007, J GLAUCOMA, V16, P205, DOI 10.1097/IJG.0b013e31802dfc35; Tanna AP, 2004, OPHTHALMOLOGY, V111, P1504, DOI 10.1016/j.ophtha.2004.01.035; TROBE JD, 1980, AM J OPHTHALMOL, V90, P654, DOI 10.1016/S0002-9394(14)75132-3; Ueda T, 2006, AM J OPHTHALMOL, V142, P856, DOI 10.1016/j.ajo.2006.05.021; Vonthein R, 2007, OPHTHALMOLOGY, V114, P1065, DOI 10.1016/j.ophtha.2006.09.030; Wakayama A, 2011, VISION RES, V51, P174, DOI 10.1016/j.visres.2010.11.002; WEINREB RN, 1986, AM J OPHTHALMOL, V101, P706, DOI 10.1016/0002-9394(86)90774-9	36	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0127159	10.1371/journal.pone.0127159	http://dx.doi.org/10.1371/journal.pone.0127159			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965816	Green Submitted, Green Published, gold			2022-12-26	WOS:000354543500095
J	Loos, JA; Cumino, AC				Loos, Julia A.; Cumino, Andrea C.			In Vitro Anti-Echinococcal and Metabolic Effects of Metformin Involve Activation of AMP-Activated Protein Kinase in Larval Stages of Echinococcus granulosus	PLOS ONE			English	Article							HEPATIC GLUCONEOGENESIS; RESPIRATORY-CHAIN; COMPLEX-I; GLUCOSE-METABOLISM; ANTIDIABETIC DRUG; DEPENDENT MANNER; ALPHA-AMYLASE; ENERGY SENSOR; CELL-GROWTH; AUTOPHAGY	Metformin (Met) is a biguanide anti-hyperglycemic agent, which also exerts antiproliferative effects on cancer cells. This drug inhibits the complex I of the mitochondrial electron transport chain inducing a fall in the cell energy charge and leading 5'-AMP-activated protein kinase (AMPK) activation. AMPK is a highly conserved heterotrimeric complex that coordinates metabolic and growth pathways in order to maintain energy homeostasis and cell survival, mainly under nutritional stress conditions, in a Liver Kinase B1 (LKB1)-dependent manner. This work describes for the first time, the in vitro anti-echinococcal effect of Met on Echinococcus granulosus larval stages, as well as the molecular characterization of AMPK (Eg-AMPK) in this parasite of clinical importance. The drug exerted a dose-dependent effect on the viability of both larval stages. Based on this, we proceeded with the identification of the genes encoding for the different subunits of Eg-AMPK alpha We cloned one gene coding for the catalytic subunit (Eg-ampk.) and two genes coding for the regulatory subunits (Eg-ampk beta and Eg-ampk gamma), all of them constitutively transcribed in E. granulosus protoscoleces and metacestodes. Their deduced amino acid sequences show all the conserved functional domains, including key amino acids involved in catalytic activity and protein-protein interactions. In protoscoleces, the drug induced the activation of AMPK (Eg-AMPK alpha-P-176), possibly as a consequence of cellular energy charge depletion evidenced by assays with the fluorescent indicator JC-1. Met also led to carbohydrate starvation, it increased glucogenolysis and homolactic fermentation, and decreased transcription of intermediary metabolism genes. By in toto immunolocalization assays, we detected Eg-AMPK alpha-P-176 expression, both in the nucleus and the cytoplasm of cells as in the larval tegument, the posterior bladder and the calcareous corpuscles of control and Met-treated protoscoleces. Interestingly, expression of Eg-AMPK alpha was observed in the developmental structures during the de-differentiation process from protoscoleces to microcysts. Therefore, the Eg-AMPK expression during the asexual development of E. granulosus, as well as the in vitro synergic therapeutic effects observed in presence of Met plus albendazole sulfoxide (ABZSO), suggest the importance of carrying out chemoprophylactic and clinical efficacy studies combining Met with conventional anti-echinococcal agents to test the potential use of this drug in hydatidosis therapy.	[Loos, Julia A.; Cumino, Andrea C.] Univ Nacl Mar del Plata UNMdP, Fac Ciencias Exactas & Nat, Dept Biol, Lab Zoonosis Parasitarias, RA-7600 Mar Del Plata, Buenos Aires, Argentina; [Loos, Julia A.; Cumino, Andrea C.] Consejo Nacl Invest Cient & Tecn, Mar Del Plata, Buenos Aires, Argentina; [Cumino, Andrea C.] Univ Nacl Mar del Plata UNMdP, Fac Ciencias Exactas & Nat, Dept Quim, RA-7600 Mar Del Plata, Buenos Aires, Argentina	National University of Mar del Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Mar del Plata	Cumino, AC (corresponding author), Univ Nacl Mar del Plata UNMdP, Fac Ciencias Exactas & Nat, Dept Biol, Lab Zoonosis Parasitarias, Funes 3350, RA-7600 Mar Del Plata, Buenos Aires, Argentina.	acumino@mdp.edu.ar		Loos, Julia/0000-0002-1407-9114; Cumino, Andrea/0000-0002-0225-6363	Universidad Nacional de Mar del Plata [EXA 572/12]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT-PICT) Argentina [2668]	Universidad Nacional de Mar del Plata(National University of La Plata); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT-PICT) Argentina	This work was supported by Universidad Nacional de Mar del Plata (Grant EXA 572/12) and Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT-PICT 2012, No 2668) Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUERO F, 1995, MOL BIOCHEM PARASIT, V72, P247, DOI 10.1016/0166-6851(95)00093-G; Alvarez LI, 2007, TRENDS PARASITOL, V23, P97, DOI 10.1016/j.pt.2007.01.003; Beale EG, 2008, EXP BIOL MED, V233, P12, DOI 10.3181/0705-MR-117; Ben Sahra I, 2010, MOL CANCER THER, V9, P1092, DOI 10.1158/1535-7163.MCT-09-1186; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Carling D, 2011, NAT CHEM BIOL, V7, P512, DOI [10.1038/nchembio.610, 10.1038/NCHEMBIO.610]; Chen HP, 2013, GUT, V62, P606, DOI 10.1136/gutjnl-2011-301708; Chen L, 2009, NATURE, V459, P1146, DOI 10.1038/nature08075; Cumino AC, 2012, PARASITOL INT, V61, P579, DOI 10.1016/j.parint.2012.05.007; Cumino AC, 2010, INT J PARASITOL, V40, P651, DOI 10.1016/j.ijpara.2009.11.011; Cumino AC, 2009, PARASITOL INT, V58, P270, DOI 10.1016/j.parint.2009.03.005; Das B, 2013, PARASITOLOGY, V140, P136, DOI 10.1017/S0031182012001254; Silva FMD, 2010, MOL CELL BIOCHEM, V340, P283, DOI 10.1007/s11010-010-0429-2; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Faubert B, 2013, CELL METAB, V17, P113, DOI 10.1016/j.cmet.2012.12.001; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Fulgencio JP, 2001, BIOCHEM PHARMACOL, V62, P439, DOI 10.1016/S0006-2952(01)00679-7; Ghillebert R, 2011, FEBS J, V278, P3978, DOI 10.1111/j.1742-4658.2011.08315.x; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2013, CANCER CELL, V23, P131, DOI 10.1016/j.ccr.2013.01.009; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; He L, 2009, CELL, V137, P635, DOI 10.1016/j.cell.2009.03.016; Hirsch HA, 2013, P NATL ACAD SCI USA, V110, P972, DOI 10.1073/pnas.1221055110; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Hoyer-Hansen M, 2007, AUTOPHAGY, V3, P381, DOI 10.4161/auto.4240; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; Iseli TJ, 2005, J BIOL CHEM, V280, P13395, DOI 10.1074/jbc.M412993200; Janecek S, 2002, BIOLOGIA, V57, P29; Jones K, 2002, ANTIMICROB AGENTS CH, V46, P2700, DOI 10.1128/AAC.46.8.2700-2703.2002; Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Kato K, 2012, MOL CANCER THER, V11, P549, DOI 10.1158/1535-7163.MCT-11-0594; Kazgan N, 2010, MOL BIOL CELL, V21, P3433, DOI 10.1091/mbc.E10-04-0347; Kobayashi M, 2013, INT J ONCOL, V42, P517, DOI 10.3892/ijo.2012.1722; Komuniecki R., 2003, MOL MEDICAL PARASITO, P339; Lee JM, 2010, J BIOL CHEM, V285, P32182, DOI 10.1074/jbc.M110.134890; Lippai M, 2008, AUTOPHAGY, V4, P476, DOI 10.4161/auto.5719; Lock R, 2011, MOL BIOL CELL, V22, P165, DOI 10.1091/mbc.E10-06-0500; Loos JA, 2014, INT J PARASITOL, V44, P415, DOI 10.1016/j.ijpara.2014.02.007; Matsumoto J, 2008, ANTIMICROB AGENTS CH, V52, P164, DOI 10.1128/AAC.00378-07; McManus DP, 2009, PARASITOLOGY, V136, P1643, DOI 10.1017/S0031182009005666; McManus DP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3866; McManus DP, 2003, LANCET, V362, P1295, DOI 10.1016/S0140-6736(03)14573-4; MCMANUS DP, 1982, PARASITOLOGY, V84, P351, DOI 10.1017/S0031182000044899; Meijer AJ, 2007, AUTOPHAGY, V3, P238, DOI 10.4161/auto.3710; Omura S, 2001, P NATL ACAD SCI USA, V98, P60, DOI 10.1073/pnas.011524698; Ouyang JY, 2011, J BIOL CHEM, V286, P1, DOI 10.1074/jbc.M110.121806; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Parkinson J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001897; Pernicova I, 2014, NAT REV ENDOCRINOL, V10, P143, DOI 10.1038/nrendo.2013.256; Ramnanan CJ, 2010, MOL CELL BIOCHEM, V335, P91, DOI 10.1007/s11010-009-0246-7; RAUSCHER E, 1985, CLIN CHEM, V31, P14; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; Rogan MT, 1986, PARASITOLOGY, V92, P370; Salani B, 2013, SCI REP-UK, V3, DOI 10.1038/srep02070; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2009, ACTA PHYSIOL, V196, P65, DOI 10.1111/j.1748-1716.2009.01972.x; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shi WY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.13; Shu Y, 2007, J CLIN INVEST, V117, P1422, DOI 10.1172/JCI30558; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Tomic T, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.86; Tsai IJ, 2013, NATURE, V496, P57, DOI 10.1038/nature12031; Viollet B, 2012, CLIN SCI, V122, P253, DOI 10.1042/CS20110386; Warden SM, 2001, BIOCHEM J, V354, P275, DOI 10.1042/0264-6021:3540275; WILCOCK C, 1994, XENOBIOTICA, V24, P49, DOI 10.3109/00498259409043220; Witters LA, 2001, J CLIN INVEST, V108, P1105, DOI 10.1172/JCI200114178; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Xie M, 2012, CELL METAB, V16, P322, DOI 10.1016/j.cmet.2012.07.016; Yamashita T, 2004, BBA-BIOENERGETICS, V1608, P97, DOI 10.1016/j.bbabio.2003.10.006; Zakikhani M, 2010, BREAST CANCER RES TR, V123, P271, DOI 10.1007/s10549-010-0763-9; Zeqiraj E, 2009, SCIENCE, V326, P1707, DOI 10.1126/science.1178377; Zheng HJ, 2013, NAT GENET, V45, P1168, DOI 10.1038/ng.2757; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	77	21	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0126009	10.1371/journal.pone.0126009	http://dx.doi.org/10.1371/journal.pone.0126009			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965910	gold, Green Submitted, Green Published			2022-12-26	WOS:000354543500036
J	Mmbando, BP; Mgaya, J; Cox, SE; Mtatiro, SN; Soka, D; Rwezaula, S; Meda, E; Msaki, E; Snow, RW; Jeffries, N; Geller, NL; Makani, J				Mmbando, Bruno P.; Mgaya, Josephine; Cox, Sharon E.; Mtatiro, Siana N.; Soka, Deogratias; Rwezaula, Stella; Meda, Elineema; Msaki, Evarist; Snow, Robert W.; Jeffries, Neal; Geller, Nancy L.; Makani, Julie			Negative Epistasis between Sickle and Foetal Haemoglobin Suggests a Reduction in Protection against Malaria	PLOS ONE			English	Article							RISK-FACTORS; CELL TRAIT; GENE; EXPLAIN; GLOBIN	Background Haemoglobin variants, Sickle (HbS) and foetal (HbF) have been associated with malaria protection. This study explores epistatic interactions between HbS and HbF on malaria infection. Methods The study was conducted between March 2004 and December 2013 within the sickle cell disease (SCD) programme at Muhimbili National Hospital, Tanzania. SCD status was categorized into HbAA, HbAS and HbSS using hemoglobin electrophoresis and High Performance Liquid Chromatography (HPLC). HbF levels were determined by HPLC. Malaria was diagnosed using rapid diagnostic test and/or blood film. Logistic regression and generalized estimating equations models were used to evaluate associations between SCD status, HbF and malaria. Findings 2,049 individuals with age range 0-70 years, HbAA 311(15.2%), HbAS 241(11.8%) and HbSS 1,497(73.1%) were analysed. At enrolment, malaria prevalence was significantly higher in HbAA 13.2% compared to HbAS 1.24% and HbSS 1.34% (p<0.001). Mean HbF was lower in those with malaria compared to those without malaria in HbAA (0.43% vs 0.82%) but was the reverse in HbSS (8.10% vs 5.59%). An increase in HbF was associated with a decrease in risk of malaria OR=0.50 (95% CI: 0.28, 0.90; p=0.021) in HbAA, whereas for HbSS the risk of malaria increased OR= 2.94 (1.44, 5.98; p=0.003). A similar pattern was seen during multiple visits; HbAA OR= 0.52 (0.34, 0.80; p=0.003) vs HbSS OR= 2.01 (1.27, 3.23; p=0.003). Conclusion Higher prevalence of malaria in HbAA compared to HbAS and HbSS confirmed the protective effect of HbS. Lower prevalence of malaria in HbAA with high HbF supports a protective effect of HbF. However, in HbSS, the higher prevalence of malaria with high levels of HbF suggests loss of malaria protection. This is the first epidemiological study to suggest a negative epistasis between HbF and HbS on malaria.	[Mmbando, Bruno P.; Mgaya, Josephine; Cox, Sharon E.; Mtatiro, Siana N.; Soka, Deogratias; Msaki, Evarist; Makani, Julie] Muhimbili Univ Hlth & Allied Sci, Dar Es Salaam, Tanzania; [Mmbando, Bruno P.] Natl Inst Med Res, Tanga, Tanzania; [Cox, Sharon E.] London Sch Hyg & Trop Med, London WC1, England; [Rwezaula, Stella; Meda, Elineema] Muhimbili Natl Hosp, Dar Es Salaam, Tanzania; [Snow, Robert W.] KEMRI Wellcome Trust Programme, Nairobi, Kenya; [Snow, Robert W.; Makani, Julie] Univ Oxford, Oxford, England; [Jeffries, Neal; Geller, Nancy L.] NHLBI, NIH, Bethesda, MD 20892 USA	Muhimbili University of Health & Allied Sciences; University of London; London School of Hygiene & Tropical Medicine; University of Oxford; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Mmbando, BP (corresponding author), Muhimbili Univ Hlth & Allied Sci, Dar Es Salaam, Tanzania.	bmmbando@muhimbili-wellcome.org	Makani, Julie/E-8525-2017; Cox, Sharon E/ABA-7986-2020; Snow, Robert William/AFR-1436-2022	Makani, Julie/0000-0002-4801-6250; Cox, Sharon E/0000-0002-9908-2936; Snow, Robert William/0000-0003-3725-6088; Mmbando, Bruno/0000-0001-7232-8708; Nkya, Siana/0000-0001-7576-6279	Wellcome Trust [080025, 084538, 079080, 103602]; NIH [4U41HG006941-02]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG006941] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This study was supported by Wellcome Trust (Project grant 080025; Strategic award 084538) to J. Makani (http://www.wellcome.ac.uk). B.P. Mmbando was supported by NIH through H3Africa (4U41HG006941-02, http://h3africa.org/). R.W. Snow is supported by The Wellcome Trust as a Principal Fellow (079080 & 103602, http://www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aidoo M, 2002, LANCET, V359, P1311, DOI 10.1016/S0140-6736(02)08273-9; ALLISON AC, 1954, BRIT MED J, V1, P290, DOI 10.1136/bmj.1.4857.290; Amaratunga C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014798; [Anonymous], 2013, 2012 TANZ POP HOUS C; Atkinson SH, 2014, BLOOD, V123, P2008, DOI 10.1182/blood-2013-10-533489; BLAU CA, 1993, BLOOD, V81, P227; Chen JJ, 2014, BLOOD, V124, P2622, DOI 10.1182/blood-2014-09-599290; European Union (EU), 2012, POPULATION HOUSING C; Haldane J.B.S., 1949, HEREDITAS, V35, P267; Makani J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014699; Makani J, 2010, BLOOD, V115, P215, DOI 10.1182/blood-2009-07-233528; PASVOL G, 1977, NATURE, V270, P171, DOI 10.1038/270171a0; PASVOL G, 1976, LANCET, V1, P1269; Penman BS, 2011, EVOLUTION, V65, P3625, DOI 10.1111/j.1558-5646.2011.01408.x; Penman BS, 2009, P NATL ACAD SCI USA, V106, P21242, DOI 10.1073/pnas.0910840106; Piel FB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001484; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Shear HL, 1998, BLOOD, V92, P2520, DOI 10.1182/blood.V92.7.2520.2520_2520_2526; Solovieff N, 2010, BLOOD, V115, P1815, DOI 10.1182/blood-2009-08-239517; Thein SL, 1998, HEMOGLOBIN, V22, P401, DOI 10.3109/03630269809071538; Williams TN, 2005, NAT GENET, V37, P1253, DOI 10.1038/ng1660	21	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0125929	10.1371/journal.pone.0125929	http://dx.doi.org/10.1371/journal.pone.0125929			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965586	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000354543500034
J	Valledor, L; Pascual, J; Meijon, M; Escandon, M; Canal, MJ				Valledor, Luis; Pascual, Jesus; Meijon, Monica; Escandon, Monica; Jesus Canal, Maria			Conserved Epigenetic Mechanisms Could Play a Key Role in Regulation of Photosynthesis and Development-Related Genes during Needle Development of Pinus radiata	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITOR; DNA METHYLATION; LEAF DEVELOPMENT; ARABIDOPSIS-THALIANA; IN-VITRO; ANACARDIC ACID; GENOMIC DNA; CHROMATIN; PLANTS; STRESS	Needle maturation is a complex process that involves cell growth, differentiation and tissue remodelling towards the acquisition of full physiological competence. Leaf induction mechanisms are well known; however, those underlying the acquisition of physiological competence are still poorly understood, especially in conifers. We studied the specific epigenetic regulation of genes defining organ function (PrRBCS and PrRBCA) and competence and stress response (PrCSDP2 and PrSHMT4) during three stages of needle development and one de-differentiated control. Gene-specific changes in DNA methylation and histone were analysed by bisulfite sequencing and chromatin immunoprecipitation (ChIP). The expression of PrRBCA and PrRBCS increased during needle maturation and was associated with the progressive loss of H3K9me3, H3K27me3 and the increase in AcH4. The maturation-related silencing of PrSHMT4 was correlated with increased H3K9me3 levels, and the repression of PrCSDP2, to the interplay between AcH4, H3K27me3, H3K9me3 and specific DNA methylation. The employ of HAT and HDAC inhibitors led to a further determination of the role of histone acetylation in the regulation of our target genes. The integration of these results with high-throughput analyses in Arabidopsis thaliana and Populus trichocarpa suggests that the specific epigenetic mechanisms that regulate photosynthetic genes are conserved between the analysed species.	[Valledor, Luis; Pascual, Jesus; Escandon, Monica; Jesus Canal, Maria] Univ Oviedo, Fac Biol, Plant Physiol, E-33071 Oviedo, Spain; [Valledor, Luis] Univ Aveiro, Dept Biol, P-3810193 Aveiro, Portugal; [Valledor, Luis] Univ Aveiro, CESAM, P-3810193 Aveiro, Portugal; [Meijon, Monica] Reg Inst Res & Agrofood Dev SERIDA, E-33825 Grado, Spain	University of Oviedo; Universidade de Aveiro; Universidade de Aveiro; Servicio Regional Investigacion Desarrollo Agroalimentario - SERIDA	Valledor, L (corresponding author), Univ Oviedo, Fac Biol, Plant Physiol, Cat Rodrigo Uria S-N, E-33071 Oviedo, Spain.	valledorluis@uniovi.es; mjcanal@uniovi.es	Valledor, Luis/E-8881-2017; Meijón, Mónica/G-7366-2016; Cañal, María Jesús/L-1005-2014; Martínez, Mónica Escandón/V-2371-2017; Valledor, Luis/B-4791-2010; Meijón, Mónica/N-6285-2014	Meijón, Mónica/0000-0003-1563-5554; Cañal, María Jesús/0000-0002-1639-9672; Martínez, Mónica Escandón/0000-0001-5686-106X; Valledor, Luis/0000-0002-0636-365X; Meijón, Mónica/0000-0003-1563-5554; Pascual Vazquez, Jesus/0000-0003-4822-409X	Ministry of Science and Innovation of the Spanish Government [AGL2007-62907, AGL2011-27904]; Juan de la Cierva Programme, (Spanish Ministry of Economy and Competitiveness) [JCI-2012-12444, JCI-2011-08958]; Severo Ochoa, (Gobierno del Principado de Asturias, Spain) [BP11117]; FPU, (Ministry of Education, Spain) [AP2010-5857]	Ministry of Science and Innovation of the Spanish Government(Spanish Government); Juan de la Cierva Programme, (Spanish Ministry of Economy and Competitiveness); Severo Ochoa, (Gobierno del Principado de Asturias, Spain); FPU, (Ministry of Education, Spain)	This work was supported by the Ministry of Science and Innovation of the Spanish Government, (Projects AGL2007-62907 and AGL2011-27904). LV and MM were funded by Juan de la Cierva Programme, (Spanish Ministry of Economy and Competitiveness, ref. JCI-2012-12444 and JCI-2011-08958, respectively). ME and JP's fellowships were respectively supported by Severo Ochoa, (Gobierno del Principado de Asturias, Spain, ref. BP11117) and FPU, (Ministry of Education, Spain, ref. AP2010-5857) grants.	Andriankaja M, 2012, DEV CELL, V22, P64, DOI 10.1016/j.devcel.2011.11.011; Barkoulas M, 2007, CURR OPIN PLANT BIOL, V10, P660, DOI 10.1016/j.pbi.2007.07.012; Baurens FC, 2004, TREE PHYSIOL, V24, P401, DOI 10.1093/treephys/24.4.401; Bennett T, 2006, PLANT MOL BIOL, V60, P843, DOI 10.1007/s11103-005-2763-4; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Blein T, 2008, SCIENCE, V322, P1835, DOI 10.1126/science.1166168; Blein T, 2010, CURR OPIN PLANT BIOL, V13, P75, DOI 10.1016/j.pbi.2009.09.017; Bonga JM, 2010, PLANT CELL TISS ORG, V100, P241, DOI 10.1007/s11240-009-9647-2; Brautigam K, 2013, ECOL EVOL, V3, P399, DOI 10.1002/ece3.461; Braybrook SA, 2010, PLANT CELL, V22, P1006, DOI 10.1105/tpc.110.073924; Charron J-BF, 2009, PLANT CELL TPC, V109; Chen M, 2010, DEV GROWTH DIFFER, V52, P555, DOI 10.1111/j.1440-169X.2010.01192.x; Cho KH, 2007, J PLANT BIOL, V50, P282, DOI 10.1007/BF03030656; Cui L, 2008, EUKARYOT CELL, V7, P1200, DOI 10.1128/EC.00063-08; Danker T, 2008, PLANT J, V53, P465, DOI 10.1111/j.1365-313X.2007.03352.x; De Carvalho DD, 2010, TRENDS CELL BIOL, V20, P609, DOI 10.1016/j.tcb.2010.08.003; De-la-Pena C, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-203; Eun SH, 2010, CURR OPIN CELL BIOL, V22, P737, DOI 10.1016/j.ceb.2010.09.004; Exner V, 2008, CURR OPIN PLANT BIOL, V11, P64, DOI 10.1016/j.pbi.2007.10.004; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Fleming AJ, 2005, NEW PHYTOL, V166, P9, DOI 10.1111/j.1469-8137.2004.01292.x; Fraga MF, 2002, PLANTA, V215, P672, DOI 10.1007/s00425-002-0795-4; Gonzalez N, 2012, TRENDS PLANT SCI, V17, P332, DOI 10.1016/j.tplants.2012.02.003; Grant-Downton RT, 2005, ANN BOT-LONDON, V96, P1143, DOI 10.1093/aob/mci273; Grant-Downton RT, 2006, ANN BOT-LONDON, V97, P11, DOI 10.1093/aob/mcj001; Hasbun R, 2008, PLANT PHYSIOL BIOCH, V46, P815, DOI 10.1016/j.plaphy.2008.04.009; He CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002911; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hemshekhar M, 2012, BASIC CLIN PHARMACOL, V110, P122, DOI 10.1111/j.1742-7843.2011.00833.x; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lafon-Placette C, 2013, NEW PHYTOL, V197, P416, DOI 10.1111/nph.12026; Lafos M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002040; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Li X, 2008, THE PLANT CELL TPC, V107; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Liu CY, 2010, ANNU REV PLANT BIOL, V61, P395, DOI 10.1146/annurev.arplant.043008.091939; Loidl P, 2004, TRENDS PLANT SCI, V9, P84, DOI 10.1016/j.tplants.2003.12.007; Meijon M, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-10; Micol JL, 2009, CURR OPIN PLANT BIOL, V12, P9, DOI 10.1016/j.pbi.2008.11.001; Mirouze M, 2011, CURR OPIN PLANT BIOL, V14, P267, DOI 10.1016/j.pbi.2011.03.004; Monteuuis O, 2009, SILVAE GENET, V58, P287, DOI 10.1515/sg-2009-0037; Moreno JI, 2005, PLANT J, V41, P451, DOI 10.1111/j.1365-313X.2004.02311.x; Nakaminami K, 2009, J EXP BOT, V60, P1047, DOI 10.1093/jxb/ern351; Nimmanapalli R, 2003, BLOOD, V101, P3236, DOI 10.1182/blood-2002-08-2675; Perrin RM, 2007, PLANT J, V49, P961, DOI 10.1111/j.1365-313X.2006.03015.x; R Development Core Team, 2012, R LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; RAISON RJ, 1992, FOREST ECOL MANAG, V52, P139, DOI 10.1016/0378-1127(92)90499-Y; Richon VM, 2006, BRIT J CANCER, V95, pS2, DOI 10.1038/sj.bjc.6603463; Sasaki K, 2012, FRONT PLANT SCI, V2, DOI [10.3389/fpls.2011.00115, DOI 10.3389/FPLS.2011.00115]; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schmitz RJ, 2012, TRENDS PLANT SCI, V17, P149, DOI 10.1016/j.tplants.2012.01.001; Schmitz RJ, 2009, PLANT PHYSIOL, V149, P1196, DOI 10.1104/pp.108.131508; Smith DR, 1996, GROWTH MEDIUM; Valledor L, 2014, PLANT J; Valledor L, 2007, PLANT CELL TISS ORG, V91, P75, DOI 10.1007/s11240-007-9262-z; Valledor L, 2012, PHYSIOL PLANTARUM, V146, P308, DOI 10.1111/j.1399-3054.2012.01629.x; Valledor L, 2010, J PROTEOME RES, V9, P3954, DOI 10.1021/pr1001669; Valledor L, 2010, J PLANT PHYSIOL, V167, P351, DOI 10.1016/j.jplph.2009.09.018; Vining KJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-27; Zhang MS, 2010, J GENET GENOMICS, V37, P1, DOI 10.1016/S1673-8527(09)60020-5; Zhang XY, 2007, PLOS BIOL, V5, P1026, DOI 10.1371/journal.pbio.0050129; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhang XY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r62	64	12	13	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0126405	10.1371/journal.pone.0126405	http://dx.doi.org/10.1371/journal.pone.0126405			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965766	Green Submitted, Green Published, gold			2022-12-26	WOS:000354543500058
J	Wozniak, MB; Scelo, G; Muller, DC; Mukeria, A; Zaridze, D; Brennan, P				Wozniak, Magdalena B.; Scelo, Ghislaine; Muller, David C.; Mukeria, Anush; Zaridze, David; Brennan, Paul			Circulating MicroRNAs as Non-Invasive Biomarkers for Early Detection of Non-Small-Cell Lung Cancer	PLOS ONE			English	Article							SERUM; EXPRESSION; SIGNATURES; DIAGNOSIS; TISSUES	Background Detection of lung cancer at an early stage by sensitive screening tests could be an important strategy to improving prognosis. Our objective was to identify a panel of circulating microRNAs in plasma that will contribute to early detection of lung cancer. Material and Methods Plasma samples from 100 early stage (I to IIIA) non-small-cell lung cancer (NSCLC) patients and 100 non-cancer controls were screened for 754 circulating microRNAs via qRT-PCR, using TaqMan MicroRNA Arrays. Logistic regression with a lasso penalty was used to select a panel of microRNAs that discriminate between cases and controls. Internal validation of model discrimination was conducted by calculating the bootstrap optimism-corrected AUC for the selected model. Results We identified a panel of 24 microRNAs with optimum classification performance. The combination of these 24 microRNAs alone could discriminate lung cancer cases from non-cancer controls with an AUC of 0.92 (95% CI: 0.87-0.95). This classification improved to an AUC of 0.94 (95% CI: 0.90-0.97) following addition of sex, age and smoking status to the model. Internal validation of the model suggests that the discriminatory power of the panel will be high when applied to independent samples with a corrected AUC of 0.78 for the 24-miRNA panel alone. Conclusion Our 24-microRNA predictor improves lung cancer prediction beyond that of known risk factors.	[Wozniak, Magdalena B.; Scelo, Ghislaine; Muller, David C.; Brennan, Paul] WHO, IARC, Genet Epidemiol Grp, Lyon, France; [Mukeria, Anush; Zaridze, David] NN Blokhin Canc Res Ctr, Inst Carcinogenesis, Moscow, Russia	World Health Organization; International Agency for Research on Cancer (IARC); N.N. Blokhin Russian Cancer Research Center	Brennan, P (corresponding author), WHO, IARC, Genet Epidemiol Grp, Lyon, France.	gep@iarc.fr	Scelo, Ghislaine/CAF-8077-2022; Muller, David C/V-8207-2017	Muller, David C/0000-0002-2350-0417	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Bach PB, 2012, JAMA-J AM MED ASSOC, V307, P2418, DOI 10.1001/jama.2012.5521; Bianchi F, 2011, EMBO MOL MED, V3, P495, DOI 10.1002/emmm.201100154; Boeri M, 2011, P NATL ACAD SCI USA, V108, P3713, DOI 10.1073/pnas.1100048108; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chen X, 2012, INT J CANCER, V130, P1620, DOI 10.1002/ijc.26177; Dvinge H, 2009, BIOINFORMATICS, V25, P3325, DOI 10.1093/bioinformatics/btp578; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Frampton A. E., 2014, ANN SURG; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Heegaard NHH, 2012, INT J CANCER, V130, P1378, DOI 10.1002/ijc.26153; Hennessey PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032307; Hu ZB, 2010, J CLIN ONCOL, V28, P1721, DOI 10.1200/JCO.2009.24.9342; Hurley James, 2012, Methods Mol Biol, V822, P33, DOI 10.1007/978-1-61779-427-8_3; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Kirschner Michaela B., 2013, Frontiers in Genetics, V4, P94, DOI 10.3389/fgene.2013.00094; Kirschner Michaela B., 2013, Frontiers in Genetics, V4, P56, DOI 10.3389/fgene.2013.00056; Lin LJ, 2013, GENE, V523, P158, DOI 10.1016/j.gene.2013.02.055; miRBase, 2014, MIRBASE MICRORNA DAT; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Shen J, 2011, LAB INVEST, V91, P579, DOI 10.1038/labinvest.2010.194; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sozzi G, 2014, J CLIN ONCOL; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041561	26	101	105	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0125026	10.1371/journal.pone.0125026	http://dx.doi.org/10.1371/journal.pone.0125026			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965386	Green Published, Green Submitted, gold			2022-12-26	WOS:000354543500007
J	Devi, YS; DeVine, M; DeKuiper, J; Ferguson, S; Fazleabas, AT				Devi, Y. Sangeeta; DeVine, Majesta; DeKuiper, Justin; Ferguson, Susan; Fazleabas, Asgerally T.			Inhibition of IL-6 Signaling Pathway by Curcumin in Uterine Decidual Cells	PLOS ONE			English	Article							SPONTANEOUS PRETERM BIRTH; TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; AMNIOTIC-FLUID; INTERLEUKIN-6 EXPRESSION; INFLAMMATORY CYTOKINES; STAT3 PHOSPHORYLATION; GENE-EXPRESSION; RECEPTOR; LABOR	IL-6 is a multifunctional pro-inflammatory cytokine and has been implicated in many gestational disorders including preterm birth. Currently, there are no appropriate therapeutic interventions available to circumvent inflammatory-mediated gestational disorders. Therefore, the goal of this study was to identify a safe and effective pharmacological compound to counterbalance inflammatory responses in the uterus. Curcumin, a naturally-occuring polyphenolic compound, has been widely used in alternative medicine to treat inflammatory diseases. However, the anti-inflammatory effect of curcumin has not been explored in uterine decidual cells, a major source of IL-6. Therefore, we examined the effect of curcumin on IL6 expression using two types of uterine decidual cells 1) HuF cells, primary human fibroblast cells obtained from the decidua parietalis; 2) UIII cells, a rodent non-transformed decidual cell line. Curcumin treatment completely abrogated the expression of IL-1 beta-induced IL-6 in these cells. Curcumin also strongly inhibited the expression of gp130, a critical molecule in IL-6 signaling, whereas expression of IL-6R and sIL-6R was not affected. Curcumin also inhibited phosphorylation and nuclear localization of STAT3, a well-known downstream mediator of IL-6 signaling. Furthermore, curcumin attenuated IL-1 beta-induced IL-6 promoter reporter activity suggesting transcriptional regulation. To further understand whether NF-kappa B is involved in this inhibition, we examined the effect of curcumin on the expression of p50 and p65 subunits of NF-kappa B in decidual cells. Expression of IL-1 beta-induced p50 mRNA was repressed by curcumin while p65 mRNA was not affected. However, curcumin treatment dramatically inhibited both p50 and p65 protein levels and prevented its nuclear localization. This effect is at least partly mediated through the deactivation of IKK, since IL-1 beta-induced IKK alpha/beta phosphorylation is decreased upon curcumin treatment. Our results not only revealed molecular mechanisms underlying curcumin action in uterine decidual cells but also suggest that this compound may have therapeutic potential for the prevention of inflammation- mediated preterm birth and other gestational disorders.	[Devi, Y. Sangeeta; DeVine, Majesta; DeKuiper, Justin; Ferguson, Susan; Fazleabas, Asgerally T.] Michigan State Univ, Coll Human Med, Dept Obstet Gynecol & Reprod Biol, Grand Rapids, MI 49503 USA	Michigan State University; Michigan State University College of Human Medicine	Devi, YS (corresponding author), Michigan State Univ, Coll Human Med, Dept Obstet Gynecol & Reprod Biol, Grand Rapids, MI 49503 USA.	sangeeta@hc.msu.edu			Michigan Alliance at Department of Obstetrics, Gynecology and Reproductive Biology, Michigan State University (YSD), National Institute Health [RO1HD42280]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD055764, R01HD042280] Funding Source: NIH RePORTER	Michigan Alliance at Department of Obstetrics, Gynecology and Reproductive Biology, Michigan State University (YSD), National Institute Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by Michigan Alliance at Department of Obstetrics, Gynecology and Reproductive Biology, Michigan State University (YSD), National Institute Health, RO1HD42280 (ATF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2009, TRENDS PHARMACOL SCI, V30, P85, DOI 10.1016/j.tips.2008.11.002; Aggarwal BB, 2009, INT J BIOCHEM CELL B, V41, P40, DOI 10.1016/j.biocel.2008.06.010; Arntzen KJ, 1999, J REPROD IMMUNOL, V45, P113; Bartuzi P, 2013, BBA-MOL BASIS DIS, V1832, P2315, DOI 10.1016/j.bbadis.2013.09.014; Berghella V, 2012, AM J OBSTET GYNECOL, V206, P376, DOI 10.1016/j.ajog.2012.03.010; Bermas BL, 2014, CURR OPIN RHEUMATOL, V26, P334, DOI 10.1097/BOR.0000000000000054; Bharti AC, 2003, J IMMUNOL, V171, P3863, DOI 10.4049/jimmunol.171.7.3863; Chan RL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/164081; Christiaens I, 2008, J REPROD IMMUNOL, V79, P50, DOI 10.1016/j.jri.2008.04.002; COHEN H, 1993, EUR J CELL BIOL, V61, P116; Deb S, 1999, ENDOCRINOLOGY, V140, P4442, DOI 10.1210/en.140.10.4442; DENDORFER U, 1994, MOL CELL BIOL, V14, P4443, DOI 10.1128/MCB.14.7.4443; Devi YS, 2009, ENDOCRINOLOGY, V150, P3327, DOI 10.1210/en.2008-1719; DUDLEY DJ, 1992, J CLIN ENDOCR METAB, V74, P884, DOI 10.1210/jc.74.4.884; DUDLEY DJ, 1993, BIOL REPROD, V48, P33, DOI 10.1095/biolreprod48.1.33; FRANCHIMONT N, 1995, ENDOCRINOLOGY, V136, P5469, DOI 10.1210/en.136.12.5469; Glienke W, 2010, CANCER INVEST, V28, P166, DOI 10.3109/07357900903287006; Goel A, 2008, MOL NUTR FOOD RES, V52, P1010, DOI 10.1002/mnfr.200700354; Haddad R, 2006, AM J OBSTET GYNECOL, V195, P394, DOI 10.1016/j.ajog.2005.08.057; HALGUNSET J, 1994, EUR J OBSTET GYN R B, V56, P153, DOI 10.1016/0028-2243(94)90162-7; Hartel C, 2004, MOL HUM REPROD, V10, P911, DOI 10.1093/molehr/gah120; Isik Y, 2013, GINEKOL POL, V84, P368; Jeon YJ, 2000, IMMUNOPHARMACOLOGY, V48, P173, DOI 10.1016/S0162-3109(00)00199-5; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; Jun JK, 2000, AM J OBSTET GYNECOL, V183, P868, DOI 10.1067/mob.2000.109034; Keelan JA, 2003, PLACENTA, V24, pS33, DOI 10.1053/plac.2002.0948; Khalife N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081394; Lee SY, 2011, J IMMUNOL, V186, P3226, DOI 10.4049/jimmunol.1003587; Li FX, 2008, BIOL REPROD, V78, P127, DOI 10.1095/biolreprod.107.063313; Lim R, 2013, MOL HUM REPROD, V19, P451, DOI 10.1093/molehr/gat015; Lockwood CJ, 2008, AM J PATHOL, V172, P1571, DOI 10.2353/ajpath.2008.070629; Lockwood CJ, 2010, AM J PATHOL, V177, P1755, DOI 10.2353/ajpath.2010.090781; MITCHELL MD, 1991, EUR J PHARMACOL, V192, P189, DOI 10.1016/0014-2999(91)90090-D; Moisiadis VG, 2014, NAT REV ENDOCRINOL, V10, P403, DOI 10.1038/nrendo.2014.74; Naugler WE, 2008, TRENDS MOL MED, V14, P109, DOI 10.1016/j.molmed.2007.12.007; Olson DM, 2007, FRONT BIOSCI-LANDMRK, V12, P1329, DOI 10.2741/2151; Prigent-Tessier A, 2001, ENDOCRINOLOGY, V142, P1242, DOI 10.1210/en.142.3.1242; Prins JR, 2012, J REPROD IMMUNOL; RAMBALDI A, 1993, BRIT J HAEMATOL, V83, P204, DOI 10.1111/j.1365-2141.1993.tb08273.x; Robertson SA, 2010, ENDOCRINOLOGY, V151, P3996, DOI 10.1210/en.2010-0063; ROMERO R, 1990, J CLIN INVEST, V85, P1392, DOI 10.1172/JCI114583; Romero R, 2006, MED INTELL UNIT, P253; Saydmohammed M, 2010, J CELL BIOCHEM, V110, P447, DOI 10.1002/jcb.22558; Shehzad A, 2013, BIOFACTORS, V39, P69, DOI 10.1002/biof.1066; Simhan HN, 2003, AM J OBSTET GYNECOL, V189, P915, DOI 10.1067/S0002-9378(03)00843-3; SINGH S, 1995, J BIOL CHEM, V270, P24995, DOI 10.1074/jbc.270.42.24995; Smith V, 2009, EUR J OBSTET GYN R B, V142, P3, DOI 10.1016/j.ejogrb.2008.09.008; Strakova Z, 2008, CELL TISSUE RES, V332, P479, DOI 10.1007/s00441-008-0604-x; Sugino N, 1998, ENDOCRINOLOGY, V139, P1936, DOI 10.1210/en.139.4.1936; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Taylor BD, 2013, HUM REPROD, V28, P942, DOI 10.1093/humrep/det019; TRAUTWEIN C, 1993, NATURE, V364, P544, DOI 10.1038/364544a0; Vanden Berghe W, 2000, BIOCHEM PHARMACOL, V60, P1185, DOI 10.1016/S0006-2952(00)00412-3; Velez DR, 2008, HUM MOL GENET, V17, P1619, DOI 10.1093/hmg/ddn049; Wei SQ, 2010, OBSTET GYNECOL, V116, P393, DOI 10.1097/AOG.0b013e3181e6dbc0; Yeagley David, 2010, Int J Interferon Cytokine Mediat Res, V2010, P9; Zhou HY, 2011, CURR DRUG TARGETS, V12, P332, DOI 10.2174/138945011794815356	57	33	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0125627	10.1371/journal.pone.0125627	http://dx.doi.org/10.1371/journal.pone.0125627			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961579	gold, Green Published, Green Submitted			2022-12-26	WOS:000354542500039
J	Virta, M; Hiltunen, S; Mattsson, M; Kallio, S				Virta, Maarit; Hiltunen, Seppo; Mattsson, Markus; Kallio, Sakari			The Impact of Hypnotic Suggestions on Reaction Times in Continuous Performance Test in Adults with ADHD and Healthy Controls	PLOS ONE			English	Article							COGNITIVE-BEHAVIORAL THERAPY; DISORDER ADHD; DEFAULT MODE; STROOP TASK; GROUP SCALE; HYPNOSIS; ATTENTION; SUSCEPTIBILITY; CONNECTIVITY; CONFLICT	Attention is one of the key factors in both hypnotic processes and patients with ADHD. In addition, the brain areas associated with hypnosis and ADHD overlap in many respects. However, the use of hypnosis in ADHD patients has still received only minor attention in research. The main purpose of the present work was to investigate whether hypnosis and hypnotic suggestions influence the performance of adult ADHD (n = 27) and control participants (n = 31) in the continuous performance test (CPT). The hypnotic susceptibility of the participants was measured by the Harvard Group Scale of Hypnotic Susceptibility (HGSHS: A) and the attentional task was a three minute long auditory version of the CPT. The CPT task was administered four times: before hypnosis (CPT1), after a hypnotic induction (CPT2), after suggestions about speed and accuracy (CPT3), and after the termination of hypnosis (CPT4). The susceptibility of the groups measured by HGSHS: A did not differ. There was a statistically significant decrease in reaction times in both ADHD and control groups between CPT2 and CPT3. The differences between CPT1 and CPT2, even though non-significant, were different in the two groups: in the ADHD group reaction times decreased whereas in the control group they increased. Both groups made very few errors in the short CPT. This study indicates that hypnotic suggestions have an effect on reaction times in the sustained attention task both in adult ADHD patients and control subjects. The theoretical and clinical implications are discussed.	[Virta, Maarit; Hiltunen, Seppo] Univ Helsinki, Inst Behav Sci, Div Cognit & Neuropsychol, Helsinki, Finland; [Hiltunen, Seppo; Mattsson, Markus] Univ Helsinki, Inst Behav Sci, Ctr Res & Dev Higher Educ, Helsinki, Finland; [Kallio, Sakari] Univ Skovde, Sch Biosci, Dept Cognit Neurosci & Philosophy, Skovde, Sweden; [Kallio, Sakari] Univ Turku, Ctr Cognit Neurosci, Turku, Finland	University of Helsinki; University of Helsinki; University of Skovde; University of Turku	Virta, M (corresponding author), Univ Helsinki, Inst Behav Sci, Div Cognit & Neuropsychol, Helsinki, Finland.	maarit.virta@helsinki.fi		Virta, Maarit/0000-0003-4471-6142; Mattsson, Markus/0000-0001-9063-8363	Society of Scientific Hypnosis In Finland	Society of Scientific Hypnosis In Finland	SH received personal grant from Society of Scientific Hypnosis In Finland. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advokat Claire, 2007, J Atten Disord, V10, P253, DOI 10.1177/1087054706292106; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Balint S, 2009, PSYCHOL MED, V39, P1337, DOI 10.1017/S0033291708004236; Brown T.E., 2006, ATTENTION DEFICIT DI; Cao M, 2014, MOL NEUROBIOL, V50, P1111, DOI 10.1007/s12035-014-8685-x; Cardena E, 2009, INT J CLIN EXP HYP, V57, P222, DOI 10.1080/00207140802665484; COE WC, 1979, AM PSYCHOL, V34, P673, DOI 10.1037/0003-066X.34.8.673; Cortese S, 2012, AM J PSYCHIAT, V169, P1038, DOI 10.1176/appi.ajp.2012.11101521; Cortese S, 2012, EUR J PAEDIATR NEURO, V16, P422, DOI 10.1016/j.ejpn.2012.01.009; Coxe S, 2009, J PERS ASSESS, V91, P121, DOI 10.1080/00223890802634175; Deeley Q, 2012, INT J CLIN EXP HYP, V60, P206, DOI 10.1080/00207144.2012.648070; Demertzi A, 2011, PROG BRAIN RES, V193, P309, DOI 10.1016/B978-0-444-53839-0.00020-X; DEROGATIS L R, 1973, Psychopharmacology Bulletin, V9, P13; Durston S, 2011, BIOL PSYCHIAT, V69, P1178, DOI 10.1016/j.biopsych.2010.07.037; Egner T, 2005, NEUROIMAGE, V27, P969, DOI 10.1016/j.neuroimage.2005.05.002; Elton A, 2014, HUM BRAIN MAPP, V35, P4531, DOI 10.1002/hbm.22492; Epstein JN, 1998, CLIN NEUROPSYCHOL, V12, P155, DOI 10.1076/clin.12.2.155.2000; Fingelkurts AA, 2007, CONT HYPNOSIS, V24, P3, DOI DOI 10.1002/CH.327; Fingelkurts AA, 2007, NEUROPSYCHOLOGIA, V45, P1452, DOI 10.1016/j.neuropsychologia.2006.11.018; Gualtieri C Thomas, 2006, J Atten Disord, V9, P534, DOI 10.1177/1087054705283758; Hervey AS, 2004, NEUROPSYCHOLOGY, V18, P485, DOI 10.1037/0894-4105.18.3.485; Hiltunen S, 2014, CONT HYPN INTEGR THE, V30, P118; Hoeft F, 2012, ARCH GEN PSYCHIAT, V69, P1064, DOI 10.1001/archgenpsychiatry.2011.2190; Huang-Pollock CL, 2012, J ABNORM PSYCHOL, V121, P360, DOI 10.1037/a0027205; Iani C, 2006, PSYCHOL SCI, V17, P721, DOI 10.1111/j.1467-9280.2006.01772.x; Iani C, 2009, CONSCIOUS COGN, V18, P856, DOI 10.1016/j.concog.2009.07.002; Jamieson GA, 2005, BRAIN RES BULL, V67, P298, DOI 10.1016/j.brainresbull.2005.06.033; Kallio S, 2001, INT J CLIN EXP HYP, V49, P95, DOI 10.1080/00207140108410061; Kallio S, 1996, HARVARDIN HYPNOOSIHE; Kallio SPI, 1999, INT J CLIN EXP HYP, V47, P227, DOI 10.1080/00207149908410034; Karlin R A, 1979, J Abnorm Psychol, V88, P92, DOI 10.1037/0021-843X.88.1.92; Kessler RC, 2005, PSYCHOL MED, V35, P245, DOI 10.1017/S0033291704002892; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; Lifshitz M, 2013, CORTEX, V49, P463, DOI 10.1016/j.cortex.2012.08.007; MACLEOD CM, 1992, J EXP PSYCHOL GEN, V121, P12, DOI 10.1037/0096-3445.121.1.12; MacLeod CM, 2003, CONSCIOUS COGN, V12, P347, DOI 10.1016/S1053-8100(03)00025-4; McCarthy H, 2013, JAMA PSYCHIAT, V70, P1329, DOI 10.1001/jamapsychiatry.2013.2174; McGeown WJ, 2009, CONSCIOUS COGN, V18, P848, DOI 10.1016/j.concog.2009.09.001; Naish P, 2014, CONT HYPN, V30, P116; Oakley DA, 2009, TRENDS COGN SCI, V13, P264, DOI 10.1016/j.tics.2009.03.004; Philipsen A, 2007, J NERV MENT DIS, V195, P1013, DOI 10.1097/NMD.0b013e31815c088b; Posner J, 2014, NEUROPSYCHOL REV, V24, P3, DOI 10.1007/s11065-014-9251-z; Rainville P, 2002, J COGNITIVE NEUROSCI, V14, P887, DOI 10.1162/089892902760191117; Raz A, 2006, PSYCHOL SCI, V17, P91, DOI 10.1111/j.1467-9280.2006.01669.x; Raz A, 2005, P NATL ACAD SCI USA, V102, P9978, DOI 10.1073/pnas.0503064102; Raz A, 2005, INT J CLIN EXP HYP, V53, P237, DOI 10.1080/00207140590961295; Raz A, 2002, ARCH GEN PSYCHIAT, V59, P1155, DOI 10.1001/archpsyc.59.12.1155; Raz A, 2007, CONSCIOUS COGN, V16, P331, DOI 10.1016/j.concog.2006.04.004; Raz A, 2011, CONSCIOUS COGN, V20, P312, DOI 10.1016/j.concog.2009.09.013; Raz S, 2014, ASSESSMENT, V21, P108, DOI 10.1177/1073191112443409; Riccio CA, 2002, ARCH CLIN NEUROPSYCH, V17, P235, DOI 10.1016/S0887-6177(01)00111-1; Safren SA, 2005, BEHAV RES THER, V43, P831, DOI 10.1016/j.brat.2004.07.001; Shor R. E., 1962, HARVARD GROUP SCALE; Solanto MV, 2010, AM J PSYCHIAT, V167, P958, DOI 10.1176/appi.ajp.2009.09081123; Virta M, 2010, CONT HYPN, V27, P5; Virta M, 2010, NEUROPSYCH DIS TREAT, V6, P443; Virta M, 2008, J ATTEN DISORD, V12, P218, DOI 10.1177/1087054707311657; Weitzenhoffer AM, 1962, STANFORD HYPNOTIC SU, V27; Williams JD, 2001, INT J CLIN EXP HYP, V49, P185, DOI 10.1080/00207140108410070; ZAMANSKY HS, 1964, J PERS, V32, P236, DOI 10.1111/j.1467-6494.1964.tb01338.x	60	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126497	10.1371/journal.pone.0126497	http://dx.doi.org/10.1371/journal.pone.0126497			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI1YY	25962151	Green Published, gold, Green Submitted			2022-12-26	WOS:000354542500106
J	Xu, H; Sun, HY; Zhang, HY; Liu, JW; Fan, FF; Li, YL; Ning, XL; Sun, Y; Dai, SC; Liu, BG; Gao, M; Fu, SB; Zhou, CS				Xu, Hui; Sun, Huiying; Zhang, Haiyuan; Liu, Jiawei; Fan, Fangfang; Li, Yilan; Ning, Xuelian; Sun, Yue; Dai, Shaochun; Liu, Baogang; Gao, Min; Fu, Songbin; Zhou, Chunshui			An ShRNA Based Genetic Screen Identified Sesn2 as a Potential Tumor Suppressor in Lung Cancer via Suppression of Akt-mTOR-p70S6K Signaling	PLOS ONE			English	Article							EXPRESSION; SESTRIN2; STRESS; BREAST; ACTIVATION; PATHWAY; TARGET; MTORC1; AKT	Background Lung cancer is emerging rapidly as the leading death cause in Chinese cancer patients. The causal factors for Chinese lung cancer development remain largely unclear. Here we employed an shRNA library-based loss-of-function screen in a genome-wide and unbiased manner to interrogate potential tumor suppressor candidates in the immortalized human lung epithelial cell line BEAS-2B. Methods/Results Soft agar assays were conducted for screening BEAS-2B cells infected with the retroviral shRNA library with the acquired feature of anchorage-independent growth, large (>0.5mm in diameter) and well-separated colonies were isolated for proliferation. PCRs were performed to amplify the integrated shRNA fragment from individual genomic DNA extracted from each colony, and each PCR product is submitted for DNA sequencing to reveal the integrated shRNA and its target gene. A total of 6 candidate transformation suppressors including INPP4B, Sesn2, TIAR, ACRC, Nup210, LMTK3 were identified. We validated Sesn2 as the candidate of lung cancer tumor suppressor. Knockdown of Sesn2 by an shRNA targeting 3' UTR of Sesn2 transcript potently stimulated the proliferation and malignant transformation of lung bronchial epithelial cell BEAS-2B via activation of Akt-mTORp70S6K signaling, whereas ectopic expression of Sens2 re-suppressed the malignant transformation elicited by the Sesn2 shRNA. Moreover, knockdown of Sesn2 in BEAS-2B cells promoted the BEAS-2B cell-transplanted xenograft tumor growth in nude mice. Lastly, DNA sequencing indicated mutations of Sesn2 gene are rare, the protein levels of Sesn2 of 77 Chinese lung cancer patients varies greatly compared to their adjacent normal tissues, and the low expression level of Sesn2 associates with the poor survival in these examined patients by Kaplan Meier analysis. Conclusions Our shRNA-based screen has demonstrated Sesn2 is a potential tumor suppressor in lung epithelial cells. The expression level of Sesn2 may serve as a prognostic marker for Chinese lung cancer patients in the clinic.	[Xu, Hui; Sun, Huiying; Zhang, Haiyuan; Liu, Jiawei; Fan, Fangfang; Li, Yilan; Ning, Xuelian; Sun, Yue; Fu, Songbin; Zhou, Chunshui] Harbin Med Univ, Med Genet Lab, Harbin, Peoples R China; [Dai, Shaochun; Liu, Baogang] Harbin Med Univ, Tumor Hosp, Harbin, Peoples R China; [Gao, Min] Harbin Med Univ, Affiliated Hosp 4, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Zhou, CS (corresponding author), Harbin Med Univ, Med Genet Lab, Harbin, Peoples R China.	Chunshuizhou@163.com	fan, fang/GQY-9173-2022; Fan, Fang/GRO-2696-2022	Xu, Hui/0000-0002-7596-8011	Natural Sciences Foundation of China [81272582]	Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	Funding was provided by the Natural Sciences Foundation of China (grant No. 81272582). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balmain A, 2003, NAT GENET, V33, P238, DOI 10.1038/ng1107; Ben-Sahra I, 2013, CELL DEATH DIFFER, V20, P611, DOI 10.1038/cdd.2012.157; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Budanov AV, 2002, ONCOGENE, V21, P6017, DOI 10.1038/sj.onc.1205877; Chang K, 2006, NAT METHODS, V3, P707, DOI 10.1038/NMETH923; Chen CC, 2010, DEV CELL, V18, P592, DOI 10.1016/j.devcel.2010.03.008; Ding J, 2009, J BIOL CHEM, V284, P33311, DOI 10.1074/jbc.M109.046417; Fedele CG, 2010, P NATL ACAD SCI USA, V107, P22231, DOI 10.1073/pnas.1015245107; Gewinner C, 2009, CANCER CELL, V16, P115, DOI 10.1016/j.ccr.2009.06.006; Hay N, 2008, CELL METAB, V8, P184, DOI 10.1016/j.cmet.2008.08.010; Hodgson MC, 2011, CANCER RES, V71, P572, DOI 10.1158/0008-5472.CAN-10-2314; Izquierdo JM, 2011, BIOCHEM J, V435, P337, DOI 10.1042/BJ20101030; Larsen JE, 2011, CLIN CHEST MED, V32, P703, DOI 10.1016/j.ccm.2011.08.003; Lee JH, 2012, CELL METAB, V16, P311, DOI 10.1016/j.cmet.2012.08.004; Lee JH, 2010, SCIENCE, V327, P1223, DOI 10.1126/science.1182228; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Mogi A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/583929; Ragnarsson G, 1999, BRIT J CANCER, V79, P1468, DOI 10.1038/sj.bjc.6690234; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Sanli T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032035; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Sun TT, 2011, CELL, V144, P703, DOI 10.1016/j.cell.2011.02.003; Velasco-Miguel S, 1999, ONCOGENE, V18, P127, DOI 10.1038/sj.onc.1202274; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yanagawa N, 2012, J THORAC ONCOL, V7, P1513, DOI 10.1097/JTO.0b013e3182641d4f; Yu HA, 2013, NAT REV CLIN ONCOL, V10, P551, DOI 10.1038/nrclinonc.2013.154; Zhang W, 2012, CELL RES, V24, P331; Zhao JJ, 2003, CANCER CELL, V3, P483, DOI 10.1016/S1535-6108(03)00088-6	32	17	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0124033	10.1371/journal.pone.0124033	http://dx.doi.org/10.1371/journal.pone.0124033			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962159	gold, Green Published, Green Submitted			2022-12-26	WOS:000354542500009
J	Zhang, YF; Zhang, Y; Chen, J; Liu, YY; Luo, W				Zhang, Yunfei; Zhang, Yong; Chen, Jun; Liu, Yunyan; Luo, Wen			Dendritic-Tumor Fusion Cells Derived Heat Shock Protein70-Peptide Complex Has Enhanced Immunogenicity	PLOS ONE			English	Article							CD4(+) T-CELLS; HEAT-SHOCK-PROTEIN-70 PEPTIDE COMPLEXES; ESTABLISHED MELANOMA; PROTEIN PREPARATIONS; METASTATIC MELANOMA; IMMUNOTHERAPY; ANTIGEN; VACCINE; PHASE; GP96	Tumor-derived heat shock protein70-peptide complexes (HSP70.PC-Tu) have shown great promise in tumor immunotherapy due to numerous advantages. However, large-scale phase III clinical trials showed that the limited immunogenicity remained to be enhanced. In previous research, we demonstrated that heat shock protein 70-peptide complexes (HSP70.PC-Fc) derived from dendritic cell (DC)-tumor fusions exhibit enhanced immunogenicity compared with HSP70.PCs from tumor cells. However, the DCs used in our previous research were obtained from healthy donors and not from the patient population. In order to promote the clinical application of these complexes, HSP70.PC-Fc was prepared from patient-derived DC fused directly with patient-derived tumor cells in the current study. Our results showed that compared with HSP70.PC-Tu, HSP70.PC-Fc elicited much more powerful immune responses against the tumor from which the HSP70 was derived, including enhanced T cell activation, and CTL responses that were shown to be antigen specific and HLA restricted. Our results further indicated that the enhanced immunogenicity is related to the activation of CD4+ T cells and increased association with other heat shock proteins, such as HSP90. Therefore, the current study confirms the enhanced immunogenicity of HSP70. PC derived from DC-tumor fusions and may provide direct evidence promoting their future clinical use.	[Zhang, Yunfei; Zhang, Yong; Chen, Jun; Liu, Yunyan] Fourth Mil Med Univ, Tangdu Hosp, Orthopaed Oncol Inst PLA, Dept Orthopaed, Xian 710032, Shaanxi Provinc, Peoples R China; [Luo, Wen] Fourth Mil Med Univ, Xijing Hosp, Dept Ultrasound, Xian 710032, Shaanxi Provinc, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Luo, W (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Ultrasound, Changle Rd, Xian 710032, Shaanxi Provinc, Peoples R China.	drluowen@163.com			Nature Science Foundation of China [81000918/81201106]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors acknowledge the grant support of Nature Science Foundation of China (81000918/81201106)(http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony PA, 2005, J IMMUNOL, V174, P2591, DOI 10.4049/jimmunol.174.5.2591; Castelli C, 2001, CANCER RES, V61, P222; Chernikov V. A., 2012, Biomeditsinskaya Khimiya, V58, P651; Ciocca DR, 2012, CURR MOL MED, V12, P1183, DOI 10.2174/156652412803306684; Crane CA, 2013, CLIN CANCER RES, V19, P205, DOI 10.1158/1078-0432.CCR-11-3358; di Pietro A, 2011, EXPERT OPIN BIOL TH, V11, P1395, DOI 10.1517/14712598.2011.605353; Eton O, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-9; Gao YW, 2012, ONCOL REP, V28, P1977, DOI 10.3892/or.2012.2051; Ge W, 2009, ONCOL REP, V22, P915, DOI 10.3892/or_00000517; Gong JL, 2010, J IMMUNOL, V184, P488, DOI 10.4049/jimmunol.0902255; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Kojima T, 2003, HUM GENE THER, V14, P715, DOI 10.1089/104303403765255129; Kovalchin J T, 2001, Cancer Immun, V1, P7; Kurotaki T, 2007, J IMMUNOL, V179, P1803, DOI 10.4049/jimmunol.179.3.1803; Li G, 2007, CLIN EXP IMMUNOL, V148, P136, DOI 10.1111/j.1365-2249.2007.03323.x; Lu ZB, 2000, J EXP MED, V191, P541, DOI 10.1084/jem.191.3.541; Milani V, 2002, INT J HYPERTHER, V18, P563, DOI 10.1080/02656730210166140; Murshid Ayesha, 2013, Methods Mol Biol, V960, P209, DOI 10.1007/978-1-62703-218-6_17; Murshid A, 2011, EXPERT REV VACCINES, V10, P1553, DOI [10.1586/erv.11.124, 10.1586/ERV.11.124]; Nicchitta CV, 1998, CURR OPIN IMMUNOL, V10, P103, DOI 10.1016/S0952-7915(98)80039-3; Noessner E, 2002, J IMMUNOL, V169, P5424, DOI 10.4049/jimmunol.169.10.5424; Park JY, 2010, J IMMUNOTHER, V33, P510, DOI 10.1097/CJI.0b013e3181d75cef; Pilla L, 2006, CANCER IMMUNOL IMMUN, V55, P958, DOI 10.1007/s00262-005-0084-8; Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918; Randazzo M, 2012, INT J CANCER, V130, P2219, DOI 10.1002/ijc.27332; Sato K, 2001, BLOOD, V98, P1852, DOI 10.1182/blood.V98.6.1852; See AP, 2011, EXPERT REV VACCINES, V10, P721, DOI [10.1586/erv.11.49, 10.1586/ERV.11.49]; Shinagawa N, 2008, CANCER IMMUNOL IMMUN, V57, P165, DOI 10.1007/s00262-007-0359-3; Srivastava PK, 2000, NAT IMMUNOL, V1, P363, DOI 10.1038/80795; SRIVASTAVA PK, 1986, P NATL ACAD SCI USA, V83, P3407, DOI 10.1073/pnas.83.10.3407; SRIVASTAVA PK, 1994, IMMUNOGENETICS, V39, P93; Tamura Y, 1997, SCIENCE, V278, P117, DOI 10.1126/science.278.5335.117; Testori A, 2008, J CLIN ONCOL, V26, P955, DOI 10.1200/JCO.2007.11.9941; Tosti G, 2014, EXPERT OPIN BIOL TH, V14, P955, DOI 10.1517/14712598.2014.902928; Tsuji T, 2012, J IMMUNOL, V188, P3851, DOI 10.4049/jimmunol.1103269; Vanaja DK, 2000, CANCER RES, V60, P4714; Wood C, 2008, LANCET, V372, P145, DOI 10.1016/S0140-6736(08)60697-2; Xie Y, 2010, J EXP MED, V207, P651, DOI 10.1084/jem.20091921; Zhang YF, 2013, ONCOL LETT, V6, P1543, DOI 10.3892/ol.2013.1616	39	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126075	10.1371/journal.pone.0126075	http://dx.doi.org/10.1371/journal.pone.0126075			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961716	Green Published, Green Submitted, gold			2022-12-26	WOS:000354542500061
J	Rosenberg, M; Pettifor, A; Van Rie, A; Thirumurthy, H; Emch, M; Miller, WC; Gomez-Olive, FX; Twine, R; Hughes, JP; Laeyendecker, O; Selin, A; Kahn, K				Rosenberg, Molly; Pettifor, Audrey; Van Rie, Annelies; Thirumurthy, Harsha; Emch, Michael; Miller, William C.; Gomez-Olive, F. Xavier; Twine, Rhian; Hughes, James P.; Laeyendecker, Oliver; Selin, Amanda; Kahn, Kathleen			The Relationship between Alcohol Outlets, HIV Risk Behavior, and HSV-2 Infection among South African Young Women: A Cross-Sectional Study	PLOS ONE			English	Article							SERVING ESTABLISHMENTS; SEXUAL-BEHAVIOR; CONSUMPTION; HEALTH; MEN; METAANALYSIS; ASSOCIATION; HIV/AIDS; PARTNERS; FOCUS	Background Alcohol consumption has a disinhibiting effect that may make sexual risk behaviors and disease transmission more likely. The characteristics of alcohol- serving outlets (e.g. music, dim lights, lack of condoms) may further encourage risky sexual activity. We hypothesize that frequenting alcohol outlets will be associated with HIV risk. Methods In a sample of 2,533 school- attending young women in rural South Africa, we performed a cross- sectional analysis to examine the association between frequency of alcohol outlet visits in the last six months and four outcomes related to HIV risk: number of sex partners in the last three months, unprotected sex acts in the last three months, transactional sex with most recent partner, and HSV- 2 infection. We also tested for interaction by alcohol consumption. Results Visiting alcohol outlets was associated with having more sex partners [adjusted odds ratio (aOR), one versus zero partners (95% confidence interval (CI)): 1.51 (1.21, 1.88)], more unprotected sex acts [aOR, one versus zero acts ( 95% CI): 2.28 ( 1.52, 3.42)], higher levels of transactional sex [aOR ( 95% CI): 1.63 ( 1.03, 2.59)], and HSV-2 infection [aOR ( 95% CI): 1.30 ( 0.88, 1.91)]. In combination with exposure to alcohol consumption, visits to alcohol outlets were more strongly associated with all four outcomes than with either risk factor alone. Statistical evidence of interaction between alcohol outlet visits and alcohol consumption was observed for all outcomes except transactional sex. Conclusions Frequenting alcohol outlets was associated with increased sexual risk in rural South African young women, especially when they consumed alcohol. Sexual health interventions targeted at alcohol outlets may effectively reach adolescents at high risk for sexually transmitted infections like HIV and HSV-2.	[Rosenberg, Molly] Harvard Univ, Ctr Populat & Dev Studies, Cambridge, MA 02138 USA; [Rosenberg, Molly; Pettifor, Audrey; Van Rie, Annelies; Emch, Michael; Miller, William C.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Rosenberg, Molly; Pettifor, Audrey; Thirumurthy, Harsha; Emch, Michael; Selin, Amanda] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC USA; [Thirumurthy, Harsha] Univ N Carolina, Dept Hlth Policy & Management, Chapel Hill, NC USA; [Emch, Michael] Univ N Carolina, Dept Geog, Chapel Hill, NC USA; [Miller, William C.] Univ N Carolina, Sch Med, Dept Med, Div Infect Dis, Chapel Hill, NC USA; [Pettifor, Audrey; Gomez-Olive, F. Xavier; Twine, Rhian; Kahn, Kathleen] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, MRC Wits Rural Publ Hlth & Hlth Transit Res Unit, Johannesburg, South Africa; [Hughes, James P.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Laeyendecker, Oliver] NIAID, Immunoregulat Lab, NIH, Baltimore, MD USA; [Laeyendecker, Oliver] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Kahn, Kathleen] Umea Univ, Ctr Global Hlth Res, Umea, Sweden; [Gomez-Olive, F. Xavier; Kahn, Kathleen] INDEPTH Network, Accra, Ghana	Harvard University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Witwatersrand; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); NIH National Institute on Aging (NIA); Johns Hopkins University; Umea University; INDEPTH Network	Rosenberg, M (corresponding author), Harvard Univ, Ctr Populat & Dev Studies, Cambridge, MA 02138 USA.	mrosenb@hsph.harvard.edu	Miller, William C/H-4800-2014; Gómez-Olivé, Francesc Xavier/AAP-7673-2021; Van Rie, Annelies/C-2082-2017; Pettifor, Audrey/H-6793-2019	Miller, William C/0000-0002-1934-7827; Gómez-Olivé, Francesc Xavier/0000-0002-4876-0848; Van Rie, Annelies/0000-0001-7666-3263; Pettifor, Audrey/0000-0002-3387-0817; Rosenberg, Molly/0000-0001-6679-6791; Thirumurthy, Harsha/0000-0002-3308-7603; Twine, Rhian/0000-0002-0766-6556; Kahn, Kathleen/0000-0003-3339-3931; Laeyendecker, Oliver/0000-0002-6429-4760	National Institutes of Health (NIH) [T32 HD007168, R24 HD050924]; National Institute of Allergy and Infectious Diseases [5R01MH087118-02, 5U01AI069423-04, UM1 AI068619]; Division of Intramural Research, National Institute of Allergy and Infectious Disease, NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007168, R24HD050924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068613, U01AI068619, U01AI069423, UM1AI068617, U01AI068617, UM1AI068619, ZIAAI000361, U01AI068613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087118] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Division of Intramural Research, National Institute of Allergy and Infectious Disease, NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The research was funded by the National Institutes of Health (NIH) through Grant Numbers T32 HD007168 and R24 HD050924 to the Carolina Population Center. The parent study described was supported by Award Number 5R01MH087118-02, 5U01AI069423-04, and UM1 AI068619 from the National Institute of Allergy and Infectious Diseases. Additional support was provided by the Division of Intramural Research, National Institute of Allergy and Infectious Disease, NIH. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassett MT, 1996, J ACQ IMMUN DEF SYND, V13, P287, DOI 10.1097/00042560-199611010-00012; Cain D, 2012, PREV SCI, V13, P627, DOI 10.1007/s11121-012-0290-5; Campbell CA, 2009, AM J PREV MED, V37, P556, DOI 10.1016/j.amepre.2009.09.028; Chersich MF, 2008, AIDS, V22, pS27, DOI 10.1097/01.aids.0000341775.94123.75; Cook RL, 2005, SEX TRANSM DIS, V32, P156, DOI 10.1097/01.olq.0000151418.03899.97; Cook WK, 2014, ADDICTION, V109, P1081, DOI 10.1111/add.12571; Davis KC, 2010, EXP CLIN PSYCHOPHARM, V18, P418, DOI 10.1037/a0020510; Delany-Moretlwe S, 2010, SEX TRANSM INFECT, V86, P46, DOI 10.1136/sti.2009.036541; Fisher JC, 2007, SEX TRANSM DIS, V34, P856, DOI 10.1097/OLQ.0b013e318067b4fd; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Fritz K. E., 2002, AIDS BEHAV, V6, P221, DOI DOI 10.1023/A:1019887707474; Go VF, 2007, JAIDS-J ACQ IMM DEF, V46, P491, DOI 10.1097/QAI.0b013e3181594c75; Graham K, 2000, ADDICTION, V95, P847, DOI 10.1046/j.1360-0443.2000.9568473.x; Kahn K, 2012, INT J EPIDEMIOL, V41, P988, DOI 10.1093/ije/dys115; Kalichman SC, 2008, PREV SCI, V9, P55, DOI 10.1007/s11121-008-0085-x; Kalichman SC, 2007, PREV SCI, V8, P141, DOI 10.1007/s11121-006-0061-2; Kalichman SC, 2010, ALCOHOL RES HEALTH, V33, P184; Lewis JJC, 2005, SEX TRANSM DIS, V32, P364, DOI 10.1097/01.olq.0000154506.84492.61; Li Q, 2010, AIDS BEHAV, V14, P1227, DOI 10.1007/s10461-009-9648-5; Mataure P, 2002, AIDS BEHAV, V6, P211, DOI DOI 10.1023/A:1019835723404; Meghdadpour S, 2012, J ADOLESCENCE, V35, P1329, DOI 10.1016/j.adolescence.2012.05.005; Morojele N.K., 2004, AFR J DRUG ALCOHOL S, V3, P1; Morojele NK, 2006, SOC SCI MED, V62, P217, DOI 10.1016/j.socscimed.2005.05.031; Parks KA, 2009, J STUD ALCOHOL DRUGS, V70, P197, DOI 10.15288/jsad.2009.70.197; Pettifor AE, 2005, AIDS, V19, P1525, DOI 10.1097/01.aids.0000183129.16830.06; PIHL RO, 1993, J STUD ALCOHOL, P128, DOI 10.15288/jsas.1993.s11.128; Pithey A, 2009, SAHARA J J SOCIAL AS, V6; Reddy S, 2010, UMTHENTE UHLANA USAM; Rehm J, 2012, ADDICTION, V107, P51, DOI 10.1111/j.1360-0443.2011.03621.x; Sales Jessica M, 2012, Curr Drug Abuse Rev, V5, P117; Singh K, 2010, AIDS BEHAV, V14, P200, DOI 10.1007/s10461-009-9572-8; Sivaram S, 2008, DRUG ALCOHOL DEPEN, V94, P133, DOI 10.1016/j.drugalcdep.2007.11.016; STEELE CM, 1990, AM PSYCHOL, V45, P921, DOI 10.1037/0003-066X.45.8.921; UNAIDS, 2012, GLOB AIDS RESP PROGR; Watt MH, 2012, SOC SCI MED, V74, P1005, DOI 10.1016/j.socscimed.2011.12.022; Weir SS, 2003, AIDS, V17, P895, DOI 10.1097/00002030-200304110-00015; Zawacki T, 2011, PSYCHOL WOMEN QUART, V35, P107, DOI 10.1177/0361684310384106	37	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0125510	10.1371/journal.pone.0125510	http://dx.doi.org/10.1371/journal.pone.0125510			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL2IX	25954812	Green Published, gold, Green Submitted			2022-12-26	WOS:000356768100057
J	Tanas, MR; Ma, S; Jadaan, FO; Ng, CKY; Weigelt, B; Reis-Filho, JS; Rubin, BP				Tanas, M. R.; Ma, S.; Jadaan, F. O.; Ng, C. K. Y.; Weigelt, B.; Reis-Filho, J. S.; Rubin, B. P.			Mechanism of action of a WWTR1(TAZ)-CAMTA1 fusion oncoprotein	ONCOGENE			English	Article							PROMOTES APOPTOSIS; CELL-PROLIFERATION; HIPPO PATHWAY; CAMTA1; GROWTH; DROSOPHILA; TAZ; ENCODES; PROTEIN; KINASE	The WWTR1 (protein is known as TAZ)-CAMTA1 (WC) fusion gene defines epithelioid hemangioendothelioma, a malignant vascular cancer. TAZ (transcriptional coactivator with PDZ binding motif) is a transcriptional coactivator and end effector of the Hippo tumor suppressor pathway. It is inhibited by phosphorylation by the Hippo kinases LATS1 and LATS2. Such phosphorylation causes cytoplasmic localization, 14-3-3 protein binding and the phorphorylation of a terminal phosphodegron promotes ubiquitin-dependent degradation (the phosphorylation of the different motifs has several effects). CAMTA1 is a putative tumor suppressive transcription factor. Here we demonstrate that TAZ-CAMTA1 (TC) fusion results in its nuclear localization and constitutive activation. Consequently, cells expressing TC display a TAZ-like transcriptional program that causes resistance to anoikis and oncogenic transformation. Our findings elucidate the mechanistic basis of TC oncogenic properties, highlight that TC is an important model to understand how the Hippo pathway can be inhibited in cancer, and provide approaches for targeting this chimeric protein.	[Tanas, M. R.; Ma, S.; Jadaan, F. O.; Rubin, B. P.] Cleveland Clin, Lerner Res Inst, Dept Mol Genet, NE2,9500 Euclid Ave, Cleveland, OH 44195 USA; [Tanas, M. R.; Rubin, B. P.] Cleveland Clin, Taussig Canc Ctr, Robert J Tomsich Pathol Inst, Lerner Res Inst, Cleveland, OH 44195 USA; [Ng, C. K. Y.; Weigelt, B.; Reis-Filho, J. S.] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Memorial Sloan Kettering Cancer Center	Rubin, BP (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Mol Genet, NE2,9500 Euclid Ave, Cleveland, OH 44195 USA.	rubinb2@ccf.org	Ng, Charlotte K Y/AAY-3178-2021; Ng, Charlotte K Y/AAA-1670-2020	Ng, Charlotte K Y/0000-0002-6100-0026; Tanas, Munir/0000-0002-6779-2642	National Cancer Institute of the National Institutes of Health [U54CA168512]; Liddy Shriver Sarcoma Initiative; Center for Research and Analysis of Vascular Tumors (CRAVAT); Friends of EHE research; NATIONAL CANCER INSTITUTE [P30CA008748, U54CA168512] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Liddy Shriver Sarcoma Initiative; Center for Research and Analysis of Vascular Tumors (CRAVAT); Friends of EHE research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under Award Number U54CA168512 to BR. This work was also supported by grants from the Liddy Shriver Sarcoma Initiative, the Center for Research and Analysis of Vascular Tumors (CRAVAT), and the Friends of EHE research to BR.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Antonescu CR, 2013, GENE CHROMOSOME CANC, V52, P775, DOI 10.1002/gcc.22073; Barbashina V, 2005, CLIN CANCER RES, V11, P1119; Chan SW, 2009, J BIOL CHEM, V284, P14347, DOI 10.1074/jbc.M901568200; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Errani C, 2011, GENE CHROMOSOME CANC, V50, P644, DOI 10.1002/gcc.20886; Finkler A, 2007, FEBS LETT, V581, P3893, DOI 10.1016/j.febslet.2007.07.051; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Henrich KO, 2012, CANCER RES, V72, P6079, DOI 10.1158/0008-5472.CAN-12-2230; Henrich KO, 2011, CANCER RES, V71, P3142, DOI 10.1158/0008-5472.CAN-10-3014; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang W, 2012, J BIOL CHEM, V287, P26245, DOI 10.1074/jbc.M112.382036; Huentelman MJ, 2007, HUM MOL GENET, V16, P1469, DOI 10.1093/hmg/ddm097; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Li Z, 2010, GENE DEV, V24, P235, DOI 10.1101/gad.1865810; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Ma S, 2014, LAB INVEST, V94, P430, DOI 10.1038/labinvest.2014.13; Mendlick MR, 2001, AM J SURG PATHOL, V25, P684, DOI 10.1097/00000478-200105000-00019; Miller LA, 2011, PSYCHOGERIATRICS, V11, P135, DOI 10.1111/j.1479-8301.2011.00357.x; Mo JS, 2014, EMBO REP, V15, P642, DOI 10.15252/embr.201438638; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Muslin AJ, 2000, CELL SIGNAL, V12, P703, DOI 10.1016/S0898-6568(00)00131-5; Nguyen BA, 2009, BMC BIOINFORMATICS, V10, P202, DOI [10.1186/1471-2105-10-202, DOI 10.1186/1471-2105-10-202]; Oka T, 2010, BIOCHEM J, V432, P461, DOI 10.1042/BJ20100870; Pandey N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-216; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Schraivogel D, 2011, EMBO J, V30, P4309, DOI 10.1038/emboj.2011.301; Song K, 2006, CELL, V125, P453, DOI 10.1016/j.cell.2006.02.048; Tanas MR, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002409; Taylor BS, 2011, NAT REV CANCER, V11, P541, DOI 10.1038/nrc3087; Thevenon J, 2012, J MED GENET, V49, P400, DOI 10.1136/jmedgenet-2012-100856; Tremblay AM, 2014, CANCER CELL, V26, P273, DOI 10.1016/j.ccr.2014.05.029; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; XU TA, 1995, DEVELOPMENT, V121, P1053; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111	46	56	57	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 18	2016	35	7					929	938		10.1038/onc.2015.148	http://dx.doi.org/10.1038/onc.2015.148			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DE0RO	25961935	Green Accepted			2022-12-26	WOS:000370332200013
J	Guan, JJ; Zhang, JY; Li, HY; Zhu, ZZ; Guo, SC; Niu, X; Wang, Y; Zhang, CQ				Guan, Junjie; Zhang, Jieyuan; Li, Haiyan; Zhu, Zhenzhong; Guo, Shangchun; Niu, Xin; Wang, Yang; Zhang, Changqing			Human Urine Derived Stem Cells in Combination with beta-TCP Can Be Applied for Bone Regeneration	PLOS ONE			English	Article							TRICALCIUM PHOSPHATE; CALVARIAL DEFECTS; STROMAL CELLS; IN-VITRO; SCAFFOLD; MEDICINE; REPAIR; RAT; SUBSTITUTES; FUSION	Bone tissue engineering requires highly proliferative stem cells that are easy to isolate. Human urine stem cells (USCs) are abundant and can be easily harvested without using an invasive procedure. In addition, in our previous studies, USCs have been proved to be able to differentiate into osteoblasts, chondrocytes, and adipocytes. Therefore, USCs may have great potential and advantages to be applied as a cell source for tissue engineering. However, there are no published studies that describe the interactions between USCs and biomaterials and applications of USCs for bone tissue engineering. Therefore, the objective of the present study was to evaluate the interactions between USCs with a typical bone tissue engineering scaffold, beta-Tricalcium Phosphate (beta-TCP), and to determine whether the USCs seeded onto beta-TCP scaffold can promote bone regeneration in a segmental femoral defect of rats. Primary USCs were isolated from urine and seeded on beta-TCP scaffolds. Results showed that USCs remained viable and proliferated within beta-TCP. The osteogenic differentiation of USCs within the scaffolds was demonstrated by increased alkaline phosphatase activity and calcium content. Furthermore, beta-TCP with adherent USCs (USCs/beta-TCP) were implanted in a 6-mm critical size femoral defect of rats for 12 weeks. Bone regeneration was determined using X-ray, micro-CT, and histologic analyses. Results further demonstrated that USCs in the scaffolds could enhance new bone formation, which spanned bone defects in 5 out of 11 rats while beta-TCP scaffold alone induced modest bone formation. The current study indicated that the USCs can be used as a cell source for bone tissue engineering as they are compatible with bone tissue engineering scaffolds and can stimulate the regeneration of bone in a critical size bone defect.	[Guan, Junjie; Zhang, Jieyuan; Zhu, Zhenzhong; Wang, Yang; Zhang, Changqing] Shanghai Jiao Tong Univ, Dept Orthoped Surg, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China; [Li, Haiyan] Shanghai Jiao Tong Univ, Med Res Inst 10, Sch Biomed Engn, Shanghai 200030, Peoples R China; [Guo, Shangchun; Niu, Xin; Wang, Yang; Zhang, Changqing] Shanghai Jiao Tong Univ, Inst Microsurg Extrem, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wang, Y (corresponding author), Shanghai Jiao Tong Univ, Dept Orthoped Surg, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China.	wangy63cn@126.com; zhangcq@sjtu.edu.cn	Guo, Shang-Chun/M-6246-2018	Guo, Shang-Chun/0000-0001-6285-6750; Li, Haiyan/0000-0002-7423-2715; zhang, changqing/0000-0002-7408-4126; Zhang, Jieyuan/0000-0001-6635-4117	National High Technology Research and Development Program of China [2012AA020506]; Special Fund for Healthy-Scientific Research in the Public Interest, China [201402016]; Doctoral Innovation Fund of Shanghai Jiaotong University School of Medicine [BXJ201341]; "Priority Among Priorities" Clinical Medical Center Construction Project of the Shanghai Municipality	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Special Fund for Healthy-Scientific Research in the Public Interest, China; Doctoral Innovation Fund of Shanghai Jiaotong University School of Medicine; "Priority Among Priorities" Clinical Medical Center Construction Project of the Shanghai Municipality	This work was supported by the National High Technology Research and Development Program of China (2012AA020506), the Special Fund for Healthy-Scientific Research in the Public Interest, China (201402016), the Doctoral Innovation Fund of Shanghai Jiaotong University School of Medicine (BXJ201341), and the "Priority Among Priorities" Clinical Medical Center Construction Project of the Shanghai Municipality.	[Anonymous], 2005, ACTA ORTHOPAEDICA, V76, P637; Bharadwaj S, 2013, STEM CELLS; Bodin A, 2010, BIOMATERIALS, V31, P8889, DOI 10.1016/j.biomaterials.2010.07.108; Bose S, 2012, TRENDS BIOTECHNOL, V30, P546, DOI 10.1016/j.tibtech.2012.07.005; Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Castano-Izquierdo H, 2007, J BIOMED MATER RES A, V82A, P129, DOI 10.1002/jbm.a.31082; Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958; de Peppo GM, 2013, P NATL ACAD SCI USA, V110, P8680, DOI 10.1073/pnas.1301190110; Dinopoulos H, 2012, SURG-J R COLL SURG E, V10, P230, DOI 10.1016/j.surge.2012.04.001; Dong JA, 2002, BIOMATERIALS, V23, P4493, DOI 10.1016/S0142-9612(02)00193-X; Fayaz HC, 2011, INT ORTHOP, V35, P1587, DOI 10.1007/s00264-011-1338-z; Gan YK, 2008, BIOMATERIALS, V29, P3973, DOI 10.1016/j.biomaterials.2008.06.026; Guan J, 2014, TISSUE ENG PART A, V6, P6; Guan JJ, 2014, TISSUE ENG PT A, V20, P1794, DOI [10.1089/ten.tea.2013.0584, 10.1089/ten.TEA.2013.0584]; Guo C, 2007, J THORAC CARDIOV SUR, V134, P1332, DOI 10.1016/j.jtcvs.2007.07.025; Jalving M, 2009, CURR OPIN MOL THER, V11, P383; Jeon O, 2007, BIOMATERIALS, V28, P2763, DOI 10.1016/j.biomaterials.2007.02.023; Karner E, 2007, STEM CELLS DEV, V16, P39, DOI 10.1089/scd.2006.0010; Kondo N, 2005, BIOMATERIALS, V26, P5600, DOI 10.1016/j.biomaterials.2005.02.026; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kwan MD, 2008, HUM MOL GENET, V17, pR93, DOI 10.1093/hmg/ddn071; Lang R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053980; Marolt D, 2012, P NATL ACAD SCI; Marolt D, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt10; Matthew B., 2012, J STEM CELL RES THER, V2012; Medvedev SP, 2010, ACTA NATURAE, V2, P18, DOI 10.32607/20758251-2010-2-2-18-27; Meijer GJ, 2008, BIOMATERIALS, V29, P3053, DOI 10.1016/j.biomaterials.2008.03.012; Meijer GJ, 2007, PLOS MED, V4, P260, DOI 10.1371/journal.pmed.0040009; Meinel L, 2006, BONE, V39, P922, DOI 10.1016/j.bone.2006.04.019; Niemeyer P, 2007, TISSUE ENG, V13, P111, DOI 10.1089/ten.2006.0114; Oest ME, 2007, J ORTHOP RES, V25, P941, DOI 10.1002/jor.20372; Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449; Prokhorova TA, 2009, STEM CELLS DEV, V18, P47, DOI 10.1089/scd.2007.0266; Rodrigues MT, 2012, BIOMATERIALS, V33, P6069, DOI 10.1016/j.biomaterials.2012.05.016; Sato Y, 2005, BLOOD, V106, P756, DOI 10.1182/blood-2005-02-0572; Szpalski C, 2012, TISSUE ENG PART B-RE, V18, P246, DOI [10.1089/ten.TEB.2011.0427, 10.1089/ten.teb.2011.0427]; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; van der Valk J, 2010, TOXICOL IN VITRO, V24, P1053, DOI 10.1016/j.tiv.2010.03.016; Wu SF, 2011, BIOMATERIALS, V32, P1317, DOI 10.1016/j.biomaterials.2010.10.006; Zhang MY, 2010, J PLAST RECONSTR AES, V63, P227, DOI 10.1016/j.bjps.2008.11.017; Zhang YY, 2008, J UROLOGY, V180, P2226, DOI 10.1016/j.juro.2008.07.023; Zou DH, 2011, BIOMATERIALS, V32, P9707, DOI 10.1016/j.biomaterials.2011.09.005	44	30	36	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0125253	10.1371/journal.pone.0125253	http://dx.doi.org/10.1371/journal.pone.0125253			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970295	gold, Green Submitted, Green Published			2022-12-26	WOS:000354544200070
J	Hollensteiner, KJ; Pieper, F; Engler, G; Konig, P; Engel, AK				Hollensteiner, Karl J.; Pieper, Florian; Engler, Gerhard; Koenig, Peter; Engel, Andreas K.			Crossmodal Integration Improves Sensory Detection Thresholds in the Ferret	PLOS ONE			English	Article							EXPERIENCE-DEPENDENT PLASTICITY; MUSTELA-PUTORIUS; STATISTICAL FACILITATION; RESPONSE PROPERTIES; VISUAL-PERCEPTION; PARIETAL CORTEX; CUE INTEGRATION; REACTION-TIME; INFORMATION; ENHANCEMENT	During the last two decades ferrets (Mustela putorius) have been established as a highly efficient animal model in different fields in neuroscience. Here we asked whether ferrets integrate sensory information according to the same principles established for other species. Since only few methods and protocols are available for behaving ferrets we developed a head-free, body-restrained approach allowing a standardized stimulation position and the utilization of the ferret's natural response behavior. We established a behavioral paradigm to test audiovisual integration in the ferret. Animals had to detect a brief auditory and/or visual stimulus presented either left or right from their midline. We first determined detection thresholds for auditory amplitude and visual contrast. In a second step, we combined both modalities and compared psychometric fits and the reaction times between all conditions. We employed Maximum Likelihood Estimation (MLE) to model bimodal psychometric curves and to investigate whether ferrets integrate modalities in an optimal manner. Furthermore, to test for a redundant signal effect we pooled the reaction times of all animals to calculate a race model. We observed that bimodal detection thresholds were reduced and reaction times were faster in the bimodal compared to unimodal conditions. The race model and MLE modeling showed that ferrets integrate modalities in a statistically optimal fashion. Taken together, the data indicate that principles of multisensory integration previously demonstrated in other species also apply to crossmodal processing in the ferret.	[Hollensteiner, Karl J.; Pieper, Florian; Engler, Gerhard; Koenig, Peter; Engel, Andreas K.] Univ Med Ctr Hamburg Eppendorf, Dept Neurophysiol & Pathophysiol, D-20246 Hamburg, Germany; [Koenig, Peter] Univ Osnabruck, Inst Cognit Sci, D-49069 Osnabruck, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University Osnabruck	Hollensteiner, KJ (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Neurophysiol & Pathophysiol, D-20246 Hamburg, Germany.	k.hollensteiner@uke.de	Engel, Andreas K/C-7781-2012; Engel, Andreas K./AAH-6384-2019; König, Peter/ABB-2380-2020	Engel, Andreas K/0000-0003-4899-8466; Engel, Andreas K./0000-0003-4899-8466; König, Peter/0000-0003-3654-5267	DFG [SFB 936/A2]	DFG(German Research Foundation (DFG))	This research was supported by a Grant from the DFG (SFB 936/A2, B6; A.K.E.; http://www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Alais D, 2010, SEEING PERCEIVING, V23, P3, DOI 10.1163/187847510X488603; Alves-Pinto A, 2012, NEUROSCIENCE, V220, P215, DOI 10.1016/j.neuroscience.2012.06.001; Angelaki DE, 2009, CURR OPIN NEUROBIOL, V19, P452, DOI 10.1016/j.conb.2009.06.008; Battaglia PW, 2003, J OPT SOC AM A, V20, P1391, DOI 10.1364/JOSAA.20.001391; Bizley JK, 2007, CEREB CORTEX, V17, P2172, DOI 10.1093/cercor/bhl128; Bizley JK, 2009, HEARING RES, V258, P55, DOI 10.1016/j.heares.2009.06.017; Bizley JK, 2005, CEREB CORTEX, V15, P1637, DOI 10.1093/cercor/bhi042; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Chiu CY, 2001, J NEUROSCI, V21, P8906, DOI 10.1523/JNEUROSCI.21-22-08906.2001; Diederich A, 2004, PERCEPT PSYCHOPHYS, V66, P1388, DOI 10.3758/BF03195006; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Farley BJ, 2007, J NEUROSCI, V27, P10299, DOI 10.1523/JNEUROSCI.2257-07.2007; Fetsch CR, 2010, EUR J NEUROSCI, V31, P1721, DOI 10.1111/j.1460-9568.2010.07207.x; Fox JG, 2014, BIOLOGY AND DISEASES OF THE FERRET, 3RD EDITION, P1, DOI 10.1002/9781118782699; Foxworthy WA, 2013, EUR J NEUROSCI, V37, P910, DOI 10.1111/ejn.12085; Frassinetti F, 2002, EXP BRAIN RES, V147, P332, DOI 10.1007/s00221-002-1262-y; Fritz JB, 2010, NAT NEUROSCI, V13, P1011, DOI 10.1038/nn.2598; Frohlich F, 2010, NEURON, V67, P129, DOI 10.1016/j.neuron.2010.06.005; Gepshtein S, 2003, CURR BIOL, V13, P483, DOI 10.1016/S0960-9822(03)00133-7; Gleiss S, 2014, J COGNITIVE NEUROSCI, V26, P699, DOI 10.1162/jocn_a_00524; Gleiss S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045677; Gu Y, 2008, NAT NEUROSCI, V11, P1201, DOI 10.1038/nn.2191; Hartley DEH, 2010, J NEUROSCI METH, V190, P214, DOI 10.1016/j.jneumeth.2010.05.014; Helmchen Fritjof, 2013, Cold Spring Harb Protoc, V2013, P904, DOI 10.1101/pdb.top078147; HERSHENSON M, 1962, J EXP PSYCHOL, V63, P289, DOI 10.1037/h0039516; Homman-Ludiye J, 2010, J COMP NEUROL, V518, P4439, DOI 10.1002/cne.22465; Innocenti GM, 2002, CEREB CORTEX, V12, P411, DOI 10.1093/cercor/12.4.411; Jarosiewicz B, 2012, CURR BIOL, V22, P269, DOI 10.1016/j.cub.2012.01.011; KAERNBACH C, 1991, PERCEPT PSYCHOPHYS, V49, P227, DOI 10.3758/BF03214307; Kalman RE, 1961, T ASME SER J BASIC E, V109; Keating P, 2014, EUR J NEUROSCI, V39, P197, DOI 10.1111/ejn.12402; Keniston LP, 2009, EXP BRAIN RES, V196, P239, DOI 10.1007/s00221-009-1843-0; Kilkenny C, 2012, OSTEOARTHR CARTILAGE, V20, P256, DOI 10.1016/j.joca.2012.02.010; King AJ, 2007, HEARING RES, V229, P106, DOI 10.1016/j.heares.2007.01.001; Knill DC, 2003, VISION RES, V43, P2539, DOI 10.1016/S0042-6989(03)00458-9; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Leach ND, 2013, J NEUROSCI, V33, P6659, DOI 10.1523/JNEUROSCI.5039-12.2013; Li Y, 2006, NAT NEUROSCI, V9, P676, DOI 10.1038/nn1684; Lippert M, 2007, BRAIN RES, V1173, P102, DOI 10.1016/j.brainres.2007.07.050; Manger PR, 2008, VISUAL NEUROSCI, V25, P27, DOI 10.1017/S0952523808080036; Manger PR, 2005, EUR J NEUROSCI, V22, P706, DOI 10.1111/j.1460-9568.2005.04246.x; Manger PR, 2002, CEREB CORTEX, V12, P1280, DOI 10.1093/cercor/12.12.1280; Manger PR, 2002, CEREB CORTEX, V12, P423, DOI 10.1093/cercor/12.4.423; McDonald JJ, 2000, NATURE, V407, P906, DOI 10.1038/35038085; MILLER J, 1986, PERCEPT PSYCHOPHYS, V40, P331, DOI 10.3758/BF03203025; Miller J, 2003, COGNITIVE PSYCHOL, V46, P101, DOI 10.1016/S0010-0285(02)00517-0; MILLER J, 1982, COGNITIVE PSYCHOL, V14, P247, DOI 10.1016/0010-0285(82)90010-X; Morasso PG, 1997, SELF ORG COMPUTATION; Nelken I, 2000, EUR J NEUROSCI, V12, P549, DOI 10.1046/j.1460-9568.2000.00935.x; Nodal FR, 2008, NEUROSCIENCE, V154, P397, DOI 10.1016/j.neuroscience.2007.12.022; Oruc I, 2003, VISION RES, V43, P2451, DOI 10.1016/S0042-6989(03)00435-8; PHILLIPS DP, 1988, BRAIN RES, V443, P281, DOI 10.1016/0006-8993(88)91622-8; RAAB DH, 1962, T NEW YORK ACAD SCI, V24, P574, DOI 10.1111/j.2164-0947.1962.tb01433.x; Rowland B, 2007, EXP BRAIN RES, V180, P153, DOI 10.1007/s00221-006-0847-2; Spence C, 2011, ATTEN PERCEPT PSYCHO, V73, P971, DOI 10.3758/s13414-010-0073-7; Stein B E, 1989, J Cogn Neurosci, V1, P12, DOI 10.1162/jocn.1989.1.1.12; Stein BE, 1996, J COGNITIVE NEUROSCI, V8, P497, DOI 10.1162/jocn.1996.8.6.497; Stein BE., 1993, MERGING SENSES; Stitt I, 2013, J NEUROPHYSIOL, V110, P1333, DOI 10.1152/jn.00957.2012; Sukhinin DI, 2013, BUILDING FERRETOME, DOI [10.3389/conf.fninf.2013.09.00007, DOI 10.3389/CONF.FNINF.2013.09.00007]; Teder-Salejarvi WA, 2005, J COGNITIVE NEUROSCI, V17, P1396, DOI 10.1162/0898929054985383; Ulrich R, 2007, BEHAV RES METHODS, V39, P291, DOI 10.3758/BF03193160; van Beers RJ, 2002, CURR BIOL, V12, P834, DOI 10.1016/S0960-9822(02)00836-9; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; Walker KMM, 2009, J ACOUST SOC AM, V126, P1321, DOI 10.1121/1.3179676; WELCH RB, 1986, HDB PERCEPTION HUMAN; Yu HB, 2011, P NATL ACAD SCI USA, V108, P21235, DOI 10.1073/pnas.1108270109	69	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0124952	10.1371/journal.pone.0124952	http://dx.doi.org/10.1371/journal.pone.0124952			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970327	Green Published, Green Submitted, gold			2022-12-26	WOS:000354544200061
J	Sharma, R; Mishra, M; Gupta, B; Parsania, C; Singla-Pareek, SL; Pareek, A				Sharma, Rita; Mishra, Manjari; Gupta, Brijesh; Parsania, Chirag; Singla-Pareek, Sneh L.; Pareek, Ashwani			De Novo Assembly and Characterization of Stress Transcriptome in a Salinity-Tolerant Variety CS52 of Brassica juncea	PLOS ONE			English	Article							SALT-STRESS; GENE-EXPRESSION; RNA-SEQ; PATHWAY; TOOL; ARABIDOPSIS; GENOMICS; PROTEIN; SETS	Oilseed mustard, Brassica juncea, exhibits high levels of genetic variability for salinity tolerance. To obtain the global view of transcriptome and investigate the molecular basis of salinity tolerance in a salt-tolerant variety CS52 of B. juncea, we performed transcriptome sequencing of control and salt-stressed seedlings. De novo assembly of 184 million high-quality paired-end reads yielded 42,327 unique transcripts longer than 300 bp with RPKM >= 1. When compared with non-redundant proteins, we could annotate 67% unigenes obtained in our study. Based on the mapping to expressed sequence tags (ESTs), 52.6% unigenes are novel compared to EST data available for B. juncea and constituent genomes. Differential expression analysis revealed altered expression of 1469 unigenes in response to salinity stress. Of these, 587, mainly associated with ROS detoxification, sulfur assimilation and calcium signaling pathways, are up regulated. Notable of these is RSA1 (SHORT ROOT IN SALT MEDIUM 1) INTERACTING TRANSCRIPTION FACTOR 1(RITF1) homolog up regulated by >100 folds in response to stress. RITF1, encoding a bHLH transcription factor, is a positive regulator of SOS1 and several key genes involved in scavenging of salt stress-induced reactive oxygen species (ROS). Further, we performed comparative expression profiling of key genes implicated in ion homeostasis and sequestration (SOS1, SOS2, SOS3, ENH1, NHX1), calcium sensing pathway (RITF1) and ROS detoxification in contrasting cultivars for salinity tolerance, B. juncea and B. nigra. The results revealed higher transcript accumulation of most of these genes in B. juncea var. CS52 compared to salt-sensitive cultivar even under normal growth conditions. Together, these findings reveal key pathways and signaling components that contribute to salinity tolerance in B. junceavar. CS52.	[Sharma, Rita; Mishra, Manjari; Pareek, Ashwani] Jawaharlal Nehru Univ, Sch Life Sci, Stress Physiol & Mol Biol Lab, New Delhi 110067, India; [Gupta, Brijesh; Singla-Pareek, Sneh L.] Int Ctr Genet Engn & Biotechnol, Plant Mol Biol Grp, New Delhi, India; [Parsania, Chirag] Bionivid Technol P Ltd, Bangalore, Karnataka, India	Jawaharlal Nehru University, New Delhi; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Pareek, A (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, Stress Physiol & Mol Biol Lab, New Delhi 110067, India.	ashwanip@mail.jnu.ac.in	Parsania, Chirag/GWC-8685-2022; Parsania, Chirag/AAZ-8033-2020; Sharma, Rita/G-2425-2017; Parsania, Chirag/GOH-2750-2022	Parsania, Chirag/0000-0003-4873-2385	Department of Biotechnology (DBT) [BT/PR12570/PBD/16/03/2009, BT/PR11677/PBD/16/832/2008]; Government of India (GOI); DBT, GOI; Council of Scientific & Industrial Research, GOI; Bionivid Technology [P] Ltd.	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Government of India (GOI); DBT, GOI(Department of Biotechnology (DBT) India); Council of Scientific & Industrial Research, GOI; Bionivid Technology [P] Ltd.	This work was financially supported by research grants BT/PR12570/PBD/16/03/2009 and BT/PR11677/PBD/16/832/2008 from Department of Biotechnology (DBT; http://www.dbtindia.nic.in/), the Government of India (GOI). Financial support provided as Ramalingaswami fellowship to RS by DBT, GOI, and Senior Research Fellowship to MM by Council of Scientific & Industrial Research, GOI, is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Bionivid Technology [P] Ltd., provided support in the form of a salary for author CP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Anjum NA, 2010, ASCORBATE-GLUTATHIONE PATHWAY AND STRESS TOLERANCE IN PLANTS, P1, DOI 10.1007/978-90-481-9404-9; Ashraf M, 2004, CRIT REV PLANT SCI, V23, P157, DOI 10.1080/07352680490433286; Chakraborty K, 2012, PLANT PHYSIOL BIOCH, V51, P90, DOI 10.1016/j.plaphy.2011.10.001; Chandna R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036918; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guan QM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003755; Ji HT, 2013, MOL PLANT, V6, P275, DOI 10.1093/mp/sst017; Johnston JS, 2005, ANN BOT-LONDON, V95, P229, DOI 10.1093/aob/mci016; Joshi PK, 2011, ACTA PHYSIOL PLANT, V33, P811, DOI 10.1007/s11738-010-0606-7; Kumar G, 2009, PLANT SIGNAL BEHAV, V4, P431, DOI 10.4161/psb.4.5.8298; Kumar G, 2009, J PLANT PHYSIOL, V166, P507, DOI 10.1016/j.jplph.2008.08.001; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu JP, 1997, PLANT PHYSIOL, V114, P591, DOI 10.1104/pp.114.2.591; Liu XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071110; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma SS, 2006, J EXP BOT, V57, P1097, DOI 10.1093/jxb/erj098; Nagatoshi Y, 2009, J BIOL CHEM, V284, P19301, DOI 10.1074/jbc.M109.001032; Olvera-Carrillo Y, 2010, PLANT PHYSIOL, V154, P373, DOI 10.1104/pp.110.158964; Paritosh K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-396; Purty Ram Singh, 2008, Physiology and Molecular Biology of Plants, V14, P39, DOI 10.1007/s12298-008-0004-4; Ruiz JM, 2002, PLANTA, V214, P965, DOI 10.1007/s00425-002-0748-y; Singh J, 2014, GRASAS ACEITES, V65, DOI 10.3989/gya.063413; Sun Q, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-53; Taji T, 2004, PLANT PHYSIOL, V135, P1697, DOI 10.1104/pp.104.039909; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Yadav S, 2011, J ENVIRON BIOL, V32, P667; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zamani S., 2010, Advances in Environmental Biology, V4, P422; Zambon AC, 2012, BIOINFORMATICS, V28, P2209, DOI 10.1093/bioinformatics/bts366	35	24	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0126783	10.1371/journal.pone.0126783	http://dx.doi.org/10.1371/journal.pone.0126783			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970274	Green Published, Green Submitted, gold			2022-12-26	WOS:000354544200130
J	Zhou, LH; Shen, Y; Jiang, LB; Yin, DN; Guo, JX; Zheng, H; Sun, H; Wu, RL; Guo, YQ				Zhou, Linghua; Shen, Yong; Jiang, Libo; Yin, Danni; Guo, Jingxin; Zheng, Hui; Sun, Hao; Wu, Rongling; Guo, Yunqian			Systems Mapping for Hematopoietic Progenitor Cell Heterogeneity	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; LINEAGE COMMITMENT; RHYTHMS; MODELS; GENES	Cells with the same genotype growing under the same conditions can show different phenotypes, which is known as "population heterogeneity". The heterogeneity of hematopoietic progenitor cells has an effect on their differentiation potential and lineage choices. However, the genetic mechanisms governing population heterogeneity remain unclear. Here, we present a statistical model for mapping the quantitative trait locus (QTL) that affects hematopoietic cell heterogeneity. This strategy, termed systems mapping, integrates a system of differential equations into the framework for systems mapping, allowing hypotheses regarding the interplay between genetic actions and cell heterogeneity to be tested. A simulation approach based on cell heterogeneity dynamics has been designed to test the statistical properties of the model. This model not only considers the traditional QTLs, but also indicates the methylated QTLs that can illustrate non-genetic individual differences. It has significant implications for probing the molecular, genetic and epigenetic mechanisms of hematopoietic progenitor cell heterogeneity.	[Zhou, Linghua; Shen, Yong; Jiang, Libo; Yin, Danni; Guo, Jingxin; Wu, Rongling; Guo, Yunqian] Beijing Forestry Univ, Ctr Computat Biol, Beijing, Peoples R China; [Zheng, Hui; Sun, Hao] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangdong Prov Key Lab Stem Cell & Regenerat Med, CAS Key Lab Regenerat Biol, Guangzhou, Guangdong, Peoples R China; [Wu, Rongling] Penn State Univ, Ctr Stat Genet, Hershey, PA USA	Beijing Forestry University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Guo, YQ (corresponding author), Beijing Forestry Univ, Ctr Computat Biol, Beijing, Peoples R China.	guoyq04@gmail.com	Guo, Yunqian/L-4716-2013		National Natural Science Foundation of China [31370669, 30900854]; Key Laboratory of Regenerative Biology, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences [KLRB201308]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Regenerative Biology, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences	The National Natural Science Foundation of China (31370669, 30900854) and the Key Laboratory of Regenerative Biology, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences (KLRB201308). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; CHURCHILL GA, 1994, GENETICS, V138, P963; Clements WK, 2013, NAT REV IMMUNOL, V13, P336, DOI 10.1038/nri3443; Cui YH, 2006, PHYSIOL GENOMICS, V25, P458, DOI 10.1152/physiolgenomics.00181.2005; Das K, 2013, STAT MED, V32, P509, DOI 10.1002/sim.5535; Fu Guifang, 2011, Journal of Biological Dynamics, V5, P84, DOI 10.1080/17513758.2010.491558; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kutta W., 1901, MATH PHY, V46, P435; Li N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009894; Liu T, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-5; Ma CX, 2002, GENETICS, V161, P1751; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Runge C., 1895, MATH ANN, V46, P167, DOI DOI 10.1007/BF01446807; Suh HC, 2006, BLOOD, V107, P4308, DOI 10.1182/blood-2005-06-2216; Wang Zhong, 2012, Frontiers in Genetics, V3, P84, DOI 10.3389/fgene.2012.00084; Wolff L, 2013, STEM CELLS, V31, P1237, DOI 10.1002/stem.1379; Wu RL, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-84; Yap JS, 2009, BIOMETRICS, V65, P1068, DOI 10.1111/j.1541-0420.2009.01222.x; Zhao W, 2007, GENETICS, V176, P1879, DOI 10.1534/genetics.107.070920; Zhao W, 2005, STAT APPL GENET MOL, V4	24	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0126937	10.1371/journal.pone.0126937	http://dx.doi.org/10.1371/journal.pone.0126937			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970338	Green Published, Green Submitted, gold			2022-12-26	WOS:000354544200141
J	Mishra, A; Antony, JS; Sundaravadivel, P; Van Tong, H; Meyer, CG; Jalli, RD; Velavan, TP; Thangaraj, K				Mishra, Anshuman; Antony, Justin S.; Sundaravadivel, Pandarisamy; Hoang Van Tong; Meyer, Christian G.; Jalli, Reshma D.; Velavan, Thirumalaisamy P.; Thangaraj, Kumarasamy			Association of Ficolin-2 Serum Levels and FCN2 Genetic Variants with Indian Visceral Leishmaniasis	PLOS ONE			English	Article							MANNOSE-BINDING LECTIN; COMPLEMENT ACTIVATION; INFECTIOUS-DISEASES; CLINICAL LEPROSY; POLYMORPHISMS; RECOGNITION; PROTEIN; SUSCEPTIBILITY; PROMASTIGOTES; MACROPHAGES	Background Visceral leishmaniasis (VL), one of the neglected tropical diseases, is endemic in the Indian subcontinent. Ficolins are circulating serum proteins of the lectin complement system and involved in innate immunity. Methods We have estimated ficolin-2 serum levels and analyzed the functional variants of the encoding gene FCN2 in 218 cases of VL and in 225 controls from an endemic region of India. Results Elevated levels of serum ficolin-2 were observed in VL cases compared to the controls (adjusted P<0.0001). The genetic analysis revealed that the FCN2structural variant +6359 C>T (p.T236M) was associated with VL (OR=2.2, 95% CI=1.23-7.25, P=0.008) and with high ficolin-2 serum levels. We also found that the FCN2*AAAC haplotype occurred more frequently among healthy controls when compared to cases (OR=0.59, 95% CI=0.37-0.94, P=0.023). Conclusions Our findings indicate that the FCN2 variant +6359C>T is associated with the occurrence of VL and that ficolin-2 serum levels are elevated in Leishmania infections.	[Mishra, Anshuman; Sundaravadivel, Pandarisamy; Jalli, Reshma D.; Thangaraj, Kumarasamy] Ctr Cellular & Mol Biol, Council Sci & Ind Res, Hyderabad 500007, Andhra Pradesh, India; [Antony, Justin S.; Hoang Van Tong; Meyer, Christian G.; Velavan, Thirumalaisamy P.] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Velavan, Thirumalaisamy P.] Fdn Congolaise Rech Med, Brazzaville, Rep Congo	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Eberhard Karls University of Tubingen	Velavan, TP (corresponding author), Univ Tubingen, Inst Trop Med, Tubingen, Germany.	velavan@medizin.uni-tuebingen.de	ANTONY, JUSTIN S/F-3994-2010; Velavan, Thirumalaisamy P/C-1223-2010; van Tong, Hoang/E-9448-2011	Velavan, Thirumalaisamy P/0000-0002-9809-9883; van Tong, Hoang/0000-0002-7170-8810; Mishra, Anshuman/0000-0002-9390-9971; Thangaraj, Kumarasamy/0000-0002-0075-0106	Department of Biotechnology, Research Associate Programme, Government of India; Council for Scientific and Industrial Research Network project [Genesis-BSC0121]; Biotechnology and Biological Sciences Research Council, United Kingdom [BB/H009337]; Deutsche Forschungsgemeinschaft (DFG); Open Access Publishing Fund of Tuebingen University	Department of Biotechnology, Research Associate Programme, Government of India; Council for Scientific and Industrial Research Network project; Biotechnology and Biological Sciences Research Council, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Open Access Publishing Fund of Tuebingen University	Anshuman Mishra was supported by Department of Biotechnology (www.dbtindia.nic.in), Research Associate Programme, Government of India. Kumarasamy Thangaraj was supported by Council for Scientific and Industrial Research (www.csir.res.in) Network project (Genesis-BSC0121) and Biotechnology and Biological Sciences Research Council (http://www.bbsrc.com), United Kingdom (BB/H009337). The authors acknowledge the support by the Deutsche Forschungsgemeinschaft (DFG) and Open Access Publishing Fund of Tuebingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Ouf E, 2012, J INFECT DIS, V206, P562, DOI 10.1093/infdis/jis396; Ambrosio AR, 2005, PARASITE IMMUNOL, V27, P333, DOI 10.1111/j.1365-3024.2005.00782.x; Assaf A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034113; Cedzynski M, 2007, CLIN EXP IMMUNOL, V150, P99, DOI 10.1111/j.1365-2249.2007.03471.x; Cestari I, 2013, MOL IMMUNOL, V53, P328, DOI 10.1016/j.molimm.2012.08.015; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; de Messias-Reason I, 2009, J INFECT DIS, V199, P801, DOI 10.1086/597070; de Messias-Reason IJ, 2007, J INFECT DIS, V196, P1379, DOI 10.1086/521627; Descoteaux A, 1999, BBA-MOL BASIS DIS, V1455, P341, DOI 10.1016/S0925-4439(99)00065-4; Descoteaux A, 2002, MICROBES INFECT, V4, P975, DOI 10.1016/S1286-4579(02)01624-6; Desjeux P, 1996, CLIN DERMATOL, V14, P417, DOI 10.1016/0738-081X(96)00057-0; Dommett RM, 2006, TISSUE ANTIGENS, V68, P193, DOI 10.1111/j.1399-0039.2006.00649.x; Endo Y, 2011, INT J BIOCHEM CELL B, V43, P705, DOI 10.1016/j.biocel.2011.02.003; Flandin JF, 2006, EUR J IMMUNOL, V36, P411, DOI 10.1002/eji.200535079; GREEN PJ, 1994, MOL BIOCHEM PARASIT, V66, P319, DOI 10.1016/0166-6851(94)90158-9; Herpers BL, 2006, MOL IMMUNOL, V43, P851, DOI 10.1016/j.molimm.2005.06.035; Hoal-van Helden EG, 1999, PEDIATR RES, V45, P459, DOI 10.1203/00006450-199904010-00002; Hotez PJ, 2004, CLIN INFECT DIS, V38, P871, DOI 10.1086/382077; Hummelshoj T, 2005, HUM MOL GENET, V14, P1651, DOI 10.1093/hmg/ddi173; Hummelshoj T, 2008, MOL IMMUNOL, V45, P2508, DOI 10.1016/j.molimm.2008.01.003; Kilpatrick DC, 2013, HUM IMMUNOL, V74, P867, DOI 10.1016/j.humimm.2013.04.011; Krarup A, 2004, J BIOL CHEM, V279, P47513, DOI 10.1074/jbc.M407161200; Laurenti MD, 1996, INT J EXP PATHOL, V77, P15, DOI 10.1046/j.1365-2613.1996.958096.x; Luo FL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073859; Luz PR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060237; Ma YJ, 2009, J BIOL CHEM, V284, P28263, DOI 10.1074/jbc.M109.009225; Mathers CD, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000114; Matsushita M, 2013, MOL IMMUNOL, V55, P22, DOI 10.1016/j.molimm.2012.08.017; Matsushita M, 2010, J INNATE IMMUN, V2, P24, DOI 10.1159/000228160; Moradin N, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00121; Muniaraj Mayilsamy, 2014, Trop Parasitol, V4, P10, DOI 10.4103/2229-5070.129143; Munthe-Fog L, 2007, SCAND J IMMUNOL, V65, P383, DOI 10.1111/j.1365-3083.2007.01915.x; Ready PD, 2014, CLIN EPIDEMIOL, V6, P147, DOI 10.2147/CLEP.S44267; Ren Yushan, 2014, Virologica Sinica, V29, P25, DOI 10.1007/s12250-014-3421-2; Sacks D, 2001, ANNU REV MICROBIOL, V55, P453, DOI 10.1146/annurev.micro.55.1.453; Santos IKFD, 2001, INFECT IMMUN, V69, P5212, DOI 10.1128/IAI.69.8.5212-5215.2001; Singh SP, 2006, TROP MED INT HEALTH, V11, P899, DOI 10.1111/j.1365-3156.2006.01647.x; Soborg C, 2003, J INFECT DIS, V188, P777, DOI 10.1086/377183; Thangaraj K, 2002, J ANDROL, V23, P815; Tong HV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028113; Wan QQ, 2013, TRANSPL P, V45, P3289, DOI 10.1016/j.transproceed.2013.05.008	41	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0125940	10.1371/journal.pone.0125940	http://dx.doi.org/10.1371/journal.pone.0125940			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965808	Green Submitted, Green Published, gold			2022-12-26	WOS:000354543500035
J	Morrison, BJ; Rubin, JE				Morrison, Beverly J.; Rubin, Joseph E.			Carbapenemase Producing Bacteria in the Food Supply Escaping Detection	PLOS ONE			English	Article							ENTEROBACTERIACEAE; SPREAD; RESISTANCE; TRAVEL; GENE	Carbapenem antimicrobials are critically important to human health and they are often the only remaining effective antibiotics for treating serious infections. Resistance to these drugs mediated by acquired carbapenemase enzymes is increasingly encountered in gramnegative bacteria and is considered a public health emergency. Animal origin food products are recognized as a potential source of resistant organisms, although carbapenem resistance has only recently been reported. In western countries there are active resistance surveillance programs targeting food animals and retail meat products. These programs primarily target beef, pork and poultry and focus exclusively on E. coli, Salmonella, Campylobacter spp. and Enterococcus spp. This global surveillance strategy does not capture the diversity of foods available nor does it address the presence of resistance gene-bearing mobile genetic elements in non-pathogenic bacterial taxa. To address this gap, a total of 121 seafood products originating in Asia purchased from retail groceries in Canada were tested. Samples were processed using a taxa-independent method for the selective isolation of carbapenem resistant organisms. Isolates were characterized by phenotypic antimicrobial susceptibility testing, PCR and DNA sequencing. Carbapenemase producing bacteria, all blaOXA-48, were isolated from 4 (3.3%) of the samples tested. Positive samples originated from China (n=2) and Korea (n=2) and included squid, sea squirt, clams and seafood medley. Carbapenemase producing organisms found include Pseudomonas, Stenotrophomonas and Myroides species. These findings suggest that non-pathogenic bacteria, excluded from resistance surveillance programs, in niche market meats may serve as a reservoir of carbapenemase genes in the food supply.	[Morrison, Beverly J.; Rubin, Joseph E.] Univ Saskatchewan, Dept Vet Microbiol, Saskatoon, SK S7N 0W0, Canada	University of Saskatchewan	Rubin, JE (corresponding author), Univ Saskatchewan, Dept Vet Microbiol, Saskatoon, SK S7N 0W0, Canada.	joe.rubin@usask.ca	Rubin, Joseph E/B-3374-2009	Rubin, Joseph E/0000-0002-2636-406X	University of Saskatchewan; Interprovincial Summer Student Research Program at the Western College of Veterinary Medicine	University of Saskatchewan; Interprovincial Summer Student Research Program at the Western College of Veterinary Medicine	This work was supported by a new investigator start up operating fund from the University of Saskatchewan. Stipend support for B.M. was provided by the Interprovincial Summer Student Research Program at the Western College of Veterinary Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, CDC ANT RES THREATS; Beyrouthy R, 2014, J ANTIMICROB CHEMOTH, V69, P2699, DOI 10.1093/jac/dku181; Canada Go, 2012, CAN INT PROGR ANT RE; Canada Go, 2012, SAF INT COOK TEMP; Carlet J, 2011, LANCET, V378, P369, DOI 10.1016/S0140-6736(11)60401-7; Clinical and Laboratory Standards Institute, 2010, METH ANT DIL DISK SU, V2rd; CLSI, 2014, M100S24 PERF STAND A; CLSI, 2012, METH DIL ANT SUSC TE; Cremet L, 2012, J ANTIMICROB CHEMOTH, V67, P1041, DOI 10.1093/jac/dkr547; DANMAP, 2013, US ANT AG OCC ANT RE; DORSCH M, 1992, J MICROBIOL METH, V16, P271, DOI 10.1016/0167-7012(92)90017-X; Doyle D, 2012, J CLIN MICROBIOL, V50, P3877, DOI 10.1128/JCM.02117-12; Food and Agriculture Organization of the United Nations Statistical Database (FAO), 2011, WORLD AQ 2010; Johnson AP, 2013, J MED MICROBIOL, V62, P499, DOI 10.1099/jmm.0.052555-0; Kwok AYC, 2003, INT J SYST EVOL MICR, V53, P87, DOI 10.1099/ijs.0.02210-0; Liu CC, 2014, GENE, V544, P75, DOI 10.1016/j.gene.2014.04.047; OIE, 2003, OIE INT STAND ANT RE, P5; Peirano G, 2014, J CLIN MICROBIOL, V52, P1575, DOI 10.1128/JCM.00162-14; Rubin JE, 2014, EMERG INFECT DIS, V20, P1264, DOI 10.3201/eid2007.140534; Rubin JE, 2014, DIAGN MICR INFEC DIS, V79, P378, DOI 10.1016/j.diagmicrobio.2014.04.003; Ryu SH, 2012, INT J FOOD MICROBIOL, V152, P14, DOI 10.1016/j.ijfoodmicro.2011.10.003; Services HaH, 2011, NARMS RET MEAT ANN R; van der Bij AK, 2012, J ANTIMICROB CHEMOTH, V67, P2090, DOI 10.1093/jac/dks214; Woodford N, 2014, J ANTIMICROB CHEMOTH, V69, P287, DOI 10.1093/jac/dkt392; World Health Organization, 2014, ANT RES GLOB REP SUR	25	41	43	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0126717	10.1371/journal.pone.0126717	http://dx.doi.org/10.1371/journal.pone.0126717			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25966303	gold, Green Published, Green Submitted			2022-12-26	WOS:000354543500074
J	Pan, CC; Kung, PT; Wang, YH; Chang, YC; Wang, ST; Tsai, WC				Pan, Chien-Chou; Kung, Pei-Tseng; Wang, Yueh-Hsin; Chang, Yu-Chia; Wang, Shih-Ting; Tsai, Wen-Chen			Effects of Multidisciplinary Team Care on the Survival of Patients with Different Stages of Non-Small Cell Lung Cancer: A National Cohort Study	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; ED AMERICAN-COLLEGE; OF-LIFE CARE; ORAL-CAVITY CANCER; MANAGEMENT; DIAGNOSIS; IMPACT; MORTALITY; MEETINGS	In Taiwan, cancer is the top cause of death, and the mortality rate of lung cancer is the highest of all cancers. Some studies have demonstrated that multidisciplinary team (MDT) care can improve survival rates of non-small cell lung cancer (NSCLC) patients. However, no study has discussed the effect of MDT care on different stages of NSCLC. The target population for this study consisted of patients with NSCLC newly diagnosed in the 2005-2010 Cancer Registry. The data was linked with the 2002-2011 National Health Insurance Research Database and the 2005-2011 Cause of Death Statistics Database. The multivariate Cox proportional hazards model was used to explore whether the involvement of MDT care had an effect on survival. This study applied the propensity score as a control variable to reduce selection bias between patients with and without involvement of MDT care. The adjusted hazard ratio (HR) of death of MDT participants with stage III & IV NSCLC was significantly lower than that of MDT non-participants (adjusted HR = 0.87, 95% confidence interval = 0.84-0.90). This study revealed that MDT care are significantly associated with higher survival rate of patients with stage III and IV NSCLC, and thus MDT care should be used in the treatment of these patients.	[Pan, Chien-Chou; Wang, Yueh-Hsin; Wang, Shih-Ting; Tsai, Wen-Chen] China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan; [Pan, Chien-Chou] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Pan, Chien-Chou] Taichung Vet Gen Hosp, Dept Orthoped Surg, Taichung, Taiwan; [Kung, Pei-Tseng; Chang, Yu-Chia] Asia Univ, Dept Healthcare Adm, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; Taichung Veterans General Hospital; Asia University Taiwan	Tsai, WC (corresponding author), China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan.	wtsai@mail.cmu.edu.tw	; Tsai, Wen-Chen/O-3095-2015	Wang, Yueh-Hsin/0000-0002-1282-5945; Tsai, Wen-Chen/0000-0002-9684-0789	China Medical University [CMU102-ASIA-12, NSC101-2410-H-468-011]; Asia University; National Science Council	China Medical University(China Medical University); Asia University; National Science Council(Ministry of Science and Technology, Taiwan)	This study was supported by grants (CMU102-ASIA-12, NSC101-2410-H-468-011) from China Medical University, Asia University, and the National Science Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, CANC REG ANN REP 201; Boxer MM, 2011, CANCER-AM CANCER SOC, V117, P5112, DOI 10.1002/cncr.26149; Chang TT, 2008, HPB, V10, P405, DOI 10.1080/13651820802356572; Chatterjee S, 2012, AM J GERIATR PHARMAC, V10, P83, DOI 10.1016/j.amjopharm.2011.10.006; COX DR, 1972, J R STAT SOC B, V34, P187; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Ellis PM, 2012, CURR ONCOL, V19, pS7, DOI 10.3747/co.19.1069; Ford DW, 2013, CHEST, V143, pE498, DOI 10.1378/chest.12-2367; Forrest LM, 2005, BRIT J CANCER, V93, P977, DOI 10.1038/sj.bjc.6602825; Forrest LF, 2015, THORAX, V70, P138, DOI 10.1136/thoraxjnl-2014-205517; Friedland PL, 2011, BRIT J CANCER, V104, P1246, DOI 10.1038/bjc.2011.92; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Griffin JP, 2007, CHEST, V132, p404S, DOI 10.1378/chest.07-1392; Griffin JP, 2003, CHEST, V123, p312S, DOI 10.1378/chest.123.1_suppl.312S; Howington JA, 2013, CHEST, V143, pE278, DOI 10.1378/chest.12-2359; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jett JR, 2013, CHEST, V143, pE400, DOI 10.1378/chest.12-2363; Kang SC, 2012, J CHIN MED ASSOC, V75, P221, DOI 10.1016/j.jcma.2012.04.005; Kesson EM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2718; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Luft HS, 2007, CLIN ORTHOP RELAT R, P3, DOI 10.1097/BLO.0b013e318034285e; Morales R, 2011, REV ESP ENFERM DIG, V103, P5, DOI 10.4321/s1130-01082011000100002; Peters S, 2012, ANN ONCOL, V23, P56, DOI 10.1093/annonc/mds226; Ramnath N, 2013, CHEST, V143, pE314, DOI 10.1378/chest.12-2360; Socinski MA, 2013, CHEST, V143, pE341, DOI 10.1378/chest.12-2361; Sorensen M, 2010, ANN ONCOL, V21, pv120, DOI 10.1093/annonc/mdq172; Tsai WC, 2015, ORAL ONCOL, V51, P105, DOI 10.1016/j.oraloncology.2014.11.006; Vathesatogkit P, 2014, J EPIDEMIOL COMMUN H, V68, P375, DOI 10.1136/jech-2013-203053; Vinod SK, 2010, J ONCOL PRACT, V6, P276, DOI 10.1200/JOP.2010.000019; Wang YH, 2012, ORAL ONCOL, V48, P803, DOI 10.1016/j.oraloncology.2012.03.023; Worni M, 2013, JAMA SURG, V148, P331, DOI 10.1001/jamasurg.2013.1058; Yu HC, 2014, HEALTH POLICY PLANN, V29, P732, DOI 10.1093/heapol/czt056; Zarogoulidis K, 2013, J THORAC DIS, V5, pS389, DOI 10.3978/j.issn.2072-1439.2013.07.10	33	58	61	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0126547	10.1371/journal.pone.0126547	http://dx.doi.org/10.1371/journal.pone.0126547			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25966317	Green Published, gold, Green Submitted			2022-12-26	WOS:000354543500062
J	Matsumoto, M; Hiyama, TY; Kuboyama, K; Suzuki, R; Fujikawa, A; Noda, M				Matsumoto, Masahito; Hiyama, Takeshi Y.; Kuboyama, Kazuya; Suzuki, Ryoko; Fujikawa, Akihiro; Noda, Masaharu			Channel Properties of Na-x Expressed in Neurons	PLOS ONE			English	Article							GATED SODIUM-CHANNEL; SUBFORNICAL ORGAN; LEVEL SENSOR; PDZ DOMAIN; PSD-95; MEMBRANE; PROTEINS; BINDING	Na-x is a sodium-concentration ([Na+])-sensitive Na channel with a gating threshold of similar to 150 mM for extracellular [Na+] ([Na+](o)) in vitro. We previously reported that Nax was preferentially expressed in the glial cells of sensory circumventricular organs including the subfornical organ, and was involved in [Na+] sensing for the control of salt-intake behavior. Although Nax was also suggested to be expressed in the neurons of some brain regions including the amygdala and cerebral cortex, the channel properties of Nax have not yet been adequately characterized in neurons. We herein verified that Nax was expressed in neurons in the lateral amygdala of mice using an antibody that was newly generated against mouse Nax. To investigate the channel properties of Nax expressed in neurons, we established an inducible cell line of Nax using the mouse neuroblastoma cell line, Neuro-2a, which is endogenously devoid of the expression of Nax. Functional analyses of this cell line revealed that the [Na+]sensitivity of Nax in neuronal cells was similar to that expressed in glial cells. The cation selectivity sequence of the Nax channel in cations was revealed to be Na+ approximate to Li+ > Rb+ > Cs+ for the first time. Furthermore, we demonstrated that Nax bound to postsynaptic density protein 95 (PSD95) through its PSD95/Disc-large/ZO-1 (PDZ)-binding motif at the C-terminus in neurons. The interaction between Nax and PSD95 may be involved in promoting the surface expression of Nax channels because the depletion of endogenous PSD95 resulted in a decrease in Nax at the plasma membrane. These results indicated, for the first time, that Nax functions as a [Na+]-sensitive Na channel in neurons as well as in glial cells.	[Matsumoto, Masahito; Hiyama, Takeshi Y.; Kuboyama, Kazuya; Suzuki, Ryoko; Fujikawa, Akihiro; Noda, Masaharu] Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 444, Japan; [Hiyama, Takeshi Y.; Noda, Masaharu] Grad Univ Adv Studies, SOKENDAI, Sch Life Sci, Okazaki, Aichi, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan	Noda, M (corresponding author), Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 444, Japan.	madon@nibb.ac.jp	Matsumoto, Masahito/ABB-3002-2021; Noda, Masaharu/D-7146-2016; Fujikawa, Akihiro/K-9805-2015; Hiyama, Takeshi/X-4134-2018	Noda, Masaharu/0000-0002-3796-524X; Fujikawa, Akihiro/0000-0002-3950-0550; Hiyama, Takeshi/0000-0001-8612-8707; Kuboyama, Kazuya/0000-0002-9878-1209	MEXT/JSPS KAKENHI [25830021, 26293043, 24220010]; Okazaki ORION project	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Okazaki ORION project	This work was supported by MEXT/JSPS KAKENHI (Grant Numbers; 25830021 to MM; 26293043 to TYH; and 24220010 to MN) and the Okazaki ORION project. URL: http://www.jsps.go.jp/english/e-grants/grants01.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian AN, 1997, FEBS LETT, V400, P183, DOI 10.1016/S0014-5793(96)01389-0; Berret E, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00413; Eldstrom J, 2002, FEBS LETT, V531, P529, DOI 10.1016/S0014-5793(02)03572-X; Eshcol JO, 2008, AM J PHYSIOL-CELL PH, V295, pC732, DOI 10.1152/ajpcell.00514.2007; FELIPE A, 1994, J BIOL CHEM, V269, P30125; Fujikawa A, 2007, J BIOCHEM, V142, P343, DOI 10.1093/jb/mvm140; Gardoni F, 2009, NEUROSCIENCE, V158, P324, DOI 10.1016/j.neuroscience.2008.07.068; GAUTRON S, 1992, P NATL ACAD SCI USA, V89, P7272, DOI 10.1073/pnas.89.15.7272; GEORGE AL, 1992, P NATL ACAD SCI USA, V89, P4893, DOI 10.1073/pnas.89.11.4893; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; Gong Q, 2007, J BIOL CHEM, V282, P13087, DOI 10.1074/jbc.M700767200; HILLE B, 1972, J GEN PHYSIOL, V59, P637, DOI 10.1085/jgp.59.6.637; Hille B, 2001, ION CHANNELS EXCITAB, P21; Hiyama TY, 2013, CELL METAB, V17, P507, DOI 10.1016/j.cmet.2013.02.018; Hiyama TY, 2010, NEURON, V66, P508, DOI 10.1016/j.neuron.2010.04.017; Hiyama TY, 2004, J NEUROSCI, V24, P9276, DOI 10.1523/JNEUROSCI.2795-04.2004; Hiyama TY, 2002, NAT NEUROSCI, V5, P511, DOI 10.1038/nn856; Imamura F, 2002, J BIOL CHEM, V277, P3640, DOI 10.1074/jbc.M106940200; Inanobe A, 2002, AM J PHYSIOL-CELL PH, V282, pC1396, DOI 10.1152/ajpcell.00615.2001; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Matsumoto M, 2012, FEBS LETT, V586, P3805, DOI 10.1016/j.febslet.2012.09.018; Nehme B, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00026; Nehring RB, 2000, J NEUROSCI, V20, P156, DOI 10.1523/JNEUROSCI.20-01-00156.2000; Noda M, 2006, NEUROSCIENTIST, V12, P80, DOI 10.1177/1073858405279683; Noda M, 2005, CHEM SENSES, V30, pI44, DOI 10.1093/chemse/bjh105; NODA M, 1993, ANN NY ACAD SCI, V707, P20, DOI 10.1111/j.1749-6632.1993.tb38039.x; Noda M, 2015, NEUROSCIENTIST, V21, P399, DOI 10.1177/1073858414541009; Noda M, 2015, PFLUG ARCH EUR J PHY, V467, P465, DOI 10.1007/s00424-014-1662-4; Polepalli JS, 2010, J NEUROSCI, V30, P14619, DOI 10.1523/JNEUROSCI.3252-10.2010; Shimizu H, 2007, NEURON, V54, P59, DOI 10.1016/j.neuron.2007.03.014; Tanemoto M, 2002, NEURON, V34, P387, DOI 10.1016/S0896-6273(02)00675-X; Tremblay C, 2011, J NEUROPHYSIOL, V105, P650, DOI 10.1152/jn.00417.2010; Uchino S, 2003, BIOCHEM BIOPH RES CO, V310, P1140, DOI 10.1016/j.bbrc.2003.09.133; Unezaki S, 2014, EUR J NEUROSCI, V39, P720, DOI 10.1111/ejn.12436; Watanabe E, 2006, AM J PHYSIOL-REG I, V290, pR568, DOI 10.1152/ajpregu.00618.2005; Watanabe E, 2002, NEUROSCI LETT, V330, P109, DOI 10.1016/S0304-3940(02)00708-5; Watanabe E, 2000, J NEUROSCI, V20, P7743; Wong W, 2002, J BIOL CHEM, V277, P20423, DOI 10.1074/jbc.M109412200	40	14	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126109	10.1371/journal.pone.0126109	http://dx.doi.org/10.1371/journal.pone.0126109			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961826	Green Published, Green Submitted, gold			2022-12-26	WOS:000354542500062
J	Matsumoto, T; Urushido, M; Ide, H; Ishihara, M; Hamada-Ode, K; Shimamura, Y; Ogata, K; Inoue, K; Taniguchi, Y; Taguchi, T; Horino, T; Fujimoto, S; Terada, Y				Matsumoto, Tatsuki; Urushido, Madoka; Ide, Haruna; Ishihara, Masayuki; Hamada-Ode, Kazu; Shimamura, Yoshiko; Ogata, Koji; Inoue, Kosuke; Taniguchi, Yoshinori; Taguchi, Takafumi; Horino, Taro; Fujimoto, Shimpei; Terada, Yoshio			Small Heat Shock Protein Beta-1 (HSPB1) Is Upregulated and Regulates Autophagy and Apoptosis of Renal Tubular Cells in Acute Kidney Injury	PLOS ONE			English	Article							B-CRYSTALLIN HSPB5; PROXIMAL TUBULE; HSP27 HSPB1; EXPRESSION; BAX; ACTIVATION; ISCHEMIA; AKT; PHOSPHORYLATION; HYPEROSMOLALITY	Background Heat shock protein beta-1 (HSPB1, also known as HSP27) is a small heat shock protein involved in many cellular processes and reportedly protects cells against oxidative stress. Autophagy protects cells from many types of stress and is thought to play a key role in preventing stress in acute kidney injury (AKI). However, little is known about the role of HSPB1 in autophagy and apoptosis in the pathogenesis of AKI. Methods We used a rat ischemia/reperfusion AKI model and cultured renal tubular cells as an in vitro model. To elucidate the regulation of HSPB1, we evaluated the promoter activity and expression of HSPB1 in normal rat kidney (NRK)-52E cells in the presence of H2O2. To examine the regulation of autophagy by HSPB1, we established NRK-light chain 3 (NRK-LC3) cells that were stably transfected with a fusion protein of green fluorescent protein and LC3. Results The results of immunohistological examination showed that HSPB1 was expressed in proximal tubule cells after AKI. Real-time quantitative reverse transcription-polymerase chain reaction and western blot analysis showed that HSPB1 messenger RNA and protein expression were upregulated 6-72 h and 12-72 h, respectively, after ischemia/reperfusion injury. HSPB1 promoter activity as well as messenger RNA and protein expression indicated dose-dependent induction by H2O2. HSPB1 overexpression-induced autophagy in NRK-LC3 cells under normoxic conditions was confirmed with confocal microscopy, which revealed the presence of LC3-positive granules. Furthermore, H2O2-induced autophagy was inhibited by the transfection of small interfering RNAs for HSPB1. Overexpression of HSPB1 reduced BAX activation and H2O2-induced apoptosis, as measured by caspase 3 activity and terminal deoxynucleotidyl transferase deoxyuridine triphosphate nick end labeling assay. Conclusions We showed that HSPB1 expression increased during oxidative stress in AKI. Incremental HSPB1 expression increased autophagic flux and inhibited apoptosis in renal tubular cells. These results indicate that HSPB1 upregulation plays a role in the pathophysiology of AKI.	[Matsumoto, Tatsuki; Hamada-Ode, Kazu; Shimamura, Yoshiko; Ogata, Koji; Inoue, Kosuke; Taniguchi, Yoshinori; Taguchi, Takafumi; Horino, Taro; Fujimoto, Shimpei; Terada, Yoshio] Kochi Univ, Kochi Med Sch, Dept Endocrinol Metab & Nephrol, Nankoku, Kochi, Japan; [Urushido, Madoka; Ide, Haruna] Kochi Univ, Kochi Med Sch, Ctr Innovat & Translat Med, Nankoku, Kochi, Japan; [Ishihara, Masayuki] Kochi Univ, Kochi Med Sch, Dept Pediat, Nankoku, Kochi, Japan	Kochi University; Kochi University; Kochi University	Terada, Y (corresponding author), Kochi Univ, Kochi Med Sch, Dept Endocrinol Metab & Nephrol, Oko Cho, Nankoku, Kochi, Japan.	terada@kochi-u.ac.jp			Kidney Foundation Japan; Ministry of Education, Science, Culture and Sports of Japan; Kochi organization for medical reformation and renewal; Grants-in-Aid for Scientific Research [15K15331] Funding Source: KAKEN	Kidney Foundation Japan(Kidney Foundation, Japan); Ministry of Education, Science, Culture and Sports of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kochi organization for medical reformation and renewal; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by The Kidney Foundation Japan and Kochi organization for medical reformation and renewal (to Y. Terada) and a grant from the Ministry of Education, Science, Culture and Sports of Japan (to Y. Terada).	Acunzo J, 2012, INT J BIOCHEM CELL B, V44, P1622, DOI 10.1016/j.biocel.2012.04.002; An JJ, 2008, FEBS J, V275, P1296, DOI 10.1111/j.1742-4658.2008.06291.x; Arrigo AP, 2007, FEBS LETT, V581, P3665, DOI 10.1016/j.febslet.2007.04.033; Bonventre JV, 2003, J AM SOC NEPHROL, V14, pS55, DOI 10.1097/01.ASN.0000067652.51441.21; Chauhan D, 2003, BLOOD, V102, P3379, DOI 10.1182/blood-2003-05-1417; Chen R, 2011, FOLIA BIOL-PRAGUE, V57, P87; Chen SWC, 2009, KIDNEY INT, V75, P499, DOI 10.1038/ki.2008.572; Creagh EM, 2000, LEUKEMIA, V14, P1161, DOI 10.1038/sj.leu.2401841; Devarajan P, 2006, J AM SOC NEPHROL, V17, P1503, DOI 10.1681/ASN.2006010017; Fujigaki Y, 2010, RENAL FAILURE, V32, P119, DOI 10.3109/08860220903367569; Gardai SJ, 2004, J BIOL CHEM, V279, P21085, DOI 10.1074/jbc.M400063200; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Gottlieb RA, 2010, AM J PHYSIOL-CELL PH, V299, pC203, DOI 10.1152/ajpcell.00097.2010; Havasi A, 2008, J BIOL CHEM, V283, P12305, DOI 10.1074/jbc.M801291200; Huber TB, 2012, AUTOPHAGY, V8, P1009, DOI 10.4161/auto.19821; Inoue K, 2010, CLIN EXP NEPHROL, V14, P112, DOI 10.1007/s10157-009-0254-7; Ishihara M, 2013, AM J PHYSIOL-RENAL, V305, pF495, DOI 10.1152/ajprenal.00642.2012; Jiang M, 2010, AM J PATHOL, V176, P1181, DOI 10.2353/ajpath.2010.090594; Kimura T, 2011, J AM SOC NEPHROL, V22, P902, DOI 10.1681/ASN.2010070705; Kobayashi T, 2008, KIDNEY INT, V73, P1240, DOI 10.1038/ki.2008.74; LANDRY J, 1989, J CELL BIOL, V109, P7, DOI 10.1083/jcb.109.1.7; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Leelahavanichkul A, 2011, KIDNEY INT, V80, P1198, DOI 10.1038/ki.2011.261; Linseman DA, 2004, J NEUROSCI, V24, P9993, DOI 10.1523/JNEUROSCI.2057-04.2004; Mikhailov V, 2001, J BIOL CHEM, V276, P18361, DOI 10.1074/jbc.M100655200; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mounier N, 2002, CELL STRESS CHAPERON, V7, P167, DOI 10.1379/1466-1268(2002)007<0167:ACASHS>2.0.CO;2; Park SW, 2009, AM J PHYSIOL-RENAL, V297, pF885, DOI 10.1152/ajprenal.00317.2009; Sanchez-Nino MD, 2012, LAB INVEST, V92, P32, DOI 10.1038/labinvest.2011.138; Sansanwal P, 2010, J AM SOC NEPHROL, V21, P272, DOI 10.1681/ASN.2009040383; Stetler RA, 2012, J NEUROSCI, V32, P2667, DOI 10.1523/JNEUROSCI.5169-11.2012; Sun XF, 2014, AUTOPHAGY, V10, P1873, DOI 10.4161/auto.32184; Suzuki C, 2008, BIOCHEM BIOPH RES CO, V368, P100, DOI 10.1016/j.bbrc.2008.01.059; Tanaka H, 2004, J AM SOC NEPHROL, V15, P3083, DOI 10.1097/01.ASN.0000145459.54236.D3; Tang DL, 2011, CELL METAB, V13, P701, DOI 10.1016/j.cmet.2011.04.008; Terada Y, 2003, J AM SOC NEPHROL, V14, P1223, DOI 10.1097/01.ASN.0000060577.94532.06; Terada Y, 2001, KIDNEY INT, V60, P553, DOI 10.1046/j.1523-1755.2001.060002553.x; TERADA Y, 1994, J BIOL CHEM, V269, P31296; WALLIN A, 1992, LAB INVEST, V66, P474; Wu R, 2007, J BIOL CHEM, V282, P21598, DOI 10.1074/jbc.M611316200; Yang C, 2008, AM J PHYSIOL-RENAL, V294, pF777, DOI 10.1152/ajprenal.00590.2007; Ye SY, 2011, MED HYPOTHESES, V76, P296, DOI 10.1016/j.mehy.2010.10.028	42	47	49	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126229	10.1371/journal.pone.0126229	http://dx.doi.org/10.1371/journal.pone.0126229			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962073	gold, Green Published, Green Submitted			2022-12-26	WOS:000354542500077
J	Ohnishi, YH; Ohnishi, YN; Nakamura, T; Ohno, M; Kennedy, PJ; Yasuyuki, O; Nishi, A; Neve, R; Tsuzuki, T; Nestler, EJ				Ohnishi, Yoko H.; Ohnishi, Yoshinori N.; Nakamura, Takanori; Ohno, Mizuki; Kennedy, Pamela J.; Yasuyuki, Ohkawa; Nishi, Akinori; Neve, Rachael; Tsuzuki, Teruhisa; Nestler, Eric J.			PSMC5, a 19S Proteasomal ATPase, Regulates Cocaine Action in the Nucleus Accumbens	PLOS ONE			English	Article							DELTA-FOSB; EXPRESSION; PROTEINS; BRAIN; SENSITIVITY; INDUCTION; IDENTIFICATION; MECHANISMS; PROMOTER; SYSTEM	Delta FosB is a stable transcription factor which accumulates in the nucleus accumbens (NAc), a key part of the brain's reward circuitry, in response to chronic exposure to cocaine or other drugs of abuse. While Delta FosB is known to heterodimerize with a Jun family member to form an active transcription factor complex, there has not to date been an open-ended exploration of other possible binding partners for Delta FosB in the brain. Here, by use of yeast two-hybrid assays, we identify PSMC5-also known as SUG1, an ATPase-containing subunit of the 19S proteasomal complex-as a novel interacting protein with Delta FosB. We verify such interactions between endogenous Delta FosB and PSMC5 in the NAc and demonstrate that both proteins also form complexes with other chromatin regulatory proteins associated with gene activation. We go on to show that chronic cocaine increases nuclear, but not cytoplasmic, levels of PSMC5 in the NAc and that overexpression of PSMC5 in this brain region promotes the locomotor responses to cocaine. Together, these findings describe a novel mechanism that contributes to the actions of Delta FosB and, for the first time, implicates PSMC5 in cocaine-induced molecular and behavioral plasticity.	[Ohnishi, Yoko H.; Ohnishi, Yoshinori N.; Kennedy, Pamela J.; Nestler, Eric J.] Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY 10029 USA; [Ohnishi, Yoko H.; Ohnishi, Yoshinori N.; Nishi, Akinori] Kurume Univ, Sch Med, Dept Pharmacol, Kurume, Fukuoka 830, Japan; [Nakamura, Takanori] Kyushu Univ, Grad Sch Med Sci, Res Ctr Human Dis Modeling, Res Support Ctr, Fukuoka 812, Japan; [Ohnishi, Yoko H.; Ohno, Mizuki; Tsuzuki, Teruhisa] Kyushu Univ, Fac Med Sci, Dept Med Biophys & Radiat Biol, Fukuoka 812, Japan; [Yasuyuki, Ohkawa] Kyushu Univ, Fac Med, Dept Adv Med Initiat, Div Epigenet, Fukuoka 812, Japan; [Neve, Rachael] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Icahn School of Medicine at Mount Sinai; Kurume University; Kyushu University; Kyushu University; Kyushu University; Massachusetts Institute of Technology (MIT)	Nestler, EJ (corresponding author), Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY 10029 USA.	eric.nestler@mssm.edu			National Institutes of Health; Ishibashi Foundation; National Institute on Drug Abuse; Japan Society for the Promotion of Science [24591735, 26290064, 25116010]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA007359, P01DA008227, R37DA007359] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [26290064, 25116010, 26281022] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ishibashi Foundation; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the National Institutes of Health, the National Institute on Drug Abuse, and by the Ishibashi Foundation and the Japan Society for the Promotion of Science (KAKENHI numbers: 24591735, 26290064, 25116010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carle TL, 2007, EUR J NEUROSCI, V25, P3009, DOI 10.1111/j.1460-9568.2007.05575.x; CHEN JS, 1995, MOL PHARMACOL, V48, P880; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; Colby CR, 2003, J NEUROSCI, V23, P2488; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; Ferrell K, 2000, TRENDS BIOCHEM SCI, V25, P83, DOI 10.1016/S0968-0004(99)01529-7; Geng FQ, 2012, ANNU REV BIOCHEM, V81, P177, DOI 10.1146/annurev-biochem-052110-120012; Hiroi N, 1998, J NEUROSCI, V18, P6952; Hiroi N, 1997, P NATL ACAD SCI USA, V94, P10397, DOI 10.1073/pnas.94.19.10397; HOPE BT, 1994, NEURON, V13, P1235, DOI 10.1016/0896-6273(94)90061-2; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Koues OI, 2008, MOL CELL BIOL, V28, P5837, DOI 10.1128/MCB.00535-08; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; Levine AA, 2005, P NATL ACAD SCI USA, V102, P19186, DOI 10.1073/pnas.0509735102; MA J, 1988, CELL, V55, P443, DOI 10.1016/0092-8674(88)90030-X; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; MORGAN JI, 1995, TRENDS NEUROSCI, V18, P66; NAKABEPPU Y, 1993, MOL CELL BIOL, V13, P4157, DOI 10.1128/MCB.13.7.4157; Nestler EJ, 2008, PHILOS T R SOC B, V363, P3245, DOI 10.1098/rstb.2008.0067; Peakman MC, 2003, BRAIN RES, V970, P73, DOI 10.1016/S0006-8993(03)02230-3; Perez-Otano I, 1998, MOL BRAIN RES, V53, P41, DOI 10.1016/S0169-328X(97)00269-6; Perrotti LI, 2008, SYNAPSE, V62, P358, DOI 10.1002/syn.20500; Robison AJ, 2013, J NEUROSCI, V33, P4295, DOI 10.1523/JNEUROSCI.5192-12.2013; Scobie KN, 2014, P NATL ACAD SCI USA, V111, P2005, DOI 10.1073/pnas.1319703111; St-Arnaud R, 1999, J CELL BIOCHEM, P32; Sun DH, 1997, J NEUROBIOL, V33, P877; Ulery PG, 2006, J NEUROSCI, V26, P5131, DOI 10.1523/JNEUROSCI.4970-05.2006; von der Lehr N, 2003, CELL CYCLE, V2, P403, DOI 10.4161/cc.2.5.484; Wang WL, 1996, P NATL ACAD SCI USA, V93, P8236, DOI 10.1073/pnas.93.16.8236; Zachariou V, 2006, NAT NEUROSCI, V9, P205, DOI 10.1038/nn1636	30	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126710	10.1371/journal.pone.0126710	http://dx.doi.org/10.1371/journal.pone.0126710			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962134	gold, Green Published			2022-12-26	WOS:000354542500141
J	Rombaldi, AJ; Pellanda, LC; Bielemann, RM; Gigante, DP; Hallal, PC; Horta, BL				Rombaldi, Airton J.; Pellanda, Lucia C.; Bielemann, Renata M.; Gigante, Denise P.; Hallal, Pedro C.; Horta, Bernardo L.			Cross-Sectional and Prospective Associations between Physical Activity and C-Reactive Protein in Males	PLOS ONE			English	Article							INFLAMMATORY MARKERS; CARDIOVASCULAR-DISEASE; EXERCISE; WOMEN; MEN; VARIABILITY; MORTALITY; STATEMENT; HEALTH; COHORT	Background There is conflicting evidence about the association between physical activity and inflammatory markers. Few prospective studies are available, particularly from low and middle-income countries. This study was aimed at assessing the cross-sectional and prospective associations between physical activity and C-reactive protein (CRP) levels in males belonging to the 1982 Pelotas (Brazil) Birth Cohort Study. Methods The sample comprised 2,213 males followed up at the ages of 18 and 23 years. We performed high sensitivity CRP assays; we used a cut-off of 3 mg/L in categorical analyses. We measured physical activity by self-report at ages 18 and 23 years. Body mass index and waist circumference were studies as possible mediators. Results CRP levels above the 3mg/L cut-off were found in 13.3%(95% CI: 11.7; 14.8) of the individuals. We found no evidence for an association between physical activity (leisure-time or all-domains) and either continuous (geometrical mean) or categorical CRP. We confirmed these null findings in (a) prospective and cross-sectional analyses; (b) trajectories analyses. Conclusions There was no association between CRP levels and physical activity levels in early adulthood in a large birth cohort. Little variability in CRP at this early age is the likely explanation for these null findings.	[Rombaldi, Airton J.; Hallal, Pedro C.] Univ Fed Pelotas, Post Grad Program Phys Educ, Pelotas, Brazil; [Pellanda, Lucia C.] Fed Univ Hlth Sci Porto Alegre, Porto Alegre, RS, Brazil; [Pellanda, Lucia C.] Inst Cardiol Rio Grande Do Sul, Porto Alegre, RS, Brazil; [Bielemann, Renata M.; Gigante, Denise P.; Hallal, Pedro C.; Horta, Bernardo L.] Univ Fed Pelotas, Post Grad Program Epidemiol, Pelotas, Brazil	Universidade Federal de Pelotas; Fundacao Universitaria de Cardiologia; Universidade Federal de Pelotas	Bielemann, RM (corresponding author), Univ Fed Pelotas, Post Grad Program Epidemiol, Pelotas, Brazil.	renatabielemann@hotmail.com	Pellanda, Lucia/ABC-1687-2020; Horta, Bernardo/A-7604-2008; Gigante, Denise/G-9285-2015; Rombaldi, Airton/AAM-6492-2021; Pellanda, Lucia C/B-4701-2010	Horta, Bernardo/0000-0001-9843-412X; Gigante, Denise/0000-0001-7309-5838; Rombaldi, Airton/0000-0002-6707-814X; Pellanda, Lucia C/0000-0002-8776-2248	Wellcome Trust Initiative [086974/Z/08/Z]; International Development Research Center; World Health Organization; Overseas Development Administration; European Union; National Support Program for Centers of Excellence (PRONEX); Brazilian National Research Council (CNPq); Brazilian Ministry of Health	Wellcome Trust Initiative(Wellcome Trust); International Development Research Center; World Health Organization(World Health Organization); Overseas Development Administration; European Union(European Commission); National Support Program for Centers of Excellence (PRONEX); Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Ministry of Health	This article is based on data from the study "Pelotas birth cohort, 1982" conducted by Postgraduate Program in Epidemiology at Universidade Federal de Pelotas. The 1982 birth cohort study was supported by the Wellcome Trust Initiative entitled Major Awards for Latin America on Health Consequences of Population Change, grant entitled: "Implications of early life and contemporary exposures on body composition, human capital, mental health and precursors of complex chronic diseases in three Brazilian cohorts (1982, 1993 and 2004)", grant No 086974/Z/08/Z. Previous phases of the study were supported by the International Development Research Center, The World Health Organization, Overseas Development Administration, European Union, National Support Program for Centers of Excellence (PRONEX), the Brazilian National Research Council (CNPq) and Brazilian Ministry of Health. This does not alter the authors' adherence to PLOS ONE policies on sharing data.	Ahmadi-Abhari S, 2013, EUR J EPIDEMIOL, V28, P541, DOI 10.1007/s10654-013-9819-6; Balducci S, 2010, NUTR METAB CARDIOVAS, V20, P608, DOI 10.1016/j.numecd.2009.04.015; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Batty GD, 2007, BRAZ J MED BIOL RES, V40, P1277, DOI 10.1590/S0100-879X2007000900015; Beavers KM, 2010, CLIN CHIM ACTA, V411, P785, DOI 10.1016/j.cca.2010.02.069; Bischoff AL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056700, 10.1371/journal.pone.0071417]; Braga F, 2012, CLIN CHIM ACTA, V413, P1179, DOI 10.1016/j.cca.2012.04.010; Cooper DM, 2004, CURR OPIN PEDIATR, V16, P286, DOI 10.1097/01.mop.0000126601.29787.39; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Ertek S, 2012, ARCH MED SCI, V8, P794, DOI 10.5114/aoms.2012.31614; Fragopoulou E, 2010, J NUTR BIOCHEM, V21, P285, DOI 10.1016/j.jnutbio.2008.12.013; Geffken DF, 2001, AM J EPIDEMIOL, V153, P242, DOI 10.1093/aje/153.3.242; Hallal Pedro C, 2011, Rev. bras. epidemiol., V14, P53, DOI 10.1590/S1415-790X2011000500006; Hamer M, 2012, CIRCULATION, V126, P928, DOI 10.1161/CIRCULATIONAHA.112.103879; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hawkins M, 2012, DIABETES RES CLIN PR, V97, pE4, DOI 10.1016/j.diabres.2012.03.019; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Isasi CR, 2003, PEDIATRICS, V111, P332, DOI 10.1542/peds.111.2.332; Jankord R, 2004, MED SCI SPORT EXER, V36, P960, DOI 10.1249/01.MSS.0000128186.09416.18; Kasapis C, 2005, J AM COLL CARDIOL, V45, P1563, DOI 10.1016/j.jacc.2004.12.077; King DE, 2003, MED SCI SPORT EXER, V35, P575, DOI 10.1249/01.MSS.0000058440.28108.CC; McDade TW, 2012, P NATL ACAD SCI USA, V109, P17281, DOI 10.1073/pnas.1202244109; Myers GL, 2004, CIRCULATION, V110, pE545, DOI 10.1161/01.CIR.0000148980.87579.5E; Nash SD, 2013, J AM GERIATR SOC, V61, P1269, DOI 10.1111/jgs.12382; Pellanda LC, 2009, INT J CARDIOL, V134, P371, DOI 10.1016/j.ijcard.2008.02.024; Plaisance EP, 2006, SPORTS MED, V36, P443, DOI 10.2165/00007256-200636050-00006; Reuben DB, 2003, J AM GERIATR SOC, V51, P1125, DOI 10.1046/j.1532-5415.2003.51380.x; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Sjogren P, 2010, EUR J CLIN NUTR, V64, P1450, DOI 10.1038/ejcn.2010.182; Strath SJ, 2013, CIRCULATION, V128, P2259, DOI 10.1161/01.cir.0000435708.67487.da; Vasquez E, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.130183; Vepsalainen T, 2011, DIABETES CARE, V34, P1492, DOI 10.2337/dc11-0469; Victora CG, 2006, INT J EPIDEMIOL, V35, P237, DOI 10.1093/ije/dyi290; Volpato S, 2004, CIRCULATION, V109, P607, DOI 10.1161/01.CIR.0000109503.13955.00; Walsh NP, 2011, EXERC IMMUNOL REV, V17, P64; Warnberg J, 2010, P NUTR SOC, V69, P400, DOI 10.1017/S0029665110001928; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Yates T, 2010, DIABETIC MED, V27, P1256, DOI 10.1111/j.1464-5491.2010.03091.x	38	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0125984	10.1371/journal.pone.0125984	http://dx.doi.org/10.1371/journal.pone.0125984			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961844	Green Submitted, Green Published, gold			2022-12-26	WOS:000354542500055
J	Shastri, MD; Stewart, N; Horne, J; Peterson, GM; Gueven, N; Sohal, SS; Patel, RP				Shastri, Madhur D.; Stewart, Niall; Horne, James; Peterson, Gregory M.; Gueven, Nuri; Sohal, Sukhwinder S.; Patel, Rahul P.			In-Vitro Suppression of IL-6 and IL-8 Release from Human Pulmonary Epithelial Cells by Non-Anticoagulant Fraction of Enoxaparin	PLOS ONE			English	Article							LOW-MOLECULAR-WEIGHT; FIBROBLAST-GROWTH-FACTOR; N-TERMINAL DOMAIN; HEPARIN-BINDING; CAPILLARY-ELECTROPHORESIS; ASTHMA; ANTITHROMBIN; SEPARATION; MODULATE; GLYCOSAMINOGLYCANS	Background Enoxaparin, a mixture of anticoagulant and non-anticoagulant fractions, is widely used as an anticoagulant agent. However, it is also reported to possess anti-inflammatory properties. Our study indicated that enoxaparin inhibits the release of IL-6 and IL-8 from A549 pulmonary epithelial cells. Their release causes extensive lung tissue damage. The use of enoxaparin as an anti-inflammatory agent is hampered due to the risk of bleeding associated with its anticoagulant fractions. Therefore, we aimed to identify the fraction responsible for the observed anti-inflammatory effect of enoxaparin and to determine the relationship between its structure and biological activities. Methods A549 pulmonary epithelial cells were pre-treated in the presence of enoxaparin and its fractions. The levels of IL-6 and IL-8 released from the trypsin-stimulated cells were measured by ELISA. The anticoagulant activity of the fraction responsible for the effect of enoxaparin was determined using an anti-factor-Xa assay. The fraction was structurally characterised using nuclear magnetic resonance. The fraction was 2-O, 6-O or N-desulfated to determine the position of sulfate groups required for the inhibition of interleukins. High-performance size-exclusion chromatography was performed to rule out that the observed effect was due to the interaction between the fraction and trypsin or interleukins. Results Enoxaparin (60 mu g/mL) inhibited the release of IL-6 and IL-8 by >30%. The fraction responsible for this effect of enoxaparin was found to be a disaccharide composed of alpha-L-iduronic-acid and alpha-D-glucosamine-6-sulfate. It (15 mu g/mL) inhibited the release of interleukins by >70%. The 6-O sulphate groups were responsible for its anti-inflammatory effect. The fraction did not bind to trypsin or interleukins, suggesting the effect was not due to an artefact of the experimental model. Conclusion The identified disaccharide has no anticoagulant activity and therefore eliminates the risk of bleeding associated with enoxaparin. Future in-vivo studies should be designed to validate findings of the current study.	[Shastri, Madhur D.; Stewart, Niall; Peterson, Gregory M.; Gueven, Nuri; Patel, Rahul P.] Univ Tasmania, Fac Hlth, Sch Med, Pharm, Hobart, Tas, Australia; [Horne, James] Univ Tasmania, Cent Sci Lab, Hobart, Tas, Australia; [Peterson, Gregory M.] Univ Tasmania, Fac Hlth, Sch Med, Hlth Serv Innovat Tasmania, Hobart, Tas, Australia; [Peterson, Gregory M.; Sohal, Sukhwinder S.] Univ Tasmania, Fac Hlth, Sch Med, Breathe Well Ctr Res Excellence Chron Resp Dis &, Hobart, Tas, Australia; [Sohal, Sukhwinder S.] Univ Tasmania, Fac Hlth, Sch Hlth Sci, Hobart, Tas, Australia	University of Tasmania; University of Tasmania; University of Tasmania; University of Tasmania; University of Tasmania	Patel, RP (corresponding author), Univ Tasmania, Fac Hlth, Sch Med, Pharm, Hobart, Tas, Australia.	Rahul.Patel@utas.edu.au		Horne, James/0000-0002-1935-2378; Guven, Nuri/0000-0003-3782-767X; Patel, Rahul/0000-0001-9344-1013; Sohal, Sukhwinder Singh/0000-0001-9627-6498; Shastri, Madhur/0000-0002-1012-2779; Peterson, Gregory/0000-0002-6764-3882				Abrahamson SL, 1997, J BIOL CHEM, V272, P2149; Ahmed T, 1999, AM J RESP CRIT CARE, V160, P576, DOI 10.1164/ajrccm.160.2.9812076; Asokananthan N, 2002, J IMMUNOL, V168, P3577, DOI 10.4049/jimmunol.168.7.3577; AUSTIN RC, 1992, BIOCHEM J, V282, P345, DOI 10.1042/bj2820345; Baram D, 1997, CLIN EXP IMMUNOL, V110, P485, DOI 10.1046/j.1365-2249.1997.4541471.x; Barnes PJ, 1998, PHARMACOL REV, V50, P515; Bezemer GFG, 2012, PHARMACOL REV, V64, P337, DOI 10.1124/pr.111.004622; Brown RA, 2006, PULM PHARMACOL THER, V19, P419, DOI 10.1016/j.pupt.2006.04.004; Carter WJ, 2005, J BIOL CHEM, V280, P2745, DOI 10.1074/jbc.M411606200; Casu B., 2005, CHEM BIOL HEPARIN HE, P1, DOI DOI 10.1016/B978-008044859-6/50002-2; DANIELSSON A, 1986, J BIOL CHEM, V261, P5467; den Dekker E, 2008, J IMMUNOL, V180, P3680, DOI 10.4049/jimmunol.180.6.3680; Descotes J, 2009, MABS, V1, P104, DOI 10.4161/mabs.1.2.7909; DIAMOND MS, 1995, J CELL BIOL, V130, P1473, DOI 10.1083/jcb.130.6.1473; Dotan I, 2001, DIGEST DIS SCI, V46, P2239, DOI 10.1023/A:1011979418914; Dulon S, 2003, AM J RESP CELL MOL, V28, P339, DOI 10.1165/rcmb.4908; Edwards JP, 2009, J IMMUNOL, V182, P1929, DOI 10.4049/jimmunol.0802703; Guerrini Marco, 2012, Handb Exp Pharmacol, P127, DOI 10.1007/978-3-642-23056-1_7; Guerrini M, 2010, J MED CHEM, V53, P8030, DOI 10.1021/jm100771s; Huang JN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109996; ISHIHARA M, 1994, GLYCOBIOLOGY, V4, P817, DOI 10.1093/glycob/4.6.817; Kagnoff MF, 1997, J CLIN INVEST, V100, P6, DOI 10.1172/JCI119522; Kanabar V, 2008, BRIT J PHARMACOL, V154, P833, DOI 10.1038/bjp.2008.109; Kanabar V, 2005, BRIT J PHARMACOL, V146, P370, DOI 10.1038/sj.bjp.0706333; Kaya S, 2004, SCAND J GASTROENTERO, V39, P613, DOI 10.1080/00365520410004622; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; Lau EK, 2004, J BIOL CHEM, V279, P22294, DOI 10.1074/jbc.M311224200; Lever R, 2007, BRIT J PHARMACOL, V151, P837, DOI 10.1038/sj.bjp.0707298; Linhardt RJ, 1999, SEMIN THROMB HEMOST, V25, P5; Louis SG, 2014, JAMA SURG, V149, P365, DOI 10.1001/jamasurg.2013.3963; Mao WJ, 2002, BIOMED CHROMATOGR, V16, P77, DOI 10.1002/bmc.153; Marandi Y, 2013, ARCH MED SCI, V9, P521, DOI 10.5114/aoms.2013.33179; MARINI M, 1992, J ALLERGY CLIN IMMUN, V89, P1001, DOI 10.1016/0091-6749(92)90223-O; Ono K, 1999, GLYCOBIOLOGY, V9, P705, DOI 10.1093/glycob/9.7.705; Palmberg L, 1998, THORAX, V53, P260, DOI 10.1136/thx.53.4.260; Patel RP, 2008, J PHARMACEUT BIOMED, V46, P30, DOI 10.1016/j.jpba.2007.10.009; Patel RP, 2009, J PHARM SCI-US, V98, P1118, DOI 10.1002/jps.21483; Patel RP, 2009, J PHARM SCI-US, V98, P1700, DOI 10.1002/jps.21556; Patel RP, 2009, ANAL BIOCHEM, V387, P113, DOI 10.1016/j.ab.2009.01.007; Pelaia G, 2012, NAT REV DRUG DISCOV, V11, P958, DOI 10.1038/nrd3792; PERVIN A, 1995, GLYCOBIOLOGY, V5, P83, DOI 10.1093/glycob/5.1.83; Peters SP, 2006, RESP MED, V100, P1139, DOI 10.1016/j.rmed.2006.03.031; Rincon M, 2012, INT J BIOL SCI, V8, P1281, DOI 10.7150/ijbs.4874; Roy S, 2011, GLYCOBIOLOGY, V21, P1194, DOI 10.1093/glycob/cwr053; Salek-Ardakani S, 2000, BLOOD, V96, P1879, DOI 10.1182/blood.V96.5.1879.h8001879_1879_1888; Shastri MD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118798; Shastri MD, 2014, EXPERT OPIN INV DRUG, V23, P357, DOI 10.1517/13543784.2014.866092; Shastri MD, 2013, ANAL BIOANAL CHEM, V405, P6043, DOI 10.1007/s00216-013-6996-9; Sheng GJ, 2013, J AM CHEM SOC, V135, P10898, DOI 10.1021/ja4027727; To T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-204; TURNBULL JE, 1992, J BIOL CHEM, V267, P10337; Tyrrell DJ, 1999, ADV PHARMACOL, V46, P151, DOI 10.1016/S1054-3589(08)60471-8; Wang LC, 2002, J CLIN INVEST, V110, P127, DOI 10.1172/JCI200214996; WEIDMANN E, 1995, ANN HEMATOL, V70, P153, DOI 10.1007/s002770050049; Whitelock JM, 1996, J BIOL CHEM, V271, P10079, DOI 10.1074/jbc.271.17.10079; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Zeilhofer HU, 2000, CURR OPIN HEMATOL, V7, P178, DOI 10.1097/00062752-200005000-00009; Zhang SY, 2012, J BIOL CHEM, V287, P5542, DOI 10.1074/jbc.M111.314716; Zhou HJ, 1998, STRUCTURE, V6, P109, DOI 10.1016/S0969-2126(98)00012-4	59	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126763	10.1371/journal.pone.0126763	http://dx.doi.org/10.1371/journal.pone.0126763			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961885	Green Published, gold, Green Submitted			2022-12-26	WOS:000354542500146
J	Balderas, PMD; Aguilera, P				de Oca Balderas, Pavel Montes; Aguilera, Penelope			A Metabotropic-Like Flux-Independent NMDA Receptor Regulates Ca2+ Exit from Endoplasmic Reticulum and Mitochondrial Membrane Potential in Cultured Astrocytes	PLOS ONE			English	Article							CATIONIC LIPIDS; IN-SITU; GLUTAMATE; SUBUNIT; ACTIVATION; GLIA; DEPOLARIZATION; LIPOFECTAMINE; LOCALIZATION; TRAFFICKING	Astrocytes were long thought to be only structural cells in the CNS; however, their functional properties support their role in information processing and cognition. The ionotropic glutamate N-methyl D-aspartate (NMDA) receptor (NMDAR) is critical for CNS functions, but its expression and function in astrocytes is still a matter of research and debate. Here, we report immunofluorescence (IF) labeling in rat cultured cortical astrocytes (rCCA) of all NMDAR subunits, with phenotypes suggesting their intracellular transport, and their mRNA were detected by qRT-PCR. IF and Western Blot revealed GluN1 full-length synthesis, subunit critical for NMDAR assembly and transport, and its plasma membrane localization. Functionally, we found an iCa(2+) rise after NMDA treatment in Fluo-4-AM labeled rCCA, an effect blocked by the NMDAR competitive inhibitors D(-)-2-amino-5-phosphonopentanoic acid (APV) and Kynurenic acid (KYNA) and dependent upon GluN1 expression as evidenced by siRNA knock down. Surprisingly, the iCa(2+) rise was not blocked by MK-801, an NMDAR channel blocker, or by extracellular Ca2+ depletion, indicating flux-independent NMDAR function. In contrast, the IP3 receptor (IP3R) inhibitor XestosponginC did block this response, whereas a Ryanodine Receptor inhibitor did so only partially. Furthermore, tyrosine kinase inhibition with genistein enhanced the NMDA elicited iCa(2+) rise to levels comparable to those reached by the gliotransmitter ATP, but with different population dynamics. Finally, NMDA depleted the rCCA mitochondrial membrane potential (m Delta psi) measured with JC-1. Our results demonstrate that rCCA express NMDAR subunits which assemble into functional receptors that mediate a metabotropic-like, non-canonical, flux-independent iCa(2+) increase.	[de Oca Balderas, Pavel Montes] Inst Nacl Neurol & Neurocirug, Dept Neuroquim, Unidad Neurobiol Dinam, Mexico City, DF, Mexico; [Aguilera, Penelope] Inst Nacl Neurol & Neurocirug, Lab Patol Vasc Cerebral, Mexico City, DF, Mexico		Balderas, PMD (corresponding author), Inst Nacl Neurol & Neurocirug, Dept Neuroquim, Unidad Neurobiol Dinam, Mexico City, DF, Mexico.	pavel73@hotmail.com	Aguilera, Penélope/L-2958-2019	Aguilera, Penélope/0000-0003-2288-1251	CONACyT (Consejo Nacional de Ciencia y Tecnologia) [138425]; Basic Science SEP-CONACyT project [132706]	CONACyT (Consejo Nacional de Ciencia y Tecnologia)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Basic Science SEP-CONACyT project	This work was supported by Repatriation project from CONACyT (Consejo Nacional de Ciencia y Tecnologia) number 138425 and by Basic Science SEP-CONACyT project 2009 number 132706 granted to Ph. D. PMOB, http://www.conacyt.gob.mx/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agulhon C, 2010, SCIENCE, V327, P1250, DOI 10.1126/science.1184821; Allen NJ, 2009, NATURE, V457, P675, DOI 10.1038/457675a; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Black JA, 2013, NEURON, V80, P280, DOI 10.1016/j.neuron.2013.09.012; Buckman JF, 2001, J NEUROSCI, V21, P5054, DOI 10.1523/JNEUROSCI.21-14-05054.2001; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; CONTI F, 1994, J COMP NEUROL, V343, P554, DOI 10.1002/cne.903430406; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; Feissner RF, 2009, FRONT BIOSCI-LANDMRK, V14, P1197, DOI 10.2741/3303; Fiacco TA, 2007, NEURON, V54, P611, DOI 10.1016/j.neuron.2007.04.032; Gerard F, 2012, BRAIN RES, V1473, P1, DOI 10.1016/j.brainres.2012.07.032; Giaume C, 2010, NAT REV NEUROSCI, V11, P87, DOI 10.1038/nrn2757; Graier WF, 2007, PFLUG ARCH EUR J PHY, V455, P375, DOI 10.1007/s00424-007-0296-1; Han J, 2012, CELL, V148, P1039, DOI 10.1016/j.cell.2012.01.037; Hansen KB, 2010, MOL PHARMACOL, V78, P535, DOI 10.1124/mol.110.067157; Hawkins LM, 2004, J BIOL CHEM, V279, P28903, DOI 10.1074/jbc.M402599200; Jeremic A, 2001, J NEUROCHEM, V77, P664, DOI 10.1046/j.1471-4159.2001.00272.x; Jiang J, 2010, NEUROCHEM INT, V56, P561, DOI 10.1016/j.neuint.2009.12.019; Kato H, 2006, SYNAPSE, V59, P10, DOI 10.1002/syn.20213; Keil VC, 2011, PFLUG ARCH EUR J PHY, V462, P693, DOI 10.1007/s00424-011-1012-8; Kessels HW, 2013, P NATL ACAD SCI USA, V110, P4033, DOI 10.1073/pnas.1219605110; KETTENMANN H, 1985, J NEUROSCI, V5, P3295; Kirchhoff F, 2010, SCIENCE, V327, P1212, DOI 10.1126/science.1187420; Koizumi S, 2010, FEBS J, V277, P286, DOI 10.1111/j.1742-4658.2009.07438.x; Kondoh T, 2001, LIFE SCI, V68, P1761, DOI 10.1016/S0024-3205(01)00971-7; Krebs C, 2003, J NEUROSCI, V23, P3364; Lalo U, 2006, J NEUROSCI, V26, P2673, DOI 10.1523/JNEUROSCI.4689-05.2006; Lalo U, 2011, BBA-MOL CELL RES, V1813, P992, DOI 10.1016/j.bbamcr.2010.09.007; Lee MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014123; Man N, 2010, AUTOPHAGY, V6, P449, DOI 10.4161/auto.6.4.11612; Matyash V, 2010, BRAIN RES REV, V63, P2, DOI 10.1016/j.brainresrev.2009.12.001; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Mo RH, 2012, MOL BIOTECHNOL, V51, P1, DOI 10.1007/s12033-011-9422-6; Montes de Oca-B Pavel, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P337; Nabavi S, 2013, P NATL ACAD SCI USA, V110, P4027, DOI 10.1073/pnas.1219454110; Nishizaki T, 1999, BIOCHEM BIOPH RES CO, V259, P661, DOI 10.1006/bbrc.1999.0520; Nong Y, 2003, NATURE, V422, P302, DOI 10.1038/nature01497; Palygin O, 2010, CELL CALCIUM, V48, P225, DOI 10.1016/j.ceca.2010.09.004; Parihar MS, 2007, J NEUROSCI RES, V85, P1018, DOI 10.1002/jnr.21218; Pauly T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002681; Perez-Otano I, 2001, J NEUROSCI, V21, P1228; Petravicz J, 2008, J NEUROSCI, V28, P4967, DOI 10.1523/JNEUROSCI.5572-07.2008; Qiu S, 2009, J BIOL CHEM, V284, P20285, DOI 10.1074/jbc.M109.004960; Reyes RC, 2009, NEUROCHEM INT, V55, P2, DOI 10.1016/j.neuint.2008.12.018; Robertson JM, 2002, J PHYSIOL-PARIS, V96, P251, DOI 10.1016/S0928-4257(02)00013-X; Scanlon JM, 1998, J NEUROCHEM, V71, P2392; Schipke CG, 2001, FASEB J, V15, P1270, DOI 10.1096/fj.00-0439fje; Schuler T, 2008, J BIOL CHEM, V283, P37, DOI 10.1074/jbc.M703539200; Scott DB, 2001, J NEUROSCI, V21, P3063, DOI 10.1523/JNEUROSCI.21-09-03063.2001; Seifert S, 2011, CELL CALCIUM, V49, P365, DOI 10.1016/j.ceca.2011.03.005; Serrano A, 2008, GLIA, V56, P1648, DOI 10.1002/glia.20717; Shigetomi E, 2010, NAT NEUROSCI, V13, P759, DOI 10.1038/nn.2557; Szklarczyk A, 2008, FASEB J, V22, P3757, DOI 10.1096/fj.07-101402; Tamburri A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065350; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Triller A, 2005, TRENDS NEUROSCI, V28, P133, DOI 10.1016/j.tins.2005.01.001; Urmoneit B, 1998, PROSTAG OTH LIPID M, V55, P331, DOI 10.1016/S0090-6980(98)00032-X; Verkhratsky A, 2007, NEUROSCIENTIST, V13, P28, DOI 10.1177/1073858406294270; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; White RJ, 1996, J NEUROSCI, V16, P5688; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P13409, DOI 10.1073/pnas.96.23.13409; Yang L, 2004, J NEUROSCI, V24, P10846, DOI 10.1523/JNEUROSCI.2496-04.2004	64	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0126314	10.1371/journal.pone.0126314	http://dx.doi.org/10.1371/journal.pone.0126314			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25954808	Green Published, gold, Green Submitted			2022-12-26	WOS:000356768100112
J	Gines, A; Bystrup, S; de Porras, VR; Guardia, C; Musulen, E; Martinez-Cardus, A; Manzano, JL; Layos, L; Abad, A; Martinez-Balibrea, E				Gines, Alba; Bystrup, Sara; Ruiz de Porras, Vicenc; Guardia, Cristina; Musulen, Eva; Martinez-Cardus, Anna; Luis Manzano, Jose; Layos, Laura; Abad, Albert; Martinez-Balibrea, Eva			PKM2 Subcellular Localization Is Involved in Oxaliplatin Resistance Acquisition in HT29 Human Colorectal Cancer Cell Lines	PLOS ONE			English	Article							PYRUVATE-KINASE M2; NUCLEAR TRANSLOCATION; MOLECULAR-MECHANISMS; GENE-TRANSCRIPTION; DEATH; IDENTIFICATION; METABOLISM; AUTOPHAGY; P53; DETERMINANTS	Chemoresistance is the main cause of treatment failure in advanced colorectal cancer (CRC). However, molecular mechanisms underlying this phenomenon remain to be elucidated. In a previous work we identified low levels of PKM2 as a putative oxaliplatin-resistance marker in HT29 CRC cell lines and also in patients. In order to assess how PKM2 influences oxaliplatin response in CRC cells, we silenced PKM2 using specific siRNAs in HT29, SW480 and HCT116 cells. MTT test demonstrated that PKM2 silencing induced resistance in HT29 and SW480 cells and sensitivity in HCT116 cells. Same experiments in isogenic HCT116 p53 null cells and double silencing of p53 and PKM2 in HT29 cells failed to show an influence of p53. By using trypan blue stain and FITC-Annexin V/PI tests we detected that PKM2 knockdown was associated with an increase in cell viability but not with a decrease in apoptosis activation in HT29 cells. Fluorescence microscopy revealed PKM2 nuclear translocation in response to oxaliplatin in HCT116 and HT29 cells but not in OXA-resistant HTOXAR3 cells. Finally, by using a qPCR Array we demonstrated that oxaliplatin and PKM2 silencing altered cell death gene expression patterns including those of BMF, which was significantly increased in HT29 cells in response to oxaliplatin, in a dose and time-dependent manner, but not in siPKM2-HT29 and HTOXAR3 cells. BMF gene silencing in HT29 cells lead to a decrease in oxaliplatin-induced cell death. In conclusion, our data report new non-glycolytic roles of PKM2 in response to genotoxic damage and proposes BMF as a possible target gene of PKM2 to be involved in oxaliplatin response and resistance in CRC cells.	[Gines, Alba; Bystrup, Sara; Ruiz de Porras, Vicenc; Guardia, Cristina; Musulen, Eva; Martinez-Cardus, Anna; Luis Manzano, Jose; Layos, Laura; Abad, Albert; Martinez-Balibrea, Eva] Germans Trias I Pujol Fdn IGTP, Hlth Sci Res Inst, Lab Mol Canc Biol, Translat Res Digest Tumours Grp, Badalona, Spain; [Musulen, Eva] Univ Hosp Germans Trias I Pujol, Human Pathol Dept, Badalona, Spain; [Luis Manzano, Jose; Layos, Laura; Abad, Albert; Martinez-Balibrea, Eva] Univ Hosp Germans Trias I Pujol, Catalan Inst Oncol ICO, Med Oncol Serv, Badalona, Spain	Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); Catalan Institute of Oncology	Martinez-Balibrea, E (corresponding author), Germans Trias I Pujol Fdn IGTP, Hlth Sci Res Inst, Lab Mol Canc Biol, Translat Res Digest Tumours Grp, Badalona, Spain.	embalibrea@iconcologia.net	Musulen, Eva/AAI-9169-2020; Martinez, Anna/AAA-4939-2020; Martinez-Balibrea, Eva/HHS-5710-2022	Musulen, Eva/0000-0002-9667-6464; Bystrup, Sara/0000-0001-9029-1734; Guardia Valenzuela, Cristina/0000-0001-5176-1924; Ruiz de Porras, Vicenc/0000-0002-4352-1784; Layos Romero, Laura/0000-0002-0537-6061; Martinez-Balibrea, Eva/0000-0002-4501-7100; Martinez Cardus, Anna/0000-0002-3937-8794	beca bianual de la Fundacion Olga Torres	beca bianual de la Fundacion Olga Torres	This work was funded by beca bianual de la Fundacion Olga Torres 2008-2009 (http://www.fundacioolgatorres.org/beques_d-investigacio/) to EMB AGM AA AMC EM JLM.	ALLEY MC, 1988, CANCER RES, V48, P589; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Arango D, 2004, BRIT J CANCER, V91, P1931, DOI 10.1038/sj.bjc.6602215; Arnould S, 2003, EUR J CANCER, V39, P112, DOI 10.1016/S0959-8049(02)00411-2; Bose D, 2011, BRIT J CANCER, V105, P1759, DOI 10.1038/bjc.2011.449; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cheung EC, 2010, CURR OPIN CELL BIOL, V22, P186, DOI 10.1016/j.ceb.2009.12.006; Choi YE, 2009, J BIOL CHEM, V284, P12772, DOI 10.1074/jbc.M807550200; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Contreras AU, 2013, J CELL BIOL, V201, P427, DOI 10.1083/jcb.201205064; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Du HL, 2012, ONCOL REP, V27, P143, DOI 10.3892/or.2011.1464; Elkholi Rana, 2011, Genes Cancer, V2, P523, DOI 10.1177/1947601911417177; Galluzzi L, 2007, CELL DEATH DIFFER, V14, P1237, DOI 10.1038/sj.cdd.4402148; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Hata T, 2005, MOL CANCER THER, V4, P1585, DOI 10.1158/1535-7163.MCT-05-0011; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Hoshino A, 2007, J BIOL CHEM, V282, P17706, DOI 10.1074/jbc.M700094200; Kang Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.422; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Lee JW, 2008, INT J BIOCHEM CELL B, V40, P1043, DOI 10.1016/j.biocel.2007.11.009; Lv L, 2011, MOL CELL, V42, P719, DOI 10.1016/j.molcel.2011.04.025; Martinez-Balibrea E, 2009, MOL CANCER THER, V8, P771, DOI 10.1158/1535-7163.MCT-08-0882; Martinez-Cardus A, 2009, MOL CANCER THER, V8, P194, DOI 10.1158/1535-7163.MCT-08-0659; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Plasencia C, 2006, INT J ONCOL, V29, P225; Rabik CA, 2007, CANCER TREAT REV, V33, P9, DOI 10.1016/j.ctrv.2006.09.006; Rakitina TV, 2007, BIOCHEM PHARMACOL, V73, P1715, DOI 10.1016/j.bcp.2007.01.037; Sakai A, 2012, J PROTEOMICS, V75, P806, DOI 10.1016/j.jprot.2011.09.023; Spoden GA, 2009, J CELL BIOCHEM, V107, P293, DOI 10.1002/jcb.22125; Stetak A, 2007, CANCER RES, V67, P1602, DOI 10.1158/0008-5472.CAN-06-2870; Tamada M, 2012, CANCER RES, V72, P1438, DOI 10.1158/0008-5472.CAN-11-3024; Tischner D, 2012, APOPTOSIS, V17, P1197, DOI 10.1007/s10495-012-0756-8; Toscano F, 2007, BIOCHEM PHARMACOL, V74, P392, DOI 10.1016/j.bcp.2007.05.001; Weitz J, 2005, LANCET, V365, P153, DOI 10.1016/S0140-6736(05)17706-X; William-Faltaos S, 2007, FUND CLIN PHARMACOL, V21, P165, DOI 10.1111/j.1472-8206.2007.00462.x; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Yoo BC, 2004, INT J CANCER, V108, P532, DOI 10.1002/ijc.11604; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhou R, 2002, CANCER RES, V62, P3515	44	28	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0123830	10.1371/journal.pone.0123830	http://dx.doi.org/10.1371/journal.pone.0123830			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955657	Green Published, Green Submitted, gold			2022-12-26	WOS:000356768100021
J	Lindner, HB; Felmly, LM; Demcheva, M; Seth, A; Norris, R; Bradshaw, AD; Vournakis, J; Muise-Helmericks, RC				Lindner, Haley Buff; Felmly, Lloyd McPherson; Demcheva, Marina; Seth, Arun; Norris, Russell; Bradshaw, Amy D.; Vournakis, John; Muise-Helmericks, Robin C.			pGlcNAc Nanofiber Treatment of Cutaneous Wounds Stimulate Increased Tensile Strength and Reduced Scarring via Activation of Akt1	PLOS ONE			English	Article							INTEGRIN ACTIVATION; COLLAGEN; MYOFIBROBLASTS; MATRIX; SAFETY	Treatment of cutaneous wounds with poly-N-acetyl-glucosamine containing nanofibers (pGlcNAc), a novel polysaccharide material derived from a marine diatom, results in increased wound closure, antibacterial activities and innate immune responses. We have shown that Akt1 plays a central role in the regulation of these activities. Here, we show that pGlcNAc treatment of cutaneous wounds results in a smaller scar that has increased tensile strength and elasticity. pGlcNAc treated wounds exhibit decreased collagen content, increased collagen organization and decreased myofibroblast content. A fibrin gel assay was used to assess the regulation of fibroblast alignment in vitro. In this assay, fibrin lattice is formed with two pins that provide focal points upon which the gel can exert force as the cells align from pole to pole. pGlcNAc stimulation of embedded fibroblasts results in cellular alignment as compared to untreated controls, by a process that is Akt1 dependent. We show that Akt1 is required in vivo for the pGlcNAc-induced increased tensile strength and elasticity. Taken together, our findings suggest that pGlcNAc nanofibers stimulate an Akt1 dependent pathway that results in the proper alignment of fibroblasts, decreased scarring, and increased tensile strength during cutaneous wound healing.	[Lindner, Haley Buff; Felmly, Lloyd McPherson; Norris, Russell; Muise-Helmericks, Robin C.] Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA; [Bradshaw, Amy D.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Demcheva, Marina; Vournakis, John] Marine Polymer Technol Inc, Danvers, MA 01923 USA; [Seth, Arun] Univ Toronto, Sunnybrook Res Inst, Toronto, ON M5G 1G6, Canada	Medical University of South Carolina; Medical University of South Carolina; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Muise-Helmericks, RC (corresponding author), Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA.	musehelm@musc.edu		Felmly, Lloyd/0000-0002-2711-9584	Marine Polymer Technologies, Inc.	Marine Polymer Technologies, Inc.	The research was funded by Marine Polymer Technologies, Inc., as a basic science grant. The funder provided support in the form of salaries for authors JK and MD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ADZICK NS, 1994, ANN SURG, V220, P10, DOI 10.1097/00000658-199407000-00003; Baicu CF, 2012, AM J PHYSIOL-HEART C, V303, pH234, DOI 10.1152/ajpheart.00227.2012; Bayat A, 2003, BRIT MED J, V326, P88, DOI 10.1136/bmj.326.7380.88; Beeson CC, 2012, J VASC RES, V49, P89, DOI 10.1159/000332326; Buehler MJ, 2006, P NATL ACAD SCI USA, V103, P12285, DOI 10.1073/pnas.0603216103; Clark RAF, 1989, CURR OPIN CELL BIOL, V1, P1000, DOI 10.1016/0955-0674(89)90072-0; Fayard E, 2010, CURR TOP MICROBIOL, V346, P31, DOI 10.1007/82_2010_58; Gauglitz GG, 2011, MOL MED, V17, P113, DOI 10.2119/molmed.2009.00153; Hankin Cheryl S, 2012, J Manag Care Pharm, V18, P375; Hirsch Joshua A, 2003, Tech Vasc Interv Radiol, V6, P92, DOI 10.1053/tvir.2003.36446; Kalson NS, 2010, MATRIX BIOL, V29, P678, DOI 10.1016/j.matbio.2010.08.009; Kelechi TJ, 2012, J AM ACAD DERMATOL, V66, pE209, DOI 10.1016/j.jaad.2011.01.031; Kelley TW, 1999, J BIOL CHEM, V274, P26393, DOI 10.1074/jbc.274.37.26393; KRUMMEL TM, 1988, J PEDIATR SURG, V23, P647, DOI 10.1016/S0022-3468(88)80638-9; Lindner HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018996; LONGAKER MT, 1991, ANN SURG, V213, P292, DOI 10.1097/00000658-199104000-00003; Mao CC, 2007, J IMMUNOL, V178, P5443, DOI 10.4049/jimmunol.178.9.5443; Marti G, 2004, GENE THER, V11, P1780, DOI 10.1038/sj.gt.3302383; Maus Erik Alberto, 2012, BMJ Case Rep, V2012, DOI 10.1136/bcr.03.2012.6091; Occleston NL, 2010, DERMAT RES PRACT, V2010, DOI 10.1155/2010/405262; Olutoye OO, 1996, J PEDIATR SURG, V31, P91, DOI 10.1016/S0022-3468(96)90326-7; Oxlund H, 1996, J SURG RES, V66, P25, DOI 10.1006/jsre.1996.0367; Palmer BL, 2004, AM J CARDIOL, V93, P96, DOI 10.1016/j.amjcard.2003.08.077; Pierce RA, 2006, AM J PHYSIOL-LUNG C, V291, pL391, DOI 10.1152/ajplung.00441.2004; Pietramaggiori G, 2008, J TRAUMA, V64, P803, DOI 10.1097/01.ta.0000244382.13937.a8; Sarrazy V, 2011, WOUND REPAIR REGEN, V19, pS10, DOI 10.1111/j.1524-475X.2011.00708.x; Scherer SS, 2009, ANN SURG, V250, P322, DOI 10.1097/SLA.0b013e3181ae9d45; SHAH M, 1995, J CELL SCI, V108, P985; Somanath PR, 2007, J BIOL CHEM, V282, P22964, DOI 10.1074/jbc.M700241200; Van Amerongen MJ, 2008, J PATHOL, V214, P377, DOI 10.1002/path.2281; Vournakis JN, 2008, J VASC RES, V45, P222, DOI 10.1159/000112544; Vrhovski B, 1998, EUR J BIOCHEM, V258, P1, DOI 10.1046/j.1432-1327.1998.2580001.x; Wang JHC, 2003, J BIOMECH, V36, P97, DOI 10.1016/S0021-9290(02)00233-6; Yordy JS, 2000, ONCOGENE, V19, P6503, DOI 10.1038/sj.onc.1204036; Zhou GL, 2003, MOL CELL BIOL, V23, P8058, DOI 10.1128/MCB.23.22.8058-8069.2003; Zhu QS, 2011, ONCOGENE, V30, P457, DOI 10.1038/onc.2010.421	36	9	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0127876	10.1371/journal.pone.0127876	http://dx.doi.org/10.1371/journal.pone.0127876			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955155	gold, Green Submitted, Green Published			2022-12-26	WOS:000356768100148
J	Qin, W; Xu, JL; Hu, GZ				Qin, Wei; Xu, Jialin; Hu, Guozhong			Numerical Simulation of Abandoned Gob Methane Drainage through Surface Vertical Wells	PLOS ONE			English	Article							EMISSIONS	The influence of the ventilation system on the abandoned gob weakens, so the gas seepage characteristics in the abandoned gob are significantly different from those in a normal mining gob. In connection with this, this study physically simulated the movement of overlying rock strata. A spatial distribution function for gob permeability was derived. A numerical model using FLUENT for abandoned gob methane drainage through surface wells was established, and the derived spatial distribution function for gob permeability was imported into the numerical model. The control range of surface wells, flow patterns and distribution rules for static pressure in the abandoned gob under different well locations were determined using the calculated results from the numerical model.	[Qin, Wei; Xu, Jialin; Hu, Guozhong] China Univ Min & Technol, State Key Lab Coal Resources & Mine Safety, Sch Mines, Xuzhou, Jiangsu, Peoples R China	China University of Mining & Technology	Xu, JL (corresponding author), China Univ Min & Technol, Univ Rd 1, Xuzhou, Jiangsu, Peoples R China.	xujlcumt@163.com	xu, jia/GSD-6347-2022		Natural Science Foundation of China [51404257]; Fundamental Research Funds for the Central Universities [2014QNB39, 2014XT01]; Jiangsu Province Science Foundation [BK20140207, BK20141131]; State Key Laboratory of Coal Resources and Mine Safety of China [SKLCRSM13X06]; Priority Academic Program Development of Jiangsu Higher Education Institutions [SZBF2011-6-B35]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Jiangsu Province Science Foundation(Natural Science Foundation of Jiangsu Province); State Key Laboratory of Coal Resources and Mine Safety of China; Priority Academic Program Development of Jiangsu Higher Education Institutions	Financial support for this work was provided by Natural Science Foundation of China [No. 51404257]; Fundamental Research Funds for the Central Universities [2014QNB39], [2014XT01]; Jiangsu Province Science Foundation for Youths [BK20140207], [BK20141131]; State Key Laboratory of Coal Resources and Mine Safety of China [SKLCRSM13X06]; Priority Academic Program Development of Jiangsu Higher Education Institutions [SZBF2011-6-B35]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibler C, 2000, TECHNICAL REPORT; Chen A, 2007, CHINESE COLL STUDENT; Cote MM, 2000, TECHNICAL REPORT; Creedy DP, 2001, TECHNICAL REPORT; Cui YJ, 2005, CHINA COALBED METHAN, V2, P27; Guo Q., 2003, MINING SAFETY ENV PR, V06, P23; [韩保山 Han Baoshan], 2004, [煤田地质与勘探, Coal Geology & Exploration], V32, P29; Karacan CO, 2007, INT J COAL GEOL, V71, P225, DOI 10.1016/j.coal.2006.08.003; Karacan CO, 2011, INT J COAL GEOL, V86, P121, DOI 10.1016/j.coal.2011.02.009; Karacan CO, 2010, TRANSPORT POROUS MED, V82, P413, DOI 10.1007/s11242-009-9437-7; Kunz Erwin, 2004, Geologica Belgica, V7, P201; Liang ZQ, 2001, FLUID MECH; Qian M., 1998, J CHINA COAL SOC, V23, P466; Qian M., 1995, CHINESE JROCK MECH E, V2, P97; Qu QD, 2010, THESIS CHINA U MININ; Ren Ting-xiang, 2008, Journal of Coal Science and Engineering (China), V15, P225, DOI 10.1007/s12404-009-0301-8; U.S. EPA, 2004, TECHNICAL REPORT; [汪有刚 WANG You-gang], 2010, [煤炭学报, Journal of China Coal Society], V35, P406; Warmuzinski K, 2008, PROCESS SAF ENVIRON, V86, P315, DOI 10.1016/j.psep.2008.04.003; Wendt M, 2002, COAL SAFETY, V20, P17; Whittles DN, 2006, INT J ROCK MECH MIN, V43, P369, DOI 10.1016/j.ijrmms.2005.07.006; [吴仁伦 Wu Renlun], 2013, [煤炭学报, Journal of China Coal Society], V38, P924; Zhang P, 2007, J CHINA COALBED METH, V4, P15	23	2	2	4	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0125963	10.1371/journal.pone.0125963	http://dx.doi.org/10.1371/journal.pone.0125963			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955438	Green Published, gold, Green Submitted			2022-12-26	WOS:000356768100085
J	Reddy, TR; Kelsall, EJ; Fevat, LMS; Munson, SE; Cowley, SM				Reddy, Thimma R.; Kelsall, Emma J.; Fevat, Lena M. S.; Munson, Sarah E.; Cowley, Shaun M.			Differential Requirements of Singleplex and Multiplex Recombineering of Large DNA Constructs	PLOS ONE			English	Article							ESCHERICHIA-COLI; HOMOLOGOUS RECOMBINATION; GENE REPLACEMENT; PROTEIN FUNCTION; PHAGE-LAMBDA; GENOME-WIDE; BETA; SYSTEM; REPAIR; MUTAGENESIS	Recombineering is an in vivo genetic engineering technique involving homologous recombination mediated by phage recombination proteins. The use of recombineering methodology is not limited by size and sequence constraints and therefore has enabled the streamlined construction of bacterial strains and multi-component plasmids. Recombineering applications commonly utilize singleplex strategies and the parameters are extensively tested. However, singleplex recombineering is not suitable for the modification of several loci in genome recoding and strain engineering exercises, which requires a multiplex recombineering design. Defining the main parameters affecting multiplex efficiency especially the insertion of multiple large genes is necessary to enable efficient large-scale modification of the genome. Here, we have tested different recombineering operational parameters of the lambda phage Red recombination system and compared singleplex and multiplex recombineering of large gene sized DNA cassettes. We have found that optimal multiplex recombination required long homology lengths in excess of 120 bp. However, efficient multiplexing was possible with only 60 bp of homology. Multiplex recombination was more limited by lower amounts of DNA than singleplex recombineering and was greatly enhanced by use of phosphorothioate protection of DNA. Exploring the mechanism of multiplexing revealed that efficient recombination required co-selection of an antibiotic marker and the presence of all three Red proteins. Building on these results, we substantially increased multiplex efficiency using an ExoVII deletion strain. Our findings elucidate key differences between singleplex and multiplex recombineering and provide important clues for further improving multiplex recombination efficiency.	[Reddy, Thimma R.; Kelsall, Emma J.; Cowley, Shaun M.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [Fevat, Lena M. S.] Ctr Fisheries Environm & Aquaculture Sci, Lowestoft NR33 0HT, Suffolk, England; [Munson, Sarah E.] Ctr Core Biotechnol Serv, ES Cell Facil, Leicester LE1 9HN, Leics, England	University of Leicester; Centre for Environment Fisheries & Aquaculture Science	Cowley, SM (corresponding author), Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England.	smc57@le.ac.uk		Cowley, Shaun/0000-0002-2510-1305	UK Medical Research Council (MRC) [MR/J009202/1]; University of Leicester, Centre for Core Biotechnology Services funding; MRC [G0600135, MR/J009202/1] Funding Source: UKRI; Medical Research Council [G0600135, MR/J009202/1] Funding Source: researchfish	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Leicester, Centre for Core Biotechnology Services funding; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the UK Medical Research Council (MRC) grant (MR/J009202/1) to SMC and University of Leicester, Centre for Core Biotechnology Services funding to SEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bao ZM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050617; Binder S, 2013, NUCLEIC ACIDS RES, V41, P6360, DOI 10.1093/nar/gkt312; Bird AW, 2012, NAT METHODS, V9, P103, DOI [10.1038/NMETH.1803, 10.1038/nmeth.1803]; Bubunenko M, 2007, J BACTERIOL, V189, P2844, DOI 10.1128/JB.01713-06; Carr PA, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks455; Chan W, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm163; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Court DL, 2002, ANNU REV GENET, V36, P361, DOI 10.1146/annurev.genet.36.061102.093104; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898; Erler A, 2009, J MOL BIOL, V391, P586, DOI 10.1016/j.jmb.2009.06.030; Esvelt KM, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.66; Fu J, 2012, NAT BIOTECHNOL, V30, P440, DOI 10.1038/nbt.2183; Fu J, 2010, METHOD ENZYMOL, V477, P125, DOI 10.1016/S0076-6879(10)77008-7; Fu J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn499; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; Lajoie MJ, 2013, SCIENCE, V342, P361, DOI 10.1126/science.1241460; Lajoie MJ, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks751; Lajoie MJ, 2013, SCIENCE, V342, P357, DOI 10.1126/science.1241459; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Li YF, 2013, ACS SYNTH BIOL, V2, P651, DOI 10.1021/sb400051t; Li Z, 1998, J MOL BIOL, V276, P733, DOI 10.1006/jmbi.1997.1572; Lim SI, 2008, J MOL BIOL, V384, P1098, DOI 10.1016/j.jmb.2008.10.047; Maresca M, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-54; Mosberg JA, 2010, GENETICS, V186, P791, DOI 10.1534/genetics.110.120782; Mosberg JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044638; MUNIYAPPA K, 1986, J BIOL CHEM, V261, P7472; MURPHY KC, 1991, J BACTERIOL, V173, P5808, DOI 10.1128/jb.173.18.5808-5821.1991; Murphy KC, 1998, J BACTERIOL, V180, P2063, DOI 10.1128/JB.180.8.2063-2071.1998; Murphy KC, 2007, J MOL BIOL, V371, P19, DOI 10.1016/j.jmb.2007.05.085; Muyrers JPP, 2000, GENE DEV, V14, P1971; Perlova O, 2006, APPL ENVIRON MICROB, V72, P7485, DOI 10.1128/AEM.01503-06; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Posfai G, 2006, SCIENCE, V312, P1044, DOI 10.1126/science.1126439; Reddy TR, 2015, JOVE-J VIS EXP, DOI 10.3791/52155; Ryu YS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094266; Sandoval NR, 2012, P NATL ACAD SCI USA, V109, P10540, DOI 10.1073/pnas.1206299109; Sarov M, 2006, NAT METHODS, V3, P839, DOI 10.1038/nmeth933; Sarov M, 2012, CELL, V150, P855, DOI 10.1016/j.cell.2012.08.001; Sawitzke JA, 2007, METHOD ENZYMOL, V421, P171, DOI 10.1016/S0076-6879(06)21015-2; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Swingle B, 2010, MOL MICROBIOL, V75, P138, DOI 10.1111/j.1365-2958.2009.06976.x; van Kessel JC, 2008, MOL MICROBIOL, V67, P1094, DOI 10.1111/j.1365-2958.2008.06109.x; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; van Pijkeren JP, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks147; Wang HH, 2012, ACS SYNTH BIOL, V1, P43, DOI 10.1021/sb3000029; Wang HH, 2012, NAT METHODS, V9, P591, DOI [10.1038/NMETH.1971, 10.1038/nmeth.1971]; Wang HH, 2011, NUCLEIC ACIDS RES, V39, P7336, DOI 10.1093/nar/gkr183; Wang HH, 2011, METHOD ENZYMOL, V498, P409, DOI 10.1016/B978-0-12-385120-8.00018-8; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Wang JP, 2006, MOL BIOTECHNOL, V32, P43, DOI 10.1385/MB:32:1:043; Wang Y, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks248; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Warner JR, 2010, NAT BIOTECHNOL, V28, P856, DOI 10.1038/nbt.1653; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Yu DG, 2003, P NATL ACAD SCI USA, V100, P7207, DOI 10.1073/pnas.1232375100; Zhang Y, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-42; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417; Zhang YM, 2000, NAT BIOTECHNOL, V18, P1314, DOI 10.1038/82449	60	0	0	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0125533	10.1371/journal.pone.0125533	http://dx.doi.org/10.1371/journal.pone.0125533			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25954970	Green Published, Green Submitted, gold			2022-12-26	WOS:000356768100058
J	Rolstad, S; Jakobsson, J; Sellgren, C; Ekman, CJ; Blennow, K; Zetterberg, H; Palsson, E; Landen, M				Rolstad, Sindre; Jakobsson, Joel; Sellgren, Carl; Ekman, Carl-Johan; Blennow, Kaj; Zetterberg, Henrik; Palsson, Erik; Landen, Mikael			Cognitive Performance and Cerebrospinal Fluid Biomarkers of Neurodegeneration: A Study of Patients with Bipolar Disorder and Healthy Controls	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; IN-VIVO; IMPAIRMENT; A-BETA(42); SCHIZOPHRENIA; NEUROTOXICITY; METAANALYSIS; IMPACT	The purpose of the present study was to investigate if cerebrospinal fluid (CSF) biomarkers of neurodegeneration are associated with cognition in bipolar disorder and healthy controls, respectively. CSF concentrations of total and phosphorylated tau, amyloid beta (A beta) 1-42, ratios of A beta 42/40 and A beta 42/38, soluble amyloid precursor protein alpha and beta, and neurofilament light chain protein were analyzed in relation to neuropsychological performance in 82 euthymic bipolar disorder patients and 71 healthy controls. Linear regression models were applied to account for performance in five cognitive domains using the CSF biomarkers. In patients, the CSF biomarkers explained a significant proportion of the variance (15-36%, p =. 002 -<. 0005) in all cognitive domains independently of age, medication, disease status, and bipolar subtype I or II. However, the CSF biomarkers specifically mirroring Alzheimer-type brain changes, i.e., P-tau and A beta 1-42, did not contribute significantly. In healthy controls, CSF biomarkers did not explain the variance in cognitive performance. Selected CSF biomarkers of neurodegenerative processes accounted for cognitive performance in persons with bipolar disorder, but not for healthy controls. Specifically, the ratios of A beta 42/40 and A beta 42/38 were consistently associated with altered cognitive performance.	[Rolstad, Sindre; Jakobsson, Joel; Blennow, Kaj; Zetterberg, Henrik; Palsson, Erik; Landen, Mikael] Gothenburg Univ, Sahlgrenska Acad, Inst Neurosci & Physiol, Gothenburg, Sweden; [Sellgren, Carl; Landen, Mikael] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Ekman, Carl-Johan; Landen, Mikael] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Zetterberg, Henrik] UCL, Inst Neurol, London, England	University of Gothenburg; Karolinska Institutet; Karolinska Institutet; University of London; University College London	Rolstad, S (corresponding author), Gothenburg Univ, Sahlgrenska Acad, Inst Neurosci & Physiol, Gothenburg, Sweden.	sindre.rolstad@neuro.gu.se	Landen, Mikael/AAD-7917-2020		Swedish Medical Research Council [K2014-62X-14647-12-51, K2010-61P-21568-01-4]; Swedish foundation for Strategic Research; Swedish Brain foundation; Swedish Federal Government [ALF 20130032, ALFGBG-142041]	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Brain foundation; Swedish Federal Government	This research study was supported by grants from the Swedish Medical Research Council (http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html) (K2014-62X-14647-12-51 and K2010-61P-21568-01-4), the Swedish foundation for Strategic Research (http://www.stratresearch.se/en/), the Swedish Brain foundation (http://swedishbrainpower.se/en/), and the Swedish Federal Government under the LUA/ALF agreement (ALF 20130032, ALFGBG-142041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreou C, 2013, PSYCHIAT RES, V210, P729, DOI 10.1016/j.psychres.2013.08.019; Arts B, 2008, PSYCHOL MED, V38, P771, DOI 10.1017/S0033291707001675; Association A.P., 2000, DIAGNOSTIC AND STATI; Bearden CE, 2011, BIPOLAR DISORD, V13, P323, DOI 10.1111/j.1399-5618.2011.00928.x; Bittner T, 2009, J NEUROSCI, V29, P10405, DOI 10.1523/JNEUROSCI.2288-09.2009; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Bora E, 2009, J AFFECT DISORDERS, V113, P1, DOI 10.1016/j.jad.2008.06.009; Bourne C, 2013, ACTA PSYCHIAT SCAND, V128, P149, DOI 10.1111/acps.12133; Damadzic R, 2002, ACTA NEUROPATHOL, V103, P488, DOI 10.1007/s00401-001-0496-2; Ekman M, 2013, SOC PSYCH PSYCH EPID, V48, P1601, DOI 10.1007/s00127-013-0724-9; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Fischer J.S., 2012, NEUROPSYCHOLOGICAL A, V5th; Jakobsson J, 2014, NEUROPSYCHOPHARMACOL, V39, P2349, DOI 10.1038/npp.2014.81; Jakobsson J, 2013, NEUROPSYCHOPHARMACOL, V38, P664, DOI 10.1038/npp.2012.231; Kempton MJ, 2008, ARCH GEN PSYCHIAT, V65, P1017, DOI 10.1001/archpsyc.65.9.1017; Kessing LV, 2004, J NEUROL NEUROSUR PS, V75, P1662, DOI 10.1136/jnnp.2003.031773; Kuperstein I, 2010, EMBO J, V29, P3408, DOI 10.1038/emboj.2010.211; Lim CS, 2013, NEUROSCI BIOBEHAV R, V37, P418, DOI 10.1016/j.neubiorev.2013.01.003; Merikangas KR, 2011, ARCH GEN PSYCHIAT, V68, P241, DOI 10.1001/archgenpsychiatry.2011.12; Mora E, 2013, PSYCHOL MED, V43, P1187, DOI 10.1017/S0033291712001948; Olsson A, 2005, CLIN CHEM, V51, P336, DOI 10.1373/clinchem.2004.039347; Page RM, 2008, J BIOL CHEM, V283, P677, DOI 10.1074/jbc.M708754200; Palsson E, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-165; Phillips ML, 2013, LANCET, V381, P1663, DOI 10.1016/S0140-6736(13)60989-7; Rolstad S, 2013, J ALZHEIMERS DIS, V34, P949, DOI 10.3233/JAD-121960; Rosengren LE, 1996, J NEUROCHEM, V67, P2013, DOI 10.1046/j.1471-4159.1996.67052013.x; Ryden E, 2009, ACTA PSYCHIAT SCAND, V120, P239, DOI 10.1111/j.1600-0447.2009.01399.x; Sachs GS, 2003, BIOL PSYCHIAT, V53, P1028, DOI 10.1016/S0006-3223(03)00165-3; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Savitz J, 2005, BIPOLAR DISORD, V7, P216, DOI 10.1111/j.1399-5618.2005.00203.x; Schoonenboom NS, 2005, ANN NEUROL, V58, P139, DOI 10.1002/ana.20508; Schwarz L, 2009, CLIN NEUROPSYCHOL, V23, P255, DOI 10.1080/13854040802220034; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Strauss E, 2006, COMPENDIUM NEUROPSYC; Torrent Carla, 2012, J Clin Psychiatry, V73, pe899, DOI 10.4088/JCP.11m07471; Torres IJ, 2007, ACTA PSYCHIAT SCAND, V116, P17, DOI 10.1111/j.1600-0447.2007.01055.x; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; Weinberger DR, 2002, ARCH GEN PSYCHIAT, V59, P553, DOI 10.1001/archpsyc.59.6.553; Yatham LN, 2010, BIPOLAR DISORD, V12, P351, DOI 10.1111/j.1399-5618.2010.00830.x; Zetterberg H, 2008, ARCH NEUROL-CHICAGO, V65, P1102, DOI 10.1001/archneur.65.8.1102; Zetterberg H, 2007, J ALZHEIMERS DIS, V12, P255, DOI 10.3233/jad-2007-12307	42	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0127100	10.1371/journal.pone.0127100	http://dx.doi.org/10.1371/journal.pone.0127100			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25954806	Green Submitted, Green Published, gold			2022-12-26	WOS:000356768100145
J	Shelton, JA; Sheikh, AS; Bornschein, J; Sterne, P; Lucke, J				Shelton, Jacquelyn A.; Sheikh, Abdul-Saboor; Bornschein, Joerg; Sterne, Philip; Luecke, Joerg			Nonlinear Spike-And-Slab Sparse Coding for Interpretable Image Encoding	PLOS ONE			English	Article							RECEPTIVE-FIELDS; COMPONENTS; MODEL	Sparse coding is a popular approach to model natural images but has faced two main challenges: modelling low-level image components (such as edge-like structures and their occlusions) and modelling varying pixel intensities. Traditionally, images are modelled as a sparse linear superposition of dictionary elements, where the probabilistic view of this problem is that the coefficients follow a Laplace or Cauchy prior distribution. We propose a novel model that instead uses a spike-and-slab prior and nonlinear combination of components. With the prior, our model can easily represent exact zeros for e.g. the absence of an image component, such as an edge, and a distribution over non-zero pixel intensities. With the nonlinearity (the nonlinear max combination rule), the idea is to target occlusions; dictionary elements correspond to image components that can occlude each other. There are major consequences of the model assumptions made by both (non) linear approaches, thus the main goal of this paper is to isolate and highlight differences between them. Parameter optimization is analytically and computationally intractable in our model, thus as a main contribution we design an exact Gibbs sampler for efficient inference which we can apply to higher dimensional data using latent variable preselection. Results on natural and artificial occlusion-rich data with controlled forms of sparse structure show that our model can extract a sparse set of edge-like components that closely match the generating process, which we refer to as interpretable components. Furthermore, the sparseness of the solution closely follows the ground-truth number of components/edges in the images. The linear model did not learn such edge-like components with any level of sparsity. This suggests that our model can adaptively well-approximate and characterize the meaningful generation process.	[Shelton, Jacquelyn A.; Sheikh, Abdul-Saboor] Tech Univ Berlin, Dept Software Engn & Theoret Comp Sci, Berlin, Germany; [Bornschein, Joerg] Univ Montreal, Dept Comp Sci & Operat Res, Montreal, PQ, Canada; [Sterne, Philip] Goethe Univ Frankfurt, Frankfurt Inst Adv Studies, D-60054 Frankfurt, Germany; [Sheikh, Abdul-Saboor; Luecke, Joerg] Carl von Ossietzky Univ Oldenburg, Sch Med & Hlth Sci, D-26111 Oldenburg, Germany; [Sheikh, Abdul-Saboor] Carl von Ossietzky Univ Oldenburg, Cluster Excellence Hearing4all, D-26111 Oldenburg, Germany	Technical University of Berlin; Universite de Montreal; Goethe University Frankfurt; Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg	Shelton, JA (corresponding author), Tech Univ Berlin, Dept Software Engn & Theoret Comp Sci, Berlin, Germany.	shelton@tu-berlin.de			German Research Foundation (DFG) [LU 1196/4-2]; Cluster of Excellence [EXC 1077/1]; German Ministry of Research and Education (BMBF) [01GQ0840]; LOEWE Neuronal Coordination Research Focus Frankfurt (NeFF); Canadian Institute for Advanced Research (CIFAR); Frankfurt Center for Scientific Computing (CSC)	German Research Foundation (DFG)(German Research Foundation (DFG)); Cluster of Excellence; German Ministry of Research and Education (BMBF)(Federal Ministry of Education & Research (BMBF)); LOEWE Neuronal Coordination Research Focus Frankfurt (NeFF); Canadian Institute for Advanced Research (CIFAR)(Canadian Institute for Advanced Research (CIFAR)); Frankfurt Center for Scientific Computing (CSC)	The work was funded by the German Research Foundation (DFG) under grant LU 1196/4-2 (JS, AS, JL) and by the Cluster of Excellence EXC 1077/1 'Hearing4all' (AS, JL). Initial stages were funded by the German Ministry of Research and Education (BMBF) under grant 01GQ0840 (BFNT Frankfurt) (JS, AS, JB, JL) and by the LOEWE Neuronal Coordination Research Focus Frankfurt (NeFF) (PS). JB is supported by the Canadian Institute for Advanced Research (CIFAR). Furthermore, we acknowledge support by the Frankfurt Center for Scientific Computing (CSC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berkes P, 2011, SCIENCE, V331, P83, DOI 10.1126/science.1195870; Bernhard S., 2007, ADV NEURAL INFORM PR, P801; Bornschein J, 2010, NIPS WORKSH LEARN CO; Bornschein J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003062; Chen SSB, 1998, SIAM J SCI COMPUT, V20, P33, DOI 10.1137/S1064827596304010; Dai Zhenwen, 2013, ADV NEURAL INFORM PR, P243; DAYAN P, 1995, NEURAL COMPUT, V7, P565, DOI 10.1162/neco.1995.7.3.565; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Eldar YC., 2012, COMPRESSED SENSING T; Frolov AA, 2014, NEUROCOMPUTING, V130, P83, DOI 10.1016/j.neucom.2012.02.055; Goodfellow I, 2012, ICML, V29; Goodfellow IJ, 2013, IEEE T PATTERN ANAL, V35, P1902, DOI 10.1109/TPAMI.2012.273; Goodfellow Ian J., 2011, NIPS WORKSH CHALL LE; Guan N, 2012, CORR; Haft M, 2003, PATTERN ANAL APPL, V6, P269, DOI 10.1007/s10044-003-0194-x; Henniges M, 2014, J MACH LEARN RES, V15, P2689; Henniges M, 2010, LECT NOTES COMPUT SC, V6365, P450, DOI 10.1007/978-3-642-15995-4_56; Hoyer PO, 2004, J MACH LEARN RES, V5, P1457; Jernite Y, 2013, ADV NEURAL INFORM PR, V26; Jernite Yacine, 2013, NIPS, P2355; Lucke J, 2008, J MACH LEARN RES, V9, P1227; Lucke J, 2010, J MACH LEARN RES, V11, P2855; Mairal J, 2009, IEEE I CONF COMP VIS, P2272, DOI 10.1109/ICCV.2009.5459452; Mallat S., 2008, WAVELET TOUR SIGNAL; Mohamed S, 2012, ICML, V29; Neal R. M., 1998, LEARNING GRAPHICAL M; NEAL RM, 1992, ARTIF INTELL, V56, P71, DOI 10.1016/0004-3702(92)90065-6; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Olshausen B.A., 2013, P SPIE, V8651; Olshausen BA, 1997, VISION RES, V37, P3311, DOI 10.1016/S0042-6989(97)00169-7; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Olshausen BA, 2000, ADV NEUR IN, V12, P841; Opper M, 2005, J MACH LEARN RES, V6, P2177; Puertas G., 2010, ADV NEURAL INF PROCE, V23, P1939; Ringach DL, 2002, J NEUROPHYSIOL, V88, P455, DOI 10.1152/jn.2002.88.1.455; Roweis S. T., 2003, P EUR, P1009; SAUND E, 1995, NEURAL COMPUT, V7, P51, DOI 10.1162/neco.1995.7.1.51; Seeger MW, 2008, J MACH LEARN RES, V9, P759; Sheikh AS, 2014, J MACH LEARN RES, V15, P2653; Shelton J, 2012, ADV NEURAL INFORM PR, V25, P2285; Shelton J. A., 2011, ADV NEURAL INFORM PR, V24, P2618; Singliar T, 2006, J MACH LEARN RES, V7, P2189; Spratling MW, 2006, J MACH LEARN RES, V7, P793; Tan X, 2010, INT CONF ACOUST SPEE, P3634, DOI 10.1109/ICASSP.2010.5495896; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Titsias M. K., 2011, PROC 24 INT C NEURAL; Usrey WM, 2003, J NEUROPHYSIOL, V89, P1003, DOI 10.1152/jn.00749.2002; Valpola H, 1999, NONLINEAR BLIND SOUR; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P359, DOI 10.1098/rspb.1998.0303; Wood F, 2006, UNCERTAINTY ARTIFICI	52	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0124088	10.1371/journal.pone.0124088	http://dx.doi.org/10.1371/journal.pone.0124088			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25954947	gold, Green Submitted, Green Published			2022-12-26	WOS:000356768100025
J	Strong, R; La Rocca, SA; Paton, D; Bensaude, E; Sandvik, T; Davis, L; Turner, J; Drew, T; Raue, R; Vangeel, I; Steinbach, F				Strong, Rebecca; La Rocca, Severina Anna; Paton, David; Bensaude, Emmanuelle; Sandvik, Torstein; Davis, Leanne; Turner, Jane; Drew, Trevor; Raue, Rudiger; Vangeel, Ilse; Steinbach, Falko			Viral Dose and Immunosuppression Modulate the Progression of Acute BVDV-1 Infection in Calves: Evidence of Long Term Persistence after Intra-Nasal Infection	PLOS ONE			English	Article							BOVINE VIRUS DIARRHEA; STRAINS; PATHOGENESIS; INOCULATION; CATTLE; THROMBOCYTOPENIA; PESTIVIRUS; VIRULENCE; DISEASE; ANTIGEN	Bovine viral diarrhoea virus (BVDV) infection of cattle causes a diverse range of clinical outcomes from being asymptomatic, or a transient mild disease, to producing severe cases of acute disease leading to death. Four groups of calves were challenged with a type 1 BVDV strain, originating from a severe outbreak of BVDV in England, to study the effect of viral dose and immunosuppression on the viral replication and transmission of BVDV. Three groups received increasing amounts of virus: Group A received 10(2.55)TCID(50)/ml, group B 10(5.25)TCID(50)/ml and group C 10(6.7)TCID(50)/ml. A fourth group (D) was inoculated with a medium dose (10(5.25)TCID(50)/ml) and concomitantly treated with dexamethasone (DMS) to assess the effects of chemically induced immunosuppression. Naive calves were added as sentinel animals to assess virus transmission. The outcome of infection was dose dependent with animals given a higher dose developing severe disease and more pronounced viral replication. Despite virus being shed by the low-dose infection group, BVD was not transmitted to sentinel calves. Administration of dexamethasone (DMS) resulted in more severe clinical signs, prolonged viraemia and virus shedding. Using PCR techniques, viral RNA was detected in blood, several weeks after the limit of infectious virus recovery. Finally, a recently developed strand-specific RT-PCR detected negative strand viral RNA, indicative of actively replicating virus, in blood samples from convalescent animals, as late as 85 days post inoculation. This detection of long term replicating virus may indicate the way in which the virus persists and/or is reintroduced within herds.	[Strong, Rebecca; La Rocca, Severina Anna; Paton, David; Bensaude, Emmanuelle; Sandvik, Torstein; Davis, Leanne; Turner, Jane; Drew, Trevor; Steinbach, Falko] AHVLA, Dept Virol, Addlestone, Surrey, England; [Raue, Rudiger; Vangeel, Ilse] Vet Med Res & Dev, Zoetis, Belgium	Zoetis	Strong, R (corresponding author), AHVLA, Dept Virol, Addlestone, Surrey, England.	Rebecca.strong@apha.gsi.gov.uk	la rocca, severina anna/D-8028-2011; Drew, Trevor W/C-5200-2011; Drew, Trevor W/ABB-5205-2020; Steinbach, Falko/V-1682-2019	Steinbach, Falko/0000-0003-1236-2837; Turner, Jane/0000-0001-9358-6001; Drew, Trevor/0000-0002-0448-1062	Defra research projects [OD0326, OD0342, OD345]	Defra research projects	This work was funded by Defra research projects OD0326, OD0342, and OD345. Part of the latest work was carried out in collaboration with Zoetis (formerly Pfizer Animal Health). Defra had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Zoetis were involved in the study design and data collection and analysis for the Group C animal experiment but played no role in the decision to publish or the analysis or interpretation of data.	BAKER JC, 1995, VET CLIN N AM-FOOD A, V11, P425, DOI 10.1016/S0749-0720(15)30460-6; BOLIN SR, 1992, AM J VET RES, V53, P2157; BROWNLIE J, 1987, ANN RECH VET, V18, P157; Brownlie J, 1990, Rev Sci Tech, V9, P43; Bruschke CJM, 1998, VET MICROBIOL, V64, P23, DOI 10.1016/S0378-1135(98)00249-1; CASTRUCC.G, 1968, ARCH GES VIRUSFORSCH, V24, P48, DOI 10.1007/BF01242901; CASTRUCCI G, 1992, COMP IMMUNOL MICROB, V15, P163, DOI 10.1016/0147-9571(92)90089-A; Collins ME, 2009, VET MICROBIOL, V138, P289, DOI 10.1016/j.vetmic.2009.04.022; CORAPI WV, 1989, J VIROL, V63, P3934, DOI 10.1128/JVI.63.9.3934-3943.1989; DAVID GP, 1994, VET REC, V134, P468, DOI 10.1136/vr.134.18.468; Edwards S, 1990, Rev Sci Tech, V9, P115; Givens MD, 2009, VET MICROBIOL, V139, P42, DOI 10.1016/j.vetmic.2009.04.029; Givens MD, 2003, AM J VET RES, V64, P428, DOI 10.2460/ajvr.2003.64.428; Gogorza LM, 2005, PREV VET MED, V72, P49, DOI 10.1016/j.prevetmed.2005.07.015; Grooms DL, 1998, J VET DIAGN INVEST, V10, P125, DOI 10.1177/104063879801000201; Hamers C, 2003, VET REC, V153, P236, DOI 10.1136/vr.153.8.236; HIBBERD RC, 1993, VET REC, V132, P227, DOI 10.1136/vr.132.9.227; Hofmann W, 2005, KLINISCHE UNTERSUCHU, V1; Houe H, 1999, VET MICROBIOL, V64, P89, DOI 10.1016/S0378-1135(98)00262-4; Howard C J, 1990, Rev Sci Tech, V9, P95; La Rocca SA, 2009, J VIROL METHODS, V161, P122, DOI 10.1016/j.jviromet.2009.06.005; La Rocca SA, 2009, 8 INT C VET VIR EUR; Larska M, 2012, COMP IMMUNOL MICROB, V35, P381, DOI 10.1016/j.cimid.2012.03.003; Marshall DJ, 1996, VET PATHOL, V33, P311, DOI 10.1177/030098589603300308; McGoldrick A, 1999, J VIROL METHODS, V79, P85, DOI 10.1016/S0166-0934(99)00010-5; Munck A, 1986, Adv Exp Med Biol, V196, P81; NUTTALL PA, 1980, ARCH VIROL, V66, P365, DOI 10.1007/BF01320633; Odeon AC, 1999, J VET DIAGN INVEST, V11, P221, DOI 10.1177/104063879901100303; OHMANN HB, 1983, RES VET SCI, V34, P5, DOI 10.1016/S0034-5288(18)32272-0; PELLERIN C, 1994, VIROLOGY, V203, P260, DOI 10.1006/viro.1994.1483; Polak MP, 2000, COMP IMMUNOL MICROB, V23, P141, DOI 10.1016/S0147-9571(99)00060-0; Raya AI, 2012, VET PATHOL, V49, P811, DOI 10.1177/0300985811414031; REBHUN WC, 1989, J VET INTERN MED, V3, P42, DOI 10.1111/j.1939-1676.1989.tb00327.x; Ridpath J, 2010, VET CLIN N AM-FOOD A, V26, P335, DOI 10.1016/j.cvfa.2010.04.003; Ridpath JF, 2007, VACCINE, V25, P8058, DOI 10.1016/j.vaccine.2007.09.014; Sandvik T, 2000, 5 INT C EUR SOC VET, P401; Schirrmeier H, 2004, J GEN VIROL, V85, P3647, DOI 10.1099/vir.0.80238-0; Thiel H-J, 2005, VIRUS TAXONOMY, P981	38	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0124689	10.1371/journal.pone.0124689	http://dx.doi.org/10.1371/journal.pone.0124689			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955849	Green Published, Green Submitted, gold			2022-12-26	WOS:000356768100034
J	Zlatanou, A; Sabbioneda, S; Miller, ES; Greenwalt, A; Aggathanggelou, A; Maurice, MM; Lehmann, AR; Stankovic, T; Reverdy, C; Colland, F; Vaziri, C; Stewart, GS				Zlatanou, A.; Sabbioneda, S.; Miller, E. S.; Greenwalt, A.; Aggathanggelou, A.; Maurice, M. M.; Lehmann, A. R.; Stankovic, T.; Reverdy, C.; Colland, F.; Vaziri, C.; Stewart, G. S.			USP7 is essential for maintaining Rad18 stability and DNA damage tolerance	ONCOGENE			English	Article							UBIQUITIN-SPECIFIC PROTEASE; CELL NUCLEAR ANTIGEN; POLYMERASE-ETA; PCNA MONOUBIQUITINATION; TRANSLESION SYNTHESIS; MAMMALIAN-CELLS; BINDING MOTIF; POL-ETA; S-PHASE; REV1	Rad18 functions at the cross-roads of three different DNA damage response (DDR) pathways involved in protecting stressed replication forks: homologous recombination repair, DNA inter-strand cross-link repair and DNA damage tolerance. Although Rad18 serves to facilitate replication of damaged genomes by promoting translesion synthesis (TLS), this comes at a cost of potentially error-prone lesion bypass. In contrast, loss of Rad18-dependent TLS potentiates the collapse of stalled forks and leads to incomplete genome replication. Given the pivotal nature with which Rad18 governs the fine balance between replication fidelity and genome stability, Rad18 levels and activity have a major impact on genomic integrity. Here, we identify the de-ubiquitylating enzyme USP7 as a critical regulator of Rad18 protein levels. Loss of USP7 destabilizes Rad18 and compromises UV-induced PCNA mono-ubiquitylation and Pol eta recruitment to stalled replication forks. USP7-depleted cells also fail to elongate nascent daughter strand DNA following UV irradiation and show reduced DNA damage tolerance. We demonstrate that USP7 associates with Rad18 directly via a consensus USP7-binding motif and can disassemble Rad18-dependent poly-ubiquitin chains both in vitro and in vivo. Taken together, these observations identify USP7 as a novel component of the cellular DDR involved in preserving the genome stability.	[Zlatanou, A.; Miller, E. S.; Aggathanggelou, A.; Stankovic, T.; Stewart, G. S.] Univ Birmingham, Sch Canc Sci, Vincent Dr, Birmingham B15 2TT, W Midlands, England; [Sabbioneda, S.] CNR, Ist Genet Mol, I-27100 Pavia, Italy; [Greenwalt, A.; Vaziri, C.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Maurice, M. M.] UMCU, Heidelberglaan 100, Utrecht, Netherlands; [Lehmann, A. R.] Univ Sussex, MRC Genome Damage & Stabil Ctr, Brighton, E Sussex, England; [Reverdy, C.; Colland, F.] Hybrigen Pharma, Paris, France	University of Birmingham; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of North Carolina; University of North Carolina Chapel Hill; Unilever; Utrecht University; Utrecht University Medical Center; University of Sussex	Stewart, GS (corresponding author), Univ Birmingham, Sch Canc Sci, Vincent Dr, Birmingham B15 2TT, W Midlands, England.	g.s.stewart@bham.ac.uk	Sabbioneda, Simone/N-7017-2015	Sabbioneda, Simone/0000-0001-8551-5465; Maurice, Madelon/0000-0001-6885-5361; Stankovic, Tatjana/0000-0002-3780-274X; Stewart, Grant/0000-0002-0960-3241	Lister Institute Research Prize; WWCR [13-1012]; CR-UK Senior Research Fellowship [C17183/A13030]; LLR [11045]; AIRC [12710]; 7th Framework Program [CIG 303806]; NIEHS [R01ES009558]; NCI [F31 CA177179]; University of Birmingham; MRC [G0501450] Funding Source: UKRI; Medical Research Council [G0501450] Funding Source: researchfish; Worldwide Cancer Research [13-1012] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [F31CA177179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009558] Funding Source: NIH RePORTER	Lister Institute Research Prize; WWCR; CR-UK Senior Research Fellowship; LLR; AIRC(Fondazione AIRC per la ricerca sul cancro); 7th Framework Program(European Commission); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Birmingham; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Worldwide Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Drs Akira Yasui, Jun Huang, Justin Leung, Junjie Chen and Patricia Kannouche for the kind gift of various Rad18 expression plasmids. We thank Drs Jan van der Knaap, Chris Boutell and Roger Everett for providing recombinant purified WT and catalytically inactive USP7 and Dr Jakob Nilsson for providing the HeLa Flp-In/T-Rex cells. We also thank Dr Malcolm Taylor for critical reading of the manuscript. This work was funded by a Lister Institute Research Prize (AZ and GS), a WWCR project grant (AZ and GS; 13-1012), a CR-UK Senior Research Fellowship (GS and EM; C17183/A13030) and a LLR program grant (AA and TS; 11045), SS was supported by an AIRC Grant 12710 and a 7th Framework Program (CIG 303806). CV was supported by R01ES009558 from the NIEHS. AMG was funded by a pre-doctoral fellowship (F31 CA177179) from the NCI. Lastly, we thank the University of Birmingham for supporting this work.	Bekes M, 2013, CELL REP, V5, P826, DOI 10.1016/j.celrep.2013.10.008; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Bi XH, 2006, MOL CELL BIOL, V26, P3527, DOI 10.1128/MCB.26.9.3527-3540.2006; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Bienko M, 2010, MOL CELL, V37, P396, DOI 10.1016/j.molcel.2009.12.039; Bomar MG, 2010, MOL CELL, V37, P408, DOI 10.1016/j.molcel.2009.12.038; Canning M, 2004, J BIOL CHEM, V279, P38160, DOI 10.1074/jbc.M402885200; Colland F, 2009, MOL CANCER THER, V8, P2286, DOI 10.1158/1535-7163.MCT-09-0097; Day TA, 2010, J CELL BIOL, V191, P953, DOI 10.1083/jcb.201006043; Everett RD, 1997, EMBO J, V16, P1519, DOI 10.1093/emboj/16.7.1519; Felle M, 2011, NUCLEIC ACIDS RES, V39, P8355, DOI 10.1093/nar/gkr528; Gan GN, 2008, CELL RES, V18, P174, DOI 10.1038/cr.2007.117; Garg P, 2005, P NATL ACAD SCI USA, V102, P18361, DOI 10.1073/pnas.0505949102; Gibbs PEM, 2000, P NATL ACAD SCI USA, V97, P4186, DOI 10.1073/pnas.97.8.4186; Guo CX, 2006, MOL CELL BIOL, V26, P8892, DOI 10.1128/MCB.01118-06; Hashimoto K, 2012, J BIOL CHEM, V287, P9613, DOI 10.1074/jbc.M111.331728; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; Huether R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4630; Jacq X, 2013, CELL BIOCHEM BIOPHYS, V67, P25, DOI 10.1007/s12013-013-9635-3; Jansen JG, 2009, MOL CELL BIOL, V29, P3113, DOI 10.1128/MCB.00071-09; Jung YS, 2012, DNA REPAIR, V11, P177, DOI 10.1016/j.dnarep.2011.10.017; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kim H, 2012, NAT STRUCT MOL BIOL, V19, P164, DOI 10.1038/nsmb.2222; LARIMER FW, 1989, J BACTERIOL, V171, P230, DOI 10.1128/jb.171.1.230-237.1989; LAWRENCE CW, 1976, GENETICS, V82, P207; LEHMANN AR, 1975, P NATL ACAD SCI USA, V72, P219, DOI 10.1073/pnas.72.1.219; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Lin JR, 2011, MOL CELL, V42, P237, DOI 10.1016/j.molcel.2011.02.026; Masuda Y, 2012, NUCLEIC ACIDS RES, V40, P1065, DOI 10.1093/nar/gkr805; McNally K, 2008, DNA REPAIR, V7, P597, DOI 10.1016/j.dnarep.2007.12.013; Meulmeester E, 2005, CELL CYCLE, V4, P1166, DOI 10.4161/cc.4.9.1981; Meulmeester E, 2005, MOL CELL, V18, P565, DOI 10.1016/j.molcel.2005.04.024; Miyase S, 2005, J BIOL CHEM, V280, P515, DOI 10.1074/jbc.M409219200; Nakajima S, 2006, J BIOL CHEM, V281, P34687, DOI 10.1074/jbc.M605545200; Nicholson B, 2011, CELL BIOCHEM BIOPHYS, V60, P61, DOI 10.1007/s12013-011-9185-5; Oh YM, 2007, BIOCHEM BIOPH RES CO, V357, P615, DOI 10.1016/j.bbrc.2007.03.193; Palle K, 2011, CELL CYCLE, V10, P1625, DOI 10.4161/cc.10.10.15617; PARRIS CN, 1992, GENE, V117, P1, DOI 10.1016/0378-1119(92)90482-5; Qian J, 2015, ONCOGENE, V34, P4791, DOI 10.1038/onc.2014.394; Qing P, 2011, J CELL BIOCHEM, V112, P3856, DOI 10.1002/jcb.23317; Reverdy C, 2012, CHEM BIOL, V19, P467, DOI 10.1016/j.chembiol.2012.02.007; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sheng Y, 2006, NAT STRUCT MOL BIOL, V13, P285, DOI 10.1038/nsmb1067; Stary A, 2003, J BIOL CHEM, V278, P18767, DOI 10.1074/jbc.M211838200; Tateishi S, 2003, MOL CELL BIOL, V23, P474, DOI 10.1128/MCB.23.2.474-481.2003; Wagner JM, 2009, MOL PHARMACOL, V76, P208, DOI 10.1124/mol.109.055178; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Wood A, 2007, J BIOL CHEM, V282, P20256, DOI 10.1074/jbc.M702366200; Yoon JH, 2012, P NATL ACAD SCI USA, V109, P7799, DOI 10.1073/pnas.1204105109; Zeman MK, 2014, J CELL BIOL, V206, P183, DOI 10.1083/jcb.201311063; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897; Zlatanou A, 2011, MOL CELL, V43, P649, DOI 10.1016/j.molcel.2011.06.023	53	47	48	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 25	2016	35	8					965	976		10.1038/onc.2015.149	http://dx.doi.org/10.1038/onc.2015.149			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DE7NF	25961918	Green Submitted			2022-12-26	WOS:000370823300003
J	Lillehoj, EP; Hyun, SW; Liu, AG; Guang, W; Verceles, AC; Luzina, IG; Atamas, SP; Kim, KC; Goldblum, SE				Lillehoj, Erik P.; Hyun, Sang Won; Liu, Anguo; Guang, Wei; Verceles, Avelino C.; Luzina, Irina G.; Atamas, Sergei P.; Kim, K. Chul; Goldblum, Simeon E.			NEU1 Sialidase Regulates Membrane-tethered Mucin (MUC1) Ectodomain Adhesiveness for Pseudomonas aeruginosa and Decoy Receptor Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; AIRWAY EPITHELIAL-CELLS; C-SRC; ANTIGEN; INTERLEUKIN-8; INFECTION; ADHERENCE; SURFACE; PILI	Airway epithelia express sialylated receptors that recognize exogenous danger signals. Regulation of receptor responsiveness to these signals remains incompletely defined. Here, we explore the mechanisms through which the human sialidase, neuraminidase-1 (NEU1), promotes the interaction between the sialoprotein, mucin 1 (MUC1), and the opportunistic pathogen, Pseudomonas aeruginosa. P. aeruginosa flagellin engaged the MUC1 ectodomain (ED), increasing NEU1 association with MUC1. The flagellin stimulus increased the association of MUC1-ED with both NEU1 and its chaperone/transport protein, protective protein/cathepsin A. Scatchard analysis demonstrated NEU1-dependent increased binding affinity of flagellin to MUC1-expressing epithelia. NEU1-driven MUC1-ED desialylation rapidly increased P. aeruginosa adhesion to and invasion of the airway epithelium. MUC1-ED desialylation also increased its shedding, and the shed MUC1-ED competitively blocked P. aeruginosa adhesion to cell-associated MUC1-ED. Levels of desialylated MUC1-ED were elevated in the bronchoalveolar lavage fluid of mechanically ventilated patients with P. aeruginosa airway colonization. Preincubation of P. aeruginosa with these same ex vivo fluids competitively inhibited bacterial adhesion to airway epithelia, and MUC1-ED immunodepletion completely abrogated their inhibitory activity. These data indicate that a prokaryote, P. aeruginosa, in a ligand-specific manner, mobilizes eukaryotic NEU1 to enhance bacterial pathogenicity, but the host retaliates by releasing MUC1-ED into the airway lumen as a hyperadhesive decoy receptor.	[Lillehoj, Erik P.; Guang, Wei] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA; [Hyun, Sang Won; Liu, Anguo; Verceles, Avelino C.; Luzina, Irina G.; Atamas, Sergei P.; Goldblum, Simeon E.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Goldblum, Simeon E.] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Luzina, Irina G.; Atamas, Sergei P.; Goldblum, Simeon E.] Baltimore Vet Affairs Med Ctr, Baltimore, MD 21201 USA; [Kim, K. Chul] Univ Arizona, Coll Med, Dept Otolaryngol, Tucson, AZ 85724 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center; University of Arizona	Goldblum, SE (corresponding author), Univ Maryland, Sch Med, 20 Penn St,Rm 351, Baltimore, MD 21201 USA.	sgoldblu@mbrc.umaryland.edu	Regan, Clinton/E-6250-2012	Lillehoj, Erik/0000-0002-2710-1704; , Erik/0000-0003-0910-6074	National Institutes of Health [HL084223, HL070155]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047125, R01HL070155, R01HL084223] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002352] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants HL084223 and HL070155 (to S. E. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Adamo R, 2004, AM J RESP CELL MOL, V30, P627, DOI 10.1165/rcmb.2003-0260OC; Ali M, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-4; Amith SR, 2010, CELL SIGNAL, V22, P314, DOI 10.1016/j.cellsig.2009.09.038; [Anonymous], 2010, MANDELL DOUGLAS BENN; Bachert C, 2013, TRAFFIC, V14, P47, DOI 10.1111/tra.12019; BAKER N, 1990, INFECT IMMUN, V58, P2361, DOI 10.1128/IAI.58.7.2361-2366.1990; Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Bonten EJ, 2014, CELL MOL LIFE SCI, V71, P2017, DOI 10.1007/s00018-013-1538-3; Brewer C, 1996, CHEST, V109, P1019; Button B, 2012, SCIENCE, V337, P937, DOI 10.1126/science.1223012; Champigny MJ, 2003, GENE, V319, P177, DOI 10.1016/S0378-1119(03)00808-4; Comolli JC, 1999, INFECT IMMUN, V67, P3207, DOI 10.1128/IAI.67.7.3207-3214.1999; Croce M V, 1999, Pathol Oncol Res, V5, P197, DOI 10.1053/paor.1999.0212; DONNENBERG MS, 1989, J INFECT DIS, V160, P452, DOI 10.1093/infdis/160.3.452; FONTENOT JD, 1995, J BIOMOL STRUCT DYN, V13, P245, DOI 10.1080/07391102.1995.10508837; Hsiao YS, 2009, BIOCHEM BIOPH RES CO, V380, P467, DOI 10.1016/j.bbrc.2009.01.108; Huang FC, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0275-6; Julian J, 2009, J CELL BIOCHEM, V108, P802, DOI 10.1002/jcb.22292; Kato Kosuke, 2010, Front Biosci (Elite Ed), V2, P68, DOI 10.2741/e67; Kitazume S, 2010, J BIOL CHEM, V285, P6515, DOI 10.1074/jbc.M109.073106; Lee C, 2014, J BIOL CHEM, V289, P9121, DOI 10.1074/jbc.M114.555888; Lewis AL, 2012, CELL MICROBIOL, V14, P1174, DOI 10.1111/j.1462-5822.2012.01807.x; Li YQ, 2001, J BIOL CHEM, V276, P35239, DOI 10.1074/jbc.C100359200; Li YQ, 2001, J BIOL CHEM, V276, P6061, DOI 10.1074/jbc.C000754200; Lillehoj EP, 2004, AM J PHYSIOL-LUNG C, V287, pL809, DOI 10.1152/ajplung.00385.2003; Lillehoj EP, 2002, AM J PHYSIOL-LUNG C, V282, pL751, DOI 10.1152/ajplung.00383.2001; Lillehoj EP, 2001, AM J PHYSIOL-LUNG C, V280, pL181, DOI 10.1152/ajplung.2001.280.1.L181; Lillehoj EP, 2013, INT REV CEL MOL BIO, V303, P139, DOI 10.1016/B978-0-12-407697-6.00004-0; Lillehoj EP, 2012, J BIOL CHEM, V287, P8214, DOI 10.1074/jbc.M111.292888; Luzina IG, 2009, ARTHRITIS RHEUM-US, V60, P1530, DOI 10.1002/art.24435; Norum LF, 1998, TUMOR BIOL, V19, P134, DOI 10.1159/000056515; Novosad SA, 2013, CURR OPIN PULM MED, V19, P133, DOI 10.1097/MCP.0b013e32835d8312; PRINCE A, 1992, MICROB PATHOGENESIS, V13, P251, DOI 10.1016/0882-4010(92)90035-M; Pshezhetsky AV, 2013, BIOCHEMISTRY-MOSCOW+, V78, P736, DOI 10.1134/S0006297913070067; Ramos HC, 2004, TRENDS MICROBIOL, V12, P509, DOI 10.1016/j.tim.2004.09.002; Ranke TD, 2012, J CLIN MICROBIOL, V50, P2791, DOI 10.1128/JCM.01338-12; Razawi H, 2013, GLYCOBIOLOGY, V23, P935, DOI 10.1093/glycob/cwt030; ROSTAND KS, 1993, J BIOL CHEM, V268, P24053; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Schroeder JA, 2001, J BIOL CHEM, V276, P13057, DOI 10.1074/jbc.M011248200; Shanks KK, 2010, CLIN VACCINE IMMUNOL, V17, P1196, DOI 10.1128/CVI.00167-10; Soong G, 2006, J CLIN INVEST, V116, P2297, DOI 10.1172/JCI27920; Stonebraker JR, 2004, J VIROL, V78, P13755, DOI 10.1128/JVI.78.24.13755-13768.2004; Thathiah A, 2004, BIOCHEM J, V382, P363, DOI 10.1042/BJ20040513; Thathiah A, 2003, J BIOL CHEM, V278, P3386, DOI 10.1074/jbc.M208326200; WOODS DE, 1980, INFECT IMMUN, V29, P1146	46	25	25	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18316	18331		10.1074/jbc.M115.657114	http://dx.doi.org/10.1074/jbc.M115.657114			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	25963144	Green Published, hybrid			2022-12-26	WOS:000358512100006
J	Chu, HL; Yip, BS; Chen, KH; Yu, HY; Chih, YH; Cheng, HT; Chou, YT; Cheng, JW				Chu, Hung-Lun; Yip, Bak-Sau; Chen, Kuan-Hao; Yu, Hui-Yuan; Chih, Ya-Han; Cheng, Hsi-Tsung; Chou, Yu-Ting; Cheng, Jya-Wei			Novel Antimicrobial Peptides with High Anticancer Activity and Selectivity	PLOS ONE			English	Article							HOST-DEFENSE PEPTIDES; SALT-RESISTANCE; TUMOR-GROWTH; SYSTEMIC INOCULATION; RATIONAL DESIGN; HUMAN PROSTATE; HYDROPHOBICITY; ANTIBACTERIAL; RICH; EXPRESSION	We describe a strategy to boost anticancer activity and reduce normal cell toxicity of short antimicrobial peptides by adding positive charge amino acids and non-nature bulky amino acid beta-naphthylalanine residues to their termini. Among the designed peptides, K4R2-Nal2- S1 displayed better salt resistance and less toxicity to hRBCs and human fibroblast than Nal2-S1 and K6-Nal2-S1. Fluorescence microscopic studies indicated that the FITC-labeled K4R2-Nal2-S1 preferentially binds cancer cells and causes apoptotic cell death. Moreover, a significant inhibition in human lung tumor growth was observed in the xenograft mice treated with K4R2-Nal2-S1. Our strategy provides new opportunities in the development of highly effective and selective antimicrobial and anticancer peptide-based therapeutics.	[Chu, Hung-Lun; Yip, Bak-Sau; Chen, Kuan-Hao; Yu, Hui-Yuan; Chih, Ya-Han; Cheng, Hsi-Tsung; Chou, Yu-Ting; Cheng, Jya-Wei] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu 300, Taiwan; [Chu, Hung-Lun; Yip, Bak-Sau; Chen, Kuan-Hao; Yu, Hui-Yuan; Chih, Ya-Han; Cheng, Hsi-Tsung; Chou, Yu-Ting; Cheng, Jya-Wei] Natl Tsing Hua Univ, Dept Med Sci, Hsinchu 300, Taiwan; [Yip, Bak-Sau] Natl Taiwan Univ Hosp, Hsinchu Branch, Dept Neurol, Hsinchu 300, Taiwan	National Tsing Hua University; National Tsing Hua University; National Taiwan University; National Taiwan University Hospital	Chou, YT (corresponding author), Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu 300, Taiwan.	ytchou@life.nthu.edu.tw; jwcheng@life.nthu.edu.tw		Chou, Yu-Ting/0000-0001-9274-8603; Yip, Bak-Sau/0000-0001-7942-8293	Minister of Science and Technology, Taiwan; National Taiwan University Hospital	Minister of Science and Technology, Taiwan; National Taiwan University Hospital(National Taiwan University)	This work is supported by grants from the Minister of Science and Technology, Taiwan. B.S. Yip is supported by research grants from National Taiwan University Hospital.	Arnusch CJ, 2012, ANTIMICROB AGENTS CH, V56, P1, DOI 10.1128/AAC.00468-11; Avrahami D, 2002, BIOCHEMISTRY-US, V41, P2254, DOI 10.1021/bi011549t; Aziz MA, 2012, ANTIMICROB AGENTS CH, V56, P280, DOI 10.1128/AAC.05463-11; Buri MV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080924; Chen CX, 2014, BIOMATERIALS, V35, P1552, DOI 10.1016/j.biomaterials.2013.10.082; Chen JJW, 1998, GENOMICS, V51, P313, DOI 10.1006/geno.1998.5354; Chen YX, 2007, ANTIMICROB AGENTS CH, V51, P1398, DOI 10.1128/AAC.00925-06; Chu HL, 2013, ANTIMICROB AGENTS CH, V57, P4050, DOI 10.1128/AAC.00252-13; Colombo G, 2002, J BIOL CHEM, V277, P47891, DOI 10.1074/jbc.M207500200; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fritsche TR, 2008, ANTIMICROB AGENTS CH, V52, P1187, DOI 10.1128/AAC.01475-07; Gaspar D, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00294; Giuliani A, 2007, CENT EUR J BIOL, V2, P1, DOI 10.2478/s11535-007-0010-5; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hu J, 2011, BIOMACROMOLECULES, V12, P3839, DOI 10.1021/bm201098j; Huang HN, 2013, BIOMATERIALS, V34, P10151, DOI 10.1016/j.biomaterials.2013.09.041; Iwasaki T, 2009, PEPTIDES, V30, P660, DOI 10.1016/j.peptides.2008.12.019; Jiang ZQ, 2011, CHEM BIOL DRUG DES, V77, P225, DOI 10.1111/j.1747-0285.2011.01086.x; Kazemzadeh-Narbat M, 2013, BIOMATERIALS, V34, P5969, DOI 10.1016/j.biomaterials.2013.04.036; Kazemzadeh-Narbat M, 2010, BIOMATERIALS, V31, P9519, DOI 10.1016/j.biomaterials.2010.08.035; La Rocca P, 1999, BIOPHYS CHEM, V76, P145, DOI 10.1016/S0301-4622(98)00232-4; Luo LM, 2013, BIOMATERIALS, V34, P1102, DOI 10.1016/j.biomaterials.2012.10.029; Ma XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042685; Makovitzki A, 2006, P NATL ACAD SCI USA, V103, P15997, DOI 10.1073/pnas.0606129103; Makovitzki A, 2009, CANCER RES, V69, P3458, DOI 10.1158/0008-5472.CAN-08-3021; Marchesan S, 2013, BIOMATERIALS, V34, P3678, DOI 10.1016/j.biomaterials.2013.01.096; Papo N, 2005, CELL MOL LIFE SCI, V62, P784, DOI 10.1007/s00018-005-4560-2; Papo N, 2004, CANCER RES, V64, P5779, DOI 10.1158/0008-5472.CAN-04-1438; Papo N, 2003, J BIOL CHEM, V278, P21018, DOI 10.1074/jbc.M211204200; Papo N, 2006, CANCER RES, V66, P5371, DOI 10.1158/0008-5472.CAN-05-4569; Pasupuleti M, 2009, BBA-GEN SUBJECTS, V1790, P800, DOI 10.1016/j.bbagen.2009.03.029; Pasupuleti M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005285; RAZ A, 1980, NATURE, V284, P363, DOI 10.1038/284363a0; Riedl S, 2011, CHEM PHYS LIPIDS, V164, P766, DOI 10.1016/j.chemphyslip.2011.09.004; Rosenfeld Y, 2010, BIOCHEMISTRY-US, V49, P853, DOI 10.1021/bi900724x; Rothstein DM, 2001, ANTIMICROB AGENTS CH, V45, P1367, DOI 10.1128/AAC.45.5.1367-1373.2001; Schmidtchen A, 2009, J BIOL CHEM, V284, P17584, DOI 10.1074/jbc.M109.011650; Serrano GN, 2009, ANTIMICROB AGENTS CH, V53, P2215, DOI 10.1128/AAC.01100-08; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sinthuvanich C, 2012, J AM CHEM SOC, V134, P6210, DOI 10.1021/ja210569f; Steinstraesser L, 2011, INT J CANCER, V128, P2994, DOI 10.1002/ijc.25627; Taguchi F, 2004, CANCER SCI, V95, P984, DOI 10.1111/j.1349-7006.2004.tb03187.x; Ting CH, 2014, BIOMATERIALS, V35, P3627, DOI 10.1016/j.biomaterials.2014.01.032; UTSUGI T, 1991, CANCER RES, V51, P3062; Veiga AS, 2012, BIOMATERIALS, V33, P8907, DOI 10.1016/j.biomaterials.2012.08.046; Wu DD, 2014, CANCER LETT, V351, P13, DOI 10.1016/j.canlet.2014.05.002; Wu DD, 2010, PEPTIDES, V31, P850, DOI 10.1016/j.peptides.2010.01.007; Yin LM, 2012, J BIOL CHEM, V287, P7738, DOI 10.1074/jbc.M111.303602; Yu HY, 2013, BBA-BIOMEMBRANES, V1828, P2720, DOI 10.1016/j.bbamem.2013.07.020; Yu HY, 2011, ANTIMICROB AGENTS CH, V55, P4918, DOI 10.1128/AAC.00202-11; Yu HY, 2010, CHEMBIOCHEM, V11, P2273, DOI 10.1002/cbic.201000372; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	52	87	91	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0126390	10.1371/journal.pone.0126390	http://dx.doi.org/10.1371/journal.pone.0126390			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970292	Green Published, gold, Green Submitted			2022-12-26	WOS:000354544200110
J	Yin, X; Hu, D; Li, JF; He, Y; Zhu, TD; Wu, MC				Yin, Xin; Hu, Die; Li, Jian-Fang; He, Yao; Zhu, Tian-Di; Wu, Min-Chen			Contribution of Disulfide Bridges to the Thermostability of a Type A Feruloyl Esterase from Aspergillus usamii	PLOS ONE			English	Article							BACILLUS-CIRCULANS XYLANASE; FAMILY 11 XYLANASE; THERMAL-STABILITY; SPECTROPHOTOMETRIC ASSAY; FUNCTIONAL EXPRESSION; BETA-MANNANASE; CLONING; NIGER; DESIGN; ACID	The contribution of disulfide bridges to the thermostability of a type A feruloyl esterase (AuFaeA) from Aspergillus usamii E001 was studied by introducing an extra disulfide bridge or eliminating a native one from the enzyme. MODIP and DbD, two computational tools that can predict the possible disulfide bridges in proteins for thermostability improvement, and molecular dynamics (MD) simulations were used to design the extra disulfide bridge. One residue pair A126-N152 was chosen, and the respective amino acid residues were mutated to cysteine. The wild-type AuFaeA and its variants were expressed in Pichia pastoris GS115. The temperature optimum of the recombinant (re-) AuFaeA(A126C-N152C) was increased by 6 degrees C compared to that of re-AuFaeA. The thermal inactivation half-lives of re-AuFaeA(A126C-N152C) at 55 and 60 degrees C were 188 and 40 min, which were 12.5- and 10-folds longer than those of re-AuFaeA. The catalytic efficiency (k(cat)/K-m) of re-AuFaeA(A126C-N152C) was similar to that of re-AuFaeA. Additionally, after elimination of each native disulfide bridge in AuFaeA, a great decrease in expression level and at least 10 degrees C decrease in thermal stability of recombinant AuEaeA variants were also observed.	[Yin, Xin; Hu, Die; He, Yao; Zhu, Tian-Di] Jiangnan Univ, Sch Biotechnol, Minist Educ, Key Lab Carbohydrate Chem & Biotechnol, Wuxi, Peoples R China; [Li, Jian-Fang] Jiangnan Univ, Sch Food Sci & Technol, State Key Lab Food Sci & Technol, Wuxi, Peoples R China; [Wu, Min-Chen] Jiangnan Univ, Wuxi Med Sch, Wuxi, Peoples R China	Jiangnan University; Jiangnan University; Jiangnan University	Wu, MC (corresponding author), Jiangnan Univ, Wuxi Med Sch, Wuxi, Peoples R China.	biowmc@126.com		Hu, Die/0000-0001-6957-2419	Fundamental Research Fund for the Central Universities of China [JUDCF13011, JUSRP51412B]; Postgraduate Innovation Training Project of Jiangsu [CXZZ13_0757]	Fundamental Research Fund for the Central Universities of China; Postgraduate Innovation Training Project of Jiangsu	This work was financially supported by the Fundamental Research Fund for the Central Universities of China (No. JUDCF13011, JUSRP51412B) (http://yjsb.jiangnan.edu.cn/, http://www.moe.gov.cn/) and the Postgraduate Innovation Training Project of Jiangsu (No. CXZZ13_0757) (http://www.ec.js.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abokitse K, 2010, APPL MICROBIOL BIOT, V87, P195, DOI 10.1007/s00253-010-2441-6; Alquati C, 2002, EUR J BIOCHEM, V269, P3321, DOI 10.1046/j.1432-1033.2002.03012.x; Badieyan S, 2012, BIOTECHNOL BIOENG, V109, P31, DOI 10.1002/bit.23280; Chen XL, 2007, J BIOTECHNOL, V128, P452, DOI 10.1016/j.jbiotec.2006.11.003; Crepin VF, 2004, APPL MICROBIOL BIOT, V63, P647, DOI 10.1007/s00253-003-1476-3; Dombkowski AA, 2014, FEBS LETT, V588, P206, DOI 10.1016/j.febslet.2013.11.024; Eijsink VGH, 2005, BIOMOL ENG, V22, P21, DOI 10.1016/j.bioeng.2004.12.003; Faulds CB, 2010, PHYTOCHEM REV, V9, P121, DOI 10.1007/s11101-009-9156-2; Gao SJ, 2013, BIOTECHNOL BIOENG, V110, P1028, DOI 10.1002/bit.24768; Gong YY, 2013, J IND MICROBIOL BIOT, V40, P1433, DOI 10.1007/s10295-013-1339-6; Han ZL, 2009, APPL MICROBIOL BIOT, V85, P117, DOI 10.1007/s00253-009-2067-8; Hegde S, 2009, ANAL BIOCHEM, V387, P128, DOI 10.1016/j.ab.2009.01.001; Hermoso JA, 2004, J MOL BIOL, V338, P495, DOI 10.1016/j.jmb.2004.03.003; Jeong MY, 2007, J BIOTECHNOL, V127, P300, DOI 10.1016/j.jbiotec.2006.07.005; Joo JC, 2011, J BIOTECHNOL, V151, P56, DOI 10.1016/j.jbiotec.2010.10.002; Joo JC, 2010, J BIOTECHNOL, V146, P31, DOI 10.1016/j.jbiotec.2009.12.021; Kim HS, 2010, ENZYME MICROB TECH, V47, P1, DOI 10.1016/j.enzmictec.2010.04.003; Koseki T, 2009, APPL MICROBIOL BIOT, V84, P803, DOI 10.1007/s00253-009-2148-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li JF, 2012, J AGR FOOD CHEM, V60, P765, DOI 10.1021/jf2041565; Mansfeld J, 1997, J BIOL CHEM, V272, P11152, DOI 10.1074/jbc.272.17.11152; Mastihuba V, 2002, ANAL BIOCHEM, V309, P96, DOI 10.1016/S0003-2697(02)00241-5; MATSUMURA M, 1989, SCIENCE, V243, P792, DOI 10.1126/science.2916125; McAuley KE, 2004, ACTA CRYSTALLOGR D, V60, P878, DOI 10.1107/S0907444904004937; PACE CN, 1988, J BIOL CHEM, V263, P11820; Quang ATL, 2012, BIOTECHNOL BIOENG, V109, P867, DOI 10.1002/bit.24371; Radestock S, 2008, ENG LIFE SCI, V8, P507, DOI 10.1002/elsc.200800043; Rakotoarivonina H, 2011, APPL MICROBIOL BIOT, V90, P541, DOI 10.1007/s00253-011-3103-z; Reetz MT, 2006, ANGEW CHEM INT EDIT, V45, P7745, DOI 10.1002/anie.200602795; Siadat Omid Ranaei, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-12; Surzhik MA, 2014, APPL BIOCHEM MICRO+, V50, P118, DOI 10.1134/S0003683814020185; TIDOR B, 1993, PROTEINS, V15, P71, DOI 10.1002/prot.340150109; Turunen O, 2001, J BIOTECHNOL, V88, P37, DOI 10.1016/S0168-1656(01)00253-X; van Beek HL, 2014, FEBS OPEN BIO, V4, P168, DOI 10.1016/j.fob.2014.01.009; Wang YW, 2012, BIORESOURCE TECHNOL, V112, P275, DOI 10.1016/j.biortech.2012.02.092; Wu MQ, 2012, APPL BIOCHEM BIOTECH, V168, P129, DOI 10.1007/s12010-011-9359-z; Zhang HM, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-3; Zhang HM, 2012, APPL BIOCHEM BIOTECH, V167, P2198, DOI 10.1007/s12010-012-9757-x; Zhang SB, 2013, PROTEIN EXPRES PURIF, V92, P36, DOI 10.1016/j.pep.2013.08.009; Zhang SB, 2012, BIORESOURCE TECHNOL, V117, P140, DOI 10.1016/j.biortech.2012.04.042; Zhang SB, 2011, BIORESOURCE TECHNOL, V102, P2093, DOI 10.1016/j.biortech.2010.08.019; Zhang Shuaibing, 2009, Chinese Journal of Applied and Environmental Biology, V15, P276, DOI 10.3724/SP.J.1145.2009.00276	42	27	29	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0126864	10.1371/journal.pone.0126864	http://dx.doi.org/10.1371/journal.pone.0126864			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25969986	Green Published, Green Submitted, gold			2022-12-26	WOS:000354544200138
J	Liu, M; Fan, R; Liu, XH; Cheng, F; Wang, J				Liu, Meng; Fan, Rui; Liu, Xinhua; Cheng, Feng; Wang, Ju			Pathways and Networks-Based Analysis of Candidate Genes Associated with Nicotine Addiction	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SYNAPTIC PLASTICITY; TRANSCRIPTION FACTORS; SMOKING-CESSATION; DOPAMINE; ENVIRONMENT; SYSTEMS; MECHANISMS; EXPRESSION; DEPENDENCE	Nicotine is the addictive substance in tobacco and it has a broad impact on both the central and peripheral nervous systems. Over the past decades, an increasing number of genes potentially involved in nicotine addiction have been identified by different technical approaches. However, the molecular mechanisms underlying nicotine addiction remain largely unclear. Under such situation, a comprehensive analysis focusing on the overall functional characteristics of these genes, as well as how they interact with each other will provide us valuable information to understand nicotine addiction. In this study, we presented a systematic analysis on nicotine addiction-related genes to identify the major underlying biological themes. Functional analysis revealed that biological processes and biochemical pathways related to neurodevelopment, immune system and metabolism were significantly enriched in the nicotine addiction-related genes. By extracting the nicotine addiction-specific subnetwork, a number of novel genes associated with addiction were identified. Moreover, we constructed a schematic molecular network for nicotine addiction via integrating the pathways and network, providing an intuitional view to understand the development of nicotine addiction. Pathway and network analysis indicated that the biological processes related to nicotine addiction were complex. Results from our work may have important implications for understanding the molecular mechanism underlying nicotine addiction.	[Liu, Meng; Fan, Rui; Liu, Xinhua; Wang, Ju] Tianjin Med Univ, Sch Biomed Engn, Tianjin, Peoples R China; [Cheng, Feng] Univ S Florida, Dept Pharmaceut Sci, Tampa, FL 33620 USA	Tianjin Medical University; State University System of Florida; University of South Florida	Cheng, F (corresponding author), Univ S Florida, Dept Pharmaceut Sci, Tampa, FL 33620 USA.	fcheng1@health.usf.edu; wangju@tmu.edu.cn	Cheng, Feng/A-9760-2009	Cheng, Feng/0000-0003-3619-8090	National Natural Science Foundation of China [31271411]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry of China(Scientific Research Foundation for the Returned Overseas Chinese ScholarsMinistry of Education, China)	This work was supported by the National Natural Science Foundation of China (Grant No. 31271411) and Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry of China to JW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah AS, 2013, TOB CONTROL, V22, P9, DOI 10.1136/tobaccocontrol-2011-050135; Adhikari B., 2009, ONCOL TIMES, V31, P40, DOI [DOI 10.1097/01.COT.0000345498.34913.FD, 10.1097/01.COT.0000345498.34913.fd]; Baranzini SE, 2009, HUM MOL GENET, V18, P2078, DOI 10.1093/hmg/ddp120; Barik J, 2006, MOL PHARMACOL, V69, P618, DOI 10.1124/mol.105.018184; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benowitz NL, 2010, NEW ENGL J MED, V362, P2295, DOI 10.1056/NEJMra0809890; Benowitz NL, 1999, PRIMARY CARE, V26, P611, DOI 10.1016/S0095-4543(05)70120-2; Cheeta S, 2001, PSYCHOPHARMACOLOGY, V155, P78, DOI 10.1007/s002130100681; Chen GQ, 2002, INT J CANCER, V99, P171, DOI 10.1002/ijc.10304; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; Dani JA, 2001, PHARMACOL BIOCHEM BE, V70, P439, DOI 10.1016/S0091-3057(01)00652-9; Dani JA, 2001, NEURON, V31, P349, DOI 10.1016/S0896-6273(01)00379-8; Di Chiara G, 2000, EUR J PHARMACOL, V393, P295, DOI 10.1016/S0014-2999(00)00122-9; Di Chiara G, 2004, NEUROPHARMACOLOGY, V47, P227, DOI 10.1016/j.neuropharm.2004.06.032; ERDOS P, 1960, B INT STATIST INST, V38, P343; Fowler CD, 2011, NATURE, V471, P597, DOI 10.1038/nature09797; Free RB, 2007, J BIOL CHEM, V282, P21285, DOI 10.1074/jbc.M701555200; GELMAN MS, 1995, J BIOL CHEM, V270, P15085, DOI 10.1074/jbc.270.25.15085; Harmey D, 2012, NICOTINE TOB RES, V14, P1300, DOI 10.1093/ntr/nts201; Hernandez CM, 2005, NEUROSCIENCE, V130, P997, DOI 10.1016/j.neuroscience.2004.10.006; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Jha P, 2014, NEW ENGL J MED, V370, P60, DOI 10.1056/NEJMra1308383; Ji D, 2001, NEURON, V31, P131, DOI 10.1016/S0896-6273(01)00332-4; Jia PL, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S3-S12; Kalivas PW, 2009, NEUROPHARMACOLOGY, V56, P169, DOI 10.1016/j.neuropharm.2008.07.011; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; KLEIN P, 1995, J ALGORITHM, V19, P104, DOI 10.1006/jagm.1995.1029; Kong MMC, 2007, MOL PHARMACOL, V72, P1157, DOI 10.1124/mol.107.034769; Laviolette SR, 2004, NAT REV NEUROSCI, V5, P55, DOI 10.1038/nrn1298; LEVIN ED, 1992, PSYCHOPHARMACOLOGY, V108, P417, DOI 10.1007/BF02247415; Li MD, 2009, NAT REV GENET, V10, P225, DOI 10.1038/nrg2536; LI SW, 1995, J BIOL CHEM, V270, P15693, DOI 10.1074/jbc.270.26.15693; Liu X., 2014, P 2014 IEEE MTT S IN, P1, DOI [10.1109/MWSYM.2014.6848553, DOI 10.1109/MWSYM.2014.6848553]; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; McAllister-Sistilli CG, 1998, PSYCHONEUROENDOCRINO, V23, P175, DOI 10.1016/S0306-4530(97)00080-2; McClung Colleen A, 2007, ScientificWorldJournal, V7, P194; MURRAY JC, 1995, AM J HUM GENET, V57, P227, DOI 10.2134/agronj1965.00021962005700020028x; Murray S, 2006, CAN MED ASSOC J, V174, P309, DOI 10.1503/cmaj.051628; Nairn AC, 2004, NEUROPHARMACOLOGY, V47, P14, DOI 10.1016/j.neuropharm.2004.05.010; Palha JA, 2006, BRAIN RES REV, V51, P61, DOI 10.1016/j.brainresrev.2005.10.001; Pandey SC, 2005, ALCOHOL CLIN EXP RES, V29, P176, DOI 10.1097/01.ALC.0000153550.31168.1D; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803; Stipanovich A, 2008, NATURE, V453, P879, DOI 10.1038/nature06994; Sullivan PF, 2004, AM J MED GENET B, V126B, P23, DOI 10.1002/ajmg.b.20138; Sun JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011351; Sun JC, 2010, CHEM BIODIVERS, V7, P1153, DOI 10.1002/cbdv.200900319; Tretter F, 2008, PHARMACOPSYCHIATRY, V41, pS2, DOI 10.1055/s-2008-1081461; Uhl GR, 2008, ARCH GEN PSYCHIAT, V65, P683, DOI 10.1001/archpsyc.65.6.683; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Watkins S S, 2000, Nicotine Tob Res, V2, P19; Wu JM, 2009, NAT METHODS, V6, P75, DOI [10.1038/nmeth.1282, 10.1038/NMETH.1282]; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zheng SY, 2012, GENOMICS, V99, P183, DOI 10.1016/j.ygeno.2011.12.005; Zimmermann M, 2001, EUR J PHARMACOL, V429, P23, DOI 10.1016/S0014-2999(01)01303-6	57	14	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0127438	10.1371/journal.pone.0127438	http://dx.doi.org/10.1371/journal.pone.0127438			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965070	Green Submitted, Green Published, gold			2022-12-26	WOS:000354543500100
J	Pandey, T; Singh, SK; Chhetri, G; Tripathi, T; Singh, AK				Pandey, Tripti; Singh, Sudhir Kumar; Chhetri, Gaurav; Tripathi, Timir; Singh, Arvind Kumar			Characterization of a Highly pH Stable Chi-Class Glutathione S-Transferase from Synechocystis PCC 6803	PLOS ONE			English	Article							N-CAPPING BOX; MOLECULAR-CLONING; ESCHERICHIA-COLI; EVOLUTION; ENZYME; MOTIF; GST; ISOTHIOCYANATES; IDENTIFICATION; STABILITY	Glutathione S-transferases (GSTs) are multifunctional enzymes present in virtually all organisms. Besides having an essential role in cellular detoxification, they also perform various other functions, including responses in stress conditions and signaling. GSTs are highly studied in plants and animals; however, the knowledge regarding GSTs in cyanobacteria seems rudimentary. In this study, we report the characterization of a highly pH stable GST from the model cyanobacterium-Synechocystis PCC 6803. The gene sll0067 was expressed in Escherichia coli (E. coli), and the protein was purified to homogeneity. The expressed protein exists as a homo-dimer, which is composed of about 20 kDa subunit. The results of the steady-state enzyme kinetics displayed protein's glutathione conjugation activity towards its class specific substrate-isothiocyanate, having the maximal activity with phenethyl isothiocyanate. Contrary to the poor catalytic activity and low specificity towards standard GST substrates such as 1-chloro-2,4-dinitrobenzene by bacterial GSTs, PmGST B1-1 from Proteus mirabilis, and E. coli GST, sll0067 has broad substrate degradation capability like most of the mammalian GST. Moreover, we have shown that cyanobacterial GST sll0067 is catalytically efficient compared to the best mammalian enzymes. The structural stability of GST was studied as a function of pH. The fluorescence and CD spectroscopy in combination with size exclusion chromatography showed a highly stable nature of the protein over a broad pH range from 2.0 to 11.0. To the best of our knowledge, this is the first GST with such a wide range of pH related structural stability. Furthermore, the presence of conserved Proline-53, structural motifs such as N-capping box and hydrophobic staple further aid in the stability and proper folding of cyanobacterial GST-sll0067.	[Pandey, Tripti; Singh, Sudhir Kumar; Chhetri, Gaurav; Tripathi, Timir; Singh, Arvind Kumar] NE Hill Univ, Dept Biochem, Mol & Struct Biophys Lab, Shillong 793014, Meghalaya, India	North Eastern Hill University	Tripathi, T (corresponding author), NE Hill Univ, Dept Biochem, Mol & Struct Biophys Lab, Shillong 793014, Meghalaya, India.	timir.tripathi@gmail.com; aksingh_nehu@yahoo.co.in	Singh, Sudhir Kumar/AAT-7156-2021; Tripathi, Timir/G-4197-2012; Singh, Arvind Kumar/AAD-5632-2021	Singh, Sudhir Kumar/0000-0002-1958-6043; Tripathi, Timir/0000-0001-5559-289X; Singh, Arvind Kumar/0000-0003-2058-2637; Chhetri, Gaurav/0000-0002-0893-7848	Department of Science and Technology, India [SB/SO/BB/009/2013]	Department of Science and Technology, India(Department of Science & Technology (India))	This work was supported by the Department of Science and Technology, India, Grant no. SB/SO/BB/009/2013. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allocati N, 1999, FEBS LETT, V445, P347, DOI 10.1016/S0014-5793(99)00147-7; Allocati N, 2006, BIOCHEM J, V394, P11, DOI 10.1042/BJ20051367; Allocati N, 2009, FEBS J, V276, P58, DOI 10.1111/j.1742-4658.2008.06743.x; Armstrong R N, 1994, Adv Enzymol Relat Areas Mol Biol, V69, P1; Cameron JC, 2010, PLANT PHYSIOL, V154, P1672, DOI 10.1104/pp.110.162990; Cocco R, 2001, J BIOL CHEM, V276, P32177, DOI 10.1074/jbc.M104057200; DIRR H, 1994, EUR J BIOCHEM, V220, P645, DOI 10.1111/j.1432-1033.1994.tb18666.x; Dixon DP, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews3004; Dragani B, 2000, INT J BIOCHEM CELL B, V32, P725, DOI 10.1016/S1357-2725(00)00018-2; Dragani B, 1997, J BIOL CHEM, V272, P25518, DOI 10.1074/jbc.272.41.25518; Frova C, 2003, PHYSIOL PLANTARUM, V119, P469, DOI 10.1046/j.1399-3054.2003.00183.x; Gilmartin N, 2005, FEMS MICROBIOL LETT, V249, P23, DOI 10.1016/j.femsle.2005.05.056; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; He NG, 1999, TOXICOL APPL PHARM, V158, P177, DOI 10.1006/taap.1999.8700; Hiller N, 2006, PROTEIN SCI, V15, P281, DOI 10.1110/ps.051891106; JI XH, 1995, BIOCHEMISTRY-US, V34, P5317, DOI 10.1021/bi00016a003; Kanai T, 2006, J BIOCHEM, V140, P703, DOI 10.1093/jb/mvj199; Kaplan W, 1997, PROTEIN SCI, V6, P399; KOLM RH, 1995, BIOCHEM J, V311, P453, DOI 10.1042/bj3110453; KOONIN EV, 1994, PROTEIN SCI, V3, P2045, DOI 10.1002/pro.5560031117; Lackowicz JR., 2004, PRINCIPLES FLUORESCE; MANNERVIK B, 1985, P NATL ACAD SCI USA, V82, P7202, DOI 10.1073/pnas.82.21.7202; MANNERVIK B, 1988, CRC CR REV BIOCH MOL, V23, P283, DOI 10.3109/10409238809088226; McGoldrick S, 2005, FEMS MICROBIOL LETT, V242, P1, DOI 10.1016/j.femsle.2004.10.033; Neuefeind T, 1997, BIOL CHEM, V378, P199; NISHIDA M, 1994, J BIOL CHEM, V269, P32536; Oakley A, 2011, DRUG METAB REV, V43, P138, DOI 10.3109/03602532.2011.558093; Perito B, 1996, BIOCHEM J, V318, P157, DOI 10.1042/bj3180157; Rossjohn J, 1998, STRUCT FOLD DES, V6, P721, DOI 10.1016/S0969-2126(98)00074-4; Salinas AE, 1999, CURR MED CHEM, V6, P279; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Sherratt PJ, 1997, BIOCHEM J, V326, P837, DOI 10.1042/bj3260837; SHISHIDO T, 1981, AGR BIOL CHEM TOKYO, V45, P2951, DOI 10.1080/00021369.1981.10864996; Simpson JS, 2004, ORG BIOMOL CHEM, V2, P939, DOI 10.1039/b315894b; Singh K, 2008, PROTEINS, V71, P1879, DOI 10.1002/prot.21872; Stenberg G, 2000, J BIOL CHEM, V275, P10421, DOI 10.1074/jbc.275.14.10421; Stourman NV, 2011, BIOCHEMISTRY-US, V50, P1274, DOI 10.1021/bi101861a; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Torres-Rivera A, 2008, ARCH BIOCHEM BIOPHYS, V477, P372, DOI 10.1016/j.abb.2008.07.008; Tripathi T, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-67; Vuilleumier S, 2002, APPL MICROBIOL BIOT, V58, P138, DOI 10.1007/s00253-001-0836-0; Vuilleumier S, 1997, J BACTERIOL, V179, P1431, DOI 10.1128/jb.179.5.1431-1441.1997; Whitton B.A., 2000, ECOLOGY CYANOBACTERI; Wiktelius E, 2007, BIOCHEM J, V406, P115, DOI 10.1042/BJ20070328; WILCE MCJ, 1994, BBA-PROTEIN STRUCT M, V1205, P1, DOI 10.1016/0167-4838(94)90086-8; WILCE MCJ, 1995, EMBO J, V14, P2133, DOI 10.1002/j.1460-2075.1995.tb07207.x; Wu KP, 2009, J MOL BIOL, V391, P784, DOI 10.1016/j.jmb.2009.06.063; Zechmann B, 2010, PROTOPLASMA, V246, P65, DOI 10.1007/s00709-010-0126-8	51	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0126811	10.1371/journal.pone.0126811	http://dx.doi.org/10.1371/journal.pone.0126811			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965384	Green Published, Green Submitted, gold			2022-12-26	WOS:000354543500079
J	Van Deun, K; Thorrez, L; van den Berg, RA; Smilde, AK; Van Mechelen, I				Van Deun, Katrijn; Thorrez, Lieven; van den Berg, Robert A.; Smilde, Age K.; Van Mechelen, Iven			Not Just a Sum? Identifying Different Types of Interplay between Constituents in Combined Interventions	PLOS ONE			English	Article							REGULATORY NETWORKS; TRANSCRIPTION; THERAPEUTICS; COMBINATION; HYPOTHESIS; SYNERGISM; CELLS	Motivation Experiments in which the effect of combined manipulations is compared with the effects of their pure constituents have received a great deal of attention. Examples include the study of combination therapies and the comparison of double and single knockout model organisms. Often the effect of the combined manipulation is not a mere addition of the effects of its constituents, with quite different forms of interplay between the constituents being possible. Yet, a well-formalized taxonomy of possible forms of interplay is lacking, let alone a statistical methodology to test for their presence in empirical data. Results Starting from a taxonomy of a broad range of forms of interplay between constituents of a combined manipulation, we propose a sound statistical hypothesis testing framework to test for the presence of each particular form of interplay. We illustrate the framework with analyses of public gene expression data on the combined treatment of dendritic cells with curdlan and GM-CSF and show that these lead to valuable insights into the mode of action of the constituent treatments and their combination. Availability and Implementation R code implementing the statistical testing procedure for microarray gene expression data is available as supplementary material. The data are available from the Gene Expression Omnibus with accession number GSE32986.	[Van Deun, Katrijn; Van Mechelen, Iven] Katholieke Univ Leuven, Fac Psychol & Educ Sci, Res Grp Quantitat Psychol & Individual Difference, Louvain, Belgium; [Thorrez, Lieven] KU Leuven Univ Leuven, Dept Dev & Regenerat Kulak, Kortrijk, Belgium; [van den Berg, Robert A.] GlaxoSmithKline Vaccines, Rixensart, Belgium; [Smilde, Age K.] Univ Amsterdam, Swammerdam Inst Life Sci, Biosyst data Anal, Amsterdam, Netherlands; [Van Deun, Katrijn] Tilburg Univ, Methodol & Stat, NL-5000 LE Tilburg, Netherlands	KU Leuven; KU Leuven; GlaxoSmithKline; University of Amsterdam; Tilburg University	Van Deun, K (corresponding author), Katholieke Univ Leuven, Fac Psychol & Educ Sci, Res Grp Quantitat Psychol & Individual Difference, Louvain, Belgium.	k.vandeun@tilburguniversity.edu	van den Berg, Robert/E-3238-2010; van den Berg, Robert/GZK-4885-2022; van den Berg, Robert A./N-1217-2019; Thorrez, Lieven/A-2583-2011	van den Berg, Robert/0000-0003-2708-7890; van den Berg, Robert A./0000-0003-2708-7890; Thorrez, Lieven/0000-0002-5896-6823; Smilde, Age/0000-0002-3052-4644	GlaxoSmithKline Biologicals S.A.; Fund for Scientific Research Flanders [G.0546.09N]; Belgian Federal Science Policy Office [IUAP P7/06]	GlaxoSmithKline Biologicals S.A.(GlaxoSmithKline); Fund for Scientific Research Flanders(FWO); Belgian Federal Science Policy Office(Belgian Federal Science Policy Office)	The research reported in this paper was supported by GlaxoSmithKline Biologicals S.A., by the Fund for Scientific Research Flanders (G.0546.09N), and by the Belgian Federal Science Policy Office (IUAP P7/06). LT is a Post-doctoral Fellow of the Research Foundation - Flanders (FWO). The funder provided support in the form of salaries for authors [RvdB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonysamy MA, 1999, J IMMUNOL, V162, P577; Awad S, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S1-S1; BERGER RL, 1982, TECHNOMETRICS, V24, P295, DOI 10.2307/1267823; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Corning P. A., 2002, Complexity, V7, P18, DOI 10.1002/cplx.10043; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gong KW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r149; Jia J, 2009, NAT REV DRUG DISCOV, V8, P111, DOI 10.1038/nrd2683; Keith CT, 2005, NAT REV DRUG DISCOV, V4, P71, DOI 10.1038/nrd1609; Lauzon C, 2009, AM STAT, V63, P147, DOI 10.1198/tast.2009.0029; Miller ML, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004014; Min L, 2012, J IMMUNOL, V188, P1789, DOI 10.4049/jimmunol.1101755; Mosca F, 2008, P NATL ACAD SCI USA, V105, P10501, DOI 10.1073/pnas.0804699105; Park SJ, 2004, J IMMUNOL, V173, P3844, DOI 10.4049/jimmunol.173.6.3844; Pujol A, 2010, TRENDS PHARMACOL SCI, V31, P115, DOI 10.1016/j.tips.2009.11.006; Roller DG, 2012, MOL CANCER THER, V11, P2505, DOI 10.1158/1535-7163.MCT-12-0461; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sun F, 2011, NATURE, V480, P372, DOI 10.1038/nature10594; THOMAS R, 1995, B MATH BIOL, V57, P247, DOI 10.1007/BF02460618; Tuke J, 2009, BIOSTATISTICS, V10, P80, DOI 10.1093/biostatistics/kxn017; Uribesalgo I, 2011, NAT CELL BIOL, V13, P1443, DOI 10.1038/ncb2355; van de Laar L, 2012, BLOOD, V119, P3383, DOI 10.1182/blood-2011-11-370130; Van Deun K, 2009, BIOINFORMATICS, V25, P2588, DOI 10.1093/bioinformatics/btp439; Yamaguchi T, 2010, GENE DEV, V24, P455, DOI 10.1101/gad.552310; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008	26	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0125334	10.1371/journal.pone.0125334	http://dx.doi.org/10.1371/journal.pone.0125334			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965065	Green Published, gold, Green Submitted			2022-12-26	WOS:000354543500016
J	Yang, L; Carrillo, M; Wu, YM; DiAngelo, SL; Silveyra, P; Umstead, TM; Halstead, ES; Davies, ML; Hu, S; Floros, J; McCormack, FX; Christensen, ND; Chroneos, ZC				Yang, Linlin; Carrillo, Marykate; Wu, Yuchieh M.; DiAngelo, Susan L.; Silveyra, Patricia; Umstead, Todd M.; Halstead, E. Scott; Davies, Michael L.; Hu, Sanmei; Floros, Joanna; McCormack, Francis X.; Christensen, Neil D.; Chroneos, Zissis C.			SP-R210 (Myo18A) Isoforms as Intrinsic Modulators of Macrophage Priming and Activation	PLOS ONE			English	Article							SURFACTANT PROTEIN-A; MONOCYTIC CELL-LINE; NF-KAPPA-B; PDZ-CONTAINING MYOSIN; LPS-BINDING-PROTEIN; RECEPTOR 2 TLR2; PULMONARY SURFACTANT; ALVEOLAR MACROPHAGES; SCAVENGER RECEPTOR; DEFICIENT MICE	The surfactant protein (SP-A) receptor SP-R210 has been shown to increase phagocytosis of SP-A-bound pathogens and to modulate cytokine secretion by immune cells. SP-A plays an important role in pulmonary immunity by enhancing opsonization and clearance of pathogens and by modulating macrophage inflammatory responses. Alternative splicing of the Myo18Agene results in two isoforms: SP-R210(S) and SP-R210(L), with the latter predominantly expressed in alveolar macrophages. In this study we show that SP-A is required for optimal expression of SP-R210(L) on alveolar macrophages. Interestingly, pre-treatment with SP-A prepared by different methods either enhances or suppresses responsiveness to LPS, possibly due to differential co-isolation of SP-B or other proteins. We also report that dominant negative disruption of SP-R210(L) augments expression of receptors including SR-A, CD14, and CD36, and enhances macrophages' inflammatory response to TLR stimulation. Finally, because SP-A is known to modulate CD14, we used a variety of techniques to investigate how SP-R210 mediates the effect of SP-A on CD14. These studies revealed a novel physical association between SP-R210(S), CD14, and SR-A leading to an enhanced response to LPS, and found that SP-R210(L) and SP-R210(S) regulate internalization of CD14 via distinct macropinocytosis-like mechanisms. Together, our findings support a model in which SP-R210 isoforms differentially regulate trafficking, expression, and activation of innate immune receptors on macrophages.	[Yang, Linlin; Carrillo, Marykate; Wu, Yuchieh M.; DiAngelo, Susan L.; Silveyra, Patricia; Umstead, Todd M.; Halstead, E. Scott; Davies, Michael L.; Hu, Sanmei; Floros, Joanna; Chroneos, Zissis C.] Penn State Univ, Coll Med, Dept Pediat, Hershey, PA 17033 USA; [Christensen, Neil D.; Chroneos, Zissis C.] Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA USA; [Silveyra, Patricia] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA USA; [Floros, Joanna] Penn State Univ, Coll Med, Dept Obstet & Gynecol, Hershey, PA USA; [Christensen, Neil D.] Penn State Univ, Coll Med, Dept Pathol, Hershey, PA USA; [Halstead, E. Scott] Penn State Univ, Coll Med, Penn State Hershey Childrens Hosp, Div Pediat Crit, Hershey, PA USA; [DiAngelo, Susan L.; Silveyra, Patricia; Umstead, Todd M.; Floros, Joanna] Penn State Univ, Coll Med, Ctr Host Def & Lung Dis Res, Hershey, PA USA; [Yang, Linlin; Carrillo, Marykate; Wu, Yuchieh M.; Silveyra, Patricia; Halstead, E. Scott; Davies, Michael L.; Hu, Sanmei; Chroneos, Zissis C.] Penn State Univ, Coll Med, Pulm Immunol & Physiol Lab, Hershey, PA USA; [Christensen, Neil D.] Penn State Univ, Coll Med, Jake Gittlen Labs Canc Res, Hershey, PA USA; [McCormack, Francis X.] Univ Cincinnati, Coll Med, Dept Internal Med, Div Pulm Crit Care & Sleep Med, Cincinnati, OH USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University System of Ohio; University of Cincinnati	Chroneos, ZC (corresponding author), Penn State Univ, Coll Med, Dept Pediat, Hershey, PA 17033 USA.	zchroneos@hmc.psu.edu	McCormack, Francis X./ABE-8398-2020; YANG, LINLIN/M-2587-2013; Silveyra, Patricia/A-7136-2018	McCormack, Francis X./0000-0001-7168-9464; Halstead, E. Scott/0000-0002-1167-0363; Silveyra, Patricia/0000-0001-7083-8915; , Zissis/0000-0002-9841-7917	National Institutes of Health [HL-34788, HL068127]; Children's Miracle Network; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD055882] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068127, R01HL034788, R37HL034788] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Miracle Network; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health grants HL-34788 and HL068127, and the Children's Miracle Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate W, 2010, J LIPID RES, V51, P334, DOI 10.1194/jlr.M000513; Agrawal V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063990; Antal JM, 1996, AM J RESP CELL MOL, V14, P374, DOI 10.1165/ajrcmb.14.4.8600942; Augusto L, 2001, AM J PHYSIOL-LUNG C, V281, pL776, DOI 10.1152/ajplung.2001.281.4.L776; Beharka AA, 2005, J IMMUNOL, V175, P2227, DOI 10.4049/jimmunol.175.4.2227; Bishe B, 2012, J BIOL CHEM, V287, P27637, DOI 10.1074/jbc.M112.346569; Booth JL, 2014, COMPARATIVE MED, V64, P424; Borron P, 1998, AM J PHYSIOL-LUNG C, V275, pL679, DOI 10.1152/ajplung.1998.275.4.L679; Brandt KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080743; Brendle SA, 2010, J GEN VIROL, V91, P1834, DOI 10.1099/vir.0.017228-0; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Byron A, 2012, PROTEOMICS, V12, P2107, DOI 10.1002/pmic.201100487; Canadas O, 2011, BIOPHYS J, V100, P108, DOI 10.1016/j.bpj.2010.11.028; Chroneos ZC, 1996, J BIOL CHEM, V271, P16375, DOI 10.1074/jbc.271.27.16375; Chroneos ZC, 2010, CELL PHYSIOL BIOCHEM, V25, P13, DOI 10.1159/000272047; CLARK JC, 1995, P NATL ACAD SCI USA, V92, P7794, DOI 10.1073/pnas.92.17.7794; Cross M, 2004, BIOCHEM J, V380, P243, DOI 10.1042/BJ20031978; Czerkies M, 2013, IMMUNOBIOLOGY, V218, P1217, DOI 10.1016/j.imbio.2013.04.005; De Lara LV, 2000, AM J PHYSIOL-LUNG C, V279, pL950, DOI 10.1152/ajplung.2000.279.5.L950; Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; Dunzendorfer S, 2004, J IMMUNOL, V173, P1166, DOI 10.4049/jimmunol.173.2.1166; Egami Y, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00374; Fan YM, 2014, BBA-MOL CELL RES, V1843, P2775, DOI 10.1016/j.bbamcr.2014.06.015; Foley JP, 2012, J BIOL CHEM, V287, P37406, DOI 10.1074/jbc.M112.360982; Fujii M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02385; Furusawa T, 2000, BIOCHEM BIOPH RES CO, V270, P67, DOI 10.1006/bbrc.2000.2377; Garcia-Verdugo I, 2005, BIOCHEM J, V391, P115, DOI 10.1042/BJ20050529; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; GAYNOR CD, 1995, J IMMUNOL, V155, P5343; GEGNER JA, 1995, J BIOL CHEM, V270, P5320, DOI 10.1074/jbc.270.10.5320; Gil M, 2009, J BIOL CHEM, V284, P7495, DOI 10.1074/jbc.M808643200; Glasser SW, 2009, AM J PHYSIOL-LUNG C, V297, pL64, DOI 10.1152/ajplung.90640.2008; Glasser SW, 2013, AM J RESP CELL MOL B, DOI [10.1165/rcmb.2012-0374OC, DOI 10.1165/RCMB.2012-0374OC]; Golioto A, 2002, PEDIATR RES, V51, P220, DOI 10.1203/00006450-200202000-00016; Guzik-Lendrum S, 2011, J BIOL CHEM, V286, P21755, DOI 10.1074/jbc.M111.218669; HAAGSMAN HP, 1987, J BIOL CHEM, V262, P13877; HALL A, 1992, MOL BIOL CELL, V3, P475, DOI 10.1091/mbc.3.5.475; Haque R, 2007, TOXICOL APPL PHARM, V220, P72, DOI 10.1016/j.taap.2006.12.017; Hawgood S, 2002, AM J PHYSIOL-LUNG C, V283, pL1002, DOI 10.1152/ajplung.00118.2002; HAWGOOD S, 1985, BIOCHEMISTRY-US, V24, P184, DOI 10.1021/bi00322a026; Hawley KL, 2013, INT J BIOL SCI, V9, P803, DOI 10.7150/ijbs.7136; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Holmskov U, 1999, P NATL ACAD SCI USA, V96, P10794, DOI 10.1073/pnas.96.19.10794; Hoogerwerf JJ, 2010, AM J RESP CELL MOL, V42, P349, DOI 10.1165/rcmb.2008-0362OC; Hsu HY, 2001, J BIOL CHEM, V276, P28719, DOI 10.1074/jbc.M011117200; Hsu RM, 2010, MOL BIOL CELL, V21, P287, DOI 10.1091/mbc.E09-03-0232; Huang WX, 2004, AM J PHYSIOL-LUNG C, V286, pL546, DOI 10.1152/ajplung.00267.2003; Huang WX, 2002, AM J PHYSIOL-LUNG C, V283, pL94, DOI 10.1152/ajplung.00434.2001; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Islam MA, 2013, INNATE IMMUN-LONDON, V19, P631, DOI 10.1177/1753425913477166; Isogawa Y, 2005, BIOCHEMISTRY-US, V44, P6190, DOI 10.1021/bi0475931; Jakel A, 2013, FRONT BIOSCI-LANDMRK, V18, P1129, DOI 10.2741/4168; Janssen WJ, 2008, AM J RESP CRIT CARE, V178, P158, DOI 10.1164/rccm.200711-1661OC; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Jozefowski S, 2014, INNATE IMMUN-LONDON, V20, P826, DOI 10.1177/1753425913510960; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kasahara K, 2012, AM J PHYSIOL-LUNG C, V303, pL834, DOI 10.1152/ajplung.00031.2012; Ketko AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082680; Kim KS, 2013, HUM MOL GENET, V22, P4805, DOI 10.1093/hmg/ddt332; Kitchens RL, 1998, J IMMUNOL, V160, P1920; Kockx M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111186; Koivusalo M, 2010, J CELL BIOL, V188, P547, DOI 10.1083/jcb.200908086; Koptides M, 1997, AM J PHYSIOL-LUNG C, V273, pL382, DOI 10.1152/ajplung.1997.273.2.L382; Korfhagen TR, 1996, P NATL ACAD SCI USA, V93, P9594, DOI 10.1073/pnas.93.18.9594; Kremlev SG, 1997, AM J PHYSIOL-LUNG C, V272, pL1070, DOI 10.1152/ajplung.1997.272.6.L1070; Kremlev SG, 1997, AM J PHYSIOL-LUNG C, V272, pL996, DOI 10.1152/ajplung.1997.272.5.L996; Kuronuma K, 2004, J BIOL CHEM, V279, P21421, DOI 10.1074/jbc.M312490200; Kuronuma K, 2009, J BIOL CHEM, V284, P25488, DOI 10.1074/jbc.M109.040832; LeVine AM, 1999, AM J RESP CELL MOL, V20, P279, DOI 10.1165/ajrcmb.20.2.3303; Li G, 2002, AM J RESP CELL MOL, V26, P277, DOI 10.1165/ajrcmb.26.3.4584; Lopez-Sanchez A, 2011, EUR J PHARM BIOPHARM, V77, P384, DOI 10.1016/j.ejpb.2010.12.013; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Matsui K, 2011, J PROTEOME RES, V10, P3983, DOI 10.1021/pr200577d; Mesaki K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019764; Mikerov AN, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-77; Miles PR, 1999, AM J PHYSIOL-LUNG C, V276, pL186, DOI 10.1152/ajplung.1999.276.1.L186; Montalbano AP, 2013, ENDOCRINOLOGY, V154, P483, DOI 10.1210/en.2012-1797; Mori K, 2005, BIOCHEM BIOPH RES CO, V326, P491, DOI 10.1016/j.bbrc.2004.11.058; Mori K, 2003, J BIOCHEM, V133, P405, DOI 10.1093/jb/mvg053; Nagy A, 2013, J BIOL CHEM, V288, P709, DOI 10.1074/jbc.M112.424671; Nayak A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00131; Nguyen HA, 2012, AM J PHYSIOL-LUNG C, V303, pL608, DOI 10.1152/ajplung.00067.2012; Ostuni R, 2010, CELL MOL LIFE SCI, V67, P4109, DOI 10.1007/s00018-010-0464-x; Park RJ, 2013, J CELL SCI, V126, P5305, DOI 10.1242/jcs.138578; Perera PY, 2001, J IMMUNOL, V166, P574, DOI 10.4049/jimmunol.166.1.574; Phelps DS, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-67; PHELPS DS, 1987, AM REV RESPIR DIS, V135, P1112; Philippart F, 2012, CRIT CARE MED, V40, P2987, DOI 10.1097/CCM.0b013e31825b8d57; Plociennikowska A, 2015, CELL MOL LIFE SCI, V72, P557, DOI 10.1007/s00018-014-1762-5; Poussin C, 1998, J BIOL CHEM, V273, P20285, DOI 10.1074/jbc.273.32.20285; RABILLOUD T, 1992, ELECTROPHORESIS, V13, P264, DOI 10.1002/elps.1150130154; Ramani V, 2013, INNATE IMMUN-LONDON, V19, P596, DOI 10.1177/1753425912474851; Raychaudhuri B, 2004, AM J RESP CELL MOL, V30, P228, DOI 10.1165/rcmb.2003-0263OC; Samten B, 2008, J LEUKOCYTE BIOL, V84, P115, DOI 10.1189/jlb.1207835; Sano H, 1999, J IMMUNOL, V163, P387; Sano H, 2000, J BIOL CHEM, V275, P22442, DOI 10.1074/jbc.M001107200; Sender V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059896; Sever-Chroneos Z, 2011, J BIOL CHEM, V286, P4854, DOI 10.1074/jbc.M110.125567; Shamsul HM, 2010, IMMUNOLOGY, V130, P262, DOI 10.1111/j.1365-2567.2009.03232.x; Song MC, 2000, AM J PHYSIOL-LUNG C, V279, pL110, DOI 10.1152/ajplung.2000.279.1.L110; Song MC, 2000, INFECT IMMUN, V68, P6611, DOI 10.1128/IAI.68.12.6611-6617.2000; Szeliga J, 2005, ANAL BIOCHEM, V346, P179, DOI 10.1016/j.ab.2005.07.021; Tan I, 2008, CELL, V135, P123, DOI 10.1016/j.cell.2008.09.018; Tanimura N, 2008, BIOCHEM BIOPH RES CO, V368, P94, DOI 10.1016/j.bbrc.2008.01.061; TENNER AJ, 1989, J BIOL CHEM, V264, P13923; Tomlinson GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040348; Tong L, 2014, BIOSCIENCE REP, V34, P283, DOI 10.1042/BSR20140021; Tonks A, 2005, AM J PHYSIOL-LUNG C, V288, pL1070, DOI 10.1152/ajplung.00386.2004; Ueno T, 2004, J BIOL CHEM, V279, P16178, DOI 10.1074/jbc.M312029200; Wang GR, 2000, AM J PHYSIOL-LUNG C, V278, pL946, DOI 10.1152/ajplung.2000.278.5.L946; Weikert LF, 2000, AM J PHYSIOL-LUNG C, V279, pL216, DOI 10.1152/ajplung.2000.279.2.L216; Weikert LF, 1997, AM J PHYSIOL-LUNG C, V272, pL989, DOI 10.1152/ajplung.1997.272.5.L989; Woischnik M, 2008, EUR RESPIR J, V31, P1197, DOI 10.1183/09031936.00081207; Wu HX, 2003, J CLIN INVEST, V111, P1589, DOI 10.1172/JCI200316889; Yamada C, 2006, J BIOL CHEM, V281, P21771, DOI 10.1074/jbc.M513041200; Yang CH, 2005, J BIOL CHEM, V280, P34447, DOI 10.1074/jbc.M505229200; Yang SX, 2002, AM J RESP CELL MOL, V27, P297, DOI 10.1165/rcmb.2002-0035OC; Yoshida S, 2009, J CELL SCI, V122, P3250, DOI 10.1242/jcs.053207; Yu HH, 2012, BBA-MOL CELL RES, V1823, P1192, DOI 10.1016/j.bbamcr.2012.05.004; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051; Zivkovic A, 2011, J IMMUNOL, V186, P1608, DOI 10.4049/jimmunol.1001665	121	17	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0126576	10.1371/journal.pone.0126576	http://dx.doi.org/10.1371/journal.pone.0126576			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965346	Green Submitted, Green Published, gold			2022-12-26	WOS:000354543500066
J	Colton, DM; Stabb, EV; Hagen, SJ				Colton, Deanna M.; Stabb, Eric V.; Hagen, Stephen J.			Modeling Analysis of Signal Sensitivity and Specificity by Vibrio fischeri LuxR Variants	PLOS ONE			English	Article							L-HOMOSERINE LACTONE; DIRECTED EVOLUTION; ESCHERICHIA-COLI; LUMINESCENCE; AUTOINDUCER; SQUID; BIOLUMINESCENCE; EXPRESSION; GENES; IDENTIFICATION	The LuxR protein of the bacterium Vibrio fischeri belongs to a family of transcriptional activators that underlie pheromone-mediated signaling by responding to acyl-homoserine lactones (-HSLs) or related molecules. V. fischeri produces two acyl-HSLs, N-3-oxo-hexanoyl-HSL (3OC6-HSL) and N-octanoyl-HSL (C8-HSL), each of which interact with LuxR to facilitate its binding to a "lux box" DNA sequence, thereby enabling LuxR to activate transcription of the lux operon responsible for bioluminescence. We have investigated the HSL sensitivity of four different variants of V. fischeri LuxR: two derived from wild-type strains ES114 and MJ1, and two derivatives of LuxR(MJ1) generated by directed evolution. For each LuxR variant, we measured the bioluminescence induced by combinations of C8-HSL and 3OC6-HSL. We fit these data to a model in which the two HSLs compete with each other to form multimeric LuxR complexes that directly interact with lux to activate bioluminescence. The model reproduces the observed effects of HSL combinations on the bioluminescence responses directed by LuxR variants, including competition and non-monotonic responses to C8-HSL and 3OC6-HSL. The analysis yields robust estimates for the underlying dissociation constants and cooperativities (Hill coefficients) of the LuxR-HSL complexes and their affinities for the lux box. It also reveals significant differences in the affinities of LuxR(MJ1) and Lux(RES114) for 3OC6-HSL. Further, LuxR(MJ1) and LuxR(ES114) differed sharply from LuxRs retrieved by directed evolution in the cooperativity of LuxR-HSL complex formation and the affinity of these complexes for lux. These results show how computational modeling of in vivo experimental data can provide insight into the mechanistic consequences of directed evolution.	[Colton, Deanna M.; Stabb, Eric V.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Hagen, Stephen J.] Univ Florida, Dept Phys, Gainesville, FL 32611 USA	University System of Georgia; University of Georgia; State University System of Florida; University of Florida	Hagen, SJ (corresponding author), Univ Florida, Dept Phys, Gainesville, FL 32611 USA.	sjhagen@ufl.edu	Hagen, Stephen J/E-9737-2015	Hagen, Stephen J/0000-0002-3373-5033	National Oceanic and Atmospheric Administration (NOAA) Oceans and Human Health (OHH) Graduate Training fellowship [S0867882]; National Science Foundation [IOS-1121106]	National Oceanic and Atmospheric Administration (NOAA) Oceans and Human Health (OHH) Graduate Training fellowship; National Science Foundation(National Science Foundation (NSF))	This study was supported by the National Oceanic and Atmospheric Administration (NOAA) Oceans and Human Health (OHH) Graduate Training fellowship (S0867882) (http://oceansandhumanhealth.noaa.gov/traineeships) and National Science Foundation (IOS-1121106) (http://www.nsf.gov/div/index.jsp?org=IOS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich H, 2005, BIOPHYS J, V89, P76, DOI 10.1529/biophysj.105.060194; Belta C, 2001, IEEE DECIS CONTR P, P869, DOI 10.1109/CDC.2001.980216; BOETTCHER KJ, 1990, J BACTERIOL, V172, P3701, DOI 10.1128/jb.172.7.3701-3706.1990; BOETTCHER KJ, 1995, J BACTERIOL, V177, P1053, DOI 10.1128/jb.177.4.1053-1058.1995; Bose JL, 2008, ARCH MICROBIOL, V190, P169, DOI 10.1007/s00203-008-0387-1; Bose JL, 2007, MOL MICROBIOL, V65, P538, DOI 10.1111/j.1365-2958.2007.05809.x; Bose JL, 2011, APPL ENVIRON MICROB, V77, P2445, DOI 10.1128/AEM.02643-10; Chai YR, 2004, MOL MICROBIOL, V51, P765, DOI 10.1046/j.1365-2958.2003.03857.x; Collins CH, 2005, MOL MICROBIOL, V55, P712, DOI 10.1111/j.1365-2958.2004.04437.x; Collins CH, 2006, NAT BIOTECHNOL, V24, P708, DOI 10.1038/nbt1209; Cox Chris D., 2003, OMICS A Journal of Integrative Biology, V7, P317, DOI 10.1089/153623103322452422; Dunn AK, 2005, PLASMID, V54, P114, DOI 10.1016/j.plasmid.2005.01.003; EBERHARD A, 1981, BIOCHEMISTRY-US, V20, P2444, DOI 10.1021/bi00512a013; Egland KA, 2001, J BACTERIOL, V183, P382, DOI 10.1128/JB.183.1.382-386.2001; ENGEBRECHT J, 1984, P NATL ACAD SCI-BIOL, V81, P4154, DOI 10.1073/pnas.81.13.4154; ENGEBRECHT J, 1983, CELL, V32, P773, DOI 10.1016/0092-8674(83)90063-6; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; GRAY KM, 1992, J BACTERIOL, V174, P4384, DOI 10.1128/JB.174.13.4384-4390.1992; Greenberg EP, 1997, ASM NEWS, V63, P371; Guerrero-Ferreira RC, 2007, CLADISTICS, V23, P497, DOI 10.1111/j.1096-0031.2007.00155.x; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hanzelka BL, 1999, J BACTERIOL, V181, P5766, DOI 10.1128/JB.181.18.5766-5770.1999; Hastings JW, 1999, J BACTERIOL, V181, P2667, DOI 10.1128/JB.181.9.2667-2668.1999; Hawkins AC, 2007, APPL ENVIRON MICROB, V73, P5775, DOI 10.1128/AEM.00060-07; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; James S, 2000, J MOL BIOL, V296, P1127, DOI 10.1006/jmbi.1999.3484; KAPLAN HB, 1985, J BACTERIOL, V163, P1210, DOI 10.1128/JB.163.3.1210-1214.1985; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; Kimbrough JH, 2013, J BACTERIOL, V195, P5223, DOI 10.1128/JB.00913-13; Kuo A, 1996, J BACTERIOL, V178, P971, DOI 10.1128/jb.178.4.971-976.1996; KUO A, 1994, J BACTERIOL, V176, P7558, DOI 10.1128/JB.176.24.7558-7565.1994; Kuttler C, 2008, J THEOR BIOL, V251, P167, DOI 10.1016/j.jtbi.2007.11.015; LEE KH, 1994, J BACTERIOL, V176, P1985, DOI 10.1128/jb.176.7.1985-1991.1994; LEVITZKI A, 1969, P NATL ACAD SCI USA, V62, P1121, DOI 10.1073/pnas.62.4.1121; Lupp C, 2003, MOL MICROBIOL, V50, P319, DOI 10.1046/j.1365-2958.2003.t01-1-03585.x; Lyell NL, 2013, J BACTERIOL, V195, P5051, DOI 10.1128/JB.00751-13; Lyell NL, 2010, J BACTERIOL, V192, P5103, DOI 10.1128/JB.00524-10; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Muller J, 2006, J MATH BIOL, V53, P672, DOI 10.1007/s00285-006-0024-z; Nasser W, 2007, ANAL BIOANAL CHEM, V387, P381, DOI 10.1007/s00216-006-0702-0; Perez PD, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-153; Schaefer AL, 1996, J BACTERIOL, V178, P2897, DOI 10.1128/jb.178.10.2897-2901.1996; Stabb EV, 2008, CHEMICAL COMMUNICATION AMONG BACTERIA, P233; Stabb EV, 2002, METHOD ENZYMOL, V358, P413; Stabb EV, 2001, J BACTERIOL, V183, P309, DOI 10.1128/JB.183.1.309-317.2001; Urbanowski AL, 2004, J BACTERIOL, V186, P631, DOI 10.1128/JB.186.3.631-637.2004; Ward JP, 2001, IMA J MATH APPL MED, V18, P263; Weiss JN, 1997, FASEB J, V11, P835, DOI 10.1096/fasebj.11.11.9285481	49	13	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126474	10.1371/journal.pone.0126474	http://dx.doi.org/10.1371/journal.pone.0126474			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962099	Green Published, gold			2022-12-26	WOS:000354542500105
J	Duchstein, P; Milek, T; Zahn, D				Duchstein, Patrick; Milek, Theodor; Zahn, Dirk			Molecular Mechanisms of ZnO Nanoparticle Dispersion in Solution: Modeling of Surfactant Association, Electrostatic Shielding and Counter Ion Dynamics	PLOS ONE			English	Article								Molecular models of 5 nm sized ZnO/Zn(OH)(2) core-shell nanoparticles in ethanolic solution were derived as scale-up models (based on an earlier model created from ion-by-ion aggregation and self-organization) and subjected to mechanistic analyses of surface stabilization by block-copolymers. The latter comprise a poly-methacrylate chain accounting for strong surfactant association to the nanoparticle by hydrogen bonding and salt-bridges. While dangling poly-ethylene oxide chains provide only a limited degree of sterical hindering to nanoparticle agglomeration, the key mechanism of surface stabilization is electrostatic shielding arising from the acrylates and a halo of Na+ counter ions associated to the nanoparticle. Molecular dynamics simulations reveal different solvent shells and distance-dependent mobility of ions and solvent molecules. From this, we provide a molecular rationale of effective particle size, net charge and polarizability of the nanoparticles in solution.	[Duchstein, Patrick; Milek, Theodor; Zahn, Dirk] Univ Erlangen Nurnberg, Comp Chem Ctr, Lehrstuhl Theoret Chem, D-91054 Erlangen, Germany	University of Erlangen Nuremberg	Zahn, D (corresponding author), Univ Erlangen Nurnberg, Comp Chem Ctr, Lehrstuhl Theoret Chem, Nagelsbach Str 25, D-91054 Erlangen, Germany.	dirk.zahn@chemie.uni-erlangen.de	Duchstein, Patrick/H-3243-2017	Duchstein, Patrick/0000-0002-9925-8639; Zahn, Dirk/0000-0002-4303-3422	deutsche forschungs gemeinschaft	deutsche forschungs gemeinschaft(German Research Foundation (DFG))	Funding was provided by deutsche forschungs gemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTSSON J, 1989, ACTA CRYSTALLOGR B, V45, P34, DOI 10.1107/S0108768188010109; Anwar J, 2011, ANGEW CHEM INT EDIT, V50, P1996, DOI 10.1002/anie.201000463; Dag D, 2011, NANO LETT, V11, P2348, DOI [10.1021/nl200647e, DOI 10.1021/NL200647E]; Israelachvili J.N., 1991, INTERMOLECULAR SURFA; Kawska A, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2145677; Kawska A, 2008, NANO LETT, V8, P2336, DOI 10.1021/nl801169x; Klingshirn C, 2010, PHYS STATUS SOLIDI B, V247, P1424, DOI 10.1002/pssb.200983195; Kolodziejczak-Radzimska A, 2014, MATERIALS, V7, P2833, DOI 10.3390/ma7042833; Miersch L, 2010, EUR J INORG CHEM, P4763, DOI 10.1002/ejic.201000753; Schapotschnikow P, 2008, NANO LETT, V8, P2930, DOI 10.1021/nl8017862; Schapotschnikow P, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3227043; Yin Y, 2005, NATURE, V437, P664, DOI 10.1038/nature04165	12	2	2	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0125872	10.1371/journal.pone.0125872	http://dx.doi.org/10.1371/journal.pone.0125872			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962096	gold, Green Published, Green Submitted			2022-12-26	WOS:000354542500049
J	Nunez-Zapata, J; Cubas, P; Hawksworth, DL; Crespo, A				Nunez-Zapata, Jano; Cubas, Paloma; Hawksworth, David L.; Crespo, Ana			Biogeography and Genetic Structure in Populations of a Widespread Lichen (Parmelina tiliacea, Parmeliaceae, Ascomycota)	PLOS ONE			English	Article							POSTGLACIAL COLONIZATION ROUTES; LOBARIA-PULMONARIA; EPIPHYTIC LICHEN; RAMALINA-MENZIESII; ECOLOGICAL DATA; R-PACKAGE; PHYLOGEOGRAPHY; DNA; FUNGUS; IDENTIFICATION	The genetic diversity and population structure of the foliose lichenized fungus Parmelina tiliacea has been analyzed through its geographical range, including samples from Macaronesia (Canary Islands), the Mediterranean, and Eurosiberia. DNA sequences from the nuclear ribosomal internal transcribed spacer, the mitochondrial large subunit ribosomal RNA gene, and the translation elongation factor 1-alpha were used as molecular markers. The haplotypes of the three markers and the molecular variance analyses of multilocus haplotypes showed the highest diversity in the Canary Islands, while restricted haplotypes occurred at high frequencies in Mediterranean coastal samples. The multilocus haplotypes formed three unevenly distributed clusters (clusters 1-3). In the Canary Islands all the haplotypes were present in a similar proportion, while the coastal Mediterranean sites had almost exclusively haplotypes of cluster 3; cluster 2 predominated in inland Mediterranean sites; and cluster 1 was more abundant in central and northern Europe (Eurosiberian area). The distribution of clusters is partially explained by climatic factors, and its interaction with local spatial structure, but much of the variation remains unexplained. The high frequency of individuals in the Canary Islands with haplotypes shared with other areas suggests that could be a refugium of genetic diversity, and the high frequency of individuals of the Mediterranean coastal sites with restricted haplotypes indicates that gene flow to contiguous areas may be restricted. This is significant for the selection of areas for conservation purposes, as those with most genetic variation may reflect historical factors and biological properties of the species.	[Nunez-Zapata, Jano; Cubas, Paloma; Hawksworth, David L.; Crespo, Ana] Univ Complutense Madrid, Fac Farm, Dept Biol Vegetal 2, Madrid, Spain	Complutense University of Madrid	Cubas, P (corresponding author), Univ Complutense Madrid, Fac Farm, Dept Biol Vegetal 2, Madrid, Spain.	cubas@ucm.es	Crespo, Ana/N-6236-2014	Crespo, Ana/0000-0002-5271-0157; Nunez-Zapata, Jano/0000-0001-9679-1617	Spanish Ministerio de Ciencia e Innovacion [CGL2010-21646CGL, 2013-42498P, CGL2011-25003]; Universidad Complutense de Madrid (SYSTEMOL research group UCM-Banco de Santander)	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Universidad Complutense de Madrid (SYSTEMOL research group UCM-Banco de Santander)	This study was supported by grants from the Spanish Ministerio de Ciencia e Innovacion (CGL2010-21646CGL, 2013-42498P and CGL2011-25003) and a Ph.D. grant to J N-Z. The Universidad Complutense de Madrid is thanked for providing all complementary facilities and funds (SYSTEMOL research group UCM-Banco de Santander, 12.03.2013).	de Paz GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028161; [Anonymous], 2014, R LANG ENV STAT COMP; Arnerup J, 2004, MYCOL RES, V108, P311, DOI 10.1017/S0953756204009360; AXELROD DI, 1975, ANN MO BOT GARD, V62, P280, DOI 10.2307/2395199; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Campbell V, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-64; Crespo A, 2010, IMA FUNGUS, V1, P167, DOI 10.5598/imafungus.2010.01.02.09; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Fernandez-Mendoza F, 2011, MOL ECOL, V20, P1208, DOI 10.1111/j.1365-294X.2010.04993.x; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hijmans R.J., 2012, DIVA GIS; Hutsemekersa V, 2011, P NATL ACAD SCI USA, V108, P18989, DOI 10.1073/pnas.1109119108; Johannesson HS, 2000, MOL ECOL, V9, P375, DOI 10.1046/j.1365-294x.2000.00874-6.x; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Legendre P, 2010, ENCY RES DESIGN, V1, P164; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Medail F, 2009, J BIOGEOGR, V36, P1333, DOI 10.1111/j.1365-2699.2008.02051.x; Mende M, 2010, EUR J ENTOMOL, V107, P101, DOI 10.14411/eje.2010.013; Nunez-Zapata J, 2011, LICHENOLOGIST, V43, P603, DOI 10.1017/S002428291100051X; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; PEARSON LC, 1969, ECOLOGY, V50, P740, DOI 10.2307/1936275; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Petit RJ, 2002, FOREST ECOL MANAG, V156, P49, DOI 10.1016/S0378-1127(01)00634-X; Printzen C, 1999, LICHENOLOGIST, V31, P491; Printzen C, 2003, MOL ECOL, V12, P1473, DOI 10.1046/j.1365-294X.2003.01812.x; Printzen C, 2008, PLANT ECOL DIVERS, V1, P265, DOI 10.1080/17550870802328702; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2010, DOCUMENTATION STRUCT; QUEZEL P, 1982, Ecologia Mediterranea, V8, P15; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Samson RA, 2014, STUD MYCOL, P141, DOI 10.1016/j.simyco.2014.07.004; Scheidegger C, 2012, ECOL EVOL, V2, P2223, DOI 10.1002/ece3.341; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Sork VL, 2014, MOL ECOL, V23, P2326, DOI 10.1111/mec.12735; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; TAJIMA F, 1989, GENETICS, V123, P585; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Venables WN., 2002, MODERN APPL STAT S 4; Visagie CM, 2014, STUD MYCOL, P343, DOI 10.1016/j.simyco.2014.09.001; Walser JC, 2005, MOL ECOL, V14, P457, DOI 10.1111/j.1365-294X.2004.02423.x; Walser JC, 2004, AM J BOT, V91, P1273, DOI 10.3732/ajb.91.8.1273; Werth S, 2006, MOL ECOL, V15, P911, DOI 10.1111/j.1365-294X.2006.02838.x; Werth S, 2008, AM J BOT, V95, P568, DOI 10.3732/ajb.2007024; Werth S, 2007, MOL ECOL, V16, P2807, DOI 10.1111/j.1365-294X.2007.03344.x; Werth S, 2014, AM J BOT, V101, P1127, DOI 10.3732/ajb.1400025; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Widmer I, 2012, MOL ECOL, V21, P5827, DOI 10.1111/mec.12051; Woerner AE, 2007, BIOINFORMATICS, V23, P1851, DOI 10.1093/bioinformatics/btm253; Yahr R, 2006, NEW PHYTOL, V171, P847, DOI 10.1111/j.1469-8137.2006.01792.x	62	7	8	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126981	10.1371/journal.pone.0126981	http://dx.doi.org/10.1371/journal.pone.0126981			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961726	Green Published, gold, Green Submitted			2022-12-26	WOS:000354542500166
J	Schumpert, C; Nelson, J; Kim, E; Dudycha, JL; Patel, RC				Schumpert, Charles; Nelson, Jacob; Kim, Eunsuk; Dudycha, Jeffry L.; Patel, Rekha C.			Telomerase Activity and Telomere Length in Daphnia	PLOS ONE			English	Article							LIFE-SPAN; STRESS-RESPONSE; DAMAGE; DNA; REPRODUCTION; SENESCENCE; EXPRESSION; SHELTERIN; LONGEVITY; CANCER	Telomeres, comprised of short repetitive sequences, are essential for genome stability and have been studied in relation to cellular senescence and aging. Telomerase, the enzyme that adds telomeric repeats to chromosome ends, is essential for maintaining the overall telomere length. A lack of telomerase activity in mammalian somatic cells results in progressive shortening of telomeres with each cellular replication event. Mammals exhibit high rates of cell proliferation during embryonic and juvenile stages but very little somatic cell proliferation occurs during adult and senescent stages. The telomere hypothesis of cellular aging states that telomeres serve as an internal mitotic clock and telomere length erosion leads to cellular senescence and eventual cell death. In this report, we have examined telomerase activity, processivity, and telomere length in Daphnia, an organism that grows continuously throughout its life. Similar to insects, Daphnia telomeric repeat sequence was determined to be TTAGG and telomerase products with five-nucleotide periodicity were generated in the telomerase activity assay. We investigated telomerase function and telomere lengths in two closely related ecotypes of Daphnia with divergent lifespans, short-lived D. pulex and long-lived D. pulicaria. Our results indicate that there is no age-dependent decline in telomere length, telomerase activity, or processivity in short-lived D. pulex. On the contrary, a significant age dependent decline in telomere length, telomerase activity and processivity is observed during life span in long-lived D. pulicaria. While providing the first report on characterization of Daphnia telomeres and telomerase activity, our results also indicate that mechanisms other than telomere shortening may be responsible for the strikingly short life span of D. pulex.	[Schumpert, Charles; Nelson, Jacob; Kim, Eunsuk; Dudycha, Jeffry L.; Patel, Rekha C.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Patel, RC (corresponding author), Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA.	patelr@biol.sc.edu	Patel, Rekha/M-7123-2015	Patel, Rekha/0000-0001-9434-4880	National Institutes of Health [1R01AG037969-01]; NATIONAL INSTITUTE ON AGING [R01AG037969] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grant 1R01AG037969-01 awarded to JLD and RCP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2008, J CELL SCI, V121, P1046, DOI 10.1242/jcs.019372; ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; [Anonymous], 2005, GUIDES IDENTIFICATIO; Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246; Armanios M, 2009, AM J HUM GENET, V85, P823, DOI 10.1016/j.ajhg.2009.10.028; Bommer UA, 2002, RNA, V8, P478, DOI 10.1017/S1355838202022586; Boonekamp JJ, 2013, AGING CELL, V12, P330, DOI 10.1111/acel.12050; Clancy D, 2013, AGEING RES REV, V12, P404, DOI 10.1016/j.arr.2012.03.011; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Dudycha JL, 2013, J PLANKTON RES, V35, P253, DOI 10.1093/plankt/fbt008; Dudycha JL, 2004, FRESHWATER BIOL, V49, P505, DOI 10.1111/j.1365-2427.2004.01201.x; Dudycha JL, 2003, OECOLOGIA, V135, P555, DOI 10.1007/s00442-003-1230-7; Dudycha JL, 2001, ECOL LETT, V4, P102; Dudycha JL, 1999, EVOLUTION, V53, P1744, DOI 10.1111/j.1558-5646.1999.tb04559.x; Evans SK, 2000, J CELL SCI, V113, P3357; Geserick C, 2006, MECH AGEING DEV, V127, P579, DOI 10.1016/j.mad.2006.01.017; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Haendeler J, 2009, ARTERIOSCL THROM VAS, V29, P929, DOI 10.1161/ATVBAHA.109.185546; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HARLEY CB, 1992, EXP GERONTOL, V27, P375, DOI 10.1016/0531-5565(92)90068-B; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Hemann MT, 2000, NUCLEIC ACIDS RES, V28, P4474, DOI 10.1093/nar/28.22.4474; Herbert Brittney-Shea, 2003, Curr Protoc Cell Biol, VChapter 18, DOI 10.1002/0471143030.cb1806s20; Indran IR, 2011, CANCER RES, V71, P266, DOI 10.1158/0008-5472.CAN-10-1588; Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603; Joeng KS, 2004, NAT GENET, V36, P607, DOI 10.1038/ng1356; Kilham SS, 1998, HYDROBIOLOGIA, V377, P147, DOI 10.1023/A:1003231628456; Kim E, 2014, J EXP ZOOL PART A, V321, P48, DOI 10.1002/jez.1836; Klapper W, 1998, FEBS LETT, V439, P143, DOI 10.1016/S0014-5793(98)01357-X; Klapper W, 1998, FEBS LETT, V434, P409, DOI 10.1016/S0014-5793(98)01020-5; Krupp G, 2000, CELL MOL LIFE SCI, V57, P464, DOI 10.1007/PL00000708; Liu L, 2007, NAT CELL BIOL, V9, P1436, DOI 10.1038/ncb1664; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lue NF, 2004, BIOESSAYS, V26, P955, DOI 10.1002/bies.20093; Lund TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007688; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Morgan G, 2013, RES REP BIOCHEM, V3, P71, DOI 10.2147/RRBC.S28603; Morimoto RI, 2009, J GERONTOL A-BIOL, V64, P167, DOI 10.1093/gerona/gln071; Morin GB, 1997, EXP GERONTOL, V32, P375, DOI 10.1016/S0531-5565(96)00164-7; Murthy M, 2015, INVERTEBR REPROD DEV, V59, P1, DOI 10.1080/07924259.2014.970002; Nakagawa S, 2004, MOL ECOL, V13, P2523, DOI 10.1111/j.1365-294X.2004.02291.x; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Raices M, 2005, PLOS GENET, V1, P295, DOI 10.1371/journal.pgen.0010030; Rodriguez-Grana L, 2010, MAR ECOL PROG SER, V401, P1, DOI 10.3354/meps08459; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Schumpert C, 2014, MECH AGEING DEV, V139, P1, DOI 10.1016/j.mad.2014.04.001; Seehuus SC, 2006, P NATL ACAD SCI USA, V103, P962, DOI 10.1073/pnas.0502681103; Shay JW, 2000, NAT REV MOL CELL BIO, V1, P72, DOI 10.1038/35036093; Singhapol C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052989; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tomas-Loba A, 2008, CELL, V135, P609, DOI 10.1016/j.cell.2008.09.034	56	27	27	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0127196	10.1371/journal.pone.0127196	http://dx.doi.org/10.1371/journal.pone.0127196			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962144	Green Published, gold, Green Submitted			2022-12-26	WOS:000354542500169
J	Tang, XH; Wu, XY; Xu, L; Fang, YX; Wang, P; Zhu, GX; Hong, Z				Tang, Xing Hua; Wu, Xun Yi; Xu, Lan; Fang, You Xin; Wang, Ping; Zhu, Guo Xing; Hong, Zhen			eEF-2 Phosphorylation Down-Regulates P-Glycoprotein Over-Expression in Rat Brain Microvessel Endothelial Cells	PLOS ONE			English	Article							ELONGATION FACTOR-II; PROTEIN KINASE-III; SKELETAL-MUSCLE; RABBIT RETICULOCYTES; MULTIDRUG-RESISTANCE; DRUG-RESISTANCE; PROSTATE-CANCER; FACTOR-2 KINASE; GLUTAMATE; BARRIER	Objective We investigated whether glutamate, NMDA receptors, and eukaryote elongation factor-2 kinase (eEF-2K)/eEF-2 regulate P-glycoprotein expression, and the effects of the eEF-2K inhibitor NH125 on the expression of P-glycoprotein in rat brain microvessel endothelial cells (RBMECs). Methods Cortex was obtained from newborn Wistar rat brains. After surface vessels and meninges were removed, the pellet containing microvessels was resuspended and incubated at 37 degrees C in culture medium. Cell viability was assessed by the MTT assay. RBMECs were identified by immunohistochemistry with anti-vWF. P-glycoprotein, phospho-eEF-2, and eEF-2 expression were determined by western blot analysis. Mdr1a gene expression was analyzed by RT-PCR. Results Mdr1a mRNA, P-glycoprotein and phospho-eEF-2 expression increased in L-glutamate stimulated RBMECs. P-glycoprotein and phospho-eEF-2 expression were down-regulated after NH125 treatment in L-glutamate stimulated RBMECs. Conclusions eEF-2K/eEF-2 should have played an important role in the regulation of P-glycoprotein expression in RBMECs. eEF-2K inhibitor NH125 could serve as an efficacious anti-multidrug resistant agent.	[Tang, Xing Hua; Wu, Xun Yi; Xu, Lan; Fang, You Xin; Wang, Ping; Zhu, Guo Xing; Hong, Zhen] Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai 200433, Peoples R China	Fudan University	Wu, XY (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai 200433, Peoples R China.	dr.xunyiwu@163.com	Wang, Ping/GZB-2001-2022		National Natural Science Foundation of China [81100964]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant of National Natural Science Foundation of China (No. 81100964).	ABBOTT NJ, 1992, J CELL SCI, V103, P23; Arora S, 2004, MOL PHARMACOL, V66, P460; Arora S, 2003, CANCER RES, V63, P6894; Bauer B, 2008, MOL PHARMACOL, V73, P1444, DOI 10.1124/mol.107.041210; Chen ZH, 2011, J BIOL CHEM, V286, P43951, DOI 10.1074/jbc.M111.301291; Chiou WL, 2000, PHARMACEUT RES, V17, P903, DOI 10.1023/A:1007570517183; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Dever TE, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013706; Diggle TA, 1999, FEBS LETT, V457, P189, DOI 10.1016/S0014-5793(99)01034-0; French JA, 2013, LANCET NEUROL, V12, P732, DOI 10.1016/S1474-4422(13)70128-5; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Hawkins RA, 2009, AM J CLIN NUTR, V90, p867S, DOI 10.3945/ajcn.2009.27462BB; Im HI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007424; Kaul G, 2011, CELL BIOCHEM FUNCT, V29, P227, DOI 10.1002/cbf.1740; Koochekpour S, 2013, ASIAN J ANDROL, V15, P212, DOI 10.1038/aja.2012.145; Koochekpour S, 2012, CLIN CANCER RES, V18, P5888, DOI 10.1158/1078-0432.CCR-12-1308; Marin P, 1997, J NEUROSCI, V17, P3445; Miranda L, 2008, PFLUG ARCH EUR J PHY, V455, P1129, DOI 10.1007/s00424-007-0368-2; MITSUI K, 1993, J BIOL CHEM, V268, P13422; NAIRN AC, 1987, J BIOL CHEM, V262, P17299; Oh MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047846; PALFREY HC, 1995, ADV SEC MESS PHOSPH, V30, P191; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Pavur KS, 2000, BIOCHEMISTRY-US, V39, P12216, DOI 10.1021/bi0007270; REDPATH NT, 1993, BIOCHEM J, V293, P31, DOI 10.1042/bj2930031; REDPATH NT, 1993, EUR J BIOCHEM, V212, P511, DOI 10.1111/j.1432-1033.1993.tb17688.x; Regina A, 1998, J NEUROCHEM, V71, P705; Rose AJ, 2009, J PHYSIOL-LONDON, V587, P1547, DOI 10.1113/jphysiol.2008.167528; Rose AJ, 2005, J PHYSIOL-LONDON, V569, P223, DOI 10.1113/jphysiol.2005.097154; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; RYAZANOV AG, 1989, FEBS LETT, V251, P187, DOI 10.1016/0014-5793(89)81452-8; SCHINKEL AH, 1994, CELL, V77, P491, DOI 10.1016/0092-8674(94)90212-7; Schmidt D, 2005, EPILEPSIA, V46, P858, DOI 10.1111/j.1528-1167.2005.54904.x; Yamamoto K, 2000, BIOSCI BIOTECH BIOCH, V64, P919, DOI 10.1271/bbb.64.919; Yamamoto K, 2001, BIOSCI BIOTECH BIOCH, V65, P2306, DOI 10.1271/bbb.65.2306; YUZAKI M, 1990, BRAIN RES, V517, P51, DOI 10.1016/0006-8993(90)91006-3; Zhu HJ, 2004, LIFE SCI, V75, P1313, DOI 10.1016/j.lfs.2004.02.027	37	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0125389	10.1371/journal.pone.0125389	http://dx.doi.org/10.1371/journal.pone.0125389			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962137	Green Published, gold, Green Submitted			2022-12-26	WOS:000354542500029
J	Wandera, B; Tumwesigye, NM; Nankabirwa, JI; Kambugu, AD; Parkes-Ratanshi, R; Mafigiri, DK; Kapiga, S; Sethi, AK				Wandera, Bonnie; Tumwesigye, Nazarius Mbona; Nankabirwa, Joaniter Immaculate; Kambugu, Andrew Ddungu; Parkes-Ratanshi, Rosalind; Mafigiri, David Kaawa; Kapiga, Saidi; Sethi, Ajay K.			Alcohol Consumption among HIV-Infected Persons in a Large Urban HIV Clinic in Kampala Uganda: A Constellation of Harmful Behaviors	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; PREVENTION INTERVENTIONS; SENSATION SEEKING; SEXUAL-BEHAVIORS; RISK BEHAVIORS; USE DISORDERS; CAPE-TOWN; ADHERENCE; TRANSMISSION	Introduction Alcohol use by persons living with HIV/AIDS (PLWHA) negatively impacts the public health benefits of antiretroviral therapy (ART). Using a standardized alcohol assessment tool, we estimate the prevalence of alcohol use, identify associated factors, and test the association of alcohol misuse with sexual risk behaviors among PLWHA in Uganda. Methods A cross-section of PLWHA in Kampala were interviewed regarding their sexual behavior and self-reported alcohol consumption in the previous 6 months. Alcohol use was assessed using the alcohol use disorders identification test (AUDIT). Gender-stratified log binomial regression analyses were used to identify independent factors associated with alcohol misuse and to test whether alcohol misuse was associated with risky sexual behaviors. Results Of the 725 subjects enrolled, 235 (33%) reported any alcohol use and 135 (18.6%) reported alcohol misuse, while 38 (5.2%) drank hazardous levels of alcohol. Alcohol misuse was more likely among subjects not yet on ART (adjusted prevalence ratio [aPR] was 1.65 p=0.043 for males and 1.79, p=0.019 for females) and those with self-reported poor adherence (aPR for males=1.56, p=0.052, and for females=1.93, p=0.0189). Belonging to Pentecostal or Muslim religious denominations was protective against alcohol misuse compared to belonging to Anglican and Catholic denominations in both sexes (aPR=0.11 for men, p<0.001, and aPR=0.32 for women, p=0.003). Alcohol misuse was independently associated with reporting risky sexual behaviors (aPR=1.67; 95% CI: 1.07-2.60, p=0.023) among males, but not significant among females (aPR=1.29; 95% CI: 0.95-1.74, p=0.098). Nondisclosure of HIV positive status to sexual partner was significantly associated with risky sex in both males (aPR=1.69; p=0.014) and females (aPR 2.45; p<0.001). Conclusion Alcohol use among PLWHA was high, and was associated with self-reported medication non-adherence, non-disclosure of HIV positive status to sexual partner(s), and risky sexual behaviors among male subjects. Interventions targeting alcohol use and the associated negative behaviors should be tested in this setting.	[Wandera, Bonnie; Tumwesigye, Nazarius Mbona] Makerere Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda; [Wandera, Bonnie; Kambugu, Andrew Ddungu; Parkes-Ratanshi, Rosalind] Makerere Univ, Infect Dis Inst, Coll Hlth Sci, Kampala, Uganda; [Nankabirwa, Joaniter Immaculate] Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda; [Mafigiri, David Kaawa] Makerere Univ, Coll Humanities & Social Sci, Dept Social Work & Social Adm, Kampala, Uganda; [Kapiga, Saidi] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Mwanza, Tanzania; [Kapiga, Saidi] Mwanza Intervent Trials Unit, Mwanza, Tanzania; [Sethi, Ajay K.] Univ Wisconsin, Dept Populat Hlth Sci, Madison, WI USA	Makerere University; Makerere University; Makerere University; Makerere University; University of Wisconsin System; University of Wisconsin Madison	Wandera, B (corresponding author), Makerere Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda.	bonniewandera@yahoo.com	Parkes-Ratanshi, Rosalind/AAR-5409-2020	Parkes-Ratanshi, Rosalind/0000-0001-9297-1311; Kapiga, Saidi/0000-0003-1753-4060; Tumwesigye, Nazarius Mbona/0000-0001-7085-8780; Mafigiri, David/0000-0002-2699-4248	Wellcome Trust through the Training of Health Researchers into Vocational excellence in East Africa (THRiVE) consortium [087540]; Vlaamse Interuniversitaire Raad (VLIR)	Wellcome Trust through the Training of Health Researchers into Vocational excellence in East Africa (THRiVE) consortium(Wellcome Trust); Vlaamse Interuniversitaire Raad (VLIR)	This work was funded by 1) Wellcome Trust grant No. 087540 to BW through the Training of Health Researchers into Vocational excellence in East Africa (THRiVE) consortium, and 2) Vlaamse Interuniversitaire Raad (VLIR) to BW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anglaret X, 2013, ANTIVIR THER, V18, P45, DOI 10.3851/IMP2231; [Anonymous], 2012, GLOB REP UNAIDS REP; Bajunirwe F, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-430; Bradley KA, 2003, ARCH INTERN MED, V163, P821, DOI 10.1001/archinte.163.7.821; Bradley KA, 2007, ALCOHOL CLIN EXP RES, V31, P1208, DOI 10.1111/j.1530-0277.2007.00403.x; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Burns E, 2010, ADDICTION, V105, P601, DOI 10.1111/j.1360-0443.2009.02842.x; Carney MA, 1998, J STUD ALCOHOL, V59, P447, DOI 10.15288/jsa.1998.59.447; Chishinga N, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-75; Cohen MS, 2013, LANCET; Crepaz N, 2006, AIDS, V20, P143, DOI 10.1097/01.aids.0000196166.48518.a0; Fonner VA, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001224.pub4; Franco RA, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-147; Hahn Judith A, 2011, Curr HIV/AIDS Rep, V8, P172, DOI 10.1007/s11904-011-0088-2; Hahn JA, 2010, AIDS BEHAV, V14, P1265, DOI 10.1007/s10461-010-9768-y; Hendershot CS, 2009, JAIDS-J ACQ IMM DEF, V52, P180, DOI 10.1097/QAI.0b013e3181b18b6e; Holmila M, 2005, ADDICTION, V100, P1763, DOI 10.1111/j.1360-0443.2005.01249.x; Kalichman SC, 2013, HIV MED, V14, P263, DOI 10.1111/j.1468-1293.2012.01062.x; Kalichman SC, 2008, ADDICT BEHAV, V33, P1630, DOI 10.1016/j.addbeh.2008.07.020; Kalichman SC, 2007, PREV SCI, V8, P141, DOI 10.1007/s11121-006-0061-2; Kalichman SC, 2006, PSYCHOL ADDICT BEHAV, V20, P298, DOI 10.1037/0893-164X.20.3.298; Kekwaletswe CT, 2014, PATIENT PREFER ADHER, V8, P401, DOI 10.2147/PPA.S55547; Kembabazi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069634; Kennedy CE, 2010, B WORLD HEALTH ORGAN, V88, P615, DOI 10.2471/BLT.09.068213; Krumme AA, 2015, J EPIDEMIOL COMMUN H, V69, P284, DOI 10.1136/jech-2014-204494; LEMLE R, 1989, J SUBST ABUSE TREAT, V6, P213, DOI 10.1016/0740-5472(89)90045-7; Luchters S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-384; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Musinguzi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085646; Namagembe I, 2010, MATERN CHILD HLTH J, V14, P492, DOI 10.1007/s10995-009-0500-3; Ndziessi G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036118; Neblett RC, 2011, J WOMENS HEALTH, V20, P279, DOI 10.1089/jwh.2010.2043; Norris J, 2004, ANN REV SEX RES, V15, P258; Opio CK, 2013, PAN AFR MED J, V15, DOI 10.11604/pamj.2013.15.23.2040; Pandrea I, 2010, ALCOHOL RES HEALTH, V33, P203; Pecoraro A, 2015, AIDS CARE, V27, P86, DOI 10.1080/09540121.2014.959464; Rehm J, 2012, ADDICTION, V107, P51, DOI 10.1111/j.1360-0443.2011.03621.x; Santos GM, 2013, DRUG ALCOHOL DEPEND; Shield KD, 2013, ADDICTION, V108, P912, DOI 10.1111/add.12112; Shuper PA, 2009, AIDS BEHAV, V13, P1021, DOI 10.1007/s10461-009-9589-z; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Thomas G, 2010, MATH BIOSCI ENG, V7, P871, DOI 10.3934/mbe.2010.7.871; Tumwesigye NM, 2013, SUBST USE MISUSE, V48, P1130, DOI 10.3109/10826084.2013.808464; Tumwesigye NM, 2005, GENDER MAJOR CONSEQU; Venkatesh KK, 2011, AIDS, V25, P1939, DOI 10.1097/QAD.0b013e32834b4ced; Wandera B, 2011, JAIDS-J ACQ IMM DEF, V57, P62, DOI 10.1097/QAI.0b013e318211b3f2; Weiser SD, 2006, PLOS MED, V3, P1940, DOI 10.1371/journal.pmed.0030392; WHO, 2001, ALCOHOL USE DISORDER, V2; WHO, 2004, GLOB STAT REP ALC 20; WHO, 2013, CONS GUID US ANT DRU, DOI [10.1371/journal.pone.0090991, DOI 10.1371/JOURNAL.PONE.0090991]; Woolf-King SE, 2011, ARCH SEX BEHAV, V40, P17, DOI 10.1007/s10508-009-9516-4; World Health Organization, 2011, GLOB STAT REP ALC HL; Zocchetti C, 1997, INT J EPIDEMIOL, V26, P220, DOI 10.1093/ije/26.1.220	53	45	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126236	10.1371/journal.pone.0126236	http://dx.doi.org/10.1371/journal.pone.0126236			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI1YY	25962171	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000354542500079
J	Borge, KS; Nord, S; Van Loo, P; Lingjaerde, OC; Gunnes, G; Alnaes, GIG; Solvang, HK; Luders, T; Kristensen, VN; Borresen-Dale, AL; Lingaas, F				Borge, Kaja S.; Nord, Silje; Van Loo, Peter; Lingjaerde, Ole C.; Gunnes, Gjermund; Alnaes, Grethe I. G.; Solvang, Hiroko K.; Luders, Torben; Kristensen, Vessela N.; Borresen-Dale, Anne-Lise; Lingaas, Frode			Canine Mammary Tumours Are Affected by Frequent Copy Number Aberrations, including Amplification of MYC and Loss of PTEN	PLOS ONE			English	Article							HUMAN BREAST-CANCER; DNA-PLOIDY; MUTATIONAL PROCESSES; PROGNOSTIC-FACTORS; DOGS; EXPRESSION; AGE; CYTOCHROME-P450; NEOPLASMS; POPULATION	Background Copy number aberrations frequently occur during the development of many cancers. Such events affect dosage of involved genes and may cause further genomic instability and progression of cancer. In this survey, canine SNP microarrays were used to study 117 canine mammary tumours from 69 dogs. Results We found a high occurrence of copy number aberrations in canine mammary tumours, losses being more frequent than gains. Increased frequency of aberrations and loss of heterozygosity were positively correlated with increased malignancy in terms of histopathological diagnosis. One of the most highly recurrently amplified regions harbored the MYC gene. PTEN was located to a frequently lost region and also homozygously deleted in five tumours. Thus, deregulation of these genes due to copy number aberrations appears to be an important event in canine mammary tumour development. Other potential contributors to canine mammary tumour pathogenesis are COL9A3, INPP5A, CYP2E1 and RB1. The present study also shows that a more detailed analysis of chromosomal aberrations associated with histopathological parameters may aid in identifying specific genes associated with canine mammary tumour progression. Conclusions The high frequency of copy number aberrations is a prominent feature of canine mammary tumours as seen in other canine and human cancers. Our findings share several features with corresponding studies in human breast tumours and strengthen the dog as a suitable model organism for this disease.	[Borge, Kaja S.; Lingaas, Frode] Norwegian Univ Life Sci NMBU, Fac Vet Med & Biosci, Genet Sect, Dept Basic Sci & Aquat Med, Oslo, Norway; [Nord, Silje; Lingjaerde, Ole C.; Alnaes, Grethe I. G.; Kristensen, Vessela N.; Borresen-Dale, Anne-Lise] Oslo Univ Hosp, Radiumhosp, Div Canc Med Surg & Transplantat, Dept Genet,Inst Canc Res, N-0450 Oslo, Norway; [Van Loo, Peter] Wellcome Trust Sanger Inst, Cambridge, England; [Van Loo, Peter] VIB, Dept Human Genet, Human Genome Lab, Leuven, Belgium; [Van Loo, Peter] Univ Leuven, Leuven, Belgium; [Lingjaerde, Ole C.] Univ Oslo, Dept Informat, Biomed Informat, N-0316 Oslo, Norway; [Lingjaerde, Ole C.] Univ Oslo, Ctr Canc Biomed, N-0316 Oslo, Norway; [Gunnes, Gjermund] Norwegian Univ Life Sci NMBU, Fac Vet Med & Biosci, Sect Anat & Pathol, Dept Basic Sci & Aquat Med, Oslo, Norway; [Solvang, Hiroko K.] Inst Marine Res, Marine Mammals Res Grp, N-5024 Bergen, Norway; [Luders, Torben] Univ Oslo, Fac Med, Inst Clin Med, N-0316 Oslo, Norway; [Luders, Torben] Akershus Univ Hosp, Dept Clin Mol Biol, Lorenskog, Norway; [Luders, Torben] Akershus Univ Hosp, Lab Sci EpiGen, Lorenskog, Norway; [Kristensen, Vessela N.; Borresen-Dale, Anne-Lise] Univ Oslo, Fac Med, Inst Clin Med, KG Jebsen Ctr Breast Canc Res, N-0316 Oslo, Norway; [Kristensen, Vessela N.] Akershus Univ Hosp, Div Med, Dept Clin Mol Biol, Ahus, Norway	Norwegian University of Life Sciences; University of Oslo; Wellcome Trust Sanger Institute; Flanders Institute for Biotechnology (VIB); KU Leuven; University of Oslo; University of Oslo; Norwegian University of Life Sciences; Institute of Marine Research - Norway; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Borge, KS (corresponding author), Norwegian Univ Life Sci NMBU, Fac Vet Med & Biosci, Genet Sect, Dept Basic Sci & Aquat Med, Oslo, Norway.	kaja.sverdrup.borge@nmbu.no	Nord, Silje/R-5212-2016	Nord, Silje/0000-0002-3271-5356; Van Loo, Peter/0000-0003-0292-1949; Lingjaerde, Ole Christian/0000-0003-3565-4912; Luders, Torben/0000-0001-5176-7808	European Commission (LUPA) [GA-201370]; The research fund; Cancer in the dog; Astri og Birger Torsteds legat til fordel for dyrene; Legacy of Veterinary Edvard Smidt; Norwegian School of Veterinary Sciences; The Francis Crick Institute [10202] Funding Source: researchfish	European Commission (LUPA)(European CommissionEuropean Commission Joint Research Centre); The research fund; Cancer in the dog; Astri og Birger Torsteds legat til fordel for dyrene; Legacy of Veterinary Edvard Smidt; Norwegian School of Veterinary Sciences; The Francis Crick Institute	This work was (partly) funded by the European Commission (LUPA, GA-201370). The authors are grateful to "The research fund; Cancer in the dog", "Astri og Birger Torsteds legat til fordel for dyrene", the Legacy of Veterinary Edvard Smidt, and the Norwegian School of Veterinary Sciences for the financial contribution to this study. PVL is a postdoctoral researcher of the Research Foundation - Flanders (FWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agundez JAG, 2004, CURR DRUG METAB, V5, P211, DOI 10.2174/1389200043335621; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Angstadt AY, 2011, GENE CHROMOSOME CANC, V50, P859, DOI 10.1002/gcc.20908; [Anonymous], 2013, UCSC GEN BIOINF; [Anonymous], 2013, ASCAT ALL SPEC COP N; [Anonymous], 2012, ENSEMBL RELEASE 67; [Anonymous], 2013, UCSC BATCH COORD CON; [Anonymous], 2013, CATALOGUE SOMATIC MU; [Anonymous], 2013, CANC GEN CENS WORK L; Arnesen K., 2001, European Journal of Companion Animal Practice, V11, P159; Balmain A, 2003, NAT GENET, V33, P238, DOI 10.1038/ng1107; Beck J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075485; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergamaschi A, 2006, GENE CHROMOSOME CANC, V45, P1033, DOI 10.1002/gcc.20366; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; BOLDIZSAR H, 1992, ACTA VET HUNG, V40, P75; Boyko AR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000451; Breen M, 2008, CHROMOSOME RES, V16, P145, DOI 10.1007/s10577-007-1212-4; Bronden LB, 2010, VET REC, V166, P586, DOI 10.1136/vr.b4808; BRONSON RT, 1982, AM J VET RES, V43, P2057; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; CORNELISSE CJ, 1994, ANTICANCER RES, V14, P1599; Dahl Kjetil, 2002, Norsk Veterinaertidsskrift, V114, P615; Deming SL, 2000, BRIT J CANCER, V83, P1688, DOI 10.1054/bjoc.2000.1522; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Diskin SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn556; Egenvall A, 2005, PREV VET MED, V69, P109, DOI 10.1016/j.prevetmed.2005.01.014; El-Rayes BF, 2003, CLIN CANCER RES, V9, P1705; Elston C W, 2002, Histopathology, V41, P154; Fosmire SP, 2007, VET PATHOL, V44, P467, DOI 10.1354/vp.44-4-467; Gama A, 2008, VIRCHOWS ARCH, V453, P123, DOI 10.1007/s00428-008-0644-3; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Goldschmidt M, 2011, VET PATHOL, V48, P117, DOI 10.1177/0300985810393258; Hedan B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-201; HELLMEN E, 1993, VET PATHOL, V30, P20, DOI 10.1177/030098589303000103; HELLMEN E, 1988, VET PATHOL, V25, P219, DOI 10.1177/030098588802500306; Karlsson EK, 2008, NAT REV GENET, V9, P713, DOI 10.1038/nrg2382; Life Technologies, 2013, LIF TECHN PROT TRI R; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Mayr B, 1998, AM J VET RES, V59, P69; Misdorp W., 2002, TUMORS DOMESTIC ANIM; Moe L, 2001, J REP FER S, P439; Nilsen G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-591; Ostrander EA, 2000, GENOME RES, V10, P1271, DOI 10.1101/gr.155900; OWEN LN, 1979, INVEST CELL PATHOL, V2, P257; Parker HG, 2012, MAMM GENOME, V23, P19, DOI 10.1007/s00335-011-9387-6; Patterson DF, 2000, J VET INTERN MED, V14, P1, DOI 10.1892/0891-6640(2000)14[1:CAMITA]2.0.CO;2; Pena L, 2013, VET PATHOL, V50, P94, DOI 10.1177/0300985812447830; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Presneau N, 2003, CURR MOL MED, V3, P605, DOI 10.2174/1566524033479500; PRIESTER WA, 1979, J SMALL ANIM PRACT, V20, P1, DOI 10.1111/j.1748-5827.1979.tb07014.x; Queiroga FL, 2011, IN VIVO, V25, P455; R Core Team, 2021, R LANGUAGE ENV STAT; Reimann-Berg N, 2012, TIERAERZTL PRAX K H, V40, P267; Riis Margit L H, 2012, ISRN Oncol, V2012, P450267, DOI 10.5402/2012/450267; Russnes HG, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000611; RUTTEMAN GR, 1988, CANCER RES, V48, P3411; Sakoda LC, 2013, NAT GENET, V45, P345, DOI 10.1038/ng.2587; Sassi F, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-5; Sekulic A, 2010, CANCER PREV RES, V3, P1277, DOI 10.1158/1940-6207.CAPR-10-0058; Shearin AL, 2010, DIS MODEL MECH, V3, P27, DOI 10.1242/dmm.004358; Singhi AD, 2012, MODERN PATHOL, V25, P378, DOI 10.1038/modpathol.2011.171; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Thomas R, 2009, J NEURO-ONCOL, V94, P333, DOI 10.1007/s11060-009-9877-5; Vaclavikova R, 2007, ANTICANCER RES, V27, P4443; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Vaysse A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002316; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; Weigman VJ, 2012, BREAST CANCER RES TR, V133, P865, DOI 10.1007/s10549-011-1846-y; Xu Jinhua, 2010, Genes Cancer, V1, P629, DOI 10.1177/1947601910378691	75	19	21	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0126371	10.1371/journal.pone.0126371	http://dx.doi.org/10.1371/journal.pone.0126371			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955013	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000356768100114
J	Chapeaurouge, A; Abu Reza, M; Mackessy, SP; Carvalho, PC; Valente, RH; Teixeira-Ferreira, A; Perales, J; Lin, QS; Kini, RM				Chapeaurouge, Alex; Abu Reza, Md; Mackessy, Stephen P.; Carvalho, Paulo C.; Valente, Richard H.; Teixeira-Ferreira, Andre; Perales, Jonas; Lin, Qingsong; Kini, R. Manjunatha			Interrogating the Venom of the Viperid Snake Sistrurus catenatus edwardsii by a Combined Approach of Electrospray and MALDI Mass Spectrometry	PLOS ONE			English	Article							CROTALUS-ATROX; PROTEINS; RATTLESNAKE; PEPTIDE; METALLOPROTEINASES; MASSASAUGA; SEQUENCE; ENZYME; IDENTIFICATION; FAMILY	The complete sequence characterization of snake venom proteins by mass spectrometry is rather challenging due to the presence of multiple isoforms from different protein families. In the present study, we investigated the tryptic digest of the venom of the viperid snake Sistrurus catenatus edwardsii by a combined approach of liquid chromatography coupled to either electrospray (online) or MALDI (offline) mass spectrometry. These different ionization techniques proved to be complementary allowing the identification a great variety of isoforms of diverse snake venom protein families, as evidenced by the detection of the corresponding unique peptides. For example, ten out of eleven predicted isoforms of serine proteinases of the venom of S. c. edwardsii were distinguished using this approach. Moreover, snake venom protein families not encountered in a previous transcriptome study of the venom gland of this snake were identified. In essence, our results support the notion that complementary ionization techniques of mass spectrometry allow for the detection of even subtle sequence differences of snake venom proteins, which is fundamental for future structure-function relationship and possible drug design studies.	[Chapeaurouge, Alex; Carvalho, Paulo C.; Valente, Richard H.; Teixeira-Ferreira, Andre; Perales, Jonas] Fiocruz MS, Inst Oswaldo Cruz, Lab Toxinol, BR-21045900 Rio De Janeiro, RJ, Brazil; [Chapeaurouge, Alex; Abu Reza, Md; Lin, Qingsong; Kini, R. Manjunatha] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Mackessy, Stephen P.] Univ No Colorado, Sch Biol Sci, Greeley, CO 80639 USA; [Carvalho, Paulo C.] Fiocruz MS, Carlos Chagas Inst, Lab Prote & Prot Engn, BR-81350010 Curitiba, PR, Brazil; [Kini, R. Manjunatha] Virginia Commonwealth Univ, Med Coll Virginia, Dept Biochem & Mol Biol, Richmond, VA 23298 USA	Fundacao Oswaldo Cruz; National University of Singapore; University of Northern Colorado; Fundacao Oswaldo Cruz; Virginia Commonwealth University	Kini, RM (corresponding author), Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore.	dbskinim@nus.edu.sg	Abu Reza/ABE-6824-2020; Valente, Richard Hemmi/I-5300-2012; Abu Reza, M./P-6725-2019; Lin, Qingsong/H-9794-2012; Mackessy, Stephen/GPT-0793-2022	Lin, Qingsong/0000-0001-9117-8514; Valente, Richard Hemmi/0000-0002-6562-7571; Mackessy, Stephen/0000-0003-4515-2545; Kini, Manjunatha/0000-0002-6100-3251	Biomedical Research Council, Agency for Science, Technology and Research, Singapore; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Programa de Desenvolvimento Tecnologico em Insumos para Saude (PDTIS)	Biomedical Research Council, Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Programa de Desenvolvimento Tecnologico em Insumos para Saude (PDTIS)	This work was supported by Biomedical Research Council, Agency for Science, Technology and Research, Singapore and grants from Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq to J. Perales), and Programa de Desenvolvimento Tecnologico em Insumos para Saude (PDTIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barceloux DG, 2008, MED TOXICOLOGY NATUR; Beardsley RL, 2000, RAPID COMMUN MASS SP, V14, P2147, DOI 10.1002/1097-0231(20001215)14:23<2147::AID-RCM145>3.0.CO;2-M; Borges D, 2013, BIOINFORMATICS, V29, P1343, DOI 10.1093/bioinformatics/btt106; Brancia FL, 2000, RAPID COMMUN MASS SP, V14, P2070, DOI 10.1002/1097-0231(20001115)14:21<2070::AID-RCM133>3.0.CO;2-G; Calvete JJ, 2012, J PROTEOMICS, V75, P4091, DOI 10.1016/j.jprot.2012.05.026; Calvete JJ, 2009, J PROTEOME RES, V8, P3055, DOI 10.1021/pr900249q; Carabetta VJ, 2010, J AM SOC MASS SPECTR, V21, P1050, DOI 10.1016/j.jasms.2010.02.004; Carvalho PC, 2012, PROTEOMICS, V12, P944, DOI 10.1002/pmic.201100529; Chatrath ST, 2011, J PROTEOME RES, V10, P739, DOI 10.1021/pr1008916; Clemetson KJ, 2009, TOXICON, V54, P83, DOI 10.1016/j.toxicon.2009.04.001; Cominetti MR, 2003, ARCH BIOCHEM BIOPHYS, V416, P171, DOI 10.1016/S0003-9861(03)00298-4; Du XY, 2002, TOXICON, V40, P659, DOI 10.1016/S0041-0101(02)00102-2; Fox JW, 2008, FEBS J, V275, P3016, DOI 10.1111/j.1742-4658.2008.06466.x; Fox JW, 2006, TOXICON, V47, P700, DOI 10.1016/j.toxicon.2006.01.022; Fox JW, 2009, J PROTEOMICS, V72, P200, DOI 10.1016/j.jprot.2009.01.015; FOX JW, 1979, BIOCHEMISTRY-US, V18, P678, DOI 10.1021/bi00571a020; Georgieva D, 2010, J PROTEOME RES, V9, P2302, DOI 10.1021/pr901042p; Gibbs HL, 2009, TOXICON, V53, P672, DOI 10.1016/j.toxicon.2009.01.034; Gutierrez JM, 2005, TOXICON, V45, P997, DOI 10.1016/j.toxicon.2005.02.029; GUTIERREZ JM, 1984, TOXICON, V22, P719, DOI 10.1016/0041-0101(84)90155-7; Gutierrez JM, 2000, BIOCHIMIE, V82, P841, DOI 10.1016/S0300-9084(00)01163-9; Hart ML, 2008, ARTERIOSCL THROM VAS, V28, P1477, DOI 10.1161/ATVBAHA.108.169219; Hinke SA, 2000, J BIOL CHEM, V275, P3827, DOI 10.1074/jbc.275.6.3827; HIRABAYASHI J, 1991, J BIOL CHEM, V266, P2320; Hobert JP, 2004, SOUTHWEST NAT, V49, P321, DOI 10.1894/0038-4909(2004)049<0321:NHOTMS>2.0.CO;2; Holycross AT, 2002, J HERPETOL, V36, P454, DOI 10.2307/1566190; Huang KF, 2005, P NATL ACAD SCI USA, V102, P13117, DOI 10.1073/pnas.0504184102; Juarez P, 2008, MOL BIOL EVOL, V25, P2391, DOI 10.1093/molbev/msn179; Kini RM, 2006, BIOCHEM J, V397, P377, DOI 10.1042/BJ20060302; KINI RM, 1990, TOXICON, V28, P1387, DOI 10.1016/0041-0101(90)90155-Z; Lee JW, 1999, BIOCHEM BIOPH RES CO, V260, P665, DOI 10.1006/bbrc.1999.0977; LINZ W, 1995, PHARMACOL REV, V47, P25; Lu QM, 2005, TOXICON, V45, P1089, DOI 10.1016/j.toxicon.2005.02.022; LUKAS RJ, 1981, BIOCHEMISTRY-US, V20, P7373, DOI 10.1021/bi00529a008; MACKESSY SP, 1988, COPEIA, P92, DOI 10.2307/1445927; Markland FS, 1998, TOXICON, V36, P1749, DOI 10.1016/S0041-0101(98)00126-3; OmPraba G, 2010, J PROTEOME RES, V9, P1882, DOI 10.1021/pr901044x; OUYANG C, 1983, TOXICON, V21, P491, DOI 10.1016/0041-0101(83)90127-7; Pahari S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-115; Pawlak J, 2006, TOXICON, V48, P278, DOI 10.1016/j.toxicon.2006.05.013; Pawlak J, 2009, FASEB J, V23, P534, DOI 10.1096/fj.08-113555; Pirkle H, 1998, THROMB HAEMOSTASIS, V79, P675; Rokyta DR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-312; Rokyta DR, 2011, TOXICON, V57, P657, DOI 10.1016/j.toxicon.2011.01.008; Russell, 1980, SNAKE VENOM POISONIN; Sanz L, 2006, J PROTEOME RES, V5, P2098, DOI 10.1021/pr0602500; Serrano SMT, 2005, TOXICON, V45, P1115, DOI 10.1016/j.toxicon.2005.02.020; Shikamoto Y, 2005, J MOL BIOL, V350, P735, DOI 10.1016/j.jmb.2005.05.020; SING K, 1994, J WILDERNESS MED, V5, P77, DOI 10.1580/0953-9859-5.1.77; Stapels MD, 2004, ANAL CHEM, V76, P5423, DOI 10.1021/ac030427z; Syka JEP, 2004, P NATL ACAD SCI USA, V101, P9528, DOI 10.1073/pnas.0402700101; Takeda S, 2012, BBA-PROTEINS PROTEOM, V1824, P164, DOI 10.1016/j.bbapap.2011.04.009; Teixeira CDP, 2005, MEM I OSWALDO CRUZ, V100, P181, DOI 10.1590/S0074-02762005000900031; Valente RH, 2009, J PROTEOMICS, V72, P241, DOI 10.1016/j.jprot.2009.01.001; Villard E, 1996, CARDIOVASC RES, V32, P999, DOI 10.1016/S0008-6363(96)00170-8; Wagstaff SC, 2006, GENE, V377, P21, DOI 10.1016/j.gene.2006.03.008; Wagstaff' SC, 2009, J PROTEOMICS, V71, P609, DOI 10.1016/j.jprot.2008.10.003; Xu T, 2006, MOL CELL PROTEOMICS, V5, pS174; Yamazaki Y, 2005, J BIOL CHEM, V280, P29989, DOI 10.1074/jbc.C500236200; Yamazaki Y, 2004, TOXICON, V44, P227, DOI 10.1016/j.toxicon.2004.05.023; Yamazaki Y, 2003, J BIOL CHEM, V278, P51985, DOI 10.1074/jbc.C300454200; Yamazaki Y, 2003, ARCH BIOCHEM BIOPHYS, V412, P133, DOI 10.1016/S0003-9861(03)00028-6; Yamazaki Y, 2002, EUR J BIOCHEM, V269, P2708, DOI 10.1046/j.1432-1033.2002.02940.x; Yang Yong, 2007, J Biomol Tech, V18, P226	64	26	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0092091	10.1371/journal.pone.0092091	http://dx.doi.org/10.1371/journal.pone.0092091			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955844	Green Published, gold			2022-12-26	WOS:000356768100001
J	Garner, JM; Ellison, DW; Finkelstein, D; Ganguly, D; Du, ZY; Sims, M; Yang, CH; Interiano, RB; Davidoff, AM; Pfeffer, LM				Garner, Jo Meagan; Ellison, David W.; Finkelstein, David; Ganguly, Debolina; Du, Ziyun; Sims, Michelle; Yang, Chuan He; Interiano, Rodrigo B.; Davidoff, Andrew M.; Pfeffer, Lawrence M.			Molecular Heterogeneity in a Patient-Derived Glioblastoma Xenoline Is Regulated by Different Cancer Stem Cell Populations	PLOS ONE			English	Article							ANGIOPOIETIN-LIKE 4; SIGNAL TRANSDUCERS; IN-VITRO; GLIOMA; STAT3; EXPRESSION; INHIBITOR; ACTIVATION; MUTATIONS; PROGNOSIS	Malignant glioblastoma (GBM) is a highly aggressive brain tumor with a dismal prognosis and limited therapeutic options. Genomic profiling of GBM samples has identified four molecular subtypes (Proneural, Neural, Classical and Mesenchymal), which may arise from different glioblastoma stem-like cell (GSC) populations. We previously showed that adherent cultures of GSCs grown on laminin-coated plates (Ad-GSCs) and spheroid cultures of GSCs (Sp-GSCs) had high expression of stem cell markers (CD133, Sox2 and Nestin), but low expression of differentiation markers (beta III-tubulin and glial fibrillary acid protein). In the present study, we characterized GBM tumors produced by subcutaneous and intracranial injection of Ad-GSCs and Sp-GSCs isolated from a patient-derived xenoline. Although they formed tumors with identical histological features, gene expression analysis revealed that xenografts of Sp-GSCs had a Classical molecular subtype similar to that of bulk tumor cells. In contrast xenografts of Ad-GSCs expressed a Mesenchymal gene signature. Adherent GSC-derived xenografts had high STAT3 and ANGPTL4 expression, and enrichment for stem cell markers, transcriptional networks and pro-angiogenic markers characteristic of the Mesenchymal subtype. Examination of clinical samples from GBM patients showed that STAT3 expression was directly correlated with ANGPTL4 expression, and that increased expression of these genes correlated with poor patient survival and performance. A pharmacological STAT3 inhibitor abrogated STAT3 binding to the ANGPTL4 promoter and exhibited anticancer activity in vivo. Therefore, Ad-GSCs and Sp-GSCs produced histologically identical tumors with different gene expression patterns, and a STAT3/ANGPTL4 pathway is identified in glioblastoma that may serve as a target for therapeutic intervention.	[Garner, Jo Meagan; Ganguly, Debolina; Du, Ziyun; Sims, Michelle; Yang, Chuan He; Pfeffer, Lawrence M.] Univ Tennessee, Ctr Hlth Sci, Dept Pathol & Lab Med, Memphis, TN 38163 USA; [Garner, Jo Meagan; Ganguly, Debolina; Du, Ziyun; Sims, Michelle; Yang, Chuan He; Pfeffer, Lawrence M.] Univ Tennessee, Ctr Hlth Sci, Ctr Canc Res, Memphis, TN 38163 USA; [Interiano, Rodrigo B.; Davidoff, Andrew M.] Univ Tennessee, Ctr Hlth Sci, Dept Surg, Memphis, TN 38163 USA; [Ellison, David W.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Finkelstein, David] St Jude Childrens Res Hosp, Dept Computat Biol, Memphis, TN 38105 USA; [Interiano, Rodrigo B.; Davidoff, Andrew M.] St Jude Childrens Res Hosp, Dept Surg, Memphis, TN 38105 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Pfeffer, LM (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Pathol & Lab Med, Memphis, TN 38163 USA.	lpfeffer@uthsc.edu		Pfeffer, Lawrence/0000-0003-2809-1234	National Institutes of Health [CA133322]; Department of Defense [W81XWH-11-1-0533]; Cancer Center Support Grant from National Cancer Institute [21766]; Assisi Foundation of Memphis; Muirhead Chair Endowment of the UTHSC; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [R01CA133322] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Cancer Center Support Grant from National Cancer Institute; Assisi Foundation of Memphis; Muirhead Chair Endowment of the UTHSC; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from the National Institutes of Health CA133322 (L.M.P. and A.M.D.), the Department of Defense W81XWH-11-1-0533 (L.M.P.), the Cancer Center Support Grant 21766 from the National Cancer Institute and the Assisi Foundation of Memphis (A.M.D.), by the Muirhead Chair Endowment (L.M.P.) of the UTHSC and by the American Lebanese Syrian Associated Charities (D.W.E., A.M.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelzaher E, CNS TUMORS PATHOLOGY; Abou-Ghazal M, 2008, CLIN CANCER RES, V14, P8228, DOI 10.1158/1078-0432.CCR-08-1329; Bhat KPL, 2013, CANCER CELL, V24, P331, DOI 10.1016/j.ccr.2013.08.001; Bonavia R, 2011, CANCER RES, V71, P4055, DOI 10.1158/0008-5472.CAN-11-0153; Brat DJ, 2005, NEURO-ONCOLOGY, V7, P122, DOI 10.1215/S1152851704001061; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Garner JM, 2013, J BIOL CHEM, V288, P26167, DOI 10.1074/jbc.M113.477950; HIROKAWA N, 1988, J NEUROSCI, V8, P2769; Horiguchi A, 2010, BRIT J CANCER, V102, P1592, DOI 10.1038/sj.bjc.6605691; Huntly BJP, 2005, NAT REV CANCER, V5, P311, DOI 10.1038/nrc1592; Hussain SF, 2007, CANCER RES, V67, P9630, DOI 10.1158/0008-5472.CAN-07-1243; Iwamaru A, 2007, ONCOGENE, V26, P2435, DOI 10.1038/sj.onc.1210031; KAHN HJ, 1983, AM J CLIN PATHOL, V79, P341, DOI 10.1093/ajcp/79.3.341; Katanasaka Y, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-31; Kleihues P, 2000, CANCER, V88, P2887, DOI 10.1002/1097-0142(20000615)88:12<2887::AID-CNCR32>3.0.CO;2-F; Kong LY, 2008, CLIN CANCER RES, V14, P5759, DOI 10.1158/1078-0432.CCR-08-0377; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lewis-Tuffin LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013665; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5814, DOI 10.1073/pnas.0402870102; Liu WM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070804; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marie Y, 2001, LANCET, V358, P298, DOI 10.1016/S0140-6736(01)05499-X; Mlarotta LLC, 2009, CURR OPIN GENET DEV, V19, P44, DOI 10.1016/j.gde.2008.12.003; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Okamura T, 2000, INT J ONCOL, V16, P295; Okochi-Takada E, 2014, ONCOGENE, V33, P2273, DOI 10.1038/onc.2013.174; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Strieter RM, 2006, EUR J CANCER, V42, P768, DOI 10.1016/j.ejca.2006.01.006; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Surawicz TS, 1998, J NEURO-ONCOL, V40, P151, DOI 10.1023/A:1006091608586; Tan MJ, 2012, MOL CANCER RES, V10, P677, DOI 10.1158/1541-7786.MCR-11-0519; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Venkatesh HS, 2012, NEURO-ONCOLOGY, V14, P315, DOI 10.1093/neuonc/nor209; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Verine J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010421; Watanabe K, 1996, BRAIN PATHOL, V6, P217, DOI 10.1111/j.1750-3639.1996.tb00848.x; Wong ET, 1999, J CLIN ONCOL, V17, P2572, DOI 10.1200/JCO.1999.17.8.2572; Xie Q, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-77; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yang CH, 2011, J BIOL CHEM, V286, P39172, DOI 10.1074/jbc.M111.285098; Zhu PC, 2012, BIOSCIENCE REP, V32, P211, DOI 10.1042/BSR20110102; Zhu Y, 2002, SCIENCE, V296, P920, DOI 10.1126/science.1068452	50	19	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0125838	10.1371/journal.pone.0125838	http://dx.doi.org/10.1371/journal.pone.0125838			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955030	Green Published, gold, Green Submitted			2022-12-26	WOS:000356768100081
J	Lewis, CL; Foch, E; Luko, MM; Loverro, KL; Khuu, A				Lewis, Cara L.; Foch, Eric; Luko, Marc M.; Loverro, Kari L.; Khuu, Anne			Differences in Lower Extremity and Trunk Kinematics between Single Leg Squat and Step Down Tasks	PLOS ONE			English	Article							HIP-MUSCLE ACTIVATION; PATELLOFEMORAL PAIN; KNEE KINEMATICS; INTERNAL-ROTATION; PROJECTION ANGLE; PERFORMANCE; FEMALES; STRENGTH; VALGUS; PELVIS	The single leg squat and single leg step down are two commonly used functional tasks to assess movement patterns. It is unknown how kinematics compare between these tasks. The purpose of this study was to identify kinematic differences in the lower extremity, pelvis and trunk between the single leg squat and the step down. Fourteen healthy individuals participated in this research and performed the functional tasks while kinematic data were collected for the trunk, pelvis, and lower extremities using a motion capture system. For the single leg squat task, the participant was instructed to squat as low as possible. For the step down task, the participant was instructed to stand on top of a box, slowly lower him/herself until the non-stance heel touched the ground, and return to standing. This was done from two different heights (16cm and 24cm). The kinematics were evaluated at peak knee flexion as well as at 60 degrees of knee flexion. Pearson correlation coefficients (r) between the angles at those two time points were also calculated to better understand the relationship between each task. The tasks resulted in kinematics differences at the knee, hip, pelvis, and trunk at both time points. The single leg squat was performed with less hip adduction (p pound 0.003), but more hip external rotation and knee abduction (p <= 0.030), than the step down tasks at 60 Phi of knee flexion. These differences were maintained at peak knee flexion except hip external rotation was only significant in the 24cm step down task (p <= 0.029). While there were multiple differences between the two step heights at peak knee flexion, the only difference at 60 Phi of knee flexion was in trunk flexion (p < 0.001). Angles at the knee and hip had a moderate to excellent correlation (r = 0.51-0.98), but less consistently so at the pelvis and trunk (r = 0.21-0.96). The differences in movement patterns between the single leg squat and the step down should be considered when selecting a single leg task for evaluation or treatment. The high correlation of knee and hip angles between the three tasks indicates that similar information about knee and hip kinematics was gained from each of these tasks, while pelvis and trunk angles were less well predicted.	[Lewis, Cara L.; Luko, Marc M.; Loverro, Kari L.; Khuu, Anne] Boston Univ, Dept Phys Therapy & Athlet Training, Boston, MA 02215 USA; [Foch, Eric] Cent Washington Univ, Nutr Exercise & Hlth Sci, Ellensburg, WA USA	Boston University; Central Washington University	Lewis, CL (corresponding author), Boston Univ, Dept Phys Therapy & Athlet Training, Boston, MA 02215 USA.	lewisc@bu.edu		McKenzie, Kari/0000-0002-5117-169X	Peter Paul Career Development Professorship; Dudley Allen Sargent Research Fund; National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [R21 AR061690, K23 AR063235, P60 AR047785]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR061690, P60AR047785, K23AR063235] Funding Source: NIH RePORTER	Peter Paul Career Development Professorship; Dudley Allen Sargent Research Fund; National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research reported in this manuscript was supported by the Peter Paul Career Development Professorship, the Dudley Allen Sargent Research Fund, and the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Numbers R21 AR061690, K23 AR063235, and P60 AR047785. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ageberg E, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-265; Anderson G, 2003, CLIN BIOMECH, V18, P500, DOI 10.1016/S0268-0033(03)00054-8; Audenaert EA, 2012, AM J SPORT MED, V40, P1329, DOI 10.1177/0363546512441328; Beaule PE, 2009, J BONE JOINT SURG AM, V91A, P701, DOI 10.2106/JBJS.H.00802; BELL AL, 1989, HUM MOVEMENT SCI, V8, P3, DOI 10.1016/0167-9457(89)90020-1; Beutler AI, 2002, J ATHL TRAINING, V37, P13; Bittencourt NFN, 2012, J ORTHOP SPORT PHYS, V42, P996, DOI 10.2519/jospt.2012.4041; Boudreau SN, 2009, J SPORT REHABIL, V18, P91, DOI 10.1123/jsr.18.1.91; Bouillon LE, 2012, INT J SPORTS PHYS TH, V7, P595; Cappozzo A, 1997, IEEE T BIO-MED ENG, V44, P1165, DOI 10.1109/10.649988; Clohisy JC, 2009, CLIN ORTHOP RELAT R, V467, P638, DOI 10.1007/s11999-008-0680-y; Cohen J.E., 1988, STAT POWER ANAL BEHA; COLE GK, 1993, J BIOMECH ENG-T ASME, V115, P344, DOI 10.1115/1.2895496; Crossley KM, 2011, AM J SPORT MED, V39, P866, DOI 10.1177/0363546510395456; Davis IS, 2010, J ORTHOP SPORT PHYS, V40, pA1, DOI 10.2519/jospt.2010.0302; DiMattia MA, 2005, J SPORT REHABIL, V14, P108, DOI 10.1123/jsr.14.2.108; Dwyer MK, 2010, J ATHL TRAINING, V45, P181, DOI 10.4085/1062-6050-45.2.181; Earl JE, 2007, J ORTHOP SPORT PHYS, V37, P245, DOI 10.2519/jospt.2007.2202; Edmondston S, 2013, MANUAL THER, V18, P231, DOI 10.1016/j.math.2012.10.010; Graci V, 2015, J SCI MED SPORT, V18, P343, DOI 10.1016/j.jsams.2014.04.011; Graci V, 2012, GAIT POSTURE, V36, P461, DOI 10.1016/j.gaitpost.2012.04.006; Hatton AL, 2014, ARTHRIT CARE RES, V66, P709, DOI 10.1002/acr.22193; Herrington L, 2014, KNEE, V21, P514, DOI 10.1016/j.knee.2013.11.011; Hewett TE, 2005, AM J SPORT MED, V33, P492, DOI 10.1177/0363546504269591; Hollman JH, 2014, CLIN BIOMECH, V29, P468, DOI 10.1016/j.clinbiomech.2013.12.017; Hollman JH, 2009, J SPORT REHABIL, V18, P104, DOI 10.1123/jsr.18.1.104; Kivlan BR, 2012, INT J SPORTS PHYS TH, V7, P402; Kulas AS, 2012, CLIN BIOMECH, V27, P16, DOI 10.1016/j.clinbiomech.2011.07.009; Lee SP, 2012, GAIT POSTURE, V36, P425, DOI 10.1016/j.gaitpost.2012.03.024; Levinger P, 2007, PHYS THER SPORT, V8, P163, DOI 10.1016/j.ptsp.2007.03.003; Lewis CL, 2008, J BIOMECH, V41, P2082, DOI 10.1016/j.jbiomech.2008.05.013; Lewis CL, 2015, MANUAL THER, V20, P508, DOI 10.1016/j.math.2015.01.014; Loudon JK, 2002, J ATHL TRAINING, V37, P256; Marmon AR, 2013, J ORTHOP SPORT PHYS, V43, P66, DOI 10.2519/jospt.2013.4372; Mascal CL, 2003, J ORTHOP SPORT PHYS, V33, P647, DOI 10.2519/jospt.2003.33.11.647; Nakagawa TH, 2013, INT J SPORTS MED, V34, P997, DOI 10.1055/s-0033-1334966; Nakagawa TH, 2012, J ORTHOP SPORT PHYS, V42, P491, DOI 10.2519/jospt.2012.3987; Nakagawa TH, 2012, MED SCI SPORT EXER, V44, P1747, DOI 10.1249/MSS.0b013e318256903a; Nepple JJ, 2013, J AM ACAD ORTHOP SUR, V21, pS16, DOI 10.5435/JAAOS-21-07-S16; Noehren B, 2012, KNEE, V19, P380, DOI 10.1016/j.knee.2011.05.012; Noehren B, 2013, MED SCI SPORT EXER, V45, P1120, DOI 10.1249/MSS.0b013e31828249d2; Ortiz A, 2011, PM&R, V3, P365, DOI 10.1016/j.pmrj.2010.12.005; Park KM, 2013, J ORTHOP SPORT PHYS, V43, P504, DOI 10.2519/jospt.2013.4073; Portney LG, 2009, FDN CLIN RES APPL PR; Quatman CE, 2009, BRIT J SPORT MED, V43, P328, DOI 10.1136/bjsm.2009.059139; Reid GD, 2010, J RHEUMATOL, V37, P1395, DOI 10.3899/jrheum.091186; Robertson DGE, 2003, J ELECTROMYOGR KINES, V13, P569, DOI 10.1016/S1050-6411(03)00080-4; Shirey M, 2012, INT J SPORTS PHYS TH, V7, P1; Souza RB, 2009, J ORTHOP SPORT PHYS, V39, P12, DOI 10.2519/jospt.2009.2885; Souza RB, 2009, AM J SPORT MED, V37, P579, DOI 10.1177/0363546508326711; Teyhen D, 2014, CURR SPORT MED REP, V13, P52, DOI 10.1249/JSR.0000000000000023; Weeks BK, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-207; Whatman C, 2011, PHYS THER SPORT, V12, P22, DOI 10.1016/j.ptsp.2010.10.006; Willson JD, 2008, J ORTHOP SPORT PHYS, V38, P606, DOI 10.2519/jospt.2008.2706; Willson JD, 2008, CLIN BIOMECH, V23, P203, DOI 10.1016/j.clinbiomech.2007.08.025; Willson JD, 2006, MED SCI SPORT EXER, V38, P945, DOI 10.1249/01.mss.0000218140.05074.fa; Willy RW, 2012, MED SCI SPORT EXER, V44, P2165, DOI 10.1249/MSS.0b013e3182629215; Yamazaki J, 2010, KNEE SURG SPORT TR A, V18, P56, DOI 10.1007/s00167-009-0892-z; Zeller BL, 2003, AM J SPORT MED, V31, P449, DOI 10.1177/03635465030310032101	59	40	40	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0126258	10.1371/journal.pone.0126258	http://dx.doi.org/10.1371/journal.pone.0126258			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955321	Green Published, gold, Green Submitted			2022-12-26	WOS:000356768100106
J	Parker, ML; Boulanger, MJ				Parker, Michelle L.; Boulanger, Martin J.			An Extended Surface Loop on Toxoplasma gondii Apical Membrane Antigen 1 (AMA1) Governs Ligand Binding Selectivity	PLOS ONE			English	Article							CELL INVASION; ERYTHROCYTE; PARASITES; INSIGHTS; PLASTICITY; INHIBITORS; PEPTIDES; COMPLEX; ENTRY; RON2	Apicomplexan parasites are the causative agents of globally prevalent diseases including malaria and toxoplasmosis. These obligate intracellular pathogens have evolved a sophisticated host cell invasion strategy that relies on a parasite-host cell junction anchored by interactions between apical membrane antigens (AMAs) on the parasite surface and rhoptry neck 2 (RON2) proteins discharged from the parasite and embedded in the host cell membrane. Key to formation of the AMA1-RON2 complex is displacement of an extended surface loop on AMA1 called the DII loop. While conformational flexibility of the DII loop is required to expose the mature RON2 binding groove, a definitive role of this substructure has not been elucidated. To establish a role of the DII loop in Toxoplasma gondii AMA1, we engineered a form of the protein where the mobile portion of the loop was replaced with a short Gly-Ser linker (TgAMA1 Delta DIIloop). Isothermal titration calorimetry measurements with a panel of RON2 peptides revealed an influential role for the DII loop in governing selectivity. Most notably, an Eimeria tenella RON2 (EtRON2) peptide that showed only weak binding to TgAMA1 bound with high affinity to TgAMA1 Delta DIIloop. To define the molecular basis for the differential binding, we determined the crystal structure of TgAMA1 Delta DIIloop in complex with the EtRON2 peptide. When analyzed in the context of existing AMA1-RON2 structures, spatially distinct anchor points in the AMA1 groove were identified that, when engaged, appear to provide the necessary traction to outcompete the DII loop. Collectively, these data support a model where the AMA1 DII loop serves as a structural gatekeeper to selectively filter out ligands otherwise capable of binding with high affinity in the AMA1 apical groove. These data also highlight the importance of considering the functional implications of the DII loop in the ongoing development of therapeutic intervention strategies targeting the AMA1-RON2 invasion complex.	[Parker, Michelle L.; Boulanger, Martin J.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada	University of Victoria	Boulanger, MJ (corresponding author), Univ Victoria, Dept Biochem & Microbiol, POB 3055 STN CSC, Victoria, BC V8W 3P6, Canada.	mboulang@uvic.ca			 [MOP82915]		Funding provided by MOP82915, http://www.cihr-irsc.gc.ca/e/193.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; AIKAWA M, 1978, J CELL BIOL, V77, P72, DOI 10.1083/jcb.77.1.72; Alam Asrar, 2014, Malar Res Treat, V2014, P642391, DOI 10.1155/2014/642391; Bai T, 2005, P NATL ACAD SCI USA, V102, P12736, DOI 10.1073/pnas.0501808102; Bargieri D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004273; Bargieri DY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3552; Besteiro S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000309; Carruthers VB, 2007, CURR OPIN MICROBIOL, V10, P82; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Coley AM, 2007, PLOS PATHOG, V3, P1308, DOI 10.1371/journal.ppat.0030138; Collins CR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000273; Crawford J, 2010, J BIOL CHEM, V285, P15644, DOI 10.1074/jbc.M109.092619; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fraser TS, 2001, MOL BIOCHEM PARASIT, V117, P49, DOI 10.1016/S0166-6851(01)00326-7; Fritz HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029955; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Ge XP, 2014, J MED CHEM, V57, P6419, DOI 10.1021/jm500390g; Harvey KL, 2014, INT J PARASITOL, V44, P853, DOI 10.1016/j.ijpara.2014.08.001; Kato K, 2005, P NATL ACAD SCI USA, V102, P5552, DOI 10.1073/pnas.0501594102; Kortagere S, 2012, EXPERT OPIN DRUG DIS, V7, P1193, DOI 10.1517/17460441.2012.729036; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lamarque M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001276; Lamarque MH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5098; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Lim SS, 2014, BIOCHEMISTRY-US, V53, P7310, DOI 10.1021/bi5012089; Lim SS, 2013, AUST J CHEM, V66, P1530, DOI 10.1071/CH13266; MacRaild CA, 2011, CURR TOP MED CHEM, V11, P2039; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller LH, 2013, NAT MED, V19, P156, DOI 10.1038/nm.3073; Montero E, 2009, INFECT IMMUN, V77, P4783, DOI 10.1128/IAI.00969-08; Paul AS, 2015, CURR OPIN HEMATOL, V22, P220, DOI 10.1097/MOH.0000000000000135; Pizarro JC, 2005, SCIENCE, V308, P408, DOI 10.1126/science.1107449; Poukchanski A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070637; Ruff MD, 1999, VET PARASITOL, V84, P337, DOI 10.1016/S0304-4017(99)00076-X; Srinivasan P, 2014, P NATL ACAD SCI USA, V111, P10311, DOI 10.1073/pnas.1409928111; Srinivasan P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3261; Srinivasan P, 2011, P NATL ACAD SCI USA, V108, P13275, DOI 10.1073/pnas.1110303108; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Tonkin ML, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004539; Tonkin ML, 2013, PROTEIN SCI, V22, P114, DOI 10.1002/pro.2193; Tonkin ML, 2011, SCIENCE, V333, P463, DOI 10.1126/science.1204988; Tyler JS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001282; Urquiza M, 2000, VACCINE, V19, P508, DOI 10.1016/S0264-410X(00)00185-7; Valbuena J, 2006, BIOCHIMIE, V88, P1447, DOI 10.1016/j.biochi.2006.05.005; Vulliez-Le Normand B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002755; Wang GQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109674; Weiss GE, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004670; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	50	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0126206	10.1371/journal.pone.0126206	http://dx.doi.org/10.1371/journal.pone.0126206			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955165	Green Submitted, Green Published, gold			2022-12-26	WOS:000356768100104
J	Shi, Y; Yang, Y; Hoang, B; Bardeleben, C; Holmes, B; Gera, J; Lichtenstein, A				Shi, Y.; Yang, Y.; Hoang, B.; Bardeleben, C.; Holmes, B.; Gera, J.; Lichtenstein, A.			Therapeutic potential of targeting IRES-dependent c-myc translation in multiple myeloma cells during ER stress	ONCOGENE			English	Article							RIBOSOME ENTRY SITE; UNFOLDED PROTEIN RESPONSE; RAPAMYCIN; KINASE; ACTIVATION; EXPRESSION; INITIATION; INDUCE; GENE	Protein translation is inhibited by the unfolded protein response (UPR)-induced eIF-2 alpha phosphorylation to protect against endoplasmic reticulum (ER) stress. In addition, we found additional inhibition of protein translation owing to diminished mTORC1 (mammalian target of rapamycin complex1) activity in ER-stressed multiple myeloma (MM) cells. However, c-myc protein levels and myc translation was maintained. To ascertain how c-myc was maintained, we studied myc IRES (internal ribosome entry site) function, which does not require mTORC1 activity. Myc IRES activity was upregulated in MM cells during ER stress induced by thapsigargin, tunicamycin or the myeloma therapeutic bortezomib. IRES activity was dependent on upstream MAPK (mitogen-activated protein kinase) and MNK1 (MAPK-interacting serine/threonine kinase 1) signaling. A screen identified hnRNP A1 (A1) and RPS25 as IRES-binding trans-acting factors required for ER stress-activated activity. A1 associated with RPS25 during ER stress and this was prevented by an MNK inhibitor. In a proof of principle, we identified a compound that prevented binding of A1 to the myc IRES and specifically inhibited myc IRES activity in MM cells. This compound, when used alone, was not cytotoxic nor did it inhibit myc translation or protein expression. However, when combined with ER stress inducers, especially bortezomib, a remarkable synergistic cytotoxicity ensued with associated inhibition of myc translation and expression. These results underscore the potential for targeting A1-mediated myc IRES activity in MM cells during ER stress.	VA West LA Hosp Hematol Oncol, West LA VA Hosp, UCLA Greater Los Angeles VA Healthcare Ctr, Div Hematol Oncol, W111H, Los Angeles, CA USA; VA West LA Hosp Hematol Oncol, West LA VA Hosp, Jonsson Comprehens Canc Ctr, W111H, Los Angeles, CA USA	UCLA Jonsson Comprehensive Cancer Center	Lichtenstein, A (corresponding author), VA West LA Hosp Hematol Oncol, West LA VA Hosp, Div Hematol Oncol, UCLA Greater Los Angeles VA Healthcare Ctr, W111H,11301 Wilshire Blvd,Bldg 500,Room 4237, Los Angeles, CA 90073 USA.; Lichtenstein, A (corresponding author), VA West LA Hosp Hematol Oncol, West LA VA Hosp, Jonsson Comprehens Canc Ctr, W111H,11301 Wilshire Blvd,Bldg 500,Room 4237, Los Angeles, CA 90073 USA.	Alan.lichtenstein@med.va.gov		Holmes, Brent/0000-0002-2768-2991; Gera, Joseph/0000-0002-2908-6894	NIH [RO1CA168700, 2RO1CA111448, RO1CA132778, R21CA168491]; Veteran's Administration; Multiple Myeloma Research Foundation; NATIONAL CANCER INSTITUTE [R01CA168700, R01CA111448, R01CA132778, R21CA168491] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veteran's Administration(US Department of Veterans Affairs); Multiple Myeloma Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH Grants RO1CA168700, 2RO1CA111448, RO1CA132778 and R21CA168491 and research funds of the Veteran's Administration and Multiple Myeloma Research Foundation	Bergsagel PL, 2001, ONCOGENE, V20, P5611, DOI 10.1038/sj.onc.1204641; Bliskovsky V, 2003, P NATL ACAD SCI USA, V100, P14982, DOI 10.1073/pnas.2431627100; Bodescot M, 1996, GENE, V174, P115, DOI 10.1016/0378-1119(96)00464-7; Bommert KS, 2013, LEUKEMIA, V27, P441, DOI 10.1038/leu.2012.185; Buxade M, 2005, IMMUNITY, V23, P177, DOI 10.1016/j.immuni.2005.06.009; Carrasco DR, 2007, CANCER CELL, V11, P349, DOI 10.1016/j.ccr.2007.02.015; Chaidos A, 2014, BLOOD, V123, P697, DOI 10.1182/blood-2013-01-478420; Damiano F, 2013, BIOCHEM J, V449, P543, DOI 10.1042/BJ20120906; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Denys A, 2004, FEBS LETT, V564, P177, DOI 10.1016/S0014-5793(04)00361-8; Dibrov SM, 2003, P NATL ACAD SCI USA, V100, P14982; Gera JF, 2002, METHOD ENZYMOL, V350, P499, DOI 10.1016/S0076-6879(02)50981-2; Gregory MA, 2000, MOL CELL BIOL, V20, P2423, DOI 10.1128/MCB.20.7.2423-2435.2000; HANN SR, 1988, CELL, V52, P185, DOI 10.1016/0092-8674(88)90507-7; Hart LS, 2012, J CLIN INVEST, V122, P4621, DOI 10.1172/JCI62973; Hoang B, 2010, BLOOD, V116, P4560, DOI 10.1182/blood-2010-05-285726; Hu P, 2004, J BIOL CHEM, V279, P49420, DOI 10.1074/jbc.M407700200; Jan E, 2002, J MOL BIOL, V324, P889, DOI 10.1016/S0022-2836(02)01099-9; Kuehl WM, 2012, BLOOD, V120, P2351, DOI 10.1182/blood-2012-08-445262; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Liang SH, 2006, BIOCHEM J, V393, P201, DOI 10.1042/BJ20050374; Lin JY, 2008, J GEN VIROL, V89, P2540, DOI 10.1099/vir.0.2008/003673-0; Liu LD, 2012, NATURE, V483, P608, DOI 10.1038/nature10927; Martin J, 2008, J BIOL CHEM, V283, P23274; Nakamura RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048194; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Paulin FEM, 1996, ONCOGENE, V13, P505; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Shi Y, 2013, ONCOGENE, V32, P190, DOI 10.1038/onc.2012.43; Shi YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094011; Shi YJ, 2008, CANCER RES, V68, P10215, DOI 10.1158/0008-5472.CAN-08-1066; Shi YJ, 2005, J BIOL CHEM, V280, P10964, DOI 10.1074/jbc.M407874200; Subkhankulova T, 2001, BIOCHEM J, V359, P183, DOI 10.1042/0264-6021:3590183; Suzuki A, 2005, ONCOGENE, V24, P6936, DOI 10.1038/sj.onc.1208844	35	51	52	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 25	2016	35	8					1015	1024		10.1038/onc.2015.156	http://dx.doi.org/10.1038/onc.2015.156			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DE7NF	25961916	Green Accepted			2022-12-26	WOS:000370823300007
J	Buras, ED; Yang, LN; Saha, P; Kim, J; Mehta, P; Yang, YS; Hilsenbeck, S; Kojima, H; Chen, WH; Smith, CW; Chan, L				Buras, Eric Dale; Yang, Lina; Saha, Pradip; Kim, Jongoh; Mehta, Pooja; Yang, Yisheng; Hilsenbeck, Susan; Kojima, Hideto; Chen, Wenhao; Smith, C. Wayne; Chan, Lawrence			Proinsulin-producing, hyperglycemia-induced adipose tissue macrophages underlie insulin resistance in high fat-fed diabetic mice	FASEB JOURNAL			English	Article						inflammation; obesity; diabetes; glucose	NECROSIS-FACTOR-ALPHA; TNF-ALPHA; ADIPOCYTE DEATH; OBESITY; CELLS; EXPRESSION; INFLAMMATION; INFILTRATION; DYSFUNCTION; SENSITIVITY	Adipose tissue macrophages (ATMs) play an important role in the pathogenesis of obese type 2 diabetes. High-fat diet (HFD)-induced obesity has been shown to lead to ATM accumulation in rodents; however, the impact of hyperglycemia on ATMdynamics in HFD-fed type 2 diabetic models has not been studied. We previously showed that hyperglycemia induces the appearance of proinsulin (PI)-producing proinflammatory bone marrow (BM)-derived cells (PI-BMDCs) in rodents. We fed a 60% HFD to C57BL6/J mice to produce an obese type 2 diabetes model. Absent in chow-fed animals, PI-BMDCs account for 60% of the ATMs in the type 2 diabetic mice. The PI-ATM subset expresses TNF-alpha and other inflammatory markers, and is highly enriched within crownlike structures (CLSs). We found that amelioration of hyperglycemia by different hypoglycemic agents forestalled PI-producing ATM accumulation and adipose inflammation in these animals. We developed a diphtheria toxin receptor-based strategy to selectively ablate PI-BMDCs among ATMs. Application of the maneuver in HFD-fed type 2 diabetic mice was found to lead to near total disappearance of complex CLSs and reversal of insulin resistance and hepatosteatosis in these animals. In sum, we have identified a novel ATM subset in type 2 diabetic rodents that underlies systemic insulin resistance.-Buras, E. D., Yang, L., Saha, P., Kim, J., Mehta, P., Yang, Y., Hilsenbeck, S., Kojima, H., Chen, W., Smith, C. W., Chan, L. Proinsulin-producing, hyperglycemia-induced adipose tissue macrophages underlie insulin resistance in high fat-fed diabetic mice.	[Buras, Eric Dale; Yang, Lina; Saha, Pradip; Kim, Jongoh; Yang, Yisheng; Hilsenbeck, Susan; Kojima, Hideto; Chen, Wenhao; Chan, Lawrence] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Buras, Eric Dale; Yang, Lina; Saha, Pradip; Kim, Jongoh; Yang, Yisheng; Hilsenbeck, Susan; Kojima, Hideto; Chen, Wenhao; Chan, Lawrence] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Mehta, Pooja; Smith, C. Wayne] USDA, Childrens Nutr Res Ctr, Houston, TX USA; [Kojima, Hideto] Shiga Univ Med Sci, Dept Stem Cell Biol & Regenerat Med, Otsu, Shiga 52021, Japan	Baylor College of Medicine; Baylor College of Medicine; United States Department of Agriculture (USDA); Shiga University of Medical Science	Chan, L (corresponding author), Baylor Coll Med, Diabet Res Ctr, R614,One Baylor Plaza, Houston, TX 77030 USA.	lchan@bcm.edu	Chen, Wenhao/J-6553-2019	Chen, Wenhao/0000-0002-0626-3739	U.S. National Institutes of Health (NIH) [National Heart, Lung and Blood Institute (NHLBI)] [R01-HL51586]; Diabetes Research Center [P30-DK079638]; Core Laboratories at Baylor College of Medicine; Betty Rutherford Chair in Diabetes Research at Baylor St. Luke's Medical Center (Houston, TX, USA); Frank and Cindy Liu Family Foundation; Cunningham (Chris, Casey and Jennifer) Family Foundation; T.T. & W.F. Chao Global Foundation; American Diabetes Association [1-14-MN-01]; NIH NHLBI training Grant [T32-HL66991]; Medical Scientist Training Program at Baylor College of Medicine; U.S. National Institutes of Health (NIH) (National Institute of Diabetes and Digestive and Kidney Diseases) [DK105527]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL066991, R01HL051586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338, P30DK079638] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) [National Heart, Lung and Blood Institute (NHLBI)](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Diabetes Research Center; Core Laboratories at Baylor College of Medicine; Betty Rutherford Chair in Diabetes Research at Baylor St. Luke's Medical Center (Houston, TX, USA); Frank and Cindy Liu Family Foundation; Cunningham (Chris, Casey and Jennifer) Family Foundation; T.T. & W.F. Chao Global Foundation; American Diabetes Association(American Diabetes Association); NIH NHLBI training Grant; Medical Scientist Training Program at Baylor College of Medicine; U.S. National Institutes of Health (NIH) (National Institute of Diabetes and Digestive and Kidney Diseases); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors acknowledge Vishal Kaila and Shinasuki Kusui for help with experiments, Vijay Yechoor for advice on experiments and provision of MIP-GFP mice, and Herbert Virgin for provision of iDTR mice. In addition, the authors thank Dr. Benny Hung-Junn Chang and Dr. Christina Camell for advice on experiments, and Sand Yu-Chih Ku and Leslie Wu for administrative help. This work was supported by the U.S. National Institutes of Health (NIH) Grants R01-HL51586 [National Heart, Lung and Blood Institute (NHLBI)] and DK105527 (National Institute of Diabetes and Digestive and Kidney Diseases) to L.C., the Diabetes Research Center (P30-DK079638) and its Core Laboratories at Baylor College of Medicine, the Betty Rutherford Chair in Diabetes Research at Baylor St. Luke's Medical Center (Houston, TX, USA), the Frank and Cindy Liu Family Foundation, the Cunningham (Chris, Casey and Jennifer) Family Foundation, the T.T. & W.F. Chao Global Foundation, and the American Diabetes Association (Grant 1-14-MN-01) to L.C. J.K. was supported by a NIH NHLBI training Grant T32-HL66991, and E.B. was supported by the Medical Scientist Training Program at Baylor College of Medicine. The authors declare no competing financial interests.	Aljada A, 2006, METABOLISM, V55, P1177, DOI 10.1016/j.metabol.2006.04.016; Apovian CM, 2008, ARTERIOSCL THROM VAS, V28, P1654, DOI 10.1161/ATVBAHA.108.170316; Brake DK, 2006, AM J PHYSIOL-CELL PH, V291, pC1232, DOI 10.1152/ajpcell.00008.2006; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Cancello R, 2006, DIABETES, V55, P1554, DOI 10.2337/db06-0133; Chang WT, 2012, FOOD CHEM, V134, P972, DOI 10.1016/j.foodchem.2012.03.002; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Dandona P, 2009, J AM COLL CARDIOL, V53, pS14, DOI 10.1016/j.jacc.2008.10.038; Dasu MR, 2011, AM J PHYSIOL-ENDOC M, V300, pE145, DOI 10.1152/ajpendo.00490.2010; De Taeye BM, 2007, AM J PHYSIOL-ENDOC M, V293, pE713, DOI 10.1152/ajpendo.00194.2007; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Ehrenkranz JRL, 2005, DIABETES-METAB RES, V21, P31, DOI 10.1002/dmrr.532; Ferrannini E, 2014, J CLIN INVEST, V124, P499, DOI 10.1172/JCI72227; Fujimiya M, 2007, P NATL ACAD SCI USA, V104, P4030, DOI 10.1073/pnas.0700220104; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; GARVEY WT, 1985, DIABETES, V34, P222, DOI 10.2337/diabetes.34.3.222; Gerner RR, 2013, CAN J PHYSIOL PHARM, V91, P867, DOI 10.1139/cjpp-2013-0050; Gonzalez F, 2006, J ENDOCRINOL, V188, P521, DOI 10.1677/joe.1.06579; Hara M, 2003, AM J PHYSIOL-ENDOC M, V284, pE177, DOI 10.1152/ajpendo.00321.2002; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Katagi M, 2014, FEBS LETT, V588, P1080, DOI 10.1016/j.febslet.2014.02.030; Kojima H, 2004, P NATL ACAD SCI USA, V101, P2458, DOI 10.1073/pnas.0308690100; Kojima H, 2014, TRENDS ENDOCRIN MET, V25, P178, DOI 10.1016/j.tem.2014.01.002; Kratz M, 2014, CELL METAB, V20, P614, DOI 10.1016/j.cmet.2014.08.010; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Merovci A, 2014, J CLIN INVEST, V124, P509, DOI 10.1172/JCI70704; Nagareddy PR, 2013, CELL METAB, V17, P695, DOI 10.1016/j.cmet.2013.04.001; Odegaard JI, 2013, CELL METAB, V18, P767, DOI 10.1016/j.cmet.2013.11.011; Parathath S, 2011, DIABETES, V60, P1759, DOI 10.2337/db10-0778; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Pavlov VA, 2012, NAT REV ENDOCRINOL, V8, P743, DOI 10.1038/nrendo.2012.189; ROSSETTI L, 1987, J CLIN INVEST, V79, P1510, DOI 10.1172/JCI112981; Saberi M, 2009, CELL METAB, V10, P419, DOI 10.1016/j.cmet.2009.09.006; Saha PK, 2010, J BIOL CHEM, V285, P40581, DOI 10.1074/jbc.M110.176545; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Terashima T, 2005, P NATL ACAD SCI USA, V102, P12525, DOI 10.1073/pnas.0505717102; Terashima T, 2012, FASEB J, V26, P295, DOI 10.1096/fj.11-186262; Urabe H, 2015, DIABETOLOGIA, V58, P402, DOI 10.1007/s00125-014-3440-4; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Westcott DJ, 2009, J EXP MED, V206, P3143, DOI 10.1084/jem.20091333; Xu HY, 2002, DIABETES, V51, P1876, DOI 10.2337/diabetes.51.6.1876; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xu XY, 2013, CELL METAB, V18, P816, DOI 10.1016/j.cmet.2013.11.001; Yong J, 2011, DIABETES, V60, P1383, DOI 10.2337/db10-0907; Yoon J, 2011, DIABETOLOGIA, V54, P1252, DOI 10.1007/s00125-011-2055-2; Zhang HH, 2001, J CLIN ENDOCR METAB, V86, P2817, DOI 10.1210/jc.86.6.2817	48	11	12	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3537	3548		10.1096/fj.15-271452	http://dx.doi.org/10.1096/fj.15-271452			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	25953849	Green Published			2022-12-26	WOS:000358796900039
J	Guo, YJ; Yang, L; Haught, K; Scarlata, S				Guo, Yuanjian; Yang, Lu; Haught, Katrina; Scarlata, Suzanne			Osmotic Stress Reduces Ca2+ Signals through Deformation of Caveolae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; G-ALPHA(Q); RECEPTOR	Caveolae are membrane invaginations that can sequester various signaling proteins. Caveolae have been shown to provide mechanical strength to cells by flattening to accommodate increased volume when cells are subjected to hypo-osmotic stress. We have previously found that caveolin, the main structural component of caveolae, specifically binds G alpha(q) and stabilizes its activation state resulting in an enhanced Ca2+ signal upon activation. Here, we show that osmotic stress caused by decreasing the osmolarity in half reversibly changes the configuration of caveolae without releasing a significant portion of caveolin molecules. This change in configuration due to flattening leads to a loss in Cav1-G alpha(q) association. This loss in G alpha(q)/Cav1 association due to osmotic stress results in a significant reduction of G alpha(q)/phospholipase C alpha(q)-mediated Ca2+ signals. This reduced Ca2+ response is also seen when caveolae are reduced by treatment with siRNA(Cav1) or by dissolving them by methyl-beta-cyclodextran. No change in Ca2+ release with osmotic swelling can be seen when growth factor pathways are activated. Taken together, these results connect the mechanical deformation of caveolae to G alpha(q)-mediated Ca2+ signals.	[Guo, Yuanjian; Yang, Lu; Haught, Katrina; Scarlata, Suzanne] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Scarlata, S (corresponding author), SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA.	Suzanne.Scarlata@stonybrook.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [GM053132]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072853, R01GM116178, R01GM053132] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM053132. The authors declare that they have no conflicts of interest with the contents of this article.	Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Calizo RC, 2013, ANAL BIOCHEM, V440, P40, DOI 10.1016/j.ab.2013.04.033; Calizo RC, 2012, BIOCHEMISTRY-US, V51, P9513, DOI 10.1021/bi301107p; D'Alessandro M, 2002, J CELL SCI, V115, P4341, DOI 10.1242/jcs.00120; Dowal L, 2006, J BIOL CHEM, V281, P23999, DOI 10.1074/jbc.M512330200; Exton JH, 1996, ANNU REV PHARMACOL, V36, P481, DOI 10.1146/annurev.pa.36.040196.002405; Galbiati F, 2001, TRENDS MOL MED, V7, P435, DOI 10.1016/S1471-4914(01)02105-0; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guo YJ, 2005, J BIOL CHEM, V280, P1438, DOI 10.1074/jbc.M407593200; Guo YJ, 2011, BIOPHYS J, V100, P1599, DOI 10.1016/j.bpj.2011.02.013; Harvey RD, 2012, J MOL CELL CARDIOL, V52, P366, DOI 10.1016/j.yjmcc.2011.07.007; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Marx J, 2001, SCIENCE, V294, P1862, DOI 10.1126/science.294.5548.1862; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x; Radel C, 2005, AM J PHYSIOL-HEART C, V288, pH936, DOI 10.1152/ajpheart.00519.2004; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; ROTHBERG KG, 1990, J CELL BIOL, V111, P2931, DOI 10.1083/jcb.111.6.2931; Schwencke C, 2006, CARDIOVASC RES, V70, P42, DOI 10.1016/j.cardiores.2005.11.029; Sengupta P, 2008, J CELL SCI, V121, P1363, DOI 10.1242/jcs.020081; Shvets E, 2014, CURR OPIN CELL BIOL, V29, P99, DOI 10.1016/j.ceb.2014.04.011; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Stary CM, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00393; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Taggart MJ, 2001, NEWS PHYSIOL SCI, V16, P61; Thomsen P, 2002, MOL BIOL CELL, V13, P238, DOI 10.1091/mbc.01-06-0317; Tjondrokoesoemo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025740; Woodman SE, 2002, J BIOL CHEM, V277, P38988, DOI 10.1074/jbc.M205511200	30	13	13	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2015	290	27					16698	16707		10.1074/jbc.M115.655126	http://dx.doi.org/10.1074/jbc.M115.655126			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CM3HN	25957403	Green Published, hybrid			2022-12-26	WOS:000357572800019
J	Goitea, VE; Hallak, ME				Goitea, Victor E.; Hallak, Marta E.			Calreticulin and Arginylated Calreticulin Have Different Susceptibilities to Proteasomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						post-translational modification (PTM); proteasome; protein degradation; protein turnover; ubiquitylation (ubiquitination); arginylation; calreticulin; dimer	RNA-PROTEIN TRANSFERASE; POSTTRANSLATIONAL ARGINYLATION; HEAT-SHOCK; STRESS GRANULES; FORMS; ARGINYLTRANSFERASE; DIMERIZATION; INDUCTION; COMPONENT; CALCIUM	Background: Calreticulin (CRT) retrotranslocated from the endoplasmic reticulum to the cytoplasm is post-translationally arginylated. Results: Arginylated CRT (R-CRT) has a longer half-life than non-arginylated CRT and displays different ubiquitin dependence. Conclusion: CRT and R-CRT differ in their susceptibility to proteasomal degradation. Significance: Arginylation is not required for proteasomal degradation of CRT, although R-CRT displays ubiquitin modification. Post-translational arginylation has been suggested to target proteins for proteasomal degradation. The degradation mechanism for arginylated calreticulin (R-CRT) localized in the cytoplasm is unknown. To evaluate the effect of arginylation on CRT stability, we examined the metabolic fates and degradation mechanisms of cytoplasmic CRT and R-CRT in NIH 3T3 and CHO cells. Both CRT isoforms were found to be proteasomal substrates, but the half-life of R-CRT (2 h) was longer than that of cytoplasmic CRT (0.7 h). Arginylation was not required for proteasomal degradation of CRT, although R-CRT displays ubiquitin modification. A CRT mutant incapable of dimerization showed reduced metabolic stability of R-CRT, indicating that R-CRT dimerization may protect it from proteasomal degradation. Our findings, taken together, demonstrate a novel function of arginylation: increasing the half-life of CRT in cytoplasm.	[Hallak, Marta E.] Univ Nacl Cordoba, Ctr Invest Quim Biol Cordoba CIQUIBIC, Consejo Nacl Invest Cient & Tecn, Fac Ciencias Quim, RA-5000 Cordoba, Argentina; Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; National University of Cordoba	Hallak, ME (corresponding author), Univ Nacl Cordoba, Ctr Invest Quim Biol Cordoba CIQUIBIC, Consejo Nacl Invest Cient & Tecn, Fac Ciencias Quim, X5000HUA, RA-5000 Cordoba, Argentina.	mhallak@fcq.unc.edu.ar		Goitea, Victor/0000-0002-1564-4111	Agencia Nacional de Promocion Cientifica y Technologica [PICT 2012-1979]; Consejo Nacional de Investigaciones Cientificas y Tecnicas; La Secretaria de Ciencia y Tecnologia, Universidad Nacional de Cordoba	Agencia Nacional de Promocion Cientifica y Technologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); La Secretaria de Ciencia y Tecnologia, Universidad Nacional de Cordoba	This work was supported by grants from the Agencia Nacional de Promocion Cientifica y Technologica (PICT 2012-1979), Consejo Nacional de Investigaciones Cientificas y Tecnicas, and La Secretaria de Ciencia y Tecnologia, Universidad Nacional de Cordoba. The authors declare that they have no conflicts of interest with the contents of this article.	Afshar N, 2005, MOL CELL BIOL, V25, P8844, DOI 10.1128/MCB.25.20.8844-8853.2005; Alvarez-Castelao B, 2009, J BIOL CHEM, V284, P28253, DOI 10.1074/jbc.M109.004101; Bogyo M, 2002, CURR TOP MICROBIOL, V268, P185; Bush KT, 1997, J BIOL CHEM, V272, P9086; Carpio MA, 2013, INT J BIOCHEM CELL B, V45, P1223, DOI 10.1016/j.biocel.2013.03.017; Carpio MA, 2010, BIOCHEM J, V429, P63, DOI 10.1042/BJ20091953; CIECHANOVER A, 1988, J BIOL CHEM, V263, P11155; Castaneda-Patlan MC, 2010, INT J BIOCHEM CELL B, V42, P120, DOI 10.1016/j.biocel.2009.09.019; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Decca MB, 2007, J BIOL CHEM, V282, P8237, DOI 10.1074/jbc.M608559200; Decca MB, 2006, NEUROCHEM RES, V31, P401, DOI 10.1007/s11064-005-9037-z; Erales J, 2014, BBA-MOL CELL RES, V1843, P216, DOI 10.1016/j.bbamcr.2013.05.008; Gold LI, 2010, FASEB J, V24, P665, DOI 10.1096/fj.09-145482; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Guo N, 2013, ASIA-PAC J CLIN ONCO, V9, P6, DOI 10.1111/j.1743-7563.2012.01535.x; Hallak ME, 1997, NEUROCHEM RES, V22, P467, DOI 10.1023/A:1027315912242; Hamalainen-Laanaya HK, 2012, ANAL BIOCHEM, V429, P32, DOI 10.1016/j.ab.2012.07.006; Hattori T, 2003, ONCOGENE, V22, P1273, DOI 10.1038/sj.onc.1206204; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hu RG, 2006, J BIOL CHEM, V281, P32559, DOI 10.1074/jbc.M604355200; Jariel-Encontre I, 2008, BBA-REV CANCER, V1786, P153, DOI 10.1016/j.bbcan.2008.05.004; Jorgensen CS, 2003, EUR J BIOCHEM, V270, P4140, DOI 10.1046/j.1432-1033.2003.03808.x; Karakozova M, 2006, SCIENCE, V313, P192, DOI 10.1126/science.1129344; Kwon YT, 1999, MOL CELL BIOL, V19, P182; Kwon YT, 2002, SCIENCE, V297, P96, DOI 10.1126/science.1069531; Labriola CA, 2011, MOL BIOCHEM PARASIT, V175, P112, DOI 10.1016/j.molbiopara.2010.10.002; Labriola CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013141; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Sambrooks CL, 2012, J BIOL CHEM, V287, P22043, DOI 10.1074/jbc.M111.338335; Menendez-Benito V, 2005, HUM MOL GENET, V14, P2787, DOI 10.1093/hmg/ddi312; Nguyen TQ, 1996, MOL IMMUNOL, V33, P379, DOI 10.1016/0161-5890(95)00149-2; Petris G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023712; Raghavan M, 2013, TRENDS IMMUNOL, V34, P13, DOI 10.1016/j.it.2012.08.002; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Rechsteiner M, 2005, TRENDS CELL BIOL, V15, P27, DOI 10.1016/j.tcb.2004.11.003; Rizvi SM, 2004, MOL CELL, V15, P913, DOI 10.1016/j.molcel.2004.09.001; Saha S, 2011, DEV BIOL, V358, P1, DOI 10.1016/j.ydbio.2011.06.043; Sriram SM, 2011, NAT REV MOL CELL BIO, V12, P735, DOI 10.1038/nrm3217; Tanahashi N, 2000, J BIOL CHEM, V275, P14336, DOI 10.1074/jbc.275.19.14336; Tasaki T, 2012, ANNU REV BIOCHEM, V81, P261, DOI 10.1146/annurev-biochem-051710-093308; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023; Wang JL, 2011, CHEM BIOL, V18, P121, DOI 10.1016/j.chembiol.2010.10.016; Wang WA, 2012, INT J BIOCHEM CELL B, V44, P842, DOI 10.1016/j.biocel.2012.02.009; Wong CCL, 2007, PLOS BIOL, V5, P2231, DOI 10.1371/journal.pbio.0050258; Xiao GQ, 1999, J NEUROSCI RES, V58, P652, DOI 10.1002/(SICI)1097-4547(19991201)58:5<652::AID-JNR6>3.0.CO;2-H; Zhang FL, 2012, J CELL BIOL, V197, P819, DOI 10.1083/jcb.201112129	47	13	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2015	290	26					16403	16414		10.1074/jbc.M114.626127	http://dx.doi.org/10.1074/jbc.M114.626127			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CL4NR	25969538	hybrid, Green Published			2022-12-26	WOS:000356930100041
J	Jalaeikhoo, H; Khajeh-Mehrizi, A				Jalaeikhoo, Hasan; Khajeh-Mehrizi, Ahmad			Immunosuppressive Therapy in Patients with Aplastic Anemia: A Single-Center Retrospective Study	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; ANTITHYMOCYTE GLOBULIN; MARROW-TRANSPLANTATION; CYCLOSPORINE-A; EPIDEMIOLOGY; MULTICENTER	Background Aplastic anemia (AA) is a rare disease in which hematopoietic stem cells are severely diminished resulting in hypocellular bone marrow and pancytopenia. Etiology of AA includes auto immunity, toxins, infection, ionizing radiation, drugs and rare genetic disorders, but in the majority of cases no cause can be identified. In the present study we assessed response rate, survival, relapse and clonal evolution in patients with AA treated with immunosuppressive therapy. Methods Patients with AA who received immunosuppressive therapy between May 1998 and September 2013 were included in this study. Patients with non-severe AA (NSAA) were treated with cyclosporine (CsA) and danazol while patients with severe AA (SAA) as well as patients with NSAA who progressed to SAA after beginning of the treatment, were candidates for receiving antithymocyte globulin in addition to CsA and danazol. Results Among the 63 studied patients, 29 (46%) had NSAA and 34 (54%) had SAA. Three months after treatment, overall response was 58.6% in NSAA and 12.9% in patients with SAA. Survival of all patients at 5, 10 and 15 years were 73%, 55% and 49%, respectively. Survival rates were significantly higher in patients with NSAA compared to patients with SAA as well as in patients who responded at 6 months compared to non-responders. The relapse risk was 39.7% at 10 years. Relapse occurred in patients who discontinued the therapy more than those who continued taking CsA (p value<0.01). The risk of clonal evolution was 9.9% at 10 years and 22.8% at 15 years after treatment. Conclusion This long-term retrospective study indicated that immunosuppressive therapy should be recommended to patients with AA. Also, our experience indicated that immunosuppressive therapy should not be discontinued after response to therapy in patients with both NSAA and SAA due to high risk of relapse. Low dose of CsA should be continued indefinitely.	[Jalaeikhoo, Hasan; Khajeh-Mehrizi, Ahmad] AJA Univ Med Sci, AJA Canc Res Ctr ACRC, Tehran, Iran		Khajeh-Mehrizi, A (corresponding author), Imam Reza Hosp, AJA Canc Res Ctr ACRC, Shahid Etemadzadeh St,West Fatemi Ave, Tehran, Iran.	khmehrizi.a@gmail.com	Khajeh-Mehrizi, Ahmad/AGV-1725-2022	Khajeh-Mehrizi, Ahmad/0000-0002-4607-7842				Bacigalupo A, 2000, BLOOD, V95, P1931, DOI 10.1182/blood.V95.6.1931; BACIGALUPO A, 1988, BRIT J HAEMATOL, V70, P177, DOI 10.1111/j.1365-2141.1988.tb02460.x; CAMITTA BM, 1976, BLOOD, V48, P63; Frickhofen N, 2003, BLOOD, V101, P1236, DOI 10.1182/blood-2002-04-1134; GLUCKMAN E, 1992, BLOOD, V79, P2540; Issaragrisil S, 2006, BLOOD, V107, P1299, DOI 10.1182/blood-2005-01-0161; Kojima S, 2000, BLOOD, V96, P2049; Li YM, 2011, ANN HEMATOL, V90, P529, DOI 10.1007/s00277-010-1140-9; Locasciulli A, 2007, HAEMATOL-HEMATOL J, V92, P11, DOI 10.3324/haematol.10075; Lu J, 2004, BLOOD, V103, P4588, DOI 10.1182/blood-2003-11-3959; Montane E, 2008, HAEMATOLOGICA, V93, P518, DOI 10.3324/haematol.12020; Morgan GJ, 2005, CHEM-BIOL INTERACT, V153, P217, DOI 10.1016/j.cbi.2005.03.025; Rosenfeld S, 2003, JAMA-J AM MED ASSOC, V289, P1130, DOI 10.1001/jama.289.9.1130; Scheinberg P, 2006, BRIT J HAEMATOL, V133, P606, DOI 10.1111/j.1365-2141.2006.06085.x; Scheinberg P, 2012, BLOOD, V120, P1185, DOI 10.1182/blood-2011-12-274019; Scheinberg P, 2009, HAEMATOL-HEMATOL J, V94, P348, DOI 10.3324/haematol.13829; Socie G, 2007, BLOOD, V109, P2794, DOI 10.1182/blood-2006-07-034272; Teramura M, 2007, BLOOD, V110, P1756, DOI 10.1182/blood-2006-11-050526; Wang W, 2011, J INT MED RES, V39, P1994, DOI 10.1177/147323001103900546; Yong A S, 1998, Med J Malaysia, V53, P59; Young NS, 2006, BLOOD, V108, P2509, DOI 10.1182/blood-2006-03-010777	21	10	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0126925	10.1371/journal.pone.0126925	http://dx.doi.org/10.1371/journal.pone.0126925			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970182	Green Published, Green Submitted, gold			2022-12-26	WOS:000354544200139
J	Packer, RMA; Hendricks, A; Burn, CC				Packer, Rowena M. A.; Hendricks, Anke; Burn, Charlotte C.			Impact of Facial Conformation on Canine Health: Corneal Ulceration	PLOS ONE			English	Article							KERATOCONJUNCTIVITIS SICCA; DOG; DISORDERS; CANTHOPLASTY; WELFARE	Concern has arisen in recent years that selection for extreme facial morphology in the domestic dog may be leading to an increased frequency of eye disorders. Corneal ulcers are a common and painful eye problem in domestic dogs that can lead to scarring and/or perforation of the cornea, potentially causing blindness. Exaggerated juvenile-like craniofacial conformations and wide eyes have been suspected as risk factors for corneal ulceration. This study aimed to quantify the relationship between corneal ulceration risk and conformational factors including relative eyelid aperture width, brachycephalic (short-muzzled) skull shape, the presence of a nasal fold (wrinkle), and exposed eye-white. A 14 month cross-sectional study of dogs entering a large UK based small animal referral hospital for both corneal ulcers and unrelated disorders was carried out. Dogs were classed as affected if they were diagnosed with a corneal ulcer using fluorescein dye while at the hospital (whether referred for this disorder or not), or if a previous diagnosis of corneal ulcer(s) was documented in the dogs' histories. Of 700 dogs recruited, measured and clinically examined, 31 were affected by corneal ulcers. Most cases were male (71%), small breed dogs (mean +/- SE weight: 11.4 +/- 1.1 kg), with the most commonly diagnosed breed being the Pug. Dogs with nasal folds were nearly five times more likely to be affected by corneal ulcers than those without, and brachycephalic dogs (craniofacial ratio < 0.5) were twenty times more likely to be affected than non-brachycephalic dogs. A 10% increase in relative eyelid aperture width more than tripled the ulcer risk. Exposed eye-white was associated with a nearly three times increased risk. The results demonstrate that artificially selecting for these facial characteristics greatly heightens the risk of corneal ulcers, and such selection should thus be discouraged to improve canine welfare.	[Packer, Rowena M. A.; Hendricks, Anke] Univ London, Royal Vet Coll, Dept Clin Sci & Serv, Brookmans Pk AL9 7TA, Herts, England; [Burn, Charlotte C.] Univ London, Royal Vet Coll, Dept Prod & Populat Hlth, Brookmans Pk AL9 7TA, Herts, England	University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College	Packer, RMA (corresponding author), Univ London, Royal Vet Coll, Dept Clin Sci & Serv, Brookmans Pk AL9 7TA, Herts, England.	rpacker@rvc.ac.uk		Packer, Rowena/0000-0002-9988-9828; Burn, Charlotte/0000-0002-8734-8610	UFAW; BBSRC/RVC	UFAW; BBSRC/RVC	This study was funded by UFAW (www.ufaw.org.uk) while the primary author was supported by a joint BBSRC/RVC doctoral studentship (www.bbsrc.ac.uk; www.rvc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Kennel Club, 2014, FRENCH BULLD BREED S; American Kennel Club, 2014, PUG BREED STAND; Asher L, 2009, VET J, V182, P402, DOI 10.1016/j.tvjl.2009.08.033; BARNETT KC, 2002, CANINE OPHTHALMOLOGY; Barrett P. M., 1991, Progress in Veterinary and Comparative Ophthalmology, V1, P245; Bateson P., 2010, INDEPENDENT INQUIRY; Bedford P, 2001, ABNORMAL APPEARNACE; Bedford PGC, 1998, J SMALL ANIM PRACT, V39, P117, DOI 10.1111/j.1748-5827.1998.tb03614.x; Bjerkas E, 2009, VISUAL IMPAIRMENT; CARRINGTON SD, 1989, VET REC, V124, P323, DOI 10.1136/vr.124.13.323; Crispin S, 2002, CORNEA; Gelatt KN., 1994, HDB SMALL ANIMAL OPH, V1, P165; Gilger BC, 2007, DIS SURG CANINE COME, P690; KASWAN RL, 1990, VET CLIN N AM-SMALL, V20, P583, DOI 10.1016/S0195-5616(90)50052-2; Kim JY, 2009, INT J APPL RES VET M, V7, P27; LAWSON DD, 1973, J SMALL ANIM PRACT, V14, P469, DOI 10.1111/j.1748-5827.1973.tb06486.x; Maggs D., 2008, SLATTERS FUNDAMENTAL; Marfurt CF, 2001, INVEST OPHTH VIS SCI, V42, P2242; Martin C L, 1973, Vet Clin North Am, V3, P367; McGreevy P, 2004, BRAIN BEHAV EVOLUT, V63, P13, DOI 10.1159/000073756; McGreevy PD, 1999, ANIM WELFARE, V8, P329; Nicholas FW, 2010, VET J, V183, P8, DOI 10.1016/j.tvjl.2009.11.008; Niles J, 2009, SPECIAL CONSIDERATIO, V2nd; Packer R, 2014, C REPORT BUILDING BE, P1; Packer RMA, 2012, ANIM WELFARE, V21, P81, DOI 10.7120/096272812X13345905673809; Purina, 2012, ASS YOUR DOGS BOD CO; RENWICK P, 1996, IN PRACTICE, V18, P315; Roongtanakiat N., 2009, TECH B, P1; Sanchez RF, 2007, J SMALL ANIM PRACT, V48, P211, DOI 10.1111/j.1748-5827.2006.00185.x; Slatter D, 2001, EYELIDS; Stades F. C., 1992, Progress in Veterinary & Comparative Ophthalmology, V2, P155; Stades FC., 2007, OPHTHALMOLOGY VET PR, V2nd ed; STARTUP FG, 1984, J SMALL ANIM PRACT, V25, P737, DOI 10.1111/j.1748-5827.1984.tb00444.x; Sutter NB, 2008, MAMM GENOME, V19, P713, DOI 10.1007/s00335-008-9153-6; The Kennel Club, 2009, JAP CHIN BREED STAND; The Kennel Club, 2010, BULLD BREED STAND; The Kennel Club, 2012, BREED WATCH PEK; The Kennel Club, 2009, BOST TERR BREED STAN; The Kennel Club, 2008, PEK BREED STAND; The Kennel Club, 2009, KING CHARL SPAN BREE; The Kennel Club, 2012, BREED WATCH BULLD; The Kennel Club, 2007, CAV KING CHARL SPAN; The Kennel Club, 2009, SHIH TZU BREED STAND; The Kennel Club, 2012, PUG BREED STAND; The Kennel Club, 2009, GRIFF BRUX BREED STA; The Kennel Club, 2011, CEL HANDB DOG REG SO; The Kennel Club, 2012, BREED WATCH PUG; WHITLEY RD, 1995, VET MED-US, V90, P574; Yi NY, 2006, J AM ANIM HOSP ASSOC, V42, P435, DOI 10.5326/0420435	49	39	39	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0123827	10.1371/journal.pone.0123827	http://dx.doi.org/10.1371/journal.pone.0123827			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25969983	Green Published, Green Submitted, gold			2022-12-26	WOS:000354544200018
J	Seto, E; Yoshida-Sugitani, R; Kobayashi, T; Toyama-Sorimachi, N				Seto, Eri; Yoshida-Sugitani, Reiko; Kobayashi, Toshihiko; Toyama-Sorimachi, Noriko			The Assembly of EDC4 and Dcp1a into Processing Bodies Is Critical for the Translational Regulation of IL-6	PLOS ONE			English	Article							EUKARYOTIC MESSENGER-RNAS; STRESS GRANULES; MACROPHAGE POLARIZATION; BINDING PROTEINS; ACTIVATION; EXPRESSION; MICRORNAS; INFLAMMATION; STABILITY; COMPONENT	Macrophages play critical roles in the onset of various diseases and in maintaining homeostasis. There are several functional subsets, of which M1 and M2 macrophages are of particular interest because they are differentially involved in inflammation and its resolution. Here, we investigated the differences in regulatory mechanisms between M1- and M2-polarized macrophages by examining mRNA metabolic machineries such as stress granules (SGs) and processing bodies (P-bodies). Human monocytic leukemia THP-1 cells cultured under M1-polarizing conditions (M1-THPs) had less ability to assemble oxidative-stress-induced SGs than those cultured under M2-polarizing conditions (M2-THPs). In contrast, P-body assembly in response to oxidative stress or TLR4 stimulation was increased in M1-THPs as compared to M2-THPs. These results suggest that mRNA metabolism is controlled differently in M1-THPs and M2-THPs. Interestingly, knocking down EDC4 or Dcp1a, which are components of P-bodies, severely reduced the production of IL-6, but not TNF-alpha in M1-THPs without decreasing the amount of IL-6 mRNA. This is the first report to demonstrate that the assembly of EDC4 and Dcp1a into P-bodies is critical in the post-transcriptional regulation of IL-6. Thus, improving our understanding of the mechanisms governing mRNA metabolism by examining macrophage subtypes may lead to new therapeutic targets.	[Seto, Eri; Yoshida-Sugitani, Reiko; Kobayashi, Toshihiko; Toyama-Sorimachi, Noriko] Natl Ctr Global Hlth & Med, Res Inst, Dept Mol Immunol & Inflammat, Tokyo, Japan; [Seto, Eri] Gunma Univ, Grad Sch Med, Dept Virol & Prevent Med, Gunma, Japan	National Center for Global Health & Medicine - Japan; Gunma University	Toyama-Sorimachi, N (corresponding author), Natl Ctr Global Hlth & Med, Res Inst, Dept Mol Immunol & Inflammat, Tokyo, Japan.	nsorima@ri.ncgm.go.jp			Funding Program for Next Generation World-Leading Researchers (Next Program) [LS134]; Ministry of Education, Science, Sports and Culture of Japan [21390123, 24790395]; National Center for Global Health and Medicine [23S001]; Grants-in-Aid for Scientific Research [25871165, 15H05897] Funding Source: KAKEN	Funding Program for Next Generation World-Leading Researchers (Next Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Funding Program for Next Generation World-Leading Researchers (Next Program) (for NT-S, LS134), grants-in-aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan (for NT-S, 21390123, for ES, 24790395), and a grant from the National Center for Global Health and Medicine (for NT-S, 23S001).	Aggarwal NR, 2014, AM J PHYSIOL-LUNG C, V306, pL709, DOI 10.1152/ajplung.00341.2013; Aizer A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049783; Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Arribere JA, 2011, MOL CELL, V44, P745, DOI 10.1016/j.molcel.2011.09.019; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bhaumik D, 2008, ONCOGENE, V27, P5643, DOI 10.1038/onc.2008.171; Boldin MP, 2012, IMMUNOL REV, V246, P205, DOI 10.1111/j.1600-065X.2011.01089.x; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Cassol E, 2006, J LEUKOCYTE BIOL, V80, P1018, DOI 10.1189/jlb.0306150; Chang CT, 2014, NUCLEIC ACIDS RES, V42, P5217, DOI 10.1093/nar/gku129; Chang WL, 2009, NUCLEIC ACIDS RES, V37, P6600, DOI 10.1093/nar/gkp717; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Donath MY, 2013, CELL METAB, V17, P860, DOI 10.1016/j.cmet.2013.05.001; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Franks TM, 2008, MOL CELL, V32, P605, DOI 10.1016/j.molcel.2008.11.001; Freytes DO, 2012, CELLS TISSUES ORGANS, V195, P171, DOI 10.1159/000331392; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Graff JW, 2012, J BIOL CHEM, V287, P21816, DOI 10.1074/jbc.M111.327031; Hardison SE, 2010, AM J PATHOL, V176, P774, DOI 10.2353/ajpath.2010.090634; Hoyle NP, 2007, J CELL BIOL, V179, P65, DOI 10.1083/jcb.200707010; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Ivashkiv LB, 2013, TRENDS IMMUNOL, V34, P216, DOI 10.1016/j.it.2012.11.001; Iwasaki H, 2011, NAT IMMUNOL, V12, P1167, DOI 10.1038/ni.2137; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha N, 2013, TRENDS BIOCHEM SCI, V38, P494, DOI 10.1016/j.tibs.2013.07.004; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Locati M, 2013, ADV IMMUNOL, V120, P163, DOI 10.1016/B978-0-12-417028-5.00006-5; Ma F, 2010, J IMMUNOL, V184, P6053, DOI 10.4049/jimmunol.0902308; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Masuda K, 2013, P NATL ACAD SCI USA, V110, P9409, DOI 10.1073/pnas.1307419110; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Palanisamy V, 2012, J DENT RES, V91, P651, DOI 10.1177/0022034512437372; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Schulte LN, 2013, NUCLEIC ACIDS RES, V41, P542, DOI 10.1093/nar/gks1030; Schulte LN, 2011, EMBO J, V30, P1977, DOI 10.1038/emboj.2011.94; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Squadrito ML, 2013, TRENDS IMMUNOL, V34, P350, DOI 10.1016/j.it.2013.02.003; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Van Dyken SJ, 2013, ANNU REV IMMUNOL, V31, P317, DOI 10.1146/annurev-immunol-032712-095906; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Xu Z, 2011, J BIOL CHEM, V286, P21401, DOI 10.1074/jbc.M110.198630; Yiakouvaki A, 2012, J CLIN INVEST, V122, P48, DOI 10.1172/JCI45021; Yu JH, 2005, RNA, V11, P1795, DOI 10.1261/rna.2142405	52	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2015	10	5							e0123223	10.1371/journal.pone.0123223	http://dx.doi.org/10.1371/journal.pone.0123223			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZP	25970328	Green Submitted, gold, Green Published			2022-12-26	WOS:000354544200011
J	Chu, PS; Ebinuma, H; Nakamoto, N; Sugiyama, K; Usui, S; Wakayama, Y; Taniki, N; Yamaguchi, A; Shiba, S; Yamagishi, Y; Wakita, T; Hibi, T; Saito, H; Kanai, T				Chu, Po-sung; Ebinuma, Hirotoshi; Nakamoto, Nobuhiro; Sugiyama, Kazuo; Usui, Shingo; Wakayama, Yuko; Taniki, Nobuhito; Yamaguchi, Akihiro; Shiba, Shunsuke; Yamagishi, Yoshiyuki; Wakita, Takaji; Hibi, Toshifumi; Saito, Hidetsugu; Kanai, Takanori			Genotype-Associated Differential NKG2D Expression on CD56+CD3+Lymphocytes Predicts Response to Pegylated-Interferon/Ribavirin Therapy in Chronic Hepatitis C	PLOS ONE			English	Article							RIBAVIRIN COMBINATION THERAPY; NATURAL T-CELLS; VIRUS-INFECTION; IN-VITRO; HUMAN LIVER; GENETIC-VARIATION; VIRAL CLEARANCE; PLUS RIBAVIRIN; CORE PROTEIN; NS5A REGION	Hepatitis C virus (HCV) genotype 1 infections are significantly more difficult to eradicate with PEG-IFN/ribavirin therapy, compared to HCV genotype 2. The aim of this work is to investigate the difference of immunological impairments underlying this phenomenon. Pretreatment NKG2D expression on peripheral CD56+CD3+ lymphocytes and CD56+CD3-NK cells from cases of chronic hepatitis C were analyzed and assessed by treatment effect. Two strains of HCV were used to co-incubate with immune cells in vitro. NKG2D expression on peripheral CD56+CD3+ lymphocytes, but not NK cells, was significantly impaired in genotype 1 infection, compared to genotype 2. When peripheral blood mononuclear cells from healthy donors were co-incubated with TNS2J1, a genotype 1b/2a chimera strain, or with JFH1, a genotype 2a strain, genotype-specific decrease of NKG2D on CD56+CD3+ lymphocytes, but not NK cells, was observed. Pre-treatment NKG2D expression on peripheral CD56+CD3+ lymphocytes significantly correlated with reduction in serum HCV RNA levels from week 0 to week 4, and predicted treatment response. Ex vivo stimulation of peripheral CD56+CD3+ lymphocytes showed NKG2D expression-correlated IFN-gamma production. In conclusion, Decreased NKG2D expression on CD56+CD3+ lymphocytes in chronic HCV genotype 1 infection predicts inferior treatment response to PEG-IFN/ribavirin therapy compared to genotype 2.	[Chu, Po-sung; Ebinuma, Hirotoshi; Nakamoto, Nobuhiro; Sugiyama, Kazuo; Usui, Shingo; Wakayama, Yuko; Taniki, Nobuhito; Yamaguchi, Akihiro; Shiba, Shunsuke; Yamagishi, Yoshiyuki; Saito, Hidetsugu; Kanai, Takanori] Keio Univ, Sch Med, Div Internal Med, Dept Gastroenterol & Hepatol, Tokyo, Japan; [Wakita, Takaji] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan; [Hibi, Toshifumi] Kitasato Univ, Kitasato Inst Hosp, Ctr Adv IBD Res & Treatment, Tokyo, Japan; [Saito, Hidetsugu] Keio Univ, Sch Pharm, Div Pharmacotherapeut, Tokyo, Japan	Keio University; National Institute of Infectious Diseases (NIID); Kitasato University; Keio University	Ebinuma, H (corresponding author), Keio Univ, Sch Med, Div Internal Med, Dept Gastroenterol & Hepatol, Tokyo, Japan.	ebinuma@a5.keio.jp	Taniki, Nobuhito/ABT-6589-2022	Taniki, Nobuhito/0000-0003-3627-5412; Chu, Po-sung/0000-0002-8687-2760; Kanai, Takanori/0000-0002-1466-4532	Japan Ministry of Education, Culture, Sports, Science and Technology; Keio Gijuku Academic Development Funds; Grants-in-Aid for Scientific Research [15K09021] Funding Source: KAKEN	Japan Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Keio Gijuku Academic Development Funds; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by grants in-aid for Scientific Research from the Japan Ministry of Education, Culture, Sports, Science and Technology and Keio Gijuku Academic Development Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2004, J LEUKOCYTE BIOL, V76, P743, DOI 10.1189/jlb.0304197; Akuta N, 2005, INTERVIROLOGY, V48, P372, DOI 10.1159/000086064; Akuta N, 2007, J MED VIROL, V79, P1686, DOI 10.1002/jmv.20979; Alter G, 2011, J HEPATOL, V55, P278, DOI 10.1016/j.jhep.2010.11.030; Bowen DG, 2005, J EXP MED, V201, P1709, DOI 10.1084/jem.20050808; Champsaur M, 2010, IMMUNOL REV, V235, P267, DOI 10.1111/j.0105-2896.2010.00893.x; Chayama K, 2011, J GASTROEN HEPATOL, V26, P83, DOI 10.1111/j.1440-1746.2010.06550.x; Doherty DG, 2000, IMMUNOL REV, V174, P5, DOI 10.1034/j.1600-0528.2002.017416.x; Doherty DG, 1999, J IMMUNOL, V163, P2314; Ebinuma H, 2008, J VIROL, V82, P5043, DOI 10.1128/JVI.01548-07; ENOMOTO N, 1995, J CLIN INVEST, V96, P224, DOI 10.1172/JCI118025; Exley MA, 2002, J IMMUNOL, V168, P1519, DOI 10.4049/jimmunol.168.4.1519; Fernandez-Sanchez A, 2013, EPIGENETICS-US, V8, P66, DOI 10.4161/epi.23115; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Godfrey DI, 2007, NAT REV IMMUNOL, V7, P505, DOI 10.1038/nri2116; Golden-Mason L, 2007, J VIROL, V81, P9292, DOI 10.1128/JVI.00834-07; Gumperz JE, 2002, J EXP MED, V195, P625, DOI 10.1084/jem.20011786; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Jouvin-Marche E, 2014, J INFECT DIS, V209, P1907, DOI 10.1093/infdis/jiu016; Karadimitris A, 2001, P NATL ACAD SCI USA, V98, P3294, DOI 10.1073/pnas.051604498; Kelly-Rogers J, 2006, HUM IMMUNOL, V67, P863, DOI 10.1016/j.humimm.2006.08.292; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Kumada H, 2010, HEPATOL RES, V40, P8, DOI 10.1111/j.1872-034X.2009.00634.x; Kurosaki M, 1997, HEPATOLOGY, V25, P750, DOI 10.1002/hep.510250343; Kuylenstierna C, 2011, EUR J IMMUNOL, V41, P1913, DOI 10.1002/eji.200940278; Lin H, 2006, J LEUKOCYTE BIOL, V80, P164, DOI 10.1189/jlb.0705421; Lopez-Rodriguez R, 2013, GENES IMMUN, V14, P317, DOI 10.1038/gene.2013.24; McMahon CW, 2001, CURR OPIN IMMUNOL, V13, P465, DOI 10.1016/S0952-7915(00)00242-9; Nakamoto N, 2008, GASTROENTEROLOGY, V134, P1927, DOI 10.1053/j.gastro.2008.02.033; Norris S, 1999, HUM IMMUNOL, V60, P20, DOI 10.1016/S0198-8859(98)00098-6; Quan H, 2014, ONCOGENE, V33, P2826, DOI 10.1038/onc.2013.225; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Rosen HR, 2013, J CLIN INVEST, V123, P4121, DOI 10.1172/JCI67714; Rosen HR, 2011, NEW ENGL J MED, V364, P2429, DOI 10.1056/NEJMcp1006613; Sato A, 2013, J CELL BIOCHEM, V114, P1987, DOI 10.1002/jcb.24541; Seino K, 2005, J EXP MED, V202, P1623, DOI 10.1084/jem.20051600; Sene D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001184; SIMMONDS P, 1994, J GEN VIROL, V75, P1053, DOI 10.1099/0022-1317-75-5-1053; Sugiyama K, 2009, J VIROL, V83, P6922, DOI 10.1128/JVI.02674-08; Szabo G, 2007, HEPATOLOGY, V46, P1279, DOI 10.1002/hep.21938; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; Toyoda H, 2014, EPIDEMIOL INFECT, V142, P2624, DOI 10.1017/S0950268814000478; Tseng CTK, 2002, J EXP MED, V195, P43, DOI 10.1084/jem.20011145; TSUKIYAMAKOHARA K, 1991, VIRUS GENES, V5, P243, DOI 10.1007/BF00568974; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Werner JM, 2013, HEPATOLOGY, V58, P1621, DOI 10.1002/hep.26353; Yamagiwa S, 2009, MED MOL MORPHOL, V42, P1, DOI 10.1007/s00795-008-0434-7; Ye L, 2009, HEPATOLOGY, V49, P753, DOI 10.1002/hep.22715; Yoon JC, 2009, HEPATOLOGY, V49, P12, DOI 10.1002/hep.22624	52	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0125664	10.1371/journal.pone.0125664	http://dx.doi.org/10.1371/journal.pone.0125664			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965701	Green Published, gold, Green Submitted			2022-12-26	WOS:000354543500023
J	Schildknecht, K; Olek, S; Dickhaus, T				Schildknecht, Konstantin; Olek, Sven; Dickhaus, Thorsten			Simultaneous Statistical Inference for Epigenetic Data	PLOS ONE			English	Article							DIFFERENTIALLY METHYLATED LOCI; BEHRENS-FISHER PROBLEM; DNA METHYLATION; GENOME; CANCER; CELLS	Epigenetic research leads to complex data structures. Since parametric model assumptions for the distribution of epigenetic data are hard to verify we introduce in the present work a nonparametric statistical framework for two-group comparisons. Furthermore, epigenetic analyses are often performed at various genetic loci simultaneously. Hence, in order to be able to draw valid conclusions for specific loci, an appropriate multiple testing correction is necessary. Finally, with technologies available for the simultaneous assessment of many interrelated biological parameters (such as gene arrays), statistical approaches also need to deal with a possibly unknown dependency structure in the data. Our statistical approach to the nonparametric comparison of two samples with independent multivariate observables is based on recently developed multivariate multiple permutation tests. We adapt their theory in order to cope with families of hypotheses regarding relative effects. Our results indicate that the multivariate multiple permutation test keeps the pre-assigned type I error level for the global null hypothesis. In combination with the closure principle, the family-wise error rate for the simultaneous test of the corresponding locus/parameter-specific null hypotheses can be controlled. In applications we demonstrate that group differences in epigenetic data can be detected reliably with our methodology.	[Schildknecht, Konstantin] Weierstrass Inst Appl Anal & Stochast, Berlin, Germany; [Olek, Sven] Epiontis GmbH, Ivana Turbachova Lab Epigenet, Berlin, Germany; [Dickhaus, Thorsten] Univ Bremen, Inst Stat, D-28359 Bremen, Germany	Weierstrass Institute for Applied Analysis & Stochastics; Epiontis GmbH; Leibniz Institute for Prevention Research & Epidemiology (BIPS); University of Bremen	Dickhaus, T (corresponding author), Univ Bremen, Inst Stat, D-28359 Bremen, Germany.	dickhaus@uni-bremen.de	Dickhaus, Thorsten/O-9120-2019	Dickhaus, Thorsten/0000-0003-3084-3036	Epiontis GmbH	Epiontis GmbH	The funder Epiontis GmbH provided support in the form of salaries for author SO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the "author contributions" section.	Baron U, 2006, EPIGENETICS-US, V1, P55, DOI 10.4161/epi.1.1.2643; Brunner E, 2002, J STAT PLAN INFER, V108, P37, DOI 10.1016/S0378-3758(02)00269-0; Brunner E., 2013, NICHTPARAMETRISCHE D, V2, P147; Chen ZX, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-142; Chen ZX, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-S1-S9; Chen ZX, 2012, BIOINFORMATICS, V28, P1109, DOI 10.1093/bioinformatics/bts093; Chung EY, 2011, TECHNICAL REPORT; Chung EY, 2013, TECHNICAL REPORT; Dickhaus T, 2014, SIMULTANEOUS STATIST; Dickhaus T, 2012, STAT APPL GENET MOL, V11; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Finner H, 2010, STAT PROBABIL LETT, V80, P1875, DOI 10.1016/j.spl.2010.08.014; Houseman EA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-365; Huang HW, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-86; Jaffe AE, 2012, BIOSTATISTICS, V13, P166, DOI 10.1093/biostatistics/kxr013; Jelizarow M, 2014, JOURNAL OF THE ROYAL; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; MARCUS R, 1976, BIOMETRIKA, V63, P655, DOI 10.1093/biomet/63.3.655; NATSUKA S, 1994, J BIOL CHEM, V269, P16789; Neubert K, 2007, COMPUT STAT DATA AN, V51, P5192, DOI 10.1016/j.csda.2006.05.024; Pauly M, 2014, JOURNAL OF THE ROYAL; Pauly M, 2014, TECHNICAL REPORT; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Romano JR, 2005, J AM STAT ASSOC, V100, P94, DOI 10.1198/016214504000000539; Ruymgaart F, 1980, LECT NOTES MATH, V821, P1; Sehouli J, 2011, EPIGENETICS-US, V6, P236, DOI 10.4161/epi.6.2.13755; Siegmund KD, 2002, METHODS, V27, P170, DOI 10.1016/S1046-2023(02)00071-3; Sugiura N, 1965, OSAKA J MATH, V2, P385; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Teschendorff AE, 2010, GENOME RES, V20, P440, DOI 10.1101/gr.103606.109; Turbachova I, 2013, EPIGENETICS-US, V8, P1226, DOI 10.4161/epi.26334; Wieczorek G, 2009, CANCER RES, V69, P599, DOI 10.1158/0008-5472.CAN-08-2361	32	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2015	10	5							e0125587	10.1371/journal.pone.0125587	http://dx.doi.org/10.1371/journal.pone.0125587			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1ZI	25965389	Green Submitted, gold, Green Published			2022-12-26	WOS:000354543500020
J	Cooper, AJM; Simmons, RK; Kuh, D; Brage, S; Cooper, R				Cooper, Andrew J. M.; Simmons, Rebecca K.; Kuh, Diana; Brage, Soren; Cooper, Rachel		NSHD Sci & Data Collection Team	Physical Activity, Sedentary Time and Physical Capability in Early Old Age: British Birth Cohort Study	PLOS ONE			English	Article							LOWER-EXTREMITY FUNCTION; HEART-RATE; GRIP STRENGTH; MUSCLE STRENGTH; GAIT SPEED; PERFORMANCE; ACCELEROMETRY; DISABILITY; MORTALITY; EXERCISE	Purpose To investigate the associations of time spent sedentary, in moderate-to-vigorous-intensity physical activity (MVPA) and physical activity energy expenditure (PAEE) with physical capability measures at age 60-64 years. Methods Time spent sedentary and in MVPA and, PAEE were assessed using individually calibrated combined heart rate and movement sensing among 1727 participants from the MRC National Survey of Health and Development in England, Scotland and Wales as part of a detailed clinical assessment undertaken in 2006-2010. Multivariable linear regression models were used to examine the cross-sectional associations between standardised measures of each of these behavioural variables with grip strength, chair rise and timed up-&-go (TUG) speed and standing balance time. Results Greater time spent in MVPA was associated with higher levels of physical capability; adjusted mean differences in each capability measure per 1standard deviation increase in MVPA time were: grip strength (0.477 kg, 95% confidence interval (CI): 0.015 to 0.939), chair rise speed (0.429 stands/min, 95% CI: 0.093 to 0.764), standing balance time (0.028 s, 95% CI: 0.003 to 0.053) and TUG speed (0.019 m/s, 95% CI: 0.011 to 0.026). In contrast, time spent sedentary was associated with lower grip strength (-0.540 kg, 95% CI: -1.013 to -0.066) and TUG speed (-0.011 m/s, 95% CI: -0.019 to -0.004). Associations for PAEE were similar to those for MVPA. Conclusion Higher levels of MVPA and overall physical activity (PAEE) are associated with greater levels of physical capability whereas time spent sedentary is associated with lower levels of capability. Future intervention studies in older adults should focus on both the promotion of physical activity and reduction in time spent sedentary.	[Cooper, Andrew J. M.; Simmons, Rebecca K.; Brage, Soren] Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, MRC Epidemiol Unit, Cambridge CB2 0QQ, England; [Kuh, Diana; Cooper, Rachel] MRC Unit Lifelong Hlth & Ageing UCL, London WC1B 5JU, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; University College London	Cooper, AJM (corresponding author), Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, MRC Epidemiol Unit, Box 285,Hills Rd, Cambridge CB2 0QQ, England.	andrew.cooper@mrc-epid.cam.ac.uk	Ghosh, Arjun/ABC-9543-2020; Wong, Andrew/M-8899-2016; Cooper, Rachel/ABE-3768-2021; Kuh, Diana/L-6019-2014; Wong, Andrew/AAE-6995-2019; Osika, Walter/AAH-7966-2020; Hughes, Alun David/N-3781-2013; Brage, Soren/C-6415-2013	Ghosh, Arjun/0000-0003-4992-2412; Wong, Andrew/0000-0003-2079-4779; Cooper, Rachel/0000-0003-3370-5720; Kuh, Diana/0000-0001-7386-2857; Wong, Andrew/0000-0003-2079-4779; Osika, Walter/0000-0002-1583-7319; Hughes, Alun David/0000-0001-5432-5271; Brage, Soren/0000-0002-1265-7355; Deanfield, John/0000-0001-8806-6052; Bruce, Ian/0000-0003-3047-500X; Richards, Marcus/0000-0001-9191-2192; Simmons, Rebecca/0000-0002-7726-8529; Steeds, Richard/0000-0001-5687-2535; Masi, Stefano/0000-0002-7591-3686; Chowienczyk, Phil/0000-0003-4507-038X; Cooper, Andrew/0000-0003-1025-0268; Westgate, Kate/0000-0002-0283-3562	UK Medical Research Council [U120063239, U123092720, MC_UU_12019/1, MC_UU_12019/4, MC_UU_12015/3, MC_UU_12015/4]; MRC [MC_U106179474, MC_UU_12015/4, MR/K025147/1, MC_UU_12015/3, MC_UU_12019/1, MC_U106179473, MC_UU_12019/4] Funding Source: UKRI; Medical Research Council [MC_U106179474, MC_UU_12019/1, MR/K025147/1, MC_UU_12015/4, MC_UU_12019/4, MC_U106179473, MC_UU_12015/3] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the UK Medical Research Council (U120063239, U123092720, MC_UU_12019/1, MC_UU_12019/4, MC_UU_12015/3, and MC_UU_12015/4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; Bassey EJ, 1998, AGE AGEING, V27, P12, DOI 10.1093/ageing/27.suppl_3.12; Brage S, 2005, EUR J CLIN NUTR, V59, P561, DOI 10.1038/sj.ejcn.1602118; Brage S, 2004, J APPL PHYSIOL, V96, P343, DOI 10.1152/japplphysiol.00703.2003; Brage S, 2007, J APPL PHYSIOL, V103, P682, DOI 10.1152/japplphysiol.00092.2006; Chief Medical Officers Of England Scotland Wales ANI, START ACT STAY ACT R; Cooper R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2219; Cooper R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4467; Cooper R, 2011, AM J PREV MED, V41, P376, DOI 10.1016/j.amepre.2011.06.035; Cress ME, 1999, J GERONTOL A-BIOL, V54, pM242, DOI 10.1093/gerona/54.5.M242; Davis MG, 2013, J AGING PHYS ACTIV, V1, P1; Dodds R, 2013, AGE AGEING, V42, P794, DOI 10.1093/ageing/aft124; Espana-Romero V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087085; Gennuso KP, 2013, MED SCI SPORT EXER, V45, P1493, DOI 10.1249/MSS.0b013e318288a1e5; Golubic R, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-58; Guralnik JM, 2000, J GERONTOL A-BIOL, V55, pM221, DOI 10.1093/gerona/55.4.M221; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Hamer M, 2013, PLOS ONE, V8; Henry CJK, 2005, PUBLIC HEALTH NUTR, V8, P1133, DOI 10.1079/PHN2005801; Hillsdon MM, 2005, AM J PREV MED, V28, P245, DOI 10.1016/j.amepre.2004.12.008; Howse K, 2007, HLTH SOCIAL CARE OLD; JANN B, NLCHECK STATA MODULE; Keevil VL, 2015, MED SCI SPORT EXER, V47, P735, DOI 10.1249/MSS.0000000000000453; Kuh D, 2005, J GERONTOL A-BIOL, V60, P224, DOI 10.1093/gerona/60.2.224; Kuh D, 2006, J GERONTOL A-BIOL, V61, P702, DOI 10.1093/gerona/61.7.702; Kuh Diana, 2011, Int J Epidemiol, V40, pe1, DOI 10.1093/ije/dyq231; Lang IA, 2007, J AM GERIATR SOC, V55, P1836, DOI 10.1111/j.1532-5415.2007.01426.x; Martin HJ, 2008, AGE AGEING, V37, P589, DOI 10.1093/ageing/afn148; Munro J, 1997, J PUBLIC HEALTH MED, V19, P397, DOI 10.1093/oxfordjournals.pubmed.a024667; NHS Information Centre for Health and Social Care, 2009, HLTH SURV ENGL 2008; Office for National Statistics, 2010 BAS NAT POP PRO; Pahor M, 2006, J GERONTOL A-BIOL, V61, P1157; Patel KV, 2006, AM J PREV MED, V31, P217, DOI 10.1016/j.amepre.2006.05.005; Paterson DH, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-38; Roux L, 2008, AM J PREV MED, V35, P578, DOI 10.1016/j.amepre.2008.06.040; Santos DA, 2012, EXP GERONTOL, V47, P908, DOI 10.1016/j.exger.2012.07.011; Seguin R, 2012, J AGING RES, V2012, DOI [10.1155/2012/271589, DOI 10.1155/2012/271589]; Stafford M, 2013, EUR J AGEING, V10, P145, DOI 10.1007/s10433-013-0258-8; Stegle O, 2008, IEEE T BIO-MED ENG, V55, P2143, DOI 10.1109/TBME.2008.923118; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Visser M, 2002, J AM GERIATR SOC, V50, P1774, DOI 10.1046/j.1532-5415.2002.50504.x; Wijndaele K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020058; Wijndaele K, 2011, INT J EPIDEMIOL, V40, P150, DOI 10.1093/ije/dyq105; World Health Organization, GLOB HLTH AGING2011	44	38	38	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126465	10.1371/journal.pone.0126465	http://dx.doi.org/10.1371/journal.pone.0126465			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI1YY	25961736	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000354542500103
J	de Jonge, A; Mesman, JAJM; Mannien, J; Zwart, JJ; Buitendijk, SE; van Roosmalen, J; van Dillen, J				de Jonge, Ank; Mesman, Jeanette A. J. M.; Mannien, Judith; Zwart, Joost J.; Buitendijk, Simone E.; van Roosmalen, Jos; van Dillen, Jeroen			Severe Adverse Maternal Outcomes among Women in Midwife-Led versus Obstetrician-Led Care at the Onset of Labour in the Netherlands: A Nationwide Cohort Study	PLOS ONE			English	Article							PLANNED HOSPITAL BIRTHS; LOW-RISK WOMEN; PERINATAL-MORTALITY; HOME BIRTHS; MORBIDITY; PREGNANCY; DELIVERY	Objective To test the hypothesis that it is possible to select a group of low risk women who can start labour in midwife-led care without having increased rates of severe adverse maternal outcomes compared to women who start labour in secondary care. Design and Methods We conducted a nationwide cohort study in the Netherlands, using data from 223 739 women with a singleton pregnancy between 37 and 42 weeks gestation without a previous caesarean section, with spontaneous onset of labour and a child in cephalic presentation. Information on all cases of severe acute maternal morbidity collected by the national study into ethnic determinants of maternal morbidity in the Netherlands (LEMMoN study), 1 August 2004 to 1 August 2006, was merged with data from the Netherlands Perinatal Registry of all births occurring during the same period. Our primary outcome was severe acute maternal morbidity (SAMM, i.e. admission to an intensive care unit, uterine rupture, eclampsia or severe HELLP, major obstetric haemorrhage, and other serious events). Secondary outcomes were postpartum haemorrhage and manual removal of placenta. Results Nulliparous and parous women who started labour in midwife-led care had lower rates of SAMM, postpartum haemorrhage and manual removal of placenta compared to women who started labour in secondary care. For SAMM the adjusted odds ratio's and 95% confidence intervals were for nulliparous women: 0.57 (0.45 to 0.71) and for parous women 0.47 (0.36 to 0.62). Conclusions Our results suggest that it is possible to identify a group of women at low risk of obstetric complications who may benefit from midwife-led care. Women can be reassured that we found no evidence that midwife-led care at the onset of labour is unsafe for women in a maternity care system with a well developed risk selection and referral system.	[de Jonge, Ank; Mannien, Judith] Vrije Univ Amsterdam, Med Ctr, AVAG, Dept Midwifery Sci, Amsterdam, Netherlands; [de Jonge, Ank; Mannien, Judith] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Mesman, Jeanette A. J. M.; van Roosmalen, Jos] Leiden Univ, Med Ctr, Dept Obstet, Leiden, Netherlands; [Zwart, Joost J.] Deventer Hosp, Dept Obstet, Deventer, Netherlands; [Buitendijk, Simone E.] Leiden Univ, Med Ctr, Leiden, Netherlands; [van Roosmalen, Jos] Vrije Univ Amsterdam, Med Ctr, Athena Inst, Amsterdam, Netherlands; [van Dillen, Jeroen] Radboud Univ Nijmegen, Med Ctr, Dept Obstet, NL-6525 ED Nijmegen, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Deventer Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; Radboud University Nijmegen	de Jonge, A (corresponding author), Vrije Univ Amsterdam, Med Ctr, AVAG, Dept Midwifery Sci, Amsterdam, Netherlands.	ank.dejonge@vumc.nl	Dillen, J./L-4275-2015; Mesman, Judi/P-2846-2015; de Jonge, Ank/F-6475-2013	Mannien, Judith/0000-0003-1698-9979	Netherlands Organisation for Health Research and Development [91611016]	Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	The study was funded with a career grant from the Netherlands Organisation for Health Research and Development, http://www.zonmw.nl, grant number 91611016 received by AJ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amelink-Verburg MP, 2009, BJOG-INT J OBSTET GY, V116, P923, DOI 10.1111/j.1471-0528.2009.02202.x; [Anonymous], 2005, INJ FACTS 2007 ED, P48; Australian College of Midwives (ACM), 2014, NAT MIDW GUID CONS R; Brocklehurst P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7400; Commissie Verloskunde van het CVZ, 2013, OBST HDB; de Jonge A, 2015, BJOG-INT J OBSTET GY, V122, P720, DOI 10.1111/1471-0528.13084; de Jonge A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3263; de Jonge A, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-103; de Jonge A, 2013, MIDWIFERY, V29, P1011, DOI 10.1016/j.midw.2013.02.005; de Jonge A, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c7020; Evers ACC, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c5639; Halfdansdottir B, 2015, BIRTH-ISS PERINAT C, V42, P16, DOI 10.1111/birt.12150; Hutton EK, 2009, BIRTH-ISS PERINAT C, V36, P180, DOI 10.1111/j.1523-536X.2009.00322.x; Janssen PA, 2002, CAN MED ASSOC J, V166, P315; Janssen PA, 2007, BIRTH-ISS PERINAT C, V34, P140, DOI 10.1111/j.1523-536X.2007.00160.x; Kramer MS, 2011, J OBSTET GYNAECOL CA, V33, P810, DOI 10.1016/S1701-2163(16)34984-2; Lindgren HE, 2011, SEX REPROD HEALTHC, V2, P101, DOI 10.1016/j.srhc.2011.03.001; Maassen MS, 2008, BIRTH-ISS PERINAT C, V35, P277, DOI 10.1111/j.1523-536X.2008.00254.x; Ministry of Health, 2012, GUID CONS OBST REL M; Offerhaus PM, 2013, BIRTH-ISS PERINAT C, V40, P193; Perdok H, 2014, BIRTH-ISS PERINAT C, V41, P195, DOI 10.1111/birt.12102; Pop VJ, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c7022; Rowe RE, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-129; Sandall J, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004667.pub3, 10.1002/14651858.CD004667.pub5]; Stichting Perinatale Registratie Nederland, 2014, PER CAR NETH 2013; Tracy SK, 2013, LANCET, V382, P1723, DOI 10.1016/S0140-6736(13)61406-3; van Dillen J, 2010, BJOG-INT J OBSTET GY, V117, P416, DOI 10.1111/j.1471-0528.2009.02480.x; van Dillen J, 2010, ACTA OBSTET GYN SCAN, V89, P1460, DOI 10.3109/00016349.2010.519018; ten Haken TV, 2012, MIDWIFERY, V28, P609, DOI 10.1016/j.midw.2012.07.010; Wiegers TA, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-18; Zwart JJ, 2008, BJOG-INT J OBSTET GY, V115, P842, DOI 10.1111/j.1471-0528.2008.01713.x; Zwart JJ, 2011, EUR J PUBLIC HEALTH, V21, P229, DOI 10.1093/eurpub/ckq046	32	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126266	10.1371/journal.pone.0126266	http://dx.doi.org/10.1371/journal.pone.0126266			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CI1YY	25961723	Green Submitted, gold, Green Published			2022-12-26	WOS:000354542500082
J	Heindl, M; Tuennemann, J; Sommerer, I; Mossner, J; Hoffmeister, A				Heindl, Mario; Tuennemann, Jan; Sommerer, Ines; Moessner, Joachim; Hoffmeister, Albrecht			Loss of Bace1 in Mice Does Not Alter the Severity of Caerulein Induced Pancreatitis	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; BETA-PEPTIDE PRODUCTION; SECRETASE ACTIVITY; ASPARTYL PROTEASE; HUMAN BRAIN; ACTIVATION; IDENTIFICATION; ENTEROKINASE; INFLAMMATION; MORTALITY	Context Beta-site alpha-amyloid protein cleaving enzyme1 (BACE1) plays a key role in the pathogenesis of Alzheimer's disease. Additional to its moderate expression in the brain, high levels of BACE1 mRNA were found in the pancreas. Murine Bace1 has been immunohistochemicaly detected at the apical pole of acinar cells within the exocrine pancreas of mice and Bace1 activity was observed in pancreatic juice. In vitro experiments revealed enteropeptidase as a putative substrate for Bace1 suggesting a role in acute pancreatitis. Objective The aim of this study was to address a protective mechanism of Bace1 in acute experimental pancreatitis in mice. Methods Acute experimental pancreatitis was induced by intraperitoneal injection of caerulein in homozygote Bace1(-/-) mice and wild type mice. Serum and tissue analyses were carried out after 4 h, 8 h and 24 h. Measurement of plasma amylase and lipase was performed to confirm pancreatitis induction. In order to assess the severity of pancreatitis H&E stained pancreatic sections were examined regarding edema, inflammation and apoptosis. Immunohistochemical detection of myeloperoxidase (MPO) positive cells was carried out to further quantify the extent of inflammation. Expression of Bace2 within the pancreas was analyzed by immunohistochemistry and RT-qPCR. Results We demonstrate that total loss of Bace1 in mice leads to no alterations in the course of acute experimental caerulein-pancreatitis. Bace1(-/-) mice develop a moderate pancreatitis that is comparable in histomorphological and serological features with those seen in wild type mice. Discussion We discuss the results in the context of the applied caerulein induced edematous pancreatitis model and possible compensatory mechanisms via Bace2 that might be responsible for the observed results.	[Heindl, Mario; Tuennemann, Jan; Sommerer, Ines; Moessner, Joachim; Hoffmeister, Albrecht] Univ Hosp Leipzig, Dept Internal Med, Leipzig, Germany	Leipzig University	Heindl, M (corresponding author), Univ Hosp Leipzig, Dept Internal Med, Leipzig, Germany.	mario.heindl@medizin.uni-leipzig.de						Bodendorf U, 2001, J BIOL CHEM, V276, P12019, DOI 10.1074/jbc.M008861200; Bumbasirevic V, 2009, PANCREAS, V38, P122, DOI 10.1097/MPA.0b013e31818a392f; Dawra R, 2011, GASTROENTEROLOGY, V141, P2210, DOI 10.1053/j.gastro.2011.08.033; Dominguez D, 2005, J BIOL CHEM, V280, P30797, DOI 10.1074/jbc.M505249200; Ehehalt R, 2002, BIOCHEM BIOPH RES CO, V293, P30, DOI 10.1016/S0006-291X(02)00169-9; Figueroa DJ, 2001, J ALZHEIMERS DIS, V3, P393, DOI 10.3233/JAD-2001-3405; GRANT D, 1986, INT J PANCREATOL, V1, P167; Hartwig W, 2007, SURGERY, V142, P327, DOI 10.1016/j.surg.2007.04.023; Hemming ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008477; Hoffmeister A, 2013, OBESITY SILVER SPRIN; Hoffmeister A, 2009, J PANCREAS, V10, P501; Holsinger RMD, 2004, ANN NEUROL, V55, P898, DOI 10.1002/ana.20144; Hoque R, 2011, GASTROENTEROLOGY, V141, P358, DOI 10.1053/j.gastro.2011.03.041; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Mareninova OA, 2009, J CLIN INVEST, V119, P3340, DOI 10.1172/JCI38674; Meakin PJ, 2012, BIOCHEM J, V441, P285, DOI 10.1042/BJ20110512; Mowrer KR, 2008, J BIOL CHEM, V283, P18694, DOI 10.1074/jbc.M801322200; Pandol SJ, 2007, GASTROENTEROLOGY, V132, P1127, DOI 10.1053/j.gastro.2007.01.055; Rongione AJ, 1997, GASTROENTEROLOGY, V112, P960, DOI 10.1053/gast.1997.v112.pm9041259; Rosendahl J, 2008, NAT GENET, V40, P78, DOI 10.1038/ng.2007.44; Sah RP, 2012, CURR OPIN GASTROEN, V28, P507, DOI 10.1097/MOG.0b013e3283567f52; Saluja AK, 1999, AM J PHYSIOL-GASTR L, V276, pG835, DOI 10.1152/ajpgi.1999.276.4.G835; Saluja AK, 2007, ANNU REV PHYSIOL, V69, P249, DOI 10.1146/annurev.physiol.69.031905.161253; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Solans A, 2000, CYTOGENET CELL GENET, V89, P177, DOI 10.1159/000015608; Tanahashi H, 2001, NEUROSCI LETT, V307, P9, DOI 10.1016/S0304-3940(01)01912-7; Teich N, 2000, GASTROENTEROLOGY, V119, P461, DOI 10.1053/gast.2000.9312; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wan MH, 2012, HPB, V14, P73, DOI 10.1111/j.1477-2574.2011.00408.x; Wang GJ, 2009, WORLD J GASTROENTERO, V15, P1427, DOI 10.3748/wjg.15.1427; Whitcomb DC, 2007, DIGEST DIS SCI, V52, P1, DOI 10.1007/s10620-006-9589-z; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107	32	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0125556	10.1371/journal.pone.0125556	http://dx.doi.org/10.1371/journal.pone.0125556			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961820	Green Published, gold			2022-12-26	WOS:000354542500034
J	Kaufmann, S; Fuchs, C; Gonik, M; Khrameeva, EE; Mironov, AA; Frishman, D				Kaufmann, Stefanie; Fuchs, Christiane; Gonik, Mariya; Khrameeva, Ekaterina E.; Mironov, Andrey A.; Frishman, Dmitrij			Inter-Chromosomal Contact Networks Provide Insights into Mammalian Chromatin Organization	PLOS ONE			English	Article							NUCLEAR-ORGANIZATION; COHESIN; CENTROMERES; CTCF; COMPLEX; GENOME; MODEL	The recent advent of conformation capture techniques has provided unprecedented insights into the spatial organization of chromatin. We present a large-scale investigation of the interchromosomal segment and gene contact networks in embryonic stem cells of two mammalian organisms: humans and mice. Both interaction networks are characterized by a high degree of clustering of genome regions and the existence of hubs. Both genomes exhibit similar structural characteristics such as increased flexibility of certain Y chromosome regions and co-localization of centromere-proximal regions. Spatial proximity is correlated with the functional similarity of genes in both species. We also found a significant association between spatial proximity and the co-expression of genes in the human genome. The structural properties of chromatin are also species specific, including the presence of two highly interactive regions in mouse chromatin and an increased contact density on short, gene-rich human chromosomes, thereby indicating their central nuclear position. Trans-interacting segments are enriched in active marks in human and had no distinct feature profile in mouse. Thus, in contrast to interactions within individual chromosomes, the inter-chromosomal interactions in human and mouse embryonic stem cells do not appear to be conserved.	[Kaufmann, Stefanie; Gonik, Mariya; Frishman, Dmitrij] Tech Univ Munich, Dept Genome Oriented Bioinformat, Wissenschaftszentrum Weihenstephan, Freising Weihenstephan, Germany; [Fuchs, Christiane] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Computat Biol, Neuherberg, Germany; [Fuchs, Christiane] Tech Univ Munich, Inst Math Sci, Garching, Germany; [Gonik, Mariya] Klinikum Univ Munchen, Inst Stroke & Dementia Res ISD, Munich, Germany; [Khrameeva, Ekaterina E.] RAS, Inst Informat Transmiss Problems, Res & Training Ctr Bioinformat, Moscow 117901, Russia; [Mironov, Andrey A.] Moscow MV Lomonosov State Univ, Dept Bioengn & Bioinformat, Moscow, Russia; [Frishman, Dmitrij] HMGU German Res Ctr Environm Hlth, Inst Bioinformat & Syst Biol, Neuherberg, Germany; [Frishman, Dmitrij] St Petersburg State Polytech Univ, Dept Bioinformat, St Petersburg, Russia	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Munich; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; Lomonosov Moscow State University; Peter the Great St. Petersburg Polytechnic University	Frishman, D (corresponding author), Tech Univ Munich, Dept Genome Oriented Bioinformat, Wissenschaftszentrum Weihenstephan, Freising Weihenstephan, Germany.	d.frishman@wzw.tum.de	Frishman, Dmitrij/AAT-7815-2020; Khrameeva, Ekaterina/I-3620-2015; Fuchs, Christiane/AAE-9892-2019	Khrameeva, Ekaterina/0000-0001-6188-9139; Fuchs, Christiane/0000-0003-3565-8315	DFG [IRTG-1563]; European Union within the ERC grant LatentCauses [259294]; Russian science foundation [14-24-00155]; RFBR [14-04-00576]	DFG(German Research Foundation (DFG)); European Union within the ERC grant LatentCauses; Russian science foundation(Russian Science Foundation (RSF)); RFBR(Russian Foundation for Basic Research (RFBR))	This work was funded by the DFG, IRTG-1563; by the European Union within the ERC grant LatentCauses (#259294) to C.F.; by the Russian science foundation (#14-24-00155) to E. Khr.; and by the RFBR (#14-04-00576) to A.M. Funding for open access charge: DFG and TU Munchen Open Access Publishing programme.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfoldi J, 2008, SEQUENCE MOUSE Y CHR, P41; Bancaud A, 2012, NUCLEIC ACIDS RES, V40, P8783, DOI 10.1093/nar/gks586; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chien R, 2011, J BIOL CHEM, V286, P17870, DOI 10.1074/jbc.M110.207365; Cremer T, 2006, CURR OPIN CELL BIOL, V18, P307, DOI 10.1016/j.ceb.2006.04.007; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dong J, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-24; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Hakimi MA, 2002, NATURE, V418, P994, DOI 10.1038/nature01024; Harmston N, 2013, NUCLEIC ACIDS RES, V41, P7185, DOI 10.1093/nar/gkt499; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Hou CH, 2010, P NATL ACAD SCI USA, V107, P3651, DOI 10.1073/pnas.0912087107; HSU TC, 1971, CHROMOSOMA, V34, P73, DOI 10.1007/BF00285517; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Kalhor R, 2012, NAT BIOTECHNOL, V30, P90, DOI 10.1038/nbt.2057; Kaufmann S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112341; Kenny PW, 2013, J COMPUT AID MOL DES, V27, P1, DOI 10.1007/s10822-012-9631-5; Khrameeva EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033947; Kruse K, 2013, NUCLEIC ACIDS RES, V41, P701, DOI 10.1093/nar/gks1096; Lappin Terence R J, 2006, Ulster Med J, V75, P23; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Liu Y, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-20; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Nagano T, 2013, NATURE, V502, P59, DOI 10.1038/nature12593; Nativio R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000739; Osborne CS, 2011, BRIEF FUNCT GENOMICS, V10, P11, DOI 10.1093/bfgp/elq034; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; R Core Team, 2013, LANG ENV STAT COMP, DOI [DOI 10.3758/S13428-013-0330-5, 10.3758/s13428-013-0330-5]; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Seitan VC, 2012, CURR OPIN GENET DEV, V22, P93, DOI 10.1016/j.gde.2011.11.003; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sofueva S, 2012, BRIEF FUNCT GENOMICS, V11, P205, DOI 10.1093/bfgp/elr048; Towbin BD, 2009, CURR OPIN GENET DEV, V19, P180, DOI 10.1016/j.gde.2009.01.006; Wainer H., 2006, CHANCE, V19, P49, DOI DOI 10.1080/09332480.2006.10722771; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Wiblin AE, 2005, J CELL SCI, V118, P3861, DOI 10.1242/jcs.02500; Witten DM, 2012, NUCLEIC ACIDS RES, V40, P3849, DOI 10.1093/nar/gks012; Yaffe E, 2011, NAT GENET, V43, P1059, DOI 10.1038/ng.947; Yu GC, 2010, BIOINFORMATICS, V26, P976, DOI 10.1093/bioinformatics/btq064	47	24	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126125	10.1371/journal.pone.0126125	http://dx.doi.org/10.1371/journal.pone.0126125			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961318	Green Published, Green Submitted, gold			2022-12-26	WOS:000354542500066
J	Roche, B; Leger, L; L'Ambert, G; Lacour, G; Foussadier, R; Besnard, G; Barre-Cardi, H; Simard, F; Fontenille, D				Roche, Benjamin; Leger, Lucas; L'Ambert, Gregory; Lacour, Guillaume; Foussadier, Remi; Besnard, Gilles; Barre-Cardi, Helene; Simard, Frederic; Fontenille, Didier			The Spread of Aedes albopictus in Metropolitan France: Contribution of Environmental Drivers and Human Activities and Predictions for a Near Future	PLOS ONE			English	Article							DIPTERA-CULICIDAE; UNITED-STATES; WEST-NILE; INVASION; POPULATIONS; CHIKUNGUNYA; TEMPERATE; MOSQUITOS; EVOLUTION; DIAPAUSE	Invasion of new territories by insect vector species that can transmit pathogens is one of the most important threats for human health. The spread of the mosquito Aedes albopictus in Europe is emblematic, because of its major role in the emergence and transmission of arbo-viruses such as dengue or chikungunya. Here, we modeled the spread of this mosquito species in France through a statistical framework taking advantage of a long-term surveillance dataset going back to the first observation of Ae. albopictus in the Metropolitan area. After validating the model, we show that human activities are especially important for mosquito dispersion while land use is a major factor for mosquito establishment. More importantly, we show that Ae. albopictus invasion is accelerating through time in this area, resulting in a geographic range extending further and further year after year. We also show that sporadic "jump" of Ae. albopictus in a new location far from the colonized area did not succeed in starting a new invasion front so far. Finally, we discuss on a potential adaptation to cooler climate and the risk of invasion into Northern latitudes.	[Roche, Benjamin] UMI IRD UPMC UMMISCO, Bondy, France; [Leger, Lucas; Simard, Frederic; Fontenille, Didier] UMR CNRS IRD UM1 UM2 MIVEGEC, Montpellier, France; [L'Ambert, Gregory; Lacour, Guillaume] EID Mediterranee, Montpellier, France; [Lacour, Guillaume] Ctr Rech Biodivers, Louvain, Belgium; [Foussadier, Remi; Besnard, Gilles] EID Rhone Alpes, Chindrieux, France; [Barre-Cardi, Helene] Off Environm Corse, Corte, France	UDICE-French Research Universities; Sorbonne Universite; Cadi Ayyad University of Marrakech; Hanoi University of Science & Technology; Institut de Recherche pour le Developpement (IRD); University Cheikh Anta Diop Dakar; University of Yaounde I; Universite de Montpellier	Roche, B (corresponding author), UMI IRD UPMC UMMISCO, Bondy, France.	benjamin.roche@ird.fr	Frederic, SIMARD/AFV-5001-2022; Lacour, Guillaume/AAQ-5935-2021; SIMARD, Frederic/J-9489-2016	Frederic, SIMARD/0000-0002-2871-5329; Lacour, Guillaume/0000-0002-9588-6064; SIMARD, Frederic/0000-0002-2871-5329; Roche, Benjamin/0000-0001-7975-4232; FONTENILLE, didier/0000-0002-0544-3885; Barre-Cardi, Helene/0000-0003-1029-9256	"Institut de Microbiologie des Maladies Infectieuses (IMMI)" (INSERM); Direction Generale de la Sante	"Institut de Microbiologie des Maladies Infectieuses (IMMI)" (INSERM); Direction Generale de la Sante(General Electric)	This study has been funded by "Institut de Microbiologie des Maladies Infectieuses (IMMI)" (INSERM) and the "Direction Generale de la Sante". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alto BW, 2001, J MED ENTOMOL, V38, P548, DOI 10.1603/0022-2585-38.4.548; ANDERSON R M, 1991; Arim M, 2006, P NATL ACAD SCI USA, V103, P374, DOI 10.1073/pnas.0504272102; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003; Caminade C, 2012, J R SOC INTERFACE, V9, P2708, DOI 10.1098/rsif.2012.0138; Crooks JA, 2005, ECOSCIENCE, V12, P316, DOI 10.2980/i1195-6860-12-3-316.1; Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026; *EEA, 2000, CORINE LAND COV TECH; Eritja R, 2005, BIOL INVASIONS, V7, P87, DOI 10.1007/s10530-004-9637-6; European Center for Disease Control and Prevention, 2013, ENV RISK MAPP AED AL; Fischer D, 2011, GLOBAL PLANET CHANGE, V78, P54, DOI 10.1016/j.gloplacha.2011.05.008; Fritts TH, 1998, ANNU REV ECOL SYST, V29, P113, DOI 10.1146/annurev.ecolsys.29.1.113; Gjenero-Margan I, 2011, EURO SURVEILL, V16; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; HANSON SM, 1994, J MED ENTOMOL, V31, P192, DOI 10.1093/jmedent/31.2.192; Higa Yukiko, 2011, Tropical Medicine and Health, V39, P17, DOI 10.2149/tmh.2011-S04; Hill MP, 2013, AUSTRAL ECOL; Holder P, 2010, J MED ENTOMOL, V47, P600, DOI 10.1603/ME09111; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; Kennedy TA, 2002, NATURE, V417, P636, DOI 10.1038/nature00776; La Ruche G, 2010, EUROSURVEILLANCE, V15, P2; Lounibos LP, 2003, ANN ENTOMOL SOC AM, V96, P512, DOI 10.1603/0013-8746(2003)096[0512:AEOPDI]2.0.CO;2; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; Marchand E, 2013, EUROSURVEILLANCE, V201, P18; McGraw EA, 2013, NAT REV MICROBIOL, V11, P181, DOI 10.1038/nrmicro2968; Moore CG, 1997, EMERG INFECT DIS, V3, P329, DOI 10.3201/eid0303.970309; O'Leary DR, 2004, VECTOR-BORNE ZOONOT, V4, P61, DOI 10.1089/153036604773083004; Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Rezza G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-72; Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874; Roiz D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014800; Rovida F, 2011, J CLIN VIROL, V50, P76, DOI 10.1016/j.jcv.2010.09.015; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Schaffner F, 2013, CLIN MICROBIOL INFEC, V19, P685, DOI 10.1111/1469-0691.12189; Scholte J-E, 2007, EMERGING PESTS VECTO; SHIGESADA N, 1995, AM NAT, V146, P229, DOI 10.1086/285796; Strayer DL, 2006, TRENDS ECOL EVOL, V21, P645, DOI 10.1016/j.tree.2006.07.007; Tran A, 2013, INT J ENV RES PUB HE, V10, P1698, DOI 10.3390/ijerph10051698; Urbanski J, 2012, AM NAT, V179, P490, DOI 10.1086/664709; Valerio L, 2010, VECTOR-BORNE ZOONOT, V10, P291, DOI 10.1089/vbz.2009.0007	42	62	63	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0125600	10.1371/journal.pone.0125600	http://dx.doi.org/10.1371/journal.pone.0125600			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962160	Green Submitted, Green Published, gold			2022-12-26	WOS:000354542500037
J	Zalecki, M				Zalecki, Michal			The Influence of Antral Ulcers on Intramural Gastric Nerve Projections Supplying the Pyloric Sphincter in the Pig (Sus scrofa domestica)-Neuronal Tracing Studies	PLOS ONE			English	Article							PATHWAYS; CLASSIFICATION; LOCALIZATION; HYPERTROPHY; DYSFUNCTION; ULCERATION; MOTILITY; MODELS; SYSTEM; SIZE	Background Gastric ulcerations in the region of antrum pylori represent a serious medical problem in humans and animals. Such localization of ulcers can influence the intrinsic descending nerve supply to the pyloric sphincter. The pyloric function is precisely regulated by intrinsic and extrinsic nerves. Impaired neural regulation could result in pyloric sphincter dysfunction and gastric emptying malfunction. The aim of the study was to determine the effect of gastric antral ulcerations on the density and distribution of intramural gastric descending neurons supplying the pyloric sphincter in pigs. Methodology/Principal Findings The experiment was performed on 2 groups of pigs: healthy gilts (n=6) and gilts with experimentally induced peptic ulcers in the region of antrum pylori (n=6). Gastric neurons supplying pyloric sphincter were labeled using the retrograde neuronal tracing technique (20 mu l of Fast Blue tracer injected into the pyloric sphincter muscle). After a week survival period the animals were sacrificed and the stomachs were collected. Then, the stomach wall was cross-cut into 0.5cm thick sections taken in specified intervals (section I - 1.5cm; section II - 3.5cm; section III - 5.5cm; section IV - 7.5cm) starting from the sphincter. Consecutive microscopic slices prepared from each section were analyzed under fluorescent microscope to count traced neurons. Obtained data were statistically analyzed. The total number of FB-positive perikarya observed within all studied sections significantly decreased from 903.3 +/- 130.7 in control to 243.8 +/- 67.3 in experimental animals. In healthy pigs 76.1 +/- 6.7% of labeled neurons were observed within the section I, 23.53 +/- 6.5% in section II and only occasional cells in section III. In experimental animals, as many as 93.8 +/- 2.1% of labeled cells were observed within the section I and only 6.2 +/- 2.2% in section II, while section III was devoid of such neurons. There were no traced perikarya in section IV observed in both groups of pigs. Conclusions/Significance Obtained results revealed for the first time significant impact of antral ulcerations on intramural descending nerve pathways supplying the pyloric sphincter in pigs, animals of increasing value in biomedical research and great economic importance.	Univ Warmia & Mazury, Fac Vet Med, Dept Anim Anat, Olsztyn, Poland	University of Warmia & Mazury	Zalecki, M (corresponding author), Univ Warmia & Mazury, Fac Vet Med, Dept Anim Anat, Olsztyn, Poland.	michal.zalecki@uwm.edu.pl			Polish Ministry of Science and Higher Education [IP2012 044172]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	Research project funded by the Polish Ministry of Science and Higher Education (from the budget for science in 2012-2015), grant Iuventus Plus, No. IP2012 044172.	ALLESCHER HD, 1988, J PHYSIOL-LONDON, V401, P17, DOI 10.1113/jphysiol.1988.sp017149; [Anonymous], 1985, DIGEST DIS SCI; ANVARI M, 1995, J PHYSIOL-LONDON, V488, P203, DOI 10.1113/jphysiol.1995.sp020958; DANIEL E, 1994, DIGEST DIS SCI, V39, pS63; FISHER RS, 1973, NEW ENGL J MED, V288, P273, DOI 10.1056/NEJM197302082880601; Friendship R., 1999, DIS SWINE, P685; Friendship RM, 2004, J SWINE HEALTH PROD, V12, P34; Furness J.B., 2006, ENTERIC NERVOUS SYST; Furness JB, 2014, ADV EXP MED BIOL, V817, P39, DOI 10.1007/978-1-4939-0897-4_3; Furness JB, 2012, NAT REV GASTRO HEPAT, V9, P286, DOI 10.1038/nrgastro.2012.32; GARRETT JM, 1966, AM J DIG DIS, V11, P780, DOI 10.1007/BF02233838; Higuchi K, 2003, ALIMENT PHARM THER, V17, P111, DOI 10.1046/j.1365-2036.2003.01402.x; JOHNSON HD, 1964, GUT, V5, P402, DOI 10.1136/gut.5.5.402; JOHNSON HD, 1957, LANCET, V2, P518; JOHNSON HD, 1965, ANN SURG, V162, P996, DOI 10.1097/00000658-196512000-00005; KANAIZUMI T, 1989, TOHOKU J EXP MED, V158, P133, DOI 10.1620/tjem.158.133; Kocak E, 2013, WIEN KLIN WOCHENSCHR, V125, P21, DOI 10.1007/s00508-012-0309-8; Liebermann-Meffert D, 1977, Prog Surg, V15, P109; LIEBERMANNMEFFERT D, 1982, BRIT J SURG, V69, P11, DOI 10.1002/bjs.1800690105; LIEBERMANNMEFFERT D, 1981, SCAND J GASTROENTERO, V16, P111; LILJA B, 1953, ACTA RADIOL, V39, P353, DOI 10.3109/00016925309136721; LILJA B, 1954, ACTA RADIOL, V41, P225, DOI 10.3109/00016925409175849; Lindestrom LM, 2002, AUTON NEUROSCI-BASIC, V97, P73, DOI 10.1016/S1566-0702(02)00056-5; Mazzuoli G, 2008, J CHEM NEUROANAT, V36, P98, DOI 10.1016/j.jchemneu.2008.05.002; Melnichouk SI, 2002, CAN VET J, V43, P223; MERTZ HR, 1991, MED CLIN N AM, V75, P799, DOI 10.1016/S0025-7125(16)30412-6; Milhomem LM, 2012, ABCD-ARQ BRAS CIR DI, V25, P235, DOI 10.1590/S0102-67202012000400005; Mochiki E, 2001, DIGEST DIS SCI, V46, P2307, DOI 10.1023/A:1012374408853; MURRAY GF, 1967, AM J SURG, V113, P199, DOI 10.1016/0002-9610(67)90222-X; Okabe S, 2005, BIOL PHARM BULL, V28, P1321, DOI 10.1248/bpb.28.1321; RAFFENSPERGER EC, 1955, GASTROENTEROLOGY, V28, P458; Ramkumar D, 2005, NEUROGASTROENT MOTIL, V17, P22, DOI 10.1111/j.1365-2982.2005.00664.x; REDDY SN, 1990, AM J PHYSIOL, V258, pG24, DOI 10.1152/ajpgi.1990.258.1.G24; Schemann M, 2005, J PEDIATR GASTR NUTR, V41, pS4, DOI 10.1097/01.scs.0000180285.51365.55; Schemann M, 2001, ANAT RECORD, V262, P47, DOI 10.1002/1097-0185(20010101)262:1<47::AID-AR1010>3.0.CO;2-1; Schemann M, 2010, AUTON NEUROSCI-BASIC, V153, P21, DOI 10.1016/j.autneu.2009.08.003; SKORYNA SC, 1959, SURG GYNECOL OBSTET, V108, P83; Sobreira LFR, 2002, DIGEST DIS SCI, V47, P2493, DOI 10.1023/A:1020508009213; STADELMANN O, 1971, SCAND J GASTROENTERO, V6, P613, DOI 10.3109/00365527109181143; Steigmann F, 1943, AM J DIG DIS, V10, P88; Swindle MM, 2012, VET PATHOL, V49, P344, DOI 10.1177/0300985811402846; Swindle M M, 1988, J Invest Surg, V1, P65, DOI 10.3109/08941938809141077; Swindle MM, 2012, FUTURE MED CHEM, V4, P1771, DOI [10.4155/FMC.12.113, 10.4155/fmc.12.113]; Swindle MM, 1992, SWINE MODELS BIOMEDI, P312; TEXTER EC, 1959, GASTROENTEROLOGY, V36, P573; Xu CY, 2009, DIGEST SURG, V26, P312, DOI 10.1159/000231881; Xu CY, 2012, HEPATO-GASTROENTEROL, V59, P612, DOI 10.5754/hge10494; Zalecki M, 2012, AUTON NEUROSCI-BASIC, V171, P21, DOI 10.1016/j.autneu.2012.10.001; Zalecki M, 2014, J MOL NEUROSCI, V52, P82, DOI 10.1007/s12031-013-0116-3; Zalecki M, 2012, J CHEM NEUROANAT, V43, P1, DOI 10.1016/j.jchemneu.2011.08.004; Zhang Zunwu, 2007, J Gastrointest Cancer, V38, P38, DOI 10.1007/s12029-008-9015-1	51	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126958	10.1371/journal.pone.0126958	http://dx.doi.org/10.1371/journal.pone.0126958			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25962176	Green Published, gold, Green Submitted			2022-12-26	WOS:000354542500163
J	Zhang, FG; Zhang, QG				Zhang, Fen-Guo; Zhang, Quan-Guo			Patterns in Species Persistence and Biomass Production in Soil Microcosms Recovering from a Disturbance Reject a Neutral Hypothesis for Bacterial Community Assembly	PLOS ONE			English	Article							MICROBIAL DIVERSITY; DYNAMICS; BIODIVERSITY; RESILIENCE; REDUNDANCY; RESISTANCE; FORESTS; MODEL	The neutral theory of biodiversity has emerged as a major null hypothesis in community ecology. The neutral theory may sufficiently well explain the structuring of microbial communities as the extremely high microbial diversity has led to an expectation of high ecological equivalence among species. To address this possibility, we worked with microcosms of two soils; the microcosms were either exposed, or not, to a dilution disturbance which reduces community sizes and removes some very rare species. After incubation for recovery, changes in bacterial species composition in microcosms compared with the source soils were assessed by pyrosequencing of bacterial 16S rRNA genes. Our assays could detect species with a proportional abundance >= 0.0001 in each community, and changes in the abundances of these species should have occurred during the recovery growth, but not be caused by the disturbance per se. The undisturbed microcosms showed slight changes in bacterial species diversity and composition, with a small number of initially low-abundance species going extinct. In microcosms recovering from the disturbance, however, species diversity decreased dramatically (by > 50%); and in most cases there was not a positive relationship between species initial abundance and their chance of persistence. Furthermore, a positive relationship between species richness and community biomass was observed in microcosms of one soil, but not in those of the other soil. The results are not consistent with a neutral hypothesis that predicts a positive abundance-persistence relationship and a null effect of diversity on ecosystem functioning. Adaptation mechanisms, in particular those associated with species interactions including facilitation and predation, may provide better explanations.	[Zhang, Quan-Guo] Beijing Normal Univ, State Key Lab Earth Surface Processes & Resource, Beijing 100875, Peoples R China; Beijing Normal Univ, MOE Key Lab Biodivers Sci & Ecol Engn, Beijing 100875, Peoples R China	Beijing Normal University; Beijing Normal University	Zhang, QG (corresponding author), Beijing Normal Univ, State Key Lab Earth Surface Processes & Resource, Beijing 100875, Peoples R China.	zhangqg@bnu.edu.cn	Zhang, Quan-Guo/D-5244-2015	Zhang, Quan-Guo/0000-0001-7128-2664	National Natural Science Foundation of China [31222010, 31421063]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China (31222010 and 31421063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Alonso D, 2006, TRENDS ECOL EVOL, V21, P451, DOI 10.1016/j.tree.2006.03.019; [Anonymous], 2014, R LANG ENV STAT COMP; Bell G, 2001, SCIENCE, V293, P2413, DOI 10.1126/science.293.5539.2413; Bell T, 2010, ISME J, V4, P1357, DOI 10.1038/ismej.2010.77; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Degens BP, 1998, SOIL BIOL BIOCHEM, V30, P1989, DOI 10.1016/S0038-0717(98)00071-6; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Eilers H, 2000, APPL ENVIRON MICROB, V66, P4634, DOI 10.1128/AEM.66.11.4634-4640.2000; Feinstein LM, 2012, ENVIRON MICROBIOL, V14, P1488, DOI 10.1111/j.1462-2920.2012.02737.x; Ferrenberg S, 2013, ISME J, V7, P1102, DOI 10.1038/ismej.2013.11; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Fuchs BM, 2000, ENVIRON MICROBIOL, V2, P191, DOI 10.1046/j.1462-2920.2000.00092.x; Fukami T, 2010, ECOL LETT, V13, P675, DOI 10.1111/j.1461-0248.2010.01465.x; Gonzalez A, 2009, ANNU REV ECOL EVOL S, V40, P393, DOI 10.1146/annurev.ecolsys.39.110707.173349; Griffiths BS, 2001, SOIL BIOL BIOCHEM, V33, P1713, DOI 10.1016/S0038-0717(01)00094-3; Hol WHG, 2010, ECOL LETT, V13, P292, DOI 10.1111/j.1461-0248.2009.01424.x; Hom EFY, 2014, SCIENCE, V345, P94, DOI 10.1126/science.1253320; Hubbell SP, 1997, CORAL REEFS, V16, pS9, DOI 10.1007/s003380050237; Hubbell Stephen P., 2001, V32, pi; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Jousset A, 2012, ENVIRON MICROBIOL, V14, P1830, DOI 10.1111/j.1462-2920.2011.02627.x; Langenheder S, 2011, ISME J, V5, P1086, DOI 10.1038/ismej.2010.207; Loreau M, 2004, OIKOS, V104, P606, DOI 10.1111/j.0030-1299.2004.12685.x; Mouquet N, 2002, ECOL LETT, V5, P56, DOI 10.1046/j.1461-0248.2002.00281.x; Muneepeerakul R, 2008, NATURE, V453, P220, DOI 10.1038/nature06813; Nannipieri P, 2003, EUR J SOIL SCI, V54, P655, DOI 10.1046/j.1351-0754.2003.0556.x; Nemergut DR, 2013, MICROBIOL MOL BIOL R, V77, P342, DOI 10.1128/MMBR.00051-12; Padmanabhan P, 2003, APPL ENVIRON MICROB, V69, P1614, DOI 10.1128/AEM.69.3.1614-1622.2003; Peter H, 2011, ISME J, V5, P351, DOI 10.1038/ismej.2010.119; Peterson CN, 2008, ENVIRON MICROBIOL, V10, P2257, DOI 10.1111/j.1462-2920.2008.01648.x; Philippot L, 2013, ISME J, V7, P1609, DOI 10.1038/ismej.2013.34; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Stegen JC, 2012, ISME J, V6, P1653, DOI 10.1038/ismej.2012.22; Terborgh J, 2012, AM NAT, V179, P303, DOI 10.1086/664183; Thompson AW, 2012, SCIENCE, V337, P1546, DOI 10.1126/science.1222700; Torsvik V, 2002, SCIENCE, V296, P1064, DOI 10.1126/science.1071698; Trevors JT, 1996, J MICROBIOL METH, V26, P53, DOI 10.1016/0167-7012(96)00843-3; Vanwonterghem I, 2014, ISME J, V8, P2015, DOI 10.1038/ismej.2014.50; Wertz S, 2007, ENVIRON MICROBIOL, V9, P2211, DOI 10.1111/j.1462-2920.2007.01335.x; Wertz S, 2006, ENVIRON MICROBIOL, V8, P2162, DOI 10.1111/j.1462-2920.2006.01098.x; Woodcock S, 2007, FEMS MICROBIOL ECOL, V62, P171, DOI 10.1111/j.1574-6941.2007.00379.x; Zhou SR, 2008, ECOLOGY, V89, P248, DOI 10.1890/06-1817.1	44	12	14	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 11	2015	10	5							e0126962	10.1371/journal.pone.0126962	http://dx.doi.org/10.1371/journal.pone.0126962			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CI1YY	25961300	gold, Green Submitted, Green Published			2022-12-26	WOS:000354542500164
J	Dahlmann, TA; Kuck, U				Dahlmann, Tim A.; Kueck, Ulrich			Dicer-Dependent Biogenesis of Small RNAs and Evidence for MicroRNA-Like RNAs in the Penicillin Producing Fungus Penicillium chrysogenum	PLOS ONE			English	Article							DEVELOPMENTALLY-REGULATED GENES; PLANT-PATHOGENIC FUNGUS; INTERFERENCE PATHWAYS; NEUROSPORA-CRASSA; MESSENGER-RNAS; MECHANISMS; RETROTRANSPOSON; CLASSIFICATION; IDENTIFICATION; HYBRIDIZATION	MicroRNAs (miRNAs) are non-coding small RNAs (sRNAs) that regulate gene expression in a wide range of eukaryotes. In this study, we analyzed regulatory sRNAs in Penicillium chrysogenum, the industrial producer of the beta-lactam antibiotic penicillin. To identify sRNAs and microRNA-like RNAs (milRNAs) on a global approach, two sRNA sequencing libraries were constructed. One library was created with pooled total RNA, obtained from twelve differently grown cultures (RNA Mix), and the other with total RNA from a single submerged cultivation (Delta ku70FRT2). Illumina sequencing of both RNA libraries produced 84,322,825 mapped reads. To distinguish between Dicer-dependent and independent sRNA formation, we further constructed two single dicer gene mutants (Delta dcl2 and Delta dcl1) and a dicer double mutant (Delta dcl2 Delta dcl1) and analyzed an sRNA library from the Dicer-deficient double-mutant. We identified 661 Dicer-dependent loci and in silico prediction revealed 34 milRNAs. Northern blot hybridization of two milRNAs provided evidence for mature milRNAs that are processed either in a complete or partial Dicer-dependent manner from an RNA precursor. Identified milRNAs share typical characteristics of previously discovered fungal milRNAs, like a strong preference for a 5' uracil and the typical length distribution. The detection of potential milRNA target sites in the genome suggests that milRNAs might play a role in post-transcriptional gene regulation. Our data will further increase our knowledge of sRNA dependent gene regulation processes, which is an important prerequisite to develop more effective strategies for improving industrial fermentations with P. chrysogenum.	[Dahlmann, Tim A.; Kueck, Ulrich] Ruhr Univ Bochum, Lehrstuhl Allgemeine & Mol Bot, Christian Doppler Lab Fungal Biotechnol, D-44780 Bochum, Germany	Ruhr University Bochum	Kuck, U (corresponding author), Ruhr Univ Bochum, Lehrstuhl Allgemeine & Mol Bot, Christian Doppler Lab Fungal Biotechnol, Univ Str 150, D-44780 Bochum, Germany.	ulrich.kueck@rub.de	Dahlmann, Tim Alexander/AAS-6500-2020					ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Avesson L, 2012, RNA, V18, P1771, DOI 10.1261/rna.033175.112; Axtell MJ, 2013, ANNU REV PLANT BIOL, V64, P137, DOI 10.1146/annurev-arplant-050312-120043; Axtell MJ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-221; Bohm J, 2013, P NATL ACAD SCI USA, V110, P1476, DOI 10.1073/pnas.1217943110; Bologna NG, 2014, ANNU REV PLANT BIOL, V65, P473, DOI 10.1146/annurev-arplant-050213-035728; Bonnet E, 2010, BIOINFORMATICS, V26, P1566, DOI 10.1093/bioinformatics/btq233; Braumann I, 2007, FUNGAL GENET BIOL, V44, P1399, DOI 10.1016/j.fgb.2007.07.010; Catalanotto C, 2004, MOL CELL BIOL, V24, P2536, DOI 10.1128/MCB.24.6.2536-2545.2004; Chang SS, 2012, ANNU REV MICROBIOL, V66, P305, DOI 10.1146/annurev-micro-092611-150138; Chen R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104956; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Drinnenberg IA, 2011, SCIENCE, V333, P1592, DOI 10.1126/science.1209575; Enright AJ, 2004, GENOME BIOL, V5; Felice KM, 2009, BIOCHEM J, V422, P329, DOI 10.1042/BJ20090534; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Fulci V, 2007, CURR OPIN MICROBIOL, V10, P199, DOI 10.1016/j.mib.2007.03.016; Gesing S, 2013, J BASIC MICROB, V53, P742, DOI 10.1002/jobm.201200223; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hoff B, 2010, EUKARYOT CELL, V9, P1236, DOI 10.1128/EC.00077-10; Hoff B, 2010, APPL MICROBIOL BIOT, V85, P1081, DOI 10.1007/s00253-009-2168-4; Iwakawa H, 2013, MOL CELL, V52, P591, DOI 10.1016/j.molcel.2013.10.033; Janus D, 2009, MICROBIOL-SGM, V155, P3946, DOI 10.1099/mic.0.032763-0; Jiang N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052734; Kang K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076288; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kim SW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1235; Kim VN, 2005, MOL CELLS, V19, P1; Kopke K, 2010, APPL ENVIRON MICROB, V76, P4664, DOI 10.1128/AEM.00670-10; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lau SKP, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002398; Lee HC, 2010, MOL CELL, V38, P803, DOI 10.1016/j.molcel.2010.04.005; Lein J., 1986, OVERPRODUCTION MICRO, P105; Li LD, 2010, CELL MOL LIFE SCI, V67, P3849, DOI 10.1007/s00018-010-0471-y; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Molnar A, 2007, NATURE, V447, P1126, DOI 10.1038/nature05903; Murata T, 2007, NUCLEIC ACIDS RES, V35, P5987, DOI 10.1093/nar/gkm646; Nakayashiki H, 2005, FEBS LETT, V579, P5950, DOI 10.1016/j.febslet.2005.08.016; Nicolas FE, 2013, INT J MOL SCI, V14, P15348, DOI 10.3390/ijms140815348; Nicolas FE, 2010, NUCLEIC ACIDS RES, V38, P5535, DOI 10.1093/nar/gkq301; Nolan T, 2005, NUCLEIC ACIDS RES, V33, P1564, DOI 10.1093/nar/gki300; Nowrousian M, 2005, MOL GENET GENOMICS, V273, P137, DOI 10.1007/s00438-005-1118-9; Nunes Cristiano C., 2011, Fungal Biology Reviews, V25, P172, DOI 10.1016/j.fbr.2011.10.001; Nunes CC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-288; Segers GC, 2007, P NATL ACAD SCI USA, V104, P12902, DOI 10.1073/pnas.0702500104; Specht T, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00577-14; van den Berg MA, 2008, NAT BIOTECHNOL, V26, P1161, DOI 10.1038/nbt.1498; Wilczynska A, 2015, CELL DEATH DIFFER, V22, P22, DOI 10.1038/cdd.2014.112; Windhofer F, 2002, FUNGAL GENET BIOL, V35, P171, DOI 10.1006/fgbi.2001.1323; Wolfers S., 2014, J BASIC MICROB, V54, P1, DOI DOI 10.1002/JOBM.201200431; Zhou JH, 2012, MOL GENET GENOMICS, V287, P275, DOI 10.1007/s00438-012-0678-8	61	29	29	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0125989	10.1371/journal.pone.0125989	http://dx.doi.org/10.1371/journal.pone.0125989			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955857	gold, Green Published, Green Submitted			2022-12-26	WOS:000356768100089
J	Feuda, R; Smith, AB				Feuda, Roberto; Smith, Andrew B.			Phylogenetic Signal Dissection Identifies the Root of Starfishes	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; ASTEROIDEA; MITOCHONDRIAL; EVOLUTION; CLASSIFICATION; DIVERGENCE; INSIGHTS; SYSTEMATICS; OPHIUROIDEA; ECHINOIDEA	Relationships within the class Asteroidea have remained controversial for almost 100 years and, despite many attempts to resolve this problem using molecular data, no consensus has yet emerged. Using two nuclear genes and a taxon sampling covering the major asteroid clades we show that non-phylogenetic signal created by three factors - Long Branch Attraction, compositional heterogeneity and the use of poorly fitting models of evolution have confounded accurate estimation of phylogenetic relationships. To overcome the effect of this non-phylogenetic signal we analyse the data using non-homogeneous models, site stripping and the creation of subpartitions aimed to reduce or amplify the systematic error, and calculate Bayes Factor support for a selection of previously suggested topological arrangements of asteroid orders. We show that most of the previous alternative hypotheses are not supported in the most reliable data partitions, including the previously suggested placement of either Forcipulatida or Paxillosida as sister group to the other major branches. The best-supported solution places Velatida as the sister group to other asteroids, and the implications of this finding for the morphological evolution of asteroids are presented.	[Feuda, Roberto] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Smith, Andrew B.] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England	California Institute of Technology; Natural History Museum London	Feuda, R (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	rfeuda@caltech.edu	feuda, roberto/L-2477-2019; Feuda, Roberto/AAB-1377-2021	Feuda, Roberto/0000-0003-0857-1732				Anisimova M, 2011, SYST BIOL, V60, P685, DOI 10.1093/sysbio/syr041; Bergsten J, 2013, SYST BIOL, V62, P660, DOI 10.1093/sysbio/syt029; Blake D. B., 1989, ASTEROIDEA FUNCTIONA; BLAKE DB, 1987, J NAT HIST, V21, P481, DOI 10.1080/00222938700771141; Blake DB, 1988, ECH BIOL P 6 INT ECH; Blanquart S, 2008, MOL BIOL EVOL, V25, P842, DOI 10.1093/molbev/msn018; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; Cummins CA, 2011, SYST BIOL, V60, P833, DOI 10.1093/sysbio/syr064; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Foster PG, 1999, J MOL EVOL, V48, P284, DOI 10.1007/PL00006471; GALE AS, 1987, ZOOL J LINN SOC-LOND, V89, P107, DOI 10.1111/j.1096-3642.1987.tb00652.x; Gale AS., 2011, SPEC PAP PALAEONTOL, P85; Heddle D, 1995, ECHINODERM RESEARCH 1995, P179; Janies D, 2001, CAN J ZOOL, V79, P1232, DOI 10.1139/cjz-79-7-1232; Janies DA, 2011, SYST BIOL, V60, P420, DOI 10.1093/sysbio/syr044; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kerr AM, 2001, ZOOL J LINN SOC-LOND, V133, P63, DOI 10.1006/zjls.2000.0280; Knott KE, 2000, AM ZOOL, V40, P382, DOI 10.1668/0003-1569(2000)040[0382:CACIAS]2.0.CO;2; Kroh A, 2010, J SYST PALAEONTOL, V8, P147, DOI 10.1080/14772011003603556; LAFAY B, 1995, SYST BIOL, V44, P190, DOI 10.2307/2413706; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Littlewood DTJ, 1997, BIOL J LINN SOC, V61, P409, DOI 10.1006/bijl.1996.0131; MacBride EW, 1921, NATURE, V106, P501; Mah C, 2011, ZOOL J LINN SOC-LOND, V162, P646, DOI 10.1111/j.1096-3642.2010.00688.x; Mah C, 2011, ZOOL J LINN SOC-LOND, V161, P769, DOI 10.1111/j.1096-3642.2010.00659.x; Mah CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035644; Matsubara M, 2005, MOL PHYLOGENET EVOL, V36, P598, DOI 10.1016/j.ympev.2005.03.018; MCEDWARD LR, 1993, BIOL BULL, V184, P255, DOI 10.2307/1542444; Mortensen T., 1921, STUDIES DEV LARVAL F; Okanishi M, 2011, MOL PHYLOGENET EVOL, V61, P392, DOI 10.1016/j.ympev.2011.07.003; Perseke M, 2010, MOL PHYLOGENET EVOL, V56, P201, DOI 10.1016/j.ympev.2010.01.035; Philippe H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000602; Pisani D, 2004, SYST BIOL, V53, P978, DOI 10.1080/10635150490888877; Pisani D, 2012, MOL PHYLOGENET EVOL, V62, P27, DOI 10.1016/j.ympev.2011.08.028; Quang LS, 2008, BIOINFORMATICS, V24, P2317, DOI 10.1093/bioinformatics/btn445; Rota-Stabelli O, 2013, SYST BIOL, V62, P121, DOI 10.1093/sysbio/sys077; Rota-Stabelli O, 2011, P ROY SOC B-BIOL SCI, V278, P298, DOI 10.1098/rspb.2010.0590; Roure B, 2012, MOL BIOL EVOLUTION; Smith AB, 2006, MOL BIOL EVOL, V23, P1832, DOI 10.1093/molbev/msl039; Smith AB, 2013, BIOL J LINN SOC, V109, P670, DOI 10.1111/bij.12073; Sperling EA, 2011, EVOL DEV, V13, P290, DOI 10.1111/j.1525-142X.2011.00480.x; Sperling EA, 2009, MOL BIOL EVOL, V26, P2261, DOI 10.1093/molbev/msp148; Telford MJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0479; Wada H, 1996, MOL PHYLOGENET EVOL, V6, P97, DOI 10.1006/mpev.1996.0062; Xie WG, 2011, SYST BIOL, V60, P150, DOI 10.1093/sysbio/syq085	45	22	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0123331	10.1371/journal.pone.0123331	http://dx.doi.org/10.1371/journal.pone.0123331			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955729	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000356768100011
J	Krabs, RU; Enk, R; Teich, N; Koelsch, S				Krabs, Roland Uwe; Enk, Ronny; Teich, Niels; Koelsch, Stefan			Autonomic Effects of Music in Health and Crohn's Disease: The Impact of Isochronicity, Emotional Valence, and Tempo	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; INFLAMMATORY-BOWEL-DISEASE; AUDITORY-STIMULATION; PHYSIOLOGICAL-RESPONSES; ULCERATIVE-COLITIS; PSYCHOPHYSIOLOGICAL RESPONSES; DIFFERENT STYLES; RELAXING MUSIC; NERVOUS-SYSTEM; NEURAL-CONTROL	Background Music can evoke strong emotions and thus elicit significant autonomic nervous system (ANS) responses. However, previous studies investigating music-evoked ANS effects produced inconsistent results. In particular, it is not clear (a) whether simply a musical tactus (without common emotional components of music) is sufficient to elicit ANS effects; (b) whether changes in the tempo of a musical piece contribute to the ANS effects; (c) whether emotional valence of music influences ANS effects; and (d) whether music-elicited ANS effects are comparable in healthy subjects and patients with Crohn's disease (CD, an inflammatory bowel disease suspected to be associated with autonomic dysfunction). Methods To address these issues, three experiments were conducted, with a total of n = 138 healthy subjects and n = 19 CD patients. Heart rate (HR), heart rate variability (HRV), and electrodermal activity (EDA) were recorded while participants listened to joyful pleasant music, isochronous tones, and unpleasant control stimuli. Results Compared to silence, both pleasant music and unpleasant control stimuli elicited an increase in HR and a decrease in a variety of HRV parameters. Surprisingly, similar ANS effects were elicited by isochronous tones (i.e., simply by a tactus). ANS effects did not differ between pleasant and unpleasant stimuli, and different tempi of the music did not entrain ANS activity. Finally, music-evoked ANS effects did not differ between healthy individuals and CD patients. Conclusions The isochronous pulse of music (i.e., the tactus) is a major factor of music-evoked ANS effects. These ANS effects are characterized by increased sympathetic activity. The emotional valence of a musical piece contributes surprisingly little to the ANS activity changes evoked by that piece.	[Krabs, Roland Uwe; Enk, Ronny; Koelsch, Stefan] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Teich, Niels] Grp Practice Digest & Metab Dis, Leipzig, Germany; [Koelsch, Stefan] Free Univ Berlin, Cluster Excellence Languages Emot, Berlin, Germany	Max Planck Society; Free University of Berlin	Koelsch, S (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany.	stefan.koelsch@fu-berlin.de	Teich, Niels/AAF-5104-2019; Koelsch, Stefan/AAV-1556-2020	Koelsch, Stefan/0000-0002-8714-3404				Acharya UR, 2006, MED BIOL ENG COMPUT, V44, P1031, DOI 10.1007/s11517-006-0119-0; Amaral JAT, 2014, TURK KARDIYOL DERN A, V42, P139, DOI 10.5543/tkda.2014.39000; Armour JA, 2004, BASIC AND CLINICAL N; Aust S, 2014, SOC COGN AFFECT NEUR, V9, P1038, DOI 10.1093/scan/nst078; Bai A, 2009, CLIN EXP IMMUNOL, V156, P353, DOI 10.1111/j.1365-2249.2009.03894.x; Baltes FR, 2011, BRAIN COGNITION, V76, P146, DOI 10.1016/j.bandc.2011.01.012; Baumgart DC, 2012, LANCET, V380, P1590, DOI 10.1016/S0140-6736(12)60026-9; Bellinger DL, 2014, AUTON NEUROSCI-BASIC, V182, P15, DOI 10.1016/j.autneu.2014.01.006; Bernardi L, 2006, HEART, V92, P445, DOI 10.1136/hrt.2005.064600; Bernardi L, 2009, CIRCULATION, V119, P3171, DOI 10.1161/CIRCULATIONAHA.108.806174; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Bonaz BL, 2013, GASTROENTEROLOGY, V144, P36, DOI 10.1053/j.gastro.2012.10.003; Borchers AT, 2014, AUTOIMMUN REV, V13, P242, DOI 10.1016/j.autrev.2013.10.006; Bos MGN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062661; Boucsein W, 2012, ELECTRODERMAL ACTIVITY, SECOND EDITION, P1, DOI 10.1007/978-1-4614-1126-0; Bradley MM, 2000, PSYCHOPHYSIOLOGY, V37, P204, DOI 10.1111/1469-8986.3720204; Bradt J, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006908.pub2; Bradt J, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD006911.pub2, 10.1002/14651858.CD006911]; Bradt J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006577.pub2; Camm AJ, 1996, EUR HEART J, V17, P354; Chen DD, 2005, SCAND J GASTROENTERO, V40, P814, DOI 10.1080/00365520510015656; Ciesielczyk K, 2013, POSTEP HIG MED DOSW, V67, P304, DOI 10.5604/17322693.1044747; Clayton M., 2005, EUR MEET ETHNOMUSICO, V11, P3, DOI DOI 10.1093/ACPROF:OSO/9780195339680.001.0001; Coruzzi P, 2007, EUR J CLIN INVEST, V37, P964, DOI 10.1111/j.1365-2362.2007.01887.x; Critchley HD, 2009, INT J PSYCHOPHYSIOL, V73, P88, DOI 10.1016/j.ijpsycho.2009.01.012; da Silva SAF, 2014, INT CARDIOVASC RES J, V8, P105; da Silva Sheila Ap F, 2014, Int Arch Med, V7, P27, DOI 10.1186/1755-7682-7-27; DAVIS WB, 1989, J MUSIC THER, V26, P168, DOI 10.1093/jmt/26.4.168; ELLIS DS, 1952, AM J PSYCHOL, V65, P39, DOI 10.2307/1418826; Escher J, 1999, Praxis (Bern 1994), V88, P951; Etzel JA, 2006, INT J PSYCHOPHYSIOL, V61, P57, DOI 10.1016/j.ijpsycho.2005.10.025; Fancourt D, 2014, BRAIN BEHAV IMMUN, V36, P15, DOI 10.1016/j.bbi.2013.10.014; Farrell RJ, 2002, LANCET, V359, P331, DOI 10.1016/S0140-6736(02)07499-8; Fritz T, 2009, CURR BIOL, V19, P573, DOI 10.1016/j.cub.2009.02.058; Furlan R, 2006, AM J PHYSIOL-REG I, V290, pR224, DOI 10.1152/ajpregu.00442.2005; Ganguli SC, 2007, NEUROGASTROENT MOTIL, V19, P961, DOI 10.1111/j.1365-2982.2007.00987.x; Gerra G, 1998, INT J PSYCHOPHYSIOL, V28, P99, DOI 10.1016/S0167-8760(97)00071-8; Ghia JE, 2008, J CLIN INVEST, V118, P2209, DOI 10.1172/JCI32849; Ghia JE, 2007, AM J PHYSIOL-GASTR L, V293, pG711, DOI 10.1152/ajpgi.00240.2007; Ghia JE, 2011, INFLAMM BOWEL DIS, V17, P1474, DOI 10.1002/ibd.21531; Giovannelli F, 2013, CORTEX, V49, P702, DOI 10.1016/j.cortex.2012.01.013; Gomez P, 2007, EMOTION, V7, P377, DOI 10.1037/1528-3542.7.2.377; Grewe O, 2009, ANN NY ACAD SCI, V1169, P351, DOI 10.1111/j.1749-6632.2009.04783.x; Gussak I, 2013, ELECTRICAL DISEASES, V1; Hanser SB, 2013, CARDIOL REV; Harrer G., 1977, MUSIC BRAIN STUDIES, P202; Heathers JAJ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00177; Hoffmann J C, 2008, Z Gastroenterol, V46, P1094, DOI 10.1055/s-2008-1027796; Irwin MR, 2008, BRAIN BEHAV IMMUN, V22, P129, DOI 10.1016/j.bbi.2007.07.013; Iwanaga M, 2005, BIOL PSYCHOL, V70, P61, DOI 10.1016/j.biopsycho.2004.11.015; Iwanaga M, 1999, J MUSIC THER, V36, P26, DOI 10.1093/jmt/36.1.26; Iwanaga M, 1997, PERCEPT MOTOR SKILL, V85, P287, DOI 10.2466/pms.1997.85.1.287; Juslin PN, 2013, PHYS LIFE REV, V10, P235, DOI 10.1016/j.plrev.2013.05.008; Juslin PN, 2010, HANDBOOK OF MUSIC AN, VXIV; Kemp AH, 2010, BIOL PSYCHIAT, V67, P1067, DOI [10.1016/j.biopsych.2009.11.019, 10.1016/j.biopsych.2009.12.012]; Khalfa S, 2008, INT J PSYCHOPHYSIOL, V68, P17, DOI 10.1016/j.ijpsycho.2007.12.001; Kiecolt-Glaser JK, 2002, ANNU REV PSYCHOL, V53, P83, DOI 10.1146/annurev.psych.53.100901.135217; Kishi T, 2012, J CARDIOL, V59, P117, DOI 10.1016/j.jjcc.2011.12.006; KLEIGER RE, 1987, AM J CARDIOL, V59, P256, DOI 10.1016/0002-9149(87)90795-8; Koelsch S, 2006, HUM BRAIN MAPP, V27, P239, DOI 10.1002/hbm.20180; Koelsch S., 2012, BRAIN MUSIC; Koelsch S, 2007, EUR J NEUROSCI, V26, P3328, DOI 10.1111/j.1460-9568.2007.05889.x; Koelsch S, 2014, NAT REV NEUROSCI, V15, P170, DOI 10.1038/nrn3666; Koelsch S, 2013, NEUROIMAGE, V81, P49, DOI 10.1016/j.neuroimage.2013.05.008; Koelsch S, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00058; Koelsch S, 2010, MUSIC PERCEPT, V27, P307, DOI 10.1525/MP.2010.27.4.307; Kreibig SD, 2010, BIOL PSYCHOL, V84, P394, DOI 10.1016/j.biopsycho.2010.03.010; Krumhansl CL, 1997, CAN J EXP PSYCHOL, V51, P336, DOI 10.1037/1196-1961.51.4.336; Laass MW, 2014, AUTOIMMUN REV, V13, P467, DOI 10.1016/j.autrev.2014.01.029; Lai HL, 2004, GERIATR NURS, V25, P286, DOI 10.1016/j.gerinurse.2004.08.009; Lai HL, 2013, STRESS HEALTH, V29, P91, DOI 10.1002/smi.2429; LECHIN F, 1985, J CLIN PHARMACOL, V25, P219, DOI 10.1002/j.1552-4604.1985.tb02828.x; LINDGREN S, 1991, SCAND J GASTROENTERO, V26, P361, DOI 10.3109/00365529108996495; LINDGREN S, 1993, SCAND J GASTROENTERO, V28, P638, DOI 10.3109/00365529309096103; Maule S, 2007, CLIN AUTON RES, V17, P217, DOI 10.1007/s10286-007-0425-0; Maunder RG, 2006, EUR J GASTROEN HEPAT, V18, P413, DOI 10.1097/00042737-200604000-00016; Mikutta CA, 2013, PSYCHOPHYSIOLOGY, V50, P909, DOI 10.1111/psyp.12071; MOCKEL M, 1994, EUR J APPL PHYSIOL, V68, P451, DOI 10.1007/BF00599512; Nakahara H, 2011, INT J PSYCHOPHYSIOL, V81, P152, DOI 10.1016/j.ijpsycho.2011.06.003; Nater UM, 2006, INT J PSYCHOPHYSIOL, V62, P300, DOI 10.1016/j.ijpsycho.2006.05.011; Nieuwenhuys R, 2007, THE HUMAN CENTRAL NE; Nilsson Ulrica, 2008, AORN J, V87, P780, DOI 10.1016/j.aorn.2007.09.013; Ohlsson B, 2007, BMC GASTROENTEROL, V7, DOI 10.1186/1471-230X-7-33; Oishi Kazuo, 1999, Applied Human Science, V18, P101; Peng SM, 2009, J ALTERN COMPLEM MED, V15, P53, DOI 10.1089/acm.2008.0243; Perez-Lloret S, 2014, NOISE HEALTH, V16, P279, DOI 10.4103/1463-1741.140507; Rickard N.S., 2004, PSYCHOL MUSIC, V32, P371, DOI [DOI 10.1177/0305735604046096, 10.1177%2F0305735604046096]; Roque AL, 2013, CLINICS, V68, P960, DOI 10.6061/clinics/2013(07)12; Roque AL, 2013, NOISE HEALTH, V15, P281, DOI 10.4103/1463-1741.113527; Russo FA, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00468; Salimpoor VN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007487; Sammler D, 2007, PSYCHOPHYSIOLOGY, V44, P293, DOI 10.1111/j.1469-8986.2007.00497.x; Scherer K, 2008, BEHAV BRAIN SCI, V31, P595, DOI 10.1017/S0140525X08005505; Scherer Klaus R, 2013, EMOTIONAL POWER MUSI, V2013, P121, DOI DOI 10.1093/ACPROF:OSO/9780199654888.003.0010; Sharma P, 2009, DIGEST DIS SCI, V54, P853, DOI 10.1007/s10620-008-0424-6; SHEPARD RN, 1964, J ACOUST SOC AM, V36, P2346, DOI 10.1121/1.1919362; Spreckelmeyer KN, 2006, BRAIN RES, V1070, P160, DOI 10.1016/j.brainres.2005.11.075; Stojanovich L, 2010, AUTOIMMUN REV, V9, pA271, DOI 10.1016/j.autrev.2009.11.014; Straub RH, 1997, J NEUROIMMUNOL, V80, P149, DOI 10.1016/S0165-5728(97)00150-1; Taylor CT, 2007, AUTON NEUROSCI-BASIC, V133, P104, DOI 10.1016/j.autneu.2006.11.005; Thayer JF, 2009, ANN BEHAV MED, V37, P141, DOI 10.1007/s12160-009-9101-z; Thomas GD, 2011, ADV PHYSIOL EDUC, V35, P28, DOI 10.1152/advan.00114.2010; Todd NPM, 2014, HEARING RES, V309, P63, DOI 10.1016/j.heares.2013.11.008; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Valenti VE, 2012, CLINICS, V67, P955, DOI 10.6061/clinics/2012(08)16; van den Bosch I, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00534; VANDERARK SD, 1994, PERCEPT MOTOR SKILL, V79, P1391, DOI 10.2466/pms.1994.79.3.1391; Xhyheri B, 2012, PROG CARDIOVASC DIS, V55, P321, DOI 10.1016/j.pcad.2012.09.001; Yamashita S, 2006, J SPORT MED PHYS FIT, V46, P425; ZIMNY GH, 1963, AM J PSYCHOL, V76, P311, DOI 10.2307/1419170	110	25	25	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0126224	10.1371/journal.pone.0126224	http://dx.doi.org/10.1371/journal.pone.0126224			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CL2IX	25955253	Green Submitted, Green Published, gold			2022-12-26	WOS:000356768100105
J	Muhlethaler-Mottet, A; Liberman, J; Ascencao, K; Flahaut, M; Bourloud, KB; Yan, P; Jauquier, N; Gross, N; Joseph, JM				Muehlethaler-Mottet, Annick; Liberman, Julie; Ascencao, Kelly; Flahaut, Marjorie; Bourloud, Katia Balmas; Yan, Pu; Jauquier, Nicolas; Gross, Nicole; Joseph, Jean-Marc			The CXCR4/CXCR7/CXCL12 Axis Is Involved in a Secondary but Complex Control of Neuroblastoma Metastatic Cell Homing	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR4; PROSTATE-CANCER; COLON-CARCINOMA; IN-VIVO; TUMOR; GROWTH; LUNG; PROGRESSION; EXPRESSION; CXCL12	Neuroblastoma (NB) is one of the most deadly solid tumors of the young child, for which new efficient and targeted therapies are strongly needed. The CXCR4/CXCR7/CXCL12 chemokine axis has been involved in the progression and organ-specific dissemination of various cancers. In NB, CXCR4 expression was shown to be associated to highly aggressive undifferentiated tumors, while CXCR7 expression was detected in more differentiated and mature neuroblastic tumors. As investigated in vivo, using an orthotopic model of tumor cell implantation of chemokine receptor-overexpressing NB cells (IGR-NB8), the CXCR4/CXCR7/CXCL12 axis was shown to regulate NB primary and secondary growth, although without any apparent influence on organ selective metastasis. In the present study, we addressed the selective role of CXCR4 and CXCR7 receptors in the homing phase of metastatic dissemination using an intravenous model of tumor cell implantation. Tail vein injection into NOD-scid-gamma mice of transduced IGR-NB8 cells overexpressing CXCR4, CXCR7, or both receptors revealed that all transduced cell variants preferentially invaded the adrenal gland and typical NB metastatic target organs, such as the liver and the bone marrow. However, CXCR4 expression favored NB cell dissemination to the liver and the lungs, while CXCR7 was able to strongly promote NB cell homing to the adrenal gland and the liver. Finally, coexpression of CXCR4 and CXCR7 receptors significantly and selectively increased NB dissemination toward the bone marrow. In conclusion, CXCR4 and CXCR7 receptors may be involved in a complex and organ-dependent control of NB growth and selective homing, making these receptors and their inhibitors potential new therapeutic targets.	[Muehlethaler-Mottet, Annick; Liberman, Julie; Ascencao, Kelly; Flahaut, Marjorie; Bourloud, Katia Balmas; Jauquier, Nicolas; Gross, Nicole; Joseph, Jean-Marc] Univ Lausanne, Univ Hosp CHUV, Dept Pediat, Lausanne, Switzerland; [Yan, Pu] Univ Lausanne, Univ Hosp CHUV, Dept Pathol, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Muhlethaler-Mottet, A (corresponding author), Univ Lausanne, Univ Hosp CHUV, Dept Pediat, Lausanne, Switzerland.	Annick.Muhlethaler@chuv.ch	Mühlethaler-Mottet, Annick/H-2848-2019	Mühlethaler-Mottet, Annick/0000-0001-8274-0907	Fondation pour la lutte contre le cancer [317]; Association Hubert Gouin "Enfance et Cancer"; FORCE Fondation recherche sur le cancer de l'enfant; Emma Muschamp foundation	Fondation pour la lutte contre le cancer; Association Hubert Gouin "Enfance et Cancer"; FORCE Fondation recherche sur le cancer de l'enfant; Emma Muschamp foundation	This work was supported by Fondation pour la lutte contre le cancer, Grant # 317 (http://www.krebsbekaempfung.ch/html/english.html) (JMJ), Association Hubert Gouin "Enfance et Cancer" (http://www.enfance-et-cancer.org/) (NG), FORCE Fondation recherche sur le cancer de l'enfant (http://www.force-fondation.ch/) (NG), and Emma Muschamp foundation (http://www.s-a-v.org/Fondations-associees-.html) (JMJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi I, 2006, CLIN CANCER RES, V12, P77, DOI 10.1158/1078-0432.CCR-05-1376; Arscott WT, 2009, ONCOGENE, V28, P479, DOI 10.1038/onc.2008.402; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Brennecke P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074045; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Cheung NKV, 2013, NAT REV CANCER, V13, P397, DOI 10.1038/nrc3526; Choi YH, 2014, MOL CANCER RES, V12, P38, DOI 10.1158/1541-7786.MCR-12-0334; CICCARONE V, 1989, CANCER RES, V49, P219; Cowie F, 1997, MED PEDIATR ONCOL, V28, P429, DOI 10.1002/(SICI)1096-911X(199706)28:6<429::AID-MPO7>3.3.CO;2-X; Domanska UM, 2013, EUR J CANCER, V49, P219, DOI 10.1016/j.ejca.2012.05.005; Goguet-Surmenian E, 2013, BRIT J CANCER, V109, P1579, DOI 10.1038/bjc.2013.482; Gross N, 2009, SEMIN CANCER BIOL, V19, P103, DOI 10.1016/j.semcancer.2008.10.009; Grymula K, 2010, INT J CANCER, V127, P2554, DOI 10.1002/ijc.25245; Guillemot E, 2012, BRIT J CANCER, V107, P1944, DOI 10.1038/bjc.2012.503; Hattermann K, 2013, ANN ANAT, V195, P103, DOI 10.1016/j.aanat.2012.10.013; Hernandez L, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3074; Joseph JM, 2005, INT J CANCER, V113, P881, DOI 10.1002/ijc.20681; Kammen BF, 2001, AM J ROENTGENOL, V176, P755, DOI 10.2214/ajr.176.3.1760755; Kollmar O, 2010, INT J CANCER, V126, P1302, DOI 10.1002/ijc.24956; Liberman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043665; Lin L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.392; Ma M, 2011, CANCER LETT, V312, P1, DOI 10.1016/j.canlet.2011.06.028; Mazzinghi B, 2008, J EXP MED, V205, P479, DOI 10.1084/jem.20071903; Meier R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001016; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Phillips RJ, 2003, AM J RESP CRIT CARE, V167, P1676, DOI 10.1164/rccm.200301-071OC; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Russell HV, 2004, J PEDIATR SURG, V39, P1506, DOI 10.1016/j.jpedsurg.2004.06.019; Sanchez-Martin L, 2013, TRENDS MOL MED, V19, P12, DOI 10.1016/j.molmed.2012.10.004; Sarvaiya PJ, 2013, ONCOTARGET, V4, P2171, DOI 10.18632/oncotarget.1426; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Thelen M, 2001, NAT IMMUNOL, V2, P129, DOI 10.1038/84224; Thelen M, 2008, J NEUROIMMUNOL, V198, P9, DOI 10.1016/j.jneuroim.2008.04.020; Thiele CJ, 1999, HUMAN CELL CULTURE, V1, P21; Vicari AP, 2002, CYTOKINE GROWTH F R, V13, P143, DOI 10.1016/S1359-6101(01)00033-8; Wang JH, 2005, CELL SIGNAL, V17, P1578, DOI 10.1016/j.cellsig.2005.03.022; Wang JH, 2008, J BIOL CHEM, V283, P4283, DOI 10.1074/jbc.M707465200; Zabel BA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-73; Zabel BA, 2009, J IMMUNOL, V183, P3204, DOI 10.4049/jimmunol.0900269; Zeelenberg IS, 2003, CANCER RES, V63, P3833; Zhang LB, 2007, NEOPLASIA, V9, P36, DOI 10.1593/neo.06670	45	23	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2015	10	5							e0125616	10.1371/journal.pone.0125616	http://dx.doi.org/10.1371/journal.pone.0125616			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL2IX	25955316	Green Published, Green Submitted, gold			2022-12-26	WOS:000356768100062
